<SEC-DOCUMENT>0000721371-21-000080.txt : 20210816
<SEC-HEADER>0000721371-21-000080.hdr.sgml : 20210816
<ACCEPTANCE-DATETIME>20210816085000
ACCESSION NUMBER:		0000721371-21-000080
CONFORMED SUBMISSION TYPE:	10-K
PUBLIC DOCUMENT COUNT:		130
CONFORMED PERIOD OF REPORT:	20210630
FILED AS OF DATE:		20210816
DATE AS OF CHANGE:		20210816

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			CARDINAL HEALTH INC
		CENTRAL INDEX KEY:			0000721371
		STANDARD INDUSTRIAL CLASSIFICATION:	WHOLESALE-DRUGS PROPRIETARIES & DRUGGISTS' SUNDRIES [5122]
		IRS NUMBER:				310958666
		STATE OF INCORPORATION:			OH
		FISCAL YEAR END:			0630

	FILING VALUES:
		FORM TYPE:		10-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-11373
		FILM NUMBER:		211174800

	BUSINESS ADDRESS:	
		STREET 1:		7000 CARDINAL PLACE
		CITY:			DUBLIN
		STATE:			OH
		ZIP:			43017
		BUSINESS PHONE:		6147573033

	MAIL ADDRESS:	
		STREET 1:		7000 CARDINAL PLACE
		CITY:			DUBLIN
		STATE:			OH
		ZIP:			43017

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CARDINAL DISTRIBUTION INC
		DATE OF NAME CHANGE:	19920703
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-K
<SEQUENCE>1
<FILENAME>cah-20210630.htm
<DESCRIPTION>10-K
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2021 Workiva--><!--r:b63e0697-7630-4efc-9622-5764c41287f3,g:18dc0520-9457-4463-b618-29c4ac061652,d:4f0ec56b9c604f1782a65ea4a19c284d--><html xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:srt="http://fasb.org/srt/2021-01-31" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:dei="http://xbrl.sec.gov/dei/2021" xmlns="http://www.w3.org/1999/xhtml" xmlns:cah="http://www.cardinal.com/20210630" xmlns:country="http://xbrl.sec.gov/country/2021" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:xbrli="http://www.xbrl.org/2003/instance" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>cah-20210630</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630" format="ixt:booleanfalse" name="dei:AmendmentFlag" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF80L2ZyYWc6NDY5NTgyNjRiYWY1NDM3YmE4ZDAyMzIxYjBjODQ2YmEvdGFibGU6YTJhYzY4ZjFjY2M4NDI4ZjgxZWQ4MzQwYTQ1MjA1YTMvdGFibGVyYW5nZTphMmFjNjhmMWNjYzg0MjhmODFlZDgzNDBhNDUyMDVhM18xLTEtMS0xLTA_648f2c0a-818f-4371-8c48-e1fe776bf23e">FALSE</ix:nonNumeric><ix:nonNumeric contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630" format="ixt:datemonthdayyearen" name="dei:DocumentPeriodEndDate" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF80L2ZyYWc6NDY5NTgyNjRiYWY1NDM3YmE4ZDAyMzIxYjBjODQ2YmEvdGFibGU6YTJhYzY4ZjFjY2M4NDI4ZjgxZWQ4MzQwYTQ1MjA1YTMvdGFibGVyYW5nZTphMmFjNjhmMWNjYzg0MjhmODFlZDgzNDBhNDUyMDVhM18yLTEtMS0xLTA_5764b1fe-c1b7-4e5e-a45c-a3ac22c8f484">June 30, 2021</ix:nonNumeric><ix:nonNumeric contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630" name="dei:DocumentFiscalYearFocus" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF80L2ZyYWc6NDY5NTgyNjRiYWY1NDM3YmE4ZDAyMzIxYjBjODQ2YmEvdGFibGU6YTJhYzY4ZjFjY2M4NDI4ZjgxZWQ4MzQwYTQ1MjA1YTMvdGFibGVyYW5nZTphMmFjNjhmMWNjYzg0MjhmODFlZDgzNDBhNDUyMDVhM18zLTEtMS0xLTA_5ceb952b-3cd4-4a7f-ab46-ac32d2050d7e">2021</ix:nonNumeric><ix:nonNumeric contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630" name="dei:DocumentFiscalPeriodFocus" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF80L2ZyYWc6NDY5NTgyNjRiYWY1NDM3YmE4ZDAyMzIxYjBjODQ2YmEvdGFibGU6YTJhYzY4ZjFjY2M4NDI4ZjgxZWQ4MzQwYTQ1MjA1YTMvdGFibGVyYW5nZTphMmFjNjhmMWNjYzg0MjhmODFlZDgzNDBhNDUyMDVhM180LTEtMS0xLTA_455ed8e3-8b92-44b8-b4dd-0fdb08dbea85">FY</ix:nonNumeric><ix:nonNumeric contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630" name="dei:EntityCentralIndexKey" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF80L2ZyYWc6NDY5NTgyNjRiYWY1NDM3YmE4ZDAyMzIxYjBjODQ2YmEvdGFibGU6YTJhYzY4ZjFjY2M4NDI4ZjgxZWQ4MzQwYTQ1MjA1YTMvdGFibGVyYW5nZTphMmFjNjhmMWNjYzg0MjhmODFlZDgzNDBhNDUyMDVhM181LTEtMS0xLTA_9a12d34e-befa-4059-a3d4-8e9bb5103e38">0000721371</ix:nonNumeric><ix:nonNumeric contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630" name="dei:CurrentFiscalYearEndDate" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF80L2ZyYWc6NDY5NTgyNjRiYWY1NDM3YmE4ZDAyMzIxYjBjODQ2YmEvdGFibGU6YTJhYzY4ZjFjY2M4NDI4ZjgxZWQ4MzQwYTQ1MjA1YTMvdGFibGVyYW5nZTphMmFjNjhmMWNjYzg0MjhmODFlZDgzNDBhNDUyMDVhM182LTEtMS0xLTA_8f2be3e5-1f87-4de2-a1cf-ac1ea8ecace7">--06-30</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="cah-20210630.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="usd"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:context id="if53145a5ccc7474d828f32716fb56f3f_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:context id="i8567a5e9e68d45bd946706441532802e_I20210731"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-07-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia31e9a409b874bb19d0ff6f2f39ecc09_D20190701-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i00a6d666bf604826b24e68ddbd63eac4_D20180701-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2018-07-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="usdPerShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:context id="i2e87824102b34590a0208cc7da91b5f5_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i299cea70f47b4fbe96772aaa8cc00b79_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iba537ecaa59e43b0a9b66571c8100267_I20180630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id3a1b5ab2e8f487b9c151040675e8c4e_I20180630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if1e3a4cc24f142cdafa5042dfc5dd64d_I20180630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifb73250f67a2413d876abaab75f9b78e_I20180630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9ffaf87e6d734e599ad2b8cf9d894639_I20180630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i39bbe70148ff4daea469e8420c1859d6_I20180630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2018-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i368e27a25f8645faa683a133e4fd114e_D20180701-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-07-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7a763b06539a46f2af8919fe47c2b61a_D20180701-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-07-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i192683d94cc4483f889528979a51af74_D20180701-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-07-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8d9cc349c75d4429b567d5aa909a3433_D20180701-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-07-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifec5466baa034dc5b60b6acb6798f00e_D20180701-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-07-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2c0babdbad624aa0b4937db55d311dfe_I20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i04bec8a518fa429988f9b9473cfeb451_I20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0acb4be80aa74c89bc743cf58fc67d77_I20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i08559a107c7a4c31965cd373a397c3af_I20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i401ce4a0ca0546f58fbbd8672082718a_I20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if6dc09eec4e74751b47cdf037a5b1860_I20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2019-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibeaaa4c81e084b86a689f640458f607a_D20190701-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6b350fae2224486aa2a6ffc44c36559b_D20190701-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4c5f25e0cc4f4d04a3afc3f86804554c_D20190701-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0361658ee5604068a75c34f27c83ef6b_D20190701-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i61b655b20bf94b27a3ebf574f93a9915_D20190701-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3eeed4226e40446da06738c489d87462_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i177d5a23d5d64051ad7ef088e9f5ebd4_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idf14ef20aa2d4674855f6bc891acf9de_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iab6212d6a7c945a59137402110f15a40_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2f4057fc39254faf97951f0ee6826f17_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i400d2c56806648c1b6c3bdbab87c1d9d_D20200701-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idaac2fb8e90844538a6c23b3c7452e2b_D20200701-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i97b5509a63f04bc7ab5194aaf760af37_D20200701-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i93e121bdfcb240d3a40552629748af1b_D20200701-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2c9548aef74d4f1a8451e70e1ab67a37_D20200701-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2356cc59616246e39e97302436e6c7df_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8c7b0f49c7c44e0398779672048b5d26_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4295fef126f64025b7be038ce6dfbe12_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idec34558c686494fbf6ff02881153059_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1335220d8ce44acc9542c3208bad8a10_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaf39bca192e042209819db3ca973f9f5_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ida278becedcc42e688e90f303ce681a6_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia892a1655a98484e8d25b9944babb1df_D20200701-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icc7d995e453e439bb115adae40076bfd_D20200701-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id99ac5e3640e4d909d5ebe92cc1a2ccc_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForLossesOnFinanceReceivablesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8572a6af84c14033a1b8f2ffeeaa45fa_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForLossesOnFinanceReceivablesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="number"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><xbrli:context id="i9acbd6b22d7142e09e2d233e54af7d6b_D20200701-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">cah:CVSCaremarkCorporationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i40defd3d1e074fa6bc03365b87fbc0b2_D20190701-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">cah:CVSCaremarkCorporationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if0d0d489f9374df68a492baec5bcd02d_D20180701-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">cah:CVSCaremarkCorporationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-07-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8e11ba21ea4c434ca0730a61f91af07b_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">cah:CVSCaremarkCorporationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i26a1dbe593234221b3e2a9fe87790b80_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">cah:CVSCaremarkCorporationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i23c2808f4a0248299010d7304821d021_D20200701-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">cah:OptumRxMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i59cb1fe9f0d846b1911e81858e217d59_D20190701-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">cah:OptumRxMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id8d95892717a49629b3d443c58d7bb6f_D20180701-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">cah:OptumRxMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-07-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ife972a3c1957499f9517925bfb292b1e_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">cah:OptumRxMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2603a56be62748bcadc6977aeeb99c1b_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">cah:OptumRxMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="organization"><xbrli:measure>cah:organization</xbrli:measure></xbrli:unit><xbrli:context id="i9ff517d7ac9a411688a31be9bf4cb05e_D20200701-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">cah:GroupPurchasingOrganizationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i996d2cdb68d6466fbd2b2c5d332e8f86_D20190701-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">cah:GroupPurchasingOrganizationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9ac168f728314508a0b6274f4b016f43_D20180701-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">cah:GroupPurchasingOrganizationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-07-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i614ddf8189e1435c9f69debafd0268da_D20200701-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingAndBuildingImprovementsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i74619ac5c2144773b658fb4dc96df2b7_D20200701-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingAndBuildingImprovementsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4462638f30ef4b028287aa4982bcdc4f_D20200701-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i931fb7e29527410db9aa126b3ff884f1_D20200701-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8ffd747abee84446822890ec937c3087_D20200701-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i761e5d4debc244e2b82864c57e70fa08_D20200701-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i863c52bff06f4314bb6767d10ced9400_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LandBuildingsAndImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia665b083fde8404d909e9610ecbf7ad2_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LandBuildingsAndImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic27322390092452ca30941dd0197b1c6_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia561b68251434cae953175730691825e_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i98ce0cd9b3ce4100a31e1cfb9d99189d_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4e7acf9f1e1840958a192fad32010e75_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="segment"><xbrli:measure>cah:segment</xbrli:measure></xbrli:unit><xbrli:context id="i2ae0fa0d058b4f21aac5c8701cbd2fb7_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cah:CordisDivestitureAxis">cah:CordisDivestitureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id2a6b6641ae248c98d689f30c606f881_D20200701-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cah:OpioidLitigationAxis">cah:TotalOpioidLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i373ba6a0cdc044dea9602bdbad13174c_D20190701-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cah:OpioidLitigationAxis">cah:TotalOpioidLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic3592f06406544abac446d0e612f00d3_D20200701-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ShippingAndHandlingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifee3aa6b50684ca4a55e508c43164afe_D20190701-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ShippingAndHandlingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6e042ca2958c43e0a7786484c6024fa9_D20180701-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ShippingAndHandlingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-07-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia92b5f17e3cb4ca99a1789f7499fb2b2_D20210802-20210802"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cah:CordisDivestitureAxis">cah:CordisDivestitureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-08-02</xbrli:startDate><xbrli:endDate>2021-08-02</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0c45da2d8021400f85c81b3a75b9c057_D20200701-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cah:CordisDivestitureAxis">cah:CordisDivestitureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7f43dacd4cde4469bf87d551b8b075a1_D20180801-20180831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cah:NaviHealthAxis">cah:NaviHealthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-08-01</xbrli:startDate><xbrli:endDate>2018-08-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibfc08d70138644988d1a3a9486dd3ada_D20180701-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cah:NaviHealthAxis">cah:NaviHealthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-07-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i463eed964bd04d08b29df93f74be293d_I20180801"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cah:NaviHealthAxis">cah:NaviHealthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-08-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i240ee16a678541f0949ac8f39755276a_D20190701-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cah:NaviHealthAxis">cah:NaviHealthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i054d56750a764f7e93ff85a2bf9a1b2b_I20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i033d53d46d0d43139442c42e765cd554_I20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:FacilityClosingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i979647fadf85426a8ed1ad60900d45dc_D20190701-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i690a654e053647b6a93151845b9d81e9_D20190701-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:FacilityClosingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6b154a090610482d9bfc35edbf9bab55_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i74208c384ff247b5a96f11cafa8f324e_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:FacilityClosingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i66e672ad39ba4fbda69ce9255eb8afa1_D20200701-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i369bbd13125e4ca2a3de4a5c3da1ffc5_D20200701-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:FacilityClosingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iec538c38949543a3a758a69a4da1d7f4_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3af47ae162d94351b026bc1510125da6_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:FacilityClosingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3b152a2afe4f4679a06346db852d336d_I20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie6cb132adb5f4ff7aba14ffe42cc56d3_I20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:MedicalMemberMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib1a6fd7bfc8b43f5b583eff60a34f03f_D20190701-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icf7ee031a48e4d11b1c35c9709df0a86_D20190701-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:MedicalMemberMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2e9e49271a494ffb9966fdbbe81322b3_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3ca9000f2c0043198ff629f5aeec40d5_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:MedicalMemberMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if8ec1f608f8f43c6bb4bb0cd8bd6fb89_D20200701-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4f2593aaba1d4bcea5ad84327da58c41_D20200701-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:MedicalMemberMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4bc96e0706314db5b186dfb752f90fbf_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cah:CordisDivestitureAxis">cah:CordisDivestitureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if49fcb6df2f04a0aa6c1338190b0051b_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cah:CordisDivestitureAxis">cah:CordisDivestitureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:MedicalMemberMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i04a42200e8d447d5a05dcf88ecdb626a_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie33f818d5fa545a6bf5a055023560358_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:MedicalMemberMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie9082e4c164d4b1eb60733de4e88ad24_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">cah:IPRDTrademarksandOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i23d1c32c20a5440bb56a79d381e03b23_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i71898d44e3ea4dc6b493f7a21c418128_D20200701-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia82a764d4393423da214b8d6611567aa_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">cah:TrademarksAndPatentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idb9a0bc30ecf49c28ad8c5f1cd53fb7f_D20200701-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">cah:TrademarksAndPatentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9d370528192046c8b78cd2c5462f6fed_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3bd75edcbf314eb28cab79abc9a18d41_D20200701-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i19314c2cdba1474abcdc53474c121932_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">cah:IPRDTrademarksandOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic919be303957403e934baefe49c63756_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5dae75b349b54d55a0e972014f606ac7_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">cah:TrademarksAndPatentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idd95a519999348e3a6516e5fa7e6fcba_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if156c7b3d30345a395262b86a56d2779_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib54859ab704046a7a3be64f76f566d69_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i473efc3a1c3141748a845b14896f4459_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if8918e18bf5f4dea9e6f6e70f8d28bcf_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7b139144658040af96c5e7fe53846762_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccruedLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4dc82a9dc1f44fe7a3214de6a700a3e1_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccruedLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iae9792a738c242f7bf603db4cdc6f6ea_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i143c1782b3aa4747968fda061bcedf08_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1f2e316db9cd4fdfabceb7ed40f4de88_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PropertyPlantAndEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie4f28db5f64a4f11b597d0108259b1f2_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PropertyPlantAndEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if00203a4c9a34b58a93c869a759f0035_D20200701-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">cah:ASC842Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i455f42e4f43447dc98cf9ec500532a90_D20190701-20190701"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">cah:ASC842Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-07-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie6662f5b1e3d4807b4fbf7aa426005bb_D20190701-20190701"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-07-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1a0dd756c14d48d7a436a9f95e4c95c3_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">cah:OperatingLeaseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i566381a05b1444c1a852e8768ae88ad3_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">cah:FinanceLeaseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6040899ecc9f44f893d3f559f74eb30e_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:A2.616Notesdue2022Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1079054a38c64aa1b73f425120be8b95_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:A2.616Notesdue2022Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4681cfaabaed494eb4cdf968725268ad_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:A3.2Notesdue2022Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idd88c476ee2d4612ba0be20c3b31959f_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:A3.2Notesdue2022Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id7a8329ac0d44ba88b3081e963420a51_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:FloatingRateNotesdue2022Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6108c3790b344ba09f455a14ad158d62_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:FloatingRateNotesdue2022Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i52aed3fcb7884bf0a519d03f6726bab7_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:A3.2Notesdue2023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i39f995524bc54afd96d0837c392791d0_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:A3.2Notesdue2023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3079877c28ab4fc7acfe2cebacdaf0a2_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:A3.079Notesdue2024Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iea859ed78b0341729f419cd2af57c361_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:A3.079Notesdue2024Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id9068073bcf44ebfa32fbd94e54fa0bb_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:A3.5Notesdue2025Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i19386d9a9665443da76f29f541da851b_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:A3.5Notesdue2025Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia1f00593041245b2884a1d027a7a5789_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:A3.75Notesdue2026Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1a8da22c2d104c07b8e124a12e07a40a_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:A3.75Notesdue2026Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7f818bbd6041415ab92166ff89fb7e19_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:A3.41Notesdue2027Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9f29332f948b439e93e2d67c75208f61_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:A3.41Notesdue2027Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i90cac66be512421fbc3704be2d9730c5_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:A4.6Notesdue2043Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id14e22824b7b4593bfd07bc8ab4bb51a_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:A4.6Notesdue2043Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9e575fac51a64f15bbc8ee5ae661cbbc_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:A4.5Notesdue2044Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3a3d93f3182045b2979e580513d975cd_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:A4.5Notesdue2044Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ife3234ddac5f446990273bd3ceb3091d_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:A4.9Notesdue2045Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5c8388e50dd844709e91931b05259f87_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:A4.9Notesdue2045Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6c1b2f1400e147e8a50fddbaf3a101ab_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:A4.368Notesdue2047Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i12b2bfab3db94c15be13cf683c78c053_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:A4.368Notesdue2047Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie0a9e0fdeffa40c9b581b00676cf4639_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:A7.0Debenturesduefiscal2027Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i89ff9fc63c07435d9b32595a42af3796_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:A7.0Debenturesduefiscal2027Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia5893ebe5da345e6a62bdc4932db4f7d_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">cah:AllegianceCorporationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:A7.0Debenturesduefiscal2027Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i48e47b1be977446da19d44b2c23cb1f4_D20200701-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:A3.2Notesdue2022Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i464045c4aa5e46c28d8ccea38aea7f82_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:A2.616Notesdue2022Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib3a5af086f334f83b59a840d35a3a24d_D20200701-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:A32Notes2616NotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i17d91fe6344242d2bf1252b509c16031_D20200701-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:FloatingRateNotesdue2022Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7837defbe13947a6aa80a30d88599754_D20200701-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:A2.616Notesdue2022Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie2038f77bf814473a8b5a3994d58411e_D20200701-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:FloatingRateNotes2616NotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id79807de4e034b8ab663df3b706eba8a_D20190701-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:A4.625Notesdue2021Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1f2e8fb9ffc746439d8749702977bc40_D20190701-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:A2.616Notesdue2022Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i97442363603544a4af2ceec2ab7ca6b2_D20190701-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:A3.2Notesdue2022Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4638eb18574e4673aa4ca0d635ff8fed_D20190701-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:FloatingRateNotesdue2022Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i230f0206f083410f87c775c9c1709681_D20190701-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:A3.41Notesdue2027Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id913564d8b3443a8af2a95fc5de03be7_D20190701-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:A4.6Notesdue2043Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibe4534f68d8a40109be5a39a86e86f4f_D20190701-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:A4.9Notesdue2045Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iab9dfb1f8e404e5d8f9dbf5632e6590f_D20190701-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:A4.368Notesdue2047Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifd0a92fc87ae4632bce31919cea5ac88_D20190701-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:A2.616Notes3.2Notes3.41Notes4.6Notes4.9Notesand4.368NotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i569c9ebb1c9744c6a46c4bedf478f497_D20190701-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:A24NotesDue2019Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9514a111b1dd465cb9bd660db2bf2bda_D20180701-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:A2.616Notesdue2022Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-07-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i211ab1e401334bc28102d404a589f244_D20180701-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:A3.2Notesdue2022Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-07-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6c59631d68f748078379fec096820b35_D20180701-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:FloatingRateNotesdue2022Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-07-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i97bd654b86404619830471d41f60a11d_D20180701-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:A3.41Notesdue2027Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-07-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i09916dad25ba4c3c8af380f01d737407_D20180701-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:A1.948Notesdue2019Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-07-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9820f36cdd3f46ff836bba721b3236ec_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0c9f608d73754d42bf91b8f887a3643b_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i74a8ee2e9e1b481491947bdcd81fe93b_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">cah:ShortTermCreditFacilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:CommittedReceivablesSalesFacilityProgramMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2085dadd50db412cae65d5356e28138c_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LetterOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6f57fbcd87fd4740ba92695d57c1ffe0_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LetterOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ide18edefc53a43f1823ee90886c4b766_D20200701-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">cah:CommittedReceivablesSalesFacilityProgramMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i947b0014f3864d1bbe6799521fc7f7ec_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">cah:CommittedReceivablesSalesFacilityProgramMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic2fe7a908c6f4f61af7f7d8c6c00e82b_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">cah:CommittedReceivablesSalesFacilityProgramMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i28f8f11500fa40cba044c5da762695f8_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:CommittedReceivablesSalesFacilityProgramMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LetterOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i12ab314ad2e0406699d32582ff5dabfd_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:CommittedReceivablesSalesFacilityProgramMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LetterOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i944f1f41fd954de4b4dc8f6b5c5c2db1_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id267a8471edd4bc9bf4d5efa60da5922_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">cah:ShortTermCreditFacilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i47649611840740c9a47bac619a623132_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">cah:NewYorkOpioidStewardshipActMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i457f80b8744948758645272a98e06c10_D20200701-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">cah:NewYorkOpioidStewardshipActMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5aad644cd5714c75b9ef8163bf7a97f7_I20210810"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">cah:OpioidLawsuitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-08-10</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i69aa4c6826204c058cfb939b8d352e27_I20210810"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">cah:OpioidLawsuitsStateDomain</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-08-10</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="stateag"><xbrli:measure>cah:StateAG</xbrli:measure></xbrli:unit><xbrli:context id="iddd4821afbbd40c4a6c811e70974bf4a_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cah:OpioidLitigationAxis">cah:TotalOpioidLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i358dc7a7b0ec46769a803fbd85db0e3a_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccruedLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cah:OpioidLitigationAxis">cah:TotalOpioidLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="lawsuit"><xbrli:measure>cah:lawsuit</xbrli:measure></xbrli:unit><xbrli:context id="i0e267f0781804e14b232b824ab81c9b0_I20210810"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cah:PlaintiffTypeAxis">cah:PrivatePartiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">cah:OpioidLawsuitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-08-10</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia0377f0db1e745b29e4b4fa403caefda_I20210810"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cah:LawsuitTypeAxis">cah:ClassActionLawsuitsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cah:PlaintiffTypeAxis">cah:PrivatePartiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">cah:OpioidLawsuitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-08-10</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ieb82df38431448b4bf42dd698ac840f8_D20210810-20210810"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">cah:ProductLiabilityLawsuitsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-08-10</xbrli:startDate><xbrli:endDate>2021-08-10</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="plaintiff"><xbrli:measure>cah:plaintiff</xbrli:measure></xbrli:unit><xbrli:context id="i31649c55524f4013acd74a3b9ce10a01_D20210810-20210810"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">cah:ProductLiabilityLawsuitsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">cah:AlamedaCountyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-08-10</xbrli:startDate><xbrli:endDate>2021-08-10</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3caca7e07f5c4d03b8646b949d36c06e_D20210810-20210810"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">cah:ProductLiabilityLawsuitsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-08-10</xbrli:startDate><xbrli:endDate>2021-08-10</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1687680dbb664c18933d117965cb34b0_D20210810-20210810"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">cah:OtherJurisdictionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">cah:ProductLiabilityLawsuitsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-08-10</xbrli:startDate><xbrli:endDate>2021-08-10</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8068ea91c8ff4c3b8bd8310ae462197c_D20210701-20210731"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">cah:ProductLiabilityLawsuitsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-07-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id300e006612f4c21bb7c72fd2b74da8f_D20200701-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">cah:DOJInvestigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i267869e21f794c639e2b4ecddb88f627_D20200701-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cah:NetOperatingLossCarrybackAxis">cah:NetOperatingLossCarrybackMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i58599d5030cc46db8dc1c2d03162cce3_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cah:NetOperatingLossCarrybackAxis">cah:NetOperatingLossCarrybackMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i44b4e02791f742199433f84d47a44563_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cah:OpioidLitigationAxis">cah:TotalOpioidLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia9314223dc824180abfdd254ebfb27a4_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:InternalRevenueServiceIRSMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0e143b481d18458ab822c450cdd8c4b9_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i78a614f0d6654bc1bcffa521f2779f70_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5861e52e19f84919b7cf3da21acd4a1c_D20190401-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6ab12e7e0f7d4134995f67ad334fc7bb_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cah:TaxMatterAxis">cah:CareFusionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia26e78a845f44434a842d2f2d0afeb9c_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cah:TaxMatterAxis">cah:CareFusionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5248507f2033461eab9f4d201b5cc2cd_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cah:TaxMatterAxis">cah:PatientRecoveryBusinessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia1d9ae03c64d4c31b1115e366d980c83_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cah:TaxMatterAxis">cah:PatientRecoveryBusinessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if0e5c8d6266b4e399e3e86ab88d0ff94_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2cb758f7ff794e2881dfc3872f11414b_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaf7e71fcba5f483ebe952262b8f49189_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i53e687ceccba4bac9c2829e01e82f358_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7a7f821903974542847e3a426b2298e4_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9b176a5bd18a4585bcea35c6994491bf_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib9e3c2a498984b619e5cd20d787935fc_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i66a08b6bbc4f404da5d4e4aeaf846429_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i19e92323b7e546339ee3ca1cd768d7dc_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ieeeae5f04d634c51844ac9a96e9b09ed_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ied457f9542c6444e96d2897053b037cd_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4f2eecbc56bc4483ba6ecd0e80dc8c95_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie2fc3cb346df4a8790d437caebe5bfeb_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3646dde5708840a9844baca98633b4d9_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if1331393b0e34887b04264776d257b9d_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i027cf29054524efda48f2d0dea27a987_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia5a1a9623870472f8b2069242d333329_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6a96679386eb4368a6920765ed1afdd6_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccruedLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i185e5c7efe754824b8a884fe900d3d71_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccruedLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i86f91bfc61ad471a9cb0bef75b551b70_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">cah:DeferredIncomeTaxesandOtherLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibe5ee12c49f146b8bc66d2c3290cbd7f_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">cah:DeferredIncomeTaxesandOtherLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibc2ebe6c60f8474283c818e4eb4db2ee_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CommodityContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccruedLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ied8ca13a46124e0186f0557c51ad5050_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CommodityContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccruedLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1f99a8613bb24104868a314b77c67aa4_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i69a44d9974c04cc3abf8c7aeb68f22c6_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0168bf25346243ffba7498cecba4a9cc_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icee22ead7e494923bbe522fa98e2c282_I20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i85f45ef64e47468d81d7e9def6ee8bdd_D20200701-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i04848fa4190a4546999fce3b74a1093a_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iffa4055c7e214900820c0a0df90cdebf_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i17248417fcbc4d118aebc5dfbe183bfc_D20200701-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0845a3b72a6e4a848138beb4170c6fba_D20190701-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibe9e1edad1c3406abdda7b5fca98220a_D20180701-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-07-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia80ca9aee82849b1a44b4c376a866386_D20200701-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">cah:FixedRateDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic47a87ff22934f0a928e5fd2824d30f8_D20190701-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">cah:FixedRateDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic94b1b2e248e48cdb5c5ff6dca1da5fb_D20180701-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">cah:FixedRateDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-07-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i58c9aa5163a64897b2ad19c7f47190d0_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i54cc6ff9187745ac8eb02d90c7a86a72_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i88d0b5894f144c978ac101959057bde3_D20200701-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8f3de44e96774f7296c0c1deb3f17775_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i82a8006ead354bb59b15285e08a487f9_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForwardContractsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie09b4e9c614244d1bd722525781f1905_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4de6f0288abd431bbc839b56b68b328b_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CommodityContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i405b6b2ebdbb4b00959f5be8d40c1adb_D20200701-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForwardContractsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3977a8adbc674a3db02afa95292219d7_D20190701-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForwardContractsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie29079d55386424da44448bd2dd0f7b9_D20180701-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForwardContractsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-07-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8660a36c1b824eb4b6d2ad1d1026a6f3_D20200701-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CommodityContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i47b375ab68594453a768538fa7711d00_D20190701-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CommodityContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3cf9aa045e7e4557acc082d5c2059d82_D20180701-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CommodityContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-07-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i88bb1d629e614ee2843091d49bcc870c_D20200701-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i45480cf9423f4da49ba73dd67b12ad65_D20190701-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib59a0c13c5ee4ae9aa9b88933c02ef8e_D20180701-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-07-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibb6fbf503d8d4b92b0852c5ea1309753_D20200701-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iff868024f7f64db3bfeadcc44347a563_D20190701-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i310f8b1e6b5d4407acac6e3bf1a8f700_D20180701-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-07-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3f26acb0755444a5b5ae1bcdc825ac67_D20200701-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i37fec931826541839b3ab83c0e5334f7_D20190701-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i987d48debeb4454198012308b3db9d71_D20180701-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-07-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iccd66091b41c4c73b464f972ba9df372_D20200701-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i63ef41121d204393a0ebe9effaf8d432_D20190701-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9f15f52c79704d46af60964d622dedab_D20180701-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-07-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7a11a5ca49904135831f29f2e02611af_D20200701-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForwardContractsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5459407c23c44c3aa651aec1bc97a889_D20190701-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForwardContractsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia2835dfb9ad14f699e13cc2bec62ea7e_D20180701-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForwardContractsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-07-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4b9f0ce7440942e7bc207e8b7e6a8b82_D20200701-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CommodityContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i70ce64c92675430e973ad1616d164211_D20190701-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CommodityContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie940dc4896674168a3ab782e27d582e1_D20180701-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CommodityContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-07-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="jpy"><xbrli:measure>iso4217:JPY</xbrli:measure></xbrli:unit><xbrli:context id="i254785c21f4b45739afff24cf0bc5323_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="eur"><xbrli:measure>iso4217:EUR</xbrli:measure></xbrli:unit><xbrli:context id="i2816c95fd6cb499095fe954700d7e965_I20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i935ecef2ff6941d394a6beccc5c10088_D20200701-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i193fb65a21864d5cb26c7c22aca8ad2b_D20190701-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if722552b851a401795eb756ce826c809_D20200701-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6ca29000e9a8453b9f0281faeb2f2ed2_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7d5cf04c44ad4849821d4bb8a6945748_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifca9e60bdc7a4338aa4de50477f141d8_D20200701-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia0fd144ab6c343f591a8767092fb681e_D20190701-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3395922d014c40c59d772a4a5b2ebd31_D20180701-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-07-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8b9a24f3941f46f085d16a60c26ec523_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i406116eedea746848300007f225725fd_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ica8d8074683f4bda8b6a214c21c399ee_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForwardContractsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic67d0c6fd59147399881dd3fb666cc2a_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i83ca59dc22f646eaa9de5eecb3e81988_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4cf22529a370428e82c5511fa7e35f8b_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CommodityContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0a081dfdf3e846b387ac5e60a2f4e8a5_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i217241ce39cf47f0acdc17b79210218f_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i61106b444fde4f55a97a7eaed9e98693_D20200701-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1eef4a3d4f414af4b5f60b07ff29ecc2_D20170701-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2017-07-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i25a5a0d717e04a1cb651e174b69d2257_I20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic2fe183f79d9435fa6fb7b20cb241684_I20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i06a1421a7f5a434ab21bb6e7f6c4217d_D20190701-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if2c1cb49d0374d86b2830517b2b187db_D20190701-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic4bf74d204c843148850dd8cf1a97c4c_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6260475b94ac4643968f9f3d0742c126_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i87f033cb2d3241b690c413fa8321d9dd_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i10ebef79cb324951a3c60cf340e5e0c7_D20200701-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6a93d5b1ddba4766830bc552988b0f64_D20200701-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifb49b5f7c6944c1ba0d4367e9d8295ee_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic7926ed91fae47b7a3fcb884911ab862_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia3fefcfeaf9c46ce91e01b1989e54336_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i76b6a114dfd6424fb4c07d91075a91ff_D20200701-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i78632f0315fd45fb85ed1c2272933a36_D20190701-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6d7435bb60af47f4a69d23c973a60d43_D20180701-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-07-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id8c82c11050f452c9befaa43705026a6_D20200701-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:MedicalMemberMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1faf47ea4d994e879fd1c1bf2cc15983_D20190701-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:MedicalMemberMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4dcc4f5896f24eb98e3473b71e1d10b7_D20180701-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:MedicalMemberMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-07-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie5f1ec6cee11430ab0571ee6201cd0f7_D20200701-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7a96c8334d2e46928c83a274df8be377_D20190701-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3ab52d1ad77045aa97d1dbfb8cb6186e_D20180701-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-07-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i792ece330cb74d35afecabca6b7f49ea_D20200701-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i16818ee6ea724c8691b1f0065031735b_D20190701-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic5128c57d92d4336ae115d6ba4e979cb_D20180701-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-07-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i155c6a70937b40b68b1699cc88ad54f0_D20200701-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">cah:PharmaceuticalDistributionandSpecialtyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i76773aa4b180454e80d866fd2a2396b6_D20190701-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">cah:PharmaceuticalDistributionandSpecialtyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic18e242a8d2744198de6fca3c9aaccdd_D20180701-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">cah:PharmaceuticalDistributionandSpecialtyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-07-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5aa6abf0d0ff4864be49a2c272e9ae17_D20200701-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">cah:NuclearPrecisionHealthServicesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i86db5a9e2c2b4d719e8263c1bfc96ca5_D20190701-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">cah:NuclearPrecisionHealthServicesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaa4c204e977543369238d8e99ef5f86e_D20180701-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">cah:NuclearPrecisionHealthServicesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-07-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i00d597531405494bb66494a39ed9a378_D20200701-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:MedicalMemberMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">cah:MedicaldistributionandproductsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icf4b31c19dc549a1883307cdf7dbe88c_D20190701-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:MedicalMemberMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">cah:MedicaldistributionandproductsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i321e2ade5757483681291e8d89208466_D20180701-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:MedicalMemberMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">cah:MedicaldistributionandproductsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-07-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2f0de7fef24f4d40bd4de0a2976f37d8_D20200701-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">cah:CardinalHealthAtHomeSolutionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:MedicalMemberMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ieaa341ac8f284f1582d38baefdc71c05_D20190701-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">cah:CardinalHealthAtHomeSolutionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:MedicalMemberMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5c109faf3fc4429686c141f4abd59a0c_D20180701-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">cah:CardinalHealthAtHomeSolutionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:MedicalMemberMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-07-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id0012edd1a484009af89832a87b38690_D20200701-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i634f4d42b1cb4e6cb3a43cc4bc98832d_D20190701-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i78774426f41940febec7d66ff52bb8d1_D20180701-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-07-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3d4fc04fd3ba4fe9b28a1f419dbc6b15_D20200701-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i780324fcbcb345e29107285be707bc45_D20190701-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if26a26c7dce04a669d805364e23fcbb7_D20180701-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-07-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic436b3ed22eb4cdcb413eaef19ec4ca5_D20190701-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cah:SterileSurgicalGownRecallAxis">cah:SterileSurgicalGownRecallMemberDomain</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if5b3bab2d32340dea26c681d53110711_D20190701-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">cah:NaviHealthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6e8acb06a2eb434ab88bfebe2a6d8a18_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia8a118e953bd4d1f9600cde58c7b110c_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i776ad5c7cad44d45a8cbf169d5b49ea5_I20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1395a9d318334a7bbf4965e8f0833f2b_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:MedicalMemberMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2921a9a3e731468c9171a26f22574eba_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:MedicalMemberMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2dbe5e7ed6284e6ba51e84d62ff6f50d_I20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:MedicalMemberMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8858cf546314492eb3e695791497ad0e_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia1e90564105346fb9b66345306cd8bed_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia3e5b233ccea481cbde3ab011c52f4b7_I20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ieb5c5f04a3584568a0813006020736e0_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1c873da0bc8f4cfea1d6280c5bb54279_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6ab941d8314b4dffa0444dc05ecc3315_I20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icd695cac6ddb4cbe8fd3520e0cdd88f2_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic6d6926b307941eea48b73ec840b45ba_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5d8622203bb84c40af423bc2e4742dc2_I20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i12a70580710847829f909cea8ceeacc3_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">cah:A2011LtipMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibaee55518fbe497ca65e202e76660b9e_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">cah:AwardsOtherThanStockOptionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">cah:A2011LtipMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib82e9bbd88e1416c896321662307b4fc_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">cah:A2011LtipMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i31f1c30559534af396751cc62e9e19a9_D20200701-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i956130d849c84807b9f6f7b055f5ebec_D20190701-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i579d152d52624fc381bd7cae2c7ddd4a_D20180701-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-07-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9fac2b1e8f484ef081a25d163aa2c3a6_D20200701-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5ec12fa139c6458fb260601a40c83a61_D20190701-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4ff833c8f18c425d87db9b23fa00bd06_D20180701-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-07-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i217c2671c6f84df1ab8278415bc34c16_D20200701-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4f0f3088df2a4e019bd09b2ef236fef0_D20190701-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id7eb385b0eaf45a0aa833269191797b8_D20180701-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-07-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icf32a92391924ff7b30fe54e99e0979b_I20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifb9b7ea1688a4fb4a266a5ac9179360e_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i401c6da5266c42ffb2f8a5466c3eba3c_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib473c6ce356d4388a73564ce9f41c306_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6844f415cc38462c93502fde5a64b55f_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0a3264d2aa5e4528bea7fa195a0d07b5_I20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6425a2ad601a4906adbbf99175836b8d_D20200701-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="vestingperiods"><xbrli:measure>cah:vestingPeriods</xbrli:measure></xbrli:unit><xbrli:context id="i2072923bec904f33a89202306af14057_D20200701-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i064bd318128c454cbd68ef31c37fed9d_D20200701-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i837fa9d3c1f04fb6aa54fd33592f52b3_I20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib996ace534574f9da807e45a4e349efc_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i09a66472ecae47489b82c3a6aade6b47_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i55e9481bb093412a97e842b3caeb64ec_D20200701-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1206afb1bf5546759bbe9e6ed075350a_D20200701-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForLossesOnFinanceReceivablesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie3de935dc1e7482faedb9bef40e18bc4_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:SalesReturnsAndAllowancesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i366d2f82d08341029a0c689efe436023_D20200701-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:SalesReturnsAndAllowancesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i35ade71063ad48868742425618cf24be_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:SalesReturnsAndAllowancesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i957454a121b24a28a13445f765e222b9_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForLoanAndLeaseLossesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i28620b092acd45fdaaad27b89277c8ad_D20200701-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForLoanAndLeaseLossesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ice14673b485d4f138bf5ec444359bc54_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForLoanAndLeaseLossesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ide7e4b7157284fadb3309a188a76b7ca_I20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i350af5c515834421987f12b1b2358e1f_D20190701-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0d2f5152ae66452889546df6cb3b59aa_I20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForLossesOnFinanceReceivablesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6b4ffa7933dc41899a2489f876ca34b9_D20190701-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForLossesOnFinanceReceivablesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5dd4173715e6498fb0d0dc27a3f02b9f_I20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:SalesReturnsAndAllowancesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i400f4736cc2f44ec981957aa5112a379_D20190701-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:SalesReturnsAndAllowancesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6e4105a2962247bab2434b9253c1a87a_I20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForLoanAndLeaseLossesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if31c4c1d06774db4b770c1df3a18845b_D20190701-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForLoanAndLeaseLossesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic65be2ae369247318f0256c8cc4689d5_I20180630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6f1dad679d0a49a586cbe4e15230d23d_D20180701-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-07-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if5788af627104325bd77f50e1ab1ce2a_I20180630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForLossesOnFinanceReceivablesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia954270fdd5c46e9a903107394449dd7_D20180701-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForLossesOnFinanceReceivablesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-07-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia84d7235822744479f9a7c898af562ac_I20180630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:SalesReturnsAndAllowancesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4bfe813f83c04e8e9985198d3c0abce1_D20180701-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:SalesReturnsAndAllowancesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-07-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifbbe723cddd144c7bb4c9eab1d1f2f33_I20180630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForLoanAndLeaseLossesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i657bcf6c5a8f4e898448d61c3949243a_D20180701-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForLoanAndLeaseLossesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-07-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1673490f38b2424cacdaabe5743e3504_D20200701-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">cah:PricingDisputesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7ed96bb7a92d4005acebfec1c9075c82_D20190701-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">cah:PricingDisputesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iecf663e1bbf54d3bbd24255d898605e0_D20180701-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">cah:PricingDisputesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-07-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5dc92adfefad4108a6405a1cbdeeaf2f_D20200701-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">cah:PriorYearRecoveriesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie90c978acfea4d6ea4dde9db8c7997ef_D20190701-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">cah:PriorYearRecoveriesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iecd1cbc227d64a688441fd4ccc382b99_D20180701-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">cah:PriorYearRecoveriesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-07-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="i4f0ec56b9c604f1782a65ea4a19c284d_1"></div><div style="min-height:40.5pt;width:100%"><div style="margin-bottom:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.234%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4f0ec56b9c604f1782a65ea4a19c284d_7">Table of Contents</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div></div><div style="margin-bottom:3pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:16pt;font-weight:700;line-height:100%">UNITED STATES</span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:16pt;font-weight:700;line-height:100%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Washington,&#160;D.C. 20549</span></div><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:16pt;font-weight:700;line-height:100%">Form <ix:nonNumeric contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630" name="dei:DocumentType" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xL2ZyYWc6ZDJkMWU5ZmExZTljNGMwODhiZThmZDIwY2YwNTQyOGYvdGV4dHJlZ2lvbjpkMmQxZTlmYTFlOWM0YzA4OGJlOGZkMjBjZjA1NDI4Zl8yMjI4_507822cc-e095-419a-b19b-bbeb214cb6a2">10-K</ix:nonNumeric> </span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:5.116%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:92.684%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630" format="ixt-sec:boolballotbox" name="dei:DocumentAnnualReport" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xL2ZyYWc6ZDJkMWU5ZmExZTljNGMwODhiZThmZDIwY2YwNTQyOGYvdGFibGU6ZWM5Mzk0OWJlOTNjNGI5MmE4MDI5ODEzMWZmNzY1NDIvdGFibGVyYW5nZTplYzkzOTQ5YmU5M2M0YjkyYTgwMjk4MTMxZmY3NjU0Ml8wLTAtMS0xLTA_b3bc4778-a72d-48ad-8ece-91b6f80c1d5b">&#9745;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the fiscal year ended June&#160;30, 2021 </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">or</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:5.116%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:92.684%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630" format="ixt-sec:boolballotbox" name="dei:DocumentTransitionReport" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xL2ZyYWc6ZDJkMWU5ZmExZTljNGMwODhiZThmZDIwY2YwNTQyOGYvdGFibGU6NzY3ZDk1ZGMxMjI3NDc3Y2JmYjk3NzRjZTY0NDUxNDkvdGFibGVyYW5nZTo3NjdkOTVkYzEyMjc0NzdjYmZiOTc3NGNlNjQ0NTE0OV8wLTAtMS0xLTA_a95d245f-662f-4b06-ad00-502dfa2cd872">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the transition period from ________ to ________</span></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Commission File Number:&#160;<ix:nonNumeric contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630" name="dei:EntityFileNumber" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xL2ZyYWc6ZDJkMWU5ZmExZTljNGMwODhiZThmZDIwY2YwNTQyOGYvdGV4dHJlZ2lvbjpkMmQxZTlmYTFlOWM0YzA4OGJlOGZkMjBjZjA1NDI4Zl8yMjIz_c6394048-0120-41f6-a511-b2a91c9cde8b">1-11373</ix:nonNumeric> </span></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:22pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630" name="dei:EntityRegistrantName" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xL2ZyYWc6ZDJkMWU5ZmExZTljNGMwODhiZThmZDIwY2YwNTQyOGYvdGV4dHJlZ2lvbjpkMmQxZTlmYTFlOWM0YzA4OGJlOGZkMjBjZjA1NDI4Zl8yMjI5_2943c814-3ba1-4d3f-b9ea-7ba462c5a6b5">Cardinal Health, Inc.</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:120%">(Exact name of registrant as specified in its charter)</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.544%"><tr><td style="width:1.0%"></td><td style="width:25.208%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.471%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.940%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.471%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.470%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.471%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.969%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xL2ZyYWc6ZDJkMWU5ZmExZTljNGMwODhiZThmZDIwY2YwNTQyOGYvdGFibGU6NmFmNGVkNDBhODdmNDY4MTk2ZTlhNjEyYzI4NDMxZTUvdGFibGVyYW5nZTo2YWY0ZWQ0MGE4N2Y0NjgxOTZlOWE2MTJjMjg0MzFlNV8wLTAtMS0xLTA_a666273c-d223-4a36-b6e0-55863e68f2a2">Ohio</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630" name="dei:EntityTaxIdentificationNumber" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xL2ZyYWc6ZDJkMWU5ZmExZTljNGMwODhiZThmZDIwY2YwNTQyOGYvdGFibGU6NmFmNGVkNDBhODdmNDY4MTk2ZTlhNjEyYzI4NDMxZTUvdGFibGVyYW5nZTo2YWY0ZWQ0MGE4N2Y0NjgxOTZlOWE2MTJjMjg0MzFlNV8wLTYtMS0xLTA_1f9c2c85-bab0-428c-b810-81a7539d9eaf">31-0958666</ix:nonNumeric></span></td></tr><tr><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(State or other jurisdiction of<br/>incorporation or organization)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(IRS Employer<br/>Identification No.)</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630" name="dei:EntityAddressAddressLine1" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xL2ZyYWc6ZDJkMWU5ZmExZTljNGMwODhiZThmZDIwY2YwNTQyOGYvdGFibGU6NmFmNGVkNDBhODdmNDY4MTk2ZTlhNjEyYzI4NDMxZTUvdGFibGVyYW5nZTo2YWY0ZWQ0MGE4N2Y0NjgxOTZlOWE2MTJjMjg0MzFlNV8zLTAtMS0xLTA_56e74991-95fa-475a-a7e9-bc41b9a195a0">7000 Cardinal Place</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:100%">,</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630" name="dei:EntityAddressCityOrTown" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xL2ZyYWc6ZDJkMWU5ZmExZTljNGMwODhiZThmZDIwY2YwNTQyOGYvdGFibGU6NmFmNGVkNDBhODdmNDY4MTk2ZTlhNjEyYzI4NDMxZTUvdGFibGVyYW5nZTo2YWY0ZWQ0MGE4N2Y0NjgxOTZlOWE2MTJjMjg0MzFlNV8zLTItMS0xLTA_659b8735-a927-471d-a4d4-1c87e60afc82">Dublin</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:100%">,</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630" format="ixt-sec:stateprovnameen" name="dei:EntityAddressStateOrProvince" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xL2ZyYWc6ZDJkMWU5ZmExZTljNGMwODhiZThmZDIwY2YwNTQyOGYvdGFibGU6NmFmNGVkNDBhODdmNDY4MTk2ZTlhNjEyYzI4NDMxZTUvdGFibGVyYW5nZTo2YWY0ZWQ0MGE4N2Y0NjgxOTZlOWE2MTJjMjg0MzFlNV8zLTQtMS0xLTA_20d999f1-f038-4c51-957e-b88bd6487213">Ohio</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630" name="dei:EntityAddressPostalZipCode" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xL2ZyYWc6ZDJkMWU5ZmExZTljNGMwODhiZThmZDIwY2YwNTQyOGYvdGFibGU6NmFmNGVkNDBhODdmNDY4MTk2ZTlhNjEyYzI4NDMxZTUvdGFibGVyYW5nZTo2YWY0ZWQ0MGE4N2Y0NjgxOTZlOWE2MTJjMjg0MzFlNV8zLTYtMS0xLTA_54fb931e-7600-4102-a02a-589163dc8509">43017</ix:nonNumeric></span></td></tr><tr><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(Address of principal executive offices)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(Zip Code)</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630" name="dei:CityAreaCode" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xL2ZyYWc6ZDJkMWU5ZmExZTljNGMwODhiZThmZDIwY2YwNTQyOGYvdGFibGU6NmFmNGVkNDBhODdmNDY4MTk2ZTlhNjEyYzI4NDMxZTUvdGFibGVyYW5nZTo2YWY0ZWQ0MGE4N2Y0NjgxOTZlOWE2MTJjMjg0MzFlNV82LTQtMS0xLTA_6b25231d-d408-4394-8337-c1fb0fd1730d">(614)</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630" name="dei:LocalPhoneNumber" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xL2ZyYWc6ZDJkMWU5ZmExZTljNGMwODhiZThmZDIwY2YwNTQyOGYvdGFibGU6NmFmNGVkNDBhODdmNDY4MTk2ZTlhNjEyYzI4NDMxZTUvdGFibGVyYW5nZTo2YWY0ZWQ0MGE4N2Y0NjgxOTZlOWE2MTJjMjg0MzFlNV82LTYtMS0xLTA_24565572-908f-4b33-8aa4-470594c68644">757-5000</ix:nonNumeric></span></td></tr><tr><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(Registrant&#8217;s telephone number, including area code)</span></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.370%"><tr><td style="width:1.0%"></td><td style="width:35.931%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:24.836%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:35.933%"></td><td style="width:0.1%"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Securities registered pursuant to Section 12(b) of the Act:</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Title of each class</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Trading Symbol(s)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Name of each exchange on which registered</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xL2ZyYWc6ZDJkMWU5ZmExZTljNGMwODhiZThmZDIwY2YwNTQyOGYvdGFibGU6YWMyMjI0YTEwZTNhNGY0NmI3YWVhOGYyMDdmOGJjZmEvdGFibGVyYW5nZTphYzIyMjRhMTBlM2E0ZjQ2YjdhZWE4ZjIwN2Y4YmNmYV8zLTAtMS0xLTA_a486d663-020c-4820-8ee6-b5f33132edbf">Common shares (without par value)</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xL2ZyYWc6ZDJkMWU5ZmExZTljNGMwODhiZThmZDIwY2YwNTQyOGYvdGFibGU6YWMyMjI0YTEwZTNhNGY0NmI3YWVhOGYyMDdmOGJjZmEvdGFibGVyYW5nZTphYzIyMjRhMTBlM2E0ZjQ2YjdhZWE4ZjIwN2Y4YmNmYV8zLTEtMS0xLTA_0fae4f93-2285-47e9-b2de-f4ea3b9dd43f">CAH</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xL2ZyYWc6ZDJkMWU5ZmExZTljNGMwODhiZThmZDIwY2YwNTQyOGYvdGFibGU6YWMyMjI0YTEwZTNhNGY0NmI3YWVhOGYyMDdmOGJjZmEvdGFibGVyYW5nZTphYzIyMjRhMTBlM2E0ZjQ2YjdhZWE4ZjIwN2Y4YmNmYV8zLTItMS0xLTA_ca96c4f4-f0d4-4584-8133-9d076b53130b">New York Stock Exchange</ix:nonNumeric></span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Securities registered pursuant to Section 12(g) of the Act: None</span></td></tr></table></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule&#160;405 of the Securities Act.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630" name="dei:EntityWellKnownSeasonedIssuer" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xL2ZyYWc6ZDJkMWU5ZmExZTljNGMwODhiZThmZDIwY2YwNTQyOGYvdGV4dHJlZ2lvbjpkMmQxZTlmYTFlOWM0YzA4OGJlOGZkMjBjZjA1NDI4Zl8yMjI0_64516982-332b-4ed7-9528-99603bf9fd7d">Yes</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#254;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:400;line-height:120%">No</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:120%">o</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark if the registrant is not required to file reports pursuant to Section&#160;13 or Section&#160;15(d) of the Act.&#160;&#160;&#160;&#160;Yes&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:120%">o</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630" name="dei:EntityVoluntaryFilers" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xL2ZyYWc6ZDJkMWU5ZmExZTljNGMwODhiZThmZDIwY2YwNTQyOGYvdGV4dHJlZ2lvbjpkMmQxZTlmYTFlOWM0YzA4OGJlOGZkMjBjZjA1NDI4Zl8yMjMw_8cc6c6ba-03f7-4ddc-8f8a-804104a57484">No</ix:nonNumeric>&#160;&#160;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#254;</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant (1)&#160;has filed all reports required to be filed by Section&#160;13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12&#160;months (or for such shorter period that the registrant was required to file such reports), and (2)&#160;has been subject to such filing requirements for the past 90&#160;days.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630" name="dei:EntityCurrentReportingStatus" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xL2ZyYWc6ZDJkMWU5ZmExZTljNGMwODhiZThmZDIwY2YwNTQyOGYvdGV4dHJlZ2lvbjpkMmQxZTlmYTFlOWM0YzA4OGJlOGZkMjBjZjA1NDI4Zl8yMjI1_1dc35fe3-f5a5-45ef-97bc-8e7997bcce41">Yes</ix:nonNumeric>&#160;&#160;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#254;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;No&#160;&#160;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:120%">o</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (&#167;232.405 of this chapter) during the preceding 12&#160;months (or for such shorter period that the registrant was required to submit such files).&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630" name="dei:EntityInteractiveDataCurrent" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xL2ZyYWc6ZDJkMWU5ZmExZTljNGMwODhiZThmZDIwY2YwNTQyOGYvdGV4dHJlZ2lvbjpkMmQxZTlmYTFlOWM0YzA4OGJlOGZkMjBjZjA1NDI4Zl8yMjMx_872588f7-690c-4f8d-b7de-ac3f1285d1fe">Yes</ix:nonNumeric>&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#254;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;No&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#9744;</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer,&#8221; &#8220;smaller reporting company,&#8221; and "emerging growth company" in Rule&#160;12b-2 of the Exchange Act.</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.089%"><tr><td style="width:1.0%"></td><td style="width:18.109%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.578%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.652%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.109%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.033%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:30.919%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630" format="ixt-sec:entityfilercategoryen" name="dei:EntityFilerCategory" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xL2ZyYWc6ZDJkMWU5ZmExZTljNGMwODhiZThmZDIwY2YwNTQyOGYvdGFibGU6NWI0OWFhYzFhYWEyNGU3YWEzMDBiM2FlNWZmN2E4ODcvdGFibGVyYW5nZTo1YjQ5YWFjMWFhYTI0ZTdhYTMwMGIzYWU1ZmY3YTg4N18wLTAtMS0xLTA_3929b577-f167-41cd-be13-52cc19f35f66">Large accelerated filer</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#254;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accelerated filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#9744;</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-accelerated filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#9744;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Smaller&#160;reporting&#160;company</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630" format="ixt-sec:boolballotbox" name="dei:EntitySmallBusiness" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xL2ZyYWc6ZDJkMWU5ZmExZTljNGMwODhiZThmZDIwY2YwNTQyOGYvdGFibGU6NWI0OWFhYzFhYWEyNGU3YWEzMDBiM2FlNWZmN2E4ODcvdGFibGVyYW5nZTo1YjQ5YWFjMWFhYTI0ZTdhYTMwMGIzYWU1ZmY3YTg4N18xLTQtMS0xLTA_123fe286-d8af-483c-b89c-39b8378bb0e0">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Emerging growth&#160;company&#160;&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630" format="ixt-sec:boolballotbox" name="dei:EntityEmergingGrowthCompany" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xL2ZyYWc6ZDJkMWU5ZmExZTljNGMwODhiZThmZDIwY2YwNTQyOGYvdGFibGU6NWI0OWFhYzFhYWEyNGU3YWEzMDBiM2FlNWZmN2E4ODcvdGFibGVyYW5nZTo1YjQ5YWFjMWFhYTI0ZTdhYTMwMGIzYWU1ZmY3YTg4N18yLTQtMS0xLTA_1f24256f-0823-4aa5-8339-033277d55455">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="18" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:400;line-height:100%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:100%">o</span></div></td></tr><tr><td colspan="18" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Indicate by check mark whether the registrant has filed a report on and attestation to its management&#8217;s assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report.<br/>&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630" format="ixt:booleantrue" name="dei:IcfrAuditorAttestationFlag" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xL2ZyYWc6ZDJkMWU5ZmExZTljNGMwODhiZThmZDIwY2YwNTQyOGYvdGFibGU6NWI0OWFhYzFhYWEyNGU3YWEzMDBiM2FlNWZmN2E4ODcvdGFibGVyYW5nZTo1YjQ5YWFjMWFhYTI0ZTdhYTMwMGIzYWU1ZmY3YTg4N181LTAtMS0xLTkwOTU_1d9b8c82-b72b-41e9-b808-ce759dcacf42">&#254;</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a shell company (as defined in Rule&#160;12b-2 of the Exchange Act).&#160;&#160;&#160;&#160;Yes </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630" format="ixt-sec:boolballotbox" name="dei:EntityShellCompany" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xL2ZyYWc6ZDJkMWU5ZmExZTljNGMwODhiZThmZDIwY2YwNTQyOGYvdGV4dHJlZ2lvbjpkMmQxZTlmYTFlOWM0YzA4OGJlOGZkMjBjZjA1NDI4Zl8yMjI2_860fddf9-d085-436e-87d5-fa6f5f043f60">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> &#160;No&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#254;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The aggregate market value of voting stock held by non-affiliates on December&#160;31, 2020, was the following: $<ix:nonFraction unitRef="usd" contextRef="if53145a5ccc7474d828f32716fb56f3f_I20201231" decimals="0" format="ixt:numdotdecimal" name="dei:EntityPublicFloat" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xL2ZyYWc6ZDJkMWU5ZmExZTljNGMwODhiZThmZDIwY2YwNTQyOGYvdGV4dHJlZ2lvbjpkMmQxZTlmYTFlOWM0YzA4OGJlOGZkMjBjZjA1NDI4Zl8xODQy_fa72b43f-502f-40e2-b0b1-d15e03f0e0e3">15,693,865,917</ix:nonFraction>.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The number of the registrant&#8217;s common shares, without par value, outstanding as of July&#160;31, 2021, was the following: <ix:nonFraction unitRef="shares" contextRef="i8567a5e9e68d45bd946706441532802e_I20210731" decimals="0" format="ixt:numdotdecimal" name="dei:EntityCommonStockSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xL2ZyYWc6ZDJkMWU5ZmExZTljNGMwODhiZThmZDIwY2YwNTQyOGYvdGV4dHJlZ2lvbjpkMmQxZTlmYTFlOWM0YzA4OGJlOGZkMjBjZjA1NDI4Zl8xOTUy_ea511691-f70e-4bd8-adbe-31c4e3b8669b">290,441,408</ix:nonFraction>.</span></div><div style="text-align:center"><span><br/></span></div><ix:nonNumeric contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630" name="dei:DocumentsIncorporatedByReferenceTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xL2ZyYWc6ZDJkMWU5ZmExZTljNGMwODhiZThmZDIwY2YwNTQyOGYvdGV4dHJlZ2lvbjpkMmQxZTlmYTFlOWM0YzA4OGJlOGZkMjBjZjA1NDI4Zl8yMjMy_5eade316-ade8-4bd7-a84d-95d336ce503d" escape="true"><div style="text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Documents Incorporated by Reference: </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Portions of the registrant&#8217;s Definitive Proxy Statement to be filed for its 2021 Annual Meeting of Shareholders are incorporated by reference into the sections of this Form 10-K addressing the requirements of Part&#160;III of Form&#160;10-K.</span></div></ix:nonNumeric><div style="height:22.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:3pt;text-align:justify"><span><br/></span></div></div></div><div id="i4f0ec56b9c604f1782a65ea4a19c284d_7"></div><hr style="page-break-after:always"/><div style="min-height:85.5pt;width:100%"><div style="margin-bottom:3pt"><span><br/></span></div><div style="margin-bottom:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:20pt;font-weight:700;line-height:100%">Cardinal Health </span><span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:18pt;font-weight:700;line-height:100%"> </span></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Fiscal 2021 Form 10-K                                                                                                                                   </span></div></td></tr></table></div></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:16pt;font-weight:700;line-height:120%">Table of Contents</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.404%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #ee2724;padding:0 1pt"></td></tr></table></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.958%"><tr><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:91.080%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.720%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Page</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4f0ec56b9c604f1782a65ea4a19c284d_10">Introduction</a></span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i4f0ec56b9c604f1782a65ea4a19c284d_10">2</a></span></div></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4f0ec56b9c604f1782a65ea4a19c284d_13">Management's Discussion and Analysis of Financial Condition and Results of Operations</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i4f0ec56b9c604f1782a65ea4a19c284d_13">3</a></span></div></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4f0ec56b9c604f1782a65ea4a19c284d_40">Explanation and Reconciliation of Non-GAAP Financial Measures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i4f0ec56b9c604f1782a65ea4a19c284d_40">26</a></span></div></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4f0ec56b9c604f1782a65ea4a19c284d_49">Quantitative and Qualitative Disclosures about Market Risk</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i4f0ec56b9c604f1782a65ea4a19c284d_49">30</a></span></div></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4f0ec56b9c604f1782a65ea4a19c284d_52">Business</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i4f0ec56b9c604f1782a65ea4a19c284d_52">32</a></span></div></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4f0ec56b9c604f1782a65ea4a19c284d_55">Risk Factors</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i4f0ec56b9c604f1782a65ea4a19c284d_55">40</a></span></div></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4f0ec56b9c604f1782a65ea4a19c284d_58">Properties</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i4f0ec56b9c604f1782a65ea4a19c284d_58">47</a></span></div></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4f0ec56b9c604f1782a65ea4a19c284d_61">Legal Proceedings</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i4f0ec56b9c604f1782a65ea4a19c284d_61">48</a></span></div></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4f0ec56b9c604f1782a65ea4a19c284d_64">Market for Registrant's Common Equity</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i4f0ec56b9c604f1782a65ea4a19c284d_64">49</a></span></div></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4f0ec56b9c604f1782a65ea4a19c284d_67">Reports</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i4f0ec56b9c604f1782a65ea4a19c284d_67">51</a></span></div></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4f0ec56b9c604f1782a65ea4a19c284d_76">Financial Statements and Supplementary Data</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i4f0ec56b9c604f1782a65ea4a19c284d_76">56</a></span></div></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4f0ec56b9c604f1782a65ea4a19c284d_178">Directors, Executive Officers, and Corporate Governance</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i4f0ec56b9c604f1782a65ea4a19c284d_178">89</a></span></div></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4f0ec56b9c604f1782a65ea4a19c284d_184">Exhibits</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i4f0ec56b9c604f1782a65ea4a19c284d_184">91</a></span></div></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4f0ec56b9c604f1782a65ea4a19c284d_187">Form 10-K Cross Reference Index</a></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i4f0ec56b9c604f1782a65ea4a19c284d_187">95</a></span></div></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4f0ec56b9c604f1782a65ea4a19c284d_190">Signatures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i4f0ec56b9c604f1782a65ea4a19c284d_190">96</a></span></div></td></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:3pt;text-align:justify"><span><br/></span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:3pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.222%"><tr><td style="width:1.0%"></td><td style="width:32.133%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.433%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.134%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardinal Health </span><span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">| </span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2021 Form 10-K</span></div></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div></div></div><div id="i4f0ec56b9c604f1782a65ea4a19c284d_10"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:3pt;text-align:center"><span><br/></span></div><div style="margin-bottom:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.851%"><tr><td style="width:1.0%"></td><td style="width:24.682%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:50.911%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.107%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#e41f35;border-bottom:1pt solid #e41f35;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Introduction</span></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span><br/></span></div></div><div style="margin-bottom:3pt"><span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:20pt;font-weight:700;line-height:120%">Introduction</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:120%">References to Cardinal Health and Fiscal Years</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As used in this report, "we," "our," "us," "Cardinal Health" and similar pronouns refer to Cardinal Health, Inc. and its majority-owned subsidiaries, unless the context requires otherwise. Our fiscal year ends on June 30.&#160;References to fiscal 2022, 2021, 2020, 2019, 2018 and 2017 are to the fiscal years ended June&#160;30, 2022, 2021, 2020, 2019, 2018 and 2017, respectively. Except as otherwise specified, information in this report is provided as of June&#160;30, 2021.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Non-GAAP Financial Measures</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In this report, including in the "Fiscal 2021 Overview" section of Management's Discussion and Analysis of Financial Condition and Results of Operations ("MD&amp;A"), we use financial measures that are derived from consolidated financial data but are not presented in our financial statements that are prepared in accordance with U.S. generally accepted accounting principles (&#8220;GAAP&#8221;). These measures are considered &#8220;non-GAAP financial measures&#8221; under the Securities and Exchange Commission (&#8220;SEC&#8221;) rules. The reasons we use these non-GAAP financial measures and the reconciliations to their most directly comparable GAAP financial measures are included in the &#8220;Explanation and Reconciliation of Non-GAAP Financial Measures&#8221; section following MD&amp;A in this report.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Management's Discussion and Analysis of Financial Condition and Results of Operations</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our MD&amp;A within this Form 10-K generally discusses fiscal 2021 and fiscal 2020 items and year-to-year comparisons between fiscal 2021 and fiscal 2020.&#160;Fiscal 2019 items and discussions of year-to-year comparisons between fiscal 2020 and fiscal 2019 that are not included in this Form 10-K can be found in Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations in our Annual Report on Form 10-K for the fiscal year ended June 30, 2020 (the "Fiscal 2020 Form 10-K").</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Important Information Regarding Forward-Looking Statements</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This report (including information incorporated by reference) includes forward-looking statements addressing expectations, prospects, estimates and other matters that are dependent upon future events or developments. Many forward-looking statements appear in MD&amp;A and Risk Factors, but there are others throughout this report, which may be identified by words such as &#8220;expect,&#8221; &#8220;anticipate,&#8221; &#8220;intend,&#8221; &#8220;plan,&#8221; &#8220;believe,&#8221; &#8220;will,&#8221; &#8220;should,&#8221; &#8220;could,&#8221; &#8220;would,&#8221; &#8220;project,&#8221; &#8220;continue,&#8221; &#8220;likely,&#8221; and similar expressions, and include statements reflecting future results or guidance, statements of outlook and expense accruals. These matters are subject to risks and uncertainties that could cause actual results to differ materially from those projected, anticipated or implied. The most significant of these risks and uncertainties are described in &#8220;Risk Factors&#8221; in this report and in Exhibit 99.1 to the Form 10-K included in this report. Forward-looking statements in this report speak only as of the date of this document. Except to the extent required by applicable law, we undertake no obligation to update or revise any forward-looking statement.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Available Information</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Annual Report on Form 10-K, Quarterly Reports on Form 10-Q, Current Reports on Form 8-K, and amendments to those reports are available free of charge on our website (www.cardinalhealth.com), under the &#8220;Investor Relations &#8212; Financial Reporting &#8212; SEC Filings&#8221; caption, as soon as reasonably practicable after we electronically file them with, or furnish them to, the SEC. The SEC also maintains a website (www.sec.gov) where you can search for annual, quarterly and current reports, proxy and information statements, and other information regarding us and other public companies.</span></div><div style="margin-bottom:3pt;text-align:justify"><span><br/></span></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:48.214%"><div style="margin-bottom:3pt;text-align:justify"><span><br/></span></div></div><div style="display:inline-block;max-width:3.571%;min-width:2.571%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:48.215%"></div></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:3pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.222%"><tr><td style="width:1.0%"></td><td style="width:32.133%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.433%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.134%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardinal Health </span><span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">| </span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2021 Form 10-K</span></div></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div></div></div><div id="i4f0ec56b9c604f1782a65ea4a19c284d_13"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:3pt"><span><br/></span></div><div style="margin-bottom:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.820%"><tr><td style="width:1.0%"></td><td style="width:24.720%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:50.989%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.991%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#e41f35;border-bottom:1pt solid #e41f35;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">MD&amp;A</span></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">About Cardinal Health</span></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span><br/></span></div></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:48.214%"><div style="margin-bottom:3pt;text-align:justify"><span><br/></span></div><div id="i4f0ec56b9c604f1782a65ea4a19c284d_16"></div></div><div style="display:inline-block;max-width:3.571%;min-width:2.571%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:48.215%"></div></div><div style="margin-bottom:3pt"><span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:20pt;font-weight:700;line-height:120%">Management's Discussion and Analysis of Financial Condition and Results of Operations</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:16pt;font-weight:700;line-height:120%">About Cardinal Health</span></div><div style="margin-top:8pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #ee2724;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cardinal Health, Inc., an Ohio corporation formed in 1979, is a globally integrated healthcare services and products company providing customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices and patients in the home. We provide pharmaceuticals and medical products and cost-effective solutions that enhance supply chain efficiency. We connect patients, providers, payers, pharmacists and manufacturers for integrated care coordination and better patient management. We manage our business and report our financial results in two segments: Pharmaceutical and Medical.</span></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:48.214%"><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Pharmaceutical Segment</span></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.691%"><tr><td style="width:1.0%"></td><td style="width:18.714%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.023%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.714%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.023%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.026%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="15" style="border-top:1pt solid #ee2724;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical and over-the-counter healthcare and consumer products in the United States. This segment also provides services to pharmaceutical manufacturers and healthcare providers for specialty pharmaceutical products; operates nuclear pharmacies and radiopharmaceutical manufacturing facilities; provides pharmacy management services to hospitals, as well as medication therapy management and patient outcomes services to hospitals, other healthcare providers and payers; and repackages generic pharmaceuticals and over-the-counter healthcare products. </span></div></div><div style="display:inline-block;max-width:3.571%;min-width:2.571%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:48.215%"><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Medical Segment</span></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="15" style="border-top:1pt solid #ee2724;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Medical segment manufactures, sources and distributes Cardinal Health branded medical, surgical and laboratory products, which are sold in the United States, Canada, Europe, Asia and other markets. In addition to distributing Cardinal Health branded products, this segment also distributes a broad range of medical, surgical and laboratory products known as national brand products and provides supply chain services and solutions to hospitals, ambulatory surgery centers, clinical laboratories and other healthcare providers in the United States and Canada. This segment also distributes medical products to patients' homes in the United States through our Cardinal Health at-Home Solutions division.</span></div></div></div><div style="margin-bottom:3pt;text-align:justify"><span><br/></span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:32.135%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.428%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.137%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardinal Health </span><span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">|</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> Fiscal 2021 Form 10-K</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3</span></div></td></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span><br/></span></div></div></div><div id="i4f0ec56b9c604f1782a65ea4a19c284d_19"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:3pt;text-align:center"><span><br/></span></div><div style="margin-bottom:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:24.720%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:50.989%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.991%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#e41f35;border-bottom:1pt solid #e41f35;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">MD&amp;A</span></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Results of Operations</span></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:0 1pt"></td></tr></table></div></div><div style="margin-bottom:3pt"><span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:20pt;font-weight:700;line-height:120%">Consolidated Results</span></div><div style="margin-bottom:3pt;text-align:center"><span><br/></span></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:16pt;font-weight:700;line-height:120%">Fiscal 2021 Overview</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #ee2724;padding:0 1pt"></td></tr></table></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Revenue</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue for fiscal 2021 was $162.5 billion, a 6 percent increase from the prior year, primarily due to sales growth from pharmaceutical distribution and specialty solutions customers.</span></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:120%">GAAP and Non-GAAP Operating Earnings/(Loss)</span></div><div style="margin-bottom:3pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:67.501%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.870%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.544%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.870%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.544%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.871%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">GAAP operating earnings/(loss)</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">472</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4,098)</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">N.M.</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Surgical gown recall costs/(income)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(28)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">85&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">State opioid assessment related to prior fiscal years</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">38</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Restructuring and employee severance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">114</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">122&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Amortization and other acquisition-related costs</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">451</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">524&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Impairments and (gain)/loss on disposal of assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">79</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Litigation (recoveries)/charges, net</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1,129</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5,741&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Non-GAAP operating earnings</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2,255</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,384&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(5)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%">The sum of the components and certain computations may reflect rounding adjustments.</span></div><div style="margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We had GAAP operating earnings of $472 million and a GAAP operating loss of $4.1 billion during fiscal 2021 and 2020, respectively, which includes pre-tax charges of $1.17 billion and $5.63 billion, respectively, recognized for the estimated liability associated with lawsuits and claims brought against us by states and political subdivisions relating to the distribution of prescription opioid pain medications. See further description of opioid lawsuits in the Significant Developments in Fiscal 2021 and Trends section in this MD&amp;A and&#160;</span><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i4f0ec56b9c604f1782a65ea4a19c284d_130">Note 7</a></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;of the "Notes to Consolidated Financial Statements." </span></div><div style="margin-bottom:6pt;margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">GAAP and Non-GAAP operating earnings during fiscal 2021 were adversely impacted by COVID-19, which includes an inventory reserve recorded to reduce the carrying value of certain Medical segment personal protective equipment, primarily certain categories of gloves, to net realizable value. Personal protective equipment ("PPE") refers to protective clothing, medical and non-medical grade gloves, face shields, face masks and other equipment designed to protect the wearer from injury or the spread of infection or illness. See Significant Developments in Fiscal 2021 and Trends section in this MD&amp;A for additional information. Volume declines in our Pharmaceutical segment generics program, which includes the impact of COVID-19, also had an adverse impact. These factors were partially offset by the beneficial impact of enterprise-wide cost-savings measures, including global manufacturing efficiencies in the Medical segment, and higher contribution from branded pharmaceutical sales mix.</span></div><div style="margin-bottom:6pt;margin-top:3pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:120%">GAAP and Non-GAAP Diluted EPS </span></div><div style="margin-bottom:6pt;margin-top:8pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:67.501%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.870%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.544%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.870%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.544%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.871%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">($ per share)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021 </span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2020 </span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(2) (3)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">GAAP diluted EPS</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"> (1)</span></div></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2.08</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(12.61)</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">N.M.</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Surgical gown recall costs/(income)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(0.07)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.22&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">State opioid assessment related to prior fiscal years</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">0.10</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.01&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Restructuring and employee severance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">0.29</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.31&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Amortization and other acquisition-related costs</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1.13</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1.34&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Impairments and (gain)/loss on disposal of assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">0.21</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.02&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Litigation (recoveries)/charges, net </span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(4)</span></div></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1.78</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">17.84&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Loss on early extinguishment of debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">0.04</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.04&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(Gain)/loss on sale of equity interest in naviHealth</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">0.01</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1.68)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Transitional tax benefit, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(0.01)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Non-GAAP diluted EPS </span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">5.57</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5.45&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%">The sum of the components and certain computations may reflect rounding adjustments.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:10pt">Diluted earnings/(loss) per share attributable to Cardinal Health, Inc. ("diluted EPS" or "diluted loss per share")</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:10pt">The reconciling items are presented within this table net of tax, except for transitional tax benefit, net. See quantification of tax effect of each reconciling item in our GAAP to Non-GAAP Reconciliations in the section titled "Explanation and Reconciliation of Non-GAAP Financial Measures." </span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:3pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.222%"><tr><td style="width:1.0%"></td><td style="width:32.133%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.433%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.134%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardinal Health </span><span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">| </span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2021 Form 10-K</span></div></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:3pt;text-align:center"><span><br/></span></div><div style="margin-bottom:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:24.720%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:50.989%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.991%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#e41f35;border-bottom:1pt solid #e41f35;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">MD&amp;A</span></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Results of Operations</span></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:0 1pt"></td></tr></table></div></div><div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:10pt">For fiscal 2020, GAAP diluted loss per share attributable to Cardinal Health, Inc. and the EPS impact from the GAAP to non-GAAP per share reconciling items are calculated using a weighted average of 293 million common shares, which excludes potentially dilutive securities from the denominator due to their anti-dilutive effects resulting from our GAAP net loss for the period. Fiscal 2020 non-GAAP diluted EPS is calculated using a weighted average of 295 million common shares, which includes potentially dilutive shares.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:10pt">Litigation (recoveries)/charges, net, includes a tax benefit recorded during fiscal 2021 related to a net operating loss carryback. Our wholly-owned insurance subsidiary recorded a self-insurance pre-tax loss in its fiscal 2020 statutory financial statements primarily related to opioid litigation. This self-insurance pre-tax loss, which did not impact our pre-tax consolidated results, was deducted on our fiscal 2020 consolidated federal income tax return and contributed to a significant net operating loss for tax purposes. The net operating loss was carried back and adjusted our taxable income for fiscal 2015, 2016, 2017 and 2018 as permitted under the Coronavirus Aid, Relief and Economic Security (&#8220;CARES&#8221;) Act. The total benefit from the net operating loss carryback was $424 million; however, for purposes of Non-GAAP financial measures, we allocated $389 million of the benefit to litigation (recoveries)/charges, net, which is excluded from non-GAAP measures, based on the relative amount of the self-insurance pre-tax loss related to opioid litigation claims versus separate tax adjustments. The tax benefit allocated to the separate tax adjustments of $35 million is included in non-GAAP measures.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The charges we recognized in fiscal 2021 and 2020 for the estimated liability associated with lawsuits and claims brought against us by states and political subdivisions relating to the distribution of prescription opioid pain medications had a $(3.21) and $(17.54) per share after-tax impact on GAAP diluted EPS, respectively. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During fiscal 2021, GAAP and non-GAAP diluted EPS were positively impacted by $1.44 and $0.12 per share, respectively, due to a tax benefit from the net operating loss carryback primarily related to a self-insurance pre-tax loss, as further described in Significant Developments in Fiscal 2021 and Trends section in this MD&amp;A and </span><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i4f0ec56b9c604f1782a65ea4a19c284d_130">Note 7</a></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of the "Notes to Consolidated Financial Statements."</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">GAAP diluted EPS during fiscal 2020 was favorably impacted by a $1.68 per share gain from the sale of the remainder of our equity interest in naviHealth described further in </span><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i4f0ec56b9c604f1782a65ea4a19c284d_106">Note 2</a></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;of the "Notes to Consolidated Financial Statements." </span></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:16pt;font-weight:700;line-height:120%">Cash and Equivalents</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #ee2724;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our cash and equivalents balance was $3.4 billion at June&#160;30, 2021 compared to $2.8 billion at June&#160;30, 2020. The increase in cash during fiscal 2021 was due to net cash provided by operating activities of $2.4 billion, offset by cash deployed of $573 million for dividends, $570&#160;million for debt repayments, $400 million for capital expenditures, and $200 million for share repurchases.</span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:32.135%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.428%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.137%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardinal Health </span><span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">|</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> Fiscal 2021 Form 10-K</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5</span></div></td></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:3pt;text-align:center"><span><br/></span></div><div style="margin-bottom:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:24.720%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:50.989%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.991%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#e41f35;border-bottom:1pt solid #e41f35;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">MD&amp;A</span></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Results of Operations</span></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:0 1pt"></td></tr></table></div></div><div style="margin-bottom:3pt"><span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:20pt;font-weight:700;line-height:120%">Significant Developments in Fiscal 2021 and Trends</span></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:16pt;font-weight:700;line-height:120%">COVID-19</span></div><div style="margin-bottom:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #ee2724;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The COVID-19 pandemic ("COVID-19") continues to affect the U.S. and global economies, and as previously disclosed, the pandemic began to materially affect our businesses during the third quarter of fiscal 2020. The length and severity of the pandemic and its impacts on our businesses and results of operations are uncertain.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">COVID-19 had a negative impact on our consolidated operating earnings/(loss) in fiscal 2021 and fiscal 2020. We estimate that the impact on fiscal 2021 operating earnings was approximately $200&#160;million greater than on fiscal 2020 operating earnings, and we estimate that the impact on fiscal 2020 operating earnings/(loss) was approximately $100 million.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pharmaceutical segment profit has been negatively impacted by COVID-19 largely due to volume declines in our generics program and Nuclear and Precision Health Solutions. While fiscal 2021 volumes within our generics program were lower than levels prior to COVID-19, the impact on Pharmaceutical segment profit improved on a year-over-year basis during the fourth quarter of fiscal 2021. Similarly, in comparison to prior year, the impact of COVID-19 on Nuclear and Precision Health Solutions was positive for Pharmaceutical segment profit during the fourth quarter of fiscal 2021.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Medical segment experienced dramatically increased demand for certain personal protective equipment due to COVID-19. Personal protective equipment ("PPE") refers to protective clothing, medical and non-medical grade gloves, face shields, face masks and other equipment designed to protect the wearer from injury or the spread of infection or illness. The peak of this heightened demand was during the second and third quarters of fiscal 2021. This increased demand resulted in higher sales volume for certain products, increased costs to manufacture and source these products and higher inventory levels to meet customer commitments. As a result, we sought out additional sources for these products and to mitigate the impact of these cost increases, we have raised our selling prices for the affected products. During the fourth quarter of fiscal 2021, selling prices and customer demand for certain PPE decreased as compared to the peak, and we expect this decline to continue into fiscal 2022. This resulted in inventory cost above net realizable value, requiring an inventory reserve of $197&#160;million, primarily related to certain categories of gloves, which adversely impacted Medical segment profit. Our estimates for customer demand and selling prices are inherently uncertain and if customer demand or selling prices decline in the future beyond our current assumptions, additional inventory reserves may be required that would adversely impact Medical segment profit. See Critical Accounting Policies and Sensitive Accounting Estimates section in this MD&amp;A for additional information.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During fiscal 2021, COVID-19 benefited Medical segment profit in some ways as well. Higher volumes in our laboratory business and cost savings positively impacted Medical segment profit. Additionally, despite declining customer demand and selling prices in some categories of PPE as described above, Medical segment profit was benefited by pricing actions intended to mitigate the impact of cost increases in certain other PPE categories. In addition, while lower demand for surgical products resulting from reduced elective procedures had an adverse impact on Medical segment profit during the first nine months of fiscal 2021, demand improved during the fourth quarter of fiscal 2021 and was a positive contributor to year-over-year segment profit.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We currently anticipate that the negative impact of the COVID-19 pandemic on operating earnings will be less in fiscal 2022 than it was in fiscal 2021, which includes the inventory reserve of $197&#160;million described above. As a result, in comparison to prior year, we expect the COVID-19 impact for fiscal 2022 will be positive. However, we cannot estimate the length or severity of the COVID-19 pandemic or of the related U.S. or global economic consequences on our businesses and results of operations, including whether and when historic economic and operating conditions will resume, or its impact on our business, financial position, results of operations or cash flow. Its impact may be greater or less than we anticipate.</span></div><div style="margin-bottom:3pt;text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:16pt;font-weight:700;line-height:120%">Opioid Lawsuits</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #ee2724;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In July 2021, we announced that we and two other national distributors have negotiated a proposed settlement agreement (the &#8220;Proposed Settlement Agreement&#8221;) and settlement process that, if all conditions are satisfied (including Boards of Directors' approval), would result in the settlement of the vast majority of opioid lawsuits filed by state and local governmental entities. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">West Virginia subdivisions and Native American tribes are not a part of this settlement process and we have been involved in separate negotiations with these groups. The settlement process does not contemplate participation by any non-governmental or non-political entities or individuals. In connection with the negotiations of the Proposed Settlement Agreement, we and the two other national distributors entered into a settlement with the State of New York and its participating subdivisions. If the Proposed Settlement Agreement becomes effective, New York and its participating subdivisions will become a part of it. </span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:3pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.222%"><tr><td style="width:1.0%"></td><td style="width:32.133%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.433%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.134%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">6</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardinal Health </span><span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">| </span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2021 Form 10-K</span></div></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:3pt;text-align:center"><span><br/></span></div><div style="margin-bottom:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:24.720%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:50.989%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.991%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#e41f35;border-bottom:1pt solid #e41f35;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">MD&amp;A</span></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Results of Operations</span></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:0 1pt"></td></tr></table></div></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Proposed Settlement Agreement is subject to contingencies and will not become effective unless and until the Boards of Directors of the three distributors each make separate independent determinations that (1) following a sign-on period, a sufficient number of states have agreed to the Proposed Settlement Agreement (the &#8220;Settling States&#8221;); and, subsequently, (2) following a notice period, that a sufficient number of states and political subdivisions, including those that have not sued, have agreed to the Agreement (or otherwise had their claims foreclosed) to proceed to effectiveness. Prior to the second determination, the Settling States will also have an opportunity to make a determination as to whether a sufficient number of political subdivisions have agreed to the Proposed Settlement Agreement (or otherwise had their claims foreclosed) to proceed with the Proposed Settlement Agreement. This process is currently contemplated to end in February 2022, although it may be extended by agreement. It is possible that a sufficient number of states and subdivisions will not agree to the Proposed Settlement Agreement or that other required contingencies will not be satisfied.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If these conditions are satisfied, the Proposed Settlement Agreement would become effective 60 days after the distributors determine that there is sufficient participation among political subdivisions. During this 60-day period, the Settling States and the distributors would cooperate to obtain consent judgments in each participating state embodying the terms of the Settlement. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Proposed Settlement Agreement includes a cash component, pursuant to which the Company would pay up to $6.37 billion, the majority of which would be paid over 18 years. The exact payment amount will depend on several factors, including the participation rate of states and political subdivisions, the extent to which states take action to foreclose opioid lawsuits by political subdivisions (e.g., laws barring opioid lawsuits by political subdivisions), and the extent to which political subdivisions in Settling States file additional opioid lawsuits against the Company after the Proposed Settlement Agreement becomes effective.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Proposed Settlement Agreement also includes injunctive relief terms relating to settling distributors&#8217; controlled substance anti-diversion programs, including with respect to: (1) governance; (2) independence and training of the personnel operating our controlled substances monitoring program; (3) due diligence for new and existing customers; (4) ordering limits for certain products; and (5) suspicious order monitoring. A monitor will be selected to oversee compliance with these provisions for a period of five years. In addition, we and the two other national distributors will engage a third-party vendor to act as a clearinghouse for data aggregation and reporting; distributors will fund the clearinghouse for ten years.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, a trial before a judge in West Virginia in the Cabell County and City of Huntington cases concluded in July 2021 and the judge has not yet issued a decision. In addition, a trial in the case brought by the Ohio Attorney General is scheduled to begin in September 2021 and a trial in the case brought by the Washington Attorney General is scheduled to begin in November 2021. The Ohio Attorney General has issued a press release indicating support for the Proposed Settlement Agreement; however, the Washington Attorney General has issued a press release stating that Washington will not agree to the Proposed Settlement Agreement. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the opioid lawsuits and settlement negotiations, we have recorded total pre-tax charges of $1.17&#160;billion and $5.63&#160;billion in litigation charges/(recoveries), net in the years ended June&#160;30, 2021 and 2020, respectively. In total, we have $6.73&#160;billion accrued at June&#160;30, 2021, of which $405 million is included in other accrued liabilities, as we expect to make our first annual settlement payment into escrow on or before September 30, 2021, and the remainder is included in deferred income taxes and other liabilities in the consolidated balance sheets. Because loss contingencies are inherently unpredictable and unfavorable developments or resolutions can occur, the assessment is highly subjective and requires judgments about future events. We regularly review these opioid litigation matters to determine whether our accrual is adequate. The amount of ultimate loss may differ materially from this accrual. See </span><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i4f0ec56b9c604f1782a65ea4a19c284d_130">Note 7</a></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of the "Notes to Consolidated Financial Statements" for additional information.</span></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Tax Effect of Opioid Litigation Charges</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The net tax benefits associated with the opioid litigation charges are $228 million and $488 million for fiscal 2021 and 2020, respectively. Our tax benefits are estimates, which reflect our current assessment of the estimated future deductibility of the amount that may be paid under the accrual taken in connection with the opioid litigation and are net of unrecognized tax benefits of $219 million and $469 million, respectively. The fiscal 2021 net tax benefit and unrecognized tax benefits were primarily due to our assessment of the specific terms of the Proposed Settlement Agreement. Our assumptions and estimates around this benefit and uncertain tax position require significant judgment and the actual amount of tax benefit may differ materially from these estimates. See </span><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i4f0ec56b9c604f1782a65ea4a19c284d_133">Note 8</a></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of the "Notes to Consolidated Financial Statements" for additional information.</span></div><div style="margin-bottom:3pt;text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:16pt;font-weight:700;line-height:120%">Tax Effects of Self-Insurance Pre-Tax Loss</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #ee2724;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During fiscal 2021, our wholly-owned insurance subsidiary recorded a self-insurance pre-tax loss in its fiscal 2020 statutory financial statements primarily related to opioid litigation. This self-insurance pre-tax loss, which did not impact our pre-tax consolidated results, was deducted on our fiscal 2020 consolidated federal income tax return and contributed to a significant net operating loss for tax purposes. The net operating loss was carried back and applied to adjust our taxable income for fiscal 2015, 2016, 2017, and 2018 as permitted under the CARES Act enacted by the United States Congress in March 2020.</span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:32.135%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.428%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.137%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardinal Health </span><span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">|</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> Fiscal 2021 Form 10-K</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">7</span></div></td></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:3pt;text-align:center"><span><br/></span></div><div style="margin-bottom:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:24.720%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:50.989%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.991%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#e41f35;border-bottom:1pt solid #e41f35;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">MD&amp;A</span></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Results of Operations</span></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:0 1pt"></td></tr></table></div></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accordingly, our provision for income taxes during fiscal 2021 included a $424 million benefit from the net operating loss carryback primarily to reflect the difference between the federal statutory income tax rate during the fiscal years from 2015 to 2018 (35 percent for fiscal 2015, 2016, and 2017 and 28 percent for fiscal 2018) and the current federal statutory income tax rate of 21 percent.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have filed for a U.S. federal income tax refund of $974 million as a result of the net operating loss carryback under the CARES Act, which we expect to receive within 12 months, and accordingly have recorded a current asset on our consolidated balance sheet at June&#160;30, 2021. We also increased our non-current deferred tax liability by approximately $700 million during fiscal 2021 related to this matter.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have recorded these amounts based on management's judgment and our current understanding of tax law; however, it is possible that the tax authorities could challenge these tax benefits or that the tax law could change. The actual amount or timing of the tax benefit may differ from these expectations. See </span><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i4f0ec56b9c604f1782a65ea4a19c284d_133">Note 8</a></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of the "Notes to Consolidated Financial Statements" for additional information.</span></div><div style="margin-bottom:3pt;text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:16pt;font-weight:700;line-height:120%">Cordis Divestiture</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #ee2724;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 12, 2021, we announced that we signed a definitive agreement to sell our Cordis business to Hellman &amp; Friedman for proceeds of $927 million in cash, subject to customary purchase price adjustments, and we retained certain working capital accounts and product liability for lawsuits and claims related to inferior vena cava ("IVC") filters in the U.S. and Canada as described in </span><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i4f0ec56b9c604f1782a65ea4a19c284d_130">Note 7</a></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of the &#8220;Notes to Consolidated Financial Statements.&#8221; The transaction closed on August 2, 2021, and we received proceeds of $927 million, net of cash transferred. In connection with the closing, we entered into a Transition Services Agreement ("TSA") with the buyer to provide support functions for a period of up to twenty-four months following the sale. See </span><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i4f0ec56b9c604f1782a65ea4a19c284d_106">Note 2</a></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of the "Notes to Consolidated Financial Statements" for additional information.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During fiscal 2021, we recognized a $60&#160;million pre-tax write-down of the net assets held for sale in impairment and (gain)/loss on disposal of assets in the consolidated statement of earnings/(loss). We recorded a net tax expense of $9&#160;million associated with the impact of the write-down and the required tax adjustments related to held for sale accounting. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the divestiture, during fiscal 2021 we recognized costs of $28 million associated with exit or disposal activities. We expect to record up to $100 million of additional costs associated with these activities, primarily during fiscal 2022. These costs are recorded in restructuring and employee severance in our consolidated statements of earnings/(loss). We expect these charges to consist of approximately $83 million of professional, project management and other service fees to support the divestiture; $19 million of employee-related costs; and additional expenses from facility exits and other restructuring activities.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We expect the divestiture of the Cordis business will decrease annual Medical segment revenue by approximately $800 million and adversely impact Medical segment profit by approximately $80 million. The divestiture of our Cordis business is subject to risks and uncertainties that may further adversely impact Medical segment profit. For example, the TSA period may be extended beyond our current expectations or could have unintended consequences, and the costs associated with the exit or disposal activities and stranded costs could be greater than anticipated.</span></div><div style="margin-bottom:3pt;text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:16pt;font-weight:700;line-height:120%">Pharmaceutical Segment</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #ee2724;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The performance of our Pharmaceutical segment generics program adversely impacted the year-over-year comparison of Pharmaceutical segment profit in fiscal 2021 due to volume declines in our generics program, including the impact of COVID-19. The Pharmaceutical segment generics program includes, among other things, the impact of generic pharmaceutical product launches, customer volumes, pricing changes and the Red Oak Sourcing, LLC venture ("Red Oak Sourcing") with CVS Health Corporation ("CVS Health"). In August 2021, we amended our agreement with CVS Health to extend the term of the Red Oak Sourcing agreement through June 2029. The frequency, timing, magnitude and profit impact of generic pharmaceutical customer volumes, pricing changes, customer contract renewals, and branded and generic pharmaceutical manufacturer pricing changes remain uncertain as does their impact on Pharmaceutical segment profit and consolidated operating earnings in fiscal 2022.</span></div><div style="margin-bottom:3pt;text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:16pt;font-weight:700;line-height:120%">Medical Segment</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #ee2724;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the fourth quarter of fiscal 2021, our Medical segment experienced increased supply chain costs, primarily related to transportation, labor and commodities. While we are taking actions to mitigate the impact of these and other sourcing cost increases primarily through cost-savings measures, including global manufacturing efficiencies, we expect these increased costs to adversely impact Medical segment profit in fiscal 2022.</span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:3pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.222%"><tr><td style="width:1.0%"></td><td style="width:32.133%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.433%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.134%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">8</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardinal Health </span><span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">| </span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2021 Form 10-K</span></div></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:3pt;text-align:center"><span><br/></span></div><div style="margin-bottom:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:24.720%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:50.989%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.991%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#e41f35;border-bottom:1pt solid #e41f35;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">MD&amp;A</span></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Results of Operations</span></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:0 1pt"></td></tr></table></div></div><div style="margin-bottom:3pt;text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:16pt;font-weight:700;line-height:120%">Information Technology Investments</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #ee2724;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Pharmaceutical segment is in a multi-year project to implement a replacement of certain finance and operating systems. Within the Medical segment, Cardinal Health at-Home Solutions is also investing in a system transformation. We expect that these investments will result in increased project-related expenses and depreciation related to capital expenditures, which will negatively impact operating earnings and segment profit in fiscal 2022 and beyond.</span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:32.135%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.428%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.137%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardinal Health </span><span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">|</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> Fiscal 2021 Form 10-K</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">9</span></div></td></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span><br/></span></div></div></div><div id="i4f0ec56b9c604f1782a65ea4a19c284d_22"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:3pt"><span><br/></span></div><div style="margin-bottom:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.852%"><tr><td style="width:1.0%"></td><td style="width:24.453%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:50.450%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.797%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#e41f35;border-bottom:1pt solid #e41f35;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">MD&amp;A</span></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Results of Operations</span></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:0 1pt"></td></tr></table></div></div><div style="margin-bottom:3pt"><span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:20pt;font-weight:700;line-height:120%">Results of Operations</span></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:16pt;font-weight:700;line-height:120%">Revenue</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.115%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #ee2724;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:3pt;text-align:center"><img src="cah-20210630_g1.jpg" alt="cah-20210630_g1.jpg" style="height:240px;margin-bottom:5pt;vertical-align:text-bottom;width:230px"/><img src="cah-20210630_g2.jpg" alt="cah-20210630_g2.jpg" style="height:240px;margin-bottom:5pt;vertical-align:text-bottom;width:230px"/></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.115%"><tr><td style="width:1.0%"></td><td style="width:72.114%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.679%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.544%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.679%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.544%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.640%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Revenue</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Pharmaceutical</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">145,796</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">137,495&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">6</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Medical</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">16,687</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">15,444&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">8</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total segment revenue</span></td><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">162,483</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">152,939&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">6</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Corporate</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(16)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(17)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">N.M.</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 7.75pt 2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total revenue</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">162,467</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">152,922&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">6</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td></tr></table></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:48.230%"><div style="margin-bottom:3pt"><span><br/></span></div></div><div style="display:inline-block;max-width:3.539%;min-width:2.539%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:48.231%"></div></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Fiscal 2021 Compared to Fiscal 2020 </span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.115%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #ee2724;padding:0 1pt"></td></tr></table></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Pharmaceutical Segment</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fiscal 2021 Pharmaceutical segment revenue grew by $8.3 billion primarily due to sales growth from pharmaceutical distribution and specialty solutions customers, which together increased revenue by $8.1 billion.</span></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Medical Segment</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fiscal 2021 Medical segment revenue increased primarily within products and distribution, which increased revenue by $1.1&#160;billion, primarily due to a net benefit from COVID-19, including the positive impact of PPE and higher volumes in our laboratory business.</span></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:16pt;font-weight:700;line-height:120%">Cost of Products Sold</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.115%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #ee2724;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cost of products sold for fiscal 2021 increased $9.6 billion (7 percent) due to the factors affecting the changes in revenue and gross margin.</span></div><div style="margin-bottom:6pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:6pt;text-align:justify"><span><br/></span></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:48.230%"></div><div style="display:inline-block;max-width:3.539%;min-width:2.539%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:48.231%"></div></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:3pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.222%"><tr><td style="width:1.0%"></td><td style="width:32.133%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.433%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.134%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">10</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardinal Health </span><span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">| </span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2021 Form 10-K</span></div></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:3pt"><span><br/></span></div><div style="margin-bottom:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.852%"><tr><td style="width:1.0%"></td><td style="width:24.453%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:50.450%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.797%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#e41f35;border-bottom:1pt solid #e41f35;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">MD&amp;A</span></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Results of Operations</span></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:0 1pt"></td></tr></table></div></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:48.230%"><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:16pt;font-weight:700;line-height:120%">Gross Margin</span></div></div><div style="display:inline-block;max-width:3.539%;min-width:2.539%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:48.231%"></div></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.115%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #ee2724;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:6pt;text-align:center"><img src="cah-20210630_g3.jpg" alt="cah-20210630_g3.jpg" style="height:233px;margin-bottom:5pt;vertical-align:text-bottom;width:200px"/><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><img src="cah-20210630_g4.jpg" alt="cah-20210630_g4.jpg" style="height:233px;margin-bottom:5pt;vertical-align:text-bottom;width:200px"/></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.858%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.422%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.422%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.424%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Consolidated Gross Margin</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Gross margin</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">6,778</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6,868&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(1)</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td></tr></table></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Fiscal 2021 Compared to Fiscal 2020</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:11pt;font-weight:700;line-height:120%"> </span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.115%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #ee2724;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fiscal 2021 consolidated gross margin decreased primarily due to the adverse impact of COVID-19, which includes an inventory reserve recorded to reduce the carrying value of certain Medical segment PPE, primarily certain categories of gloves, to net realizable value, partially offset by higher volumes in our laboratory business. For additional information regarding inventory reserves, see Significant Developments in Fiscal 2021 and Trends section in this MD&amp;A. Volume declines in our Pharmaceutical segment generics program, which includes the impact of COVID-19, also had an adverse impact. These factors were partially offset by higher contribution from branded pharmaceutical sales mix and the beneficial comparison of the current year insurance recoveries with the prior-year charge in connection with a voluntary recall for certain surgical gowns and a voluntary recall and field actions for surgical procedure packs containing affected gowns (together, the "Recalls").</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Gross margin rate declined during fiscal 2021 mainly due to changes in pharmaceutical distribution product sales mix and an inventory reserve recorded to reduce the carrying value of certain Medical segment PPE to net realizable value. While branded pharmaceutical sales contributed positively to gross margin dollars during fiscal 2021, they had a dilutive impact on our overall gross margin rate.</span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:32.135%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.428%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.137%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardinal Health </span><span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">|</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> Fiscal 2021 Form 10-K</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">11</span></div></td></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:3pt"><span><br/></span></div><div style="margin-bottom:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.852%"><tr><td style="width:1.0%"></td><td style="width:24.453%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:50.450%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.797%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#e41f35;border-bottom:1pt solid #e41f35;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">MD&amp;A</span></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Results of Operations</span></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:0 1pt"></td></tr></table></div></div><div style="margin-bottom:3pt;text-align:justify"><span><br/></span></div><div style="margin-top:3pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:16pt;font-weight:700;line-height:120%">Distribution, Selling, General and Administrative ("SG&amp;A") Expenses</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.115%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #ee2724;padding:0 1pt"></td></tr></table></div><div style="margin-top:11pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.858%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.422%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.422%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.424%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">SG&amp;A Expenses</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SG&amp;A expenses</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">4,533</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,572&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(1)</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td></tr></table></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:400;line-height:120%"> </span></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Fiscal 2021 Compared to Fiscal 2020</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:11pt;font-weight:700;line-height:120%"> </span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.115%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #ee2724;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fiscal 2021 SG&amp;A expenses decreased primarily due to the beneficial impact of enterprise-wide cost-savings measures. The year-over-year comparison was also favorably impacted by the&#160;$37&#160;million&#160;charge in connection with the Recalls recognized during fiscal 2020. These factors were partially offset by information technology investments and the $41&#160;million assessment on prescription opioid medications that were sold or distributed in New York state in calendar years 2017 and 2018. See </span><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i4f0ec56b9c604f1782a65ea4a19c284d_130">Note 7</a></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of the "Notes to Consolidated Financial Statements" for additional information on the New York Opioid Stewardship Act.</span></div><div style="margin-bottom:6pt;text-align:justify"><span><br/></span></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:48.230%"></div><div style="display:inline-block;max-width:3.539%;min-width:2.539%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:48.231%"></div></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:3pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.222%"><tr><td style="width:1.0%"></td><td style="width:32.133%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.433%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.134%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">12</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardinal Health </span><span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">| </span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2021 Form 10-K</span></div></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:3pt"><span><br/></span></div><div style="margin-bottom:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.852%"><tr><td style="width:1.0%"></td><td style="width:24.453%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:50.450%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.797%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#e41f35;border-bottom:1pt solid #e41f35;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">MD&amp;A</span></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Results of Operations</span></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:0 1pt"></td></tr></table></div></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:48.230%"><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:16pt;font-weight:700;line-height:120%">Segment Profit</span></div></div><div style="display:inline-block;max-width:3.539%;min-width:2.539%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:48.231%"></div></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.115%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #ee2724;padding:0 1pt"></td></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We evaluate segment performance based on segment profit, among other measures. See </span><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i4f0ec56b9c604f1782a65ea4a19c284d_154">Note 13</a></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of the "Notes to Consolidated Financial Statements" for additional information on segment profit.</span></div><div style="margin-bottom:6pt;text-align:center"><img src="cah-20210630_g5.jpg" alt="cah-20210630_g5.jpg" style="height:240px;margin-bottom:5pt;vertical-align:text-bottom;width:200px"/><img src="cah-20210630_g6.jpg" alt="cah-20210630_g6.jpg" style="height:240px;margin-bottom:5pt;vertical-align:text-bottom;width:200px"/></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.858%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.422%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.422%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.424%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Segment Profit and Operating Earnings</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Pharmaceutical</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1,684</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,753&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(4)</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Medical</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">577</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">663&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(13)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total segment profit</span></td><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2,261</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,416&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(6)</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Corporate</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(1,789)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(6,514)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">N.M.</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total consolidated operating earnings/(loss)</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">472</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4,098)</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">N.M.</span></td></tr></table></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:48.230%"><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Fiscal 2021 Compared to Fiscal 2020 </span></div></div><div style="display:inline-block;max-width:3.539%;min-width:2.539%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:48.231%"></div></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="15" style="border-top:1pt solid #ee2724;padding:0 1pt"></td></tr></table></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Pharmaceutical Segment Profit</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fiscal 2021 Pharmaceutical segment profit was adversely impacted due to volume declines in our generics program, including the impact of COVID-19, partially offset by higher contribution from branded pharmaceutical sales mix.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pharmaceutical segment financial results do not include the $1.17 billion and $5.63 billion charges associated with the opioid litigation during fiscal 2021 and 2020, respectively. See Significant Developments in Fiscal 2021 and Trends section in this MD&amp;A and&#160;</span><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i4f0ec56b9c604f1782a65ea4a19c284d_130">Note 7</a></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;of the "Notes to Consolidated Financial Statements" for additional information. In addition, Pharmaceutical segment financial results do not include the $41&#160;million assessment on prescription opioid medications that were sold or distributed in New York state in calendar years 2017 and 2018. See </span><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i4f0ec56b9c604f1782a65ea4a19c284d_130">Note 7</a></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;of the "Notes to Consolidated Financial Statements" for additional information on the New York Opioid Stewardship Act.</span></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Medical Segment Profit</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fiscal 2021 Medical segment profit decreased largely due to the adverse impact of COVID-19, which primarily includes an inventory reserve recorded to reduce the carrying value of certain PPE, primarily certain categories of gloves, to net realizable value, partially offset by higher volumes in our laboratory business. In addition, enterprise-wide cost-savings measures, including global manufacturing efficiencies, had a positive impact on Medical segment profit.</span></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Corporate</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The changes in Corporate during fiscal 2021 are due to the factors discussed in the Other Components of Consolidated Operating Earnings/(Loss) section that follows.</span></div><div style="margin-bottom:3pt"><span><br/></span></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:48.230%"><div style="margin-bottom:3pt;text-align:justify"><span><br/></span></div></div><div style="display:inline-block;max-width:3.539%;min-width:2.539%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:48.231%"></div></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:32.135%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.428%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.137%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardinal Health </span><span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">|</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> Fiscal 2021 Form 10-K</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">13</span></div></td></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:3pt"><span><br/></span></div><div style="margin-bottom:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.852%"><tr><td style="width:1.0%"></td><td style="width:24.453%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:50.450%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.797%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#e41f35;border-bottom:1pt solid #e41f35;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">MD&amp;A</span></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Results of Operations</span></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:0 1pt"></td></tr></table></div></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:16pt;font-weight:700;line-height:120%">Other Components of Consolidated Operating Earnings/(Loss)</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.115%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #ee2724;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to revenue, gross margin, and SG&amp;A expenses discussed previously, consolidated operating earnings/(loss) were impacted by the following:</span></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.852%"><tr><td style="width:1.0%"></td><td style="width:74.527%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.716%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.538%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.719%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Restructuring and employee severance</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">114</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">122&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Amortization and other acquisition-related costs</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">451</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">524&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Impairments and (gain)/loss on disposal of assets, net</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">79</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Litigation (recoveries)/charges, net</span></td><td colspan="2" style="border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1,129</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"></td><td colspan="2" style="border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5,741&#160;</span></td><td style="border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Restructuring and Employee Severance</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In fiscal 2021, restructuring costs were primarily related to the implementation of certain enterprise-wide cost-savings measures and the divestiture of our Cordis business. In fiscal 2020, restructuring costs were primarily related to the implementation of certain enterprise-wide cost-savings measures.</span></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Amortization and Other Acquisition-Related Costs</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amortization of acquisition-related intangible assets was $428 million and $512 million for fiscal 2021 and 2020, respectively. </span></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Impairments and (Gain)/Loss on Disposal of Assets, Net</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During fiscal 2021, we recognized a $60 million pre-tax write-down of the assets held for sale from the divestiture of our Cordis business. See the Significant Developments in Fiscal 2021 and Trends section in this MD&amp;A and </span><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i4f0ec56b9c604f1782a65ea4a19c284d_106">Note 2</a></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of the "Notes to Consolidated Financial Statements" for additional information.</span></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Litigation (Recoveries)/Charges, Net</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During fiscal 2021 and 2020, we recognized pre-tax charges of $1.17 billion and $5.63 billion, respectively, associated with certain opioid matters. See Significant Developments in Fiscal 2021 and Trends section in this MD&amp;A and&#160;</span><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i4f0ec56b9c604f1782a65ea4a19c284d_130">Note 7</a></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;of the "Notes to Consolidated Financial Statements" for additional information.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During fiscal 2021 and 2020, we recognized $56 million and $103 million, respectively, of estimated losses and legal defense costs associated with the IVC filter product liability claims.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During fiscal 2021 and 2020, we recognized income of $112 million and $16 million, respectively, for</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">recoveries in class action antitrust lawsuits in which we were a class member.</span></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:16pt;font-weight:700;line-height:120%">Other Components of Earnings/(Loss) Before Income Taxes</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.115%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #ee2724;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to the items discussed above, earnings/(loss) before income taxes was impacted by the following:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.858%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.422%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.422%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.424%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other (income)/expense, net</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(47)</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">N.M.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Interest expense, net</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">180</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">238&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(24)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Loss on early extinguishment of debt</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">14</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">N.M.</span></td></tr><tr><td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(Gain)/Loss on sale of equity interest in naviHealth</span></td><td colspan="2" style="border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"></td><td colspan="2" style="border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(579)</span></td><td style="border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">N.M.</span></td></tr></table></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:48.230%"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Other (Income)/Expense, Net</span></div></div><div style="display:inline-block;max-width:3.539%;min-width:2.539%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:48.231%"></div></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During fiscal 2021, other (income)/expense, net was favorable compared to the prior-year period primarily due to an increase in the value of our deferred compensation plan investments, which offsets fluctuations included within SG&amp;A expenses and is discussed further in </span><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i4f0ec56b9c604f1782a65ea4a19c284d_136">Note 9</a></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of the "Notes to Consolidated Financial Statements," gains on investments in non-marketable equity securities, and fluctuations in foreign exchange rates.</span></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Interest Expense, Net</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fiscal 2021 interest expense decreased from fiscal 2020 primarily due to lower debt outstanding and lower short-term interest rates.</span></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:48.230%"><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Loss On Early Extinguishment Of Debt</span></div></div><div style="display:inline-block;max-width:3.539%;min-width:2.539%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:48.231%"></div></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During fiscal 2021 and 2020, we recognized losses of $14 million and $16&#160;million, respectively, in connection with the redemption and early debt repurchases as described further in </span><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i4f0ec56b9c604f1782a65ea4a19c284d_124">Note 6</a></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of the "Notes to Consolidated Financial Statements."</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Gain)/Loss on Sale of Equity Interest in naviHealth</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During fiscal 2020, we recognized a pre-tax gain of $579&#160;million from the sale of our equity interest in a partnership that owned naviHealth, as described further in </span><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i4f0ec56b9c604f1782a65ea4a19c284d_106">Note 2</a></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of the "Notes to Consolidated Financial Statements." </span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:3pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.222%"><tr><td style="width:1.0%"></td><td style="width:32.133%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.433%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.134%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">14</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardinal Health </span><span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">| </span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2021 Form 10-K</span></div></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:3pt"><span><br/></span></div><div style="margin-bottom:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.852%"><tr><td style="width:1.0%"></td><td style="width:24.453%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:50.450%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.797%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#e41f35;border-bottom:1pt solid #e41f35;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">MD&amp;A</span></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Results of Operations</span></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:0 1pt"></td></tr></table></div></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:16pt;font-weight:700;line-height:120%">Provision for Income Taxes</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.115%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #ee2724;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fluctuations in the effective tax rates are primarily due to the impact of opioid litigation in fiscal 2021 and 2020, as well as the impact of the carryback claim filed in accordance with the CARES Act provision in fiscal year 2021.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of the provision based on the federal statutory income tax rate to our effective income tax rate from continuing operations is as follows</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(see </span><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i4f0ec56b9c604f1782a65ea4a19c284d_133">Note 8</a></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of the "Notes to Consolidated Financial Statements" for additional information):</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.852%"><tr><td style="width:1.0%"></td><td style="width:74.527%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.716%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.538%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.719%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021 </span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2020 </span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Provision at Federal statutory rate</span></td><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">21.0</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">21.0&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">State and local income taxes, net of federal benefit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">3.2</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Tax effect of foreign operations</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">0.7</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Nondeductible/nontaxable items </span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1.6</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cordis Disposition</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">7.0</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Withholding Taxes </span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">9.0</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(0.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Change in Valuation Allowances</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(1.4)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1.5&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">US Taxes on International Income </span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(2)(3)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(6.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Impact of Resolutions with IRS and other related matters </span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(13.6)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(0.4)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Opioid litigation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">17.7</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(23.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Loss Carryback Claims</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(129.9)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other </span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1.7</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Effective income tax rate</span></td><td colspan="2" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(89.7)</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2.1&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1) &#160;&#160;&#160;&#160;The table represents the following: fiscal 2021 is pretax income with tax benefit and fiscal 2020 is pretax loss with tax benefit.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2) &#160;&#160;&#160;&#160;Certain prior year amounts have been reclassified to conform to current year presentation.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(3)&#160;&#160;&#160;&#160;Includes the tax impact of Global Intangible Low-Taxed Income ("GILTI") tax, the Foreign-Derived Intangible Income deduction and other foreign income that is taxable under the U.S. tax code.</span></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:48.230%"><div style="margin-bottom:3pt;text-align:justify"><span><br/></span></div></div><div style="display:inline-block;max-width:3.539%;min-width:2.539%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:48.231%"></div></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Fiscal 2021 </span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.115%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #ee2724;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During fiscal 2021 and 2020, the effective tax rate was (89.7) percent and 2.1 percent, respectively. Included in the effective tax rate for fiscal 2021 was a $424 million benefit from the net operating loss carryback primarily related to a self-insurance pre-tax loss. Included in both 2021 and 2020 were net tax benefits related to the treatment of the tax impacts of the fiscal 2021 and 2020 opioid litigation charges</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:120%">.</span></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Tax Effects of Self-Insurance Pre-tax Loss</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During fiscal 2021, our wholly-owned insurance subsidiary recorded a self-insurance pre-tax loss in its fiscal 2020 statutory financial statements primarily related to opioid litigation. This self-insurance pre-tax loss, which did not impact our pre-tax consolidated results, was deducted on our fiscal 2020 consolidated federal income tax return and contributed to a significant net operating loss for tax purposes. The net operating loss was carried back and applied to adjust our taxable income for fiscal 2015, 2016, 2017, and 2018 as permitted under the CARES Act enacted by the United States Congress in March 2020.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accordingly, our provision for income taxes during fiscal 2021 included a $424 million benefit from the net operating loss carryback primarily to reflect the difference between the federal statutory income tax rate during the fiscal years from 2015 to 2018 (35 percent for fiscal 2015, 2016, and 2017 and 28 percent for fiscal 2018) and the current federal statutory income tax rate of 21 percent.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have filed for a U.S. federal income tax refund of $974 million as a result of the net operating loss carryback under the CARES Act, which we expect to receive within 12 months, and accordingly have recorded a current asset on our consolidated balance sheet at June&#160;30, 2021. We also increased our non-current deferred tax liability by approximately $700 million during fiscal 2021 related to this matter.</span></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Tax Effect of Opioid Litigation Charges</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The net tax benefits associated with the opioid litigation charges are $228 million and $488 million for fiscal 2021 and 2020, respectively. Our tax benefits are estimates, which reflect our current assessment of the estimated future deductibility of the amount that may be paid under the accrual taken in connection with the opioid litigation and are net of unrecognized tax benefits of $219 million and $469 million, respectively. The fiscal 2021 net tax benefit and unrecognized tax benefits were primarily due to our assessment of the specific terms of the Proposed Settlement Agreement. Our assumptions and estimates around this benefit and uncertain tax position require significant judgment and the actual amount of tax benefit may differ materially from these estimates. </span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:32.135%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.428%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.137%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardinal Health </span><span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">|</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> Fiscal 2021 Form 10-K</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">15</span></div></td></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:3pt"><span><br/></span></div><div style="margin-bottom:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.852%"><tr><td style="width:1.0%"></td><td style="width:24.453%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:50.450%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.797%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#e41f35;border-bottom:1pt solid #e41f35;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">MD&amp;A</span></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Results of Operations</span></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:0 1pt"></td></tr></table></div></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Ongoing Audits</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We file income tax returns in the U.S. federal jurisdiction, various U.S. state jurisdictions and various foreign jurisdictions. With few exceptions, we are subject to audit by taxing authorities for fiscal years 2015 through the current fiscal year. Tax laws are complex and subject to varying interpretations. During fiscal 2021, we resolved all open issues with respect to the Company&#8217;s activity within fiscal years 2008 through 2014 with the U.S. Internal Revenue Service ("IRS"). This resolution resulted in an adjustment to our provision for income taxes, including an impact to reserves for later years. New challenges related to future audits may adversely affect our effective tax rate or tax payments.</span></div><div style="margin-bottom:3pt;text-align:justify"><span><br/></span></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:48.230%"><div style="margin-bottom:3pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:3pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:3pt;text-align:justify"><span><br/></span></div></div><div style="display:inline-block;max-width:3.539%;min-width:2.539%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:48.231%"></div></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:3pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.222%"><tr><td style="width:1.0%"></td><td style="width:32.133%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.433%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.134%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">16</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardinal Health </span><span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">| </span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2021 Form 10-K</span></div></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div></div></div><div id="i4f0ec56b9c604f1782a65ea4a19c284d_25"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:3pt;text-align:center"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.262%"><tr><td style="width:1.0%"></td><td style="width:24.605%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:50.757%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.338%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#e41f35;border-bottom:1pt solid #e41f35;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">MD&amp;A</span></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liquidity and Capital Resources</span></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:0 1pt"></td></tr></table></div></div><div style="margin-bottom:3pt"><span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:20pt;font-weight:700;line-height:120%">Liquidity and Capital Resources</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We currently believe that, based on available capital resources (cash on hand and committed credit facilities) and projected operating cash flow, we have adequate capital resources to fund working capital needs; currently anticipated capital expenditures; currently anticipated business growth and expansion; contractual obligations; tax payments; current and projected debt service requirements, early extinguishment of debt, dividends and share repurchases; and potential opioid litigation settlement payments associated with the Proposed Settlement Agreement. If we decide to engage in one or more acquisitions, depending on the size and timing of such transactions, we may need to access capital markets for additional financing.</span></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:48.214%"><div><span><br/></span></div></div><div style="display:inline-block;max-width:3.571%;min-width:2.571%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:48.215%"><div><span><br/></span></div></div></div><div style="margin-top:3pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:16pt;font-weight:700;line-height:120%">Cash and Equivalents</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #ee2724;padding:0 1pt"></td></tr></table></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:48.214%"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our cash and equivalents balance was $3.4 billion at June&#160;30, 2021 compared to $2.8 billion at June&#160;30, 2020. The increase in cash during fiscal 2021 was due to net cash provided by operating activities of $2.4 billion, offset by cash deployed of $573 million for dividends, $570 million for debt repayments, $400 million for capital expenditures and $200 million for share repurchases. At June&#160;30, 2021, our cash and equivalents were held in cash depository accounts with major banks or invested in high quality, short-term liquid investments.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During fiscal 2020, our cash and equivalents increased due to $2.0 billion of net cash provided by operating activities, which reflects increases to working capital associated with the timing of payments to vendors, and $886 million of net cash proceeds from the sale of investments, substantially all of which was related to the sale of our equity interest in naviHealth, offset by cash deployed of $1.4 billion for debt repayments, $569 million for dividends and $350 million for share repurchases.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in working capital, which impact operating cash flow, can vary significantly depending on factors such as the timing of customer payments, inventory purchases, payments to vendors and tax payments in the regular course of business, as well as </span></div></div><div style="display:inline-block;max-width:3.571%;min-width:2.571%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:48.215%"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">fluctuating working capital needs driven by customer and product mix.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The cash and equivalents balance at June&#160;30, 2021 included $523 million of cash and equivalents held by subsidiaries outside of the United States.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2021, we returned $127 million of cash held by foreign subsidiaries to the U.S.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of June&#160;30, 2021, foreign earnings of approximately $825 million are considered indefinitely reinvested for working capital and other offshore investment needs. The computation of tax required if those earnings are repatriated is not practicable. For amounts not considered indefinitely reinvested, we have recorded an immaterial amount of income tax expense in our financial statements in fiscal 2021.</span></div><div style="margin-bottom:3pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:3pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:3pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:3pt;text-align:justify"><span><br/></span></div></div></div><div style="margin-top:3pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:16pt;font-weight:700;line-height:120%">Other Financing Arrangements and Financial Instruments</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #ee2724;padding:0 1pt"></td></tr></table></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:48.214%"><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Credit Facilities and Commercial Paper</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to cash and equivalents and operating cash flow, other sources of liquidity at June&#160;30, 2021 include a $2.0 billion commercial paper program, backed by a $2.0 billion revolving credit facility. We also have a $1.0 billion committed receivables sales facility. At June&#160;30, 2021, we had no amounts outstanding under our commercial paper program, revolving credit facility or our committed receivables sales facility. During fiscal 2021, under our commercial paper program and our committed receivables program, we had maximum combined total daily amounts outstanding of $200 million&#160;and an immaterial average combined daily amount outstanding.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our revolving credit and committed receivables sales facilities require us to maintain a consolidated net leverage ratio of no more than 3.75-to-1. As of June&#160;30, 2021, we were in compliance with this financial covenant. </span></div></div><div style="display:inline-block;max-width:3.571%;min-width:2.571%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:48.215%"><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Long-Term Obligations</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At June&#160;30, 2021, we had total long-term obligations, including the current portion and other short-term borrowings of $6.2 billion. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2021, we redeemed all outstanding 3.2% Notes due June 2022 for $238&#160;million and $262&#160;million aggregate principle amount of 2.616% Notes due June 2022 at a redemption price equal to 100% of the principal amount and accrued but unpaid interest, plus the make-whole premium applicable to the notes. In connection with these redemptions, we recorded a $13&#160;million loss on early extinguishment of debt. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During fiscal 2021, we also early repurchased $40 million of the Floating Rate Notes due 2022</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and $2 million of the 2.616% Notes due 2022 with available cash. In connection with the early debt repurchases, we recorded a $1&#160;million</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">loss on early extinguishment of debt.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2020, we redeemed $500 million aggregate principle amount of 4.625% Notes due December 2020 at a redemption </span></div></div></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:32.135%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.428%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.137%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardinal Health </span><span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">|</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> Fiscal 2021 Form 10-K</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">17</span></div></td></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:3pt;text-align:center"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.262%"><tr><td style="width:1.0%"></td><td style="width:24.605%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:50.757%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.338%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#e41f35;border-bottom:1pt solid #e41f35;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">MD&amp;A</span></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liquidity and Capital Resources</span></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:0 1pt"></td></tr></table></div></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:48.214%"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">price equal to 100% of the principal amount and accrued but unpaid interest, plus the make-whole premium applicable to the notes. In connection with the redemption, we recorded a $7 million loss on early extinguishment of debt. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During fiscal 2020, we also early repurchased&#160;$247 million&#160;of the&#160;2.616%&#160;Notes due 2022,&#160;$11&#160;million&#160;of the&#160;3.2% Notes due 2022,&#160;$20&#160;million&#160;of the&#160;Floating Rate Notes due 2022,&#160;$104&#160;million&#160;of the&#160;3.41% Notes due 2027,&#160;$6&#160;million&#160;of the&#160;4.6% Notes due 2043,&#160;$5&#160;million&#160;of the&#160;4.9% Notes due 2045, and&#160;$35&#160;million&#160;of the&#160;4.368% Notes due 2047.&#160;In connection with these early debt repurchases, we recognized a&#160;$9 million&#160;loss on early extinguishment of debt. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The redemption and repurchases were paid for with available cash and other short-term borrowings.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 13, 2021, we announced our intention to early redeem all remaining outstanding 2.616% Notes due June 2022 on </span></div></div><div style="display:inline-block;max-width:3.571%;min-width:2.571%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:48.215%"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">September 15, 2021 at an expected redemption price equal to 100% of the principal amount and accrued but unpaid interest, plus the make-whole premium applicable to the notes.</span></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Risk Management</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We use interest rate swaps, foreign currency contracts and commodity contracts to manage our exposure to cash flow variability. We also use interest rate swaps to protect the value of our debt and use foreign currency forward contracts to protect the value of our existing and forecasted foreign currency assets and liabilities. See the "Quantitative and Qualitative Disclosures About Market Risk" section as well as </span><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i4f0ec56b9c604f1782a65ea4a19c284d_100">Note 1</a></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i4f0ec56b9c604f1782a65ea4a19c284d_139">Note 10</a></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of the &#8220;Notes to Consolidated Financial Statements&#8221; for information regarding the use of financial instruments and derivatives as well as foreign currency, interest rate and commodity exposures.</span></div></div></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:16pt;font-weight:700;line-height:120%">Anticipated Capital Resources</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #ee2724;padding:0 1pt"></td></tr></table></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:48.214%"><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Tax Effects of Self-Insurance Pre-tax Loss</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In connection with a tax benefit from the net operating loss carryback primarily related to a self-insurance pre-tax loss as described further in Significant Developments in Fiscal 2021 and Trends section in this MD&amp;A and </span><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i4f0ec56b9c604f1782a65ea4a19c284d_133">Note 8</a></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> of the "Notes to Consolidated Financial Statements," we have filed for a U.S. federal income tax refund of $974 million, which we expect to receive within 12 months. Accordingly, we have recorded a current asset for this amount on our consolidated balance sheet at June&#160;30, 2021. We also increased our non-current deferred tax liability by approximately $700 million during fiscal 2021 related to this matter.</span></div><div style="margin-bottom:3pt"><span><br/></span></div></div><div style="display:inline-block;max-width:3.571%;min-width:2.571%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:48.215%"><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Cordis Divestiture</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 12, 2021, we announced that we signed a definitive agreement to sell our Cordis business to Hellman &amp; Friedman for proceeds of $927 million in cash, subject to customary purchase price adjustments, and we retained certain working capital accounts and certain liabilities. The transaction closed on August 2, 2021 and we received proceeds of $927 million, net of cash transferred.</span></div></div></div><div style="margin-bottom:3pt;text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:16pt;font-weight:700;line-height:120%">Capital Deployment</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #ee2724;padding:0 1pt"></td></tr></table></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:48.214%"><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Opioid Settlement Framework</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We had $6.73&#160;billion accrued at June&#160;30, 2021 related to certain opioid litigation, including the Proposed Settlement Agreement, as further described within the Significant Developments in Fiscal 2021 and Trends section in this MD&amp;A and </span><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i4f0ec56b9c604f1782a65ea4a19c284d_130">Note 7</a></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of the "Notes to Consolidated Financial Statements." We expect the majority of the payment amounts to be spread over 18 years. We currently expect to make our first annual settlement payment under the Proposed Settlement Agreement in the amount of $405 million into escrow on or before September 30, 2021. If the Proposed Settlement Agreement does not become effective, this payment will be returned to us. We expect to make subsequent annual payments beginning in July 2022.</span></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Capital Expenditures</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Capital expenditures during fiscal 2021 and 2020 were $400 million and $375 million, respectively.</span></div></div><div style="display:inline-block;max-width:3.571%;min-width:2.571%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:48.215%"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%">We expect capital expenditures in fiscal 2022 to be between $400 million and $450 million and to be primarily for information technology and infrastructure projects. </span></div></div></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:3pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.222%"><tr><td style="width:1.0%"></td><td style="width:32.133%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.433%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.134%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">18</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardinal Health </span><span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">| </span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2021 Form 10-K</span></div></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:3pt;text-align:center"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.262%"><tr><td style="width:1.0%"></td><td style="width:24.605%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:50.757%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.338%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#e41f35;border-bottom:1pt solid #e41f35;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">MD&amp;A</span></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liquidity and Capital Resources</span></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:0 1pt"></td></tr></table></div></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:48.214%"><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Dividends</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During fiscal 2021, we paid quarterly dividends totaling $1.94 per share, an increase of 1 percent from fiscal 2020.</span></div><div style="margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May 5, 2021, our Board of Directors approved a quarterly dividend of $0.4908 per share, or $1.96 per share on an annualized basis, which was paid on July 15, 2021 to shareholders of record on July 1, 2021.</span></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 4, 2021, our Board of Directors approved a quarterly dividend of $0.4908 per share, payable on October 15, 2021 to shareholders of record on October 1, 2021.</span></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Share Repurchases</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During fiscal 2021 and 2020, we repurchased $200 million and $350 million, respectively, of our common shares. We funded the repurchases with available cash and short-term borrowings. See </span><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i4f0ec56b9c604f1782a65ea4a19c284d_145">Note 11</a></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of the "Notes to Consolidated Financial Statements" for additional information. At June&#160;30, 2021, we had $743 million authorized for share repurchases remaining on a program that expires on December 31, 2021.</span></div></div><div style="display:inline-block;max-width:3.571%;min-width:2.571%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:48.215%"></div></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:32.135%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.428%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.137%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardinal Health </span><span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">|</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> Fiscal 2021 Form 10-K</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">19</span></div></td></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span><br/></span></div></div></div><div id="i4f0ec56b9c604f1782a65ea4a19c284d_28"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.976%"><tr><td style="width:1.0%"></td><td style="width:24.453%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:50.450%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.797%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#e41f35;border-bottom:1pt solid #e41f35;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">MD&amp;A</span></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other</span></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span><br/></span></div></div><div style="margin-bottom:3pt"><span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:20pt;font-weight:700;line-height:120%">Contractual Obligations</span></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:48.214%"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At June&#160;30, 2021, our contractual obligations, including estimated payments due by period, were as follows: </span></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.382%"><tr><td style="width:1.0%"></td><td style="width:33.993%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.769%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.352%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.390%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.352%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.390%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.352%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.390%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.352%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.260%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2023 to 2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2025 to 2026</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">There-after</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Long-term debt and short-term borrowings (1)</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">853&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,359&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">934&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,026&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">6,172</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Interest on long-term debt</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">232&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">378&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">286&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,540&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2,436</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Finance lease obligations (2)</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">70</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Operating lease obligations (3)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">116&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">165&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">115&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">141&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">537</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Purchase obligations and other payments (4)</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">715&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">488&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">189&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">273&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1,665</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Total contractual obligations (5) (6)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1,936</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2,424</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1,535</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">4,985</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">10,880</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:10pt">Represents maturities of our long-term debt obligations and other short-term borrowings excluding finance lease obligations described below. See </span><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i4f0ec56b9c604f1782a65ea4a19c284d_124">Note 6</a></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> of the &#8220;Notes to Consolidated Financial Statements&#8221; for further information.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:10pt">Represents minimum finance lease obligations included within current portion of long-term obligations and other short-term borrowings and long-term obligations, less current portion in our consolidated balance sheets and further described in </span><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i4f0ec56b9c604f1782a65ea4a19c284d_121">Note 5</a></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> of the &#8220;Notes to Consolidated Financial Statements.&#8221;</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:10pt">Represents minimum operating lease obligations included within other accrued liabilities and deferred income taxes and other liabilities in our consolidated balance sheets and further described in </span><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i4f0ec56b9c604f1782a65ea4a19c284d_121">Note 5</a></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> of the &#8220;Notes to Consolidated Financial Statements.&#8221;</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:10pt">A purchase obligation is defined as an agreement to purchase goods or services that is legally enforceable and specifies all significant terms, including fixed or minimum quantities to be purchased; fixed, minimum or </span></div></div><div style="display:inline-block;max-width:3.571%;min-width:2.571%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:48.215%"><div style="margin-bottom:3pt;padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%">variable price provisions; and approximate timing of the transaction. The purchase obligation amounts disclosed above represent estimates of the minimum for which we are obligated and the time period in which cash outflows will occur. Purchase orders and authorizations to purchase that involve no firm commitment from either party are excluded from the above table. In addition, contracts that can be unilaterally canceled with no termination fee or with proper notice are excluded from our total purchase obligations except for the amount of the termination fee or the minimum amount of goods that must be purchased during the requisite notice period. Purchase obligations and other payments also includes quarterly payments to CVS Health Corporation in connection with Red Oak Sourcing, which also reflects the August 2021 amendment to extend the term through June 2029. See </span><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i4f0ec56b9c604f1782a65ea4a19c284d_130">Note </a><a style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i4f0ec56b9c604f1782a65ea4a19c284d_130">7</a></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> of the &#8220;Notes to Consolidated Financial Statements&#8221; for additional information.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(5)</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:10pt">Long-term liabilities, such as unrecognized tax benefits, deferred taxes and other tax liabilities, have been excluded from the above table due to the inherent uncertainty of the underlying tax positions or because of the inability to reasonably estimate the timing of any cash outflows. See </span><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i4f0ec56b9c604f1782a65ea4a19c284d_133">Note 8</a></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> of the "Notes to Consolidated Financial Statements" for further discussion of income taxes.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(6)</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:10pt">Total contractual obligations do not include payments that may be made in connection with the opioid litigation, as further described in Significant Developments in Fiscal 2021 and Trends section in this MD&amp;A and&#160;<a style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:none" href="#i4f0ec56b9c604f1782a65ea4a19c284d_130">Note 7</a>&#160;of the "Notes to Consolidated Financial Statements." In July 2021, we announced that we and two other national distributors have negotiated the Proposed Settlement Agreement and settlement process that, if all conditions are satisfied, would result in the settlement of the vast majority of opioid lawsuits filed by state and local governmental entities. The Proposed Settlement Agreement is subject to certain contingencies and includes a cash component, pursuant to which the Company would pay up to approximately $6.37&#160;billion, the majority of which would be paid over 18 years. We currently expect to make our first annual settlement payment of $405 million into escrow on or before September 30, 2021. If the settlement agreement does not become effective, this payment will be returned to us. We expect subsequent annual payments to be made beginning in July 2022.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-align:justify"><span><br/></span></div><div id="i4f0ec56b9c604f1782a65ea4a19c284d_31"></div></div></div><div style="margin-bottom:3pt;margin-top:3pt"><span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:20pt;font-weight:700;line-height:120%">Off-Balance Sheet Arrangements</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We had no significant "off-balance sheet arrangements" at&#160;June&#160;30, 2021, as that term is defined in the SEC rules.</span></div><div id="i4f0ec56b9c604f1782a65ea4a19c284d_34"></div><div style="margin-bottom:3pt;margin-top:3pt"><span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:20pt;font-weight:700;line-height:120%">Recent Financial Accounting Standards</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See </span><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i4f0ec56b9c604f1782a65ea4a19c284d_100">Note 1</a></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of the &#8220;Notes to Consolidated Financial Statements&#8221; for a discussion of recent financial accounting standards.</span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:3pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.222%"><tr><td style="width:1.0%"></td><td style="width:32.133%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.433%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.134%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">20</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardinal Health </span><span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">| </span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2021 Form 10-K</span></div></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div></div></div><div id="i4f0ec56b9c604f1782a65ea4a19c284d_37"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:3pt"><span><br/></span></div><div style="margin-bottom:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.820%"><tr><td style="width:1.0%"></td><td style="width:24.720%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:50.989%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.991%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#e41f35;border-bottom:1pt solid #e41f35;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">MD&amp;A</span></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Critical Accounting Policies and Sensitive Accounting Estimates</span></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:0 1pt"></td></tr></table></div></div><div style="margin-bottom:3pt"><span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:20pt;font-weight:700;line-height:120%">Critical Accounting Policies and Sensitive Accounting Estimates</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Critical accounting policies are those accounting policies that (i)&#160;can have a significant impact on our financial condition and results of operations and (ii)&#160;require the use of complex and subjective estimates based upon past experience and management&#8217;s judgment. Other people applying reasonable judgment to the same facts and circumstances could develop different estimates. Because estimates are inherently uncertain, actual results may differ. In this section, we describe the significant policies applied in preparing our consolidated financial statements that management believes are the most dependent on estimates and assumptions. For further discussion of accounting policies for items within this section and of additional accounting policies, see </span><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i4f0ec56b9c604f1782a65ea4a19c284d_100">Note 1</a></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of the &#8220;Notes to Consolidated Financial Statements.&#8221;</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The COVID-19 pandemic continues to affect the U.S. and global economies, and as previously disclosed, the pandemic began to materially affect our businesses during the third quarter of fiscal 2020. The length and severity of the pandemic and its impacts on our businesses and results of operations are uncertain.</span></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:16pt;font-weight:700;line-height:120%">Allowance for Doubtful Accounts</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #ee2724;padding:0 1pt"></td></tr></table></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:48.214%"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The allowance for doubtful accounts includes general and specific reserves. We determine our allowance for doubtful accounts by reviewing accounts receivable aging, historical write-off trends, payment history, industry trends, customer financial strength, customer credit ratings or bankruptcies. We regularly evaluate how changes in economic conditions, including the economic impact of the COVID-19 pandemic, may affect credit risks. See </span><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i4f0ec56b9c604f1782a65ea4a19c284d_100">Note 1</a></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of the &#8220;Notes to Consolidated Financial Statements&#8221; for further information on our policy for Receivables and Allowance for Doubtful Accounts.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A hypothetical 0.1 percent increase or decrease in the reserve as a percentage of trade receivables at June&#160;30, 2021, would result in an increase or decrease in bad debt expense of $9 million. We believe the reserve maintained and expenses recorded in fiscal 2021 are appropriate.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At this time, we are not aware of any analytical findings or customer issues that are likely to lead to a significant future increase in the allowance for doubtful accounts as a percentage of revenue. In addition, the Financial Accounting Standards Board&#8217;s </span></div></div><div style="display:inline-block;max-width:3.571%;min-width:2.571%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:48.215%"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">amended accounting guidance that requires entities to measure credit losses on trade and other receivables using an "expected credit loss" model that considers historical experience, current conditions and reasonable and supportable forecasts was effective for us in the first quarter of fiscal 2021. This guidance did not have a material impact on our consolidated financial statements or disclosures. The following table presents information regarding our allowance for doubtful accounts over the past three fiscal years:</span></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:63.097%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.011%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.343%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.702%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.343%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.704%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in millions, except percentages)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Allowance for doubtful&#160;accounts at beginning of period</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">206</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">193&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">139&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Charged to costs and expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">130</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">140&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">141&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Reduction&#160;to allowance&#160;for&#160;customer deductions&#160;and write-offs </span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(94)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(127)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(87)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Allowance for doubtful accounts at end of period</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">242</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">206&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">193&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Allowance&#160;as a&#160;percentage of customer receivables</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2.7</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2.5&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2.3&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Allowance&#160;as a&#160;percentage of revenue</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">0.15</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.13&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.13&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%">The sum of the components may not equal the total due to rounding.</span></div></div></div><div style="margin-top:3pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:16pt;font-weight:700;line-height:120%">Inventories</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #ee2724;padding:0 1pt"></td></tr></table></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:48.214%"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:120%">LIFO Inventory</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A portion of our inventories (50 percent and 56 percent at June&#160;30, 2021 and 2020, respectively) are valued at the lower of cost, using the last-in, first-out ("LIFO") method, or market. These are primarily merchandise inventories at the core pharmaceutical distribution facilities within our Pharmaceutical segment (&#8220;distribution facilities&#8221;). The LIFO impact on the consolidated statements of earnings/(loss) depends on pharmaceutical manufacturer price appreciation or deflation and our fiscal year-end inventory levels, which can be meaningfully influenced by customer buying behavior immediately preceding our fiscal year-end. Historically, prices for branded pharmaceuticals have generally tended to rise, resulting in an increase in cost of products sold, whereas prices for generic pharmaceuticals generally tend to decline, resulting in a decrease in cost of products sold. See </span><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i4f0ec56b9c604f1782a65ea4a19c284d_100">Note 1</a></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of the &#8220;Notes to Consolidated Financial Statements&#8221; for further information on our policy for Inventories.</span></div></div><div style="display:inline-block;max-width:3.571%;min-width:2.571%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:48.215%"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Using LIFO, if there is a decrease in inventory levels that have experienced pharmaceutical price appreciation, the result generally will be a decrease in future cost of products sold as our older inventory is held at a lower cost. Conversely, if there is a decrease in inventory levels that have experienced a pharmaceutical price decline, the result generally will be an increase in future cost of products sold as our older inventory is held at a higher cost. </span></div></div></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:32.135%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.428%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.137%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardinal Health </span><span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">|</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> Fiscal 2021 Form 10-K</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">21</span></div></td></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:3pt"><span><br/></span></div><div style="margin-bottom:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.820%"><tr><td style="width:1.0%"></td><td style="width:24.720%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:50.989%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.991%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#e41f35;border-bottom:1pt solid #e41f35;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">MD&amp;A</span></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Critical Accounting Policies and Sensitive Accounting Estimates</span></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:0 1pt"></td></tr></table></div></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:48.214%"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that the average cost method of inventory valuation provides a reasonable approximation of the current cost of replacing inventory within these distribution facilities. As such, the LIFO reserve is the difference between (a) inventory at the lower of LIFO cost or market and (b) inventory at replacement cost determined using the average cost method of inventory valuation. At June&#160;30, 2021 and 2020, respectively, inventories valued at LIFO cost were $565 million and</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$411 million higher than the average cost value. We do not record inventories in excess of replacement cost. As such, we did not write-up the value of our inventory from average cost to LIFO cost at June&#160;30, 2021 or 2020.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FIFO Inventory</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our remaining inventory, including inventory in our Medical segment, that is not valued at the lower of LIFO cost or market is stated at the lower of cost, using the first-in, first-out ("FIFO") method, or net realizable value. We reserve for the lower of cost or net realizable value using the estimated selling prices and estimated sales demand in the ordinary course of business, less reasonably predictable costs of completion, disposal and transportation. Due to the unprecedented demand for certain PPE as a result of COVID-19, our Medical segment manufactured and sourced inventory at higher costs than in periods prior to </span></div></div><div style="display:inline-block;max-width:3.571%;min-width:2.571%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:48.215%"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">COVID-19. As selling prices and customer demand have decreased compared to the peak of COVID-19, we recorded a reserve of $197&#160;million, primarily related to certain categories of gloves, to reduce the carrying value of certain PPE to its net realizable value. Our estimates for selling prices and demand are inherently uncertain and if our assumptions decline in the future, additional inventory reserves may be required. For example, a hypothetical 5 percent decline in the estimated selling prices would have decreased the estimated net realizable value of our inventory by approximately $30 million as of June 30, 2021. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Excess and Obsolete Inventory</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We reserve for inventory obsolescence using estimates based on historical experience, historical and projected sales trends, specific&#160;categories of inventory, age and expiration dates of on-hand inventory and manufacturer return policies. Inventories presented in the consolidated balance sheets are net of reserves for excess and obsolete inventory which were $185 million and $155 million at June&#160;30, 2021 and 2020, respectively. If actual conditions are less favorable than our assumptions, additional inventory reserves may be required.</span></div><div style="margin-bottom:6pt;text-align:justify"><span><br/></span></div></div></div><div style="margin-top:3pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:16pt;font-weight:700;line-height:120%">Goodwill and Other Indefinite-Lived Intangible Assets</span></div><div style="margin-top:8pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #ee2724;padding:0 1pt"></td></tr></table></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:48.214%"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Purchased goodwill and intangible assets with indefinite lives are tested for impairment annually or when indicators of impairment exist. Goodwill impairment testing involves a comparison of the estimated fair value of reporting units to the respective carrying amount, which may be performed utilizing either a qualitative or quantitative assessment. Qualitative factors are first assessed to determine if it is more likely than not that the fair value of a reporting unit is less than its carrying amount. There is an option to bypass the qualitative assessment for any reporting unit in any period and proceed directly to performing the quantitative goodwill impairment test. We have elected to bypass the qualitative assessment for the annual goodwill impairment test in the current year. The quantitative goodwill impairment test involves a comparison of the estimated fair value of the reporting unit to the respective carrying amount. A reporting unit is defined as an operating segment or one level below an operating segment (also known as a component). </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have two operating segments, which are the same as our reportable segments: Pharmaceutical and Medical. These operating segments are comprised of divisions (which are components), for which discrete financial information is available. Components are aggregated into reporting units for purposes of goodwill impairment testing to the extent that they share similar economic characteristics. Our reporting units are: Pharmaceutical operating segment (excluding our Nuclear and Precision Health Solutions division); Nuclear and Precision Health Solutions division; Medical operating segment (excluding our Cardinal Health </span></div></div><div style="display:inline-block;max-width:3.571%;min-width:2.571%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:48.215%"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">at-Home Solutions division) (&#8220;Medical Unit&#8221;); and Cardinal Health at-Home Solutions division. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Goodwill impairment testing involves judgment, including the identification of reporting units, qualitative evaluation of events and circumstances to determine if it is more likely than not that an impairment exists and, if necessary, the estimation of the fair value of the applicable reporting unit. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our determination of estimated fair value of our reporting units is based on a combination of the income-based and market-based approaches (using discount rates ranging from 8.5 percent to 11.5 percent). We use discount rates that are commensurate with the risks and uncertainty inherent in the respective reporting units and in our internally-developed forecasts. Under the market-based guideline public company method, we determine fair value by comparing our reporting units to similar businesses or guideline companies whose securities are actively traded in public markets. We also use the market-based guideline transaction method to determine fair value based on pricing multiples derived from the sale of companies that are similar to our reporting units.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Estimating the fair value of reporting units requires the use of estimates and significant judgments that are based on a number of factors including actual operating results. The use of alternate estimates and assumptions, changes in the industry or peer groups, or changes in weightings assigned to the discounted cash flow method, guideline public company method or guideline transaction method could materially affect the determination of fair value for each reporting unit and potentially result in goodwill impairment. If a reporting unit fails to achieve expected earnings or </span></div></div></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:3pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.222%"><tr><td style="width:1.0%"></td><td style="width:32.133%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.433%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.134%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">22</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardinal Health </span><span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">| </span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2021 Form 10-K</span></div></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:3pt"><span><br/></span></div><div style="margin-bottom:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.820%"><tr><td style="width:1.0%"></td><td style="width:24.720%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:50.989%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.991%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#e41f35;border-bottom:1pt solid #e41f35;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">MD&amp;A</span></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Critical Accounting Policies and Sensitive Accounting Estimates</span></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:0 1pt"></td></tr></table></div></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:48.214%"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">operating cash flow, or otherwise fails to meet current financial plans, or if there were changes to any other key assumptions used in the tests, the reporting unit could incur a goodwill impairment in a future period. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We performed annual impairment testing in fiscal 2021, 2020 and 2019 and concluded that there were no impairments of goodwill as the estimated fair value of each reporting unit exceeded its carrying value. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Medical Unit Goodwill</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Due to the planned divestiture of our Cordis business, we allocated $388&#160;million of goodwill from the Medical Unit to the Cordis disposal group based on the estimated relative fair values of the business to be disposed of and the portion of the reporting unit that will be retained. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For our annual impairment test in fiscal 2021, the fair value of the Medical Unit (which includes the Cordis disposal group) exceeded its carrying value of $10.2 billion by approximately 3 percent. For this test, we used a discount rate of 8.5 percent and a terminal growth rate of 2 percent. Additionally, we assigned a weighting of 80 percent to the discounted cash flow method, 10 percent to the guideline public company method, and 10 percent to the guideline transaction method. The goodwill balance for the Medical Unit was $4.1 billion at June&#160;30, 2021. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additional adverse changes in key assumptions, such as assumptions about the impact of the Cordis divestiture and the COVID-19 pandemic, including estimated demand and selling prices for PPE; an increase in the discount rate; a decrease in the terminal growth rate; or increases in tax rates, among other things, could result in a goodwill impairment for the Medical Unit. For example, if we were to increase the discount rate by a hypothetical 0.3 percent or decrease the terminal growth rate by a hypothetical 1 percent, the carrying value would have exceeded the fair value for the Medical Unit by approximately 1 percent for fiscal 2021. Additionally, the estimated tax rate used in goodwill impairment </span></div></div><div style="display:inline-block;max-width:3.571%;min-width:2.571%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:48.215%"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">testing is a market-based assumption, which is impacted by the U.S. federal statutory tax rate. If the U.S. federal statutory tax rate were to increase to 28 percent and no other inputs were changed, the carrying value would have exceeded the fair value of the Medical Unit. For any of our other reporting units, the fair value would not have been less than the carrying amount for fiscal 2021 if we increased the discount rate by 1 percent or if the U.S. federal statutory tax rate were to increase to 28 percent.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also performed goodwill impairment testing during the three months ended March 31, 2021 for the portion of the Medical Unit that would be retained. The carrying value of the Medical Unit that would be retained was $9.3 billion, of which $4.1 billion was goodwill. The fair value of the reporting unit was estimated to exceed its carrying value, using a combination of the income-based approach and the market-based approach, based on assumptions as of March 31, 2021. There have been no known significant changes in the relative fair values for the Medical Unit that would be retained or the Cordis disposal group.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The impairment test for indefinite-lived intangibles other than goodwill (primarily trademarks) involves first assessing qualitative factors to determine if it is more likely than not that the fair value of the indefinite-lived intangible asset is less than its carrying amount. If so, then a quantitative test is performed to compare the estimated fair value of the indefinite-lived intangible asset to the respective asset's carrying amount. Our qualitative evaluation requires the use of estimates and significant judgments and considers the weight of evidence and significance of all identified events and circumstances and most relevant drivers of fair value, both positive and negative, in determining whether it is more likely than not that the fair value of the indefinite-lived intangible asset is less than its carrying amount.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See </span><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i4f0ec56b9c604f1782a65ea4a19c284d_100">Note 1</a></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of "Notes to Consolidated Financial Statements" for additional information regarding goodwill and other intangible assets.</span></div></div></div><div style="margin-top:5pt;text-align:center"><span><br/></span></div><div style="margin-top:5pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:16pt;font-weight:700;line-height:120%">Loss Contingencies and Self-Insurance</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #ee2724;padding:0 1pt"></td></tr></table></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:48.214%"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We regularly review contingencies and self-insurance accruals to determine whether our accruals and related disclosures are adequate. Any adjustments for changes in reserves are recorded in the period in which the change in estimate occurs.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Loss Contingencies</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We accrue for contingencies related to disputes, litigation and regulatory matters if it is probable that a liability has been incurred and the amount of the loss can be reasonably estimated. Because these matters are inherently unpredictable and unfavorable developments or outcomes can occur, assessing contingencies is highly subjective and requires judgments about future events.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Examples of such contingencies include various lawsuits related to the distribution of prescription opioid pain medications and the Cordis inferior vena cava ("Cordis IVC") filter lawsuits. </span></div></div><div style="display:inline-block;max-width:3.571%;min-width:2.571%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:48.215%"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the opioid litigation as described further in the Significant Developments in Fiscal 2021 and Trends section in this MD&amp;A, we recorded pre-tax charges of&#160;$1.17 billion&#160;and $5.63&#160;billion during fiscal 2021 and 2020, respectively. In July 2021, we announced that we and two other national distributors have negotiated a proposed settlement agreement, subject to certain conditions and contingencies. There is no assurance that the contingencies to the proposed settlement agreement will be satisfied. </span></div></div></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:32.135%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.428%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.137%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardinal Health </span><span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">|</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> Fiscal 2021 Form 10-K</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">23</span></div></td></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:3pt"><span><br/></span></div><div style="margin-bottom:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.820%"><tr><td style="width:1.0%"></td><td style="width:24.720%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:50.989%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.991%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#e41f35;border-bottom:1pt solid #e41f35;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">MD&amp;A</span></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Critical Accounting Policies and Sensitive Accounting Estimates</span></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:0 1pt"></td></tr></table></div></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:48.214%"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We develop and periodically update reserve estimates for the Cordis IVC claims, including those received to date and expected to be received in the future and related costs. To project future Cordis IVC claim costs, we use a methodology based largely on recent experience, including claim filing rates, estimated severity by claim type, sales data, implant and injury to report lag patterns and estimated defense costs. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Self-Insurance</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We self-insure through a wholly-owned insurance subsidiary for employee healthcare, certain product liability matters, auto liability, property and workers' compensation and maintain insurance for losses exceeding certain limits.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Self-insurance accruals include an estimate for expected settlements on pending claims, defense costs, administrative fees, claims adjustment costs and an estimate for claims incurred but not reported. For certain types of exposures, we develop the estimate of expected ultimate costs to settle each claim based on specific information related to each claim if available. Other estimates are based on an assessment of outstanding claims, historical analysis and current payment trends. For claims incurred but not reported, the liabilities are calculated and derived in accordance with generally accepted actuarial practices or using an estimated lag period.</span></div></div><div style="display:inline-block;max-width:3.571%;min-width:2.571%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:48.215%"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The amount of loss may differ materially from these estimates. See </span><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i4f0ec56b9c604f1782a65ea4a19c284d_130">Note 7</a></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of the &#8220;Notes to Consolidated Financial Statements&#8221; for additional information regarding loss contingencies and product liability lawsuits.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We regularly review contingencies and self-insurance accruals to determine whether our accruals and related disclosures are adequate. Any adjustments for changes in reserves are recorded in the period in which the change in estimate occurs.</span></div></div></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:16pt;font-weight:700;line-height:120%">Provision for Income Taxes</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #ee2724;padding:0 1pt"></td></tr></table></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:48.214%"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We account for income taxes using the asset and liability method. Deferred tax assets and liabilities are measured using enacted tax rates in the respective jurisdictions in which we operate. Our income tax expense, deferred income tax assets and liabilities, and unrecognized tax benefits reflect management&#8217;s assessment of estimated future taxes to be paid on items in the consolidated financial statements.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents information about our tax position at June 30:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.665%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.245%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.343%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.247%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total deferred income tax assets (1)</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1,808</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,412&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Valuation allowance for deferred income tax assets (2)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(515)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(470)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Net deferred&#160;income&#160;tax assets</span></td><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1,293</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">942&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total deferred income tax liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(3,225)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(2,161)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Net deferred income tax liability</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(1,932)</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1,219)</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;Total deferred income tax assets included $805 million and $589 million of loss and tax credit carryforwards at June&#160;30, 2021 and 2020, respectively.</span></div><div style="margin-bottom:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)&#160;&#160;&#160;&#160;The valuation allowance primarily relates to federal, state and international loss and credit carryforwards for which the ultimate realization of future benefits is uncertain.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Expiring or unusable loss and credit carryforwards and the required valuation allowances are adjusted quarterly when it is more likely than not that at least a portion of the respective deferred tax assets will not be realized. After applying the valuation allowances, we do not anticipate any limitations on our use of any of the other net deferred income tax assets described above. We </span></div></div><div style="display:inline-block;max-width:3.571%;min-width:2.571%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:48.215%"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">operate in a complex multinational tax environment and are subject to tax treaty arrangements and transfer pricing guidelines for intercompany transactions that are subject to interpretation. Uncertainty in a tax position may arise as tax laws are subject to interpretation. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Tax benefits from uncertain tax positions are recognized when it is more likely than not that the position will be sustained upon examination of the technical merits of the position, including resolutions of any related appeals or litigation. The amount recognized is measured as the largest amount of tax benefit that is greater than 50 percent likely of being realized upon settlement. For tax benefits that do not qualify for recognition, we recognize a liability for unrecognized tax benefits.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Tax Effects of Self-Insurance Pre-tax Loss</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During fiscal 2021, our wholly-owned insurance subsidiary recorded a self-insurance pre-tax loss in its fiscal 2020 statutory financial statements primarily related to opioid litigation. This self-insurance pre-tax loss, which did not impact our pre-tax consolidated results, was deducted on our fiscal 2020 consolidated federal income tax return and contributed to a significant net operating loss for tax purposes. The net operating loss was carried back and applied to adjust our taxable income for fiscal 2015, 2016, 2017, and 2018 as permitted under the CARES Act enacted by the United States Congress in March 2020.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accordingly, our provision for income taxes during fiscal 2021 included a $424 million benefit from the net operating loss carryback primarily to reflect the difference between the federal </span></div></div></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:3pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.222%"><tr><td style="width:1.0%"></td><td style="width:32.133%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.433%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.134%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">24</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardinal Health </span><span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">| </span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2021 Form 10-K</span></div></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:3pt"><span><br/></span></div><div style="margin-bottom:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.820%"><tr><td style="width:1.0%"></td><td style="width:24.720%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:50.989%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.991%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#e41f35;border-bottom:1pt solid #e41f35;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">MD&amp;A</span></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Critical Accounting Policies and Sensitive Accounting Estimates</span></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:0 1pt"></td></tr></table></div></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:48.214%"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">statutory income tax rate during the fiscal years from 2015 to 2018 (35 percent for fiscal 2015, 2016, and 2017 and 28 percent for fiscal 2018) and the current federal statutory income tax rate of 21 percent.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have filed for a U.S. federal income tax refund of $974&#160;million as a result of the net operating loss carryback under the CARES Act, which we expect to receive within 12 months, and accordingly have recorded a current asset on our consolidated balance sheets at June&#160;30, 2021. We also increased our non-current deferred tax liability by approximately $700&#160;million during fiscal 2021 related to this matter.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Tax Effects of Opioid Litigation Charges</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the $1.17&#160;billion and $5.63&#160;billion pre-tax charges for the opioid litigation, during fiscal year 2021 and 2020, respectively we recorded a tax benefit of $228 million and $488&#160;million, respectively. Our tax benefits are estimates, which reflect our current assessment of the estimated future deductibility of the amount that may be paid under the accrual taken in connection with the opioid litigation and are net of unrecognized tax benefits of $219&#160;million and $469&#160;million, respectively. The fiscal 2021 net tax benefit and unrecognized tax benefits were primarily due to our assessment of the specific terms of the Proposed Settlement Agreement. We have made reasonable estimates and recorded amounts based on management's judgment and our current understanding of the Tax Act; however, these estimates require significant judgment since the U.S. tax law governing deductibility was changed by the U.S. Tax Cuts and Jobs Act ("Tax Act"). Further, it is possible that Congress or the tax authorities could challenge our interpretation of the Tax Act or the estimates and assumptions used to assess the future deductibility of these benefits. The actual amount of the tax benefit may differ materially from these estimates. See </span><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i4f0ec56b9c604f1782a65ea4a19c284d_133">Note 8</a></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of the &#8220;Notes to the Consolidated Financial Statements.&#8221;</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We file income tax returns in the U.S. federal jurisdiction, various U.S. state jurisdictions and various foreign jurisdictions. With few exceptions, we are subject to audit by taxing authorities for fiscal years 2015 through the current fiscal year. Tax laws are complex and subject to varying interpretations. During fiscal 2021, we resolved all open issues with respect to the Company&#8217;s activity within fiscal years 2008 through 2014 with the U.S. Internal Revenue Service ("IRS"). This resolution resulted in an adjustment to our provision for income taxes, including an impact to reserves for later years. New challenges related to future audits may adversely affect our effective tax rate or tax payments.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our assumptions and estimates around uncertain tax positions require significant judgment; the actual amount of tax benefit related to uncertain tax positions may differ from these estimates. See </span><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i4f0ec56b9c604f1782a65ea4a19c284d_133">Note 8</a></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of the &#8220;Notes to Consolidated Financial Statements&#8221; for additional information regarding unrecognized tax benefits.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that our estimates for the valuation allowances against deferred tax assets and unrecognized tax benefits are appropriate based on current facts and circumstances. The amount we ultimately pay when matters are resolved may differ from the amounts accrued. Changes in our current estimates due to </span></div></div><div style="display:inline-block;max-width:3.571%;min-width:2.571%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:48.215%"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">unanticipated market conditions, tax law changes or other factors could have a material effect on our ability to utilize deferred tax assets. For a further discussion on Provision for Income Taxes, see </span><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i4f0ec56b9c604f1782a65ea4a19c284d_133">Note 8</a></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of the &#8220;Notes to the Consolidated Financial Statements.&#8221;</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The calculation of our tax liabilities includes estimates for uncertainties in the application of broad and complex changes to the U.S. tax code as per the Tax Act as enacted by the United States government on December 22, 2017. We have made reasonable estimates and recorded amounts based on management judgment and our current understanding of the Tax Act which is subject to further interpretation by the IRS. See </span><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i4f0ec56b9c604f1782a65ea4a19c284d_133">Note 8</a></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of the &#8220;Notes to Consolidated Financial Statements&#8221; for additional information.</span></div><div style="margin-bottom:3pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:3pt;text-align:justify"><span><br/></span></div><div><span><br/></span></div></div></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:32.135%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.428%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.137%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardinal Health </span><span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">|</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> Fiscal 2021 Form 10-K</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">25</span></div></td></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span><br/></span></div></div></div><div id="i4f0ec56b9c604f1782a65ea4a19c284d_40"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:3pt;text-align:center"><span><br/></span></div><div style="margin-bottom:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.115%"><tr><td style="width:1.0%"></td><td style="width:50.685%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.155%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:22.860%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#e41f35;border-bottom:1pt solid #e41f35;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Explanation and Reconciliation of Non-GAAP Financial Measures</span></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:0 1pt"></td></tr></table></div></div><div style="margin-bottom:3pt"><span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:20pt;font-weight:700;line-height:120%">Explanation and Reconciliation of Non-GAAP Financial Measures</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This report, including the "Fiscal 2021 Overview" section within MD&amp;A, contains financial measures that are not calculated in accordance with GAAP. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to analyzing our business based on financial information prepared in accordance with GAAP, we use these non-GAAP financial measures internally to evaluate our performance, engage in financial and operational planning, and determine incentive compensation because we believe that these measures provide additional perspective on and, in some circumstances are more closely correlated to, the performance of our underlying, ongoing business. We provide these non-GAAP financial measures to investors as supplemental metrics to assist readers in assessing the effects of items and events on our financial and operating results on a year-over-year basis and in comparing our performance to that of our competitors. However, the non-GAAP financial measures that we use may be calculated differently from, and therefore may not be comparable to, similarly titled measures used by other companies. The non-GAAP financial measures disclosed by us should not be considered a substitute for, or superior to, financial measures calculated in accordance with GAAP, and the financial results calculated in accordance with GAAP and reconciliations to those financial statements set forth below should be carefully evaluated. </span></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:16pt;font-weight:700;line-height:120%">Exclusions from Non-GAAP Financial Measures</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Management believes it is useful to exclude the following items from the non-GAAP measures presented in this report for its own and for investors&#8217; assessment of the business for the reasons identified below:</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.13pt;text-decoration:underline">LIFO charges and credits</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> are excluded because the factors that drive last-in first-out ("LIFO") inventory charges or credits, such as pharmaceutical manufacturer price appreciation or deflation and year-end inventory levels (which can be meaningfully influenced by customer buying behavior immediately preceding our fiscal year-end), are largely out of our control and cannot be accurately predicted. The exclusion of LIFO charges and credits from non-GAAP metrics facilitates comparison of our current financial results to our historical financial results and to our peer group companies&#8217; financial results. We did not recognize any LIFO charges or credits during the periods presented. </span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.13pt;text-decoration:underline">Surgical gown recall costs or income</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> includes inventory write-offs and certain remediation and supply disruption costs, net of related insurance recoveries, arising from the January 2020 recall of select Association for the Advancement of Medical Instrumentation ("AAMI") Level 3 surgical gowns and voluntary field actions (a recall of some packs and a corrective action allowing overlabeling of other packs) for Presource Procedure Packs containing affected gowns. Income from surgical gown recall costs represents insurance recoveries of these certain costs. We have excluded these costs from our non-GAAP metrics to allow investors to better understand the underlying operating results of the business and to facilitate comparison of our current financial results to our historical financial results and to our peer group companies&#8217; financial results. </span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.13pt;text-decoration:underline">State opioid assessments related to prior fiscal years</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> is the portion of state assessments for prescription opioid medications that were sold or distributed in periods prior to the period in which the expense is incurred. This portion is excluded from non-GAAP financial measures because it is retrospectively applied to sales in prior fiscal years and inclusion would obscure analysis of the current fiscal year results of our underlying, ongoing business. Additionally, while states' laws may require us to make payments on an ongoing basis, the portion of the assessment related to sales in prior periods are contemplated to be one-time, nonrecurring items. Income from state opioid assessments related to prior fiscal years represents reversals of accruals when the underlying assessments were invalidated by a Court or reimbursed by manufacturers. </span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.13pt;text-decoration:underline">Restructuring and employee severance costs</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> are excluded because they are not part of the ongoing operations of our underlying business. </span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.13pt;text-decoration:underline">Amortization and other acquisition-related costs</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, which include transaction costs, integration costs, and changes in the fair value of contingent consideration obligations, are excluded because they are not part of the ongoing operations of our underlying business and to facilitate comparison of our current financial results to our historical financial results and to our peer group companies' financial results. Additionally, costs for amortization of acquisition-related intangible assets are non-cash amounts, which are variable in amount and frequency and are significantly impacted by the timing and size of acquisitions, so their exclusion facilitates comparison of historical, current and forecasted financial results. We also exclude other acquisition-related costs, which are directly related to an acquisition but do not meet the criteria to be recognized on the acquired entity&#8217;s initial balance sheet as part of the purchase price allocation. These costs are also significantly impacted by the timing, complexity and size of acquisitions. </span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:3pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.222%"><tr><td style="width:1.0%"></td><td style="width:32.133%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.433%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.134%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">26</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardinal Health </span><span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">| </span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2021 Form 10-K</span></div></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:3pt;text-align:center"><span><br/></span></div><div style="margin-bottom:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.115%"><tr><td style="width:1.0%"></td><td style="width:50.685%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.155%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:22.860%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#e41f35;border-bottom:1pt solid #e41f35;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Explanation and Reconciliation of Non-GAAP Financial Measures</span></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:0 1pt"></td></tr></table></div></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.13pt;text-decoration:underline">Impairments and gain or loss on disposal of assets</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;are excluded because they do not occur in or reflect the ordinary course of our ongoing business operations and are inherently unpredictable in timing and amount, and in the case of impairments, are non-cash amounts, so their exclusion facilitates comparison of historical, current and forecasted financial results. </span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.13pt;text-decoration:underline">Litigation recoveries or charges, net</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> are excluded because they often relate to events that may have occurred in prior or multiple periods, do not occur in or reflect the ordinary course of our business and are inherently unpredictable in timing and amount. During fiscal 2021, we incurred a tax benefit related to a carryback of a net operating loss. Some pre-tax amounts, which contributed to this loss, relate to litigation charges. As a result, we allocated substantially all of the tax benefit to litigation charges. </span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.13pt;text-decoration:underline">Loss on early extinguishment of debt</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> is excluded because it does not typically occur in the normal course of business and may obscure analysis of trends and financial performance. Additionally, the amount and frequency of this type of charge is not consistent and is significantly impacted by the timing and size of debt extinguishment transactions. </span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.13pt;text-decoration:underline">(Gain)/Loss on sale of equity interest in naviHealth</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> was incurred in connection with the sale of our remaining equity interest in naviHealth in fiscal 2020. The equity interest was retained in connection with the initial sale of our majority interest in naviHealth during fiscal 2019. We exclude this significant gain because gains or losses on investments of this magnitude do not typically occur in the normal course of business and are similar in nature to a gain or loss from a divestiture of a majority interest, which we exclude from non-GAAP results. The gain on the initial sale of our majority interest in naviHealth in fiscal 2019 was also excluded from our non-GAAP measures. </span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.13pt;text-decoration:underline">Transitional tax benefit, net</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> related to the Tax Cuts and Jobs Act is excluded because it results from the one-time impact of a very significant change in the U.S. federal corporate tax rate and, due to the significant size of the benefit, obscures analysis of trends and financial performance. The transitional tax benefit includes the initial estimate and subsequent adjustments for the re-measurement of deferred tax assets and liabilities due to the reduction of the U.S. federal corporate income tax rate and the repatriation tax on undistributed foreign earnings. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The tax effect for each of the items listed above, other than the transitional tax benefit item, is determined using the tax rate and other tax attributes applicable to the item and the jurisdiction(s) in which the item is recorded. The gross, tax and net impact of each item are presented with our GAAP to non-GAAP reconciliations. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:16pt;font-weight:700;line-height:120%">Definitions</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Growth rate calculation</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: growth rates in this report are determined by dividing the difference between current period results and prior period results by prior period results.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Non-GAAP operating earnings</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: operating earnings/(loss) excluding (1) LIFO charges/(credits), (2) surgical gown recall costs/(income), (3) state opioid assessment related to prior fiscal years, (4) restructuring and employee severance, (5) amortization and other acquisition-related costs, (6) impairments and (gain)/loss on disposal of assets, and (7) litigation (recoveries)/charges, net. </span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Non-GAAP earnings before income taxes</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: earnings/(loss) before income taxes excluding (1) LIFO charges/(credits), (2) surgical gown recall costs/(income), (3) state opioid assessment related to prior fiscal years, (4) restructuring and employee severance, (5) amortization and other acquisition-related costs, (6) impairments and (gain)/loss on disposal of assets, (7) litigation (recoveries)/charges, net, (8) loss on early extinguishment of debt and (9) (gain)/loss on sale of equity interest in naviHealth. </span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Non-GAAP net earnings attributable to Cardinal Health, Inc.</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: net earnings/(loss) attributable to Cardinal Health, Inc. excluding (1) LIFO charges/(credits), (2) surgical gown recall costs/(income), (3) state opioid assessment related to prior fiscal years, (4) restructuring and employee severance, (5) amortization and other acquisition-related costs, (6) impairments and (gain)/loss on disposal of assets, (7) litigation (recoveries)/charges, net, (8) loss on early extinguishment of debt and (9) (gain)/loss on sale of equity interest in naviHealth, each net of tax, and (10) transitional tax benefit, net. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Non-GAAP effective tax rate</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: provision for/(benefit from) income taxes adjusted for (1) LIFO charges/(credits), (2) surgical gown recall costs/(income), (3) state opioid assessment related to prior fiscal years, (4) restructuring and employee severance, (5) amortization and other acquisition-related costs, (6) impairments and (gain)/loss on disposal of assets, (7) litigation (recoveries)/charges, net, (8) loss on early extinguishment of debt and (9) (gain)/loss on sale of equity interest in naviHealth, each net of tax, and (10) transitional tax benefit, net divided by (earnings before income taxes adjusted for the first nine items). </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Non-GAAP diluted earnings per share attributable to Cardinal Health, Inc.</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: non-GAAP net earnings attributable to Cardinal Health, Inc. divided by diluted weighted-average shares outstanding. </span></div><div style="margin-bottom:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span><br/></span></div><div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span><br/></span></div><div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span><br/></span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:32.135%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.428%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.137%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardinal Health </span><span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">|</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> Fiscal 2021 Form 10-K</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">27</span></div></td></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span><br/></span></div></div></div><div id="i4f0ec56b9c604f1782a65ea4a19c284d_43"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:3pt;text-align:center"><span><br/></span></div><div style="margin-bottom:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.115%"><tr><td style="width:1.0%"></td><td style="width:50.685%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.155%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:22.860%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#e41f35;border-bottom:1pt solid #e41f35;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Explanation and Reconciliation of Non-GAAP Financial Measures</span></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:0 1pt"></td></tr></table></div></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:16pt;font-weight:700;line-height:120%">GAAP to Non-GAAP Reconciliations</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:32.382%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:7.084%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.084%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.042%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.042%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.042%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.191%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.042%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.894%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.197%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in millions, except per common share amounts)</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Operating Earnings/(Loss)</span></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Operating Earnings/(Loss) Growth Rate</span></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Earnings/(Loss) Before Income Taxes</span></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Provision for/(Benefit From) Income Taxes</span></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Earnings/(Loss)</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">1</span></div></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Earnings/(Loss)</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">1</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> Growth Rate</span></div></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Effective Tax Rate</span></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Diluted EPS</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">1.2</span></div></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Diluted EPS</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">1</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> Growth Rate</span></div></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="27" style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fiscal Year 2021</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">GAAP</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">472</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">N.M.</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">323</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(289)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">611</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">N.M.</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(89.7)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2.08</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">N.M.</span></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Surgical gown recall costs/(income)</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(28)</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(28)</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(21)</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(0.07)</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">State opioid assessment related to prior fiscal years</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">38&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">38&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Restructuring and employee severance</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">114&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">114&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">87&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.29&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Amortization and other acquisition-related costs</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">451&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">451&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">118&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">333&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1.13&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Impairments and (gain)/loss on disposal of assets</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">79&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">79&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">64&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.21&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Litigation (recoveries)/charges, net</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">3</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,129&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,129&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">606&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">523&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1.78&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Loss on early extinguishment of debt</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.04&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Loss on sale of equity interest in naviHealth investment</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.01&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Non-GAAP</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2,255</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(5)</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2,122</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">483</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1,637</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td><td colspan="2" style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">22.8</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">5.57</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Fiscal Year 2020</span></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">GAAP</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4,098)</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">N.M.</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(3,772)</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(79)</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(3,696)</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">N.M.</span></td><td colspan="2" style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2.1&#160;</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(12.61)</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">N.M.</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Surgical gown recall costs/(income)</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">85&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">85&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">63&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.22&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">State opioid assessment related to prior fiscal years</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.01&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Restructuring and employee severance</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">122&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">122&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">93&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.31&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Amortization and other acquisition-related costs</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">524&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">524&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">130&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">394&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1.34&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Impairments and (gain)/loss on disposal of assets</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.02&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Litigation (recoveries)/charges, net</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">3</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5,741&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5,741&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">514&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5,227&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">17.84&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Loss on early extinguishment of debt</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.04&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Gain on sale of equity interest in naviHealth investment</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(579)</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(86)</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(493)</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1.68)</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Transitional tax benefit, net</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">4</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(0.01)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Non-GAAP</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,384&#160;</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,147&#160;</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">539&#160;</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,605&#160;</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1 %</span></td><td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">25.1 %</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5.45&#160;</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Fiscal Year 2019</span></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">GAAP</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,060&#160;</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">N.M.</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,751&#160;</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">386&#160;</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,363&#160;</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">N.M.</span></td><td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">22.1 %</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4.53&#160;</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">N.M.</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Restructuring and employee severance</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">125&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">125&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">93&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.31&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Amortization and other acquisition-related costs</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">621&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">621&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">148&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">473&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1.57&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Impairments and (gain)/loss on disposal of assets</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">5</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(488)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(488)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(113)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(375)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1.25)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Litigation (recoveries)/charges, net</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.09&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Transitional tax benefit, net</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">4</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.03&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Non-GAAP</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,353&#160;</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,044&#160;</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">453&#160;</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,589&#160;</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1 %</span></div></td><td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">22.1 %</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5.28&#160;</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6 %</span></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">1&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Attributable to Cardinal Health, Inc.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">2</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%">For fiscal 2020, GAAP diluted loss per share attributable to Cardinal Health, Inc. and the EPS impact from the GAAP to non-GAAP per share reconciling items are calculated using a weighted average of 293 million common shares, which excludes potentially dilutive securities from the denominator due to their anti-dilutive effects resulting from our GAAP net loss for the period. Fiscal 2020, non-GAAP diluted EPS is calculated using a weighted average of 295 million common shares, which includes potentially dilutive shares</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:400;line-height:120%">. </span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">3&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Litigation (recoveries)/charges, net includes pre-tax charges of $1.17 billion and $5.63 billion recorded in fiscal 2021 and 2020, respectively, related to the opioid litigation. The net tax benefits associated with the opioid litigation charges are $228 million and $488 million for fiscal 2021 and 2020, respectively.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Litigation (recoveries)/charges, net, includes a tax benefit recorded during fiscal 2021 related to a net operating loss carryback. Our wholly-owned insurance subsidiary recorded a self-insurance pre-tax loss in its fiscal 2020 statutory financial statements primarily related to opioid litigation. This self-insurance pre-tax loss, which did not impact our pre-tax consolidated results, was deducted on our fiscal 2020 consolidated federal income tax return and contributed to a significant net operating loss for tax purposes. The net operating loss was carried back and adjusted our taxable income for fiscal 2015, 2016, 2017 and 2018 as permitted under the Coronavirus Aid, Relief and Economic Security (&#8220;CARES&#8221;) Act. The total benefit from the net operating loss carryback was $424 million; however, for purposes of Non-GAAP financial measures, we allocated $389 million of the benefit to litigation (recoveries)/charges, net, which is excluded from non-GAAP measures, based on the relative amount of the self-insurance pre-tax loss related to opioid litigation claims versus separate tax adjustments. The tax benefit allocated to the separate tax adjustments of $35 </span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:3pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.222%"><tr><td style="width:1.0%"></td><td style="width:32.133%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.433%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.134%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">28</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardinal Health </span><span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">| </span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2021 Form 10-K</span></div></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:3pt;text-align:center"><span><br/></span></div><div style="margin-bottom:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.115%"><tr><td style="width:1.0%"></td><td style="width:50.685%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.155%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:22.860%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#e41f35;border-bottom:1pt solid #e41f35;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Explanation and Reconciliation of Non-GAAP Financial Measures</span></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:0 1pt"></td></tr></table></div></div><div style="padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%">million is included in non-GAAP measures.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">4&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Reflects the net transitional benefit from the remeasurement of our deferred tax assets and liabilities partially offset by the repatriation tax on cash and earnings of foreign subsidiaries.&#160;See </span><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i4f0ec56b9c604f1782a65ea4a19c284d_133">Note 8</a></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> of the "Notes to Consolidated Financial Statements" for more information.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">5&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%">During fiscal 2019, we sold our majority interest in naviHealth and recognized a pre-tax gain of $508 million ($378 million after tax).</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span><br/></span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The sum of the components and certain computations may reflect rounding adjustments.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We apply varying tax rates depending on the item's nature and tax jurisdiction where it is incurred.</span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:32.135%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.428%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.137%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardinal Health </span><span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">|</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> Fiscal 2021 Form 10-K</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">29</span></div></td></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span><br/></span></div></div></div><div id="i4f0ec56b9c604f1782a65ea4a19c284d_49"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:23.642%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:74.158%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#e41f35;border-bottom:1pt solid #e41f35;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Disclosures about Market Risk</span></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:0 1pt"></td></tr></table></div></div><div style="margin-bottom:3pt"><span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:20pt;font-weight:700;line-height:120%">Quantitative and Qualitative Disclosures About Market Risk</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are exposed to cash flow and earnings fluctuations as a result of certain market risks. These market risks primarily relate to foreign exchange, interest rate, and commodity price-related changes. We maintain a hedging program to manage volatility related to some of these market exposures which employs operational, economic, and derivative financial instruments in order to mitigate risk. See </span><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i4f0ec56b9c604f1782a65ea4a19c284d_100">Note 1</a></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i4f0ec56b9c604f1782a65ea4a19c284d_139">Note 10</a></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of the &#8220;Notes to Consolidated Financial Statements&#8221; for further discussion regarding our use of derivative instruments.</span></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:16pt;font-weight:700;line-height:120%">Foreign Exchange Rate Sensitivity</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #ee2724;padding:0 1pt"></td></tr></table></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:48.214%"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">By the nature of our global operations, we are exposed to cash flow and earnings fluctuations resulting from foreign exchange rate variation. These exposures are transactional and translational in nature. The following foreign currencies represent the principal drivers of our foreign exchange exposure: Canadian dollar, euro, Thai baht, Mexican peso, Chinese renminbi, Australian dollar, British pound and Japanese yen.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We apply a Value-At-Risk ("VAR") methodology to our transactional and translational exposures. The VAR model is a risk estimation tool and is not intended to represent actual losses in fair value that could be incurred.</span></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Transactional Exposure</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Transactional exposure arises from the purchase and sale of goods and services in currencies other than our functional currency or the functional currency of our subsidiaries. At the end of each fiscal year we perform sensitivity analyses on our </span></div></div><div style="display:inline-block;max-width:3.571%;min-width:2.571%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:48.215%"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">forecasted transactional exposure for the upcoming fiscal year. These analyses include the estimated impact of our hedging program, which is designed to mitigate transactional exposure. Applying a VAR methodology to our transactional exposure and including the impact of our hedging program, the potential maximum loss in earnings for the upcoming fiscal year is estimated to be $16 million, which is based on a one-year horizon and a 95 percent confidence level.</span></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Translational Exposure</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have exposure related to the translation of financial statements of our foreign operations into U.S.&#160;dollars, our functional currency. Applying a VAR methodology to our translational exposure, the potential maximum loss in earnings for the upcoming fiscal year is estimated to be $5 million, which is based on a one-year horizon and a 95 percent confidence level. </span></div></div></div><div style="margin-top:3pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:16pt;font-weight:700;line-height:120%">Interest Rate Sensitivity</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #ee2724;padding:0 1pt"></td></tr></table></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:48.214%"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are exposed to changes in interest rates primarily as a result of our borrowing and investing activities to maintain liquidity and fund operations. The nature and amount of our long-term and short-term debt can be expected to fluctuate as a result of business requirements, market conditions and other factors. Our policy is to manage exposures to interest rates using a mix of fixed and floating rate debt as deemed appropriate by management. We utilize interest rate swap instruments to mitigate our exposure to interest rate movements.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As part of our risk management program, we perform an annual sensitivity analysis on our forecasted exposure to interest rates for the upcoming fiscal year. This analysis assumes a hypothetical 50 basis point change in interest rates. At June&#160;30, 2021, the potential increase or decrease in annual interest expense under this analysis as a result of this hypothetical change would be $2 million.</span></div></div><div style="display:inline-block;max-width:3.571%;min-width:2.571%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:48.215%"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are also exposed to market risk from changes in interest rates related to our cash and cash equivalents, which includes marketable securities that are carried at fair value in the consolidated balance sheets. The fair value of our cash and cash equivalents is subject to change primarily as a result of changes in market interest rates and investment risk related to the issuers' credit worthiness. At June&#160;30, 2021, a hypothetical increase or decrease of 50 basis points in interest rates would result in a hypothetical $10 million change in the estimated fair value.</span></div><div style="margin-bottom:3pt;text-align:justify"><span><br/></span></div></div></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:3pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.222%"><tr><td style="width:1.0%"></td><td style="width:32.133%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.433%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.134%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">30</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardinal Health </span><span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">| </span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2021 Form 10-K</span></div></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:23.642%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:74.158%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#e41f35;border-bottom:1pt solid #e41f35;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Disclosures about Market Risk</span></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:0 1pt"></td></tr></table></div></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:16pt;font-weight:700;line-height:120%">Commodity Price Sensitivity</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #ee2724;padding:0 1pt"></td></tr></table></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:48.214%"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are directly exposed to market price changes for certain commodities, including oil-based resins, nitrile, cotton, diesel fuel and latex. We typically purchase raw materials at either market prices or prices tied to a commodity index and some finished goods at prices based in part on a commodity price index. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As part of our risk management program, we perform sensitivity analysis on our forecasted direct commodity exposure for the upcoming fiscal year. Our forecasted direct commodity exposure at June&#160;30, 2021 increased approximately $4 million from June&#160;30, 2020. At June&#160;30, 2020, we had hedged a portion of these direct commodity exposures (see </span><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i4f0ec56b9c604f1782a65ea4a19c284d_139">Note 10</a></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of the &#8220;Notes to Consolidated Financial Statements&#8221; for further discussion). There were no outstanding commodity contracts in our hedging program at June&#160;30, 2021.</span></div></div><div style="display:inline-block;max-width:3.571%;min-width:2.571%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:48.215%"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our forecasted direct commodity exposures for the upcoming fiscal year is $449 million. The potential gain/loss given a hypothetical 10 percent fluctuation in commodity prices, assuming pricing collectively shifts in the same direction and we are unable to change customer pricing in response to those shifts or otherwise offset, for the upcoming fiscal year is $45 million at June 30, 2021. The hypothetical offsetting impact of hedges in both periods was minimal. </span></div><div style="margin-bottom:3pt;padding-left:18pt;text-align:justify"><span><br/></span></div><div style="margin-top:6pt;text-align:justify"><span><br/></span></div></div></div><div style="margin-bottom:3pt;text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:32.135%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.428%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.137%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardinal Health </span><span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">|</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> Fiscal 2021 Form 10-K</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">31</span></div></td></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span><br/></span></div></div></div><div id="i4f0ec56b9c604f1782a65ea4a19c284d_52"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:3pt;text-align:center"><span><br/></span></div><div style="margin-bottom:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:24.682%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:50.911%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.107%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#e41f35;border-bottom:1pt solid #e41f35;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Business</span></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span><br/></span></div></div><div style="margin-bottom:3pt"><span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:20pt;font-weight:700;line-height:120%">Business</span></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:16pt;font-weight:700;line-height:120%">General</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #ee2724;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cardinal Health, Inc. is a global integrated healthcare services and products company providing customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices and patients in the home. We provide medical products and pharmaceuticals and cost-effective solutions that enhance supply chain efficiency. </span></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:16pt;font-weight:700;line-height:120%">Pharmaceutical Segment</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #ee2724;padding:0 1pt"></td></tr></table></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:48.214%"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the United States, our Pharmaceutical segment:</span></div><div style="margin-bottom:3pt;padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.13pt">through its Pharmaceutical Distribution division, distributes branded and generic pharmaceutical and over-the-counter healthcare and consumer products to retailers (including chain and independent drug stores and pharmacy departments of supermarkets and mass merchandisers), hospitals and other healthcare providers. This division:</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.46pt">maintains prime vendor relationships that streamline the purchasing process resulting in greater efficiency and lower costs for our retail, hospital and other healthcare provider customers;</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.46pt">provides services to pharmaceutical manufacturers, including distribution, inventory management, data reporting, new product launch support and chargeback administration;</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.46pt">through the Outcomes service offering, connects pharmacists, payers and pharmaceutical companies and delivers health solutions for personalized medication therapy management, digital patient engagement and telepharmacy;</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.13pt">provides pharmacy management services to hospitals and operates a limited number of pharmacies, including in community health centers; and</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.13pt">repackages generic pharmaceuticals and over-the-counter healthcare products;</span></div><div style="margin-bottom:3pt;padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.13pt">through its Specialty Solutions division, distributes specialty pharmaceutical products to hospitals and other healthcare providers and provides consulting, patient support and other services for specialty pharmaceutical products to pharmaceutical manufacturers and healthcare providers; and</span></div><div style="margin-bottom:3pt;padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.13pt">through its Nuclear and Precision Health Solutions division, operates nuclear pharmacies and manufacturing facilities, which manufacture, prepare and deliver radiopharmaceuticals for use in nuclear imaging and other procedures in hospitals and physician offices. This division also contract manufactures a radiopharmaceutical treatment (Xofigo) and holds the North American rights to manufacture and distribute Lymphoseek, a radiopharmaceutical diagnostic imaging agent.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See </span><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i4f0ec56b9c604f1782a65ea4a19c284d_154">Note 13</a></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of the &#8220;Notes to Consolidated Financial Statements&#8221; for Pharmaceutical segment revenue, profit and assets for fiscal 2021, 2020 and 2019.</span></div></div><div style="display:inline-block;max-width:3.571%;min-width:2.571%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:48.215%"><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Pharmaceutical Distribution</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Pharmaceutical Distribution division&#8217;s gross margin includes margin from our generic pharmaceutical program, from distribution services agreements with branded pharmaceutical manufacturers and from over-the-counter healthcare and consumer products. It also includes manufacturer cash discounts. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Margin from our generic pharmaceutical program includes price discounts and rebates from manufacturers and may in limited instances include price appreciation. Our earnings on generic pharmaceuticals are generally highest during the period immediately following the initial launch of a product, because generic pharmaceutical selling prices are generally highest during that period and tend to decline over time. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Margin from distribution services agreements with branded pharmaceutical manufacturers is derived from compensation we receive for providing a range of distribution and related services to manufacturers. Our compensation typically is a percentage of the wholesale acquisition cost that is set by manufacturers. In addition, under a limited number of agreements, branded pharmaceutical price appreciation, which is determined by the manufacturers, also serves as part of our compensation. </span></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Sourcing Venture with CVS Health Corporation</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Red Oak Sourcing, LLC ("Red Oak Sourcing"), a U.S.-based generic pharmaceutical sourcing venture with CVS Health negotiates generic pharmaceutical supply contracts on behalf of both companies. In August 2021, we amended our agreement with CVS Health to extend the term of Red Oak Sourcing through June 2029.</span></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Specialty Pharmaceutical Products and Services</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We refer to products and services offered by our Specialty Solutions division as &#8220;specialty pharmaceutical products and services.&#8221; The Specialty Solutions division distributes oncology, rheumatology, urology, nephrology and other pharmaceutical products ("specialty pharmaceutical products") and human-derived plasma products to hospitals, dialysis clinics, physician offices and other healthcare providers; provides consulting, patient support, logistics, group purchasing and other services to pharmaceutical manufacturers and healthcare providers primarily supporting the development, marketing and distribution of specialty pharmaceutical products; and provides specialty pharmacy services. Our use of the terminology "specialty pharmaceutical products and services" may not be comparable to the terminology used by other industry participants.</span></div></div></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:3pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.222%"><tr><td style="width:1.0%"></td><td style="width:32.133%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.433%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.134%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">32</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardinal Health </span><span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">| </span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2021 Form 10-K</span></div></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:3pt;text-align:center"><span><br/></span></div><div style="margin-bottom:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:24.682%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:50.911%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.107%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#e41f35;border-bottom:1pt solid #e41f35;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Business</span></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span><br/></span></div></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:48.214%"><div style="margin-bottom:3pt;padding-right:4.5pt;text-align:justify"><span><br/></span></div></div><div style="display:inline-block;max-width:3.571%;min-width:2.571%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:48.215%"></div></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:16pt;font-weight:700;line-height:120%">Medical Segment</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #ee2724;padding:0 1pt"></td></tr></table></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:48.214%"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Medical segment manufactures and sources Cardinal Health branded general and specialty medical, surgical and laboratory products and devices. These products include exam and surgical gloves; needle, syringe and sharps disposal; compression; incontinence; nutritional delivery; wound care; single-use surgical drapes, gowns and apparel; fluid suction and collection systems; urology; operating room supply; and electrode product lines. Our Cardinal Health Brand products are sold directly or through third-party distributors in the United States, Canada, Europe, Asia and other markets. These products are generally higher-margin products. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Medical segment also distributes a broad range of medical, surgical and laboratory products known as national brand products </span></div></div><div style="display:inline-block;max-width:3.571%;min-width:2.571%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:48.215%"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and provides supply chain services and solutions to hospitals, ambulatory surgery centers, clinical laboratories and other healthcare providers in the United States and Canada and this segment also assembles and sells sterile and non-sterile procedure kits. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Through Cardinal Health at-Home Solutions, this segment also distributes medical products to patients' homes in the United States. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Medical segment, through its Wavemark division, also provides an automated technology platform for inventory management. </span></div><div style="margin-bottom:3pt;text-align:justify"><span><br/></span></div></div></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:16pt;font-weight:700;line-height:120%">Acquisitions and Divestitures</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #ee2724;padding:0 1pt"></td></tr></table></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:48.214%"><div style="padding-right:4.5pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Acquisitions</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have acquired a number of businesses over the years that have enhanced our core strategic areas of Cardinal Health Brand medical products, generic pharmaceutical distribution and services, specialty pharmaceutical products and services, international and post-acute care. We expect to continue to pursue additional acquisitions in the future.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the last five fiscal years, we completed several acquisitions. In July 2017, we acquired the Patient Care, Deep Vein Thrombosis, and Nutritional Insufficiency businesses (the "Patient Recovery Business") from Medtronic plc for $6.1 billion in cash. We also completed several smaller acquisitions during the last five fiscal years, including, in fiscal 2017, the acquisition of the North American rights to Lymphoseek, a radiopharmaceutical diagnostic imaging agent, from Navidea Biopharmaceuticals, Inc.</span></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:10.011%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.579%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.937%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.073%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Date</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Company</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Location</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Lines</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">of&#160;Business</span></div></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Acquisition</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Price</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">(in billions)</span></div></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">07/17</span></td><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Patient Recovery Business of Medtronic, plc</span></td><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Mansfield, MA</span></td><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Patient Care, Deep Vein Thrombosis and Nutritional Insufficiency</span></td><td colspan="6" style="background-color:#cccccc;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$6.1</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></div><div style="display:inline-block;max-width:3.571%;min-width:2.571%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:48.215%"><div style="padding-right:4.5pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Divestitures</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Over the past five fiscal years, we have also completed several divestitures. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 2, 2021, we completed the divestiture of our Cordis business to Hellman &amp; Freidman ("H&amp;F") for net proceeds of $927 million in cash, subject to customary purchase price adjustments. We have retained certain working capital accounts and product liability for lawsuits related to inferior vena cava filters in the U.S. and Canada, as described in Note 7 of the Notes to the Consolidated Financial Statements. We acquired the Cordis business from Johnson &amp; Johnson for $1.9 billion in October 2015. This divestiture also includes Access Closure, Inc., a manufacturer and distributor of extravascular closure devices, that we acquired for approximately $320 million in May 2014. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2018, we completed the sale of our equity interest in naviHealth, Inc. to investor entities controlled by Clayton, Dubilier &amp; Rice, LLC ("CD&amp;R") for proceeds of $737 million (after adjusting for certain fees and expenses) and a noncontrolling equity interest in a partnership that owned naviHealth. In May 2020, we sold the remainder of our equity interest in naviHealth.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We had acquired our equity interest in naviHealth through a series of transactions beginning in fiscal 2016, when we acquired a majority equity interest. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In February 2018, we completed the sale of our pharmaceutical and medical products distribution business in China to Shanghai Pharmaceuticals Holding Co., Ltd. for proceeds of $861 million (after adjusting for third party indebtedness and preliminary transaction adjustments).</span></div><div style="margin-bottom:3pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:3pt;padding-right:4.5pt;text-align:justify"><span><br/></span></div></div></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:32.135%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.428%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.137%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardinal Health </span><span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">|</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> Fiscal 2021 Form 10-K</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">33</span></div></td></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:3pt;text-align:center"><span><br/></span></div><div style="margin-bottom:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:24.682%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:50.911%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.107%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#e41f35;border-bottom:1pt solid #e41f35;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Business</span></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span><br/></span></div></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:16pt;font-weight:700;line-height:120%">Customers</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #ee2724;padding:0 1pt"></td></tr></table></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:48.214%"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our largest customers, CVS and OptumRx, accounted for 26 percent and 15 percent of our fiscal 2021 revenue, respectively. In the aggregate, our five largest customers, including CVS and OptumRx, accounted for 50 percent of our fiscal 2021 revenue. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2021, we extended our pharmaceutical distribution agreements with CVS through June 2027. </span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have agreements with group purchasing organizations (&#8220;GPOs&#8221;) that act as agents to negotiate vendor contracts on </span></div></div><div style="display:inline-block;max-width:3.571%;min-width:2.571%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:48.215%"><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">behalf of their members. Our two largest GPO relationships in terms of revenue are with Vizient, Inc. and Premier, Inc. Sales to members of these two GPOs, under numerous contracts across our businesses, collectively accounted for 15 percent of our revenue in fiscal 2021.</span></div></div></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:16pt;font-weight:700;line-height:120%">Suppliers</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #ee2724;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We rely on many different suppliers. Products obtained from our five largest suppliers accounted for an aggregate of 30 percent of our revenue during fiscal 2021, and our largest supplier&#8217;s products accounted for approximately 7 percent of revenue.</span></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:16pt;font-weight:700;line-height:120%">Competition</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #ee2724;padding:0 1pt"></td></tr></table></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:48.214%"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We operate in a highly competitive environment in the distribution of pharmaceuticals and consumer healthcare products. We also operate in a highly competitive environment in the manufacturing and distribution of medical devices and surgical products. We compete on many levels, including price, service offerings, support services, customer service, breadth of product lines and product quality and efficacy.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the Pharmaceutical segment, we compete with wholesale distributors with national reach, including McKesson Corporation and AmerisourceBergen Corporation, regional wholesale distributors, self-warehousing chains, specialty distributors, third-party logistics companies, companies that provide specialty pharmaceutical services and nuclear pharmacies, among others. </span></div></div><div style="display:inline-block;max-width:3.571%;min-width:2.571%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:48.215%"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, the Pharmaceutical segment has experienced competition from a number of organizations offering generic pharmaceuticals, including telemarketers. We also compete with manufacturers that sell their products directly.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the Medical segment, we compete with many diversified healthcare companies and national medical product distributors, such as Medline Industries, Inc., Owens&#160;&amp; Minor, Inc. and Becton, Dickinson and Company, as well as regional medical product distributors and companies that are focused on specific product categories. We also compete with companies that distribute medical products to patients' homes and third-party logistics companies. </span></div></div></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:16pt;font-weight:700;line-height:120%">Human Capital Management</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #ee2724;padding:0 1pt"></td></tr></table></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Employees </span></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:48.214%"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We, through our employees, improve the lives of people every day by solving complex healthcare problems. As of June 30, 2021, we had approximately 47,300 employees globally, approximately 18,300 of whom are based outside the United States. Approximately 98% of our workforce is full time employees. Approximately 29,000 of our employees worked in our distribution centers, manufacturing facilities and pharmacies, and 18,300 worked in other functions, including finance, information technology, human resources and sales.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Approximately 3,230 employees were primarily associated with our Cordis business and were transferred in the divestiture in August 2021. Most of these employees are based outside the United States.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, we have engaged global professional services firms to perform certain business processes on our behalf, including within finance, information technology and human resources.</span></div></div><div style="display:inline-block;max-width:3.571%;min-width:2.571%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:48.215%"><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Diversity, Equity &amp; Inclusion </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At Cardinal Health, we are focused on building a diverse workforce and an inclusive workplace that values the unique perspectives and contributions of all of our employees. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We promote a culture of diversity, equity and inclusion through, for example, seven Employee Resource Groups (ERGs), including groups focused on various racial and ethnic groups, members of the LGBTQ community, employees with disabilities, veterans and women. They are designed to foster an inclusive and engaged workforce and develop future leaders. In addition, we have manager and broad-based unconscious bias and racial equity training courses. Our work is led by our senior executives with advice from a Diversity and Inclusion Steering Council which consists of senior leaders from across the company. Additionally, in December 2019, we created a new African American and Black Racial Equity Cabinet to provide guidance to our senior executives in addressing racism and social injustice. </span></div></div></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:3pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.222%"><tr><td style="width:1.0%"></td><td style="width:32.133%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.433%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.134%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">34</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardinal Health </span><span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">| </span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2021 Form 10-K</span></div></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:3pt;text-align:center"><span><br/></span></div><div style="margin-bottom:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:24.682%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:50.911%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.107%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#e41f35;border-bottom:1pt solid #e41f35;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Business</span></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span><br/></span></div></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:48.214%"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also monitor pay equity. We define pay equity as equal pay for people of all gender identities and ethnicities who are performing substantially similar work. We have a pay equity committee, which guides the ongoing analysis and benchmarking, in regular consultation with an independent third-party, to review and help inform our salary and compensation practices. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have established long-range aspirational representation goals for specific under-represented groups in our manager-and-above level employee population. </span></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Employee Health &amp; Safety </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The health, safety and security of our employees is an priority for us. We employ systems designed to continually monitor our facilities and work environment to promote employee safety and identify and prevent or mitigate any potential risks. This includes procedures and equipment for security. We routinely assess facilities to closely monitor adherence to established security and safety standards. Our employees receive specialized training related to their role, work setting, and equipment used in their work environment. As our processes evolve, we update relevant safety training modules, which may include new employee training programs. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:120%">COVID-19 Response</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Protecting the health and safety of our employees and their families has been a priority throughout the COVID-19 pandemic. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March, 2020, all employees who could work remotely began working from home. We expanded our technology infrastructure to help employees perform their duties remotely and continue to support customers, patients and our frontline colleagues. Many of these employees continue to work remotely. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Because Cardinal Health is part of a critical infrastructure industry, more than 30,000 of our employees have continued to report to work in distribution centers, supply chain operations, manufacturing sites, pharmacies and other clinical sites.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To help prevent the spread of COVID-19 and protect the safety of our frontline employees, all of our facilities are thoroughly cleaned regularly and we implemented safety measures, including mask and social distancing requirements, in accordance with the U.S. </span></div></div><div style="display:inline-block;max-width:3.571%;min-width:2.571%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:48.215%"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Centers for Disease Control and Prevention and the World Health Organization guidelines. We also educated employees on how they can help keep themselves and their families safe and have training programs to help employees stay safe in their jobs. Our safety measures have helped us to avoid a wide spread outbreak of COVID-19 among our employees. Since June 2021, we have provided clinics for employees, contractors and their families and friends to receive a COVID-19 vaccine. </span></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Talent Retention &amp; Culture </span></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Talent Development and Learning</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cardinal Health&#8217;s talent development strategy is a segmented, multi-pronged approach to build capabilities, skills and competencies of leaders and employees throughout the enterprise ensuring employees capabilities connect to business needs and outcomes. This segmented approach includes broad based employee skill development and learning, manager capabilities and development, differentiated diverse talent development and executive development.</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%"> </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Culture </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cardinal Health&#8217;s culture is rooted in our values and behaviors and aligned to the company&#8217;s strategic framework. Providing a positive work environment supports our ability to attract, retain and develop our employees and enables business performance. We reinforce, monitor and assess our culture through a variety of programs and processes which include performance management, talent/succession planning, employee engagement surveys and other listening strategies.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div></div></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:16pt;font-weight:700;line-height:120%">Intellectual Property</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #ee2724;padding:0 1pt"></td></tr></table></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:48.214%"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We rely on a combination of trade secret, patent, copyright and trademark laws, nondisclosure and other contractual provisions, and technical measures to protect our products, services and intangible assets. We hold patents, and continue to pursue patent protection throughout the world, relating to the manufacture, operation and use of various medical and surgical products, to certain distribution and logistics systems, to the production and distribution of our nuclear pharmacy products and to other service offerings. We also operate under licenses for certain proprietary technologies, and in certain instances we license our technologies to third parties.</span></div></div><div style="display:inline-block;max-width:3.571%;min-width:2.571%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:48.215%"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that we have taken all necessary steps to protect our proprietary rights, but no assurance can be given that we will be able to successfully enforce or protect our rights in the event that they are infringed upon by a third party. While all of these proprietary rights are important to our operations, we do not consider any particular patent, trademark, license, franchise or concession to be material to our overall business.</span></div></div></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:32.135%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.428%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.137%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardinal Health </span><span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">|</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> Fiscal 2021 Form 10-K</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">35</span></div></td></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:3pt;text-align:center"><span><br/></span></div><div style="margin-bottom:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:24.682%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:50.911%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.107%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#e41f35;border-bottom:1pt solid #e41f35;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Business</span></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span><br/></span></div></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:16pt;font-weight:700;line-height:120%">Regulatory Matters</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #ee2724;padding:0 1pt"></td></tr></table></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:48.214%"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our business is highly regulated in the United States, at both the federal and state level, and in foreign countries. Depending upon the specific business, we may be subject to regulation by government entities including:</span></div><div style="margin-bottom:3pt;padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.13pt">the U.S. Drug Enforcement Administration (the &#8220;DEA&#8221;);</span></div><div style="margin-bottom:3pt;padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.13pt">certain agencies within the U.S. Department of Health and Human Services, including the U.S. Food and Drug Administration (the &#8220;FDA&#8221;), the Centers for Medicare and Medicaid Services, the Office of Inspector General and the Office for Civil Rights;</span></div><div style="margin-bottom:3pt;padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.13pt">state health departments, insurance departments, Medicaid departments or other comparable state agencies; </span></div><div style="margin-bottom:3pt;padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.13pt">state boards of pharmacy and other controlled substance authorities;</span></div><div style="margin-bottom:3pt;padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.13pt">the U.S. Nuclear Regulatory Commission (the &#8220;NRC&#8221;);</span></div><div style="margin-bottom:3pt;padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.13pt">the U.S. Federal Trade Commission (the "FTC");</span></div><div style="margin-bottom:3pt;padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.13pt">U.S. Customs and Border Protection; and</span></div><div style="margin-bottom:3pt;padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.13pt">agencies comparable to those listed above in markets outside the United States.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These regulatory agencies have a variety of civil, administrative and criminal sanctions at their disposal for failure to comply with applicable legal or regulatory requirements. They can suspend our ability to manufacture and distribute products, require us to initiate product recalls, seize products or impose criminal, civil and administrative sanctions.</span></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Distribution</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">State Boards of Pharmacy, FDA, DEA and various other state authorities regulate the marketing, purchase, storage and distribution of pharmaceutical and medical products under various federal and state statutes including the federal Prescription Drug Marketing Act of 1987, Drug Quality and Security Act of 2013 (the &#8220;DQSA&#8221;), and Controlled Substances Act (the "CSA"). The CSA governs the sale, packaging, storage and distribution of controlled substances. Wholesale distributors of controlled substances must hold valid DEA registrations and state-level licenses, meet various security and operating standards including effective anti-diversion programs, and comply with the CSA. They must also comply with state requirements relating to controlled substances that differ from state to state. </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Proposed Settlement Agreement, as described in the Significant Developments in Fiscal 2021 and Trends section in MD&amp;A and </span><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline" href="#i4f0ec56b9c604f1782a65ea4a19c284d_130">Note 7</a></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> of the Notes to Consolidated Financial Statements, if it becomes effective, also includes injunctive relief terms related to settling distributors' controlled substance anti-diversion programs, including with respect to: (1) governance; (2) independence and training of the personnel operating our controlled substances monitoring program; (3) due diligence for new and existing customers; (4) ordering limits for certain products; and (5) suspicious order monitoring. A monitor will be selected to oversee compliance with these provisions for a period </span></div></div><div style="display:inline-block;max-width:3.571%;min-width:2.571%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:48.215%"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%">of five years. In addition, the settling distributors will engage a third-party vendor to act as a clearinghouse for data aggregation and reporting and will fund the clearinghouse for ten years. </span></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Manufacturing, Sourcing and Marketing</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We sell our manufactured products in the United States, Canada, Europe, Asia, Latin America and other markets. The FDA and other governmental agencies in the United States, as well as foreign governmental agencies, administer requirements that cover the design, testing, safety, effectiveness, manufacturing (including good manufacturing practices), quality systems, labeling, promotion and advertising (including restrictions on promoting or advertising a product other than for the product's cleared or approved uses), distribution, importation and post-market surveillance for most of our manufactured products. We are also subject to these requirements when we source certain Medical segment products from third-party manufacturers. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We need specific approval or clearance from, and registrations with, regulatory authorities before we can market and sell some products in the United States and certain other countries, including countries in the European Union ("EU"). </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the United States, authorization to commercially market a medical device is generally received in one of two ways. The first, known as pre-market notification or the 510(k) process, requires us to demonstrate that a medical device is substantially equivalent to a legally marketed medical device. The second more rigorous process, known as pre-market approval (&#8220;PMA&#8221;), requires us to independently demonstrate that a medical device is safe and effective. Many of our Medical segment branded products are cleared through the 510(k) process and certain products must be approved through the PMA process. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the EU, we are required to obtain CE Mark Certification in order to market medical devices. In 2017, EU regulatory bodies finalized a new Medical Device Regulation ("MDR") became effective in May 2021. Under the MDR, medical devices marketed in the EU require significant pre-market and post-market requirements. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">It can be costly and time-consuming to obtain regulatory approvals, clearances and registrations of medical devices, and they might not be granted on a timely basis, if at all. Even after we obtain approval or clearance to market a product or obtain product registrations, the product and our manufacturing processes are subject to continued regulatory oversight, including periodic inspection of manufacturing facilities by FDA and other regulatory authorities both in the United States and internationally. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, we may determine that products we manufacture or market do not meet our specifications, regulatory requirements or published standards. When we or a regulatory agency identify a quality or regulatory issue, we investigate and take appropriate corrective action, which may include recalling the product, correcting the product at the customer location, revising product labeling and notifying customers. For example, in January 2020, we issued a voluntary recall for certain surgical gowns and </span></div></div></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:3pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.222%"><tr><td style="width:1.0%"></td><td style="width:32.133%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.433%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.134%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">36</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardinal Health </span><span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">| </span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2021 Form 10-K</span></div></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:3pt;text-align:center"><span><br/></span></div><div style="margin-bottom:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:24.682%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:50.911%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.107%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#e41f35;border-bottom:1pt solid #e41f35;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Business</span></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span><br/></span></div></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:48.214%"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">two voluntary field actions for certain Presource Procedure Packs because one of our FDA-registered suppliers in China had shifted production of some gowns to unapproved sites. </span></div></div><div style="display:inline-block;max-width:3.571%;min-width:2.571%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:48.215%"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any adverse regulatory action, depending on its magnitude, may limit our ability to effectively manufacture, source, market and sell our products, limit our ability to obtain future premarket approvals or result in a substantial modification to our business practices and operations. For additional information, please see our Risk Factor entitled</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> "Our business is subject to rigorous quality regulatory and licensing requirements."</span></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Privacy and Data Protection </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are subject to various and evolving privacy laws and regulations in many jurisdictions. Because we collect, handle and maintain patient-identifiable health information, we are subject to laws that require specified privacy and security measures and that regulate the use and disclosure of such information, including the U.S. Health Insurance Portability and Accountability Act of 1996 ("HIPAA"), as augmented by the Health Information Technology for Economic and Clinical Health Act as well as state laws, in the United States. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also collect, handle, and maintain other sensitive personal and financial information. Within the U.S., these activities are regulated by certain federal and state laws. For example, the new California Consumer Privacy Act became effective in January 2020 and grants specified rights to consumers over the use of their personal information, including increased transparency. Other states have adopted or are considering adopting similar or different comprehensive privacy laws. Internationally, we are also subject to privacy and data protection laws that require significant compliance efforts, including the EU's General Data Protection Regulation (GDPR), Canada's Personal Information Protection and Electronic Documents Act (PIPEDA) and Japan's Act on the Protection of Personal Information (APPI), among many others. </span></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Nuclear Pharmacies and Related Businesses</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our nuclear pharmacies and radiopharmaceutical manufacturing facilities (including for Xofigo) require licenses or permits and must abide by regulations issued by the NRC, applicable state boards of pharmacy and the radiologic health agency or department of health of each state in which we operate, including pharmacy sterile compounding standards and practices. In addition, our radiopharmaceutical manufacturing facilities also must comply with FDA regulations, including good manufacturing practices.</span></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Product Tracing and Supply Chain Integrity</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Title II of the DQSA, known as the Drug Supply Chain Security Act or "Track and Trace," establishes a phased-in national system for tracing pharmaceutical products through the pharmaceutical distribution supply chain to detect, prevent and rapidly respond to the introduction of drugs that may be counterfeit, diverted, stolen, adulterated, subject of a fraudulent transaction or otherwise unfit for distribution. The first phase of implementation began in 2015, and upon full implementation in 2023, we and other supply chain stakeholders will participate in an electronic, interoperable, prescription drug tracing system. In addition, the FDA also has issued regulations requiring most medical device labeling to bear a unique device identifier. The MDR, described above, also introduces a new unique device identifier requirement.</span></div></div></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:32.135%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.428%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.137%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardinal Health </span><span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">|</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> Fiscal 2021 Form 10-K</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">37</span></div></td></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:3pt;text-align:center"><span><br/></span></div><div style="margin-bottom:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:24.682%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:50.911%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.107%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#e41f35;border-bottom:1pt solid #e41f35;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Business</span></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span><br/></span></div></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:48.214%"><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Government Healthcare Programs</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are subject to U.S. federal healthcare fraud and abuse laws. These laws generally prohibit persons from soliciting, offering, receiving or paying any compensation in order to induce someone to order, recommend or purchase products or services that are in any way paid for by Medicare, Medicaid or other federally-funded healthcare programs. They also prohibit submitting any fraudulent claim for payment by the federal government. There are similar state healthcare fraud and abuse laws that apply to Medicaid and other state-funded healthcare programs. Violations of these laws may result in criminal or civil penalties, as well as breach of contract claims and qui tam actions (false claims cases initiated by private parties purporting to act on behalf of federal or state governments).</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Some businesses within each of our segments are Medicare-certified suppliers or participate in other federal and state healthcare programs, such as state Medicaid programs and the federal 340B drug pricing program. These businesses are subject to accreditation and quality standards and other rules and regulations, including applicable reporting, billing, payment and record-keeping requirements. Other businesses within each segment manufacture pharmaceutical or medical products or repackage pharmaceuticals that are purchased or reimbursed through, or are otherwise governed by, federal or state healthcare programs. Failure to comply with applicable eligibility requirements, standards and regulations could result in civil or criminal sanctions, including the loss of our ability to participate in Medicare, Medicaid and other federal and state healthcare programs. For example, the United States Attorney&#8217;s Office for the District of Massachusetts has been conducting an investigation related to discounts and rebates offered or provided to certain Specialty Solutions customers as a result of qui tam actions. For more information on this investigation, see </span><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i4f0ec56b9c604f1782a65ea4a19c284d_130">Note 7</a></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to the Consolidated Financial Statements. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our U.S. federal and state government contracts are subject to specific procurement requirements. Failure to comply with applicable rules or regulations or with contractual or other requirements may result in monetary damages and criminal or civil penalties as well as termination of our government contracts or our suspension or debarment from government contract work.</span></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Environmental, Health and Safety Laws</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the United States and other countries, we are subject to various federal, state and local environmental laws, including laws regulating the production or use of hazardous substances, as well as laws relating to safe working conditions and laboratory practices.</span></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Antitrust Laws</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The U.S. federal government, most U.S. states and many foreign countries have laws that prohibit certain types of conduct deemed to be anti-competitive. Violations of these laws can result in various sanctions, including criminal and civil penalties. Private plaintiffs also could bring civil lawsuits against us in the United States for alleged antitrust law violations, including claims for treble damages. </span></div></div><div style="display:inline-block;max-width:3.571%;min-width:2.571%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:48.215%"><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Laws Relating to Foreign Trade and Operations</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">U.S. and foreign laws require us to abide by standards relating to the import and export of finished goods, raw materials and supplies and the handling of information. We also must comply with various export control and trade embargo laws, which may require licenses or other authorizations for transactions within some countries or with some counterparties.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Similarly, we are subject to U.S. and foreign laws concerning the conduct of our foreign operations, including the U.S. Foreign Corrupt Practices Act, the U.K. Bribery Act and other foreign anti-bribery laws. Among other things, these laws generally prohibit companies and their intermediaries from offering, promising or making payments to officials of foreign governments for the purpose of obtaining or retaining business. For example, in February 2020, we paid approximately $8.4 million to the Securities and Exchange Commission to settle charges that our internal controls were not sufficient to detect improper payments made by employees of our former China distribution business. </span></div></div></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:3pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.222%"><tr><td style="width:1.0%"></td><td style="width:32.133%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.433%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.134%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">38</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardinal Health </span><span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">| </span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2021 Form 10-K</span></div></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:3pt;text-align:center"><span><br/></span></div><div style="margin-bottom:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:24.682%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:50.911%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.107%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#e41f35;border-bottom:1pt solid #e41f35;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Business</span></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span><br/></span></div></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:16pt;font-weight:700;line-height:120%">Other Information </span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #ee2724;padding:0 1pt"></td></tr></table></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:48.214%"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Although our agreements with manufacturers sometimes require us to maintain inventory levels within specified ranges, our distribution businesses are generally not required by our customers to maintain particular inventory levels other than as needed to meet service level requirements. Certain customer contracts require us to maintain sufficient inventory to meet emergency demands, but we do not believe those requirements materially affect inventory levels.</span></div></div><div style="display:inline-block;max-width:3.571%;min-width:2.571%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:48.215%"><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our customer return policies generally require that the product be physically returned, subject to restocking fees. We only allow customers to return product for credit that can be added back to inventory and resold at full value, or that can be returned to vendors for credit.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We offer market payment terms to our customers.</span></div></div></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:32.135%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.428%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.137%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardinal Health </span><span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">|</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> Fiscal 2021 Form 10-K</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">39</span></div></td></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span><br/></span></div></div></div><div id="i4f0ec56b9c604f1782a65ea4a19c284d_55"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:3pt;text-align:center"><span><br/></span></div><div style="margin-bottom:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:10.044%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.553%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:67.103%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#e41f35;border-bottom:1pt solid #e41f35;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Risk Factors</span></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span><br/></span></div></div><div style="margin-bottom:3pt"><span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:20pt;font-weight:700;line-height:120%">Risk Factors </span></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:48.214%"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The risks described below could materially and adversely affect our results of operations, financial condition, liquidity or cash flows. These are not the only risks we face. Our businesses also could be affected by risks we do not currently consider material to our operations or of which we are not presently aware.</span></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:16pt;font-weight:700;line-height:120%">COVID-19 Risks</span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:120%">We have been and expect to continue to be negatively affected by the ongoing COVID-19 pandemic.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See the description of the actual and possible effects of the COVID-19 pandemic and resulting disruptions on our business and operations discussed above in &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations.&#8221; In addition to the adverse impacts and uncertainties from the COVID-19 pandemic identified there, we continue to face additional possible adverse impacts, including those described below. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the COVID-19 pandemic, our Medical segment experienced dramatically increased demand for and industry shortages of certain PPE, such as masks, gowns and gloves. This increased demand resulted in increased costs to manufacture and source these products, and ultimately, higher inventory levels. As a result, we have sought additional sources for these products and to mitigate the cost increases, we have raised our selling prices for affected products. During the fourth quarter of fiscal year 2021, selling prices and customer demand for certain PPE declined, which we expect to continue into fiscal year 2022. This has resulted in inventory reserves. Our estimates for demand and selling prices are inherently uncertain and if demand or selling prices or other market dynamics decline in the future beyond our current assumptions, additional inventory reserves may be required, which would adversely impact Medical segment profit. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, pricing actions have mitigated the impact of the increased costs to manufacture and source PPE, as a result of the decreased demand and selling price, we may not be successful at continuing to mitigate the impact of these increased costs in the future. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Within our Pharmaceutical segment, COVID-19-related volume declines have negatively impacted our Pharmaceutical segment generics program, but are expected to moderate in fiscal year 2022. If demand for these products does not return to pre-COVID-19 levels, or returns more slowly than anticipated, the negative impact could be more prolonged or significant than we currently expect. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Federal, state and local government policies and initiatives designed to reduce the transmission of COVID-19 also resulted in the cancellation or deferral of many elective medical procedures and some of our customers closing or severely curtailing their operations. While lower demand for surgical products resulting from reduced elective procedures had an adverse impact on Medical segment profit during the first nine months of fiscal 2021, demand improved during the fourth quarter of fiscal 2021. If </span></div></div><div style="display:inline-block;max-width:3.571%;min-width:2.571%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:48.215%"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">governmental policies designed to reduce the transmission of COVID-19 return and demand for these procedures does not increase or decreases further, we could have less sales of the affected products and services than we currently expect. Additionally, sustained changes in the manner in which patients access healthcare may result in shifts in consumer preferences that may not be favorable to us. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We cannot estimate the continued length or severity of the COVID-19 pandemic or the related consequences on the U.S. and global economy and our business and operations, including whether and when normal economic and operating conditions will resume or the extent to which further disruption may impact our business, financial position, results of operations or cash flow. The COVID-19 pandemic has also heightened other risks, including risks associated with competitive pressures, supplier relationships, international operations, regulatory and licensing, changes to the U.S. healthcare environment, cyber security, and access to capital markets.</span></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:16pt;font-weight:700;line-height:120%">Legal, Regulatory &amp; Compliance Risks</span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:120%">The public health crisis involving the abuse of prescription opioid pain medication and our efforts to resolve related claims could have additional or unexpected material negative effects on our business</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Pharmaceutical segment distributes prescription opioid pain medications. In recent years, the abuse of prescription opioid pain medication has become a public health crisis.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A significant number of states, counties, municipalities and other public plaintiffs, have filed lawsuits against pharmaceutical manufacturers, pharmaceutical wholesale distributors (including us), retail chains and others relating to the manufacturing, marketing or distribution of prescription opioid pain medications. In July 2021, we announced that, as a result of the previously disclosed settlement framework, we and two other national distributors have negotiated a proposed settlement agreement and settlement process that, if all conditions are satisfied (including the approval of the Board of Directors), would result in the settlement of the vast majority of opioid lawsuits filed by state and local governmental entities (the &#8220;Proposed Settlement Agreement&#8221;). This Proposed Settlement Agreement is subject to contingencies and there is no assurance that a sufficient number of states and subdivisions will agree to the proposed settlement agreement or that the required contingencies will be satisfied. It is possible that we may fail to reach a final settlement. For more information on the proposed settlement and other opioid-related litigation matters, see </span><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i4f0ec56b9c604f1782a65ea4a19c284d_130">Note 7</a></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to the Consolidated Financial Statements. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A trial in the case brought by the Ohio Attorney General is scheduled to begin in September 2021 and a trial in the case brought by the Washington Attorney General is scheduled to begin in November 2021. The Ohio Attorney General has issued a press released indicating support for the Proposed Settlement Agreement; however, the Washington Attorney General has issued </span></div></div></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:3pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.222%"><tr><td style="width:1.0%"></td><td style="width:32.133%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.433%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.134%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">40</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardinal Health </span><span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">| </span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2021 Form 10-K</span></div></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:3pt;text-align:center"><span><br/></span></div><div style="margin-bottom:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:10.044%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.553%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:67.103%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#e41f35;border-bottom:1pt solid #e41f35;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Risk Factors</span></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span><br/></span></div></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:48.214%"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a press release stating that Washington will not agree to the Proposed Settlement Agreement.  These public announcements are not binding and there is no assurance that any state that has made a public announcement of support for the Proposed Settlement Agreement will ultimately execute the Proposed Settlement Agreement. It is also possible that, even if the Proposed Settlement Agreement becomes effective, we could have trials for lawsuits brought by other states or subdivisions as well. West Virginia subdivisions and Native American Tribes are not a part of this settlement process and we are involved in separate negotiations with these groups. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to the claims addressed by the Proposed Settlement Agreement, we are also being sued by private plaintiffs, such as unions, other health and welfare funds, hospital systems, other healthcare providers and individuals alleging personal injury for the same activities and could be named as a defendant in additional lawsuits. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have received federal grand jury subpoenas issued in connection with investigations being conducted by the U.S. Attorney's Office for the Eastern District of New York and the Fraud Section of the U.S. Department of Justice ("DOJ"). We have also received civil requests for information from other DOJ offices. We believe that these investigations concern operation of our anti-diversion program, our anti-diversion policies and procedures, and distribution of certain controlled substances. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The defense and resolution of current and future lawsuits and investigations are subject to uncertainty and could have a material adverse effect on our results of operations, financial condition, cash flows, liquidity, or our ability to pay dividends or repurchase our shares, beyond the amounts accrued. In addition, they could have adverse reputational or operational effects on our business.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other legislative, regulatory or industry measures related to the public health crisis involving the abuse of prescription opioid pain medication and the distribution of these medications could affect our business in ways that we may not be able to predict. For example, several states have now adopted or proposed taxes or other fees on the sale of opioids. These laws and proposals vary in the tax amounts imposed and the means of calculation. Liabilities for taxes or assessments under any such laws could have an adverse impact on our results of operations unless we are able to mitigate them through operational changes or commercial arrangements where permitted.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Ongoing unfavorable publicity regarding the abuse or misuse of prescription opioid pain medications and the role of wholesale distributors in the supply chain of such prescription medications, as well as the continued proliferation of the opioid lawsuits, investigations, regulations and legislative actions, and unfavorable publicity in relation to those lawsuits could have a material adverse effect on our reputation or results of operations.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Our business is subject to other rigorous quality, regulatory and licensing requirements.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As described in greater detail in the "Business" section, products that we manufacture, source, distribute or market must comply with quality and regulatory requirements. Noncompliance or </span></div></div><div style="display:inline-block;max-width:3.571%;min-width:2.571%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:48.215%"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">concerns over noncompliance, including noncompliance by third-party contract manufacturers, may result in suspension of our ability to distribute, import, manufacture or source products, as well as product bans, recalls, safety alerts or seizures, or criminal or civil sanctions, which, in turn, could result in product liability claims and lawsuits, including class actions. In addition, it can be costly and time-consuming to obtain regulatory approvals or product registrations to market a medical device or other product, and such approvals or registrations might not be granted on a timely basis, if at all. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Also as described in greater detail in the "Business" section, our business is highly regulated in the United States, at both the federal and state level, and in foreign countries. If we fail to comply with regulatory requirements, or if allegations are made that we fail to comply, our results of operations and financial condition could be adversely affected.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To lawfully operate our businesses, we are required to obtain and hold permits, product registrations, licenses and other regulatory approvals from, and to comply with operating and security standards of, numerous governmental bodies. For example, as a wholesale distributor of controlled substances, we must hold valid DEA registrations and state-level licenses, meet various security and operating standards, and comply with the CSA. Failure to maintain or renew necessary permits, product registrations, licenses or approvals, or to comply with required standards, could have an adverse effect on our results of operations and financial condition.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We collect, handle and maintain patient-identifiable health information and other sensitive personal and financial information which are subject to federal, state and foreign laws that regulate the use and disclosure of such information. Regulations currently in place continue to evolve, and new laws in this area could further restrict our ability to collect, handle and maintain personal or patient information, or could require us to incur additional compliance costs, either of which could have an adverse impact on our results of operations. Violations of federal, state or foreign laws concerning privacy and data protection could subject us to civil or criminal penalties, breach of contract claims, costs for remediation and harm to our reputation.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are required to comply with laws relating to healthcare fraud and abuse. The requirements of these laws are complex and subject to varying interpretations. From time to time, regulatory authorities investigate our policies or practices, and may challenge them. We are periodically subject to federal or state government investigations or qui tam actions (false claims cases initiated by private parties purporting to act on behalf of federal or state governments), which could result in civil or criminal sanctions, including the loss of licenses or the ability to participate in Medicare, Medicaid and other federal and state healthcare programs or other remedial measures. For example, the United States Attorney&#8217;s Office for the District of Massachusetts and the Department of Health and Human Services, Officer of Inspector General have been conducting an investigation related to discounts and rebates offered or provided to certain Specialty </span></div></div></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:32.135%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.428%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.137%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardinal Health </span><span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">|</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> Fiscal 2021 Form 10-K</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">41</span></div></td></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:3pt;text-align:center"><span><br/></span></div><div style="margin-bottom:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:10.044%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.553%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:67.103%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#e41f35;border-bottom:1pt solid #e41f35;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Risk Factors</span></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span><br/></span></div></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:48.214%"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Solutions customers as a result of qui tam actions. For more information on this investigation, see </span><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i4f0ec56b9c604f1782a65ea4a19c284d_130">Note 7</a></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to the Consolidated Financial Statements. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Some businesses within each of our segments are Medicare-certified suppliers or participate in other federal and state healthcare programs, such as state Medicaid programs and the federal 340B drug pricing program. In addition, some businesses manufacture pharmaceutical or medical products or repackage pharmaceuticals that are purchased or reimbursed through, or are otherwise governed by, federal or state healthcare programs. Failure to comply with applicable eligibility requirements, standards and regulations could result in civil or criminal sanctions, including the loss of our ability to participate in Medicare, Medicaid and other federal and state healthcare programs.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Industry participants, including us, rely on ethylene oxide (&#8220;EtO&#8221;) to sterilize certain medical products that we manufacture or distribute. Regulatory actions have been taken by certain environmental regulatory authorities to reduce EtO emissions during the sterilization and distribution process. If such measures become more widespread, we could experience increased costs to comply with reduced emissions standards and it is possible that we and other industry participants may be unable to effectively sterilize medical products, possibly resulting in industry-wide supply shortages or a reduction in surgical or medical procedures. Such increased costs or industry-wide reductions in surgical and medical procedures would have a negative impact on our Medical segment profit. It is also possible that these regulatory actions could adversely impact our ability to procure products to distribute, resulting in increased costs or industry supply disruptions.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our government contracts are subject to specific procurement requirements. Failure to comply with applicable rules or regulations or with contractual or other requirements may result in monetary damages and criminal or civil penalties as well as termination of our government contracts or our suspension or debarment from government contract work.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our global operations (including transition services in connection with divestitures) are subject to the U.S. Foreign Corrupt Practices Act ("FCPA"), the U.K. Bribery Act and similar anti-bribery laws in other jurisdictions and U.S. and foreign export control, trade embargo and customs laws. If we fail to comply, or are alleged to fail to comply, with any of these laws, we could be subject to investigations or suffer civil or criminal sanctions. For example, in February 2020, we paid approximately $8.4 million to the Securities and Exchange Commission to settle charges that our internal controls were not sufficient to detect improper payments made by employees of our former China distribution business. </span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:120%">We could be subject to adverse changes in the tax laws or </span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:120%">challenges to our tax positions. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are a large multinational corporation with operations in the United States and many foreign countries. As a result, we are subject to the tax laws of many jurisdictions. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, proposals are made in the United States and other jurisdictions in which we operate that could adversely affect our tax positions, effective tax rate or tax payments. Specific </span></div></div><div style="display:inline-block;max-width:3.571%;min-width:2.571%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:48.215%"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">initiatives that may impact us include possible increases in U.S. or foreign corporate income tax rates or other changes in tax law to raise revenue, the repeal of the LIFO (last-in, first-out) method of inventory accounting for income tax purposes, the establishment or increase in taxation at the U.S. state level on the basis of gross revenues, recommendations of the recently completed base erosion and profit shifting project undertaken by the Organization for Economic Cooperation and Development and the European Commission&#8217;s investigation into illegal state aid. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, in connection with the $5.63 billion pre-tax charge for the opioid litigation taken in the fiscal year ended June 30, 2020, and the additional $1.17 billion pre-tax charge recorded in fiscal year 2021, we recorded net tax benefits of $488 million and $228 million, respectively, reflecting our current assessment of the estimated future deductibility of the amount that may be paid. We have made reasonable estimates and recorded amounts based on management's judgment and our current understanding of the Tax Act; however, these estimates require significant judgment. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The U.S. tax law governing deductibility was changed by the Tax Act and the tax authorities could challenge our interpretation of the Tax Act or the estimates and assumptions used to assess the future deductibility of these benefits, or tax law could change again. The actual amount of tax benefit related to uncertain tax positions may differ materially from these estimates. See </span><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i4f0ec56b9c604f1782a65ea4a19c284d_130">Note 7</a></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of the "Notes to Consolidated Financial Statements" for more information regarding these matters. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In fiscal year 2021, our provision for income taxes reflects a $424 million benefit from the tax benefits of a net operating loss carryback under the CARES Act. Also as a result of this net operating loss carryback, we have filed for a U.S. federal income tax refund of $974 million. In connection with this net operating loss carryback, certain industry participants, including us, received a letter from the U.S. House of Representatives&#8217; Committee on Oversight and Reform questioning, among other things, our plans to take tax deductions for opioid-related losses, including our use of the net operating loss carryback provisions under the CARES Act and deductibility under the Tax Act. We have responded to the letter. Additionally, legislation has been proposed that would retroactively repeal the net operating loss carryback provision of the CARES Act. If these initiatives are successful, our effective tax rate could be adversely impacted. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We file income tax returns in the U.S. federal jurisdiction, various U.S. state jurisdictions and various foreign jurisdictions. With few exceptions, we are subject to audit by taxing authorities for fiscal years 2015 through the current fiscal year. Tax laws are complex and subject to varying interpretations. Tax authorities have challenged some of our tax positions for the periods from 2011 to 2014. During fiscal year 2021, we resolved all open matters with the IRS for fiscal years 2008 to 2014, which also impacted reserves for later years. This resolution has resulted in an adjustment to our provision for income taxes. Proposed adjustments in future audits may adversely affect our effective tax rate or tax payments.</span></div></div></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:3pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.222%"><tr><td style="width:1.0%"></td><td style="width:32.133%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.433%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.134%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">42</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardinal Health </span><span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">| </span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2021 Form 10-K</span></div></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:3pt;text-align:center"><span><br/></span></div><div style="margin-bottom:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:10.044%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.553%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:67.103%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#e41f35;border-bottom:1pt solid #e41f35;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Risk Factors</span></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span><br/></span></div></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:48.214%"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Changes to the U.S. healthcare environment may not be favorable to us. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Over a number of years, the U.S. healthcare industry has undergone significant changes designed to increase access to medical care, improve safety and patient outcomes, contain costs and increase efficiencies. These changes include a general decline in Medicare and Medicaid reimbursement levels, efforts by healthcare insurance companies to limit or reduce payments to pharmacies and providers, the basis for payments beginning to transition from a fee-for-service model to value-based payments and risk-sharing models, and the industry shifting away from traditional healthcare venues like hospitals and into clinics, physician offices and patients&#8217; homes.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We expect the U.S. healthcare industry to continue to change significantly in the future. Possible changes include further reduction or limitations on governmental funding at the state or federal level, efforts by healthcare insurance companies to further limit payments for products and services or changes in legislation or regulations governing prescription pharmaceutical pricing, healthcare services or mandated benefits. These possible changes, and the uncertainty surrounding these possible changes, may adversely affect us.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Legal proceedings could adversely impact our cash flows or results of operations.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Due to the nature of our business, which includes the distribution of controlled substances and other pharmaceutical products and the sourcing, marketing and manufacturing of medical products, we regularly become involved in disputes, litigation and regulatory matters. Litigation is inherently unpredictable and the unfavorable outcome of legal proceedings could adversely affect our results of operations or financial condition.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For example, we are subject to a number of lawsuits and investigations related to the national health crisis involving the abuse of opioid pain medication as described above in the Risk Factor titled "The public health crisis involving the abuse of prescription opioid pain medication and our efforts to resolve related claims could have additional or unexpected material negative effects on our business" and in </span><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i4f0ec56b9c604f1782a65ea4a19c284d_130">Note 7</a></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to the "Notes to Consolidated Financial Statements."</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, some of the products that we distribute or manufacture have been and may in the future be alleged to cause personal injury, subjecting us to product liability claims. For example, we are a defendant in product liability lawsuits that allege personal injuries associated with the use of Cordis OptEase and TrapEase inferior vena cava (IVC) filter products and in lawsuits alleging impurities in the active pharmaceutical ingredients in certain pharmaceutical products. In addition, product liability insurance for these types of claims is becoming more limited and may not be available to us at amounts that we historically have obtained or that we would like to obtain. It is possible that a settlement of or judgment for a product liability claim may not be covered by insurance or exceed available insurance recoveries. If this happens, and if any such settlement or judgment is in excess </span></div></div><div style="display:inline-block;max-width:3.571%;min-width:2.571%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:48.215%"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">of any prior accruals, our results of operations and financial condition could be adversely affected.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also operate in an industry characterized by extensive intellectual property litigation. Patent litigation can result in significant damage awards and injunctions that could prevent the manufacture and sale of affected products or force us to make royalty payments in order to continue selling the affected products.</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:16pt;font-weight:700;line-height:120%">Business &amp; Operational Risks</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Our business and operations depend on the proper functioning of information systems, business processes, critical facilities and distribution networks.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We rely on our and third-party service providers' information systems for a wide variety of critical operations, including to obtain, rapidly process, analyze and manage data to:</span></div><div style="margin-bottom:3pt;padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.13pt">facilitate the purchase and distribution of inventory items from numerous distribution centers;</span></div><div style="margin-bottom:3pt;padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.13pt">receive, process and ship orders on a timely basis;</span></div><div style="margin-bottom:3pt;padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.13pt">manage accurate billing and collections for thousands of customers;</span></div><div style="margin-bottom:3pt;padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.13pt">process payments to suppliers;</span></div><div style="margin-bottom:3pt;padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.13pt">facilitate manufacturing and assembly of medical products; and</span></div><div style="margin-bottom:3pt;padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.13pt">generate financial information.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our business also depends on the proper functioning of our and our suppliers' business processes, critical facilities, including our national logistics center, and our distribution networks. Our results of operations could be adversely affected if our or a service provider's business processes, information systems, critical facilities or distribution networks are disrupted (including disruption of access), are damaged or fail, whether due to physical disruptions, such as fire, natural disaster, pandemic (as they have been by the COVID-19 pandemic, as discussed above) or power outage, or due to cyber-security incidents, ransomware or other actions of third parties, including labor strikes or shortages, political unrest and terrorist attacks. Manufacturing disruptions also can occur due to regulatory action, production quality deviations, safety issues or raw material shortages or defects, or because a key product or component is manufactured at a single manufacturing facility with limited alternate facilities.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, our businesses perform business process improvements or infrastructure modernizations or use service providers for key systems and processes, such as receiving and processing customer orders, customer service and accounts payable. For example, our Pharmaceutical segment is currently engaged in a multi-year project to implement a replacement of certain finance and operating information systems and we recently transitioned certain finance processes to a third-party service provider. If any of these initiatives are not successfully or efficiently implemented or maintained, they could adversely affect our business and our internal control over financial reporting.</span></div></div></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:32.135%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.428%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.137%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardinal Health </span><span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">|</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> Fiscal 2021 Form 10-K</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">43</span></div></td></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:3pt;text-align:center"><span><br/></span></div><div style="margin-bottom:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:10.044%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.553%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:67.103%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#e41f35;border-bottom:1pt solid #e41f35;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Risk Factors</span></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span><br/></span></div></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:48.214%"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Our business and results of operations could be adversely affected if we experience a cyber-attack or other systems breach.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our business relies on the secure transmission, storage and hosting of patient-identifiable health information, financial information and other sensitive protected information relating to our customers, company, workforce and individuals with whom we and our customers conduct business. We have programs in place to detect, contain and respond to information security incidents. However, because the techniques used to obtain unauthorized access, disable or degrade service or sabotage systems change frequently and may be difficult to detect for long periods of time, we may be unable to anticipate these techniques or to implement adequate preventative measures. In addition, hardware, software or applications developed internally or procured from third parties may contain defects in design or manufacture or other problems that could unexpectedly compromise information security.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unauthorized parties have gained access and will continue to attempt to gain access to our or a service provider's systems or facilities through fraud, trickery or other forms of deception. We have been the target of cyber attacks, including, in prior fiscal years, incidents where certain customer account information was accessed. Although we do not believe these incidents had a material impact on us, similar incidents or events in the future may negatively impact our business, reputation or financial results.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any compromise of our or a service provider's information systems, including unauthorized access to or use or disclosure of sensitive information, could adversely impact our operations, results of operations or our ability to satisfy legal or regulatory requirements, including the EU general data protection regulation (GDPR) and those related to patient-identifiable health information and other sensitive personal and financial information as further described in the Risk Factor titled &#8220;Our business is subject to rigorous regulatory and licensing requirements,&#8221; above.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, insurance for losses arising from cyber-attacks or other breaches is becoming more costly and limited and may not be available to us at amounts that we historically have obtained or that we would like to obtain. It is possible that we could incur losses that may not be covered by insurance or that would exceed available insurance recoveries. If this happens, our results of operations and financial condition could be adversely affected.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Our sales and credit concentration is significant.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CVS is a large customer that generates a significant amount of our revenue. CVS accounted for 26 percent of our fiscal 2021 revenue and 24 percent of our gross trade receivable balance at June&#160;30, 2021. If CVS terminates the agreements due to an alleged default by us, defaults in payment or significantly reduces its purchases from us, our results of operations and financial condition could be adversely affected.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Our results of operations could be adversely impacted if we fail to manage and complete divestitures.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We regularly evaluate our portfolio of businesses to determine whether an asset or business may no longer help us meet our objectives or whether there may be a more advantaged owner for </span></div></div><div style="display:inline-block;max-width:3.571%;min-width:2.571%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:48.215%"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">that business. For example, we recently completed the divestiture of our Cordis business, and in the past few years, we have also divested our pharmaceutical and medical products distribution business in China and our ownership interest in naviHealth, Inc. When we decide to sell assets or a business, we may encounter difficulty finding buyers or alternative exit strategies, which could delay the achievement of our strategic objectives. We could also incur higher costs or charges than planned or incur unexpected charges and could experience greater dis-synergies than expected, which could have a negative impact on our results of operations.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Our ability to manage and complete acquisitions could impact our strategic objectives and financial condition.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">An important element of our growth strategy has been to acquire other businesses that expand or complement our existing businesses. Completion of acquisitions and the integration of acquired businesses involve a number of risks, including the following: we may overpay for a business or fail to realize the synergies and other benefits we expect from the acquisition; our management&#8217;s attention may be diverted to integration efforts; we may fail to retain key personnel of the acquired business; future developments may impair the value of our purchased goodwill or intangible assets; we may face difficulties or delays establishing, integrating or combining operations and systems, including manufacturing facilities; we may assume liabilities related to legal proceedings involving the acquired business; we may face challenges retaining the customers of the acquired business; or we may encounter unforeseen internal control, regulatory or compliance issues.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Our goodwill may be impaired, which would require us to record a significant charge to earnings in accordance with generally accepted accounting principles.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">U.S. GAAP requires us to test our goodwill for impairment on an annual basis, or more frequently if indicators for potential impairment exist. For our annual impairment test in fiscal 2021, the fair value of the Medical Unit (which includes the Cordis disposal group) exceeded its carrying value by approximately three percent. This testing involves estimates and significant judgments by management. Additional adverse changes in key assumptions, including current assumptions about the impact of the Cordis divestiture and the COVID-19 pandemic, including estimated demand and selling prices for PPE; an increase in the discount rate; a decrease in the terminal growth rate or increases in tax rates, among other things, could result in a goodwill impairment in our Medical Unit. For example, if we were to increase the discount rate by a hypothetical 0.5 percent, the carrying value of our Medical Unit would have exceeded the fair value by approximately one percent in fiscal 2021. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">It is also possible that we may record significant charges related to other reporting units. Any charge or charges could adversely affect our results of operations. See "Critical Accounting Policies and Sensitive Accounting Estimates" in MD&amp;A above for more information regarding goodwill impairment testing.</span></div></div></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:3pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.222%"><tr><td style="width:1.0%"></td><td style="width:32.133%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.433%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.134%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">44</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardinal Health </span><span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">| </span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2021 Form 10-K</span></div></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:3pt;text-align:center"><span><br/></span></div><div style="margin-bottom:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:10.044%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.553%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:67.103%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#e41f35;border-bottom:1pt solid #e41f35;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Risk Factors</span></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span><br/></span></div></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:48.214%"><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:16pt;font-weight:700;line-height:120%">Industry &amp; Economic Risks</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:120%">We could continue to suffer the adverse effects of competitive pressures.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As described in greater detail in the "Business" section, we operate in markets that are highly competitive and dynamic. In addition, competitive pressures in our pharmaceutical and medical segments may be increased by COVID-19, new business models, new entrants, new regulations, changes in consumer demand or general competitive dynamics. Our businesses face continued pricing pressure from these factors, which adversely affects our margins. If we are unable to offset margin reductions caused by these pricing pressures through steps such as sourcing or cost control measures, additional service offerings and sales of higher margin products, our results of operations could continue to be adversely affected. </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Our Pharmaceutical segment&#8217;s profit margin could be adversely affected by changes in industry or market dynamics that we are not able to accurately predict. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In fiscal year 2021, our Pharmaceutical segment&#8217;s generics program was negatively impacted by volume declines. As has been the case for several years, the frequency, timing, magnitude and profit impact of generic pharmaceutical customer purchase volumes, pricing changes, customer contract renewals, generic pharmaceutical launches, and generic pharmaceutical manufacturer pricing changes remain uncertain as does their impact on Pharmaceutical segment profit and consolidated operating earnings. These factors have contributed to declines in some prior years and have more than offset the benefits from sourcing generic pharmaceuticals through our Red Oak Sourcing venture with CVS. If performance of our generic pharmaceutical program declines in future fiscal years and we are unable to offset the decline, our Pharmaceutical segment profit and consolidated operating earnings will be adversely affected.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">With respect to branded pharmaceutical products, compensation under our contractual arrangements with manufacturers for the purchase of branded pharmaceutical products is generally based on the wholesale acquisition cost set by the manufacturer. Sales prices of branded pharmaceutical products to our customers generally are a percentage discount from wholesale acquisition cost.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Also, almost all of our distribution services agreements with branded pharmaceutical manufacturers provide that we receive fees from the manufacturers to compensate us for services we provide them. However, under certain agreements, branded pharmaceutical price appreciation, which is determined by the manufacturers also serves as a part of our compensation. In recent years, manufacturers have increased prices less than in prior years. If manufacturers, in the aggregate, change their historical approach to setting and increasing wholesale acquisition cost, decide to reduce prices, not to increase prices or to implement only small increases and we are unable to negotiate alternative ways to be compensated by manufacturers or customers for the value of our services, our margins could be adversely affected.</span></div></div><div style="display:inline-block;max-width:3.571%;min-width:2.571%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:48.215%"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:120%">We depend on direct and indirect suppliers to make their products and raw materials available to us and are subject to fluctuations in costs, availability and regulatory risks associated with these products and raw materials.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We depend on others to manufacture some products that we market and distribute. Our operations are also dependent on various components, compounds, raw materials and energy supplied by others. We purchase many of these components, raw materials and energy, and source certain products from numerous suppliers in various countries. In some instances, for reasons of quality assurance, cost effectiveness, or availability, we procure certain components and raw materials from a sole supplier. Our supplier relationships could be interrupted, become less favorable to us or be terminated and the supply of these components, compounds, raw materials or products could be interrupted or become insufficient. These supply interruptions or other disruptions in manufacturing processes could be caused by events beyond our control, including natural disasters, supplier facility shut-downs, defective raw materials, the impact of epidemics or pandemics, such as COVID-19, and actions by U.S. or international governments, including export restrictions or tariffs. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, due to the stringent regulatory requirements regarding the manufacture and sourcing of our products, we may not be able to quickly establish additional or replacement sources for certain components, materials or products. A sustained supply reduction or interruption, and an inability to develop alternative and additional sources for such supply, could result in lost sales, increased cost, damage to our reputation, and may have an adverse effect on our business.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our manufacturing businesses use oil-based resins, pulp, cotton, latex and other commodities as raw materials in many products. Prices of oil and gas also affect our distribution and transportation costs. Prices of these commodities are volatile and can fluctuate significantly, causing our costs to produce and distribute our products to fluctuate. Beginning in the fourth quarter of fiscal year 2021, we have experienced higher supply chain costs, primarily related to the sourcing of certain components, compounds, raw materials and commodities. Due to competitive dynamics and contractual limitations, we may be unable to pass along cost increases through higher prices. If we cannot fully offset cost increases through other cost reductions, or recover these costs through price increases or surcharges, our results of operations could continue to be adversely affected.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Consolidation in the U.S. healthcare industry may negatively impact our results of operations.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In recent years, U.S. healthcare industry participants, including distributors, manufacturers, suppliers, healthcare providers, insurers and pharmacy chains, have consolidated or formed strategic alliances. Consolidations create larger enterprises with greater negotiating power, and also could result in the possible loss of a customer where the combined enterprise selects one distributor from two incumbents. If this consolidation trend continues, it could adversely affect our results of operations.</span></div></div></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:32.135%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.428%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.137%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardinal Health </span><span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">|</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> Fiscal 2021 Form 10-K</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">45</span></div></td></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:3pt;text-align:center"><span><br/></span></div><div style="margin-bottom:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:10.044%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.553%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:67.103%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#e41f35;border-bottom:1pt solid #e41f35;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Risk Factors</span></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span><br/></span></div></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:48.214%"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Changes or uncertainty in U.S. or international trade policies</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:120%">and exposure to economic, political and currency risks, could disrupt our global operations or negatively impact our financial results.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We conduct our operations in various regions of the world outside of the United States, including Europe, Asia and Latin America. Global developments can affect our business in many ways. Our global operations are affected by local economic environments, including inflation, recession and competition. Additionally, divergent or unfamiliar regulatory systems and labor markets can increase the risks and burdens of operating in numerous countries.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our foreign operations expose us to a number of risks related to trade protection laws, tariffs, excise or other border taxes on goods sourced from certain countries or on the importation or exportation of products or raw materials. Changes or uncertainty in U.S. or international trade policies or tariffs could impact our global operations, as well as our customers and suppliers. We may be required to spend more money to source certain products or materials that we need or to manufacture certain of our products. This could adversely impact our business and results of operations.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, we conduct our business in U.S. dollars and various functional currencies of our foreign subsidiaries. Changes in foreign currency exchange rates could adversely affect our financial results, which are reported in U.S. dollars. We may not be able to hedge to protect us against these exposures, and any hedges may not successfully mitigate these exposures.</span></div><div><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:3pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:3pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:3pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:3pt;text-align:justify"><span><br/></span></div></div><div style="display:inline-block;max-width:3.571%;min-width:2.571%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:48.215%"></div></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:3pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.222%"><tr><td style="width:1.0%"></td><td style="width:32.133%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.433%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.134%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">46</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardinal Health </span><span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">| </span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2021 Form 10-K</span></div></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div></div></div><div id="i4f0ec56b9c604f1782a65ea4a19c284d_58"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:3pt;text-align:center"><span><br/></span></div><div style="margin-bottom:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:26.026%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:50.073%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.601%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#e41f35;border-bottom:1pt solid #e41f35;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Properties and Legal Proceedings</span></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:0 1pt"></td></tr></table></div></div><div style="margin-bottom:3pt"><span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:20pt;font-weight:700;line-height:120%">Properties</span></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:48.214%"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the United States, at June&#160;30, 2021, the Pharmaceutical segment operated one national logistics center; a number of primary pharmaceutical and specialty distribution facilities as well as nuclear pharmacy and radiopharmaceutical manufacturing facilities. The Medical segment operated medical-surgical distribution, assembly, manufacturing and other operating facilities in the United States. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At June&#160;30, 2021, our Medical segment also operated manufacturing facilities in Canada, Costa Rica, the Dominican Republic, Germany, Ireland, Japan, Malaysia, Malta, Mexico and Thailand.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our principal executive offices are headquartered in an owned building located at 7000 Cardinal Place in Dublin, Ohio.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We consider our operating properties to be in satisfactory condition and adequate to meet our present needs. However, we regularly evaluate operating properties and may make further additions and improvements or consolidate locations as we seek opportunities to expand or enhance the efficiency of our business.</span></div><div style="margin-bottom:3pt;text-align:justify"><span><br/></span></div></div><div style="display:inline-block;max-width:3.571%;min-width:2.571%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:48.215%"></div></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:32.135%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.428%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.137%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardinal Health </span><span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">|</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> Fiscal 2021 Form 10-K</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">47</span></div></td></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span><br/></span></div></div></div><div id="i4f0ec56b9c604f1782a65ea4a19c284d_61"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:3pt;text-align:center"><span><br/></span></div><div style="margin-bottom:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:26.026%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:50.073%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.601%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#e41f35;border-bottom:1pt solid #e41f35;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Properties and Legal Proceedings</span></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:0 1pt"></td></tr></table></div></div><div style="margin-bottom:3pt"><span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:20pt;font-weight:700;line-height:120%">Legal Proceedings</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to the proceedings described below, the legal proceedings described in </span><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i4f0ec56b9c604f1782a65ea4a19c284d_130">Note 7</a></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of the "Notes to Consolidated Financial Statements" are incorporated in this "Legal Proceedings" section by reference.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2019, Melissa Cohen, a purported shareholder, filed an action on behalf of Cardinal Health, Inc. in the U.S. District Court for the Southern District of Ohio against certain current and former members of our Board of Directors alleging that the defendants breached their fiduciary duties by failing to effectively monitor Cardinal Health's distribution of controlled substances and approving certain payments of executive compensation. In December 2019 and January 2020, similar complaints were filed in the U.S. District Court for the Southern District of Ohio by purported shareholders, Stanley M. Malone and Michael Splaine, respectively. In January, 2020, the court consolidated the derivative cases under the caption In re Cardinal Health, Inc. Derivative Litigation and in March 2020, plaintiffs filed an amended complaint. The amended consolidated derivative complaint seeks, among other things, unspecified money damages against the defendants and an award of attorneys' fees. In February 2021, the court granted in part and denied in part defendants' motion to dismiss. The court dismissed the claim with respect to executive compensation but declined to dismiss the failure to monitor claim.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:3pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.222%"><tr><td style="width:1.0%"></td><td style="width:32.133%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.433%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.134%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">48</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardinal Health </span><span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">| </span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2021 Form 10-K</span></div></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div></div></div><div id="i4f0ec56b9c604f1782a65ea4a19c284d_64"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:3pt"><span><br/></span></div><div style="margin-bottom:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:30.941%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:30.941%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:34.818%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#e41f35;border-bottom:1pt solid #e41f35;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Market for Registrant's Common Equity</span></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:0 1pt"></td></tr></table></div></div><div style="margin-bottom:3pt"><span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:20pt;font-weight:700;line-height:120%">Market for Registrant's Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities </span></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our common shares are listed on the New York Stock Exchange under the symbol &#8220;CAH.&#8221; </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At July&#160;31, 2021 there were approximately 7,102 shareholders of record of our common shares.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We anticipate that we will continue to pay quarterly cash dividends in the future. The payment and amount of future dividends remain, however, within the discretion of our Board of Directors and will depend upon our future earnings, financial condition, capital requirements and other factors. </span></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Issuer Purchases of Equity Securities</span></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:25.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.822%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.544%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.822%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.544%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.691%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.544%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.397%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Period</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total Number<br/>of Shares<br/>Purchased&#160;(1)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Average Price Paid&#160;per Share</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total Number of Shares<br/>Purchased<br/>as Part of Publicly Announced Programs&#160;(2)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Approximate<br/>Dollar Value of<br/>Shares That May<br/>Yet be Purchased<br/>Under the Programs&#160;(2)<br/>(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">April 2021</span></td><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,311&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">60.84&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">743&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">May 2021</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">101&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">56.34&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">743&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">June 2021</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">304&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">57.03&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">743&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1,716</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">59.90</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">743</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:10pt">Reflects 1,311, 101 and 304 common shares purchased in April, May and June 2021, respectively, through a rabbi trust as investments of participants in our Deferred Compensation Plan.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:10pt">On November 7, 2018, our Board of Directors approved a $1.0 billion share repurchase program that expires on December 31, 2021. As of June 30, 2021, we have $743 million authorized for share repurchases remaining under this program.</span></div><div style="margin-bottom:3pt;text-align:justify"><span><br/></span></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:48.214%"><div style="margin-bottom:3pt;text-align:justify"><span><br/></span></div></div><div style="display:inline-block;max-width:3.571%;min-width:2.571%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:48.215%"></div></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:32.135%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.428%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.137%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardinal Health </span><span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">|</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> Fiscal 2021 Form 10-K</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">49</span></div></td></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:3pt"><span><br/></span></div><div style="margin-bottom:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:30.941%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:30.941%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:34.818%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#e41f35;border-bottom:1pt solid #e41f35;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Market for Registrant's Common Equity</span></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:0 1pt"></td></tr></table></div></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Five Year Performance Graph</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following line graph compares the cumulative total return of our common shares with the cumulative total return of the Standard &amp; Poor&#8217;s Composite&#8212;500 Stock Index (the "S&amp;P 500 Index") and the Standard &amp; Poor's Composite&#8212;500 Healthcare Index (the "S&amp;P 500 Healthcare Index"). The line graph assumes, in each case, an initial investment of $100 invested at the closing price on June 30, 2016, and is based on the market prices at the end of each fiscal year through and including June&#160;30, 2021, and reinvestment of dividends. The S&amp;P 500 Index and S&amp;P 500 Healthcare Index investments are weighted on the basis of market capitalization at the beginning of each period. </span></div><div style="margin-bottom:3pt;text-align:center"><img src="cah-20210630_g7.jpg" alt="cah-20210630_g7.jpg" style="height:463px;margin-bottom:5pt;vertical-align:text-bottom;width:672px"/></div><div style="margin-top:5pt;padding-left:9pt;padding-right:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:58.630%"><tr><td style="width:1.0%"></td><td style="width:27.326%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.828%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.828%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.828%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.828%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.828%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.834%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="18" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">2016</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">2017</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">2018</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">2021</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cardinal Health, Inc.</span></td><td style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">100.00&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">102.25&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">66.12&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">66.34&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">76.43&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">86.65</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">S&amp;P 500 Index</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">100.00&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">117.89&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">134.82&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">148.86&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">160.01&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">225.25</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">S&amp;P 500 Healthcare Index</span></td><td colspan="2" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">100.00&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">112.47&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">120.46&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">136.11&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">150.95&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">193.09</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:3pt;padding-left:9pt;padding-right:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  </span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:3pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.222%"><tr><td style="width:1.0%"></td><td style="width:32.133%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.433%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.134%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">50</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardinal Health </span><span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">| </span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2021 Form 10-K</span></div></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div></div></div><div id="i4f0ec56b9c604f1782a65ea4a19c284d_67"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:3pt;text-indent:-4.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:29.835%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:33.432%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:33.433%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#e41f35;border-bottom:1pt solid #e41f35;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Reports</span></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:0 1pt"></td></tr></table></div></div><div style="margin-bottom:3pt"><span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:20pt;font-weight:700;line-height:120%">Management Reports</span></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:16pt;font-weight:700;line-height:120%">Evaluation of Disclosure Controls and Procedures</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We evaluated, with the participation of our principal executive officer and principal financial officer, the effectiveness of our disclosure controls and procedures (as defined in Rule 13a-15(e) under the Securities Exchange Act of 1934 (the "Exchange Act")) as of June&#160;30, 2021. Based on this evaluation, our principal executive officer and principal financial officer has concluded that our disclosure controls and procedures were effective as of June&#160;30, 2021 to provide reasonable assurance that information required to be disclosed in our reports under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC rules and forms and that such information is accumulated and communicated to management as appropriate to allow timely decisions regarding required disclosure.</span></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:16pt;font-weight:700;line-height:120%">Management&#8217;s Report on Internal Control Over Financial Reporting</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Management is responsible for establishing and maintaining adequate internal control over financial reporting as defined in Rule 13a-15(f) under the Exchange Act. Our internal control system is designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, controls deemed effective now may become inadequate in the future because of changes in conditions, or because compliance with policies or procedures has deteriorated or been circumvented.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Management assessed the effectiveness of our internal control over financial reporting as of June&#160;30, 2021. In making this assessment, management used the criteria established in the Internal Control-Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (2013 framework) (the &#8220;COSO criteria&#8221;). Based on management&#8217;s assessment and the COSO criteria, management believes that our internal control over financial reporting was effective as of June&#160;30, 2021.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our independent registered public accounting firm, Ernst&#160;&amp; Young LLP, has issued a report on our internal control over financial reporting. Ernst&#160;&amp; Young LLP&#8217;s report appears following this "Management Reports" section and expresses an unqualified opinion on the effectiveness of our internal control over financial reporting.</span></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:16pt;font-weight:700;line-height:120%">Changes in Internal Control Over Financial Reporting</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no changes in our internal control over financial reporting during the quarter ended June&#160;30, 2021 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.</span></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:16pt;font-weight:700;line-height:120%">Pharmaceutical Segment Information Technology Initiative</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Pharmaceutical segment is in a multi-year project to implement a replacement of certain finance and operating information systems. During the fiscal year ended June 30, 2021, we transitioned selected processes to the new systems and expect that we will transition additional processes to the new systems throughout fiscal year 2022. If these new systems are not effectively implemented, or fail to operate as intended, it could adversely affect internal control over financial reporting. </span></div><div style="margin-bottom:3pt;text-align:justify"><span><br/></span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:32.135%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.428%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.137%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardinal Health </span><span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">|</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> Fiscal 2021 Form 10-K</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">51</span></div></td></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span><br/></span></div></div></div><div id="i4f0ec56b9c604f1782a65ea4a19c284d_70"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:3pt;text-indent:-4.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:29.835%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:33.432%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:33.433%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#e41f35;border-bottom:1pt solid #e41f35;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Reports</span></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:0 1pt"></td></tr></table></div></div><div style="margin-bottom:3pt"><span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:20pt;font-weight:700;line-height:120%">Report of Independent Registered Public Accounting Firm on Internal Control Over Financial Reporting</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Shareholders and the Board of Directors of Cardinal Health, Inc.</span></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Opinion on Internal Control over Financial Reporting</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have audited Cardinal Health, Inc. and subsidiaries&#8217; internal control over financial reporting as of June&#160;30, 2021, based on criteria established in Internal Control&#8212;Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (2013 framework) (the COSO criteria). In our opinion, Cardinal Health, Inc. and subsidiaries (the Company) maintained, in all material respects, effective internal control over financial reporting as of June&#160;30, 2021, based on the COSO criteria.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), the consolidated balance sheets of the Company as of June&#160;30, 2021 and 2020, the related consolidated statements of earnings/(loss), comprehensive income/(loss), shareholders' equity and cash flows for each of the three years in the period ended June&#160;30, 2021, and the related notes and the financial statement schedule listed in the Index at Item 15(a)(2) and our report dated August&#160;16, 2021 expressed an unqualified opinion thereon.</span></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Basis for Opinion</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s management is responsible for maintaining effective internal control over financial reporting and for its assessment of the effectiveness of internal control over financial reporting included in the accompanying &#8220;Management&#8217;s Report on Internal Control Over Financial Reporting.&#8221; Our responsibility is to express an opinion on the Company&#8217;s internal control over financial reporting based on our audit. We are a public accounting firm registered with the PCAOB and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We conducted our audit in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether effective internal control over financial reporting was maintained in all material respects. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our audit included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, testing and evaluating the design and operating effectiveness of internal control based on the assessed risk, and performing such other procedures as we considered necessary in the circumstances. We believe that our audit provides a reasonable basis for our opinion.</span></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Definition and Limitations of Internal Control Over Financial Reporting</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A company&#8217;s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company&#8217;s internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company&#8217;s assets that could have a material effect on the financial statements.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.</span></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:48.214%"><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:91.358%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Ernst&#160;&amp; Young LLP</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Grandview Heights, Ohio</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">August 16, 2021</span></td></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span><br/></span></div></div><div style="display:inline-block;max-width:3.571%;min-width:2.571%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:48.215%"></div></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:3pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.222%"><tr><td style="width:1.0%"></td><td style="width:32.133%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.433%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.134%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">52</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardinal Health </span><span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">| </span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2021 Form 10-K</span></div></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div></div></div><div id="i4f0ec56b9c604f1782a65ea4a19c284d_73"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:3pt;text-indent:-4.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:29.835%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:33.432%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:33.433%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#e41f35;border-bottom:1pt solid #e41f35;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Reports</span></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:0 1pt"></td></tr></table></div></div><div style="margin-bottom:3pt"><span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:20pt;font-weight:700;line-height:120%">Report of Independent Registered Public Accounting Firm</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To the Shareholders and the Board of Directors of Cardinal Health, Inc.</span></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Opinion on the Financial Statements</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have audited the accompanying consolidated balance sheets of Cardinal Health, Inc. and subsidiaries (the Company) as of June&#160;30, 2021 and 2020, the related consolidated statements of earnings/(loss), comprehensive income/(loss), shareholders' equity and cash flows for each of the three years in the period ended June&#160;30, 2021, and the related notes and the financial statement schedule listed in the Index at Item 15(a)(2) (collectively referred to as the &#8220;consolidated financial statements&#8221;). In our opinion, the consolidated financial statements present fairly, in all material respects, the financial position of the Company at June&#160;30, 2021 and 2020, and the results of its operations and its cash flows for each of the three years in the period ended June&#160;30, 2021, in conformity with U.S. generally accepted accounting principles.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), the Company's internal control over financial reporting as of June&#160;30, 2021, based on criteria established in Internal Control-Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (2013 framework) and our report dated August&#160;16, 2021 expressed an unqualified opinion thereon.</span></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Basis for Opinion</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These financial statements are the responsibility of the Company's management. Our responsibility is to express an opinion on the Company&#8217;s financial statements based on our audits. We are a public accounting firm registered with the PCAOB and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. Our audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audits provide a reasonable basis for our opinion.</span></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Critical Audit Matters</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The critical audit matters communicated below are matters arising from the current period audit of the financial statements that were communicated or required to be communicated to the audit committee and that: (1) relate to accounts or disclosures that are material to the financial statements and (2) involved our especially challenging, subjective, or complex judgments. The communication of critical audit matters does not alter in any way our opinion on the consolidated financial statements, taken as a whole, and we are not, by communicating the critical audit matters below, providing separate opinions on the critical audit matters or on the accounts or disclosures to which they relate.</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.851%"><tr><td style="width:1.0%"></td><td style="width:8.885%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:88.915%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Medical Unit Goodwill</span></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #ffffff;border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Description of the Matter<br/></span></div></td><td colspan="3" style="border-bottom:1pt solid #ffffff;border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">At June 30, 2021, goodwill related to the Company&#8217;s Medical segment, including the Medical Unit was $5.3 billion. As discussed in </span><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4f0ec56b9c604f1782a65ea4a19c284d_100">Note 1</a></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"> to the consolidated financial statements, goodwill is tested for impairment at least annually at the reporting unit level. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Auditing management&#8217;s goodwill impairment test for the Medical Unit was challenging because there is significant judgement required in determining the fair value of the reporting unit. In particular, the fair value estimate was sensitive to significant judgmental assumptions including the revenue growth rate, gross margin, distribution, selling, general and administrative expenses, and company specific risk premium, which are affected by expectations about future market or economic conditions.</span></div></td></tr></table></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:32.135%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.428%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.137%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardinal Health </span><span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">|</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> Fiscal 2021 Form 10-K</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">53</span></div></td></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:3pt;text-indent:-4.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:29.835%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:33.432%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:33.433%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#e41f35;border-bottom:1pt solid #e41f35;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Reports</span></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:0 1pt"></td></tr></table></div></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.851%"><tr><td style="width:1.0%"></td><td style="width:8.885%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:88.915%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">How We Addressed the Matter in Our Audit<br/></span></div></td><td colspan="3" style="border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#24282d;font-family:'Arial Narrow',sans-serif;font-size:9.5pt;font-weight:400;line-height:106%">We obtained an understanding, evaluated the design and tested the operating effectiveness of controls over the Company&#8217;s goodwill impairment review process. For example, we tested controls over management&#8217;s review of significant judgmental assumptions, including the revenue growth rate, gross margin, distribution, selling, general and administrative expenses, and company specific risk premium, among other assumptions.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#24282d;font-family:'Arial Narrow',sans-serif;font-size:9.5pt;font-weight:400;line-height:107%">To test the estimated fair value of the Company&#8217;s Medical Unit, we performed audit procedures that included, among others, evaluating methodologies used, involving our valuation specialists in testing the significant assumptions described above and testing the underlying data used by the Company in its analysis for completeness and accuracy. We compared the significant assumptions used by management to current industry and economic trends, recent historical performance, changes to the reporting unit&#8217;s business model, customer base or product mix and other relevant factors. We assessed the historical accuracy of management&#8217;s estimates and performed sensitivity analyses of significant assumptions to evaluate the changes in the fair value of the reporting unit that would result from changes in the assumptions. We evaluated the incorporation of the applicable assumptions into the model and tested the model&#8217;s computational accuracy. In addition, we inspected the Company&#8217;s reconciliation of the fair value of all reporting units to the market capitalization of the Company and assessed the result.</span></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Product Liability Lawsuits</span></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Description of the Matter</span></div><div style="text-align:justify"><span><br/></span></div></td><td colspan="3" style="border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">As described in </span><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4f0ec56b9c604f1782a65ea4a19c284d_100">Note 1</a></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"> and </span><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4f0ec56b9c604f1782a65ea4a19c284d_130">Note 7</a></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"> to the consolidated financial statements, the Company is a defendant in various product liability claims in which individuals seek damages associated with the use of Cordis OptEase and TrapEase inferior vena cava (IVC) filter products. The Company accrues for losses and defense costs related to product liability at the time a loss is probable and the amount of loss can be reasonably estimated. The methodology used by the Company to project future Cordis IVC claim costs is based largely on recent experience, including claim filing rates, indemnity severity by claim type, sales data, implant and injury to report lag patterns, and defense costs. The Company periodically reviews such estimates and records adjustments for changes in reserves in the period in which the change in estimate occurs. At June 30, 2021, the Company&#8217;s product liability reserve balance related to the Cordis IVC lawsuits totaled $524 million, net of estimated insurance recoveries. The Company believes there is a range of estimated losses with respect to these matters. Because no amount within the range is a better estimate than any other amount within the range, the Company has accrued the minimum amount in the range. The Company estimates the high end of the range to be approximately $1.03 billion net of estimated insurance recoveries. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Auditing management&#8217;s accounting for and disclosure of loss contingencies related to the Cordis IVC product liability lawsuits was challenging due to the significant judgment required to develop the key assumptions utilized in the model and the nature of information available given the early stages of these lawsuits and the limited claims history. </span></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">How We Addressed the Matter in Our Audit</span></div><div style="text-align:justify"><span><br/></span></div></td><td colspan="3" style="border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">We obtained an understanding, evaluated the design, and tested the operating effectiveness of controls over management&#8217;s evaluation of the product liability litigation reserve. For example, we tested controls over management&#8217;s review of the model used to estimate the product liability reserve amount and the significant assumptions as described above used within the model. We also tested management&#8217;s controls over the completeness and accuracy of the data used in the model.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">To test management&#8217;s assessment of the probability of occurrence of a loss and whether the loss was reasonably estimable, we evaluated, for example, claims data of the Company, we evaluated the legal letters obtained from internal and external legal counsel, and we discussed with internal and external legal counsel of the plaintiffs&#8217; claims. Among other procedures we performed to test the measurement of the product liability litigation reserve, we evaluated the method of measuring the reserve for claims including analyses to determine the range of possible losses, obtained and performed audit procedures relative to the analysis, tested the accuracy and completeness of the data, and evaluated new or contrary information affecting the estimate. In addition, we involved internal actuarial specialists to assist with our procedures related to the measurement of the product liability reserve. We have also assessed the adequacy of the Company&#8217;s disclosures included in </span><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4f0ec56b9c604f1782a65ea4a19c284d_130">Note 7</a></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"> in relation to these matters.</span></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Uncertain Tax Positions</span></div></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #ffffff;border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Description of the Matter </span></div><div style="text-align:justify"><span><br/></span></div></td><td colspan="3" style="border-bottom:1pt solid #ffffff;border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">As described in </span><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4f0ec56b9c604f1782a65ea4a19c284d_133">Note 8</a></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"> to the consolidated financial statements, the Company&#8217;s unrecognized tax benefits related to its uncertain tax positions were approximately $932 million at June 30, 2021. Uncertain tax positions may arise as tax laws are subject to interpretation. The Company uses significant judgment in (1) determining if the tax position is more likely than not to be sustained upon examination, based on the technical merits of the position and (2) measuring the amount of tax benefit that qualifies for recognition.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9.5pt;font-weight:400;line-height:107%">Auditing management's estimate of the amount of tax benefit related to the Company's uncertain tax positions that qualified for recognition was challenging because management's estimate required significant judgment in evaluating the technical merits of the positions, including interpretations of applicable tax laws and regulations.</span></div></td></tr></table></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:3pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.222%"><tr><td style="width:1.0%"></td><td style="width:32.133%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.433%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.134%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">54</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardinal Health </span><span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">| </span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2021 Form 10-K</span></div></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:3pt;text-indent:-4.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:29.835%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:33.432%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:33.433%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#e41f35;border-bottom:1pt solid #e41f35;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Reports</span></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:0 1pt"></td></tr></table></div></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.851%"><tr><td style="width:1.0%"></td><td style="width:8.885%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:88.915%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">How We Addressed the Matter in Our Audit</span></div><div style="text-align:justify"><span><br/></span></div></td><td colspan="3" style="border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">We obtained an understanding, evaluated the design, and tested the operating effectiveness of controls over the Company&#8217;s process to assess the technical merits of its uncertain tax positions, including the Company&#8217;s assessment as to whether a tax position is more likely than not to be sustained and management&#8217;s process to measure the benefit of its tax positions. <br/></span><span style="font-family:'Arial Narrow',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><br/></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">We involved our international tax, transfer pricing, and national tax professionals in assessing the technical merits of certain of the Company&#8217;s tax positions. Depending on the nature of the specific tax position and, where applicable, developments with the relevant tax authorities relating thereto, our procedures included obtaining and examining the Company&#8217;s analysis. For example, we evaluated the underlying facts upon which the tax positions are based, and, where applicable, obtained the Company&#8217;s correspondence with local tax authorities. We used our knowledge of international and local income tax laws, as well as historical settlement activity, where applicable, with local income tax authorities, to evaluate the Company&#8217;s accounting for its uncertain tax positions. We evaluated developments in the applicable tax jurisdictions to assess potential effects on the Company&#8217;s positions. We analyzed the Company&#8217;s assumptions and data used to evaluate the appropriateness of the Company&#8217;s measurement of tax benefits. We have also evaluated the Company&#8217;s income tax disclosures in relation to these matters.<br/></span></td></tr><tr><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Opioid Lawsuits</span></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Description of the Matter<br/></span></div></td><td colspan="3" style="border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">As discussed in </span><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4f0ec56b9c604f1782a65ea4a19c284d_130">Note 7</a></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"> to the consolidated financial statements, the Company is a defendant in numerous lawsuits brought by certain state governments, Native American tribes, and other political subdivisions related to opioid matters. The Company accrues for losses related to legal matters at the time a loss is probable and the amount of loss can be reasonably estimated. In July 2021, the Company negotiated a global proposed settlement agreement (the &#8220;Proposed Settlement Agreement&#8221;), however, the Proposed Settlement Agreement is subject to contingencies. In addition, the Native American tribes and certain other sub-divisions are not included within the Proposed Settlement Agreement and are negotiated separately. The Company has accrued $6.73 billion pretax under the cash component of the Proposed Settlement Agreement and for negotiations with Native American tribes and other sub-divisions as of June 30, 2021. The Company is unable to reasonably estimate the liability associated with other plaintiffs that are not subject to the Proposed Settlement Agreement or other ongoing negotiations. Additionally, management is unable to estimate the range of possible loss associated with these matters.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9.5pt;font-weight:400;line-height:107%">Auditing the Company&#8217;s accounting for, and disclosure of, loss contingencies related to the opioid lawsuits was challenging due to the significant judgment required to evaluate management&#8217;s assessment of the likelihood of a loss being incurred and management&#8217;s determination of whether a reasonable estimate of the range of loss can be made.</span></div><div style="text-align:justify"><span><br/></span></div></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #ffffff;border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">How We Addressed the Matter in Our Audit</span></div><div style="text-align:justify"><span><br/></span></div></td><td colspan="3" style="border-bottom:1pt solid #ffffff;border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">We obtained an understanding, evaluated the design and tested the operating effectiveness of controls over the identification and evaluation of this legal contingency. For example, we tested controls over management&#8217;s review of the assessment of the probability of occurrence of a loss and whether the loss was reasonably estimable and whether the assessment considered all relevant facts.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9.5pt;font-weight:400;line-height:107%">To test the Company&#8217;s assessment of the probability of a loss and whether the loss was reasonably estimable, among other procedures, we read the Proposed Settlement Agreement, requested and received internal and external legal counsel confirmation letters, met with internal counsel to discuss the status of the proceedings and negotiations of the Proposed Settlement Agreement and negotiations with other plaintiffs, and evaluated the reasonableness of management&#8217;s assessment regarding whether an unfavorable outcome is reasonably possible or probable and reasonably estimable. We also assessed the adequacy and the sufficiency of the Company&#8217;s disclosures included in </span><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:9.5pt;font-weight:400;line-height:107%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:9.5pt;font-weight:400;line-height:107%;text-decoration:underline" href="#i4f0ec56b9c604f1782a65ea4a19c284d_130">Note 7</a></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9.5pt;font-weight:400;line-height:107%"> in relation to these matters.</span></div></td></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:44.642%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Ernst&#160;&amp; Young LLP</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">We have served as the Company's auditor since 2002.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Grandview Heights, Ohio</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">August 16, 2021</span></td></tr></table></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:48.214%"><div style="margin-bottom:3pt;text-align:justify"><span><br/></span></div></div><div style="display:inline-block;max-width:3.571%;min-width:2.571%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:48.215%"></div></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:32.135%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.428%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.137%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardinal Health </span><span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">|</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> Fiscal 2021 Form 10-K</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">55</span></div></td></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span><br/></span></div></div></div><div id="i4f0ec56b9c604f1782a65ea4a19c284d_76"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:3pt;text-align:center"><span><br/></span></div><div style="margin-bottom:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:24.682%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:50.911%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.107%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#e41f35;border-bottom:1pt solid #e41f35;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Financial Statements</span></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:0 1pt"></td></tr></table></div></div><div style="margin-bottom:3pt"><span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:20pt;font-weight:700;line-height:120%">Financial Statements and Supplementary Data </span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:93.691%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.109%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Page</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consolidated Financial Statements and Schedule:</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4f0ec56b9c604f1782a65ea4a19c284d_79">Consolidated Statements of Earnings/(Loss) for the Fiscal Years Ended June&#160;30, 2021, 2020 and 2019</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i4f0ec56b9c604f1782a65ea4a19c284d_79">57</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4f0ec56b9c604f1782a65ea4a19c284d_82">Consolidated Statements of Comprehensive Income/(Loss) for the Fiscal Years Ended June&#160;30, 2021, 2020 and 2019</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i4f0ec56b9c604f1782a65ea4a19c284d_82">58</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4f0ec56b9c604f1782a65ea4a19c284d_85">Consolidated Balance Sheets at June&#160;30, 2021 and 2020</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i4f0ec56b9c604f1782a65ea4a19c284d_85">59</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4f0ec56b9c604f1782a65ea4a19c284d_91">Consolidated Statements of Shareholders&#8217; Equity for the Fiscal Years Ended June</a><a style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4f0ec56b9c604f1782a65ea4a19c284d_91"> 30,</a><a style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4f0ec56b9c604f1782a65ea4a19c284d_91"> 2021, 2020, and 2019</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i4f0ec56b9c604f1782a65ea4a19c284d_91">60</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4f0ec56b9c604f1782a65ea4a19c284d_94">Consolidated Statements of Cash Flows for the Fiscal Years Ended June&#160;30, 2021, 2020 and 2019</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i4f0ec56b9c604f1782a65ea4a19c284d_94">61</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4f0ec56b9c604f1782a65ea4a19c284d_97">Notes to Consolidated Financial Statements</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i4f0ec56b9c604f1782a65ea4a19c284d_97">62</a></span></div></td></tr></table></div><div style="margin-bottom:3pt"><span><br/></span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:3pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.222%"><tr><td style="width:1.0%"></td><td style="width:32.133%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.433%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.134%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">56</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardinal Health </span><span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">| </span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2021 Form 10-K</span></div></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div></div></div><div id="i4f0ec56b9c604f1782a65ea4a19c284d_79"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:3pt;text-align:center"><span><br/></span></div><div style="margin-bottom:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:24.682%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:50.911%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.107%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#e41f35;border-bottom:1pt solid #e41f35;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Financial Statements</span></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:0 1pt"></td></tr></table></div></div><div style="margin-bottom:3pt"><span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:20pt;font-weight:700;line-height:120%">Consolidated Statements of Earnings/(Loss) </span></div><div style="margin-bottom:3pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.107%"><tr><td style="width:1.0%"></td><td style="width:62.713%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.461%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.550%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.461%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.550%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.465%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in millions, except per common share amounts)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Revenue</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF83OS9mcmFnOmYxNjk1NzMwNTY2MzRiMzg5NDM4MDUzMzY5ODYzNDA3L3RhYmxlOjUyZjNlMzM5YjkzMjRkN2NhZTc5MmM2ZGM4N2E1YzY4L3RhYmxlcmFuZ2U6NTJmM2UzMzliOTMyNGQ3Y2FlNzkyYzZkYzg3YTVjNjhfMS0xLTEtMS0w_6c0ff04c-7f7a-4588-9c9f-fa025c4aa544">162,467</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia31e9a409b874bb19d0ff6f2f39ecc09_D20190701-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF83OS9mcmFnOmYxNjk1NzMwNTY2MzRiMzg5NDM4MDUzMzY5ODYzNDA3L3RhYmxlOjUyZjNlMzM5YjkzMjRkN2NhZTc5MmM2ZGM4N2E1YzY4L3RhYmxlcmFuZ2U6NTJmM2UzMzliOTMyNGQ3Y2FlNzkyYzZkYzg3YTVjNjhfMS0zLTEtMS0w_ce401778-03c2-4212-9f68-a03f64f51448">152,922</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i00a6d666bf604826b24e68ddbd63eac4_D20180701-20190630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF83OS9mcmFnOmYxNjk1NzMwNTY2MzRiMzg5NDM4MDUzMzY5ODYzNDA3L3RhYmxlOjUyZjNlMzM5YjkzMjRkN2NhZTc5MmM2ZGM4N2E1YzY4L3RhYmxlcmFuZ2U6NTJmM2UzMzliOTMyNGQ3Y2FlNzkyYzZkYzg3YTVjNjhfMS01LTEtMS0w_899eb95a-4e0b-436f-abbd-967524a0aa7a">145,534</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cost of products sold</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CostOfGoodsAndServicesSold" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF83OS9mcmFnOmYxNjk1NzMwNTY2MzRiMzg5NDM4MDUzMzY5ODYzNDA3L3RhYmxlOjUyZjNlMzM5YjkzMjRkN2NhZTc5MmM2ZGM4N2E1YzY4L3RhYmxlcmFuZ2U6NTJmM2UzMzliOTMyNGQ3Y2FlNzkyYzZkYzg3YTVjNjhfMi0xLTEtMS0w_2ad22b0d-f207-4acf-9a4c-751857e88f2f">155,689</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia31e9a409b874bb19d0ff6f2f39ecc09_D20190701-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CostOfGoodsAndServicesSold" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF83OS9mcmFnOmYxNjk1NzMwNTY2MzRiMzg5NDM4MDUzMzY5ODYzNDA3L3RhYmxlOjUyZjNlMzM5YjkzMjRkN2NhZTc5MmM2ZGM4N2E1YzY4L3RhYmxlcmFuZ2U6NTJmM2UzMzliOTMyNGQ3Y2FlNzkyYzZkYzg3YTVjNjhfMi0zLTEtMS0w_72518c51-b544-405e-8a1c-5df2eae16160">146,054</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i00a6d666bf604826b24e68ddbd63eac4_D20180701-20190630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CostOfGoodsAndServicesSold" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF83OS9mcmFnOmYxNjk1NzMwNTY2MzRiMzg5NDM4MDUzMzY5ODYzNDA3L3RhYmxlOjUyZjNlMzM5YjkzMjRkN2NhZTc5MmM2ZGM4N2E1YzY4L3RhYmxlcmFuZ2U6NTJmM2UzMzliOTMyNGQ3Y2FlNzkyYzZkYzg3YTVjNjhfMi01LTEtMS0w_8ca10d9d-6e74-4842-b0f0-68fea29f60bb">138,700</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Gross margin</span></td><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:GrossProfit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF83OS9mcmFnOmYxNjk1NzMwNTY2MzRiMzg5NDM4MDUzMzY5ODYzNDA3L3RhYmxlOjUyZjNlMzM5YjkzMjRkN2NhZTc5MmM2ZGM4N2E1YzY4L3RhYmxlcmFuZ2U6NTJmM2UzMzliOTMyNGQ3Y2FlNzkyYzZkYzg3YTVjNjhfMy0xLTEtMS0w_f3b623e1-eb17-47e3-88f9-eec33c486215">6,778</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia31e9a409b874bb19d0ff6f2f39ecc09_D20190701-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:GrossProfit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF83OS9mcmFnOmYxNjk1NzMwNTY2MzRiMzg5NDM4MDUzMzY5ODYzNDA3L3RhYmxlOjUyZjNlMzM5YjkzMjRkN2NhZTc5MmM2ZGM4N2E1YzY4L3RhYmxlcmFuZ2U6NTJmM2UzMzliOTMyNGQ3Y2FlNzkyYzZkYzg3YTVjNjhfMy0zLTEtMS0w_22be9707-e53d-4bee-a780-c9703bdef95d">6,868</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i00a6d666bf604826b24e68ddbd63eac4_D20180701-20190630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:GrossProfit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF83OS9mcmFnOmYxNjk1NzMwNTY2MzRiMzg5NDM4MDUzMzY5ODYzNDA3L3RhYmxlOjUyZjNlMzM5YjkzMjRkN2NhZTc5MmM2ZGM4N2E1YzY4L3RhYmxlcmFuZ2U6NTJmM2UzMzliOTMyNGQ3Y2FlNzkyYzZkYzg3YTVjNjhfMy01LTEtMS0w_5ce0ddb1-275a-4f4a-900c-c36fa9c80802">6,834</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Operating expenses:</span></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Distribution, selling, general and administrative expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:SellingGeneralAndAdministrativeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF83OS9mcmFnOmYxNjk1NzMwNTY2MzRiMzg5NDM4MDUzMzY5ODYzNDA3L3RhYmxlOjUyZjNlMzM5YjkzMjRkN2NhZTc5MmM2ZGM4N2E1YzY4L3RhYmxlcmFuZ2U6NTJmM2UzMzliOTMyNGQ3Y2FlNzkyYzZkYzg3YTVjNjhfNi0xLTEtMS0w_ffc14c8e-4baf-4ffa-8ba7-e8188b0f617f">4,533</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia31e9a409b874bb19d0ff6f2f39ecc09_D20190701-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:SellingGeneralAndAdministrativeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF83OS9mcmFnOmYxNjk1NzMwNTY2MzRiMzg5NDM4MDUzMzY5ODYzNDA3L3RhYmxlOjUyZjNlMzM5YjkzMjRkN2NhZTc5MmM2ZGM4N2E1YzY4L3RhYmxlcmFuZ2U6NTJmM2UzMzliOTMyNGQ3Y2FlNzkyYzZkYzg3YTVjNjhfNi0zLTEtMS0w_99ed2833-d6cf-43a8-a209-537f932b3aff">4,572</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i00a6d666bf604826b24e68ddbd63eac4_D20180701-20190630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:SellingGeneralAndAdministrativeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF83OS9mcmFnOmYxNjk1NzMwNTY2MzRiMzg5NDM4MDUzMzY5ODYzNDA3L3RhYmxlOjUyZjNlMzM5YjkzMjRkN2NhZTc5MmM2ZGM4N2E1YzY4L3RhYmxlcmFuZ2U6NTJmM2UzMzliOTMyNGQ3Y2FlNzkyYzZkYzg3YTVjNjhfNi01LTEtMS0w_7ac6d5ca-1afc-45d3-b21a-cfc0b3b69412">4,480</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Restructuring and employee severance</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF83OS9mcmFnOmYxNjk1NzMwNTY2MzRiMzg5NDM4MDUzMzY5ODYzNDA3L3RhYmxlOjUyZjNlMzM5YjkzMjRkN2NhZTc5MmM2ZGM4N2E1YzY4L3RhYmxlcmFuZ2U6NTJmM2UzMzliOTMyNGQ3Y2FlNzkyYzZkYzg3YTVjNjhfNy0xLTEtMS0w_6f0a251d-4c2d-4423-8c00-8ea0122d61fd">114</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia31e9a409b874bb19d0ff6f2f39ecc09_D20190701-20200630" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF83OS9mcmFnOmYxNjk1NzMwNTY2MzRiMzg5NDM4MDUzMzY5ODYzNDA3L3RhYmxlOjUyZjNlMzM5YjkzMjRkN2NhZTc5MmM2ZGM4N2E1YzY4L3RhYmxlcmFuZ2U6NTJmM2UzMzliOTMyNGQ3Y2FlNzkyYzZkYzg3YTVjNjhfNy0zLTEtMS0w_2ff923e0-1296-4eea-b168-bcd9788ce67b">122</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i00a6d666bf604826b24e68ddbd63eac4_D20180701-20190630" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF83OS9mcmFnOmYxNjk1NzMwNTY2MzRiMzg5NDM4MDUzMzY5ODYzNDA3L3RhYmxlOjUyZjNlMzM5YjkzMjRkN2NhZTc5MmM2ZGM4N2E1YzY4L3RhYmxlcmFuZ2U6NTJmM2UzMzliOTMyNGQ3Y2FlNzkyYzZkYzg3YTVjNjhfNy01LTEtMS0w_318d2461-a0e3-4ff3-af56-41a67baf7e51">125</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Amortization and other acquisition-related costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630" decimals="-6" name="cah:Amortizationandotheracquisitionrelatedcosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF83OS9mcmFnOmYxNjk1NzMwNTY2MzRiMzg5NDM4MDUzMzY5ODYzNDA3L3RhYmxlOjUyZjNlMzM5YjkzMjRkN2NhZTc5MmM2ZGM4N2E1YzY4L3RhYmxlcmFuZ2U6NTJmM2UzMzliOTMyNGQ3Y2FlNzkyYzZkYzg3YTVjNjhfOC0xLTEtMS0w_bc47ea25-a6e0-4ced-b238-ef7a2fbfb819">451</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia31e9a409b874bb19d0ff6f2f39ecc09_D20190701-20200630" decimals="-6" name="cah:Amortizationandotheracquisitionrelatedcosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF83OS9mcmFnOmYxNjk1NzMwNTY2MzRiMzg5NDM4MDUzMzY5ODYzNDA3L3RhYmxlOjUyZjNlMzM5YjkzMjRkN2NhZTc5MmM2ZGM4N2E1YzY4L3RhYmxlcmFuZ2U6NTJmM2UzMzliOTMyNGQ3Y2FlNzkyYzZkYzg3YTVjNjhfOC0zLTEtMS0w_1b78a558-5d0f-494b-8ab5-274a9407c28a">524</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i00a6d666bf604826b24e68ddbd63eac4_D20180701-20190630" decimals="-6" name="cah:Amortizationandotheracquisitionrelatedcosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF83OS9mcmFnOmYxNjk1NzMwNTY2MzRiMzg5NDM4MDUzMzY5ODYzNDA3L3RhYmxlOjUyZjNlMzM5YjkzMjRkN2NhZTc5MmM2ZGM4N2E1YzY4L3RhYmxlcmFuZ2U6NTJmM2UzMzliOTMyNGQ3Y2FlNzkyYzZkYzg3YTVjNjhfOC01LTEtMS0w_ba74d5c0-11bd-4223-97c6-59eca4738121">621</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Impairments and (gain)/loss on disposal of assets, net</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630" decimals="-6" sign="-" name="us-gaap:GainLossOnSalesOfAssetsAndAssetImpairmentCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF83OS9mcmFnOmYxNjk1NzMwNTY2MzRiMzg5NDM4MDUzMzY5ODYzNDA3L3RhYmxlOjUyZjNlMzM5YjkzMjRkN2NhZTc5MmM2ZGM4N2E1YzY4L3RhYmxlcmFuZ2U6NTJmM2UzMzliOTMyNGQ3Y2FlNzkyYzZkYzg3YTVjNjhfOS0xLTEtMS0w_435adf2c-92ec-406d-ad32-d374aefb78a9">79</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia31e9a409b874bb19d0ff6f2f39ecc09_D20190701-20200630" decimals="-6" sign="-" name="us-gaap:GainLossOnSalesOfAssetsAndAssetImpairmentCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF83OS9mcmFnOmYxNjk1NzMwNTY2MzRiMzg5NDM4MDUzMzY5ODYzNDA3L3RhYmxlOjUyZjNlMzM5YjkzMjRkN2NhZTc5MmM2ZGM4N2E1YzY4L3RhYmxlcmFuZ2U6NTJmM2UzMzliOTMyNGQ3Y2FlNzkyYzZkYzg3YTVjNjhfOS0zLTEtMS0w_61ecaf19-9f23-46f8-8ede-7c13533d263e">7</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i00a6d666bf604826b24e68ddbd63eac4_D20180701-20190630" decimals="-6" name="us-gaap:GainLossOnSalesOfAssetsAndAssetImpairmentCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF83OS9mcmFnOmYxNjk1NzMwNTY2MzRiMzg5NDM4MDUzMzY5ODYzNDA3L3RhYmxlOjUyZjNlMzM5YjkzMjRkN2NhZTc5MmM2ZGM4N2E1YzY4L3RhYmxlcmFuZ2U6NTJmM2UzMzliOTMyNGQ3Y2FlNzkyYzZkYzg3YTVjNjhfOS01LTEtMS0w_a19432e3-9a6d-4332-a331-a7cd061b2832">488</ix:nonFraction>)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Litigation (recoveries)/charges, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:GainLossRelatedToLitigationSettlement" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF83OS9mcmFnOmYxNjk1NzMwNTY2MzRiMzg5NDM4MDUzMzY5ODYzNDA3L3RhYmxlOjUyZjNlMzM5YjkzMjRkN2NhZTc5MmM2ZGM4N2E1YzY4L3RhYmxlcmFuZ2U6NTJmM2UzMzliOTMyNGQ3Y2FlNzkyYzZkYzg3YTVjNjhfMTAtMS0xLTEtMA_d162e042-9b27-4739-9c4a-79effa8be25e">1,129</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia31e9a409b874bb19d0ff6f2f39ecc09_D20190701-20200630" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:GainLossRelatedToLitigationSettlement" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF83OS9mcmFnOmYxNjk1NzMwNTY2MzRiMzg5NDM4MDUzMzY5ODYzNDA3L3RhYmxlOjUyZjNlMzM5YjkzMjRkN2NhZTc5MmM2ZGM4N2E1YzY4L3RhYmxlcmFuZ2U6NTJmM2UzMzliOTMyNGQ3Y2FlNzkyYzZkYzg3YTVjNjhfMTAtMy0xLTEtMA_b0996665-5a85-439a-b223-0afc6f855598">5,741</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i00a6d666bf604826b24e68ddbd63eac4_D20180701-20190630" decimals="-6" sign="-" name="us-gaap:GainLossRelatedToLitigationSettlement" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF83OS9mcmFnOmYxNjk1NzMwNTY2MzRiMzg5NDM4MDUzMzY5ODYzNDA3L3RhYmxlOjUyZjNlMzM5YjkzMjRkN2NhZTc5MmM2ZGM4N2E1YzY4L3RhYmxlcmFuZ2U6NTJmM2UzMzliOTMyNGQ3Y2FlNzkyYzZkYzg3YTVjNjhfMTAtNS0xLTEtMA_19de35a3-966e-428d-9992-c4edc80024b6">36</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Operating earnings/(loss)</span></td><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630" decimals="-6" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF83OS9mcmFnOmYxNjk1NzMwNTY2MzRiMzg5NDM4MDUzMzY5ODYzNDA3L3RhYmxlOjUyZjNlMzM5YjkzMjRkN2NhZTc5MmM2ZGM4N2E1YzY4L3RhYmxlcmFuZ2U6NTJmM2UzMzliOTMyNGQ3Y2FlNzkyYzZkYzg3YTVjNjhfMTEtMS0xLTEtMA_2386ef12-51c9-467b-937f-36ac223c7b63">472</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia31e9a409b874bb19d0ff6f2f39ecc09_D20190701-20200630" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF83OS9mcmFnOmYxNjk1NzMwNTY2MzRiMzg5NDM4MDUzMzY5ODYzNDA3L3RhYmxlOjUyZjNlMzM5YjkzMjRkN2NhZTc5MmM2ZGM4N2E1YzY4L3RhYmxlcmFuZ2U6NTJmM2UzMzliOTMyNGQ3Y2FlNzkyYzZkYzg3YTVjNjhfMTEtMy0xLTEtMA_3de119ed-5e05-4ab7-ba28-84aff098bc2e">4,098</ix:nonFraction>)</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i00a6d666bf604826b24e68ddbd63eac4_D20180701-20190630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF83OS9mcmFnOmYxNjk1NzMwNTY2MzRiMzg5NDM4MDUzMzY5ODYzNDA3L3RhYmxlOjUyZjNlMzM5YjkzMjRkN2NhZTc5MmM2ZGM4N2E1YzY4L3RhYmxlcmFuZ2U6NTJmM2UzMzliOTMyNGQ3Y2FlNzkyYzZkYzg3YTVjNjhfMTEtNS0xLTEtMA_d7aa8d99-9474-41c8-b42e-d1903357440f">2,060</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other (income)/expense, net</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630" decimals="-6" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF83OS9mcmFnOmYxNjk1NzMwNTY2MzRiMzg5NDM4MDUzMzY5ODYzNDA3L3RhYmxlOjUyZjNlMzM5YjkzMjRkN2NhZTc5MmM2ZGM4N2E1YzY4L3RhYmxlcmFuZ2U6NTJmM2UzMzliOTMyNGQ3Y2FlNzkyYzZkYzg3YTVjNjhfMTMtMS0xLTEtMA_cfad6aa9-5de7-4216-afd8-925089aace32">47</ix:nonFraction>)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia31e9a409b874bb19d0ff6f2f39ecc09_D20190701-20200630" decimals="-6" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF83OS9mcmFnOmYxNjk1NzMwNTY2MzRiMzg5NDM4MDUzMzY5ODYzNDA3L3RhYmxlOjUyZjNlMzM5YjkzMjRkN2NhZTc5MmM2ZGM4N2E1YzY4L3RhYmxlcmFuZ2U6NTJmM2UzMzliOTMyNGQ3Y2FlNzkyYzZkYzg3YTVjNjhfMTMtMy0xLTEtMA_82b43a08-2a73-459e-b1a5-eaf440178f4c">1</ix:nonFraction>)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i00a6d666bf604826b24e68ddbd63eac4_D20180701-20190630" decimals="-6" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF83OS9mcmFnOmYxNjk1NzMwNTY2MzRiMzg5NDM4MDUzMzY5ODYzNDA3L3RhYmxlOjUyZjNlMzM5YjkzMjRkN2NhZTc5MmM2ZGM4N2E1YzY4L3RhYmxlcmFuZ2U6NTJmM2UzMzliOTMyNGQ3Y2FlNzkyYzZkYzg3YTVjNjhfMTMtNS0xLTEtMA_e9cf0b33-aeeb-465c-bb57-1f672048e718">15</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Interest expense, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630" decimals="-6" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF83OS9mcmFnOmYxNjk1NzMwNTY2MzRiMzg5NDM4MDUzMzY5ODYzNDA3L3RhYmxlOjUyZjNlMzM5YjkzMjRkN2NhZTc5MmM2ZGM4N2E1YzY4L3RhYmxlcmFuZ2U6NTJmM2UzMzliOTMyNGQ3Y2FlNzkyYzZkYzg3YTVjNjhfMTQtMS0xLTEtMA_c0422a6d-4a22-48ce-a889-a743c3e31630">180</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia31e9a409b874bb19d0ff6f2f39ecc09_D20190701-20200630" decimals="-6" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF83OS9mcmFnOmYxNjk1NzMwNTY2MzRiMzg5NDM4MDUzMzY5ODYzNDA3L3RhYmxlOjUyZjNlMzM5YjkzMjRkN2NhZTc5MmM2ZGM4N2E1YzY4L3RhYmxlcmFuZ2U6NTJmM2UzMzliOTMyNGQ3Y2FlNzkyYzZkYzg3YTVjNjhfMTQtMy0xLTEtMA_70845fc7-2929-461d-87d8-87bf3f381b78">238</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i00a6d666bf604826b24e68ddbd63eac4_D20180701-20190630" decimals="-6" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF83OS9mcmFnOmYxNjk1NzMwNTY2MzRiMzg5NDM4MDUzMzY5ODYzNDA3L3RhYmxlOjUyZjNlMzM5YjkzMjRkN2NhZTc5MmM2ZGM4N2E1YzY4L3RhYmxlcmFuZ2U6NTJmM2UzMzliOTMyNGQ3Y2FlNzkyYzZkYzg3YTVjNjhfMTQtNS0xLTEtMA_2982cb19-6ca4-4abd-828c-125892b1bb08">294</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Loss on early extinguishment of debt</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630" decimals="-6" sign="-" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF83OS9mcmFnOmYxNjk1NzMwNTY2MzRiMzg5NDM4MDUzMzY5ODYzNDA3L3RhYmxlOjUyZjNlMzM5YjkzMjRkN2NhZTc5MmM2ZGM4N2E1YzY4L3RhYmxlcmFuZ2U6NTJmM2UzMzliOTMyNGQ3Y2FlNzkyYzZkYzg3YTVjNjhfMTUtMS0xLTEtMA_9606e17b-751d-4007-9a0d-dcd682af9754">14</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia31e9a409b874bb19d0ff6f2f39ecc09_D20190701-20200630" decimals="-6" sign="-" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF83OS9mcmFnOmYxNjk1NzMwNTY2MzRiMzg5NDM4MDUzMzY5ODYzNDA3L3RhYmxlOjUyZjNlMzM5YjkzMjRkN2NhZTc5MmM2ZGM4N2E1YzY4L3RhYmxlcmFuZ2U6NTJmM2UzMzliOTMyNGQ3Y2FlNzkyYzZkYzg3YTVjNjhfMTUtMy0xLTEtMA_9c5a2459-b232-4758-a908-5aba0e69872f">16</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i00a6d666bf604826b24e68ddbd63eac4_D20180701-20190630" decimals="-6" format="ixt:zerodash" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF83OS9mcmFnOmYxNjk1NzMwNTY2MzRiMzg5NDM4MDUzMzY5ODYzNDA3L3RhYmxlOjUyZjNlMzM5YjkzMjRkN2NhZTc5MmM2ZGM4N2E1YzY4L3RhYmxlcmFuZ2U6NTJmM2UzMzliOTMyNGQ3Y2FlNzkyYzZkYzg3YTVjNjhfMTUtNS0xLTEtMA_96a0a786-0bd6-491e-a888-61c5bd0661b5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(Gain)/Loss on sale of equity interest in naviHealth<br/></span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630" decimals="-6" sign="-" name="us-gaap:GainLossOnSaleOfInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF83OS9mcmFnOmYxNjk1NzMwNTY2MzRiMzg5NDM4MDUzMzY5ODYzNDA3L3RhYmxlOjUyZjNlMzM5YjkzMjRkN2NhZTc5MmM2ZGM4N2E1YzY4L3RhYmxlcmFuZ2U6NTJmM2UzMzliOTMyNGQ3Y2FlNzkyYzZkYzg3YTVjNjhfMTYtMS0xLTEtMA_c9facd2a-2b20-4e59-a23b-f4bac88159da">2</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia31e9a409b874bb19d0ff6f2f39ecc09_D20190701-20200630" decimals="-6" name="us-gaap:GainLossOnSaleOfInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF83OS9mcmFnOmYxNjk1NzMwNTY2MzRiMzg5NDM4MDUzMzY5ODYzNDA3L3RhYmxlOjUyZjNlMzM5YjkzMjRkN2NhZTc5MmM2ZGM4N2E1YzY4L3RhYmxlcmFuZ2U6NTJmM2UzMzliOTMyNGQ3Y2FlNzkyYzZkYzg3YTVjNjhfMTYtMy0xLTEtMA_4c6487be-d69e-4229-81ec-a334be98c516">579</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i00a6d666bf604826b24e68ddbd63eac4_D20180701-20190630" decimals="-6" format="ixt:zerodash" name="us-gaap:GainLossOnSaleOfInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF83OS9mcmFnOmYxNjk1NzMwNTY2MzRiMzg5NDM4MDUzMzY5ODYzNDA3L3RhYmxlOjUyZjNlMzM5YjkzMjRkN2NhZTc5MmM2ZGM4N2E1YzY4L3RhYmxlcmFuZ2U6NTJmM2UzMzliOTMyNGQ3Y2FlNzkyYzZkYzg3YTVjNjhfMTYtNS0xLTEtMA_c3afae0c-ae2a-4701-8337-cee06888e55a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Earnings/(loss) before income taxes</span></td><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF83OS9mcmFnOmYxNjk1NzMwNTY2MzRiMzg5NDM4MDUzMzY5ODYzNDA3L3RhYmxlOjUyZjNlMzM5YjkzMjRkN2NhZTc5MmM2ZGM4N2E1YzY4L3RhYmxlcmFuZ2U6NTJmM2UzMzliOTMyNGQ3Y2FlNzkyYzZkYzg3YTVjNjhfMTctMS0xLTEtMA_9e78b5ea-9a6d-48aa-b25d-19416d149973">323</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia31e9a409b874bb19d0ff6f2f39ecc09_D20190701-20200630" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF83OS9mcmFnOmYxNjk1NzMwNTY2MzRiMzg5NDM4MDUzMzY5ODYzNDA3L3RhYmxlOjUyZjNlMzM5YjkzMjRkN2NhZTc5MmM2ZGM4N2E1YzY4L3RhYmxlcmFuZ2U6NTJmM2UzMzliOTMyNGQ3Y2FlNzkyYzZkYzg3YTVjNjhfMTctMy0xLTEtMA_f423b403-af23-478b-b258-96b4c0a942e7">3,772</ix:nonFraction>)</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i00a6d666bf604826b24e68ddbd63eac4_D20180701-20190630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF83OS9mcmFnOmYxNjk1NzMwNTY2MzRiMzg5NDM4MDUzMzY5ODYzNDA3L3RhYmxlOjUyZjNlMzM5YjkzMjRkN2NhZTc5MmM2ZGM4N2E1YzY4L3RhYmxlcmFuZ2U6NTJmM2UzMzliOTMyNGQ3Y2FlNzkyYzZkYzg3YTVjNjhfMTctNS0xLTEtMA_4cd6d960-559f-41f1-bd52-b4d8eb4c7da9">1,751</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Provision for/(benefit from) income taxes</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630" decimals="-6" sign="-" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF83OS9mcmFnOmYxNjk1NzMwNTY2MzRiMzg5NDM4MDUzMzY5ODYzNDA3L3RhYmxlOjUyZjNlMzM5YjkzMjRkN2NhZTc5MmM2ZGM4N2E1YzY4L3RhYmxlcmFuZ2U6NTJmM2UzMzliOTMyNGQ3Y2FlNzkyYzZkYzg3YTVjNjhfMTktMS0xLTEtMA_2236bc98-0715-4a56-833a-ebab6402cf98">289</ix:nonFraction>)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia31e9a409b874bb19d0ff6f2f39ecc09_D20190701-20200630" decimals="-6" sign="-" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF83OS9mcmFnOmYxNjk1NzMwNTY2MzRiMzg5NDM4MDUzMzY5ODYzNDA3L3RhYmxlOjUyZjNlMzM5YjkzMjRkN2NhZTc5MmM2ZGM4N2E1YzY4L3RhYmxlcmFuZ2U6NTJmM2UzMzliOTMyNGQ3Y2FlNzkyYzZkYzg3YTVjNjhfMTktMy0xLTEtMA_b6b41f4f-0aec-4a65-83c1-793cdeb01c72">79</ix:nonFraction>)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i00a6d666bf604826b24e68ddbd63eac4_D20180701-20190630" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF83OS9mcmFnOmYxNjk1NzMwNTY2MzRiMzg5NDM4MDUzMzY5ODYzNDA3L3RhYmxlOjUyZjNlMzM5YjkzMjRkN2NhZTc5MmM2ZGM4N2E1YzY4L3RhYmxlcmFuZ2U6NTJmM2UzMzliOTMyNGQ3Y2FlNzkyYzZkYzg3YTVjNjhfMTktNS0xLTEtMA_e79ae2a2-fc20-4afb-95a0-19aba67ce784">386</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net earnings/(loss)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF83OS9mcmFnOmYxNjk1NzMwNTY2MzRiMzg5NDM4MDUzMzY5ODYzNDA3L3RhYmxlOjUyZjNlMzM5YjkzMjRkN2NhZTc5MmM2ZGM4N2E1YzY4L3RhYmxlcmFuZ2U6NTJmM2UzMzliOTMyNGQ3Y2FlNzkyYzZkYzg3YTVjNjhfMjAtMS0xLTEtMA_93c32009-fe11-4248-a81f-a0cddb385adb">612</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia31e9a409b874bb19d0ff6f2f39ecc09_D20190701-20200630" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF83OS9mcmFnOmYxNjk1NzMwNTY2MzRiMzg5NDM4MDUzMzY5ODYzNDA3L3RhYmxlOjUyZjNlMzM5YjkzMjRkN2NhZTc5MmM2ZGM4N2E1YzY4L3RhYmxlcmFuZ2U6NTJmM2UzMzliOTMyNGQ3Y2FlNzkyYzZkYzg3YTVjNjhfMjAtMy0xLTEtMA_ef4455fd-ac83-4947-8873-f04823175360">3,693</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i00a6d666bf604826b24e68ddbd63eac4_D20180701-20190630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF83OS9mcmFnOmYxNjk1NzMwNTY2MzRiMzg5NDM4MDUzMzY5ODYzNDA3L3RhYmxlOjUyZjNlMzM5YjkzMjRkN2NhZTc5MmM2ZGM4N2E1YzY4L3RhYmxlcmFuZ2U6NTJmM2UzMzliOTMyNGQ3Y2FlNzkyYzZkYzg3YTVjNjhfMjAtNS0xLTEtMA_7103a0a9-eeb5-4179-8300-4a1cf29e3ce1">1,365</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Less: Net earnings attributable to noncontrolling interests</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630" decimals="-6" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF83OS9mcmFnOmYxNjk1NzMwNTY2MzRiMzg5NDM4MDUzMzY5ODYzNDA3L3RhYmxlOjUyZjNlMzM5YjkzMjRkN2NhZTc5MmM2ZGM4N2E1YzY4L3RhYmxlcmFuZ2U6NTJmM2UzMzliOTMyNGQ3Y2FlNzkyYzZkYzg3YTVjNjhfMjItMS0xLTEtMA_eed69b1a-4481-4f2c-9c2f-5042d7a37f34">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia31e9a409b874bb19d0ff6f2f39ecc09_D20190701-20200630" decimals="-6" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF83OS9mcmFnOmYxNjk1NzMwNTY2MzRiMzg5NDM4MDUzMzY5ODYzNDA3L3RhYmxlOjUyZjNlMzM5YjkzMjRkN2NhZTc5MmM2ZGM4N2E1YzY4L3RhYmxlcmFuZ2U6NTJmM2UzMzliOTMyNGQ3Y2FlNzkyYzZkYzg3YTVjNjhfMjItMy0xLTEtMA_7bb6209f-17c5-46ac-82fe-064374496a27">3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i00a6d666bf604826b24e68ddbd63eac4_D20180701-20190630" decimals="-6" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF83OS9mcmFnOmYxNjk1NzMwNTY2MzRiMzg5NDM4MDUzMzY5ODYzNDA3L3RhYmxlOjUyZjNlMzM5YjkzMjRkN2NhZTc5MmM2ZGM4N2E1YzY4L3RhYmxlcmFuZ2U6NTJmM2UzMzliOTMyNGQ3Y2FlNzkyYzZkYzg3YTVjNjhfMjItNS0xLTEtMA_f5033487-a052-47e6-bf87-72437eb32df4">2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net earnings/(loss) attributable to Cardinal Health, Inc. </span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630" decimals="-6" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF83OS9mcmFnOmYxNjk1NzMwNTY2MzRiMzg5NDM4MDUzMzY5ODYzNDA3L3RhYmxlOjUyZjNlMzM5YjkzMjRkN2NhZTc5MmM2ZGM4N2E1YzY4L3RhYmxlcmFuZ2U6NTJmM2UzMzliOTMyNGQ3Y2FlNzkyYzZkYzg3YTVjNjhfMjMtMS0xLTEtMA_030f1bdb-7425-49bc-8a6e-f2d6ee903024">611</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia31e9a409b874bb19d0ff6f2f39ecc09_D20190701-20200630" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF83OS9mcmFnOmYxNjk1NzMwNTY2MzRiMzg5NDM4MDUzMzY5ODYzNDA3L3RhYmxlOjUyZjNlMzM5YjkzMjRkN2NhZTc5MmM2ZGM4N2E1YzY4L3RhYmxlcmFuZ2U6NTJmM2UzMzliOTMyNGQ3Y2FlNzkyYzZkYzg3YTVjNjhfMjMtMy0xLTEtMA_ed44b04b-b169-4c03-be1d-6eff6a89b284">3,696</ix:nonFraction>)</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i00a6d666bf604826b24e68ddbd63eac4_D20180701-20190630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF83OS9mcmFnOmYxNjk1NzMwNTY2MzRiMzg5NDM4MDUzMzY5ODYzNDA3L3RhYmxlOjUyZjNlMzM5YjkzMjRkN2NhZTc5MmM2ZGM4N2E1YzY4L3RhYmxlcmFuZ2U6NTJmM2UzMzliOTMyNGQ3Y2FlNzkyYzZkYzg3YTVjNjhfMjMtNS0xLTEtMA_b201c961-3a07-4ff1-bff6-51c0a041797b">1,363</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Earnings/(loss) per common share attributable to Cardinal Health, Inc.</span></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Basic</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF83OS9mcmFnOmYxNjk1NzMwNTY2MzRiMzg5NDM4MDUzMzY5ODYzNDA3L3RhYmxlOjUyZjNlMzM5YjkzMjRkN2NhZTc5MmM2ZGM4N2E1YzY4L3RhYmxlcmFuZ2U6NTJmM2UzMzliOTMyNGQ3Y2FlNzkyYzZkYzg3YTVjNjhfMjYtMS0xLTEtMA_8122f096-b95e-45f5-bebf-2adf7a1c601d">2.09</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="ia31e9a409b874bb19d0ff6f2f39ecc09_D20190701-20200630" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF83OS9mcmFnOmYxNjk1NzMwNTY2MzRiMzg5NDM4MDUzMzY5ODYzNDA3L3RhYmxlOjUyZjNlMzM5YjkzMjRkN2NhZTc5MmM2ZGM4N2E1YzY4L3RhYmxlcmFuZ2U6NTJmM2UzMzliOTMyNGQ3Y2FlNzkyYzZkYzg3YTVjNjhfMjYtMy0xLTEtMA_bc43877f-4f77-4e5d-9d09-df4eae92a237">12.61</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i00a6d666bf604826b24e68ddbd63eac4_D20180701-20190630" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF83OS9mcmFnOmYxNjk1NzMwNTY2MzRiMzg5NDM4MDUzMzY5ODYzNDA3L3RhYmxlOjUyZjNlMzM5YjkzMjRkN2NhZTc5MmM2ZGM4N2E1YzY4L3RhYmxlcmFuZ2U6NTJmM2UzMzliOTMyNGQ3Y2FlNzkyYzZkYzg3YTVjNjhfMjYtNS0xLTEtMA_3cdd316a-c0d2-42a7-9d03-ac5ab0b7e4c9">4.55</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Diluted</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF83OS9mcmFnOmYxNjk1NzMwNTY2MzRiMzg5NDM4MDUzMzY5ODYzNDA3L3RhYmxlOjUyZjNlMzM5YjkzMjRkN2NhZTc5MmM2ZGM4N2E1YzY4L3RhYmxlcmFuZ2U6NTJmM2UzMzliOTMyNGQ3Y2FlNzkyYzZkYzg3YTVjNjhfMjctMS0xLTEtMA_db7c0727-84a9-41bc-afe3-85f540a4fc07">2.08</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="ia31e9a409b874bb19d0ff6f2f39ecc09_D20190701-20200630" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF83OS9mcmFnOmYxNjk1NzMwNTY2MzRiMzg5NDM4MDUzMzY5ODYzNDA3L3RhYmxlOjUyZjNlMzM5YjkzMjRkN2NhZTc5MmM2ZGM4N2E1YzY4L3RhYmxlcmFuZ2U6NTJmM2UzMzliOTMyNGQ3Y2FlNzkyYzZkYzg3YTVjNjhfMjctMy0xLTEtMA_82523bf2-4938-4dd1-9419-e763b9798a79">12.61</ix:nonFraction>)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i00a6d666bf604826b24e68ddbd63eac4_D20180701-20190630" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF83OS9mcmFnOmYxNjk1NzMwNTY2MzRiMzg5NDM4MDUzMzY5ODYzNDA3L3RhYmxlOjUyZjNlMzM5YjkzMjRkN2NhZTc5MmM2ZGM4N2E1YzY4L3RhYmxlcmFuZ2U6NTJmM2UzMzliOTMyNGQ3Y2FlNzkyYzZkYzg3YTVjNjhfMjctNS0xLTEtMA_65aa49df-9479-4d44-9163-3fb24c0af710">4.53</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-average number of common shares outstanding:</span></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Basic</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630" decimals="-6" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF83OS9mcmFnOmYxNjk1NzMwNTY2MzRiMzg5NDM4MDUzMzY5ODYzNDA3L3RhYmxlOjUyZjNlMzM5YjkzMjRkN2NhZTc5MmM2ZGM4N2E1YzY4L3RhYmxlcmFuZ2U6NTJmM2UzMzliOTMyNGQ3Y2FlNzkyYzZkYzg3YTVjNjhfMzAtMS0xLTEtMA_65ff9ac0-f24c-45ef-98c4-279c3914c1b4">292</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia31e9a409b874bb19d0ff6f2f39ecc09_D20190701-20200630" decimals="-6" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF83OS9mcmFnOmYxNjk1NzMwNTY2MzRiMzg5NDM4MDUzMzY5ODYzNDA3L3RhYmxlOjUyZjNlMzM5YjkzMjRkN2NhZTc5MmM2ZGM4N2E1YzY4L3RhYmxlcmFuZ2U6NTJmM2UzMzliOTMyNGQ3Y2FlNzkyYzZkYzg3YTVjNjhfMzAtMy0xLTEtMA_1d368dc1-feda-434d-b506-95a9db8ddf20">293</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i00a6d666bf604826b24e68ddbd63eac4_D20180701-20190630" decimals="-6" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF83OS9mcmFnOmYxNjk1NzMwNTY2MzRiMzg5NDM4MDUzMzY5ODYzNDA3L3RhYmxlOjUyZjNlMzM5YjkzMjRkN2NhZTc5MmM2ZGM4N2E1YzY4L3RhYmxlcmFuZ2U6NTJmM2UzMzliOTMyNGQ3Y2FlNzkyYzZkYzg3YTVjNjhfMzAtNS0xLTEtMA_2de8edae-3913-4ee0-ae53-0aa70ecd4dc7">300</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Diluted</span></td><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630" decimals="-6" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF83OS9mcmFnOmYxNjk1NzMwNTY2MzRiMzg5NDM4MDUzMzY5ODYzNDA3L3RhYmxlOjUyZjNlMzM5YjkzMjRkN2NhZTc5MmM2ZGM4N2E1YzY4L3RhYmxlcmFuZ2U6NTJmM2UzMzliOTMyNGQ3Y2FlNzkyYzZkYzg3YTVjNjhfMzEtMS0xLTEtMA_019ad1b9-d948-4932-9b6f-28ce6f9533df">294</ix:nonFraction></span></td><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia31e9a409b874bb19d0ff6f2f39ecc09_D20190701-20200630" decimals="-6" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF83OS9mcmFnOmYxNjk1NzMwNTY2MzRiMzg5NDM4MDUzMzY5ODYzNDA3L3RhYmxlOjUyZjNlMzM5YjkzMjRkN2NhZTc5MmM2ZGM4N2E1YzY4L3RhYmxlcmFuZ2U6NTJmM2UzMzliOTMyNGQ3Y2FlNzkyYzZkYzg3YTVjNjhfMzEtMy0xLTEtMA_9dad21d8-d7f8-425d-bd0d-46c29602e89f">293</ix:nonFraction></span></td><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i00a6d666bf604826b24e68ddbd63eac4_D20180701-20190630" decimals="-6" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF83OS9mcmFnOmYxNjk1NzMwNTY2MzRiMzg5NDM4MDUzMzY5ODYzNDA3L3RhYmxlOjUyZjNlMzM5YjkzMjRkN2NhZTc5MmM2ZGM4N2E1YzY4L3RhYmxlcmFuZ2U6NTJmM2UzMzliOTMyNGQ3Y2FlNzkyYzZkYzg3YTVjNjhfMzEtNS0xLTEtMA_7f6b9a38-4683-46bc-9255-89fa8f21b4c6">301</ix:nonFraction></span></td></tr></table></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these consolidated statements.</span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:32.135%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.428%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.137%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardinal Health </span><span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">|</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> Fiscal 2021 Form 10-K</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">57</span></div></td></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span><br/></span></div></div></div><div id="i4f0ec56b9c604f1782a65ea4a19c284d_82"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:3pt;text-align:center"><span><br/></span></div><div style="margin-bottom:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:24.682%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:50.911%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.107%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#e41f35;border-bottom:1pt solid #e41f35;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Financial Statements</span></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:0 1pt"></td></tr></table></div></div><div style="margin-bottom:3pt"><span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:20pt;font-weight:700;line-height:120%">Consolidated Statements of Comprehensive Income/(Loss)</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:67.501%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.870%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.544%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.870%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.544%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.871%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net earnings/(loss)</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF84Mi9mcmFnOjZmZGVjOTljZTU5MDQ3OTQ4ZTJiM2FmYmEzZDdjMDFlL3RhYmxlOjRjZjQ1YjgzM2I3YjQ3MTdhMGU2M2FkOWEzOGU4NTRiL3RhYmxlcmFuZ2U6NGNmNDViODMzYjdiNDcxN2EwZTYzYWQ5YTM4ZTg1NGJfMS0xLTEtMS0w_93c32009-fe11-4248-a81f-a0cddb385adb">612</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia31e9a409b874bb19d0ff6f2f39ecc09_D20190701-20200630" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF84Mi9mcmFnOjZmZGVjOTljZTU5MDQ3OTQ4ZTJiM2FmYmEzZDdjMDFlL3RhYmxlOjRjZjQ1YjgzM2I3YjQ3MTdhMGU2M2FkOWEzOGU4NTRiL3RhYmxlcmFuZ2U6NGNmNDViODMzYjdiNDcxN2EwZTYzYWQ5YTM4ZTg1NGJfMS0zLTEtMS0w_ef4455fd-ac83-4947-8873-f04823175360">3,693</ix:nonFraction>)</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i00a6d666bf604826b24e68ddbd63eac4_D20180701-20190630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF84Mi9mcmFnOjZmZGVjOTljZTU5MDQ3OTQ4ZTJiM2FmYmEzZDdjMDFlL3RhYmxlOjRjZjQ1YjgzM2I3YjQ3MTdhMGU2M2FkOWEzOGU4NTRiL3RhYmxlcmFuZ2U6NGNmNDViODMzYjdiNDcxN2EwZTYzYWQ5YTM4ZTg1NGJfMS01LTEtMS0w_7103a0a9-eeb5-4179-8300-4a1cf29e3ce1">1,365</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other comprehensive income/(loss):</span></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Foreign currency translation adjustments and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF84Mi9mcmFnOjZmZGVjOTljZTU5MDQ3OTQ4ZTJiM2FmYmEzZDdjMDFlL3RhYmxlOjRjZjQ1YjgzM2I3YjQ3MTdhMGU2M2FkOWEzOGU4NTRiL3RhYmxlcmFuZ2U6NGNmNDViODMzYjdiNDcxN2EwZTYzYWQ5YTM4ZTg1NGJfNC0xLTEtMS0w_7f94b6e6-00ca-44bf-9258-0ab9f944fef6">46</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia31e9a409b874bb19d0ff6f2f39ecc09_D20190701-20200630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF84Mi9mcmFnOjZmZGVjOTljZTU5MDQ3OTQ4ZTJiM2FmYmEzZDdjMDFlL3RhYmxlOjRjZjQ1YjgzM2I3YjQ3MTdhMGU2M2FkOWEzOGU4NTRiL3RhYmxlcmFuZ2U6NGNmNDViODMzYjdiNDcxN2EwZTYzYWQ5YTM4ZTg1NGJfNC0zLTEtMS0w_1587038d-a89c-4372-b637-242ad40ee951">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i00a6d666bf604826b24e68ddbd63eac4_D20180701-20190630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF84Mi9mcmFnOjZmZGVjOTljZTU5MDQ3OTQ4ZTJiM2FmYmEzZDdjMDFlL3RhYmxlOjRjZjQ1YjgzM2I3YjQ3MTdhMGU2M2FkOWEzOGU4NTRiL3RhYmxlcmFuZ2U6NGNmNDViODMzYjdiNDcxN2EwZTYzYWQ5YTM4ZTg1NGJfNC01LTEtMS0w_0e4bbeb3-c3cd-448b-aa8b-8f49882b6770">18</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net unrealized gain/(loss) on derivative instruments, net of tax</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF84Mi9mcmFnOjZmZGVjOTljZTU5MDQ3OTQ4ZTJiM2FmYmEzZDdjMDFlL3RhYmxlOjRjZjQ1YjgzM2I3YjQ3MTdhMGU2M2FkOWEzOGU4NTRiL3RhYmxlcmFuZ2U6NGNmNDViODMzYjdiNDcxN2EwZTYzYWQ5YTM4ZTg1NGJfNi0xLTEtMS0w_7fb93fa2-000b-4b81-b89f-c0b29fb2f162">24</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia31e9a409b874bb19d0ff6f2f39ecc09_D20190701-20200630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF84Mi9mcmFnOjZmZGVjOTljZTU5MDQ3OTQ4ZTJiM2FmYmEzZDdjMDFlL3RhYmxlOjRjZjQ1YjgzM2I3YjQ3MTdhMGU2M2FkOWEzOGU4NTRiL3RhYmxlcmFuZ2U6NGNmNDViODMzYjdiNDcxN2EwZTYzYWQ5YTM4ZTg1NGJfNi0zLTEtMS0w_14c32b84-91bd-4749-97ab-347b193173b1">28</ix:nonFraction>)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i00a6d666bf604826b24e68ddbd63eac4_D20180701-20190630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF84Mi9mcmFnOjZmZGVjOTljZTU5MDQ3OTQ4ZTJiM2FmYmEzZDdjMDFlL3RhYmxlOjRjZjQ1YjgzM2I3YjQ3MTdhMGU2M2FkOWEzOGU4NTRiL3RhYmxlcmFuZ2U6NGNmNDViODMzYjdiNDcxN2EwZTYzYWQ5YTM4ZTg1NGJfNi01LTEtMS0w_21330e3d-9cf8-4e4c-b419-4d816949a791">5</ix:nonFraction>)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total other comprehensive income/(loss), net of tax</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF84Mi9mcmFnOjZmZGVjOTljZTU5MDQ3OTQ4ZTJiM2FmYmEzZDdjMDFlL3RhYmxlOjRjZjQ1YjgzM2I3YjQ3MTdhMGU2M2FkOWEzOGU4NTRiL3RhYmxlcmFuZ2U6NGNmNDViODMzYjdiNDcxN2EwZTYzYWQ5YTM4ZTg1NGJfNy0xLTEtMS0w_3c51796a-7653-4e1a-9765-fcb8d6343f45">70</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia31e9a409b874bb19d0ff6f2f39ecc09_D20190701-20200630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF84Mi9mcmFnOjZmZGVjOTljZTU5MDQ3OTQ4ZTJiM2FmYmEzZDdjMDFlL3RhYmxlOjRjZjQ1YjgzM2I3YjQ3MTdhMGU2M2FkOWEzOGU4NTRiL3RhYmxlcmFuZ2U6NGNmNDViODMzYjdiNDcxN2EwZTYzYWQ5YTM4ZTg1NGJfNy0zLTEtMS0w_5c8b7052-c239-4545-aa19-4bd528cfb9bd">25</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i00a6d666bf604826b24e68ddbd63eac4_D20180701-20190630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF84Mi9mcmFnOjZmZGVjOTljZTU5MDQ3OTQ4ZTJiM2FmYmEzZDdjMDFlL3RhYmxlOjRjZjQ1YjgzM2I3YjQ3MTdhMGU2M2FkOWEzOGU4NTRiL3RhYmxlcmFuZ2U6NGNmNDViODMzYjdiNDcxN2EwZTYzYWQ5YTM4ZTg1NGJfNy01LTEtMS0w_1c7af253-660a-4bc1-8493-224cd4eadaf8">13</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total comprehensive income/(loss)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF84Mi9mcmFnOjZmZGVjOTljZTU5MDQ3OTQ4ZTJiM2FmYmEzZDdjMDFlL3RhYmxlOjRjZjQ1YjgzM2I3YjQ3MTdhMGU2M2FkOWEzOGU4NTRiL3RhYmxlcmFuZ2U6NGNmNDViODMzYjdiNDcxN2EwZTYzYWQ5YTM4ZTg1NGJfOS0xLTEtMS0w_6f06d793-9cc6-480a-91e1-cac0531cb3fc">682</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia31e9a409b874bb19d0ff6f2f39ecc09_D20190701-20200630" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF84Mi9mcmFnOjZmZGVjOTljZTU5MDQ3OTQ4ZTJiM2FmYmEzZDdjMDFlL3RhYmxlOjRjZjQ1YjgzM2I3YjQ3MTdhMGU2M2FkOWEzOGU4NTRiL3RhYmxlcmFuZ2U6NGNmNDViODMzYjdiNDcxN2EwZTYzYWQ5YTM4ZTg1NGJfOS0zLTEtMS0w_9eb98061-1707-49c4-9416-8b8c5edebbc6">3,718</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i00a6d666bf604826b24e68ddbd63eac4_D20180701-20190630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF84Mi9mcmFnOjZmZGVjOTljZTU5MDQ3OTQ4ZTJiM2FmYmEzZDdjMDFlL3RhYmxlOjRjZjQ1YjgzM2I3YjQ3MTdhMGU2M2FkOWEzOGU4NTRiL3RhYmxlcmFuZ2U6NGNmNDViODMzYjdiNDcxN2EwZTYzYWQ5YTM4ZTg1NGJfOS01LTEtMS0w_2681ed09-7388-4238-a322-68c7a4c068d0">1,378</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Less: comprehensive income attributable to noncontrolling interests</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630" decimals="-6" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF84Mi9mcmFnOjZmZGVjOTljZTU5MDQ3OTQ4ZTJiM2FmYmEzZDdjMDFlL3RhYmxlOjRjZjQ1YjgzM2I3YjQ3MTdhMGU2M2FkOWEzOGU4NTRiL3RhYmxlcmFuZ2U6NGNmNDViODMzYjdiNDcxN2EwZTYzYWQ5YTM4ZTg1NGJfMTEtMS0xLTEtMA_eed69b1a-4481-4f2c-9c2f-5042d7a37f34">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia31e9a409b874bb19d0ff6f2f39ecc09_D20190701-20200630" decimals="-6" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF84Mi9mcmFnOjZmZGVjOTljZTU5MDQ3OTQ4ZTJiM2FmYmEzZDdjMDFlL3RhYmxlOjRjZjQ1YjgzM2I3YjQ3MTdhMGU2M2FkOWEzOGU4NTRiL3RhYmxlcmFuZ2U6NGNmNDViODMzYjdiNDcxN2EwZTYzYWQ5YTM4ZTg1NGJfMTEtMy0xLTEtMA_7bb6209f-17c5-46ac-82fe-064374496a27">3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i00a6d666bf604826b24e68ddbd63eac4_D20180701-20190630" decimals="-6" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF84Mi9mcmFnOjZmZGVjOTljZTU5MDQ3OTQ4ZTJiM2FmYmEzZDdjMDFlL3RhYmxlOjRjZjQ1YjgzM2I3YjQ3MTdhMGU2M2FkOWEzOGU4NTRiL3RhYmxlcmFuZ2U6NGNmNDViODMzYjdiNDcxN2EwZTYzYWQ5YTM4ZTg1NGJfMTEtNS0xLTEtMA_f5033487-a052-47e6-bf87-72437eb32df4">2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total comprehensive income/(loss) attributable to Cardinal Health, Inc. </span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF84Mi9mcmFnOjZmZGVjOTljZTU5MDQ3OTQ4ZTJiM2FmYmEzZDdjMDFlL3RhYmxlOjRjZjQ1YjgzM2I3YjQ3MTdhMGU2M2FkOWEzOGU4NTRiL3RhYmxlcmFuZ2U6NGNmNDViODMzYjdiNDcxN2EwZTYzYWQ5YTM4ZTg1NGJfMTItMS0xLTEtMA_54d39793-1d4a-4b44-a427-0139101ae3a1">681</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia31e9a409b874bb19d0ff6f2f39ecc09_D20190701-20200630" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF84Mi9mcmFnOjZmZGVjOTljZTU5MDQ3OTQ4ZTJiM2FmYmEzZDdjMDFlL3RhYmxlOjRjZjQ1YjgzM2I3YjQ3MTdhMGU2M2FkOWEzOGU4NTRiL3RhYmxlcmFuZ2U6NGNmNDViODMzYjdiNDcxN2EwZTYzYWQ5YTM4ZTg1NGJfMTItMy0xLTEtMA_30a0ff79-2d77-43a0-b48d-19117cd88d33">3,721</ix:nonFraction>)</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i00a6d666bf604826b24e68ddbd63eac4_D20180701-20190630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF84Mi9mcmFnOjZmZGVjOTljZTU5MDQ3OTQ4ZTJiM2FmYmEzZDdjMDFlL3RhYmxlOjRjZjQ1YjgzM2I3YjQ3MTdhMGU2M2FkOWEzOGU4NTRiL3RhYmxlcmFuZ2U6NGNmNDViODMzYjdiNDcxN2EwZTYzYWQ5YTM4ZTg1NGJfMTItNS0xLTEtMA_d38b96d6-9fcc-4176-812f-06c2912de349">1,376</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these consolidated statements.</span></div><div style="margin-bottom:3pt;text-align:center"><span><br/></span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:3pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.222%"><tr><td style="width:1.0%"></td><td style="width:32.133%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.433%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.134%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">58</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardinal Health </span><span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">| </span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2021 Form 10-K</span></div></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div></div></div><div id="i4f0ec56b9c604f1782a65ea4a19c284d_85"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:3pt;text-align:center"><span><br/></span></div><div style="margin-bottom:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:24.682%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:50.911%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.107%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#e41f35;border-bottom:1pt solid #e41f35;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Financial Statements</span></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:0 1pt"></td></tr></table></div></div><div style="margin-bottom:3pt"><span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:20pt;font-weight:700;line-height:120%">Consolidated Balance Sheets</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:75.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.209%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.544%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.211%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Current assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cash and equivalents</span></td><td style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2e87824102b34590a0208cc7da91b5f5_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF84NS9mcmFnOjE0MGZhMGNkNWI5YTRiMzJiNGJiZjVlMTQ2OWJjMzU0L3RhYmxlOjI5YjhkZTNhZWM3ZTRjZjFhNTA0MzVjODBlYTg4ZDQyL3RhYmxlcmFuZ2U6MjliOGRlM2FlYzdlNGNmMWE1MDQzNWM4MGVhODhkNDJfNC0xLTEtMS0w_a37da982-62c8-4556-a68e-dcec22257c6d">3,407</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i299cea70f47b4fbe96772aaa8cc00b79_I20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF84NS9mcmFnOjE0MGZhMGNkNWI5YTRiMzJiNGJiZjVlMTQ2OWJjMzU0L3RhYmxlOjI5YjhkZTNhZWM3ZTRjZjFhNTA0MzVjODBlYTg4ZDQyL3RhYmxlcmFuZ2U6MjliOGRlM2FlYzdlNGNmMWE1MDQzNWM4MGVhODhkNDJfNC0zLTEtMS0w_7bbca213-0d90-419a-b4d9-2820eb990c1e">2,771</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Trade receivables, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2e87824102b34590a0208cc7da91b5f5_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ReceivablesNetCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF84NS9mcmFnOjE0MGZhMGNkNWI5YTRiMzJiNGJiZjVlMTQ2OWJjMzU0L3RhYmxlOjI5YjhkZTNhZWM3ZTRjZjFhNTA0MzVjODBlYTg4ZDQyL3RhYmxlcmFuZ2U6MjliOGRlM2FlYzdlNGNmMWE1MDQzNWM4MGVhODhkNDJfNS0xLTEtMS0w_04ec09bd-b5f3-4b15-af64-deaa9ec964b5">9,103</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i299cea70f47b4fbe96772aaa8cc00b79_I20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ReceivablesNetCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF84NS9mcmFnOjE0MGZhMGNkNWI5YTRiMzJiNGJiZjVlMTQ2OWJjMzU0L3RhYmxlOjI5YjhkZTNhZWM3ZTRjZjFhNTA0MzVjODBlYTg4ZDQyL3RhYmxlcmFuZ2U6MjliOGRlM2FlYzdlNGNmMWE1MDQzNWM4MGVhODhkNDJfNS0zLTEtMS0w_cf9e9319-17f0-4b48-9b2e-a30504750926">8,264</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Inventories, net</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2e87824102b34590a0208cc7da91b5f5_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:InventoryNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF84NS9mcmFnOjE0MGZhMGNkNWI5YTRiMzJiNGJiZjVlMTQ2OWJjMzU0L3RhYmxlOjI5YjhkZTNhZWM3ZTRjZjFhNTA0MzVjODBlYTg4ZDQyL3RhYmxlcmFuZ2U6MjliOGRlM2FlYzdlNGNmMWE1MDQzNWM4MGVhODhkNDJfNi0xLTEtMS0w_ddef79f7-47d8-40ec-a531-451d3a0446b9">14,594</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i299cea70f47b4fbe96772aaa8cc00b79_I20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:InventoryNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF84NS9mcmFnOjE0MGZhMGNkNWI5YTRiMzJiNGJiZjVlMTQ2OWJjMzU0L3RhYmxlOjI5YjhkZTNhZWM3ZTRjZjFhNTA0MzVjODBlYTg4ZDQyL3RhYmxlcmFuZ2U6MjliOGRlM2FlYzdlNGNmMWE1MDQzNWM4MGVhODhkNDJfNi0zLTEtMS0w_ef196aaf-e9a1-4a65-94ff-ac7434f69dbc">13,198</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Prepaid expenses and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2e87824102b34590a0208cc7da91b5f5_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OtherAssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF84NS9mcmFnOjE0MGZhMGNkNWI5YTRiMzJiNGJiZjVlMTQ2OWJjMzU0L3RhYmxlOjI5YjhkZTNhZWM3ZTRjZjFhNTA0MzVjODBlYTg4ZDQyL3RhYmxlcmFuZ2U6MjliOGRlM2FlYzdlNGNmMWE1MDQzNWM4MGVhODhkNDJfNy0xLTEtMS0w_edc931a7-aa68-4304-adf7-39b09f341a42">2,843</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i299cea70f47b4fbe96772aaa8cc00b79_I20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OtherAssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF84NS9mcmFnOjE0MGZhMGNkNWI5YTRiMzJiNGJiZjVlMTQ2OWJjMzU0L3RhYmxlOjI5YjhkZTNhZWM3ZTRjZjFhNTA0MzVjODBlYTg4ZDQyL3RhYmxlcmFuZ2U6MjliOGRlM2FlYzdlNGNmMWE1MDQzNWM4MGVhODhkNDJfNy0zLTEtMS0w_20f605d0-41c5-4b25-bc08-580c6557d73a">1,707</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Assets held for sale</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2e87824102b34590a0208cc7da91b5f5_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF84NS9mcmFnOjE0MGZhMGNkNWI5YTRiMzJiNGJiZjVlMTQ2OWJjMzU0L3RhYmxlOjI5YjhkZTNhZWM3ZTRjZjFhNTA0MzVjODBlYTg4ZDQyL3RhYmxlcmFuZ2U6MjliOGRlM2FlYzdlNGNmMWE1MDQzNWM4MGVhODhkNDJfOC0xLTEtMS0w_c399854d-ed3e-4fbf-8f00-d0dd63ef3a50">1,101</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i299cea70f47b4fbe96772aaa8cc00b79_I20200630" decimals="-6" format="ixt:zerodash" name="us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF84NS9mcmFnOjE0MGZhMGNkNWI5YTRiMzJiNGJiZjVlMTQ2OWJjMzU0L3RhYmxlOjI5YjhkZTNhZWM3ZTRjZjFhNTA0MzVjODBlYTg4ZDQyL3RhYmxlcmFuZ2U6MjliOGRlM2FlYzdlNGNmMWE1MDQzNWM4MGVhODhkNDJfOC0zLTEtMS0w_fd0ffbd4-2dcf-4655-9216-cb2d09b498df">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total current assets</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2e87824102b34590a0208cc7da91b5f5_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF84NS9mcmFnOjE0MGZhMGNkNWI5YTRiMzJiNGJiZjVlMTQ2OWJjMzU0L3RhYmxlOjI5YjhkZTNhZWM3ZTRjZjFhNTA0MzVjODBlYTg4ZDQyL3RhYmxlcmFuZ2U6MjliOGRlM2FlYzdlNGNmMWE1MDQzNWM4MGVhODhkNDJfOS0xLTEtMS0w_287eb241-9a30-4f8b-bb9e-c3835426c497">31,048</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i299cea70f47b4fbe96772aaa8cc00b79_I20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF84NS9mcmFnOjE0MGZhMGNkNWI5YTRiMzJiNGJiZjVlMTQ2OWJjMzU0L3RhYmxlOjI5YjhkZTNhZWM3ZTRjZjFhNTA0MzVjODBlYTg4ZDQyL3RhYmxlcmFuZ2U6MjliOGRlM2FlYzdlNGNmMWE1MDQzNWM4MGVhODhkNDJfOS0zLTEtMS0w_6f0a69e9-ffc7-40bb-8d36-637f89e655ad">25,940</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Property and equipment, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2e87824102b34590a0208cc7da91b5f5_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF84NS9mcmFnOjE0MGZhMGNkNWI5YTRiMzJiNGJiZjVlMTQ2OWJjMzU0L3RhYmxlOjI5YjhkZTNhZWM3ZTRjZjFhNTA0MzVjODBlYTg4ZDQyL3RhYmxlcmFuZ2U6MjliOGRlM2FlYzdlNGNmMWE1MDQzNWM4MGVhODhkNDJfMTEtMS0xLTEtMA_da579983-2095-47b8-8542-c0ee4c2c23b5">2,360</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i299cea70f47b4fbe96772aaa8cc00b79_I20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF84NS9mcmFnOjE0MGZhMGNkNWI5YTRiMzJiNGJiZjVlMTQ2OWJjMzU0L3RhYmxlOjI5YjhkZTNhZWM3ZTRjZjFhNTA0MzVjODBlYTg4ZDQyL3RhYmxlcmFuZ2U6MjliOGRlM2FlYzdlNGNmMWE1MDQzNWM4MGVhODhkNDJfMTEtMy0xLTEtMA_f8a4a7a4-697d-4faa-81ca-005c0456b9fb">2,366</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Goodwill and other intangibles, net</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2e87824102b34590a0208cc7da91b5f5_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:IntangibleAssetsNetIncludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF84NS9mcmFnOjE0MGZhMGNkNWI5YTRiMzJiNGJiZjVlMTQ2OWJjMzU0L3RhYmxlOjI5YjhkZTNhZWM3ZTRjZjFhNTA0MzVjODBlYTg4ZDQyL3RhYmxlcmFuZ2U6MjliOGRlM2FlYzdlNGNmMWE1MDQzNWM4MGVhODhkNDJfMTItMS0xLTEtMA_8d3c12aa-0875-443b-9006-863890cd740a">10,094</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i299cea70f47b4fbe96772aaa8cc00b79_I20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:IntangibleAssetsNetIncludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF84NS9mcmFnOjE0MGZhMGNkNWI5YTRiMzJiNGJiZjVlMTQ2OWJjMzU0L3RhYmxlOjI5YjhkZTNhZWM3ZTRjZjFhNTA0MzVjODBlYTg4ZDQyL3RhYmxlcmFuZ2U6MjliOGRlM2FlYzdlNGNmMWE1MDQzNWM4MGVhODhkNDJfMTItMy0xLTEtMA_353b03df-dbfd-49a0-bc35-2ed3d698e350">11,275</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2e87824102b34590a0208cc7da91b5f5_I20210630" decimals="-6" name="us-gaap:OtherAssetsNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF84NS9mcmFnOjE0MGZhMGNkNWI5YTRiMzJiNGJiZjVlMTQ2OWJjMzU0L3RhYmxlOjI5YjhkZTNhZWM3ZTRjZjFhNTA0MzVjODBlYTg4ZDQyL3RhYmxlcmFuZ2U6MjliOGRlM2FlYzdlNGNmMWE1MDQzNWM4MGVhODhkNDJfMTMtMS0xLTEtMA_9c84e538-adeb-4348-ac53-e6d1362e93c1">951</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i299cea70f47b4fbe96772aaa8cc00b79_I20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OtherAssetsNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF84NS9mcmFnOjE0MGZhMGNkNWI5YTRiMzJiNGJiZjVlMTQ2OWJjMzU0L3RhYmxlOjI5YjhkZTNhZWM3ZTRjZjFhNTA0MzVjODBlYTg4ZDQyL3RhYmxlcmFuZ2U6MjliOGRlM2FlYzdlNGNmMWE1MDQzNWM4MGVhODhkNDJfMTMtMy0xLTEtMA_a4c9d7fc-0b5d-48f5-80fa-a715710af05e">1,185</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total assets</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2e87824102b34590a0208cc7da91b5f5_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Assets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF84NS9mcmFnOjE0MGZhMGNkNWI5YTRiMzJiNGJiZjVlMTQ2OWJjMzU0L3RhYmxlOjI5YjhkZTNhZWM3ZTRjZjFhNTA0MzVjODBlYTg4ZDQyL3RhYmxlcmFuZ2U6MjliOGRlM2FlYzdlNGNmMWE1MDQzNWM4MGVhODhkNDJfMTQtMS0xLTEtMA_8b3c60e5-20ba-4060-9bd8-3df83091d5d7">44,453</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i299cea70f47b4fbe96772aaa8cc00b79_I20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Assets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF84NS9mcmFnOjE0MGZhMGNkNWI5YTRiMzJiNGJiZjVlMTQ2OWJjMzU0L3RhYmxlOjI5YjhkZTNhZWM3ZTRjZjFhNTA0MzVjODBlYTg4ZDQyL3RhYmxlcmFuZ2U6MjliOGRlM2FlYzdlNGNmMWE1MDQzNWM4MGVhODhkNDJfMTQtMy0xLTEtMA_9488952c-06f9-41a0-a17c-9bfcb2d43d8b">40,766</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Liabilities and Shareholders&#8217; Equity</span></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Current liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accounts payable</span></td><td style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2e87824102b34590a0208cc7da91b5f5_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AccountsPayableCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF84NS9mcmFnOjE0MGZhMGNkNWI5YTRiMzJiNGJiZjVlMTQ2OWJjMzU0L3RhYmxlOjI5YjhkZTNhZWM3ZTRjZjFhNTA0MzVjODBlYTg4ZDQyL3RhYmxlcmFuZ2U6MjliOGRlM2FlYzdlNGNmMWE1MDQzNWM4MGVhODhkNDJfMTgtMS0xLTEtMA_f02d5a1c-bc5c-45e2-a6fc-0a5c403c134f">23,700</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i299cea70f47b4fbe96772aaa8cc00b79_I20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AccountsPayableCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF84NS9mcmFnOjE0MGZhMGNkNWI5YTRiMzJiNGJiZjVlMTQ2OWJjMzU0L3RhYmxlOjI5YjhkZTNhZWM3ZTRjZjFhNTA0MzVjODBlYTg4ZDQyL3RhYmxlcmFuZ2U6MjliOGRlM2FlYzdlNGNmMWE1MDQzNWM4MGVhODhkNDJfMTgtMy0xLTEtMA_a9395471-0c31-4638-8eef-3838e758e37a">21,374</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Current portion of long-term obligations and other short-term borrowings</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2e87824102b34590a0208cc7da91b5f5_I20210630" decimals="-6" name="us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF84NS9mcmFnOjE0MGZhMGNkNWI5YTRiMzJiNGJiZjVlMTQ2OWJjMzU0L3RhYmxlOjI5YjhkZTNhZWM3ZTRjZjFhNTA0MzVjODBlYTg4ZDQyL3RhYmxlcmFuZ2U6MjliOGRlM2FlYzdlNGNmMWE1MDQzNWM4MGVhODhkNDJfMTktMS0xLTEtMA_1e7f0d19-514b-482e-b932-470915a386dc">871</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i299cea70f47b4fbe96772aaa8cc00b79_I20200630" decimals="-6" name="us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF84NS9mcmFnOjE0MGZhMGNkNWI5YTRiMzJiNGJiZjVlMTQ2OWJjMzU0L3RhYmxlOjI5YjhkZTNhZWM3ZTRjZjFhNTA0MzVjODBlYTg4ZDQyL3RhYmxlcmFuZ2U6MjliOGRlM2FlYzdlNGNmMWE1MDQzNWM4MGVhODhkNDJfMTktMy0xLTEtMA_f95fe53f-ce2d-43ef-90b0-56553ba4caff">10</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other accrued liabilities</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2e87824102b34590a0208cc7da91b5f5_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OtherAccruedLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF84NS9mcmFnOjE0MGZhMGNkNWI5YTRiMzJiNGJiZjVlMTQ2OWJjMzU0L3RhYmxlOjI5YjhkZTNhZWM3ZTRjZjFhNTA0MzVjODBlYTg4ZDQyL3RhYmxlcmFuZ2U6MjliOGRlM2FlYzdlNGNmMWE1MDQzNWM4MGVhODhkNDJfMjAtMS0xLTEtMA_0b998b54-a287-4a0e-a017-d3e3d9910e74">2,957</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i299cea70f47b4fbe96772aaa8cc00b79_I20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OtherAccruedLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF84NS9mcmFnOjE0MGZhMGNkNWI5YTRiMzJiNGJiZjVlMTQ2OWJjMzU0L3RhYmxlOjI5YjhkZTNhZWM3ZTRjZjFhNTA0MzVjODBlYTg4ZDQyL3RhYmxlcmFuZ2U6MjliOGRlM2FlYzdlNGNmMWE1MDQzNWM4MGVhODhkNDJfMjAtMy0xLTEtMA_aa116538-8228-4bb3-8b6c-dcc605a2247f">2,231</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Liabilities related to assets held for sale</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2e87824102b34590a0208cc7da91b5f5_I20210630" decimals="-6" name="us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF84NS9mcmFnOjE0MGZhMGNkNWI5YTRiMzJiNGJiZjVlMTQ2OWJjMzU0L3RhYmxlOjI5YjhkZTNhZWM3ZTRjZjFhNTA0MzVjODBlYTg4ZDQyL3RhYmxlcmFuZ2U6MjliOGRlM2FlYzdlNGNmMWE1MDQzNWM4MGVhODhkNDJfMjEtMS0xLTEtMA_3606ac8b-8a07-44c4-aa4d-cc08f770067e">96</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i299cea70f47b4fbe96772aaa8cc00b79_I20200630" decimals="-6" format="ixt:zerodash" name="us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF84NS9mcmFnOjE0MGZhMGNkNWI5YTRiMzJiNGJiZjVlMTQ2OWJjMzU0L3RhYmxlOjI5YjhkZTNhZWM3ZTRjZjFhNTA0MzVjODBlYTg4ZDQyL3RhYmxlcmFuZ2U6MjliOGRlM2FlYzdlNGNmMWE1MDQzNWM4MGVhODhkNDJfMjEtMy0xLTEtMA_bb234d6e-2cec-4cc2-b0d0-bf2b6e83c18c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total current liabilities</span></td><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2e87824102b34590a0208cc7da91b5f5_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF84NS9mcmFnOjE0MGZhMGNkNWI5YTRiMzJiNGJiZjVlMTQ2OWJjMzU0L3RhYmxlOjI5YjhkZTNhZWM3ZTRjZjFhNTA0MzVjODBlYTg4ZDQyL3RhYmxlcmFuZ2U6MjliOGRlM2FlYzdlNGNmMWE1MDQzNWM4MGVhODhkNDJfMjItMS0xLTEtMA_64146158-72b5-49b2-b55c-334d6004655d">27,624</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i299cea70f47b4fbe96772aaa8cc00b79_I20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF84NS9mcmFnOjE0MGZhMGNkNWI5YTRiMzJiNGJiZjVlMTQ2OWJjMzU0L3RhYmxlOjI5YjhkZTNhZWM3ZTRjZjFhNTA0MzVjODBlYTg4ZDQyL3RhYmxlcmFuZ2U6MjliOGRlM2FlYzdlNGNmMWE1MDQzNWM4MGVhODhkNDJfMjItMy0xLTEtMA_d8d84bb1-a5ef-4b79-a878-225bd3f50e16">23,615</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Long-term obligations, less current portion</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2e87824102b34590a0208cc7da91b5f5_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtAndCapitalLeaseObligations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF84NS9mcmFnOjE0MGZhMGNkNWI5YTRiMzJiNGJiZjVlMTQ2OWJjMzU0L3RhYmxlOjI5YjhkZTNhZWM3ZTRjZjFhNTA0MzVjODBlYTg4ZDQyL3RhYmxlcmFuZ2U6MjliOGRlM2FlYzdlNGNmMWE1MDQzNWM4MGVhODhkNDJfMjQtMS0xLTEtMA_db73a7d4-45d2-4dc3-a6e6-6b40c7da2114">5,365</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i299cea70f47b4fbe96772aaa8cc00b79_I20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtAndCapitalLeaseObligations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF84NS9mcmFnOjE0MGZhMGNkNWI5YTRiMzJiNGJiZjVlMTQ2OWJjMzU0L3RhYmxlOjI5YjhkZTNhZWM3ZTRjZjFhNTA0MzVjODBlYTg4ZDQyL3RhYmxlcmFuZ2U6MjliOGRlM2FlYzdlNGNmMWE1MDQzNWM4MGVhODhkNDJfMjQtMy0xLTEtMjI0_11dfadfa-8117-417a-997c-07fff8d83db0">6,765</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Deferred income taxes and other liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2e87824102b34590a0208cc7da91b5f5_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DeferredTaxAndOtherLiabilitiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF84NS9mcmFnOjE0MGZhMGNkNWI5YTRiMzJiNGJiZjVlMTQ2OWJjMzU0L3RhYmxlOjI5YjhkZTNhZWM3ZTRjZjFhNTA0MzVjODBlYTg4ZDQyL3RhYmxlcmFuZ2U6MjliOGRlM2FlYzdlNGNmMWE1MDQzNWM4MGVhODhkNDJfMjUtMS0xLTEtMA_7e1a9ad3-5096-40f6-9ee6-3b5fbf5010c5">9,670</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i299cea70f47b4fbe96772aaa8cc00b79_I20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DeferredTaxAndOtherLiabilitiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF84NS9mcmFnOjE0MGZhMGNkNWI5YTRiMzJiNGJiZjVlMTQ2OWJjMzU0L3RhYmxlOjI5YjhkZTNhZWM3ZTRjZjFhNTA0MzVjODBlYTg4ZDQyL3RhYmxlcmFuZ2U6MjliOGRlM2FlYzdlNGNmMWE1MDQzNWM4MGVhODhkNDJfMjUtMy0xLTEtMjI0_60360d36-8ece-4040-a0a8-fc48c57a7d1d">8,594</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shareholders&#8217; equity:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Preferred shares, without par value:</span></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Authorized&#8212;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i2e87824102b34590a0208cc7da91b5f5_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PreferredStockSharesAuthorized" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF84NS9mcmFnOjE0MGZhMGNkNWI5YTRiMzJiNGJiZjVlMTQ2OWJjMzU0L3RhYmxlOjI5YjhkZTNhZWM3ZTRjZjFhNTA0MzVjODBlYTg4ZDQyL3RhYmxlcmFuZ2U6MjliOGRlM2FlYzdlNGNmMWE1MDQzNWM4MGVhODhkNDJfMzEtMC0xLTEtMC90ZXh0cmVnaW9uOmFjZWY5NWE4YTI2NzQwNjBhM2Y0MTNkZmQwYmUwMDYwXzI3NDg3NzkwNjk1MDA_45574df7-6af4-4591-bb04-be7bb0bc6668"><ix:nonFraction unitRef="shares" contextRef="i299cea70f47b4fbe96772aaa8cc00b79_I20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PreferredStockSharesAuthorized" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF84NS9mcmFnOjE0MGZhMGNkNWI5YTRiMzJiNGJiZjVlMTQ2OWJjMzU0L3RhYmxlOjI5YjhkZTNhZWM3ZTRjZjFhNTA0MzVjODBlYTg4ZDQyL3RhYmxlcmFuZ2U6MjliOGRlM2FlYzdlNGNmMWE1MDQzNWM4MGVhODhkNDJfMzEtMC0xLTEtMC90ZXh0cmVnaW9uOmFjZWY5NWE4YTI2NzQwNjBhM2Y0MTNkZmQwYmUwMDYwXzI3NDg3NzkwNjk1MDA_f4b44134-82c6-4576-9159-6cfc6e4b0238">500</ix:nonFraction></ix:nonFraction> thousand</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> shares, Issued&#8212;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i299cea70f47b4fbe96772aaa8cc00b79_I20200630" decimals="-3" format="ixt-sec:numwordsen" name="us-gaap:PreferredStockSharesIssued" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF84NS9mcmFnOjE0MGZhMGNkNWI5YTRiMzJiNGJiZjVlMTQ2OWJjMzU0L3RhYmxlOjI5YjhkZTNhZWM3ZTRjZjFhNTA0MzVjODBlYTg4ZDQyL3RhYmxlcmFuZ2U6MjliOGRlM2FlYzdlNGNmMWE1MDQzNWM4MGVhODhkNDJfMzEtMC0xLTEtMC90ZXh0cmVnaW9uOmFjZWY5NWE4YTI2NzQwNjBhM2Y0MTNkZmQwYmUwMDYwXzI3NDg3NzkwNjk1NDI_69f5dc45-5677-44a6-a544-c447013bdbaa"><ix:nonFraction unitRef="shares" contextRef="i2e87824102b34590a0208cc7da91b5f5_I20210630" decimals="-3" format="ixt-sec:numwordsen" name="us-gaap:PreferredStockSharesIssued" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF84NS9mcmFnOjE0MGZhMGNkNWI5YTRiMzJiNGJiZjVlMTQ2OWJjMzU0L3RhYmxlOjI5YjhkZTNhZWM3ZTRjZjFhNTA0MzVjODBlYTg4ZDQyL3RhYmxlcmFuZ2U6MjliOGRlM2FlYzdlNGNmMWE1MDQzNWM4MGVhODhkNDJfMzEtMC0xLTEtMC90ZXh0cmVnaW9uOmFjZWY5NWE4YTI2NzQwNjBhM2Y0MTNkZmQwYmUwMDYwXzI3NDg3NzkwNjk1NDI_99106033-c517-4523-82b8-34470e2673ed">none</ix:nonFraction></ix:nonFraction></span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2e87824102b34590a0208cc7da91b5f5_I20210630" decimals="-6" format="ixt:zerodash" name="us-gaap:PreferredStockValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF84NS9mcmFnOjE0MGZhMGNkNWI5YTRiMzJiNGJiZjVlMTQ2OWJjMzU0L3RhYmxlOjI5YjhkZTNhZWM3ZTRjZjFhNTA0MzVjODBlYTg4ZDQyL3RhYmxlcmFuZ2U6MjliOGRlM2FlYzdlNGNmMWE1MDQzNWM4MGVhODhkNDJfMzEtMS0xLTEtMA_f83ff81e-669a-44cf-8e15-e97818af20a4">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i299cea70f47b4fbe96772aaa8cc00b79_I20200630" decimals="-6" format="ixt:zerodash" name="us-gaap:PreferredStockValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF84NS9mcmFnOjE0MGZhMGNkNWI5YTRiMzJiNGJiZjVlMTQ2OWJjMzU0L3RhYmxlOjI5YjhkZTNhZWM3ZTRjZjFhNTA0MzVjODBlYTg4ZDQyL3RhYmxlcmFuZ2U6MjliOGRlM2FlYzdlNGNmMWE1MDQzNWM4MGVhODhkNDJfMzEtMy0xLTEtMA_17ed1b6a-5c16-4468-a3cf-7e1bdc8002af">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Common shares, without par value:</span></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Authorized&#8212;<ix:nonFraction unitRef="shares" contextRef="i299cea70f47b4fbe96772aaa8cc00b79_I20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesAuthorized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF84NS9mcmFnOjE0MGZhMGNkNWI5YTRiMzJiNGJiZjVlMTQ2OWJjMzU0L3RhYmxlOjI5YjhkZTNhZWM3ZTRjZjFhNTA0MzVjODBlYTg4ZDQyL3RhYmxlcmFuZ2U6MjliOGRlM2FlYzdlNGNmMWE1MDQzNWM4MGVhODhkNDJfMzMtMC0xLTEtMC90ZXh0cmVnaW9uOmQ5MGYxNThhNzhmNTQ2YTVhNjc0NjhkOGIxMjg5MWIyXzI3NDg3NzkwNjk2NDc_838a4009-d0c4-4765-a4a5-9177de9161ab"><ix:nonFraction unitRef="shares" contextRef="i2e87824102b34590a0208cc7da91b5f5_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesAuthorized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF84NS9mcmFnOjE0MGZhMGNkNWI5YTRiMzJiNGJiZjVlMTQ2OWJjMzU0L3RhYmxlOjI5YjhkZTNhZWM3ZTRjZjFhNTA0MzVjODBlYTg4ZDQyL3RhYmxlcmFuZ2U6MjliOGRlM2FlYzdlNGNmMWE1MDQzNWM4MGVhODhkNDJfMzMtMC0xLTEtMC90ZXh0cmVnaW9uOmQ5MGYxNThhNzhmNTQ2YTVhNjc0NjhkOGIxMjg5MWIyXzI3NDg3NzkwNjk2NDc_e37b1568-c939-4728-89fd-c139e22a7cc3">755</ix:nonFraction></ix:nonFraction> million shares, Issued&#8212; <ix:nonFraction unitRef="shares" contextRef="i299cea70f47b4fbe96772aaa8cc00b79_I20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesIssued" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF84NS9mcmFnOjE0MGZhMGNkNWI5YTRiMzJiNGJiZjVlMTQ2OWJjMzU0L3RhYmxlOjI5YjhkZTNhZWM3ZTRjZjFhNTA0MzVjODBlYTg4ZDQyL3RhYmxlcmFuZ2U6MjliOGRlM2FlYzdlNGNmMWE1MDQzNWM4MGVhODhkNDJfMzMtMC0xLTEtMC90ZXh0cmVnaW9uOmQ5MGYxNThhNzhmNTQ2YTVhNjc0NjhkOGIxMjg5MWIyXzI3NDg3NzkwNjk2Nzc_49133e1e-9911-45c5-ab67-66ab58aebd11"><ix:nonFraction unitRef="shares" contextRef="i2e87824102b34590a0208cc7da91b5f5_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesIssued" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF84NS9mcmFnOjE0MGZhMGNkNWI5YTRiMzJiNGJiZjVlMTQ2OWJjMzU0L3RhYmxlOjI5YjhkZTNhZWM3ZTRjZjFhNTA0MzVjODBlYTg4ZDQyL3RhYmxlcmFuZ2U6MjliOGRlM2FlYzdlNGNmMWE1MDQzNWM4MGVhODhkNDJfMzMtMC0xLTEtMC90ZXh0cmVnaW9uOmQ5MGYxNThhNzhmNTQ2YTVhNjc0NjhkOGIxMjg5MWIyXzI3NDg3NzkwNjk2Nzc_dc8c6cab-6141-4d08-8704-cdef77b1c352">327</ix:nonFraction></ix:nonFraction> million shares at </span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2021</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> and 2020</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2e87824102b34590a0208cc7da91b5f5_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CommonStockValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF84NS9mcmFnOjE0MGZhMGNkNWI5YTRiMzJiNGJiZjVlMTQ2OWJjMzU0L3RhYmxlOjI5YjhkZTNhZWM3ZTRjZjFhNTA0MzVjODBlYTg4ZDQyL3RhYmxlcmFuZ2U6MjliOGRlM2FlYzdlNGNmMWE1MDQzNWM4MGVhODhkNDJfMzMtMS0xLTEtMA_7f2224df-1af2-4a0a-9950-5fb9bf49ed45">2,806</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i299cea70f47b4fbe96772aaa8cc00b79_I20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CommonStockValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF84NS9mcmFnOjE0MGZhMGNkNWI5YTRiMzJiNGJiZjVlMTQ2OWJjMzU0L3RhYmxlOjI5YjhkZTNhZWM3ZTRjZjFhNTA0MzVjODBlYTg4ZDQyL3RhYmxlcmFuZ2U6MjliOGRlM2FlYzdlNGNmMWE1MDQzNWM4MGVhODhkNDJfMzMtMy0xLTEtMA_3499b2bc-4f96-4506-ba7d-b4f42bdcf1e7">2,789</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Retained earnings</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2e87824102b34590a0208cc7da91b5f5_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RetainedEarningsAccumulatedDeficit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF84NS9mcmFnOjE0MGZhMGNkNWI5YTRiMzJiNGJiZjVlMTQ2OWJjMzU0L3RhYmxlOjI5YjhkZTNhZWM3ZTRjZjFhNTA0MzVjODBlYTg4ZDQyL3RhYmxlcmFuZ2U6MjliOGRlM2FlYzdlNGNmMWE1MDQzNWM4MGVhODhkNDJfMzQtMS0xLTEtMA_25c0298e-c72b-4447-86b4-6ef9d967595b">1,205</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i299cea70f47b4fbe96772aaa8cc00b79_I20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RetainedEarningsAccumulatedDeficit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF84NS9mcmFnOjE0MGZhMGNkNWI5YTRiMzJiNGJiZjVlMTQ2OWJjMzU0L3RhYmxlOjI5YjhkZTNhZWM3ZTRjZjFhNTA0MzVjODBlYTg4ZDQyL3RhYmxlcmFuZ2U6MjliOGRlM2FlYzdlNGNmMWE1MDQzNWM4MGVhODhkNDJfMzQtMy0xLTEtMA_c2562bf2-7ffc-46cc-8b31-e84abd9809f1">1,170</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Common shares in treasury, at cost: </span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i2e87824102b34590a0208cc7da91b5f5_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:TreasuryStockShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF84NS9mcmFnOjE0MGZhMGNkNWI5YTRiMzJiNGJiZjVlMTQ2OWJjMzU0L3RhYmxlOjI5YjhkZTNhZWM3ZTRjZjFhNTA0MzVjODBlYTg4ZDQyL3RhYmxlcmFuZ2U6MjliOGRlM2FlYzdlNGNmMWE1MDQzNWM4MGVhODhkNDJfMzUtMC0xLTEtMC90ZXh0cmVnaW9uOmMyZmZlMDJjYjdjNTQ3NWQ4MTZlZDBhZTdjNmQ2OTVkXzI3NDg3NzkwNjk3MTE_55e012da-ea0f-4ef5-abad-7cd14afb88ce">36</ix:nonFraction> million </span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">shares and <ix:nonFraction unitRef="shares" contextRef="i299cea70f47b4fbe96772aaa8cc00b79_I20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:TreasuryStockShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF84NS9mcmFnOjE0MGZhMGNkNWI5YTRiMzJiNGJiZjVlMTQ2OWJjMzU0L3RhYmxlOjI5YjhkZTNhZWM3ZTRjZjFhNTA0MzVjODBlYTg4ZDQyL3RhYmxlcmFuZ2U6MjliOGRlM2FlYzdlNGNmMWE1MDQzNWM4MGVhODhkNDJfMzUtMC0xLTEtMC90ZXh0cmVnaW9uOmMyZmZlMDJjYjdjNTQ3NWQ4MTZlZDBhZTdjNmQ2OTVkXzI3NDg3NzkwNjk2OTk_d6ba7812-b7da-4cc3-93f4-8374eabec5c2">34</ix:nonFraction> million shares at </span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2021</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> and 2020, respectively</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2e87824102b34590a0208cc7da91b5f5_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:TreasuryStockValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF84NS9mcmFnOjE0MGZhMGNkNWI5YTRiMzJiNGJiZjVlMTQ2OWJjMzU0L3RhYmxlOjI5YjhkZTNhZWM3ZTRjZjFhNTA0MzVjODBlYTg4ZDQyL3RhYmxlcmFuZ2U6MjliOGRlM2FlYzdlNGNmMWE1MDQzNWM4MGVhODhkNDJfMzUtMS0xLTEtMA_e3a4bf8b-5a79-4973-bf65-35fda67c68e3">2,186</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i299cea70f47b4fbe96772aaa8cc00b79_I20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:TreasuryStockValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF84NS9mcmFnOjE0MGZhMGNkNWI5YTRiMzJiNGJiZjVlMTQ2OWJjMzU0L3RhYmxlOjI5YjhkZTNhZWM3ZTRjZjFhNTA0MzVjODBlYTg4ZDQyL3RhYmxlcmFuZ2U6MjliOGRlM2FlYzdlNGNmMWE1MDQzNWM4MGVhODhkNDJfMzUtMy0xLTEtMA_b52172bb-9cb7-4bf8-acd7-bd86fd30adc5">2,066</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accumulated other comprehensive loss</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2e87824102b34590a0208cc7da91b5f5_I20210630" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF84NS9mcmFnOjE0MGZhMGNkNWI5YTRiMzJiNGJiZjVlMTQ2OWJjMzU0L3RhYmxlOjI5YjhkZTNhZWM3ZTRjZjFhNTA0MzVjODBlYTg4ZDQyL3RhYmxlcmFuZ2U6MjliOGRlM2FlYzdlNGNmMWE1MDQzNWM4MGVhODhkNDJfMzYtMS0xLTEtMA_d0920879-99f6-4eca-ba4f-23a6d06f99f6">34</ix:nonFraction>)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i299cea70f47b4fbe96772aaa8cc00b79_I20200630" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF84NS9mcmFnOjE0MGZhMGNkNWI5YTRiMzJiNGJiZjVlMTQ2OWJjMzU0L3RhYmxlOjI5YjhkZTNhZWM3ZTRjZjFhNTA0MzVjODBlYTg4ZDQyL3RhYmxlcmFuZ2U6MjliOGRlM2FlYzdlNGNmMWE1MDQzNWM4MGVhODhkNDJfMzYtMy0xLTEtMA_1de5fa9d-2247-4796-8b19-e155d1dac811">104</ix:nonFraction>)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total Cardinal Health, Inc. shareholders' equity</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2e87824102b34590a0208cc7da91b5f5_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF84NS9mcmFnOjE0MGZhMGNkNWI5YTRiMzJiNGJiZjVlMTQ2OWJjMzU0L3RhYmxlOjI5YjhkZTNhZWM3ZTRjZjFhNTA0MzVjODBlYTg4ZDQyL3RhYmxlcmFuZ2U6MjliOGRlM2FlYzdlNGNmMWE1MDQzNWM4MGVhODhkNDJfMzctMS0xLTEtMA_282cc6b5-cb05-4d60-a63b-bacbe165d6be">1,791</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i299cea70f47b4fbe96772aaa8cc00b79_I20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF84NS9mcmFnOjE0MGZhMGNkNWI5YTRiMzJiNGJiZjVlMTQ2OWJjMzU0L3RhYmxlOjI5YjhkZTNhZWM3ZTRjZjFhNTA0MzVjODBlYTg4ZDQyL3RhYmxlcmFuZ2U6MjliOGRlM2FlYzdlNGNmMWE1MDQzNWM4MGVhODhkNDJfMzctMy0xLTEtMA_b890f853-e9dd-478f-958b-aeb2379069cd">1,789</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Noncontrolling interests</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2e87824102b34590a0208cc7da91b5f5_I20210630" decimals="-6" name="us-gaap:MinorityInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF84NS9mcmFnOjE0MGZhMGNkNWI5YTRiMzJiNGJiZjVlMTQ2OWJjMzU0L3RhYmxlOjI5YjhkZTNhZWM3ZTRjZjFhNTA0MzVjODBlYTg4ZDQyL3RhYmxlcmFuZ2U6MjliOGRlM2FlYzdlNGNmMWE1MDQzNWM4MGVhODhkNDJfMzgtMS0xLTEtMA_cf172500-58f1-47c4-9ef8-d575028b8e44">3</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i299cea70f47b4fbe96772aaa8cc00b79_I20200630" decimals="-6" name="us-gaap:MinorityInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF84NS9mcmFnOjE0MGZhMGNkNWI5YTRiMzJiNGJiZjVlMTQ2OWJjMzU0L3RhYmxlOjI5YjhkZTNhZWM3ZTRjZjFhNTA0MzVjODBlYTg4ZDQyL3RhYmxlcmFuZ2U6MjliOGRlM2FlYzdlNGNmMWE1MDQzNWM4MGVhODhkNDJfMzgtMy0xLTEtMA_2b954c10-84bd-451f-9c78-dcd40959e91f">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total shareholders&#8217; equity</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2e87824102b34590a0208cc7da91b5f5_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF84NS9mcmFnOjE0MGZhMGNkNWI5YTRiMzJiNGJiZjVlMTQ2OWJjMzU0L3RhYmxlOjI5YjhkZTNhZWM3ZTRjZjFhNTA0MzVjODBlYTg4ZDQyL3RhYmxlcmFuZ2U6MjliOGRlM2FlYzdlNGNmMWE1MDQzNWM4MGVhODhkNDJfMzktMS0xLTEtMA_577c4808-ece3-43ee-973e-177bac99fbff">1,794</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i299cea70f47b4fbe96772aaa8cc00b79_I20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF84NS9mcmFnOjE0MGZhMGNkNWI5YTRiMzJiNGJiZjVlMTQ2OWJjMzU0L3RhYmxlOjI5YjhkZTNhZWM3ZTRjZjFhNTA0MzVjODBlYTg4ZDQyL3RhYmxlcmFuZ2U6MjliOGRlM2FlYzdlNGNmMWE1MDQzNWM4MGVhODhkNDJfMzktMy0xLTEtMA_44a2c1f6-b88d-4b39-9cae-0a70a2477ab2">1,792</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total liabilities and shareholders&#8217; equity</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2e87824102b34590a0208cc7da91b5f5_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesAndStockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF84NS9mcmFnOjE0MGZhMGNkNWI5YTRiMzJiNGJiZjVlMTQ2OWJjMzU0L3RhYmxlOjI5YjhkZTNhZWM3ZTRjZjFhNTA0MzVjODBlYTg4ZDQyL3RhYmxlcmFuZ2U6MjliOGRlM2FlYzdlNGNmMWE1MDQzNWM4MGVhODhkNDJfNDAtMS0xLTEtMA_42b3c642-bd35-4840-b7a1-422410cde0ac">44,453</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i299cea70f47b4fbe96772aaa8cc00b79_I20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesAndStockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF84NS9mcmFnOjE0MGZhMGNkNWI5YTRiMzJiNGJiZjVlMTQ2OWJjMzU0L3RhYmxlOjI5YjhkZTNhZWM3ZTRjZjFhNTA0MzVjODBlYTg4ZDQyL3RhYmxlcmFuZ2U6MjliOGRlM2FlYzdlNGNmMWE1MDQzNWM4MGVhODhkNDJfNDAtMy0xLTEtMA_e3b1e932-82d8-4ffe-b3f1-dcbf2f83db99">40,766</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these consolidated statements.</span></div><div style="margin-bottom:3pt;text-align:center"><span><br/></span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:32.135%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.428%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.137%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardinal Health </span><span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">|</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> Fiscal 2021 Form 10-K</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">59</span></div></td></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span><br/></span></div></div></div><div id="i4f0ec56b9c604f1782a65ea4a19c284d_91"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:3pt;text-align:center"><span><br/></span></div><div style="margin-bottom:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:24.682%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:50.911%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.107%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#e41f35;border-bottom:1pt solid #e41f35;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Financial Statements</span></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:0 1pt"></td></tr></table></div></div><div style="margin-bottom:3pt"><span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:20pt;font-weight:700;line-height:120%">Consolidated Statements of Shareholders' Equity</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.553%"><tr><td style="width:1.0%"></td><td style="width:28.944%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.626%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.547%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.476%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.547%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.476%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.547%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.626%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.547%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.476%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.547%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.512%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.547%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.662%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.547%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.073%"></td><td style="width:0.1%"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Common Shares</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Treasury Shares</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accumulated Other<br/>Comprehensive<br/>Loss</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Noncontrolling Interests</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total<br/>Shareholders&#8217;<br/>Equity</span></td></tr><tr style="height:21pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Shares Issued</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Retained<br/>Earnings</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance at June 30, 2018</span></td><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iba537ecaa59e43b0a9b66571c8100267_I20180630" decimals="-6" name="us-gaap:CommonStockSharesIssued" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85MS9mcmFnOmYzYjg0MmI1OWMxNzQ4OTU4NGJhNzkzYzQ5MWUxNzMwL3RhYmxlOjE2ZTc3ZjNhYjg4YzQ1ODY5NDkyZGU4ZWQzMTllMWJhL3RhYmxlcmFuZ2U6MTZlNzdmM2FiODhjNDU4Njk0OTJkZThlZDMxOWUxYmFfMi0xLTEtMS0w_59cc9fe5-bc8f-4468-871d-81c1185d5740">327</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iba537ecaa59e43b0a9b66571c8100267_I20180630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85MS9mcmFnOmYzYjg0MmI1OWMxNzQ4OTU4NGJhNzkzYzQ5MWUxNzMwL3RhYmxlOjE2ZTc3ZjNhYjg4YzQ1ODY5NDkyZGU4ZWQzMTllMWJhL3RhYmxlcmFuZ2U6MTZlNzdmM2FiODhjNDU4Njk0OTJkZThlZDMxOWUxYmFfMi0zLTEtMS0w_7c2958f1-0270-4c2e-90ac-d29cf3622ea6">2,730</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id3a1b5ab2e8f487b9c151040675e8c4e_I20180630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85MS9mcmFnOmYzYjg0MmI1OWMxNzQ4OTU4NGJhNzkzYzQ5MWUxNzMwL3RhYmxlOjE2ZTc3ZjNhYjg4YzQ1ODY5NDkyZGU4ZWQzMTllMWJhL3RhYmxlcmFuZ2U6MTZlNzdmM2FiODhjNDU4Njk0OTJkZThlZDMxOWUxYmFfMi01LTEtMS0w_cefab5cd-ec29-4a6e-bf2c-2c07905d7ae4">4,645</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="if1e3a4cc24f142cdafa5042dfc5dd64d_I20180630" decimals="-6" name="us-gaap:TreasuryStockShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85MS9mcmFnOmYzYjg0MmI1OWMxNzQ4OTU4NGJhNzkzYzQ5MWUxNzMwL3RhYmxlOjE2ZTc3ZjNhYjg4YzQ1ODY5NDkyZGU4ZWQzMTllMWJhL3RhYmxlcmFuZ2U6MTZlNzdmM2FiODhjNDU4Njk0OTJkZThlZDMxOWUxYmFfMi03LTEtMS0w_202cd800-f504-46a7-a6e3-1df7547a7708">18</ix:nonFraction>)</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if1e3a4cc24f142cdafa5042dfc5dd64d_I20180630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:TreasuryStockValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85MS9mcmFnOmYzYjg0MmI1OWMxNzQ4OTU4NGJhNzkzYzQ5MWUxNzMwL3RhYmxlOjE2ZTc3ZjNhYjg4YzQ1ODY5NDkyZGU4ZWQzMTllMWJhL3RhYmxlcmFuZ2U6MTZlNzdmM2FiODhjNDU4Njk0OTJkZThlZDMxOWUxYmFfMi05LTEtMS0w_a362e27a-2c62-4870-b572-0c132ebb524e">1,224</ix:nonFraction>)</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifb73250f67a2413d876abaab75f9b78e_I20180630" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85MS9mcmFnOmYzYjg0MmI1OWMxNzQ4OTU4NGJhNzkzYzQ5MWUxNzMwL3RhYmxlOjE2ZTc3ZjNhYjg4YzQ1ODY5NDkyZGU4ZWQzMTllMWJhL3RhYmxlcmFuZ2U6MTZlNzdmM2FiODhjNDU4Njk0OTJkZThlZDMxOWUxYmFfMi0xMS0xLTEtMA_11d10067-0a45-4859-bab0-d77e1774d568">92</ix:nonFraction>)</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ffaf87e6d734e599ad2b8cf9d894639_I20180630" decimals="-6" format="ixt:zerodash" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85MS9mcmFnOmYzYjg0MmI1OWMxNzQ4OTU4NGJhNzkzYzQ5MWUxNzMwL3RhYmxlOjE2ZTc3ZjNhYjg4YzQ1ODY5NDkyZGU4ZWQzMTllMWJhL3RhYmxlcmFuZ2U6MTZlNzdmM2FiODhjNDU4Njk0OTJkZThlZDMxOWUxYmFfMi0xMy0xLTEtMA_9f282fe3-94df-4f80-adca-4599df00dec7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39bbe70148ff4daea469e8420c1859d6_I20180630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85MS9mcmFnOmYzYjg0MmI1OWMxNzQ4OTU4NGJhNzkzYzQ5MWUxNzMwL3RhYmxlOjE2ZTc3ZjNhYjg4YzQ1ODY5NDkyZGU4ZWQzMTllMWJhL3RhYmxlcmFuZ2U6MTZlNzdmM2FiODhjNDU4Njk0OTJkZThlZDMxOWUxYmFfMi0xNS0xLTEtMA_d418c83a-8392-4282-8298-0d387f090f2c">6,059</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net earnings</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i368e27a25f8645faa683a133e4fd114e_D20180701-20190630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85MS9mcmFnOmYzYjg0MmI1OWMxNzQ4OTU4NGJhNzkzYzQ5MWUxNzMwL3RhYmxlOjE2ZTc3ZjNhYjg4YzQ1ODY5NDkyZGU4ZWQzMTllMWJhL3RhYmxlcmFuZ2U6MTZlNzdmM2FiODhjNDU4Njk0OTJkZThlZDMxOWUxYmFfMy01LTEtMS0w_6d66a8a6-4643-44c3-ac25-b778c79c4361">1,363</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7a763b06539a46f2af8919fe47c2b61a_D20180701-20190630" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85MS9mcmFnOmYzYjg0MmI1OWMxNzQ4OTU4NGJhNzkzYzQ5MWUxNzMwL3RhYmxlOjE2ZTc3ZjNhYjg4YzQ1ODY5NDkyZGU4ZWQzMTllMWJhL3RhYmxlcmFuZ2U6MTZlNzdmM2FiODhjNDU4Njk0OTJkZThlZDMxOWUxYmFfMy0xMy0xLTEtMA_d447be2b-9fb4-4af9-a216-b833969671da">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i00a6d666bf604826b24e68ddbd63eac4_D20180701-20190630" decimals="-6" format="ixt:numdotdecimal" name="cah:NetEarningsIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85MS9mcmFnOmYzYjg0MmI1OWMxNzQ4OTU4NGJhNzkzYzQ5MWUxNzMwL3RhYmxlOjE2ZTc3ZjNhYjg4YzQ1ODY5NDkyZGU4ZWQzMTllMWJhL3RhYmxlcmFuZ2U6MTZlNzdmM2FiODhjNDU4Njk0OTJkZThlZDMxOWUxYmFfMy0xNS0xLTEtMA_487855be-cbd8-4ef9-9fec-d86f82932b69">1,365</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other comprehensive income, net of tax</span></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i192683d94cc4483f889528979a51af74_D20180701-20190630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85MS9mcmFnOmYzYjg0MmI1OWMxNzQ4OTU4NGJhNzkzYzQ5MWUxNzMwL3RhYmxlOjE2ZTc3ZjNhYjg4YzQ1ODY5NDkyZGU4ZWQzMTllMWJhL3RhYmxlcmFuZ2U6MTZlNzdmM2FiODhjNDU4Njk0OTJkZThlZDMxOWUxYmFfNC0xMS0xLTEtMA_2dc6b582-c7be-44f4-821a-effeb6337c40">13</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i00a6d666bf604826b24e68ddbd63eac4_D20180701-20190630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85MS9mcmFnOmYzYjg0MmI1OWMxNzQ4OTU4NGJhNzkzYzQ5MWUxNzMwL3RhYmxlOjE2ZTc3ZjNhYjg4YzQ1ODY5NDkyZGU4ZWQzMTllMWJhL3RhYmxlcmFuZ2U6MTZlNzdmM2FiODhjNDU4Njk0OTJkZThlZDMxOWUxYmFfNC0xNS0xLTEtMA_ce90e5f2-5af5-4d04-9e83-948b821e18db">13</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Employee stock plans activity, net of shares withheld for employee taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i8d9cc349c75d4429b567d5aa909a3433_D20180701-20190630" decimals="-6" format="ixt:zerodash" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85MS9mcmFnOmYzYjg0MmI1OWMxNzQ4OTU4NGJhNzkzYzQ5MWUxNzMwL3RhYmxlOjE2ZTc3ZjNhYjg4YzQ1ODY5NDkyZGU4ZWQzMTllMWJhL3RhYmxlcmFuZ2U6MTZlNzdmM2FiODhjNDU4Njk0OTJkZThlZDMxOWUxYmFfNi0xLTEtMS0w_461b8508-b2cf-48d9-8b8c-453d514902e7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8d9cc349c75d4429b567d5aa909a3433_D20180701-20190630" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85MS9mcmFnOmYzYjg0MmI1OWMxNzQ4OTU4NGJhNzkzYzQ5MWUxNzMwL3RhYmxlOjE2ZTc3ZjNhYjg4YzQ1ODY5NDkyZGU4ZWQzMTllMWJhL3RhYmxlcmFuZ2U6MTZlNzdmM2FiODhjNDU4Njk0OTJkZThlZDMxOWUxYmFfNi0zLTEtMS0w_caa7d35d-6c4a-4ab9-a98e-2f0f5cd1862b">33</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ifec5466baa034dc5b60b6acb6798f00e_D20180701-20190630" decimals="-6" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85MS9mcmFnOmYzYjg0MmI1OWMxNzQ4OTU4NGJhNzkzYzQ5MWUxNzMwL3RhYmxlOjE2ZTc3ZjNhYjg4YzQ1ODY5NDkyZGU4ZWQzMTllMWJhL3RhYmxlcmFuZ2U6MTZlNzdmM2FiODhjNDU4Njk0OTJkZThlZDMxOWUxYmFfNi03LTEtMS0w_05e64804-e0e4-441a-8f91-d332399d19bf">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifec5466baa034dc5b60b6acb6798f00e_D20180701-20190630" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85MS9mcmFnOmYzYjg0MmI1OWMxNzQ4OTU4NGJhNzkzYzQ5MWUxNzMwL3RhYmxlOjE2ZTc3ZjNhYjg4YzQ1ODY5NDkyZGU4ZWQzMTllMWJhL3RhYmxlcmFuZ2U6MTZlNzdmM2FiODhjNDU4Njk0OTJkZThlZDMxOWUxYmFfNi05LTEtMS0w_8bdcb67b-ec58-4c9a-9b08-1b2067f2ef1c">34</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i00a6d666bf604826b24e68ddbd63eac4_D20180701-20190630" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85MS9mcmFnOmYzYjg0MmI1OWMxNzQ4OTU4NGJhNzkzYzQ5MWUxNzMwL3RhYmxlOjE2ZTc3ZjNhYjg4YzQ1ODY5NDkyZGU4ZWQzMTllMWJhL3RhYmxlcmFuZ2U6MTZlNzdmM2FiODhjNDU4Njk0OTJkZThlZDMxOWUxYmFfNi0xNS0xLTEtMA_f9c96be0-814d-4d61-bf8d-09cf03ce59ca">67</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Share repurchase program activity</span></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="ifec5466baa034dc5b60b6acb6798f00e_D20180701-20190630" decimals="-6" name="us-gaap:TreasuryStockSharesAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85MS9mcmFnOmYzYjg0MmI1OWMxNzQ4OTU4NGJhNzkzYzQ5MWUxNzMwL3RhYmxlOjE2ZTc3ZjNhYjg4YzQ1ODY5NDkyZGU4ZWQzMTllMWJhL3RhYmxlcmFuZ2U6MTZlNzdmM2FiODhjNDU4Njk0OTJkZThlZDMxOWUxYmFfNy03LTEtMS0w_0bc4009d-cbbc-444b-b11b-8421bbb16c3c">11</ix:nonFraction>)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifec5466baa034dc5b60b6acb6798f00e_D20180701-20190630" decimals="-6" name="us-gaap:TreasuryStockValueAcquiredCostMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85MS9mcmFnOmYzYjg0MmI1OWMxNzQ4OTU4NGJhNzkzYzQ5MWUxNzMwL3RhYmxlOjE2ZTc3ZjNhYjg4YzQ1ODY5NDkyZGU4ZWQzMTllMWJhL3RhYmxlcmFuZ2U6MTZlNzdmM2FiODhjNDU4Njk0OTJkZThlZDMxOWUxYmFfNy05LTEtMS0w_9828b28b-f51b-4762-8c18-81ad48cdd0f9">600</ix:nonFraction>)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i00a6d666bf604826b24e68ddbd63eac4_D20180701-20190630" decimals="-6" name="us-gaap:TreasuryStockValueAcquiredCostMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85MS9mcmFnOmYzYjg0MmI1OWMxNzQ4OTU4NGJhNzkzYzQ5MWUxNzMwL3RhYmxlOjE2ZTc3ZjNhYjg4YzQ1ODY5NDkyZGU4ZWQzMTllMWJhL3RhYmxlcmFuZ2U6MTZlNzdmM2FiODhjNDU4Njk0OTJkZThlZDMxOWUxYmFfNy0xNS0xLTEtMA_fdf40dd6-f9d3-4446-90b0-48e319572032">600</ix:nonFraction>)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dividends declared</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i368e27a25f8645faa683a133e4fd114e_D20180701-20190630" decimals="-6" name="us-gaap:Dividends" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85MS9mcmFnOmYzYjg0MmI1OWMxNzQ4OTU4NGJhNzkzYzQ5MWUxNzMwL3RhYmxlOjE2ZTc3ZjNhYjg4YzQ1ODY5NDkyZGU4ZWQzMTllMWJhL3RhYmxlcmFuZ2U6MTZlNzdmM2FiODhjNDU4Njk0OTJkZThlZDMxOWUxYmFfOC01LTEtMS0w_efb4558c-da72-4f65-ba4c-5fe7a9e82324">575</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i00a6d666bf604826b24e68ddbd63eac4_D20180701-20190630" decimals="-6" name="us-gaap:Dividends" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85MS9mcmFnOmYzYjg0MmI1OWMxNzQ4OTU4NGJhNzkzYzQ5MWUxNzMwL3RhYmxlOjE2ZTc3ZjNhYjg4YzQ1ODY5NDkyZGU4ZWQzMTllMWJhL3RhYmxlcmFuZ2U6MTZlNzdmM2FiODhjNDU4Njk0OTJkZThlZDMxOWUxYmFfOC0xNS0xLTEtMA_13b33974-586c-4799-b37c-1befa086ae23">575</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8d9cc349c75d4429b567d5aa909a3433_D20180701-20190630" decimals="-6" format="ixt:zerodash" name="us-gaap:StockholdersEquityOther" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85MS9mcmFnOmYzYjg0MmI1OWMxNzQ4OTU4NGJhNzkzYzQ5MWUxNzMwL3RhYmxlOjE2ZTc3ZjNhYjg4YzQ1ODY5NDkyZGU4ZWQzMTllMWJhL3RhYmxlcmFuZ2U6MTZlNzdmM2FiODhjNDU4Njk0OTJkZThlZDMxOWUxYmFfOS0zLTEtMS0xMjYwNg_84bcf332-98c4-4ea6-bb78-8b66b98bd1dc">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i368e27a25f8645faa683a133e4fd114e_D20180701-20190630" decimals="-6" sign="-" name="us-gaap:StockholdersEquityOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85MS9mcmFnOmYzYjg0MmI1OWMxNzQ4OTU4NGJhNzkzYzQ5MWUxNzMwL3RhYmxlOjE2ZTc3ZjNhYjg4YzQ1ODY5NDkyZGU4ZWQzMTllMWJhL3RhYmxlcmFuZ2U6MTZlNzdmM2FiODhjNDU4Njk0OTJkZThlZDMxOWUxYmFfOS01LTEtMS0w_0c50fb86-cdbb-4e23-9756-ff91fa019e51">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ifec5466baa034dc5b60b6acb6798f00e_D20180701-20190630" decimals="-6" format="ixt:zerodash" name="us-gaap:StockholdersEquityOtherShares" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85MS9mcmFnOmYzYjg0MmI1OWMxNzQ4OTU4NGJhNzkzYzQ5MWUxNzMwL3RhYmxlOjE2ZTc3ZjNhYjg4YzQ1ODY5NDkyZGU4ZWQzMTllMWJhL3RhYmxlcmFuZ2U6MTZlNzdmM2FiODhjNDU4Njk0OTJkZThlZDMxOWUxYmFfOS03LTEtMS0xMjYwOA_5e451b7b-fc70-400d-8c9e-a52687d10de4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7a763b06539a46f2af8919fe47c2b61a_D20180701-20190630" decimals="-6" format="ixt:zerodash" name="us-gaap:StockholdersEquityOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85MS9mcmFnOmYzYjg0MmI1OWMxNzQ4OTU4NGJhNzkzYzQ5MWUxNzMwL3RhYmxlOjE2ZTc3ZjNhYjg4YzQ1ODY5NDkyZGU4ZWQzMTllMWJhL3RhYmxlcmFuZ2U6MTZlNzdmM2FiODhjNDU4Njk0OTJkZThlZDMxOWUxYmFfOS0xMy0xLTEtMA_65c47594-5b05-48b9-aeac-cdf44991441b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i00a6d666bf604826b24e68ddbd63eac4_D20180701-20190630" decimals="-6" sign="-" name="us-gaap:StockholdersEquityOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85MS9mcmFnOmYzYjg0MmI1OWMxNzQ4OTU4NGJhNzkzYzQ5MWUxNzMwL3RhYmxlOjE2ZTc3ZjNhYjg4YzQ1ODY5NDkyZGU4ZWQzMTllMWJhL3RhYmxlcmFuZ2U6MTZlNzdmM2FiODhjNDU4Njk0OTJkZThlZDMxOWUxYmFfOS0xNS0xLTEtMA_3cec4cf1-764d-41fc-819a-fd7424e55618">1</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance at June 30, 2019</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i2c0babdbad624aa0b4937db55d311dfe_I20190630" decimals="-6" name="us-gaap:CommonStockSharesIssued" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85MS9mcmFnOmYzYjg0MmI1OWMxNzQ4OTU4NGJhNzkzYzQ5MWUxNzMwL3RhYmxlOjE2ZTc3ZjNhYjg4YzQ1ODY5NDkyZGU4ZWQzMTllMWJhL3RhYmxlcmFuZ2U6MTZlNzdmM2FiODhjNDU4Njk0OTJkZThlZDMxOWUxYmFfMTEtMS0xLTEtMA_5df72bd4-da68-4bd5-9373-303873124716">327</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2c0babdbad624aa0b4937db55d311dfe_I20190630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85MS9mcmFnOmYzYjg0MmI1OWMxNzQ4OTU4NGJhNzkzYzQ5MWUxNzMwL3RhYmxlOjE2ZTc3ZjNhYjg4YzQ1ODY5NDkyZGU4ZWQzMTllMWJhL3RhYmxlcmFuZ2U6MTZlNzdmM2FiODhjNDU4Njk0OTJkZThlZDMxOWUxYmFfMTEtMy0xLTEtMA_44c9c01d-ced2-4378-899d-3342e43a1de7">2,763</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04bec8a518fa429988f9b9473cfeb451_I20190630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85MS9mcmFnOmYzYjg0MmI1OWMxNzQ4OTU4NGJhNzkzYzQ5MWUxNzMwL3RhYmxlOjE2ZTc3ZjNhYjg4YzQ1ODY5NDkyZGU4ZWQzMTllMWJhL3RhYmxlcmFuZ2U6MTZlNzdmM2FiODhjNDU4Njk0OTJkZThlZDMxOWUxYmFfMTEtNS0xLTEtMA_b01c84a9-b639-4539-8068-990d101f2a04">5,434</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i0acb4be80aa74c89bc743cf58fc67d77_I20190630" decimals="-6" name="us-gaap:TreasuryStockShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85MS9mcmFnOmYzYjg0MmI1OWMxNzQ4OTU4NGJhNzkzYzQ5MWUxNzMwL3RhYmxlOjE2ZTc3ZjNhYjg4YzQ1ODY5NDkyZGU4ZWQzMTllMWJhL3RhYmxlcmFuZ2U6MTZlNzdmM2FiODhjNDU4Njk0OTJkZThlZDMxOWUxYmFfMTEtNy0xLTEtMA_cc24578d-cdae-47de-a9b9-764432c0bd9c">28</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0acb4be80aa74c89bc743cf58fc67d77_I20190630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:TreasuryStockValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85MS9mcmFnOmYzYjg0MmI1OWMxNzQ4OTU4NGJhNzkzYzQ5MWUxNzMwL3RhYmxlOjE2ZTc3ZjNhYjg4YzQ1ODY5NDkyZGU4ZWQzMTllMWJhL3RhYmxlcmFuZ2U6MTZlNzdmM2FiODhjNDU4Njk0OTJkZThlZDMxOWUxYmFfMTEtOS0xLTEtMA_d27e13a9-1eca-4dc0-8b2b-2af2dcf7ed03">1,790</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i08559a107c7a4c31965cd373a397c3af_I20190630" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85MS9mcmFnOmYzYjg0MmI1OWMxNzQ4OTU4NGJhNzkzYzQ5MWUxNzMwL3RhYmxlOjE2ZTc3ZjNhYjg4YzQ1ODY5NDkyZGU4ZWQzMTllMWJhL3RhYmxlcmFuZ2U6MTZlNzdmM2FiODhjNDU4Njk0OTJkZThlZDMxOWUxYmFfMTEtMTEtMS0xLTA_ae431964-b2d2-4925-8926-bdbbc37c3eb4">79</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i401ce4a0ca0546f58fbbd8672082718a_I20190630" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85MS9mcmFnOmYzYjg0MmI1OWMxNzQ4OTU4NGJhNzkzYzQ5MWUxNzMwL3RhYmxlOjE2ZTc3ZjNhYjg4YzQ1ODY5NDkyZGU4ZWQzMTllMWJhL3RhYmxlcmFuZ2U6MTZlNzdmM2FiODhjNDU4Njk0OTJkZThlZDMxOWUxYmFfMTEtMTMtMS0xLTA_5ef7a439-cd30-4885-8499-e44c31b526e9">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if6dc09eec4e74751b47cdf037a5b1860_I20190630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85MS9mcmFnOmYzYjg0MmI1OWMxNzQ4OTU4NGJhNzkzYzQ5MWUxNzMwL3RhYmxlOjE2ZTc3ZjNhYjg4YzQ1ODY5NDkyZGU4ZWQzMTllMWJhL3RhYmxlcmFuZ2U6MTZlNzdmM2FiODhjNDU4Njk0OTJkZThlZDMxOWUxYmFfMTEtMTUtMS0xLTA_bb5999db-8ed3-484a-a006-193c731176ca">6,330</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net earnings/(loss)</span></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia31e9a409b874bb19d0ff6f2f39ecc09_D20190701-20200630" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85MS9mcmFnOmYzYjg0MmI1OWMxNzQ4OTU4NGJhNzkzYzQ5MWUxNzMwL3RhYmxlOjE2ZTc3ZjNhYjg4YzQ1ODY5NDkyZGU4ZWQzMTllMWJhL3RhYmxlcmFuZ2U6MTZlNzdmM2FiODhjNDU4Njk0OTJkZThlZDMxOWUxYmFfMTItNS0xLTEtMA_dd3267f4-7714-46c1-80c2-b97144b82301">3,696</ix:nonFraction>)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibeaaa4c81e084b86a689f640458f607a_D20190701-20200630" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85MS9mcmFnOmYzYjg0MmI1OWMxNzQ4OTU4NGJhNzkzYzQ5MWUxNzMwL3RhYmxlOjE2ZTc3ZjNhYjg4YzQ1ODY5NDkyZGU4ZWQzMTllMWJhL3RhYmxlcmFuZ2U6MTZlNzdmM2FiODhjNDU4Njk0OTJkZThlZDMxOWUxYmFfMTItMTMtMS0xLTA_2c6e84c5-c271-43f4-b4c6-2d674b7002d2">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia31e9a409b874bb19d0ff6f2f39ecc09_D20190701-20200630" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85MS9mcmFnOmYzYjg0MmI1OWMxNzQ4OTU4NGJhNzkzYzQ5MWUxNzMwL3RhYmxlOjE2ZTc3ZjNhYjg4YzQ1ODY5NDkyZGU4ZWQzMTllMWJhL3RhYmxlcmFuZ2U6MTZlNzdmM2FiODhjNDU4Njk0OTJkZThlZDMxOWUxYmFfMTItMTUtMS0xLTA_858a1a46-be8b-4dfc-9bee-99d679058637">3,693</ix:nonFraction>)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other comprehensive loss, net of tax</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6b350fae2224486aa2a6ffc44c36559b_D20190701-20200630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85MS9mcmFnOmYzYjg0MmI1OWMxNzQ4OTU4NGJhNzkzYzQ5MWUxNzMwL3RhYmxlOjE2ZTc3ZjNhYjg4YzQ1ODY5NDkyZGU4ZWQzMTllMWJhL3RhYmxlcmFuZ2U6MTZlNzdmM2FiODhjNDU4Njk0OTJkZThlZDMxOWUxYmFfMTMtMTEtMS0xLTA_edf1bf80-5977-46e8-acfc-4f2a14caad56">25</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia31e9a409b874bb19d0ff6f2f39ecc09_D20190701-20200630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85MS9mcmFnOmYzYjg0MmI1OWMxNzQ4OTU4NGJhNzkzYzQ5MWUxNzMwL3RhYmxlOjE2ZTc3ZjNhYjg4YzQ1ODY5NDkyZGU4ZWQzMTllMWJhL3RhYmxlcmFuZ2U6MTZlNzdmM2FiODhjNDU4Njk0OTJkZThlZDMxOWUxYmFfMTMtMTUtMS0xLTA_da56eb6f-d90d-4fb0-aa5b-b826d0550597">25</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Employee stock plans activity, net of shares withheld for employee taxes</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i4c5f25e0cc4f4d04a3afc3f86804554c_D20190701-20200630" decimals="-6" format="ixt:zerodash" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85MS9mcmFnOmYzYjg0MmI1OWMxNzQ4OTU4NGJhNzkzYzQ5MWUxNzMwL3RhYmxlOjE2ZTc3ZjNhYjg4YzQ1ODY5NDkyZGU4ZWQzMTllMWJhL3RhYmxlcmFuZ2U6MTZlNzdmM2FiODhjNDU4Njk0OTJkZThlZDMxOWUxYmFfMTUtMS0xLTEtMA_a382272a-4d23-4b30-9324-0d5274f8c984">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c5f25e0cc4f4d04a3afc3f86804554c_D20190701-20200630" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85MS9mcmFnOmYzYjg0MmI1OWMxNzQ4OTU4NGJhNzkzYzQ5MWUxNzMwL3RhYmxlOjE2ZTc3ZjNhYjg4YzQ1ODY5NDkyZGU4ZWQzMTllMWJhL3RhYmxlcmFuZ2U6MTZlNzdmM2FiODhjNDU4Njk0OTJkZThlZDMxOWUxYmFfMTUtMy0xLTEtMA_966dd227-8348-4db3-9dce-604a46cb5817">26</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i0361658ee5604068a75c34f27c83ef6b_D20190701-20200630" decimals="-6" format="ixt:zerodash" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85MS9mcmFnOmYzYjg0MmI1OWMxNzQ4OTU4NGJhNzkzYzQ5MWUxNzMwL3RhYmxlOjE2ZTc3ZjNhYjg4YzQ1ODY5NDkyZGU4ZWQzMTllMWJhL3RhYmxlcmFuZ2U6MTZlNzdmM2FiODhjNDU4Njk0OTJkZThlZDMxOWUxYmFfMTUtNy0xLTEtMA_160af5b4-ee66-4ccb-b670-8062fce7c99e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0361658ee5604068a75c34f27c83ef6b_D20190701-20200630" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85MS9mcmFnOmYzYjg0MmI1OWMxNzQ4OTU4NGJhNzkzYzQ5MWUxNzMwL3RhYmxlOjE2ZTc3ZjNhYjg4YzQ1ODY5NDkyZGU4ZWQzMTllMWJhL3RhYmxlcmFuZ2U6MTZlNzdmM2FiODhjNDU4Njk0OTJkZThlZDMxOWUxYmFfMTUtOS0xLTEtMA_c8e5bff4-1cc1-453e-bc94-2990c7a4ec0a">74</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia31e9a409b874bb19d0ff6f2f39ecc09_D20190701-20200630" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85MS9mcmFnOmYzYjg0MmI1OWMxNzQ4OTU4NGJhNzkzYzQ5MWUxNzMwL3RhYmxlOjE2ZTc3ZjNhYjg4YzQ1ODY5NDkyZGU4ZWQzMTllMWJhL3RhYmxlcmFuZ2U6MTZlNzdmM2FiODhjNDU4Njk0OTJkZThlZDMxOWUxYmFfMTUtMTUtMS0xLTA_8e6fd656-a9d8-431c-8150-59fe7150c3e4">100</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Share repurchase program activity</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i0361658ee5604068a75c34f27c83ef6b_D20190701-20200630" decimals="-6" name="us-gaap:TreasuryStockSharesAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85MS9mcmFnOmYzYjg0MmI1OWMxNzQ4OTU4NGJhNzkzYzQ5MWUxNzMwL3RhYmxlOjE2ZTc3ZjNhYjg4YzQ1ODY5NDkyZGU4ZWQzMTllMWJhL3RhYmxlcmFuZ2U6MTZlNzdmM2FiODhjNDU4Njk0OTJkZThlZDMxOWUxYmFfMTYtNy0xLTEtMA_8dca8de4-47dc-4a4d-81d5-e2b2d5d6de35">7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0361658ee5604068a75c34f27c83ef6b_D20190701-20200630" decimals="-6" name="us-gaap:TreasuryStockValueAcquiredCostMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85MS9mcmFnOmYzYjg0MmI1OWMxNzQ4OTU4NGJhNzkzYzQ5MWUxNzMwL3RhYmxlOjE2ZTc3ZjNhYjg4YzQ1ODY5NDkyZGU4ZWQzMTllMWJhL3RhYmxlcmFuZ2U6MTZlNzdmM2FiODhjNDU4Njk0OTJkZThlZDMxOWUxYmFfMTYtOS0xLTEtMA_4c277ff8-e558-4431-a9ee-7ac3fbbbb819">350</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia31e9a409b874bb19d0ff6f2f39ecc09_D20190701-20200630" decimals="-6" name="us-gaap:TreasuryStockValueAcquiredCostMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85MS9mcmFnOmYzYjg0MmI1OWMxNzQ4OTU4NGJhNzkzYzQ5MWUxNzMwL3RhYmxlOjE2ZTc3ZjNhYjg4YzQ1ODY5NDkyZGU4ZWQzMTllMWJhL3RhYmxlcmFuZ2U6MTZlNzdmM2FiODhjNDU4Njk0OTJkZThlZDMxOWUxYmFfMTYtMTUtMS0xLTA_474cc08d-d12b-45ad-9958-432293be862a">350</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dividends declared</span></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i61b655b20bf94b27a3ebf574f93a9915_D20190701-20200630" decimals="-6" name="us-gaap:Dividends" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85MS9mcmFnOmYzYjg0MmI1OWMxNzQ4OTU4NGJhNzkzYzQ5MWUxNzMwL3RhYmxlOjE2ZTc3ZjNhYjg4YzQ1ODY5NDkyZGU4ZWQzMTllMWJhL3RhYmxlcmFuZ2U6MTZlNzdmM2FiODhjNDU4Njk0OTJkZThlZDMxOWUxYmFfMTctNS0xLTEtMA_49a14b7a-998f-4d44-8a9d-217f11d7ec0c">570</ix:nonFraction>)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia31e9a409b874bb19d0ff6f2f39ecc09_D20190701-20200630" decimals="-6" name="us-gaap:Dividends" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85MS9mcmFnOmYzYjg0MmI1OWMxNzQ4OTU4NGJhNzkzYzQ5MWUxNzMwL3RhYmxlOjE2ZTc3ZjNhYjg4YzQ1ODY5NDkyZGU4ZWQzMTllMWJhL3RhYmxlcmFuZ2U6MTZlNzdmM2FiODhjNDU4Njk0OTJkZThlZDMxOWUxYmFfMTctMTUtMS0xLTA_b607939d-2f23-44b8-8d7b-46ec97c739b8">570</ix:nonFraction>)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c5f25e0cc4f4d04a3afc3f86804554c_D20190701-20200630" decimals="-6" format="ixt:zerodash" name="us-gaap:StockholdersEquityOther" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85MS9mcmFnOmYzYjg0MmI1OWMxNzQ4OTU4NGJhNzkzYzQ5MWUxNzMwL3RhYmxlOjE2ZTc3ZjNhYjg4YzQ1ODY5NDkyZGU4ZWQzMTllMWJhL3RhYmxlcmFuZ2U6MTZlNzdmM2FiODhjNDU4Njk0OTJkZThlZDMxOWUxYmFfMTgtMy0xLTEtMTI2MTE_1a8443a7-5797-4149-bc16-260bd0290b5e">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61b655b20bf94b27a3ebf574f93a9915_D20190701-20200630" decimals="-6" sign="-" name="us-gaap:StockholdersEquityOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85MS9mcmFnOmYzYjg0MmI1OWMxNzQ4OTU4NGJhNzkzYzQ5MWUxNzMwL3RhYmxlOjE2ZTc3ZjNhYjg4YzQ1ODY5NDkyZGU4ZWQzMTllMWJhL3RhYmxlcmFuZ2U6MTZlNzdmM2FiODhjNDU4Njk0OTJkZThlZDMxOWUxYmFfMTgtNS0xLTEtMA_cf115b96-8971-48b7-b1b2-c53143c9c178">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i0361658ee5604068a75c34f27c83ef6b_D20190701-20200630" decimals="-6" format="ixt:zerodash" name="us-gaap:StockholdersEquityOtherShares" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85MS9mcmFnOmYzYjg0MmI1OWMxNzQ4OTU4NGJhNzkzYzQ5MWUxNzMwL3RhYmxlOjE2ZTc3ZjNhYjg4YzQ1ODY5NDkyZGU4ZWQzMTllMWJhL3RhYmxlcmFuZ2U6MTZlNzdmM2FiODhjNDU4Njk0OTJkZThlZDMxOWUxYmFfMTgtNy0xLTEtMTI2MTY_2d6c914c-5d50-4e8b-a494-5a8fe6d1c2f9">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibeaaa4c81e084b86a689f640458f607a_D20190701-20200630" decimals="-6" sign="-" name="us-gaap:StockholdersEquityOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85MS9mcmFnOmYzYjg0MmI1OWMxNzQ4OTU4NGJhNzkzYzQ5MWUxNzMwL3RhYmxlOjE2ZTc3ZjNhYjg4YzQ1ODY5NDkyZGU4ZWQzMTllMWJhL3RhYmxlcmFuZ2U6MTZlNzdmM2FiODhjNDU4Njk0OTJkZThlZDMxOWUxYmFfMTgtMTMtMS0xLTYzNQ_d30b094d-d4dc-40eb-80a3-ffd06fe93f3d">2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia31e9a409b874bb19d0ff6f2f39ecc09_D20190701-20200630" decimals="-6" format="ixt:zerodash" name="us-gaap:StockholdersEquityOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85MS9mcmFnOmYzYjg0MmI1OWMxNzQ4OTU4NGJhNzkzYzQ5MWUxNzMwL3RhYmxlOjE2ZTc3ZjNhYjg4YzQ1ODY5NDkyZGU4ZWQzMTllMWJhL3RhYmxlcmFuZ2U6MTZlNzdmM2FiODhjNDU4Njk0OTJkZThlZDMxOWUxYmFfMTgtMTUtMS0xLTA_0ba139b2-add2-4409-9446-f66aa14c13a2">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance at June 30, 2020</span></td><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i3eeed4226e40446da06738c489d87462_I20200630" decimals="-6" name="us-gaap:CommonStockSharesIssued" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85MS9mcmFnOmYzYjg0MmI1OWMxNzQ4OTU4NGJhNzkzYzQ5MWUxNzMwL3RhYmxlOjE2ZTc3ZjNhYjg4YzQ1ODY5NDkyZGU4ZWQzMTllMWJhL3RhYmxlcmFuZ2U6MTZlNzdmM2FiODhjNDU4Njk0OTJkZThlZDMxOWUxYmFfMjAtMS0xLTEtMA_077c5804-c5ad-49c5-9126-89cb281e0336">327</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3eeed4226e40446da06738c489d87462_I20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85MS9mcmFnOmYzYjg0MmI1OWMxNzQ4OTU4NGJhNzkzYzQ5MWUxNzMwL3RhYmxlOjE2ZTc3ZjNhYjg4YzQ1ODY5NDkyZGU4ZWQzMTllMWJhL3RhYmxlcmFuZ2U6MTZlNzdmM2FiODhjNDU4Njk0OTJkZThlZDMxOWUxYmFfMjAtMy0xLTEtMA_a29e3c82-b080-469c-994f-163b0bf2b796">2,789</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i177d5a23d5d64051ad7ef088e9f5ebd4_I20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85MS9mcmFnOmYzYjg0MmI1OWMxNzQ4OTU4NGJhNzkzYzQ5MWUxNzMwL3RhYmxlOjE2ZTc3ZjNhYjg4YzQ1ODY5NDkyZGU4ZWQzMTllMWJhL3RhYmxlcmFuZ2U6MTZlNzdmM2FiODhjNDU4Njk0OTJkZThlZDMxOWUxYmFfMjAtNS0xLTEtMA_cc21447d-19dc-492a-97a4-fa569381d415">1,170</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="idf14ef20aa2d4674855f6bc891acf9de_I20200630" decimals="-6" name="us-gaap:TreasuryStockShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85MS9mcmFnOmYzYjg0MmI1OWMxNzQ4OTU4NGJhNzkzYzQ5MWUxNzMwL3RhYmxlOjE2ZTc3ZjNhYjg4YzQ1ODY5NDkyZGU4ZWQzMTllMWJhL3RhYmxlcmFuZ2U6MTZlNzdmM2FiODhjNDU4Njk0OTJkZThlZDMxOWUxYmFfMjAtNy0xLTEtMA_da4f5811-5890-4e2c-ad5b-9b0468e92e20">35</ix:nonFraction>)</span></td><td style="background-color:#cccccc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idf14ef20aa2d4674855f6bc891acf9de_I20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:TreasuryStockValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85MS9mcmFnOmYzYjg0MmI1OWMxNzQ4OTU4NGJhNzkzYzQ5MWUxNzMwL3RhYmxlOjE2ZTc3ZjNhYjg4YzQ1ODY5NDkyZGU4ZWQzMTllMWJhL3RhYmxlcmFuZ2U6MTZlNzdmM2FiODhjNDU4Njk0OTJkZThlZDMxOWUxYmFfMjAtOS0xLTEtMA_2db55e15-3358-4d17-a449-a5a9d803a742">2,066</ix:nonFraction>)</span></td><td style="background-color:#cccccc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iab6212d6a7c945a59137402110f15a40_I20200630" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85MS9mcmFnOmYzYjg0MmI1OWMxNzQ4OTU4NGJhNzkzYzQ5MWUxNzMwL3RhYmxlOjE2ZTc3ZjNhYjg4YzQ1ODY5NDkyZGU4ZWQzMTllMWJhL3RhYmxlcmFuZ2U6MTZlNzdmM2FiODhjNDU4Njk0OTJkZThlZDMxOWUxYmFfMjAtMTEtMS0xLTA_566152c3-7da1-4429-9256-27a7990aedc0">104</ix:nonFraction>)</span></td><td style="background-color:#cccccc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f4057fc39254faf97951f0ee6826f17_I20200630" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85MS9mcmFnOmYzYjg0MmI1OWMxNzQ4OTU4NGJhNzkzYzQ5MWUxNzMwL3RhYmxlOjE2ZTc3ZjNhYjg4YzQ1ODY5NDkyZGU4ZWQzMTllMWJhL3RhYmxlcmFuZ2U6MTZlNzdmM2FiODhjNDU4Njk0OTJkZThlZDMxOWUxYmFfMjAtMTMtMS0xLTA_8df1bf62-1ac5-47b2-b7c9-646a99441266">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i299cea70f47b4fbe96772aaa8cc00b79_I20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85MS9mcmFnOmYzYjg0MmI1OWMxNzQ4OTU4NGJhNzkzYzQ5MWUxNzMwL3RhYmxlOjE2ZTc3ZjNhYjg4YzQ1ODY5NDkyZGU4ZWQzMTllMWJhL3RhYmxlcmFuZ2U6MTZlNzdmM2FiODhjNDU4Njk0OTJkZThlZDMxOWUxYmFfMjAtMTUtMS0xLTA_16c74c5c-2fb7-43de-b69f-918600d3c38e">1,792</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net earnings/(loss)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630" decimals="-6" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85MS9mcmFnOmYzYjg0MmI1OWMxNzQ4OTU4NGJhNzkzYzQ5MWUxNzMwL3RhYmxlOjE2ZTc3ZjNhYjg4YzQ1ODY5NDkyZGU4ZWQzMTllMWJhL3RhYmxlcmFuZ2U6MTZlNzdmM2FiODhjNDU4Njk0OTJkZThlZDMxOWUxYmFfMjEtNS0xLTEtMA_81c6e5e0-508d-4942-b3b7-d9e47a567521">611</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i400d2c56806648c1b6c3bdbab87c1d9d_D20200701-20210630" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85MS9mcmFnOmYzYjg0MmI1OWMxNzQ4OTU4NGJhNzkzYzQ5MWUxNzMwL3RhYmxlOjE2ZTc3ZjNhYjg4YzQ1ODY5NDkyZGU4ZWQzMTllMWJhL3RhYmxlcmFuZ2U6MTZlNzdmM2FiODhjNDU4Njk0OTJkZThlZDMxOWUxYmFfMjEtMTMtMS0xLTA_0629ab16-a309-46b0-b16e-fbb25aaa3c9d">1</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85MS9mcmFnOmYzYjg0MmI1OWMxNzQ4OTU4NGJhNzkzYzQ5MWUxNzMwL3RhYmxlOjE2ZTc3ZjNhYjg4YzQ1ODY5NDkyZGU4ZWQzMTllMWJhL3RhYmxlcmFuZ2U6MTZlNzdmM2FiODhjNDU4Njk0OTJkZThlZDMxOWUxYmFfMjEtMTUtMS0xLTA_934b16eb-2d24-4f5a-bd9b-715e04b612d3">612</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other comprehensive income, net of tax</span></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idaac2fb8e90844538a6c23b3c7452e2b_D20200701-20210630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85MS9mcmFnOmYzYjg0MmI1OWMxNzQ4OTU4NGJhNzkzYzQ5MWUxNzMwL3RhYmxlOjE2ZTc3ZjNhYjg4YzQ1ODY5NDkyZGU4ZWQzMTllMWJhL3RhYmxlcmFuZ2U6MTZlNzdmM2FiODhjNDU4Njk0OTJkZThlZDMxOWUxYmFfMjItMTEtMS0xLTA_22766971-72f6-48de-aa49-df54a10e7369">70</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85MS9mcmFnOmYzYjg0MmI1OWMxNzQ4OTU4NGJhNzkzYzQ5MWUxNzMwL3RhYmxlOjE2ZTc3ZjNhYjg4YzQ1ODY5NDkyZGU4ZWQzMTllMWJhL3RhYmxlcmFuZ2U6MTZlNzdmM2FiODhjNDU4Njk0OTJkZThlZDMxOWUxYmFfMjItMTUtMS0xLTA_6ba54859-c26f-4992-92cf-4bf90941161c">70</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Employee stock plans activity, net of shares withheld for employee taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i97b5509a63f04bc7ab5194aaf760af37_D20200701-20210630" decimals="-6" format="ixt:zerodash" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85MS9mcmFnOmYzYjg0MmI1OWMxNzQ4OTU4NGJhNzkzYzQ5MWUxNzMwL3RhYmxlOjE2ZTc3ZjNhYjg4YzQ1ODY5NDkyZGU4ZWQzMTllMWJhL3RhYmxlcmFuZ2U6MTZlNzdmM2FiODhjNDU4Njk0OTJkZThlZDMxOWUxYmFfMjQtMS0xLTEtMA_3bca5951-6536-4c3d-a799-400f9887e1e9">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97b5509a63f04bc7ab5194aaf760af37_D20200701-20210630" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85MS9mcmFnOmYzYjg0MmI1OWMxNzQ4OTU4NGJhNzkzYzQ5MWUxNzMwL3RhYmxlOjE2ZTc3ZjNhYjg4YzQ1ODY5NDkyZGU4ZWQzMTllMWJhL3RhYmxlcmFuZ2U6MTZlNzdmM2FiODhjNDU4Njk0OTJkZThlZDMxOWUxYmFfMjQtMy0xLTEtMA_fb7900bc-b403-4e14-99d6-576a7fcb425b">17</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i93e121bdfcb240d3a40552629748af1b_D20200701-20210630" decimals="-6" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85MS9mcmFnOmYzYjg0MmI1OWMxNzQ4OTU4NGJhNzkzYzQ5MWUxNzMwL3RhYmxlOjE2ZTc3ZjNhYjg4YzQ1ODY5NDkyZGU4ZWQzMTllMWJhL3RhYmxlcmFuZ2U6MTZlNzdmM2FiODhjNDU4Njk0OTJkZThlZDMxOWUxYmFfMjQtNy0xLTEtMA_00a24100-38e5-41c9-b9ce-1c8b9a0ac6a9">3</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i93e121bdfcb240d3a40552629748af1b_D20200701-20210630" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85MS9mcmFnOmYzYjg0MmI1OWMxNzQ4OTU4NGJhNzkzYzQ5MWUxNzMwL3RhYmxlOjE2ZTc3ZjNhYjg4YzQ1ODY5NDkyZGU4ZWQzMTllMWJhL3RhYmxlcmFuZ2U6MTZlNzdmM2FiODhjNDU4Njk0OTJkZThlZDMxOWUxYmFfMjQtOS0xLTEtMA_e54193fb-a4f8-4423-bee2-4afc1726c2c6">80</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85MS9mcmFnOmYzYjg0MmI1OWMxNzQ4OTU4NGJhNzkzYzQ5MWUxNzMwL3RhYmxlOjE2ZTc3ZjNhYjg4YzQ1ODY5NDkyZGU4ZWQzMTllMWJhL3RhYmxlcmFuZ2U6MTZlNzdmM2FiODhjNDU4Njk0OTJkZThlZDMxOWUxYmFfMjQtMTUtMS0xLTA_0f8cc29c-bc40-4c8f-96fc-70f2cb819363">97</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Share repurchase program activity</span></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i93e121bdfcb240d3a40552629748af1b_D20200701-20210630" decimals="-6" name="us-gaap:TreasuryStockSharesAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85MS9mcmFnOmYzYjg0MmI1OWMxNzQ4OTU4NGJhNzkzYzQ5MWUxNzMwL3RhYmxlOjE2ZTc3ZjNhYjg4YzQ1ODY5NDkyZGU4ZWQzMTllMWJhL3RhYmxlcmFuZ2U6MTZlNzdmM2FiODhjNDU4Njk0OTJkZThlZDMxOWUxYmFfMjUtNy0xLTEtMA_9b49c117-649f-48b0-9570-28f0f54ffbe1">4</ix:nonFraction>)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i93e121bdfcb240d3a40552629748af1b_D20200701-20210630" decimals="-6" name="us-gaap:TreasuryStockValueAcquiredCostMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85MS9mcmFnOmYzYjg0MmI1OWMxNzQ4OTU4NGJhNzkzYzQ5MWUxNzMwL3RhYmxlOjE2ZTc3ZjNhYjg4YzQ1ODY5NDkyZGU4ZWQzMTllMWJhL3RhYmxlcmFuZ2U6MTZlNzdmM2FiODhjNDU4Njk0OTJkZThlZDMxOWUxYmFfMjUtOS0xLTEtMA_eca1a3cc-ab4b-41e2-a26e-5197a91d59ef">200</ix:nonFraction>)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630" decimals="-6" name="us-gaap:TreasuryStockValueAcquiredCostMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85MS9mcmFnOmYzYjg0MmI1OWMxNzQ4OTU4NGJhNzkzYzQ5MWUxNzMwL3RhYmxlOjE2ZTc3ZjNhYjg4YzQ1ODY5NDkyZGU4ZWQzMTllMWJhL3RhYmxlcmFuZ2U6MTZlNzdmM2FiODhjNDU4Njk0OTJkZThlZDMxOWUxYmFfMjUtMTUtMS0xLTA_c328f80c-7ae1-4afe-a7d2-1030dcfb9f79">200</ix:nonFraction>)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dividends declared</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2c9548aef74d4f1a8451e70e1ab67a37_D20200701-20210630" decimals="-6" name="us-gaap:Dividends" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85MS9mcmFnOmYzYjg0MmI1OWMxNzQ4OTU4NGJhNzkzYzQ5MWUxNzMwL3RhYmxlOjE2ZTc3ZjNhYjg4YzQ1ODY5NDkyZGU4ZWQzMTllMWJhL3RhYmxlcmFuZ2U6MTZlNzdmM2FiODhjNDU4Njk0OTJkZThlZDMxOWUxYmFfMjYtNS0xLTEtMA_68d079fe-95bc-42b3-b0c6-abd28c77440d">576</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630" decimals="-6" name="us-gaap:Dividends" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85MS9mcmFnOmYzYjg0MmI1OWMxNzQ4OTU4NGJhNzkzYzQ5MWUxNzMwL3RhYmxlOjE2ZTc3ZjNhYjg4YzQ1ODY5NDkyZGU4ZWQzMTllMWJhL3RhYmxlcmFuZ2U6MTZlNzdmM2FiODhjNDU4Njk0OTJkZThlZDMxOWUxYmFfMjYtMTUtMS0xLTA_0d05da4f-286e-48f2-9054-0f93869756d1">576</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="i97b5509a63f04bc7ab5194aaf760af37_D20200701-20210630" xsi:nil="true" name="us-gaap:StockholdersEquityOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85MS9mcmFnOmYzYjg0MmI1OWMxNzQ4OTU4NGJhNzkzYzQ5MWUxNzMwL3RhYmxlOjE2ZTc3ZjNhYjg4YzQ1ODY5NDkyZGU4ZWQzMTllMWJhL3RhYmxlcmFuZ2U6MTZlNzdmM2FiODhjNDU4Njk0OTJkZThlZDMxOWUxYmFfMjctMy0xLTEtODQzOA_5fa3e5b4-8821-4631-acc2-0305d37867cc"></ix:nonFraction></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="i2c9548aef74d4f1a8451e70e1ab67a37_D20200701-20210630" xsi:nil="true" name="us-gaap:StockholdersEquityOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85MS9mcmFnOmYzYjg0MmI1OWMxNzQ4OTU4NGJhNzkzYzQ5MWUxNzMwL3RhYmxlOjE2ZTc3ZjNhYjg4YzQ1ODY5NDkyZGU4ZWQzMTllMWJhL3RhYmxlcmFuZ2U6MTZlNzdmM2FiODhjNDU4Njk0OTJkZThlZDMxOWUxYmFfMjctNS0xLTEtMA_6b01fbc6-5c8c-4719-95af-30641571bd17"></ix:nonFraction></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"><ix:nonFraction unitRef="shares" contextRef="i93e121bdfcb240d3a40552629748af1b_D20200701-20210630" xsi:nil="true" name="us-gaap:StockholdersEquityOtherShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85MS9mcmFnOmYzYjg0MmI1OWMxNzQ4OTU4NGJhNzkzYzQ5MWUxNzMwL3RhYmxlOjE2ZTc3ZjNhYjg4YzQ1ODY5NDkyZGU4ZWQzMTllMWJhL3RhYmxlcmFuZ2U6MTZlNzdmM2FiODhjNDU4Njk0OTJkZThlZDMxOWUxYmFfMjctNy0xLTEtODQzNA_08d723d0-5ed6-48e1-8b4e-6c1fbeca2b6e"></ix:nonFraction></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i400d2c56806648c1b6c3bdbab87c1d9d_D20200701-20210630" decimals="-6" sign="-" name="us-gaap:StockholdersEquityOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85MS9mcmFnOmYzYjg0MmI1OWMxNzQ4OTU4NGJhNzkzYzQ5MWUxNzMwL3RhYmxlOjE2ZTc3ZjNhYjg4YzQ1ODY5NDkyZGU4ZWQzMTllMWJhL3RhYmxlcmFuZ2U6MTZlNzdmM2FiODhjNDU4Njk0OTJkZThlZDMxOWUxYmFfMjctMTMtMS0xLTA_c7343592-32ce-4301-83ab-d28b9f455fac">1</ix:nonFraction>)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630" decimals="-6" sign="-" name="us-gaap:StockholdersEquityOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85MS9mcmFnOmYzYjg0MmI1OWMxNzQ4OTU4NGJhNzkzYzQ5MWUxNzMwL3RhYmxlOjE2ZTc3ZjNhYjg4YzQ1ODY5NDkyZGU4ZWQzMTllMWJhL3RhYmxlcmFuZ2U6MTZlNzdmM2FiODhjNDU4Njk0OTJkZThlZDMxOWUxYmFfMjctMTUtMS0xLTA_f3f03204-edde-4367-b66f-b0cd73d27537">1</ix:nonFraction>)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance at June 30, 2021</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i2356cc59616246e39e97302436e6c7df_I20210630" decimals="-6" name="us-gaap:CommonStockSharesIssued" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85MS9mcmFnOmYzYjg0MmI1OWMxNzQ4OTU4NGJhNzkzYzQ5MWUxNzMwL3RhYmxlOjE2ZTc3ZjNhYjg4YzQ1ODY5NDkyZGU4ZWQzMTllMWJhL3RhYmxlcmFuZ2U6MTZlNzdmM2FiODhjNDU4Njk0OTJkZThlZDMxOWUxYmFfMjktMS0xLTEtMA_74a51308-9e32-4037-8bed-8e669fd1ba30">327</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2356cc59616246e39e97302436e6c7df_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85MS9mcmFnOmYzYjg0MmI1OWMxNzQ4OTU4NGJhNzkzYzQ5MWUxNzMwL3RhYmxlOjE2ZTc3ZjNhYjg4YzQ1ODY5NDkyZGU4ZWQzMTllMWJhL3RhYmxlcmFuZ2U6MTZlNzdmM2FiODhjNDU4Njk0OTJkZThlZDMxOWUxYmFfMjktMy0xLTEtMA_4a78e7d1-f9e0-4800-a985-776cc7667085">2,806</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c7b0f49c7c44e0398779672048b5d26_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85MS9mcmFnOmYzYjg0MmI1OWMxNzQ4OTU4NGJhNzkzYzQ5MWUxNzMwL3RhYmxlOjE2ZTc3ZjNhYjg4YzQ1ODY5NDkyZGU4ZWQzMTllMWJhL3RhYmxlcmFuZ2U6MTZlNzdmM2FiODhjNDU4Njk0OTJkZThlZDMxOWUxYmFfMjktNS0xLTEtMA_1a249a1e-1848-42e7-9bc2-06254e2b3bc5">1,205</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i4295fef126f64025b7be038ce6dfbe12_I20210630" decimals="-6" name="us-gaap:TreasuryStockShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85MS9mcmFnOmYzYjg0MmI1OWMxNzQ4OTU4NGJhNzkzYzQ5MWUxNzMwL3RhYmxlOjE2ZTc3ZjNhYjg4YzQ1ODY5NDkyZGU4ZWQzMTllMWJhL3RhYmxlcmFuZ2U6MTZlNzdmM2FiODhjNDU4Njk0OTJkZThlZDMxOWUxYmFfMjktNy0xLTEtMA_ccfbebc6-f569-4f99-a325-4162474b6a11">36</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4295fef126f64025b7be038ce6dfbe12_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:TreasuryStockValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85MS9mcmFnOmYzYjg0MmI1OWMxNzQ4OTU4NGJhNzkzYzQ5MWUxNzMwL3RhYmxlOjE2ZTc3ZjNhYjg4YzQ1ODY5NDkyZGU4ZWQzMTllMWJhL3RhYmxlcmFuZ2U6MTZlNzdmM2FiODhjNDU4Njk0OTJkZThlZDMxOWUxYmFfMjktOS0xLTEtMA_eaa58d73-91d1-4e0d-b588-eb41abae7d07">2,186</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idec34558c686494fbf6ff02881153059_I20210630" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85MS9mcmFnOmYzYjg0MmI1OWMxNzQ4OTU4NGJhNzkzYzQ5MWUxNzMwL3RhYmxlOjE2ZTc3ZjNhYjg4YzQ1ODY5NDkyZGU4ZWQzMTllMWJhL3RhYmxlcmFuZ2U6MTZlNzdmM2FiODhjNDU4Njk0OTJkZThlZDMxOWUxYmFfMjktMTEtMS0xLTA_86c19dbe-0199-4a88-b542-b9fab80547ad">34</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1335220d8ce44acc9542c3208bad8a10_I20210630" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85MS9mcmFnOmYzYjg0MmI1OWMxNzQ4OTU4NGJhNzkzYzQ5MWUxNzMwL3RhYmxlOjE2ZTc3ZjNhYjg4YzQ1ODY5NDkyZGU4ZWQzMTllMWJhL3RhYmxlcmFuZ2U6MTZlNzdmM2FiODhjNDU4Njk0OTJkZThlZDMxOWUxYmFfMjktMTMtMS0xLTA_5aa1edc9-62b1-47d2-aabb-fc0a1d08d3d6">3</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2e87824102b34590a0208cc7da91b5f5_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85MS9mcmFnOmYzYjg0MmI1OWMxNzQ4OTU4NGJhNzkzYzQ5MWUxNzMwL3RhYmxlOjE2ZTc3ZjNhYjg4YzQ1ODY5NDkyZGU4ZWQzMTllMWJhL3RhYmxlcmFuZ2U6MTZlNzdmM2FiODhjNDU4Njk0OTJkZThlZDMxOWUxYmFfMjktMTUtMS0xLTA_11a389ea-c264-4f5e-9184-4bddb6cfb260">1,794</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these consolidated statements.</span></div><div style="margin-bottom:3pt;text-align:center"><span><br/></span></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:48.214%"><div style="margin-bottom:3pt;text-align:justify"><span><br/></span></div></div><div style="display:inline-block;max-width:3.571%;min-width:2.571%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:48.215%"></div></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:3pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.222%"><tr><td style="width:1.0%"></td><td style="width:32.133%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.433%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.134%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">60</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardinal Health </span><span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">| </span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2021 Form 10-K</span></div></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div></div></div><div id="i4f0ec56b9c604f1782a65ea4a19c284d_94"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:3pt;text-align:center"><span><br/></span></div><div style="margin-bottom:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:24.682%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:50.911%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.107%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#e41f35;border-bottom:1pt solid #e41f35;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Financial Statements</span></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:0 1pt"></td></tr></table></div></div><div style="margin-bottom:3pt"><span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:20pt;font-weight:700;line-height:120%">Consolidated Statements of Cash Flows</span></div><div style="margin-bottom:3pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:67.501%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.870%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.544%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.870%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.544%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.871%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cash flows from operating activities:</span></td><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net earnings/(loss)</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85NC9mcmFnOmEwNGZkMjE3YTk3YjQ1Nzg5OWYyZTRlY2M2OGVmOTEwL3RhYmxlOmZhYTkxYWJmNjdkYzQ3ODdhY2NjZTgwNTcwMzUyZTU1L3RhYmxlcmFuZ2U6ZmFhOTFhYmY2N2RjNDc4N2FjY2NlODA1NzAzNTJlNTVfMi0xLTEtMS0w_93c32009-fe11-4248-a81f-a0cddb385adb">612</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia31e9a409b874bb19d0ff6f2f39ecc09_D20190701-20200630" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85NC9mcmFnOmEwNGZkMjE3YTk3YjQ1Nzg5OWYyZTRlY2M2OGVmOTEwL3RhYmxlOmZhYTkxYWJmNjdkYzQ3ODdhY2NjZTgwNTcwMzUyZTU1L3RhYmxlcmFuZ2U6ZmFhOTFhYmY2N2RjNDc4N2FjY2NlODA1NzAzNTJlNTVfMi0zLTEtMS0w_ef4455fd-ac83-4947-8873-f04823175360">3,693</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i00a6d666bf604826b24e68ddbd63eac4_D20180701-20190630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85NC9mcmFnOmEwNGZkMjE3YTk3YjQ1Nzg5OWYyZTRlY2M2OGVmOTEwL3RhYmxlOmZhYTkxYWJmNjdkYzQ3ODdhY2NjZTgwNTcwMzUyZTU1L3RhYmxlcmFuZ2U6ZmFhOTFhYmY2N2RjNDc4N2FjY2NlODA1NzAzNTJlNTVfMi01LTEtMS0w_7103a0a9-eeb5-4179-8300-4a1cf29e3ce1">1,365</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Adjustments to reconcile net earnings/(loss) to net cash provided by operating activities:</span></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630" decimals="-6" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85NC9mcmFnOmEwNGZkMjE3YTk3YjQ1Nzg5OWYyZTRlY2M2OGVmOTEwL3RhYmxlOmZhYTkxYWJmNjdkYzQ3ODdhY2NjZTgwNTcwMzUyZTU1L3RhYmxlcmFuZ2U6ZmFhOTFhYmY2N2RjNDc4N2FjY2NlODA1NzAzNTJlNTVfNC0xLTEtMS0w_4daefabe-c566-448e-9b88-063784ee1c3a">783</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia31e9a409b874bb19d0ff6f2f39ecc09_D20190701-20200630" decimals="-6" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85NC9mcmFnOmEwNGZkMjE3YTk3YjQ1Nzg5OWYyZTRlY2M2OGVmOTEwL3RhYmxlOmZhYTkxYWJmNjdkYzQ3ODdhY2NjZTgwNTcwMzUyZTU1L3RhYmxlcmFuZ2U6ZmFhOTFhYmY2N2RjNDc4N2FjY2NlODA1NzAzNTJlNTVfNC0zLTEtMS0w_4d371759-0011-4a12-b10e-a158e500b5a0">913</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i00a6d666bf604826b24e68ddbd63eac4_D20180701-20190630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85NC9mcmFnOmEwNGZkMjE3YTk3YjQ1Nzg5OWYyZTRlY2M2OGVmOTEwL3RhYmxlOmZhYTkxYWJmNjdkYzQ3ODdhY2NjZTgwNTcwMzUyZTU1L3RhYmxlcmFuZ2U6ZmFhOTFhYmY2N2RjNDc4N2FjY2NlODA1NzAzNTJlNTVfNC01LTEtMS0w_379af5ad-a6f8-407d-b15a-327e4593b3f5">1,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Impairments and loss on sale of other investments</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630" decimals="-6" format="ixt:zerodash" name="us-gaap:GainLossOnSaleOfOtherInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85NC9mcmFnOmEwNGZkMjE3YTk3YjQ1Nzg5OWYyZTRlY2M2OGVmOTEwL3RhYmxlOmZhYTkxYWJmNjdkYzQ3ODdhY2NjZTgwNTcwMzUyZTU1L3RhYmxlcmFuZ2U6ZmFhOTFhYmY2N2RjNDc4N2FjY2NlODA1NzAzNTJlNTVfNS0xLTEtMS0w_7f705a6f-ec88-486d-ab02-11f72d641520">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia31e9a409b874bb19d0ff6f2f39ecc09_D20190701-20200630" decimals="-6" format="ixt:zerodash" name="us-gaap:GainLossOnSaleOfOtherInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85NC9mcmFnOmEwNGZkMjE3YTk3YjQ1Nzg5OWYyZTRlY2M2OGVmOTEwL3RhYmxlOmZhYTkxYWJmNjdkYzQ3ODdhY2NjZTgwNTcwMzUyZTU1L3RhYmxlcmFuZ2U6ZmFhOTFhYmY2N2RjNDc4N2FjY2NlODA1NzAzNTJlNTVfNS0zLTEtMS0w_f9151eba-c19b-4270-8224-2446d0e1bd83">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i00a6d666bf604826b24e68ddbd63eac4_D20180701-20190630" decimals="-6" sign="-" name="us-gaap:GainLossOnSaleOfOtherInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85NC9mcmFnOmEwNGZkMjE3YTk3YjQ1Nzg5OWYyZTRlY2M2OGVmOTEwL3RhYmxlOmZhYTkxYWJmNjdkYzQ3ODdhY2NjZTgwNTcwMzUyZTU1L3RhYmxlcmFuZ2U6ZmFhOTFhYmY2N2RjNDc4N2FjY2NlODA1NzAzNTJlNTVfNS01LTEtMS0w_565bcac0-a07d-4845-93ee-03d1e8da039a">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(Gain)/Loss on sale of equity interest in naviHealth</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630" decimals="-6" sign="-" name="us-gaap:GainLossOnSaleOfInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85NC9mcmFnOmEwNGZkMjE3YTk3YjQ1Nzg5OWYyZTRlY2M2OGVmOTEwL3RhYmxlOmZhYTkxYWJmNjdkYzQ3ODdhY2NjZTgwNTcwMzUyZTU1L3RhYmxlcmFuZ2U6ZmFhOTFhYmY2N2RjNDc4N2FjY2NlODA1NzAzNTJlNTVfNi0xLTEtMS0w_a3915a2f-51ca-4aea-91f5-1e0a6e12b0a1">2</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia31e9a409b874bb19d0ff6f2f39ecc09_D20190701-20200630" decimals="-6" name="us-gaap:GainLossOnSaleOfInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85NC9mcmFnOmEwNGZkMjE3YTk3YjQ1Nzg5OWYyZTRlY2M2OGVmOTEwL3RhYmxlOmZhYTkxYWJmNjdkYzQ3ODdhY2NjZTgwNTcwMzUyZTU1L3RhYmxlcmFuZ2U6ZmFhOTFhYmY2N2RjNDc4N2FjY2NlODA1NzAzNTJlNTVfNi0zLTEtMS0w_0176b869-45bb-4398-b77a-29ad39b5ca46">579</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i00a6d666bf604826b24e68ddbd63eac4_D20180701-20190630" decimals="-6" format="ixt:zerodash" name="us-gaap:GainLossOnSaleOfInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85NC9mcmFnOmEwNGZkMjE3YTk3YjQ1Nzg5OWYyZTRlY2M2OGVmOTEwL3RhYmxlOmZhYTkxYWJmNjdkYzQ3ODdhY2NjZTgwNTcwMzUyZTU1L3RhYmxlcmFuZ2U6ZmFhOTFhYmY2N2RjNDc4N2FjY2NlODA1NzAzNTJlNTVfNi01LTEtMS0w_caff3d65-5c9b-428d-b097-1fc4274f43bf">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Impairments and (gain)/loss on disposal of assets, net</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630" decimals="-6" sign="-" name="us-gaap:GainLossOnSalesOfAssetsAndAssetImpairmentCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85NC9mcmFnOmEwNGZkMjE3YTk3YjQ1Nzg5OWYyZTRlY2M2OGVmOTEwL3RhYmxlOmZhYTkxYWJmNjdkYzQ3ODdhY2NjZTgwNTcwMzUyZTU1L3RhYmxlcmFuZ2U6ZmFhOTFhYmY2N2RjNDc4N2FjY2NlODA1NzAzNTJlNTVfNy0xLTEtMS0w_bb25287d-b639-43b5-9667-28cc9e17d17a">79</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia31e9a409b874bb19d0ff6f2f39ecc09_D20190701-20200630" decimals="-6" sign="-" name="us-gaap:GainLossOnSalesOfAssetsAndAssetImpairmentCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85NC9mcmFnOmEwNGZkMjE3YTk3YjQ1Nzg5OWYyZTRlY2M2OGVmOTEwL3RhYmxlOmZhYTkxYWJmNjdkYzQ3ODdhY2NjZTgwNTcwMzUyZTU1L3RhYmxlcmFuZ2U6ZmFhOTFhYmY2N2RjNDc4N2FjY2NlODA1NzAzNTJlNTVfNy0zLTEtMS0w_fa8de549-def5-4193-a9aa-aa2342b81b91">7</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i00a6d666bf604826b24e68ddbd63eac4_D20180701-20190630" decimals="-6" name="us-gaap:GainLossOnSalesOfAssetsAndAssetImpairmentCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85NC9mcmFnOmEwNGZkMjE3YTk3YjQ1Nzg5OWYyZTRlY2M2OGVmOTEwL3RhYmxlOmZhYTkxYWJmNjdkYzQ3ODdhY2NjZTgwNTcwMzUyZTU1L3RhYmxlcmFuZ2U6ZmFhOTFhYmY2N2RjNDc4N2FjY2NlODA1NzAzNTJlNTVfNy01LTEtMS0w_2795b340-af62-42d3-9f83-536eede14457">488</ix:nonFraction>)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Loss on early extinguishment of debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630" decimals="-6" sign="-" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85NC9mcmFnOmEwNGZkMjE3YTk3YjQ1Nzg5OWYyZTRlY2M2OGVmOTEwL3RhYmxlOmZhYTkxYWJmNjdkYzQ3ODdhY2NjZTgwNTcwMzUyZTU1L3RhYmxlcmFuZ2U6ZmFhOTFhYmY2N2RjNDc4N2FjY2NlODA1NzAzNTJlNTVfOC0xLTEtMS0w_310eb12b-e65f-4a71-98f4-11f0721f5eba">14</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia31e9a409b874bb19d0ff6f2f39ecc09_D20190701-20200630" decimals="-6" sign="-" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85NC9mcmFnOmEwNGZkMjE3YTk3YjQ1Nzg5OWYyZTRlY2M2OGVmOTEwL3RhYmxlOmZhYTkxYWJmNjdkYzQ3ODdhY2NjZTgwNTcwMzUyZTU1L3RhYmxlcmFuZ2U6ZmFhOTFhYmY2N2RjNDc4N2FjY2NlODA1NzAzNTJlNTVfOC0zLTEtMS0w_3c9055eb-0a46-46d4-a6f7-6000bca17d6c">16</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i00a6d666bf604826b24e68ddbd63eac4_D20180701-20190630" decimals="-6" format="ixt:zerodash" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85NC9mcmFnOmEwNGZkMjE3YTk3YjQ1Nzg5OWYyZTRlY2M2OGVmOTEwL3RhYmxlOmZhYTkxYWJmNjdkYzQ3ODdhY2NjZTgwNTcwMzUyZTU1L3RhYmxlcmFuZ2U6ZmFhOTFhYmY2N2RjNDc4N2FjY2NlODA1NzAzNTJlNTVfOC01LTEtMS0w_df615853-a87c-48f6-8d6d-d895229c820a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Share-based compensation</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630" decimals="-6" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85NC9mcmFnOmEwNGZkMjE3YTk3YjQ1Nzg5OWYyZTRlY2M2OGVmOTEwL3RhYmxlOmZhYTkxYWJmNjdkYzQ3ODdhY2NjZTgwNTcwMzUyZTU1L3RhYmxlcmFuZ2U6ZmFhOTFhYmY2N2RjNDc4N2FjY2NlODA1NzAzNTJlNTVfOS0xLTEtMS0w_ef443f9a-aa62-4ccb-86fd-97a46e9d2e55">89</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia31e9a409b874bb19d0ff6f2f39ecc09_D20190701-20200630" decimals="-6" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85NC9mcmFnOmEwNGZkMjE3YTk3YjQ1Nzg5OWYyZTRlY2M2OGVmOTEwL3RhYmxlOmZhYTkxYWJmNjdkYzQ3ODdhY2NjZTgwNTcwMzUyZTU1L3RhYmxlcmFuZ2U6ZmFhOTFhYmY2N2RjNDc4N2FjY2NlODA1NzAzNTJlNTVfOS0zLTEtMS0w_fefb9a4c-463d-40c2-8595-fa28946bb677">90</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i00a6d666bf604826b24e68ddbd63eac4_D20180701-20190630" decimals="-6" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85NC9mcmFnOmEwNGZkMjE3YTk3YjQ1Nzg5OWYyZTRlY2M2OGVmOTEwL3RhYmxlOmZhYTkxYWJmNjdkYzQ3ODdhY2NjZTgwNTcwMzUyZTU1L3RhYmxlcmFuZ2U6ZmFhOTFhYmY2N2RjNDc4N2FjY2NlODA1NzAzNTJlNTVfOS01LTEtMS0w_f4959ee9-a95a-45bc-b647-7caa98bd44da">82</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Provision for/(benefit from) deferred income taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630" decimals="-6" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85NC9mcmFnOmEwNGZkMjE3YTk3YjQ1Nzg5OWYyZTRlY2M2OGVmOTEwL3RhYmxlOmZhYTkxYWJmNjdkYzQ3ODdhY2NjZTgwNTcwMzUyZTU1L3RhYmxlcmFuZ2U6ZmFhOTFhYmY2N2RjNDc4N2FjY2NlODA1NzAzNTJlNTVfMTAtMS0xLTEtMA_d52c249f-3216-4df3-9eb0-16965098b179">496</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia31e9a409b874bb19d0ff6f2f39ecc09_D20190701-20200630" decimals="-6" sign="-" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85NC9mcmFnOmEwNGZkMjE3YTk3YjQ1Nzg5OWYyZTRlY2M2OGVmOTEwL3RhYmxlOmZhYTkxYWJmNjdkYzQ3ODdhY2NjZTgwNTcwMzUyZTU1L3RhYmxlcmFuZ2U6ZmFhOTFhYmY2N2RjNDc4N2FjY2NlODA1NzAzNTJlNTVfMTAtMy0xLTEtMA_b06df6f5-1921-4272-af43-a08a44541bf5">961</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i00a6d666bf604826b24e68ddbd63eac4_D20180701-20190630" decimals="-6" sign="-" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85NC9mcmFnOmEwNGZkMjE3YTk3YjQ1Nzg5OWYyZTRlY2M2OGVmOTEwL3RhYmxlOmZhYTkxYWJmNjdkYzQ3ODdhY2NjZTgwNTcwMzUyZTU1L3RhYmxlcmFuZ2U6ZmFhOTFhYmY2N2RjNDc4N2FjY2NlODA1NzAzNTJlNTVfMTAtNS0xLTEtMA_ce8ae665-4296-4ab7-9398-84dc0348cfca">83</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Provision for bad debts</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630" decimals="-6" name="us-gaap:ProvisionForDoubtfulAccounts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85NC9mcmFnOmEwNGZkMjE3YTk3YjQ1Nzg5OWYyZTRlY2M2OGVmOTEwL3RhYmxlOmZhYTkxYWJmNjdkYzQ3ODdhY2NjZTgwNTcwMzUyZTU1L3RhYmxlcmFuZ2U6ZmFhOTFhYmY2N2RjNDc4N2FjY2NlODA1NzAzNTJlNTVfMTEtMS0xLTEtMA_9bd74add-85a6-4fab-8a0b-25fa6c9901fb">65</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia31e9a409b874bb19d0ff6f2f39ecc09_D20190701-20200630" decimals="-6" name="us-gaap:ProvisionForDoubtfulAccounts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85NC9mcmFnOmEwNGZkMjE3YTk3YjQ1Nzg5OWYyZTRlY2M2OGVmOTEwL3RhYmxlOmZhYTkxYWJmNjdkYzQ3ODdhY2NjZTgwNTcwMzUyZTU1L3RhYmxlcmFuZ2U6ZmFhOTFhYmY2N2RjNDc4N2FjY2NlODA1NzAzNTJlNTVfMTEtMy0xLTEtMA_d4bd3fb1-9ff5-40f5-90bb-3c67d63f2a16">106</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i00a6d666bf604826b24e68ddbd63eac4_D20180701-20190630" decimals="-6" name="us-gaap:ProvisionForDoubtfulAccounts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85NC9mcmFnOmEwNGZkMjE3YTk3YjQ1Nzg5OWYyZTRlY2M2OGVmOTEwL3RhYmxlOmZhYTkxYWJmNjdkYzQ3ODdhY2NjZTgwNTcwMzUyZTU1L3RhYmxlcmFuZ2U6ZmFhOTFhYmY2N2RjNDc4N2FjY2NlODA1NzAzNTJlNTVfMTEtNS0xLTEtMA_2887b5f5-a7eb-43b6-8309-8b21c43fd064">88</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Change in operating assets and liabilities, net of effects from acquisitions and divestitures:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(Increase)/decrease in trade receivables</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630" decimals="-6" name="us-gaap:IncreaseDecreaseInReceivables" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85NC9mcmFnOmEwNGZkMjE3YTk3YjQ1Nzg5OWYyZTRlY2M2OGVmOTEwL3RhYmxlOmZhYTkxYWJmNjdkYzQ3ODdhY2NjZTgwNTcwMzUyZTU1L3RhYmxlcmFuZ2U6ZmFhOTFhYmY2N2RjNDc4N2FjY2NlODA1NzAzNTJlNTVfMTQtMS0xLTEtMA_6ce1aa4c-e82e-45d4-91b7-efd3dea6ac4c">904</ix:nonFraction>)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia31e9a409b874bb19d0ff6f2f39ecc09_D20190701-20200630" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInReceivables" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85NC9mcmFnOmEwNGZkMjE3YTk3YjQ1Nzg5OWYyZTRlY2M2OGVmOTEwL3RhYmxlOmZhYTkxYWJmNjdkYzQ3ODdhY2NjZTgwNTcwMzUyZTU1L3RhYmxlcmFuZ2U6ZmFhOTFhYmY2N2RjNDc4N2FjY2NlODA1NzAzNTJlNTVfMTQtMy0xLTEtMA_c13bfafd-5253-4608-9d90-c30882d89efe">82</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i00a6d666bf604826b24e68ddbd63eac4_D20180701-20190630" decimals="-6" name="us-gaap:IncreaseDecreaseInReceivables" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85NC9mcmFnOmEwNGZkMjE3YTk3YjQ1Nzg5OWYyZTRlY2M2OGVmOTEwL3RhYmxlOmZhYTkxYWJmNjdkYzQ3ODdhY2NjZTgwNTcwMzUyZTU1L3RhYmxlcmFuZ2U6ZmFhOTFhYmY2N2RjNDc4N2FjY2NlODA1NzAzNTJlNTVfMTQtNS0xLTEtMA_846abce2-2498-4752-9ed6-2a0a74ba1e51">751</ix:nonFraction>)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Increase in inventories</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInInventories" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85NC9mcmFnOmEwNGZkMjE3YTk3YjQ1Nzg5OWYyZTRlY2M2OGVmOTEwL3RhYmxlOmZhYTkxYWJmNjdkYzQ3ODdhY2NjZTgwNTcwMzUyZTU1L3RhYmxlcmFuZ2U6ZmFhOTFhYmY2N2RjNDc4N2FjY2NlODA1NzAzNTJlNTVfMTUtMS0xLTEtMA_0e42c056-cfd1-4d5c-802a-e4b59546e054">1,584</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia31e9a409b874bb19d0ff6f2f39ecc09_D20190701-20200630" decimals="-6" name="us-gaap:IncreaseDecreaseInInventories" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85NC9mcmFnOmEwNGZkMjE3YTk3YjQ1Nzg5OWYyZTRlY2M2OGVmOTEwL3RhYmxlOmZhYTkxYWJmNjdkYzQ3ODdhY2NjZTgwNTcwMzUyZTU1L3RhYmxlcmFuZ2U6ZmFhOTFhYmY2N2RjNDc4N2FjY2NlODA1NzAzNTJlNTVfMTUtMy0xLTEtMA_d6de9587-8323-456e-b80a-27dc1d9f7a9f">409</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i00a6d666bf604826b24e68ddbd63eac4_D20180701-20190630" decimals="-6" name="us-gaap:IncreaseDecreaseInInventories" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85NC9mcmFnOmEwNGZkMjE3YTk3YjQ1Nzg5OWYyZTRlY2M2OGVmOTEwL3RhYmxlOmZhYTkxYWJmNjdkYzQ3ODdhY2NjZTgwNTcwMzUyZTU1L3RhYmxlcmFuZ2U6ZmFhOTFhYmY2N2RjNDc4N2FjY2NlODA1NzAzNTJlNTVfMTUtNS0xLTEtMA_0e0b948f-a349-492d-9cc4-df6931eb0c6f">551</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Increase/(decrease) in accounts payable</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInAccountsPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85NC9mcmFnOmEwNGZkMjE3YTk3YjQ1Nzg5OWYyZTRlY2M2OGVmOTEwL3RhYmxlOmZhYTkxYWJmNjdkYzQ3ODdhY2NjZTgwNTcwMzUyZTU1L3RhYmxlcmFuZ2U6ZmFhOTFhYmY2N2RjNDc4N2FjY2NlODA1NzAzNTJlNTVfMTYtMS0xLTEtMA_9f40155b-030a-40b2-809a-79f78c5572f3">2,325</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia31e9a409b874bb19d0ff6f2f39ecc09_D20190701-20200630" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInAccountsPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85NC9mcmFnOmEwNGZkMjE3YTk3YjQ1Nzg5OWYyZTRlY2M2OGVmOTEwL3RhYmxlOmZhYTkxYWJmNjdkYzQ3ODdhY2NjZTgwNTcwMzUyZTU1L3RhYmxlcmFuZ2U6ZmFhOTFhYmY2N2RjNDc4N2FjY2NlODA1NzAzNTJlNTVfMTYtMy0xLTEtMA_bc665474-09c8-4350-8780-798f1ac8f30f">162</ix:nonFraction>)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i00a6d666bf604826b24e68ddbd63eac4_D20180701-20190630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInAccountsPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85NC9mcmFnOmEwNGZkMjE3YTk3YjQ1Nzg5OWYyZTRlY2M2OGVmOTEwL3RhYmxlOmZhYTkxYWJmNjdkYzQ3ODdhY2NjZTgwNTcwMzUyZTU1L3RhYmxlcmFuZ2U6ZmFhOTFhYmY2N2RjNDc4N2FjY2NlODA1NzAzNTJlNTVfMTYtNS0xLTEtMA_d7301f7f-3e96-4600-ada4-6e8bda350ee4">1,864</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other accrued liabilities and operating items, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85NC9mcmFnOmEwNGZkMjE3YTk3YjQ1Nzg5OWYyZTRlY2M2OGVmOTEwL3RhYmxlOmZhYTkxYWJmNjdkYzQ3ODdhY2NjZTgwNTcwMzUyZTU1L3RhYmxlcmFuZ2U6ZmFhOTFhYmY2N2RjNDc4N2FjY2NlODA1NzAzNTJlNTVfMTctMS0xLTEtMA_0c5365b9-9cdc-43ca-8316-443761d5a6b5">452</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia31e9a409b874bb19d0ff6f2f39ecc09_D20190701-20200630" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85NC9mcmFnOmEwNGZkMjE3YTk3YjQ1Nzg5OWYyZTRlY2M2OGVmOTEwL3RhYmxlOmZhYTkxYWJmNjdkYzQ3ODdhY2NjZTgwNTcwMzUyZTU1L3RhYmxlcmFuZ2U6ZmFhOTFhYmY2N2RjNDc4N2FjY2NlODA1NzAzNTJlNTVfMTctMy0xLTEtMA_31619a24-02d5-4ffa-96d9-82cc4de9ac2f">6,550</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i00a6d666bf604826b24e68ddbd63eac4_D20180701-20190630" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85NC9mcmFnOmEwNGZkMjE3YTk3YjQ1Nzg5OWYyZTRlY2M2OGVmOTEwL3RhYmxlOmZhYTkxYWJmNjdkYzQ3ODdhY2NjZTgwNTcwMzUyZTU1L3RhYmxlcmFuZ2U6ZmFhOTFhYmY2N2RjNDc4N2FjY2NlODA1NzAzNTJlNTVfMTctNS0xLTEtMA_d9a73033-6c2c-4e8c-bd49-f3f4c4ce2cdf">193</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net cash provided by operating activities</span></td><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85NC9mcmFnOmEwNGZkMjE3YTk3YjQ1Nzg5OWYyZTRlY2M2OGVmOTEwL3RhYmxlOmZhYTkxYWJmNjdkYzQ3ODdhY2NjZTgwNTcwMzUyZTU1L3RhYmxlcmFuZ2U6ZmFhOTFhYmY2N2RjNDc4N2FjY2NlODA1NzAzNTJlNTVfMTgtMS0xLTEtMA_172cb3ea-bd0d-421c-9b21-7f1104a56c4f">2,429</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia31e9a409b874bb19d0ff6f2f39ecc09_D20190701-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85NC9mcmFnOmEwNGZkMjE3YTk3YjQ1Nzg5OWYyZTRlY2M2OGVmOTEwL3RhYmxlOmZhYTkxYWJmNjdkYzQ3ODdhY2NjZTgwNTcwMzUyZTU1L3RhYmxlcmFuZ2U6ZmFhOTFhYmY2N2RjNDc4N2FjY2NlODA1NzAzNTJlNTVfMTgtMy0xLTEtMA_781fce66-7311-40f9-af61-d7fd8129b569">1,960</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i00a6d666bf604826b24e68ddbd63eac4_D20180701-20190630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85NC9mcmFnOmEwNGZkMjE3YTk3YjQ1Nzg5OWYyZTRlY2M2OGVmOTEwL3RhYmxlOmZhYTkxYWJmNjdkYzQ3ODdhY2NjZTgwNTcwMzUyZTU1L3RhYmxlcmFuZ2U6ZmFhOTFhYmY2N2RjNDc4N2FjY2NlODA1NzAzNTJlNTVfMTgtNS0xLTEtMA_e8dd1cc0-6009-4678-aded-6c12c805f7d5">2,722</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cash flows from investing activities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Acquisition of subsidiaries, net of cash acquired</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630" decimals="-6" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85NC9mcmFnOmEwNGZkMjE3YTk3YjQ1Nzg5OWYyZTRlY2M2OGVmOTEwL3RhYmxlOmZhYTkxYWJmNjdkYzQ3ODdhY2NjZTgwNTcwMzUyZTU1L3RhYmxlcmFuZ2U6ZmFhOTFhYmY2N2RjNDc4N2FjY2NlODA1NzAzNTJlNTVfMjAtMS0xLTEtMA_1c95364d-877a-4822-8479-aadbdfab13cf">3</ix:nonFraction>)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia31e9a409b874bb19d0ff6f2f39ecc09_D20190701-20200630" decimals="-6" format="ixt:zerodash" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85NC9mcmFnOmEwNGZkMjE3YTk3YjQ1Nzg5OWYyZTRlY2M2OGVmOTEwL3RhYmxlOmZhYTkxYWJmNjdkYzQ3ODdhY2NjZTgwNTcwMzUyZTU1L3RhYmxlcmFuZ2U6ZmFhOTFhYmY2N2RjNDc4N2FjY2NlODA1NzAzNTJlNTVfMjAtMy0xLTEtMA_c433a62c-6ddb-420f-a5d8-254a3642a155">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i00a6d666bf604826b24e68ddbd63eac4_D20180701-20190630" decimals="-6" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85NC9mcmFnOmEwNGZkMjE3YTk3YjQ1Nzg5OWYyZTRlY2M2OGVmOTEwL3RhYmxlOmZhYTkxYWJmNjdkYzQ3ODdhY2NjZTgwNTcwMzUyZTU1L3RhYmxlcmFuZ2U6ZmFhOTFhYmY2N2RjNDc4N2FjY2NlODA1NzAzNTJlNTVfMjAtNS0xLTEtMA_621fd1d6-9c91-42f0-a49d-c644c4c580af">82</ix:nonFraction>)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Additions to property and equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630" decimals="-6" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85NC9mcmFnOmEwNGZkMjE3YTk3YjQ1Nzg5OWYyZTRlY2M2OGVmOTEwL3RhYmxlOmZhYTkxYWJmNjdkYzQ3ODdhY2NjZTgwNTcwMzUyZTU1L3RhYmxlcmFuZ2U6ZmFhOTFhYmY2N2RjNDc4N2FjY2NlODA1NzAzNTJlNTVfMjEtMS0xLTEtMA_e5a29e3f-402c-4e2d-a903-72eea3001e01">400</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia31e9a409b874bb19d0ff6f2f39ecc09_D20190701-20200630" decimals="-6" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85NC9mcmFnOmEwNGZkMjE3YTk3YjQ1Nzg5OWYyZTRlY2M2OGVmOTEwL3RhYmxlOmZhYTkxYWJmNjdkYzQ3ODdhY2NjZTgwNTcwMzUyZTU1L3RhYmxlcmFuZ2U6ZmFhOTFhYmY2N2RjNDc4N2FjY2NlODA1NzAzNTJlNTVfMjEtMy0xLTEtMA_76cfaecb-4761-42f5-9d8b-ee93abd96ed0">375</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i00a6d666bf604826b24e68ddbd63eac4_D20180701-20190630" decimals="-6" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85NC9mcmFnOmEwNGZkMjE3YTk3YjQ1Nzg5OWYyZTRlY2M2OGVmOTEwL3RhYmxlOmZhYTkxYWJmNjdkYzQ3ODdhY2NjZTgwNTcwMzUyZTU1L3RhYmxlcmFuZ2U6ZmFhOTFhYmY2N2RjNDc4N2FjY2NlODA1NzAzNTJlNTVfMjEtNS0xLTEtMA_7e28e0d6-0dab-447c-ac11-241a8795f0d4">328</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Purchase of other investments</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630" decimals="-6" name="cah:Purchaseofavailableforsalesecuritiesandotherinvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85NC9mcmFnOmEwNGZkMjE3YTk3YjQ1Nzg5OWYyZTRlY2M2OGVmOTEwL3RhYmxlOmZhYTkxYWJmNjdkYzQ3ODdhY2NjZTgwNTcwMzUyZTU1L3RhYmxlcmFuZ2U6ZmFhOTFhYmY2N2RjNDc4N2FjY2NlODA1NzAzNTJlNTVfMjItMS0xLTEtMA_1b20973a-17b4-472f-8f9d-cf492a37545f">22</ix:nonFraction>)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia31e9a409b874bb19d0ff6f2f39ecc09_D20190701-20200630" decimals="-6" name="cah:Purchaseofavailableforsalesecuritiesandotherinvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85NC9mcmFnOmEwNGZkMjE3YTk3YjQ1Nzg5OWYyZTRlY2M2OGVmOTEwL3RhYmxlOmZhYTkxYWJmNjdkYzQ3ODdhY2NjZTgwNTcwMzUyZTU1L3RhYmxlcmFuZ2U6ZmFhOTFhYmY2N2RjNDc4N2FjY2NlODA1NzAzNTJlNTVfMjItMy0xLTEtMA_5745eb35-ee50-4a98-86e1-f9dc45ab8cfd">20</ix:nonFraction>)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i00a6d666bf604826b24e68ddbd63eac4_D20180701-20190630" decimals="-6" name="cah:Purchaseofavailableforsalesecuritiesandotherinvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85NC9mcmFnOmEwNGZkMjE3YTk3YjQ1Nzg5OWYyZTRlY2M2OGVmOTEwL3RhYmxlOmZhYTkxYWJmNjdkYzQ3ODdhY2NjZTgwNTcwMzUyZTU1L3RhYmxlcmFuZ2U6ZmFhOTFhYmY2N2RjNDc4N2FjY2NlODA1NzAzNTJlNTVfMjItNS0xLTEtMA_a9812dbe-783f-40fa-be00-31ce00d06be3">18</ix:nonFraction>)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Proceeds from sale of investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630" decimals="-6" name="cah:Proceedsfromsaleofavailableforsalesecuritiesandotherinvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85NC9mcmFnOmEwNGZkMjE3YTk3YjQ1Nzg5OWYyZTRlY2M2OGVmOTEwL3RhYmxlOmZhYTkxYWJmNjdkYzQ3ODdhY2NjZTgwNTcwMzUyZTU1L3RhYmxlcmFuZ2U6ZmFhOTFhYmY2N2RjNDc4N2FjY2NlODA1NzAzNTJlNTVfMjMtMS0xLTEtMA_1875e5c8-5f70-4d5f-9f36-d048e8bdaa44">47</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia31e9a409b874bb19d0ff6f2f39ecc09_D20190701-20200630" decimals="-6" name="cah:Proceedsfromsaleofavailableforsalesecuritiesandotherinvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85NC9mcmFnOmEwNGZkMjE3YTk3YjQ1Nzg5OWYyZTRlY2M2OGVmOTEwL3RhYmxlOmZhYTkxYWJmNjdkYzQ3ODdhY2NjZTgwNTcwMzUyZTU1L3RhYmxlcmFuZ2U6ZmFhOTFhYmY2N2RjNDc4N2FjY2NlODA1NzAzNTJlNTVfMjMtMy0xLTEtMA_f80f7859-1cc1-41a5-be8d-9bfdce827fbc">886</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i00a6d666bf604826b24e68ddbd63eac4_D20180701-20190630" decimals="-6" name="cah:Proceedsfromsaleofavailableforsalesecuritiesandotherinvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85NC9mcmFnOmEwNGZkMjE3YTk3YjQ1Nzg5OWYyZTRlY2M2OGVmOTEwL3RhYmxlOmZhYTkxYWJmNjdkYzQ3ODdhY2NjZTgwNTcwMzUyZTU1L3RhYmxlcmFuZ2U6ZmFhOTFhYmY2N2RjNDc4N2FjY2NlODA1NzAzNTJlNTVfMjMtNS0xLTEtMA_0f9efa2a-a1a4-47d5-863c-d61aec8411d8">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Proceeds from divestitures, net of cash sold, and disposal of property and equipment</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630" decimals="-6" format="ixt:zerodash" name="cah:Proceedsfromdivestituresanddisposalofpropertyandequipmentandheldforsaleassets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85NC9mcmFnOmEwNGZkMjE3YTk3YjQ1Nzg5OWYyZTRlY2M2OGVmOTEwL3RhYmxlOmZhYTkxYWJmNjdkYzQ3ODdhY2NjZTgwNTcwMzUyZTU1L3RhYmxlcmFuZ2U6ZmFhOTFhYmY2N2RjNDc4N2FjY2NlODA1NzAzNTJlNTVfMjYtMS0xLTEtMA_7d2663e3-479c-42df-892e-df65ef7284ca">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia31e9a409b874bb19d0ff6f2f39ecc09_D20190701-20200630" decimals="-6" name="cah:Proceedsfromdivestituresanddisposalofpropertyandequipmentandheldforsaleassets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85NC9mcmFnOmEwNGZkMjE3YTk3YjQ1Nzg5OWYyZTRlY2M2OGVmOTEwL3RhYmxlOmZhYTkxYWJmNjdkYzQ3ODdhY2NjZTgwNTcwMzUyZTU1L3RhYmxlcmFuZ2U6ZmFhOTFhYmY2N2RjNDc4N2FjY2NlODA1NzAzNTJlNTVfMjYtMy0xLTEtMA_0fa5ecee-126a-42e7-8f1c-de5c19e8255d">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i00a6d666bf604826b24e68ddbd63eac4_D20180701-20190630" decimals="-6" name="cah:Proceedsfromdivestituresanddisposalofpropertyandequipmentandheldforsaleassets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85NC9mcmFnOmEwNGZkMjE3YTk3YjQ1Nzg5OWYyZTRlY2M2OGVmOTEwL3RhYmxlOmZhYTkxYWJmNjdkYzQ3ODdhY2NjZTgwNTcwMzUyZTU1L3RhYmxlcmFuZ2U6ZmFhOTFhYmY2N2RjNDc4N2FjY2NlODA1NzAzNTJlNTVfMjYtNS0xLTEtMA_02a3ee8b-db5d-42d2-9218-1d8180dce903">763</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net cash provided by/(used in) investing activities </span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630" decimals="-6" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85NC9mcmFnOmEwNGZkMjE3YTk3YjQ1Nzg5OWYyZTRlY2M2OGVmOTEwL3RhYmxlOmZhYTkxYWJmNjdkYzQ3ODdhY2NjZTgwNTcwMzUyZTU1L3RhYmxlcmFuZ2U6ZmFhOTFhYmY2N2RjNDc4N2FjY2NlODA1NzAzNTJlNTVfMjctMS0xLTEtMA_2a5913f1-ecac-44c9-992c-b9e6f65bfaf0">378</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia31e9a409b874bb19d0ff6f2f39ecc09_D20190701-20200630" decimals="-6" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85NC9mcmFnOmEwNGZkMjE3YTk3YjQ1Nzg5OWYyZTRlY2M2OGVmOTEwL3RhYmxlOmZhYTkxYWJmNjdkYzQ3ODdhY2NjZTgwNTcwMzUyZTU1L3RhYmxlcmFuZ2U6ZmFhOTFhYmY2N2RjNDc4N2FjY2NlODA1NzAzNTJlNTVfMjctMy0xLTEtMA_c21a4e97-7011-4da0-8fae-ee98b6d829b5">493</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i00a6d666bf604826b24e68ddbd63eac4_D20180701-20190630" decimals="-6" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85NC9mcmFnOmEwNGZkMjE3YTk3YjQ1Nzg5OWYyZTRlY2M2OGVmOTEwL3RhYmxlOmZhYTkxYWJmNjdkYzQ3ODdhY2NjZTgwNTcwMzUyZTU1L3RhYmxlcmFuZ2U6ZmFhOTFhYmY2N2RjNDc4N2FjY2NlODA1NzAzNTJlNTVfMjctNS0xLTEtMA_ed38cda2-0c4b-4638-b140-3efff154f04e">338</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cash flows from financing activities:</span></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net change in short-term borrowings</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630" decimals="-6" format="ixt:zerodash" name="us-gaap:ProceedsFromRepaymentsOfShortTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85NC9mcmFnOmEwNGZkMjE3YTk3YjQ1Nzg5OWYyZTRlY2M2OGVmOTEwL3RhYmxlOmZhYTkxYWJmNjdkYzQ3ODdhY2NjZTgwNTcwMzUyZTU1L3RhYmxlcmFuZ2U6ZmFhOTFhYmY2N2RjNDc4N2FjY2NlODA1NzAzNTJlNTVfMzAtMS0xLTEtMA_f6f13849-38cf-4937-a780-3118510cb7e1">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia31e9a409b874bb19d0ff6f2f39ecc09_D20190701-20200630" decimals="-6" sign="-" name="us-gaap:ProceedsFromRepaymentsOfShortTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85NC9mcmFnOmEwNGZkMjE3YTk3YjQ1Nzg5OWYyZTRlY2M2OGVmOTEwL3RhYmxlOmZhYTkxYWJmNjdkYzQ3ODdhY2NjZTgwNTcwMzUyZTU1L3RhYmxlcmFuZ2U6ZmFhOTFhYmY2N2RjNDc4N2FjY2NlODA1NzAzNTJlNTVfMzAtMy0xLTEtMA_4422145c-c986-4f39-921e-2fc1d6a5af3c">2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i00a6d666bf604826b24e68ddbd63eac4_D20180701-20190630" decimals="-6" format="ixt:zerodash" name="us-gaap:ProceedsFromRepaymentsOfShortTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85NC9mcmFnOmEwNGZkMjE3YTk3YjQ1Nzg5OWYyZTRlY2M2OGVmOTEwL3RhYmxlOmZhYTkxYWJmNjdkYzQ3ODdhY2NjZTgwNTcwMzUyZTU1L3RhYmxlcmFuZ2U6ZmFhOTFhYmY2N2RjNDc4N2FjY2NlODA1NzAzNTJlNTVfMzAtNS0xLTEtMA_95ec271d-f890-4aa1-a350-cb128d578ae1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Proceeds from interest rate swap terminations</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630" decimals="-6" sign="-" name="us-gaap:PaymentsForProceedsFromHedgeFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85NC9mcmFnOmEwNGZkMjE3YTk3YjQ1Nzg5OWYyZTRlY2M2OGVmOTEwL3RhYmxlOmZhYTkxYWJmNjdkYzQ3ODdhY2NjZTgwNTcwMzUyZTU1L3RhYmxlcmFuZ2U6ZmFhOTFhYmY2N2RjNDc4N2FjY2NlODA1NzAzNTJlNTVfMzItMS0xLTEtMA_d7767386-aa2e-49a8-b5fb-7205be35bed0">18</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia31e9a409b874bb19d0ff6f2f39ecc09_D20190701-20200630" decimals="-6" sign="-" name="us-gaap:PaymentsForProceedsFromHedgeFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85NC9mcmFnOmEwNGZkMjE3YTk3YjQ1Nzg5OWYyZTRlY2M2OGVmOTEwL3RhYmxlOmZhYTkxYWJmNjdkYzQ3ODdhY2NjZTgwNTcwMzUyZTU1L3RhYmxlcmFuZ2U6ZmFhOTFhYmY2N2RjNDc4N2FjY2NlODA1NzAzNTJlNTVfMzItMy0xLTEtMA_c9d72c00-05cd-44ed-9ff2-3bb51f9be728">112</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i00a6d666bf604826b24e68ddbd63eac4_D20180701-20190630" decimals="-6" format="ixt:zerodash" name="us-gaap:PaymentsForProceedsFromHedgeFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85NC9mcmFnOmEwNGZkMjE3YTk3YjQ1Nzg5OWYyZTRlY2M2OGVmOTEwL3RhYmxlOmZhYTkxYWJmNjdkYzQ3ODdhY2NjZTgwNTcwMzUyZTU1L3RhYmxlcmFuZ2U6ZmFhOTFhYmY2N2RjNDc4N2FjY2NlODA1NzAzNTJlNTVfMzItNS0xLTEtMA_b977c119-d193-46ed-bd67-c2941954992e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Reduction of long-term obligations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630" decimals="-6" name="us-gaap:RepaymentsOfLongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85NC9mcmFnOmEwNGZkMjE3YTk3YjQ1Nzg5OWYyZTRlY2M2OGVmOTEwL3RhYmxlOmZhYTkxYWJmNjdkYzQ3ODdhY2NjZTgwNTcwMzUyZTU1L3RhYmxlcmFuZ2U6ZmFhOTFhYmY2N2RjNDc4N2FjY2NlODA1NzAzNTJlNTVfMzQtMS0xLTEtMA_39ca85ef-2d67-4c63-b793-d635a8d8878c">570</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia31e9a409b874bb19d0ff6f2f39ecc09_D20190701-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RepaymentsOfLongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85NC9mcmFnOmEwNGZkMjE3YTk3YjQ1Nzg5OWYyZTRlY2M2OGVmOTEwL3RhYmxlOmZhYTkxYWJmNjdkYzQ3ODdhY2NjZTgwNTcwMzUyZTU1L3RhYmxlcmFuZ2U6ZmFhOTFhYmY2N2RjNDc4N2FjY2NlODA1NzAzNTJlNTVfMzQtMy0xLTEtMA_c8514fc2-1e11-46e8-9a6c-e4c001bdf8ee">1,399</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i00a6d666bf604826b24e68ddbd63eac4_D20180701-20190630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RepaymentsOfLongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85NC9mcmFnOmEwNGZkMjE3YTk3YjQ1Nzg5OWYyZTRlY2M2OGVmOTEwL3RhYmxlOmZhYTkxYWJmNjdkYzQ3ODdhY2NjZTgwNTcwMzUyZTU1L3RhYmxlcmFuZ2U6ZmFhOTFhYmY2N2RjNDc4N2FjY2NlODA1NzAzNTJlNTVfMzQtNS0xLTEtMA_f39ea348-48ec-4b48-a7be-91ad00b148a7">1,102</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net tax proceeds/(withholding) from share-based compensation</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630" decimals="-6" name="cah:Netproceedstaxwithholdingsfromsharebasedcompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85NC9mcmFnOmEwNGZkMjE3YTk3YjQ1Nzg5OWYyZTRlY2M2OGVmOTEwL3RhYmxlOmZhYTkxYWJmNjdkYzQ3ODdhY2NjZTgwNTcwMzUyZTU1L3RhYmxlcmFuZ2U6ZmFhOTFhYmY2N2RjNDc4N2FjY2NlODA1NzAzNTJlNTVfMzUtMS0xLTEtMA_93130f83-777e-4bee-a842-82093233a554">8</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia31e9a409b874bb19d0ff6f2f39ecc09_D20190701-20200630" decimals="-6" name="cah:Netproceedstaxwithholdingsfromsharebasedcompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85NC9mcmFnOmEwNGZkMjE3YTk3YjQ1Nzg5OWYyZTRlY2M2OGVmOTEwL3RhYmxlOmZhYTkxYWJmNjdkYzQ3ODdhY2NjZTgwNTcwMzUyZTU1L3RhYmxlcmFuZ2U6ZmFhOTFhYmY2N2RjNDc4N2FjY2NlODA1NzAzNTJlNTVfMzUtMy0xLTEtMA_3ca7dd34-4445-45a7-a4cb-e314919b15ff">8</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i00a6d666bf604826b24e68ddbd63eac4_D20180701-20190630" decimals="-6" sign="-" name="cah:Netproceedstaxwithholdingsfromsharebasedcompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85NC9mcmFnOmEwNGZkMjE3YTk3YjQ1Nzg5OWYyZTRlY2M2OGVmOTEwL3RhYmxlOmZhYTkxYWJmNjdkYzQ3ODdhY2NjZTgwNTcwMzUyZTU1L3RhYmxlcmFuZ2U6ZmFhOTFhYmY2N2RjNDc4N2FjY2NlODA1NzAzNTJlNTVfMzUtNS0xLTEtMA_5b395b95-6072-4c27-91d7-903cc13ad860">14</ix:nonFraction>)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dividends on common shares</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630" decimals="-6" name="us-gaap:PaymentsOfDividendsCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85NC9mcmFnOmEwNGZkMjE3YTk3YjQ1Nzg5OWYyZTRlY2M2OGVmOTEwL3RhYmxlOmZhYTkxYWJmNjdkYzQ3ODdhY2NjZTgwNTcwMzUyZTU1L3RhYmxlcmFuZ2U6ZmFhOTFhYmY2N2RjNDc4N2FjY2NlODA1NzAzNTJlNTVfMzctMS0xLTEtMA_94474177-f50f-4147-94e2-e96163021a11">573</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia31e9a409b874bb19d0ff6f2f39ecc09_D20190701-20200630" decimals="-6" name="us-gaap:PaymentsOfDividendsCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85NC9mcmFnOmEwNGZkMjE3YTk3YjQ1Nzg5OWYyZTRlY2M2OGVmOTEwL3RhYmxlOmZhYTkxYWJmNjdkYzQ3ODdhY2NjZTgwNTcwMzUyZTU1L3RhYmxlcmFuZ2U6ZmFhOTFhYmY2N2RjNDc4N2FjY2NlODA1NzAzNTJlNTVfMzctMy0xLTEtMA_145e66ad-5db6-4688-a021-fc12414a3b01">569</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i00a6d666bf604826b24e68ddbd63eac4_D20180701-20190630" decimals="-6" name="us-gaap:PaymentsOfDividendsCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85NC9mcmFnOmEwNGZkMjE3YTk3YjQ1Nzg5OWYyZTRlY2M2OGVmOTEwL3RhYmxlOmZhYTkxYWJmNjdkYzQ3ODdhY2NjZTgwNTcwMzUyZTU1L3RhYmxlcmFuZ2U6ZmFhOTFhYmY2N2RjNDc4N2FjY2NlODA1NzAzNTJlNTVfMzctNS0xLTEtMA_60004693-7b0b-4a36-bcbc-9ba674af0663">577</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Purchase of treasury shares</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630" decimals="-6" name="us-gaap:PaymentsForRepurchaseOfCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85NC9mcmFnOmEwNGZkMjE3YTk3YjQ1Nzg5OWYyZTRlY2M2OGVmOTEwL3RhYmxlOmZhYTkxYWJmNjdkYzQ3ODdhY2NjZTgwNTcwMzUyZTU1L3RhYmxlcmFuZ2U6ZmFhOTFhYmY2N2RjNDc4N2FjY2NlODA1NzAzNTJlNTVfMzgtMS0xLTEtMA_5023aba7-ffef-4cb1-a176-20b480df2fb1">200</ix:nonFraction>)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia31e9a409b874bb19d0ff6f2f39ecc09_D20190701-20200630" decimals="-6" name="us-gaap:PaymentsForRepurchaseOfCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85NC9mcmFnOmEwNGZkMjE3YTk3YjQ1Nzg5OWYyZTRlY2M2OGVmOTEwL3RhYmxlOmZhYTkxYWJmNjdkYzQ3ODdhY2NjZTgwNTcwMzUyZTU1L3RhYmxlcmFuZ2U6ZmFhOTFhYmY2N2RjNDc4N2FjY2NlODA1NzAzNTJlNTVfMzgtMy0xLTEtMA_8a5bdf60-532d-4511-9f2d-da45e3943cbd">350</ix:nonFraction>)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i00a6d666bf604826b24e68ddbd63eac4_D20180701-20190630" decimals="-6" name="us-gaap:PaymentsForRepurchaseOfCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85NC9mcmFnOmEwNGZkMjE3YTk3YjQ1Nzg5OWYyZTRlY2M2OGVmOTEwL3RhYmxlOmZhYTkxYWJmNjdkYzQ3ODdhY2NjZTgwNTcwMzUyZTU1L3RhYmxlcmFuZ2U6ZmFhOTFhYmY2N2RjNDc4N2FjY2NlODA1NzAzNTJlNTVfMzgtNS0xLTEtMA_ee8ad828-08b0-4fe9-ad90-8a8f9eec8689">600</ix:nonFraction>)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net cash used in financing activities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85NC9mcmFnOmEwNGZkMjE3YTk3YjQ1Nzg5OWYyZTRlY2M2OGVmOTEwL3RhYmxlOmZhYTkxYWJmNjdkYzQ3ODdhY2NjZTgwNTcwMzUyZTU1L3RhYmxlcmFuZ2U6ZmFhOTFhYmY2N2RjNDc4N2FjY2NlODA1NzAzNTJlNTVfMzktMS0xLTEtMA_83e8f827-bbd4-4635-9576-de9edb389d12">1,317</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia31e9a409b874bb19d0ff6f2f39ecc09_D20190701-20200630" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85NC9mcmFnOmEwNGZkMjE3YTk3YjQ1Nzg5OWYyZTRlY2M2OGVmOTEwL3RhYmxlOmZhYTkxYWJmNjdkYzQ3ODdhY2NjZTgwNTcwMzUyZTU1L3RhYmxlcmFuZ2U6ZmFhOTFhYmY2N2RjNDc4N2FjY2NlODA1NzAzNTJlNTVfMzktMy0xLTEtMA_1363dfdb-723a-4aa5-853a-6367435fdab7">2,200</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i00a6d666bf604826b24e68ddbd63eac4_D20180701-20190630" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85NC9mcmFnOmEwNGZkMjE3YTk3YjQ1Nzg5OWYyZTRlY2M2OGVmOTEwL3RhYmxlOmZhYTkxYWJmNjdkYzQ3ODdhY2NjZTgwNTcwMzUyZTU1L3RhYmxlcmFuZ2U6ZmFhOTFhYmY2N2RjNDc4N2FjY2NlODA1NzAzNTJlNTVfMzktNS0xLTEtMA_9cfd9a91-7193-4eb2-9035-b4313e9ceca3">2,293</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Effect of exchange rates changes on cash and equivalents</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630" decimals="-6" name="us-gaap:EffectOfExchangeRateOnCashAndCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85NC9mcmFnOmEwNGZkMjE3YTk3YjQ1Nzg5OWYyZTRlY2M2OGVmOTEwL3RhYmxlOmZhYTkxYWJmNjdkYzQ3ODdhY2NjZTgwNTcwMzUyZTU1L3RhYmxlcmFuZ2U6ZmFhOTFhYmY2N2RjNDc4N2FjY2NlODA1NzAzNTJlNTVfNDAtMS0xLTEtMA_7bafcbbc-13f0-4852-a840-d6fe94d7c38b">11</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia31e9a409b874bb19d0ff6f2f39ecc09_D20190701-20200630" decimals="-6" sign="-" name="us-gaap:EffectOfExchangeRateOnCashAndCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85NC9mcmFnOmEwNGZkMjE3YTk3YjQ1Nzg5OWYyZTRlY2M2OGVmOTEwL3RhYmxlOmZhYTkxYWJmNjdkYzQ3ODdhY2NjZTgwNTcwMzUyZTU1L3RhYmxlcmFuZ2U6ZmFhOTFhYmY2N2RjNDc4N2FjY2NlODA1NzAzNTJlNTVfNDAtMy0xLTEtMA_5f2eee34-e3af-499d-a12f-6d8420c6a39a">13</ix:nonFraction>)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i00a6d666bf604826b24e68ddbd63eac4_D20180701-20190630" decimals="-6" name="us-gaap:EffectOfExchangeRateOnCashAndCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85NC9mcmFnOmEwNGZkMjE3YTk3YjQ1Nzg5OWYyZTRlY2M2OGVmOTEwL3RhYmxlOmZhYTkxYWJmNjdkYzQ3ODdhY2NjZTgwNTcwMzUyZTU1L3RhYmxlcmFuZ2U6ZmFhOTFhYmY2N2RjNDc4N2FjY2NlODA1NzAzNTJlNTVfNDAtNS0xLTEtMA_8a71b5c0-6123-4aed-9bc9-a88236eeda0c">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cash reclassified to assets held for sale</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630" decimals="-6" sign="-" name="cah:CashReclassifiedtoAssetsHeldforSale" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85NC9mcmFnOmEwNGZkMjE3YTk3YjQ1Nzg5OWYyZTRlY2M2OGVmOTEwL3RhYmxlOmZhYTkxYWJmNjdkYzQ3ODdhY2NjZTgwNTcwMzUyZTU1L3RhYmxlcmFuZ2U6ZmFhOTFhYmY2N2RjNDc4N2FjY2NlODA1NzAzNTJlNTVfNDEtMS0xLTEtMA_c548da81-be9a-4a24-99c0-88e31aad02fc">109</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia31e9a409b874bb19d0ff6f2f39ecc09_D20190701-20200630" decimals="-6" format="ixt:zerodash" name="cah:CashReclassifiedtoAssetsHeldforSale" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85NC9mcmFnOmEwNGZkMjE3YTk3YjQ1Nzg5OWYyZTRlY2M2OGVmOTEwL3RhYmxlOmZhYTkxYWJmNjdkYzQ3ODdhY2NjZTgwNTcwMzUyZTU1L3RhYmxlcmFuZ2U6ZmFhOTFhYmY2N2RjNDc4N2FjY2NlODA1NzAzNTJlNTVfNDEtMy0xLTEtMA_ee83ab31-c4a6-4609-9674-848adc509319">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i00a6d666bf604826b24e68ddbd63eac4_D20180701-20190630" decimals="-6" format="ixt:zerodash" name="cah:CashReclassifiedtoAssetsHeldforSale" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85NC9mcmFnOmEwNGZkMjE3YTk3YjQ1Nzg5OWYyZTRlY2M2OGVmOTEwL3RhYmxlOmZhYTkxYWJmNjdkYzQ3ODdhY2NjZTgwNTcwMzUyZTU1L3RhYmxlcmFuZ2U6ZmFhOTFhYmY2N2RjNDc4N2FjY2NlODA1NzAzNTJlNTVfNDEtNS0xLTEtMA_01478922-a5ed-4d2f-8822-73cab9ac6d73">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net increase in cash and equivalents</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85NC9mcmFnOmEwNGZkMjE3YTk3YjQ1Nzg5OWYyZTRlY2M2OGVmOTEwL3RhYmxlOmZhYTkxYWJmNjdkYzQ3ODdhY2NjZTgwNTcwMzUyZTU1L3RhYmxlcmFuZ2U6ZmFhOTFhYmY2N2RjNDc4N2FjY2NlODA1NzAzNTJlNTVfNDItMS0xLTEtMA_7a7f328a-2bac-48f5-9047-46dd87058587">636</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia31e9a409b874bb19d0ff6f2f39ecc09_D20190701-20200630" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85NC9mcmFnOmEwNGZkMjE3YTk3YjQ1Nzg5OWYyZTRlY2M2OGVmOTEwL3RhYmxlOmZhYTkxYWJmNjdkYzQ3ODdhY2NjZTgwNTcwMzUyZTU1L3RhYmxlcmFuZ2U6ZmFhOTFhYmY2N2RjNDc4N2FjY2NlODA1NzAzNTJlNTVfNDItMy0xLTEtMA_655d3065-d71c-42db-bec7-506bd38da2f3">240</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i00a6d666bf604826b24e68ddbd63eac4_D20180701-20190630" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85NC9mcmFnOmEwNGZkMjE3YTk3YjQ1Nzg5OWYyZTRlY2M2OGVmOTEwL3RhYmxlOmZhYTkxYWJmNjdkYzQ3ODdhY2NjZTgwNTcwMzUyZTU1L3RhYmxlcmFuZ2U6ZmFhOTFhYmY2N2RjNDc4N2FjY2NlODA1NzAzNTJlNTVfNDItNS0xLTEtMA_c0961f3a-c5c2-426c-af25-061a6d6ad1b9">768</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cash and equivalents at beginning of period</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i299cea70f47b4fbe96772aaa8cc00b79_I20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85NC9mcmFnOmEwNGZkMjE3YTk3YjQ1Nzg5OWYyZTRlY2M2OGVmOTEwL3RhYmxlOmZhYTkxYWJmNjdkYzQ3ODdhY2NjZTgwNTcwMzUyZTU1L3RhYmxlcmFuZ2U6ZmFhOTFhYmY2N2RjNDc4N2FjY2NlODA1NzAzNTJlNTVfNDMtMS0xLTEtMA_07e5b125-5f4c-4e41-bb4b-a55d9f0d28ea">2,771</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if6dc09eec4e74751b47cdf037a5b1860_I20190630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85NC9mcmFnOmEwNGZkMjE3YTk3YjQ1Nzg5OWYyZTRlY2M2OGVmOTEwL3RhYmxlOmZhYTkxYWJmNjdkYzQ3ODdhY2NjZTgwNTcwMzUyZTU1L3RhYmxlcmFuZ2U6ZmFhOTFhYmY2N2RjNDc4N2FjY2NlODA1NzAzNTJlNTVfNDMtMy0xLTEtMA_baa5e6bf-e62c-458a-9b4b-b2aaafd4712e">2,531</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39bbe70148ff4daea469e8420c1859d6_I20180630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85NC9mcmFnOmEwNGZkMjE3YTk3YjQ1Nzg5OWYyZTRlY2M2OGVmOTEwL3RhYmxlOmZhYTkxYWJmNjdkYzQ3ODdhY2NjZTgwNTcwMzUyZTU1L3RhYmxlcmFuZ2U6ZmFhOTFhYmY2N2RjNDc4N2FjY2NlODA1NzAzNTJlNTVfNDMtNS0xLTEtMA_9a0c7710-6125-4613-8be5-704f66bdf201">1,763</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cash and equivalents at end of period</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2e87824102b34590a0208cc7da91b5f5_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85NC9mcmFnOmEwNGZkMjE3YTk3YjQ1Nzg5OWYyZTRlY2M2OGVmOTEwL3RhYmxlOmZhYTkxYWJmNjdkYzQ3ODdhY2NjZTgwNTcwMzUyZTU1L3RhYmxlcmFuZ2U6ZmFhOTFhYmY2N2RjNDc4N2FjY2NlODA1NzAzNTJlNTVfNDQtMS0xLTEtMA_a37da982-62c8-4556-a68e-dcec22257c6d">3,407</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i299cea70f47b4fbe96772aaa8cc00b79_I20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85NC9mcmFnOmEwNGZkMjE3YTk3YjQ1Nzg5OWYyZTRlY2M2OGVmOTEwL3RhYmxlOmZhYTkxYWJmNjdkYzQ3ODdhY2NjZTgwNTcwMzUyZTU1L3RhYmxlcmFuZ2U6ZmFhOTFhYmY2N2RjNDc4N2FjY2NlODA1NzAzNTJlNTVfNDQtMy0xLTEtMA_cf23685f-4f44-4d65-914c-6c8b62a4b2a6">2,771</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if6dc09eec4e74751b47cdf037a5b1860_I20190630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85NC9mcmFnOmEwNGZkMjE3YTk3YjQ1Nzg5OWYyZTRlY2M2OGVmOTEwL3RhYmxlOmZhYTkxYWJmNjdkYzQ3ODdhY2NjZTgwNTcwMzUyZTU1L3RhYmxlcmFuZ2U6ZmFhOTFhYmY2N2RjNDc4N2FjY2NlODA1NzAzNTJlNTVfNDQtNS0xLTEtMA_e53311ae-23ba-40bc-be25-efb43664d687">2,531</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Supplemental Information:</span></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cash payments for interest</span></td><td style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630" decimals="-6" name="us-gaap:InterestPaidNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85NC9mcmFnOmEwNGZkMjE3YTk3YjQ1Nzg5OWYyZTRlY2M2OGVmOTEwL3RhYmxlOmZhYTkxYWJmNjdkYzQ3ODdhY2NjZTgwNTcwMzUyZTU1L3RhYmxlcmFuZ2U6ZmFhOTFhYmY2N2RjNDc4N2FjY2NlODA1NzAzNTJlNTVfNDYtMS0xLTEtMA_eddf4cf9-ea81-49a4-bfdf-bd8395a63c55">182</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia31e9a409b874bb19d0ff6f2f39ecc09_D20190701-20200630" decimals="-6" name="us-gaap:InterestPaidNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85NC9mcmFnOmEwNGZkMjE3YTk3YjQ1Nzg5OWYyZTRlY2M2OGVmOTEwL3RhYmxlOmZhYTkxYWJmNjdkYzQ3ODdhY2NjZTgwNTcwMzUyZTU1L3RhYmxlcmFuZ2U6ZmFhOTFhYmY2N2RjNDc4N2FjY2NlODA1NzAzNTJlNTVfNDYtMy0xLTEtMA_b239b213-d064-421d-8294-dfc9b351b44e">226</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i00a6d666bf604826b24e68ddbd63eac4_D20180701-20190630" decimals="-6" name="us-gaap:InterestPaidNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85NC9mcmFnOmEwNGZkMjE3YTk3YjQ1Nzg5OWYyZTRlY2M2OGVmOTEwL3RhYmxlOmZhYTkxYWJmNjdkYzQ3ODdhY2NjZTgwNTcwMzUyZTU1L3RhYmxlcmFuZ2U6ZmFhOTFhYmY2N2RjNDc4N2FjY2NlODA1NzAzNTJlNTVfNDYtNS0xLTEtMA_33e10ca9-ebd6-4f95-aedd-23a59ca11ddb">285</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cash payments for income taxes</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630" decimals="-6" name="us-gaap:IncomeTaxesPaidNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85NC9mcmFnOmEwNGZkMjE3YTk3YjQ1Nzg5OWYyZTRlY2M2OGVmOTEwL3RhYmxlOmZhYTkxYWJmNjdkYzQ3ODdhY2NjZTgwNTcwMzUyZTU1L3RhYmxlcmFuZ2U6ZmFhOTFhYmY2N2RjNDc4N2FjY2NlODA1NzAzNTJlNTVfNDctMS0xLTEtMA_2f97f638-9232-4c3c-93cf-4ea75c1afa5d">273</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia31e9a409b874bb19d0ff6f2f39ecc09_D20190701-20200630" decimals="-6" name="us-gaap:IncomeTaxesPaidNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85NC9mcmFnOmEwNGZkMjE3YTk3YjQ1Nzg5OWYyZTRlY2M2OGVmOTEwL3RhYmxlOmZhYTkxYWJmNjdkYzQ3ODdhY2NjZTgwNTcwMzUyZTU1L3RhYmxlcmFuZ2U6ZmFhOTFhYmY2N2RjNDc4N2FjY2NlODA1NzAzNTJlNTVfNDctMy0xLTEtMA_9a239b99-9fff-4b62-8cb2-66eaf700ce0b">368</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i00a6d666bf604826b24e68ddbd63eac4_D20180701-20190630" decimals="-6" name="us-gaap:IncomeTaxesPaidNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85NC9mcmFnOmEwNGZkMjE3YTk3YjQ1Nzg5OWYyZTRlY2M2OGVmOTEwL3RhYmxlOmZhYTkxYWJmNjdkYzQ3ODdhY2NjZTgwNTcwMzUyZTU1L3RhYmxlcmFuZ2U6ZmFhOTFhYmY2N2RjNDc4N2FjY2NlODA1NzAzNTJlNTVfNDctNS0xLTEtMA_eeb2695a-682c-4bdd-a13e-0676494896ed">311</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these consolidated statements.</span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:32.135%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.428%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.137%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardinal Health </span><span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">|</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> Fiscal 2021 Form 10-K</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">61</span></div></td></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span><br/></span></div></div></div><div id="i4f0ec56b9c604f1782a65ea4a19c284d_97"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:3pt"><span><br/></span></div><div style="margin-bottom:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:24.720%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:50.989%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.991%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#e41f35;border-bottom:1pt solid #e41f35;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Notes to Financial Statements</span></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:0 1pt"></td></tr></table></div></div><div style="margin-bottom:3pt"><span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:20pt;font-weight:700;line-height:120%">Notes to Consolidated Financial Statements </span></div><div style="margin-bottom:1pt;text-align:center"><span><br/></span></div><div id="i4f0ec56b9c604f1782a65ea4a19c284d_100"></div><div style="width:100.000%"><ix:nonNumeric contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630" name="us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDAvZnJhZzpiYzA3ODhjZjRkZDE0YTM3OGRlYzVjMDA1NTk3Zjc0OS90ZXh0cmVnaW9uOmJjMDc4OGNmNGRkMTRhMzc4ZGVjNWMwMDU1OTdmNzQ5XzM5NjE5_46bda56d-d127-48db-a644-320e64622644" continuedAt="i1cdbbbfccc9d4f03a1bd5dea871a82b8" escape="true"><div style="display:inline-block;vertical-align:top;width:48.214%"><div style="margin-bottom:6pt;text-align:justify"><span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:13pt;font-weight:700;line-height:120%">1. Basis of Presentation and Summary of Significant Accounting Policies </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cardinal Health, Inc. is a globally integrated healthcare services and products company providing customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories and physician offices. We provide pharmaceuticals and medical products and cost-effective solutions that enhance supply chain efficiency. References to &#8220;we&#8221;, &#8220;our&#8221; and similar pronouns in these consolidated financial statements are to Cardinal Health, Inc. and its majority-owned or controlled subsidiaries unless the context otherwise requires.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our fiscal year ends on June&#160;30. References to fiscal 2021, 2020 and 2019 in these consolidated financial statements are to the fiscal years ended June&#160;30, 2021, 2020 and 2019, respectively.</span></div><ix:nonNumeric contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630" name="us-gaap:BasisOfAccountingPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDAvZnJhZzpiYzA3ODhjZjRkZDE0YTM3OGRlYzVjMDA1NTk3Zjc0OS90ZXh0cmVnaW9uOmJjMDc4OGNmNGRkMTRhMzc4ZGVjNWMwMDU1OTdmNzQ5XzM5NTU3_f838702f-5cc1-49de-8f28-e0756b3fee43" escape="true"><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Basis of Presentation</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our consolidated financial statements include the accounts of all majority-owned or controlled subsidiaries, and all significant intercompany transactions and amounts have been eliminated. The results of businesses acquired or disposed of are included in the consolidated financial statements from the date of the acquisition or up to the date of disposal, respectively.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630" name="us-gaap:UseOfEstimates" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDAvZnJhZzpiYzA3ODhjZjRkZDE0YTM3OGRlYzVjMDA1NTk3Zjc0OS90ZXh0cmVnaW9uOmJjMDc4OGNmNGRkMTRhMzc4ZGVjNWMwMDU1OTdmNzQ5XzM5NjY4_5fa4363d-7b1a-4f96-9921-d68d242e34ea" escape="true"><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our consolidated financial statements are prepared in accordance with accounting principles generally accepted in the United States (&#8220;GAAP&#8221;). The preparation of financial statements in accordance with GAAP requires us to make estimates, judgments and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes. Estimates, judgments and assumptions are used in the accounting and disclosure related to, among other items, allowance for doubtful accounts, inventory valuation and reserves, goodwill and other intangible asset impairment, loss contingencies (including product liability and self-insurance accruals), and income taxes. Actual amounts could ultimately differ from these estimated amounts.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The COVID-19 pandemic ("COVID-19") continues to affect the U.S. and global economies, and as previously disclosed, the pandemic began to materially affect our businesses during the third quarter of fiscal 2020. The length and severity of the pandemic and its impacts on our businesses and results of operations are uncertain.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630" name="us-gaap:CashAndCashEquivalentsPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDAvZnJhZzpiYzA3ODhjZjRkZDE0YTM3OGRlYzVjMDA1NTk3Zjc0OS90ZXh0cmVnaW9uOmJjMDc4OGNmNGRkMTRhMzc4ZGVjNWMwMDU1OTdmNzQ5XzM5NTQw_aaf13367-d143-411e-9a7b-7d042d162f60" escape="true"><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Cash Equivalents</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We consider liquid investments purchased with an initial maturity of three months or less to be cash equivalents. The carrying value of cash equivalents approximates fair value.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630" name="us-gaap:ReceivablesPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDAvZnJhZzpiYzA3ODhjZjRkZDE0YTM3OGRlYzVjMDA1NTk3Zjc0OS90ZXh0cmVnaW9uOmJjMDc4OGNmNGRkMTRhMzc4ZGVjNWMwMDU1OTdmNzQ5XzM5NzAz_6f648e5d-5e65-4ef3-b482-f5a025e73ef1" continuedAt="i6d082fa5a0224cf9a42043431b7f1434" escape="true"><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Receivables and Allowance for Doubtful Accounts</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Trade receivables are presented net of an allowance for doubtful accounts of $<ix:nonFraction unitRef="usd" contextRef="iaf39bca192e042209819db3ca973f9f5_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDAvZnJhZzpiYzA3ODhjZjRkZDE0YTM3OGRlYzVjMDA1NTk3Zjc0OS90ZXh0cmVnaW9uOmJjMDc4OGNmNGRkMTRhMzc4ZGVjNWMwMDU1OTdmNzQ5XzI5MjY_e2baecf5-20b7-4918-bf52-772c1465c16b">242</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ida278becedcc42e688e90f303ce681a6_I20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDAvZnJhZzpiYzA3ODhjZjRkZDE0YTM3OGRlYzVjMDA1NTk3Zjc0OS90ZXh0cmVnaW9uOmJjMDc4OGNmNGRkMTRhMzc4ZGVjNWMwMDU1OTdmNzQ5XzI5MzM_a388bfe1-927b-4cb6-b275-454d64e6101e">206</ix:nonFraction> million at June&#160;30, 2021 and 2020, respectively. An account is considered past due on the first </span></div></ix:nonNumeric></div><div style="display:inline-block;max-width:3.571%;min-width:2.571%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:48.215%"><ix:continuation id="i6d082fa5a0224cf9a42043431b7f1434"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">day after its due date. In accordance with contract terms, we generally have the ability to charge customers service fees or higher prices if an account is considered past due. We regularly monitor past due accounts and establish appropriate reserves to cover potential losses, and consider historical experience, the current economic environment, customer credit ratings or bankruptcies, and reasonable and supportable forecasts to develop our allowance for credit losses. We review these factors quarterly to determine if any adjustments are needed to the allowance. We write off any amounts deemed uncollectible against the established allowance for doubtful accounts.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We provide financing to various customers. Such financing arrangements range from <ix:nonNumeric contextRef="ia892a1655a98484e8d25b9944babb1df_D20200701-20210630" format="ixt-sec:duryear" name="cah:ReceivableFinancingAgreementTerm" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDAvZnJhZzpiYzA3ODhjZjRkZDE0YTM3OGRlYzVjMDA1NTk3Zjc0OS90ZXh0cmVnaW9uOmJjMDc4OGNmNGRkMTRhMzc4ZGVjNWMwMDU1OTdmNzQ5XzM1NzQ_3f3fdfa7-888d-4ab9-8370-f4bcfbe9c20a">1</ix:nonNumeric> year&#160;to <ix:nonNumeric contextRef="icc7d995e453e439bb115adae40076bfd_D20200701-20210630" format="ixt-sec:duryear" name="cah:ReceivableFinancingAgreementTerm" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDAvZnJhZzpiYzA3ODhjZjRkZDE0YTM3OGRlYzVjMDA1NTk3Zjc0OS90ZXh0cmVnaW9uOmJjMDc4OGNmNGRkMTRhMzc4ZGVjNWMwMDU1OTdmNzQ5XzM1ODA_329714df-a369-40f0-a89c-a276412c140e">5</ix:nonNumeric> years at interest rates that are generally subject to fluctuation. Interest income on these arrangements is recognized as it is earned. The financings may be collateralized, guaranteed by third parties or unsecured. Finance notes, net and related accrued interest were $<ix:nonFraction unitRef="usd" contextRef="i2e87824102b34590a0208cc7da91b5f5_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:NotesReceivableNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDAvZnJhZzpiYzA3ODhjZjRkZDE0YTM3OGRlYzVjMDA1NTk3Zjc0OS90ZXh0cmVnaW9uOmJjMDc4OGNmNGRkMTRhMzc4ZGVjNWMwMDU1OTdmNzQ5XzM4NDY_76695071-386f-433b-bc01-e8d1693b55b2">63</ix:nonFraction> million (current portion $<ix:nonFraction unitRef="usd" contextRef="i2e87824102b34590a0208cc7da91b5f5_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:NotesAndLoansReceivableNetCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDAvZnJhZzpiYzA3ODhjZjRkZDE0YTM3OGRlYzVjMDA1NTk3Zjc0OS90ZXh0cmVnaW9uOmJjMDc4OGNmNGRkMTRhMzc4ZGVjNWMwMDU1OTdmNzQ5XzM4NjY_41373b3e-87f8-4c87-abe6-2e7ca7751f24">7</ix:nonFraction> million) and $<ix:nonFraction unitRef="usd" contextRef="i299cea70f47b4fbe96772aaa8cc00b79_I20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:NotesReceivableNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDAvZnJhZzpiYzA3ODhjZjRkZDE0YTM3OGRlYzVjMDA1NTk3Zjc0OS90ZXh0cmVnaW9uOmJjMDc4OGNmNGRkMTRhMzc4ZGVjNWMwMDU1OTdmNzQ5XzM4NzQ_bd9206d2-224d-4772-8764-aa436ca21fa6">104</ix:nonFraction> million (current portion $<ix:nonFraction unitRef="usd" contextRef="i299cea70f47b4fbe96772aaa8cc00b79_I20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:NotesAndLoansReceivableNetCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDAvZnJhZzpiYzA3ODhjZjRkZDE0YTM3OGRlYzVjMDA1NTk3Zjc0OS90ZXh0cmVnaW9uOmJjMDc4OGNmNGRkMTRhMzc4ZGVjNWMwMDU1OTdmNzQ5XzM4OTQ_3c8a4b67-7c90-4758-ba6e-42ab4085f951">12</ix:nonFraction> million) at June&#160;30, 2021 and 2020, respectively, and are included in other assets (current portion is included in prepaid expenses and other) in the consolidated balance sheets. Finance notes receivable allowance for doubtful accounts were $<ix:nonFraction unitRef="usd" contextRef="id99ac5e3640e4d909d5ebe92cc1a2ccc_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDAvZnJhZzpiYzA3ODhjZjRkZDE0YTM3OGRlYzVjMDA1NTk3Zjc0OS90ZXh0cmVnaW9uOmJjMDc4OGNmNGRkMTRhMzc4ZGVjNWMwMDU1OTdmNzQ5XzQ5NDc4MDIzODI1NjI_476f21f1-02dc-4429-bf2f-1ad952e3876b">12</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i8572a6af84c14033a1b8f2ffeeaa45fa_I20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDAvZnJhZzpiYzA3ODhjZjRkZDE0YTM3OGRlYzVjMDA1NTk3Zjc0OS90ZXh0cmVnaW9uOmJjMDc4OGNmNGRkMTRhMzc4ZGVjNWMwMDU1OTdmNzQ5XzQ5NDc4MDIzODI1NzI_6fd0ca3e-3f78-4744-b522-854a7e595f33">27</ix:nonFraction> million at June&#160;30, 2021 and 2020, respectively. We estimate an allowance for these financing receivables based on historical collection rates and the credit worthiness of the customer. We write off any amounts deemed uncollectible against the established allowance for doubtful accounts.</span></div></ix:continuation><ix:nonNumeric contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630" name="us-gaap:ConcentrationRiskCreditRisk" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDAvZnJhZzpiYzA3ODhjZjRkZDE0YTM3OGRlYzVjMDA1NTk3Zjc0OS90ZXh0cmVnaW9uOmJjMDc4OGNmNGRkMTRhMzc4ZGVjNWMwMDU1OTdmNzQ5XzM5Njg3_f9f26915-9563-4caa-b590-c694209c99e6" continuedAt="ida7a686744274419b0750627c770c824" escape="true"><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Concentrations of Credit Risk</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We maintain cash depository accounts with major banks, and we invest in high quality, short-term liquid instruments, and in marketable securities. Our short-term liquid instruments mature within three months and we have not historically incurred any related losses.</span></div></ix:nonNumeric><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ida7a686744274419b0750627c770c824">Our trade receivables and finance notes and related accrued interest are exposed to a concentration of credit risk with certain large customers and with customers in the retail and healthcare sectors. Credit risk can be affected by changes in reimbursement and other economic pressures impacting the healthcare industry. With respect to customers in the retail and healthcare sectors, such credit risk is limited due to supporting collateral and the diversity of the customer base, including its wide geographic dispersion. We perform regular credit evaluations of our customers&#8217; financial conditions and maintain reserves for losses through the established allowance for doubtful accounts. Historically, such losses have been within our expectations. Refer to the "Receivables and Allowance for Doubtful Accounts" section within this Note for additional information on the accounting treatment of reserves for allowance for doubtful accounts.</ix:continuation> </span></div></div></ix:nonNumeric></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:3pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.222%"><tr><td style="width:1.0%"></td><td style="width:32.133%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.433%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.134%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">62</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardinal Health </span><span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">| </span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2021 Form 10-K</span></div></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:3pt"><span><br/></span></div><div style="margin-bottom:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:24.720%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:50.989%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.991%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#e41f35;border-bottom:1pt solid #e41f35;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Notes to Financial Statements</span></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:0 1pt"></td></tr></table></div></div><div style="width:100.000%"><ix:continuation id="i1cdbbbfccc9d4f03a1bd5dea871a82b8" continuedAt="ibbe9d9c6014b48abb0d5b8e2ba3ff5f8"><div style="display:inline-block;vertical-align:top;width:48.214%"><ix:nonNumeric contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630" name="us-gaap:MajorCustomersPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDAvZnJhZzpiYzA3ODhjZjRkZDE0YTM3OGRlYzVjMDA1NTk3Zjc0OS90ZXh0cmVnaW9uOmJjMDc4OGNmNGRkMTRhMzc4ZGVjNWMwMDU1OTdmNzQ5XzM5NzEx_817e66e7-ee1c-4f98-84fc-1a9f7db95dd5" continuedAt="id2e20d86b96c4dd6897796720a106c48" escape="true"><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Major Customers</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CVS Health Corporation ("CVS") and OptumRx, are our only customers that individually account for at least 10 percent of revenue and gross trade receivables. These customers are primarily serviced through our Pharmaceutical segment.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2021, we extended our pharmaceutical distribution agreements with CVS through June 2027. </span></div><ix:nonNumeric contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630" name="us-gaap:ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDAvZnJhZzpiYzA3ODhjZjRkZDE0YTM3OGRlYzVjMDA1NTk3Zjc0OS90ZXh0cmVnaW9uOmJjMDc4OGNmNGRkMTRhMzc4ZGVjNWMwMDU1OTdmNzQ5XzM5NTky_d413f0d4-e4f3-411f-a90d-2eb0a96e8ebb" escape="true"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes historical percent of revenue and gross trade receivables from CVS and OptumRx:</span></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.382%"><tr><td style="width:1.0%"></td><td style="width:35.235%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.148%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.352%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.769%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.352%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.769%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.352%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.632%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.352%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.639%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Percent of Revenue</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Percent&#160;of&#160;Gross Trade&#160;Receivables at June 30</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CVS</span></td><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i9acbd6b22d7142e09e2d233e54af7d6b_D20200701-20210630" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDAvZnJhZzpiYzA3ODhjZjRkZDE0YTM3OGRlYzVjMDA1NTk3Zjc0OS90YWJsZToxMGI5YjljZjkzZTE0NDQ5OTRjYzYzZTViNzhiZThmYi90YWJsZXJhbmdlOjEwYjliOWNmOTNlMTQ0NDk5NGNjNjNlNWI3OGJlOGZiXzItMS0xLTEtMA_d1b7f021-1fda-414d-9ad5-c887e8a8b698">26</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i40defd3d1e074fa6bc03365b87fbc0b2_D20190701-20200630" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDAvZnJhZzpiYzA3ODhjZjRkZDE0YTM3OGRlYzVjMDA1NTk3Zjc0OS90YWJsZToxMGI5YjljZjkzZTE0NDQ5OTRjYzYzZTViNzhiZThmYi90YWJsZXJhbmdlOjEwYjliOWNmOTNlMTQ0NDk5NGNjNjNlNWI3OGJlOGZiXzItMy0xLTEtMA_8a030c56-e44a-4a89-9c8d-77ea87287b61">26</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="if0d0d489f9374df68a492baec5bcd02d_D20180701-20190630" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDAvZnJhZzpiYzA3ODhjZjRkZDE0YTM3OGRlYzVjMDA1NTk3Zjc0OS90YWJsZToxMGI5YjljZjkzZTE0NDQ5OTRjYzYzZTViNzhiZThmYi90YWJsZXJhbmdlOjEwYjliOWNmOTNlMTQ0NDk5NGNjNjNlNWI3OGJlOGZiXzItNS0xLTEtMA_dd61db83-5907-401d-8e9f-da638390382c">26</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i8e11ba21ea4c434ca0730a61f91af07b_I20210630" decimals="2" name="cah:GrossTradeReceivablesMajorCustomerPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDAvZnJhZzpiYzA3ODhjZjRkZDE0YTM3OGRlYzVjMDA1NTk3Zjc0OS90YWJsZToxMGI5YjljZjkzZTE0NDQ5OTRjYzYzZTViNzhiZThmYi90YWJsZXJhbmdlOjEwYjliOWNmOTNlMTQ0NDk5NGNjNjNlNWI3OGJlOGZiXzItNy0xLTEtMA_f3cc50b8-d7d1-4307-9570-696709942133">24</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i26a1dbe593234221b3e2a9fe87790b80_I20200630" decimals="2" name="cah:GrossTradeReceivablesMajorCustomerPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDAvZnJhZzpiYzA3ODhjZjRkZDE0YTM3OGRlYzVjMDA1NTk3Zjc0OS90YWJsZToxMGI5YjljZjkzZTE0NDQ5OTRjYzYzZTViNzhiZThmYi90YWJsZXJhbmdlOjEwYjliOWNmOTNlMTQ0NDk5NGNjNjNlNWI3OGJlOGZiXzItOS0xLTEtMA_39876640-eeb0-4c81-8ff9-90e73c20695f">26</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">OptumRx</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i23c2808f4a0248299010d7304821d021_D20200701-20210630" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDAvZnJhZzpiYzA3ODhjZjRkZDE0YTM3OGRlYzVjMDA1NTk3Zjc0OS90YWJsZToxMGI5YjljZjkzZTE0NDQ5OTRjYzYzZTViNzhiZThmYi90YWJsZXJhbmdlOjEwYjliOWNmOTNlMTQ0NDk5NGNjNjNlNWI3OGJlOGZiXzMtMS0xLTEtMA_5715e260-b661-47f5-b84c-86179cbbbd4b">15</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i59cb1fe9f0d846b1911e81858e217d59_D20190701-20200630" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDAvZnJhZzpiYzA3ODhjZjRkZDE0YTM3OGRlYzVjMDA1NTk3Zjc0OS90YWJsZToxMGI5YjljZjkzZTE0NDQ5OTRjYzYzZTViNzhiZThmYi90YWJsZXJhbmdlOjEwYjliOWNmOTNlMTQ0NDk5NGNjNjNlNWI3OGJlOGZiXzMtMy0xLTEtMA_a3f1b582-7111-40e9-8fa9-e4b9b32320b6">14</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="id8d95892717a49629b3d443c58d7bb6f_D20180701-20190630" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDAvZnJhZzpiYzA3ODhjZjRkZDE0YTM3OGRlYzVjMDA1NTk3Zjc0OS90YWJsZToxMGI5YjljZjkzZTE0NDQ5OTRjYzYzZTViNzhiZThmYi90YWJsZXJhbmdlOjEwYjliOWNmOTNlMTQ0NDk5NGNjNjNlNWI3OGJlOGZiXzMtNS0xLTEtMA_04fd11cb-287d-4fba-89ad-d1d0ac82cc4b">13</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ife972a3c1957499f9517925bfb292b1e_I20210630" decimals="2" name="cah:GrossTradeReceivablesMajorCustomerPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDAvZnJhZzpiYzA3ODhjZjRkZDE0YTM3OGRlYzVjMDA1NTk3Zjc0OS90YWJsZToxMGI5YjljZjkzZTE0NDQ5OTRjYzYzZTViNzhiZThmYi90YWJsZXJhbmdlOjEwYjliOWNmOTNlMTQ0NDk5NGNjNjNlNWI3OGJlOGZiXzMtNy0xLTEtMA_d7d5c023-5046-4cbd-ab6a-e5ac92757cc9">3</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i2603a56be62748bcadc6977aeeb99c1b_I20200630" decimals="2" name="cah:GrossTradeReceivablesMajorCustomerPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDAvZnJhZzpiYzA3ODhjZjRkZDE0YTM3OGRlYzVjMDA1NTk3Zjc0OS90YWJsZToxMGI5YjljZjkzZTE0NDQ5OTRjYzYzZTViNzhiZThmYi90YWJsZXJhbmdlOjEwYjliOWNmOTNlMTQ0NDk5NGNjNjNlNWI3OGJlOGZiXzMtOS0xLTEtMA_18f87e1a-0296-4460-ab0b-b7c5530855ce">6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr></table></div></ix:nonNumeric></ix:nonNumeric><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="id2e20d86b96c4dd6897796720a106c48">We have entered into agreements with group purchasing organizations (&#8220;GPOs&#8221;) which act as purchasing agents that negotiate vendor contracts on behalf of their members. Vizient, Inc. and Premier, Inc. are our <ix:nonFraction unitRef="organization" contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630" decimals="INF" format="ixt-sec:numwordsen" name="cah:ConcentrationRiskLargestGroupPurchasingOrganizations" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDAvZnJhZzpiYzA3ODhjZjRkZDE0YTM3OGRlYzVjMDA1NTk3Zjc0OS90ZXh0cmVnaW9uOmJjMDc4OGNmNGRkMTRhMzc4ZGVjNWMwMDU1OTdmNzQ5XzYyMDY_da0f3c10-60b7-4c6f-9e23-738466527940">two</ix:nonFraction> largest GPO member relationships in terms of revenue. Sales to members of these <ix:nonFraction unitRef="organization" contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630" decimals="INF" format="ixt-sec:numwordsen" name="cah:ConcentrationRiskLargestGroupPurchasingOrganizations" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDAvZnJhZzpiYzA3ODhjZjRkZDE0YTM3OGRlYzVjMDA1NTk3Zjc0OS90ZXh0cmVnaW9uOmJjMDc4OGNmNGRkMTRhMzc4ZGVjNWMwMDU1OTdmNzQ5XzYyODk_da0f3c10-60b7-4c6f-9e23-738466527940">two</ix:nonFraction> GPOs collectively accounted for <ix:nonFraction unitRef="number" contextRef="i9ff517d7ac9a411688a31be9bf4cb05e_D20200701-20210630" decimals="2" format="ixt:numdotdecimal" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDAvZnJhZzpiYzA3ODhjZjRkZDE0YTM3OGRlYzVjMDA1NTk3Zjc0OS90ZXh0cmVnaW9uOmJjMDc4OGNmNGRkMTRhMzc4ZGVjNWMwMDU1OTdmNzQ5XzYzMjQ_48bd2286-84fc-414b-994d-4e663c68d41f">15</ix:nonFraction> percent, <ix:nonFraction unitRef="number" contextRef="i996d2cdb68d6466fbd2b2c5d332e8f86_D20190701-20200630" decimals="2" format="ixt:numdotdecimal" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDAvZnJhZzpiYzA3ODhjZjRkZDE0YTM3OGRlYzVjMDA1NTk3Zjc0OS90ZXh0cmVnaW9uOmJjMDc4OGNmNGRkMTRhMzc4ZGVjNWMwMDU1OTdmNzQ5XzYzMjg_4c4b7351-4ab7-4b3d-96df-e91d069fdd73">16</ix:nonFraction> percent and <ix:nonFraction unitRef="number" contextRef="i9ac168f728314508a0b6274f4b016f43_D20180701-20190630" decimals="2" format="ixt:numdotdecimal" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDAvZnJhZzpiYzA3ODhjZjRkZDE0YTM3OGRlYzVjMDA1NTk3Zjc0OS90ZXh0cmVnaW9uOmJjMDc4OGNmNGRkMTRhMzc4ZGVjNWMwMDU1OTdmNzQ5XzYzMzU_72785fee-01cd-4cd1-a7c1-cb8f753c8fd5">22</ix:nonFraction> percent of revenue for fiscal 2021, 2020 and 2019, respectively. Our trade receivable balances are with individual members of the GPO, and therefore no significant concentration of credit risk exists with these types of arrangements</ix:continuation>.</span></div><ix:nonNumeric contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630" name="us-gaap:InventoryPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDAvZnJhZzpiYzA3ODhjZjRkZDE0YTM3OGRlYzVjMDA1NTk3Zjc0OS90ZXh0cmVnaW9uOmJjMDc4OGNmNGRkMTRhMzc4ZGVjNWMwMDU1OTdmNzQ5XzM5NjY5_0d8b263b-b48a-4e72-9d37-b543d6277ccc" continuedAt="i1e555ac34be0463289ead68d3448bd41" escape="true"><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Inventories</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A portion of our inventories (<ix:nonFraction unitRef="number" contextRef="i2e87824102b34590a0208cc7da91b5f5_I20210630" decimals="2" format="ixt:numdotdecimal" name="us-gaap:PercentageOfLIFOInventory" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDAvZnJhZzpiYzA3ODhjZjRkZDE0YTM3OGRlYzVjMDA1NTk3Zjc0OS90ZXh0cmVnaW9uOmJjMDc4OGNmNGRkMTRhMzc4ZGVjNWMwMDU1OTdmNzQ5XzY2MTI_19857964-ee03-4931-ba4c-53afb2fdb534">50</ix:nonFraction> percent and <ix:nonFraction unitRef="number" contextRef="i299cea70f47b4fbe96772aaa8cc00b79_I20200630" decimals="2" format="ixt:numdotdecimal" name="us-gaap:PercentageOfLIFOInventory" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDAvZnJhZzpiYzA3ODhjZjRkZDE0YTM3OGRlYzVjMDA1NTk3Zjc0OS90ZXh0cmVnaW9uOmJjMDc4OGNmNGRkMTRhMzc4ZGVjNWMwMDU1OTdmNzQ5XzQ5NDc4MDIzODIzNzc_bc5ff157-961a-4e30-92d8-baab64d29df3">56</ix:nonFraction> percent at June&#160;30, 2021 and 2020, respectively) are valued at the lower of cost, using the last-in, first-out ("LIFO") method, or market. These inventories are included within the core pharmaceutical distribution facilities of our Pharmaceutical segment (&#8220;distribution facilities&#8221;) and are primarily merchandise inventories. The LIFO method presumes that the most recent inventory purchases are the first items sold, so LIFO helps us better match current costs and revenue. We believe that the average cost method of inventory valuation provides a reasonable approximation of the current cost of replacing inventory within the distribution facilities. As such, the LIFO reserve is the difference between (a) inventory at the lower of LIFO cost or market and (b) inventory at replacement cost determined using the average cost method of inventory valuation.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At June&#160;30, 2021 and 2020, respectively, inventories valued at LIFO cost were $<ix:nonFraction unitRef="usd" contextRef="i2e87824102b34590a0208cc7da91b5f5_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:InventoryLIFOReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDAvZnJhZzpiYzA3ODhjZjRkZDE0YTM3OGRlYzVjMDA1NTk3Zjc0OS90ZXh0cmVnaW9uOmJjMDc4OGNmNGRkMTRhMzc4ZGVjNWMwMDU1OTdmNzQ5Xzc1MDg_1d921f53-8043-470e-a58d-9adcc4e36bcf">565</ix:nonFraction> million and</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$<ix:nonFraction unitRef="usd" contextRef="i299cea70f47b4fbe96772aaa8cc00b79_I20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:InventoryLIFOReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDAvZnJhZzpiYzA3ODhjZjRkZDE0YTM3OGRlYzVjMDA1NTk3Zjc0OS90ZXh0cmVnaW9uOmJjMDc4OGNmNGRkMTRhMzc4ZGVjNWMwMDU1OTdmNzQ5Xzc1MTU_caf07329-39ed-410f-a51e-f705d995ee77">411</ix:nonFraction> million higher than the average cost value. We do not record inventories in excess of replacement cost. As such, we did not write-up the value of our inventory from average cost to LIFO cost at June&#160;30, 2021 or 2020. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our remaining inventory, including inventory in our Medical segment, that is not valued at the lower of LIFO cost or market is stated at the lower of cost, using the first-in, first-out method, or net realizable value. Net realizable value is defined as the estimated selling prices and estimated sales demand in the ordinary course of business, less reasonably predictable costs of completion, disposal and transportation. Due to the unprecedented demand for </span></div></ix:nonNumeric></div><div style="display:inline-block;max-width:3.571%;min-width:2.571%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:48.215%"><ix:continuation id="i1e555ac34be0463289ead68d3448bd41"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">certain personal protective equipment as a result of COVID-19, our Medical segment manufactured and sourced inventory at higher costs than in periods prior to COVID-19. Personal protective equipment ("PPE") refers to protective clothing, medical and non-medical grade gloves, face shields, face masks and other equipment designed to protect the wearer from injury or the spread of infection or illness. As selling prices and customer demand have decreased compared to the peak of COVID-19, we recorded a reserve of $<ix:nonFraction unitRef="usd" contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:InventoryWriteDown" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDAvZnJhZzpiYzA3ODhjZjRkZDE0YTM3OGRlYzVjMDA1NTk3Zjc0OS90ZXh0cmVnaW9uOmJjMDc4OGNmNGRkMTRhMzc4ZGVjNWMwMDU1OTdmNzQ5XzIxOTkwMjMzMjIzNzA_0af402cc-5b40-4426-b043-8125e75c2161">197</ix:nonFraction>&#160;million, primarily related to certain categories of gloves, to reduce the carrying value of certain PPE to its net realizable value.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We reserve for inventory obsolescence using estimates based on historical experience, historical and projected sales trends, specific&#160;categories of inventory, age and expiration dates of on-hand inventory and manufacturer return policies. Inventories presented in the consolidated balance sheets are net of reserves for excess and obsolete inventory which were $<ix:nonFraction unitRef="usd" contextRef="i2e87824102b34590a0208cc7da91b5f5_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:InventoryValuationReserves" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDAvZnJhZzpiYzA3ODhjZjRkZDE0YTM3OGRlYzVjMDA1NTk3Zjc0OS90ZXh0cmVnaW9uOmJjMDc4OGNmNGRkMTRhMzc4ZGVjNWMwMDU1OTdmNzQ5XzEyMDk0NjI3OTYzNjYx_e5975be3-df1c-4ebf-aed6-f7151b648478">185</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i299cea70f47b4fbe96772aaa8cc00b79_I20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:InventoryValuationReserves" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDAvZnJhZzpiYzA3ODhjZjRkZDE0YTM3OGRlYzVjMDA1NTk3Zjc0OS90ZXh0cmVnaW9uOmJjMDc4OGNmNGRkMTRhMzc4ZGVjNWMwMDU1OTdmNzQ5XzEyMDk0NjI3OTYzNjcw_74f33589-015c-4e75-8957-d290d52cecbd">155</ix:nonFraction> million at June&#160;30, 2021 and 2020, respectively.</span></div></ix:continuation><ix:nonNumeric contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630" name="cah:CashDiscountsPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDAvZnJhZzpiYzA3ODhjZjRkZDE0YTM3OGRlYzVjMDA1NTk3Zjc0OS90ZXh0cmVnaW9uOmJjMDc4OGNmNGRkMTRhMzc4ZGVjNWMwMDU1OTdmNzQ5XzM5NTQx_8ce7f488-4f68-40c1-a0c6-d6a952acbd6c" escape="true"><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Cash Discounts</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Manufacturer cash discounts are recorded as a component of inventory cost and recognized as a reduction of cost of products sold as inventory is sold.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630" name="us-gaap:PropertyPlantAndEquipmentPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDAvZnJhZzpiYzA3ODhjZjRkZDE0YTM3OGRlYzVjMDA1NTk3Zjc0OS90ZXh0cmVnaW9uOmJjMDc4OGNmNGRkMTRhMzc4ZGVjNWMwMDU1OTdmNzQ5XzM5NjI3_830b3b01-48e5-4b12-b8e0-d4fdb8a0cecf" continuedAt="i173e7457b2414768b1f7995be28a46f5" escape="true"><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Property and Equipment</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Property and equipment are carried at cost less accumulated depreciation. Property and equipment held for sale are recorded at the lower of cost less accumulated depreciation before the decision to dispose of the asset was made or fair value less cost to sell. When certain events or changes in operating conditions occur, an impairment assessment may be performed on the recoverability of the carrying amounts.</span></div><div style="margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Depreciation expense is computed using the straight-line method over the estimated useful lives of the assets, including finance lease assets which are depreciated over the terms of their respective leases. We generally use the following range of useful lives for our property and equipment categories: buildings and improvements&#8212;<ix:nonNumeric contextRef="i614ddf8189e1435c9f69debafd0268da_D20200701-20210630" format="ixt-sec:duryear" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDAvZnJhZzpiYzA3ODhjZjRkZDE0YTM3OGRlYzVjMDA1NTk3Zjc0OS90ZXh0cmVnaW9uOmJjMDc4OGNmNGRkMTRhMzc4ZGVjNWMwMDU1OTdmNzQ5XzkzMTU_1e6e74b8-b823-4418-996d-22db8ec9b959">3</ix:nonNumeric> to <ix:nonNumeric contextRef="i74619ac5c2144773b658fb4dc96df2b7_D20200701-20210630" format="ixt-sec:duryear" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDAvZnJhZzpiYzA3ODhjZjRkZDE0YTM3OGRlYzVjMDA1NTk3Zjc0OS90ZXh0cmVnaW9uOmJjMDc4OGNmNGRkMTRhMzc4ZGVjNWMwMDU1OTdmNzQ5XzkzMjE_b7cbb8f6-be12-453d-8572-89ab1cf4718b">39</ix:nonNumeric> years; machinery and equipment&#8212;<ix:nonNumeric contextRef="i4462638f30ef4b028287aa4982bcdc4f_D20200701-20210630" format="ixt-sec:duryear" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDAvZnJhZzpiYzA3ODhjZjRkZDE0YTM3OGRlYzVjMDA1NTk3Zjc0OS90ZXh0cmVnaW9uOmJjMDc4OGNmNGRkMTRhMzc4ZGVjNWMwMDU1OTdmNzQ5XzkzNDk_2e03d07f-c528-458a-a32b-4c1c91153dd7">3</ix:nonNumeric> to <ix:nonNumeric contextRef="i931fb7e29527410db9aa126b3ff884f1_D20200701-20210630" format="ixt-sec:duryear" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDAvZnJhZzpiYzA3ODhjZjRkZDE0YTM3OGRlYzVjMDA1NTk3Zjc0OS90ZXh0cmVnaW9uOmJjMDc4OGNmNGRkMTRhMzc4ZGVjNWMwMDU1OTdmNzQ5XzkzNTU_f06405b9-38e8-4470-9e96-73d4e9ea4bfd">20</ix:nonNumeric> years; and furniture and fixtures&#8212;<ix:nonNumeric contextRef="i8ffd747abee84446822890ec937c3087_D20200701-20210630" format="ixt-sec:duryear" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDAvZnJhZzpiYzA3ODhjZjRkZDE0YTM3OGRlYzVjMDA1NTk3Zjc0OS90ZXh0cmVnaW9uOmJjMDc4OGNmNGRkMTRhMzc4ZGVjNWMwMDU1OTdmNzQ5XzkzODY_c2ba5d38-6093-490b-9076-5b6b8eecc3d8">3</ix:nonNumeric> to <ix:nonNumeric contextRef="i761e5d4debc244e2b82864c57e70fa08_D20200701-20210630" format="ixt-sec:duryear" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDAvZnJhZzpiYzA3ODhjZjRkZDE0YTM3OGRlYzVjMDA1NTk3Zjc0OS90ZXh0cmVnaW9uOmJjMDc4OGNmNGRkMTRhMzc4ZGVjNWMwMDU1OTdmNzQ5XzkzOTI_335d86d9-08af-4dcc-8e5c-8e25e13b59c5">7</ix:nonNumeric> years. We recorded depreciation and amortization expense of $<ix:nonFraction unitRef="usd" contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Depreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDAvZnJhZzpiYzA3ODhjZjRkZDE0YTM3OGRlYzVjMDA1NTk3Zjc0OS90ZXh0cmVnaW9uOmJjMDc4OGNmNGRkMTRhMzc4ZGVjNWMwMDU1OTdmNzQ5Xzk0NDk_9754d1e3-7f50-4f8b-a4e8-857607417365">377</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="ia31e9a409b874bb19d0ff6f2f39ecc09_D20190701-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Depreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDAvZnJhZzpiYzA3ODhjZjRkZDE0YTM3OGRlYzVjMDA1NTk3Zjc0OS90ZXh0cmVnaW9uOmJjMDc4OGNmNGRkMTRhMzc4ZGVjNWMwMDU1OTdmNzQ5Xzk0NTM_64296993-0aab-4cf8-8931-6ca147ed5aa5">405</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i00a6d666bf604826b24e68ddbd63eac4_D20180701-20190630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Depreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDAvZnJhZzpiYzA3ODhjZjRkZDE0YTM3OGRlYzVjMDA1NTk3Zjc0OS90ZXh0cmVnaW9uOmJjMDc4OGNmNGRkMTRhMzc4ZGVjNWMwMDU1OTdmNzQ5Xzk0NjA_b0d4e260-2fde-43d0-8369-dac58629ddd3">455</ix:nonFraction> million for fiscal 2021, 2020 and 2019, respectively.</span></div><ix:nonNumeric contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630" name="us-gaap:PropertyPlantAndEquipmentTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDAvZnJhZzpiYzA3ODhjZjRkZDE0YTM3OGRlYzVjMDA1NTk3Zjc0OS90ZXh0cmVnaW9uOmJjMDc4OGNmNGRkMTRhMzc4ZGVjNWMwMDU1OTdmNzQ5XzM5NzE2_c858f00f-54c9-4b85-bf8a-53376cc763a7" escape="true"><div style="margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the components of property and equipment, net at June&#160;30:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:62.788%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.183%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.343%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.186%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Land, building and improvements</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i863c52bff06f4314bb6767d10ced9400_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDAvZnJhZzpiYzA3ODhjZjRkZDE0YTM3OGRlYzVjMDA1NTk3Zjc0OS90YWJsZTphMzkwOGY5YWViNDI0MzA0OTY4ZjQ3OWE1ODIyYzFiMS90YWJsZXJhbmdlOmEzOTA4ZjlhZWI0MjQzMDQ5NjhmNDc5YTU4MjJjMWIxXzEtMS0xLTEtMA_42bd4456-63aa-4595-9163-222c2e610831">2,359</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia665b083fde8404d909e9610ecbf7ad2_I20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDAvZnJhZzpiYzA3ODhjZjRkZDE0YTM3OGRlYzVjMDA1NTk3Zjc0OS90YWJsZTphMzkwOGY5YWViNDI0MzA0OTY4ZjQ3OWE1ODIyYzFiMS90YWJsZXJhbmdlOmEzOTA4ZjlhZWI0MjQzMDQ5NjhmNDc5YTU4MjJjMWIxXzEtMy0xLTEtMA_f1db9bf1-cb29-4892-a500-528bcf463c66">2,185</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Machinery and equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic27322390092452ca30941dd0197b1c6_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDAvZnJhZzpiYzA3ODhjZjRkZDE0YTM3OGRlYzVjMDA1NTk3Zjc0OS90YWJsZTphMzkwOGY5YWViNDI0MzA0OTY4ZjQ3OWE1ODIyYzFiMS90YWJsZXJhbmdlOmEzOTA4ZjlhZWI0MjQzMDQ5NjhmNDc5YTU4MjJjMWIxXzItMS0xLTEtMA_a67c33f9-6a57-46cc-9bb2-2e681b201843">3,093</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia561b68251434cae953175730691825e_I20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDAvZnJhZzpiYzA3ODhjZjRkZDE0YTM3OGRlYzVjMDA1NTk3Zjc0OS90YWJsZTphMzkwOGY5YWViNDI0MzA0OTY4ZjQ3OWE1ODIyYzFiMS90YWJsZXJhbmdlOmEzOTA4ZjlhZWI0MjQzMDQ5NjhmNDc5YTU4MjJjMWIxXzItMy0xLTEtMA_187ca5fd-685b-44fe-b9dd-e889562eb814">3,008</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Furniture and fixtures</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i98ce0cd9b3ce4100a31e1cfb9d99189d_I20210630" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDAvZnJhZzpiYzA3ODhjZjRkZDE0YTM3OGRlYzVjMDA1NTk3Zjc0OS90YWJsZTphMzkwOGY5YWViNDI0MzA0OTY4ZjQ3OWE1ODIyYzFiMS90YWJsZXJhbmdlOmEzOTA4ZjlhZWI0MjQzMDQ5NjhmNDc5YTU4MjJjMWIxXzMtMS0xLTEtMA_49e5ebf3-d7e0-4367-80f9-f03682cbd6df">136</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4e7acf9f1e1840958a192fad32010e75_I20200630" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDAvZnJhZzpiYzA3ODhjZjRkZDE0YTM3OGRlYzVjMDA1NTk3Zjc0OS90YWJsZTphMzkwOGY5YWViNDI0MzA0OTY4ZjQ3OWE1ODIyYzFiMS90YWJsZXJhbmdlOmEzOTA4ZjlhZWI0MjQzMDQ5NjhmNDc5YTU4MjJjMWIxXzMtMy0xLTEtMA_d6da300e-7f50-4812-b6fe-2e35bb02003b">138</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total property and equipment, at cost</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2e87824102b34590a0208cc7da91b5f5_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDAvZnJhZzpiYzA3ODhjZjRkZDE0YTM3OGRlYzVjMDA1NTk3Zjc0OS90YWJsZTphMzkwOGY5YWViNDI0MzA0OTY4ZjQ3OWE1ODIyYzFiMS90YWJsZXJhbmdlOmEzOTA4ZjlhZWI0MjQzMDQ5NjhmNDc5YTU4MjJjMWIxXzQtMS0xLTEtMA_0ce89af2-6a8d-4396-acf2-42c86a875166">5,588</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i299cea70f47b4fbe96772aaa8cc00b79_I20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDAvZnJhZzpiYzA3ODhjZjRkZDE0YTM3OGRlYzVjMDA1NTk3Zjc0OS90YWJsZTphMzkwOGY5YWViNDI0MzA0OTY4ZjQ3OWE1ODIyYzFiMS90YWJsZXJhbmdlOmEzOTA4ZjlhZWI0MjQzMDQ5NjhmNDc5YTU4MjJjMWIxXzQtMy0xLTEtMA_741f3c31-b5de-4530-be82-b0bad73c3f09">5,331</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accumulated depreciation and amortization</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2e87824102b34590a0208cc7da91b5f5_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDAvZnJhZzpiYzA3ODhjZjRkZDE0YTM3OGRlYzVjMDA1NTk3Zjc0OS90YWJsZTphMzkwOGY5YWViNDI0MzA0OTY4ZjQ3OWE1ODIyYzFiMS90YWJsZXJhbmdlOmEzOTA4ZjlhZWI0MjQzMDQ5NjhmNDc5YTU4MjJjMWIxXzUtMS0xLTEtMA_18c9e19c-5657-424b-b55a-74e122c33897">3,228</ix:nonFraction>)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i299cea70f47b4fbe96772aaa8cc00b79_I20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDAvZnJhZzpiYzA3ODhjZjRkZDE0YTM3OGRlYzVjMDA1NTk3Zjc0OS90YWJsZTphMzkwOGY5YWViNDI0MzA0OTY4ZjQ3OWE1ODIyYzFiMS90YWJsZXJhbmdlOmEzOTA4ZjlhZWI0MjQzMDQ5NjhmNDc5YTU4MjJjMWIxXzUtMy0xLTEtMA_f3e7418a-6c0c-48fd-8fe5-0378e22b54f1">2,965</ix:nonFraction>)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Property and equipment, net</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2e87824102b34590a0208cc7da91b5f5_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDAvZnJhZzpiYzA3ODhjZjRkZDE0YTM3OGRlYzVjMDA1NTk3Zjc0OS90YWJsZTphMzkwOGY5YWViNDI0MzA0OTY4ZjQ3OWE1ODIyYzFiMS90YWJsZXJhbmdlOmEzOTA4ZjlhZWI0MjQzMDQ5NjhmNDc5YTU4MjJjMWIxXzYtMS0xLTEtMA_da579983-2095-47b8-8542-c0ee4c2c23b5">2,360</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i299cea70f47b4fbe96772aaa8cc00b79_I20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDAvZnJhZzpiYzA3ODhjZjRkZDE0YTM3OGRlYzVjMDA1NTk3Zjc0OS90YWJsZTphMzkwOGY5YWViNDI0MzA0OTY4ZjQ3OWE1ODIyYzFiMS90YWJsZXJhbmdlOmEzOTA4ZjlhZWI0MjQzMDQ5NjhmNDc5YTU4MjJjMWIxXzYtMy0xLTEtMA_f8a4a7a4-697d-4faa-81ca-005c0456b9fb">2,366</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Repairs and maintenance expenditures are expensed as incurred. Interest on long-term projects is capitalized using a rate that approximates the weighted-average interest rate on long-term </span></div></ix:nonNumeric></div></ix:continuation></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:32.135%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.428%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.137%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardinal Health </span><span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">|</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> Fiscal 2021 Form 10-K</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">63</span></div></td></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:3pt"><span><br/></span></div><div style="margin-bottom:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:24.720%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:50.989%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.991%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#e41f35;border-bottom:1pt solid #e41f35;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Notes to Financial Statements</span></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:0 1pt"></td></tr></table></div></div><div style="width:100.000%"><ix:continuation id="ibbe9d9c6014b48abb0d5b8e2ba3ff5f8" continuedAt="i80558680f5484c1da2cdacc8624e457e"><div style="display:inline-block;vertical-align:top;width:48.214%"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i173e7457b2414768b1f7995be28a46f5">obligations, which was <ix:nonFraction unitRef="number" contextRef="i2e87824102b34590a0208cc7da91b5f5_I20210630" decimals="2" format="ixt:numdotdecimal" name="us-gaap:LongtermDebtWeightedAverageInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDAvZnJhZzpiYzA3ODhjZjRkZDE0YTM3OGRlYzVjMDA1NTk3Zjc0OS90ZXh0cmVnaW9uOmJjMDc4OGNmNGRkMTRhMzc4ZGVjNWMwMDU1OTdmNzQ5Xzk4MDM_4d50ac7f-1867-4e90-9da5-2b5a4ac514ab">3</ix:nonFraction> percent at June&#160;30, 2021. The amount of capitalized interest was immaterial for all periods presented.</ix:continuation></span></div><ix:nonNumeric contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630" name="us-gaap:GoodwillAndIntangibleAssetsPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDAvZnJhZzpiYzA3ODhjZjRkZDE0YTM3OGRlYzVjMDA1NTk3Zjc0OS90ZXh0cmVnaW9uOmJjMDc4OGNmNGRkMTRhMzc4ZGVjNWMwMDU1OTdmNzQ5XzM5NjY1_118a249c-5825-4ef7-9ca2-199bb57b1c7c" continuedAt="i1708a15d8cfe4e50bb79ea2539a725f8" escape="true"><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Goodwill and Other Intangible Assets</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Purchased goodwill and intangible assets with indefinite lives are not amortized, but instead are tested for impairment annually or when indicators of impairment exist.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Purchased goodwill is tested for impairment at least annually. Qualitative factors are first assessed to determine if it is more likely than not that the fair value of a reporting unit is less than its carrying amount. There is an option to bypass the qualitative assessment for any reporting unit in any period and proceed directly to performing the quantitative goodwill impairment test. We have elected to bypass the qualitative assessment for our annual goodwill impairment test in the current year. The quantitative goodwill impairment test involves a comparison of the estimated fair value of the reporting unit to the respective carrying amount. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Goodwill impairment testing involves judgment, including the identification of reporting units, qualitative evaluation of events and circumstances to determine if it is more likely than not that an impairment exists, and, if necessary, the estimation of the fair value of the applicable reporting unit. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have <ix:nonFraction unitRef="segment" contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:NumberOfReportableSegments" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDAvZnJhZzpiYzA3ODhjZjRkZDE0YTM3OGRlYzVjMDA1NTk3Zjc0OS90ZXh0cmVnaW9uOmJjMDc4OGNmNGRkMTRhMzc4ZGVjNWMwMDU1OTdmNzQ5XzExMDYy_a0ed16e6-1f98-4436-b7af-838e7be5f525"><ix:nonFraction unitRef="segment" contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:NumberOfOperatingSegments" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDAvZnJhZzpiYzA3ODhjZjRkZDE0YTM3OGRlYzVjMDA1NTk3Zjc0OS90ZXh0cmVnaW9uOmJjMDc4OGNmNGRkMTRhMzc4ZGVjNWMwMDU1OTdmNzQ5XzExMDYy_f090cdaf-7eab-4dd2-a990-822e2864749f">two</ix:nonFraction></ix:nonFraction> operating segments, which are the same as our reportable segments: Pharmaceutical and Medical. These operating segments are comprised of divisions (components), for which discrete financial information is available. Components are aggregated into reporting units for purposes of goodwill impairment testing to the extent that they share similar economic characteristics. Our reporting units are: Pharmaceutical operating segment (excluding our Nuclear and Precision Health Solutions division); Nuclear and Precision Health Solutions division; Medical operating segment (excluding our Cardinal Health at-Home Solutions division) (&#8220;Medical Unit&#8221;); and Cardinal Health at-Home Solutions division.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fair value can be determined using market, income or cost-based approaches. Our determination of estimated fair value of the reporting units is based on a combination of the income-based and market-based approaches. Under the income-based approach, we use a discounted cash flow model in which cash flows anticipated over several future periods, plus a terminal value at the end of that time horizon, are discounted to their present value using an appropriate risk-adjusted rate of return.&#160;We use our internal forecasts to estimate future cash flows, which we believe are consistent with those of a market participant, and include an estimate of long-term growth rates based on our most recent views of the long-term outlook for each reporting unit. Actual results may differ materially from those used in our forecasts. We use discount rates that are commensurate with the risks and uncertainty inherent in the respective reporting units and in our internally-developed forecasts. Discount rates used in our reporting unit valuations ranged from <ix:nonFraction unitRef="number" contextRef="ia892a1655a98484e8d25b9944babb1df_D20200701-20210630" decimals="3" format="ixt:numdotdecimal" name="cah:DiscountRatefairvalueinputs" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDAvZnJhZzpiYzA3ODhjZjRkZDE0YTM3OGRlYzVjMDA1NTk3Zjc0OS90ZXh0cmVnaW9uOmJjMDc4OGNmNGRkMTRhMzc4ZGVjNWMwMDU1OTdmNzQ5XzEzMDQy_ce6541d7-cf98-4904-bbf8-30cf5b6fc61e">8.5</ix:nonFraction> percent to <ix:nonFraction unitRef="number" contextRef="icc7d995e453e439bb115adae40076bfd_D20200701-20210630" decimals="3" format="ixt:numdotdecimal" name="cah:DiscountRatefairvalueinputs" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDAvZnJhZzpiYzA3ODhjZjRkZDE0YTM3OGRlYzVjMDA1NTk3Zjc0OS90ZXh0cmVnaW9uOmJjMDc4OGNmNGRkMTRhMzc4ZGVjNWMwMDU1OTdmNzQ5XzEzMDQ4_99bb9076-c935-444b-bd94-0b9275e9cb94">11.5</ix:nonFraction> percent. Under the market-based guideline public company method, we determine fair value by comparing our reporting units to similar businesses or guideline companies whose securities are actively traded in public markets. We also use the guideline transaction method to </span></div></ix:nonNumeric></div><div style="display:inline-block;max-width:3.571%;min-width:2.571%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:48.215%"><ix:continuation id="i1708a15d8cfe4e50bb79ea2539a725f8"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">determine fair value based on pricing multiples derived from the sale of companies that are similar to our reporting units. To further confirm fair value, we compare the aggregate fair value of our reporting units to our total market capitalization.&#160;Estimating the fair value of reporting units requires the use of estimates and significant judgments that are based on a number of factors including forecasted operating results. The use of alternate estimates and assumptions or changes in the industry or peer groups could materially affect the determination of fair value for each reporting unit and potentially result in goodwill impairment.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We performed annual impairment testing in fiscal 2021, 2020 and 2019 and concluded that there were <ix:nonFraction unitRef="usd" contextRef="i00a6d666bf604826b24e68ddbd63eac4_D20180701-20190630" decimals="-6" format="ixt-sec:numwordsen" name="us-gaap:GoodwillImpairmentLoss" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDAvZnJhZzpiYzA3ODhjZjRkZDE0YTM3OGRlYzVjMDA1NTk3Zjc0OS90ZXh0cmVnaW9uOmJjMDc4OGNmNGRkMTRhMzc4ZGVjNWMwMDU1OTdmNzQ5XzQ5NDc4MDI0MDQyMjA_613f647d-88c8-49c1-8fe4-8e83670f68d2"><ix:nonFraction unitRef="usd" contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630" decimals="-6" format="ixt-sec:numwordsen" name="us-gaap:GoodwillImpairmentLoss" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDAvZnJhZzpiYzA3ODhjZjRkZDE0YTM3OGRlYzVjMDA1NTk3Zjc0OS90ZXh0cmVnaW9uOmJjMDc4OGNmNGRkMTRhMzc4ZGVjNWMwMDU1OTdmNzQ5XzQ5NDc4MDI0MDQyMjA_7c4b8bba-c5ec-402b-bd38-7e13fa6ef60b"><ix:nonFraction unitRef="usd" contextRef="ia31e9a409b874bb19d0ff6f2f39ecc09_D20190701-20200630" decimals="-6" format="ixt-sec:numwordsen" name="us-gaap:GoodwillImpairmentLoss" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDAvZnJhZzpiYzA3ODhjZjRkZDE0YTM3OGRlYzVjMDA1NTk3Zjc0OS90ZXh0cmVnaW9uOmJjMDc4OGNmNGRkMTRhMzc4ZGVjNWMwMDU1OTdmNzQ5XzQ5NDc4MDI0MDQyMjA_cfbc5b00-0a08-49fc-b9d6-859f07e62088">no</ix:nonFraction></ix:nonFraction></ix:nonFraction> impairments of goodwill as the estimated fair value of each reporting unit exceeded its carrying value.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The impairment test for indefinite-lived intangibles other than goodwill involves first assessing qualitative factors to determine if it is more likely than not that the fair value of the indefinite-lived intangible asset is less than its carrying amount. If so, then a quantitative test is performed to compare the estimated fair value of the indefinite-lived intangible asset to the respective asset's carrying amount. Our qualitative evaluation requires the use of estimates and significant judgments and considers the weight of evidence and significance of all identified events and circumstances and most relevant drivers of fair value, both positive and negative, in determining whether it is more likely than not that the fair value of the indefinite-lived intangible asset is less than its carrying amount.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intangible assets with finite lives, primarily customer relationships; trademarks, trade names and patents; and developed technology, are amortized using a combination of straight-line and accelerated methods based on the expected cash flows from the asset over their estimated useful lives. We review intangible assets with finite lives for impairment whenever events or changes in circumstances indicate that the related carrying amounts may not be recoverable. Determining whether an impairment loss occurred requires a comparison of the carrying amount to the sum of the future forecasted undiscounted cash flows expected to be generated by the asset group. Actual results may differ materially from those used in our forecasts.</span></div></ix:continuation><ix:nonNumeric contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630" name="cah:AssetsHeldforSalePolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDAvZnJhZzpiYzA3ODhjZjRkZDE0YTM3OGRlYzVjMDA1NTk3Zjc0OS90ZXh0cmVnaW9uOmJjMDc4OGNmNGRkMTRhMzc4ZGVjNWMwMDU1OTdmNzQ5XzM5Njc1_dac08363-793b-4b75-97dc-cae436055c9c" continuedAt="iaf69ede049044b4fb37779500da1eddb" escape="true"><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Assets Held for Sale</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We classify assets and liabilities (the &#8220;disposal group&#8221;) as held for sale when management commits to a plan to sell the disposal group in its present condition and at a price that is reasonable in relation to its current fair value. We also consider whether an active program to locate a buyer has been initiated and if it is probable that the sale will occur within one year without significant changes to the plan to sell. Upon classification of the disposal group as held for sale, we test the assets for impairment and cease related depreciation and amortization.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 12, 2021, we announced that we signed a definitive agreement to sell our Cordis business to Hellman &amp; Friedman for proceeds of $<ix:nonFraction unitRef="usd" contextRef="i2ae0fa0d058b4f21aac5c8701cbd2fb7_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationConsideration" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDAvZnJhZzpiYzA3ODhjZjRkZDE0YTM3OGRlYzVjMDA1NTk3Zjc0OS90ZXh0cmVnaW9uOmJjMDc4OGNmNGRkMTRhMzc4ZGVjNWMwMDU1OTdmNzQ5XzQ5NDc4MDIzNzk5MzY_282278f6-c8b0-4889-b9e9-f8451242aa43">927</ix:nonFraction> million in cash, subject to customary purchase price adjustments, and we retained certain working capital accounts and certain liabilities, including product liability for </span></div></ix:nonNumeric></div></ix:continuation></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:3pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.222%"><tr><td style="width:1.0%"></td><td style="width:32.133%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.433%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.134%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">64</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardinal Health </span><span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">| </span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2021 Form 10-K</span></div></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:3pt"><span><br/></span></div><div style="margin-bottom:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:24.720%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:50.989%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.991%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#e41f35;border-bottom:1pt solid #e41f35;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Notes to Financial Statements</span></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:0 1pt"></td></tr></table></div></div><div style="width:100.000%"><ix:continuation id="i80558680f5484c1da2cdacc8624e457e" continuedAt="i8eb109097cc140b7bbe2596d3af973af"><div style="display:inline-block;vertical-align:top;width:48.214%"><div style="margin-bottom:3pt;text-align:justify"><ix:continuation id="iaf69ede049044b4fb37779500da1eddb"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">lawsuits related to inferior vena cava filters in the U.S. and Canada as described in </span><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i4f0ec56b9c604f1782a65ea4a19c284d_130">Note 7</a></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of the &#8220;Notes to Consolidated Financial Statements.&#8221; The transaction closed on August 2, 2021. See </span><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i4f0ec56b9c604f1782a65ea4a19c284d_106">Note 2</a></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for additional information.</span></ix:continuation></div><ix:nonNumeric contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630" name="us-gaap:InvestmentPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDAvZnJhZzpiYzA3ODhjZjRkZDE0YTM3OGRlYzVjMDA1NTk3Zjc0OS90ZXh0cmVnaW9uOmJjMDc4OGNmNGRkMTRhMzc4ZGVjNWMwMDU1OTdmNzQ5XzM5NjMx_ef4ea813-7f1d-49f3-a43c-2a527c061b82" escape="true"><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Investments</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Investments in non-marketable equity securities are accounted for under the fair value, equity or net asset value method of&#160;accounting and are included in other assets in the consolidated balance sheets. For equity securities without a readily determinable fair value, we use the fair value measurement alternative and measure the securities at cost less impairment, if any, including adjustments for observable price changes in orderly transactions for an identical or similar investment of the same issuer. For investments in which we can exercise significant influence but do not control, we use the equity method of accounting. Our share of the earnings and losses are recorded in other (income)/expense, net in the consolidated statements of earnings/(loss). We monitor our investments for impairment&#160;by considering factors such as the operating performance of the investment and current economic and market conditions.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630" name="cah:CostofSalesVendorReservesPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDAvZnJhZzpiYzA3ODhjZjRkZDE0YTM3OGRlYzVjMDA1NTk3Zjc0OS90ZXh0cmVnaW9uOmJjMDc4OGNmNGRkMTRhMzc4ZGVjNWMwMDU1OTdmNzQ5XzM5NTQ4_b53deae8-c382-4906-9911-dce0fdef5364" escape="true"><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Vendor Reserves</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the ordinary course of business, our vendors may dispute deductions taken against payments otherwise due to them or assert other disputes. These disputes are researched and resolved based upon the findings of the research performed. At any given time, there are outstanding items in various stages of research and resolution. In determining appropriate reserves for areas of exposure with our vendors, we assess historical experience and current outstanding claims. We have established various levels of reserves based on the type of claim and status of review. Though the claim types are relatively consistent, we periodically refine our methodology by updating the reserve estimate percentages to reflect actual historical experience. The ultimate outcome of certain claims may be different than our original estimate and may require an adjustment. Adjustments to vendor reserves are included in cost of products sold. In addition, the reserve balance will fluctuate due to variations of outstanding claims from period-to-period, timing of settlements and specific vendor issues, such as bankruptcies. Vendor reserves were $<ix:nonFraction unitRef="usd" contextRef="i2e87824102b34590a0208cc7da91b5f5_I20210630" decimals="-6" format="ixt:numdotdecimal" name="cah:VendorReserves" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDAvZnJhZzpiYzA3ODhjZjRkZDE0YTM3OGRlYzVjMDA1NTk3Zjc0OS90ZXh0cmVnaW9uOmJjMDc4OGNmNGRkMTRhMzc4ZGVjNWMwMDU1OTdmNzQ5XzE5NDI1_1d7436ea-7c92-4174-80be-9d62900e6704"><ix:nonFraction unitRef="usd" contextRef="i299cea70f47b4fbe96772aaa8cc00b79_I20200630" decimals="-6" format="ixt:numdotdecimal" name="cah:VendorReserves" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDAvZnJhZzpiYzA3ODhjZjRkZDE0YTM3OGRlYzVjMDA1NTk3Zjc0OS90ZXh0cmVnaW9uOmJjMDc4OGNmNGRkMTRhMzc4ZGVjNWMwMDU1OTdmNzQ5XzE5NDI1_95d1199e-f2b1-471d-a035-b0d10ca5b0d3">77</ix:nonFraction></ix:nonFraction> million at both June&#160;30, 2021 and 2020, excluding third-party returns. See Third-Party Returns section within this Note for a description of third-party returns.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630" name="cah:DistributionServiceAgreementAndOtherVendorFeesPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDAvZnJhZzpiYzA3ODhjZjRkZDE0YTM3OGRlYzVjMDA1NTk3Zjc0OS90ZXh0cmVnaW9uOmJjMDc4OGNmNGRkMTRhMzc4ZGVjNWMwMDU1OTdmNzQ5XzM5NTU4_28d6d39d-b5b3-4333-bbf8-ffa9ac1a26a1" escape="true"><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Distribution Services Agreement and Other Vendor Fees</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Pharmaceutical segment recognizes fees received from distribution services agreements and other fees received from vendors related to the purchase or distribution of the vendors&#8217; inventory when those fees have been earned and we are entitled to payment. Since the benefit provided to a vendor is related to the purchase and distribution of the vendor&#8217;s inventory, we recognize the fees as a reduction in the carrying value of the inventory that generated the fees, and as such, a reduction of cost of products sold in our consolidated statements of earnings/(loss) when the inventory is sold.</span></div></ix:nonNumeric></div><div style="display:inline-block;max-width:3.571%;min-width:2.571%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:48.215%"><ix:nonNumeric contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630" name="us-gaap:CommitmentsAndContingenciesPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDAvZnJhZzpiYzA3ODhjZjRkZDE0YTM3OGRlYzVjMDA1NTk3Zjc0OS90ZXh0cmVnaW9uOmJjMDc4OGNmNGRkMTRhMzc4ZGVjNWMwMDU1OTdmNzQ5XzM5NTc1_18438b33-675d-4dd4-9dad-d2232cb19082" escape="true"><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Loss Contingencies and Self-Insurance</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Loss Contingencies</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We accrue for contingencies related to disputes, litigation and regulatory matters if it is probable that a liability has been incurred and the amount of the loss can be reasonably estimated. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the opioid litigation as described further in the </span><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i4f0ec56b9c604f1782a65ea4a19c284d_130">Note 7</a></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, we recorded pre-tax charges of&#160;$<ix:nonFraction unitRef="usd" contextRef="id2a6b6641ae248c98d689f30c606f881_D20200701-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:GainLossRelatedToLitigationSettlement" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDAvZnJhZzpiYzA3ODhjZjRkZDE0YTM3OGRlYzVjMDA1NTk3Zjc0OS90ZXh0cmVnaW9uOmJjMDc4OGNmNGRkMTRhMzc4ZGVjNWMwMDU1OTdmNzQ5XzIwNTc2_fa04a4d2-d99c-4c13-92d5-b636406cf116">1.17</ix:nonFraction> billion and $<ix:nonFraction unitRef="usd" contextRef="i373ba6a0cdc044dea9602bdbad13174c_D20190701-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:GainLossRelatedToLitigationSettlement" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDAvZnJhZzpiYzA3ODhjZjRkZDE0YTM3OGRlYzVjMDA1NTk3Zjc0OS90ZXh0cmVnaW9uOmJjMDc4OGNmNGRkMTRhMzc4ZGVjNWMwMDU1OTdmNzQ5XzEwOTk1MTE2Njc2OTI_1a313f61-c937-4037-8038-233b7a976d14">5.63</ix:nonFraction> billion during fiscal 2021 and 2020 respectively which were retained at Corporate. In July 2021, we announced that we and two other national distributors have negotiated a proposed settlement agreement, subject to certain conditions and contingencies. There is no assurance that the contingencies to the proposed settlement agreement will be satisfied. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We develop and periodically update reserve estimates for the Cordis inferior vena cava ("Cordis IVC") claims, including those received to date and expected to be received in the future and related costs. To project future Cordis IVC claim costs, we use a methodology based largely on recent experience, including claim filing rates, estimated indemnity severity by claim type, sales data, implant and injury to report lag patterns and estimated defense costs.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Self-Insurance</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also self-insure for employee healthcare, general liability, certain product liability matters, auto liability, property and workers' compensation. Self-insurance accruals include an estimate for expected settlements or pending claims, defense costs, administrative fees, claim adjustment costs and an estimate for claims incurred but not reported. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Because these matters are inherently unpredictable and unfavorable developments or resolutions can occur, assessing contingencies and other liabilities is highly subjective and requires judgments about future&#160;events. We regularly review contingencies and our self-insurance accruals to determine whether our accruals and related disclosures are adequate. Any adjustments for changes in reserves are recorded in the period in which the change in estimate occurs.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The amount of ultimate loss may differ materially from these estimates. We recognize these estimated loss contingencies, income from favorable resolution of litigation and certain defense costs in litigation (recoveries)/charges in our consolidated statements of earnings/(loss). See </span><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i4f0ec56b9c604f1782a65ea4a19c284d_130">Note 7</a></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for additional information regarding loss contingencies and product liability lawsuits.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630" name="us-gaap:GuaranteesIndemnificationsAndWarrantiesPolicies" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDAvZnJhZzpiYzA3ODhjZjRkZDE0YTM3OGRlYzVjMDA1NTk3Zjc0OS90ZXh0cmVnaW9uOmJjMDc4OGNmNGRkMTRhMzc4ZGVjNWMwMDU1OTdmNzQ5XzM5NjEy_472e1240-eca3-4135-9276-38acbac8729a" continuedAt="i3c66d435e1e44468a387dc09326b3135" escape="true"><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Guarantees</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the ordinary course of business, we agree to indemnify certain other parties under acquisition and disposition agreements, customer agreements, intellectual property licensing agreements, and other agreements. Such indemnification obligations vary in scope and, when defined, in duration. In many cases, a maximum obligation is not explicitly stated, and therefore the overall maximum amount of the liability under such indemnification obligations cannot be reasonably estimated. Where appropriate, such indemnification obligations are recorded as a liability. Historically, we have not, individually or in the aggregate, made </span></div></ix:nonNumeric></div></ix:continuation></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:32.135%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.428%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.137%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardinal Health </span><span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">|</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> Fiscal 2021 Form 10-K</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">65</span></div></td></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:3pt"><span><br/></span></div><div style="margin-bottom:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:24.720%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:50.989%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.991%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#e41f35;border-bottom:1pt solid #e41f35;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Notes to Financial Statements</span></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:0 1pt"></td></tr></table></div></div><div style="width:100.000%"><ix:continuation id="i8eb109097cc140b7bbe2596d3af973af" continuedAt="i9cfa0f8b42a64a5d852afca2ab41558a"><div style="display:inline-block;vertical-align:top;width:48.214%"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i3c66d435e1e44468a387dc09326b3135" continuedAt="i67752c2af6eb4be6bb539d1784210141">payments under these indemnification obligations in any material amounts. In certain circumstances, we believe that existing insurance arrangements, subject to the general deduction and exclusion provisions, would cover portions of the liability that may arise from these indemnification obligations. In addition, we believe that the likelihood of a material liability being triggered under these indemnification obligations is not probable.</ix:continuation></span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i67752c2af6eb4be6bb539d1784210141">From time to time we enter into agreements that obligate us to make fixed payments upon the occurrence of certain events. Such obligations primarily relate to obligations arising under acquisition transactions, where we have agreed to make payments based upon the achievement of certain financial performance measures by the acquired business. Generally, the obligation is capped at an explicit amount. There were no material obligations at June&#160;30, 2021.</ix:continuation> </span></div><ix:nonNumeric contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630" name="us-gaap:IncomeTaxPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDAvZnJhZzpiYzA3ODhjZjRkZDE0YTM3OGRlYzVjMDA1NTk3Zjc0OS90ZXh0cmVnaW9uOmJjMDc4OGNmNGRkMTRhMzc4ZGVjNWMwMDU1OTdmNzQ5XzM5NjIz_bb2b6d91-222b-45f1-b15b-cf14fab07b3c" escape="true"><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Income Taxes</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We account for income taxes using the asset and liability method. Deferred tax assets and liabilities are measured using enacted tax rates in the respective jurisdictions in which we operate. We assess the realizability of deferred tax assets on a quarterly basis and provide a valuation allowance for deferred tax assets when it is more likely than not that at least a portion of the deferred tax assets will not be realized. The realizability of deferred tax assets depends on our ability to generate sufficient taxable income within the carryback or carryforward periods provided for in the tax law for each applicable tax jurisdiction and also considers all available positive and negative evidence.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deferred taxes for non-U.S. liabilities are not provided on the unremitted earnings of subsidiaries outside of the United States&#160;when it is expected that these earnings are indefinitely reinvested.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We operate in a complex multinational tax environment and are subject to tax treaty arrangements and transfer pricing guidelines for intercompany transactions that are subject to interpretation. Uncertainty in a tax position may arise as tax laws are subject to interpretation. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Tax benefits from uncertain tax positions are recognized when it is more likely than not that the position will be sustained upon examination of the technical merits of the position, including resolutions of any related appeals or litigation processes. The amount recognized is measured as the largest amount of tax benefit that is greater than 50 percent likely of being realized upon settlement. For tax benefits that do not qualify for recognition, we recognize a liability for unrecognized tax benefits. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See </span><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i4f0ec56b9c604f1782a65ea4a19c284d_133">Note 8</a></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for additional information regarding income taxes.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630" name="cah:OtherAccruedLiabilitiesPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDAvZnJhZzpiYzA3ODhjZjRkZDE0YTM3OGRlYzVjMDA1NTk3Zjc0OS90ZXh0cmVnaW9uOmJjMDc4OGNmNGRkMTRhMzc4ZGVjNWMwMDU1OTdmNzQ5XzM5NzEz_3f35b02e-036e-4b5c-a372-46d3725d288a" escape="true"><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Other Accrued Liabilities</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other accrued liabilities represent various current obligations, including certain accrued operating expenses and taxes payable.</span></div></ix:nonNumeric><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630" name="us-gaap:ConsolidationPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDAvZnJhZzpiYzA3ODhjZjRkZDE0YTM3OGRlYzVjMDA1NTk3Zjc0OS90ZXh0cmVnaW9uOmJjMDc4OGNmNGRkMTRhMzc4ZGVjNWMwMDU1OTdmNzQ5XzM5NjUx_346c1afa-9145-489a-980c-60362f7c02d4" continuedAt="i345286eb150d45b58b69686c73dcd9ef" escape="true">Noncontrolling Interests</ix:nonNumeric></span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i345286eb150d45b58b69686c73dcd9ef">Noncontrolling interests represent the portion of net earnings, comprehensive income and net assets that is not attributable to Cardinal Health, Inc.</ix:continuation> </span></div></div><div style="display:inline-block;max-width:3.571%;min-width:2.571%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:48.215%"><ix:nonNumeric contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630" name="us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDAvZnJhZzpiYzA3ODhjZjRkZDE0YTM3OGRlYzVjMDA1NTk3Zjc0OS90ZXh0cmVnaW9uOmJjMDc4OGNmNGRkMTRhMzc4ZGVjNWMwMDU1OTdmNzQ5XzM5NjI0_ed1ceb39-8f25-420b-b515-57c1c57c77d6" escape="true"><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Share-Based Compensation</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Share-based compensation provided to employees is recognized in the consolidated statements of earnings/(loss) based on the grant date fair value of the awards. The fair value of restricted share units and performance share units is determined by the grant date market price of our common shares. The fair value of stock options is determined on the grant date using a lattice valuation model. The compensation expense associated with nonvested performance share units is dependent on our periodic assessment of the probability of the targets being achieved and our estimate, which may vary over time, of the number of shares that ultimately will be issued. The compensation expense recognized for share-based awards is net of estimated forfeitures and is recognized ratably over the service period of the awards. All income tax effects of share-based awards are recognized in the consolidated statements of earnings/(loss) as awards vest or are settled. We classify share-based compensation expense in distribution, selling, general and administrative ("SG&amp;A") expenses to correspond with the same line item as the majority of the cash compensation paid to employees. If awards are modified in connection with a restructuring activity, the incremental share-based compensation expense is classified in restructuring and employee severance. See </span><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i4f0ec56b9c604f1782a65ea4a19c284d_160">Note 14</a></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for additional information regarding share-based compensation.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630" name="cah:DividendsPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDAvZnJhZzpiYzA3ODhjZjRkZDE0YTM3OGRlYzVjMDA1NTk3Zjc0OS90ZXh0cmVnaW9uOmJjMDc4OGNmNGRkMTRhMzc4ZGVjNWMwMDU1OTdmNzQ5XzM5Njc2_a97cee0b-4ebe-4a0c-b2b7-82baf464e444" escape="true"><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Dividends</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We paid cash dividends per common share of $<ix:nonFraction unitRef="usdPerShare" contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630" decimals="2" name="us-gaap:CommonStockDividendsPerShareCashPaid" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDAvZnJhZzpiYzA3ODhjZjRkZDE0YTM3OGRlYzVjMDA1NTk3Zjc0OS90ZXh0cmVnaW9uOmJjMDc4OGNmNGRkMTRhMzc4ZGVjNWMwMDU1OTdmNzQ5XzQ5NDc4MDIzNzI0ODU_dc354ede-2155-48e1-9c54-c995f32de3fa">1.94</ix:nonFraction>, $<ix:nonFraction unitRef="usdPerShare" contextRef="ia31e9a409b874bb19d0ff6f2f39ecc09_D20190701-20200630" decimals="2" name="us-gaap:CommonStockDividendsPerShareCashPaid" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDAvZnJhZzpiYzA3ODhjZjRkZDE0YTM3OGRlYzVjMDA1NTk3Zjc0OS90ZXh0cmVnaW9uOmJjMDc4OGNmNGRkMTRhMzc4ZGVjNWMwMDU1OTdmNzQ5XzI3NDg3NzkxMjkxMjM_5f933a44-2846-4b34-a33e-ac63a91a290e">1.92</ix:nonFraction> and $<ix:nonFraction unitRef="usdPerShare" contextRef="i00a6d666bf604826b24e68ddbd63eac4_D20180701-20190630" decimals="2" name="us-gaap:CommonStockDividendsPerShareCashPaid" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDAvZnJhZzpiYzA3ODhjZjRkZDE0YTM3OGRlYzVjMDA1NTk3Zjc0OS90ZXh0cmVnaW9uOmJjMDc4OGNmNGRkMTRhMzc4ZGVjNWMwMDU1OTdmNzQ5XzI3NjU3_846e0adb-44fb-4d52-90ae-2bb13a6880cb">1.91</ix:nonFraction> in fiscal 2021, 2020 and 2019, respectively.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630" name="us-gaap:RevenueRecognitionPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDAvZnJhZzpiYzA3ODhjZjRkZDE0YTM3OGRlYzVjMDA1NTk3Zjc0OS90ZXh0cmVnaW9uOmJjMDc4OGNmNGRkMTRhMzc4ZGVjNWMwMDU1OTdmNzQ5XzM5NTY4_2a3daea5-40cc-4a7f-958d-e8e23074ec6d" continuedAt="ib3c37e9d27e9491c9fe37690d9ee62f1" escape="true"><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Revenue Recognition</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recognize revenue in an amount that reflects the consideration to which we expect to be entitled in exchange for the transfer of goods or services to customers.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue in both segments is primarily related to the distribution of pharmaceutical and medical products, which include both manufactured and sourced products, and we recognize at a point in time when title transfers to customers and we have no further obligation to provide services related to such merchandise. Service revenues are recognized over the period that services are provided to the customer. Revenues derived from services are not material for either segment for all periods presented.</span></div></ix:nonNumeric><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ib3c37e9d27e9491c9fe37690d9ee62f1">We are generally the principal in a transaction, therefore our revenue is primarily recorded on a gross basis. When we are a principal in a transaction, we have determined that we control the ability to direct the use of the product or service prior to transfer to a customer, are primarily responsible for fulfilling the promise to provide the product or service to our customer, have discretion in establishing prices, and ultimately control the transfer of the product or services provided to the customer.</ix:continuation> </span></div><ix:nonNumeric contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630" name="cah:SalesreturnsPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDAvZnJhZzpiYzA3ODhjZjRkZDE0YTM3OGRlYzVjMDA1NTk3Zjc0OS90ZXh0cmVnaW9uOmJjMDc4OGNmNGRkMTRhMzc4ZGVjNWMwMDU1OTdmNzQ5XzM5NTcx_5d352f4f-c8c3-4fc9-b1e0-ee6de032a428" continuedAt="i439a6015378d4d71bbd9d712c4e9f70a" escape="true"><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Sales Returns and Allowances</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue is recorded net of sales returns and allowances. Revenues are measured based on the amount of consideration that we expect to receive, reduced by estimates for return allowances, discounts, rebates and other variable consideration. Sales returns are recorded based on estimates using historical </span></div></ix:nonNumeric></div></ix:continuation></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:3pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.222%"><tr><td style="width:1.0%"></td><td style="width:32.133%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.433%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.134%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">66</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardinal Health </span><span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">| </span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2021 Form 10-K</span></div></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:3pt"><span><br/></span></div><div style="margin-bottom:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:24.720%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:50.989%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.991%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#e41f35;border-bottom:1pt solid #e41f35;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Notes to Financial Statements</span></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:0 1pt"></td></tr></table></div></div><div style="width:100.000%"><ix:continuation id="i9cfa0f8b42a64a5d852afca2ab41558a" continuedAt="i9102dca0507848109b27efd0783d9dbf"><div style="display:inline-block;vertical-align:top;width:48.214%"><ix:continuation id="i439a6015378d4d71bbd9d712c4e9f70a"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">data. Our customer return policies generally require that the product be physically returned, subject to restocking fees. We only allow customers to return products for credit in a condition suitable to be added back to inventory and resold at full value (&#8220;merchantable product&#8221;) or returned to vendors for credit. Product returns are generally consistent throughout the year and typically are not specific to any particular product or customer.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We accrue for estimated sales returns and allowances at the time of sale based upon historical customer return trends, margin rates and processing costs. Our accrual for sales returns is reflected as a reduction of revenue and cost of products sold for the sales price and cost, respectively. At June&#160;30, 2021 and 2020, the accrual for estimated sales returns and allowances was $<ix:nonFraction unitRef="usd" contextRef="i2e87824102b34590a0208cc7da91b5f5_I20210630" decimals="-6" format="ixt:numdotdecimal" name="cah:RevenueRecognitionReserveforSalesReturnsandAllowances" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDAvZnJhZzpiYzA3ODhjZjRkZDE0YTM3OGRlYzVjMDA1NTk3Zjc0OS90ZXh0cmVnaW9uOmJjMDc4OGNmNGRkMTRhMzc4ZGVjNWMwMDU1OTdmNzQ5XzMwMDQy_fde85c30-5a20-4b6f-a665-1f4ecb7cca6e">689</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i299cea70f47b4fbe96772aaa8cc00b79_I20200630" decimals="-6" format="ixt:numdotdecimal" name="cah:RevenueRecognitionReserveforSalesReturnsandAllowances" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDAvZnJhZzpiYzA3ODhjZjRkZDE0YTM3OGRlYzVjMDA1NTk3Zjc0OS90ZXh0cmVnaW9uOmJjMDc4OGNmNGRkMTRhMzc4ZGVjNWMwMDU1OTdmNzQ5XzMwMDQ5_099041ba-c097-4c8a-a0c6-efa33d762631">495</ix:nonFraction> million, respectively, which is reflected in trade receivables, net and inventories, net in the consolidated balance sheets. Sales returns and allowances were $<ix:nonFraction unitRef="usd" contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:RevenueRecognitionSalesReturnsReserveForSalesReturns" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDAvZnJhZzpiYzA3ODhjZjRkZDE0YTM3OGRlYzVjMDA1NTk3Zjc0OS90ZXh0cmVnaW9uOmJjMDc4OGNmNGRkMTRhMzc4ZGVjNWMwMDU1OTdmNzQ5XzMwMjAz_6d741194-7b48-40c4-ae45-6d3ccd7d274d">2.6</ix:nonFraction> billion, $<ix:nonFraction unitRef="usd" contextRef="ia31e9a409b874bb19d0ff6f2f39ecc09_D20190701-20200630" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:RevenueRecognitionSalesReturnsReserveForSalesReturns" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDAvZnJhZzpiYzA3ODhjZjRkZDE0YTM3OGRlYzVjMDA1NTk3Zjc0OS90ZXh0cmVnaW9uOmJjMDc4OGNmNGRkMTRhMzc4ZGVjNWMwMDU1OTdmNzQ5XzMwMjA3_d28b33a2-4a1d-483e-82e1-adbd54dece6a">2.3</ix:nonFraction> billion and $<ix:nonFraction unitRef="usd" contextRef="i00a6d666bf604826b24e68ddbd63eac4_D20180701-20190630" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:RevenueRecognitionSalesReturnsReserveForSalesReturns" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDAvZnJhZzpiYzA3ODhjZjRkZDE0YTM3OGRlYzVjMDA1NTk3Zjc0OS90ZXh0cmVnaW9uOmJjMDc4OGNmNGRkMTRhMzc4ZGVjNWMwMDU1OTdmNzQ5XzMwMjE0_60627c1a-f9e5-44f1-9f97-8729bd0981e2">2.2</ix:nonFraction> billion, for fiscal 2021, 2020 and 2019, respectively, and the net impact on net earnings/(loss) in the consolidated statements of earnings/(loss) was immaterial in fiscal 2021, 2020 and 2019. </span></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Third-Party Returns</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We generally do not accept non-merchantable pharmaceutical product returns from our customers, so many of our customers return non-merchantable pharmaceutical products to the manufacturer through third parties. Since our customers generally do not have a direct relationship with manufacturers, our vendors pass the value of such returns to us (usually in the form of an accounts payable deduction). We, in turn, pass the value received to our customer. In certain instances, we pass the estimated value of the return to our customer prior to our receipt of the value from the vendor. Although we believe we have satisfactory protections, we could be subject to claims from customers or vendors if our administration of this overall process was deficient in some respect or our contractual terms with vendors are in conflict with our contractual terms with our customers. We have maintained reserves for some of these situations based on their nature and our historical experience with their resolution.</span></div></ix:continuation><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630" name="cah:ShippingandHandlingCostsPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDAvZnJhZzpiYzA3ODhjZjRkZDE0YTM3OGRlYzVjMDA1NTk3Zjc0OS90ZXh0cmVnaW9uOmJjMDc4OGNmNGRkMTRhMzc4ZGVjNWMwMDU1OTdmNzQ5XzM5Njg1_65229788-3197-46c4-a6a2-a048b3863f27" continuedAt="i76878aa6b12c4ff99221c6a77c4bcd13" escape="true">Shipping and Handling</ix:nonNumeric></span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i76878aa6b12c4ff99221c6a77c4bcd13">Shipping and handling costs are primarily included in SG&amp;A expenses in our consolidated statements of earnings/(loss) and include all delivery expenses as well as all costs to prepare the product for shipment to the end customer. Shipping and handling costs were $<ix:nonFraction unitRef="usd" contextRef="ic3592f06406544abac446d0e612f00d3_D20200701-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:SellingGeneralAndAdministrativeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDAvZnJhZzpiYzA3ODhjZjRkZDE0YTM3OGRlYzVjMDA1NTk3Zjc0OS90ZXh0cmVnaW9uOmJjMDc4OGNmNGRkMTRhMzc4ZGVjNWMwMDU1OTdmNzQ5XzMxNzAw_6682425a-8580-449a-a4d2-3b7dcd23cd11">634</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="ifee3aa6b50684ca4a55e508c43164afe_D20190701-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:SellingGeneralAndAdministrativeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDAvZnJhZzpiYzA3ODhjZjRkZDE0YTM3OGRlYzVjMDA1NTk3Zjc0OS90ZXh0cmVnaW9uOmJjMDc4OGNmNGRkMTRhMzc4ZGVjNWMwMDU1OTdmNzQ5XzMxNzA0_c1205275-8cfd-489c-a1d3-a3ffc984ac55">620</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i6e042ca2958c43e0a7786484c6024fa9_D20180701-20190630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:SellingGeneralAndAdministrativeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDAvZnJhZzpiYzA3ODhjZjRkZDE0YTM3OGRlYzVjMDA1NTk3Zjc0OS90ZXh0cmVnaW9uOmJjMDc4OGNmNGRkMTRhMzc4ZGVjNWMwMDU1OTdmNzQ5XzMxNzEx_8c107584-1051-4912-a99d-cdcd6284cf45">622</ix:nonFraction> million, for fiscal 2021, 2020 and 2019, respectively.</ix:continuation> </span></div><ix:nonNumeric contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630" name="us-gaap:CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDAvZnJhZzpiYzA3ODhjZjRkZDE0YTM3OGRlYzVjMDA1NTk3Zjc0OS90ZXh0cmVnaW9uOmJjMDc4OGNmNGRkMTRhMzc4ZGVjNWMwMDU1OTdmNzQ5XzM5NTYx_f77e7a9d-e40f-4df4-b548-38539b6d0ae3" continuedAt="i58819671732e4f1bbe84aa3f0b19bfbc" escape="true"><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Restructuring and Employee Severance</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Restructuring activities are programs that are not part of the ongoing operations of our underlying business, such as divestitures, closing and consolidating facilities, changing the way we manufacture or distribute our products, moving manufacturing of a product to another location, changes in production or business process outsourcing or insourcing, employee severance (including rationalizing headcount or other significant changes in personnel) and realigning operations (including realignment of the management structure in response to changing market conditions). Also included within restructuring and employee severance are </span></div></ix:nonNumeric></div><div style="display:inline-block;max-width:3.571%;min-width:2.571%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:48.215%"><div style="margin-bottom:3pt;text-align:justify"><ix:continuation id="i58819671732e4f1bbe84aa3f0b19bfbc"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">employee severance costs that are not incurred in connection with a restructuring activity. See </span><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i4f0ec56b9c604f1782a65ea4a19c284d_109">Note 3</a></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for additional information regarding our restructuring activities.</span></ix:continuation></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630" name="cah:AmortizationandOtherAcquisitionRelatedCostsPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDAvZnJhZzpiYzA3ODhjZjRkZDE0YTM3OGRlYzVjMDA1NTk3Zjc0OS90ZXh0cmVnaW9uOmJjMDc4OGNmNGRkMTRhMzc4ZGVjNWMwMDU1OTdmNzQ5XzM5NjQ3_aed6b30a-317a-4e55-b688-26473f6fef8d" continuedAt="ifd1652a479f140aca96523f1503879f1" escape="true">Amortization and Other Acquisition-Related Costs</ix:nonNumeric></span></div><div style="margin-bottom:3pt;text-align:justify"><ix:continuation id="ifd1652a479f140aca96523f1503879f1" continuedAt="i0e6ca5a917b04af8ba9571308444504e"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We classify certain costs incurred in connection with acquisitions as amortization and other acquisition-related costs in our consolidated statements of earnings/(loss). These costs consist of amortization of acquisition-related intangible assets, transaction costs, integration costs and changes in the fair value of contingent consideration obligations. Transaction costs are incurred during the initial evaluation of a potential acquisition and primarily relate to costs to analyze, negotiate and consummate the transaction as well as due diligence activities. Integration costs relate to activities required to combine the operations of an acquired enterprise into our operations and, in the case of the Cordis and Patient Recovery businesses, to stand-up the systems and processes needed to support an expanded geographic footprint. We record changes in the fair value of contingent consideration obligations relating to acquisitions as income or expense in amortization and other acquisition-related costs. See </span><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i4f0ec56b9c604f1782a65ea4a19c284d_112">Note 4</a></span></ix:continuation><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i0e6ca5a917b04af8ba9571308444504e"> for additional information regarding amortization of acquisition-related intangible assets.</ix:continuation> </span></div><ix:nonNumeric contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630" name="us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDAvZnJhZzpiYzA3ODhjZjRkZDE0YTM3OGRlYzVjMDA1NTk3Zjc0OS90ZXh0cmVnaW9uOmJjMDc4OGNmNGRkMTRhMzc4ZGVjNWMwMDU1OTdmNzQ5XzM5NTU1_6331b20f-ecbb-467c-91ca-d29d4d5a3f4b" escape="true"><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Translation of Foreign Currencies</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial statements of our subsidiaries outside the United States&#160;are generally measured using the local currency as the functional currency. Adjustments to translate the assets and liabilities of these foreign subsidiaries into U.S.&#160;dollars are accumulated in shareholders&#8217; equity through accumulated and other comprehensive loss ("AOCI") utilizing period-end exchange rates. Revenues and expenses of these foreign subsidiaries are translated using average exchange rates during the year.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The foreign currency translation gains/(losses) included in AOCI at June&#160;30, 2021 and 2020 are presented in </span><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i4f0ec56b9c604f1782a65ea4a19c284d_145">Note 11</a></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Foreign currency transaction gains and losses for the period are included in the consolidated statements of earnings/(loss) in the respective financial statement line item.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630" name="us-gaap:DerivativesMethodsOfAccountingHedgingDerivatives" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDAvZnJhZzpiYzA3ODhjZjRkZDE0YTM3OGRlYzVjMDA1NTk3Zjc0OS90ZXh0cmVnaW9uOmJjMDc4OGNmNGRkMTRhMzc4ZGVjNWMwMDU1OTdmNzQ5XzM5NjY3_cc38de73-5902-4978-9138-3d1f19b67ca2" continuedAt="i2ba71b1dd9ea45c98a9af8db49095df8" escape="true"><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Interest Rate, Currency and Commodity Risk</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All derivative instruments are recognized at fair value on the consolidated balance sheets and all changes in fair value are recognized in net earnings or shareholders&#8217; equity through AOCI, net of tax.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For contracts that qualify for hedge accounting treatment, the hedge contracts must be effective at reducing the risk associated with the exposure being hedged and must be designated as a hedge at the inception of the contract. Hedge effectiveness is assessed periodically. Any contract not designated as a hedge, or so designated but ineffective, is adjusted to fair value and recognized immediately in net earnings. If a fair value or cash flow hedge ceases to qualify for hedge accounting treatment, the contract continues to be carried on the balance sheet at fair value until settled and future adjustments to the contract&#8217;s fair value are recognized immediately in net earnings. If a forecasted transaction is probable not to occur, amounts previously deferred in AOCI are recognized immediately in net earnings. Interest payments </span></div></ix:nonNumeric></div></ix:continuation></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:32.135%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.428%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.137%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardinal Health </span><span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">|</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> Fiscal 2021 Form 10-K</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">67</span></div></td></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:3pt"><span><br/></span></div><div style="margin-bottom:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:24.720%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:50.989%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.991%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#e41f35;border-bottom:1pt solid #e41f35;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Notes to Financial Statements</span></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:0 1pt"></td></tr></table></div></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:48.214%"><ix:continuation id="i9102dca0507848109b27efd0783d9dbf" continuedAt="ic0453321ebaa47b1b4c9ce1f0ba81519"><ix:continuation id="i2ba71b1dd9ea45c98a9af8db49095df8"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">received from the cross currency swap are excluded from the net investment hedge effectiveness assessment and are recorded in interest expense, net in the consolidated statements of earnings/(loss).</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See </span><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i4f0ec56b9c604f1782a65ea4a19c284d_139">Note 10</a></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for additional information regarding our derivative instruments, including the accounting treatment for instruments designated as fair value, cash flow, net investment and economic hedges.</span></div></ix:continuation><ix:nonNumeric contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630" name="us-gaap:FairValueMeasurementPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDAvZnJhZzpiYzA3ODhjZjRkZDE0YTM3OGRlYzVjMDA1NTk3Zjc0OS90ZXh0cmVnaW9uOmJjMDc4OGNmNGRkMTRhMzc4ZGVjNWMwMDU1OTdmNzQ5XzM5NjYw_95b61696-412f-41df-98c9-8de933f002d3" escape="true"><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Fair Value Measurements</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fair value is defined as the price that would be received upon selling an asset or the price paid to transfer a liability on the measurement date. It focuses on the exit price in the principal or most advantageous market for the asset or liability in an orderly transaction between willing market participants. A three-tier fair value hierarchy is established as a basis for considering such assumptions and for inputs used in the valuation methodologies in measuring fair value. This hierarchy requires entities to maximize the use of observable inputs and minimize the use of unobservable inputs. The three levels of inputs used to measure fair values are:</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 1 -&#160;&#160;&#160;&#160;Observable prices in active markets for identical assets and liabilities.</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 2 -&#160;&#160;&#160;&#160;Observable inputs other than quoted prices in active markets for identical assets and liabilities.</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 3 -&#160;&#160;&#160;&#160;Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets and liabilities.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See </span><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i4f0ec56b9c604f1782a65ea4a19c284d_136">Note 9</a></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for additional information regarding fair value measurements.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDAvZnJhZzpiYzA3ODhjZjRkZDE0YTM3OGRlYzVjMDA1NTk3Zjc0OS90ZXh0cmVnaW9uOmJjMDc4OGNmNGRkMTRhMzc4ZGVjNWMwMDU1OTdmNzQ5XzM5NjI4_ece7ceaf-739e-4f03-ad82-005712414fd8" continuedAt="ifbe0c5d70ead4852a5b66a95a4c7a023" escape="true"><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Recently Adopted Financial Accounting Standards</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financial Instruments - Credit Losses</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2016, the Financial Accounting Standards Board ("FASB") issued amended accounting guidance that will require entities to measure credit losses on trade and other receivables, held-to-maturity debt securities, loans and other instruments using an "expected credit loss" model that considers historical experience, current conditions and reasonable supportable forecasts. This guidance also requires that credit losses on available-for-sale debt securities with unrealized losses be recognized as allowances rather than as deductions in the amortized cost of the securities. We consider historical experience, the current economic environment, customer credit ratings or bankruptcies, and reasonable and supportable forecasts to develop our allowance for credit losses. We review these factors quarterly to determine if any adjustments are needed to the allowance. This guidance was effective beginning the first quarter of fiscal 2021 and did not have a material impact on our consolidated financial statements.</span></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Recently Issued Financial Accounting Standards Not Yet Adopted</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We address the adoption impacts of recently issued accounting standards by the FASB on the our consolidated financial statements as well as material updates to previous assessments, if any, from our fiscal 2020 Form 10-K. There were no accounting </span></div></ix:nonNumeric></ix:continuation></div><div style="display:inline-block;max-width:3.571%;min-width:2.571%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:48.215%"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ic0453321ebaa47b1b4c9ce1f0ba81519"><ix:continuation id="ifbe0c5d70ead4852a5b66a95a4c7a023">standards issued in fiscal 2021 that will have a material impact on our consolidated financial statements.</ix:continuation></ix:continuation></span></div><div id="i4f0ec56b9c604f1782a65ea4a19c284d_106"></div><ix:nonNumeric contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630" name="us-gaap:BusinessCombinationDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDYvZnJhZzpjN2ZmYWQ5NzA5YjM0M2Q1OWVjZWY1OTQ0YzA1NDM0NS90ZXh0cmVnaW9uOmM3ZmZhZDk3MDliMzQzZDU5ZWNlZjU5NDRjMDU0MzQ1XzI3NDg3NzkwNzY3MTA_a96258a5-726b-4f24-96a5-85cb2556822c" continuedAt="i257affc5ba4e4553aaceb963db86ac66" escape="true"><div style="margin-bottom:6pt;text-align:justify"><span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:13pt;font-weight:700;line-height:120%">2. Divestitures and Acquisitions</span></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Divestitures</span></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cordis Assets Held for Sale</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 12, 2021, we signed a definitive agreement with Hellman &amp; Friedman to sell our Cordis business for gross proceeds of $<ix:nonFraction unitRef="usd" contextRef="i2ae0fa0d058b4f21aac5c8701cbd2fb7_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationConsideration" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDYvZnJhZzpjN2ZmYWQ5NzA5YjM0M2Q1OWVjZWY1OTQ0YzA1NDM0NS90ZXh0cmVnaW9uOmM3ZmZhZDk3MDliMzQzZDU5ZWNlZjU5NDRjMDU0MzQ1XzQ5NDc4MDIzMjk1ODg_282278f6-c8b0-4889-b9e9-f8451242aa43">927</ix:nonFraction> million in cash, subject to customary purchase price adjustments, and we retained certain working capital accounts and certain liabilities. The transaction closed on August 2, 2021 and we received proceeds of $<ix:nonFraction unitRef="usd" contextRef="ia92b5f17e3cb4ca99a1789f7499fb2b2_D20210802-20210802" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromDivestitureOfBusinesses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDYvZnJhZzpjN2ZmYWQ5NzA5YjM0M2Q1OWVjZWY1OTQ0YzA1NDM0NS90ZXh0cmVnaW9uOmM3ZmZhZDk3MDliMzQzZDU5ZWNlZjU5NDRjMDU0MzQ1XzQ5NDc4MDIzMzIxNTM_4b4adbbf-dab8-4cd2-a148-7ca28dc9f968">927</ix:nonFraction> million, net of cash transferred. Cardinal Health will retain product liability associated with lawsuits and claims related to inferior vena cava ("IVC") filters in the U.S. and Canada, as well as authority for these matters discussed in </span><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i4f0ec56b9c604f1782a65ea4a19c284d_130">Note 7</a></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Upon signing the agreement, we met the criteria for the related assets and liabilities of the Cordis business to be classified as held for sale. In connection with the divestiture, we allocated $<ix:nonFraction unitRef="usd" contextRef="i2ae0fa0d058b4f21aac5c8701cbd2fb7_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationGoodwill1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDYvZnJhZzpjN2ZmYWQ5NzA5YjM0M2Q1OWVjZWY1OTQ0YzA1NDM0NS90ZXh0cmVnaW9uOmM3ZmZhZDk3MDliMzQzZDU5ZWNlZjU5NDRjMDU0MzQ1XzI3NDg3NzkwNzY3NDA_75317e52-aae2-445f-9221-ecff7ffc13b0">388</ix:nonFraction>&#160;million of goodwill from the Medical Unit (within our Medical Segment) to the Cordis disposal group based on the estimated relative fair values of the business to be disposed of and the portion of the reporting unit that will be retained. We determined that the sale of the Cordis business does not meet the criteria to be classified as discontinued operations. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At June&#160;30, 2021, the book value of the disposal group exceeded its fair value less costs to sell. Accordingly, we recognized a $<ix:nonFraction unitRef="usd" contextRef="i2ae0fa0d058b4f21aac5c8701cbd2fb7_I20210630" decimals="-6" sign="-" format="ixt:numdotdecimal" name="cah:WriteDownOfAssetsHeldForSale" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDYvZnJhZzpjN2ZmYWQ5NzA5YjM0M2Q1OWVjZWY1OTQ0YzA1NDM0NS90ZXh0cmVnaW9uOmM3ZmZhZDk3MDliMzQzZDU5ZWNlZjU5NDRjMDU0MzQ1XzQ5NDc4MDIzMzA4MjM_a39c35cc-26f6-469f-be2c-86c121fa736b">60</ix:nonFraction> million pre-tax write-down on the disposal group in impairments and (gain)/loss on disposal of assets in our consolidated statement of earnings/(loss). This write-down includes a $<ix:nonFraction unitRef="usd" contextRef="i0c45da2d8021400f85c81b3a75b9c057_D20200701-20210630" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationForeignCurrencyTranslationGainsLosses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDYvZnJhZzpjN2ZmYWQ5NzA5YjM0M2Q1OWVjZWY1OTQ0YzA1NDM0NS90ZXh0cmVnaW9uOmM3ZmZhZDk3MDliMzQzZDU5ZWNlZjU5NDRjMDU0MzQ1XzQ5NDc4MDIzMzA4Mzk_f1a03d95-8357-4a1b-85f4-6a02dfe06620">3</ix:nonFraction> million loss related to currency translation adjustments in accumulated other comprehensive loss. We recorded a net tax expense of $<ix:nonFraction unitRef="usd" contextRef="i0c45da2d8021400f85c81b3a75b9c057_D20200701-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DiscontinuedOperationTaxEffectOfIncomeLossFromDisposalOfDiscontinuedOperation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDYvZnJhZzpjN2ZmYWQ5NzA5YjM0M2Q1OWVjZWY1OTQ0YzA1NDM0NS90ZXh0cmVnaW9uOmM3ZmZhZDk3MDliMzQzZDU5ZWNlZjU5NDRjMDU0MzQ1XzQ5NDc4MDIzMzA4NDU_452c6975-b517-4f16-8e62-1d9cc77596dd">9</ix:nonFraction> million associated with the impact of the write-down and the required tax adjustments related to held for sale accounting.</span></div><ix:nonNumeric contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630" name="us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDYvZnJhZzpjN2ZmYWQ5NzA5YjM0M2Q1OWVjZWY1OTQ0YzA1NDM0NS90ZXh0cmVnaW9uOmM3ZmZhZDk3MDliMzQzZDU5ZWNlZjU5NDRjMDU0MzQ1XzI3NDg3NzkwNzY3MTM_fcd3a24e-7c4b-43fd-a861-f67500d49715" escape="true"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents information related to the assets and liabilities that were classified as held for sale at June&#160;30, 2021 related to the Cordis divestiture in the consolidated balance sheets:</span></div><div style="margin-bottom:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:61.554%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:36.246%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cash and equivalents</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ae0fa0d058b4f21aac5c8701cbd2fb7_I20210630" decimals="-6" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDYvZnJhZzpjN2ZmYWQ5NzA5YjM0M2Q1OWVjZWY1OTQ0YzA1NDM0NS90YWJsZTowNGIzZTNmMDM4NTg0MzFlOWU2ZDk0NmViYzAxOWU0OS90YWJsZXJhbmdlOjA0YjNlM2YwMzg1ODQzMWU5ZTZkOTQ2ZWJjMDE5ZTQ5XzEtMS0xLTEtMzYzOQ_7348cadb-6a11-4ba8-b9dd-1573c2ad3bf7">109</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Inventories, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ae0fa0d058b4f21aac5c8701cbd2fb7_I20210630" decimals="-6" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationInventory1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDYvZnJhZzpjN2ZmYWQ5NzA5YjM0M2Q1OWVjZWY1OTQ0YzA1NDM0NS90YWJsZTowNGIzZTNmMDM4NTg0MzFlOWU2ZDk0NmViYzAxOWU0OS90YWJsZXJhbmdlOjA0YjNlM2YwMzg1ODQzMWU5ZTZkOTQ2ZWJjMDE5ZTQ5XzItMS0xLTEtMzYzOQ_2b608cee-d8fc-4344-a523-57e0fd381345">164</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Property and equipment, net</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ae0fa0d058b4f21aac5c8701cbd2fb7_I20210630" decimals="-6" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDYvZnJhZzpjN2ZmYWQ5NzA5YjM0M2Q1OWVjZWY1OTQ0YzA1NDM0NS90YWJsZTowNGIzZTNmMDM4NTg0MzFlOWU2ZDk0NmViYzAxOWU0OS90YWJsZXJhbmdlOjA0YjNlM2YwMzg1ODQzMWU5ZTZkOTQ2ZWJjMDE5ZTQ5XzMtMS0xLTEtMzY0Mg_8fe10c00-7c21-402a-9f26-7f1b90816a1d">90</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Goodwill and other intangibles, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ae0fa0d058b4f21aac5c8701cbd2fb7_I20210630" decimals="-6" name="cah:DisposalGroupIncludingDiscontinuedOperationsGoodwillAndOtherIntangiblesNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDYvZnJhZzpjN2ZmYWQ5NzA5YjM0M2Q1OWVjZWY1OTQ0YzA1NDM0NS90YWJsZTowNGIzZTNmMDM4NTg0MzFlOWU2ZDk0NmViYzAxOWU0OS90YWJsZXJhbmdlOjA0YjNlM2YwMzg1ODQzMWU5ZTZkOTQ2ZWJjMDE5ZTQ5XzQtMS0xLTEtMzY0Mg_a49934ef-5186-41f0-93ee-62f398c0c80e">778</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ae0fa0d058b4f21aac5c8701cbd2fb7_I20210630" decimals="-6" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationOtherAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDYvZnJhZzpjN2ZmYWQ5NzA5YjM0M2Q1OWVjZWY1OTQ0YzA1NDM0NS90YWJsZTowNGIzZTNmMDM4NTg0MzFlOWU2ZDk0NmViYzAxOWU0OS90YWJsZXJhbmdlOjA0YjNlM2YwMzg1ODQzMWU5ZTZkOTQ2ZWJjMDE5ZTQ5XzUtMS0xLTEtMzY0Mg_d50fbe70-0c1d-42ee-92d1-c246c0bbab6e">10</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Write-down of assets held for sale</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2ae0fa0d058b4f21aac5c8701cbd2fb7_I20210630" decimals="-6" sign="-" name="cah:WriteDownOfAssetsHeldForSale" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDYvZnJhZzpjN2ZmYWQ5NzA5YjM0M2Q1OWVjZWY1OTQ0YzA1NDM0NS90YWJsZTowNGIzZTNmMDM4NTg0MzFlOWU2ZDk0NmViYzAxOWU0OS90YWJsZXJhbmdlOjA0YjNlM2YwMzg1ODQzMWU5ZTZkOTQ2ZWJjMDE5ZTQ5XzYtMS0xLTEtMzY0Mg_94c39bbf-3268-44d0-b6e4-ac0e52d098a5">60</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total assets held for sale</span></td><td style="background-color:#cccccc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ae0fa0d058b4f21aac5c8701cbd2fb7_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDYvZnJhZzpjN2ZmYWQ5NzA5YjM0M2Q1OWVjZWY1OTQ0YzA1NDM0NS90YWJsZTowNGIzZTNmMDM4NTg0MzFlOWU2ZDk0NmViYzAxOWU0OS90YWJsZXJhbmdlOjA0YjNlM2YwMzg1ODQzMWU5ZTZkOTQ2ZWJjMDE5ZTQ5XzctMS0xLTEtMzY0NQ_b65f8d5e-1c1c-48ad-927c-b3d6fef597a7">1,091</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other accrued liabilities</span></td><td style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ae0fa0d058b4f21aac5c8701cbd2fb7_I20210630" decimals="-6" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationAccruedLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDYvZnJhZzpjN2ZmYWQ5NzA5YjM0M2Q1OWVjZWY1OTQ0YzA1NDM0NS90YWJsZTowNGIzZTNmMDM4NTg0MzFlOWU2ZDk0NmViYzAxOWU0OS90YWJsZXJhbmdlOjA0YjNlM2YwMzg1ODQzMWU5ZTZkOTQ2ZWJjMDE5ZTQ5XzktMS0xLTEtMzY0OA_08edabcb-5030-47ea-b0c6-a8f692411798">61</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Deferred income taxes and other liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ae0fa0d058b4f21aac5c8701cbd2fb7_I20210630" decimals="-6" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationOtherLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDYvZnJhZzpjN2ZmYWQ5NzA5YjM0M2Q1OWVjZWY1OTQ0YzA1NDM0NS90YWJsZTowNGIzZTNmMDM4NTg0MzFlOWU2ZDk0NmViYzAxOWU0OS90YWJsZXJhbmdlOjA0YjNlM2YwMzg1ODQzMWU5ZTZkOTQ2ZWJjMDE5ZTQ5XzEwLTEtMS0xLTM2NDg_a9ac9c13-dccb-4f69-90ca-ec6abc602892">34</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total liabilities related to assets held for sale</span></td><td style="background-color:#cccccc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ae0fa0d058b4f21aac5c8701cbd2fb7_I20210630" decimals="-6" name="us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDYvZnJhZzpjN2ZmYWQ5NzA5YjM0M2Q1OWVjZWY1OTQ0YzA1NDM0NS90YWJsZTowNGIzZTNmMDM4NTg0MzFlOWU2ZDk0NmViYzAxOWU0OS90YWJsZXJhbmdlOjA0YjNlM2YwMzg1ODQzMWU5ZTZkOTQ2ZWJjMDE5ZTQ5XzExLTEtMS0xLTM2NTE_ef47dbec-19f2-490b-835b-7c5a261fa63f">95</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:nonNumeric></div></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:3pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.222%"><tr><td style="width:1.0%"></td><td style="width:32.133%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.433%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.134%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">68</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardinal Health </span><span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">| </span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2021 Form 10-K</span></div></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:3pt"><span><br/></span></div><div style="margin-bottom:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:24.720%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:50.989%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.991%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#e41f35;border-bottom:1pt solid #e41f35;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Notes to Financial Statements</span></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:0 1pt"></td></tr></table></div></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:48.214%"><ix:continuation id="i257affc5ba4e4553aaceb963db86ac66"><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:120%">naviHealth</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2018, we sold our majority ownership interest in naviHealth, which operated within our Medical segment in exchange for cash proceeds of $<ix:nonFraction unitRef="usd" contextRef="i7f43dacd4cde4469bf87d551b8b075a1_D20180801-20180831" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromDivestitureOfBusinesses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDYvZnJhZzpjN2ZmYWQ5NzA5YjM0M2Q1OWVjZWY1OTQ0YzA1NDM0NS90ZXh0cmVnaW9uOmM3ZmZhZDk3MDliMzQzZDU5ZWNlZjU5NDRjMDU0MzQ1XzQ5NDc4MDIzMjgyMDE_b6ef2970-175c-4e28-b2be-663e15602fc3">737</ix:nonFraction> million (after adjusting for certain fees and expenses) and a noncontrolling equity interest in a partnership that owned naviHealth. We also had certain call rights to reacquire naviHealth. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a result of this divestiture, during the fiscal year ended June&#160;30, 2019, we recognized a pre-tax gain of $<ix:nonFraction unitRef="usd" contextRef="ibfc08d70138644988d1a3a9486dd3ada_D20180701-20190630" decimals="-6" format="ixt:numdotdecimal" name="cah:PreTaxGainonDivestiture" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDYvZnJhZzpjN2ZmYWQ5NzA5YjM0M2Q1OWVjZWY1OTQ0YzA1NDM0NS90ZXh0cmVnaW9uOmM3ZmZhZDk3MDliMzQzZDU5ZWNlZjU5NDRjMDU0MzQ1XzQ5NDc4MDIzMjgyMDY_e9c9ab43-152a-4833-824c-920546c9a873">508</ix:nonFraction> million in impairments and (gain)/loss on disposal of assets in our consolidated statements of earnings/(loss). This gain included our initial recognition of an equity method investment for $<ix:nonFraction unitRef="usd" contextRef="i463eed964bd04d08b29df93f74be293d_I20180801" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:EquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDYvZnJhZzpjN2ZmYWQ5NzA5YjM0M2Q1OWVjZWY1OTQ0YzA1NDM0NS90ZXh0cmVnaW9uOmM3ZmZhZDk3MDliMzQzZDU5ZWNlZjU5NDRjMDU0MzQ1XzQ5NDc4MDIzMjgyMTA_6beb73f7-cf8b-46ec-b9db-82a1765789e9">358</ix:nonFraction> million and the derecognition of redeemable noncontrolling interests of $<ix:nonFraction unitRef="usd" contextRef="i463eed964bd04d08b29df93f74be293d_I20180801" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDYvZnJhZzpjN2ZmYWQ5NzA5YjM0M2Q1OWVjZWY1OTQ0YzA1NDM0NS90ZXh0cmVnaW9uOmM3ZmZhZDk3MDliMzQzZDU5ZWNlZjU5NDRjMDU0MzQ1XzQ5NDc4MDIzMjgyMTQ_38e67e15-0773-4ade-9a3d-6205e503646c">12</ix:nonFraction> million. The fiscal 2019 tax expense as a result of this transaction was $<ix:nonFraction unitRef="usd" contextRef="i7f43dacd4cde4469bf87d551b8b075a1_D20180801-20180831" decimals="-6" format="ixt:numdotdecimal" name="cah:Provisionaltaxbenefitrelatedtotransaction" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDYvZnJhZzpjN2ZmYWQ5NzA5YjM0M2Q1OWVjZWY1OTQ0YzA1NDM0NS90ZXh0cmVnaW9uOmM3ZmZhZDk3MDliMzQzZDU5ZWNlZjU5NDRjMDU0MzQ1XzQ5NDc4MDIzMjgyMTg_f3690a52-05eb-49d9-8f2b-3601ffc8f113">130</ix:nonFraction> million. We determined that the sale of the naviHealth business did not meet the criteria to be classified as discontinued operations.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2020 we sold the remainder of our noncontrolling equity interest in a partnership that owned naviHealth. We recognized a pre-tax gain of $<ix:nonFraction unitRef="usd" contextRef="i240ee16a678541f0949ac8f39755276a_D20190701-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:GainOnSaleOfInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDYvZnJhZzpjN2ZmYWQ5NzA5YjM0M2Q1OWVjZWY1OTQ0YzA1NDM0NS90ZXh0cmVnaW9uOmM3ZmZhZDk3MDliMzQzZDU5ZWNlZjU5NDRjMDU0MzQ1XzQ5NDc4MDIzMjgyMjI_a40541cb-0d05-490c-8680-029c1ebae141">579</ix:nonFraction>&#160;million from this disposal in gain on sale of equity interest in naviHealth in our consolidated statements of earnings/(loss) during fiscal year 2020.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our proportionate share of naviHealth&#8217;s results, which was recorded in other (income)/expense, net in the consolidated statements of earnings/(loss), was income of $<ix:nonFraction unitRef="usd" contextRef="ia31e9a409b874bb19d0ff6f2f39ecc09_D20190701-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDYvZnJhZzpjN2ZmYWQ5NzA5YjM0M2Q1OWVjZWY1OTQ0YzA1NDM0NS90ZXh0cmVnaW9uOmM3ZmZhZDk3MDliMzQzZDU5ZWNlZjU5NDRjMDU0MzQ1XzEzNzM_4a271d31-fc8f-4de0-88a4-9ecc75808fd5">2</ix:nonFraction> million and a loss of $<ix:nonFraction unitRef="usd" contextRef="i00a6d666bf604826b24e68ddbd63eac4_D20180701-20190630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDYvZnJhZzpjN2ZmYWQ5NzA5YjM0M2Q1OWVjZWY1OTQ0YzA1NDM0NS90ZXh0cmVnaW9uOmM3ZmZhZDk3MDliMzQzZDU5ZWNlZjU5NDRjMDU0MzQ1XzEzOTA_e0ad1485-c505-4dd7-9a20-fac9407b8dcc">10</ix:nonFraction> million during fiscal 2020 and 2019, respectively. </span></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Acquisitions</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We did not complete any acquisitions during fiscal 2020. While we completed several small acquisitions during fiscal 2021 and 2019, the pro forma results of operations and the results of operations for acquired businesses since the acquisition dates have not been separately disclosed because the effects were not significant compared to the consolidated financial statements, individually or in the aggregate. The cash paid for these acquisitions, net of cash acquired was $<ix:nonFraction unitRef="usd" contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDYvZnJhZzpjN2ZmYWQ5NzA5YjM0M2Q1OWVjZWY1OTQ0YzA1NDM0NS90ZXh0cmVnaW9uOmM3ZmZhZDk3MDliMzQzZDU5ZWNlZjU5NDRjMDU0MzQ1XzQ5NDc4MDIzMzE0OTU_1c95364d-877a-4822-8479-aadbdfab13cf">3</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i00a6d666bf604826b24e68ddbd63eac4_D20180701-20190630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDYvZnJhZzpjN2ZmYWQ5NzA5YjM0M2Q1OWVjZWY1OTQ0YzA1NDM0NS90ZXh0cmVnaW9uOmM3ZmZhZDk3MDliMzQzZDU5ZWNlZjU5NDRjMDU0MzQ1XzI1NDk_3ad0b7a1-d125-4af8-863b-1a9a8d6464f1">82</ix:nonFraction> million for fiscal 2021 and 2019, respectively.</span></div></ix:continuation><div id="i4f0ec56b9c604f1782a65ea4a19c284d_109"></div><ix:nonNumeric contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630" name="us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDkvZnJhZzo1MTBkNDY1OTZlNDk0ZWRiOGViOGY1MWZmYTk4OTMxYS90ZXh0cmVnaW9uOjUxMGQ0NjU5NmU0OTRlZGI4ZWI4ZjUxZmZhOTg5MzFhXzE0ODE_4eabfc78-f098-4431-8b5a-f3e88f826329" continuedAt="i0cc4575eade14e97bd76901d3aa4f478" escape="true"><div style="margin-bottom:6pt;text-align:justify"><span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:13pt;font-weight:700;line-height:120%">3. Restructuring and Employee Severance </span></div><ix:nonNumeric contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630" name="us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDkvZnJhZzo1MTBkNDY1OTZlNDk0ZWRiOGViOGY1MWZmYTk4OTMxYS90ZXh0cmVnaW9uOjUxMGQ0NjU5NmU0OTRlZGI4ZWI4ZjUxZmZhOTg5MzFhXzE0ODg_527268cb-dbac-410b-ac37-c7efdc3be03b" escape="true"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables summarize restructuring and employee severance costs:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.382%"><tr><td style="width:1.0%"></td><td style="width:57.595%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.632%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.352%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.632%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.352%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Employee-related costs </span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630" decimals="-6" name="us-gaap:SeveranceCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDkvZnJhZzo1MTBkNDY1OTZlNDk0ZWRiOGViOGY1MWZmYTk4OTMxYS90YWJsZTo2ZDU5ZWRiZDVmMDI0NzFjYWU5OWI5NjBlYjFiNzdlNy90YWJsZXJhbmdlOjZkNTllZGJkNWYwMjQ3MWNhZTk5Yjk2MGViMWI3N2U3XzEtMS0xLTEtMA_2a2f5585-d0f4-4f23-9a02-5dd8f030a595">53</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia31e9a409b874bb19d0ff6f2f39ecc09_D20190701-20200630" decimals="-6" name="us-gaap:SeveranceCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDkvZnJhZzo1MTBkNDY1OTZlNDk0ZWRiOGViOGY1MWZmYTk4OTMxYS90YWJsZTo2ZDU5ZWRiZDVmMDI0NzFjYWU5OWI5NjBlYjFiNzdlNy90YWJsZXJhbmdlOjZkNTllZGJkNWYwMjQ3MWNhZTk5Yjk2MGViMWI3N2U3XzEtMy0xLTEtMA_131ca3d7-5171-4321-b38f-0269bbe648ff">66</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i00a6d666bf604826b24e68ddbd63eac4_D20180701-20190630" decimals="-6" name="us-gaap:SeveranceCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDkvZnJhZzo1MTBkNDY1OTZlNDk0ZWRiOGViOGY1MWZmYTk4OTMxYS90YWJsZTo2ZDU5ZWRiZDVmMDI0NzFjYWU5OWI5NjBlYjFiNzdlNy90YWJsZXJhbmdlOjZkNTllZGJkNWYwMjQ3MWNhZTk5Yjk2MGViMWI3N2U3XzEtNS0xLTEtMA_ee9d1648-db2e-4ed2-950a-66ae99986ec9">95</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Facility exit and other costs </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630" decimals="-6" name="cah:FacilityExitAndOtherCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDkvZnJhZzo1MTBkNDY1OTZlNDk0ZWRiOGViOGY1MWZmYTk4OTMxYS90YWJsZTo2ZDU5ZWRiZDVmMDI0NzFjYWU5OWI5NjBlYjFiNzdlNy90YWJsZXJhbmdlOjZkNTllZGJkNWYwMjQ3MWNhZTk5Yjk2MGViMWI3N2U3XzItMS0xLTEtMA_7ab63a86-d9ed-48c6-bbc6-8a884a62544a">61</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia31e9a409b874bb19d0ff6f2f39ecc09_D20190701-20200630" decimals="-6" name="cah:FacilityExitAndOtherCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDkvZnJhZzo1MTBkNDY1OTZlNDk0ZWRiOGViOGY1MWZmYTk4OTMxYS90YWJsZTo2ZDU5ZWRiZDVmMDI0NzFjYWU5OWI5NjBlYjFiNzdlNy90YWJsZXJhbmdlOjZkNTllZGJkNWYwMjQ3MWNhZTk5Yjk2MGViMWI3N2U3XzItMy0xLTEtMA_cbfadd10-3a18-467d-9c41-2e51e1edf84a">56</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i00a6d666bf604826b24e68ddbd63eac4_D20180701-20190630" decimals="-6" name="cah:FacilityExitAndOtherCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDkvZnJhZzo1MTBkNDY1OTZlNDk0ZWRiOGViOGY1MWZmYTk4OTMxYS90YWJsZTo2ZDU5ZWRiZDVmMDI0NzFjYWU5OWI5NjBlYjFiNzdlNy90YWJsZXJhbmdlOjZkNTllZGJkNWYwMjQ3MWNhZTk5Yjk2MGViMWI3N2U3XzItNS0xLTEtMA_c63816a1-f7dd-4531-8c73-0fd68b4ae54b">30</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total restructuring and employee severance</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDkvZnJhZzo1MTBkNDY1OTZlNDk0ZWRiOGViOGY1MWZmYTk4OTMxYS90YWJsZTo2ZDU5ZWRiZDVmMDI0NzFjYWU5OWI5NjBlYjFiNzdlNy90YWJsZXJhbmdlOjZkNTllZGJkNWYwMjQ3MWNhZTk5Yjk2MGViMWI3N2U3XzMtMS0xLTEtMA_407dde4d-008b-468b-8e7e-a5626933717c">114</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia31e9a409b874bb19d0ff6f2f39ecc09_D20190701-20200630" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDkvZnJhZzo1MTBkNDY1OTZlNDk0ZWRiOGViOGY1MWZmYTk4OTMxYS90YWJsZTo2ZDU5ZWRiZDVmMDI0NzFjYWU5OWI5NjBlYjFiNzdlNy90YWJsZXJhbmdlOjZkNTllZGJkNWYwMjQ3MWNhZTk5Yjk2MGViMWI3N2U3XzMtMy0xLTEtMA_ea0e13b9-fcf1-4264-a06e-ed8909f3087a">122</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i00a6d666bf604826b24e68ddbd63eac4_D20180701-20190630" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDkvZnJhZzo1MTBkNDY1OTZlNDk0ZWRiOGViOGY1MWZmYTk4OTMxYS90YWJsZTo2ZDU5ZWRiZDVmMDI0NzFjYWU5OWI5NjBlYjFiNzdlNy90YWJsZXJhbmdlOjZkNTllZGJkNWYwMjQ3MWNhZTk5Yjk2MGViMWI3N2U3XzMtNS0xLTEtMA_b44ecfcd-99e8-4eb6-9bb8-9ace640740e1">125</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Employee-related costs primarily consist of termination benefits provided to employees who have been involuntarily terminated, duplicate payroll costs and retention bonuses incurred during transition periods. Facility exit and other costs primarily consist of professional, project management and other service fees to support divestitures, vendor transition fees, accelerated depreciation, lease costs associated with vacant facilities, equipment relocation costs, project consulting fees, costs </span></div></ix:nonNumeric></div><div style="display:inline-block;max-width:3.571%;min-width:2.571%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:48.215%"><ix:continuation id="i0cc4575eade14e97bd76901d3aa4f478"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">associated with restructuring our delivery of information technology infrastructure services and certain other divestiture-related costs.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In fiscal 2021, restructuring costs were primarily related to the implementation of certain enterprise-wide cost-savings measures and the divestiture of our Cordis business. In fiscal 2020 and 2019, restructuring costs were primarily related to the implementation of certain enterprise-wide cost-savings measures.</span></div><ix:nonNumeric contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630" name="us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDkvZnJhZzo1MTBkNDY1OTZlNDk0ZWRiOGViOGY1MWZmYTk4OTMxYS90ZXh0cmVnaW9uOjUxMGQ0NjU5NmU0OTRlZGI4ZWI4ZjUxZmZhOTg5MzFhXzE1MDk_c4f5d0bf-e395-47d4-a4d9-82ef89452e6a" escape="true"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes activity related to liabilities associated with restructuring and employee severance:</span></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.691%"><tr><td style="width:1.0%"></td><td style="width:42.553%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.714%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.347%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.191%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.347%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.048%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Employee-<br/>Related Costs</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Facility Exit<br/>and Other Costs</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance at June 30, 2019</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i054d56750a764f7e93ff85a2bf9a1b2b_I20190630" decimals="-6" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDkvZnJhZzo1MTBkNDY1OTZlNDk0ZWRiOGViOGY1MWZmYTk4OTMxYS90YWJsZTo5MDFjZTJmMTc5M2M0ODIzYWQ5MjYwODY1YjVlMmY0Yi90YWJsZXJhbmdlOjkwMWNlMmYxNzkzYzQ4MjNhZDkyNjA4NjViNWUyZjRiXzEtMS0xLTEtMA_b8437c0c-694f-4628-b807-638d6ff8d3d3">64</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i033d53d46d0d43139442c42e765cd554_I20190630" decimals="-6" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDkvZnJhZzo1MTBkNDY1OTZlNDk0ZWRiOGViOGY1MWZmYTk4OTMxYS90YWJsZTo5MDFjZTJmMTc5M2M0ODIzYWQ5MjYwODY1YjVlMmY0Yi90YWJsZXJhbmdlOjkwMWNlMmYxNzkzYzQ4MjNhZDkyNjA4NjViNWUyZjRiXzEtMy0xLTEtMA_cadb1195-874f-4f70-ae03-187995878a7c">8</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if6dc09eec4e74751b47cdf037a5b1860_I20190630" decimals="-6" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDkvZnJhZzo1MTBkNDY1OTZlNDk0ZWRiOGViOGY1MWZmYTk4OTMxYS90YWJsZTo5MDFjZTJmMTc5M2M0ODIzYWQ5MjYwODY1YjVlMmY0Yi90YWJsZXJhbmdlOjkwMWNlMmYxNzkzYzQ4MjNhZDkyNjA4NjViNWUyZjRiXzEtNS0xLTEtMA_4d7cb679-5adb-4bde-9f7f-9b13c4c29fbd">72</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Additions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i979647fadf85426a8ed1ad60900d45dc_D20190701-20200630" decimals="-6" name="us-gaap:RestructuringCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDkvZnJhZzo1MTBkNDY1OTZlNDk0ZWRiOGViOGY1MWZmYTk4OTMxYS90YWJsZTo5MDFjZTJmMTc5M2M0ODIzYWQ5MjYwODY1YjVlMmY0Yi90YWJsZXJhbmdlOjkwMWNlMmYxNzkzYzQ4MjNhZDkyNjA4NjViNWUyZjRiXzItMS0xLTEtMA_d2b13e6b-b75d-4b8b-8107-33e91cb79e0c">85</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i690a654e053647b6a93151845b9d81e9_D20190701-20200630" decimals="-6" name="us-gaap:RestructuringCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDkvZnJhZzo1MTBkNDY1OTZlNDk0ZWRiOGViOGY1MWZmYTk4OTMxYS90YWJsZTo5MDFjZTJmMTc5M2M0ODIzYWQ5MjYwODY1YjVlMmY0Yi90YWJsZXJhbmdlOjkwMWNlMmYxNzkzYzQ4MjNhZDkyNjA4NjViNWUyZjRiXzItMy0xLTEtMA_c75bde5f-f20d-4181-8574-5e86ead934b5">24</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia31e9a409b874bb19d0ff6f2f39ecc09_D20190701-20200630" decimals="-6" name="us-gaap:RestructuringCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDkvZnJhZzo1MTBkNDY1OTZlNDk0ZWRiOGViOGY1MWZmYTk4OTMxYS90YWJsZTo5MDFjZTJmMTc5M2M0ODIzYWQ5MjYwODY1YjVlMmY0Yi90YWJsZXJhbmdlOjkwMWNlMmYxNzkzYzQ4MjNhZDkyNjA4NjViNWUyZjRiXzItNS0xLTEtMA_a4f49f1e-4d86-4bde-ad15-a51c7054e51c">109</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Payments and other adjustments</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i979647fadf85426a8ed1ad60900d45dc_D20190701-20200630" decimals="-6" name="us-gaap:PaymentsForRestructuring" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDkvZnJhZzo1MTBkNDY1OTZlNDk0ZWRiOGViOGY1MWZmYTk4OTMxYS90YWJsZTo5MDFjZTJmMTc5M2M0ODIzYWQ5MjYwODY1YjVlMmY0Yi90YWJsZXJhbmdlOjkwMWNlMmYxNzkzYzQ4MjNhZDkyNjA4NjViNWUyZjRiXzMtMS0xLTEtMA_3a6d355e-29c5-439a-9a6e-21e3f65e2e58">81</ix:nonFraction>)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i690a654e053647b6a93151845b9d81e9_D20190701-20200630" decimals="-6" name="us-gaap:PaymentsForRestructuring" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDkvZnJhZzo1MTBkNDY1OTZlNDk0ZWRiOGViOGY1MWZmYTk4OTMxYS90YWJsZTo5MDFjZTJmMTc5M2M0ODIzYWQ5MjYwODY1YjVlMmY0Yi90YWJsZXJhbmdlOjkwMWNlMmYxNzkzYzQ4MjNhZDkyNjA4NjViNWUyZjRiXzMtMy0xLTEtMA_f574ea45-b725-49ed-95a5-cb223f20377f">4</ix:nonFraction>)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia31e9a409b874bb19d0ff6f2f39ecc09_D20190701-20200630" decimals="-6" name="us-gaap:PaymentsForRestructuring" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDkvZnJhZzo1MTBkNDY1OTZlNDk0ZWRiOGViOGY1MWZmYTk4OTMxYS90YWJsZTo5MDFjZTJmMTc5M2M0ODIzYWQ5MjYwODY1YjVlMmY0Yi90YWJsZXJhbmdlOjkwMWNlMmYxNzkzYzQ4MjNhZDkyNjA4NjViNWUyZjRiXzMtNS0xLTEtMA_eeb0cc9d-e634-4228-97a7-2163f4f869c9">85</ix:nonFraction>)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance at June 30, 2020</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b154a090610482d9bfc35edbf9bab55_I20200630" decimals="-6" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDkvZnJhZzo1MTBkNDY1OTZlNDk0ZWRiOGViOGY1MWZmYTk4OTMxYS90YWJsZTo5MDFjZTJmMTc5M2M0ODIzYWQ5MjYwODY1YjVlMmY0Yi90YWJsZXJhbmdlOjkwMWNlMmYxNzkzYzQ4MjNhZDkyNjA4NjViNWUyZjRiXzQtMS0xLTEtMA_71c886ee-32fe-4813-b0b0-8eb26be921e8">68</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i74208c384ff247b5a96f11cafa8f324e_I20200630" decimals="-6" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDkvZnJhZzo1MTBkNDY1OTZlNDk0ZWRiOGViOGY1MWZmYTk4OTMxYS90YWJsZTo5MDFjZTJmMTc5M2M0ODIzYWQ5MjYwODY1YjVlMmY0Yi90YWJsZXJhbmdlOjkwMWNlMmYxNzkzYzQ4MjNhZDkyNjA4NjViNWUyZjRiXzQtMy0xLTEtMA_d09d9141-76bd-45ae-9036-f665f6d1f973">28</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i299cea70f47b4fbe96772aaa8cc00b79_I20200630" decimals="-6" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDkvZnJhZzo1MTBkNDY1OTZlNDk0ZWRiOGViOGY1MWZmYTk4OTMxYS90YWJsZTo5MDFjZTJmMTc5M2M0ODIzYWQ5MjYwODY1YjVlMmY0Yi90YWJsZXJhbmdlOjkwMWNlMmYxNzkzYzQ4MjNhZDkyNjA4NjViNWUyZjRiXzQtNS0xLTEtMA_1ec68b6d-bee9-4243-8fc1-5933dcf87491">96</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Additions</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i66e672ad39ba4fbda69ce9255eb8afa1_D20200701-20210630" decimals="-6" name="us-gaap:RestructuringCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDkvZnJhZzo1MTBkNDY1OTZlNDk0ZWRiOGViOGY1MWZmYTk4OTMxYS90YWJsZTo5MDFjZTJmMTc5M2M0ODIzYWQ5MjYwODY1YjVlMmY0Yi90YWJsZXJhbmdlOjkwMWNlMmYxNzkzYzQ4MjNhZDkyNjA4NjViNWUyZjRiXzUtMS0xLTEtMA_159f063f-e2c0-463b-a7e7-3924a8586aab">49</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i369bbd13125e4ca2a3de4a5c3da1ffc5_D20200701-20210630" decimals="-6" name="us-gaap:RestructuringCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDkvZnJhZzo1MTBkNDY1OTZlNDk0ZWRiOGViOGY1MWZmYTk4OTMxYS90YWJsZTo5MDFjZTJmMTc5M2M0ODIzYWQ5MjYwODY1YjVlMmY0Yi90YWJsZXJhbmdlOjkwMWNlMmYxNzkzYzQ4MjNhZDkyNjA4NjViNWUyZjRiXzUtMy0xLTEtMA_a70a8761-b370-4e91-a2c4-9f9f0a8aedd1">26</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630" decimals="-6" name="us-gaap:RestructuringCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDkvZnJhZzo1MTBkNDY1OTZlNDk0ZWRiOGViOGY1MWZmYTk4OTMxYS90YWJsZTo5MDFjZTJmMTc5M2M0ODIzYWQ5MjYwODY1YjVlMmY0Yi90YWJsZXJhbmdlOjkwMWNlMmYxNzkzYzQ4MjNhZDkyNjA4NjViNWUyZjRiXzUtNS0xLTEtMA_1a531aa1-f04b-4fbb-a4e6-e4b9ac94cbf0">75</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Payments and other adjustments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i66e672ad39ba4fbda69ce9255eb8afa1_D20200701-20210630" decimals="-6" name="us-gaap:PaymentsForRestructuring" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDkvZnJhZzo1MTBkNDY1OTZlNDk0ZWRiOGViOGY1MWZmYTk4OTMxYS90YWJsZTo5MDFjZTJmMTc5M2M0ODIzYWQ5MjYwODY1YjVlMmY0Yi90YWJsZXJhbmdlOjkwMWNlMmYxNzkzYzQ4MjNhZDkyNjA4NjViNWUyZjRiXzYtMS0xLTEtMA_70e6df47-2e83-4f26-9967-f5eb361d3436">64</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i369bbd13125e4ca2a3de4a5c3da1ffc5_D20200701-20210630" decimals="-6" name="us-gaap:PaymentsForRestructuring" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDkvZnJhZzo1MTBkNDY1OTZlNDk0ZWRiOGViOGY1MWZmYTk4OTMxYS90YWJsZTo5MDFjZTJmMTc5M2M0ODIzYWQ5MjYwODY1YjVlMmY0Yi90YWJsZXJhbmdlOjkwMWNlMmYxNzkzYzQ4MjNhZDkyNjA4NjViNWUyZjRiXzYtMy0xLTEtMA_19de4726-aeb0-4640-8f28-c5ec9e38717c">28</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630" decimals="-6" name="us-gaap:PaymentsForRestructuring" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDkvZnJhZzo1MTBkNDY1OTZlNDk0ZWRiOGViOGY1MWZmYTk4OTMxYS90YWJsZTo5MDFjZTJmMTc5M2M0ODIzYWQ5MjYwODY1YjVlMmY0Yi90YWJsZXJhbmdlOjkwMWNlMmYxNzkzYzQ4MjNhZDkyNjA4NjViNWUyZjRiXzYtNS0xLTEtMA_13ec2ee1-2adc-4fe3-9ad6-2d3f402378b0">92</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance at June 30, 2021</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec538c38949543a3a758a69a4da1d7f4_I20210630" decimals="-6" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDkvZnJhZzo1MTBkNDY1OTZlNDk0ZWRiOGViOGY1MWZmYTk4OTMxYS90YWJsZTo5MDFjZTJmMTc5M2M0ODIzYWQ5MjYwODY1YjVlMmY0Yi90YWJsZXJhbmdlOjkwMWNlMmYxNzkzYzQ4MjNhZDkyNjA4NjViNWUyZjRiXzctMS0xLTEtMA_139dd230-487b-4e35-9403-cb9712340236">53</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3af47ae162d94351b026bc1510125da6_I20210630" decimals="-6" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDkvZnJhZzo1MTBkNDY1OTZlNDk0ZWRiOGViOGY1MWZmYTk4OTMxYS90YWJsZTo5MDFjZTJmMTc5M2M0ODIzYWQ5MjYwODY1YjVlMmY0Yi90YWJsZXJhbmdlOjkwMWNlMmYxNzkzYzQ4MjNhZDkyNjA4NjViNWUyZjRiXzctMy0xLTEtMA_96869d70-f1e6-467c-b2e6-1d3e3c6c3e6c">26</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2e87824102b34590a0208cc7da91b5f5_I20210630" decimals="-6" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDkvZnJhZzo1MTBkNDY1OTZlNDk0ZWRiOGViOGY1MWZmYTk4OTMxYS90YWJsZTo5MDFjZTJmMTc5M2M0ODIzYWQ5MjYwODY1YjVlMmY0Yi90YWJsZXJhbmdlOjkwMWNlMmYxNzkzYzQ4MjNhZDkyNjA4NjViNWUyZjRiXzctNS0xLTEtMA_91cf4f3f-1e83-4436-bbf3-56ab307d4fba">79</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div id="i4f0ec56b9c604f1782a65ea4a19c284d_112"></div><ix:nonNumeric contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630" name="us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMTIvZnJhZzoxZjM3NDE4OGI0M2U0ZGQ4YjU1YzhiY2RlNzA0NjZmNi90ZXh0cmVnaW9uOjFmMzc0MTg4YjQzZTRkZDhiNTVjOGJjZGU3MDQ2NmY2XzYyOQ_f9644742-5b9b-4d3a-a915-6cbde4a955f8" continuedAt="idc35381d48d94a1189f725a22d8f67da" escape="true"><div style="margin-bottom:6pt;text-align:justify"><span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:13pt;font-weight:700;line-height:120%">4. Goodwill and Other Intangible Assets </span></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Goodwill</span></div><ix:nonNumeric contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630" name="us-gaap:ScheduleOfGoodwillTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMTIvZnJhZzoxZjM3NDE4OGI0M2U0ZGQ4YjU1YzhiY2RlNzA0NjZmNi90ZXh0cmVnaW9uOjFmMzc0MTg4YjQzZTRkZDhiNTVjOGJjZGU3MDQ2NmY2XzY0NA_394cfd4f-2a0a-4055-96a1-6389bb7574be" continuedAt="ia57e91cd17b745fb817e7986b253b121" escape="true"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the changes in the carrying amount of goodwill by segment and in total:</span></div><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:41.801%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:24.517%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.343%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.949%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.343%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.247%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Pharmaceutical (1)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Medical (2)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total </span></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance at June 30, 2019</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b152a2afe4f4679a06346db852d336d_I20190630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMTIvZnJhZzoxZjM3NDE4OGI0M2U0ZGQ4YjU1YzhiY2RlNzA0NjZmNi90YWJsZTplZTgyNjg0YmNkNTI0YTI1ODY2MjFiM2Q5M2QxMzcwNC90YWJsZXJhbmdlOmVlODI2ODRiY2Q1MjRhMjU4NjYyMWIzZDkzZDEzNzA0XzEtMS0xLTEtMA_9b0178c8-6067-480e-9ecb-8236dcebb4d0">2,663</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie6cb132adb5f4ff7aba14ffe42cc56d3_I20190630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMTIvZnJhZzoxZjM3NDE4OGI0M2U0ZGQ4YjU1YzhiY2RlNzA0NjZmNi90YWJsZTplZTgyNjg0YmNkNTI0YTI1ODY2MjFiM2Q5M2QxMzcwNC90YWJsZXJhbmdlOmVlODI2ODRiY2Q1MjRhMjU4NjYyMWIzZDkzZDEzNzA0XzEtMy0xLTEtMA_f0c9bb29-9eb1-47f0-900c-f6daa943fa85">5,715</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if6dc09eec4e74751b47cdf037a5b1860_I20190630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMTIvZnJhZzoxZjM3NDE4OGI0M2U0ZGQ4YjU1YzhiY2RlNzA0NjZmNi90YWJsZTplZTgyNjg0YmNkNTI0YTI1ODY2MjFiM2Q5M2QxMzcwNC90YWJsZXJhbmdlOmVlODI2ODRiY2Q1MjRhMjU4NjYyMWIzZDkzZDEzNzA0XzEtNS0xLTEtMA_ea53c095-5ab0-4786-9e05-728de7592ca4">8,378</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Goodwill acquired, net of purchase price adjustments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib1a6fd7bfc8b43f5b583eff60a34f03f_D20190701-20200630" decimals="-6" sign="-" name="us-gaap:GoodwillTransfers" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMTIvZnJhZzoxZjM3NDE4OGI0M2U0ZGQ4YjU1YzhiY2RlNzA0NjZmNi90YWJsZTplZTgyNjg0YmNkNTI0YTI1ODY2MjFiM2Q5M2QxMzcwNC90YWJsZXJhbmdlOmVlODI2ODRiY2Q1MjRhMjU4NjYyMWIzZDkzZDEzNzA0XzItMS0xLTEtMA_da79163c-02b6-4912-a825-4a76b9bad282">5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icf7ee031a48e4d11b1c35c9709df0a86_D20190701-20200630" decimals="-6" format="ixt:zerodash" name="us-gaap:GoodwillTransfers" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMTIvZnJhZzoxZjM3NDE4OGI0M2U0ZGQ4YjU1YzhiY2RlNzA0NjZmNi90YWJsZTplZTgyNjg0YmNkNTI0YTI1ODY2MjFiM2Q5M2QxMzcwNC90YWJsZXJhbmdlOmVlODI2ODRiY2Q1MjRhMjU4NjYyMWIzZDkzZDEzNzA0XzItMy0xLTEtMA_465f92f5-1553-4132-bc0b-21a7b7625ca9">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia31e9a409b874bb19d0ff6f2f39ecc09_D20190701-20200630" decimals="-6" sign="-" name="us-gaap:GoodwillTransfers" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMTIvZnJhZzoxZjM3NDE4OGI0M2U0ZGQ4YjU1YzhiY2RlNzA0NjZmNi90YWJsZTplZTgyNjg0YmNkNTI0YTI1ODY2MjFiM2Q5M2QxMzcwNC90YWJsZXJhbmdlOmVlODI2ODRiY2Q1MjRhMjU4NjYyMWIzZDkzZDEzNzA0XzItNS0xLTEtMA_5eb23618-3d0f-45ea-bc42-4ba6dbea38a8">5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Foreign currency translation adjustments and other</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib1a6fd7bfc8b43f5b583eff60a34f03f_D20190701-20200630" decimals="-6" sign="-" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMTIvZnJhZzoxZjM3NDE4OGI0M2U0ZGQ4YjU1YzhiY2RlNzA0NjZmNi90YWJsZTplZTgyNjg0YmNkNTI0YTI1ODY2MjFiM2Q5M2QxMzcwNC90YWJsZXJhbmdlOmVlODI2ODRiY2Q1MjRhMjU4NjYyMWIzZDkzZDEzNzA0XzMtMS0xLTEtMA_c8562cf6-399c-45bd-bf48-1af2bb5120f7">1</ix:nonFraction>)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icf7ee031a48e4d11b1c35c9709df0a86_D20190701-20200630" decimals="-6" sign="-" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMTIvZnJhZzoxZjM3NDE4OGI0M2U0ZGQ4YjU1YzhiY2RlNzA0NjZmNi90YWJsZTplZTgyNjg0YmNkNTI0YTI1ODY2MjFiM2Q5M2QxMzcwNC90YWJsZXJhbmdlOmVlODI2ODRiY2Q1MjRhMjU4NjYyMWIzZDkzZDEzNzA0XzMtMy0xLTEtMA_3b069c6d-806f-422c-8440-9127fcc2fc3c">15</ix:nonFraction>)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia31e9a409b874bb19d0ff6f2f39ecc09_D20190701-20200630" decimals="-6" sign="-" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMTIvZnJhZzoxZjM3NDE4OGI0M2U0ZGQ4YjU1YzhiY2RlNzA0NjZmNi90YWJsZTplZTgyNjg0YmNkNTI0YTI1ODY2MjFiM2Q5M2QxMzcwNC90YWJsZXJhbmdlOmVlODI2ODRiY2Q1MjRhMjU4NjYyMWIzZDkzZDEzNzA0XzMtNS0xLTEtMA_24ccc529-4694-4e58-9152-2ce222fab5a8">16</ix:nonFraction>)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance at June 30, 2020</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2e9e49271a494ffb9966fdbbe81322b3_I20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMTIvZnJhZzoxZjM3NDE4OGI0M2U0ZGQ4YjU1YzhiY2RlNzA0NjZmNi90YWJsZTplZTgyNjg0YmNkNTI0YTI1ODY2MjFiM2Q5M2QxMzcwNC90YWJsZXJhbmdlOmVlODI2ODRiY2Q1MjRhMjU4NjYyMWIzZDkzZDEzNzA0XzctMS0xLTEtMA_f7e2e2fc-f5a0-4723-9ddf-a1bc67668ab3">2,657</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ca9000f2c0043198ff629f5aeec40d5_I20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMTIvZnJhZzoxZjM3NDE4OGI0M2U0ZGQ4YjU1YzhiY2RlNzA0NjZmNi90YWJsZTplZTgyNjg0YmNkNTI0YTI1ODY2MjFiM2Q5M2QxMzcwNC90YWJsZXJhbmdlOmVlODI2ODRiY2Q1MjRhMjU4NjYyMWIzZDkzZDEzNzA0XzctMy0xLTEtMA_663cf3d3-7eba-40bf-b6de-586992963f17">5,700</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i299cea70f47b4fbe96772aaa8cc00b79_I20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMTIvZnJhZzoxZjM3NDE4OGI0M2U0ZGQ4YjU1YzhiY2RlNzA0NjZmNi90YWJsZTplZTgyNjg0YmNkNTI0YTI1ODY2MjFiM2Q5M2QxMzcwNC90YWJsZXJhbmdlOmVlODI2ODRiY2Q1MjRhMjU4NjYyMWIzZDkzZDEzNzA0XzctNS0xLTEtMA_51f1114b-8141-408f-86a4-a40b99c617a0">8,357</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Goodwill acquired, net of purchase price adjustments</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8ec1f608f8f43c6bb4bb0cd8bd6fb89_D20200701-20210630" decimals="-6" name="us-gaap:GoodwillTransfers" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMTIvZnJhZzoxZjM3NDE4OGI0M2U0ZGQ4YjU1YzhiY2RlNzA0NjZmNi90YWJsZTplZTgyNjg0YmNkNTI0YTI1ODY2MjFiM2Q5M2QxMzcwNC90YWJsZXJhbmdlOmVlODI2ODRiY2Q1MjRhMjU4NjYyMWIzZDkzZDEzNzA0XzgtMS0xLTEtMA_a75045d7-7421-47cf-93cc-43234cf5743a">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4f2593aaba1d4bcea5ad84327da58c41_D20200701-20210630" decimals="-6" format="ixt:zerodash" name="us-gaap:GoodwillTransfers" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMTIvZnJhZzoxZjM3NDE4OGI0M2U0ZGQ4YjU1YzhiY2RlNzA0NjZmNi90YWJsZTplZTgyNjg0YmNkNTI0YTI1ODY2MjFiM2Q5M2QxMzcwNC90YWJsZXJhbmdlOmVlODI2ODRiY2Q1MjRhMjU4NjYyMWIzZDkzZDEzNzA0XzgtMy0xLTEtMA_067c89a5-30ca-411a-b403-5f2621548589">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630" decimals="-6" name="us-gaap:GoodwillTransfers" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMTIvZnJhZzoxZjM3NDE4OGI0M2U0ZGQ4YjU1YzhiY2RlNzA0NjZmNi90YWJsZTplZTgyNjg0YmNkNTI0YTI1ODY2MjFiM2Q5M2QxMzcwNC90YWJsZXJhbmdlOmVlODI2ODRiY2Q1MjRhMjU4NjYyMWIzZDkzZDEzNzA0XzgtNS0xLTEtMA_591e2dfb-df13-4c92-865e-2bb6c5df9770">2</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Foreign currency translation adjustments and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8ec1f608f8f43c6bb4bb0cd8bd6fb89_D20200701-20210630" decimals="-6" format="ixt:zerodash" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMTIvZnJhZzoxZjM3NDE4OGI0M2U0ZGQ4YjU1YzhiY2RlNzA0NjZmNi90YWJsZTplZTgyNjg0YmNkNTI0YTI1ODY2MjFiM2Q5M2QxMzcwNC90YWJsZXJhbmdlOmVlODI2ODRiY2Q1MjRhMjU4NjYyMWIzZDkzZDEzNzA0XzktMS0xLTEtMA_bdfcf130-f4be-4939-9a2e-18f13b494b64">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4f2593aaba1d4bcea5ad84327da58c41_D20200701-20210630" decimals="-6" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMTIvZnJhZzoxZjM3NDE4OGI0M2U0ZGQ4YjU1YzhiY2RlNzA0NjZmNi90YWJsZTplZTgyNjg0YmNkNTI0YTI1ODY2MjFiM2Q5M2QxMzcwNC90YWJsZXJhbmdlOmVlODI2ODRiY2Q1MjRhMjU4NjYyMWIzZDkzZDEzNzA0XzktMy0xLTEtMA_c21d1edd-8b5d-41f9-8764-ad08d4f6bba2">18</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630" decimals="-6" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMTIvZnJhZzoxZjM3NDE4OGI0M2U0ZGQ4YjU1YzhiY2RlNzA0NjZmNi90YWJsZTplZTgyNjg0YmNkNTI0YTI1ODY2MjFiM2Q5M2QxMzcwNC90YWJsZXJhbmdlOmVlODI2ODRiY2Q1MjRhMjU4NjYyMWIzZDkzZDEzNzA0XzktNS0xLTEtMA_d0878ea8-f050-4f52-b255-eb5c58a66992">18</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cordis goodwill reclassified to assets held for sale</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4bc96e0706314db5b186dfb752f90fbf_I20210630" decimals="-6" format="ixt:zerodash" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationGoodwill1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMTIvZnJhZzoxZjM3NDE4OGI0M2U0ZGQ4YjU1YzhiY2RlNzA0NjZmNi90YWJsZTplZTgyNjg0YmNkNTI0YTI1ODY2MjFiM2Q5M2QxMzcwNC90YWJsZXJhbmdlOmVlODI2ODRiY2Q1MjRhMjU4NjYyMWIzZDkzZDEzNzA0XzEwLTEtMS0xLTI1MDM_82903ac0-2248-4907-aae2-f6132c5fb120">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if49fcb6df2f04a0aa6c1338190b0051b_I20210630" decimals="-6" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationGoodwill1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMTIvZnJhZzoxZjM3NDE4OGI0M2U0ZGQ4YjU1YzhiY2RlNzA0NjZmNi90YWJsZTplZTgyNjg0YmNkNTI0YTI1ODY2MjFiM2Q5M2QxMzcwNC90YWJsZXJhbmdlOmVlODI2ODRiY2Q1MjRhMjU4NjYyMWIzZDkzZDEzNzA0XzEwLTMtMS0xLTI1MDY_03430da0-ac3c-4891-a9bb-3dfebd21dc32">388</ix:nonFraction>)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2ae0fa0d058b4f21aac5c8701cbd2fb7_I20210630" decimals="-6" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationGoodwill1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMTIvZnJhZzoxZjM3NDE4OGI0M2U0ZGQ4YjU1YzhiY2RlNzA0NjZmNi90YWJsZTplZTgyNjg0YmNkNTI0YTI1ODY2MjFiM2Q5M2QxMzcwNC90YWJsZXJhbmdlOmVlODI2ODRiY2Q1MjRhMjU4NjYyMWIzZDkzZDEzNzA0XzEwLTUtMS0xLTI1MDk_d8d2d2b9-325a-4500-870f-1f691600218e">388</ix:nonFraction>)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2.5pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance at June 30, 2021</span></td><td style="background-color:#ffffff;border-bottom:2.5pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2.5pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04a42200e8d447d5a05dcf88ecdb626a_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMTIvZnJhZzoxZjM3NDE4OGI0M2U0ZGQ4YjU1YzhiY2RlNzA0NjZmNi90YWJsZTplZTgyNjg0YmNkNTI0YTI1ODY2MjFiM2Q5M2QxMzcwNC90YWJsZXJhbmdlOmVlODI2ODRiY2Q1MjRhMjU4NjYyMWIzZDkzZDEzNzA0XzEwLTEtMS0xLTA_03446a75-f1da-4228-9b49-3e275c54dca7">2,659</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:2.5pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2.5pt solid #000000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2.5pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2.5pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie33f818d5fa545a6bf5a055023560358_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMTIvZnJhZzoxZjM3NDE4OGI0M2U0ZGQ4YjU1YzhiY2RlNzA0NjZmNi90YWJsZTplZTgyNjg0YmNkNTI0YTI1ODY2MjFiM2Q5M2QxMzcwNC90YWJsZXJhbmdlOmVlODI2ODRiY2Q1MjRhMjU4NjYyMWIzZDkzZDEzNzA0XzEwLTMtMS0xLTA_0feef2df-273a-4082-b92a-4a6172895743">5,330</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:2.5pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2.5pt solid #000000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2.5pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2.5pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2e87824102b34590a0208cc7da91b5f5_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMTIvZnJhZzoxZjM3NDE4OGI0M2U0ZGQ4YjU1YzhiY2RlNzA0NjZmNi90YWJsZTplZTgyNjg0YmNkNTI0YTI1ODY2MjFiM2Q5M2QxMzcwNC90YWJsZXJhbmdlOmVlODI2ODRiY2Q1MjRhMjU4NjYyMWIzZDkzZDEzNzA0XzEwLTUtMS0xLTA_794cefa3-dece-4a3f-a813-00699b77a7db">7,989</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:2.5pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;At June&#160;30, 2021 and 2020, the Pharmaceutical segment accumulated goodwill impairment loss was $<ix:nonFraction unitRef="usd" contextRef="i04a42200e8d447d5a05dcf88ecdb626a_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:GoodwillImpairedAccumulatedImpairmentLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMTIvZnJhZzoxZjM3NDE4OGI0M2U0ZGQ4YjU1YzhiY2RlNzA0NjZmNi90ZXh0cmVnaW9uOjFmMzc0MTg4YjQzZTRkZDhiNTVjOGJjZGU3MDQ2NmY2XzIwOQ_d2b4ea74-998d-442d-b266-1318c6810817"><ix:nonFraction unitRef="usd" contextRef="i2e9e49271a494ffb9966fdbbe81322b3_I20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:GoodwillImpairedAccumulatedImpairmentLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMTIvZnJhZzoxZjM3NDE4OGI0M2U0ZGQ4YjU1YzhiY2RlNzA0NjZmNi90ZXh0cmVnaW9uOjFmMzc0MTg4YjQzZTRkZDhiNTVjOGJjZGU3MDQ2NmY2XzIwOQ_eece39d6-16c1-4b94-92fb-4246e3cb4ae2">829</ix:nonFraction></ix:nonFraction> million.</span></div></ix:nonNumeric><div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:continuation id="ia57e91cd17b745fb817e7986b253b121">(2)&#160;&#160;&#160;&#160;At June&#160;30, 2021 and 2020, the Medical segment accumulated goodwill impairment loss was $<ix:nonFraction unitRef="usd" contextRef="ie33f818d5fa545a6bf5a055023560358_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:GoodwillImpairedAccumulatedImpairmentLoss" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMTIvZnJhZzoxZjM3NDE4OGI0M2U0ZGQ4YjU1YzhiY2RlNzA0NjZmNi90ZXh0cmVnaW9uOjFmMzc0MTg4YjQzZTRkZDhiNTVjOGJjZGU3MDQ2NmY2XzI5Mg_67acf34c-c0f0-4036-933c-04f7ced27b19"><ix:nonFraction unitRef="usd" contextRef="i3ca9000f2c0043198ff629f5aeec40d5_I20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:GoodwillImpairedAccumulatedImpairmentLoss" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMTIvZnJhZzoxZjM3NDE4OGI0M2U0ZGQ4YjU1YzhiY2RlNzA0NjZmNi90ZXh0cmVnaW9uOjFmMzc0MTg4YjQzZTRkZDhiNTVjOGJjZGU3MDQ2NmY2XzI5Mg_9c383cbb-f422-49c6-8f43-355c8c217272">1.4</ix:nonFraction></ix:nonFraction> billion.</ix:continuation> </span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the divestiture of our Cordis business, during fiscal 2021 we allocated and reclassified $<ix:nonFraction unitRef="usd" contextRef="if49fcb6df2f04a0aa6c1338190b0051b_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationGoodwill1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMTIvZnJhZzoxZjM3NDE4OGI0M2U0ZGQ4YjU1YzhiY2RlNzA0NjZmNi90ZXh0cmVnaW9uOjFmMzc0MTg4YjQzZTRkZDhiNTVjOGJjZGU3MDQ2NmY2XzcxNDY4MjU1ODE3Mzg_03430da0-ac3c-4891-a9bb-3dfebd21dc32">388</ix:nonFraction> million of goodwill from the Medical Unit (within our Medical Segment) to the Cordis disposal group based on the estimated relative fair values of the business to be disposed of and the portion of the reporting unit that will be retained, discussed further in </span><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i4f0ec56b9c604f1782a65ea4a19c284d_106">Note 2</a></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div></ix:nonNumeric></div></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:32.135%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.428%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.137%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardinal Health </span><span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">|</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> Fiscal 2021 Form 10-K</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">69</span></div></td></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:3pt"><span><br/></span></div><div style="margin-bottom:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:24.720%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:50.989%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.991%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#e41f35;border-bottom:1pt solid #e41f35;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Notes to Financial Statements</span></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span><br/></span></div></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:48.214%"><ix:continuation id="idc35381d48d94a1189f725a22d8f67da" continuedAt="idcfd6cbbd54748df94a8a2e399f31df7"><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Other Intangible Assets</span></div><ix:nonNumeric contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630" name="us-gaap:ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMTIvZnJhZzoxZjM3NDE4OGI0M2U0ZGQ4YjU1YzhiY2RlNzA0NjZmNi90ZXh0cmVnaW9uOjFmMzc0MTg4YjQzZTRkZDhiNTVjOGJjZGU3MDQ2NmY2XzYyMQ_bfd393bd-b812-4511-8189-7a3d8d2922b3" escape="true"><ix:nonNumeric contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630" name="us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMTIvZnJhZzoxZjM3NDE4OGI0M2U0ZGQ4YjU1YzhiY2RlNzA0NjZmNi90ZXh0cmVnaW9uOjFmMzc0MTg4YjQzZTRkZDhiNTVjOGJjZGU3MDQ2NmY2XzY0OQ_49dfe660-da8e-46b4-82e5-4fc3b8972f9f" escape="true"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables summarize other intangible assets by class at June&#160;30:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:22.356%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.023%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.343%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.653%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.343%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.023%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.343%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.816%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Intangible</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net<br/>Intangible</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted- Average Remaining Amortization Period (Years)</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Indefinite-life intangibles:</span></td><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Trademarks and patents</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie9082e4c164d4b1eb60733de4e88ad24_I20210630" decimals="-6" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMTIvZnJhZzoxZjM3NDE4OGI0M2U0ZGQ4YjU1YzhiY2RlNzA0NjZmNi90YWJsZTpiMWE4YjJiMjIzZjc0ZDU1OWJmNDExOTU0NmUzNmE5MC90YWJsZXJhbmdlOmIxYThiMmIyMjNmNzRkNTU5YmY0MTE5NTQ2ZTM2YTkwXzMtMS0xLTEtMA_6bed1a6b-3e76-4b1a-a9c6-6e554d99d86f">12</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie9082e4c164d4b1eb60733de4e88ad24_I20210630" decimals="-6" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMTIvZnJhZzoxZjM3NDE4OGI0M2U0ZGQ4YjU1YzhiY2RlNzA0NjZmNi90YWJsZTpiMWE4YjJiMjIzZjc0ZDU1OWJmNDExOTU0NmUzNmE5MC90YWJsZXJhbmdlOmIxYThiMmIyMjNmNzRkNTU5YmY0MTE5NTQ2ZTM2YTkwXzMtNS0xLTEtMA_9e9c20c8-fb28-47a7-8183-e15014effd62">12</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total indefinite-life intangibles</span></td><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2e87824102b34590a0208cc7da91b5f5_I20210630" decimals="-6" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMTIvZnJhZzoxZjM3NDE4OGI0M2U0ZGQ4YjU1YzhiY2RlNzA0NjZmNi90YWJsZTpiMWE4YjJiMjIzZjc0ZDU1OWJmNDExOTU0NmUzNmE5MC90YWJsZXJhbmdlOmIxYThiMmIyMjNmNzRkNTU5YmY0MTE5NTQ2ZTM2YTkwXzQtMS0xLTEtMA_148b1861-4e1b-44e4-8ca3-f9ad77ff4d27">12</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2e87824102b34590a0208cc7da91b5f5_I20210630" decimals="-6" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMTIvZnJhZzoxZjM3NDE4OGI0M2U0ZGQ4YjU1YzhiY2RlNzA0NjZmNi90YWJsZTpiMWE4YjJiMjIzZjc0ZDU1OWJmNDExOTU0NmUzNmE5MC90YWJsZXJhbmdlOmIxYThiMmIyMjNmNzRkNTU5YmY0MTE5NTQ2ZTM2YTkwXzQtNS0xLTEtMA_6ec4abe8-2fa3-416b-bc04-ce37b2089f6f">12</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Definite-life intangibles:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i23d1c32c20a5440bb56a79d381e03b23_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMTIvZnJhZzoxZjM3NDE4OGI0M2U0ZGQ4YjU1YzhiY2RlNzA0NjZmNi90YWJsZTpiMWE4YjJiMjIzZjc0ZDU1OWJmNDExOTU0NmUzNmE5MC90YWJsZXJhbmdlOmIxYThiMmIyMjNmNzRkNTU5YmY0MTE5NTQ2ZTM2YTkwXzYtMS0xLTEtMA_ba6473d2-8a1c-446a-a195-7e001d933445">3,330</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i23d1c32c20a5440bb56a79d381e03b23_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMTIvZnJhZzoxZjM3NDE4OGI0M2U0ZGQ4YjU1YzhiY2RlNzA0NjZmNi90YWJsZTpiMWE4YjJiMjIzZjc0ZDU1OWJmNDExOTU0NmUzNmE5MC90YWJsZXJhbmdlOmIxYThiMmIyMjNmNzRkNTU5YmY0MTE5NTQ2ZTM2YTkwXzYtMy0xLTEtMA_ef69719d-d23c-4ce2-8a53-488db35f5b98">1,989</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i23d1c32c20a5440bb56a79d381e03b23_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMTIvZnJhZzoxZjM3NDE4OGI0M2U0ZGQ4YjU1YzhiY2RlNzA0NjZmNi90YWJsZTpiMWE4YjJiMjIzZjc0ZDU1OWJmNDExOTU0NmUzNmE5MC90YWJsZXJhbmdlOmIxYThiMmIyMjNmNzRkNTU5YmY0MTE5NTQ2ZTM2YTkwXzYtNS0xLTEtMA_1ceb61ea-7c91-4d49-9261-a6b50294b4c1">1,341</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i71898d44e3ea4dc6b493f7a21c418128_D20200701-20210630" format="ixt-sec:duryear" name="us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMTIvZnJhZzoxZjM3NDE4OGI0M2U0ZGQ4YjU1YzhiY2RlNzA0NjZmNi90YWJsZTpiMWE4YjJiMjIzZjc0ZDU1OWJmNDExOTU0NmUzNmE5MC90YWJsZXJhbmdlOmIxYThiMmIyMjNmNzRkNTU5YmY0MTE5NTQ2ZTM2YTkwXzYtNy0xLTEtMA_751a9d2d-6599-4340-b034-51d9535bf069">11</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Trademarks, trade names and patents</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia82a764d4393423da214b8d6611567aa_I20210630" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMTIvZnJhZzoxZjM3NDE4OGI0M2U0ZGQ4YjU1YzhiY2RlNzA0NjZmNi90YWJsZTpiMWE4YjJiMjIzZjc0ZDU1OWJmNDExOTU0NmUzNmE5MC90YWJsZXJhbmdlOmIxYThiMmIyMjNmNzRkNTU5YmY0MTE5NTQ2ZTM2YTkwXzctMS0xLTEtMA_3616bb68-1e38-46b5-b561-4d9849874ff4">551</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia82a764d4393423da214b8d6611567aa_I20210630" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMTIvZnJhZzoxZjM3NDE4OGI0M2U0ZGQ4YjU1YzhiY2RlNzA0NjZmNi90YWJsZTpiMWE4YjJiMjIzZjc0ZDU1OWJmNDExOTU0NmUzNmE5MC90YWJsZXJhbmdlOmIxYThiMmIyMjNmNzRkNTU5YmY0MTE5NTQ2ZTM2YTkwXzctMy0xLTEtMA_b3d21013-737d-4a21-b52e-8181bcffe2e7">328</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia82a764d4393423da214b8d6611567aa_I20210630" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMTIvZnJhZzoxZjM3NDE4OGI0M2U0ZGQ4YjU1YzhiY2RlNzA0NjZmNi90YWJsZTpiMWE4YjJiMjIzZjc0ZDU1OWJmNDExOTU0NmUzNmE5MC90YWJsZXJhbmdlOmIxYThiMmIyMjNmNzRkNTU5YmY0MTE5NTQ2ZTM2YTkwXzctNS0xLTEtMA_6623f58d-788c-400c-8005-c92c11152135">223</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="idb9a0bc30ecf49c28ad8c5f1cd53fb7f_D20200701-20210630" format="ixt-sec:duryear" name="us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMTIvZnJhZzoxZjM3NDE4OGI0M2U0ZGQ4YjU1YzhiY2RlNzA0NjZmNi90YWJsZTpiMWE4YjJiMjIzZjc0ZDU1OWJmNDExOTU0NmUzNmE5MC90YWJsZXJhbmdlOmIxYThiMmIyMjNmNzRkNTU5YmY0MTE5NTQ2ZTM2YTkwXzctNy0xLTEtMA_7878fea7-a39e-45a2-99ee-e692211bd724">9</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Developed technology and other</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9d370528192046c8b78cd2c5462f6fed_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMTIvZnJhZzoxZjM3NDE4OGI0M2U0ZGQ4YjU1YzhiY2RlNzA0NjZmNi90YWJsZTpiMWE4YjJiMjIzZjc0ZDU1OWJmNDExOTU0NmUzNmE5MC90YWJsZXJhbmdlOmIxYThiMmIyMjNmNzRkNTU5YmY0MTE5NTQ2ZTM2YTkwXzgtMS0xLTEtMA_a0e06f1d-39ba-4c53-9ee9-6a6980b0a33b">1,035</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9d370528192046c8b78cd2c5462f6fed_I20210630" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMTIvZnJhZzoxZjM3NDE4OGI0M2U0ZGQ4YjU1YzhiY2RlNzA0NjZmNi90YWJsZTpiMWE4YjJiMjIzZjc0ZDU1OWJmNDExOTU0NmUzNmE5MC90YWJsZXJhbmdlOmIxYThiMmIyMjNmNzRkNTU5YmY0MTE5NTQ2ZTM2YTkwXzgtMy0xLTEtMA_1721963f-aea5-49c8-b992-26a1f4018b2e">506</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9d370528192046c8b78cd2c5462f6fed_I20210630" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMTIvZnJhZzoxZjM3NDE4OGI0M2U0ZGQ4YjU1YzhiY2RlNzA0NjZmNi90YWJsZTpiMWE4YjJiMjIzZjc0ZDU1OWJmNDExOTU0NmUzNmE5MC90YWJsZXJhbmdlOmIxYThiMmIyMjNmNzRkNTU5YmY0MTE5NTQ2ZTM2YTkwXzgtNS0xLTEtMA_e140ee4d-cde3-40a9-9f2c-4827d4395b18">529</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i3bd75edcbf314eb28cab79abc9a18d41_D20200701-20210630" format="ixt-sec:duryear" name="us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMTIvZnJhZzoxZjM3NDE4OGI0M2U0ZGQ4YjU1YzhiY2RlNzA0NjZmNi90YWJsZTpiMWE4YjJiMjIzZjc0ZDU1OWJmNDExOTU0NmUzNmE5MC90YWJsZXJhbmdlOmIxYThiMmIyMjNmNzRkNTU5YmY0MTE5NTQ2ZTM2YTkwXzgtNy0xLTEtMA_eec0a9d7-f256-45a4-a4e6-0f90507f6641">10</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total definite-life intangibles</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2e87824102b34590a0208cc7da91b5f5_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMTIvZnJhZzoxZjM3NDE4OGI0M2U0ZGQ4YjU1YzhiY2RlNzA0NjZmNi90YWJsZTpiMWE4YjJiMjIzZjc0ZDU1OWJmNDExOTU0NmUzNmE5MC90YWJsZXJhbmdlOmIxYThiMmIyMjNmNzRkNTU5YmY0MTE5NTQ2ZTM2YTkwXzktMS0xLTEtMA_20d2ad39-409f-444c-8c03-84f47e5f224b">4,916</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2e87824102b34590a0208cc7da91b5f5_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMTIvZnJhZzoxZjM3NDE4OGI0M2U0ZGQ4YjU1YzhiY2RlNzA0NjZmNi90YWJsZTpiMWE4YjJiMjIzZjc0ZDU1OWJmNDExOTU0NmUzNmE5MC90YWJsZXJhbmdlOmIxYThiMmIyMjNmNzRkNTU5YmY0MTE5NTQ2ZTM2YTkwXzktMy0xLTEtMA_63711e0f-aeea-4cc9-953c-7f01222ae840">2,823</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2e87824102b34590a0208cc7da91b5f5_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMTIvZnJhZzoxZjM3NDE4OGI0M2U0ZGQ4YjU1YzhiY2RlNzA0NjZmNi90YWJsZTpiMWE4YjJiMjIzZjc0ZDU1OWJmNDExOTU0NmUzNmE5MC90YWJsZXJhbmdlOmIxYThiMmIyMjNmNzRkNTU5YmY0MTE5NTQ2ZTM2YTkwXzktNS0xLTEtMA_083b94ea-13e5-4feb-b103-9ceb8b045fd6">2,093</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630" format="ixt-sec:duryear" name="us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMTIvZnJhZzoxZjM3NDE4OGI0M2U0ZGQ4YjU1YzhiY2RlNzA0NjZmNi90YWJsZTpiMWE4YjJiMjIzZjc0ZDU1OWJmNDExOTU0NmUzNmE5MC90YWJsZXJhbmdlOmIxYThiMmIyMjNmNzRkNTU5YmY0MTE5NTQ2ZTM2YTkwXzktNy0xLTEtMA_81382b7d-b45f-4d23-8993-ddf2cc92338e">10</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total other intangible assets</span></td><td style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2e87824102b34590a0208cc7da91b5f5_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:IntangibleAssetsGrossExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMTIvZnJhZzoxZjM3NDE4OGI0M2U0ZGQ4YjU1YzhiY2RlNzA0NjZmNi90YWJsZTpiMWE4YjJiMjIzZjc0ZDU1OWJmNDExOTU0NmUzNmE5MC90YWJsZXJhbmdlOmIxYThiMmIyMjNmNzRkNTU5YmY0MTE5NTQ2ZTM2YTkwXzEwLTEtMS0xLTA_e454f8ce-05ea-4120-9542-54cb22f45393">4,928</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2e87824102b34590a0208cc7da91b5f5_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMTIvZnJhZzoxZjM3NDE4OGI0M2U0ZGQ4YjU1YzhiY2RlNzA0NjZmNi90YWJsZTpiMWE4YjJiMjIzZjc0ZDU1OWJmNDExOTU0NmUzNmE5MC90YWJsZXJhbmdlOmIxYThiMmIyMjNmNzRkNTU5YmY0MTE5NTQ2ZTM2YTkwXzEwLTMtMS0xLTA_b2d9ef88-89ac-44e5-9168-a74cc23be370">2,823</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2e87824102b34590a0208cc7da91b5f5_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMTIvZnJhZzoxZjM3NDE4OGI0M2U0ZGQ4YjU1YzhiY2RlNzA0NjZmNi90YWJsZTpiMWE4YjJiMjIzZjc0ZDU1OWJmNDExOTU0NmUzNmE5MC90YWJsZXJhbmdlOmIxYThiMmIyMjNmNzRkNTU5YmY0MTE5NTQ2ZTM2YTkwXzEwLTUtMS0xLTA_d010e1c5-e2bd-483e-86fa-ded19d64384f">2,105</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">N/A</span></td></tr></table></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.691%"><tr><td style="width:1.0%"></td><td style="width:42.243%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.308%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.347%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.643%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.347%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.312%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Gross<br/>Intangible</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net<br/>Intangible</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Indefinite-life intangibles:</span></td><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">IPR&amp;D, trademarks and other</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i19314c2cdba1474abcdc53474c121932_I20200630" decimals="-6" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMTIvZnJhZzoxZjM3NDE4OGI0M2U0ZGQ4YjU1YzhiY2RlNzA0NjZmNi90YWJsZTozN2EzMGQxMjFmZjY0NjBkOWM2MmM3MjllNjE4NjQ1MS90YWJsZXJhbmdlOjM3YTMwZDEyMWZmNjQ2MGQ5YzYyYzcyOWU2MTg2NDUxXzMtMS0xLTEtMA_9b0e65ae-e057-4faa-964f-578d26662b80">23</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i19314c2cdba1474abcdc53474c121932_I20200630" decimals="-6" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMTIvZnJhZzoxZjM3NDE4OGI0M2U0ZGQ4YjU1YzhiY2RlNzA0NjZmNi90YWJsZTozN2EzMGQxMjFmZjY0NjBkOWM2MmM3MjllNjE4NjQ1MS90YWJsZXJhbmdlOjM3YTMwZDEyMWZmNjQ2MGQ5YzYyYzcyOWU2MTg2NDUxXzMtNS0xLTEtMA_6a2acf70-47ab-4a6d-b085-3ebf34b5bf05">23</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total indefinite-life intangibles</span></td><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i299cea70f47b4fbe96772aaa8cc00b79_I20200630" decimals="-6" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMTIvZnJhZzoxZjM3NDE4OGI0M2U0ZGQ4YjU1YzhiY2RlNzA0NjZmNi90YWJsZTozN2EzMGQxMjFmZjY0NjBkOWM2MmM3MjllNjE4NjQ1MS90YWJsZXJhbmdlOjM3YTMwZDEyMWZmNjQ2MGQ5YzYyYzcyOWU2MTg2NDUxXzQtMS0xLTEtMA_c6957d40-e357-44ee-947c-70509d2dd98e">23</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i299cea70f47b4fbe96772aaa8cc00b79_I20200630" decimals="-6" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMTIvZnJhZzoxZjM3NDE4OGI0M2U0ZGQ4YjU1YzhiY2RlNzA0NjZmNi90YWJsZTozN2EzMGQxMjFmZjY0NjBkOWM2MmM3MjllNjE4NjQ1MS90YWJsZXJhbmdlOjM3YTMwZDEyMWZmNjQ2MGQ5YzYyYzcyOWU2MTg2NDUxXzQtNS0xLTEtMA_acd51075-3a2b-4e30-ba89-43a78de764fc">23</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Definite-life intangibles:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic919be303957403e934baefe49c63756_I20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMTIvZnJhZzoxZjM3NDE4OGI0M2U0ZGQ4YjU1YzhiY2RlNzA0NjZmNi90YWJsZTozN2EzMGQxMjFmZjY0NjBkOWM2MmM3MjllNjE4NjQ1MS90YWJsZXJhbmdlOjM3YTMwZDEyMWZmNjQ2MGQ5YzYyYzcyOWU2MTg2NDUxXzYtMS0xLTEtMA_4bd01306-4a72-4db8-ad17-e68aca735bd9">3,554</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic919be303957403e934baefe49c63756_I20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMTIvZnJhZzoxZjM3NDE4OGI0M2U0ZGQ4YjU1YzhiY2RlNzA0NjZmNi90YWJsZTozN2EzMGQxMjFmZjY0NjBkOWM2MmM3MjllNjE4NjQ1MS90YWJsZXJhbmdlOjM3YTMwZDEyMWZmNjQ2MGQ5YzYyYzcyOWU2MTg2NDUxXzYtMy0xLTEtMA_5f23a5bf-8570-4fd8-b313-07f02236c4e0">1,828</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic919be303957403e934baefe49c63756_I20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMTIvZnJhZzoxZjM3NDE4OGI0M2U0ZGQ4YjU1YzhiY2RlNzA0NjZmNi90YWJsZTozN2EzMGQxMjFmZjY0NjBkOWM2MmM3MjllNjE4NjQ1MS90YWJsZXJhbmdlOjM3YTMwZDEyMWZmNjQ2MGQ5YzYyYzcyOWU2MTg2NDUxXzYtNS0xLTEtMA_6cf3ac64-a928-4261-b095-6a8902d63dcc">1,726</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Trademarks, trade names and patents</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5dae75b349b54d55a0e972014f606ac7_I20200630" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMTIvZnJhZzoxZjM3NDE4OGI0M2U0ZGQ4YjU1YzhiY2RlNzA0NjZmNi90YWJsZTozN2EzMGQxMjFmZjY0NjBkOWM2MmM3MjllNjE4NjQ1MS90YWJsZXJhbmdlOjM3YTMwZDEyMWZmNjQ2MGQ5YzYyYzcyOWU2MTg2NDUxXzctMS0xLTEtMA_c7faddd5-bd96-48d3-9f82-109db65d1400">673</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5dae75b349b54d55a0e972014f606ac7_I20200630" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMTIvZnJhZzoxZjM3NDE4OGI0M2U0ZGQ4YjU1YzhiY2RlNzA0NjZmNi90YWJsZTozN2EzMGQxMjFmZjY0NjBkOWM2MmM3MjllNjE4NjQ1MS90YWJsZXJhbmdlOjM3YTMwZDEyMWZmNjQ2MGQ5YzYyYzcyOWU2MTg2NDUxXzctMy0xLTEtMA_c8ba11f6-45aa-485f-bc17-4a2cab297620">341</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5dae75b349b54d55a0e972014f606ac7_I20200630" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMTIvZnJhZzoxZjM3NDE4OGI0M2U0ZGQ4YjU1YzhiY2RlNzA0NjZmNi90YWJsZTozN2EzMGQxMjFmZjY0NjBkOWM2MmM3MjllNjE4NjQ1MS90YWJsZXJhbmdlOjM3YTMwZDEyMWZmNjQ2MGQ5YzYyYzcyOWU2MTg2NDUxXzctNS0xLTEtMA_85a9f5f6-3e87-44da-9f4b-b7fb3e620626">332</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Developed technology and other</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idd95a519999348e3a6516e5fa7e6fcba_I20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMTIvZnJhZzoxZjM3NDE4OGI0M2U0ZGQ4YjU1YzhiY2RlNzA0NjZmNi90YWJsZTozN2EzMGQxMjFmZjY0NjBkOWM2MmM3MjllNjE4NjQ1MS90YWJsZXJhbmdlOjM3YTMwZDEyMWZmNjQ2MGQ5YzYyYzcyOWU2MTg2NDUxXzgtMS0xLTEtMA_b35067ac-9929-48c2-acc6-6cb4ff02610b">1,604</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idd95a519999348e3a6516e5fa7e6fcba_I20200630" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMTIvZnJhZzoxZjM3NDE4OGI0M2U0ZGQ4YjU1YzhiY2RlNzA0NjZmNi90YWJsZTozN2EzMGQxMjFmZjY0NjBkOWM2MmM3MjllNjE4NjQ1MS90YWJsZXJhbmdlOjM3YTMwZDEyMWZmNjQ2MGQ5YzYyYzcyOWU2MTg2NDUxXzgtMy0xLTEtMA_d29f9026-ba27-4fe8-8e4a-f6bb07ae467a">767</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idd95a519999348e3a6516e5fa7e6fcba_I20200630" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMTIvZnJhZzoxZjM3NDE4OGI0M2U0ZGQ4YjU1YzhiY2RlNzA0NjZmNi90YWJsZTozN2EzMGQxMjFmZjY0NjBkOWM2MmM3MjllNjE4NjQ1MS90YWJsZXJhbmdlOjM3YTMwZDEyMWZmNjQ2MGQ5YzYyYzcyOWU2MTg2NDUxXzgtNS0xLTEtMA_0c802f9b-e8d8-436e-b9e7-b6322d6468f5">837</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total definite-life intangibles</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i299cea70f47b4fbe96772aaa8cc00b79_I20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMTIvZnJhZzoxZjM3NDE4OGI0M2U0ZGQ4YjU1YzhiY2RlNzA0NjZmNi90YWJsZTozN2EzMGQxMjFmZjY0NjBkOWM2MmM3MjllNjE4NjQ1MS90YWJsZXJhbmdlOjM3YTMwZDEyMWZmNjQ2MGQ5YzYyYzcyOWU2MTg2NDUxXzktMS0xLTEtMA_fd94cee6-a700-456a-ba9b-0ed4d5a804dd">5,831</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i299cea70f47b4fbe96772aaa8cc00b79_I20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMTIvZnJhZzoxZjM3NDE4OGI0M2U0ZGQ4YjU1YzhiY2RlNzA0NjZmNi90YWJsZTozN2EzMGQxMjFmZjY0NjBkOWM2MmM3MjllNjE4NjQ1MS90YWJsZXJhbmdlOjM3YTMwZDEyMWZmNjQ2MGQ5YzYyYzcyOWU2MTg2NDUxXzktMy0xLTEtMA_f284be98-c4e5-4848-8b54-4c685af5ea6c">2,936</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i299cea70f47b4fbe96772aaa8cc00b79_I20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMTIvZnJhZzoxZjM3NDE4OGI0M2U0ZGQ4YjU1YzhiY2RlNzA0NjZmNi90YWJsZTozN2EzMGQxMjFmZjY0NjBkOWM2MmM3MjllNjE4NjQ1MS90YWJsZXJhbmdlOjM3YTMwZDEyMWZmNjQ2MGQ5YzYyYzcyOWU2MTg2NDUxXzktNS0xLTEtMA_997cb3a9-df3c-4143-9295-e40decbc086d">2,895</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total other intangible assets</span></td><td style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i299cea70f47b4fbe96772aaa8cc00b79_I20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:IntangibleAssetsGrossExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMTIvZnJhZzoxZjM3NDE4OGI0M2U0ZGQ4YjU1YzhiY2RlNzA0NjZmNi90YWJsZTozN2EzMGQxMjFmZjY0NjBkOWM2MmM3MjllNjE4NjQ1MS90YWJsZXJhbmdlOjM3YTMwZDEyMWZmNjQ2MGQ5YzYyYzcyOWU2MTg2NDUxXzEwLTEtMS0xLTA_ecd5380c-2694-4a1f-833e-35d52d2684f4">5,854</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i299cea70f47b4fbe96772aaa8cc00b79_I20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMTIvZnJhZzoxZjM3NDE4OGI0M2U0ZGQ4YjU1YzhiY2RlNzA0NjZmNi90YWJsZTozN2EzMGQxMjFmZjY0NjBkOWM2MmM3MjllNjE4NjQ1MS90YWJsZXJhbmdlOjM3YTMwZDEyMWZmNjQ2MGQ5YzYyYzcyOWU2MTg2NDUxXzEwLTMtMS0xLTA_b8619e6c-26ce-4630-95b1-6c2730d528ed">2,936</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i299cea70f47b4fbe96772aaa8cc00b79_I20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMTIvZnJhZzoxZjM3NDE4OGI0M2U0ZGQ4YjU1YzhiY2RlNzA0NjZmNi90YWJsZTozN2EzMGQxMjFmZjY0NjBkOWM2MmM3MjllNjE4NjQ1MS90YWJsZXJhbmdlOjM3YTMwZDEyMWZmNjQ2MGQ5YzYyYzcyOWU2MTg2NDUxXzEwLTUtMS0xLTA_ac9ed1d5-281c-4de1-b40f-5fa85165370b">2,918</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:nonNumeric></ix:continuation><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="idcfd6cbbd54748df94a8a2e399f31df7">Total amortization of intangible assets was $<ix:nonFraction unitRef="usd" contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMTIvZnJhZzoxZjM3NDE4OGI0M2U0ZGQ4YjU1YzhiY2RlNzA0NjZmNi90ZXh0cmVnaW9uOjFmMzc0MTg4YjQzZTRkZDhiNTVjOGJjZGU3MDQ2NmY2XzQ0Nw_0c4205e9-0601-4dbd-91e2-df40677d0d7e">428</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="ia31e9a409b874bb19d0ff6f2f39ecc09_D20190701-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMTIvZnJhZzoxZjM3NDE4OGI0M2U0ZGQ4YjU1YzhiY2RlNzA0NjZmNi90ZXh0cmVnaW9uOjFmMzc0MTg4YjQzZTRkZDhiNTVjOGJjZGU3MDQ2NmY2XzQ1MQ_21f34d7b-02fa-4297-8a1e-c4080b3a1faa">512</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i00a6d666bf604826b24e68ddbd63eac4_D20180701-20190630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMTIvZnJhZzoxZjM3NDE4OGI0M2U0ZGQ4YjU1YzhiY2RlNzA0NjZmNi90ZXh0cmVnaW9uOjFmMzc0MTg4YjQzZTRkZDhiNTVjOGJjZGU3MDQ2NmY2XzQ1OA_07d4fc7b-5cff-4cec-88a0-e251d12a450d">531</ix:nonFraction> million for fiscal 2021, 2020 and 2019, respectively. The estimated annual amortization for intangible assets for fiscal 2022 through 2026 is as follows: $<ix:nonFraction unitRef="usd" contextRef="i2e87824102b34590a0208cc7da91b5f5_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMTIvZnJhZzoxZjM3NDE4OGI0M2U0ZGQ4YjU1YzhiY2RlNzA0NjZmNi90ZXh0cmVnaW9uOjFmMzc0MTg4YjQzZTRkZDhiNTVjOGJjZGU3MDQ2NmY2XzU5Nw_6d310470-31b2-414b-944a-98c068afd9fa">315</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="i2e87824102b34590a0208cc7da91b5f5_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMTIvZnJhZzoxZjM3NDE4OGI0M2U0ZGQ4YjU1YzhiY2RlNzA0NjZmNi90ZXh0cmVnaW9uOjFmMzc0MTg4YjQzZTRkZDhiNTVjOGJjZGU3MDQ2NmY2XzYwMQ_96889e6b-0ee8-4a94-805c-3d08a78ae7a8">287</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="i2e87824102b34590a0208cc7da91b5f5_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMTIvZnJhZzoxZjM3NDE4OGI0M2U0ZGQ4YjU1YzhiY2RlNzA0NjZmNi90ZXh0cmVnaW9uOjFmMzc0MTg4YjQzZTRkZDhiNTVjOGJjZGU3MDQ2NmY2XzYwNQ_5608e92e-7943-4db2-94d8-77a9654e9e2a">264</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="i2e87824102b34590a0208cc7da91b5f5_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMTIvZnJhZzoxZjM3NDE4OGI0M2U0ZGQ4YjU1YzhiY2RlNzA0NjZmNi90ZXh0cmVnaW9uOjFmMzc0MTg4YjQzZTRkZDhiNTVjOGJjZGU3MDQ2NmY2XzYwOQ_d022a6ff-4be7-4f79-9f74-93c558538d3d">238</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i2e87824102b34590a0208cc7da91b5f5_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMTIvZnJhZzoxZjM3NDE4OGI0M2U0ZGQ4YjU1YzhiY2RlNzA0NjZmNi90ZXh0cmVnaW9uOjFmMzc0MTg4YjQzZTRkZDhiNTVjOGJjZGU3MDQ2NmY2XzYxNg_bdf4f26c-c5c5-4c09-b714-64114903ce4f">212</ix:nonFraction> million.</ix:continuation> </span></div></div><div style="display:inline-block;max-width:3.571%;min-width:2.571%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:48.215%"></div></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:3pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.222%"><tr><td style="width:1.0%"></td><td style="width:32.133%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.433%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.134%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">70</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardinal Health </span><span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">| </span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2021 Form 10-K</span></div></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div></div></div><div id="i4f0ec56b9c604f1782a65ea4a19c284d_121"></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div style="margin-bottom:3pt"><span><br/></span></div><div style="margin-bottom:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.702%"><tr><td style="width:1.0%"></td><td style="width:24.720%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:50.989%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.991%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#e41f35;border-bottom:1pt solid #e41f35;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Notes to Financial Statements</span></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span><br/></span></div></div><div style="width:100.000%"><ix:nonNumeric contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630" name="cah:LeasesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMjEvZnJhZzpkNTEwOTAyZDMwZDc0NDk5YWUzNWE3NTg1ZDkwNDA4Ni90ZXh0cmVnaW9uOmQ1MTA5MDJkMzBkNzQ0OTlhZTM1YTc1ODVkOTA0MDg2XzQxNzQ_288e20eb-1bd6-48e7-9fa1-cc518189f899" continuedAt="i1c96d05e49b347f98024cad439e859cb" escape="true"><div style="display:inline-block;vertical-align:top;width:48.214%"><div style="margin-bottom:6pt;text-align:justify"><span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:13pt;font-weight:700;line-height:120%">5. Leases </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our operating leases are primarily for corporate offices, distribution facilities, vehicles, and equipment. We determine if an arrangement is a lease at its inception by evaluating whether the arrangement conveys the right to use an identified asset and whether we obtain substantially all of the economic benefits from and have the ability to direct the use of the asset. Our lease agreements generally do not contain any material residual value guarantees or material restrictive covenants. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Beginning July 1, 2019, operating lease right-of-use assets and corresponding operating lease liabilities are recognized in our consolidated balance sheets at lease commencement date based on the present value of lease payments over the lease term. Operating lease expense for operating lease assets is recognized on a straight-line basis over the lease term. As most of our leases do not provide an implicit rate, we use our collateralized incremental borrowing rate based on the information available at the lease commencement date in determining the present value of lease payments. We use the implicit rate if it is readily determinable. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our lease agreements contain lease components and non-lease components. For all asset classes, we have elected to account for both of these components as a single lease component. We also, from time to time, sublease portions of our real estate property, resulting in sublease income. Sublease income and the related assets and cash flows are not material to the consolidated financial statements at or for the fiscal years ended June&#160;30, 2021 and 2020.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also have elected to apply a practical expedient for short-term leases whereby we do not recognize a lease liability and right-of-use asset for leases with a term of less than 12 months. Short-term lease expense recognized in fiscal 2021 and 2020 was not material. In addition, upon adoption of the new lease standard, we elected the package of three practical expedients permitted under the transition guidance, which include the carry forward of our leases without reassessing 1) whether any contracts are leases or contain leases, 2) lease classification and 3) initial direct costs. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our leases have remaining lease terms from less than <ix:nonNumeric contextRef="if156c7b3d30345a395262b86a56d2779_I20210630" format="ixt-sec:duryear" name="us-gaap:LesseeOperatingLeaseTermOfContract" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMjEvZnJhZzpkNTEwOTAyZDMwZDc0NDk5YWUzNWE3NTg1ZDkwNDA4Ni90ZXh0cmVnaW9uOmQ1MTA5MDJkMzBkNzQ0OTlhZTM1YTc1ODVkOTA0MDg2XzIyMTQ_77a8f6ef-ccfe-47c2-9d28-d3f07563c1e0">1</ix:nonNumeric> year up to approximately <ix:nonNumeric contextRef="ib54859ab704046a7a3be64f76f566d69_I20210630" format="ixt-sec:duryear" name="us-gaap:LesseeOperatingLeaseTermOfContract" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMjEvZnJhZzpkNTEwOTAyZDMwZDc0NDk5YWUzNWE3NTg1ZDkwNDA4Ni90ZXh0cmVnaW9uOmQ1MTA5MDJkMzBkNzQ0OTlhZTM1YTc1ODVkOTA0MDg2XzIyMzc_2505e291-d198-469d-b5a4-8ba66244af76">21</ix:nonNumeric> years. Our lease terms may include options to extend or terminate the lease when it is reasonably certain and there is a significant economic incentive to exercise that option. </span></div><ix:nonNumeric contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630" name="us-gaap:LeaseCostTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMjEvZnJhZzpkNTEwOTAyZDMwZDc0NDk5YWUzNWE3NTg1ZDkwNDA4Ni90ZXh0cmVnaW9uOmQ1MTA5MDJkMzBkNzQ0OTlhZTM1YTc1ODVkOTA0MDg2XzQxNzU_95dacd65-6716-462e-8b8a-41b06870f715" continuedAt="iac96fe897fb845ba82a76c3ea5a102cc" escape="true"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the components of lease cost:  </span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:85.185%"><tr><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.234%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Operating lease cost</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630" decimals="-6" name="us-gaap:OperatingLeaseCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMjEvZnJhZzpkNTEwOTAyZDMwZDc0NDk5YWUzNWE3NTg1ZDkwNDA4Ni90YWJsZToyNzM1MGUyNDc5MWY0YWY1YmEzOWQ3ZTQ2OGNmM2I4Yy90YWJsZXJhbmdlOjI3MzUwZTI0NzkxZjRhZjViYTM5ZDdlNDY4Y2YzYjhjXzItMS0xLTEtOTk4_c67fb445-47af-4b84-8e00-72755a91f78a">119</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia31e9a409b874bb19d0ff6f2f39ecc09_D20190701-20200630" decimals="-6" name="us-gaap:OperatingLeaseCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMjEvZnJhZzpkNTEwOTAyZDMwZDc0NDk5YWUzNWE3NTg1ZDkwNDA4Ni90YWJsZToyNzM1MGUyNDc5MWY0YWY1YmEzOWQ3ZTQ2OGNmM2I4Yy90YWJsZXJhbmdlOjI3MzUwZTI0NzkxZjRhZjViYTM5ZDdlNDY4Y2YzYjhjXzItMi0xLTEtMA_72d8ec8a-2936-4972-99a1-ef776b3ecdb3">134</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Finance lease cost</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630" decimals="-6" name="us-gaap:FinanceLeaseRightOfUseAssetAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMjEvZnJhZzpkNTEwOTAyZDMwZDc0NDk5YWUzNWE3NTg1ZDkwNDA4Ni90YWJsZToyNzM1MGUyNDc5MWY0YWY1YmEzOWQ3ZTQ2OGNmM2I4Yy90YWJsZXJhbmdlOjI3MzUwZTI0NzkxZjRhZjViYTM5ZDdlNDY4Y2YzYjhjXzQtMS0xLTEtMTAxMA_b440edea-b2b2-40c9-9a15-43982e1358bd">16</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia31e9a409b874bb19d0ff6f2f39ecc09_D20190701-20200630" decimals="-6" name="us-gaap:FinanceLeaseRightOfUseAssetAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMjEvZnJhZzpkNTEwOTAyZDMwZDc0NDk5YWUzNWE3NTg1ZDkwNDA4Ni90YWJsZToyNzM1MGUyNDc5MWY0YWY1YmEzOWQ3ZTQ2OGNmM2I4Yy90YWJsZXJhbmdlOjI3MzUwZTI0NzkxZjRhZjViYTM5ZDdlNDY4Y2YzYjhjXzQtMi0xLTEtMA_567ee3a6-b5ef-4823-8142-c839fab5be4b">13</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Variable lease cost</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630" decimals="-6" name="us-gaap:VariableLeaseCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMjEvZnJhZzpkNTEwOTAyZDMwZDc0NDk5YWUzNWE3NTg1ZDkwNDA4Ni90YWJsZToyNzM1MGUyNDc5MWY0YWY1YmEzOWQ3ZTQ2OGNmM2I4Yy90YWJsZXJhbmdlOjI3MzUwZTI0NzkxZjRhZjViYTM5ZDdlNDY4Y2YzYjhjXzgtMS0xLTEtMTAxNA_7c6609c5-8562-4ad1-86e2-20fc696878d0">24</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia31e9a409b874bb19d0ff6f2f39ecc09_D20190701-20200630" decimals="-6" name="us-gaap:VariableLeaseCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMjEvZnJhZzpkNTEwOTAyZDMwZDc0NDk5YWUzNWE3NTg1ZDkwNDA4Ni90YWJsZToyNzM1MGUyNDc5MWY0YWY1YmEzOWQ3ZTQ2OGNmM2I4Yy90YWJsZXJhbmdlOjI3MzUwZTI0NzkxZjRhZjViYTM5ZDdlNDY4Y2YzYjhjXzgtMi0xLTEtMA_88067a13-0c98-49b0-918a-a112899e8d99">17</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total lease cost</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630" decimals="-6" name="us-gaap:LeaseCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMjEvZnJhZzpkNTEwOTAyZDMwZDc0NDk5YWUzNWE3NTg1ZDkwNDA4Ni90YWJsZToyNzM1MGUyNDc5MWY0YWY1YmEzOWQ3ZTQ2OGNmM2I4Yy90YWJsZXJhbmdlOjI3MzUwZTI0NzkxZjRhZjViYTM5ZDdlNDY4Y2YzYjhjXzEwLTEtMS0xLTgwMzE_6a2141ad-dd9d-485d-b6bb-719bb317b2fb">159</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia31e9a409b874bb19d0ff6f2f39ecc09_D20190701-20200630" decimals="-6" name="us-gaap:LeaseCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMjEvZnJhZzpkNTEwOTAyZDMwZDc0NDk5YWUzNWE3NTg1ZDkwNDA4Ni90YWJsZToyNzM1MGUyNDc5MWY0YWY1YmEzOWQ3ZTQ2OGNmM2I4Yy90YWJsZXJhbmdlOjI3MzUwZTI0NzkxZjRhZjViYTM5ZDdlNDY4Y2YzYjhjXzEwLTItMS0xLTA_77647ac4-48da-4ee9-99e5-707cf51f1312">164</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="iac96fe897fb845ba82a76c3ea5a102cc">Variable lease cost primarily includes payments for property taxes, maintenance and insurance.</ix:continuation> Our rental expense relating to operating leases&#160;was $<ix:nonFraction unitRef="usd" contextRef="i00a6d666bf604826b24e68ddbd63eac4_D20180701-20190630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LeaseAndRentalExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMjEvZnJhZzpkNTEwOTAyZDMwZDc0NDk5YWUzNWE3NTg1ZDkwNDA4Ni90ZXh0cmVnaW9uOmQ1MTA5MDJkMzBkNzQ0OTlhZTM1YTc1ODVkOTA0MDg2XzI2MzY_e7c0b3af-fe49-4e4c-86dd-59f38dc85984">153</ix:nonFraction> million in fiscal 2019. </span></div></div><div style="display:inline-block;max-width:3.571%;min-width:2.571%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:48.215%"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630" name="cah:LeasesSupplementalBalanceSheetInformationTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMjEvZnJhZzpkNTEwOTAyZDMwZDc0NDk5YWUzNWE3NTg1ZDkwNDA4Ni90ZXh0cmVnaW9uOmQ1MTA5MDJkMzBkNzQ0OTlhZTM1YTc1ODVkOTA0MDg2XzQxNzY_3d6739e4-9c53-4982-b015-dd6b34a29cb7" continuedAt="i1b9600d256084fc9b5d781b8ad01b952" escape="true">The following table summarizes supplemental balance sheet and other information related to leases at June&#160;30:</ix:nonNumeric></span></div><div style="margin-top:5pt;text-align:justify"><ix:continuation id="i1b9600d256084fc9b5d781b8ad01b952"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:47.974%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:24.208%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:24.518%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Operating Leases</span></td><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i473efc3a1c3141748a845b14896f4459_I20210630" decimals="-6" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMjEvZnJhZzpkNTEwOTAyZDMwZDc0NDk5YWUzNWE3NTg1ZDkwNDA4Ni90YWJsZTo0Yjk2NjQ4MWNlZjk0NDM1ODExOTBkZDc1N2M1ZmU1Ni90YWJsZXJhbmdlOjRiOTY2NDgxY2VmOTQ0MzU4MTE5MGRkNzU3YzVmZTU2XzItMS0xLTEtMA_ca8cf378-24ed-48ae-8e08-390c39d3eeaa">460</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8918e18bf5f4dea9e6f6e70f8d28bcf_I20200630" decimals="-6" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMjEvZnJhZzpkNTEwOTAyZDMwZDc0NDk5YWUzNWE3NTg1ZDkwNDA4Ni90YWJsZTo0Yjk2NjQ4MWNlZjk0NDM1ODExOTBkZDc1N2M1ZmU1Ni90YWJsZXJhbmdlOjRiOTY2NDgxY2VmOTQ0MzU4MTE5MGRkNzU3YzVmZTU2XzItMi0xLTEtMTA4OQ_13f17a0b-500c-4f71-ac2d-cc7fada40dd9">426</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Current portion of operating lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7b139144658040af96c5e7fe53846762_I20210630" decimals="-6" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMjEvZnJhZzpkNTEwOTAyZDMwZDc0NDk5YWUzNWE3NTg1ZDkwNDA4Ni90YWJsZTo0Yjk2NjQ4MWNlZjk0NDM1ODExOTBkZDc1N2M1ZmU1Ni90YWJsZXJhbmdlOjRiOTY2NDgxY2VmOTQ0MzU4MTE5MGRkNzU3YzVmZTU2XzQtMS0xLTEtMA_eebf36e4-c392-4e2e-b2b9-552fe9b8cd7c">105</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4dc82a9dc1f44fe7a3214de6a700a3e1_I20200630" decimals="-6" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMjEvZnJhZzpkNTEwOTAyZDMwZDc0NDk5YWUzNWE3NTg1ZDkwNDA4Ni90YWJsZTo0Yjk2NjQ4MWNlZjk0NDM1ODExOTBkZDc1N2M1ZmU1Ni90YWJsZXJhbmdlOjRiOTY2NDgxY2VmOTQ0MzU4MTE5MGRkNzU3YzVmZTU2XzQtMi0xLTEtMTA4OQ_78b45218-dbbd-464e-9123-5ec2d46eaa0e">104</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Long-term operating lease liabilities</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae9792a738c242f7bf603db4cdc6f6ea_I20210630" decimals="-6" name="us-gaap:OperatingLeaseLiabilityNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMjEvZnJhZzpkNTEwOTAyZDMwZDc0NDk5YWUzNWE3NTg1ZDkwNDA4Ni90YWJsZTo0Yjk2NjQ4MWNlZjk0NDM1ODExOTBkZDc1N2M1ZmU1Ni90YWJsZXJhbmdlOjRiOTY2NDgxY2VmOTQ0MzU4MTE5MGRkNzU3YzVmZTU2XzUtMS0xLTEtMA_31cccf26-adb3-4971-88c3-b1f1c638288a">374</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i143c1782b3aa4747968fda061bcedf08_I20200630" decimals="-6" name="us-gaap:OperatingLeaseLiabilityNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMjEvZnJhZzpkNTEwOTAyZDMwZDc0NDk5YWUzNWE3NTg1ZDkwNDA4Ni90YWJsZTo0Yjk2NjQ4MWNlZjk0NDM1ODExOTBkZDc1N2M1ZmU1Ni90YWJsZXJhbmdlOjRiOTY2NDgxY2VmOTQ0MzU4MTE5MGRkNzU3YzVmZTU2XzUtMi0xLTEtMTA4OQ_d1ffdd25-5976-43fb-b2ee-ecdc3e9d4352">341</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total operating lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2e87824102b34590a0208cc7da91b5f5_I20210630" decimals="-6" name="us-gaap:OperatingLeaseLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMjEvZnJhZzpkNTEwOTAyZDMwZDc0NDk5YWUzNWE3NTg1ZDkwNDA4Ni90YWJsZTo0Yjk2NjQ4MWNlZjk0NDM1ODExOTBkZDc1N2M1ZmU1Ni90YWJsZXJhbmdlOjRiOTY2NDgxY2VmOTQ0MzU4MTE5MGRkNzU3YzVmZTU2XzYtMS0xLTEtMA_5d072339-4cbc-4534-80c0-9c49717826b7">479</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i299cea70f47b4fbe96772aaa8cc00b79_I20200630" decimals="-6" name="us-gaap:OperatingLeaseLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMjEvZnJhZzpkNTEwOTAyZDMwZDc0NDk5YWUzNWE3NTg1ZDkwNDA4Ni90YWJsZTo0Yjk2NjQ4MWNlZjk0NDM1ODExOTBkZDc1N2M1ZmU1Ni90YWJsZXJhbmdlOjRiOTY2NDgxY2VmOTQ0MzU4MTE5MGRkNzU3YzVmZTU2XzYtMi0xLTEtODAzNg_c4840675-7290-47e5-8298-d584baf66280">445</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Finance Leases</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Finance lease right-of-use assets</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f2e316db9cd4fdfabceb7ed40f4de88_I20210630" decimals="-6" name="us-gaap:FinanceLeaseRightOfUseAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMjEvZnJhZzpkNTEwOTAyZDMwZDc0NDk5YWUzNWE3NTg1ZDkwNDA4Ni90YWJsZTo0Yjk2NjQ4MWNlZjk0NDM1ODExOTBkZDc1N2M1ZmU1Ni90YWJsZXJhbmdlOjRiOTY2NDgxY2VmOTQ0MzU4MTE5MGRkNzU3YzVmZTU2XzktMS0xLTEtMA_b5eb0733-695e-473d-b050-8a784b9b3fde">63</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie4f28db5f64a4f11b597d0108259b1f2_I20200630" decimals="-6" name="us-gaap:FinanceLeaseRightOfUseAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMjEvZnJhZzpkNTEwOTAyZDMwZDc0NDk5YWUzNWE3NTg1ZDkwNDA4Ni90YWJsZTo0Yjk2NjQ4MWNlZjk0NDM1ODExOTBkZDc1N2M1ZmU1Ni90YWJsZXJhbmdlOjRiOTY2NDgxY2VmOTQ0MzU4MTE5MGRkNzU3YzVmZTU2XzktMi0xLTEtMTA5Mg_a5a93d41-74ab-48cf-8407-063fbba6c54e">33</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Current portion of finance lease liabilities</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2e87824102b34590a0208cc7da91b5f5_I20210630" decimals="-6" name="us-gaap:FinanceLeaseLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMjEvZnJhZzpkNTEwOTAyZDMwZDc0NDk5YWUzNWE3NTg1ZDkwNDA4Ni90YWJsZTo0Yjk2NjQ4MWNlZjk0NDM1ODExOTBkZDc1N2M1ZmU1Ni90YWJsZXJhbmdlOjRiOTY2NDgxY2VmOTQ0MzU4MTE5MGRkNzU3YzVmZTU2XzExLTEtMS0xLTA_185fac82-ff7a-45b2-a289-d20580767fc6">19</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i299cea70f47b4fbe96772aaa8cc00b79_I20200630" decimals="-6" name="us-gaap:FinanceLeaseLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMjEvZnJhZzpkNTEwOTAyZDMwZDc0NDk5YWUzNWE3NTg1ZDkwNDA4Ni90YWJsZTo0Yjk2NjQ4MWNlZjk0NDM1ODExOTBkZDc1N2M1ZmU1Ni90YWJsZXJhbmdlOjRiOTY2NDgxY2VmOTQ0MzU4MTE5MGRkNzU3YzVmZTU2XzExLTItMS0xLTEwOTI_841de90f-2f51-492e-a368-0b94cdfb4503">9</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Long-term finance lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2e87824102b34590a0208cc7da91b5f5_I20210630" decimals="-6" name="us-gaap:FinanceLeaseLiabilityNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMjEvZnJhZzpkNTEwOTAyZDMwZDc0NDk5YWUzNWE3NTg1ZDkwNDA4Ni90YWJsZTo0Yjk2NjQ4MWNlZjk0NDM1ODExOTBkZDc1N2M1ZmU1Ni90YWJsZXJhbmdlOjRiOTY2NDgxY2VmOTQ0MzU4MTE5MGRkNzU3YzVmZTU2XzEyLTEtMS0xLTA_898ae2de-a286-465e-8dde-9bcb73a7d6af">45</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i299cea70f47b4fbe96772aaa8cc00b79_I20200630" decimals="-6" name="us-gaap:FinanceLeaseLiabilityNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMjEvZnJhZzpkNTEwOTAyZDMwZDc0NDk5YWUzNWE3NTg1ZDkwNDA4Ni90YWJsZTo0Yjk2NjQ4MWNlZjk0NDM1ODExOTBkZDc1N2M1ZmU1Ni90YWJsZXJhbmdlOjRiOTY2NDgxY2VmOTQ0MzU4MTE5MGRkNzU3YzVmZTU2XzEyLTItMS0xLTEwOTI_3b403b25-ac9e-47b4-a9c1-44eb47dab210">25</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total finance lease liabilities</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2e87824102b34590a0208cc7da91b5f5_I20210630" decimals="-6" name="us-gaap:FinanceLeaseLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMjEvZnJhZzpkNTEwOTAyZDMwZDc0NDk5YWUzNWE3NTg1ZDkwNDA4Ni90YWJsZTo0Yjk2NjQ4MWNlZjk0NDM1ODExOTBkZDc1N2M1ZmU1Ni90YWJsZXJhbmdlOjRiOTY2NDgxY2VmOTQ0MzU4MTE5MGRkNzU3YzVmZTU2XzEzLTEtMS0xLTA_c51488f6-fc1d-49ed-a1ae-c52feb8274f8">64</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i299cea70f47b4fbe96772aaa8cc00b79_I20200630" decimals="-6" name="us-gaap:FinanceLeaseLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMjEvZnJhZzpkNTEwOTAyZDMwZDc0NDk5YWUzNWE3NTg1ZDkwNDA4Ni90YWJsZTo0Yjk2NjQ4MWNlZjk0NDM1ODExOTBkZDc1N2M1ZmU1Ni90YWJsZXJhbmdlOjRiOTY2NDgxY2VmOTQ0MzU4MTE5MGRkNzU3YzVmZTU2XzEzLTItMS0xLTgwMzg_b635a410-ccaa-4491-8934-540090b0a252">34</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-average remaining lease term (years)</span></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i2e87824102b34590a0208cc7da91b5f5_I20210630" format="ixt-sec:duryear" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMjEvZnJhZzpkNTEwOTAyZDMwZDc0NDk5YWUzNWE3NTg1ZDkwNDA4Ni90YWJsZTo0Yjk2NjQ4MWNlZjk0NDM1ODExOTBkZDc1N2M1ZmU1Ni90YWJsZXJhbmdlOjRiOTY2NDgxY2VmOTQ0MzU4MTE5MGRkNzU3YzVmZTU2XzE2LTEtMS0xLTg1NDA_b9ceafb6-6bc7-464d-850d-2fb6a86464cc">6.5</ix:nonNumeric> years</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i299cea70f47b4fbe96772aaa8cc00b79_I20200630" format="ixt-sec:duryear" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMjEvZnJhZzpkNTEwOTAyZDMwZDc0NDk5YWUzNWE3NTg1ZDkwNDA4Ni90YWJsZTo0Yjk2NjQ4MWNlZjk0NDM1ODExOTBkZDc1N2M1ZmU1Ni90YWJsZXJhbmdlOjRiOTY2NDgxY2VmOTQ0MzU4MTE5MGRkNzU3YzVmZTU2XzE2LTItMS0xLTg1NDA_68c82446-d4c9-4af0-975a-016e899f6484">6.4</ix:nonNumeric> years</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Finance leases</span></td><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i2e87824102b34590a0208cc7da91b5f5_I20210630" format="ixt-sec:duryear" name="us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMjEvZnJhZzpkNTEwOTAyZDMwZDc0NDk5YWUzNWE3NTg1ZDkwNDA4Ni90YWJsZTo0Yjk2NjQ4MWNlZjk0NDM1ODExOTBkZDc1N2M1ZmU1Ni90YWJsZXJhbmdlOjRiOTY2NDgxY2VmOTQ0MzU4MTE5MGRkNzU3YzVmZTU2XzE3LTEtMS0xLTg1NDA_8847feef-55b0-49cc-aad6-33efa0fe7126">4.2</ix:nonNumeric> years</span></td><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i299cea70f47b4fbe96772aaa8cc00b79_I20200630" format="ixt-sec:duryear" name="us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMjEvZnJhZzpkNTEwOTAyZDMwZDc0NDk5YWUzNWE3NTg1ZDkwNDA4Ni90YWJsZTo0Yjk2NjQ4MWNlZjk0NDM1ODExOTBkZDc1N2M1ZmU1Ni90YWJsZXJhbmdlOjRiOTY2NDgxY2VmOTQ0MzU4MTE5MGRkNzU3YzVmZTU2XzE3LTItMS0xLTg1NDA_ffc54b81-fee5-4d1e-9105-11c5821012f7">4.3</ix:nonNumeric> years</span></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-average discount rate</span></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i2e87824102b34590a0208cc7da91b5f5_I20210630" decimals="3" name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMjEvZnJhZzpkNTEwOTAyZDMwZDc0NDk5YWUzNWE3NTg1ZDkwNDA4Ni90YWJsZTo0Yjk2NjQ4MWNlZjk0NDM1ODExOTBkZDc1N2M1ZmU1Ni90YWJsZXJhbmdlOjRiOTY2NDgxY2VmOTQ0MzU4MTE5MGRkNzU3YzVmZTU2XzIwLTEtMS0xLTg1NDA_79bbea84-ecf4-4edd-94e5-3f4654f8aa4e">2.9</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i299cea70f47b4fbe96772aaa8cc00b79_I20200630" decimals="3" name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMjEvZnJhZzpkNTEwOTAyZDMwZDc0NDk5YWUzNWE3NTg1ZDkwNDA4Ni90YWJsZTo0Yjk2NjQ4MWNlZjk0NDM1ODExOTBkZDc1N2M1ZmU1Ni90YWJsZXJhbmdlOjRiOTY2NDgxY2VmOTQ0MzU4MTE5MGRkNzU3YzVmZTU2XzIwLTItMS0xLTg1NDA_2bfd9455-b102-42db-8fcc-a390107f508d">2.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Finance leases</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i2e87824102b34590a0208cc7da91b5f5_I20210630" decimals="3" name="us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMjEvZnJhZzpkNTEwOTAyZDMwZDc0NDk5YWUzNWE3NTg1ZDkwNDA4Ni90YWJsZTo0Yjk2NjQ4MWNlZjk0NDM1ODExOTBkZDc1N2M1ZmU1Ni90YWJsZXJhbmdlOjRiOTY2NDgxY2VmOTQ0MzU4MTE5MGRkNzU3YzVmZTU2XzIxLTEtMS0xLTg1NDA_d54011de-f48d-4e27-addc-8666b47e6614">1.5</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i299cea70f47b4fbe96772aaa8cc00b79_I20200630" decimals="3" name="us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMjEvZnJhZzpkNTEwOTAyZDMwZDc0NDk5YWUzNWE3NTg1ZDkwNDA4Ni90YWJsZTo0Yjk2NjQ4MWNlZjk0NDM1ODExOTBkZDc1N2M1ZmU1Ni90YWJsZXJhbmdlOjRiOTY2NDgxY2VmOTQ0MzU4MTE5MGRkNzU3YzVmZTU2XzIxLTItMS0xLTg1NDA_01f1b91f-4572-43ae-8675-5648a751f009">2.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr></table></ix:continuation><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating leases are included in other assets, other accrued liabilities, and deferred income taxes and other liabilities in our consolidated balance sheet. Finance leases are included in property and equipment, net, current portion of long-term obligations and other short-term borrowings, and long-term obligations, less current portion in our consolidated balance sheet. </span></div><ix:nonNumeric contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630" name="cah:LeasePaymentsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMjEvZnJhZzpkNTEwOTAyZDMwZDc0NDk5YWUzNWE3NTg1ZDkwNDA4Ni90ZXh0cmVnaW9uOmQ1MTA5MDJkMzBkNzQ0OTlhZTM1YTc1ODVkOTA0MDg2XzQxNzc_a60f0918-7feb-4207-9f27-a3ed4c5568f9" continuedAt="i6f87aacc80f24dd1bbf3e2a170735fbd" escape="true"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables summarizes supplemental cash flow information related to leases:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:40.258%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:28.220%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:28.222%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cash paid for lease liabilities:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Operating cash flows paid for operating leases</span></td><td style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630" decimals="-6" name="us-gaap:OperatingLeasePayments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMjEvZnJhZzpkNTEwOTAyZDMwZDc0NDk5YWUzNWE3NTg1ZDkwNDA4Ni90YWJsZToyYTRlM2FjMGQzZGQ0Y2Q2YTUwMjQ4ZjViOGM5YjEwYS90YWJsZXJhbmdlOjJhNGUzYWMwZDNkZDRjZDZhNTAyNDhmNWI4YzliMTBhXzMtMS0xLTEtMA_9e735386-b872-452e-8881-33318110b982">115</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia31e9a409b874bb19d0ff6f2f39ecc09_D20190701-20200630" decimals="-6" name="us-gaap:OperatingLeasePayments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMjEvZnJhZzpkNTEwOTAyZDMwZDc0NDk5YWUzNWE3NTg1ZDkwNDA4Ni90YWJsZToyYTRlM2FjMGQzZGQ0Y2Q2YTUwMjQ4ZjViOGM5YjEwYS90YWJsZXJhbmdlOjJhNGUzYWMwZDNkZDRjZDZhNTAyNDhmNWI4YzliMTBhXzMtMi0xLTEtMTEwOQ_f2729ddc-cf66-41cd-a7ca-82dcf61d75f5">125</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Financing cash flows paid for finance leases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630" decimals="-6" name="us-gaap:FinanceLeasePrincipalPayments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMjEvZnJhZzpkNTEwOTAyZDMwZDc0NDk5YWUzNWE3NTg1ZDkwNDA4Ni90YWJsZToyYTRlM2FjMGQzZGQ0Y2Q2YTUwMjQ4ZjViOGM5YjEwYS90YWJsZXJhbmdlOjJhNGUzYWMwZDNkZDRjZDZhNTAyNDhmNWI4YzliMTBhXzUtMS0xLTEtMA_0422b3c6-220e-45c6-9171-d46f588e9adf">15</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia31e9a409b874bb19d0ff6f2f39ecc09_D20190701-20200630" decimals="-6" name="us-gaap:FinanceLeasePrincipalPayments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMjEvZnJhZzpkNTEwOTAyZDMwZDc0NDk5YWUzNWE3NTg1ZDkwNDA4Ni90YWJsZToyYTRlM2FjMGQzZGQ0Y2Q2YTUwMjQ4ZjViOGM5YjEwYS90YWJsZXJhbmdlOjJhNGUzYWMwZDNkZDRjZDZhNTAyNDhmNWI4YzliMTBhXzUtMi0xLTEtMTEwOQ_8e440466-05c6-4640-910f-63684e3881f8">7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Non-cash right-of-use assets obtained in exchange for lease obligations:</span></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">New operating leases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630" decimals="-6" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMjEvZnJhZzpkNTEwOTAyZDMwZDc0NDk5YWUzNWE3NTg1ZDkwNDA4Ni90YWJsZToyYTRlM2FjMGQzZGQ0Y2Q2YTUwMjQ4ZjViOGM5YjEwYS90YWJsZXJhbmdlOjJhNGUzYWMwZDNkZDRjZDZhNTAyNDhmNWI4YzliMTBhXzctMS0xLTEtMA_ef2df7a8-8b6e-4c63-b1b1-d3b21a135edd">138</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia31e9a409b874bb19d0ff6f2f39ecc09_D20190701-20200630" decimals="-6" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMjEvZnJhZzpkNTEwOTAyZDMwZDc0NDk5YWUzNWE3NTg1ZDkwNDA4Ni90YWJsZToyYTRlM2FjMGQzZGQ0Y2Q2YTUwMjQ4ZjViOGM5YjEwYS90YWJsZXJhbmdlOjJhNGUzYWMwZDNkZDRjZDZhNTAyNDhmNWI4YzliMTBhXzctMi0xLTEtMTEwOQ_88e33e9b-98d8-4c98-a486-28d40b70be0b">150</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">New finance leases</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630" decimals="-6" name="us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMjEvZnJhZzpkNTEwOTAyZDMwZDc0NDk5YWUzNWE3NTg1ZDkwNDA4Ni90YWJsZToyYTRlM2FjMGQzZGQ0Y2Q2YTUwMjQ4ZjViOGM5YjEwYS90YWJsZXJhbmdlOjJhNGUzYWMwZDNkZDRjZDZhNTAyNDhmNWI4YzliMTBhXzgtMS0xLTEtMA_00774946-9d63-495c-bfc7-dc9c723ad6b7">45</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia31e9a409b874bb19d0ff6f2f39ecc09_D20190701-20200630" decimals="-6" name="us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMjEvZnJhZzpkNTEwOTAyZDMwZDc0NDk5YWUzNWE3NTg1ZDkwNDA4Ni90YWJsZToyYTRlM2FjMGQzZGQ0Y2Q2YTUwMjQ4ZjViOGM5YjEwYS90YWJsZXJhbmdlOjJhNGUzYWMwZDNkZDRjZDZhNTAyNDhmNWI4YzliMTBhXzgtMi0xLTEtMTEwOQ_072e3a4e-43b0-4dfe-b146-f43acadacb9d">40</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Amended lease standard adoption impact as of July 1, 2019 </span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if00203a4c9a34b58a93c869a759f0035_D20200701-20210630" decimals="-6" format="ixt:zerodash" name="cah:Impactofadoptionofnewaccountingstandard" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMjEvZnJhZzpkNTEwOTAyZDMwZDc0NDk5YWUzNWE3NTg1ZDkwNDA4Ni90YWJsZToyYTRlM2FjMGQzZGQ0Y2Q2YTUwMjQ4ZjViOGM5YjEwYS90YWJsZXJhbmdlOjJhNGUzYWMwZDNkZDRjZDZhNTAyNDhmNWI4YzliMTBhXzktMS0xLTEtMA_8871bbee-9545-4d2d-adab-5977a04de223">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i455f42e4f43447dc98cf9ec500532a90_D20190701-20190701" decimals="-6" name="cah:Impactofadoptionofnewaccountingstandard" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMjEvZnJhZzpkNTEwOTAyZDMwZDc0NDk5YWUzNWE3NTg1ZDkwNDA4Ni90YWJsZToyYTRlM2FjMGQzZGQ0Y2Q2YTUwMjQ4ZjViOGM5YjEwYS90YWJsZXJhbmdlOjJhNGUzYWMwZDNkZDRjZDZhNTAyNDhmNWI4YzliMTBhXzktMi0xLTEtMTEwOQ_153271ab-fe6d-4872-ad22-7bbc1fc350b7">400</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:continuation id="i6f87aacc80f24dd1bbf3e2a170735fbd" continuedAt="ia2a538f68a1341da9fd69e57eb70e7f7">(1)</ix:continuation></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:10pt"><ix:continuation id="ia2a538f68a1341da9fd69e57eb70e7f7">Includes the effect of $<ix:nonFraction unitRef="usd" contextRef="ie6662f5b1e3d4807b4fbf7aa426005bb_D20190701-20190701" decimals="-6" format="ixt:numdotdecimal" name="cah:ReclassificationofdeferredrentinaccordancewithASC842" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMjEvZnJhZzpkNTEwOTAyZDMwZDc0NDk5YWUzNWE3NTg1ZDkwNDA4Ni90ZXh0cmVnaW9uOmQ1MTA5MDJkMzBkNzQ0OTlhZTM1YTc1ODVkOTA0MDg2XzI3NDg3NzkwNzQ4ODM_28165712-ff0a-4eec-b779-e49269d1857c">22</ix:nonFraction>&#160;million from reclassifying deferred rent as an offset to the lease right-of-use asset in accordance with the transition guidance.</ix:continuation> </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:3pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:3pt;text-align:justify"><span><br/></span></div></div></ix:nonNumeric></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:32.135%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.428%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.137%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardinal Health </span><span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">|</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> Fiscal 2021 Form 10-K</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">71</span></div></td></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div style="margin-bottom:3pt"><span><br/></span></div><div style="margin-bottom:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.702%"><tr><td style="width:1.0%"></td><td style="width:24.720%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:50.989%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.991%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#e41f35;border-bottom:1pt solid #e41f35;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Notes to Financial Statements</span></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span><br/></span></div></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:48.214%"><ix:continuation id="i1c96d05e49b347f98024cad439e859cb" continuedAt="i7e9d2791eab648b1a96374acfebbfbde"><ix:nonNumeric contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630" name="us-gaap:ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMjEvZnJhZzpkNTEwOTAyZDMwZDc0NDk5YWUzNWE3NTg1ZDkwNDA4Ni90ZXh0cmVnaW9uOmQ1MTA5MDJkMzBkNzQ0OTlhZTM1YTc1ODVkOTA0MDg2XzQxNzM_7c19373c-3745-449d-b1e6-d555daf3bf37" continuedAt="ib26f03aa34b34da69493eafad954cae4" escape="true"><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Future lease payments under non-cancellable leases as of June&#160;30, 2021 were as follows: </span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.382%"><tr><td style="width:1.0%"></td><td style="width:50.142%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.117%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.352%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.117%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.352%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.120%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Operating Leases</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Finance Leases</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2022</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a0dd756c14d48d7a436a9f95e4c95c3_I20210630" decimals="-6" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMjEvZnJhZzpkNTEwOTAyZDMwZDc0NDk5YWUzNWE3NTg1ZDkwNDA4Ni90YWJsZTpiZGJkNzVhODZlMzU0NDI3ODQyYjJmZDg3ZTM1NGM1YS90YWJsZXJhbmdlOmJkYmQ3NWE4NmUzNTQ0Mjc4NDJiMmZkODdlMzU0YzVhXzItMS0xLTEtMA_2409ee3d-9c23-4d53-b711-9bf1bb50941c">116</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i566381a05b1444c1a852e8768ae88ad3_I20210630" decimals="-6" name="us-gaap:FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMjEvZnJhZzpkNTEwOTAyZDMwZDc0NDk5YWUzNWE3NTg1ZDkwNDA4Ni90YWJsZTpiZGJkNzVhODZlMzU0NDI3ODQyYjJmZDg3ZTM1NGM1YS90YWJsZXJhbmdlOmJkYmQ3NWE4NmUzNTQ0Mjc4NDJiMmZkODdlMzU0YzVhXzItMy0xLTEtMA_7e9020fd-324b-477b-b129-1d1750877df8">20</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2e87824102b34590a0208cc7da91b5f5_I20210630" decimals="-6" name="cah:LesseeLeaseLiabilityPaymentsDueYearOne" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMjEvZnJhZzpkNTEwOTAyZDMwZDc0NDk5YWUzNWE3NTg1ZDkwNDA4Ni90YWJsZTpiZGJkNzVhODZlMzU0NDI3ODQyYjJmZDg3ZTM1NGM1YS90YWJsZXJhbmdlOmJkYmQ3NWE4NmUzNTQ0Mjc4NDJiMmZkODdlMzU0YzVhXzItNS0xLTEtMA_581003ec-dd16-42c6-9490-526d7cb86976">136</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a0dd756c14d48d7a436a9f95e4c95c3_I20210630" decimals="-6" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMjEvZnJhZzpkNTEwOTAyZDMwZDc0NDk5YWUzNWE3NTg1ZDkwNDA4Ni90YWJsZTpiZGJkNzVhODZlMzU0NDI3ODQyYjJmZDg3ZTM1NGM1YS90YWJsZXJhbmdlOmJkYmQ3NWE4NmUzNTQ0Mjc4NDJiMmZkODdlMzU0YzVhXzMtMS0xLTEtMA_00d1b9a0-f086-4d4b-a413-ee9af27038ad">93</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i566381a05b1444c1a852e8768ae88ad3_I20210630" decimals="-6" name="us-gaap:FinanceLeaseLiabilityPaymentsDueYearTwo" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMjEvZnJhZzpkNTEwOTAyZDMwZDc0NDk5YWUzNWE3NTg1ZDkwNDA4Ni90YWJsZTpiZGJkNzVhODZlMzU0NDI3ODQyYjJmZDg3ZTM1NGM1YS90YWJsZXJhbmdlOmJkYmQ3NWE4NmUzNTQ0Mjc4NDJiMmZkODdlMzU0YzVhXzMtMy0xLTEtMA_44c1ae98-c9b7-466e-bd30-72f591c44115">20</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2e87824102b34590a0208cc7da91b5f5_I20210630" decimals="-6" name="cah:LesseeLeaseLiabilityPaymentsDueYearTwo" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMjEvZnJhZzpkNTEwOTAyZDMwZDc0NDk5YWUzNWE3NTg1ZDkwNDA4Ni90YWJsZTpiZGJkNzVhODZlMzU0NDI3ODQyYjJmZDg3ZTM1NGM1YS90YWJsZXJhbmdlOmJkYmQ3NWE4NmUzNTQ0Mjc4NDJiMmZkODdlMzU0YzVhXzMtNS0xLTEtMA_9be7050b-27c6-4919-b9c7-b4503cc47c24">113</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a0dd756c14d48d7a436a9f95e4c95c3_I20210630" decimals="-6" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMjEvZnJhZzpkNTEwOTAyZDMwZDc0NDk5YWUzNWE3NTg1ZDkwNDA4Ni90YWJsZTpiZGJkNzVhODZlMzU0NDI3ODQyYjJmZDg3ZTM1NGM1YS90YWJsZXJhbmdlOmJkYmQ3NWE4NmUzNTQ0Mjc4NDJiMmZkODdlMzU0YzVhXzQtMS0xLTEtMA_6dcb4016-019c-45b7-b037-882da2f22659">72</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i566381a05b1444c1a852e8768ae88ad3_I20210630" decimals="-6" name="us-gaap:FinanceLeaseLiabilityPaymentsDueYearThree" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMjEvZnJhZzpkNTEwOTAyZDMwZDc0NDk5YWUzNWE3NTg1ZDkwNDA4Ni90YWJsZTpiZGJkNzVhODZlMzU0NDI3ODQyYjJmZDg3ZTM1NGM1YS90YWJsZXJhbmdlOmJkYmQ3NWE4NmUzNTQ0Mjc4NDJiMmZkODdlMzU0YzVhXzQtMy0xLTEtMA_2fd13d0d-785c-4594-8576-779717dd33be">14</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2e87824102b34590a0208cc7da91b5f5_I20210630" decimals="-6" name="cah:LesseeLeaseLiabilityPaymentsDueYearThree" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMjEvZnJhZzpkNTEwOTAyZDMwZDc0NDk5YWUzNWE3NTg1ZDkwNDA4Ni90YWJsZTpiZGJkNzVhODZlMzU0NDI3ODQyYjJmZDg3ZTM1NGM1YS90YWJsZXJhbmdlOmJkYmQ3NWE4NmUzNTQ0Mjc4NDJiMmZkODdlMzU0YzVhXzQtNS0xLTEtMA_9f78629e-15cd-448f-918a-e7e430d80dbf">86</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a0dd756c14d48d7a436a9f95e4c95c3_I20210630" decimals="-6" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMjEvZnJhZzpkNTEwOTAyZDMwZDc0NDk5YWUzNWE3NTg1ZDkwNDA4Ni90YWJsZTpiZGJkNzVhODZlMzU0NDI3ODQyYjJmZDg3ZTM1NGM1YS90YWJsZXJhbmdlOmJkYmQ3NWE4NmUzNTQ0Mjc4NDJiMmZkODdlMzU0YzVhXzUtMS0xLTEtMA_c3277353-acc0-4411-8dd8-7f78ff57ecd0">65</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i566381a05b1444c1a852e8768ae88ad3_I20210630" decimals="-6" name="us-gaap:FinanceLeaseLiabilityPaymentsDueYearFour" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMjEvZnJhZzpkNTEwOTAyZDMwZDc0NDk5YWUzNWE3NTg1ZDkwNDA4Ni90YWJsZTpiZGJkNzVhODZlMzU0NDI3ODQyYjJmZDg3ZTM1NGM1YS90YWJsZXJhbmdlOmJkYmQ3NWE4NmUzNTQ0Mjc4NDJiMmZkODdlMzU0YzVhXzUtMy0xLTEtMA_9404d6fb-0a26-45a9-9928-3c20ea57bda6">8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2e87824102b34590a0208cc7da91b5f5_I20210630" decimals="-6" name="cah:LesseeLeaseLiabilityPaymentsDueYearFour" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMjEvZnJhZzpkNTEwOTAyZDMwZDc0NDk5YWUzNWE3NTg1ZDkwNDA4Ni90YWJsZTpiZGJkNzVhODZlMzU0NDI3ODQyYjJmZDg3ZTM1NGM1YS90YWJsZXJhbmdlOmJkYmQ3NWE4NmUzNTQ0Mjc4NDJiMmZkODdlMzU0YzVhXzUtNS0xLTEtMA_16586532-b153-43e3-8c0b-5e1f5c0793f0">73</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a0dd756c14d48d7a436a9f95e4c95c3_I20210630" decimals="-6" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMjEvZnJhZzpkNTEwOTAyZDMwZDc0NDk5YWUzNWE3NTg1ZDkwNDA4Ni90YWJsZTpiZGJkNzVhODZlMzU0NDI3ODQyYjJmZDg3ZTM1NGM1YS90YWJsZXJhbmdlOmJkYmQ3NWE4NmUzNTQ0Mjc4NDJiMmZkODdlMzU0YzVhXzYtMS0xLTEtMA_24e28e74-404d-40ca-ada6-37e4dff9fca0">50</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i566381a05b1444c1a852e8768ae88ad3_I20210630" decimals="-6" name="us-gaap:FinanceLeaseLiabilityPaymentsDueYearFive" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMjEvZnJhZzpkNTEwOTAyZDMwZDc0NDk5YWUzNWE3NTg1ZDkwNDA4Ni90YWJsZTpiZGJkNzVhODZlMzU0NDI3ODQyYjJmZDg3ZTM1NGM1YS90YWJsZXJhbmdlOmJkYmQ3NWE4NmUzNTQ0Mjc4NDJiMmZkODdlMzU0YzVhXzYtMy0xLTEtMA_a0bccf50-7914-4eca-a454-2aff024cafb2">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2e87824102b34590a0208cc7da91b5f5_I20210630" decimals="-6" name="cah:LesseeLeaseLiabilityPaymentsDueYearFive" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMjEvZnJhZzpkNTEwOTAyZDMwZDc0NDk5YWUzNWE3NTg1ZDkwNDA4Ni90YWJsZTpiZGJkNzVhODZlMzU0NDI3ODQyYjJmZDg3ZTM1NGM1YS90YWJsZXJhbmdlOmJkYmQ3NWE4NmUzNTQ0Mjc4NDJiMmZkODdlMzU0YzVhXzYtNS0xLTEtMA_7704d536-b05f-4199-9794-f887e371ec54">53</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a0dd756c14d48d7a436a9f95e4c95c3_I20210630" decimals="-6" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMjEvZnJhZzpkNTEwOTAyZDMwZDc0NDk5YWUzNWE3NTg1ZDkwNDA4Ni90YWJsZTpiZGJkNzVhODZlMzU0NDI3ODQyYjJmZDg3ZTM1NGM1YS90YWJsZXJhbmdlOmJkYmQ3NWE4NmUzNTQ0Mjc4NDJiMmZkODdlMzU0YzVhXzctMS0xLTEtMA_48b13e42-bfb6-43e7-83a9-04e1f794249d">141</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i566381a05b1444c1a852e8768ae88ad3_I20210630" decimals="-6" name="us-gaap:FinanceLeaseLiabilityPaymentsDueAfterYearFive" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMjEvZnJhZzpkNTEwOTAyZDMwZDc0NDk5YWUzNWE3NTg1ZDkwNDA4Ni90YWJsZTpiZGJkNzVhODZlMzU0NDI3ODQyYjJmZDg3ZTM1NGM1YS90YWJsZXJhbmdlOmJkYmQ3NWE4NmUzNTQ0Mjc4NDJiMmZkODdlMzU0YzVhXzctMy0xLTEtMA_c6da1cf7-18d3-4dc9-acf0-123dcde3ae0b">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2e87824102b34590a0208cc7da91b5f5_I20210630" decimals="-6" name="cah:LesseeLeaseLiabilityPaymentsDueAfterYearFive" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMjEvZnJhZzpkNTEwOTAyZDMwZDc0NDk5YWUzNWE3NTg1ZDkwNDA4Ni90YWJsZTpiZGJkNzVhODZlMzU0NDI3ODQyYjJmZDg3ZTM1NGM1YS90YWJsZXJhbmdlOmJkYmQ3NWE4NmUzNTQ0Mjc4NDJiMmZkODdlMzU0YzVhXzctNS0xLTEtMA_b34343ff-ce56-4df0-a805-108924997c18">146</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total future lease payments</span></td><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a0dd756c14d48d7a436a9f95e4c95c3_I20210630" decimals="-6" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMjEvZnJhZzpkNTEwOTAyZDMwZDc0NDk5YWUzNWE3NTg1ZDkwNDA4Ni90YWJsZTpiZGJkNzVhODZlMzU0NDI3ODQyYjJmZDg3ZTM1NGM1YS90YWJsZXJhbmdlOmJkYmQ3NWE4NmUzNTQ0Mjc4NDJiMmZkODdlMzU0YzVhXzgtMS0xLTEtMA_3cabb972-be48-427a-8bbe-73aa7f6eabdb">537</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i566381a05b1444c1a852e8768ae88ad3_I20210630" decimals="-6" name="us-gaap:FinanceLeaseLiabilityPaymentsDue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMjEvZnJhZzpkNTEwOTAyZDMwZDc0NDk5YWUzNWE3NTg1ZDkwNDA4Ni90YWJsZTpiZGJkNzVhODZlMzU0NDI3ODQyYjJmZDg3ZTM1NGM1YS90YWJsZXJhbmdlOmJkYmQ3NWE4NmUzNTQ0Mjc4NDJiMmZkODdlMzU0YzVhXzgtMy0xLTEtMA_f4e560f6-66fe-43e6-bf1a-879b149c9cc3">70</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2e87824102b34590a0208cc7da91b5f5_I20210630" decimals="-6" name="cah:TotalLeaseLiabilityPaymentsDue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMjEvZnJhZzpkNTEwOTAyZDMwZDc0NDk5YWUzNWE3NTg1ZDkwNDA4Ni90YWJsZTpiZGJkNzVhODZlMzU0NDI3ODQyYjJmZDg3ZTM1NGM1YS90YWJsZXJhbmdlOmJkYmQ3NWE4NmUzNTQ0Mjc4NDJiMmZkODdlMzU0YzVhXzgtNS0xLTEtMA_cae6caeb-5515-4bba-a0e3-302704e8081b">607</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Less: leases not yet commenced </span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a0dd756c14d48d7a436a9f95e4c95c3_I20210630" decimals="-6" name="cah:LesseeOperatingLeaseLiabilityNotYetCommencedAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMjEvZnJhZzpkNTEwOTAyZDMwZDc0NDk5YWUzNWE3NTg1ZDkwNDA4Ni90YWJsZTpiZGJkNzVhODZlMzU0NDI3ODQyYjJmZDg3ZTM1NGM1YS90YWJsZXJhbmdlOmJkYmQ3NWE4NmUzNTQ0Mjc4NDJiMmZkODdlMzU0YzVhXzktMS0xLTEtMA_bee2c146-484d-4fc4-b961-bbf9e51d8197">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i566381a05b1444c1a852e8768ae88ad3_I20210630" decimals="-6" format="ixt:zerodash" name="cah:LesseeFinanceLeaseLiabilityNotYetCommencedAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMjEvZnJhZzpkNTEwOTAyZDMwZDc0NDk5YWUzNWE3NTg1ZDkwNDA4Ni90YWJsZTpiZGJkNzVhODZlMzU0NDI3ODQyYjJmZDg3ZTM1NGM1YS90YWJsZXJhbmdlOmJkYmQ3NWE4NmUzNTQ0Mjc4NDJiMmZkODdlMzU0YzVhXzktMy0xLTEtMA_655e951a-d12f-4e9d-8073-bc84c86482ba">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2e87824102b34590a0208cc7da91b5f5_I20210630" decimals="-6" name="cah:TotalLeaseLiabilityNotYetCommencedAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMjEvZnJhZzpkNTEwOTAyZDMwZDc0NDk5YWUzNWE3NTg1ZDkwNDA4Ni90YWJsZTpiZGJkNzVhODZlMzU0NDI3ODQyYjJmZDg3ZTM1NGM1YS90YWJsZXJhbmdlOmJkYmQ3NWE4NmUzNTQ0Mjc4NDJiMmZkODdlMzU0YzVhXzktNS0xLTEtMA_88ae3380-81a2-44a5-b2c1-6613f5a37a2b">3</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Less: imputed interest</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a0dd756c14d48d7a436a9f95e4c95c3_I20210630" decimals="-6" name="cah:OperatingLeaseImputedInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMjEvZnJhZzpkNTEwOTAyZDMwZDc0NDk5YWUzNWE3NTg1ZDkwNDA4Ni90YWJsZTpiZGJkNzVhODZlMzU0NDI3ODQyYjJmZDg3ZTM1NGM1YS90YWJsZXJhbmdlOmJkYmQ3NWE4NmUzNTQ0Mjc4NDJiMmZkODdlMzU0YzVhXzEwLTEtMS0xLTA_b22466e7-188c-41d6-962e-86ed48b3e25b">55</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i566381a05b1444c1a852e8768ae88ad3_I20210630" decimals="-6" name="cah:FinanceLeaseImputedInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMjEvZnJhZzpkNTEwOTAyZDMwZDc0NDk5YWUzNWE3NTg1ZDkwNDA4Ni90YWJsZTpiZGJkNzVhODZlMzU0NDI3ODQyYjJmZDg3ZTM1NGM1YS90YWJsZXJhbmdlOmJkYmQ3NWE4NmUzNTQ0Mjc4NDJiMmZkODdlMzU0YzVhXzEwLTMtMS0xLTA_b237694e-78fe-4b05-8a8b-db748b2cc6dc">6</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2e87824102b34590a0208cc7da91b5f5_I20210630" decimals="-6" name="cah:TotalLeaseLiabilityUndiscountedExcessAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMjEvZnJhZzpkNTEwOTAyZDMwZDc0NDk5YWUzNWE3NTg1ZDkwNDA4Ni90YWJsZTpiZGJkNzVhODZlMzU0NDI3ODQyYjJmZDg3ZTM1NGM1YS90YWJsZXJhbmdlOmJkYmQ3NWE4NmUzNTQ0Mjc4NDJiMmZkODdlMzU0YzVhXzEwLTUtMS0xLTA_5617a0cf-be74-45b2-b1e2-8a4d1d55cec7">61</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total lease liabilities</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a0dd756c14d48d7a436a9f95e4c95c3_I20210630" decimals="-6" name="us-gaap:OperatingLeaseLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMjEvZnJhZzpkNTEwOTAyZDMwZDc0NDk5YWUzNWE3NTg1ZDkwNDA4Ni90YWJsZTpiZGJkNzVhODZlMzU0NDI3ODQyYjJmZDg3ZTM1NGM1YS90YWJsZXJhbmdlOmJkYmQ3NWE4NmUzNTQ0Mjc4NDJiMmZkODdlMzU0YzVhXzExLTEtMS0xLTA_5078eaba-cc38-418a-adc0-01a98b878a53">479</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i566381a05b1444c1a852e8768ae88ad3_I20210630" decimals="-6" name="us-gaap:FinanceLeaseLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMjEvZnJhZzpkNTEwOTAyZDMwZDc0NDk5YWUzNWE3NTg1ZDkwNDA4Ni90YWJsZTpiZGJkNzVhODZlMzU0NDI3ODQyYjJmZDg3ZTM1NGM1YS90YWJsZXJhbmdlOmJkYmQ3NWE4NmUzNTQ0Mjc4NDJiMmZkODdlMzU0YzVhXzExLTMtMS0xLTA_47655e6a-0f11-4178-9678-7d24cb798e68">64</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2e87824102b34590a0208cc7da91b5f5_I20210630" decimals="-6" name="cah:TotalLeaseLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMjEvZnJhZzpkNTEwOTAyZDMwZDc0NDk5YWUzNWE3NTg1ZDkwNDA4Ni90YWJsZTpiZGJkNzVhODZlMzU0NDI3ODQyYjJmZDg3ZTM1NGM1YS90YWJsZXJhbmdlOmJkYmQ3NWE4NmUzNTQ0Mjc4NDJiMmZkODdlMzU0YzVhXzExLTUtMS0xLTA_450138f1-7688-4fd9-a349-661bcb598251">543</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:continuation id="i7e9d2791eab648b1a96374acfebbfbde" continuedAt="i29fa209dfb2f477396b35a11ab928b0b"><ix:continuation id="ib26f03aa34b34da69493eafad954cae4" continuedAt="ie9bf54d163c443c796bd960fe54f3247">(1)</ix:continuation></ix:continuation></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:10pt"><ix:continuation id="i29fa209dfb2f477396b35a11ab928b0b"><ix:continuation id="ie9bf54d163c443c796bd960fe54f3247">As of June&#160;30, 2021, we had certain leases that were executed but did not have control of the underlying assets; therefore, the lease liabilities and right-of-use assets are not recorded in the consolidated balance sheet.</ix:continuation></ix:continuation> </span></div><div style="margin-bottom:3pt;text-align:justify"><span><br/></span></div><div id="i4f0ec56b9c604f1782a65ea4a19c284d_124"></div><ix:nonNumeric contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630" name="us-gaap:DebtDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMjQvZnJhZzpkMGRmMDA1NjdlMmI0ZWVjOTNmYTVlYWRiNjUyY2YzZS90ZXh0cmVnaW9uOmQwZGYwMDU2N2UyYjRlZWM5M2ZhNWVhZGI2NTJjZjNlXzUxNzI_56d1df23-ef64-418d-a9f2-cbddf2a6f846" continuedAt="i0b9dfa93ecb048cfb5c3c23bf8f43913" escape="true"><div style="margin-bottom:6pt;text-align:justify"><span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:13pt;font-weight:700;line-height:120%">6. Long-Term Obligations and Other Short-Term Borrowings </span></div><ix:nonNumeric contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630" name="us-gaap:ScheduleOfDebtTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMjQvZnJhZzpkMGRmMDA1NjdlMmI0ZWVjOTNmYTVlYWRiNjUyY2YzZS90ZXh0cmVnaW9uOmQwZGYwMDU2N2UyYjRlZWM5M2ZhNWVhZGI2NTJjZjNlXzUxNzE_64aded48-285f-45c9-91d9-64741044852a" continuedAt="i416b2cbcd1a64e58b84dc37f904baa71" escape="true"><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes long-term obligations and other short-term borrowings at June 30:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.691%"><tr><td style="width:1.0%"></td><td style="width:57.104%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.023%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.347%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.026%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in millions) (1)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2.616% Notes due 2022</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6040899ecc9f44f893d3f559f74eb30e_I20210630" decimals="-6" name="us-gaap:NotesPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMjQvZnJhZzpkMGRmMDA1NjdlMmI0ZWVjOTNmYTVlYWRiNjUyY2YzZS90YWJsZTo5NTk5NjRhNjdkMDI0YzM0ODMxMmU5ZTE2ODc4ZjcxMC90YWJsZXJhbmdlOjk1OTk2NGE2N2QwMjRjMzQ4MzEyZTllMTY4NzhmNzEwXzMtMS0xLTEtMA_98d730d1-33a6-4820-badf-812eef84e36f">572</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1079054a38c64aa1b73f425120be8b95_I20200630" decimals="-6" name="us-gaap:NotesPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMjQvZnJhZzpkMGRmMDA1NjdlMmI0ZWVjOTNmYTVlYWRiNjUyY2YzZS90YWJsZTo5NTk5NjRhNjdkMDI0YzM0ODMxMmU5ZTE2ODc4ZjcxMC90YWJsZXJhbmdlOjk1OTk2NGE2N2QwMjRjMzQ4MzEyZTllMTY4NzhmNzEwXzMtMy0xLTEtMA_1f3dd93d-c800-46a6-b34d-500be298621b">834</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3.2% Notes due 2022</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4681cfaabaed494eb4cdf968725268ad_I20210630" decimals="-6" format="ixt:zerodash" name="us-gaap:NotesPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMjQvZnJhZzpkMGRmMDA1NjdlMmI0ZWVjOTNmYTVlYWRiNjUyY2YzZS90YWJsZTo5NTk5NjRhNjdkMDI0YzM0ODMxMmU5ZTE2ODc4ZjcxMC90YWJsZXJhbmdlOjk1OTk2NGE2N2QwMjRjMzQ4MzEyZTllMTY4NzhmNzEwXzQtMS0xLTEtMA_12e21ee5-ec0f-411e-a348-4f90138aeb35">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idd88c476ee2d4612ba0be20c3b31959f_I20200630" decimals="-6" name="us-gaap:NotesPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMjQvZnJhZzpkMGRmMDA1NjdlMmI0ZWVjOTNmYTVlYWRiNjUyY2YzZS90YWJsZTo5NTk5NjRhNjdkMDI0YzM0ODMxMmU5ZTE2ODc4ZjcxMC90YWJsZXJhbmdlOjk1OTk2NGE2N2QwMjRjMzQ4MzEyZTllMTY4NzhmNzEwXzQtMy0xLTEtMA_8e178a2a-3450-442f-903c-e532046b7598">236</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Floating Rate Notes due 2022</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id7a8329ac0d44ba88b3081e963420a51_I20210630" decimals="-6" name="us-gaap:NotesPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMjQvZnJhZzpkMGRmMDA1NjdlMmI0ZWVjOTNmYTVlYWRiNjUyY2YzZS90YWJsZTo5NTk5NjRhNjdkMDI0YzM0ODMxMmU5ZTE2ODc4ZjcxMC90YWJsZXJhbmdlOjk1OTk2NGE2N2QwMjRjMzQ4MzEyZTllMTY4NzhmNzEwXzUtMS0xLTEtMA_4fe6d7ff-805e-4e24-a445-1032d14487e3">281</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6108c3790b344ba09f455a14ad158d62_I20200630" decimals="-6" name="us-gaap:NotesPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMjQvZnJhZzpkMGRmMDA1NjdlMmI0ZWVjOTNmYTVlYWRiNjUyY2YzZS90YWJsZTo5NTk5NjRhNjdkMDI0YzM0ODMxMmU5ZTE2ODc4ZjcxMC90YWJsZXJhbmdlOjk1OTk2NGE2N2QwMjRjMzQ4MzEyZTllMTY4NzhmNzEwXzUtMy0xLTEtMA_05c60622-240c-4b5c-bb7f-dbbe8ff440a9">321</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3.2% Notes due 2023</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i52aed3fcb7884bf0a519d03f6726bab7_I20210630" decimals="-6" name="us-gaap:NotesPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMjQvZnJhZzpkMGRmMDA1NjdlMmI0ZWVjOTNmYTVlYWRiNjUyY2YzZS90YWJsZTo5NTk5NjRhNjdkMDI0YzM0ODMxMmU5ZTE2ODc4ZjcxMC90YWJsZXJhbmdlOjk1OTk2NGE2N2QwMjRjMzQ4MzEyZTllMTY4NzhmNzEwXzYtMS0xLTEtMA_39b36d39-7e49-4717-8fe3-fc660a2a8eea">564</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39f995524bc54afd96d0837c392791d0_I20200630" decimals="-6" name="us-gaap:NotesPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMjQvZnJhZzpkMGRmMDA1NjdlMmI0ZWVjOTNmYTVlYWRiNjUyY2YzZS90YWJsZTo5NTk5NjRhNjdkMDI0YzM0ODMxMmU5ZTE2ODc4ZjcxMC90YWJsZXJhbmdlOjk1OTk2NGE2N2QwMjRjMzQ4MzEyZTllMTY4NzhmNzEwXzYtMy0xLTEtMA_77f3bd6a-81aa-40c2-8eeb-6f07ed1eaca2">576</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3.079% Notes due 2024</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3079877c28ab4fc7acfe2cebacdaf0a2_I20210630" decimals="-6" name="us-gaap:NotesPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMjQvZnJhZzpkMGRmMDA1NjdlMmI0ZWVjOTNmYTVlYWRiNjUyY2YzZS90YWJsZTo5NTk5NjRhNjdkMDI0YzM0ODMxMmU5ZTE2ODc4ZjcxMC90YWJsZXJhbmdlOjk1OTk2NGE2N2QwMjRjMzQ4MzEyZTllMTY4NzhmNzEwXzctMS0xLTEtMA_40d1cf6f-4e41-4756-98b3-7b964121425b">794</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iea859ed78b0341729f419cd2af57c361_I20200630" decimals="-6" name="us-gaap:NotesPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMjQvZnJhZzpkMGRmMDA1NjdlMmI0ZWVjOTNmYTVlYWRiNjUyY2YzZS90YWJsZTo5NTk5NjRhNjdkMDI0YzM0ODMxMmU5ZTE2ODc4ZjcxMC90YWJsZXJhbmdlOjk1OTk2NGE2N2QwMjRjMzQ4MzEyZTllMTY4NzhmNzEwXzctMy0xLTEtMA_f4658982-81b7-42d4-a7fd-e404cc13fb5f">809</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3.5% Notes due 2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id9068073bcf44ebfa32fbd94e54fa0bb_I20210630" decimals="-6" name="us-gaap:NotesPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMjQvZnJhZzpkMGRmMDA1NjdlMmI0ZWVjOTNmYTVlYWRiNjUyY2YzZS90YWJsZTo5NTk5NjRhNjdkMDI0YzM0ODMxMmU5ZTE2ODc4ZjcxMC90YWJsZXJhbmdlOjk1OTk2NGE2N2QwMjRjMzQ4MzEyZTllMTY4NzhmNzEwXzgtMS0xLTEtMA_f3506010-02fa-4b8a-9fa0-f6ab4950693e">410</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i19386d9a9665443da76f29f541da851b_I20200630" decimals="-6" name="us-gaap:NotesPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMjQvZnJhZzpkMGRmMDA1NjdlMmI0ZWVjOTNmYTVlYWRiNjUyY2YzZS90YWJsZTo5NTk5NjRhNjdkMDI0YzM0ODMxMmU5ZTE2ODc4ZjcxMC90YWJsZXJhbmdlOjk1OTk2NGE2N2QwMjRjMzQ4MzEyZTllMTY4NzhmNzEwXzgtMy0xLTEtMA_a1f8e906-dc9a-4cd7-982a-08160c3102f3">413</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3.75% Notes due 2025</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia1f00593041245b2884a1d027a7a5789_I20210630" decimals="-6" name="us-gaap:NotesPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMjQvZnJhZzpkMGRmMDA1NjdlMmI0ZWVjOTNmYTVlYWRiNjUyY2YzZS90YWJsZTo5NTk5NjRhNjdkMDI0YzM0ODMxMmU5ZTE2ODc4ZjcxMC90YWJsZXJhbmdlOjk1OTk2NGE2N2QwMjRjMzQ4MzEyZTllMTY4NzhmNzEwXzktMS0xLTEtMA_4d813aa9-9611-4980-8ea4-236cc3b29f75">524</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a8da22c2d104c07b8e124a12e07a40a_I20200630" decimals="-6" name="us-gaap:NotesPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMjQvZnJhZzpkMGRmMDA1NjdlMmI0ZWVjOTNmYTVlYWRiNjUyY2YzZS90YWJsZTo5NTk5NjRhNjdkMDI0YzM0ODMxMmU5ZTE2ODc4ZjcxMC90YWJsZXJhbmdlOjk1OTk2NGE2N2QwMjRjMzQ4MzEyZTllMTY4NzhmNzEwXzktMy0xLTEtMA_26709b17-1d80-453a-9734-c433762bb70d">529</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3.41% Notes due 2027</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7f818bbd6041415ab92166ff89fb7e19_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:NotesPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMjQvZnJhZzpkMGRmMDA1NjdlMmI0ZWVjOTNmYTVlYWRiNjUyY2YzZS90YWJsZTo5NTk5NjRhNjdkMDI0YzM0ODMxMmU5ZTE2ODc4ZjcxMC90YWJsZXJhbmdlOjk1OTk2NGE2N2QwMjRjMzQ4MzEyZTllMTY4NzhmNzEwXzEwLTEtMS0xLTA_8b1b6a7c-dd16-4eb7-89ef-d55d2a8140f1">1,216</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f29332f948b439e93e2d67c75208f61_I20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:NotesPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMjQvZnJhZzpkMGRmMDA1NjdlMmI0ZWVjOTNmYTVlYWRiNjUyY2YzZS90YWJsZTo5NTk5NjRhNjdkMDI0YzM0ODMxMmU5ZTE2ODc4ZjcxMC90YWJsZXJhbmdlOjk1OTk2NGE2N2QwMjRjMzQ4MzEyZTllMTY4NzhmNzEwXzEwLTMtMS0xLTA_601f820f-c136-4368-bf16-776a782d2eee">1,215</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4.6% Notes due 2043</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i90cac66be512421fbc3704be2d9730c5_I20210630" decimals="-6" name="us-gaap:NotesPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMjQvZnJhZzpkMGRmMDA1NjdlMmI0ZWVjOTNmYTVlYWRiNjUyY2YzZS90YWJsZTo5NTk5NjRhNjdkMDI0YzM0ODMxMmU5ZTE2ODc4ZjcxMC90YWJsZXJhbmdlOjk1OTk2NGE2N2QwMjRjMzQ4MzEyZTllMTY4NzhmNzEwXzExLTEtMS0xLTA_5966de21-6801-4a1f-b0b6-36610426bb29">341</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id14e22824b7b4593bfd07bc8ab4bb51a_I20200630" decimals="-6" name="us-gaap:NotesPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMjQvZnJhZzpkMGRmMDA1NjdlMmI0ZWVjOTNmYTVlYWRiNjUyY2YzZS90YWJsZTo5NTk5NjRhNjdkMDI0YzM0ODMxMmU5ZTE2ODc4ZjcxMC90YWJsZXJhbmdlOjk1OTk2NGE2N2QwMjRjMzQ4MzEyZTllMTY4NzhmNzEwXzExLTMtMS0xLTA_a39d82db-b3a1-42fa-8772-a8eafdee4c5d">340</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4.5% Notes due 2044</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9e575fac51a64f15bbc8ee5ae661cbbc_I20210630" decimals="-6" name="us-gaap:NotesPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMjQvZnJhZzpkMGRmMDA1NjdlMmI0ZWVjOTNmYTVlYWRiNjUyY2YzZS90YWJsZTo5NTk5NjRhNjdkMDI0YzM0ODMxMmU5ZTE2ODc4ZjcxMC90YWJsZXJhbmdlOjk1OTk2NGE2N2QwMjRjMzQ4MzEyZTllMTY4NzhmNzEwXzEyLTEtMS0xLTA_7b6589f3-8d8e-45de-9f6a-cc984a1ba0d2">342</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3a3d93f3182045b2979e580513d975cd_I20200630" decimals="-6" name="us-gaap:NotesPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMjQvZnJhZzpkMGRmMDA1NjdlMmI0ZWVjOTNmYTVlYWRiNjUyY2YzZS90YWJsZTo5NTk5NjRhNjdkMDI0YzM0ODMxMmU5ZTE2ODc4ZjcxMC90YWJsZXJhbmdlOjk1OTk2NGE2N2QwMjRjMzQ4MzEyZTllMTY4NzhmNzEwXzEyLTMtMS0xLTA_e47137c7-a3c8-459d-a036-90f377159b4c">342</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4.9% Notes due 2045</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife3234ddac5f446990273bd3ceb3091d_I20210630" decimals="-6" name="us-gaap:NotesPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMjQvZnJhZzpkMGRmMDA1NjdlMmI0ZWVjOTNmYTVlYWRiNjUyY2YzZS90YWJsZTo5NTk5NjRhNjdkMDI0YzM0ODMxMmU5ZTE2ODc4ZjcxMC90YWJsZXJhbmdlOjk1OTk2NGE2N2QwMjRjMzQ4MzEyZTllMTY4NzhmNzEwXzEzLTEtMS0xLTA_5ce43d0e-ee2c-4d39-a725-81c6a20307c8">441</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c8388e50dd844709e91931b05259f87_I20200630" decimals="-6" name="us-gaap:NotesPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMjQvZnJhZzpkMGRmMDA1NjdlMmI0ZWVjOTNmYTVlYWRiNjUyY2YzZS90YWJsZTo5NTk5NjRhNjdkMDI0YzM0ODMxMmU5ZTE2ODc4ZjcxMC90YWJsZXJhbmdlOjk1OTk2NGE2N2QwMjRjMzQ4MzEyZTllMTY4NzhmNzEwXzEzLTMtMS0xLTA_76977563-4d9b-4791-a4ee-cb9eb0e0d272">441</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4.368% Notes due 2047</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c1b2f1400e147e8a50fddbaf3a101ab_I20210630" decimals="-6" name="us-gaap:NotesPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMjQvZnJhZzpkMGRmMDA1NjdlMmI0ZWVjOTNmYTVlYWRiNjUyY2YzZS90YWJsZTo5NTk5NjRhNjdkMDI0YzM0ODMxMmU5ZTE2ODc4ZjcxMC90YWJsZXJhbmdlOjk1OTk2NGE2N2QwMjRjMzQ4MzEyZTllMTY4NzhmNzEwXzE0LTEtMS0xLTA_39ec0abb-104d-407d-911e-4430d425e2d4">560</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i12b2bfab3db94c15be13cf683c78c053_I20200630" decimals="-6" name="us-gaap:NotesPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMjQvZnJhZzpkMGRmMDA1NjdlMmI0ZWVjOTNmYTVlYWRiNjUyY2YzZS90YWJsZTo5NTk5NjRhNjdkMDI0YzM0ODMxMmU5ZTE2ODc4ZjcxMC90YWJsZXJhbmdlOjk1OTk2NGE2N2QwMjRjMzQ4MzEyZTllMTY4NzhmNzEwXzE0LTMtMS0xLTA_65cc6f69-68b7-4682-8cc1-4851d15ca3d6">560</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7.0%&#160;Debentures due 2026</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie0a9e0fdeffa40c9b581b00676cf4639_I20210630" decimals="-6" name="us-gaap:NotesPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMjQvZnJhZzpkMGRmMDA1NjdlMmI0ZWVjOTNmYTVlYWRiNjUyY2YzZS90YWJsZTo5NTk5NjRhNjdkMDI0YzM0ODMxMmU5ZTE2ODc4ZjcxMC90YWJsZXJhbmdlOjk1OTk2NGE2N2QwMjRjMzQ4MzEyZTllMTY4NzhmNzEwXzE1LTEtMS0xLTA_b6d5e9f0-8b39-42dc-8d25-6fce19727c1e">124</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i89ff9fc63c07435d9b32595a42af3796_I20200630" decimals="-6" name="us-gaap:NotesPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMjQvZnJhZzpkMGRmMDA1NjdlMmI0ZWVjOTNmYTVlYWRiNjUyY2YzZS90YWJsZTo5NTk5NjRhNjdkMDI0YzM0ODMxMmU5ZTE2ODc4ZjcxMC90YWJsZXJhbmdlOjk1OTk2NGE2N2QwMjRjMzQ4MzEyZTllMTY4NzhmNzEwXzE1LTMtMS0xLTA_31d616ac-5d98-43d8-a2a1-2f9065555100">124</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other Obligations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2e87824102b34590a0208cc7da91b5f5_I20210630" decimals="-6" name="us-gaap:OtherBorrowings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMjQvZnJhZzpkMGRmMDA1NjdlMmI0ZWVjOTNmYTVlYWRiNjUyY2YzZS90YWJsZTo5NTk5NjRhNjdkMDI0YzM0ODMxMmU5ZTE2ODc4ZjcxMC90YWJsZXJhbmdlOjk1OTk2NGE2N2QwMjRjMzQ4MzEyZTllMTY4NzhmNzEwXzE2LTEtMS0xLTA_8f6fc2f8-e7ac-4e7b-8702-d84d9088c767">67</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i299cea70f47b4fbe96772aaa8cc00b79_I20200630" decimals="-6" name="us-gaap:OtherBorrowings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMjQvZnJhZzpkMGRmMDA1NjdlMmI0ZWVjOTNmYTVlYWRiNjUyY2YzZS90YWJsZTo5NTk5NjRhNjdkMDI0YzM0ODMxMmU5ZTE2ODc4ZjcxMC90YWJsZXJhbmdlOjk1OTk2NGE2N2QwMjRjMzQ4MzEyZTllMTY4NzhmNzEwXzE2LTMtMS0xLTA_1521b0bb-ce0f-4af0-a5ab-8db70dd52412">35</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2e87824102b34590a0208cc7da91b5f5_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DebtAndCapitalLeaseObligations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMjQvZnJhZzpkMGRmMDA1NjdlMmI0ZWVjOTNmYTVlYWRiNjUyY2YzZS90YWJsZTo5NTk5NjRhNjdkMDI0YzM0ODMxMmU5ZTE2ODc4ZjcxMC90YWJsZXJhbmdlOjk1OTk2NGE2N2QwMjRjMzQ4MzEyZTllMTY4NzhmNzEwXzE3LTEtMS0xLTA_1e151989-4337-40de-b477-8794bc06d432">6,236</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i299cea70f47b4fbe96772aaa8cc00b79_I20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DebtAndCapitalLeaseObligations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMjQvZnJhZzpkMGRmMDA1NjdlMmI0ZWVjOTNmYTVlYWRiNjUyY2YzZS90YWJsZTo5NTk5NjRhNjdkMDI0YzM0ODMxMmU5ZTE2ODc4ZjcxMC90YWJsZXJhbmdlOjk1OTk2NGE2N2QwMjRjMzQ4MzEyZTllMTY4NzhmNzEwXzE3LTMtMS0xLTA_a7e9f413-a325-4084-a5e3-a4424c47f56a">6,775</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Less: current portion of long-term obligations and other short-term borrowings</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2e87824102b34590a0208cc7da91b5f5_I20210630" decimals="-6" name="us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMjQvZnJhZzpkMGRmMDA1NjdlMmI0ZWVjOTNmYTVlYWRiNjUyY2YzZS90YWJsZTo5NTk5NjRhNjdkMDI0YzM0ODMxMmU5ZTE2ODc4ZjcxMC90YWJsZXJhbmdlOjk1OTk2NGE2N2QwMjRjMzQ4MzEyZTllMTY4NzhmNzEwXzE4LTEtMS0xLTA_1e7f0d19-514b-482e-b932-470915a386dc">871</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i299cea70f47b4fbe96772aaa8cc00b79_I20200630" decimals="-6" name="us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMjQvZnJhZzpkMGRmMDA1NjdlMmI0ZWVjOTNmYTVlYWRiNjUyY2YzZS90YWJsZTo5NTk5NjRhNjdkMDI0YzM0ODMxMmU5ZTE2ODc4ZjcxMC90YWJsZXJhbmdlOjk1OTk2NGE2N2QwMjRjMzQ4MzEyZTllMTY4NzhmNzEwXzE4LTMtMS0xLTA_f95fe53f-ce2d-43ef-90b0-56553ba4caff">10</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;&#160;&#160;Long-term obligations, less current portion</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2e87824102b34590a0208cc7da91b5f5_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtAndCapitalLeaseObligations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMjQvZnJhZzpkMGRmMDA1NjdlMmI0ZWVjOTNmYTVlYWRiNjUyY2YzZS90YWJsZTo5NTk5NjRhNjdkMDI0YzM0ODMxMmU5ZTE2ODc4ZjcxMC90YWJsZXJhbmdlOjk1OTk2NGE2N2QwMjRjMzQ4MzEyZTllMTY4NzhmNzEwXzE5LTEtMS0xLTA_db73a7d4-45d2-4dc3-a6e6-6b40c7da2114">5,365</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i299cea70f47b4fbe96772aaa8cc00b79_I20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtAndCapitalLeaseObligations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMjQvZnJhZzpkMGRmMDA1NjdlMmI0ZWVjOTNmYTVlYWRiNjUyY2YzZS90YWJsZTo5NTk5NjRhNjdkMDI0YzM0ODMxMmU5ZTE2ODc4ZjcxMC90YWJsZXJhbmdlOjk1OTk2NGE2N2QwMjRjMzQ4MzEyZTllMTY4NzhmNzEwXzE5LTMtMS0xLTgxNjA_25ce7731-652f-4d93-be10-c7ae8bd461de">6,765</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:continuation id="i416b2cbcd1a64e58b84dc37f904baa71">(1)      Maturities are presented on a calendar year basis.</ix:continuation> </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Maturities of existing long-term obligations and other short-term borrowings for fiscal 2022 through 2026 and thereafter are as follows: $<ix:nonFraction unitRef="usd" contextRef="i2e87824102b34590a0208cc7da91b5f5_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMjQvZnJhZzpkMGRmMDA1NjdlMmI0ZWVjOTNmYTVlYWRiNjUyY2YzZS90ZXh0cmVnaW9uOmQwZGYwMDU2N2UyYjRlZWM5M2ZhNWVhZGI2NTJjZjNlXzMwMg_618abbc8-42b8-4a38-9724-45875464bc3e">872</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="i2e87824102b34590a0208cc7da91b5f5_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMjQvZnJhZzpkMGRmMDA1NjdlMmI0ZWVjOTNmYTVlYWRiNjUyY2YzZS90ZXh0cmVnaW9uOmQwZGYwMDU2N2UyYjRlZWM5M2ZhNWVhZGI2NTJjZjNlXzMwNg_e0aee49a-2a57-4cfc-b9e0-98093f29d0c9">584</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="i2e87824102b34590a0208cc7da91b5f5_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMjQvZnJhZzpkMGRmMDA1NjdlMmI0ZWVjOTNmYTVlYWRiNjUyY2YzZS90ZXh0cmVnaW9uOmQwZGYwMDU2N2UyYjRlZWM5M2ZhNWVhZGI2NTJjZjNlXzMxMA_ef3344cc-dcf1-45da-980c-6b0c863728a7">808</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="i2e87824102b34590a0208cc7da91b5f5_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMjQvZnJhZzpkMGRmMDA1NjdlMmI0ZWVjOTNmYTVlYWRiNjUyY2YzZS90ZXh0cmVnaW9uOmQwZGYwMDU2N2UyYjRlZWM5M2ZhNWVhZGI2NTJjZjNlXzMxNA_b2b9bbf8-7ef7-448a-b73e-ce718143bf00">418</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="i2e87824102b34590a0208cc7da91b5f5_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMjQvZnJhZzpkMGRmMDA1NjdlMmI0ZWVjOTNmYTVlYWRiNjUyY2YzZS90ZXh0cmVnaW9uOmQwZGYwMDU2N2UyYjRlZWM5M2ZhNWVhZGI2NTJjZjNlXzMxOA_14cf237b-8580-4119-90b3-6f5eddf27bb5">525</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i2e87824102b34590a0208cc7da91b5f5_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMjQvZnJhZzpkMGRmMDA1NjdlMmI0ZWVjOTNmYTVlYWRiNjUyY2YzZS90ZXh0cmVnaW9uOmQwZGYwMDU2N2UyYjRlZWM5M2ZhNWVhZGI2NTJjZjNlXzMyNQ_8748d49e-3801-4e38-b5d5-15c9cb1848dd">3.0</ix:nonFraction> billion.</span></div></ix:nonNumeric></div><div style="display:inline-block;max-width:3.571%;min-width:2.571%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:48.215%"><ix:continuation id="i0b9dfa93ecb048cfb5c3c23bf8f43913" continuedAt="i63a30a9767ff4be0837ea7229b832ac0"><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Long-Term Debt</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All the notes represent unsecured obligations of Cardinal Health, Inc. and rank equally in right of payment with all of our existing and future unsecured and unsubordinated indebtedness. The <ix:nonFraction unitRef="number" contextRef="ia5893ebe5da345e6a62bdc4932db4f7d_I20210630" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMjQvZnJhZzpkMGRmMDA1NjdlMmI0ZWVjOTNmYTVlYWRiNjUyY2YzZS90ZXh0cmVnaW9uOmQwZGYwMDU2N2UyYjRlZWM5M2ZhNWVhZGI2NTJjZjNlXzUzNQ_3a2beb69-dfeb-43f4-932d-4ed1029f493a">7.0</ix:nonFraction>% Debentures represent unsecured obligations of Allegiance Corporation (a wholly-owned subsidiary), which Cardinal Health, Inc. has guaranteed. None of these obligations are subject to a sinking fund and the Allegiance obligations are not redeemable prior to maturity. Interest is paid pursuant to the terms of the obligations. These notes are effectively subordinated to the liabilities of our subsidiaries, including trade payables of $<ix:nonFraction unitRef="usd" contextRef="i2e87824102b34590a0208cc7da91b5f5_I20210630" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:AccountsPayableCurrentAndNoncurrent" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMjQvZnJhZzpkMGRmMDA1NjdlMmI0ZWVjOTNmYTVlYWRiNjUyY2YzZS90ZXh0cmVnaW9uOmQwZGYwMDU2N2UyYjRlZWM5M2ZhNWVhZGI2NTJjZjNlXzI3NDg3NzkwNzcwNTg_7f6c3077-a117-4a1e-8026-c30f88767951">23.7</ix:nonFraction> billion and $<ix:nonFraction unitRef="usd" contextRef="i299cea70f47b4fbe96772aaa8cc00b79_I20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AccountsPayableCurrentAndNoncurrent" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMjQvZnJhZzpkMGRmMDA1NjdlMmI0ZWVjOTNmYTVlYWRiNjUyY2YzZS90ZXh0cmVnaW9uOmQwZGYwMDU2N2UyYjRlZWM5M2ZhNWVhZGI2NTJjZjNlXzI3NDg3NzkwNzcwNjg_f1ae863e-b41c-45e7-a77f-bc00f865cd6d">21.4</ix:nonFraction> billion at June&#160;30, 2021 and 2020, respectively.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2021, we redeemed all outstanding 3.2% Notes due June 2022 for $<ix:nonFraction unitRef="usd" contextRef="i48e47b1be977446da19d44b2c23cb1f4_D20200701-20210630" decimals="-6" format="ixt:numdotdecimal" name="cah:NotesPayableRepurchased" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMjQvZnJhZzpkMGRmMDA1NjdlMmI0ZWVjOTNmYTVlYWRiNjUyY2YzZS90ZXh0cmVnaW9uOmQwZGYwMDU2N2UyYjRlZWM5M2ZhNWVhZGI2NTJjZjNlXzEyMDk0NjI3OTEzMDY2_4a704007-8006-4f6e-b401-7b81e8ae79a5">238</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="i464045c4aa5e46c28d8ccea38aea7f82_D20210401-20210630" decimals="-6" format="ixt:numdotdecimal" name="cah:NotesPayableRepurchased" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMjQvZnJhZzpkMGRmMDA1NjdlMmI0ZWVjOTNmYTVlYWRiNjUyY2YzZS90ZXh0cmVnaW9uOmQwZGYwMDU2N2UyYjRlZWM5M2ZhNWVhZGI2NTJjZjNlXzQ5NDc4MDIzMzA3NjA_7d4a13de-81bb-4e91-8179-a6d8a052c642">262</ix:nonFraction>&#160;million aggregate principle amount of 2.616% Notes due June 2022 at a redemption price equal to 100% of the principal amount and accrued but unpaid interest, plus the make-whole premium applicable to the notes. In connection with these redemptions, we recorded a $<ix:nonFraction unitRef="usd" contextRef="ib3a5af086f334f83b59a840d35a3a24d_D20200701-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMjQvZnJhZzpkMGRmMDA1NjdlMmI0ZWVjOTNmYTVlYWRiNjUyY2YzZS90ZXh0cmVnaW9uOmQwZGYwMDU2N2UyYjRlZWM5M2ZhNWVhZGI2NTJjZjNlXzQ5NDc4MDIzMzE5NzA_8f13fc13-ebb7-4bcf-8c86-071b2626463a">13</ix:nonFraction>&#160;million loss on early extinguishment of debt. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During fiscal 2021, we also early repurchased $<ix:nonFraction unitRef="usd" contextRef="i17d91fe6344242d2bf1252b509c16031_D20200701-20210630" decimals="-6" format="ixt:numdotdecimal" name="cah:NotesPayableRepurchased" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMjQvZnJhZzpkMGRmMDA1NjdlMmI0ZWVjOTNmYTVlYWRiNjUyY2YzZS90ZXh0cmVnaW9uOmQwZGYwMDU2N2UyYjRlZWM5M2ZhNWVhZGI2NTJjZjNlXzQ5NDc4MDIzMzExMjk_bf801710-2bda-4f47-a75e-eb706840ee2f">40</ix:nonFraction> million of the Floating Rate Notes due 2022</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and $<ix:nonFraction unitRef="usd" contextRef="i7837defbe13947a6aa80a30d88599754_D20200701-20210630" decimals="-6" format="ixt:numdotdecimal" name="cah:NotesPayableRepurchased" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMjQvZnJhZzpkMGRmMDA1NjdlMmI0ZWVjOTNmYTVlYWRiNjUyY2YzZS90ZXh0cmVnaW9uOmQwZGYwMDU2N2UyYjRlZWM5M2ZhNWVhZGI2NTJjZjNlXzQ5NDc4MDIzMzI0Njg_9d8ab84a-dd9e-4ba8-a6ad-65894eb5c1d7">2</ix:nonFraction> million of the 2.616% Notes due 2022 with available cash. In connection with the early debt repurchases, we recorded a $<ix:nonFraction unitRef="usd" contextRef="ie2038f77bf814473a8b5a3994d58411e_D20200701-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMjQvZnJhZzpkMGRmMDA1NjdlMmI0ZWVjOTNmYTVlYWRiNjUyY2YzZS90ZXh0cmVnaW9uOmQwZGYwMDU2N2UyYjRlZWM5M2ZhNWVhZGI2NTJjZjNlXzQ5NDc4MDIzMzE3NDk_91e1777d-58eb-42a2-a2a5-26166e8c08ac">1</ix:nonFraction>&#160;million</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">loss on early extinguishment of debt.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During fiscal 2020, we redeemed $<ix:nonFraction unitRef="usd" contextRef="id79807de4e034b8ab663df3b706eba8a_D20190701-20200630" decimals="-6" format="ixt:numdotdecimal" name="cah:NotesPayableRepurchased" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMjQvZnJhZzpkMGRmMDA1NjdlMmI0ZWVjOTNmYTVlYWRiNjUyY2YzZS90ZXh0cmVnaW9uOmQwZGYwMDU2N2UyYjRlZWM5M2ZhNWVhZGI2NTJjZjNlXzEwMDM_59b8c578-c89f-4b36-8e46-574a41000818">500</ix:nonFraction> million aggregate principle amount of 4.625% Notes due December 2020 at a redemption price equal to 100% of the principal amount and accrued but unpaid interest, plus the make-whole premium applicable to the notes. In connection with the redemption, we recorded a $<ix:nonFraction unitRef="usd" contextRef="id79807de4e034b8ab663df3b706eba8a_D20190701-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMjQvZnJhZzpkMGRmMDA1NjdlMmI0ZWVjOTNmYTVlYWRiNjUyY2YzZS90ZXh0cmVnaW9uOmQwZGYwMDU2N2UyYjRlZWM5M2ZhNWVhZGI2NTJjZjNlXzEyNjI_0e31c00e-a4b2-4822-aecd-e21c00797d36">7</ix:nonFraction> million loss on early extinguishment of debt. We also early repurchased&#160;$<ix:nonFraction unitRef="usd" contextRef="i1f2e8fb9ffc746439d8749702977bc40_D20190701-20200630" decimals="-6" format="ixt:numdotdecimal" name="cah:NotesPayableRepurchased" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMjQvZnJhZzpkMGRmMDA1NjdlMmI0ZWVjOTNmYTVlYWRiNjUyY2YzZS90ZXh0cmVnaW9uOmQwZGYwMDU2N2UyYjRlZWM5M2ZhNWVhZGI2NTJjZjNlXzQ5NDc4MDIzMzEyOTI_502488df-2eb5-45d4-a677-daebf4f3567a">247</ix:nonFraction>&#160;million&#160;of the&#160;2.616%&#160;Notes due 2022,&#160;$<ix:nonFraction unitRef="usd" contextRef="i97442363603544a4af2ceec2ab7ca6b2_D20190701-20200630" decimals="-6" format="ixt:numdotdecimal" name="cah:NotesPayableRepurchased" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMjQvZnJhZzpkMGRmMDA1NjdlMmI0ZWVjOTNmYTVlYWRiNjUyY2YzZS90ZXh0cmVnaW9uOmQwZGYwMDU2N2UyYjRlZWM5M2ZhNWVhZGI2NTJjZjNlXzQ5NDc4MDIzMzEzMDA_08ab1beb-c5c0-45c8-814b-7fe08b628bfa">11</ix:nonFraction>&#160;million&#160;of the&#160;3.2% Notes due 2022,&#160;$<ix:nonFraction unitRef="usd" contextRef="i4638eb18574e4673aa4ca0d635ff8fed_D20190701-20200630" decimals="-6" format="ixt:numdotdecimal" name="cah:NotesPayableRepurchased" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMjQvZnJhZzpkMGRmMDA1NjdlMmI0ZWVjOTNmYTVlYWRiNjUyY2YzZS90ZXh0cmVnaW9uOmQwZGYwMDU2N2UyYjRlZWM5M2ZhNWVhZGI2NTJjZjNlXzQ5NDc4MDIzMzEzMDc_4e786a81-9e3c-4f69-9a6b-53f3619df879">20</ix:nonFraction>&#160;million&#160;of the&#160;Floating Rate Notes due 2022, $<ix:nonFraction unitRef="usd" contextRef="i230f0206f083410f87c775c9c1709681_D20190701-20200630" decimals="-6" format="ixt:numdotdecimal" name="cah:NotesPayableRepurchased" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMjQvZnJhZzpkMGRmMDA1NjdlMmI0ZWVjOTNmYTVlYWRiNjUyY2YzZS90ZXh0cmVnaW9uOmQwZGYwMDU2N2UyYjRlZWM5M2ZhNWVhZGI2NTJjZjNlXzQ5NDc4MDIzMzEzMTY_e954c12b-8750-45b0-8401-1456d84ffb0f">104</ix:nonFraction>&#160;million&#160;of the&#160;3.41% Notes due 2027,&#160;$<ix:nonFraction unitRef="usd" contextRef="id913564d8b3443a8af2a95fc5de03be7_D20190701-20200630" decimals="-6" format="ixt:numdotdecimal" name="cah:NotesPayableRepurchased" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMjQvZnJhZzpkMGRmMDA1NjdlMmI0ZWVjOTNmYTVlYWRiNjUyY2YzZS90ZXh0cmVnaW9uOmQwZGYwMDU2N2UyYjRlZWM5M2ZhNWVhZGI2NTJjZjNlXzQ5NDc4MDIzMzEzMjA_692d2266-9485-473e-82e0-9e9bcebff386">6</ix:nonFraction>&#160;million&#160;of the&#160;4.6% Notes due 2043,&#160;$<ix:nonFraction unitRef="usd" contextRef="ibe4534f68d8a40109be5a39a86e86f4f_D20190701-20200630" decimals="-6" format="ixt:numdotdecimal" name="cah:NotesPayableRepurchased" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMjQvZnJhZzpkMGRmMDA1NjdlMmI0ZWVjOTNmYTVlYWRiNjUyY2YzZS90ZXh0cmVnaW9uOmQwZGYwMDU2N2UyYjRlZWM5M2ZhNWVhZGI2NTJjZjNlXzQ5NDc4MDIzMzEzMjQ_326a82ee-2280-4cac-87cd-ee6bea49217f">5</ix:nonFraction>&#160;million&#160;of the&#160;4.9% Notes due 2045, and&#160;$<ix:nonFraction unitRef="usd" contextRef="iab9dfb1f8e404e5d8f9dbf5632e6590f_D20190701-20200630" decimals="-6" format="ixt:numdotdecimal" name="cah:NotesPayableRepurchased" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMjQvZnJhZzpkMGRmMDA1NjdlMmI0ZWVjOTNmYTVlYWRiNjUyY2YzZS90ZXh0cmVnaW9uOmQwZGYwMDU2N2UyYjRlZWM5M2ZhNWVhZGI2NTJjZjNlXzQ5NDc4MDIzMzEzMzc_557ece6b-57b2-440b-8b98-24dc3ed55844">35</ix:nonFraction>&#160;million&#160;of the&#160;4.368% Notes due 2047. In connection with the early debt repurchases, we recognized a&#160;$<ix:nonFraction unitRef="usd" contextRef="ifd0a92fc87ae4632bce31919cea5ac88_D20190701-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMjQvZnJhZzpkMGRmMDA1NjdlMmI0ZWVjOTNmYTVlYWRiNjUyY2YzZS90ZXh0cmVnaW9uOmQwZGYwMDU2N2UyYjRlZWM5M2ZhNWVhZGI2NTJjZjNlXzE2NDk_b3891642-b132-472a-9e45-fd9ac5c0ff96">9</ix:nonFraction> million&#160;loss on early extinguishment of debt. We also repaid the full principal of the $<ix:nonFraction unitRef="usd" contextRef="i569c9ebb1c9744c6a46c4bedf478f497_D20190701-20200630" decimals="-6" format="ixt:numdotdecimal" name="cah:NotesPayableRepurchased" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMjQvZnJhZzpkMGRmMDA1NjdlMmI0ZWVjOTNmYTVlYWRiNjUyY2YzZS90ZXh0cmVnaW9uOmQwZGYwMDU2N2UyYjRlZWM5M2ZhNWVhZGI2NTJjZjNlXzQ5NDc4MDIzMzE0ODE_d97e2bc2-ae70-4e50-89fe-8c72907b30e0">450</ix:nonFraction>&#160;million 2.4% Notes due 2019 as they became due. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During fiscal 2019, we repurchased $<ix:nonFraction unitRef="usd" contextRef="i9514a111b1dd465cb9bd660db2bf2bda_D20180701-20190630" decimals="-6" format="ixt:numdotdecimal" name="cah:NotesPayableRepurchased" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMjQvZnJhZzpkMGRmMDA1NjdlMmI0ZWVjOTNmYTVlYWRiNjUyY2YzZS90ZXh0cmVnaW9uOmQwZGYwMDU2N2UyYjRlZWM5M2ZhNWVhZGI2NTJjZjNlXzE5MTU_32820777-866f-478b-b61a-721bb41a3fc0">67</ix:nonFraction> million of the 2.616% Notes due 2022, $<ix:nonFraction unitRef="usd" contextRef="i211ab1e401334bc28102d404a589f244_D20180701-20190630" decimals="-6" format="ixt:numdotdecimal" name="cah:NotesPayableRepurchased" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMjQvZnJhZzpkMGRmMDA1NjdlMmI0ZWVjOTNmYTVlYWRiNjUyY2YzZS90ZXh0cmVnaW9uOmQwZGYwMDU2N2UyYjRlZWM5M2ZhNWVhZGI2NTJjZjNlXzE5NDg_053017cf-46b1-4491-9e8d-0a6b584e203b">1</ix:nonFraction> million of the 3.2% Notes due 2022, <ix:nonFraction unitRef="usd" contextRef="i6c59631d68f748078379fec096820b35_D20180701-20190630" decimals="-6" format="ixt:numdotdecimal" name="cah:NotesPayableRepurchased" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMjQvZnJhZzpkMGRmMDA1NjdlMmI0ZWVjOTNmYTVlYWRiNjUyY2YzZS90ZXh0cmVnaW9uOmQwZGYwMDU2N2UyYjRlZWM5M2ZhNWVhZGI2NTJjZjNlXzE5Nzk_c23c3e56-8ba6-49e8-8c3e-84de906c2221">8</ix:nonFraction> million of the Floating Rate Notes due 2022, and $<ix:nonFraction unitRef="usd" contextRef="i97bd654b86404619830471d41f60a11d_D20180701-20190630" decimals="-6" format="ixt:numdotdecimal" name="cah:NotesPayableRepurchased" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMjQvZnJhZzpkMGRmMDA1NjdlMmI0ZWVjOTNmYTVlYWRiNjUyY2YzZS90ZXh0cmVnaW9uOmQwZGYwMDU2N2UyYjRlZWM5M2ZhNWVhZGI2NTJjZjNlXzIwMjM_c0142512-e270-4ea3-9aac-7f6453d69323">24</ix:nonFraction> million of the 3.41% Notes due 2027 for a total of $<ix:nonFraction unitRef="usd" contextRef="i00a6d666bf604826b24e68ddbd63eac4_D20180701-20190630" decimals="-6" format="ixt:numdotdecimal" name="cah:NotesPayableRepurchased" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMjQvZnJhZzpkMGRmMDA1NjdlMmI0ZWVjOTNmYTVlYWRiNjUyY2YzZS90ZXh0cmVnaW9uOmQwZGYwMDU2N2UyYjRlZWM5M2ZhNWVhZGI2NTJjZjNlXzIwNjk_3c98473a-a6f9-4c1f-94bd-bc5b7d0c87fe">100</ix:nonFraction> million. The loss on early extinguishment of debt in connection with these early repurchases was immaterial. We also repaid the full principal of the $<ix:nonFraction unitRef="usd" contextRef="i09916dad25ba4c3c8af380f01d737407_D20180701-20190630" decimals="-6" format="ixt:numdotdecimal" name="cah:NotesPayableRepurchased" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMjQvZnJhZzpkMGRmMDA1NjdlMmI0ZWVjOTNmYTVlYWRiNjUyY2YzZS90ZXh0cmVnaW9uOmQwZGYwMDU2N2UyYjRlZWM5M2ZhNWVhZGI2NTJjZjNlXzIyNDU_354dc62f-27c9-46e4-8796-8bfaaf876408">1.0</ix:nonFraction> billion 1.948% Notes due 2019 as they became due.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The redemptions and repurchases were paid for with available cash and other short-term borrowings.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 13, 2021, we announced our intention to early redeem all remaining outstanding 2.616% Notes due June 2022 on September 15, 2021 at an expected redemption price equal to 100% of the principal amount and accrued but unpaid interest, plus the make-whole premium applicable to the notes.</span></div></ix:continuation></div></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:3pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.222%"><tr><td style="width:1.0%"></td><td style="width:32.133%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.433%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.134%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">72</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardinal Health </span><span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">| </span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2021 Form 10-K</span></div></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div style="margin-bottom:3pt"><span><br/></span></div><div style="margin-bottom:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:24.720%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:50.989%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.991%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#e41f35;border-bottom:1pt solid #e41f35;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Notes to Financial Statements</span></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span><br/></span></div></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:48.214%"><ix:continuation id="i63a30a9767ff4be0837ea7229b832ac0"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If we undergo a change of control, as defined in the notes, and if the notes receive specified ratings below investment grade by each of Standard &amp; Poors Ratings Services, Moody&#8217;s Investors Services and Fitch Ratings, any holder of the notes, excluding the debentures, can require with respect to the notes owned by such holder, or we can offer, to repurchase the notes at <ix:nonFraction unitRef="number" contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630" decimals="INF" name="cah:OfferAsPercentageOfPrincipalAmount" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMjQvZnJhZzpkMGRmMDA1NjdlMmI0ZWVjOTNmYTVlYWRiNjUyY2YzZS90ZXh0cmVnaW9uOmQwZGYwMDU2N2UyYjRlZWM5M2ZhNWVhZGI2NTJjZjNlXzI3NzU_c18472bb-6c80-4144-ac80-ff6fea11c1a1">101</ix:nonFraction>% of the principal amount plus accrued and unpaid interest.</span></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Other Financing Arrangements</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to cash and equivalents and operating cash flow, other sources of liquidity include a&#160;$<ix:nonFraction unitRef="usd" contextRef="i9820f36cdd3f46ff836bba721b3236ec_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMjQvZnJhZzpkMGRmMDA1NjdlMmI0ZWVjOTNmYTVlYWRiNjUyY2YzZS90ZXh0cmVnaW9uOmQwZGYwMDU2N2UyYjRlZWM5M2ZhNWVhZGI2NTJjZjNlXzI5NjM_387182db-3b3b-4590-906f-151d66e2e24f">2.0</ix:nonFraction> billion&#160;commercial paper program backed by a $<ix:nonFraction unitRef="usd" contextRef="i0c9f608d73754d42bf91b8f887a3643b_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMjQvZnJhZzpkMGRmMDA1NjdlMmI0ZWVjOTNmYTVlYWRiNjUyY2YzZS90ZXh0cmVnaW9uOmQwZGYwMDU2N2UyYjRlZWM5M2ZhNWVhZGI2NTJjZjNlXzMwMDM_2473d512-ea23-4f64-ae12-b603b99ff969">2.0</ix:nonFraction> billion&#160;revolving credit facility. We also have a&#160;$<ix:nonFraction unitRef="usd" contextRef="i74a8ee2e9e1b481491947bdcd81fe93b_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMjQvZnJhZzpkMGRmMDA1NjdlMmI0ZWVjOTNmYTVlYWRiNjUyY2YzZS90ZXh0cmVnaW9uOmQwZGYwMDU2N2UyYjRlZWM5M2ZhNWVhZGI2NTJjZjNlXzMwNDg_390ed2fa-5f67-45ce-9350-cc9952e9e964">1.0</ix:nonFraction> billion&#160;committed receivables sales facility.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In September 2019, we renewed our committed receivables sales facility program through Cardinal Health Funding, LLC (&#8220;CHF&#8221;) through September 30, 2022. CHF was organized for</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the sole purpose of buying receivables and selling undivided interests in those receivables to third-party purchasers. Although consolidated with Cardinal Health, Inc. in accordance with GAAP, CHF is a separate legal entity from Cardinal Health, Inc. and from our subsidiary that sells receivables to CHF. CHF is designed to be a special purpose, bankruptcy-remote entity whose assets are available solely to satisfy the claims of its creditors. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our revolving credit and committed receivables sales facilities require us to maintain a consolidated net leverage ratio of no more than 3.75-to-1. As of June&#160;30, 2021, we were in compliance with this financial covenant.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At June&#160;30, 2021 and 2020, we had <ix:nonFraction unitRef="usd" contextRef="i2085dadd50db412cae65d5356e28138c_I20210630" decimals="-6" format="ixt-sec:numwordsen" name="us-gaap:OtherShortTermBorrowings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMjQvZnJhZzpkMGRmMDA1NjdlMmI0ZWVjOTNmYTVlYWRiNjUyY2YzZS90ZXh0cmVnaW9uOmQwZGYwMDU2N2UyYjRlZWM5M2ZhNWVhZGI2NTJjZjNlXzQ5NDc4MDIzMzI3MzA_866672f8-6c76-4207-bdaf-c096c398ad72"><ix:nonFraction unitRef="usd" contextRef="i6f57fbcd87fd4740ba92695d57c1ffe0_I20200630" decimals="-6" format="ixt-sec:numwordsen" name="us-gaap:OtherShortTermBorrowings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMjQvZnJhZzpkMGRmMDA1NjdlMmI0ZWVjOTNmYTVlYWRiNjUyY2YzZS90ZXh0cmVnaW9uOmQwZGYwMDU2N2UyYjRlZWM5M2ZhNWVhZGI2NTJjZjNlXzQ5NDc4MDIzMzI3MzA_cddb899b-692e-4a96-95d0-92c8018c77d3">no</ix:nonFraction></ix:nonFraction> amounts outstanding under the revolving credit facility; however, availability was reduced by outstanding letters of credit of $<ix:nonFraction unitRef="usd" contextRef="i2085dadd50db412cae65d5356e28138c_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LineOfCredit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMjQvZnJhZzpkMGRmMDA1NjdlMmI0ZWVjOTNmYTVlYWRiNjUyY2YzZS90ZXh0cmVnaW9uOmQwZGYwMDU2N2UyYjRlZWM5M2ZhNWVhZGI2NTJjZjNlXzQyNDg_80f97bfd-2823-4af7-ba77-5e03fcb1009a">1</ix:nonFraction> million at both June&#160;30, 2021 and 2020.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under our committed receivables sales facility program, we had a maximum amount outstanding of $<ix:nonFraction unitRef="usd" contextRef="ide18edefc53a43f1823ee90886c4b766_D20200701-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LineOfCreditFacilityMaximumAmountOutstandingDuringPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMjQvZnJhZzpkMGRmMDA1NjdlMmI0ZWVjOTNmYTVlYWRiNjUyY2YzZS90ZXh0cmVnaW9uOmQwZGYwMDU2N2UyYjRlZWM5M2ZhNWVhZGI2NTJjZjNlXzQzODM_f391ceb3-b531-4408-80f7-596e0666d38e">200</ix:nonFraction> million and an immaterial daily amount outstanding during fiscal 2021. We had <ix:nonFraction unitRef="usd" contextRef="i947b0014f3864d1bbe6799521fc7f7ec_I20200630" decimals="-6" format="ixt-sec:numwordsen" name="us-gaap:OtherShortTermBorrowings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMjQvZnJhZzpkMGRmMDA1NjdlMmI0ZWVjOTNmYTVlYWRiNjUyY2YzZS90ZXh0cmVnaW9uOmQwZGYwMDU2N2UyYjRlZWM5M2ZhNWVhZGI2NTJjZjNlXzQ5NDc4MDIzMzI3MjE_1ae7319c-6f8f-4a04-ac5b-3295833aa66d"><ix:nonFraction unitRef="usd" contextRef="ic2fe7a908c6f4f61af7f7d8c6c00e82b_I20210630" decimals="-6" format="ixt-sec:numwordsen" name="us-gaap:OtherShortTermBorrowings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMjQvZnJhZzpkMGRmMDA1NjdlMmI0ZWVjOTNmYTVlYWRiNjUyY2YzZS90ZXh0cmVnaW9uOmQwZGYwMDU2N2UyYjRlZWM5M2ZhNWVhZGI2NTJjZjNlXzQ5NDc4MDIzMzI3MjE_f36bc104-de08-4c39-8571-c802d6bf3698">no</ix:nonFraction></ix:nonFraction> amounts outstanding as of June&#160;30, 2021 under the committed receivables sales facility program; however, availability was reduced by outstanding standby letters of credit of $<ix:nonFraction unitRef="usd" contextRef="i28f8f11500fa40cba044c5da762695f8_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LineOfCredit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMjQvZnJhZzpkMGRmMDA1NjdlMmI0ZWVjOTNmYTVlYWRiNjUyY2YzZS90ZXh0cmVnaW9uOmQwZGYwMDU2N2UyYjRlZWM5M2ZhNWVhZGI2NTJjZjNlXzQ2MTk_b6b794c2-366d-4345-a5c5-844224fa58dd">31</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i12ab314ad2e0406699d32582ff5dabfd_I20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LineOfCredit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMjQvZnJhZzpkMGRmMDA1NjdlMmI0ZWVjOTNmYTVlYWRiNjUyY2YzZS90ZXh0cmVnaW9uOmQwZGYwMDU2N2UyYjRlZWM5M2ZhNWVhZGI2NTJjZjNlXzQ2MjY_256ab8c2-26e7-490a-bbd8-46aad3fa6e77">29</ix:nonFraction> million at June&#160;30, 2021 and 2020, respectively. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We had <ix:nonFraction unitRef="usd" contextRef="i944f1f41fd954de4b4dc8f6b5c5c2db1_I20200630" decimals="-6" format="ixt-sec:numwordsen" name="us-gaap:OtherShortTermBorrowings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMjQvZnJhZzpkMGRmMDA1NjdlMmI0ZWVjOTNmYTVlYWRiNjUyY2YzZS90ZXh0cmVnaW9uOmQwZGYwMDU2N2UyYjRlZWM5M2ZhNWVhZGI2NTJjZjNlXzQ5NDc4MDIzMzI3MTI_328cca0a-e0d0-48c2-9b21-f06d8dc3df10"><ix:nonFraction unitRef="usd" contextRef="i9820f36cdd3f46ff836bba721b3236ec_I20210630" decimals="-6" format="ixt-sec:numwordsen" name="us-gaap:OtherShortTermBorrowings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMjQvZnJhZzpkMGRmMDA1NjdlMmI0ZWVjOTNmYTVlYWRiNjUyY2YzZS90ZXh0cmVnaW9uOmQwZGYwMDU2N2UyYjRlZWM5M2ZhNWVhZGI2NTJjZjNlXzQ5NDc4MDIzMzI3MTI_e967a81f-0548-48c7-a533-9592843d326b">no</ix:nonFraction></ix:nonFraction> amounts outstanding under the commercial paper program as of June&#160;30, 2021 and 2020. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also maintain other short-term credit facilities and an unsecured line of credit that allowed for borrowings up to $<ix:nonFraction unitRef="usd" contextRef="id267a8471edd4bc9bf4d5efa60da5922_I20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMjQvZnJhZzpkMGRmMDA1NjdlMmI0ZWVjOTNmYTVlYWRiNjUyY2YzZS90ZXh0cmVnaW9uOmQwZGYwMDU2N2UyYjRlZWM5M2ZhNWVhZGI2NTJjZjNlXzUwMDc_6d256de8-af92-4df2-8edd-e3d92653887f">6</ix:nonFraction> million at both June&#160;30, 2021 and 2020. The $<ix:nonFraction unitRef="usd" contextRef="i2e87824102b34590a0208cc7da91b5f5_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OtherBorrowings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMjQvZnJhZzpkMGRmMDA1NjdlMmI0ZWVjOTNmYTVlYWRiNjUyY2YzZS90ZXh0cmVnaW9uOmQwZGYwMDU2N2UyYjRlZWM5M2ZhNWVhZGI2NTJjZjNlXzUwNDI_8f6fc2f8-e7ac-4e7b-8702-d84d9088c767">67</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i299cea70f47b4fbe96772aaa8cc00b79_I20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OtherBorrowings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMjQvZnJhZzpkMGRmMDA1NjdlMmI0ZWVjOTNmYTVlYWRiNjUyY2YzZS90ZXh0cmVnaW9uOmQwZGYwMDU2N2UyYjRlZWM5M2ZhNWVhZGI2NTJjZjNlXzUwNDk_1521b0bb-ce0f-4af0-a5ab-8db70dd52412">35</ix:nonFraction> million balance of other obligations at June&#160;30, 2021 and 2020, respectively, consisted of finance leases and short-term borrowings.</span></div></ix:continuation><div style="margin-bottom:3pt;text-align:justify"><span><br/></span></div></div><div style="display:inline-block;max-width:3.571%;min-width:2.571%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:48.215%"></div></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:32.135%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.428%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.137%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardinal Health </span><span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">|</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> Fiscal 2021 Form 10-K</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">73</span></div></td></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span><br/></span></div></div></div><div id="i4f0ec56b9c604f1782a65ea4a19c284d_130"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:3pt"><span><br/></span></div><div style="margin-bottom:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:24.682%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:50.911%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.107%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#e41f35;border-bottom:1pt solid #e41f35;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Notes to Financial Statements</span></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:0 1pt"></td></tr></table></div></div><div style="width:100.000%"><ix:nonNumeric contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzAvZnJhZzoxYzE1YWJmYzUxMTY0ZGUwODljYmRhNDgyYjQwNWYzYi90ZXh0cmVnaW9uOjFjMTVhYmZjNTExNjRkZTA4OWNiZGE0ODJiNDA1ZjNiXzE2MzY2_1ec74220-222b-412f-8f4f-c1e8cc6f7766" continuedAt="i4a46cc6596df4c3a99c6c0897fbc4119" escape="true"><div style="display:inline-block;vertical-align:top;width:48.214%"><div style="margin-bottom:6pt;text-align:justify"><span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:13pt;font-weight:700;line-height:120%">7. Commitments, Contingent Liabilities and Litigation </span></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Commitments</span></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Generic Sourcing Venture with CVS Health Corporation ("CVS Health")</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In July 2014, we established Red Oak Sourcing, LLC ("Red Oak Sourcing"), a U.S.-based generic pharmaceutical sourcing venture with CVS Health for an initial term of 10 years. Red Oak Sourcing negotiates generic pharmaceutical supply contracts on behalf of its participants. In August 2021, we amended our agreement to extend the term through June 2029. We are required to make quarterly payments to CVS Health for the term of the arrangement. These payments are included as purchase obligations and other payments in the Contractual Obligations section of MD&amp;A. </span></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Contingencies</span></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:120%">New York Opioid Stewardship Act</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In April 2018, the State of New York passed a budget which included the Opioid Stewardship Act (the "OSA"). The OSA created an aggregate $<ix:nonFraction unitRef="usd" contextRef="i47649611840740c9a47bac619a623132_I20210630" decimals="-6" format="ixt:numdotdecimal" name="cah:AggregateAnnualAssessment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzAvZnJhZzoxYzE1YWJmYzUxMTY0ZGUwODljYmRhNDgyYjQwNWYzYi90ZXh0cmVnaW9uOjFjMTVhYmZjNTExNjRkZTA4OWNiZGE0ODJiNDA1ZjNiXzI3NDg3NzkxMjE2MDk_26c31dc6-91cd-4f36-82f3-3a7ba0c69ac1">100</ix:nonFraction>&#160;million annual assessment on all manufacturers and distributors licensed to sell or distribute opioids in New York. Under the OSA, each licensed manufacturer and distributor would be required to pay a portion of the assessment based on its share of the total morphine milligram equivalents sold or distributed in New York during the applicable calendar year, beginning in 2017.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The constitutionality of portions of the OSA has been challenged in court. In December 2018, the OSA was ruled unconstitutional by the U.S. District Court for the Southern District of New York. Subsequently, New York passed a new statute that modified the assessment going forward and limited the OSA to two years (2017 and 2018). The U.S. Court of Appeals for the Second Circuit reversed the district court's decision on procedural grounds. In February 2021, the Second Circuit stayed the effect of the ruling pending a petition to the U.S. Supreme Court to review the Second Circuit's opinion. If the U.S. Supreme Court declines to take the case, or if it ultimately upholds the Second Circuit's ruling, New York State would likely seek to collect amounts allegedly owed under the OSA. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We accrue contingencies if it is probable that a liability has been incurred and the amount can be estimated. Because of the Second Circuit ruling, we recorded an aggregate accrual of $<ix:nonFraction unitRef="usd" contextRef="i457f80b8744948758645272a98e06c10_D20200701-20210630" decimals="-6" format="ixt:numdotdecimal" name="cah:EstimatedLiabilityForNewYorkOpioidStewardshipAct" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzAvZnJhZzoxYzE1YWJmYzUxMTY0ZGUwODljYmRhNDgyYjQwNWYzYi90ZXh0cmVnaW9uOjFjMTVhYmZjNTExNjRkZTA4OWNiZGE0ODJiNDA1ZjNiXzI3NDg3NzkxMjE2MTY_bdd45fc0-f43f-4ecc-ab36-9831321fbbc8">41</ix:nonFraction>&#160;million for calendar years 2017 and 2018 in the fiscal year ended June&#160;30, 2021 based on the probable estimated payment amount, which is our best estimate of the OSA payments probable at June 30, 2021.</span></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Legal Proceedings</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We become involved from time to time in disputes, litigation and regulatory matters.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, we determine that products we source, manufacture or market do not meet our specifications, regulatory requirements, or published standards. When we or a regulatory agency identify a potential quality or regulatory issue, we investigate and take appropriate corrective action. Such actions </span></div></div><div style="display:inline-block;max-width:3.571%;min-width:2.571%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:48.215%"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">have led to product recalls, costs to repair or replace affected products, temporary interruptions in product sales, product liability claims and lawsuits and can lead to action by regulators. Even absent an identified regulatory or quality issue or product recall, we can become subject to product liability claims and lawsuits.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, we become aware through employees, internal audits or other parties of possible product quality, regulatory or compliance matters, such as complaints or concerns relating to accounting, internal accounting controls, financial reporting, auditing, or other ethical matters or relating to compliance with laws such as healthcare fraud and abuse, anti-corruption or anti-bribery laws. When we become aware of such possible compliance matters, we investigate internally and take appropriate corrective action. In addition, from time to time, we receive subpoenas or requests for information from various federal or state agencies relating to our business or to the business of a customer, supplier or other industry participants. Internal investigations, subpoenas or requests for information could directly or indirectly lead to the assertion of claims or the commencement of legal proceedings against us or result in sanctions.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have been named from time to time in qui tam actions initiated by private third parties. In such actions, the private parties purport to act on behalf of federal or state governments, allege that false claims have been submitted for payment by the government and may receive an award if their claims are successful. After a private party has filed a qui tam action, the government must investigate the private party's claim and determine whether to intervene in and take control over the litigation. These actions may remain under seal while the government makes this determination. If the government declines to intervene, the private party may nonetheless continue to pursue the litigation on his or her own purporting to act on behalf of the government.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We accrue for contingencies related to disputes, litigation and regulatory matters if it is probable that a liability has been incurred and the amount of the loss can be reasonably estimated. Because these matters are inherently unpredictable and unfavorable developments or resolutions can occur, assessing contingencies is highly subjective and requires judgments about future events. We regularly review contingencies to determine whether our accruals and related disclosures are adequate. The amount of ultimate loss may differ from these estimates.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recognize income from the favorable outcome of litigation when we receive the associated cash or assets.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recognize estimated loss contingencies for certain litigation and regulatory matters and income from favorable resolution of litigation in litigation (recoveries)/charges in our consolidated statements of earnings/(loss).</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Opioid Lawsuits and Investigations</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pharmaceutical wholesale distributors, including us, have been named as defendants in approximately <ix:nonFraction unitRef="number" contextRef="i5aad644cd5714c75b9ef8163bf7a97f7_I20210810" decimals="0" format="ixt:numdotdecimal" name="cah:LossContingencyLawsuitsNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzAvZnJhZzoxYzE1YWJmYzUxMTY0ZGUwODljYmRhNDgyYjQwNWYzYi90ZXh0cmVnaW9uOjFjMTVhYmZjNTExNjRkZTA4OWNiZGE0ODJiNDA1ZjNiXzI3NDg3NzkxMjE2MjY_8e1ecbe7-f25e-4327-bb1b-e368f6a4cfca">3,300</ix:nonFraction> lawsuits relating to the distribution of prescription opioid pain medications. The lawsuits seek equitable relief and monetary damages based on a variety of legal theories including various common law claims, such as public nuisance, negligence and unjust enrichment as well </span></div></div></ix:nonNumeric></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:3pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.222%"><tr><td style="width:1.0%"></td><td style="width:32.133%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.433%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.134%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">74</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardinal Health </span><span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">| </span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2021 Form 10-K</span></div></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:3pt"><span><br/></span></div><div style="margin-bottom:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:24.682%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:50.911%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.107%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#e41f35;border-bottom:1pt solid #e41f35;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Notes to Financial Statements</span></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:0 1pt"></td></tr></table></div></div><div style="width:100.000%"><ix:continuation id="i4a46cc6596df4c3a99c6c0897fbc4119" continuedAt="ibe39b28b2b7c4b21a11c65f945128cb4"><div style="display:inline-block;vertical-align:top;width:48.214%"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">as violations of controlled substance laws, the Racketeer Influenced and Corrupt Organizations Act and various other statutes. These lawsuits also name pharmaceutical manufacturers, retail pharmacy chains and other entities as defendants.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">States &amp; Political Subdivisions</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Approximately <ix:nonFraction unitRef="number" contextRef="i69aa4c6826204c058cfb939b8d352e27_I20210810" decimals="0" format="ixt:numdotdecimal" name="cah:LossContingencyLawsuitsNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzAvZnJhZzoxYzE1YWJmYzUxMTY0ZGUwODljYmRhNDgyYjQwNWYzYi90ZXh0cmVnaW9uOjFjMTVhYmZjNTExNjRkZTA4OWNiZGE0ODJiNDA1ZjNiXzI3NDg3NzkxMjE2MzA_f0cbe59b-3fc7-4b9a-ac15-a1f5206fabe4">2,900</ix:nonFraction> of these lawsuits have been filed by counties, municipalities, cities and political subdivisions in various federal, state, and other courts. The vast majority of these lawsuits were filed in U.S. federal court and have been transferred for consolidated pre-trial proceedings in a Multi-District Litigation proceeding in the U.S. District Court for the Northern District of Ohio (the &#8220;MDL&#8221;).</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, <ix:nonFraction unitRef="stateag" contextRef="i5aad644cd5714c75b9ef8163bf7a97f7_I20210810" decimals="0" name="cah:NumberofStateAttorneysGeneralfilinglawsuits" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzAvZnJhZzoxYzE1YWJmYzUxMTY0ZGUwODljYmRhNDgyYjQwNWYzYi90ZXh0cmVnaW9uOjFjMTVhYmZjNTExNjRkZTA4OWNiZGE0ODJiNDA1ZjNiXzI3NDg3NzkxMjE2MzQ_b0c99c44-ee7c-40c0-8e77-b697484558e9">25</ix:nonFraction> state attorneys general have filed lawsuits against distributors, including us, in various state courts. We have also received requests, civil investigative demands, subpoenas or requests for information from additional state attorneys general offices and governmental authorities. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In October 2019, we agreed in principle to a global settlement framework with a leadership group of state attorneys general; the framework is designed to resolve pending and future opioid lawsuits and claims by states and political subdivisions, but not private plaintiffs (the "Settlement Framework"). We continued to build out the Settlement Framework and to negotiate the terms of the settlement with the leadership group and other representatives of states and political subdivisions. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In July, 2021, we announced that we and two other national distributors have negotiated a proposed settlement agreement (the &#8220;Proposed Settlement Agreement&#8221;) and settlement process that, if all conditions are satisfied, would result in the settlement of the vast majority of opioid lawsuits filed by state and local governmental entities. West Virginia subdivisions and Native American tribes are not a part of this settlement process and we have been involved in separate negotiations with these groups. The settlement process does not contemplate participation by any non-governmental or non-political entities or individuals. In connection with the negotiations of the Proposed Settlement Agreement, we and the two other national distributors entered into a settlement with the State of New York and its participating subdivisions. If the Proposed Settlement Agreement becomes effective, New York and its participating subdivisions will become a part of it. </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Proposed Settlement Agreement is subject to contingencies and will not become effective unless and until the three distributors each make separate independent determinations that (1) following a sign-on period, a sufficient number of states have agreed to the Proposed Settlement Agreement (the &#8220;Settling States&#8221;); and, subsequently, (2) following a notice period, that a sufficient number of states and political subdivisions, including those that have not sued, have agreed to the Agreement (or otherwise had their claims foreclosed) to proceed to effectiveness. Prior to the second determination, the Settling States will also have an opportunity to make a determination as to whether a sufficient number of political subdivisions have agreed to the Proposed Settlement Agreement (or otherwise had their claims foreclosed) to proceed with the </span></div></div><div style="display:inline-block;max-width:3.571%;min-width:2.571%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:48.215%"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Proposed Settlement Agreement. This process is currently contemplated to end in February 2022, although it may be extended by agreement. It is possible that a sufficient number of states and subdivisions will not agree to the Proposed Settlement Agreement or that other required contingencies will not be satisfied.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If these conditions are satisfied, the Proposed Settlement Agreement would become effective sixty (60) days after the distributors determine that there is sufficient participation among political subdivisions. During this 60-day period, the Settling States and the distributors would cooperate to obtain consent judgments in each participating state embodying the terms of the Settlement. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Proposed Settlement Agreement includes a cash component, pursuant to which the Company would pay up to approximately $<ix:nonFraction unitRef="usd" contextRef="iddd4821afbbd40c4a6c811e70974bf4a_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LossContingencyEstimateOfPossibleLoss" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzAvZnJhZzoxYzE1YWJmYzUxMTY0ZGUwODljYmRhNDgyYjQwNWYzYi90ZXh0cmVnaW9uOjFjMTVhYmZjNTExNjRkZTA4OWNiZGE0ODJiNDA1ZjNiXzYwNDczMTQwMzU1NDg_6cb1edc8-f047-4176-8f70-2f2a18ebe53e">6.37</ix:nonFraction>&#160;billion, the majority of which would be paid over 18 years. The exact payment amount will depend on several factors, including the participation rate of states and political subdivisions, the extent to which states take action to foreclose opioid lawsuits by political subdivisions (</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">e.g.</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, laws barring or limiting opioid lawsuits by political subdivisions), and the extent to which political subdivisions in Settling States file additional opioid lawsuits against the Company after the Proposed Settlement Agreement becomes effective. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Proposed Settlement Agreement also includes injunctive relief terms related to settling distributors&#8217; controlled substance anti-diversion programs, including with respect to: (1) governance; (2) independence and training of the personnel operating our controlled substances monitoring program; (3) due diligence for new and existing customers; (4) ordering limits for certain products; and (5) suspicious order monitoring. A monitor will be selected to oversee compliance with these provisions for a period of five years. In addition, we and the two other settling distributors will engage a third-party vendor to act as a clearinghouse for data aggregation and reporting; distributors will fund the clearinghouse for ten years.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In total, we have recorded total pre-tax charges of $<ix:nonFraction unitRef="usd" contextRef="id2a6b6641ae248c98d689f30c606f881_D20200701-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:GainLossRelatedToLitigationSettlement" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzAvZnJhZzoxYzE1YWJmYzUxMTY0ZGUwODljYmRhNDgyYjQwNWYzYi90ZXh0cmVnaW9uOjFjMTVhYmZjNTExNjRkZTA4OWNiZGE0ODJiNDA1ZjNiXzI3NDg3NzkxMjE2Mzg_fa04a4d2-d99c-4c13-92d5-b636406cf116">1.17</ix:nonFraction>&#160;billion and $<ix:nonFraction unitRef="usd" contextRef="i373ba6a0cdc044dea9602bdbad13174c_D20190701-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:GainLossRelatedToLitigationSettlement" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzAvZnJhZzoxYzE1YWJmYzUxMTY0ZGUwODljYmRhNDgyYjQwNWYzYi90ZXh0cmVnaW9uOjFjMTVhYmZjNTExNjRkZTA4OWNiZGE0ODJiNDA1ZjNiXzI3NDg3NzkxMjE2NDY_1a313f61-c937-4037-8038-233b7a976d14">5.63</ix:nonFraction>&#160;billion in litigation charges/(recoveries), net in the years ended June&#160;30, 2021 and 2020, respectively. In total, we have $<ix:nonFraction unitRef="usd" contextRef="iddd4821afbbd40c4a6c811e70974bf4a_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LitigationReserve" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzAvZnJhZzoxYzE1YWJmYzUxMTY0ZGUwODljYmRhNDgyYjQwNWYzYi90ZXh0cmVnaW9uOjFjMTVhYmZjNTExNjRkZTA4OWNiZGE0ODJiNDA1ZjNiXzI3NDg3NzkxMjE2NzA_28b38008-945f-454f-9a53-178811986b71">6.73</ix:nonFraction>&#160;billion accrued at June&#160;30, 2021, of which $<ix:nonFraction unitRef="usd" contextRef="i358dc7a7b0ec46769a803fbd85db0e3a_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LitigationReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzAvZnJhZzoxYzE1YWJmYzUxMTY0ZGUwODljYmRhNDgyYjQwNWYzYi90ZXh0cmVnaW9uOjFjMTVhYmZjNTExNjRkZTA4OWNiZGE0ODJiNDA1ZjNiXzI3NDg3NzkxNTIxNzY_ed4f0b1f-aee9-4015-94af-0fe1bc302ff6">405</ix:nonFraction>&#160;million is included in other accrued liabilities and the remainder is included in deferred income taxes and other liabilities in the consolidated balance sheets. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Because loss contingencies are inherently unpredictable and unfavorable developments or resolutions can occur, the assessment is highly subjective and requires judgments about future events. We regularly review these opioid litigation matters to determine whether our accrual is adequate. The amount of ultimate loss may differ materially from this accrual, whether as a result of settlement discussions, a judicial decision or verdict or otherwise, but we are not able to estimate a range of reasonably possible additional losses for these matters. We continue to strongly dispute the allegations made in these lawsuits and reaching an agreement in principle on a global settlement framework is not an admission of liability or wrongdoing.</span></div></div></ix:continuation></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:32.135%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.428%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.137%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardinal Health </span><span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">|</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> Fiscal 2021 Form 10-K</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">75</span></div></td></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:3pt"><span><br/></span></div><div style="margin-bottom:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:24.682%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:50.911%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.107%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#e41f35;border-bottom:1pt solid #e41f35;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Notes to Financial Statements</span></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:0 1pt"></td></tr></table></div></div><div style="width:100.000%"><ix:continuation id="ibe39b28b2b7c4b21a11c65f945128cb4" continuedAt="ib1116e6affde428faa15c4e04504f1b1"><div style="display:inline-block;vertical-align:top;width:48.214%"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, a trial before a judge in West Virginia in the Cabell County and City of Huntington cases concluded in July 2021 and the judge has not yet issued a decision. In addition, a trial in the case brought by the Ohio Attorney General is scheduled to begin in September 2021 and a trial in the case brought by the Washington Attorney General is scheduled to begin in November 2021. The Ohio Attorney General has issued a press release indicating support for the Proposed Settlement Agreement; however, the Washington Attorney General has issued a press release stating that Washington will not agree to the Proposed Settlement Agreement. These public announcements are not binding and there is no assurance that any state that has made a public announcement of support for the Proposed Settlement Agreement will ultimately execute the Proposed Settlement Agreement.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Private Plaintiffs</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Proposed Settlement Agreement does not address claims by private parties, which includes unions and other health and welfare funds, hospital systems and other healthcare providers, businesses and individuals alleging personal injury. Private parties had brought approximately <ix:nonFraction unitRef="lawsuit" contextRef="i0e267f0781804e14b232b824ab81c9b0_I20210810" decimals="0" name="cah:LossContingencyLawsuitsNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzAvZnJhZzoxYzE1YWJmYzUxMTY0ZGUwODljYmRhNDgyYjQwNWYzYi90ZXh0cmVnaW9uOjFjMTVhYmZjNTExNjRkZTA4OWNiZGE0ODJiNDA1ZjNiXzI3NDg3NzkxMjE2Nzg_72ee3a45-216f-468e-8c32-668bef0d2697">442</ix:nonFraction> lawsuits as of August 10, 2021. Of these, <ix:nonFraction unitRef="lawsuit" contextRef="ia0377f0db1e745b29e4b4fa403caefda_I20210810" decimals="0" name="cah:LossContingencyLawsuitsNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzAvZnJhZzoxYzE1YWJmYzUxMTY0ZGUwODljYmRhNDgyYjQwNWYzYi90ZXh0cmVnaW9uOjFjMTVhYmZjNTExNjRkZTA4OWNiZGE0ODJiNDA1ZjNiXzI3NDg3NzkxMjE2ODI_9651e1d8-65c3-412e-be61-671cda9af5ce">128</ix:nonFraction> are purported class actions. The causes of action asserted by these plaintiffs are similar to those asserted by public plaintiffs. A trial in one case is currently scheduled to begin in October 2021. We are vigorously defending ourselves in these matters.</span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Insurance Litigation</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are involved in legal proceedings with two insurers related to the availability of insurance coverage for the lawsuits described above. In October 2020, we filed a complaint for declaratory judgment against National Union Fire Insurance Company of Pittsburgh, PA (&#8220;National Union&#8221;) seeking a declaration that National Union is obligated to reimburse us for defense costs incurred in connection with the lawsuits described above. In January, 2021, Swiss Re International SE commenced an arbitration in London seeking a determination that it does not have an obligation to reimburse us for defense and indemnity expenses incurred in connection with the lawsuits described above. We have not recorded a receivable for any recoveries related to these insurance litigation matters as of June&#160;30, 2021.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Department of Justice Investigations</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have received federal grand jury subpoenas issued in connection with investigations being conducted by the U.S. Attorney's Office for the Eastern District of New York and the Fraud Section of the U.S. Department of Justice ("DOJ"). We have also received civil requests for information from other DOJ offices. We believe that these investigations concern operation of our anti-diversion program, our anti-diversion policies and procedures, and distribution of certain controlled substances. We are cooperating with these requests. We are unable to predict the outcome of any of these investigations. </span></div></div><div style="display:inline-block;max-width:3.571%;min-width:2.571%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:48.215%"><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cordis Product Liability Lawsuits</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of August 10, 2021, we are named as a defendant in <ix:nonFraction unitRef="lawsuit" contextRef="ieb82df38431448b4bf42dd698ac840f8_D20210810-20210810" decimals="0" name="us-gaap:LossContingencyNewClaimsFiledNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzAvZnJhZzoxYzE1YWJmYzUxMTY0ZGUwODljYmRhNDgyYjQwNWYzYi90ZXh0cmVnaW9uOjFjMTVhYmZjNTExNjRkZTA4OWNiZGE0ODJiNDA1ZjNiXzI3NDg3NzkxMjE3MDM_0e069a5f-0bff-4a1b-ac30-550d2e25933c">419</ix:nonFraction> product liability lawsuits coordinated in Alameda County Superior Court in California involving claims by approximately <ix:nonFraction unitRef="plaintiff" contextRef="i31649c55524f4013acd74a3b9ce10a01_D20210810-20210810" decimals="0" format="ixt:numdotdecimal" name="us-gaap:LossContingencyNumberOfPlaintiffs" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzAvZnJhZzoxYzE1YWJmYzUxMTY0ZGUwODljYmRhNDgyYjQwNWYzYi90ZXh0cmVnaW9uOjFjMTVhYmZjNTExNjRkZTA4OWNiZGE0ODJiNDA1ZjNiXzI3NDg3NzkxMjE3MDc_0ada15b2-57ae-4282-93b6-d1f1a15661ff">5,427</ix:nonFraction> plaintiffs that allege personal injuries associated with the use of Cordis OptEase and TrapEase inferior vena cava ("IVC") filter products. Another <ix:nonFraction unitRef="lawsuit" contextRef="i3caca7e07f5c4d03b8646b949d36c06e_D20210810-20210810" decimals="0" name="us-gaap:LossContingencyNewClaimsFiledNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzAvZnJhZzoxYzE1YWJmYzUxMTY0ZGUwODljYmRhNDgyYjQwNWYzYi90ZXh0cmVnaW9uOjFjMTVhYmZjNTExNjRkZTA4OWNiZGE0ODJiNDA1ZjNiXzI3NDg3NzkxMjE3MTE_2d065ee3-d4a4-4dc3-b956-41e3294e6300">32</ix:nonFraction> lawsuits involving similar claims by approximately <ix:nonFraction unitRef="plaintiff" contextRef="i1687680dbb664c18933d117965cb34b0_D20210810-20210810" decimals="0" name="us-gaap:LossContingencyNumberOfPlaintiffs" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzAvZnJhZzoxYzE1YWJmYzUxMTY0ZGUwODljYmRhNDgyYjQwNWYzYi90ZXh0cmVnaW9uOjFjMTVhYmZjNTExNjRkZTA4OWNiZGE0ODJiNDA1ZjNiXzI3NDg3NzkxMjE3MTU_c9ff876a-2697-44c7-b079-09140c9e67d7">37</ix:nonFraction> plaintiffs are pending in other jurisdictions. These lawsuits seek a variety of remedies, including unspecified monetary damages. In July 2021, we entered into an agreement to settle approximately <ix:nonFraction unitRef="lawsuit" contextRef="i8068ea91c8ff4c3b8bd8310ae462197c_D20210701-20210731" decimals="0" format="ixt:numdotdecimal" name="us-gaap:LossContingencyClaimsSettledNumber" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzAvZnJhZzoxYzE1YWJmYzUxMTY0ZGUwODljYmRhNDgyYjQwNWYzYi90ZXh0cmVnaW9uOjFjMTVhYmZjNTExNjRkZTA4OWNiZGE0ODJiNDA1ZjNiXzQ5NDc4MDI0MDc3NDI_e689c141-af08-4c6a-9c8d-5d8cdd3d961f">1,300</ix:nonFraction> claims. This agreement is subject to certain contingencies. We continue to vigorously defend ourselves in these lawsuits and are engaged in ongoing resolution discussions with certain plaintiffs. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At June&#160;30, 2021, we had a total of $<ix:nonFraction unitRef="usd" contextRef="if156c7b3d30345a395262b86a56d2779_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LossContingencyAccrualAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzAvZnJhZzoxYzE1YWJmYzUxMTY0ZGUwODljYmRhNDgyYjQwNWYzYi90ZXh0cmVnaW9uOjFjMTVhYmZjNTExNjRkZTA4OWNiZGE0ODJiNDA1ZjNiXzI3NDg3NzkxMjE3MTk_a05abe99-d345-43eb-bfc9-17ea0c0f5ebd">524</ix:nonFraction>&#160;million net of estimated insurance recoveries, accrued for losses and legal defense costs, net of expected insurance recoveries, related to the Cordis IVC filter lawsuits in the consolidated balance sheets. We believe there is a range of estimated losses with respect to these matters. Because no amount within the range is a better estimate than any other amount within the range, we have accrued the minimum amount in the range. We estimate the high end of the range to be approximately $<ix:nonFraction unitRef="usd" contextRef="ib54859ab704046a7a3be64f76f566d69_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LossContingencyEstimateOfPossibleLoss" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzAvZnJhZzoxYzE1YWJmYzUxMTY0ZGUwODljYmRhNDgyYjQwNWYzYi90ZXh0cmVnaW9uOjFjMTVhYmZjNTExNjRkZTA4OWNiZGE0ODJiNDA1ZjNiXzI3NDg3NzkxMjE3Mjc_d403f7da-72bd-4542-937e-c1bfe2872a9a">1.03</ix:nonFraction>&#160;billion, net of estimated insurance recoveries. The sale of the Cordis disposal group does not include product liability related to the IVC filters in the U.S. and Canada, which we retained. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SEC Investigation</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In February 2021, we received a subpoena from the U.S. Securities and Exchange Commission requesting the production of documents from 2015 through 2019 relating to inventory in the Cordis business, analysis of goodwill of the Medical segment and other matters. We are cooperating with this inquiry and cannot predict its outcome or duration. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Shareholder Securities Litigation</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2019, the Louisiana Sheriffs' Pension &amp; Relief Fund filed a purported class action complaint against Cardinal Health and certain current and former officers and employees in the United States District Court for the Southern District of Ohio purportedly on behalf of all purchasers of our common shares between March 2015 and May 2018. In June 2020, the court appointed 1199 SEIU Health Care Employees Pension Fund as lead plaintiff and a consolidated amended complaint was filed in September 2020. The amended complaint alleges that the defendants violated Sections 10(b) and 20(a) of the Securities and Exchange Act of 1934 by making misrepresentations and omissions related to the acquisition integration of the Cordis business and inventory and supply chain problems within the Cordis business, and seeks to recover unspecified damages and equitable relief for the alleged misstatements and omissions. The complaint also alleges that one of the individual defendants violated Section 20A of the Exchange Act because he sold shares of Cardinal Health stock during the time period. In November 2020, we filed a motion to dismiss the amended complaint. We believe that the claims asserted in this </span></div></div></ix:continuation></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:3pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.222%"><tr><td style="width:1.0%"></td><td style="width:32.133%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.433%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.134%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">76</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardinal Health </span><span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">| </span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2021 Form 10-K</span></div></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:3pt"><span><br/></span></div><div style="margin-bottom:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:24.682%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:50.911%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.107%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#e41f35;border-bottom:1pt solid #e41f35;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Notes to Financial Statements</span></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:0 1pt"></td></tr></table></div></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:48.214%"><ix:continuation id="ib1116e6affde428faa15c4e04504f1b1"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">complaint are without merit and intend to vigorously defend against them.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Specialty Solutions DOJ Investigation</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2018, the United States Attorney&#8217;s Office for the District of Massachusetts (the "USAO") commenced an investigation pertaining to the U.S. federal healthcare fraud and abuse laws. These requests sought, among other things, documents and information relating to discounts and rebates offered or provided to certain Specialty Solutions customers. We are cooperating with these requests and are engaged in resolution discussions with the USAO and Department of Health and Human Services, Office of Inspector General. In connection with these discussions, we recorded $<ix:nonFraction unitRef="usd" contextRef="id300e006612f4c21bb7c72fd2b74da8f_D20200701-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:GainLossRelatedToLitigationSettlement" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzAvZnJhZzoxYzE1YWJmYzUxMTY0ZGUwODljYmRhNDgyYjQwNWYzYi90ZXh0cmVnaW9uOjFjMTVhYmZjNTExNjRkZTA4OWNiZGE0ODJiNDA1ZjNiXzI3NDg3NzkxMjE3Mzc_aec459f5-de19-4cc4-bddb-dbbedcf9009a">13</ix:nonFraction> million of expense within litigation charges/(recoveries) on our consolidated statements of earnings/(loss) during the fiscal year ended June&#160;30, 2021. We cannot predict the outcome of the discussions and it is possible that we may incur additional losses or agree to other remedial measures; however, we are not currently able to estimate a range of reasonably possible additional losses.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Other Civil Litigation </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Generic Pharmaceutical Pricing Antitrust Litigation </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2019, pharmaceutical distributors including us were added as defendants in a civil class action lawsuit filed by indirect purchasers of generic drugs, such as hospitals and retail pharmacies. The indirect purchaser case is part of a multidistrict litigation consisting of multiple individual class action matters consolidated in the Eastern District of Pennsylvania. The indirect purchaser plaintiffs allege that pharmaceutical distributors encouraged manufacturers to increase prices, provided anti-competitive pricing information to manufacturers and improperly engaged in customer allocation. We have filed a motion to dismiss the complaints and we intend to vigorously defend ourselves. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Active Pharmaceutical Ingredient Impurity Litigation</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Many participants in the pharmaceutical supply chain, including active pharmaceutical ingredient ("API") manufacturers, finished dose manufacturers, repackagers, distributors, and retailers have been named as defendants in lawsuits arising out of recalls of certain medications due to alleged impurities in the active pharmaceutical ingredients or finished product. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In February 2019, a Multidistrict Litigation was created in the U.S. District Court for the District of New Jersey (the &#8220;Sartan MDL&#8221;) alleging API impurities in certain generic blood pressure medications. We have been named as a defendant in the Sartan MDL. We are vigorously defending ourselves in this matter. </span></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Antitrust Litigation Proceeds</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We received and recognized income resulting from settlements of lawsuits in which we were a class member or plaintiff of $<ix:nonFraction unitRef="usd" contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630" decimals="-6" format="ixt:numdotdecimal" name="cah:IncomefromSettlementsofClassActionLawsuits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzAvZnJhZzoxYzE1YWJmYzUxMTY0ZGUwODljYmRhNDgyYjQwNWYzYi90ZXh0cmVnaW9uOjFjMTVhYmZjNTExNjRkZTA4OWNiZGE0ODJiNDA1ZjNiXzI3NDg3NzkwODkxMzc_3585a0a8-5c5b-4132-8e0b-dec54a9c3293">112</ix:nonFraction> million</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$<ix:nonFraction unitRef="usd" contextRef="ia31e9a409b874bb19d0ff6f2f39ecc09_D20190701-20200630" decimals="-6" format="ixt:numdotdecimal" name="cah:IncomefromSettlementsofClassActionLawsuits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzAvZnJhZzoxYzE1YWJmYzUxMTY0ZGUwODljYmRhNDgyYjQwNWYzYi90ZXh0cmVnaW9uOjFjMTVhYmZjNTExNjRkZTA4OWNiZGE0ODJiNDA1ZjNiXzE2MzAx_a478533d-25e1-4bb7-b1a6-bc9a7853a2d4">16</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i00a6d666bf604826b24e68ddbd63eac4_D20180701-20190630" decimals="-6" format="ixt:numdotdecimal" name="cah:IncomefromSettlementsofClassActionLawsuits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzAvZnJhZzoxYzE1YWJmYzUxMTY0ZGUwODljYmRhNDgyYjQwNWYzYi90ZXh0cmVnaW9uOjFjMTVhYmZjNTExNjRkZTA4OWNiZGE0ODJiNDA1ZjNiXzE2MzA4_e900e6a5-5ac2-4914-8549-a5c84fa7196a">94</ix:nonFraction> million during fiscal 2021, 2020, and 2019, respectively.</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div></div><div style="display:inline-block;max-width:3.571%;min-width:2.571%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:48.215%"><div id="i4f0ec56b9c604f1782a65ea4a19c284d_133"></div><ix:nonNumeric contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630" name="us-gaap:IncomeTaxDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90ZXh0cmVnaW9uOmViYTAwMWFhMmQ5YjRmODZiMGIyMTI2YzNmMjlhODhmXzI3NDg3NzkwOTk3OTc_64a3f317-f854-4ecf-ba84-014b50704a78" continuedAt="i8104e3c781c741e1aef9584b723f03bb" escape="true"><div style="margin-bottom:6pt;text-align:justify"><span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:13pt;font-weight:700;line-height:120%">8. Income Taxes </span></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Earnings/(Loss) before Income Taxes and Provision for/(Benefit From) Income Taxes</span></div><ix:nonNumeric contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630" name="us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90ZXh0cmVnaW9uOmViYTAwMWFhMmQ5YjRmODZiMGIyMTI2YzNmMjlhODhmXzg3ODg_4fd4f502-7019-4ca5-85e2-cf9cf6aff503" escape="true"><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes earnings/(loss) before income taxes:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.691%"><tr><td style="width:1.0%"></td><td style="width:53.389%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.999%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.347%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.522%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.347%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.596%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">U.S. operations</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630" decimals="-6" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90YWJsZTo3MGQ0NWU0YjdmZmY0N2JmYjJmMTlmZmNkYzkwMThiMC90YWJsZXJhbmdlOjcwZDQ1ZTRiN2ZmZjQ3YmZiMmYxOWZmY2RjOTAxOGIwXzEtMS0xLTEtMA_449f771b-1846-4e2c-9961-4bc7b6b23e51">47</ix:nonFraction>)</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia31e9a409b874bb19d0ff6f2f39ecc09_D20190701-20200630" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90YWJsZTo3MGQ0NWU0YjdmZmY0N2JmYjJmMTlmZmNkYzkwMThiMC90YWJsZXJhbmdlOjcwZDQ1ZTRiN2ZmZjQ3YmZiMmYxOWZmY2RjOTAxOGIwXzEtMy0xLTEtMA_f039d5bc-afc6-42dc-9c7c-1e184a19bf11">4,056</ix:nonFraction>)</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i00a6d666bf604826b24e68ddbd63eac4_D20180701-20190630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90YWJsZTo3MGQ0NWU0YjdmZmY0N2JmYjJmMTlmZmNkYzkwMThiMC90YWJsZXJhbmdlOjcwZDQ1ZTRiN2ZmZjQ3YmZiMmYxOWZmY2RjOTAxOGIwXzEtNS0xLTEtMA_90238659-1cfc-4d2b-8440-6037e4fa5612">1,478</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Non-U.S. operations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90YWJsZTo3MGQ0NWU0YjdmZmY0N2JmYjJmMTlmZmNkYzkwMThiMC90YWJsZXJhbmdlOjcwZDQ1ZTRiN2ZmZjQ3YmZiMmYxOWZmY2RjOTAxOGIwXzItMS0xLTEtMA_abbe52bd-9fe6-4cd5-ba2a-e7a24c2ec419">370</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia31e9a409b874bb19d0ff6f2f39ecc09_D20190701-20200630" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90YWJsZTo3MGQ0NWU0YjdmZmY0N2JmYjJmMTlmZmNkYzkwMThiMC90YWJsZXJhbmdlOjcwZDQ1ZTRiN2ZmZjQ3YmZiMmYxOWZmY2RjOTAxOGIwXzItMy0xLTEtMA_419eea01-1547-4c5b-9691-03596d7e22dc">284</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i00a6d666bf604826b24e68ddbd63eac4_D20180701-20190630" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90YWJsZTo3MGQ0NWU0YjdmZmY0N2JmYjJmMTlmZmNkYzkwMThiMC90YWJsZXJhbmdlOjcwZDQ1ZTRiN2ZmZjQ3YmZiMmYxOWZmY2RjOTAxOGIwXzItNS0xLTEtMA_a6dffc8d-f803-4a65-8eb3-9b5f8ef3c77b">273</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Earnings/(loss) before income taxes</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90YWJsZTo3MGQ0NWU0YjdmZmY0N2JmYjJmMTlmZmNkYzkwMThiMC90YWJsZXJhbmdlOjcwZDQ1ZTRiN2ZmZjQ3YmZiMmYxOWZmY2RjOTAxOGIwXzMtMS0xLTEtMA_b86e0a6d-d87d-420c-b0cb-5cc3a2430e2f">323</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia31e9a409b874bb19d0ff6f2f39ecc09_D20190701-20200630" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90YWJsZTo3MGQ0NWU0YjdmZmY0N2JmYjJmMTlmZmNkYzkwMThiMC90YWJsZXJhbmdlOjcwZDQ1ZTRiN2ZmZjQ3YmZiMmYxOWZmY2RjOTAxOGIwXzMtMy0xLTEtMA_2f9cc3e2-1e0d-44b8-8265-c656e9e3e9a0">3,772</ix:nonFraction>)</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i00a6d666bf604826b24e68ddbd63eac4_D20180701-20190630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90YWJsZTo3MGQ0NWU0YjdmZmY0N2JmYjJmMTlmZmNkYzkwMThiMC90YWJsZXJhbmdlOjcwZDQ1ZTRiN2ZmZjQ3YmZiMmYxOWZmY2RjOTAxOGIwXzMtNS0xLTEtMA_39b9ecc4-9e23-414b-ace2-7c845e5f6ce0">1,751</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><ix:nonNumeric contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630" name="us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90ZXh0cmVnaW9uOmViYTAwMWFhMmQ5YjRmODZiMGIyMTI2YzNmMjlhODhmXzg3NzI_69258910-c9a7-454f-93a9-1a4a84aa3151" escape="true"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the components of provision for/(benefit from) income taxes:</span></div><div style="margin-top:8pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:53.220%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.949%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.343%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.171%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.343%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.174%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Current:</span></td><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Federal</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630" decimals="-6" sign="-" name="us-gaap:CurrentFederalTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90YWJsZTo3ZjVkNzE0NjNhZmE0M2FlOWU4YWYxY2YxODFjODI3YS90YWJsZXJhbmdlOjdmNWQ3MTQ2M2FmYTQzYWU5ZThhZjFjZjE4MWM4MjdhXzItMS0xLTEtMA_dd9f13f1-4eb0-43b5-884b-8f2b28594742">989</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia31e9a409b874bb19d0ff6f2f39ecc09_D20190701-20200630" decimals="-6" name="us-gaap:CurrentFederalTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90YWJsZTo3ZjVkNzE0NjNhZmE0M2FlOWU4YWYxY2YxODFjODI3YS90YWJsZXJhbmdlOjdmNWQ3MTQ2M2FmYTQzYWU5ZThhZjFjZjE4MWM4MjdhXzItMy0xLTEtMA_fed5e635-c47f-4e20-a2a9-bcdeccf5f090">659</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i00a6d666bf604826b24e68ddbd63eac4_D20180701-20190630" decimals="-6" name="us-gaap:CurrentFederalTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90YWJsZTo3ZjVkNzE0NjNhZmE0M2FlOWU4YWYxY2YxODFjODI3YS90YWJsZXJhbmdlOjdmNWQ3MTQ2M2FmYTQzYWU5ZThhZjFjZjE4MWM4MjdhXzItNS0xLTEtMA_68abb596-7d5e-487e-8ddf-db556d49d999">295</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">State and local</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630" decimals="-6" name="us-gaap:CurrentStateAndLocalTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90YWJsZTo3ZjVkNzE0NjNhZmE0M2FlOWU4YWYxY2YxODFjODI3YS90YWJsZXJhbmdlOjdmNWQ3MTQ2M2FmYTQzYWU5ZThhZjFjZjE4MWM4MjdhXzMtMS0xLTEtMA_5e225082-702a-4b99-9cf6-c847a60833bf">92</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia31e9a409b874bb19d0ff6f2f39ecc09_D20190701-20200630" decimals="-6" name="us-gaap:CurrentStateAndLocalTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90YWJsZTo3ZjVkNzE0NjNhZmE0M2FlOWU4YWYxY2YxODFjODI3YS90YWJsZXJhbmdlOjdmNWQ3MTQ2M2FmYTQzYWU5ZThhZjFjZjE4MWM4MjdhXzMtMy0xLTEtMA_324fdc52-e7ff-465b-9ed9-86e3bf009406">154</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i00a6d666bf604826b24e68ddbd63eac4_D20180701-20190630" decimals="-6" name="us-gaap:CurrentStateAndLocalTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90YWJsZTo3ZjVkNzE0NjNhZmE0M2FlOWU4YWYxY2YxODFjODI3YS90YWJsZXJhbmdlOjdmNWQ3MTQ2M2FmYTQzYWU5ZThhZjFjZjE4MWM4MjdhXzMtNS0xLTEtMA_b007ca43-7d09-47f6-bd5e-007eeb872f20">89</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Non-U.S.</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630" decimals="-6" name="us-gaap:CurrentForeignTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90YWJsZTo3ZjVkNzE0NjNhZmE0M2FlOWU4YWYxY2YxODFjODI3YS90YWJsZXJhbmdlOjdmNWQ3MTQ2M2FmYTQzYWU5ZThhZjFjZjE4MWM4MjdhXzQtMS0xLTEtMA_4967330d-3e83-4bcb-9136-c8b914215e81">112</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia31e9a409b874bb19d0ff6f2f39ecc09_D20190701-20200630" decimals="-6" name="us-gaap:CurrentForeignTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90YWJsZTo3ZjVkNzE0NjNhZmE0M2FlOWU4YWYxY2YxODFjODI3YS90YWJsZXJhbmdlOjdmNWQ3MTQ2M2FmYTQzYWU5ZThhZjFjZjE4MWM4MjdhXzQtMy0xLTEtMA_6742f58c-9371-4a0e-9cb5-5d739bed9618">69</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i00a6d666bf604826b24e68ddbd63eac4_D20180701-20190630" decimals="-6" name="us-gaap:CurrentForeignTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90YWJsZTo3ZjVkNzE0NjNhZmE0M2FlOWU4YWYxY2YxODFjODI3YS90YWJsZXJhbmdlOjdmNWQ3MTQ2M2FmYTQzYWU5ZThhZjFjZjE4MWM4MjdhXzQtNS0xLTEtMA_af09f46d-5125-4a8e-bd77-cec2289c367e">85</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total current</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630" decimals="-6" sign="-" name="us-gaap:CurrentIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90YWJsZTo3ZjVkNzE0NjNhZmE0M2FlOWU4YWYxY2YxODFjODI3YS90YWJsZXJhbmdlOjdmNWQ3MTQ2M2FmYTQzYWU5ZThhZjFjZjE4MWM4MjdhXzUtMS0xLTEtMA_feb69bb8-bc2f-42d9-91ce-53a7e198eb60">785</ix:nonFraction>)</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia31e9a409b874bb19d0ff6f2f39ecc09_D20190701-20200630" decimals="-6" name="us-gaap:CurrentIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90YWJsZTo3ZjVkNzE0NjNhZmE0M2FlOWU4YWYxY2YxODFjODI3YS90YWJsZXJhbmdlOjdmNWQ3MTQ2M2FmYTQzYWU5ZThhZjFjZjE4MWM4MjdhXzUtMy0xLTEtMA_58815527-a3b4-4a40-960a-63b5b884f7ac">882</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i00a6d666bf604826b24e68ddbd63eac4_D20180701-20190630" decimals="-6" name="us-gaap:CurrentIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90YWJsZTo3ZjVkNzE0NjNhZmE0M2FlOWU4YWYxY2YxODFjODI3YS90YWJsZXJhbmdlOjdmNWQ3MTQ2M2FmYTQzYWU5ZThhZjFjZjE4MWM4MjdhXzUtNS0xLTEtMA_8be84b1a-720e-4b7e-a005-4f491dfb220a">469</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:3pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Deferred:</span></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Federal</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630" decimals="-6" name="us-gaap:DeferredFederalIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90YWJsZTo3ZjVkNzE0NjNhZmE0M2FlOWU4YWYxY2YxODFjODI3YS90YWJsZXJhbmdlOjdmNWQ3MTQ2M2FmYTQzYWU5ZThhZjFjZjE4MWM4MjdhXzgtMS0xLTEtMA_da9a6c00-0e88-41a8-b524-1f16696db96e">539</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia31e9a409b874bb19d0ff6f2f39ecc09_D20190701-20200630" decimals="-6" sign="-" name="us-gaap:DeferredFederalIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90YWJsZTo3ZjVkNzE0NjNhZmE0M2FlOWU4YWYxY2YxODFjODI3YS90YWJsZXJhbmdlOjdmNWQ3MTQ2M2FmYTQzYWU5ZThhZjFjZjE4MWM4MjdhXzgtMy0xLTEtMA_363325ac-686a-484e-87f8-d0ecaff8c87c">822</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i00a6d666bf604826b24e68ddbd63eac4_D20180701-20190630" decimals="-6" sign="-" name="us-gaap:DeferredFederalIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90YWJsZTo3ZjVkNzE0NjNhZmE0M2FlOWU4YWYxY2YxODFjODI3YS90YWJsZXJhbmdlOjdmNWQ3MTQ2M2FmYTQzYWU5ZThhZjFjZjE4MWM4MjdhXzgtNS0xLTEtMA_3389a107-9823-4e68-b840-3398a0fdb911">28</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">State and local</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630" decimals="-6" sign="-" name="us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90YWJsZTo3ZjVkNzE0NjNhZmE0M2FlOWU4YWYxY2YxODFjODI3YS90YWJsZXJhbmdlOjdmNWQ3MTQ2M2FmYTQzYWU5ZThhZjFjZjE4MWM4MjdhXzktMS0xLTEtMA_9240fac8-b382-4f21-8564-e69f31f59b76">28</ix:nonFraction>)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia31e9a409b874bb19d0ff6f2f39ecc09_D20190701-20200630" decimals="-6" sign="-" name="us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90YWJsZTo3ZjVkNzE0NjNhZmE0M2FlOWU4YWYxY2YxODFjODI3YS90YWJsZXJhbmdlOjdmNWQ3MTQ2M2FmYTQzYWU5ZThhZjFjZjE4MWM4MjdhXzktMy0xLTEtMA_933e5ac8-9de3-4b22-abbe-4c1b8fabb880">127</ix:nonFraction>)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i00a6d666bf604826b24e68ddbd63eac4_D20180701-20190630" decimals="-6" sign="-" name="us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90YWJsZTo3ZjVkNzE0NjNhZmE0M2FlOWU4YWYxY2YxODFjODI3YS90YWJsZXJhbmdlOjdmNWQ3MTQ2M2FmYTQzYWU5ZThhZjFjZjE4MWM4MjdhXzktNS0xLTEtMA_0248a9f4-4b22-4876-be12-024981a05754">37</ix:nonFraction>)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Non-U.S.</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630" decimals="-6" sign="-" name="us-gaap:DeferredForeignIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90YWJsZTo3ZjVkNzE0NjNhZmE0M2FlOWU4YWYxY2YxODFjODI3YS90YWJsZXJhbmdlOjdmNWQ3MTQ2M2FmYTQzYWU5ZThhZjFjZjE4MWM4MjdhXzEwLTEtMS0xLTA_23a61afd-8e2f-4941-9262-9eabdf762008">15</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia31e9a409b874bb19d0ff6f2f39ecc09_D20190701-20200630" decimals="-6" sign="-" name="us-gaap:DeferredForeignIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90YWJsZTo3ZjVkNzE0NjNhZmE0M2FlOWU4YWYxY2YxODFjODI3YS90YWJsZXJhbmdlOjdmNWQ3MTQ2M2FmYTQzYWU5ZThhZjFjZjE4MWM4MjdhXzEwLTMtMS0xLTA_25b68730-a177-4101-834e-f934c9b3b834">12</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i00a6d666bf604826b24e68ddbd63eac4_D20180701-20190630" decimals="-6" sign="-" name="us-gaap:DeferredForeignIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90YWJsZTo3ZjVkNzE0NjNhZmE0M2FlOWU4YWYxY2YxODFjODI3YS90YWJsZXJhbmdlOjdmNWQ3MTQ2M2FmYTQzYWU5ZThhZjFjZjE4MWM4MjdhXzEwLTUtMS0xLTA_2420d338-f135-49bb-9868-e68eb118a797">18</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total deferred</span></td><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630" decimals="-6" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90YWJsZTo3ZjVkNzE0NjNhZmE0M2FlOWU4YWYxY2YxODFjODI3YS90YWJsZXJhbmdlOjdmNWQ3MTQ2M2FmYTQzYWU5ZThhZjFjZjE4MWM4MjdhXzExLTEtMS0xLTA_d86f5b19-febb-418a-aa32-6115ef6dabdc">496</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia31e9a409b874bb19d0ff6f2f39ecc09_D20190701-20200630" decimals="-6" sign="-" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90YWJsZTo3ZjVkNzE0NjNhZmE0M2FlOWU4YWYxY2YxODFjODI3YS90YWJsZXJhbmdlOjdmNWQ3MTQ2M2FmYTQzYWU5ZThhZjFjZjE4MWM4MjdhXzExLTMtMS0xLTA_132a7027-04d6-457c-a21a-8cfd035f3b82">961</ix:nonFraction>)</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i00a6d666bf604826b24e68ddbd63eac4_D20180701-20190630" decimals="-6" sign="-" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90YWJsZTo3ZjVkNzE0NjNhZmE0M2FlOWU4YWYxY2YxODFjODI3YS90YWJsZXJhbmdlOjdmNWQ3MTQ2M2FmYTQzYWU5ZThhZjFjZjE4MWM4MjdhXzExLTUtMS0xLTA_9bdbcb51-d987-46e5-9811-f540876147b0">83</ix:nonFraction>)</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Provision for/(benefit from) income taxes</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630" decimals="-6" sign="-" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90YWJsZTo3ZjVkNzE0NjNhZmE0M2FlOWU4YWYxY2YxODFjODI3YS90YWJsZXJhbmdlOjdmNWQ3MTQ2M2FmYTQzYWU5ZThhZjFjZjE4MWM4MjdhXzEyLTEtMS0xLTA_d9145237-32c1-4c7a-ab10-b8a7459eb17a">289</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia31e9a409b874bb19d0ff6f2f39ecc09_D20190701-20200630" decimals="-6" sign="-" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90YWJsZTo3ZjVkNzE0NjNhZmE0M2FlOWU4YWYxY2YxODFjODI3YS90YWJsZXJhbmdlOjdmNWQ3MTQ2M2FmYTQzYWU5ZThhZjFjZjE4MWM4MjdhXzEyLTMtMS0xLTA_41d4030c-16d3-433d-a1e4-d23b90309c88">79</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i00a6d666bf604826b24e68ddbd63eac4_D20180701-20190630" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90YWJsZTo3ZjVkNzE0NjNhZmE0M2FlOWU4YWYxY2YxODFjODI3YS90YWJsZXJhbmdlOjdmNWQ3MTQ2M2FmYTQzYWU5ZThhZjFjZjE4MWM4MjdhXzEyLTUtMS0xLTA_0d2befc9-89d3-4176-846a-bc622100fabd">386</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Tax Effects of Self-Insurance Pre-Tax Loss</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During fiscal 2021, our wholly-owned insurance subsidiary recorded a self-insurance pre-tax loss in its fiscal 2020 statutory financial statements primarily related to opioid litigation. This self-insurance pre-tax loss, which did not impact our pre-tax consolidated results, was deducted on our fiscal 2020 consolidated federal income tax return and contributed to a significant net operating loss for tax purposes. The net operating loss was carried back and applied to adjust our taxable income for fiscal 2015, 2016, 2017, and 2018 as permitted under the Coronavirus Aid, Relief and Economic Security ("CARES") Act enacted by the United States Congress in March 2020.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accordingly, our provision for income taxes during fiscal 2021 included a $<ix:nonFraction unitRef="usd" contextRef="i267869e21f794c639e2b4ecddb88f627_D20200701-20210630" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90ZXh0cmVnaW9uOmViYTAwMWFhMmQ5YjRmODZiMGIyMTI2YzNmMjlhODhmXzIxOTkwMjMyNzE1NTE_8bd3bafd-59c4-4d19-9336-3df80c877450">424</ix:nonFraction> million benefit from the net operating loss carryback primarily to reflect the difference between the federal statutory income tax rate during the fiscal years from 2015 to 2018 (35 percent for fiscal 2015, 2016, and 2017 and 28 percent for fiscal 2018) and the current federal statutory income tax rate of 21 percent.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have filed for a U.S. federal income tax refund of $<ix:nonFraction unitRef="usd" contextRef="i58599d5030cc46db8dc1c2d03162cce3_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90ZXh0cmVnaW9uOmViYTAwMWFhMmQ5YjRmODZiMGIyMTI2YzNmMjlhODhmXzI3NDg3NzkwOTI0ODE_79cc2e63-3df2-4331-98a6-141d86db8867">974</ix:nonFraction>&#160;million as a result of the net operating loss carryback under the CARES Act, which we expect to receive within 12 months, and accordingly have recorded a current asset on our consolidated balance sheet at June&#160;30, 2021. We also increased our non-current deferred tax </span></div></ix:nonNumeric></div></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:32.135%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.428%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.137%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardinal Health </span><span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">|</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> Fiscal 2021 Form 10-K</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">77</span></div></td></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:3pt"><span><br/></span></div><div style="margin-bottom:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:24.682%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:50.911%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.107%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#e41f35;border-bottom:1pt solid #e41f35;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Notes to Financial Statements</span></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:0 1pt"></td></tr></table></div></div><div style="width:100.000%"><ix:continuation id="i8104e3c781c741e1aef9584b723f03bb" continuedAt="i404826af41e7493b9c6956c5c04f1ac7"><div style="display:inline-block;vertical-align:top;width:48.214%"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">liability by approximately $<ix:nonFraction unitRef="usd" contextRef="i58599d5030cc46db8dc1c2d03162cce3_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DeferredTaxAndOtherLiabilitiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90ZXh0cmVnaW9uOmViYTAwMWFhMmQ5YjRmODZiMGIyMTI2YzNmMjlhODhmXzI3NDg3NzkwOTI0OTU_50589e8c-8718-4a7e-a459-b0520d82ac73">700</ix:nonFraction>&#160;million during fiscal 2021 related to this matter.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have recorded these amounts based on management's judgment and our current understanding of tax law; however, it is possible that the tax authorities could challenge these tax benefits or that the tax law could change. The actual amount of the tax benefit may differ materially from these estimates.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Tax Effects of Opioid Litigation Charges</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the $<ix:nonFraction unitRef="usd" contextRef="id2a6b6641ae248c98d689f30c606f881_D20200701-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LitigationSettlementExpense" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90ZXh0cmVnaW9uOmViYTAwMWFhMmQ5YjRmODZiMGIyMTI2YzNmMjlhODhmXzIwODkwNzIwOTU3NjE3_f7b0a9d5-fb4b-4824-99dc-1e65da0fc4ee">1.17</ix:nonFraction>&#160;billion and $<ix:nonFraction unitRef="usd" contextRef="i373ba6a0cdc044dea9602bdbad13174c_D20190701-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LitigationSettlementExpense" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90ZXh0cmVnaW9uOmViYTAwMWFhMmQ5YjRmODZiMGIyMTI2YzNmMjlhODhmXzI3NDg3NzkwOTk3ODM_1e2c07c1-e98e-4edc-9c1a-bef2d1c59d0d">5.63</ix:nonFraction>&#160;billion pre-tax charges for the opioid litigation, during fiscal 2021 and 2020, we recorded a tax benefit of $<ix:nonFraction unitRef="usd" contextRef="id2a6b6641ae248c98d689f30c606f881_D20200701-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90ZXh0cmVnaW9uOmViYTAwMWFhMmQ5YjRmODZiMGIyMTI2YzNmMjlhODhmXzQ5NDc4MDIzMzg0ODc_69fd5dc6-9099-4960-8508-46f05d1a2013">228</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i373ba6a0cdc044dea9602bdbad13174c_D20190701-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90ZXh0cmVnaW9uOmViYTAwMWFhMmQ5YjRmODZiMGIyMTI2YzNmMjlhODhmXzQ5NDc4MDIzMzg0OTY_7c52794a-9098-47f3-9f16-43f389a65451">488</ix:nonFraction>&#160;million, respectively. Our tax benefits are estimates, which reflect our current assessment of the estimated future deductibility of the amount that may be paid under the accrual taken in connection with the opioid litigation and are net of unrecognized tax benefits of $<ix:nonFraction unitRef="usd" contextRef="iddd4821afbbd40c4a6c811e70974bf4a_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90ZXh0cmVnaW9uOmViYTAwMWFhMmQ5YjRmODZiMGIyMTI2YzNmMjlhODhmXzQ5NDc4MDIzMzg3NjM_f262da9f-cf3c-4182-a632-baeca19bab0c">219</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="i44b4e02791f742199433f84d47a44563_I20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90ZXh0cmVnaW9uOmViYTAwMWFhMmQ5YjRmODZiMGIyMTI2YzNmMjlhODhmXzQ5NDc4MDIzMzg3NzI_e8e9df7e-f92a-4e8a-b918-df5359b9ba11">469</ix:nonFraction>&#160;million, respectively. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have made reasonable estimates and recorded amounts based on management's judgment and our current understanding of the Tax Act; however, these estimates require significant judgment since the U.S. tax law governing deductibility was changed by the U.S. Tax Cuts and Jobs Act ("Tax Act"). Further, it is possible Congress or the tax authorities could challenge our interpretation of the Tax Act or the estimates and assumptions used to assess the future deductibility of these benefits. The actual amount of the tax benefit may differ materially from these estimates.</span></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Effective Tax Rate</span></div><ix:nonNumeric contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630" name="us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90ZXh0cmVnaW9uOmViYTAwMWFhMmQ5YjRmODZiMGIyMTI2YzNmMjlhODhmXzg3OTA_8329e244-fdea-4902-9d31-a773bd3392ae" escape="true"><div style="margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents a reconciliation of the provision based on the federal statutory income tax rate to our effective income tax rate:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:53.220%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.406%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.343%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.406%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.343%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.482%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021 </span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2020</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"> (1)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2019 </span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Provision at Federal statutory rate</span></td><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90YWJsZTowODVmMDBiY2Q2YWQ0NDRhYmY3ODM4MGEwZWFhNWRkNy90YWJsZXJhbmdlOjA4NWYwMGJjZDZhZDQ0NGFiZjc4MzgwYTBlYWE1ZGQ3XzEtMS0xLTEtMA_ec877842-7ea6-48f9-bf85-8b869511bb9a">21.0</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ia31e9a409b874bb19d0ff6f2f39ecc09_D20190701-20200630" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90YWJsZTowODVmMDBiY2Q2YWQ0NDRhYmY3ODM4MGEwZWFhNWRkNy90YWJsZXJhbmdlOjA4NWYwMGJjZDZhZDQ0NGFiZjc4MzgwYTBlYWE1ZGQ3XzEtMy0xLTEtMA_61d8e46b-3c4d-467f-a159-133e2ca775b3">21.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i00a6d666bf604826b24e68ddbd63eac4_D20180701-20190630" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90YWJsZTowODVmMDBiY2Q2YWQ0NDRhYmY3ODM4MGEwZWFhNWRkNy90YWJsZXJhbmdlOjA4NWYwMGJjZDZhZDQ0NGFiZjc4MzgwYTBlYWE1ZGQ3XzEtNS0xLTEtMA_31bdb3ab-2fd9-435f-8d12-3fdd8c890a58">21.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">State and local income taxes, net of federal benefit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90YWJsZTowODVmMDBiY2Q2YWQ0NDRhYmY3ODM4MGEwZWFhNWRkNy90YWJsZXJhbmdlOjA4NWYwMGJjZDZhZDQ0NGFiZjc4MzgwYTBlYWE1ZGQ3XzItMS0xLTEtMA_d8f9196e-f4e7-4e1a-948f-c81c5261b87d">3.2</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ia31e9a409b874bb19d0ff6f2f39ecc09_D20190701-20200630" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90YWJsZTowODVmMDBiY2Q2YWQ0NDRhYmY3ODM4MGEwZWFhNWRkNy90YWJsZXJhbmdlOjA4NWYwMGJjZDZhZDQ0NGFiZjc4MzgwYTBlYWE1ZGQ3XzItMy0xLTEtMA_7983bd23-291d-4af3-8760-aed4ce4cc281">2.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i00a6d666bf604826b24e68ddbd63eac4_D20180701-20190630" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90YWJsZTowODVmMDBiY2Q2YWQ0NDRhYmY3ODM4MGEwZWFhNWRkNy90YWJsZXJhbmdlOjA4NWYwMGJjZDZhZDQ0NGFiZjc4MzgwYTBlYWE1ZGQ3XzItNS0xLTEtMA_0cb316e2-47db-46c2-b8b9-05b3189be875">0.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Tax effect of foreign operations</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630" decimals="3" name="cah:EffectiveIncomeTaxRateReconciliationTaxEffectOfForeignOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90YWJsZTowODVmMDBiY2Q2YWQ0NDRhYmY3ODM4MGEwZWFhNWRkNy90YWJsZXJhbmdlOjA4NWYwMGJjZDZhZDQ0NGFiZjc4MzgwYTBlYWE1ZGQ3XzMtMS0xLTEtMA_18298b90-0f2e-4246-9f5a-43784f9485dd">0.7</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ia31e9a409b874bb19d0ff6f2f39ecc09_D20190701-20200630" decimals="3" format="ixt:zerodash" name="cah:EffectiveIncomeTaxRateReconciliationTaxEffectOfForeignOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90YWJsZTowODVmMDBiY2Q2YWQ0NDRhYmY3ODM4MGEwZWFhNWRkNy90YWJsZXJhbmdlOjA4NWYwMGJjZDZhZDQ0NGFiZjc4MzgwYTBlYWE1ZGQ3XzMtMy0xLTEtMA_5eaf91fc-e357-424b-a852-e35ff6d5874d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i00a6d666bf604826b24e68ddbd63eac4_D20180701-20190630" decimals="3" sign="-" name="cah:EffectiveIncomeTaxRateReconciliationTaxEffectOfForeignOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90YWJsZTowODVmMDBiY2Q2YWQ0NDRhYmY3ODM4MGEwZWFhNWRkNy90YWJsZXJhbmdlOjA4NWYwMGJjZDZhZDQ0NGFiZjc4MzgwYTBlYWE1ZGQ3XzMtNS0xLTEtMA_6b250053-2d30-496d-98ec-d6e59f8edc64">0.7</ix:nonFraction>)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Nondeductible/nontaxable items </span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpense" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90YWJsZTowODVmMDBiY2Q2YWQ0NDRhYmY3ODM4MGEwZWFhNWRkNy90YWJsZXJhbmdlOjA4NWYwMGJjZDZhZDQ0NGFiZjc4MzgwYTBlYWE1ZGQ3XzQtMS0xLTEtMA_8b0cd247-63c0-4ff1-9037-ce3a9270fe39">1.6</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ia31e9a409b874bb19d0ff6f2f39ecc09_D20190701-20200630" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpense" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90YWJsZTowODVmMDBiY2Q2YWQ0NDRhYmY3ODM4MGEwZWFhNWRkNy90YWJsZXJhbmdlOjA4NWYwMGJjZDZhZDQ0NGFiZjc4MzgwYTBlYWE1ZGQ3XzQtMy0xLTEtMA_cebec030-da8f-4056-9e8a-cc4aec599aa4">0.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i00a6d666bf604826b24e68ddbd63eac4_D20180701-20190630" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpense" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90YWJsZTowODVmMDBiY2Q2YWQ0NDRhYmY3ODM4MGEwZWFhNWRkNy90YWJsZXJhbmdlOjA4NWYwMGJjZDZhZDQ0NGFiZjc4MzgwYTBlYWE1ZGQ3XzQtNS0xLTEtMA_d49bb07f-a7f0-4ec1-a01c-3dec36a54f5d">0.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cordis Disposition</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90YWJsZTowODVmMDBiY2Q2YWQ0NDRhYmY3ODM4MGEwZWFhNWRkNy90YWJsZXJhbmdlOjA4NWYwMGJjZDZhZDQ0NGFiZjc4MzgwYTBlYWE1ZGQ3XzUtMS0xLTEtOTg1NA_25f15fbb-7883-438e-a15f-27984d64de38">7.0</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ia31e9a409b874bb19d0ff6f2f39ecc09_D20190701-20200630" decimals="3" format="ixt:zerodash" name="us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90YWJsZTowODVmMDBiY2Q2YWQ0NDRhYmY3ODM4MGEwZWFhNWRkNy90YWJsZXJhbmdlOjA4NWYwMGJjZDZhZDQ0NGFiZjc4MzgwYTBlYWE1ZGQ3XzUtMy0xLTEtOTg1Nw_f06dc55d-02b4-463f-8518-a3d3b3c0af1d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i00a6d666bf604826b24e68ddbd63eac4_D20180701-20190630" decimals="3" format="ixt:zerodash" name="us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90YWJsZTowODVmMDBiY2Q2YWQ0NDRhYmY3ODM4MGEwZWFhNWRkNy90YWJsZXJhbmdlOjA4NWYwMGJjZDZhZDQ0NGFiZjc4MzgwYTBlYWE1ZGQ3XzUtNS0xLTEtOTg2Mg_1f165bc1-6903-4f40-9de6-b3617e371a5f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Withholding Taxes </span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630" decimals="3" name="cah:EffectiveIncomeTaxRateReconciliationWithholdingTaxes" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90YWJsZTowODVmMDBiY2Q2YWQ0NDRhYmY3ODM4MGEwZWFhNWRkNy90YWJsZXJhbmdlOjA4NWYwMGJjZDZhZDQ0NGFiZjc4MzgwYTBlYWE1ZGQ3XzYtMS0xLTEtOTg2Ng_eb24cf64-35ab-4054-97e6-31e33c7f9238">9.0</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="ia31e9a409b874bb19d0ff6f2f39ecc09_D20190701-20200630" decimals="3" sign="-" name="cah:EffectiveIncomeTaxRateReconciliationWithholdingTaxes" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90YWJsZTowODVmMDBiY2Q2YWQ0NDRhYmY3ODM4MGEwZWFhNWRkNy90YWJsZXJhbmdlOjA4NWYwMGJjZDZhZDQ0NGFiZjc4MzgwYTBlYWE1ZGQ3XzYtMy0xLTEtOTg2OQ_f9c48c79-aed0-42cd-a9dc-e204d249bdc5">0.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i00a6d666bf604826b24e68ddbd63eac4_D20180701-20190630" decimals="3" name="cah:EffectiveIncomeTaxRateReconciliationWithholdingTaxes" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90YWJsZTowODVmMDBiY2Q2YWQ0NDRhYmY3ODM4MGEwZWFhNWRkNy90YWJsZXJhbmdlOjA4NWYwMGJjZDZhZDQ0NGFiZjc4MzgwYTBlYWE1ZGQ3XzYtNS0xLTEtOTg3Mg_5bcffea5-34a4-473b-a86b-4dbd9b805840">0.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Change in Valuation Allowances</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90YWJsZTowODVmMDBiY2Q2YWQ0NDRhYmY3ODM4MGEwZWFhNWRkNy90YWJsZXJhbmdlOjA4NWYwMGJjZDZhZDQ0NGFiZjc4MzgwYTBlYWE1ZGQ3XzUtMS0xLTEtMA_e3c64ad2-0dcb-4d4b-9c7a-2059fc46ad59">1.4</ix:nonFraction>)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ia31e9a409b874bb19d0ff6f2f39ecc09_D20190701-20200630" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90YWJsZTowODVmMDBiY2Q2YWQ0NDRhYmY3ODM4MGEwZWFhNWRkNy90YWJsZXJhbmdlOjA4NWYwMGJjZDZhZDQ0NGFiZjc4MzgwYTBlYWE1ZGQ3XzUtMy0xLTEtMA_348a2440-2b53-4207-a36c-55ce999431a5">1.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i00a6d666bf604826b24e68ddbd63eac4_D20180701-20190630" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90YWJsZTowODVmMDBiY2Q2YWQ0NDRhYmY3ODM4MGEwZWFhNWRkNy90YWJsZXJhbmdlOjA4NWYwMGJjZDZhZDQ0NGFiZjc4MzgwYTBlYWE1ZGQ3XzUtNS0xLTEtMA_30a85656-0237-43ac-ac17-bae75c1d66a0">4.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">US Taxes on International Income</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"> (2)(3)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630" decimals="3" sign="-" name="cah:EffectiveTaxRateReconciliationUSTaxesOnInternationalIncome" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90YWJsZTowODVmMDBiY2Q2YWQ0NDRhYmY3ODM4MGEwZWFhNWRkNy90YWJsZXJhbmdlOjA4NWYwMGJjZDZhZDQ0NGFiZjc4MzgwYTBlYWE1ZGQ3XzYtMS0xLTEtMA_a99ea6bc-ef26-40f9-893f-ba9b30428b66">6.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ia31e9a409b874bb19d0ff6f2f39ecc09_D20190701-20200630" decimals="3" name="cah:EffectiveTaxRateReconciliationUSTaxesOnInternationalIncome" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90YWJsZTowODVmMDBiY2Q2YWQ0NDRhYmY3ODM4MGEwZWFhNWRkNy90YWJsZXJhbmdlOjA4NWYwMGJjZDZhZDQ0NGFiZjc4MzgwYTBlYWE1ZGQ3XzYtMy0xLTEtMA_69777a28-2929-47e8-b700-76b8487583a4">0.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i00a6d666bf604826b24e68ddbd63eac4_D20180701-20190630" decimals="3" name="cah:EffectiveTaxRateReconciliationUSTaxesOnInternationalIncome" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90YWJsZTowODVmMDBiY2Q2YWQ0NDRhYmY3ODM4MGEwZWFhNWRkNy90YWJsZXJhbmdlOjA4NWYwMGJjZDZhZDQ0NGFiZjc4MzgwYTBlYWE1ZGQ3XzYtNS0xLTEtMA_36f6c2ec-3417-464a-84b7-37bbdb24459d">0.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Impact of Resolutions with IRS and other related matters </span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630" decimals="3" sign="-" name="cah:EffectiveTaxRateReconciliationImpactOfResolutionsWithIRSAndOtherRelatedMatters" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90YWJsZTowODVmMDBiY2Q2YWQ0NDRhYmY3ODM4MGEwZWFhNWRkNy90YWJsZXJhbmdlOjA4NWYwMGJjZDZhZDQ0NGFiZjc4MzgwYTBlYWE1ZGQ3XzgtMS0xLTEtMA_6434d1f2-1fa0-4879-865b-3cbbbf8f32d8">13.6</ix:nonFraction>)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="ia31e9a409b874bb19d0ff6f2f39ecc09_D20190701-20200630" decimals="3" sign="-" name="cah:EffectiveTaxRateReconciliationImpactOfResolutionsWithIRSAndOtherRelatedMatters" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90YWJsZTowODVmMDBiY2Q2YWQ0NDRhYmY3ODM4MGEwZWFhNWRkNy90YWJsZXJhbmdlOjA4NWYwMGJjZDZhZDQ0NGFiZjc4MzgwYTBlYWE1ZGQ3XzgtMy0xLTEtMA_90ab4014-2059-48dd-96e2-a1f2959ab9ef">0.4</ix:nonFraction>)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i00a6d666bf604826b24e68ddbd63eac4_D20180701-20190630" decimals="3" sign="-" name="cah:EffectiveTaxRateReconciliationImpactOfResolutionsWithIRSAndOtherRelatedMatters" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90YWJsZTowODVmMDBiY2Q2YWQ0NDRhYmY3ODM4MGEwZWFhNWRkNy90YWJsZXJhbmdlOjA4NWYwMGJjZDZhZDQ0NGFiZjc4MzgwYTBlYWE1ZGQ3XzgtNS0xLTEtMA_d8671394-b864-4fc2-90e4-e73a76ade3a2">0.1</ix:nonFraction>)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Legal Entity Reorganization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630" decimals="3" format="ixt:zerodash" name="cah:EffectiveIncomeTaxRateReconciliationLegalEntityReorganizationReconcilingItemsPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90YWJsZTowODVmMDBiY2Q2YWQ0NDRhYmY3ODM4MGEwZWFhNWRkNy90YWJsZXJhbmdlOjA4NWYwMGJjZDZhZDQ0NGFiZjc4MzgwYTBlYWE1ZGQ3XzktMS0xLTEtMA_fed1df49-b079-411b-ba32-c4dfa55e7e70">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ia31e9a409b874bb19d0ff6f2f39ecc09_D20190701-20200630" decimals="3" format="ixt:zerodash" name="cah:EffectiveIncomeTaxRateReconciliationLegalEntityReorganizationReconcilingItemsPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90YWJsZTowODVmMDBiY2Q2YWQ0NDRhYmY3ODM4MGEwZWFhNWRkNy90YWJsZXJhbmdlOjA4NWYwMGJjZDZhZDQ0NGFiZjc4MzgwYTBlYWE1ZGQ3XzktMy0xLTEtMA_8a29416b-6355-4d16-b953-bc64256de459">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i00a6d666bf604826b24e68ddbd63eac4_D20180701-20190630" decimals="3" sign="-" name="cah:EffectiveIncomeTaxRateReconciliationLegalEntityReorganizationReconcilingItemsPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90YWJsZTowODVmMDBiY2Q2YWQ0NDRhYmY3ODM4MGEwZWFhNWRkNy90YWJsZXJhbmdlOjA4NWYwMGJjZDZhZDQ0NGFiZjc4MzgwYTBlYWE1ZGQ3XzktNS0xLTEtMA_c88d6e86-3aa8-46fd-b713-cbb9c77d6675">3.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Opioid litigation</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630" decimals="3" name="cah:EffectiveIncomeTaxReconciliationOpioidLitigation" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90YWJsZTowODVmMDBiY2Q2YWQ0NDRhYmY3ODM4MGEwZWFhNWRkNy90YWJsZXJhbmdlOjA4NWYwMGJjZDZhZDQ0NGFiZjc4MzgwYTBlYWE1ZGQ3XzExLTEtMS0xLTA_a3386edb-c17c-4ad7-90b7-167e4fcc393d">17.7</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="ia31e9a409b874bb19d0ff6f2f39ecc09_D20190701-20200630" decimals="3" sign="-" name="cah:EffectiveIncomeTaxReconciliationOpioidLitigation" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90YWJsZTowODVmMDBiY2Q2YWQ0NDRhYmY3ODM4MGEwZWFhNWRkNy90YWJsZXJhbmdlOjA4NWYwMGJjZDZhZDQ0NGFiZjc4MzgwYTBlYWE1ZGQ3XzExLTMtMS0xLTA_b1074647-09a6-46f3-9e51-b4a874694452">23.2</ix:nonFraction>)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i00a6d666bf604826b24e68ddbd63eac4_D20180701-20190630" decimals="3" format="ixt:zerodash" name="cah:EffectiveIncomeTaxReconciliationOpioidLitigation" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90YWJsZTowODVmMDBiY2Q2YWQ0NDRhYmY3ODM4MGEwZWFhNWRkNy90YWJsZXJhbmdlOjA4NWYwMGJjZDZhZDQ0NGFiZjc4MzgwYTBlYWE1ZGQ3XzExLTUtMS0xLTA_22ca0f68-0588-4cce-9f9c-e24e4b90c92c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Loss Carryback Claims</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630" decimals="3" sign="-" name="cah:EffectiveIncomeTaxRateReconciliationLossCarrybackClaims" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90YWJsZTowODVmMDBiY2Q2YWQ0NDRhYmY3ODM4MGEwZWFhNWRkNy90YWJsZXJhbmdlOjA4NWYwMGJjZDZhZDQ0NGFiZjc4MzgwYTBlYWE1ZGQ3XzEyLTEtMS0xLTA_9e8a618b-bd4c-4b27-8c96-ee695d45eb5e">129.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ia31e9a409b874bb19d0ff6f2f39ecc09_D20190701-20200630" decimals="3" format="ixt:zerodash" name="cah:EffectiveIncomeTaxRateReconciliationLossCarrybackClaims" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90YWJsZTowODVmMDBiY2Q2YWQ0NDRhYmY3ODM4MGEwZWFhNWRkNy90YWJsZXJhbmdlOjA4NWYwMGJjZDZhZDQ0NGFiZjc4MzgwYTBlYWE1ZGQ3XzEyLTMtMS0xLTA_fe4752fc-b967-4e69-bf99-2d23e82c5d45">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i00a6d666bf604826b24e68ddbd63eac4_D20180701-20190630" decimals="3" format="ixt:zerodash" name="cah:EffectiveIncomeTaxRateReconciliationLossCarrybackClaims" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90YWJsZTowODVmMDBiY2Q2YWQ0NDRhYmY3ODM4MGEwZWFhNWRkNy90YWJsZXJhbmdlOjA4NWYwMGJjZDZhZDQ0NGFiZjc4MzgwYTBlYWE1ZGQ3XzEyLTUtMS0xLTA_19afa086-bb91-4d0d-87e9-7358fe949a84">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other </span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90YWJsZTowODVmMDBiY2Q2YWQ0NDRhYmY3ODM4MGEwZWFhNWRkNy90YWJsZXJhbmdlOjA4NWYwMGJjZDZhZDQ0NGFiZjc4MzgwYTBlYWE1ZGQ3XzEzLTEtMS0xLTA_02955519-4228-4180-bc33-ca81d08bf20d">1.7</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ia31e9a409b874bb19d0ff6f2f39ecc09_D20190701-20200630" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90YWJsZTowODVmMDBiY2Q2YWQ0NDRhYmY3ODM4MGEwZWFhNWRkNy90YWJsZXJhbmdlOjA4NWYwMGJjZDZhZDQ0NGFiZjc4MzgwYTBlYWE1ZGQ3XzEzLTMtMS0xLTA_fcb7c909-5ed5-4c7a-80d7-5523237cdb9f">0.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i00a6d666bf604826b24e68ddbd63eac4_D20180701-20190630" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90YWJsZTowODVmMDBiY2Q2YWQ0NDRhYmY3ODM4MGEwZWFhNWRkNy90YWJsZXJhbmdlOjA4NWYwMGJjZDZhZDQ0NGFiZjc4MzgwYTBlYWE1ZGQ3XzEzLTUtMS0xLTA_38d10ca9-edb5-454f-9dc4-fa35793795c1">2.1</ix:nonFraction>)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Effective income tax rate</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90YWJsZTowODVmMDBiY2Q2YWQ0NDRhYmY3ODM4MGEwZWFhNWRkNy90YWJsZXJhbmdlOjA4NWYwMGJjZDZhZDQ0NGFiZjc4MzgwYTBlYWE1ZGQ3XzE0LTEtMS0xLTA_5ce68634-cfb8-4f8e-8057-77cb1f40b47a">89.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ia31e9a409b874bb19d0ff6f2f39ecc09_D20190701-20200630" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90YWJsZTowODVmMDBiY2Q2YWQ0NDRhYmY3ODM4MGEwZWFhNWRkNy90YWJsZXJhbmdlOjA4NWYwMGJjZDZhZDQ0NGFiZjc4MzgwYTBlYWE1ZGQ3XzE0LTMtMS0xLTA_f4ed847a-7aef-4e4b-b39c-436e9c8b3f0a">2.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i00a6d666bf604826b24e68ddbd63eac4_D20180701-20190630" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90YWJsZTowODVmMDBiY2Q2YWQ0NDRhYmY3ODM4MGEwZWFhNWRkNy90YWJsZXJhbmdlOjA4NWYwMGJjZDZhZDQ0NGFiZjc4MzgwYTBlYWE1ZGQ3XzE0LTUtMS0xLTA_9913af26-15c8-47e5-bfbe-93b48e90f933">22.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;The table represents the following: fiscal 2021 is pretax income with tax benefit, fiscal 2020 is pretax loss with tax benefit, and fiscal 2019 is pretax income with tax expense.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)&#160;&#160;&#160;&#160;Certain prior year amounts have been reclassified to conform to current year presentation.</span></div></ix:nonNumeric></div><div style="display:inline-block;max-width:3.571%;min-width:2.571%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:48.215%"><div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(3)&#160;&#160;&#160;&#160;Includes the tax impact of Global Intangible Low-Taxed Income ("GILTI") tax, the Foreign-Derived Intangible Income deduction and other foreign income that is taxable under the U.S. tax code. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The income tax benefit rate was <ix:nonFraction unitRef="number" contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90ZXh0cmVnaW9uOmViYTAwMWFhMmQ5YjRmODZiMGIyMTI2YzNmMjlhODhmXzI3NDg3NzkwOTk3NzY_c6c80c77-b6e0-48c1-a8a4-69693359c479">89.7</ix:nonFraction>% and <ix:nonFraction unitRef="number" contextRef="ia31e9a409b874bb19d0ff6f2f39ecc09_D20190701-20200630" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90ZXh0cmVnaW9uOmViYTAwMWFhMmQ5YjRmODZiMGIyMTI2YzNmMjlhODhmXzcxNDY4MjU1ODk2NTA_f4ed847a-7aef-4e4b-b39c-436e9c8b3f0a">2.1</ix:nonFraction>% in fiscal 2021 and fiscal 2020 compared to an income tax expense rate of <ix:nonFraction unitRef="number" contextRef="i00a6d666bf604826b24e68ddbd63eac4_D20180701-20190630" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90ZXh0cmVnaW9uOmViYTAwMWFhMmQ5YjRmODZiMGIyMTI2YzNmMjlhODhmXzcxNDY4MjU1ODk2NjI_9913af26-15c8-47e5-bfbe-93b48e90f933">22.1</ix:nonFraction>% in fiscal 2019. Fluctuations in the effective tax rates are primarily due to the impact of opioid litigation in fiscal 2021 and 2020, as well as the impact of the carryback claim filed in accordance with the CARES Act provision in fiscal year 2021.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our effective tax rate has benefits from negotiated lower than statutory tax rates in select foreign jurisdictions which individually are not material to our effective tax rate but in aggregate have a favorable tax impact of approximately $<ix:nonFraction unitRef="usd" contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630" decimals="-6" format="ixt:numdotdecimal" name="cah:EffectiveTaxRateImpactFromCertainForeignJurisdictions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90ZXh0cmVnaW9uOmViYTAwMWFhMmQ5YjRmODZiMGIyMTI2YzNmMjlhODhmXzI1NjE_b7559e2f-edaf-4719-825f-02cccca87c5e">20</ix:nonFraction> million during fiscal 2021.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of June&#160;30, 2021, foreign earnings of approximately $<ix:nonFraction unitRef="usd" contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:TaxCutsAndJobsActOf2017TransitionTaxForAccumulatedForeignEarningsIncomeTaxExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90ZXh0cmVnaW9uOmViYTAwMWFhMmQ5YjRmODZiMGIyMTI2YzNmMjlhODhmXzM4NTA_126bb505-6352-4c07-a3ee-cf1f83d42a63">825</ix:nonFraction> million are considered indefinitely reinvested for working capital and other offshore investment needs. The computation of tax required if those earnings are repatriated is not practicable. For amounts not considered indefinitely reinvested, we have recorded an immaterial amount of income tax expense in our financial statements in fiscal 2021. </span></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Deferred Income Taxes</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deferred income taxes arise from temporary differences between financial reporting and tax reporting bases of assets and liabilities and operating loss and tax credit carryforwards for tax purposes. </span></div><ix:nonNumeric contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630" name="us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90ZXh0cmVnaW9uOmViYTAwMWFhMmQ5YjRmODZiMGIyMTI2YzNmMjlhODhmXzg3OTc_b5561716-7a92-447f-a242-d26d3b0c3e08" escape="true"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the components of the deferred income tax assets and liabilities at June 30:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:60.937%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.109%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.343%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.111%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Deferred income tax assets:</span></td><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Receivable basis difference</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2e87824102b34590a0208cc7da91b5f5_I20210630" decimals="-6" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90YWJsZTo2NWM3MmU1ZDI1N2M0MzZlYjQ0NGJjMjViMzU4ODIzZS90YWJsZXJhbmdlOjY1YzcyZTVkMjU3YzQzNmViNDQ0YmMyNWIzNTg4MjNlXzItMS0xLTEtMA_73a9945d-8b96-411b-ad60-fb622f20218c">40</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i299cea70f47b4fbe96772aaa8cc00b79_I20200630" decimals="-6" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90YWJsZTo2NWM3MmU1ZDI1N2M0MzZlYjQ0NGJjMjViMzU4ODIzZS90YWJsZXJhbmdlOjY1YzcyZTVkMjU3YzQzNmViNDQ0YmMyNWIzNTg4MjNlXzItMy0xLTEtMA_1b26551a-fb37-4725-8816-7580d499dcaa">39</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accrued liabilities</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2e87824102b34590a0208cc7da91b5f5_I20210630" decimals="-6" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90YWJsZTo2NWM3MmU1ZDI1N2M0MzZlYjQ0NGJjMjViMzU4ODIzZS90YWJsZXJhbmdlOjY1YzcyZTVkMjU3YzQzNmViNDQ0YmMyNWIzNTg4MjNlXzMtMS0xLTEtMA_adb28125-abf4-4ee3-9176-44f9bef10e0b">874</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i299cea70f47b4fbe96772aaa8cc00b79_I20200630" decimals="-6" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90YWJsZTo2NWM3MmU1ZDI1N2M0MzZlYjQ0NGJjMjViMzU4ODIzZS90YWJsZXJhbmdlOjY1YzcyZTVkMjU3YzQzNmViNDQ0YmMyNWIzNTg4MjNlXzMtMy0xLTEtMA_75160e8d-a4ee-421a-952c-6df1f6601a31">607</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Share-based compensation</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2e87824102b34590a0208cc7da91b5f5_I20210630" decimals="-6" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90YWJsZTo2NWM3MmU1ZDI1N2M0MzZlYjQ0NGJjMjViMzU4ODIzZS90YWJsZXJhbmdlOjY1YzcyZTVkMjU3YzQzNmViNDQ0YmMyNWIzNTg4MjNlXzQtMS0xLTEtMA_fee6d89a-abda-44c3-935e-3d8404301c35">38</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i299cea70f47b4fbe96772aaa8cc00b79_I20200630" decimals="-6" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90YWJsZTo2NWM3MmU1ZDI1N2M0MzZlYjQ0NGJjMjViMzU4ODIzZS90YWJsZXJhbmdlOjY1YzcyZTVkMjU3YzQzNmViNDQ0YmMyNWIzNTg4MjNlXzQtMy0xLTEtMA_eff753c0-e5fb-455f-a0b9-c893add81e3f">38</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Loss and tax credit carryforwards</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2e87824102b34590a0208cc7da91b5f5_I20210630" decimals="-6" name="us-gaap:DeferredTaxAssetsTaxCreditCarryforwards" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90YWJsZTo2NWM3MmU1ZDI1N2M0MzZlYjQ0NGJjMjViMzU4ODIzZS90YWJsZXJhbmdlOjY1YzcyZTVkMjU3YzQzNmViNDQ0YmMyNWIzNTg4MjNlXzUtMS0xLTEtMA_f2633284-07fa-4a76-b288-a6c406c6b93d">805</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i299cea70f47b4fbe96772aaa8cc00b79_I20200630" decimals="-6" name="us-gaap:DeferredTaxAssetsTaxCreditCarryforwards" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90YWJsZTo2NWM3MmU1ZDI1N2M0MzZlYjQ0NGJjMjViMzU4ODIzZS90YWJsZXJhbmdlOjY1YzcyZTVkMjU3YzQzNmViNDQ0YmMyNWIzNTg4MjNlXzUtMy0xLTEtMA_743fe2f7-5bd5-49e4-b07b-0d0e76a56b32">589</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Deferred tax assets related to uncertain tax positions</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2e87824102b34590a0208cc7da91b5f5_I20210630" decimals="-6" name="cah:DeferredTaxAssetsRelatedtouncertaintaxpositions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90YWJsZTo2NWM3MmU1ZDI1N2M0MzZlYjQ0NGJjMjViMzU4ODIzZS90YWJsZXJhbmdlOjY1YzcyZTVkMjU3YzQzNmViNDQ0YmMyNWIzNTg4MjNlXzYtMS0xLTEtMA_afd56c84-29e1-47bb-8293-910c24c9e23c">35</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i299cea70f47b4fbe96772aaa8cc00b79_I20200630" decimals="-6" name="cah:DeferredTaxAssetsRelatedtouncertaintaxpositions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90YWJsZTo2NWM3MmU1ZDI1N2M0MzZlYjQ0NGJjMjViMzU4ODIzZS90YWJsZXJhbmdlOjY1YzcyZTVkMjU3YzQzNmViNDQ0YmMyNWIzNTg4MjNlXzYtMy0xLTEtMA_adb8468d-fe7a-4ad2-99d2-4158bab5bc04">52</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2e87824102b34590a0208cc7da91b5f5_I20210630" decimals="-6" name="us-gaap:DeferredTaxAssetsOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90YWJsZTo2NWM3MmU1ZDI1N2M0MzZlYjQ0NGJjMjViMzU4ODIzZS90YWJsZXJhbmdlOjY1YzcyZTVkMjU3YzQzNmViNDQ0YmMyNWIzNTg4MjNlXzctMS0xLTEtMA_6b416c17-830b-4283-bf60-6bd4d82184eb">16</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i299cea70f47b4fbe96772aaa8cc00b79_I20200630" decimals="-6" name="us-gaap:DeferredTaxAssetsOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90YWJsZTo2NWM3MmU1ZDI1N2M0MzZlYjQ0NGJjMjViMzU4ODIzZS90YWJsZXJhbmdlOjY1YzcyZTVkMjU3YzQzNmViNDQ0YmMyNWIzNTg4MjNlXzctMy0xLTEtMA_55e50b39-278d-4102-961d-dbcbc7474c2f">87</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total deferred income tax assets</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2e87824102b34590a0208cc7da91b5f5_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DeferredTaxAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90YWJsZTo2NWM3MmU1ZDI1N2M0MzZlYjQ0NGJjMjViMzU4ODIzZS90YWJsZXJhbmdlOjY1YzcyZTVkMjU3YzQzNmViNDQ0YmMyNWIzNTg4MjNlXzgtMS0xLTEtMA_a398ae8c-c1a0-4c82-99c1-aec25034b823">1,808</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i299cea70f47b4fbe96772aaa8cc00b79_I20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DeferredTaxAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90YWJsZTo2NWM3MmU1ZDI1N2M0MzZlYjQ0NGJjMjViMzU4ODIzZS90YWJsZXJhbmdlOjY1YzcyZTVkMjU3YzQzNmViNDQ0YmMyNWIzNTg4MjNlXzgtMy0xLTEtMA_056b79e8-4f4b-4fca-97ae-a3f4856e5291">1,412</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Valuation allowance for deferred income tax assets</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2e87824102b34590a0208cc7da91b5f5_I20210630" decimals="-6" name="us-gaap:DeferredTaxAssetsValuationAllowance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90YWJsZTo2NWM3MmU1ZDI1N2M0MzZlYjQ0NGJjMjViMzU4ODIzZS90YWJsZXJhbmdlOjY1YzcyZTVkMjU3YzQzNmViNDQ0YmMyNWIzNTg4MjNlXzktMS0xLTEtMA_1577cede-a3d4-48ea-bd56-b903fbec328b">515</ix:nonFraction>)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i299cea70f47b4fbe96772aaa8cc00b79_I20200630" decimals="-6" name="us-gaap:DeferredTaxAssetsValuationAllowance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90YWJsZTo2NWM3MmU1ZDI1N2M0MzZlYjQ0NGJjMjViMzU4ODIzZS90YWJsZXJhbmdlOjY1YzcyZTVkMjU3YzQzNmViNDQ0YmMyNWIzNTg4MjNlXzktMy0xLTEtMA_86c79d97-6b0f-4c51-bdaa-2fde2786ff78">470</ix:nonFraction>)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net deferred income tax assets</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2e87824102b34590a0208cc7da91b5f5_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DeferredTaxAssetsLiabilitiesNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90YWJsZTo2NWM3MmU1ZDI1N2M0MzZlYjQ0NGJjMjViMzU4ODIzZS90YWJsZXJhbmdlOjY1YzcyZTVkMjU3YzQzNmViNDQ0YmMyNWIzNTg4MjNlXzEwLTEtMS0xLTA_41a1a88b-91df-4092-9430-f6855609b855">1,293</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i299cea70f47b4fbe96772aaa8cc00b79_I20200630" decimals="-6" name="us-gaap:DeferredTaxAssetsLiabilitiesNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90YWJsZTo2NWM3MmU1ZDI1N2M0MzZlYjQ0NGJjMjViMzU4ODIzZS90YWJsZXJhbmdlOjY1YzcyZTVkMjU3YzQzNmViNDQ0YmMyNWIzNTg4MjNlXzEwLTMtMS0xLTA_80747fae-1201-4f62-afbf-8d37f553338a">942</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cccccc;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;border-top:2pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Deferred income tax liabilities:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Inventory basis differences</span></td><td style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2e87824102b34590a0208cc7da91b5f5_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DeferredTaxLiabilitiesDeferredExpenseCapitalizedInventoryCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90YWJsZTo2NWM3MmU1ZDI1N2M0MzZlYjQ0NGJjMjViMzU4ODIzZS90YWJsZXJhbmdlOjY1YzcyZTVkMjU3YzQzNmViNDQ0YmMyNWIzNTg4MjNlXzEzLTEtMS0xLTA_9c5a6b38-d388-4607-bf80-2fd6c66e0b97">1,119</ix:nonFraction>)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i299cea70f47b4fbe96772aaa8cc00b79_I20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DeferredTaxLiabilitiesDeferredExpenseCapitalizedInventoryCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90YWJsZTo2NWM3MmU1ZDI1N2M0MzZlYjQ0NGJjMjViMzU4ODIzZS90YWJsZXJhbmdlOjY1YzcyZTVkMjU3YzQzNmViNDQ0YmMyNWIzNTg4MjNlXzEzLTMtMS0xLTA_9a99ccd5-7db2-47d0-acf4-956f40ae20e8">1,083</ix:nonFraction>)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Property-related</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2e87824102b34590a0208cc7da91b5f5_I20210630" decimals="-6" name="us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90YWJsZTo2NWM3MmU1ZDI1N2M0MzZlYjQ0NGJjMjViMzU4ODIzZS90YWJsZXJhbmdlOjY1YzcyZTVkMjU3YzQzNmViNDQ0YmMyNWIzNTg4MjNlXzE0LTEtMS0xLTA_479e39a1-623a-4bed-9f48-07f68a182427">375</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i299cea70f47b4fbe96772aaa8cc00b79_I20200630" decimals="-6" name="us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90YWJsZTo2NWM3MmU1ZDI1N2M0MzZlYjQ0NGJjMjViMzU4ODIzZS90YWJsZXJhbmdlOjY1YzcyZTVkMjU3YzQzNmViNDQ0YmMyNWIzNTg4MjNlXzE0LTMtMS0xLTA_2763d7aa-ec33-41ae-bfbc-332087633316">327</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Goodwill and other intangibles</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2e87824102b34590a0208cc7da91b5f5_I20210630" decimals="-6" name="us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90YWJsZTo2NWM3MmU1ZDI1N2M0MzZlYjQ0NGJjMjViMzU4ODIzZS90YWJsZXJhbmdlOjY1YzcyZTVkMjU3YzQzNmViNDQ0YmMyNWIzNTg4MjNlXzE1LTEtMS0xLTEwMDQ4_3d260399-ca28-4f8f-a262-4352abd2f3c1">733</ix:nonFraction>)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i299cea70f47b4fbe96772aaa8cc00b79_I20200630" decimals="-6" name="us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90YWJsZTo2NWM3MmU1ZDI1N2M0MzZlYjQ0NGJjMjViMzU4ODIzZS90YWJsZXJhbmdlOjY1YzcyZTVkMjU3YzQzNmViNDQ0YmMyNWIzNTg4MjNlXzE1LTMtMS0xLTEwMDU0_6aab67f4-367c-442c-b797-3d5d388b5c20">751</ix:nonFraction>)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Self-Insurance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2e87824102b34590a0208cc7da91b5f5_I20210630" decimals="-6" name="us-gaap:DeferredTaxLiabilitiesDeferredExpenseReservesAndAccruals" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90YWJsZTo2NWM3MmU1ZDI1N2M0MzZlYjQ0NGJjMjViMzU4ODIzZS90YWJsZXJhbmdlOjY1YzcyZTVkMjU3YzQzNmViNDQ0YmMyNWIzNTg4MjNlXzE2LTEtMS0xLTEwMDQ4_4d4c5242-febd-4ffa-9d15-af731dd5f961">975</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i299cea70f47b4fbe96772aaa8cc00b79_I20200630" decimals="-6" format="ixt:zerodash" name="us-gaap:DeferredTaxLiabilitiesDeferredExpenseReservesAndAccruals" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90YWJsZTo2NWM3MmU1ZDI1N2M0MzZlYjQ0NGJjMjViMzU4ODIzZS90YWJsZXJhbmdlOjY1YzcyZTVkMjU3YzQzNmViNDQ0YmMyNWIzNTg4MjNlXzE2LTMtMS0xLTEwMDU0_ee4d33c0-540c-4cc1-afae-ff0f18a72b3c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2e87824102b34590a0208cc7da91b5f5_I20210630" decimals="-6" name="us-gaap:DeferredTaxLiabilitiesOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90YWJsZTo2NWM3MmU1ZDI1N2M0MzZlYjQ0NGJjMjViMzU4ODIzZS90YWJsZXJhbmdlOjY1YzcyZTVkMjU3YzQzNmViNDQ0YmMyNWIzNTg4MjNlXzE1LTEtMS0xLTA_307a2789-05a2-4634-a615-49a9e2b4b1e7">23</ix:nonFraction>)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i299cea70f47b4fbe96772aaa8cc00b79_I20200630" decimals="-6" format="ixt:zerodash" name="us-gaap:DeferredTaxLiabilitiesOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90YWJsZTo2NWM3MmU1ZDI1N2M0MzZlYjQ0NGJjMjViMzU4ODIzZS90YWJsZXJhbmdlOjY1YzcyZTVkMjU3YzQzNmViNDQ0YmMyNWIzNTg4MjNlXzE1LTMtMS0xLTA_078b59d7-5787-4099-a683-f93f8cd5d7c4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total deferred income tax liabilities</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2e87824102b34590a0208cc7da91b5f5_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DeferredIncomeTaxLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90YWJsZTo2NWM3MmU1ZDI1N2M0MzZlYjQ0NGJjMjViMzU4ODIzZS90YWJsZXJhbmdlOjY1YzcyZTVkMjU3YzQzNmViNDQ0YmMyNWIzNTg4MjNlXzE2LTEtMS0xLTA_6cf606a2-df7e-4367-a7c6-0a4cce7d2ed2">3,225</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i299cea70f47b4fbe96772aaa8cc00b79_I20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DeferredIncomeTaxLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90YWJsZTo2NWM3MmU1ZDI1N2M0MzZlYjQ0NGJjMjViMzU4ODIzZS90YWJsZXJhbmdlOjY1YzcyZTVkMjU3YzQzNmViNDQ0YmMyNWIzNTg4MjNlXzE2LTMtMS0xLTA_2dd9d3c7-74a1-4e3a-bd01-431720255492">2,161</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:6pt;padding-left:6.75pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net deferred income tax liability</span></div></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2e87824102b34590a0208cc7da91b5f5_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DeferredTaxLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90YWJsZTo2NWM3MmU1ZDI1N2M0MzZlYjQ0NGJjMjViMzU4ODIzZS90YWJsZXJhbmdlOjY1YzcyZTVkMjU3YzQzNmViNDQ0YmMyNWIzNTg4MjNlXzE3LTEtMS0xLTA_9b50dad6-2324-447d-8e75-008c28f9690a">1,932</ix:nonFraction>)</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i299cea70f47b4fbe96772aaa8cc00b79_I20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DeferredTaxLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90YWJsZTo2NWM3MmU1ZDI1N2M0MzZlYjQ0NGJjMjViMzU4ODIzZS90YWJsZXJhbmdlOjY1YzcyZTVkMjU3YzQzNmViNDQ0YmMyNWIzNTg4MjNlXzE3LTMtMS0xLTA_18e66764-740d-4270-9d82-4c8ee70c6cfb">1,219</ix:nonFraction>)</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></div></ix:continuation></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:3pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.222%"><tr><td style="width:1.0%"></td><td style="width:32.133%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.433%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.134%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">78</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardinal Health </span><span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">| </span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2021 Form 10-K</span></div></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:3pt"><span><br/></span></div><div style="margin-bottom:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:24.682%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:50.911%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.107%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#e41f35;border-bottom:1pt solid #e41f35;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Notes to Financial Statements</span></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:0 1pt"></td></tr></table></div></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:48.214%"><ix:continuation id="i404826af41e7493b9c6956c5c04f1ac7" continuedAt="icfca45672e8644aab16311fe97c3f11f"><ix:nonNumeric contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630" name="cah:ScheduleOfDeferredTaxAssetsAndLiabilitiesAfterNettingByTaxJurisdictionTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90ZXh0cmVnaW9uOmViYTAwMWFhMmQ5YjRmODZiMGIyMTI2YzNmMjlhODhmXzg4MjM_99975c15-83de-47a7-8d6f-75a5bfb7190d" escape="true"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deferred income tax assets and liabilities in the preceding table, after netting by taxing jurisdiction and for uncertain tax positions, are in the following captions in the consolidated balance sheets at June 30:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:60.937%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.109%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.343%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.111%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Noncurrent deferred income tax asset (1)</span></td><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2e87824102b34590a0208cc7da91b5f5_I20210630" decimals="-6" name="us-gaap:DeferredIncomeTaxesAndOtherAssetsNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90YWJsZToxYTY5NmEzZGNjZDI0MmZlOWM5MzI4NGE2NzRlZWUzMS90YWJsZXJhbmdlOjFhNjk2YTNkY2NkMjQyZmU5YzkzMjg0YTY3NGVlZTMxXzItMS0xLTEtMA_b6fa07e9-c08b-43c3-91da-8c98d5c78685">52</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i299cea70f47b4fbe96772aaa8cc00b79_I20200630" decimals="-6" name="us-gaap:DeferredIncomeTaxesAndOtherAssetsNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90YWJsZToxYTY5NmEzZGNjZDI0MmZlOWM5MzI4NGE2NzRlZWUzMS90YWJsZXJhbmdlOjFhNjk2YTNkY2NkMjQyZmU5YzkzMjg0YTY3NGVlZTMxXzItMy0xLTEtMA_3ad403d6-40f3-49f4-9ffa-8be6f3ca613b">39</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Noncurrent deferred income tax liability (2)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2e87824102b34590a0208cc7da91b5f5_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DeferredIncomeTaxesAndOtherTaxLiabilitiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90YWJsZToxYTY5NmEzZGNjZDI0MmZlOWM5MzI4NGE2NzRlZWUzMS90YWJsZXJhbmdlOjFhNjk2YTNkY2NkMjQyZmU5YzkzMjg0YTY3NGVlZTMxXzQtMS0xLTEtMTEyNDA_a8cd68d3-548e-41ff-918a-ff4775ccf485">1,981</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i299cea70f47b4fbe96772aaa8cc00b79_I20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DeferredIncomeTaxesAndOtherTaxLiabilitiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90YWJsZToxYTY5NmEzZGNjZDI0MmZlOWM5MzI4NGE2NzRlZWUzMS90YWJsZXJhbmdlOjFhNjk2YTNkY2NkMjQyZmU5YzkzMjg0YTY3NGVlZTMxXzQtMy0xLTEtMTEyNTQ_64fdba6c-d4d4-492b-85c7-d05abb0c669a">1,258</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Noncurrent deferred income tax liability transferred to held for sale</span></td><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2e87824102b34590a0208cc7da91b5f5_I20210630" decimals="-6" name="cah:DeferredIncomeTaxesAndOtherTaxLiabilitiesTransferredToHeldForSaleNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90YWJsZToxYTY5NmEzZGNjZDI0MmZlOWM5MzI4NGE2NzRlZWUzMS90YWJsZXJhbmdlOjFhNjk2YTNkY2NkMjQyZmU5YzkzMjg0YTY3NGVlZTMxXzMtMS0xLTEtMTAwNjY_dfb9c86e-6b5e-4c47-a2b0-62962188af23">3</ix:nonFraction>)</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i299cea70f47b4fbe96772aaa8cc00b79_I20200630" decimals="-6" format="ixt:zerodash" name="cah:DeferredIncomeTaxesAndOtherTaxLiabilitiesTransferredToHeldForSaleNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90YWJsZToxYTY5NmEzZGNjZDI0MmZlOWM5MzI4NGE2NzRlZWUzMS90YWJsZXJhbmdlOjFhNjk2YTNkY2NkMjQyZmU5YzkzMjg0YTY3NGVlZTMxXzMtMy0xLTEtMTAwNjk_7aff8341-0d3e-402c-a1a7-7f8113754760">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net deferred income tax liability</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2e87824102b34590a0208cc7da91b5f5_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DeferredTaxLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90YWJsZToxYTY5NmEzZGNjZDI0MmZlOWM5MzI4NGE2NzRlZWUzMS90YWJsZXJhbmdlOjFhNjk2YTNkY2NkMjQyZmU5YzkzMjg0YTY3NGVlZTMxXzMtMS0xLTEtMA_2fd02357-beba-403b-a575-b28924d47634">1,932</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i299cea70f47b4fbe96772aaa8cc00b79_I20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DeferredTaxLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90YWJsZToxYTY5NmEzZGNjZDI0MmZlOWM5MzI4NGE2NzRlZWUzMS90YWJsZXJhbmdlOjFhNjk2YTNkY2NkMjQyZmU5YzkzMjg0YTY3NGVlZTMxXzMtMy0xLTEtMA_46480403-4990-49f5-98c0-f4d796221560">1,219</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:10pt">Included in other assets in the consolidated balance sheets.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:10pt">Included in deferred income taxes and other liabilities in the consolidated balance sheets.</span></div></ix:nonNumeric><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At June&#160;30, 2021 we had gross federal, state and international loss and credit carryforwards of $<ix:nonFraction unitRef="usd" contextRef="ia9314223dc824180abfdd254ebfb27a4_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:TaxCreditCarryforwardAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90ZXh0cmVnaW9uOmViYTAwMWFhMmQ5YjRmODZiMGIyMTI2YzNmMjlhODhmXzQ5Nzc_691d29cb-4558-4a46-9587-53213b47f283">272</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="i0e143b481d18458ab822c450cdd8c4b9_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:TaxCreditCarryforwardAmount" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90ZXh0cmVnaW9uOmViYTAwMWFhMmQ5YjRmODZiMGIyMTI2YzNmMjlhODhmXzQ5ODE_2d4fe3c0-fd20-446d-99c9-842507802c6d">3.9</ix:nonFraction> billion and $<ix:nonFraction unitRef="usd" contextRef="i78a614f0d6654bc1bcffa521f2779f70_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:TaxCreditCarryforwardAmount" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90ZXh0cmVnaW9uOmViYTAwMWFhMmQ5YjRmODZiMGIyMTI2YzNmMjlhODhmXzQ5ODg_b8a9d8d2-b515-44d5-b339-3b5a117f84b1">2.3</ix:nonFraction> billion, respectively, the tax effect of which is an aggregate deferred tax asset of $<ix:nonFraction unitRef="usd" contextRef="i2e87824102b34590a0208cc7da91b5f5_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DeferredTaxAssetsTaxCreditCarryforwards" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90ZXh0cmVnaW9uOmViYTAwMWFhMmQ5YjRmODZiMGIyMTI2YzNmMjlhODhmXzUwNjg_e1c39e85-c752-496b-ae12-0a8935cbe269">805</ix:nonFraction> million. Substantially all of these carryforwards are available for at least three years. Approximately $<ix:nonFraction unitRef="usd" contextRef="i2e87824102b34590a0208cc7da91b5f5_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OperatingLossCarryforwardsValuationAllowance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90ZXh0cmVnaW9uOmViYTAwMWFhMmQ5YjRmODZiMGIyMTI2YzNmMjlhODhmXzUxNjc_93006099-4acd-4688-91f5-11e55042c8f5">477</ix:nonFraction> million of the valuation allowance at June&#160;30, 2021 applies to certain federal, state and international loss carryforwards that, in our opinion, are more likely than not to expire unutilized. However, to the extent that tax benefits related</span><span style="color:#ffffff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">to these carryforwards are realized in the future, the reduction in the valuation allowance would reduce income tax expense.</span></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Unrecognized Tax Benefits</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We had $<ix:nonFraction unitRef="usd" contextRef="i2e87824102b34590a0208cc7da91b5f5_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:UnrecognizedTaxBenefits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90ZXh0cmVnaW9uOmViYTAwMWFhMmQ5YjRmODZiMGIyMTI2YzNmMjlhODhmXzU1NTA_d0b01471-ebba-42aa-a402-98cd329aa595">932</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="i299cea70f47b4fbe96772aaa8cc00b79_I20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:UnrecognizedTaxBenefits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90ZXh0cmVnaW9uOmViYTAwMWFhMmQ5YjRmODZiMGIyMTI2YzNmMjlhODhmXzU1NTQ_c2f75399-5d5f-420f-aa75-fe6f97452881">998</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="if6dc09eec4e74751b47cdf037a5b1860_I20190630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:UnrecognizedTaxBenefits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90ZXh0cmVnaW9uOmViYTAwMWFhMmQ5YjRmODZiMGIyMTI2YzNmMjlhODhmXzU1NjE_fb581d71-49e5-47d4-895f-0104f12f4aa1">456</ix:nonFraction> million of unrecognized tax benefits at June&#160;30, 2021, 2020 and 2019, respectively. The June&#160;30, 2021, 2020 and 2019 balances include $<ix:nonFraction unitRef="usd" contextRef="i2e87824102b34590a0208cc7da91b5f5_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90ZXh0cmVnaW9uOmViYTAwMWFhMmQ5YjRmODZiMGIyMTI2YzNmMjlhODhmXzU2NjA_44978611-ad60-4dc9-b98a-3df65514b98b">849</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="i299cea70f47b4fbe96772aaa8cc00b79_I20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90ZXh0cmVnaW9uOmViYTAwMWFhMmQ5YjRmODZiMGIyMTI2YzNmMjlhODhmXzU2NjQ_d6dcce72-3fc3-483f-b110-ecfe220e25f0">753</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="if6dc09eec4e74751b47cdf037a5b1860_I20190630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90ZXh0cmVnaW9uOmViYTAwMWFhMmQ5YjRmODZiMGIyMTI2YzNmMjlhODhmXzU2NzE_6ce308ca-5fb5-4857-be8c-d9dba5ea5394">303</ix:nonFraction> million, respectively, of unrecognized tax benefits that, if recognized, would have an impact on the effective tax rate. The remaining unrecognized tax benefits relate to tax positions for which ultimate deductibility is highly certain but for which there is uncertainty as to the timing of such deductibility. Recognition of these tax benefits would not affect our effective tax rate. We include the full amount of unrecognized tax benefits in deferred income taxes and other liabilities in the consolidated balance sheets. <ix:nonNumeric contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630" name="us-gaap:ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90ZXh0cmVnaW9uOmViYTAwMWFhMmQ5YjRmODZiMGIyMTI2YzNmMjlhODhmXzg3NTQ_272b8cd8-5384-4634-96ca-7d0c06edba31" continuedAt="id51b58da505f496096f93db32a2c5606" escape="true">The following table presents a reconciliation of the beginning and ending amounts of unrecognized tax benefits:</ix:nonNumeric></span></div><div style="margin-top:5pt;text-align:center"><ix:continuation id="id51b58da505f496096f93db32a2c5606"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.691%"><tr><td style="width:1.0%"></td><td style="width:53.389%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.999%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.347%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.831%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.347%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.287%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance at beginning of fiscal year</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i299cea70f47b4fbe96772aaa8cc00b79_I20200630" decimals="-6" name="us-gaap:UnrecognizedTaxBenefits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90YWJsZToyNzU1NGI1NDNhOGQ0OWRjOWQ2OWU1YzU2YzhiNDE0OC90YWJsZXJhbmdlOjI3NTU0YjU0M2E4ZDQ5ZGM5ZDY5ZTVjNTZjOGI0MTQ4XzEtMS0xLTEtMA_1a47146d-d9c6-4a68-80b1-22d5e880b4d8">998</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if6dc09eec4e74751b47cdf037a5b1860_I20190630" decimals="-6" name="us-gaap:UnrecognizedTaxBenefits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90YWJsZToyNzU1NGI1NDNhOGQ0OWRjOWQ2OWU1YzU2YzhiNDE0OC90YWJsZXJhbmdlOjI3NTU0YjU0M2E4ZDQ5ZGM5ZDY5ZTVjNTZjOGI0MTQ4XzEtMy0xLTEtMA_5a447305-3846-4e2b-8647-09b12a6eb476">456</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39bbe70148ff4daea469e8420c1859d6_I20180630" decimals="-6" name="us-gaap:UnrecognizedTaxBenefits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90YWJsZToyNzU1NGI1NDNhOGQ0OWRjOWQ2OWU1YzU2YzhiNDE0OC90YWJsZXJhbmdlOjI3NTU0YjU0M2E4ZDQ5ZGM5ZDY5ZTVjNTZjOGI0MTQ4XzEtNS0xLTEtMA_5203d616-e9ac-4ffd-9132-a26bfaae32fe">423</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Additions for tax positions of the current year</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90YWJsZToyNzU1NGI1NDNhOGQ0OWRjOWQ2OWU1YzU2YzhiNDE0OC90YWJsZXJhbmdlOjI3NTU0YjU0M2E4ZDQ5ZGM5ZDY5ZTVjNTZjOGI0MTQ4XzItMS0xLTEtMA_27bcf558-4259-4876-be91-0684b51c63b5">121</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia31e9a409b874bb19d0ff6f2f39ecc09_D20190701-20200630" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90YWJsZToyNzU1NGI1NDNhOGQ0OWRjOWQ2OWU1YzU2YzhiNDE0OC90YWJsZXJhbmdlOjI3NTU0YjU0M2E4ZDQ5ZGM5ZDY5ZTVjNTZjOGI0MTQ4XzItMy0xLTEtMA_33e9d705-c678-45d6-9528-ca6a42735197">500</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i00a6d666bf604826b24e68ddbd63eac4_D20180701-20190630" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90YWJsZToyNzU1NGI1NDNhOGQ0OWRjOWQ2OWU1YzU2YzhiNDE0OC90YWJsZXJhbmdlOjI3NTU0YjU0M2E4ZDQ5ZGM5ZDY5ZTVjNTZjOGI0MTQ4XzItNS0xLTEtMA_c3bcde63-f07d-4d56-8ef3-34b29990bbd5">24</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Additions for tax positions of prior years</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90YWJsZToyNzU1NGI1NDNhOGQ0OWRjOWQ2OWU1YzU2YzhiNDE0OC90YWJsZXJhbmdlOjI3NTU0YjU0M2E4ZDQ5ZGM5ZDY5ZTVjNTZjOGI0MTQ4XzMtMS0xLTEtMA_c96ad109-f5cb-44ed-9c94-f9e8192b3b71">223</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia31e9a409b874bb19d0ff6f2f39ecc09_D20190701-20200630" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90YWJsZToyNzU1NGI1NDNhOGQ0OWRjOWQ2OWU1YzU2YzhiNDE0OC90YWJsZXJhbmdlOjI3NTU0YjU0M2E4ZDQ5ZGM5ZDY5ZTVjNTZjOGI0MTQ4XzMtMy0xLTEtMA_ee082112-a033-4cc2-abe5-08a70a89606d">78</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i00a6d666bf604826b24e68ddbd63eac4_D20180701-20190630" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90YWJsZToyNzU1NGI1NDNhOGQ0OWRjOWQ2OWU1YzU2YzhiNDE0OC90YWJsZXJhbmdlOjI3NTU0YjU0M2E4ZDQ5ZGM5ZDY5ZTVjNTZjOGI0MTQ4XzMtNS0xLTEtMA_67ecd746-d5f4-4c66-bcf8-9419213e5a2f">39</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Reductions for tax positions of prior years</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90YWJsZToyNzU1NGI1NDNhOGQ0OWRjOWQ2OWU1YzU2YzhiNDE0OC90YWJsZXJhbmdlOjI3NTU0YjU0M2E4ZDQ5ZGM5ZDY5ZTVjNTZjOGI0MTQ4XzQtMS0xLTEtMA_a9f99bd7-8458-4764-9ac0-fae788f0947d">138</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia31e9a409b874bb19d0ff6f2f39ecc09_D20190701-20200630" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90YWJsZToyNzU1NGI1NDNhOGQ0OWRjOWQ2OWU1YzU2YzhiNDE0OC90YWJsZXJhbmdlOjI3NTU0YjU0M2E4ZDQ5ZGM5ZDY5ZTVjNTZjOGI0MTQ4XzQtMy0xLTEtMA_c6f3fd0a-6257-410c-bd60-0832e77086d0">27</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i00a6d666bf604826b24e68ddbd63eac4_D20180701-20190630" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90YWJsZToyNzU1NGI1NDNhOGQ0OWRjOWQ2OWU1YzU2YzhiNDE0OC90YWJsZXJhbmdlOjI3NTU0YjU0M2E4ZDQ5ZGM5ZDY5ZTVjNTZjOGI0MTQ4XzQtNS0xLTEtMA_72d7ddc1-341f-4f42-a04a-452068114b7f">5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Settlements with tax authorities </span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90YWJsZToyNzU1NGI1NDNhOGQ0OWRjOWQ2OWU1YzU2YzhiNDE0OC90YWJsZXJhbmdlOjI3NTU0YjU0M2E4ZDQ5ZGM5ZDY5ZTVjNTZjOGI0MTQ4XzUtMS0xLTEtMA_06498216-0cd2-456b-9fe3-3b308e638d92">271</ix:nonFraction>)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia31e9a409b874bb19d0ff6f2f39ecc09_D20190701-20200630" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90YWJsZToyNzU1NGI1NDNhOGQ0OWRjOWQ2OWU1YzU2YzhiNDE0OC90YWJsZXJhbmdlOjI3NTU0YjU0M2E4ZDQ5ZGM5ZDY5ZTVjNTZjOGI0MTQ4XzUtMy0xLTEtMA_afa456a6-903d-47fd-9bd1-caa0e91db746">6</ix:nonFraction>)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i00a6d666bf604826b24e68ddbd63eac4_D20180701-20190630" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90YWJsZToyNzU1NGI1NDNhOGQ0OWRjOWQ2OWU1YzU2YzhiNDE0OC90YWJsZXJhbmdlOjI3NTU0YjU0M2E4ZDQ5ZGM5ZDY5ZTVjNTZjOGI0MTQ4XzUtNS0xLTEtMA_3a91971b-f42c-411b-840a-6f91ee934dbc">25</ix:nonFraction>)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Expiration of the statute of limitations </span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90YWJsZToyNzU1NGI1NDNhOGQ0OWRjOWQ2OWU1YzU2YzhiNDE0OC90YWJsZXJhbmdlOjI3NTU0YjU0M2E4ZDQ5ZGM5ZDY5ZTVjNTZjOGI0MTQ4XzYtMS0xLTEtMA_d5680bc5-297c-47b6-ba78-d0cc5d547d47">1</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia31e9a409b874bb19d0ff6f2f39ecc09_D20190701-20200630" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90YWJsZToyNzU1NGI1NDNhOGQ0OWRjOWQ2OWU1YzU2YzhiNDE0OC90YWJsZXJhbmdlOjI3NTU0YjU0M2E4ZDQ5ZGM5ZDY5ZTVjNTZjOGI0MTQ4XzYtMy0xLTEtMA_809dc6bc-3739-4b1a-ba96-e9354eff1528">3</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i00a6d666bf604826b24e68ddbd63eac4_D20180701-20190630" decimals="-6" format="ixt:zerodash" name="us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90YWJsZToyNzU1NGI1NDNhOGQ0OWRjOWQ2OWU1YzU2YzhiNDE0OC90YWJsZXJhbmdlOjI3NTU0YjU0M2E4ZDQ5ZGM5ZDY5ZTVjNTZjOGI0MTQ4XzYtNS0xLTEtMA_0e930bc5-af7c-4372-bd0a-5bdd23cdee2f">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance at end of fiscal year</span></div></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2e87824102b34590a0208cc7da91b5f5_I20210630" decimals="-6" name="us-gaap:UnrecognizedTaxBenefits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90YWJsZToyNzU1NGI1NDNhOGQ0OWRjOWQ2OWU1YzU2YzhiNDE0OC90YWJsZXJhbmdlOjI3NTU0YjU0M2E4ZDQ5ZGM5ZDY5ZTVjNTZjOGI0MTQ4XzctMS0xLTEtMA_d0b01471-ebba-42aa-a402-98cd329aa595">932</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i299cea70f47b4fbe96772aaa8cc00b79_I20200630" decimals="-6" name="us-gaap:UnrecognizedTaxBenefits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90YWJsZToyNzU1NGI1NDNhOGQ0OWRjOWQ2OWU1YzU2YzhiNDE0OC90YWJsZXJhbmdlOjI3NTU0YjU0M2E4ZDQ5ZGM5ZDY5ZTVjNTZjOGI0MTQ4XzctMy0xLTEtMA_c2f75399-5d5f-420f-aa75-fe6f97452881">998</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if6dc09eec4e74751b47cdf037a5b1860_I20190630" decimals="-6" name="us-gaap:UnrecognizedTaxBenefits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90YWJsZToyNzU1NGI1NDNhOGQ0OWRjOWQ2OWU1YzU2YzhiNDE0OC90YWJsZXJhbmdlOjI3NTU0YjU0M2E4ZDQ5ZGM5ZDY5ZTVjNTZjOGI0MTQ4XzctNS0xLTEtMA_fb581d71-49e5-47d4-895f-0104f12f4aa1">456</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div style="margin-bottom:3pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">It is reasonably possible that there could be a change in the amount of unrecognized tax benefits within the next 12 months due to activities of the U.S. Internal Revenue Service ("IRS") or other taxing authorities, possible settlement of audit issues, </span></div></ix:continuation></div><div style="display:inline-block;max-width:3.571%;min-width:2.571%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:48.215%"><ix:continuation id="icfca45672e8644aab16311fe97c3f11f"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">reassessment of existing unrecognized tax benefits or the expiration of statutes of limitations. We estimate that the range of the possible change in unrecognized tax benefits within the next 12 months is a net decrease of $<ix:nonFraction unitRef="usd" contextRef="if156c7b3d30345a395262b86a56d2779_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90ZXh0cmVnaW9uOmViYTAwMWFhMmQ5YjRmODZiMGIyMTI2YzNmMjlhODhmXzcwODU_c1a62763-682a-4e6a-bd9b-c9bee4895e17">0</ix:nonFraction> million to $<ix:nonFraction unitRef="usd" contextRef="ib54859ab704046a7a3be64f76f566d69_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90ZXh0cmVnaW9uOmViYTAwMWFhMmQ5YjRmODZiMGIyMTI2YzNmMjlhODhmXzcwOTE_55ed0d5f-9c7d-472a-ad17-c4ab264d19a5">20</ix:nonFraction> million, exclusive of penalties and interest.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recognize accrued interest and penalties related to unrecognized tax benefits in the provision for income taxes. At June&#160;30, 2021, 2020 and 2019, we had $<ix:nonFraction unitRef="usd" contextRef="i2e87824102b34590a0208cc7da91b5f5_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90ZXh0cmVnaW9uOmViYTAwMWFhMmQ5YjRmODZiMGIyMTI2YzNmMjlhODhmXzcyNzM_aa0098f4-051d-4220-96fd-ed3fc17ab9a4">49</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="i299cea70f47b4fbe96772aaa8cc00b79_I20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90ZXh0cmVnaW9uOmViYTAwMWFhMmQ5YjRmODZiMGIyMTI2YzNmMjlhODhmXzcyNzc_8b9303e2-405e-46bc-a1f1-16fe7699e6ba">146</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="if6dc09eec4e74751b47cdf037a5b1860_I20190630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90ZXh0cmVnaW9uOmViYTAwMWFhMmQ5YjRmODZiMGIyMTI2YzNmMjlhODhmXzcyODQ_797887dc-eb9c-459b-9149-5802373171b9">122</ix:nonFraction> million, respectively, accrued for the payment of interest and penalties. These balances are gross amounts before any tax benefits and are included in deferred income taxes and other liabilities in the consolidated balance sheets. As a result of our IRS audit settlements and carryback claim, an immaterial amount of interest was recorded in fiscal 2021. During fiscal 2020 and 2019, we recognized $<ix:nonFraction unitRef="usd" contextRef="i5861e52e19f84919b7cf3da21acd4a1c_D20190401-20190630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90ZXh0cmVnaW9uOmViYTAwMWFhMmQ5YjRmODZiMGIyMTI2YzNmMjlhODhmXzc1NTc_7514e426-849d-472f-9c88-d44814dc37ae">16</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i00a6d666bf604826b24e68ddbd63eac4_D20180701-20190630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90ZXh0cmVnaW9uOmViYTAwMWFhMmQ5YjRmODZiMGIyMTI2YzNmMjlhODhmXzc1NjU_146f30ce-e09e-4f7a-9908-572b10982531">8</ix:nonFraction> million of expense for interest and penalties in income tax expense, respectively. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Other Tax Matters</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We file income tax returns in the U.S. federal jurisdiction, various U.S. state and local jurisdictions, and various foreign jurisdictions. With few exceptions, we are subject to audit by taxing authorities for fiscal years 2015 through the current fiscal year. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are a party to a tax matters agreement with CareFusion Corporation ("CareFusion"), which has been acquired by Becton, Dickinson and Company. Under the tax matters agreement, CareFusion is obligated to indemnify us for certain tax exposures and transaction taxes prior to our fiscal 2010 spin-off of CareFusion. The indemnification receivable was $<ix:nonFraction unitRef="usd" contextRef="i6ab12e7e0f7d4134995f67ad334fc7bb_I20210630" decimals="-6" format="ixt:numdotdecimal" name="cah:IndemnificationReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90ZXh0cmVnaW9uOmViYTAwMWFhMmQ5YjRmODZiMGIyMTI2YzNmMjlhODhmXzgyNzQ_82e16ee4-10c9-43d1-8b22-59943e5757cc">72</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ia26e78a845f44434a842d2f2d0afeb9c_I20200630" decimals="-6" format="ixt:numdotdecimal" name="cah:IndemnificationReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90ZXh0cmVnaW9uOmViYTAwMWFhMmQ5YjRmODZiMGIyMTI2YzNmMjlhODhmXzgyODE_5e4266fd-b223-4227-ac5f-f9f90a6efe80">176</ix:nonFraction> million at June&#160;30, 2021 and 2020, respectively, and is included in other assets in the consolidated balance sheets.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a result of the acquisition of the Patient Recovery Business, Medtronic plc is obligated to indemnify us for certain tax exposures and transaction taxes related to periods prior to the acquisition under the purchase agreement. The indemnification receivable was $<ix:nonFraction unitRef="usd" contextRef="i5248507f2033461eab9f4d201b5cc2cd_I20210630" decimals="-6" format="ixt:numdotdecimal" name="cah:IndemnificationReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90ZXh0cmVnaW9uOmViYTAwMWFhMmQ5YjRmODZiMGIyMTI2YzNmMjlhODhmXzg2NDU_ac678ca9-3089-432b-917e-a193cd6832e2">12</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ia1d9ae03c64d4c31b1115e366d980c83_I20200630" decimals="-6" format="ixt:numdotdecimal" name="cah:IndemnificationReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90ZXh0cmVnaW9uOmViYTAwMWFhMmQ5YjRmODZiMGIyMTI2YzNmMjlhODhmXzg2NTI_a3954d50-e723-4718-8a73-1ad826d838c5">19</ix:nonFraction> million at June&#160;30, 2021 and 2020, respectively, and is included in other assets in the consolidated balance sheets.</span></div></ix:continuation><div id="i4f0ec56b9c604f1782a65ea4a19c284d_136"></div><ix:nonNumeric contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630" name="us-gaap:FairValueMeasurementInputsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzYvZnJhZzozOWViYWM3NDQzM2U0NzdhYjRmM2Y4MTM2OTJmMjA3Ny90ZXh0cmVnaW9uOjM5ZWJhYzc0NDMzZTQ3N2FiNGYzZjgxMzY5MmYyMDc3XzEyNzI_440570af-d3d9-4411-bffe-126f9c132dfd" continuedAt="i0d432f0ba0c94a64a253e17b9671e475" escape="true"><ix:nonNumeric contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630" name="us-gaap:FairValueDisclosuresTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzYvZnJhZzozOWViYWM3NDQzM2U0NzdhYjRmM2Y4MTM2OTJmMjA3Ny90ZXh0cmVnaW9uOjM5ZWJhYzc0NDMzZTQ3N2FiNGYzZjgxMzY5MmYyMDc3XzI3NDg3NzkwNzEzMjg_653b2fbc-97eb-4836-b6a2-ffd1cdf94648" continuedAt="i35d8afb504c141f596b7baa677902eda" escape="true"><div style="margin-bottom:6pt;text-align:justify"><span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:13pt;font-weight:700;line-height:120%">9. Fair Value Measurements </span></div><ix:nonNumeric contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630" name="us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzYvZnJhZzozOWViYWM3NDQzM2U0NzdhYjRmM2Y4MTM2OTJmMjA3Ny90ZXh0cmVnaW9uOjM5ZWJhYzc0NDMzZTQ3N2FiNGYzZjgxMzY5MmYyMDc3XzEyNTI_f64dff48-5250-4666-94f1-b368a2708c1a" continuedAt="i482eaeacd2e742429373eda04c432ea9" escape="true"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables present the fair values for assets and (liabilities) measured on a recurring basis at June 30:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:46.122%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.937%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.343%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.937%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.343%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.937%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.343%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.938%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cash equivalents</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if0e5c8d6266b4e399e3e86ab88d0ff94_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzYvZnJhZzozOWViYWM3NDQzM2U0NzdhYjRmM2Y4MTM2OTJmMjA3Ny90YWJsZTowNDY5YjFjNjE3NmQ0MzZhOGRkODUxMDZiMjAxM2FmYi90YWJsZXJhbmdlOjA0NjliMWM2MTc2ZDQzNmE4ZGQ4NTEwNmIyMDEzYWZiXzMtMS0xLTEtMA_03f78dca-cfa2-4f56-9383-ad06eb7e5783">1,883</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2cb758f7ff794e2881dfc3872f11414b_I20210630" decimals="-6" format="ixt:zerodash" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzYvZnJhZzozOWViYWM3NDQzM2U0NzdhYjRmM2Y4MTM2OTJmMjA3Ny90YWJsZTowNDY5YjFjNjE3NmQ0MzZhOGRkODUxMDZiMjAxM2FmYi90YWJsZXJhbmdlOjA0NjliMWM2MTc2ZDQzNmE4ZGQ4NTEwNmIyMDEzYWZiXzMtMy0xLTEtMA_0f41f671-6c85-48cf-a907-00e44a890cab">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf7e71fcba5f483ebe952262b8f49189_I20210630" decimals="-6" format="ixt:zerodash" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzYvZnJhZzozOWViYWM3NDQzM2U0NzdhYjRmM2Y4MTM2OTJmMjA3Ny90YWJsZTowNDY5YjFjNjE3NmQ0MzZhOGRkODUxMDZiMjAxM2FmYi90YWJsZXJhbmdlOjA0NjliMWM2MTc2ZDQzNmE4ZGQ4NTEwNmIyMDEzYWZiXzMtNS0xLTEtMA_564b651d-2793-42c3-858a-16ac023dc0c4">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i53e687ceccba4bac9c2829e01e82f358_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzYvZnJhZzozOWViYWM3NDQzM2U0NzdhYjRmM2Y4MTM2OTJmMjA3Ny90YWJsZTowNDY5YjFjNjE3NmQ0MzZhOGRkODUxMDZiMjAxM2FmYi90YWJsZXJhbmdlOjA0NjliMWM2MTc2ZDQzNmE4ZGQ4NTEwNmIyMDEzYWZiXzMtNy0xLTEtMA_46cbfc7a-c3ba-4bc5-85c1-496545df1a00">1,883</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other investments (1)</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if0e5c8d6266b4e399e3e86ab88d0ff94_I20210630" decimals="-6" name="us-gaap:InvestmentsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzYvZnJhZzozOWViYWM3NDQzM2U0NzdhYjRmM2Y4MTM2OTJmMjA3Ny90YWJsZTowNDY5YjFjNjE3NmQ0MzZhOGRkODUxMDZiMjAxM2FmYi90YWJsZXJhbmdlOjA0NjliMWM2MTc2ZDQzNmE4ZGQ4NTEwNmIyMDEzYWZiXzUtMS0xLTEtMA_dc2ca87d-02de-40a3-8338-f9ba62787ab5">126</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2cb758f7ff794e2881dfc3872f11414b_I20210630" decimals="-6" format="ixt:zerodash" name="us-gaap:InvestmentsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzYvZnJhZzozOWViYWM3NDQzM2U0NzdhYjRmM2Y4MTM2OTJmMjA3Ny90YWJsZTowNDY5YjFjNjE3NmQ0MzZhOGRkODUxMDZiMjAxM2FmYi90YWJsZXJhbmdlOjA0NjliMWM2MTc2ZDQzNmE4ZGQ4NTEwNmIyMDEzYWZiXzUtMy0xLTEtMA_5c9b0b7a-6ef9-4686-a035-c189d939a016">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf7e71fcba5f483ebe952262b8f49189_I20210630" decimals="-6" format="ixt:zerodash" name="us-gaap:InvestmentsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzYvZnJhZzozOWViYWM3NDQzM2U0NzdhYjRmM2Y4MTM2OTJmMjA3Ny90YWJsZTowNDY5YjFjNjE3NmQ0MzZhOGRkODUxMDZiMjAxM2FmYi90YWJsZXJhbmdlOjA0NjliMWM2MTc2ZDQzNmE4ZGQ4NTEwNmIyMDEzYWZiXzUtNS0xLTEtMA_66199c49-2de9-4c51-9024-6ec04b2bf298">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i53e687ceccba4bac9c2829e01e82f358_I20210630" decimals="-6" name="us-gaap:InvestmentsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzYvZnJhZzozOWViYWM3NDQzM2U0NzdhYjRmM2Y4MTM2OTJmMjA3Ny90YWJsZTowNDY5YjFjNjE3NmQ0MzZhOGRkODUxMDZiMjAxM2FmYi90YWJsZXJhbmdlOjA0NjliMWM2MTc2ZDQzNmE4ZGQ4NTEwNmIyMDEzYWZiXzUtNy0xLTEtMA_c96be184-444b-4820-aa30-9e79e948ded4">126</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Forward contracts (2)</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if0e5c8d6266b4e399e3e86ab88d0ff94_I20210630" decimals="-6" format="ixt:zerodash" name="us-gaap:DerivativeAssetsLiabilitiesAtFairValueNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzYvZnJhZzozOWViYWM3NDQzM2U0NzdhYjRmM2Y4MTM2OTJmMjA3Ny90YWJsZTowNDY5YjFjNjE3NmQ0MzZhOGRkODUxMDZiMjAxM2FmYi90YWJsZXJhbmdlOjA0NjliMWM2MTc2ZDQzNmE4ZGQ4NTEwNmIyMDEzYWZiXzYtMS0xLTEtMA_f78d9cd9-9d93-494b-9087-228eee5b4a73">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2cb758f7ff794e2881dfc3872f11414b_I20210630" decimals="-6" name="us-gaap:DerivativeAssetsLiabilitiesAtFairValueNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzYvZnJhZzozOWViYWM3NDQzM2U0NzdhYjRmM2Y4MTM2OTJmMjA3Ny90YWJsZTowNDY5YjFjNjE3NmQ0MzZhOGRkODUxMDZiMjAxM2FmYi90YWJsZXJhbmdlOjA0NjliMWM2MTc2ZDQzNmE4ZGQ4NTEwNmIyMDEzYWZiXzYtMy0xLTEtMA_428306fc-9b83-4df9-a5d0-1248639b8bfb">42</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf7e71fcba5f483ebe952262b8f49189_I20210630" decimals="-6" format="ixt:zerodash" name="us-gaap:DerivativeAssetsLiabilitiesAtFairValueNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzYvZnJhZzozOWViYWM3NDQzM2U0NzdhYjRmM2Y4MTM2OTJmMjA3Ny90YWJsZTowNDY5YjFjNjE3NmQ0MzZhOGRkODUxMDZiMjAxM2FmYi90YWJsZXJhbmdlOjA0NjliMWM2MTc2ZDQzNmE4ZGQ4NTEwNmIyMDEzYWZiXzYtNS0xLTEtMA_f04dcf3f-b77d-4fb4-8e13-92ac345c9890">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i53e687ceccba4bac9c2829e01e82f358_I20210630" decimals="-6" name="us-gaap:DerivativeAssetsLiabilitiesAtFairValueNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzYvZnJhZzozOWViYWM3NDQzM2U0NzdhYjRmM2Y4MTM2OTJmMjA3Ny90YWJsZTowNDY5YjFjNjE3NmQ0MzZhOGRkODUxMDZiMjAxM2FmYi90YWJsZXJhbmdlOjA0NjliMWM2MTc2ZDQzNmE4ZGQ4NTEwNmIyMDEzYWZiXzYtNy0xLTEtMA_e7bfcbdd-688e-4866-aa67-1dda5ffedf92">42</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:46.122%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.937%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.343%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.937%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.343%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.937%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.343%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.938%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Level&#160;1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Level&#160;2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Level&#160;3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cash equivalents</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7a7f821903974542847e3a426b2298e4_I20200630" decimals="-6" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzYvZnJhZzozOWViYWM3NDQzM2U0NzdhYjRmM2Y4MTM2OTJmMjA3Ny90YWJsZToyNmQ3MmE4ZWVhZWU0MDY5OTg1MTc1ZTlmMGYzODNiMC90YWJsZXJhbmdlOjI2ZDcyYThlZWFlZTQwNjk5ODUxNzVlOWYwZjM4M2IwXzMtMS0xLTEtMA_87c4e340-3b8e-4239-b399-fba983b938b9">721</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b176a5bd18a4585bcea35c6994491bf_I20200630" decimals="-6" format="ixt:zerodash" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzYvZnJhZzozOWViYWM3NDQzM2U0NzdhYjRmM2Y4MTM2OTJmMjA3Ny90YWJsZToyNmQ3MmE4ZWVhZWU0MDY5OTg1MTc1ZTlmMGYzODNiMC90YWJsZXJhbmdlOjI2ZDcyYThlZWFlZTQwNjk5ODUxNzVlOWYwZjM4M2IwXzMtMy0xLTEtMA_8055a975-19e0-426c-94bc-1c6e2790acb5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib9e3c2a498984b619e5cd20d787935fc_I20200630" decimals="-6" format="ixt:zerodash" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzYvZnJhZzozOWViYWM3NDQzM2U0NzdhYjRmM2Y4MTM2OTJmMjA3Ny90YWJsZToyNmQ3MmE4ZWVhZWU0MDY5OTg1MTc1ZTlmMGYzODNiMC90YWJsZXJhbmdlOjI2ZDcyYThlZWFlZTQwNjk5ODUxNzVlOWYwZjM4M2IwXzMtNS0xLTEtMA_bccad5d3-96a4-47d7-a355-9447831aec68">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i66a08b6bbc4f404da5d4e4aeaf846429_I20200630" decimals="-6" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzYvZnJhZzozOWViYWM3NDQzM2U0NzdhYjRmM2Y4MTM2OTJmMjA3Ny90YWJsZToyNmQ3MmE4ZWVhZWU0MDY5OTg1MTc1ZTlmMGYzODNiMC90YWJsZXJhbmdlOjI2ZDcyYThlZWFlZTQwNjk5ODUxNzVlOWYwZjM4M2IwXzMtNy0xLTEtMA_dc44b61c-bd45-49a1-8075-6b9b15322daf">721</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other investments (1)</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7a7f821903974542847e3a426b2298e4_I20200630" decimals="-6" name="us-gaap:InvestmentsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzYvZnJhZzozOWViYWM3NDQzM2U0NzdhYjRmM2Y4MTM2OTJmMjA3Ny90YWJsZToyNmQ3MmE4ZWVhZWU0MDY5OTg1MTc1ZTlmMGYzODNiMC90YWJsZXJhbmdlOjI2ZDcyYThlZWFlZTQwNjk5ODUxNzVlOWYwZjM4M2IwXzUtMS0xLTEtMA_c490daef-cde9-41cf-a5ed-5903614a1482">114</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b176a5bd18a4585bcea35c6994491bf_I20200630" decimals="-6" format="ixt:zerodash" name="us-gaap:InvestmentsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzYvZnJhZzozOWViYWM3NDQzM2U0NzdhYjRmM2Y4MTM2OTJmMjA3Ny90YWJsZToyNmQ3MmE4ZWVhZWU0MDY5OTg1MTc1ZTlmMGYzODNiMC90YWJsZXJhbmdlOjI2ZDcyYThlZWFlZTQwNjk5ODUxNzVlOWYwZjM4M2IwXzUtMy0xLTEtMA_45c59a4d-0506-4818-8969-fc806831f300">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib9e3c2a498984b619e5cd20d787935fc_I20200630" decimals="-6" format="ixt:zerodash" name="us-gaap:InvestmentsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzYvZnJhZzozOWViYWM3NDQzM2U0NzdhYjRmM2Y4MTM2OTJmMjA3Ny90YWJsZToyNmQ3MmE4ZWVhZWU0MDY5OTg1MTc1ZTlmMGYzODNiMC90YWJsZXJhbmdlOjI2ZDcyYThlZWFlZTQwNjk5ODUxNzVlOWYwZjM4M2IwXzUtNS0xLTEtMA_c915708b-9b86-4b18-969d-0f5d93a0203c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i66a08b6bbc4f404da5d4e4aeaf846429_I20200630" decimals="-6" name="us-gaap:InvestmentsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzYvZnJhZzozOWViYWM3NDQzM2U0NzdhYjRmM2Y4MTM2OTJmMjA3Ny90YWJsZToyNmQ3MmE4ZWVhZWU0MDY5OTg1MTc1ZTlmMGYzODNiMC90YWJsZXJhbmdlOjI2ZDcyYThlZWFlZTQwNjk5ODUxNzVlOWYwZjM4M2IwXzUtNy0xLTEtMA_f5598531-c85c-4f42-b5e3-eefdb3d6232e">114</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Forward contracts (2)</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7a7f821903974542847e3a426b2298e4_I20200630" decimals="-6" format="ixt:zerodash" name="us-gaap:DerivativeAssetsLiabilitiesAtFairValueNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzYvZnJhZzozOWViYWM3NDQzM2U0NzdhYjRmM2Y4MTM2OTJmMjA3Ny90YWJsZToyNmQ3MmE4ZWVhZWU0MDY5OTg1MTc1ZTlmMGYzODNiMC90YWJsZXJhbmdlOjI2ZDcyYThlZWFlZTQwNjk5ODUxNzVlOWYwZjM4M2IwXzYtMS0xLTEtMA_5d3a885c-d2b9-459a-86f3-f19ea6884c4a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b176a5bd18a4585bcea35c6994491bf_I20200630" decimals="-6" name="us-gaap:DerivativeAssetsLiabilitiesAtFairValueNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzYvZnJhZzozOWViYWM3NDQzM2U0NzdhYjRmM2Y4MTM2OTJmMjA3Ny90YWJsZToyNmQ3MmE4ZWVhZWU0MDY5OTg1MTc1ZTlmMGYzODNiMC90YWJsZXJhbmdlOjI2ZDcyYThlZWFlZTQwNjk5ODUxNzVlOWYwZjM4M2IwXzYtMy0xLTEtMA_4f469210-aad9-4bb7-97ec-7d6fca37b89f">53</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib9e3c2a498984b619e5cd20d787935fc_I20200630" decimals="-6" format="ixt:zerodash" name="us-gaap:DerivativeAssetsLiabilitiesAtFairValueNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzYvZnJhZzozOWViYWM3NDQzM2U0NzdhYjRmM2Y4MTM2OTJmMjA3Ny90YWJsZToyNmQ3MmE4ZWVhZWU0MDY5OTg1MTc1ZTlmMGYzODNiMC90YWJsZXJhbmdlOjI2ZDcyYThlZWFlZTQwNjk5ODUxNzVlOWYwZjM4M2IwXzYtNS0xLTEtMA_711e0b00-7cb8-4ac2-8969-fcf2259564eb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i66a08b6bbc4f404da5d4e4aeaf846429_I20200630" decimals="-6" name="us-gaap:DerivativeAssetsLiabilitiesAtFairValueNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzYvZnJhZzozOWViYWM3NDQzM2U0NzdhYjRmM2Y4MTM2OTJmMjA3Ny90YWJsZToyNmQ3MmE4ZWVhZWU0MDY5OTg1MTc1ZTlmMGYzODNiMC90YWJsZXJhbmdlOjI2ZDcyYThlZWFlZTQwNjk5ODUxNzVlOWYwZjM4M2IwXzYtNy0xLTEtMA_d9d8880f-3003-422f-9489-0d9ca47840e9">53</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric></ix:nonNumeric></ix:nonNumeric></div></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:32.135%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.428%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.137%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardinal Health </span><span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">|</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> Fiscal 2021 Form 10-K</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">79</span></div></td></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:3pt"><span><br/></span></div><div style="margin-bottom:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:24.720%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:50.989%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.991%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#e41f35;border-bottom:1pt solid #e41f35;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Notes to Financial Statements</span></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:0 1pt"></td></tr></table></div></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:48.214%"><ix:continuation id="i35d8afb504c141f596b7baa677902eda"><div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><ix:continuation id="i0d432f0ba0c94a64a253e17b9671e475" continuedAt="ic18a933a88384719b11de40a9eaecc89"><ix:continuation id="i482eaeacd2e742429373eda04c432ea9" continuedAt="if68f34aba2854bdeb93058bb6b7643b9"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:10pt">The other investments balance includes investments in mutual funds, which offset fluctuations in deferred compensation liabilities. These mutual funds invest in the equity securities of companies with both large and small market capitalization and high-quality fixed income debt securities. The fair value of these investments is determined using quoted market prices.</span></ix:continuation></ix:continuation></div><div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:continuation id="ic18a933a88384719b11de40a9eaecc89" continuedAt="ib5aa3cac97974cb5bf21b7d48fb9398e"><ix:continuation id="if68f34aba2854bdeb93058bb6b7643b9" continuedAt="icbeab55bdaab45b791eaec8c1a760016">(2)</ix:continuation></ix:continuation></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:10pt"><ix:continuation id="ib5aa3cac97974cb5bf21b7d48fb9398e"><ix:continuation id="icbeab55bdaab45b791eaec8c1a760016">The fair value of interest rate swaps, foreign currency contracts, net investment hedges and commodity contracts is determined based on the present value of expected future cash flows considering the risks involved, including non-performance risk, and using discount rates appropriate for the respective maturities. Observable Level 2 inputs are used to determine the present value of expected future cash flows. The fair value of these derivative contracts, which are subject to master netting arrangements under certain circumstances, is presented on a gross basis in prepaid expenses and other, other assets, other accrued liabilities, and deferred income taxes and other liabilities within the consolidated balance sheets.</ix:continuation></ix:continuation> </span></div><div style="margin-bottom:3pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Assets and (Liabilities) Measured on a Nonrecurring Basis</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Assets and liabilities held for sale of $<ix:nonFraction unitRef="usd" contextRef="i19e92323b7e546339ee3ca1cd768d7dc_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperation" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzYvZnJhZzozOWViYWM3NDQzM2U0NzdhYjRmM2Y4MTM2OTJmMjA3Ny90ZXh0cmVnaW9uOjM5ZWJhYzc0NDMzZTQ3N2FiNGYzZjgxMzY5MmYyMDc3XzI3NDg3NzkwNzEzMzU_fdbb4285-e2fc-449c-b843-dbd406181a0f">1.1</ix:nonFraction>&#160;billion and $<ix:nonFraction unitRef="usd" contextRef="i2e87824102b34590a0208cc7da91b5f5_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzYvZnJhZzozOWViYWM3NDQzM2U0NzdhYjRmM2Y4MTM2OTJmMjA3Ny90ZXh0cmVnaW9uOjM5ZWJhYzc0NDMzZTQ3N2FiNGYzZjgxMzY5MmYyMDc3XzI3NDg3NzkwNzEyNjA_3606ac8b-8a07-44c4-aa4d-cc08f770067e">96</ix:nonFraction> million, respectively, at June&#160;30, 2021 are primarily related to the divestiture of our Cordis business. These estimated fair values utilized Level 3 unobservable inputs based on expected sales proceeds following a competitive bidding process. See </span><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i4f0ec56b9c604f1782a65ea4a19c284d_106">Note 2</a></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for additional information regarding assets and liabilities held for sale.</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div id="i4f0ec56b9c604f1782a65ea4a19c284d_139"></div><ix:nonNumeric contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630" name="us-gaap:FinancialInstrumentsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzkvZnJhZzo4OGQ2MDhlMWNlMjY0N2E5OGJjZWNlYjAxZDg1NjFiMC90ZXh0cmVnaW9uOjg4ZDYwOGUxY2UyNjQ3YTk4YmNlY2ViMDFkODU2MWIwXzExMTMz_1a789c6f-21c1-4352-86f6-03682ea102a8" continuedAt="ie59fc1867c4f45daad10d94f382f61ea" escape="true"><div style="margin-bottom:6pt;text-align:justify"><span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:13pt;font-weight:700;line-height:120%">10. Financial Instruments </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We utilize derivative financial instruments to manage exposure to certain risks related to our ongoing operations. The primary risks managed through the use of derivative instruments include interest rate risk, currency exchange risk, and commodity price risk. We do not use derivative instruments for trading or speculative purposes. While the majority of our derivative instruments are designated as hedging instruments, we also enter into derivative instruments that are designed to hedge a risk, but are not designated as hedging instruments. These derivative instruments are adjusted to current fair value through earnings at the end of each period. We are exposed to counterparty credit risk on all of our derivative instruments. Accordingly, we have established and maintain strict counterparty credit guidelines and only enter into derivative instruments with major financial institutions that are rated investment grade or better. We do not have significant exposure to any one counterparty and we believe the risk of loss is remote. Additionally, we do not require collateral under these agreements.</span></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Interest Rate Risk Management</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are exposed to the impact of interest rate changes. Our objective is to manage the impact of interest rate changes on cash flows and the market value of our borrowings. We utilize a mix of debt maturities along with both fixed-rate and variable-rate debt to manage changes in interest rates. In addition, we enter into interest rate swaps to further manage our exposure to interest rate variations related to our borrowings and to lower our overall borrowing costs.</span></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Currency Exchange Risk Management</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We conduct business in several major international currencies and are subject to risks associated with changing foreign exchange </span></div></ix:nonNumeric></div><div style="display:inline-block;max-width:3.571%;min-width:2.571%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:48.215%"><ix:continuation id="ie59fc1867c4f45daad10d94f382f61ea" continuedAt="i6bd54f15df9148178c7081eafe804112"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">rates. Our objective is to reduce earnings and cash flow volatility associated with foreign exchange rate changes to allow management to focus its attention on business operations. Accordingly, we enter into various contracts that change in value as foreign exchange rates change to protect the value of existing foreign currency assets and liabilities, commitments and anticipated foreign currency revenue and expenses.</span></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Commodity Price Risk Management</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are exposed to changes in the price of certain commodities. Our objective is to reduce earnings and cash flow volatility associated with forecasted purchases of these commodities to allow management to focus its attention on business operations. Accordingly, we enter into derivative contracts when possible to manage the price risk associated with certain forecasted purchases.</span></div><ix:nonNumeric contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630" name="us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzkvZnJhZzo4OGQ2MDhlMWNlMjY0N2E5OGJjZWNlYjAxZDg1NjFiMC90ZXh0cmVnaW9uOjg4ZDYwOGUxY2UyNjQ3YTk4YmNlY2ViMDFkODU2MWIwXzExMTM1_69ad9c78-5b66-43a6-9008-4f1a8d030fd2" escape="true"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the fair value of our assets and liabilities related to derivatives designated as hedging instruments and the respective line items in which they were recorded in the consolidated balance sheets at June 30:</span></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.691%"><tr><td style="width:1.0%"></td><td style="width:69.488%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.831%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.347%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.834%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Pay-floating interest rate swaps (1)</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieeeae5f04d634c51844ac9a96e9b09ed_I20210630" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzkvZnJhZzo4OGQ2MDhlMWNlMjY0N2E5OGJjZWNlYjAxZDg1NjFiMC90YWJsZTpiNDU0MDkwYzljMDc0NGZmODg0NjcwNTY0NWJiNjU3OS90YWJsZXJhbmdlOmI0NTQwOTBjOWMwNzQ0ZmY4ODQ2NzA1NjQ1YmI2NTc5XzItMS0xLTEtMA_63a8c5ab-b50b-464c-934b-0e538d9f13b1">1</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied457f9542c6444e96d2897053b037cd_I20200630" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzkvZnJhZzo4OGQ2MDhlMWNlMjY0N2E5OGJjZWNlYjAxZDg1NjFiMC90YWJsZTpiNDU0MDkwYzljMDc0NGZmODg0NjcwNTY0NWJiNjU3OS90YWJsZXJhbmdlOmI0NTQwOTBjOWMwNzQ0ZmY4ODQ2NzA1NjQ1YmI2NTc5XzItMy0xLTEtMA_774ec016-9343-43b1-b88f-5761f3bf974e">27</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cross-currency swap (1) </span></td><td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4f2eecbc56bc4483ba6ecd0e80dc8c95_I20210630" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzkvZnJhZzo4OGQ2MDhlMWNlMjY0N2E5OGJjZWNlYjAxZDg1NjFiMC90YWJsZTpiNDU0MDkwYzljMDc0NGZmODg0NjcwNTY0NWJiNjU3OS90YWJsZXJhbmdlOmI0NTQwOTBjOWMwNzQ0ZmY4ODQ2NzA1NjQ1YmI2NTc5XzMtMS0xLTEtMA_ac234445-3787-4c17-a648-169ce99adbc7">6</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie2fc3cb346df4a8790d437caebe5bfeb_I20200630" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzkvZnJhZzo4OGQ2MDhlMWNlMjY0N2E5OGJjZWNlYjAxZDg1NjFiMC90YWJsZTpiNDU0MDkwYzljMDc0NGZmODg0NjcwNTY0NWJiNjU3OS90YWJsZXJhbmdlOmI0NTQwOTBjOWMwNzQ0ZmY4ODQ2NzA1NjQ1YmI2NTc5XzMtMy0xLTEtMA_5cc6fe0e-3d77-4f99-bce6-dcb7dbc8557a">47</ix:nonFraction>&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cross-currency swap (2)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3646dde5708840a9844baca98633b4d9_I20210630" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzkvZnJhZzo4OGQ2MDhlMWNlMjY0N2E5OGJjZWNlYjAxZDg1NjFiMC90YWJsZTpiNDU0MDkwYzljMDc0NGZmODg0NjcwNTY0NWJiNjU3OS90YWJsZXJhbmdlOmI0NTQwOTBjOWMwNzQ0ZmY4ODQ2NzA1NjQ1YmI2NTc5XzQtMS0xLTEtNTY4NQ_49991901-0665-49b5-8187-2402774aaee5">34</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1331393b0e34887b04264776d257b9d_I20200630" decimals="-6" format="ixt:zerodash" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzkvZnJhZzo4OGQ2MDhlMWNlMjY0N2E5OGJjZWNlYjAxZDg1NjFiMC90YWJsZTpiNDU0MDkwYzljMDc0NGZmODg0NjcwNTY0NWJiNjU3OS90YWJsZXJhbmdlOmI0NTQwOTBjOWMwNzQ0ZmY4ODQ2NzA1NjQ1YmI2NTc5XzQtMy0xLTEtNTY5Mw_ad8fef73-cd7f-403d-b28c-8d2190ae5a28">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Foreign currency contracts (2)</span></td><td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i027cf29054524efda48f2d0dea27a987_I20210630" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzkvZnJhZzo4OGQ2MDhlMWNlMjY0N2E5OGJjZWNlYjAxZDg1NjFiMC90YWJsZTpiNDU0MDkwYzljMDc0NGZmODg0NjcwNTY0NWJiNjU3OS90YWJsZXJhbmdlOmI0NTQwOTBjOWMwNzQ0ZmY4ODQ2NzA1NjQ1YmI2NTc5XzQtMS0xLTEtMA_79f0fe7b-4ef0-4d14-891c-5c363252854c">5</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5a1a9623870472f8b2069242d333329_I20200630" decimals="-6" format="ixt:zerodash" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzkvZnJhZzo4OGQ2MDhlMWNlMjY0N2E5OGJjZWNlYjAxZDg1NjFiMC90YWJsZTpiNDU0MDkwYzljMDc0NGZmODg0NjcwNTY0NWJiNjU3OS90YWJsZXJhbmdlOmI0NTQwOTBjOWMwNzQ0ZmY4ODQ2NzA1NjQ1YmI2NTc5XzQtMy0xLTEtMA_7144558e-1ee6-407a-836f-deaf8b715893">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total assets</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2e87824102b34590a0208cc7da91b5f5_I20210630" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzkvZnJhZzo4OGQ2MDhlMWNlMjY0N2E5OGJjZWNlYjAxZDg1NjFiMC90YWJsZTpiNDU0MDkwYzljMDc0NGZmODg0NjcwNTY0NWJiNjU3OS90YWJsZXJhbmdlOmI0NTQwOTBjOWMwNzQ0ZmY4ODQ2NzA1NjQ1YmI2NTc5XzgtMS0xLTEtMA_91181d35-970a-4673-bf54-80edaedc93e3">46</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i299cea70f47b4fbe96772aaa8cc00b79_I20200630" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzkvZnJhZzo4OGQ2MDhlMWNlMjY0N2E5OGJjZWNlYjAxZDg1NjFiMC90YWJsZTpiNDU0MDkwYzljMDc0NGZmODg0NjcwNTY0NWJiNjU3OS90YWJsZXJhbmdlOmI0NTQwOTBjOWMwNzQ0ZmY4ODQ2NzA1NjQ1YmI2NTc5XzgtMy0xLTEtMA_ceda5445-a907-44b0-9f50-5e50b861f5b5">74</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:6pt"><td colspan="3" style="background-color:#dbdbdb;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#dbdbdb;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#dbdbdb;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#dbdbdb;border-top:2pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Foreign currency contracts (4)</span></td><td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6a96679386eb4368a6920765ed1afdd6_I20210630" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzkvZnJhZzo4OGQ2MDhlMWNlMjY0N2E5OGJjZWNlYjAxZDg1NjFiMC90YWJsZTpiNDU0MDkwYzljMDc0NGZmODg0NjcwNTY0NWJiNjU3OS90YWJsZXJhbmdlOmI0NTQwOTBjOWMwNzQ0ZmY4ODQ2NzA1NjQ1YmI2NTc5XzEyLTEtMS0xLTA_6773c97c-73e4-4296-b0db-121edafaa9f5">4</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i185e5c7efe754824b8a884fe900d3d71_I20200630" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzkvZnJhZzo4OGQ2MDhlMWNlMjY0N2E5OGJjZWNlYjAxZDg1NjFiMC90YWJsZTpiNDU0MDkwYzljMDc0NGZmODg0NjcwNTY0NWJiNjU3OS90YWJsZXJhbmdlOmI0NTQwOTBjOWMwNzQ0ZmY4ODQ2NzA1NjQ1YmI2NTc5XzEyLTMtMS0xLTA_5c51e4cd-5f45-4aa8-b756-525cdec2485e">4</ix:nonFraction>&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Forward interest rate swaps (3)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i86f91bfc61ad471a9cb0bef75b551b70_I20210630" decimals="-6" format="ixt:zerodash" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzkvZnJhZzo4OGQ2MDhlMWNlMjY0N2E5OGJjZWNlYjAxZDg1NjFiMC90YWJsZTpiNDU0MDkwYzljMDc0NGZmODg0NjcwNTY0NWJiNjU3OS90YWJsZXJhbmdlOmI0NTQwOTBjOWMwNzQ0ZmY4ODQ2NzA1NjQ1YmI2NTc5XzEzLTEtMS0xLTA_45a1c7b8-1ec9-4b16-8cf6-6411b14a55e6">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibe5ee12c49f146b8bc66d2c3290cbd7f_I20200630" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzkvZnJhZzo4OGQ2MDhlMWNlMjY0N2E5OGJjZWNlYjAxZDg1NjFiMC90YWJsZTpiNDU0MDkwYzljMDc0NGZmODg0NjcwNTY0NWJiNjU3OS90YWJsZXJhbmdlOmI0NTQwOTBjOWMwNzQ0ZmY4ODQ2NzA1NjQ1YmI2NTc5XzEzLTMtMS0xLTA_a1e10bb8-ccb5-427a-83d4-af7031035e7b">16</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Commodity contracts (4)</span></td><td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibc2ebe6c60f8474283c818e4eb4db2ee_I20210630" decimals="-6" format="ixt:zerodash" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzkvZnJhZzo4OGQ2MDhlMWNlMjY0N2E5OGJjZWNlYjAxZDg1NjFiMC90YWJsZTpiNDU0MDkwYzljMDc0NGZmODg0NjcwNTY0NWJiNjU3OS90YWJsZXJhbmdlOmI0NTQwOTBjOWMwNzQ0ZmY4ODQ2NzA1NjQ1YmI2NTc5XzE1LTEtMS0xLTA_4e97882f-0cb4-4a76-8272-b1fdd7e0f9a4">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied8ca13a46124e0186f0557c51ad5050_I20200630" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzkvZnJhZzo4OGQ2MDhlMWNlMjY0N2E5OGJjZWNlYjAxZDg1NjFiMC90YWJsZTpiNDU0MDkwYzljMDc0NGZmODg0NjcwNTY0NWJiNjU3OS90YWJsZXJhbmdlOmI0NTQwOTBjOWMwNzQ0ZmY4ODQ2NzA1NjQ1YmI2NTc5XzE1LTMtMS0xLTA_c2523650-30e3-468d-b6ca-8424e070fdbf">1</ix:nonFraction>&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total liabilities</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2e87824102b34590a0208cc7da91b5f5_I20210630" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzkvZnJhZzo4OGQ2MDhlMWNlMjY0N2E5OGJjZWNlYjAxZDg1NjFiMC90YWJsZTpiNDU0MDkwYzljMDc0NGZmODg0NjcwNTY0NWJiNjU3OS90YWJsZXJhbmdlOmI0NTQwOTBjOWMwNzQ0ZmY4ODQ2NzA1NjQ1YmI2NTc5XzE2LTEtMS0xLTA_5949fd1d-acb9-4f32-9b99-cadd047ce88b">4</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i299cea70f47b4fbe96772aaa8cc00b79_I20200630" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzkvZnJhZzo4OGQ2MDhlMWNlMjY0N2E5OGJjZWNlYjAxZDg1NjFiMC90YWJsZTpiNDU0MDkwYzljMDc0NGZmODg0NjcwNTY0NWJiNjU3OS90YWJsZXJhbmdlOmI0NTQwOTBjOWMwNzQ0ZmY4ODQ2NzA1NjQ1YmI2NTc5XzE2LTMtMS0xLTA_7d0b90ac-b5e6-4a3f-bfb8-34232fd5891a">21</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;Included in other assets in the consolidated balance sheets.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)&#160;&#160;&#160;&#160;Included in prepaid expenses and other in the consolidated balance sheets.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(3)&#160;&#160;&#160;&#160;Included in deferred income taxes and other liabilities in the consolidated balance sheets.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(4)&#160;&#160;&#160;&#160;Included in other accrued liabilities in the consolidated balance sheets.</span></div></ix:nonNumeric><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Fair Value Hedges</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We enter into pay-floating interest rate swaps to hedge the changes in the fair value of fixed-rate debt resulting from fluctuations in interest rates. These contracts are designated and qualify as fair value hedges. Accordingly, the gain or loss recorded on the pay-floating interest rate swaps is directly offset by the change in fair value of the underlying debt. Both the derivative instrument and the underlying debt are adjusted to market value at the end of each period with any resulting gain or loss recorded in interest expense, net in the consolidated statements of earnings/(loss). During fiscal 2021, 2020 and 2019 there was <ix:nonFraction unitRef="usd" contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630" decimals="-6" format="ixt-sec:numwordsen" name="us-gaap:ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzkvZnJhZzo4OGQ2MDhlMWNlMjY0N2E5OGJjZWNlYjAxZDg1NjFiMC90ZXh0cmVnaW9uOjg4ZDYwOGUxY2UyNjQ3YTk4YmNlY2ViMDFkODU2MWIwXzM4MjE_3bc369c3-dab5-459c-97bc-213d34363847"><ix:nonFraction unitRef="usd" contextRef="ia31e9a409b874bb19d0ff6f2f39ecc09_D20190701-20200630" decimals="-6" format="ixt-sec:numwordsen" name="us-gaap:ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzkvZnJhZzo4OGQ2MDhlMWNlMjY0N2E5OGJjZWNlYjAxZDg1NjFiMC90ZXh0cmVnaW9uOjg4ZDYwOGUxY2UyNjQ3YTk4YmNlY2ViMDFkODU2MWIwXzM4MjE_62f665ff-f473-486e-9078-7680684edee8">no</ix:nonFraction></ix:nonFraction> gain or loss recorded to interest expense as changes in the market value of our derivative instruments offset changes in the market value of the underlying debt.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:115%">During fiscal 2021, we unwound certain interest rate swap contracts with the notional amount of $<ix:nonFraction unitRef="usd" contextRef="i1f99a8613bb24104868a314b77c67aa4_I20210630" decimals="-6" format="ixt:numdotdecimal" name="cah:DerivatesHedgeDiscontinuancesHedgingInstrumentTerminatedAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzkvZnJhZzo4OGQ2MDhlMWNlMjY0N2E5OGJjZWNlYjAxZDg1NjFiMC90ZXh0cmVnaW9uOjg4ZDYwOGUxY2UyNjQ3YTk4YmNlY2ViMDFkODU2MWIwXzI3NDg3NzkwODIxMTM_99a6ec36-206c-4956-9883-5d186cd14770">550</ix:nonFraction>&#160;million. In connection with the unwind of these contracts, we received cash proceeds of </span></div></ix:continuation></div></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:3pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.222%"><tr><td style="width:1.0%"></td><td style="width:32.133%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.433%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.134%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">80</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardinal Health </span><span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">| </span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2021 Form 10-K</span></div></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:3pt"><span><br/></span></div><div style="margin-bottom:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:24.682%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:50.911%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.107%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#e41f35;border-bottom:1pt solid #e41f35;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Notes to Financial Statements</span></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:0 1pt"></td></tr></table></div></div><div style="width:100.000%"><ix:continuation id="i6bd54f15df9148178c7081eafe804112" continuedAt="i7bf39609d2894b2ca6833676233cb178"><div style="display:inline-block;vertical-align:top;width:48.214%"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$<ix:nonFraction unitRef="usd" contextRef="i69a44d9974c04cc3abf8c7aeb68f22c6_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DeferredGainLossOnDiscontinuationOfInterestRateFairValueHedge" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzkvZnJhZzo4OGQ2MDhlMWNlMjY0N2E5OGJjZWNlYjAxZDg1NjFiMC90ZXh0cmVnaW9uOjg4ZDYwOGUxY2UyNjQ3YTk4YmNlY2ViMDFkODU2MWIwXzI3NDg3NzkwODIxOTc_c92e8b5d-c0a3-4b32-8c29-64eba46d0f95">18</ix:nonFraction>&#160;million. The related gain will be recognized in interest expense, net in our statements of earnings/(loss) over the remaining term of the debt agreement, which matures in March 2023.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During fiscal 2021, we entered into a pay-floating interest rate swap with total notional amounts of $<ix:nonFraction unitRef="usd" contextRef="i1f99a8613bb24104868a314b77c67aa4_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DerivativeLiabilityNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzkvZnJhZzo4OGQ2MDhlMWNlMjY0N2E5OGJjZWNlYjAxZDg1NjFiMC90ZXh0cmVnaW9uOjg4ZDYwOGUxY2UyNjQ3YTk4YmNlY2ViMDFkODU2MWIwXzI3NDg3NzkwODI0ODc_162ce315-d320-4010-839f-88469a94bd85">200</ix:nonFraction>&#160;million. This swap has been designated as fair value hedges of our fixed rate debt and is included in deferred income taxes and other liabilities in the consolidated balance sheets.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2020, we unwound certain interest rate swap contracts. In connection with the unwind of these contracts, we received cash proceeds of $<ix:nonFraction unitRef="usd" contextRef="i0168bf25346243ffba7498cecba4a9cc_I20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DeferredGainLossOnDiscontinuationOfInterestRateFairValueHedge" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzkvZnJhZzo4OGQ2MDhlMWNlMjY0N2E5OGJjZWNlYjAxZDg1NjFiMC90ZXh0cmVnaW9uOjg4ZDYwOGUxY2UyNjQ3YTk4YmNlY2ViMDFkODU2MWIwXzQxMjU_8f1877e9-fc75-4149-a8df-3c9b794e4c8a">112</ix:nonFraction> million. The related gain will be recognized in interest expense, net in our statements of earnings/(loss) over the remaining term of the related debt agreements, which ranged from 48 months to 63 months at June&#160;30, 2020.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the debt repayment as described in </span><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i4f0ec56b9c604f1782a65ea4a19c284d_124">Note 6</a></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, two pay-floating interest rate swaps with notional amounts of $<ix:nonFraction unitRef="usd" contextRef="i0168bf25346243ffba7498cecba4a9cc_I20200630" decimals="-6" format="ixt:numdotdecimal" name="cah:DerivativesHedgeDiscontinuancesHedgingInstrumentMaturedAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzkvZnJhZzo4OGQ2MDhlMWNlMjY0N2E5OGJjZWNlYjAxZDg1NjFiMC90ZXh0cmVnaW9uOjg4ZDYwOGUxY2UyNjQ3YTk4YmNlY2ViMDFkODU2MWIwXzQ0NTQ_e4a4715e-2a78-4222-82a9-9e480440bb70">200</ix:nonFraction> million matured in the second quarter of fiscal 2020. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During fiscal&#160;2019, we terminated notional amounts of&#160;$<ix:nonFraction unitRef="usd" contextRef="icee22ead7e494923bbe522fa98e2c282_I20190630" decimals="-6" format="ixt:numdotdecimal" name="cah:DerivativesHedgeDiscontinuancesTerminationofHedgingInstrumentAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzkvZnJhZzo4OGQ2MDhlMWNlMjY0N2E5OGJjZWNlYjAxZDg1NjFiMC90ZXh0cmVnaW9uOjg4ZDYwOGUxY2UyNjQ3YTk4YmNlY2ViMDFkODU2MWIwXzI3NDg3NzkwODE1MDM_750cca7d-e6ec-46ce-9868-a02278b1013e">163</ix:nonFraction>&#160;million&#160;of pay-floating interest rate swaps in connection with the debt repurchases in&#160;fiscal 2019&#160;described in </span><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i4f0ec56b9c604f1782a65ea4a19c284d_124">Note 6</a></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. These swaps were previously designated as fair value hedges.</span></div><ix:nonNumeric contextRef="i85f45ef64e47468d81d7e9def6ee8bdd_D20200701-20210630" name="us-gaap:ScheduleOfDerivativeInstrumentsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzkvZnJhZzo4OGQ2MDhlMWNlMjY0N2E5OGJjZWNlYjAxZDg1NjFiMC90ZXh0cmVnaW9uOjg4ZDYwOGUxY2UyNjQ3YTk4YmNlY2ViMDFkODU2MWIwXzExMTIw_a60c18e4-fabf-4bb7-b077-5217e7faa2a9" escape="true"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables summarize the outstanding interest rate swaps designated as fair value hedges at June 30:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.691%"><tr><td style="width:1.0%"></td><td style="width:43.482%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:26.454%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.347%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.045%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.615%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.357%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Notional Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Maturity&#160;Date</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Pay-floating interest rate swaps</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04848fa4190a4546999fce3b74a1093a_I20210630" decimals="-6" name="us-gaap:DerivativeAssetNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzkvZnJhZzo4OGQ2MDhlMWNlMjY0N2E5OGJjZWNlYjAxZDg1NjFiMC90YWJsZTo4YzM1Y2Q5YmRiNjI0NzcyYTU5NDA4MGM2MTNkYTIwOC90YWJsZXJhbmdlOjhjMzVjZDliZGI2MjQ3NzJhNTk0MDgwYzYxM2RhMjA4XzItMS0xLTEtMA_38a6cb71-d95d-4a31-af79-a2947d4ab843">200</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:0 1pt"></td><td colspan="9" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Mar 2028</span></td></tr></table></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.691%"><tr><td style="width:1.0%"></td><td style="width:43.791%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:26.144%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.347%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.045%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.615%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.358%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Notional Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Maturity&#160;Date</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Pay-floating interest rate swaps</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iffa4055c7e214900820c0a0df90cdebf_I20200630" decimals="-6" name="us-gaap:DerivativeAssetNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzkvZnJhZzo4OGQ2MDhlMWNlMjY0N2E5OGJjZWNlYjAxZDg1NjFiMC90YWJsZTo2NWRkOTYyYzdiNDg0NWNmYWU1OGVhNmFkMzlmODY5NC90YWJsZXJhbmdlOjY1ZGQ5NjJjN2I0ODQ1Y2ZhZTU4ZWE2YWQzOWY4Njk0XzItMS0xLTEtMA_f7da8e31-5953-4540-aabc-49e9a6f51fa5">550</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:0 1pt"></td><td colspan="9" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Mar 2023</span></td></tr></table></div></ix:nonNumeric><ix:nonNumeric contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630" name="us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzkvZnJhZzo4OGQ2MDhlMWNlMjY0N2E5OGJjZWNlYjAxZDg1NjFiMC90ZXh0cmVnaW9uOjg4ZDYwOGUxY2UyNjQ3YTk4YmNlY2ViMDFkODU2MWIwXzExMTQ4_1ee43e0a-e643-4a7d-9c39-b3acebfc6b72" escape="true"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the gain/(loss) recognized in earnings for interest rate swaps designated as fair value hedges:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:52.912%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.788%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.343%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.406%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.343%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.408%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Pay-floating interest rate swaps (1)</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i17248417fcbc4d118aebc5dfbe183bfc_D20200701-20210630" decimals="-6" sign="-" name="us-gaap:DerivativeGainLossOnDerivativeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzkvZnJhZzo4OGQ2MDhlMWNlMjY0N2E5OGJjZWNlYjAxZDg1NjFiMC90YWJsZTplNDI3OWExYjM5M2U0Y2U4OTY5NzdiNmYzYjc1Njg3NS90YWJsZXJhbmdlOmU0Mjc5YTFiMzkzZTRjZTg5Njk3N2I2ZjNiNzU2ODc1XzEtMS0xLTEtMA_476cee54-6cfd-4f9c-9117-9c7fb8389348">8</ix:nonFraction>)</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0845a3b72a6e4a848138beb4170c6fba_D20190701-20200630" decimals="-6" name="us-gaap:DerivativeGainLossOnDerivativeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzkvZnJhZzo4OGQ2MDhlMWNlMjY0N2E5OGJjZWNlYjAxZDg1NjFiMC90YWJsZTplNDI3OWExYjM5M2U0Y2U4OTY5NzdiNmYzYjc1Njg3NS90YWJsZXJhbmdlOmU0Mjc5YTFiMzkzZTRjZTg5Njk3N2I2ZjNiNzU2ODc1XzEtMy0xLTEtMA_c733c423-142f-484b-b123-7131115c8b9b">106</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibe9e1edad1c3406abdda7b5fca98220a_D20180701-20190630" decimals="-6" name="us-gaap:DerivativeGainLossOnDerivativeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzkvZnJhZzo4OGQ2MDhlMWNlMjY0N2E5OGJjZWNlYjAxZDg1NjFiMC90YWJsZTplNDI3OWExYjM5M2U0Y2U4OTY5NzdiNmYzYjc1Njg3NS90YWJsZXJhbmdlOmU0Mjc5YTFiMzkzZTRjZTg5Njk3N2I2ZjNiNzU2ODc1XzEtNS0xLTEtMA_fb390cb8-81c9-4d68-94c0-d82c92d6899b">9</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Fixed-rate debt (1)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia80ca9aee82849b1a44b4c376a866386_D20200701-20210630" decimals="-6" name="us-gaap:DerivativeGainLossOnDerivativeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzkvZnJhZzo4OGQ2MDhlMWNlMjY0N2E5OGJjZWNlYjAxZDg1NjFiMC90YWJsZTplNDI3OWExYjM5M2U0Y2U4OTY5NzdiNmYzYjc1Njg3NS90YWJsZXJhbmdlOmU0Mjc5YTFiMzkzZTRjZTg5Njk3N2I2ZjNiNzU2ODc1XzItMS0xLTEtMA_f8b9d81d-de0f-47de-82f3-792948650b2a">8</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic47a87ff22934f0a928e5fd2824d30f8_D20190701-20200630" decimals="-6" sign="-" name="us-gaap:DerivativeGainLossOnDerivativeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzkvZnJhZzo4OGQ2MDhlMWNlMjY0N2E5OGJjZWNlYjAxZDg1NjFiMC90YWJsZTplNDI3OWExYjM5M2U0Y2U4OTY5NzdiNmYzYjc1Njg3NS90YWJsZXJhbmdlOmU0Mjc5YTFiMzkzZTRjZTg5Njk3N2I2ZjNiNzU2ODc1XzItMy0xLTEtMA_b94cb63c-197c-47de-88bc-a0b26f9e9549">106</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic94b1b2e248e48cdb5c5ff6dca1da5fb_D20180701-20190630" decimals="-6" sign="-" name="us-gaap:DerivativeGainLossOnDerivativeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzkvZnJhZzo4OGQ2MDhlMWNlMjY0N2E5OGJjZWNlYjAxZDg1NjFiMC90YWJsZTplNDI3OWExYjM5M2U0Y2U4OTY5NzdiNmYzYjc1Njg3NS90YWJsZXJhbmdlOmU0Mjc5YTFiMzkzZTRjZTg5Njk3N2I2ZjNiNzU2ODc1XzItNS0xLTEtMA_a8fbcb22-8874-471c-9d7f-87705df57bec">9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:3pt;padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1) Included in interest expense, net in the consolidated statements of earnings/(loss).</span></div></ix:nonNumeric><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Cash Flow Hedges</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We enter into derivative instruments to hedge our exposure to changes in cash flows attributable to interest rate, foreign currency and commodity price fluctuations associated with certain forecasted transactions. These derivative instruments are designated and qualify as cash flow hedges. Accordingly, the gain or loss on the derivative instrument is reported as a component of accumulated other comprehensive loss and reclassified into earnings in the same line item associated with the forecasted transaction and in the same period during which the hedged transaction affects earnings. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During fiscal 2020, we entered into forward interest rate swaps with a total notional amount of $<ix:nonFraction unitRef="usd" contextRef="i58c9aa5163a64897b2ad19c7f47190d0_I20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DerivativeLiabilityNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzkvZnJhZzo4OGQ2MDhlMWNlMjY0N2E5OGJjZWNlYjAxZDg1NjFiMC90ZXh0cmVnaW9uOjg4ZDYwOGUxY2UyNjQ3YTk4YmNlY2ViMDFkODU2MWIwXzQ5NDc4MDIzMzg0Mzk_85f6c044-ef61-4532-85e3-d8cef475aa6b"><ix:nonFraction unitRef="usd" contextRef="i54cc6ff9187745ac8eb02d90c7a86a72_I20210630" decimals="-6" format="ixt:numdotdecimal" name="cah:DerivatesHedgeDiscontinuancesHedgingInstrumentTerminatedAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzkvZnJhZzo4OGQ2MDhlMWNlMjY0N2E5OGJjZWNlYjAxZDg1NjFiMC90ZXh0cmVnaW9uOjg4ZDYwOGUxY2UyNjQ3YTk4YmNlY2ViMDFkODU2MWIwXzQ5NDc4MDIzMzg0Mzk_e576cea9-d070-4097-a14a-3fabc3ae6a2a">200</ix:nonFraction></ix:nonFraction>&#160;million to hedge probable, but </span></div></div><div style="display:inline-block;max-width:3.571%;min-width:2.571%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:48.215%"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">not firmly committed, future transactions associated with our debt. During fiscal 2021, we terminated these swaps and reclassified an immaterial deferred gain from accumulated other comprehensive loss into interest expense, net in our consolidated statements of earnings/(loss) because the forecasted transactions were probable of not occurring. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All gains and losses currently included within accumulated other comprehensive loss associated with our cash flow hedges that are expected to be reclassified into net earnings within the next 12 months are immaterial.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We enter into foreign currency contracts to protect the value of anticipated foreign currency revenues and expenses. At June&#160;30, 2021 and 2020, we held contracts to hedge probable, but not firmly committed, revenue and expenses. The principal currencies hedged are the Chinese renminbi, Canadian dollar, euro, Thai baht and Mexican peso.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We enter into commodity contracts to manage the price risk associated with forecasted purchases of certain commodities used in our Medical segment.</span></div><ix:nonNumeric contextRef="i88d0b5894f144c978ac101959057bde3_D20200701-20210630" name="us-gaap:ScheduleOfDerivativeInstrumentsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzkvZnJhZzo4OGQ2MDhlMWNlMjY0N2E5OGJjZWNlYjAxZDg1NjFiMC90ZXh0cmVnaW9uOjg4ZDYwOGUxY2UyNjQ3YTk4YmNlY2ViMDFkODU2MWIwXzExMTE0_7e395f89-d438-4030-adb6-835c3918d2b0" escape="true"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables summarize the outstanding cash flow hedges at June 30:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:38.714%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:24.517%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.343%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.912%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.408%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Notional Amount</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Maturity&#160;Date</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td style="background-color:#dbdbdb;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#dbdbdb;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8f3de44e96774f7296c0c1deb3f17775_I20210630" decimals="-6" name="us-gaap:DerivativeAssetNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzkvZnJhZzo4OGQ2MDhlMWNlMjY0N2E5OGJjZWNlYjAxZDg1NjFiMC90YWJsZTo4MmM4NzM3ZGYwYWY0ZWZhOGE3N2IxNjIyNDBkNGMzNC90YWJsZXJhbmdlOjgyYzg3MzdkZjBhZjRlZmE4YTc3YjE2MjI0MGQ0YzM0XzMtMS0xLTEtMA_605ead05-2e68-40de-93ce-29ebc19d8363">436</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dbdbdb;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dbdbdb;border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#dbdbdb;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Jul 2021</span></td><td colspan="3" style="background-color:#dbdbdb;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">-</span></td><td colspan="3" style="background-color:#dbdbdb;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Jun 2022</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:38.714%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:24.517%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.343%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.912%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.408%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Notional Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Maturity&#160;Date</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Forward interest rate swaps</span></td><td style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i82a8006ead354bb59b15285e08a487f9_I20200630" decimals="-6" name="us-gaap:DerivativeAssetNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzkvZnJhZzo4OGQ2MDhlMWNlMjY0N2E5OGJjZWNlYjAxZDg1NjFiMC90YWJsZTo0ZWEwNWEzMTJjNTc0ODIxOGE2ZjQ0MTY3ZThkNzI2Ni90YWJsZXJhbmdlOjRlYTA1YTMxMmM1NzQ4MjE4YTZmNDQxNjdlOGQ3MjY2XzItMS0xLTEtMA_42a7e674-a773-4204-8321-bfe727d010e2">200</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="9" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Jun 2022</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie09b4e9c614244d1bd722525781f1905_I20200630" decimals="-6" name="us-gaap:DerivativeAssetNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzkvZnJhZzo4OGQ2MDhlMWNlMjY0N2E5OGJjZWNlYjAxZDg1NjFiMC90YWJsZTo0ZWEwNWEzMTJjNTc0ODIxOGE2ZjQ0MTY3ZThkNzI2Ni90YWJsZXJhbmdlOjRlYTA1YTMxMmM1NzQ4MjE4YTZmNDQxNjdlOGQ3MjY2XzMtMS0xLTEtMA_470de256-6e15-49a9-b8ad-d72281eb2192">328</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Jul 2020</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Jun 2021</span></div></td></tr><tr><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Commodity contracts</span></td><td colspan="2" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4de6f0288abd431bbc839b56b68b328b_I20200630" decimals="-6" name="us-gaap:DerivativeAssetNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzkvZnJhZzo4OGQ2MDhlMWNlMjY0N2E5OGJjZWNlYjAxZDg1NjFiMC90YWJsZTo0ZWEwNWEzMTJjNTc0ODIxOGE2ZjQ0MTY3ZThkNzI2Ni90YWJsZXJhbmdlOjRlYTA1YTMxMmM1NzQ4MjE4YTZmNDQxNjdlOGQ3MjY2XzQtMS0xLTEtMA_5581695f-6d53-408b-93ae-69ad9c75a527">16</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Jul 2020</span></div></td><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Jun 2021</span></div></td></tr></table></div></ix:nonNumeric><ix:nonNumeric contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630" name="us-gaap:ScheduleOfDerivativeInstrumentsEffectOnOtherComprehensiveIncomeLossTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzkvZnJhZzo4OGQ2MDhlMWNlMjY0N2E5OGJjZWNlYjAxZDg1NjFiMC90ZXh0cmVnaW9uOjg4ZDYwOGUxY2UyNjQ3YTk4YmNlY2ViMDFkODU2MWIwXzExMTM5_209e50cc-15eb-4b07-ba0b-0c0b9844299e" escape="true"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the pre-tax gain/(loss) included in OCI for derivative instruments designated as cash flow hedges:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:46.739%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.492%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.343%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.023%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.960%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.643%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Forward interest rate swaps</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i405b6b2ebdbb4b00959f5be8d40c1adb_D20200701-20210630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzkvZnJhZzo4OGQ2MDhlMWNlMjY0N2E5OGJjZWNlYjAxZDg1NjFiMC90YWJsZTo0NWU1NGM2OTA5MDM0YjlhYTE1YjZhMGFmNjhhZTVmMy90YWJsZXJhbmdlOjQ1ZTU0YzY5MDkwMzRiOWFhMTViNmEwYWY2OGFlNWYzXzEtMS0xLTEtMA_430acc03-f66a-464d-be5b-e0e76168d123">16</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3977a8adbc674a3db02afa95292219d7_D20190701-20200630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzkvZnJhZzo4OGQ2MDhlMWNlMjY0N2E5OGJjZWNlYjAxZDg1NjFiMC90YWJsZTo0NWU1NGM2OTA5MDM0YjlhYTE1YjZhMGFmNjhhZTVmMy90YWJsZXJhbmdlOjQ1ZTU0YzY5MDkwMzRiOWFhMTViNmEwYWY2OGFlNWYzXzEtMy0xLTEtMA_62b65816-733c-42f9-aa92-ab83753ce84a">16</ix:nonFraction>)</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie29079d55386424da44448bd2dd0f7b9_D20180701-20190630" decimals="-6" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzkvZnJhZzo4OGQ2MDhlMWNlMjY0N2E5OGJjZWNlYjAxZDg1NjFiMC90YWJsZTo0NWU1NGM2OTA5MDM0YjlhYTE1YjZhMGFmNjhhZTVmMy90YWJsZXJhbmdlOjQ1ZTU0YzY5MDkwMzRiOWFhMTViNmEwYWY2OGFlNWYzXzEtNS0xLTEtMA_8f4bd03d-2034-464c-b89f-2b655a77b79b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Commodity contracts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8660a36c1b824eb4b6d2ad1d1026a6f3_D20200701-20210630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzkvZnJhZzo4OGQ2MDhlMWNlMjY0N2E5OGJjZWNlYjAxZDg1NjFiMC90YWJsZTo0NWU1NGM2OTA5MDM0YjlhYTE1YjZhMGFmNjhhZTVmMy90YWJsZXJhbmdlOjQ1ZTU0YzY5MDkwMzRiOWFhMTViNmEwYWY2OGFlNWYzXzItMS0xLTEtMA_ab14baf3-ce39-4656-b042-a7f3d3ad9698">1</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i47b375ab68594453a768538fa7711d00_D20190701-20200630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzkvZnJhZzo4OGQ2MDhlMWNlMjY0N2E5OGJjZWNlYjAxZDg1NjFiMC90YWJsZTo0NWU1NGM2OTA5MDM0YjlhYTE1YjZhMGFmNjhhZTVmMy90YWJsZXJhbmdlOjQ1ZTU0YzY5MDkwMzRiOWFhMTViNmEwYWY2OGFlNWYzXzItMy0xLTEtMA_da61b2c7-2e25-41bc-942c-732ec0f42462">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3cf9aa045e7e4557acc082d5c2059d82_D20180701-20190630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzkvZnJhZzo4OGQ2MDhlMWNlMjY0N2E5OGJjZWNlYjAxZDg1NjFiMC90YWJsZTo0NWU1NGM2OTA5MDM0YjlhYTE1YjZhMGFmNjhhZTVmMy90YWJsZXJhbmdlOjQ1ZTU0YzY5MDkwMzRiOWFhMTViNmEwYWY2OGFlNWYzXzItNS0xLTEtMA_c24cff24-67da-43ed-876f-f469d3489d70">5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td colspan="2" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i88bb1d629e614ee2843091d49bcc870c_D20200701-20210630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzkvZnJhZzo4OGQ2MDhlMWNlMjY0N2E5OGJjZWNlYjAxZDg1NjFiMC90YWJsZTo0NWU1NGM2OTA5MDM0YjlhYTE1YjZhMGFmNjhhZTVmMy90YWJsZXJhbmdlOjQ1ZTU0YzY5MDkwMzRiOWFhMTViNmEwYWY2OGFlNWYzXzMtMS0xLTEtMA_04fac6eb-41f5-4d9b-84a5-6c2016e37f50">5</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i45480cf9423f4da49ba73dd67b12ad65_D20190701-20200630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzkvZnJhZzo4OGQ2MDhlMWNlMjY0N2E5OGJjZWNlYjAxZDg1NjFiMC90YWJsZTo0NWU1NGM2OTA5MDM0YjlhYTE1YjZhMGFmNjhhZTVmMy90YWJsZXJhbmdlOjQ1ZTU0YzY5MDkwMzRiOWFhMTViNmEwYWY2OGFlNWYzXzMtMy0xLTEtMA_162a99f3-11bf-43e1-9cf9-a1bf54f8ef18">8</ix:nonFraction>)</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib59a0c13c5ee4ae9aa9b88933c02ef8e_D20180701-20190630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzkvZnJhZzo4OGQ2MDhlMWNlMjY0N2E5OGJjZWNlYjAxZDg1NjFiMC90YWJsZTo0NWU1NGM2OTA5MDM0YjlhYTE1YjZhMGFmNjhhZTVmMy90YWJsZXJhbmdlOjQ1ZTU0YzY5MDkwMzRiOWFhMTViNmEwYWY2OGFlNWYzXzMtNS0xLTEtMA_b455693d-d849-49b2-a253-33f8d54a9b7c">5</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><ix:nonNumeric contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630" name="us-gaap:ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzkvZnJhZzo4OGQ2MDhlMWNlMjY0N2E5OGJjZWNlYjAxZDg1NjFiMC90ZXh0cmVnaW9uOjg4ZDYwOGUxY2UyNjQ3YTk4YmNlY2ViMDFkODU2MWIwXzExMDgy_e92eebf9-d117-4e2e-8ccf-05fb0e546611" escape="true"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the pre-tax gain/(loss) reclassified from AOCI into earnings for derivative instruments designated as cash flow hedges:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.382%"><tr><td style="width:1.0%"></td><td style="width:46.415%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.359%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.352%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.359%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.352%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.363%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Foreign currency contracts (1)</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibb6fbf503d8d4b92b0852c5ea1309753_D20200701-20210630" decimals="-6" sign="-" name="us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzkvZnJhZzo4OGQ2MDhlMWNlMjY0N2E5OGJjZWNlYjAxZDg1NjFiMC90YWJsZTo1OTBhYTg2MjMwNjA0OTEyOTgxZTI2Mjc4NDQxN2U4ZS90YWJsZXJhbmdlOjU5MGFhODYyMzA2MDQ5MTI5ODFlMjYyNzg0NDE3ZThlXzEtMS0xLTEtMA_a9b41294-0816-4c2f-b5b5-64ac6a062e1c">12</ix:nonFraction>)</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff868024f7f64db3bfeadcc44347a563_D20190701-20200630" decimals="-6" name="us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzkvZnJhZzo4OGQ2MDhlMWNlMjY0N2E5OGJjZWNlYjAxZDg1NjFiMC90YWJsZTo1OTBhYTg2MjMwNjA0OTEyOTgxZTI2Mjc4NDQxN2U4ZS90YWJsZXJhbmdlOjU5MGFhODYyMzA2MDQ5MTI5ODFlMjYyNzg0NDE3ZThlXzEtMy0xLTEtMA_480a708c-9f1e-4515-8dbe-c5ec931d3582">7</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i310f8b1e6b5d4407acac6e3bf1a8f700_D20180701-20190630" decimals="-6" name="us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzkvZnJhZzo4OGQ2MDhlMWNlMjY0N2E5OGJjZWNlYjAxZDg1NjFiMC90YWJsZTo1OTBhYTg2MjMwNjA0OTEyOTgxZTI2Mjc4NDQxN2U4ZS90YWJsZXJhbmdlOjU5MGFhODYyMzA2MDQ5MTI5ODFlMjYyNzg0NDE3ZThlXzEtNS0xLTEtMA_dcdb2438-eadf-46b6-8908-745953379e2d">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Foreign currency contracts (2)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3f26acb0755444a5b5ae1bcdc825ac67_D20200701-20210630" decimals="-6" sign="-" name="us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzkvZnJhZzo4OGQ2MDhlMWNlMjY0N2E5OGJjZWNlYjAxZDg1NjFiMC90YWJsZTo1OTBhYTg2MjMwNjA0OTEyOTgxZTI2Mjc4NDQxN2U4ZS90YWJsZXJhbmdlOjU5MGFhODYyMzA2MDQ5MTI5ODFlMjYyNzg0NDE3ZThlXzItMS0xLTEtMA_9324c84e-d4a0-4269-be8d-2df6f9ca55f0">2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i37fec931826541839b3ab83c0e5334f7_D20190701-20200630" decimals="-6" name="us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzkvZnJhZzo4OGQ2MDhlMWNlMjY0N2E5OGJjZWNlYjAxZDg1NjFiMC90YWJsZTo1OTBhYTg2MjMwNjA0OTEyOTgxZTI2Mjc4NDQxN2U4ZS90YWJsZXJhbmdlOjU5MGFhODYyMzA2MDQ5MTI5ODFlMjYyNzg0NDE3ZThlXzItMy0xLTEtMA_512a1863-d900-421f-bf82-8265a8dd43da">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i987d48debeb4454198012308b3db9d71_D20180701-20190630" decimals="-6" format="ixt:zerodash" name="us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzkvZnJhZzo4OGQ2MDhlMWNlMjY0N2E5OGJjZWNlYjAxZDg1NjFiMC90YWJsZTo1OTBhYTg2MjMwNjA0OTEyOTgxZTI2Mjc4NDQxN2U4ZS90YWJsZXJhbmdlOjU5MGFhODYyMzA2MDQ5MTI5ODFlMjYyNzg0NDE3ZThlXzItNS0xLTEtMA_d6679ef1-e6b1-481f-a929-926cca574e8d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Foreign currency contracts (3)</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iccd66091b41c4c73b464f972ba9df372_D20200701-20210630" decimals="-6" name="us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzkvZnJhZzo4OGQ2MDhlMWNlMjY0N2E5OGJjZWNlYjAxZDg1NjFiMC90YWJsZTo1OTBhYTg2MjMwNjA0OTEyOTgxZTI2Mjc4NDQxN2U4ZS90YWJsZXJhbmdlOjU5MGFhODYyMzA2MDQ5MTI5ODFlMjYyNzg0NDE3ZThlXzMtMS0xLTEtMA_161bffb2-29be-410e-b8c7-4d2d00c36f1f">4</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i63ef41121d204393a0ebe9effaf8d432_D20190701-20200630" decimals="-6" format="ixt:zerodash" name="us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzkvZnJhZzo4OGQ2MDhlMWNlMjY0N2E5OGJjZWNlYjAxZDg1NjFiMC90YWJsZTo1OTBhYTg2MjMwNjA0OTEyOTgxZTI2Mjc4NDQxN2U4ZS90YWJsZXJhbmdlOjU5MGFhODYyMzA2MDQ5MTI5ODFlMjYyNzg0NDE3ZThlXzMtMy0xLTEtMA_510d944d-4242-4ebd-8304-7ad3c3d34261">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f15f52c79704d46af60964d622dedab_D20180701-20190630" decimals="-6" name="us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzkvZnJhZzo4OGQ2MDhlMWNlMjY0N2E5OGJjZWNlYjAxZDg1NjFiMC90YWJsZTo1OTBhYTg2MjMwNjA0OTEyOTgxZTI2Mjc4NDQxN2U4ZS90YWJsZXJhbmdlOjU5MGFhODYyMzA2MDQ5MTI5ODFlMjYyNzg0NDE3ZThlXzMtNS0xLTEtMA_49c8a0ce-f352-49b7-a516-8943bec12094">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Forward interest rate swaps (4)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7a11a5ca49904135831f29f2e02611af_D20200701-20210630" decimals="-6" name="us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzkvZnJhZzo4OGQ2MDhlMWNlMjY0N2E5OGJjZWNlYjAxZDg1NjFiMC90YWJsZTo1OTBhYTg2MjMwNjA0OTEyOTgxZTI2Mjc4NDQxN2U4ZS90YWJsZXJhbmdlOjU5MGFhODYyMzA2MDQ5MTI5ODFlMjYyNzg0NDE3ZThlXzQtMS0xLTEtMA_3a91f68e-91c5-4194-96bc-bfb9fda5c65f">2</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5459407c23c44c3aa651aec1bc97a889_D20190701-20200630" decimals="-6" name="us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzkvZnJhZzo4OGQ2MDhlMWNlMjY0N2E5OGJjZWNlYjAxZDg1NjFiMC90YWJsZTo1OTBhYTg2MjMwNjA0OTEyOTgxZTI2Mjc4NDQxN2U4ZS90YWJsZXJhbmdlOjU5MGFhODYyMzA2MDQ5MTI5ODFlMjYyNzg0NDE3ZThlXzQtMy0xLTEtMA_1d97bfd0-d8e0-4de4-a003-b6c198350fe4">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia2835dfb9ad14f699e13cc2bec62ea7e_D20180701-20190630" decimals="-6" name="us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzkvZnJhZzo4OGQ2MDhlMWNlMjY0N2E5OGJjZWNlYjAxZDg1NjFiMC90YWJsZTo1OTBhYTg2MjMwNjA0OTEyOTgxZTI2Mjc4NDQxN2U4ZS90YWJsZXJhbmdlOjU5MGFhODYyMzA2MDQ5MTI5ODFlMjYyNzg0NDE3ZThlXzQtNS0xLTEtMA_9f3c7029-3a63-48c5-bbcd-39eb1956de16">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Commodity contracts (3)</span></td><td colspan="2" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b9f0ce7440942e7bc207e8b7e6a8b82_D20200701-20210630" decimals="-6" name="us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzkvZnJhZzo4OGQ2MDhlMWNlMjY0N2E5OGJjZWNlYjAxZDg1NjFiMC90YWJsZTo1OTBhYTg2MjMwNjA0OTEyOTgxZTI2Mjc4NDQxN2U4ZS90YWJsZXJhbmdlOjU5MGFhODYyMzA2MDQ5MTI5ODFlMjYyNzg0NDE3ZThlXzUtMS0xLTEtMA_ca16be7c-8907-422d-948b-2847609f97ae">6</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i70ce64c92675430e973ad1616d164211_D20190701-20200630" decimals="-6" sign="-" name="us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzkvZnJhZzo4OGQ2MDhlMWNlMjY0N2E5OGJjZWNlYjAxZDg1NjFiMC90YWJsZTo1OTBhYTg2MjMwNjA0OTEyOTgxZTI2Mjc4NDQxN2U4ZS90YWJsZXJhbmdlOjU5MGFhODYyMzA2MDQ5MTI5ODFlMjYyNzg0NDE3ZThlXzUtMy0xLTEtMA_beef23a3-a668-47a8-9927-8cfb1f26b5a9">5</ix:nonFraction>)</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie940dc4896674168a3ab782e27d582e1_D20180701-20190630" decimals="-6" format="ixt:zerodash" name="us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzkvZnJhZzo4OGQ2MDhlMWNlMjY0N2E5OGJjZWNlYjAxZDg1NjFiMC90YWJsZTo1OTBhYTg2MjMwNjA0OTEyOTgxZTI2Mjc4NDQxN2U4ZS90YWJsZXJhbmdlOjU5MGFhODYyMzA2MDQ5MTI5ODFlMjYyNzg0NDE3ZThlXzUtNS0xLTEtMA_bede33eb-c6e8-48e6-9f92-a685b8b03f30">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;Included in revenue in the consolidated statements of earnings/(loss).</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)&#160;&#160;&#160;&#160;Included in cost of products sold in the consolidated statements of earnings/(loss).</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(3)&#160;&#160;&#160;&#160;Included in SG&amp;A expenses in the consolidated statements of earnings/(loss).</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(4) &#160;&#160;&#160;&#160;Included in interest expense, net in the consolidated statements of earnings/(loss).</span></div></ix:nonNumeric></div></ix:continuation></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:32.135%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.428%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.137%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardinal Health </span><span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">|</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> Fiscal 2021 Form 10-K</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">81</span></div></td></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:3pt"><span><br/></span></div><div style="margin-bottom:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:24.682%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:50.911%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.107%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#e41f35;border-bottom:1pt solid #e41f35;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Notes to Financial Statements</span></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:0 1pt"></td></tr></table></div></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:48.214%"><ix:continuation id="i7bf39609d2894b2ca6833676233cb178" continuedAt="i09ae1f3ec74f4632a32b081ec8044f85"><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Net Investment Hedges</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We hedge the foreign currency risk associated with certain net investment positions in foreign subsidiaries. To accomplish this, we enter into cross-currency swaps that are designated as hedges of net investments.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2019, we entered into a &#165;<ix:nonFraction unitRef="jpy" contextRef="i254785c21f4b45739afff24cf0bc5323_I20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DerivativeLiabilityNotionalAmount" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzkvZnJhZzo4OGQ2MDhlMWNlMjY0N2E5OGJjZWNlYjAxZDg1NjFiMC90ZXh0cmVnaW9uOjg4ZDYwOGUxY2UyNjQ3YTk4YmNlY2ViMDFkODU2MWIwXzc5MTM_e3acfb1e-8793-4f0f-a652-ad66ad80b9ce">64</ix:nonFraction> billion ($<ix:nonFraction unitRef="usd" contextRef="i254785c21f4b45739afff24cf0bc5323_I20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DerivativeLiabilityNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzkvZnJhZzo4OGQ2MDhlMWNlMjY0N2E5OGJjZWNlYjAxZDg1NjFiMC90ZXh0cmVnaW9uOjg4ZDYwOGUxY2UyNjQ3YTk4YmNlY2ViMDFkODU2MWIwXzc5MTc_aa8b92ea-6d23-4e72-ab13-7dfb16a1b68f">600</ix:nonFraction> million) cross-currency swap maturing in 2022.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In September 2018, we entered into a &#8364;<ix:nonFraction unitRef="eur" contextRef="i2816c95fd6cb499095fe954700d7e965_I20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DerivativeLiabilityNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzkvZnJhZzo4OGQ2MDhlMWNlMjY0N2E5OGJjZWNlYjAxZDg1NjFiMC90ZXh0cmVnaW9uOjg4ZDYwOGUxY2UyNjQ3YTk4YmNlY2ViMDFkODU2MWIwXzI3NDg3NzkwODE5NjY_b80f6599-f749-4b85-a3bf-c620422a6136">200</ix:nonFraction>&#160;million ($<ix:nonFraction unitRef="usd" contextRef="i2816c95fd6cb499095fe954700d7e965_I20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DerivativeLiabilityNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzkvZnJhZzo4OGQ2MDhlMWNlMjY0N2E5OGJjZWNlYjAxZDg1NjFiMC90ZXh0cmVnaW9uOjg4ZDYwOGUxY2UyNjQ3YTk4YmNlY2ViMDFkODU2MWIwXzI3NDg3NzkwODE5OTg_710467b6-4bbf-4cc7-bfec-a9c01eb53855">233</ix:nonFraction>&#160;million) cross-currency swap maturing in 2023.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cross-currency swaps designated as net investment hedges are marked-to-market using the current spot exchange rate as of the end of the period, with gains and losses included in the foreign currency translation component of accumulated other comprehensive loss until the sale or substantial liquidation of the underlying net investments. To the extent the cross-currency swaps designated as net investment hedges are not highly effective, changes in carrying value attributable to the change in spot rates are recorded in earnings. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pre-tax gain and loss from net investment hedges recorded in the foreign currency translation component of accumulated other comprehensive loss was a $<ix:nonFraction unitRef="usd" contextRef="i935ecef2ff6941d394a6beccc5c10088_D20200701-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzkvZnJhZzo4OGQ2MDhlMWNlMjY0N2E5OGJjZWNlYjAxZDg1NjFiMC90ZXh0cmVnaW9uOjg4ZDYwOGUxY2UyNjQ3YTk4YmNlY2ViMDFkODU2MWIwXzg2NTE_a2788a3e-5e4a-4c7d-9cae-5f2237c495e7">7</ix:nonFraction> million loss and a $<ix:nonFraction unitRef="usd" contextRef="i193fb65a21864d5cb26c7c22aca8ad2b_D20190701-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzkvZnJhZzo4OGQ2MDhlMWNlMjY0N2E5OGJjZWNlYjAxZDg1NjFiMC90ZXh0cmVnaW9uOjg4ZDYwOGUxY2UyNjQ3YTk4YmNlY2ViMDFkODU2MWIwXzg2NTg_f28b7ebe-f19d-44cf-9e4d-30bf74cac752">35</ix:nonFraction> million gain during fiscal 2021 and 2020, respectively. Gains recognized in interest expense, net in the consolidated statements of earnings/(loss) for the portion of the net investment hedges excluded from the assessment of hedge effectiveness were $<ix:nonFraction unitRef="usd" contextRef="i935ecef2ff6941d394a6beccc5c10088_D20200701-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:InterestIncomeExpenseNonoperatingNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzkvZnJhZzo4OGQ2MDhlMWNlMjY0N2E5OGJjZWNlYjAxZDg1NjFiMC90ZXh0cmVnaW9uOjg4ZDYwOGUxY2UyNjQ3YTk4YmNlY2ViMDFkODU2MWIwXzg4OTI_46986dee-864c-47a0-901f-c9849b1c8b53">19</ix:nonFraction> million and</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$<ix:nonFraction unitRef="usd" contextRef="i193fb65a21864d5cb26c7c22aca8ad2b_D20190701-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:InterestIncomeExpenseNonoperatingNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzkvZnJhZzo4OGQ2MDhlMWNlMjY0N2E5OGJjZWNlYjAxZDg1NjFiMC90ZXh0cmVnaW9uOjg4ZDYwOGUxY2UyNjQ3YTk4YmNlY2ViMDFkODU2MWIwXzg4OTk_d3b62c82-cf25-42a0-afdd-bb080bb1ad24">17</ix:nonFraction> million during fiscal 2021 and 2020, respectively.</span></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Economic (Non-Designated) Hedges</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We enter into foreign currency contracts to manage our foreign exchange exposure related to sales transactions, intercompany financing transactions and other balance sheet items subject to revaluation that do not meet the requirements for hedge accounting treatment. Accordingly, these derivative instruments are adjusted to current market value at the end of each period through earnings. The gain or loss recorded on these instruments is substantially offset by the remeasurement adjustment on the foreign currency denominated asset or liability. The settlement of the derivative instrument and the remeasurement adjustment on the foreign currency denominated asset or liability are both recorded in other (income)/expense, net. The principal currency managed through foreign currency contracts is the Chinese renminbi, Canadian dollar, euro, Mexican Peso, and Brazilian Real. </span></div><ix:nonNumeric contextRef="if722552b851a401795eb756ce826c809_D20200701-20210630" name="us-gaap:ScheduleOfDerivativeInstrumentsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzkvZnJhZzo4OGQ2MDhlMWNlMjY0N2E5OGJjZWNlYjAxZDg1NjFiMC90ZXh0cmVnaW9uOjg4ZDYwOGUxY2UyNjQ3YTk4YmNlY2ViMDFkODU2MWIwXzExMTUy_449ba516-af94-40f6-8299-af86690281cd" escape="true"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables summarize the outstanding economic (non-designated) derivative instruments at June 30:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:38.714%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:24.517%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.343%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.912%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.408%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Notional Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Maturity Date</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ca29000e9a8453b9f0281faeb2f2ed2_I20210630" decimals="-6" name="us-gaap:DerivativeAssetNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzkvZnJhZzo4OGQ2MDhlMWNlMjY0N2E5OGJjZWNlYjAxZDg1NjFiMC90YWJsZTpjZDBhNDY3M2RkNWU0MTQ5Yjc4ODhlMjkwYmU5ZTFiOC90YWJsZXJhbmdlOmNkMGE0NjczZGQ1ZTQxNDliNzg4OGUyOTBiZTllMWI4XzItMS0xLTEtMA_090b6868-ef2f-4207-95e9-867dceb4188d">254</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:0 1pt"></td><td colspan="9" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">July 2021</span></td></tr></table></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:38.714%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:24.517%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.343%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.912%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.408%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Notional Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Maturity Date</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7d5cf04c44ad4849821d4bb8a6945748_I20200630" decimals="-6" name="us-gaap:DerivativeAssetNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzkvZnJhZzo4OGQ2MDhlMWNlMjY0N2E5OGJjZWNlYjAxZDg1NjFiMC90YWJsZTpmMzYwZDU3NjA1ZjI0ZGY2ODE5ZjA4NDg1ZTVkY2YxNy90YWJsZXJhbmdlOmYzNjBkNTc2MDVmMjRkZjY4MTlmMDg0ODVlNWRjZjE3XzItMS0xLTEtMA_76446e05-02b0-49e2-a1b9-7ed102cf57b1">325</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:0 1pt"></td><td colspan="9" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Jul 2020</span></td></tr></table></div></ix:nonNumeric></ix:continuation></div><div style="display:inline-block;max-width:3.571%;min-width:2.571%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:48.215%"><ix:continuation id="i09ae1f3ec74f4632a32b081ec8044f85"><ix:nonNumeric contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630" name="us-gaap:ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzkvZnJhZzo4OGQ2MDhlMWNlMjY0N2E5OGJjZWNlYjAxZDg1NjFiMC90ZXh0cmVnaW9uOjg4ZDYwOGUxY2UyNjQ3YTk4YmNlY2ViMDFkODU2MWIwXzExMTIy_4ce7c8eb-b914-4609-bf37-cfd2b092ded6" escape="true"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the gain/(loss) recognized in earnings for economic (non-designated) derivative instruments:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.382%"><tr><td style="width:1.0%"></td><td style="width:46.415%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.359%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.352%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.359%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.352%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.363%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Foreign currency contracts (1)</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifca9e60bdc7a4338aa4de50477f141d8_D20200701-20210630" decimals="-6" sign="-" name="us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzkvZnJhZzo4OGQ2MDhlMWNlMjY0N2E5OGJjZWNlYjAxZDg1NjFiMC90YWJsZTo0NTZhNjk0NDJlNDI0YzI5YTE2MjliZmM3ZmRiMDI2OC90YWJsZXJhbmdlOjQ1NmE2OTQ0MmU0MjRjMjlhMTYyOWJmYzdmZGIwMjY4XzEtMS0xLTEtMA_a514122c-0045-4c22-99df-41ff1198fc2f">8</ix:nonFraction>)</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia0fd144ab6c343f591a8767092fb681e_D20190701-20200630" decimals="-6" sign="-" name="us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzkvZnJhZzo4OGQ2MDhlMWNlMjY0N2E5OGJjZWNlYjAxZDg1NjFiMC90YWJsZTo0NTZhNjk0NDJlNDI0YzI5YTE2MjliZmM3ZmRiMDI2OC90YWJsZXJhbmdlOjQ1NmE2OTQ0MmU0MjRjMjlhMTYyOWJmYzdmZGIwMjY4XzEtMy0xLTEtMA_9c54bc00-e2a5-4358-bd21-accedaf49b30">11</ix:nonFraction>)</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3395922d014c40c59d772a4a5b2ebd31_D20180701-20190630" decimals="-6" sign="-" name="us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzkvZnJhZzo4OGQ2MDhlMWNlMjY0N2E5OGJjZWNlYjAxZDg1NjFiMC90YWJsZTo0NTZhNjk0NDJlNDI0YzI5YTE2MjliZmM3ZmRiMDI2OC90YWJsZXJhbmdlOjQ1NmE2OTQ0MmU0MjRjMjlhMTYyOWJmYzdmZGIwMjY4XzEtNS0xLTEtMA_6e37b820-7340-4b7e-9070-e2d9a12dc1bc">13</ix:nonFraction>)</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;Included in other income, net in the consolidated statements of earnings/(loss).</span></div></ix:nonNumeric><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Fair Value of Financial Instruments</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The carrying amounts of cash and equivalents, trade receivables, net, accounts payable, and other accrued liabilities at June&#160;30, 2021 and 2020 approximate fair value due to their short-term maturities.</span></div><ix:nonNumeric contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630" name="us-gaap:ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzkvZnJhZzo4OGQ2MDhlMWNlMjY0N2E5OGJjZWNlYjAxZDg1NjFiMC90ZXh0cmVnaW9uOjg4ZDYwOGUxY2UyNjQ3YTk4YmNlY2ViMDFkODU2MWIwXzExMDgz_818558a5-d07c-4df8-b454-2d72ca74e837" escape="true"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the estimated fair value of our long-term obligations and other short-term borrowings compared to the respective carrying amounts at June 30:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:47.974%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.591%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.343%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.592%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Estimated fair value</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b9a24f3941f46f085d16a60c26ec523_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzkvZnJhZzo4OGQ2MDhlMWNlMjY0N2E5OGJjZWNlYjAxZDg1NjFiMC90YWJsZTo5ZTAyMDhhNTU5ZjI0OTI3OWUxNTFhNDc3YTIwN2UxZC90YWJsZXJhbmdlOjllMDIwOGE1NTlmMjQ5Mjc5ZTE1MWE0NzdhMjA3ZTFkXzEtMS0xLTEtMA_4e1edc98-9f7b-4bc9-bdd3-eb17b485a10c">6,751</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i406116eedea746848300007f225725fd_I20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzkvZnJhZzo4OGQ2MDhlMWNlMjY0N2E5OGJjZWNlYjAxZDg1NjFiMC90YWJsZTo5ZTAyMDhhNTU5ZjI0OTI3OWUxNTFhNDc3YTIwN2UxZC90YWJsZXJhbmdlOjllMDIwOGE1NTlmMjQ5Mjc5ZTE1MWE0NzdhMjA3ZTFkXzEtMy0xLTEtMA_522378da-92bc-447b-940d-ff943f989d76">7,273</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Carrying amount</span></td><td colspan="2" style="border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2e87824102b34590a0208cc7da91b5f5_I20210630" decimals="-6" format="ixt:numdotdecimal" name="cah:CarryingAmountofLongTermandotherShortTermBorrowings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzkvZnJhZzo4OGQ2MDhlMWNlMjY0N2E5OGJjZWNlYjAxZDg1NjFiMC90YWJsZTo5ZTAyMDhhNTU5ZjI0OTI3OWUxNTFhNDc3YTIwN2UxZC90YWJsZXJhbmdlOjllMDIwOGE1NTlmMjQ5Mjc5ZTE1MWE0NzdhMjA3ZTFkXzItMS0xLTEtMA_cc3abe0a-d2ba-4f01-a0c5-aec3bfed2657">6,236</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"></td><td colspan="2" style="border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i299cea70f47b4fbe96772aaa8cc00b79_I20200630" decimals="-6" format="ixt:numdotdecimal" name="cah:CarryingAmountofLongTermandotherShortTermBorrowings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzkvZnJhZzo4OGQ2MDhlMWNlMjY0N2E5OGJjZWNlYjAxZDg1NjFiMC90YWJsZTo5ZTAyMDhhNTU5ZjI0OTI3OWUxNTFhNDc3YTIwN2UxZC90YWJsZXJhbmdlOjllMDIwOGE1NTlmMjQ5Mjc5ZTE1MWE0NzdhMjA3ZTFkXzItMy0xLTEtMA_9e7125bf-8eed-43df-84e9-16215dc8d541">6,775</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of our long-term obligations and other short-term borrowings is estimated based on either the quoted market prices for the same or similar issues or other inputs derived from available market information, which represents a Level 2 measurement.</span></div><ix:nonNumeric contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630" name="cah:ScheduleOfFairValueGainLossDerivativeInstrumentTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzkvZnJhZzo4OGQ2MDhlMWNlMjY0N2E5OGJjZWNlYjAxZDg1NjFiMC90ZXh0cmVnaW9uOjg4ZDYwOGUxY2UyNjQ3YTk4YmNlY2ViMDFkODU2MWIwXzExMDgw_ae488212-95a3-4bc8-946b-87ef3e40033c" escape="true"><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table is a summary of the fair value gain/(loss) of our derivative instruments based upon the estimated amount that we would receive (or pay), considering counter-party credit risk, to terminate the contracts at June 30:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.691%"><tr><td style="width:1.0%"></td><td style="width:31.098%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.451%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.347%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.547%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.347%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.451%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.347%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.312%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Notional<br/>Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair&#160;Value<br/>Gain/(Loss)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Notional<br/>Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Fair&#160;Value<br/>Gain/(Loss)</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Pay-floating interest rate swaps</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04848fa4190a4546999fce3b74a1093a_I20210630" decimals="-6" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzkvZnJhZzo4OGQ2MDhlMWNlMjY0N2E5OGJjZWNlYjAxZDg1NjFiMC90YWJsZToyOGYzZTI3OTI4OTQ0ZjE1ODg0NTE1NTEwMjk2YTllMC90YWJsZXJhbmdlOjI4ZjNlMjc5Mjg5NDRmMTU4ODQ1MTU1MTAyOTZhOWUwXzItMS0xLTEtMA_ce415d5b-a2f7-46cd-863e-09e5b889bd57">200</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04848fa4190a4546999fce3b74a1093a_I20210630" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzkvZnJhZzo4OGQ2MDhlMWNlMjY0N2E5OGJjZWNlYjAxZDg1NjFiMC90YWJsZToyOGYzZTI3OTI4OTQ0ZjE1ODg0NTE1NTEwMjk2YTllMC90YWJsZXJhbmdlOjI4ZjNlMjc5Mjg5NDRmMTU4ODQ1MTU1MTAyOTZhOWUwXzItMy0xLTEtMA_2f69e2ac-769e-4b27-b4e0-89d89a697571">1</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iffa4055c7e214900820c0a0df90cdebf_I20200630" decimals="-6" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzkvZnJhZzo4OGQ2MDhlMWNlMjY0N2E5OGJjZWNlYjAxZDg1NjFiMC90YWJsZToyOGYzZTI3OTI4OTQ0ZjE1ODg0NTE1NTEwMjk2YTllMC90YWJsZXJhbmdlOjI4ZjNlMjc5Mjg5NDRmMTU4ODQ1MTU1MTAyOTZhOWUwXzItNS0xLTEtMA_d7917433-816a-4f22-a8ed-e389301ca601">550</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iffa4055c7e214900820c0a0df90cdebf_I20200630" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzkvZnJhZzo4OGQ2MDhlMWNlMjY0N2E5OGJjZWNlYjAxZDg1NjFiMC90YWJsZToyOGYzZTI3OTI4OTQ0ZjE1ODg0NTE1NTEwMjk2YTllMC90YWJsZXJhbmdlOjI4ZjNlMjc5Mjg5NDRmMTU4ODQ1MTU1MTAyOTZhOWUwXzItNy0xLTEtMA_855c2e3b-ec70-4597-ae51-977231e23e33">27</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8f3de44e96774f7296c0c1deb3f17775_I20210630" decimals="-6" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzkvZnJhZzo4OGQ2MDhlMWNlMjY0N2E5OGJjZWNlYjAxZDg1NjFiMC90YWJsZToyOGYzZTI3OTI4OTQ0ZjE1ODg0NTE1NTEwMjk2YTllMC90YWJsZXJhbmdlOjI4ZjNlMjc5Mjg5NDRmMTU4ODQ1MTU1MTAyOTZhOWUwXzMtMS0xLTEtMA_ed1cbd02-de58-4e0d-9d98-48436c5b7099">690</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8f3de44e96774f7296c0c1deb3f17775_I20210630" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzkvZnJhZzo4OGQ2MDhlMWNlMjY0N2E5OGJjZWNlYjAxZDg1NjFiMC90YWJsZToyOGYzZTI3OTI4OTQ0ZjE1ODg0NTE1NTEwMjk2YTllMC90YWJsZXJhbmdlOjI4ZjNlMjc5Mjg5NDRmMTU4ODQ1MTU1MTAyOTZhOWUwXzMtMy0xLTEtMA_e527da88-7c14-4e39-b255-01f80816117e">1</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie09b4e9c614244d1bd722525781f1905_I20200630" decimals="-6" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzkvZnJhZzo4OGQ2MDhlMWNlMjY0N2E5OGJjZWNlYjAxZDg1NjFiMC90YWJsZToyOGYzZTI3OTI4OTQ0ZjE1ODg0NTE1NTEwMjk2YTllMC90YWJsZXJhbmdlOjI4ZjNlMjc5Mjg5NDRmMTU4ODQ1MTU1MTAyOTZhOWUwXzMtNS0xLTEtMA_1b2812f5-2060-4626-93dc-e7833bc92ffe">653</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie09b4e9c614244d1bd722525781f1905_I20200630" decimals="-6" sign="-" name="us-gaap:DerivativeFairValueOfDerivativeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzkvZnJhZzo4OGQ2MDhlMWNlMjY0N2E5OGJjZWNlYjAxZDg1NjFiMC90YWJsZToyOGYzZTI3OTI4OTQ0ZjE1ODg0NTE1NTEwMjk2YTllMC90YWJsZXJhbmdlOjI4ZjNlMjc5Mjg5NDRmMTU4ODQ1MTU1MTAyOTZhOWUwXzMtNy0xLTEtMA_1524c810-068b-4229-9221-20b4b79a42b5">4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Forward interest rate swaps</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica8d8074683f4bda8b6a214c21c399ee_I20210630" decimals="-6" format="ixt:zerodash" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzkvZnJhZzo4OGQ2MDhlMWNlMjY0N2E5OGJjZWNlYjAxZDg1NjFiMC90YWJsZToyOGYzZTI3OTI4OTQ0ZjE1ODg0NTE1NTEwMjk2YTllMC90YWJsZXJhbmdlOjI4ZjNlMjc5Mjg5NDRmMTU4ODQ1MTU1MTAyOTZhOWUwXzQtMS0xLTEtMA_1513afb5-815d-4ce5-9516-5d4c050aea72">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica8d8074683f4bda8b6a214c21c399ee_I20210630" decimals="-6" format="ixt:zerodash" name="us-gaap:DerivativeFairValueOfDerivativeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzkvZnJhZzo4OGQ2MDhlMWNlMjY0N2E5OGJjZWNlYjAxZDg1NjFiMC90YWJsZToyOGYzZTI3OTI4OTQ0ZjE1ODg0NTE1NTEwMjk2YTllMC90YWJsZXJhbmdlOjI4ZjNlMjc5Mjg5NDRmMTU4ODQ1MTU1MTAyOTZhOWUwXzQtMy0xLTEtMA_527dc698-33a6-4725-9dfb-84d58e2ab694">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i82a8006ead354bb59b15285e08a487f9_I20200630" decimals="-6" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzkvZnJhZzo4OGQ2MDhlMWNlMjY0N2E5OGJjZWNlYjAxZDg1NjFiMC90YWJsZToyOGYzZTI3OTI4OTQ0ZjE1ODg0NTE1NTEwMjk2YTllMC90YWJsZXJhbmdlOjI4ZjNlMjc5Mjg5NDRmMTU4ODQ1MTU1MTAyOTZhOWUwXzQtNS0xLTEtMA_d85765ee-48e7-4c8e-b53e-6f69d533657d">200</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i82a8006ead354bb59b15285e08a487f9_I20200630" decimals="-6" sign="-" name="us-gaap:DerivativeFairValueOfDerivativeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzkvZnJhZzo4OGQ2MDhlMWNlMjY0N2E5OGJjZWNlYjAxZDg1NjFiMC90YWJsZToyOGYzZTI3OTI4OTQ0ZjE1ODg0NTE1NTEwMjk2YTllMC90YWJsZXJhbmdlOjI4ZjNlMjc5Mjg5NDRmMTU4ODQ1MTU1MTAyOTZhOWUwXzQtNy0xLTEtMA_c7122063-0922-4951-a21b-b43f19ff9dbc">16</ix:nonFraction>)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cross-currency swap</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic67d0c6fd59147399881dd3fb666cc2a_I20210630" decimals="-6" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzkvZnJhZzo4OGQ2MDhlMWNlMjY0N2E5OGJjZWNlYjAxZDg1NjFiMC90YWJsZToyOGYzZTI3OTI4OTQ0ZjE1ODg0NTE1NTEwMjk2YTllMC90YWJsZXJhbmdlOjI4ZjNlMjc5Mjg5NDRmMTU4ODQ1MTU1MTAyOTZhOWUwXzUtMS0xLTEtMA_8933ddc2-87fd-46ed-8cc7-f2f488d864f9">833</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic67d0c6fd59147399881dd3fb666cc2a_I20210630" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzkvZnJhZzo4OGQ2MDhlMWNlMjY0N2E5OGJjZWNlYjAxZDg1NjFiMC90YWJsZToyOGYzZTI3OTI4OTQ0ZjE1ODg0NTE1NTEwMjk2YTllMC90YWJsZXJhbmdlOjI4ZjNlMjc5Mjg5NDRmMTU4ODQ1MTU1MTAyOTZhOWUwXzUtMy0xLTEtMA_97385e84-05eb-4f31-8981-e477c2858e22">40</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i83ca59dc22f646eaa9de5eecb3e81988_I20200630" decimals="-6" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzkvZnJhZzo4OGQ2MDhlMWNlMjY0N2E5OGJjZWNlYjAxZDg1NjFiMC90YWJsZToyOGYzZTI3OTI4OTQ0ZjE1ODg0NTE1NTEwMjk2YTllMC90YWJsZXJhbmdlOjI4ZjNlMjc5Mjg5NDRmMTU4ODQ1MTU1MTAyOTZhOWUwXzUtNS0xLTEtMA_0de310e2-8cd3-4c0a-897c-75ef7c99b775">833</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i83ca59dc22f646eaa9de5eecb3e81988_I20200630" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzkvZnJhZzo4OGQ2MDhlMWNlMjY0N2E5OGJjZWNlYjAxZDg1NjFiMC90YWJsZToyOGYzZTI3OTI4OTQ0ZjE1ODg0NTE1NTEwMjk2YTllMC90YWJsZXJhbmdlOjI4ZjNlMjc5Mjg5NDRmMTU4ODQ1MTU1MTAyOTZhOWUwXzUtNy0xLTEtMA_b5c5211a-6c33-458c-9982-d1b689315157">47</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Commodity contracts</span></td><td colspan="2" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4cf22529a370428e82c5511fa7e35f8b_I20210630" decimals="-6" format="ixt:zerodash" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzkvZnJhZzo4OGQ2MDhlMWNlMjY0N2E5OGJjZWNlYjAxZDg1NjFiMC90YWJsZToyOGYzZTI3OTI4OTQ0ZjE1ODg0NTE1NTEwMjk2YTllMC90YWJsZXJhbmdlOjI4ZjNlMjc5Mjg5NDRmMTU4ODQ1MTU1MTAyOTZhOWUwXzYtMS0xLTEtMA_20a3e2bb-ac93-4a0a-b4e1-9c18ed303d35">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4cf22529a370428e82c5511fa7e35f8b_I20210630" decimals="-6" format="ixt:zerodash" name="us-gaap:DerivativeFairValueOfDerivativeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzkvZnJhZzo4OGQ2MDhlMWNlMjY0N2E5OGJjZWNlYjAxZDg1NjFiMC90YWJsZToyOGYzZTI3OTI4OTQ0ZjE1ODg0NTE1NTEwMjk2YTllMC90YWJsZXJhbmdlOjI4ZjNlMjc5Mjg5NDRmMTU4ODQ1MTU1MTAyOTZhOWUwXzYtMy0xLTEtMA_414dc60e-4114-4aeb-81a5-c80787460da7">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4de6f0288abd431bbc839b56b68b328b_I20200630" decimals="-6" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzkvZnJhZzo4OGQ2MDhlMWNlMjY0N2E5OGJjZWNlYjAxZDg1NjFiMC90YWJsZToyOGYzZTI3OTI4OTQ0ZjE1ODg0NTE1NTEwMjk2YTllMC90YWJsZXJhbmdlOjI4ZjNlMjc5Mjg5NDRmMTU4ODQ1MTU1MTAyOTZhOWUwXzYtNS0xLTEtMA_4e0f3dc3-8fca-4a06-b77f-ac021e892f07">16</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4de6f0288abd431bbc839b56b68b328b_I20200630" decimals="-6" sign="-" name="us-gaap:DerivativeFairValueOfDerivativeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzkvZnJhZzo4OGQ2MDhlMWNlMjY0N2E5OGJjZWNlYjAxZDg1NjFiMC90YWJsZToyOGYzZTI3OTI4OTQ0ZjE1ODg0NTE1NTEwMjk2YTllMC90YWJsZXJhbmdlOjI4ZjNlMjc5Mjg5NDRmMTU4ODQ1MTU1MTAyOTZhOWUwXzYtNy0xLTEtMA_3829187a-71ce-426d-a12f-7b15cc12fad0">1</ix:nonFraction>)</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div id="i4f0ec56b9c604f1782a65ea4a19c284d_145"></div><ix:nonNumeric contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630" name="us-gaap:StockholdersEquityNoteDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNDUvZnJhZzoyODYyODkzYjc2Yjk0ZjdhOGU1ZjAyYmY4YzhlNzZiYS90ZXh0cmVnaW9uOjI4NjI4OTNiNzZiOTRmN2E4ZTVmMDJiZjhjOGU3NmJhXzIxNDQ_9572ad25-b44e-4c2e-bebb-5698725092d1" continuedAt="ifa690a8d2ea745e7b86696d0d9c2979e" escape="true"><div style="margin-bottom:6pt;text-align:justify"><span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:13pt;font-weight:700;line-height:120%">11. Shareholders' Equity </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At June&#160;30, 2021 and 2020, authorized capital shares consisted of the following: <ix:nonFraction unitRef="shares" contextRef="i0a081dfdf3e846b387ac5e60a2f4e8a5_I20210630" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesAuthorized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNDUvZnJhZzoyODYyODkzYjc2Yjk0ZjdhOGU1ZjAyYmY4YzhlNzZiYS90ZXh0cmVnaW9uOjI4NjI4OTNiNzZiOTRmN2E4ZTVmMDJiZjhjOGU3NmJhXzcxNDY4MjU1ODI4NTY_bad53ddf-2851-4e83-8fb3-6cb001006545">750</ix:nonFraction> million Class A common shares, without par value; <ix:nonFraction unitRef="shares" contextRef="i217241ce39cf47f0acdc17b79210218f_I20210630" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesAuthorized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNDUvZnJhZzoyODYyODkzYjc2Yjk0ZjdhOGU1ZjAyYmY4YzhlNzZiYS90ZXh0cmVnaW9uOjI4NjI4OTNiNzZiOTRmN2E4ZTVmMDJiZjhjOGU3NmJhXzEyMg_27c2cb4d-3fa1-4374-bb3c-888d49a8c30f">5</ix:nonFraction> million Class B common shares, without par value; and <ix:nonFraction unitRef="shares" contextRef="i2e87824102b34590a0208cc7da91b5f5_I20210630" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:PreferredStockSharesAuthorized" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNDUvZnJhZzoyODYyODkzYjc2Yjk0ZjdhOGU1ZjAyYmY4YzhlNzZiYS90ZXh0cmVnaW9uOjI4NjI4OTNiNzZiOTRmN2E4ZTVmMDJiZjhjOGU3NmJhXzE3MQ_3945bb0a-32e7-4e42-8f08-d90280c81fa7">500</ix:nonFraction> thousand non-voting preferred shares, without par value. The Class A common shares and Class B common shares are collectively referred to below as &#8220;common shares&#8221;. Holders of common shares are entitled to share equally in any dividends declared by the Board of Directors and to participate equally in all distributions of assets upon liquidation. Generally, the holders of Class A common shares are entitled to <ix:nonFraction unitRef="number" contextRef="i61106b444fde4f55a97a7eaed9e98693_D20200701-20210630" decimals="INF" format="ixt-sec:numwordsen" name="cah:CommonStockVotingRightsVotes" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNDUvZnJhZzoyODYyODkzYjc2Yjk0ZjdhOGU1ZjAyYmY4YzhlNzZiYS90ZXh0cmVnaW9uOjI4NjI4OTNiNzZiOTRmN2E4ZTVmMDJiZjhjOGU3NmJhXzI3NDg3NzkwNzE2MjY_37dd7902-453d-48cf-948d-729986e415da">one</ix:nonFraction> vote per share, and the holders of Class B common shares are entitled to one-fifth of one vote per share on proposals presented to shareholders for vote. Under certain circumstances, the holders of Class B common </span></div></ix:nonNumeric></div></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:3pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.222%"><tr><td style="width:1.0%"></td><td style="width:32.133%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.433%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.134%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">82</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardinal Health </span><span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">| </span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2021 Form 10-K</span></div></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:3pt"><span><br/></span></div><div style="margin-bottom:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:24.682%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:50.911%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.107%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#e41f35;border-bottom:1pt solid #e41f35;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Notes to Financial Statements</span></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span><br/></span></div></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:48.214%"><ix:continuation id="ifa690a8d2ea745e7b86696d0d9c2979e"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">shares are entitled to vote as a separate class. Only Class A common shares were outstanding at June&#160;30, 2021 and 2020.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We repurchased $<ix:nonFraction unitRef="usd" contextRef="i1eef4a3d4f414af4b5f60b07ff29ecc2_D20170701-20200630" decimals="-7" format="ixt:numdotdecimal" name="us-gaap:TreasuryStockValueAcquiredCostMethod" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNDUvZnJhZzoyODYyODkzYjc2Yjk0ZjdhOGU1ZjAyYmY4YzhlNzZiYS90ZXh0cmVnaW9uOjI4NjI4OTNiNzZiOTRmN2E4ZTVmMDJiZjhjOGU3NmJhXzg5MA_34987894-8383-4c9b-8bf0-c6d9b8c76987">1.15</ix:nonFraction> billion of our common shares, in the aggregate, through share repurchase programs during fiscal 2021</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2020 and 2019, as described below. We funded the repurchases with available cash and short term borrowings. The common shares repurchased are held in treasury to be used for general corporate purposes.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During fiscal 2021, we repurchased <ix:nonFraction unitRef="shares" contextRef="i93e121bdfcb240d3a40552629748af1b_D20200701-20210630" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:TreasuryStockSharesAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNDUvZnJhZzoyODYyODkzYjc2Yjk0ZjdhOGU1ZjAyYmY4YzhlNzZiYS90ZXh0cmVnaW9uOjI4NjI4OTNiNzZiOTRmN2E4ZTVmMDJiZjhjOGU3NmJhXzEyMTY_a7f03be5-113b-4ce3-b2c7-3cda9c69cb1e">3.7</ix:nonFraction> million common shares having an aggregate cost of $<ix:nonFraction unitRef="usd" contextRef="i93e121bdfcb240d3a40552629748af1b_D20200701-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PaymentsForRepurchaseOfCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNDUvZnJhZzoyODYyODkzYjc2Yjk0ZjdhOGU1ZjAyYmY4YzhlNzZiYS90ZXh0cmVnaW9uOjI4NjI4OTNiNzZiOTRmN2E4ZTVmMDJiZjhjOGU3NmJhXzEyNjE_5b7a22cd-4d8a-477d-b469-18f0c23baf79">200</ix:nonFraction> million. The average price paid per common share was $<ix:nonFraction unitRef="usdPerShare" contextRef="i93e121bdfcb240d3a40552629748af1b_D20200701-20210630" decimals="2" name="us-gaap:TreasuryStockAcquiredAverageCostPerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNDUvZnJhZzoyODYyODkzYjc2Yjk0ZjdhOGU1ZjAyYmY4YzhlNzZiYS90ZXh0cmVnaW9uOjI4NjI4OTNiNzZiOTRmN2E4ZTVmMDJiZjhjOGU3NmJhXzEzMDk_b1fc5650-09d0-4ca5-b4f3-c1fa9a5f07f0">54.40</ix:nonFraction>. These repurchases were made under an accelerated share repurchase ("ASR") program, which began on February&#160;9, 2021 and was completed on March&#160;31, 2021. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During fiscal 2020, we repurchased <ix:nonFraction unitRef="shares" contextRef="i0361658ee5604068a75c34f27c83ef6b_D20190701-20200630" decimals="-5" format="ixt:numdotdecimal" name="cah:TreasuryStockAcquiredShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNDUvZnJhZzoyODYyODkzYjc2Yjk0ZjdhOGU1ZjAyYmY4YzhlNzZiYS90ZXh0cmVnaW9uOjI4NjI4OTNiNzZiOTRmN2E4ZTVmMDJiZjhjOGU3NmJhXzE0NzM_6d626264-335a-4cec-92aa-cdb91b0be66b">7.3</ix:nonFraction> million common shares having an aggregate cost of $<ix:nonFraction unitRef="usd" contextRef="i0361658ee5604068a75c34f27c83ef6b_D20190701-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:TreasuryStockValueAcquiredCostMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNDUvZnJhZzoyODYyODkzYjc2Yjk0ZjdhOGU1ZjAyYmY4YzhlNzZiYS90ZXh0cmVnaW9uOjI4NjI4OTNiNzZiOTRmN2E4ZTVmMDJiZjhjOGU3NmJhXzE1MTg_eea97f63-3d89-47a6-802a-70d7b2789ceb">350</ix:nonFraction> million. The average price paid per common share was $<ix:nonFraction unitRef="usdPerShare" contextRef="i0361658ee5604068a75c34f27c83ef6b_D20190701-20200630" decimals="2" name="us-gaap:TreasuryStockAcquiredAverageCostPerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNDUvZnJhZzoyODYyODkzYjc2Yjk0ZjdhOGU1ZjAyYmY4YzhlNzZiYS90ZXh0cmVnaW9uOjI4NjI4OTNiNzZiOTRmN2E4ZTVmMDJiZjhjOGU3NmJhXzE1NjY_485e6cb6-3913-486c-9a26-a280a3f8a22f">48.00</ix:nonFraction>. These repurchases were made under an ASR program, which began on August&#160;20, 2019 and was completed on December&#160;4, 2019. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During fiscal 2019, we repurchased <ix:nonFraction unitRef="shares" contextRef="ifec5466baa034dc5b60b6acb6798f00e_D20180701-20190630" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:TreasuryStockSharesAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNDUvZnJhZzoyODYyODkzYjc2Yjk0ZjdhOGU1ZjAyYmY4YzhlNzZiYS90ZXh0cmVnaW9uOjI4NjI4OTNiNzZiOTRmN2E4ZTVmMDJiZjhjOGU3NmJhXzE2OTQ_130d290e-e2ab-453e-9ee7-6da70ba220a1">11.5</ix:nonFraction> million common shares having an aggregate cost of $<ix:nonFraction unitRef="usd" contextRef="ifec5466baa034dc5b60b6acb6798f00e_D20180701-20190630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:TreasuryStockValueAcquiredCostMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNDUvZnJhZzoyODYyODkzYjc2Yjk0ZjdhOGU1ZjAyYmY4YzhlNzZiYS90ZXh0cmVnaW9uOjI4NjI4OTNiNzZiOTRmN2E4ZTVmMDJiZjhjOGU3NmJhXzE3Mzk_75595602-d4c0-4de2-915c-7f5afd514480">600</ix:nonFraction> million. The average price paid per common share was $<ix:nonFraction unitRef="usdPerShare" contextRef="ifec5466baa034dc5b60b6acb6798f00e_D20180701-20190630" decimals="2" name="us-gaap:TreasuryStockAcquiredAverageCostPerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNDUvZnJhZzoyODYyODkzYjc2Yjk0ZjdhOGU1ZjAyYmY4YzhlNzZiYS90ZXh0cmVnaW9uOjI4NjI4OTNiNzZiOTRmN2E4ZTVmMDJiZjhjOGU3NmJhXzE3ODc_0bd28cd1-d4b0-49ad-8995-f0843827b412">52.32</ix:nonFraction>. These repurchases were made under an ASR program, which began on August&#160;16, 2018 and was completed on October&#160;25, 2018.</span></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Accumulated Other Comprehensive Loss</span></div><ix:nonNumeric contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630" name="us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNDUvZnJhZzoyODYyODkzYjc2Yjk0ZjdhOGU1ZjAyYmY4YzhlNzZiYS90ZXh0cmVnaW9uOjI4NjI4OTNiNzZiOTRmN2E4ZTVmMDJiZjhjOGU3NmJhXzIxNDI_17ff58cf-cab6-4561-b47c-672e5b8f9109" escape="true"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the changes in the balance of accumulated other comprehensive loss by component and in total:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:38.097%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.492%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.343%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.875%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.343%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:22.050%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Foreign<br/>Currency<br/>Translation<br/>Adjustments and other</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Unrealized<br/>Gain/(Loss) on<br/>Derivatives,<br/>net of tax</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated Other<br/>Comprehensive<br/>Loss</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance at June 30, 2019</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i25a5a0d717e04a1cb651e174b69d2257_I20190630" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNDUvZnJhZzoyODYyODkzYjc2Yjk0ZjdhOGU1ZjAyYmY4YzhlNzZiYS90YWJsZTo0NTU4ZDdiYWFmZmI0MTZjODg4ZjFhZDVjN2NlM2U0Mi90YWJsZXJhbmdlOjQ1NThkN2JhYWZmYjQxNmM4ODhmMWFkNWM3Y2UzZTQyXzEtMS0xLTEtMA_f22441f0-79a2-40ae-9c27-c35b6b9351fe">95</ix:nonFraction>)</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic2fe183f79d9435fa6fb7b20cb241684_I20190630" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNDUvZnJhZzoyODYyODkzYjc2Yjk0ZjdhOGU1ZjAyYmY4YzhlNzZiYS90YWJsZTo0NTU4ZDdiYWFmZmI0MTZjODg4ZjFhZDVjN2NlM2U0Mi90YWJsZXJhbmdlOjQ1NThkN2JhYWZmYjQxNmM4ODhmMWFkNWM3Y2UzZTQyXzEtMy0xLTEtMA_62acb658-078f-4551-953d-85a85632ae3e">16</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i08559a107c7a4c31965cd373a397c3af_I20190630" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNDUvZnJhZzoyODYyODkzYjc2Yjk0ZjdhOGU1ZjAyYmY4YzhlNzZiYS90YWJsZTo0NTU4ZDdiYWFmZmI0MTZjODg4ZjFhZDVjN2NlM2U0Mi90YWJsZXJhbmdlOjQ1NThkN2JhYWZmYjQxNmM4ODhmMWFkNWM3Y2UzZTQyXzEtNS0xLTEtMA_eac7e8e9-aca3-4b30-a616-3473eb042c6c">79</ix:nonFraction>)</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other comprehensive income/(loss), net before reclassifications</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i06a1421a7f5a434ab21bb6e7f6c4217d_D20190701-20200630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNDUvZnJhZzoyODYyODkzYjc2Yjk0ZjdhOGU1ZjAyYmY4YzhlNzZiYS90YWJsZTo0NTU4ZDdiYWFmZmI0MTZjODg4ZjFhZDVjN2NlM2U0Mi90YWJsZXJhbmdlOjQ1NThkN2JhYWZmYjQxNmM4ODhmMWFkNWM3Y2UzZTQyXzItMS0xLTEtMA_7ba968bc-e55e-4f75-b399-4ec77136ee13">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if2c1cb49d0374d86b2830517b2b187db_D20190701-20200630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNDUvZnJhZzoyODYyODkzYjc2Yjk0ZjdhOGU1ZjAyYmY4YzhlNzZiYS90YWJsZTo0NTU4ZDdiYWFmZmI0MTZjODg4ZjFhZDVjN2NlM2U0Mi90YWJsZXJhbmdlOjQ1NThkN2JhYWZmYjQxNmM4ODhmMWFkNWM3Y2UzZTQyXzItMy0xLTEtMA_0fbcd6af-9356-4712-b9e6-4872539ba4c6">23</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6b350fae2224486aa2a6ffc44c36559b_D20190701-20200630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNDUvZnJhZzoyODYyODkzYjc2Yjk0ZjdhOGU1ZjAyYmY4YzhlNzZiYS90YWJsZTo0NTU4ZDdiYWFmZmI0MTZjODg4ZjFhZDVjN2NlM2U0Mi90YWJsZXJhbmdlOjQ1NThkN2JhYWZmYjQxNmM4ODhmMWFkNWM3Y2UzZTQyXzItNS0xLTEtMA_0f11f774-db37-4428-bfe9-3a2344c11ce9">20</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Amounts reclassified to earnings</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i06a1421a7f5a434ab21bb6e7f6c4217d_D20190701-20200630" decimals="-6" format="ixt:zerodash" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNDUvZnJhZzoyODYyODkzYjc2Yjk0ZjdhOGU1ZjAyYmY4YzhlNzZiYS90YWJsZTo0NTU4ZDdiYWFmZmI0MTZjODg4ZjFhZDVjN2NlM2U0Mi90YWJsZXJhbmdlOjQ1NThkN2JhYWZmYjQxNmM4ODhmMWFkNWM3Y2UzZTQyXzMtMS0xLTEtMA_41062cab-b7fd-46b8-8ae7-91689de66078">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if2c1cb49d0374d86b2830517b2b187db_D20190701-20200630" decimals="-6" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNDUvZnJhZzoyODYyODkzYjc2Yjk0ZjdhOGU1ZjAyYmY4YzhlNzZiYS90YWJsZTo0NTU4ZDdiYWFmZmI0MTZjODg4ZjFhZDVjN2NlM2U0Mi90YWJsZXJhbmdlOjQ1NThkN2JhYWZmYjQxNmM4ODhmMWFkNWM3Y2UzZTQyXzMtMy0xLTEtMA_3c506e86-282c-4186-8518-b27dff308bc7">5</ix:nonFraction>)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6b350fae2224486aa2a6ffc44c36559b_D20190701-20200630" decimals="-6" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNDUvZnJhZzoyODYyODkzYjc2Yjk0ZjdhOGU1ZjAyYmY4YzhlNzZiYS90YWJsZTo0NTU4ZDdiYWFmZmI0MTZjODg4ZjFhZDVjN2NlM2U0Mi90YWJsZXJhbmdlOjQ1NThkN2JhYWZmYjQxNmM4ODhmMWFkNWM3Y2UzZTQyXzMtNS0xLTEtMA_23841b08-3fa5-48e4-afc1-c772f3bc7602">5</ix:nonFraction>)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total other comprehensive income/(loss) attributable to Cardinal Health, Inc., net of tax of $4 million</span></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i06a1421a7f5a434ab21bb6e7f6c4217d_D20190701-20200630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNDUvZnJhZzoyODYyODkzYjc2Yjk0ZjdhOGU1ZjAyYmY4YzhlNzZiYS90YWJsZTo0NTU4ZDdiYWFmZmI0MTZjODg4ZjFhZDVjN2NlM2U0Mi90YWJsZXJhbmdlOjQ1NThkN2JhYWZmYjQxNmM4ODhmMWFkNWM3Y2UzZTQyXzQtMS0xLTEtMA_fb64379b-05c5-468c-bfe6-e6c5c027820b">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if2c1cb49d0374d86b2830517b2b187db_D20190701-20200630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNDUvZnJhZzoyODYyODkzYjc2Yjk0ZjdhOGU1ZjAyYmY4YzhlNzZiYS90YWJsZTo0NTU4ZDdiYWFmZmI0MTZjODg4ZjFhZDVjN2NlM2U0Mi90YWJsZXJhbmdlOjQ1NThkN2JhYWZmYjQxNmM4ODhmMWFkNWM3Y2UzZTQyXzQtMy0xLTEtMA_6f75d8e7-d57f-4be5-b475-c21a44993974">28</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6b350fae2224486aa2a6ffc44c36559b_D20190701-20200630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNDUvZnJhZzoyODYyODkzYjc2Yjk0ZjdhOGU1ZjAyYmY4YzhlNzZiYS90YWJsZTo0NTU4ZDdiYWFmZmI0MTZjODg4ZjFhZDVjN2NlM2U0Mi90YWJsZXJhbmdlOjQ1NThkN2JhYWZmYjQxNmM4ODhmMWFkNWM3Y2UzZTQyXzQtNS0xLTEtMA_96a63079-a889-4685-9186-9f2a9e8bd409">25</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance at June 30, 2020</span></td><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic4bf74d204c843148850dd8cf1a97c4c_I20200630" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNDUvZnJhZzoyODYyODkzYjc2Yjk0ZjdhOGU1ZjAyYmY4YzhlNzZiYS90YWJsZTo0NTU4ZDdiYWFmZmI0MTZjODg4ZjFhZDVjN2NlM2U0Mi90YWJsZXJhbmdlOjQ1NThkN2JhYWZmYjQxNmM4ODhmMWFkNWM3Y2UzZTQyXzUtMS0xLTEtMA_4d14fd37-94f6-4871-8614-87cbed7eeaad">92</ix:nonFraction>)</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6260475b94ac4643968f9f3d0742c126_I20200630" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNDUvZnJhZzoyODYyODkzYjc2Yjk0ZjdhOGU1ZjAyYmY4YzhlNzZiYS90YWJsZTo0NTU4ZDdiYWFmZmI0MTZjODg4ZjFhZDVjN2NlM2U0Mi90YWJsZXJhbmdlOjQ1NThkN2JhYWZmYjQxNmM4ODhmMWFkNWM3Y2UzZTQyXzUtMy0xLTEtMA_244195dc-02cf-4ef1-a240-4a997f563677">12</ix:nonFraction>)</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i87f033cb2d3241b690c413fa8321d9dd_I20200630" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNDUvZnJhZzoyODYyODkzYjc2Yjk0ZjdhOGU1ZjAyYmY4YzhlNzZiYS90YWJsZTo0NTU4ZDdiYWFmZmI0MTZjODg4ZjFhZDVjN2NlM2U0Mi90YWJsZXJhbmdlOjQ1NThkN2JhYWZmYjQxNmM4ODhmMWFkNWM3Y2UzZTQyXzUtNS0xLTEtMA_86e2ff0f-b5bb-4993-bd63-25b5e9573550">104</ix:nonFraction>)</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other comprehensive income, before reclassifications</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i10ebef79cb324951a3c60cf340e5e0c7_D20200701-20210630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNDUvZnJhZzoyODYyODkzYjc2Yjk0ZjdhOGU1ZjAyYmY4YzhlNzZiYS90YWJsZTo0NTU4ZDdiYWFmZmI0MTZjODg4ZjFhZDVjN2NlM2U0Mi90YWJsZXJhbmdlOjQ1NThkN2JhYWZmYjQxNmM4ODhmMWFkNWM3Y2UzZTQyXzYtMS0xLTEtMA_e098a86c-d449-436c-90d7-2d49c5d28e03">46</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6a93d5b1ddba4766830bc552988b0f64_D20200701-20210630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNDUvZnJhZzoyODYyODkzYjc2Yjk0ZjdhOGU1ZjAyYmY4YzhlNzZiYS90YWJsZTo0NTU4ZDdiYWFmZmI0MTZjODg4ZjFhZDVjN2NlM2U0Mi90YWJsZXJhbmdlOjQ1NThkN2JhYWZmYjQxNmM4ODhmMWFkNWM3Y2UzZTQyXzYtMy0xLTEtMA_42eedf14-7598-44d0-b604-a47c154ca461">22</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idaac2fb8e90844538a6c23b3c7452e2b_D20200701-20210630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNDUvZnJhZzoyODYyODkzYjc2Yjk0ZjdhOGU1ZjAyYmY4YzhlNzZiYS90YWJsZTo0NTU4ZDdiYWFmZmI0MTZjODg4ZjFhZDVjN2NlM2U0Mi90YWJsZXJhbmdlOjQ1NThkN2JhYWZmYjQxNmM4ODhmMWFkNWM3Y2UzZTQyXzYtNS0xLTEtMA_eb446aef-2f81-4b15-9755-27f4928335b8">68</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Amounts reclassified to earnings</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i10ebef79cb324951a3c60cf340e5e0c7_D20200701-20210630" decimals="-6" format="ixt:zerodash" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNDUvZnJhZzoyODYyODkzYjc2Yjk0ZjdhOGU1ZjAyYmY4YzhlNzZiYS90YWJsZTo0NTU4ZDdiYWFmZmI0MTZjODg4ZjFhZDVjN2NlM2U0Mi90YWJsZXJhbmdlOjQ1NThkN2JhYWZmYjQxNmM4ODhmMWFkNWM3Y2UzZTQyXzctMS0xLTEtMA_ba6280ea-633a-4cee-8be4-757a5bb1276b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6a93d5b1ddba4766830bc552988b0f64_D20200701-20210630" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNDUvZnJhZzoyODYyODkzYjc2Yjk0ZjdhOGU1ZjAyYmY4YzhlNzZiYS90YWJsZTo0NTU4ZDdiYWFmZmI0MTZjODg4ZjFhZDVjN2NlM2U0Mi90YWJsZXJhbmdlOjQ1NThkN2JhYWZmYjQxNmM4ODhmMWFkNWM3Y2UzZTQyXzctMy0xLTEtMA_7b7368b7-6850-4432-a596-db00ea7d5c8a">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idaac2fb8e90844538a6c23b3c7452e2b_D20200701-20210630" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNDUvZnJhZzoyODYyODkzYjc2Yjk0ZjdhOGU1ZjAyYmY4YzhlNzZiYS90YWJsZTo0NTU4ZDdiYWFmZmI0MTZjODg4ZjFhZDVjN2NlM2U0Mi90YWJsZXJhbmdlOjQ1NThkN2JhYWZmYjQxNmM4ODhmMWFkNWM3Y2UzZTQyXzctNS0xLTEtMA_f896d043-0153-438b-8e0a-fbb87bd7b4d8">2</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total other comprehensive income/(loss) attributable to Cardinal Health, Inc., net of tax of $4 million</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i10ebef79cb324951a3c60cf340e5e0c7_D20200701-20210630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNDUvZnJhZzoyODYyODkzYjc2Yjk0ZjdhOGU1ZjAyYmY4YzhlNzZiYS90YWJsZTo0NTU4ZDdiYWFmZmI0MTZjODg4ZjFhZDVjN2NlM2U0Mi90YWJsZXJhbmdlOjQ1NThkN2JhYWZmYjQxNmM4ODhmMWFkNWM3Y2UzZTQyXzgtMS0xLTEtMA_4f3766c6-7e23-4b50-b26f-c7da38a75e7e">46</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6a93d5b1ddba4766830bc552988b0f64_D20200701-20210630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNDUvZnJhZzoyODYyODkzYjc2Yjk0ZjdhOGU1ZjAyYmY4YzhlNzZiYS90YWJsZTo0NTU4ZDdiYWFmZmI0MTZjODg4ZjFhZDVjN2NlM2U0Mi90YWJsZXJhbmdlOjQ1NThkN2JhYWZmYjQxNmM4ODhmMWFkNWM3Y2UzZTQyXzgtMy0xLTEtMA_11929f45-5d99-423a-8328-bf4a79917487">24</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idaac2fb8e90844538a6c23b3c7452e2b_D20200701-20210630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNDUvZnJhZzoyODYyODkzYjc2Yjk0ZjdhOGU1ZjAyYmY4YzhlNzZiYS90YWJsZTo0NTU4ZDdiYWFmZmI0MTZjODg4ZjFhZDVjN2NlM2U0Mi90YWJsZXJhbmdlOjQ1NThkN2JhYWZmYjQxNmM4ODhmMWFkNWM3Y2UzZTQyXzgtNS0xLTEtMA_52f34a41-53c4-4064-a1ca-ece9db158a96">70</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance at June 30, 2021</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifb49b5f7c6944c1ba0d4367e9d8295ee_I20210630" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNDUvZnJhZzoyODYyODkzYjc2Yjk0ZjdhOGU1ZjAyYmY4YzhlNzZiYS90YWJsZTo0NTU4ZDdiYWFmZmI0MTZjODg4ZjFhZDVjN2NlM2U0Mi90YWJsZXJhbmdlOjQ1NThkN2JhYWZmYjQxNmM4ODhmMWFkNWM3Y2UzZTQyXzktMS0xLTEtMA_0f0d4869-ab88-4e9d-bd3d-5c498d3ecd07">46</ix:nonFraction>)</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic7926ed91fae47b7a3fcb884911ab862_I20210630" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNDUvZnJhZzoyODYyODkzYjc2Yjk0ZjdhOGU1ZjAyYmY4YzhlNzZiYS90YWJsZTo0NTU4ZDdiYWFmZmI0MTZjODg4ZjFhZDVjN2NlM2U0Mi90YWJsZXJhbmdlOjQ1NThkN2JhYWZmYjQxNmM4ODhmMWFkNWM3Y2UzZTQyXzktMy0xLTEtMA_f7924d8c-4ab7-47a2-9bff-f76488608566">12</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia3fefcfeaf9c46ce91e01b1989e54336_I20210630" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNDUvZnJhZzoyODYyODkzYjc2Yjk0ZjdhOGU1ZjAyYmY4YzhlNzZiYS90YWJsZTo0NTU4ZDdiYWFmZmI0MTZjODg4ZjFhZDVjN2NlM2U0Mi90YWJsZXJhbmdlOjQ1NThkN2JhYWZmYjQxNmM4ODhmMWFkNWM3Y2UzZTQyXzktNS0xLTEtMA_78145cf9-ba3f-4b02-922a-44ed30ddd097">34</ix:nonFraction>)</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="margin-bottom:3pt;text-align:justify"><span><br/></span></div></div><div style="display:inline-block;max-width:3.571%;min-width:2.571%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:48.215%"><div id="i4f0ec56b9c604f1782a65ea4a19c284d_151"></div><ix:nonNumeric contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630" name="us-gaap:EarningsPerShareTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTEvZnJhZzo0M2E4ZTJiZTY1ZTM0MDIxOTkxZWVhYTgxNjNlODAxYS90ZXh0cmVnaW9uOjQzYThlMmJlNjVlMzQwMjE5OTFlZWFhODE2M2U4MDFhXzY1Ng_54c10310-deff-431a-b43e-1bd4149c3645" escape="true"><div style="margin-bottom:6pt;text-align:justify"><span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:13pt;font-weight:700;line-height:120%">12. Earnings/(Loss) Per Share Attributable to Cardinal Health, Inc. </span></div><ix:nonNumeric contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630" name="us-gaap:ScheduleOfWeightedAverageNumberOfSharesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTEvZnJhZzo0M2E4ZTJiZTY1ZTM0MDIxOTkxZWVhYTgxNjNlODAxYS90ZXh0cmVnaW9uOjQzYThlMmJlNjVlMzQwMjE5OTFlZWFhODE2M2U4MDFhXzY1MA_13136c61-103b-4683-834d-7661ed64d5b7" escape="true"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table reconciles the computation of basic and diluted earnings per share attributable to Cardinal Health, Inc.:</span></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.691%"><tr><td style="width:1.0%"></td><td style="width:61.748%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.045%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.347%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.355%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.347%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.358%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in millions, except per share amounts)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net earnings/(loss)</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTEvZnJhZzo0M2E4ZTJiZTY1ZTM0MDIxOTkxZWVhYTgxNjNlODAxYS90YWJsZToyY2UwMTVkMzFhNDc0Zjk3ODYxNTE3MjA0ZmQ0MGI3Mi90YWJsZXJhbmdlOjJjZTAxNWQzMWE0NzRmOTc4NjE1MTcyMDRmZDQwYjcyXzEtMS0xLTEtMA_5dc9de89-fc9f-45d1-b378-262f02dc4a49">612</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia31e9a409b874bb19d0ff6f2f39ecc09_D20190701-20200630" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTEvZnJhZzo0M2E4ZTJiZTY1ZTM0MDIxOTkxZWVhYTgxNjNlODAxYS90YWJsZToyY2UwMTVkMzFhNDc0Zjk3ODYxNTE3MjA0ZmQ0MGI3Mi90YWJsZXJhbmdlOjJjZTAxNWQzMWE0NzRmOTc4NjE1MTcyMDRmZDQwYjcyXzEtMy0xLTEtMA_23bb9c60-4a85-4383-afb4-1036b99af086">3,693</ix:nonFraction>)</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i00a6d666bf604826b24e68ddbd63eac4_D20180701-20190630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTEvZnJhZzo0M2E4ZTJiZTY1ZTM0MDIxOTkxZWVhYTgxNjNlODAxYS90YWJsZToyY2UwMTVkMzFhNDc0Zjk3ODYxNTE3MjA0ZmQ0MGI3Mi90YWJsZXJhbmdlOjJjZTAxNWQzMWE0NzRmOTc4NjE1MTcyMDRmZDQwYjcyXzEtNS0xLTEtMA_2da7c4d7-b4c4-4349-a185-fa319bcef210">1,365</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net earnings attributable to noncontrolling interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630" decimals="-6" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTEvZnJhZzo0M2E4ZTJiZTY1ZTM0MDIxOTkxZWVhYTgxNjNlODAxYS90YWJsZToyY2UwMTVkMzFhNDc0Zjk3ODYxNTE3MjA0ZmQ0MGI3Mi90YWJsZXJhbmdlOjJjZTAxNWQzMWE0NzRmOTc4NjE1MTcyMDRmZDQwYjcyXzItMS0xLTEtMA_affb2e3a-30c5-4bcf-961a-a9a87ba46869">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia31e9a409b874bb19d0ff6f2f39ecc09_D20190701-20200630" decimals="-6" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTEvZnJhZzo0M2E4ZTJiZTY1ZTM0MDIxOTkxZWVhYTgxNjNlODAxYS90YWJsZToyY2UwMTVkMzFhNDc0Zjk3ODYxNTE3MjA0ZmQ0MGI3Mi90YWJsZXJhbmdlOjJjZTAxNWQzMWE0NzRmOTc4NjE1MTcyMDRmZDQwYjcyXzItMy0xLTEtMA_7bb6209f-17c5-46ac-82fe-064374496a27">3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i00a6d666bf604826b24e68ddbd63eac4_D20180701-20190630" decimals="-6" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTEvZnJhZzo0M2E4ZTJiZTY1ZTM0MDIxOTkxZWVhYTgxNjNlODAxYS90YWJsZToyY2UwMTVkMzFhNDc0Zjk3ODYxNTE3MjA0ZmQ0MGI3Mi90YWJsZXJhbmdlOjJjZTAxNWQzMWE0NzRmOTc4NjE1MTcyMDRmZDQwYjcyXzItNS0xLTEtMA_f5033487-a052-47e6-bf87-72437eb32df4">2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net earnings/(loss) attributable to Cardinal Health, Inc.</span></div></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630" decimals="-6" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTEvZnJhZzo0M2E4ZTJiZTY1ZTM0MDIxOTkxZWVhYTgxNjNlODAxYS90YWJsZToyY2UwMTVkMzFhNDc0Zjk3ODYxNTE3MjA0ZmQ0MGI3Mi90YWJsZXJhbmdlOjJjZTAxNWQzMWE0NzRmOTc4NjE1MTcyMDRmZDQwYjcyXzUtMS0xLTEtMA_797a6a5d-77bd-449f-aee9-0da69aaba5f5">611</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia31e9a409b874bb19d0ff6f2f39ecc09_D20190701-20200630" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTEvZnJhZzo0M2E4ZTJiZTY1ZTM0MDIxOTkxZWVhYTgxNjNlODAxYS90YWJsZToyY2UwMTVkMzFhNDc0Zjk3ODYxNTE3MjA0ZmQ0MGI3Mi90YWJsZXJhbmdlOjJjZTAxNWQzMWE0NzRmOTc4NjE1MTcyMDRmZDQwYjcyXzUtMy0xLTEtMA_ed44b04b-b169-4c03-be1d-6eff6a89b284">3,696</ix:nonFraction>)</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i00a6d666bf604826b24e68ddbd63eac4_D20180701-20190630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTEvZnJhZzo0M2E4ZTJiZTY1ZTM0MDIxOTkxZWVhYTgxNjNlODAxYS90YWJsZToyY2UwMTVkMzFhNDc0Zjk3ODYxNTE3MjA0ZmQ0MGI3Mi90YWJsZXJhbmdlOjJjZTAxNWQzMWE0NzRmOTc4NjE1MTcyMDRmZDQwYjcyXzUtNS0xLTEtMA_b201c961-3a07-4ff1-bff6-51c0a041797b">1,363</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Weighted-average common shares&#8211;basic</span></td><td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630" decimals="-6" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTEvZnJhZzo0M2E4ZTJiZTY1ZTM0MDIxOTkxZWVhYTgxNjNlODAxYS90YWJsZToyY2UwMTVkMzFhNDc0Zjk3ODYxNTE3MjA0ZmQ0MGI3Mi90YWJsZXJhbmdlOjJjZTAxNWQzMWE0NzRmOTc4NjE1MTcyMDRmZDQwYjcyXzYtMS0xLTEtMA_84acd046-361e-4c51-b844-75cb49ee4498">292</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia31e9a409b874bb19d0ff6f2f39ecc09_D20190701-20200630" decimals="-6" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTEvZnJhZzo0M2E4ZTJiZTY1ZTM0MDIxOTkxZWVhYTgxNjNlODAxYS90YWJsZToyY2UwMTVkMzFhNDc0Zjk3ODYxNTE3MjA0ZmQ0MGI3Mi90YWJsZXJhbmdlOjJjZTAxNWQzMWE0NzRmOTc4NjE1MTcyMDRmZDQwYjcyXzYtMy0xLTEtMA_1d368dc1-feda-434d-b506-95a9db8ddf20">293</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i00a6d666bf604826b24e68ddbd63eac4_D20180701-20190630" decimals="-6" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTEvZnJhZzo0M2E4ZTJiZTY1ZTM0MDIxOTkxZWVhYTgxNjNlODAxYS90YWJsZToyY2UwMTVkMzFhNDc0Zjk3ODYxNTE3MjA0ZmQ0MGI3Mi90YWJsZXJhbmdlOjJjZTAxNWQzMWE0NzRmOTc4NjE1MTcyMDRmZDQwYjcyXzYtNS0xLTEtMA_2de8edae-3913-4ee0-ae53-0aa70ecd4dc7">300</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Effect of dilutive securities:</span></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Employee stock options, restricted share units, and performance share units</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630" decimals="-6" name="us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTEvZnJhZzo0M2E4ZTJiZTY1ZTM0MDIxOTkxZWVhYTgxNjNlODAxYS90YWJsZToyY2UwMTVkMzFhNDc0Zjk3ODYxNTE3MjA0ZmQ0MGI3Mi90YWJsZXJhbmdlOjJjZTAxNWQzMWE0NzRmOTc4NjE1MTcyMDRmZDQwYjcyXzgtMS0xLTEtMA_2ede7023-5dca-4b16-9c7e-d59191a7c5cd">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia31e9a409b874bb19d0ff6f2f39ecc09_D20190701-20200630" decimals="-6" format="ixt:zerodash" name="us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTEvZnJhZzo0M2E4ZTJiZTY1ZTM0MDIxOTkxZWVhYTgxNjNlODAxYS90YWJsZToyY2UwMTVkMzFhNDc0Zjk3ODYxNTE3MjA0ZmQ0MGI3Mi90YWJsZXJhbmdlOjJjZTAxNWQzMWE0NzRmOTc4NjE1MTcyMDRmZDQwYjcyXzgtMy0xLTEtMA_54c5947a-398f-4bd7-b283-eeee289358d2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i00a6d666bf604826b24e68ddbd63eac4_D20180701-20190630" decimals="-6" name="us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTEvZnJhZzo0M2E4ZTJiZTY1ZTM0MDIxOTkxZWVhYTgxNjNlODAxYS90YWJsZToyY2UwMTVkMzFhNDc0Zjk3ODYxNTE3MjA0ZmQ0MGI3Mi90YWJsZXJhbmdlOjJjZTAxNWQzMWE0NzRmOTc4NjE1MTcyMDRmZDQwYjcyXzgtNS0xLTEtMA_49ae8a39-24ba-4658-b0f9-4c70c830cbcd">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-average common shares&#8211;diluted</span></td><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630" decimals="-6" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTEvZnJhZzo0M2E4ZTJiZTY1ZTM0MDIxOTkxZWVhYTgxNjNlODAxYS90YWJsZToyY2UwMTVkMzFhNDc0Zjk3ODYxNTE3MjA0ZmQ0MGI3Mi90YWJsZXJhbmdlOjJjZTAxNWQzMWE0NzRmOTc4NjE1MTcyMDRmZDQwYjcyXzktMS0xLTEtMA_ff1e24bb-9de9-439b-97fd-62c334eb42e4">294</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia31e9a409b874bb19d0ff6f2f39ecc09_D20190701-20200630" decimals="-6" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTEvZnJhZzo0M2E4ZTJiZTY1ZTM0MDIxOTkxZWVhYTgxNjNlODAxYS90YWJsZToyY2UwMTVkMzFhNDc0Zjk3ODYxNTE3MjA0ZmQ0MGI3Mi90YWJsZXJhbmdlOjJjZTAxNWQzMWE0NzRmOTc4NjE1MTcyMDRmZDQwYjcyXzktMy0xLTEtMA_9dad21d8-d7f8-425d-bd0d-46c29602e89f">293</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i00a6d666bf604826b24e68ddbd63eac4_D20180701-20190630" decimals="-6" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTEvZnJhZzo0M2E4ZTJiZTY1ZTM0MDIxOTkxZWVhYTgxNjNlODAxYS90YWJsZToyY2UwMTVkMzFhNDc0Zjk3ODYxNTE3MjA0ZmQ0MGI3Mi90YWJsZXJhbmdlOjJjZTAxNWQzMWE0NzRmOTc4NjE1MTcyMDRmZDQwYjcyXzktNS0xLTEtMA_7f6b9a38-4683-46bc-9255-89fa8f21b4c6">301</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Basic earnings/(loss) per common share attributable to Cardinal Health, Inc.:</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTEvZnJhZzo0M2E4ZTJiZTY1ZTM0MDIxOTkxZWVhYTgxNjNlODAxYS90YWJsZToyY2UwMTVkMzFhNDc0Zjk3ODYxNTE3MjA0ZmQ0MGI3Mi90YWJsZXJhbmdlOjJjZTAxNWQzMWE0NzRmOTc4NjE1MTcyMDRmZDQwYjcyXzEwLTEtMS0xLTA_557eea4e-fe51-4fd8-81a4-50b3273746e3">2.09</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="ia31e9a409b874bb19d0ff6f2f39ecc09_D20190701-20200630" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTEvZnJhZzo0M2E4ZTJiZTY1ZTM0MDIxOTkxZWVhYTgxNjNlODAxYS90YWJsZToyY2UwMTVkMzFhNDc0Zjk3ODYxNTE3MjA0ZmQ0MGI3Mi90YWJsZXJhbmdlOjJjZTAxNWQzMWE0NzRmOTc4NjE1MTcyMDRmZDQwYjcyXzEwLTMtMS0xLTA_127ebfca-cc47-4b29-a8b3-9940c4b745f9">12.61</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i00a6d666bf604826b24e68ddbd63eac4_D20180701-20190630" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTEvZnJhZzo0M2E4ZTJiZTY1ZTM0MDIxOTkxZWVhYTgxNjNlODAxYS90YWJsZToyY2UwMTVkMzFhNDc0Zjk3ODYxNTE3MjA0ZmQ0MGI3Mi90YWJsZXJhbmdlOjJjZTAxNWQzMWE0NzRmOTc4NjE1MTcyMDRmZDQwYjcyXzEwLTUtMS0xLTA_54e6b0fb-8e36-4143-aa05-d4734014d06f">4.55</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Diluted earnings/(loss) per common share attributable to Cardinal Health, Inc.:</span></td><td colspan="2" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTEvZnJhZzo0M2E4ZTJiZTY1ZTM0MDIxOTkxZWVhYTgxNjNlODAxYS90YWJsZToyY2UwMTVkMzFhNDc0Zjk3ODYxNTE3MjA0ZmQ0MGI3Mi90YWJsZXJhbmdlOjJjZTAxNWQzMWE0NzRmOTc4NjE1MTcyMDRmZDQwYjcyXzE1LTEtMS0xLTA_97204efd-cd2f-4469-875d-8c01ef045482">2.08</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="ia31e9a409b874bb19d0ff6f2f39ecc09_D20190701-20200630" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTEvZnJhZzo0M2E4ZTJiZTY1ZTM0MDIxOTkxZWVhYTgxNjNlODAxYS90YWJsZToyY2UwMTVkMzFhNDc0Zjk3ODYxNTE3MjA0ZmQ0MGI3Mi90YWJsZXJhbmdlOjJjZTAxNWQzMWE0NzRmOTc4NjE1MTcyMDRmZDQwYjcyXzE1LTMtMS0xLTA_82523bf2-4938-4dd1-9419-e763b9798a79">12.61</ix:nonFraction>)</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i00a6d666bf604826b24e68ddbd63eac4_D20180701-20190630" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTEvZnJhZzo0M2E4ZTJiZTY1ZTM0MDIxOTkxZWVhYTgxNjNlODAxYS90YWJsZToyY2UwMTVkMzFhNDc0Zjk3ODYxNTE3MjA0ZmQ0MGI3Mi90YWJsZXJhbmdlOjJjZTAxNWQzMWE0NzRmOTc4NjE1MTcyMDRmZDQwYjcyXzE1LTUtMS0xLTA_935ac921-102b-4b00-8061-753ed9ed8171">4.53</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The potentially dilutive employee stock options, restricted share units and performance share units that were anti-dilutive for fiscal 2021</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2020 and 2019 were <ix:nonFraction unitRef="shares" contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTEvZnJhZzo0M2E4ZTJiZTY1ZTM0MDIxOTkxZWVhYTgxNjNlODAxYS90ZXh0cmVnaW9uOjQzYThlMmJlNjVlMzQwMjE5OTFlZWFhODE2M2U4MDFhXzI5MQ_8ce82a7b-84a0-43ad-8f1a-2a4b2124e8e6">3</ix:nonFraction> million, <ix:nonFraction unitRef="shares" contextRef="ia31e9a409b874bb19d0ff6f2f39ecc09_D20190701-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTEvZnJhZzo0M2E4ZTJiZTY1ZTM0MDIxOTkxZWVhYTgxNjNlODAxYS90ZXh0cmVnaW9uOjQzYThlMmJlNjVlMzQwMjE5OTFlZWFhODE2M2U4MDFhXzI5NQ_91416819-3865-468c-ad02-0a753fe6362d">6</ix:nonFraction> million and <ix:nonFraction unitRef="shares" contextRef="i00a6d666bf604826b24e68ddbd63eac4_D20180701-20190630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTEvZnJhZzo0M2E4ZTJiZTY1ZTM0MDIxOTkxZWVhYTgxNjNlODAxYS90ZXh0cmVnaW9uOjQzYThlMmJlNjVlMzQwMjE5OTFlZWFhODE2M2U4MDFhXzMwMg_f396e177-2037-4606-b7b2-8cc69191f356">7</ix:nonFraction> million, respectively. During fiscal 2020, there were <ix:nonFraction unitRef="shares" contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630" decimals="-3" format="ixt:numdotdecimal" name="cah:Sharesthatwouldbeantidilutiveasaresultofnetloss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTEvZnJhZzo0M2E4ZTJiZTY1ZTM0MDIxOTkxZWVhYTgxNjNlODAxYS90ZXh0cmVnaW9uOjQzYThlMmJlNjVlMzQwMjE5OTFlZWFhODE2M2U4MDFhXzcxNDY4MjU1ODE2OTQ_1df0979a-b3b1-4dbc-a887-fddf9b15e432">2</ix:nonFraction> million potentially dilutive employee stock options, restricted share units and performance share units not included in the computation of diluted loss per common share attributable to Cardinal Health, Inc. because their effect would be anti-dilutive as a result of the net loss for the fiscal year.</span></div></ix:nonNumeric><div id="i4f0ec56b9c604f1782a65ea4a19c284d_154"></div><ix:nonNumeric contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630" name="us-gaap:SegmentReportingDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTQvZnJhZzo3OWNmN2IxZmM4OTI0ODhkYjBjZTZhNDYxZmMyNjIzNC90ZXh0cmVnaW9uOjc5Y2Y3YjFmYzg5MjQ4OGRiMGNlNmE0NjFmYzI2MjM0XzYwMzE_eadbb003-b030-4991-96ab-5f0ab61f4265" continuedAt="i9ef50a48a6f24f30a6908cb39f272ea2" escape="true"><div style="margin-bottom:6pt;text-align:justify"><span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:13pt;font-weight:700;line-height:120%">13. Segment Information </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our operations are principally managed on a products and services basis and are comprised of <ix:nonFraction unitRef="segment" contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:NumberOfReportableSegments" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTQvZnJhZzo3OWNmN2IxZmM4OTI0ODhkYjBjZTZhNDYxZmMyNjIzNC90ZXh0cmVnaW9uOjc5Y2Y3YjFmYzg5MjQ4OGRiMGNlNmE0NjFmYzI2MjM0XzEwMg_a0ed16e6-1f98-4436-b7af-838e7be5f525"><ix:nonFraction unitRef="segment" contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:NumberOfOperatingSegments" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTQvZnJhZzo3OWNmN2IxZmM4OTI0ODhkYjBjZTZhNDYxZmMyNjIzNC90ZXh0cmVnaW9uOjc5Y2Y3YjFmYzg5MjQ4OGRiMGNlNmE0NjFmYzI2MjM0XzEwMg_f090cdaf-7eab-4dd2-a990-822e2864749f">two</ix:nonFraction></ix:nonFraction> operating segments, which are the same as our reportable segments: Pharmaceutical and Medical. The factors for determining the reportable segments include the manner in which management evaluates performance for purposes of allocating resources and assessing performance combined with the nature of the individual business activities.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Revenue</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical and over-the-counter healthcare and consumer products in the United States. This segment also provides services to pharmaceutical manufacturers and healthcare providers for specialty pharmaceutical products; operates pharmacies, including pharmacies in community health centers, nuclear pharmacies and radiopharmaceutical manufacturing facilities; provides pharmacy management services to hospitals as well as medication therapy management and patient outcomes services to hospitals, other healthcare providers and payers; and repackages generic pharmaceuticals and over-the-counter healthcare products. </span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Medical segment manufactures, sources and distributes Cardinal Health branded medical, surgical and laboratory products, which are sold in the United States, Canada, Europe, Asia and other markets. In addition to distributing Cardinal Health branded </span></div></ix:nonNumeric></div></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:32.135%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.428%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.137%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardinal Health </span><span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">|</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> Fiscal 2021 Form 10-K</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">83</span></div></td></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:3pt"><span><br/></span></div><div style="margin-bottom:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:24.682%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:50.911%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.107%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#e41f35;border-bottom:1pt solid #e41f35;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Notes to Financial Statements</span></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:3pt;text-align:justify"><span><br/></span></div></div><div style="width:100.000%"><ix:continuation id="i9ef50a48a6f24f30a6908cb39f272ea2" continuedAt="i0da9a4e146934a058a0a4a1d31a86b49"><div style="display:inline-block;vertical-align:top;width:48.214%"><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">products, this segment also distributes a broad range of medical, surgical and laboratory products known as national brand products and provides supply chain services and solutions to hospitals, ambulatory surgery centers, clinical laboratories and other healthcare providers in the United States and Canada. This segment also distributes medical products to patients' homes in the United States through our Cardinal Health at-Home Solutions division.</span></div><ix:nonNumeric contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630" name="us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTQvZnJhZzo3OWNmN2IxZmM4OTI0ODhkYjBjZTZhNDYxZmMyNjIzNC90ZXh0cmVnaW9uOjc5Y2Y3YjFmYzg5MjQ4OGRiMGNlNmE0NjFmYzI2MjM0XzU5ODU_eeec1433-d04a-4b69-bdee-f01b4dec1a74" escape="true"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents revenue for each reportable segment and Corporate:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:55.690%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.480%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.343%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.171%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.343%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.173%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Pharmaceutical</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i76b6a114dfd6424fb4c07d91075a91ff_D20200701-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTQvZnJhZzo3OWNmN2IxZmM4OTI0ODhkYjBjZTZhNDYxZmMyNjIzNC90YWJsZToxMDUyNWQyNDhlZWY0NTdjOTdhNTE3MDc4ZjA3MDNkOS90YWJsZXJhbmdlOjEwNTI1ZDI0OGVlZjQ1N2M5N2E1MTcwNzhmMDcwM2Q5XzEtMS0xLTEtMA_da101699-fd8b-426a-bff7-82e5597e6faa">145,796</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i78632f0315fd45fb85ed1c2272933a36_D20190701-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTQvZnJhZzo3OWNmN2IxZmM4OTI0ODhkYjBjZTZhNDYxZmMyNjIzNC90YWJsZToxMDUyNWQyNDhlZWY0NTdjOTdhNTE3MDc4ZjA3MDNkOS90YWJsZXJhbmdlOjEwNTI1ZDI0OGVlZjQ1N2M5N2E1MTcwNzhmMDcwM2Q5XzEtMy0xLTEtMA_df95e01a-ab1e-42a8-92bf-653585f20247">137,495</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d7435bb60af47f4a69d23c973a60d43_D20180701-20190630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTQvZnJhZzo3OWNmN2IxZmM4OTI0ODhkYjBjZTZhNDYxZmMyNjIzNC90YWJsZToxMDUyNWQyNDhlZWY0NTdjOTdhNTE3MDc4ZjA3MDNkOS90YWJsZXJhbmdlOjEwNTI1ZDI0OGVlZjQ1N2M5N2E1MTcwNzhmMDcwM2Q5XzEtNS0xLTEtMA_4ed76c01-d25e-4bef-ba40-e7140e526880">129,917</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Medical</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id8c82c11050f452c9befaa43705026a6_D20200701-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTQvZnJhZzo3OWNmN2IxZmM4OTI0ODhkYjBjZTZhNDYxZmMyNjIzNC90YWJsZToxMDUyNWQyNDhlZWY0NTdjOTdhNTE3MDc4ZjA3MDNkOS90YWJsZXJhbmdlOjEwNTI1ZDI0OGVlZjQ1N2M5N2E1MTcwNzhmMDcwM2Q5XzItMS0xLTEtMA_801f9b18-3be1-4c0f-aac3-e8e91cd89a36">16,687</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1faf47ea4d994e879fd1c1bf2cc15983_D20190701-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTQvZnJhZzo3OWNmN2IxZmM4OTI0ODhkYjBjZTZhNDYxZmMyNjIzNC90YWJsZToxMDUyNWQyNDhlZWY0NTdjOTdhNTE3MDc4ZjA3MDNkOS90YWJsZXJhbmdlOjEwNTI1ZDI0OGVlZjQ1N2M5N2E1MTcwNzhmMDcwM2Q5XzItMy0xLTEtMA_37a08ebe-7653-480e-b7dc-4663eeaf9074">15,444</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4dcc4f5896f24eb98e3473b71e1d10b7_D20180701-20190630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTQvZnJhZzo3OWNmN2IxZmM4OTI0ODhkYjBjZTZhNDYxZmMyNjIzNC90YWJsZToxMDUyNWQyNDhlZWY0NTdjOTdhNTE3MDc4ZjA3MDNkOS90YWJsZXJhbmdlOjEwNTI1ZDI0OGVlZjQ1N2M5N2E1MTcwNzhmMDcwM2Q5XzItNS0xLTEtMA_ce1af9fd-d5f3-4b1f-8f93-15d3905879f1">15,633</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total segment revenue</span></td><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie5f1ec6cee11430ab0571ee6201cd0f7_D20200701-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTQvZnJhZzo3OWNmN2IxZmM4OTI0ODhkYjBjZTZhNDYxZmMyNjIzNC90YWJsZToxMDUyNWQyNDhlZWY0NTdjOTdhNTE3MDc4ZjA3MDNkOS90YWJsZXJhbmdlOjEwNTI1ZDI0OGVlZjQ1N2M5N2E1MTcwNzhmMDcwM2Q5XzMtMS0xLTEtMA_90ed073f-559b-49f4-9223-6278957c6088">162,483</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7a96c8334d2e46928c83a274df8be377_D20190701-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTQvZnJhZzo3OWNmN2IxZmM4OTI0ODhkYjBjZTZhNDYxZmMyNjIzNC90YWJsZToxMDUyNWQyNDhlZWY0NTdjOTdhNTE3MDc4ZjA3MDNkOS90YWJsZXJhbmdlOjEwNTI1ZDI0OGVlZjQ1N2M5N2E1MTcwNzhmMDcwM2Q5XzMtMy0xLTEtMA_06bce748-9e45-4e78-bf2e-119935ac02a7">152,939</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ab52d1ad77045aa97d1dbfb8cb6186e_D20180701-20190630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTQvZnJhZzo3OWNmN2IxZmM4OTI0ODhkYjBjZTZhNDYxZmMyNjIzNC90YWJsZToxMDUyNWQyNDhlZWY0NTdjOTdhNTE3MDc4ZjA3MDNkOS90YWJsZXJhbmdlOjEwNTI1ZDI0OGVlZjQ1N2M5N2E1MTcwNzhmMDcwM2Q5XzMtNS0xLTEtMA_3c6993ad-dbd3-4758-be7e-22ec9b83d585">145,550</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Corporate (1)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i792ece330cb74d35afecabca6b7f49ea_D20200701-20210630" decimals="-6" sign="-" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTQvZnJhZzo3OWNmN2IxZmM4OTI0ODhkYjBjZTZhNDYxZmMyNjIzNC90YWJsZToxMDUyNWQyNDhlZWY0NTdjOTdhNTE3MDc4ZjA3MDNkOS90YWJsZXJhbmdlOjEwNTI1ZDI0OGVlZjQ1N2M5N2E1MTcwNzhmMDcwM2Q5XzQtMS0xLTEtMA_9e76f224-ff2d-4a8c-b583-7e2d68faf978">16</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i16818ee6ea724c8691b1f0065031735b_D20190701-20200630" decimals="-6" sign="-" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTQvZnJhZzo3OWNmN2IxZmM4OTI0ODhkYjBjZTZhNDYxZmMyNjIzNC90YWJsZToxMDUyNWQyNDhlZWY0NTdjOTdhNTE3MDc4ZjA3MDNkOS90YWJsZXJhbmdlOjEwNTI1ZDI0OGVlZjQ1N2M5N2E1MTcwNzhmMDcwM2Q5XzQtMy0xLTEtMA_b8abbb9c-7906-4872-ac85-d5b62459b468">17</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic5128c57d92d4336ae115d6ba4e979cb_D20180701-20190630" decimals="-6" sign="-" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTQvZnJhZzo3OWNmN2IxZmM4OTI0ODhkYjBjZTZhNDYxZmMyNjIzNC90YWJsZToxMDUyNWQyNDhlZWY0NTdjOTdhNTE3MDc4ZjA3MDNkOS90YWJsZXJhbmdlOjEwNTI1ZDI0OGVlZjQ1N2M5N2E1MTcwNzhmMDcwM2Q5XzQtNS0xLTEtMA_d2aaa116-bd3e-4eb8-a9f5-ea17607e2712">16</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total revenue</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTQvZnJhZzo3OWNmN2IxZmM4OTI0ODhkYjBjZTZhNDYxZmMyNjIzNC90YWJsZToxMDUyNWQyNDhlZWY0NTdjOTdhNTE3MDc4ZjA3MDNkOS90YWJsZXJhbmdlOjEwNTI1ZDI0OGVlZjQ1N2M5N2E1MTcwNzhmMDcwM2Q5XzUtMS0xLTEtMA_4a77e242-386e-4d53-961f-128155e243f5">162,467</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia31e9a409b874bb19d0ff6f2f39ecc09_D20190701-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTQvZnJhZzo3OWNmN2IxZmM4OTI0ODhkYjBjZTZhNDYxZmMyNjIzNC90YWJsZToxMDUyNWQyNDhlZWY0NTdjOTdhNTE3MDc4ZjA3MDNkOS90YWJsZXJhbmdlOjEwNTI1ZDI0OGVlZjQ1N2M5N2E1MTcwNzhmMDcwM2Q5XzUtMy0xLTEtMA_96ceb081-e684-426a-ad23-e690088f8ad1">152,922</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i00a6d666bf604826b24e68ddbd63eac4_D20180701-20190630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTQvZnJhZzo3OWNmN2IxZmM4OTI0ODhkYjBjZTZhNDYxZmMyNjIzNC90YWJsZToxMDUyNWQyNDhlZWY0NTdjOTdhNTE3MDc4ZjA3MDNkOS90YWJsZXJhbmdlOjEwNTI1ZDI0OGVlZjQ1N2M5N2E1MTcwNzhmMDcwM2Q5XzUtNS0xLTEtMA_2bc53c50-202b-4f00-9beb-ccf18b4af9d5">145,534</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:10pt">Corporate revenue consists of the elimination of inter-segment revenue and other revenue not allocated to the segments.</span></div></ix:nonNumeric><div style="margin-bottom:3pt;text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630" name="us-gaap:ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTQvZnJhZzo3OWNmN2IxZmM4OTI0ODhkYjBjZTZhNDYxZmMyNjIzNC90ZXh0cmVnaW9uOjc5Y2Y3YjFmYzg5MjQ4OGRiMGNlNmE0NjFmYzI2MjM0XzYwMjE_3a868714-2f70-4023-bf5e-d8acf0321095" escape="true"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables present revenue for each reportable segment and disaggregated revenue within our two reportable segments and Corporate:</span></div><ix:nonNumeric contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630" name="us-gaap:DisaggregationOfRevenueTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTQvZnJhZzo3OWNmN2IxZmM4OTI0ODhkYjBjZTZhNDYxZmMyNjIzNC90ZXh0cmVnaW9uOjc5Y2Y3YjFmYzg5MjQ4OGRiMGNlNmE0NjFmYzI2MjM0XzU5OTk_f90cfdfd-95f5-496f-8412-4f61ebe4b50d" escape="true"><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:46.791%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.466%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.004%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.466%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.004%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.469%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Pharmaceutical Distribution and Specialty Solutions (1) (2)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i155c6a70937b40b68b1699cc88ad54f0_D20200701-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTQvZnJhZzo3OWNmN2IxZmM4OTI0ODhkYjBjZTZhNDYxZmMyNjIzNC90YWJsZTpmZGYzNWU3MjZhMjk0YzllOGFiNGU3YTY2ZWI0ZDkxZC90YWJsZXJhbmdlOmZkZjM1ZTcyNmEyOTRjOWU4YWI0ZTdhNjZlYjRkOTFkXzEtMS0xLTEtMA_0101509f-cdc1-4f5e-bf51-47ef86a9a08c">144,988</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i76773aa4b180454e80d866fd2a2396b6_D20190701-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTQvZnJhZzo3OWNmN2IxZmM4OTI0ODhkYjBjZTZhNDYxZmMyNjIzNC90YWJsZTpmZGYzNWU3MjZhMjk0YzllOGFiNGU3YTY2ZWI0ZDkxZC90YWJsZXJhbmdlOmZkZjM1ZTcyNmEyOTRjOWU4YWI0ZTdhNjZlYjRkOTFkXzEtMi0xLTEtMA_fe59fc25-20b2-423b-a1c5-d7695583dbf4">136,693</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic18e242a8d2744198de6fca3c9aaccdd_D20180701-20190630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTQvZnJhZzo3OWNmN2IxZmM4OTI0ODhkYjBjZTZhNDYxZmMyNjIzNC90YWJsZTpmZGYzNWU3MjZhMjk0YzllOGFiNGU3YTY2ZWI0ZDkxZC90YWJsZXJhbmdlOmZkZjM1ZTcyNmEyOTRjOWU4YWI0ZTdhNjZlYjRkOTFkXzEtMy0xLTEtNTIxMQ_331e8959-c5dd-4960-a4dc-7230f2a88023">129,067</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Nuclear and Precision Health Solutions</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5aa6abf0d0ff4864be49a2c272e9ae17_D20200701-20210630" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTQvZnJhZzo3OWNmN2IxZmM4OTI0ODhkYjBjZTZhNDYxZmMyNjIzNC90YWJsZTpmZGYzNWU3MjZhMjk0YzllOGFiNGU3YTY2ZWI0ZDkxZC90YWJsZXJhbmdlOmZkZjM1ZTcyNmEyOTRjOWU4YWI0ZTdhNjZlYjRkOTFkXzItMS0xLTEtMA_0dc0ffce-ce58-4e60-8e73-90b4834110b9">808</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i86db5a9e2c2b4d719e8263c1bfc96ca5_D20190701-20200630" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTQvZnJhZzo3OWNmN2IxZmM4OTI0ODhkYjBjZTZhNDYxZmMyNjIzNC90YWJsZTpmZGYzNWU3MjZhMjk0YzllOGFiNGU3YTY2ZWI0ZDkxZC90YWJsZXJhbmdlOmZkZjM1ZTcyNmEyOTRjOWU4YWI0ZTdhNjZlYjRkOTFkXzItMi0xLTEtMA_f297f67e-4726-4f7b-a19c-aa49b7781c76">802</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaa4c204e977543369238d8e99ef5f86e_D20180701-20190630" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTQvZnJhZzo3OWNmN2IxZmM4OTI0ODhkYjBjZTZhNDYxZmMyNjIzNC90YWJsZTpmZGYzNWU3MjZhMjk0YzllOGFiNGU3YTY2ZWI0ZDkxZC90YWJsZXJhbmdlOmZkZjM1ZTcyNmEyOTRjOWU4YWI0ZTdhNjZlYjRkOTFkXzItMy0xLTEtNTIxNQ_96f58353-74e5-44f8-867b-b766089d4720">850</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Pharmaceutical segment revenue</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i76b6a114dfd6424fb4c07d91075a91ff_D20200701-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTQvZnJhZzo3OWNmN2IxZmM4OTI0ODhkYjBjZTZhNDYxZmMyNjIzNC90YWJsZTpmZGYzNWU3MjZhMjk0YzllOGFiNGU3YTY2ZWI0ZDkxZC90YWJsZXJhbmdlOmZkZjM1ZTcyNmEyOTRjOWU4YWI0ZTdhNjZlYjRkOTFkXzMtMS0xLTEtMA_da101699-fd8b-426a-bff7-82e5597e6faa">145,796</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i78632f0315fd45fb85ed1c2272933a36_D20190701-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTQvZnJhZzo3OWNmN2IxZmM4OTI0ODhkYjBjZTZhNDYxZmMyNjIzNC90YWJsZTpmZGYzNWU3MjZhMjk0YzllOGFiNGU3YTY2ZWI0ZDkxZC90YWJsZXJhbmdlOmZkZjM1ZTcyNmEyOTRjOWU4YWI0ZTdhNjZlYjRkOTFkXzMtMi0xLTEtMA_df95e01a-ab1e-42a8-92bf-653585f20247">137,495</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d7435bb60af47f4a69d23c973a60d43_D20180701-20190630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTQvZnJhZzo3OWNmN2IxZmM4OTI0ODhkYjBjZTZhNDYxZmMyNjIzNC90YWJsZTpmZGYzNWU3MjZhMjk0YzllOGFiNGU3YTY2ZWI0ZDkxZC90YWJsZXJhbmdlOmZkZjM1ZTcyNmEyOTRjOWU4YWI0ZTdhNjZlYjRkOTFkXzMtMy0xLTEtNTIxOQ_4ed76c01-d25e-4bef-ba40-e7140e526880">129,917</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Medical distribution and products (3)</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i00d597531405494bb66494a39ed9a378_D20200701-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTQvZnJhZzo3OWNmN2IxZmM4OTI0ODhkYjBjZTZhNDYxZmMyNjIzNC90YWJsZTpmZGYzNWU3MjZhMjk0YzllOGFiNGU3YTY2ZWI0ZDkxZC90YWJsZXJhbmdlOmZkZjM1ZTcyNmEyOTRjOWU4YWI0ZTdhNjZlYjRkOTFkXzQtMS0xLTEtMA_b9d70dab-961a-4b19-a0c9-6957772ef01e">14,485</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icf4b31c19dc549a1883307cdf7dbe88c_D20190701-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTQvZnJhZzo3OWNmN2IxZmM4OTI0ODhkYjBjZTZhNDYxZmMyNjIzNC90YWJsZTpmZGYzNWU3MjZhMjk0YzllOGFiNGU3YTY2ZWI0ZDkxZC90YWJsZXJhbmdlOmZkZjM1ZTcyNmEyOTRjOWU4YWI0ZTdhNjZlYjRkOTFkXzQtMi0xLTEtMA_9deb09ca-ef89-4394-a62e-c40423ccebd5">13,429</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i321e2ade5757483681291e8d89208466_D20180701-20190630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTQvZnJhZzo3OWNmN2IxZmM4OTI0ODhkYjBjZTZhNDYxZmMyNjIzNC90YWJsZTpmZGYzNWU3MjZhMjk0YzllOGFiNGU3YTY2ZWI0ZDkxZC90YWJsZXJhbmdlOmZkZjM1ZTcyNmEyOTRjOWU4YWI0ZTdhNjZlYjRkOTFkXzQtMy0xLTEtNTIyMg_f58beaba-6927-4a32-bbf0-96b580409e6e">13,833</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cardinal Health at-Home Solutions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f0de7fef24f4d40bd4de0a2976f37d8_D20200701-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTQvZnJhZzo3OWNmN2IxZmM4OTI0ODhkYjBjZTZhNDYxZmMyNjIzNC90YWJsZTpmZGYzNWU3MjZhMjk0YzllOGFiNGU3YTY2ZWI0ZDkxZC90YWJsZXJhbmdlOmZkZjM1ZTcyNmEyOTRjOWU4YWI0ZTdhNjZlYjRkOTFkXzUtMS0xLTEtMA_bdc9be64-1380-4d16-ad52-4c2f1cde9de1">2,202</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieaa341ac8f284f1582d38baefdc71c05_D20190701-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTQvZnJhZzo3OWNmN2IxZmM4OTI0ODhkYjBjZTZhNDYxZmMyNjIzNC90YWJsZTpmZGYzNWU3MjZhMjk0YzllOGFiNGU3YTY2ZWI0ZDkxZC90YWJsZXJhbmdlOmZkZjM1ZTcyNmEyOTRjOWU4YWI0ZTdhNjZlYjRkOTFkXzUtMi0xLTEtMA_3229137f-3f40-40c7-91af-3dee9420ae75">2,015</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c109faf3fc4429686c141f4abd59a0c_D20180701-20190630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTQvZnJhZzo3OWNmN2IxZmM4OTI0ODhkYjBjZTZhNDYxZmMyNjIzNC90YWJsZTpmZGYzNWU3MjZhMjk0YzllOGFiNGU3YTY2ZWI0ZDkxZC90YWJsZXJhbmdlOmZkZjM1ZTcyNmEyOTRjOWU4YWI0ZTdhNjZlYjRkOTFkXzUtMy0xLTEtNTIyNg_c6a275b2-882b-4b0e-af1e-4fa18b3e1bbe">1,800</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Medical segment revenue</span></div></td><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id8c82c11050f452c9befaa43705026a6_D20200701-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTQvZnJhZzo3OWNmN2IxZmM4OTI0ODhkYjBjZTZhNDYxZmMyNjIzNC90YWJsZTpmZGYzNWU3MjZhMjk0YzllOGFiNGU3YTY2ZWI0ZDkxZC90YWJsZXJhbmdlOmZkZjM1ZTcyNmEyOTRjOWU4YWI0ZTdhNjZlYjRkOTFkXzYtMS0xLTEtMA_801f9b18-3be1-4c0f-aac3-e8e91cd89a36">16,687</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1faf47ea4d994e879fd1c1bf2cc15983_D20190701-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTQvZnJhZzo3OWNmN2IxZmM4OTI0ODhkYjBjZTZhNDYxZmMyNjIzNC90YWJsZTpmZGYzNWU3MjZhMjk0YzllOGFiNGU3YTY2ZWI0ZDkxZC90YWJsZXJhbmdlOmZkZjM1ZTcyNmEyOTRjOWU4YWI0ZTdhNjZlYjRkOTFkXzYtMi0xLTEtMA_37a08ebe-7653-480e-b7dc-4663eeaf9074">15,444</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4dcc4f5896f24eb98e3473b71e1d10b7_D20180701-20190630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTQvZnJhZzo3OWNmN2IxZmM4OTI0ODhkYjBjZTZhNDYxZmMyNjIzNC90YWJsZTpmZGYzNWU3MjZhMjk0YzllOGFiNGU3YTY2ZWI0ZDkxZC90YWJsZXJhbmdlOmZkZjM1ZTcyNmEyOTRjOWU4YWI0ZTdhNjZlYjRkOTFkXzYtMy0xLTEtNTIzMA_ce1af9fd-d5f3-4b1f-8f93-15d3905879f1">15,633</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;Total segment revenue</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie5f1ec6cee11430ab0571ee6201cd0f7_D20200701-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTQvZnJhZzo3OWNmN2IxZmM4OTI0ODhkYjBjZTZhNDYxZmMyNjIzNC90YWJsZTpmZGYzNWU3MjZhMjk0YzllOGFiNGU3YTY2ZWI0ZDkxZC90YWJsZXJhbmdlOmZkZjM1ZTcyNmEyOTRjOWU4YWI0ZTdhNjZlYjRkOTFkXzctMS0xLTEtMA_90ed073f-559b-49f4-9223-6278957c6088">162,483</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7a96c8334d2e46928c83a274df8be377_D20190701-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTQvZnJhZzo3OWNmN2IxZmM4OTI0ODhkYjBjZTZhNDYxZmMyNjIzNC90YWJsZTpmZGYzNWU3MjZhMjk0YzllOGFiNGU3YTY2ZWI0ZDkxZC90YWJsZXJhbmdlOmZkZjM1ZTcyNmEyOTRjOWU4YWI0ZTdhNjZlYjRkOTFkXzctMi0xLTEtMA_06bce748-9e45-4e78-bf2e-119935ac02a7">152,939</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ab52d1ad77045aa97d1dbfb8cb6186e_D20180701-20190630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTQvZnJhZzo3OWNmN2IxZmM4OTI0ODhkYjBjZTZhNDYxZmMyNjIzNC90YWJsZTpmZGYzNWU3MjZhMjk0YzllOGFiNGU3YTY2ZWI0ZDkxZC90YWJsZXJhbmdlOmZkZjM1ZTcyNmEyOTRjOWU4YWI0ZTdhNjZlYjRkOTFkXzctMy0xLTEtNTIzMw_3c6993ad-dbd3-4758-be7e-22ec9b83d585">145,550</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Corporate (4)</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i792ece330cb74d35afecabca6b7f49ea_D20200701-20210630" decimals="-6" sign="-" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTQvZnJhZzo3OWNmN2IxZmM4OTI0ODhkYjBjZTZhNDYxZmMyNjIzNC90YWJsZTpmZGYzNWU3MjZhMjk0YzllOGFiNGU3YTY2ZWI0ZDkxZC90YWJsZXJhbmdlOmZkZjM1ZTcyNmEyOTRjOWU4YWI0ZTdhNjZlYjRkOTFkXzgtMS0xLTEtMA_9e76f224-ff2d-4a8c-b583-7e2d68faf978">16</ix:nonFraction>)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i16818ee6ea724c8691b1f0065031735b_D20190701-20200630" decimals="-6" sign="-" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTQvZnJhZzo3OWNmN2IxZmM4OTI0ODhkYjBjZTZhNDYxZmMyNjIzNC90YWJsZTpmZGYzNWU3MjZhMjk0YzllOGFiNGU3YTY2ZWI0ZDkxZC90YWJsZXJhbmdlOmZkZjM1ZTcyNmEyOTRjOWU4YWI0ZTdhNjZlYjRkOTFkXzgtMi0xLTEtMA_b8abbb9c-7906-4872-ac85-d5b62459b468">17</ix:nonFraction>)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic5128c57d92d4336ae115d6ba4e979cb_D20180701-20190630" decimals="-6" sign="-" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTQvZnJhZzo3OWNmN2IxZmM4OTI0ODhkYjBjZTZhNDYxZmMyNjIzNC90YWJsZTpmZGYzNWU3MjZhMjk0YzllOGFiNGU3YTY2ZWI0ZDkxZC90YWJsZXJhbmdlOmZkZjM1ZTcyNmEyOTRjOWU4YWI0ZTdhNjZlYjRkOTFkXzgtMy0xLTEtNTIzNg_d2aaa116-bd3e-4eb8-a9f5-ea17607e2712">16</ix:nonFraction>)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total revenue</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTQvZnJhZzo3OWNmN2IxZmM4OTI0ODhkYjBjZTZhNDYxZmMyNjIzNC90YWJsZTpmZGYzNWU3MjZhMjk0YzllOGFiNGU3YTY2ZWI0ZDkxZC90YWJsZXJhbmdlOmZkZjM1ZTcyNmEyOTRjOWU4YWI0ZTdhNjZlYjRkOTFkXzktMS0xLTEtMA_4a77e242-386e-4d53-961f-128155e243f5">162,467</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia31e9a409b874bb19d0ff6f2f39ecc09_D20190701-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTQvZnJhZzo3OWNmN2IxZmM4OTI0ODhkYjBjZTZhNDYxZmMyNjIzNC90YWJsZTpmZGYzNWU3MjZhMjk0YzllOGFiNGU3YTY2ZWI0ZDkxZC90YWJsZXJhbmdlOmZkZjM1ZTcyNmEyOTRjOWU4YWI0ZTdhNjZlYjRkOTFkXzktMi0xLTEtMA_96ceb081-e684-426a-ad23-e690088f8ad1">152,922</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i00a6d666bf604826b24e68ddbd63eac4_D20180701-20190630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTQvZnJhZzo3OWNmN2IxZmM4OTI0ODhkYjBjZTZhNDYxZmMyNjIzNC90YWJsZTpmZGYzNWU3MjZhMjk0YzllOGFiNGU3YTY2ZWI0ZDkxZC90YWJsZXJhbmdlOmZkZjM1ZTcyNmEyOTRjOWU4YWI0ZTdhNjZlYjRkOTFkXzktMy0xLTEtNTIzOQ_2bc53c50-202b-4f00-9beb-ccf18b4af9d5">145,534</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:10pt">Products and services offered by our Specialty Solutions division are referred to as &#8220;specialty pharmaceutical products and services"</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:10pt">Comprised of all Pharmaceutical segment businesses except for Nuclear and Precision Health Solutions division.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:10pt">Comprised of all Medical segment businesses except for Cardinal Health at-Home Solutions division</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:10pt">Corporate revenue consists of the elimination of inter-segment revenue and other revenue not allocated to the segments.</span></div></ix:nonNumeric></ix:nonNumeric><ix:nonNumeric contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630" name="us-gaap:RevenueFromExternalCustomersByGeographicAreasTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTQvZnJhZzo3OWNmN2IxZmM4OTI0ODhkYjBjZTZhNDYxZmMyNjIzNC90ZXh0cmVnaW9uOjc5Y2Y3YjFmYzg5MjQ4OGRiMGNlNmE0NjFmYzI2MjM0XzYwMjU_de3d1881-f4fb-44a5-8220-d4d51cc85849" escape="true"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents revenue by geographic area:</span></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:42.109%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.183%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.269%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.183%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.269%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.187%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">United States</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id0012edd1a484009af89832a87b38690_D20200701-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTQvZnJhZzo3OWNmN2IxZmM4OTI0ODhkYjBjZTZhNDYxZmMyNjIzNC90YWJsZTo1MjJhMmQ1OWRmZjU0ODI3OTU5NzNkNTdlYzE3ZjM3My90YWJsZXJhbmdlOjUyMmEyZDU5ZGZmNTQ4Mjc5NTk3M2Q1N2VjMTdmMzczXzEtMS0xLTEtMA_dd1fb910-4b73-42c0-8889-2c16023477fe">157,756</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i634f4d42b1cb4e6cb3a43cc4bc98832d_D20190701-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTQvZnJhZzo3OWNmN2IxZmM4OTI0ODhkYjBjZTZhNDYxZmMyNjIzNC90YWJsZTo1MjJhMmQ1OWRmZjU0ODI3OTU5NzNkNTdlYzE3ZjM3My90YWJsZXJhbmdlOjUyMmEyZDU5ZGZmNTQ4Mjc5NTk3M2Q1N2VjMTdmMzczXzEtMy0xLTEtMA_b1e7e725-ef05-408c-abda-235d27501265">148,707</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i78774426f41940febec7d66ff52bb8d1_D20180701-20190630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTQvZnJhZzo3OWNmN2IxZmM4OTI0ODhkYjBjZTZhNDYxZmMyNjIzNC90YWJsZTo1MjJhMmQ1OWRmZjU0ODI3OTU5NzNkNTdlYzE3ZjM3My90YWJsZXJhbmdlOjUyMmEyZDU5ZGZmNTQ4Mjc5NTk3M2Q1N2VjMTdmMzczXzEtNS0xLTEtMA_e4a9e942-1a4a-4014-8058-8d563a5ed13f">141,479</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">International</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3d4fc04fd3ba4fe9b28a1f419dbc6b15_D20200701-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTQvZnJhZzo3OWNmN2IxZmM4OTI0ODhkYjBjZTZhNDYxZmMyNjIzNC90YWJsZTo1MjJhMmQ1OWRmZjU0ODI3OTU5NzNkNTdlYzE3ZjM3My90YWJsZXJhbmdlOjUyMmEyZDU5ZGZmNTQ4Mjc5NTk3M2Q1N2VjMTdmMzczXzItMS0xLTEtMA_101ed0ec-a4f6-444c-aab5-b12d93024a01">4,727</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i780324fcbcb345e29107285be707bc45_D20190701-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTQvZnJhZzo3OWNmN2IxZmM4OTI0ODhkYjBjZTZhNDYxZmMyNjIzNC90YWJsZTo1MjJhMmQ1OWRmZjU0ODI3OTU5NzNkNTdlYzE3ZjM3My90YWJsZXJhbmdlOjUyMmEyZDU5ZGZmNTQ4Mjc5NTk3M2Q1N2VjMTdmMzczXzItMy0xLTEtMA_63bc4dc0-711f-430c-a806-381686dbb873">4,232</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if26a26c7dce04a669d805364e23fcbb7_D20180701-20190630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTQvZnJhZzo3OWNmN2IxZmM4OTI0ODhkYjBjZTZhNDYxZmMyNjIzNC90YWJsZTo1MjJhMmQ1OWRmZjU0ODI3OTU5NzNkNTdlYzE3ZjM3My90YWJsZXJhbmdlOjUyMmEyZDU5ZGZmNTQ4Mjc5NTk3M2Q1N2VjMTdmMzczXzItNS0xLTEtMA_8f96bb09-8ff4-492e-92a9-13a8bdedcaeb">4,071</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total segment revenue</span></td><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie5f1ec6cee11430ab0571ee6201cd0f7_D20200701-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTQvZnJhZzo3OWNmN2IxZmM4OTI0ODhkYjBjZTZhNDYxZmMyNjIzNC90YWJsZTo1MjJhMmQ1OWRmZjU0ODI3OTU5NzNkNTdlYzE3ZjM3My90YWJsZXJhbmdlOjUyMmEyZDU5ZGZmNTQ4Mjc5NTk3M2Q1N2VjMTdmMzczXzMtMS0xLTEtMA_9c5609cb-7d09-46b9-899a-c2d69e3dcbc0">162,483</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7a96c8334d2e46928c83a274df8be377_D20190701-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTQvZnJhZzo3OWNmN2IxZmM4OTI0ODhkYjBjZTZhNDYxZmMyNjIzNC90YWJsZTo1MjJhMmQ1OWRmZjU0ODI3OTU5NzNkNTdlYzE3ZjM3My90YWJsZXJhbmdlOjUyMmEyZDU5ZGZmNTQ4Mjc5NTk3M2Q1N2VjMTdmMzczXzMtMy0xLTEtMA_66fd9ba1-546c-4b6a-9604-136229092fd2">152,939</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ab52d1ad77045aa97d1dbfb8cb6186e_D20180701-20190630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTQvZnJhZzo3OWNmN2IxZmM4OTI0ODhkYjBjZTZhNDYxZmMyNjIzNC90YWJsZTo1MjJhMmQ1OWRmZjU0ODI3OTU5NzNkNTdlYzE3ZjM3My90YWJsZXJhbmdlOjUyMmEyZDU5ZGZmNTQ4Mjc5NTk3M2Q1N2VjMTdmMzczXzMtNS0xLTEtMA_b501e6d9-105b-4ef4-9c87-7a6f142157b5">145,550</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Corporate (1)</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i792ece330cb74d35afecabca6b7f49ea_D20200701-20210630" decimals="-6" sign="-" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTQvZnJhZzo3OWNmN2IxZmM4OTI0ODhkYjBjZTZhNDYxZmMyNjIzNC90YWJsZTo1MjJhMmQ1OWRmZjU0ODI3OTU5NzNkNTdlYzE3ZjM3My90YWJsZXJhbmdlOjUyMmEyZDU5ZGZmNTQ4Mjc5NTk3M2Q1N2VjMTdmMzczXzQtMS0xLTEtMA_30162340-322b-4d3f-b28c-2c785eb46a1e">16</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i16818ee6ea724c8691b1f0065031735b_D20190701-20200630" decimals="-6" sign="-" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTQvZnJhZzo3OWNmN2IxZmM4OTI0ODhkYjBjZTZhNDYxZmMyNjIzNC90YWJsZTo1MjJhMmQ1OWRmZjU0ODI3OTU5NzNkNTdlYzE3ZjM3My90YWJsZXJhbmdlOjUyMmEyZDU5ZGZmNTQ4Mjc5NTk3M2Q1N2VjMTdmMzczXzQtMy0xLTEtMA_1bfb6f86-e959-42a7-9aab-5c5ea3c53fbb">17</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic5128c57d92d4336ae115d6ba4e979cb_D20180701-20190630" decimals="-6" sign="-" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTQvZnJhZzo3OWNmN2IxZmM4OTI0ODhkYjBjZTZhNDYxZmMyNjIzNC90YWJsZTo1MjJhMmQ1OWRmZjU0ODI3OTU5NzNkNTdlYzE3ZjM3My90YWJsZXJhbmdlOjUyMmEyZDU5ZGZmNTQ4Mjc5NTk3M2Q1N2VjMTdmMzczXzQtNS0xLTEtMA_98159bb7-3c8c-4f40-afbb-cc5e1efe9423">16</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total revenue</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTQvZnJhZzo3OWNmN2IxZmM4OTI0ODhkYjBjZTZhNDYxZmMyNjIzNC90YWJsZTo1MjJhMmQ1OWRmZjU0ODI3OTU5NzNkNTdlYzE3ZjM3My90YWJsZXJhbmdlOjUyMmEyZDU5ZGZmNTQ4Mjc5NTk3M2Q1N2VjMTdmMzczXzUtMS0xLTEtMA_58987dee-0750-4b3b-8a00-c6657c19d0bf">162,467</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia31e9a409b874bb19d0ff6f2f39ecc09_D20190701-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTQvZnJhZzo3OWNmN2IxZmM4OTI0ODhkYjBjZTZhNDYxZmMyNjIzNC90YWJsZTo1MjJhMmQ1OWRmZjU0ODI3OTU5NzNkNTdlYzE3ZjM3My90YWJsZXJhbmdlOjUyMmEyZDU5ZGZmNTQ4Mjc5NTk3M2Q1N2VjMTdmMzczXzUtMy0xLTEtMA_96b48f98-c46c-4e22-a61e-02f4a4538c90">152,922</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i00a6d666bf604826b24e68ddbd63eac4_D20180701-20190630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTQvZnJhZzo3OWNmN2IxZmM4OTI0ODhkYjBjZTZhNDYxZmMyNjIzNC90YWJsZTo1MjJhMmQ1OWRmZjU0ODI3OTU5NzNkNTdlYzE3ZjM3My90YWJsZXJhbmdlOjUyMmEyZDU5ZGZmNTQ4Mjc5NTk3M2Q1N2VjMTdmMzczXzUtNS0xLTEtMA_e05b2622-d468-45f0-a074-0527aa14c08b">145,534</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:10pt">Corporate revenue consists of the elimination of inter-segment revenue and other revenue not allocated to the segments.</span></div></ix:nonNumeric></div><div style="display:inline-block;max-width:3.571%;min-width:2.571%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:48.215%"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Segment Profit</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We evaluate segment performance based on segment profit, among other measures. Segment profit is segment revenue, less segment cost of products sold, less segment distribution, selling, general, and administrative ("SG&amp;A") expenses. Segment SG&amp;A expenses include share-based compensation expense as well as allocated corporate expenses for shared functions, including corporate management, corporate finance, financial and customer care shared services, human resources, information technology, legal and compliance, including certain litigation defense costs. Corporate expenses are allocated to the segments based on headcount, level of benefit provided and other ratable allocation methodologies. The results attributable to noncontrolling interests are recorded within segment profit.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We do not allocate the following items to our segments: </span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.13pt">last-in first-out, or ("LIFO"), inventory charges/(credits);</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.13pt">surgical gown recall costs/(income); in connection with a voluntary recall for certain surgical gowns and a voluntary recall and field actions for surgical procedure packs containing affected gowns, we recognized a pre-tax charge of $<ix:nonFraction unitRef="usd" contextRef="ic436b3ed22eb4cdcb413eaef19ec4ca5_D20190701-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:InventoryRecallExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTQvZnJhZzo3OWNmN2IxZmM4OTI0ODhkYjBjZTZhNDYxZmMyNjIzNC90ZXh0cmVnaW9uOjc5Y2Y3YjFmYzg5MjQ4OGRiMGNlNmE0NjFmYzI2MjM0XzEyMDk0NjI3OTE2MDcz_8b2538f0-11bf-42ad-a1f0-ed657bc12965">85</ix:nonFraction>&#160;million during fiscal 2020;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.13pt">restructuring and employee severance;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.13pt">amortization and other acquisition-related costs;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.13pt">impairments and (gain)/loss on disposal of assets; in connection with the divestiture of the Cordis business, we recognized a $<ix:nonFraction unitRef="usd" contextRef="i2ae0fa0d058b4f21aac5c8701cbd2fb7_I20210630" decimals="-6" sign="-" format="ixt:numdotdecimal" name="cah:WriteDownOfAssetsHeldForSale" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTQvZnJhZzo3OWNmN2IxZmM4OTI0ODhkYjBjZTZhNDYxZmMyNjIzNC90ZXh0cmVnaW9uOjc5Y2Y3YjFmYzg5MjQ4OGRiMGNlNmE0NjFmYzI2MjM0XzEyMDk0NjI3OTE0NzM1_a39c35cc-26f6-469f-be2c-86c121fa736b">60</ix:nonFraction> million pre-tax write-down of the net assets held for sale</span><span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:13pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">during fiscal 2021; in connection with the naviHealth divestiture discussed in </span><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i4f0ec56b9c604f1782a65ea4a19c284d_106">Note 2</a></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, we recognized a pre-tax gain of $<ix:nonFraction unitRef="usd" contextRef="i00a6d666bf604826b24e68ddbd63eac4_D20180701-20190630" decimals="-6" format="ixt:numdotdecimal" name="cah:PreTaxGainonDivestiture" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTQvZnJhZzo3OWNmN2IxZmM4OTI0ODhkYjBjZTZhNDYxZmMyNjIzNC90ZXh0cmVnaW9uOjc5Y2Y3YjFmYzg5MjQ4OGRiMGNlNmE0NjFmYzI2MjM0XzEyMDk0NjI3OTE2NDc5_e1ed3fce-d0e9-4227-ae77-b20abda7b42f">508</ix:nonFraction> million during fiscal 2019;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.13pt">litigation (recoveries)/charges, net; in connection with the opioid litigation as discussed further in </span><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i4f0ec56b9c604f1782a65ea4a19c284d_130">Note 7</a></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, we recognized pre-tax charges of $<ix:nonFraction unitRef="usd" contextRef="id2a6b6641ae248c98d689f30c606f881_D20200701-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:GainLossRelatedToLitigationSettlement" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTQvZnJhZzo3OWNmN2IxZmM4OTI0ODhkYjBjZTZhNDYxZmMyNjIzNC90ZXh0cmVnaW9uOjc5Y2Y3YjFmYzg5MjQ4OGRiMGNlNmE0NjFmYzI2MjM0XzEyMDk0NjI3OTE1MTM2_fa04a4d2-d99c-4c13-92d5-b636406cf116">1.17</ix:nonFraction>&#160;billion and $<ix:nonFraction unitRef="usd" contextRef="i373ba6a0cdc044dea9602bdbad13174c_D20190701-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:GainLossRelatedToLitigationSettlement" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTQvZnJhZzo3OWNmN2IxZmM4OTI0ODhkYjBjZTZhNDYxZmMyNjIzNC90ZXh0cmVnaW9uOjc5Y2Y3YjFmYzg5MjQ4OGRiMGNlNmE0NjFmYzI2MjM0XzEyMDk0NjI3OTE1MTQ1_1a313f61-c937-4037-8038-233b7a976d14">5.63</ix:nonFraction>&#160;billion</span><span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:13pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">during fiscal 2021 and 2020, respectively;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.13pt">state opioid assessment related to prior fiscal years; in connection with the New York Opioid Stewardship Act as discussed further in </span><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i4f0ec56b9c604f1782a65ea4a19c284d_130">Note 7</a></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, we recognized a pre-tax charge of $<ix:nonFraction unitRef="usd" contextRef="i457f80b8744948758645272a98e06c10_D20200701-20210630" decimals="-6" format="ixt:numdotdecimal" name="cah:EstimatedLiabilityForNewYorkOpioidStewardshipAct" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTQvZnJhZzo3OWNmN2IxZmM4OTI0ODhkYjBjZTZhNDYxZmMyNjIzNC90ZXh0cmVnaW9uOjc5Y2Y3YjFmYzg5MjQ4OGRiMGNlNmE0NjFmYzI2MjM0XzEyMDk0NjI3OTE1NTQx_bdd45fc0-f43f-4ecc-ab36-9831321fbbc8">41</ix:nonFraction>&#160;million during fiscal 2021, related to calendar years 2017 and 2018 assessments;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.13pt">other (income)/expense, net;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.13pt">interest expense, net;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.13pt">loss on early extinguishment of debt;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.13pt">(gain)/loss on sale of equity interest in naviHealth; in connection with the sale of our remaining equity interest in a partnership that owned naviHealth as discussed in </span><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i4f0ec56b9c604f1782a65ea4a19c284d_106">Note 2</a></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, we recognized a $<ix:nonFraction unitRef="usd" contextRef="if5b3bab2d32340dea26c681d53110711_D20190701-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:GainOnSaleOfInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTQvZnJhZzo3OWNmN2IxZmM4OTI0ODhkYjBjZTZhNDYxZmMyNjIzNC90ZXh0cmVnaW9uOjc5Y2Y3YjFmYzg5MjQ4OGRiMGNlNmE0NjFmYzI2MjM0XzEyMDk0NjI3OTE2ODI4_13e3d38e-6296-40e2-81da-9180e950e86f">579</ix:nonFraction>&#160;million pre-tax gain ($<ix:nonFraction unitRef="usd" contextRef="if5b3bab2d32340dea26c681d53110711_D20190701-20200630" decimals="-6" format="ixt:numdotdecimal" name="cah:GainonDivestitureAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTQvZnJhZzo3OWNmN2IxZmM4OTI0ODhkYjBjZTZhNDYxZmMyNjIzNC90ZXh0cmVnaW9uOjc5Y2Y3YjFmYzg5MjQ4OGRiMGNlNmE0NjFmYzI2MjM0XzEyMDk0NjI3OTE2ODQ2_c27bde83-c24a-4937-b09f-458ad707e5e8">493</ix:nonFraction> million after tax) during fiscal 2020;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.13pt">provision for/(benefit from) income taxes </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, certain investment spending, certain portions of enterprise-wide incentive compensation and other spending are not allocated to the segments. Investment spending generally </span></div></div></ix:continuation></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:3pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.222%"><tr><td style="width:1.0%"></td><td style="width:32.133%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.433%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.134%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">84</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardinal Health </span><span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">| </span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2021 Form 10-K</span></div></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:3pt"><span><br/></span></div><div style="margin-bottom:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:24.682%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:50.911%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.107%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#e41f35;border-bottom:1pt solid #e41f35;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Notes to Financial Statements</span></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:3pt;text-align:justify"><span><br/></span></div></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:48.214%"><ix:continuation id="i0da9a4e146934a058a0a4a1d31a86b49"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">includes the first-year spend for certain projects that require incremental investments in the form of additional operating expenses. Because approval for these projects is dependent on executive management, we retain these expenses at Corporate. Investment spending within Corporate was $<ix:nonFraction unitRef="usd" contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630" decimals="-6" format="ixt:numdotdecimal" name="cah:ProjectCostsOnInvestmentAndOtherSpending" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTQvZnJhZzo3OWNmN2IxZmM4OTI0ODhkYjBjZTZhNDYxZmMyNjIzNC90ZXh0cmVnaW9uOjc5Y2Y3YjFmYzg5MjQ4OGRiMGNlNmE0NjFmYzI2MjM0XzQ2ODg_b5419a98-6728-41a5-9da8-17197d5e41b4">27</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="ia31e9a409b874bb19d0ff6f2f39ecc09_D20190701-20200630" decimals="-6" format="ixt:numdotdecimal" name="cah:ProjectCostsOnInvestmentAndOtherSpending" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTQvZnJhZzo3OWNmN2IxZmM4OTI0ODhkYjBjZTZhNDYxZmMyNjIzNC90ZXh0cmVnaW9uOjc5Y2Y3YjFmYzg5MjQ4OGRiMGNlNmE0NjFmYzI2MjM0XzQ2OTI_a615bd56-d3d9-4a8b-b24d-ea6aed1bd3b8">69</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i00a6d666bf604826b24e68ddbd63eac4_D20180701-20190630" decimals="-6" format="ixt:numdotdecimal" name="cah:ProjectCostsOnInvestmentAndOtherSpending" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTQvZnJhZzo3OWNmN2IxZmM4OTI0ODhkYjBjZTZhNDYxZmMyNjIzNC90ZXh0cmVnaW9uOjc5Y2Y3YjFmYzg5MjQ4OGRiMGNlNmE0NjFmYzI2MjM0XzQ2OTk_d9e0e203-72d0-4df2-b082-b90f5c976daa">55</ix:nonFraction> million for fiscal 2021, 2020 and 2019, respectively. </span></div><ix:nonNumeric contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630" name="us-gaap:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTQvZnJhZzo3OWNmN2IxZmM4OTI0ODhkYjBjZTZhNDYxZmMyNjIzNC90ZXh0cmVnaW9uOjc5Y2Y3YjFmYzg5MjQ4OGRiMGNlNmE0NjFmYzI2MjM0XzYwMjY_2a2ffd9c-baaa-4f1d-bee9-833f14281fa4" escape="true"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables present segment profit by reportable segment and Corporate:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.691%"><tr><td style="width:1.0%"></td><td style="width:51.221%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.451%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.347%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.760%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.347%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.074%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Pharmaceutical</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i76b6a114dfd6424fb4c07d91075a91ff_D20200701-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTQvZnJhZzo3OWNmN2IxZmM4OTI0ODhkYjBjZTZhNDYxZmMyNjIzNC90YWJsZTo4Yzg1NWU1ZThkNzM0NjAyODY3NmYyMDQ5MDhmMmE2MS90YWJsZXJhbmdlOjhjODU1ZTVlOGQ3MzQ2MDI4Njc2ZjIwNDkwOGYyYTYxXzEtMS0xLTEtMA_3fdfaea3-0ed7-4a59-b23c-6f7c5c06f7cd">1,684</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i78632f0315fd45fb85ed1c2272933a36_D20190701-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTQvZnJhZzo3OWNmN2IxZmM4OTI0ODhkYjBjZTZhNDYxZmMyNjIzNC90YWJsZTo4Yzg1NWU1ZThkNzM0NjAyODY3NmYyMDQ5MDhmMmE2MS90YWJsZXJhbmdlOjhjODU1ZTVlOGQ3MzQ2MDI4Njc2ZjIwNDkwOGYyYTYxXzEtMy0xLTEtMA_485b958b-6552-4cc6-8bc4-4307bb692c54">1,753</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d7435bb60af47f4a69d23c973a60d43_D20180701-20190630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTQvZnJhZzo3OWNmN2IxZmM4OTI0ODhkYjBjZTZhNDYxZmMyNjIzNC90YWJsZTo4Yzg1NWU1ZThkNzM0NjAyODY3NmYyMDQ5MDhmMmE2MS90YWJsZXJhbmdlOjhjODU1ZTVlOGQ3MzQ2MDI4Njc2ZjIwNDkwOGYyYTYxXzEtNS0xLTEtMA_86ee69cc-9d24-4b53-92b7-42ca0ba6d15f">1,834</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Medical</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id8c82c11050f452c9befaa43705026a6_D20200701-20210630" decimals="-6" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTQvZnJhZzo3OWNmN2IxZmM4OTI0ODhkYjBjZTZhNDYxZmMyNjIzNC90YWJsZTo4Yzg1NWU1ZThkNzM0NjAyODY3NmYyMDQ5MDhmMmE2MS90YWJsZXJhbmdlOjhjODU1ZTVlOGQ3MzQ2MDI4Njc2ZjIwNDkwOGYyYTYxXzItMS0xLTEtMA_17c8fe16-a6d9-4b69-a5ae-e76ea38d5c55">577</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1faf47ea4d994e879fd1c1bf2cc15983_D20190701-20200630" decimals="-6" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTQvZnJhZzo3OWNmN2IxZmM4OTI0ODhkYjBjZTZhNDYxZmMyNjIzNC90YWJsZTo4Yzg1NWU1ZThkNzM0NjAyODY3NmYyMDQ5MDhmMmE2MS90YWJsZXJhbmdlOjhjODU1ZTVlOGQ3MzQ2MDI4Njc2ZjIwNDkwOGYyYTYxXzItMy0xLTEtMA_5d592b6a-36eb-47b8-8690-fc806ce1c452">663</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4dcc4f5896f24eb98e3473b71e1d10b7_D20180701-20190630" decimals="-6" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTQvZnJhZzo3OWNmN2IxZmM4OTI0ODhkYjBjZTZhNDYxZmMyNjIzNC90YWJsZTo4Yzg1NWU1ZThkNzM0NjAyODY3NmYyMDQ5MDhmMmE2MS90YWJsZXJhbmdlOjhjODU1ZTVlOGQ3MzQ2MDI4Njc2ZjIwNDkwOGYyYTYxXzItNS0xLTEtMA_afe49f3c-4b63-47ae-bff2-9edff9101a85">576</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total segment profit</span></td><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie5f1ec6cee11430ab0571ee6201cd0f7_D20200701-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTQvZnJhZzo3OWNmN2IxZmM4OTI0ODhkYjBjZTZhNDYxZmMyNjIzNC90YWJsZTo4Yzg1NWU1ZThkNzM0NjAyODY3NmYyMDQ5MDhmMmE2MS90YWJsZXJhbmdlOjhjODU1ZTVlOGQ3MzQ2MDI4Njc2ZjIwNDkwOGYyYTYxXzMtMS0xLTEtMA_d15fd05d-1fde-4a58-82ac-3827b5c6012a">2,261</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7a96c8334d2e46928c83a274df8be377_D20190701-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTQvZnJhZzo3OWNmN2IxZmM4OTI0ODhkYjBjZTZhNDYxZmMyNjIzNC90YWJsZTo4Yzg1NWU1ZThkNzM0NjAyODY3NmYyMDQ5MDhmMmE2MS90YWJsZXJhbmdlOjhjODU1ZTVlOGQ3MzQ2MDI4Njc2ZjIwNDkwOGYyYTYxXzMtMy0xLTEtMA_bcd27fe4-d28d-4b7c-b965-53b127949fde">2,416</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ab52d1ad77045aa97d1dbfb8cb6186e_D20180701-20190630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTQvZnJhZzo3OWNmN2IxZmM4OTI0ODhkYjBjZTZhNDYxZmMyNjIzNC90YWJsZTo4Yzg1NWU1ZThkNzM0NjAyODY3NmYyMDQ5MDhmMmE2MS90YWJsZXJhbmdlOjhjODU1ZTVlOGQ3MzQ2MDI4Njc2ZjIwNDkwOGYyYTYxXzMtNS0xLTEtMA_fce0ba17-945d-4685-90dc-898ffdfbdd74">2,410</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Corporate</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i792ece330cb74d35afecabca6b7f49ea_D20200701-20210630" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTQvZnJhZzo3OWNmN2IxZmM4OTI0ODhkYjBjZTZhNDYxZmMyNjIzNC90YWJsZTo4Yzg1NWU1ZThkNzM0NjAyODY3NmYyMDQ5MDhmMmE2MS90YWJsZXJhbmdlOjhjODU1ZTVlOGQ3MzQ2MDI4Njc2ZjIwNDkwOGYyYTYxXzQtMS0xLTEtMA_2e3bc6af-f979-4056-b9b4-df9e29de841c">1,789</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i16818ee6ea724c8691b1f0065031735b_D20190701-20200630" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTQvZnJhZzo3OWNmN2IxZmM4OTI0ODhkYjBjZTZhNDYxZmMyNjIzNC90YWJsZTo4Yzg1NWU1ZThkNzM0NjAyODY3NmYyMDQ5MDhmMmE2MS90YWJsZXJhbmdlOjhjODU1ZTVlOGQ3MzQ2MDI4Njc2ZjIwNDkwOGYyYTYxXzQtMy0xLTEtMA_9d02ca00-19e3-445a-95ae-1bdb025c9d56">6,514</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic5128c57d92d4336ae115d6ba4e979cb_D20180701-20190630" decimals="-6" sign="-" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTQvZnJhZzo3OWNmN2IxZmM4OTI0ODhkYjBjZTZhNDYxZmMyNjIzNC90YWJsZTo4Yzg1NWU1ZThkNzM0NjAyODY3NmYyMDQ5MDhmMmE2MS90YWJsZXJhbmdlOjhjODU1ZTVlOGQ3MzQ2MDI4Njc2ZjIwNDkwOGYyYTYxXzQtNS0xLTEtMA_7cb1a13e-7acc-42d7-8552-3fa0a924a8de">350</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total operating earnings</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630" decimals="-6" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTQvZnJhZzo3OWNmN2IxZmM4OTI0ODhkYjBjZTZhNDYxZmMyNjIzNC90YWJsZTo4Yzg1NWU1ZThkNzM0NjAyODY3NmYyMDQ5MDhmMmE2MS90YWJsZXJhbmdlOjhjODU1ZTVlOGQ3MzQ2MDI4Njc2ZjIwNDkwOGYyYTYxXzUtMS0xLTEtMA_b88216f7-fc16-4820-af72-ff2ae667a4ec">472</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia31e9a409b874bb19d0ff6f2f39ecc09_D20190701-20200630" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTQvZnJhZzo3OWNmN2IxZmM4OTI0ODhkYjBjZTZhNDYxZmMyNjIzNC90YWJsZTo4Yzg1NWU1ZThkNzM0NjAyODY3NmYyMDQ5MDhmMmE2MS90YWJsZXJhbmdlOjhjODU1ZTVlOGQ3MzQ2MDI4Njc2ZjIwNDkwOGYyYTYxXzUtMy0xLTEtMA_dc479f95-16da-4cf6-b359-c0093ecd890b">4,098</ix:nonFraction>)</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i00a6d666bf604826b24e68ddbd63eac4_D20180701-20190630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTQvZnJhZzo3OWNmN2IxZmM4OTI0ODhkYjBjZTZhNDYxZmMyNjIzNC90YWJsZTo4Yzg1NWU1ZThkNzM0NjAyODY3NmYyMDQ5MDhmMmE2MS90YWJsZXJhbmdlOjhjODU1ZTVlOGQ3MzQ2MDI4Njc2ZjIwNDkwOGYyYTYxXzUtNS0xLTEtMA_eef02984-c29e-4200-8c56-1ceaf77e8c40">2,060</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><ix:nonNumeric contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630" name="us-gaap:ReconciliationOfOtherSignificantReconcilingItemsFromSegmentsToConsolidatedTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTQvZnJhZzo3OWNmN2IxZmM4OTI0ODhkYjBjZTZhNDYxZmMyNjIzNC90ZXh0cmVnaW9uOjc5Y2Y3YjFmYzg5MjQ4OGRiMGNlNmE0NjFmYzI2MjM0XzYwMjM_3a385a29-7244-46b7-84f2-3dcc7d38c6d0" escape="true"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables present depreciation and amortization and additions to property and equipment by reportable segment and Corporate:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.691%"><tr><td style="width:1.0%"></td><td style="width:47.506%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.999%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.347%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.999%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.347%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.002%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Pharmaceutical</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i76b6a114dfd6424fb4c07d91075a91ff_D20200701-20210630" decimals="-6" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTQvZnJhZzo3OWNmN2IxZmM4OTI0ODhkYjBjZTZhNDYxZmMyNjIzNC90YWJsZTpkN2JhMmI3YjA2ZjA0OGU4YjY2ZDE5NzUwZDRiNWYzMC90YWJsZXJhbmdlOmQ3YmEyYjdiMDZmMDQ4ZThiNjZkMTk3NTBkNGI1ZjMwXzEtMS0xLTEtMA_3b796f63-e7f8-4de4-b6ef-c8386519e521">151</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i78632f0315fd45fb85ed1c2272933a36_D20190701-20200630" decimals="-6" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTQvZnJhZzo3OWNmN2IxZmM4OTI0ODhkYjBjZTZhNDYxZmMyNjIzNC90YWJsZTpkN2JhMmI3YjA2ZjA0OGU4YjY2ZDE5NzUwZDRiNWYzMC90YWJsZXJhbmdlOmQ3YmEyYjdiMDZmMDQ4ZThiNjZkMTk3NTBkNGI1ZjMwXzEtMy0xLTEtMA_ebd2ae2d-49d8-4266-9dd7-b7f57bb19fd0">135</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d7435bb60af47f4a69d23c973a60d43_D20180701-20190630" decimals="-6" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTQvZnJhZzo3OWNmN2IxZmM4OTI0ODhkYjBjZTZhNDYxZmMyNjIzNC90YWJsZTpkN2JhMmI3YjA2ZjA0OGU4YjY2ZDE5NzUwZDRiNWYzMC90YWJsZXJhbmdlOmQ3YmEyYjdiMDZmMDQ4ZThiNjZkMTk3NTBkNGI1ZjMwXzEtNS0xLTEtMA_ffc1ed07-7a68-41bc-bcab-1d3f8b343436">147</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Medical</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id8c82c11050f452c9befaa43705026a6_D20200701-20210630" decimals="-6" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTQvZnJhZzo3OWNmN2IxZmM4OTI0ODhkYjBjZTZhNDYxZmMyNjIzNC90YWJsZTpkN2JhMmI3YjA2ZjA0OGU4YjY2ZDE5NzUwZDRiNWYzMC90YWJsZXJhbmdlOmQ3YmEyYjdiMDZmMDQ4ZThiNjZkMTk3NTBkNGI1ZjMwXzItMS0xLTEtMA_1e3fc59b-3187-43a3-947f-58f102a05145">226</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1faf47ea4d994e879fd1c1bf2cc15983_D20190701-20200630" decimals="-6" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTQvZnJhZzo3OWNmN2IxZmM4OTI0ODhkYjBjZTZhNDYxZmMyNjIzNC90YWJsZTpkN2JhMmI3YjA2ZjA0OGU4YjY2ZDE5NzUwZDRiNWYzMC90YWJsZXJhbmdlOmQ3YmEyYjdiMDZmMDQ4ZThiNjZkMTk3NTBkNGI1ZjMwXzItMy0xLTEtMA_7e885987-d090-4f00-9c14-d17269c2291a">243</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4dcc4f5896f24eb98e3473b71e1d10b7_D20180701-20190630" decimals="-6" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTQvZnJhZzo3OWNmN2IxZmM4OTI0ODhkYjBjZTZhNDYxZmMyNjIzNC90YWJsZTpkN2JhMmI3YjA2ZjA0OGU4YjY2ZDE5NzUwZDRiNWYzMC90YWJsZXJhbmdlOmQ3YmEyYjdiMDZmMDQ4ZThiNjZkMTk3NTBkNGI1ZjMwXzItNS0xLTEtMA_b3642999-0d28-41c1-a275-2ae333b07f71">288</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Corporate</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i792ece330cb74d35afecabca6b7f49ea_D20200701-20210630" decimals="-6" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTQvZnJhZzo3OWNmN2IxZmM4OTI0ODhkYjBjZTZhNDYxZmMyNjIzNC90YWJsZTpkN2JhMmI3YjA2ZjA0OGU4YjY2ZDE5NzUwZDRiNWYzMC90YWJsZXJhbmdlOmQ3YmEyYjdiMDZmMDQ4ZThiNjZkMTk3NTBkNGI1ZjMwXzMtMS0xLTEtMA_1c7f4ea7-6b42-45b4-93b5-9a53aa9083e6">406</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i16818ee6ea724c8691b1f0065031735b_D20190701-20200630" decimals="-6" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTQvZnJhZzo3OWNmN2IxZmM4OTI0ODhkYjBjZTZhNDYxZmMyNjIzNC90YWJsZTpkN2JhMmI3YjA2ZjA0OGU4YjY2ZDE5NzUwZDRiNWYzMC90YWJsZXJhbmdlOmQ3YmEyYjdiMDZmMDQ4ZThiNjZkMTk3NTBkNGI1ZjMwXzMtMy0xLTEtMA_dce572cc-9e10-4d7e-b3dd-5fd20204fd5b">535</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5128c57d92d4336ae115d6ba4e979cb_D20180701-20190630" decimals="-6" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTQvZnJhZzo3OWNmN2IxZmM4OTI0ODhkYjBjZTZhNDYxZmMyNjIzNC90YWJsZTpkN2JhMmI3YjA2ZjA0OGU4YjY2ZDE5NzUwZDRiNWYzMC90YWJsZXJhbmdlOmQ3YmEyYjdiMDZmMDQ4ZThiNjZkMTk3NTBkNGI1ZjMwXzMtNS0xLTEtMA_bc2a522e-343a-48ee-a219-d550b1b4e0e2">565</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total depreciation and amortization</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630" decimals="-6" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTQvZnJhZzo3OWNmN2IxZmM4OTI0ODhkYjBjZTZhNDYxZmMyNjIzNC90YWJsZTpkN2JhMmI3YjA2ZjA0OGU4YjY2ZDE5NzUwZDRiNWYzMC90YWJsZXJhbmdlOmQ3YmEyYjdiMDZmMDQ4ZThiNjZkMTk3NTBkNGI1ZjMwXzQtMS0xLTEtMA_1927365d-82e8-42c5-b21a-9ef917dcbb66">783</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia31e9a409b874bb19d0ff6f2f39ecc09_D20190701-20200630" decimals="-6" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTQvZnJhZzo3OWNmN2IxZmM4OTI0ODhkYjBjZTZhNDYxZmMyNjIzNC90YWJsZTpkN2JhMmI3YjA2ZjA0OGU4YjY2ZDE5NzUwZDRiNWYzMC90YWJsZXJhbmdlOmQ3YmEyYjdiMDZmMDQ4ZThiNjZkMTk3NTBkNGI1ZjMwXzQtMy0xLTEtMA_342a3b0e-e5f4-4b40-99b3-2029c1332838">913</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i00a6d666bf604826b24e68ddbd63eac4_D20180701-20190630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTQvZnJhZzo3OWNmN2IxZmM4OTI0ODhkYjBjZTZhNDYxZmMyNjIzNC90YWJsZTpkN2JhMmI3YjA2ZjA0OGU4YjY2ZDE5NzUwZDRiNWYzMC90YWJsZXJhbmdlOmQ3YmEyYjdiMDZmMDQ4ZThiNjZkMTk3NTBkNGI1ZjMwXzQtNS0xLTEtMA_228ae087-f1f1-48f6-a155-6a73c98e3cb8">1,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.691%"><tr><td style="width:1.0%"></td><td style="width:47.506%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.999%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.347%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.999%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.347%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.002%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Pharmaceutical</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i76b6a114dfd6424fb4c07d91075a91ff_D20200701-20210630" decimals="-6" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTQvZnJhZzo3OWNmN2IxZmM4OTI0ODhkYjBjZTZhNDYxZmMyNjIzNC90YWJsZTpjNjg2ZDI0YzJiZmE0ZmM4OTkxM2RlMmZjODFhNDY2YS90YWJsZXJhbmdlOmM2ODZkMjRjMmJmYTRmYzg5OTEzZGUyZmM4MWE0NjZhXzEtMS0xLTEtMA_07ceaf45-a245-4b2e-9237-7651386613cc">55</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i78632f0315fd45fb85ed1c2272933a36_D20190701-20200630" decimals="-6" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTQvZnJhZzo3OWNmN2IxZmM4OTI0ODhkYjBjZTZhNDYxZmMyNjIzNC90YWJsZTpjNjg2ZDI0YzJiZmE0ZmM4OTkxM2RlMmZjODFhNDY2YS90YWJsZXJhbmdlOmM2ODZkMjRjMmJmYTRmYzg5OTEzZGUyZmM4MWE0NjZhXzEtMy0xLTEtMA_19118a8a-b657-4d70-9b83-9bbb74daa555">47</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d7435bb60af47f4a69d23c973a60d43_D20180701-20190630" decimals="-6" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTQvZnJhZzo3OWNmN2IxZmM4OTI0ODhkYjBjZTZhNDYxZmMyNjIzNC90YWJsZTpjNjg2ZDI0YzJiZmE0ZmM4OTkxM2RlMmZjODFhNDY2YS90YWJsZXJhbmdlOmM2ODZkMjRjMmJmYTRmYzg5OTEzZGUyZmM4MWE0NjZhXzEtNS0xLTEtMA_bff80207-2c3d-402e-87d2-d6c523f9a98c">35</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Medical</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id8c82c11050f452c9befaa43705026a6_D20200701-20210630" decimals="-6" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTQvZnJhZzo3OWNmN2IxZmM4OTI0ODhkYjBjZTZhNDYxZmMyNjIzNC90YWJsZTpjNjg2ZDI0YzJiZmE0ZmM4OTkxM2RlMmZjODFhNDY2YS90YWJsZXJhbmdlOmM2ODZkMjRjMmJmYTRmYzg5OTEzZGUyZmM4MWE0NjZhXzItMS0xLTEtMA_8b4a8235-51c8-4051-8ec2-464a6991d7d3">97</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1faf47ea4d994e879fd1c1bf2cc15983_D20190701-20200630" decimals="-6" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTQvZnJhZzo3OWNmN2IxZmM4OTI0ODhkYjBjZTZhNDYxZmMyNjIzNC90YWJsZTpjNjg2ZDI0YzJiZmE0ZmM4OTkxM2RlMmZjODFhNDY2YS90YWJsZXJhbmdlOmM2ODZkMjRjMmJmYTRmYzg5OTEzZGUyZmM4MWE0NjZhXzItMy0xLTEtMA_ae8c5bac-1e5a-4a7f-a7df-004ed47b4509">86</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4dcc4f5896f24eb98e3473b71e1d10b7_D20180701-20190630" decimals="-6" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTQvZnJhZzo3OWNmN2IxZmM4OTI0ODhkYjBjZTZhNDYxZmMyNjIzNC90YWJsZTpjNjg2ZDI0YzJiZmE0ZmM4OTkxM2RlMmZjODFhNDY2YS90YWJsZXJhbmdlOmM2ODZkMjRjMmJmYTRmYzg5OTEzZGUyZmM4MWE0NjZhXzItNS0xLTEtMA_15ae8a9a-faf5-408c-b675-3f7df150c7e2">74</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Corporate</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i792ece330cb74d35afecabca6b7f49ea_D20200701-20210630" decimals="-6" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTQvZnJhZzo3OWNmN2IxZmM4OTI0ODhkYjBjZTZhNDYxZmMyNjIzNC90YWJsZTpjNjg2ZDI0YzJiZmE0ZmM4OTkxM2RlMmZjODFhNDY2YS90YWJsZXJhbmdlOmM2ODZkMjRjMmJmYTRmYzg5OTEzZGUyZmM4MWE0NjZhXzMtMS0xLTEtMA_dc12ffec-4ada-44bc-bc6c-a1f997fd84af">248</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i16818ee6ea724c8691b1f0065031735b_D20190701-20200630" decimals="-6" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTQvZnJhZzo3OWNmN2IxZmM4OTI0ODhkYjBjZTZhNDYxZmMyNjIzNC90YWJsZTpjNjg2ZDI0YzJiZmE0ZmM4OTkxM2RlMmZjODFhNDY2YS90YWJsZXJhbmdlOmM2ODZkMjRjMmJmYTRmYzg5OTEzZGUyZmM4MWE0NjZhXzMtMy0xLTEtMA_4710ebbf-5db8-4a7e-83fa-dba760078a41">242</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5128c57d92d4336ae115d6ba4e979cb_D20180701-20190630" decimals="-6" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTQvZnJhZzo3OWNmN2IxZmM4OTI0ODhkYjBjZTZhNDYxZmMyNjIzNC90YWJsZTpjNjg2ZDI0YzJiZmE0ZmM4OTkxM2RlMmZjODFhNDY2YS90YWJsZXJhbmdlOmM2ODZkMjRjMmJmYTRmYzg5OTEzZGUyZmM4MWE0NjZhXzMtNS0xLTEtMA_49e45eb9-a328-44d5-9e44-e902e62bc956">219</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total additions to property and equipment</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630" decimals="-6" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTQvZnJhZzo3OWNmN2IxZmM4OTI0ODhkYjBjZTZhNDYxZmMyNjIzNC90YWJsZTpjNjg2ZDI0YzJiZmE0ZmM4OTkxM2RlMmZjODFhNDY2YS90YWJsZXJhbmdlOmM2ODZkMjRjMmJmYTRmYzg5OTEzZGUyZmM4MWE0NjZhXzQtMS0xLTEtMA_4e0358f3-0203-4ca2-9a0c-bb9635fec031">400</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia31e9a409b874bb19d0ff6f2f39ecc09_D20190701-20200630" decimals="-6" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTQvZnJhZzo3OWNmN2IxZmM4OTI0ODhkYjBjZTZhNDYxZmMyNjIzNC90YWJsZTpjNjg2ZDI0YzJiZmE0ZmM4OTkxM2RlMmZjODFhNDY2YS90YWJsZXJhbmdlOmM2ODZkMjRjMmJmYTRmYzg5OTEzZGUyZmM4MWE0NjZhXzQtMy0xLTEtMA_daa0d9a7-f20d-47a2-af89-7399724fd79d">375</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i00a6d666bf604826b24e68ddbd63eac4_D20180701-20190630" decimals="-6" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTQvZnJhZzo3OWNmN2IxZmM4OTI0ODhkYjBjZTZhNDYxZmMyNjIzNC90YWJsZTpjNjg2ZDI0YzJiZmE0ZmM4OTkxM2RlMmZjODFhNDY2YS90YWJsZXJhbmdlOmM2ODZkMjRjMmJmYTRmYzg5OTEzZGUyZmM4MWE0NjZhXzQtNS0xLTEtMA_4d43379a-df37-4a03-b0db-db51be43574a">328</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><ix:nonNumeric contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630" name="us-gaap:ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTQvZnJhZzo3OWNmN2IxZmM4OTI0ODhkYjBjZTZhNDYxZmMyNjIzNC90ZXh0cmVnaW9uOjc5Y2Y3YjFmYzg5MjQ4OGRiMGNlNmE0NjFmYzI2MjM0XzU5ODM_bc1a741d-3394-4ae7-bc29-693185c2b386" escape="true"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents total assets for each reportable segment and Corporate at June 30:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.691%"><tr><td style="width:1.0%"></td><td style="width:46.887%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.547%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.347%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.547%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.347%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.525%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Pharmaceutical</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6e8acb06a2eb434ab88bfebe2a6d8a18_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Assets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTQvZnJhZzo3OWNmN2IxZmM4OTI0ODhkYjBjZTZhNDYxZmMyNjIzNC90YWJsZTpkOGY5NzBiNDBlODU0MTM3OTgwZTMzZWI3MjA4ZTg2ZC90YWJsZXJhbmdlOmQ4Zjk3MGI0MGU4NTQxMzc5ODBlMzNlYjcyMDhlODZkXzEtMS0xLTEtMA_60d91d1f-f723-4d16-9354-431262fa61b2">23,624</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia8a118e953bd4d1f9600cde58c7b110c_I20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Assets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTQvZnJhZzo3OWNmN2IxZmM4OTI0ODhkYjBjZTZhNDYxZmMyNjIzNC90YWJsZTpkOGY5NzBiNDBlODU0MTM3OTgwZTMzZWI3MjA4ZTg2ZC90YWJsZXJhbmdlOmQ4Zjk3MGI0MGU4NTQxMzc5ODBlMzNlYjcyMDhlODZkXzEtMy0xLTEtMA_83b724ea-e197-42ee-abb4-3b7b52824029">22,398</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i776ad5c7cad44d45a8cbf169d5b49ea5_I20190630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Assets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTQvZnJhZzo3OWNmN2IxZmM4OTI0ODhkYjBjZTZhNDYxZmMyNjIzNC90YWJsZTpkOGY5NzBiNDBlODU0MTM3OTgwZTMzZWI3MjA4ZTg2ZC90YWJsZXJhbmdlOmQ4Zjk3MGI0MGU4NTQxMzc5ODBlMzNlYjcyMDhlODZkXzEtNS0xLTEtMA_897e6854-0ca5-4af7-9c48-3d4ccf14b61b">22,446</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Medical (1)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1395a9d318334a7bbf4965e8f0833f2b_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Assets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTQvZnJhZzo3OWNmN2IxZmM4OTI0ODhkYjBjZTZhNDYxZmMyNjIzNC90YWJsZTpkOGY5NzBiNDBlODU0MTM3OTgwZTMzZWI3MjA4ZTg2ZC90YWJsZXJhbmdlOmQ4Zjk3MGI0MGU4NTQxMzc5ODBlMzNlYjcyMDhlODZkXzItMS0xLTEtMA_51836d29-1dd5-45f9-8738-db09e5f864c1">15,408</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2921a9a3e731468c9171a26f22574eba_I20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Assets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTQvZnJhZzo3OWNmN2IxZmM4OTI0ODhkYjBjZTZhNDYxZmMyNjIzNC90YWJsZTpkOGY5NzBiNDBlODU0MTM3OTgwZTMzZWI3MjA4ZTg2ZC90YWJsZXJhbmdlOmQ4Zjk3MGI0MGU4NTQxMzc5ODBlMzNlYjcyMDhlODZkXzItMy0xLTEtMA_eddbbb16-59d9-4f92-a271-13be42716081">14,691</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2dbe5e7ed6284e6ba51e84d62ff6f50d_I20190630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Assets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTQvZnJhZzo3OWNmN2IxZmM4OTI0ODhkYjBjZTZhNDYxZmMyNjIzNC90YWJsZTpkOGY5NzBiNDBlODU0MTM3OTgwZTMzZWI3MjA4ZTg2ZC90YWJsZXJhbmdlOmQ4Zjk3MGI0MGU4NTQxMzc5ODBlMzNlYjcyMDhlODZkXzItNS0xLTEtMA_fb0316a4-d2dd-4b34-8cea-bcf207e241b2">15,284</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Corporate</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8858cf546314492eb3e695791497ad0e_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Assets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTQvZnJhZzo3OWNmN2IxZmM4OTI0ODhkYjBjZTZhNDYxZmMyNjIzNC90YWJsZTpkOGY5NzBiNDBlODU0MTM3OTgwZTMzZWI3MjA4ZTg2ZC90YWJsZXJhbmdlOmQ4Zjk3MGI0MGU4NTQxMzc5ODBlMzNlYjcyMDhlODZkXzMtMS0xLTEtMA_31c7882f-a02c-4164-9771-14c1f6623fc2">5,421</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia1e90564105346fb9b66345306cd8bed_I20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Assets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTQvZnJhZzo3OWNmN2IxZmM4OTI0ODhkYjBjZTZhNDYxZmMyNjIzNC90YWJsZTpkOGY5NzBiNDBlODU0MTM3OTgwZTMzZWI3MjA4ZTg2ZC90YWJsZXJhbmdlOmQ4Zjk3MGI0MGU4NTQxMzc5ODBlMzNlYjcyMDhlODZkXzMtMy0xLTEtMA_a655ec89-e4f3-45d8-bfb0-4dcc551cb9fd">3,677</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia3e5b233ccea481cbde3ab011c52f4b7_I20190630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Assets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTQvZnJhZzo3OWNmN2IxZmM4OTI0ODhkYjBjZTZhNDYxZmMyNjIzNC90YWJsZTpkOGY5NzBiNDBlODU0MTM3OTgwZTMzZWI3MjA4ZTg2ZC90YWJsZXJhbmdlOmQ4Zjk3MGI0MGU4NTQxMzc5ODBlMzNlYjcyMDhlODZkXzMtNS0xLTEtMA_b198f1c1-97c4-4b80-9c8e-2de2dec3c862">3,233</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total assets</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2e87824102b34590a0208cc7da91b5f5_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Assets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTQvZnJhZzo3OWNmN2IxZmM4OTI0ODhkYjBjZTZhNDYxZmMyNjIzNC90YWJsZTpkOGY5NzBiNDBlODU0MTM3OTgwZTMzZWI3MjA4ZTg2ZC90YWJsZXJhbmdlOmQ4Zjk3MGI0MGU4NTQxMzc5ODBlMzNlYjcyMDhlODZkXzQtMS0xLTEtMA_56cba758-09bf-4b50-b298-d48783493a36">44,453</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i299cea70f47b4fbe96772aaa8cc00b79_I20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Assets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTQvZnJhZzo3OWNmN2IxZmM4OTI0ODhkYjBjZTZhNDYxZmMyNjIzNC90YWJsZTpkOGY5NzBiNDBlODU0MTM3OTgwZTMzZWI3MjA4ZTg2ZC90YWJsZXJhbmdlOmQ4Zjk3MGI0MGU4NTQxMzc5ODBlMzNlYjcyMDhlODZkXzQtMy0xLTEtMA_545c73f6-01b7-4514-85bf-6d26f58d2bc1">40,766</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if6dc09eec4e74751b47cdf037a5b1860_I20190630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Assets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTQvZnJhZzo3OWNmN2IxZmM4OTI0ODhkYjBjZTZhNDYxZmMyNjIzNC90YWJsZTpkOGY5NzBiNDBlODU0MTM3OTgwZTMzZWI3MjA4ZTg2ZC90YWJsZXJhbmdlOmQ4Zjk3MGI0MGU4NTQxMzc5ODBlMzNlYjcyMDhlODZkXzQtNS0xLTEtMA_5f46aee3-a00b-40c3-bd18-e47d3950b9c3">40,963</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:5pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Assets of $<ix:nonFraction unitRef="usd" contextRef="if49fcb6df2f04a0aa6c1338190b0051b_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperation" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTQvZnJhZzo3OWNmN2IxZmM4OTI0ODhkYjBjZTZhNDYxZmMyNjIzNC90ZXh0cmVnaW9uOjc5Y2Y3YjFmYzg5MjQ4OGRiMGNlNmE0NjFmYzI2MjM0XzI3NDg3NzkwNzg0Nzc_7da6973f-87dd-4fae-bf91-ca83d9577014">1.1</ix:nonFraction> billion classified as held for sale related to the Cordis divestiture were included within Medical at June&#160;30, 2021</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div></ix:nonNumeric><div style="margin-bottom:3pt;text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630" name="us-gaap:LongLivedAssetsByGeographicAreasTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTQvZnJhZzo3OWNmN2IxZmM4OTI0ODhkYjBjZTZhNDYxZmMyNjIzNC90ZXh0cmVnaW9uOjc5Y2Y3YjFmYzg5MjQ4OGRiMGNlNmE0NjFmYzI2MjM0XzU5OTg_9ad13db1-7a4c-489f-bb60-fff6bbdb26a1" escape="true"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables present property and equipment, net by geographic area:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.691%"><tr><td style="width:1.0%"></td><td style="width:46.887%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.547%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.347%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.547%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.347%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.525%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">United States</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieb5c5f04a3584568a0813006020736e0_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTQvZnJhZzo3OWNmN2IxZmM4OTI0ODhkYjBjZTZhNDYxZmMyNjIzNC90YWJsZTo1ZmM2YTUzMGE1OWE0ZDJkOTNkOTJmMDIyNmQ3YWViYS90YWJsZXJhbmdlOjVmYzZhNTMwYTU5YTRkMmQ5M2Q5MmYwMjI2ZDdhZWJhXzEtMS0xLTEtMA_02e63521-5b88-49f8-912a-da364c3f512c">1,958</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1c873da0bc8f4cfea1d6280c5bb54279_I20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTQvZnJhZzo3OWNmN2IxZmM4OTI0ODhkYjBjZTZhNDYxZmMyNjIzNC90YWJsZTo1ZmM2YTUzMGE1OWE0ZDJkOTNkOTJmMDIyNmQ3YWViYS90YWJsZXJhbmdlOjVmYzZhNTMwYTU5YTRkMmQ5M2Q5MmYwMjI2ZDdhZWJhXzEtMy0xLTEtMA_03afae22-2337-4a00-899c-3357c27347de">1,880</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ab941d8314b4dffa0444dc05ecc3315_I20190630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTQvZnJhZzo3OWNmN2IxZmM4OTI0ODhkYjBjZTZhNDYxZmMyNjIzNC90YWJsZTo1ZmM2YTUzMGE1OWE0ZDJkOTNkOTJmMDIyNmQ3YWViYS90YWJsZXJhbmdlOjVmYzZhNTMwYTU5YTRkMmQ5M2Q5MmYwMjI2ZDdhZWJhXzEtNS0xLTEtMA_5efecb7c-b16c-4969-9f35-cfab914f9009">1,846</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">International</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icd695cac6ddb4cbe8fd3520e0cdd88f2_I20210630" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTQvZnJhZzo3OWNmN2IxZmM4OTI0ODhkYjBjZTZhNDYxZmMyNjIzNC90YWJsZTo1ZmM2YTUzMGE1OWE0ZDJkOTNkOTJmMDIyNmQ3YWViYS90YWJsZXJhbmdlOjVmYzZhNTMwYTU5YTRkMmQ5M2Q5MmYwMjI2ZDdhZWJhXzItMS0xLTEtMA_1f2e4c9a-93be-4b36-9461-9e0b0135950a">402</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic6d6926b307941eea48b73ec840b45ba_I20200630" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTQvZnJhZzo3OWNmN2IxZmM4OTI0ODhkYjBjZTZhNDYxZmMyNjIzNC90YWJsZTo1ZmM2YTUzMGE1OWE0ZDJkOTNkOTJmMDIyNmQ3YWViYS90YWJsZXJhbmdlOjVmYzZhNTMwYTU5YTRkMmQ5M2Q5MmYwMjI2ZDdhZWJhXzItMy0xLTEtMA_7fd5b03c-6d76-4956-951c-e467a0957656">486</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5d8622203bb84c40af423bc2e4742dc2_I20190630" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTQvZnJhZzo3OWNmN2IxZmM4OTI0ODhkYjBjZTZhNDYxZmMyNjIzNC90YWJsZTo1ZmM2YTUzMGE1OWE0ZDJkOTNkOTJmMDIyNmQ3YWViYS90YWJsZXJhbmdlOjVmYzZhNTMwYTU5YTRkMmQ5M2Q5MmYwMjI2ZDdhZWJhXzItNS0xLTEtMA_57d1dc6d-a3ee-4557-adad-0613e366d9a7">510</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Property and equipment, net</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2e87824102b34590a0208cc7da91b5f5_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTQvZnJhZzo3OWNmN2IxZmM4OTI0ODhkYjBjZTZhNDYxZmMyNjIzNC90YWJsZTo1ZmM2YTUzMGE1OWE0ZDJkOTNkOTJmMDIyNmQ3YWViYS90YWJsZXJhbmdlOjVmYzZhNTMwYTU5YTRkMmQ5M2Q5MmYwMjI2ZDdhZWJhXzMtMS0xLTEtMA_f6e61643-c03d-4981-b0c7-0fe84d8d27be">2,360</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i299cea70f47b4fbe96772aaa8cc00b79_I20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTQvZnJhZzo3OWNmN2IxZmM4OTI0ODhkYjBjZTZhNDYxZmMyNjIzNC90YWJsZTo1ZmM2YTUzMGE1OWE0ZDJkOTNkOTJmMDIyNmQ3YWViYS90YWJsZXJhbmdlOjVmYzZhNTMwYTU5YTRkMmQ5M2Q5MmYwMjI2ZDdhZWJhXzMtMy0xLTEtMA_c0637a65-8247-4cac-9996-77b9631350ca">2,366</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if6dc09eec4e74751b47cdf037a5b1860_I20190630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTQvZnJhZzo3OWNmN2IxZmM4OTI0ODhkYjBjZTZhNDYxZmMyNjIzNC90YWJsZTo1ZmM2YTUzMGE1OWE0ZDJkOTNkOTJmMDIyNmQ3YWViYS90YWJsZXJhbmdlOjVmYzZhNTMwYTU5YTRkMmQ5M2Q5MmYwMjI2ZDdhZWJhXzMtNS0xLTEtMA_08013765-2c95-4375-bfbb-a4a4ed160b21">2,356</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation></div><div style="display:inline-block;max-width:3.571%;min-width:2.571%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:48.215%"><div id="i4f0ec56b9c604f1782a65ea4a19c284d_160"></div><ix:nonNumeric contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630" name="us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNjAvZnJhZzozYmFjYzZmYWNhNmU0ZTMyYTU0NmNjZjhmNzBmY2Y4Yy90ZXh0cmVnaW9uOjNiYWNjNmZhY2E2ZTRlMzJhNTQ2Y2NmOGY3MGZjZjhjXzQxODc_1f4254a9-d1be-4e75-8ccc-7fa34d3d0fe9" continuedAt="i1bb00b21ec4c41d984b95a36e1fae787" escape="true"><div style="margin-bottom:6pt;text-align:justify"><span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:13pt;font-weight:700;line-height:120%">14. Share-Based Compensation </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We maintain stock incentive plans (collectively, the &#8220;Plans&#8221;) for the benefit of certain of our officers, directors and employees. At June&#160;30, 2021, <ix:nonFraction unitRef="shares" contextRef="i12a70580710847829f909cea8ceeacc3_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNjAvZnJhZzozYmFjYzZmYWNhNmU0ZTMyYTU0NmNjZjhmNzBmY2Y4Yy90ZXh0cmVnaW9uOjNiYWNjNmZhY2E2ZTRlMzJhNTQ2Y2NmOGY3MGZjZjhjXzE0Nw_73e1ccce-7b6f-45be-ba9d-1b40073ce0dc">9</ix:nonFraction> million shares remain available for future grants under the Amended Cardinal Health, Inc. 2011 Long-Term Incentive Plan ("2011 LTIP"). Under the 2011 LTIP's fungible share counting provisions, stock options are counted against the plan as one share for every share issued; awards other than stock options are counted against the plan as two and one-half shares for every share issued. This means that only <ix:nonFraction unitRef="shares" contextRef="ibaee55518fbe497ca65e202e76660b9e_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNjAvZnJhZzozYmFjYzZmYWNhNmU0ZTMyYTU0NmNjZjhmNzBmY2Y4Yy90ZXh0cmVnaW9uOjNiYWNjNmZhY2E2ZTRlMzJhNTQ2Y2NmOGY3MGZjZjhjXzQ3NA_1ff238f1-0e4a-45f9-b20e-65faca69a155">3</ix:nonFraction> million shares could be issued under awards other than stock options while <ix:nonFraction unitRef="shares" contextRef="ib82e9bbd88e1416c896321662307b4fc_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNjAvZnJhZzozYmFjYzZmYWNhNmU0ZTMyYTU0NmNjZjhmNzBmY2Y4Yy90ZXh0cmVnaW9uOjNiYWNjNmZhY2E2ZTRlMzJhNTQ2Y2NmOGY3MGZjZjhjXzU0NA_db859877-5c29-4524-a414-c4285a527e06">9</ix:nonFraction> million shares could be issued under stock options. Shares are issued out of treasury shares when stock options are exercised and when restricted share units and performance share units vest. </span></div><ix:nonNumeric contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630" name="us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNjAvZnJhZzozYmFjYzZmYWNhNmU0ZTMyYTU0NmNjZjhmNzBmY2Y4Yy90ZXh0cmVnaW9uOjNiYWNjNmZhY2E2ZTRlMzJhNTQ2Y2NmOGY3MGZjZjhjXzQxNzk_436f07f0-589e-44a6-948c-07438e312f9c" escape="true"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides total share-based compensation expense by type of award:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.691%"><tr><td style="width:1.0%"></td><td style="width:58.652%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.283%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.347%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.283%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.347%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.288%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Restricted share unit expense</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i31f1c30559534af396751cc62e9e19a9_D20200701-20210630" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNjAvZnJhZzozYmFjYzZmYWNhNmU0ZTMyYTU0NmNjZjhmNzBmY2Y4Yy90YWJsZTo3MjgxMDU3MGRlMDg0MmE5YmJlMTUxOTIyZjljMmFjOC90YWJsZXJhbmdlOjcyODEwNTcwZGUwODQyYTliYmUxNTE5MjJmOWMyYWM4XzEtMS0xLTEtMA_d9b1e4d4-997e-483f-8606-01407ec2adb1">73</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i956130d849c84807b9f6f7b055f5ebec_D20190701-20200630" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNjAvZnJhZzozYmFjYzZmYWNhNmU0ZTMyYTU0NmNjZjhmNzBmY2Y4Yy90YWJsZTo3MjgxMDU3MGRlMDg0MmE5YmJlMTUxOTIyZjljMmFjOC90YWJsZXJhbmdlOjcyODEwNTcwZGUwODQyYTliYmUxNTE5MjJmOWMyYWM4XzEtMy0xLTEtMA_dfb12c07-12a8-4504-805c-a3995756247f">70</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i579d152d52624fc381bd7cae2c7ddd4a_D20180701-20190630" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNjAvZnJhZzozYmFjYzZmYWNhNmU0ZTMyYTU0NmNjZjhmNzBmY2Y4Yy90YWJsZTo3MjgxMDU3MGRlMDg0MmE5YmJlMTUxOTIyZjljMmFjOC90YWJsZXJhbmdlOjcyODEwNTcwZGUwODQyYTliYmUxNTE5MjJmOWMyYWM4XzEtNS0xLTEtMA_35c85eaa-644b-47fc-97e6-df4a40bea24f">63</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Employee stock option expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9fac2b1e8f484ef081a25d163aa2c3a6_D20200701-20210630" decimals="-6" format="ixt:zerodash" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNjAvZnJhZzozYmFjYzZmYWNhNmU0ZTMyYTU0NmNjZjhmNzBmY2Y4Yy90YWJsZTo3MjgxMDU3MGRlMDg0MmE5YmJlMTUxOTIyZjljMmFjOC90YWJsZXJhbmdlOjcyODEwNTcwZGUwODQyYTliYmUxNTE5MjJmOWMyYWM4XzItMS0xLTEtMA_0d4551b1-4356-4fb0-858a-6d01ac887216">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5ec12fa139c6458fb260601a40c83a61_D20190701-20200630" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNjAvZnJhZzozYmFjYzZmYWNhNmU0ZTMyYTU0NmNjZjhmNzBmY2Y4Yy90YWJsZTo3MjgxMDU3MGRlMDg0MmE5YmJlMTUxOTIyZjljMmFjOC90YWJsZXJhbmdlOjcyODEwNTcwZGUwODQyYTliYmUxNTE5MjJmOWMyYWM4XzItMy0xLTEtMA_f814cfcb-49c4-4af8-b3a5-ffa19c085875">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4ff833c8f18c425d87db9b23fa00bd06_D20180701-20190630" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNjAvZnJhZzozYmFjYzZmYWNhNmU0ZTMyYTU0NmNjZjhmNzBmY2Y4Yy90YWJsZTo3MjgxMDU3MGRlMDg0MmE5YmJlMTUxOTIyZjljMmFjOC90YWJsZXJhbmdlOjcyODEwNTcwZGUwODQyYTliYmUxNTE5MjJmOWMyYWM4XzItNS0xLTEtMA_f3649d14-4a51-4a43-9060-27bcc3877eb3">10</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Performance share unit expense</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i217c2671c6f84df1ab8278415bc34c16_D20200701-20210630" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNjAvZnJhZzozYmFjYzZmYWNhNmU0ZTMyYTU0NmNjZjhmNzBmY2Y4Yy90YWJsZTo3MjgxMDU3MGRlMDg0MmE5YmJlMTUxOTIyZjljMmFjOC90YWJsZXJhbmdlOjcyODEwNTcwZGUwODQyYTliYmUxNTE5MjJmOWMyYWM4XzMtMS0xLTEtMA_f248da08-835e-4263-bbb5-7687e541cf1b">16</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4f0f3088df2a4e019bd09b2ef236fef0_D20190701-20200630" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNjAvZnJhZzozYmFjYzZmYWNhNmU0ZTMyYTU0NmNjZjhmNzBmY2Y4Yy90YWJsZTo3MjgxMDU3MGRlMDg0MmE5YmJlMTUxOTIyZjljMmFjOC90YWJsZXJhbmdlOjcyODEwNTcwZGUwODQyYTliYmUxNTE5MjJmOWMyYWM4XzMtMy0xLTEtMA_70937af3-a785-4df9-89d2-575dcd930f88">17</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id7eb385b0eaf45a0aa833269191797b8_D20180701-20190630" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNjAvZnJhZzozYmFjYzZmYWNhNmU0ZTMyYTU0NmNjZjhmNzBmY2Y4Yy90YWJsZTo3MjgxMDU3MGRlMDg0MmE5YmJlMTUxOTIyZjljMmFjOC90YWJsZXJhbmdlOjcyODEwNTcwZGUwODQyYTliYmUxNTE5MjJmOWMyYWM4XzMtNS0xLTEtMA_885379b0-d62d-4533-be24-64d73443dd6e">9</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total share-based compensation expense</span></div></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNjAvZnJhZzozYmFjYzZmYWNhNmU0ZTMyYTU0NmNjZjhmNzBmY2Y4Yy90YWJsZTo3MjgxMDU3MGRlMDg0MmE5YmJlMTUxOTIyZjljMmFjOC90YWJsZXJhbmdlOjcyODEwNTcwZGUwODQyYTliYmUxNTE5MjJmOWMyYWM4XzQtMS0xLTEtMA_54221fbf-b378-4a40-92b8-741822882729">89</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia31e9a409b874bb19d0ff6f2f39ecc09_D20190701-20200630" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNjAvZnJhZzozYmFjYzZmYWNhNmU0ZTMyYTU0NmNjZjhmNzBmY2Y4Yy90YWJsZTo3MjgxMDU3MGRlMDg0MmE5YmJlMTUxOTIyZjljMmFjOC90YWJsZXJhbmdlOjcyODEwNTcwZGUwODQyYTliYmUxNTE5MjJmOWMyYWM4XzQtMy0xLTEtMA_704a92ae-9bf3-4d10-9f52-1154c6f4fc8f">90</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i00a6d666bf604826b24e68ddbd63eac4_D20180701-20190630" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNjAvZnJhZzozYmFjYzZmYWNhNmU0ZTMyYTU0NmNjZjhmNzBmY2Y4Yy90YWJsZTo3MjgxMDU3MGRlMDg0MmE5YmJlMTUxOTIyZjljMmFjOC90YWJsZXJhbmdlOjcyODEwNTcwZGUwODQyYTliYmUxNTE5MjJmOWMyYWM4XzQtNS0xLTEtMA_ed99a2fd-f459-4aa0-88d8-823618c27245">82</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total tax benefit related to share-based compensation was $<ix:nonFraction unitRef="usd" contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNjAvZnJhZzozYmFjYzZmYWNhNmU0ZTMyYTU0NmNjZjhmNzBmY2Y4Yy90ZXh0cmVnaW9uOjNiYWNjNmZhY2E2ZTRlMzJhNTQ2Y2NmOGY3MGZjZjhjXzg4Mg_4d767512-1fb5-4463-9fbe-3919219fc3d4">12</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="ia31e9a409b874bb19d0ff6f2f39ecc09_D20190701-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNjAvZnJhZzozYmFjYzZmYWNhNmU0ZTMyYTU0NmNjZjhmNzBmY2Y4Yy90ZXh0cmVnaW9uOjNiYWNjNmZhY2E2ZTRlMzJhNTQ2Y2NmOGY3MGZjZjhjXzg4Ng_17d6c02a-9b27-4212-b8b0-aa517f3852f0">16</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i00a6d666bf604826b24e68ddbd63eac4_D20180701-20190630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNjAvZnJhZzozYmFjYzZmYWNhNmU0ZTMyYTU0NmNjZjhmNzBmY2Y4Yy90ZXh0cmVnaW9uOjNiYWNjNmZhY2E2ZTRlMzJhNTQ2Y2NmOGY3MGZjZjhjXzg5Mw_6f93e28c-71fc-4acb-b95a-557d573bbbb0">16</ix:nonFraction> million for fiscal 2021, 2020 and 2019, respectively.</span></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Restricted Share Units</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Restricted share units granted under the Plans generally vest in equal annual installments over <ix:nonNumeric contextRef="i31f1c30559534af396751cc62e9e19a9_D20200701-20210630" format="ixt-sec:durwordsen" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNjAvZnJhZzozYmFjYzZmYWNhNmU0ZTMyYTU0NmNjZjhmNzBmY2Y4Yy90ZXh0cmVnaW9uOjNiYWNjNmZhY2E2ZTRlMzJhNTQ2Y2NmOGY3MGZjZjhjXzEwNTU_e94a06a2-4c26-461f-86f8-a3a82a7734fc">three years</ix:nonNumeric>. Restricted share units accrue cash dividend equivalents that are payable upon vesting of the awards.</span></div><ix:nonNumeric contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630" name="us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNjAvZnJhZzozYmFjYzZmYWNhNmU0ZTMyYTU0NmNjZjhmNzBmY2Y4Yy90ZXh0cmVnaW9uOjNiYWNjNmZhY2E2ZTRlMzJhNTQ2Y2NmOGY3MGZjZjhjXzQxNzM_b1574c28-3c2e-486e-b9ee-ca1242e31609" escape="true"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes all transactions related to restricted share units under the Plans:</span></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.691%"><tr><td style="width:1.0%"></td><td style="width:51.221%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.714%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.347%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:25.218%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in millions, except per share amounts)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Restricted Share Units</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-Average<br/>Grant Date Fair<br/>Value per Share</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Nonvested at June 30, 2019</span></td><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="icf32a92391924ff7b30fe54e99e0979b_I20190630" decimals="-6" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNjAvZnJhZzozYmFjYzZmYWNhNmU0ZTMyYTU0NmNjZjhmNzBmY2Y4Yy90YWJsZTphMzY4Y2FiZTJiNTQ0ZGU2YmM3OTJjMzU0ZmVkNTdhYi90YWJsZXJhbmdlOmEzNjhjYWJlMmI1NDRkZTZiYzc5MmMzNTRmZWQ1N2FiXzEtMS0xLTEtMA_a860d793-0071-4ef3-939a-311bf27ba330">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="icf32a92391924ff7b30fe54e99e0979b_I20190630" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNjAvZnJhZzozYmFjYzZmYWNhNmU0ZTMyYTU0NmNjZjhmNzBmY2Y4Yy90YWJsZTphMzY4Y2FiZTJiNTQ0ZGU2YmM3OTJjMzU0ZmVkNTdhYi90YWJsZXJhbmdlOmEzNjhjYWJlMmI1NDRkZTZiYzc5MmMzNTRmZWQ1N2FiXzEtMy0xLTEtMA_8f348326-a7de-4ae8-90cf-a62d558168ca">51.65</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i956130d849c84807b9f6f7b055f5ebec_D20190701-20200630" decimals="-6" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNjAvZnJhZzozYmFjYzZmYWNhNmU0ZTMyYTU0NmNjZjhmNzBmY2Y4Yy90YWJsZTphMzY4Y2FiZTJiNTQ0ZGU2YmM3OTJjMzU0ZmVkNTdhYi90YWJsZXJhbmdlOmEzNjhjYWJlMmI1NDRkZTZiYzc5MmMzNTRmZWQ1N2FiXzItMS0xLTEtMA_5dea4628-5f49-4b32-8fef-e96117e93938">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i956130d849c84807b9f6f7b055f5ebec_D20190701-20200630" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNjAvZnJhZzozYmFjYzZmYWNhNmU0ZTMyYTU0NmNjZjhmNzBmY2Y4Yy90YWJsZTphMzY4Y2FiZTJiNTQ0ZGU2YmM3OTJjMzU0ZmVkNTdhYi90YWJsZXJhbmdlOmEzNjhjYWJlMmI1NDRkZTZiYzc5MmMzNTRmZWQ1N2FiXzItMy0xLTEtMA_478747c7-822e-47b2-a5bd-5fdef424bc33">42.71</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i956130d849c84807b9f6f7b055f5ebec_D20190701-20200630" decimals="-6" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNjAvZnJhZzozYmFjYzZmYWNhNmU0ZTMyYTU0NmNjZjhmNzBmY2Y4Yy90YWJsZTphMzY4Y2FiZTJiNTQ0ZGU2YmM3OTJjMzU0ZmVkNTdhYi90YWJsZXJhbmdlOmEzNjhjYWJlMmI1NDRkZTZiYzc5MmMzNTRmZWQ1N2FiXzMtMS0xLTEtMA_6c7b63ea-5316-4f01-b7e3-ee0332daadaa">1</ix:nonFraction>)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i956130d849c84807b9f6f7b055f5ebec_D20190701-20200630" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNjAvZnJhZzozYmFjYzZmYWNhNmU0ZTMyYTU0NmNjZjhmNzBmY2Y4Yy90YWJsZTphMzY4Y2FiZTJiNTQ0ZGU2YmM3OTJjMzU0ZmVkNTdhYi90YWJsZXJhbmdlOmEzNjhjYWJlMmI1NDRkZTZiYzc5MmMzNTRmZWQ1N2FiXzMtMy0xLTEtMA_293fd15e-28cb-4cee-b33f-af0095789ebf">60.21</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Canceled and forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i956130d849c84807b9f6f7b055f5ebec_D20190701-20200630" decimals="-6" format="ixt:zerodash" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNjAvZnJhZzozYmFjYzZmYWNhNmU0ZTMyYTU0NmNjZjhmNzBmY2Y4Yy90YWJsZTphMzY4Y2FiZTJiNTQ0ZGU2YmM3OTJjMzU0ZmVkNTdhYi90YWJsZXJhbmdlOmEzNjhjYWJlMmI1NDRkZTZiYzc5MmMzNTRmZWQ1N2FiXzQtMS0xLTEtMA_b1a6f0ef-879c-4e76-a2c7-6594d868c945">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i956130d849c84807b9f6f7b055f5ebec_D20190701-20200630" decimals="2" format="ixt:zerodash" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNjAvZnJhZzozYmFjYzZmYWNhNmU0ZTMyYTU0NmNjZjhmNzBmY2Y4Yy90YWJsZTphMzY4Y2FiZTJiNTQ0ZGU2YmM3OTJjMzU0ZmVkNTdhYi90YWJsZXJhbmdlOmEzNjhjYWJlMmI1NDRkZTZiYzc5MmMzNTRmZWQ1N2FiXzQtMy0xLTEtMA_cfba553d-894b-4032-8fb8-0f8430a8cc86">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Nonvested at June 30, 2020</span></td><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ifb9b7ea1688a4fb4a266a5ac9179360e_I20200630" decimals="-6" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNjAvZnJhZzozYmFjYzZmYWNhNmU0ZTMyYTU0NmNjZjhmNzBmY2Y4Yy90YWJsZTphMzY4Y2FiZTJiNTQ0ZGU2YmM3OTJjMzU0ZmVkNTdhYi90YWJsZXJhbmdlOmEzNjhjYWJlMmI1NDRkZTZiYzc5MmMzNTRmZWQ1N2FiXzUtMS0xLTEtMA_99630eed-08a7-478d-a3a9-31550941af52">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ifb9b7ea1688a4fb4a266a5ac9179360e_I20200630" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNjAvZnJhZzozYmFjYzZmYWNhNmU0ZTMyYTU0NmNjZjhmNzBmY2Y4Yy90YWJsZTphMzY4Y2FiZTJiNTQ0ZGU2YmM3OTJjMzU0ZmVkNTdhYi90YWJsZXJhbmdlOmEzNjhjYWJlMmI1NDRkZTZiYzc5MmMzNTRmZWQ1N2FiXzUtMy0xLTEtMA_8615b08b-5ade-4bac-80cf-2762831dc8aa">45.92</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i31f1c30559534af396751cc62e9e19a9_D20200701-20210630" decimals="-6" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNjAvZnJhZzozYmFjYzZmYWNhNmU0ZTMyYTU0NmNjZjhmNzBmY2Y4Yy90YWJsZTphMzY4Y2FiZTJiNTQ0ZGU2YmM3OTJjMzU0ZmVkNTdhYi90YWJsZXJhbmdlOmEzNjhjYWJlMmI1NDRkZTZiYzc5MmMzNTRmZWQ1N2FiXzYtMS0xLTEtMA_ea588246-1ea3-4c3e-9801-2e5c943e0be2">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i31f1c30559534af396751cc62e9e19a9_D20200701-20210630" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNjAvZnJhZzozYmFjYzZmYWNhNmU0ZTMyYTU0NmNjZjhmNzBmY2Y4Yy90YWJsZTphMzY4Y2FiZTJiNTQ0ZGU2YmM3OTJjMzU0ZmVkNTdhYi90YWJsZXJhbmdlOmEzNjhjYWJlMmI1NDRkZTZiYzc5MmMzNTRmZWQ1N2FiXzYtMy0xLTEtMA_812707cd-bed8-4b84-9aae-ca41b0e57e6a">53.76</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i31f1c30559534af396751cc62e9e19a9_D20200701-20210630" decimals="-6" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNjAvZnJhZzozYmFjYzZmYWNhNmU0ZTMyYTU0NmNjZjhmNzBmY2Y4Yy90YWJsZTphMzY4Y2FiZTJiNTQ0ZGU2YmM3OTJjMzU0ZmVkNTdhYi90YWJsZXJhbmdlOmEzNjhjYWJlMmI1NDRkZTZiYzc5MmMzNTRmZWQ1N2FiXzctMS0xLTEtMA_4dbffece-20b8-484b-8501-62f72919f0ce">1</ix:nonFraction>)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i31f1c30559534af396751cc62e9e19a9_D20200701-20210630" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNjAvZnJhZzozYmFjYzZmYWNhNmU0ZTMyYTU0NmNjZjhmNzBmY2Y4Yy90YWJsZTphMzY4Y2FiZTJiNTQ0ZGU2YmM3OTJjMzU0ZmVkNTdhYi90YWJsZXJhbmdlOmEzNjhjYWJlMmI1NDRkZTZiYzc5MmMzNTRmZWQ1N2FiXzctMy0xLTEtMA_374e2284-189d-49e2-9cf5-5d6a241d0d66">49.37</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Canceled and forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i31f1c30559534af396751cc62e9e19a9_D20200701-20210630" decimals="-6" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNjAvZnJhZzozYmFjYzZmYWNhNmU0ZTMyYTU0NmNjZjhmNzBmY2Y4Yy90YWJsZTphMzY4Y2FiZTJiNTQ0ZGU2YmM3OTJjMzU0ZmVkNTdhYi90YWJsZXJhbmdlOmEzNjhjYWJlMmI1NDRkZTZiYzc5MmMzNTRmZWQ1N2FiXzgtMS0xLTEtMA_0a12cc93-75ee-4f34-8f80-271f42ec8185">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i31f1c30559534af396751cc62e9e19a9_D20200701-20210630" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNjAvZnJhZzozYmFjYzZmYWNhNmU0ZTMyYTU0NmNjZjhmNzBmY2Y4Yy90YWJsZTphMzY4Y2FiZTJiNTQ0ZGU2YmM3OTJjMzU0ZmVkNTdhYi90YWJsZXJhbmdlOmEzNjhjYWJlMmI1NDRkZTZiYzc5MmMzNTRmZWQ1N2FiXzgtMy0xLTEtMA_710d9670-f6a8-4ad9-8831-18258792fd18">48.74</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nonvested at June 30, 2021</span></td><td colspan="2" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i401c6da5266c42ffb2f8a5466c3eba3c_I20210630" decimals="-6" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNjAvZnJhZzozYmFjYzZmYWNhNmU0ZTMyYTU0NmNjZjhmNzBmY2Y4Yy90YWJsZTphMzY4Y2FiZTJiNTQ0ZGU2YmM3OTJjMzU0ZmVkNTdhYi90YWJsZXJhbmdlOmEzNjhjYWJlMmI1NDRkZTZiYzc5MmMzNTRmZWQ1N2FiXzktMS0xLTEtMA_f609b914-78df-43c1-a143-d00ab43ff8ef">3</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i401c6da5266c42ffb2f8a5466c3eba3c_I20210630" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNjAvZnJhZzozYmFjYzZmYWNhNmU0ZTMyYTU0NmNjZjhmNzBmY2Y4Yy90YWJsZTphMzY4Y2FiZTJiNTQ0ZGU2YmM3OTJjMzU0ZmVkNTdhYi90YWJsZXJhbmdlOmEzNjhjYWJlMmI1NDRkZTZiYzc5MmMzNTRmZWQ1N2FiXzktMy0xLTEtMA_654b879e-2dc1-4d16-bd15-6444aa394063">49.05</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:nonNumeric></div></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:32.135%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.428%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.137%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardinal Health </span><span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">|</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> Fiscal 2021 Form 10-K</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">85</span></div></td></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:3pt"><span><br/></span></div><div style="margin-bottom:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.702%"><tr><td style="width:1.0%"></td><td style="width:24.720%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:50.989%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.991%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#e41f35;border-bottom:1pt solid #e41f35;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Notes to Financial Statements</span></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span><br/></span></div></div><div style="width:100.000%"><ix:continuation id="i1bb00b21ec4c41d984b95a36e1fae787" continuedAt="i26f7aba060bf44c5a8ad457ee8c2e292"><div style="display:inline-block;vertical-align:top;width:48.214%"><ix:nonNumeric contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630" name="cah:AdditionalRestrictedSharesAndRestrictedShareUnitsDataTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNjAvZnJhZzozYmFjYzZmYWNhNmU0ZTMyYTU0NmNjZjhmNzBmY2Y4Yy90ZXh0cmVnaW9uOjNiYWNjNmZhY2E2ZTRlMzJhNTQ2Y2NmOGY3MGZjZjhjXzQxMjg_bef7e7bf-f2bf-4adf-a704-b1302ccd613b" escape="true"><div style="margin-bottom:4pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides additional data related to restricted share unit activity:</span></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.691%"><tr><td style="width:1.0%"></td><td style="width:53.698%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.451%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.347%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.522%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.347%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.835%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total compensation cost, net of estimated forfeitures, related to nonvested restricted share and share unit awards not yet recognized, pre-tax</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i401c6da5266c42ffb2f8a5466c3eba3c_I20210630" decimals="-6" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNjAvZnJhZzozYmFjYzZmYWNhNmU0ZTMyYTU0NmNjZjhmNzBmY2Y4Yy90YWJsZTowZjE3NDM5OGVhNWM0OWY4YWI2YjJjZWMzMjQ5MTBkMy90YWJsZXJhbmdlOjBmMTc0Mzk4ZWE1YzQ5ZjhhYjZiMmNlYzMyNDkxMGQzXzEtMS0xLTEtMA_20cb6d89-fd9c-4132-b957-aa5530250fd1">73</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifb9b7ea1688a4fb4a266a5ac9179360e_I20200630" decimals="-6" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNjAvZnJhZzozYmFjYzZmYWNhNmU0ZTMyYTU0NmNjZjhmNzBmY2Y4Yy90YWJsZTowZjE3NDM5OGVhNWM0OWY4YWI2YjJjZWMzMjQ5MTBkMy90YWJsZXJhbmdlOjBmMTc0Mzk4ZWE1YzQ5ZjhhYjZiMmNlYzMyNDkxMGQzXzEtMy0xLTEtMA_d7088a84-4146-496d-ba0d-44a9d0ebab06">77</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icf32a92391924ff7b30fe54e99e0979b_I20190630" decimals="-6" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNjAvZnJhZzozYmFjYzZmYWNhNmU0ZTMyYTU0NmNjZjhmNzBmY2Y4Yy90YWJsZTowZjE3NDM5OGVhNWM0OWY4YWI2YjJjZWMzMjQ5MTBkMy90YWJsZXJhbmdlOjBmMTc0Mzk4ZWE1YzQ5ZjhhYjZiMmNlYzMyNDkxMGQzXzEtNS0xLTEtMA_d821f126-4072-4dcb-9013-754e768948c8">75</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Weighted-average period in years over which restricted share and share unit cost is expected to be recognized (in years)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i31f1c30559534af396751cc62e9e19a9_D20200701-20210630" format="ixt-sec:duryear" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNjAvZnJhZzozYmFjYzZmYWNhNmU0ZTMyYTU0NmNjZjhmNzBmY2Y4Yy90YWJsZTowZjE3NDM5OGVhNWM0OWY4YWI2YjJjZWMzMjQ5MTBkMy90YWJsZXJhbmdlOjBmMTc0Mzk4ZWE1YzQ5ZjhhYjZiMmNlYzMyNDkxMGQzXzItMS0xLTEtMA_d73e9db3-d856-4a4a-9769-87dc53c3707b">2</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i956130d849c84807b9f6f7b055f5ebec_D20190701-20200630" format="ixt-sec:duryear" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNjAvZnJhZzozYmFjYzZmYWNhNmU0ZTMyYTU0NmNjZjhmNzBmY2Y4Yy90YWJsZTowZjE3NDM5OGVhNWM0OWY4YWI2YjJjZWMzMjQ5MTBkMy90YWJsZXJhbmdlOjBmMTc0Mzk4ZWE1YzQ5ZjhhYjZiMmNlYzMyNDkxMGQzXzItMy0xLTEtMA_029b886d-ffcf-4607-9ae4-1ff5366bf36b">2</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i579d152d52624fc381bd7cae2c7ddd4a_D20180701-20190630" format="ixt-sec:duryear" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNjAvZnJhZzozYmFjYzZmYWNhNmU0ZTMyYTU0NmNjZjhmNzBmY2Y4Yy90YWJsZTowZjE3NDM5OGVhNWM0OWY4YWI2YjJjZWMzMjQ5MTBkMy90YWJsZXJhbmdlOjBmMTc0Mzk4ZWE1YzQ5ZjhhYjZiMmNlYzMyNDkxMGQzXzItNS0xLTEtMA_189a3d21-98c0-47cd-9f47-0310873e0c1f">2</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total fair value of shares vested during the year</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i31f1c30559534af396751cc62e9e19a9_D20200701-20210630" decimals="-6" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNjAvZnJhZzozYmFjYzZmYWNhNmU0ZTMyYTU0NmNjZjhmNzBmY2Y4Yy90YWJsZTowZjE3NDM5OGVhNWM0OWY4YWI2YjJjZWMzMjQ5MTBkMy90YWJsZXJhbmdlOjBmMTc0Mzk4ZWE1YzQ5ZjhhYjZiMmNlYzMyNDkxMGQzXzMtMS0xLTEtMA_127a2565-a6c9-46e0-821f-8bf6e2730c0a">70</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i956130d849c84807b9f6f7b055f5ebec_D20190701-20200630" decimals="-6" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNjAvZnJhZzozYmFjYzZmYWNhNmU0ZTMyYTU0NmNjZjhmNzBmY2Y4Yy90YWJsZTowZjE3NDM5OGVhNWM0OWY4YWI2YjJjZWMzMjQ5MTBkMy90YWJsZXJhbmdlOjBmMTc0Mzk4ZWE1YzQ5ZjhhYjZiMmNlYzMyNDkxMGQzXzMtMy0xLTEtMA_1f9f2f7c-3e0a-4398-82e8-2b9d63d5e27d">57</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i579d152d52624fc381bd7cae2c7ddd4a_D20180701-20190630" decimals="-6" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNjAvZnJhZzozYmFjYzZmYWNhNmU0ZTMyYTU0NmNjZjhmNzBmY2Y4Yy90YWJsZTowZjE3NDM5OGVhNWM0OWY4YWI2YjJjZWMzMjQ5MTBkMy90YWJsZXJhbmdlOjBmMTc0Mzk4ZWE1YzQ5ZjhhYjZiMmNlYzMyNDkxMGQzXzMtNS0xLTEtMA_87338921-cc86-4e45-828b-4b2faeb8ace4">68</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Stock Options</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Until the end of fiscal 2018, stock options were granted to our officers and certain employees. There were <ix:nonFraction unitRef="shares" contextRef="i00a6d666bf604826b24e68ddbd63eac4_D20180701-20190630" decimals="-6" format="ixt-sec:numwordsen" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNjAvZnJhZzozYmFjYzZmYWNhNmU0ZTMyYTU0NmNjZjhmNzBmY2Y4Yy90ZXh0cmVnaW9uOjNiYWNjNmZhY2E2ZTRlMzJhNTQ2Y2NmOGY3MGZjZjhjXzU0OTc1NTgxNDM3MDA_0dabb7b7-3e66-469c-bd5a-1d49516a3bac"><ix:nonFraction unitRef="shares" contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630" decimals="-6" format="ixt-sec:numwordsen" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNjAvZnJhZzozYmFjYzZmYWNhNmU0ZTMyYTU0NmNjZjhmNzBmY2Y4Yy90ZXh0cmVnaW9uOjNiYWNjNmZhY2E2ZTRlMzJhNTQ2Y2NmOGY3MGZjZjhjXzU0OTc1NTgxNDM3MDA_4fe32eb5-9a03-496e-9a71-db761555b0ff"><ix:nonFraction unitRef="shares" contextRef="ia31e9a409b874bb19d0ff6f2f39ecc09_D20190701-20200630" decimals="-6" format="ixt-sec:numwordsen" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNjAvZnJhZzozYmFjYzZmYWNhNmU0ZTMyYTU0NmNjZjhmNzBmY2Y4Yy90ZXh0cmVnaW9uOjNiYWNjNmZhY2E2ZTRlMzJhNTQ2Y2NmOGY3MGZjZjhjXzU0OTc1NTgxNDM3MDA_e3a383ce-dbfd-4a13-86a9-9ba79c176f4b">no</ix:nonFraction></ix:nonFraction></ix:nonFraction> stock options granted to employees during fiscal year 2021, 2020 or 2019. Employee stock options granted under the Plans generally vest in equal annual installments over <ix:nonNumeric contextRef="i9fac2b1e8f484ef081a25d163aa2c3a6_D20200701-20210630" format="ixt-sec:durwordsen" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNjAvZnJhZzozYmFjYzZmYWNhNmU0ZTMyYTU0NmNjZjhmNzBmY2Y4Yy90ZXh0cmVnaW9uOjNiYWNjNmZhY2E2ZTRlMzJhNTQ2Y2NmOGY3MGZjZjhjXzE0NjE_b85ed10e-aa5d-4b9c-84d3-0de56e2de8a4">three years</ix:nonNumeric> and are exercisable for a period up to <ix:nonNumeric contextRef="i9fac2b1e8f484ef081a25d163aa2c3a6_D20200701-20210630" format="ixt-sec:durwordsen" name="cah:ExercisablePeriodOfPlansInYears" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNjAvZnJhZzozYmFjYzZmYWNhNmU0ZTMyYTU0NmNjZjhmNzBmY2Y4Yy90ZXh0cmVnaW9uOjNiYWNjNmZhY2E2ZTRlMzJhNTQ2Y2NmOGY3MGZjZjhjXzE1MDM_83ec77e0-d695-46d3-8929-898b47143678">ten years</ix:nonNumeric> from the grant date. All stock options are exercisable at a price equal to the market value of the common shares underlying the option on the grant date.</span></div><ix:nonNumeric contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630" name="us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNjAvZnJhZzozYmFjYzZmYWNhNmU0ZTMyYTU0NmNjZjhmNzBmY2Y4Yy90ZXh0cmVnaW9uOjNiYWNjNmZhY2E2ZTRlMzJhNTQ2Y2NmOGY3MGZjZjhjXzQyMjY_e3216f75-6536-4838-b1c0-071b118608aa" escape="true"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes all stock option transactions under the Plans:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:56.616%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.480%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.343%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:26.061%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in millions, except per share amounts)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Stock<br/>Options</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-Average<br/>Exercise Price per<br/>Common Share</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Outstanding at June 30, 2019</span></td><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if6dc09eec4e74751b47cdf037a5b1860_I20190630" decimals="-6" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNjAvZnJhZzozYmFjYzZmYWNhNmU0ZTMyYTU0NmNjZjhmNzBmY2Y4Yy90YWJsZToxZjdmNmZkY2U2NTI0Zjc4OWU4NjY4NTFlNjUwZmI0Mi90YWJsZXJhbmdlOjFmN2Y2ZmRjZTY1MjRmNzg5ZTg2Njg1MWU2NTBmYjQyXzEtMS0xLTEtMA_6e64bd0c-6d7a-41cb-80ce-955c25e30620">6</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="if6dc09eec4e74751b47cdf037a5b1860_I20190630" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNjAvZnJhZzozYmFjYzZmYWNhNmU0ZTMyYTU0NmNjZjhmNzBmY2Y4Yy90YWJsZToxZjdmNmZkY2U2NTI0Zjc4OWU4NjY4NTFlNjUwZmI0Mi90YWJsZXJhbmdlOjFmN2Y2ZmRjZTY1MjRmNzg5ZTg2Njg1MWU2NTBmYjQyXzEtMy0xLTEtMA_60053b25-93de-4500-adea-b6296d0a9488">63.78</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia31e9a409b874bb19d0ff6f2f39ecc09_D20190701-20200630" decimals="-6" format="ixt:zerodash" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNjAvZnJhZzozYmFjYzZmYWNhNmU0ZTMyYTU0NmNjZjhmNzBmY2Y4Yy90YWJsZToxZjdmNmZkY2U2NTI0Zjc4OWU4NjY4NTFlNjUwZmI0Mi90YWJsZXJhbmdlOjFmN2Y2ZmRjZTY1MjRmNzg5ZTg2Njg1MWU2NTBmYjQyXzItMS0xLTEtMA_8301f52b-0b25-43e5-ab09-de8d341fdaf7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ia31e9a409b874bb19d0ff6f2f39ecc09_D20190701-20200630" decimals="2" format="ixt:zerodash" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNjAvZnJhZzozYmFjYzZmYWNhNmU0ZTMyYTU0NmNjZjhmNzBmY2Y4Yy90YWJsZToxZjdmNmZkY2U2NTI0Zjc4OWU4NjY4NTFlNjUwZmI0Mi90YWJsZXJhbmdlOjFmN2Y2ZmRjZTY1MjRmNzg5ZTg2Njg1MWU2NTBmYjQyXzItMy0xLTEtMA_ddc486d6-7258-4782-ab71-b3c3deff5e31">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="ia31e9a409b874bb19d0ff6f2f39ecc09_D20190701-20200630" decimals="-6" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNjAvZnJhZzozYmFjYzZmYWNhNmU0ZTMyYTU0NmNjZjhmNzBmY2Y4Yy90YWJsZToxZjdmNmZkY2U2NTI0Zjc4OWU4NjY4NTFlNjUwZmI0Mi90YWJsZXJhbmdlOjFmN2Y2ZmRjZTY1MjRmNzg5ZTg2Njg1MWU2NTBmYjQyXzMtMS0xLTEtMA_32552193-39a4-4a23-aef1-6029c8f482ff">1</ix:nonFraction>)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ia31e9a409b874bb19d0ff6f2f39ecc09_D20190701-20200630" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNjAvZnJhZzozYmFjYzZmYWNhNmU0ZTMyYTU0NmNjZjhmNzBmY2Y4Yy90YWJsZToxZjdmNmZkY2U2NTI0Zjc4OWU4NjY4NTFlNjUwZmI0Mi90YWJsZXJhbmdlOjFmN2Y2ZmRjZTY1MjRmNzg5ZTg2Njg1MWU2NTBmYjQyXzMtMy0xLTEtMA_02888f8b-85cb-4f1a-880e-6756d254c82a">42.36</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Canceled and forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia31e9a409b874bb19d0ff6f2f39ecc09_D20190701-20200630" decimals="-6" format="ixt:zerodash" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNjAvZnJhZzozYmFjYzZmYWNhNmU0ZTMyYTU0NmNjZjhmNzBmY2Y4Yy90YWJsZToxZjdmNmZkY2U2NTI0Zjc4OWU4NjY4NTFlNjUwZmI0Mi90YWJsZXJhbmdlOjFmN2Y2ZmRjZTY1MjRmNzg5ZTg2Njg1MWU2NTBmYjQyXzQtMS0xLTEtMA_e6a301ae-d075-4400-92dd-04198b5d28a6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ia31e9a409b874bb19d0ff6f2f39ecc09_D20190701-20200630" decimals="2" format="ixt:zerodash" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNjAvZnJhZzozYmFjYzZmYWNhNmU0ZTMyYTU0NmNjZjhmNzBmY2Y4Yy90YWJsZToxZjdmNmZkY2U2NTI0Zjc4OWU4NjY4NTFlNjUwZmI0Mi90YWJsZXJhbmdlOjFmN2Y2ZmRjZTY1MjRmNzg5ZTg2Njg1MWU2NTBmYjQyXzQtMy0xLTEtMA_60ef644c-c230-4e66-8cbf-b5c11794db62">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Outstanding at June 30, 2020</span></td><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i299cea70f47b4fbe96772aaa8cc00b79_I20200630" decimals="-6" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNjAvZnJhZzozYmFjYzZmYWNhNmU0ZTMyYTU0NmNjZjhmNzBmY2Y4Yy90YWJsZToxZjdmNmZkY2U2NTI0Zjc4OWU4NjY4NTFlNjUwZmI0Mi90YWJsZXJhbmdlOjFmN2Y2ZmRjZTY1MjRmNzg5ZTg2Njg1MWU2NTBmYjQyXzUtMS0xLTEtMA_25af2f04-8990-4140-815e-857ea62417ef">5</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i299cea70f47b4fbe96772aaa8cc00b79_I20200630" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNjAvZnJhZzozYmFjYzZmYWNhNmU0ZTMyYTU0NmNjZjhmNzBmY2Y4Yy90YWJsZToxZjdmNmZkY2U2NTI0Zjc4OWU4NjY4NTFlNjUwZmI0Mi90YWJsZXJhbmdlOjFmN2Y2ZmRjZTY1MjRmNzg5ZTg2Njg1MWU2NTBmYjQyXzUtMy0xLTEtMA_9cd9f14b-2a35-402e-85a9-a52c910c6e00">65.15</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630" decimals="-6" format="ixt:zerodash" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNjAvZnJhZzozYmFjYzZmYWNhNmU0ZTMyYTU0NmNjZjhmNzBmY2Y4Yy90YWJsZToxZjdmNmZkY2U2NTI0Zjc4OWU4NjY4NTFlNjUwZmI0Mi90YWJsZXJhbmdlOjFmN2Y2ZmRjZTY1MjRmNzg5ZTg2Njg1MWU2NTBmYjQyXzYtMS0xLTEtMA_8f67d16b-818d-4035-81c3-6ea0474f8eaa">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630" decimals="2" format="ixt:zerodash" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNjAvZnJhZzozYmFjYzZmYWNhNmU0ZTMyYTU0NmNjZjhmNzBmY2Y4Yy90YWJsZToxZjdmNmZkY2U2NTI0Zjc4OWU4NjY4NTFlNjUwZmI0Mi90YWJsZXJhbmdlOjFmN2Y2ZmRjZTY1MjRmNzg5ZTg2Njg1MWU2NTBmYjQyXzYtMy0xLTEtMA_2f788c50-a8b9-4d32-9ebf-b7eedcf134c8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630" decimals="-6" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNjAvZnJhZzozYmFjYzZmYWNhNmU0ZTMyYTU0NmNjZjhmNzBmY2Y4Yy90YWJsZToxZjdmNmZkY2U2NTI0Zjc4OWU4NjY4NTFlNjUwZmI0Mi90YWJsZXJhbmdlOjFmN2Y2ZmRjZTY1MjRmNzg5ZTg2Njg1MWU2NTBmYjQyXzctMS0xLTEtMA_f0ccd87f-91ee-4084-9acd-f4cec7911f8e">1</ix:nonFraction>)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNjAvZnJhZzozYmFjYzZmYWNhNmU0ZTMyYTU0NmNjZjhmNzBmY2Y4Yy90YWJsZToxZjdmNmZkY2U2NTI0Zjc4OWU4NjY4NTFlNjUwZmI0Mi90YWJsZXJhbmdlOjFmN2Y2ZmRjZTY1MjRmNzg5ZTg2Njg1MWU2NTBmYjQyXzctMy0xLTEtMA_3bf54816-8c2c-4f70-a745-5bb660058961">43.08</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Canceled and forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630" decimals="-6" format="ixt:zerodash" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNjAvZnJhZzozYmFjYzZmYWNhNmU0ZTMyYTU0NmNjZjhmNzBmY2Y4Yy90YWJsZToxZjdmNmZkY2U2NTI0Zjc4OWU4NjY4NTFlNjUwZmI0Mi90YWJsZXJhbmdlOjFmN2Y2ZmRjZTY1MjRmNzg5ZTg2Njg1MWU2NTBmYjQyXzgtMS0xLTEtMA_8a8f44a9-c582-4ad4-9384-ed9efd15491c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630" decimals="2" format="ixt:zerodash" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNjAvZnJhZzozYmFjYzZmYWNhNmU0ZTMyYTU0NmNjZjhmNzBmY2Y4Yy90YWJsZToxZjdmNmZkY2U2NTI0Zjc4OWU4NjY4NTFlNjUwZmI0Mi90YWJsZXJhbmdlOjFmN2Y2ZmRjZTY1MjRmNzg5ZTg2Njg1MWU2NTBmYjQyXzgtMy0xLTEtMA_065c8a88-deb5-4e53-809f-e030d25d7c7c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Outstanding at June 30, 2021</span></td><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i2e87824102b34590a0208cc7da91b5f5_I20210630" decimals="-6" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNjAvZnJhZzozYmFjYzZmYWNhNmU0ZTMyYTU0NmNjZjhmNzBmY2Y4Yy90YWJsZToxZjdmNmZkY2U2NTI0Zjc4OWU4NjY4NTFlNjUwZmI0Mi90YWJsZXJhbmdlOjFmN2Y2ZmRjZTY1MjRmNzg5ZTg2Njg1MWU2NTBmYjQyXzktMS0xLTEtMA_b4b1ec9a-3964-4f58-a4a0-fd4082a0e42b">4</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i2e87824102b34590a0208cc7da91b5f5_I20210630" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNjAvZnJhZzozYmFjYzZmYWNhNmU0ZTMyYTU0NmNjZjhmNzBmY2Y4Yy90YWJsZToxZjdmNmZkY2U2NTI0Zjc4OWU4NjY4NTFlNjUwZmI0Mi90YWJsZXJhbmdlOjFmN2Y2ZmRjZTY1MjRmNzg5ZTg2Njg1MWU2NTBmYjQyXzktMy0xLTEtMA_b3c22d2c-95d4-4961-b7c6-e93f35a12821">68.46</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Exercisable at June 30, 2021</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i2e87824102b34590a0208cc7da91b5f5_I20210630" decimals="-6" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNjAvZnJhZzozYmFjYzZmYWNhNmU0ZTMyYTU0NmNjZjhmNzBmY2Y4Yy90YWJsZToxZjdmNmZkY2U2NTI0Zjc4OWU4NjY4NTFlNjUwZmI0Mi90YWJsZXJhbmdlOjFmN2Y2ZmRjZTY1MjRmNzg5ZTg2Njg1MWU2NTBmYjQyXzEwLTEtMS0xLTA_1d0bb6cd-772c-41c2-b297-b7aadd1aaba9">4</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i2e87824102b34590a0208cc7da91b5f5_I20210630" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNjAvZnJhZzozYmFjYzZmYWNhNmU0ZTMyYTU0NmNjZjhmNzBmY2Y4Yy90YWJsZToxZjdmNmZkY2U2NTI0Zjc4OWU4NjY4NTFlNjUwZmI0Mi90YWJsZXJhbmdlOjFmN2Y2ZmRjZTY1MjRmNzg5ZTg2Njg1MWU2NTBmYjQyXzEwLTMtMS0xLTA_b896cbda-30d6-4697-95c3-33d4f6a18786">68.62</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></div><div style="display:inline-block;max-width:3.571%;min-width:2.571%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:48.215%"><ix:nonNumeric contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630" name="cah:AdditionalStockOptionPlanDataTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNjAvZnJhZzozYmFjYzZmYWNhNmU0ZTMyYTU0NmNjZjhmNzBmY2Y4Yy90ZXh0cmVnaW9uOjNiYWNjNmZhY2E2ZTRlMzJhNTQ2Y2NmOGY3MGZjZjhjXzQyMDE_c01d9ca8-37eb-4392-bde0-bc820f1f01a2" escape="true"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides additional detail related to stock options:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.691%"><tr><td style="width:1.0%"></td><td style="width:53.698%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.451%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.347%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.522%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.347%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.835%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in millions, except per share amounts)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Aggregate intrinsic value of outstanding options at period end</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib473c6ce356d4388a73564ce9f41c306_I20210630" decimals="-6" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNjAvZnJhZzozYmFjYzZmYWNhNmU0ZTMyYTU0NmNjZjhmNzBmY2Y4Yy90YWJsZTpkY2QzNzk2ZGQwZDM0NmZiYjNhMDllMDg2Y2IyZTVjMi90YWJsZXJhbmdlOmRjZDM3OTZkZDBkMzQ2ZmJiM2EwOWUwODZjYjJlNWMyXzEtMS0xLTEtMA_5cb6d88d-0c05-4a65-9b53-51136dd1e676">11</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6844f415cc38462c93502fde5a64b55f_I20200630" decimals="-6" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNjAvZnJhZzozYmFjYzZmYWNhNmU0ZTMyYTU0NmNjZjhmNzBmY2Y4Yy90YWJsZTpkY2QzNzk2ZGQwZDM0NmZiYjNhMDllMDg2Y2IyZTVjMi90YWJsZXJhbmdlOmRjZDM3OTZkZDBkMzQ2ZmJiM2EwOWUwODZjYjJlNWMyXzEtMy0xLTEtMA_dd9c78ee-a555-4bdc-b6b6-fb3526b6cd27">12</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0a3264d2aa5e4528bea7fa195a0d07b5_I20190630" decimals="-6" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNjAvZnJhZzozYmFjYzZmYWNhNmU0ZTMyYTU0NmNjZjhmNzBmY2Y4Yy90YWJsZTpkY2QzNzk2ZGQwZDM0NmZiYjNhMDllMDg2Y2IyZTVjMi90YWJsZXJhbmdlOmRjZDM3OTZkZDBkMzQ2ZmJiM2EwOWUwODZjYjJlNWMyXzEtNS0xLTEtMA_b5e6bf44-15d6-41e7-905e-08fef2cd5116">10</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Aggregate intrinsic value of exercisable options at period end</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib473c6ce356d4388a73564ce9f41c306_I20210630" decimals="-6" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNjAvZnJhZzozYmFjYzZmYWNhNmU0ZTMyYTU0NmNjZjhmNzBmY2Y4Yy90YWJsZTpkY2QzNzk2ZGQwZDM0NmZiYjNhMDllMDg2Y2IyZTVjMi90YWJsZXJhbmdlOmRjZDM3OTZkZDBkMzQ2ZmJiM2EwOWUwODZjYjJlNWMyXzItMS0xLTEtMA_7e30d46d-31e0-420e-a08b-20ee6a57c3b1">11</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6844f415cc38462c93502fde5a64b55f_I20200630" decimals="-6" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNjAvZnJhZzozYmFjYzZmYWNhNmU0ZTMyYTU0NmNjZjhmNzBmY2Y4Yy90YWJsZTpkY2QzNzk2ZGQwZDM0NmZiYjNhMDllMDg2Y2IyZTVjMi90YWJsZXJhbmdlOmRjZDM3OTZkZDBkMzQ2ZmJiM2EwOWUwODZjYjJlNWMyXzItMy0xLTEtMA_adbf785a-48f7-4b12-8a10-8c6035b3c8e4">12</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0a3264d2aa5e4528bea7fa195a0d07b5_I20190630" decimals="-6" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNjAvZnJhZzozYmFjYzZmYWNhNmU0ZTMyYTU0NmNjZjhmNzBmY2Y4Yy90YWJsZTpkY2QzNzk2ZGQwZDM0NmZiYjNhMDllMDg2Y2IyZTVjMi90YWJsZXJhbmdlOmRjZDM3OTZkZDBkMzQ2ZmJiM2EwOWUwODZjYjJlNWMyXzItNS0xLTEtMA_df41fb26-dab7-405f-aff3-defec4a8dbc5">10</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Aggregate intrinsic value of exercised options</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9fac2b1e8f484ef081a25d163aa2c3a6_D20200701-20210630" decimals="-6" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNjAvZnJhZzozYmFjYzZmYWNhNmU0ZTMyYTU0NmNjZjhmNzBmY2Y4Yy90YWJsZTpkY2QzNzk2ZGQwZDM0NmZiYjNhMDllMDg2Y2IyZTVjMi90YWJsZXJhbmdlOmRjZDM3OTZkZDBkMzQ2ZmJiM2EwOWUwODZjYjJlNWMyXzMtMS0xLTEtMA_cb0ac67a-66ce-400b-bcf2-7148c421019b">10</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5ec12fa139c6458fb260601a40c83a61_D20190701-20200630" decimals="-6" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNjAvZnJhZzozYmFjYzZmYWNhNmU0ZTMyYTU0NmNjZjhmNzBmY2Y4Yy90YWJsZTpkY2QzNzk2ZGQwZDM0NmZiYjNhMDllMDg2Y2IyZTVjMi90YWJsZXJhbmdlOmRjZDM3OTZkZDBkMzQ2ZmJiM2EwOWUwODZjYjJlNWMyXzMtMy0xLTEtMA_f28de040-1ddf-44f8-8f7d-403f85c524e1">8</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4ff833c8f18c425d87db9b23fa00bd06_D20180701-20190630" decimals="-6" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNjAvZnJhZzozYmFjYzZmYWNhNmU0ZTMyYTU0NmNjZjhmNzBmY2Y4Yy90YWJsZTpkY2QzNzk2ZGQwZDM0NmZiYjNhMDllMDg2Y2IyZTVjMi90YWJsZXJhbmdlOmRjZDM3OTZkZDBkMzQ2ZmJiM2EwOWUwODZjYjJlNWMyXzMtNS0xLTEtMA_19b7d70c-c711-40c3-836d-b3b40ea55a05">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net proceeds/(withholding) from share-based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9fac2b1e8f484ef081a25d163aa2c3a6_D20200701-20210630" decimals="-6" name="cah:Netproceedstaxwithholdingsfromsharebasedcompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNjAvZnJhZzozYmFjYzZmYWNhNmU0ZTMyYTU0NmNjZjhmNzBmY2Y4Yy90YWJsZTpkY2QzNzk2ZGQwZDM0NmZiYjNhMDllMDg2Y2IyZTVjMi90YWJsZXJhbmdlOmRjZDM3OTZkZDBkMzQ2ZmJiM2EwOWUwODZjYjJlNWMyXzQtMS0xLTEtMA_6d489a65-3370-4bd3-99fd-fad45be1868e">32</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5ec12fa139c6458fb260601a40c83a61_D20190701-20200630" decimals="-6" name="cah:Netproceedstaxwithholdingsfromsharebasedcompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNjAvZnJhZzozYmFjYzZmYWNhNmU0ZTMyYTU0NmNjZjhmNzBmY2Y4Yy90YWJsZTpkY2QzNzk2ZGQwZDM0NmZiYjNhMDllMDg2Y2IyZTVjMi90YWJsZXJhbmdlOmRjZDM3OTZkZDBkMzQ2ZmJiM2EwOWUwODZjYjJlNWMyXzQtMy0xLTEtMA_53476298-20ab-4c69-871d-658be91cfe5e">26</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4ff833c8f18c425d87db9b23fa00bd06_D20180701-20190630" decimals="-6" name="cah:Netproceedstaxwithholdingsfromsharebasedcompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNjAvZnJhZzozYmFjYzZmYWNhNmU0ZTMyYTU0NmNjZjhmNzBmY2Y4Yy90YWJsZTpkY2QzNzk2ZGQwZDM0NmZiYjNhMDllMDg2Y2IyZTVjMi90YWJsZXJhbmdlOmRjZDM3OTZkZDBkMzQ2ZmJiM2EwOWUwODZjYjJlNWMyXzQtNS0xLTEtMA_059ed624-6281-4eb8-a918-85393620c063">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Excess tax benefits from share based compensation</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9fac2b1e8f484ef081a25d163aa2c3a6_D20200701-20210630" decimals="-6" sign="-" name="us-gaap:ExcessTaxBenefitFromShareBasedCompensationFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNjAvZnJhZzozYmFjYzZmYWNhNmU0ZTMyYTU0NmNjZjhmNzBmY2Y4Yy90YWJsZTpkY2QzNzk2ZGQwZDM0NmZiYjNhMDllMDg2Y2IyZTVjMi90YWJsZXJhbmdlOmRjZDM3OTZkZDBkMzQ2ZmJiM2EwOWUwODZjYjJlNWMyXzUtMS0xLTEtMA_6fdb590b-2a56-49fb-8943-e5f99c627970">5</ix:nonFraction>)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5ec12fa139c6458fb260601a40c83a61_D20190701-20200630" decimals="-6" name="us-gaap:ExcessTaxBenefitFromShareBasedCompensationFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNjAvZnJhZzozYmFjYzZmYWNhNmU0ZTMyYTU0NmNjZjhmNzBmY2Y4Yy90YWJsZTpkY2QzNzk2ZGQwZDM0NmZiYjNhMDllMDg2Y2IyZTVjMi90YWJsZXJhbmdlOmRjZDM3OTZkZDBkMzQ2ZmJiM2EwOWUwODZjYjJlNWMyXzUtMy0xLTEtMA_445f52a8-8ae6-4941-8ad7-944f03be7971">6</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4ff833c8f18c425d87db9b23fa00bd06_D20180701-20190630" decimals="-6" name="us-gaap:ExcessTaxBenefitFromShareBasedCompensationFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNjAvZnJhZzozYmFjYzZmYWNhNmU0ZTMyYTU0NmNjZjhmNzBmY2Y4Yy90YWJsZTpkY2QzNzk2ZGQwZDM0NmZiYjNhMDllMDg2Y2IyZTVjMi90YWJsZXJhbmdlOmRjZDM3OTZkZDBkMzQ2ZmJiM2EwOWUwODZjYjJlNWMyXzUtNS0xLTEtMA_d77a2c7e-12a3-4983-a05d-f38a027f40ef">7</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total compensation cost, net of estimated forfeitures, related to unvested stock options not yet recognized, pre-tax</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib473c6ce356d4388a73564ce9f41c306_I20210630" decimals="-6" format="ixt:zerodash" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNjAvZnJhZzozYmFjYzZmYWNhNmU0ZTMyYTU0NmNjZjhmNzBmY2Y4Yy90YWJsZTpkY2QzNzk2ZGQwZDM0NmZiYjNhMDllMDg2Y2IyZTVjMi90YWJsZXJhbmdlOmRjZDM3OTZkZDBkMzQ2ZmJiM2EwOWUwODZjYjJlNWMyXzYtMS0xLTEtMA_97dc39bf-6a5a-430b-ab4b-6f80e1b68512">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6844f415cc38462c93502fde5a64b55f_I20200630" decimals="-6" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNjAvZnJhZzozYmFjYzZmYWNhNmU0ZTMyYTU0NmNjZjhmNzBmY2Y4Yy90YWJsZTpkY2QzNzk2ZGQwZDM0NmZiYjNhMDllMDg2Y2IyZTVjMi90YWJsZXJhbmdlOmRjZDM3OTZkZDBkMzQ2ZmJiM2EwOWUwODZjYjJlNWMyXzYtMy0xLTEtMA_ec0f6a70-1bd7-4b2e-a1ee-cfb59292555a">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0a3264d2aa5e4528bea7fa195a0d07b5_I20190630" decimals="-6" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNjAvZnJhZzozYmFjYzZmYWNhNmU0ZTMyYTU0NmNjZjhmNzBmY2Y4Yy90YWJsZTpkY2QzNzk2ZGQwZDM0NmZiYjNhMDllMDg2Y2IyZTVjMi90YWJsZXJhbmdlOmRjZDM3OTZkZDBkMzQ2ZmJiM2EwOWUwODZjYjJlNWMyXzYtNS0xLTEtMA_014218b3-d34a-4e8c-a1f4-a9419f9f16f6">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total fair value of shares vested during the year</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9fac2b1e8f484ef081a25d163aa2c3a6_D20200701-20210630" decimals="-6" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNjAvZnJhZzozYmFjYzZmYWNhNmU0ZTMyYTU0NmNjZjhmNzBmY2Y4Yy90YWJsZTpkY2QzNzk2ZGQwZDM0NmZiYjNhMDllMDg2Y2IyZTVjMi90YWJsZXJhbmdlOmRjZDM3OTZkZDBkMzQ2ZmJiM2EwOWUwODZjYjJlNWMyXzctMS0xLTEtMA_429f0361-3779-46a3-92e5-3a1b767b7b3f">3</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5ec12fa139c6458fb260601a40c83a61_D20190701-20200630" decimals="-6" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNjAvZnJhZzozYmFjYzZmYWNhNmU0ZTMyYTU0NmNjZjhmNzBmY2Y4Yy90YWJsZTpkY2QzNzk2ZGQwZDM0NmZiYjNhMDllMDg2Y2IyZTVjMi90YWJsZXJhbmdlOmRjZDM3OTZkZDBkMzQ2ZmJiM2EwOWUwODZjYjJlNWMyXzctMy0xLTEtMA_0a3a5500-f8ea-4926-9fe3-3a7ae9982c8f">8</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4ff833c8f18c425d87db9b23fa00bd06_D20180701-20190630" decimals="-6" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNjAvZnJhZzozYmFjYzZmYWNhNmU0ZTMyYTU0NmNjZjhmNzBmY2Y4Yy90YWJsZTpkY2QzNzk2ZGQwZDM0NmZiYjNhMDllMDg2Y2IyZTVjMi90YWJsZXJhbmdlOmRjZDM3OTZkZDBkMzQ2ZmJiM2EwOWUwODZjYjJlNWMyXzctNS0xLTEtMA_b9341ff2-032d-4086-8e6c-a39882d8ff6f">20</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Weighted-average grant date fair value per stock option</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i9fac2b1e8f484ef081a25d163aa2c3a6_D20200701-20210630" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNjAvZnJhZzozYmFjYzZmYWNhNmU0ZTMyYTU0NmNjZjhmNzBmY2Y4Yy90YWJsZTpkY2QzNzk2ZGQwZDM0NmZiYjNhMDllMDg2Y2IyZTVjMi90YWJsZXJhbmdlOmRjZDM3OTZkZDBkMzQ2ZmJiM2EwOWUwODZjYjJlNWMyXzgtMS0xLTEtMA_a170c38d-0e88-4c35-8a47-34acf0aad10b">12.94</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i5ec12fa139c6458fb260601a40c83a61_D20190701-20200630" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNjAvZnJhZzozYmFjYzZmYWNhNmU0ZTMyYTU0NmNjZjhmNzBmY2Y4Yy90YWJsZTpkY2QzNzk2ZGQwZDM0NmZiYjNhMDllMDg2Y2IyZTVjMi90YWJsZXJhbmdlOmRjZDM3OTZkZDBkMzQ2ZmJiM2EwOWUwODZjYjJlNWMyXzgtMy0xLTEtMA_b5d1ae85-ed67-4161-85d6-8de99ac130fc">8.26</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i4ff833c8f18c425d87db9b23fa00bd06_D20180701-20190630" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNjAvZnJhZzozYmFjYzZmYWNhNmU0ZTMyYTU0NmNjZjhmNzBmY2Y4Yy90YWJsZTpkY2QzNzk2ZGQwZDM0NmZiYjNhMDllMDg2Y2IyZTVjMi90YWJsZXJhbmdlOmRjZDM3OTZkZDBkMzQ2ZmJiM2EwOWUwODZjYjJlNWMyXzgtNS0xLTEtMA_57b525df-7890-4e22-9ee6-c70af15f4633">8.34</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="text-align:justify"><ix:nonNumeric contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630" name="cah:RemainingStockOptionPlanDataTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNjAvZnJhZzozYmFjYzZmYWNhNmU0ZTMyYTU0NmNjZjhmNzBmY2Y4Yy90ZXh0cmVnaW9uOjNiYWNjNmZhY2E2ZTRlMzJhNTQ2Y2NmOGY3MGZjZjhjXzQxNDE_6d8c801d-7974-4e83-a652-f62fdd10c23d" escape="true"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.382%"><tr><td style="width:1.0%"></td><td style="width:65.049%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.148%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.352%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.148%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.352%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.151%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in years)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Weighted-average remaining contractual life of outstanding options</span></td><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i9fac2b1e8f484ef081a25d163aa2c3a6_D20200701-20210630" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNjAvZnJhZzozYmFjYzZmYWNhNmU0ZTMyYTU0NmNjZjhmNzBmY2Y4Yy90YWJsZTplZGVlNGJjY2U4YTk0MDQzOGM5MTkwMDk2MDFkZTM4Ny90YWJsZXJhbmdlOmVkZWU0YmNjZThhOTQwNDM4YzkxOTAwOTYwMWRlMzg3XzEtMS0xLTEtMA_17769ada-f201-494d-87c6-0d0e06f7ef5c">4</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i5ec12fa139c6458fb260601a40c83a61_D20190701-20200630" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNjAvZnJhZzozYmFjYzZmYWNhNmU0ZTMyYTU0NmNjZjhmNzBmY2Y4Yy90YWJsZTplZGVlNGJjY2U4YTk0MDQzOGM5MTkwMDk2MDFkZTM4Ny90YWJsZXJhbmdlOmVkZWU0YmNjZThhOTQwNDM4YzkxOTAwOTYwMWRlMzg3XzEtMy0xLTEtMA_22ef05aa-aab0-4315-90a6-5186d67d8f94">5</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i4ff833c8f18c425d87db9b23fa00bd06_D20180701-20190630" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNjAvZnJhZzozYmFjYzZmYWNhNmU0ZTMyYTU0NmNjZjhmNzBmY2Y4Yy90YWJsZTplZGVlNGJjY2U4YTk0MDQzOGM5MTkwMDk2MDFkZTM4Ny90YWJsZXJhbmdlOmVkZWU0YmNjZThhOTQwNDM4YzkxOTAwOTYwMWRlMzg3XzEtNS0xLTEtMA_5cb93c72-a3a1-41a8-a8d7-ae719b048730">5</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Weighted-average remaining contractual life of exercisable options</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i9fac2b1e8f484ef081a25d163aa2c3a6_D20200701-20210630" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNjAvZnJhZzozYmFjYzZmYWNhNmU0ZTMyYTU0NmNjZjhmNzBmY2Y4Yy90YWJsZTplZGVlNGJjY2U4YTk0MDQzOGM5MTkwMDk2MDFkZTM4Ny90YWJsZXJhbmdlOmVkZWU0YmNjZThhOTQwNDM4YzkxOTAwOTYwMWRlMzg3XzItMS0xLTEtMA_52bb573c-3d83-4058-95e7-60a6bc287e29">4</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i5ec12fa139c6458fb260601a40c83a61_D20190701-20200630" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNjAvZnJhZzozYmFjYzZmYWNhNmU0ZTMyYTU0NmNjZjhmNzBmY2Y4Yy90YWJsZTplZGVlNGJjY2U4YTk0MDQzOGM5MTkwMDk2MDFkZTM4Ny90YWJsZXJhbmdlOmVkZWU0YmNjZThhOTQwNDM4YzkxOTAwOTYwMWRlMzg3XzItMy0xLTEtMA_4ae622c5-9bcb-4359-9635-1b802d9d9c00">5</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i4ff833c8f18c425d87db9b23fa00bd06_D20180701-20190630" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNjAvZnJhZzozYmFjYzZmYWNhNmU0ZTMyYTU0NmNjZjhmNzBmY2Y4Yy90YWJsZTplZGVlNGJjY2U4YTk0MDQzOGM5MTkwMDk2MDFkZTM4Ny90YWJsZXJhbmdlOmVkZWU0YmNjZThhOTQwNDM4YzkxOTAwOTYwMWRlMzg3XzItNS0xLTEtMA_2d3f2a1c-732b-442a-ba04-2c5adb8198d3">5</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Weighted-average period over which stock option compensation cost is expected to be recognized</span></td><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i9fac2b1e8f484ef081a25d163aa2c3a6_D20200701-20210630" format="ixt-sec:duryear" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNjAvZnJhZzozYmFjYzZmYWNhNmU0ZTMyYTU0NmNjZjhmNzBmY2Y4Yy90YWJsZTplZGVlNGJjY2U4YTk0MDQzOGM5MTkwMDk2MDFkZTM4Ny90YWJsZXJhbmdlOmVkZWU0YmNjZThhOTQwNDM4YzkxOTAwOTYwMWRlMzg3XzMtMS0xLTEtMA_411875a7-6675-4b0f-9a4b-279d9797034d">2</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i5ec12fa139c6458fb260601a40c83a61_D20190701-20200630" format="ixt-sec:duryear" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNjAvZnJhZzozYmFjYzZmYWNhNmU0ZTMyYTU0NmNjZjhmNzBmY2Y4Yy90YWJsZTplZGVlNGJjY2U4YTk0MDQzOGM5MTkwMDk2MDFkZTM4Ny90YWJsZXJhbmdlOmVkZWU0YmNjZThhOTQwNDM4YzkxOTAwOTYwMWRlMzg3XzMtMy0xLTEtMA_02b9181a-dfd6-414c-928f-6fb684c107cf">1</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i4ff833c8f18c425d87db9b23fa00bd06_D20180701-20190630" format="ixt-sec:duryear" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNjAvZnJhZzozYmFjYzZmYWNhNmU0ZTMyYTU0NmNjZjhmNzBmY2Y4Yy90YWJsZTplZGVlNGJjY2U4YTk0MDQzOGM5MTkwMDk2MDFkZTM4Ny90YWJsZXJhbmdlOmVkZWU0YmNjZThhOTQwNDM4YzkxOTAwOTYwMWRlMzg3XzMtNS0xLTEtMA_a3339ed2-137a-4a32-865b-2ad4cfcdacc7">1</ix:nonNumeric></span></td></tr></table></ix:nonNumeric></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair values were estimated on the grant date using a lattice valuation model. We believe the lattice model provides reasonable estimates because it has the ability to take into account individual exercise patterns based on changes in our stock price and other variables, and it provides for a range of input assumptions, which are disclosed in the table below. The risk-free rate is based on the U.S. Treasury yield curve at the time of the grant. We analyzed historical data to estimate option exercise behaviors and employee terminations to be used within the lattice model. The expected life of the options granted was calculated from the option valuation model and represents the length of time in years that the options granted are expected to be outstanding. Expected volatilities are based on implied volatility from traded options on our common shares and historical volatility over a period of time commensurate with the contractual term of the option grant (up to <ix:nonNumeric contextRef="i6425a2ad601a4906adbbf99175836b8d_D20200701-20210630" format="ixt-sec:durwordsen" name="cah:ExercisablePeriodOfPlansInYears" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNjAvZnJhZzozYmFjYzZmYWNhNmU0ZTMyYTU0NmNjZjhmNzBmY2Y4Yy90ZXh0cmVnaW9uOjNiYWNjNmZhY2E2ZTRlMzJhNTQ2Y2NmOGY3MGZjZjhjXzI4OTI_377872dd-ebc5-4db9-83ba-35f9e48d8ceb">ten years</ix:nonNumeric>). </span></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630" xsi:nil="true" name="us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNjAvZnJhZzozYmFjYzZmYWNhNmU0ZTMyYTU0NmNjZjhmNzBmY2Y4Yy90ZXh0cmVnaW9uOjNiYWNjNmZhY2E2ZTRlMzJhNTQ2Y2NmOGY3MGZjZjhjXzQxNjY_9497ff4a-3726-4562-824f-d9d526bd930e" escape="true"></ix:nonNumeric>Performance Share Units</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Performance share units generally vest over a <ix:nonFraction unitRef="vestingperiods" contextRef="i217c2671c6f84df1ab8278415bc34c16_D20200701-20210630" decimals="INF" name="cah:VestingPeriodinyearsforShares" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNjAvZnJhZzozYmFjYzZmYWNhNmU0ZTMyYTU0NmNjZjhmNzBmY2Y4Yy90ZXh0cmVnaW9uOjNiYWNjNmZhY2E2ZTRlMzJhNTQ2Y2NmOGY3MGZjZjhjXzMxNTY_b6f193a6-aebe-4bca-814a-316bd24bda47">3</ix:nonFraction>-year performance period based on achievement of specific performance goals. Based on the extent to which the targets are achieved, vested shares may range from <ix:nonFraction unitRef="number" contextRef="i2072923bec904f33a89202306af14057_D20200701-20210630" decimals="2" format="ixt-sec:numwordsen" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNjAvZnJhZzozYmFjYzZmYWNhNmU0ZTMyYTU0NmNjZjhmNzBmY2Y4Yy90ZXh0cmVnaW9uOjNiYWNjNmZhY2E2ZTRlMzJhNTQ2Y2NmOGY3MGZjZjhjXzMzMTk_81cf0376-bb93-4dbb-a29e-1db46692db76">zero</ix:nonFraction> to <ix:nonFraction unitRef="number" contextRef="i064bd318128c454cbd68ef31c37fed9d_D20200701-20210630" decimals="2" format="ixt:numdotdecimal" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNjAvZnJhZzozYmFjYzZmYWNhNmU0ZTMyYTU0NmNjZjhmNzBmY2Y4Yy90ZXh0cmVnaW9uOjNiYWNjNmZhY2E2ZTRlMzJhNTQ2Y2NmOGY3MGZjZjhjXzMzMjU_22e62abc-a373-47fb-b454-c76878be24f0">240</ix:nonFraction> percent of the target award amount. Performance share units accrue cash dividend equivalents that are payable upon vesting of the awards.</span></div></div></ix:continuation></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:3pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.222%"><tr><td style="width:1.0%"></td><td style="width:32.133%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.433%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.134%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">86</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardinal Health </span><span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">| </span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2021 Form 10-K</span></div></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:3pt"><span><br/></span></div><div style="margin-bottom:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.702%"><tr><td style="width:1.0%"></td><td style="width:24.720%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:50.989%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.991%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#e41f35;border-bottom:1pt solid #e41f35;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Notes to Financial Statements</span></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span><br/></span></div></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:48.214%"><ix:continuation id="i26f7aba060bf44c5a8ad457ee8c2e292"><ix:nonNumeric contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630" name="us-gaap:ScheduleOfNonvestedPerformanceBasedUnitsActivityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNjAvZnJhZzozYmFjYzZmYWNhNmU0ZTMyYTU0NmNjZjhmNzBmY2Y4Yy90ZXh0cmVnaW9uOjNiYWNjNmZhY2E2ZTRlMzJhNTQ2Y2NmOGY3MGZjZjhjXzQxMzU_c6039185-4dcf-4fe0-bdad-3da5a3ec979b" escape="true"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes all transactions related to performance share units under the Plans (based on target award amounts):</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.691%"><tr><td style="width:1.0%"></td><td style="width:49.983%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.023%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.347%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:26.147%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in millions, except per share amounts)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Performance<br/>Share Units</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-Average<br/>Grant Date Fair<br/>Value per Share</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Nonvested at June 30, 2019</span></td><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i837fa9d3c1f04fb6aa54fd33592f52b3_I20190630" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNjAvZnJhZzozYmFjYzZmYWNhNmU0ZTMyYTU0NmNjZjhmNzBmY2Y4Yy90YWJsZTo3ODZkYTk4M2E2MTU0NGFlODE4NWM3ZmM0NGE0YjA1MS90YWJsZXJhbmdlOjc4NmRhOTgzYTYxNTQ0YWU4MTg1YzdmYzQ0YTRiMDUxXzEtMS0xLTEtMA_2a545e5c-c4e3-44be-8cd7-514b848fc781">0.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i837fa9d3c1f04fb6aa54fd33592f52b3_I20190630" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNjAvZnJhZzozYmFjYzZmYWNhNmU0ZTMyYTU0NmNjZjhmNzBmY2Y4Yy90YWJsZTo3ODZkYTk4M2E2MTU0NGFlODE4NWM3ZmM0NGE0YjA1MS90YWJsZXJhbmdlOjc4NmRhOTgzYTYxNTQ0YWU4MTg1YzdmYzQ0YTRiMDUxXzEtMy0xLTEtMA_c300ed3c-63c1-4c14-a159-a4e6ac191aa4">51.45</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i4f0f3088df2a4e019bd09b2ef236fef0_D20190701-20200630" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNjAvZnJhZzozYmFjYzZmYWNhNmU0ZTMyYTU0NmNjZjhmNzBmY2Y4Yy90YWJsZTo3ODZkYTk4M2E2MTU0NGFlODE4NWM3ZmM0NGE0YjA1MS90YWJsZXJhbmdlOjc4NmRhOTgzYTYxNTQ0YWU4MTg1YzdmYzQ0YTRiMDUxXzItMS0xLTEtMA_887c1c86-c892-4fbd-ba5a-5989c6d493bd">0.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i4f0f3088df2a4e019bd09b2ef236fef0_D20190701-20200630" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNjAvZnJhZzozYmFjYzZmYWNhNmU0ZTMyYTU0NmNjZjhmNzBmY2Y4Yy90YWJsZTo3ODZkYTk4M2E2MTU0NGFlODE4NWM3ZmM0NGE0YjA1MS90YWJsZXJhbmdlOjc4NmRhOTgzYTYxNTQ0YWU4MTg1YzdmYzQ0YTRiMDUxXzItMy0xLTEtMA_770b97f2-e660-4f15-8cdf-4a70639b628c">44.03</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i4f0f3088df2a4e019bd09b2ef236fef0_D20190701-20200630" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNjAvZnJhZzozYmFjYzZmYWNhNmU0ZTMyYTU0NmNjZjhmNzBmY2Y4Yy90YWJsZTo3ODZkYTk4M2E2MTU0NGFlODE4NWM3ZmM0NGE0YjA1MS90YWJsZXJhbmdlOjc4NmRhOTgzYTYxNTQ0YWU4MTg1YzdmYzQ0YTRiMDUxXzMtMS0xLTEtMA_efb5c137-aea9-4c4c-aecd-f7e6551323e7">0.1</ix:nonFraction>)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i4f0f3088df2a4e019bd09b2ef236fef0_D20190701-20200630" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNjAvZnJhZzozYmFjYzZmYWNhNmU0ZTMyYTU0NmNjZjhmNzBmY2Y4Yy90YWJsZTo3ODZkYTk4M2E2MTU0NGFlODE4NWM3ZmM0NGE0YjA1MS90YWJsZXJhbmdlOjc4NmRhOTgzYTYxNTQ0YWU4MTg1YzdmYzQ0YTRiMDUxXzMtMy0xLTEtMA_0ca071f1-2fc3-4fde-8e42-3cc8c9f5d47e">48.40</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Canceled and forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i4f0f3088df2a4e019bd09b2ef236fef0_D20190701-20200630" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNjAvZnJhZzozYmFjYzZmYWNhNmU0ZTMyYTU0NmNjZjhmNzBmY2Y4Yy90YWJsZTo3ODZkYTk4M2E2MTU0NGFlODE4NWM3ZmM0NGE0YjA1MS90YWJsZXJhbmdlOjc4NmRhOTgzYTYxNTQ0YWU4MTg1YzdmYzQ0YTRiMDUxXzQtMS0xLTEtMA_e8eda6b2-2cf6-461e-a56e-3bf662102555">0.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i4f0f3088df2a4e019bd09b2ef236fef0_D20190701-20200630" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNjAvZnJhZzozYmFjYzZmYWNhNmU0ZTMyYTU0NmNjZjhmNzBmY2Y4Yy90YWJsZTo3ODZkYTk4M2E2MTU0NGFlODE4NWM3ZmM0NGE0YjA1MS90YWJsZXJhbmdlOjc4NmRhOTgzYTYxNTQ0YWU4MTg1YzdmYzQ0YTRiMDUxXzQtMy0xLTEtMA_26742176-5560-4562-9667-8fe77d43f8c6">50.92</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Nonvested at June 30, 2020</span></td><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib996ace534574f9da807e45a4e349efc_I20200630" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNjAvZnJhZzozYmFjYzZmYWNhNmU0ZTMyYTU0NmNjZjhmNzBmY2Y4Yy90YWJsZTo3ODZkYTk4M2E2MTU0NGFlODE4NWM3ZmM0NGE0YjA1MS90YWJsZXJhbmdlOjc4NmRhOTgzYTYxNTQ0YWU4MTg1YzdmYzQ0YTRiMDUxXzUtMS0xLTEtMA_0a8e5a6b-61ca-442f-8760-1f56157b0655">1.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ib996ace534574f9da807e45a4e349efc_I20200630" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNjAvZnJhZzozYmFjYzZmYWNhNmU0ZTMyYTU0NmNjZjhmNzBmY2Y4Yy90YWJsZTo3ODZkYTk4M2E2MTU0NGFlODE4NWM3ZmM0NGE0YjA1MS90YWJsZXJhbmdlOjc4NmRhOTgzYTYxNTQ0YWU4MTg1YzdmYzQ0YTRiMDUxXzUtMy0xLTEtMA_5c98fb8e-4f48-42fd-a832-722b55237192">54.24</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i217c2671c6f84df1ab8278415bc34c16_D20200701-20210630" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNjAvZnJhZzozYmFjYzZmYWNhNmU0ZTMyYTU0NmNjZjhmNzBmY2Y4Yy90YWJsZTo3ODZkYTk4M2E2MTU0NGFlODE4NWM3ZmM0NGE0YjA1MS90YWJsZXJhbmdlOjc4NmRhOTgzYTYxNTQ0YWU4MTg1YzdmYzQ0YTRiMDUxXzYtMS0xLTEtMA_1bda76d9-1498-455e-af3f-e7ff1af32383">0.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i217c2671c6f84df1ab8278415bc34c16_D20200701-20210630" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNjAvZnJhZzozYmFjYzZmYWNhNmU0ZTMyYTU0NmNjZjhmNzBmY2Y4Yy90YWJsZTo3ODZkYTk4M2E2MTU0NGFlODE4NWM3ZmM0NGE0YjA1MS90YWJsZXJhbmdlOjc4NmRhOTgzYTYxNTQ0YWU4MTg1YzdmYzQ0YTRiMDUxXzYtMy0xLTEtMA_93eac170-0b7b-4c92-8a3c-6ea867e69434">55.45</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i217c2671c6f84df1ab8278415bc34c16_D20200701-20210630" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNjAvZnJhZzozYmFjYzZmYWNhNmU0ZTMyYTU0NmNjZjhmNzBmY2Y4Yy90YWJsZTo3ODZkYTk4M2E2MTU0NGFlODE4NWM3ZmM0NGE0YjA1MS90YWJsZXJhbmdlOjc4NmRhOTgzYTYxNTQ0YWU4MTg1YzdmYzQ0YTRiMDUxXzctMS0xLTEtMA_6ea23060-ef3f-48a8-acd7-77f1be56afb4">0.1</ix:nonFraction>)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i217c2671c6f84df1ab8278415bc34c16_D20200701-20210630" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNjAvZnJhZzozYmFjYzZmYWNhNmU0ZTMyYTU0NmNjZjhmNzBmY2Y4Yy90YWJsZTo3ODZkYTk4M2E2MTU0NGFlODE4NWM3ZmM0NGE0YjA1MS90YWJsZXJhbmdlOjc4NmRhOTgzYTYxNTQ0YWU4MTg1YzdmYzQ0YTRiMDUxXzctMy0xLTEtMA_ccb4455a-a308-4381-bff0-ac9852346d5b">42.72</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Canceled and forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i217c2671c6f84df1ab8278415bc34c16_D20200701-20210630" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNjAvZnJhZzozYmFjYzZmYWNhNmU0ZTMyYTU0NmNjZjhmNzBmY2Y4Yy90YWJsZTo3ODZkYTk4M2E2MTU0NGFlODE4NWM3ZmM0NGE0YjA1MS90YWJsZXJhbmdlOjc4NmRhOTgzYTYxNTQ0YWU4MTg1YzdmYzQ0YTRiMDUxXzgtMS0xLTEtMA_bf099aa7-31c9-4e3b-b7c9-666e58a92b9f">0.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i217c2671c6f84df1ab8278415bc34c16_D20200701-20210630" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNjAvZnJhZzozYmFjYzZmYWNhNmU0ZTMyYTU0NmNjZjhmNzBmY2Y4Yy90YWJsZTo3ODZkYTk4M2E2MTU0NGFlODE4NWM3ZmM0NGE0YjA1MS90YWJsZXJhbmdlOjc4NmRhOTgzYTYxNTQ0YWU4MTg1YzdmYzQ0YTRiMDUxXzgtMy0xLTEtMA_94046633-564e-4fdf-ad62-27d40d58f59b">53.71</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nonvested at June 30, 2021</span></td><td colspan="2" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i09a66472ecae47489b82c3a6aade6b47_I20210630" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNjAvZnJhZzozYmFjYzZmYWNhNmU0ZTMyYTU0NmNjZjhmNzBmY2Y4Yy90YWJsZTo3ODZkYTk4M2E2MTU0NGFlODE4NWM3ZmM0NGE0YjA1MS90YWJsZXJhbmdlOjc4NmRhOTgzYTYxNTQ0YWU4MTg1YzdmYzQ0YTRiMDUxXzktMS0xLTEtMA_411b79a5-65c0-4e75-9879-b761d69fa558">1.2</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i09a66472ecae47489b82c3a6aade6b47_I20210630" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNjAvZnJhZzozYmFjYzZmYWNhNmU0ZTMyYTU0NmNjZjhmNzBmY2Y4Yy90YWJsZTo3ODZkYTk4M2E2MTU0NGFlODE4NWM3ZmM0NGE0YjA1MS90YWJsZXJhbmdlOjc4NmRhOTgzYTYxNTQ0YWU4MTg1YzdmYzQ0YTRiMDUxXzktMy0xLTEtMA_961fb6db-1ab4-40f9-a907-7dea02a19cb2">54.89</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:3pt;text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630" name="cah:AdditionalPerformanceShareUnitsDataTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNjAvZnJhZzozYmFjYzZmYWNhNmU0ZTMyYTU0NmNjZjhmNzBmY2Y4Yy90ZXh0cmVnaW9uOjNiYWNjNmZhY2E2ZTRlMzJhNTQ2Y2NmOGY3MGZjZjhjXzQxNDI_7a2f04b2-cfc9-4231-8803-66f0b06c233c" escape="true"><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides additional data related to performance share unit activity:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.691%"><tr><td style="width:1.0%"></td><td style="width:58.652%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.283%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.347%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.283%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.347%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.288%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total compensation cost, net of estimated forfeitures, related to nonvested performance share units not yet recognized, pre-tax</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09a66472ecae47489b82c3a6aade6b47_I20210630" decimals="-6" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNjAvZnJhZzozYmFjYzZmYWNhNmU0ZTMyYTU0NmNjZjhmNzBmY2Y4Yy90YWJsZTpkY2ExNzc1NGI3NzI0OWI3YThjYWNjZDM2OTE3MmNkZi90YWJsZXJhbmdlOmRjYTE3NzU0Yjc3MjQ5YjdhOGNhY2NkMzY5MTcyY2RmXzEtMS0xLTEtMA_f9bda7bb-de2a-4df9-936d-cc39441fb59c">26</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib996ace534574f9da807e45a4e349efc_I20200630" decimals="-6" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNjAvZnJhZzozYmFjYzZmYWNhNmU0ZTMyYTU0NmNjZjhmNzBmY2Y4Yy90YWJsZTpkY2ExNzc1NGI3NzI0OWI3YThjYWNjZDM2OTE3MmNkZi90YWJsZXJhbmdlOmRjYTE3NzU0Yjc3MjQ5YjdhOGNhY2NkMzY5MTcyY2RmXzEtMy0xLTEtMA_35558724-f425-42d1-9a52-1a4bf1d7ff95">29</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i837fa9d3c1f04fb6aa54fd33592f52b3_I20190630" decimals="-6" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNjAvZnJhZzozYmFjYzZmYWNhNmU0ZTMyYTU0NmNjZjhmNzBmY2Y4Yy90YWJsZTpkY2ExNzc1NGI3NzI0OWI3YThjYWNjZDM2OTE3MmNkZi90YWJsZXJhbmdlOmRjYTE3NzU0Yjc3MjQ5YjdhOGNhY2NkMzY5MTcyY2RmXzEtNS0xLTEtMA_a66003be-ac61-4bf1-81f9-9ccf483ea8d7">12</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Weighted-average period over which performance share unit cost is expected to be recognized (in years)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i217c2671c6f84df1ab8278415bc34c16_D20200701-20210630" format="ixt-sec:duryear" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNjAvZnJhZzozYmFjYzZmYWNhNmU0ZTMyYTU0NmNjZjhmNzBmY2Y4Yy90YWJsZTpkY2ExNzc1NGI3NzI0OWI3YThjYWNjZDM2OTE3MmNkZi90YWJsZXJhbmdlOmRjYTE3NzU0Yjc3MjQ5YjdhOGNhY2NkMzY5MTcyY2RmXzItMS0xLTEtMA_47bb9bb6-8122-4912-a963-6a6b375d387a">2</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i4f0f3088df2a4e019bd09b2ef236fef0_D20190701-20200630" format="ixt-sec:duryear" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNjAvZnJhZzozYmFjYzZmYWNhNmU0ZTMyYTU0NmNjZjhmNzBmY2Y4Yy90YWJsZTpkY2ExNzc1NGI3NzI0OWI3YThjYWNjZDM2OTE3MmNkZi90YWJsZXJhbmdlOmRjYTE3NzU0Yjc3MjQ5YjdhOGNhY2NkMzY5MTcyY2RmXzItMy0xLTEtMA_689bedfe-c7cb-4ae8-9ef9-369cd2bcf416">2</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="id7eb385b0eaf45a0aa833269191797b8_D20180701-20190630" format="ixt-sec:duryear" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNjAvZnJhZzozYmFjYzZmYWNhNmU0ZTMyYTU0NmNjZjhmNzBmY2Y4Yy90YWJsZTpkY2ExNzc1NGI3NzI0OWI3YThjYWNjZDM2OTE3MmNkZi90YWJsZXJhbmdlOmRjYTE3NzU0Yjc3MjQ5YjdhOGNhY2NkMzY5MTcyY2RmXzItNS0xLTEtMA_3a1ac462-d31d-47b6-aa67-6e56df960b47">2</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total fair value of shares vested during the year</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i217c2671c6f84df1ab8278415bc34c16_D20200701-20210630" decimals="-6" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNjAvZnJhZzozYmFjYzZmYWNhNmU0ZTMyYTU0NmNjZjhmNzBmY2Y4Yy90YWJsZTpkY2ExNzc1NGI3NzI0OWI3YThjYWNjZDM2OTE3MmNkZi90YWJsZXJhbmdlOmRjYTE3NzU0Yjc3MjQ5YjdhOGNhY2NkMzY5MTcyY2RmXzMtMS0xLTEtMA_7be0b0e0-3fa2-466b-a65f-10c69f2c352f">1</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4f0f3088df2a4e019bd09b2ef236fef0_D20190701-20200630" decimals="-6" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNjAvZnJhZzozYmFjYzZmYWNhNmU0ZTMyYTU0NmNjZjhmNzBmY2Y4Yy90YWJsZTpkY2ExNzc1NGI3NzI0OWI3YThjYWNjZDM2OTE3MmNkZi90YWJsZXJhbmdlOmRjYTE3NzU0Yjc3MjQ5YjdhOGNhY2NkMzY5MTcyY2RmXzMtMy0xLTEtMA_50163f7d-0098-444e-a8ff-d13afa300e30">5</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id7eb385b0eaf45a0aa833269191797b8_D20180701-20190630" decimals="-6" format="ixt:zerodash" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNjAvZnJhZzozYmFjYzZmYWNhNmU0ZTMyYTU0NmNjZjhmNzBmY2Y4Yy90YWJsZTpkY2ExNzc1NGI3NzI0OWI3YThjYWNjZDM2OTE3MmNkZi90YWJsZXJhbmdlOmRjYTE3NzU0Yjc3MjQ5YjdhOGNhY2NkMzY5MTcyY2RmXzMtNS0xLTEtMA_4795a370-1431-4a75-bc71-2b16af2d7a5f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Employee Retirement Savings Plans</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Substantially all of our domestic non-union employees are eligible to be enrolled in our company-sponsored contributory retirement savings plans, which include features under Section 401(k) of the Internal Revenue Code of 1986, and provide for matching and discretionary contributions by us. The total expense for our employee retirement savings plans was $<ix:nonFraction unitRef="usd" contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DefinedContributionPlanCostRecognized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNjAvZnJhZzozYmFjYzZmYWNhNmU0ZTMyYTU0NmNjZjhmNzBmY2Y4Yy90ZXh0cmVnaW9uOjNiYWNjNmZhY2E2ZTRlMzJhNTQ2Y2NmOGY3MGZjZjhjXzQwNzU_de01263d-64d5-46c6-83e7-f826fe3ca09f">55</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="ia31e9a409b874bb19d0ff6f2f39ecc09_D20190701-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DefinedContributionPlanCostRecognized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNjAvZnJhZzozYmFjYzZmYWNhNmU0ZTMyYTU0NmNjZjhmNzBmY2Y4Yy90ZXh0cmVnaW9uOjNiYWNjNmZhY2E2ZTRlMzJhNTQ2Y2NmOGY3MGZjZjhjXzQwNzk_c4c85960-c00d-4cee-8af1-cbb4c0f575fb">66</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i00a6d666bf604826b24e68ddbd63eac4_D20180701-20190630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DefinedContributionPlanCostRecognized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNjAvZnJhZzozYmFjYzZmYWNhNmU0ZTMyYTU0NmNjZjhmNzBmY2Y4Yy90ZXh0cmVnaW9uOjNiYWNjNmZhY2E2ZTRlMzJhNTQ2Y2NmOGY3MGZjZjhjXzQwODY_0927a0f4-fc09-4adb-9582-cdf699670e54">99</ix:nonFraction> million for fiscal 2021, 2020 and 2019, respectively.</span></div></ix:continuation></div><div style="display:inline-block;max-width:3.571%;min-width:2.571%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:48.215%"></div></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:32.135%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.428%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.137%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardinal Health </span><span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">|</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> Fiscal 2021 Form 10-K</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">87</span></div></td></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span><br/></span></div></div></div><div id="i4f0ec56b9c604f1782a65ea4a19c284d_172"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:3pt"><span><br/></span></div><div style="margin-bottom:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.553%"><tr><td style="width:1.0%"></td><td style="width:24.759%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:51.067%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.874%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#e41f35;border-bottom:1pt solid #e41f35;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Schedule II</span></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Valuation and Qualifying Accounts</span></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span><br/></span></div></div><ix:nonNumeric contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630" name="srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNzIvZnJhZzo2YzUyMDU0YWU0ZTk0NTlmOTdjN2ExNDljMmZhNGU3Mi90ZXh0cmVnaW9uOjZjNTIwNTRhZTRlOTQ1OWY5N2M3YTE0OWMyZmE0ZTcyXzY0Mg_7be7b2e0-00ba-44b5-8697-7111f6c7ee79" continuedAt="i7b5e314e54c6409198d54d5506476e61" escape="true"><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:14pt;font-weight:700;line-height:120%">Cardinal Health, Inc. and Subsidiaries</span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#ff0000;font-family:'Arial Narrow',sans-serif;font-size:13pt;font-weight:700;line-height:120%">Schedule&#160;II - Valuation and Qualifying Accounts</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:27.471%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.036%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.544%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.441%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.544%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.441%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.544%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.441%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.544%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.594%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance&#160;at<br/>Beginning of Period</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Charged&#160;to Costs<br/>and Expenses (1)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Charged&#160;to<br/>Other Accounts&#160;(2)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Deductions&#160;(3)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance&#160;at<br/>End of Period</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fiscal 2021</span></td><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida278becedcc42e688e90f303ce681a6_I20200630" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNzIvZnJhZzo2YzUyMDU0YWU0ZTk0NTlmOTdjN2ExNDljMmZhNGU3Mi90YWJsZTpjMjBmNmY4ZGNmNTk0ZmUyOWY2OTNiN2MxZjliNzU3Mi90YWJsZXJhbmdlOmMyMGY2ZjhkY2Y1OTRmZTI5ZjY5M2I3YzFmOWI3NTcyXzItMS0xLTEtMA_a388bfe1-927b-4cb6-b275-454d64e6101e">206</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i55e9481bb093412a97e842b3caeb64ec_D20200701-20210630" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNzIvZnJhZzo2YzUyMDU0YWU0ZTk0NTlmOTdjN2ExNDljMmZhNGU3Mi90YWJsZTpjMjBmNmY4ZGNmNTk0ZmUyOWY2OTNiN2MxZjliNzU3Mi90YWJsZXJhbmdlOmMyMGY2ZjhkY2Y1OTRmZTI5ZjY5M2I3YzFmOWI3NTcyXzItMy0xLTEtMA_ee758d27-d959-486b-ba8a-f60744b717a3">129</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i55e9481bb093412a97e842b3caeb64ec_D20200701-20210630" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNzIvZnJhZzo2YzUyMDU0YWU0ZTk0NTlmOTdjN2ExNDljMmZhNGU3Mi90YWJsZTpjMjBmNmY4ZGNmNTk0ZmUyOWY2OTNiN2MxZjliNzU3Mi90YWJsZXJhbmdlOmMyMGY2ZjhkY2Y1OTRmZTI5ZjY5M2I3YzFmOWI3NTcyXzItNS0xLTEtMA_4a9a8d07-d3dd-4af3-896c-c197e6f3f090">1</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i55e9481bb093412a97e842b3caeb64ec_D20200701-20210630" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesDeductions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNzIvZnJhZzo2YzUyMDU0YWU0ZTk0NTlmOTdjN2ExNDljMmZhNGU3Mi90YWJsZTpjMjBmNmY4ZGNmNTk0ZmUyOWY2OTNiN2MxZjliNzU3Mi90YWJsZXJhbmdlOmMyMGY2ZjhkY2Y1OTRmZTI5ZjY5M2I3YzFmOWI3NTcyXzItNy0xLTEtMA_ecbea82e-75d4-40c7-962a-a5ece71f5ec6">94</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf39bca192e042209819db3ca973f9f5_I20210630" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNzIvZnJhZzo2YzUyMDU0YWU0ZTk0NTlmOTdjN2ExNDljMmZhNGU3Mi90YWJsZTpjMjBmNmY4ZGNmNTk0ZmUyOWY2OTNiN2MxZjliNzU3Mi90YWJsZXJhbmdlOmMyMGY2ZjhkY2Y1OTRmZTI5ZjY5M2I3YzFmOWI3NTcyXzItOS0xLTEtMA_e2baecf5-20b7-4918-bf52-772c1465c16b">242</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Finance notes receivable</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8572a6af84c14033a1b8f2ffeeaa45fa_I20200630" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNzIvZnJhZzo2YzUyMDU0YWU0ZTk0NTlmOTdjN2ExNDljMmZhNGU3Mi90YWJsZTpjMjBmNmY4ZGNmNTk0ZmUyOWY2OTNiN2MxZjliNzU3Mi90YWJsZXJhbmdlOmMyMGY2ZjhkY2Y1OTRmZTI5ZjY5M2I3YzFmOWI3NTcyXzMtMS0xLTEtMA_081b4523-6b04-4c65-9b29-fb0ffce5f778">27</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1206afb1bf5546759bbe9e6ed075350a_D20200701-20210630" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNzIvZnJhZzo2YzUyMDU0YWU0ZTk0NTlmOTdjN2ExNDljMmZhNGU3Mi90YWJsZTpjMjBmNmY4ZGNmNTk0ZmUyOWY2OTNiN2MxZjliNzU3Mi90YWJsZXJhbmdlOmMyMGY2ZjhkY2Y1OTRmZTI5ZjY5M2I3YzFmOWI3NTcyXzMtMy0xLTEtMA_2e00b519-0e57-4ee6-a2e1-ff3d2e900c8a">5</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1206afb1bf5546759bbe9e6ed075350a_D20200701-20210630" decimals="-6" format="ixt:zerodash" name="us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNzIvZnJhZzo2YzUyMDU0YWU0ZTk0NTlmOTdjN2ExNDljMmZhNGU3Mi90YWJsZTpjMjBmNmY4ZGNmNTk0ZmUyOWY2OTNiN2MxZjliNzU3Mi90YWJsZXJhbmdlOmMyMGY2ZjhkY2Y1OTRmZTI5ZjY5M2I3YzFmOWI3NTcyXzMtNS0xLTEtMA_d355f08c-384e-4e96-bebd-584b530ba40b">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1206afb1bf5546759bbe9e6ed075350a_D20200701-20210630" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesDeductions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNzIvZnJhZzo2YzUyMDU0YWU0ZTk0NTlmOTdjN2ExNDljMmZhNGU3Mi90YWJsZTpjMjBmNmY4ZGNmNTk0ZmUyOWY2OTNiN2MxZjliNzU3Mi90YWJsZXJhbmdlOmMyMGY2ZjhkY2Y1OTRmZTI5ZjY5M2I3YzFmOWI3NTcyXzMtNy0xLTEtMA_e57003de-cc5f-40d6-a1cf-4c9a236ab9e9">20</ix:nonFraction>)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id99ac5e3640e4d909d5ebe92cc1a2ccc_I20210630" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNzIvZnJhZzo2YzUyMDU0YWU0ZTk0NTlmOTdjN2ExNDljMmZhNGU3Mi90YWJsZTpjMjBmNmY4ZGNmNTk0ZmUyOWY2OTNiN2MxZjliNzU3Mi90YWJsZXJhbmdlOmMyMGY2ZjhkY2Y1OTRmZTI5ZjY5M2I3YzFmOWI3NTcyXzMtOS0xLTEtMA_b6a896a2-c6f9-4710-ad0e-f5c09fe6acac">12</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Sales returns and allowances</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie3de935dc1e7482faedb9bef40e18bc4_I20200630" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNzIvZnJhZzo2YzUyMDU0YWU0ZTk0NTlmOTdjN2ExNDljMmZhNGU3Mi90YWJsZTpjMjBmNmY4ZGNmNTk0ZmUyOWY2OTNiN2MxZjliNzU3Mi90YWJsZXJhbmdlOmMyMGY2ZjhkY2Y1OTRmZTI5ZjY5M2I3YzFmOWI3NTcyXzQtMS0xLTEtMA_66841199-2891-469a-9d8c-4925a45d7599">495</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i366d2f82d08341029a0c689efe436023_D20200701-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNzIvZnJhZzo2YzUyMDU0YWU0ZTk0NTlmOTdjN2ExNDljMmZhNGU3Mi90YWJsZTpjMjBmNmY4ZGNmNTk0ZmUyOWY2OTNiN2MxZjliNzU3Mi90YWJsZXJhbmdlOmMyMGY2ZjhkY2Y1OTRmZTI5ZjY5M2I3YzFmOWI3NTcyXzQtMy0xLTEtMA_899965b7-2195-4a6f-8612-a47fb3ffe822">2,568</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i366d2f82d08341029a0c689efe436023_D20200701-20210630" decimals="-6" format="ixt:zerodash" name="us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNzIvZnJhZzo2YzUyMDU0YWU0ZTk0NTlmOTdjN2ExNDljMmZhNGU3Mi90YWJsZTpjMjBmNmY4ZGNmNTk0ZmUyOWY2OTNiN2MxZjliNzU3Mi90YWJsZXJhbmdlOmMyMGY2ZjhkY2Y1OTRmZTI5ZjY5M2I3YzFmOWI3NTcyXzQtNS0xLTEtMA_7caa6251-3af0-44d2-a899-db7c7ba4c8d3">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i366d2f82d08341029a0c689efe436023_D20200701-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ValuationAllowancesAndReservesDeductions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNzIvZnJhZzo2YzUyMDU0YWU0ZTk0NTlmOTdjN2ExNDljMmZhNGU3Mi90YWJsZTpjMjBmNmY4ZGNmNTk0ZmUyOWY2OTNiN2MxZjliNzU3Mi90YWJsZXJhbmdlOmMyMGY2ZjhkY2Y1OTRmZTI5ZjY5M2I3YzFmOWI3NTcyXzQtNy0xLTEtMA_ec8fb846-aed7-4ca7-bedc-c63b4a312426">2,374</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i35ade71063ad48868742425618cf24be_I20210630" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNzIvZnJhZzo2YzUyMDU0YWU0ZTk0NTlmOTdjN2ExNDljMmZhNGU3Mi90YWJsZTpjMjBmNmY4ZGNmNTk0ZmUyOWY2OTNiN2MxZjliNzU3Mi90YWJsZXJhbmdlOmMyMGY2ZjhkY2Y1OTRmZTI5ZjY5M2I3YzFmOWI3NTcyXzQtOS0xLTEtMA_a5fe1c6a-2c32-43bc-a1e8-3fb1333b5054">689</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i957454a121b24a28a13445f765e222b9_I20200630" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNzIvZnJhZzo2YzUyMDU0YWU0ZTk0NTlmOTdjN2ExNDljMmZhNGU3Mi90YWJsZTpjMjBmNmY4ZGNmNTk0ZmUyOWY2OTNiN2MxZjliNzU3Mi90YWJsZXJhbmdlOmMyMGY2ZjhkY2Y1OTRmZTI5ZjY5M2I3YzFmOWI3NTcyXzUtMS0xLTEtMA_71ce7cc9-1e50-4197-a955-4e7697bab30d">1</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28620b092acd45fdaaad27b89277c8ad_D20200701-20210630" decimals="-6" format="ixt:zerodash" name="us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNzIvZnJhZzo2YzUyMDU0YWU0ZTk0NTlmOTdjN2ExNDljMmZhNGU3Mi90YWJsZTpjMjBmNmY4ZGNmNTk0ZmUyOWY2OTNiN2MxZjliNzU3Mi90YWJsZXJhbmdlOmMyMGY2ZjhkY2Y1OTRmZTI5ZjY5M2I3YzFmOWI3NTcyXzUtMy0xLTEtMA_b80faae0-78d8-45a2-bf46-e53e38219bca">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28620b092acd45fdaaad27b89277c8ad_D20200701-20210630" decimals="-6" format="ixt:zerodash" name="us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNzIvZnJhZzo2YzUyMDU0YWU0ZTk0NTlmOTdjN2ExNDljMmZhNGU3Mi90YWJsZTpjMjBmNmY4ZGNmNTk0ZmUyOWY2OTNiN2MxZjliNzU3Mi90YWJsZXJhbmdlOmMyMGY2ZjhkY2Y1OTRmZTI5ZjY5M2I3YzFmOWI3NTcyXzUtNS0xLTEtMA_96b4aec4-115c-411c-8318-e88c0a5a98bf">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28620b092acd45fdaaad27b89277c8ad_D20200701-20210630" decimals="-6" format="ixt:zerodash" name="us-gaap:ValuationAllowancesAndReservesDeductions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNzIvZnJhZzo2YzUyMDU0YWU0ZTk0NTlmOTdjN2ExNDljMmZhNGU3Mi90YWJsZTpjMjBmNmY4ZGNmNTk0ZmUyOWY2OTNiN2MxZjliNzU3Mi90YWJsZXJhbmdlOmMyMGY2ZjhkY2Y1OTRmZTI5ZjY5M2I3YzFmOWI3NTcyXzUtNy0xLTEtMA_6e4cf0e5-1711-4644-870a-2454232e0904">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ice14673b485d4f138bf5ec444359bc54_I20210630" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNzIvZnJhZzo2YzUyMDU0YWU0ZTk0NTlmOTdjN2ExNDljMmZhNGU3Mi90YWJsZTpjMjBmNmY4ZGNmNTk0ZmUyOWY2OTNiN2MxZjliNzU3Mi90YWJsZXJhbmdlOmMyMGY2ZjhkY2Y1OTRmZTI5ZjY5M2I3YzFmOWI3NTcyXzUtOS0xLTEtMA_55cd4d87-25d3-4287-95b7-d89310eba023">1</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i299cea70f47b4fbe96772aaa8cc00b79_I20200630" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNzIvZnJhZzo2YzUyMDU0YWU0ZTk0NTlmOTdjN2ExNDljMmZhNGU3Mi90YWJsZTpjMjBmNmY4ZGNmNTk0ZmUyOWY2OTNiN2MxZjliNzU3Mi90YWJsZXJhbmdlOmMyMGY2ZjhkY2Y1OTRmZTI5ZjY5M2I3YzFmOWI3NTcyXzYtMS0xLTEtMA_7a7e2374-d115-40af-894b-7c3c20a410ad">729</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNzIvZnJhZzo2YzUyMDU0YWU0ZTk0NTlmOTdjN2ExNDljMmZhNGU3Mi90YWJsZTpjMjBmNmY4ZGNmNTk0ZmUyOWY2OTNiN2MxZjliNzU3Mi90YWJsZXJhbmdlOmMyMGY2ZjhkY2Y1OTRmZTI5ZjY5M2I3YzFmOWI3NTcyXzYtMy0xLTEtMA_f1d3ff19-3cee-48b4-96cc-70ddc90d32bd">2,702</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNzIvZnJhZzo2YzUyMDU0YWU0ZTk0NTlmOTdjN2ExNDljMmZhNGU3Mi90YWJsZTpjMjBmNmY4ZGNmNTk0ZmUyOWY2OTNiN2MxZjliNzU3Mi90YWJsZXJhbmdlOmMyMGY2ZjhkY2Y1OTRmZTI5ZjY5M2I3YzFmOWI3NTcyXzYtNS0xLTEtMA_67f63c27-ac08-489b-bde5-b529d0b14629">1</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ValuationAllowancesAndReservesDeductions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNzIvZnJhZzo2YzUyMDU0YWU0ZTk0NTlmOTdjN2ExNDljMmZhNGU3Mi90YWJsZTpjMjBmNmY4ZGNmNTk0ZmUyOWY2OTNiN2MxZjliNzU3Mi90YWJsZXJhbmdlOmMyMGY2ZjhkY2Y1OTRmZTI5ZjY5M2I3YzFmOWI3NTcyXzYtNy0xLTEtMA_e7c87bfe-464e-41bc-8264-2321a5345c42">2,488</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2e87824102b34590a0208cc7da91b5f5_I20210630" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNzIvZnJhZzo2YzUyMDU0YWU0ZTk0NTlmOTdjN2ExNDljMmZhNGU3Mi90YWJsZTpjMjBmNmY4ZGNmNTk0ZmUyOWY2OTNiN2MxZjliNzU3Mi90YWJsZXJhbmdlOmMyMGY2ZjhkY2Y1OTRmZTI5ZjY5M2I3YzFmOWI3NTcyXzYtOS0xLTEtMA_6c52d0e9-33c8-48d6-aa4a-063023fd3050">944</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:3pt"><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;border-top:1.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;border-top:1.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;border-top:1.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;border-top:1.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;border-top:1.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;border-top:1.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;border-top:1.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;border-top:1.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;border-top:1.5pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Fiscal 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ide7e4b7157284fadb3309a188a76b7ca_I20190630" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNzIvZnJhZzo2YzUyMDU0YWU0ZTk0NTlmOTdjN2ExNDljMmZhNGU3Mi90YWJsZTpjMjBmNmY4ZGNmNTk0ZmUyOWY2OTNiN2MxZjliNzU3Mi90YWJsZXJhbmdlOmMyMGY2ZjhkY2Y1OTRmZTI5ZjY5M2I3YzFmOWI3NTcyXzktMS0xLTEtMA_f86cfbee-2fcc-46f9-b022-dac671674ddb">193</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i350af5c515834421987f12b1b2358e1f_D20190701-20200630" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNzIvZnJhZzo2YzUyMDU0YWU0ZTk0NTlmOTdjN2ExNDljMmZhNGU3Mi90YWJsZTpjMjBmNmY4ZGNmNTk0ZmUyOWY2OTNiN2MxZjliNzU3Mi90YWJsZXJhbmdlOmMyMGY2ZjhkY2Y1OTRmZTI5ZjY5M2I3YzFmOWI3NTcyXzktMy0xLTEtMA_52483b20-99c6-4b9a-bb6e-0fff3226ec08">139</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i350af5c515834421987f12b1b2358e1f_D20190701-20200630" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNzIvZnJhZzo2YzUyMDU0YWU0ZTk0NTlmOTdjN2ExNDljMmZhNGU3Mi90YWJsZTpjMjBmNmY4ZGNmNTk0ZmUyOWY2OTNiN2MxZjliNzU3Mi90YWJsZXJhbmdlOmMyMGY2ZjhkY2Y1OTRmZTI5ZjY5M2I3YzFmOWI3NTcyXzktNS0xLTEtMA_b7c2d111-e82f-4e6d-ab7c-aa0449952944">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i350af5c515834421987f12b1b2358e1f_D20190701-20200630" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesDeductions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNzIvZnJhZzo2YzUyMDU0YWU0ZTk0NTlmOTdjN2ExNDljMmZhNGU3Mi90YWJsZTpjMjBmNmY4ZGNmNTk0ZmUyOWY2OTNiN2MxZjliNzU3Mi90YWJsZXJhbmdlOmMyMGY2ZjhkY2Y1OTRmZTI5ZjY5M2I3YzFmOWI3NTcyXzktNy0xLTEtMA_c0d80852-93b5-405e-a6a0-638185270cf9">127</ix:nonFraction>)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida278becedcc42e688e90f303ce681a6_I20200630" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNzIvZnJhZzo2YzUyMDU0YWU0ZTk0NTlmOTdjN2ExNDljMmZhNGU3Mi90YWJsZTpjMjBmNmY4ZGNmNTk0ZmUyOWY2OTNiN2MxZjliNzU3Mi90YWJsZXJhbmdlOmMyMGY2ZjhkY2Y1OTRmZTI5ZjY5M2I3YzFmOWI3NTcyXzktOS0xLTEtMA_a388bfe1-927b-4cb6-b275-454d64e6101e">206</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Finance notes receivable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d2f5152ae66452889546df6cb3b59aa_I20190630" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNzIvZnJhZzo2YzUyMDU0YWU0ZTk0NTlmOTdjN2ExNDljMmZhNGU3Mi90YWJsZTpjMjBmNmY4ZGNmNTk0ZmUyOWY2OTNiN2MxZjliNzU3Mi90YWJsZXJhbmdlOmMyMGY2ZjhkY2Y1OTRmZTI5ZjY5M2I3YzFmOWI3NTcyXzEwLTEtMS0xLTA_532f7592-e7c0-40f8-9e99-6ae295743c44">14</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b4ffa7933dc41899a2489f876ca34b9_D20190701-20200630" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNzIvZnJhZzo2YzUyMDU0YWU0ZTk0NTlmOTdjN2ExNDljMmZhNGU3Mi90YWJsZTpjMjBmNmY4ZGNmNTk0ZmUyOWY2OTNiN2MxZjliNzU3Mi90YWJsZXJhbmdlOmMyMGY2ZjhkY2Y1OTRmZTI5ZjY5M2I3YzFmOWI3NTcyXzEwLTMtMS0xLTA_865cca69-a512-4097-86a7-a173b45daece">15</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b4ffa7933dc41899a2489f876ca34b9_D20190701-20200630" decimals="-6" format="ixt:zerodash" name="us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNzIvZnJhZzo2YzUyMDU0YWU0ZTk0NTlmOTdjN2ExNDljMmZhNGU3Mi90YWJsZTpjMjBmNmY4ZGNmNTk0ZmUyOWY2OTNiN2MxZjliNzU3Mi90YWJsZXJhbmdlOmMyMGY2ZjhkY2Y1OTRmZTI5ZjY5M2I3YzFmOWI3NTcyXzEwLTUtMS0xLTA_0c1029ba-974d-44b8-b93d-f1e603eb0411">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6b4ffa7933dc41899a2489f876ca34b9_D20190701-20200630" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesDeductions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNzIvZnJhZzo2YzUyMDU0YWU0ZTk0NTlmOTdjN2ExNDljMmZhNGU3Mi90YWJsZTpjMjBmNmY4ZGNmNTk0ZmUyOWY2OTNiN2MxZjliNzU3Mi90YWJsZXJhbmdlOmMyMGY2ZjhkY2Y1OTRmZTI5ZjY5M2I3YzFmOWI3NTcyXzEwLTctMS0xLTA_0e12de9a-581f-4a74-87d0-94103f5cc079">2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8572a6af84c14033a1b8f2ffeeaa45fa_I20200630" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNzIvZnJhZzo2YzUyMDU0YWU0ZTk0NTlmOTdjN2ExNDljMmZhNGU3Mi90YWJsZTpjMjBmNmY4ZGNmNTk0ZmUyOWY2OTNiN2MxZjliNzU3Mi90YWJsZXJhbmdlOmMyMGY2ZjhkY2Y1OTRmZTI5ZjY5M2I3YzFmOWI3NTcyXzEwLTktMS0xLTA_081b4523-6b04-4c65-9b29-fb0ffce5f778">27</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Sales returns and allowances</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5dd4173715e6498fb0d0dc27a3f02b9f_I20190630" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNzIvZnJhZzo2YzUyMDU0YWU0ZTk0NTlmOTdjN2ExNDljMmZhNGU3Mi90YWJsZTpjMjBmNmY4ZGNmNTk0ZmUyOWY2OTNiN2MxZjliNzU3Mi90YWJsZXJhbmdlOmMyMGY2ZjhkY2Y1OTRmZTI5ZjY5M2I3YzFmOWI3NTcyXzExLTEtMS0xLTA_072fffd6-1760-4fc9-a13c-6898219d1515">479</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i400f4736cc2f44ec981957aa5112a379_D20190701-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNzIvZnJhZzo2YzUyMDU0YWU0ZTk0NTlmOTdjN2ExNDljMmZhNGU3Mi90YWJsZTpjMjBmNmY4ZGNmNTk0ZmUyOWY2OTNiN2MxZjliNzU3Mi90YWJsZXJhbmdlOmMyMGY2ZjhkY2Y1OTRmZTI5ZjY5M2I3YzFmOWI3NTcyXzExLTMtMS0xLTA_02f0f641-4b38-48e2-985b-571ed5cc1dfc">2,253</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i400f4736cc2f44ec981957aa5112a379_D20190701-20200630" decimals="-6" format="ixt:zerodash" name="us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNzIvZnJhZzo2YzUyMDU0YWU0ZTk0NTlmOTdjN2ExNDljMmZhNGU3Mi90YWJsZTpjMjBmNmY4ZGNmNTk0ZmUyOWY2OTNiN2MxZjliNzU3Mi90YWJsZXJhbmdlOmMyMGY2ZjhkY2Y1OTRmZTI5ZjY5M2I3YzFmOWI3NTcyXzExLTUtMS0xLTA_c96e29a9-107c-4b17-9dd7-efd6d31c738f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i400f4736cc2f44ec981957aa5112a379_D20190701-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ValuationAllowancesAndReservesDeductions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNzIvZnJhZzo2YzUyMDU0YWU0ZTk0NTlmOTdjN2ExNDljMmZhNGU3Mi90YWJsZTpjMjBmNmY4ZGNmNTk0ZmUyOWY2OTNiN2MxZjliNzU3Mi90YWJsZXJhbmdlOmMyMGY2ZjhkY2Y1OTRmZTI5ZjY5M2I3YzFmOWI3NTcyXzExLTctMS0xLTA_a3764552-8f79-4f57-b0a0-850d416ab256">2,237</ix:nonFraction>)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie3de935dc1e7482faedb9bef40e18bc4_I20200630" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNzIvZnJhZzo2YzUyMDU0YWU0ZTk0NTlmOTdjN2ExNDljMmZhNGU3Mi90YWJsZTpjMjBmNmY4ZGNmNTk0ZmUyOWY2OTNiN2MxZjliNzU3Mi90YWJsZXJhbmdlOmMyMGY2ZjhkY2Y1OTRmZTI5ZjY5M2I3YzFmOWI3NTcyXzExLTktMS0xLTA_66841199-2891-469a-9d8c-4925a45d7599">495</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6e4105a2962247bab2434b9253c1a87a_I20190630" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNzIvZnJhZzo2YzUyMDU0YWU0ZTk0NTlmOTdjN2ExNDljMmZhNGU3Mi90YWJsZTpjMjBmNmY4ZGNmNTk0ZmUyOWY2OTNiN2MxZjliNzU3Mi90YWJsZXJhbmdlOmMyMGY2ZjhkY2Y1OTRmZTI5ZjY5M2I3YzFmOWI3NTcyXzEyLTEtMS0xLTA_58924c35-e598-481a-a8c4-92d8b6ab1898">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if31c4c1d06774db4b770c1df3a18845b_D20190701-20200630" decimals="-6" format="ixt:zerodash" name="us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNzIvZnJhZzo2YzUyMDU0YWU0ZTk0NTlmOTdjN2ExNDljMmZhNGU3Mi90YWJsZTpjMjBmNmY4ZGNmNTk0ZmUyOWY2OTNiN2MxZjliNzU3Mi90YWJsZXJhbmdlOmMyMGY2ZjhkY2Y1OTRmZTI5ZjY5M2I3YzFmOWI3NTcyXzEyLTMtMS0xLTA_31efb779-6948-42e8-999b-ccc940316a00">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if31c4c1d06774db4b770c1df3a18845b_D20190701-20200630" decimals="-6" format="ixt:zerodash" name="us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNzIvZnJhZzo2YzUyMDU0YWU0ZTk0NTlmOTdjN2ExNDljMmZhNGU3Mi90YWJsZTpjMjBmNmY4ZGNmNTk0ZmUyOWY2OTNiN2MxZjliNzU3Mi90YWJsZXJhbmdlOmMyMGY2ZjhkY2Y1OTRmZTI5ZjY5M2I3YzFmOWI3NTcyXzEyLTUtMS0xLTA_945bc5c0-e071-4a1b-8d71-9c2f72381b7f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if31c4c1d06774db4b770c1df3a18845b_D20190701-20200630" decimals="-6" format="ixt:zerodash" name="us-gaap:ValuationAllowancesAndReservesDeductions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNzIvZnJhZzo2YzUyMDU0YWU0ZTk0NTlmOTdjN2ExNDljMmZhNGU3Mi90YWJsZTpjMjBmNmY4ZGNmNTk0ZmUyOWY2OTNiN2MxZjliNzU3Mi90YWJsZXJhbmdlOmMyMGY2ZjhkY2Y1OTRmZTI5ZjY5M2I3YzFmOWI3NTcyXzEyLTctMS0xLTA_8048cfe0-cc72-4287-bda0-cadd568a1445">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i957454a121b24a28a13445f765e222b9_I20200630" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNzIvZnJhZzo2YzUyMDU0YWU0ZTk0NTlmOTdjN2ExNDljMmZhNGU3Mi90YWJsZTpjMjBmNmY4ZGNmNTk0ZmUyOWY2OTNiN2MxZjliNzU3Mi90YWJsZXJhbmdlOmMyMGY2ZjhkY2Y1OTRmZTI5ZjY5M2I3YzFmOWI3NTcyXzEyLTktMS0xLTA_71ce7cc9-1e50-4197-a955-4e7697bab30d">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if6dc09eec4e74751b47cdf037a5b1860_I20190630" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNzIvZnJhZzo2YzUyMDU0YWU0ZTk0NTlmOTdjN2ExNDljMmZhNGU3Mi90YWJsZTpjMjBmNmY4ZGNmNTk0ZmUyOWY2OTNiN2MxZjliNzU3Mi90YWJsZXJhbmdlOmMyMGY2ZjhkY2Y1OTRmZTI5ZjY5M2I3YzFmOWI3NTcyXzEzLTEtMS0xLTA_3bea77eb-4a7f-4cfc-b79c-3ded6ead1869">687</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia31e9a409b874bb19d0ff6f2f39ecc09_D20190701-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNzIvZnJhZzo2YzUyMDU0YWU0ZTk0NTlmOTdjN2ExNDljMmZhNGU3Mi90YWJsZTpjMjBmNmY4ZGNmNTk0ZmUyOWY2OTNiN2MxZjliNzU3Mi90YWJsZXJhbmdlOmMyMGY2ZjhkY2Y1OTRmZTI5ZjY5M2I3YzFmOWI3NTcyXzEzLTMtMS0xLTA_d3dd79b3-b4f9-4506-880f-8436c169079b">2,407</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia31e9a409b874bb19d0ff6f2f39ecc09_D20190701-20200630" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNzIvZnJhZzo2YzUyMDU0YWU0ZTk0NTlmOTdjN2ExNDljMmZhNGU3Mi90YWJsZTpjMjBmNmY4ZGNmNTk0ZmUyOWY2OTNiN2MxZjliNzU3Mi90YWJsZXJhbmdlOmMyMGY2ZjhkY2Y1OTRmZTI5ZjY5M2I3YzFmOWI3NTcyXzEzLTUtMS0xLTA_fb7f0c5f-9865-4fcb-9e8e-d4bba7a48ee6">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia31e9a409b874bb19d0ff6f2f39ecc09_D20190701-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ValuationAllowancesAndReservesDeductions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNzIvZnJhZzo2YzUyMDU0YWU0ZTk0NTlmOTdjN2ExNDljMmZhNGU3Mi90YWJsZTpjMjBmNmY4ZGNmNTk0ZmUyOWY2OTNiN2MxZjliNzU3Mi90YWJsZXJhbmdlOmMyMGY2ZjhkY2Y1OTRmZTI5ZjY5M2I3YzFmOWI3NTcyXzEzLTctMS0xLTA_4f47ef44-7089-4077-9685-aae64b3767f4">2,366</ix:nonFraction>)</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i299cea70f47b4fbe96772aaa8cc00b79_I20200630" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNzIvZnJhZzo2YzUyMDU0YWU0ZTk0NTlmOTdjN2ExNDljMmZhNGU3Mi90YWJsZTpjMjBmNmY4ZGNmNTk0ZmUyOWY2OTNiN2MxZjliNzU3Mi90YWJsZXJhbmdlOmMyMGY2ZjhkY2Y1OTRmZTI5ZjY5M2I3YzFmOWI3NTcyXzEzLTktMS0xLTA_de0d5a5e-d408-43bf-9f15-ac0dc25fcdd9">729</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:3pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Fiscal 2019</span></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic65be2ae369247318f0256c8cc4689d5_I20180630" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNzIvZnJhZzo2YzUyMDU0YWU0ZTk0NTlmOTdjN2ExNDljMmZhNGU3Mi90YWJsZTpjMjBmNmY4ZGNmNTk0ZmUyOWY2OTNiN2MxZjliNzU3Mi90YWJsZXJhbmdlOmMyMGY2ZjhkY2Y1OTRmZTI5ZjY5M2I3YzFmOWI3NTcyXzE2LTEtMS0xLTA_06ad0fda-d2d5-4651-b8dc-4d3076290f48">139</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f1dad679d0a49a586cbe4e15230d23d_D20180701-20190630" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNzIvZnJhZzo2YzUyMDU0YWU0ZTk0NTlmOTdjN2ExNDljMmZhNGU3Mi90YWJsZTpjMjBmNmY4ZGNmNTk0ZmUyOWY2OTNiN2MxZjliNzU3Mi90YWJsZXJhbmdlOmMyMGY2ZjhkY2Y1OTRmZTI5ZjY5M2I3YzFmOWI3NTcyXzE2LTMtMS0xLTA_62b73573-6ab0-4154-9094-bd1fbe11b151">140</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f1dad679d0a49a586cbe4e15230d23d_D20180701-20190630" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNzIvZnJhZzo2YzUyMDU0YWU0ZTk0NTlmOTdjN2ExNDljMmZhNGU3Mi90YWJsZTpjMjBmNmY4ZGNmNTk0ZmUyOWY2OTNiN2MxZjliNzU3Mi90YWJsZXJhbmdlOmMyMGY2ZjhkY2Y1OTRmZTI5ZjY5M2I3YzFmOWI3NTcyXzE2LTUtMS0xLTA_f4e09b33-66a6-4974-a8a9-a9a34c499cc8">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6f1dad679d0a49a586cbe4e15230d23d_D20180701-20190630" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesDeductions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNzIvZnJhZzo2YzUyMDU0YWU0ZTk0NTlmOTdjN2ExNDljMmZhNGU3Mi90YWJsZTpjMjBmNmY4ZGNmNTk0ZmUyOWY2OTNiN2MxZjliNzU3Mi90YWJsZXJhbmdlOmMyMGY2ZjhkY2Y1OTRmZTI5ZjY5M2I3YzFmOWI3NTcyXzE2LTctMS0xLTA_d50fb1a4-abb0-4e18-b710-cf998552ff01">87</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ide7e4b7157284fadb3309a188a76b7ca_I20190630" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNzIvZnJhZzo2YzUyMDU0YWU0ZTk0NTlmOTdjN2ExNDljMmZhNGU3Mi90YWJsZTpjMjBmNmY4ZGNmNTk0ZmUyOWY2OTNiN2MxZjliNzU3Mi90YWJsZXJhbmdlOmMyMGY2ZjhkY2Y1OTRmZTI5ZjY5M2I3YzFmOWI3NTcyXzE2LTktMS0xLTA_7ccd9a21-a7d8-4f97-91fb-797b727b2537">193</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Finance notes receivable</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if5788af627104325bd77f50e1ab1ce2a_I20180630" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNzIvZnJhZzo2YzUyMDU0YWU0ZTk0NTlmOTdjN2ExNDljMmZhNGU3Mi90YWJsZTpjMjBmNmY4ZGNmNTk0ZmUyOWY2OTNiN2MxZjliNzU3Mi90YWJsZXJhbmdlOmMyMGY2ZjhkY2Y1OTRmZTI5ZjY5M2I3YzFmOWI3NTcyXzE3LTEtMS0xLTA_bb18cf1c-7fa4-4e93-a71b-cf69683e1ba7">7</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia954270fdd5c46e9a903107394449dd7_D20180701-20190630" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNzIvZnJhZzo2YzUyMDU0YWU0ZTk0NTlmOTdjN2ExNDljMmZhNGU3Mi90YWJsZTpjMjBmNmY4ZGNmNTk0ZmUyOWY2OTNiN2MxZjliNzU3Mi90YWJsZXJhbmdlOmMyMGY2ZjhkY2Y1OTRmZTI5ZjY5M2I3YzFmOWI3NTcyXzE3LTMtMS0xLTA_53e7348e-c1e3-4bdc-a3a9-1cf722ff4c68">8</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia954270fdd5c46e9a903107394449dd7_D20180701-20190630" decimals="-6" format="ixt:zerodash" name="us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNzIvZnJhZzo2YzUyMDU0YWU0ZTk0NTlmOTdjN2ExNDljMmZhNGU3Mi90YWJsZTpjMjBmNmY4ZGNmNTk0ZmUyOWY2OTNiN2MxZjliNzU3Mi90YWJsZXJhbmdlOmMyMGY2ZjhkY2Y1OTRmZTI5ZjY5M2I3YzFmOWI3NTcyXzE3LTUtMS0xLTA_0bb3e24e-b97c-40af-9cf5-1fbc07eb3c10">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia954270fdd5c46e9a903107394449dd7_D20180701-20190630" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesDeductions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNzIvZnJhZzo2YzUyMDU0YWU0ZTk0NTlmOTdjN2ExNDljMmZhNGU3Mi90YWJsZTpjMjBmNmY4ZGNmNTk0ZmUyOWY2OTNiN2MxZjliNzU3Mi90YWJsZXJhbmdlOmMyMGY2ZjhkY2Y1OTRmZTI5ZjY5M2I3YzFmOWI3NTcyXzE3LTctMS0xLTA_c042f002-7391-4062-be36-b1f716f1a5a7">1</ix:nonFraction>)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d2f5152ae66452889546df6cb3b59aa_I20190630" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNzIvZnJhZzo2YzUyMDU0YWU0ZTk0NTlmOTdjN2ExNDljMmZhNGU3Mi90YWJsZTpjMjBmNmY4ZGNmNTk0ZmUyOWY2OTNiN2MxZjliNzU3Mi90YWJsZXJhbmdlOmMyMGY2ZjhkY2Y1OTRmZTI5ZjY5M2I3YzFmOWI3NTcyXzE3LTktMS0xLTA_fd6bc68f-ea83-4c48-9085-6d102a6d0455">14</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Sales returns and allowances</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia84d7235822744479f9a7c898af562ac_I20180630" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNzIvZnJhZzo2YzUyMDU0YWU0ZTk0NTlmOTdjN2ExNDljMmZhNGU3Mi90YWJsZTpjMjBmNmY4ZGNmNTk0ZmUyOWY2OTNiN2MxZjliNzU3Mi90YWJsZXJhbmdlOmMyMGY2ZjhkY2Y1OTRmZTI5ZjY5M2I3YzFmOWI3NTcyXzE4LTEtMS0xLTA_262feede-e658-44e5-83d7-d1eb88cf1caf">479</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4bfe813f83c04e8e9985198d3c0abce1_D20180701-20190630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNzIvZnJhZzo2YzUyMDU0YWU0ZTk0NTlmOTdjN2ExNDljMmZhNGU3Mi90YWJsZTpjMjBmNmY4ZGNmNTk0ZmUyOWY2OTNiN2MxZjliNzU3Mi90YWJsZXJhbmdlOmMyMGY2ZjhkY2Y1OTRmZTI5ZjY5M2I3YzFmOWI3NTcyXzE4LTMtMS0xLTA_e69e5353-307f-4b6b-b446-ea690c8af976">2,205</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4bfe813f83c04e8e9985198d3c0abce1_D20180701-20190630" decimals="-6" format="ixt:zerodash" name="us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNzIvZnJhZzo2YzUyMDU0YWU0ZTk0NTlmOTdjN2ExNDljMmZhNGU3Mi90YWJsZTpjMjBmNmY4ZGNmNTk0ZmUyOWY2OTNiN2MxZjliNzU3Mi90YWJsZXJhbmdlOmMyMGY2ZjhkY2Y1OTRmZTI5ZjY5M2I3YzFmOWI3NTcyXzE4LTUtMS0xLTA_c4fc71e6-3b94-4d54-871c-c3ef85709c68">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4bfe813f83c04e8e9985198d3c0abce1_D20180701-20190630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ValuationAllowancesAndReservesDeductions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNzIvZnJhZzo2YzUyMDU0YWU0ZTk0NTlmOTdjN2ExNDljMmZhNGU3Mi90YWJsZTpjMjBmNmY4ZGNmNTk0ZmUyOWY2OTNiN2MxZjliNzU3Mi90YWJsZXJhbmdlOmMyMGY2ZjhkY2Y1OTRmZTI5ZjY5M2I3YzFmOWI3NTcyXzE4LTctMS0xLTA_0f153b28-759d-47ea-833f-bb84945a1039">2,205</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5dd4173715e6498fb0d0dc27a3f02b9f_I20190630" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNzIvZnJhZzo2YzUyMDU0YWU0ZTk0NTlmOTdjN2ExNDljMmZhNGU3Mi90YWJsZTpjMjBmNmY4ZGNmNTk0ZmUyOWY2OTNiN2MxZjliNzU3Mi90YWJsZXJhbmdlOmMyMGY2ZjhkY2Y1OTRmZTI5ZjY5M2I3YzFmOWI3NTcyXzE4LTktMS0xLTA_c4c11fa1-b085-49a8-bafa-c8c875d04795">479</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifbbe723cddd144c7bb4c9eab1d1f2f33_I20180630" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNzIvZnJhZzo2YzUyMDU0YWU0ZTk0NTlmOTdjN2ExNDljMmZhNGU3Mi90YWJsZTpjMjBmNmY4ZGNmNTk0ZmUyOWY2OTNiN2MxZjliNzU3Mi90YWJsZXJhbmdlOmMyMGY2ZjhkY2Y1OTRmZTI5ZjY5M2I3YzFmOWI3NTcyXzE5LTEtMS0xLTA_64d41589-deaf-44a5-923d-bdbaa84d58f9">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i657bcf6c5a8f4e898448d61c3949243a_D20180701-20190630" decimals="-6" format="ixt:zerodash" name="us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNzIvZnJhZzo2YzUyMDU0YWU0ZTk0NTlmOTdjN2ExNDljMmZhNGU3Mi90YWJsZTpjMjBmNmY4ZGNmNTk0ZmUyOWY2OTNiN2MxZjliNzU3Mi90YWJsZXJhbmdlOmMyMGY2ZjhkY2Y1OTRmZTI5ZjY5M2I3YzFmOWI3NTcyXzE5LTMtMS0xLTA_cad69b23-9d4c-45d6-92d0-7ec0eea046d2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i657bcf6c5a8f4e898448d61c3949243a_D20180701-20190630" decimals="-6" format="ixt:zerodash" name="us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNzIvZnJhZzo2YzUyMDU0YWU0ZTk0NTlmOTdjN2ExNDljMmZhNGU3Mi90YWJsZTpjMjBmNmY4ZGNmNTk0ZmUyOWY2OTNiN2MxZjliNzU3Mi90YWJsZXJhbmdlOmMyMGY2ZjhkY2Y1OTRmZTI5ZjY5M2I3YzFmOWI3NTcyXzE5LTUtMS0xLTA_40d689e4-b957-4921-8b84-8c5263513763">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i657bcf6c5a8f4e898448d61c3949243a_D20180701-20190630" decimals="-6" format="ixt:zerodash" name="us-gaap:ValuationAllowancesAndReservesDeductions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNzIvZnJhZzo2YzUyMDU0YWU0ZTk0NTlmOTdjN2ExNDljMmZhNGU3Mi90YWJsZTpjMjBmNmY4ZGNmNTk0ZmUyOWY2OTNiN2MxZjliNzU3Mi90YWJsZXJhbmdlOmMyMGY2ZjhkY2Y1OTRmZTI5ZjY5M2I3YzFmOWI3NTcyXzE5LTctMS0xLTA_642de194-3549-434d-a189-6e134bd7a068">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6e4105a2962247bab2434b9253c1a87a_I20190630" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNzIvZnJhZzo2YzUyMDU0YWU0ZTk0NTlmOTdjN2ExNDljMmZhNGU3Mi90YWJsZTpjMjBmNmY4ZGNmNTk0ZmUyOWY2OTNiN2MxZjliNzU3Mi90YWJsZXJhbmdlOmMyMGY2ZjhkY2Y1OTRmZTI5ZjY5M2I3YzFmOWI3NTcyXzE5LTktMS0xLTA_fded0164-dc07-4f86-a424-5856b274c646">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39bbe70148ff4daea469e8420c1859d6_I20180630" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNzIvZnJhZzo2YzUyMDU0YWU0ZTk0NTlmOTdjN2ExNDljMmZhNGU3Mi90YWJsZTpjMjBmNmY4ZGNmNTk0ZmUyOWY2OTNiN2MxZjliNzU3Mi90YWJsZXJhbmdlOmMyMGY2ZjhkY2Y1OTRmZTI5ZjY5M2I3YzFmOWI3NTcyXzIwLTEtMS0xLTA_32d50882-707c-4aad-bb74-bd9c812a0af4">626</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i00a6d666bf604826b24e68ddbd63eac4_D20180701-20190630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNzIvZnJhZzo2YzUyMDU0YWU0ZTk0NTlmOTdjN2ExNDljMmZhNGU3Mi90YWJsZTpjMjBmNmY4ZGNmNTk0ZmUyOWY2OTNiN2MxZjliNzU3Mi90YWJsZXJhbmdlOmMyMGY2ZjhkY2Y1OTRmZTI5ZjY5M2I3YzFmOWI3NTcyXzIwLTMtMS0xLTA_4c8acc20-7d69-461e-9072-1f80cc1cbe88">2,353</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i00a6d666bf604826b24e68ddbd63eac4_D20180701-20190630" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNzIvZnJhZzo2YzUyMDU0YWU0ZTk0NTlmOTdjN2ExNDljMmZhNGU3Mi90YWJsZTpjMjBmNmY4ZGNmNTk0ZmUyOWY2OTNiN2MxZjliNzU3Mi90YWJsZXJhbmdlOmMyMGY2ZjhkY2Y1OTRmZTI5ZjY5M2I3YzFmOWI3NTcyXzIwLTUtMS0xLTA_dc819f75-393d-471b-9eb7-9578d36732a0">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i00a6d666bf604826b24e68ddbd63eac4_D20180701-20190630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ValuationAllowancesAndReservesDeductions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNzIvZnJhZzo2YzUyMDU0YWU0ZTk0NTlmOTdjN2ExNDljMmZhNGU3Mi90YWJsZTpjMjBmNmY4ZGNmNTk0ZmUyOWY2OTNiN2MxZjliNzU3Mi90YWJsZXJhbmdlOmMyMGY2ZjhkY2Y1OTRmZTI5ZjY5M2I3YzFmOWI3NTcyXzIwLTctMS0xLTA_46fb777a-c4fc-4f01-92cf-7c9b227bd989">2,293</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if6dc09eec4e74751b47cdf037a5b1860_I20190630" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNzIvZnJhZzo2YzUyMDU0YWU0ZTk0NTlmOTdjN2ExNDljMmZhNGU3Mi90YWJsZTpjMjBmNmY4ZGNmNTk0ZmUyOWY2OTNiN2MxZjliNzU3Mi90YWJsZXJhbmdlOmMyMGY2ZjhkY2Y1OTRmZTI5ZjY5M2I3YzFmOWI3NTcyXzIwLTktMS0xLTA_87cb846c-41d7-4453-906b-1091b4357fd2">687</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:10pt">Fiscal 2021, 2020 and 2019 include $<ix:nonFraction unitRef="usd" contextRef="i1673490f38b2424cacdaabe5743e3504_D20200701-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNzIvZnJhZzo2YzUyMDU0YWU0ZTk0NTlmOTdjN2ExNDljMmZhNGU3Mi90ZXh0cmVnaW9uOjZjNTIwNTRhZTRlOTQ1OWY5N2M3YTE0OWMyZmE0ZTcyXzEyNQ_3088e5c2-e70c-4102-8c17-8692344430c2">70</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="i7ed96bb7a92d4005acebfec1c9075c82_D20190701-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNzIvZnJhZzo2YzUyMDU0YWU0ZTk0NTlmOTdjN2ExNDljMmZhNGU3Mi90ZXh0cmVnaW9uOjZjNTIwNTRhZTRlOTQ1OWY5N2M3YTE0OWMyZmE0ZTcyXzEyOQ_e0003f06-4d7d-4d93-b5e5-faaf26dd110b">49</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="iecf663e1bbf54d3bbd24255d898605e0_D20180701-20190630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNzIvZnJhZzo2YzUyMDU0YWU0ZTk0NTlmOTdjN2ExNDljMmZhNGU3Mi90ZXh0cmVnaW9uOjZjNTIwNTRhZTRlOTQ1OWY5N2M3YTE0OWMyZmE0ZTcyXzEzNg_bc0da923-8ee3-4a7d-b730-b79b4bbadcc7">60</ix:nonFraction> million, respectively, for reserves related to service charges and customer pricing disputes, excluded from provision for bad debts on the consolidated statements of cash flows and classified as a reduction in revenue in the consolidated statements of earnings/(loss).</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:10pt">Recoveries of amounts provided for or written off in prior years was $<ix:nonFraction unitRef="usd" contextRef="i5dc92adfefad4108a6405a1cbdeeaf2f_D20200701-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ValuationAllowancesAndReservesRecoveries" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNzIvZnJhZzo2YzUyMDU0YWU0ZTk0NTlmOTdjN2ExNDljMmZhNGU3Mi90ZXh0cmVnaW9uOjZjNTIwNTRhZTRlOTQ1OWY5N2M3YTE0OWMyZmE0ZTcyXzQ2OQ_08271ad3-bc4e-4918-98ab-0a0c888961ef"><ix:nonFraction unitRef="usd" contextRef="ie90c978acfea4d6ea4dde9db8c7997ef_D20190701-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ValuationAllowancesAndReservesRecoveries" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNzIvZnJhZzo2YzUyMDU0YWU0ZTk0NTlmOTdjN2ExNDljMmZhNGU3Mi90ZXh0cmVnaW9uOjZjNTIwNTRhZTRlOTQ1OWY5N2M3YTE0OWMyZmE0ZTcyXzQ2OQ_b66e09b8-208f-4059-a324-93dbfbf1fe1d"><ix:nonFraction unitRef="usd" contextRef="iecd1cbc227d64a688441fd4ccc382b99_D20180701-20190630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ValuationAllowancesAndReservesRecoveries" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNzIvZnJhZzo2YzUyMDU0YWU0ZTk0NTlmOTdjN2ExNDljMmZhNGU3Mi90ZXh0cmVnaW9uOjZjNTIwNTRhZTRlOTQ1OWY5N2M3YTE0OWMyZmE0ZTcyXzQ2OQ_d6b02bc4-2bce-4a89-9bdc-bac3c3507016">1</ix:nonFraction></ix:nonFraction></ix:nonFraction> million in each fiscal year 2021, 2020 and 2019.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:10pt">Write-off of uncollectible accounts or actual sales returns.</span></div></ix:nonNumeric><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:continuation id="i7b5e314e54c6409198d54d5506476e61">The sum of the components may not equal the total due to rounding.</ix:continuation> </span></div><div style="margin-bottom:3pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:3pt;text-align:justify"><span><br/></span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:3pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.222%"><tr><td style="width:1.0%"></td><td style="width:32.133%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.433%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.134%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">88</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardinal Health </span><span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">| </span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2021 Form 10-K</span></div></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div></div></div><div id="i4f0ec56b9c604f1782a65ea4a19c284d_178"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:3pt"><span><br/></span></div><div style="margin-bottom:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:44.219%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.926%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.555%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#e41f35;border-bottom:1pt solid #e41f35;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Directors, Executive Officers, and Corporate Governance</span></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:0 1pt"></td></tr></table></div></div><div style="margin-bottom:3pt"><span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:20pt;font-weight:700;line-height:120%">Directors, Executive Officers and Corporate Governance</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:16pt;font-weight:700;line-height:120%">Information About Our Executive Officers</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a list of our executive officers:</span></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:30.252%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.911%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:63.537%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Name</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Age</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Position</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Michael C. Kaufmann</span></td><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">58</span></td><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Chief Executive Officer</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Jason M. Hollar</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">48</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Chief Financial Officer</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Victor L. Crawford</span></td><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">60</span></td><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Chief Executive Officer, Pharmaceutical segment</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stephen M. Mason</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">50</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Chief Executive Officer, Medical segment</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Michele A. M. Holcomb</span></td><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">53</span></td><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Executive Vice President, Strategy and Corporate Development</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Ola M. Snow</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">54</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Chief Human Resources Officer</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Jessica L. Mayer</span></td><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">52</span></td><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Chief Legal and Compliance Officer</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Brian S. Rice</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">58</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Executive Vice President, Chief Information Officer and Customer Support Services</span></td></tr></table></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The business experience summaries provided below for our executive officers describe positions held during the last five years (unless otherwise indicated).</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Mr.&#160;Kaufmann has served as Chief Executive Officer since January 2018. From November 2014 through December 2017, Mr. Kaufmann served as Chief Financial Officer. </span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Mr. Hollar has served as Chief Financial Officer since May 2020. Prior to that, Mr. Hollar served as the Executive Vice President and Chief Financial Officer of Tenneco Inc. ("Tenneco") from July 2018. From June 2017 to June 2018, Mr. Hollar was Senior Vice President Finance at Tenneco. Prior to that, Mr. Hollar served as Chief Financial Officer of Sears Holding Corporation ("Sears") from October 2016 to April 2017 and was Senior Vice President, Finance, at Sears beginning in October 2014. Sears filed for Chapter 11 bankruptcy in October 2018.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Mr. Crawford has served as Chief Executive Officer, Pharmaceutical segment since November 2018. From September 2012 until November 2018, Mr. Crawford served as the Chief Operating Officer, Healthcare, Education, Business Dining for Aramark Corporation.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Mr.&#160;Mason has served as Chief Executive Officer, Medical segment since August 2019. From September 2016 through August 2019, he served as President of our Cardinal Health at-Home Solutions within our Medical segment.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Ms. Holcomb has served as Executive Vice President, Strategy and Corporate Development since January 2017. She joined us from Teva Pharmaceutical Industries Ltd., where she served as Senior Vice President, Strategy, Portfolio, Search, and Partnerships and Chief Operating Officer, Global R&amp;D from October 2015 to December 2016.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Ms. Snow has served as Chief Human Resources Officer since October 2018. From January 2016 through September 2018, Ms. Snow served as Senior Vice President, Human Resources, Total Rewards, Talent Acquisition and Corporate Business Partner. </span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Ms. Mayer has served as Chief Legal and Compliance Officer since March 2019. Ms. Mayer served as Executive Vice President, Deputy General Counsel and Secretary from September 2017 through March 2019 and was Senior Vice President, Deputy General Counsel from December 2015 through September 2017.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Mr. Rice has served as Executive Vice President, Chief Information Officer and Customer Support Services since February 2019. From 2009 until the beginning of 2019, Mr. Rice served as Senior Vice President, Chief Information Officer &amp; Global and Business Services for Kellogg Company.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:16pt;font-weight:700;line-height:120%">Directors and Corporate Governance</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have adopted </span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Standards of Business Conduct</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> that apply to all of our directors, officers and employees. The </span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Standards of Business Conduct</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> outline our corporate values and standards of integrity and behavior and are designed to protect and promote our reputation. The full text of the </span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Standards of Business Conduct</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> is posted on our website at www.cardinalhealth.com under &#8220;About Us &#8212; Ethics and Compliance.&#8221; </span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any waiver of the </span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Standards of Business Conduct</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for directors or executive officers must be approved by the Risk Oversight Committee. As required under SEC and New York Stock Exchange rules, we will disclose future amendments to our </span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Standards of Business Conduct</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and waivers from the </span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Standards of Business Conduct</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for our principal executive officer, principal financial officer, and principal accounting officer, or persons performing similar functions, and our other executive officers and directors on our website within four business days following the date of the amendment or waiver.</span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:32.135%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.428%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.137%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardinal Health </span><span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">|</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> Fiscal 2021 Form 10-K</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">89</span></div></td></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:3pt"><span><br/></span></div><div style="margin-bottom:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:44.219%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.926%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.555%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#e41f35;border-bottom:1pt solid #e41f35;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Directors, Executive Officers, and Corporate Governance</span></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:0 1pt"></td></tr></table></div></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The other information called for by Item&#160;10 of Form 10-K is incorporated by reference to our Definitive Proxy Statement (which will be filed with the SEC pursuant to Regulation 14A under the Exchange Act) relating to our 2021 Annual Meeting of Shareholders (our &#8220;2021 Proxy Statement&#8221;) under the captions &#8220;Corporate Governance&#8221; and &#8220;Share Ownership Information.&#8221;</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The other information called for by Item 12 of Form 10-K is incorporated by reference to our 2021 Proxy Statement under the caption "Share Ownership Information."</span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:3pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.222%"><tr><td style="width:1.0%"></td><td style="width:32.133%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.433%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.134%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">90</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardinal Health </span><span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">| </span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2021 Form 10-K</span></div></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div></div></div><div id="i4f0ec56b9c604f1782a65ea4a19c284d_184"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:3pt"><span><br/></span></div><div style="-sec-extract:summary;margin-bottom:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:24.605%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:50.757%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.338%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#e41f35;border-bottom:1pt solid #e41f35;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Exhibits</span></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:0 1pt"></td></tr></table></div></div><div style="-sec-extract:summary;margin-bottom:3pt"><span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:20pt;font-weight:700;line-height:120%">Exhibits, Financial Statement Schedules</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)(1) The following financial statements are included in the "Financial Statements" section of this report:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:93.691%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.109%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Page</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consolidated Financial Statements and Schedule:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i4f0ec56b9c604f1782a65ea4a19c284d_76">56</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4f0ec56b9c604f1782a65ea4a19c284d_79">Consolidated Statements of Earnings/(Loss) for the Fiscal Years Ended June&#160;30, 202</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4f0ec56b9c604f1782a65ea4a19c284d_79">1</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4f0ec56b9c604f1782a65ea4a19c284d_79">, 20</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4f0ec56b9c604f1782a65ea4a19c284d_79">20</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4f0ec56b9c604f1782a65ea4a19c284d_79"> and 201</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4f0ec56b9c604f1782a65ea4a19c284d_79">9</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i4f0ec56b9c604f1782a65ea4a19c284d_79">57</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4f0ec56b9c604f1782a65ea4a19c284d_82">Consolidated Statements of Comprehensive Income/(Loss) for the Fiscal Years Ended June&#160;30, 2021, 2020 and 2019</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i4f0ec56b9c604f1782a65ea4a19c284d_82">58</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4f0ec56b9c604f1782a65ea4a19c284d_85">Consolidated Balance Sheets at June&#160;30, 2021</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4f0ec56b9c604f1782a65ea4a19c284d_85"> and 2020</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i4f0ec56b9c604f1782a65ea4a19c284d_85">59</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4f0ec56b9c604f1782a65ea4a19c284d_91">Consolidated Statements of Shareholders&#8217; Equity for the Fiscal Years Ended June</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4f0ec56b9c604f1782a65ea4a19c284d_91"> 30, 202</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4f0ec56b9c604f1782a65ea4a19c284d_91">1</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4f0ec56b9c604f1782a65ea4a19c284d_91">, 20</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4f0ec56b9c604f1782a65ea4a19c284d_91">20</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4f0ec56b9c604f1782a65ea4a19c284d_91"> and 201</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4f0ec56b9c604f1782a65ea4a19c284d_91">9</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i4f0ec56b9c604f1782a65ea4a19c284d_91">60</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4f0ec56b9c604f1782a65ea4a19c284d_94">Consolidated Statements of Cash Flows for the Fiscal Years Ended June&#160;30, 202</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4f0ec56b9c604f1782a65ea4a19c284d_94">1</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4f0ec56b9c604f1782a65ea4a19c284d_94">, 20</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4f0ec56b9c604f1782a65ea4a19c284d_94">20</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4f0ec56b9c604f1782a65ea4a19c284d_94"> and 201</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4f0ec56b9c604f1782a65ea4a19c284d_94">9</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i4f0ec56b9c604f1782a65ea4a19c284d_94">61</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4f0ec56b9c604f1782a65ea4a19c284d_97">Notes to Consolidated Financial Statements</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i4f0ec56b9c604f1782a65ea4a19c284d_97">62</a></span></div></td></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)(2) The following Supplemental Schedule is included in this report:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:93.691%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.109%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Page</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4f0ec56b9c604f1782a65ea4a19c284d_172">Schedule II - Valuation and Qualifying Accounts</a></span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i4f0ec56b9c604f1782a65ea4a19c284d_172">88</a></span></div></td></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All other schedules not listed above have been omitted as not applicable or because the required information is included in the Consolidated Financial Statements or in the Notes thereto.</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:6.042%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:91.758%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Exhibit<br/>Number</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Exhibit Description</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2.1.1</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/721371/000119312517127390/d380332dex21.htm">Stock and Asset Purchase Agreement, dated April 18, 2017, between Cardinal Health, Inc. and Medtronic plc (incorporated by reference to Exhibit 2.1 to Cardinal Health's Current Report on Form 8-K filed on April 18, 2017, File No. 1-11373)</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2.1.2</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/721371/000072137117000083/a17q4_10kx063017xexhibit222.htm">Amendment No. 1, dated as of July 28, 2017, to Stock and Asset Purchase Agreement, dated April 18, 2017, between Cardinal Health, Inc. and Medtronic plc (incorporated by reference to Exhibit 2.2.2 to Cardinal Health's Annual Report on Form 10-K for the year ended June 30, 2017, File No. 1-11373)</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3.1</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/721371/000119312508230011/dex31.htm">Amended and Restated Articles of Incorporation of Cardinal Health, Inc., as amended (incorporated by reference to Exhibit 3.1 to Cardinal Health&#8217;s Quarterly Report on Form 10-Q for the quarter ended September 30, 2008, File No. 1-11373)</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3.2</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/721371/000072137119000129/exhibit32-restatedcode.htm">Cardinal Health, Inc. Restated Code of Regulations (incorporated by reference to Exhibit 3.2 to Cardinal Health&#8217;s Current Report on Form 8-K filed on November 12, 2019, File No. 1-11373)</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4.1</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/721371/000095015201504123/l89994aex4-01.txt">Specimen Certificate for Common Shares of Cardinal Health, Inc. (incorporated by reference to Exhibit 4.01 to Cardinal Health&#8217;s Annual Report on Form 10-K for the fiscal year ended June 30, 2001, File No. 1-11373)</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4.2.1</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/721371/000095015208004364/l31811aexv4w1.htm">Indenture, dated as of June 2, 2008, between Cardinal Health, Inc. and The Bank of New York Trust Company, N.A. (incorporated by reference to Exhibit 4.1 to Cardinal Health&#8217;s Current Report on Form 8-K filed on June 2, 2008, File No. 1-11373)</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4.2.2</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/721371/000119312512241732/d351025dex42.htm">Form of 3.200% Notes due 2022 (incorporated by reference to Exhibit 4.2 to Cardinal Health's Current Report on Form 8-K filed on May 21, 2012, File No. 1-11373)</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4.2.3</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/721371/000119312513071020/d490312dex42.htm">Form of 3.200% Notes due 2023 (incorporated by reference to Exhibit 4.2 to Cardinal Health's Current Report on Form 8-K filed on February 22, 2013, File No. 1-11373)</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4.2.4</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/721371/000119312513071020/d490312dex43.htm">Form of 4.600% Notes due 2043 (incorporated by reference to Exhibit 4.3 to Cardinal Health's Current Report on Form 8-K filed on February 22, 2013, File No. 1-11373)</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4.2.5</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/721371/000072137114000270/ex41formof2019note.htm">Form of 2.400% Notes due 2019 (incorporated by reference to Exhibit 4.1 to Cardinal Health&#8217;s Current Report on Form 8-K filed on November 19, 2014, File No. 1-11373)</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4.2.6</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/721371/000072137114000270/ex42formof2024note.htm">Form of 3.500% Notes due 2024 (incorporated by reference to Exhibit 4.2 to Cardinal Health&#8217;s Current Report on Form 8-K filed on November 19, 2014, File No. 1-11373)</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4.2.7</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/721371/000072137114000270/ex43formof2044note.htm">Form of 4.500% Notes due 2044 (incorporated by reference to Exhibit 4.3 to Cardinal Health&#8217;s Current Report on Form 8-K filed on November 19, 2014, File No. 1-11373)</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4.2.8</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/721371/000119312515232063/d941651dex42.htm">Form of 3.750% Notes due 2025 (incorporated by reference to Exhibit 4.2 to Cardinal Health&#8217;s Current Report on Form 8-K filed on June 23, 2015, File No. 1-11373)</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4.2.9</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/721371/000119312515232063/d941651dex43.htm">Form of 4.900% Notes due 2045 (incorporated by reference to Exhibit 4.3 to Cardinal Health&#8217;s Current Report on Form 8-K filed on June 23, 2015, File No. 1-11373)</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4.2.10</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/721371/000119312517200734/d412167dex42.htm">Form of 2.616% notes due 2022 (incorporated by reference to Exhibit 4.2 to Cardinal Health's Current Report on Form 8-K filed on June 12, 2017, File No. 1-11373)</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4.2.11</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/721371/000119312517200734/d412167dex43.htm">Form of Floating rate notes due 2022 (incorporated by reference to Exhibit 4.3 to Cardinal Health's Current Report on Form 8-K filed on June 12, 2017, File No. 1-11373)</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4.2.12</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/721371/000119312517200734/d412167dex44.htm">Form of 3.079% notes due 2024 (incorporated by reference to Exhibit 4.4 to Cardinal Health's Current Report on Form 8-K filed on June 12, 2017, File No. 1-11373)</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4.2.13</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/721371/000119312517200734/d412167dex45.htm">Form of 3.410% notes due 2027 (incorporated by reference to Exhibit 4.5 to Cardinal Health's Current Report on Form 8-K filed on June 12, 2017, File No. 1-11373)</a></span></div></td></tr></table></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;margin-bottom:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:32.135%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.428%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.137%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardinal Health </span><span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">|</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> Fiscal 2021 Form 10-K</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">91</span></div></td></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:3pt"><span><br/></span></div><div style="-sec-extract:summary;margin-bottom:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:24.605%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:50.757%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.338%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#e41f35;border-bottom:1pt solid #e41f35;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Exhibits</span></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:0 1pt"></td></tr></table></div></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:6.042%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:91.758%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4.2.14</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/721371/000119312517200734/d412167dex46.htm">Form of 4.368% notes due 2047 (incorporated by reference to Exhibit 4.6 to Cardinal Health's Current Report on Form 8-K filed on June 12, 2017, File No. 1-11373)</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4.3</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/721371/000095015205007585/l15839aexv4w07.txt">Agreement to furnish to the Securities and Exchange Commission upon request a copy of instruments defining the rights of holders of certain long-term debt of Cardinal Health, Inc. and consolidated subsidiaries (incorporated by reference to Exhibit 4.07 to Cardinal Health&#8217;s Annual Report on Form&#160;10-K for the fiscal year ended June 30, 2005, File No. 1-11373)</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4.4</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/721371/000072137119000090/a19q4_10-kx63019xexhibit44.htm">Description of Securities (incorporated by reference to Exhibit 4.4 to Cardinal Health's Annual Report on Form 10-K for the fiscal year ended June 30, 2019, File No. 1-11373)</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10.1.1</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/721371/000119312511296273/d241126dex101.htm">Cardinal Health, Inc. 2011 Long-Term Incentive Plan (incorporated by reference to Exhibit 10.1 to Cardinal Health&#8217;s Current Report on Form 8-K/A filed on November 4, 2011, File No. 1-11373)*</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10.1.2</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/721371/000072137114000181/a14q4_10kx063014xexhibit1012.htm">First Amendment to Cardinal Health, Inc. 2011 Long-Term Incentive Plan (incorporated by reference to Exhibit 10.1.2 to Cardinal Health's Annual Report on Form 10-K for the fiscal year ended June 30, 2014)*</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10.1.3</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/721371/000119312511296273/d241126dex102.htm">Form of Nonqualified Stock Option Agreement under the Cardinal Health, Inc. 2011 Long-Term Incentive Plan (incorporated by reference to Exhibit 10.2 to Cardinal Health&#8217;s Current Report on Form 8-K/A filed on November 4, 2011, File No. 1-11373)*</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10.1.4</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/721371/000072137112000069/a10-kexhibit1013nqso.htm">Form of Nonqualified Stock Option Agreement under the Cardinal Health, Inc. 2011 Long-Term Incentive Plan (incorporated by reference to Exhibit 10.1.3 to Cardinal Health&#8217;s Annual Report on Form 10-K for the fiscal year ended June 30, 2012, File No. 1-11373)*</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10.1.5</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/721371/000072137114000181/a14q4_10kx063014xexhibit1018.htm">Form of Restricted Share Units Agreement under the Cardinal Health, Inc. 2011 Long-Term Incentive Plan (incorporated by reference to Exhibit 10.1.8 to Cardinal Health's Annual Report on Form 10-K for the fiscal year ended June 30, 2014)*</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10.1.6</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/721371/000119312511296273/d241126dex104.htm">Form of Performance Share Units Agreement under the Cardinal Health, Inc. 2011 Long-Term Incentive Plan (incorporated by reference to Exhibit 10.4 to Cardinal Health's Current Report on Form 8-K/A filed on November 4, 2011, File No. 1-11373)*</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10.1.7</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/721371/000072137113000154/a13q4_10kx063013xex1019.htm">Form of Amendment to Stock Option and Restricted Share Units Agreements under the Cardinal Health, Inc. 2011 Long-Term Incentive Plan, the Cardinal Health, Inc. 2005 Long-Term Incentive Plan and the Cardinal Health, Inc. 2007 Nonemployee Directors Equity Incentive Plan (incorporated by reference to Exhibit 10.1.9 to Cardinal Health's Annual Report on Form 10-K for the fiscal year ended June 30, 2013, File No. 1-11373)*</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10.2.1</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/721371/000072137116000353/exhibit101-amendedcardinal.htm">Amended Cardinal Health, Inc. 2011 Long-Term Incentive Plan (incorporated by reference to Exhibit 10.1 to Cardinal Health's Current Report on Form 8-K filed on November 7, 2016, File No. 1-11373)*</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10.2.2</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/721371/000072137117000083/a17q4_10kx063017xexhibit1022.htm">First Amendment to Amended Cardinal Health, Inc. 2011 Long-Term Incentive Plan (incorporated by reference to Exhibit 10.2.2 to Cardinal Health's Annual Report on Form 10-K  for the fiscal year end June 30, 2017, File No. 1-11373)*</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10.2.3</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/721371/000072137120000023/a20q210q123119exhibit102.htm">Second Amendment to the Amended Cardinal Health, Inc. 2011 Long-Term Incentive Plan (incorporated by reference to Exhibit 10.2 to Cardinal Health's Quarterly Report on Form 10-Q for the quarter ended December 31, 3019, File No. 1-11373)*</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10.2.4</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/721371/000072137117000083/a17q4_10kx063017xexhibit1023.htm">Form of Nonqualified Stock Option Agreement under the Amended Cardinal Health, Inc. 2011 Long-Term Incentive Plan  (incorporated by reference to Exhibit 10.2.3 to Cardinal Health's Annual Report on Form 10-K  for the fiscal year end June 30, 2017, File No. 1-11373)*</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10.2.5</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/721371/000072137117000083/a17q4_10kx063017xexhibit1024.htm">Form of Restricted Share Units Agreement under the Amended Cardinal Health, Inc. 2011 Long-Term Incentive Plan  (incorporated by reference to Exhibit 10.2.4 to Cardinal Health's Annual Report on Form 10-K  for the fiscal year end June 30, 2017, File No. 1-11373)*</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10.2.6</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/721371/000072137120000023/a20q210q123119exhibit103.htm">Form of Restricted Share Units Agreement under the Amended Cardinal Health, Inc. 2011 Long-Term Incentive Plan (incorporate by reference to Exhibit 10.3 to Cardinal Health's Quarterly Report on Form 10-Q for the quarter ended December 31, 2019, File No. 1-11373)*</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10.2.7</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/721371/000072137117000083/a17q4_10kx063017xexhibit1025.htm">Form of Performance Share Units Agreement under the Amended Cardinal Health, Inc. 2011 Long-Term Incentive Plan  (incorporated by reference to Exhibit 10.2.5 to Cardinal Health's Annual Report on Form 10-K  for the fiscal year end June 30, 2017, File No. 1-11373)*</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10.2.8</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/721371/000072137119000010/a19q2_10qx123118xexhibit104.htm">Form of Directors Restricted Share Units Agreement under the Amended Cardinal Health, Inc. 2011 Long-Term Incentive Plan (incorporated by reference to Exhibit 10.4 to Cardinal Health's Quarterly Report on Form 10-Q for the quarter ended December 31, 2018, File No. 1-11373)</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10.3.1</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/721371/000119312508230011/dex101.htm">Cardinal Health, Inc. 2005 Long-Term Incentive Plan (incorporated by reference to Exhibit 10.1 to Cardinal Health&#8217;s Quarterly Report on Form 10-Q for the quarter ended September 30, 2008, File No. 1-11373)*</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10.3.2</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/721371/000119312509229321/dex1011.htm">First Amendment to Cardinal Health, Inc. 2005 Long-Term Incentive Plan (incorporated by reference to Exhibit 10.1.1 to Cardinal Health&#8217;s Quarterly Report on Form 10-Q for the quarter ended September 30, 2009, File No. 1-11373)*</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10.3.3</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/721371/000119312509229321/dex1012.htm">Second Amendment to Cardinal Health, Inc. 2005 Long-Term Incentive Plan (incorporated by reference to Exhibit 10.1.2 to Cardinal Health&#8217;s Quarterly Report on Form 10-Q for the quarter ended September 30, 2009, File No. 1-11373)*</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10.3.4</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/721371/000072137114000181/a14q4_10kx063014xexhibit1024.htm">Third Amendment to Cardinal Health, Inc. 2005 Long-Term Incentive Plan (incorporated by reference to Exhibit 10.2.4 to Cardinal Health's Annual Report on Form 10-K for the fiscal year ended June 30, 2014)*</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10.3.5</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/721371/000119312510198300/dex10111.htm">Form of Nonqualified Stock Option Agreement under the Cardinal Health, Inc. 2005 Long-Term Incentive Plan (incorporated by reference to Exhibit 10.1.11 to Cardinal Health's Annual Report on Form 10-K for the fiscal year ended June 30, 2010, File No. 1-11373)*</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10.4.1</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/721371/000119312508020700/dex104.htm">Cardinal Health, Inc. 2007 Nonemployee Directors Equity Incentive Plan (incorporated by reference to Exhibit 10.4 to Cardinal Health&#8217;s Quarterly Report on Form 10-Q for the quarter ended December&#160;31, 2007, File No. 1-11373)*</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10.4.2</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/721371/000119312509229321/dex1021.htm">First Amendment to Cardinal Health, Inc. 2007 Nonemployee Directors Equity Incentive Plan (incorporated by reference to Exhibit 10.2.1 to Cardinal Health&#8217;s Quarterly Report on Form 10-Q for the quarter ended September&#160;30, 2009, File No. 1-11373)*</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10.4.3</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/721371/000119312512042612/d263502dex105.htm">Second Amendment to the Cardinal Health, Inc. 2007 Nonemployee Directors Equity Incentive Plan (incorporated by reference to Exhibit 10.5 to Cardinal Health's Quarterly Report on Form 10-Q for the Quarter ended December 31, 2011, File No. 1-11373)*</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10.5</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/721371/000072137120000023/a20q210q123119exhibit1.htm">Cardinal Health Deferred Compensation Plan, Amended and Restated effective January 1, 2020 (incorporated by reference to Exhibit 10.4 to Cardinal Health's Quarterly Report on Form 10-Q for the quarter ended December 31, 2019, File No. 1-11373)*</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10.6.1</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/721371/000072137118000088/exhibit101-seniorexecutive.htm">Cardinal Health, Inc. Senior Executive Severance Plan (incorporated by reference to Exhibit 10.1 to Cardinal Health's Current Report on Form 8-K filed on September 26, 2018, File No. 1-11373)</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10.6.2</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/721371/000072137120000023/a20q210q123119exhibit101.htm">First Amendment to the Cardinal Health, Inc. Senior Executive Severance Plan (incorporated by reference to Exhibit 10.1 to Cardinal Health's Quarterly Report on Form 10-Q for the quarter ended December 31, 2019, File No. 1-11373)</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10.7</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/721371/000095015206006573/l21691aexv10w09.htm">Cardinal Health, Inc. Policy Regarding Shareholder Approval of Severance Agreements (incorporated by reference to Exhibit 10.09 to Cardinal Health&#8217;s Current Report on Form 8-K filed on August&#160;7, 2006, File No. 1-11373)*</a></span></div></td></tr></table></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;margin-bottom:3pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.222%"><tr><td style="width:1.0%"></td><td style="width:32.133%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.433%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.134%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">92</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardinal Health </span><span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">| </span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2021 Form 10-K</span></div></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:3pt"><span><br/></span></div><div style="-sec-extract:summary;margin-bottom:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:24.605%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:50.757%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.338%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#e41f35;border-bottom:1pt solid #e41f35;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Exhibits</span></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:0 1pt"></td></tr></table></div></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:6.042%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:91.758%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10.8.1</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/721371/000119312510198300/dex1015.htm">Confidentiality and Business Protection Agreement, effective as of February 15, 2010, between Cardinal Health, Inc. and Michael C. Kaufmann (incorporated by reference to Exhibit 10.15 to Cardinal Health&#8217;s Annual Report on Form 10-K for the fiscal year ended June 30, 2010, File&#160;No.&#160;1-11373)*</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10.8.2</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:8pt;text-align:justify"><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/721371/000072137118000038/a18q3_10qx033118xexhibit102.htm">Aircraft Time Sharing Agreement, effective as of February 8, 2018, by and between Cardinal Health, Inc. and Michael C. Kaufmann (incorporated by reference to Exhibit 10.2 to Cardinal Health&#8217;s Quarterly Report on Form 10-Q for the quarter ended March 31, 2018, File No. 1-11373)</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10.9.1</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/721371/000072137119000090/exhibit10131.htm">Confidentiality and Business Protection Agreement, effective as of November 1, 2018, between Cardinal Health, Inc. and Victor L. Crawford (incorporated by reference to Exhibit 10.13.1 to Cardinal Health's Annual Report on Form 10-K for the fiscal year ended June 30, 2019, File No. 1-11373)*</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10.9.2</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/721371/000072137119000090/exhibit10132.htm">Letter Agreement, dated October 30, 2018, between Cardinal Health, Inc. and Victor L. Crawford (incorporated by reference to Exhibit 10.13.2 to Cardinal Health's Annual Report on Form 10-K for the fiscal year ended June 30, 2019, File No. 1-11373) *</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10.9.3</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/721371/000072137120000033/exhibit101cfoofferlett.htm">Letter Agreement, dated March 9, 2020, between Cardinal Health, Inc. and Jason Hollar (incorporated by reference to Exhibit 10.1 to Cardinal Health's Current Report on Form 8-K filed on March 19, 2020, File No. 1-11373)*</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10.9.4</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/721371/000072137120000033/exhibit102cfocbpagreem.htm">Confidentiality and Business Protection Agreement, effective as of April 27, 2020, between Cardinal Health, Inc. and Jason Hollar (incorporated by reference to Exhibit 10.2 to Cardinal Health's Current Report on Form 8-K filed on March 19, 2020, File No. 1-11373)*</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10.10</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/721371/000095015204007635/l09353bexv10w38.txt">Form of Indemnification Agreement between Cardinal Health, Inc. and certain individual directors (incorporated by reference to Exhibit 10.38 to Cardinal Health&#8217;s Annual Report on Form&#160;10-K for the fiscal year ended June 30, 2004, File No. 1-11373)</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10.11.1</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/721371/000119312506184453/dex1001.htm">Issuing and Paying Agency Agreement, dated August 9, 2006, between Cardinal Health, Inc. and The Bank of New York (incorporated by reference to Exhibit 10.01 to Cardinal Health&#8217;s Annual Report on Form 10-K for the fiscal year ended June 30, 2006, File No. 1-11373)</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10.11.2</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/721371/000119312507046940/dex1001.htm">First Amendment to Issuing and Paying Agency Agreement, dated February 28, 2007, between Cardinal Health, Inc. and The Bank of New York (incorporated by reference to Exhibit 10.01 to Cardinal Health&#8217;s Current Report on Form 8-K filed on March 6, 2007, File No. 1-11373)</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10.11.3</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/721371/000072137117000015/a17q2_10qx123116xexhibit102.htm">Second Amendment to Issuing and Paying Agency Agreement, effective as of December 1, 2016, between Cardinal Health, Inc. and The Bank of New York (incorporated by reference to Exhibit 10.2 to Cardinal Health's Quarterly Report on Form 10-Q for the quarter ended December 31, 2016, File No. 1-11373)</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10.11.4</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/721371/000072137117000145/a18q1_10qx93017xexhibit102.htm">Third Amendment to Issuing and Paying Agency Agreement, dated September 15, 2017, between Cardinal Health, Inc. and The Bank of New York (incorporated by reference to Exhibit 10.2 to Cardinal Health's Quarterly Report on Form 10-Q for the quarter ended September 30, 2017, File No. 1-11373)</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10.11.5</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/721371/000119312506184453/dex1002.htm">Commercial Paper Dealer Agreement, dated August&#160;9, 2006, between Cardinal Health, Inc. and J.P.&#160;Morgan Securities Inc. (incorporated by reference to Exhibit 10.02 to Cardinal Health&#8217;s Annual Report on Form 10-K for the fiscal year ended June&#160;30, 2006, File No. 1-11373)</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10.11.6</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/721371/000119312507046940/dex1002.htm">First Amendment to Commercial Paper Dealer Agreement, dated February 28, 2007, between Cardinal Health, Inc. and J.P. Morgan Securities Inc. (incorporated by reference to Exhibit 10.02 to Cardinal Health&#8217;s Current Report on Form 8-K filed on March 6, 2007, File No. 1-11373)</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10.11.7</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/721371/000072137113000022/a13q2_10qx123112xexhibit104.htm">Second Amendment to Commercial Paper Dealer Agreement, effective as of December 31, 2012, between Cardinal Health, Inc. and J.P. Morgan Securities LLC (formerly known as J.P. Morgan Securities Inc.) (incorporated by reference to Exhibit 10.4 to Cardinal Health&#8217;s Quarterly Report on Form 10-Q for the quarter ended December 31, 2012, File No. 1-11373)</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10.11.8</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/721371/000072137117000015/a17q2_10qx123116xexhibit106.htm">Commercial Paper Dealer Agreement between Cardinal Health, Inc. and J.P. Morgan Securities LLC, effective as of December 1, 2016 (incorporated by reference to Exhibit 10.6 to Cardinal Health's Quarterly Report on Form 10-Q for the quarter ended December 31, 2016, File No. 1-11373)</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10.11.9</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/721371/000119312506184453/dex1003.htm">Commercial Paper Dealer Agreement, dated August 9, 2006, between Cardinal Health, Inc. and Banc of America Securities LLC (incorporated by reference to Exhibit 10.03 to Cardinal Health&#8217;s Annual Report on Form 10-K for the fiscal year ended June 30, 2006, File No. 1-11373)</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10.11.10</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/721371/000119312507046940/dex1003.htm">First Amendment to Commercial Paper Dealer Agreement, dated February&#160;28, 2007, between Cardinal Health, Inc. and Banc of America Securities LLC (incorporated by reference to Exhibit&#160;10.03 to Cardinal Health&#8217;s Current Report on Form 8-K filed on March&#160;6, 2007, File&#160;No.&#160;1-11373)</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10.11.11</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/721371/000072137113000022/a13q2_10qx123112xexhibit105.htm">Second Amendment to Commercial Paper Dealer Agreement, effective as of December 31, 2012, between Cardinal Health, Inc. and Merrill Lynch, Pierce, Fenner &amp; Smith Incorporated, f/k/a Banc of America Securities LLC (incorporated by reference to Exhibit 10.5 to Cardinal Health&#8217;s Quarterly Report on Form 10-Q for the quarter ended December 31, 2012, File No. 1-11373)</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10.11.12</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/721371/000072137117000015/a17q2_10qx123116xexhibit103.htm">Commercial Paper Dealer Agreement between Cardinal Health, Inc. and Merrill Lynch, Pierce, Fenner &amp; Smith Incorporated, effective as of December 1, 2016 (incorporated by reference to Exhibit 10.3 to Cardinal Health's Quarterly Report on Form 10-Q for the quarter ended December 31, 2016, File No. 1-11373)</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10.11.13</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/721371/000119312506184453/dex1004.htm">Commercial Paper Dealer Agreement, dated August 9, 2006, between Cardinal Health, Inc. and Wachovia Capital Markets, LLC (incorporated by reference to Exhibit 10.04 to Cardinal Health&#8217;s Annual Report on Form 10-K for the fiscal year ended June 30, 2006, File No. 1-11373)</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10.11.14</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/721371/000119312507046940/dex1004.htm">First Amendment to Commercial Paper Dealer Agreement, dated February 28, 2007, between Cardinal Health, Inc. and Wachovia Capital Markets, LLC (incorporated by reference to Exhibit&#160;10.04 to Cardinal Health&#8217;s Current Report on Form 8-K filed on March 6, 2007, File&#160;No.&#160;1-11373)</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10.11.15</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/721371/000072137113000022/a13q2_10qx123112xexhibit106.htm">Second Amendment to Commercial Paper Dealer Agreement, effective as of December 31, 2012, between Cardinal Health, Inc. and Wells Fargo Securities, LLC, as successor in interest to Wachovia Capital Markets, LLC (incorporated by reference to Exhibit 10.6 to Cardinal Health&#8217;s Quarterly Report on Form 10-Q for the quarter ended December 31, 2012, File No. 1-11373)</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10.11.16</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/721371/000072137117000015/a17q2_10qx123116xexhibit105.htm">Commercial Paper Dealer Agreement between Cardinal Health, Inc. and Wells Fargo Securities, LLC, effective as of December 1, 2016 (incorporated by reference to Exhibit 10.5 to Cardinal Health's Quarterly Report on Form 10-Q for the quarter ended December 31, 2016, File No. 1-11373)</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10.11.17</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/721371/000119312506184453/dex1005.htm">Commercial Paper Dealer Agreement, dated August&#160;9, 2006, between Cardinal Health, Inc. and Goldman, Sachs &amp; Co. (incorporated by reference to Exhibit 10.05 to Cardinal Health&#8217;s Annual Report on Form 10-K for the fiscal year ended June&#160;30, 2006, File No. 1-11373)</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10.11.18</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/721371/000119312507046940/dex1005.htm">First Amendment to Commercial Paper Dealer Agreement, dated February 28, 2007, between Cardinal Health, Inc. and Goldman, Sachs &amp; Co. (incorporated by reference to Exhibit 10.05 to Cardinal Health&#8217;s Current Report on Form 8-K filed on March 6, 2007, File No. 1-11373)</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10.11.19</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/721371/000072137113000022/a13q2_10qx123112xexhibit107.htm">Second Amendment to Commercial Paper Dealer Agreement, effective as of December 31, 2012, between Cardinal Health, Inc. and Goldman, Sachs &amp; Co. (incorporated by reference to Exhibit 10.7 to Cardinal Health&#8217;s Quarterly Report on Form 10-Q for the quarter ended December 31, 2012, File No. 1-11373)</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10.11.20</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/721371/000072137117000015/a17q2_10qx123116xexhibit104.htm">Commercial Paper Dealer Agreement between Cardinal Health, Inc. and Goldman Sachs &amp; Co., effective as of December 1, 2016 (incorporated by reference to Exhibit 10.4 to Cardinal Health's Quarterly Report on Form 10-Q for the quarter ended December 31, 2016, File No. 1-11373)</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10.11.21</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/721371/000119312509083079/dex102.htm">Form of Commercial Paper Dealer Agreement between Cardinal Health, Inc. and SunTrust Robinson Humphrey, Inc. (incorporated by reference to Exhibit 10.2 to Cardinal Health&#8217;s Current Report on Form 8-K filed on April 21, 2009, File No. 1-11373)</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10.11.22</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/721371/000072137113000022/a13q2_10qx123112xexhibit108.htm">Form of First Amendment to Commercial Paper Dealer Agreement between Cardinal Health, Inc. and SunTrust Robinson Humphrey, Inc. (incorporated by reference to Exhibit 10.8 to Cardinal Health&#8217;s Quarterly Report on Form 10-Q for the quarter ended December 31, 2012, File No. 1-11373)</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10.11.23</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/721371/000072137117000015/a17q2_10qx123116xexhibit107.htm">Commercial Paper Dealer Agreement between Cardinal Health, Inc. and SunTrust Robinson Humphrey, Inc., effective as of December 1, 2016 (incorporated by reference to Exhibit 10.7 to Cardinal Health's Quarterly Report on Form 10-Q for the quarter ended December 31, 2016, File No. 1-11373)</a></span></div></td></tr></table></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;margin-bottom:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:32.135%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.428%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.137%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardinal Health </span><span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">|</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> Fiscal 2021 Form 10-K</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">93</span></div></td></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:3pt"><span><br/></span></div><div style="-sec-extract:summary;margin-bottom:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:24.605%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:50.757%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.338%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#e41f35;border-bottom:1pt solid #e41f35;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Exhibits</span></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:0 1pt"></td></tr></table></div></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:6.042%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:91.758%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10.12</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/721371/000072137119000042/ex101secondamendedandresta.htm">Second Amended and Restated Five-Year Credit Agreement, dated as of June 27, 2019, among JPMorgan Chase Bank, N.A. as Administrative Agent, Joint Lead Arranger and Joint Book Manager, Bank of America, N.A. as Syndication Agent, MUFG Bank, Ltd. as Syndication Agent, Joint Lead Arranger and Joint Book Manager, Barclays Bank PLC, Deutsche Bank AG New York Branch, Goldman Sachs Bank USA, HSBC Bank USA, N.A. and Wells Fargo Bank, N.A., as Documentation Agents, and BOFA Securities, Inc., as Joint Lead Arranger and Joint Book Manager (incorporated by reference to Exhibit 10.1 to Cardinal Health's Current Report on Form 8-K filed on June 28, 2019, File No. 1-11373)</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10.13.1</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/721371/000072137113000179/a14q1_10qx093013xexhibit101.htm">Fourth Amended and Restated Receivables Purchase Agreement, dated as of November 1, 2013, among Cardinal Health Funding, LLC, as Seller, Griffin Capital, LLC, as Servicer, the Conduits party thereto, the Financial Institutions Party thereto, the Managing Agents party thereto, and LC Banks party thereto and the Bank of Tokyo-Mitsubishi UFJ, Ltd., New York Branch, as the Agent (incorporated by reference to Exhibit 10.1 to Cardinal Health&#8217;s Quarterly Report on Form 10-Q for the quarter ended September 30, 2013, File No. 1-11373)</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10.13.2</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/721371/000072137114000235/a15q1_10qx093014xexhibit103.htm">First Amendment and Joinder, dated as of November 3, 2014, to the Fourth Amended and Restated Receivables Purchase Agreement, dated as of November 1, 2013 (incorporated by reference to Exhibit 10.3 to Cardinal Health&#8217;s Quarterly Report on Form 10-Q for the quarter ended September 30, 2014, File No. 1-11373)</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10.13.3</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:8pt;text-align:justify"><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/721371/000072137117000145/a18q1_10qx093017xexhibit1043.htm">Second Amendment, dated as of November 14, 2016, to the Fourth Amended and Restated Receivables Purchase Agreement, dated as of November 1, 2013 (incorporated by reference to Exhibit 10.4.3 to Cardinal Health&#8217;s Quarterly Report on Form 10-Q for the quarter ended September 30, 2017, File No. 1-11373)</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10.13.4</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/721371/000072137117000110/a83117_8kxex101.htm">Third Amendment, dated as of August 30, 2017, to the Fourth Amended and Receivables Purchase Agreement, dated as of November 1, 2013 (incorporated by reference to Exhibit 10.1 to Cardinal Health's Current Report on Form 8-K filed on August 31, 2017, File No. 1-11373)</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10.13.5</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/721371/000072137119000109/ex101_4thamendmentjoindert.htm">Fourth Amendment and Joinder, dated September 30, 2019, to the Fourth Amended and Restated Receivables Purchase Agreement (incorporated by reference to Exhibit 10.1 to Cardinal Health's Current Report on Form 8-K filed on October 2, 2019, File No. 1-11373)</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10.14.1</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/721371/000072137117000145/a18q1_10qx093017xexhibit1051.htm">Seventh Amended and Restated Performance Guaranty, dated as of November 14, 2016, executed by Cardinal Health, Inc. in favor of Cardinal Health Funding, LLC (incorporated by reference to Exhibit 10.5.1 to Cardinal Health&#8217;s Quarterly Report on Form 10-Q for the quarter ended September 30, 2017, File No. 1-11373)</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10.14.2</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/721371/000072137117000145/a18q1_10qx93017xexhibit1052.htm">Amendment No. 1 to Seventh Amended and Restated Performance Guaranty, dated as of November 14, 2016 (incorporated by reference to Exhibit 10.5.2 to Cardinal Health&#8217;s Quarterly Report on Form 10-Q for the quarter ended September 30, 2017, File No. 1-11373</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10.14.3</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/721371/000072137118000100/a19q1_10qx93018xexhibit104.htm">Amendment No. 2 to Seventh Amended and Restated Performance Guaranty, dated as of November 6, 2018 (incorporated by reference to Exhibit 10.4 to Cardinal Health's Quarterly Report on Form 10-Q for the Quarter ended September 30, 2018, File No. 1-11373)</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10.14.4</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/721371/000072137119000109/ex102_3rdamendmentto7tharp.htm">Amendment No. 3 to Seventh Amended and Restated Performance Guaranty (incorporated by reference to Exhibit 10.2 to Cardinal Health's Current Report on Form 8-K filed October 2, 2019, File No. 1-11373)</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10.15.1</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/721371/000119312509187778/dex103.htm">Tax Matters Agreement, dated as of August 31, 2009, by and between Cardinal Health, Inc. and CareFusion Corporation (incorporated by reference to Exhibit 10.3 to Cardinal Health&#8217;s Current Report on Form 8-K filed on September 4, 2009, File No. 1-11373)</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10.15.2</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/721371/000072137112000069/a10-kexhibit102021stamendt.htm">First Amendment to Tax Matters Agreement, dated as of May 28, 2012, by and between Cardinal Health, Inc. and CareFusion Corporation (incorporated by reference to Exhibit 10.20.2 to Cardinal Health&#8217;s Annual Report on Form 10-K for the fiscal year ended June 30, 2012, File No. 1-11373)</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">21.1</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="a21q4_10kx63021xexhibit211.htm">List of Subsidiaries of Cardinal Health, Inc.</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">23.1</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="a21q4_10kx63021xexhibit231.htm">Consent of Independent Registered Public Accounting Firm</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">31.1</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="a21q4_10kx063021xexhibit311.htm">Certification of Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">31.2</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="a21q4_10kx063021xexhibit312.htm">Certification of Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">32.1</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="a21q4_10kx063021xexhibit321.htm">Certification of Chief Executive Officer and Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">99.1</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="a21q4_10kx063021xexhibit991.htm">Statement Regarding Forward-Looking Information</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">101.INS</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Inline XBRL Instance Document</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">101.SCH</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Schema Document</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">101.CAL</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Calculation Linkbase Document</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">101.DEF</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Definition Linkbase Document</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">101.LAB</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Label Linkbase Document</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">101.PRE</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Presentation Linkbase Document</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">104</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cover Page Interactive Data File - formatted in Inline XBRL (included as Exhibit 101)</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">* Management contract or compensatory plan or arrangement.</span></td></tr></table></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;margin-bottom:3pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.222%"><tr><td style="width:1.0%"></td><td style="width:32.133%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.433%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.134%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">94</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardinal Health </span><span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">| </span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2021 Form 10-K</span></div></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div></div></div><div id="i4f0ec56b9c604f1782a65ea4a19c284d_187"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:3pt"><span><br/></span></div><div style="margin-bottom:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.115%"><tr><td style="width:1.0%"></td><td style="width:27.471%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:45.923%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.306%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#e41f35;border-bottom:1pt solid #e41f35;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Form 10-K Cross Reference Index</span></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:3pt;text-align:center"><span><br/></span></div><div style="margin-bottom:3pt;text-align:justify"><span><br/></span></div></div><div style="margin-bottom:3pt"><span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:20pt;font-weight:700;line-height:120%">Form 10-K Cross Reference Index</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:3.513%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:87.144%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.043%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Item</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Page(s)</span></td></tr><tr style="height:15pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Part 1</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4f0ec56b9c604f1782a65ea4a19c284d_52">Business</a></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i4f0ec56b9c604f1782a65ea4a19c284d_52">32</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1A</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4f0ec56b9c604f1782a65ea4a19c284d_55">Risk Factors</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i4f0ec56b9c604f1782a65ea4a19c284d_55">40</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1B</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unresolved Staff Comments </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4f0ec56b9c604f1782a65ea4a19c284d_58">Properties</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i4f0ec56b9c604f1782a65ea4a19c284d_58">47</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4f0ec56b9c604f1782a65ea4a19c284d_61">Legal Proceedings</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i4f0ec56b9c604f1782a65ea4a19c284d_61">48</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mine Safety Disclosures </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">N/A</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Part II</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4f0ec56b9c604f1782a65ea4a19c284d_64">Market for Registrant's Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i4f0ec56b9c604f1782a65ea4a19c284d_64">49</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reserved</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4f0ec56b9c604f1782a65ea4a19c284d_13">Management's Discussion and Analysis of Financial Condition and Results of Operations</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i4f0ec56b9c604f1782a65ea4a19c284d_13">3</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7A</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4f0ec56b9c604f1782a65ea4a19c284d_49">Quantitative and Qualitative Disclosures about Market Risk</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i4f0ec56b9c604f1782a65ea4a19c284d_49">30</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4f0ec56b9c604f1782a65ea4a19c284d_76">Financial Statements and Supplementary Data</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i4f0ec56b9c604f1782a65ea4a19c284d_76">56</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Changes in and Disagreements With Accountants on Accounting and Financial Disclosure</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9A</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4f0ec56b9c604f1782a65ea4a19c284d_67">Controls and Procedures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i4f0ec56b9c604f1782a65ea4a19c284d_67">51</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9B</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other Information </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">N/A</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Part III</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4f0ec56b9c604f1782a65ea4a19c284d_178">Directors, Executive Officers and Corporate Governance </a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i4f0ec56b9c604f1782a65ea4a19c284d_178">89</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Executive Compensation </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(a)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(b)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certain Relationships and Related Transactions, and Director Independence </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(c)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Principal Accounting Fees and Services</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(d)</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Part IV</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4f0ec56b9c604f1782a65ea4a19c284d_184">Exhibits, Financial Statement Schedules</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i4f0ec56b9c604f1782a65ea4a19c284d_184">91</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Form 10-K Summary</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4f0ec56b9c604f1782a65ea4a19c284d_190">Signatures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i4f0ec56b9c604f1782a65ea4a19c284d_190">96</a></span></div></td></tr></table></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.851%"><tr><td style="width:1.0%"></td><td style="width:3.221%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:46.739%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:46.740%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">N/A</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Not applicable</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(a)</span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">The information called for by Item 11 of Form 10-K is incorporated by reference to our 2021 Proxy Statement under the captions &#8220;Corporate Governance&#8221; and &#8220;Executive Compensation.&#8221;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(b)</span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">The information called for by Item 12 of Form 10-K is incorporated by reference to our 2021 Proxy Statement under the caption "Executive Compensation."</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(c)</span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">The information called for by Item 13 of Form 10-K is incorporated by reference to our 2021 Proxy Statement under the caption "Corporate Governance."</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(d)</span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">The information called for by Item 14 of Form 10-K is incorporated by reference to our 2021 Proxy Statement under the caption &#8220;Audit Committee Matters.&#8221;</span></td></tr></table></div><div style="margin-bottom:3pt"><span><br/></span></div><div style="margin-bottom:3pt;text-align:center"><span><br/></span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:32.135%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.428%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.137%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardinal Health </span><span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">|</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> Fiscal 2021 Form 10-K</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">95</span></div></td></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span><br/></span></div></div></div><div id="i4f0ec56b9c604f1782a65ea4a19c284d_190"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:3pt"><span><br/></span></div><div style="margin-bottom:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.262%"><tr><td style="width:1.0%"></td><td style="width:24.605%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:50.757%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.338%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#e41f35;border-bottom:1pt solid #e41f35;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Signatures</span></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:0 1pt"></td></tr></table></div></div><div style="margin-bottom:3pt"><span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:20pt;font-weight:700;line-height:120%">Signatures</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized on August&#160;16, 2021.</span></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.852%"><tr><td style="width:1.0%"></td><td style="width:54.439%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.445%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:39.816%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardinal Health, Inc.</span></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/&#160;&#160;&#160;&#160;MICHAEL C. KAUFMANN</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Michael C. Kaufmann</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Chief Executive Officer </span></td></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed below by the following persons on behalf of the registrant and in the capacities indicated on August&#160;16, 2021.</span></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:504.00pt"><tr><td style="width:1.0pt"></td><td style="width:184.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:16.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:298.00pt"></td><td style="width:1.0pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline">Name</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline">Title</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:400;line-height:100%">/s/&#160;&#160;&#160;&#160;MICHAEL C. KAUFMANN</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Chief Executive Officer and Director (principal executive officer)</span></td></tr><tr style="height:15pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Michael C. Kaufmann</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:400;line-height:100%">/s/&#160;&#160;&#160;&#160;JASON M. HOLLAR</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Chief Financial Officer (principal financial officer)</span></td></tr><tr style="height:14pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Jason M. Hollar</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:400;line-height:100%">/s/&#160;&#160;&#160;&#160;PATRICIA  M. ENGLISH</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Senior Vice President and Chief Accounting Officer (principal accounting officer)</span></td></tr><tr style="height:15pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Patricia M. English</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:400;line-height:100%">/s/&#160;&#160;&#160;&#160;CARRIE S. COX</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Director</span></td></tr><tr style="height:14pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Carrie S. Cox</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:400;line-height:100%">/s/   BRUCE L. DOWNEY</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Director</span></td></tr><tr style="height:14pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Bruce L. Downey</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:400;line-height:100%">/s/&#160;&#160;&#160;&#160;SHERI H. EDISON</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Director</span></td></tr><tr style="height:14pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Sheri H. Edison</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:400;line-height:100%">/s/&#160;&#160;DAVID C. EVANS</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Director</span></td></tr><tr style="height:14pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:100%">David C. Evans</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:400;line-height:100%">/s/&#160;&#160;PATRICIA A. HEMINGWAY HALL<br/></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Director<br/></span></td></tr><tr style="height:14pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Patricia A. Hemingway Hall</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:400;line-height:100%">/s/&#160;&#160;&#160;&#160;AKHIL JOHRI</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Director</span></td></tr><tr style="height:14pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Akhil Johri</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:400;line-height:100%">/s/&#160;&#160;&#160;&#160;GREGORY B. KENNY</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Director</span></td></tr><tr style="height:14pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gregory B. Kenny</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:400;line-height:100%">/s/&#160;&#160;&#160;NANCY KILLEFER</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Director</span></td></tr><tr style="height:14pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nancy Killefer</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:400;line-height:100%">/s/    J. MICHAEL LOSH</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Director</span></td></tr><tr style="height:14pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:100%">J. Michael Losh</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:400;line-height:100%">/s/&#160;&#160;&#160;&#160;DEAN A. SCARBOROUGH</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Director</span></td></tr><tr style="height:14pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Dean A. Scarborough</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:400;line-height:100%">/s/  JOHN H. WEILAND</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Director</span></td></tr><tr style="height:12pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:100%">John H. Weiland</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"><span style="font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><br/></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:3pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.222%"><tr><td style="width:1.0%"></td><td style="width:32.133%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.433%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.134%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">96</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardinal Health </span><span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">| </span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2021 Form 10-K</span></div></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-21.1
<SEQUENCE>2
<FILENAME>a21q4_10kx63021xexhibit211.htm
<DESCRIPTION>EX-21.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="ia5d859801fb34beeaeecd180cc24a6d9_1"></div><div style="min-height:45pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 21.1</font></div><div><font><br></font></div></div><div style="margin-bottom:6pt;text-align:center"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Subsidiaries of the Registrant</font></div><div style="margin-bottom:3pt;text-align:justify"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Listed below are majority-owned subsidiaries of Cardinal Health, Inc. as of June 30, 2021.  Subsidiaries excluded from the list below would not, considered in the aggregate as a single subsidiary, constitute a &#8220;significant subsidiary&#8221; of Cardinal Health, Inc. as that term is defined in Rule 1-02(w) of SEC Regulation S-X.</font></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:46.491%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:237.75pt"><tr><td style="width:1.0pt"></td><td style="width:169.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:1.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:61.00pt"></td><td style="width:1.0pt"></td></tr><tr style="height:21pt"><td colspan="3" style="background-color:#acacac;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Subsidiary Name</font></td><td colspan="3" style="background-color:#acacac;padding:0 1pt"></td><td colspan="3" style="background-color:#acacac;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">State&#47;Jurisdiction<br>of Incorporation</font></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">A+ Secure Packaging, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Tennessee</font></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#acacac;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Access Closure, Inc.</font></td><td colspan="3" style="background-color:#acacac;padding:0 1pt"></td><td colspan="3" style="background-color:#acacac;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">California</font></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Aero-Med, Ltd.</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Connecticut</font></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#acacac;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Allegiance Corporation</font></td><td colspan="3" style="background-color:#acacac;padding:0 1pt"></td><td colspan="3" style="background-color:#acacac;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">AssuraMed, Inc.</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#acacac;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cardinal Health 2, LLC</font></td><td colspan="3" style="background-color:#acacac;padding:0 1pt"></td><td colspan="3" style="background-color:#acacac;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Nevada</font></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cardinal Health 3, LLC</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#acacac;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cardinal Health 5, LLC</font></td><td colspan="3" style="background-color:#acacac;padding:0 1pt"></td><td colspan="3" style="background-color:#acacac;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cardinal Health 6, Inc.</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Nevada</font></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#acacac;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cardinal Health 7, LLC</font></td><td colspan="3" style="background-color:#acacac;padding:0 1pt"></td><td colspan="3" style="background-color:#acacac;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cardinal Health 100, Inc.</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Indiana</font></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#acacac;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cardinal Health 104 LP</font></td><td colspan="3" style="background-color:#acacac;padding:0 1pt"></td><td colspan="3" style="background-color:#acacac;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Ohio</font></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cardinal Health 105, Inc.</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Ohio</font></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#acacac;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cardinal Health 107, LLC</font></td><td colspan="3" style="background-color:#acacac;padding:0 1pt"></td><td colspan="3" style="background-color:#acacac;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Ohio</font></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cardinal Health 108, LLC</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#acacac;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cardinal Health 110, LLC</font></td><td colspan="3" style="background-color:#acacac;padding:0 1pt"></td><td colspan="3" style="background-color:#acacac;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cardinal Health 112, LLC</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#acacac;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cardinal Health 113, LLC</font></td><td colspan="3" style="background-color:#acacac;padding:0 1pt"></td><td colspan="3" style="background-color:#acacac;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Wisconsin</font></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cardinal Health 114, Inc.</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#acacac;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cardinal Health 115, LLC</font></td><td colspan="3" style="background-color:#acacac;padding:0 1pt"></td><td colspan="3" style="background-color:#acacac;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Ohio</font></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cardinal Health 116, LLC</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#acacac;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cardinal Health 118, LLC</font></td><td colspan="3" style="background-color:#acacac;padding:0 1pt"></td><td colspan="3" style="background-color:#acacac;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cardinal Health 119, LLC</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#acacac;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cardinal Health 121, LLC</font></td><td colspan="3" style="background-color:#acacac;padding:0 1pt"></td><td colspan="3" style="background-color:#acacac;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cardinal Health 122, LLC</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#acacac;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cardinal Health 123, LLC</font></td><td colspan="3" style="background-color:#acacac;padding:0 1pt"></td><td colspan="3" style="background-color:#acacac;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cardinal Health 124, LLC</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#acacac;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cardinal Health 126, LLC</font></td><td colspan="3" style="background-color:#acacac;padding:0 1pt"></td><td colspan="3" style="background-color:#acacac;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cardinal Health 127, Inc.</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Kansas</font></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#acacac;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cardinal Health 132, LLC</font></td><td colspan="3" style="background-color:#acacac;padding:0 1pt"></td><td colspan="3" style="background-color:#acacac;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cardinal Health 200, LLC</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#acacac;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cardinal Health 201, Inc.</font></td><td colspan="3" style="background-color:#acacac;padding:0 1pt"></td><td colspan="3" style="background-color:#acacac;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cardinal Health 222 (Thailand) Ltd.</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Thailand</font></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#acacac;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cardinal Health 247, Inc. </font></td><td colspan="3" style="background-color:#acacac;padding:0 1pt"></td><td colspan="3" style="background-color:#acacac;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Colorado</font></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cardinal Health 249, LLC</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#acacac;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cardinal Health 414, LLC</font></td><td colspan="3" style="background-color:#acacac;padding:0 1pt"></td><td colspan="3" style="background-color:#acacac;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cardinal Health Australia 503 Pty. Ltd.</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Australia</font></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#acacac;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cardinal Health Austria 504 GmbH</font></td><td colspan="3" style="background-color:#acacac;padding:0 1pt"></td><td colspan="3" style="background-color:#acacac;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Austria</font></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cardinal Health Belgium 505 BVBA</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Belgium</font></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#acacac;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cardinal Health Canada Inc.</font></td><td colspan="3" style="background-color:#acacac;padding:0 1pt"></td><td colspan="3" style="background-color:#acacac;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Canada</font></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cardinal Health Canada Holdings Cooperative U.A.</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Netherlands</font></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#acacac;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cardinal Health Chile Limitada</font></td><td colspan="3" style="background-color:#acacac;padding:0 1pt"></td><td colspan="3" style="background-color:#acacac;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Chile</font></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cardinal Health Colombia S.A.S.</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Colombia</font></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#acacac;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cardinal Health do Brasil Ltd.</font></td><td colspan="3" style="background-color:#acacac;padding:0 1pt"></td><td colspan="3" style="background-color:#acacac;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Brazil</font></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cardinal Health D.R. 203 II Ltd.</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Bermuda</font></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#acacac;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cardinal Health Denmark ApS</font></td><td colspan="3" style="background-color:#acacac;padding:0 1pt"></td><td colspan="3" style="background-color:#acacac;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Denmark</font></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cardinal Health Finland Oy</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Finland</font></td></tr></table></div></div><div style="display:inline-block;max-width:7.017%;min-width:6.017%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:46.492%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:237.75pt"><tr><td style="width:1.0pt"></td><td style="width:169.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:1.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:61.00pt"></td><td style="width:1.0pt"></td></tr><tr style="height:21pt"><td colspan="3" style="background-color:#acacac;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Subsidiary Name</font></td><td colspan="3" style="background-color:#acacac;padding:0 1pt"></td><td colspan="3" style="background-color:#acacac;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">State&#47;Jurisdiction<br>of Incorporation</font></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cardinal Health Foundation</font></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Ohio</font></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#acacac;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cardinal Health France 506 SAS</font></td><td colspan="3" style="background-color:#acacac;padding:0 1pt"></td><td colspan="3" style="background-color:#acacac;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">France</font></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cardinal Health Funding, LLC</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Nevada</font></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#acacac;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cardinal Health Germany 507 GmbH</font></td><td colspan="3" style="background-color:#acacac;padding:0 1pt"></td><td colspan="3" style="background-color:#acacac;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Germany</font></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cardinal Health Germany Manufacturing GmbH</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Germany</font></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#acacac;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cardinal Health International India Private Limited</font></td><td colspan="3" style="background-color:#acacac;padding:0 1pt"></td><td colspan="3" style="background-color:#acacac;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">India</font></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cardinal Health International Philippines, Inc.</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Philippines</font></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#acacac;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cardinal Health IPS, LLC</font></td><td colspan="3" style="background-color:#acacac;padding:0 1pt"></td><td colspan="3" style="background-color:#acacac;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr style="height:21pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cardinal Health Ireland 419 Designated Activity Company</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Ireland</font></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#acacac;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cardinal Health Ireland 508 Limited</font></td><td colspan="3" style="background-color:#acacac;padding:0 1pt"></td><td colspan="3" style="background-color:#acacac;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Ireland</font></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cardinal Health Ireland Unlimited Company</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Ireland</font></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#acacac;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cardinal Health Italy 509 Srl</font></td><td colspan="3" style="background-color:#acacac;padding:0 1pt"></td><td colspan="3" style="background-color:#acacac;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Italy</font></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cardinal Health Japan G.K.</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Japan</font></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#acacac;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cardinal Health Korea Limited</font></td><td colspan="3" style="background-color:#acacac;padding:0 1pt"></td><td colspan="3" style="background-color:#acacac;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Korea</font></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cardinal Health Malaysia 211 Sdn. Bhd.</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Malaysia</font></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#acacac;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cardinal Health Malta 212 Limited</font></td><td colspan="3" style="background-color:#acacac;padding:0 1pt"></td><td colspan="3" style="background-color:#acacac;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Malta</font></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cardinal Health Managed Care Services, LLC</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#acacac;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cardinal Health Medical Products India Private Limited</font></td><td colspan="3" style="background-color:#acacac;padding:0 1pt"></td><td colspan="3" style="background-color:#acacac;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">India</font></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cardinal Health Mexico 244 S. de R.L. de C.V.</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Mexico</font></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#acacac;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cardinal Health Mexico 514 S. de R.L. de C.V.</font></td><td colspan="3" style="background-color:#acacac;padding:0 1pt"></td><td colspan="3" style="background-color:#acacac;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Mexico</font></td></tr><tr style="height:18pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cardinal Health Middle East FZ-LLC</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">United Arab Emirates</font></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#acacac;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cardinal Health Netherlands 502 B.V.</font></td><td colspan="3" style="background-color:#acacac;padding:0 1pt"></td><td colspan="3" style="background-color:#acacac;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Netherlands</font></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cardinal Health Norway AS</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Norway</font></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#acacac;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cardinal Health Pharmaceutical Contracting, LLC</font></td><td colspan="3" style="background-color:#acacac;padding:0 1pt"></td><td colspan="3" style="background-color:#acacac;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cardinal Health Pharmacy Services, LLC</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr style="height:21pt"><td colspan="3" style="background-color:#acacac;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cardinal Health Poland Sp&#243;&#322;lka z ograniczon&#261;a odpowiedzialno&#347;sci&#261;a</font></td><td colspan="3" style="background-color:#acacac;padding:0 1pt"></td><td colspan="3" style="background-color:#acacac;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Poland</font></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cardinal Health Portugal 513 Unipessoal Lda.</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Portugal</font></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#acacac;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cardinal Health P.R. 120, Inc.</font></td><td colspan="3" style="background-color:#acacac;padding:0 1pt"></td><td colspan="3" style="background-color:#acacac;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Puerto Rico</font></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cardinal Health P.R. 218, Inc.</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Puerto Rico</font></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#acacac;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cardinal Health P.R. 220, LLC</font></td><td colspan="3" style="background-color:#acacac;padding:0 1pt"></td><td colspan="3" style="background-color:#acacac;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Puerto Rico</font></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cardinal Health Singapore 225 Pte. Ltd.</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Singapore</font></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#acacac;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cardinal Health Spain 511 S.L.</font></td><td colspan="3" style="background-color:#acacac;padding:0 1pt"></td><td colspan="3" style="background-color:#acacac;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Spain</font></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cardinal Health Specialty Pharmacy, LLC</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#acacac;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cardinal Health Sweden 512 A.B.</font></td><td colspan="3" style="background-color:#acacac;padding:0 1pt"></td><td colspan="3" style="background-color:#acacac;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Sweden</font></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cardinal Health Switzerland 515 GmbH</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Switzerland</font></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#acacac;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cardinal Health Systems, Inc.</font></td><td colspan="3" style="background-color:#acacac;padding:0 1pt"></td><td colspan="3" style="background-color:#acacac;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Ohio</font></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cardinal Health Technologies, LLC</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Nevada</font></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#acacac;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cardinal Health Technologies Switzerland GmbH</font></td><td colspan="3" style="background-color:#acacac;padding:0 1pt"></td><td colspan="3" style="background-color:#acacac;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Switzerland</font></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cardinal Health U.K. 432 Limited</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">United Kingdom</font></td></tr><tr style="height:18pt"><td colspan="3" style="background-color:#acacac;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cardinal Health Medical Equipment Consulting (Shanghai) Co., Ltd.</font></td><td colspan="3" style="background-color:#acacac;padding:0 1pt"></td><td colspan="3" style="background-color:#acacac;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">China</font></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cirpro de Delicias S.A. de C.V.</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Mexico</font></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#acacac;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Convertors de Mexico S.A. de C.V.</font></td><td colspan="3" style="background-color:#acacac;padding:0 1pt"></td><td colspan="3" style="background-color:#acacac;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Mexico</font></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cordis Cashel Company Unlimited</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Ireland</font></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#acacac;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cordis Corporation</font></td><td colspan="3" style="background-color:#acacac;padding:0 1pt"></td><td colspan="3" style="background-color:#acacac;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Florida</font></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cordis (Shanghai) Medical Devices Co., Ltd.</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">China</font></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#acacac;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cornerstone Rheumatology, L.P.</font></td><td colspan="3" style="background-color:#acacac;padding:0 1pt"></td><td colspan="3" style="background-color:#acacac;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Tennessee</font></td></tr></table></div></div></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:45pt;width:100%"><div><font><br></font></div></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:46.491%"><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:237.75pt"><tr><td style="width:1.0pt"></td><td style="width:169.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:1.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:61.00pt"></td><td style="width:1.0pt"></td></tr><tr style="height:21pt"><td colspan="3" style="background-color:#acacac;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Subsidiary Name</font></td><td colspan="3" style="background-color:#acacac;padding:0 1pt"></td><td colspan="3" style="background-color:#acacac;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">State&#47;Jurisdiction<br>of Incorporation</font></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Covidien Manufacturing Solutions, S.A.</font></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Costa Rica</font></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#acacac;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Curaspan Health Group, Inc.</font></td><td colspan="3" style="background-color:#acacac;padding:0 1pt"></td><td colspan="3" style="background-color:#acacac;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">EPIC Insurance Company</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Vermont</font></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#acacac;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Especialidades Medicas Kenmex S.A. de C.V.</font></td><td colspan="3" style="background-color:#acacac;padding:0 1pt"></td><td colspan="3" style="background-color:#acacac;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Mexico</font></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">GetOutcomes, LLC</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#acacac;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Griffin Capital, LLC</font></td><td colspan="3" style="background-color:#acacac;padding:0 1pt"></td><td colspan="3" style="background-color:#acacac;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Nevada</font></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Innovative Therapies, Inc.</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#acacac;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Instant Diagnostic Systems, Inc.</font></td><td colspan="3" style="background-color:#acacac;padding:0 1pt"></td><td colspan="3" style="background-color:#acacac;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Alabama</font></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Kendall Patient Recovery BVBA</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Belgiuum</font></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#acacac;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Kendall-Gammatron Limited</font></td><td colspan="3" style="background-color:#acacac;padding:0 1pt"></td><td colspan="3" style="background-color:#acacac;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Thailand</font></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">KPR Australia Pty. Ltd.</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Australia</font></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#acacac;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">KPR Italia S.r.l.</font></td><td colspan="3" style="background-color:#acacac;padding:0 1pt"></td><td colspan="3" style="background-color:#acacac;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Italy</font></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">KPR Switzerland Sales Gmbh</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Switzerland</font></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#acacac;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">KPR U.S., LLC</font></td><td colspan="3" style="background-color:#acacac;padding:0 1pt"></td><td colspan="3" style="background-color:#acacac;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Leader Drugstores, Inc.</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#acacac;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Limited Liability Company &#34;Cardinal Health Russia&#34;</font></td><td colspan="3" style="background-color:#acacac;padding:0 1pt"></td><td colspan="3" style="background-color:#acacac;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Russian Federation</font></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Ludlow Technical Products Canada, Ltd.</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Canada</font></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#acacac;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Marin Apothecaries</font></td><td colspan="3" style="background-color:#acacac;padding:0 1pt"></td><td colspan="3" style="background-color:#acacac;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">California</font></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Medicine Shoppe International, Inc.</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#acacac;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Mediquip Sdn. Bhd.</font></td><td colspan="3" style="background-color:#acacac;padding:0 1pt"></td><td colspan="3" style="background-color:#acacac;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Malaysia</font></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Mirixa Corporation</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#acacac;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">MosaicGPO, LLC</font></td><td colspan="3" style="background-color:#acacac;padding:0 1pt"></td><td colspan="3" style="background-color:#acacac;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">mscripts, LLC</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#acacac;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Nippon Covidien Ltd.</font></td><td colspan="3" style="background-color:#acacac;padding:0 1pt"></td><td colspan="3" style="background-color:#acacac;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Japan</font></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">One Cloverleaf, LLC</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#acacac;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Outcomes Incorporated</font></td><td colspan="3" style="background-color:#acacac;padding:0 1pt"></td><td colspan="3" style="background-color:#acacac;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Iowa</font></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Pinnacle Intellectual Property Services, Inc.</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Nevada</font></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#acacac;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Pinnacle Intellectual Property Services-International, Inc.</font></td><td colspan="3" style="background-color:#acacac;padding:0 1pt"></td><td colspan="3" style="background-color:#acacac;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Nevada</font></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Quiroproductos de Cuauhtemoc S. de R.L. de C.V.</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Mexico</font></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#acacac;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">RainTree GPO, LLC</font></td><td colspan="3" style="background-color:#acacac;padding:0 1pt"></td><td colspan="3" style="background-color:#acacac;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Renal Purchasing Group, LLC</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Tennessee</font></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#acacac;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">RGH Enterprises, Inc.</font></td><td colspan="3" style="background-color:#acacac;padding:0 1pt"></td><td colspan="3" style="background-color:#acacac;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Ohio</font></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Rxealtime, Inc.</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Nevada</font></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#acacac;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Sonexus Health, LLC</font></td><td colspan="3" style="background-color:#acacac;padding:0 1pt"></td><td colspan="3" style="background-color:#acacac;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Texas</font></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">TelePharm, LLC</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Iowa</font></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#acacac;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">The Harvard Drug Group, L.L.C.</font></td><td colspan="3" style="background-color:#acacac;padding:0 1pt"></td><td colspan="3" style="background-color:#acacac;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Michigan</font></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Traverse GPO, LLC</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#acacac;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">WaveMark, Inc.</font></td><td colspan="3" style="background-color:#acacac;padding:0 1pt"></td><td colspan="3" style="background-color:#acacac;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Delaware</font></td></tr></table></div><div><font><br></font></div></div><div style="display:inline-block;max-width:7.017%;min-width:6.017%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:46.492%"></div></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.1
<SEQUENCE>3
<FILENAME>a21q4_10kx63021xexhibit231.htm
<DESCRIPTION>EX-23.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="i7218275819c14b84a56bc74e63b1c796_1"></div><div style="min-height:63pt;width:100%"><div style="margin-bottom:3pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.234%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Exhibit 23.1</font></td></tr></table></div><div style="margin-bottom:3pt"><font><br></font></div><div style="text-align:center"><font><br></font></div><div><font><br></font></div></div><div style="margin-bottom:6pt;text-align:center"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Consent of Independent Registered Public Accounting Firm </font></div><div style="margin-bottom:6pt;text-align:justify"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We consent to the incorporation by reference in the following Registration Statements&#58; </font></div><div style="margin-bottom:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;Registration Statement on Form S-3 No.&#160;333-233377 of Cardinal Health, Inc., </font></div><div style="margin-bottom:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)&#160;&#160;&#160;&#160;Registration Statements on Form S-4 No.&#160;333-62938 and No.&#160;333-74761 of Cardinal Health, Inc., and </font></div><div style="margin-bottom:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(3)&#160;&#160;&#160;&#160;Registration Statements on Form S-8 No.&#160;33-42357, No.&#160;333-90423, No.&#160;333-38192, No.&#160;333-38198, No.&#160;333-56010, No.&#160;333-129725, No.&#160;333-149107, No.&#160;333-155156, No.&#160;333-163128, No.&#160;333-164736, No. 333-177728, No. 333-183471, No.&#160;333-206339, No.&#160;333-206340, No. 333-214412, No. 333-219892, and 333-233380 of Cardinal Health, Inc.&#59; </font></div><div style="margin-bottom:3pt;text-align:justify"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">of our reports dated August&#160;16, 2021, with respect to the consolidated financial statements and schedule of Cardinal Health, Inc. and subsidiaries and the effectiveness of internal control over financial reporting of Cardinal Health, Inc. and subsidiaries, included in this Annual Report (Form 10-K) of Cardinal Health, Inc. and subsidiaries for the year ended June&#160;30, 2021.</font></div><div style="margin-bottom:3pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:94.861%"><tr><td style="width:1.0%"></td><td style="width:35.796%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:62.004%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Ernst&#160;&#38; Young LLP</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Grandview Heights, Ohio</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">August 16, 2021</font></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><font><br></font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>4
<FILENAME>a21q4_10kx063021xexhibit311.htm
<DESCRIPTION>EX-31.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="i04e7bb1a7e3d484c8184b7866da22697_1"></div><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:31.988%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.282%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.430%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Exhibit 31.1</font></td></tr></table></div><div><font><br></font></div></div><div style="margin-bottom:6pt;text-align:justify"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Michael C. Kaufmann, certify that&#58;</font></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.16pt">I have reviewed this Form 10-K of Cardinal Health, Inc.&#59;</font></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.16pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.16pt">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.16pt">The registrant&#8217;s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div style="margin-bottom:6pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:8pt">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="margin-bottom:6pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:8pt">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="margin-bottom:6pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:8.46pt">Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="margin-bottom:6pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:8pt">Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.16pt">The registrant&#8217;s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="margin-bottom:6pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:8pt">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div style="margin-bottom:6pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:8pt">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div><div style="margin-top:9pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Date&#58; August&#160;16, 2021 </font></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:470.25pt"><tr><td style="width:1.0pt"></td><td style="width:147.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:319.00pt"></td><td style="width:1.0pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; MICHAEL C. KAUFMANN</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Michael C. Kaufmann</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Executive Officer</font></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>5
<FILENAME>a21q4_10kx063021xexhibit312.htm
<DESCRIPTION>EX-31.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="i6380760402fa44d3895307700c77522c_1"></div><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:31.988%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.282%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.430%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Exhibit 31.2</font></td></tr></table></div><div><font><br></font></div></div><div style="margin-bottom:6pt;text-align:justify"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Jason M. Hollar, certify that&#58;</font></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.16pt">I have reviewed this Form 10-K of Cardinal Health, Inc.&#59;</font></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.16pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.16pt">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.16pt">The registrant&#8217;s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div style="margin-bottom:6pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:8pt">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="margin-bottom:6pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:8pt">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="margin-bottom:6pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:8.46pt">Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="margin-bottom:6pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:8pt">Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.16pt">The registrant&#8217;s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="margin-bottom:6pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:8pt">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div style="margin-bottom:6pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:8pt">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div><div style="margin-top:9pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Date&#58; August&#160;16, 2021 </font></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:512.25pt"><tr><td style="width:1.0pt"></td><td style="width:136.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:372.25pt"></td><td style="width:1.0pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47;</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> JASON M. HOLLAR</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Jason M. Hollar</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Financial Officer</font></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>6
<FILENAME>a21q4_10kx063021xexhibit321.htm
<DESCRIPTION>EX-32.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="i0012dad623c142d796a658c661db8dbd_1"></div><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:31.988%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.282%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.430%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Exhibit 32.1</font></td></tr></table></div><div><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Certification of the Chief Executive Officer and the Chief Financial Officer Pursuant to 18 U.S.C. Section&#160;1350, as Adopted </font></div><div style="margin-bottom:6pt;text-align:center"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Pursuant to Section&#160;906 of the Sarbanes-Oxley Act of 2002</font></div><div style="margin-bottom:6pt;text-align:justify"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Michael C. Kaufmann, Chief Executive Officer of Cardinal Health, Inc. (the &#8220;Company&#8221;) and Jason M. Hollar, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section&#160;1350, that&#58;</font></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:26pt">the Periodic Report on Form 10-K for the fiscal year ended June 30, 2021 containing the financial statements of the Company (the &#8220;Periodic Report&#8221;), which this statement accompanies, fully complies with the requirements of Section&#160;13(a) or 15(d) of the Securities Exchange Act of 1934 (15 U.S.C. 78m or 78o(d))&#59; and</font></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:26pt">the information contained in the Periodic Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></div><div style="margin-top:9pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dated&#58; August&#160;16, 2021 </font></div><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:69.031%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:28.769%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; MICHAEL C. KAUFMANN</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Michael C. Kaufmann</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Executive Officer </font></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:69.031%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:28.769%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; JASON M. HOLLAR</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Jason M. Hollar</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Financial Officer</font></td></tr></table></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>7
<FILENAME>a21q4_10kx063021xexhibit991.htm
<DESCRIPTION>EX-99.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="i8b7c5b84d74a4bde99ece7024d1d1e55_1"></div><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:31.988%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.282%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.430%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Exhibit 99.1</font></td></tr></table></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:13pt;font-weight:700;line-height:120%">Statement Regarding Forward-Looking Information </font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As used in this exhibit, &#8220;we,&#8221; &#8220;our,&#8221; &#8220;us&#8221; and similar pronouns refer to Cardinal Health, Inc. and its subsidiaries, unless the context requires otherwise. Our filings with the Securities and Exchange Commission, including this Annual Report on Form 10-K for the fiscal year ended June&#160;30, 2021 (the &#8220;2021 Form 10-K&#8221;), our quarterly reports on Form 10-Q and our current reports on Form 8-K (along with any exhibits and amendments to such reports), as well as our news releases or any other written or oral statements made by or on behalf of us, including materials posted on our website, may include, directly or by incorporation by reference, forward-looking statements that reflect our current view (as of the date the forward-looking statement is first made) about future events, prospects, projections or financial performance. The matters discussed in these forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those projected, anticipated or implied in or by such statements. These risks and uncertainties include&#58;</font></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.13pt">risks arising from the COVID-19 pandemic, including the possibility that we will experience additional inventory reserves as a result of future decreases in demand or selling price&#59; the risk that we may not be able to offset significant cost increases for certain personal protective equipment (PPE) products or that and price increases for these products could result in lost sales or customer losses or disputes&#59; and the possibility that sustained reduced demand for generic pharmaceutical product may continue to advsersely impact our pharmaceutical generics program&#59;</font></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.13pt">competitive pressures in the markets in which we operate, including pricing pressures&#59;</font></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.13pt">uncertainties relating to the pricing of and demand for generic pharmaceuticals&#59;</font></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.13pt">uncertainties relating to the timing, frequency and profitability of generic pharmaceutical launches or other components of our pharmaceutical generics program&#59;  </font></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.13pt">our ability to maintain the benefits of our generic pharmaceutical sourcing venture with CVS Health Corporation&#59;</font></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.13pt">changes in manufacturer approaches to pricing branded pharmaceutical products and risks related to our compensation under contractual arrangements with manufacturers being set as a percentage of the wholesale acquisition cost of branded pharmaceuticals and where a part of our compensation is based on branded pharmaceutical price appreciation, changes in the magnitude of such price appreciation&#59; </font></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.13pt">changes in the timing or frequency of the introduction of branded pharmaceuticals&#59;</font></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.13pt">risks associated with the resolution and defense of the lawsuits and investigations in which we have been or will be named relating to the distribution of prescription opioid pain medication, including risks associated with the proposed settlement agreement and process designed to resolve lawsuits and claims brought by states and local governmental entities, including the risk that we could fail to reach a final resolution and that any injunctive or non-monetary relief that we may agree to could have unintended consequences&#59; and the risk that the outcome of other opioid-related lawsuits and investigations could have a material adverse effect on our results of operations, financial condition, cash flows or liquidity or the operations of our business&#59;</font></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.13pt">potential damage to our reputation, adverse operational impacts or other effects that may result from the national opioid epidemic, the allegations that have been made about our role in such epidemic and the ongoing unfavorable publicity surrounding the lawsuits and investigations against us&#59;</font></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.13pt">risks associated with the tax benefit from our self-insurance loss claims, including risks associated with the letter certain industry participants, including us, received from the U.S. House of Representatives' Committee on Oversight and Reform questioning, among other things, our plans to take tax deductions for opioid-related losses, including the net operating loss carryback provisions under the CARES Act and deductibility under the Tax Act&#59; the possibility that we may receive additional negative or unfavorable publicity or that the IRS may not agree with our underlying assumptions and judgments&#59;</font></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.13pt">potential adverse impact to our financial results from enacted and proposed state taxes or other assessments on the sale or distribution of opioid medications&#59;</font></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.13pt">our high sales concentration with certain key customers, including CVS Health Corporation and OptumRx&#59;</font></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.13pt">costs or claims resulting from quality issues, whether related to the manufacture of some of our sterile surgical gowns or pre-filled syringes, or other potential errors or defects in our manufacturing of medical devices or other products or in our compounding, repackaging, information systems or pharmacy management services that may injure persons or damage property or operations, including costs from recalls, remediation efforts, and related product liability claims and lawsuits, including class action lawsuits&#59;</font></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.13pt">actions of regulatory bodies and other governmental authorities, including the U.S. Drug Enforcement Administration, certain agencies within the U.S. Department of Health and Human Services (including the U.S. Food and Drug Administration, Centers for Medicare and Medicaid Services, the Office of Inspector General and the Office for Civil Rights), the U.S. Nuclear Regulatory Commission, the U.S. Federal Trade Commission, the U.S. Customs and Border Protection, various state boards of pharmacy, state controlled substance authorities, state health departments, state insurance departments, state Medicaid departments or comparable regulatory bodies or governmental authorities or foreign equivalents that, in each case, could delay, limit or suspend product development, manufacturing, distribution, importation or sales or result in warning letters, recalls, seizures, injunctions or monetary sanctions&#59;</font></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.13pt">any compromise of our information systems or of those of a third-party service provider, including unauthorized access to or use or disclosure of company or customer information, disruption of access and ancillary risks associated with our ability to effectively manage any issues arising from any such compromise or disruption&#59;</font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.13pt">uncertainties related to our Medical segment's Cardinal Health Brand products, including our ability to manage cost, infrastructure and to retain margin or improve its performance&#59;</font></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.13pt">risks associated with the realignment of our Medical segment's supply chain and other businesses, including our ability to achieve the expected benefits from such realignment&#59; </font></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.13pt">uncertainties with respect to our cost-savings initiatives or IT infrastructure activities, including the ability to achieve the expected benefits from such initiatives, the risk that we could incur unexpected charges, and the risk that we may fail to retain key personnel&#59; </font></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.13pt">difficulties or delays in the development, production, manufacturing, sourcing and marketing of new or existing products and services, including difficulties or delays associated with obtaining or maintaining requisite regulatory consents, whether our own or third parties', or approvals associated with those activities&#59;</font></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.13pt">manufacturing disruptions, whether due to regulatory action, including regulatory action to reduce Ethylene Oxide emissions, production quality deviations, safety issues or raw material shortages or defects, or because a key product is manufactured at a single manufacturing facility with limited alternate facilities&#59;</font></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.13pt">the possibility that we could be subject to adverse changes in the tax laws or challenges to our tax positions, including the possibility that the corporate tax rate in the U.S. could be increased&#59;</font></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.13pt">risks arising from possible violations of healthcare fraud and abuse laws&#59;</font></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.13pt">risks arising from possible violations of the U.S. Foreign Corrupt Practices Act and other similar anti-corruption laws in other jurisdictions and U.S. and foreign export control, trade embargo and customs laws&#59;</font></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.13pt">risks arising from our collecting, handling and maintaining patient-identifiable health information and other sensitive personal and financial information, which are subject to federal, state and foreign laws that regulate the use and disclosure of such information&#59;</font></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.13pt">risks arising from certain of our businesses being Medicare-certified suppliers or participating in other federal and state healthcare programs, such as state Medicaid programs and the federal 340B drug pricing program, which businesses are subject to accreditation and quality standards and other rules and regulations, including applicable reporting, billing, payment and record-keeping requirements&#59;</font></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.13pt">risks arising from certain of our businesses manufacturing pharmaceutical and medical products or repackaging pharmaceuticals that are purchased or reimbursed through, or are otherwise governed by, federal or state healthcare programs, which businesses are subject to federal and state laws that establish eligibility for reimbursement by such programs and other applicable standards and regulations&#59;</font></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.13pt">changes in laws or changes in the interpretation or application of laws or regulations, as well as possible failures to comply with applicable laws or regulations, including as a result of possible misinterpretations or misapplications&#59;</font></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.13pt">material reductions in purchases, pricing changes, non-renewal, early termination, or delinquencies or defaults under contracts with key customers&#59;</font></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.13pt">unfavorable changes to the terms or with our ability to meet contractual obligations of key customer or supplier relationships, or changes in customer mix&#59;</font></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.13pt">risks arising from changes in U.S. or foreign tax laws and unfavorable challenges to our tax positions and payments to settle these challenges, which may adversely affect our effective tax rate or tax payments&#59;</font></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.13pt">uncertainties due to possible government healthcare reform, including proposals related to Medicare drug rebate arrangements, possible repeal or replacement of major parts of the Patient Protection and Affordable Care Act, proposals related to prescription drug pricing transparency and the possible adoption of Medicare-For-All&#59;</font></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.13pt">reductions or limitations on governmental funding at the state or federal level or efforts by healthcare insurance companies to limit payments for products and services&#59;</font></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.13pt">changes in manufacturers' pricing, selling, inventory, distribution or supply policies or practices&#59;</font></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.13pt">changes in legislation or regulations governing prescription drug pricing, healthcare services or mandated benefits&#59;</font></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.13pt">changes in hospital buying groups or hospital buying practices&#59;</font></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.13pt">changes in distribution or sourcing models for pharmaceutical and medical and surgical products, including an increase in direct and limited distribution&#59;</font></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.13pt">changes to the prescription drug reimbursement formula and related reporting requirements for generic pharmaceuticals under Medicaid&#59;</font></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.13pt">continuing consolidation in the healthcare industry, which could give the resulting enterprises greater bargaining power and may increase pressure on prices for our products and services or result in the loss of customers&#59;</font></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.13pt">disruption, damage or lack of access to, or failure of, our or our third-party service providers' information systems, our critical facilities, including our national logistics center, or our distribution networks&#59;</font></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.13pt">risks to our business and information and controls systems in the event that business process improvements, infrastructure modernizations or initiatives to use third-party service providers for key systems and processes are not effectively implemented&#59;</font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.13pt">the results, costs, effects or timing of any commercial disputes, government contract compliance matters, patent infringement claims, </font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">qui tam</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> actions, government investigations, shareholder lawsuits or other legal proceedings&#59;</font></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.13pt">possible losses relating to product liability lawsuits and claims regarding products for which we cannot obtain product liability insurance or for which such insurance may not be adequate to cover our losses, including the product liability lawsuits we are currently defending relating to alleged personal injuries associated with the use of Cordis inferior vena cava filter products&#59;</font></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.13pt">our ability to maintain adequate intellectual property protections&#59;</font></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.13pt">the costs, difficulties and uncertainties related to the integration of acquired businesses, including liabilities relating to the operations or activities of such businesses prior to their acquisition, and uncertainties relating to our ability to achieve the anticipated results from acquisitions&#59;</font></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.13pt">risks associated with the divestiture of the Cordis business, including the risk that the costs associated with exit or disposal activities could ultimately be greater than we currently expect or that we could incur greater stranded costs than expected, and the risk that the impairment of the transferred assets could ultimately be greater than we currently expect&#59; </font></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.13pt">our ability to manage and complete divestitures or other strategic business combination transactions, including our ability to find buyers or other strategic exit opportunities and risks associated with the possibility that we could experience greater dis-synergies than anticipated or otherwise fail to achieve our strategic objectives&#59;</font></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.13pt">increased costs for commodities and other materials used in the Medical segment manufacturing, including various components, compounds, raw materials or energy such as oil-based resins, pulp, cotton, latex and other commodities&#59;</font></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.13pt">shortages in commodities, components, compounds, raw materials or energy used by our businesses, including supply disruptions of radioisotopes&#59;</font></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.13pt">the loss of, or default by, one or more key suppliers for which alternative suppliers may not be readily available&#59;</font></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.13pt">bankruptcy, insolvency or other credit failure of a customer or supplier that owes us a substantial amount&#59;</font></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.13pt">risks associated with global operations, including the effect of local economic environments, inflation, recession, currency volatility and global competition, in addition to risks associated with compliance with U.S. and international laws relating to global operations&#59;</font></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.13pt">uncertainties with respect to U.S. or international trade policies, tariffs, excise or border taxes and their impact on our ability to source products or materials that we need to conduct our business&#59;</font></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.13pt">risks associated with our use of and reliance on the global capital and credit markets, including our ability to access credit and our cost of credit, which may adversely affect our ability to efficiently fund our operations or undertake certain expenditures&#59;</font></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.13pt">our ability to introduce and market new products and our ability to keep pace with advances in technology&#59;</font></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.13pt">significant charges to earnings if goodwill or intangible assets become impaired&#59; </font></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.13pt">uncertainties relating to general political, business, industry, regulatory and market conditions&#59; and</font></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.13pt">other factors described in the &#8220;Risk Factors&#8221; section of the 2021 Form 10-K.</font></div><div style="margin-top:9pt;text-align:justify"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The words &#8220;expect,&#8221; &#8220;anticipate,&#8221; &#8220;intend,&#8221; &#8220;plan,&#8221; &#8220;believe,&#8221; &#8220;will,&#8221; &#8220;should,&#8221; &#8220;could,&#8221; &#8220;would,&#8221; &#8220;project,&#8221; &#8220;continue,&#8221; &#8220;likely,&#8221; and similar expressions generally identify &#8220;forward-looking statements,&#8221; which speak only as of the date the statements were made, and also include statements reflecting future results or guidance, statements of outlook and expense accruals. We undertake no obligation to update or revise any forward-looking statements, except to the extent required by applicable law.</font></div><div style="margin-top:9pt;text-align:justify"><font><br></font></div><div style="margin-top:9pt;text-align:justify"><font><br></font></div><div style="margin-top:9pt;text-align:justify"><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>8
<FILENAME>cah-20210630.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:b63e0697-7630-4efc-9622-5764c41287f3,g:18dc0520-9457-4463-b618-29c4ac061652-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:cah="http://www.cardinal.com/20210630" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.cardinal.com/20210630">
  <xs:import namespace="http://fasb.org/srt/2021-01-31" schemaLocation="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd"/>
  <xs:import namespace="http://fasb.org/us-gaap/2021-01-31" schemaLocation="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd"/>
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd"/>
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/country/2021" schemaLocation="https://xbrl.sec.gov/country/2021/country-2021.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2021" schemaLocation="https://xbrl.sec.gov/dei/2021/dei-2021.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="cah-20210630_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="cah-20210630_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="cah-20210630_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="cah-20210630_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="CoverPage" roleURI="http://www.cardinal.com/role/CoverPage">
        <link:definition>000010001 - Document - Cover Page</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsofEarnings" roleURI="http://www.cardinal.com/role/ConsolidatedStatementsofEarnings">
        <link:definition>100010002 - Statement - Consolidated Statements of Earnings</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsofComprehensiveIncome" roleURI="http://www.cardinal.com/role/ConsolidatedStatementsofComprehensiveIncome">
        <link:definition>100020003 - Statement - Consolidated Statements of Comprehensive Income</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedBalanceSheets" roleURI="http://www.cardinal.com/role/ConsolidatedBalanceSheets">
        <link:definition>100030004 - Statement - Consolidated Balance Sheets</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedBalanceSheetsParenthetical" roleURI="http://www.cardinal.com/role/ConsolidatedBalanceSheetsParenthetical">
        <link:definition>100040005 - Statement - Consolidated Balance Sheets (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsofShareholdersEquity" roleURI="http://www.cardinal.com/role/ConsolidatedStatementsofShareholdersEquity">
        <link:definition>100050006 - Statement - Consolidated Statements of Shareholders' Equity</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsofCashFlows" roleURI="http://www.cardinal.com/role/ConsolidatedStatementsofCashFlows">
        <link:definition>100060007 - Statement - Consolidated Statements of Cash Flows</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BasisofPresentationandSummaryofSignificantAccountingPolicies" roleURI="http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPolicies">
        <link:definition>210011001 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies" roleURI="http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies">
        <link:definition>220022001 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BasisofPresentationandSummaryofSignificantAccountingPoliciesTables" roleURI="http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesTables">
        <link:definition>230033001 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeReceivablesDetails" roleURI="http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeReceivablesDetails">
        <link:definition>240044001 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Narrative, Receivables) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BasisofPresentationandSummaryofSignificantAccountingPoliciesRevenueandGrossTradeReceivablesPercentagebyMajorCustomersDetails" roleURI="http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesRevenueandGrossTradeReceivablesPercentagebyMajorCustomersDetails">
        <link:definition>240054002 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Revenue and Gross Trade Receivables Percentage by Major Customers) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeMajorCustomersDetails" roleURI="http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeMajorCustomersDetails">
        <link:definition>240064003 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Narrative, Major Customers) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeInventoriesDetails" roleURI="http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeInventoriesDetails">
        <link:definition>240074004 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Narrative, Inventories) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativePropertyandEquipmentDetails" roleURI="http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativePropertyandEquipmentDetails">
        <link:definition>240084005 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Narrative, Property and Equipment) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BasisofPresentationandSummaryofSignificantAccountingPoliciesComponentsofPropertyandEquipmentDetails" roleURI="http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesComponentsofPropertyandEquipmentDetails">
        <link:definition>240094006 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Components of Property and Equipment) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeGoodwillandOtherIntangibleAssetsDetails" roleURI="http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeGoodwillandOtherIntangibleAssetsDetails">
        <link:definition>240104007 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Narrative, Goodwill and Other Intangible Assets) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeInvestmentsDetails" roleURI="http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeInvestmentsDetails">
        <link:definition>240114008 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Narrative, Investments) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeVendorReservesDetails" roleURI="http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeVendorReservesDetails">
        <link:definition>240124009 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Narrative, Vendor Reserves) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDividendsDetails" roleURI="http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDividendsDetails">
        <link:definition>240134010 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Narrative, Dividends) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeSalesReturnsandAllowancesDetails" roleURI="http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeSalesReturnsandAllowancesDetails">
        <link:definition>240144011 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Narrative, Sales Returns and Allowances) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeShippingandHandlingDetails" roleURI="http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeShippingandHandlingDetails">
        <link:definition>240154012 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Narrative, Shipping and Handling) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BasisofPresentationandSummaryofSignificantAccountingPoliciesLossContingenciesDetails" roleURI="http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesLossContingenciesDetails">
        <link:definition>240164013 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies Loss Contingencies (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DivestituresandAcquisitions" roleURI="http://www.cardinal.com/role/DivestituresandAcquisitions">
        <link:definition>210171002 - Disclosure - Divestitures and Acquisitions</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DivestituresandAcquisitionsTables" roleURI="http://www.cardinal.com/role/DivestituresandAcquisitionsTables">
        <link:definition>230183002 - Disclosure - Divestitures and Acquisitions (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DivestituresandAcquisitionsNarrativeDetails" roleURI="http://www.cardinal.com/role/DivestituresandAcquisitionsNarrativeDetails">
        <link:definition>240194014 - Disclosure - Divestitures and Acquisitions (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RestructuringandEmployeeSeverance" roleURI="http://www.cardinal.com/role/RestructuringandEmployeeSeverance">
        <link:definition>210201003 - Disclosure - Restructuring and Employee Severance</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RestructuringandEmployeeSeveranceTables" roleURI="http://www.cardinal.com/role/RestructuringandEmployeeSeveranceTables">
        <link:definition>230213003 - Disclosure - Restructuring and Employee Severance (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RestructuringandEmployeeSeveranceActivityRelatedtoRestructuringandEmployeeSeveranceCostsDetails" roleURI="http://www.cardinal.com/role/RestructuringandEmployeeSeveranceActivityRelatedtoRestructuringandEmployeeSeveranceCostsDetails">
        <link:definition>240224015 - Disclosure - Restructuring and Employee Severance (Activity Related to Restructuring and Employee Severance Costs) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RestructuringandEmployeeSeveranceLiabilitiesAssociatedwithRestructuringandEmployeeSeveranceActivitiesDetails" roleURI="http://www.cardinal.com/role/RestructuringandEmployeeSeveranceLiabilitiesAssociatedwithRestructuringandEmployeeSeveranceActivitiesDetails">
        <link:definition>240234016 - Disclosure - Restructuring and Employee Severance (Liabilities Associated with Restructuring and Employee Severance Activities) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandOtherIntangibleAssets" roleURI="http://www.cardinal.com/role/GoodwillandOtherIntangibleAssets">
        <link:definition>210241004 - Disclosure - Goodwill and Other Intangible Assets</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandOtherIntangibleAssetsTables" roleURI="http://www.cardinal.com/role/GoodwillandOtherIntangibleAssetsTables">
        <link:definition>230253004 - Disclosure - Goodwill and Other Intangible Assets (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandOtherIntangibleAssetsScheduleofGoodwillbyReportableSegmentDetails" roleURI="http://www.cardinal.com/role/GoodwillandOtherIntangibleAssetsScheduleofGoodwillbyReportableSegmentDetails">
        <link:definition>240264017 - Disclosure - Goodwill and Other Intangible Assets (Schedule of Goodwill by Reportable Segment) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandOtherIntangibleAssetsScheduleofIntangibleAssetsDetails" roleURI="http://www.cardinal.com/role/GoodwillandOtherIntangibleAssetsScheduleofIntangibleAssetsDetails">
        <link:definition>240274018 - Disclosure - Goodwill and Other Intangible Assets (Schedule of Intangible Assets) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandOtherIntangibleAssetsNarrativeDetails" roleURI="http://www.cardinal.com/role/GoodwillandOtherIntangibleAssetsNarrativeDetails">
        <link:definition>240284019 - Disclosure - Goodwill and Other Intangible Assets (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Leases" roleURI="http://www.cardinal.com/role/Leases">
        <link:definition>210291005 - Disclosure - Leases</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesTables" roleURI="http://www.cardinal.com/role/LeasesTables">
        <link:definition>230303005 - Disclosure - Leases (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesDetails" roleURI="http://www.cardinal.com/role/LeasesDetails">
        <link:definition>240314020 - Disclosure - Leases (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesScheduleofLeaseCostsDetails" roleURI="http://www.cardinal.com/role/LeasesScheduleofLeaseCostsDetails">
        <link:definition>240324021 - Disclosure - Leases Schedule of Lease Costs (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesSupplementalBalanceSheetInformationDetails" roleURI="http://www.cardinal.com/role/LeasesSupplementalBalanceSheetInformationDetails">
        <link:definition>240334022 - Disclosure - Leases Supplemental Balance Sheet Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesSupplementalCashFlowInformationDetails" roleURI="http://www.cardinal.com/role/LeasesSupplementalCashFlowInformationDetails">
        <link:definition>240344023 - Disclosure - Leases Supplemental Cash Flow Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesScheduleofFutureLeasePaymentsDetails" roleURI="http://www.cardinal.com/role/LeasesScheduleofFutureLeasePaymentsDetails">
        <link:definition>240354024 - Disclosure - Leases Schedule of Future Lease Payments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LongTermObligationsandOtherShortTermBorrowings" roleURI="http://www.cardinal.com/role/LongTermObligationsandOtherShortTermBorrowings">
        <link:definition>210361006 - Disclosure - Long-Term Obligations and Other Short-Term Borrowings</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LongTermObligationsandOtherShortTermBorrowingsTables" roleURI="http://www.cardinal.com/role/LongTermObligationsandOtherShortTermBorrowingsTables">
        <link:definition>230373006 - Disclosure - Long-Term Obligations and Other Short-Term Borrowings (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LongTermObligationsandOtherShortTermBorrowingsSummaryofDebtDetails" roleURI="http://www.cardinal.com/role/LongTermObligationsandOtherShortTermBorrowingsSummaryofDebtDetails">
        <link:definition>240384025 - Disclosure - Long-Term Obligations and Other Short-Term Borrowings Summary of Debt (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LongTermObligationsandOtherShortTermBorrowingsNarrativeDetails" roleURI="http://www.cardinal.com/role/LongTermObligationsandOtherShortTermBorrowingsNarrativeDetails">
        <link:definition>240394026 - Disclosure - Long-Term Obligations and Other Short-Term Borrowings Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LongTermObligationsandOtherShortTermBorrowingsLongTermDebtDetails" roleURI="http://www.cardinal.com/role/LongTermObligationsandOtherShortTermBorrowingsLongTermDebtDetails">
        <link:definition>240404027 - Disclosure - Long-Term Obligations and Other Short-Term Borrowings Long-Term Debt (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LongTermObligationsandOtherShortTermBorrowingsOtherFinancingArrangementsDetails" roleURI="http://www.cardinal.com/role/LongTermObligationsandOtherShortTermBorrowingsOtherFinancingArrangementsDetails">
        <link:definition>240414028 - Disclosure - Long-Term Obligations and Other Short-Term Borrowings Other Financing Arrangements (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsContingentLiabilitiesandLitigation" roleURI="http://www.cardinal.com/role/CommitmentsContingentLiabilitiesandLitigation">
        <link:definition>210421007 - Disclosure - Commitments, Contingent Liabilities and Litigation</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsContingentLiabilitiesandLitigationDetails" roleURI="http://www.cardinal.com/role/CommitmentsContingentLiabilitiesandLitigationDetails">
        <link:definition>240434029 - Disclosure - Commitments, Contingent Liabilities and Litigation (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxes" roleURI="http://www.cardinal.com/role/IncomeTaxes">
        <link:definition>210441008 - Disclosure - Income Taxes</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesTables" roleURI="http://www.cardinal.com/role/IncomeTaxesTables">
        <link:definition>230453007 - Disclosure - Income Taxes (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesScheduleofIncomebeforeIncomeTaxDomesticandForeignDetails" roleURI="http://www.cardinal.com/role/IncomeTaxesScheduleofIncomebeforeIncomeTaxDomesticandForeignDetails">
        <link:definition>240464030 - Disclosure - Income Taxes (Schedule of Income before Income Tax, Domestic and Foreign) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesScheduleofComponentsofIncomeTaxExpenseBenefitCurrentandDeferredDetails" roleURI="http://www.cardinal.com/role/IncomeTaxesScheduleofComponentsofIncomeTaxExpenseBenefitCurrentandDeferredDetails">
        <link:definition>240474031 - Disclosure - Income Taxes (Schedule of Components of Income Tax Expense (Benefit), Current and Deferred) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesScheduleofEffectiveIncomeTaxRateReconciliationDetails" roleURI="http://www.cardinal.com/role/IncomeTaxesScheduleofEffectiveIncomeTaxRateReconciliationDetails">
        <link:definition>240484032 - Disclosure - Income Taxes (Schedule of Effective Income Tax Rate Reconciliation) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesNarrativeDetails" roleURI="http://www.cardinal.com/role/IncomeTaxesNarrativeDetails">
        <link:definition>240494033 - Disclosure - Income Taxes (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails" roleURI="http://www.cardinal.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails">
        <link:definition>240504034 - Disclosure - Income Taxes (Schedule of Deferred Tax Assets and Liabilities) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesAfterNettingbyTaxJurisdictionDetails" roleURI="http://www.cardinal.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesAfterNettingbyTaxJurisdictionDetails">
        <link:definition>240514035 - Disclosure - Income Taxes (Schedule of Deferred Tax Assets and Liabilities After Netting by Tax Jurisdiction) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesScheduleofUnrecognizedTaxBenefitsRollForwardDetails" roleURI="http://www.cardinal.com/role/IncomeTaxesScheduleofUnrecognizedTaxBenefitsRollForwardDetails">
        <link:definition>240524036 - Disclosure - Income Taxes (Schedule of Unrecognized Tax Benefits Roll Forward) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Guarantees" roleURI="http://www.cardinal.com/role/Guarantees">
        <link:definition>210531009 - Disclosure - Guarantees</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurements" roleURI="http://www.cardinal.com/role/FairValueMeasurements">
        <link:definition>210541010 - Disclosure - Fair Value Measurements</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsTables" roleURI="http://www.cardinal.com/role/FairValueMeasurementsTables">
        <link:definition>230553008 - Disclosure - Fair Value Measurements (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsFairValueofAssetsandLiabilitiesMeasuredonaRecurringBasisDetails" roleURI="http://www.cardinal.com/role/FairValueMeasurementsFairValueofAssetsandLiabilitiesMeasuredonaRecurringBasisDetails">
        <link:definition>240564037 - Disclosure - Fair Value Measurements (Fair Value of Assets and Liabilities Measured on a Recurring Basis) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsReconciliationofLiabilitiesMeasuredatFairValueonaRecurringBasisUsingUnobservableInputsLevel3Details" roleURI="http://www.cardinal.com/role/FairValueMeasurementsReconciliationofLiabilitiesMeasuredatFairValueonaRecurringBasisUsingUnobservableInputsLevel3Details">
        <link:definition>240574038 - Disclosure - Fair Value Measurements (Reconciliation of Liabilities Measured at Fair Value on a Recurring Basis Using Unobservable Inputs (Level 3)) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsDetails" roleURI="http://www.cardinal.com/role/FairValueMeasurementsDetails">
        <link:definition>240584039 - Disclosure - Fair Value Measurements (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FinancialInstruments" roleURI="http://www.cardinal.com/role/FinancialInstruments">
        <link:definition>210591011 - Disclosure - Financial Instruments</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FinancialInstrumentsTables" roleURI="http://www.cardinal.com/role/FinancialInstrumentsTables">
        <link:definition>230603009 - Disclosure - Financial Instruments (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FinancialInstrumentsScheduleoftheFairValueofAssetsandLiabilitiesRelatedtoDerivativesDesignatedasHedgingInstrumentsDetails" roleURI="http://www.cardinal.com/role/FinancialInstrumentsScheduleoftheFairValueofAssetsandLiabilitiesRelatedtoDerivativesDesignatedasHedgingInstrumentsDetails">
        <link:definition>240614040 - Disclosure - Financial Instruments (Schedule of the Fair Value of Assets and Liabilities Related to Derivatives Designated as Hedging Instruments) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FinancialInstrumentsNarrativeDetails" roleURI="http://www.cardinal.com/role/FinancialInstrumentsNarrativeDetails">
        <link:definition>240624041 - Disclosure - Financial Instruments (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FinancialInstrumentsScheduleofOutstandingInstrumentsFairValueHedgesDetails" roleURI="http://www.cardinal.com/role/FinancialInstrumentsScheduleofOutstandingInstrumentsFairValueHedgesDetails">
        <link:definition>240634042 - Disclosure - Financial Instruments (Schedule of Outstanding Instruments, Fair Value Hedges) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FinancialInstrumentsScheduleofGainLossRecognizedinEarningsforInterestRateContractsDesignatedasFairValueHedgesDetails" roleURI="http://www.cardinal.com/role/FinancialInstrumentsScheduleofGainLossRecognizedinEarningsforInterestRateContractsDesignatedasFairValueHedgesDetails">
        <link:definition>240644043 - Disclosure - Financial Instruments (Schedule of Gain/(Loss) Recognized in Earnings for Interest Rate Contracts Designated as Fair Value Hedges) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FinancialInstrumentsScheduleofOutstandingInstrumentsCashFlowHedgesDetails" roleURI="http://www.cardinal.com/role/FinancialInstrumentsScheduleofOutstandingInstrumentsCashFlowHedgesDetails">
        <link:definition>240654044 - Disclosure - Financial Instruments (Schedule of Outstanding Instruments, Cash Flow Hedges) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FinancialInstrumentsScheduleofGainLossIncludedinAOCIforDerivativeInstrumentsDesignatedasCashFlowHedgesDetails" roleURI="http://www.cardinal.com/role/FinancialInstrumentsScheduleofGainLossIncludedinAOCIforDerivativeInstrumentsDesignatedasCashFlowHedgesDetails">
        <link:definition>240664045 - Disclosure - Financial Instruments (Schedule of Gain/(Loss) Included in AOCI for Derivative Instruments Designated as Cash Flow Hedges) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FinancialInstrumentsScheduleofGainLossReclassifiedfromAOCIintoEarningsforDerivativeInstrumentsDesignatedasCashFlowHedgesDetails" roleURI="http://www.cardinal.com/role/FinancialInstrumentsScheduleofGainLossReclassifiedfromAOCIintoEarningsforDerivativeInstrumentsDesignatedasCashFlowHedgesDetails">
        <link:definition>240674046 - Disclosure - Financial Instruments (Schedule of Gain/(Loss) Reclassified from AOCI into Earnings for Derivative Instruments Designated as Cash Flow Hedges) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FinancialInstrumentsScheduleofOutstandingInstrumentsEconomicHedgesDetails" roleURI="http://www.cardinal.com/role/FinancialInstrumentsScheduleofOutstandingInstrumentsEconomicHedgesDetails">
        <link:definition>240684047 - Disclosure - Financial Instruments (Schedule of Outstanding Instruments, Economic Hedges) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FinancialInstrumentsScheduleofGainLossRecognizedinEarningsforDerivativesNotDesignatedasHedgingInstrumentDetails" roleURI="http://www.cardinal.com/role/FinancialInstrumentsScheduleofGainLossRecognizedinEarningsforDerivativesNotDesignatedasHedgingInstrumentDetails">
        <link:definition>240694048 - Disclosure - Financial Instruments (Schedule of Gain/(Loss) Recognized in Earnings for Derivatives Not Designated as Hedging Instrument) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FinancialInstrumentsSummaryofEstimatedFairValueofLongtermObligationsandOtherShorttermBorrowingsDetails" roleURI="http://www.cardinal.com/role/FinancialInstrumentsSummaryofEstimatedFairValueofLongtermObligationsandOtherShorttermBorrowingsDetails">
        <link:definition>240704049 - Disclosure - Financial Instruments (Summary of Estimated Fair Value of Long-term Obligations and Other Short-term Borrowings) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FinancialInstrumentsScheduleofFairValueGainLossDerivativeInstrumentDetails" roleURI="http://www.cardinal.com/role/FinancialInstrumentsScheduleofFairValueGainLossDerivativeInstrumentDetails">
        <link:definition>240714050 - Disclosure - Financial Instruments (Schedule of Fair Value Gain Loss Derivative Instrument) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareholdersEquity" roleURI="http://www.cardinal.com/role/ShareholdersEquity">
        <link:definition>210721012 - Disclosure - Shareholders' Equity</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareholdersEquityTables" roleURI="http://www.cardinal.com/role/ShareholdersEquityTables">
        <link:definition>230733010 - Disclosure - Shareholders' Equity (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareholdersEquityNarrativeDetails" roleURI="http://www.cardinal.com/role/ShareholdersEquityNarrativeDetails">
        <link:definition>240744051 - Disclosure - Shareholders' Equity (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareholdersEquityChangesintheAccumulatedOtherComprehensiveIncomeLossDetails" roleURI="http://www.cardinal.com/role/ShareholdersEquityChangesintheAccumulatedOtherComprehensiveIncomeLossDetails">
        <link:definition>240754052 - Disclosure - Shareholders' Equity (Changes in the Accumulated Other Comprehensive Income (Loss)) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EarningsPerShareAttributabletoCardinalHealthInc" roleURI="http://www.cardinal.com/role/EarningsPerShareAttributabletoCardinalHealthInc">
        <link:definition>210761013 - Disclosure - Earnings Per Share Attributable to Cardinal Health, Inc.</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EarningsPerShareAttributabletoCardinalHealthIncTables" roleURI="http://www.cardinal.com/role/EarningsPerShareAttributabletoCardinalHealthIncTables">
        <link:definition>230773011 - Disclosure - Earnings Per Share Attributable to Cardinal Health, Inc. (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EarningsPerShareAttributabletoCardinalHealthIncReconciliationofCommonSharesUsedtoComputeBasicandDilutedEPSDetails" roleURI="http://www.cardinal.com/role/EarningsPerShareAttributabletoCardinalHealthIncReconciliationofCommonSharesUsedtoComputeBasicandDilutedEPSDetails">
        <link:definition>240784053 - Disclosure - Earnings Per Share Attributable to Cardinal Health, Inc. (Reconciliation of Common Shares Used to Compute Basic and Diluted EPS) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EarningsPerShareAttributabletoCardinalHealthIncNarrativeDetails" roleURI="http://www.cardinal.com/role/EarningsPerShareAttributabletoCardinalHealthIncNarrativeDetails">
        <link:definition>240794054 - Disclosure - Earnings Per Share Attributable to Cardinal Health, Inc. (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentInformation" roleURI="http://www.cardinal.com/role/SegmentInformation">
        <link:definition>210801014 - Disclosure - Segment Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentInformationTables" roleURI="http://www.cardinal.com/role/SegmentInformationTables">
        <link:definition>230813012 - Disclosure - Segment Information (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentInformationNarrativeDetails" roleURI="http://www.cardinal.com/role/SegmentInformationNarrativeDetails">
        <link:definition>240824055 - Disclosure - Segment Information (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentInformationRevenuebyReportableSegmentDetails" roleURI="http://www.cardinal.com/role/SegmentInformationRevenuebyReportableSegmentDetails">
        <link:definition>240834056 - Disclosure - Segment Information (Revenue by Reportable Segment) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentInformationSegmentProfitbyReportableSegmentDetails" roleURI="http://www.cardinal.com/role/SegmentInformationSegmentProfitbyReportableSegmentDetails">
        <link:definition>240844057 - Disclosure - Segment Information (Segment Profit by Reportable Segment) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentInformationDepreciationandAmortizationandAdditionstoPropertyandEquipmentbyReportableSegmentDetails" roleURI="http://www.cardinal.com/role/SegmentInformationDepreciationandAmortizationandAdditionstoPropertyandEquipmentbyReportableSegmentDetails">
        <link:definition>240854058 - Disclosure - Segment Information (Depreciation and Amortization and Additions to Property and Equipment by Reportable Segment) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentInformationAssetsbyReportableSegmentDetails" roleURI="http://www.cardinal.com/role/SegmentInformationAssetsbyReportableSegmentDetails">
        <link:definition>240864059 - Disclosure - Segment Information (Assets by Reportable Segment) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentInformationPropertyandEquipmentnetbyGeographicAreaDetails" roleURI="http://www.cardinal.com/role/SegmentInformationPropertyandEquipmentnetbyGeographicAreaDetails">
        <link:definition>240874060 - Disclosure - Segment Information Property and Equipment, net by Geographic Area) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareBasedCompensation" roleURI="http://www.cardinal.com/role/ShareBasedCompensation">
        <link:definition>210881015 - Disclosure - Share-Based Compensation</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareBasedCompensationTables" roleURI="http://www.cardinal.com/role/ShareBasedCompensationTables">
        <link:definition>230893013 - Disclosure - Share-Based Compensation (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareBasedCompensationNarrativeDetails" roleURI="http://www.cardinal.com/role/ShareBasedCompensationNarrativeDetails">
        <link:definition>240904061 - Disclosure - Share-Based Compensation (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareBasedCompensationScheduleofTotalShareBasedCompensationExpensebyTypeofAwardDetails" roleURI="http://www.cardinal.com/role/ShareBasedCompensationScheduleofTotalShareBasedCompensationExpensebyTypeofAwardDetails">
        <link:definition>240914062 - Disclosure - Share-Based Compensation (Schedule of Total Share-Based Compensation Expense by Type of Award) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareBasedCompensationScheduleofAllStockOptionTransactionsUnderthePlansDetails" roleURI="http://www.cardinal.com/role/ShareBasedCompensationScheduleofAllStockOptionTransactionsUnderthePlansDetails">
        <link:definition>240924063 - Disclosure - Share-Based Compensation (Schedule of All Stock Option Transactions Under the Plans) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareBasedCompensationScheduleofAdditionalDataRelatedtoStockOptionsDetails" roleURI="http://www.cardinal.com/role/ShareBasedCompensationScheduleofAdditionalDataRelatedtoStockOptionsDetails">
        <link:definition>240934064 - Disclosure - Share-Based Compensation (Schedule of Additional Data Related to Stock Options) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareBasedCompensationScheduleofRemainingStockOptionPlanDataDetails" roleURI="http://www.cardinal.com/role/ShareBasedCompensationScheduleofRemainingStockOptionPlanDataDetails">
        <link:definition>240944065 - Disclosure - Share-Based Compensation Schedule of Remaining Stock Option Plan Data (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareBasedCompensationScheduleofAllTransactionsRelatedtoRestrictedShareUnitsUnderthePlansDetails" roleURI="http://www.cardinal.com/role/ShareBasedCompensationScheduleofAllTransactionsRelatedtoRestrictedShareUnitsUnderthePlansDetails">
        <link:definition>240954066 - Disclosure - Share-Based Compensation (Schedule of All Transactions Related to Restricted Share Units Under the Plans) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareBasedCompensationAdditionalDataRelatedtoRestrictedShareUnitActivityDetails" roleURI="http://www.cardinal.com/role/ShareBasedCompensationAdditionalDataRelatedtoRestrictedShareUnitActivityDetails">
        <link:definition>240964067 - Disclosure - Share-Based Compensation (Additional Data Related to Restricted Share Unit Activity) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareBasedCompensationScheduleofAllTransactionsRelatedtoPerformanceShareUnitsUnderthePlansDetails" roleURI="http://www.cardinal.com/role/ShareBasedCompensationScheduleofAllTransactionsRelatedtoPerformanceShareUnitsUnderthePlansDetails">
        <link:definition>240974068 - Disclosure - Share-Based Compensation (Schedule of All Transactions Related to Performance Share Units Under the Plans) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareBasedCompensationAdditionalDataRelatedtoPerformanceShareUnitActivityDetails" roleURI="http://www.cardinal.com/role/ShareBasedCompensationAdditionalDataRelatedtoPerformanceShareUnitActivityDetails">
        <link:definition>240984069 - Disclosure - Share-Based Compensation (Additional Data Related to Performance Share Unit Activity) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ScheduleIIValuationsandQualifyingAccounts" roleURI="http://www.cardinal.com/role/ScheduleIIValuationsandQualifyingAccounts">
        <link:definition>210991016 - Disclosure - Schedule II - Valuations and Qualifying Accounts</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ScheduleIIValuationsandQualifyingAccountsDetails" roleURI="http://www.cardinal.com/role/ScheduleIIValuationsandQualifyingAccountsDetails">
        <link:definition>241004070 - Disclosure - Schedule II - Valuations and Qualifying Accounts (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:element id="cah_EffectiveTaxRateImpactFromCertainForeignJurisdictions" abstract="false" name="EffectiveTaxRateImpactFromCertainForeignJurisdictions" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cah_ScheduleOfFairValueGainLossDerivativeInstrumentTableTextBlock" abstract="false" name="ScheduleOfFairValueGainLossDerivativeInstrumentTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="cah_TotalLeaseLiabilityPaymentsDue" abstract="false" name="TotalLeaseLiabilityPaymentsDue" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cah_DistributionServiceAgreementAndOtherVendorFeesPolicyTextBlock" abstract="false" name="DistributionServiceAgreementAndOtherVendorFeesPolicyTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="cah_DiscountRatefairvalueinputs" abstract="false" name="DiscountRatefairvalueinputs" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="cah_SterileSurgicalGownRecallAxis" abstract="true" name="SterileSurgicalGownRecallAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="cah_FloatingRateNotes2616NotesMember" abstract="true" name="FloatingRateNotes2616NotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cah_AssetsHeldforSalePolicyPolicyTextBlock" abstract="false" name="AssetsHeldforSalePolicyPolicyTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="cah_EffectiveIncomeTaxRateReconciliationLossCarrybackClaims" abstract="false" name="EffectiveIncomeTaxRateReconciliationLossCarrybackClaims" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="cah_GownRecallDomain" abstract="true" name="GownRecallDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cah_NumberofStateAttorneysGeneralfilinglawsuits" abstract="false" name="NumberofStateAttorneysGeneralfilinglawsuits" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="cah_ASC842Member" abstract="true" name="ASC842Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cah_WriteDownOfAssetsHeldForSale" abstract="false" name="WriteDownOfAssetsHeldForSale" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cah_LesseeFinanceLeaseLiabilityNotYetCommencedAmount" abstract="false" name="LesseeFinanceLeaseLiabilityNotYetCommencedAmount" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cah_LesseeLeaseLiabilityPaymentsDueYearTwo" abstract="false" name="LesseeLeaseLiabilityPaymentsDueYearTwo" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cah_IPRDTrademarksandOtherMember" abstract="true" name="IPRDTrademarksandOtherMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cah_LesseeLeaseLiabilityPaymentsDueYearOne" abstract="false" name="LesseeLeaseLiabilityPaymentsDueYearOne" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cah_LesseeLeaseLiabilityPaymentsDueYearFive" abstract="false" name="LesseeLeaseLiabilityPaymentsDueYearFive" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cah_PriorYearRecoveriesMember" abstract="true" name="PriorYearRecoveriesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cah_FacilityExitAndOtherCosts" abstract="false" name="FacilityExitAndOtherCosts" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cah_A3.2Notesdue2023Member" abstract="true" name="A3.2Notesdue2023Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cah_LesseeLeaseLiabilityPaymentsDueYearFour" abstract="false" name="LesseeLeaseLiabilityPaymentsDueYearFour" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cah_NetOperatingLossCarrybackAxis" abstract="true" name="NetOperatingLossCarrybackAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="cah_TrademarksAndPatentsMember" abstract="true" name="TrademarksAndPatentsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cah_DerivatesHedgeDiscontinuancesHedgingInstrumentTerminatedAmount" abstract="false" name="DerivatesHedgeDiscontinuancesHedgingInstrumentTerminatedAmount" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cah_TotalOpioidLitigationMember" abstract="true" name="TotalOpioidLitigationMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cah_NetOperatingLossCarrybackMember" abstract="true" name="NetOperatingLossCarrybackMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cah_LitigationTypeDomain" abstract="true" name="LitigationTypeDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cah_FixedRateDebtMember" abstract="true" name="FixedRateDebtMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cah_ClassActionLawsuitsMember" abstract="true" name="ClassActionLawsuitsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cah_RevenueRecognitionReserveforSalesReturnsandAllowances" abstract="false" name="RevenueRecognitionReserveforSalesReturnsandAllowances" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cah_OpioidLitigationDomain" abstract="true" name="OpioidLitigationDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cah_NaviHealthAxis" abstract="true" name="NaviHealthAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="cah_NaviHealthMember" abstract="true" name="NaviHealthMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cah_ScheduleOfDeferredTaxAssetsAndLiabilitiesAfterNettingByTaxJurisdictionTableTextBlock" abstract="false" name="ScheduleOfDeferredTaxAssetsAndLiabilitiesAfterNettingByTaxJurisdictionTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="cah_GoodwillAndIntangibleAssetsTable" abstract="true" name="GoodwillAndIntangibleAssetsTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="cah_TaxMatterDomain" abstract="true" name="TaxMatterDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cah_EffectiveIncomeTaxRateReconciliationWithholdingTaxes" abstract="false" name="EffectiveIncomeTaxRateReconciliationWithholdingTaxes" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="cah_A32Notes2616NotesMember" abstract="true" name="A32Notes2616NotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cah_OpioidLawsuitsStateDomain" abstract="true" name="OpioidLawsuitsStateDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cah_GoodsandservicessoldLineItems" abstract="true" name="GoodsandservicessoldLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="cah_AmortizationandOtherAcquisitionRelatedCostsPolicyPolicyTextBlock" abstract="false" name="AmortizationandOtherAcquisitionRelatedCostsPolicyPolicyTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="cah_DerivativesHedgeDiscontinuancesHedgingInstrumentMaturedAmount" abstract="false" name="DerivativesHedgeDiscontinuancesHedgingInstrumentMaturedAmount" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cah_Provisionaltaxbenefitrelatedtotransaction" abstract="false" name="Provisionaltaxbenefitrelatedtotransaction" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cah_GrossTradeReceivablesMajorCustomerPercentage" abstract="false" name="GrossTradeReceivablesMajorCustomerPercentage" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="cah_OperatingLeaseImputedInterest" abstract="false" name="OperatingLeaseImputedInterest" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cah_MedicaldistributionandproductsMember" abstract="true" name="MedicaldistributionandproductsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cah_SterileSurgicalGownRecallDomain" abstract="true" name="SterileSurgicalGownRecallDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cah_RemainingStockOptionPlanDataTableTextBlock" abstract="false" name="RemainingStockOptionPlanDataTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="cah_PlaintiffTypeDomain" abstract="true" name="PlaintiffTypeDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cah_A3.2Notesdue2022Member" abstract="true" name="A3.2Notesdue2022Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cah_EffectiveIncomeTaxRateReconciliationLegalEntityReorganizationReconcilingItemsPercent" abstract="false" name="EffectiveIncomeTaxRateReconciliationLegalEntityReorganizationReconcilingItemsPercent" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="cah_AwardsOtherThanStockOptionsMember" abstract="true" name="AwardsOtherThanStockOptionsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cah_A3.75Notesdue2026Member" abstract="true" name="A3.75Notesdue2026Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cah_A24NotesDue2019Member" abstract="true" name="A24NotesDue2019Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cah_PlaintiffTypeAxis" abstract="true" name="PlaintiffTypeAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="cah_A4.9Notesdue2045Member" abstract="true" name="A4.9Notesdue2045Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cah_IndemnificationReceivable" abstract="false" name="IndemnificationReceivable" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cah_TreasuryStockAcquiredShares" abstract="false" name="TreasuryStockAcquiredShares" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="cah_LesseeOperatingLeaseLiabilityNotYetCommencedAmount" abstract="false" name="LesseeOperatingLeaseLiabilityNotYetCommencedAmount" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cah_FinanceLeaseImputedInterest" abstract="false" name="FinanceLeaseImputedInterest" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cah_AllegianceCorporationMember" abstract="true" name="AllegianceCorporationMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cah_SalesreturnsPolicyTextBlock" abstract="false" name="SalesreturnsPolicyTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="cah_Proceedsfromsaleofavailableforsalesecuritiesandotherinvestments" abstract="false" name="Proceedsfromsaleofavailableforsalesecuritiesandotherinvestments" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cah_LawsuitTypeAxis" abstract="true" name="LawsuitTypeAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="cah_OtherAccruedLiabilitiesPolicyPolicyTextBlock" abstract="false" name="OtherAccruedLiabilitiesPolicyPolicyTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="cah_AdditionalRestrictedSharesAndRestrictedShareUnitsDataTableTextBlock" abstract="false" name="AdditionalRestrictedSharesAndRestrictedShareUnitsDataTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="cah_VendorReserves" abstract="false" name="VendorReserves" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cah_A4.625Notesdue2021Member" abstract="true" name="A4.625Notesdue2021Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cah_CommittedReceivablesSalesFacilityProgramMember" abstract="true" name="CommittedReceivablesSalesFacilityProgramMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cah_NetOperatingLossCarrybackDomain" abstract="true" name="NetOperatingLossCarrybackDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cah_GoodwillAndIntangibleAssetsLineItems" abstract="true" name="GoodwillAndIntangibleAssetsLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="cah_LeasePaymentsTableTextBlock" abstract="false" name="LeasePaymentsTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="cah_CarryingAmountofLongTermandotherShortTermBorrowings" abstract="false" name="CarryingAmountofLongTermandotherShortTermBorrowings" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cah_GownRecallAxis" abstract="true" name="GownRecallAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="cah_LeasesTextBlock" abstract="false" name="LeasesTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="cah_A7.0Debenturesduefiscal2027Member" abstract="true" name="A7.0Debenturesduefiscal2027Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cah_LitigationTypeAxis" abstract="true" name="LitigationTypeAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="cah_ConcentrationRiskLargestGroupPurchasingOrganizations" abstract="false" name="ConcentrationRiskLargestGroupPurchasingOrganizations" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="cah_CashDiscountsPolicyTextBlock" abstract="false" name="CashDiscountsPolicyTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="cah_OptumRxMember" abstract="true" name="OptumRxMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cah_LesseeLeaseLiabilityPaymentsDueYearThree" abstract="false" name="LesseeLeaseLiabilityPaymentsDueYearThree" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cah_DOJInvestigationMember" abstract="true" name="DOJInvestigationMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cah_A3.5Notesdue2025Member" abstract="true" name="A3.5Notesdue2025Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cah_CardinalHealthAtHomeSolutionsMember" abstract="true" name="CardinalHealthAtHomeSolutionsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cah_AdditionalPerformanceShareUnitsDataTableTextBlock" abstract="false" name="AdditionalPerformanceShareUnitsDataTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="cah_DividendsPolicyPolicyTextBlock" abstract="false" name="DividendsPolicyPolicyTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="cah_LesseeLeaseLiabilityPaymentsDueAfterYearFive" abstract="false" name="LesseeLeaseLiabilityPaymentsDueAfterYearFive" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cah_MedicalMemberMember" abstract="true" name="MedicalMemberMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cah_FinanceLeaseMember" abstract="true" name="FinanceLeaseMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cah_PreTaxGainonDivestiture" abstract="false" name="PreTaxGainonDivestiture" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cah_ShortTermCreditFacilitiesMember" abstract="true" name="ShortTermCreditFacilitiesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cah_Netproceedstaxwithholdingsfromsharebasedcompensation" abstract="false" name="Netproceedstaxwithholdingsfromsharebasedcompensation" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cah_ReclassificationofdeferredrentinaccordancewithASC842" abstract="false" name="ReclassificationofdeferredrentinaccordancewithASC842" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cah_NetEarningsIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest" abstract="false" name="NetEarningsIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cah_A2011LtipMember" abstract="true" name="A2011LtipMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cah_A3.079Notesdue2024Member" abstract="true" name="A3.079Notesdue2024Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cah_FloatingRateNotesdue2022Member" abstract="true" name="FloatingRateNotesdue2022Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cah_NaviHealthDomain" abstract="true" name="NaviHealthDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cah_CordisDivestitureDomain" abstract="true" name="CordisDivestitureDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cah_DeferredIncomeTaxesAndOtherTaxLiabilitiesTransferredToHeldForSaleNoncurrent" abstract="false" name="DeferredIncomeTaxesAndOtherTaxLiabilitiesTransferredToHeldForSaleNoncurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cah_CostofSalesVendorReservesPolicyPolicyTextBlock" abstract="false" name="CostofSalesVendorReservesPolicyPolicyTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="cah_DeferredIncomeTaxesandOtherLiabilitiesMember" abstract="true" name="DeferredIncomeTaxesandOtherLiabilitiesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cah_OpioidLitigationAxis" abstract="true" name="OpioidLitigationAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="cah_SterileSurgicalGownRecallMemberDomain" abstract="true" name="SterileSurgicalGownRecallMemberDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cah_LossContingencyLawsuitsNumber" abstract="false" name="LossContingencyLawsuitsNumber" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="cah_CashReclassifiedtoAssetsHeldforSale" abstract="false" name="CashReclassifiedtoAssetsHeldforSale" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cah_AggregateAnnualAssessment" abstract="false" name="AggregateAnnualAssessment" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cah_CVSCaremarkCorporationMember" abstract="true" name="CVSCaremarkCorporationMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cah_NotesPayableRepurchased" abstract="false" name="NotesPayableRepurchased" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cah_TotalLeaseLiabilityNotYetCommencedAmount" abstract="false" name="TotalLeaseLiabilityNotYetCommencedAmount" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cah_A2.616Notes3.2Notes3.41Notes4.6Notes4.9Notesand4.368NotesMember" abstract="true" name="A2.616Notes3.2Notes3.41Notes4.6Notes4.9Notesand4.368NotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cah_TotalLeaseLiabilityUndiscountedExcessAmount" abstract="false" name="TotalLeaseLiabilityUndiscountedExcessAmount" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cah_A4.368Notesdue2047Member" abstract="true" name="A4.368Notesdue2047Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cah_CareFusionMember" abstract="true" name="CareFusionMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cah_Proceedsfromdivestituresanddisposalofpropertyandequipmentandheldforsaleassets" abstract="false" name="Proceedsfromdivestituresanddisposalofpropertyandequipmentandheldforsaleassets" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cah_DerivativesHedgeDiscontinuancesTerminationofHedgingInstrumentAmount" abstract="false" name="DerivativesHedgeDiscontinuancesTerminationofHedgingInstrumentAmount" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cah_EstimatedLiabilityForNewYorkOpioidStewardshipAct" abstract="false" name="EstimatedLiabilityForNewYorkOpioidStewardshipAct" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cah_GoodsandservicessoldTable" abstract="true" name="GoodsandservicessoldTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="cah_NuclearPrecisionHealthServicesMember" abstract="true" name="NuclearPrecisionHealthServicesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cah_GainonDivestitureAfterTax" abstract="false" name="GainonDivestitureAfterTax" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cah_Purchaseofavailableforsalesecuritiesandotherinvestments" abstract="false" name="Purchaseofavailableforsalesecuritiesandotherinvestments" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cah_PatientRecoveryBusinessMember" abstract="true" name="PatientRecoveryBusinessMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cah_LawsuitTypeDomain" abstract="true" name="LawsuitTypeDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cah_CordisDivestitureAxis" abstract="true" name="CordisDivestitureAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="cah_DisposalGroupIncludingDiscontinuedOperationsGoodwillAndOtherIntangiblesNet" abstract="false" name="DisposalGroupIncludingDiscontinuedOperationsGoodwillAndOtherIntangiblesNet" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cah_A2.616Notesdue2022Member" abstract="true" name="A2.616Notesdue2022Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cah_ProjectCostsOnInvestmentAndOtherSpending" abstract="false" name="ProjectCostsOnInvestmentAndOtherSpending" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cah_CommonStockVotingRightsVotes" abstract="false" name="CommonStockVotingRightsVotes" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:pureItemType"/>
  <xs:element id="cah_AlamedaCountyMember" abstract="true" name="AlamedaCountyMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cah_LeasesSupplementalBalanceSheetInformationTableTextBlock" abstract="false" name="LeasesSupplementalBalanceSheetInformationTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="cah_A4.6Notesdue2043Member" abstract="true" name="A4.6Notesdue2043Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cah_ShippingandHandlingCostsPolicyTextBlock" abstract="false" name="ShippingandHandlingCostsPolicyTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="cah_EffectiveIncomeTaxRateReconciliationTaxEffectOfForeignOperations" abstract="false" name="EffectiveIncomeTaxRateReconciliationTaxEffectOfForeignOperations" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="cah_NewYorkOpioidStewardshipActMember" abstract="true" name="NewYorkOpioidStewardshipActMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cah_CordisDivestitureMember" abstract="true" name="CordisDivestitureMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cah_DeferredTaxAssetsRelatedtouncertaintaxpositions" abstract="false" name="DeferredTaxAssetsRelatedtouncertaintaxpositions" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cah_Amortizationandotheracquisitionrelatedcosts" abstract="false" name="Amortizationandotheracquisitionrelatedcosts" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cah_Sharesthatwouldbeantidilutiveasaresultofnetloss" abstract="false" name="Sharesthatwouldbeantidilutiveasaresultofnetloss" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="cah_OtherJurisdictionsMember" abstract="true" name="OtherJurisdictionsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cah_AdditionalStockOptionPlanDataTableTextBlock" abstract="false" name="AdditionalStockOptionPlanDataTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="cah_OperatingLeaseMember" abstract="true" name="OperatingLeaseMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cah_OpioidLawsuitsMember" abstract="true" name="OpioidLawsuitsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cah_ProductLiabilityLawsuitsMember" abstract="true" name="ProductLiabilityLawsuitsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cah_EffectiveIncomeTaxReconciliationOpioidLitigation" abstract="false" name="EffectiveIncomeTaxReconciliationOpioidLitigation" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="cah_TotalLeaseLiability" abstract="false" name="TotalLeaseLiability" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cah_A3.41Notesdue2027Member" abstract="true" name="A3.41Notesdue2027Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cah_Impactofadoptionofnewaccountingstandard" abstract="false" name="Impactofadoptionofnewaccountingstandard" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cah_PharmaceuticalDistributionandSpecialtyMember" abstract="true" name="PharmaceuticalDistributionandSpecialtyMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cah_A4.5Notesdue2044Member" abstract="true" name="A4.5Notesdue2044Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cah_PrivatePartiesMember" abstract="true" name="PrivatePartiesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cah_PricingDisputesMember" abstract="true" name="PricingDisputesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cah_ReceivableFinancingAgreementTerm" abstract="false" name="ReceivableFinancingAgreementTerm" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="cah_GroupPurchasingOrganizationsMember" abstract="true" name="GroupPurchasingOrganizationsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cah_ExercisablePeriodOfPlansInYears" abstract="false" name="ExercisablePeriodOfPlansInYears" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="cah_PharmaceuticalMember" abstract="true" name="PharmaceuticalMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cah_VestingPeriodinyearsforShares" abstract="false" name="VestingPeriodinyearsforShares" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="cah_IncomefromSettlementsofClassActionLawsuits" abstract="false" name="IncomefromSettlementsofClassActionLawsuits" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cah_OfferAsPercentageOfPrincipalAmount" abstract="false" name="OfferAsPercentageOfPrincipalAmount" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="cah_EffectiveTaxRateReconciliationUSTaxesOnInternationalIncome" abstract="false" name="EffectiveTaxRateReconciliationUSTaxesOnInternationalIncome" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="cah_TaxMatterAxis" abstract="true" name="TaxMatterAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="cah_EffectiveTaxRateReconciliationImpactOfResolutionsWithIRSAndOtherRelatedMatters" abstract="false" name="EffectiveTaxRateReconciliationImpactOfResolutionsWithIRSAndOtherRelatedMatters" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="cah_A1.948Notesdue2019Member" abstract="true" name="A1.948Notesdue2019Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>9
<FILENAME>cah-20210630_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:b63e0697-7630-4efc-9622-5764c41287f3,g:18dc0520-9457-4463-b618-29c4ac061652-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.cardinal.com/role/ConsolidatedStatementsofEarnings" xlink:type="simple" xlink:href="cah-20210630.xsd#ConsolidatedStatementsofEarnings"/>
  <link:calculationLink xlink:role="http://www.cardinal.com/role/ConsolidatedStatementsofEarnings" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_9aa8ec5a-9348-4945-9c0f-0240279c33ef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_9ccbf52f-9bf2-4310-9568-048015ca97f3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ProfitLoss_9aa8ec5a-9348-4945-9c0f-0240279c33ef" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_9ccbf52f-9bf2-4310-9568-048015ca97f3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_0efe697a-d636-4067-908d-04b0f5f8b5b6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ProfitLoss_9aa8ec5a-9348-4945-9c0f-0240279c33ef" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_0efe697a-d636-4067-908d-04b0f5f8b5b6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_e71b467d-7e16-4430-9528-56e03b0ac2c6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_52f3ed66-233d-4159-8625-6c7c6d72f744" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_e71b467d-7e16-4430-9528-56e03b0ac2c6" xlink:to="loc_us-gaap_ProfitLoss_52f3ed66-233d-4159-8625-6c7c6d72f744" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_93619fa7-73e4-441f-95e7-c46576ffe680" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_e71b467d-7e16-4430-9528-56e03b0ac2c6" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_93619fa7-73e4-441f-95e7-c46576ffe680" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_37f82bf3-8c86-45c4-aff5-19fc137da349" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_9ed568f2-b615-4764-820f-3ef64ce0f590" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GrossProfit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_37f82bf3-8c86-45c4-aff5-19fc137da349" xlink:to="loc_us-gaap_GrossProfit_9ed568f2-b615-4764-820f-3ef64ce0f590" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_97de9f7e-d81a-45d3-8810-68c800d35802" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_37f82bf3-8c86-45c4-aff5-19fc137da349" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_97de9f7e-d81a-45d3-8810-68c800d35802" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_4d7e626f-42a2-487d-9d6d-de19f8ff2872" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCharges"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_37f82bf3-8c86-45c4-aff5-19fc137da349" xlink:to="loc_us-gaap_RestructuringCharges_4d7e626f-42a2-487d-9d6d-de19f8ff2872" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_Amortizationandotheracquisitionrelatedcosts_16c661ab-1aa3-4fa6-8567-c5c7e7d56858" xlink:href="cah-20210630.xsd#cah_Amortizationandotheracquisitionrelatedcosts"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_37f82bf3-8c86-45c4-aff5-19fc137da349" xlink:to="loc_cah_Amortizationandotheracquisitionrelatedcosts_16c661ab-1aa3-4fa6-8567-c5c7e7d56858" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges_dc2f5078-26e2-4259-a19e-28f29db6c949" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_37f82bf3-8c86-45c4-aff5-19fc137da349" xlink:to="loc_us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges_dc2f5078-26e2-4259-a19e-28f29db6c949" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossRelatedToLitigationSettlement_c81de673-022b-4a07-84ce-90c59d968ff4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossRelatedToLitigationSettlement"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_37f82bf3-8c86-45c4-aff5-19fc137da349" xlink:to="loc_us-gaap_GainLossRelatedToLitigationSettlement_c81de673-022b-4a07-84ce-90c59d968ff4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_4e3c53cf-668e-4af1-88ec-5a649ee04f93" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GrossProfit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_015c17b4-7b12-42cf-bee4-2d0182864c76" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Revenues"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GrossProfit_4e3c53cf-668e-4af1-88ec-5a649ee04f93" xlink:to="loc_us-gaap_Revenues_015c17b4-7b12-42cf-bee4-2d0182864c76" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_10d45e81-3f0e-43c2-a8b1-62e1f057ab79" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GrossProfit_4e3c53cf-668e-4af1-88ec-5a649ee04f93" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_10d45e81-3f0e-43c2-a8b1-62e1f057ab79" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_84530b1f-b287-454e-b210-5f1aa2ddfc96" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_907dd91c-1266-450e-8506-cf1c14d1fca9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_84530b1f-b287-454e-b210-5f1aa2ddfc96" xlink:to="loc_us-gaap_OperatingIncomeLoss_907dd91c-1266-450e-8506-cf1c14d1fca9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_9ba76e06-1a71-4995-89f7-e58141beaa72" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_84530b1f-b287-454e-b210-5f1aa2ddfc96" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_9ba76e06-1a71-4995-89f7-e58141beaa72" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_2026e557-7879-4230-9498-a52d0c5c9615" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpense"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_84530b1f-b287-454e-b210-5f1aa2ddfc96" xlink:to="loc_us-gaap_InterestExpense_2026e557-7879-4230-9498-a52d0c5c9615" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_b915d58f-54d9-47f6-b774-84645407397b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_84530b1f-b287-454e-b210-5f1aa2ddfc96" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_b915d58f-54d9-47f6-b774-84645407397b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfInvestments_d1f7d78a-6ad5-41cb-8630-9638f5296b04" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnSaleOfInvestments"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_84530b1f-b287-454e-b210-5f1aa2ddfc96" xlink:to="loc_us-gaap_GainLossOnSaleOfInvestments_d1f7d78a-6ad5-41cb-8630-9638f5296b04" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/ConsolidatedStatementsofComprehensiveIncome" xlink:type="simple" xlink:href="cah-20210630.xsd#ConsolidatedStatementsofComprehensiveIncome"/>
  <link:calculationLink xlink:role="http://www.cardinal.com/role/ConsolidatedStatementsofComprehensiveIncome" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_7252392c-3c6a-4d28-ade2-5f3954f1e5d4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_092e2b22-d57d-44f8-b037-f585ef2b2ecd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_7252392c-3c6a-4d28-ade2-5f3954f1e5d4" xlink:to="loc_us-gaap_ProfitLoss_092e2b22-d57d-44f8-b037-f585ef2b2ecd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_21e66092-32cd-4402-8eaa-72d999fd9e2f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_7252392c-3c6a-4d28-ade2-5f3954f1e5d4" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_21e66092-32cd-4402-8eaa-72d999fd9e2f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_f80ca489-ede1-4e97-8e04-5acbb182959c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_39d9f12e-96b8-4083-a3cc-fd3162ba54c7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_f80ca489-ede1-4e97-8e04-5acbb182959c" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_39d9f12e-96b8-4083-a3cc-fd3162ba54c7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax_8bbd5e91-04be-4ed2-a77a-37694d2d29f5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_f80ca489-ede1-4e97-8e04-5acbb182959c" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax_8bbd5e91-04be-4ed2-a77a-37694d2d29f5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_87d34887-16fe-4f98-9e5a-88e9d22ec074" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_f80ca489-ede1-4e97-8e04-5acbb182959c" xlink:to="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_87d34887-16fe-4f98-9e5a-88e9d22ec074" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_fe074b9b-4d3f-4591-bdec-d5b66629827d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_500e4c33-d1eb-4a9b-870e-0c10d3f14851" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_fe074b9b-4d3f-4591-bdec-d5b66629827d" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_500e4c33-d1eb-4a9b-870e-0c10d3f14851" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_c4ccafb4-de0d-4d84-8570-3a6d0d6cfe40" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_fe074b9b-4d3f-4591-bdec-d5b66629827d" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_c4ccafb4-de0d-4d84-8570-3a6d0d6cfe40" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/ConsolidatedBalanceSheets" xlink:type="simple" xlink:href="cah-20210630.xsd#ConsolidatedBalanceSheets"/>
  <link:calculationLink xlink:role="http://www.cardinal.com/role/ConsolidatedBalanceSheets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_17ee73ab-a9cf-4ee5-b323-02365a70f9cc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_ae532420-10f3-4f88-8ccb-3f8ff55dee11" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_17ee73ab-a9cf-4ee5-b323-02365a70f9cc" xlink:to="loc_us-gaap_StockholdersEquity_ae532420-10f3-4f88-8ccb-3f8ff55dee11" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest_f9d54e83-0a27-4054-bfa3-1c73b15ff10f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterest"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_17ee73ab-a9cf-4ee5-b323-02365a70f9cc" xlink:to="loc_us-gaap_MinorityInterest_f9d54e83-0a27-4054-bfa3-1c73b15ff10f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_79b33bee-73f3-401c-a5da-36bdab71d981" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_b23abf17-e6c2-4361-8a64-8f888ef05698" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_79b33bee-73f3-401c-a5da-36bdab71d981" xlink:to="loc_us-gaap_PreferredStockValue_b23abf17-e6c2-4361-8a64-8f888ef05698" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_38be2491-a14b-4be5-836a-ed2baa731c35" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_79b33bee-73f3-401c-a5da-36bdab71d981" xlink:to="loc_us-gaap_CommonStockValue_38be2491-a14b-4be5-836a-ed2baa731c35" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_6dbd37f2-3f2d-4563-9f1d-9ae88bf08c10" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_79b33bee-73f3-401c-a5da-36bdab71d981" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_6dbd37f2-3f2d-4563-9f1d-9ae88bf08c10" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValue_962926c2-754f-4eb9-aefa-e0400a42e29c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockValue"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_79b33bee-73f3-401c-a5da-36bdab71d981" xlink:to="loc_us-gaap_TreasuryStockValue_962926c2-754f-4eb9-aefa-e0400a42e29c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_80be603d-4c87-46fb-a4dd-3859c63fc8d5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_79b33bee-73f3-401c-a5da-36bdab71d981" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_80be603d-4c87-46fb-a4dd-3859c63fc8d5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_b98e78d0-d1db-4b11-bceb-a830066a0ba6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_99c5d86d-661d-45f8-805f-0c3982682c2f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_b98e78d0-d1db-4b11-bceb-a830066a0ba6" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_99c5d86d-661d-45f8-805f-0c3982682c2f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_1b9e3b20-1e56-4396-96f3-f80b20359fb0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_b98e78d0-d1db-4b11-bceb-a830066a0ba6" xlink:to="loc_us-gaap_AssetsCurrent_1b9e3b20-1e56-4396-96f3-f80b20359fb0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_fd1b21ef-c089-4856-aab1-966e5eebda8a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_b98e78d0-d1db-4b11-bceb-a830066a0ba6" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_fd1b21ef-c089-4856-aab1-966e5eebda8a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetIncludingGoodwill_eaa2beb5-6a4b-4bae-a94c-e278bfcb40a2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsNetIncludingGoodwill"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_b98e78d0-d1db-4b11-bceb-a830066a0ba6" xlink:to="loc_us-gaap_IntangibleAssetsNetIncludingGoodwill_eaa2beb5-6a4b-4bae-a94c-e278bfcb40a2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_a39f3c8a-91bb-471d-a5c5-3f9f35dc6b87" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_e2c8378c-6aad-48ed-bf92-ec3026f0215f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_a39f3c8a-91bb-471d-a5c5-3f9f35dc6b87" xlink:to="loc_us-gaap_LiabilitiesCurrent_e2c8378c-6aad-48ed-bf92-ec3026f0215f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_a9b28ef9-726d-4f3a-8be3-ac7eebd493e0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_a39f3c8a-91bb-471d-a5c5-3f9f35dc6b87" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_a9b28ef9-726d-4f3a-8be3-ac7eebd493e0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAndOtherLiabilitiesNoncurrent_65d4a21b-5c71-4c09-a742-312d3f4ba529" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAndOtherLiabilitiesNoncurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_a39f3c8a-91bb-471d-a5c5-3f9f35dc6b87" xlink:to="loc_us-gaap_DeferredTaxAndOtherLiabilitiesNoncurrent_65d4a21b-5c71-4c09-a742-312d3f4ba529" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_a04f5e27-ad9a-4f17-a9db-2bdff3390c20" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_a39f3c8a-91bb-471d-a5c5-3f9f35dc6b87" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_a04f5e27-ad9a-4f17-a9db-2bdff3390c20" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_d4c061f2-62b8-4fe7-8028-9e2d4783b59e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_35355dd7-e62e-474c-8a5e-ac010e59c12e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_d4c061f2-62b8-4fe7-8028-9e2d4783b59e" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_35355dd7-e62e-474c-8a5e-ac010e59c12e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesNetCurrent_70a8aa7e-1e34-4344-ac16-b5d86aa10b37" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReceivablesNetCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_d4c061f2-62b8-4fe7-8028-9e2d4783b59e" xlink:to="loc_us-gaap_ReceivablesNetCurrent_70a8aa7e-1e34-4344-ac16-b5d86aa10b37" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_d2de8762-b9ef-41d9-a565-43171496e154" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNet"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_d4c061f2-62b8-4fe7-8028-9e2d4783b59e" xlink:to="loc_us-gaap_InventoryNet_d2de8762-b9ef-41d9-a565-43171496e154" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent_abbe482b-eb9c-4ff8-869f-910aec065d9c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_d4c061f2-62b8-4fe7-8028-9e2d4783b59e" xlink:to="loc_us-gaap_OtherAssetsCurrent_abbe482b-eb9c-4ff8-869f-910aec065d9c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_b0ee799e-d6ef-4a75-adad-a203d7e9fd2b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_d4c061f2-62b8-4fe7-8028-9e2d4783b59e" xlink:to="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_b0ee799e-d6ef-4a75-adad-a203d7e9fd2b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_b22886c3-5384-45d6-9186-464e597caa40" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_d0a65e46-b2e3-4599-b85f-528047005611" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_b22886c3-5384-45d6-9186-464e597caa40" xlink:to="loc_us-gaap_AccountsPayableCurrent_d0a65e46-b2e3-4599-b85f-528047005611" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_5c14ba0e-89c6-4414-bafa-69e7e47131d4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_b22886c3-5384-45d6-9186-464e597caa40" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_5c14ba0e-89c6-4414-bafa-69e7e47131d4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent_2f03302d-6142-4368-b617-2d594a8202ce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_b22886c3-5384-45d6-9186-464e597caa40" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesCurrent_2f03302d-6142-4368-b617-2d594a8202ce" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_64214d21-c74f-41fb-8f13-aa5c33e9689f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_b22886c3-5384-45d6-9186-464e597caa40" xlink:to="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_64214d21-c74f-41fb-8f13-aa5c33e9689f" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/ConsolidatedStatementsofCashFlows" xlink:type="simple" xlink:href="cah-20210630.xsd#ConsolidatedStatementsofCashFlows"/>
  <link:calculationLink xlink:role="http://www.cardinal.com/role/ConsolidatedStatementsofCashFlows" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_712e9e08-88a9-406f-955c-88dd6464e93a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_10949390-f069-481d-af3b-e8bd4cba2ce3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_712e9e08-88a9-406f-955c-88dd6464e93a" xlink:to="loc_us-gaap_ProfitLoss_10949390-f069-481d-af3b-e8bd4cba2ce3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_d9335d17-f20c-48fd-a187-51e3f88f2a6b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_712e9e08-88a9-406f-955c-88dd6464e93a" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_d9335d17-f20c-48fd-a187-51e3f88f2a6b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfOtherInvestments_544efad2-61db-4ccb-9a08-1e03c47b3f14" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnSaleOfOtherInvestments"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_712e9e08-88a9-406f-955c-88dd6464e93a" xlink:to="loc_us-gaap_GainLossOnSaleOfOtherInvestments_544efad2-61db-4ccb-9a08-1e03c47b3f14" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfInvestments_1b9c3022-4967-459b-9f11-fa46b409d7c9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnSaleOfInvestments"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_712e9e08-88a9-406f-955c-88dd6464e93a" xlink:to="loc_us-gaap_GainLossOnSaleOfInvestments_1b9c3022-4967-459b-9f11-fa46b409d7c9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges_5a18089e-af55-45bf-b2d8-cd312fed2bc5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_712e9e08-88a9-406f-955c-88dd6464e93a" xlink:to="loc_us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges_5a18089e-af55-45bf-b2d8-cd312fed2bc5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_8a67f4da-6c1a-44a1-bb7d-840438f5d75c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_712e9e08-88a9-406f-955c-88dd6464e93a" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_8a67f4da-6c1a-44a1-bb7d-840438f5d75c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_275b631b-19e4-4f59-8994-b9df0df67039" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_712e9e08-88a9-406f-955c-88dd6464e93a" xlink:to="loc_us-gaap_ShareBasedCompensation_275b631b-19e4-4f59-8994-b9df0df67039" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_fc7c3a47-641a-4e64-93f7-fcd1f155f61a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_712e9e08-88a9-406f-955c-88dd6464e93a" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_fc7c3a47-641a-4e64-93f7-fcd1f155f61a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProvisionForDoubtfulAccounts_372d90d2-3b1a-434c-bf34-31856f7daa04" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProvisionForDoubtfulAccounts"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_712e9e08-88a9-406f-955c-88dd6464e93a" xlink:to="loc_us-gaap_ProvisionForDoubtfulAccounts_372d90d2-3b1a-434c-bf34-31856f7daa04" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInReceivables_22ece333-5f1d-4aff-85ef-e2f015f84297" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInReceivables"/>
    <link:calculationArc order="10" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_712e9e08-88a9-406f-955c-88dd6464e93a" xlink:to="loc_us-gaap_IncreaseDecreaseInReceivables_22ece333-5f1d-4aff-85ef-e2f015f84297" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_6911b023-a858-4e08-9ee3-ddd133be2007" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:calculationArc order="11" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_712e9e08-88a9-406f-955c-88dd6464e93a" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_6911b023-a858-4e08-9ee3-ddd133be2007" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_3887c17c-9804-4e61-b1f1-3685c4cd9499" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:calculationArc order="12" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_712e9e08-88a9-406f-955c-88dd6464e93a" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_3887c17c-9804-4e61-b1f1-3685c4cd9499" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_aa91250c-6608-4e83-b944-d599a2dcc7ca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet"/>
    <link:calculationArc order="13" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_712e9e08-88a9-406f-955c-88dd6464e93a" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_aa91250c-6608-4e83-b944-d599a2dcc7ca" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_cb43489e-aa49-4cee-b3f9-d99e5c686c9c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_f4fef6a8-463b-4b27-96d4-12e41aa1147d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_cb43489e-aa49-4cee-b3f9-d99e5c686c9c" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_f4fef6a8-463b-4b27-96d4-12e41aa1147d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_ae1d59be-9e12-40fa-b34f-fc49860c8f97" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_cb43489e-aa49-4cee-b3f9-d99e5c686c9c" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_ae1d59be-9e12-40fa-b34f-fc49860c8f97" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_f8abbd6d-b48a-4208-bf92-f23fec56a30a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_cb43489e-aa49-4cee-b3f9-d99e5c686c9c" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_f8abbd6d-b48a-4208-bf92-f23fec56a30a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents_569a991e-f0c1-47d3-9ea4-354eef91b3d3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_cb43489e-aa49-4cee-b3f9-d99e5c686c9c" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents_569a991e-f0c1-47d3-9ea4-354eef91b3d3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_CashReclassifiedtoAssetsHeldforSale_2be9b98e-6178-456e-900d-b86e82441018" xlink:href="cah-20210630.xsd#cah_CashReclassifiedtoAssetsHeldforSale"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_cb43489e-aa49-4cee-b3f9-d99e5c686c9c" xlink:to="loc_cah_CashReclassifiedtoAssetsHeldforSale_2be9b98e-6178-456e-900d-b86e82441018" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_e5704d0e-4679-430f-a93e-dba2929edb65" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromRepaymentsOfShortTermDebt_abc4e2fb-9489-4efa-9b01-436bbc6624fc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromRepaymentsOfShortTermDebt"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_e5704d0e-4679-430f-a93e-dba2929edb65" xlink:to="loc_us-gaap_ProceedsFromRepaymentsOfShortTermDebt_abc4e2fb-9489-4efa-9b01-436bbc6624fc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromHedgeFinancingActivities_da3581ef-6c46-4625-b931-7c5cce3e23bf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForProceedsFromHedgeFinancingActivities"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_e5704d0e-4679-430f-a93e-dba2929edb65" xlink:to="loc_us-gaap_PaymentsForProceedsFromHedgeFinancingActivities_da3581ef-6c46-4625-b931-7c5cce3e23bf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt_4d84fbc1-d86e-4a79-a13d-9eee12e1b226" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_e5704d0e-4679-430f-a93e-dba2929edb65" xlink:to="loc_us-gaap_RepaymentsOfLongTermDebt_4d84fbc1-d86e-4a79-a13d-9eee12e1b226" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_Netproceedstaxwithholdingsfromsharebasedcompensation_de3e611a-8cbc-4873-8306-b54e6f87e90d" xlink:href="cah-20210630.xsd#cah_Netproceedstaxwithholdingsfromsharebasedcompensation"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_e5704d0e-4679-430f-a93e-dba2929edb65" xlink:to="loc_cah_Netproceedstaxwithholdingsfromsharebasedcompensation_de3e611a-8cbc-4873-8306-b54e6f87e90d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividendsCommonStock_c7f3543f-a3e0-4708-94d5-b1317997cc7a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfDividendsCommonStock"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_e5704d0e-4679-430f-a93e-dba2929edb65" xlink:to="loc_us-gaap_PaymentsOfDividendsCommonStock_c7f3543f-a3e0-4708-94d5-b1317997cc7a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_8d4834aa-832a-4df4-854a-65f70ba71b5b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_e5704d0e-4679-430f-a93e-dba2929edb65" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_8d4834aa-832a-4df4-854a-65f70ba71b5b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_e5b31753-0890-46f2-93e4-49564a2546ca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_43ab7f92-b306-4f10-9920-60c9c6d7b1cc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_e5b31753-0890-46f2-93e4-49564a2546ca" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_43ab7f92-b306-4f10-9920-60c9c6d7b1cc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_cdaef3e7-fc08-483a-8e12-f0b0ec08efab" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_e5b31753-0890-46f2-93e4-49564a2546ca" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_cdaef3e7-fc08-483a-8e12-f0b0ec08efab" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_Purchaseofavailableforsalesecuritiesandotherinvestments_df9a0f5c-c6e5-40a6-8902-6c7f779e6bad" xlink:href="cah-20210630.xsd#cah_Purchaseofavailableforsalesecuritiesandotherinvestments"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_e5b31753-0890-46f2-93e4-49564a2546ca" xlink:to="loc_cah_Purchaseofavailableforsalesecuritiesandotherinvestments_df9a0f5c-c6e5-40a6-8902-6c7f779e6bad" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_Proceedsfromsaleofavailableforsalesecuritiesandotherinvestments_b5902947-e890-44e7-a659-311e8343ab36" xlink:href="cah-20210630.xsd#cah_Proceedsfromsaleofavailableforsalesecuritiesandotherinvestments"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_e5b31753-0890-46f2-93e4-49564a2546ca" xlink:to="loc_cah_Proceedsfromsaleofavailableforsalesecuritiesandotherinvestments_b5902947-e890-44e7-a659-311e8343ab36" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_Proceedsfromdivestituresanddisposalofpropertyandequipmentandheldforsaleassets_5f904a65-c419-4944-9d44-230553a4d2e0" xlink:href="cah-20210630.xsd#cah_Proceedsfromdivestituresanddisposalofpropertyandequipmentandheldforsaleassets"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_e5b31753-0890-46f2-93e4-49564a2546ca" xlink:to="loc_cah_Proceedsfromdivestituresanddisposalofpropertyandequipmentandheldforsaleassets_5f904a65-c419-4944-9d44-230553a4d2e0" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/RestructuringandEmployeeSeveranceActivityRelatedtoRestructuringandEmployeeSeveranceCostsDetails" xlink:type="simple" xlink:href="cah-20210630.xsd#RestructuringandEmployeeSeveranceActivityRelatedtoRestructuringandEmployeeSeveranceCostsDetails"/>
  <link:calculationLink xlink:role="http://www.cardinal.com/role/RestructuringandEmployeeSeveranceActivityRelatedtoRestructuringandEmployeeSeveranceCostsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_3d7c2440-272a-47f6-b352-7615c63f1f52" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCharges"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeveranceCosts1_66902ad7-494e-499d-b8a7-b70ef5f86906" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeveranceCosts1"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_RestructuringCharges_3d7c2440-272a-47f6-b352-7615c63f1f52" xlink:to="loc_us-gaap_SeveranceCosts1_66902ad7-494e-499d-b8a7-b70ef5f86906" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_FacilityExitAndOtherCosts_8274bc72-d5d5-42ca-8085-69d24df9276a" xlink:href="cah-20210630.xsd#cah_FacilityExitAndOtherCosts"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_RestructuringCharges_3d7c2440-272a-47f6-b352-7615c63f1f52" xlink:to="loc_cah_FacilityExitAndOtherCosts_8274bc72-d5d5-42ca-8085-69d24df9276a" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/LeasesScheduleofLeaseCostsDetails" xlink:type="simple" xlink:href="cah-20210630.xsd#LeasesScheduleofLeaseCostsDetails"/>
  <link:calculationLink xlink:role="http://www.cardinal.com/role/LeasesScheduleofLeaseCostsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCost_3d474b7c-fbc2-4167-80f1-b99cb26352d4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseCost"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseCost_6d7ddb1e-595b-44b5-8483-7852ca50f7da" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseCost"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LeaseCost_3d474b7c-fbc2-4167-80f1-b99cb26352d4" xlink:to="loc_us-gaap_OperatingLeaseCost_6d7ddb1e-595b-44b5-8483-7852ca50f7da" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization_dfa3380c-801b-4671-b23f-51a83ddca29f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseRightOfUseAssetAmortization"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LeaseCost_3d474b7c-fbc2-4167-80f1-b99cb26352d4" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization_dfa3380c-801b-4671-b23f-51a83ddca29f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableLeaseCost_875891b7-bfde-426f-94cb-0eafa82de790" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableLeaseCost"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LeaseCost_3d474b7c-fbc2-4167-80f1-b99cb26352d4" xlink:to="loc_us-gaap_VariableLeaseCost_875891b7-bfde-426f-94cb-0eafa82de790" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/LeasesSupplementalBalanceSheetInformationDetails" xlink:type="simple" xlink:href="cah-20210630.xsd#LeasesSupplementalBalanceSheetInformationDetails"/>
  <link:calculationLink xlink:role="http://www.cardinal.com/role/LeasesSupplementalBalanceSheetInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_7e3afa1f-7f8d-4c2a-8d9e-be94e6dd682b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_5e6be1e5-bc1d-4ee3-b29c-51c32899fd23" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingLeaseLiability_7e3afa1f-7f8d-4c2a-8d9e-be94e6dd682b" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_5e6be1e5-bc1d-4ee3-b29c-51c32899fd23" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_3eb1d181-4f81-4dff-9412-be243c106d5d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingLeaseLiability_7e3afa1f-7f8d-4c2a-8d9e-be94e6dd682b" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_3eb1d181-4f81-4dff-9412-be243c106d5d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability_07342cfc-d82e-499d-aa8d-0b45ce867268" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_c2b6c829-80f9-4620-9eb7-9db94107bd4b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiability_07342cfc-d82e-499d-aa8d-0b45ce867268" xlink:to="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_c2b6c829-80f9-4620-9eb7-9db94107bd4b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrent_e870e18d-9945-4f51-be49-2bbce9fe6df9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiability_07342cfc-d82e-499d-aa8d-0b45ce867268" xlink:to="loc_us-gaap_FinanceLeaseLiabilityCurrent_e870e18d-9945-4f51-be49-2bbce9fe6df9" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/LongTermObligationsandOtherShortTermBorrowingsSummaryofDebtDetails" xlink:type="simple" xlink:href="cah-20210630.xsd#LongTermObligationsandOtherShortTermBorrowingsSummaryofDebtDetails"/>
  <link:calculationLink xlink:role="http://www.cardinal.com/role/LongTermObligationsandOtherShortTermBorrowingsSummaryofDebtDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtAndCapitalLeaseObligations_e43e05ca-29b9-4145-9401-b4ea6816352e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtAndCapitalLeaseObligations"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_4de6167a-1699-44ad-b4ff-81fbfe5481b9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtAndCapitalLeaseObligations_e43e05ca-29b9-4145-9401-b4ea6816352e" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_4de6167a-1699-44ad-b4ff-81fbfe5481b9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_c3b16cac-1362-4276-bfc5-41550ad708b2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtAndCapitalLeaseObligations_e43e05ca-29b9-4145-9401-b4ea6816352e" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_c3b16cac-1362-4276-bfc5-41550ad708b2" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/IncomeTaxesScheduleofIncomebeforeIncomeTaxDomesticandForeignDetails" xlink:type="simple" xlink:href="cah-20210630.xsd#IncomeTaxesScheduleofIncomebeforeIncomeTaxDomesticandForeignDetails"/>
  <link:calculationLink xlink:role="http://www.cardinal.com/role/IncomeTaxesScheduleofIncomebeforeIncomeTaxDomesticandForeignDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_5674b26c-fced-4014-84b7-1fbb59b9e33f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_12289a4b-904f-45ae-805f-927fa366b447" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_5674b26c-fced-4014-84b7-1fbb59b9e33f" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_12289a4b-904f-45ae-805f-927fa366b447" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_8bff042b-1372-4bec-90fb-3056349a5400" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_5674b26c-fced-4014-84b7-1fbb59b9e33f" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_8bff042b-1372-4bec-90fb-3056349a5400" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/IncomeTaxesScheduleofComponentsofIncomeTaxExpenseBenefitCurrentandDeferredDetails" xlink:type="simple" xlink:href="cah-20210630.xsd#IncomeTaxesScheduleofComponentsofIncomeTaxExpenseBenefitCurrentandDeferredDetails"/>
  <link:calculationLink xlink:role="http://www.cardinal.com/role/IncomeTaxesScheduleofComponentsofIncomeTaxExpenseBenefitCurrentandDeferredDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_627723ab-75c8-4e83-85f3-a7ce7ce55104" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_d19edf80-c447-4b90-bdfa-9a0ed49f9a3d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_627723ab-75c8-4e83-85f3-a7ce7ce55104" xlink:to="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_d19edf80-c447-4b90-bdfa-9a0ed49f9a3d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_dbbe25b5-9d72-4150-a9bd-16813e261f86" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_627723ab-75c8-4e83-85f3-a7ce7ce55104" xlink:to="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_dbbe25b5-9d72-4150-a9bd-16813e261f86" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_436440d5-9587-4589-a75d-7a36430a02d9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredForeignIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_627723ab-75c8-4e83-85f3-a7ce7ce55104" xlink:to="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_436440d5-9587-4589-a75d-7a36430a02d9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_5ddff5b2-c9e5-4726-b1be-c62a1b297df3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_1bebf84d-2e90-48ce-8317-d885a2b6bb44" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_5ddff5b2-c9e5-4726-b1be-c62a1b297df3" xlink:to="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_1bebf84d-2e90-48ce-8317-d885a2b6bb44" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_ff549e70-117d-4bb7-8811-8d94e8f2a15e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_5ddff5b2-c9e5-4726-b1be-c62a1b297df3" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_ff549e70-117d-4bb7-8811-8d94e8f2a15e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_3b3c852d-028b-4a88-bd36-98739b576e9e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentFederalTaxExpenseBenefit_544cc387-ecb6-4c69-ad7b-65bef850985a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentFederalTaxExpenseBenefit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_3b3c852d-028b-4a88-bd36-98739b576e9e" xlink:to="loc_us-gaap_CurrentFederalTaxExpenseBenefit_544cc387-ecb6-4c69-ad7b-65bef850985a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_3b61c542-34ab-473f-86ba-44413c07db7d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_3b3c852d-028b-4a88-bd36-98739b576e9e" xlink:to="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_3b61c542-34ab-473f-86ba-44413c07db7d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentForeignTaxExpenseBenefit_b1d1ba11-4231-4e47-a4ab-64c31173819b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentForeignTaxExpenseBenefit"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_3b3c852d-028b-4a88-bd36-98739b576e9e" xlink:to="loc_us-gaap_CurrentForeignTaxExpenseBenefit_b1d1ba11-4231-4e47-a4ab-64c31173819b" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/IncomeTaxesScheduleofEffectiveIncomeTaxRateReconciliationDetails" xlink:type="simple" xlink:href="cah-20210630.xsd#IncomeTaxesScheduleofEffectiveIncomeTaxRateReconciliationDetails"/>
  <link:calculationLink xlink:role="http://www.cardinal.com/role/IncomeTaxesScheduleofEffectiveIncomeTaxRateReconciliationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_2dd729ca-8e5d-4961-9114-0de8815c3e3c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense_644323f1-6390-46af-b7d2-384e7f34519a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_2dd729ca-8e5d-4961-9114-0de8815c3e3c" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense_644323f1-6390-46af-b7d2-384e7f34519a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_5a69f150-5285-4cdc-918a-65e495df35c9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_2dd729ca-8e5d-4961-9114-0de8815c3e3c" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_5a69f150-5285-4cdc-918a-65e495df35c9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_EffectiveIncomeTaxRateReconciliationTaxEffectOfForeignOperations_99222498-1402-4b98-bb30-ef1083c0b0e4" xlink:href="cah-20210630.xsd#cah_EffectiveIncomeTaxRateReconciliationTaxEffectOfForeignOperations"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_2dd729ca-8e5d-4961-9114-0de8815c3e3c" xlink:to="loc_cah_EffectiveIncomeTaxRateReconciliationTaxEffectOfForeignOperations_99222498-1402-4b98-bb30-ef1083c0b0e4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_EffectiveTaxRateReconciliationUSTaxesOnInternationalIncome_69dd4715-42f7-4b4f-b1af-433ac4bc8a52" xlink:href="cah-20210630.xsd#cah_EffectiveTaxRateReconciliationUSTaxesOnInternationalIncome"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_2dd729ca-8e5d-4961-9114-0de8815c3e3c" xlink:to="loc_cah_EffectiveTaxRateReconciliationUSTaxesOnInternationalIncome_69dd4715-42f7-4b4f-b1af-433ac4bc8a52" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_EffectiveIncomeTaxRateReconciliationLossCarrybackClaims_285fe62a-8131-4f7e-9d29-7ec858dcd358" xlink:href="cah-20210630.xsd#cah_EffectiveIncomeTaxRateReconciliationLossCarrybackClaims"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_2dd729ca-8e5d-4961-9114-0de8815c3e3c" xlink:to="loc_cah_EffectiveIncomeTaxRateReconciliationLossCarrybackClaims_285fe62a-8131-4f7e-9d29-7ec858dcd358" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_EffectiveIncomeTaxRateReconciliationWithholdingTaxes_a7933165-dd2f-4040-a13c-380b372b47f7" xlink:href="cah-20210630.xsd#cah_EffectiveIncomeTaxRateReconciliationWithholdingTaxes"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_2dd729ca-8e5d-4961-9114-0de8815c3e3c" xlink:to="loc_cah_EffectiveIncomeTaxRateReconciliationWithholdingTaxes_a7933165-dd2f-4040-a13c-380b372b47f7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_EffectiveIncomeTaxRateReconciliationLegalEntityReorganizationReconcilingItemsPercent_d43e820b-7573-46ab-8234-7474565cd5da" xlink:href="cah-20210630.xsd#cah_EffectiveIncomeTaxRateReconciliationLegalEntityReorganizationReconcilingItemsPercent"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_2dd729ca-8e5d-4961-9114-0de8815c3e3c" xlink:to="loc_cah_EffectiveIncomeTaxRateReconciliationLegalEntityReorganizationReconcilingItemsPercent_d43e820b-7573-46ab-8234-7474565cd5da" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_7e231ebf-5919-479d-ad9a-3e3a9ad56877" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_2dd729ca-8e5d-4961-9114-0de8815c3e3c" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_7e231ebf-5919-479d-ad9a-3e3a9ad56877" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent_ae9aeba2-61a4-43e1-8377-90c589ecc8f9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_2dd729ca-8e5d-4961-9114-0de8815c3e3c" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent_ae9aeba2-61a4-43e1-8377-90c589ecc8f9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_EffectiveTaxRateReconciliationImpactOfResolutionsWithIRSAndOtherRelatedMatters_8cdb7029-2972-4e59-bb52-5dabeb52bfa5" xlink:href="cah-20210630.xsd#cah_EffectiveTaxRateReconciliationImpactOfResolutionsWithIRSAndOtherRelatedMatters"/>
    <link:calculationArc order="10" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_2dd729ca-8e5d-4961-9114-0de8815c3e3c" xlink:to="loc_cah_EffectiveTaxRateReconciliationImpactOfResolutionsWithIRSAndOtherRelatedMatters_8cdb7029-2972-4e59-bb52-5dabeb52bfa5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_b327b44d-2583-411c-a269-14930466fe2e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <link:calculationArc order="11" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_2dd729ca-8e5d-4961-9114-0de8815c3e3c" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_b327b44d-2583-411c-a269-14930466fe2e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses_823b4598-96b1-40cb-8294-d1e4c8ab1fe9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses"/>
    <link:calculationArc order="12" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_2dd729ca-8e5d-4961-9114-0de8815c3e3c" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses_823b4598-96b1-40cb-8294-d1e4c8ab1fe9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_EffectiveIncomeTaxReconciliationOpioidLitigation_9b8aca8d-d90e-4570-83e0-edc0064765c6" xlink:href="cah-20210630.xsd#cah_EffectiveIncomeTaxReconciliationOpioidLitigation"/>
    <link:calculationArc order="13" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_2dd729ca-8e5d-4961-9114-0de8815c3e3c" xlink:to="loc_cah_EffectiveIncomeTaxReconciliationOpioidLitigation_9b8aca8d-d90e-4570-83e0-edc0064765c6" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails" xlink:type="simple" xlink:href="cah-20210630.xsd#IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails"/>
  <link:calculationLink xlink:role="http://www.cardinal.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities_25947fb2-1666-406d-a1d5-5529bd79487e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_eee733db-d5db-4ab5-82f0-c0a1b6b1e11c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities_25947fb2-1666-406d-a1d5-5529bd79487e" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_eee733db-d5db-4ab5-82f0-c0a1b6b1e11c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesDeferredExpenseCapitalizedInventoryCosts_ca745a51-ba9d-42e7-8229-6ce672519e91" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilitiesDeferredExpenseCapitalizedInventoryCosts"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities_25947fb2-1666-406d-a1d5-5529bd79487e" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesDeferredExpenseCapitalizedInventoryCosts_ca745a51-ba9d-42e7-8229-6ce672519e91" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesOther_6d67c593-2d9c-4955-a652-dc8065ad87b9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilitiesOther"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities_25947fb2-1666-406d-a1d5-5529bd79487e" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesOther_6d67c593-2d9c-4955-a652-dc8065ad87b9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets_f4584336-cc31-47fc-a4b3-4ef4be66aaa4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities_25947fb2-1666-406d-a1d5-5529bd79487e" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets_f4584336-cc31-47fc-a4b3-4ef4be66aaa4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesDeferredExpenseReservesAndAccruals_cee1575a-afe9-4712-93ba-b00f21956a2c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilitiesDeferredExpenseReservesAndAccruals"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities_25947fb2-1666-406d-a1d5-5529bd79487e" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesDeferredExpenseReservesAndAccruals_cee1575a-afe9-4712-93ba-b00f21956a2c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilities_62755f45-6520-48f5-b5df-07df9e30790b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities_00f77fb9-a17e-466d-857b-6768f8304d24" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxLiabilities_62755f45-6520-48f5-b5df-07df9e30790b" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilities_00f77fb9-a17e-466d-857b-6768f8304d24" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_2aa35c8c-1b5b-4f39-bb1f-28dc8da64118" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxLiabilities_62755f45-6520-48f5-b5df-07df9e30790b" xlink:to="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_2aa35c8c-1b5b-4f39-bb1f-28dc8da64118" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_01f7ba29-9791-4a34-ae55-e0f93738e3cb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross_a4d4ccff-a108-46b4-87f7-9ba32b50f2cb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_01f7ba29-9791-4a34-ae55-e0f93738e3cb" xlink:to="loc_us-gaap_DeferredTaxAssetsGross_a4d4ccff-a108-46b4-87f7-9ba32b50f2cb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_633f158e-c1ba-4dc3-86f0-e84660d0476e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_01f7ba29-9791-4a34-ae55-e0f93738e3cb" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_633f158e-c1ba-4dc3-86f0-e84660d0476e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross_1e1031b4-38c9-492b-a610-23ab15ad0c64" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts_20841d4e-3b29-447f-ac19-b4a29c08589a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_1e1031b4-38c9-492b-a610-23ab15ad0c64" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts_20841d4e-3b29-447f-ac19-b4a29c08589a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities_35ceceb2-7059-4e60-9de1-e0d4ec4a97f8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_1e1031b4-38c9-492b-a610-23ab15ad0c64" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities_35ceceb2-7059-4e60-9de1-e0d4ec4a97f8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_ab09478d-d202-4488-925a-7f7e46bcba0d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_1e1031b4-38c9-492b-a610-23ab15ad0c64" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_ab09478d-d202-4488-925a-7f7e46bcba0d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_a2909269-0e44-4f4d-b813-30c4e68b4837" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwards"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_1e1031b4-38c9-492b-a610-23ab15ad0c64" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_a2909269-0e44-4f4d-b813-30c4e68b4837" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_DeferredTaxAssetsRelatedtouncertaintaxpositions_9689004b-8c17-4abc-930d-faf8711eabe5" xlink:href="cah-20210630.xsd#cah_DeferredTaxAssetsRelatedtouncertaintaxpositions"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_1e1031b4-38c9-492b-a610-23ab15ad0c64" xlink:to="loc_cah_DeferredTaxAssetsRelatedtouncertaintaxpositions_9689004b-8c17-4abc-930d-faf8711eabe5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOther_32a413cb-b80f-4019-bca9-6ca2b5a02f8c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsOther"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_1e1031b4-38c9-492b-a610-23ab15ad0c64" xlink:to="loc_us-gaap_DeferredTaxAssetsOther_32a413cb-b80f-4019-bca9-6ca2b5a02f8c" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesAfterNettingbyTaxJurisdictionDetails" xlink:type="simple" xlink:href="cah-20210630.xsd#IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesAfterNettingbyTaxJurisdictionDetails"/>
  <link:calculationLink xlink:role="http://www.cardinal.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesAfterNettingbyTaxJurisdictionDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilities_bd5943bd-3912-4bd6-8483-edf6c61c9ed5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_DeferredIncomeTaxesAndOtherTaxLiabilitiesTransferredToHeldForSaleNoncurrent_ae66aa7f-2541-4cf4-a8de-5afff129f2a9" xlink:href="cah-20210630.xsd#cah_DeferredIncomeTaxesAndOtherTaxLiabilitiesTransferredToHeldForSaleNoncurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxLiabilities_bd5943bd-3912-4bd6-8483-edf6c61c9ed5" xlink:to="loc_cah_DeferredIncomeTaxesAndOtherTaxLiabilitiesTransferredToHeldForSaleNoncurrent_ae66aa7f-2541-4cf4-a8de-5afff129f2a9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxesAndOtherAssetsNoncurrent_a807598a-8c1e-43ea-a6b6-b72890746050" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxesAndOtherAssetsNoncurrent"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxLiabilities_bd5943bd-3912-4bd6-8483-edf6c61c9ed5" xlink:to="loc_us-gaap_DeferredIncomeTaxesAndOtherAssetsNoncurrent_a807598a-8c1e-43ea-a6b6-b72890746050" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxesAndOtherTaxLiabilitiesNoncurrent_74113495-f6aa-441e-b34f-4b3efd7d6210" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxesAndOtherTaxLiabilitiesNoncurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxLiabilities_bd5943bd-3912-4bd6-8483-edf6c61c9ed5" xlink:to="loc_us-gaap_DeferredIncomeTaxesAndOtherTaxLiabilitiesNoncurrent_74113495-f6aa-441e-b34f-4b3efd7d6210" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/EarningsPerShareAttributabletoCardinalHealthIncReconciliationofCommonSharesUsedtoComputeBasicandDilutedEPSDetails" xlink:type="simple" xlink:href="cah-20210630.xsd#EarningsPerShareAttributabletoCardinalHealthIncReconciliationofCommonSharesUsedtoComputeBasicandDilutedEPSDetails"/>
  <link:calculationLink xlink:role="http://www.cardinal.com/role/EarningsPerShareAttributabletoCardinalHealthIncReconciliationofCommonSharesUsedtoComputeBasicandDilutedEPSDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_54130d32-629a-445f-9900-f4256a2c8aea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_2bb24996-371f-48cd-9c2c-930d3c3000c5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_54130d32-629a-445f-9900-f4256a2c8aea" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_2bb24996-371f-48cd-9c2c-930d3c3000c5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_edaebcda-1388-4424-9110-36030bfb364b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_54130d32-629a-445f-9900-f4256a2c8aea" xlink:to="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_edaebcda-1388-4424-9110-36030bfb364b" xlink:type="arc"/>
  </link:calculationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>10
<FILENAME>cah-20210630_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:b63e0697-7630-4efc-9622-5764c41287f3,g:18dc0520-9457-4463-b618-29c4ac061652-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://www.cardinal.com/role/ConsolidatedStatementsofShareholdersEquity" xlink:type="simple" xlink:href="cah-20210630.xsd#ConsolidatedStatementsofShareholdersEquity"/>
  <link:definitionLink xlink:role="http://www.cardinal.com/role/ConsolidatedStatementsofShareholdersEquity" xlink:type="extended" id="ie7d8534556ce4e62982e774f4c0b8ede_ConsolidatedStatementsofShareholdersEquity">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_ba665c51-df36-4a29-81a3-eb755cb03b50" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_2c26fabf-6f66-49ad-93d5-9723eeef86ba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_ba665c51-df36-4a29-81a3-eb755cb03b50" xlink:to="loc_us-gaap_NetIncomeLoss_2c26fabf-6f66-49ad-93d5-9723eeef86ba" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_36196214-2bf3-44a8-9248-b8e1d2403c9f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_ba665c51-df36-4a29-81a3-eb755cb03b50" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_36196214-2bf3-44a8-9248-b8e1d2403c9f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_eaf51552-1565-4136-83fa-d5b3a881284c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_36196214-2bf3-44a8-9248-b8e1d2403c9f" xlink:to="loc_us-gaap_CommonStockSharesIssued_eaf51552-1565-4136-83fa-d5b3a881284c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_21db4a68-d694-4884-8b7b-9c24ca9c117a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_36196214-2bf3-44a8-9248-b8e1d2403c9f" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_21db4a68-d694-4884-8b7b-9c24ca9c117a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockShares_5008db7b-534f-4758-be49-049754ffc598" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_36196214-2bf3-44a8-9248-b8e1d2403c9f" xlink:to="loc_us-gaap_TreasuryStockShares_5008db7b-534f-4758-be49-049754ffc598" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValue_8a00d917-09bc-4ab8-a61f-87de005a4823" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_36196214-2bf3-44a8-9248-b8e1d2403c9f" xlink:to="loc_us-gaap_TreasuryStockValue_8a00d917-09bc-4ab8-a61f-87de005a4823" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_c9f4e61b-25c1-49b5-95ec-42ffcd94b1e2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_36196214-2bf3-44a8-9248-b8e1d2403c9f" xlink:to="loc_us-gaap_ProfitLoss_c9f4e61b-25c1-49b5-95ec-42ffcd94b1e2" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_NetEarningsIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest_0c031154-ff56-407b-ab21-afc3fc3ad4b8" xlink:href="cah-20210630.xsd#cah_NetEarningsIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_36196214-2bf3-44a8-9248-b8e1d2403c9f" xlink:to="loc_cah_NetEarningsIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest_0c031154-ff56-407b-ab21-afc3fc3ad4b8" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_da875d9f-cb7a-40d6-968d-52ce09d8d6e6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_36196214-2bf3-44a8-9248-b8e1d2403c9f" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_da875d9f-cb7a-40d6-968d-52ce09d8d6e6" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_5411f639-ea0a-4695-a5b1-0001883cf08a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_36196214-2bf3-44a8-9248-b8e1d2403c9f" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_5411f639-ea0a-4695-a5b1-0001883cf08a" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_5b1a79be-6d75-44c7-9b7a-ca2bf3af4846" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_36196214-2bf3-44a8-9248-b8e1d2403c9f" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_5b1a79be-6d75-44c7-9b7a-ca2bf3af4846" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired_92a62721-8d4b-471b-8a6e-44a6d620d7c6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_36196214-2bf3-44a8-9248-b8e1d2403c9f" xlink:to="loc_us-gaap_TreasuryStockSharesAcquired_92a62721-8d4b-471b-8a6e-44a6d620d7c6" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_b13d2615-6f56-4cbb-bec6-b9079acb7db3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_36196214-2bf3-44a8-9248-b8e1d2403c9f" xlink:to="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_b13d2615-6f56-4cbb-bec6-b9079acb7db3" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Dividends_4702a521-9ce0-4388-99af-3b86063ef715" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Dividends"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_36196214-2bf3-44a8-9248-b8e1d2403c9f" xlink:to="loc_us-gaap_Dividends_4702a521-9ce0-4388-99af-3b86063ef715" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityOtherShares_ad7a0ba2-4657-4574-a80f-99783fb90b73" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityOtherShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_36196214-2bf3-44a8-9248-b8e1d2403c9f" xlink:to="loc_us-gaap_StockholdersEquityOtherShares_ad7a0ba2-4657-4574-a80f-99783fb90b73" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityOther_504a4161-d106-4326-a43b-6ca039ed5bd9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityOther"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_36196214-2bf3-44a8-9248-b8e1d2403c9f" xlink:to="loc_us-gaap_StockholdersEquityOther_504a4161-d106-4326-a43b-6ca039ed5bd9" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_04ae8f93-15ff-41ff-9399-9017b38cb952" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_1085146b-36d9-4317-8122-db68cee643eb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockShares_69b17122-74e7-4f08-a20c-ce296ccb28c2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockShares"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValue_e38901b0-f04a-4ed0-8ece-a79e34605a4c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockValue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_d31d740e-966a-4f7a-b8f9-2c5e2d0c9580" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_ba665c51-df36-4a29-81a3-eb755cb03b50" xlink:to="loc_us-gaap_StatementTable_d31d740e-966a-4f7a-b8f9-2c5e2d0c9580" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_0c890837-221e-4fc3-8ec7-90c34dacc92a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_d31d740e-966a-4f7a-b8f9-2c5e2d0c9580" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_0c890837-221e-4fc3-8ec7-90c34dacc92a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_0c890837-221e-4fc3-8ec7-90c34dacc92a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_0c890837-221e-4fc3-8ec7-90c34dacc92a" xlink:to="loc_us-gaap_EquityComponentDomain_0c890837-221e-4fc3-8ec7-90c34dacc92a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_58fd05bc-a89c-47de-a077-4b29f0b6ae9f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_0c890837-221e-4fc3-8ec7-90c34dacc92a" xlink:to="loc_us-gaap_EquityComponentDomain_58fd05bc-a89c-47de-a077-4b29f0b6ae9f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_a535d906-e7ad-4f82-9c36-d90b78c4dcb7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_58fd05bc-a89c-47de-a077-4b29f0b6ae9f" xlink:to="loc_us-gaap_CommonStockMember_a535d906-e7ad-4f82-9c36-d90b78c4dcb7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_29ccc6b5-8f6d-4ec9-84b1-40775b540bc6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_58fd05bc-a89c-47de-a077-4b29f0b6ae9f" xlink:to="loc_us-gaap_RetainedEarningsMember_29ccc6b5-8f6d-4ec9-84b1-40775b540bc6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockMember_6ba87895-4e1a-4265-ac3d-10aad5221fe3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_58fd05bc-a89c-47de-a077-4b29f0b6ae9f" xlink:to="loc_us-gaap_TreasuryStockMember_6ba87895-4e1a-4265-ac3d-10aad5221fe3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_b8a986c7-294c-476b-9e2e-f31dbafbc985" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_58fd05bc-a89c-47de-a077-4b29f0b6ae9f" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_b8a986c7-294c-476b-9e2e-f31dbafbc985" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember_06035d44-14ff-4fe2-842a-531295466110" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_58fd05bc-a89c-47de-a077-4b29f0b6ae9f" xlink:to="loc_us-gaap_NoncontrollingInterestMember_06035d44-14ff-4fe2-842a-531295466110" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeReceivablesDetails" xlink:type="simple" xlink:href="cah-20210630.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeReceivablesDetails"/>
  <link:definitionLink xlink:role="http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeReceivablesDetails" xlink:type="extended" id="ie04a77a9f82c4c948219f3b7501fbaa8_BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeReceivablesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_caabced3-1993-42c6-8901-a551ae91e4fa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsNotesAndLoansReceivableLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesBalance_c931df37-2b89-47f4-97de-5dfdb5b16b6e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationAllowancesAndReservesBalance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_caabced3-1993-42c6-8901-a551ae91e4fa" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesBalance_c931df37-2b89-47f4-97de-5dfdb5b16b6e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_ReceivableFinancingAgreementTerm_3883a30b-75b6-4d77-bd89-2801c462a283" xlink:href="cah-20210630.xsd#cah_ReceivableFinancingAgreementTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_caabced3-1993-42c6-8901-a551ae91e4fa" xlink:to="loc_cah_ReceivableFinancingAgreementTerm_3883a30b-75b6-4d77-bd89-2801c462a283" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesReceivableNet_06db3e33-7df9-497e-9c8e-e225b504a184" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NotesReceivableNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_caabced3-1993-42c6-8901-a551ae91e4fa" xlink:to="loc_us-gaap_NotesReceivableNet_06db3e33-7df9-497e-9c8e-e225b504a184" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesAndLoansReceivableNetCurrent_b77267bb-b838-4da3-9db4-9e591528d279" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NotesAndLoansReceivableNetCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_caabced3-1993-42c6-8901-a551ae91e4fa" xlink:to="loc_us-gaap_NotesAndLoansReceivableNetCurrent_b77267bb-b838-4da3-9db4-9e591528d279" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_a45f9035-7aed-454b-8910-098183ff38df" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_caabced3-1993-42c6-8901-a551ae91e4fa" xlink:to="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_a45f9035-7aed-454b-8910-098183ff38df" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_80a01ab1-0a3f-42b7-a098-6800c49cc2ca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationAllowancesAndReservesTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_a45f9035-7aed-454b-8910-098183ff38df" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_80a01ab1-0a3f-42b7-a098-6800c49cc2ca" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesDomain_80a01ab1-0a3f-42b7-a098-6800c49cc2ca_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationAllowancesAndReservesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_80a01ab1-0a3f-42b7-a098-6800c49cc2ca" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesDomain_80a01ab1-0a3f-42b7-a098-6800c49cc2ca_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesDomain_251dc626-fdbe-4fc8-962c-4bdbb1a43b2a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationAllowancesAndReservesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_80a01ab1-0a3f-42b7-a098-6800c49cc2ca" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesDomain_251dc626-fdbe-4fc8-962c-4bdbb1a43b2a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForCreditLossMember_6003c759-c558-4e35-bb7f-e24b0ebcc2a3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllowanceForCreditLossMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesDomain_251dc626-fdbe-4fc8-962c-4bdbb1a43b2a" xlink:to="loc_us-gaap_AllowanceForCreditLossMember_6003c759-c558-4e35-bb7f-e24b0ebcc2a3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForLossesOnFinanceReceivablesMember_b1199dc7-17fe-4f8f-9f3e-211ee92f2d9f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllowanceForLossesOnFinanceReceivablesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesDomain_251dc626-fdbe-4fc8-962c-4bdbb1a43b2a" xlink:to="loc_us-gaap_AllowanceForLossesOnFinanceReceivablesMember_b1199dc7-17fe-4f8f-9f3e-211ee92f2d9f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_89b28642-9e13-4458-8679-120bffc782e8" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_a45f9035-7aed-454b-8910-098183ff38df" xlink:to="loc_srt_RangeAxis_89b28642-9e13-4458-8679-120bffc782e8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_89b28642-9e13-4458-8679-120bffc782e8_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_89b28642-9e13-4458-8679-120bffc782e8" xlink:to="loc_srt_RangeMember_89b28642-9e13-4458-8679-120bffc782e8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_8f3282fd-0999-4d9e-9ef8-398fcb7effcb" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_89b28642-9e13-4458-8679-120bffc782e8" xlink:to="loc_srt_RangeMember_8f3282fd-0999-4d9e-9ef8-398fcb7effcb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_7d0a3bfd-69b3-4901-8935-2eda2cc1057f" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_8f3282fd-0999-4d9e-9ef8-398fcb7effcb" xlink:to="loc_srt_MinimumMember_7d0a3bfd-69b3-4901-8935-2eda2cc1057f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_8ab70286-417d-46dc-b302-64c7a128f3ae" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_8f3282fd-0999-4d9e-9ef8-398fcb7effcb" xlink:to="loc_srt_MaximumMember_8ab70286-417d-46dc-b302-64c7a128f3ae" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_3cb98235-af38-439a-8496-458db8e0006a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_a45f9035-7aed-454b-8910-098183ff38df" xlink:to="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_3cb98235-af38-439a-8496-458db8e0006a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivableTypeDomain_3cb98235-af38-439a-8496-458db8e0006a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReceivableTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_3cb98235-af38-439a-8496-458db8e0006a" xlink:to="loc_us-gaap_ReceivableTypeDomain_3cb98235-af38-439a-8496-458db8e0006a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivableTypeDomain_4ed43ff7-39b0-4c92-80b5-694caefe3c9e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReceivableTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_3cb98235-af38-439a-8496-458db8e0006a" xlink:to="loc_us-gaap_ReceivableTypeDomain_4ed43ff7-39b0-4c92-80b5-694caefe3c9e" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesRevenueandGrossTradeReceivablesPercentagebyMajorCustomersDetails" xlink:type="simple" xlink:href="cah-20210630.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesRevenueandGrossTradeReceivablesPercentagebyMajorCustomersDetails"/>
  <link:definitionLink xlink:role="http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesRevenueandGrossTradeReceivablesPercentagebyMajorCustomersDetails" xlink:type="extended" id="i19c445237b8c4327823f61879f661c42_BasisofPresentationandSummaryofSignificantAccountingPoliciesRevenueandGrossTradeReceivablesPercentagebyMajorCustomersDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EntityWideRevenueMajorCustomerLineItems_271168ac-56e1-4ee3-bb4b-57ed3278dcdd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EntityWideRevenueMajorCustomerLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_a430189d-f7c1-4dbe-898d-128bcd83718b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EntityWideRevenueMajorCustomerLineItems_271168ac-56e1-4ee3-bb4b-57ed3278dcdd" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_a430189d-f7c1-4dbe-898d-128bcd83718b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_GrossTradeReceivablesMajorCustomerPercentage_e4d0bc61-725e-4fd6-8447-271730f1021e" xlink:href="cah-20210630.xsd#cah_GrossTradeReceivablesMajorCustomerPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EntityWideRevenueMajorCustomerLineItems_271168ac-56e1-4ee3-bb4b-57ed3278dcdd" xlink:to="loc_cah_GrossTradeReceivablesMajorCustomerPercentage_e4d0bc61-725e-4fd6-8447-271730f1021e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable_a1969dd3-d977-4d95-84a0-5bb31875f798" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_EntityWideRevenueMajorCustomerLineItems_271168ac-56e1-4ee3-bb4b-57ed3278dcdd" xlink:to="loc_us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable_a1969dd3-d977-4d95-84a0-5bb31875f798" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_d768025b-a6b2-432d-85fb-b52dde7dc0f7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable_a1969dd3-d977-4d95-84a0-5bb31875f798" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_d768025b-a6b2-432d-85fb-b52dde7dc0f7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_d768025b-a6b2-432d-85fb-b52dde7dc0f7_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_d768025b-a6b2-432d-85fb-b52dde7dc0f7" xlink:to="loc_us-gaap_SegmentDomain_d768025b-a6b2-432d-85fb-b52dde7dc0f7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_b3fa2556-7e10-4b3e-a42d-02d9acdd1404" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_d768025b-a6b2-432d-85fb-b52dde7dc0f7" xlink:to="loc_us-gaap_SegmentDomain_b3fa2556-7e10-4b3e-a42d-02d9acdd1404" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_PharmaceuticalMember_f43d1d0a-98f0-45dc-bff7-7e95bf670785" xlink:href="cah-20210630.xsd#cah_PharmaceuticalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_b3fa2556-7e10-4b3e-a42d-02d9acdd1404" xlink:to="loc_cah_PharmaceuticalMember_f43d1d0a-98f0-45dc-bff7-7e95bf670785" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MajorCustomersAxis_c9d3c208-c0b6-4293-9eb4-8d4be40512bd" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MajorCustomersAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable_a1969dd3-d977-4d95-84a0-5bb31875f798" xlink:to="loc_srt_MajorCustomersAxis_c9d3c208-c0b6-4293-9eb4-8d4be40512bd" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_c9d3c208-c0b6-4293-9eb4-8d4be40512bd_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_MajorCustomersAxis_c9d3c208-c0b6-4293-9eb4-8d4be40512bd" xlink:to="loc_srt_NameOfMajorCustomerDomain_c9d3c208-c0b6-4293-9eb4-8d4be40512bd_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_7276ecce-b754-44ef-bb63-3ab0c9e49a75" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_MajorCustomersAxis_c9d3c208-c0b6-4293-9eb4-8d4be40512bd" xlink:to="loc_srt_NameOfMajorCustomerDomain_7276ecce-b754-44ef-bb63-3ab0c9e49a75" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_CVSCaremarkCorporationMember_588fab9a-d347-4b48-b908-bfe511b3a62b" xlink:href="cah-20210630.xsd#cah_CVSCaremarkCorporationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_7276ecce-b754-44ef-bb63-3ab0c9e49a75" xlink:to="loc_cah_CVSCaremarkCorporationMember_588fab9a-d347-4b48-b908-bfe511b3a62b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_OptumRxMember_b445a353-989e-4b6d-a7f9-df4e0bfa7015" xlink:href="cah-20210630.xsd#cah_OptumRxMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_7276ecce-b754-44ef-bb63-3ab0c9e49a75" xlink:to="loc_cah_OptumRxMember_b445a353-989e-4b6d-a7f9-df4e0bfa7015" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_16e68e53-906e-41f1-b3a2-92f9595da1e6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable_a1969dd3-d977-4d95-84a0-5bb31875f798" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_16e68e53-906e-41f1-b3a2-92f9595da1e6" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_16e68e53-906e-41f1-b3a2-92f9595da1e6_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_16e68e53-906e-41f1-b3a2-92f9595da1e6" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_16e68e53-906e-41f1-b3a2-92f9595da1e6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_748148de-4d5c-4325-93dd-684fae776c45" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_16e68e53-906e-41f1-b3a2-92f9595da1e6" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_748148de-4d5c-4325-93dd-684fae776c45" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesRevenueNetMember_96db67c7-14dc-420c-9713-9cc30eeda0e5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SalesRevenueNetMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_748148de-4d5c-4325-93dd-684fae776c45" xlink:to="loc_us-gaap_SalesRevenueNetMember_96db67c7-14dc-420c-9713-9cc30eeda0e5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_c14e6f88-5796-44cc-b1bb-bfe76942fa19" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable_a1969dd3-d977-4d95-84a0-5bb31875f798" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_c14e6f88-5796-44cc-b1bb-bfe76942fa19" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_c14e6f88-5796-44cc-b1bb-bfe76942fa19_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_c14e6f88-5796-44cc-b1bb-bfe76942fa19" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_c14e6f88-5796-44cc-b1bb-bfe76942fa19_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_6d6962b1-f552-40bb-a5ea-512a9bc4c5c3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_c14e6f88-5796-44cc-b1bb-bfe76942fa19" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_6d6962b1-f552-40bb-a5ea-512a9bc4c5c3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerConcentrationRiskMember_d14bc52e-5888-40fd-9b67-93790706df84" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerConcentrationRiskMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_6d6962b1-f552-40bb-a5ea-512a9bc4c5c3" xlink:to="loc_us-gaap_CustomerConcentrationRiskMember_d14bc52e-5888-40fd-9b67-93790706df84" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeMajorCustomersDetails" xlink:type="simple" xlink:href="cah-20210630.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeMajorCustomersDetails"/>
  <link:definitionLink xlink:role="http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeMajorCustomersDetails" xlink:type="extended" id="i07f4af05b5d34b2ea974a51fbaae78f0_BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeMajorCustomersDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskLineItems_eb251b9d-7026-4a1a-9d0e-6486e19359e7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_ConcentrationRiskLargestGroupPurchasingOrganizations_f9a52157-3c1e-464c-8491-59115041f561" xlink:href="cah-20210630.xsd#cah_ConcentrationRiskLargestGroupPurchasingOrganizations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_eb251b9d-7026-4a1a-9d0e-6486e19359e7" xlink:to="loc_cah_ConcentrationRiskLargestGroupPurchasingOrganizations_f9a52157-3c1e-464c-8491-59115041f561" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_447bcc63-9f14-4b4d-bf09-a16d14197371" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_eb251b9d-7026-4a1a-9d0e-6486e19359e7" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_447bcc63-9f14-4b4d-bf09-a16d14197371" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTable_481ac5a4-fea9-40f0-8b96-d2d5b6e4d789" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_eb251b9d-7026-4a1a-9d0e-6486e19359e7" xlink:to="loc_us-gaap_ConcentrationRiskTable_481ac5a4-fea9-40f0-8b96-d2d5b6e4d789" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MajorCustomersAxis_c3c35dc5-d1e1-4f4a-a87c-6982a6f81b56" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MajorCustomersAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ConcentrationRiskTable_481ac5a4-fea9-40f0-8b96-d2d5b6e4d789" xlink:to="loc_srt_MajorCustomersAxis_c3c35dc5-d1e1-4f4a-a87c-6982a6f81b56" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_c3c35dc5-d1e1-4f4a-a87c-6982a6f81b56_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_MajorCustomersAxis_c3c35dc5-d1e1-4f4a-a87c-6982a6f81b56" xlink:to="loc_srt_NameOfMajorCustomerDomain_c3c35dc5-d1e1-4f4a-a87c-6982a6f81b56_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_de894dc5-98b2-4a6c-9a11-083a367d07e2" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_MajorCustomersAxis_c3c35dc5-d1e1-4f4a-a87c-6982a6f81b56" xlink:to="loc_srt_NameOfMajorCustomerDomain_de894dc5-98b2-4a6c-9a11-083a367d07e2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_GroupPurchasingOrganizationsMember_5363c3b6-f9ec-4be4-a97e-02fa062b81c1" xlink:href="cah-20210630.xsd#cah_GroupPurchasingOrganizationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_de894dc5-98b2-4a6c-9a11-083a367d07e2" xlink:to="loc_cah_GroupPurchasingOrganizationsMember_5363c3b6-f9ec-4be4-a97e-02fa062b81c1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_eaa6a604-aaac-4aee-a4ad-ee26880bf062" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ConcentrationRiskTable_481ac5a4-fea9-40f0-8b96-d2d5b6e4d789" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_eaa6a604-aaac-4aee-a4ad-ee26880bf062" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_eaa6a604-aaac-4aee-a4ad-ee26880bf062_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_eaa6a604-aaac-4aee-a4ad-ee26880bf062" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_eaa6a604-aaac-4aee-a4ad-ee26880bf062_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_0c180662-da39-4d93-95ee-cd138a0c9b74" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_eaa6a604-aaac-4aee-a4ad-ee26880bf062" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_0c180662-da39-4d93-95ee-cd138a0c9b74" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesRevenueNetMember_b1ff3a70-3c66-4237-abd7-351d2d4c6298" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SalesRevenueNetMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_0c180662-da39-4d93-95ee-cd138a0c9b74" xlink:to="loc_us-gaap_SalesRevenueNetMember_b1ff3a70-3c66-4237-abd7-351d2d4c6298" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_c58e7af2-1a29-4945-9026-94994da00816" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ConcentrationRiskTable_481ac5a4-fea9-40f0-8b96-d2d5b6e4d789" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_c58e7af2-1a29-4945-9026-94994da00816" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_c58e7af2-1a29-4945-9026-94994da00816_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_c58e7af2-1a29-4945-9026-94994da00816" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_c58e7af2-1a29-4945-9026-94994da00816_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_f4c3c055-55b9-46dc-b9c5-f4633e13f29e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_c58e7af2-1a29-4945-9026-94994da00816" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_f4c3c055-55b9-46dc-b9c5-f4633e13f29e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerConcentrationRiskMember_d8df9b2e-4350-4c08-8e0f-7dcc710017e9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerConcentrationRiskMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_f4c3c055-55b9-46dc-b9c5-f4633e13f29e" xlink:to="loc_us-gaap_CustomerConcentrationRiskMember_d8df9b2e-4350-4c08-8e0f-7dcc710017e9" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativePropertyandEquipmentDetails" xlink:type="simple" xlink:href="cah-20210630.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativePropertyandEquipmentDetails"/>
  <link:definitionLink xlink:role="http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativePropertyandEquipmentDetails" xlink:type="extended" id="i7010adf9aa474cedb8b78fd94a78ebb8_BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativePropertyandEquipmentDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_c120f956-b2d0-457e-9215-019ba398520e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_b0a9a900-9ab1-43ce-bcde-2f30fcd179a3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_c120f956-b2d0-457e-9215-019ba398520e" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_b0a9a900-9ab1-43ce-bcde-2f30fcd179a3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_b8cb53e4-0de6-4690-af8a-7f6063f15981" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Depreciation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_c120f956-b2d0-457e-9215-019ba398520e" xlink:to="loc_us-gaap_Depreciation_b8cb53e4-0de6-4690-af8a-7f6063f15981" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_f97e6961-3726-40a5-92fa-420f77a0de1e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_c120f956-b2d0-457e-9215-019ba398520e" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_f97e6961-3726-40a5-92fa-420f77a0de1e" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_32360898-fd79-4ec9-aee9-777469f3d886" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_f97e6961-3726-40a5-92fa-420f77a0de1e" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_32360898-fd79-4ec9-aee9-777469f3d886" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_32360898-fd79-4ec9-aee9-777469f3d886_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_32360898-fd79-4ec9-aee9-777469f3d886" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_32360898-fd79-4ec9-aee9-777469f3d886_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_b63afad6-4b22-4a3c-9e4f-5dff548193ea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_32360898-fd79-4ec9-aee9-777469f3d886" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_b63afad6-4b22-4a3c-9e4f-5dff548193ea" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingAndBuildingImprovementsMember_1ae6695e-3224-47ba-9728-d70edb9aea57" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BuildingAndBuildingImprovementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_b63afad6-4b22-4a3c-9e4f-5dff548193ea" xlink:to="loc_us-gaap_BuildingAndBuildingImprovementsMember_1ae6695e-3224-47ba-9728-d70edb9aea57" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MachineryAndEquipmentMember_d6163515-8fd5-47c6-84f4-ae828a6841e1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MachineryAndEquipmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_b63afad6-4b22-4a3c-9e4f-5dff548193ea" xlink:to="loc_us-gaap_MachineryAndEquipmentMember_d6163515-8fd5-47c6-84f4-ae828a6841e1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesMember_e74cf4e2-75ce-4de7-b5d1-6117d312eb6f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FurnitureAndFixturesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_b63afad6-4b22-4a3c-9e4f-5dff548193ea" xlink:to="loc_us-gaap_FurnitureAndFixturesMember_e74cf4e2-75ce-4de7-b5d1-6117d312eb6f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_9f8e463a-6c7f-4c13-819a-ac38bb6e35e0" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_f97e6961-3726-40a5-92fa-420f77a0de1e" xlink:to="loc_srt_RangeAxis_9f8e463a-6c7f-4c13-819a-ac38bb6e35e0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_9f8e463a-6c7f-4c13-819a-ac38bb6e35e0_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_9f8e463a-6c7f-4c13-819a-ac38bb6e35e0" xlink:to="loc_srt_RangeMember_9f8e463a-6c7f-4c13-819a-ac38bb6e35e0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_2bfbf3bb-78af-442b-ae67-e9a0dc785208" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_9f8e463a-6c7f-4c13-819a-ac38bb6e35e0" xlink:to="loc_srt_RangeMember_2bfbf3bb-78af-442b-ae67-e9a0dc785208" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_8ef733f7-ccdd-4191-9d57-e5a9bda641db" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_2bfbf3bb-78af-442b-ae67-e9a0dc785208" xlink:to="loc_srt_MinimumMember_8ef733f7-ccdd-4191-9d57-e5a9bda641db" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_5d834210-ccad-4588-bdbf-2b1cda5341bd" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_2bfbf3bb-78af-442b-ae67-e9a0dc785208" xlink:to="loc_srt_MaximumMember_5d834210-ccad-4588-bdbf-2b1cda5341bd" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesComponentsofPropertyandEquipmentDetails" xlink:type="simple" xlink:href="cah-20210630.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesComponentsofPropertyandEquipmentDetails"/>
  <link:definitionLink xlink:role="http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesComponentsofPropertyandEquipmentDetails" xlink:type="extended" id="ifb9a57a438b44d09a19a5417f91c6ba6_BasisofPresentationandSummaryofSignificantAccountingPoliciesComponentsofPropertyandEquipmentDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_6d0c16b0-74b4-4abe-b520-7ba3e2e7fa5e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_5610a1d5-6094-48d5-b1b6-80b29553626d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_6d0c16b0-74b4-4abe-b520-7ba3e2e7fa5e" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_5610a1d5-6094-48d5-b1b6-80b29553626d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_f2dee4ad-65b4-4ac5-adce-aabd12bd340b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_6d0c16b0-74b4-4abe-b520-7ba3e2e7fa5e" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_f2dee4ad-65b4-4ac5-adce-aabd12bd340b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_88962cbf-e660-4ba8-a3ac-2750793784ce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_6d0c16b0-74b4-4abe-b520-7ba3e2e7fa5e" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_88962cbf-e660-4ba8-a3ac-2750793784ce" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_e2d53e94-0e96-4bdf-8842-970ed0b3b3eb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_6d0c16b0-74b4-4abe-b520-7ba3e2e7fa5e" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_e2d53e94-0e96-4bdf-8842-970ed0b3b3eb" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_fe99661a-7a52-4161-bf25-a2a01696837d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_6d0c16b0-74b4-4abe-b520-7ba3e2e7fa5e" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_fe99661a-7a52-4161-bf25-a2a01696837d" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_21b83f73-fefc-4f62-b513-112671a687a1" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_fe99661a-7a52-4161-bf25-a2a01696837d" xlink:to="loc_srt_RangeAxis_21b83f73-fefc-4f62-b513-112671a687a1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_21b83f73-fefc-4f62-b513-112671a687a1_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_21b83f73-fefc-4f62-b513-112671a687a1" xlink:to="loc_srt_RangeMember_21b83f73-fefc-4f62-b513-112671a687a1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_3722ecc7-4cdd-412b-9c53-61af91fe60f7" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_21b83f73-fefc-4f62-b513-112671a687a1" xlink:to="loc_srt_RangeMember_3722ecc7-4cdd-412b-9c53-61af91fe60f7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_f17278d1-8f41-400c-9f0c-8658472d3689" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_3722ecc7-4cdd-412b-9c53-61af91fe60f7" xlink:to="loc_srt_MaximumMember_f17278d1-8f41-400c-9f0c-8658472d3689" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_55b75f5e-3f32-4ad3-ad16-84726b28ba78" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_3722ecc7-4cdd-412b-9c53-61af91fe60f7" xlink:to="loc_srt_MinimumMember_55b75f5e-3f32-4ad3-ad16-84726b28ba78" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_e3b617f2-d269-4fb5-ad5e-b1404c509cca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_fe99661a-7a52-4161-bf25-a2a01696837d" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_e3b617f2-d269-4fb5-ad5e-b1404c509cca" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_e3b617f2-d269-4fb5-ad5e-b1404c509cca_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_e3b617f2-d269-4fb5-ad5e-b1404c509cca" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_e3b617f2-d269-4fb5-ad5e-b1404c509cca_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_7d2d3cce-4c2f-433c-8f2e-685351366361" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_e3b617f2-d269-4fb5-ad5e-b1404c509cca" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_7d2d3cce-4c2f-433c-8f2e-685351366361" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingAndBuildingImprovementsMember_2edb3899-d5b9-4e0e-bffe-ff65313fd2db" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BuildingAndBuildingImprovementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_7d2d3cce-4c2f-433c-8f2e-685351366361" xlink:to="loc_us-gaap_BuildingAndBuildingImprovementsMember_2edb3899-d5b9-4e0e-bffe-ff65313fd2db" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LandBuildingsAndImprovementsMember_aa54f518-7372-4fb4-950f-9bc01e9f0035" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LandBuildingsAndImprovementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_7d2d3cce-4c2f-433c-8f2e-685351366361" xlink:to="loc_us-gaap_LandBuildingsAndImprovementsMember_aa54f518-7372-4fb4-950f-9bc01e9f0035" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MachineryAndEquipmentMember_7d240e97-d749-4ab7-999e-a4c6f9de69d1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MachineryAndEquipmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_7d2d3cce-4c2f-433c-8f2e-685351366361" xlink:to="loc_us-gaap_MachineryAndEquipmentMember_7d240e97-d749-4ab7-999e-a4c6f9de69d1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesMember_e94f559d-569e-42fb-92e6-5d852430e896" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FurnitureAndFixturesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_7d2d3cce-4c2f-433c-8f2e-685351366361" xlink:to="loc_us-gaap_FurnitureAndFixturesMember_e94f559d-569e-42fb-92e6-5d852430e896" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeGoodwillandOtherIntangibleAssetsDetails" xlink:type="simple" xlink:href="cah-20210630.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeGoodwillandOtherIntangibleAssetsDetails"/>
  <link:definitionLink xlink:role="http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeGoodwillandOtherIntangibleAssetsDetails" xlink:type="extended" id="i5eb63b744f6844b48b5d8dce7ce69903_BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeGoodwillandOtherIntangibleAssetsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_cah_GoodwillAndIntangibleAssetsLineItems_aaadc2b4-e7fc-4a0e-b6ac-efa6e17f1ce1" xlink:href="cah-20210630.xsd#cah_GoodwillAndIntangibleAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_DiscountRatefairvalueinputs_1416cbc6-245d-48d3-b9c2-6df2ad733ecf" xlink:href="cah-20210630.xsd#cah_DiscountRatefairvalueinputs"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cah_GoodwillAndIntangibleAssetsLineItems_aaadc2b4-e7fc-4a0e-b6ac-efa6e17f1ce1" xlink:to="loc_cah_DiscountRatefairvalueinputs_1416cbc6-245d-48d3-b9c2-6df2ad733ecf" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfOperatingSegments_2a8112eb-5fee-4233-8fad-da843a29cfce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfOperatingSegments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cah_GoodwillAndIntangibleAssetsLineItems_aaadc2b4-e7fc-4a0e-b6ac-efa6e17f1ce1" xlink:to="loc_us-gaap_NumberOfOperatingSegments_2a8112eb-5fee-4233-8fad-da843a29cfce" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_43a779c1-adb3-4c4d-a9da-0b480a961387" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cah_GoodwillAndIntangibleAssetsLineItems_aaadc2b4-e7fc-4a0e-b6ac-efa6e17f1ce1" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_43a779c1-adb3-4c4d-a9da-0b480a961387" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_GoodwillAndIntangibleAssetsTable_92d51f42-136a-4f72-b6e3-af641c5c067d" xlink:href="cah-20210630.xsd#cah_GoodwillAndIntangibleAssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_cah_GoodwillAndIntangibleAssetsLineItems_aaadc2b4-e7fc-4a0e-b6ac-efa6e17f1ce1" xlink:to="loc_cah_GoodwillAndIntangibleAssetsTable_92d51f42-136a-4f72-b6e3-af641c5c067d" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_527f7329-979b-477e-b6e1-de6a3b3ce80b" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_cah_GoodwillAndIntangibleAssetsTable_92d51f42-136a-4f72-b6e3-af641c5c067d" xlink:to="loc_srt_RangeAxis_527f7329-979b-477e-b6e1-de6a3b3ce80b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_527f7329-979b-477e-b6e1-de6a3b3ce80b_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_527f7329-979b-477e-b6e1-de6a3b3ce80b" xlink:to="loc_srt_RangeMember_527f7329-979b-477e-b6e1-de6a3b3ce80b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_168aa16c-791c-44bb-a696-80ae07df0790" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_527f7329-979b-477e-b6e1-de6a3b3ce80b" xlink:to="loc_srt_RangeMember_168aa16c-791c-44bb-a696-80ae07df0790" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_4ab65867-7c0d-45d6-af5c-0b8cc6f50091" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_168aa16c-791c-44bb-a696-80ae07df0790" xlink:to="loc_srt_MinimumMember_4ab65867-7c0d-45d6-af5c-0b8cc6f50091" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_69184d80-6c08-491e-99d4-9677339b7944" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_168aa16c-791c-44bb-a696-80ae07df0790" xlink:to="loc_srt_MaximumMember_69184d80-6c08-491e-99d4-9677339b7944" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeShippingandHandlingDetails" xlink:type="simple" xlink:href="cah-20210630.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeShippingandHandlingDetails"/>
  <link:definitionLink xlink:role="http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeShippingandHandlingDetails" xlink:type="extended" id="id85c8c20000546b1ac4ce6dfb5f41cf9_BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeShippingandHandlingDetails">
    <link:loc xlink:type="locator" xlink:label="loc_cah_GoodsandservicessoldLineItems_3984a288-70af-4b18-9bdc-c6d75fa8c180" xlink:href="cah-20210630.xsd#cah_GoodsandservicessoldLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_13e4bdb9-a6cb-4d19-9679-8d0883fbf8b7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cah_GoodsandservicessoldLineItems_3984a288-70af-4b18-9bdc-c6d75fa8c180" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_13e4bdb9-a6cb-4d19-9679-8d0883fbf8b7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_GoodsandservicessoldTable_88b81ed6-fa25-4327-9524-5e076dcc9381" xlink:href="cah-20210630.xsd#cah_GoodsandservicessoldTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_cah_GoodsandservicessoldLineItems_3984a288-70af-4b18-9bdc-c6d75fa8c180" xlink:to="loc_cah_GoodsandservicessoldTable_88b81ed6-fa25-4327-9524-5e076dcc9381" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_48dc3b52-25c6-47d1-93f2-ff93defd3f64" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_cah_GoodsandservicessoldTable_88b81ed6-fa25-4327-9524-5e076dcc9381" xlink:to="loc_srt_ProductOrServiceAxis_48dc3b52-25c6-47d1-93f2-ff93defd3f64" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_48dc3b52-25c6-47d1-93f2-ff93defd3f64_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_48dc3b52-25c6-47d1-93f2-ff93defd3f64" xlink:to="loc_srt_ProductsAndServicesDomain_48dc3b52-25c6-47d1-93f2-ff93defd3f64_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_259b6f61-7f6e-4699-a27c-8b57657e3e2b" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_48dc3b52-25c6-47d1-93f2-ff93defd3f64" xlink:to="loc_srt_ProductsAndServicesDomain_259b6f61-7f6e-4699-a27c-8b57657e3e2b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShippingAndHandlingMember_16452c3e-2a6b-4e8d-9827-c1784c7a0514" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShippingAndHandlingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_259b6f61-7f6e-4699-a27c-8b57657e3e2b" xlink:to="loc_us-gaap_ShippingAndHandlingMember_16452c3e-2a6b-4e8d-9827-c1784c7a0514" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesLossContingenciesDetails" xlink:type="simple" xlink:href="cah-20210630.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesLossContingenciesDetails"/>
  <link:definitionLink xlink:role="http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesLossContingenciesDetails" xlink:type="extended" id="i2783a6c36e934547b127d1f72fe5c3ee_BasisofPresentationandSummaryofSignificantAccountingPoliciesLossContingenciesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_bd4be2aa-1084-416c-9708-d45db97765e9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossRelatedToLitigationSettlement_cc2b99a5-679b-4b38-b190-d7c6e3189e1b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossRelatedToLitigationSettlement"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_bd4be2aa-1084-416c-9708-d45db97765e9" xlink:to="loc_us-gaap_GainLossRelatedToLitigationSettlement_cc2b99a5-679b-4b38-b190-d7c6e3189e1b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_64094af3-d2fa-4e9a-b94f-1c469afdd16b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LossContingenciesLineItems_bd4be2aa-1084-416c-9708-d45db97765e9" xlink:to="loc_us-gaap_LossContingenciesTable_64094af3-d2fa-4e9a-b94f-1c469afdd16b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_OpioidLitigationAxis_11cf0d5c-a977-4e1f-abc7-d84b4cede8fa" xlink:href="cah-20210630.xsd#cah_OpioidLitigationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_64094af3-d2fa-4e9a-b94f-1c469afdd16b" xlink:to="loc_cah_OpioidLitigationAxis_11cf0d5c-a977-4e1f-abc7-d84b4cede8fa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_OpioidLitigationDomain_11cf0d5c-a977-4e1f-abc7-d84b4cede8fa_default" xlink:href="cah-20210630.xsd#cah_OpioidLitigationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_cah_OpioidLitigationAxis_11cf0d5c-a977-4e1f-abc7-d84b4cede8fa" xlink:to="loc_cah_OpioidLitigationDomain_11cf0d5c-a977-4e1f-abc7-d84b4cede8fa_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_OpioidLitigationDomain_46959b3c-7e0e-4fe7-9694-dd4eb8095e24" xlink:href="cah-20210630.xsd#cah_OpioidLitigationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_cah_OpioidLitigationAxis_11cf0d5c-a977-4e1f-abc7-d84b4cede8fa" xlink:to="loc_cah_OpioidLitigationDomain_46959b3c-7e0e-4fe7-9694-dd4eb8095e24" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_TotalOpioidLitigationMember_b9f8b5a6-b82a-42bb-83ac-a4467ab7a164" xlink:href="cah-20210630.xsd#cah_TotalOpioidLitigationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cah_OpioidLitigationDomain_46959b3c-7e0e-4fe7-9694-dd4eb8095e24" xlink:to="loc_cah_TotalOpioidLitigationMember_b9f8b5a6-b82a-42bb-83ac-a4467ab7a164" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/DivestituresandAcquisitionsNarrativeDetails" xlink:type="simple" xlink:href="cah-20210630.xsd#DivestituresandAcquisitionsNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.cardinal.com/role/DivestituresandAcquisitionsNarrativeDetails" xlink:type="extended" id="icec4d869755e4cb6a83f5912d946ffcb_DivestituresandAcquisitionsNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_224386de-5798-4c7d-ba0c-bcb978fabb2f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_76806bab-80b8-4794-b538-097111891e04" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_224386de-5798-4c7d-ba0c-bcb978fabb2f" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_76806bab-80b8-4794-b538-097111891e04" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_a0d92269-45cf-4bc5-bf9a-4218eca3fb06" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromDivestitureOfBusinesses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_224386de-5798-4c7d-ba0c-bcb978fabb2f" xlink:to="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_a0d92269-45cf-4bc5-bf9a-4218eca3fb06" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_PreTaxGainonDivestiture_2b6a77c4-8c7d-49b9-87a6-4a7bcde26a98" xlink:href="cah-20210630.xsd#cah_PreTaxGainonDivestiture"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_224386de-5798-4c7d-ba0c-bcb978fabb2f" xlink:to="loc_cah_PreTaxGainonDivestiture_2b6a77c4-8c7d-49b9-87a6-4a7bcde26a98" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments_8c4dc2da-78ac-4518-aac4-144e6e18c83a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_224386de-5798-4c7d-ba0c-bcb978fabb2f" xlink:to="loc_us-gaap_EquityMethodInvestments_8c4dc2da-78ac-4518-aac4-144e6e18c83a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_a8d2551f-1112-4f98-8ccd-daf0dfd1400d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_224386de-5798-4c7d-ba0c-bcb978fabb2f" xlink:to="loc_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_a8d2551f-1112-4f98-8ccd-daf0dfd1400d" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_Provisionaltaxbenefitrelatedtotransaction_265e4c07-898b-4672-a7bb-bd913c03e71a" xlink:href="cah-20210630.xsd#cah_Provisionaltaxbenefitrelatedtotransaction"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_224386de-5798-4c7d-ba0c-bcb978fabb2f" xlink:to="loc_cah_Provisionaltaxbenefitrelatedtotransaction_265e4c07-898b-4672-a7bb-bd913c03e71a" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_0fa91f9d-d8bf-4bb7-b4d8-dcdfb3c816f9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_224386de-5798-4c7d-ba0c-bcb978fabb2f" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_0fa91f9d-d8bf-4bb7-b4d8-dcdfb3c816f9" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration_55f3264c-1366-47d5-a031-9eb3dcd37011" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_224386de-5798-4c7d-ba0c-bcb978fabb2f" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration_55f3264c-1366-47d5-a031-9eb3dcd37011" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1_1cd214f3-d4e8-4a7b-9d2d-1ebbdda78fd6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_224386de-5798-4c7d-ba0c-bcb978fabb2f" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1_1cd214f3-d4e8-4a7b-9d2d-1ebbdda78fd6" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_WriteDownOfAssetsHeldForSale_cb21bfc3-f2bf-482b-8f35-3883e1b859e8" xlink:href="cah-20210630.xsd#cah_WriteDownOfAssetsHeldForSale"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_224386de-5798-4c7d-ba0c-bcb978fabb2f" xlink:to="loc_cah_WriteDownOfAssetsHeldForSale_cb21bfc3-f2bf-482b-8f35-3883e1b859e8" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_c88bfd6a-e369-44af-8bb1-74404297bf35" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_224386de-5798-4c7d-ba0c-bcb978fabb2f" xlink:to="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_c88bfd6a-e369-44af-8bb1-74404297bf35" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccruedLiabilities_5d0be3c0-cd53-4042-b207-c9205ef3ff5a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationAccruedLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_224386de-5798-4c7d-ba0c-bcb978fabb2f" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccruedLiabilities_5d0be3c0-cd53-4042-b207-c9205ef3ff5a" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherLiabilities_3b3b8e70-df36-43ec-92f6-26736e358178" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_224386de-5798-4c7d-ba0c-bcb978fabb2f" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherLiabilities_3b3b8e70-df36-43ec-92f6-26736e358178" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_60be32fa-c8c5-4de1-b51b-2c81a880baec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_224386de-5798-4c7d-ba0c-bcb978fabb2f" xlink:to="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_60be32fa-c8c5-4de1-b51b-2c81a880baec" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationForeignCurrencyTranslationGainsLosses_c475cf98-cf11-4939-8c1f-56bab4d371a1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationForeignCurrencyTranslationGainsLosses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_224386de-5798-4c7d-ba0c-bcb978fabb2f" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationForeignCurrencyTranslationGainsLosses_c475cf98-cf11-4939-8c1f-56bab4d371a1" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationTaxEffectOfIncomeLossFromDisposalOfDiscontinuedOperation_6282540a-ef57-4be1-9506-6e3f7f3c13e0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DiscontinuedOperationTaxEffectOfIncomeLossFromDisposalOfDiscontinuedOperation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_224386de-5798-4c7d-ba0c-bcb978fabb2f" xlink:to="loc_us-gaap_DiscontinuedOperationTaxEffectOfIncomeLossFromDisposalOfDiscontinuedOperation_6282540a-ef57-4be1-9506-6e3f7f3c13e0" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents_6f73a4e4-385f-4b38-a4df-c2cc3a11d590" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_224386de-5798-4c7d-ba0c-bcb978fabb2f" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents_6f73a4e4-385f-4b38-a4df-c2cc3a11d590" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1_79fe0e1e-3d67-4e21-ba5c-12004f64eda1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_224386de-5798-4c7d-ba0c-bcb978fabb2f" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1_79fe0e1e-3d67-4e21-ba5c-12004f64eda1" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment_b4274337-d8be-4c67-a93b-f6b645dff271" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_224386de-5798-4c7d-ba0c-bcb978fabb2f" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment_b4274337-d8be-4c67-a93b-f6b645dff271" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_DisposalGroupIncludingDiscontinuedOperationsGoodwillAndOtherIntangiblesNet_6d3ac9c5-6e63-4080-9e80-6ce068729f2f" xlink:href="cah-20210630.xsd#cah_DisposalGroupIncludingDiscontinuedOperationsGoodwillAndOtherIntangiblesNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_224386de-5798-4c7d-ba0c-bcb978fabb2f" xlink:to="loc_cah_DisposalGroupIncludingDiscontinuedOperationsGoodwillAndOtherIntangiblesNet_6d3ac9c5-6e63-4080-9e80-6ce068729f2f" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets_cce7c90c-d47f-4f44-a878-9e43dbccd6fa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_224386de-5798-4c7d-ba0c-bcb978fabb2f" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets_cce7c90c-d47f-4f44-a878-9e43dbccd6fa" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainOnSaleOfInvestments_fa24d4bd-f0d9-4f76-86a0-f3af47608db7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainOnSaleOfInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_224386de-5798-4c7d-ba0c-bcb978fabb2f" xlink:to="loc_us-gaap_GainOnSaleOfInvestments_fa24d4bd-f0d9-4f76-86a0-f3af47608db7" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_3d42aec9-50bd-4b52-a25e-6a766f434b31" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_224386de-5798-4c7d-ba0c-bcb978fabb2f" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_3d42aec9-50bd-4b52-a25e-6a766f434b31" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_6855cb1b-36a1-4bd7-a9b4-75f60dec9169" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_3d42aec9-50bd-4b52-a25e-6a766f434b31" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_6855cb1b-36a1-4bd7-a9b4-75f60dec9169" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_6855cb1b-36a1-4bd7-a9b4-75f60dec9169_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_6855cb1b-36a1-4bd7-a9b4-75f60dec9169" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_6855cb1b-36a1-4bd7-a9b4-75f60dec9169_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_e9360c3c-03d2-419a-a31e-7eb9e65bad5a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_6855cb1b-36a1-4bd7-a9b4-75f60dec9169" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_e9360c3c-03d2-419a-a31e-7eb9e65bad5a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_NaviHealthMember_f9d85615-67c1-41d4-8a78-7ad871fadca0" xlink:href="cah-20210630.xsd#cah_NaviHealthMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_e9360c3c-03d2-419a-a31e-7eb9e65bad5a" xlink:to="loc_cah_NaviHealthMember_f9d85615-67c1-41d4-8a78-7ad871fadca0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_6c8539ff-7933-4af1-b5a7-a0cd852b143f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_3d42aec9-50bd-4b52-a25e-6a766f434b31" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_6c8539ff-7933-4af1-b5a7-a0cd852b143f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_6c8539ff-7933-4af1-b5a7-a0cd852b143f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_6c8539ff-7933-4af1-b5a7-a0cd852b143f" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_6c8539ff-7933-4af1-b5a7-a0cd852b143f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_61b9071c-0370-4578-a7b2-3fd59361de74" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_6c8539ff-7933-4af1-b5a7-a0cd852b143f" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_61b9071c-0370-4578-a7b2-3fd59361de74" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_PatientRecoveryBusinessMember_53f16cb7-4787-4c5c-b942-21892af35c42" xlink:href="cah-20210630.xsd#cah_PatientRecoveryBusinessMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_61b9071c-0370-4578-a7b2-3fd59361de74" xlink:to="loc_cah_PatientRecoveryBusinessMember_53f16cb7-4787-4c5c-b942-21892af35c42" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_932229e0-815e-4eb0-93d8-f95b5b512ca8" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_3d42aec9-50bd-4b52-a25e-6a766f434b31" xlink:to="loc_srt_RangeAxis_932229e0-815e-4eb0-93d8-f95b5b512ca8" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_932229e0-815e-4eb0-93d8-f95b5b512ca8_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_932229e0-815e-4eb0-93d8-f95b5b512ca8" xlink:to="loc_srt_RangeMember_932229e0-815e-4eb0-93d8-f95b5b512ca8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_0bb9477b-7ec3-471c-8ece-4fdabb678dfa" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_932229e0-815e-4eb0-93d8-f95b5b512ca8" xlink:to="loc_srt_RangeMember_0bb9477b-7ec3-471c-8ece-4fdabb678dfa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_7384d848-2cb0-453c-97f6-dc3e4566858a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_3d42aec9-50bd-4b52-a25e-6a766f434b31" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_7384d848-2cb0-453c-97f6-dc3e4566858a" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_7384d848-2cb0-453c-97f6-dc3e4566858a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_7384d848-2cb0-453c-97f6-dc3e4566858a" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_7384d848-2cb0-453c-97f6-dc3e4566858a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_33e870e8-906a-48de-a6c2-e6afceefd05d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_7384d848-2cb0-453c-97f6-dc3e4566858a" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_33e870e8-906a-48de-a6c2-e6afceefd05d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_PatientRecoveryBusinessMember_fb883830-b763-43ad-ba17-47852e3e63f9" xlink:href="cah-20210630.xsd#cah_PatientRecoveryBusinessMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_33e870e8-906a-48de-a6c2-e6afceefd05d" xlink:to="loc_cah_PatientRecoveryBusinessMember_fb883830-b763-43ad-ba17-47852e3e63f9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_CordisDivestitureAxis_f509a4a3-c055-4031-813e-47861b4b3ff8" xlink:href="cah-20210630.xsd#cah_CordisDivestitureAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_3d42aec9-50bd-4b52-a25e-6a766f434b31" xlink:to="loc_cah_CordisDivestitureAxis_f509a4a3-c055-4031-813e-47861b4b3ff8" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_CordisDivestitureDomain_f509a4a3-c055-4031-813e-47861b4b3ff8_default" xlink:href="cah-20210630.xsd#cah_CordisDivestitureDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_cah_CordisDivestitureAxis_f509a4a3-c055-4031-813e-47861b4b3ff8" xlink:to="loc_cah_CordisDivestitureDomain_f509a4a3-c055-4031-813e-47861b4b3ff8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_CordisDivestitureDomain_a67e6003-4877-4df1-9b82-1f68a199842e" xlink:href="cah-20210630.xsd#cah_CordisDivestitureDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_cah_CordisDivestitureAxis_f509a4a3-c055-4031-813e-47861b4b3ff8" xlink:to="loc_cah_CordisDivestitureDomain_a67e6003-4877-4df1-9b82-1f68a199842e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_CordisDivestitureMember_0814d2cf-42a0-4289-a1ef-9c36d1fe9f7e" xlink:href="cah-20210630.xsd#cah_CordisDivestitureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cah_CordisDivestitureDomain_a67e6003-4877-4df1-9b82-1f68a199842e" xlink:to="loc_cah_CordisDivestitureMember_0814d2cf-42a0-4289-a1ef-9c36d1fe9f7e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_NaviHealthAxis_bba41ab1-8aee-4bfb-b930-05c1440fc227" xlink:href="cah-20210630.xsd#cah_NaviHealthAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_3d42aec9-50bd-4b52-a25e-6a766f434b31" xlink:to="loc_cah_NaviHealthAxis_bba41ab1-8aee-4bfb-b930-05c1440fc227" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_NaviHealthDomain_bba41ab1-8aee-4bfb-b930-05c1440fc227_default" xlink:href="cah-20210630.xsd#cah_NaviHealthDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_cah_NaviHealthAxis_bba41ab1-8aee-4bfb-b930-05c1440fc227" xlink:to="loc_cah_NaviHealthDomain_bba41ab1-8aee-4bfb-b930-05c1440fc227_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_NaviHealthDomain_1b28b250-a397-4470-bde1-036ae3d78177" xlink:href="cah-20210630.xsd#cah_NaviHealthDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_cah_NaviHealthAxis_bba41ab1-8aee-4bfb-b930-05c1440fc227" xlink:to="loc_cah_NaviHealthDomain_1b28b250-a397-4470-bde1-036ae3d78177" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_NaviHealthMember_3a305441-8337-45c6-a3f9-fe2eda8b1fb2" xlink:href="cah-20210630.xsd#cah_NaviHealthMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cah_NaviHealthDomain_1b28b250-a397-4470-bde1-036ae3d78177" xlink:to="loc_cah_NaviHealthMember_3a305441-8337-45c6-a3f9-fe2eda8b1fb2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_cf5078ec-4737-4f0e-86a0-77d1b1a31f2a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_3d42aec9-50bd-4b52-a25e-6a766f434b31" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_cf5078ec-4737-4f0e-86a0-77d1b1a31f2a" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_cf5078ec-4737-4f0e-86a0-77d1b1a31f2a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_cf5078ec-4737-4f0e-86a0-77d1b1a31f2a" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_cf5078ec-4737-4f0e-86a0-77d1b1a31f2a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_ffe319f5-4d24-40c3-9c8e-2d941aad5e8f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_cf5078ec-4737-4f0e-86a0-77d1b1a31f2a" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_ffe319f5-4d24-40c3-9c8e-2d941aad5e8f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_c71221d2-8b1c-4c7b-9fa6-510a58fec28d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_ffe319f5-4d24-40c3-9c8e-2d941aad5e8f" xlink:to="loc_us-gaap_SubsequentEventMember_c71221d2-8b1c-4c7b-9fa6-510a58fec28d" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/RestructuringandEmployeeSeveranceLiabilitiesAssociatedwithRestructuringandEmployeeSeveranceActivitiesDetails" xlink:type="simple" xlink:href="cah-20210630.xsd#RestructuringandEmployeeSeveranceLiabilitiesAssociatedwithRestructuringandEmployeeSeveranceActivitiesDetails"/>
  <link:definitionLink xlink:role="http://www.cardinal.com/role/RestructuringandEmployeeSeveranceLiabilitiesAssociatedwithRestructuringandEmployeeSeveranceActivitiesDetails" xlink:type="extended" id="i600fcb5f86c647a6a621d871d2cbb79e_RestructuringandEmployeeSeveranceLiabilitiesAssociatedwithRestructuringandEmployeeSeveranceActivitiesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_7ba7fd43-201d-4a40-9243-85637861bfc6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveRollForward_abd4a35d-f1ce-4dc3-975e-6c11b44d1ea3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringReserveRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_7ba7fd43-201d-4a40-9243-85637861bfc6" xlink:to="loc_us-gaap_RestructuringReserveRollForward_abd4a35d-f1ce-4dc3-975e-6c11b44d1ea3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve_5ee9239f-9f54-4817-8a15-a1db246b41b0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringReserve"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringReserveRollForward_abd4a35d-f1ce-4dc3-975e-6c11b44d1ea3" xlink:to="loc_us-gaap_RestructuringReserve_5ee9239f-9f54-4817-8a15-a1db246b41b0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCosts_9b362643-5bc0-4426-b815-54f87cffd35e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringReserveRollForward_abd4a35d-f1ce-4dc3-975e-6c11b44d1ea3" xlink:to="loc_us-gaap_RestructuringCosts_9b362643-5bc0-4426-b815-54f87cffd35e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRestructuring_1c87baf6-f263-4b87-a7b9-25ac8364a4f2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForRestructuring"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringReserveRollForward_abd4a35d-f1ce-4dc3-975e-6c11b44d1ea3" xlink:to="loc_us-gaap_PaymentsForRestructuring_1c87baf6-f263-4b87-a7b9-25ac8364a4f2" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve_67642006-91e8-46f6-9eb7-b3b8f7b35b60" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringReserve"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_e2678b0b-0131-4c5c-b74a-ad7891732a7b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_7ba7fd43-201d-4a40-9243-85637861bfc6" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_e2678b0b-0131-4c5c-b74a-ad7891732a7b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveAxis_e72fec6e-a82f-43d0-8c05-ff055cecf5be" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCostAndReserveAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_e2678b0b-0131-4c5c-b74a-ad7891732a7b" xlink:to="loc_us-gaap_RestructuringCostAndReserveAxis_e72fec6e-a82f-43d0-8c05-ff055cecf5be" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain_e72fec6e-a82f-43d0-8c05-ff055cecf5be_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis_e72fec6e-a82f-43d0-8c05-ff055cecf5be" xlink:to="loc_us-gaap_TypeOfRestructuringDomain_e72fec6e-a82f-43d0-8c05-ff055cecf5be_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain_7fc52240-7492-4f9d-b3cf-2a58ce9102bb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis_e72fec6e-a82f-43d0-8c05-ff055cecf5be" xlink:to="loc_us-gaap_TypeOfRestructuringDomain_7fc52240-7492-4f9d-b3cf-2a58ce9102bb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeSeveranceMember_2f5e9cb3-5274-40f2-8b7d-e89c0cf1ccc6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeSeveranceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_7fc52240-7492-4f9d-b3cf-2a58ce9102bb" xlink:to="loc_us-gaap_EmployeeSeveranceMember_2f5e9cb3-5274-40f2-8b7d-e89c0cf1ccc6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FacilityClosingMember_af806ec9-3596-4d6c-90d7-551f1d12b15e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FacilityClosingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_7fc52240-7492-4f9d-b3cf-2a58ce9102bb" xlink:to="loc_us-gaap_FacilityClosingMember_af806ec9-3596-4d6c-90d7-551f1d12b15e" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/GoodwillandOtherIntangibleAssetsScheduleofGoodwillbyReportableSegmentDetails" xlink:type="simple" xlink:href="cah-20210630.xsd#GoodwillandOtherIntangibleAssetsScheduleofGoodwillbyReportableSegmentDetails"/>
  <link:definitionLink xlink:role="http://www.cardinal.com/role/GoodwillandOtherIntangibleAssetsScheduleofGoodwillbyReportableSegmentDetails" xlink:type="extended" id="i24f4981c14a24de39b3bed2b84c30264_GoodwillandOtherIntangibleAssetsScheduleofGoodwillbyReportableSegmentDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems_927e8b73-d30f-4b86-b5d4-a48362704cd5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillTransfers_4b9a6f23-08dd-4604-ba25-23d5425b00bc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillTransfers"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_927e8b73-d30f-4b86-b5d4-a48362704cd5" xlink:to="loc_us-gaap_GoodwillTransfers_4b9a6f23-08dd-4604-ba25-23d5425b00bc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward_8f9486ea-40dd-40bb-8862-6c1eaca575b7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_927e8b73-d30f-4b86-b5d4-a48362704cd5" xlink:to="loc_us-gaap_GoodwillRollForward_8f9486ea-40dd-40bb-8862-6c1eaca575b7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_b69ce59a-814d-44d4-bc14-78c87d53c7f1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_8f9486ea-40dd-40bb-8862-6c1eaca575b7" xlink:to="loc_us-gaap_Goodwill_b69ce59a-814d-44d4-bc14-78c87d53c7f1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_d6c43baa-1c3f-4135-b378-3794bcd19949" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillForeignCurrencyTranslationGainLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_8f9486ea-40dd-40bb-8862-6c1eaca575b7" xlink:to="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_d6c43baa-1c3f-4135-b378-3794bcd19949" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_27541b4e-2a56-429d-b320-cb4d4e5b529f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_a1ead8ce-c5ff-4495-be51-d2e48fd200d2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillImpairedAccumulatedImpairmentLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_927e8b73-d30f-4b86-b5d4-a48362704cd5" xlink:to="loc_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_a1ead8ce-c5ff-4495-be51-d2e48fd200d2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1_b9aca2df-6963-4943-8014-75e23dc0a795" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_927e8b73-d30f-4b86-b5d4-a48362704cd5" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1_b9aca2df-6963-4943-8014-75e23dc0a795" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable_db0ddf02-6e79-448f-bf5a-389580995d5d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_GoodwillLineItems_927e8b73-d30f-4b86-b5d4-a48362704cd5" xlink:to="loc_us-gaap_ScheduleOfGoodwillTable_db0ddf02-6e79-448f-bf5a-389580995d5d" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_1b5c0e5c-8025-4745-9d85-ca2e65b6be7e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_db0ddf02-6e79-448f-bf5a-389580995d5d" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_1b5c0e5c-8025-4745-9d85-ca2e65b6be7e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_1b5c0e5c-8025-4745-9d85-ca2e65b6be7e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_1b5c0e5c-8025-4745-9d85-ca2e65b6be7e" xlink:to="loc_us-gaap_SegmentDomain_1b5c0e5c-8025-4745-9d85-ca2e65b6be7e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_3944b19d-9908-4b7f-a22f-8d4036a57b3f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_1b5c0e5c-8025-4745-9d85-ca2e65b6be7e" xlink:to="loc_us-gaap_SegmentDomain_3944b19d-9908-4b7f-a22f-8d4036a57b3f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_MedicalMemberMember_dae69b3b-8e0e-488f-8fc0-6738ce9402da" xlink:href="cah-20210630.xsd#cah_MedicalMemberMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_3944b19d-9908-4b7f-a22f-8d4036a57b3f" xlink:to="loc_cah_MedicalMemberMember_dae69b3b-8e0e-488f-8fc0-6738ce9402da" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_PharmaceuticalMember_03ebbacd-5e25-40d2-90bd-be26cd9d0815" xlink:href="cah-20210630.xsd#cah_PharmaceuticalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_3944b19d-9908-4b7f-a22f-8d4036a57b3f" xlink:to="loc_cah_PharmaceuticalMember_03ebbacd-5e25-40d2-90bd-be26cd9d0815" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_CordisDivestitureAxis_012cf448-9151-469c-9ad1-5df56c2c34c0" xlink:href="cah-20210630.xsd#cah_CordisDivestitureAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_db0ddf02-6e79-448f-bf5a-389580995d5d" xlink:to="loc_cah_CordisDivestitureAxis_012cf448-9151-469c-9ad1-5df56c2c34c0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_CordisDivestitureDomain_012cf448-9151-469c-9ad1-5df56c2c34c0_default" xlink:href="cah-20210630.xsd#cah_CordisDivestitureDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_cah_CordisDivestitureAxis_012cf448-9151-469c-9ad1-5df56c2c34c0" xlink:to="loc_cah_CordisDivestitureDomain_012cf448-9151-469c-9ad1-5df56c2c34c0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_CordisDivestitureDomain_1feb5bf2-4623-4ac8-a992-f87c3ddc9779" xlink:href="cah-20210630.xsd#cah_CordisDivestitureDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_cah_CordisDivestitureAxis_012cf448-9151-469c-9ad1-5df56c2c34c0" xlink:to="loc_cah_CordisDivestitureDomain_1feb5bf2-4623-4ac8-a992-f87c3ddc9779" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_CordisDivestitureMember_0aa87f79-1698-494c-ac91-fa61abd46c05" xlink:href="cah-20210630.xsd#cah_CordisDivestitureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cah_CordisDivestitureDomain_1feb5bf2-4623-4ac8-a992-f87c3ddc9779" xlink:to="loc_cah_CordisDivestitureMember_0aa87f79-1698-494c-ac91-fa61abd46c05" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/GoodwillandOtherIntangibleAssetsScheduleofIntangibleAssetsDetails" xlink:type="simple" xlink:href="cah-20210630.xsd#GoodwillandOtherIntangibleAssetsScheduleofIntangibleAssetsDetails"/>
  <link:definitionLink xlink:role="http://www.cardinal.com/role/GoodwillandOtherIntangibleAssetsScheduleofIntangibleAssetsDetails" xlink:type="extended" id="ib6a793c5b3fe4521a30de5547ba483d7_GoodwillandOtherIntangibleAssetsScheduleofIntangibleAssetsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_dfc4d75e-5999-4cb9-99c5-32b0fac69bfa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_49221700-c9f2-45a8-9e76-4cbcea1e9c6d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_dfc4d75e-5999-4cb9-99c5-32b0fac69bfa" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_49221700-c9f2-45a8-9e76-4cbcea1e9c6d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_bd95afe1-7c77-4f4c-b3f3-6410e9f7b190" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_dfc4d75e-5999-4cb9-99c5-32b0fac69bfa" xlink:to="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_bd95afe1-7c77-4f4c-b3f3-6410e9f7b190" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_99ed62a5-e03a-48a4-9a2e-1082dadf63d9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_bd95afe1-7c77-4f4c-b3f3-6410e9f7b190" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_99ed62a5-e03a-48a4-9a2e-1082dadf63d9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_99ed62a5-e03a-48a4-9a2e-1082dadf63d9_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_99ed62a5-e03a-48a4-9a2e-1082dadf63d9" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_99ed62a5-e03a-48a4-9a2e-1082dadf63d9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_c3578a57-cc7a-4cc4-a550-24f8c416375a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_99ed62a5-e03a-48a4-9a2e-1082dadf63d9" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_c3578a57-cc7a-4cc4-a550-24f8c416375a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_IPRDTrademarksandOtherMember_6ac71202-7908-4366-8674-cdbcceeeb75a" xlink:href="cah-20210630.xsd#cah_IPRDTrademarksandOtherMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_c3578a57-cc7a-4cc4-a550-24f8c416375a" xlink:to="loc_cah_IPRDTrademarksandOtherMember_6ac71202-7908-4366-8674-cdbcceeeb75a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_b69b201e-9208-4f45-afe9-6f7a476be930" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_6ba69351-8975-43e4-8d1e-8d86fb8660da" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_b69b201e-9208-4f45-afe9-6f7a476be930" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_6ba69351-8975-43e4-8d1e-8d86fb8660da" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_58de4486-9c47-491a-a475-5fa0ca3a1cb8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_b69b201e-9208-4f45-afe9-6f7a476be930" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_58de4486-9c47-491a-a475-5fa0ca3a1cb8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_01528946-d210-472e-92e7-0af463a37c83" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_b69b201e-9208-4f45-afe9-6f7a476be930" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_01528946-d210-472e-92e7-0af463a37c83" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_eaea2381-72c1-4939-930c-33ff028a8685" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_b69b201e-9208-4f45-afe9-6f7a476be930" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_eaea2381-72c1-4939-930c-33ff028a8685" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_d7930561-bd6e-47fc-b093-0569b9e21993" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_b69b201e-9208-4f45-afe9-6f7a476be930" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_d7930561-bd6e-47fc-b093-0569b9e21993" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_740d9d41-c072-4eaf-97ab-c8abf26fa80f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_b69b201e-9208-4f45-afe9-6f7a476be930" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_740d9d41-c072-4eaf-97ab-c8abf26fa80f" xlink:type="arc" order="2" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_261bbbc2-9134-4e3a-ba9d-e18af97e70f2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_740d9d41-c072-4eaf-97ab-c8abf26fa80f" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_261bbbc2-9134-4e3a-ba9d-e18af97e70f2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_261bbbc2-9134-4e3a-ba9d-e18af97e70f2_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_261bbbc2-9134-4e3a-ba9d-e18af97e70f2" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_261bbbc2-9134-4e3a-ba9d-e18af97e70f2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_c53e91f4-0d65-4316-b1bd-e2a20e3e0257" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_261bbbc2-9134-4e3a-ba9d-e18af97e70f2" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_c53e91f4-0d65-4316-b1bd-e2a20e3e0257" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_365cec02-397d-4f42-9204-f576130faf5f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_c53e91f4-0d65-4316-b1bd-e2a20e3e0257" xlink:to="loc_us-gaap_CustomerRelationshipsMember_365cec02-397d-4f42-9204-f576130faf5f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_TrademarksAndPatentsMember_d6db97ed-be9e-4f96-90df-59f7a51c2972" xlink:href="cah-20210630.xsd#cah_TrademarksAndPatentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_c53e91f4-0d65-4316-b1bd-e2a20e3e0257" xlink:to="loc_cah_TrademarksAndPatentsMember_d6db97ed-be9e-4f96-90df-59f7a51c2972" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DevelopedTechnologyRightsMember_17df908e-7249-4133-827a-3c9ccbb308e4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DevelopedTechnologyRightsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_c53e91f4-0d65-4316-b1bd-e2a20e3e0257" xlink:to="loc_us-gaap_DevelopedTechnologyRightsMember_17df908e-7249-4133-827a-3c9ccbb308e4" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/GoodwillandOtherIntangibleAssetsNarrativeDetails" xlink:type="simple" xlink:href="cah-20210630.xsd#GoodwillandOtherIntangibleAssetsNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.cardinal.com/role/GoodwillandOtherIntangibleAssetsNarrativeDetails" xlink:type="extended" id="i5972d3344ef14f4c8e6268c14ea8edf5_GoodwillandOtherIntangibleAssetsNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems_72bc7ebc-3369-432d-994e-66ef1b25c54c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_DiscountRatefairvalueinputs_c0a1d6d4-9040-4f09-ba85-351897db1c8c" xlink:href="cah-20210630.xsd#cah_DiscountRatefairvalueinputs"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_72bc7ebc-3369-432d-994e-66ef1b25c54c" xlink:to="loc_cah_DiscountRatefairvalueinputs_c0a1d6d4-9040-4f09-ba85-351897db1c8c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_52fc93e3-caf5-4846-a052-5f7028a66e02" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_72bc7ebc-3369-432d-994e-66ef1b25c54c" xlink:to="loc_us-gaap_Goodwill_52fc93e3-caf5-4846-a052-5f7028a66e02" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_f5197f83-195f-4cbb-8663-b3e4b11ddda1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_72bc7ebc-3369-432d-994e-66ef1b25c54c" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_f5197f83-195f-4cbb-8663-b3e4b11ddda1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_559135d7-c854-478d-90d2-4f8cf462dbdd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_72bc7ebc-3369-432d-994e-66ef1b25c54c" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_559135d7-c854-478d-90d2-4f8cf462dbdd" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_d10c0fed-415d-4cf1-93ff-d9a7ca504c5c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_72bc7ebc-3369-432d-994e-66ef1b25c54c" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_d10c0fed-415d-4cf1-93ff-d9a7ca504c5c" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_be7b678b-5f46-43a6-a28a-515419bdc102" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_72bc7ebc-3369-432d-994e-66ef1b25c54c" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_be7b678b-5f46-43a6-a28a-515419bdc102" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_62d7f977-6455-4fb0-bb2f-6d457139b474" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_72bc7ebc-3369-432d-994e-66ef1b25c54c" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_62d7f977-6455-4fb0-bb2f-6d457139b474" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_09a0adb9-91eb-42d4-bd05-c0f49af541f0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_72bc7ebc-3369-432d-994e-66ef1b25c54c" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_09a0adb9-91eb-42d4-bd05-c0f49af541f0" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_bc373d52-dcb1-495f-9010-d8327575e012" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillImpairedAccumulatedImpairmentLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_72bc7ebc-3369-432d-994e-66ef1b25c54c" xlink:to="loc_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_bc373d52-dcb1-495f-9010-d8327575e012" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable_e36b71b8-3976-4ed0-a287-cfd8b9f2f8ff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_GoodwillLineItems_72bc7ebc-3369-432d-994e-66ef1b25c54c" xlink:to="loc_us-gaap_ScheduleOfGoodwillTable_e36b71b8-3976-4ed0-a287-cfd8b9f2f8ff" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_f3638321-83e9-4a05-b92e-db2e03cb7164" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_e36b71b8-3976-4ed0-a287-cfd8b9f2f8ff" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_f3638321-83e9-4a05-b92e-db2e03cb7164" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_f3638321-83e9-4a05-b92e-db2e03cb7164_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_f3638321-83e9-4a05-b92e-db2e03cb7164" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_f3638321-83e9-4a05-b92e-db2e03cb7164_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_f882d85d-3d37-47ac-a564-57a062858b98" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_f3638321-83e9-4a05-b92e-db2e03cb7164" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_f882d85d-3d37-47ac-a564-57a062858b98" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_NaviHealthMember_674e492d-eb4d-4b86-885f-7d5f367ee340" xlink:href="cah-20210630.xsd#cah_NaviHealthMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_f882d85d-3d37-47ac-a564-57a062858b98" xlink:to="loc_cah_NaviHealthMember_674e492d-eb4d-4b86-885f-7d5f367ee340" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_0f2f6639-124c-41fc-ae41-1b60c5f0fb15" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_e36b71b8-3976-4ed0-a287-cfd8b9f2f8ff" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_0f2f6639-124c-41fc-ae41-1b60c5f0fb15" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_0f2f6639-124c-41fc-ae41-1b60c5f0fb15_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_0f2f6639-124c-41fc-ae41-1b60c5f0fb15" xlink:to="loc_us-gaap_SegmentDomain_0f2f6639-124c-41fc-ae41-1b60c5f0fb15_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_556ba078-980a-43ee-a9ce-3c06e02bc383" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_0f2f6639-124c-41fc-ae41-1b60c5f0fb15" xlink:to="loc_us-gaap_SegmentDomain_556ba078-980a-43ee-a9ce-3c06e02bc383" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_MedicalMemberMember_de4b3415-c796-44f4-8de5-fac59f2c1ceb" xlink:href="cah-20210630.xsd#cah_MedicalMemberMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_556ba078-980a-43ee-a9ce-3c06e02bc383" xlink:to="loc_cah_MedicalMemberMember_de4b3415-c796-44f4-8de5-fac59f2c1ceb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_PharmaceuticalMember_d283841b-c64c-4994-9cda-dde4e3fd0f4e" xlink:href="cah-20210630.xsd#cah_PharmaceuticalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_556ba078-980a-43ee-a9ce-3c06e02bc383" xlink:to="loc_cah_PharmaceuticalMember_d283841b-c64c-4994-9cda-dde4e3fd0f4e" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/LeasesDetails" xlink:type="simple" xlink:href="cah-20210630.xsd#LeasesDetails"/>
  <link:definitionLink xlink:role="http://www.cardinal.com/role/LeasesDetails" xlink:type="extended" id="i34688df028a54f0588eff1ef5f8fdaed_LeasesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_9486aa64-0c19-4399-a17a-5988338f771e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseAndRentalExpense_82683ec6-f504-40a5-b8d0-e40acea69ac1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseAndRentalExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_9486aa64-0c19-4399-a17a-5988338f771e" xlink:to="loc_us-gaap_LeaseAndRentalExpense_82683ec6-f504-40a5-b8d0-e40acea69ac1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseTermOfContract_df39754d-9704-48dd-b1b5-86e9b9ddd1f1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseTermOfContract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_9486aa64-0c19-4399-a17a-5988338f771e" xlink:to="loc_us-gaap_LesseeOperatingLeaseTermOfContract_df39754d-9704-48dd-b1b5-86e9b9ddd1f1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_ReclassificationofdeferredrentinaccordancewithASC842_70727d47-3747-4e5c-a00b-974559fe2886" xlink:href="cah-20210630.xsd#cah_ReclassificationofdeferredrentinaccordancewithASC842"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_9486aa64-0c19-4399-a17a-5988338f771e" xlink:to="loc_cah_ReclassificationofdeferredrentinaccordancewithASC842_70727d47-3747-4e5c-a00b-974559fe2886" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_8679cae5-ed33-4c22-87ba-f40c1cd35146" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_9486aa64-0c19-4399-a17a-5988338f771e" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_8679cae5-ed33-4c22-87ba-f40c1cd35146" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_11be32a2-863b-4b4a-a55b-08e49b1c5183" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_9486aa64-0c19-4399-a17a-5988338f771e" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_11be32a2-863b-4b4a-a55b-08e49b1c5183" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1_60e4f7c0-b44d-4005-9880-06ac44d7178d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_9486aa64-0c19-4399-a17a-5988338f771e" xlink:to="loc_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1_60e4f7c0-b44d-4005-9880-06ac44d7178d" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_bb596b7f-cdbd-4929-a872-eeaa1568df96" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_9486aa64-0c19-4399-a17a-5988338f771e" xlink:to="loc_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_bb596b7f-cdbd-4929-a872-eeaa1568df96" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_8a4de65e-fa35-4e84-80de-a6c314ecae04" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_9486aa64-0c19-4399-a17a-5988338f771e" xlink:to="loc_us-gaap_StatementTable_8a4de65e-fa35-4e84-80de-a6c314ecae04" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_cd2db966-43cf-49b3-920b-d34b80db5ae9" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_8a4de65e-fa35-4e84-80de-a6c314ecae04" xlink:to="loc_srt_RangeAxis_cd2db966-43cf-49b3-920b-d34b80db5ae9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_cd2db966-43cf-49b3-920b-d34b80db5ae9_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_cd2db966-43cf-49b3-920b-d34b80db5ae9" xlink:to="loc_srt_RangeMember_cd2db966-43cf-49b3-920b-d34b80db5ae9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_decebbfa-7c19-4f67-a076-e856e440f1c0" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_cd2db966-43cf-49b3-920b-d34b80db5ae9" xlink:to="loc_srt_RangeMember_decebbfa-7c19-4f67-a076-e856e440f1c0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_a69c10bc-3408-4ac7-8a46-d983d4fd2dce" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_decebbfa-7c19-4f67-a076-e856e440f1c0" xlink:to="loc_srt_MinimumMember_a69c10bc-3408-4ac7-8a46-d983d4fd2dce" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_718e0817-01fa-4fe5-9f48-491d1037097a" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_decebbfa-7c19-4f67-a076-e856e440f1c0" xlink:to="loc_srt_MaximumMember_718e0817-01fa-4fe5-9f48-491d1037097a" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/LeasesSupplementalBalanceSheetInformationDetails" xlink:type="simple" xlink:href="cah-20210630.xsd#LeasesSupplementalBalanceSheetInformationDetails"/>
  <link:definitionLink xlink:role="http://www.cardinal.com/role/LeasesSupplementalBalanceSheetInformationDetails" xlink:type="extended" id="i9728a8d315ec457f8cd2792beecf6b79_LeasesSupplementalBalanceSheetInformationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_277d46ea-9c72-42e0-ab00-aa8cd3f97402" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_56bfea7a-65d4-4295-b41f-557282fbd3b2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_277d46ea-9c72-42e0-ab00-aa8cd3f97402" xlink:to="loc_us-gaap_OperatingLeaseLiability_56bfea7a-65d4-4295-b41f-557282fbd3b2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_cd634f8f-a0e0-4370-9f30-c940b28bb857" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_277d46ea-9c72-42e0-ab00-aa8cd3f97402" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_cd634f8f-a0e0-4370-9f30-c940b28bb857" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_1d2bc8dd-0ba1-4cb6-b5a9-0ab48953b864" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_277d46ea-9c72-42e0-ab00-aa8cd3f97402" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_1d2bc8dd-0ba1-4cb6-b5a9-0ab48953b864" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAsset_5c293326-e97c-419e-a144-5957344371eb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseRightOfUseAsset"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_277d46ea-9c72-42e0-ab00-aa8cd3f97402" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAsset_5c293326-e97c-419e-a144-5957344371eb" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrent_ed9ee376-c3e7-4250-99f8-1b781fe828d0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_277d46ea-9c72-42e0-ab00-aa8cd3f97402" xlink:to="loc_us-gaap_FinanceLeaseLiabilityCurrent_ed9ee376-c3e7-4250-99f8-1b781fe828d0" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_c1db4c61-2a79-45b0-bb6b-4d85071a4fd2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_277d46ea-9c72-42e0-ab00-aa8cd3f97402" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_c1db4c61-2a79-45b0-bb6b-4d85071a4fd2" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_23f1be86-9ca5-4034-9dc5-7025ed79a852" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_277d46ea-9c72-42e0-ab00-aa8cd3f97402" xlink:to="loc_us-gaap_StatementTable_23f1be86-9ca5-4034-9dc5-7025ed79a852" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_390c9b69-5cd6-4088-b676-81569969ed05" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_23f1be86-9ca5-4034-9dc5-7025ed79a852" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_390c9b69-5cd6-4088-b676-81569969ed05" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_390c9b69-5cd6-4088-b676-81569969ed05_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_390c9b69-5cd6-4088-b676-81569969ed05" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_390c9b69-5cd6-4088-b676-81569969ed05_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_3a9984f8-e5f1-4207-ae35-263226f24753" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_390c9b69-5cd6-4088-b676-81569969ed05" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_3a9984f8-e5f1-4207-ae35-263226f24753" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsMember_f2c66117-c98d-49aa-b400-a537270fa173" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_3a9984f8-e5f1-4207-ae35-263226f24753" xlink:to="loc_us-gaap_OtherAssetsMember_f2c66117-c98d-49aa-b400-a537270fa173" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesMember_480fb8de-62e5-4115-89fb-6ba8d28ecd6f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_3a9984f8-e5f1-4207-ae35-263226f24753" xlink:to="loc_us-gaap_OtherLiabilitiesMember_480fb8de-62e5-4115-89fb-6ba8d28ecd6f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesMember_44f6144d-7d50-412e-8ffe-22d624a036fd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_3a9984f8-e5f1-4207-ae35-263226f24753" xlink:to="loc_us-gaap_AccruedLiabilitiesMember_44f6144d-7d50-412e-8ffe-22d624a036fd" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentMember_5b51ee70-517b-4e4f-a514-9871a046eec9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_3a9984f8-e5f1-4207-ae35-263226f24753" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentMember_5b51ee70-517b-4e4f-a514-9871a046eec9" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/LeasesSupplementalCashFlowInformationDetails" xlink:type="simple" xlink:href="cah-20210630.xsd#LeasesSupplementalCashFlowInformationDetails"/>
  <link:definitionLink xlink:role="http://www.cardinal.com/role/LeasesSupplementalCashFlowInformationDetails" xlink:type="extended" id="i1fac3fd8d8494a70b7e9f84b4f6061ce_LeasesSupplementalCashFlowInformationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_e95652ef-64c0-453f-9d40-73d350084bea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_Impactofadoptionofnewaccountingstandard_c46947df-fbc9-44a1-90e2-358a8626684f" xlink:href="cah-20210630.xsd#cah_Impactofadoptionofnewaccountingstandard"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_e95652ef-64c0-453f-9d40-73d350084bea" xlink:to="loc_cah_Impactofadoptionofnewaccountingstandard_c46947df-fbc9-44a1-90e2-358a8626684f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasePayments_99f44d17-a5df-46ec-8638-c5f1a55cdd4b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeasePayments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_e95652ef-64c0-453f-9d40-73d350084bea" xlink:to="loc_us-gaap_OperatingLeasePayments_99f44d17-a5df-46ec-8638-c5f1a55cdd4b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeasePrincipalPayments_ab51ede8-875e-4838-a1fb-0012e07fe0e7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeasePrincipalPayments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_e95652ef-64c0-453f-9d40-73d350084bea" xlink:to="loc_us-gaap_FinanceLeasePrincipalPayments_ab51ede8-875e-4838-a1fb-0012e07fe0e7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_45fb4fca-c2aa-44a4-8097-20d4bb33de60" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_e95652ef-64c0-453f-9d40-73d350084bea" xlink:to="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_45fb4fca-c2aa-44a4-8097-20d4bb33de60" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability_42ec693f-da18-4eb0-a3e3-47d2991c18fa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_e95652ef-64c0-453f-9d40-73d350084bea" xlink:to="loc_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability_42ec693f-da18-4eb0-a3e3-47d2991c18fa" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_ReclassificationofdeferredrentinaccordancewithASC842_f3862670-950c-4ec8-a0f0-50d3279b032f" xlink:href="cah-20210630.xsd#cah_ReclassificationofdeferredrentinaccordancewithASC842"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_e95652ef-64c0-453f-9d40-73d350084bea" xlink:to="loc_cah_ReclassificationofdeferredrentinaccordancewithASC842_f3862670-950c-4ec8-a0f0-50d3279b032f" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_cd8a1b17-7f48-4fda-b363-02460435cc93" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_e95652ef-64c0-453f-9d40-73d350084bea" xlink:to="loc_us-gaap_StatementTable_cd8a1b17-7f48-4fda-b363-02460435cc93" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_03cf3a56-b0f0-4e76-ab3d-22a852a59711" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_cd8a1b17-7f48-4fda-b363-02460435cc93" xlink:to="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_03cf3a56-b0f0-4e76-ab3d-22a852a59711" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember_03cf3a56-b0f0-4e76-ab3d-22a852a59711_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_03cf3a56-b0f0-4e76-ab3d-22a852a59711" xlink:to="loc_us-gaap_TypeOfAdoptionMember_03cf3a56-b0f0-4e76-ab3d-22a852a59711_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember_135c5f26-8a85-4550-b17d-6635f2ee81f9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_03cf3a56-b0f0-4e76-ab3d-22a852a59711" xlink:to="loc_us-gaap_TypeOfAdoptionMember_135c5f26-8a85-4550-b17d-6635f2ee81f9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_ASC842Member_bfe0acce-9d53-407b-856f-d43368d131aa" xlink:href="cah-20210630.xsd#cah_ASC842Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfAdoptionMember_135c5f26-8a85-4550-b17d-6635f2ee81f9" xlink:to="loc_cah_ASC842Member_bfe0acce-9d53-407b-856f-d43368d131aa" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/LeasesScheduleofFutureLeasePaymentsDetails" xlink:type="simple" xlink:href="cah-20210630.xsd#LeasesScheduleofFutureLeasePaymentsDetails"/>
  <link:definitionLink xlink:role="http://www.cardinal.com/role/LeasesScheduleofFutureLeasePaymentsDetails" xlink:type="extended" id="i0c87604144ad4479b45fbc4d9cd82d55_LeasesScheduleofFutureLeasePaymentsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_b532911c-2bb8-4b73-9ded-13087cb8930d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_d451795f-4dab-4cf9-8152-3df00f3153ba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_b532911c-2bb8-4b73-9ded-13087cb8930d" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_d451795f-4dab-4cf9-8152-3df00f3153ba" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_d750f579-a0e3-40ad-9806-15685d7dc749" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_b532911c-2bb8-4b73-9ded-13087cb8930d" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_d750f579-a0e3-40ad-9806-15685d7dc749" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_LesseeLeaseLiabilityPaymentsDueYearTwo_4da79581-e548-4350-9b4e-0c2c44f8a0cb" xlink:href="cah-20210630.xsd#cah_LesseeLeaseLiabilityPaymentsDueYearTwo"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_b532911c-2bb8-4b73-9ded-13087cb8930d" xlink:to="loc_cah_LesseeLeaseLiabilityPaymentsDueYearTwo_4da79581-e548-4350-9b4e-0c2c44f8a0cb" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_9e5dffda-91b6-449e-8d08-8c6600541c91" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_b532911c-2bb8-4b73-9ded-13087cb8930d" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_9e5dffda-91b6-449e-8d08-8c6600541c91" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_95bba681-4c87-4470-9d85-a19d23f91d27" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_b532911c-2bb8-4b73-9ded-13087cb8930d" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_95bba681-4c87-4470-9d85-a19d23f91d27" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_LesseeLeaseLiabilityPaymentsDueYearThree_d40427bd-065d-45ac-8d57-6f17c55ba3dd" xlink:href="cah-20210630.xsd#cah_LesseeLeaseLiabilityPaymentsDueYearThree"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_b532911c-2bb8-4b73-9ded-13087cb8930d" xlink:to="loc_cah_LesseeLeaseLiabilityPaymentsDueYearThree_d40427bd-065d-45ac-8d57-6f17c55ba3dd" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_22afe804-1a37-4244-928c-d4c1125001d2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_b532911c-2bb8-4b73-9ded-13087cb8930d" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_22afe804-1a37-4244-928c-d4c1125001d2" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_e7388645-f278-4500-9249-bc757e6dd3d2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_b532911c-2bb8-4b73-9ded-13087cb8930d" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_e7388645-f278-4500-9249-bc757e6dd3d2" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_LesseeLeaseLiabilityPaymentsDueYearFour_5c868530-0ca4-4581-bfd0-199c7e992ad3" xlink:href="cah-20210630.xsd#cah_LesseeLeaseLiabilityPaymentsDueYearFour"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_b532911c-2bb8-4b73-9ded-13087cb8930d" xlink:to="loc_cah_LesseeLeaseLiabilityPaymentsDueYearFour_5c868530-0ca4-4581-bfd0-199c7e992ad3" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_cf664dad-c2b2-4e4f-805f-c395cfded259" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_b532911c-2bb8-4b73-9ded-13087cb8930d" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_cf664dad-c2b2-4e4f-805f-c395cfded259" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive_0fcf36d5-6a50-439b-a93e-f7a6d9789a59" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_b532911c-2bb8-4b73-9ded-13087cb8930d" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive_0fcf36d5-6a50-439b-a93e-f7a6d9789a59" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_LesseeLeaseLiabilityPaymentsDueYearFive_51f4ef14-4f42-4e3e-99a1-de290dc4f5d1" xlink:href="cah-20210630.xsd#cah_LesseeLeaseLiabilityPaymentsDueYearFive"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_b532911c-2bb8-4b73-9ded-13087cb8930d" xlink:to="loc_cah_LesseeLeaseLiabilityPaymentsDueYearFive_51f4ef14-4f42-4e3e-99a1-de290dc4f5d1" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_14252da2-3bed-42c3-9504-31ea566490c3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_b532911c-2bb8-4b73-9ded-13087cb8930d" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_14252da2-3bed-42c3-9504-31ea566490c3" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive_48dc080c-bcf6-4866-8c8a-77836dcc0ffb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_b532911c-2bb8-4b73-9ded-13087cb8930d" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive_48dc080c-bcf6-4866-8c8a-77836dcc0ffb" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_LesseeLeaseLiabilityPaymentsDueAfterYearFive_bd706234-6eb9-494c-9c8f-4fb40c94806c" xlink:href="cah-20210630.xsd#cah_LesseeLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_b532911c-2bb8-4b73-9ded-13087cb8930d" xlink:to="loc_cah_LesseeLeaseLiabilityPaymentsDueAfterYearFive_bd706234-6eb9-494c-9c8f-4fb40c94806c" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_a2158460-2a28-4bfc-afa3-76a8c79caab0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_b532911c-2bb8-4b73-9ded-13087cb8930d" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_a2158460-2a28-4bfc-afa3-76a8c79caab0" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_65e38722-30cc-4f5a-8707-9e92ed3869a8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_b532911c-2bb8-4b73-9ded-13087cb8930d" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_65e38722-30cc-4f5a-8707-9e92ed3869a8" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_TotalLeaseLiabilityPaymentsDue_d252ae18-6d68-48e1-984d-c19307c0acc8" xlink:href="cah-20210630.xsd#cah_TotalLeaseLiabilityPaymentsDue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_b532911c-2bb8-4b73-9ded-13087cb8930d" xlink:to="loc_cah_TotalLeaseLiabilityPaymentsDue_d252ae18-6d68-48e1-984d-c19307c0acc8" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_LesseeOperatingLeaseLiabilityNotYetCommencedAmount_0d75a36e-0c04-4024-b2a9-55a6058c1eae" xlink:href="cah-20210630.xsd#cah_LesseeOperatingLeaseLiabilityNotYetCommencedAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_b532911c-2bb8-4b73-9ded-13087cb8930d" xlink:to="loc_cah_LesseeOperatingLeaseLiabilityNotYetCommencedAmount_0d75a36e-0c04-4024-b2a9-55a6058c1eae" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_LesseeFinanceLeaseLiabilityNotYetCommencedAmount_f2de94d0-5ba9-42ed-ab90-6e75eebd558a" xlink:href="cah-20210630.xsd#cah_LesseeFinanceLeaseLiabilityNotYetCommencedAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_b532911c-2bb8-4b73-9ded-13087cb8930d" xlink:to="loc_cah_LesseeFinanceLeaseLiabilityNotYetCommencedAmount_f2de94d0-5ba9-42ed-ab90-6e75eebd558a" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_TotalLeaseLiabilityNotYetCommencedAmount_e3b21759-8129-4c3b-9f56-cd122fb57b7f" xlink:href="cah-20210630.xsd#cah_TotalLeaseLiabilityNotYetCommencedAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_b532911c-2bb8-4b73-9ded-13087cb8930d" xlink:to="loc_cah_TotalLeaseLiabilityNotYetCommencedAmount_e3b21759-8129-4c3b-9f56-cd122fb57b7f" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_OperatingLeaseImputedInterest_057e7d7f-1a42-4899-b378-3b9d4d2c2389" xlink:href="cah-20210630.xsd#cah_OperatingLeaseImputedInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_b532911c-2bb8-4b73-9ded-13087cb8930d" xlink:to="loc_cah_OperatingLeaseImputedInterest_057e7d7f-1a42-4899-b378-3b9d4d2c2389" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_FinanceLeaseImputedInterest_286308f0-2bed-4bba-8004-1595b77d3f94" xlink:href="cah-20210630.xsd#cah_FinanceLeaseImputedInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_b532911c-2bb8-4b73-9ded-13087cb8930d" xlink:to="loc_cah_FinanceLeaseImputedInterest_286308f0-2bed-4bba-8004-1595b77d3f94" xlink:type="arc" order="22"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_TotalLeaseLiabilityUndiscountedExcessAmount_f1cf6a65-de88-41eb-8811-f6fa7d68fc94" xlink:href="cah-20210630.xsd#cah_TotalLeaseLiabilityUndiscountedExcessAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_b532911c-2bb8-4b73-9ded-13087cb8930d" xlink:to="loc_cah_TotalLeaseLiabilityUndiscountedExcessAmount_f1cf6a65-de88-41eb-8811-f6fa7d68fc94" xlink:type="arc" order="23"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_bc0b963a-b2c6-45f6-98c4-e96eb856f97c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_b532911c-2bb8-4b73-9ded-13087cb8930d" xlink:to="loc_us-gaap_OperatingLeaseLiability_bc0b963a-b2c6-45f6-98c4-e96eb856f97c" xlink:type="arc" order="24"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability_73f6c53a-b4a2-4056-ae2e-84a7524702fe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_b532911c-2bb8-4b73-9ded-13087cb8930d" xlink:to="loc_us-gaap_FinanceLeaseLiability_73f6c53a-b4a2-4056-ae2e-84a7524702fe" xlink:type="arc" order="25"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_TotalLeaseLiability_4f39f4cf-f32c-434d-9538-82c1c6e1ff3e" xlink:href="cah-20210630.xsd#cah_TotalLeaseLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_b532911c-2bb8-4b73-9ded-13087cb8930d" xlink:to="loc_cah_TotalLeaseLiability_4f39f4cf-f32c-434d-9538-82c1c6e1ff3e" xlink:type="arc" order="26"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_e2582449-e104-454b-8297-26da36a96810" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_b532911c-2bb8-4b73-9ded-13087cb8930d" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_e2582449-e104-454b-8297-26da36a96810" xlink:type="arc" order="27"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_LesseeLeaseLiabilityPaymentsDueYearOne_227bcbc7-8d67-45a7-988a-16990625956f" xlink:href="cah-20210630.xsd#cah_LesseeLeaseLiabilityPaymentsDueYearOne"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_b532911c-2bb8-4b73-9ded-13087cb8930d" xlink:to="loc_cah_LesseeLeaseLiabilityPaymentsDueYearOne_227bcbc7-8d67-45a7-988a-16990625956f" xlink:type="arc" order="28"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_d6bc9995-e38b-4d7e-b1b1-cef839577721" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_b532911c-2bb8-4b73-9ded-13087cb8930d" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_d6bc9995-e38b-4d7e-b1b1-cef839577721" xlink:type="arc" order="29"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_4f533192-d1e6-4465-8838-221cbe077120" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_b532911c-2bb8-4b73-9ded-13087cb8930d" xlink:to="loc_us-gaap_StatementTable_4f533192-d1e6-4465-8838-221cbe077120" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_d1920d4d-3b33-444c-8951-8ab6f74f7010" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_4f533192-d1e6-4465-8838-221cbe077120" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_d1920d4d-3b33-444c-8951-8ab6f74f7010" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_d1920d4d-3b33-444c-8951-8ab6f74f7010_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_d1920d4d-3b33-444c-8951-8ab6f74f7010" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_d1920d4d-3b33-444c-8951-8ab6f74f7010_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_1c607a4a-aea0-483e-a717-ba7c7debd57a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_d1920d4d-3b33-444c-8951-8ab6f74f7010" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_1c607a4a-aea0-483e-a717-ba7c7debd57a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_OperatingLeaseMember_da1761ef-3881-4649-9714-0d0fdeb14bf3" xlink:href="cah-20210630.xsd#cah_OperatingLeaseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_1c607a4a-aea0-483e-a717-ba7c7debd57a" xlink:to="loc_cah_OperatingLeaseMember_da1761ef-3881-4649-9714-0d0fdeb14bf3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_FinanceLeaseMember_37efafc3-22f0-415d-8e2e-1a8dfdd09287" xlink:href="cah-20210630.xsd#cah_FinanceLeaseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_1c607a4a-aea0-483e-a717-ba7c7debd57a" xlink:to="loc_cah_FinanceLeaseMember_37efafc3-22f0-415d-8e2e-1a8dfdd09287" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/LongTermObligationsandOtherShortTermBorrowingsSummaryofDebtDetails" xlink:type="simple" xlink:href="cah-20210630.xsd#LongTermObligationsandOtherShortTermBorrowingsSummaryofDebtDetails"/>
  <link:definitionLink xlink:role="http://www.cardinal.com/role/LongTermObligationsandOtherShortTermBorrowingsSummaryofDebtDetails" xlink:type="extended" id="ib9358678206c41cabbc56beca9278f87_LongTermObligationsandOtherShortTermBorrowingsSummaryofDebtDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_f8d49a5c-46e9-442a-9690-df76acb24001" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_62dbb93b-2a48-417d-a7e9-82b8de6263d1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f8d49a5c-46e9-442a-9690-df76acb24001" xlink:to="loc_us-gaap_AccountsPayableCurrent_62dbb93b-2a48-417d-a7e9-82b8de6263d1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesPayable_fcc3146f-5fe0-4b89-94be-4412145f4e7e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NotesPayable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f8d49a5c-46e9-442a-9690-df76acb24001" xlink:to="loc_us-gaap_NotesPayable_fcc3146f-5fe0-4b89-94be-4412145f4e7e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherBorrowings_087ce289-2cc6-4476-9f25-90cbe3da19fc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherBorrowings"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f8d49a5c-46e9-442a-9690-df76acb24001" xlink:to="loc_us-gaap_OtherBorrowings_087ce289-2cc6-4476-9f25-90cbe3da19fc" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtAndCapitalLeaseObligations_00bed322-ec6b-4a5e-ba3b-7c5b36cf8a53" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtAndCapitalLeaseObligations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f8d49a5c-46e9-442a-9690-df76acb24001" xlink:to="loc_us-gaap_DebtAndCapitalLeaseObligations_00bed322-ec6b-4a5e-ba3b-7c5b36cf8a53" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_95dddece-4ea7-402b-9dfd-e7861a05c796" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f8d49a5c-46e9-442a-9690-df76acb24001" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_95dddece-4ea7-402b-9dfd-e7861a05c796" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_56714b5e-3c25-4cb1-b770-8eb18ae5c0a0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f8d49a5c-46e9-442a-9690-df76acb24001" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_56714b5e-3c25-4cb1-b770-8eb18ae5c0a0" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_b0ead12f-2dd4-4edf-9fa0-d1b68465c2ec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f8d49a5c-46e9-442a-9690-df76acb24001" xlink:to="loc_us-gaap_DebtInstrumentTable_b0ead12f-2dd4-4edf-9fa0-d1b68465c2ec" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_169272ef-4390-44f2-9f13-afd8d31fee8a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_b0ead12f-2dd4-4edf-9fa0-d1b68465c2ec" xlink:to="loc_us-gaap_DebtInstrumentAxis_169272ef-4390-44f2-9f13-afd8d31fee8a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_169272ef-4390-44f2-9f13-afd8d31fee8a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_169272ef-4390-44f2-9f13-afd8d31fee8a" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_169272ef-4390-44f2-9f13-afd8d31fee8a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_4f476087-964a-48e4-93fb-578819177b79" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_169272ef-4390-44f2-9f13-afd8d31fee8a" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_4f476087-964a-48e4-93fb-578819177b79" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_A1.948Notesdue2019Member_b8b234b2-5fd5-435c-a88b-d3f7a97edc8a" xlink:href="cah-20210630.xsd#cah_A1.948Notesdue2019Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_4f476087-964a-48e4-93fb-578819177b79" xlink:to="loc_cah_A1.948Notesdue2019Member_b8b234b2-5fd5-435c-a88b-d3f7a97edc8a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_A24NotesDue2019Member_a5eea93b-2023-49e9-92d7-5da5851d7cf8" xlink:href="cah-20210630.xsd#cah_A24NotesDue2019Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_4f476087-964a-48e4-93fb-578819177b79" xlink:to="loc_cah_A24NotesDue2019Member_a5eea93b-2023-49e9-92d7-5da5851d7cf8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_A4.625Notesdue2021Member_0f8416bf-88dc-4d27-9573-a645aa0ea6bd" xlink:href="cah-20210630.xsd#cah_A4.625Notesdue2021Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_4f476087-964a-48e4-93fb-578819177b79" xlink:to="loc_cah_A4.625Notesdue2021Member_0f8416bf-88dc-4d27-9573-a645aa0ea6bd" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_A2.616Notesdue2022Member_2030930f-f334-4875-a053-e365f148bbc3" xlink:href="cah-20210630.xsd#cah_A2.616Notesdue2022Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_4f476087-964a-48e4-93fb-578819177b79" xlink:to="loc_cah_A2.616Notesdue2022Member_2030930f-f334-4875-a053-e365f148bbc3" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_A3.2Notesdue2022Member_b737cdfe-9059-4304-ab65-715750febc61" xlink:href="cah-20210630.xsd#cah_A3.2Notesdue2022Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_4f476087-964a-48e4-93fb-578819177b79" xlink:to="loc_cah_A3.2Notesdue2022Member_b737cdfe-9059-4304-ab65-715750febc61" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_FloatingRateNotesdue2022Member_122e9f52-fafd-4ea3-be9b-ba218e7716bb" xlink:href="cah-20210630.xsd#cah_FloatingRateNotesdue2022Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_4f476087-964a-48e4-93fb-578819177b79" xlink:to="loc_cah_FloatingRateNotesdue2022Member_122e9f52-fafd-4ea3-be9b-ba218e7716bb" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_A3.2Notesdue2023Member_3a5e2d2c-e196-4e26-bfe7-09617c37ef96" xlink:href="cah-20210630.xsd#cah_A3.2Notesdue2023Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_4f476087-964a-48e4-93fb-578819177b79" xlink:to="loc_cah_A3.2Notesdue2023Member_3a5e2d2c-e196-4e26-bfe7-09617c37ef96" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_A3.079Notesdue2024Member_e80d2a84-2833-41a5-bf45-9042f2b95bf9" xlink:href="cah-20210630.xsd#cah_A3.079Notesdue2024Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_4f476087-964a-48e4-93fb-578819177b79" xlink:to="loc_cah_A3.079Notesdue2024Member_e80d2a84-2833-41a5-bf45-9042f2b95bf9" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_A3.5Notesdue2025Member_7581027e-301a-462d-b46f-e06a0341b8b9" xlink:href="cah-20210630.xsd#cah_A3.5Notesdue2025Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_4f476087-964a-48e4-93fb-578819177b79" xlink:to="loc_cah_A3.5Notesdue2025Member_7581027e-301a-462d-b46f-e06a0341b8b9" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_A3.75Notesdue2026Member_aeba954a-9d8d-4069-a777-51db124d40a1" xlink:href="cah-20210630.xsd#cah_A3.75Notesdue2026Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_4f476087-964a-48e4-93fb-578819177b79" xlink:to="loc_cah_A3.75Notesdue2026Member_aeba954a-9d8d-4069-a777-51db124d40a1" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_A3.41Notesdue2027Member_fb184d96-33dd-4eb1-809c-f35903dc9dee" xlink:href="cah-20210630.xsd#cah_A3.41Notesdue2027Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_4f476087-964a-48e4-93fb-578819177b79" xlink:to="loc_cah_A3.41Notesdue2027Member_fb184d96-33dd-4eb1-809c-f35903dc9dee" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_A4.6Notesdue2043Member_50bf7e49-d7f4-4f3f-9c87-9651f6566a46" xlink:href="cah-20210630.xsd#cah_A4.6Notesdue2043Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_4f476087-964a-48e4-93fb-578819177b79" xlink:to="loc_cah_A4.6Notesdue2043Member_50bf7e49-d7f4-4f3f-9c87-9651f6566a46" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_A4.5Notesdue2044Member_673f2bd1-5fe6-4ee4-933b-69800794e617" xlink:href="cah-20210630.xsd#cah_A4.5Notesdue2044Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_4f476087-964a-48e4-93fb-578819177b79" xlink:to="loc_cah_A4.5Notesdue2044Member_673f2bd1-5fe6-4ee4-933b-69800794e617" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_A4.9Notesdue2045Member_47ce30a4-c139-406b-818e-ed6d350d283a" xlink:href="cah-20210630.xsd#cah_A4.9Notesdue2045Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_4f476087-964a-48e4-93fb-578819177b79" xlink:to="loc_cah_A4.9Notesdue2045Member_47ce30a4-c139-406b-818e-ed6d350d283a" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_A4.368Notesdue2047Member_f19df12e-2bf1-45dc-a064-994b92ab9616" xlink:href="cah-20210630.xsd#cah_A4.368Notesdue2047Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_4f476087-964a-48e4-93fb-578819177b79" xlink:to="loc_cah_A4.368Notesdue2047Member_f19df12e-2bf1-45dc-a064-994b92ab9616" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_A7.0Debenturesduefiscal2027Member_2c59aad6-e547-4a59-b27b-43bd94b1c915" xlink:href="cah-20210630.xsd#cah_A7.0Debenturesduefiscal2027Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_4f476087-964a-48e4-93fb-578819177b79" xlink:to="loc_cah_A7.0Debenturesduefiscal2027Member_2c59aad6-e547-4a59-b27b-43bd94b1c915" xlink:type="arc" order="15"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/LongTermObligationsandOtherShortTermBorrowingsNarrativeDetails" xlink:type="simple" xlink:href="cah-20210630.xsd#LongTermObligationsandOtherShortTermBorrowingsNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.cardinal.com/role/LongTermObligationsandOtherShortTermBorrowingsNarrativeDetails" xlink:type="extended" id="if4acc33450a44a15993909acac814c42_LongTermObligationsandOtherShortTermBorrowingsNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLineItems_f170b4d4-fdc2-43e2-92e1-99a840c22bfa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCredit_74965a3d-f07c-4d28-ad61-3416faac7705" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCredit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_f170b4d4-fdc2-43e2-92e1-99a840c22bfa" xlink:to="loc_us-gaap_LineOfCredit_74965a3d-f07c-4d28-ad61-3416faac7705" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_a8b792ff-5b32-4e63-8438-cc1a36bac3d3" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentFiscalYearFocus"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_f170b4d4-fdc2-43e2-92e1-99a840c22bfa" xlink:to="loc_dei_DocumentFiscalYearFocus_a8b792ff-5b32-4e63-8438-cc1a36bac3d3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_e4e97eea-5b05-4e7b-8e6b-0d3ea282ac3e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_f170b4d4-fdc2-43e2-92e1-99a840c22bfa" xlink:to="loc_us-gaap_AccountsPayableCurrent_e4e97eea-5b05-4e7b-8e6b-0d3ea282ac3e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_NotesPayableRepurchased_64cdb682-9002-4680-83de-0f68ee30637d" xlink:href="cah-20210630.xsd#cah_NotesPayableRepurchased"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_f170b4d4-fdc2-43e2-92e1-99a840c22bfa" xlink:to="loc_cah_NotesPayableRepurchased_64cdb682-9002-4680-83de-0f68ee30637d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumAmountOutstandingDuringPeriod_a5bdb145-7b92-4768-8ada-1953be2e9530" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumAmountOutstandingDuringPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_f170b4d4-fdc2-43e2-92e1-99a840c22bfa" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumAmountOutstandingDuringPeriod_a5bdb145-7b92-4768-8ada-1953be2e9530" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_3f17a1ab-a22f-4fff-ab78-7185fe0caeb5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_f170b4d4-fdc2-43e2-92e1-99a840c22bfa" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_3f17a1ab-a22f-4fff-ab78-7185fe0caeb5" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherBorrowings_d3e13602-a220-4f2b-a3d2-85280b54220c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherBorrowings"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_f170b4d4-fdc2-43e2-92e1-99a840c22bfa" xlink:to="loc_us-gaap_OtherBorrowings_d3e13602-a220-4f2b-a3d2-85280b54220c" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_0caaabf5-1ed8-41fe-9c23-0974f2388485" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_f170b4d4-fdc2-43e2-92e1-99a840c22bfa" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_0caaabf5-1ed8-41fe-9c23-0974f2388485" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrentAndNoncurrent_82cc022c-0b58-4c5b-9143-7f41b7f680cb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableCurrentAndNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_f170b4d4-fdc2-43e2-92e1-99a840c22bfa" xlink:to="loc_us-gaap_AccountsPayableCurrentAndNoncurrent_82cc022c-0b58-4c5b-9143-7f41b7f680cb" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityTable_a6e40596-7b21-4ba7-965e-e20938320ecc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_f170b4d4-fdc2-43e2-92e1-99a840c22bfa" xlink:to="loc_us-gaap_LineOfCreditFacilityTable_a6e40596-7b21-4ba7-965e-e20938320ecc" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_b8105bc0-087b-4113-832a-5735e61ff9a4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_a6e40596-7b21-4ba7-965e-e20938320ecc" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_b8105bc0-087b-4113-832a-5735e61ff9a4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_b8105bc0-087b-4113-832a-5735e61ff9a4_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_b8105bc0-087b-4113-832a-5735e61ff9a4" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_b8105bc0-087b-4113-832a-5735e61ff9a4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_c8ac81ec-8ebd-488c-9117-aec1e4a8ae57" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_b8105bc0-087b-4113-832a-5735e61ff9a4" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_c8ac81ec-8ebd-488c-9117-aec1e4a8ae57" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_e4c76d17-0a02-4e0f-beaa-0a7337d9388d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_a6e40596-7b21-4ba7-965e-e20938320ecc" xlink:to="loc_us-gaap_DebtInstrumentAxis_e4c76d17-0a02-4e0f-beaa-0a7337d9388d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_e4c76d17-0a02-4e0f-beaa-0a7337d9388d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_e4c76d17-0a02-4e0f-beaa-0a7337d9388d" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_e4c76d17-0a02-4e0f-beaa-0a7337d9388d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_c7a55edb-e7ff-4b50-9864-c0df65d2f6f3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_e4c76d17-0a02-4e0f-beaa-0a7337d9388d" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_c7a55edb-e7ff-4b50-9864-c0df65d2f6f3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_A2.616Notesdue2022Member_62a2ef27-f854-4641-811c-5957ef79f6ab" xlink:href="cah-20210630.xsd#cah_A2.616Notesdue2022Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_c7a55edb-e7ff-4b50-9864-c0df65d2f6f3" xlink:to="loc_cah_A2.616Notesdue2022Member_62a2ef27-f854-4641-811c-5957ef79f6ab" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_A3.2Notesdue2023Member_0502eadc-8824-4617-a594-f0bc72d0d44c" xlink:href="cah-20210630.xsd#cah_A3.2Notesdue2023Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_c7a55edb-e7ff-4b50-9864-c0df65d2f6f3" xlink:to="loc_cah_A3.2Notesdue2023Member_0502eadc-8824-4617-a594-f0bc72d0d44c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_FloatingRateNotesdue2022Member_84414ea2-8a03-429f-81ce-08ef9a5ceb37" xlink:href="cah-20210630.xsd#cah_FloatingRateNotesdue2022Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_c7a55edb-e7ff-4b50-9864-c0df65d2f6f3" xlink:to="loc_cah_FloatingRateNotesdue2022Member_84414ea2-8a03-429f-81ce-08ef9a5ceb37" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_A3.41Notesdue2027Member_3b35591c-c505-40c9-a237-2d85c131cace" xlink:href="cah-20210630.xsd#cah_A3.41Notesdue2027Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_c7a55edb-e7ff-4b50-9864-c0df65d2f6f3" xlink:to="loc_cah_A3.41Notesdue2027Member_3b35591c-c505-40c9-a237-2d85c131cace" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_A4.6Notesdue2043Member_8fe889bf-27f6-4abf-b994-6fd5bb7b74bd" xlink:href="cah-20210630.xsd#cah_A4.6Notesdue2043Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_c7a55edb-e7ff-4b50-9864-c0df65d2f6f3" xlink:to="loc_cah_A4.6Notesdue2043Member_8fe889bf-27f6-4abf-b994-6fd5bb7b74bd" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_A4.9Notesdue2045Member_631b5e54-cfdb-4688-ad0b-997f0bc906ae" xlink:href="cah-20210630.xsd#cah_A4.9Notesdue2045Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_c7a55edb-e7ff-4b50-9864-c0df65d2f6f3" xlink:to="loc_cah_A4.9Notesdue2045Member_631b5e54-cfdb-4688-ad0b-997f0bc906ae" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_A4.368Notesdue2047Member_22187768-676a-4d96-a640-6e86a33d3b59" xlink:href="cah-20210630.xsd#cah_A4.368Notesdue2047Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_c7a55edb-e7ff-4b50-9864-c0df65d2f6f3" xlink:to="loc_cah_A4.368Notesdue2047Member_22187768-676a-4d96-a640-6e86a33d3b59" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_A2.616Notes3.2Notes3.41Notes4.6Notes4.9Notesand4.368NotesMember_b9afb13e-ac04-4230-8f8b-b94b18884888" xlink:href="cah-20210630.xsd#cah_A2.616Notes3.2Notes3.41Notes4.6Notes4.9Notesand4.368NotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_c7a55edb-e7ff-4b50-9864-c0df65d2f6f3" xlink:to="loc_cah_A2.616Notes3.2Notes3.41Notes4.6Notes4.9Notesand4.368NotesMember_b9afb13e-ac04-4230-8f8b-b94b18884888" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_A4.625Notesdue2021Member_c157acb3-24b6-48ca-8501-c51a01181e87" xlink:href="cah-20210630.xsd#cah_A4.625Notesdue2021Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_c7a55edb-e7ff-4b50-9864-c0df65d2f6f3" xlink:to="loc_cah_A4.625Notesdue2021Member_c157acb3-24b6-48ca-8501-c51a01181e87" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_A3.2Notesdue2022Member_04dbce16-74e2-4149-88ed-4df48f5ad6ee" xlink:href="cah-20210630.xsd#cah_A3.2Notesdue2022Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_c7a55edb-e7ff-4b50-9864-c0df65d2f6f3" xlink:to="loc_cah_A3.2Notesdue2022Member_04dbce16-74e2-4149-88ed-4df48f5ad6ee" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_FloatingRateNotes2616NotesMember_b380cd1e-873a-4ec6-8df8-8d0130069706" xlink:href="cah-20210630.xsd#cah_FloatingRateNotes2616NotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_c7a55edb-e7ff-4b50-9864-c0df65d2f6f3" xlink:to="loc_cah_FloatingRateNotes2616NotesMember_b380cd1e-873a-4ec6-8df8-8d0130069706" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_A32Notes2616NotesMember_61991f34-9c2f-4a89-b804-14d1b28b4f2b" xlink:href="cah-20210630.xsd#cah_A32Notes2616NotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_c7a55edb-e7ff-4b50-9864-c0df65d2f6f3" xlink:to="loc_cah_A32Notes2616NotesMember_61991f34-9c2f-4a89-b804-14d1b28b4f2b" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_A24NotesDue2019Member_cecade87-7e1c-45c7-92a5-7df632f87985" xlink:href="cah-20210630.xsd#cah_A24NotesDue2019Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_c7a55edb-e7ff-4b50-9864-c0df65d2f6f3" xlink:to="loc_cah_A24NotesDue2019Member_cecade87-7e1c-45c7-92a5-7df632f87985" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityAxis_7303153c-43c4-482f-912f-e83bf5615870" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_a6e40596-7b21-4ba7-965e-e20938320ecc" xlink:to="loc_us-gaap_LineOfCreditFacilityAxis_7303153c-43c4-482f-912f-e83bf5615870" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLenderDomain_7303153c-43c4-482f-912f-e83bf5615870_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityLenderDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LineOfCreditFacilityAxis_7303153c-43c4-482f-912f-e83bf5615870" xlink:to="loc_us-gaap_LineOfCreditFacilityLenderDomain_7303153c-43c4-482f-912f-e83bf5615870_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLenderDomain_21235d30-09ce-4bef-b880-614e5fcbda21" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityLenderDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LineOfCreditFacilityAxis_7303153c-43c4-482f-912f-e83bf5615870" xlink:to="loc_us-gaap_LineOfCreditFacilityLenderDomain_21235d30-09ce-4bef-b880-614e5fcbda21" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_8683b586-f9e3-41eb-ac69-252c3923eec8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_a6e40596-7b21-4ba7-965e-e20938320ecc" xlink:to="loc_us-gaap_CreditFacilityAxis_8683b586-f9e3-41eb-ac69-252c3923eec8" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_8683b586-f9e3-41eb-ac69-252c3923eec8_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CreditFacilityAxis_8683b586-f9e3-41eb-ac69-252c3923eec8" xlink:to="loc_us-gaap_CreditFacilityDomain_8683b586-f9e3-41eb-ac69-252c3923eec8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_d6d86ccb-1e55-448f-a307-620858a14a32" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CreditFacilityAxis_8683b586-f9e3-41eb-ac69-252c3923eec8" xlink:to="loc_us-gaap_CreditFacilityDomain_d6d86ccb-1e55-448f-a307-620858a14a32" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LetterOfCreditMember_318f4000-a58c-4307-b06f-d3396f7b01c8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LetterOfCreditMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_d6d86ccb-1e55-448f-a307-620858a14a32" xlink:to="loc_us-gaap_LetterOfCreditMember_318f4000-a58c-4307-b06f-d3396f7b01c8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_CommittedReceivablesSalesFacilityProgramMember_0832873d-2520-4a49-9f01-f8c78822d0ed" xlink:href="cah-20210630.xsd#cah_CommittedReceivablesSalesFacilityProgramMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_d6d86ccb-1e55-448f-a307-620858a14a32" xlink:to="loc_cah_CommittedReceivablesSalesFacilityProgramMember_0832873d-2520-4a49-9f01-f8c78822d0ed" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_c67c0326-368d-4930-b216-498a5980a811" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_d6d86ccb-1e55-448f-a307-620858a14a32" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_c67c0326-368d-4930-b216-498a5980a811" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember_f430dac3-4721-4233-a5b0-171a66ae14b4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommercialPaperMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_d6d86ccb-1e55-448f-a307-620858a14a32" xlink:to="loc_us-gaap_CommercialPaperMember_f430dac3-4721-4233-a5b0-171a66ae14b4" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_ShortTermCreditFacilitiesMember_15e78515-510f-4342-a5e5-b52667622ab3" xlink:href="cah-20210630.xsd#cah_ShortTermCreditFacilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_d6d86ccb-1e55-448f-a307-620858a14a32" xlink:to="loc_cah_ShortTermCreditFacilitiesMember_15e78515-510f-4342-a5e5-b52667622ab3" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/LongTermObligationsandOtherShortTermBorrowingsLongTermDebtDetails" xlink:type="simple" xlink:href="cah-20210630.xsd#LongTermObligationsandOtherShortTermBorrowingsLongTermDebtDetails"/>
  <link:definitionLink xlink:role="http://www.cardinal.com/role/LongTermObligationsandOtherShortTermBorrowingsLongTermDebtDetails" xlink:type="extended" id="i77df0133398f4459a63c690620c7c089_LongTermObligationsandOtherShortTermBorrowingsLongTermDebtDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_7d7151b9-f8f5-484f-83a0-996574e119f6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_f762eced-3050-4205-af06-3c42d016adff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_7d7151b9-f8f5-484f-83a0-996574e119f6" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_f762eced-3050-4205-af06-3c42d016adff" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_87823449-3905-47a3-a3db-a72c64fb2d45" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_7d7151b9-f8f5-484f-83a0-996574e119f6" xlink:to="loc_us-gaap_AccountsPayableCurrent_87823449-3905-47a3-a3db-a72c64fb2d45" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_218cccd3-04ef-4299-8771-34c73dcace6a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_7d7151b9-f8f5-484f-83a0-996574e119f6" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_218cccd3-04ef-4299-8771-34c73dcace6a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_OfferAsPercentageOfPrincipalAmount_2aeb32ee-d86a-43bb-b84c-28df8fedd687" xlink:href="cah-20210630.xsd#cah_OfferAsPercentageOfPrincipalAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_7d7151b9-f8f5-484f-83a0-996574e119f6" xlink:to="loc_cah_OfferAsPercentageOfPrincipalAmount_2aeb32ee-d86a-43bb-b84c-28df8fedd687" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCredit_49afc3a7-9fa2-4e28-a498-0d01b630238c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCredit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_7d7151b9-f8f5-484f-83a0-996574e119f6" xlink:to="loc_us-gaap_LineOfCredit_49afc3a7-9fa2-4e28-a498-0d01b630238c" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_a5fb931d-edb5-4e1f-afe6-d69775eac184" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_7d7151b9-f8f5-484f-83a0-996574e119f6" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_a5fb931d-edb5-4e1f-afe6-d69775eac184" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_NotesPayableRepurchased_3b2cc7ae-3592-4fbb-a21c-d977b4241ae7" xlink:href="cah-20210630.xsd#cah_NotesPayableRepurchased"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_7d7151b9-f8f5-484f-83a0-996574e119f6" xlink:to="loc_cah_NotesPayableRepurchased_3b2cc7ae-3592-4fbb-a21c-d977b4241ae7" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_6ea5b715-bbfa-48a0-b454-68949b285dae" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_7d7151b9-f8f5-484f-83a0-996574e119f6" xlink:to="loc_us-gaap_DebtInstrumentTable_6ea5b715-bbfa-48a0-b454-68949b285dae" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_50fd4930-c131-4db1-a7ba-44e849784917" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_6ea5b715-bbfa-48a0-b454-68949b285dae" xlink:to="loc_us-gaap_CreditFacilityAxis_50fd4930-c131-4db1-a7ba-44e849784917" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_50fd4930-c131-4db1-a7ba-44e849784917_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CreditFacilityAxis_50fd4930-c131-4db1-a7ba-44e849784917" xlink:to="loc_us-gaap_CreditFacilityDomain_50fd4930-c131-4db1-a7ba-44e849784917_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_f135b2e3-d513-4385-8939-abd49d18099d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CreditFacilityAxis_50fd4930-c131-4db1-a7ba-44e849784917" xlink:to="loc_us-gaap_CreditFacilityDomain_f135b2e3-d513-4385-8939-abd49d18099d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_e6bebf4d-fdc1-4d12-a807-a5fb294e91e6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_6ea5b715-bbfa-48a0-b454-68949b285dae" xlink:to="loc_us-gaap_DebtInstrumentAxis_e6bebf4d-fdc1-4d12-a807-a5fb294e91e6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_e6bebf4d-fdc1-4d12-a807-a5fb294e91e6_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_e6bebf4d-fdc1-4d12-a807-a5fb294e91e6" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_e6bebf4d-fdc1-4d12-a807-a5fb294e91e6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_6e8fd735-4830-447a-a7f5-cf1c615d85dc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_e6bebf4d-fdc1-4d12-a807-a5fb294e91e6" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_6e8fd735-4830-447a-a7f5-cf1c615d85dc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_A1.948Notesdue2019Member_696966cd-fd46-421d-b868-548744a2fff6" xlink:href="cah-20210630.xsd#cah_A1.948Notesdue2019Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_6e8fd735-4830-447a-a7f5-cf1c615d85dc" xlink:to="loc_cah_A1.948Notesdue2019Member_696966cd-fd46-421d-b868-548744a2fff6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_A2.616Notesdue2022Member_06893df5-c679-4207-966a-094aa3427b2f" xlink:href="cah-20210630.xsd#cah_A2.616Notesdue2022Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_6e8fd735-4830-447a-a7f5-cf1c615d85dc" xlink:to="loc_cah_A2.616Notesdue2022Member_06893df5-c679-4207-966a-094aa3427b2f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_A3.079Notesdue2024Member_2f0e5cba-08a1-458c-980b-555a25613791" xlink:href="cah-20210630.xsd#cah_A3.079Notesdue2024Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_6e8fd735-4830-447a-a7f5-cf1c615d85dc" xlink:to="loc_cah_A3.079Notesdue2024Member_2f0e5cba-08a1-458c-980b-555a25613791" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_A3.41Notesdue2027Member_04bf4e56-d0a2-4c95-a067-ba425fab9b27" xlink:href="cah-20210630.xsd#cah_A3.41Notesdue2027Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_6e8fd735-4830-447a-a7f5-cf1c615d85dc" xlink:to="loc_cah_A3.41Notesdue2027Member_04bf4e56-d0a2-4c95-a067-ba425fab9b27" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_A4.368Notesdue2047Member_d20d6449-e4f7-4f60-b0c3-240cad5df686" xlink:href="cah-20210630.xsd#cah_A4.368Notesdue2047Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_6e8fd735-4830-447a-a7f5-cf1c615d85dc" xlink:to="loc_cah_A4.368Notesdue2047Member_d20d6449-e4f7-4f60-b0c3-240cad5df686" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_A2.616Notes3.2Notes3.41Notes4.6Notes4.9Notesand4.368NotesMember_bfcf93a7-25a3-4db2-9438-dc2d0c0e16f2" xlink:href="cah-20210630.xsd#cah_A2.616Notes3.2Notes3.41Notes4.6Notes4.9Notesand4.368NotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_6e8fd735-4830-447a-a7f5-cf1c615d85dc" xlink:to="loc_cah_A2.616Notes3.2Notes3.41Notes4.6Notes4.9Notesand4.368NotesMember_bfcf93a7-25a3-4db2-9438-dc2d0c0e16f2" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_FloatingRateNotesdue2022Member_deeafed3-23ab-4b2b-b8d9-cc22fe70456e" xlink:href="cah-20210630.xsd#cah_FloatingRateNotesdue2022Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_6e8fd735-4830-447a-a7f5-cf1c615d85dc" xlink:to="loc_cah_FloatingRateNotesdue2022Member_deeafed3-23ab-4b2b-b8d9-cc22fe70456e" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_A24NotesDue2019Member_58a85a0e-0f4f-486f-9428-6ce2d975dac0" xlink:href="cah-20210630.xsd#cah_A24NotesDue2019Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_6e8fd735-4830-447a-a7f5-cf1c615d85dc" xlink:to="loc_cah_A24NotesDue2019Member_58a85a0e-0f4f-486f-9428-6ce2d975dac0" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_A3.2Notesdue2022Member_cdc98570-9c03-4e88-92f9-34993b4228b8" xlink:href="cah-20210630.xsd#cah_A3.2Notesdue2022Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_6e8fd735-4830-447a-a7f5-cf1c615d85dc" xlink:to="loc_cah_A3.2Notesdue2022Member_cdc98570-9c03-4e88-92f9-34993b4228b8" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_A3.2Notesdue2023Member_b624f52c-15ba-4172-9c4d-3456163c48b5" xlink:href="cah-20210630.xsd#cah_A3.2Notesdue2023Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_6e8fd735-4830-447a-a7f5-cf1c615d85dc" xlink:to="loc_cah_A3.2Notesdue2023Member_b624f52c-15ba-4172-9c4d-3456163c48b5" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_A3.5Notesdue2025Member_a9e2f5e0-8978-481a-81c0-f8711076bab4" xlink:href="cah-20210630.xsd#cah_A3.5Notesdue2025Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_6e8fd735-4830-447a-a7f5-cf1c615d85dc" xlink:to="loc_cah_A3.5Notesdue2025Member_a9e2f5e0-8978-481a-81c0-f8711076bab4" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_A3.75Notesdue2026Member_2bcdd9d7-4b2d-4f66-8670-165c230ac080" xlink:href="cah-20210630.xsd#cah_A3.75Notesdue2026Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_6e8fd735-4830-447a-a7f5-cf1c615d85dc" xlink:to="loc_cah_A3.75Notesdue2026Member_2bcdd9d7-4b2d-4f66-8670-165c230ac080" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_A4.5Notesdue2044Member_573c4de1-6d5d-4816-a903-cfe1fff61212" xlink:href="cah-20210630.xsd#cah_A4.5Notesdue2044Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_6e8fd735-4830-447a-a7f5-cf1c615d85dc" xlink:to="loc_cah_A4.5Notesdue2044Member_573c4de1-6d5d-4816-a903-cfe1fff61212" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_A4.6Notesdue2043Member_c126d81c-88c4-4c19-9365-c47c2cf2d9b4" xlink:href="cah-20210630.xsd#cah_A4.6Notesdue2043Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_6e8fd735-4830-447a-a7f5-cf1c615d85dc" xlink:to="loc_cah_A4.6Notesdue2043Member_c126d81c-88c4-4c19-9365-c47c2cf2d9b4" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_A4.625Notesdue2021Member_f35282a1-c187-4c09-9631-a1ae60973c22" xlink:href="cah-20210630.xsd#cah_A4.625Notesdue2021Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_6e8fd735-4830-447a-a7f5-cf1c615d85dc" xlink:to="loc_cah_A4.625Notesdue2021Member_f35282a1-c187-4c09-9631-a1ae60973c22" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_A4.9Notesdue2045Member_67526b3c-5d01-4f1b-b8ec-38147751b49e" xlink:href="cah-20210630.xsd#cah_A4.9Notesdue2045Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_6e8fd735-4830-447a-a7f5-cf1c615d85dc" xlink:to="loc_cah_A4.9Notesdue2045Member_67526b3c-5d01-4f1b-b8ec-38147751b49e" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_A7.0Debenturesduefiscal2027Member_39550ff0-4a64-4be5-8021-d55e1f7d20dd" xlink:href="cah-20210630.xsd#cah_A7.0Debenturesduefiscal2027Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_6e8fd735-4830-447a-a7f5-cf1c615d85dc" xlink:to="loc_cah_A7.0Debenturesduefiscal2027Member_39550ff0-4a64-4be5-8021-d55e1f7d20dd" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_73fbe6a5-63c7-40d5-8b20-e0677901f1df" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LegalEntityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_6ea5b715-bbfa-48a0-b454-68949b285dae" xlink:to="loc_dei_LegalEntityAxis_73fbe6a5-63c7-40d5-8b20-e0677901f1df" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_73fbe6a5-63c7-40d5-8b20-e0677901f1df_default" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_73fbe6a5-63c7-40d5-8b20-e0677901f1df" xlink:to="loc_dei_EntityDomain_73fbe6a5-63c7-40d5-8b20-e0677901f1df_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_8c971183-7e22-43d9-954b-ec8cff8f6302" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_73fbe6a5-63c7-40d5-8b20-e0677901f1df" xlink:to="loc_dei_EntityDomain_8c971183-7e22-43d9-954b-ec8cff8f6302" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_AllegianceCorporationMember_57e65b30-8455-4013-8fc0-7208a754cb5e" xlink:href="cah-20210630.xsd#cah_AllegianceCorporationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_8c971183-7e22-43d9-954b-ec8cff8f6302" xlink:to="loc_cah_AllegianceCorporationMember_57e65b30-8455-4013-8fc0-7208a754cb5e" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/LongTermObligationsandOtherShortTermBorrowingsOtherFinancingArrangementsDetails" xlink:type="simple" xlink:href="cah-20210630.xsd#LongTermObligationsandOtherShortTermBorrowingsOtherFinancingArrangementsDetails"/>
  <link:definitionLink xlink:role="http://www.cardinal.com/role/LongTermObligationsandOtherShortTermBorrowingsOtherFinancingArrangementsDetails" xlink:type="extended" id="i9c78c68ae78248bda6a2d67bdc1fc5b6_LongTermObligationsandOtherShortTermBorrowingsOtherFinancingArrangementsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_760106cf-2c41-4fe7-9182-57bba2e53445" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_bc34813d-66f6-462d-bc36-001174db564d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_760106cf-2c41-4fe7-9182-57bba2e53445" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_bc34813d-66f6-462d-bc36-001174db564d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCredit_a6f39be3-1ca7-4e7c-83cb-55cc57c346f2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCredit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_760106cf-2c41-4fe7-9182-57bba2e53445" xlink:to="loc_us-gaap_LineOfCredit_a6f39be3-1ca7-4e7c-83cb-55cc57c346f2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherBorrowings_d3b60d61-e52f-4fee-b4b3-afeb82df13fd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherBorrowings"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_760106cf-2c41-4fe7-9182-57bba2e53445" xlink:to="loc_us-gaap_OtherBorrowings_d3b60d61-e52f-4fee-b4b3-afeb82df13fd" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherShortTermBorrowings_521cc29d-9d88-4c07-a371-cd38e7fe5a5b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherShortTermBorrowings"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_760106cf-2c41-4fe7-9182-57bba2e53445" xlink:to="loc_us-gaap_OtherShortTermBorrowings_521cc29d-9d88-4c07-a371-cd38e7fe5a5b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_28cfbcc3-f921-4a15-b6a2-b46b7321e1c1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_760106cf-2c41-4fe7-9182-57bba2e53445" xlink:to="loc_us-gaap_DebtInstrumentTable_28cfbcc3-f921-4a15-b6a2-b46b7321e1c1" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_4d239dce-2d86-4bc0-a673-2667de2e5749" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_28cfbcc3-f921-4a15-b6a2-b46b7321e1c1" xlink:to="loc_us-gaap_CreditFacilityAxis_4d239dce-2d86-4bc0-a673-2667de2e5749" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_4d239dce-2d86-4bc0-a673-2667de2e5749_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CreditFacilityAxis_4d239dce-2d86-4bc0-a673-2667de2e5749" xlink:to="loc_us-gaap_CreditFacilityDomain_4d239dce-2d86-4bc0-a673-2667de2e5749_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_66dc1d3e-92e5-4757-9cb9-9e6b2c8b64b3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CreditFacilityAxis_4d239dce-2d86-4bc0-a673-2667de2e5749" xlink:to="loc_us-gaap_CreditFacilityDomain_66dc1d3e-92e5-4757-9cb9-9e6b2c8b64b3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_46c9ab12-aac1-438c-a8e6-dcc338279303" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_66dc1d3e-92e5-4757-9cb9-9e6b2c8b64b3" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_46c9ab12-aac1-438c-a8e6-dcc338279303" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LetterOfCreditMember_31575e8b-6b82-4f68-8cdd-baa451d48160" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LetterOfCreditMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_66dc1d3e-92e5-4757-9cb9-9e6b2c8b64b3" xlink:to="loc_us-gaap_LetterOfCreditMember_31575e8b-6b82-4f68-8cdd-baa451d48160" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_ShortTermCreditFacilitiesMember_1dba517f-fe19-45ff-9f16-70a589576211" xlink:href="cah-20210630.xsd#cah_ShortTermCreditFacilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_66dc1d3e-92e5-4757-9cb9-9e6b2c8b64b3" xlink:to="loc_cah_ShortTermCreditFacilitiesMember_1dba517f-fe19-45ff-9f16-70a589576211" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember_36b4d5e2-b36f-4ac2-b06e-eab42ed173c0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommercialPaperMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_66dc1d3e-92e5-4757-9cb9-9e6b2c8b64b3" xlink:to="loc_us-gaap_CommercialPaperMember_36b4d5e2-b36f-4ac2-b06e-eab42ed173c0" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_CommittedReceivablesSalesFacilityProgramMember_67cac161-fdfe-45e1-8069-b8bfc749d4ac" xlink:href="cah-20210630.xsd#cah_CommittedReceivablesSalesFacilityProgramMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_66dc1d3e-92e5-4757-9cb9-9e6b2c8b64b3" xlink:to="loc_cah_CommittedReceivablesSalesFacilityProgramMember_67cac161-fdfe-45e1-8069-b8bfc749d4ac" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_aae4a8bb-215f-41f4-a5e5-c2bff5e8e17d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_28cfbcc3-f921-4a15-b6a2-b46b7321e1c1" xlink:to="loc_us-gaap_DebtInstrumentAxis_aae4a8bb-215f-41f4-a5e5-c2bff5e8e17d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_aae4a8bb-215f-41f4-a5e5-c2bff5e8e17d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_aae4a8bb-215f-41f4-a5e5-c2bff5e8e17d" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_aae4a8bb-215f-41f4-a5e5-c2bff5e8e17d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_7c344bc1-27d3-4603-a623-0ee8c8d16c4a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_aae4a8bb-215f-41f4-a5e5-c2bff5e8e17d" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_7c344bc1-27d3-4603-a623-0ee8c8d16c4a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_CommittedReceivablesSalesFacilityProgramMember_76608997-aaef-40d8-a31c-3a803f8cf2f6" xlink:href="cah-20210630.xsd#cah_CommittedReceivablesSalesFacilityProgramMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_7c344bc1-27d3-4603-a623-0ee8c8d16c4a" xlink:to="loc_cah_CommittedReceivablesSalesFacilityProgramMember_76608997-aaef-40d8-a31c-3a803f8cf2f6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_91f2562c-8dee-4507-961f-fc8d785e0d0f" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_28cfbcc3-f921-4a15-b6a2-b46b7321e1c1" xlink:to="loc_srt_RangeAxis_91f2562c-8dee-4507-961f-fc8d785e0d0f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_91f2562c-8dee-4507-961f-fc8d785e0d0f_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_91f2562c-8dee-4507-961f-fc8d785e0d0f" xlink:to="loc_srt_RangeMember_91f2562c-8dee-4507-961f-fc8d785e0d0f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_e9e34545-57d0-4f0c-9197-2351131263f7" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_91f2562c-8dee-4507-961f-fc8d785e0d0f" xlink:to="loc_srt_RangeMember_e9e34545-57d0-4f0c-9197-2351131263f7" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/CommitmentsContingentLiabilitiesandLitigationDetails" xlink:type="simple" xlink:href="cah-20210630.xsd#CommitmentsContingentLiabilitiesandLitigationDetails"/>
  <link:definitionLink xlink:role="http://www.cardinal.com/role/CommitmentsContingentLiabilitiesandLitigationDetails" xlink:type="extended" id="id7de1219d3804b1fb1e721c5a9c1f621_CommitmentsContingentLiabilitiesandLitigationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_b3073278-0fbe-4e07-b2f0-aea9a93601fa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationReserve_0e3e0d40-de8b-448f-92cf-a787f4fc37c8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LitigationReserve"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_b3073278-0fbe-4e07-b2f0-aea9a93601fa" xlink:to="loc_us-gaap_LitigationReserve_0e3e0d40-de8b-448f-92cf-a787f4fc37c8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRecallExpense_8ca7228f-e8c4-45bb-abfb-59edd0ca8d78" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryRecallExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_b3073278-0fbe-4e07-b2f0-aea9a93601fa" xlink:to="loc_us-gaap_InventoryRecallExpense_8ca7228f-e8c4-45bb-abfb-59edd0ca8d78" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNewClaimsFiledNumber_c86c023b-3034-418f-85e5-15e73531ee9c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyNewClaimsFiledNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_b3073278-0fbe-4e07-b2f0-aea9a93601fa" xlink:to="loc_us-gaap_LossContingencyNewClaimsFiledNumber_c86c023b-3034-418f-85e5-15e73531ee9c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNumberOfPlaintiffs_f426dcab-3a32-4cdc-af04-83a14fca7643" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyNumberOfPlaintiffs"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_b3073278-0fbe-4e07-b2f0-aea9a93601fa" xlink:to="loc_us-gaap_LossContingencyNumberOfPlaintiffs_f426dcab-3a32-4cdc-af04-83a14fca7643" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualAtCarryingValue_4a9a55b0-c543-4d27-8033-3c8a7a2138af" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyAccrualAtCarryingValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_b3073278-0fbe-4e07-b2f0-aea9a93601fa" xlink:to="loc_us-gaap_LossContingencyAccrualAtCarryingValue_4a9a55b0-c543-4d27-8033-3c8a7a2138af" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyEstimateOfPossibleLoss_be6542d9-8866-40db-9cbb-767ac0065bd6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyEstimateOfPossibleLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_b3073278-0fbe-4e07-b2f0-aea9a93601fa" xlink:to="loc_us-gaap_LossContingencyEstimateOfPossibleLoss_be6542d9-8866-40db-9cbb-767ac0065bd6" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_IncomefromSettlementsofClassActionLawsuits_da031d35-a300-44d4-991d-49ec6d16b0be" xlink:href="cah-20210630.xsd#cah_IncomefromSettlementsofClassActionLawsuits"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_b3073278-0fbe-4e07-b2f0-aea9a93601fa" xlink:to="loc_cah_IncomefromSettlementsofClassActionLawsuits_da031d35-a300-44d4-991d-49ec6d16b0be" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_dd12fb33-632c-4a67-bf7e-8d9aab0d13a3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_b3073278-0fbe-4e07-b2f0-aea9a93601fa" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_dd12fb33-632c-4a67-bf7e-8d9aab0d13a3" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_c913c09a-dfae-4d89-830e-ca822058287d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_b3073278-0fbe-4e07-b2f0-aea9a93601fa" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_c913c09a-dfae-4d89-830e-ca822058287d" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossRelatedToLitigationSettlement_638e0b35-1888-4682-b8e5-94a2204fc913" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossRelatedToLitigationSettlement"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_b3073278-0fbe-4e07-b2f0-aea9a93601fa" xlink:to="loc_us-gaap_GainLossRelatedToLitigationSettlement_638e0b35-1888-4682-b8e5-94a2204fc913" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_LossContingencyLawsuitsNumber_10fd181c-7a78-4139-a7f0-8f8da214b12d" xlink:href="cah-20210630.xsd#cah_LossContingencyLawsuitsNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_b3073278-0fbe-4e07-b2f0-aea9a93601fa" xlink:to="loc_cah_LossContingencyLawsuitsNumber_10fd181c-7a78-4139-a7f0-8f8da214b12d" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_NumberofStateAttorneysGeneralfilinglawsuits_587115a7-8fa5-492d-81af-56ff5c6c7172" xlink:href="cah-20210630.xsd#cah_NumberofStateAttorneysGeneralfilinglawsuits"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_b3073278-0fbe-4e07-b2f0-aea9a93601fa" xlink:to="loc_cah_NumberofStateAttorneysGeneralfilinglawsuits_587115a7-8fa5-492d-81af-56ff5c6c7172" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_AggregateAnnualAssessment_b180eec2-42d3-40d6-bd97-178af5387d20" xlink:href="cah-20210630.xsd#cah_AggregateAnnualAssessment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_b3073278-0fbe-4e07-b2f0-aea9a93601fa" xlink:to="loc_cah_AggregateAnnualAssessment_b180eec2-42d3-40d6-bd97-178af5387d20" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationSettlementExpense_942d602b-9585-46f3-8b1d-10bc5dd8b96a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LitigationSettlementExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_b3073278-0fbe-4e07-b2f0-aea9a93601fa" xlink:to="loc_us-gaap_LitigationSettlementExpense_942d602b-9585-46f3-8b1d-10bc5dd8b96a" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyClaimsSettledNumber_436e2c7f-e1c8-4071-9871-fdfa8621ec57" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyClaimsSettledNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_b3073278-0fbe-4e07-b2f0-aea9a93601fa" xlink:to="loc_us-gaap_LossContingencyClaimsSettledNumber_436e2c7f-e1c8-4071-9871-fdfa8621ec57" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_b6c5f8f3-6823-48dc-9ec7-e4e86e9cd968" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LossContingenciesLineItems_b3073278-0fbe-4e07-b2f0-aea9a93601fa" xlink:to="loc_us-gaap_LossContingenciesTable_b6c5f8f3-6823-48dc-9ec7-e4e86e9cd968" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_LawsuitTypeAxis_668a12bf-5239-48db-a150-8a3036472b87" xlink:href="cah-20210630.xsd#cah_LawsuitTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_b6c5f8f3-6823-48dc-9ec7-e4e86e9cd968" xlink:to="loc_cah_LawsuitTypeAxis_668a12bf-5239-48db-a150-8a3036472b87" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_LawsuitTypeDomain_668a12bf-5239-48db-a150-8a3036472b87_default" xlink:href="cah-20210630.xsd#cah_LawsuitTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_cah_LawsuitTypeAxis_668a12bf-5239-48db-a150-8a3036472b87" xlink:to="loc_cah_LawsuitTypeDomain_668a12bf-5239-48db-a150-8a3036472b87_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_LawsuitTypeDomain_caad946b-ecb7-4461-bba9-d005b50c7269" xlink:href="cah-20210630.xsd#cah_LawsuitTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_cah_LawsuitTypeAxis_668a12bf-5239-48db-a150-8a3036472b87" xlink:to="loc_cah_LawsuitTypeDomain_caad946b-ecb7-4461-bba9-d005b50c7269" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_ClassActionLawsuitsMember_d7215d30-d5a8-4a2a-91cb-6ec5aee00934" xlink:href="cah-20210630.xsd#cah_ClassActionLawsuitsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cah_LawsuitTypeDomain_caad946b-ecb7-4461-bba9-d005b50c7269" xlink:to="loc_cah_ClassActionLawsuitsMember_d7215d30-d5a8-4a2a-91cb-6ec5aee00934" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_PlaintiffTypeAxis_b8956a6f-7d68-48af-96e9-89c74eccdb8e" xlink:href="cah-20210630.xsd#cah_PlaintiffTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_b6c5f8f3-6823-48dc-9ec7-e4e86e9cd968" xlink:to="loc_cah_PlaintiffTypeAxis_b8956a6f-7d68-48af-96e9-89c74eccdb8e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_PlaintiffTypeDomain_b8956a6f-7d68-48af-96e9-89c74eccdb8e_default" xlink:href="cah-20210630.xsd#cah_PlaintiffTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_cah_PlaintiffTypeAxis_b8956a6f-7d68-48af-96e9-89c74eccdb8e" xlink:to="loc_cah_PlaintiffTypeDomain_b8956a6f-7d68-48af-96e9-89c74eccdb8e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_PlaintiffTypeDomain_2c5d3a69-e33c-43cd-9139-27f0e26f7ff4" xlink:href="cah-20210630.xsd#cah_PlaintiffTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_cah_PlaintiffTypeAxis_b8956a6f-7d68-48af-96e9-89c74eccdb8e" xlink:to="loc_cah_PlaintiffTypeDomain_2c5d3a69-e33c-43cd-9139-27f0e26f7ff4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_PrivatePartiesMember_479c5c9b-4422-4514-9a8d-90f2397d26df" xlink:href="cah-20210630.xsd#cah_PrivatePartiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cah_PlaintiffTypeDomain_2c5d3a69-e33c-43cd-9139-27f0e26f7ff4" xlink:to="loc_cah_PrivatePartiesMember_479c5c9b-4422-4514-9a8d-90f2397d26df" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_OpioidLitigationAxis_3eeab3c2-bcc5-419b-ad10-9b1d23de8f3b" xlink:href="cah-20210630.xsd#cah_OpioidLitigationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_b6c5f8f3-6823-48dc-9ec7-e4e86e9cd968" xlink:to="loc_cah_OpioidLitigationAxis_3eeab3c2-bcc5-419b-ad10-9b1d23de8f3b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_OpioidLitigationDomain_3eeab3c2-bcc5-419b-ad10-9b1d23de8f3b_default" xlink:href="cah-20210630.xsd#cah_OpioidLitigationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_cah_OpioidLitigationAxis_3eeab3c2-bcc5-419b-ad10-9b1d23de8f3b" xlink:to="loc_cah_OpioidLitigationDomain_3eeab3c2-bcc5-419b-ad10-9b1d23de8f3b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_OpioidLitigationDomain_80a981d6-8dbe-4005-a626-892382a85faa" xlink:href="cah-20210630.xsd#cah_OpioidLitigationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_cah_OpioidLitigationAxis_3eeab3c2-bcc5-419b-ad10-9b1d23de8f3b" xlink:to="loc_cah_OpioidLitigationDomain_80a981d6-8dbe-4005-a626-892382a85faa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_TotalOpioidLitigationMember_475c61dc-7fb8-4174-b22c-383956b8ea52" xlink:href="cah-20210630.xsd#cah_TotalOpioidLitigationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cah_OpioidLitigationDomain_80a981d6-8dbe-4005-a626-892382a85faa" xlink:to="loc_cah_TotalOpioidLitigationMember_475c61dc-7fb8-4174-b22c-383956b8ea52" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_GownRecallAxis_0dcbb089-0772-4d96-8579-71c0dcb2da07" xlink:href="cah-20210630.xsd#cah_GownRecallAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_b6c5f8f3-6823-48dc-9ec7-e4e86e9cd968" xlink:to="loc_cah_GownRecallAxis_0dcbb089-0772-4d96-8579-71c0dcb2da07" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_GownRecallDomain_0dcbb089-0772-4d96-8579-71c0dcb2da07_default" xlink:href="cah-20210630.xsd#cah_GownRecallDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_cah_GownRecallAxis_0dcbb089-0772-4d96-8579-71c0dcb2da07" xlink:to="loc_cah_GownRecallDomain_0dcbb089-0772-4d96-8579-71c0dcb2da07_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_GownRecallDomain_a94ebd00-0f33-4af1-ac6a-fbbc2b0e06b6" xlink:href="cah-20210630.xsd#cah_GownRecallDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_cah_GownRecallAxis_0dcbb089-0772-4d96-8579-71c0dcb2da07" xlink:to="loc_cah_GownRecallDomain_a94ebd00-0f33-4af1-ac6a-fbbc2b0e06b6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_SterileSurgicalGownRecallMemberDomain_69909b71-0c2a-43c5-8a6f-6c9430f54e1c" xlink:href="cah-20210630.xsd#cah_SterileSurgicalGownRecallMemberDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_cah_GownRecallAxis_0dcbb089-0772-4d96-8579-71c0dcb2da07" xlink:to="loc_cah_SterileSurgicalGownRecallMemberDomain_69909b71-0c2a-43c5-8a6f-6c9430f54e1c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_c0668676-e2a4-43bc-a5ae-381fd5108219" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_b6c5f8f3-6823-48dc-9ec7-e4e86e9cd968" xlink:to="loc_srt_RangeAxis_c0668676-e2a4-43bc-a5ae-381fd5108219" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_c0668676-e2a4-43bc-a5ae-381fd5108219_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_c0668676-e2a4-43bc-a5ae-381fd5108219" xlink:to="loc_srt_RangeMember_c0668676-e2a4-43bc-a5ae-381fd5108219_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_738a7aef-d671-4604-8b08-64b272072523" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_c0668676-e2a4-43bc-a5ae-381fd5108219" xlink:to="loc_srt_RangeMember_738a7aef-d671-4604-8b08-64b272072523" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_ed0abce1-b7e6-4e5d-9b5b-976e9580e425" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_738a7aef-d671-4604-8b08-64b272072523" xlink:to="loc_srt_MinimumMember_ed0abce1-b7e6-4e5d-9b5b-976e9580e425" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_4758106a-9675-464b-9564-3066130f08b5" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_738a7aef-d671-4604-8b08-64b272072523" xlink:to="loc_srt_MaximumMember_4758106a-9675-464b-9564-3066130f08b5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_6863f270-5eaa-4474-b013-2280118ffdab" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesByNatureOfContingencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_b6c5f8f3-6823-48dc-9ec7-e4e86e9cd968" xlink:to="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_6863f270-5eaa-4474-b013-2280118ffdab" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNatureDomain_6863f270-5eaa-4474-b013-2280118ffdab_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyNatureDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_6863f270-5eaa-4474-b013-2280118ffdab" xlink:to="loc_us-gaap_LossContingencyNatureDomain_6863f270-5eaa-4474-b013-2280118ffdab_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNatureDomain_e6752762-cda7-426e-ab02-fff59b97e636" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyNatureDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_6863f270-5eaa-4474-b013-2280118ffdab" xlink:to="loc_us-gaap_LossContingencyNatureDomain_e6752762-cda7-426e-ab02-fff59b97e636" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_ProductLiabilityLawsuitsMember_ee3b152f-2f70-470e-8ecb-b1cafb866d6d" xlink:href="cah-20210630.xsd#cah_ProductLiabilityLawsuitsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingencyNatureDomain_e6752762-cda7-426e-ab02-fff59b97e636" xlink:to="loc_cah_ProductLiabilityLawsuitsMember_ee3b152f-2f70-470e-8ecb-b1cafb866d6d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_LitigationTypeAxis_efe819ed-ca37-4db4-a2b2-19f401865e67" xlink:href="cah-20210630.xsd#cah_LitigationTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_b6c5f8f3-6823-48dc-9ec7-e4e86e9cd968" xlink:to="loc_cah_LitigationTypeAxis_efe819ed-ca37-4db4-a2b2-19f401865e67" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_LitigationTypeDomain_efe819ed-ca37-4db4-a2b2-19f401865e67_default" xlink:href="cah-20210630.xsd#cah_LitigationTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_cah_LitigationTypeAxis_efe819ed-ca37-4db4-a2b2-19f401865e67" xlink:to="loc_cah_LitigationTypeDomain_efe819ed-ca37-4db4-a2b2-19f401865e67_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_LitigationTypeDomain_add98df8-19cf-4f74-80d8-6d9b51b192b6" xlink:href="cah-20210630.xsd#cah_LitigationTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_cah_LitigationTypeAxis_efe819ed-ca37-4db4-a2b2-19f401865e67" xlink:to="loc_cah_LitigationTypeDomain_add98df8-19cf-4f74-80d8-6d9b51b192b6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_ClassActionLawsuitsMember_2e8fb563-3c8e-477d-95fa-4678c596c716" xlink:href="cah-20210630.xsd#cah_ClassActionLawsuitsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cah_LitigationTypeDomain_add98df8-19cf-4f74-80d8-6d9b51b192b6" xlink:to="loc_cah_ClassActionLawsuitsMember_2e8fb563-3c8e-477d-95fa-4678c596c716" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_ad27272f-d42e-46ed-9f08-9a3cb806f949" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_b6c5f8f3-6823-48dc-9ec7-e4e86e9cd968" xlink:to="loc_srt_StatementGeographicalAxis_ad27272f-d42e-46ed-9f08-9a3cb806f949" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_ad27272f-d42e-46ed-9f08-9a3cb806f949_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_ad27272f-d42e-46ed-9f08-9a3cb806f949" xlink:to="loc_srt_SegmentGeographicalDomain_ad27272f-d42e-46ed-9f08-9a3cb806f949_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_c70b3bb1-53f2-4941-a6d6-dc78ff319fbe" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_ad27272f-d42e-46ed-9f08-9a3cb806f949" xlink:to="loc_srt_SegmentGeographicalDomain_c70b3bb1-53f2-4941-a6d6-dc78ff319fbe" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_AlamedaCountyMember_3b59f170-eec9-4ee4-8f07-20fe6b1c3d8f" xlink:href="cah-20210630.xsd#cah_AlamedaCountyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_c70b3bb1-53f2-4941-a6d6-dc78ff319fbe" xlink:to="loc_cah_AlamedaCountyMember_3b59f170-eec9-4ee4-8f07-20fe6b1c3d8f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_OtherJurisdictionsMember_8d97cc2f-0085-4382-89c0-db7c9d9526e7" xlink:href="cah-20210630.xsd#cah_OtherJurisdictionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_c70b3bb1-53f2-4941-a6d6-dc78ff319fbe" xlink:to="loc_cah_OtherJurisdictionsMember_8d97cc2f-0085-4382-89c0-db7c9d9526e7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_669e6d3d-2a4a-451e-a1c6-822813d783cb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_b6c5f8f3-6823-48dc-9ec7-e4e86e9cd968" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_669e6d3d-2a4a-451e-a1c6-822813d783cb" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_669e6d3d-2a4a-451e-a1c6-822813d783cb_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_669e6d3d-2a4a-451e-a1c6-822813d783cb" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_669e6d3d-2a4a-451e-a1c6-822813d783cb_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_8aa94b00-1b21-4051-b6e0-488484da3e55" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_669e6d3d-2a4a-451e-a1c6-822813d783cb" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_8aa94b00-1b21-4051-b6e0-488484da3e55" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_ca93a0a3-0856-4511-968f-da5e62482348" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LitigationCaseAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_b6c5f8f3-6823-48dc-9ec7-e4e86e9cd968" xlink:to="loc_srt_LitigationCaseAxis_ca93a0a3-0856-4511-968f-da5e62482348" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_ca93a0a3-0856-4511-968f-da5e62482348_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_LitigationCaseAxis_ca93a0a3-0856-4511-968f-da5e62482348" xlink:to="loc_srt_LitigationCaseTypeDomain_ca93a0a3-0856-4511-968f-da5e62482348_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_913d9f7f-4b0c-4254-a700-51744fb0aad1" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_LitigationCaseAxis_ca93a0a3-0856-4511-968f-da5e62482348" xlink:to="loc_srt_LitigationCaseTypeDomain_913d9f7f-4b0c-4254-a700-51744fb0aad1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_OpioidLawsuitsMember_1852942c-2850-4d4b-b70f-8c96d9a4100c" xlink:href="cah-20210630.xsd#cah_OpioidLawsuitsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_913d9f7f-4b0c-4254-a700-51744fb0aad1" xlink:to="loc_cah_OpioidLawsuitsMember_1852942c-2850-4d4b-b70f-8c96d9a4100c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_OpioidLawsuitsStateDomain_927ccc55-93e7-414c-bc8d-2301652fe50f" xlink:href="cah-20210630.xsd#cah_OpioidLawsuitsStateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_913d9f7f-4b0c-4254-a700-51744fb0aad1" xlink:to="loc_cah_OpioidLawsuitsStateDomain_927ccc55-93e7-414c-bc8d-2301652fe50f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_ProductLiabilityLawsuitsMember_314c01d1-8c5b-4fa3-9f70-b8a2c5d5189a" xlink:href="cah-20210630.xsd#cah_ProductLiabilityLawsuitsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_913d9f7f-4b0c-4254-a700-51744fb0aad1" xlink:to="loc_cah_ProductLiabilityLawsuitsMember_314c01d1-8c5b-4fa3-9f70-b8a2c5d5189a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_NewYorkOpioidStewardshipActMember_68da8b07-9de6-40a5-acdb-1eb3daff5655" xlink:href="cah-20210630.xsd#cah_NewYorkOpioidStewardshipActMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_913d9f7f-4b0c-4254-a700-51744fb0aad1" xlink:to="loc_cah_NewYorkOpioidStewardshipActMember_68da8b07-9de6-40a5-acdb-1eb3daff5655" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_DOJInvestigationMember_935e54e3-77cc-4e61-8b66-465d9b6fc3b9" xlink:href="cah-20210630.xsd#cah_DOJInvestigationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_913d9f7f-4b0c-4254-a700-51744fb0aad1" xlink:to="loc_cah_DOJInvestigationMember_935e54e3-77cc-4e61-8b66-465d9b6fc3b9" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_579d4b10-0104-4b03-84c9-1b5ca52e5157" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_b6c5f8f3-6823-48dc-9ec7-e4e86e9cd968" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_579d4b10-0104-4b03-84c9-1b5ca52e5157" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_579d4b10-0104-4b03-84c9-1b5ca52e5157_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_579d4b10-0104-4b03-84c9-1b5ca52e5157" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_579d4b10-0104-4b03-84c9-1b5ca52e5157_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_b5297589-4367-4140-97d2-f95312259772" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_579d4b10-0104-4b03-84c9-1b5ca52e5157" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_b5297589-4367-4140-97d2-f95312259772" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_dab5aefd-f7a2-4dc9-af03-eefea0bbe59c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_b5297589-4367-4140-97d2-f95312259772" xlink:to="loc_us-gaap_SubsequentEventMember_dab5aefd-f7a2-4dc9-af03-eefea0bbe59c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_1a895162-d548-4ab3-8229-93a299a16548" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_b6c5f8f3-6823-48dc-9ec7-e4e86e9cd968" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_1a895162-d548-4ab3-8229-93a299a16548" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_1a895162-d548-4ab3-8229-93a299a16548_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_1a895162-d548-4ab3-8229-93a299a16548" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_1a895162-d548-4ab3-8229-93a299a16548_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_089f12c5-0a5c-4589-b9ac-a8e644882312" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_1a895162-d548-4ab3-8229-93a299a16548" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_089f12c5-0a5c-4589-b9ac-a8e644882312" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesMember_42c5f4b9-c727-46cc-9313-a3f5f05900d7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_089f12c5-0a5c-4589-b9ac-a8e644882312" xlink:to="loc_us-gaap_AccruedLiabilitiesMember_42c5f4b9-c727-46cc-9313-a3f5f05900d7" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/IncomeTaxesNarrativeDetails" xlink:type="simple" xlink:href="cah-20210630.xsd#IncomeTaxesNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.cardinal.com/role/IncomeTaxesNarrativeDetails" xlink:type="extended" id="i234d7e63f16046a8b96bae2c9869326b_IncomeTaxesNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardLineItems_b1583ecf-7b8d-4cf6-a42c-bd404a99f808" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxCreditCarryforwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_efe0ace6-991a-4712-902f-0bbf6d2d1106" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TaxCreditCarryforwardLineItems_b1583ecf-7b8d-4cf6-a42c-bd404a99f808" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_efe0ace6-991a-4712-902f-0bbf6d2d1106" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationReserve_5f63382a-3bdd-4581-9539-cdcd616e99c1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LitigationReserve"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TaxCreditCarryforwardLineItems_b1583ecf-7b8d-4cf6-a42c-bd404a99f808" xlink:to="loc_us-gaap_LitigationReserve_5f63382a-3bdd-4581-9539-cdcd616e99c1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_4a14fb87-80ef-4b25-9c4d-2799adf94244" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TaxCreditCarryforwardLineItems_b1583ecf-7b8d-4cf6-a42c-bd404a99f808" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_4a14fb87-80ef-4b25-9c4d-2799adf94244" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_EffectiveTaxRateImpactFromCertainForeignJurisdictions_9c676819-bbd1-4c4e-a392-98d30c3606d7" xlink:href="cah-20210630.xsd#cah_EffectiveTaxRateImpactFromCertainForeignJurisdictions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TaxCreditCarryforwardLineItems_b1583ecf-7b8d-4cf6-a42c-bd404a99f808" xlink:to="loc_cah_EffectiveTaxRateImpactFromCertainForeignJurisdictions_9c676819-bbd1-4c4e-a392-98d30c3606d7" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_cf3f6475-4fac-40fc-81be-6c5e1dbbecce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TaxCreditCarryforwardLineItems_b1583ecf-7b8d-4cf6-a42c-bd404a99f808" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_cf3f6475-4fac-40fc-81be-6c5e1dbbecce" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_5b29675d-6186-4aad-9984-109cd264fd47" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TaxCreditCarryforwardLineItems_b1583ecf-7b8d-4cf6-a42c-bd404a99f808" xlink:to="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_5b29675d-6186-4aad-9984-109cd264fd47" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardAmount_492e1783-88da-4d0e-8a1a-96c5a999ba36" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxCreditCarryforwardAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TaxCreditCarryforwardLineItems_b1583ecf-7b8d-4cf6-a42c-bd404a99f808" xlink:to="loc_us-gaap_TaxCreditCarryforwardAmount_492e1783-88da-4d0e-8a1a-96c5a999ba36" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_ab4d12bf-24ad-40b2-bbcb-cf305355f087" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwards"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TaxCreditCarryforwardLineItems_b1583ecf-7b8d-4cf6-a42c-bd404a99f808" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_ab4d12bf-24ad-40b2-bbcb-cf305355f087" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwardsValuationAllowance_fd2dcdba-c094-42e3-81b8-57e1a65b9f25" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLossCarryforwardsValuationAllowance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TaxCreditCarryforwardLineItems_b1583ecf-7b8d-4cf6-a42c-bd404a99f808" xlink:to="loc_us-gaap_OperatingLossCarryforwardsValuationAllowance_fd2dcdba-c094-42e3-81b8-57e1a65b9f25" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_f53d1077-c6eb-4bfd-a2fd-ca4933d0912b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TaxCreditCarryforwardLineItems_b1583ecf-7b8d-4cf6-a42c-bd404a99f808" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_f53d1077-c6eb-4bfd-a2fd-ca4933d0912b" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_f1b6f759-9337-4905-ae79-7aab7c7a2dd0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TaxCreditCarryforwardLineItems_b1583ecf-7b8d-4cf6-a42c-bd404a99f808" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_f1b6f759-9337-4905-ae79-7aab7c7a2dd0" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_f708c5d7-6f1e-43e2-b1db-b2d3598261cb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TaxCreditCarryforwardLineItems_b1583ecf-7b8d-4cf6-a42c-bd404a99f808" xlink:to="loc_us-gaap_UnrecognizedTaxBenefits_f708c5d7-6f1e-43e2-b1db-b2d3598261cb" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities_997cc9ce-75bd-46e5-bc3e-5b67a1844824" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TaxCreditCarryforwardLineItems_b1583ecf-7b8d-4cf6-a42c-bd404a99f808" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities_997cc9ce-75bd-46e5-bc3e-5b67a1844824" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_738939dc-1f63-41f0-88e5-12b02c40672a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TaxCreditCarryforwardLineItems_b1583ecf-7b8d-4cf6-a42c-bd404a99f808" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_738939dc-1f63-41f0-88e5-12b02c40672a" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible_dde15bdf-4e87-4b16-984f-7978eedde537" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TaxCreditCarryforwardLineItems_b1583ecf-7b8d-4cf6-a42c-bd404a99f808" xlink:to="loc_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible_dde15bdf-4e87-4b16-984f-7978eedde537" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_2e29cb53-793f-4eac-88fd-6b0a73de2ea1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TaxCreditCarryforwardLineItems_b1583ecf-7b8d-4cf6-a42c-bd404a99f808" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_2e29cb53-793f-4eac-88fd-6b0a73de2ea1" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense_d66e5aa1-d522-491a-8dec-c92ed879ebb5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TaxCreditCarryforwardLineItems_b1583ecf-7b8d-4cf6-a42c-bd404a99f808" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense_d66e5aa1-d522-491a-8dec-c92ed879ebb5" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_IndemnificationReceivable_87622ce0-ce47-4c28-8dbe-5c5405c52027" xlink:href="cah-20210630.xsd#cah_IndemnificationReceivable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TaxCreditCarryforwardLineItems_b1583ecf-7b8d-4cf6-a42c-bd404a99f808" xlink:to="loc_cah_IndemnificationReceivable_87622ce0-ce47-4c28-8dbe-5c5405c52027" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCutsAndJobsActOf2017TransitionTaxForAccumulatedForeignEarningsIncomeTaxExpense_f669a408-fbfe-46a7-9747-5fdf6b39b573" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxCutsAndJobsActOf2017TransitionTaxForAccumulatedForeignEarningsIncomeTaxExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TaxCreditCarryforwardLineItems_b1583ecf-7b8d-4cf6-a42c-bd404a99f808" xlink:to="loc_us-gaap_TaxCutsAndJobsActOf2017TransitionTaxForAccumulatedForeignEarningsIncomeTaxExpense_f669a408-fbfe-46a7-9747-5fdf6b39b573" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReceivable_17c9829e-c1fd-4914-8b52-1295a5b904e0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReceivable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TaxCreditCarryforwardLineItems_b1583ecf-7b8d-4cf6-a42c-bd404a99f808" xlink:to="loc_us-gaap_IncomeTaxReceivable_17c9829e-c1fd-4914-8b52-1295a5b904e0" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAndOtherLiabilitiesNoncurrent_21c5b8c7-8d25-40aa-be71-482c0718f3ac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAndOtherLiabilitiesNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TaxCreditCarryforwardLineItems_b1583ecf-7b8d-4cf6-a42c-bd404a99f808" xlink:to="loc_us-gaap_DeferredTaxAndOtherLiabilitiesNoncurrent_21c5b8c7-8d25-40aa-be71-482c0718f3ac" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationSettlementExpense_727d27a5-49fe-4ff0-aabf-710c0b1cf26b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LitigationSettlementExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TaxCreditCarryforwardLineItems_b1583ecf-7b8d-4cf6-a42c-bd404a99f808" xlink:to="loc_us-gaap_LitigationSettlementExpense_727d27a5-49fe-4ff0-aabf-710c0b1cf26b" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardTable_b5b030a8-c344-440c-bee2-ba92ef8a76e9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxCreditCarryforwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_TaxCreditCarryforwardLineItems_b1583ecf-7b8d-4cf6-a42c-bd404a99f808" xlink:to="loc_us-gaap_TaxCreditCarryforwardTable_b5b030a8-c344-440c-bee2-ba92ef8a76e9" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_OpioidLitigationAxis_e560f399-be00-4e7f-9bae-428129de34de" xlink:href="cah-20210630.xsd#cah_OpioidLitigationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_TaxCreditCarryforwardTable_b5b030a8-c344-440c-bee2-ba92ef8a76e9" xlink:to="loc_cah_OpioidLitigationAxis_e560f399-be00-4e7f-9bae-428129de34de" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_OpioidLitigationDomain_e560f399-be00-4e7f-9bae-428129de34de_default" xlink:href="cah-20210630.xsd#cah_OpioidLitigationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_cah_OpioidLitigationAxis_e560f399-be00-4e7f-9bae-428129de34de" xlink:to="loc_cah_OpioidLitigationDomain_e560f399-be00-4e7f-9bae-428129de34de_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_OpioidLitigationDomain_71edd299-858a-4029-91e0-ec0406d63597" xlink:href="cah-20210630.xsd#cah_OpioidLitigationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_cah_OpioidLitigationAxis_e560f399-be00-4e7f-9bae-428129de34de" xlink:to="loc_cah_OpioidLitigationDomain_71edd299-858a-4029-91e0-ec0406d63597" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_TotalOpioidLitigationMember_755fb1cd-9831-4d60-baf7-a842889ecd4e" xlink:href="cah-20210630.xsd#cah_TotalOpioidLitigationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cah_OpioidLitigationDomain_71edd299-858a-4029-91e0-ec0406d63597" xlink:to="loc_cah_TotalOpioidLitigationMember_755fb1cd-9831-4d60-baf7-a842889ecd4e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_TaxMatterAxis_85493557-3441-4454-b875-23488762a434" xlink:href="cah-20210630.xsd#cah_TaxMatterAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_TaxCreditCarryforwardTable_b5b030a8-c344-440c-bee2-ba92ef8a76e9" xlink:to="loc_cah_TaxMatterAxis_85493557-3441-4454-b875-23488762a434" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_TaxMatterDomain_85493557-3441-4454-b875-23488762a434_default" xlink:href="cah-20210630.xsd#cah_TaxMatterDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_cah_TaxMatterAxis_85493557-3441-4454-b875-23488762a434" xlink:to="loc_cah_TaxMatterDomain_85493557-3441-4454-b875-23488762a434_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_TaxMatterDomain_dc5164e3-762e-469f-93ef-190e728548e2" xlink:href="cah-20210630.xsd#cah_TaxMatterDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_cah_TaxMatterAxis_85493557-3441-4454-b875-23488762a434" xlink:to="loc_cah_TaxMatterDomain_dc5164e3-762e-469f-93ef-190e728548e2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_PatientRecoveryBusinessMember_6562f0c2-dc0f-4ae0-87e6-2b69a5b2dff0" xlink:href="cah-20210630.xsd#cah_PatientRecoveryBusinessMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cah_TaxMatterDomain_dc5164e3-762e-469f-93ef-190e728548e2" xlink:to="loc_cah_PatientRecoveryBusinessMember_6562f0c2-dc0f-4ae0-87e6-2b69a5b2dff0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_CareFusionMember_1a3aeab4-aa0e-4eb3-b503-ef68f8e58113" xlink:href="cah-20210630.xsd#cah_CareFusionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cah_TaxMatterDomain_dc5164e3-762e-469f-93ef-190e728548e2" xlink:to="loc_cah_CareFusionMember_1a3aeab4-aa0e-4eb3-b503-ef68f8e58113" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_fd774e44-b7a1-4ca2-98e3-8a8df04b3238" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_TaxCreditCarryforwardTable_b5b030a8-c344-440c-bee2-ba92ef8a76e9" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_fd774e44-b7a1-4ca2-98e3-8a8df04b3238" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_fd774e44-b7a1-4ca2-98e3-8a8df04b3238_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_fd774e44-b7a1-4ca2-98e3-8a8df04b3238" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_fd774e44-b7a1-4ca2-98e3-8a8df04b3238_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_77fc70c7-c3eb-4a06-9b11-23a27d896b2f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_fd774e44-b7a1-4ca2-98e3-8a8df04b3238" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_77fc70c7-c3eb-4a06-9b11-23a27d896b2f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_PatientRecoveryBusinessMember_7b39cf9f-ccac-45a8-a8fc-cdd3843d0cee" xlink:href="cah-20210630.xsd#cah_PatientRecoveryBusinessMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_77fc70c7-c3eb-4a06-9b11-23a27d896b2f" xlink:to="loc_cah_PatientRecoveryBusinessMember_7b39cf9f-ccac-45a8-a8fc-cdd3843d0cee" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_9b4ce147-e47d-4bf9-b6eb-ba17fb7cc4c0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_TaxCreditCarryforwardTable_b5b030a8-c344-440c-bee2-ba92ef8a76e9" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_9b4ce147-e47d-4bf9-b6eb-ba17fb7cc4c0" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_9b4ce147-e47d-4bf9-b6eb-ba17fb7cc4c0_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_9b4ce147-e47d-4bf9-b6eb-ba17fb7cc4c0" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_9b4ce147-e47d-4bf9-b6eb-ba17fb7cc4c0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_fe0abe78-e586-4c44-94bb-721d4b84dadc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_9b4ce147-e47d-4bf9-b6eb-ba17fb7cc4c0" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_fe0abe78-e586-4c44-94bb-721d4b84dadc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis_d7a5cc01-f575-4cd8-8672-40939da7cda3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_TaxCreditCarryforwardTable_b5b030a8-c344-440c-bee2-ba92ef8a76e9" xlink:to="loc_us-gaap_IncomeTaxAuthorityAxis_d7a5cc01-f575-4cd8-8672-40939da7cda3" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_d7a5cc01-f575-4cd8-8672-40939da7cda3_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_d7a5cc01-f575-4cd8-8672-40939da7cda3" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_d7a5cc01-f575-4cd8-8672-40939da7cda3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_59eac478-c58d-4734-8c54-bb000bf11359" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_d7a5cc01-f575-4cd8-8672-40939da7cda3" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_59eac478-c58d-4734-8c54-bb000bf11359" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InternalRevenueServiceIRSMember_fad71ef7-ae72-44cc-9c96-f680cf125a25" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InternalRevenueServiceIRSMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_59eac478-c58d-4734-8c54-bb000bf11359" xlink:to="loc_us-gaap_InternalRevenueServiceIRSMember_fad71ef7-ae72-44cc-9c96-f680cf125a25" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StateAndLocalJurisdictionMember_96db8afc-3e73-4449-bfdd-5f84743c29f6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StateAndLocalJurisdictionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_59eac478-c58d-4734-8c54-bb000bf11359" xlink:to="loc_us-gaap_StateAndLocalJurisdictionMember_96db8afc-3e73-4449-bfdd-5f84743c29f6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCountryMember_1dd5cc04-7b34-4317-bbb9-1d5216370ad0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCountryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_59eac478-c58d-4734-8c54-bb000bf11359" xlink:to="loc_us-gaap_ForeignCountryMember_1dd5cc04-7b34-4317-bbb9-1d5216370ad0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_bedb3931-a233-4de3-8033-b19ba825ddfb" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_TaxCreditCarryforwardTable_b5b030a8-c344-440c-bee2-ba92ef8a76e9" xlink:to="loc_srt_RangeAxis_bedb3931-a233-4de3-8033-b19ba825ddfb" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_bedb3931-a233-4de3-8033-b19ba825ddfb_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_bedb3931-a233-4de3-8033-b19ba825ddfb" xlink:to="loc_srt_RangeMember_bedb3931-a233-4de3-8033-b19ba825ddfb_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_8c5c5bc3-709c-4e85-948e-88686411744e" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_bedb3931-a233-4de3-8033-b19ba825ddfb" xlink:to="loc_srt_RangeMember_8c5c5bc3-709c-4e85-948e-88686411744e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_23a1af59-9dbe-4c0b-a331-43eace29c39c" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_8c5c5bc3-709c-4e85-948e-88686411744e" xlink:to="loc_srt_MinimumMember_23a1af59-9dbe-4c0b-a331-43eace29c39c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_d0070404-6172-4ea7-8034-cba438338a97" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_8c5c5bc3-709c-4e85-948e-88686411744e" xlink:to="loc_srt_MaximumMember_d0070404-6172-4ea7-8034-cba438338a97" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_NetOperatingLossCarrybackAxis_3a6b6bb6-03c0-48d5-a4bf-b3455fab26c5" xlink:href="cah-20210630.xsd#cah_NetOperatingLossCarrybackAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_TaxCreditCarryforwardTable_b5b030a8-c344-440c-bee2-ba92ef8a76e9" xlink:to="loc_cah_NetOperatingLossCarrybackAxis_3a6b6bb6-03c0-48d5-a4bf-b3455fab26c5" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_NetOperatingLossCarrybackDomain_3a6b6bb6-03c0-48d5-a4bf-b3455fab26c5_default" xlink:href="cah-20210630.xsd#cah_NetOperatingLossCarrybackDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_cah_NetOperatingLossCarrybackAxis_3a6b6bb6-03c0-48d5-a4bf-b3455fab26c5" xlink:to="loc_cah_NetOperatingLossCarrybackDomain_3a6b6bb6-03c0-48d5-a4bf-b3455fab26c5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_NetOperatingLossCarrybackDomain_a84ee9a4-242c-4c78-82f5-064253a1b214" xlink:href="cah-20210630.xsd#cah_NetOperatingLossCarrybackDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_cah_NetOperatingLossCarrybackAxis_3a6b6bb6-03c0-48d5-a4bf-b3455fab26c5" xlink:to="loc_cah_NetOperatingLossCarrybackDomain_a84ee9a4-242c-4c78-82f5-064253a1b214" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_NetOperatingLossCarrybackMember_da317081-43e6-4667-ae6e-919baa064b0f" xlink:href="cah-20210630.xsd#cah_NetOperatingLossCarrybackMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cah_NetOperatingLossCarrybackDomain_a84ee9a4-242c-4c78-82f5-064253a1b214" xlink:to="loc_cah_NetOperatingLossCarrybackMember_da317081-43e6-4667-ae6e-919baa064b0f" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/IncomeTaxesScheduleofUnrecognizedTaxBenefitsRollForwardDetails" xlink:type="simple" xlink:href="cah-20210630.xsd#IncomeTaxesScheduleofUnrecognizedTaxBenefitsRollForwardDetails"/>
  <link:definitionLink xlink:role="http://www.cardinal.com/role/IncomeTaxesScheduleofUnrecognizedTaxBenefitsRollForwardDetails" xlink:type="extended" id="i3aa2fec4dcf64d31912266fa935bca07_IncomeTaxesScheduleofUnrecognizedTaxBenefitsRollForwardDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxContingencyLineItems_02be7ca0-e1b4-46d8-86d9-71bf524a7217" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxContingencyLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentFederalTaxExpenseBenefit_87a80115-6210-474c-a63b-368a4d89a728" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentFederalTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_02be7ca0-e1b4-46d8-86d9-71bf524a7217" xlink:to="loc_us-gaap_CurrentFederalTaxExpenseBenefit_87a80115-6210-474c-a63b-368a4d89a728" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_30fb23bc-47a7-42d0-9ff2-f305a4cf1855" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_02be7ca0-e1b4-46d8-86d9-71bf524a7217" xlink:to="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_30fb23bc-47a7-42d0-9ff2-f305a4cf1855" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentForeignTaxExpenseBenefit_f3d13069-bd49-48e4-947c-20188ec986b0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentForeignTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_02be7ca0-e1b4-46d8-86d9-71bf524a7217" xlink:to="loc_us-gaap_CurrentForeignTaxExpenseBenefit_f3d13069-bd49-48e4-947c-20188ec986b0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_014c4f97-aa15-4871-bc5a-980c7112933b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_02be7ca0-e1b4-46d8-86d9-71bf524a7217" xlink:to="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_014c4f97-aa15-4871-bc5a-980c7112933b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_a0f4ae8b-6291-4f72-baf3-eb03881fecb7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_02be7ca0-e1b4-46d8-86d9-71bf524a7217" xlink:to="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_a0f4ae8b-6291-4f72-baf3-eb03881fecb7" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_2703ca1f-4792-4a10-9119-fa91a8d5ceb8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_02be7ca0-e1b4-46d8-86d9-71bf524a7217" xlink:to="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_2703ca1f-4792-4a10-9119-fa91a8d5ceb8" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_ba5f860a-f844-491d-af3b-c2073b1f5369" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredForeignIncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_02be7ca0-e1b4-46d8-86d9-71bf524a7217" xlink:to="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_ba5f860a-f844-491d-af3b-c2073b1f5369" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_dd0e7d1a-dd80-425f-803d-3f91402afbab" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_02be7ca0-e1b4-46d8-86d9-71bf524a7217" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_dd0e7d1a-dd80-425f-803d-3f91402afbab" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_e5303228-ad66-43a5-b631-5dd5c5e733f7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_02be7ca0-e1b4-46d8-86d9-71bf524a7217" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_e5303228-ad66-43a5-b631-5dd5c5e733f7" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_528c83f5-a735-41b5-817f-aef604a1f293" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_02be7ca0-e1b4-46d8-86d9-71bf524a7217" xlink:to="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_528c83f5-a735-41b5-817f-aef604a1f293" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_1fe69abd-b88f-407e-ae78-97bd3bff4a99" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_528c83f5-a735-41b5-817f-aef604a1f293" xlink:to="loc_us-gaap_UnrecognizedTaxBenefits_1fe69abd-b88f-407e-ae78-97bd3bff4a99" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_f1fee133-9034-4885-9c7a-4f03453c0dbb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_528c83f5-a735-41b5-817f-aef604a1f293" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_f1fee133-9034-4885-9c7a-4f03453c0dbb" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_e197b81e-c12b-49d3-a6f1-a75fb68fe2d9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_528c83f5-a735-41b5-817f-aef604a1f293" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_e197b81e-c12b-49d3-a6f1-a75fb68fe2d9" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions_1be48ee2-fa08-4685-9f2e-bba53be3466e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_528c83f5-a735-41b5-817f-aef604a1f293" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions_1be48ee2-fa08-4685-9f2e-bba53be3466e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities_4beb6cff-1ef3-4152-a2b2-e3fe6dfca66a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_528c83f5-a735-41b5-817f-aef604a1f293" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities_4beb6cff-1ef3-4152-a2b2-e3fe6dfca66a" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_a06fb1f8-0800-4f6e-a01f-f4e27aae34dc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_528c83f5-a735-41b5-817f-aef604a1f293" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_a06fb1f8-0800-4f6e-a01f-f4e27aae34dc" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_4927f000-156b-4dcb-96b1-62f78e0428b7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxContingencyTable_ce0c52a1-b5ab-41db-9ff2-5a864e4f9c98" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxContingencyTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_02be7ca0-e1b4-46d8-86d9-71bf524a7217" xlink:to="loc_us-gaap_IncomeTaxContingencyTable_ce0c52a1-b5ab-41db-9ff2-5a864e4f9c98" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_4dd6c8ad-114f-40fb-b319-b42850464d52" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_ce0c52a1-b5ab-41db-9ff2-5a864e4f9c98" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_4dd6c8ad-114f-40fb-b319-b42850464d52" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_4dd6c8ad-114f-40fb-b319-b42850464d52_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_4dd6c8ad-114f-40fb-b319-b42850464d52" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_4dd6c8ad-114f-40fb-b319-b42850464d52_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_4bec96da-2c47-40b1-ad00-7aa9b42cbecf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_4dd6c8ad-114f-40fb-b319-b42850464d52" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_4bec96da-2c47-40b1-ad00-7aa9b42cbecf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_PatientRecoveryBusinessMember_f20a6cb5-cc57-49bc-a155-434f84ac5795" xlink:href="cah-20210630.xsd#cah_PatientRecoveryBusinessMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_4bec96da-2c47-40b1-ad00-7aa9b42cbecf" xlink:to="loc_cah_PatientRecoveryBusinessMember_f20a6cb5-cc57-49bc-a155-434f84ac5795" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameAxis_b25551af-84f5-4a7a-898f-e1d4600e6cba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_ce0c52a1-b5ab-41db-9ff2-5a864e4f9c98" xlink:to="loc_us-gaap_IncomeTaxAuthorityNameAxis_b25551af-84f5-4a7a-898f-e1d4600e6cba" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameDomain_b25551af-84f5-4a7a-898f-e1d4600e6cba_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameAxis_b25551af-84f5-4a7a-898f-e1d4600e6cba" xlink:to="loc_us-gaap_IncomeTaxAuthorityNameDomain_b25551af-84f5-4a7a-898f-e1d4600e6cba_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameDomain_3da8db90-6766-4f62-925a-99d86b7cb52b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameAxis_b25551af-84f5-4a7a-898f-e1d4600e6cba" xlink:to="loc_us-gaap_IncomeTaxAuthorityNameDomain_3da8db90-6766-4f62-925a-99d86b7cb52b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxPeriodAxis_2d10f6a0-af1d-4057-bf14-a07af83613b7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxPeriodAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_ce0c52a1-b5ab-41db-9ff2-5a864e4f9c98" xlink:to="loc_us-gaap_TaxPeriodAxis_2d10f6a0-af1d-4057-bf14-a07af83613b7" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxPeriodDomain_2d10f6a0-af1d-4057-bf14-a07af83613b7_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxPeriodDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_TaxPeriodAxis_2d10f6a0-af1d-4057-bf14-a07af83613b7" xlink:to="loc_us-gaap_TaxPeriodDomain_2d10f6a0-af1d-4057-bf14-a07af83613b7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxPeriodDomain_30bdc83d-b8c2-4d61-b329-b31bf3193030" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxPeriodDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_TaxPeriodAxis_2d10f6a0-af1d-4057-bf14-a07af83613b7" xlink:to="loc_us-gaap_TaxPeriodDomain_30bdc83d-b8c2-4d61-b329-b31bf3193030" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/FairValueMeasurementsFairValueofAssetsandLiabilitiesMeasuredonaRecurringBasisDetails" xlink:type="simple" xlink:href="cah-20210630.xsd#FairValueMeasurementsFairValueofAssetsandLiabilitiesMeasuredonaRecurringBasisDetails"/>
  <link:definitionLink xlink:role="http://www.cardinal.com/role/FairValueMeasurementsFairValueofAssetsandLiabilitiesMeasuredonaRecurringBasisDetails" xlink:type="extended" id="i6f215406c5094a2984d2c433195cd449_FairValueMeasurementsFairValueofAssetsandLiabilitiesMeasuredonaRecurringBasisDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_d847ef17-e8ca-4600-8734-2f495b42b55a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosureAbstract_c5ad94ea-59c2-48a0-b711-8922e91f68f5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsFairValueDisclosureAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_d847ef17-e8ca-4600-8734-2f495b42b55a" xlink:to="loc_us-gaap_AssetsFairValueDisclosureAbstract_c5ad94ea-59c2-48a0-b711-8922e91f68f5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_91228a03-a7ad-4250-afdf-3173b4a10d3d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_c5ad94ea-59c2-48a0-b711-8922e91f68f5" xlink:to="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_91228a03-a7ad-4250-afdf-3173b4a10d3d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsFairValueDisclosure_3e784d17-fde1-4a32-915d-979aae025243" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_c5ad94ea-59c2-48a0-b711-8922e91f68f5" xlink:to="loc_us-gaap_InvestmentsFairValueDisclosure_3e784d17-fde1-4a32-915d-979aae025243" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_f2020a2a-ec4e-4066-accd-f07d9ae629f8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesFairValueDisclosureAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_d847ef17-e8ca-4600-8734-2f495b42b55a" xlink:to="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_f2020a2a-ec4e-4066-accd-f07d9ae629f8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet_5f20a7a5-3fb5-466e-a51c-03f0b516f6db" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_f2020a2a-ec4e-4066-accd-f07d9ae629f8" xlink:to="loc_us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet_5f20a7a5-3fb5-466e-a51c-03f0b516f6db" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_76366918-6ef1-4369-a9dd-7869119b174c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_d847ef17-e8ca-4600-8734-2f495b42b55a" xlink:to="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_76366918-6ef1-4369-a9dd-7869119b174c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_fae029c8-9545-4b3b-9267-63a4e7fa9fb2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_d847ef17-e8ca-4600-8734-2f495b42b55a" xlink:to="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_fae029c8-9545-4b3b-9267-63a4e7fa9fb2" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_d008e87f-8631-4b8b-bbf9-9bdd0d87bf48" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_d847ef17-e8ca-4600-8734-2f495b42b55a" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_d008e87f-8631-4b8b-bbf9-9bdd0d87bf48" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_6b3731b9-d4fc-4230-b009-69500a30fc08" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_d008e87f-8631-4b8b-bbf9-9bdd0d87bf48" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_6b3731b9-d4fc-4230-b009-69500a30fc08" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_6b3731b9-d4fc-4230-b009-69500a30fc08_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_6b3731b9-d4fc-4230-b009-69500a30fc08" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_6b3731b9-d4fc-4230-b009-69500a30fc08_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_2e77fd68-42c6-40ce-bb90-b89aee1a0b62" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_6b3731b9-d4fc-4230-b009-69500a30fc08" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_2e77fd68-42c6-40ce-bb90-b89aee1a0b62" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_8057fb21-583a-4de9-998d-7d01d8999138" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_2e77fd68-42c6-40ce-bb90-b89aee1a0b62" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_8057fb21-583a-4de9-998d-7d01d8999138" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsNonrecurringMember_274b9002-f440-4025-97de-c2e2ef02b6f0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsNonrecurringMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_2e77fd68-42c6-40ce-bb90-b89aee1a0b62" xlink:to="loc_us-gaap_FairValueMeasurementsNonrecurringMember_274b9002-f440-4025-97de-c2e2ef02b6f0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_31b3c2d9-1c7b-4ad2-a78a-1357e0d3eaf3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_d008e87f-8631-4b8b-bbf9-9bdd0d87bf48" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_31b3c2d9-1c7b-4ad2-a78a-1357e0d3eaf3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_31b3c2d9-1c7b-4ad2-a78a-1357e0d3eaf3_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_31b3c2d9-1c7b-4ad2-a78a-1357e0d3eaf3" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_31b3c2d9-1c7b-4ad2-a78a-1357e0d3eaf3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_2f6794fe-aa73-49eb-af1e-7c903b064714" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_31b3c2d9-1c7b-4ad2-a78a-1357e0d3eaf3" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_2f6794fe-aa73-49eb-af1e-7c903b064714" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_c57e8536-ea55-47ae-aaef-8b15fbb6bb1d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_2f6794fe-aa73-49eb-af1e-7c903b064714" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_c57e8536-ea55-47ae-aaef-8b15fbb6bb1d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_7630f0d5-e7d4-42f1-a0ba-d729bdd01a5c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_2f6794fe-aa73-49eb-af1e-7c903b064714" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_7630f0d5-e7d4-42f1-a0ba-d729bdd01a5c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_13bc6e2b-4011-4b3e-8bda-aca3c8ee8ecf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_2f6794fe-aa73-49eb-af1e-7c903b064714" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_13bc6e2b-4011-4b3e-8bda-aca3c8ee8ecf" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/FairValueMeasurementsReconciliationofLiabilitiesMeasuredatFairValueonaRecurringBasisUsingUnobservableInputsLevel3Details" xlink:type="simple" xlink:href="cah-20210630.xsd#FairValueMeasurementsReconciliationofLiabilitiesMeasuredatFairValueonaRecurringBasisUsingUnobservableInputsLevel3Details"/>
  <link:definitionLink xlink:role="http://www.cardinal.com/role/FairValueMeasurementsReconciliationofLiabilitiesMeasuredatFairValueonaRecurringBasisUsingUnobservableInputsLevel3Details" xlink:type="extended" id="i61f797245ccc424b87b2543e5989b3bc_FairValueMeasurementsReconciliationofLiabilitiesMeasuredatFairValueonaRecurringBasisUsingUnobservableInputsLevel3Details">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_01b6500c-fd44-4270-b63d-40ea08d67639" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet_ec0b8a71-c4f6-47c1-8dcb-4c0a129a9736" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_01b6500c-fd44-4270-b63d-40ea08d67639" xlink:to="loc_us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet_ec0b8a71-c4f6-47c1-8dcb-4c0a129a9736" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_3dc25161-1093-41c7-81fa-b945f36fee11" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_01b6500c-fd44-4270-b63d-40ea08d67639" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_3dc25161-1093-41c7-81fa-b945f36fee11" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable_4b68c539-a8ba-4b48-955c-23ea90915ef1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_01b6500c-fd44-4270-b63d-40ea08d67639" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable_4b68c539-a8ba-4b48-955c-23ea90915ef1" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_a45999a2-06c2-4174-92c9-176d64972d1c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable_4b68c539-a8ba-4b48-955c-23ea90915ef1" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_a45999a2-06c2-4174-92c9-176d64972d1c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_a45999a2-06c2-4174-92c9-176d64972d1c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_a45999a2-06c2-4174-92c9-176d64972d1c" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_a45999a2-06c2-4174-92c9-176d64972d1c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_00962f6a-147b-4502-bbc8-ecfc099f2024" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_a45999a2-06c2-4174-92c9-176d64972d1c" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_00962f6a-147b-4502-bbc8-ecfc099f2024" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_774bde54-af0b-4744-8f6b-722b6363b0d1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_00962f6a-147b-4502-bbc8-ecfc099f2024" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_774bde54-af0b-4744-8f6b-722b6363b0d1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_93c96261-b5f4-4120-b0cc-113cd7dedfef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_00962f6a-147b-4502-bbc8-ecfc099f2024" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_93c96261-b5f4-4120-b0cc-113cd7dedfef" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_da06165d-077c-4ae4-86db-1812482093c8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_00962f6a-147b-4502-bbc8-ecfc099f2024" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_da06165d-077c-4ae4-86db-1812482093c8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_7708d09e-153c-450a-8fe3-b6888643779e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable_4b68c539-a8ba-4b48-955c-23ea90915ef1" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_7708d09e-153c-450a-8fe3-b6888643779e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_7708d09e-153c-450a-8fe3-b6888643779e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_7708d09e-153c-450a-8fe3-b6888643779e" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_7708d09e-153c-450a-8fe3-b6888643779e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_f971eee2-9088-4243-a0cf-15e7ceb88ed1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_7708d09e-153c-450a-8fe3-b6888643779e" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_f971eee2-9088-4243-a0cf-15e7ceb88ed1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_c752c739-fc1c-445f-83d3-07b3044971a3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_f971eee2-9088-4243-a0cf-15e7ceb88ed1" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_c752c739-fc1c-445f-83d3-07b3044971a3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByLiabilityClassAxis_18345d2a-cd7d-47a2-b7f0-59ac8ce09ada" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByLiabilityClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable_4b68c539-a8ba-4b48-955c-23ea90915ef1" xlink:to="loc_us-gaap_FairValueByLiabilityClassAxis_18345d2a-cd7d-47a2-b7f0-59ac8ce09ada" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_18345d2a-cd7d-47a2-b7f0-59ac8ce09ada_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis_18345d2a-cd7d-47a2-b7f0-59ac8ce09ada" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_18345d2a-cd7d-47a2-b7f0-59ac8ce09ada_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_8cfbad76-2211-4380-9c54-3657752d622e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis_18345d2a-cd7d-47a2-b7f0-59ac8ce09ada" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_8cfbad76-2211-4380-9c54-3657752d622e" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/FinancialInstrumentsTables" xlink:type="simple" xlink:href="cah-20210630.xsd#FinancialInstrumentsTables"/>
  <link:definitionLink xlink:role="http://www.cardinal.com/role/FinancialInstrumentsTables" xlink:type="extended" id="i21a0a3eec66442e7a2bc67cdfc274af1_FinancialInstrumentsTables">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_5d56f25f-287c-4528-bdc7-e274612de99a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock_c1e42b4f-5de3-4ab9-9337-3e73b8366490" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDerivativeInstrumentsTextBlock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_5d56f25f-287c-4528-bdc7-e274612de99a" xlink:to="loc_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock_c1e42b4f-5de3-4ab9-9337-3e73b8366490" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_955c1dad-1919-4050-826b-22fecaf954a3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeLineItems_5d56f25f-287c-4528-bdc7-e274612de99a" xlink:to="loc_us-gaap_DerivativeTable_955c1dad-1919-4050-826b-22fecaf954a3" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_f5c187b2-fff3-4591-951e-bbc20788a464" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_955c1dad-1919-4050-826b-22fecaf954a3" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_f5c187b2-fff3-4591-951e-bbc20788a464" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_f5c187b2-fff3-4591-951e-bbc20788a464_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_f5c187b2-fff3-4591-951e-bbc20788a464" xlink:to="loc_us-gaap_HedgingRelationshipDomain_f5c187b2-fff3-4591-951e-bbc20788a464_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_19ad2354-15e6-488b-9538-952650c4fb3c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_f5c187b2-fff3-4591-951e-bbc20788a464" xlink:to="loc_us-gaap_HedgingRelationshipDomain_19ad2354-15e6-488b-9538-952650c4fb3c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueHedgingMember_0af3b82d-b8da-45fc-9830-bdc2141a7dcf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_19ad2354-15e6-488b-9538-952650c4fb3c" xlink:to="loc_us-gaap_FairValueHedgingMember_0af3b82d-b8da-45fc-9830-bdc2141a7dcf" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember_2014ef6a-12ef-4f32-b4e4-180a87555751" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_19ad2354-15e6-488b-9538-952650c4fb3c" xlink:to="loc_us-gaap_CashFlowHedgingMember_2014ef6a-12ef-4f32-b4e4-180a87555751" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_7e0bf192-7213-42a9-95ce-ce0f599177f0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_955c1dad-1919-4050-826b-22fecaf954a3" xlink:to="loc_us-gaap_HedgingDesignationAxis_7e0bf192-7213-42a9-95ce-ce0f599177f0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_7e0bf192-7213-42a9-95ce-ce0f599177f0_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_HedgingDesignationAxis_7e0bf192-7213-42a9-95ce-ce0f599177f0" xlink:to="loc_us-gaap_HedgingDesignationDomain_7e0bf192-7213-42a9-95ce-ce0f599177f0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_1e489ecc-5809-4ab1-bbd8-97c43e77beb6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_HedgingDesignationAxis_7e0bf192-7213-42a9-95ce-ce0f599177f0" xlink:to="loc_us-gaap_HedgingDesignationDomain_1e489ecc-5809-4ab1-bbd8-97c43e77beb6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember_6c28fb31-2b17-4a55-9ec9-b53bed72e02d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NondesignatedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_1e489ecc-5809-4ab1-bbd8-97c43e77beb6" xlink:to="loc_us-gaap_NondesignatedMember_6c28fb31-2b17-4a55-9ec9-b53bed72e02d" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/FinancialInstrumentsScheduleoftheFairValueofAssetsandLiabilitiesRelatedtoDerivativesDesignatedasHedgingInstrumentsDetails" xlink:type="simple" xlink:href="cah-20210630.xsd#FinancialInstrumentsScheduleoftheFairValueofAssetsandLiabilitiesRelatedtoDerivativesDesignatedasHedgingInstrumentsDetails"/>
  <link:definitionLink xlink:role="http://www.cardinal.com/role/FinancialInstrumentsScheduleoftheFairValueofAssetsandLiabilitiesRelatedtoDerivativesDesignatedasHedgingInstrumentsDetails" xlink:type="extended" id="i488021681fb54c4e85a9ec84755edf95_FinancialInstrumentsScheduleoftheFairValueofAssetsandLiabilitiesRelatedtoDerivativesDesignatedasHedgingInstrumentsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesFairValueLineItems_aea0826b-9e59-40eb-b1df-073e18551a74" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativesFairValueLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_ae220fd7-af47-41ef-ad03-afb5390b3956" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeAsset"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_aea0826b-9e59-40eb-b1df-073e18551a74" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_ae220fd7-af47-41ef-ad03-afb5390b3956" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_4eee14fa-419a-4ae3-8d06-7ce6acdd2ec7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_aea0826b-9e59-40eb-b1df-073e18551a74" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_4eee14fa-419a-4ae3-8d06-7ce6acdd2ec7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_9f1a6f67-0163-47a4-b92b-c2969ea8796c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_aea0826b-9e59-40eb-b1df-073e18551a74" xlink:to="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_9f1a6f67-0163-47a4-b92b-c2969ea8796c" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_a339663b-1861-4b39-af7d-3b1751095d28" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_9f1a6f67-0163-47a4-b92b-c2969ea8796c" xlink:to="loc_us-gaap_HedgingDesignationAxis_a339663b-1861-4b39-af7d-3b1751095d28" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_a339663b-1861-4b39-af7d-3b1751095d28_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_HedgingDesignationAxis_a339663b-1861-4b39-af7d-3b1751095d28" xlink:to="loc_us-gaap_HedgingDesignationDomain_a339663b-1861-4b39-af7d-3b1751095d28_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_ea8d3c9f-fff1-4076-84c6-e08301f6bb65" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_HedgingDesignationAxis_a339663b-1861-4b39-af7d-3b1751095d28" xlink:to="loc_us-gaap_HedgingDesignationDomain_ea8d3c9f-fff1-4076-84c6-e08301f6bb65" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_5079e261-2317-4175-89e5-11621a0d9f12" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_ea8d3c9f-fff1-4076-84c6-e08301f6bb65" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_5079e261-2317-4175-89e5-11621a0d9f12" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_73184009-f385-49a7-8656-090b25574a9f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_9f1a6f67-0163-47a4-b92b-c2969ea8796c" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_73184009-f385-49a7-8656-090b25574a9f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_73184009-f385-49a7-8656-090b25574a9f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_73184009-f385-49a7-8656-090b25574a9f" xlink:to="loc_us-gaap_HedgingRelationshipDomain_73184009-f385-49a7-8656-090b25574a9f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_a872fc17-9179-4405-94af-7b585d608d92" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_73184009-f385-49a7-8656-090b25574a9f" xlink:to="loc_us-gaap_HedgingRelationshipDomain_a872fc17-9179-4405-94af-7b585d608d92" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember_d83e3fba-27db-4439-9548-8d95c9fb904a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_a872fc17-9179-4405-94af-7b585d608d92" xlink:to="loc_us-gaap_CashFlowHedgingMember_d83e3fba-27db-4439-9548-8d95c9fb904a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueHedgingMember_0a9084b9-6f20-453e-8d4c-d7eb1e4da1b0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_a872fc17-9179-4405-94af-7b585d608d92" xlink:to="loc_us-gaap_FairValueHedgingMember_0a9084b9-6f20-453e-8d4c-d7eb1e4da1b0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_e42fd855-1917-4039-a758-6abca00749ab" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_9f1a6f67-0163-47a4-b92b-c2969ea8796c" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_e42fd855-1917-4039-a758-6abca00749ab" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_e42fd855-1917-4039-a758-6abca00749ab_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_e42fd855-1917-4039-a758-6abca00749ab" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_e42fd855-1917-4039-a758-6abca00749ab_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_1a9b541d-56b1-45f8-8f5e-ea51522fb153" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_e42fd855-1917-4039-a758-6abca00749ab" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_1a9b541d-56b1-45f8-8f5e-ea51522fb153" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_73554753-e8ef-4017-b29e-8d9b94b9284b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_1a9b541d-56b1-45f8-8f5e-ea51522fb153" xlink:to="loc_us-gaap_ForeignExchangeContractMember_73554753-e8ef-4017-b29e-8d9b94b9284b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_eccffb22-1f9d-4cd9-ab72-42971ac4d278" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_1a9b541d-56b1-45f8-8f5e-ea51522fb153" xlink:to="loc_us-gaap_InterestRateSwapMember_eccffb22-1f9d-4cd9-ab72-42971ac4d278" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CrossCurrencyInterestRateContractMember_6c935a04-4340-4573-824a-4b005d874639" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CrossCurrencyInterestRateContractMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_1a9b541d-56b1-45f8-8f5e-ea51522fb153" xlink:to="loc_us-gaap_CrossCurrencyInterestRateContractMember_6c935a04-4340-4573-824a-4b005d874639" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommodityContractMember_340580c8-d1bb-41e6-a3cc-1029b9636e8c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommodityContractMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_1a9b541d-56b1-45f8-8f5e-ea51522fb153" xlink:to="loc_us-gaap_CommodityContractMember_340580c8-d1bb-41e6-a3cc-1029b9636e8c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_0006d5ef-4ff3-4144-929b-598e98b11688" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_9f1a6f67-0163-47a4-b92b-c2969ea8796c" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_0006d5ef-4ff3-4144-929b-598e98b11688" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_0006d5ef-4ff3-4144-929b-598e98b11688_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_0006d5ef-4ff3-4144-929b-598e98b11688" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_0006d5ef-4ff3-4144-929b-598e98b11688_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_b0ae157a-0429-41d9-bdfa-c4eefa82fd29" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_0006d5ef-4ff3-4144-929b-598e98b11688" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_b0ae157a-0429-41d9-bdfa-c4eefa82fd29" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsMember_8ecec568-7c45-44ca-8e80-7b4cd2278c5b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_b0ae157a-0429-41d9-bdfa-c4eefa82fd29" xlink:to="loc_us-gaap_OtherAssetsMember_8ecec568-7c45-44ca-8e80-7b4cd2278c5b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_302ae657-a36f-4bef-bef5-04a0d91260da" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_b0ae157a-0429-41d9-bdfa-c4eefa82fd29" xlink:to="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_302ae657-a36f-4bef-bef5-04a0d91260da" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesMember_ca1efbae-d821-43f3-9770-0350c115615e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_b0ae157a-0429-41d9-bdfa-c4eefa82fd29" xlink:to="loc_us-gaap_AccruedLiabilitiesMember_ca1efbae-d821-43f3-9770-0350c115615e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_DeferredIncomeTaxesandOtherLiabilitiesMember_ed619703-a3ba-4ac3-9a46-64980559c7a2" xlink:href="cah-20210630.xsd#cah_DeferredIncomeTaxesandOtherLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_b0ae157a-0429-41d9-bdfa-c4eefa82fd29" xlink:to="loc_cah_DeferredIncomeTaxesandOtherLiabilitiesMember_ed619703-a3ba-4ac3-9a46-64980559c7a2" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/FinancialInstrumentsNarrativeDetails" xlink:type="simple" xlink:href="cah-20210630.xsd#FinancialInstrumentsNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.cardinal.com/role/FinancialInstrumentsNarrativeDetails" xlink:type="extended" id="i73f7fab43c2947c096478891c7402786_FinancialInstrumentsNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_bde7356e-3f7b-470a-957a-d2fffe49fbe9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1_d1efebac-d240-46fb-81a9-70a6c0d3c1a9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_bde7356e-3f7b-470a-957a-d2fffe49fbe9" xlink:to="loc_us-gaap_ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1_d1efebac-d240-46fb-81a9-70a6c0d3c1a9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilityNotionalAmount_e5f930fe-e630-4c9d-a485-a6081b2438ae" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLiabilityNotionalAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_bde7356e-3f7b-470a-957a-d2fffe49fbe9" xlink:to="loc_us-gaap_DerivativeLiabilityNotionalAmount_e5f930fe-e630-4c9d-a485-a6081b2438ae" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax_c9c77029-9b1b-4f1a-8c8b-f86b4c62559d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_bde7356e-3f7b-470a-957a-d2fffe49fbe9" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax_c9c77029-9b1b-4f1a-8c8b-f86b4c62559d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeExpenseNonoperatingNet_efb87c09-be11-49b2-a52f-b92908d0c77a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestIncomeExpenseNonoperatingNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_bde7356e-3f7b-470a-957a-d2fffe49fbe9" xlink:to="loc_us-gaap_InterestIncomeExpenseNonoperatingNet_efb87c09-be11-49b2-a52f-b92908d0c77a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetNotionalAmount_80ff20d4-393c-436f-9cf4-8aa3d7e22825" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeAssetNotionalAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_bde7356e-3f7b-470a-957a-d2fffe49fbe9" xlink:to="loc_us-gaap_DerivativeAssetNotionalAmount_80ff20d4-393c-436f-9cf4-8aa3d7e22825" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_DerivativesHedgeDiscontinuancesHedgingInstrumentMaturedAmount_139775b2-7fa0-45d6-b0a7-54190fcf8d9b" xlink:href="cah-20210630.xsd#cah_DerivativesHedgeDiscontinuancesHedgingInstrumentMaturedAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_bde7356e-3f7b-470a-957a-d2fffe49fbe9" xlink:to="loc_cah_DerivativesHedgeDiscontinuancesHedgingInstrumentMaturedAmount_139775b2-7fa0-45d6-b0a7-54190fcf8d9b" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_VestingPeriodinyearsforShares_72e2d4e1-2654-455c-8434-c67c76130aa3" xlink:href="cah-20210630.xsd#cah_VestingPeriodinyearsforShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_bde7356e-3f7b-470a-957a-d2fffe49fbe9" xlink:to="loc_cah_VestingPeriodinyearsforShares_72e2d4e1-2654-455c-8434-c67c76130aa3" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_DerivatesHedgeDiscontinuancesHedgingInstrumentTerminatedAmount_af74e253-8419-4e5b-a2de-1f7c3017d0d5" xlink:href="cah-20210630.xsd#cah_DerivatesHedgeDiscontinuancesHedgingInstrumentTerminatedAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_bde7356e-3f7b-470a-957a-d2fffe49fbe9" xlink:to="loc_cah_DerivatesHedgeDiscontinuancesHedgingInstrumentTerminatedAmount_af74e253-8419-4e5b-a2de-1f7c3017d0d5" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredGainLossOnDiscontinuationOfInterestRateFairValueHedge_05e36141-57ce-4284-8527-d1863b11c24a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredGainLossOnDiscontinuationOfInterestRateFairValueHedge"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_bde7356e-3f7b-470a-957a-d2fffe49fbe9" xlink:to="loc_us-gaap_DeferredGainLossOnDiscontinuationOfInterestRateFairValueHedge_05e36141-57ce-4284-8527-d1863b11c24a" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_DerivativesHedgeDiscontinuancesTerminationofHedgingInstrumentAmount_0cc0a3e6-27b0-4c61-9f0c-c11ea77a2830" xlink:href="cah-20210630.xsd#cah_DerivativesHedgeDiscontinuancesTerminationofHedgingInstrumentAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_bde7356e-3f7b-470a-957a-d2fffe49fbe9" xlink:to="loc_cah_DerivativesHedgeDiscontinuancesTerminationofHedgingInstrumentAmount_0cc0a3e6-27b0-4c61-9f0c-c11ea77a2830" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_d7a61cdb-2d25-42db-9fb3-ca3291405482" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeLineItems_bde7356e-3f7b-470a-957a-d2fffe49fbe9" xlink:to="loc_us-gaap_DerivativeTable_d7a61cdb-2d25-42db-9fb3-ca3291405482" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_1d81af91-ad48-47cb-9570-6e01d76c0508" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_d7a61cdb-2d25-42db-9fb3-ca3291405482" xlink:to="loc_us-gaap_HedgingDesignationAxis_1d81af91-ad48-47cb-9570-6e01d76c0508" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_1d81af91-ad48-47cb-9570-6e01d76c0508_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_HedgingDesignationAxis_1d81af91-ad48-47cb-9570-6e01d76c0508" xlink:to="loc_us-gaap_HedgingDesignationDomain_1d81af91-ad48-47cb-9570-6e01d76c0508_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_9ba0621b-a12a-47d8-8ffa-8189d5ab49ee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_HedgingDesignationAxis_1d81af91-ad48-47cb-9570-6e01d76c0508" xlink:to="loc_us-gaap_HedgingDesignationDomain_9ba0621b-a12a-47d8-8ffa-8189d5ab49ee" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_9e4b2528-5fda-4124-bbb3-55e2c278c3ca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_9ba0621b-a12a-47d8-8ffa-8189d5ab49ee" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_9e4b2528-5fda-4124-bbb3-55e2c278c3ca" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_a9306abc-60c1-4b1d-8bd8-5264c7fea278" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_d7a61cdb-2d25-42db-9fb3-ca3291405482" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_a9306abc-60c1-4b1d-8bd8-5264c7fea278" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_a9306abc-60c1-4b1d-8bd8-5264c7fea278_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_a9306abc-60c1-4b1d-8bd8-5264c7fea278" xlink:to="loc_us-gaap_HedgingRelationshipDomain_a9306abc-60c1-4b1d-8bd8-5264c7fea278_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_b52a140b-cdd1-4d41-bc6c-594e858db462" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_a9306abc-60c1-4b1d-8bd8-5264c7fea278" xlink:to="loc_us-gaap_HedgingRelationshipDomain_b52a140b-cdd1-4d41-bc6c-594e858db462" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueHedgingMember_c4048fbd-6eb7-46da-99c7-05af4eab7878" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_b52a140b-cdd1-4d41-bc6c-594e858db462" xlink:to="loc_us-gaap_FairValueHedgingMember_c4048fbd-6eb7-46da-99c7-05af4eab7878" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember_45d4fdb4-f0d3-443b-977c-6895a80a0db0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_b52a140b-cdd1-4d41-bc6c-594e858db462" xlink:to="loc_us-gaap_CashFlowHedgingMember_45d4fdb4-f0d3-443b-977c-6895a80a0db0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_9d94c1ce-bf42-41f0-8aa9-25e13be35668" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_d7a61cdb-2d25-42db-9fb3-ca3291405482" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_9d94c1ce-bf42-41f0-8aa9-25e13be35668" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_9d94c1ce-bf42-41f0-8aa9-25e13be35668_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_9d94c1ce-bf42-41f0-8aa9-25e13be35668" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_9d94c1ce-bf42-41f0-8aa9-25e13be35668_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_7ed05ee2-b825-4217-9285-ef7b4408924c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_9d94c1ce-bf42-41f0-8aa9-25e13be35668" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_7ed05ee2-b825-4217-9285-ef7b4408924c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_d11e9bc7-24bd-4257-b9e1-40f9735ae824" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_7ed05ee2-b825-4217-9285-ef7b4408924c" xlink:to="loc_us-gaap_InterestRateSwapMember_d11e9bc7-24bd-4257-b9e1-40f9735ae824" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrencySwapMember_bde95337-61a6-4a2e-acc4-f177193ae7e6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrencySwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_7ed05ee2-b825-4217-9285-ef7b4408924c" xlink:to="loc_us-gaap_CurrencySwapMember_bde95337-61a6-4a2e-acc4-f177193ae7e6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_958d18fe-f10e-47a8-85dd-b8a0355260f8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_7ed05ee2-b825-4217-9285-ef7b4408924c" xlink:to="loc_us-gaap_ForeignExchangeContractMember_958d18fe-f10e-47a8-85dd-b8a0355260f8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember_f3d011b1-6622-4827-bfd9-ad4a109e944e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_7ed05ee2-b825-4217-9285-ef7b4408924c" xlink:to="loc_us-gaap_CashFlowHedgingMember_f3d011b1-6622-4827-bfd9-ad4a109e944e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_258f136d-a4a4-42b7-a307-5d42b355867b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_d7a61cdb-2d25-42db-9fb3-ca3291405482" xlink:to="loc_us-gaap_DebtInstrumentAxis_258f136d-a4a4-42b7-a307-5d42b355867b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_258f136d-a4a4-42b7-a307-5d42b355867b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_258f136d-a4a4-42b7-a307-5d42b355867b" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_258f136d-a4a4-42b7-a307-5d42b355867b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_95b059cb-54c6-482a-a375-63649ee05b56" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_258f136d-a4a4-42b7-a307-5d42b355867b" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_95b059cb-54c6-482a-a375-63649ee05b56" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/FinancialInstrumentsScheduleofOutstandingInstrumentsFairValueHedgesDetails" xlink:type="simple" xlink:href="cah-20210630.xsd#FinancialInstrumentsScheduleofOutstandingInstrumentsFairValueHedgesDetails"/>
  <link:definitionLink xlink:role="http://www.cardinal.com/role/FinancialInstrumentsScheduleofOutstandingInstrumentsFairValueHedgesDetails" xlink:type="extended" id="id7732faff45746e7bc9ae8a6137cb808_FinancialInstrumentsScheduleofOutstandingInstrumentsFairValueHedgesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_dd0c353e-9906-4e6d-bc12-2d2075eac4dd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredGainLossOnDiscontinuationOfInterestRateFairValueHedge_0bf80ad9-5d63-4b4b-afe6-522f429c85b8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredGainLossOnDiscontinuationOfInterestRateFairValueHedge"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_dd0c353e-9906-4e6d-bc12-2d2075eac4dd" xlink:to="loc_us-gaap_DeferredGainLossOnDiscontinuationOfInterestRateFairValueHedge_0bf80ad9-5d63-4b4b-afe6-522f429c85b8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_DerivativesHedgeDiscontinuancesHedgingInstrumentMaturedAmount_6f4ddfe3-5882-499b-81ad-aa63da4830a1" xlink:href="cah-20210630.xsd#cah_DerivativesHedgeDiscontinuancesHedgingInstrumentMaturedAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_dd0c353e-9906-4e6d-bc12-2d2075eac4dd" xlink:to="loc_cah_DerivativesHedgeDiscontinuancesHedgingInstrumentMaturedAmount_6f4ddfe3-5882-499b-81ad-aa63da4830a1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetNotionalAmount_9013bb1c-5be3-4079-b7ef-214c31bfb1a6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeAssetNotionalAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_dd0c353e-9906-4e6d-bc12-2d2075eac4dd" xlink:to="loc_us-gaap_DerivativeAssetNotionalAmount_9013bb1c-5be3-4079-b7ef-214c31bfb1a6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_b0ce9383-e73e-48bb-ad1b-6fc09e1ae82f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeLineItems_dd0c353e-9906-4e6d-bc12-2d2075eac4dd" xlink:to="loc_us-gaap_DerivativeTable_b0ce9383-e73e-48bb-ad1b-6fc09e1ae82f" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_b6523ce7-ce41-42c7-bfea-149ef37256ce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_b0ce9383-e73e-48bb-ad1b-6fc09e1ae82f" xlink:to="loc_us-gaap_HedgingDesignationAxis_b6523ce7-ce41-42c7-bfea-149ef37256ce" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_b6523ce7-ce41-42c7-bfea-149ef37256ce_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_HedgingDesignationAxis_b6523ce7-ce41-42c7-bfea-149ef37256ce" xlink:to="loc_us-gaap_HedgingDesignationDomain_b6523ce7-ce41-42c7-bfea-149ef37256ce_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_a70eeea1-aad7-477e-a5db-13207c90e04b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_HedgingDesignationAxis_b6523ce7-ce41-42c7-bfea-149ef37256ce" xlink:to="loc_us-gaap_HedgingDesignationDomain_a70eeea1-aad7-477e-a5db-13207c90e04b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_2a3d8c74-0fe3-4f5d-8fcc-d281e25c6508" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_a70eeea1-aad7-477e-a5db-13207c90e04b" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_2a3d8c74-0fe3-4f5d-8fcc-d281e25c6508" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_8cfb0954-21a3-4ddd-ad1a-8d954235b6a5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_b0ce9383-e73e-48bb-ad1b-6fc09e1ae82f" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_8cfb0954-21a3-4ddd-ad1a-8d954235b6a5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_8cfb0954-21a3-4ddd-ad1a-8d954235b6a5_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_8cfb0954-21a3-4ddd-ad1a-8d954235b6a5" xlink:to="loc_us-gaap_HedgingRelationshipDomain_8cfb0954-21a3-4ddd-ad1a-8d954235b6a5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_1ffa5b31-7558-4d1f-94b3-02d0c88182af" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_8cfb0954-21a3-4ddd-ad1a-8d954235b6a5" xlink:to="loc_us-gaap_HedgingRelationshipDomain_1ffa5b31-7558-4d1f-94b3-02d0c88182af" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueHedgingMember_9c221c23-122d-4233-8b7a-9838e3a7b2db" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_1ffa5b31-7558-4d1f-94b3-02d0c88182af" xlink:to="loc_us-gaap_FairValueHedgingMember_9c221c23-122d-4233-8b7a-9838e3a7b2db" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_705322ec-3cca-4771-9896-842716619084" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_b0ce9383-e73e-48bb-ad1b-6fc09e1ae82f" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_705322ec-3cca-4771-9896-842716619084" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_705322ec-3cca-4771-9896-842716619084_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_705322ec-3cca-4771-9896-842716619084" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_705322ec-3cca-4771-9896-842716619084_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_cedbec70-c702-47bf-b4f7-43df9c661910" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_705322ec-3cca-4771-9896-842716619084" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_cedbec70-c702-47bf-b4f7-43df9c661910" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_1a92514a-4eec-486f-ad46-65eccc142b24" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_cedbec70-c702-47bf-b4f7-43df9c661910" xlink:to="loc_us-gaap_InterestRateSwapMember_1a92514a-4eec-486f-ad46-65eccc142b24" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_0b8d6a04-a1e9-4800-84a3-65763f9e6751" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_b0ce9383-e73e-48bb-ad1b-6fc09e1ae82f" xlink:to="loc_srt_RangeAxis_0b8d6a04-a1e9-4800-84a3-65763f9e6751" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_0b8d6a04-a1e9-4800-84a3-65763f9e6751_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_0b8d6a04-a1e9-4800-84a3-65763f9e6751" xlink:to="loc_srt_RangeMember_0b8d6a04-a1e9-4800-84a3-65763f9e6751_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_84a08491-27ed-481b-945f-5267dc252639" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_0b8d6a04-a1e9-4800-84a3-65763f9e6751" xlink:to="loc_srt_RangeMember_84a08491-27ed-481b-945f-5267dc252639" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_d217dca5-f909-445c-894d-0c00717a3bf6" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_84a08491-27ed-481b-945f-5267dc252639" xlink:to="loc_srt_MinimumMember_d217dca5-f909-445c-894d-0c00717a3bf6" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/FinancialInstrumentsScheduleofGainLossRecognizedinEarningsforInterestRateContractsDesignatedasFairValueHedgesDetails" xlink:type="simple" xlink:href="cah-20210630.xsd#FinancialInstrumentsScheduleofGainLossRecognizedinEarningsforInterestRateContractsDesignatedasFairValueHedgesDetails"/>
  <link:definitionLink xlink:role="http://www.cardinal.com/role/FinancialInstrumentsScheduleofGainLossRecognizedinEarningsforInterestRateContractsDesignatedasFairValueHedgesDetails" xlink:type="extended" id="i7c7c2398ccfe4c09a7285737fa974610_FinancialInstrumentsScheduleofGainLossRecognizedinEarningsforInterestRateContractsDesignatedasFairValueHedgesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_042d22ad-99e3-43d2-9de6-53b8259389fd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeGainLossOnDerivativeNet_c151dcd7-d093-405d-b9f7-12010a1dc13b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeGainLossOnDerivativeNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_042d22ad-99e3-43d2-9de6-53b8259389fd" xlink:to="loc_us-gaap_DerivativeGainLossOnDerivativeNet_c151dcd7-d093-405d-b9f7-12010a1dc13b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_25dbc9d6-a711-4443-acff-3a935734c13e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeLineItems_042d22ad-99e3-43d2-9de6-53b8259389fd" xlink:to="loc_us-gaap_DerivativeTable_25dbc9d6-a711-4443-acff-3a935734c13e" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_61d45059-02b5-417e-b9bb-61ee048ecd20" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_25dbc9d6-a711-4443-acff-3a935734c13e" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_61d45059-02b5-417e-b9bb-61ee048ecd20" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_61d45059-02b5-417e-b9bb-61ee048ecd20_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_61d45059-02b5-417e-b9bb-61ee048ecd20" xlink:to="loc_us-gaap_HedgingRelationshipDomain_61d45059-02b5-417e-b9bb-61ee048ecd20_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_b2dfee4e-839b-4470-831a-eb6c8f1d5322" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_61d45059-02b5-417e-b9bb-61ee048ecd20" xlink:to="loc_us-gaap_HedgingRelationshipDomain_b2dfee4e-839b-4470-831a-eb6c8f1d5322" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueHedgingMember_1e888a67-d5cf-4030-ae0e-fc7eae28c9ad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_b2dfee4e-839b-4470-831a-eb6c8f1d5322" xlink:to="loc_us-gaap_FairValueHedgingMember_1e888a67-d5cf-4030-ae0e-fc7eae28c9ad" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_8df11d74-7cb3-4af1-a873-41957b49490e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_25dbc9d6-a711-4443-acff-3a935734c13e" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_8df11d74-7cb3-4af1-a873-41957b49490e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_8df11d74-7cb3-4af1-a873-41957b49490e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_8df11d74-7cb3-4af1-a873-41957b49490e" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_8df11d74-7cb3-4af1-a873-41957b49490e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_2cf2428b-2f8e-4e9f-b059-c08bf638d891" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_8df11d74-7cb3-4af1-a873-41957b49490e" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_2cf2428b-2f8e-4e9f-b059-c08bf638d891" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_44982702-fb13-4842-99ba-a5fdc7220115" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_2cf2428b-2f8e-4e9f-b059-c08bf638d891" xlink:to="loc_us-gaap_InterestRateSwapMember_44982702-fb13-4842-99ba-a5fdc7220115" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_FixedRateDebtMember_c4b83c6f-3d66-423f-9e77-b76031566028" xlink:href="cah-20210630.xsd#cah_FixedRateDebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_2cf2428b-2f8e-4e9f-b059-c08bf638d891" xlink:to="loc_cah_FixedRateDebtMember_c4b83c6f-3d66-423f-9e77-b76031566028" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_239d877d-0ef9-4141-99c3-e77732bda919" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_25dbc9d6-a711-4443-acff-3a935734c13e" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_239d877d-0ef9-4141-99c3-e77732bda919" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_239d877d-0ef9-4141-99c3-e77732bda919_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_239d877d-0ef9-4141-99c3-e77732bda919" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_239d877d-0ef9-4141-99c3-e77732bda919_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_882ede23-f715-48e4-8f93-9a37574d7bba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_239d877d-0ef9-4141-99c3-e77732bda919" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_882ede23-f715-48e4-8f93-9a37574d7bba" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseMember_99fe1439-b29c-490f-9d8e-b12a92659bcf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_882ede23-f715-48e4-8f93-9a37574d7bba" xlink:to="loc_us-gaap_InterestExpenseMember_99fe1439-b29c-490f-9d8e-b12a92659bcf" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/FinancialInstrumentsScheduleofOutstandingInstrumentsCashFlowHedgesDetails" xlink:type="simple" xlink:href="cah-20210630.xsd#FinancialInstrumentsScheduleofOutstandingInstrumentsCashFlowHedgesDetails"/>
  <link:definitionLink xlink:role="http://www.cardinal.com/role/FinancialInstrumentsScheduleofOutstandingInstrumentsCashFlowHedgesDetails" xlink:type="extended" id="i25333f6717a74d84b68b51aab87f47b6_FinancialInstrumentsScheduleofOutstandingInstrumentsCashFlowHedgesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_3221f6ca-adfa-4ce7-98bb-bb78481eb1dd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilityNotionalAmount_f006286e-d16f-4c47-bb2f-4119d17c5ab2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLiabilityNotionalAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_3221f6ca-adfa-4ce7-98bb-bb78481eb1dd" xlink:to="loc_us-gaap_DerivativeLiabilityNotionalAmount_f006286e-d16f-4c47-bb2f-4119d17c5ab2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetNotionalAmount_cf5ee2d2-50d2-4cce-859f-a087ecdc59dc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeAssetNotionalAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_3221f6ca-adfa-4ce7-98bb-bb78481eb1dd" xlink:to="loc_us-gaap_DerivativeAssetNotionalAmount_cf5ee2d2-50d2-4cce-859f-a087ecdc59dc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_ca390fde-4558-4a05-b781-c681e3cf3dc1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeLineItems_3221f6ca-adfa-4ce7-98bb-bb78481eb1dd" xlink:to="loc_us-gaap_DerivativeTable_ca390fde-4558-4a05-b781-c681e3cf3dc1" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_279f1cbb-8f22-4d90-b53a-56d0a8ee165a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_ca390fde-4558-4a05-b781-c681e3cf3dc1" xlink:to="loc_us-gaap_HedgingDesignationAxis_279f1cbb-8f22-4d90-b53a-56d0a8ee165a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_279f1cbb-8f22-4d90-b53a-56d0a8ee165a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_HedgingDesignationAxis_279f1cbb-8f22-4d90-b53a-56d0a8ee165a" xlink:to="loc_us-gaap_HedgingDesignationDomain_279f1cbb-8f22-4d90-b53a-56d0a8ee165a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_586aa4a1-5c29-4bbf-9ea9-a1ed0005c1d9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_HedgingDesignationAxis_279f1cbb-8f22-4d90-b53a-56d0a8ee165a" xlink:to="loc_us-gaap_HedgingDesignationDomain_586aa4a1-5c29-4bbf-9ea9-a1ed0005c1d9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_b4cc2e50-ed01-4786-85c3-c8f557b4adba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_586aa4a1-5c29-4bbf-9ea9-a1ed0005c1d9" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_b4cc2e50-ed01-4786-85c3-c8f557b4adba" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_f410f18b-104a-460b-87c0-ab5288f190ab" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_ca390fde-4558-4a05-b781-c681e3cf3dc1" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_f410f18b-104a-460b-87c0-ab5288f190ab" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_f410f18b-104a-460b-87c0-ab5288f190ab_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_f410f18b-104a-460b-87c0-ab5288f190ab" xlink:to="loc_us-gaap_HedgingRelationshipDomain_f410f18b-104a-460b-87c0-ab5288f190ab_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_9fe60bc1-11d7-47fe-92ac-5076af7e2264" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_f410f18b-104a-460b-87c0-ab5288f190ab" xlink:to="loc_us-gaap_HedgingRelationshipDomain_9fe60bc1-11d7-47fe-92ac-5076af7e2264" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueHedgingMember_bc11fc7c-2b39-41e4-b554-761820b58d6c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_9fe60bc1-11d7-47fe-92ac-5076af7e2264" xlink:to="loc_us-gaap_FairValueHedgingMember_bc11fc7c-2b39-41e4-b554-761820b58d6c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember_7812b10c-5c7c-40e6-aff9-dcc7814982d9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_9fe60bc1-11d7-47fe-92ac-5076af7e2264" xlink:to="loc_us-gaap_CashFlowHedgingMember_7812b10c-5c7c-40e6-aff9-dcc7814982d9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_96c3c6b4-781c-4d66-8771-d602bfaf35af" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_ca390fde-4558-4a05-b781-c681e3cf3dc1" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_96c3c6b4-781c-4d66-8771-d602bfaf35af" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_96c3c6b4-781c-4d66-8771-d602bfaf35af_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_96c3c6b4-781c-4d66-8771-d602bfaf35af" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_96c3c6b4-781c-4d66-8771-d602bfaf35af_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_57305aac-5985-479a-9c12-43f6cd16f4d2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_96c3c6b4-781c-4d66-8771-d602bfaf35af" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_57305aac-5985-479a-9c12-43f6cd16f4d2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_c105d9ce-4ebc-43bd-aa25-107b66d19a34" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_57305aac-5985-479a-9c12-43f6cd16f4d2" xlink:to="loc_us-gaap_InterestRateSwapMember_c105d9ce-4ebc-43bd-aa25-107b66d19a34" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_d7891921-9def-489e-9cea-d821176ef9d1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_57305aac-5985-479a-9c12-43f6cd16f4d2" xlink:to="loc_us-gaap_ForeignExchangeContractMember_d7891921-9def-489e-9cea-d821176ef9d1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommodityContractMember_feeb98fb-595e-4807-819c-ca85797fab08" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommodityContractMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_57305aac-5985-479a-9c12-43f6cd16f4d2" xlink:to="loc_us-gaap_CommodityContractMember_feeb98fb-595e-4807-819c-ca85797fab08" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember_a3fd77c8-8c3a-4d7b-8bc4-824d3f8506b5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_57305aac-5985-479a-9c12-43f6cd16f4d2" xlink:to="loc_us-gaap_CashFlowHedgingMember_a3fd77c8-8c3a-4d7b-8bc4-824d3f8506b5" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForwardContractsMember_b0696da0-0108-4bcc-ba4a-d5e439db0f8b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForwardContractsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_57305aac-5985-479a-9c12-43f6cd16f4d2" xlink:to="loc_us-gaap_ForwardContractsMember_b0696da0-0108-4bcc-ba4a-d5e439db0f8b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_55510999-5020-45a2-91de-f48a474c18a0" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_ca390fde-4558-4a05-b781-c681e3cf3dc1" xlink:to="loc_srt_RangeAxis_55510999-5020-45a2-91de-f48a474c18a0" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_55510999-5020-45a2-91de-f48a474c18a0_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_55510999-5020-45a2-91de-f48a474c18a0" xlink:to="loc_srt_RangeMember_55510999-5020-45a2-91de-f48a474c18a0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_b1489dc4-cf15-45f4-bc88-2c83aa0a6c57" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_55510999-5020-45a2-91de-f48a474c18a0" xlink:to="loc_srt_RangeMember_b1489dc4-cf15-45f4-bc88-2c83aa0a6c57" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_c04fd123-5b7c-4067-b03f-8e5581067428" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_b1489dc4-cf15-45f4-bc88-2c83aa0a6c57" xlink:to="loc_srt_MinimumMember_c04fd123-5b7c-4067-b03f-8e5581067428" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_aabf9d26-a46e-4bfb-95ee-0eeafec13ce4" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_b1489dc4-cf15-45f4-bc88-2c83aa0a6c57" xlink:to="loc_srt_MaximumMember_aabf9d26-a46e-4bfb-95ee-0eeafec13ce4" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/FinancialInstrumentsScheduleofGainLossIncludedinAOCIforDerivativeInstrumentsDesignatedasCashFlowHedgesDetails" xlink:type="simple" xlink:href="cah-20210630.xsd#FinancialInstrumentsScheduleofGainLossIncludedinAOCIforDerivativeInstrumentsDesignatedasCashFlowHedgesDetails"/>
  <link:definitionLink xlink:role="http://www.cardinal.com/role/FinancialInstrumentsScheduleofGainLossIncludedinAOCIforDerivativeInstrumentsDesignatedasCashFlowHedgesDetails" xlink:type="extended" id="iefcd5212eeda45099c3f6f89f1da2ea0_FinancialInstrumentsScheduleofGainLossIncludedinAOCIforDerivativeInstrumentsDesignatedasCashFlowHedgesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_f772a243-8f68-4143-a524-beff56c70e1b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax_5d74f186-d7f0-426f-b990-34dba9661ee6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_f772a243-8f68-4143-a524-beff56c70e1b" xlink:to="loc_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax_5d74f186-d7f0-426f-b990-34dba9661ee6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_e498a61c-de61-4087-aadf-7637aaa70fce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeLineItems_f772a243-8f68-4143-a524-beff56c70e1b" xlink:to="loc_us-gaap_DerivativeTable_e498a61c-de61-4087-aadf-7637aaa70fce" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_43755512-8da6-483d-8350-a6fb8130d117" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_e498a61c-de61-4087-aadf-7637aaa70fce" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_43755512-8da6-483d-8350-a6fb8130d117" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_43755512-8da6-483d-8350-a6fb8130d117_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_43755512-8da6-483d-8350-a6fb8130d117" xlink:to="loc_us-gaap_HedgingRelationshipDomain_43755512-8da6-483d-8350-a6fb8130d117_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_7c9cde01-4b03-4629-b09f-9d86fc436918" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_43755512-8da6-483d-8350-a6fb8130d117" xlink:to="loc_us-gaap_HedgingRelationshipDomain_7c9cde01-4b03-4629-b09f-9d86fc436918" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember_46eca9b4-efd1-41b5-8ca6-c490e6dc1475" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_7c9cde01-4b03-4629-b09f-9d86fc436918" xlink:to="loc_us-gaap_CashFlowHedgingMember_46eca9b4-efd1-41b5-8ca6-c490e6dc1475" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_0c3379aa-336b-45e5-a464-14d5c1e84ae1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_e498a61c-de61-4087-aadf-7637aaa70fce" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_0c3379aa-336b-45e5-a464-14d5c1e84ae1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_0c3379aa-336b-45e5-a464-14d5c1e84ae1_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_0c3379aa-336b-45e5-a464-14d5c1e84ae1" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_0c3379aa-336b-45e5-a464-14d5c1e84ae1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_6dd61e7c-e466-4909-8f36-44045da7fb51" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_0c3379aa-336b-45e5-a464-14d5c1e84ae1" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_6dd61e7c-e466-4909-8f36-44045da7fb51" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForwardContractsMember_14e88834-9e0b-4019-ae9a-c26ae8d827d8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForwardContractsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_6dd61e7c-e466-4909-8f36-44045da7fb51" xlink:to="loc_us-gaap_ForwardContractsMember_14e88834-9e0b-4019-ae9a-c26ae8d827d8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_7b3d224e-27e6-4015-a596-5c317fa0ddee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_6dd61e7c-e466-4909-8f36-44045da7fb51" xlink:to="loc_us-gaap_InterestRateSwapMember_7b3d224e-27e6-4015-a596-5c317fa0ddee" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommodityContractMember_30acb404-14d8-4045-96de-d3e865d8e36f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommodityContractMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_6dd61e7c-e466-4909-8f36-44045da7fb51" xlink:to="loc_us-gaap_CommodityContractMember_30acb404-14d8-4045-96de-d3e865d8e36f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_3d7d31e8-661c-4f93-998d-b3690d50b39a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_6dd61e7c-e466-4909-8f36-44045da7fb51" xlink:to="loc_us-gaap_ForeignExchangeContractMember_3d7d31e8-661c-4f93-998d-b3690d50b39a" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/FinancialInstrumentsScheduleofGainLossReclassifiedfromAOCIintoEarningsforDerivativeInstrumentsDesignatedasCashFlowHedgesDetails" xlink:type="simple" xlink:href="cah-20210630.xsd#FinancialInstrumentsScheduleofGainLossReclassifiedfromAOCIintoEarningsforDerivativeInstrumentsDesignatedasCashFlowHedgesDetails"/>
  <link:definitionLink xlink:role="http://www.cardinal.com/role/FinancialInstrumentsScheduleofGainLossReclassifiedfromAOCIintoEarningsforDerivativeInstrumentsDesignatedasCashFlowHedgesDetails" xlink:type="extended" id="ic807a11ceb8442c79b7f1243418f4515_FinancialInstrumentsScheduleofGainLossReclassifiedfromAOCIintoEarningsforDerivativeInstrumentsDesignatedasCashFlowHedgesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_b7cac97c-54dd-4d9b-b300-5b9ebf1a7b41" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet_2828e0d9-354a-4cf5-8cf9-936fd39e04b3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_b7cac97c-54dd-4d9b-b300-5b9ebf1a7b41" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet_2828e0d9-354a-4cf5-8cf9-936fd39e04b3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_ff8c01c6-ce92-4e74-8395-b2ec2298942d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeLineItems_b7cac97c-54dd-4d9b-b300-5b9ebf1a7b41" xlink:to="loc_us-gaap_DerivativeTable_ff8c01c6-ce92-4e74-8395-b2ec2298942d" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_d190f847-ae3e-48f2-b4b4-a86d92693109" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_ff8c01c6-ce92-4e74-8395-b2ec2298942d" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_d190f847-ae3e-48f2-b4b4-a86d92693109" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_d190f847-ae3e-48f2-b4b4-a86d92693109_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_d190f847-ae3e-48f2-b4b4-a86d92693109" xlink:to="loc_us-gaap_HedgingRelationshipDomain_d190f847-ae3e-48f2-b4b4-a86d92693109_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_9adaee16-ae6e-4585-a3c1-06bccc9eadde" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_d190f847-ae3e-48f2-b4b4-a86d92693109" xlink:to="loc_us-gaap_HedgingRelationshipDomain_9adaee16-ae6e-4585-a3c1-06bccc9eadde" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember_fea43ce4-cf78-4054-a87f-8ad402233030" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_9adaee16-ae6e-4585-a3c1-06bccc9eadde" xlink:to="loc_us-gaap_CashFlowHedgingMember_fea43ce4-cf78-4054-a87f-8ad402233030" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_a08a391b-4d25-4a83-9df0-62e0852dafae" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_ff8c01c6-ce92-4e74-8395-b2ec2298942d" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_a08a391b-4d25-4a83-9df0-62e0852dafae" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_a08a391b-4d25-4a83-9df0-62e0852dafae_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_a08a391b-4d25-4a83-9df0-62e0852dafae" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_a08a391b-4d25-4a83-9df0-62e0852dafae_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_23da4d3f-b2b7-43e0-9313-698b0a13392a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_a08a391b-4d25-4a83-9df0-62e0852dafae" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_23da4d3f-b2b7-43e0-9313-698b0a13392a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_eacfc8af-2fdb-4800-bd5e-ef6a832cca83" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_23da4d3f-b2b7-43e0-9313-698b0a13392a" xlink:to="loc_us-gaap_ForeignExchangeContractMember_eacfc8af-2fdb-4800-bd5e-ef6a832cca83" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForwardContractsMember_7193419a-8d4a-4f74-8d5b-bd7bd3384181" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForwardContractsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_23da4d3f-b2b7-43e0-9313-698b0a13392a" xlink:to="loc_us-gaap_ForwardContractsMember_7193419a-8d4a-4f74-8d5b-bd7bd3384181" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommodityContractMember_7712a1c7-cba7-4854-802f-ad81656f176d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommodityContractMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_23da4d3f-b2b7-43e0-9313-698b0a13392a" xlink:to="loc_us-gaap_CommodityContractMember_7712a1c7-cba7-4854-802f-ad81656f176d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_100b7a02-500a-4b22-bb3a-5af9ad14c657" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_ff8c01c6-ce92-4e74-8395-b2ec2298942d" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_100b7a02-500a-4b22-bb3a-5af9ad14c657" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_100b7a02-500a-4b22-bb3a-5af9ad14c657_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_100b7a02-500a-4b22-bb3a-5af9ad14c657" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_100b7a02-500a-4b22-bb3a-5af9ad14c657_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_89a014fc-4c9e-4eb3-ac25-c9959da2bdec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_100b7a02-500a-4b22-bb3a-5af9ad14c657" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_89a014fc-4c9e-4eb3-ac25-c9959da2bdec" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesMember_396da7b2-4da9-4bca-92cb-0cd987a34588" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SalesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_89a014fc-4c9e-4eb3-ac25-c9959da2bdec" xlink:to="loc_us-gaap_SalesMember_396da7b2-4da9-4bca-92cb-0cd987a34588" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_f55d8790-3674-42cd-82e4-ffa1e551fbe9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfSalesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_89a014fc-4c9e-4eb3-ac25-c9959da2bdec" xlink:to="loc_us-gaap_CostOfSalesMember_f55d8790-3674-42cd-82e4-ffa1e551fbe9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_5e694b94-c642-448d-bd7a-fb1504002764" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_89a014fc-4c9e-4eb3-ac25-c9959da2bdec" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_5e694b94-c642-448d-bd7a-fb1504002764" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseMember_3aabdeee-a944-4c41-9882-21a507acc47a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_89a014fc-4c9e-4eb3-ac25-c9959da2bdec" xlink:to="loc_us-gaap_InterestExpenseMember_3aabdeee-a944-4c41-9882-21a507acc47a" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/FinancialInstrumentsScheduleofOutstandingInstrumentsEconomicHedgesDetails" xlink:type="simple" xlink:href="cah-20210630.xsd#FinancialInstrumentsScheduleofOutstandingInstrumentsEconomicHedgesDetails"/>
  <link:definitionLink xlink:role="http://www.cardinal.com/role/FinancialInstrumentsScheduleofOutstandingInstrumentsEconomicHedgesDetails" xlink:type="extended" id="ic58884b148ea4c79a33397b7844bd690_FinancialInstrumentsScheduleofOutstandingInstrumentsEconomicHedgesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_a6d12fcb-ddef-40aa-b79c-921932ead084" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetNotionalAmount_cf3aaf63-be8a-41b8-b587-780de0babfdf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeAssetNotionalAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_a6d12fcb-ddef-40aa-b79c-921932ead084" xlink:to="loc_us-gaap_DerivativeAssetNotionalAmount_cf3aaf63-be8a-41b8-b587-780de0babfdf" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_84223cb1-0faf-4ec3-95f3-ced1621f9f04" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeLineItems_a6d12fcb-ddef-40aa-b79c-921932ead084" xlink:to="loc_us-gaap_DerivativeTable_84223cb1-0faf-4ec3-95f3-ced1621f9f04" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_a4183c3c-93e2-490f-8741-787f13d9452f" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_84223cb1-0faf-4ec3-95f3-ced1621f9f04" xlink:to="loc_srt_RangeAxis_a4183c3c-93e2-490f-8741-787f13d9452f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_a4183c3c-93e2-490f-8741-787f13d9452f_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_a4183c3c-93e2-490f-8741-787f13d9452f" xlink:to="loc_srt_RangeMember_a4183c3c-93e2-490f-8741-787f13d9452f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_9fcec2f4-f589-4ddc-9a47-ae66008a41ab" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_a4183c3c-93e2-490f-8741-787f13d9452f" xlink:to="loc_srt_RangeMember_9fcec2f4-f589-4ddc-9a47-ae66008a41ab" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_661dd70f-d0d0-46d0-bc61-2813894f011b" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_9fcec2f4-f589-4ddc-9a47-ae66008a41ab" xlink:to="loc_srt_MinimumMember_661dd70f-d0d0-46d0-bc61-2813894f011b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_8d9b42a7-e095-4d69-89e0-16a889d45565" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_9fcec2f4-f589-4ddc-9a47-ae66008a41ab" xlink:to="loc_srt_MaximumMember_8d9b42a7-e095-4d69-89e0-16a889d45565" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_87c14b97-6085-42e5-b770-bd55fc9c174d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_84223cb1-0faf-4ec3-95f3-ced1621f9f04" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_87c14b97-6085-42e5-b770-bd55fc9c174d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_87c14b97-6085-42e5-b770-bd55fc9c174d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_87c14b97-6085-42e5-b770-bd55fc9c174d" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_87c14b97-6085-42e5-b770-bd55fc9c174d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_f31033a5-1905-4e9c-8a7c-e187fbca2794" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_87c14b97-6085-42e5-b770-bd55fc9c174d" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_f31033a5-1905-4e9c-8a7c-e187fbca2794" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_58364d47-c064-4c19-a3a1-cd7b2285c5eb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_f31033a5-1905-4e9c-8a7c-e187fbca2794" xlink:to="loc_us-gaap_ForeignExchangeContractMember_58364d47-c064-4c19-a3a1-cd7b2285c5eb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_fe1d07ef-e4ca-4fd5-96f3-e3712c7955b9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_84223cb1-0faf-4ec3-95f3-ced1621f9f04" xlink:to="loc_us-gaap_HedgingDesignationAxis_fe1d07ef-e4ca-4fd5-96f3-e3712c7955b9" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_fe1d07ef-e4ca-4fd5-96f3-e3712c7955b9_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_HedgingDesignationAxis_fe1d07ef-e4ca-4fd5-96f3-e3712c7955b9" xlink:to="loc_us-gaap_HedgingDesignationDomain_fe1d07ef-e4ca-4fd5-96f3-e3712c7955b9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_76484af1-7530-4c1e-987c-3556db5784ba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_HedgingDesignationAxis_fe1d07ef-e4ca-4fd5-96f3-e3712c7955b9" xlink:to="loc_us-gaap_HedgingDesignationDomain_76484af1-7530-4c1e-987c-3556db5784ba" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember_22b25165-21d0-4971-9441-d92ae3406b8d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NondesignatedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_76484af1-7530-4c1e-987c-3556db5784ba" xlink:to="loc_us-gaap_NondesignatedMember_22b25165-21d0-4971-9441-d92ae3406b8d" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/FinancialInstrumentsScheduleofGainLossRecognizedinEarningsforDerivativesNotDesignatedasHedgingInstrumentDetails" xlink:type="simple" xlink:href="cah-20210630.xsd#FinancialInstrumentsScheduleofGainLossRecognizedinEarningsforDerivativesNotDesignatedasHedgingInstrumentDetails"/>
  <link:definitionLink xlink:role="http://www.cardinal.com/role/FinancialInstrumentsScheduleofGainLossRecognizedinEarningsforDerivativesNotDesignatedasHedgingInstrumentDetails" xlink:type="extended" id="i538f5348e2ad4653b0651e7716fc0d89_FinancialInstrumentsScheduleofGainLossRecognizedinEarningsforDerivativesNotDesignatedasHedgingInstrumentDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_9867514e-55b0-4235-8044-898fad0b8672" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet_95f5ec0e-3cd0-40d4-ace4-b9f737a60870" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_9867514e-55b0-4235-8044-898fad0b8672" xlink:to="loc_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet_95f5ec0e-3cd0-40d4-ace4-b9f737a60870" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_cf168442-7160-48b7-9fe8-a188f7aac3be" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeLineItems_9867514e-55b0-4235-8044-898fad0b8672" xlink:to="loc_us-gaap_DerivativeTable_cf168442-7160-48b7-9fe8-a188f7aac3be" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_7d218fdc-7e71-44b3-8e05-9b8a6edcfc45" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_cf168442-7160-48b7-9fe8-a188f7aac3be" xlink:to="loc_us-gaap_HedgingDesignationAxis_7d218fdc-7e71-44b3-8e05-9b8a6edcfc45" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_7d218fdc-7e71-44b3-8e05-9b8a6edcfc45_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_HedgingDesignationAxis_7d218fdc-7e71-44b3-8e05-9b8a6edcfc45" xlink:to="loc_us-gaap_HedgingDesignationDomain_7d218fdc-7e71-44b3-8e05-9b8a6edcfc45_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_25fe4fe7-3efc-494a-9e85-7f5c6d6b740f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_HedgingDesignationAxis_7d218fdc-7e71-44b3-8e05-9b8a6edcfc45" xlink:to="loc_us-gaap_HedgingDesignationDomain_25fe4fe7-3efc-494a-9e85-7f5c6d6b740f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember_6a01ab66-a772-4a50-bed5-0037287ebdcf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NondesignatedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_25fe4fe7-3efc-494a-9e85-7f5c6d6b740f" xlink:to="loc_us-gaap_NondesignatedMember_6a01ab66-a772-4a50-bed5-0037287ebdcf" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_3d96c644-817a-43ed-9c97-117b55901e06" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_cf168442-7160-48b7-9fe8-a188f7aac3be" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_3d96c644-817a-43ed-9c97-117b55901e06" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_3d96c644-817a-43ed-9c97-117b55901e06_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_3d96c644-817a-43ed-9c97-117b55901e06" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_3d96c644-817a-43ed-9c97-117b55901e06_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_9cbdcb58-83d7-4545-94fb-f902ccc002c1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_3d96c644-817a-43ed-9c97-117b55901e06" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_9cbdcb58-83d7-4545-94fb-f902ccc002c1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_edb0d6e9-79ec-4a0d-b70e-0190b7f1199e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_9cbdcb58-83d7-4545-94fb-f902ccc002c1" xlink:to="loc_us-gaap_ForeignExchangeContractMember_edb0d6e9-79ec-4a0d-b70e-0190b7f1199e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_f11c218b-87cb-4096-a98d-4dca3e60fd12" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_cf168442-7160-48b7-9fe8-a188f7aac3be" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_f11c218b-87cb-4096-a98d-4dca3e60fd12" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_f11c218b-87cb-4096-a98d-4dca3e60fd12_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_f11c218b-87cb-4096-a98d-4dca3e60fd12" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_f11c218b-87cb-4096-a98d-4dca3e60fd12_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_7849725f-f335-4804-b113-4ed86a205008" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_f11c218b-87cb-4096-a98d-4dca3e60fd12" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_7849725f-f335-4804-b113-4ed86a205008" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpenseMember_c224b704-c990-4944-bb66-151342481b9b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_7849725f-f335-4804-b113-4ed86a205008" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpenseMember_c224b704-c990-4944-bb66-151342481b9b" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/FinancialInstrumentsSummaryofEstimatedFairValueofLongtermObligationsandOtherShorttermBorrowingsDetails" xlink:type="simple" xlink:href="cah-20210630.xsd#FinancialInstrumentsSummaryofEstimatedFairValueofLongtermObligationsandOtherShorttermBorrowingsDetails"/>
  <link:definitionLink xlink:role="http://www.cardinal.com/role/FinancialInstrumentsSummaryofEstimatedFairValueofLongtermObligationsandOtherShorttermBorrowingsDetails" xlink:type="extended" id="ib7e2a4aed589428c9b9f0feff6a200d6_FinancialInstrumentsSummaryofEstimatedFairValueofLongtermObligationsandOtherShorttermBorrowingsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_df9534ac-c8fa-427e-8d12-7c6bed17270d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFairValue_47f2d3ed-8427-46d1-9165-1c3afc3966a1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_df9534ac-c8fa-427e-8d12-7c6bed17270d" xlink:to="loc_us-gaap_DebtInstrumentFairValue_47f2d3ed-8427-46d1-9165-1c3afc3966a1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_CarryingAmountofLongTermandotherShortTermBorrowings_ee3ab0a7-7b07-47b5-b80b-d98ed42c64d6" xlink:href="cah-20210630.xsd#cah_CarryingAmountofLongTermandotherShortTermBorrowings"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_df9534ac-c8fa-427e-8d12-7c6bed17270d" xlink:to="loc_cah_CarryingAmountofLongTermandotherShortTermBorrowings_ee3ab0a7-7b07-47b5-b80b-d98ed42c64d6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtAndCapitalLeaseObligations_3bc88b48-52ea-442f-9e40-042b693351cb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtAndCapitalLeaseObligations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_df9534ac-c8fa-427e-8d12-7c6bed17270d" xlink:to="loc_us-gaap_DebtAndCapitalLeaseObligations_3bc88b48-52ea-442f-9e40-042b693351cb" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_129e3742-a6b0-41f7-a34d-de264cc5a828" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_df9534ac-c8fa-427e-8d12-7c6bed17270d" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_129e3742-a6b0-41f7-a34d-de264cc5a828" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_3ed49582-347b-4486-9f85-c927e6367ace" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_129e3742-a6b0-41f7-a34d-de264cc5a828" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_3ed49582-347b-4486-9f85-c927e6367ace" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_3ed49582-347b-4486-9f85-c927e6367ace_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_3ed49582-347b-4486-9f85-c927e6367ace" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_3ed49582-347b-4486-9f85-c927e6367ace_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_bf9e9eae-4e07-4164-8aa1-3152816dfd50" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_3ed49582-347b-4486-9f85-c927e6367ace" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_bf9e9eae-4e07-4164-8aa1-3152816dfd50" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_6eb01775-9d9b-4d17-9351-065ce67e4248" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_bf9e9eae-4e07-4164-8aa1-3152816dfd50" xlink:to="loc_us-gaap_InterestRateSwapMember_6eb01775-9d9b-4d17-9351-065ce67e4248" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_d2138e81-0bba-4868-9b3d-dc5668533219" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_129e3742-a6b0-41f7-a34d-de264cc5a828" xlink:to="loc_us-gaap_HedgingDesignationAxis_d2138e81-0bba-4868-9b3d-dc5668533219" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_d2138e81-0bba-4868-9b3d-dc5668533219_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_HedgingDesignationAxis_d2138e81-0bba-4868-9b3d-dc5668533219" xlink:to="loc_us-gaap_HedgingDesignationDomain_d2138e81-0bba-4868-9b3d-dc5668533219_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_de690637-289c-48de-a55e-478d019f7c7a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_HedgingDesignationAxis_d2138e81-0bba-4868-9b3d-dc5668533219" xlink:to="loc_us-gaap_HedgingDesignationDomain_de690637-289c-48de-a55e-478d019f7c7a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_c682b988-4046-49b0-a0b8-9c2f92f94e83" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_de690637-289c-48de-a55e-478d019f7c7a" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_c682b988-4046-49b0-a0b8-9c2f92f94e83" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_e25778be-929a-4a91-bc19-a910165114e3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_129e3742-a6b0-41f7-a34d-de264cc5a828" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_e25778be-929a-4a91-bc19-a910165114e3" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_e25778be-929a-4a91-bc19-a910165114e3_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_e25778be-929a-4a91-bc19-a910165114e3" xlink:to="loc_us-gaap_HedgingRelationshipDomain_e25778be-929a-4a91-bc19-a910165114e3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_f1c5ebe9-9dae-4ffd-aff0-8deda0844321" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_e25778be-929a-4a91-bc19-a910165114e3" xlink:to="loc_us-gaap_HedgingRelationshipDomain_f1c5ebe9-9dae-4ffd-aff0-8deda0844321" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueHedgingMember_cae1a7a0-13f3-4258-982e-7f21743ac6d0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_f1c5ebe9-9dae-4ffd-aff0-8deda0844321" xlink:to="loc_us-gaap_FairValueHedgingMember_cae1a7a0-13f3-4258-982e-7f21743ac6d0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_2c17d492-05d2-4abb-bea3-a6ddd84f8a5e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_129e3742-a6b0-41f7-a34d-de264cc5a828" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_2c17d492-05d2-4abb-bea3-a6ddd84f8a5e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_2c17d492-05d2-4abb-bea3-a6ddd84f8a5e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_2c17d492-05d2-4abb-bea3-a6ddd84f8a5e" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_2c17d492-05d2-4abb-bea3-a6ddd84f8a5e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_c7866d84-8752-417e-bebd-bc63b99654e5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_2c17d492-05d2-4abb-bea3-a6ddd84f8a5e" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_c7866d84-8752-417e-bebd-bc63b99654e5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_c154588b-5491-4bc4-95b6-ce6e5c0f2d31" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_c7866d84-8752-417e-bebd-bc63b99654e5" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_c154588b-5491-4bc4-95b6-ce6e5c0f2d31" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/FinancialInstrumentsScheduleofFairValueGainLossDerivativeInstrumentDetails" xlink:type="simple" xlink:href="cah-20210630.xsd#FinancialInstrumentsScheduleofFairValueGainLossDerivativeInstrumentDetails"/>
  <link:definitionLink xlink:role="http://www.cardinal.com/role/FinancialInstrumentsScheduleofFairValueGainLossDerivativeInstrumentDetails" xlink:type="extended" id="i1b83e13ab2d64bdfaa396dceb60bb3d3_FinancialInstrumentsScheduleofFairValueGainLossDerivativeInstrumentDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_7fdc73ec-5a73-47a8-ae71-ebf7999ea567" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_8060f6ae-4c25-4b96-85c6-5e96c89c7c16" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_7fdc73ec-5a73-47a8-ae71-ebf7999ea567" xlink:to="loc_us-gaap_DerivativeNotionalAmount_8060f6ae-4c25-4b96-85c6-5e96c89c7c16" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeNet_aea53dd9-dbcc-406c-892e-4d5249b0e515" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_7fdc73ec-5a73-47a8-ae71-ebf7999ea567" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeNet_aea53dd9-dbcc-406c-892e-4d5249b0e515" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_a3305b20-1469-437d-b49a-38f1bfab892d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeLineItems_7fdc73ec-5a73-47a8-ae71-ebf7999ea567" xlink:to="loc_us-gaap_DerivativeTable_a3305b20-1469-437d-b49a-38f1bfab892d" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_3c2e741b-da9c-4be4-bd55-aa963ee19397" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_a3305b20-1469-437d-b49a-38f1bfab892d" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_3c2e741b-da9c-4be4-bd55-aa963ee19397" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_3c2e741b-da9c-4be4-bd55-aa963ee19397_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_3c2e741b-da9c-4be4-bd55-aa963ee19397" xlink:to="loc_us-gaap_HedgingRelationshipDomain_3c2e741b-da9c-4be4-bd55-aa963ee19397_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_3aa9e5bb-65f0-4e7c-8eae-7e2ccf609528" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_3c2e741b-da9c-4be4-bd55-aa963ee19397" xlink:to="loc_us-gaap_HedgingRelationshipDomain_3aa9e5bb-65f0-4e7c-8eae-7e2ccf609528" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueHedgingMember_fd41ed69-d52e-4662-b49c-e3b9d638cb69" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_3aa9e5bb-65f0-4e7c-8eae-7e2ccf609528" xlink:to="loc_us-gaap_FairValueHedgingMember_fd41ed69-d52e-4662-b49c-e3b9d638cb69" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember_bac61974-8980-422e-bc4a-ed6d4967de05" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_3aa9e5bb-65f0-4e7c-8eae-7e2ccf609528" xlink:to="loc_us-gaap_CashFlowHedgingMember_bac61974-8980-422e-bc4a-ed6d4967de05" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_c4c6fe5a-f913-4aa8-b6c8-517652e3e401" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_a3305b20-1469-437d-b49a-38f1bfab892d" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_c4c6fe5a-f913-4aa8-b6c8-517652e3e401" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_c4c6fe5a-f913-4aa8-b6c8-517652e3e401_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_c4c6fe5a-f913-4aa8-b6c8-517652e3e401" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_c4c6fe5a-f913-4aa8-b6c8-517652e3e401_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_b15de776-cac9-4149-bde6-265c0f95dc93" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_c4c6fe5a-f913-4aa8-b6c8-517652e3e401" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_b15de776-cac9-4149-bde6-265c0f95dc93" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_6de0ef35-d18f-4a48-8076-230b558c5452" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_b15de776-cac9-4149-bde6-265c0f95dc93" xlink:to="loc_us-gaap_InterestRateSwapMember_6de0ef35-d18f-4a48-8076-230b558c5452" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_4680b6c4-af10-4506-9317-712cce272773" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_b15de776-cac9-4149-bde6-265c0f95dc93" xlink:to="loc_us-gaap_ForeignExchangeContractMember_4680b6c4-af10-4506-9317-712cce272773" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForwardContractsMember_a8f29cf1-d304-4765-846a-036b05a0f0e6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForwardContractsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_b15de776-cac9-4149-bde6-265c0f95dc93" xlink:to="loc_us-gaap_ForwardContractsMember_a8f29cf1-d304-4765-846a-036b05a0f0e6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrencySwapMember_00289724-7b24-47f0-a3e7-8e54966dbe53" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrencySwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_b15de776-cac9-4149-bde6-265c0f95dc93" xlink:to="loc_us-gaap_CurrencySwapMember_00289724-7b24-47f0-a3e7-8e54966dbe53" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommodityContractMember_2824d220-0d82-47d9-99de-f254cb8aec03" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommodityContractMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_b15de776-cac9-4149-bde6-265c0f95dc93" xlink:to="loc_us-gaap_CommodityContractMember_2824d220-0d82-47d9-99de-f254cb8aec03" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/ShareholdersEquityNarrativeDetails" xlink:type="simple" xlink:href="cah-20210630.xsd#ShareholdersEquityNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.cardinal.com/role/ShareholdersEquityNarrativeDetails" xlink:type="extended" id="i03fc44c688984f188b9ccc690343b137_ShareholdersEquityNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems_937b9b7c-ec25-40f8-bdf7-be56d4632635" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_5ecff69b-c4df-4984-89af-bb08ce2117e1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_937b9b7c-ec25-40f8-bdf7-be56d4632635" xlink:to="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_5ecff69b-c4df-4984-89af-bb08ce2117e1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired_e2f206f7-ad6b-41df-8647-eeda759958cd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_937b9b7c-ec25-40f8-bdf7-be56d4632635" xlink:to="loc_us-gaap_TreasuryStockSharesAcquired_e2f206f7-ad6b-41df-8647-eeda759958cd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_b637b24d-63bf-4e49-ab85-210ddcda7beb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_937b9b7c-ec25-40f8-bdf7-be56d4632635" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_b637b24d-63bf-4e49-ab85-210ddcda7beb" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockAcquiredAverageCostPerShare_a24fccb2-593e-4ed2-b737-2000689d5ef8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockAcquiredAverageCostPerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_937b9b7c-ec25-40f8-bdf7-be56d4632635" xlink:to="loc_us-gaap_TreasuryStockAcquiredAverageCostPerShare_a24fccb2-593e-4ed2-b737-2000689d5ef8" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_TreasuryStockAcquiredShares_45ba53ce-e9cb-48a4-bc14-ab440cf3adcf" xlink:href="cah-20210630.xsd#cah_TreasuryStockAcquiredShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_937b9b7c-ec25-40f8-bdf7-be56d4632635" xlink:to="loc_cah_TreasuryStockAcquiredShares_45ba53ce-e9cb-48a4-bc14-ab440cf3adcf" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_2ca1f940-f0c0-4e33-9496-1a51c0dc1242" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_937b9b7c-ec25-40f8-bdf7-be56d4632635" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_2ca1f940-f0c0-4e33-9496-1a51c0dc1242" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_d7f6a725-91e7-4ad4-9b7b-2807c89cded3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_937b9b7c-ec25-40f8-bdf7-be56d4632635" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_d7f6a725-91e7-4ad4-9b7b-2807c89cded3" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_CommonStockVotingRightsVotes_a0128964-5711-4ff1-9759-6e4a9eeade7d" xlink:href="cah-20210630.xsd#cah_CommonStockVotingRightsVotes"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_937b9b7c-ec25-40f8-bdf7-be56d4632635" xlink:to="loc_cah_CommonStockVotingRightsVotes_a0128964-5711-4ff1-9759-6e4a9eeade7d" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_ab5a9810-f745-488d-b6c0-4563e82e280f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ClassOfStockLineItems_937b9b7c-ec25-40f8-bdf7-be56d4632635" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_ab5a9810-f745-488d-b6c0-4563e82e280f" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_92b920df-a6f9-4bdc-b6d8-bea019609723" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_ab5a9810-f745-488d-b6c0-4563e82e280f" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_92b920df-a6f9-4bdc-b6d8-bea019609723" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_92b920df-a6f9-4bdc-b6d8-bea019609723_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_92b920df-a6f9-4bdc-b6d8-bea019609723" xlink:to="loc_us-gaap_EquityComponentDomain_92b920df-a6f9-4bdc-b6d8-bea019609723_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_123efc04-d7cf-4727-957d-077417e22b65" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_92b920df-a6f9-4bdc-b6d8-bea019609723" xlink:to="loc_us-gaap_EquityComponentDomain_123efc04-d7cf-4727-957d-077417e22b65" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockMember_547efc80-4403-4a80-82c5-a02ef5e647f7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_123efc04-d7cf-4727-957d-077417e22b65" xlink:to="loc_us-gaap_TreasuryStockMember_547efc80-4403-4a80-82c5-a02ef5e647f7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_34a9a72b-eac2-436d-b2c8-72820e75b10b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_ab5a9810-f745-488d-b6c0-4563e82e280f" xlink:to="loc_us-gaap_StatementClassOfStockAxis_34a9a72b-eac2-436d-b2c8-72820e75b10b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_34a9a72b-eac2-436d-b2c8-72820e75b10b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_34a9a72b-eac2-436d-b2c8-72820e75b10b" xlink:to="loc_us-gaap_ClassOfStockDomain_34a9a72b-eac2-436d-b2c8-72820e75b10b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_a69caa75-4ccf-498d-b892-6ddebe497a63" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_34a9a72b-eac2-436d-b2c8-72820e75b10b" xlink:to="loc_us-gaap_ClassOfStockDomain_a69caa75-4ccf-498d-b892-6ddebe497a63" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassAMember_c3479769-8a56-4f19-b3af-6cfaad7ad6a1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonClassAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_a69caa75-4ccf-498d-b892-6ddebe497a63" xlink:to="loc_us-gaap_CommonClassAMember_c3479769-8a56-4f19-b3af-6cfaad7ad6a1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassBMember_17d1ea04-8492-4642-af7a-893bd16ad89e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonClassBMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_a69caa75-4ccf-498d-b892-6ddebe497a63" xlink:to="loc_us-gaap_CommonClassBMember_17d1ea04-8492-4642-af7a-893bd16ad89e" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/ShareholdersEquityChangesintheAccumulatedOtherComprehensiveIncomeLossDetails" xlink:type="simple" xlink:href="cah-20210630.xsd#ShareholdersEquityChangesintheAccumulatedOtherComprehensiveIncomeLossDetails"/>
  <link:definitionLink xlink:role="http://www.cardinal.com/role/ShareholdersEquityChangesintheAccumulatedOtherComprehensiveIncomeLossDetails" xlink:type="extended" id="i38d46cec2f8f417c9302697b58efe38f_ShareholdersEquityChangesintheAccumulatedOtherComprehensiveIncomeLossDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_aa40c434-3b87-48af-bd3b-487ec38f0414" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_543922aa-f5b8-46ae-adb1-1c70bb8e4487" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AOCIAttributableToParentNetOfTaxRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_aa40c434-3b87-48af-bd3b-487ec38f0414" xlink:to="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_543922aa-f5b8-46ae-adb1-1c70bb8e4487" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_b9487240-506c-4859-8fac-e0037cb718fa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_543922aa-f5b8-46ae-adb1-1c70bb8e4487" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_b9487240-506c-4859-8fac-e0037cb718fa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_53d63553-37be-40e3-9464-fc2440fd42c6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_543922aa-f5b8-46ae-adb1-1c70bb8e4487" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_53d63553-37be-40e3-9464-fc2440fd42c6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_2b54ce8e-d4e1-47ae-86c4-b35a3eeb9b8b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_543922aa-f5b8-46ae-adb1-1c70bb8e4487" xlink:to="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_2b54ce8e-d4e1-47ae-86c4-b35a3eeb9b8b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_1f768487-0197-4cd4-b32d-a442e1f4f892" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_543922aa-f5b8-46ae-adb1-1c70bb8e4487" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_1f768487-0197-4cd4-b32d-a442e1f4f892" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_f156b4fb-6c04-45f0-8760-5357ace3dfeb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_1bb8902b-ce6e-4616-805d-3af3f8178b93" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_aa40c434-3b87-48af-bd3b-487ec38f0414" xlink:to="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_1bb8902b-ce6e-4616-805d-3af3f8178b93" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_794e9d51-470b-400b-8872-81f0ca89f26e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_1bb8902b-ce6e-4616-805d-3af3f8178b93" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_794e9d51-470b-400b-8872-81f0ca89f26e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_794e9d51-470b-400b-8872-81f0ca89f26e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_794e9d51-470b-400b-8872-81f0ca89f26e" xlink:to="loc_us-gaap_EquityComponentDomain_794e9d51-470b-400b-8872-81f0ca89f26e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_808cabe5-d212-4f30-a3fd-e4346f3ca70f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_794e9d51-470b-400b-8872-81f0ca89f26e" xlink:to="loc_us-gaap_EquityComponentDomain_808cabe5-d212-4f30-a3fd-e4346f3ca70f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember_f074a85d-7bdb-40ef-9cc4-c91e4a61bc15" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_808cabe5-d212-4f30-a3fd-e4346f3ca70f" xlink:to="loc_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember_f074a85d-7bdb-40ef-9cc4-c91e4a61bc15" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember_ea8e9326-b2b1-49db-8be7-89b42ba092f7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_808cabe5-d212-4f30-a3fd-e4346f3ca70f" xlink:to="loc_us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember_ea8e9326-b2b1-49db-8be7-89b42ba092f7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember_2f4e7fe8-8799-48bf-8f31-b75801514964" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_808cabe5-d212-4f30-a3fd-e4346f3ca70f" xlink:to="loc_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember_2f4e7fe8-8799-48bf-8f31-b75801514964" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_dbe54106-bedd-425b-a661-e9dacf412ae1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_808cabe5-d212-4f30-a3fd-e4346f3ca70f" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_dbe54106-bedd-425b-a661-e9dacf412ae1" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/SegmentInformationNarrativeDetails" xlink:type="simple" xlink:href="cah-20210630.xsd#SegmentInformationNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.cardinal.com/role/SegmentInformationNarrativeDetails" xlink:type="extended" id="i713eb7c8027848d2a2cd17c3bcf8b4f2_SegmentInformationNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_f024f3de-76bb-449c-b6ef-855c233741a1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_PreTaxGainonDivestiture_52e560b6-b6c9-48f1-97f0-2d14103f7e79" xlink:href="cah-20210630.xsd#cah_PreTaxGainonDivestiture"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_f024f3de-76bb-449c-b6ef-855c233741a1" xlink:to="loc_cah_PreTaxGainonDivestiture_52e560b6-b6c9-48f1-97f0-2d14103f7e79" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossRelatedToLitigationSettlement_40c355a9-a3a9-4791-8168-e58c12c9472e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossRelatedToLitigationSettlement"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_f024f3de-76bb-449c-b6ef-855c233741a1" xlink:to="loc_us-gaap_GainLossRelatedToLitigationSettlement_40c355a9-a3a9-4791-8168-e58c12c9472e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_EstimatedLiabilityForNewYorkOpioidStewardshipAct_6b4313ab-0e56-4ba9-819e-e3f2cfbdbdcf" xlink:href="cah-20210630.xsd#cah_EstimatedLiabilityForNewYorkOpioidStewardshipAct"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_f024f3de-76bb-449c-b6ef-855c233741a1" xlink:to="loc_cah_EstimatedLiabilityForNewYorkOpioidStewardshipAct_6b4313ab-0e56-4ba9-819e-e3f2cfbdbdcf" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRecallExpense_41203ade-5b6b-4a45-8aee-61afd56762b3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryRecallExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_f024f3de-76bb-449c-b6ef-855c233741a1" xlink:to="loc_us-gaap_InventoryRecallExpense_41203ade-5b6b-4a45-8aee-61afd56762b3" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_ProjectCostsOnInvestmentAndOtherSpending_2a94460d-9506-43f3-a6b4-d4566a85b909" xlink:href="cah-20210630.xsd#cah_ProjectCostsOnInvestmentAndOtherSpending"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_f024f3de-76bb-449c-b6ef-855c233741a1" xlink:to="loc_cah_ProjectCostsOnInvestmentAndOtherSpending_2a94460d-9506-43f3-a6b4-d4566a85b909" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments_10623d5c-ed15-4b21-bbb1-c6e48b296ba3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_f024f3de-76bb-449c-b6ef-855c233741a1" xlink:to="loc_us-gaap_NumberOfReportableSegments_10623d5c-ed15-4b21-bbb1-c6e48b296ba3" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainOnSaleOfInvestments_402a5835-65ba-405d-a24a-b6745e0e1477" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainOnSaleOfInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_f024f3de-76bb-449c-b6ef-855c233741a1" xlink:to="loc_us-gaap_GainOnSaleOfInvestments_402a5835-65ba-405d-a24a-b6745e0e1477" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_GainonDivestitureAfterTax_0cf64e13-56bf-4149-ad8d-9bda65bf34fc" xlink:href="cah-20210630.xsd#cah_GainonDivestitureAfterTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_f024f3de-76bb-449c-b6ef-855c233741a1" xlink:to="loc_cah_GainonDivestitureAfterTax_0cf64e13-56bf-4149-ad8d-9bda65bf34fc" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_143b970a-91ff-4567-99a9-c6980bf0128c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_f024f3de-76bb-449c-b6ef-855c233741a1" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_143b970a-91ff-4567-99a9-c6980bf0128c" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_OpioidLitigationAxis_f74c9bd1-78c0-410a-aaa3-d21314147f5e" xlink:href="cah-20210630.xsd#cah_OpioidLitigationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_143b970a-91ff-4567-99a9-c6980bf0128c" xlink:to="loc_cah_OpioidLitigationAxis_f74c9bd1-78c0-410a-aaa3-d21314147f5e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_OpioidLitigationDomain_f74c9bd1-78c0-410a-aaa3-d21314147f5e_default" xlink:href="cah-20210630.xsd#cah_OpioidLitigationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_cah_OpioidLitigationAxis_f74c9bd1-78c0-410a-aaa3-d21314147f5e" xlink:to="loc_cah_OpioidLitigationDomain_f74c9bd1-78c0-410a-aaa3-d21314147f5e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_OpioidLitigationDomain_515cca71-5f67-4e03-b71d-149e76f74278" xlink:href="cah-20210630.xsd#cah_OpioidLitigationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_cah_OpioidLitigationAxis_f74c9bd1-78c0-410a-aaa3-d21314147f5e" xlink:to="loc_cah_OpioidLitigationDomain_515cca71-5f67-4e03-b71d-149e76f74278" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_TotalOpioidLitigationMember_fe808021-8166-4ee0-8e8c-a6a72e49104d" xlink:href="cah-20210630.xsd#cah_TotalOpioidLitigationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cah_OpioidLitigationDomain_515cca71-5f67-4e03-b71d-149e76f74278" xlink:to="loc_cah_TotalOpioidLitigationMember_fe808021-8166-4ee0-8e8c-a6a72e49104d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_9cc9bb14-3158-4e85-9aa5-4602276a2034" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_143b970a-91ff-4567-99a9-c6980bf0128c" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_9cc9bb14-3158-4e85-9aa5-4602276a2034" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_9cc9bb14-3158-4e85-9aa5-4602276a2034_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_9cc9bb14-3158-4e85-9aa5-4602276a2034" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_9cc9bb14-3158-4e85-9aa5-4602276a2034_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_b0f2bef0-bc27-4cae-ad4c-7809e8b3f0a7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_9cc9bb14-3158-4e85-9aa5-4602276a2034" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_b0f2bef0-bc27-4cae-ad4c-7809e8b3f0a7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_NaviHealthMember_b6d89605-0a9c-4d41-b643-8ac12c240b98" xlink:href="cah-20210630.xsd#cah_NaviHealthMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_b0f2bef0-bc27-4cae-ad4c-7809e8b3f0a7" xlink:to="loc_cah_NaviHealthMember_b6d89605-0a9c-4d41-b643-8ac12c240b98" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_675d87b1-7bc2-48c5-b9d8-71f7dc82b144" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LitigationCaseAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_143b970a-91ff-4567-99a9-c6980bf0128c" xlink:to="loc_srt_LitigationCaseAxis_675d87b1-7bc2-48c5-b9d8-71f7dc82b144" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_675d87b1-7bc2-48c5-b9d8-71f7dc82b144_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_LitigationCaseAxis_675d87b1-7bc2-48c5-b9d8-71f7dc82b144" xlink:to="loc_srt_LitigationCaseTypeDomain_675d87b1-7bc2-48c5-b9d8-71f7dc82b144_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_8beba5fe-5fd9-42d2-9564-cd85143e1d78" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_LitigationCaseAxis_675d87b1-7bc2-48c5-b9d8-71f7dc82b144" xlink:to="loc_srt_LitigationCaseTypeDomain_8beba5fe-5fd9-42d2-9564-cd85143e1d78" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_NewYorkOpioidStewardshipActMember_5a56adfe-ff8b-418b-81e9-e5931a36adb8" xlink:href="cah-20210630.xsd#cah_NewYorkOpioidStewardshipActMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_8beba5fe-5fd9-42d2-9564-cd85143e1d78" xlink:to="loc_cah_NewYorkOpioidStewardshipActMember_5a56adfe-ff8b-418b-81e9-e5931a36adb8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_SterileSurgicalGownRecallAxis_ef16e9ff-803d-432d-828f-15b1d034248c" xlink:href="cah-20210630.xsd#cah_SterileSurgicalGownRecallAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_143b970a-91ff-4567-99a9-c6980bf0128c" xlink:to="loc_cah_SterileSurgicalGownRecallAxis_ef16e9ff-803d-432d-828f-15b1d034248c" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_SterileSurgicalGownRecallDomain_ef16e9ff-803d-432d-828f-15b1d034248c_default" xlink:href="cah-20210630.xsd#cah_SterileSurgicalGownRecallDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_cah_SterileSurgicalGownRecallAxis_ef16e9ff-803d-432d-828f-15b1d034248c" xlink:to="loc_cah_SterileSurgicalGownRecallDomain_ef16e9ff-803d-432d-828f-15b1d034248c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_SterileSurgicalGownRecallDomain_cd0e017c-dfcc-4d76-8a94-b05cf338c561" xlink:href="cah-20210630.xsd#cah_SterileSurgicalGownRecallDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_cah_SterileSurgicalGownRecallAxis_ef16e9ff-803d-432d-828f-15b1d034248c" xlink:to="loc_cah_SterileSurgicalGownRecallDomain_cd0e017c-dfcc-4d76-8a94-b05cf338c561" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_SterileSurgicalGownRecallMemberDomain_5259f8ba-157c-4632-9bc2-b3d0c90e6791" xlink:href="cah-20210630.xsd#cah_SterileSurgicalGownRecallMemberDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cah_SterileSurgicalGownRecallDomain_cd0e017c-dfcc-4d76-8a94-b05cf338c561" xlink:to="loc_cah_SterileSurgicalGownRecallMemberDomain_5259f8ba-157c-4632-9bc2-b3d0c90e6791" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/SegmentInformationRevenuebyReportableSegmentDetails" xlink:type="simple" xlink:href="cah-20210630.xsd#SegmentInformationRevenuebyReportableSegmentDetails"/>
  <link:definitionLink xlink:role="http://www.cardinal.com/role/SegmentInformationRevenuebyReportableSegmentDetails" xlink:type="extended" id="iabeb60a1ddee480e9caea6de6a43b472_SegmentInformationRevenuebyReportableSegmentDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_409e5cfa-cea6-47e4-a319-4fb1cc2b8f14" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_3397e51c-1723-42d0-b61e-a7f2d1145bda" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Revenues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_409e5cfa-cea6-47e4-a319-4fb1cc2b8f14" xlink:to="loc_us-gaap_Revenues_3397e51c-1723-42d0-b61e-a7f2d1145bda" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_05e6d26d-765c-460f-b483-bb283562c759" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_409e5cfa-cea6-47e4-a319-4fb1cc2b8f14" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_05e6d26d-765c-460f-b483-bb283562c759" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_6da44989-4ba3-4886-80b2-9d0e0bf3833e" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_05e6d26d-765c-460f-b483-bb283562c759" xlink:to="loc_srt_ConsolidationItemsAxis_6da44989-4ba3-4886-80b2-9d0e0bf3833e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_6da44989-4ba3-4886-80b2-9d0e0bf3833e_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidationItemsAxis_6da44989-4ba3-4886-80b2-9d0e0bf3833e" xlink:to="loc_srt_ConsolidationItemsDomain_6da44989-4ba3-4886-80b2-9d0e0bf3833e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_96a32952-0393-4bb2-857f-cb37afce9d1e" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidationItemsAxis_6da44989-4ba3-4886-80b2-9d0e0bf3833e" xlink:to="loc_srt_ConsolidationItemsDomain_96a32952-0393-4bb2-857f-cb37afce9d1e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_2ebdefcc-de22-4524-8425-2d0f7b23e89b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_96a32952-0393-4bb2-857f-cb37afce9d1e" xlink:to="loc_us-gaap_OperatingSegmentsMember_2ebdefcc-de22-4524-8425-2d0f7b23e89b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember_f55edc37-d1d2-4eed-8636-5f0c81fa2ef8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_96a32952-0393-4bb2-857f-cb37afce9d1e" xlink:to="loc_us-gaap_CorporateNonSegmentMember_f55edc37-d1d2-4eed-8636-5f0c81fa2ef8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_b2f2d342-7531-4a79-a342-20c0a9e20f76" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_05e6d26d-765c-460f-b483-bb283562c759" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_b2f2d342-7531-4a79-a342-20c0a9e20f76" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_b2f2d342-7531-4a79-a342-20c0a9e20f76_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_b2f2d342-7531-4a79-a342-20c0a9e20f76" xlink:to="loc_us-gaap_SegmentDomain_b2f2d342-7531-4a79-a342-20c0a9e20f76_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_a21221b1-7cf4-4cef-8891-810e545787b5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_b2f2d342-7531-4a79-a342-20c0a9e20f76" xlink:to="loc_us-gaap_SegmentDomain_a21221b1-7cf4-4cef-8891-810e545787b5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_PharmaceuticalMember_ec049c31-c0de-4ef5-a2d4-ea0b408f6194" xlink:href="cah-20210630.xsd#cah_PharmaceuticalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_a21221b1-7cf4-4cef-8891-810e545787b5" xlink:to="loc_cah_PharmaceuticalMember_ec049c31-c0de-4ef5-a2d4-ea0b408f6194" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_MedicalMemberMember_ac17134a-d040-4bce-a3bc-26c422b302e3" xlink:href="cah-20210630.xsd#cah_MedicalMemberMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_a21221b1-7cf4-4cef-8891-810e545787b5" xlink:to="loc_cah_MedicalMemberMember_ac17134a-d040-4bce-a3bc-26c422b302e3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsegmentsAxis_bcb34ccd-7182-4cd0-88af-411893170dac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_05e6d26d-765c-460f-b483-bb283562c759" xlink:to="loc_us-gaap_SubsegmentsAxis_bcb34ccd-7182-4cd0-88af-411893170dac" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsegmentsDomain_bcb34ccd-7182-4cd0-88af-411893170dac_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsegmentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsegmentsAxis_bcb34ccd-7182-4cd0-88af-411893170dac" xlink:to="loc_us-gaap_SubsegmentsDomain_bcb34ccd-7182-4cd0-88af-411893170dac_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsegmentsDomain_d1b1057a-7cf6-42c5-b264-48070d28f2a6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsegmentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsegmentsAxis_bcb34ccd-7182-4cd0-88af-411893170dac" xlink:to="loc_us-gaap_SubsegmentsDomain_d1b1057a-7cf6-42c5-b264-48070d28f2a6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_PharmaceuticalDistributionandSpecialtyMember_0f5ca610-73b6-4e8c-b533-adcbdd02f020" xlink:href="cah-20210630.xsd#cah_PharmaceuticalDistributionandSpecialtyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsegmentsDomain_d1b1057a-7cf6-42c5-b264-48070d28f2a6" xlink:to="loc_cah_PharmaceuticalDistributionandSpecialtyMember_0f5ca610-73b6-4e8c-b533-adcbdd02f020" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_NuclearPrecisionHealthServicesMember_991afe78-5a70-408d-98b7-676eae6f6b3a" xlink:href="cah-20210630.xsd#cah_NuclearPrecisionHealthServicesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsegmentsDomain_d1b1057a-7cf6-42c5-b264-48070d28f2a6" xlink:to="loc_cah_NuclearPrecisionHealthServicesMember_991afe78-5a70-408d-98b7-676eae6f6b3a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_MedicaldistributionandproductsMember_e8cf71a0-0823-40d4-b2f4-79dcff731548" xlink:href="cah-20210630.xsd#cah_MedicaldistributionandproductsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsegmentsDomain_d1b1057a-7cf6-42c5-b264-48070d28f2a6" xlink:to="loc_cah_MedicaldistributionandproductsMember_e8cf71a0-0823-40d4-b2f4-79dcff731548" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_CardinalHealthAtHomeSolutionsMember_13fd7c73-54c2-4d7f-a771-43c77c27cdf4" xlink:href="cah-20210630.xsd#cah_CardinalHealthAtHomeSolutionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsegmentsDomain_d1b1057a-7cf6-42c5-b264-48070d28f2a6" xlink:to="loc_cah_CardinalHealthAtHomeSolutionsMember_13fd7c73-54c2-4d7f-a771-43c77c27cdf4" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsegmentsConsolidationItemsAxis_bea894dd-cbe9-453b-a8d5-36d30925ee47" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsegmentsConsolidationItemsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_05e6d26d-765c-460f-b483-bb283562c759" xlink:to="loc_us-gaap_SubsegmentsConsolidationItemsAxis_bea894dd-cbe9-453b-a8d5-36d30925ee47" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsegmentsConsolidationItemsDomain_bea894dd-cbe9-453b-a8d5-36d30925ee47_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsegmentsConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsegmentsConsolidationItemsAxis_bea894dd-cbe9-453b-a8d5-36d30925ee47" xlink:to="loc_us-gaap_SubsegmentsConsolidationItemsDomain_bea894dd-cbe9-453b-a8d5-36d30925ee47_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsegmentsConsolidationItemsDomain_152c45b3-3d04-4ece-8efa-194fedfe39b2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsegmentsConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsegmentsConsolidationItemsAxis_bea894dd-cbe9-453b-a8d5-36d30925ee47" xlink:to="loc_us-gaap_SubsegmentsConsolidationItemsDomain_152c45b3-3d04-4ece-8efa-194fedfe39b2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_271a2601-263e-4a89-a817-db67118a3e07" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_05e6d26d-765c-460f-b483-bb283562c759" xlink:to="loc_srt_StatementGeographicalAxis_271a2601-263e-4a89-a817-db67118a3e07" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_271a2601-263e-4a89-a817-db67118a3e07_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_271a2601-263e-4a89-a817-db67118a3e07" xlink:to="loc_srt_SegmentGeographicalDomain_271a2601-263e-4a89-a817-db67118a3e07_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_e5557c61-85d2-4e68-a2ec-a256b276e439" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_271a2601-263e-4a89-a817-db67118a3e07" xlink:to="loc_srt_SegmentGeographicalDomain_e5557c61-85d2-4e68-a2ec-a256b276e439" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonUsMember_db21b6b3-3e11-4b71-a367-011d88afdbcc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonUsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_e5557c61-85d2-4e68-a2ec-a256b276e439" xlink:to="loc_us-gaap_NonUsMember_db21b6b3-3e11-4b71-a367-011d88afdbcc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_0d9e65a2-3d52-4beb-ae3a-4ac99b643959" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_US"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_e5557c61-85d2-4e68-a2ec-a256b276e439" xlink:to="loc_country_US_0d9e65a2-3d52-4beb-ae3a-4ac99b643959" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/SegmentInformationSegmentProfitbyReportableSegmentDetails" xlink:type="simple" xlink:href="cah-20210630.xsd#SegmentInformationSegmentProfitbyReportableSegmentDetails"/>
  <link:definitionLink xlink:role="http://www.cardinal.com/role/SegmentInformationSegmentProfitbyReportableSegmentDetails" xlink:type="extended" id="i57f2cd89b6ae45828c421810ea50f910_SegmentInformationSegmentProfitbyReportableSegmentDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems_33c8ba7e-f5cc-438c-a31d-35672bf27547" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_d76abbec-11f6-4a89-89da-12b9ba6338d4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems_33c8ba7e-f5cc-438c-a31d-35672bf27547" xlink:to="loc_us-gaap_OperatingIncomeLoss_d76abbec-11f6-4a89-89da-12b9ba6338d4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable_273fe0d7-39c9-4986-bed3-15726e94a80a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems_33c8ba7e-f5cc-438c-a31d-35672bf27547" xlink:to="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable_273fe0d7-39c9-4986-bed3-15726e94a80a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_89879e77-45af-4266-a9cf-139e8c954299" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable_273fe0d7-39c9-4986-bed3-15726e94a80a" xlink:to="loc_srt_ConsolidationItemsAxis_89879e77-45af-4266-a9cf-139e8c954299" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_89879e77-45af-4266-a9cf-139e8c954299_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidationItemsAxis_89879e77-45af-4266-a9cf-139e8c954299" xlink:to="loc_srt_ConsolidationItemsDomain_89879e77-45af-4266-a9cf-139e8c954299_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_b73b4b8a-e110-4491-86eb-965f6cdc59f5" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidationItemsAxis_89879e77-45af-4266-a9cf-139e8c954299" xlink:to="loc_srt_ConsolidationItemsDomain_b73b4b8a-e110-4491-86eb-965f6cdc59f5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_e0d253cd-6c14-4049-9642-9b4b4501a04f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_b73b4b8a-e110-4491-86eb-965f6cdc59f5" xlink:to="loc_us-gaap_OperatingSegmentsMember_e0d253cd-6c14-4049-9642-9b4b4501a04f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember_2a95deba-cad7-4ce7-8591-5e17f076c3bb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_b73b4b8a-e110-4491-86eb-965f6cdc59f5" xlink:to="loc_us-gaap_CorporateNonSegmentMember_2a95deba-cad7-4ce7-8591-5e17f076c3bb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_a631f6e2-f66b-4901-b1a9-a7495d9a563d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable_273fe0d7-39c9-4986-bed3-15726e94a80a" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_a631f6e2-f66b-4901-b1a9-a7495d9a563d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_a631f6e2-f66b-4901-b1a9-a7495d9a563d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_a631f6e2-f66b-4901-b1a9-a7495d9a563d" xlink:to="loc_us-gaap_SegmentDomain_a631f6e2-f66b-4901-b1a9-a7495d9a563d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_6750f3a8-8093-4553-9c4a-024ef4fde2fc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_a631f6e2-f66b-4901-b1a9-a7495d9a563d" xlink:to="loc_us-gaap_SegmentDomain_6750f3a8-8093-4553-9c4a-024ef4fde2fc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_PharmaceuticalMember_bb623312-6253-4f1d-9151-2c1c5fe28014" xlink:href="cah-20210630.xsd#cah_PharmaceuticalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_6750f3a8-8093-4553-9c4a-024ef4fde2fc" xlink:to="loc_cah_PharmaceuticalMember_bb623312-6253-4f1d-9151-2c1c5fe28014" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_MedicalMemberMember_ce9ed144-7a12-481a-b8da-c68dd091e92b" xlink:href="cah-20210630.xsd#cah_MedicalMemberMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_6750f3a8-8093-4553-9c4a-024ef4fde2fc" xlink:to="loc_cah_MedicalMemberMember_ce9ed144-7a12-481a-b8da-c68dd091e92b" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/SegmentInformationDepreciationandAmortizationandAdditionstoPropertyandEquipmentbyReportableSegmentDetails" xlink:type="simple" xlink:href="cah-20210630.xsd#SegmentInformationDepreciationandAmortizationandAdditionstoPropertyandEquipmentbyReportableSegmentDetails"/>
  <link:definitionLink xlink:role="http://www.cardinal.com/role/SegmentInformationDepreciationandAmortizationandAdditionstoPropertyandEquipmentbyReportableSegmentDetails" xlink:type="extended" id="ic2dbf108586749299863cdc123b45298_SegmentInformationDepreciationandAmortizationandAdditionstoPropertyandEquipmentbyReportableSegmentDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_975bb12f-2864-4ea7-9e48-73a69ba83c9e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_d8472cd2-ca6c-427a-bfd1-ce944fed1db8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_975bb12f-2864-4ea7-9e48-73a69ba83c9e" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_d8472cd2-ca6c-427a-bfd1-ce944fed1db8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_5d426bbe-82da-47dd-9a70-f8c514bda931" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_975bb12f-2864-4ea7-9e48-73a69ba83c9e" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_5d426bbe-82da-47dd-9a70-f8c514bda931" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_6d30362b-b55c-44c9-8ca0-1be56ac7cf76" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_975bb12f-2864-4ea7-9e48-73a69ba83c9e" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_6d30362b-b55c-44c9-8ca0-1be56ac7cf76" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_90ef2c95-e067-4749-acd2-0c38de8ae93c" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_6d30362b-b55c-44c9-8ca0-1be56ac7cf76" xlink:to="loc_srt_ConsolidationItemsAxis_90ef2c95-e067-4749-acd2-0c38de8ae93c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_90ef2c95-e067-4749-acd2-0c38de8ae93c_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidationItemsAxis_90ef2c95-e067-4749-acd2-0c38de8ae93c" xlink:to="loc_srt_ConsolidationItemsDomain_90ef2c95-e067-4749-acd2-0c38de8ae93c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_337d091f-33b7-4838-9588-4eca6e8a1a4b" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidationItemsAxis_90ef2c95-e067-4749-acd2-0c38de8ae93c" xlink:to="loc_srt_ConsolidationItemsDomain_337d091f-33b7-4838-9588-4eca6e8a1a4b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_91bae7af-0be5-44a0-8bee-725c19b195cd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_337d091f-33b7-4838-9588-4eca6e8a1a4b" xlink:to="loc_us-gaap_OperatingSegmentsMember_91bae7af-0be5-44a0-8bee-725c19b195cd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember_d0b40f13-48cf-4dfd-92b3-14ac007891dd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_337d091f-33b7-4838-9588-4eca6e8a1a4b" xlink:to="loc_us-gaap_CorporateNonSegmentMember_d0b40f13-48cf-4dfd-92b3-14ac007891dd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_1d2ab568-92b9-4587-8149-5c07d12f0187" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_6d30362b-b55c-44c9-8ca0-1be56ac7cf76" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_1d2ab568-92b9-4587-8149-5c07d12f0187" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_1d2ab568-92b9-4587-8149-5c07d12f0187_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_1d2ab568-92b9-4587-8149-5c07d12f0187" xlink:to="loc_us-gaap_SegmentDomain_1d2ab568-92b9-4587-8149-5c07d12f0187_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_80e86aed-caf1-4c61-8bd7-0b5f3a0b7572" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_1d2ab568-92b9-4587-8149-5c07d12f0187" xlink:to="loc_us-gaap_SegmentDomain_80e86aed-caf1-4c61-8bd7-0b5f3a0b7572" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_PharmaceuticalMember_74595d19-36f2-4859-8c7e-565a57840ab5" xlink:href="cah-20210630.xsd#cah_PharmaceuticalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_80e86aed-caf1-4c61-8bd7-0b5f3a0b7572" xlink:to="loc_cah_PharmaceuticalMember_74595d19-36f2-4859-8c7e-565a57840ab5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_MedicalMemberMember_dbc5010f-e2b7-471c-8db8-1ba29955c106" xlink:href="cah-20210630.xsd#cah_MedicalMemberMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_80e86aed-caf1-4c61-8bd7-0b5f3a0b7572" xlink:to="loc_cah_MedicalMemberMember_dbc5010f-e2b7-471c-8db8-1ba29955c106" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/SegmentInformationAssetsbyReportableSegmentDetails" xlink:type="simple" xlink:href="cah-20210630.xsd#SegmentInformationAssetsbyReportableSegmentDetails"/>
  <link:definitionLink xlink:role="http://www.cardinal.com/role/SegmentInformationAssetsbyReportableSegmentDetails" xlink:type="extended" id="i1b68c18307224397af7f764a36c172b7_SegmentInformationAssetsbyReportableSegmentDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_e9dc9a8f-fe35-40a4-9a78-f8ae3550e434" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_20ab0108-1829-40e3-8553-a47438efec15" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_e9dc9a8f-fe35-40a4-9a78-f8ae3550e434" xlink:to="loc_us-gaap_Assets_20ab0108-1829-40e3-8553-a47438efec15" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_fbb696fc-f744-4336-91ce-f27b1aa1045c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_e9dc9a8f-fe35-40a4-9a78-f8ae3550e434" xlink:to="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_fbb696fc-f744-4336-91ce-f27b1aa1045c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_dda079a9-5a7a-4649-9797-27d4c69085a8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_e9dc9a8f-fe35-40a4-9a78-f8ae3550e434" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_dda079a9-5a7a-4649-9797-27d4c69085a8" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_c9199b0e-e6cd-4df8-9130-4ac9c15cd000" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_dda079a9-5a7a-4649-9797-27d4c69085a8" xlink:to="loc_srt_ConsolidationItemsAxis_c9199b0e-e6cd-4df8-9130-4ac9c15cd000" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_c9199b0e-e6cd-4df8-9130-4ac9c15cd000_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidationItemsAxis_c9199b0e-e6cd-4df8-9130-4ac9c15cd000" xlink:to="loc_srt_ConsolidationItemsDomain_c9199b0e-e6cd-4df8-9130-4ac9c15cd000_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_1021f903-fdab-46db-9ac2-859441762df2" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidationItemsAxis_c9199b0e-e6cd-4df8-9130-4ac9c15cd000" xlink:to="loc_srt_ConsolidationItemsDomain_1021f903-fdab-46db-9ac2-859441762df2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_92cad0bd-365f-43c6-a592-4bb2872cbe51" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_1021f903-fdab-46db-9ac2-859441762df2" xlink:to="loc_us-gaap_OperatingSegmentsMember_92cad0bd-365f-43c6-a592-4bb2872cbe51" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember_5cb3d753-5ea3-4111-8179-e5501693e3ea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_1021f903-fdab-46db-9ac2-859441762df2" xlink:to="loc_us-gaap_CorporateNonSegmentMember_5cb3d753-5ea3-4111-8179-e5501693e3ea" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_046d3b18-291e-41a7-8b75-8a3b132d1d8e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_dda079a9-5a7a-4649-9797-27d4c69085a8" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_046d3b18-291e-41a7-8b75-8a3b132d1d8e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_046d3b18-291e-41a7-8b75-8a3b132d1d8e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_046d3b18-291e-41a7-8b75-8a3b132d1d8e" xlink:to="loc_us-gaap_SegmentDomain_046d3b18-291e-41a7-8b75-8a3b132d1d8e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_1c9d5a60-e883-44b4-bf8a-8097c40a6669" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_046d3b18-291e-41a7-8b75-8a3b132d1d8e" xlink:to="loc_us-gaap_SegmentDomain_1c9d5a60-e883-44b4-bf8a-8097c40a6669" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_PharmaceuticalMember_3268d1f8-65e1-4e55-a72d-541139c01b1f" xlink:href="cah-20210630.xsd#cah_PharmaceuticalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_1c9d5a60-e883-44b4-bf8a-8097c40a6669" xlink:to="loc_cah_PharmaceuticalMember_3268d1f8-65e1-4e55-a72d-541139c01b1f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_MedicalMemberMember_f9e9003a-7983-45f4-a98b-d051e3921e55" xlink:href="cah-20210630.xsd#cah_MedicalMemberMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_1c9d5a60-e883-44b4-bf8a-8097c40a6669" xlink:to="loc_cah_MedicalMemberMember_f9e9003a-7983-45f4-a98b-d051e3921e55" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_CordisDivestitureAxis_3ddd4ecd-0962-43f9-8983-3a2def3eba98" xlink:href="cah-20210630.xsd#cah_CordisDivestitureAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_dda079a9-5a7a-4649-9797-27d4c69085a8" xlink:to="loc_cah_CordisDivestitureAxis_3ddd4ecd-0962-43f9-8983-3a2def3eba98" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_CordisDivestitureDomain_3ddd4ecd-0962-43f9-8983-3a2def3eba98_default" xlink:href="cah-20210630.xsd#cah_CordisDivestitureDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_cah_CordisDivestitureAxis_3ddd4ecd-0962-43f9-8983-3a2def3eba98" xlink:to="loc_cah_CordisDivestitureDomain_3ddd4ecd-0962-43f9-8983-3a2def3eba98_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_CordisDivestitureDomain_34fa786a-2a5a-43ca-86ad-17b718fd4380" xlink:href="cah-20210630.xsd#cah_CordisDivestitureDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_cah_CordisDivestitureAxis_3ddd4ecd-0962-43f9-8983-3a2def3eba98" xlink:to="loc_cah_CordisDivestitureDomain_34fa786a-2a5a-43ca-86ad-17b718fd4380" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_CordisDivestitureMember_57142c71-4268-41b1-b023-9220bf258af6" xlink:href="cah-20210630.xsd#cah_CordisDivestitureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cah_CordisDivestitureDomain_34fa786a-2a5a-43ca-86ad-17b718fd4380" xlink:to="loc_cah_CordisDivestitureMember_57142c71-4268-41b1-b023-9220bf258af6" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/SegmentInformationPropertyandEquipmentnetbyGeographicAreaDetails" xlink:type="simple" xlink:href="cah-20210630.xsd#SegmentInformationPropertyandEquipmentnetbyGeographicAreaDetails"/>
  <link:definitionLink xlink:role="http://www.cardinal.com/role/SegmentInformationPropertyandEquipmentnetbyGeographicAreaDetails" xlink:type="extended" id="i05a97429aba34d849c5b459efc0231ae_SegmentInformationPropertyandEquipmentnetbyGeographicAreaDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_1c615ba7-d8e4-4b0f-bd7f-72d7633790cd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_45e7d1cc-bfd6-4e3d-9599-d6d0595bfcca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_1c615ba7-d8e4-4b0f-bd7f-72d7633790cd" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_45e7d1cc-bfd6-4e3d-9599-d6d0595bfcca" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_62aaf170-baaf-468b-85cf-e3d695813c43" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_1c615ba7-d8e4-4b0f-bd7f-72d7633790cd" xlink:to="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_62aaf170-baaf-468b-85cf-e3d695813c43" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_a686f119-016e-4d31-991c-399cfefd9c67" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_62aaf170-baaf-468b-85cf-e3d695813c43" xlink:to="loc_srt_StatementGeographicalAxis_a686f119-016e-4d31-991c-399cfefd9c67" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_a686f119-016e-4d31-991c-399cfefd9c67_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_a686f119-016e-4d31-991c-399cfefd9c67" xlink:to="loc_srt_SegmentGeographicalDomain_a686f119-016e-4d31-991c-399cfefd9c67_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_6145390c-748e-48bd-9b9b-6ae81200364f" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_a686f119-016e-4d31-991c-399cfefd9c67" xlink:to="loc_srt_SegmentGeographicalDomain_6145390c-748e-48bd-9b9b-6ae81200364f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_07f4b914-e5c8-48ef-9df3-bae84804f51c" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_US"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_6145390c-748e-48bd-9b9b-6ae81200364f" xlink:to="loc_country_US_07f4b914-e5c8-48ef-9df3-bae84804f51c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonUsMember_cfe17581-ca21-4a1b-bb19-671635a08bf5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonUsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_6145390c-748e-48bd-9b9b-6ae81200364f" xlink:to="loc_us-gaap_NonUsMember_cfe17581-ca21-4a1b-bb19-671635a08bf5" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/ShareBasedCompensationNarrativeDetails" xlink:type="simple" xlink:href="cah-20210630.xsd#ShareBasedCompensationNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.cardinal.com/role/ShareBasedCompensationNarrativeDetails" xlink:type="extended" id="i03a732c25b3b4fe08c2b4a73695fd398_ShareBasedCompensationNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_997cffec-8314-455e-a9d8-3de8194abd96" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_e9125ae3-ad2b-4310-a255-624acfe96629" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_997cffec-8314-455e-a9d8-3de8194abd96" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_e9125ae3-ad2b-4310-a255-624acfe96629" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_e43b933b-17f0-4a60-917f-0eb3be5186c4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_997cffec-8314-455e-a9d8-3de8194abd96" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_e43b933b-17f0-4a60-917f-0eb3be5186c4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_c980bdca-121f-419a-96bd-ea87e463f7c3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_997cffec-8314-455e-a9d8-3de8194abd96" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_c980bdca-121f-419a-96bd-ea87e463f7c3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_ExercisablePeriodOfPlansInYears_3f94eda1-bbbc-4551-9e76-5ae93b505e6f" xlink:href="cah-20210630.xsd#cah_ExercisablePeriodOfPlansInYears"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_997cffec-8314-455e-a9d8-3de8194abd96" xlink:to="loc_cah_ExercisablePeriodOfPlansInYears_3f94eda1-bbbc-4551-9e76-5ae93b505e6f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_30710197-aabb-4ed5-86f3-5382e2873f51" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_997cffec-8314-455e-a9d8-3de8194abd96" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_30710197-aabb-4ed5-86f3-5382e2873f51" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanCostRecognized_87fb1f8e-f633-4569-96a8-ff034f8cc0fc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedContributionPlanCostRecognized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_997cffec-8314-455e-a9d8-3de8194abd96" xlink:to="loc_us-gaap_DefinedContributionPlanCostRecognized_87fb1f8e-f633-4569-96a8-ff034f8cc0fc" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_eb5f41e7-4b96-44e9-8a16-c9ba2321854b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_997cffec-8314-455e-a9d8-3de8194abd96" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_eb5f41e7-4b96-44e9-8a16-c9ba2321854b" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_08585156-da8d-4aad-80f1-c52462dfe19d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_997cffec-8314-455e-a9d8-3de8194abd96" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_08585156-da8d-4aad-80f1-c52462dfe19d" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_2dc61c9e-47c3-4b6f-8964-2ea681748a1e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_08585156-da8d-4aad-80f1-c52462dfe19d" xlink:to="loc_us-gaap_PlanNameAxis_2dc61c9e-47c3-4b6f-8964-2ea681748a1e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_2dc61c9e-47c3-4b6f-8964-2ea681748a1e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PlanNameAxis_2dc61c9e-47c3-4b6f-8964-2ea681748a1e" xlink:to="loc_us-gaap_PlanNameDomain_2dc61c9e-47c3-4b6f-8964-2ea681748a1e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_e72ab2b4-40ec-4b08-aa2f-c74df11de4c2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PlanNameAxis_2dc61c9e-47c3-4b6f-8964-2ea681748a1e" xlink:to="loc_us-gaap_PlanNameDomain_e72ab2b4-40ec-4b08-aa2f-c74df11de4c2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_A2011LtipMember_a0982a55-68ae-4bd6-a2d4-2956ac429781" xlink:href="cah-20210630.xsd#cah_A2011LtipMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_e72ab2b4-40ec-4b08-aa2f-c74df11de4c2" xlink:to="loc_cah_A2011LtipMember_a0982a55-68ae-4bd6-a2d4-2956ac429781" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_45efa945-4569-47af-803f-dd3cf2e35b71" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_08585156-da8d-4aad-80f1-c52462dfe19d" xlink:to="loc_us-gaap_AwardTypeAxis_45efa945-4569-47af-803f-dd3cf2e35b71" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_45efa945-4569-47af-803f-dd3cf2e35b71_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_45efa945-4569-47af-803f-dd3cf2e35b71" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_45efa945-4569-47af-803f-dd3cf2e35b71_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_29fbf45d-fd5d-4c2c-9c1e-043672981984" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_45efa945-4569-47af-803f-dd3cf2e35b71" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_29fbf45d-fd5d-4c2c-9c1e-043672981984" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_AwardsOtherThanStockOptionsMember_d0acf7c4-19b1-411a-a62a-cc4ed7c87657" xlink:href="cah-20210630.xsd#cah_AwardsOtherThanStockOptionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_29fbf45d-fd5d-4c2c-9c1e-043672981984" xlink:to="loc_cah_AwardsOtherThanStockOptionsMember_d0acf7c4-19b1-411a-a62a-cc4ed7c87657" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceSharesMember_af50ab9f-35c5-44d6-9eaa-6df164aceb7f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PerformanceSharesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_29fbf45d-fd5d-4c2c-9c1e-043672981984" xlink:to="loc_us-gaap_PerformanceSharesMember_af50ab9f-35c5-44d6-9eaa-6df164aceb7f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_acabd121-b738-4f2a-98ce-682620c29f11" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_29fbf45d-fd5d-4c2c-9c1e-043672981984" xlink:to="loc_us-gaap_EmployeeStockOptionMember_acabd121-b738-4f2a-98ce-682620c29f11" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_5076d7bb-e651-4407-91ed-676e8e012e5d" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_08585156-da8d-4aad-80f1-c52462dfe19d" xlink:to="loc_srt_RangeAxis_5076d7bb-e651-4407-91ed-676e8e012e5d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_5076d7bb-e651-4407-91ed-676e8e012e5d_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_5076d7bb-e651-4407-91ed-676e8e012e5d" xlink:to="loc_srt_RangeMember_5076d7bb-e651-4407-91ed-676e8e012e5d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_3f934713-ffb8-4415-85aa-25dfc76fbf10" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_5076d7bb-e651-4407-91ed-676e8e012e5d" xlink:to="loc_srt_RangeMember_3f934713-ffb8-4415-85aa-25dfc76fbf10" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_9840d71f-0bf6-4c65-b344-df84e010ced0" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_3f934713-ffb8-4415-85aa-25dfc76fbf10" xlink:to="loc_srt_MaximumMember_9840d71f-0bf6-4c65-b344-df84e010ced0" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/ShareBasedCompensationScheduleofTotalShareBasedCompensationExpensebyTypeofAwardDetails" xlink:type="simple" xlink:href="cah-20210630.xsd#ShareBasedCompensationScheduleofTotalShareBasedCompensationExpensebyTypeofAwardDetails"/>
  <link:definitionLink xlink:role="http://www.cardinal.com/role/ShareBasedCompensationScheduleofTotalShareBasedCompensationExpensebyTypeofAwardDetails" xlink:type="extended" id="i9251f79be5fe4614b2b7afed25f015d8_ShareBasedCompensationScheduleofTotalShareBasedCompensationExpensebyTypeofAwardDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_32299059-f5e7-4116-b2d6-8ea13fee1722" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_56a35403-6d66-4b4d-9474-c66870762d2b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_32299059-f5e7-4116-b2d6-8ea13fee1722" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_56a35403-6d66-4b4d-9474-c66870762d2b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_defeb823-6f4d-4d33-82fd-7e023994ad8e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_32299059-f5e7-4116-b2d6-8ea13fee1722" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_defeb823-6f4d-4d33-82fd-7e023994ad8e" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_48c5f632-686d-46c3-8ce3-f30daad6c091" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_defeb823-6f4d-4d33-82fd-7e023994ad8e" xlink:to="loc_us-gaap_AwardTypeAxis_48c5f632-686d-46c3-8ce3-f30daad6c091" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_48c5f632-686d-46c3-8ce3-f30daad6c091_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_48c5f632-686d-46c3-8ce3-f30daad6c091" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_48c5f632-686d-46c3-8ce3-f30daad6c091_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_43b35ba3-bae7-4186-8c97-2205ffd7a07b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_48c5f632-686d-46c3-8ce3-f30daad6c091" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_43b35ba3-bae7-4186-8c97-2205ffd7a07b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_4bec3763-f382-469b-bc0c-452360d3f4d0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_43b35ba3-bae7-4186-8c97-2205ffd7a07b" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_4bec3763-f382-469b-bc0c-452360d3f4d0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_21ef6f47-efef-46e3-8530-844d2557a675" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_43b35ba3-bae7-4186-8c97-2205ffd7a07b" xlink:to="loc_us-gaap_EmployeeStockOptionMember_21ef6f47-efef-46e3-8530-844d2557a675" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceSharesMember_f60feace-1ea4-4658-9703-4cec5d25bd2d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PerformanceSharesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_43b35ba3-bae7-4186-8c97-2205ffd7a07b" xlink:to="loc_us-gaap_PerformanceSharesMember_f60feace-1ea4-4658-9703-4cec5d25bd2d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_fa5edcf2-5934-4975-849d-d9d824d1fc34" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_defeb823-6f4d-4d33-82fd-7e023994ad8e" xlink:to="loc_us-gaap_PlanNameAxis_fa5edcf2-5934-4975-849d-d9d824d1fc34" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_fa5edcf2-5934-4975-849d-d9d824d1fc34_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PlanNameAxis_fa5edcf2-5934-4975-849d-d9d824d1fc34" xlink:to="loc_us-gaap_PlanNameDomain_fa5edcf2-5934-4975-849d-d9d824d1fc34_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_04a16cc9-9ed8-4320-981e-0df31cb37a69" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PlanNameAxis_fa5edcf2-5934-4975-849d-d9d824d1fc34" xlink:to="loc_us-gaap_PlanNameDomain_04a16cc9-9ed8-4320-981e-0df31cb37a69" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_A2011LtipMember_2d3a5132-c0bb-46b7-ad62-91c435153c67" xlink:href="cah-20210630.xsd#cah_A2011LtipMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_04a16cc9-9ed8-4320-981e-0df31cb37a69" xlink:to="loc_cah_A2011LtipMember_2d3a5132-c0bb-46b7-ad62-91c435153c67" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_cbcc20b4-f037-4109-8a9b-64d84c747875" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_defeb823-6f4d-4d33-82fd-7e023994ad8e" xlink:to="loc_srt_RangeAxis_cbcc20b4-f037-4109-8a9b-64d84c747875" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_cbcc20b4-f037-4109-8a9b-64d84c747875_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_cbcc20b4-f037-4109-8a9b-64d84c747875" xlink:to="loc_srt_RangeMember_cbcc20b4-f037-4109-8a9b-64d84c747875_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_b08d1397-f6f1-4c07-a3f0-9d18490f0d68" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_cbcc20b4-f037-4109-8a9b-64d84c747875" xlink:to="loc_srt_RangeMember_b08d1397-f6f1-4c07-a3f0-9d18490f0d68" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_c4ab9384-0391-4cd1-b8a2-a34d030a5c46" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_b08d1397-f6f1-4c07-a3f0-9d18490f0d68" xlink:to="loc_srt_MinimumMember_c4ab9384-0391-4cd1-b8a2-a34d030a5c46" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_6c100d63-341a-4239-a994-4ffb8d0022c4" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_b08d1397-f6f1-4c07-a3f0-9d18490f0d68" xlink:to="loc_srt_MaximumMember_6c100d63-341a-4239-a994-4ffb8d0022c4" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/ShareBasedCompensationScheduleofAdditionalDataRelatedtoStockOptionsDetails" xlink:type="simple" xlink:href="cah-20210630.xsd#ShareBasedCompensationScheduleofAdditionalDataRelatedtoStockOptionsDetails"/>
  <link:definitionLink xlink:role="http://www.cardinal.com/role/ShareBasedCompensationScheduleofAdditionalDataRelatedtoStockOptionsDetails" xlink:type="extended" id="i86f88714f5c442868647a91854764ced_ShareBasedCompensationScheduleofAdditionalDataRelatedtoStockOptionsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_04b5e3a4-a7ff-4cdc-8e16-ced9e41f779b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_9dc64f79-bed3-46be-99c1-f2b8e21a83e0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_04b5e3a4-a7ff-4cdc-8e16-ced9e41f779b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_9dc64f79-bed3-46be-99c1-f2b8e21a83e0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_79a5c6de-b977-4f25-be00-c37850c7054e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_04b5e3a4-a7ff-4cdc-8e16-ced9e41f779b" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_79a5c6de-b977-4f25-be00-c37850c7054e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_917a78ce-dd3c-471a-99a1-2cb68dc27e6f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_04b5e3a4-a7ff-4cdc-8e16-ced9e41f779b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_917a78ce-dd3c-471a-99a1-2cb68dc27e6f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_Netproceedstaxwithholdingsfromsharebasedcompensation_f604861d-c172-4cda-9828-29982412e3bb" xlink:href="cah-20210630.xsd#cah_Netproceedstaxwithholdingsfromsharebasedcompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_04b5e3a4-a7ff-4cdc-8e16-ced9e41f779b" xlink:to="loc_cah_Netproceedstaxwithholdingsfromsharebasedcompensation_f604861d-c172-4cda-9828-29982412e3bb" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ExcessTaxBenefitFromShareBasedCompensationFinancingActivities_b601fb94-fe73-4a41-9086-776db23d1167" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ExcessTaxBenefitFromShareBasedCompensationFinancingActivities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_04b5e3a4-a7ff-4cdc-8e16-ced9e41f779b" xlink:to="loc_us-gaap_ExcessTaxBenefitFromShareBasedCompensationFinancingActivities_b601fb94-fe73-4a41-9086-776db23d1167" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_0dbcc9dd-5b60-45c1-9a96-59403e761527" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_04b5e3a4-a7ff-4cdc-8e16-ced9e41f779b" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_0dbcc9dd-5b60-45c1-9a96-59403e761527" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_45c494ba-e397-4f95-84e5-a387ad1fc387" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_04b5e3a4-a7ff-4cdc-8e16-ced9e41f779b" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_45c494ba-e397-4f95-84e5-a387ad1fc387" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_7e2a33f7-302a-4c86-90d6-f2089bbf2877" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_04b5e3a4-a7ff-4cdc-8e16-ced9e41f779b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_7e2a33f7-302a-4c86-90d6-f2089bbf2877" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_623580db-24c3-4b7c-881f-e0c8cd9ae7ad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_04b5e3a4-a7ff-4cdc-8e16-ced9e41f779b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_623580db-24c3-4b7c-881f-e0c8cd9ae7ad" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_ExercisablePeriodOfPlansInYears_9335a02b-ed85-4ce8-87fa-04f7c914c02e" xlink:href="cah-20210630.xsd#cah_ExercisablePeriodOfPlansInYears"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_04b5e3a4-a7ff-4cdc-8e16-ced9e41f779b" xlink:to="loc_cah_ExercisablePeriodOfPlansInYears_9335a02b-ed85-4ce8-87fa-04f7c914c02e" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_10fc1908-d0ce-4cb1-8d97-b6d93c2fe026" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_04b5e3a4-a7ff-4cdc-8e16-ced9e41f779b" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_10fc1908-d0ce-4cb1-8d97-b6d93c2fe026" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_597c0368-07b6-4e5c-904b-d7e9d7afffba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_10fc1908-d0ce-4cb1-8d97-b6d93c2fe026" xlink:to="loc_us-gaap_AwardTypeAxis_597c0368-07b6-4e5c-904b-d7e9d7afffba" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_597c0368-07b6-4e5c-904b-d7e9d7afffba_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_597c0368-07b6-4e5c-904b-d7e9d7afffba" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_597c0368-07b6-4e5c-904b-d7e9d7afffba_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_a0ba6bca-b593-4192-ac6e-5b15bed55cd3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_597c0368-07b6-4e5c-904b-d7e9d7afffba" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_a0ba6bca-b593-4192-ac6e-5b15bed55cd3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_bbbadf36-1822-4467-8b38-e16f3872ec34" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_a0ba6bca-b593-4192-ac6e-5b15bed55cd3" xlink:to="loc_us-gaap_EmployeeStockOptionMember_bbbadf36-1822-4467-8b38-e16f3872ec34" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_2a1bc396-b319-4d38-997b-698f8da73372" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_10fc1908-d0ce-4cb1-8d97-b6d93c2fe026" xlink:to="loc_srt_RangeAxis_2a1bc396-b319-4d38-997b-698f8da73372" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_2a1bc396-b319-4d38-997b-698f8da73372_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_2a1bc396-b319-4d38-997b-698f8da73372" xlink:to="loc_srt_RangeMember_2a1bc396-b319-4d38-997b-698f8da73372_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_d007e72a-306e-470d-ae98-8d28cbc67d97" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_2a1bc396-b319-4d38-997b-698f8da73372" xlink:to="loc_srt_RangeMember_d007e72a-306e-470d-ae98-8d28cbc67d97" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_507cb449-e0f4-455e-af50-0801c9108b7a" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_d007e72a-306e-470d-ae98-8d28cbc67d97" xlink:to="loc_srt_MaximumMember_507cb449-e0f4-455e-af50-0801c9108b7a" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/ShareBasedCompensationScheduleofRemainingStockOptionPlanDataDetails" xlink:type="simple" xlink:href="cah-20210630.xsd#ShareBasedCompensationScheduleofRemainingStockOptionPlanDataDetails"/>
  <link:definitionLink xlink:role="http://www.cardinal.com/role/ShareBasedCompensationScheduleofRemainingStockOptionPlanDataDetails" xlink:type="extended" id="i027c9360a7b545a38bb0fc42c50ae514_ShareBasedCompensationScheduleofRemainingStockOptionPlanDataDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c7a528ab-6d13-4580-98a8-f713aa171137" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_548987b8-8076-4bc2-a8b0-7fa29f37144b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c7a528ab-6d13-4580-98a8-f713aa171137" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_548987b8-8076-4bc2-a8b0-7fa29f37144b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_993c49eb-b754-4811-b6ca-4b7bc3c29115" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c7a528ab-6d13-4580-98a8-f713aa171137" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_993c49eb-b754-4811-b6ca-4b7bc3c29115" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_784ef5b9-94e2-4f58-bba4-c6eb5061278d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c7a528ab-6d13-4580-98a8-f713aa171137" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_784ef5b9-94e2-4f58-bba4-c6eb5061278d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_2b64c298-0954-4c04-a4ca-9f68783d85a1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c7a528ab-6d13-4580-98a8-f713aa171137" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_2b64c298-0954-4c04-a4ca-9f68783d85a1" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_a9691cf7-4394-4eec-b1c5-417ea44b73ac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_2b64c298-0954-4c04-a4ca-9f68783d85a1" xlink:to="loc_us-gaap_AwardTypeAxis_a9691cf7-4394-4eec-b1c5-417ea44b73ac" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_a9691cf7-4394-4eec-b1c5-417ea44b73ac_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_a9691cf7-4394-4eec-b1c5-417ea44b73ac" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_a9691cf7-4394-4eec-b1c5-417ea44b73ac_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8faffaab-40da-46cd-b6f6-55e2326342c8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_a9691cf7-4394-4eec-b1c5-417ea44b73ac" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8faffaab-40da-46cd-b6f6-55e2326342c8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_ef6653c9-2ee2-4c9a-8a3c-9088ca18c63f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8faffaab-40da-46cd-b6f6-55e2326342c8" xlink:to="loc_us-gaap_EmployeeStockOptionMember_ef6653c9-2ee2-4c9a-8a3c-9088ca18c63f" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/ShareBasedCompensationScheduleofAllTransactionsRelatedtoRestrictedShareUnitsUnderthePlansDetails" xlink:type="simple" xlink:href="cah-20210630.xsd#ShareBasedCompensationScheduleofAllTransactionsRelatedtoRestrictedShareUnitsUnderthePlansDetails"/>
  <link:definitionLink xlink:role="http://www.cardinal.com/role/ShareBasedCompensationScheduleofAllTransactionsRelatedtoRestrictedShareUnitsUnderthePlansDetails" xlink:type="extended" id="iad26a69590b344139911bd30725461bd_ShareBasedCompensationScheduleofAllTransactionsRelatedtoRestrictedShareUnitsUnderthePlansDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_08ac4bf1-1a2e-4281-8e1b-4bd6c3566c47" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_d216b205-d629-4713-a0cc-39ac784d3118" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_08ac4bf1-1a2e-4281-8e1b-4bd6c3566c47" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_d216b205-d629-4713-a0cc-39ac784d3118" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_33e333c3-3c70-411c-b769-23c708e12413" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_d216b205-d629-4713-a0cc-39ac784d3118" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_33e333c3-3c70-411c-b769-23c708e12413" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_8f0843a9-38ea-4afa-b531-dcc823ed6236" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_d216b205-d629-4713-a0cc-39ac784d3118" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_8f0843a9-38ea-4afa-b531-dcc823ed6236" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_0d4ab964-e6ee-4b7b-a15a-3c9725405b2d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_d216b205-d629-4713-a0cc-39ac784d3118" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_0d4ab964-e6ee-4b7b-a15a-3c9725405b2d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_ac7456b4-566e-4676-a914-e6a0796f8564" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_d216b205-d629-4713-a0cc-39ac784d3118" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_ac7456b4-566e-4676-a914-e6a0796f8564" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_057d7e0f-db2b-4a09-83dd-01f34bffcb4a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_8a820b50-1552-4272-955e-d8311eb45009" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_08ac4bf1-1a2e-4281-8e1b-4bd6c3566c47" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_8a820b50-1552-4272-955e-d8311eb45009" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_e773fd86-c2eb-4e7e-9591-b0953add3bcf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_8a820b50-1552-4272-955e-d8311eb45009" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_e773fd86-c2eb-4e7e-9591-b0953add3bcf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_7cb3b257-f756-4c1a-8048-719318722391" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_8a820b50-1552-4272-955e-d8311eb45009" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_7cb3b257-f756-4c1a-8048-719318722391" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_81acd6db-341e-49ce-b473-453af2f4c3a0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_8a820b50-1552-4272-955e-d8311eb45009" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_81acd6db-341e-49ce-b473-453af2f4c3a0" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_99145d91-b07b-4a26-b3a3-0ccb42e23862" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_8a820b50-1552-4272-955e-d8311eb45009" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_99145d91-b07b-4a26-b3a3-0ccb42e23862" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_413cbf0e-e91a-42e4-a3af-4ed03b8d3e21" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_48894ea4-425e-41be-a1f5-aa821618f46a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_08ac4bf1-1a2e-4281-8e1b-4bd6c3566c47" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_48894ea4-425e-41be-a1f5-aa821618f46a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_16e27a1a-8181-4082-9344-8a5734b18aa2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_48894ea4-425e-41be-a1f5-aa821618f46a" xlink:to="loc_us-gaap_AwardTypeAxis_16e27a1a-8181-4082-9344-8a5734b18aa2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_16e27a1a-8181-4082-9344-8a5734b18aa2_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_16e27a1a-8181-4082-9344-8a5734b18aa2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_16e27a1a-8181-4082-9344-8a5734b18aa2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_384161b9-1544-4945-9ce5-c0ee320a9e1a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_16e27a1a-8181-4082-9344-8a5734b18aa2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_384161b9-1544-4945-9ce5-c0ee320a9e1a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_e24c1778-67cb-4eb1-a38a-7aff904f7895" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_384161b9-1544-4945-9ce5-c0ee320a9e1a" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_e24c1778-67cb-4eb1-a38a-7aff904f7895" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/ShareBasedCompensationAdditionalDataRelatedtoRestrictedShareUnitActivityDetails" xlink:type="simple" xlink:href="cah-20210630.xsd#ShareBasedCompensationAdditionalDataRelatedtoRestrictedShareUnitActivityDetails"/>
  <link:definitionLink xlink:role="http://www.cardinal.com/role/ShareBasedCompensationAdditionalDataRelatedtoRestrictedShareUnitActivityDetails" xlink:type="extended" id="i8a003a7212dd4e2dbef27c196f8e53a1_ShareBasedCompensationAdditionalDataRelatedtoRestrictedShareUnitActivityDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_d5935ce6-49e6-4aa1-af37-e2c71b378d98" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_a4eb8d2f-3ac6-487a-b637-44838bc9fd83" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_d5935ce6-49e6-4aa1-af37-e2c71b378d98" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_a4eb8d2f-3ac6-487a-b637-44838bc9fd83" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_b9adecfa-ce3a-4da3-b129-c32eb4faae2b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_d5935ce6-49e6-4aa1-af37-e2c71b378d98" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_b9adecfa-ce3a-4da3-b129-c32eb4faae2b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_503c7ef1-1da5-440f-9ed4-b135b3cf9c24" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_d5935ce6-49e6-4aa1-af37-e2c71b378d98" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_503c7ef1-1da5-440f-9ed4-b135b3cf9c24" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_a47d42aa-1e2d-45fa-9d42-b84486ea77b8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_d5935ce6-49e6-4aa1-af37-e2c71b378d98" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_a47d42aa-1e2d-45fa-9d42-b84486ea77b8" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_6a60c4a2-d7c5-465a-bbb9-5d8ca5b8a076" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_d5935ce6-49e6-4aa1-af37-e2c71b378d98" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_6a60c4a2-d7c5-465a-bbb9-5d8ca5b8a076" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_6d7ffdc0-04a6-495c-b2f8-b5af53c0951e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_6a60c4a2-d7c5-465a-bbb9-5d8ca5b8a076" xlink:to="loc_us-gaap_AwardTypeAxis_6d7ffdc0-04a6-495c-b2f8-b5af53c0951e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_6d7ffdc0-04a6-495c-b2f8-b5af53c0951e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_6d7ffdc0-04a6-495c-b2f8-b5af53c0951e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_6d7ffdc0-04a6-495c-b2f8-b5af53c0951e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_70bb3494-423d-4b66-ba1b-64b7e80f6193" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_6d7ffdc0-04a6-495c-b2f8-b5af53c0951e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_70bb3494-423d-4b66-ba1b-64b7e80f6193" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_4055ac20-221a-4d7c-88d8-8926bc3fb1ac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_70bb3494-423d-4b66-ba1b-64b7e80f6193" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_4055ac20-221a-4d7c-88d8-8926bc3fb1ac" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceSharesMember_d610fb99-f21e-4276-9675-8f0ba6f17aaa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PerformanceSharesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_70bb3494-423d-4b66-ba1b-64b7e80f6193" xlink:to="loc_us-gaap_PerformanceSharesMember_d610fb99-f21e-4276-9675-8f0ba6f17aaa" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/ShareBasedCompensationScheduleofAllTransactionsRelatedtoPerformanceShareUnitsUnderthePlansDetails" xlink:type="simple" xlink:href="cah-20210630.xsd#ShareBasedCompensationScheduleofAllTransactionsRelatedtoPerformanceShareUnitsUnderthePlansDetails"/>
  <link:definitionLink xlink:role="http://www.cardinal.com/role/ShareBasedCompensationScheduleofAllTransactionsRelatedtoPerformanceShareUnitsUnderthePlansDetails" xlink:type="extended" id="i20ecb2158c2449d687d9957beeb71e46_ShareBasedCompensationScheduleofAllTransactionsRelatedtoPerformanceShareUnitsUnderthePlansDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e9c939c7-9a18-4bd7-869b-9da7b53e272e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_3dd8ab2a-0c49-4b5c-a6bb-ed79e5c2a7a7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e9c939c7-9a18-4bd7-869b-9da7b53e272e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_3dd8ab2a-0c49-4b5c-a6bb-ed79e5c2a7a7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_30e2ddec-25dd-4a54-a9d3-31100af9986d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_3dd8ab2a-0c49-4b5c-a6bb-ed79e5c2a7a7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_30e2ddec-25dd-4a54-a9d3-31100af9986d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_bf1c5026-83ac-45b9-9d78-83e60f15f974" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_3dd8ab2a-0c49-4b5c-a6bb-ed79e5c2a7a7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_bf1c5026-83ac-45b9-9d78-83e60f15f974" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_315f722e-419e-498d-a396-23b2b3d4304b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_3dd8ab2a-0c49-4b5c-a6bb-ed79e5c2a7a7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_315f722e-419e-498d-a396-23b2b3d4304b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_fb52efb8-27c1-4af4-9e89-065d6f80309f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_3dd8ab2a-0c49-4b5c-a6bb-ed79e5c2a7a7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_fb52efb8-27c1-4af4-9e89-065d6f80309f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_dab22622-2e28-4a1d-be3c-730b971b91f9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_21a10e23-530d-411f-8d3d-3db51967584f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e9c939c7-9a18-4bd7-869b-9da7b53e272e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_21a10e23-530d-411f-8d3d-3db51967584f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_9e7dcb03-6909-41fe-b5b6-cffa11af8c33" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_21a10e23-530d-411f-8d3d-3db51967584f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_9e7dcb03-6909-41fe-b5b6-cffa11af8c33" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_1a0ab315-1002-4a4f-bd6f-5e602ba740ec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_21a10e23-530d-411f-8d3d-3db51967584f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_1a0ab315-1002-4a4f-bd6f-5e602ba740ec" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_c0d4f2bf-6551-41bc-be8f-c71c017448e0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_21a10e23-530d-411f-8d3d-3db51967584f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_c0d4f2bf-6551-41bc-be8f-c71c017448e0" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_030d9583-ed97-4a7a-af06-28382641062d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_21a10e23-530d-411f-8d3d-3db51967584f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_030d9583-ed97-4a7a-af06-28382641062d" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_b69c78f9-a7b0-4f4f-8225-43058a783ac8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_8739dc30-2387-4f13-9df8-4c897f8d5632" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_21a10e23-530d-411f-8d3d-3db51967584f" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_8739dc30-2387-4f13-9df8-4c897f8d5632" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_2d627ac7-8d3b-4157-a863-d8ca11332dab" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e9c939c7-9a18-4bd7-869b-9da7b53e272e" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_2d627ac7-8d3b-4157-a863-d8ca11332dab" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_4177d5b1-0b08-42b3-99b4-39402a98c644" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_2d627ac7-8d3b-4157-a863-d8ca11332dab" xlink:to="loc_us-gaap_AwardTypeAxis_4177d5b1-0b08-42b3-99b4-39402a98c644" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_4177d5b1-0b08-42b3-99b4-39402a98c644_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_4177d5b1-0b08-42b3-99b4-39402a98c644" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_4177d5b1-0b08-42b3-99b4-39402a98c644_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_3ed0d0c7-a061-401f-9b9f-a51b838f8292" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_4177d5b1-0b08-42b3-99b4-39402a98c644" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_3ed0d0c7-a061-401f-9b9f-a51b838f8292" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceSharesMember_68d899a3-c390-4e99-b239-02f1f1e51195" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PerformanceSharesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_3ed0d0c7-a061-401f-9b9f-a51b838f8292" xlink:to="loc_us-gaap_PerformanceSharesMember_68d899a3-c390-4e99-b239-02f1f1e51195" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/ShareBasedCompensationAdditionalDataRelatedtoPerformanceShareUnitActivityDetails" xlink:type="simple" xlink:href="cah-20210630.xsd#ShareBasedCompensationAdditionalDataRelatedtoPerformanceShareUnitActivityDetails"/>
  <link:definitionLink xlink:role="http://www.cardinal.com/role/ShareBasedCompensationAdditionalDataRelatedtoPerformanceShareUnitActivityDetails" xlink:type="extended" id="ic1437940d24e460a91adeae2082b5b0a_ShareBasedCompensationAdditionalDataRelatedtoPerformanceShareUnitActivityDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_242d9bc8-22cc-463f-abbc-83d38746956b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_86994b70-bf52-48c1-be82-c74dbef4f872" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_242d9bc8-22cc-463f-abbc-83d38746956b" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_86994b70-bf52-48c1-be82-c74dbef4f872" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_882e0e7d-cdbb-471e-9cc2-80aa8ba6e8f5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_242d9bc8-22cc-463f-abbc-83d38746956b" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_882e0e7d-cdbb-471e-9cc2-80aa8ba6e8f5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_f915cd4e-3a21-4903-8bb2-5abf63f6fc68" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_242d9bc8-22cc-463f-abbc-83d38746956b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_f915cd4e-3a21-4903-8bb2-5abf63f6fc68" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_VestingPeriodinyearsforShares_597ad2ac-a048-4abc-9869-3f85080f2c5f" xlink:href="cah-20210630.xsd#cah_VestingPeriodinyearsforShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_242d9bc8-22cc-463f-abbc-83d38746956b" xlink:to="loc_cah_VestingPeriodinyearsforShares_597ad2ac-a048-4abc-9869-3f85080f2c5f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_4ce874da-4cec-4cec-b6f0-87f221e49fdf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_242d9bc8-22cc-463f-abbc-83d38746956b" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_4ce874da-4cec-4cec-b6f0-87f221e49fdf" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_f86244c5-5a79-4389-b0b5-a2c4f972c41a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_242d9bc8-22cc-463f-abbc-83d38746956b" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_f86244c5-5a79-4389-b0b5-a2c4f972c41a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_7c0b041b-34a3-47db-9783-6e28b216fefa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_f86244c5-5a79-4389-b0b5-a2c4f972c41a" xlink:to="loc_us-gaap_AwardTypeAxis_7c0b041b-34a3-47db-9783-6e28b216fefa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_7c0b041b-34a3-47db-9783-6e28b216fefa_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_7c0b041b-34a3-47db-9783-6e28b216fefa" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_7c0b041b-34a3-47db-9783-6e28b216fefa_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_ad950051-d1e2-4a4a-bb2a-d10388dd2430" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_7c0b041b-34a3-47db-9783-6e28b216fefa" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_ad950051-d1e2-4a4a-bb2a-d10388dd2430" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceSharesMember_533125cd-267e-4dea-a9ba-06db150c87a4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PerformanceSharesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_ad950051-d1e2-4a4a-bb2a-d10388dd2430" xlink:to="loc_us-gaap_PerformanceSharesMember_533125cd-267e-4dea-a9ba-06db150c87a4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_d144bfec-a58a-40bd-bed6-b27388832a87" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_f86244c5-5a79-4389-b0b5-a2c4f972c41a" xlink:to="loc_srt_RangeAxis_d144bfec-a58a-40bd-bed6-b27388832a87" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_d144bfec-a58a-40bd-bed6-b27388832a87_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_d144bfec-a58a-40bd-bed6-b27388832a87" xlink:to="loc_srt_RangeMember_d144bfec-a58a-40bd-bed6-b27388832a87_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_3bcba638-40d4-430e-8fa9-b5300cad6a71" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_d144bfec-a58a-40bd-bed6-b27388832a87" xlink:to="loc_srt_RangeMember_3bcba638-40d4-430e-8fa9-b5300cad6a71" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_4c20c689-b71d-46ff-99f0-8feda610d528" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_3bcba638-40d4-430e-8fa9-b5300cad6a71" xlink:to="loc_srt_MinimumMember_4c20c689-b71d-46ff-99f0-8feda610d528" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/ScheduleIIValuationsandQualifyingAccountsDetails" xlink:type="simple" xlink:href="cah-20210630.xsd#ScheduleIIValuationsandQualifyingAccountsDetails"/>
  <link:definitionLink xlink:role="http://www.cardinal.com/role/ScheduleIIValuationsandQualifyingAccountsDetails" xlink:type="extended" id="i1fd6b7ed67284d62acf7cf6caca9640b_ScheduleIIValuationsandQualifyingAccountsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems_bdbc4f88-569d-4f43-9e0b-4c701e608c2c" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ValuationAndQualifyingAccountsDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesBalance_6618911d-c225-40a6-9c70-2057797b3e2f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationAllowancesAndReservesBalance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems_bdbc4f88-569d-4f43-9e0b-4c701e608c2c" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesBalance_6618911d-c225-40a6-9c70-2057797b3e2f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesRecoveries_1f5384d4-5616-4408-8c29-7149ebc4d770" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationAllowancesAndReservesRecoveries"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems_bdbc4f88-569d-4f43-9e0b-4c701e608c2c" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesRecoveries_1f5384d4-5616-4408-8c29-7149ebc4d770" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_455e1081-13e2-4395-94df-8fef37e8b274" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MovementInValuationAllowancesAndReservesRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems_bdbc4f88-569d-4f43-9e0b-4c701e608c2c" xlink:to="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_455e1081-13e2-4395-94df-8fef37e8b274" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_881aee50-9791-42bc-b82a-51141eed5e5a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems_bdbc4f88-569d-4f43-9e0b-4c701e608c2c" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_881aee50-9791-42bc-b82a-51141eed5e5a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesChargedToOtherAccounts_f6048b16-f643-4293-8165-871879a91080" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationAllowancesAndReservesChargedToOtherAccounts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems_bdbc4f88-569d-4f43-9e0b-4c701e608c2c" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesChargedToOtherAccounts_f6048b16-f643-4293-8165-871879a91080" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesDeductions_5f192b78-45ff-4572-aa1f-7e60d4ad51af" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationAllowancesAndReservesDeductions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems_bdbc4f88-569d-4f43-9e0b-4c701e608c2c" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesDeductions_5f192b78-45ff-4572-aa1f-7e60d4ad51af" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ValuationAndQualifyingAccountsDisclosureTable_f2695750-7727-466c-a5dc-27f29e6eb7d8" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ValuationAndQualifyingAccountsDisclosureTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems_bdbc4f88-569d-4f43-9e0b-4c701e608c2c" xlink:to="loc_srt_ValuationAndQualifyingAccountsDisclosureTable_f2695750-7727-466c-a5dc-27f29e6eb7d8" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_28fbce3a-20ba-4975-bd22-b0a6cf277a7c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureTable_f2695750-7727-466c-a5dc-27f29e6eb7d8" xlink:to="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_28fbce3a-20ba-4975-bd22-b0a6cf277a7c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivableTypeDomain_28fbce3a-20ba-4975-bd22-b0a6cf277a7c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReceivableTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_28fbce3a-20ba-4975-bd22-b0a6cf277a7c" xlink:to="loc_us-gaap_ReceivableTypeDomain_28fbce3a-20ba-4975-bd22-b0a6cf277a7c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivableTypeDomain_04afd755-9586-4035-893e-111a88fa4fb0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReceivableTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_28fbce3a-20ba-4975-bd22-b0a6cf277a7c" xlink:to="loc_us-gaap_ReceivableTypeDomain_04afd755-9586-4035-893e-111a88fa4fb0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_c363f75d-1930-4b41-9c7c-fc2443f7fcc2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationAllowancesAndReservesTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureTable_f2695750-7727-466c-a5dc-27f29e6eb7d8" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_c363f75d-1930-4b41-9c7c-fc2443f7fcc2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesDomain_c363f75d-1930-4b41-9c7c-fc2443f7fcc2_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationAllowancesAndReservesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_c363f75d-1930-4b41-9c7c-fc2443f7fcc2" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesDomain_c363f75d-1930-4b41-9c7c-fc2443f7fcc2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesDomain_9dc9cf6d-97f6-422f-aa52-d97a561047a7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationAllowancesAndReservesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_c363f75d-1930-4b41-9c7c-fc2443f7fcc2" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesDomain_9dc9cf6d-97f6-422f-aa52-d97a561047a7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_PricingDisputesMember_1302e1bb-181f-49c2-99cb-2bb301936623" xlink:href="cah-20210630.xsd#cah_PricingDisputesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesDomain_9dc9cf6d-97f6-422f-aa52-d97a561047a7" xlink:to="loc_cah_PricingDisputesMember_1302e1bb-181f-49c2-99cb-2bb301936623" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForCreditLossMember_1e1a4fa1-c9c8-4955-adb2-ea7e57a67ada" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllowanceForCreditLossMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesDomain_9dc9cf6d-97f6-422f-aa52-d97a561047a7" xlink:to="loc_us-gaap_AllowanceForCreditLossMember_1e1a4fa1-c9c8-4955-adb2-ea7e57a67ada" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_PriorYearRecoveriesMember_2408823c-fb2c-48cb-b8c2-b7727d923c70" xlink:href="cah-20210630.xsd#cah_PriorYearRecoveriesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesDomain_9dc9cf6d-97f6-422f-aa52-d97a561047a7" xlink:to="loc_cah_PriorYearRecoveriesMember_2408823c-fb2c-48cb-b8c2-b7727d923c70" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForLossesOnFinanceReceivablesMember_8ad1c9d1-8ddd-465d-a5c9-7bb3c250d6c4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllowanceForLossesOnFinanceReceivablesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesDomain_9dc9cf6d-97f6-422f-aa52-d97a561047a7" xlink:to="loc_us-gaap_AllowanceForLossesOnFinanceReceivablesMember_8ad1c9d1-8ddd-465d-a5c9-7bb3c250d6c4" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesReturnsAndAllowancesMember_017d6b9b-0fb6-4a75-8184-baa74ea6cf4b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SalesReturnsAndAllowancesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesDomain_9dc9cf6d-97f6-422f-aa52-d97a561047a7" xlink:to="loc_us-gaap_SalesReturnsAndAllowancesMember_017d6b9b-0fb6-4a75-8184-baa74ea6cf4b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForLoanAndLeaseLossesMember_c5e64b03-c8b2-47a3-95f9-90f5f8befcf6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllowanceForLoanAndLeaseLossesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesDomain_9dc9cf6d-97f6-422f-aa52-d97a561047a7" xlink:to="loc_us-gaap_AllowanceForLoanAndLeaseLossesMember_c5e64b03-c8b2-47a3-95f9-90f5f8befcf6" xlink:type="arc" order="5"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>11
<FILENAME>cah-20210630_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:b63e0697-7630-4efc-9622-5764c41287f3,g:18dc0520-9457-4463-b618-29c4ac061652-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_us-gaap_DerivativesMethodsOfAccountingHedgingDerivatives_e4e03926-56a2-4337-b419-a84f2b0d0c97_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativesMethodsOfAccountingHedgingDerivatives" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate, Currency and Commodity Risk</link:label>
    <link:label id="lab_us-gaap_DerivativesMethodsOfAccountingHedgingDerivatives_label_en-US" xlink:label="lab_us-gaap_DerivativesMethodsOfAccountingHedgingDerivatives" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives, Methods of Accounting, Hedging Derivatives [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesMethodsOfAccountingHedgingDerivatives" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativesMethodsOfAccountingHedgingDerivatives"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativesMethodsOfAccountingHedgingDerivatives" xlink:to="lab_us-gaap_DerivativesMethodsOfAccountingHedgingDerivatives" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SupplementalCashFlowInformationAbstract_7868a20f-d1a7-4ef9-880a-69db26f1a9ba_terseLabel_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Information:</link:label>
    <link:label id="lab_us-gaap_SupplementalCashFlowInformationAbstract_label_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Cash Flow Information [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_NameOfMajorCustomerDomain_8cb3a960-c7d0-47c9-86a9-e43c1442382f_terseLabel_en-US" xlink:label="lab_srt_NameOfMajorCustomerDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer [Domain]</link:label>
    <link:label id="lab_srt_NameOfMajorCustomerDomain_label_en-US" xlink:label="lab_srt_NameOfMajorCustomerDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_NameOfMajorCustomerDomain" xlink:to="lab_srt_NameOfMajorCustomerDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_cah_A4.9Notesdue2045Member_6167daea-2a52-4cb9-b59f-e4ff5d55a24c_terseLabel_en-US" xlink:label="lab_cah_A4.9Notesdue2045Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.9% Notes due 2045</link:label>
    <link:label id="lab_cah_A4.9Notesdue2045Member_label_en-US" xlink:label="lab_cah_A4.9Notesdue2045Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.9% Notes due 2045 [Member]</link:label>
    <link:label id="lab_cah_A4.9Notesdue2045Member_documentation_en-US" xlink:label="lab_cah_A4.9Notesdue2045Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.9% Notes due 2045</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cah_A4.9Notesdue2045Member" xlink:href="cah-20210630.xsd#cah_A4.9Notesdue2045Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_A4.9Notesdue2045Member" xlink:to="lab_cah_A4.9Notesdue2045Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LetterOfCreditMember_6782d5c3-b61f-47b6-b86e-7592ad3f489f_terseLabel_en-US" xlink:label="lab_us-gaap_LetterOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Letter of Credit</link:label>
    <link:label id="lab_us-gaap_LetterOfCreditMember_label_en-US" xlink:label="lab_us-gaap_LetterOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Letter of Credit [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LetterOfCreditMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LetterOfCreditMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LetterOfCreditMember" xlink:to="lab_us-gaap_LetterOfCreditMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cah_NetOperatingLossCarrybackDomain_b9cffcd0-6a1c-4cd4-a425-58a82fce240b_terseLabel_en-US" xlink:label="lab_cah_NetOperatingLossCarrybackDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Operating Loss Carryback [Domain]</link:label>
    <link:label id="lab_cah_NetOperatingLossCarrybackDomain_label_en-US" xlink:label="lab_cah_NetOperatingLossCarrybackDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Operating Loss Carryback [Domain]</link:label>
    <link:label id="lab_cah_NetOperatingLossCarrybackDomain_documentation_en-US" xlink:label="lab_cah_NetOperatingLossCarrybackDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Operating Loss Carryback [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cah_NetOperatingLossCarrybackDomain" xlink:href="cah-20210630.xsd#cah_NetOperatingLossCarrybackDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_NetOperatingLossCarrybackDomain" xlink:to="lab_cah_NetOperatingLossCarrybackDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_f973b11c-45b7-4222-8486-72b7d62dd1ab_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vested (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_2cede685-c5d7-4a0c-beeb-261cf6b218cd_terseLabel_en-US" xlink:label="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State and local</link:label>
    <link:label id="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_a800addc-689b-40e1-9965-aa1962f09de7_verboseLabel_en-US" xlink:label="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current State and Local Tax Expense (Benefit)</link:label>
    <link:label id="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current State and Local Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:to="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_9a19bf23-7660-4ce4-a6a9-82312e14cde7_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivable Type [Axis]</link:label>
    <link:label id="lab_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_label_en-US" xlink:label="lab_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivable Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" xlink:to="lab_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_c80d2662-9de9-4f58-bedf-9424c79092bf_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:to="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_cah_LesseeOperatingLeaseLiabilityNotYetCommencedAmount_8e1db644-c575-427c-8471-3781542eef60_terseLabel_en-US" xlink:label="lab_cah_LesseeOperatingLeaseLiabilityNotYetCommencedAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: leases not yet commenced (1)</link:label>
    <link:label id="lab_cah_LesseeOperatingLeaseLiabilityNotYetCommencedAmount_label_en-US" xlink:label="lab_cah_LesseeOperatingLeaseLiabilityNotYetCommencedAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee Operating Lease Liability Not Yet Commenced, Amount</link:label>
    <link:label id="lab_cah_LesseeOperatingLeaseLiabilityNotYetCommencedAmount_documentation_en-US" xlink:label="lab_cah_LesseeOperatingLeaseLiabilityNotYetCommencedAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee Operating Lease Liability Not Yet Commenced, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cah_LesseeOperatingLeaseLiabilityNotYetCommencedAmount" xlink:href="cah-20210630.xsd#cah_LesseeOperatingLeaseLiabilityNotYetCommencedAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_LesseeOperatingLeaseLiabilityNotYetCommencedAmount" xlink:to="lab_cah_LesseeOperatingLeaseLiabilityNotYetCommencedAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_150001c1-5bff-4557-a12c-f62ef70ba751_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Canceled and forfeited (in usd per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_cah_GoodwillAndIntangibleAssetsTable_48b84764-e059-4f78-9700-39d333b1a23e_terseLabel_en-US" xlink:label="lab_cah_GoodwillAndIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets [Table]</link:label>
    <link:label id="lab_cah_GoodwillAndIntangibleAssetsTable_label_en-US" xlink:label="lab_cah_GoodwillAndIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets [Table]</link:label>
    <link:label id="lab_cah_GoodwillAndIntangibleAssetsTable_documentation_en-US" xlink:label="lab_cah_GoodwillAndIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cah_GoodwillAndIntangibleAssetsTable" xlink:href="cah-20210630.xsd#cah_GoodwillAndIntangibleAssetsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_GoodwillAndIntangibleAssetsTable" xlink:to="lab_cah_GoodwillAndIntangibleAssetsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_b11ceb36-6fdb-44f6-b7e5-e7292d40e4ed_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Weighted Average Remaining Lease Term</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Weighted Average Remaining Lease Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:to="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_fb2ba956-0d2f-4cdf-8b54-4f910a3504c4_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Translation of Foreign Currencies</link:label>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Transactions and Translations Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:to="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NotesAndLoansReceivableNetCurrent_91c8ee59-3be2-4343-8267-e7acb6e5ccf4_terseLabel_en-US" xlink:label="lab_us-gaap_NotesAndLoansReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance notes and related accrued interest, net, current</link:label>
    <link:label id="lab_us-gaap_NotesAndLoansReceivableNetCurrent_label_en-US" xlink:label="lab_us-gaap_NotesAndLoansReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing Receivable, after Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesAndLoansReceivableNetCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NotesAndLoansReceivableNetCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NotesAndLoansReceivableNetCurrent" xlink:to="lab_us-gaap_NotesAndLoansReceivableNetCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_5244df70-3e0d-4a81-bf51-5a716f3d389d_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_df89a9a2-5f4c-4e7c-9af8-91a60697513b_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of shares available for grant</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_e68a52b0-de6d-49f3-b671-89838f129cb4_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_b4dd080e-1116-4b9e-a921-fa902266fa3e_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_label_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:to="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_f125bdb5-5ddc-4b36-aee1-d63e81084963_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maturities of existing long-term obligations and other short-term borrowings-2021</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_cah_ClassActionLawsuitsMember_5e2f4807-625f-4641-96ef-29575d898b05_terseLabel_en-US" xlink:label="lab_cah_ClassActionLawsuitsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class Action Lawsuits [Member]</link:label>
    <link:label id="lab_cah_ClassActionLawsuitsMember_label_en-US" xlink:label="lab_cah_ClassActionLawsuitsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class Action Lawsuits [Member]</link:label>
    <link:label id="lab_cah_ClassActionLawsuitsMember_documentation_en-US" xlink:label="lab_cah_ClassActionLawsuitsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class Action Lawsuits [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cah_ClassActionLawsuitsMember" xlink:href="cah-20210630.xsd#cah_ClassActionLawsuitsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_ClassActionLawsuitsMember" xlink:to="lab_cah_ClassActionLawsuitsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_f3de0baa-d4f1-4f09-9259-e6f4f2bc6245_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate intrinsic value of exercised options</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TaxCreditCarryforwardLineItems_10e2d1f4-8425-4f7a-a1ab-59368e724684_terseLabel_en-US" xlink:label="lab_us-gaap_TaxCreditCarryforwardLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes</link:label>
    <link:label id="lab_us-gaap_TaxCreditCarryforwardLineItems_label_en-US" xlink:label="lab_us-gaap_TaxCreditCarryforwardLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Credit Carryforward [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxCreditCarryforwardLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TaxCreditCarryforwardLineItems" xlink:to="lab_us-gaap_TaxCreditCarryforwardLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueHedgingMember_ea855b51-1d29-42eb-b694-a5fedd03bbdb_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueHedgingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hedging</link:label>
    <link:label id="lab_us-gaap_FairValueHedgingMember_label_en-US" xlink:label="lab_us-gaap_FairValueHedgingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hedging [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueHedgingMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueHedgingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueHedgingMember" xlink:to="lab_us-gaap_FairValueHedgingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalYearFocus_ce3fc6a1-90ce-4def-97e3-bfffb534ea8c_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalYearFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentFiscalYearFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalYearFocus" xlink:to="lab_dei_DocumentFiscalYearFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_9502d131-f9f3-47f6-b9d1-1eaa6ebb41cf_terseLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves, Additions, Charge to Cost and Expense</link:label>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_label_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves, Additions, Charge to Cost and Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense" xlink:to="lab_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_cah_AdditionalRestrictedSharesAndRestrictedShareUnitsDataTableTextBlock_f9cbc3a8-897c-4e8b-965f-63bceb24e9c6_terseLabel_en-US" xlink:label="lab_cah_AdditionalRestrictedSharesAndRestrictedShareUnitsDataTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Restricted Shares and Restricted Share Units Activity</link:label>
    <link:label id="lab_cah_AdditionalRestrictedSharesAndRestrictedShareUnitsDataTableTextBlock_label_en-US" xlink:label="lab_cah_AdditionalRestrictedSharesAndRestrictedShareUnitsDataTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Restricted Shares And Restricted Share Units Data [Table Text Block]</link:label>
    <link:label id="lab_cah_AdditionalRestrictedSharesAndRestrictedShareUnitsDataTableTextBlock_documentation_en-US" xlink:label="lab_cah_AdditionalRestrictedSharesAndRestrictedShareUnitsDataTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Restricted Shares And Restricted Share Units Data [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cah_AdditionalRestrictedSharesAndRestrictedShareUnitsDataTableTextBlock" xlink:href="cah-20210630.xsd#cah_AdditionalRestrictedSharesAndRestrictedShareUnitsDataTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_AdditionalRestrictedSharesAndRestrictedShareUnitsDataTableTextBlock" xlink:to="lab_cah_AdditionalRestrictedSharesAndRestrictedShareUnitsDataTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentsIncorporatedByReferenceTextBlock_23998cda-bb83-4e7c-94ee-63509c6bd374_terseLabel_en-US" xlink:label="lab_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Documents Incorporated by Reference</link:label>
    <link:label id="lab_dei_DocumentsIncorporatedByReferenceTextBlock_label_en-US" xlink:label="lab_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentsIncorporatedByReferenceTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="lab_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember_99a0a501-2c2b-4398-8ff0-706dc1939920_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Translation Adjustments and other</link:label>
    <link:label id="lab_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Foreign Currency Adjustment Including Portion Attributable to Noncontrolling Interest [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember" xlink:to="lab_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTypeDomain_a1eee5a3-0a22-4820-a371-d98d2555b97c_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Domain]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTypeDomain_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeDomain" xlink:to="lab_us-gaap_SubsequentEventTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_4ed44a82-6d6b-4f57-a8c6-fa07f5e468a9_terseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Intangible Assets</link:label>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_label_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:to="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityWellKnownSeasonedIssuer_1c0bd097-1b22-4827-9786-732e99cf4152_terseLabel_en-US" xlink:label="lab_dei_EntityWellKnownSeasonedIssuer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Well-Known Seasoned Issuer</link:label>
    <link:label id="lab_dei_EntityWellKnownSeasonedIssuer_label_en-US" xlink:label="lab_dei_EntityWellKnownSeasonedIssuer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityWellKnownSeasonedIssuer" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityWellKnownSeasonedIssuer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityWellKnownSeasonedIssuer" xlink:to="lab_dei_EntityWellKnownSeasonedIssuer" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock_a14e6372-ce89-4404-aaae-0b20cd1ea1ba_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Activity Related to Liabilities Associated with Restructuring and Employee Severance</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Restructuring Reserve by Type of Cost [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock" xlink:to="lab_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_4c20fc47-4a32-4d75-bade-400b2639f8c2_verboseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_a18434bb-1f2b-424d-8b0c-5bdb469c77d8_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additions for tax positions of prior years</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsLiabilitiesNet_985296b7-483d-44d1-83e9-fbdae3f2bd3a_totalLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Net</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsLiabilitiesNet_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:to="lab_us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_855381e9-d33f-4021-b9d2-54bf867d6a67_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Potentially dilutive employee stock options, restricted share units and performance share units that were antidilutive (in shares)</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_1190f58b-c2f7-44bf-9ca2-3a5cf68285b7_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Weighted Average Discount Rate, Percent</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Weighted Average Discount Rate, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:to="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:type="arc" order="1"/>
    <link:label id="lab_cah_WriteDownOfAssetsHeldForSale_7f977eff-e9b9-443a-aec7-8f73ca236a73_terseLabel_en-US" xlink:label="lab_cah_WriteDownOfAssetsHeldForSale" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Write-down of assets held for sale</link:label>
    <link:label id="lab_cah_WriteDownOfAssetsHeldForSale_label_en-US" xlink:label="lab_cah_WriteDownOfAssetsHeldForSale" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Write-down of assets held for sale</link:label>
    <link:label id="lab_cah_WriteDownOfAssetsHeldForSale_documentation_en-US" xlink:label="lab_cah_WriteDownOfAssetsHeldForSale" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Write-down of assets held for sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cah_WriteDownOfAssetsHeldForSale" xlink:href="cah-20210630.xsd#cah_WriteDownOfAssetsHeldForSale"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_WriteDownOfAssetsHeldForSale" xlink:to="lab_cah_WriteDownOfAssetsHeldForSale" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination and Asset Acquisition [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:to="lab_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_de5444d7-7374-475c-a169-e9dc5478be8d_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Axis]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAxis" xlink:to="lab_us-gaap_BusinessAcquisitionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashFlowHedgingMember_b04f9324-1c4c-4a1e-a563-83d691cdf310_terseLabel_en-US" xlink:label="lab_us-gaap_CashFlowHedgingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flow Hedging</link:label>
    <link:label id="lab_us-gaap_CashFlowHedgingMember_label_en-US" xlink:label="lab_us-gaap_CashFlowHedgingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flow Hedging [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashFlowHedgingMember" xlink:to="lab_us-gaap_CashFlowHedgingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityNameAxis_1a4af565-b676-4a06-a15e-0db1c47ba009_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority, Name [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityNameAxis_label_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority, Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameAxis" xlink:to="lab_us-gaap_IncomeTaxAuthorityNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock_8d0594c7-814a-4420-b41e-3ac040df4c0f_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Indefinite-Lived Intangible Assets</link:label>
    <link:label id="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Indefinite-Lived Intangible Assets [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_06a7ee4a-91b0-46f1-be99-e6eb2b37969f_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable_83ea2d99-172c-4bef-baeb-7747700059fa_terseLabel_en-US" xlink:label="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Table]</link:label>
    <link:label id="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable_label_en-US" xlink:label="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable" xlink:to="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossOnSaleOfInvestments_ad19d094-99a8-47f1-96ac-3135117e6baf_terseLabel_en-US" xlink:label="lab_us-gaap_GainLossOnSaleOfInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Sale of Investments</link:label>
    <link:label id="lab_us-gaap_GainLossOnSaleOfInvestments_label_en-US" xlink:label="lab_us-gaap_GainLossOnSaleOfInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Sale of Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnSaleOfInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossOnSaleOfInvestments" xlink:to="lab_us-gaap_GainLossOnSaleOfInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_cah_EffectiveIncomeTaxReconciliationOpioidLitigation_ff8b49b1-8065-443b-ac84-45d521190477_terseLabel_en-US" xlink:label="lab_cah_EffectiveIncomeTaxReconciliationOpioidLitigation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Reconciliation, Opioid Litigation</link:label>
    <link:label id="lab_cah_EffectiveIncomeTaxReconciliationOpioidLitigation_label_en-US" xlink:label="lab_cah_EffectiveIncomeTaxReconciliationOpioidLitigation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Reconciliation, Opioid Litigation</link:label>
    <link:label id="lab_cah_EffectiveIncomeTaxReconciliationOpioidLitigation_documentation_en-US" xlink:label="lab_cah_EffectiveIncomeTaxReconciliationOpioidLitigation" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Reconciliation, Opioid Litigation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cah_EffectiveIncomeTaxReconciliationOpioidLitigation" xlink:href="cah-20210630.xsd#cah_EffectiveIncomeTaxReconciliationOpioidLitigation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_EffectiveIncomeTaxReconciliationOpioidLitigation" xlink:to="lab_cah_EffectiveIncomeTaxReconciliationOpioidLitigation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsNonrecurringMember_dc6bdbb3-604b-4914-aac5-8b18572a3951_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsNonrecurringMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Nonrecurring</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsNonrecurringMember_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsNonrecurringMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Nonrecurring [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsNonrecurringMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsNonrecurringMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsNonrecurringMember" xlink:to="lab_us-gaap_FairValueMeasurementsNonrecurringMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_08f14710-4ce8-4811-ab25-c5edb87409d9_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercisable at end of period (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock_7558f1e4-5b76-49a9-9e6f-1f3ce7b56a3a_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Other Intangible Assets</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible_23ce4a23-09e3-426a-87c8-de49eaad4ca6_terseLabel_en-US" xlink:label="lab_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated range of decrease in unrecognized tax benefits within the next 12 months</link:label>
    <link:label id="lab_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible_label_en-US" xlink:label="lab_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Decrease in Unrecognized Tax Benefits is Reasonably Possible</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible" xlink:to="lab_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockValue_d95b400a-958c-411f-9d1c-761bcedf91ef_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Authorized&#8212;500 thousand shares, Issued&#8212;none</link:label>
    <link:label id="lab_us-gaap_PreferredStockValue_label_en-US" xlink:label="lab_us-gaap_PreferredStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockValue" xlink:to="lab_us-gaap_PreferredStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet_398e5078-b202-4d43-814f-fffc78c735cc_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forward contracts</link:label>
    <link:label id="lab_us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet_label_en-US" xlink:label="lab_us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Assets (Liabilities), at Fair Value, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet" xlink:to="lab_us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsMember_b43b16e2-551c-455f-bda2-a56564e0e73a_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsMember_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsMember" xlink:to="lab_us-gaap_RetainedEarningsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cah_ProjectCostsOnInvestmentAndOtherSpending_570175d3-f92d-4cc9-92b8-1910961716f6_terseLabel_en-US" xlink:label="lab_cah_ProjectCostsOnInvestmentAndOtherSpending" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Project costs on investment and other spending</link:label>
    <link:label id="lab_cah_ProjectCostsOnInvestmentAndOtherSpending_label_en-US" xlink:label="lab_cah_ProjectCostsOnInvestmentAndOtherSpending" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Project Costs On Investment And Other Spending</link:label>
    <link:label id="lab_cah_ProjectCostsOnInvestmentAndOtherSpending_documentation_en-US" xlink:label="lab_cah_ProjectCostsOnInvestmentAndOtherSpending" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment spending at the Corporate level. Investment spending generally includes the first year spend for certain projects that require incremental investments in the form of additional operating expenses.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cah_ProjectCostsOnInvestmentAndOtherSpending" xlink:href="cah-20210630.xsd#cah_ProjectCostsOnInvestmentAndOtherSpending"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_ProjectCostsOnInvestmentAndOtherSpending" xlink:to="lab_cah_ProjectCostsOnInvestmentAndOtherSpending" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentFairValue_43298fc9-0979-4455-86c4-6fdf61d7d05d_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated fair value</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentFairValue_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentFairValue" xlink:to="lab_us-gaap_DebtInstrumentFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_cah_CommonStockVotingRightsVotes_a983e2b1-3a21-4f7c-ae9b-e3b26883081b_terseLabel_en-US" xlink:label="lab_cah_CommonStockVotingRightsVotes" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Voting Rights, Votes</link:label>
    <link:label id="lab_cah_CommonStockVotingRightsVotes_label_en-US" xlink:label="lab_cah_CommonStockVotingRightsVotes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Voting Rights, Votes</link:label>
    <link:label id="lab_cah_CommonStockVotingRightsVotes_documentation_en-US" xlink:label="lab_cah_CommonStockVotingRightsVotes" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Voting Rights, Votes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cah_CommonStockVotingRightsVotes" xlink:href="cah-20210630.xsd#cah_CommonStockVotingRightsVotes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_CommonStockVotingRightsVotes" xlink:to="lab_cah_CommonStockVotingRightsVotes" xlink:type="arc" order="1"/>
    <link:label id="lab_cah_IndemnificationReceivable_f9f440de-a063-43be-9ce3-514465cd4b07_terseLabel_en-US" xlink:label="lab_cah_IndemnificationReceivable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount CareFusion is liable under tax matters agreement in the event amount must be paid to the taxing authority</link:label>
    <link:label id="lab_cah_IndemnificationReceivable_label_en-US" xlink:label="lab_cah_IndemnificationReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indemnification Receivable</link:label>
    <link:label id="lab_cah_IndemnificationReceivable_documentation_en-US" xlink:label="lab_cah_IndemnificationReceivable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indemnification receivable from Patient recovery related to certain pre-acquisition tax exposures and transaction taxes.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cah_IndemnificationReceivable" xlink:href="cah-20210630.xsd#cah_IndemnificationReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_IndemnificationReceivable" xlink:to="lab_cah_IndemnificationReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_cah_A24NotesDue2019Member_f4180225-53c6-4d0f-a637-a21a50f79085_terseLabel_en-US" xlink:label="lab_cah_A24NotesDue2019Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.4% Notes due 2019</link:label>
    <link:label id="lab_cah_A24NotesDue2019Member_label_en-US" xlink:label="lab_cah_A24NotesDue2019Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.4% Notes due 2019 [Member]</link:label>
    <link:label id="lab_cah_A24NotesDue2019Member_documentation_en-US" xlink:label="lab_cah_A24NotesDue2019Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.4% Notes due 2019</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cah_A24NotesDue2019Member" xlink:href="cah-20210630.xsd#cah_A24NotesDue2019Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_A24NotesDue2019Member" xlink:to="lab_cah_A24NotesDue2019Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesDeferredExpenseCapitalizedInventoryCosts_7a087d18-040f-4366-a895-dc0fa1152446_negatedLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesDeferredExpenseCapitalizedInventoryCosts" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory basis differences</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesDeferredExpenseCapitalizedInventoryCosts_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesDeferredExpenseCapitalizedInventoryCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Inventory</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesDeferredExpenseCapitalizedInventoryCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilitiesDeferredExpenseCapitalizedInventoryCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesDeferredExpenseCapitalizedInventoryCosts" xlink:to="lab_us-gaap_DeferredTaxLiabilitiesDeferredExpenseCapitalizedInventoryCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_d96e0f82-31f4-4a68-897b-91929002ad78_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:to="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentLineItems_a71ab049-ac39-43b5-bc28-99933d878aae_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Line Items]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentLineItems_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_cah_GoodwillAndIntangibleAssetsLineItems_0207d464-9aaa-47bc-8111-d41d3cb59586_terseLabel_en-US" xlink:label="lab_cah_GoodwillAndIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets [Line Items]</link:label>
    <link:label id="lab_cah_GoodwillAndIntangibleAssetsLineItems_label_en-US" xlink:label="lab_cah_GoodwillAndIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets [Line Items]</link:label>
    <link:label id="lab_cah_GoodwillAndIntangibleAssetsLineItems_documentation_en-US" xlink:label="lab_cah_GoodwillAndIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cah_GoodwillAndIntangibleAssetsLineItems" xlink:href="cah-20210630.xsd#cah_GoodwillAndIntangibleAssetsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_GoodwillAndIntangibleAssetsLineItems" xlink:to="lab_cah_GoodwillAndIntangibleAssetsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_2f950bd4-5b7f-4989-8493-4794e56c7b09_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total comprehensive income/(loss)</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment_108e50d7-824d-49df-a9bc-5bdd31ca98cd_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Property, Plant and Equipment</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Property, Plant and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TaxPeriodDomain_5ce0c305-70e4-413d-b660-930ec14794b0_terseLabel_en-US" xlink:label="lab_us-gaap_TaxPeriodDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Period [Domain]</link:label>
    <link:label id="lab_us-gaap_TaxPeriodDomain_label_en-US" xlink:label="lab_us-gaap_TaxPeriodDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Period [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxPeriodDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxPeriodDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TaxPeriodDomain" xlink:to="lab_us-gaap_TaxPeriodDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherShortTermBorrowings_e9576227-3a9a-4e04-bde9-a650c301d453_terseLabel_en-US" xlink:label="lab_us-gaap_OtherShortTermBorrowings" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Short-term Borrowings</link:label>
    <link:label id="lab_us-gaap_OtherShortTermBorrowings_label_en-US" xlink:label="lab_us-gaap_OtherShortTermBorrowings" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Short-term Borrowings</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherShortTermBorrowings" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherShortTermBorrowings"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherShortTermBorrowings" xlink:to="lab_us-gaap_OtherShortTermBorrowings" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeasePrincipalPayments_5371485b-35fe-4336-8277-612aa883a693_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeasePrincipalPayments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Principal Payments</link:label>
    <link:label id="lab_us-gaap_FinanceLeasePrincipalPayments_label_en-US" xlink:label="lab_us-gaap_FinanceLeasePrincipalPayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Principal Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeasePrincipalPayments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeasePrincipalPayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeasePrincipalPayments" xlink:to="lab_us-gaap_FinanceLeasePrincipalPayments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpenseMember_e5562a0b-55e4-47e8-ace8-a2235e86f0d4_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Income, Net</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpenseMember_label_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Nonoperating Income (Expense) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpenseMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseMember" xlink:to="lab_us-gaap_OtherNonoperatingIncomeExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_5a2b6e23-2702-4bcb-bb4f-32b8fcd9e86d_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasic" xlink:to="lab_us-gaap_EarningsPerShareBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_e9ee5c6b-cea7-4f37-a2ac-a0d18577ec48_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonvested at beginning of period (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_9fb13b56-489b-4472-93cd-3c4c7a892276_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonvested at end of period (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_0d19fd89-925f-4748-a515-76827ab18c02_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_c4ff7ffd-c1c8-463c-9874-22b32ec76f38_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maturities of existing long-term obligations and other short-term borrowings - 2020</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_cah_TotalLeaseLiabilityNotYetCommencedAmount_3d55f7ca-65ce-4d65-b927-59097411d3b9_terseLabel_en-US" xlink:label="lab_cah_TotalLeaseLiabilityNotYetCommencedAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: leases not yet commenced (1)</link:label>
    <link:label id="lab_cah_TotalLeaseLiabilityNotYetCommencedAmount_label_en-US" xlink:label="lab_cah_TotalLeaseLiabilityNotYetCommencedAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Lease Liability Not Yet Commenced, Amount</link:label>
    <link:label id="lab_cah_TotalLeaseLiabilityNotYetCommencedAmount_documentation_en-US" xlink:label="lab_cah_TotalLeaseLiabilityNotYetCommencedAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Lease Liability Not Yet Commenced, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cah_TotalLeaseLiabilityNotYetCommencedAmount" xlink:href="cah-20210630.xsd#cah_TotalLeaseLiabilityNotYetCommencedAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_TotalLeaseLiabilityNotYetCommencedAmount" xlink:to="lab_cah_TotalLeaseLiabilityNotYetCommencedAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareDilutedAbstract_d85ea0ce-58ab-4d24-bb45-0dc2f03a7495_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDilutedAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted earnings per common share attributable to Cardinal Health, Inc.:</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDilutedAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDilutedAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Diluted [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDilutedAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDilutedAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDilutedAbstract" xlink:to="lab_us-gaap_EarningsPerShareDilutedAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock_8b5b9620-67ff-4a34-93ad-2fdcc39321aa_terseLabel_en-US" xlink:label="lab_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Schedule of Valuation and Qualifying Accounts Disclosure [Text Block]</link:label>
    <link:label id="lab_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock_label_en-US" xlink:label="lab_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Schedule of Valuation and Qualifying Accounts Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock" xlink:to="lab_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCurrentReportingStatus_b3a2edbe-ef3d-4186-ab63-ab5b98f2d60f_terseLabel_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:label id="lab_dei_EntityCurrentReportingStatus_label_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCurrentReportingStatus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCurrentReportingStatus" xlink:to="lab_dei_EntityCurrentReportingStatus" xlink:type="arc" order="1"/>
    <link:label id="lab_cah_A4.368Notesdue2047Member_b3bc8a66-c67a-4cfd-aa62-75366e3d06ae_terseLabel_en-US" xlink:label="lab_cah_A4.368Notesdue2047Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.368% Notes due fiscal 2047</link:label>
    <link:label id="lab_cah_A4.368Notesdue2047Member_label_en-US" xlink:label="lab_cah_A4.368Notesdue2047Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.368% Notes due 2047 [Member]</link:label>
    <link:label id="lab_cah_A4.368Notesdue2047Member_documentation_en-US" xlink:label="lab_cah_A4.368Notesdue2047Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.368% Notes due 2047</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cah_A4.368Notesdue2047Member" xlink:href="cah-20210630.xsd#cah_A4.368Notesdue2047Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_A4.368Notesdue2047Member" xlink:to="lab_cah_A4.368Notesdue2047Member" xlink:type="arc" order="1"/>
    <link:label id="lab_cah_A1.948Notesdue2019Member_042fec4c-9f23-422b-9dc3-fad4a78122fc_terseLabel_en-US" xlink:label="lab_cah_A1.948Notesdue2019Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.948% Notes due 2019</link:label>
    <link:label id="lab_cah_A1.948Notesdue2019Member_label_en-US" xlink:label="lab_cah_A1.948Notesdue2019Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.948% Notes due 2019 [Member]</link:label>
    <link:label id="lab_cah_A1.948Notesdue2019Member_documentation_en-US" xlink:label="lab_cah_A1.948Notesdue2019Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.948% Notes due 2019</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cah_A1.948Notesdue2019Member" xlink:href="cah-20210630.xsd#cah_A1.948Notesdue2019Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_A1.948Notesdue2019Member" xlink:to="lab_cah_A1.948Notesdue2019Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MachineryAndEquipmentMember_dc2b7d43-0c9c-4c10-8303-fad6525c92e8_verboseLabel_en-US" xlink:label="lab_us-gaap_MachineryAndEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Machinery and equipment</link:label>
    <link:label id="lab_us-gaap_MachineryAndEquipmentMember_label_en-US" xlink:label="lab_us-gaap_MachineryAndEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Machinery and Equipment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MachineryAndEquipmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MachineryAndEquipmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MachineryAndEquipmentMember" xlink:to="lab_us-gaap_MachineryAndEquipmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommercialPaperMember_f337c957-de0a-4f4b-af6b-c96472ee8d97_terseLabel_en-US" xlink:label="lab_us-gaap_CommercialPaperMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial paper</link:label>
    <link:label id="lab_us-gaap_CommercialPaperMember_c87742ac-0f48-464f-a283-206644d895fe_verboseLabel_en-US" xlink:label="lab_us-gaap_CommercialPaperMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial Paper</link:label>
    <link:label id="lab_us-gaap_CommercialPaperMember_label_en-US" xlink:label="lab_us-gaap_CommercialPaperMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial Paper [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommercialPaperMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommercialPaperMember" xlink:to="lab_us-gaap_CommercialPaperMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilities_e512892a-8fa9-47cc-bc9d-bc68acaf6e8d_negatedTotalLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilities" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net deferred income tax liability</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilities_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilities" xlink:to="lab_us-gaap_DeferredTaxLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeAsset_17be0a3c-e8d5-4cdf-beab-ba11461fa8d0_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets</link:label>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeAsset_label_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Asset, Fair Value, Gross Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:to="lab_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyNumberOfPlaintiffs_c35e1543-5a28-478a-b6e4-d9b0aa504f1f_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyNumberOfPlaintiffs" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of plaintiffs</link:label>
    <link:label id="lab_us-gaap_LossContingencyNumberOfPlaintiffs_label_en-US" xlink:label="lab_us-gaap_LossContingencyNumberOfPlaintiffs" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Number of Plaintiffs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNumberOfPlaintiffs" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyNumberOfPlaintiffs"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyNumberOfPlaintiffs" xlink:to="lab_us-gaap_LossContingencyNumberOfPlaintiffs" xlink:type="arc" order="1"/>
    <link:label id="lab_cah_A2.616Notesdue2022Member_5a01ddf5-68ff-41f0-a6ed-0ee026420c6a_terseLabel_en-US" xlink:label="lab_cah_A2.616Notesdue2022Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.616% Notes due fiscal 2022</link:label>
    <link:label id="lab_cah_A2.616Notesdue2022Member_label_en-US" xlink:label="lab_cah_A2.616Notesdue2022Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.616% Notes due 2022 [Member]</link:label>
    <link:label id="lab_cah_A2.616Notesdue2022Member_documentation_en-US" xlink:label="lab_cah_A2.616Notesdue2022Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.616% Notes due 2022</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cah_A2.616Notesdue2022Member" xlink:href="cah-20210630.xsd#cah_A2.616Notesdue2022Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_A2.616Notesdue2022Member" xlink:to="lab_cah_A2.616Notesdue2022Member" xlink:type="arc" order="1"/>
    <link:label id="lab_cah_TotalLeaseLiability_1b9e818a-fc34-4901-8d19-7bfd6f0566a1_terseLabel_en-US" xlink:label="lab_cah_TotalLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Lease Liability</link:label>
    <link:label id="lab_cah_TotalLeaseLiability_label_en-US" xlink:label="lab_cah_TotalLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Lease Liability</link:label>
    <link:label id="lab_cah_TotalLeaseLiability_documentation_en-US" xlink:label="lab_cah_TotalLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Lease Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cah_TotalLeaseLiability" xlink:href="cah-20210630.xsd#cah_TotalLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_TotalLeaseLiability" xlink:to="lab_cah_TotalLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_14f5ae16-6d37-4c0f-866c-47cd45e69997_negatedLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property-related</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Property, Plant and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:to="lab_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReceivablesNetCurrent_dfa6cc72-6250-4fac-8364-73a700f65853_terseLabel_en-US" xlink:label="lab_us-gaap_ReceivablesNetCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trade receivables, net</link:label>
    <link:label id="lab_us-gaap_ReceivablesNetCurrent_label_en-US" xlink:label="lab_us-gaap_ReceivablesNetCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivables, Net, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesNetCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReceivablesNetCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReceivablesNetCurrent" xlink:to="lab_us-gaap_ReceivablesNetCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_cah_DiscountRatefairvalueinputs_08f9f707-2cad-4d36-a4cb-636d42665ad7_terseLabel_en-US" xlink:label="lab_cah_DiscountRatefairvalueinputs" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discount Rate, fair value inputs</link:label>
    <link:label id="lab_cah_DiscountRatefairvalueinputs_label_en-US" xlink:label="lab_cah_DiscountRatefairvalueinputs" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discount Rate, fair value inputs</link:label>
    <link:label id="lab_cah_DiscountRatefairvalueinputs_documentation_en-US" xlink:label="lab_cah_DiscountRatefairvalueinputs" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discount Rate, fair value inputs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cah_DiscountRatefairvalueinputs" xlink:href="cah-20210630.xsd#cah_DiscountRatefairvalueinputs"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_DiscountRatefairvalueinputs" xlink:to="lab_cah_DiscountRatefairvalueinputs" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_fa002b68-de97-4ca4-9b94-a2ab56fab051_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current portion of long-term obligations and other short-term borrowings</link:label>
    <link:label id="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_05a4f81f-cf1f-4d2b-ba79-466c49f56028_verboseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: current portion of long-term obligations and other short-term borrowings</link:label>
    <link:label id="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_label_en-US" xlink:label="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt and Lease Obligation, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent" xlink:to="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_6c4bc174-1f10-4fa8-8120-503b0ddada16_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total fair value of shares vested during the year</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DiscontinuedOperationTaxEffectOfIncomeLossFromDisposalOfDiscontinuedOperation_0887e4be-8038-47c8-a41c-c40715524685_terseLabel_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationTaxEffectOfIncomeLossFromDisposalOfDiscontinuedOperation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discontinued Operation, Tax Effect of Gain (Loss) from Disposal of Discontinued Operation</link:label>
    <link:label id="lab_us-gaap_DiscontinuedOperationTaxEffectOfIncomeLossFromDisposalOfDiscontinuedOperation_label_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationTaxEffectOfIncomeLossFromDisposalOfDiscontinuedOperation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discontinued Operation, Tax Effect of Gain (Loss) from Disposal of Discontinued Operation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationTaxEffectOfIncomeLossFromDisposalOfDiscontinuedOperation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DiscontinuedOperationTaxEffectOfIncomeLossFromDisposalOfDiscontinuedOperation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DiscontinuedOperationTaxEffectOfIncomeLossFromDisposalOfDiscontinuedOperation" xlink:to="lab_us-gaap_DiscontinuedOperationTaxEffectOfIncomeLossFromDisposalOfDiscontinuedOperation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PlanNameAxis_391d48f5-9b89-4836-a69e-87f018a05613_terseLabel_en-US" xlink:label="lab_us-gaap_PlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Axis]</link:label>
    <link:label id="lab_us-gaap_PlanNameAxis_label_en-US" xlink:label="lab_us-gaap_PlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameAxis" xlink:to="lab_us-gaap_PlanNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosureAbstract_9bcf93a0-6c55-4bf0-a8cb-1fa1166c89d7_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets:</link:label>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Fair Value Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsFairValueDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract" xlink:to="lab_us-gaap_AssetsFairValueDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_2ab3fb9a-a9e5-4aa3-b64a-4f58127c4f5b_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level&#160;1</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 1 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel1Member" xlink:to="lab_us-gaap_FairValueInputsLevel1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_07a63112-676a-4888-adfe-a126c02e51b9_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from investing activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillImpairmentLoss_20ca6964-7e5d-42de-a692-abe577757a6d_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillImpairmentLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Impairment Loss</link:label>
    <link:label id="lab_us-gaap_GoodwillImpairmentLoss_label_en-US" xlink:label="lab_us-gaap_GoodwillImpairmentLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Impairment Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillImpairmentLoss" xlink:to="lab_us-gaap_GoodwillImpairmentLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_e61271af-d90e-458a-a028-dd73f76c3a82_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:to="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_cah_FacilityExitAndOtherCosts_98ffcfb9-4fdc-4fb8-a214-672e481753e9_terseLabel_en-US" xlink:label="lab_cah_FacilityExitAndOtherCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Facility Exit and Other Costs</link:label>
    <link:label id="lab_cah_FacilityExitAndOtherCosts_label_en-US" xlink:label="lab_cah_FacilityExitAndOtherCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Facility Exit and Other Costs</link:label>
    <link:label id="lab_cah_FacilityExitAndOtherCosts_documentation_en-US" xlink:label="lab_cah_FacilityExitAndOtherCosts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Facility exit and other costs primarily consist of lease termination costs, accelerated depreciation, equipment relocation costs, project consulting fees and costs associated with restructuring our delivery of information technology infrastructure services.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cah_FacilityExitAndOtherCosts" xlink:href="cah-20210630.xsd#cah_FacilityExitAndOtherCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_FacilityExitAndOtherCosts" xlink:to="lab_cah_FacilityExitAndOtherCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_5e1cf014-029c-47ca-9bb7-55191abdb07d_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additions for tax positions of the current year</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems_cba8cd0b-7c50-4524-b80e-cce72f6dcbb5_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets [Line Items]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_cah_EffectiveIncomeTaxRateReconciliationWithholdingTaxes_f5db286a-a8e0-472e-b6ad-0d0be1419b0c_terseLabel_en-US" xlink:label="lab_cah_EffectiveIncomeTaxRateReconciliationWithholdingTaxes" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Withholding Taxes</link:label>
    <link:label id="lab_cah_EffectiveIncomeTaxRateReconciliationWithholdingTaxes_label_en-US" xlink:label="lab_cah_EffectiveIncomeTaxRateReconciliationWithholdingTaxes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Withholding Taxes</link:label>
    <link:label id="lab_cah_EffectiveIncomeTaxRateReconciliationWithholdingTaxes_documentation_en-US" xlink:label="lab_cah_EffectiveIncomeTaxRateReconciliationWithholdingTaxes" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Withholding Taxes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cah_EffectiveIncomeTaxRateReconciliationWithholdingTaxes" xlink:href="cah-20210630.xsd#cah_EffectiveIncomeTaxRateReconciliationWithholdingTaxes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_EffectiveIncomeTaxRateReconciliationWithholdingTaxes" xlink:to="lab_cah_EffectiveIncomeTaxRateReconciliationWithholdingTaxes" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_ef17d2c9-e874-4918-8a95-ee40012c9c0b_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Shareholders&#8217; Equity</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_2e117872-5919-4f14-8df4-8f5b432780a4_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized tax benefits that would impact effective tax rate</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits that Would Impact Effective Tax Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:type="arc" order="1"/>
    <link:label id="lab_cah_NetOperatingLossCarrybackMember_1729dc6d-a6f3-4e26-af72-428e311e2ad0_terseLabel_en-US" xlink:label="lab_cah_NetOperatingLossCarrybackMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Operating Loss Carryback</link:label>
    <link:label id="lab_cah_NetOperatingLossCarrybackMember_label_en-US" xlink:label="lab_cah_NetOperatingLossCarrybackMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Operating Loss Carryback [Member]</link:label>
    <link:label id="lab_cah_NetOperatingLossCarrybackMember_documentation_en-US" xlink:label="lab_cah_NetOperatingLossCarrybackMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Operating Loss Carryback</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cah_NetOperatingLossCarrybackMember" xlink:href="cah-20210630.xsd#cah_NetOperatingLossCarrybackMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_NetOperatingLossCarrybackMember" xlink:to="lab_cah_NetOperatingLossCarrybackMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayable_9b590f3f-e389-48d3-bb87-29ceade49738_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase/(decrease) in accounts payable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestRateSwapMember_9092a089-3db6-4add-9815-efd8e49d0d5e_verboseLabel_en-US" xlink:label="lab_us-gaap_InterestRateSwapMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swaps</link:label>
    <link:label id="lab_us-gaap_InterestRateSwapMember_9389d8a6-e9ba-4a51-b407-d78d53b66dab_terseLabel_en-US" xlink:label="lab_us-gaap_InterestRateSwapMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swaps</link:label>
    <link:label id="lab_us-gaap_InterestRateSwapMember_label_en-US" xlink:label="lab_us-gaap_InterestRateSwapMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestRateSwapMember" xlink:to="lab_us-gaap_InterestRateSwapMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HedgingRelationshipDomain_0f459268-5c98-4908-94c0-c981f76d31e9_terseLabel_en-US" xlink:label="lab_us-gaap_HedgingRelationshipDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Domain]</link:label>
    <link:label id="lab_us-gaap_HedgingRelationshipDomain_label_en-US" xlink:label="lab_us-gaap_HedgingRelationshipDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgingRelationshipDomain" xlink:to="lab_us-gaap_HedgingRelationshipDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_cah_ASC842Member_fb2e6dd7-8409-40d8-a176-fb2be3e22864_terseLabel_en-US" xlink:label="lab_cah_ASC842Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ASC 842</link:label>
    <link:label id="lab_cah_ASC842Member_label_en-US" xlink:label="lab_cah_ASC842Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ASC 842 [Member]</link:label>
    <link:label id="lab_cah_ASC842Member_documentation_en-US" xlink:label="lab_cah_ASC842Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ASC 842</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cah_ASC842Member" xlink:href="cah-20210630.xsd#cah_ASC842Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_ASC842Member" xlink:to="lab_cah_ASC842Member" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ValuationAndQualifyingAccountsDisclosureTable_135c2ed2-41e7-4178-a0b1-8793359f6965_terseLabel_en-US" xlink:label="lab_srt_ValuationAndQualifyingAccountsDisclosureTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Table]</link:label>
    <link:label id="lab_srt_ValuationAndQualifyingAccountsDisclosureTable_label_en-US" xlink:label="lab_srt_ValuationAndQualifyingAccountsDisclosureTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ValuationAndQualifyingAccountsDisclosureTable" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ValuationAndQualifyingAccountsDisclosureTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureTable" xlink:to="lab_srt_ValuationAndQualifyingAccountsDisclosureTable" xlink:type="arc" order="1"/>
    <link:label id="lab_cah_Amortizationandotheracquisitionrelatedcosts_2582660d-a7cb-4e9e-917c-dc5acd4348d3_terseLabel_en-US" xlink:label="lab_cah_Amortizationandotheracquisitionrelatedcosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization and other acquisition-related costs</link:label>
    <link:label id="lab_cah_Amortizationandotheracquisitionrelatedcosts_label_en-US" xlink:label="lab_cah_Amortizationandotheracquisitionrelatedcosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization and other acquisition-related costs</link:label>
    <link:label id="lab_cah_Amortizationandotheracquisitionrelatedcosts_documentation_en-US" xlink:label="lab_cah_Amortizationandotheracquisitionrelatedcosts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The aggregate expense charged against earnings to allocate the cost of acquired intangible assets and changes in the fair value of contingent consideration obligations. This also represents acquisition-related costs incurred to effect a business combination which costs have been expensed during the period. Such costs include finder's fees; advisory, legal, accounting, valuation, and other professional or consulting fees; general administrative costs, including the costs of maintaining an internal acquisitions department; and may include costs of registering and issuing debt and equity securities.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cah_Amortizationandotheracquisitionrelatedcosts" xlink:href="cah-20210630.xsd#cah_Amortizationandotheracquisitionrelatedcosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_Amortizationandotheracquisitionrelatedcosts" xlink:to="lab_cah_Amortizationandotheracquisitionrelatedcosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock_822f9c4d-bdae-4012-9bd9-f1301f1a8ca8_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Gain/(Loss) Reclassified from AOCI into Earnings for Derivative Instruments Designated as Cash Flow Hedges</link:label>
    <link:label id="lab_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Cash Flow Hedges Included in Accumulated Other Comprehensive Income (Loss) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive_b6f2f058-b5fb-44bb-9bf8-c18a172163ba_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maturities of existing long-term obligations and other short-term borrowings-Thereafter</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, after Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_b8786a17-97d6-4918-b402-12155e7f2888_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated annual amortization of intangible assets - 2025</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities_d2e23b8b-62af-49bf-ad16-af0f205aa116_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Decrease Resulting from Settlements with Taxing Authorities</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities_23b42224-129d-44fb-8aa1-4d19a642486a_negatedLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Settlements with tax authorities</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Decrease Resulting from Settlements with Taxing Authorities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock_38aa93f0-0220-4492-aec8-370dc92d5e57_terseLabel_en-US" xlink:label="lab_us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets by Reportable Segment</link:label>
    <link:label id="lab_us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock_label_en-US" xlink:label="lab_us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Assets from Segment to Consolidated [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock" xlink:to="lab_us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BalanceSheetLocationDomain_8e9c940c-6d41-468f-b4e2-86c798904744_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Domain]</link:label>
    <link:label id="lab_us-gaap_BalanceSheetLocationDomain_label_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetLocationDomain" xlink:to="lab_us-gaap_BalanceSheetLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_9f00c423-2421-4189-b23f-457b62de8363_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized tax benefits</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_6fe327c2-73ee-4556-ad00-89e5ab949158_periodStartLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at beginning of fiscal year</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_3aef6c02-d51e-449a-9451-87a6a5924751_periodEndLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at end of fiscal year</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefits" xlink:to="lab_us-gaap_UnrecognizedTaxBenefits" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsGross_47fca3ef-d97c-4fbf-9975-1fc3fa59a74e_totalLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsGross" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total deferred income tax assets</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsGross_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsGross" xlink:to="lab_us-gaap_DeferredTaxAssetsGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityDomain_fc9a7eb3-3302-449d-9e54-4ea37e4bfb57_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority</link:label>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityDomain_label_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain" xlink:to="lab_us-gaap_IncomeTaxAuthorityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherBorrowings_6f726e73-bd6e-4719-a908-568e7dbaad1d_terseLabel_en-US" xlink:label="lab_us-gaap_OtherBorrowings" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other obligations</link:label>
    <link:label id="lab_us-gaap_OtherBorrowings_25b2e6aa-fe88-488f-8a05-bf494e4eb374_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherBorrowings" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Borrowings</link:label>
    <link:label id="lab_us-gaap_OtherBorrowings_label_en-US" xlink:label="lab_us-gaap_OtherBorrowings" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Borrowings</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherBorrowings" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherBorrowings"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherBorrowings" xlink:to="lab_us-gaap_OtherBorrowings" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringReserve_b5e9b181-0c24-4ebf-84c2-e20139c55431_periodStartLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserve" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning Balance</link:label>
    <link:label id="lab_us-gaap_RestructuringReserve_f2c96cc0-87fe-44a4-86b8-f22c9a8c332b_periodEndLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserve" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending Balance</link:label>
    <link:label id="lab_us-gaap_RestructuringReserve_label_en-US" xlink:label="lab_us-gaap_RestructuringReserve" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Reserve</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringReserve"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringReserve" xlink:to="lab_us-gaap_RestructuringReserve" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_2b4f113a-3452-43db-bac7-a11264ca4c99_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_cah_CostofSalesVendorReservesPolicyPolicyTextBlock_5d3e937a-c9ee-4d78-9aa9-5a7b148aeea0_terseLabel_en-US" xlink:label="lab_cah_CostofSalesVendorReservesPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vendor Reserves</link:label>
    <link:label id="lab_cah_CostofSalesVendorReservesPolicyPolicyTextBlock_label_en-US" xlink:label="lab_cah_CostofSalesVendorReservesPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Sales, Vendor Reserves, Policy [Policy Text Block]</link:label>
    <link:label id="lab_cah_CostofSalesVendorReservesPolicyPolicyTextBlock_documentation_en-US" xlink:label="lab_cah_CostofSalesVendorReservesPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of accounting policy for allowances received from a vendor. The disclosure differentiates between those allowances that are recorded as a reduction in the price of the vendors' products or services (that is, the entity's inventory) and which ultimately will be recorded as a reduction in the entity's cost of sales and those that are not.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cah_CostofSalesVendorReservesPolicyPolicyTextBlock" xlink:href="cah-20210630.xsd#cah_CostofSalesVendorReservesPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_CostofSalesVendorReservesPolicyPolicyTextBlock" xlink:to="lab_cah_CostofSalesVendorReservesPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_afb65998-34ad-41c4-9e48-77165bb34602_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current liabilities:</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:to="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReceivableTypeDomain_1abdc1a2-c4c1-4f88-994e-872215e3c37e_terseLabel_en-US" xlink:label="lab_us-gaap_ReceivableTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivable [Domain]</link:label>
    <link:label id="lab_us-gaap_ReceivableTypeDomain_label_en-US" xlink:label="lab_us-gaap_ReceivableTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivable [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivableTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReceivableTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReceivableTypeDomain" xlink:to="lab_us-gaap_ReceivableTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLossCarryforwardsValuationAllowance_c7eea946-0e85-47a5-be13-864adf51e7f9_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwardsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation allowance on operating loss carryforwards</link:label>
    <link:label id="lab_us-gaap_OperatingLossCarryforwardsValuationAllowance_label_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwardsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Loss Carryforwards, Valuation Allowance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwardsValuationAllowance" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLossCarryforwardsValuationAllowance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLossCarryforwardsValuationAllowance" xlink:to="lab_us-gaap_OperatingLossCarryforwardsValuationAllowance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_2584906e-0b82-4351-90b1-2ebafcff625b_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercisable at end of period (in usd per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_cah_DeferredTaxAssetsRelatedtouncertaintaxpositions_c3f7be9f-d36a-4da7-860c-2f691492bcba_terseLabel_en-US" xlink:label="lab_cah_DeferredTaxAssetsRelatedtouncertaintaxpositions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax assets related to uncertain tax positions</link:label>
    <link:label id="lab_cah_DeferredTaxAssetsRelatedtouncertaintaxpositions_label_en-US" xlink:label="lab_cah_DeferredTaxAssetsRelatedtouncertaintaxpositions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Related to uncertain tax positions</link:label>
    <link:label id="lab_cah_DeferredTaxAssetsRelatedtouncertaintaxpositions_documentation_en-US" xlink:label="lab_cah_DeferredTaxAssetsRelatedtouncertaintaxpositions" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax assets related to uncertain tax positions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cah_DeferredTaxAssetsRelatedtouncertaintaxpositions" xlink:href="cah-20210630.xsd#cah_DeferredTaxAssetsRelatedtouncertaintaxpositions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_DeferredTaxAssetsRelatedtouncertaintaxpositions" xlink:to="lab_cah_DeferredTaxAssetsRelatedtouncertaintaxpositions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_06b1677a-342b-4ca2-8f43-e520724a6fa9_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized tax benefits, interest and penalties accrued</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_9d190c13-3106-4b52-9755-58d37e8e865f_terseLabel_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_label_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingPoliciesAbstract" xlink:to="lab_us-gaap_AccountingPoliciesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_d794591f-fb26-4f78-a0cb-d91d848a8260_verboseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average remaining contractual life of outstanding options</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentRiskAxis_6d487750-7485-4ed3-83cf-c67c4b142510_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentRiskAxis_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis" xlink:to="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentFederalTaxExpenseBenefit_f90d771d-7c40-4805-9a20-ebafe4981c40_terseLabel_en-US" xlink:label="lab_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Federal</link:label>
    <link:label id="lab_us-gaap_CurrentFederalTaxExpenseBenefit_82c91f45-5798-483d-8d83-4853aee94f2e_verboseLabel_en-US" xlink:label="lab_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Federal Tax Expense (Benefit)</link:label>
    <link:label id="lab_us-gaap_CurrentFederalTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Federal Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentFederalTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:to="lab_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_26d8de83-0a04-4036-b501-2c02feecda3b_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_a395c3e9-2745-4a3a-a71f-9800ad0b4b7c_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiability" xlink:to="lab_us-gaap_OperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_205aee41-7ab8-4c4e-85d8-9c5c565984d1_terseLabel_en-US" xlink:label="lab_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable Noncontrolling Interest, Equity, Carrying Amount</link:label>
    <link:label id="lab_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_label_en-US" xlink:label="lab_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable Noncontrolling Interest, Equity, Carrying Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount" xlink:to="lab_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_cah_ShortTermCreditFacilitiesMember_1f0569f6-3cf8-460b-ba15-1ade2ca9d284_terseLabel_en-US" xlink:label="lab_cah_ShortTermCreditFacilitiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short Term Credit Facilities</link:label>
    <link:label id="lab_cah_ShortTermCreditFacilitiesMember_label_en-US" xlink:label="lab_cah_ShortTermCreditFacilitiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short Term Credit Facilities Member</link:label>
    <link:label id="lab_cah_ShortTermCreditFacilitiesMember_documentation_en-US" xlink:label="lab_cah_ShortTermCreditFacilitiesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other short-term credit facilities and an unsecured line of credit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cah_ShortTermCreditFacilitiesMember" xlink:href="cah-20210630.xsd#cah_ShortTermCreditFacilitiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_ShortTermCreditFacilitiesMember" xlink:to="lab_cah_ShortTermCreditFacilitiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockValue_1e62ed25-39b9-4e84-9b5d-09fc6ebaf57f_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Authorized&#8212;755 million shares, Issued&#8212; 327 million shares at June 30, 2021 and 2020</link:label>
    <link:label id="lab_us-gaap_CommonStockValue_label_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockValue" xlink:to="lab_us-gaap_CommonStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_e7474751-6e67-49a8-8d7d-aa1432948d57_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Weighted Average Discount Rate, Percent</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Weighted Average Discount Rate, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:to="lab_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_ab36024b-55f0-4da4-b68c-b4b45a8873f1_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_label_en-US" xlink:label="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation" xlink:to="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_9663b0a7-6f52-4ac9-92cb-504fdca08951_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average period over which stock option compensation cost is expected to be recognized</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_c91407d1-4fd9-4019-82b7-69db39786a63_verboseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average period in years over which restricted share and share unit cost is expected to be recognized (in years)</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_6cbe1c73-697d-4e32-95d6-6220b646b977_netLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average period over which performance share unit cost is expected to be recognized (in years)</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_a4305ba9-92b8-411d-bcb5-47b04ac626e2_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonvested at beginning of period (in usd per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_5ae34e72-572d-4cfb-ad3f-ce1285238822_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonvested at end of period (in usd per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CustomerConcentrationRiskMember_77a7bd1c-8980-45f2-b99f-8e0626152785_terseLabel_en-US" xlink:label="lab_us-gaap_CustomerConcentrationRiskMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Concentration Risk</link:label>
    <link:label id="lab_us-gaap_CustomerConcentrationRiskMember_label_en-US" xlink:label="lab_us-gaap_CustomerConcentrationRiskMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Concentration Risk [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerConcentrationRiskMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerConcentrationRiskMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CustomerConcentrationRiskMember" xlink:to="lab_us-gaap_CustomerConcentrationRiskMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAssetAmortization_a3fc4c80-7a77-4e2f-8695-dbc1adc86974_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of right-of-use assets</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAssetAmortization_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Right-of-Use Asset, Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseRightOfUseAssetAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:to="lab_us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationDisclosureTextBlock_7336c850-2276-40db-96ce-c50f88cd4472_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination Disclosure</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:to="lab_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_6625862d-4db5-4bd3-abc4-9fdf7ad7f0a1_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Range of Assumptions Used to Estimate Fair Value of Stock Options</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_994ed56b-8421-476f-997d-2a64b2c03582_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-U.S.</link:label>
    <link:label id="lab_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_065ff0af-d0ae-4f3f-ac91-7f0d013dc4ff_verboseLabel_en-US" xlink:label="lab_us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Foreign Income Tax Expense (Benefit)</link:label>
    <link:label id="lab_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Foreign Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredForeignIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_cah_LesseeLeaseLiabilityPaymentsDueYearThree_d67ab4b0-8616-4155-b043-5122d377d5ee_terseLabel_en-US" xlink:label="lab_cah_LesseeLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_cah_LesseeLeaseLiabilityPaymentsDueYearThree_label_en-US" xlink:label="lab_cah_LesseeLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee Lease Liability Payments Due Year Three</link:label>
    <link:label id="lab_cah_LesseeLeaseLiabilityPaymentsDueYearThree_documentation_en-US" xlink:label="lab_cah_LesseeLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee Lease Liability Payments Due Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cah_LesseeLeaseLiabilityPaymentsDueYearThree" xlink:href="cah-20210630.xsd#cah_LesseeLeaseLiabilityPaymentsDueYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_LesseeLeaseLiabilityPaymentsDueYearThree" xlink:to="lab_cah_LesseeLeaseLiabilityPaymentsDueYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_cah_AdditionalPerformanceShareUnitsDataTableTextBlock_2758b5a7-85ac-4c50-9d39-aca1aeb24d20_terseLabel_en-US" xlink:label="lab_cah_AdditionalPerformanceShareUnitsDataTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Data Related to Performance Share Units Activity</link:label>
    <link:label id="lab_cah_AdditionalPerformanceShareUnitsDataTableTextBlock_label_en-US" xlink:label="lab_cah_AdditionalPerformanceShareUnitsDataTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Performance Share Units Data [Table Text Block]</link:label>
    <link:label id="lab_cah_AdditionalPerformanceShareUnitsDataTableTextBlock_documentation_en-US" xlink:label="lab_cah_AdditionalPerformanceShareUnitsDataTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Performance Share Units Data [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cah_AdditionalPerformanceShareUnitsDataTableTextBlock" xlink:href="cah-20210630.xsd#cah_AdditionalPerformanceShareUnitsDataTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_AdditionalPerformanceShareUnitsDataTableTextBlock" xlink:to="lab_cah_AdditionalPerformanceShareUnitsDataTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillLineItems_26b889c7-77d6-40e1-b94d-4b20b03e465a_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Line Items]</link:label>
    <link:label id="lab_us-gaap_GoodwillLineItems_label_en-US" xlink:label="lab_us-gaap_GoodwillLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillLineItems" xlink:to="lab_us-gaap_GoodwillLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock_e3ebca6f-ad73-4318-ad29-13be89ad40ce_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from External Customers by Geographic Areas [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock_label_en-US" xlink:label="lab_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from External Customers by Geographic Areas [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock" xlink:to="lab_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementClassOfStockAxis_e344c785-3d59-4abd-82a9-319dcef494bc_terseLabel_en-US" xlink:label="lab_us-gaap_StatementClassOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementClassOfStockAxis_label_en-US" xlink:label="lab_us-gaap_StatementClassOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementClassOfStockAxis" xlink:to="lab_us-gaap_StatementClassOfStockAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities_92360204-fc3c-4773-a413-b5ad612dd54d_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued liabilities</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Accrued Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities" xlink:to="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_cah_A4.6Notesdue2043Member_473e8b06-5c74-47ba-a43c-4e2d50ab8e55_terseLabel_en-US" xlink:label="lab_cah_A4.6Notesdue2043Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.6% Notes due 2043</link:label>
    <link:label id="lab_cah_A4.6Notesdue2043Member_label_en-US" xlink:label="lab_cah_A4.6Notesdue2043Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.6% Notes due 2043 [Member]</link:label>
    <link:label id="lab_cah_A4.6Notesdue2043Member_documentation_en-US" xlink:label="lab_cah_A4.6Notesdue2043Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.6% Notes due 2043</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cah_A4.6Notesdue2043Member" xlink:href="cah-20210630.xsd#cah_A4.6Notesdue2043Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_A4.6Notesdue2043Member" xlink:to="lab_cah_A4.6Notesdue2043Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LandBuildingsAndImprovementsMember_38f32860-f9f8-45a0-bdf1-f526985b5fdc_terseLabel_en-US" xlink:label="lab_us-gaap_LandBuildingsAndImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Land, building and improvements</link:label>
    <link:label id="lab_us-gaap_LandBuildingsAndImprovementsMember_label_en-US" xlink:label="lab_us-gaap_LandBuildingsAndImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Land, Buildings and Improvements [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LandBuildingsAndImprovementsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LandBuildingsAndImprovementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LandBuildingsAndImprovementsMember" xlink:to="lab_us-gaap_LandBuildingsAndImprovementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxContingencyLineItems_810d8be2-d7bd-49d4-be2e-1965a9be2cce_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxContingencyLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Contingency [Line Items]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxContingencyLineItems_label_en-US" xlink:label="lab_us-gaap_IncomeTaxContingencyLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Contingency [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxContingencyLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxContingencyLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems" xlink:to="lab_us-gaap_IncomeTaxContingencyLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityAxis_057402d3-e364-4627-a45f-ee56b3f406aa_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority</link:label>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityAxis_label_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis" xlink:to="lab_us-gaap_IncomeTaxAuthorityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ExcessTaxBenefitFromShareBasedCompensationFinancingActivities_77fd4fac-dcf7-46a1-b47f-a3898787c562_verboseLabel_en-US" xlink:label="lab_us-gaap_ExcessTaxBenefitFromShareBasedCompensationFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Excess tax benefits from share based compensation</link:label>
    <link:label id="lab_us-gaap_ExcessTaxBenefitFromShareBasedCompensationFinancingActivities_label_en-US" xlink:label="lab_us-gaap_ExcessTaxBenefitFromShareBasedCompensationFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Excess Tax Benefit from Share-based Compensation, Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ExcessTaxBenefitFromShareBasedCompensationFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ExcessTaxBenefitFromShareBasedCompensationFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ExcessTaxBenefitFromShareBasedCompensationFinancingActivities" xlink:to="lab_us-gaap_ExcessTaxBenefitFromShareBasedCompensationFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive_568b9c23-af53-4b2b-91d3-2ee76608ad38_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Thereafter</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid, after Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumAmountOutstandingDuringPeriod_af020a54-3f7a-45e7-8aba-17bef02809d0_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumAmountOutstandingDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Maximum Amount Outstanding During Period</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumAmountOutstandingDuringPeriod_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumAmountOutstandingDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Maximum Amount Outstanding During Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumAmountOutstandingDuringPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumAmountOutstandingDuringPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityMaximumAmountOutstandingDuringPeriod" xlink:to="lab_us-gaap_LineOfCreditFacilityMaximumAmountOutstandingDuringPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember_44f56426-d3de-4bdc-ac56-36bc823a03b0_terseLabel_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SG&amp;A Expenses</link:label>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember_label_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, General and Administrative Expenses [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:to="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_12d88ebe-cf8b-4e30-b308-98a25a52f630_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based compensation</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:to="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:type="arc" order="1"/>
    <link:label id="lab_cah_NotesPayableRepurchased_ebb4c9d6-59a8-4d7e-978b-7017949848fa_terseLabel_en-US" xlink:label="lab_cah_NotesPayableRepurchased" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes Payable Repurchased</link:label>
    <link:label id="lab_cah_NotesPayableRepurchased_label_en-US" xlink:label="lab_cah_NotesPayableRepurchased" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes Payable Repurchased</link:label>
    <link:label id="lab_cah_NotesPayableRepurchased_documentation_en-US" xlink:label="lab_cah_NotesPayableRepurchased" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Principal Amount of Notes Payable Repurchased during the year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cah_NotesPayableRepurchased" xlink:href="cah-20210630.xsd#cah_NotesPayableRepurchased"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_NotesPayableRepurchased" xlink:to="lab_cah_NotesPayableRepurchased" xlink:type="arc" order="1"/>
    <link:label id="lab_cah_IPRDTrademarksandOtherMember_576bbe33-8a77-4b88-96dc-49b4b73ae04f_terseLabel_en-US" xlink:label="lab_cah_IPRDTrademarksandOtherMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trademarks and patents</link:label>
    <link:label id="lab_cah_IPRDTrademarksandOtherMember_label_en-US" xlink:label="lab_cah_IPRDTrademarksandOtherMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">IPR&amp;D,TrademarksandOther [Member]</link:label>
    <link:label id="lab_cah_IPRDTrademarksandOtherMember_documentation_en-US" xlink:label="lab_cah_IPRDTrademarksandOtherMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Includes in process investigation of new knowledge useful in developing new product or service or new process or techniques or improvement to existing product or process, and translation of knowledge into plan or design for new product or process or for the improvements to existing product or process and rights acquired through registration of a trademark to gain or protect exclusive use of a business name, symbol or other device or style.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cah_IPRDTrademarksandOtherMember" xlink:href="cah-20210630.xsd#cah_IPRDTrademarksandOtherMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_IPRDTrademarksandOtherMember" xlink:to="lab_cah_IPRDTrademarksandOtherMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_94cf5b9a-3975-46a2-b19f-aa44869d1267_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Options</link:label>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_ecd95a21-7a40-47d2-9256-56d857c996ff_verboseLabel_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Options</link:label>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_label_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Option [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeStockOptionMember" xlink:to="lab_us-gaap_EmployeeStockOptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidationItemsDomain_e1e1c0a1-79ed-491b-aab0-feed4dfe937d_terseLabel_en-US" xlink:label="lab_srt_ConsolidationItemsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Domain]</link:label>
    <link:label id="lab_srt_ConsolidationItemsDomain_label_en-US" xlink:label="lab_srt_ConsolidationItemsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidationItemsDomain" xlink:to="lab_srt_ConsolidationItemsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityAbstract_9cc9fd25-ae41-48d6-bc4b-c060f1f64b94_terseLabel_en-US" xlink:label="lab_us-gaap_EquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_EquityAbstract_label_en-US" xlink:label="lab_us-gaap_EquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityAbstract" xlink:to="lab_us-gaap_EquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_ee96748e-e8eb-4ac1-aab8-f6dfb8c4f592_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents_0f41162a-f0b4-4622-9ed2-6439ef649f2d_terseLabel_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of exchange rates changes on cash and equivalents</link:label>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents_label_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of Exchange Rate on Cash and Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents" xlink:to="lab_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesDeferredExpenseReservesAndAccruals_fdd77ea1-0ccf-4270-838d-ebec76c53b66_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesDeferredExpenseReservesAndAccruals" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Deferred Expense, Reserves and Accruals</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesDeferredExpenseReservesAndAccruals_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesDeferredExpenseReservesAndAccruals" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Deferred Expense, Reserves and Accruals</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesDeferredExpenseReservesAndAccruals" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilitiesDeferredExpenseReservesAndAccruals"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesDeferredExpenseReservesAndAccruals" xlink:to="lab_us-gaap_DeferredTaxLiabilitiesDeferredExpenseReservesAndAccruals" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax_5021efb7-7ce2-4c5f-a395-c2167a3fd535_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net Investment Hedge, Gain (Loss), before Reclassification and Tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net Investment Hedge, Gain (Loss), before Reclassification and Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_b11db7b7-5541-4d29-b174-37f43f5cd93d_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Information</link:label>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:to="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1_e6a45c31-a3db-4219-814e-3c41f984e95b_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Weighted Average Remaining Lease Term</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Weighted Average Remaining Lease Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" xlink:to="lab_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_0f87e9d0-69fc-482a-80ad-84b374f3abfb_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_cah_IncomefromSettlementsofClassActionLawsuits_110b2c5f-fa71-48c9-8e94-9fcc005c71f0_terseLabel_en-US" xlink:label="lab_cah_IncomefromSettlementsofClassActionLawsuits" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income from Settlements of Class Action Lawsuits</link:label>
    <link:label id="lab_cah_IncomefromSettlementsofClassActionLawsuits_label_en-US" xlink:label="lab_cah_IncomefromSettlementsofClassActionLawsuits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income from Settlements of Class Action Lawsuits</link:label>
    <link:label id="lab_cah_IncomefromSettlementsofClassActionLawsuits_documentation_en-US" xlink:label="lab_cah_IncomefromSettlementsofClassActionLawsuits" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income from Settlements of Class Action Lawsuits</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cah_IncomefromSettlementsofClassActionLawsuits" xlink:href="cah-20210630.xsd#cah_IncomefromSettlementsofClassActionLawsuits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_IncomefromSettlementsofClassActionLawsuits" xlink:to="lab_cah_IncomefromSettlementsofClassActionLawsuits" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ade0bdd5-cc9f-46d6-a53d-e0074c9a33e9_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Shareholders' Equity</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_cah_A4.5Notesdue2044Member_75d68c78-5d39-4503-993b-4505b6f5227c_terseLabel_en-US" xlink:label="lab_cah_A4.5Notesdue2044Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.5% Notes due 2044</link:label>
    <link:label id="lab_cah_A4.5Notesdue2044Member_label_en-US" xlink:label="lab_cah_A4.5Notesdue2044Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.5% Notes due 2044 [Member]</link:label>
    <link:label id="lab_cah_A4.5Notesdue2044Member_documentation_en-US" xlink:label="lab_cah_A4.5Notesdue2044Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.5% Notes due 2044</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cah_A4.5Notesdue2044Member" xlink:href="cah-20210630.xsd#cah_A4.5Notesdue2044Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_A4.5Notesdue2044Member" xlink:to="lab_cah_A4.5Notesdue2044Member" xlink:type="arc" order="1"/>
    <link:label id="lab_cah_LeasesSupplementalBalanceSheetInformationTableTextBlock_235f3ff2-afb8-4f4a-88ac-8b77c3f4b7c6_terseLabel_en-US" xlink:label="lab_cah_LeasesSupplementalBalanceSheetInformationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases Supplemental Balance Sheet Information</link:label>
    <link:label id="lab_cah_LeasesSupplementalBalanceSheetInformationTableTextBlock_label_en-US" xlink:label="lab_cah_LeasesSupplementalBalanceSheetInformationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LeasesSupplementalBalanceSheetInformation [Table Text Block]</link:label>
    <link:label id="lab_cah_LeasesSupplementalBalanceSheetInformationTableTextBlock_documentation_en-US" xlink:label="lab_cah_LeasesSupplementalBalanceSheetInformationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">[Table Text Block] for LeasesSupplementalBalanceSheetInformation [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cah_LeasesSupplementalBalanceSheetInformationTableTextBlock" xlink:href="cah-20210630.xsd#cah_LeasesSupplementalBalanceSheetInformationTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_LeasesSupplementalBalanceSheetInformationTableTextBlock" xlink:to="lab_cah_LeasesSupplementalBalanceSheetInformationTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_cah_TaxMatterDomain_3fd979c5-ea24-4a93-9177-ea8c61924491_terseLabel_en-US" xlink:label="lab_cah_TaxMatterDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Matter [Domain]</link:label>
    <link:label id="lab_cah_TaxMatterDomain_label_en-US" xlink:label="lab_cah_TaxMatterDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Matter [Domain]</link:label>
    <link:label id="lab_cah_TaxMatterDomain_documentation_en-US" xlink:label="lab_cah_TaxMatterDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">[Domain] for Tax Matter [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cah_TaxMatterDomain" xlink:href="cah-20210630.xsd#cah_TaxMatterDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_TaxMatterDomain" xlink:to="lab_cah_TaxMatterDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockDividendsPerShareCashPaid_af77ed23-7741-4970-9b51-44a21b6cf6e1_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockDividendsPerShareCashPaid" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash dividends per common share (in usd per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockDividendsPerShareCashPaid_label_en-US" xlink:label="lab_us-gaap_CommonStockDividendsPerShareCashPaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Dividends, Per Share, Cash Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareCashPaid" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockDividendsPerShareCashPaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockDividendsPerShareCashPaid" xlink:to="lab_us-gaap_CommonStockDividendsPerShareCashPaid" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillTransfers_b03bf576-6abc-4cf6-86d3-71a50a750fe4_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillTransfers" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Transfers</link:label>
    <link:label id="lab_us-gaap_GoodwillTransfers_label_en-US" xlink:label="lab_us-gaap_GoodwillTransfers" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Transfers</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillTransfers" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillTransfers"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillTransfers" xlink:to="lab_us-gaap_GoodwillTransfers" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsMember_1cabb4a9-c7c7-4bbf-ad22-1fa76815dce5_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets [Member]</link:label>
    <link:label id="lab_us-gaap_OtherAssetsMember_label_en-US" xlink:label="lab_us-gaap_OtherAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsMember" xlink:to="lab_us-gaap_OtherAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NotesReceivableNet_3a6c23d2-e682-47c5-9015-6e0082a64d35_terseLabel_en-US" xlink:label="lab_us-gaap_NotesReceivableNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance notes and related accrued interest, net, total</link:label>
    <link:label id="lab_us-gaap_NotesReceivableNet_label_en-US" xlink:label="lab_us-gaap_NotesReceivableNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing Receivable, after Allowance for Credit Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesReceivableNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NotesReceivableNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NotesReceivableNet" xlink:to="lab_us-gaap_NotesReceivableNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_c17454b8-ce62-4c45-a784-d217ced6adfa_negatedLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other (income)/expense, net</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_label_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Nonoperating Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:to="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_cah_GownRecallAxis_6f81e95a-5b4d-404f-94e9-f11cb8e7962d_terseLabel_en-US" xlink:label="lab_cah_GownRecallAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gown Recall [Axis]</link:label>
    <link:label id="lab_cah_GownRecallAxis_label_en-US" xlink:label="lab_cah_GownRecallAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gown Recall [Axis]</link:label>
    <link:label id="lab_cah_GownRecallAxis_documentation_en-US" xlink:label="lab_cah_GownRecallAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gown Recall [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cah_GownRecallAxis" xlink:href="cah-20210630.xsd#cah_GownRecallAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_GownRecallAxis" xlink:to="lab_cah_GownRecallAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryRecallExpense_4e5984f5-c033-4933-9974-f415f6856b07_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryRecallExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory Recall Expense</link:label>
    <link:label id="lab_us-gaap_InventoryRecallExpense_label_en-US" xlink:label="lab_us-gaap_InventoryRecallExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory Recall Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRecallExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryRecallExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryRecallExpense" xlink:to="lab_us-gaap_InventoryRecallExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_cah_CashDiscountsPolicyTextBlock_e1d7aadf-d126-414f-a4fa-31e125baf380_terseLabel_en-US" xlink:label="lab_cah_CashDiscountsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Discounts</link:label>
    <link:label id="lab_cah_CashDiscountsPolicyTextBlock_label_en-US" xlink:label="lab_cah_CashDiscountsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Discounts [Policy Text Block]</link:label>
    <link:label id="lab_cah_CashDiscountsPolicyTextBlock_documentation_en-US" xlink:label="lab_cah_CashDiscountsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Discounts [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cah_CashDiscountsPolicyTextBlock" xlink:href="cah-20210630.xsd#cah_CashDiscountsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_CashDiscountsPolicyTextBlock" xlink:to="lab_cah_CashDiscountsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FacilityClosingMember_cc64d495-602c-4522-baae-fed712bbd8ed_terseLabel_en-US" xlink:label="lab_us-gaap_FacilityClosingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Facility Exit and Other Costs</link:label>
    <link:label id="lab_us-gaap_FacilityClosingMember_label_en-US" xlink:label="lab_us-gaap_FacilityClosingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Facility Closing [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FacilityClosingMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FacilityClosingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FacilityClosingMember" xlink:to="lab_us-gaap_FacilityClosingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationsAbstract_fc8e5df3-c9c8-4f65-927f-811e7c0976ec_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combinations [Abstract]</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationsAbstract_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combinations [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationsAbstract" xlink:to="lab_us-gaap_BusinessCombinationsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MaximumMember_699961f5-8f81-45e5-94c7-fd05ad6f3944_terseLabel_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum</link:label>
    <link:label id="lab_srt_MaximumMember_label_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MaximumMember" xlink:to="lab_srt_MaximumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_aba88942-8bee-41c5-9cc5-3b0d38b48ab8_terseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement [Abstract]</link:label>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyNatureDomain_a19cc326-a33d-4953-94d4-afd44a1d87e4_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyNatureDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Nature [Domain]</link:label>
    <link:label id="lab_us-gaap_LossContingencyNatureDomain_label_en-US" xlink:label="lab_us-gaap_LossContingencyNatureDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Nature [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNatureDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyNatureDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyNatureDomain" xlink:to="lab_us-gaap_LossContingencyNatureDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LegalEntityAxis_e39a6347-1b42-445c-a6fd-532cf5fecc5d_terseLabel_en-US" xlink:label="lab_dei_LegalEntityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal Entity [Axis]</link:label>
    <link:label id="lab_dei_LegalEntityAxis_label_en-US" xlink:label="lab_dei_LegalEntityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal Entity [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LegalEntityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LegalEntityAxis" xlink:to="lab_dei_LegalEntityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInReceivables_45270d14-ea36-475a-a974-dfeaf1d18a71_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInReceivables" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">(Increase)/decrease in trade receivables</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInReceivables_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInReceivables" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Receivables</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInReceivables" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInReceivables"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInReceivables" xlink:to="lab_us-gaap_IncreaseDecreaseInReceivables" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AwardTypeAxis_5b9a671d-de9c-4630-afb5-dcbf0834b036_terseLabel_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:label id="lab_us-gaap_AwardTypeAxis_label_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AwardTypeAxis" xlink:to="lab_us-gaap_AwardTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_e2559cee-e5e1-40bf-9d04-82af0ae485c8_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from financing activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock_2638fbf0-8d66-4dc0-8af4-0dfcac121f96_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Revenue and Gross Trade Receivables Percentage by Major Customers</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Revenue by Major Customers by Reporting Segments [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquity_99e4e219-52a9-4c04-9e22-2b491b4672a9_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Cardinal Health, Inc. shareholders' equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_label_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquity" xlink:to="lab_us-gaap_StockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_cah_GoodsandservicessoldLineItems_f497fd24-d6ce-4195-9e0e-86f4c4b7af6a_terseLabel_en-US" xlink:label="lab_cah_GoodsandservicessoldLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Distribution, selling, general and administrative expenses [Line Items]</link:label>
    <link:label id="lab_cah_GoodsandservicessoldLineItems_label_en-US" xlink:label="lab_cah_GoodsandservicessoldLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">goods and services sold [Line Items]</link:label>
    <link:label id="lab_cah_GoodsandservicessoldLineItems_documentation_en-US" xlink:label="lab_cah_GoodsandservicessoldLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">[Line Items] for goods and services sold [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cah_GoodsandservicessoldLineItems" xlink:href="cah-20210630.xsd#cah_GoodsandservicessoldLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_GoodsandservicessoldLineItems" xlink:to="lab_cah_GoodsandservicessoldLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_cah_CarryingAmountofLongTermandotherShortTermBorrowings_0b23c8d1-4532-4d7e-86cb-be04af7e56f2_terseLabel_en-US" xlink:label="lab_cah_CarryingAmountofLongTermandotherShortTermBorrowings" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Carrying Amount of Long-Term and other Short-Term Borrowings</link:label>
    <link:label id="lab_cah_CarryingAmountofLongTermandotherShortTermBorrowings_label_en-US" xlink:label="lab_cah_CarryingAmountofLongTermandotherShortTermBorrowings" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Carrying Amount of Long-Term and other Short-Term Borrowings</link:label>
    <link:label id="lab_cah_CarryingAmountofLongTermandotherShortTermBorrowings_documentation_en-US" xlink:label="lab_cah_CarryingAmountofLongTermandotherShortTermBorrowings" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Carrying Amount of Long-Term and other Short-Term Borrowings</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cah_CarryingAmountofLongTermandotherShortTermBorrowings" xlink:href="cah-20210630.xsd#cah_CarryingAmountofLongTermandotherShortTermBorrowings"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_CarryingAmountofLongTermandotherShortTermBorrowings" xlink:to="lab_cah_CarryingAmountofLongTermandotherShortTermBorrowings" xlink:type="arc" order="1"/>
    <link:label id="lab_cah_DistributionServiceAgreementAndOtherVendorFeesPolicyTextBlock_1bda8610-c811-42d5-bb65-b9c531c33957_terseLabel_en-US" xlink:label="lab_cah_DistributionServiceAgreementAndOtherVendorFeesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Distribution Service Agreement and Other Vendor Fees</link:label>
    <link:label id="lab_cah_DistributionServiceAgreementAndOtherVendorFeesPolicyTextBlock_label_en-US" xlink:label="lab_cah_DistributionServiceAgreementAndOtherVendorFeesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Distribution Service Agreement And Other Vendor Fees [Policy Text Block]</link:label>
    <link:label id="lab_cah_DistributionServiceAgreementAndOtherVendorFeesPolicyTextBlock_documentation_en-US" xlink:label="lab_cah_DistributionServiceAgreementAndOtherVendorFeesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Describes an entity's accounting policy for fees received from distribution service agreements and other fees received from vendors related to the purchase or distribution of the vendor's inventory. Such fees are recognized as a reduction of inventory when those fees have been earned and the entity is entitled to payment.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cah_DistributionServiceAgreementAndOtherVendorFeesPolicyTextBlock" xlink:href="cah-20210630.xsd#cah_DistributionServiceAgreementAndOtherVendorFeesPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_DistributionServiceAgreementAndOtherVendorFeesPolicyTextBlock" xlink:to="lab_cah_DistributionServiceAgreementAndOtherVendorFeesPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_2fef63b9-06fb-41f3-a427-f5b76745fb15_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate intrinsic value of exercisable options at period end</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:type="arc" order="1"/>
    <link:label id="lab_cah_LawsuitTypeDomain_078e45e0-1bbe-4496-81dd-70e8c56a1fa0_terseLabel_en-US" xlink:label="lab_cah_LawsuitTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lawsuit Type [Domain]</link:label>
    <link:label id="lab_cah_LawsuitTypeDomain_label_en-US" xlink:label="lab_cah_LawsuitTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lawsuit Type [Domain]</link:label>
    <link:label id="lab_cah_LawsuitTypeDomain_documentation_en-US" xlink:label="lab_cah_LawsuitTypeDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">[Domain] for Lawsuit Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cah_LawsuitTypeDomain" xlink:href="cah-20210630.xsd#cah_LawsuitTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_LawsuitTypeDomain" xlink:to="lab_cah_LawsuitTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_cah_OpioidLitigationDomain_ee3322a1-a5f7-4389-ace1-ec043c8c8c69_terseLabel_en-US" xlink:label="lab_cah_OpioidLitigationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Opioid Litigation [Domain]</link:label>
    <link:label id="lab_cah_OpioidLitigationDomain_label_en-US" xlink:label="lab_cah_OpioidLitigationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Opioid Litigation [Domain]</link:label>
    <link:label id="lab_cah_OpioidLitigationDomain_documentation_en-US" xlink:label="lab_cah_OpioidLitigationDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Opioid Litigation [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cah_OpioidLitigationDomain" xlink:href="cah-20210630.xsd#cah_OpioidLitigationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_OpioidLitigationDomain" xlink:to="lab_cah_OpioidLitigationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DesignatedAsHedgingInstrumentMember_6f750d5d-6a5d-4305-aa09-acdd52fcfc5a_terseLabel_en-US" xlink:label="lab_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Designated as Hedging Instrument</link:label>
    <link:label id="lab_us-gaap_DesignatedAsHedgingInstrumentMember_label_en-US" xlink:label="lab_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Designated as Hedging Instrument [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:to="lab_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_33eb2528-3ee4-4908-b457-dd705bba8910_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentAnnualReport_8a60182e-ee84-4ae2-87be-67e379b1d1e4_terseLabel_en-US" xlink:label="lab_dei_DocumentAnnualReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Annual Report</link:label>
    <link:label id="lab_dei_DocumentAnnualReport_label_en-US" xlink:label="lab_dei_DocumentAnnualReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Annual Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentAnnualReport" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentAnnualReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentAnnualReport" xlink:to="lab_dei_DocumentAnnualReport" xlink:type="arc" order="1"/>
    <link:label id="lab_cah_CareFusionMember_c76add0c-79ee-4279-a057-1e43500f214a_terseLabel_en-US" xlink:label="lab_cah_CareFusionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CareFusion [Member]</link:label>
    <link:label id="lab_cah_CareFusionMember_label_en-US" xlink:label="lab_cah_CareFusionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CareFusion [Member]</link:label>
    <link:label id="lab_cah_CareFusionMember_documentation_en-US" xlink:label="lab_cah_CareFusionMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CareFusion [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cah_CareFusionMember" xlink:href="cah-20210630.xsd#cah_CareFusionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_CareFusionMember" xlink:to="lab_cah_CareFusionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_14542765-6fb8-44c8-b887-b7a74b08960a_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase of treasury shares</link:label>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_3e339ec3-79e1-4637-8990-5f9772bb3846_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Repurchase of Common Stock</link:label>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_label_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Repurchase of Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:to="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife_58d566d3-377d-4701-879b-953c9a274e35_verboseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Useful life of property and equipment</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife_ba5d79a1-5fb2-4381-856d-c09d10904104_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Useful Life</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Useful Life</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_8b80c904-9899-454e-8050-8c893766373d_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shareholders&#8217; equity:</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityAbstract" xlink:to="lab_us-gaap_StockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_cah_LitigationTypeDomain_d12210bf-d45b-49f6-a21d-8bddb2c3f1a4_terseLabel_en-US" xlink:label="lab_cah_LitigationTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Type [Domain]</link:label>
    <link:label id="lab_cah_LitigationTypeDomain_label_en-US" xlink:label="lab_cah_LitigationTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Type [Domain]</link:label>
    <link:label id="lab_cah_LitigationTypeDomain_documentation_en-US" xlink:label="lab_cah_LitigationTypeDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">[Domain] for Litigation Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cah_LitigationTypeDomain" xlink:href="cah-20210630.xsd#cah_LitigationTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_LitigationTypeDomain" xlink:to="lab_cah_LitigationTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityNameDomain_f4db39a3-4056-468b-97fe-f0931ed33b17_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityNameDomain_label_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameDomain" xlink:to="lab_us-gaap_IncomeTaxAuthorityNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskCreditRisk_f6c616c6-328a-445a-85d4-25d406c4f195_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskCreditRisk" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentrations of Credit Risk</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskCreditRisk_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskCreditRisk" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk, Credit Risk, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskCreditRisk" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskCreditRisk"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskCreditRisk" xlink:to="lab_us-gaap_ConcentrationRiskCreditRisk" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_0965bddb-ae2a-4a39-aded-41b5f344180f_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Noncurrent</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDue_134a8582-8648-4869-be15-0cc0df471bc2_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total future lease payments</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDue_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Payment, Due</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_4aab5bd6-d936-4417-8c59-ca5558215d2a_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update [Axis]</link:label>
    <link:label id="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_label_en-US" xlink:label="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:to="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentIncomeTaxExpenseBenefit_ab0bd29e-cd4a-4fbd-b0b3-0633bdd45596_totalLabel_en-US" xlink:label="lab_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current</link:label>
    <link:label id="lab_us-gaap_CurrentIncomeTaxExpenseBenefit_ff6d7a18-3db3-4741-9ffb-57f79194cee9_terseLabel_en-US" xlink:label="lab_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Income Tax Expense (Benefit)</link:label>
    <link:label id="lab_us-gaap_CurrentIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_19410115-97bc-4cc9-ba74-bb1f571f5e92_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax benefit related to share-based compensation</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Expense, Tax Benefit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_cah_DisposalGroupIncludingDiscontinuedOperationsGoodwillAndOtherIntangiblesNet_fb59c401-a4c3-4fb4-841a-513070987478_terseLabel_en-US" xlink:label="lab_cah_DisposalGroupIncludingDiscontinuedOperationsGoodwillAndOtherIntangiblesNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Including Discontinued Operations Goodwill and Other Intangibles, net</link:label>
    <link:label id="lab_cah_DisposalGroupIncludingDiscontinuedOperationsGoodwillAndOtherIntangiblesNet_label_en-US" xlink:label="lab_cah_DisposalGroupIncludingDiscontinuedOperationsGoodwillAndOtherIntangiblesNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Including Discontinued Operations Goodwill and Other Intangibles, net</link:label>
    <link:label id="lab_cah_DisposalGroupIncludingDiscontinuedOperationsGoodwillAndOtherIntangiblesNet_documentation_en-US" xlink:label="lab_cah_DisposalGroupIncludingDiscontinuedOperationsGoodwillAndOtherIntangiblesNet" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Including Discontinued Operations Goodwill and Other Intangibles, net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cah_DisposalGroupIncludingDiscontinuedOperationsGoodwillAndOtherIntangiblesNet" xlink:href="cah-20210630.xsd#cah_DisposalGroupIncludingDiscontinuedOperationsGoodwillAndOtherIntangiblesNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_DisposalGroupIncludingDiscontinuedOperationsGoodwillAndOtherIntangiblesNet" xlink:to="lab_cah_DisposalGroupIncludingDiscontinuedOperationsGoodwillAndOtherIntangiblesNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingSegmentsMember_9e2c5228-149e-4800-bfbb-eb33c3e7cec6_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingSegmentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Segments</link:label>
    <link:label id="lab_us-gaap_OperatingSegmentsMember_label_en-US" xlink:label="lab_us-gaap_OperatingSegmentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Segments [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingSegmentsMember" xlink:to="lab_us-gaap_OperatingSegmentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cah_FixedRateDebtMember_7fbf43e3-c4ba-4254-88ac-311fd68fad70_terseLabel_en-US" xlink:label="lab_cah_FixedRateDebtMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fixed-Rate Debt</link:label>
    <link:label id="lab_cah_FixedRateDebtMember_label_en-US" xlink:label="lab_cah_FixedRateDebtMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fixed Rate Debt [Member]</link:label>
    <link:label id="lab_cah_FixedRateDebtMember_documentation_en-US" xlink:label="lab_cah_FixedRateDebtMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fixed Rate Debt [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cah_FixedRateDebtMember" xlink:href="cah-20210630.xsd#cah_FixedRateDebtMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_FixedRateDebtMember" xlink:to="lab_cah_FixedRateDebtMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseTermOfContract_bfc6b448-ffd3-4592-a781-ecd3f995a9e2_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Term of Contract</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseTermOfContract_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Term of Contract</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseTermOfContract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:to="lab_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativesFairValueLineItems_6a2879bf-15f5-4d91-b2e1-1df93749543e_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativesFairValueLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives, Fair Value [Line Items]</link:label>
    <link:label id="lab_us-gaap_DerivativesFairValueLineItems_label_en-US" xlink:label="lab_us-gaap_DerivativesFairValueLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives, Fair Value [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesFairValueLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativesFairValueLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativesFairValueLineItems" xlink:to="lab_us-gaap_DerivativesFairValueLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedStockUnitsRSUMember_cae95d31-95ba-4eeb-9f17-a8b39894fb76_verboseLabel_en-US" xlink:label="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Share Unit</link:label>
    <link:label id="lab_us-gaap_RestrictedStockUnitsRSUMember_21687f15-b4c4-4988-a248-9ba351ad34ad_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Share Units</link:label>
    <link:label id="lab_us-gaap_RestrictedStockUnitsRSUMember_label_en-US" xlink:label="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock Units (RSUs) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedStockUnitsRSUMember" xlink:to="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cah_LitigationTypeAxis_643eac02-c44b-4b78-8872-06033426e6a0_terseLabel_en-US" xlink:label="lab_cah_LitigationTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Type [Axis]</link:label>
    <link:label id="lab_cah_LitigationTypeAxis_label_en-US" xlink:label="lab_cah_LitigationTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Type [Axis]</link:label>
    <link:label id="lab_cah_LitigationTypeAxis_documentation_en-US" xlink:label="lab_cah_LitigationTypeAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cah_LitigationTypeAxis" xlink:href="cah-20210630.xsd#cah_LitigationTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_LitigationTypeAxis" xlink:to="lab_cah_LitigationTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesChargedToOtherAccounts_c99078a5-d311-4fc0-a752-8234b5b931cc_terseLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesChargedToOtherAccounts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves, Additions, Charge to Other Account</link:label>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesChargedToOtherAccounts_label_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesChargedToOtherAccounts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves, Additions, Charge to Other Account</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesChargedToOtherAccounts" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationAllowancesAndReservesChargedToOtherAccounts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesChargedToOtherAccounts" xlink:to="lab_us-gaap_ValuationAllowancesAndReservesChargedToOtherAccounts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiability_d8a5e011-bfec-4cfe-9dba-afbcbb4daad0_totalLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total finance lease liabilities</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiability_6658650c-a26f-4aba-b151-fa2bb256e7b9_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total lease liabilities</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiability_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiability" xlink:to="lab_us-gaap_FinanceLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_cah_PatientRecoveryBusinessMember_9f685f32-483b-46aa-a001-6864e3f1e9b4_terseLabel_en-US" xlink:label="lab_cah_PatientRecoveryBusinessMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Patient Recovery Business [Member]</link:label>
    <link:label id="lab_cah_PatientRecoveryBusinessMember_label_en-US" xlink:label="lab_cah_PatientRecoveryBusinessMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Patient Recovery Business [Member]</link:label>
    <link:label id="lab_cah_PatientRecoveryBusinessMember_documentation_en-US" xlink:label="lab_cah_PatientRecoveryBusinessMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Patient Recovery Business [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cah_PatientRecoveryBusinessMember" xlink:href="cah-20210630.xsd#cah_PatientRecoveryBusinessMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_PatientRecoveryBusinessMember" xlink:to="lab_cah_PatientRecoveryBusinessMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilities_6b77ad49-bd9a-4b05-91d9-71389e665c38_negatedTotalLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilities" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total deferred income tax liabilities</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilities_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities" xlink:to="lab_us-gaap_DeferredIncomeTaxLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionLineItems_e0dee9d2-867e-464f-b1d5-1ea79128826f_verboseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionLineItems" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionLineItems_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems" xlink:to="lab_us-gaap_BusinessAcquisitionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems_52003202-5646-435c-927b-7e2faf2bd414_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems_label_en-US" xlink:label="lab_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems" xlink:to="lab_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestments_9ee5826d-4593-4b18-be10-2f61c722b5ea_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestments_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestments" xlink:to="lab_us-gaap_EquityMethodInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_331c7d65-c4ec-4628-a7b5-7ade9dd915e7_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementAbstract" xlink:to="lab_us-gaap_IncomeStatementAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_cah_EffectiveTaxRateImpactFromCertainForeignJurisdictions_62a7d6d3-f4dc-42a6-a2e2-8bd02203f763_terseLabel_en-US" xlink:label="lab_cah_EffectiveTaxRateImpactFromCertainForeignJurisdictions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Tax Rate Impact From Certain Foreign Jurisdictions</link:label>
    <link:label id="lab_cah_EffectiveTaxRateImpactFromCertainForeignJurisdictions_label_en-US" xlink:label="lab_cah_EffectiveTaxRateImpactFromCertainForeignJurisdictions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Tax Rate Impact From Certain Foreign Jurisdictions</link:label>
    <link:label id="lab_cah_EffectiveTaxRateImpactFromCertainForeignJurisdictions_documentation_en-US" xlink:label="lab_cah_EffectiveTaxRateImpactFromCertainForeignJurisdictions" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Tax Rate Impact From Certain Foreign Jurisdictions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cah_EffectiveTaxRateImpactFromCertainForeignJurisdictions" xlink:href="cah-20210630.xsd#cah_EffectiveTaxRateImpactFromCertainForeignJurisdictions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_EffectiveTaxRateImpactFromCertainForeignJurisdictions" xlink:to="lab_cah_EffectiveTaxRateImpactFromCertainForeignJurisdictions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_7bba1f03-a091-4da1-8d9d-0c94b9db6e77_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_0e3d9c48-a437-49e5-a240-ede7ccbda7b1_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesDeductions_06bb6e54-c5c0-448d-8c03-5d887855cc47_terseLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesDeductions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves, Deduction</link:label>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesDeductions_label_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesDeductions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves, Deduction</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesDeductions" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationAllowancesAndReservesDeductions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesDeductions" xlink:to="lab_us-gaap_ValuationAllowancesAndReservesDeductions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_ab269c88-e1cd-4ae9-9d9a-3b55b5c134f2_verboseLabel_en-US" xlink:label="lab_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Presentation and Summary of Significant Accounting Policies</link:label>
    <link:label id="lab_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_label_en-US" xlink:label="lab_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Presentation and Significant Accounting Policies [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" xlink:to="lab_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_cah_VendorReserves_2f3e7e9d-59b8-492f-894d-fdf5930e9cf7_terseLabel_en-US" xlink:label="lab_cah_VendorReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vendor reserves</link:label>
    <link:label id="lab_cah_VendorReserves_label_en-US" xlink:label="lab_cah_VendorReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vendor Reserves</link:label>
    <link:label id="lab_cah_VendorReserves_documentation_en-US" xlink:label="lab_cah_VendorReserves" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total of reserves, relating to vendor disputes or deductions, that are netted against vendor liabilities in the ordinary course of business.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cah_VendorReserves" xlink:href="cah-20210630.xsd#cah_VendorReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_VendorReserves" xlink:to="lab_cah_VendorReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_0b83a432-1582-46f2-958e-518dce9dfe33_verboseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provision for/(benefit from) income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_04de9238-668b-48d7-9232-5ddf6d3fdf50_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provision for/(benefit from) income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_3d9078a5-15ed-4616-81dc-0cdf7000fcca_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Expense (Benefit)</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityVoluntaryFilers_22c9ba45-5ba1-4071-9ff2-fb60ce5907d7_terseLabel_en-US" xlink:label="lab_dei_EntityVoluntaryFilers" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Voluntary Filers</link:label>
    <link:label id="lab_dei_EntityVoluntaryFilers_label_en-US" xlink:label="lab_dei_EntityVoluntaryFilers" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Voluntary Filers</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityVoluntaryFilers" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityVoluntaryFilers"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityVoluntaryFilers" xlink:to="lab_dei_EntityVoluntaryFilers" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrent_53f142e0-51b7-464f-88da-1570a92421d1_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrent_label_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrent" xlink:to="lab_us-gaap_AssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_4bd09bcf-9dec-48fa-9b9d-49bccc218916_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total future lease payments</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_d2a8aa26-525c-4c68-b1ed-6bce8234434e_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Canceled and forfeited (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_cah_ScheduleOfFairValueGainLossDerivativeInstrumentTableTextBlock_91ffc52f-6a63-4896-8e9a-3db40e035670_terseLabel_en-US" xlink:label="lab_cah_ScheduleOfFairValueGainLossDerivativeInstrumentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Fair Value Gain/(Loss) Derivative Instrument</link:label>
    <link:label id="lab_cah_ScheduleOfFairValueGainLossDerivativeInstrumentTableTextBlock_label_en-US" xlink:label="lab_cah_ScheduleOfFairValueGainLossDerivativeInstrumentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Fair Value Gain Loss Derivative Instrument [Table Text Block]</link:label>
    <link:label id="lab_cah_ScheduleOfFairValueGainLossDerivativeInstrumentTableTextBlock_documentation_en-US" xlink:label="lab_cah_ScheduleOfFairValueGainLossDerivativeInstrumentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summarizes the fair value and notional amounts of derivative instruments held as of the balance sheet date.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cah_ScheduleOfFairValueGainLossDerivativeInstrumentTableTextBlock" xlink:href="cah-20210630.xsd#cah_ScheduleOfFairValueGainLossDerivativeInstrumentTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_ScheduleOfFairValueGainLossDerivativeInstrumentTableTextBlock" xlink:to="lab_cah_ScheduleOfFairValueGainLossDerivativeInstrumentTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfStockByClassTable_b061a8e4-300e-4c7c-aa74-2e1fb2f27977_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfStockByClassTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Stock by Class [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfStockByClassTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfStockByClassTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Stock by Class [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable" xlink:to="lab_us-gaap_ScheduleOfStockByClassTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_1a3e1f5d-f6ec-4747-9f9b-7b4616eb0fc6_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:to="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_28086408-271f-4a78-a7a7-33e13cea0e0b_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:to="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ValuationAndQualifyingAccountsAbstract_a057128d-a066-4f29-b761-3ae84288c4bc_terseLabel_en-US" xlink:label="lab_srt_ValuationAndQualifyingAccountsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract]</link:label>
    <link:label id="lab_srt_ValuationAndQualifyingAccountsAbstract_label_en-US" xlink:label="lab_srt_ValuationAndQualifyingAccountsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ValuationAndQualifyingAccountsAbstract" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ValuationAndQualifyingAccountsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ValuationAndQualifyingAccountsAbstract" xlink:to="lab_srt_ValuationAndQualifyingAccountsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherLiabilities_88a4a3d5-3f71-46a5-aa2d-2ed1fa834cda_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Other Liabilities</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherLiabilities_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Other Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherLiabilities" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_3c1a1c8e-c1ce-43e4-9f28-5a817538d176_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurements</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:to="lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain_bf6e7898-4e39-4704-84be-9ec2c5448283_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Tangible Asset [Domain]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Tangible Asset [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_54bc2d92-b898-4274-b987-d8e732a79950_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock_35e05e6b-c3a3-4356-868e-63b4756bf108_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Common Shares Used to Compute Basic and Diluted Earnings Per Share</link:label>
    <link:label id="lab_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Weighted Average Number of Shares [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_cah_A32Notes2616NotesMember_f85d477a-c5c0-4e30-93aa-bf4513716c20_terseLabel_en-US" xlink:label="lab_cah_A32Notes2616NotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.2% notes, 2.616% Notes</link:label>
    <link:label id="lab_cah_A32Notes2616NotesMember_label_en-US" xlink:label="lab_cah_A32Notes2616NotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.2% notes, 2.616% Notes [Member]</link:label>
    <link:label id="lab_cah_A32Notes2616NotesMember_documentation_en-US" xlink:label="lab_cah_A32Notes2616NotesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.2% notes, 2.616% Notes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cah_A32Notes2616NotesMember" xlink:href="cah-20210630.xsd#cah_A32Notes2616NotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_A32Notes2616NotesMember" xlink:to="lab_cah_A32Notes2616NotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntitySmallBusiness_c9305851-1073-403a-847a-16f83c1beb59_terseLabel_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:label id="lab_dei_EntitySmallBusiness_label_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntitySmallBusiness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitySmallBusiness" xlink:to="lab_dei_EntitySmallBusiness" xlink:type="arc" order="1"/>
    <link:label id="lab_cah_ScheduleOfDeferredTaxAssetsAndLiabilitiesAfterNettingByTaxJurisdictionTableTextBlock_a93cf02d-70d8-43fa-974f-787a6760d843_terseLabel_en-US" xlink:label="lab_cah_ScheduleOfDeferredTaxAssetsAndLiabilitiesAfterNettingByTaxJurisdictionTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Deferred Tax Assets and Liabilities after Netting by Tax Jurisdiction</link:label>
    <link:label id="lab_cah_ScheduleOfDeferredTaxAssetsAndLiabilitiesAfterNettingByTaxJurisdictionTableTextBlock_label_en-US" xlink:label="lab_cah_ScheduleOfDeferredTaxAssetsAndLiabilitiesAfterNettingByTaxJurisdictionTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Deferred Tax Assets And Liabilities After Netting By Tax Jurisdiction [Table Text Block]</link:label>
    <link:label id="lab_cah_ScheduleOfDeferredTaxAssetsAndLiabilitiesAfterNettingByTaxJurisdictionTableTextBlock_documentation_en-US" xlink:label="lab_cah_ScheduleOfDeferredTaxAssetsAndLiabilitiesAfterNettingByTaxJurisdictionTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Deferred Tax Assets And Liabilities After Netting By Tax Jurisdiction [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cah_ScheduleOfDeferredTaxAssetsAndLiabilitiesAfterNettingByTaxJurisdictionTableTextBlock" xlink:href="cah-20210630.xsd#cah_ScheduleOfDeferredTaxAssetsAndLiabilitiesAfterNettingByTaxJurisdictionTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_ScheduleOfDeferredTaxAssetsAndLiabilitiesAfterNettingByTaxJurisdictionTableTextBlock" xlink:to="lab_cah_ScheduleOfDeferredTaxAssetsAndLiabilitiesAfterNettingByTaxJurisdictionTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SalesRevenueNetMember_973a2f8e-782c-4502-b309-109439fb5130_terseLabel_en-US" xlink:label="lab_us-gaap_SalesRevenueNetMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue Benchmark</link:label>
    <link:label id="lab_us-gaap_SalesRevenueNetMember_label_en-US" xlink:label="lab_us-gaap_SalesRevenueNetMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue Benchmark [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesRevenueNetMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SalesRevenueNetMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SalesRevenueNetMember" xlink:to="lab_us-gaap_SalesRevenueNetMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_6409ec68-2f2f-421f-af91-660e368515e1_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average grant date fair value per stock option (in usd per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityComponentDomain_6d85e7fb-4102-460f-b460-81cd29cecb2e_terseLabel_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:label id="lab_us-gaap_EquityComponentDomain_label_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityComponentDomain" xlink:to="lab_us-gaap_EquityComponentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityOther_22e19392-7980-4252-a10c-d8e2bf8ac8f9_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityOther" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityOther_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity, Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityOther" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityOther" xlink:to="lab_us-gaap_StockholdersEquityOther" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_024b51d2-2c22-4e52-be37-5229374c621e_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2022</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_3287e3be-d4a5-4d2b-8806-03df15aa704d_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Name [Domain]</link:label>
    <link:label id="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_label_en-US" xlink:label="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:to="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_3e19d184-e72c-4a2b-8899-fa2060f3557d_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accounts, Notes, Loans and Financing Receivable [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accounts, Notes, Loans and Financing Receivable [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable" xlink:to="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_799aa9bc-79b2-4323-8e64-3cf2c6e93477_terseLabel_en-US" xlink:label="lab_us-gaap_ComponentsOfDeferredTaxAssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income tax assets:</link:label>
    <link:label id="lab_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_label_en-US" xlink:label="lab_us-gaap_ComponentsOfDeferredTaxAssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Components of Deferred Tax Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComponentsOfDeferredTaxAssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract" xlink:to="lab_us-gaap_ComponentsOfDeferredTaxAssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_cah_Provisionaltaxbenefitrelatedtotransaction_eebc0407-294b-467e-8f43-d98328b83676_terseLabel_en-US" xlink:label="lab_cah_Provisionaltaxbenefitrelatedtotransaction" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provisional tax benefit related to transaction</link:label>
    <link:label id="lab_cah_Provisionaltaxbenefitrelatedtotransaction_label_en-US" xlink:label="lab_cah_Provisionaltaxbenefitrelatedtotransaction" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provisional tax benefit related to transaction</link:label>
    <link:label id="lab_cah_Provisionaltaxbenefitrelatedtotransaction_documentation_en-US" xlink:label="lab_cah_Provisionaltaxbenefitrelatedtotransaction" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provisional tax benefit related to transaction</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cah_Provisionaltaxbenefitrelatedtotransaction" xlink:href="cah-20210630.xsd#cah_Provisionaltaxbenefitrelatedtotransaction"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_Provisionaltaxbenefitrelatedtotransaction" xlink:to="lab_cah_Provisionaltaxbenefitrelatedtotransaction" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_LitigationCaseAxis_4b6506bc-8dfb-4537-bbed-1418e86d683f_terseLabel_en-US" xlink:label="lab_srt_LitigationCaseAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Case</link:label>
    <link:label id="lab_srt_LitigationCaseAxis_label_en-US" xlink:label="lab_srt_LitigationCaseAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Case [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LitigationCaseAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_LitigationCaseAxis" xlink:to="lab_srt_LitigationCaseAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_cah_NetEarningsIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest_d3fc3ba5-ed30-45f9-8da0-ec6afb35ad79_terseLabel_en-US" xlink:label="lab_cah_NetEarningsIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Earnings Including Portion Attributable to Noncontrolling Interest Excluding Redeemable Noncontrolling Interest</link:label>
    <link:label id="lab_cah_NetEarningsIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest_label_en-US" xlink:label="lab_cah_NetEarningsIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Earnings Including Portion Attributable to Noncontrolling Interest Excluding Redeemable Noncontrolling Interest</link:label>
    <link:label id="lab_cah_NetEarningsIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest_documentation_en-US" xlink:label="lab_cah_NetEarningsIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Earnings Including Portion Attributable to Noncontrolling Interest Excluding Redeemable Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cah_NetEarningsIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest" xlink:href="cah-20210630.xsd#cah_NetEarningsIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_NetEarningsIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest" xlink:to="lab_cah_NetEarningsIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock_44637d73-9d8f-4b98-8531-5162e7863e56_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Total Share-based Compensation Expense by Type of Award</link:label>
    <link:label id="lab_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Cost by Plan [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock_ccb93070-fb17-4e59-8a57-0f7457958144_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Estimated Fair Value of Long-term Obligations and Other Short-term Borrowings Compared to the Respective Carrying Amount</link:label>
    <link:label id="lab_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Carrying Values and Estimated Fair Values of Debt Instruments [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_3f84614f-aef5-4dcb-ae65-3064aa11cffd_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in valuation allowances</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:type="arc" order="1"/>
    <link:label id="lab_cah_SalesreturnsPolicyTextBlock_378900fc-d1e1-4e99-ac14-047a7316068b_terseLabel_en-US" xlink:label="lab_cah_SalesreturnsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales Returns and Allowances</link:label>
    <link:label id="lab_cah_SalesreturnsPolicyTextBlock_label_en-US" xlink:label="lab_cah_SalesreturnsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">sales returns [Policy Text Block]</link:label>
    <link:label id="lab_cah_SalesreturnsPolicyTextBlock_documentation_en-US" xlink:label="lab_cah_SalesreturnsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">sales returns [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cah_SalesreturnsPolicyTextBlock" xlink:href="cah-20210630.xsd#cah_SalesreturnsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_SalesreturnsPolicyTextBlock" xlink:to="lab_cah_SalesreturnsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_38183c54-aab8-4be5-861b-3ab2fddd2ee6_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill_f4a5ce92-26f7-4669-9974-7515d947c940_terseLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Intangible, Total other intangible assets</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Gross (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsGrossExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:to="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementInputsDisclosureTextBlock_2bd97107-34b9-429c-a98e-424ba12039b1_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementInputsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurements</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementInputsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementInputsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement and Measurement Inputs, Recurring and Nonrecurring [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementInputsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementInputsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementInputsDisclosureTextBlock" xlink:to="lab_us-gaap_FairValueMeasurementInputsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityCurrent_5a8fa2ca-7d93-4bb2-81b5-abca63ee2b14_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Current</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityCurrent" xlink:to="lab_us-gaap_FinanceLeaseLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_626ebaf9-7310-4418-b980-83ea17e2d3ff_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level&#160;2</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 2 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel2Member" xlink:to="lab_us-gaap_FairValueInputsLevel2Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TypeOfAdoptionMember_e04a934e-8b53-4839-826d-fc9367af6c09_terseLabel_en-US" xlink:label="lab_us-gaap_TypeOfAdoptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update [Domain]</link:label>
    <link:label id="lab_us-gaap_TypeOfAdoptionMember_label_en-US" xlink:label="lab_us-gaap_TypeOfAdoptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TypeOfAdoptionMember" xlink:to="lab_us-gaap_TypeOfAdoptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cah_AssetsHeldforSalePolicyPolicyTextBlock_cd22136a-6c5f-425b-a187-3f15573b7ce9_terseLabel_en-US" xlink:label="lab_cah_AssetsHeldforSalePolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets Held for Sale, Policy [Policy Text Block]</link:label>
    <link:label id="lab_cah_AssetsHeldforSalePolicyPolicyTextBlock_label_en-US" xlink:label="lab_cah_AssetsHeldforSalePolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets Held for Sale, Policy [Policy Text Block]</link:label>
    <link:label id="lab_cah_AssetsHeldforSalePolicyPolicyTextBlock_documentation_en-US" xlink:label="lab_cah_AssetsHeldforSalePolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets Held for Sale, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cah_AssetsHeldforSalePolicyPolicyTextBlock" xlink:href="cah-20210630.xsd#cah_AssetsHeldforSalePolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_AssetsHeldforSalePolicyPolicyTextBlock" xlink:to="lab_cah_AssetsHeldforSalePolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeGainLossOnDerivativeNet_96c896ac-cc59-4ef9-b373-ac647e98c3f4_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeGainLossOnDerivativeNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain/(loss) on derivative</link:label>
    <link:label id="lab_us-gaap_DerivativeGainLossOnDerivativeNet_label_en-US" xlink:label="lab_us-gaap_DerivativeGainLossOnDerivativeNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Gain (Loss) on Derivative, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeGainLossOnDerivativeNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeGainLossOnDerivativeNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeGainLossOnDerivativeNet" xlink:to="lab_us-gaap_DerivativeGainLossOnDerivativeNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_28ca9f49-7b93-4f10-aac1-d61e4d80f52a_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_label_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingAbstract" xlink:to="lab_us-gaap_SegmentReportingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TypeOfRestructuringDomain_5bfe6cd1-9b0e-4c4e-abc7-12e4947c91d7_terseLabel_en-US" xlink:label="lab_us-gaap_TypeOfRestructuringDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Type of Restructuring [Domain]</link:label>
    <link:label id="lab_us-gaap_TypeOfRestructuringDomain_label_en-US" xlink:label="lab_us-gaap_TypeOfRestructuringDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Type of Restructuring [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TypeOfRestructuringDomain" xlink:to="lab_us-gaap_TypeOfRestructuringDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_cah_LawsuitTypeAxis_385ad1c9-1097-499b-9023-718e9e689e74_terseLabel_en-US" xlink:label="lab_cah_LawsuitTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lawsuit Type [Axis]</link:label>
    <link:label id="lab_cah_LawsuitTypeAxis_label_en-US" xlink:label="lab_cah_LawsuitTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lawsuit Type [Axis]</link:label>
    <link:label id="lab_cah_LawsuitTypeAxis_documentation_en-US" xlink:label="lab_cah_LawsuitTypeAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lawsuit Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cah_LawsuitTypeAxis" xlink:href="cah-20210630.xsd#cah_LawsuitTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_LawsuitTypeAxis" xlink:to="lab_cah_LawsuitTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommodityContractMember_3ee6f1ad-7211-461b-b198-704c7abe9d22_terseLabel_en-US" xlink:label="lab_us-gaap_CommodityContractMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commodity Contracts</link:label>
    <link:label id="lab_us-gaap_CommodityContractMember_label_en-US" xlink:label="lab_us-gaap_CommodityContractMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commodity Contract [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommodityContractMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommodityContractMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommodityContractMember" xlink:to="lab_us-gaap_CommodityContractMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cah_CashReclassifiedtoAssetsHeldforSale_8ab2a6d1-4ab8-4c5e-938a-44390d3ce0c5_terseLabel_en-US" xlink:label="lab_cah_CashReclassifiedtoAssetsHeldforSale" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash reclassified to assets held for sale</link:label>
    <link:label id="lab_cah_CashReclassifiedtoAssetsHeldforSale_label_en-US" xlink:label="lab_cah_CashReclassifiedtoAssetsHeldforSale" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CashReclassifiedtoAssetsHeldforSale</link:label>
    <link:label id="lab_cah_CashReclassifiedtoAssetsHeldforSale_documentation_en-US" xlink:label="lab_cah_CashReclassifiedtoAssetsHeldforSale" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CashReclassifiedtoAssetsHeldforSale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cah_CashReclassifiedtoAssetsHeldforSale" xlink:href="cah-20210630.xsd#cah_CashReclassifiedtoAssetsHeldforSale"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_CashReclassifiedtoAssetsHeldforSale" xlink:to="lab_cah_CashReclassifiedtoAssetsHeldforSale" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UseOfEstimates_bf80f44d-cba4-44e9-8fbe-43b0f6e8111f_terseLabel_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Use of Estimates</link:label>
    <link:label id="lab_us-gaap_UseOfEstimates_label_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Use of Estimates, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UseOfEstimates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UseOfEstimates" xlink:to="lab_us-gaap_UseOfEstimates" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_a5af3e3b-52f8-41e5-bf72-9284ecf2ce80_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive loss, net of tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_ac58bf4e-ee2d-4f30-a01c-078c31d4d307_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:type="arc" order="1"/>
    <link:label id="lab_cah_LesseeLeaseLiabilityPaymentsDueYearFive_92ac559f-975c-4286-8c48-87406648250d_terseLabel_en-US" xlink:label="lab_cah_LesseeLeaseLiabilityPaymentsDueYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2026</link:label>
    <link:label id="lab_cah_LesseeLeaseLiabilityPaymentsDueYearFive_label_en-US" xlink:label="lab_cah_LesseeLeaseLiabilityPaymentsDueYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee Lease Liability Payments Due Year Five</link:label>
    <link:label id="lab_cah_LesseeLeaseLiabilityPaymentsDueYearFive_documentation_en-US" xlink:label="lab_cah_LesseeLeaseLiabilityPaymentsDueYearFive" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee Lease Liability Payments Due Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cah_LesseeLeaseLiabilityPaymentsDueYearFive" xlink:href="cah-20210630.xsd#cah_LesseeLeaseLiabilityPaymentsDueYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_LesseeLeaseLiabilityPaymentsDueYearFive" xlink:to="lab_cah_LesseeLeaseLiabilityPaymentsDueYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_43296268-e2ac-4239-9fda-45a22a145284_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common shares, authorized</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesAuthorized" xlink:to="lab_us-gaap_CommonStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductsAndServicesDomain_63460d82-0944-4206-9dca-d15c77995e0e_terseLabel_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:label id="lab_srt_ProductsAndServicesDomain_label_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductsAndServicesDomain" xlink:to="lab_srt_ProductsAndServicesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_cah_GroupPurchasingOrganizationsMember_08033ad3-6c4c-41a8-98ca-c7211f018c6e_terseLabel_en-US" xlink:label="lab_cah_GroupPurchasingOrganizationsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Group Purchasing Organizations</link:label>
    <link:label id="lab_cah_GroupPurchasingOrganizationsMember_label_en-US" xlink:label="lab_cah_GroupPurchasingOrganizationsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Group Purchasing Organizations [Member]</link:label>
    <link:label id="lab_cah_GroupPurchasingOrganizationsMember_documentation_en-US" xlink:label="lab_cah_GroupPurchasingOrganizationsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Group Purchasing Organizations [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cah_GroupPurchasingOrganizationsMember" xlink:href="cah-20210630.xsd#cah_GroupPurchasingOrganizationsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_GroupPurchasingOrganizationsMember" xlink:to="lab_cah_GroupPurchasingOrganizationsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_292b0ae8-dd89-4d7d-ac10-c3ef469f0b9b_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stated interest rate</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Interest Rate, Stated Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:to="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_cah_Impactofadoptionofnewaccountingstandard_2d1edac8-29f6-4166-a1b1-0605ca15d5e4_terseLabel_en-US" xlink:label="lab_cah_Impactofadoptionofnewaccountingstandard" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncement or Change in Accounting Principle, Effect of Adoption, Quantification (Deprecated 2020-01-31)</link:label>
    <link:label id="lab_cah_Impactofadoptionofnewaccountingstandard_label_en-US" xlink:label="lab_cah_Impactofadoptionofnewaccountingstandard" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">impact of adoption of new accounting standard</link:label>
    <link:label id="lab_cah_Impactofadoptionofnewaccountingstandard_documentation_en-US" xlink:label="lab_cah_Impactofadoptionofnewaccountingstandard" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">impact of adoption of new accounting standard</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cah_Impactofadoptionofnewaccountingstandard" xlink:href="cah-20210630.xsd#cah_Impactofadoptionofnewaccountingstandard"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_Impactofadoptionofnewaccountingstandard" xlink:to="lab_cah_Impactofadoptionofnewaccountingstandard" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_06a8e636-191e-425b-b765-a6a1e43ac72c_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: Net earnings attributable to noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_7456b89b-b946-416b-ae44-3fd43d59f6f1_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Noncontrolling Interest</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_da261a65-a803-4d25-8982-421ccaed3b73_negatedLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net earnings attributable to noncontrolling interest</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_337096a8-46aa-4c33-9bcd-40c0f52261f3_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevolvingCreditFacilityMember_be255170-8160-4b23-89c5-52fdbd91c130_terseLabel_en-US" xlink:label="lab_us-gaap_RevolvingCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Facility</link:label>
    <link:label id="lab_us-gaap_RevolvingCreditFacilityMember_label_en-US" xlink:label="lab_us-gaap_RevolvingCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Facility [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevolvingCreditFacilityMember" xlink:to="lab_us-gaap_RevolvingCreditFacilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByMeasurementFrequencyAxis_0ecf11ca-e6fc-4a65-a1f9-d46afa3fd275_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByMeasurementFrequencyAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:to="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeLiabilityNotionalAmount_8e1f9a96-1713-4e16-aa56-4bdb37142378_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeLiabilityNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Liability, Notional Amount</link:label>
    <link:label id="lab_us-gaap_DerivativeLiabilityNotionalAmount_label_en-US" xlink:label="lab_us-gaap_DerivativeLiabilityNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Liability, Notional Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilityNotionalAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLiabilityNotionalAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeLiabilityNotionalAmount" xlink:to="lab_us-gaap_DerivativeLiabilityNotionalAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseCostTableTextBlock_41b1dddc-fda7-4ba0-abfa-2604edd2b765_terseLabel_en-US" xlink:label="lab_us-gaap_LeaseCostTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Lease Costs</link:label>
    <link:label id="lab_us-gaap_LeaseCostTableTextBlock_label_en-US" xlink:label="lab_us-gaap_LeaseCostTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Cost [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCostTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseCostTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseCostTableTextBlock" xlink:to="lab_us-gaap_LeaseCostTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_cah_CordisDivestitureAxis_086363ad-6c2f-4069-bd7d-d487287040b8_terseLabel_en-US" xlink:label="lab_cah_CordisDivestitureAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cordis Divestiture [Axis]</link:label>
    <link:label id="lab_cah_CordisDivestitureAxis_label_en-US" xlink:label="lab_cah_CordisDivestitureAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cordis Divestiture [Axis]</link:label>
    <link:label id="lab_cah_CordisDivestitureAxis_documentation_en-US" xlink:label="lab_cah_CordisDivestitureAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cordis Divestiture</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cah_CordisDivestitureAxis" xlink:href="cah-20210630.xsd#cah_CordisDivestitureAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_CordisDivestitureAxis" xlink:to="lab_cah_CordisDivestitureAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_StatementGeographicalAxis_b4a3f958-f9e7-438b-b91e-d24e86bc87e9_terseLabel_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:label id="lab_srt_StatementGeographicalAxis_label_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_StatementGeographicalAxis" xlink:to="lab_srt_StatementGeographicalAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_9f66a172-151f-42f9-8255-c7b8c0efae1a_terseLabel_en-US" xlink:label="lab_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table]</link:label>
    <link:label id="lab_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_label_en-US" xlink:label="lab_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" xlink:to="lab_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StateAndLocalJurisdictionMember_0102aaf6-ebb6-4e6b-8b98-aea020dbce39_terseLabel_en-US" xlink:label="lab_us-gaap_StateAndLocalJurisdictionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State and Local</link:label>
    <link:label id="lab_us-gaap_StateAndLocalJurisdictionMember_label_en-US" xlink:label="lab_us-gaap_StateAndLocalJurisdictionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State and Local Jurisdiction [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StateAndLocalJurisdictionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StateAndLocalJurisdictionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StateAndLocalJurisdictionMember" xlink:to="lab_us-gaap_StateAndLocalJurisdictionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_2cabb6a0-a403-4882-ac38-af5f7202da9c_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Axis]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:to="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtWeightedAverageInterestRate_c45478ee-18bd-4801-b9e8-d823d39fc524_verboseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtWeightedAverageInterestRate" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest rate on long-term projects (approximates weighted-average on long-term obligations)</link:label>
    <link:label id="lab_us-gaap_LongtermDebtWeightedAverageInterestRate_label_en-US" xlink:label="lab_us-gaap_LongtermDebtWeightedAverageInterestRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Weighted Average Interest Rate, at Point in Time</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtWeightedAverageInterestRate" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtWeightedAverageInterestRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtWeightedAverageInterestRate" xlink:to="lab_us-gaap_LongtermDebtWeightedAverageInterestRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpenseMember_6a1f8848-4da3-4827-8454-4df09ed52761_terseLabel_en-US" xlink:label="lab_us-gaap_InterestExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense, Net</link:label>
    <link:label id="lab_us-gaap_InterestExpenseMember_label_en-US" xlink:label="lab_us-gaap_InterestExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpenseMember" xlink:to="lab_us-gaap_InterestExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForProceedsFromHedgeFinancingActivities_397c5af1-77ef-43bf-95dc-543f92e39f34_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsForProceedsFromHedgeFinancingActivities" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from interest rate swap terminations</link:label>
    <link:label id="lab_us-gaap_PaymentsForProceedsFromHedgeFinancingActivities_label_en-US" xlink:label="lab_us-gaap_PaymentsForProceedsFromHedgeFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for (Proceeds from) Hedge, Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromHedgeFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForProceedsFromHedgeFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForProceedsFromHedgeFinancingActivities" xlink:to="lab_us-gaap_PaymentsForProceedsFromHedgeFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentPolicyTextBlock_08ed0bba-68ea-46a3-9091-093c9780e717_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments</link:label>
    <link:label id="lab_us-gaap_InvestmentPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_InvestmentPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentPolicyTextBlock" xlink:to="lab_us-gaap_InvestmentPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_f682b068-6bb9-481c-9773-0a5a9b8ca47d_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash used in financing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockValue_0fd3df4a-a2e9-4c88-875b-ad696d4e01e9_negatedLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockValue" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common shares in treasury, at cost: 36 million shares and 34 million shares at June 30, 2021 and 2020, respectively</link:label>
    <link:label id="lab_us-gaap_TreasuryStockValue_8ece7750-e693-4e32-ad71-2c4276322aa5_negatedPeriodStartLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockValue" xlink:role="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury, balance at beginning of period</link:label>
    <link:label id="lab_us-gaap_TreasuryStockValue_47809fc0-d31f-482f-9248-644a9e070a79_negatedPeriodEndLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockValue" xlink:role="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury, balance at end of period</link:label>
    <link:label id="lab_us-gaap_TreasuryStockValue_label_en-US" xlink:label="lab_us-gaap_TreasuryStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockValue" xlink:to="lab_us-gaap_TreasuryStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_139e7651-d27c-4f81-ade1-9cc9d5e56a58_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award vesting period (in years)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:type="arc" order="1"/>
    <link:label id="lab_cah_NewYorkOpioidStewardshipActMember_03781d6d-b67a-4c0a-884f-704829d1ff90_terseLabel_en-US" xlink:label="lab_cah_NewYorkOpioidStewardshipActMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New York Opioid Stewardship Act</link:label>
    <link:label id="lab_cah_NewYorkOpioidStewardshipActMember_label_en-US" xlink:label="lab_cah_NewYorkOpioidStewardshipActMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New York Opioid Stewardship Act [Member]</link:label>
    <link:label id="lab_cah_NewYorkOpioidStewardshipActMember_documentation_en-US" xlink:label="lab_cah_NewYorkOpioidStewardshipActMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New York Opioid Stewardship Act</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cah_NewYorkOpioidStewardshipActMember" xlink:href="cah-20210630.xsd#cah_NewYorkOpioidStewardshipActMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_NewYorkOpioidStewardshipActMember" xlink:to="lab_cah_NewYorkOpioidStewardshipActMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense_77853d55-6bf3-4351-b364-13af9ec25dff_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized tax benefits, interest and penalties</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromEquityMethodInvestments_cb6080e2-e5c5-42ce-b5ba-818939fa1aff_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Equity Method Investments</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromEquityMethodInvestments_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Equity Method Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:to="lab_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_cah_ExercisablePeriodOfPlansInYears_b54005d1-f683-4d6b-a792-ed828e8ead0c_terseLabel_en-US" xlink:label="lab_cah_ExercisablePeriodOfPlansInYears" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercisable period of plans (in years)</link:label>
    <link:label id="lab_cah_ExercisablePeriodOfPlansInYears_label_en-US" xlink:label="lab_cah_ExercisablePeriodOfPlansInYears" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercisable period of plans, in years</link:label>
    <link:label id="lab_cah_ExercisablePeriodOfPlansInYears_documentation_en-US" xlink:label="lab_cah_ExercisablePeriodOfPlansInYears" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The instrument's contractual term.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cah_ExercisablePeriodOfPlansInYears" xlink:href="cah-20210630.xsd#cah_ExercisablePeriodOfPlansInYears"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_ExercisablePeriodOfPlansInYears" xlink:to="lab_cah_ExercisablePeriodOfPlansInYears" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_cfd0048b-a005-40b0-b829-7bf51764cc33_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:to="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationForeignCurrencyTranslationGainsLosses_0eb36e6b-d174-4dcd-a103-15faa5abc2bf_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationForeignCurrencyTranslationGainsLosses" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Foreign Currency Translation Gains (Losses)</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationForeignCurrencyTranslationGainsLosses_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationForeignCurrencyTranslationGainsLosses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Foreign Currency Translation Gains (Losses)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationForeignCurrencyTranslationGainsLosses" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationForeignCurrencyTranslationGainsLosses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationForeignCurrencyTranslationGainsLosses" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationForeignCurrencyTranslationGainsLosses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringCharges_37fbcaf9-483b-471e-bcab-8be227b8b72c_verboseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCharges" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and employee severance</link:label>
    <link:label id="lab_us-gaap_RestructuringCharges_df58c4a0-86ee-4735-b34d-e25235f62461_totalLabel_en-US" xlink:label="lab_us-gaap_RestructuringCharges" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total restructuring and employee severance</link:label>
    <link:label id="lab_us-gaap_RestructuringCharges_label_en-US" xlink:label="lab_us-gaap_RestructuringCharges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Charges</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCharges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringCharges" xlink:to="lab_us-gaap_RestructuringCharges" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskByTypeAxis_ba991221-a181-4e5f-b828-04a866ea890d_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Axis]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskByTypeAxis_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis" xlink:to="lab_us-gaap_ConcentrationRiskByTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_5a23f2a9-3b4b-4fe7-a2a9-3eebe0fd378d_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated annual amortization of intangible assets - 2024</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignCountryMember_36aa36c0-f212-4bc7-bb56-b62e0284f865_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignCountryMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign</link:label>
    <link:label id="lab_us-gaap_ForeignCountryMember_label_en-US" xlink:label="lab_us-gaap_ForeignCountryMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Tax Authority [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCountryMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCountryMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCountryMember" xlink:to="lab_us-gaap_ForeignCountryMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringChargesAbstract_0c0508c4-1365-4cad-af98-d59c16815981_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringChargesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Charges [Abstract]</link:label>
    <link:label id="lab_us-gaap_RestructuringChargesAbstract_label_en-US" xlink:label="lab_us-gaap_RestructuringChargesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Charges [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringChargesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringChargesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringChargesAbstract" xlink:to="lab_us-gaap_RestructuringChargesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeTable_4d7e2111-edd4-4b5c-a239-6dcca548414c_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Table]</link:label>
    <link:label id="lab_us-gaap_DerivativeTable_label_en-US" xlink:label="lab_us-gaap_DerivativeTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeTable" xlink:to="lab_us-gaap_DerivativeTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskBenchmarkDomain_23fcdeca-70aa-46d6-970d-a9e3e6693d57_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Domain]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskBenchmarkDomain_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:to="lab_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_cah_ReceivableFinancingAgreementTerm_8ec2afa0-a239-47f2-a7ce-d4d5db9f0292_terseLabel_en-US" xlink:label="lab_cah_ReceivableFinancingAgreementTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivable financing agreement term</link:label>
    <link:label id="lab_cah_ReceivableFinancingAgreementTerm_label_en-US" xlink:label="lab_cah_ReceivableFinancingAgreementTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivable Financing Agreement Term</link:label>
    <link:label id="lab_cah_ReceivableFinancingAgreementTerm_documentation_en-US" xlink:label="lab_cah_ReceivableFinancingAgreementTerm" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivable Financing Agreement Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cah_ReceivableFinancingAgreementTerm" xlink:href="cah-20210630.xsd#cah_ReceivableFinancingAgreementTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_ReceivableFinancingAgreementTerm" xlink:to="lab_cah_ReceivableFinancingAgreementTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_2797cf15-3bb5-4828-a323-d170cc0f3546_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Options</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SalesReturnsAndAllowancesMember_15575b5d-4797-44d2-9288-0255062d588d_terseLabel_en-US" xlink:label="lab_us-gaap_SalesReturnsAndAllowancesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales Returns and Allowances [Member]</link:label>
    <link:label id="lab_us-gaap_SalesReturnsAndAllowancesMember_label_en-US" xlink:label="lab_us-gaap_SalesReturnsAndAllowancesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales Returns and Allowances [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesReturnsAndAllowancesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SalesReturnsAndAllowancesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SalesReturnsAndAllowancesMember" xlink:to="lab_us-gaap_SalesReturnsAndAllowancesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_3435767d-c97a-42e5-b117-b10ff7c93d01_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State and local income taxes, net of federal benefit</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_96d40ee7-53be-4e78-aa6e-8e982d10efc0_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State and local</link:label>
    <link:label id="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_e50c1ea9-7995-4450-97fa-7125c44c947b_verboseLabel_en-US" xlink:label="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred State and Local Income Tax Expense (Benefit)</link:label>
    <link:label id="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred State and Local Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_2bcfd119-3c4d-4317-9b2b-12f7de39fca4_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Components of Property and Equipment</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_88d39b3d-d85d-4978-811b-3e667b1e3529_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationDomain" xlink:to="lab_us-gaap_IncomeStatementLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentsFairValueDisclosure_fe59a49f-5234-4bb3-b4e5-8ab28ec61c7b_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other investments</link:label>
    <link:label id="lab_us-gaap_InvestmentsFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_InvestmentsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsFairValueDisclosure" xlink:to="lab_us-gaap_InvestmentsFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_f93337f5-a76f-4f41-8c54-68429de777b4_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:type="arc" order="1"/>
    <link:label id="lab_cah_DeferredIncomeTaxesAndOtherTaxLiabilitiesTransferredToHeldForSaleNoncurrent_bb0d7f29-6ebb-4928-bb02-eb71f16a504d_negatedTerseLabel_en-US" xlink:label="lab_cah_DeferredIncomeTaxesAndOtherTaxLiabilitiesTransferredToHeldForSaleNoncurrent" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Taxes and Other Tax Liabilities, Transferred to Held for Sale, Noncurrent</link:label>
    <link:label id="lab_cah_DeferredIncomeTaxesAndOtherTaxLiabilitiesTransferredToHeldForSaleNoncurrent_label_en-US" xlink:label="lab_cah_DeferredIncomeTaxesAndOtherTaxLiabilitiesTransferredToHeldForSaleNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Taxes and Other Tax Liabilities, Transferred to Held for Sale, Noncurrent</link:label>
    <link:label id="lab_cah_DeferredIncomeTaxesAndOtherTaxLiabilitiesTransferredToHeldForSaleNoncurrent_documentation_en-US" xlink:label="lab_cah_DeferredIncomeTaxesAndOtherTaxLiabilitiesTransferredToHeldForSaleNoncurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Taxes and Other Tax Liabilities, Transferred to Held for Sale, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cah_DeferredIncomeTaxesAndOtherTaxLiabilitiesTransferredToHeldForSaleNoncurrent" xlink:href="cah-20210630.xsd#cah_DeferredIncomeTaxesAndOtherTaxLiabilitiesTransferredToHeldForSaleNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_DeferredIncomeTaxesAndOtherTaxLiabilitiesTransferredToHeldForSaleNoncurrent" xlink:to="lab_cah_DeferredIncomeTaxesAndOtherTaxLiabilitiesTransferredToHeldForSaleNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember_d915ba24-0d0f-421e-92d0-6a39fcc70d01_terseLabel_en-US" xlink:label="lab_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Including Portion Attributable to Noncontrolling Interest [Member]</link:label>
    <link:label id="lab_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember_label_en-US" xlink:label="lab_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Including Portion Attributable to Noncontrolling Interest [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember" xlink:to="lab_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cah_TreasuryStockAcquiredShares_1018fd0c-4ad8-4e69-99f2-20970f93c619_terseLabel_en-US" xlink:label="lab_cah_TreasuryStockAcquiredShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock Acquired Shares</link:label>
    <link:label id="lab_cah_TreasuryStockAcquiredShares_label_en-US" xlink:label="lab_cah_TreasuryStockAcquiredShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock Acquired Shares</link:label>
    <link:label id="lab_cah_TreasuryStockAcquiredShares_documentation_en-US" xlink:label="lab_cah_TreasuryStockAcquiredShares" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock Acquired Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cah_TreasuryStockAcquiredShares" xlink:href="cah-20210630.xsd#cah_TreasuryStockAcquiredShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_TreasuryStockAcquiredShares" xlink:to="lab_cah_TreasuryStockAcquiredShares" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfLongTermDebt_915b8c47-6ecc-4807-b0c4-1d7e18862f22_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reduction of long-term obligations</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfLongTermDebt_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Long-term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfLongTermDebt" xlink:to="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_3217fc02-27de-43bc-ab30-6d1105e536a7_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareAbstract" xlink:to="lab_us-gaap_EarningsPerShareAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_cah_PlaintiffTypeAxis_10663e13-5549-4943-9c3a-ead39021e25e_terseLabel_en-US" xlink:label="lab_cah_PlaintiffTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plaintiff Type [Axis]</link:label>
    <link:label id="lab_cah_PlaintiffTypeAxis_label_en-US" xlink:label="lab_cah_PlaintiffTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plaintiff Type [Axis]</link:label>
    <link:label id="lab_cah_PlaintiffTypeAxis_documentation_en-US" xlink:label="lab_cah_PlaintiffTypeAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plaintiff Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cah_PlaintiffTypeAxis" xlink:href="cah-20210630.xsd#cah_PlaintiffTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_PlaintiffTypeAxis" xlink:to="lab_cah_PlaintiffTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossOnSaleOfOtherInvestments_8c79288c-1b23-45de-a395-81f9c8918bae_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_GainLossOnSaleOfOtherInvestments" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss on Sale of Investments</link:label>
    <link:label id="lab_us-gaap_GainLossOnSaleOfOtherInvestments_label_en-US" xlink:label="lab_us-gaap_GainLossOnSaleOfOtherInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Sale of Other Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfOtherInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnSaleOfOtherInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossOnSaleOfOtherInvestments" xlink:to="lab_us-gaap_GainLossOnSaleOfOtherInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_cah_RemainingStockOptionPlanDataTableTextBlock_9cf27729-1b4a-46be-8fc6-021ecaad2eea_terseLabel_en-US" xlink:label="lab_cah_RemainingStockOptionPlanDataTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Remaining Stock Option Plan Data</link:label>
    <link:label id="lab_cah_RemainingStockOptionPlanDataTableTextBlock_label_en-US" xlink:label="lab_cah_RemainingStockOptionPlanDataTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Remaining Stock Option Plan Data [Table Text Block]</link:label>
    <link:label id="lab_cah_RemainingStockOptionPlanDataTableTextBlock_documentation_en-US" xlink:label="lab_cah_RemainingStockOptionPlanDataTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">[Table Text Block] for Remaining Stock Option Plan Data [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cah_RemainingStockOptionPlanDataTableTextBlock" xlink:href="cah-20210630.xsd#cah_RemainingStockOptionPlanDataTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_RemainingStockOptionPlanDataTableTextBlock" xlink:to="lab_cah_RemainingStockOptionPlanDataTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentGross_487281bf-7425-4f6c-bdb5-d45c36dc2100_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total property and equipment, at cost</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentGross_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentGross" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Revenues_1f086b5e-20e1-4e8c-b3f5-625b01ea2895_terseLabel_en-US" xlink:label="lab_us-gaap_Revenues" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue</link:label>
    <link:label id="lab_us-gaap_Revenues_label_en-US" xlink:label="lab_us-gaap_Revenues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Revenues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Revenues" xlink:to="lab_us-gaap_Revenues" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_5b9db071-ca14-4f42-bf18-7258b50c1df4_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amounts reclassified to earnings</link:label>
    <link:label id="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_label_en-US" xlink:label="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:to="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignExchangeContractMember_b21db4f7-420a-4474-8872-031578c1d08a_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignExchangeContractMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Contracts</link:label>
    <link:label id="lab_us-gaap_ForeignExchangeContractMember_label_en-US" xlink:label="lab_us-gaap_ForeignExchangeContractMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Exchange Contract [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignExchangeContractMember" xlink:to="lab_us-gaap_ForeignExchangeContractMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyAccrualAtCarryingValue_3c65e689-fed8-4615-a848-87eae071c0aa_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyAccrualAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency Accrual</link:label>
    <link:label id="lab_us-gaap_LossContingencyAccrualAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_LossContingencyAccrualAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency Accrual</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyAccrualAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyAccrualAtCarryingValue" xlink:to="lab_us-gaap_LossContingencyAccrualAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_b32a808b-ec14-47c4-93d4-197404662b8a_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding at beginning of period (in usd per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_c19131a2-f0da-4061-bf28-ef423a26e52a_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding at end of period (in usd per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_de702eba-0f18-417c-8bdb-6bcfd8d6ca8e_terseLabel_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_label_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCommonStockSharesOutstanding" xlink:to="lab_dei_EntityCommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_cah_GainonDivestitureAfterTax_c76ff773-45f0-493d-b118-f3389020afba_terseLabel_en-US" xlink:label="lab_cah_GainonDivestitureAfterTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain on Divestiture After Tax</link:label>
    <link:label id="lab_cah_GainonDivestitureAfterTax_label_en-US" xlink:label="lab_cah_GainonDivestitureAfterTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain on Divestiture After Tax</link:label>
    <link:label id="lab_cah_GainonDivestitureAfterTax_documentation_en-US" xlink:label="lab_cah_GainonDivestitureAfterTax" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain on Divestiture After Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cah_GainonDivestitureAfterTax" xlink:href="cah-20210630.xsd#cah_GainonDivestitureAfterTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_GainonDivestitureAfterTax" xlink:to="lab_cah_GainonDivestitureAfterTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TaxCutsAndJobsActOf2017TransitionTaxForAccumulatedForeignEarningsIncomeTaxExpense_6640ce63-d5a1-427a-bd11-d38288cd5544_terseLabel_en-US" xlink:label="lab_us-gaap_TaxCutsAndJobsActOf2017TransitionTaxForAccumulatedForeignEarningsIncomeTaxExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Cuts and Jobs Act, Transition Tax for Accumulated Foreign Earnings, Income Tax Expense</link:label>
    <link:label id="lab_us-gaap_TaxCutsAndJobsActOf2017TransitionTaxForAccumulatedForeignEarningsIncomeTaxExpense_label_en-US" xlink:label="lab_us-gaap_TaxCutsAndJobsActOf2017TransitionTaxForAccumulatedForeignEarningsIncomeTaxExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Cuts and Jobs Act, Transition Tax for Accumulated Foreign Earnings, Income Tax Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCutsAndJobsActOf2017TransitionTaxForAccumulatedForeignEarningsIncomeTaxExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxCutsAndJobsActOf2017TransitionTaxForAccumulatedForeignEarningsIncomeTaxExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TaxCutsAndJobsActOf2017TransitionTaxForAccumulatedForeignEarningsIncomeTaxExpense" xlink:to="lab_us-gaap_TaxCutsAndJobsActOf2017TransitionTaxForAccumulatedForeignEarningsIncomeTaxExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_cah_DerivatesHedgeDiscontinuancesHedgingInstrumentTerminatedAmount_4c0b1ed6-2aa9-4920-9cb1-b2cf3fa03f36_terseLabel_en-US" xlink:label="lab_cah_DerivatesHedgeDiscontinuancesHedgingInstrumentTerminatedAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivates, Hedge Discontinuances, Hedging Instrument Terminated, Amount</link:label>
    <link:label id="lab_cah_DerivatesHedgeDiscontinuancesHedgingInstrumentTerminatedAmount_label_en-US" xlink:label="lab_cah_DerivatesHedgeDiscontinuancesHedgingInstrumentTerminatedAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivates, Hedge Discontinuances, Hedging Instrument Terminated, Amount</link:label>
    <link:label id="lab_cah_DerivatesHedgeDiscontinuancesHedgingInstrumentTerminatedAmount_documentation_en-US" xlink:label="lab_cah_DerivatesHedgeDiscontinuancesHedgingInstrumentTerminatedAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivates, Hedge Discontinuances, Hedging Instrument Terminated, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cah_DerivatesHedgeDiscontinuancesHedgingInstrumentTerminatedAmount" xlink:href="cah-20210630.xsd#cah_DerivatesHedgeDiscontinuancesHedgingInstrumentTerminatedAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_DerivatesHedgeDiscontinuancesHedgingInstrumentTerminatedAmount" xlink:to="lab_cah_DerivatesHedgeDiscontinuancesHedgingInstrumentTerminatedAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_cah_TaxMatterAxis_dc8e7235-758c-4717-a2de-423a04ddc7fe_terseLabel_en-US" xlink:label="lab_cah_TaxMatterAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Matter [Axis]</link:label>
    <link:label id="lab_cah_TaxMatterAxis_label_en-US" xlink:label="lab_cah_TaxMatterAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Matter [Axis]</link:label>
    <link:label id="lab_cah_TaxMatterAxis_documentation_en-US" xlink:label="lab_cah_TaxMatterAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Matter [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cah_TaxMatterAxis" xlink:href="cah-20210630.xsd#cah_TaxMatterAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_TaxMatterAxis" xlink:to="lab_cah_TaxMatterAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_cah_OpioidLawsuitsMember_84c55ecf-5c63-456c-93e7-cc766a789a46_terseLabel_en-US" xlink:label="lab_cah_OpioidLawsuitsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Opioid Lawsuits</link:label>
    <link:label id="lab_cah_OpioidLawsuitsMember_label_en-US" xlink:label="lab_cah_OpioidLawsuitsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Opioid Lawsuits [Member]</link:label>
    <link:label id="lab_cah_OpioidLawsuitsMember_documentation_en-US" xlink:label="lab_cah_OpioidLawsuitsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Opioid Lawsuits [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cah_OpioidLawsuitsMember" xlink:href="cah-20210630.xsd#cah_OpioidLawsuitsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_OpioidLawsuitsMember" xlink:to="lab_cah_OpioidLawsuitsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueRecognitionSalesReturnsReserveForSalesReturns_0ae653d2-7191-43bf-b464-637629204d43_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueRecognitionSalesReturnsReserveForSalesReturns" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue Recognition, Sales Returns, Reserve for Sales Returns</link:label>
    <link:label id="lab_us-gaap_RevenueRecognitionSalesReturnsReserveForSalesReturns_label_en-US" xlink:label="lab_us-gaap_RevenueRecognitionSalesReturnsReserveForSalesReturns" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue Recognition, Sales Returns, Reserve for Sales Returns</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRecognitionSalesReturnsReserveForSalesReturns" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRecognitionSalesReturnsReserveForSalesReturns"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueRecognitionSalesReturnsReserveForSalesReturns" xlink:to="lab_us-gaap_RevenueRecognitionSalesReturnsReserveForSalesReturns" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_cb0c70d3-f4b8-4dd8-b923-4991e9d84308_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-Average Grant Date Fair Value per Share</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_e96188a6-ffa9-4fa0-bad5-2fce28abc318_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-Average Grant Date Fair Value per Share</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_ef348896-b18f-4ed4-80ac-3a0cfe066410_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalPeriodFocus" xlink:to="lab_dei_DocumentFiscalPeriodFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_cah_PrivatePartiesMember_2308c0af-487e-4bbe-8388-512d3dcef72c_terseLabel_en-US" xlink:label="lab_cah_PrivatePartiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Private Parties [Member]</link:label>
    <link:label id="lab_cah_PrivatePartiesMember_label_en-US" xlink:label="lab_cah_PrivatePartiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Private Parties [Member]</link:label>
    <link:label id="lab_cah_PrivatePartiesMember_documentation_en-US" xlink:label="lab_cah_PrivatePartiesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Private Parties [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cah_PrivatePartiesMember" xlink:href="cah-20210630.xsd#cah_PrivatePartiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_PrivatePartiesMember" xlink:to="lab_cah_PrivatePartiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_f76527a5-6bea-4474-867d-1af8b3531785_totalLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective income tax rate</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_df0e3330-875a-4f07-bb63-a37225a7f623_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Percent</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyEstimateOfPossibleLoss_9b658752-f92a-4e49-9024-379e70d722f3_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyEstimateOfPossibleLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Estimate of Possible Loss</link:label>
    <link:label id="lab_us-gaap_LossContingencyEstimateOfPossibleLoss_label_en-US" xlink:label="lab_us-gaap_LossContingencyEstimateOfPossibleLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Estimate of Possible Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyEstimateOfPossibleLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyEstimateOfPossibleLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyEstimateOfPossibleLoss" xlink:to="lab_us-gaap_LossContingencyEstimateOfPossibleLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_cah_A4.625Notesdue2021Member_920fb4de-8558-4030-97b9-0f1231d1753d_terseLabel_en-US" xlink:label="lab_cah_A4.625Notesdue2021Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.625% Notes due 2020</link:label>
    <link:label id="lab_cah_A4.625Notesdue2021Member_label_en-US" xlink:label="lab_cah_A4.625Notesdue2021Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.625% Notes due 2021 [Member]</link:label>
    <link:label id="lab_cah_A4.625Notesdue2021Member_documentation_en-US" xlink:label="lab_cah_A4.625Notesdue2021Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.625% Notes due 2021</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cah_A4.625Notesdue2021Member" xlink:href="cah-20210630.xsd#cah_A4.625Notesdue2021Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_A4.625Notesdue2021Member" xlink:to="lab_cah_A4.625Notesdue2021Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Dividends_c4e4587b-beaa-4473-a97f-1ebb188f617d_negatedLabel_en-US" xlink:label="lab_us-gaap_Dividends" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends declared</link:label>
    <link:label id="lab_us-gaap_Dividends_label_en-US" xlink:label="lab_us-gaap_Dividends" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Dividends" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Dividends"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Dividends" xlink:to="lab_us-gaap_Dividends" xlink:type="arc" order="1"/>
    <link:label id="lab_country_US_76f1cb76-3d90-47cb-9f51-32c857c91c36_terseLabel_en-US" xlink:label="lab_country_US" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">United States</link:label>
    <link:label id="lab_country_US_label_en-US" xlink:label="lab_country_US" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">UNITED STATES</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_country_US" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_US"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_US" xlink:to="lab_country_US" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestIncomeExpenseNonoperatingNet_a3842ff5-6f42-417b-a9d7-5a3ca3d016b6_terseLabel_en-US" xlink:label="lab_us-gaap_InterestIncomeExpenseNonoperatingNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Income (Expense), Nonoperating, Net</link:label>
    <link:label id="lab_us-gaap_InterestIncomeExpenseNonoperatingNet_label_en-US" xlink:label="lab_us-gaap_InterestIncomeExpenseNonoperatingNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Income (Expense), Nonoperating, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeExpenseNonoperatingNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestIncomeExpenseNonoperatingNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestIncomeExpenseNonoperatingNet" xlink:to="lab_us-gaap_InterestIncomeExpenseNonoperatingNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeasesAbstract_74418219-75d7-42ee-a793-88710f39d7a5_terseLabel_en-US" xlink:label="lab_us-gaap_LeasesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases [Abstract]</link:label>
    <link:label id="lab_us-gaap_LeasesAbstract_label_en-US" xlink:label="lab_us-gaap_LeasesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeasesAbstract" xlink:to="lab_us-gaap_LeasesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents_14260909-fcb9-4315-a735-2ac248794067_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Cash and Cash Equivalents</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Cash and Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxPolicyTextBlock_678cea14-d94e-4e8b-bb1e-2cc5681dfb23_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_IncomeTaxPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxPolicyTextBlock" xlink:to="lab_us-gaap_IncomeTaxPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_92f19016-be6d-42b7-8e1c-20f3e9ace6f6_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted- Average Remaining Amortization Period (Years)</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Remaining Amortization Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfNonvestedPerformanceBasedUnitsActivityTableTextBlock_6f246338-7325-4341-8c87-3ae0540c2991_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfNonvestedPerformanceBasedUnitsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Transactions Related to Performance Share Units Under the Plans</link:label>
    <link:label id="lab_us-gaap_ScheduleOfNonvestedPerformanceBasedUnitsActivityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfNonvestedPerformanceBasedUnitsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Nonvested Performance-based Units Activity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNonvestedPerformanceBasedUnitsActivityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfNonvestedPerformanceBasedUnitsActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfNonvestedPerformanceBasedUnitsActivityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfNonvestedPerformanceBasedUnitsActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_cah_EffectiveTaxRateReconciliationUSTaxesOnInternationalIncome_78a1063f-1104-4a3a-ba5f-4fec35015150_terseLabel_en-US" xlink:label="lab_cah_EffectiveTaxRateReconciliationUSTaxesOnInternationalIncome" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">US Taxes on International Income</link:label>
    <link:label id="lab_cah_EffectiveTaxRateReconciliationUSTaxesOnInternationalIncome_label_en-US" xlink:label="lab_cah_EffectiveTaxRateReconciliationUSTaxesOnInternationalIncome" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Tax Rate Reconciliation, US Taxes on International Income</link:label>
    <link:label id="lab_cah_EffectiveTaxRateReconciliationUSTaxesOnInternationalIncome_documentation_en-US" xlink:label="lab_cah_EffectiveTaxRateReconciliationUSTaxesOnInternationalIncome" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Tax Rate Reconciliation, US Taxes on International Income</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cah_EffectiveTaxRateReconciliationUSTaxesOnInternationalIncome" xlink:href="cah-20210630.xsd#cah_EffectiveTaxRateReconciliationUSTaxesOnInternationalIncome"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_EffectiveTaxRateReconciliationUSTaxesOnInternationalIncome" xlink:to="lab_cah_EffectiveTaxRateReconciliationUSTaxesOnInternationalIncome" xlink:type="arc" order="1"/>
    <link:label id="lab_cah_AggregateAnnualAssessment_69a48cc5-09aa-4b12-88b6-ab2de1e3e289_terseLabel_en-US" xlink:label="lab_cah_AggregateAnnualAssessment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate Annual Assessment</link:label>
    <link:label id="lab_cah_AggregateAnnualAssessment_label_en-US" xlink:label="lab_cah_AggregateAnnualAssessment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate Annual Assessment</link:label>
    <link:label id="lab_cah_AggregateAnnualAssessment_documentation_en-US" xlink:label="lab_cah_AggregateAnnualAssessment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate Annual Assessment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cah_AggregateAnnualAssessment" xlink:href="cah-20210630.xsd#cah_AggregateAnnualAssessment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_AggregateAnnualAssessment" xlink:to="lab_cah_AggregateAnnualAssessment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_250ee35a-29ce-42df-858c-57990c00a708_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_729912e5-7ef6-4553-9755-0bf46a5dd398_totalLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average common shares&#8211;diluted (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_16577254-43e5-4c68-9c02-566aa5d5269f_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.S. operations</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Domestic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:type="arc" order="1"/>
    <link:label id="lab_cah_A2.616Notes3.2Notes3.41Notes4.6Notes4.9Notesand4.368NotesMember_c83c292f-971f-4024-88aa-cd836d88fe60_terseLabel_en-US" xlink:label="lab_cah_A2.616Notes3.2Notes3.41Notes4.6Notes4.9Notesand4.368NotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.616% Notes, 3.2% Notes, 3.41% Notes, 4.6% Notes, 4.9% Notes and 4.368% Notes [Member]</link:label>
    <link:label id="lab_cah_A2.616Notes3.2Notes3.41Notes4.6Notes4.9Notesand4.368NotesMember_label_en-US" xlink:label="lab_cah_A2.616Notes3.2Notes3.41Notes4.6Notes4.9Notesand4.368NotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.616% Notes, 3.2% Notes, 3.41% Notes, 4.6% Notes, 4.9% Notes and 4.368% Notes [Member]</link:label>
    <link:label id="lab_cah_A2.616Notes3.2Notes3.41Notes4.6Notes4.9Notesand4.368NotesMember_documentation_en-US" xlink:label="lab_cah_A2.616Notes3.2Notes3.41Notes4.6Notes4.9Notesand4.368NotesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.616% Notes, 3.2% Notes, 3.41% Notes, 4.6% Notes, 4.9% Notes and 4.368% Notes [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cah_A2.616Notes3.2Notes3.41Notes4.6Notes4.9Notesand4.368NotesMember" xlink:href="cah-20210630.xsd#cah_A2.616Notes3.2Notes3.41Notes4.6Notes4.9Notesand4.368NotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_A2.616Notes3.2Notes3.41Notes4.6Notes4.9Notesand4.368NotesMember" xlink:to="lab_cah_A2.616Notes3.2Notes3.41Notes4.6Notes4.9Notesand4.368NotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_7a579a04-3ed1-428a-bd11-03676aae2e94_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_cah_NaviHealthDomain_284779d5-e60d-49b6-99db-721ea2f13404_terseLabel_en-US" xlink:label="lab_cah_NaviHealthDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">naviHealth [Domain]</link:label>
    <link:label id="lab_cah_NaviHealthDomain_label_en-US" xlink:label="lab_cah_NaviHealthDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">naviHealth [Domain]</link:label>
    <link:label id="lab_cah_NaviHealthDomain_documentation_en-US" xlink:label="lab_cah_NaviHealthDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">naviHealth [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cah_NaviHealthDomain" xlink:href="cah-20210630.xsd#cah_NaviHealthDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_NaviHealthDomain" xlink:to="lab_cah_NaviHealthDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_7a042de0-3b79-4b07-9835-681946079055_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Stock Option Transactions Under the Plans</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Option, Activity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_cah_Purchaseofavailableforsalesecuritiesandotherinvestments_7fad36ef-4ac2-4a9b-bbe0-1e3fa9b146f2_negatedLabel_en-US" xlink:label="lab_cah_Purchaseofavailableforsalesecuritiesandotherinvestments" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase of other investments</link:label>
    <link:label id="lab_cah_Purchaseofavailableforsalesecuritiesandotherinvestments_label_en-US" xlink:label="lab_cah_Purchaseofavailableforsalesecuritiesandotherinvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase of available-for-sale securities and other investments</link:label>
    <link:label id="lab_cah_Purchaseofavailableforsalesecuritiesandotherinvestments_documentation_en-US" xlink:label="lab_cah_Purchaseofavailableforsalesecuritiesandotherinvestments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The cash outflow from purchases of available-for-sale securities and other investments.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cah_Purchaseofavailableforsalesecuritiesandotherinvestments" xlink:href="cah-20210630.xsd#cah_Purchaseofavailableforsalesecuritiesandotherinvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_Purchaseofavailableforsalesecuritiesandotherinvestments" xlink:to="lab_cah_Purchaseofavailableforsalesecuritiesandotherinvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_1ba156e8-a42c-43f5-9061-20d1e488d53f_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:to="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_cah_FinanceLeaseImputedInterest_a8bb2ab2-bf09-4801-beff-d27d1c8cd8c7_terseLabel_en-US" xlink:label="lab_cah_FinanceLeaseImputedInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: imputed interest</link:label>
    <link:label id="lab_cah_FinanceLeaseImputedInterest_label_en-US" xlink:label="lab_cah_FinanceLeaseImputedInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease Imputed Interest</link:label>
    <link:label id="lab_cah_FinanceLeaseImputedInterest_documentation_en-US" xlink:label="lab_cah_FinanceLeaseImputedInterest" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease Imputed Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cah_FinanceLeaseImputedInterest" xlink:href="cah-20210630.xsd#cah_FinanceLeaseImputedInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_FinanceLeaseImputedInterest" xlink:to="lab_cah_FinanceLeaseImputedInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfStockLineItems_ce386df5-deba-430e-bac1-dc1620435966_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfStockLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Line Items]</link:label>
    <link:label id="lab_us-gaap_ClassOfStockLineItems_label_en-US" xlink:label="lab_us-gaap_ClassOfStockLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfStockLineItems" xlink:to="lab_us-gaap_ClassOfStockLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NondesignatedMember_4dd0b6e4-d342-40f6-9c99-d652b4a32f2f_terseLabel_en-US" xlink:label="lab_us-gaap_NondesignatedMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Not Designated as Hedging Instrument</link:label>
    <link:label id="lab_us-gaap_NondesignatedMember_label_en-US" xlink:label="lab_us-gaap_NondesignatedMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Not Designated as Hedging Instrument [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NondesignatedMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NondesignatedMember" xlink:to="lab_us-gaap_NondesignatedMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditFacilityAxis_bf8eb6af-7694-4afe-beee-c1450ba24ffe_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityAxis_label_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityAxis" xlink:to="lab_us-gaap_CreditFacilityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_9fcacde0-9cfd-4641-8296-77aa7b6a7916_verboseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_f155f86e-e334-4edf-baa0-545364b7684f_terseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets [Line Items]</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_label_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems" xlink:to="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_cbdc2aa5-6019-4790-97bb-637faf7def19_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:to="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_602fa17d-b12f-456a-adf8-f7d94b4b373c_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from operating activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsegmentsConsolidationItemsAxis_f2c62ef9-55fa-4505-a362-70dacfc976ab_terseLabel_en-US" xlink:label="lab_us-gaap_SubsegmentsConsolidationItemsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsegments Consolidation Items [Axis]</link:label>
    <link:label id="lab_us-gaap_SubsegmentsConsolidationItemsAxis_label_en-US" xlink:label="lab_us-gaap_SubsegmentsConsolidationItemsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsegments Consolidation Items [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsegmentsConsolidationItemsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsegmentsConsolidationItemsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsegmentsConsolidationItemsAxis" xlink:to="lab_us-gaap_SubsegmentsConsolidationItemsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConsolidationPolicyTextBlock_a03a26b3-788e-4133-bd74-dc23a590fe74_terseLabel_en-US" xlink:label="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interests and Redeemable Noncontrolling Interests</link:label>
    <link:label id="lab_us-gaap_ConsolidationPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConsolidationPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConsolidationPolicyTextBlock" xlink:to="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_62fdba78-cc74-41bd-909f-72bdff4274ba_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrent" xlink:to="lab_us-gaap_LiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_cah_TotalLeaseLiabilityUndiscountedExcessAmount_5fa97b09-4ddd-475c-ab28-88cb4a335cf4_terseLabel_en-US" xlink:label="lab_cah_TotalLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: imputed interest</link:label>
    <link:label id="lab_cah_TotalLeaseLiabilityUndiscountedExcessAmount_label_en-US" xlink:label="lab_cah_TotalLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Lease Liability Undiscounted Excess Amount</link:label>
    <link:label id="lab_cah_TotalLeaseLiabilityUndiscountedExcessAmount_documentation_en-US" xlink:label="lab_cah_TotalLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Lease Liability Undiscounted Excess Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cah_TotalLeaseLiabilityUndiscountedExcessAmount" xlink:href="cah-20210630.xsd#cah_TotalLeaseLiabilityUndiscountedExcessAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_TotalLeaseLiabilityUndiscountedExcessAmount" xlink:to="lab_cah_TotalLeaseLiabilityUndiscountedExcessAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_d001f732-6b06-42f8-8e58-8902a4fc7eaf_terseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]</link:label>
    <link:label id="lab_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_label_en-US" xlink:label="lab_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems" xlink:to="lab_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingenciesTable_33eb09b4-58fe-40cf-bfa4-724263ffb3af_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingenciesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies</link:label>
    <link:label id="lab_us-gaap_LossContingenciesTable_label_en-US" xlink:label="lab_us-gaap_LossContingenciesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingenciesTable" xlink:to="lab_us-gaap_LossContingenciesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_d1b46be1-2a9d-4577-b4c8-0f32707405ed_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinancialInstrumentsDisclosureTextBlock_862371f6-2028-41d6-9b16-f15de019218c_terseLabel_en-US" xlink:label="lab_us-gaap_FinancialInstrumentsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instruments</link:label>
    <link:label id="lab_us-gaap_FinancialInstrumentsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_FinancialInstrumentsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instruments Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancialInstrumentsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinancialInstrumentsDisclosureTextBlock" xlink:to="lab_us-gaap_FinancialInstrumentsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_9c999e40-0282-4360-ad86-e131320a5b3f_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementTable_9872e718-eaac-4959-ace0-eb6fec7667eb_terseLabel_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:label id="lab_us-gaap_StatementTable_label_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementTable" xlink:to="lab_us-gaap_StatementTable" xlink:type="arc" order="1"/>
    <link:label id="lab_cah_A3.2Notesdue2023Member_b572a6c5-050e-4938-a550-01c2ee3bd387_terseLabel_en-US" xlink:label="lab_cah_A3.2Notesdue2023Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.2% Notes due 2023</link:label>
    <link:label id="lab_cah_A3.2Notesdue2023Member_label_en-US" xlink:label="lab_cah_A3.2Notesdue2023Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.2% Notes due 2023 [Member]</link:label>
    <link:label id="lab_cah_A3.2Notesdue2023Member_documentation_en-US" xlink:label="lab_cah_A3.2Notesdue2023Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.2% Notes due 2023</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cah_A3.2Notesdue2023Member" xlink:href="cah-20210630.xsd#cah_A3.2Notesdue2023Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_A3.2Notesdue2023Member" xlink:to="lab_cah_A3.2Notesdue2023Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_ff8686e8-9a6b-445d-8fc5-96e23761c5d8_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Recent Financial Accounting Standards</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOther_945fb1fc-db4f-4edc-bc64-2cc1e94ffcb4_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOther" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOther_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOther" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsOther" xlink:to="lab_us-gaap_DeferredTaxAssetsOther" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_6190cae1-128c-462f-9e0b-8770fbae4ebb_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total compensation cost, net of estimated forfeitures, related to unvested stock options not yet recognized, pre-tax</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_0656b765-6ec2-487d-98d6-b12e690fba32_verboseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total compensation cost, net of estimated forfeitures, related to nonvested restricted share and share unit awards not yet recognized, pre-tax</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_03b80d72-a3a2-4d56-8af3-c2835607019f_netLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total compensation cost, net of estimated forfeitures, related to nonvested performance share units not yet recognized, pre-tax</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock_c9978fe6-29ef-476c-9730-72ed67742887_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Gain/(Loss) Recognized in Earnings for Economic (Non-designated) Derivative Instruments</link:label>
    <link:label id="lab_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives Not Designated as Hedging Instruments [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyNewClaimsFiledNumber_09f7cee0-c0ea-4d2c-be8b-3fa1ba24d871_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyNewClaimsFiledNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of lawsuits filed</link:label>
    <link:label id="lab_us-gaap_LossContingencyNewClaimsFiledNumber_label_en-US" xlink:label="lab_us-gaap_LossContingencyNewClaimsFiledNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, New Claims Filed, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNewClaimsFiledNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyNewClaimsFiledNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyNewClaimsFiledNumber" xlink:to="lab_us-gaap_LossContingencyNewClaimsFiledNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeAxis_706e0906-a6e2-4c97-8f18-c43ed36ca61e_terseLabel_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:label id="lab_srt_RangeAxis_label_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeAxis" xlink:to="lab_srt_RangeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventMember_6986d9b6-6324-4d37-ba83-b08d3b5c8891_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event</link:label>
    <link:label id="lab_us-gaap_SubsequentEventMember_label_en-US" xlink:label="lab_us-gaap_SubsequentEventMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventMember" xlink:to="lab_us-gaap_SubsequentEventMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_6e900592-4fd7-4031-95a3-870c946fd037_terseLabel_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityNoncurrent_786789c0-035a-4e21-893d-9bf636bb5b5a_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Noncurrent</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:to="lab_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GuaranteesIndemnificationsAndWarrantiesPolicies_45c1ae86-cde0-4de4-b91c-8c454dff2bb5_terseLabel_en-US" xlink:label="lab_us-gaap_GuaranteesIndemnificationsAndWarrantiesPolicies" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Guarantees, Indemnifications and Warranties Policies [Policy Text Block]</link:label>
    <link:label id="lab_us-gaap_GuaranteesIndemnificationsAndWarrantiesPolicies_label_en-US" xlink:label="lab_us-gaap_GuaranteesIndemnificationsAndWarrantiesPolicies" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Guarantees, Indemnifications and Warranties Policies [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GuaranteesIndemnificationsAndWarrantiesPolicies" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GuaranteesIndemnificationsAndWarrantiesPolicies"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GuaranteesIndemnificationsAndWarrantiesPolicies" xlink:to="lab_us-gaap_GuaranteesIndemnificationsAndWarrantiesPolicies" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_b74fa69a-5295-44d9-af70-6d0828d37077_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Intangible</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Goodwill_099d30fb-673c-403e-a9d6-dcf57f814051_periodStartLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_Goodwill_8a507166-7919-4cbd-a783-b694d787f466_periodEndLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_Goodwill_bab8ba06-5e06-43cc-88dd-ae459ce39a3f_terseLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_Goodwill_label_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Goodwill" xlink:to="lab_us-gaap_Goodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_cah_DeferredIncomeTaxesandOtherLiabilitiesMember_502072c8-02b5-4f68-a842-caf1c32c532b_terseLabel_en-US" xlink:label="lab_cah_DeferredIncomeTaxesandOtherLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Taxes and Other Liabilities</link:label>
    <link:label id="lab_cah_DeferredIncomeTaxesandOtherLiabilitiesMember_label_en-US" xlink:label="lab_cah_DeferredIncomeTaxesandOtherLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Taxes and Other Liabilities [Member]</link:label>
    <link:label id="lab_cah_DeferredIncomeTaxesandOtherLiabilitiesMember_documentation_en-US" xlink:label="lab_cah_DeferredIncomeTaxesandOtherLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Taxes and Other Liabilities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cah_DeferredIncomeTaxesandOtherLiabilitiesMember" xlink:href="cah-20210630.xsd#cah_DeferredIncomeTaxesandOtherLiabilitiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_DeferredIncomeTaxesandOtherLiabilitiesMember" xlink:to="lab_cah_DeferredIncomeTaxesandOtherLiabilitiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MinorityInterest_96821547-098a-40a7-9693-70bdcafd9312_terseLabel_en-US" xlink:label="lab_us-gaap_MinorityInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_MinorityInterest_label_en-US" xlink:label="lab_us-gaap_MinorityInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterest" xlink:to="lab_us-gaap_MinorityInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_cah_LesseeLeaseLiabilityPaymentsDueYearTwo_6ad51dc3-7b5d-462e-8c8d-944d6c583a41_terseLabel_en-US" xlink:label="lab_cah_LesseeLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023</link:label>
    <link:label id="lab_cah_LesseeLeaseLiabilityPaymentsDueYearTwo_label_en-US" xlink:label="lab_cah_LesseeLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee Lease Liability Payments Due Year Two</link:label>
    <link:label id="lab_cah_LesseeLeaseLiabilityPaymentsDueYearTwo_documentation_en-US" xlink:label="lab_cah_LesseeLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee Lease Liability Payments Due Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cah_LesseeLeaseLiabilityPaymentsDueYearTwo" xlink:href="cah-20210630.xsd#cah_LesseeLeaseLiabilityPaymentsDueYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_LesseeLeaseLiabilityPaymentsDueYearTwo" xlink:to="lab_cah_LesseeLeaseLiabilityPaymentsDueYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForwardContractsMember_cbe793ce-eaa6-49c2-8be9-b9d6b3f1d63c_terseLabel_en-US" xlink:label="lab_us-gaap_ForwardContractsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forward Contracts [Member]</link:label>
    <link:label id="lab_us-gaap_ForwardContractsMember_label_en-US" xlink:label="lab_us-gaap_ForwardContractsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forward Contracts [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForwardContractsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForwardContractsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForwardContractsMember" xlink:to="lab_us-gaap_ForwardContractsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTextBlock_ea504b04-8316-470d-9df7-2285ba2f375d_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill by Reportable Segment</link:label>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfGoodwillTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfGoodwillTextBlock" xlink:to="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_03509088-0550-4e8e-bb84-6d6a93c9ed4b_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to reconcile net earnings/(loss) to net cash provided by operating activities:</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTypeAxis_682195f4-141d-4d36-bd75-fbebefcda305_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTypeAxis_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeAxis" xlink:to="lab_us-gaap_SubsequentEventTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock_14c336d6-5f5e-4408-bdd3-d83161cbd66d_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Fair Value of Assets and Liabilities Related to Derivatives Designated as Hedging Instruments</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Derivative Instruments in Statement of Financial Position, Fair Value [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" xlink:to="lab_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_cah_A3.2Notesdue2022Member_01e1f943-e5ba-42be-b43d-bfe740159c2d_terseLabel_en-US" xlink:label="lab_cah_A3.2Notesdue2022Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.2% Notes due 2022</link:label>
    <link:label id="lab_cah_A3.2Notesdue2022Member_label_en-US" xlink:label="lab_cah_A3.2Notesdue2022Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.2% Notes due 2022 [Member]</link:label>
    <link:label id="lab_cah_A3.2Notesdue2022Member_documentation_en-US" xlink:label="lab_cah_A3.2Notesdue2022Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.2% Notes due 2022</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cah_A3.2Notesdue2022Member" xlink:href="cah-20210630.xsd#cah_A3.2Notesdue2022Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_A3.2Notesdue2022Member" xlink:to="lab_cah_A3.2Notesdue2022Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseCost_3d9d3f5b-3a4c-4e4e-89c8-067a703bff35_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Cost</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseCost_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseCost" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseCost" xlink:to="lab_us-gaap_OperatingLeaseCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseAndRentalExpense_482385d2-6879-40c3-b66b-529c75204f3f_terseLabel_en-US" xlink:label="lab_us-gaap_LeaseAndRentalExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Leases, Rent Expense</link:label>
    <link:label id="lab_us-gaap_LeaseAndRentalExpense_label_en-US" xlink:label="lab_us-gaap_LeaseAndRentalExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Leases, Rent Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseAndRentalExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseAndRentalExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseAndRentalExpense" xlink:to="lab_us-gaap_LeaseAndRentalExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_d9e69d11-45f8-4779-a07f-59ee991d46cc_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provision for/(benefit from) deferred income taxes</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_a1349954-30bc-47aa-9d8e-9410870c1bed_totalLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total deferred</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_0667f135-c132-446e-adec-e406a75ceb7e_verboseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Expense (Benefit)</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HedgingDesignationDomain_7e35e579-5456-44eb-976b-9c3bab5a1d38_terseLabel_en-US" xlink:label="lab_us-gaap_HedgingDesignationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Domain]</link:label>
    <link:label id="lab_us-gaap_HedgingDesignationDomain_label_en-US" xlink:label="lab_us-gaap_HedgingDesignationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgingDesignationDomain" xlink:to="lab_us-gaap_HedgingDesignationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1_5f6d7f60-8366-4996-9d54-bb542f15eddc_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Goodwill</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_a13c1dea-84aa-4aaa-9716-cc945a3f6a3c_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provision at Federal statutory rate</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_06d62a99-ccc2-487d-8493-623940e33d10_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLoss_fc887a2b-e629-4103-8a6d-aef8d8d8129e_totalLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net earnings/(loss) attributable to Cardinal Health, Inc.</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_055ffb74-6223-4f29-89dd-0e239def3b82_verboseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Parent</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_label_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLoss" xlink:to="lab_us-gaap_NetIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReceivablesPolicyTextBlock_46fd4d37-c022-4ad4-9503-84b0d8a56585_terseLabel_en-US" xlink:label="lab_us-gaap_ReceivablesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivables</link:label>
    <link:label id="lab_us-gaap_ReceivablesPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ReceivablesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivable [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReceivablesPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReceivablesPolicyTextBlock" xlink:to="lab_us-gaap_ReceivablesPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_68734cf7-e4e2-4401-9258-d8592484962b_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_540af452-ea7e-43b5-ba12-cf739306cec6_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right-of-Use Asset</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right-of-Use Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock_803001d1-34ca-4a57-83bf-092f4b5a0390_terseLabel_en-US" xlink:label="lab_us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Employee Severance</link:label>
    <link:label id="lab_us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Costs Associated with Exit or Disposal Activities or Restructurings, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock" xlink:to="lab_us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_cah_Sharesthatwouldbeantidilutiveasaresultofnetloss_910915ca-9889-42df-9a3d-908d34ae82c2_terseLabel_en-US" xlink:label="lab_cah_Sharesthatwouldbeantidilutiveasaresultofnetloss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">shares that would be antidilutive as a result of net loss</link:label>
    <link:label id="lab_cah_Sharesthatwouldbeantidilutiveasaresultofnetloss_label_en-US" xlink:label="lab_cah_Sharesthatwouldbeantidilutiveasaresultofnetloss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">shares that would be antidilutive as a result of net loss</link:label>
    <link:label id="lab_cah_Sharesthatwouldbeantidilutiveasaresultofnetloss_documentation_en-US" xlink:label="lab_cah_Sharesthatwouldbeantidilutiveasaresultofnetloss" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">shares that would be antidilutive as a result of net loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cah_Sharesthatwouldbeantidilutiveasaresultofnetloss" xlink:href="cah-20210630.xsd#cah_Sharesthatwouldbeantidilutiveasaresultofnetloss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_Sharesthatwouldbeantidilutiveasaresultofnetloss" xlink:to="lab_cah_Sharesthatwouldbeantidilutiveasaresultofnetloss" xlink:type="arc" order="1"/>
    <link:label id="lab_cah_LesseeLeaseLiabilityPaymentsDueYearFour_e6bce935-3b7e-43ad-b2be-b04601c9361a_terseLabel_en-US" xlink:label="lab_cah_LesseeLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025</link:label>
    <link:label id="lab_cah_LesseeLeaseLiabilityPaymentsDueYearFour_label_en-US" xlink:label="lab_cah_LesseeLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee Lease Liability Payments Due Year Four</link:label>
    <link:label id="lab_cah_LesseeLeaseLiabilityPaymentsDueYearFour_documentation_en-US" xlink:label="lab_cah_LesseeLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee Lease Liability Payments Due Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cah_LesseeLeaseLiabilityPaymentsDueYearFour" xlink:href="cah-20210630.xsd#cah_LesseeLeaseLiabilityPaymentsDueYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_LesseeLeaseLiabilityPaymentsDueYearFour" xlink:to="lab_cah_LesseeLeaseLiabilityPaymentsDueYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_7ea06d41-8cd4-442e-99cc-52545ca18a39_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationAxis" xlink:to="lab_us-gaap_IncomeStatementLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_894274a9-d199-445b-83f6-7bec6574fadb_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Amortization</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Accumulated Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeMember_759d90cc-9b8f-4005-be1d-1ba10e661206_terseLabel_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:label id="lab_srt_RangeMember_label_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeMember" xlink:to="lab_srt_RangeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_92ae5cd8-f198-4dda-8323-acefeaad159b_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_cah_PharmaceuticalMember_82ab4321-b7e9-48a9-aed4-2194cdf47f0d_terseLabel_en-US" xlink:label="lab_cah_PharmaceuticalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pharmaceutical</link:label>
    <link:label id="lab_cah_PharmaceuticalMember_label_en-US" xlink:label="lab_cah_PharmaceuticalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pharmaceutical Member</link:label>
    <link:label id="lab_cah_PharmaceuticalMember_documentation_en-US" xlink:label="lab_cah_PharmaceuticalMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pharmaceutical [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cah_PharmaceuticalMember" xlink:href="cah-20210630.xsd#cah_PharmaceuticalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_PharmaceuticalMember" xlink:to="lab_cah_PharmaceuticalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax_4233c6f3-8ce4-4dd5-bb33-da9f62cbafb2_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net unrealized gain/(loss) on derivative instruments, net of tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Derivatives Qualifying as Hedges, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration_b35e7166-069e-40d1-89e0-e24bc797b13f_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Consideration</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Consideration</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFilerCategory_92a5455b-047e-49ab-996a-c8eaeb69dd79_terseLabel_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:label id="lab_dei_EntityFilerCategory_label_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFilerCategory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFilerCategory" xlink:to="lab_dei_EntityFilerCategory" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringCostAndReserveAxis_fe468567-5855-4cac-a8d1-3ed21e409a02_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Type [Axis]</link:label>
    <link:label id="lab_us-gaap_RestructuringCostAndReserveAxis_label_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCostAndReserveAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis" xlink:to="lab_us-gaap_RestructuringCostAndReserveAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_1cad6e4d-4d13-40dc-a094-80225a206233_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsNoncurrent" xlink:to="lab_us-gaap_OtherAssetsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_27853e19-8006-4ec2-a5e4-1e7786646c04_terseLabel_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_2e3c16d4-07da-4280-ab3b-7f0f88c7766c_verboseLabel_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating and Reportable Segment</link:label>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:to="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_cah_VestingPeriodinyearsforShares_41456ff2-fb81-477b-b5a6-80cbb74572ea_terseLabel_en-US" xlink:label="lab_cah_VestingPeriodinyearsforShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vesting Period in years for Shares</link:label>
    <link:label id="lab_cah_VestingPeriodinyearsforShares_label_en-US" xlink:label="lab_cah_VestingPeriodinyearsforShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vesting Period in years for Shares</link:label>
    <link:label id="lab_cah_VestingPeriodinyearsforShares_documentation_en-US" xlink:label="lab_cah_VestingPeriodinyearsforShares" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vesting Period in years for Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cah_VestingPeriodinyearsforShares" xlink:href="cah-20210630.xsd#cah_VestingPeriodinyearsforShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_VestingPeriodinyearsforShares" xlink:to="lab_cah_VestingPeriodinyearsforShares" xlink:type="arc" order="1"/>
    <link:label id="lab_cah_ProductLiabilityLawsuitsMember_c1d63e7e-a0e2-426e-a45e-a02f319fb2bd_terseLabel_en-US" xlink:label="lab_cah_ProductLiabilityLawsuitsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product Liability Lawsuits</link:label>
    <link:label id="lab_cah_ProductLiabilityLawsuitsMember_label_en-US" xlink:label="lab_cah_ProductLiabilityLawsuitsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product Liability Lawsuits [Member]</link:label>
    <link:label id="lab_cah_ProductLiabilityLawsuitsMember_documentation_en-US" xlink:label="lab_cah_ProductLiabilityLawsuitsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product Liability Lawsuits [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cah_ProductLiabilityLawsuitsMember" xlink:href="cah-20210630.xsd#cah_ProductLiabilityLawsuitsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_ProductLiabilityLawsuitsMember" xlink:to="lab_cah_ProductLiabilityLawsuitsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract_1517b06d-901c-4665-8442-c4f5ae74d97f_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common shares, without par value:</link:label>
    <link:label id="lab_us-gaap_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Number of Shares, Par Value and Other Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract" xlink:to="lab_us-gaap_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAndOtherLiabilitiesNoncurrent_d3a525f9-394a-4d34-af42-dc890f0a588e_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAndOtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income taxes and other liabilities</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAndOtherLiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAndOtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax and Other Liabilities, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAndOtherLiabilitiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAndOtherLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAndOtherLiabilitiesNoncurrent" xlink:to="lab_us-gaap_DeferredTaxAndOtherLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_cah_GoodsandservicessoldTable_bca4bac9-3142-4f18-a388-4424fce9958f_terseLabel_en-US" xlink:label="lab_cah_GoodsandservicessoldTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Distribution, selling, general and administrative expenses [Table]</link:label>
    <link:label id="lab_cah_GoodsandservicessoldTable_label_en-US" xlink:label="lab_cah_GoodsandservicessoldTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">goods and services sold [Table]</link:label>
    <link:label id="lab_cah_GoodsandservicessoldTable_documentation_en-US" xlink:label="lab_cah_GoodsandservicessoldTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">goods and services sold [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cah_GoodsandservicessoldTable" xlink:href="cah-20210630.xsd#cah_GoodsandservicessoldTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_GoodsandservicessoldTable" xlink:to="lab_cah_GoodsandservicessoldTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_b350a872-92f7-48f9-8c32-ad5f222e77d7_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Canceled and forfeited (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ValuationAndQualifyingAccountsDisclosureLineItems_07b4523f-a3e4-44af-8c61-37215ab02c02_terseLabel_en-US" xlink:label="lab_srt_ValuationAndQualifyingAccountsDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Line Items]</link:label>
    <link:label id="lab_srt_ValuationAndQualifyingAccountsDisclosureLineItems_label_en-US" xlink:label="lab_srt_ValuationAndQualifyingAccountsDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ValuationAndQualifyingAccountsDisclosureLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems" xlink:to="lab_srt_ValuationAndQualifyingAccountsDisclosureLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_cah_NumberofStateAttorneysGeneralfilinglawsuits_d28c2bcd-8a1c-480a-87a8-efd51190cf58_terseLabel_en-US" xlink:label="lab_cah_NumberofStateAttorneysGeneralfilinglawsuits" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of State Attorneys General filing lawsuits</link:label>
    <link:label id="lab_cah_NumberofStateAttorneysGeneralfilinglawsuits_label_en-US" xlink:label="lab_cah_NumberofStateAttorneysGeneralfilinglawsuits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of State Attorneys General filing lawsuits</link:label>
    <link:label id="lab_cah_NumberofStateAttorneysGeneralfilinglawsuits_documentation_en-US" xlink:label="lab_cah_NumberofStateAttorneysGeneralfilinglawsuits" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of State Attorneys General filing lawsuits</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cah_NumberofStateAttorneysGeneralfilinglawsuits" xlink:href="cah-20210630.xsd#cah_NumberofStateAttorneysGeneralfilinglawsuits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_NumberofStateAttorneysGeneralfilinglawsuits" xlink:to="lab_cah_NumberofStateAttorneysGeneralfilinglawsuits" xlink:type="arc" order="1"/>
    <link:label id="lab_cah_CordisDivestitureDomain_45a9c45e-75d8-4469-8e21-5eb25acd3bd4_terseLabel_en-US" xlink:label="lab_cah_CordisDivestitureDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cordis Divestiture [Domain]</link:label>
    <link:label id="lab_cah_CordisDivestitureDomain_label_en-US" xlink:label="lab_cah_CordisDivestitureDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cordis Divestiture [Domain]</link:label>
    <link:label id="lab_cah_CordisDivestitureDomain_documentation_en-US" xlink:label="lab_cah_CordisDivestitureDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cordis Divestiture [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cah_CordisDivestitureDomain" xlink:href="cah-20210630.xsd#cah_CordisDivestitureDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_CordisDivestitureDomain" xlink:to="lab_cah_CordisDivestitureDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LitigationSettlementExpense_e190eee5-063b-4878-82d5-6bfcf1a002d1_terseLabel_en-US" xlink:label="lab_us-gaap_LitigationSettlementExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Settlement, Expense</link:label>
    <link:label id="lab_us-gaap_LitigationSettlementExpense_label_en-US" xlink:label="lab_us-gaap_LitigationSettlementExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Settlement, Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationSettlementExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LitigationSettlementExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LitigationSettlementExpense" xlink:to="lab_us-gaap_LitigationSettlementExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable_bd8576f6-85ff-4212-96d1-f2d9c848133f_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Revenue by Major Customers, by Reporting Segments [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Revenue by Major Customers, by Reporting Segments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable" xlink:to="lab_us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableLeaseCost_56c1bc2b-1ac5-4349-a139-dae471e7771f_terseLabel_en-US" xlink:label="lab_us-gaap_VariableLeaseCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable lease cost</link:label>
    <link:label id="lab_us-gaap_VariableLeaseCost_label_en-US" xlink:label="lab_us-gaap_VariableLeaseCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Lease, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableLeaseCost" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableLeaseCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableLeaseCost" xlink:to="lab_us-gaap_VariableLeaseCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations_bec5aceb-ef25-4f9b-a61d-4442994c53cd_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term obligations, less current portion</link:label>
    <link:label id="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations_label_en-US" xlink:label="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt and Lease Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:to="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:type="arc" order="1"/>
    <link:label id="lab_cah_NuclearPrecisionHealthServicesMember_410813d1-44d6-498e-8108-3728d49ddd00_terseLabel_en-US" xlink:label="lab_cah_NuclearPrecisionHealthServicesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nuclear Precision Health Services [Member]</link:label>
    <link:label id="lab_cah_NuclearPrecisionHealthServicesMember_label_en-US" xlink:label="lab_cah_NuclearPrecisionHealthServicesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nuclear Precision Health Services [Member]</link:label>
    <link:label id="lab_cah_NuclearPrecisionHealthServicesMember_documentation_en-US" xlink:label="lab_cah_NuclearPrecisionHealthServicesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nuclear Precision Health Services [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cah_NuclearPrecisionHealthServicesMember" xlink:href="cah-20210630.xsd#cah_NuclearPrecisionHealthServicesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_NuclearPrecisionHealthServicesMember" xlink:to="lab_cah_NuclearPrecisionHealthServicesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByLiabilityClassAxis_f937cbae-f1da-49ee-9f06-0d0fc724b7d5_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByLiabilityClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability Class [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByLiabilityClassAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByLiabilityClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability Class [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByLiabilityClassAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByLiabilityClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis" xlink:to="lab_us-gaap_FairValueByLiabilityClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_cah_FloatingRateNotes2616NotesMember_cb6d1b89-573f-4343-902d-3a71dede0a4e_terseLabel_en-US" xlink:label="lab_cah_FloatingRateNotes2616NotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Floating rate notes, 2.616% Notes</link:label>
    <link:label id="lab_cah_FloatingRateNotes2616NotesMember_label_en-US" xlink:label="lab_cah_FloatingRateNotes2616NotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Floating rate notes, 2.616% Notes [Member]</link:label>
    <link:label id="lab_cah_FloatingRateNotes2616NotesMember_documentation_en-US" xlink:label="lab_cah_FloatingRateNotes2616NotesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Floating rate notes, 2.616% Notes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cah_FloatingRateNotes2616NotesMember" xlink:href="cah-20210630.xsd#cah_FloatingRateNotes2616NotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_FloatingRateNotes2616NotesMember" xlink:to="lab_cah_FloatingRateNotes2616NotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_d7f38062-7687-4772-8b5a-767e762e2f0b_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total fair value of shares vested during the year</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_1a25ea02-f438-4545-890d-2adf92cf9104_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted (in usd per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_9c9faa63-92f3-40af-879b-a516d7496394_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Name [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_label_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:to="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet_1d623f3f-2356-4092-b64b-265bfde1407d_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain/(loss) recognized in earnings for economic (non-designated) derivative instruments</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments Not Designated as Hedging Instruments, Gain (Loss), Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" xlink:to="lab_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" xlink:type="arc" order="1"/>
    <link:label id="lab_cah_AwardsOtherThanStockOptionsMember_a5a61a27-4fd0-4719-af97-20482904cdf6_terseLabel_en-US" xlink:label="lab_cah_AwardsOtherThanStockOptionsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Awards Other than Stock Options</link:label>
    <link:label id="lab_cah_AwardsOtherThanStockOptionsMember_label_en-US" xlink:label="lab_cah_AwardsOtherThanStockOptionsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Awards Other than Stock Options [Member]</link:label>
    <link:label id="lab_cah_AwardsOtherThanStockOptionsMember_documentation_en-US" xlink:label="lab_cah_AwardsOtherThanStockOptionsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Awards Other than Stock Options [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cah_AwardsOtherThanStockOptionsMember" xlink:href="cah-20210630.xsd#cah_AwardsOtherThanStockOptionsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_AwardsOtherThanStockOptionsMember" xlink:to="lab_cah_AwardsOtherThanStockOptionsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditFacilityDomain_bdd612f7-a89d-4615-aa1d-1a75743e6349_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityDomain_label_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityDomain" xlink:to="lab_us-gaap_CreditFacilityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsAbstract_b3230594-438f-47f0-bf2c-8d219d0e2167_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:label id="lab_us-gaap_AssetsAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsAbstract" xlink:to="lab_us-gaap_AssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsegmentsAxis_824f3fd3-1dbc-473a-a2b2-6375c96ef6cb_terseLabel_en-US" xlink:label="lab_us-gaap_SubsegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsegments [Axis]</link:label>
    <link:label id="lab_us-gaap_SubsegmentsAxis_label_en-US" xlink:label="lab_us-gaap_SubsegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsegments [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsegmentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsegmentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsegmentsAxis" xlink:to="lab_us-gaap_SubsegmentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_4e5e4490-dc09-4b94-b68a-ae78e88acfca_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maturities of existing long-term obligations and other short-term borrowings-2022</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_18378a7e-475c-463c-ad38-bafde640429c_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated goodwill impairment loss</link:label>
    <link:label id="lab_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_label_en-US" xlink:label="lab_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Impaired, Accumulated Impairment Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillImpairedAccumulatedImpairmentLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss" xlink:to="lab_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_cah_SterileSurgicalGownRecallAxis_ab418b2a-c5a7-480e-98f5-0e6678baff00_terseLabel_en-US" xlink:label="lab_cah_SterileSurgicalGownRecallAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sterile Surgical Gown Recall [Axis]</link:label>
    <link:label id="lab_cah_SterileSurgicalGownRecallAxis_label_en-US" xlink:label="lab_cah_SterileSurgicalGownRecallAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sterile Surgical Gown Recall [Axis]</link:label>
    <link:label id="lab_cah_SterileSurgicalGownRecallAxis_documentation_en-US" xlink:label="lab_cah_SterileSurgicalGownRecallAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sterile Surgical Gown Recall</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cah_SterileSurgicalGownRecallAxis" xlink:href="cah-20210630.xsd#cah_SterileSurgicalGownRecallAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_SterileSurgicalGownRecallAxis" xlink:to="lab_cah_SterileSurgicalGownRecallAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesMember_ead7fc34-dc02-4ee7-b599-df65d373b69e_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesMember_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesMember" xlink:to="lab_us-gaap_OtherLiabilitiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability_772cad05-e6c0-4fba-b219-f11452abea7a_terseLabel_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-Use Asset Obtained in Exchange for Finance Lease Liability</link:label>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability_label_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-Use Asset Obtained in Exchange for Finance Lease Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" xlink:to="lab_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_da53c070-c6fc-4a43-9fb8-31eab7d4e3ed_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringCosts_f0acb400-da2a-4726-9a6c-72e5b174d16d_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additions</link:label>
    <link:label id="lab_us-gaap_RestructuringCosts_label_en-US" xlink:label="lab_us-gaap_RestructuringCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringCosts" xlink:to="lab_us-gaap_RestructuringCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_cah_CVSCaremarkCorporationMember_5db366b4-3d69-4753-b351-19836e8fc599_terseLabel_en-US" xlink:label="lab_cah_CVSCaremarkCorporationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CVS Health</link:label>
    <link:label id="lab_cah_CVSCaremarkCorporationMember_label_en-US" xlink:label="lab_cah_CVSCaremarkCorporationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CVS Caremark Corporation [Member]</link:label>
    <link:label id="lab_cah_CVSCaremarkCorporationMember_documentation_en-US" xlink:label="lab_cah_CVSCaremarkCorporationMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CVS Caremark Corporation [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cah_CVSCaremarkCorporationMember" xlink:href="cah-20210630.xsd#cah_CVSCaremarkCorporationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_CVSCaremarkCorporationMember" xlink:to="lab_cah_CVSCaremarkCorporationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_IcfrAuditorAttestationFlag_d55b1dcb-efdd-4a08-be59-67e178649701_terseLabel_en-US" xlink:label="lab_dei_IcfrAuditorAttestationFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ICFR Auditor Attestation Flag</link:label>
    <link:label id="lab_dei_IcfrAuditorAttestationFlag_label_en-US" xlink:label="lab_dei_IcfrAuditorAttestationFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ICFR Auditor Attestation Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_IcfrAuditorAttestationFlag" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_IcfrAuditorAttestationFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_IcfrAuditorAttestationFlag" xlink:to="lab_dei_IcfrAuditorAttestationFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_cah_GownRecallDomain_d8bd4424-f1cb-473b-aa47-3412550fa8cf_terseLabel_en-US" xlink:label="lab_cah_GownRecallDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gown Recall [Domain]</link:label>
    <link:label id="lab_cah_GownRecallDomain_label_en-US" xlink:label="lab_cah_GownRecallDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gown Recall [Domain]</link:label>
    <link:label id="lab_cah_GownRecallDomain_documentation_en-US" xlink:label="lab_cah_GownRecallDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">[Domain] for Gown Recall [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cah_GownRecallDomain" xlink:href="cah-20210630.xsd#cah_GownRecallDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_GownRecallDomain" xlink:to="lab_cah_GownRecallDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_53f32a63-daa7-4cad-a43d-86b6946fc77f_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Other Intangible Assets</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskPercentage1_08a411f7-ae60-4532-a497-08969ace1cbb_verboseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskPercentage1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percent of Revenue</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskPercentage1_1e9825ff-e1cd-41ee-b880-35b429a75563_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskPercentage1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, major customer, percentage</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskPercentage1_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskPercentage1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskPercentage1" xlink:to="lab_us-gaap_ConcentrationRiskPercentage1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_5a2e2b79-6967-4afa-b3ea-73dbd8f59e67_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property and Equipment</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_cah_CommittedReceivablesSalesFacilityProgramMember_d960f038-0ec0-4cba-af79-679e39648d22_terseLabel_en-US" xlink:label="lab_cah_CommittedReceivablesSalesFacilityProgramMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Committed Receivables Sales Facility Program</link:label>
    <link:label id="lab_cah_CommittedReceivablesSalesFacilityProgramMember_label_en-US" xlink:label="lab_cah_CommittedReceivablesSalesFacilityProgramMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Committed Receivables Sales Facility Program [Member]</link:label>
    <link:label id="lab_cah_CommittedReceivablesSalesFacilityProgramMember_documentation_en-US" xlink:label="lab_cah_CommittedReceivablesSalesFacilityProgramMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Committed receivables sales facility program that exists largely to provide liquidity by selling interests in trade receivables.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cah_CommittedReceivablesSalesFacilityProgramMember" xlink:href="cah-20210630.xsd#cah_CommittedReceivablesSalesFacilityProgramMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_CommittedReceivablesSalesFacilityProgramMember" xlink:to="lab_cah_CommittedReceivablesSalesFacilityProgramMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_400df65a-044f-4be7-ac0c-766dfc93ccc3_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding at beginning of period (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_1b3c635e-cac7-44f0-bd83-a17a6c51c6c6_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding at end of period (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_f050dde5-8abf-44ad-893a-da8fa0f7297e_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_34ca6b1b-f6dc-474c-9563-ef0068609477_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentAxis" xlink:to="lab_us-gaap_DebtInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_cah_A3.079Notesdue2024Member_5ef33ac2-dafc-4d61-a6c8-18241cb27df5_terseLabel_en-US" xlink:label="lab_cah_A3.079Notesdue2024Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.079% Notes due fiscal 2024</link:label>
    <link:label id="lab_cah_A3.079Notesdue2024Member_label_en-US" xlink:label="lab_cah_A3.079Notesdue2024Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.079% Notes due 2024 [Member]</link:label>
    <link:label id="lab_cah_A3.079Notesdue2024Member_documentation_en-US" xlink:label="lab_cah_A3.079Notesdue2024Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.079% Notes due 2024</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cah_A3.079Notesdue2024Member" xlink:href="cah-20210630.xsd#cah_A3.079Notesdue2024Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_A3.079Notesdue2024Member" xlink:to="lab_cah_A3.079Notesdue2024Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccruedLiabilities_9e1aa9d3-ccd5-49d3-9528-7b5b937adf6e_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Accrued Liabilities</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccruedLiabilities_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Accrued Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccruedLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationAccruedLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccruedLiabilities" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccruedLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_b1045dfc-daa1-4d45-950a-7e85f5310292_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments, Contingent Liabilities and Litigation</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_cah_DOJInvestigationMember_b7ca7807-e06e-4bbe-b488-e1ff01bad59b_terseLabel_en-US" xlink:label="lab_cah_DOJInvestigationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">DOJ Investigation</link:label>
    <link:label id="lab_cah_DOJInvestigationMember_label_en-US" xlink:label="lab_cah_DOJInvestigationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">DOJ Investigation [Member]</link:label>
    <link:label id="lab_cah_DOJInvestigationMember_documentation_en-US" xlink:label="lab_cah_DOJInvestigationMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">DOJ Investigation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cah_DOJInvestigationMember" xlink:href="cah-20210630.xsd#cah_DOJInvestigationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_DOJInvestigationMember" xlink:to="lab_cah_DOJInvestigationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock_479eccd1-12ec-440a-b3e3-a87e0a23ea53_terseLabel_en-US" xlink:label="lab_us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property and Equipment, Net by Geographic Area</link:label>
    <link:label id="lab_us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock_label_en-US" xlink:label="lab_us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-lived Assets by Geographic Areas [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock" xlink:to="lab_us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_cah_Netproceedstaxwithholdingsfromsharebasedcompensation_5ac9a43a-c370-4957-99f5-44f266e33caa_terseLabel_en-US" xlink:label="lab_cah_Netproceedstaxwithholdingsfromsharebasedcompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net tax proceeds/(withholding) from share-based compensation</link:label>
    <link:label id="lab_cah_Netproceedstaxwithholdingsfromsharebasedcompensation_5681c05b-6256-4406-a6c5-087c3dd9fa7a_verboseLabel_en-US" xlink:label="lab_cah_Netproceedstaxwithholdingsfromsharebasedcompensation" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net proceeds/(withholding) from share-based compensation</link:label>
    <link:label id="lab_cah_Netproceedstaxwithholdingsfromsharebasedcompensation_label_en-US" xlink:label="lab_cah_Netproceedstaxwithholdingsfromsharebasedcompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net proceeds/(tax withholdings) from share-based compensation</link:label>
    <link:label id="lab_cah_Netproceedstaxwithholdingsfromsharebasedcompensation_documentation_en-US" xlink:label="lab_cah_Netproceedstaxwithholdingsfromsharebasedcompensation" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The net cash inflow/(outflow) associated with the amount received from holders exercising their stock options and paid by the company to satisfy an employee's income tax withholding obligation when shares are withheld from settlement of a share-based award to cover taxes. This item inherently excludes any excess tax benefit, which the entity may have realized and reported separately.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cah_Netproceedstaxwithholdingsfromsharebasedcompensation" xlink:href="cah-20210630.xsd#cah_Netproceedstaxwithholdingsfromsharebasedcompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_Netproceedstaxwithholdingsfromsharebasedcompensation" xlink:to="lab_cah_Netproceedstaxwithholdingsfromsharebasedcompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_74f4c69d-fe89-406a-b95c-bb01850bfbbb_terseLabel_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-Use Asset Obtained in Exchange for Operating Lease Liability</link:label>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_label_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-Use Asset Obtained in Exchange for Operating Lease Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:to="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_46f5ff1d-379c-4066-bc82-246649469a85_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Deferred Tax Assets and Liabilities</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Deferred Tax Assets and Liabilities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_cah_PlaintiffTypeDomain_d80d9629-5393-4a19-98b6-e114d98b4e06_terseLabel_en-US" xlink:label="lab_cah_PlaintiffTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plaintiff Type [Domain]</link:label>
    <link:label id="lab_cah_PlaintiffTypeDomain_label_en-US" xlink:label="lab_cah_PlaintiffTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plaintiff Type [Domain]</link:label>
    <link:label id="lab_cah_PlaintiffTypeDomain_documentation_en-US" xlink:label="lab_cah_PlaintiffTypeDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">[Domain] for Plaintiff Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cah_PlaintiffTypeDomain" xlink:href="cah-20210630.xsd#cah_PlaintiffTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_PlaintiffTypeDomain" xlink:to="lab_cah_PlaintiffTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_1cc4152f-bb3b-4372-85ad-ad83d8216754_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Target performance goal (as a percent)</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_62e1fef7-7475-443c-aca0-656b83a272fa_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_317f764e-98cb-46f7-8079-5b6442072de4_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:to="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_cah_LesseeFinanceLeaseLiabilityNotYetCommencedAmount_3e0f1d9e-03f7-4523-bc44-79ecd520c0e3_terseLabel_en-US" xlink:label="lab_cah_LesseeFinanceLeaseLiabilityNotYetCommencedAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: leases not yet commenced (1)</link:label>
    <link:label id="lab_cah_LesseeFinanceLeaseLiabilityNotYetCommencedAmount_label_en-US" xlink:label="lab_cah_LesseeFinanceLeaseLiabilityNotYetCommencedAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee Finance Lease Liability Not Yet Commenced, Amount</link:label>
    <link:label id="lab_cah_LesseeFinanceLeaseLiabilityNotYetCommencedAmount_documentation_en-US" xlink:label="lab_cah_LesseeFinanceLeaseLiabilityNotYetCommencedAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee Finance Lease Liability Not Yet Commenced, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cah_LesseeFinanceLeaseLiabilityNotYetCommencedAmount" xlink:href="cah-20210630.xsd#cah_LesseeFinanceLeaseLiabilityNotYetCommencedAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_LesseeFinanceLeaseLiabilityNotYetCommencedAmount" xlink:to="lab_cah_LesseeFinanceLeaseLiabilityNotYetCommencedAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_069d489d-b783-4b94-bab7-8e459bbd651b_terseLabel_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_label_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInteractiveDataCurrent" xlink:to="lab_dei_EntityInteractiveDataCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TaxCreditCarryforwardTable_9107070b-268d-49d5-ad8d-2532299eb54e_terseLabel_en-US" xlink:label="lab_us-gaap_TaxCreditCarryforwardTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes</link:label>
    <link:label id="lab_us-gaap_TaxCreditCarryforwardTable_label_en-US" xlink:label="lab_us-gaap_TaxCreditCarryforwardTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Credit Carryforward [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxCreditCarryforwardTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TaxCreditCarryforwardTable" xlink:to="lab_us-gaap_TaxCreditCarryforwardTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NumberOfOperatingSegments_18541309-4a90-44cd-b6e7-a1f92a23b5e1_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfOperatingSegments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Operating Segments</link:label>
    <link:label id="lab_us-gaap_NumberOfOperatingSegments_label_en-US" xlink:label="lab_us-gaap_NumberOfOperatingSegments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Operating Segments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfOperatingSegments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfOperatingSegments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfOperatingSegments" xlink:to="lab_us-gaap_NumberOfOperatingSegments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_e82495ba-02b6-41c6-8fe0-3812760beb73_terseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_label_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_0fd68b36-5135-4e3c-a623-4a195edd34c1_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_cah_OperatingLeaseImputedInterest_8f3a6a5c-47d6-4432-8ffa-13877540ae09_terseLabel_en-US" xlink:label="lab_cah_OperatingLeaseImputedInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: imputed interest</link:label>
    <link:label id="lab_cah_OperatingLeaseImputedInterest_label_en-US" xlink:label="lab_cah_OperatingLeaseImputedInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease Imputed Interest</link:label>
    <link:label id="lab_cah_OperatingLeaseImputedInterest_documentation_en-US" xlink:label="lab_cah_OperatingLeaseImputedInterest" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease Imputed Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cah_OperatingLeaseImputedInterest" xlink:href="cah-20210630.xsd#cah_OperatingLeaseImputedInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_OperatingLeaseImputedInterest" xlink:to="lab_cah_OperatingLeaseImputedInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllowanceForCreditLossMember_eb0891d2-5b56-4b03-9786-404a04cd551f_terseLabel_en-US" xlink:label="lab_us-gaap_AllowanceForCreditLossMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Allowance, Credit Loss [Member]</link:label>
    <link:label id="lab_us-gaap_AllowanceForCreditLossMember_label_en-US" xlink:label="lab_us-gaap_AllowanceForCreditLossMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Allowance, Credit Loss [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForCreditLossMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllowanceForCreditLossMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForCreditLossMember" xlink:to="lab_us-gaap_AllowanceForCreditLossMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cah_OfferAsPercentageOfPrincipalAmount_064b905a-a620-4b77-b9c2-e20256ab7acb_terseLabel_en-US" xlink:label="lab_cah_OfferAsPercentageOfPrincipalAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Offer as percentage of principal amount</link:label>
    <link:label id="lab_cah_OfferAsPercentageOfPrincipalAmount_label_en-US" xlink:label="lab_cah_OfferAsPercentageOfPrincipalAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Offer As Percentage Of Principal Amount</link:label>
    <link:label id="lab_cah_OfferAsPercentageOfPrincipalAmount_documentation_en-US" xlink:label="lab_cah_OfferAsPercentageOfPrincipalAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of principal amount that the company is required to offer to purchase certain notes, under certain circumstances.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cah_OfferAsPercentageOfPrincipalAmount" xlink:href="cah-20210630.xsd#cah_OfferAsPercentageOfPrincipalAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_OfferAsPercentageOfPrincipalAmount" xlink:to="lab_cah_OfferAsPercentageOfPrincipalAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesTypeAxis_f1d2dbd4-b61b-4152-84a3-7f130c32fb08_terseLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves Type [Axis]</link:label>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesTypeAxis_label_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationAllowancesAndReservesTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis" xlink:to="lab_us-gaap_ValuationAllowancesAndReservesTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesPolicyTextBlock_44d989e9-bdd8-493a-9a8e-cc8adce78de6_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesPolicyTextBlock" xlink:to="lab_us-gaap_CommitmentsAndContingenciesPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_b78b794e-8895-405f-95b3-22c088f3bca7_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:to="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_749c2021-6ab4-4d50-961b-c041fc498ec6_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maturities of existing long-term obligations and other short-term borrowings-2024</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_cah_LesseeLeaseLiabilityPaymentsDueAfterYearFive_985bb409-b045-43b9-969a-e7dbd78c0480_terseLabel_en-US" xlink:label="lab_cah_LesseeLeaseLiabilityPaymentsDueAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Thereafter</link:label>
    <link:label id="lab_cah_LesseeLeaseLiabilityPaymentsDueAfterYearFive_label_en-US" xlink:label="lab_cah_LesseeLeaseLiabilityPaymentsDueAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee Lease Liability Payments Due After Year Five</link:label>
    <link:label id="lab_cah_LesseeLeaseLiabilityPaymentsDueAfterYearFive_documentation_en-US" xlink:label="lab_cah_LesseeLeaseLiabilityPaymentsDueAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee Lease Liability Payments Due After Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cah_LesseeLeaseLiabilityPaymentsDueAfterYearFive" xlink:href="cah-20210630.xsd#cah_LesseeLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_LesseeLeaseLiabilityPaymentsDueAfterYearFive" xlink:to="lab_cah_LesseeLeaseLiabilityPaymentsDueAfterYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedContributionPlanCostRecognized_664c8533-b042-4b63-988b-680eb455cd19_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanCostRecognized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total expense on employee retirement savings plans</link:label>
    <link:label id="lab_us-gaap_DefinedContributionPlanCostRecognized_label_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanCostRecognized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Contribution Plan, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanCostRecognized" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedContributionPlanCostRecognized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedContributionPlanCostRecognized" xlink:to="lab_us-gaap_DefinedContributionPlanCostRecognized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShippingAndHandlingMember_b0138e15-51f7-44c9-8a9b-42b1f52769d5_terseLabel_en-US" xlink:label="lab_us-gaap_ShippingAndHandlingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shipping and Handling [Member]</link:label>
    <link:label id="lab_us-gaap_ShippingAndHandlingMember_label_en-US" xlink:label="lab_us-gaap_ShippingAndHandlingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shipping and Handling [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShippingAndHandlingMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShippingAndHandlingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShippingAndHandlingMember" xlink:to="lab_us-gaap_ShippingAndHandlingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_c6587343-2766-46aa-b42c-791dfe324c12_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Share Units</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_3b40c4cb-5498-445e-917c-f0af4da80805_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance Share Units</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_abf6fc66-c0dc-4188-82ce-0c272af32ac6_negatedLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax assets on tax credit carryforwards</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_9a8f8a38-1d39-47c4-b3ba-3f0ce675f694_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss and tax credit carryforwards</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Tax Credit Carryforwards</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwards"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" xlink:to="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" xlink:type="arc" order="1"/>
    <link:label id="lab_cah_A7.0Debenturesduefiscal2027Member_715c7187-cc13-4a0f-9451-b0b167aae8b5_terseLabel_en-US" xlink:label="lab_cah_A7.0Debenturesduefiscal2027Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">7.0%&#160;Debentures due 2026</link:label>
    <link:label id="lab_cah_A7.0Debenturesduefiscal2027Member_label_en-US" xlink:label="lab_cah_A7.0Debenturesduefiscal2027Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">7.0% Debentures due fiscal 2027 [Member]</link:label>
    <link:label id="lab_cah_A7.0Debenturesduefiscal2027Member_documentation_en-US" xlink:label="lab_cah_A7.0Debenturesduefiscal2027Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">7.0% Debentures due fiscal 2027</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cah_A7.0Debenturesduefiscal2027Member" xlink:href="cah-20210630.xsd#cah_A7.0Debenturesduefiscal2027Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_A7.0Debenturesduefiscal2027Member" xlink:to="lab_cah_A7.0Debenturesduefiscal2027Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeasePayments_d5a7a119-70fc-42c2-9a0a-e4a2eb85226b_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeasePayments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Payments</link:label>
    <link:label id="lab_us-gaap_OperatingLeasePayments_label_en-US" xlink:label="lab_us-gaap_OperatingLeasePayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasePayments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeasePayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeasePayments" xlink:to="lab_us-gaap_OperatingLeasePayments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromRepaymentsOfShortTermDebt_da6625e9-3aaa-45c9-a68f-375b9488bf84_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromRepaymentsOfShortTermDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net change in short-term borrowings</link:label>
    <link:label id="lab_us-gaap_ProceedsFromRepaymentsOfShortTermDebt_label_en-US" xlink:label="lab_us-gaap_ProceedsFromRepaymentsOfShortTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from (Repayments of) Short-term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromRepaymentsOfShortTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromRepaymentsOfShortTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromRepaymentsOfShortTermDebt" xlink:to="lab_us-gaap_ProceedsFromRepaymentsOfShortTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_cah_CordisDivestitureMember_dff0f6f9-4358-4e85-a4bb-d4c21b89821f_terseLabel_en-US" xlink:label="lab_cah_CordisDivestitureMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cordis Divestiture</link:label>
    <link:label id="lab_cah_CordisDivestitureMember_label_en-US" xlink:label="lab_cah_CordisDivestitureMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cordis Divestiture [Member]</link:label>
    <link:label id="lab_cah_CordisDivestitureMember_documentation_en-US" xlink:label="lab_cah_CordisDivestitureMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cordis Divestiture</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cah_CordisDivestitureMember" xlink:href="cah-20210630.xsd#cah_CordisDivestitureMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_CordisDivestitureMember" xlink:to="lab_cah_CordisDivestitureMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cah_Proceedsfromsaleofavailableforsalesecuritiesandotherinvestments_d47898a3-fa9a-46ef-bbe3-66344244ec32_terseLabel_en-US" xlink:label="lab_cah_Proceedsfromsaleofavailableforsalesecuritiesandotherinvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from sale of investments</link:label>
    <link:label id="lab_cah_Proceedsfromsaleofavailableforsalesecuritiesandotherinvestments_label_en-US" xlink:label="lab_cah_Proceedsfromsaleofavailableforsalesecuritiesandotherinvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from sale of available-for-sale securities and other investments</link:label>
    <link:label id="lab_cah_Proceedsfromsaleofavailableforsalesecuritiesandotherinvestments_documentation_en-US" xlink:label="lab_cah_Proceedsfromsaleofavailableforsalesecuritiesandotherinvestments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The cash inflow from sales of available-for-sale securities and other investments.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cah_Proceedsfromsaleofavailableforsalesecuritiesandotherinvestments" xlink:href="cah-20210630.xsd#cah_Proceedsfromsaleofavailableforsalesecuritiesandotherinvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_Proceedsfromsaleofavailableforsalesecuritiesandotherinvestments" xlink:to="lab_cah_Proceedsfromsaleofavailableforsalesecuritiesandotherinvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProvisionForDoubtfulAccounts_f37f1171-59e4-41df-ba32-dbbb15fd2339_terseLabel_en-US" xlink:label="lab_us-gaap_ProvisionForDoubtfulAccounts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provision for bad debts</link:label>
    <link:label id="lab_us-gaap_ProvisionForDoubtfulAccounts_label_en-US" xlink:label="lab_us-gaap_ProvisionForDoubtfulAccounts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Credit Loss Expense (Reversal)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProvisionForDoubtfulAccounts" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProvisionForDoubtfulAccounts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProvisionForDoubtfulAccounts" xlink:to="lab_us-gaap_ProvisionForDoubtfulAccounts" xlink:type="arc" order="1"/>
    <link:label id="lab_cah_EffectiveIncomeTaxRateReconciliationLegalEntityReorganizationReconcilingItemsPercent_1e23e314-3245-4083-9d91-e47fc6d76608_terseLabel_en-US" xlink:label="lab_cah_EffectiveIncomeTaxRateReconciliationLegalEntityReorganizationReconcilingItemsPercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation Legal Entity Reorganization Reconciling Items Percent</link:label>
    <link:label id="lab_cah_EffectiveIncomeTaxRateReconciliationLegalEntityReorganizationReconcilingItemsPercent_label_en-US" xlink:label="lab_cah_EffectiveIncomeTaxRateReconciliationLegalEntityReorganizationReconcilingItemsPercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation Legal Entity Reorganization Reconciling Items Percent</link:label>
    <link:label id="lab_cah_EffectiveIncomeTaxRateReconciliationLegalEntityReorganizationReconcilingItemsPercent_documentation_en-US" xlink:label="lab_cah_EffectiveIncomeTaxRateReconciliationLegalEntityReorganizationReconcilingItemsPercent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation Legal Entity Reorganization Reconciling Items Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cah_EffectiveIncomeTaxRateReconciliationLegalEntityReorganizationReconcilingItemsPercent" xlink:href="cah-20210630.xsd#cah_EffectiveIncomeTaxRateReconciliationLegalEntityReorganizationReconcilingItemsPercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_EffectiveIncomeTaxRateReconciliationLegalEntityReorganizationReconcilingItemsPercent" xlink:to="lab_cah_EffectiveIncomeTaxRateReconciliationLegalEntityReorganizationReconcilingItemsPercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillRollForward_383fea5e-8df2-433a-be68-4bf4b6ac00cf_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_GoodwillRollForward_label_en-US" xlink:label="lab_us-gaap_GoodwillRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillRollForward" xlink:to="lab_us-gaap_GoodwillRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAsset_c1262b84-48d1-483c-a324-45b8bade7a86_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Right-of-Use Asset, after Accumulated Amortization</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAsset_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Right-of-Use Asset, after Accumulated Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseRightOfUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseRightOfUseAsset" xlink:to="lab_us-gaap_FinanceLeaseRightOfUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_467e247e-5ae8-4a4d-9780-2e8b4ac251d3_terseLabel_en-US" xlink:label="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_label_en-US" xlink:label="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:to="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_d29f2482-a994-42a2-b1ae-bb17156b9c2c_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value by Liability Class [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_label_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value by Liability Class [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:to="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentTransitionReport_37a477fa-8b76-44f3-886c-453525b2d650_terseLabel_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:label id="lab_dei_DocumentTransitionReport_label_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentTransitionReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentTransitionReport" xlink:to="lab_dei_DocumentTransitionReport" xlink:type="arc" order="1"/>
    <link:label id="lab_cah_GrossTradeReceivablesMajorCustomerPercentage_5b3203f8-1cf3-4c70-9a0a-ee14f012fd0f_terseLabel_en-US" xlink:label="lab_cah_GrossTradeReceivablesMajorCustomerPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percent&#160;of&#160;Gross Trade&#160;Receivables</link:label>
    <link:label id="lab_cah_GrossTradeReceivablesMajorCustomerPercentage_label_en-US" xlink:label="lab_cah_GrossTradeReceivablesMajorCustomerPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Trade Receivables, Major Customer Percentage</link:label>
    <link:label id="lab_cah_GrossTradeReceivablesMajorCustomerPercentage_documentation_en-US" xlink:label="lab_cah_GrossTradeReceivablesMajorCustomerPercentage" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Trade Receivables, Major Customer Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cah_GrossTradeReceivablesMajorCustomerPercentage" xlink:href="cah-20210630.xsd#cah_GrossTradeReceivablesMajorCustomerPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_GrossTradeReceivablesMajorCustomerPercentage" xlink:to="lab_cah_GrossTradeReceivablesMajorCustomerPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_cah_CardinalHealthAtHomeSolutionsMember_79f3e8d6-74fc-46ef-b470-15ad51d7215a_terseLabel_en-US" xlink:label="lab_cah_CardinalHealthAtHomeSolutionsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cardinal Health At Home Solutions [Member]</link:label>
    <link:label id="lab_cah_CardinalHealthAtHomeSolutionsMember_label_en-US" xlink:label="lab_cah_CardinalHealthAtHomeSolutionsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cardinal Health At Home Solutions [Member]</link:label>
    <link:label id="lab_cah_CardinalHealthAtHomeSolutionsMember_documentation_en-US" xlink:label="lab_cah_CardinalHealthAtHomeSolutionsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cardinal Health At Home Solutions [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cah_CardinalHealthAtHomeSolutionsMember" xlink:href="cah-20210630.xsd#cah_CardinalHealthAtHomeSolutionsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_CardinalHealthAtHomeSolutionsMember" xlink:to="lab_cah_CardinalHealthAtHomeSolutionsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_cfe2c38c-66ff-4388-9113-3e79ebf59d97_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities and shareholders&#8217; equity</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAccruedLiabilitiesCurrent_cfdba51c-60de-4865-830f-83fea6ecd709_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other accrued liabilities</link:label>
    <link:label id="lab_us-gaap_OtherAccruedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Accrued Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:to="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_cah_OtherAccruedLiabilitiesPolicyPolicyTextBlock_83037a2c-0ae8-4c10-9815-10c2af90efdc_terseLabel_en-US" xlink:label="lab_cah_OtherAccruedLiabilitiesPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Accrued Liabilities, Policy [Policy Text Block]</link:label>
    <link:label id="lab_cah_OtherAccruedLiabilitiesPolicyPolicyTextBlock_label_en-US" xlink:label="lab_cah_OtherAccruedLiabilitiesPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Accrued Liabilities, Policy [Policy Text Block]</link:label>
    <link:label id="lab_cah_OtherAccruedLiabilitiesPolicyPolicyTextBlock_documentation_en-US" xlink:label="lab_cah_OtherAccruedLiabilitiesPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Accrued Liabilities, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cah_OtherAccruedLiabilitiesPolicyPolicyTextBlock" xlink:href="cah-20210630.xsd#cah_OtherAccruedLiabilitiesPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_OtherAccruedLiabilitiesPolicyPolicyTextBlock" xlink:to="lab_cah_OtherAccruedLiabilitiesPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_2b8d1c67-6973-46d3-a1e5-997c9f0faee8_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2026</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_2e61dff7-24d9-41c2-8ea3-e25eee3b3b88_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercised (in usd per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskLineItems_33a48c57-d7f4-4a71-a9a7-4981464581c8_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk [Line Items]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskLineItems_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskLineItems" xlink:to="lab_us-gaap_ConcentrationRiskLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeLineItems_cb28a17a-0192-422c-9d0e-9d9648ab2467_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Line Items]</link:label>
    <link:label id="lab_us-gaap_DerivativeLineItems_label_en-US" xlink:label="lab_us-gaap_DerivativeLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeLineItems" xlink:to="lab_us-gaap_DerivativeLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringReserveRollForward_7e7ca1b7-9317-4865-835b-52005b7b9308_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserveRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Reserve [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_RestructuringReserveRollForward_label_en-US" xlink:label="lab_us-gaap_RestructuringReserveRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Reserve [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringReserveRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringReserveRollForward" xlink:to="lab_us-gaap_RestructuringReserveRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxContingencyTable_77b66c83-c81c-4c57-b715-7723dfe826e4_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxContingencyTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Contingency [Table]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxContingencyTable_label_en-US" xlink:label="lab_us-gaap_IncomeTaxContingencyTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Contingency [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxContingencyTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxContingencyTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxContingencyTable" xlink:to="lab_us-gaap_IncomeTaxContingencyTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_9ddd22a3-0812-4b3d-b239-9698e10b4f0d_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share Attributable to Cardinal Health, Inc.</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareTextBlock" xlink:to="lab_us-gaap_EarningsPerShareTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockValueAcquiredCostMethod_74996257-cdf5-4a2d-84ff-86616fe6483a_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share repurchase program activity</link:label>
    <link:label id="lab_us-gaap_TreasuryStockValueAcquiredCostMethod_97c79ef1-77ce-47dd-89de-4b4faa170305_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury shares acquired</link:label>
    <link:label id="lab_us-gaap_TreasuryStockValueAcquiredCostMethod_label_en-US" xlink:label="lab_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Value, Acquired, Cost Method</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:to="lab_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_4e8e152c-6edc-48a0-9e9d-a577dd6e390e_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Assets</link:label>
    <link:label id="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_label_en-US" xlink:label="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation" xlink:to="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingExpensesAbstract_bc0a8bdc-de9f-4383-9555-c03f5fb0a790_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating expenses:</link:label>
    <link:label id="lab_us-gaap_OperatingExpensesAbstract_label_en-US" xlink:label="lab_us-gaap_OperatingExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Expenses [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpensesAbstract" xlink:to="lab_us-gaap_OperatingExpensesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockAcquiredAverageCostPerShare_2f6edb44-67e9-4f07-8d0b-e7ead80a0238_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockAcquiredAverageCostPerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury shares acquired, average price per share (in usd per share)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockAcquiredAverageCostPerShare_label_en-US" xlink:label="lab_us-gaap_TreasuryStockAcquiredAverageCostPerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock Acquired, Average Cost Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockAcquiredAverageCostPerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockAcquiredAverageCostPerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockAcquiredAverageCostPerShare" xlink:to="lab_us-gaap_TreasuryStockAcquiredAverageCostPerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MinimumMember_053bd814-92aa-4f9e-8726-241689d9689b_terseLabel_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum</link:label>
    <link:label id="lab_srt_MinimumMember_label_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MinimumMember" xlink:to="lab_srt_MinimumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_f3dbd7f8-d384-4f63-bf8f-1b754d8f4e37_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other accrued liabilities and operating items, net</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Other Operating Assets and Liabilities, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet" xlink:type="arc" order="1"/>
    <link:label id="lab_cah_TotalLeaseLiabilityPaymentsDue_569c3a81-ab8f-4e64-a00a-6a32de7a875d_terseLabel_en-US" xlink:label="lab_cah_TotalLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total future lease payments</link:label>
    <link:label id="lab_cah_TotalLeaseLiabilityPaymentsDue_label_en-US" xlink:label="lab_cah_TotalLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Lease Liability Payments Due</link:label>
    <link:label id="lab_cah_TotalLeaseLiabilityPaymentsDue_documentation_en-US" xlink:label="lab_cah_TotalLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total undiscounted Lease Liability Payments Due for both operating and financing leases</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cah_TotalLeaseLiabilityPaymentsDue" xlink:href="cah-20210630.xsd#cah_TotalLeaseLiabilityPaymentsDue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_TotalLeaseLiabilityPaymentsDue" xlink:to="lab_cah_TotalLeaseLiabilityPaymentsDue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GrossProfit_d3fe0dc9-6d09-4dfd-9ab2-5ba910216a4b_totalLabel_en-US" xlink:label="lab_us-gaap_GrossProfit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross margin</link:label>
    <link:label id="lab_us-gaap_GrossProfit_label_en-US" xlink:label="lab_us-gaap_GrossProfit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Profit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GrossProfit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GrossProfit" xlink:to="lab_us-gaap_GrossProfit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCredit_4ffb764d-442d-4aa2-9db2-011cf4bcdc29_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCredit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Line of Credit</link:label>
    <link:label id="lab_us-gaap_LineOfCredit_e607b77b-2b50-4be0-b4d6-a3fa8287ed8b_verboseLabel_en-US" xlink:label="lab_us-gaap_LineOfCredit" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of credit</link:label>
    <link:label id="lab_us-gaap_LineOfCredit_label_en-US" xlink:label="lab_us-gaap_LineOfCredit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Line of Credit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCredit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCredit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCredit" xlink:to="lab_us-gaap_LineOfCredit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_85ad2fe0-4c10-45ce-b8dd-4c5ad36cc36d_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_c297465c-d263-4d3b-8611-f2c6f79aabfb_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-Lived Assets [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Revenues from External Customers and Long-Lived Assets [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:to="lab_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_34fecbe8-d8f0-4de8-9d0c-35a0e897e43e_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings/(loss) before income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpense_d80164d7-11ec-4f42-b647-a7c14df66415_terseLabel_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Distribution, selling, general and administrative expenses</link:label>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpense_label_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, General and Administrative Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:to="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_dba1224b-39e8-4bc0-a237-06a2d29bf427_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Canceled and forfeited (in usd per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_f4f1fdd1-6ea9-492a-ba3b-e9e5fb10a5de_terseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets [Axis]</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_label_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_eba340f9-0103-4292-9fd8-554128743e9e_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred shares, authorized</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesAuthorized" xlink:to="lab_us-gaap_PreferredStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredGainLossOnDiscontinuationOfInterestRateFairValueHedge_e24df845-82c2-4dd6-a5a0-09cbe0df28da_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredGainLossOnDiscontinuationOfInterestRateFairValueHedge" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Gain (Loss) on Discontinuation of Interest Rate Fair Value Hedge</link:label>
    <link:label id="lab_us-gaap_DeferredGainLossOnDiscontinuationOfInterestRateFairValueHedge_label_en-US" xlink:label="lab_us-gaap_DeferredGainLossOnDiscontinuationOfInterestRateFairValueHedge" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Gain (Loss) on Discontinuation of Interest Rate Fair Value Hedge</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredGainLossOnDiscontinuationOfInterestRateFairValueHedge" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredGainLossOnDiscontinuationOfInterestRateFairValueHedge"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredGainLossOnDiscontinuationOfInterestRateFairValueHedge" xlink:to="lab_us-gaap_DeferredGainLossOnDiscontinuationOfInterestRateFairValueHedge" xlink:type="arc" order="1"/>
    <link:label id="lab_cah_EffectiveTaxRateReconciliationImpactOfResolutionsWithIRSAndOtherRelatedMatters_2f340549-6741-4f92-a125-bbdbd361e55b_terseLabel_en-US" xlink:label="lab_cah_EffectiveTaxRateReconciliationImpactOfResolutionsWithIRSAndOtherRelatedMatters" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">China tax related to divestiture</link:label>
    <link:label id="lab_cah_EffectiveTaxRateReconciliationImpactOfResolutionsWithIRSAndOtherRelatedMatters_label_en-US" xlink:label="lab_cah_EffectiveTaxRateReconciliationImpactOfResolutionsWithIRSAndOtherRelatedMatters" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Tax Rate Reconciliation, Impact of Resolutions with IRS and other related matters</link:label>
    <link:label id="lab_cah_EffectiveTaxRateReconciliationImpactOfResolutionsWithIRSAndOtherRelatedMatters_documentation_en-US" xlink:label="lab_cah_EffectiveTaxRateReconciliationImpactOfResolutionsWithIRSAndOtherRelatedMatters" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Tax Rate Reconciliation, Impact of Resolutions with IRS and other related matters</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cah_EffectiveTaxRateReconciliationImpactOfResolutionsWithIRSAndOtherRelatedMatters" xlink:href="cah-20210630.xsd#cah_EffectiveTaxRateReconciliationImpactOfResolutionsWithIRSAndOtherRelatedMatters"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_EffectiveTaxRateReconciliationImpactOfResolutionsWithIRSAndOtherRelatedMatters" xlink:to="lab_cah_EffectiveTaxRateReconciliationImpactOfResolutionsWithIRSAndOtherRelatedMatters" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable_852483df-3d25-4125-a8e7-91726e7d064a_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Table]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:to="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryLIFOReserve_93fcd480-eee0-4e8e-b83a-2da540612ad0_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryLIFOReserve" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories valued at LIFO amount higher than average cost value</link:label>
    <link:label id="lab_us-gaap_InventoryLIFOReserve_label_en-US" xlink:label="lab_us-gaap_InventoryLIFOReserve" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, LIFO Reserve</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryLIFOReserve" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryLIFOReserve"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryLIFOReserve" xlink:to="lab_us-gaap_InventoryLIFOReserve" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_aab69b84-c141-4d40-aca2-7026fc08efb7_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maturities of existing long-term obligations and other short-term borrowings-2023</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_cah_OptumRxMember_8a051c56-26ab-43fb-a0f8-367137384868_terseLabel_en-US" xlink:label="lab_cah_OptumRxMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OptumRx [Member]</link:label>
    <link:label id="lab_cah_OptumRxMember_label_en-US" xlink:label="lab_cah_OptumRxMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OptumRx [Member]</link:label>
    <link:label id="lab_cah_OptumRxMember_documentation_en-US" xlink:label="lab_cah_OptumRxMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OptumRx [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cah_OptumRxMember" xlink:href="cah-20210630.xsd#cah_OptumRxMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_OptumRxMember" xlink:to="lab_cah_OptumRxMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxesAndOtherTaxLiabilitiesNoncurrent_351a3fc2-f794-47f1-947f-8d2cd9cced11_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxesAndOtherTaxLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Taxes and Other Tax Liabilities, Noncurrent</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxesAndOtherTaxLiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxesAndOtherTaxLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Taxes and Other Tax Liabilities, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxesAndOtherTaxLiabilitiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxesAndOtherTaxLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxesAndOtherTaxLiabilitiesNoncurrent" xlink:to="lab_us-gaap_DeferredIncomeTaxesAndOtherTaxLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueRecognitionPolicyTextBlock_095a45a3-1db0-42ef-ae55-b22b963a1153_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueRecognitionPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue Recognition</link:label>
    <link:label id="lab_us-gaap_RevenueRecognitionPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_RevenueRecognitionPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRecognitionPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRecognitionPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueRecognitionPolicyTextBlock" xlink:to="lab_us-gaap_RevenueRecognitionPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_5a242658-38ff-47ed-bd07-39f7714d1560_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisition of subsidiaries, net of cash acquired</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_bf3cf1fb-4ffc-4d2b-b839-1e34102e088d_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Businesses, Net of Cash Acquired</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Businesses, Net of Cash Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:to="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_a9d1a817-e222-460a-b618-9f2670b5a624_terseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Obligations and Other Short-Term Borrowings</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureTextBlock" xlink:to="lab_us-gaap_DebtDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_56ba86e3-d7fd-41a7-ae30-eb26820062e0_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Components of Income Tax Expense (Benefit), Current and Deferred</link:label>
    <link:label id="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_0245325f-fde4-43be-90bb-0cdf0e46bc42_verboseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation</link:label>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_cah_A3.5Notesdue2025Member_fdb02d1f-5737-46ed-9835-8e980532fdd2_terseLabel_en-US" xlink:label="lab_cah_A3.5Notesdue2025Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.5% Notes due fiscal 2025</link:label>
    <link:label id="lab_cah_A3.5Notesdue2025Member_label_en-US" xlink:label="lab_cah_A3.5Notesdue2025Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.5% Notes due 2025 [Member]</link:label>
    <link:label id="lab_cah_A3.5Notesdue2025Member_documentation_en-US" xlink:label="lab_cah_A3.5Notesdue2025Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.5% Notes due 2025</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cah_A3.5Notesdue2025Member" xlink:href="cah-20210630.xsd#cah_A3.5Notesdue2025Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_A3.5Notesdue2025Member" xlink:to="lab_cah_A3.5Notesdue2025Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_eab78071-bf57-4d87-85f6-4e153668907a_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level&#160;3</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 3 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel3Member" xlink:to="lab_us-gaap_FairValueInputsLevel3Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsOfDividendsCommonStock_06776258-514c-44f6-8ab3-29b9f3f645be_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfDividendsCommonStock" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends on common shares</link:label>
    <link:label id="lab_us-gaap_PaymentsOfDividendsCommonStock_label_en-US" xlink:label="lab_us-gaap_PaymentsOfDividendsCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments of Ordinary Dividends, Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividendsCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfDividendsCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsOfDividendsCommonStock" xlink:to="lab_us-gaap_PaymentsOfDividendsCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NumberOfReportableSegments_8e83f2d3-764f-4e7a-8293-fd9a3eaacfc0_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfReportableSegments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Reportable Segments</link:label>
    <link:label id="lab_us-gaap_NumberOfReportableSegments_label_en-US" xlink:label="lab_us-gaap_NumberOfReportableSegments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Reportable Segments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfReportableSegments" xlink:to="lab_us-gaap_NumberOfReportableSegments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllowanceForLossesOnFinanceReceivablesMember_27caffb4-ac86-4aaa-b46f-014632edf443_verboseLabel_en-US" xlink:label="lab_us-gaap_AllowanceForLossesOnFinanceReceivablesMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Allowance, Loss on Finance Receivable [Member]</link:label>
    <link:label id="lab_us-gaap_AllowanceForLossesOnFinanceReceivablesMember_45f0e7da-3aa5-4073-8cc4-f17bfe66e4ef_terseLabel_en-US" xlink:label="lab_us-gaap_AllowanceForLossesOnFinanceReceivablesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Allowance, Loss on Finance Receivable [Member]</link:label>
    <link:label id="lab_us-gaap_AllowanceForLossesOnFinanceReceivablesMember_label_en-US" xlink:label="lab_us-gaap_AllowanceForLossesOnFinanceReceivablesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Allowance, Loss on Finance Receivable [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForLossesOnFinanceReceivablesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllowanceForLossesOnFinanceReceivablesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForLossesOnFinanceReceivablesMember" xlink:to="lab_us-gaap_AllowanceForLossesOnFinanceReceivablesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cah_PreTaxGainonDivestiture_8d09458b-36ec-4c15-afd2-196df7c98014_terseLabel_en-US" xlink:label="lab_cah_PreTaxGainonDivestiture" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-Tax Gain on Divestiture</link:label>
    <link:label id="lab_cah_PreTaxGainonDivestiture_label_en-US" xlink:label="lab_cah_PreTaxGainonDivestiture" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-Tax Gain on Divestiture</link:label>
    <link:label id="lab_cah_PreTaxGainonDivestiture_documentation_en-US" xlink:label="lab_cah_PreTaxGainonDivestiture" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-Tax Gain on Divestiture</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cah_PreTaxGainonDivestiture" xlink:href="cah-20210630.xsd#cah_PreTaxGainonDivestiture"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_PreTaxGainonDivestiture" xlink:to="lab_cah_PreTaxGainonDivestiture" xlink:type="arc" order="1"/>
    <link:label id="lab_cah_DerivativesHedgeDiscontinuancesHedgingInstrumentMaturedAmount_4e12f0af-4550-42d0-a151-cca8c469d521_terseLabel_en-US" xlink:label="lab_cah_DerivativesHedgeDiscontinuancesHedgingInstrumentMaturedAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives, matured notional amounts</link:label>
    <link:label id="lab_cah_DerivativesHedgeDiscontinuancesHedgingInstrumentMaturedAmount_label_en-US" xlink:label="lab_cah_DerivativesHedgeDiscontinuancesHedgingInstrumentMaturedAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives, Hedge Discontinuances, Hedging Instrument Matured, Amount</link:label>
    <link:label id="lab_cah_DerivativesHedgeDiscontinuancesHedgingInstrumentMaturedAmount_documentation_en-US" xlink:label="lab_cah_DerivativesHedgeDiscontinuancesHedgingInstrumentMaturedAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives, Hedge Discontinuances, Hedging Instrument Matured, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cah_DerivativesHedgeDiscontinuancesHedgingInstrumentMaturedAmount" xlink:href="cah-20210630.xsd#cah_DerivativesHedgeDiscontinuancesHedgingInstrumentMaturedAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_DerivativesHedgeDiscontinuancesHedgingInstrumentMaturedAmount" xlink:to="lab_cah_DerivativesHedgeDiscontinuancesHedgingInstrumentMaturedAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_f21ef4de-ae5b-4e88-bfe8-8d81a1ce3e93_terseLabel_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Presentation</link:label>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Accounting, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:to="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PerformanceSharesMember_bddc837c-0f9a-4ed6-9d51-16cadcb257b0_terseLabel_en-US" xlink:label="lab_us-gaap_PerformanceSharesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance Share Units</link:label>
    <link:label id="lab_us-gaap_PerformanceSharesMember_label_en-US" xlink:label="lab_us-gaap_PerformanceSharesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance Shares [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceSharesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PerformanceSharesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PerformanceSharesMember" xlink:to="lab_us-gaap_PerformanceSharesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_9d7a38a5-4dca-4603-832e-ace954733d84_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated other comprehensive loss</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_cah_EstimatedLiabilityForNewYorkOpioidStewardshipAct_7e4b6477-1918-4ecf-8fad-9f60636b14c8_terseLabel_en-US" xlink:label="lab_cah_EstimatedLiabilityForNewYorkOpioidStewardshipAct" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated Liability for New York Opioid Stewardship Act</link:label>
    <link:label id="lab_cah_EstimatedLiabilityForNewYorkOpioidStewardshipAct_label_en-US" xlink:label="lab_cah_EstimatedLiabilityForNewYorkOpioidStewardshipAct" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated Liability for New York Opioid Stewardship Act</link:label>
    <link:label id="lab_cah_EstimatedLiabilityForNewYorkOpioidStewardshipAct_documentation_en-US" xlink:label="lab_cah_EstimatedLiabilityForNewYorkOpioidStewardshipAct" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated Liability for New York Opioid Stewardship Act</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cah_EstimatedLiabilityForNewYorkOpioidStewardshipAct" xlink:href="cah-20210630.xsd#cah_EstimatedLiabilityForNewYorkOpioidStewardshipAct"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_EstimatedLiabilityForNewYorkOpioidStewardshipAct" xlink:to="lab_cah_EstimatedLiabilityForNewYorkOpioidStewardshipAct" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryWriteDown_c49ecd81-1ac0-4b66-b784-610ef8b79411_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryWriteDown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory Write-down</link:label>
    <link:label id="lab_us-gaap_InventoryWriteDown_label_en-US" xlink:label="lab_us-gaap_InventoryWriteDown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory Write-down</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWriteDown" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryWriteDown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryWriteDown" xlink:to="lab_us-gaap_InventoryWriteDown" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses_839a3306-f20c-40cb-b54f-68cf17fea658_verboseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill impairment</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Nondeductible Expense, Impairment Losses, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_db28d6a1-0e69-458b-b53d-966c76c52e5b_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyClaimsSettledNumber_8b354a1b-5280-4c77-8293-e732442642b9_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyClaimsSettledNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Claims Settled, Number</link:label>
    <link:label id="lab_us-gaap_LossContingencyClaimsSettledNumber_label_en-US" xlink:label="lab_us-gaap_LossContingencyClaimsSettledNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Claims Settled, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyClaimsSettledNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyClaimsSettledNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyClaimsSettledNumber" xlink:to="lab_us-gaap_LossContingencyClaimsSettledNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_31bf1d27-a61d-449b-9759-f81549d89032_terseLabel_en-US" xlink:label="lab_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Assets [Line Items]</link:label>
    <link:label id="lab_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_label_en-US" xlink:label="lab_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues from External Customers and Long-Lived Assets [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:to="lab_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_568557f4-a8d8-4a18-9f06-3a912a1c90dc_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income/(loss), net before reclassifications</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), before Reclassifications, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_485e830c-bb5a-4094-9945-96751be6910f_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_cah_TrademarksAndPatentsMember_2e34254c-0a73-4d49-9244-419eb34deb05_terseLabel_en-US" xlink:label="lab_cah_TrademarksAndPatentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trademarks, trade names and patents</link:label>
    <link:label id="lab_cah_TrademarksAndPatentsMember_label_en-US" xlink:label="lab_cah_TrademarksAndPatentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trademarks And Patents Member</link:label>
    <link:label id="lab_cah_TrademarksAndPatentsMember_documentation_en-US" xlink:label="lab_cah_TrademarksAndPatentsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The rights acquired through registration of a trademark to gain or protect exclusive use of a business name, symbol or other device or style, and the exclusive legal right granted by the government to the owner of the patent to exploit an invention or a process for a period of time specified by law.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cah_TrademarksAndPatentsMember" xlink:href="cah-20210630.xsd#cah_TrademarksAndPatentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_TrademarksAndPatentsMember" xlink:to="lab_cah_TrademarksAndPatentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock_b84a0917-c674-452a-8fb4-f57e6a24db12_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:to="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockShares_0e56e0da-1e73-42ae-95ef-1087c9b325ab_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common shares in treasury</link:label>
    <link:label id="lab_us-gaap_TreasuryStockShares_2d64affb-44ee-4e06-a04e-43cd99524d11_negatedPeriodStartLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockShares" xlink:role="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury, balance at beginning of period (in shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockShares_61f23263-352a-4121-a826-414d2c3aa6a9_negatedPeriodEndLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockShares" xlink:role="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury, balance at end of period (in shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockShares_label_en-US" xlink:label="lab_us-gaap_TreasuryStockShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockShares" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockShares" xlink:to="lab_us-gaap_TreasuryStockShares" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_e00ece4d-a288-4267-8b8b-d0347a7b7fb9_terseLabel_en-US" xlink:label="lab_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current:</link:label>
    <link:label id="lab_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_label_en-US" xlink:label="lab_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Income Tax Expense (Benefit), Continuing Operations [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="lab_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForRestructuring_5b954a59-694a-4c42-bd4b-0983dae5e571_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsForRestructuring" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments and other adjustments</link:label>
    <link:label id="lab_us-gaap_PaymentsForRestructuring_label_en-US" xlink:label="lab_us-gaap_PaymentsForRestructuring" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Restructuring</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRestructuring" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForRestructuring"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForRestructuring" xlink:to="lab_us-gaap_PaymentsForRestructuring" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive_e3197c3b-b02a-4331-b244-9ec62a308b1e_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2026</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid, Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_cah_DividendsPolicyPolicyTextBlock_950e0d54-0c88-403d-b9e5-64e5443997bf_terseLabel_en-US" xlink:label="lab_cah_DividendsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends, Policy [Policy Text Block]</link:label>
    <link:label id="lab_cah_DividendsPolicyPolicyTextBlock_label_en-US" xlink:label="lab_cah_DividendsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends, Policy [Policy Text Block]</link:label>
    <link:label id="lab_cah_DividendsPolicyPolicyTextBlock_documentation_en-US" xlink:label="lab_cah_DividendsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cah_DividendsPolicyPolicyTextBlock" xlink:href="cah-20210630.xsd#cah_DividendsPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_DividendsPolicyPolicyTextBlock" xlink:to="lab_cah_DividendsPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockMember_8c563d06-b665-41b6-9f88-f28b7033a3c8_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Shares</link:label>
    <link:label id="lab_us-gaap_CommonStockMember_label_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockMember" xlink:to="lab_us-gaap_CommonStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1_10c51d96-d7e5-4f5c-a011-84b27c1bd860_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Inventory</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Inventory</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_b02d0d03-df31-4829-91bc-b313688f7beb_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-U.S. operations</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Foreign</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_42c0360b-9f61-4495-a94c-b7869fa2ef2c_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating earnings/(loss)</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_1650599d-ee8f-40d6-b18a-e0bb5b83a1ec_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total operating earnings</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_label_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingIncomeLoss" xlink:to="lab_us-gaap_OperatingIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_f6364934-09e1-4eb6-860b-ff91e529ae95_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Current</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_a73eb512-834c-4f14-b943-00c35259ac49_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated annual amortization of intangible assets - 2023</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HedgingDesignationAxis_e225c287-af39-43c8-9bfd-bdacee6a2294_terseLabel_en-US" xlink:label="lab_us-gaap_HedgingDesignationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Axis]</link:label>
    <link:label id="lab_us-gaap_HedgingDesignationAxis_label_en-US" xlink:label="lab_us-gaap_HedgingDesignationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgingDesignationAxis" xlink:to="lab_us-gaap_HedgingDesignationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensation_47ad530f-78dd-4728-912d-2da5876cf21b_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based compensation</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Noncash Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensation" xlink:to="lab_us-gaap_ShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_ca7ade69-f00a-4388-aedd-f1647d9ff6da_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Employee Severance</link:label>
    <link:label id="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Activities Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:to="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_d3e00825-9804-4d64-8b9e-503642fbf1ba_terseLabel_en-US" xlink:label="lab_us-gaap_AOCIAttributableToParentNetOfTaxRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Attributable to Parent, Net of Tax [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_label_en-US" xlink:label="lab_us-gaap_AOCIAttributableToParentNetOfTaxRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Attributable to Parent, Net of Tax [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AOCIAttributableToParentNetOfTaxRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward" xlink:to="lab_us-gaap_AOCIAttributableToParentNetOfTaxRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_2ed7a68f-e429-4e62-9bbd-0635659dcec9_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_5cbb0648-9aed-4e70-8e2c-7470b26b349e_periodStartLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and equivalents at beginning of period</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_4e45a5f0-2b60-4453-9eef-acc56ab09a51_periodEndLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and equivalents at end of period</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, at Carrying Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_cah_MedicaldistributionandproductsMember_bbf35972-8822-4ba8-a2e2-128892644747_terseLabel_en-US" xlink:label="lab_cah_MedicaldistributionandproductsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical distribution and products [Member]</link:label>
    <link:label id="lab_cah_MedicaldistributionandproductsMember_label_en-US" xlink:label="lab_cah_MedicaldistributionandproductsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical distribution and products [Member]</link:label>
    <link:label id="lab_cah_MedicaldistributionandproductsMember_documentation_en-US" xlink:label="lab_cah_MedicaldistributionandproductsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical distribution and products [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cah_MedicaldistributionandproductsMember" xlink:href="cah-20210630.xsd#cah_MedicaldistributionandproductsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_MedicaldistributionandproductsMember" xlink:to="lab_cah_MedicaldistributionandproductsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Depreciation_79ba548c-6bfb-4bb3-8159-b34c27e0d231_terseLabel_en-US" xlink:label="lab_us-gaap_Depreciation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation</link:label>
    <link:label id="lab_us-gaap_Depreciation_label_en-US" xlink:label="lab_us-gaap_Depreciation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Depreciation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Depreciation" xlink:to="lab_us-gaap_Depreciation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockMember_add03b54-7bc3-4b19-87a0-5ab9a3fa88fb_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Shares</link:label>
    <link:label id="lab_us-gaap_TreasuryStockMember_label_en-US" xlink:label="lab_us-gaap_TreasuryStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockMember" xlink:to="lab_us-gaap_TreasuryStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock_5ac7c300-b37e-4447-a16b-6c4d23cabb19_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Transactions Related to Restricted Share Units Under the Plans</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Restricted Stock Unit, Activity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_cah_ConcentrationRiskLargestGroupPurchasingOrganizations_45430b3f-20ed-458f-b3d5-33aaf9666fe1_terseLabel_en-US" xlink:label="lab_cah_ConcentrationRiskLargestGroupPurchasingOrganizations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Largest group purchasing organizations</link:label>
    <link:label id="lab_cah_ConcentrationRiskLargestGroupPurchasingOrganizations_label_en-US" xlink:label="lab_cah_ConcentrationRiskLargestGroupPurchasingOrganizations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk, Largest Group Purchasing Organizations</link:label>
    <link:label id="lab_cah_ConcentrationRiskLargestGroupPurchasingOrganizations_documentation_en-US" xlink:label="lab_cah_ConcentrationRiskLargestGroupPurchasingOrganizations" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk, Largest Group Purchasing Organizations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cah_ConcentrationRiskLargestGroupPurchasingOrganizations" xlink:href="cah-20210630.xsd#cah_ConcentrationRiskLargestGroupPurchasingOrganizations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_ConcentrationRiskLargestGroupPurchasingOrganizations" xlink:to="lab_cah_ConcentrationRiskLargestGroupPurchasingOrganizations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeNotionalAmount_215c845e-481c-4c4c-9fe7-55c9a3e90f55_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notional Amount</link:label>
    <link:label id="lab_us-gaap_DerivativeNotionalAmount_label_en-US" xlink:label="lab_us-gaap_DerivativeNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Notional Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeNotionalAmount" xlink:to="lab_us-gaap_DerivativeNotionalAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_ad0e71f9-4183-4853-bca5-c85bf83879f0_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additions to property and equipment</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_cc0ffacf-a2ec-4bf6-ac8b-6d8420aa83c2_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total additions to property and equipment</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentMember_d8a53a89-bc2a-4892-8704-7e4bfd445d11_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentMember_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentMember" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeNet_5ad23431-d10c-44b5-9565-e6e882650be1_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair&#160;Value Gain/(Loss)</link:label>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeNet_label_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Fair Value, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeFairValueOfDerivativeNet" xlink:to="lab_us-gaap_DerivativeFairValueOfDerivativeNet" xlink:type="arc" order="1"/>
    <link:label id="lab_cah_FloatingRateNotesdue2022Member_6e85b8df-0185-49c5-b73e-44cded533649_terseLabel_en-US" xlink:label="lab_cah_FloatingRateNotesdue2022Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Floating Rate Notes due fiscal 2022</link:label>
    <link:label id="lab_cah_FloatingRateNotesdue2022Member_label_en-US" xlink:label="lab_cah_FloatingRateNotesdue2022Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Floating Rate Notes due 2022 [Member]</link:label>
    <link:label id="lab_cah_FloatingRateNotesdue2022Member_documentation_en-US" xlink:label="lab_cah_FloatingRateNotesdue2022Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Floating Rate Notes due 2022</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cah_FloatingRateNotesdue2022Member" xlink:href="cah-20210630.xsd#cah_FloatingRateNotesdue2022Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_FloatingRateNotesdue2022Member" xlink:to="lab_cah_FloatingRateNotesdue2022Member" xlink:type="arc" order="1"/>
    <link:label id="lab_cah_OpioidLawsuitsStateDomain_21becf38-1e7d-4cd1-b9f5-f39ecdbfee81_terseLabel_en-US" xlink:label="lab_cah_OpioidLawsuitsStateDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Opioid Lawsuits State [Domain]</link:label>
    <link:label id="lab_cah_OpioidLawsuitsStateDomain_label_en-US" xlink:label="lab_cah_OpioidLawsuitsStateDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Opioid Lawsuits State [Domain]</link:label>
    <link:label id="lab_cah_OpioidLawsuitsStateDomain_documentation_en-US" xlink:label="lab_cah_OpioidLawsuitsStateDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Opioid Lawsuits State and Political Subdivisions [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cah_OpioidLawsuitsStateDomain" xlink:href="cah-20210630.xsd#cah_OpioidLawsuitsStateDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_OpioidLawsuitsStateDomain" xlink:to="lab_cah_OpioidLawsuitsStateDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember_6ee37def-6560-490d-bb5b-5737b10383fd_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized Gain/(Loss) on Derivatives, net of tax</link:label>
    <link:label id="lab_us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Net Gain (Loss) from Cash Flow Hedges Including Portion Attributable to Noncontrolling Interest [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember" xlink:to="lab_us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_a772184f-f4a5-4d79-b60c-6dfa6406593d_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated annual amortization of intangible assets - 2022</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_1d7709c4-aaca-4bbc-a180-875b89781510_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted (in usd per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_71560493-4441-455c-b414-36f6568eac0c_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate intrinsic value of outstanding options at period end</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidationItemsAxis_af11823d-4a97-46aa-89d8-7d0ff607c988_terseLabel_en-US" xlink:label="lab_srt_ConsolidationItemsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Axis]</link:label>
    <link:label id="lab_srt_ConsolidationItemsAxis_label_en-US" xlink:label="lab_srt_ConsolidationItemsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidationItemsAxis" xlink:to="lab_srt_ConsolidationItemsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_cah_OtherJurisdictionsMember_d78e798c-53df-438d-8685-691e4a4fd556_terseLabel_en-US" xlink:label="lab_cah_OtherJurisdictionsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Jurisdictions [Member]</link:label>
    <link:label id="lab_cah_OtherJurisdictionsMember_label_en-US" xlink:label="lab_cah_OtherJurisdictionsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Jurisdictions [Member]</link:label>
    <link:label id="lab_cah_OtherJurisdictionsMember_documentation_en-US" xlink:label="lab_cah_OtherJurisdictionsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Jurisdictions [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cah_OtherJurisdictionsMember" xlink:href="cah-20210630.xsd#cah_OtherJurisdictionsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_OtherJurisdictionsMember" xlink:to="lab_cah_OtherJurisdictionsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_bb801841-f473-440c-88ba-f1221d351904_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common shares, issued</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_7f83304c-8c2c-4851-9f13-32f456aa5a67_periodStartLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at beginning of period (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_5ea1730f-01c7-4f6c-8751-6684c55fab8c_periodEndLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at end of period (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesIssued" xlink:to="lab_us-gaap_CommonStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesIssued_7ff00206-03a3-4364-9254-308edf857c2a_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred shares, issued</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesIssued" xlink:to="lab_us-gaap_PreferredStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockNumberOfSharesParValueAndOtherDisclosuresAbstract_9af44920-865d-41be-aebf-2c2132d3c752_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockNumberOfSharesParValueAndOtherDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred shares, without par value:</link:label>
    <link:label id="lab_us-gaap_PreferredStockNumberOfSharesParValueAndOtherDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_PreferredStockNumberOfSharesParValueAndOtherDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Number of Shares, Par Value and Other Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockNumberOfSharesParValueAndOtherDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockNumberOfSharesParValueAndOtherDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockNumberOfSharesParValueAndOtherDisclosuresAbstract" xlink:to="lab_us-gaap_PreferredStockNumberOfSharesParValueAndOtherDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt_908b2881-8469-4952-a530-548886a38660_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss on early extinguishment of debt</link:label>
    <link:label id="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt_1200b560-85e2-4bd3-9dc2-febe7e334195_terseLabel_en-US" xlink:label="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Extinguishment of Debt</link:label>
    <link:label id="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt_label_en-US" xlink:label="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Extinguishment of Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:to="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_1290b2b0-cf31-4ead-bbf2-445403ca2be3_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Changes in the Balance of Accumulated Other Comprehensive Loss by Component and in Total</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_cah_ReclassificationofdeferredrentinaccordancewithASC842_e5b8d1f1-196d-4458-b89d-e9c1954b1300_terseLabel_en-US" xlink:label="lab_cah_ReclassificationofdeferredrentinaccordancewithASC842" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification of deferred rent in accordance with ASC 842</link:label>
    <link:label id="lab_cah_ReclassificationofdeferredrentinaccordancewithASC842_label_en-US" xlink:label="lab_cah_ReclassificationofdeferredrentinaccordancewithASC842" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification of deferred rent in accordance with ASC 842</link:label>
    <link:label id="lab_cah_ReclassificationofdeferredrentinaccordancewithASC842_documentation_en-US" xlink:label="lab_cah_ReclassificationofdeferredrentinaccordancewithASC842" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification of deferred rent in accordance with ASC 842</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cah_ReclassificationofdeferredrentinaccordancewithASC842" xlink:href="cah-20210630.xsd#cah_ReclassificationofdeferredrentinaccordancewithASC842"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_ReclassificationofdeferredrentinaccordancewithASC842" xlink:to="lab_cah_ReclassificationofdeferredrentinaccordancewithASC842" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock_ec4d3326-b764-45d7-a298-931d518e0462_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Unrecognized Tax Benefits Roll Forward</link:label>
    <link:label id="lab_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Unrecognized Tax Benefits Roll Forward [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_f7b01eea-eafc-4117-9c9b-933eee04e5ee_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Indefinite-Lived Intangible Assets [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Indefinite-Lived Intangible Assets [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable" xlink:to="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BalanceSheetLocationAxis_94bd8d3e-31c8-4d26-a00c-f650c2fd0058_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Axis]</link:label>
    <link:label id="lab_us-gaap_BalanceSheetLocationAxis_label_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetLocationAxis" xlink:to="lab_us-gaap_BalanceSheetLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsegmentsConsolidationItemsDomain_bbcbc603-b848-4963-8943-87b90c4de7bf_terseLabel_en-US" xlink:label="lab_us-gaap_SubsegmentsConsolidationItemsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsegments Consolidation Items [Domain]</link:label>
    <link:label id="lab_us-gaap_SubsegmentsConsolidationItemsDomain_label_en-US" xlink:label="lab_us-gaap_SubsegmentsConsolidationItemsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsegments Consolidation Items [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsegmentsConsolidationItemsDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsegmentsConsolidationItemsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsegmentsConsolidationItemsDomain" xlink:to="lab_us-gaap_SubsegmentsConsolidationItemsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityOtherShares_364149c5-3efa-414f-857b-9a432067151a_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityOtherShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity, Other Shares</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityOtherShares_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityOtherShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity, Other Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityOtherShares" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityOtherShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityOtherShares" xlink:to="lab_us-gaap_StockholdersEquityOtherShares" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedLiabilitiesMember_deb0383e-4cf8-4b8f-979c-cb3cbd22547b_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Accrued Liabilities</link:label>
    <link:label id="lab_us-gaap_AccruedLiabilitiesMember_label_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Liabilities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedLiabilitiesMember" xlink:to="lab_us-gaap_AccruedLiabilitiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementFrequencyDomain_23fc5914-ab39-4a98-b163-e1fdc89ddea1_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementFrequencyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain" xlink:to="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpense_757b8984-52ed-4317-9ef4-c35893e9bec3_terseLabel_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense, net</link:label>
    <link:label id="lab_us-gaap_InterestExpense_label_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpense" xlink:to="lab_us-gaap_InterestExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_27ff8b75-1fd6-40b1-bf54-81dabe847575_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2022</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_f7482b1a-853e-4d8d-aae2-c0a01a37edda_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred:</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Expense (Benefit), Continuing Operations [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="lab_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingenciesByNatureOfContingencyAxis_b9f85dc1-f34b-4d0d-8968-be97c249574d_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingenciesByNatureOfContingencyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency Nature [Axis]</link:label>
    <link:label id="lab_us-gaap_LossContingenciesByNatureOfContingencyAxis_label_en-US" xlink:label="lab_us-gaap_LossContingenciesByNatureOfContingencyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency Nature [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesByNatureOfContingencyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis" xlink:to="lab_us-gaap_LossContingenciesByNatureOfContingencyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_3669b084-14de-4247-ae97-ea28dfd89e4c_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_421fbb26-5459-477a-a33f-35b20ee41b1f_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained earnings</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_c7aa99c4-b014-4b40-8f2d-c4acd67bac9d_negatedLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained earnings decrease</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings (Accumulated Deficit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityPublicFloat_17943e56-755f-4261-9a7a-003e233c0a52_terseLabel_en-US" xlink:label="lab_dei_EntityPublicFloat" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Public Float</link:label>
    <link:label id="lab_dei_EntityPublicFloat_label_en-US" xlink:label="lab_dei_EntityPublicFloat" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Public Float</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityPublicFloat" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityPublicFloat"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityPublicFloat" xlink:to="lab_dei_EntityPublicFloat" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_LitigationCaseTypeDomain_6e0673ae-e7ed-4fba-8051-bb453d69bec6_terseLabel_en-US" xlink:label="lab_srt_LitigationCaseTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Case Type</link:label>
    <link:label id="lab_srt_LitigationCaseTypeDomain_label_en-US" xlink:label="lab_srt_LitigationCaseTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Case [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_LitigationCaseTypeDomain" xlink:to="lab_srt_LitigationCaseTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_b99fe67c-b436-4922-8200-8758afe9e0f0_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock_a7fb208a-0262-4a1c-b16a-b71dbf5e28bb_terseLabel_en-US" xlink:label="lab_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue by Reportable Segment</link:label>
    <link:label id="lab_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock_label_en-US" xlink:label="lab_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Revenue from Segments to Consolidated [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock" xlink:to="lab_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CrossCurrencyInterestRateContractMember_0099525e-962e-49d9-a9de-4296eb5c770f_terseLabel_en-US" xlink:label="lab_us-gaap_CrossCurrencyInterestRateContractMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cross Currency Interest Rate Contract [Member]</link:label>
    <link:label id="lab_us-gaap_CrossCurrencyInterestRateContractMember_label_en-US" xlink:label="lab_us-gaap_CrossCurrencyInterestRateContractMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cross Currency Interest Rate Contract [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CrossCurrencyInterestRateContractMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CrossCurrencyInterestRateContractMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CrossCurrencyInterestRateContractMember" xlink:to="lab_us-gaap_CrossCurrencyInterestRateContractMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock_c5ae349c-ee0c-455b-b148-d3df25fd04e9_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Gain/(Loss) Recognized in Earnings for Interest Rate Contracts Designated as Fair Value Hedges</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" xlink:to="lab_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_3f8bc27e-ce95-4a09-b4fb-d4f7d8116fac_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskTable_89f8b56c-25a6-43e0-a3a3-0748df840534_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk [Table]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskTable_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskTable" xlink:to="lab_us-gaap_ConcentrationRiskTable" xlink:type="arc" order="1"/>
    <link:label id="lab_cah_PharmaceuticalDistributionandSpecialtyMember_6b7023a6-bd31-445f-a73b-60949eee674e_terseLabel_en-US" xlink:label="lab_cah_PharmaceuticalDistributionandSpecialtyMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pharmaceutical Distribution and Specialty [Member]</link:label>
    <link:label id="lab_cah_PharmaceuticalDistributionandSpecialtyMember_label_en-US" xlink:label="lab_cah_PharmaceuticalDistributionandSpecialtyMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pharmaceutical Distribution and Specialty [Member]</link:label>
    <link:label id="lab_cah_PharmaceuticalDistributionandSpecialtyMember_documentation_en-US" xlink:label="lab_cah_PharmaceuticalDistributionandSpecialtyMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pharmaceutical Distribution and Specialty [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cah_PharmaceuticalDistributionandSpecialtyMember" xlink:href="cah-20210630.xsd#cah_PharmaceuticalDistributionandSpecialtyMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_PharmaceuticalDistributionandSpecialtyMember" xlink:to="lab_cah_PharmaceuticalDistributionandSpecialtyMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_59202740-6b4b-42c5-add2-4c83ccba46fa_terseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Intangible</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:to="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_f02faf0e-6380-411f-baa7-56867b609560_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_a30b23cc-86e8-4cbe-84c5-432cee493af0_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_5ffad88d-d96b-4d67-80c9-46d79c21f169_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total shareholders&#8217; equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_be413f6a-e6d3-48e1-b60b-f4cb50a87998_periodStartLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at beginning of period</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_b23b1da0-e16d-42d9-9f08-779c8791a37c_periodEndLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at end of period</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_fbe72ade-fe6a-475f-8c67-f28a2894989a_terseLabel_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementEquityComponentsAxis" xlink:to="lab_us-gaap_StatementEquityComponentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MovementInValuationAllowancesAndReservesRollForward_7e6a3bc7-7a65-46b8-86df-90f5bda83c5d_terseLabel_en-US" xlink:label="lab_us-gaap_MovementInValuationAllowancesAndReservesRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_MovementInValuationAllowancesAndReservesRollForward_label_en-US" xlink:label="lab_us-gaap_MovementInValuationAllowancesAndReservesRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MovementInValuationAllowancesAndReservesRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward" xlink:to="lab_us-gaap_MovementInValuationAllowancesAndReservesRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_ea32061f-265c-42ee-a8bc-07cd5a28d2a7_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract" xlink:to="lab_us-gaap_FairValueDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1_895d29cf-3b51-4e90-861f-613e3eefd6cd_terseLabel_en-US" xlink:label="lab_us-gaap_ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in Unrealized Gain (Loss) on Fair Value Hedging Instruments</link:label>
    <link:label id="lab_us-gaap_ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1_label_en-US" xlink:label="lab_us-gaap_ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in Unrealized Gain (Loss) on Fair Value Hedging Instruments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1" xlink:to="lab_us-gaap_ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskTypeDomain_21da2283-2122-4884-92b1-6c3ee5b68836_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskTypeDomain_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain" xlink:to="lab_us-gaap_ConcentrationRiskTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_2f45b4f9-2752-4980-9ea8-59b7122260de_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average number of common shares outstanding:</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding Reconciliation [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryNet_d5348f00-4372-4e33-82ff-3e0133032776_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories, net</link:label>
    <link:label id="lab_us-gaap_InventoryNet_label_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryNet" xlink:to="lab_us-gaap_InventoryNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_cdfb8c4a-07cf-4945-a8ea-35525d474891_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:to="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_6b0ad3fe-b645-437f-ac9c-92bcfcd411bc_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_1fb19fd3-ba52-49a7-afee-6e4fd2f30684_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_0cffdf89-65bd-413f-98b7-90132cd6f072_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Federal</link:label>
    <link:label id="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_8f408200-438d-4027-a399-3888443421d1_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Federal</link:label>
    <link:label id="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_70cc5753-fd30-4d59-8886-68f59b807972_verboseLabel_en-US" xlink:label="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Federal Income Tax Expense (Benefit)</link:label>
    <link:label id="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Federal Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_3761ff69-85b7-4b69-bb45-a91d89426998_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Thereafter</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, after Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesRecoveries_4170c4c5-70ae-4ba8-843d-dc1ee69d994f_terseLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesRecoveries" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves, Addition, Recovery</link:label>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesRecoveries_label_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesRecoveries" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves, Addition, Recovery</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesRecoveries" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationAllowancesAndReservesRecoveries"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesRecoveries" xlink:to="lab_us-gaap_ValuationAllowancesAndReservesRecoveries" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductOrServiceAxis_bc60eed5-679d-47fa-bc2e-16c7fb01e0c9_terseLabel_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:label id="lab_srt_ProductOrServiceAxis_label_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductOrServiceAxis" xlink:to="lab_srt_ProductOrServiceAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReconciliationOfOtherSignificantReconcilingItemsFromSegmentsToConsolidatedTextBlock_414bf14b-9aa8-45b8-9956-c55135244bea_terseLabel_en-US" xlink:label="lab_us-gaap_ReconciliationOfOtherSignificantReconcilingItemsFromSegmentsToConsolidatedTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation and Amortization and Additions to Property and Equipment by Reportable Segment</link:label>
    <link:label id="lab_us-gaap_ReconciliationOfOtherSignificantReconcilingItemsFromSegmentsToConsolidatedTextBlock_label_en-US" xlink:label="lab_us-gaap_ReconciliationOfOtherSignificantReconcilingItemsFromSegmentsToConsolidatedTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Other Significant Reconciling Items from Segments to Consolidated [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfOtherSignificantReconcilingItemsFromSegmentsToConsolidatedTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReconciliationOfOtherSignificantReconcilingItemsFromSegmentsToConsolidatedTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReconciliationOfOtherSignificantReconcilingItemsFromSegmentsToConsolidatedTextBlock" xlink:to="lab_us-gaap_ReconciliationOfOtherSignificantReconcilingItemsFromSegmentsToConsolidatedTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_cah_LeasePaymentsTableTextBlock_4f0ba13e-b592-4dae-a386-23bb7dbdf304_terseLabel_en-US" xlink:label="lab_cah_LeasePaymentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases Supplemental Cash Flow Information</link:label>
    <link:label id="lab_cah_LeasePaymentsTableTextBlock_label_en-US" xlink:label="lab_cah_LeasePaymentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease Payments [Table Text Block]</link:label>
    <link:label id="lab_cah_LeasePaymentsTableTextBlock_documentation_en-US" xlink:label="lab_cah_LeasePaymentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">[Table Text Block] for Lease Payments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cah_LeasePaymentsTableTextBlock" xlink:href="cah-20210630.xsd#cah_LeasePaymentsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_LeasePaymentsTableTextBlock" xlink:to="lab_cah_LeasePaymentsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_cah_FinanceLeaseMember_bec89f5b-efe8-47ad-872c-4c0a4fc744f7_terseLabel_en-US" xlink:label="lab_cah_FinanceLeaseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Leases</link:label>
    <link:label id="lab_cah_FinanceLeaseMember_label_en-US" xlink:label="lab_cah_FinanceLeaseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease [Member]</link:label>
    <link:label id="lab_cah_FinanceLeaseMember_documentation_en-US" xlink:label="lab_cah_FinanceLeaseMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cah_FinanceLeaseMember" xlink:href="cah-20210630.xsd#cah_FinanceLeaseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_FinanceLeaseMember" xlink:to="lab_cah_FinanceLeaseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_7ef4adaf-3db3-4f28-ba02-534e5fb98afd_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_12579e13-6a3c-4087-b7e3-da1df4532981_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency translation adjustments and other</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementLineItems_c902e3fe-84e4-46d7-8636-fc11b6d26223_terseLabel_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:label id="lab_us-gaap_StatementLineItems_label_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementLineItems" xlink:to="lab_us-gaap_StatementLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesDomain_f4b9d979-91c2-4f54-9315-f85f809d259e_terseLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves [Domain]</link:label>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesDomain_label_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationAllowancesAndReservesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesDomain" xlink:to="lab_us-gaap_ValuationAllowancesAndReservesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_a2e09fa0-76c9-4db8-8710-3b71943a37d2_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-Average Exercise Price per Common Share</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_8e4abfae-7ece-4f48-b11d-f7b81c47b167_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_cah_TotalOpioidLitigationMember_d2215fa2-7459-427f-84dc-01dfa7727e32_terseLabel_en-US" xlink:label="lab_cah_TotalOpioidLitigationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Opioid Litigation [Member]</link:label>
    <link:label id="lab_cah_TotalOpioidLitigationMember_label_en-US" xlink:label="lab_cah_TotalOpioidLitigationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Opioid Litigation [Member]</link:label>
    <link:label id="lab_cah_TotalOpioidLitigationMember_documentation_en-US" xlink:label="lab_cah_TotalOpioidLitigationMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Opioid Litigation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cah_TotalOpioidLitigationMember" xlink:href="cah-20210630.xsd#cah_TotalOpioidLitigationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_TotalOpioidLitigationMember" xlink:to="lab_cah_TotalOpioidLitigationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_3d77fcdb-a2fe-48c4-ae42-f19488298170_terseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureAbstract" xlink:to="lab_us-gaap_DebtDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_ff9b704f-aacb-41df-853a-e6b8d22cbbd3_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TaxPeriodAxis_f9d134fe-0f44-4a89-be9e-7e6f7e158670_terseLabel_en-US" xlink:label="lab_us-gaap_TaxPeriodAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Period [Axis]</link:label>
    <link:label id="lab_us-gaap_TaxPeriodAxis_label_en-US" xlink:label="lab_us-gaap_TaxPeriodAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Period [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxPeriodAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxPeriodAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TaxPeriodAxis" xlink:to="lab_us-gaap_TaxPeriodAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_e93e42f9-894f-495e-b5d5-851e379e35c9_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Tangible Asset [Axis]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Tangible Asset [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsValuationAllowance_77faeb32-4a95-4b08-bd20-a3ba55960b61_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Valuation Allowance</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsValuationAllowance_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Valuation Allowance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:to="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CorporateNonSegmentMember_669113e8-fb86-4dfa-b468-c5376ac76a90_terseLabel_en-US" xlink:label="lab_us-gaap_CorporateNonSegmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate</link:label>
    <link:label id="lab_us-gaap_CorporateNonSegmentMember_label_en-US" xlink:label="lab_us-gaap_CorporateNonSegmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate, Non-Segment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CorporateNonSegmentMember" xlink:to="lab_us-gaap_CorporateNonSegmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityDomain_f67d52de-a251-41f6-b4cf-85d9fd78967d_terseLabel_en-US" xlink:label="lab_dei_EntityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity [Domain]</link:label>
    <link:label id="lab_dei_EntityDomain_label_en-US" xlink:label="lab_dei_EntityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityDomain" xlink:to="lab_dei_EntityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_cah_LeasesTextBlock_6ea15625-9131-4c1d-8bbb-e5ab1f07a3ca_terseLabel_en-US" xlink:label="lab_cah_LeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases</link:label>
    <link:label id="lab_cah_LeasesTextBlock_label_en-US" xlink:label="lab_cah_LeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases [Text Block]</link:label>
    <link:label id="lab_cah_LeasesTextBlock_documentation_en-US" xlink:label="lab_cah_LeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cah_LeasesTextBlock" xlink:href="cah-20210630.xsd#cah_LeasesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_LeasesTextBlock" xlink:to="lab_cah_LeasesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MajorCustomersAxis_e0f48916-f3d2-4d30-991a-d36c84275109_terseLabel_en-US" xlink:label="lab_srt_MajorCustomersAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer [Axis]</link:label>
    <link:label id="lab_srt_MajorCustomersAxis_label_en-US" xlink:label="lab_srt_MajorCustomersAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MajorCustomersAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MajorCustomersAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MajorCustomersAxis" xlink:to="lab_srt_MajorCustomersAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringCostAndReserveLineItems_78e1f5be-3e83-4606-b86e-6dd2aa999c8b_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Cost and Reserve [Line Items]</link:label>
    <link:label id="lab_us-gaap_RestructuringCostAndReserveLineItems_label_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Cost and Reserve [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems" xlink:to="lab_us-gaap_RestructuringCostAndReserveLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_7f269ea5-b5a5-4323-817f-6cab64167f9e_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:type="arc" order="1"/>
    <link:label id="lab_cah_ShippingandHandlingCostsPolicyTextBlock_9b5b9929-04a6-4437-b2f8-c22c7288bd37_terseLabel_en-US" xlink:label="lab_cah_ShippingandHandlingCostsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shipping and Handling</link:label>
    <link:label id="lab_cah_ShippingandHandlingCostsPolicyTextBlock_label_en-US" xlink:label="lab_cah_ShippingandHandlingCostsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ShippingandHandlingCosts [Policy Text Block]</link:label>
    <link:label id="lab_cah_ShippingandHandlingCostsPolicyTextBlock_documentation_en-US" xlink:label="lab_cah_ShippingandHandlingCostsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ShippingandHandlingCosts [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cah_ShippingandHandlingCostsPolicyTextBlock" xlink:href="cah-20210630.xsd#cah_ShippingandHandlingCostsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_ShippingandHandlingCostsPolicyTextBlock" xlink:to="lab_cah_ShippingandHandlingCostsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityShellCompany_ddb55dbf-6912-4df1-b22f-a9cdf77d6397_terseLabel_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:label id="lab_dei_EntityShellCompany_label_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityShellCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityShellCompany" xlink:to="lab_dei_EntityShellCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_e9b293d7-0ed4-4b22-8625-1bfbf38b223b_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_1618fbf6-6871-4fd7-98c2-13a94215b48d_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent_e04c453f-fbe6-49e9-8c80-9b907cb04fe0_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other (2)</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation,Other Reconciling Items, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Assets_6ee9feb6-a419-49a9-94f4-784cc1304547_totalLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets</link:label>
    <link:label id="lab_us-gaap_Assets_bb04c250-f11e-4043-91f4-17d73e96c481_terseLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets</link:label>
    <link:label id="lab_us-gaap_Assets_label_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Assets" xlink:to="lab_us-gaap_Assets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossRelatedToLitigationSettlement_091ee13a-617c-4286-b45a-2c48c210437e_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_GainLossRelatedToLitigationSettlement" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation (recoveries)/charges, net</link:label>
    <link:label id="lab_us-gaap_GainLossRelatedToLitigationSettlement_27d67fb4-cc1e-4af5-9514-ca326840aaad_terseLabel_en-US" xlink:label="lab_us-gaap_GainLossRelatedToLitigationSettlement" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) Related to Litigation Settlement</link:label>
    <link:label id="lab_us-gaap_GainLossRelatedToLitigationSettlement_label_en-US" xlink:label="lab_us-gaap_GainLossRelatedToLitigationSettlement" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) Related to Litigation Settlement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossRelatedToLitigationSettlement" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossRelatedToLitigationSettlement"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossRelatedToLitigationSettlement" xlink:to="lab_us-gaap_GainLossRelatedToLitigationSettlement" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PlanNameDomain_a4ed3804-730f-4c48-a122-dd5b9c3cfac9_terseLabel_en-US" xlink:label="lab_us-gaap_PlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Domain]</link:label>
    <link:label id="lab_us-gaap_PlanNameDomain_label_en-US" xlink:label="lab_us-gaap_PlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameDomain" xlink:to="lab_us-gaap_PlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract_84bdabc7-b500-4dac-8808-192e3a6fc159_terseLabel_en-US" xlink:label="lab_us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income tax liabilities:</link:label>
    <link:label id="lab_us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract_label_en-US" xlink:label="lab_us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Components of Deferred Tax Liabilities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract" xlink:to="lab_us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MajorCustomersPolicyPolicyTextBlock_59bedb91-4f1c-4dbf-bcff-e879ccb13de7_terseLabel_en-US" xlink:label="lab_us-gaap_MajorCustomersPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Major Customers</link:label>
    <link:label id="lab_us-gaap_MajorCustomersPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_MajorCustomersPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Major Customers, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MajorCustomersPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MajorCustomersPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MajorCustomersPolicyPolicyTextBlock" xlink:to="lab_us-gaap_MajorCustomersPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestPaidNet_9af473f0-cd08-4c19-b0fb-6f019031ff61_terseLabel_en-US" xlink:label="lab_us-gaap_InterestPaidNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash payments for interest</link:label>
    <link:label id="lab_us-gaap_InterestPaidNet_label_en-US" xlink:label="lab_us-gaap_InterestPaidNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Paid, Excluding Capitalized Interest, Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestPaidNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestPaidNet" xlink:to="lab_us-gaap_InterestPaidNet" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_SegmentGeographicalDomain_d527abf5-f535-485f-9598-93c4bce949f5_terseLabel_en-US" xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:label id="lab_srt_SegmentGeographicalDomain_label_en-US" xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_SegmentGeographicalDomain" xlink:to="lab_srt_SegmentGeographicalDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_cah_SterileSurgicalGownRecallDomain_f618f95a-f549-4ba2-b69f-431f500cf4e1_terseLabel_en-US" xlink:label="lab_cah_SterileSurgicalGownRecallDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sterile Surgical Gown Recall [Domain]</link:label>
    <link:label id="lab_cah_SterileSurgicalGownRecallDomain_label_en-US" xlink:label="lab_cah_SterileSurgicalGownRecallDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sterile Surgical Gown Recall [Domain]</link:label>
    <link:label id="lab_cah_SterileSurgicalGownRecallDomain_documentation_en-US" xlink:label="lab_cah_SterileSurgicalGownRecallDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sterile Surgical Gown Recall [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cah_SterileSurgicalGownRecallDomain" xlink:href="cah-20210630.xsd#cah_SterileSurgicalGownRecallDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_SterileSurgicalGownRecallDomain" xlink:to="lab_cah_SterileSurgicalGownRecallDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncontrollingInterestMember_0aab8901-a690-4ddc-b5fd-5143b0bf4630_terseLabel_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interests</link:label>
    <link:label id="lab_us-gaap_NoncontrollingInterestMember_label_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncontrollingInterestMember" xlink:to="lab_us-gaap_NoncontrollingInterestMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cah_A2011LtipMember_20bc5ae2-eb29-426a-8f85-41e464e79c9c_terseLabel_en-US" xlink:label="lab_cah_A2011LtipMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2011 LTIP</link:label>
    <link:label id="lab_cah_A2011LtipMember_label_en-US" xlink:label="lab_cah_A2011LtipMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2011 LTIP [Member]</link:label>
    <link:label id="lab_cah_A2011LtipMember_documentation_en-US" xlink:label="lab_cah_A2011LtipMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2011 LTIP [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cah_A2011LtipMember" xlink:href="cah-20210630.xsd#cah_A2011LtipMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_A2011LtipMember" xlink:to="lab_cah_A2011LtipMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxesAndOtherAssetsNoncurrent_12e79925-9019-4554-835a-a44596d103fc_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxesAndOtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Taxes and Other Assets, Noncurrent</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxesAndOtherAssetsNoncurrent_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxesAndOtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Taxes and Other Assets, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxesAndOtherAssetsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxesAndOtherAssetsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxesAndOtherAssetsNoncurrent" xlink:to="lab_us-gaap_DeferredIncomeTaxesAndOtherAssetsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeContractTypeDomain_d9a8ce6b-9f01-458c-9efb-7074082cf9fa_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeContractTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_DerivativeContractTypeDomain_ac2eee95-5f1a-4854-8b91-48564eaa7a1a_verboseLabel_en-US" xlink:label="lab_us-gaap_DerivativeContractTypeDomain" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Contract [Domain]</link:label>
    <link:label id="lab_us-gaap_DerivativeContractTypeDomain_label_en-US" xlink:label="lab_us-gaap_DerivativeContractTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Contract [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeContractTypeDomain" xlink:to="lab_us-gaap_DerivativeContractTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_380ca91d-1a02-4d5e-9163-983ca1a92dde_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash provided by operating activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TaxCreditCarryforwardAmount_2e8ee91e-917d-40ab-8078-8c434e454ae9_terseLabel_en-US" xlink:label="lab_us-gaap_TaxCreditCarryforwardAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax credit carryforwards</link:label>
    <link:label id="lab_us-gaap_TaxCreditCarryforwardAmount_label_en-US" xlink:label="lab_us-gaap_TaxCreditCarryforwardAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Credit Carryforward, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxCreditCarryforwardAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TaxCreditCarryforwardAmount" xlink:to="lab_us-gaap_TaxCreditCarryforwardAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsNotesAndLoansReceivableLineItems_e3a1df3b-69a8-46ea-9d0b-eab8121afe64_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsNotesAndLoansReceivableLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts, Notes, Loans and Financing Receivable [Line Items]</link:label>
    <link:label id="lab_us-gaap_AccountsNotesAndLoansReceivableLineItems_label_en-US" xlink:label="lab_us-gaap_AccountsNotesAndLoansReceivableLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts, Notes, Loans and Financing Receivable [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsNotesAndLoansReceivableLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems" xlink:to="lab_us-gaap_AccountsNotesAndLoansReceivableLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDebtTableTextBlock_c6d9692b-1dc8-49c6-81e3-5ca4b8101774_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Debt</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDebtTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Debt [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDebtTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDebtTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfDebtTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_cah_Proceedsfromdivestituresanddisposalofpropertyandequipmentandheldforsaleassets_bb402e3a-114e-416f-bd50-638fa924c0b9_terseLabel_en-US" xlink:label="lab_cah_Proceedsfromdivestituresanddisposalofpropertyandequipmentandheldforsaleassets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from divestitures, net of cash sold, and disposal of property and equipment</link:label>
    <link:label id="lab_cah_Proceedsfromdivestituresanddisposalofpropertyandequipmentandheldforsaleassets_label_en-US" xlink:label="lab_cah_Proceedsfromdivestituresanddisposalofpropertyandequipmentandheldforsaleassets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from divestitures and disposal of property and equipment and held for sale assets</link:label>
    <link:label id="lab_cah_Proceedsfromdivestituresanddisposalofpropertyandequipmentandheldforsaleassets_documentation_en-US" xlink:label="lab_cah_Proceedsfromdivestituresanddisposalofpropertyandequipmentandheldforsaleassets" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from divestitures and disposal of property and equipment and held for sale assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cah_Proceedsfromdivestituresanddisposalofpropertyandequipmentandheldforsaleassets" xlink:href="cah-20210630.xsd#cah_Proceedsfromdivestituresanddisposalofpropertyandequipmentandheldforsaleassets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_Proceedsfromdivestituresanddisposalofpropertyandequipmentandheldforsaleassets" xlink:to="lab_cah_Proceedsfromdivestituresanddisposalofpropertyandequipmentandheldforsaleassets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_537478f4-3b47-4a6b-b678-a1544fe5f536_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurements, Recurring and Nonrecurring</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring and Nonrecurring [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FurnitureAndFixturesMember_af614e5e-e633-4bb1-b0bf-0434048833fd_verboseLabel_en-US" xlink:label="lab_us-gaap_FurnitureAndFixturesMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Furniture and fixtures</link:label>
    <link:label id="lab_us-gaap_FurnitureAndFixturesMember_label_en-US" xlink:label="lab_us-gaap_FurnitureAndFixturesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Furniture and Fixtures [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FurnitureAndFixturesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FurnitureAndFixturesMember" xlink:to="lab_us-gaap_FurnitureAndFixturesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentTable_4045f89c-94f5-47e1-bb6c-8f1a23293459_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentTable_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentTable" xlink:to="lab_us-gaap_DebtInstrumentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_7aafc822-5120-4adf-b2a0-9dca79763e0c_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasicAbstract_ea3837a4-07ae-42a3-962f-66e2fa9e903a_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasicAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings/(loss) per common share attributable to Cardinal Health, Inc.</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasicAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasicAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasicAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasicAbstract" xlink:to="lab_us-gaap_EarningsPerShareBasicAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets_fd2f1ca0-ca36-41f1-bc62-b2de4c9571a2_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Other Assets</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Other Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_cah_NaviHealthAxis_4467cfec-04ae-4947-bf50-84973936ccfb_terseLabel_en-US" xlink:label="lab_cah_NaviHealthAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">naviHealth [Axis]</link:label>
    <link:label id="lab_cah_NaviHealthAxis_label_en-US" xlink:label="lab_cah_NaviHealthAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">naviHealth [Axis]</link:label>
    <link:label id="lab_cah_NaviHealthAxis_documentation_en-US" xlink:label="lab_cah_NaviHealthAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">naviHealth</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cah_NaviHealthAxis" xlink:href="cah-20210630.xsd#cah_NaviHealthAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_NaviHealthAxis" xlink:to="lab_cah_NaviHealthAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense_6068145d-f16e-4987-af42-49ea2ba64c67_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nondeductible/nontaxable items (2)</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_2cabab26-b583-4dee-8b94-f54fb7cbecc6_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_3d18db51-db96-4f66-abed-45d630deb048_verboseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average common shares&#8211;basic (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_742e623b-7fd9-48a9-bbc5-1b703977792b_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Diluted</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDiluted" xlink:to="lab_us-gaap_EarningsPerShareDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract_51f06514-a736-4e45-bafd-35eaafee0c4f_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of dilutive securities:</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Incremental Weighted Average Shares Attributable to Dilutive Effect [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract" xlink:to="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentDomain_23920b59-bb26-4f2f-80e3-43c66fe2dd12_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Domain]</link:label>
    <link:label id="lab_us-gaap_SegmentDomain_label_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentDomain" xlink:to="lab_us-gaap_SegmentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_5a529f55-c39d-429f-8fa5-6171f2f05ad5_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee stock options, restricted share units, and performance share units (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number Diluted Shares Outstanding Adjustment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:to="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:type="arc" order="1"/>
    <link:label id="lab_cah_SterileSurgicalGownRecallMemberDomain_b4df7603-d89d-47a1-b633-344caf91773f_terseLabel_en-US" xlink:label="lab_cah_SterileSurgicalGownRecallMemberDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sterile Surgical Gown Recall [Member] [Domain]</link:label>
    <link:label id="lab_cah_SterileSurgicalGownRecallMemberDomain_label_en-US" xlink:label="lab_cah_SterileSurgicalGownRecallMemberDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sterile Surgical Gown Recall [Member] [Domain]</link:label>
    <link:label id="lab_cah_SterileSurgicalGownRecallMemberDomain_documentation_en-US" xlink:label="lab_cah_SterileSurgicalGownRecallMemberDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sterile Surgical Gown Recall [Member] [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cah_SterileSurgicalGownRecallMemberDomain" xlink:href="cah-20210630.xsd#cah_SterileSurgicalGownRecallMemberDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_SterileSurgicalGownRecallMemberDomain" xlink:to="lab_cah_SterileSurgicalGownRecallMemberDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet_884d5ab9-923b-47ed-8a55-edc713d08f97_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain/(loss) reclassified from AOCI into earnings for derivative instruments designated as cash flow hedges</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) Reclassified from Accumulated OCI into Income, Effective Portion, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet" xlink:to="lab_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SalesMember_eb1b8202-bd3f-4375-91ee-4c264db005ea_terseLabel_en-US" xlink:label="lab_us-gaap_SalesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue</link:label>
    <link:label id="lab_us-gaap_SalesMember_label_en-US" xlink:label="lab_us-gaap_SalesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SalesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SalesMember" xlink:to="lab_us-gaap_SalesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxesPaidNet_a8db125b-bad1-4d33-888b-bf8162c91da5_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxesPaidNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash payments for income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxesPaidNet_label_en-US" xlink:label="lab_us-gaap_IncomeTaxesPaidNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes Paid, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaidNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxesPaidNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxesPaidNet" xlink:to="lab_us-gaap_IncomeTaxesPaidNet" xlink:type="arc" order="1"/>
    <link:label id="lab_cah_NetOperatingLossCarrybackAxis_f0b215b6-d20d-4f01-9606-9b1afa80a3a9_terseLabel_en-US" xlink:label="lab_cah_NetOperatingLossCarrybackAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Operating Loss Carryback [Axis]</link:label>
    <link:label id="lab_cah_NetOperatingLossCarrybackAxis_label_en-US" xlink:label="lab_cah_NetOperatingLossCarrybackAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Operating Loss Carryback [Axis]</link:label>
    <link:label id="lab_cah_NetOperatingLossCarrybackAxis_documentation_en-US" xlink:label="lab_cah_NetOperatingLossCarrybackAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Operating Loss Carryback</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cah_NetOperatingLossCarrybackAxis" xlink:href="cah-20210630.xsd#cah_NetOperatingLossCarrybackAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_NetOperatingLossCarrybackAxis" xlink:to="lab_cah_NetOperatingLossCarrybackAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NonUsMember_4867b9dc-bee6-4b15-b860-d32d3e54f41c_verboseLabel_en-US" xlink:label="lab_us-gaap_NonUsMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-US [Member]</link:label>
    <link:label id="lab_us-gaap_NonUsMember_5f9fad6b-9dd7-4a15-bd26-3095b89ee0d3_terseLabel_en-US" xlink:label="lab_us-gaap_NonUsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">International</link:label>
    <link:label id="lab_us-gaap_NonUsMember_label_en-US" xlink:label="lab_us-gaap_NonUsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-US [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonUsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonUsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonUsMember" xlink:to="lab_us-gaap_NonUsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_01849c81-a27b-4edb-a78e-7a63cd53df56_terseLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Intangible, Total other intangible assets</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Net (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:to="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_26fcf236-def4-4f29-9b59-9a7b486bd49b_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Restructuring and Related Costs [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Restructuring and Related Costs [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:to="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_912d7a41-5025-4033-bbf7-4348a984f81b_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total comprehensive income attributable to Cardinal Health, Inc.</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeSeveranceMember_06d07bb4-e476-486b-8c05-0166020abd5a_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeSeveranceMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee- Related Costs</link:label>
    <link:label id="lab_us-gaap_EmployeeSeveranceMember_label_en-US" xlink:label="lab_us-gaap_EmployeeSeveranceMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Severance [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeSeveranceMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeSeveranceMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeSeveranceMember" xlink:to="lab_us-gaap_EmployeeSeveranceMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_4e1c309f-d989-45aa-98f2-0cefb2456781_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income/(loss):</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_c59d298b-c5ea-4ee3-a345-2b2f39d7962a_verboseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Acquiree</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_547bcd88-66f2-4475-90d0-89413b1e1a69_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NotesPayable_113e81f0-409b-4a2d-9d5c-e265780bee88_terseLabel_en-US" xlink:label="lab_us-gaap_NotesPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes Payable</link:label>
    <link:label id="lab_us-gaap_NotesPayable_label_en-US" xlink:label="lab_us-gaap_NotesPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NotesPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NotesPayable" xlink:to="lab_us-gaap_NotesPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_88935d5c-89f3-451c-beb2-668bc9daeba6_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Effective Income Tax Rate Reconciliation</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsegmentsDomain_468b7be9-8b35-4ad1-8e8f-2b40ffa681a9_terseLabel_en-US" xlink:label="lab_us-gaap_SubsegmentsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsegments [Domain]</link:label>
    <link:label id="lab_us-gaap_SubsegmentsDomain_label_en-US" xlink:label="lab_us-gaap_SubsegmentsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsegments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsegmentsDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsegmentsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsegmentsDomain" xlink:to="lab_us-gaap_SubsegmentsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_9c42ee48-6176-49ee-9314-ad24a08ccaf2_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_17457f36-3216-4193-aea7-b1f73684bb50_verboseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable, Current</link:label>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableCurrent" xlink:to="lab_us-gaap_AccountsPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts_6c608d43-6fca-4a34-85c8-2b234d15ad84_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivable basis difference</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Asset, Tax Deferred Expense, Reserve and Accrual, Accounts Receivable, Allowance for Credit Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" xlink:to="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_6d8347f5-42af-42f7-8685-8dfe0a18c99b_terseLabel_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_f39273a7-d48a-419b-bca3-9494a0a3a61d_verboseLabel_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_label_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation, Depletion and Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:to="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_cah_NaviHealthMember_98cf63c2-b0a6-4632-b4c2-e2acf972d66d_terseLabel_en-US" xlink:label="lab_cah_NaviHealthMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">naviHealth [Member]</link:label>
    <link:label id="lab_cah_NaviHealthMember_label_en-US" xlink:label="lab_cah_NaviHealthMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">naviHealth [Member]</link:label>
    <link:label id="lab_cah_NaviHealthMember_documentation_en-US" xlink:label="lab_cah_NaviHealthMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">naviHealth [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cah_NaviHealthMember" xlink:href="cah-20210630.xsd#cah_NaviHealthMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_NaviHealthMember" xlink:to="lab_cah_NaviHealthMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EntityWideRevenueMajorCustomerLineItems_f8713570-e102-4b44-979c-39ad25dc13de_terseLabel_en-US" xlink:label="lab_us-gaap_EntityWideRevenueMajorCustomerLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Major Customer [Line Items]</link:label>
    <link:label id="lab_us-gaap_EntityWideRevenueMajorCustomerLineItems_label_en-US" xlink:label="lab_us-gaap_EntityWideRevenueMajorCustomerLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Major Customer [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EntityWideRevenueMajorCustomerLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EntityWideRevenueMajorCustomerLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EntityWideRevenueMajorCustomerLineItems" xlink:to="lab_us-gaap_EntityWideRevenueMajorCustomerLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_268f5169-b6f0-4a8e-b083-55e74aa84211_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring Basis</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_6071dc8d-309e-475c-87a6-db4625b2ced0_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Loss</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_d99780aa-c121-45f0-8de9-939ca15f2924_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase in inventories</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Inventories</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInInventories" xlink:to="lab_us-gaap_IncreaseDecreaseInInventories" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_65ebe1fd-b7d3-4a9f-aed8-04a4caa4d03c_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Restructuring and Employee Severance</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Costs [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:to="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges_d247afb9-2a30-49ec-ac51-ea8620b3a893_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairments and (gain)/loss on disposal of assets, net</link:label>
    <link:label id="lab_us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges_label_en-US" xlink:label="lab_us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Sale of Assets and Asset Impairment Charges</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges" xlink:to="lab_us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_c32b3115-c64c-4c93-8253-cd297374c9ed_verboseLabel_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of products sold</link:label>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_c5d5ccd8-dd47-4ac0-9b0c-a63b15a1ce3b_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Goods and Services Sold</link:label>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_label_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Goods and Services Sold</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfGoodsAndServicesSold" xlink:to="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:type="arc" order="1"/>
    <link:label id="lab_cah_AllegianceCorporationMember_b8241309-31f0-438c-b592-5de785c8dc3b_terseLabel_en-US" xlink:label="lab_cah_AllegianceCorporationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Allegiance Corporation</link:label>
    <link:label id="lab_cah_AllegianceCorporationMember_label_en-US" xlink:label="lab_cah_AllegianceCorporationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Allegiance Corporation [Member]</link:label>
    <link:label id="lab_cah_AllegianceCorporationMember_documentation_en-US" xlink:label="lab_cah_AllegianceCorporationMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Allegiance Corporation [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cah_AllegianceCorporationMember" xlink:href="cah-20210630.xsd#cah_AllegianceCorporationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_AllegianceCorporationMember" xlink:to="lab_cah_AllegianceCorporationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonClassBMember_6f39130a-973b-4bcb-9669-bea4aff852b6_terseLabel_en-US" xlink:label="lab_us-gaap_CommonClassBMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Class B</link:label>
    <link:label id="lab_us-gaap_CommonClassBMember_label_en-US" xlink:label="lab_us-gaap_CommonClassBMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Class B [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassBMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonClassBMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonClassBMember" xlink:to="lab_us-gaap_CommonClassBMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax_a166f1db-a10e-4c1c-adae-279fd41787ae_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain/(loss) included in AOCI for derivative instruments designated as cash flow hedges</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Unrealized Gain (Loss) on Derivatives Arising During Period, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReceivable_10ee9865-1003-4d5e-943c-2782b8fa3052_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReceivable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes Receivable</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReceivable_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReceivable" xlink:to="lab_us-gaap_IncomeTaxReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromDivestitureOfBusinesses_1b3370b5-7cd1-43e5-9e86-805f24fa3425_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromDivestitureOfBusinesses" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Divestiture of Businesses</link:label>
    <link:label id="lab_us-gaap_ProceedsFromDivestitureOfBusinesses_label_en-US" xlink:label="lab_us-gaap_ProceedsFromDivestitureOfBusinesses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Divestiture of Businesses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfBusinesses" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromDivestitureOfBusinesses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromDivestitureOfBusinesses" xlink:to="lab_us-gaap_ProceedsFromDivestitureOfBusinesses" xlink:type="arc" order="1"/>
    <link:label id="lab_cah_PricingDisputesMember_011b56d7-eb88-4c4d-b2e9-b8f8c8e6d1c2_terseLabel_en-US" xlink:label="lab_cah_PricingDisputesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pricing Disputes [Member]</link:label>
    <link:label id="lab_cah_PricingDisputesMember_label_en-US" xlink:label="lab_cah_PricingDisputesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pricing Disputes [Member]</link:label>
    <link:label id="lab_cah_PricingDisputesMember_documentation_en-US" xlink:label="lab_cah_PricingDisputesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expense related to pricing disputes, excluded from provision for bad debts in the consolidated statements of cash flows and recorded as a reduction in gross margin in the consolidated statements of earnings.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cah_PricingDisputesMember" xlink:href="cah-20210630.xsd#cah_PricingDisputesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_PricingDisputesMember" xlink:to="lab_cah_PricingDisputesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cah_LesseeLeaseLiabilityPaymentsDueYearOne_66f4d3dd-0343-418e-aee1-6751aefa172e_terseLabel_en-US" xlink:label="lab_cah_LesseeLeaseLiabilityPaymentsDueYearOne" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2022</link:label>
    <link:label id="lab_cah_LesseeLeaseLiabilityPaymentsDueYearOne_label_en-US" xlink:label="lab_cah_LesseeLeaseLiabilityPaymentsDueYearOne" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee Lease Liability Payments Due Year One</link:label>
    <link:label id="lab_cah_LesseeLeaseLiabilityPaymentsDueYearOne_documentation_en-US" xlink:label="lab_cah_LesseeLeaseLiabilityPaymentsDueYearOne" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee Lease Liability Payments Due Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cah_LesseeLeaseLiabilityPaymentsDueYearOne" xlink:href="cah-20210630.xsd#cah_LesseeLeaseLiabilityPaymentsDueYearOne"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_LesseeLeaseLiabilityPaymentsDueYearOne" xlink:to="lab_cah_LesseeLeaseLiabilityPaymentsDueYearOne" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityLenderDomain_0e2cd8c4-21a7-42e5-99e7-d311a63ec8f5_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityLenderDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Lender [Domain]</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityLenderDomain_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityLenderDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Lender [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLenderDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityLenderDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityLenderDomain" xlink:to="lab_us-gaap_LineOfCreditFacilityLenderDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseCost_c0676fc1-3f1b-41f2-8e26-8d441aa85557_totalLabel_en-US" xlink:label="lab_us-gaap_LeaseCost" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total lease cost</link:label>
    <link:label id="lab_us-gaap_LeaseCost_label_en-US" xlink:label="lab_us-gaap_LeaseCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCost" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseCost" xlink:to="lab_us-gaap_LeaseCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions_9460a309-1f52-494f-8e07-41667a54cd1e_negatedLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reductions for tax positions of prior years</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CustomerRelationshipsMember_fd1bcffe-141e-492b-9e19-0bf341de2ca1_terseLabel_en-US" xlink:label="lab_us-gaap_CustomerRelationshipsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer relationships</link:label>
    <link:label id="lab_us-gaap_CustomerRelationshipsMember_label_en-US" xlink:label="lab_us-gaap_CustomerRelationshipsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Relationships [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CustomerRelationshipsMember" xlink:to="lab_us-gaap_CustomerRelationshipsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingenciesLineItems_4b78e523-3a61-45ad-bad0-ff626a636945_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingenciesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Line Items]</link:label>
    <link:label id="lab_us-gaap_LossContingenciesLineItems_label_en-US" xlink:label="lab_us-gaap_LossContingenciesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingenciesLineItems" xlink:to="lab_us-gaap_LossContingenciesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PercentageOfLIFOInventory_83af6cae-3b27-4aa0-9b29-ad0db5718b20_terseLabel_en-US" xlink:label="lab_us-gaap_PercentageOfLIFOInventory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Portion of inventories held at LIFO, percentage</link:label>
    <link:label id="lab_us-gaap_PercentageOfLIFOInventory_label_en-US" xlink:label="lab_us-gaap_PercentageOfLIFOInventory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of LIFO Inventory</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PercentageOfLIFOInventory" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PercentageOfLIFOInventory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PercentageOfLIFOInventory" xlink:to="lab_us-gaap_PercentageOfLIFOInventory" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityAxis_1d03bb87-c176-4c00-9dc2-9fe31901c8c8_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lender Name [Axis]</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityAxis_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lender Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityAxis" xlink:to="lab_us-gaap_LineOfCreditFacilityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockSharesAcquired_383c0f26-0035-4eba-826c-0fb1835b297a_negatedLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockSharesAcquired" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury shares acquired (in shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockSharesAcquired_fc89da33-a2d7-4996-981c-fd77b0960829_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockSharesAcquired" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Shares, Acquired</link:label>
    <link:label id="lab_us-gaap_TreasuryStockSharesAcquired_label_en-US" xlink:label="lab_us-gaap_TreasuryStockSharesAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Shares, Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockSharesAcquired" xlink:to="lab_us-gaap_TreasuryStockSharesAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_81c68e2f-1782-47bd-a8f0-81fd31c2e57a_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentLineItems" xlink:to="lab_us-gaap_DebtInstrumentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesOther_dfe9b02e-7c3f-491f-9a06-ca9381bdfefd_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesOther" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Other</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesOther_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesOther" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilitiesOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesOther" xlink:to="lab_us-gaap_DeferredTaxLiabilitiesOther" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock_2cb8ece7-e628-4326-aae0-7cc5a4e1e2de_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Future Lease Payments</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Future Minimum Rental Payments for Operating Leases [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_cah_A3.41Notesdue2027Member_33ba5332-eb57-475e-b5b4-3c71b49a728f_terseLabel_en-US" xlink:label="lab_cah_A3.41Notesdue2027Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.41% Notes due fiscal 2027</link:label>
    <link:label id="lab_cah_A3.41Notesdue2027Member_label_en-US" xlink:label="lab_cah_A3.41Notesdue2027Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.41% Notes due 2027 [Member]</link:label>
    <link:label id="lab_cah_A3.41Notesdue2027Member_documentation_en-US" xlink:label="lab_cah_A3.41Notesdue2027Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.41% Notes due 2027</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cah_A3.41Notesdue2027Member" xlink:href="cah-20210630.xsd#cah_A3.41Notesdue2027Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_A3.41Notesdue2027Member" xlink:to="lab_cah_A3.41Notesdue2027Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SeveranceCosts1_af83b570-38f3-45fb-a466-6fd3d6f09679_verboseLabel_en-US" xlink:label="lab_us-gaap_SeveranceCosts1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee-related costs</link:label>
    <link:label id="lab_us-gaap_SeveranceCosts1_label_en-US" xlink:label="lab_us-gaap_SeveranceCosts1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Severance Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeveranceCosts1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeveranceCosts1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SeveranceCosts1" xlink:to="lab_us-gaap_SeveranceCosts1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityTable_435b1978-2cf2-4be2-9fed-3c4fa8151580_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility [Table]</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityTable_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityTable" xlink:to="lab_us-gaap_LineOfCreditFacilityTable" xlink:type="arc" order="1"/>
    <link:label id="lab_cah_OperatingLeaseMember_c5359ce9-bcc4-41a3-b105-a1e09c570fee_terseLabel_en-US" xlink:label="lab_cah_OperatingLeaseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Leases</link:label>
    <link:label id="lab_cah_OperatingLeaseMember_label_en-US" xlink:label="lab_cah_OperatingLeaseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease [Member]</link:label>
    <link:label id="lab_cah_OperatingLeaseMember_documentation_en-US" xlink:label="lab_cah_OperatingLeaseMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cah_OperatingLeaseMember" xlink:href="cah-20210630.xsd#cah_OperatingLeaseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_OperatingLeaseMember" xlink:to="lab_cah_OperatingLeaseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_a1c5bd6b-234a-4f8f-8e4f-89326ec9e698_terseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification out of Accumulated Other Comprehensive Loss [Table]</link:label>
    <link:label id="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_label_en-US" xlink:label="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification out of Accumulated Other Comprehensive Income [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable" xlink:to="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtAndCapitalLeaseObligations_7ef21d79-37cb-4cf2-bfb7-0988347f4055_totalLabel_en-US" xlink:label="lab_us-gaap_DebtAndCapitalLeaseObligations" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_DebtAndCapitalLeaseObligations_eae8bb7d-f9e9-41de-b474-ab28a1d986ba_verboseLabel_en-US" xlink:label="lab_us-gaap_DebtAndCapitalLeaseObligations" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Carrying amount</link:label>
    <link:label id="lab_us-gaap_DebtAndCapitalLeaseObligations_label_en-US" xlink:label="lab_us-gaap_DebtAndCapitalLeaseObligations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt and Lease Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtAndCapitalLeaseObligations" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtAndCapitalLeaseObligations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtAndCapitalLeaseObligations" xlink:to="lab_us-gaap_DebtAndCapitalLeaseObligations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesFairValueDisclosureAbstract_ff623e2f-372d-425d-af71-ade1c600024d_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesFairValueDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities:</link:label>
    <link:label id="lab_us-gaap_LiabilitiesFairValueDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesFairValueDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Fair Value Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesFairValueDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract" xlink:to="lab_us-gaap_LiabilitiesFairValueDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTable_35f49922-1085-4cd1-8c8c-55c6119ed2c6_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTable" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTable_4ab67742-eb7d-41a2-93a7-4139133c1cc0_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable" xlink:to="lab_us-gaap_ScheduleOfGoodwillTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_e7ea09a2-1316-4636-a3cb-03fb9cd260fd_terseLabel_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total share-based compensation expense</link:label>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_label_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllocatedShareBasedCompensationExpense" xlink:to="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_edcda103-597c-4fb0-8333-d725a9be03c9_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average remaining contractual life of exercisable options</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntangibleAssetsNetIncludingGoodwill_fb24e505-6040-4fa1-8437-ef51d2218ae5_terseLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetIncludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and other intangibles, net</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsNetIncludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetIncludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Net (Including Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetIncludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsNetIncludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsNetIncludingGoodwill" xlink:to="lab_us-gaap_IntangibleAssetsNetIncludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_cah_AlamedaCountyMember_32a8738d-404b-4e27-9a8f-2565075b9536_terseLabel_en-US" xlink:label="lab_cah_AlamedaCountyMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Alameda County [Member]</link:label>
    <link:label id="lab_cah_AlamedaCountyMember_label_en-US" xlink:label="lab_cah_AlamedaCountyMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Alameda County [Member]</link:label>
    <link:label id="lab_cah_AlamedaCountyMember_documentation_en-US" xlink:label="lab_cah_AlamedaCountyMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Alameda County [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cah_AlamedaCountyMember" xlink:href="cah-20210630.xsd#cah_AlamedaCountyMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_AlamedaCountyMember" xlink:to="lab_cah_AlamedaCountyMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeInstrumentsEffectOnOtherComprehensiveIncomeLossTableTextBlock_fb344c59-6153-4aab-8514-66f6c9cc050d_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeInstrumentsEffectOnOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Gain/(Loss) Included in AOCI for Derivative Instruments</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeInstrumentsEffectOnOtherComprehensiveIncomeLossTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeInstrumentsEffectOnOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Derivative Instruments, Effect on Other Comprehensive Income (Loss) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsEffectOnOtherComprehensiveIncomeLossTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDerivativeInstrumentsEffectOnOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDerivativeInstrumentsEffectOnOtherComprehensiveIncomeLossTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfDerivativeInstrumentsEffectOnOtherComprehensiveIncomeLossTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_cah_EffectiveIncomeTaxRateReconciliationTaxEffectOfForeignOperations_1d1128cf-fd71-448e-927e-c036236e454b_terseLabel_en-US" xlink:label="lab_cah_EffectiveIncomeTaxRateReconciliationTaxEffectOfForeignOperations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Tax Effect of Foreign Operations</link:label>
    <link:label id="lab_cah_EffectiveIncomeTaxRateReconciliationTaxEffectOfForeignOperations_label_en-US" xlink:label="lab_cah_EffectiveIncomeTaxRateReconciliationTaxEffectOfForeignOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Tax Effect of Foreign Operations</link:label>
    <link:label id="lab_cah_EffectiveIncomeTaxRateReconciliationTaxEffectOfForeignOperations_documentation_en-US" xlink:label="lab_cah_EffectiveIncomeTaxRateReconciliationTaxEffectOfForeignOperations" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Tax Effect of Foreign Operations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cah_EffectiveIncomeTaxRateReconciliationTaxEffectOfForeignOperations" xlink:href="cah-20210630.xsd#cah_EffectiveIncomeTaxRateReconciliationTaxEffectOfForeignOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_EffectiveIncomeTaxRateReconciliationTaxEffectOfForeignOperations" xlink:to="lab_cah_EffectiveIncomeTaxRateReconciliationTaxEffectOfForeignOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProfitLoss_9ea09fff-8827-4cc0-ab52-77ebebb18921_totalLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net earnings</link:label>
    <link:label id="lab_us-gaap_ProfitLoss_bcf8411e-3f26-44d8-8241-5d1aff7363fc_terseLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net earnings</link:label>
    <link:label id="lab_us-gaap_ProfitLoss_28f0c493-22b2-4af4-84b0-0b3594de0606_verboseLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss), Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:label id="lab_us-gaap_ProfitLoss_label_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss), Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProfitLoss" xlink:to="lab_us-gaap_ProfitLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_cah_DerivativesHedgeDiscontinuancesTerminationofHedgingInstrumentAmount_c6e0d6aa-c541-4b0e-92bc-8682c27ef0d9_terseLabel_en-US" xlink:label="lab_cah_DerivativesHedgeDiscontinuancesTerminationofHedgingInstrumentAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives, terminated notional amounts</link:label>
    <link:label id="lab_cah_DerivativesHedgeDiscontinuancesTerminationofHedgingInstrumentAmount_label_en-US" xlink:label="lab_cah_DerivativesHedgeDiscontinuancesTerminationofHedgingInstrumentAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives, Hedge Discontinuances, Termination of Hedging Instrument, Amount</link:label>
    <link:label id="lab_cah_DerivativesHedgeDiscontinuancesTerminationofHedgingInstrumentAmount_documentation_en-US" xlink:label="lab_cah_DerivativesHedgeDiscontinuancesTerminationofHedgingInstrumentAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives, Hedge Discontinuances, Termination of Hedging Instrument, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cah_DerivativesHedgeDiscontinuancesTerminationofHedgingInstrumentAmount" xlink:href="cah-20210630.xsd#cah_DerivativesHedgeDiscontinuancesTerminationofHedgingInstrumentAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_DerivativesHedgeDiscontinuancesTerminationofHedgingInstrumentAmount" xlink:to="lab_cah_DerivativesHedgeDiscontinuancesTerminationofHedgingInstrumentAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryValuationReserves_21c204f7-1e6c-4ddd-b49e-38e8acebbfa5_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryValuationReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reserves for excess and obsolete inventory</link:label>
    <link:label id="lab_us-gaap_InventoryValuationReserves_label_en-US" xlink:label="lab_us-gaap_InventoryValuationReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory Valuation Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryValuationReserves" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryValuationReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryValuationReserves" xlink:to="lab_us-gaap_InventoryValuationReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_fe86c21c-4943-4ec3-bef6-a2a08870ef3a_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Income Before Income Tax, Domestic and Foreign</link:label>
    <link:label id="lab_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Income before Income Tax, Domestic and Foreign [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonClassAMember_137e463b-255c-48f7-bbe7-b1e643e20621_terseLabel_en-US" xlink:label="lab_us-gaap_CommonClassAMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Class A</link:label>
    <link:label id="lab_us-gaap_CommonClassAMember_label_en-US" xlink:label="lab_us-gaap_CommonClassAMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Class A [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassAMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonClassAMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonClassAMember" xlink:to="lab_us-gaap_CommonClassAMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock_c9d88854-edec-4c42-a1c8-59cf41efce0a_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Outstanding Instruments</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Derivative Instruments [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDerivativeInstrumentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock" xlink:to="lab_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_cah_EffectiveIncomeTaxRateReconciliationLossCarrybackClaims_f690cbd6-3a51-4044-94c6-84717a54b8bd_terseLabel_en-US" xlink:label="lab_cah_EffectiveIncomeTaxRateReconciliationLossCarrybackClaims" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Loss Carryback Claims</link:label>
    <link:label id="lab_cah_EffectiveIncomeTaxRateReconciliationLossCarrybackClaims_label_en-US" xlink:label="lab_cah_EffectiveIncomeTaxRateReconciliationLossCarrybackClaims" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Loss Carryback Claims</link:label>
    <link:label id="lab_cah_EffectiveIncomeTaxRateReconciliationLossCarrybackClaims_documentation_en-US" xlink:label="lab_cah_EffectiveIncomeTaxRateReconciliationLossCarrybackClaims" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Loss Carryback Claims</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cah_EffectiveIncomeTaxRateReconciliationLossCarrybackClaims" xlink:href="cah-20210630.xsd#cah_EffectiveIncomeTaxRateReconciliationLossCarrybackClaims"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_EffectiveIncomeTaxRateReconciliationLossCarrybackClaims" xlink:to="lab_cah_EffectiveIncomeTaxRateReconciliationLossCarrybackClaims" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainOnSaleOfInvestments_5f90bdba-ab1f-476e-a98c-807c14cf23de_terseLabel_en-US" xlink:label="lab_us-gaap_GainOnSaleOfInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain on Sale of Investments</link:label>
    <link:label id="lab_us-gaap_GainOnSaleOfInvestments_label_en-US" xlink:label="lab_us-gaap_GainOnSaleOfInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain on Sale of Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainOnSaleOfInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainOnSaleOfInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainOnSaleOfInvestments" xlink:to="lab_us-gaap_GainOnSaleOfInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_f3f45f78-db97-45c3-a22b-32de6059de32_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current assets:</link:label>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrentAbstract" xlink:to="lab_us-gaap_AssetsCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_56235e7d-8403-4dbb-9119-3bd514df2b70_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:to="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsGross_dffb8dc2-c2b6-4df6-98db-01815f9fcca6_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Intangible</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsGross_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_750a7f7a-7813-4037-bdc5-146f6bc09b7c_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_62dc674a-1352-4507-9082-4a691600d820_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_cah_OpioidLitigationAxis_e73f8eb6-ba03-4c73-8f58-9b401370884e_terseLabel_en-US" xlink:label="lab_cah_OpioidLitigationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Opioid Litigation [Axis]</link:label>
    <link:label id="lab_cah_OpioidLitigationAxis_label_en-US" xlink:label="lab_cah_OpioidLitigationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Opioid Litigation [Axis]</link:label>
    <link:label id="lab_cah_OpioidLitigationAxis_documentation_en-US" xlink:label="lab_cah_OpioidLitigationAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Opioid Litigation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cah_OpioidLitigationAxis" xlink:href="cah-20210630.xsd#cah_OpioidLitigationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_OpioidLitigationAxis" xlink:to="lab_cah_OpioidLitigationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_2f2dca87-5ee5-408a-a004-bcacb3c392ff_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_cah_AdditionalStockOptionPlanDataTableTextBlock_5f647c4f-31ed-40b6-a2c7-cb158044bce7_terseLabel_en-US" xlink:label="lab_cah_AdditionalStockOptionPlanDataTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Additional Data Related to Stock Option Activity</link:label>
    <link:label id="lab_cah_AdditionalStockOptionPlanDataTableTextBlock_label_en-US" xlink:label="lab_cah_AdditionalStockOptionPlanDataTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Stock Option Plan Data [Table Text Block]</link:label>
    <link:label id="lab_cah_AdditionalStockOptionPlanDataTableTextBlock_documentation_en-US" xlink:label="lab_cah_AdditionalStockOptionPlanDataTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">A disclosure of additional data related to all stock option activity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cah_AdditionalStockOptionPlanDataTableTextBlock" xlink:href="cah-20210630.xsd#cah_AdditionalStockOptionPlanDataTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_AdditionalStockOptionPlanDataTableTextBlock" xlink:to="lab_cah_AdditionalStockOptionPlanDataTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InternalRevenueServiceIRSMember_3b209f52-392b-4681-9833-9e40eaf8c527_terseLabel_en-US" xlink:label="lab_us-gaap_InternalRevenueServiceIRSMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Federal</link:label>
    <link:label id="lab_us-gaap_InternalRevenueServiceIRSMember_label_en-US" xlink:label="lab_us-gaap_InternalRevenueServiceIRSMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Internal Revenue Service (IRS) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InternalRevenueServiceIRSMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InternalRevenueServiceIRSMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InternalRevenueServiceIRSMember" xlink:to="lab_us-gaap_InternalRevenueServiceIRSMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure_d0b2cf60-dfd4-48cd-b4c9-37670636ee0f_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:to="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_519d8617-5e1d-419d-b11d-55f42af6d838_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercised (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_52bd5073-99aa-4999-a768-b117b8b58518_totalLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total other comprehensive income/(loss), net of tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsRecurringMember_f0f2742c-e3cb-4ae2-bc38-c212fa0f8027_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurements, Recurring</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsRecurringMember_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsRecurringMember" xlink:to="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LitigationReserve_d5a3aba5-7565-4c02-a6da-d12b7d82c6ce_terseLabel_en-US" xlink:label="lab_us-gaap_LitigationReserve" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated Litigation Liability</link:label>
    <link:label id="lab_us-gaap_LitigationReserve_label_en-US" xlink:label="lab_us-gaap_LitigationReserve" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated Litigation Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationReserve" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LitigationReserve"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LitigationReserve" xlink:to="lab_us-gaap_LitigationReserve" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_cbbb479b-ba70-4cba-bed4-48caeb5ec23e_terseLabel_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_label_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CurrentFiscalYearEndDate" xlink:to="lab_dei_CurrentFiscalYearEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_cah_MedicalMemberMember_f5cc4c4a-9d99-4971-b56b-a403180577be_terseLabel_en-US" xlink:label="lab_cah_MedicalMemberMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical</link:label>
    <link:label id="lab_cah_MedicalMemberMember_label_en-US" xlink:label="lab_cah_MedicalMemberMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical Member [Member]</link:label>
    <link:label id="lab_cah_MedicalMemberMember_documentation_en-US" xlink:label="lab_cah_MedicalMemberMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cah_MedicalMemberMember" xlink:href="cah-20210630.xsd#cah_MedicalMemberMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_MedicalMemberMember" xlink:to="lab_cah_MedicalMemberMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_255ad146-b14d-4cf6-a8e1-893e271993f6_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shareholders' Equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Note Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:to="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock_48c79e70-1235-4c38-80a9-7ce813f7d30f_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Groups, Including Discontinued Operations</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Groups, Including Discontinued Operations [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" xlink:to="lab_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_88463ec8-f472-4c6e-bf78-647ac11f52f5_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_25e295e4-d27f-4d91-9ec4-11cb1b116d90_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expiration of the statute of limitations</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_cac2c4ab-959f-49bd-8260-cff2168dfe2e_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated annual amortization of intangible assets - 2026</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_cah_RevenueRecognitionReserveforSalesReturnsandAllowances_7fa67743-db3b-4815-8796-99950022e5a4_terseLabel_en-US" xlink:label="lab_cah_RevenueRecognitionReserveforSalesReturnsandAllowances" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrual for estimated sales returns and allowances</link:label>
    <link:label id="lab_cah_RevenueRecognitionReserveforSalesReturnsandAllowances_label_en-US" xlink:label="lab_cah_RevenueRecognitionReserveforSalesReturnsandAllowances" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue Recognition, Reserve for Sales Returns and Allowances</link:label>
    <link:label id="lab_cah_RevenueRecognitionReserveforSalesReturnsandAllowances_documentation_en-US" xlink:label="lab_cah_RevenueRecognitionReserveforSalesReturnsandAllowances" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue Recognition, Reserve for Sales Returns and Allowances</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cah_RevenueRecognitionReserveforSalesReturnsandAllowances" xlink:href="cah-20210630.xsd#cah_RevenueRecognitionReserveforSalesReturnsandAllowances"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_RevenueRecognitionReserveforSalesReturnsandAllowances" xlink:to="lab_cah_RevenueRecognitionReserveforSalesReturnsandAllowances" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrencySwapMember_11574cae-c349-48ce-9344-869d02f32e1d_terseLabel_en-US" xlink:label="lab_us-gaap_CurrencySwapMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Currency Swap [Member]</link:label>
    <link:label id="lab_us-gaap_CurrencySwapMember_label_en-US" xlink:label="lab_us-gaap_CurrencySwapMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Currency Swap [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrencySwapMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrencySwapMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrencySwapMember" xlink:to="lab_us-gaap_CurrencySwapMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cah_LossContingencyLawsuitsNumber_95a8b728-e28c-4c0f-b84f-0eaf954aede4_terseLabel_en-US" xlink:label="lab_cah_LossContingencyLawsuitsNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Lawsuits, Number</link:label>
    <link:label id="lab_cah_LossContingencyLawsuitsNumber_label_en-US" xlink:label="lab_cah_LossContingencyLawsuitsNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Lawsuits, Number</link:label>
    <link:label id="lab_cah_LossContingencyLawsuitsNumber_documentation_en-US" xlink:label="lab_cah_LossContingencyLawsuitsNumber" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Lawsuits, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cah_LossContingencyLawsuitsNumber" xlink:href="cah-20210630.xsd#cah_LossContingencyLawsuitsNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_LossContingencyLawsuitsNumber" xlink:to="lab_cah_LossContingencyLawsuitsNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_cah_A3.75Notesdue2026Member_9a1ae50a-8b15-4c43-9545-df964b7f0eec_terseLabel_en-US" xlink:label="lab_cah_A3.75Notesdue2026Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.75% Notes due 2025</link:label>
    <link:label id="lab_cah_A3.75Notesdue2026Member_label_en-US" xlink:label="lab_cah_A3.75Notesdue2026Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.75% Notes due 2026 [Member]</link:label>
    <link:label id="lab_cah_A3.75Notesdue2026Member_documentation_en-US" xlink:label="lab_cah_A3.75Notesdue2026Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.75% Notes due 2026</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cah_A3.75Notesdue2026Member" xlink:href="cah-20210630.xsd#cah_A3.75Notesdue2026Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_A3.75Notesdue2026Member" xlink:to="lab_cah_A3.75Notesdue2026Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_94c1248f-9c40-4292-a2dd-f081920a71e9_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash provided by/(used in) investing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock_83a0f79e-b6af-4671-bdeb-052d1b67e486_terseLabel_en-US" xlink:label="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Profit by Reportable Segment</link:label>
    <link:label id="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock_label_en-US" xlink:label="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock" xlink:to="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BuildingAndBuildingImprovementsMember_9f0a7e71-8a2e-487c-a884-16aac5e62c54_terseLabel_en-US" xlink:label="lab_us-gaap_BuildingAndBuildingImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Building and Improvements</link:label>
    <link:label id="lab_us-gaap_BuildingAndBuildingImprovementsMember_label_en-US" xlink:label="lab_us-gaap_BuildingAndBuildingImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Building and Building Improvements [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingAndBuildingImprovementsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BuildingAndBuildingImprovementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BuildingAndBuildingImprovementsMember" xlink:to="lab_us-gaap_BuildingAndBuildingImprovementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_e88bc6c5-d183-4530-be64-7ce38228c9e5_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in operating assets and liabilities, net of effects from acquisitions and divestitures:</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Operating Capital [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeAssetNotionalAmount_d43f9ff7-a0e3-48a9-bc62-9d26aa38991a_verboseLabel_en-US" xlink:label="lab_us-gaap_DerivativeAssetNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, notional amount</link:label>
    <link:label id="lab_us-gaap_DerivativeAssetNotionalAmount_14ac59e0-b5c9-49c2-b87c-4207145a143e_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeAssetNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notional Amount</link:label>
    <link:label id="lab_us-gaap_DerivativeAssetNotionalAmount_label_en-US" xlink:label="lab_us-gaap_DerivativeAssetNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Asset, Notional Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetNotionalAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeAssetNotionalAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeAssetNotionalAmount" xlink:to="lab_us-gaap_DerivativeAssetNotionalAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_20bb6453-7b9e-469b-93f2-7169c3ea122c_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vested (in usd per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfStockDomain_bfb28713-4ad3-4fde-9d14-22ae3e3f56df_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfStockDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Domain]</link:label>
    <link:label id="lab_us-gaap_ClassOfStockDomain_label_en-US" xlink:label="lab_us-gaap_ClassOfStockDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfStockDomain" xlink:to="lab_us-gaap_ClassOfStockDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets_2ee59c7c-fba5-447f-b720-4cba09a7929e_negatedLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Goodwill and Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets" xlink:to="lab_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_eb737fde-51f9-4b1d-b03d-ca265d6a5364_verboseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Maximum Borrowing Capacity</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_13b551d7-7300-4bc4-aba8-066a4ec87c57_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum borrowing capacity</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Maximum Borrowing Capacity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:to="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:type="arc" order="1"/>
    <link:label id="lab_cah_PriorYearRecoveriesMember_705b885c-a6af-4a28-8f3c-7a904b93f8dc_terseLabel_en-US" xlink:label="lab_cah_PriorYearRecoveriesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prior Year Recoveries</link:label>
    <link:label id="lab_cah_PriorYearRecoveriesMember_label_en-US" xlink:label="lab_cah_PriorYearRecoveriesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prior Year Recoveries [Member]</link:label>
    <link:label id="lab_cah_PriorYearRecoveriesMember_documentation_en-US" xlink:label="lab_cah_PriorYearRecoveriesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prior Year Recoveries [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cah_PriorYearRecoveriesMember" xlink:href="cah-20210630.xsd#cah_PriorYearRecoveriesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_PriorYearRecoveriesMember" xlink:to="lab_cah_PriorYearRecoveriesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_30db873f-a02e-4271-ab3d-da2d370167ee_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency translation adjustments and other</link:label>
    <link:label id="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_label_en-US" xlink:label="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Foreign Currency Translation Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillForeignCurrencyTranslationGainLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:to="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_e99a944d-5f21-4913-857e-76253a5e812e_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_label_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems" xlink:to="lab_us-gaap_SegmentReportingInformationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableCurrentAndNoncurrent_132208b7-1ff3-42f5-afee-f8b632a767f9_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable</link:label>
    <link:label id="lab_us-gaap_AccountsPayableCurrentAndNoncurrent_label_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrentAndNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableCurrentAndNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableCurrentAndNoncurrent" xlink:to="lab_us-gaap_AccountsPayableCurrentAndNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityLineItems_a7fa4408-78c4-4710-a98d-ca3e91a74557_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility [Line Items]</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityLineItems_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems" xlink:to="lab_us-gaap_LineOfCreditFacilityLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_79f0ed85-cb1c-455e-824b-dd1c6836317a_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentNameDomain" xlink:to="lab_us-gaap_DebtInstrumentNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsCurrent_074d9c9c-eddc-4079-891c-c187b0c524cf_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses and other</link:label>
    <link:label id="lab_us-gaap_OtherAssetsCurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsCurrent" xlink:to="lab_us-gaap_OtherAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_df378fa6-55fb-4d19-b321-be866a911048_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Expenses and Other</link:label>
    <link:label id="lab_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_label_en-US" xlink:label="lab_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Expenses and Other Current Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" xlink:to="lab_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cah_AmortizationandOtherAcquisitionRelatedCostsPolicyPolicyTextBlock_8613de22-3e6f-4978-97b4-500add7106fd_terseLabel_en-US" xlink:label="lab_cah_AmortizationandOtherAcquisitionRelatedCostsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization and Other Acquisition-Related Costs</link:label>
    <link:label id="lab_cah_AmortizationandOtherAcquisitionRelatedCostsPolicyPolicyTextBlock_label_en-US" xlink:label="lab_cah_AmortizationandOtherAcquisitionRelatedCostsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization and Other Acquisition Related Costs Policy [Policy Text Block]</link:label>
    <link:label id="lab_cah_AmortizationandOtherAcquisitionRelatedCostsPolicyPolicyTextBlock_documentation_en-US" xlink:label="lab_cah_AmortizationandOtherAcquisitionRelatedCostsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of accounting policy for the costs incurred during and relating to an acquisition. These costs specifically include transaction and integration costs; changes in fair value of contingent consideration obligations and amortization of acquisition-related intangible assets, and are recorded within amortization and other acquisition-related costs.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cah_AmortizationandOtherAcquisitionRelatedCostsPolicyPolicyTextBlock" xlink:href="cah-20210630.xsd#cah_AmortizationandOtherAcquisitionRelatedCostsPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_AmortizationandOtherAcquisitionRelatedCostsPolicyPolicyTextBlock" xlink:to="lab_cah_AmortizationandOtherAcquisitionRelatedCostsPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeLiability_7bb2fdd7-4ae3-4b9d-aef1-26da3ae981e3_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities</link:label>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeLiability_label_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Liability, Fair Value, Gross Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeFairValueOfDerivativeLiability" xlink:to="lab_us-gaap_DerivativeFairValueOfDerivativeLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesBalance_2620155d-bedf-449e-9c5d-8121cfc8b8ba_terseLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesBalance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves, Amount</link:label>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesBalance_label_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesBalance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesBalance" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationAllowancesAndReservesBalance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesBalance" xlink:to="lab_us-gaap_ValuationAllowancesAndReservesBalance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfSalesMember_7ac05005-0737-4e82-ad0f-12e12fa59f09_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfSalesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Products Sold</link:label>
    <link:label id="lab_us-gaap_CostOfSalesMember_label_en-US" xlink:label="lab_us-gaap_CostOfSalesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Sales [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfSalesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfSalesMember" xlink:to="lab_us-gaap_CostOfSalesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllowanceForLoanAndLeaseLossesMember_03d14933-9f2f-4780-aa41-0fb5245524b9_terseLabel_en-US" xlink:label="lab_us-gaap_AllowanceForLoanAndLeaseLossesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Allowance, Loan and Lease Loss [Member]</link:label>
    <link:label id="lab_us-gaap_AllowanceForLoanAndLeaseLossesMember_label_en-US" xlink:label="lab_us-gaap_AllowanceForLoanAndLeaseLossesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Allowance, Loan and Lease Loss [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForLoanAndLeaseLossesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllowanceForLoanAndLeaseLossesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForLoanAndLeaseLossesMember" xlink:to="lab_us-gaap_AllowanceForLoanAndLeaseLossesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryPolicyTextBlock_59f3a63a-3740-4a10-b126-ac4ddae5720c_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_InventoryPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_InventoryPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryPolicyTextBlock" xlink:to="lab_us-gaap_InventoryPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentForeignTaxExpenseBenefit_ecd24d57-bb48-43b7-8c3c-1380668c868c_terseLabel_en-US" xlink:label="lab_us-gaap_CurrentForeignTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-U.S.</link:label>
    <link:label id="lab_us-gaap_CurrentForeignTaxExpenseBenefit_e360afd6-1a90-40a1-b36c-dbe10461b148_verboseLabel_en-US" xlink:label="lab_us-gaap_CurrentForeignTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Foreign Tax Expense (Benefit)</link:label>
    <link:label id="lab_us-gaap_CurrentForeignTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_CurrentForeignTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Foreign Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentForeignTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentForeignTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentForeignTaxExpenseBenefit" xlink:to="lab_us-gaap_CurrentForeignTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DevelopedTechnologyRightsMember_c78e5a1d-14c4-49e6-8b31-4d27cb05eb95_verboseLabel_en-US" xlink:label="lab_us-gaap_DevelopedTechnologyRightsMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Developed technology and other</link:label>
    <link:label id="lab_us-gaap_DevelopedTechnologyRightsMember_label_en-US" xlink:label="lab_us-gaap_DevelopedTechnologyRightsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Developed Technology Rights [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DevelopedTechnologyRightsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DevelopedTechnologyRightsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DevelopedTechnologyRightsMember" xlink:to="lab_us-gaap_DevelopedTechnologyRightsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskByBenchmarkAxis_93d5ae31-0667-4519-830c-b170ee0c8377_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Axis]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskByBenchmarkAxis_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:to="lab_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_892e1b95-6bf2-41f3-8571-143ac9a0704e_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>12
<FILENAME>cah-20210630_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:b63e0697-7630-4efc-9622-5764c41287f3,g:18dc0520-9457-4463-b618-29c4ac061652-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.cardinal.com/role/CoverPage" xlink:type="simple" xlink:href="cah-20210630.xsd#CoverPage"/>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/CoverPage" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_ca4de85f-b85f-4995-a426-b93a7d4fc325" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_1afb84a5-7c0b-4d7a-8ede-00e268248c1f" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ca4de85f-b85f-4995-a426-b93a7d4fc325" xlink:to="loc_dei_DocumentType_1afb84a5-7c0b-4d7a-8ede-00e268248c1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentAnnualReport_369909ac-7495-4c4d-8ab9-d0b4231f298a" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentAnnualReport"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ca4de85f-b85f-4995-a426-b93a7d4fc325" xlink:to="loc_dei_DocumentAnnualReport_369909ac-7495-4c4d-8ab9-d0b4231f298a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_6ed70294-02e6-474d-aad3-11e4adfd2e87" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentTransitionReport"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ca4de85f-b85f-4995-a426-b93a7d4fc325" xlink:to="loc_dei_DocumentTransitionReport_6ed70294-02e6-474d-aad3-11e4adfd2e87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_71eee1b8-1803-4534-a423-107c3c64c6b4" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ca4de85f-b85f-4995-a426-b93a7d4fc325" xlink:to="loc_dei_EntityFileNumber_71eee1b8-1803-4534-a423-107c3c64c6b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_19e065e9-126c-47cc-91f1-6dac1295b262" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ca4de85f-b85f-4995-a426-b93a7d4fc325" xlink:to="loc_dei_EntityRegistrantName_19e065e9-126c-47cc-91f1-6dac1295b262" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_bdc9bd57-91ff-43e2-b67e-ed8473a7e3e7" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ca4de85f-b85f-4995-a426-b93a7d4fc325" xlink:to="loc_dei_EntityIncorporationStateCountryCode_bdc9bd57-91ff-43e2-b67e-ed8473a7e3e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_23ecb604-f710-4a73-8912-faef76e77219" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ca4de85f-b85f-4995-a426-b93a7d4fc325" xlink:to="loc_dei_EntityTaxIdentificationNumber_23ecb604-f710-4a73-8912-faef76e77219" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_826fd2a2-3784-4c42-9211-04d530108da6" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ca4de85f-b85f-4995-a426-b93a7d4fc325" xlink:to="loc_dei_EntityAddressAddressLine1_826fd2a2-3784-4c42-9211-04d530108da6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_9713536e-06e2-45a6-9cbc-dd4538f6095d" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ca4de85f-b85f-4995-a426-b93a7d4fc325" xlink:to="loc_dei_EntityAddressCityOrTown_9713536e-06e2-45a6-9cbc-dd4538f6095d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_9000ae48-d72f-47fb-9e11-328cf7c35e88" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ca4de85f-b85f-4995-a426-b93a7d4fc325" xlink:to="loc_dei_EntityAddressStateOrProvince_9000ae48-d72f-47fb-9e11-328cf7c35e88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_f94aab95-2447-4b9a-8a25-43cfd6ecd09e" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ca4de85f-b85f-4995-a426-b93a7d4fc325" xlink:to="loc_dei_EntityAddressPostalZipCode_f94aab95-2447-4b9a-8a25-43cfd6ecd09e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_055148ec-bfe1-4265-ab4a-be74af0524a3" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ca4de85f-b85f-4995-a426-b93a7d4fc325" xlink:to="loc_dei_CityAreaCode_055148ec-bfe1-4265-ab4a-be74af0524a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_19704ec3-3318-4308-aaa5-bfa67eee15f1" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ca4de85f-b85f-4995-a426-b93a7d4fc325" xlink:to="loc_dei_LocalPhoneNumber_19704ec3-3318-4308-aaa5-bfa67eee15f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_f6b9c627-372f-4edb-85a1-eb305e6f533e" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ca4de85f-b85f-4995-a426-b93a7d4fc325" xlink:to="loc_dei_Security12bTitle_f6b9c627-372f-4edb-85a1-eb305e6f533e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_8058dd68-6208-4945-a6f3-dee49c184e6e" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ca4de85f-b85f-4995-a426-b93a7d4fc325" xlink:to="loc_dei_TradingSymbol_8058dd68-6208-4945-a6f3-dee49c184e6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_f052a6f4-c250-4902-85df-fdc323b529a2" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ca4de85f-b85f-4995-a426-b93a7d4fc325" xlink:to="loc_dei_SecurityExchangeName_f052a6f4-c250-4902-85df-fdc323b529a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityWellKnownSeasonedIssuer_ac2548e0-3e96-49a6-969e-175bd350209d" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityWellKnownSeasonedIssuer"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ca4de85f-b85f-4995-a426-b93a7d4fc325" xlink:to="loc_dei_EntityWellKnownSeasonedIssuer_ac2548e0-3e96-49a6-969e-175bd350209d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityVoluntaryFilers_98d981ca-a716-4806-b5fb-c60526bf5934" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityVoluntaryFilers"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ca4de85f-b85f-4995-a426-b93a7d4fc325" xlink:to="loc_dei_EntityVoluntaryFilers_98d981ca-a716-4806-b5fb-c60526bf5934" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_29f3397f-374c-4109-aeca-59b6f0999c67" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCurrentReportingStatus"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ca4de85f-b85f-4995-a426-b93a7d4fc325" xlink:to="loc_dei_EntityCurrentReportingStatus_29f3397f-374c-4109-aeca-59b6f0999c67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_2ae3543a-9205-41d7-9a59-f92a835f17bf" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ca4de85f-b85f-4995-a426-b93a7d4fc325" xlink:to="loc_dei_EntityInteractiveDataCurrent_2ae3543a-9205-41d7-9a59-f92a835f17bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_b3258313-528b-443f-920d-c4aa8d5c1d8f" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFilerCategory"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ca4de85f-b85f-4995-a426-b93a7d4fc325" xlink:to="loc_dei_EntityFilerCategory_b3258313-528b-443f-920d-c4aa8d5c1d8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness_d73e5b5c-aca8-45d6-9ca2-d378bb108a59" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntitySmallBusiness"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ca4de85f-b85f-4995-a426-b93a7d4fc325" xlink:to="loc_dei_EntitySmallBusiness_d73e5b5c-aca8-45d6-9ca2-d378bb108a59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_3a00dfda-7d5d-4a8e-bee9-135370f94171" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ca4de85f-b85f-4995-a426-b93a7d4fc325" xlink:to="loc_dei_EntityEmergingGrowthCompany_3a00dfda-7d5d-4a8e-bee9-135370f94171" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_IcfrAuditorAttestationFlag_db169ace-b7e6-4377-a01c-28c5946a4b19" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_IcfrAuditorAttestationFlag"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ca4de85f-b85f-4995-a426-b93a7d4fc325" xlink:to="loc_dei_IcfrAuditorAttestationFlag_db169ace-b7e6-4377-a01c-28c5946a4b19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_e78e1ba9-8cbd-40c7-bf24-39b02cc3b397" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityShellCompany"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ca4de85f-b85f-4995-a426-b93a7d4fc325" xlink:to="loc_dei_EntityShellCompany_e78e1ba9-8cbd-40c7-bf24-39b02cc3b397" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityPublicFloat_5d71bd9e-bce1-4eb6-93bc-50521e0b6fd4" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityPublicFloat"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ca4de85f-b85f-4995-a426-b93a7d4fc325" xlink:to="loc_dei_EntityPublicFloat_5d71bd9e-bce1-4eb6-93bc-50521e0b6fd4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_c7281df5-b91e-4060-a18e-7e96d34d0793" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ca4de85f-b85f-4995-a426-b93a7d4fc325" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_c7281df5-b91e-4060-a18e-7e96d34d0793" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_30c88550-73bd-45c2-a99e-d9f0bd50f543" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ca4de85f-b85f-4995-a426-b93a7d4fc325" xlink:to="loc_dei_AmendmentFlag_30c88550-73bd-45c2-a99e-d9f0bd50f543" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_93dcc020-fc70-4f94-9147-9937790abb76" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ca4de85f-b85f-4995-a426-b93a7d4fc325" xlink:to="loc_dei_DocumentPeriodEndDate_93dcc020-fc70-4f94-9147-9937790abb76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_dba1975a-f093-488b-8eba-228c1e0ec888" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentFiscalYearFocus"/>
    <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ca4de85f-b85f-4995-a426-b93a7d4fc325" xlink:to="loc_dei_DocumentFiscalYearFocus_dba1975a-f093-488b-8eba-228c1e0ec888" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_cd7e3670-c781-48ba-9ee4-24df0a80c169" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:presentationArc order="31" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ca4de85f-b85f-4995-a426-b93a7d4fc325" xlink:to="loc_dei_DocumentFiscalPeriodFocus_cd7e3670-c781-48ba-9ee4-24df0a80c169" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_b4489726-b0cd-4df5-9521-4415936ab5fe" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="32" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ca4de85f-b85f-4995-a426-b93a7d4fc325" xlink:to="loc_dei_EntityCentralIndexKey_b4489726-b0cd-4df5-9521-4415936ab5fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_7b6770d9-20af-43b4-bf9e-584e88b4b9af" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:presentationArc order="33" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ca4de85f-b85f-4995-a426-b93a7d4fc325" xlink:to="loc_dei_CurrentFiscalYearEndDate_7b6770d9-20af-43b4-bf9e-584e88b4b9af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentsIncorporatedByReferenceTextBlock_90e5163e-e8b4-4b44-9d4c-26b09b6c91a4" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentsIncorporatedByReferenceTextBlock"/>
    <link:presentationArc order="34" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ca4de85f-b85f-4995-a426-b93a7d4fc325" xlink:to="loc_dei_DocumentsIncorporatedByReferenceTextBlock_90e5163e-e8b4-4b44-9d4c-26b09b6c91a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/ConsolidatedStatementsofEarnings" xlink:type="simple" xlink:href="cah-20210630.xsd#ConsolidatedStatementsofEarnings"/>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/ConsolidatedStatementsofEarnings" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract_c9748f7e-e018-407a-8b83-c4d6fb4b6b65" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_dd50427a-3454-4f29-bbf4-363b5174cdb9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Revenues"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_c9748f7e-e018-407a-8b83-c4d6fb4b6b65" xlink:to="loc_us-gaap_Revenues_dd50427a-3454-4f29-bbf4-363b5174cdb9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_caa9037b-eefa-461f-9caa-2761104a3f62" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_c9748f7e-e018-407a-8b83-c4d6fb4b6b65" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_caa9037b-eefa-461f-9caa-2761104a3f62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_a1a73a84-eb52-4f8a-a13d-c65f3e93e4f8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GrossProfit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_c9748f7e-e018-407a-8b83-c4d6fb4b6b65" xlink:to="loc_us-gaap_GrossProfit_a1a73a84-eb52-4f8a-a13d-c65f3e93e4f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract_5827636c-2f35-4118-a52c-3db04b0d1664" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_c9748f7e-e018-407a-8b83-c4d6fb4b6b65" xlink:to="loc_us-gaap_OperatingExpensesAbstract_5827636c-2f35-4118-a52c-3db04b0d1664" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_ba1a8d25-0ac5-4874-9846-708699894ae1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_5827636c-2f35-4118-a52c-3db04b0d1664" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_ba1a8d25-0ac5-4874-9846-708699894ae1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_dd9dc711-568a-48f7-ac57-a3578a724e8d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCharges"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_5827636c-2f35-4118-a52c-3db04b0d1664" xlink:to="loc_us-gaap_RestructuringCharges_dd9dc711-568a-48f7-ac57-a3578a724e8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_Amortizationandotheracquisitionrelatedcosts_d584ba3f-5e0a-41c5-aef6-1eb16c500051" xlink:href="cah-20210630.xsd#cah_Amortizationandotheracquisitionrelatedcosts"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_5827636c-2f35-4118-a52c-3db04b0d1664" xlink:to="loc_cah_Amortizationandotheracquisitionrelatedcosts_d584ba3f-5e0a-41c5-aef6-1eb16c500051" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges_187f6c8b-4346-4671-bf8b-c1ce8fa199ca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_5827636c-2f35-4118-a52c-3db04b0d1664" xlink:to="loc_us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges_187f6c8b-4346-4671-bf8b-c1ce8fa199ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossRelatedToLitigationSettlement_3325fe61-9bd4-4f74-be4f-d5424ee406c0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossRelatedToLitigationSettlement"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_5827636c-2f35-4118-a52c-3db04b0d1664" xlink:to="loc_us-gaap_GainLossRelatedToLitigationSettlement_3325fe61-9bd4-4f74-be4f-d5424ee406c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_763fa43d-16a0-424f-9fbe-77890869e02b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_c9748f7e-e018-407a-8b83-c4d6fb4b6b65" xlink:to="loc_us-gaap_OperatingIncomeLoss_763fa43d-16a0-424f-9fbe-77890869e02b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_378c64b6-55a1-4a37-b34d-a721656977f8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_c9748f7e-e018-407a-8b83-c4d6fb4b6b65" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_378c64b6-55a1-4a37-b34d-a721656977f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_6c74b4b4-84dc-4bd6-9b83-d965ee35e427" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpense"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_c9748f7e-e018-407a-8b83-c4d6fb4b6b65" xlink:to="loc_us-gaap_InterestExpense_6c74b4b4-84dc-4bd6-9b83-d965ee35e427" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_06d7b61f-dd44-4764-ab45-a234a1eea344" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_c9748f7e-e018-407a-8b83-c4d6fb4b6b65" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_06d7b61f-dd44-4764-ab45-a234a1eea344" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfInvestments_baab9265-44bf-4cca-a2b5-b1eb2854cf0a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnSaleOfInvestments"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_c9748f7e-e018-407a-8b83-c4d6fb4b6b65" xlink:to="loc_us-gaap_GainLossOnSaleOfInvestments_baab9265-44bf-4cca-a2b5-b1eb2854cf0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_a0851b03-1777-4d49-bbb2-65625d8bbe94" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_c9748f7e-e018-407a-8b83-c4d6fb4b6b65" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_a0851b03-1777-4d49-bbb2-65625d8bbe94" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_3b82017a-465f-4262-88a0-dd6cb050881d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_c9748f7e-e018-407a-8b83-c4d6fb4b6b65" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_3b82017a-465f-4262-88a0-dd6cb050881d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_ee53cf29-1710-4794-9f34-4bfbd71af774" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_c9748f7e-e018-407a-8b83-c4d6fb4b6b65" xlink:to="loc_us-gaap_ProfitLoss_ee53cf29-1710-4794-9f34-4bfbd71af774" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_7302c1c2-43bf-4268-aa1c-16ad645b2fd1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_c9748f7e-e018-407a-8b83-c4d6fb4b6b65" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_7302c1c2-43bf-4268-aa1c-16ad645b2fd1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_5ea3a920-5f58-4e36-b391-81da4ff974c2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_c9748f7e-e018-407a-8b83-c4d6fb4b6b65" xlink:to="loc_us-gaap_NetIncomeLoss_5ea3a920-5f58-4e36-b391-81da4ff974c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAbstract_be993370-bfdf-4129-8f22-6082a7846250" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasicAbstract"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_c9748f7e-e018-407a-8b83-c4d6fb4b6b65" xlink:to="loc_us-gaap_EarningsPerShareBasicAbstract_be993370-bfdf-4129-8f22-6082a7846250" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_f4ce4592-827b-4b54-8329-70b0369d32a4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAbstract_be993370-bfdf-4129-8f22-6082a7846250" xlink:to="loc_us-gaap_EarningsPerShareBasic_f4ce4592-827b-4b54-8329-70b0369d32a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_ec34f750-a9fc-4022-8750-e3fe1ff306ec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAbstract_be993370-bfdf-4129-8f22-6082a7846250" xlink:to="loc_us-gaap_EarningsPerShareDiluted_ec34f750-a9fc-4022-8750-e3fe1ff306ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_b7c1d578-bdf4-4e08-8fbc-9bae5521431f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_c9748f7e-e018-407a-8b83-c4d6fb4b6b65" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_b7c1d578-bdf4-4e08-8fbc-9bae5521431f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_226c43b7-2455-4ca3-93f7-773e778b844d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_b7c1d578-bdf4-4e08-8fbc-9bae5521431f" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_226c43b7-2455-4ca3-93f7-773e778b844d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_43b881a4-5d4a-4e2e-aa55-d3c876df38d9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_b7c1d578-bdf4-4e08-8fbc-9bae5521431f" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_43b881a4-5d4a-4e2e-aa55-d3c876df38d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/ConsolidatedStatementsofComprehensiveIncome" xlink:type="simple" xlink:href="cah-20210630.xsd#ConsolidatedStatementsofComprehensiveIncome"/>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/ConsolidatedStatementsofComprehensiveIncome" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_ca41e5c1-d2ab-49b2-bf90-1805cb25a8c6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_ee48ec96-c2fb-4bea-aeba-eb4351a24b27" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_ca41e5c1-d2ab-49b2-bf90-1805cb25a8c6" xlink:to="loc_us-gaap_ProfitLoss_ee48ec96-c2fb-4bea-aeba-eb4351a24b27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_1d7c91ea-4a88-42f7-afd1-ad714e7f3e8b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_ca41e5c1-d2ab-49b2-bf90-1805cb25a8c6" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_1d7c91ea-4a88-42f7-afd1-ad714e7f3e8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_aa0f0893-cab5-4b59-89d2-313b38ece465" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_1d7c91ea-4a88-42f7-afd1-ad714e7f3e8b" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_aa0f0893-cab5-4b59-89d2-313b38ece465" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_53e2db59-9105-495d-b611-f987628e3084" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_1d7c91ea-4a88-42f7-afd1-ad714e7f3e8b" xlink:to="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_53e2db59-9105-495d-b611-f987628e3084" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax_a034986b-4466-4105-9aa0-3deca4be9c84" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_1d7c91ea-4a88-42f7-afd1-ad714e7f3e8b" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax_a034986b-4466-4105-9aa0-3deca4be9c84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_d2e28450-11c3-440d-8505-6a571adb15c6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_1d7c91ea-4a88-42f7-afd1-ad714e7f3e8b" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_d2e28450-11c3-440d-8505-6a571adb15c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_282d3d40-45a3-4c01-9a69-15ffe5a54f8b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_ca41e5c1-d2ab-49b2-bf90-1805cb25a8c6" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_282d3d40-45a3-4c01-9a69-15ffe5a54f8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_c04f8c14-bcdb-41dc-b179-a7a7a7175b17" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_ca41e5c1-d2ab-49b2-bf90-1805cb25a8c6" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_c04f8c14-bcdb-41dc-b179-a7a7a7175b17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_a664eff9-53f2-4cc9-b1c9-ebb274a136ef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_ca41e5c1-d2ab-49b2-bf90-1805cb25a8c6" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_a664eff9-53f2-4cc9-b1c9-ebb274a136ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/ConsolidatedBalanceSheets" xlink:type="simple" xlink:href="cah-20210630.xsd#ConsolidatedBalanceSheets"/>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/ConsolidatedBalanceSheets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_af5080da-fb5c-4133-8abf-a6d6408da6b1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_66f2ff98-d3b5-470b-bf36-522f9602a038" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_af5080da-fb5c-4133-8abf-a6d6408da6b1" xlink:to="loc_us-gaap_AssetsAbstract_66f2ff98-d3b5-470b-bf36-522f9602a038" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract_9d2ffc5d-ce77-4248-b99d-e10f4db08834" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_66f2ff98-d3b5-470b-bf36-522f9602a038" xlink:to="loc_us-gaap_AssetsCurrentAbstract_9d2ffc5d-ce77-4248-b99d-e10f4db08834" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_0733d966-0107-4b9d-8427-e9d2c1daecf2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_9d2ffc5d-ce77-4248-b99d-e10f4db08834" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_0733d966-0107-4b9d-8427-e9d2c1daecf2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesNetCurrent_1144108d-5b1b-479b-839f-a43c971eae89" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReceivablesNetCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_9d2ffc5d-ce77-4248-b99d-e10f4db08834" xlink:to="loc_us-gaap_ReceivablesNetCurrent_1144108d-5b1b-479b-839f-a43c971eae89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_6b3bef93-924d-4b92-b387-01d3a9091c5e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_9d2ffc5d-ce77-4248-b99d-e10f4db08834" xlink:to="loc_us-gaap_InventoryNet_6b3bef93-924d-4b92-b387-01d3a9091c5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent_118f272f-bf7e-476c-8a4a-8ee463d5b545" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_9d2ffc5d-ce77-4248-b99d-e10f4db08834" xlink:to="loc_us-gaap_OtherAssetsCurrent_118f272f-bf7e-476c-8a4a-8ee463d5b545" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_ca63dced-d9b5-47f5-b7cd-5ba6715580e2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_9d2ffc5d-ce77-4248-b99d-e10f4db08834" xlink:to="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_ca63dced-d9b5-47f5-b7cd-5ba6715580e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_ef980e44-d367-482d-a6ab-4e04a7956640" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_9d2ffc5d-ce77-4248-b99d-e10f4db08834" xlink:to="loc_us-gaap_AssetsCurrent_ef980e44-d367-482d-a6ab-4e04a7956640" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_7126be8e-3fd2-4e1e-9f69-b77b8473319f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_66f2ff98-d3b5-470b-bf36-522f9602a038" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_7126be8e-3fd2-4e1e-9f69-b77b8473319f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetIncludingGoodwill_5dacde53-5a0e-42e1-bf86-b326526d5d2d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsNetIncludingGoodwill"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_66f2ff98-d3b5-470b-bf36-522f9602a038" xlink:to="loc_us-gaap_IntangibleAssetsNetIncludingGoodwill_5dacde53-5a0e-42e1-bf86-b326526d5d2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_7dcc0928-789d-4ec9-af7e-33801805354e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_66f2ff98-d3b5-470b-bf36-522f9602a038" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_7dcc0928-789d-4ec9-af7e-33801805354e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_2becfcaa-e2ac-4661-9cc7-ce5da814ecae" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_66f2ff98-d3b5-470b-bf36-522f9602a038" xlink:to="loc_us-gaap_Assets_2becfcaa-e2ac-4661-9cc7-ce5da814ecae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_2d055f87-efd4-4482-87d8-cc25b922398e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_af5080da-fb5c-4133-8abf-a6d6408da6b1" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_2d055f87-efd4-4482-87d8-cc25b922398e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_1395975b-fb97-4a32-8c21-b23ce2842535" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_2d055f87-efd4-4482-87d8-cc25b922398e" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_1395975b-fb97-4a32-8c21-b23ce2842535" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_39125cdb-fda7-418a-99fb-7c1b283a62a0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_1395975b-fb97-4a32-8c21-b23ce2842535" xlink:to="loc_us-gaap_AccountsPayableCurrent_39125cdb-fda7-418a-99fb-7c1b283a62a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_166783c3-1cb2-4d65-881f-e7cdfb1936ae" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_1395975b-fb97-4a32-8c21-b23ce2842535" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_166783c3-1cb2-4d65-881f-e7cdfb1936ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent_6ce87f76-8ae9-4deb-a10f-fba3f675f418" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_1395975b-fb97-4a32-8c21-b23ce2842535" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesCurrent_6ce87f76-8ae9-4deb-a10f-fba3f675f418" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_30307092-f9d5-4bdd-81ee-bcc311ec3eb2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_1395975b-fb97-4a32-8c21-b23ce2842535" xlink:to="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_30307092-f9d5-4bdd-81ee-bcc311ec3eb2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_5403bbff-c2fd-49a9-a6f2-cb825c448d36" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_1395975b-fb97-4a32-8c21-b23ce2842535" xlink:to="loc_us-gaap_LiabilitiesCurrent_5403bbff-c2fd-49a9-a6f2-cb825c448d36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_a9c66232-3b5a-48fc-b53d-d3e5914d558b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_2d055f87-efd4-4482-87d8-cc25b922398e" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_a9c66232-3b5a-48fc-b53d-d3e5914d558b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAndOtherLiabilitiesNoncurrent_f7e0dbef-a299-4ef0-9b5d-ad25d3c7db16" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAndOtherLiabilitiesNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_2d055f87-efd4-4482-87d8-cc25b922398e" xlink:to="loc_us-gaap_DeferredTaxAndOtherLiabilitiesNoncurrent_f7e0dbef-a299-4ef0-9b5d-ad25d3c7db16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract_02fd2cd6-3d5d-4d89-b3a7-d2adb2365c4a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_2d055f87-efd4-4482-87d8-cc25b922398e" xlink:to="loc_us-gaap_StockholdersEquityAbstract_02fd2cd6-3d5d-4d89-b3a7-d2adb2365c4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockNumberOfSharesParValueAndOtherDisclosuresAbstract_c8c83f8f-1c43-45be-8264-4a64dddba15b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockNumberOfSharesParValueAndOtherDisclosuresAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_02fd2cd6-3d5d-4d89-b3a7-d2adb2365c4a" xlink:to="loc_us-gaap_PreferredStockNumberOfSharesParValueAndOtherDisclosuresAbstract_c8c83f8f-1c43-45be-8264-4a64dddba15b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_fa2eda55-18b9-4468-a0ea-2e8bf4c41fbc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PreferredStockNumberOfSharesParValueAndOtherDisclosuresAbstract_c8c83f8f-1c43-45be-8264-4a64dddba15b" xlink:to="loc_us-gaap_PreferredStockValue_fa2eda55-18b9-4468-a0ea-2e8bf4c41fbc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract_adb84bf2-72ca-4fef-af40-6ed29a5aaa0b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_02fd2cd6-3d5d-4d89-b3a7-d2adb2365c4a" xlink:to="loc_us-gaap_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract_adb84bf2-72ca-4fef-af40-6ed29a5aaa0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_c811e45e-7084-46e4-96b9-5aed9c611b01" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract_adb84bf2-72ca-4fef-af40-6ed29a5aaa0b" xlink:to="loc_us-gaap_CommonStockValue_c811e45e-7084-46e4-96b9-5aed9c611b01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_d4749044-02b7-40a1-a14c-00aa6e99c0d0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_02fd2cd6-3d5d-4d89-b3a7-d2adb2365c4a" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_d4749044-02b7-40a1-a14c-00aa6e99c0d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockShares_050f485e-b2b4-4d20-9bf2-a42dae122f52" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockShares"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_02fd2cd6-3d5d-4d89-b3a7-d2adb2365c4a" xlink:to="loc_us-gaap_TreasuryStockShares_050f485e-b2b4-4d20-9bf2-a42dae122f52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValue_36c903f8-9fe3-422a-bc94-3f1299ae66a4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_02fd2cd6-3d5d-4d89-b3a7-d2adb2365c4a" xlink:to="loc_us-gaap_TreasuryStockValue_36c903f8-9fe3-422a-bc94-3f1299ae66a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_f0744c12-2354-4d6b-b013-7f36b22c7426" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_02fd2cd6-3d5d-4d89-b3a7-d2adb2365c4a" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_f0744c12-2354-4d6b-b013-7f36b22c7426" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_d630870d-4060-48cd-b981-f4c81db7e3b0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_02fd2cd6-3d5d-4d89-b3a7-d2adb2365c4a" xlink:to="loc_us-gaap_StockholdersEquity_d630870d-4060-48cd-b981-f4c81db7e3b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest_5af97912-f778-42de-ab66-25e41d21342d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterest"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_02fd2cd6-3d5d-4d89-b3a7-d2adb2365c4a" xlink:to="loc_us-gaap_MinorityInterest_5af97912-f778-42de-ab66-25e41d21342d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_18f60dbd-166d-45c5-8da4-a95d0493d3b1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_02fd2cd6-3d5d-4d89-b3a7-d2adb2365c4a" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_18f60dbd-166d-45c5-8da4-a95d0493d3b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_12ae39f8-6dbc-4e86-9f0e-5f4bc2d29618" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_2d055f87-efd4-4482-87d8-cc25b922398e" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_12ae39f8-6dbc-4e86-9f0e-5f4bc2d29618" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_ff54612f-e834-400a-84b4-99367674d33a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_af5080da-fb5c-4133-8abf-a6d6408da6b1" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_ff54612f-e834-400a-84b4-99367674d33a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued_ede015ac-10b4-408a-bc6e-7e09927108c2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_af5080da-fb5c-4133-8abf-a6d6408da6b1" xlink:to="loc_us-gaap_PreferredStockSharesIssued_ede015ac-10b4-408a-bc6e-7e09927108c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_06e1a68d-2168-43ab-ab89-c0970910afd9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_af5080da-fb5c-4133-8abf-a6d6408da6b1" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_06e1a68d-2168-43ab-ab89-c0970910afd9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_1bdc3429-836a-4a42-8049-136f3728123d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_af5080da-fb5c-4133-8abf-a6d6408da6b1" xlink:to="loc_us-gaap_CommonStockSharesIssued_1bdc3429-836a-4a42-8049-136f3728123d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:type="simple" xlink:href="cah-20210630.xsd#ConsolidatedBalanceSheetsParenthetical"/>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_9af1545f-be50-4b61-a2e8-a710eb6ef1f4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/ConsolidatedStatementsofShareholdersEquity" xlink:type="simple" xlink:href="cah-20210630.xsd#ConsolidatedStatementsofShareholdersEquity"/>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/ConsolidatedStatementsofShareholdersEquity" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_ef496e09-569a-4b0e-9b8b-d965d75cf0fe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_d31d740e-966a-4f7a-b8f9-2c5e2d0c9580" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_ef496e09-569a-4b0e-9b8b-d965d75cf0fe" xlink:to="loc_us-gaap_StatementTable_d31d740e-966a-4f7a-b8f9-2c5e2d0c9580" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_0c890837-221e-4fc3-8ec7-90c34dacc92a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_d31d740e-966a-4f7a-b8f9-2c5e2d0c9580" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_0c890837-221e-4fc3-8ec7-90c34dacc92a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_58fd05bc-a89c-47de-a077-4b29f0b6ae9f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_0c890837-221e-4fc3-8ec7-90c34dacc92a" xlink:to="loc_us-gaap_EquityComponentDomain_58fd05bc-a89c-47de-a077-4b29f0b6ae9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_a535d906-e7ad-4f82-9c36-d90b78c4dcb7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_58fd05bc-a89c-47de-a077-4b29f0b6ae9f" xlink:to="loc_us-gaap_CommonStockMember_a535d906-e7ad-4f82-9c36-d90b78c4dcb7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_29ccc6b5-8f6d-4ec9-84b1-40775b540bc6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_58fd05bc-a89c-47de-a077-4b29f0b6ae9f" xlink:to="loc_us-gaap_RetainedEarningsMember_29ccc6b5-8f6d-4ec9-84b1-40775b540bc6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockMember_6ba87895-4e1a-4265-ac3d-10aad5221fe3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_58fd05bc-a89c-47de-a077-4b29f0b6ae9f" xlink:to="loc_us-gaap_TreasuryStockMember_6ba87895-4e1a-4265-ac3d-10aad5221fe3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_b8a986c7-294c-476b-9e2e-f31dbafbc985" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_58fd05bc-a89c-47de-a077-4b29f0b6ae9f" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_b8a986c7-294c-476b-9e2e-f31dbafbc985" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember_06035d44-14ff-4fe2-842a-531295466110" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_58fd05bc-a89c-47de-a077-4b29f0b6ae9f" xlink:to="loc_us-gaap_NoncontrollingInterestMember_06035d44-14ff-4fe2-842a-531295466110" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_ba665c51-df36-4a29-81a3-eb755cb03b50" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_d31d740e-966a-4f7a-b8f9-2c5e2d0c9580" xlink:to="loc_us-gaap_StatementLineItems_ba665c51-df36-4a29-81a3-eb755cb03b50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_2c26fabf-6f66-49ad-93d5-9723eeef86ba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_ba665c51-df36-4a29-81a3-eb755cb03b50" xlink:to="loc_us-gaap_NetIncomeLoss_2c26fabf-6f66-49ad-93d5-9723eeef86ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_36196214-2bf3-44a8-9248-b8e1d2403c9f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_ba665c51-df36-4a29-81a3-eb755cb03b50" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_36196214-2bf3-44a8-9248-b8e1d2403c9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_eaf51552-1565-4136-83fa-d5b3a881284c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_36196214-2bf3-44a8-9248-b8e1d2403c9f" xlink:to="loc_us-gaap_CommonStockSharesIssued_eaf51552-1565-4136-83fa-d5b3a881284c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_21db4a68-d694-4884-8b7b-9c24ca9c117a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_36196214-2bf3-44a8-9248-b8e1d2403c9f" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_21db4a68-d694-4884-8b7b-9c24ca9c117a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockShares_5008db7b-534f-4758-be49-049754ffc598" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockShares"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_36196214-2bf3-44a8-9248-b8e1d2403c9f" xlink:to="loc_us-gaap_TreasuryStockShares_5008db7b-534f-4758-be49-049754ffc598" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedPeriodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValue_8a00d917-09bc-4ab8-a61f-87de005a4823" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_36196214-2bf3-44a8-9248-b8e1d2403c9f" xlink:to="loc_us-gaap_TreasuryStockValue_8a00d917-09bc-4ab8-a61f-87de005a4823" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedPeriodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_c9f4e61b-25c1-49b5-95ec-42ffcd94b1e2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_36196214-2bf3-44a8-9248-b8e1d2403c9f" xlink:to="loc_us-gaap_ProfitLoss_c9f4e61b-25c1-49b5-95ec-42ffcd94b1e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_NetEarningsIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest_0c031154-ff56-407b-ab21-afc3fc3ad4b8" xlink:href="cah-20210630.xsd#cah_NetEarningsIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_36196214-2bf3-44a8-9248-b8e1d2403c9f" xlink:to="loc_cah_NetEarningsIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest_0c031154-ff56-407b-ab21-afc3fc3ad4b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_da875d9f-cb7a-40d6-968d-52ce09d8d6e6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_36196214-2bf3-44a8-9248-b8e1d2403c9f" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_da875d9f-cb7a-40d6-968d-52ce09d8d6e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_5411f639-ea0a-4695-a5b1-0001883cf08a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_36196214-2bf3-44a8-9248-b8e1d2403c9f" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_5411f639-ea0a-4695-a5b1-0001883cf08a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_5b1a79be-6d75-44c7-9b7a-ca2bf3af4846" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_36196214-2bf3-44a8-9248-b8e1d2403c9f" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_5b1a79be-6d75-44c7-9b7a-ca2bf3af4846" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired_92a62721-8d4b-471b-8a6e-44a6d620d7c6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_36196214-2bf3-44a8-9248-b8e1d2403c9f" xlink:to="loc_us-gaap_TreasuryStockSharesAcquired_92a62721-8d4b-471b-8a6e-44a6d620d7c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_b13d2615-6f56-4cbb-bec6-b9079acb7db3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_36196214-2bf3-44a8-9248-b8e1d2403c9f" xlink:to="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_b13d2615-6f56-4cbb-bec6-b9079acb7db3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Dividends_4702a521-9ce0-4388-99af-3b86063ef715" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Dividends"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_36196214-2bf3-44a8-9248-b8e1d2403c9f" xlink:to="loc_us-gaap_Dividends_4702a521-9ce0-4388-99af-3b86063ef715" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityOtherShares_ad7a0ba2-4657-4574-a80f-99783fb90b73" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityOtherShares"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_36196214-2bf3-44a8-9248-b8e1d2403c9f" xlink:to="loc_us-gaap_StockholdersEquityOtherShares_ad7a0ba2-4657-4574-a80f-99783fb90b73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityOther_504a4161-d106-4326-a43b-6ca039ed5bd9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityOther"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_36196214-2bf3-44a8-9248-b8e1d2403c9f" xlink:to="loc_us-gaap_StockholdersEquityOther_504a4161-d106-4326-a43b-6ca039ed5bd9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_04ae8f93-15ff-41ff-9399-9017b38cb952" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_36196214-2bf3-44a8-9248-b8e1d2403c9f" xlink:to="loc_us-gaap_CommonStockSharesIssued_04ae8f93-15ff-41ff-9399-9017b38cb952" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_1085146b-36d9-4317-8122-db68cee643eb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_36196214-2bf3-44a8-9248-b8e1d2403c9f" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_1085146b-36d9-4317-8122-db68cee643eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockShares_69b17122-74e7-4f08-a20c-ce296ccb28c2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockShares"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_36196214-2bf3-44a8-9248-b8e1d2403c9f" xlink:to="loc_us-gaap_TreasuryStockShares_69b17122-74e7-4f08-a20c-ce296ccb28c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedPeriodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValue_e38901b0-f04a-4ed0-8ece-a79e34605a4c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockValue"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_36196214-2bf3-44a8-9248-b8e1d2403c9f" xlink:to="loc_us-gaap_TreasuryStockValue_e38901b0-f04a-4ed0-8ece-a79e34605a4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedPeriodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/ConsolidatedStatementsofCashFlows" xlink:type="simple" xlink:href="cah-20210630.xsd#ConsolidatedStatementsofCashFlows"/>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/ConsolidatedStatementsofCashFlows" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_98807af8-1a16-4de3-ac14-8c3156d6e26c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_feb649a4-25da-441d-9e65-b83f5858510e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_98807af8-1a16-4de3-ac14-8c3156d6e26c" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_feb649a4-25da-441d-9e65-b83f5858510e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_74b92ea9-8976-471e-a0de-d52a82814db7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_feb649a4-25da-441d-9e65-b83f5858510e" xlink:to="loc_us-gaap_ProfitLoss_74b92ea9-8976-471e-a0de-d52a82814db7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_b3ee4b3c-421c-4696-a440-00eb0e8e12f0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_feb649a4-25da-441d-9e65-b83f5858510e" xlink:to="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_b3ee4b3c-421c-4696-a440-00eb0e8e12f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_25294da9-0edb-4190-8e6e-332cebfcbafd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_b3ee4b3c-421c-4696-a440-00eb0e8e12f0" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_25294da9-0edb-4190-8e6e-332cebfcbafd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfOtherInvestments_59488338-56d2-4cea-b209-b5b294ab5d33" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnSaleOfOtherInvestments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_b3ee4b3c-421c-4696-a440-00eb0e8e12f0" xlink:to="loc_us-gaap_GainLossOnSaleOfOtherInvestments_59488338-56d2-4cea-b209-b5b294ab5d33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfInvestments_26f708f0-ace9-40b8-b21c-c9450f46b889" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnSaleOfInvestments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_b3ee4b3c-421c-4696-a440-00eb0e8e12f0" xlink:to="loc_us-gaap_GainLossOnSaleOfInvestments_26f708f0-ace9-40b8-b21c-c9450f46b889" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges_e0f76cca-d274-4475-9573-47efc4620ab8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_b3ee4b3c-421c-4696-a440-00eb0e8e12f0" xlink:to="loc_us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges_e0f76cca-d274-4475-9573-47efc4620ab8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_9357b4f7-b53a-437a-aebb-0e6cb2840a60" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_b3ee4b3c-421c-4696-a440-00eb0e8e12f0" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_9357b4f7-b53a-437a-aebb-0e6cb2840a60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_0dac979c-ec5e-4733-b28e-324af94109ee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_b3ee4b3c-421c-4696-a440-00eb0e8e12f0" xlink:to="loc_us-gaap_ShareBasedCompensation_0dac979c-ec5e-4733-b28e-324af94109ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_c400fc0b-af4f-46f2-825c-732c6a8e12a9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_b3ee4b3c-421c-4696-a440-00eb0e8e12f0" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_c400fc0b-af4f-46f2-825c-732c6a8e12a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProvisionForDoubtfulAccounts_6fd406d7-c897-4c77-ab7d-8ba8d6017bed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProvisionForDoubtfulAccounts"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_b3ee4b3c-421c-4696-a440-00eb0e8e12f0" xlink:to="loc_us-gaap_ProvisionForDoubtfulAccounts_6fd406d7-c897-4c77-ab7d-8ba8d6017bed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_5bd1c87f-08e6-45b6-bb5d-2e85e29a3321" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_b3ee4b3c-421c-4696-a440-00eb0e8e12f0" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_5bd1c87f-08e6-45b6-bb5d-2e85e29a3321" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInReceivables_89b5c753-57a7-42d0-ba4e-5ada7cc65bd1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInReceivables"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_5bd1c87f-08e6-45b6-bb5d-2e85e29a3321" xlink:to="loc_us-gaap_IncreaseDecreaseInReceivables_89b5c753-57a7-42d0-ba4e-5ada7cc65bd1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_a88e9ab3-1858-49dd-aaef-fae3e6102cec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_5bd1c87f-08e6-45b6-bb5d-2e85e29a3321" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_a88e9ab3-1858-49dd-aaef-fae3e6102cec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_79a40542-aa49-480b-abaf-3f9e39226f3c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_5bd1c87f-08e6-45b6-bb5d-2e85e29a3321" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_79a40542-aa49-480b-abaf-3f9e39226f3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_e2d0eafb-9e9d-4c6e-aac0-90880a120256" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_5bd1c87f-08e6-45b6-bb5d-2e85e29a3321" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_e2d0eafb-9e9d-4c6e-aac0-90880a120256" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_459bb233-13ae-4ff2-a663-3a78eecb6e10" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_feb649a4-25da-441d-9e65-b83f5858510e" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_459bb233-13ae-4ff2-a663-3a78eecb6e10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_6c03f065-9434-43fe-adae-beff2b4f0aa1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_98807af8-1a16-4de3-ac14-8c3156d6e26c" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_6c03f065-9434-43fe-adae-beff2b4f0aa1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_1ca2282b-8800-488e-8036-fc17953677a1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_6c03f065-9434-43fe-adae-beff2b4f0aa1" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_1ca2282b-8800-488e-8036-fc17953677a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_597d151f-1e5a-41ff-afc3-eb0f7fce7203" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_6c03f065-9434-43fe-adae-beff2b4f0aa1" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_597d151f-1e5a-41ff-afc3-eb0f7fce7203" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_Purchaseofavailableforsalesecuritiesandotherinvestments_b54cacf2-190c-4f15-b10b-561be187a543" xlink:href="cah-20210630.xsd#cah_Purchaseofavailableforsalesecuritiesandotherinvestments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_6c03f065-9434-43fe-adae-beff2b4f0aa1" xlink:to="loc_cah_Purchaseofavailableforsalesecuritiesandotherinvestments_b54cacf2-190c-4f15-b10b-561be187a543" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_Proceedsfromsaleofavailableforsalesecuritiesandotherinvestments_dd7a1ce3-67ad-4d4c-8a3e-6c0a1e09a048" xlink:href="cah-20210630.xsd#cah_Proceedsfromsaleofavailableforsalesecuritiesandotherinvestments"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_6c03f065-9434-43fe-adae-beff2b4f0aa1" xlink:to="loc_cah_Proceedsfromsaleofavailableforsalesecuritiesandotherinvestments_dd7a1ce3-67ad-4d4c-8a3e-6c0a1e09a048" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_Proceedsfromdivestituresanddisposalofpropertyandequipmentandheldforsaleassets_1024e1fe-6253-469c-9683-7652d1f78996" xlink:href="cah-20210630.xsd#cah_Proceedsfromdivestituresanddisposalofpropertyandequipmentandheldforsaleassets"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_6c03f065-9434-43fe-adae-beff2b4f0aa1" xlink:to="loc_cah_Proceedsfromdivestituresanddisposalofpropertyandequipmentandheldforsaleassets_1024e1fe-6253-469c-9683-7652d1f78996" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_28a9af15-a9ba-46af-8f7e-d777edc9df90" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_6c03f065-9434-43fe-adae-beff2b4f0aa1" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_28a9af15-a9ba-46af-8f7e-d777edc9df90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_1a6d2e4e-9f92-4df8-8fed-8925ffb13410" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_98807af8-1a16-4de3-ac14-8c3156d6e26c" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_1a6d2e4e-9f92-4df8-8fed-8925ffb13410" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromRepaymentsOfShortTermDebt_65acb0d8-3d6e-433e-b5cd-7019c73e5a92" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromRepaymentsOfShortTermDebt"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_1a6d2e4e-9f92-4df8-8fed-8925ffb13410" xlink:to="loc_us-gaap_ProceedsFromRepaymentsOfShortTermDebt_65acb0d8-3d6e-433e-b5cd-7019c73e5a92" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromHedgeFinancingActivities_5b6a2361-c381-49b1-980c-2190c48ea001" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForProceedsFromHedgeFinancingActivities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_1a6d2e4e-9f92-4df8-8fed-8925ffb13410" xlink:to="loc_us-gaap_PaymentsForProceedsFromHedgeFinancingActivities_5b6a2361-c381-49b1-980c-2190c48ea001" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt_4011b488-d006-4a1a-bf6b-baffd92eb7c9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_1a6d2e4e-9f92-4df8-8fed-8925ffb13410" xlink:to="loc_us-gaap_RepaymentsOfLongTermDebt_4011b488-d006-4a1a-bf6b-baffd92eb7c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_Netproceedstaxwithholdingsfromsharebasedcompensation_a9e256f7-d0b3-4925-82be-c65f7d244263" xlink:href="cah-20210630.xsd#cah_Netproceedstaxwithholdingsfromsharebasedcompensation"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_1a6d2e4e-9f92-4df8-8fed-8925ffb13410" xlink:to="loc_cah_Netproceedstaxwithholdingsfromsharebasedcompensation_a9e256f7-d0b3-4925-82be-c65f7d244263" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividendsCommonStock_a23cf6ee-fdab-4756-8d73-6175134ca006" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfDividendsCommonStock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_1a6d2e4e-9f92-4df8-8fed-8925ffb13410" xlink:to="loc_us-gaap_PaymentsOfDividendsCommonStock_a23cf6ee-fdab-4756-8d73-6175134ca006" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_c64dec33-e97c-4dee-bf2a-a34414197bdd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_1a6d2e4e-9f92-4df8-8fed-8925ffb13410" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_c64dec33-e97c-4dee-bf2a-a34414197bdd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_dd9e26f7-e483-40a1-a218-9be6e416c161" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_1a6d2e4e-9f92-4df8-8fed-8925ffb13410" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_dd9e26f7-e483-40a1-a218-9be6e416c161" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents_aca69b17-13be-44ed-8bc9-9cd9df416a96" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_98807af8-1a16-4de3-ac14-8c3156d6e26c" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents_aca69b17-13be-44ed-8bc9-9cd9df416a96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_CashReclassifiedtoAssetsHeldforSale_cbec35ec-d07e-45b1-a71f-47584347153a" xlink:href="cah-20210630.xsd#cah_CashReclassifiedtoAssetsHeldforSale"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_98807af8-1a16-4de3-ac14-8c3156d6e26c" xlink:to="loc_cah_CashReclassifiedtoAssetsHeldforSale_cbec35ec-d07e-45b1-a71f-47584347153a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_57bf5948-92b3-4d2d-b864-372c83f4d103" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_98807af8-1a16-4de3-ac14-8c3156d6e26c" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_57bf5948-92b3-4d2d-b864-372c83f4d103" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_dfb12c3c-3c1d-4299-9002-d2b742b9d89b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_98807af8-1a16-4de3-ac14-8c3156d6e26c" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_dfb12c3c-3c1d-4299-9002-d2b742b9d89b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_ee153dd6-4ec3-4fb6-b6c5-899df586332a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_98807af8-1a16-4de3-ac14-8c3156d6e26c" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_ee153dd6-4ec3-4fb6-b6c5-899df586332a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract_4b736b3e-53d7-44ed-bb90-bde764414d08" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_98807af8-1a16-4de3-ac14-8c3156d6e26c" xlink:to="loc_us-gaap_SupplementalCashFlowInformationAbstract_4b736b3e-53d7-44ed-bb90-bde764414d08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet_f529557c-9e1c-402c-a247-3a0a06fa537f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestPaidNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_4b736b3e-53d7-44ed-bb90-bde764414d08" xlink:to="loc_us-gaap_InterestPaidNet_f529557c-9e1c-402c-a247-3a0a06fa537f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaidNet_df7777ff-5fd7-44b2-a41d-699cee4bcc6a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxesPaidNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_4b736b3e-53d7-44ed-bb90-bde764414d08" xlink:to="loc_us-gaap_IncomeTaxesPaidNet_df7777ff-5fd7-44b2-a41d-699cee4bcc6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPolicies" xlink:type="simple" xlink:href="cah-20210630.xsd#BasisofPresentationandSummaryofSignificantAccountingPolicies"/>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_68ebb3c4-3caa-4314-9644-8a68921704d7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_e52e7e8b-ff5e-45e0-a64e-9c5dda26ec26" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_68ebb3c4-3caa-4314-9644-8a68921704d7" xlink:to="loc_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_e52e7e8b-ff5e-45e0-a64e-9c5dda26ec26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies" xlink:type="simple" xlink:href="cah-20210630.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"/>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_4aae1925-42f1-47fd-9556-58ad8834324b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_07e9fcdf-dbc1-4bfd-b2f7-51a9c14fd5cb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_4aae1925-42f1-47fd-9556-58ad8834324b" xlink:to="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_07e9fcdf-dbc1-4bfd-b2f7-51a9c14fd5cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates_4998ee27-f405-4cc8-8a59-9fdebd05de14" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UseOfEstimates"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_4aae1925-42f1-47fd-9556-58ad8834324b" xlink:to="loc_us-gaap_UseOfEstimates_4998ee27-f405-4cc8-8a59-9fdebd05de14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock_33679b38-5741-49a7-a8c8-338e0dbdde4f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_4aae1925-42f1-47fd-9556-58ad8834324b" xlink:to="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock_33679b38-5741-49a7-a8c8-338e0dbdde4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesPolicyTextBlock_78a30aa0-3263-42ab-b7ae-9cb8f0359511" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReceivablesPolicyTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_4aae1925-42f1-47fd-9556-58ad8834324b" xlink:to="loc_us-gaap_ReceivablesPolicyTextBlock_78a30aa0-3263-42ab-b7ae-9cb8f0359511" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskCreditRisk_8da5892c-1651-4321-a57b-d11312f3ce86" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskCreditRisk"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_4aae1925-42f1-47fd-9556-58ad8834324b" xlink:to="loc_us-gaap_ConcentrationRiskCreditRisk_8da5892c-1651-4321-a57b-d11312f3ce86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MajorCustomersPolicyPolicyTextBlock_835bdafe-59d7-48dc-9649-e90b80b54ed7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MajorCustomersPolicyPolicyTextBlock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_4aae1925-42f1-47fd-9556-58ad8834324b" xlink:to="loc_us-gaap_MajorCustomersPolicyPolicyTextBlock_835bdafe-59d7-48dc-9649-e90b80b54ed7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryPolicyTextBlock_c2f10894-0028-40d9-b732-2f4d069956c6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryPolicyTextBlock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_4aae1925-42f1-47fd-9556-58ad8834324b" xlink:to="loc_us-gaap_InventoryPolicyTextBlock_c2f10894-0028-40d9-b732-2f4d069956c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_CashDiscountsPolicyTextBlock_71dee2f1-0b4c-4851-99cc-1a1579487206" xlink:href="cah-20210630.xsd#cah_CashDiscountsPolicyTextBlock"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_4aae1925-42f1-47fd-9556-58ad8834324b" xlink:to="loc_cah_CashDiscountsPolicyTextBlock_71dee2f1-0b4c-4851-99cc-1a1579487206" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_3e9416cb-df1f-4851-ab61-9039721078b0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_4aae1925-42f1-47fd-9556-58ad8834324b" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_3e9416cb-df1f-4851-ab61-9039721078b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock_649af4ca-a5b5-4df4-858e-5caa658fad5d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_4aae1925-42f1-47fd-9556-58ad8834324b" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock_649af4ca-a5b5-4df4-858e-5caa658fad5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_AssetsHeldforSalePolicyPolicyTextBlock_37217a64-364c-4070-9cfb-cc05a8d87050" xlink:href="cah-20210630.xsd#cah_AssetsHeldforSalePolicyPolicyTextBlock"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_4aae1925-42f1-47fd-9556-58ad8834324b" xlink:to="loc_cah_AssetsHeldforSalePolicyPolicyTextBlock_37217a64-364c-4070-9cfb-cc05a8d87050" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentPolicyTextBlock_ee9b1669-1afd-4743-b724-9c200875aec6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentPolicyTextBlock"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_4aae1925-42f1-47fd-9556-58ad8834324b" xlink:to="loc_us-gaap_InvestmentPolicyTextBlock_ee9b1669-1afd-4743-b724-9c200875aec6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_CostofSalesVendorReservesPolicyPolicyTextBlock_3582e457-fd0c-466f-ba2d-1113baa325fa" xlink:href="cah-20210630.xsd#cah_CostofSalesVendorReservesPolicyPolicyTextBlock"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_4aae1925-42f1-47fd-9556-58ad8834324b" xlink:to="loc_cah_CostofSalesVendorReservesPolicyPolicyTextBlock_3582e457-fd0c-466f-ba2d-1113baa325fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_DistributionServiceAgreementAndOtherVendorFeesPolicyTextBlock_ffbe8666-a14d-40fe-a1d3-efb2b2c44835" xlink:href="cah-20210630.xsd#cah_DistributionServiceAgreementAndOtherVendorFeesPolicyTextBlock"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_4aae1925-42f1-47fd-9556-58ad8834324b" xlink:to="loc_cah_DistributionServiceAgreementAndOtherVendorFeesPolicyTextBlock_ffbe8666-a14d-40fe-a1d3-efb2b2c44835" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesPolicyTextBlock_4b7b2762-f55d-4a34-9769-97b4c2e43576" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesPolicyTextBlock"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_4aae1925-42f1-47fd-9556-58ad8834324b" xlink:to="loc_us-gaap_CommitmentsAndContingenciesPolicyTextBlock_4b7b2762-f55d-4a34-9769-97b4c2e43576" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxPolicyTextBlock_dfb2e8ff-92f5-445a-86bb-b0009222cc2a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxPolicyTextBlock"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_4aae1925-42f1-47fd-9556-58ad8834324b" xlink:to="loc_us-gaap_IncomeTaxPolicyTextBlock_dfb2e8ff-92f5-445a-86bb-b0009222cc2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_OtherAccruedLiabilitiesPolicyPolicyTextBlock_1a29498a-1de6-4e36-a8f3-419b4d0d8ad0" xlink:href="cah-20210630.xsd#cah_OtherAccruedLiabilitiesPolicyPolicyTextBlock"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_4aae1925-42f1-47fd-9556-58ad8834324b" xlink:to="loc_cah_OtherAccruedLiabilitiesPolicyPolicyTextBlock_1a29498a-1de6-4e36-a8f3-419b4d0d8ad0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationPolicyTextBlock_81c4602d-be21-4c51-b2db-207965ffee17" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConsolidationPolicyTextBlock"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_4aae1925-42f1-47fd-9556-58ad8834324b" xlink:to="loc_us-gaap_ConsolidationPolicyTextBlock_81c4602d-be21-4c51-b2db-207965ffee17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_b70028ec-fab4-47e7-b612-b5afbbff9ea2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_4aae1925-42f1-47fd-9556-58ad8834324b" xlink:to="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_b70028ec-fab4-47e7-b612-b5afbbff9ea2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_DividendsPolicyPolicyTextBlock_a77f5664-4c55-409b-b666-bb92a01ac2e3" xlink:href="cah-20210630.xsd#cah_DividendsPolicyPolicyTextBlock"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_4aae1925-42f1-47fd-9556-58ad8834324b" xlink:to="loc_cah_DividendsPolicyPolicyTextBlock_a77f5664-4c55-409b-b666-bb92a01ac2e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRecognitionPolicyTextBlock_19cf39fd-498b-4333-b5f6-b383108e4587" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRecognitionPolicyTextBlock"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_4aae1925-42f1-47fd-9556-58ad8834324b" xlink:to="loc_us-gaap_RevenueRecognitionPolicyTextBlock_19cf39fd-498b-4333-b5f6-b383108e4587" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_SalesreturnsPolicyTextBlock_3f3b43b9-5c8f-4ce5-8c06-cd241ff27abe" xlink:href="cah-20210630.xsd#cah_SalesreturnsPolicyTextBlock"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_4aae1925-42f1-47fd-9556-58ad8834324b" xlink:to="loc_cah_SalesreturnsPolicyTextBlock_3f3b43b9-5c8f-4ce5-8c06-cd241ff27abe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_ShippingandHandlingCostsPolicyTextBlock_dd7a96eb-052f-4bb9-b4d5-019148c210a0" xlink:href="cah-20210630.xsd#cah_ShippingandHandlingCostsPolicyTextBlock"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_4aae1925-42f1-47fd-9556-58ad8834324b" xlink:to="loc_cah_ShippingandHandlingCostsPolicyTextBlock_dd7a96eb-052f-4bb9-b4d5-019148c210a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock_a88a9e33-a764-4b0a-9044-faed8153779f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_4aae1925-42f1-47fd-9556-58ad8834324b" xlink:to="loc_us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock_a88a9e33-a764-4b0a-9044-faed8153779f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_AmortizationandOtherAcquisitionRelatedCostsPolicyPolicyTextBlock_b2a9cb01-dace-44e8-86c4-08c2b5e1d619" xlink:href="cah-20210630.xsd#cah_AmortizationandOtherAcquisitionRelatedCostsPolicyPolicyTextBlock"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_4aae1925-42f1-47fd-9556-58ad8834324b" xlink:to="loc_cah_AmortizationandOtherAcquisitionRelatedCostsPolicyPolicyTextBlock_b2a9cb01-dace-44e8-86c4-08c2b5e1d619" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_86155831-db71-44d1-8a28-0078cc38ad2f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_4aae1925-42f1-47fd-9556-58ad8834324b" xlink:to="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_86155831-db71-44d1-8a28-0078cc38ad2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesMethodsOfAccountingHedgingDerivatives_843bdd59-7ecb-4330-b181-7e9fbc6b7c8f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativesMethodsOfAccountingHedgingDerivatives"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_4aae1925-42f1-47fd-9556-58ad8834324b" xlink:to="loc_us-gaap_DerivativesMethodsOfAccountingHedgingDerivatives_843bdd59-7ecb-4330-b181-7e9fbc6b7c8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_4f4c126b-8ace-4fe7-9fcd-e98cf7a99a80" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementPolicyPolicyTextBlock"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_4aae1925-42f1-47fd-9556-58ad8834324b" xlink:to="loc_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_4f4c126b-8ace-4fe7-9fcd-e98cf7a99a80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_4b149189-79a8-4b02-86c3-45918e4ef5ad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_4aae1925-42f1-47fd-9556-58ad8834324b" xlink:to="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_4b149189-79a8-4b02-86c3-45918e4ef5ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GuaranteesIndemnificationsAndWarrantiesPolicies_05cc86be-a325-439e-87bc-50008a4603d5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GuaranteesIndemnificationsAndWarrantiesPolicies"/>
    <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_4aae1925-42f1-47fd-9556-58ad8834324b" xlink:to="loc_us-gaap_GuaranteesIndemnificationsAndWarrantiesPolicies_05cc86be-a325-439e-87bc-50008a4603d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesTables" xlink:type="simple" xlink:href="cah-20210630.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesTables"/>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_34a30c56-028a-4e4b-93e5-470c7bc894c2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock_3bf585a2-9fa4-4623-a649-92a8a7798cc3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_34a30c56-028a-4e4b-93e5-470c7bc894c2" xlink:to="loc_us-gaap_ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock_3bf585a2-9fa4-4623-a649-92a8a7798cc3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_f63f784d-c491-41fc-8709-ca3a2e4bb583" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_34a30c56-028a-4e4b-93e5-470c7bc894c2" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_f63f784d-c491-41fc-8709-ca3a2e4bb583" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeReceivablesDetails" xlink:type="simple" xlink:href="cah-20210630.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeReceivablesDetails"/>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeReceivablesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_f66db420-bf9a-43e5-b452-f0e4d65dae3c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_a45f9035-7aed-454b-8910-098183ff38df" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_f66db420-bf9a-43e5-b452-f0e4d65dae3c" xlink:to="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_a45f9035-7aed-454b-8910-098183ff38df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_80a01ab1-0a3f-42b7-a098-6800c49cc2ca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationAllowancesAndReservesTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_a45f9035-7aed-454b-8910-098183ff38df" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_80a01ab1-0a3f-42b7-a098-6800c49cc2ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesDomain_251dc626-fdbe-4fc8-962c-4bdbb1a43b2a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationAllowancesAndReservesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_80a01ab1-0a3f-42b7-a098-6800c49cc2ca" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesDomain_251dc626-fdbe-4fc8-962c-4bdbb1a43b2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForCreditLossMember_6003c759-c558-4e35-bb7f-e24b0ebcc2a3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllowanceForCreditLossMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesDomain_251dc626-fdbe-4fc8-962c-4bdbb1a43b2a" xlink:to="loc_us-gaap_AllowanceForCreditLossMember_6003c759-c558-4e35-bb7f-e24b0ebcc2a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForLossesOnFinanceReceivablesMember_b1199dc7-17fe-4f8f-9f3e-211ee92f2d9f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllowanceForLossesOnFinanceReceivablesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesDomain_251dc626-fdbe-4fc8-962c-4bdbb1a43b2a" xlink:to="loc_us-gaap_AllowanceForLossesOnFinanceReceivablesMember_b1199dc7-17fe-4f8f-9f3e-211ee92f2d9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_89b28642-9e13-4458-8679-120bffc782e8" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_a45f9035-7aed-454b-8910-098183ff38df" xlink:to="loc_srt_RangeAxis_89b28642-9e13-4458-8679-120bffc782e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_8f3282fd-0999-4d9e-9ef8-398fcb7effcb" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_89b28642-9e13-4458-8679-120bffc782e8" xlink:to="loc_srt_RangeMember_8f3282fd-0999-4d9e-9ef8-398fcb7effcb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_7d0a3bfd-69b3-4901-8935-2eda2cc1057f" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_8f3282fd-0999-4d9e-9ef8-398fcb7effcb" xlink:to="loc_srt_MinimumMember_7d0a3bfd-69b3-4901-8935-2eda2cc1057f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_8ab70286-417d-46dc-b302-64c7a128f3ae" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_8f3282fd-0999-4d9e-9ef8-398fcb7effcb" xlink:to="loc_srt_MaximumMember_8ab70286-417d-46dc-b302-64c7a128f3ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_3cb98235-af38-439a-8496-458db8e0006a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_a45f9035-7aed-454b-8910-098183ff38df" xlink:to="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_3cb98235-af38-439a-8496-458db8e0006a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivableTypeDomain_4ed43ff7-39b0-4c92-80b5-694caefe3c9e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReceivableTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_3cb98235-af38-439a-8496-458db8e0006a" xlink:to="loc_us-gaap_ReceivableTypeDomain_4ed43ff7-39b0-4c92-80b5-694caefe3c9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_caabced3-1993-42c6-8901-a551ae91e4fa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsNotesAndLoansReceivableLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_a45f9035-7aed-454b-8910-098183ff38df" xlink:to="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_caabced3-1993-42c6-8901-a551ae91e4fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesBalance_c931df37-2b89-47f4-97de-5dfdb5b16b6e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationAllowancesAndReservesBalance"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_caabced3-1993-42c6-8901-a551ae91e4fa" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesBalance_c931df37-2b89-47f4-97de-5dfdb5b16b6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_ReceivableFinancingAgreementTerm_3883a30b-75b6-4d77-bd89-2801c462a283" xlink:href="cah-20210630.xsd#cah_ReceivableFinancingAgreementTerm"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_caabced3-1993-42c6-8901-a551ae91e4fa" xlink:to="loc_cah_ReceivableFinancingAgreementTerm_3883a30b-75b6-4d77-bd89-2801c462a283" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesReceivableNet_06db3e33-7df9-497e-9c8e-e225b504a184" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NotesReceivableNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_caabced3-1993-42c6-8901-a551ae91e4fa" xlink:to="loc_us-gaap_NotesReceivableNet_06db3e33-7df9-497e-9c8e-e225b504a184" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesAndLoansReceivableNetCurrent_b77267bb-b838-4da3-9db4-9e591528d279" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NotesAndLoansReceivableNetCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_caabced3-1993-42c6-8901-a551ae91e4fa" xlink:to="loc_us-gaap_NotesAndLoansReceivableNetCurrent_b77267bb-b838-4da3-9db4-9e591528d279" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesRevenueandGrossTradeReceivablesPercentagebyMajorCustomersDetails" xlink:type="simple" xlink:href="cah-20210630.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesRevenueandGrossTradeReceivablesPercentagebyMajorCustomersDetails"/>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesRevenueandGrossTradeReceivablesPercentagebyMajorCustomersDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_626f7898-7109-4c13-a546-339bd604a29b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable_a1969dd3-d977-4d95-84a0-5bb31875f798" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_626f7898-7109-4c13-a546-339bd604a29b" xlink:to="loc_us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable_a1969dd3-d977-4d95-84a0-5bb31875f798" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_d768025b-a6b2-432d-85fb-b52dde7dc0f7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable_a1969dd3-d977-4d95-84a0-5bb31875f798" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_d768025b-a6b2-432d-85fb-b52dde7dc0f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_b3fa2556-7e10-4b3e-a42d-02d9acdd1404" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_d768025b-a6b2-432d-85fb-b52dde7dc0f7" xlink:to="loc_us-gaap_SegmentDomain_b3fa2556-7e10-4b3e-a42d-02d9acdd1404" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_PharmaceuticalMember_f43d1d0a-98f0-45dc-bff7-7e95bf670785" xlink:href="cah-20210630.xsd#cah_PharmaceuticalMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_b3fa2556-7e10-4b3e-a42d-02d9acdd1404" xlink:to="loc_cah_PharmaceuticalMember_f43d1d0a-98f0-45dc-bff7-7e95bf670785" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MajorCustomersAxis_c9d3c208-c0b6-4293-9eb4-8d4be40512bd" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MajorCustomersAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable_a1969dd3-d977-4d95-84a0-5bb31875f798" xlink:to="loc_srt_MajorCustomersAxis_c9d3c208-c0b6-4293-9eb4-8d4be40512bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_7276ecce-b754-44ef-bb63-3ab0c9e49a75" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MajorCustomersAxis_c9d3c208-c0b6-4293-9eb4-8d4be40512bd" xlink:to="loc_srt_NameOfMajorCustomerDomain_7276ecce-b754-44ef-bb63-3ab0c9e49a75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_CVSCaremarkCorporationMember_588fab9a-d347-4b48-b908-bfe511b3a62b" xlink:href="cah-20210630.xsd#cah_CVSCaremarkCorporationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_7276ecce-b754-44ef-bb63-3ab0c9e49a75" xlink:to="loc_cah_CVSCaremarkCorporationMember_588fab9a-d347-4b48-b908-bfe511b3a62b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_OptumRxMember_b445a353-989e-4b6d-a7f9-df4e0bfa7015" xlink:href="cah-20210630.xsd#cah_OptumRxMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_7276ecce-b754-44ef-bb63-3ab0c9e49a75" xlink:to="loc_cah_OptumRxMember_b445a353-989e-4b6d-a7f9-df4e0bfa7015" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_16e68e53-906e-41f1-b3a2-92f9595da1e6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable_a1969dd3-d977-4d95-84a0-5bb31875f798" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_16e68e53-906e-41f1-b3a2-92f9595da1e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_748148de-4d5c-4325-93dd-684fae776c45" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_16e68e53-906e-41f1-b3a2-92f9595da1e6" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_748148de-4d5c-4325-93dd-684fae776c45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesRevenueNetMember_96db67c7-14dc-420c-9713-9cc30eeda0e5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SalesRevenueNetMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_748148de-4d5c-4325-93dd-684fae776c45" xlink:to="loc_us-gaap_SalesRevenueNetMember_96db67c7-14dc-420c-9713-9cc30eeda0e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_c14e6f88-5796-44cc-b1bb-bfe76942fa19" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable_a1969dd3-d977-4d95-84a0-5bb31875f798" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_c14e6f88-5796-44cc-b1bb-bfe76942fa19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_6d6962b1-f552-40bb-a5ea-512a9bc4c5c3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_c14e6f88-5796-44cc-b1bb-bfe76942fa19" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_6d6962b1-f552-40bb-a5ea-512a9bc4c5c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerConcentrationRiskMember_d14bc52e-5888-40fd-9b67-93790706df84" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerConcentrationRiskMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_6d6962b1-f552-40bb-a5ea-512a9bc4c5c3" xlink:to="loc_us-gaap_CustomerConcentrationRiskMember_d14bc52e-5888-40fd-9b67-93790706df84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EntityWideRevenueMajorCustomerLineItems_271168ac-56e1-4ee3-bb4b-57ed3278dcdd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EntityWideRevenueMajorCustomerLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable_a1969dd3-d977-4d95-84a0-5bb31875f798" xlink:to="loc_us-gaap_EntityWideRevenueMajorCustomerLineItems_271168ac-56e1-4ee3-bb4b-57ed3278dcdd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_a430189d-f7c1-4dbe-898d-128bcd83718b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EntityWideRevenueMajorCustomerLineItems_271168ac-56e1-4ee3-bb4b-57ed3278dcdd" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_a430189d-f7c1-4dbe-898d-128bcd83718b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_GrossTradeReceivablesMajorCustomerPercentage_e4d0bc61-725e-4fd6-8447-271730f1021e" xlink:href="cah-20210630.xsd#cah_GrossTradeReceivablesMajorCustomerPercentage"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EntityWideRevenueMajorCustomerLineItems_271168ac-56e1-4ee3-bb4b-57ed3278dcdd" xlink:to="loc_cah_GrossTradeReceivablesMajorCustomerPercentage_e4d0bc61-725e-4fd6-8447-271730f1021e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeMajorCustomersDetails" xlink:type="simple" xlink:href="cah-20210630.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeMajorCustomersDetails"/>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeMajorCustomersDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_d1cb2791-7720-4acf-9def-a4f3ea10077c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTable_481ac5a4-fea9-40f0-8b96-d2d5b6e4d789" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_d1cb2791-7720-4acf-9def-a4f3ea10077c" xlink:to="loc_us-gaap_ConcentrationRiskTable_481ac5a4-fea9-40f0-8b96-d2d5b6e4d789" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MajorCustomersAxis_c3c35dc5-d1e1-4f4a-a87c-6982a6f81b56" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MajorCustomersAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_481ac5a4-fea9-40f0-8b96-d2d5b6e4d789" xlink:to="loc_srt_MajorCustomersAxis_c3c35dc5-d1e1-4f4a-a87c-6982a6f81b56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_de894dc5-98b2-4a6c-9a11-083a367d07e2" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MajorCustomersAxis_c3c35dc5-d1e1-4f4a-a87c-6982a6f81b56" xlink:to="loc_srt_NameOfMajorCustomerDomain_de894dc5-98b2-4a6c-9a11-083a367d07e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_GroupPurchasingOrganizationsMember_5363c3b6-f9ec-4be4-a97e-02fa062b81c1" xlink:href="cah-20210630.xsd#cah_GroupPurchasingOrganizationsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_de894dc5-98b2-4a6c-9a11-083a367d07e2" xlink:to="loc_cah_GroupPurchasingOrganizationsMember_5363c3b6-f9ec-4be4-a97e-02fa062b81c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_eaa6a604-aaac-4aee-a4ad-ee26880bf062" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_481ac5a4-fea9-40f0-8b96-d2d5b6e4d789" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_eaa6a604-aaac-4aee-a4ad-ee26880bf062" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_0c180662-da39-4d93-95ee-cd138a0c9b74" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_eaa6a604-aaac-4aee-a4ad-ee26880bf062" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_0c180662-da39-4d93-95ee-cd138a0c9b74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesRevenueNetMember_b1ff3a70-3c66-4237-abd7-351d2d4c6298" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SalesRevenueNetMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_0c180662-da39-4d93-95ee-cd138a0c9b74" xlink:to="loc_us-gaap_SalesRevenueNetMember_b1ff3a70-3c66-4237-abd7-351d2d4c6298" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_c58e7af2-1a29-4945-9026-94994da00816" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_481ac5a4-fea9-40f0-8b96-d2d5b6e4d789" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_c58e7af2-1a29-4945-9026-94994da00816" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_f4c3c055-55b9-46dc-b9c5-f4633e13f29e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_c58e7af2-1a29-4945-9026-94994da00816" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_f4c3c055-55b9-46dc-b9c5-f4633e13f29e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerConcentrationRiskMember_d8df9b2e-4350-4c08-8e0f-7dcc710017e9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerConcentrationRiskMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_f4c3c055-55b9-46dc-b9c5-f4633e13f29e" xlink:to="loc_us-gaap_CustomerConcentrationRiskMember_d8df9b2e-4350-4c08-8e0f-7dcc710017e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskLineItems_eb251b9d-7026-4a1a-9d0e-6486e19359e7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_481ac5a4-fea9-40f0-8b96-d2d5b6e4d789" xlink:to="loc_us-gaap_ConcentrationRiskLineItems_eb251b9d-7026-4a1a-9d0e-6486e19359e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_ConcentrationRiskLargestGroupPurchasingOrganizations_f9a52157-3c1e-464c-8491-59115041f561" xlink:href="cah-20210630.xsd#cah_ConcentrationRiskLargestGroupPurchasingOrganizations"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_eb251b9d-7026-4a1a-9d0e-6486e19359e7" xlink:to="loc_cah_ConcentrationRiskLargestGroupPurchasingOrganizations_f9a52157-3c1e-464c-8491-59115041f561" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_447bcc63-9f14-4b4d-bf09-a16d14197371" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_eb251b9d-7026-4a1a-9d0e-6486e19359e7" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_447bcc63-9f14-4b4d-bf09-a16d14197371" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeInventoriesDetails" xlink:type="simple" xlink:href="cah-20210630.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeInventoriesDetails"/>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeInventoriesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_c4370727-e3bb-4266-9291-3cd849682455" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PercentageOfLIFOInventory_e7de23b5-0a61-4b54-bd69-0e127af06e0c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PercentageOfLIFOInventory"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_c4370727-e3bb-4266-9291-3cd849682455" xlink:to="loc_us-gaap_PercentageOfLIFOInventory_e7de23b5-0a61-4b54-bd69-0e127af06e0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryLIFOReserve_a1b228f1-db62-4129-b5d3-e51c94e658aa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryLIFOReserve"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_c4370727-e3bb-4266-9291-3cd849682455" xlink:to="loc_us-gaap_InventoryLIFOReserve_a1b228f1-db62-4129-b5d3-e51c94e658aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryValuationReserves_3291ebf2-f50e-4099-9853-e5fa1f22793f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryValuationReserves"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_c4370727-e3bb-4266-9291-3cd849682455" xlink:to="loc_us-gaap_InventoryValuationReserves_3291ebf2-f50e-4099-9853-e5fa1f22793f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWriteDown_3aa24652-43fe-4b33-89d0-d50074f904b4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryWriteDown"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_c4370727-e3bb-4266-9291-3cd849682455" xlink:to="loc_us-gaap_InventoryWriteDown_3aa24652-43fe-4b33-89d0-d50074f904b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativePropertyandEquipmentDetails" xlink:type="simple" xlink:href="cah-20210630.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativePropertyandEquipmentDetails"/>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativePropertyandEquipmentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_0aba0e0d-22d0-457f-b5d7-f91663302e93" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_f97e6961-3726-40a5-92fa-420f77a0de1e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0aba0e0d-22d0-457f-b5d7-f91663302e93" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_f97e6961-3726-40a5-92fa-420f77a0de1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_32360898-fd79-4ec9-aee9-777469f3d886" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_f97e6961-3726-40a5-92fa-420f77a0de1e" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_32360898-fd79-4ec9-aee9-777469f3d886" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_b63afad6-4b22-4a3c-9e4f-5dff548193ea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_32360898-fd79-4ec9-aee9-777469f3d886" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_b63afad6-4b22-4a3c-9e4f-5dff548193ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingAndBuildingImprovementsMember_1ae6695e-3224-47ba-9728-d70edb9aea57" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BuildingAndBuildingImprovementsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_b63afad6-4b22-4a3c-9e4f-5dff548193ea" xlink:to="loc_us-gaap_BuildingAndBuildingImprovementsMember_1ae6695e-3224-47ba-9728-d70edb9aea57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MachineryAndEquipmentMember_d6163515-8fd5-47c6-84f4-ae828a6841e1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MachineryAndEquipmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_b63afad6-4b22-4a3c-9e4f-5dff548193ea" xlink:to="loc_us-gaap_MachineryAndEquipmentMember_d6163515-8fd5-47c6-84f4-ae828a6841e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesMember_e74cf4e2-75ce-4de7-b5d1-6117d312eb6f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FurnitureAndFixturesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_b63afad6-4b22-4a3c-9e4f-5dff548193ea" xlink:to="loc_us-gaap_FurnitureAndFixturesMember_e74cf4e2-75ce-4de7-b5d1-6117d312eb6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_9f8e463a-6c7f-4c13-819a-ac38bb6e35e0" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_f97e6961-3726-40a5-92fa-420f77a0de1e" xlink:to="loc_srt_RangeAxis_9f8e463a-6c7f-4c13-819a-ac38bb6e35e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_2bfbf3bb-78af-442b-ae67-e9a0dc785208" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_9f8e463a-6c7f-4c13-819a-ac38bb6e35e0" xlink:to="loc_srt_RangeMember_2bfbf3bb-78af-442b-ae67-e9a0dc785208" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_8ef733f7-ccdd-4191-9d57-e5a9bda641db" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_2bfbf3bb-78af-442b-ae67-e9a0dc785208" xlink:to="loc_srt_MinimumMember_8ef733f7-ccdd-4191-9d57-e5a9bda641db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_5d834210-ccad-4588-bdbf-2b1cda5341bd" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_2bfbf3bb-78af-442b-ae67-e9a0dc785208" xlink:to="loc_srt_MaximumMember_5d834210-ccad-4588-bdbf-2b1cda5341bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_c120f956-b2d0-457e-9215-019ba398520e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_f97e6961-3726-40a5-92fa-420f77a0de1e" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentLineItems_c120f956-b2d0-457e-9215-019ba398520e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_b0a9a900-9ab1-43ce-bcde-2f30fcd179a3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_c120f956-b2d0-457e-9215-019ba398520e" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_b0a9a900-9ab1-43ce-bcde-2f30fcd179a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_b8cb53e4-0de6-4690-af8a-7f6063f15981" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Depreciation"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_c120f956-b2d0-457e-9215-019ba398520e" xlink:to="loc_us-gaap_Depreciation_b8cb53e4-0de6-4690-af8a-7f6063f15981" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtWeightedAverageInterestRate_5b346bd8-7e54-4cc6-8ae6-e27bd71f9301" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtWeightedAverageInterestRate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0aba0e0d-22d0-457f-b5d7-f91663302e93" xlink:to="loc_us-gaap_LongtermDebtWeightedAverageInterestRate_5b346bd8-7e54-4cc6-8ae6-e27bd71f9301" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesComponentsofPropertyandEquipmentDetails" xlink:type="simple" xlink:href="cah-20210630.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesComponentsofPropertyandEquipmentDetails"/>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesComponentsofPropertyandEquipmentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_6eae685b-f361-4727-a684-852770b5d7cd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_fe99661a-7a52-4161-bf25-a2a01696837d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_6eae685b-f361-4727-a684-852770b5d7cd" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_fe99661a-7a52-4161-bf25-a2a01696837d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_21b83f73-fefc-4f62-b513-112671a687a1" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_fe99661a-7a52-4161-bf25-a2a01696837d" xlink:to="loc_srt_RangeAxis_21b83f73-fefc-4f62-b513-112671a687a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_3722ecc7-4cdd-412b-9c53-61af91fe60f7" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_21b83f73-fefc-4f62-b513-112671a687a1" xlink:to="loc_srt_RangeMember_3722ecc7-4cdd-412b-9c53-61af91fe60f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_f17278d1-8f41-400c-9f0c-8658472d3689" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_3722ecc7-4cdd-412b-9c53-61af91fe60f7" xlink:to="loc_srt_MaximumMember_f17278d1-8f41-400c-9f0c-8658472d3689" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_55b75f5e-3f32-4ad3-ad16-84726b28ba78" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_3722ecc7-4cdd-412b-9c53-61af91fe60f7" xlink:to="loc_srt_MinimumMember_55b75f5e-3f32-4ad3-ad16-84726b28ba78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_e3b617f2-d269-4fb5-ad5e-b1404c509cca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_fe99661a-7a52-4161-bf25-a2a01696837d" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_e3b617f2-d269-4fb5-ad5e-b1404c509cca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_7d2d3cce-4c2f-433c-8f2e-685351366361" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_e3b617f2-d269-4fb5-ad5e-b1404c509cca" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_7d2d3cce-4c2f-433c-8f2e-685351366361" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingAndBuildingImprovementsMember_2edb3899-d5b9-4e0e-bffe-ff65313fd2db" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BuildingAndBuildingImprovementsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_7d2d3cce-4c2f-433c-8f2e-685351366361" xlink:to="loc_us-gaap_BuildingAndBuildingImprovementsMember_2edb3899-d5b9-4e0e-bffe-ff65313fd2db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LandBuildingsAndImprovementsMember_aa54f518-7372-4fb4-950f-9bc01e9f0035" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LandBuildingsAndImprovementsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_7d2d3cce-4c2f-433c-8f2e-685351366361" xlink:to="loc_us-gaap_LandBuildingsAndImprovementsMember_aa54f518-7372-4fb4-950f-9bc01e9f0035" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MachineryAndEquipmentMember_7d240e97-d749-4ab7-999e-a4c6f9de69d1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MachineryAndEquipmentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_7d2d3cce-4c2f-433c-8f2e-685351366361" xlink:to="loc_us-gaap_MachineryAndEquipmentMember_7d240e97-d749-4ab7-999e-a4c6f9de69d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesMember_e94f559d-569e-42fb-92e6-5d852430e896" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FurnitureAndFixturesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_7d2d3cce-4c2f-433c-8f2e-685351366361" xlink:to="loc_us-gaap_FurnitureAndFixturesMember_e94f559d-569e-42fb-92e6-5d852430e896" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_6d0c16b0-74b4-4abe-b520-7ba3e2e7fa5e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_fe99661a-7a52-4161-bf25-a2a01696837d" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentLineItems_6d0c16b0-74b4-4abe-b520-7ba3e2e7fa5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_5610a1d5-6094-48d5-b1b6-80b29553626d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_6d0c16b0-74b4-4abe-b520-7ba3e2e7fa5e" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_5610a1d5-6094-48d5-b1b6-80b29553626d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_f2dee4ad-65b4-4ac5-adce-aabd12bd340b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_6d0c16b0-74b4-4abe-b520-7ba3e2e7fa5e" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_f2dee4ad-65b4-4ac5-adce-aabd12bd340b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_88962cbf-e660-4ba8-a3ac-2750793784ce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_6d0c16b0-74b4-4abe-b520-7ba3e2e7fa5e" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_88962cbf-e660-4ba8-a3ac-2750793784ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_e2d53e94-0e96-4bdf-8842-970ed0b3b3eb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_6d0c16b0-74b4-4abe-b520-7ba3e2e7fa5e" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_e2d53e94-0e96-4bdf-8842-970ed0b3b3eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeGoodwillandOtherIntangibleAssetsDetails" xlink:type="simple" xlink:href="cah-20210630.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeGoodwillandOtherIntangibleAssetsDetails"/>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeGoodwillandOtherIntangibleAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_24139fe1-c3b1-4f39-8a41-44d978477f4f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_GoodwillAndIntangibleAssetsTable_92d51f42-136a-4f72-b6e3-af641c5c067d" xlink:href="cah-20210630.xsd#cah_GoodwillAndIntangibleAssetsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_24139fe1-c3b1-4f39-8a41-44d978477f4f" xlink:to="loc_cah_GoodwillAndIntangibleAssetsTable_92d51f42-136a-4f72-b6e3-af641c5c067d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_527f7329-979b-477e-b6e1-de6a3b3ce80b" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cah_GoodwillAndIntangibleAssetsTable_92d51f42-136a-4f72-b6e3-af641c5c067d" xlink:to="loc_srt_RangeAxis_527f7329-979b-477e-b6e1-de6a3b3ce80b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_168aa16c-791c-44bb-a696-80ae07df0790" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_527f7329-979b-477e-b6e1-de6a3b3ce80b" xlink:to="loc_srt_RangeMember_168aa16c-791c-44bb-a696-80ae07df0790" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_4ab65867-7c0d-45d6-af5c-0b8cc6f50091" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_168aa16c-791c-44bb-a696-80ae07df0790" xlink:to="loc_srt_MinimumMember_4ab65867-7c0d-45d6-af5c-0b8cc6f50091" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_69184d80-6c08-491e-99d4-9677339b7944" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_168aa16c-791c-44bb-a696-80ae07df0790" xlink:to="loc_srt_MaximumMember_69184d80-6c08-491e-99d4-9677339b7944" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_GoodwillAndIntangibleAssetsLineItems_aaadc2b4-e7fc-4a0e-b6ac-efa6e17f1ce1" xlink:href="cah-20210630.xsd#cah_GoodwillAndIntangibleAssetsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cah_GoodwillAndIntangibleAssetsTable_92d51f42-136a-4f72-b6e3-af641c5c067d" xlink:to="loc_cah_GoodwillAndIntangibleAssetsLineItems_aaadc2b4-e7fc-4a0e-b6ac-efa6e17f1ce1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_DiscountRatefairvalueinputs_1416cbc6-245d-48d3-b9c2-6df2ad733ecf" xlink:href="cah-20210630.xsd#cah_DiscountRatefairvalueinputs"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cah_GoodwillAndIntangibleAssetsLineItems_aaadc2b4-e7fc-4a0e-b6ac-efa6e17f1ce1" xlink:to="loc_cah_DiscountRatefairvalueinputs_1416cbc6-245d-48d3-b9c2-6df2ad733ecf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfOperatingSegments_2a8112eb-5fee-4233-8fad-da843a29cfce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfOperatingSegments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cah_GoodwillAndIntangibleAssetsLineItems_aaadc2b4-e7fc-4a0e-b6ac-efa6e17f1ce1" xlink:to="loc_us-gaap_NumberOfOperatingSegments_2a8112eb-5fee-4233-8fad-da843a29cfce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_43a779c1-adb3-4c4d-a9da-0b480a961387" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cah_GoodwillAndIntangibleAssetsLineItems_aaadc2b4-e7fc-4a0e-b6ac-efa6e17f1ce1" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_43a779c1-adb3-4c4d-a9da-0b480a961387" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeInvestmentsDetails" xlink:type="simple" xlink:href="cah-20210630.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeInvestmentsDetails"/>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeInvestmentsDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeVendorReservesDetails" xlink:type="simple" xlink:href="cah-20210630.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeVendorReservesDetails"/>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeVendorReservesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_17ad9d33-ca7d-4720-8fda-ca4f63d7cc62" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_VendorReserves_ff5c5de0-a846-4e72-aa14-c34ee3fedf72" xlink:href="cah-20210630.xsd#cah_VendorReserves"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_17ad9d33-ca7d-4720-8fda-ca4f63d7cc62" xlink:to="loc_cah_VendorReserves_ff5c5de0-a846-4e72-aa14-c34ee3fedf72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDividendsDetails" xlink:type="simple" xlink:href="cah-20210630.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDividendsDetails"/>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDividendsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_2233c2dc-6295-4a79-a739-afd5678c4e21" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareCashPaid_8795a7af-fbd3-4858-bf71-36f703e387f0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockDividendsPerShareCashPaid"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_2233c2dc-6295-4a79-a739-afd5678c4e21" xlink:to="loc_us-gaap_CommonStockDividendsPerShareCashPaid_8795a7af-fbd3-4858-bf71-36f703e387f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeSalesReturnsandAllowancesDetails" xlink:type="simple" xlink:href="cah-20210630.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeSalesReturnsandAllowancesDetails"/>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeSalesReturnsandAllowancesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_ad10b824-5fc5-4a21-b44e-e7e8879daad9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_RevenueRecognitionReserveforSalesReturnsandAllowances_0d63896c-cfc9-4bcf-84a7-d1e2637f0ce2" xlink:href="cah-20210630.xsd#cah_RevenueRecognitionReserveforSalesReturnsandAllowances"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_ad10b824-5fc5-4a21-b44e-e7e8879daad9" xlink:to="loc_cah_RevenueRecognitionReserveforSalesReturnsandAllowances_0d63896c-cfc9-4bcf-84a7-d1e2637f0ce2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRecognitionSalesReturnsReserveForSalesReturns_b715ba5b-96c2-4a8e-aa08-211fcf0c6958" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRecognitionSalesReturnsReserveForSalesReturns"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_ad10b824-5fc5-4a21-b44e-e7e8879daad9" xlink:to="loc_us-gaap_RevenueRecognitionSalesReturnsReserveForSalesReturns_b715ba5b-96c2-4a8e-aa08-211fcf0c6958" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeShippingandHandlingDetails" xlink:type="simple" xlink:href="cah-20210630.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeShippingandHandlingDetails"/>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeShippingandHandlingDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_2957315d-1e27-4147-8162-08179155f45e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_GoodsandservicessoldTable_88b81ed6-fa25-4327-9524-5e076dcc9381" xlink:href="cah-20210630.xsd#cah_GoodsandservicessoldTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_2957315d-1e27-4147-8162-08179155f45e" xlink:to="loc_cah_GoodsandservicessoldTable_88b81ed6-fa25-4327-9524-5e076dcc9381" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_48dc3b52-25c6-47d1-93f2-ff93defd3f64" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cah_GoodsandservicessoldTable_88b81ed6-fa25-4327-9524-5e076dcc9381" xlink:to="loc_srt_ProductOrServiceAxis_48dc3b52-25c6-47d1-93f2-ff93defd3f64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_259b6f61-7f6e-4699-a27c-8b57657e3e2b" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_48dc3b52-25c6-47d1-93f2-ff93defd3f64" xlink:to="loc_srt_ProductsAndServicesDomain_259b6f61-7f6e-4699-a27c-8b57657e3e2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShippingAndHandlingMember_16452c3e-2a6b-4e8d-9827-c1784c7a0514" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShippingAndHandlingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_259b6f61-7f6e-4699-a27c-8b57657e3e2b" xlink:to="loc_us-gaap_ShippingAndHandlingMember_16452c3e-2a6b-4e8d-9827-c1784c7a0514" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_GoodsandservicessoldLineItems_3984a288-70af-4b18-9bdc-c6d75fa8c180" xlink:href="cah-20210630.xsd#cah_GoodsandservicessoldLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cah_GoodsandservicessoldTable_88b81ed6-fa25-4327-9524-5e076dcc9381" xlink:to="loc_cah_GoodsandservicessoldLineItems_3984a288-70af-4b18-9bdc-c6d75fa8c180" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_13e4bdb9-a6cb-4d19-9679-8d0883fbf8b7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cah_GoodsandservicessoldLineItems_3984a288-70af-4b18-9bdc-c6d75fa8c180" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_13e4bdb9-a6cb-4d19-9679-8d0883fbf8b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesLossContingenciesDetails" xlink:type="simple" xlink:href="cah-20210630.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesLossContingenciesDetails"/>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesLossContingenciesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_1c407f31-6493-4c0d-86bc-c4e5ed8e2db4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_64094af3-d2fa-4e9a-b94f-1c469afdd16b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_1c407f31-6493-4c0d-86bc-c4e5ed8e2db4" xlink:to="loc_us-gaap_LossContingenciesTable_64094af3-d2fa-4e9a-b94f-1c469afdd16b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_OpioidLitigationAxis_11cf0d5c-a977-4e1f-abc7-d84b4cede8fa" xlink:href="cah-20210630.xsd#cah_OpioidLitigationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_64094af3-d2fa-4e9a-b94f-1c469afdd16b" xlink:to="loc_cah_OpioidLitigationAxis_11cf0d5c-a977-4e1f-abc7-d84b4cede8fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_OpioidLitigationDomain_46959b3c-7e0e-4fe7-9694-dd4eb8095e24" xlink:href="cah-20210630.xsd#cah_OpioidLitigationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cah_OpioidLitigationAxis_11cf0d5c-a977-4e1f-abc7-d84b4cede8fa" xlink:to="loc_cah_OpioidLitigationDomain_46959b3c-7e0e-4fe7-9694-dd4eb8095e24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_TotalOpioidLitigationMember_b9f8b5a6-b82a-42bb-83ac-a4467ab7a164" xlink:href="cah-20210630.xsd#cah_TotalOpioidLitigationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cah_OpioidLitigationDomain_46959b3c-7e0e-4fe7-9694-dd4eb8095e24" xlink:to="loc_cah_TotalOpioidLitigationMember_b9f8b5a6-b82a-42bb-83ac-a4467ab7a164" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_bd4be2aa-1084-416c-9708-d45db97765e9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_64094af3-d2fa-4e9a-b94f-1c469afdd16b" xlink:to="loc_us-gaap_LossContingenciesLineItems_bd4be2aa-1084-416c-9708-d45db97765e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossRelatedToLitigationSettlement_cc2b99a5-679b-4b38-b190-d7c6e3189e1b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossRelatedToLitigationSettlement"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_bd4be2aa-1084-416c-9708-d45db97765e9" xlink:to="loc_us-gaap_GainLossRelatedToLitigationSettlement_cc2b99a5-679b-4b38-b190-d7c6e3189e1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/DivestituresandAcquisitions" xlink:type="simple" xlink:href="cah-20210630.xsd#DivestituresandAcquisitions"/>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/DivestituresandAcquisitions" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_545f3bd4-39d1-44f9-8f37-6b42a5d30f12" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationDisclosureTextBlock_72f3de23-bb85-4ffc-8569-eaf2bca8ced5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_545f3bd4-39d1-44f9-8f37-6b42a5d30f12" xlink:to="loc_us-gaap_BusinessCombinationDisclosureTextBlock_72f3de23-bb85-4ffc-8569-eaf2bca8ced5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/DivestituresandAcquisitionsTables" xlink:type="simple" xlink:href="cah-20210630.xsd#DivestituresandAcquisitionsTables"/>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/DivestituresandAcquisitionsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_344a3bde-5f79-4870-9842-60bf89d16cd8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock_0bef2e08-e6c5-417c-9836-6b23066b88cb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_344a3bde-5f79-4870-9842-60bf89d16cd8" xlink:to="loc_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock_0bef2e08-e6c5-417c-9836-6b23066b88cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/DivestituresandAcquisitionsNarrativeDetails" xlink:type="simple" xlink:href="cah-20210630.xsd#DivestituresandAcquisitionsNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/DivestituresandAcquisitionsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_7a1d177d-7510-4a52-ade5-e38ec591c26f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_3d42aec9-50bd-4b52-a25e-6a766f434b31" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_7a1d177d-7510-4a52-ade5-e38ec591c26f" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_3d42aec9-50bd-4b52-a25e-6a766f434b31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_6855cb1b-36a1-4bd7-a9b4-75f60dec9169" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_3d42aec9-50bd-4b52-a25e-6a766f434b31" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_6855cb1b-36a1-4bd7-a9b4-75f60dec9169" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_e9360c3c-03d2-419a-a31e-7eb9e65bad5a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_6855cb1b-36a1-4bd7-a9b4-75f60dec9169" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_e9360c3c-03d2-419a-a31e-7eb9e65bad5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_NaviHealthMember_f9d85615-67c1-41d4-8a78-7ad871fadca0" xlink:href="cah-20210630.xsd#cah_NaviHealthMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_e9360c3c-03d2-419a-a31e-7eb9e65bad5a" xlink:to="loc_cah_NaviHealthMember_f9d85615-67c1-41d4-8a78-7ad871fadca0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_6c8539ff-7933-4af1-b5a7-a0cd852b143f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_3d42aec9-50bd-4b52-a25e-6a766f434b31" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_6c8539ff-7933-4af1-b5a7-a0cd852b143f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_61b9071c-0370-4578-a7b2-3fd59361de74" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_6c8539ff-7933-4af1-b5a7-a0cd852b143f" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_61b9071c-0370-4578-a7b2-3fd59361de74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_PatientRecoveryBusinessMember_53f16cb7-4787-4c5c-b942-21892af35c42" xlink:href="cah-20210630.xsd#cah_PatientRecoveryBusinessMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_61b9071c-0370-4578-a7b2-3fd59361de74" xlink:to="loc_cah_PatientRecoveryBusinessMember_53f16cb7-4787-4c5c-b942-21892af35c42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_932229e0-815e-4eb0-93d8-f95b5b512ca8" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_3d42aec9-50bd-4b52-a25e-6a766f434b31" xlink:to="loc_srt_RangeAxis_932229e0-815e-4eb0-93d8-f95b5b512ca8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_0bb9477b-7ec3-471c-8ece-4fdabb678dfa" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_932229e0-815e-4eb0-93d8-f95b5b512ca8" xlink:to="loc_srt_RangeMember_0bb9477b-7ec3-471c-8ece-4fdabb678dfa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_7384d848-2cb0-453c-97f6-dc3e4566858a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_3d42aec9-50bd-4b52-a25e-6a766f434b31" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_7384d848-2cb0-453c-97f6-dc3e4566858a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_33e870e8-906a-48de-a6c2-e6afceefd05d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_7384d848-2cb0-453c-97f6-dc3e4566858a" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_33e870e8-906a-48de-a6c2-e6afceefd05d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_PatientRecoveryBusinessMember_fb883830-b763-43ad-ba17-47852e3e63f9" xlink:href="cah-20210630.xsd#cah_PatientRecoveryBusinessMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_33e870e8-906a-48de-a6c2-e6afceefd05d" xlink:to="loc_cah_PatientRecoveryBusinessMember_fb883830-b763-43ad-ba17-47852e3e63f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_CordisDivestitureAxis_f509a4a3-c055-4031-813e-47861b4b3ff8" xlink:href="cah-20210630.xsd#cah_CordisDivestitureAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_3d42aec9-50bd-4b52-a25e-6a766f434b31" xlink:to="loc_cah_CordisDivestitureAxis_f509a4a3-c055-4031-813e-47861b4b3ff8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_CordisDivestitureDomain_a67e6003-4877-4df1-9b82-1f68a199842e" xlink:href="cah-20210630.xsd#cah_CordisDivestitureDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cah_CordisDivestitureAxis_f509a4a3-c055-4031-813e-47861b4b3ff8" xlink:to="loc_cah_CordisDivestitureDomain_a67e6003-4877-4df1-9b82-1f68a199842e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_CordisDivestitureMember_0814d2cf-42a0-4289-a1ef-9c36d1fe9f7e" xlink:href="cah-20210630.xsd#cah_CordisDivestitureMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cah_CordisDivestitureDomain_a67e6003-4877-4df1-9b82-1f68a199842e" xlink:to="loc_cah_CordisDivestitureMember_0814d2cf-42a0-4289-a1ef-9c36d1fe9f7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_NaviHealthAxis_bba41ab1-8aee-4bfb-b930-05c1440fc227" xlink:href="cah-20210630.xsd#cah_NaviHealthAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_3d42aec9-50bd-4b52-a25e-6a766f434b31" xlink:to="loc_cah_NaviHealthAxis_bba41ab1-8aee-4bfb-b930-05c1440fc227" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_NaviHealthDomain_1b28b250-a397-4470-bde1-036ae3d78177" xlink:href="cah-20210630.xsd#cah_NaviHealthDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cah_NaviHealthAxis_bba41ab1-8aee-4bfb-b930-05c1440fc227" xlink:to="loc_cah_NaviHealthDomain_1b28b250-a397-4470-bde1-036ae3d78177" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_NaviHealthMember_3a305441-8337-45c6-a3f9-fe2eda8b1fb2" xlink:href="cah-20210630.xsd#cah_NaviHealthMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cah_NaviHealthDomain_1b28b250-a397-4470-bde1-036ae3d78177" xlink:to="loc_cah_NaviHealthMember_3a305441-8337-45c6-a3f9-fe2eda8b1fb2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_cf5078ec-4737-4f0e-86a0-77d1b1a31f2a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_3d42aec9-50bd-4b52-a25e-6a766f434b31" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_cf5078ec-4737-4f0e-86a0-77d1b1a31f2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_ffe319f5-4d24-40c3-9c8e-2d941aad5e8f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_cf5078ec-4737-4f0e-86a0-77d1b1a31f2a" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_ffe319f5-4d24-40c3-9c8e-2d941aad5e8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_c71221d2-8b1c-4c7b-9fa6-510a58fec28d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_ffe319f5-4d24-40c3-9c8e-2d941aad5e8f" xlink:to="loc_us-gaap_SubsequentEventMember_c71221d2-8b1c-4c7b-9fa6-510a58fec28d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_224386de-5798-4c7d-ba0c-bcb978fabb2f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_3d42aec9-50bd-4b52-a25e-6a766f434b31" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_224386de-5798-4c7d-ba0c-bcb978fabb2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_76806bab-80b8-4794-b538-097111891e04" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_224386de-5798-4c7d-ba0c-bcb978fabb2f" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_76806bab-80b8-4794-b538-097111891e04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_a0d92269-45cf-4bc5-bf9a-4218eca3fb06" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromDivestitureOfBusinesses"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_224386de-5798-4c7d-ba0c-bcb978fabb2f" xlink:to="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_a0d92269-45cf-4bc5-bf9a-4218eca3fb06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_PreTaxGainonDivestiture_2b6a77c4-8c7d-49b9-87a6-4a7bcde26a98" xlink:href="cah-20210630.xsd#cah_PreTaxGainonDivestiture"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_224386de-5798-4c7d-ba0c-bcb978fabb2f" xlink:to="loc_cah_PreTaxGainonDivestiture_2b6a77c4-8c7d-49b9-87a6-4a7bcde26a98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments_8c4dc2da-78ac-4518-aac4-144e6e18c83a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestments"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_224386de-5798-4c7d-ba0c-bcb978fabb2f" xlink:to="loc_us-gaap_EquityMethodInvestments_8c4dc2da-78ac-4518-aac4-144e6e18c83a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_a8d2551f-1112-4f98-8ccd-daf0dfd1400d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_224386de-5798-4c7d-ba0c-bcb978fabb2f" xlink:to="loc_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_a8d2551f-1112-4f98-8ccd-daf0dfd1400d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_Provisionaltaxbenefitrelatedtotransaction_265e4c07-898b-4672-a7bb-bd913c03e71a" xlink:href="cah-20210630.xsd#cah_Provisionaltaxbenefitrelatedtotransaction"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_224386de-5798-4c7d-ba0c-bcb978fabb2f" xlink:to="loc_cah_Provisionaltaxbenefitrelatedtotransaction_265e4c07-898b-4672-a7bb-bd913c03e71a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_0fa91f9d-d8bf-4bb7-b4d8-dcdfb3c816f9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_224386de-5798-4c7d-ba0c-bcb978fabb2f" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_0fa91f9d-d8bf-4bb7-b4d8-dcdfb3c816f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration_55f3264c-1366-47d5-a031-9eb3dcd37011" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_224386de-5798-4c7d-ba0c-bcb978fabb2f" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration_55f3264c-1366-47d5-a031-9eb3dcd37011" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1_1cd214f3-d4e8-4a7b-9d2d-1ebbdda78fd6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_224386de-5798-4c7d-ba0c-bcb978fabb2f" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1_1cd214f3-d4e8-4a7b-9d2d-1ebbdda78fd6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_WriteDownOfAssetsHeldForSale_cb21bfc3-f2bf-482b-8f35-3883e1b859e8" xlink:href="cah-20210630.xsd#cah_WriteDownOfAssetsHeldForSale"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_224386de-5798-4c7d-ba0c-bcb978fabb2f" xlink:to="loc_cah_WriteDownOfAssetsHeldForSale_cb21bfc3-f2bf-482b-8f35-3883e1b859e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_c88bfd6a-e369-44af-8bb1-74404297bf35" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_224386de-5798-4c7d-ba0c-bcb978fabb2f" xlink:to="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_c88bfd6a-e369-44af-8bb1-74404297bf35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccruedLiabilities_5d0be3c0-cd53-4042-b207-c9205ef3ff5a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationAccruedLiabilities"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_224386de-5798-4c7d-ba0c-bcb978fabb2f" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccruedLiabilities_5d0be3c0-cd53-4042-b207-c9205ef3ff5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherLiabilities_3b3b8e70-df36-43ec-92f6-26736e358178" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherLiabilities"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_224386de-5798-4c7d-ba0c-bcb978fabb2f" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherLiabilities_3b3b8e70-df36-43ec-92f6-26736e358178" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_60be32fa-c8c5-4de1-b51b-2c81a880baec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_224386de-5798-4c7d-ba0c-bcb978fabb2f" xlink:to="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_60be32fa-c8c5-4de1-b51b-2c81a880baec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationForeignCurrencyTranslationGainsLosses_c475cf98-cf11-4939-8c1f-56bab4d371a1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationForeignCurrencyTranslationGainsLosses"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_224386de-5798-4c7d-ba0c-bcb978fabb2f" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationForeignCurrencyTranslationGainsLosses_c475cf98-cf11-4939-8c1f-56bab4d371a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationTaxEffectOfIncomeLossFromDisposalOfDiscontinuedOperation_6282540a-ef57-4be1-9506-6e3f7f3c13e0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DiscontinuedOperationTaxEffectOfIncomeLossFromDisposalOfDiscontinuedOperation"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_224386de-5798-4c7d-ba0c-bcb978fabb2f" xlink:to="loc_us-gaap_DiscontinuedOperationTaxEffectOfIncomeLossFromDisposalOfDiscontinuedOperation_6282540a-ef57-4be1-9506-6e3f7f3c13e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents_6f73a4e4-385f-4b38-a4df-c2cc3a11d590" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_224386de-5798-4c7d-ba0c-bcb978fabb2f" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents_6f73a4e4-385f-4b38-a4df-c2cc3a11d590" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1_79fe0e1e-3d67-4e21-ba5c-12004f64eda1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_224386de-5798-4c7d-ba0c-bcb978fabb2f" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1_79fe0e1e-3d67-4e21-ba5c-12004f64eda1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment_b4274337-d8be-4c67-a93b-f6b645dff271" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_224386de-5798-4c7d-ba0c-bcb978fabb2f" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment_b4274337-d8be-4c67-a93b-f6b645dff271" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_DisposalGroupIncludingDiscontinuedOperationsGoodwillAndOtherIntangiblesNet_6d3ac9c5-6e63-4080-9e80-6ce068729f2f" xlink:href="cah-20210630.xsd#cah_DisposalGroupIncludingDiscontinuedOperationsGoodwillAndOtherIntangiblesNet"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_224386de-5798-4c7d-ba0c-bcb978fabb2f" xlink:to="loc_cah_DisposalGroupIncludingDiscontinuedOperationsGoodwillAndOtherIntangiblesNet_6d3ac9c5-6e63-4080-9e80-6ce068729f2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets_cce7c90c-d47f-4f44-a878-9e43dbccd6fa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_224386de-5798-4c7d-ba0c-bcb978fabb2f" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets_cce7c90c-d47f-4f44-a878-9e43dbccd6fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainOnSaleOfInvestments_fa24d4bd-f0d9-4f76-86a0-f3af47608db7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainOnSaleOfInvestments"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_224386de-5798-4c7d-ba0c-bcb978fabb2f" xlink:to="loc_us-gaap_GainOnSaleOfInvestments_fa24d4bd-f0d9-4f76-86a0-f3af47608db7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/RestructuringandEmployeeSeverance" xlink:type="simple" xlink:href="cah-20210630.xsd#RestructuringandEmployeeSeverance"/>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/RestructuringandEmployeeSeverance" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringChargesAbstract_3df57cf5-185d-4884-8027-4d89ff940f5f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringChargesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_fa2fec91-7368-4dd7-a94b-72c948e29011" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringChargesAbstract_3df57cf5-185d-4884-8027-4d89ff940f5f" xlink:to="loc_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_fa2fec91-7368-4dd7-a94b-72c948e29011" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/RestructuringandEmployeeSeveranceTables" xlink:type="simple" xlink:href="cah-20210630.xsd#RestructuringandEmployeeSeveranceTables"/>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/RestructuringandEmployeeSeveranceTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringChargesAbstract_8daa2c48-de1e-4d09-8bf8-3a228b35e394" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringChargesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_5c5e6f7c-b060-409b-b869-4782a0bc0bec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringChargesAbstract_8daa2c48-de1e-4d09-8bf8-3a228b35e394" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_5c5e6f7c-b060-409b-b869-4782a0bc0bec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock_2843d63f-802d-49dd-8c7f-22382f59251b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringChargesAbstract_8daa2c48-de1e-4d09-8bf8-3a228b35e394" xlink:to="loc_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock_2843d63f-802d-49dd-8c7f-22382f59251b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/RestructuringandEmployeeSeveranceActivityRelatedtoRestructuringandEmployeeSeveranceCostsDetails" xlink:type="simple" xlink:href="cah-20210630.xsd#RestructuringandEmployeeSeveranceActivityRelatedtoRestructuringandEmployeeSeveranceCostsDetails"/>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/RestructuringandEmployeeSeveranceActivityRelatedtoRestructuringandEmployeeSeveranceCostsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringChargesAbstract_85ce988b-723e-4a8a-86d6-11ad50c5d1db" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringChargesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeveranceCosts1_1f92faea-2a69-49fc-8c84-dca52e284cc0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeveranceCosts1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringChargesAbstract_85ce988b-723e-4a8a-86d6-11ad50c5d1db" xlink:to="loc_us-gaap_SeveranceCosts1_1f92faea-2a69-49fc-8c84-dca52e284cc0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_FacilityExitAndOtherCosts_b9e89ee7-e63c-4834-ad0e-6bd05633add7" xlink:href="cah-20210630.xsd#cah_FacilityExitAndOtherCosts"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringChargesAbstract_85ce988b-723e-4a8a-86d6-11ad50c5d1db" xlink:to="loc_cah_FacilityExitAndOtherCosts_b9e89ee7-e63c-4834-ad0e-6bd05633add7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_9bdd7a0b-b2b1-461f-acc3-a23628586d47" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCharges"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringChargesAbstract_85ce988b-723e-4a8a-86d6-11ad50c5d1db" xlink:to="loc_us-gaap_RestructuringCharges_9bdd7a0b-b2b1-461f-acc3-a23628586d47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/RestructuringandEmployeeSeveranceLiabilitiesAssociatedwithRestructuringandEmployeeSeveranceActivitiesDetails" xlink:type="simple" xlink:href="cah-20210630.xsd#RestructuringandEmployeeSeveranceLiabilitiesAssociatedwithRestructuringandEmployeeSeveranceActivitiesDetails"/>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/RestructuringandEmployeeSeveranceLiabilitiesAssociatedwithRestructuringandEmployeeSeveranceActivitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringChargesAbstract_7ad15605-d008-4997-a43a-b0c1d019d0f9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringChargesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_e2678b0b-0131-4c5c-b74a-ad7891732a7b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringChargesAbstract_7ad15605-d008-4997-a43a-b0c1d019d0f9" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_e2678b0b-0131-4c5c-b74a-ad7891732a7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveAxis_e72fec6e-a82f-43d0-8c05-ff055cecf5be" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCostAndReserveAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_e2678b0b-0131-4c5c-b74a-ad7891732a7b" xlink:to="loc_us-gaap_RestructuringCostAndReserveAxis_e72fec6e-a82f-43d0-8c05-ff055cecf5be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain_7fc52240-7492-4f9d-b3cf-2a58ce9102bb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis_e72fec6e-a82f-43d0-8c05-ff055cecf5be" xlink:to="loc_us-gaap_TypeOfRestructuringDomain_7fc52240-7492-4f9d-b3cf-2a58ce9102bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeSeveranceMember_2f5e9cb3-5274-40f2-8b7d-e89c0cf1ccc6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeSeveranceMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_7fc52240-7492-4f9d-b3cf-2a58ce9102bb" xlink:to="loc_us-gaap_EmployeeSeveranceMember_2f5e9cb3-5274-40f2-8b7d-e89c0cf1ccc6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FacilityClosingMember_af806ec9-3596-4d6c-90d7-551f1d12b15e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FacilityClosingMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_7fc52240-7492-4f9d-b3cf-2a58ce9102bb" xlink:to="loc_us-gaap_FacilityClosingMember_af806ec9-3596-4d6c-90d7-551f1d12b15e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_7ba7fd43-201d-4a40-9243-85637861bfc6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_e2678b0b-0131-4c5c-b74a-ad7891732a7b" xlink:to="loc_us-gaap_RestructuringCostAndReserveLineItems_7ba7fd43-201d-4a40-9243-85637861bfc6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveRollForward_abd4a35d-f1ce-4dc3-975e-6c11b44d1ea3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringReserveRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_7ba7fd43-201d-4a40-9243-85637861bfc6" xlink:to="loc_us-gaap_RestructuringReserveRollForward_abd4a35d-f1ce-4dc3-975e-6c11b44d1ea3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve_5ee9239f-9f54-4817-8a15-a1db246b41b0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringReserve"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringReserveRollForward_abd4a35d-f1ce-4dc3-975e-6c11b44d1ea3" xlink:to="loc_us-gaap_RestructuringReserve_5ee9239f-9f54-4817-8a15-a1db246b41b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCosts_9b362643-5bc0-4426-b815-54f87cffd35e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCosts"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringReserveRollForward_abd4a35d-f1ce-4dc3-975e-6c11b44d1ea3" xlink:to="loc_us-gaap_RestructuringCosts_9b362643-5bc0-4426-b815-54f87cffd35e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRestructuring_1c87baf6-f263-4b87-a7b9-25ac8364a4f2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForRestructuring"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringReserveRollForward_abd4a35d-f1ce-4dc3-975e-6c11b44d1ea3" xlink:to="loc_us-gaap_PaymentsForRestructuring_1c87baf6-f263-4b87-a7b9-25ac8364a4f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve_67642006-91e8-46f6-9eb7-b3b8f7b35b60" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringReserve"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringReserveRollForward_abd4a35d-f1ce-4dc3-975e-6c11b44d1ea3" xlink:to="loc_us-gaap_RestructuringReserve_67642006-91e8-46f6-9eb7-b3b8f7b35b60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/GoodwillandOtherIntangibleAssets" xlink:type="simple" xlink:href="cah-20210630.xsd#GoodwillandOtherIntangibleAssets"/>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/GoodwillandOtherIntangibleAssets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_cbc0b5ce-90cb-49f8-b9ef-fdb45ca94666" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_941c5448-f41d-485b-aca9-93b4707c1b03" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_cbc0b5ce-90cb-49f8-b9ef-fdb45ca94666" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_941c5448-f41d-485b-aca9-93b4707c1b03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/GoodwillandOtherIntangibleAssetsTables" xlink:type="simple" xlink:href="cah-20210630.xsd#GoodwillandOtherIntangibleAssetsTables"/>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/GoodwillandOtherIntangibleAssetsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_1f20ce36-36c4-43a6-ad2d-42232fa070f6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTextBlock_024d393f-f9df-4166-8535-0fb09cd7f97c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfGoodwillTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_1f20ce36-36c4-43a6-ad2d-42232fa070f6" xlink:to="loc_us-gaap_ScheduleOfGoodwillTextBlock_024d393f-f9df-4166-8535-0fb09cd7f97c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_02da17f6-9501-40e2-b5d6-3d6ce7edc08a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_1f20ce36-36c4-43a6-ad2d-42232fa070f6" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_02da17f6-9501-40e2-b5d6-3d6ce7edc08a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock_af2dad65-040c-46d6-ab83-a5fffd432102" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_1f20ce36-36c4-43a6-ad2d-42232fa070f6" xlink:to="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock_af2dad65-040c-46d6-ab83-a5fffd432102" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/GoodwillandOtherIntangibleAssetsScheduleofGoodwillbyReportableSegmentDetails" xlink:type="simple" xlink:href="cah-20210630.xsd#GoodwillandOtherIntangibleAssetsScheduleofGoodwillbyReportableSegmentDetails"/>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/GoodwillandOtherIntangibleAssetsScheduleofGoodwillbyReportableSegmentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_2a6f4d99-5731-437c-9dc7-b682cc1f35b6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable_db0ddf02-6e79-448f-bf5a-389580995d5d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_2a6f4d99-5731-437c-9dc7-b682cc1f35b6" xlink:to="loc_us-gaap_ScheduleOfGoodwillTable_db0ddf02-6e79-448f-bf5a-389580995d5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_1b5c0e5c-8025-4745-9d85-ca2e65b6be7e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_db0ddf02-6e79-448f-bf5a-389580995d5d" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_1b5c0e5c-8025-4745-9d85-ca2e65b6be7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_3944b19d-9908-4b7f-a22f-8d4036a57b3f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_1b5c0e5c-8025-4745-9d85-ca2e65b6be7e" xlink:to="loc_us-gaap_SegmentDomain_3944b19d-9908-4b7f-a22f-8d4036a57b3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_MedicalMemberMember_dae69b3b-8e0e-488f-8fc0-6738ce9402da" xlink:href="cah-20210630.xsd#cah_MedicalMemberMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_3944b19d-9908-4b7f-a22f-8d4036a57b3f" xlink:to="loc_cah_MedicalMemberMember_dae69b3b-8e0e-488f-8fc0-6738ce9402da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_PharmaceuticalMember_03ebbacd-5e25-40d2-90bd-be26cd9d0815" xlink:href="cah-20210630.xsd#cah_PharmaceuticalMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_3944b19d-9908-4b7f-a22f-8d4036a57b3f" xlink:to="loc_cah_PharmaceuticalMember_03ebbacd-5e25-40d2-90bd-be26cd9d0815" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_CordisDivestitureAxis_012cf448-9151-469c-9ad1-5df56c2c34c0" xlink:href="cah-20210630.xsd#cah_CordisDivestitureAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_db0ddf02-6e79-448f-bf5a-389580995d5d" xlink:to="loc_cah_CordisDivestitureAxis_012cf448-9151-469c-9ad1-5df56c2c34c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_CordisDivestitureDomain_1feb5bf2-4623-4ac8-a992-f87c3ddc9779" xlink:href="cah-20210630.xsd#cah_CordisDivestitureDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cah_CordisDivestitureAxis_012cf448-9151-469c-9ad1-5df56c2c34c0" xlink:to="loc_cah_CordisDivestitureDomain_1feb5bf2-4623-4ac8-a992-f87c3ddc9779" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_CordisDivestitureMember_0aa87f79-1698-494c-ac91-fa61abd46c05" xlink:href="cah-20210630.xsd#cah_CordisDivestitureMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cah_CordisDivestitureDomain_1feb5bf2-4623-4ac8-a992-f87c3ddc9779" xlink:to="loc_cah_CordisDivestitureMember_0aa87f79-1698-494c-ac91-fa61abd46c05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems_927e8b73-d30f-4b86-b5d4-a48362704cd5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_db0ddf02-6e79-448f-bf5a-389580995d5d" xlink:to="loc_us-gaap_GoodwillLineItems_927e8b73-d30f-4b86-b5d4-a48362704cd5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillTransfers_4b9a6f23-08dd-4604-ba25-23d5425b00bc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillTransfers"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_927e8b73-d30f-4b86-b5d4-a48362704cd5" xlink:to="loc_us-gaap_GoodwillTransfers_4b9a6f23-08dd-4604-ba25-23d5425b00bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward_8f9486ea-40dd-40bb-8862-6c1eaca575b7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillRollForward"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_927e8b73-d30f-4b86-b5d4-a48362704cd5" xlink:to="loc_us-gaap_GoodwillRollForward_8f9486ea-40dd-40bb-8862-6c1eaca575b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_b69ce59a-814d-44d4-bc14-78c87d53c7f1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_8f9486ea-40dd-40bb-8862-6c1eaca575b7" xlink:to="loc_us-gaap_Goodwill_b69ce59a-814d-44d4-bc14-78c87d53c7f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_d6c43baa-1c3f-4135-b378-3794bcd19949" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillForeignCurrencyTranslationGainLoss"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_8f9486ea-40dd-40bb-8862-6c1eaca575b7" xlink:to="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_d6c43baa-1c3f-4135-b378-3794bcd19949" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_27541b4e-2a56-429d-b320-cb4d4e5b529f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_8f9486ea-40dd-40bb-8862-6c1eaca575b7" xlink:to="loc_us-gaap_Goodwill_27541b4e-2a56-429d-b320-cb4d4e5b529f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_a1ead8ce-c5ff-4495-be51-d2e48fd200d2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillImpairedAccumulatedImpairmentLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_927e8b73-d30f-4b86-b5d4-a48362704cd5" xlink:to="loc_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_a1ead8ce-c5ff-4495-be51-d2e48fd200d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1_b9aca2df-6963-4943-8014-75e23dc0a795" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_927e8b73-d30f-4b86-b5d4-a48362704cd5" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1_b9aca2df-6963-4943-8014-75e23dc0a795" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/GoodwillandOtherIntangibleAssetsScheduleofIntangibleAssetsDetails" xlink:type="simple" xlink:href="cah-20210630.xsd#GoodwillandOtherIntangibleAssetsScheduleofIntangibleAssetsDetails"/>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/GoodwillandOtherIntangibleAssetsScheduleofIntangibleAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_e12621b1-91d0-4b3b-b36f-71aac68f061e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_bd95afe1-7c77-4f4c-b3f3-6410e9f7b190" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_e12621b1-91d0-4b3b-b36f-71aac68f061e" xlink:to="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_bd95afe1-7c77-4f4c-b3f3-6410e9f7b190" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_99ed62a5-e03a-48a4-9a2e-1082dadf63d9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_bd95afe1-7c77-4f4c-b3f3-6410e9f7b190" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_99ed62a5-e03a-48a4-9a2e-1082dadf63d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_c3578a57-cc7a-4cc4-a550-24f8c416375a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_99ed62a5-e03a-48a4-9a2e-1082dadf63d9" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_c3578a57-cc7a-4cc4-a550-24f8c416375a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_IPRDTrademarksandOtherMember_6ac71202-7908-4366-8674-cdbcceeeb75a" xlink:href="cah-20210630.xsd#cah_IPRDTrademarksandOtherMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_c3578a57-cc7a-4cc4-a550-24f8c416375a" xlink:to="loc_cah_IPRDTrademarksandOtherMember_6ac71202-7908-4366-8674-cdbcceeeb75a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_dfc4d75e-5999-4cb9-99c5-32b0fac69bfa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_bd95afe1-7c77-4f4c-b3f3-6410e9f7b190" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_dfc4d75e-5999-4cb9-99c5-32b0fac69bfa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_49221700-c9f2-45a8-9e76-4cbcea1e9c6d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_dfc4d75e-5999-4cb9-99c5-32b0fac69bfa" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_49221700-c9f2-45a8-9e76-4cbcea1e9c6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_740d9d41-c072-4eaf-97ab-c8abf26fa80f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_e12621b1-91d0-4b3b-b36f-71aac68f061e" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_740d9d41-c072-4eaf-97ab-c8abf26fa80f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_261bbbc2-9134-4e3a-ba9d-e18af97e70f2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_740d9d41-c072-4eaf-97ab-c8abf26fa80f" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_261bbbc2-9134-4e3a-ba9d-e18af97e70f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_c53e91f4-0d65-4316-b1bd-e2a20e3e0257" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_261bbbc2-9134-4e3a-ba9d-e18af97e70f2" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_c53e91f4-0d65-4316-b1bd-e2a20e3e0257" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_365cec02-397d-4f42-9204-f576130faf5f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_c53e91f4-0d65-4316-b1bd-e2a20e3e0257" xlink:to="loc_us-gaap_CustomerRelationshipsMember_365cec02-397d-4f42-9204-f576130faf5f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_TrademarksAndPatentsMember_d6db97ed-be9e-4f96-90df-59f7a51c2972" xlink:href="cah-20210630.xsd#cah_TrademarksAndPatentsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_c53e91f4-0d65-4316-b1bd-e2a20e3e0257" xlink:to="loc_cah_TrademarksAndPatentsMember_d6db97ed-be9e-4f96-90df-59f7a51c2972" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DevelopedTechnologyRightsMember_17df908e-7249-4133-827a-3c9ccbb308e4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DevelopedTechnologyRightsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_c53e91f4-0d65-4316-b1bd-e2a20e3e0257" xlink:to="loc_us-gaap_DevelopedTechnologyRightsMember_17df908e-7249-4133-827a-3c9ccbb308e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_b69b201e-9208-4f45-afe9-6f7a476be930" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_740d9d41-c072-4eaf-97ab-c8abf26fa80f" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_b69b201e-9208-4f45-afe9-6f7a476be930" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_6ba69351-8975-43e4-8d1e-8d86fb8660da" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_b69b201e-9208-4f45-afe9-6f7a476be930" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_6ba69351-8975-43e4-8d1e-8d86fb8660da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_58de4486-9c47-491a-a475-5fa0ca3a1cb8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_b69b201e-9208-4f45-afe9-6f7a476be930" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_58de4486-9c47-491a-a475-5fa0ca3a1cb8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_01528946-d210-472e-92e7-0af463a37c83" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_b69b201e-9208-4f45-afe9-6f7a476be930" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_01528946-d210-472e-92e7-0af463a37c83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_eaea2381-72c1-4939-930c-33ff028a8685" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_b69b201e-9208-4f45-afe9-6f7a476be930" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_eaea2381-72c1-4939-930c-33ff028a8685" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_d7930561-bd6e-47fc-b093-0569b9e21993" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_b69b201e-9208-4f45-afe9-6f7a476be930" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_d7930561-bd6e-47fc-b093-0569b9e21993" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_03eca220-42d0-4175-8ffc-50a4e23b9bd2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsGrossExcludingGoodwill"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_e12621b1-91d0-4b3b-b36f-71aac68f061e" xlink:to="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_03eca220-42d0-4175-8ffc-50a4e23b9bd2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_eb0f0c1c-b3a4-481b-9ac6-fb80c7d99676" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_e12621b1-91d0-4b3b-b36f-71aac68f061e" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_eb0f0c1c-b3a4-481b-9ac6-fb80c7d99676" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/GoodwillandOtherIntangibleAssetsNarrativeDetails" xlink:type="simple" xlink:href="cah-20210630.xsd#GoodwillandOtherIntangibleAssetsNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/GoodwillandOtherIntangibleAssetsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_913dfed8-49b4-4131-bf4b-2f2e64aee092" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable_e36b71b8-3976-4ed0-a287-cfd8b9f2f8ff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_913dfed8-49b4-4131-bf4b-2f2e64aee092" xlink:to="loc_us-gaap_ScheduleOfGoodwillTable_e36b71b8-3976-4ed0-a287-cfd8b9f2f8ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_f3638321-83e9-4a05-b92e-db2e03cb7164" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_e36b71b8-3976-4ed0-a287-cfd8b9f2f8ff" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_f3638321-83e9-4a05-b92e-db2e03cb7164" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_f882d85d-3d37-47ac-a564-57a062858b98" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_f3638321-83e9-4a05-b92e-db2e03cb7164" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_f882d85d-3d37-47ac-a564-57a062858b98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_NaviHealthMember_674e492d-eb4d-4b86-885f-7d5f367ee340" xlink:href="cah-20210630.xsd#cah_NaviHealthMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_f882d85d-3d37-47ac-a564-57a062858b98" xlink:to="loc_cah_NaviHealthMember_674e492d-eb4d-4b86-885f-7d5f367ee340" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_0f2f6639-124c-41fc-ae41-1b60c5f0fb15" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_e36b71b8-3976-4ed0-a287-cfd8b9f2f8ff" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_0f2f6639-124c-41fc-ae41-1b60c5f0fb15" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_556ba078-980a-43ee-a9ce-3c06e02bc383" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_0f2f6639-124c-41fc-ae41-1b60c5f0fb15" xlink:to="loc_us-gaap_SegmentDomain_556ba078-980a-43ee-a9ce-3c06e02bc383" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_MedicalMemberMember_de4b3415-c796-44f4-8de5-fac59f2c1ceb" xlink:href="cah-20210630.xsd#cah_MedicalMemberMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_556ba078-980a-43ee-a9ce-3c06e02bc383" xlink:to="loc_cah_MedicalMemberMember_de4b3415-c796-44f4-8de5-fac59f2c1ceb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_PharmaceuticalMember_d283841b-c64c-4994-9cda-dde4e3fd0f4e" xlink:href="cah-20210630.xsd#cah_PharmaceuticalMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_556ba078-980a-43ee-a9ce-3c06e02bc383" xlink:to="loc_cah_PharmaceuticalMember_d283841b-c64c-4994-9cda-dde4e3fd0f4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems_72bc7ebc-3369-432d-994e-66ef1b25c54c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_e36b71b8-3976-4ed0-a287-cfd8b9f2f8ff" xlink:to="loc_us-gaap_GoodwillLineItems_72bc7ebc-3369-432d-994e-66ef1b25c54c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_DiscountRatefairvalueinputs_c0a1d6d4-9040-4f09-ba85-351897db1c8c" xlink:href="cah-20210630.xsd#cah_DiscountRatefairvalueinputs"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_72bc7ebc-3369-432d-994e-66ef1b25c54c" xlink:to="loc_cah_DiscountRatefairvalueinputs_c0a1d6d4-9040-4f09-ba85-351897db1c8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_52fc93e3-caf5-4846-a052-5f7028a66e02" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_72bc7ebc-3369-432d-994e-66ef1b25c54c" xlink:to="loc_us-gaap_Goodwill_52fc93e3-caf5-4846-a052-5f7028a66e02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_f5197f83-195f-4cbb-8663-b3e4b11ddda1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_72bc7ebc-3369-432d-994e-66ef1b25c54c" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_f5197f83-195f-4cbb-8663-b3e4b11ddda1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_559135d7-c854-478d-90d2-4f8cf462dbdd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_72bc7ebc-3369-432d-994e-66ef1b25c54c" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_559135d7-c854-478d-90d2-4f8cf462dbdd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_d10c0fed-415d-4cf1-93ff-d9a7ca504c5c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_72bc7ebc-3369-432d-994e-66ef1b25c54c" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_d10c0fed-415d-4cf1-93ff-d9a7ca504c5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_be7b678b-5f46-43a6-a28a-515419bdc102" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_72bc7ebc-3369-432d-994e-66ef1b25c54c" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_be7b678b-5f46-43a6-a28a-515419bdc102" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_62d7f977-6455-4fb0-bb2f-6d457139b474" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_72bc7ebc-3369-432d-994e-66ef1b25c54c" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_62d7f977-6455-4fb0-bb2f-6d457139b474" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_09a0adb9-91eb-42d4-bd05-c0f49af541f0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_72bc7ebc-3369-432d-994e-66ef1b25c54c" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_09a0adb9-91eb-42d4-bd05-c0f49af541f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_bc373d52-dcb1-495f-9010-d8327575e012" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillImpairedAccumulatedImpairmentLoss"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_72bc7ebc-3369-432d-994e-66ef1b25c54c" xlink:to="loc_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_bc373d52-dcb1-495f-9010-d8327575e012" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/Leases" xlink:type="simple" xlink:href="cah-20210630.xsd#Leases"/>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/Leases" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_3d70848b-0a5a-4cd5-92eb-894d108fad45" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_LeasesTextBlock_e6fa40a8-7da0-498e-a833-9ad99e430cbb" xlink:href="cah-20210630.xsd#cah_LeasesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_3d70848b-0a5a-4cd5-92eb-894d108fad45" xlink:to="loc_cah_LeasesTextBlock_e6fa40a8-7da0-498e-a833-9ad99e430cbb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/LeasesTables" xlink:type="simple" xlink:href="cah-20210630.xsd#LeasesTables"/>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/LeasesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_5c628d14-e22b-4024-8bc3-aa4ec6a09661" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCostTableTextBlock_bd236268-a4b8-4dba-95d3-c0373acf2a3c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseCostTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_5c628d14-e22b-4024-8bc3-aa4ec6a09661" xlink:to="loc_us-gaap_LeaseCostTableTextBlock_bd236268-a4b8-4dba-95d3-c0373acf2a3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_LeasesSupplementalBalanceSheetInformationTableTextBlock_75f636fe-843a-4818-a00f-89d74f8d46ae" xlink:href="cah-20210630.xsd#cah_LeasesSupplementalBalanceSheetInformationTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_5c628d14-e22b-4024-8bc3-aa4ec6a09661" xlink:to="loc_cah_LeasesSupplementalBalanceSheetInformationTableTextBlock_75f636fe-843a-4818-a00f-89d74f8d46ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_LeasePaymentsTableTextBlock_4bfd8bf5-195f-4dfb-9bd3-8fbbed80cc6a" xlink:href="cah-20210630.xsd#cah_LeasePaymentsTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_5c628d14-e22b-4024-8bc3-aa4ec6a09661" xlink:to="loc_cah_LeasePaymentsTableTextBlock_4bfd8bf5-195f-4dfb-9bd3-8fbbed80cc6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock_1c326130-bc2a-4cd4-9a6b-f56272884fe7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_5c628d14-e22b-4024-8bc3-aa4ec6a09661" xlink:to="loc_us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock_1c326130-bc2a-4cd4-9a6b-f56272884fe7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/LeasesDetails" xlink:type="simple" xlink:href="cah-20210630.xsd#LeasesDetails"/>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/LeasesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_aaa12b36-4bb7-4cce-b845-017cd426416c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_8a4de65e-fa35-4e84-80de-a6c314ecae04" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_aaa12b36-4bb7-4cce-b845-017cd426416c" xlink:to="loc_us-gaap_StatementTable_8a4de65e-fa35-4e84-80de-a6c314ecae04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_cd2db966-43cf-49b3-920b-d34b80db5ae9" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_8a4de65e-fa35-4e84-80de-a6c314ecae04" xlink:to="loc_srt_RangeAxis_cd2db966-43cf-49b3-920b-d34b80db5ae9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_decebbfa-7c19-4f67-a076-e856e440f1c0" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_cd2db966-43cf-49b3-920b-d34b80db5ae9" xlink:to="loc_srt_RangeMember_decebbfa-7c19-4f67-a076-e856e440f1c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_a69c10bc-3408-4ac7-8a46-d983d4fd2dce" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_decebbfa-7c19-4f67-a076-e856e440f1c0" xlink:to="loc_srt_MinimumMember_a69c10bc-3408-4ac7-8a46-d983d4fd2dce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_718e0817-01fa-4fe5-9f48-491d1037097a" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_decebbfa-7c19-4f67-a076-e856e440f1c0" xlink:to="loc_srt_MaximumMember_718e0817-01fa-4fe5-9f48-491d1037097a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_9486aa64-0c19-4399-a17a-5988338f771e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_8a4de65e-fa35-4e84-80de-a6c314ecae04" xlink:to="loc_us-gaap_StatementLineItems_9486aa64-0c19-4399-a17a-5988338f771e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseAndRentalExpense_82683ec6-f504-40a5-b8d0-e40acea69ac1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseAndRentalExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_9486aa64-0c19-4399-a17a-5988338f771e" xlink:to="loc_us-gaap_LeaseAndRentalExpense_82683ec6-f504-40a5-b8d0-e40acea69ac1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseTermOfContract_df39754d-9704-48dd-b1b5-86e9b9ddd1f1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseTermOfContract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_9486aa64-0c19-4399-a17a-5988338f771e" xlink:to="loc_us-gaap_LesseeOperatingLeaseTermOfContract_df39754d-9704-48dd-b1b5-86e9b9ddd1f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_ReclassificationofdeferredrentinaccordancewithASC842_70727d47-3747-4e5c-a00b-974559fe2886" xlink:href="cah-20210630.xsd#cah_ReclassificationofdeferredrentinaccordancewithASC842"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_9486aa64-0c19-4399-a17a-5988338f771e" xlink:to="loc_cah_ReclassificationofdeferredrentinaccordancewithASC842_70727d47-3747-4e5c-a00b-974559fe2886" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_8679cae5-ed33-4c22-87ba-f40c1cd35146" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_9486aa64-0c19-4399-a17a-5988338f771e" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_8679cae5-ed33-4c22-87ba-f40c1cd35146" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_11be32a2-863b-4b4a-a55b-08e49b1c5183" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_9486aa64-0c19-4399-a17a-5988338f771e" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_11be32a2-863b-4b4a-a55b-08e49b1c5183" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1_60e4f7c0-b44d-4005-9880-06ac44d7178d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_9486aa64-0c19-4399-a17a-5988338f771e" xlink:to="loc_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1_60e4f7c0-b44d-4005-9880-06ac44d7178d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_bb596b7f-cdbd-4929-a872-eeaa1568df96" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_9486aa64-0c19-4399-a17a-5988338f771e" xlink:to="loc_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_bb596b7f-cdbd-4929-a872-eeaa1568df96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/LeasesScheduleofLeaseCostsDetails" xlink:type="simple" xlink:href="cah-20210630.xsd#LeasesScheduleofLeaseCostsDetails"/>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/LeasesScheduleofLeaseCostsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_9c5b2dbd-6f78-4813-bc96-e77fc297833e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseCost_11bd7601-b03b-49b8-8d98-070ec6556c18" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseCost"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_9c5b2dbd-6f78-4813-bc96-e77fc297833e" xlink:to="loc_us-gaap_OperatingLeaseCost_11bd7601-b03b-49b8-8d98-070ec6556c18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization_d3232922-16ee-48d4-941a-a3bcd77040a3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseRightOfUseAssetAmortization"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_9c5b2dbd-6f78-4813-bc96-e77fc297833e" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization_d3232922-16ee-48d4-941a-a3bcd77040a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableLeaseCost_6190326f-c58e-48b9-9040-0ed04bb063e6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableLeaseCost"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_9c5b2dbd-6f78-4813-bc96-e77fc297833e" xlink:to="loc_us-gaap_VariableLeaseCost_6190326f-c58e-48b9-9040-0ed04bb063e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCost_bdb86366-8b13-4a16-93f5-14965ac38705" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseCost"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_9c5b2dbd-6f78-4813-bc96-e77fc297833e" xlink:to="loc_us-gaap_LeaseCost_bdb86366-8b13-4a16-93f5-14965ac38705" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/LeasesSupplementalBalanceSheetInformationDetails" xlink:type="simple" xlink:href="cah-20210630.xsd#LeasesSupplementalBalanceSheetInformationDetails"/>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/LeasesSupplementalBalanceSheetInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_aba720fa-6494-4085-8d2d-6976106a9f24" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_ad99098c-72bf-40c0-b89b-6a30bc55c699" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_aba720fa-6494-4085-8d2d-6976106a9f24" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_ad99098c-72bf-40c0-b89b-6a30bc55c699" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_08f492fb-8be3-4066-b6f1-219302685856" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_aba720fa-6494-4085-8d2d-6976106a9f24" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_08f492fb-8be3-4066-b6f1-219302685856" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_051fd725-f98b-4506-8929-7a14458f4dc3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_aba720fa-6494-4085-8d2d-6976106a9f24" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_051fd725-f98b-4506-8929-7a14458f4dc3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_378115b5-74df-49e8-ba42-a68d67228764" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_aba720fa-6494-4085-8d2d-6976106a9f24" xlink:to="loc_us-gaap_OperatingLeaseLiability_378115b5-74df-49e8-ba42-a68d67228764" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability_204c8223-b43e-4ddb-851b-fca50994a5f4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_aba720fa-6494-4085-8d2d-6976106a9f24" xlink:to="loc_us-gaap_FinanceLeaseLiability_204c8223-b43e-4ddb-851b-fca50994a5f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAsset_58ed06c6-3e7a-46fa-9a00-ad23ea8bd395" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseRightOfUseAsset"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_aba720fa-6494-4085-8d2d-6976106a9f24" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAsset_58ed06c6-3e7a-46fa-9a00-ad23ea8bd395" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrent_8b90f895-65bf-46b4-a3a1-c6acae2a5300" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityCurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_aba720fa-6494-4085-8d2d-6976106a9f24" xlink:to="loc_us-gaap_FinanceLeaseLiabilityCurrent_8b90f895-65bf-46b4-a3a1-c6acae2a5300" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_03c780a8-69a6-4809-adec-5d44ba87b370" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_aba720fa-6494-4085-8d2d-6976106a9f24" xlink:to="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_03c780a8-69a6-4809-adec-5d44ba87b370" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_e2598a47-22d8-4792-85ec-6e42faa5a118" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_aba720fa-6494-4085-8d2d-6976106a9f24" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_e2598a47-22d8-4792-85ec-6e42faa5a118" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1_28ff30b0-bffb-4494-85d7-576be5db43a3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_aba720fa-6494-4085-8d2d-6976106a9f24" xlink:to="loc_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1_28ff30b0-bffb-4494-85d7-576be5db43a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_155a744e-ecf6-45cf-851a-2ed7fd6499d9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_aba720fa-6494-4085-8d2d-6976106a9f24" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_155a744e-ecf6-45cf-851a-2ed7fd6499d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_a3ba941f-c662-451c-8779-c1120493fcdb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_aba720fa-6494-4085-8d2d-6976106a9f24" xlink:to="loc_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_a3ba941f-c662-451c-8779-c1120493fcdb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_23f1be86-9ca5-4034-9dc5-7025ed79a852" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_aba720fa-6494-4085-8d2d-6976106a9f24" xlink:to="loc_us-gaap_StatementTable_23f1be86-9ca5-4034-9dc5-7025ed79a852" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_390c9b69-5cd6-4088-b676-81569969ed05" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_23f1be86-9ca5-4034-9dc5-7025ed79a852" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_390c9b69-5cd6-4088-b676-81569969ed05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_3a9984f8-e5f1-4207-ae35-263226f24753" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_390c9b69-5cd6-4088-b676-81569969ed05" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_3a9984f8-e5f1-4207-ae35-263226f24753" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsMember_f2c66117-c98d-49aa-b400-a537270fa173" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_3a9984f8-e5f1-4207-ae35-263226f24753" xlink:to="loc_us-gaap_OtherAssetsMember_f2c66117-c98d-49aa-b400-a537270fa173" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesMember_480fb8de-62e5-4115-89fb-6ba8d28ecd6f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_3a9984f8-e5f1-4207-ae35-263226f24753" xlink:to="loc_us-gaap_OtherLiabilitiesMember_480fb8de-62e5-4115-89fb-6ba8d28ecd6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesMember_44f6144d-7d50-412e-8ffe-22d624a036fd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_3a9984f8-e5f1-4207-ae35-263226f24753" xlink:to="loc_us-gaap_AccruedLiabilitiesMember_44f6144d-7d50-412e-8ffe-22d624a036fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentMember_5b51ee70-517b-4e4f-a514-9871a046eec9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_3a9984f8-e5f1-4207-ae35-263226f24753" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentMember_5b51ee70-517b-4e4f-a514-9871a046eec9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_277d46ea-9c72-42e0-ab00-aa8cd3f97402" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_23f1be86-9ca5-4034-9dc5-7025ed79a852" xlink:to="loc_us-gaap_StatementLineItems_277d46ea-9c72-42e0-ab00-aa8cd3f97402" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_56bfea7a-65d4-4295-b41f-557282fbd3b2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_277d46ea-9c72-42e0-ab00-aa8cd3f97402" xlink:to="loc_us-gaap_OperatingLeaseLiability_56bfea7a-65d4-4295-b41f-557282fbd3b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_cd634f8f-a0e0-4370-9f30-c940b28bb857" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_277d46ea-9c72-42e0-ab00-aa8cd3f97402" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_cd634f8f-a0e0-4370-9f30-c940b28bb857" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_1d2bc8dd-0ba1-4cb6-b5a9-0ab48953b864" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_277d46ea-9c72-42e0-ab00-aa8cd3f97402" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_1d2bc8dd-0ba1-4cb6-b5a9-0ab48953b864" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAsset_5c293326-e97c-419e-a144-5957344371eb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseRightOfUseAsset"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_277d46ea-9c72-42e0-ab00-aa8cd3f97402" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAsset_5c293326-e97c-419e-a144-5957344371eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrent_ed9ee376-c3e7-4250-99f8-1b781fe828d0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_277d46ea-9c72-42e0-ab00-aa8cd3f97402" xlink:to="loc_us-gaap_FinanceLeaseLiabilityCurrent_ed9ee376-c3e7-4250-99f8-1b781fe828d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_c1db4c61-2a79-45b0-bb6b-4d85071a4fd2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_277d46ea-9c72-42e0-ab00-aa8cd3f97402" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_c1db4c61-2a79-45b0-bb6b-4d85071a4fd2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/LeasesSupplementalCashFlowInformationDetails" xlink:type="simple" xlink:href="cah-20210630.xsd#LeasesSupplementalCashFlowInformationDetails"/>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/LeasesSupplementalCashFlowInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_cdf1f32d-ca16-4f8c-b8b2-3eaa8d63688d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_cd8a1b17-7f48-4fda-b363-02460435cc93" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_cdf1f32d-ca16-4f8c-b8b2-3eaa8d63688d" xlink:to="loc_us-gaap_StatementTable_cd8a1b17-7f48-4fda-b363-02460435cc93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_03cf3a56-b0f0-4e76-ab3d-22a852a59711" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_cd8a1b17-7f48-4fda-b363-02460435cc93" xlink:to="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_03cf3a56-b0f0-4e76-ab3d-22a852a59711" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember_135c5f26-8a85-4550-b17d-6635f2ee81f9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_03cf3a56-b0f0-4e76-ab3d-22a852a59711" xlink:to="loc_us-gaap_TypeOfAdoptionMember_135c5f26-8a85-4550-b17d-6635f2ee81f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_ASC842Member_bfe0acce-9d53-407b-856f-d43368d131aa" xlink:href="cah-20210630.xsd#cah_ASC842Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfAdoptionMember_135c5f26-8a85-4550-b17d-6635f2ee81f9" xlink:to="loc_cah_ASC842Member_bfe0acce-9d53-407b-856f-d43368d131aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_e95652ef-64c0-453f-9d40-73d350084bea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_cd8a1b17-7f48-4fda-b363-02460435cc93" xlink:to="loc_us-gaap_StatementLineItems_e95652ef-64c0-453f-9d40-73d350084bea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_Impactofadoptionofnewaccountingstandard_c46947df-fbc9-44a1-90e2-358a8626684f" xlink:href="cah-20210630.xsd#cah_Impactofadoptionofnewaccountingstandard"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_e95652ef-64c0-453f-9d40-73d350084bea" xlink:to="loc_cah_Impactofadoptionofnewaccountingstandard_c46947df-fbc9-44a1-90e2-358a8626684f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasePayments_99f44d17-a5df-46ec-8638-c5f1a55cdd4b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeasePayments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_e95652ef-64c0-453f-9d40-73d350084bea" xlink:to="loc_us-gaap_OperatingLeasePayments_99f44d17-a5df-46ec-8638-c5f1a55cdd4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeasePrincipalPayments_ab51ede8-875e-4838-a1fb-0012e07fe0e7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeasePrincipalPayments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_e95652ef-64c0-453f-9d40-73d350084bea" xlink:to="loc_us-gaap_FinanceLeasePrincipalPayments_ab51ede8-875e-4838-a1fb-0012e07fe0e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_45fb4fca-c2aa-44a4-8097-20d4bb33de60" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_e95652ef-64c0-453f-9d40-73d350084bea" xlink:to="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_45fb4fca-c2aa-44a4-8097-20d4bb33de60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability_42ec693f-da18-4eb0-a3e3-47d2991c18fa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_e95652ef-64c0-453f-9d40-73d350084bea" xlink:to="loc_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability_42ec693f-da18-4eb0-a3e3-47d2991c18fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_ReclassificationofdeferredrentinaccordancewithASC842_f3862670-950c-4ec8-a0f0-50d3279b032f" xlink:href="cah-20210630.xsd#cah_ReclassificationofdeferredrentinaccordancewithASC842"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_e95652ef-64c0-453f-9d40-73d350084bea" xlink:to="loc_cah_ReclassificationofdeferredrentinaccordancewithASC842_f3862670-950c-4ec8-a0f0-50d3279b032f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/LeasesScheduleofFutureLeasePaymentsDetails" xlink:type="simple" xlink:href="cah-20210630.xsd#LeasesScheduleofFutureLeasePaymentsDetails"/>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/LeasesScheduleofFutureLeasePaymentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_0110b030-efa3-442b-be1a-8085acf10a08" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_4f533192-d1e6-4465-8838-221cbe077120" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_0110b030-efa3-442b-be1a-8085acf10a08" xlink:to="loc_us-gaap_StatementTable_4f533192-d1e6-4465-8838-221cbe077120" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_d1920d4d-3b33-444c-8951-8ab6f74f7010" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_4f533192-d1e6-4465-8838-221cbe077120" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_d1920d4d-3b33-444c-8951-8ab6f74f7010" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_1c607a4a-aea0-483e-a717-ba7c7debd57a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_d1920d4d-3b33-444c-8951-8ab6f74f7010" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_1c607a4a-aea0-483e-a717-ba7c7debd57a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_OperatingLeaseMember_da1761ef-3881-4649-9714-0d0fdeb14bf3" xlink:href="cah-20210630.xsd#cah_OperatingLeaseMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_1c607a4a-aea0-483e-a717-ba7c7debd57a" xlink:to="loc_cah_OperatingLeaseMember_da1761ef-3881-4649-9714-0d0fdeb14bf3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_FinanceLeaseMember_37efafc3-22f0-415d-8e2e-1a8dfdd09287" xlink:href="cah-20210630.xsd#cah_FinanceLeaseMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_1c607a4a-aea0-483e-a717-ba7c7debd57a" xlink:to="loc_cah_FinanceLeaseMember_37efafc3-22f0-415d-8e2e-1a8dfdd09287" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_b532911c-2bb8-4b73-9ded-13087cb8930d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_4f533192-d1e6-4465-8838-221cbe077120" xlink:to="loc_us-gaap_StatementLineItems_b532911c-2bb8-4b73-9ded-13087cb8930d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_d451795f-4dab-4cf9-8152-3df00f3153ba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_b532911c-2bb8-4b73-9ded-13087cb8930d" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_d451795f-4dab-4cf9-8152-3df00f3153ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_d750f579-a0e3-40ad-9806-15685d7dc749" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_b532911c-2bb8-4b73-9ded-13087cb8930d" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_d750f579-a0e3-40ad-9806-15685d7dc749" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_LesseeLeaseLiabilityPaymentsDueYearTwo_4da79581-e548-4350-9b4e-0c2c44f8a0cb" xlink:href="cah-20210630.xsd#cah_LesseeLeaseLiabilityPaymentsDueYearTwo"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_b532911c-2bb8-4b73-9ded-13087cb8930d" xlink:to="loc_cah_LesseeLeaseLiabilityPaymentsDueYearTwo_4da79581-e548-4350-9b4e-0c2c44f8a0cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_9e5dffda-91b6-449e-8d08-8c6600541c91" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_b532911c-2bb8-4b73-9ded-13087cb8930d" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_9e5dffda-91b6-449e-8d08-8c6600541c91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_95bba681-4c87-4470-9d85-a19d23f91d27" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_b532911c-2bb8-4b73-9ded-13087cb8930d" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_95bba681-4c87-4470-9d85-a19d23f91d27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_LesseeLeaseLiabilityPaymentsDueYearThree_d40427bd-065d-45ac-8d57-6f17c55ba3dd" xlink:href="cah-20210630.xsd#cah_LesseeLeaseLiabilityPaymentsDueYearThree"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_b532911c-2bb8-4b73-9ded-13087cb8930d" xlink:to="loc_cah_LesseeLeaseLiabilityPaymentsDueYearThree_d40427bd-065d-45ac-8d57-6f17c55ba3dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_22afe804-1a37-4244-928c-d4c1125001d2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_b532911c-2bb8-4b73-9ded-13087cb8930d" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_22afe804-1a37-4244-928c-d4c1125001d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_e7388645-f278-4500-9249-bc757e6dd3d2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_b532911c-2bb8-4b73-9ded-13087cb8930d" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_e7388645-f278-4500-9249-bc757e6dd3d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_LesseeLeaseLiabilityPaymentsDueYearFour_5c868530-0ca4-4581-bfd0-199c7e992ad3" xlink:href="cah-20210630.xsd#cah_LesseeLeaseLiabilityPaymentsDueYearFour"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_b532911c-2bb8-4b73-9ded-13087cb8930d" xlink:to="loc_cah_LesseeLeaseLiabilityPaymentsDueYearFour_5c868530-0ca4-4581-bfd0-199c7e992ad3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_cf664dad-c2b2-4e4f-805f-c395cfded259" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_b532911c-2bb8-4b73-9ded-13087cb8930d" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_cf664dad-c2b2-4e4f-805f-c395cfded259" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive_0fcf36d5-6a50-439b-a93e-f7a6d9789a59" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_b532911c-2bb8-4b73-9ded-13087cb8930d" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive_0fcf36d5-6a50-439b-a93e-f7a6d9789a59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_LesseeLeaseLiabilityPaymentsDueYearFive_51f4ef14-4f42-4e3e-99a1-de290dc4f5d1" xlink:href="cah-20210630.xsd#cah_LesseeLeaseLiabilityPaymentsDueYearFive"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_b532911c-2bb8-4b73-9ded-13087cb8930d" xlink:to="loc_cah_LesseeLeaseLiabilityPaymentsDueYearFive_51f4ef14-4f42-4e3e-99a1-de290dc4f5d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_14252da2-3bed-42c3-9504-31ea566490c3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_b532911c-2bb8-4b73-9ded-13087cb8930d" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_14252da2-3bed-42c3-9504-31ea566490c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive_48dc080c-bcf6-4866-8c8a-77836dcc0ffb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_b532911c-2bb8-4b73-9ded-13087cb8930d" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive_48dc080c-bcf6-4866-8c8a-77836dcc0ffb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_LesseeLeaseLiabilityPaymentsDueAfterYearFive_bd706234-6eb9-494c-9c8f-4fb40c94806c" xlink:href="cah-20210630.xsd#cah_LesseeLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_b532911c-2bb8-4b73-9ded-13087cb8930d" xlink:to="loc_cah_LesseeLeaseLiabilityPaymentsDueAfterYearFive_bd706234-6eb9-494c-9c8f-4fb40c94806c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_a2158460-2a28-4bfc-afa3-76a8c79caab0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_b532911c-2bb8-4b73-9ded-13087cb8930d" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_a2158460-2a28-4bfc-afa3-76a8c79caab0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_65e38722-30cc-4f5a-8707-9e92ed3869a8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDue"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_b532911c-2bb8-4b73-9ded-13087cb8930d" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_65e38722-30cc-4f5a-8707-9e92ed3869a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_TotalLeaseLiabilityPaymentsDue_d252ae18-6d68-48e1-984d-c19307c0acc8" xlink:href="cah-20210630.xsd#cah_TotalLeaseLiabilityPaymentsDue"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_b532911c-2bb8-4b73-9ded-13087cb8930d" xlink:to="loc_cah_TotalLeaseLiabilityPaymentsDue_d252ae18-6d68-48e1-984d-c19307c0acc8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_LesseeOperatingLeaseLiabilityNotYetCommencedAmount_0d75a36e-0c04-4024-b2a9-55a6058c1eae" xlink:href="cah-20210630.xsd#cah_LesseeOperatingLeaseLiabilityNotYetCommencedAmount"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_b532911c-2bb8-4b73-9ded-13087cb8930d" xlink:to="loc_cah_LesseeOperatingLeaseLiabilityNotYetCommencedAmount_0d75a36e-0c04-4024-b2a9-55a6058c1eae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_LesseeFinanceLeaseLiabilityNotYetCommencedAmount_f2de94d0-5ba9-42ed-ab90-6e75eebd558a" xlink:href="cah-20210630.xsd#cah_LesseeFinanceLeaseLiabilityNotYetCommencedAmount"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_b532911c-2bb8-4b73-9ded-13087cb8930d" xlink:to="loc_cah_LesseeFinanceLeaseLiabilityNotYetCommencedAmount_f2de94d0-5ba9-42ed-ab90-6e75eebd558a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_TotalLeaseLiabilityNotYetCommencedAmount_e3b21759-8129-4c3b-9f56-cd122fb57b7f" xlink:href="cah-20210630.xsd#cah_TotalLeaseLiabilityNotYetCommencedAmount"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_b532911c-2bb8-4b73-9ded-13087cb8930d" xlink:to="loc_cah_TotalLeaseLiabilityNotYetCommencedAmount_e3b21759-8129-4c3b-9f56-cd122fb57b7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_OperatingLeaseImputedInterest_057e7d7f-1a42-4899-b378-3b9d4d2c2389" xlink:href="cah-20210630.xsd#cah_OperatingLeaseImputedInterest"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_b532911c-2bb8-4b73-9ded-13087cb8930d" xlink:to="loc_cah_OperatingLeaseImputedInterest_057e7d7f-1a42-4899-b378-3b9d4d2c2389" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_FinanceLeaseImputedInterest_286308f0-2bed-4bba-8004-1595b77d3f94" xlink:href="cah-20210630.xsd#cah_FinanceLeaseImputedInterest"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_b532911c-2bb8-4b73-9ded-13087cb8930d" xlink:to="loc_cah_FinanceLeaseImputedInterest_286308f0-2bed-4bba-8004-1595b77d3f94" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_TotalLeaseLiabilityUndiscountedExcessAmount_f1cf6a65-de88-41eb-8811-f6fa7d68fc94" xlink:href="cah-20210630.xsd#cah_TotalLeaseLiabilityUndiscountedExcessAmount"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_b532911c-2bb8-4b73-9ded-13087cb8930d" xlink:to="loc_cah_TotalLeaseLiabilityUndiscountedExcessAmount_f1cf6a65-de88-41eb-8811-f6fa7d68fc94" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_bc0b963a-b2c6-45f6-98c4-e96eb856f97c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_b532911c-2bb8-4b73-9ded-13087cb8930d" xlink:to="loc_us-gaap_OperatingLeaseLiability_bc0b963a-b2c6-45f6-98c4-e96eb856f97c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability_73f6c53a-b4a2-4056-ae2e-84a7524702fe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_b532911c-2bb8-4b73-9ded-13087cb8930d" xlink:to="loc_us-gaap_FinanceLeaseLiability_73f6c53a-b4a2-4056-ae2e-84a7524702fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_TotalLeaseLiability_4f39f4cf-f32c-434d-9538-82c1c6e1ff3e" xlink:href="cah-20210630.xsd#cah_TotalLeaseLiability"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_b532911c-2bb8-4b73-9ded-13087cb8930d" xlink:to="loc_cah_TotalLeaseLiability_4f39f4cf-f32c-434d-9538-82c1c6e1ff3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_e2582449-e104-454b-8297-26da36a96810" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_b532911c-2bb8-4b73-9ded-13087cb8930d" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_e2582449-e104-454b-8297-26da36a96810" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_LesseeLeaseLiabilityPaymentsDueYearOne_227bcbc7-8d67-45a7-988a-16990625956f" xlink:href="cah-20210630.xsd#cah_LesseeLeaseLiabilityPaymentsDueYearOne"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_b532911c-2bb8-4b73-9ded-13087cb8930d" xlink:to="loc_cah_LesseeLeaseLiabilityPaymentsDueYearOne_227bcbc7-8d67-45a7-988a-16990625956f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_d6bc9995-e38b-4d7e-b1b1-cef839577721" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_b532911c-2bb8-4b73-9ded-13087cb8930d" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_d6bc9995-e38b-4d7e-b1b1-cef839577721" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/LongTermObligationsandOtherShortTermBorrowings" xlink:type="simple" xlink:href="cah-20210630.xsd#LongTermObligationsandOtherShortTermBorrowings"/>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/LongTermObligationsandOtherShortTermBorrowings" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_8e379f0c-38ae-4353-badc-7ce478c2c9c6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock_7a10f05c-7797-44b8-80a7-a1811c6182fa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_8e379f0c-38ae-4353-badc-7ce478c2c9c6" xlink:to="loc_us-gaap_DebtDisclosureTextBlock_7a10f05c-7797-44b8-80a7-a1811c6182fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/LongTermObligationsandOtherShortTermBorrowingsTables" xlink:type="simple" xlink:href="cah-20210630.xsd#LongTermObligationsandOtherShortTermBorrowingsTables"/>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/LongTermObligationsandOtherShortTermBorrowingsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_cb5d2422-e703-4903-bdb6-62c61ea7af87" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtTableTextBlock_049edbcb-e842-400a-956a-fb0468a109f8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDebtTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_cb5d2422-e703-4903-bdb6-62c61ea7af87" xlink:to="loc_us-gaap_ScheduleOfDebtTableTextBlock_049edbcb-e842-400a-956a-fb0468a109f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/LongTermObligationsandOtherShortTermBorrowingsSummaryofDebtDetails" xlink:type="simple" xlink:href="cah-20210630.xsd#LongTermObligationsandOtherShortTermBorrowingsSummaryofDebtDetails"/>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/LongTermObligationsandOtherShortTermBorrowingsSummaryofDebtDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_b36cfd2e-0839-4f53-8e37-2abdd07b4b9c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_b0ead12f-2dd4-4edf-9fa0-d1b68465c2ec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_b36cfd2e-0839-4f53-8e37-2abdd07b4b9c" xlink:to="loc_us-gaap_DebtInstrumentTable_b0ead12f-2dd4-4edf-9fa0-d1b68465c2ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_169272ef-4390-44f2-9f13-afd8d31fee8a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_b0ead12f-2dd4-4edf-9fa0-d1b68465c2ec" xlink:to="loc_us-gaap_DebtInstrumentAxis_169272ef-4390-44f2-9f13-afd8d31fee8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_4f476087-964a-48e4-93fb-578819177b79" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_169272ef-4390-44f2-9f13-afd8d31fee8a" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_4f476087-964a-48e4-93fb-578819177b79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_A1.948Notesdue2019Member_b8b234b2-5fd5-435c-a88b-d3f7a97edc8a" xlink:href="cah-20210630.xsd#cah_A1.948Notesdue2019Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_4f476087-964a-48e4-93fb-578819177b79" xlink:to="loc_cah_A1.948Notesdue2019Member_b8b234b2-5fd5-435c-a88b-d3f7a97edc8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_A24NotesDue2019Member_a5eea93b-2023-49e9-92d7-5da5851d7cf8" xlink:href="cah-20210630.xsd#cah_A24NotesDue2019Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_4f476087-964a-48e4-93fb-578819177b79" xlink:to="loc_cah_A24NotesDue2019Member_a5eea93b-2023-49e9-92d7-5da5851d7cf8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_A4.625Notesdue2021Member_0f8416bf-88dc-4d27-9573-a645aa0ea6bd" xlink:href="cah-20210630.xsd#cah_A4.625Notesdue2021Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_4f476087-964a-48e4-93fb-578819177b79" xlink:to="loc_cah_A4.625Notesdue2021Member_0f8416bf-88dc-4d27-9573-a645aa0ea6bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_A2.616Notesdue2022Member_2030930f-f334-4875-a053-e365f148bbc3" xlink:href="cah-20210630.xsd#cah_A2.616Notesdue2022Member"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_4f476087-964a-48e4-93fb-578819177b79" xlink:to="loc_cah_A2.616Notesdue2022Member_2030930f-f334-4875-a053-e365f148bbc3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_A3.2Notesdue2022Member_b737cdfe-9059-4304-ab65-715750febc61" xlink:href="cah-20210630.xsd#cah_A3.2Notesdue2022Member"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_4f476087-964a-48e4-93fb-578819177b79" xlink:to="loc_cah_A3.2Notesdue2022Member_b737cdfe-9059-4304-ab65-715750febc61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_FloatingRateNotesdue2022Member_122e9f52-fafd-4ea3-be9b-ba218e7716bb" xlink:href="cah-20210630.xsd#cah_FloatingRateNotesdue2022Member"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_4f476087-964a-48e4-93fb-578819177b79" xlink:to="loc_cah_FloatingRateNotesdue2022Member_122e9f52-fafd-4ea3-be9b-ba218e7716bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_A3.2Notesdue2023Member_3a5e2d2c-e196-4e26-bfe7-09617c37ef96" xlink:href="cah-20210630.xsd#cah_A3.2Notesdue2023Member"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_4f476087-964a-48e4-93fb-578819177b79" xlink:to="loc_cah_A3.2Notesdue2023Member_3a5e2d2c-e196-4e26-bfe7-09617c37ef96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_A3.079Notesdue2024Member_e80d2a84-2833-41a5-bf45-9042f2b95bf9" xlink:href="cah-20210630.xsd#cah_A3.079Notesdue2024Member"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_4f476087-964a-48e4-93fb-578819177b79" xlink:to="loc_cah_A3.079Notesdue2024Member_e80d2a84-2833-41a5-bf45-9042f2b95bf9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_A3.5Notesdue2025Member_7581027e-301a-462d-b46f-e06a0341b8b9" xlink:href="cah-20210630.xsd#cah_A3.5Notesdue2025Member"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_4f476087-964a-48e4-93fb-578819177b79" xlink:to="loc_cah_A3.5Notesdue2025Member_7581027e-301a-462d-b46f-e06a0341b8b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_A3.75Notesdue2026Member_aeba954a-9d8d-4069-a777-51db124d40a1" xlink:href="cah-20210630.xsd#cah_A3.75Notesdue2026Member"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_4f476087-964a-48e4-93fb-578819177b79" xlink:to="loc_cah_A3.75Notesdue2026Member_aeba954a-9d8d-4069-a777-51db124d40a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_A3.41Notesdue2027Member_fb184d96-33dd-4eb1-809c-f35903dc9dee" xlink:href="cah-20210630.xsd#cah_A3.41Notesdue2027Member"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_4f476087-964a-48e4-93fb-578819177b79" xlink:to="loc_cah_A3.41Notesdue2027Member_fb184d96-33dd-4eb1-809c-f35903dc9dee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_A4.6Notesdue2043Member_50bf7e49-d7f4-4f3f-9c87-9651f6566a46" xlink:href="cah-20210630.xsd#cah_A4.6Notesdue2043Member"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_4f476087-964a-48e4-93fb-578819177b79" xlink:to="loc_cah_A4.6Notesdue2043Member_50bf7e49-d7f4-4f3f-9c87-9651f6566a46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_A4.5Notesdue2044Member_673f2bd1-5fe6-4ee4-933b-69800794e617" xlink:href="cah-20210630.xsd#cah_A4.5Notesdue2044Member"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_4f476087-964a-48e4-93fb-578819177b79" xlink:to="loc_cah_A4.5Notesdue2044Member_673f2bd1-5fe6-4ee4-933b-69800794e617" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_A4.9Notesdue2045Member_47ce30a4-c139-406b-818e-ed6d350d283a" xlink:href="cah-20210630.xsd#cah_A4.9Notesdue2045Member"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_4f476087-964a-48e4-93fb-578819177b79" xlink:to="loc_cah_A4.9Notesdue2045Member_47ce30a4-c139-406b-818e-ed6d350d283a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_A4.368Notesdue2047Member_f19df12e-2bf1-45dc-a064-994b92ab9616" xlink:href="cah-20210630.xsd#cah_A4.368Notesdue2047Member"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_4f476087-964a-48e4-93fb-578819177b79" xlink:to="loc_cah_A4.368Notesdue2047Member_f19df12e-2bf1-45dc-a064-994b92ab9616" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_A7.0Debenturesduefiscal2027Member_2c59aad6-e547-4a59-b27b-43bd94b1c915" xlink:href="cah-20210630.xsd#cah_A7.0Debenturesduefiscal2027Member"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_4f476087-964a-48e4-93fb-578819177b79" xlink:to="loc_cah_A7.0Debenturesduefiscal2027Member_2c59aad6-e547-4a59-b27b-43bd94b1c915" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_f8d49a5c-46e9-442a-9690-df76acb24001" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_b0ead12f-2dd4-4edf-9fa0-d1b68465c2ec" xlink:to="loc_us-gaap_DebtInstrumentLineItems_f8d49a5c-46e9-442a-9690-df76acb24001" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_62dbb93b-2a48-417d-a7e9-82b8de6263d1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f8d49a5c-46e9-442a-9690-df76acb24001" xlink:to="loc_us-gaap_AccountsPayableCurrent_62dbb93b-2a48-417d-a7e9-82b8de6263d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesPayable_fcc3146f-5fe0-4b89-94be-4412145f4e7e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NotesPayable"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f8d49a5c-46e9-442a-9690-df76acb24001" xlink:to="loc_us-gaap_NotesPayable_fcc3146f-5fe0-4b89-94be-4412145f4e7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherBorrowings_087ce289-2cc6-4476-9f25-90cbe3da19fc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherBorrowings"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f8d49a5c-46e9-442a-9690-df76acb24001" xlink:to="loc_us-gaap_OtherBorrowings_087ce289-2cc6-4476-9f25-90cbe3da19fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtAndCapitalLeaseObligations_00bed322-ec6b-4a5e-ba3b-7c5b36cf8a53" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtAndCapitalLeaseObligations"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f8d49a5c-46e9-442a-9690-df76acb24001" xlink:to="loc_us-gaap_DebtAndCapitalLeaseObligations_00bed322-ec6b-4a5e-ba3b-7c5b36cf8a53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_95dddece-4ea7-402b-9dfd-e7861a05c796" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f8d49a5c-46e9-442a-9690-df76acb24001" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_95dddece-4ea7-402b-9dfd-e7861a05c796" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_56714b5e-3c25-4cb1-b770-8eb18ae5c0a0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f8d49a5c-46e9-442a-9690-df76acb24001" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_56714b5e-3c25-4cb1-b770-8eb18ae5c0a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/LongTermObligationsandOtherShortTermBorrowingsNarrativeDetails" xlink:type="simple" xlink:href="cah-20210630.xsd#LongTermObligationsandOtherShortTermBorrowingsNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/LongTermObligationsandOtherShortTermBorrowingsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_2f607f7c-d503-4a9e-a3b8-bacd2aaa852f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityTable_a6e40596-7b21-4ba7-965e-e20938320ecc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_2f607f7c-d503-4a9e-a3b8-bacd2aaa852f" xlink:to="loc_us-gaap_LineOfCreditFacilityTable_a6e40596-7b21-4ba7-965e-e20938320ecc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_b8105bc0-087b-4113-832a-5735e61ff9a4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_a6e40596-7b21-4ba7-965e-e20938320ecc" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_b8105bc0-087b-4113-832a-5735e61ff9a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_c8ac81ec-8ebd-488c-9117-aec1e4a8ae57" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_b8105bc0-087b-4113-832a-5735e61ff9a4" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_c8ac81ec-8ebd-488c-9117-aec1e4a8ae57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_e4c76d17-0a02-4e0f-beaa-0a7337d9388d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_a6e40596-7b21-4ba7-965e-e20938320ecc" xlink:to="loc_us-gaap_DebtInstrumentAxis_e4c76d17-0a02-4e0f-beaa-0a7337d9388d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_c7a55edb-e7ff-4b50-9864-c0df65d2f6f3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_e4c76d17-0a02-4e0f-beaa-0a7337d9388d" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_c7a55edb-e7ff-4b50-9864-c0df65d2f6f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_A2.616Notesdue2022Member_62a2ef27-f854-4641-811c-5957ef79f6ab" xlink:href="cah-20210630.xsd#cah_A2.616Notesdue2022Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_c7a55edb-e7ff-4b50-9864-c0df65d2f6f3" xlink:to="loc_cah_A2.616Notesdue2022Member_62a2ef27-f854-4641-811c-5957ef79f6ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_A3.2Notesdue2023Member_0502eadc-8824-4617-a594-f0bc72d0d44c" xlink:href="cah-20210630.xsd#cah_A3.2Notesdue2023Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_c7a55edb-e7ff-4b50-9864-c0df65d2f6f3" xlink:to="loc_cah_A3.2Notesdue2023Member_0502eadc-8824-4617-a594-f0bc72d0d44c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_FloatingRateNotesdue2022Member_84414ea2-8a03-429f-81ce-08ef9a5ceb37" xlink:href="cah-20210630.xsd#cah_FloatingRateNotesdue2022Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_c7a55edb-e7ff-4b50-9864-c0df65d2f6f3" xlink:to="loc_cah_FloatingRateNotesdue2022Member_84414ea2-8a03-429f-81ce-08ef9a5ceb37" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_A3.41Notesdue2027Member_3b35591c-c505-40c9-a237-2d85c131cace" xlink:href="cah-20210630.xsd#cah_A3.41Notesdue2027Member"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_c7a55edb-e7ff-4b50-9864-c0df65d2f6f3" xlink:to="loc_cah_A3.41Notesdue2027Member_3b35591c-c505-40c9-a237-2d85c131cace" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_A4.6Notesdue2043Member_8fe889bf-27f6-4abf-b994-6fd5bb7b74bd" xlink:href="cah-20210630.xsd#cah_A4.6Notesdue2043Member"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_c7a55edb-e7ff-4b50-9864-c0df65d2f6f3" xlink:to="loc_cah_A4.6Notesdue2043Member_8fe889bf-27f6-4abf-b994-6fd5bb7b74bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_A4.9Notesdue2045Member_631b5e54-cfdb-4688-ad0b-997f0bc906ae" xlink:href="cah-20210630.xsd#cah_A4.9Notesdue2045Member"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_c7a55edb-e7ff-4b50-9864-c0df65d2f6f3" xlink:to="loc_cah_A4.9Notesdue2045Member_631b5e54-cfdb-4688-ad0b-997f0bc906ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_A4.368Notesdue2047Member_22187768-676a-4d96-a640-6e86a33d3b59" xlink:href="cah-20210630.xsd#cah_A4.368Notesdue2047Member"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_c7a55edb-e7ff-4b50-9864-c0df65d2f6f3" xlink:to="loc_cah_A4.368Notesdue2047Member_22187768-676a-4d96-a640-6e86a33d3b59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_A2.616Notes3.2Notes3.41Notes4.6Notes4.9Notesand4.368NotesMember_b9afb13e-ac04-4230-8f8b-b94b18884888" xlink:href="cah-20210630.xsd#cah_A2.616Notes3.2Notes3.41Notes4.6Notes4.9Notesand4.368NotesMember"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_c7a55edb-e7ff-4b50-9864-c0df65d2f6f3" xlink:to="loc_cah_A2.616Notes3.2Notes3.41Notes4.6Notes4.9Notesand4.368NotesMember_b9afb13e-ac04-4230-8f8b-b94b18884888" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_A4.625Notesdue2021Member_c157acb3-24b6-48ca-8501-c51a01181e87" xlink:href="cah-20210630.xsd#cah_A4.625Notesdue2021Member"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_c7a55edb-e7ff-4b50-9864-c0df65d2f6f3" xlink:to="loc_cah_A4.625Notesdue2021Member_c157acb3-24b6-48ca-8501-c51a01181e87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_A3.2Notesdue2022Member_04dbce16-74e2-4149-88ed-4df48f5ad6ee" xlink:href="cah-20210630.xsd#cah_A3.2Notesdue2022Member"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_c7a55edb-e7ff-4b50-9864-c0df65d2f6f3" xlink:to="loc_cah_A3.2Notesdue2022Member_04dbce16-74e2-4149-88ed-4df48f5ad6ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_FloatingRateNotes2616NotesMember_b380cd1e-873a-4ec6-8df8-8d0130069706" xlink:href="cah-20210630.xsd#cah_FloatingRateNotes2616NotesMember"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_c7a55edb-e7ff-4b50-9864-c0df65d2f6f3" xlink:to="loc_cah_FloatingRateNotes2616NotesMember_b380cd1e-873a-4ec6-8df8-8d0130069706" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_A32Notes2616NotesMember_61991f34-9c2f-4a89-b804-14d1b28b4f2b" xlink:href="cah-20210630.xsd#cah_A32Notes2616NotesMember"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_c7a55edb-e7ff-4b50-9864-c0df65d2f6f3" xlink:to="loc_cah_A32Notes2616NotesMember_61991f34-9c2f-4a89-b804-14d1b28b4f2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_A24NotesDue2019Member_cecade87-7e1c-45c7-92a5-7df632f87985" xlink:href="cah-20210630.xsd#cah_A24NotesDue2019Member"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_c7a55edb-e7ff-4b50-9864-c0df65d2f6f3" xlink:to="loc_cah_A24NotesDue2019Member_cecade87-7e1c-45c7-92a5-7df632f87985" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityAxis_7303153c-43c4-482f-912f-e83bf5615870" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_a6e40596-7b21-4ba7-965e-e20938320ecc" xlink:to="loc_us-gaap_LineOfCreditFacilityAxis_7303153c-43c4-482f-912f-e83bf5615870" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLenderDomain_21235d30-09ce-4bef-b880-614e5fcbda21" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityLenderDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityAxis_7303153c-43c4-482f-912f-e83bf5615870" xlink:to="loc_us-gaap_LineOfCreditFacilityLenderDomain_21235d30-09ce-4bef-b880-614e5fcbda21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_8683b586-f9e3-41eb-ac69-252c3923eec8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_a6e40596-7b21-4ba7-965e-e20938320ecc" xlink:to="loc_us-gaap_CreditFacilityAxis_8683b586-f9e3-41eb-ac69-252c3923eec8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_d6d86ccb-1e55-448f-a307-620858a14a32" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityAxis_8683b586-f9e3-41eb-ac69-252c3923eec8" xlink:to="loc_us-gaap_CreditFacilityDomain_d6d86ccb-1e55-448f-a307-620858a14a32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LetterOfCreditMember_318f4000-a58c-4307-b06f-d3396f7b01c8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LetterOfCreditMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_d6d86ccb-1e55-448f-a307-620858a14a32" xlink:to="loc_us-gaap_LetterOfCreditMember_318f4000-a58c-4307-b06f-d3396f7b01c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_CommittedReceivablesSalesFacilityProgramMember_0832873d-2520-4a49-9f01-f8c78822d0ed" xlink:href="cah-20210630.xsd#cah_CommittedReceivablesSalesFacilityProgramMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_d6d86ccb-1e55-448f-a307-620858a14a32" xlink:to="loc_cah_CommittedReceivablesSalesFacilityProgramMember_0832873d-2520-4a49-9f01-f8c78822d0ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_c67c0326-368d-4930-b216-498a5980a811" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_d6d86ccb-1e55-448f-a307-620858a14a32" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_c67c0326-368d-4930-b216-498a5980a811" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember_f430dac3-4721-4233-a5b0-171a66ae14b4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommercialPaperMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_d6d86ccb-1e55-448f-a307-620858a14a32" xlink:to="loc_us-gaap_CommercialPaperMember_f430dac3-4721-4233-a5b0-171a66ae14b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_ShortTermCreditFacilitiesMember_15e78515-510f-4342-a5e5-b52667622ab3" xlink:href="cah-20210630.xsd#cah_ShortTermCreditFacilitiesMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_d6d86ccb-1e55-448f-a307-620858a14a32" xlink:to="loc_cah_ShortTermCreditFacilitiesMember_15e78515-510f-4342-a5e5-b52667622ab3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLineItems_f170b4d4-fdc2-43e2-92e1-99a840c22bfa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_a6e40596-7b21-4ba7-965e-e20938320ecc" xlink:to="loc_us-gaap_LineOfCreditFacilityLineItems_f170b4d4-fdc2-43e2-92e1-99a840c22bfa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCredit_74965a3d-f07c-4d28-ad61-3416faac7705" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCredit"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_f170b4d4-fdc2-43e2-92e1-99a840c22bfa" xlink:to="loc_us-gaap_LineOfCredit_74965a3d-f07c-4d28-ad61-3416faac7705" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_a8b792ff-5b32-4e63-8438-cc1a36bac3d3" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentFiscalYearFocus"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_f170b4d4-fdc2-43e2-92e1-99a840c22bfa" xlink:to="loc_dei_DocumentFiscalYearFocus_a8b792ff-5b32-4e63-8438-cc1a36bac3d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_e4e97eea-5b05-4e7b-8e6b-0d3ea282ac3e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_f170b4d4-fdc2-43e2-92e1-99a840c22bfa" xlink:to="loc_us-gaap_AccountsPayableCurrent_e4e97eea-5b05-4e7b-8e6b-0d3ea282ac3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_NotesPayableRepurchased_64cdb682-9002-4680-83de-0f68ee30637d" xlink:href="cah-20210630.xsd#cah_NotesPayableRepurchased"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_f170b4d4-fdc2-43e2-92e1-99a840c22bfa" xlink:to="loc_cah_NotesPayableRepurchased_64cdb682-9002-4680-83de-0f68ee30637d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumAmountOutstandingDuringPeriod_a5bdb145-7b92-4768-8ada-1953be2e9530" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumAmountOutstandingDuringPeriod"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_f170b4d4-fdc2-43e2-92e1-99a840c22bfa" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumAmountOutstandingDuringPeriod_a5bdb145-7b92-4768-8ada-1953be2e9530" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_3f17a1ab-a22f-4fff-ab78-7185fe0caeb5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_f170b4d4-fdc2-43e2-92e1-99a840c22bfa" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_3f17a1ab-a22f-4fff-ab78-7185fe0caeb5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherBorrowings_d3e13602-a220-4f2b-a3d2-85280b54220c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherBorrowings"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_f170b4d4-fdc2-43e2-92e1-99a840c22bfa" xlink:to="loc_us-gaap_OtherBorrowings_d3e13602-a220-4f2b-a3d2-85280b54220c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_0caaabf5-1ed8-41fe-9c23-0974f2388485" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_f170b4d4-fdc2-43e2-92e1-99a840c22bfa" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_0caaabf5-1ed8-41fe-9c23-0974f2388485" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrentAndNoncurrent_82cc022c-0b58-4c5b-9143-7f41b7f680cb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableCurrentAndNoncurrent"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_f170b4d4-fdc2-43e2-92e1-99a840c22bfa" xlink:to="loc_us-gaap_AccountsPayableCurrentAndNoncurrent_82cc022c-0b58-4c5b-9143-7f41b7f680cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_202a65db-a3f7-484f-85cf-3c2e177c6d81" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_2f607f7c-d503-4a9e-a3b8-bacd2aaa852f" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_202a65db-a3f7-484f-85cf-3c2e177c6d81" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_89049d10-4b78-40f6-8264-69b785d51631" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_2f607f7c-d503-4a9e-a3b8-bacd2aaa852f" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_89049d10-4b78-40f6-8264-69b785d51631" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_cb6f3d40-df4d-4625-9f16-99edf4f6afba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_2f607f7c-d503-4a9e-a3b8-bacd2aaa852f" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_cb6f3d40-df4d-4625-9f16-99edf4f6afba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_5e6fef18-c2ac-46d2-a491-121e069feebf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_2f607f7c-d503-4a9e-a3b8-bacd2aaa852f" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_5e6fef18-c2ac-46d2-a491-121e069feebf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_ee0b31f3-789e-4435-bf9c-df16e829491b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_2f607f7c-d503-4a9e-a3b8-bacd2aaa852f" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_ee0b31f3-789e-4435-bf9c-df16e829491b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive_3d173c7a-4834-4240-ada3-481dc053dd16" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_2f607f7c-d503-4a9e-a3b8-bacd2aaa852f" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive_3d173c7a-4834-4240-ada3-481dc053dd16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/LongTermObligationsandOtherShortTermBorrowingsLongTermDebtDetails" xlink:type="simple" xlink:href="cah-20210630.xsd#LongTermObligationsandOtherShortTermBorrowingsLongTermDebtDetails"/>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/LongTermObligationsandOtherShortTermBorrowingsLongTermDebtDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_79dc805f-c1e6-45c7-a981-eeb808a40dcc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_6ea5b715-bbfa-48a0-b454-68949b285dae" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_79dc805f-c1e6-45c7-a981-eeb808a40dcc" xlink:to="loc_us-gaap_DebtInstrumentTable_6ea5b715-bbfa-48a0-b454-68949b285dae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_50fd4930-c131-4db1-a7ba-44e849784917" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_6ea5b715-bbfa-48a0-b454-68949b285dae" xlink:to="loc_us-gaap_CreditFacilityAxis_50fd4930-c131-4db1-a7ba-44e849784917" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_f135b2e3-d513-4385-8939-abd49d18099d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityAxis_50fd4930-c131-4db1-a7ba-44e849784917" xlink:to="loc_us-gaap_CreditFacilityDomain_f135b2e3-d513-4385-8939-abd49d18099d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_e6bebf4d-fdc1-4d12-a807-a5fb294e91e6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_6ea5b715-bbfa-48a0-b454-68949b285dae" xlink:to="loc_us-gaap_DebtInstrumentAxis_e6bebf4d-fdc1-4d12-a807-a5fb294e91e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_6e8fd735-4830-447a-a7f5-cf1c615d85dc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_e6bebf4d-fdc1-4d12-a807-a5fb294e91e6" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_6e8fd735-4830-447a-a7f5-cf1c615d85dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_A1.948Notesdue2019Member_696966cd-fd46-421d-b868-548744a2fff6" xlink:href="cah-20210630.xsd#cah_A1.948Notesdue2019Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_6e8fd735-4830-447a-a7f5-cf1c615d85dc" xlink:to="loc_cah_A1.948Notesdue2019Member_696966cd-fd46-421d-b868-548744a2fff6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_A2.616Notesdue2022Member_06893df5-c679-4207-966a-094aa3427b2f" xlink:href="cah-20210630.xsd#cah_A2.616Notesdue2022Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_6e8fd735-4830-447a-a7f5-cf1c615d85dc" xlink:to="loc_cah_A2.616Notesdue2022Member_06893df5-c679-4207-966a-094aa3427b2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_A3.079Notesdue2024Member_2f0e5cba-08a1-458c-980b-555a25613791" xlink:href="cah-20210630.xsd#cah_A3.079Notesdue2024Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_6e8fd735-4830-447a-a7f5-cf1c615d85dc" xlink:to="loc_cah_A3.079Notesdue2024Member_2f0e5cba-08a1-458c-980b-555a25613791" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_A3.41Notesdue2027Member_04bf4e56-d0a2-4c95-a067-ba425fab9b27" xlink:href="cah-20210630.xsd#cah_A3.41Notesdue2027Member"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_6e8fd735-4830-447a-a7f5-cf1c615d85dc" xlink:to="loc_cah_A3.41Notesdue2027Member_04bf4e56-d0a2-4c95-a067-ba425fab9b27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_A4.368Notesdue2047Member_d20d6449-e4f7-4f60-b0c3-240cad5df686" xlink:href="cah-20210630.xsd#cah_A4.368Notesdue2047Member"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_6e8fd735-4830-447a-a7f5-cf1c615d85dc" xlink:to="loc_cah_A4.368Notesdue2047Member_d20d6449-e4f7-4f60-b0c3-240cad5df686" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_A2.616Notes3.2Notes3.41Notes4.6Notes4.9Notesand4.368NotesMember_bfcf93a7-25a3-4db2-9438-dc2d0c0e16f2" xlink:href="cah-20210630.xsd#cah_A2.616Notes3.2Notes3.41Notes4.6Notes4.9Notesand4.368NotesMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_6e8fd735-4830-447a-a7f5-cf1c615d85dc" xlink:to="loc_cah_A2.616Notes3.2Notes3.41Notes4.6Notes4.9Notesand4.368NotesMember_bfcf93a7-25a3-4db2-9438-dc2d0c0e16f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_FloatingRateNotesdue2022Member_deeafed3-23ab-4b2b-b8d9-cc22fe70456e" xlink:href="cah-20210630.xsd#cah_FloatingRateNotesdue2022Member"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_6e8fd735-4830-447a-a7f5-cf1c615d85dc" xlink:to="loc_cah_FloatingRateNotesdue2022Member_deeafed3-23ab-4b2b-b8d9-cc22fe70456e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_A24NotesDue2019Member_58a85a0e-0f4f-486f-9428-6ce2d975dac0" xlink:href="cah-20210630.xsd#cah_A24NotesDue2019Member"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_6e8fd735-4830-447a-a7f5-cf1c615d85dc" xlink:to="loc_cah_A24NotesDue2019Member_58a85a0e-0f4f-486f-9428-6ce2d975dac0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_A3.2Notesdue2022Member_cdc98570-9c03-4e88-92f9-34993b4228b8" xlink:href="cah-20210630.xsd#cah_A3.2Notesdue2022Member"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_6e8fd735-4830-447a-a7f5-cf1c615d85dc" xlink:to="loc_cah_A3.2Notesdue2022Member_cdc98570-9c03-4e88-92f9-34993b4228b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_A3.2Notesdue2023Member_b624f52c-15ba-4172-9c4d-3456163c48b5" xlink:href="cah-20210630.xsd#cah_A3.2Notesdue2023Member"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_6e8fd735-4830-447a-a7f5-cf1c615d85dc" xlink:to="loc_cah_A3.2Notesdue2023Member_b624f52c-15ba-4172-9c4d-3456163c48b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_A3.5Notesdue2025Member_a9e2f5e0-8978-481a-81c0-f8711076bab4" xlink:href="cah-20210630.xsd#cah_A3.5Notesdue2025Member"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_6e8fd735-4830-447a-a7f5-cf1c615d85dc" xlink:to="loc_cah_A3.5Notesdue2025Member_a9e2f5e0-8978-481a-81c0-f8711076bab4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_A3.75Notesdue2026Member_2bcdd9d7-4b2d-4f66-8670-165c230ac080" xlink:href="cah-20210630.xsd#cah_A3.75Notesdue2026Member"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_6e8fd735-4830-447a-a7f5-cf1c615d85dc" xlink:to="loc_cah_A3.75Notesdue2026Member_2bcdd9d7-4b2d-4f66-8670-165c230ac080" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_A4.5Notesdue2044Member_573c4de1-6d5d-4816-a903-cfe1fff61212" xlink:href="cah-20210630.xsd#cah_A4.5Notesdue2044Member"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_6e8fd735-4830-447a-a7f5-cf1c615d85dc" xlink:to="loc_cah_A4.5Notesdue2044Member_573c4de1-6d5d-4816-a903-cfe1fff61212" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_A4.6Notesdue2043Member_c126d81c-88c4-4c19-9365-c47c2cf2d9b4" xlink:href="cah-20210630.xsd#cah_A4.6Notesdue2043Member"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_6e8fd735-4830-447a-a7f5-cf1c615d85dc" xlink:to="loc_cah_A4.6Notesdue2043Member_c126d81c-88c4-4c19-9365-c47c2cf2d9b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_A4.625Notesdue2021Member_f35282a1-c187-4c09-9631-a1ae60973c22" xlink:href="cah-20210630.xsd#cah_A4.625Notesdue2021Member"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_6e8fd735-4830-447a-a7f5-cf1c615d85dc" xlink:to="loc_cah_A4.625Notesdue2021Member_f35282a1-c187-4c09-9631-a1ae60973c22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_A4.9Notesdue2045Member_67526b3c-5d01-4f1b-b8ec-38147751b49e" xlink:href="cah-20210630.xsd#cah_A4.9Notesdue2045Member"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_6e8fd735-4830-447a-a7f5-cf1c615d85dc" xlink:to="loc_cah_A4.9Notesdue2045Member_67526b3c-5d01-4f1b-b8ec-38147751b49e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_A7.0Debenturesduefiscal2027Member_39550ff0-4a64-4be5-8021-d55e1f7d20dd" xlink:href="cah-20210630.xsd#cah_A7.0Debenturesduefiscal2027Member"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_6e8fd735-4830-447a-a7f5-cf1c615d85dc" xlink:to="loc_cah_A7.0Debenturesduefiscal2027Member_39550ff0-4a64-4be5-8021-d55e1f7d20dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_73fbe6a5-63c7-40d5-8b20-e0677901f1df" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_6ea5b715-bbfa-48a0-b454-68949b285dae" xlink:to="loc_dei_LegalEntityAxis_73fbe6a5-63c7-40d5-8b20-e0677901f1df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_8c971183-7e22-43d9-954b-ec8cff8f6302" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_73fbe6a5-63c7-40d5-8b20-e0677901f1df" xlink:to="loc_dei_EntityDomain_8c971183-7e22-43d9-954b-ec8cff8f6302" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_AllegianceCorporationMember_57e65b30-8455-4013-8fc0-7208a754cb5e" xlink:href="cah-20210630.xsd#cah_AllegianceCorporationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_8c971183-7e22-43d9-954b-ec8cff8f6302" xlink:to="loc_cah_AllegianceCorporationMember_57e65b30-8455-4013-8fc0-7208a754cb5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_7d7151b9-f8f5-484f-83a0-996574e119f6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_6ea5b715-bbfa-48a0-b454-68949b285dae" xlink:to="loc_us-gaap_DebtInstrumentLineItems_7d7151b9-f8f5-484f-83a0-996574e119f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_f762eced-3050-4205-af06-3c42d016adff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_7d7151b9-f8f5-484f-83a0-996574e119f6" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_f762eced-3050-4205-af06-3c42d016adff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_87823449-3905-47a3-a3db-a72c64fb2d45" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_7d7151b9-f8f5-484f-83a0-996574e119f6" xlink:to="loc_us-gaap_AccountsPayableCurrent_87823449-3905-47a3-a3db-a72c64fb2d45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_218cccd3-04ef-4299-8771-34c73dcace6a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_7d7151b9-f8f5-484f-83a0-996574e119f6" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_218cccd3-04ef-4299-8771-34c73dcace6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_OfferAsPercentageOfPrincipalAmount_2aeb32ee-d86a-43bb-b84c-28df8fedd687" xlink:href="cah-20210630.xsd#cah_OfferAsPercentageOfPrincipalAmount"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_7d7151b9-f8f5-484f-83a0-996574e119f6" xlink:to="loc_cah_OfferAsPercentageOfPrincipalAmount_2aeb32ee-d86a-43bb-b84c-28df8fedd687" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCredit_49afc3a7-9fa2-4e28-a498-0d01b630238c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCredit"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_7d7151b9-f8f5-484f-83a0-996574e119f6" xlink:to="loc_us-gaap_LineOfCredit_49afc3a7-9fa2-4e28-a498-0d01b630238c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_a5fb931d-edb5-4e1f-afe6-d69775eac184" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_7d7151b9-f8f5-484f-83a0-996574e119f6" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_a5fb931d-edb5-4e1f-afe6-d69775eac184" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_NotesPayableRepurchased_3b2cc7ae-3592-4fbb-a21c-d977b4241ae7" xlink:href="cah-20210630.xsd#cah_NotesPayableRepurchased"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_7d7151b9-f8f5-484f-83a0-996574e119f6" xlink:to="loc_cah_NotesPayableRepurchased_3b2cc7ae-3592-4fbb-a21c-d977b4241ae7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/LongTermObligationsandOtherShortTermBorrowingsOtherFinancingArrangementsDetails" xlink:type="simple" xlink:href="cah-20210630.xsd#LongTermObligationsandOtherShortTermBorrowingsOtherFinancingArrangementsDetails"/>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/LongTermObligationsandOtherShortTermBorrowingsOtherFinancingArrangementsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_b02ef2a4-1322-49b2-9c01-fdaaf2225010" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_28cfbcc3-f921-4a15-b6a2-b46b7321e1c1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_b02ef2a4-1322-49b2-9c01-fdaaf2225010" xlink:to="loc_us-gaap_DebtInstrumentTable_28cfbcc3-f921-4a15-b6a2-b46b7321e1c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_4d239dce-2d86-4bc0-a673-2667de2e5749" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_28cfbcc3-f921-4a15-b6a2-b46b7321e1c1" xlink:to="loc_us-gaap_CreditFacilityAxis_4d239dce-2d86-4bc0-a673-2667de2e5749" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_66dc1d3e-92e5-4757-9cb9-9e6b2c8b64b3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityAxis_4d239dce-2d86-4bc0-a673-2667de2e5749" xlink:to="loc_us-gaap_CreditFacilityDomain_66dc1d3e-92e5-4757-9cb9-9e6b2c8b64b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_46c9ab12-aac1-438c-a8e6-dcc338279303" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_66dc1d3e-92e5-4757-9cb9-9e6b2c8b64b3" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_46c9ab12-aac1-438c-a8e6-dcc338279303" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LetterOfCreditMember_31575e8b-6b82-4f68-8cdd-baa451d48160" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LetterOfCreditMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_66dc1d3e-92e5-4757-9cb9-9e6b2c8b64b3" xlink:to="loc_us-gaap_LetterOfCreditMember_31575e8b-6b82-4f68-8cdd-baa451d48160" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_ShortTermCreditFacilitiesMember_1dba517f-fe19-45ff-9f16-70a589576211" xlink:href="cah-20210630.xsd#cah_ShortTermCreditFacilitiesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_66dc1d3e-92e5-4757-9cb9-9e6b2c8b64b3" xlink:to="loc_cah_ShortTermCreditFacilitiesMember_1dba517f-fe19-45ff-9f16-70a589576211" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember_36b4d5e2-b36f-4ac2-b06e-eab42ed173c0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommercialPaperMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_66dc1d3e-92e5-4757-9cb9-9e6b2c8b64b3" xlink:to="loc_us-gaap_CommercialPaperMember_36b4d5e2-b36f-4ac2-b06e-eab42ed173c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_CommittedReceivablesSalesFacilityProgramMember_67cac161-fdfe-45e1-8069-b8bfc749d4ac" xlink:href="cah-20210630.xsd#cah_CommittedReceivablesSalesFacilityProgramMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_66dc1d3e-92e5-4757-9cb9-9e6b2c8b64b3" xlink:to="loc_cah_CommittedReceivablesSalesFacilityProgramMember_67cac161-fdfe-45e1-8069-b8bfc749d4ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_aae4a8bb-215f-41f4-a5e5-c2bff5e8e17d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_28cfbcc3-f921-4a15-b6a2-b46b7321e1c1" xlink:to="loc_us-gaap_DebtInstrumentAxis_aae4a8bb-215f-41f4-a5e5-c2bff5e8e17d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_7c344bc1-27d3-4603-a623-0ee8c8d16c4a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_aae4a8bb-215f-41f4-a5e5-c2bff5e8e17d" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_7c344bc1-27d3-4603-a623-0ee8c8d16c4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_CommittedReceivablesSalesFacilityProgramMember_76608997-aaef-40d8-a31c-3a803f8cf2f6" xlink:href="cah-20210630.xsd#cah_CommittedReceivablesSalesFacilityProgramMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_7c344bc1-27d3-4603-a623-0ee8c8d16c4a" xlink:to="loc_cah_CommittedReceivablesSalesFacilityProgramMember_76608997-aaef-40d8-a31c-3a803f8cf2f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_91f2562c-8dee-4507-961f-fc8d785e0d0f" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_28cfbcc3-f921-4a15-b6a2-b46b7321e1c1" xlink:to="loc_srt_RangeAxis_91f2562c-8dee-4507-961f-fc8d785e0d0f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_e9e34545-57d0-4f0c-9197-2351131263f7" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_91f2562c-8dee-4507-961f-fc8d785e0d0f" xlink:to="loc_srt_RangeMember_e9e34545-57d0-4f0c-9197-2351131263f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_760106cf-2c41-4fe7-9182-57bba2e53445" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_28cfbcc3-f921-4a15-b6a2-b46b7321e1c1" xlink:to="loc_us-gaap_DebtInstrumentLineItems_760106cf-2c41-4fe7-9182-57bba2e53445" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_bc34813d-66f6-462d-bc36-001174db564d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_760106cf-2c41-4fe7-9182-57bba2e53445" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_bc34813d-66f6-462d-bc36-001174db564d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCredit_a6f39be3-1ca7-4e7c-83cb-55cc57c346f2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCredit"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_760106cf-2c41-4fe7-9182-57bba2e53445" xlink:to="loc_us-gaap_LineOfCredit_a6f39be3-1ca7-4e7c-83cb-55cc57c346f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherBorrowings_d3b60d61-e52f-4fee-b4b3-afeb82df13fd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherBorrowings"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_760106cf-2c41-4fe7-9182-57bba2e53445" xlink:to="loc_us-gaap_OtherBorrowings_d3b60d61-e52f-4fee-b4b3-afeb82df13fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherShortTermBorrowings_521cc29d-9d88-4c07-a371-cd38e7fe5a5b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherShortTermBorrowings"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_760106cf-2c41-4fe7-9182-57bba2e53445" xlink:to="loc_us-gaap_OtherShortTermBorrowings_521cc29d-9d88-4c07-a371-cd38e7fe5a5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/CommitmentsContingentLiabilitiesandLitigation" xlink:type="simple" xlink:href="cah-20210630.xsd#CommitmentsContingentLiabilitiesandLitigation"/>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/CommitmentsContingentLiabilitiesandLitigation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_6a2b4d99-7052-4c37-bb70-2b962cf97e0c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_e09f3dd4-c072-4208-8faa-312f859578b3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_6a2b4d99-7052-4c37-bb70-2b962cf97e0c" xlink:to="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_e09f3dd4-c072-4208-8faa-312f859578b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/CommitmentsContingentLiabilitiesandLitigationDetails" xlink:type="simple" xlink:href="cah-20210630.xsd#CommitmentsContingentLiabilitiesandLitigationDetails"/>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/CommitmentsContingentLiabilitiesandLitigationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_6eb91704-9661-4303-b2bf-97207b733f53" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_b6c5f8f3-6823-48dc-9ec7-e4e86e9cd968" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_6eb91704-9661-4303-b2bf-97207b733f53" xlink:to="loc_us-gaap_LossContingenciesTable_b6c5f8f3-6823-48dc-9ec7-e4e86e9cd968" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_LawsuitTypeAxis_668a12bf-5239-48db-a150-8a3036472b87" xlink:href="cah-20210630.xsd#cah_LawsuitTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_b6c5f8f3-6823-48dc-9ec7-e4e86e9cd968" xlink:to="loc_cah_LawsuitTypeAxis_668a12bf-5239-48db-a150-8a3036472b87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_LawsuitTypeDomain_caad946b-ecb7-4461-bba9-d005b50c7269" xlink:href="cah-20210630.xsd#cah_LawsuitTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cah_LawsuitTypeAxis_668a12bf-5239-48db-a150-8a3036472b87" xlink:to="loc_cah_LawsuitTypeDomain_caad946b-ecb7-4461-bba9-d005b50c7269" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_ClassActionLawsuitsMember_d7215d30-d5a8-4a2a-91cb-6ec5aee00934" xlink:href="cah-20210630.xsd#cah_ClassActionLawsuitsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cah_LawsuitTypeDomain_caad946b-ecb7-4461-bba9-d005b50c7269" xlink:to="loc_cah_ClassActionLawsuitsMember_d7215d30-d5a8-4a2a-91cb-6ec5aee00934" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_PlaintiffTypeAxis_b8956a6f-7d68-48af-96e9-89c74eccdb8e" xlink:href="cah-20210630.xsd#cah_PlaintiffTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_b6c5f8f3-6823-48dc-9ec7-e4e86e9cd968" xlink:to="loc_cah_PlaintiffTypeAxis_b8956a6f-7d68-48af-96e9-89c74eccdb8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_PlaintiffTypeDomain_2c5d3a69-e33c-43cd-9139-27f0e26f7ff4" xlink:href="cah-20210630.xsd#cah_PlaintiffTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cah_PlaintiffTypeAxis_b8956a6f-7d68-48af-96e9-89c74eccdb8e" xlink:to="loc_cah_PlaintiffTypeDomain_2c5d3a69-e33c-43cd-9139-27f0e26f7ff4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_PrivatePartiesMember_479c5c9b-4422-4514-9a8d-90f2397d26df" xlink:href="cah-20210630.xsd#cah_PrivatePartiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cah_PlaintiffTypeDomain_2c5d3a69-e33c-43cd-9139-27f0e26f7ff4" xlink:to="loc_cah_PrivatePartiesMember_479c5c9b-4422-4514-9a8d-90f2397d26df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_OpioidLitigationAxis_3eeab3c2-bcc5-419b-ad10-9b1d23de8f3b" xlink:href="cah-20210630.xsd#cah_OpioidLitigationAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_b6c5f8f3-6823-48dc-9ec7-e4e86e9cd968" xlink:to="loc_cah_OpioidLitigationAxis_3eeab3c2-bcc5-419b-ad10-9b1d23de8f3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_OpioidLitigationDomain_80a981d6-8dbe-4005-a626-892382a85faa" xlink:href="cah-20210630.xsd#cah_OpioidLitigationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cah_OpioidLitigationAxis_3eeab3c2-bcc5-419b-ad10-9b1d23de8f3b" xlink:to="loc_cah_OpioidLitigationDomain_80a981d6-8dbe-4005-a626-892382a85faa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_TotalOpioidLitigationMember_475c61dc-7fb8-4174-b22c-383956b8ea52" xlink:href="cah-20210630.xsd#cah_TotalOpioidLitigationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cah_OpioidLitigationDomain_80a981d6-8dbe-4005-a626-892382a85faa" xlink:to="loc_cah_TotalOpioidLitigationMember_475c61dc-7fb8-4174-b22c-383956b8ea52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_GownRecallAxis_0dcbb089-0772-4d96-8579-71c0dcb2da07" xlink:href="cah-20210630.xsd#cah_GownRecallAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_b6c5f8f3-6823-48dc-9ec7-e4e86e9cd968" xlink:to="loc_cah_GownRecallAxis_0dcbb089-0772-4d96-8579-71c0dcb2da07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_GownRecallDomain_a94ebd00-0f33-4af1-ac6a-fbbc2b0e06b6" xlink:href="cah-20210630.xsd#cah_GownRecallDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cah_GownRecallAxis_0dcbb089-0772-4d96-8579-71c0dcb2da07" xlink:to="loc_cah_GownRecallDomain_a94ebd00-0f33-4af1-ac6a-fbbc2b0e06b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_SterileSurgicalGownRecallMemberDomain_69909b71-0c2a-43c5-8a6f-6c9430f54e1c" xlink:href="cah-20210630.xsd#cah_SterileSurgicalGownRecallMemberDomain"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cah_GownRecallAxis_0dcbb089-0772-4d96-8579-71c0dcb2da07" xlink:to="loc_cah_SterileSurgicalGownRecallMemberDomain_69909b71-0c2a-43c5-8a6f-6c9430f54e1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_c0668676-e2a4-43bc-a5ae-381fd5108219" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_b6c5f8f3-6823-48dc-9ec7-e4e86e9cd968" xlink:to="loc_srt_RangeAxis_c0668676-e2a4-43bc-a5ae-381fd5108219" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_738a7aef-d671-4604-8b08-64b272072523" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_c0668676-e2a4-43bc-a5ae-381fd5108219" xlink:to="loc_srt_RangeMember_738a7aef-d671-4604-8b08-64b272072523" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_ed0abce1-b7e6-4e5d-9b5b-976e9580e425" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_738a7aef-d671-4604-8b08-64b272072523" xlink:to="loc_srt_MinimumMember_ed0abce1-b7e6-4e5d-9b5b-976e9580e425" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_4758106a-9675-464b-9564-3066130f08b5" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_738a7aef-d671-4604-8b08-64b272072523" xlink:to="loc_srt_MaximumMember_4758106a-9675-464b-9564-3066130f08b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_6863f270-5eaa-4474-b013-2280118ffdab" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesByNatureOfContingencyAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_b6c5f8f3-6823-48dc-9ec7-e4e86e9cd968" xlink:to="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_6863f270-5eaa-4474-b013-2280118ffdab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNatureDomain_e6752762-cda7-426e-ab02-fff59b97e636" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyNatureDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_6863f270-5eaa-4474-b013-2280118ffdab" xlink:to="loc_us-gaap_LossContingencyNatureDomain_e6752762-cda7-426e-ab02-fff59b97e636" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_ProductLiabilityLawsuitsMember_ee3b152f-2f70-470e-8ecb-b1cafb866d6d" xlink:href="cah-20210630.xsd#cah_ProductLiabilityLawsuitsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingencyNatureDomain_e6752762-cda7-426e-ab02-fff59b97e636" xlink:to="loc_cah_ProductLiabilityLawsuitsMember_ee3b152f-2f70-470e-8ecb-b1cafb866d6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_LitigationTypeAxis_efe819ed-ca37-4db4-a2b2-19f401865e67" xlink:href="cah-20210630.xsd#cah_LitigationTypeAxis"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_b6c5f8f3-6823-48dc-9ec7-e4e86e9cd968" xlink:to="loc_cah_LitigationTypeAxis_efe819ed-ca37-4db4-a2b2-19f401865e67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_LitigationTypeDomain_add98df8-19cf-4f74-80d8-6d9b51b192b6" xlink:href="cah-20210630.xsd#cah_LitigationTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cah_LitigationTypeAxis_efe819ed-ca37-4db4-a2b2-19f401865e67" xlink:to="loc_cah_LitigationTypeDomain_add98df8-19cf-4f74-80d8-6d9b51b192b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_ClassActionLawsuitsMember_2e8fb563-3c8e-477d-95fa-4678c596c716" xlink:href="cah-20210630.xsd#cah_ClassActionLawsuitsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cah_LitigationTypeDomain_add98df8-19cf-4f74-80d8-6d9b51b192b6" xlink:to="loc_cah_ClassActionLawsuitsMember_2e8fb563-3c8e-477d-95fa-4678c596c716" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_ad27272f-d42e-46ed-9f08-9a3cb806f949" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_b6c5f8f3-6823-48dc-9ec7-e4e86e9cd968" xlink:to="loc_srt_StatementGeographicalAxis_ad27272f-d42e-46ed-9f08-9a3cb806f949" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_c70b3bb1-53f2-4941-a6d6-dc78ff319fbe" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_ad27272f-d42e-46ed-9f08-9a3cb806f949" xlink:to="loc_srt_SegmentGeographicalDomain_c70b3bb1-53f2-4941-a6d6-dc78ff319fbe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_AlamedaCountyMember_3b59f170-eec9-4ee4-8f07-20fe6b1c3d8f" xlink:href="cah-20210630.xsd#cah_AlamedaCountyMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_c70b3bb1-53f2-4941-a6d6-dc78ff319fbe" xlink:to="loc_cah_AlamedaCountyMember_3b59f170-eec9-4ee4-8f07-20fe6b1c3d8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_OtherJurisdictionsMember_8d97cc2f-0085-4382-89c0-db7c9d9526e7" xlink:href="cah-20210630.xsd#cah_OtherJurisdictionsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_c70b3bb1-53f2-4941-a6d6-dc78ff319fbe" xlink:to="loc_cah_OtherJurisdictionsMember_8d97cc2f-0085-4382-89c0-db7c9d9526e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_669e6d3d-2a4a-451e-a1c6-822813d783cb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_b6c5f8f3-6823-48dc-9ec7-e4e86e9cd968" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_669e6d3d-2a4a-451e-a1c6-822813d783cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_8aa94b00-1b21-4051-b6e0-488484da3e55" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_669e6d3d-2a4a-451e-a1c6-822813d783cb" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_8aa94b00-1b21-4051-b6e0-488484da3e55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_ca93a0a3-0856-4511-968f-da5e62482348" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LitigationCaseAxis"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_b6c5f8f3-6823-48dc-9ec7-e4e86e9cd968" xlink:to="loc_srt_LitigationCaseAxis_ca93a0a3-0856-4511-968f-da5e62482348" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_913d9f7f-4b0c-4254-a700-51744fb0aad1" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseAxis_ca93a0a3-0856-4511-968f-da5e62482348" xlink:to="loc_srt_LitigationCaseTypeDomain_913d9f7f-4b0c-4254-a700-51744fb0aad1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_OpioidLawsuitsMember_1852942c-2850-4d4b-b70f-8c96d9a4100c" xlink:href="cah-20210630.xsd#cah_OpioidLawsuitsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_913d9f7f-4b0c-4254-a700-51744fb0aad1" xlink:to="loc_cah_OpioidLawsuitsMember_1852942c-2850-4d4b-b70f-8c96d9a4100c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_OpioidLawsuitsStateDomain_927ccc55-93e7-414c-bc8d-2301652fe50f" xlink:href="cah-20210630.xsd#cah_OpioidLawsuitsStateDomain"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_913d9f7f-4b0c-4254-a700-51744fb0aad1" xlink:to="loc_cah_OpioidLawsuitsStateDomain_927ccc55-93e7-414c-bc8d-2301652fe50f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_ProductLiabilityLawsuitsMember_314c01d1-8c5b-4fa3-9f70-b8a2c5d5189a" xlink:href="cah-20210630.xsd#cah_ProductLiabilityLawsuitsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_913d9f7f-4b0c-4254-a700-51744fb0aad1" xlink:to="loc_cah_ProductLiabilityLawsuitsMember_314c01d1-8c5b-4fa3-9f70-b8a2c5d5189a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_NewYorkOpioidStewardshipActMember_68da8b07-9de6-40a5-acdb-1eb3daff5655" xlink:href="cah-20210630.xsd#cah_NewYorkOpioidStewardshipActMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_913d9f7f-4b0c-4254-a700-51744fb0aad1" xlink:to="loc_cah_NewYorkOpioidStewardshipActMember_68da8b07-9de6-40a5-acdb-1eb3daff5655" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_DOJInvestigationMember_935e54e3-77cc-4e61-8b66-465d9b6fc3b9" xlink:href="cah-20210630.xsd#cah_DOJInvestigationMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_913d9f7f-4b0c-4254-a700-51744fb0aad1" xlink:to="loc_cah_DOJInvestigationMember_935e54e3-77cc-4e61-8b66-465d9b6fc3b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_579d4b10-0104-4b03-84c9-1b5ca52e5157" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_b6c5f8f3-6823-48dc-9ec7-e4e86e9cd968" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_579d4b10-0104-4b03-84c9-1b5ca52e5157" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_b5297589-4367-4140-97d2-f95312259772" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_579d4b10-0104-4b03-84c9-1b5ca52e5157" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_b5297589-4367-4140-97d2-f95312259772" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_dab5aefd-f7a2-4dc9-af03-eefea0bbe59c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_b5297589-4367-4140-97d2-f95312259772" xlink:to="loc_us-gaap_SubsequentEventMember_dab5aefd-f7a2-4dc9-af03-eefea0bbe59c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_1a895162-d548-4ab3-8229-93a299a16548" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_b6c5f8f3-6823-48dc-9ec7-e4e86e9cd968" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_1a895162-d548-4ab3-8229-93a299a16548" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_089f12c5-0a5c-4589-b9ac-a8e644882312" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_1a895162-d548-4ab3-8229-93a299a16548" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_089f12c5-0a5c-4589-b9ac-a8e644882312" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesMember_42c5f4b9-c727-46cc-9313-a3f5f05900d7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_089f12c5-0a5c-4589-b9ac-a8e644882312" xlink:to="loc_us-gaap_AccruedLiabilitiesMember_42c5f4b9-c727-46cc-9313-a3f5f05900d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_b3073278-0fbe-4e07-b2f0-aea9a93601fa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_b6c5f8f3-6823-48dc-9ec7-e4e86e9cd968" xlink:to="loc_us-gaap_LossContingenciesLineItems_b3073278-0fbe-4e07-b2f0-aea9a93601fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationReserve_0e3e0d40-de8b-448f-92cf-a787f4fc37c8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LitigationReserve"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_b3073278-0fbe-4e07-b2f0-aea9a93601fa" xlink:to="loc_us-gaap_LitigationReserve_0e3e0d40-de8b-448f-92cf-a787f4fc37c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRecallExpense_8ca7228f-e8c4-45bb-abfb-59edd0ca8d78" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryRecallExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_b3073278-0fbe-4e07-b2f0-aea9a93601fa" xlink:to="loc_us-gaap_InventoryRecallExpense_8ca7228f-e8c4-45bb-abfb-59edd0ca8d78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNewClaimsFiledNumber_c86c023b-3034-418f-85e5-15e73531ee9c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyNewClaimsFiledNumber"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_b3073278-0fbe-4e07-b2f0-aea9a93601fa" xlink:to="loc_us-gaap_LossContingencyNewClaimsFiledNumber_c86c023b-3034-418f-85e5-15e73531ee9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNumberOfPlaintiffs_f426dcab-3a32-4cdc-af04-83a14fca7643" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyNumberOfPlaintiffs"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_b3073278-0fbe-4e07-b2f0-aea9a93601fa" xlink:to="loc_us-gaap_LossContingencyNumberOfPlaintiffs_f426dcab-3a32-4cdc-af04-83a14fca7643" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualAtCarryingValue_4a9a55b0-c543-4d27-8033-3c8a7a2138af" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyAccrualAtCarryingValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_b3073278-0fbe-4e07-b2f0-aea9a93601fa" xlink:to="loc_us-gaap_LossContingencyAccrualAtCarryingValue_4a9a55b0-c543-4d27-8033-3c8a7a2138af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyEstimateOfPossibleLoss_be6542d9-8866-40db-9cbb-767ac0065bd6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyEstimateOfPossibleLoss"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_b3073278-0fbe-4e07-b2f0-aea9a93601fa" xlink:to="loc_us-gaap_LossContingencyEstimateOfPossibleLoss_be6542d9-8866-40db-9cbb-767ac0065bd6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_IncomefromSettlementsofClassActionLawsuits_da031d35-a300-44d4-991d-49ec6d16b0be" xlink:href="cah-20210630.xsd#cah_IncomefromSettlementsofClassActionLawsuits"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_b3073278-0fbe-4e07-b2f0-aea9a93601fa" xlink:to="loc_cah_IncomefromSettlementsofClassActionLawsuits_da031d35-a300-44d4-991d-49ec6d16b0be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_dd12fb33-632c-4a67-bf7e-8d9aab0d13a3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_b3073278-0fbe-4e07-b2f0-aea9a93601fa" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_dd12fb33-632c-4a67-bf7e-8d9aab0d13a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_c913c09a-dfae-4d89-830e-ca822058287d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_b3073278-0fbe-4e07-b2f0-aea9a93601fa" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_c913c09a-dfae-4d89-830e-ca822058287d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossRelatedToLitigationSettlement_638e0b35-1888-4682-b8e5-94a2204fc913" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossRelatedToLitigationSettlement"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_b3073278-0fbe-4e07-b2f0-aea9a93601fa" xlink:to="loc_us-gaap_GainLossRelatedToLitigationSettlement_638e0b35-1888-4682-b8e5-94a2204fc913" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_LossContingencyLawsuitsNumber_10fd181c-7a78-4139-a7f0-8f8da214b12d" xlink:href="cah-20210630.xsd#cah_LossContingencyLawsuitsNumber"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_b3073278-0fbe-4e07-b2f0-aea9a93601fa" xlink:to="loc_cah_LossContingencyLawsuitsNumber_10fd181c-7a78-4139-a7f0-8f8da214b12d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_NumberofStateAttorneysGeneralfilinglawsuits_587115a7-8fa5-492d-81af-56ff5c6c7172" xlink:href="cah-20210630.xsd#cah_NumberofStateAttorneysGeneralfilinglawsuits"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_b3073278-0fbe-4e07-b2f0-aea9a93601fa" xlink:to="loc_cah_NumberofStateAttorneysGeneralfilinglawsuits_587115a7-8fa5-492d-81af-56ff5c6c7172" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_AggregateAnnualAssessment_b180eec2-42d3-40d6-bd97-178af5387d20" xlink:href="cah-20210630.xsd#cah_AggregateAnnualAssessment"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_b3073278-0fbe-4e07-b2f0-aea9a93601fa" xlink:to="loc_cah_AggregateAnnualAssessment_b180eec2-42d3-40d6-bd97-178af5387d20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationSettlementExpense_942d602b-9585-46f3-8b1d-10bc5dd8b96a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LitigationSettlementExpense"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_b3073278-0fbe-4e07-b2f0-aea9a93601fa" xlink:to="loc_us-gaap_LitigationSettlementExpense_942d602b-9585-46f3-8b1d-10bc5dd8b96a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyClaimsSettledNumber_436e2c7f-e1c8-4071-9871-fdfa8621ec57" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyClaimsSettledNumber"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_b3073278-0fbe-4e07-b2f0-aea9a93601fa" xlink:to="loc_us-gaap_LossContingencyClaimsSettledNumber_436e2c7f-e1c8-4071-9871-fdfa8621ec57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/IncomeTaxes" xlink:type="simple" xlink:href="cah-20210630.xsd#IncomeTaxes"/>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/IncomeTaxes" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_71468423-fa00-441c-a243-ab86f668baa4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock_8b0ddf7c-b1ac-40db-a45f-72a359e4acbe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_71468423-fa00-441c-a243-ab86f668baa4" xlink:to="loc_us-gaap_IncomeTaxDisclosureTextBlock_8b0ddf7c-b1ac-40db-a45f-72a359e4acbe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/IncomeTaxesTables" xlink:type="simple" xlink:href="cah-20210630.xsd#IncomeTaxesTables"/>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/IncomeTaxesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_d795c369-d3f3-406e-8dcb-efc6d88b99f2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_5e9c999b-72a9-4698-9dc4-a29ee281a8ab" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_d795c369-d3f3-406e-8dcb-efc6d88b99f2" xlink:to="loc_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_5e9c999b-72a9-4698-9dc4-a29ee281a8ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_0d618394-334b-4cd7-a1c8-5bcea433852a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_d795c369-d3f3-406e-8dcb-efc6d88b99f2" xlink:to="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_0d618394-334b-4cd7-a1c8-5bcea433852a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_15954d6b-775c-415d-9c5b-e60a5052650c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_d795c369-d3f3-406e-8dcb-efc6d88b99f2" xlink:to="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_15954d6b-775c-415d-9c5b-e60a5052650c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_2b979cbc-bbef-4fd8-af6c-771e6fe60cee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_d795c369-d3f3-406e-8dcb-efc6d88b99f2" xlink:to="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_2b979cbc-bbef-4fd8-af6c-771e6fe60cee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_ScheduleOfDeferredTaxAssetsAndLiabilitiesAfterNettingByTaxJurisdictionTableTextBlock_427b94ac-0862-4d41-8d1a-ca89c0e3488b" xlink:href="cah-20210630.xsd#cah_ScheduleOfDeferredTaxAssetsAndLiabilitiesAfterNettingByTaxJurisdictionTableTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_d795c369-d3f3-406e-8dcb-efc6d88b99f2" xlink:to="loc_cah_ScheduleOfDeferredTaxAssetsAndLiabilitiesAfterNettingByTaxJurisdictionTableTextBlock_427b94ac-0862-4d41-8d1a-ca89c0e3488b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock_f6b83179-7a3e-441c-b0a6-165769c1222f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_d795c369-d3f3-406e-8dcb-efc6d88b99f2" xlink:to="loc_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock_f6b83179-7a3e-441c-b0a6-165769c1222f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/IncomeTaxesScheduleofIncomebeforeIncomeTaxDomesticandForeignDetails" xlink:type="simple" xlink:href="cah-20210630.xsd#IncomeTaxesScheduleofIncomebeforeIncomeTaxDomesticandForeignDetails"/>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/IncomeTaxesScheduleofIncomebeforeIncomeTaxDomesticandForeignDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_5f461ccb-869f-4761-9870-f2c0af99bc0b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_e046468c-6273-4476-acd7-2692eb944088" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentFiscalYearFocus"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_5f461ccb-869f-4761-9870-f2c0af99bc0b" xlink:to="loc_dei_DocumentFiscalYearFocus_e046468c-6273-4476-acd7-2692eb944088" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_6ef790ac-4c47-4359-88db-ad9236b3bec2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_5f461ccb-869f-4761-9870-f2c0af99bc0b" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_6ef790ac-4c47-4359-88db-ad9236b3bec2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_b61e0e72-5906-468d-a0a1-769910e33944" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_5f461ccb-869f-4761-9870-f2c0af99bc0b" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_b61e0e72-5906-468d-a0a1-769910e33944" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_05ff609c-93c3-4a1c-8bfa-f7189f8796fb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_5f461ccb-869f-4761-9870-f2c0af99bc0b" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_05ff609c-93c3-4a1c-8bfa-f7189f8796fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/IncomeTaxesScheduleofComponentsofIncomeTaxExpenseBenefitCurrentandDeferredDetails" xlink:type="simple" xlink:href="cah-20210630.xsd#IncomeTaxesScheduleofComponentsofIncomeTaxExpenseBenefitCurrentandDeferredDetails"/>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/IncomeTaxesScheduleofComponentsofIncomeTaxExpenseBenefitCurrentandDeferredDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_fce29414-555d-42cd-81f1-84e01fc54ad4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_ed900a63-7e03-446f-af24-0217d82b177a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_fce29414-555d-42cd-81f1-84e01fc54ad4" xlink:to="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_ed900a63-7e03-446f-af24-0217d82b177a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentFederalTaxExpenseBenefit_aefc4014-9bde-4538-86b9-cfa4877dbd3c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentFederalTaxExpenseBenefit"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_ed900a63-7e03-446f-af24-0217d82b177a" xlink:to="loc_us-gaap_CurrentFederalTaxExpenseBenefit_aefc4014-9bde-4538-86b9-cfa4877dbd3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_2f5bafce-e9be-401a-b419-aba9625168ff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_ed900a63-7e03-446f-af24-0217d82b177a" xlink:to="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_2f5bafce-e9be-401a-b419-aba9625168ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentForeignTaxExpenseBenefit_c08016ac-1346-4864-b1e4-3b8de9c47043" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentForeignTaxExpenseBenefit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_ed900a63-7e03-446f-af24-0217d82b177a" xlink:to="loc_us-gaap_CurrentForeignTaxExpenseBenefit_c08016ac-1346-4864-b1e4-3b8de9c47043" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_f84dc78d-2853-4f74-b0fa-ba1315b77b8c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_ed900a63-7e03-446f-af24-0217d82b177a" xlink:to="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_f84dc78d-2853-4f74-b0fa-ba1315b77b8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_3a5016c1-be6e-404c-8b9d-3087292034e9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_fce29414-555d-42cd-81f1-84e01fc54ad4" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_3a5016c1-be6e-404c-8b9d-3087292034e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_6a61c696-14ea-4874-9212-d645599319b8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_3a5016c1-be6e-404c-8b9d-3087292034e9" xlink:to="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_6a61c696-14ea-4874-9212-d645599319b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_ab57ab63-3892-4d5a-bfc6-4bda137a75f4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_3a5016c1-be6e-404c-8b9d-3087292034e9" xlink:to="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_ab57ab63-3892-4d5a-bfc6-4bda137a75f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_f73f53c6-3db6-4037-95bb-388820a93f27" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredForeignIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_3a5016c1-be6e-404c-8b9d-3087292034e9" xlink:to="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_f73f53c6-3db6-4037-95bb-388820a93f27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_326a1a5e-7093-4f39-8e67-0b6b61408091" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_3a5016c1-be6e-404c-8b9d-3087292034e9" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_326a1a5e-7093-4f39-8e67-0b6b61408091" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_7e7e86bc-128b-4270-96aa-415364d66e54" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_fce29414-555d-42cd-81f1-84e01fc54ad4" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_7e7e86bc-128b-4270-96aa-415364d66e54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/IncomeTaxesScheduleofEffectiveIncomeTaxRateReconciliationDetails" xlink:type="simple" xlink:href="cah-20210630.xsd#IncomeTaxesScheduleofEffectiveIncomeTaxRateReconciliationDetails"/>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/IncomeTaxesScheduleofEffectiveIncomeTaxRateReconciliationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_ff4b138c-7135-4c2e-b006-6204551376f1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_2aee14c5-554b-4f20-9083-181736b50eb6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_ff4b138c-7135-4c2e-b006-6204551376f1" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_2aee14c5-554b-4f20-9083-181736b50eb6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_7c7cf252-ad51-4ba4-952c-147aa23a24c2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_ff4b138c-7135-4c2e-b006-6204551376f1" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_7c7cf252-ad51-4ba4-952c-147aa23a24c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_EffectiveIncomeTaxRateReconciliationTaxEffectOfForeignOperations_f04befaa-009c-4a90-aadf-415f58b37864" xlink:href="cah-20210630.xsd#cah_EffectiveIncomeTaxRateReconciliationTaxEffectOfForeignOperations"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_ff4b138c-7135-4c2e-b006-6204551376f1" xlink:to="loc_cah_EffectiveIncomeTaxRateReconciliationTaxEffectOfForeignOperations_f04befaa-009c-4a90-aadf-415f58b37864" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense_d3e5057b-aa63-40af-98ba-4dc65d0b9d32" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_ff4b138c-7135-4c2e-b006-6204551376f1" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense_d3e5057b-aa63-40af-98ba-4dc65d0b9d32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses_2200ff76-ad9f-4b8c-97b3-f3735626fd1b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_ff4b138c-7135-4c2e-b006-6204551376f1" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses_2200ff76-ad9f-4b8c-97b3-f3735626fd1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_EffectiveIncomeTaxRateReconciliationWithholdingTaxes_b0deb3a4-6aed-4378-a96c-a24e600c08a3" xlink:href="cah-20210630.xsd#cah_EffectiveIncomeTaxRateReconciliationWithholdingTaxes"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_ff4b138c-7135-4c2e-b006-6204551376f1" xlink:to="loc_cah_EffectiveIncomeTaxRateReconciliationWithholdingTaxes_b0deb3a4-6aed-4378-a96c-a24e600c08a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_ec557b27-0a4e-4488-89db-9e3409c4bf99" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_ff4b138c-7135-4c2e-b006-6204551376f1" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_ec557b27-0a4e-4488-89db-9e3409c4bf99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_EffectiveTaxRateReconciliationImpactOfResolutionsWithIRSAndOtherRelatedMatters_6949c960-4f33-43ab-821e-367d858a1f57" xlink:href="cah-20210630.xsd#cah_EffectiveTaxRateReconciliationImpactOfResolutionsWithIRSAndOtherRelatedMatters"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_ff4b138c-7135-4c2e-b006-6204551376f1" xlink:to="loc_cah_EffectiveTaxRateReconciliationImpactOfResolutionsWithIRSAndOtherRelatedMatters_6949c960-4f33-43ab-821e-367d858a1f57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_EffectiveIncomeTaxRateReconciliationLegalEntityReorganizationReconcilingItemsPercent_f0c8674b-bfca-45d3-af88-aa01fd114d06" xlink:href="cah-20210630.xsd#cah_EffectiveIncomeTaxRateReconciliationLegalEntityReorganizationReconcilingItemsPercent"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_ff4b138c-7135-4c2e-b006-6204551376f1" xlink:to="loc_cah_EffectiveIncomeTaxRateReconciliationLegalEntityReorganizationReconcilingItemsPercent_f0c8674b-bfca-45d3-af88-aa01fd114d06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_EffectiveIncomeTaxReconciliationOpioidLitigation_b02ffbfe-f5c7-4432-828f-72870315a3b2" xlink:href="cah-20210630.xsd#cah_EffectiveIncomeTaxReconciliationOpioidLitigation"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_ff4b138c-7135-4c2e-b006-6204551376f1" xlink:to="loc_cah_EffectiveIncomeTaxReconciliationOpioidLitigation_b02ffbfe-f5c7-4432-828f-72870315a3b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_EffectiveIncomeTaxRateReconciliationLossCarrybackClaims_aeb4f0a3-2883-407d-8a74-1b1a93d29bed" xlink:href="cah-20210630.xsd#cah_EffectiveIncomeTaxRateReconciliationLossCarrybackClaims"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_ff4b138c-7135-4c2e-b006-6204551376f1" xlink:to="loc_cah_EffectiveIncomeTaxRateReconciliationLossCarrybackClaims_aeb4f0a3-2883-407d-8a74-1b1a93d29bed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent_76a63c76-10a1-44b7-bd66-89ccf9be5921" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_ff4b138c-7135-4c2e-b006-6204551376f1" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent_76a63c76-10a1-44b7-bd66-89ccf9be5921" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_EffectiveTaxRateReconciliationUSTaxesOnInternationalIncome_31200cac-3eb9-4a69-a4e4-2fcaa678ccb4" xlink:href="cah-20210630.xsd#cah_EffectiveTaxRateReconciliationUSTaxesOnInternationalIncome"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_ff4b138c-7135-4c2e-b006-6204551376f1" xlink:to="loc_cah_EffectiveTaxRateReconciliationUSTaxesOnInternationalIncome_31200cac-3eb9-4a69-a4e4-2fcaa678ccb4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_55a0dafa-67ca-4bf7-8dee-569b7b9eeb06" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_ff4b138c-7135-4c2e-b006-6204551376f1" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_55a0dafa-67ca-4bf7-8dee-569b7b9eeb06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/IncomeTaxesNarrativeDetails" xlink:type="simple" xlink:href="cah-20210630.xsd#IncomeTaxesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/IncomeTaxesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_4d28a2bd-f303-49ad-a59e-ae3a78b814b5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardTable_b5b030a8-c344-440c-bee2-ba92ef8a76e9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxCreditCarryforwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_4d28a2bd-f303-49ad-a59e-ae3a78b814b5" xlink:to="loc_us-gaap_TaxCreditCarryforwardTable_b5b030a8-c344-440c-bee2-ba92ef8a76e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_OpioidLitigationAxis_e560f399-be00-4e7f-9bae-428129de34de" xlink:href="cah-20210630.xsd#cah_OpioidLitigationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxCreditCarryforwardTable_b5b030a8-c344-440c-bee2-ba92ef8a76e9" xlink:to="loc_cah_OpioidLitigationAxis_e560f399-be00-4e7f-9bae-428129de34de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_OpioidLitigationDomain_71edd299-858a-4029-91e0-ec0406d63597" xlink:href="cah-20210630.xsd#cah_OpioidLitigationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cah_OpioidLitigationAxis_e560f399-be00-4e7f-9bae-428129de34de" xlink:to="loc_cah_OpioidLitigationDomain_71edd299-858a-4029-91e0-ec0406d63597" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_TotalOpioidLitigationMember_755fb1cd-9831-4d60-baf7-a842889ecd4e" xlink:href="cah-20210630.xsd#cah_TotalOpioidLitigationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cah_OpioidLitigationDomain_71edd299-858a-4029-91e0-ec0406d63597" xlink:to="loc_cah_TotalOpioidLitigationMember_755fb1cd-9831-4d60-baf7-a842889ecd4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_TaxMatterAxis_85493557-3441-4454-b875-23488762a434" xlink:href="cah-20210630.xsd#cah_TaxMatterAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxCreditCarryforwardTable_b5b030a8-c344-440c-bee2-ba92ef8a76e9" xlink:to="loc_cah_TaxMatterAxis_85493557-3441-4454-b875-23488762a434" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_TaxMatterDomain_dc5164e3-762e-469f-93ef-190e728548e2" xlink:href="cah-20210630.xsd#cah_TaxMatterDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cah_TaxMatterAxis_85493557-3441-4454-b875-23488762a434" xlink:to="loc_cah_TaxMatterDomain_dc5164e3-762e-469f-93ef-190e728548e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_PatientRecoveryBusinessMember_6562f0c2-dc0f-4ae0-87e6-2b69a5b2dff0" xlink:href="cah-20210630.xsd#cah_PatientRecoveryBusinessMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cah_TaxMatterDomain_dc5164e3-762e-469f-93ef-190e728548e2" xlink:to="loc_cah_PatientRecoveryBusinessMember_6562f0c2-dc0f-4ae0-87e6-2b69a5b2dff0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_CareFusionMember_1a3aeab4-aa0e-4eb3-b503-ef68f8e58113" xlink:href="cah-20210630.xsd#cah_CareFusionMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cah_TaxMatterDomain_dc5164e3-762e-469f-93ef-190e728548e2" xlink:to="loc_cah_CareFusionMember_1a3aeab4-aa0e-4eb3-b503-ef68f8e58113" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_fd774e44-b7a1-4ca2-98e3-8a8df04b3238" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxCreditCarryforwardTable_b5b030a8-c344-440c-bee2-ba92ef8a76e9" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_fd774e44-b7a1-4ca2-98e3-8a8df04b3238" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_77fc70c7-c3eb-4a06-9b11-23a27d896b2f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_fd774e44-b7a1-4ca2-98e3-8a8df04b3238" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_77fc70c7-c3eb-4a06-9b11-23a27d896b2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_PatientRecoveryBusinessMember_7b39cf9f-ccac-45a8-a8fc-cdd3843d0cee" xlink:href="cah-20210630.xsd#cah_PatientRecoveryBusinessMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_77fc70c7-c3eb-4a06-9b11-23a27d896b2f" xlink:to="loc_cah_PatientRecoveryBusinessMember_7b39cf9f-ccac-45a8-a8fc-cdd3843d0cee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_9b4ce147-e47d-4bf9-b6eb-ba17fb7cc4c0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxCreditCarryforwardTable_b5b030a8-c344-440c-bee2-ba92ef8a76e9" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_9b4ce147-e47d-4bf9-b6eb-ba17fb7cc4c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_fe0abe78-e586-4c44-94bb-721d4b84dadc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_9b4ce147-e47d-4bf9-b6eb-ba17fb7cc4c0" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_fe0abe78-e586-4c44-94bb-721d4b84dadc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis_d7a5cc01-f575-4cd8-8672-40939da7cda3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxCreditCarryforwardTable_b5b030a8-c344-440c-bee2-ba92ef8a76e9" xlink:to="loc_us-gaap_IncomeTaxAuthorityAxis_d7a5cc01-f575-4cd8-8672-40939da7cda3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_59eac478-c58d-4734-8c54-bb000bf11359" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_d7a5cc01-f575-4cd8-8672-40939da7cda3" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_59eac478-c58d-4734-8c54-bb000bf11359" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InternalRevenueServiceIRSMember_fad71ef7-ae72-44cc-9c96-f680cf125a25" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InternalRevenueServiceIRSMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_59eac478-c58d-4734-8c54-bb000bf11359" xlink:to="loc_us-gaap_InternalRevenueServiceIRSMember_fad71ef7-ae72-44cc-9c96-f680cf125a25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StateAndLocalJurisdictionMember_96db8afc-3e73-4449-bfdd-5f84743c29f6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StateAndLocalJurisdictionMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_59eac478-c58d-4734-8c54-bb000bf11359" xlink:to="loc_us-gaap_StateAndLocalJurisdictionMember_96db8afc-3e73-4449-bfdd-5f84743c29f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCountryMember_1dd5cc04-7b34-4317-bbb9-1d5216370ad0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCountryMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_59eac478-c58d-4734-8c54-bb000bf11359" xlink:to="loc_us-gaap_ForeignCountryMember_1dd5cc04-7b34-4317-bbb9-1d5216370ad0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_bedb3931-a233-4de3-8033-b19ba825ddfb" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxCreditCarryforwardTable_b5b030a8-c344-440c-bee2-ba92ef8a76e9" xlink:to="loc_srt_RangeAxis_bedb3931-a233-4de3-8033-b19ba825ddfb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_8c5c5bc3-709c-4e85-948e-88686411744e" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_bedb3931-a233-4de3-8033-b19ba825ddfb" xlink:to="loc_srt_RangeMember_8c5c5bc3-709c-4e85-948e-88686411744e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_23a1af59-9dbe-4c0b-a331-43eace29c39c" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_8c5c5bc3-709c-4e85-948e-88686411744e" xlink:to="loc_srt_MinimumMember_23a1af59-9dbe-4c0b-a331-43eace29c39c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_d0070404-6172-4ea7-8034-cba438338a97" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_8c5c5bc3-709c-4e85-948e-88686411744e" xlink:to="loc_srt_MaximumMember_d0070404-6172-4ea7-8034-cba438338a97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_NetOperatingLossCarrybackAxis_3a6b6bb6-03c0-48d5-a4bf-b3455fab26c5" xlink:href="cah-20210630.xsd#cah_NetOperatingLossCarrybackAxis"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxCreditCarryforwardTable_b5b030a8-c344-440c-bee2-ba92ef8a76e9" xlink:to="loc_cah_NetOperatingLossCarrybackAxis_3a6b6bb6-03c0-48d5-a4bf-b3455fab26c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_NetOperatingLossCarrybackDomain_a84ee9a4-242c-4c78-82f5-064253a1b214" xlink:href="cah-20210630.xsd#cah_NetOperatingLossCarrybackDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cah_NetOperatingLossCarrybackAxis_3a6b6bb6-03c0-48d5-a4bf-b3455fab26c5" xlink:to="loc_cah_NetOperatingLossCarrybackDomain_a84ee9a4-242c-4c78-82f5-064253a1b214" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_NetOperatingLossCarrybackMember_da317081-43e6-4667-ae6e-919baa064b0f" xlink:href="cah-20210630.xsd#cah_NetOperatingLossCarrybackMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cah_NetOperatingLossCarrybackDomain_a84ee9a4-242c-4c78-82f5-064253a1b214" xlink:to="loc_cah_NetOperatingLossCarrybackMember_da317081-43e6-4667-ae6e-919baa064b0f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardLineItems_b1583ecf-7b8d-4cf6-a42c-bd404a99f808" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxCreditCarryforwardLineItems"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxCreditCarryforwardTable_b5b030a8-c344-440c-bee2-ba92ef8a76e9" xlink:to="loc_us-gaap_TaxCreditCarryforwardLineItems_b1583ecf-7b8d-4cf6-a42c-bd404a99f808" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_efe0ace6-991a-4712-902f-0bbf6d2d1106" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxCreditCarryforwardLineItems_b1583ecf-7b8d-4cf6-a42c-bd404a99f808" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_efe0ace6-991a-4712-902f-0bbf6d2d1106" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationReserve_5f63382a-3bdd-4581-9539-cdcd616e99c1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LitigationReserve"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxCreditCarryforwardLineItems_b1583ecf-7b8d-4cf6-a42c-bd404a99f808" xlink:to="loc_us-gaap_LitigationReserve_5f63382a-3bdd-4581-9539-cdcd616e99c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_4a14fb87-80ef-4b25-9c4d-2799adf94244" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxCreditCarryforwardLineItems_b1583ecf-7b8d-4cf6-a42c-bd404a99f808" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_4a14fb87-80ef-4b25-9c4d-2799adf94244" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_EffectiveTaxRateImpactFromCertainForeignJurisdictions_9c676819-bbd1-4c4e-a392-98d30c3606d7" xlink:href="cah-20210630.xsd#cah_EffectiveTaxRateImpactFromCertainForeignJurisdictions"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxCreditCarryforwardLineItems_b1583ecf-7b8d-4cf6-a42c-bd404a99f808" xlink:to="loc_cah_EffectiveTaxRateImpactFromCertainForeignJurisdictions_9c676819-bbd1-4c4e-a392-98d30c3606d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_cf3f6475-4fac-40fc-81be-6c5e1dbbecce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxCreditCarryforwardLineItems_b1583ecf-7b8d-4cf6-a42c-bd404a99f808" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_cf3f6475-4fac-40fc-81be-6c5e1dbbecce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_5b29675d-6186-4aad-9984-109cd264fd47" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxCreditCarryforwardLineItems_b1583ecf-7b8d-4cf6-a42c-bd404a99f808" xlink:to="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_5b29675d-6186-4aad-9984-109cd264fd47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardAmount_492e1783-88da-4d0e-8a1a-96c5a999ba36" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxCreditCarryforwardAmount"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxCreditCarryforwardLineItems_b1583ecf-7b8d-4cf6-a42c-bd404a99f808" xlink:to="loc_us-gaap_TaxCreditCarryforwardAmount_492e1783-88da-4d0e-8a1a-96c5a999ba36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_ab4d12bf-24ad-40b2-bbcb-cf305355f087" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwards"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxCreditCarryforwardLineItems_b1583ecf-7b8d-4cf6-a42c-bd404a99f808" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_ab4d12bf-24ad-40b2-bbcb-cf305355f087" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwardsValuationAllowance_fd2dcdba-c094-42e3-81b8-57e1a65b9f25" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLossCarryforwardsValuationAllowance"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxCreditCarryforwardLineItems_b1583ecf-7b8d-4cf6-a42c-bd404a99f808" xlink:to="loc_us-gaap_OperatingLossCarryforwardsValuationAllowance_fd2dcdba-c094-42e3-81b8-57e1a65b9f25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_f53d1077-c6eb-4bfd-a2fd-ca4933d0912b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxCreditCarryforwardLineItems_b1583ecf-7b8d-4cf6-a42c-bd404a99f808" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_f53d1077-c6eb-4bfd-a2fd-ca4933d0912b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_f1b6f759-9337-4905-ae79-7aab7c7a2dd0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxCreditCarryforwardLineItems_b1583ecf-7b8d-4cf6-a42c-bd404a99f808" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_f1b6f759-9337-4905-ae79-7aab7c7a2dd0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_f708c5d7-6f1e-43e2-b1db-b2d3598261cb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxCreditCarryforwardLineItems_b1583ecf-7b8d-4cf6-a42c-bd404a99f808" xlink:to="loc_us-gaap_UnrecognizedTaxBenefits_f708c5d7-6f1e-43e2-b1db-b2d3598261cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities_997cc9ce-75bd-46e5-bc3e-5b67a1844824" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxCreditCarryforwardLineItems_b1583ecf-7b8d-4cf6-a42c-bd404a99f808" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities_997cc9ce-75bd-46e5-bc3e-5b67a1844824" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_738939dc-1f63-41f0-88e5-12b02c40672a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxCreditCarryforwardLineItems_b1583ecf-7b8d-4cf6-a42c-bd404a99f808" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_738939dc-1f63-41f0-88e5-12b02c40672a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible_dde15bdf-4e87-4b16-984f-7978eedde537" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxCreditCarryforwardLineItems_b1583ecf-7b8d-4cf6-a42c-bd404a99f808" xlink:to="loc_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible_dde15bdf-4e87-4b16-984f-7978eedde537" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_2e29cb53-793f-4eac-88fd-6b0a73de2ea1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxCreditCarryforwardLineItems_b1583ecf-7b8d-4cf6-a42c-bd404a99f808" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_2e29cb53-793f-4eac-88fd-6b0a73de2ea1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense_d66e5aa1-d522-491a-8dec-c92ed879ebb5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxCreditCarryforwardLineItems_b1583ecf-7b8d-4cf6-a42c-bd404a99f808" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense_d66e5aa1-d522-491a-8dec-c92ed879ebb5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_IndemnificationReceivable_87622ce0-ce47-4c28-8dbe-5c5405c52027" xlink:href="cah-20210630.xsd#cah_IndemnificationReceivable"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxCreditCarryforwardLineItems_b1583ecf-7b8d-4cf6-a42c-bd404a99f808" xlink:to="loc_cah_IndemnificationReceivable_87622ce0-ce47-4c28-8dbe-5c5405c52027" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCutsAndJobsActOf2017TransitionTaxForAccumulatedForeignEarningsIncomeTaxExpense_f669a408-fbfe-46a7-9747-5fdf6b39b573" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxCutsAndJobsActOf2017TransitionTaxForAccumulatedForeignEarningsIncomeTaxExpense"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxCreditCarryforwardLineItems_b1583ecf-7b8d-4cf6-a42c-bd404a99f808" xlink:to="loc_us-gaap_TaxCutsAndJobsActOf2017TransitionTaxForAccumulatedForeignEarningsIncomeTaxExpense_f669a408-fbfe-46a7-9747-5fdf6b39b573" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReceivable_17c9829e-c1fd-4914-8b52-1295a5b904e0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReceivable"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxCreditCarryforwardLineItems_b1583ecf-7b8d-4cf6-a42c-bd404a99f808" xlink:to="loc_us-gaap_IncomeTaxReceivable_17c9829e-c1fd-4914-8b52-1295a5b904e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAndOtherLiabilitiesNoncurrent_21c5b8c7-8d25-40aa-be71-482c0718f3ac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAndOtherLiabilitiesNoncurrent"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxCreditCarryforwardLineItems_b1583ecf-7b8d-4cf6-a42c-bd404a99f808" xlink:to="loc_us-gaap_DeferredTaxAndOtherLiabilitiesNoncurrent_21c5b8c7-8d25-40aa-be71-482c0718f3ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationSettlementExpense_727d27a5-49fe-4ff0-aabf-710c0b1cf26b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LitigationSettlementExpense"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxCreditCarryforwardLineItems_b1583ecf-7b8d-4cf6-a42c-bd404a99f808" xlink:to="loc_us-gaap_LitigationSettlementExpense_727d27a5-49fe-4ff0-aabf-710c0b1cf26b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails" xlink:type="simple" xlink:href="cah-20210630.xsd#IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails"/>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_3e2d650f-3b1d-4414-88fd-c358b7e32791" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_8f76e8f8-20d6-4628-b77e-d617de7205cb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComponentsOfDeferredTaxAssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_3e2d650f-3b1d-4414-88fd-c358b7e32791" xlink:to="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_8f76e8f8-20d6-4628-b77e-d617de7205cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts_f8361ed1-f8e0-4c6b-b355-bff6b03d2c77" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_8f76e8f8-20d6-4628-b77e-d617de7205cb" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts_f8361ed1-f8e0-4c6b-b355-bff6b03d2c77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities_c4c0821d-eebc-4228-bfb7-6d957df8bd2e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_8f76e8f8-20d6-4628-b77e-d617de7205cb" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities_c4c0821d-eebc-4228-bfb7-6d957df8bd2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_e042f9e4-aa61-46b8-b844-e66a4479a34f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_8f76e8f8-20d6-4628-b77e-d617de7205cb" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_e042f9e4-aa61-46b8-b844-e66a4479a34f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_87f689bc-f8d6-4b49-9970-0906c9e8d9ed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwards"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_8f76e8f8-20d6-4628-b77e-d617de7205cb" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_87f689bc-f8d6-4b49-9970-0906c9e8d9ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_DeferredTaxAssetsRelatedtouncertaintaxpositions_e1b85c91-45af-4ca8-aae8-eacff396988f" xlink:href="cah-20210630.xsd#cah_DeferredTaxAssetsRelatedtouncertaintaxpositions"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_8f76e8f8-20d6-4628-b77e-d617de7205cb" xlink:to="loc_cah_DeferredTaxAssetsRelatedtouncertaintaxpositions_e1b85c91-45af-4ca8-aae8-eacff396988f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOther_22cc5b7c-f122-45ca-a5a1-ac9d6f8efce3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsOther"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_8f76e8f8-20d6-4628-b77e-d617de7205cb" xlink:to="loc_us-gaap_DeferredTaxAssetsOther_22cc5b7c-f122-45ca-a5a1-ac9d6f8efce3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross_d4511742-a6a1-40b8-b0bb-4f38ddcd5140" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_8f76e8f8-20d6-4628-b77e-d617de7205cb" xlink:to="loc_us-gaap_DeferredTaxAssetsGross_d4511742-a6a1-40b8-b0bb-4f38ddcd5140" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_562e15c2-1b0f-459c-a1de-c9131e10bea7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_8f76e8f8-20d6-4628-b77e-d617de7205cb" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_562e15c2-1b0f-459c-a1de-c9131e10bea7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_8ab512c0-3783-4e8a-80cf-679f2420bdfd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_8f76e8f8-20d6-4628-b77e-d617de7205cb" xlink:to="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_8ab512c0-3783-4e8a-80cf-679f2420bdfd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract_1314dc80-26ed-4061-9f7d-7d8c0e4d38ee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_3e2d650f-3b1d-4414-88fd-c358b7e32791" xlink:to="loc_us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract_1314dc80-26ed-4061-9f7d-7d8c0e4d38ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesDeferredExpenseCapitalizedInventoryCosts_90da0c06-4bd3-4ecb-bc75-61c772dbbf46" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilitiesDeferredExpenseCapitalizedInventoryCosts"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract_1314dc80-26ed-4061-9f7d-7d8c0e4d38ee" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesDeferredExpenseCapitalizedInventoryCosts_90da0c06-4bd3-4ecb-bc75-61c772dbbf46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_bdc10f96-f089-4f84-b946-ca22dd07e3bc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract_1314dc80-26ed-4061-9f7d-7d8c0e4d38ee" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_bdc10f96-f089-4f84-b946-ca22dd07e3bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets_0991eb29-0b35-489d-97c5-b6606546aa82" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract_1314dc80-26ed-4061-9f7d-7d8c0e4d38ee" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets_0991eb29-0b35-489d-97c5-b6606546aa82" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesDeferredExpenseReservesAndAccruals_2c27c285-4524-402f-952f-4b397ea9919f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilitiesDeferredExpenseReservesAndAccruals"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract_1314dc80-26ed-4061-9f7d-7d8c0e4d38ee" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesDeferredExpenseReservesAndAccruals_2c27c285-4524-402f-952f-4b397ea9919f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesOther_075027fb-bc04-4e31-b555-ca654721af15" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilitiesOther"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract_1314dc80-26ed-4061-9f7d-7d8c0e4d38ee" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesOther_075027fb-bc04-4e31-b555-ca654721af15" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities_f77fe1c7-2906-45b0-be44-e9b17f85794c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract_1314dc80-26ed-4061-9f7d-7d8c0e4d38ee" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilities_f77fe1c7-2906-45b0-be44-e9b17f85794c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilities_274eedbd-d068-40d3-9edc-10e9367f0423" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_3e2d650f-3b1d-4414-88fd-c358b7e32791" xlink:to="loc_us-gaap_DeferredTaxLiabilities_274eedbd-d068-40d3-9edc-10e9367f0423" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesAfterNettingbyTaxJurisdictionDetails" xlink:type="simple" xlink:href="cah-20210630.xsd#IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesAfterNettingbyTaxJurisdictionDetails"/>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesAfterNettingbyTaxJurisdictionDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_40a00979-171d-4a61-9e42-e1b8a756035a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxesAndOtherAssetsNoncurrent_eda386a1-547d-4b6b-83d8-eb07182b0f63" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxesAndOtherAssetsNoncurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_40a00979-171d-4a61-9e42-e1b8a756035a" xlink:to="loc_us-gaap_DeferredIncomeTaxesAndOtherAssetsNoncurrent_eda386a1-547d-4b6b-83d8-eb07182b0f63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxesAndOtherTaxLiabilitiesNoncurrent_74ce1b71-d829-4380-87cf-21734e66a4ce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxesAndOtherTaxLiabilitiesNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_40a00979-171d-4a61-9e42-e1b8a756035a" xlink:to="loc_us-gaap_DeferredIncomeTaxesAndOtherTaxLiabilitiesNoncurrent_74ce1b71-d829-4380-87cf-21734e66a4ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_DeferredIncomeTaxesAndOtherTaxLiabilitiesTransferredToHeldForSaleNoncurrent_86f3518f-581e-4266-b983-fbbb6df7118b" xlink:href="cah-20210630.xsd#cah_DeferredIncomeTaxesAndOtherTaxLiabilitiesTransferredToHeldForSaleNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_40a00979-171d-4a61-9e42-e1b8a756035a" xlink:to="loc_cah_DeferredIncomeTaxesAndOtherTaxLiabilitiesTransferredToHeldForSaleNoncurrent_86f3518f-581e-4266-b983-fbbb6df7118b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilities_d126b9c6-52b1-4cda-a1cf-032db06e8f8e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_40a00979-171d-4a61-9e42-e1b8a756035a" xlink:to="loc_us-gaap_DeferredTaxLiabilities_d126b9c6-52b1-4cda-a1cf-032db06e8f8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/IncomeTaxesScheduleofUnrecognizedTaxBenefitsRollForwardDetails" xlink:type="simple" xlink:href="cah-20210630.xsd#IncomeTaxesScheduleofUnrecognizedTaxBenefitsRollForwardDetails"/>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/IncomeTaxesScheduleofUnrecognizedTaxBenefitsRollForwardDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_fbf0f576-00a2-4133-a07a-683bb963fde7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxContingencyTable_ce0c52a1-b5ab-41db-9ff2-5a864e4f9c98" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxContingencyTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_fbf0f576-00a2-4133-a07a-683bb963fde7" xlink:to="loc_us-gaap_IncomeTaxContingencyTable_ce0c52a1-b5ab-41db-9ff2-5a864e4f9c98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_4dd6c8ad-114f-40fb-b319-b42850464d52" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_ce0c52a1-b5ab-41db-9ff2-5a864e4f9c98" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_4dd6c8ad-114f-40fb-b319-b42850464d52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_4bec96da-2c47-40b1-ad00-7aa9b42cbecf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_4dd6c8ad-114f-40fb-b319-b42850464d52" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_4bec96da-2c47-40b1-ad00-7aa9b42cbecf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_PatientRecoveryBusinessMember_f20a6cb5-cc57-49bc-a155-434f84ac5795" xlink:href="cah-20210630.xsd#cah_PatientRecoveryBusinessMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_4bec96da-2c47-40b1-ad00-7aa9b42cbecf" xlink:to="loc_cah_PatientRecoveryBusinessMember_f20a6cb5-cc57-49bc-a155-434f84ac5795" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameAxis_b25551af-84f5-4a7a-898f-e1d4600e6cba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityNameAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_ce0c52a1-b5ab-41db-9ff2-5a864e4f9c98" xlink:to="loc_us-gaap_IncomeTaxAuthorityNameAxis_b25551af-84f5-4a7a-898f-e1d4600e6cba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameDomain_3da8db90-6766-4f62-925a-99d86b7cb52b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameAxis_b25551af-84f5-4a7a-898f-e1d4600e6cba" xlink:to="loc_us-gaap_IncomeTaxAuthorityNameDomain_3da8db90-6766-4f62-925a-99d86b7cb52b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxPeriodAxis_2d10f6a0-af1d-4057-bf14-a07af83613b7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxPeriodAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_ce0c52a1-b5ab-41db-9ff2-5a864e4f9c98" xlink:to="loc_us-gaap_TaxPeriodAxis_2d10f6a0-af1d-4057-bf14-a07af83613b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxPeriodDomain_30bdc83d-b8c2-4d61-b329-b31bf3193030" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxPeriodDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxPeriodAxis_2d10f6a0-af1d-4057-bf14-a07af83613b7" xlink:to="loc_us-gaap_TaxPeriodDomain_30bdc83d-b8c2-4d61-b329-b31bf3193030" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxContingencyLineItems_02be7ca0-e1b4-46d8-86d9-71bf524a7217" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxContingencyLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_ce0c52a1-b5ab-41db-9ff2-5a864e4f9c98" xlink:to="loc_us-gaap_IncomeTaxContingencyLineItems_02be7ca0-e1b4-46d8-86d9-71bf524a7217" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentFederalTaxExpenseBenefit_87a80115-6210-474c-a63b-368a4d89a728" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentFederalTaxExpenseBenefit"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_02be7ca0-e1b4-46d8-86d9-71bf524a7217" xlink:to="loc_us-gaap_CurrentFederalTaxExpenseBenefit_87a80115-6210-474c-a63b-368a4d89a728" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_30fb23bc-47a7-42d0-9ff2-f305a4cf1855" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_02be7ca0-e1b4-46d8-86d9-71bf524a7217" xlink:to="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_30fb23bc-47a7-42d0-9ff2-f305a4cf1855" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentForeignTaxExpenseBenefit_f3d13069-bd49-48e4-947c-20188ec986b0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentForeignTaxExpenseBenefit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_02be7ca0-e1b4-46d8-86d9-71bf524a7217" xlink:to="loc_us-gaap_CurrentForeignTaxExpenseBenefit_f3d13069-bd49-48e4-947c-20188ec986b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_014c4f97-aa15-4871-bc5a-980c7112933b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_02be7ca0-e1b4-46d8-86d9-71bf524a7217" xlink:to="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_014c4f97-aa15-4871-bc5a-980c7112933b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_a0f4ae8b-6291-4f72-baf3-eb03881fecb7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_02be7ca0-e1b4-46d8-86d9-71bf524a7217" xlink:to="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_a0f4ae8b-6291-4f72-baf3-eb03881fecb7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_2703ca1f-4792-4a10-9119-fa91a8d5ceb8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_02be7ca0-e1b4-46d8-86d9-71bf524a7217" xlink:to="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_2703ca1f-4792-4a10-9119-fa91a8d5ceb8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_ba5f860a-f844-491d-af3b-c2073b1f5369" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredForeignIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_02be7ca0-e1b4-46d8-86d9-71bf524a7217" xlink:to="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_ba5f860a-f844-491d-af3b-c2073b1f5369" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_dd0e7d1a-dd80-425f-803d-3f91402afbab" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_02be7ca0-e1b4-46d8-86d9-71bf524a7217" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_dd0e7d1a-dd80-425f-803d-3f91402afbab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_e5303228-ad66-43a5-b631-5dd5c5e733f7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_02be7ca0-e1b4-46d8-86d9-71bf524a7217" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_e5303228-ad66-43a5-b631-5dd5c5e733f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_528c83f5-a735-41b5-817f-aef604a1f293" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_02be7ca0-e1b4-46d8-86d9-71bf524a7217" xlink:to="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_528c83f5-a735-41b5-817f-aef604a1f293" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_1fe69abd-b88f-407e-ae78-97bd3bff4a99" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_528c83f5-a735-41b5-817f-aef604a1f293" xlink:to="loc_us-gaap_UnrecognizedTaxBenefits_1fe69abd-b88f-407e-ae78-97bd3bff4a99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_f1fee133-9034-4885-9c7a-4f03453c0dbb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_528c83f5-a735-41b5-817f-aef604a1f293" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_f1fee133-9034-4885-9c7a-4f03453c0dbb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_e197b81e-c12b-49d3-a6f1-a75fb68fe2d9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_528c83f5-a735-41b5-817f-aef604a1f293" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_e197b81e-c12b-49d3-a6f1-a75fb68fe2d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions_1be48ee2-fa08-4685-9f2e-bba53be3466e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_528c83f5-a735-41b5-817f-aef604a1f293" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions_1be48ee2-fa08-4685-9f2e-bba53be3466e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities_4beb6cff-1ef3-4152-a2b2-e3fe6dfca66a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_528c83f5-a735-41b5-817f-aef604a1f293" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities_4beb6cff-1ef3-4152-a2b2-e3fe6dfca66a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_a06fb1f8-0800-4f6e-a01f-f4e27aae34dc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_528c83f5-a735-41b5-817f-aef604a1f293" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_a06fb1f8-0800-4f6e-a01f-f4e27aae34dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_4927f000-156b-4dcb-96b1-62f78e0428b7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_528c83f5-a735-41b5-817f-aef604a1f293" xlink:to="loc_us-gaap_UnrecognizedTaxBenefits_4927f000-156b-4dcb-96b1-62f78e0428b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/Guarantees" xlink:type="simple" xlink:href="cah-20210630.xsd#Guarantees"/>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/Guarantees" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.cardinal.com/role/FairValueMeasurements" xlink:type="simple" xlink:href="cah-20210630.xsd#FairValueMeasurements"/>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/FairValueMeasurements" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_512af25f-b04e-41e0-9763-7fe0ba59fe65" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementInputsDisclosureTextBlock_d0f24c9a-9c9e-44c5-b268-17792fcec869" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementInputsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_512af25f-b04e-41e0-9763-7fe0ba59fe65" xlink:to="loc_us-gaap_FairValueMeasurementInputsDisclosureTextBlock_d0f24c9a-9c9e-44c5-b268-17792fcec869" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock_4267ff71-23d9-4a79-9651-b15736e7f43f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_512af25f-b04e-41e0-9763-7fe0ba59fe65" xlink:to="loc_us-gaap_FairValueDisclosuresTextBlock_4267ff71-23d9-4a79-9651-b15736e7f43f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/FairValueMeasurementsTables" xlink:type="simple" xlink:href="cah-20210630.xsd#FairValueMeasurementsTables"/>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/FairValueMeasurementsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_03ccf7a5-f015-40ce-89ea-f158808e2857" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_9fa44133-a381-4a14-8c2d-ec58b14ddedc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_03ccf7a5-f015-40ce-89ea-f158808e2857" xlink:to="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_9fa44133-a381-4a14-8c2d-ec58b14ddedc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/FairValueMeasurementsFairValueofAssetsandLiabilitiesMeasuredonaRecurringBasisDetails" xlink:type="simple" xlink:href="cah-20210630.xsd#FairValueMeasurementsFairValueofAssetsandLiabilitiesMeasuredonaRecurringBasisDetails"/>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/FairValueMeasurementsFairValueofAssetsandLiabilitiesMeasuredonaRecurringBasisDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_fddf009c-55d1-478c-83bd-a4810d8ba748" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_d008e87f-8631-4b8b-bbf9-9bdd0d87bf48" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_fddf009c-55d1-478c-83bd-a4810d8ba748" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_d008e87f-8631-4b8b-bbf9-9bdd0d87bf48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_6b3731b9-d4fc-4230-b009-69500a30fc08" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_d008e87f-8631-4b8b-bbf9-9bdd0d87bf48" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_6b3731b9-d4fc-4230-b009-69500a30fc08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_2e77fd68-42c6-40ce-bb90-b89aee1a0b62" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_6b3731b9-d4fc-4230-b009-69500a30fc08" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_2e77fd68-42c6-40ce-bb90-b89aee1a0b62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_8057fb21-583a-4de9-998d-7d01d8999138" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_2e77fd68-42c6-40ce-bb90-b89aee1a0b62" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_8057fb21-583a-4de9-998d-7d01d8999138" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsNonrecurringMember_274b9002-f440-4025-97de-c2e2ef02b6f0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsNonrecurringMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_2e77fd68-42c6-40ce-bb90-b89aee1a0b62" xlink:to="loc_us-gaap_FairValueMeasurementsNonrecurringMember_274b9002-f440-4025-97de-c2e2ef02b6f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_31b3c2d9-1c7b-4ad2-a78a-1357e0d3eaf3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_d008e87f-8631-4b8b-bbf9-9bdd0d87bf48" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_31b3c2d9-1c7b-4ad2-a78a-1357e0d3eaf3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_2f6794fe-aa73-49eb-af1e-7c903b064714" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_31b3c2d9-1c7b-4ad2-a78a-1357e0d3eaf3" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_2f6794fe-aa73-49eb-af1e-7c903b064714" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_c57e8536-ea55-47ae-aaef-8b15fbb6bb1d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_2f6794fe-aa73-49eb-af1e-7c903b064714" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_c57e8536-ea55-47ae-aaef-8b15fbb6bb1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_7630f0d5-e7d4-42f1-a0ba-d729bdd01a5c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_2f6794fe-aa73-49eb-af1e-7c903b064714" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_7630f0d5-e7d4-42f1-a0ba-d729bdd01a5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_13bc6e2b-4011-4b3e-8bda-aca3c8ee8ecf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_2f6794fe-aa73-49eb-af1e-7c903b064714" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_13bc6e2b-4011-4b3e-8bda-aca3c8ee8ecf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_d847ef17-e8ca-4600-8734-2f495b42b55a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_d008e87f-8631-4b8b-bbf9-9bdd0d87bf48" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_d847ef17-e8ca-4600-8734-2f495b42b55a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosureAbstract_c5ad94ea-59c2-48a0-b711-8922e91f68f5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsFairValueDisclosureAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_d847ef17-e8ca-4600-8734-2f495b42b55a" xlink:to="loc_us-gaap_AssetsFairValueDisclosureAbstract_c5ad94ea-59c2-48a0-b711-8922e91f68f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_91228a03-a7ad-4250-afdf-3173b4a10d3d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_c5ad94ea-59c2-48a0-b711-8922e91f68f5" xlink:to="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_91228a03-a7ad-4250-afdf-3173b4a10d3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsFairValueDisclosure_3e784d17-fde1-4a32-915d-979aae025243" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsFairValueDisclosure"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_c5ad94ea-59c2-48a0-b711-8922e91f68f5" xlink:to="loc_us-gaap_InvestmentsFairValueDisclosure_3e784d17-fde1-4a32-915d-979aae025243" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_f2020a2a-ec4e-4066-accd-f07d9ae629f8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesFairValueDisclosureAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_d847ef17-e8ca-4600-8734-2f495b42b55a" xlink:to="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_f2020a2a-ec4e-4066-accd-f07d9ae629f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet_5f20a7a5-3fb5-466e-a51c-03f0b516f6db" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_f2020a2a-ec4e-4066-accd-f07d9ae629f8" xlink:to="loc_us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet_5f20a7a5-3fb5-466e-a51c-03f0b516f6db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_76366918-6ef1-4369-a9dd-7869119b174c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_d847ef17-e8ca-4600-8734-2f495b42b55a" xlink:to="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_76366918-6ef1-4369-a9dd-7869119b174c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_fae029c8-9545-4b3b-9267-63a4e7fa9fb2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_d847ef17-e8ca-4600-8734-2f495b42b55a" xlink:to="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_fae029c8-9545-4b3b-9267-63a4e7fa9fb2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/FairValueMeasurementsReconciliationofLiabilitiesMeasuredatFairValueonaRecurringBasisUsingUnobservableInputsLevel3Details" xlink:type="simple" xlink:href="cah-20210630.xsd#FairValueMeasurementsReconciliationofLiabilitiesMeasuredatFairValueonaRecurringBasisUsingUnobservableInputsLevel3Details"/>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/FairValueMeasurementsReconciliationofLiabilitiesMeasuredatFairValueonaRecurringBasisUsingUnobservableInputsLevel3Details" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_7f11a409-87c1-4b9a-906a-82ae49708283" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable_4b68c539-a8ba-4b48-955c-23ea90915ef1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_7f11a409-87c1-4b9a-906a-82ae49708283" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable_4b68c539-a8ba-4b48-955c-23ea90915ef1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_a45999a2-06c2-4174-92c9-176d64972d1c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable_4b68c539-a8ba-4b48-955c-23ea90915ef1" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_a45999a2-06c2-4174-92c9-176d64972d1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_00962f6a-147b-4502-bbc8-ecfc099f2024" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_a45999a2-06c2-4174-92c9-176d64972d1c" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_00962f6a-147b-4502-bbc8-ecfc099f2024" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_774bde54-af0b-4744-8f6b-722b6363b0d1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_00962f6a-147b-4502-bbc8-ecfc099f2024" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_774bde54-af0b-4744-8f6b-722b6363b0d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_93c96261-b5f4-4120-b0cc-113cd7dedfef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_00962f6a-147b-4502-bbc8-ecfc099f2024" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_93c96261-b5f4-4120-b0cc-113cd7dedfef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_da06165d-077c-4ae4-86db-1812482093c8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_00962f6a-147b-4502-bbc8-ecfc099f2024" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_da06165d-077c-4ae4-86db-1812482093c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_7708d09e-153c-450a-8fe3-b6888643779e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable_4b68c539-a8ba-4b48-955c-23ea90915ef1" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_7708d09e-153c-450a-8fe3-b6888643779e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_f971eee2-9088-4243-a0cf-15e7ceb88ed1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_7708d09e-153c-450a-8fe3-b6888643779e" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_f971eee2-9088-4243-a0cf-15e7ceb88ed1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_c752c739-fc1c-445f-83d3-07b3044971a3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_f971eee2-9088-4243-a0cf-15e7ceb88ed1" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_c752c739-fc1c-445f-83d3-07b3044971a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByLiabilityClassAxis_18345d2a-cd7d-47a2-b7f0-59ac8ce09ada" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByLiabilityClassAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable_4b68c539-a8ba-4b48-955c-23ea90915ef1" xlink:to="loc_us-gaap_FairValueByLiabilityClassAxis_18345d2a-cd7d-47a2-b7f0-59ac8ce09ada" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_8cfbad76-2211-4380-9c54-3657752d622e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis_18345d2a-cd7d-47a2-b7f0-59ac8ce09ada" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_8cfbad76-2211-4380-9c54-3657752d622e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_01b6500c-fd44-4270-b63d-40ea08d67639" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable_4b68c539-a8ba-4b48-955c-23ea90915ef1" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_01b6500c-fd44-4270-b63d-40ea08d67639" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet_ec0b8a71-c4f6-47c1-8dcb-4c0a129a9736" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_01b6500c-fd44-4270-b63d-40ea08d67639" xlink:to="loc_us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet_ec0b8a71-c4f6-47c1-8dcb-4c0a129a9736" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_3dc25161-1093-41c7-81fa-b945f36fee11" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_01b6500c-fd44-4270-b63d-40ea08d67639" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_3dc25161-1093-41c7-81fa-b945f36fee11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/FairValueMeasurementsDetails" xlink:type="simple" xlink:href="cah-20210630.xsd#FairValueMeasurementsDetails"/>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/FairValueMeasurementsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_6ff0e32a-04ad-4223-8142-072349b466bf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_eebe00ae-7ff0-46bc-8abb-835701300f67" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_6ff0e32a-04ad-4223-8142-072349b466bf" xlink:to="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_eebe00ae-7ff0-46bc-8abb-835701300f67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/FinancialInstruments" xlink:type="simple" xlink:href="cah-20210630.xsd#FinancialInstruments"/>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/FinancialInstruments" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_b1cf3921-76d5-49d2-b98f-4d6e13d3157f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentsDisclosureTextBlock_8aab4ced-f910-43be-9671-b92a1645efe2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancialInstrumentsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_b1cf3921-76d5-49d2-b98f-4d6e13d3157f" xlink:to="loc_us-gaap_FinancialInstrumentsDisclosureTextBlock_8aab4ced-f910-43be-9671-b92a1645efe2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/FinancialInstrumentsTables" xlink:type="simple" xlink:href="cah-20210630.xsd#FinancialInstrumentsTables"/>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/FinancialInstrumentsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_37f8618f-0962-4656-8ff5-f690d0c1de51" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock_7462cb55-d85e-440f-8f83-d090ca0cdd9f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_37f8618f-0962-4656-8ff5-f690d0c1de51" xlink:to="loc_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock_7462cb55-d85e-440f-8f83-d090ca0cdd9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_955c1dad-1919-4050-826b-22fecaf954a3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeTable"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_37f8618f-0962-4656-8ff5-f690d0c1de51" xlink:to="loc_us-gaap_DerivativeTable_955c1dad-1919-4050-826b-22fecaf954a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_f5c187b2-fff3-4591-951e-bbc20788a464" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_955c1dad-1919-4050-826b-22fecaf954a3" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_f5c187b2-fff3-4591-951e-bbc20788a464" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_19ad2354-15e6-488b-9538-952650c4fb3c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_f5c187b2-fff3-4591-951e-bbc20788a464" xlink:to="loc_us-gaap_HedgingRelationshipDomain_19ad2354-15e6-488b-9538-952650c4fb3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueHedgingMember_0af3b82d-b8da-45fc-9830-bdc2141a7dcf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueHedgingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_19ad2354-15e6-488b-9538-952650c4fb3c" xlink:to="loc_us-gaap_FairValueHedgingMember_0af3b82d-b8da-45fc-9830-bdc2141a7dcf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember_2014ef6a-12ef-4f32-b4e4-180a87555751" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_19ad2354-15e6-488b-9538-952650c4fb3c" xlink:to="loc_us-gaap_CashFlowHedgingMember_2014ef6a-12ef-4f32-b4e4-180a87555751" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_7e0bf192-7213-42a9-95ce-ce0f599177f0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_955c1dad-1919-4050-826b-22fecaf954a3" xlink:to="loc_us-gaap_HedgingDesignationAxis_7e0bf192-7213-42a9-95ce-ce0f599177f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_1e489ecc-5809-4ab1-bbd8-97c43e77beb6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationAxis_7e0bf192-7213-42a9-95ce-ce0f599177f0" xlink:to="loc_us-gaap_HedgingDesignationDomain_1e489ecc-5809-4ab1-bbd8-97c43e77beb6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember_6c28fb31-2b17-4a55-9ec9-b53bed72e02d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NondesignatedMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_1e489ecc-5809-4ab1-bbd8-97c43e77beb6" xlink:to="loc_us-gaap_NondesignatedMember_6c28fb31-2b17-4a55-9ec9-b53bed72e02d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_5d56f25f-287c-4528-bdc7-e274612de99a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_955c1dad-1919-4050-826b-22fecaf954a3" xlink:to="loc_us-gaap_DerivativeLineItems_5d56f25f-287c-4528-bdc7-e274612de99a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock_c1e42b4f-5de3-4ab9-9337-3e73b8366490" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDerivativeInstrumentsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_5d56f25f-287c-4528-bdc7-e274612de99a" xlink:to="loc_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock_c1e42b4f-5de3-4ab9-9337-3e73b8366490" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsEffectOnOtherComprehensiveIncomeLossTableTextBlock_404c8ca2-2897-4ec1-8063-03b7a4eafba9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDerivativeInstrumentsEffectOnOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_37f8618f-0962-4656-8ff5-f690d0c1de51" xlink:to="loc_us-gaap_ScheduleOfDerivativeInstrumentsEffectOnOtherComprehensiveIncomeLossTableTextBlock_404c8ca2-2897-4ec1-8063-03b7a4eafba9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock_6f7713ae-f221-4d10-970f-8878731408cd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_37f8618f-0962-4656-8ff5-f690d0c1de51" xlink:to="loc_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock_6f7713ae-f221-4d10-970f-8878731408cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock_995d2246-ce36-4d26-83d3-2f9abbcd2c0d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_37f8618f-0962-4656-8ff5-f690d0c1de51" xlink:to="loc_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock_995d2246-ce36-4d26-83d3-2f9abbcd2c0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock_1bd1646c-8510-407e-9308-0de1389672a1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_37f8618f-0962-4656-8ff5-f690d0c1de51" xlink:to="loc_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock_1bd1646c-8510-407e-9308-0de1389672a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock_4bfe603f-135d-4367-8e19-c3db3cf1dd08" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_37f8618f-0962-4656-8ff5-f690d0c1de51" xlink:to="loc_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock_4bfe603f-135d-4367-8e19-c3db3cf1dd08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_ScheduleOfFairValueGainLossDerivativeInstrumentTableTextBlock_51d5692d-485c-4eed-a919-1d27f9669ddd" xlink:href="cah-20210630.xsd#cah_ScheduleOfFairValueGainLossDerivativeInstrumentTableTextBlock"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_37f8618f-0962-4656-8ff5-f690d0c1de51" xlink:to="loc_cah_ScheduleOfFairValueGainLossDerivativeInstrumentTableTextBlock_51d5692d-485c-4eed-a919-1d27f9669ddd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/FinancialInstrumentsScheduleoftheFairValueofAssetsandLiabilitiesRelatedtoDerivativesDesignatedasHedgingInstrumentsDetails" xlink:type="simple" xlink:href="cah-20210630.xsd#FinancialInstrumentsScheduleoftheFairValueofAssetsandLiabilitiesRelatedtoDerivativesDesignatedasHedgingInstrumentsDetails"/>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/FinancialInstrumentsScheduleoftheFairValueofAssetsandLiabilitiesRelatedtoDerivativesDesignatedasHedgingInstrumentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_14ebb275-6446-49d9-b2d2-b15d7ee034a5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_9f1a6f67-0163-47a4-b92b-c2969ea8796c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_14ebb275-6446-49d9-b2d2-b15d7ee034a5" xlink:to="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_9f1a6f67-0163-47a4-b92b-c2969ea8796c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_a339663b-1861-4b39-af7d-3b1751095d28" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_9f1a6f67-0163-47a4-b92b-c2969ea8796c" xlink:to="loc_us-gaap_HedgingDesignationAxis_a339663b-1861-4b39-af7d-3b1751095d28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_ea8d3c9f-fff1-4076-84c6-e08301f6bb65" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationAxis_a339663b-1861-4b39-af7d-3b1751095d28" xlink:to="loc_us-gaap_HedgingDesignationDomain_ea8d3c9f-fff1-4076-84c6-e08301f6bb65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_5079e261-2317-4175-89e5-11621a0d9f12" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_ea8d3c9f-fff1-4076-84c6-e08301f6bb65" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_5079e261-2317-4175-89e5-11621a0d9f12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_73184009-f385-49a7-8656-090b25574a9f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_9f1a6f67-0163-47a4-b92b-c2969ea8796c" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_73184009-f385-49a7-8656-090b25574a9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_a872fc17-9179-4405-94af-7b585d608d92" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_73184009-f385-49a7-8656-090b25574a9f" xlink:to="loc_us-gaap_HedgingRelationshipDomain_a872fc17-9179-4405-94af-7b585d608d92" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember_d83e3fba-27db-4439-9548-8d95c9fb904a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_a872fc17-9179-4405-94af-7b585d608d92" xlink:to="loc_us-gaap_CashFlowHedgingMember_d83e3fba-27db-4439-9548-8d95c9fb904a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueHedgingMember_0a9084b9-6f20-453e-8d4c-d7eb1e4da1b0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueHedgingMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_a872fc17-9179-4405-94af-7b585d608d92" xlink:to="loc_us-gaap_FairValueHedgingMember_0a9084b9-6f20-453e-8d4c-d7eb1e4da1b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_e42fd855-1917-4039-a758-6abca00749ab" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_9f1a6f67-0163-47a4-b92b-c2969ea8796c" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_e42fd855-1917-4039-a758-6abca00749ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_1a9b541d-56b1-45f8-8f5e-ea51522fb153" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_e42fd855-1917-4039-a758-6abca00749ab" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_1a9b541d-56b1-45f8-8f5e-ea51522fb153" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_73554753-e8ef-4017-b29e-8d9b94b9284b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_1a9b541d-56b1-45f8-8f5e-ea51522fb153" xlink:to="loc_us-gaap_ForeignExchangeContractMember_73554753-e8ef-4017-b29e-8d9b94b9284b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_eccffb22-1f9d-4cd9-ab72-42971ac4d278" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_1a9b541d-56b1-45f8-8f5e-ea51522fb153" xlink:to="loc_us-gaap_InterestRateSwapMember_eccffb22-1f9d-4cd9-ab72-42971ac4d278" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CrossCurrencyInterestRateContractMember_6c935a04-4340-4573-824a-4b005d874639" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CrossCurrencyInterestRateContractMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_1a9b541d-56b1-45f8-8f5e-ea51522fb153" xlink:to="loc_us-gaap_CrossCurrencyInterestRateContractMember_6c935a04-4340-4573-824a-4b005d874639" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommodityContractMember_340580c8-d1bb-41e6-a3cc-1029b9636e8c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommodityContractMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_1a9b541d-56b1-45f8-8f5e-ea51522fb153" xlink:to="loc_us-gaap_CommodityContractMember_340580c8-d1bb-41e6-a3cc-1029b9636e8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_0006d5ef-4ff3-4144-929b-598e98b11688" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_9f1a6f67-0163-47a4-b92b-c2969ea8796c" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_0006d5ef-4ff3-4144-929b-598e98b11688" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_b0ae157a-0429-41d9-bdfa-c4eefa82fd29" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_0006d5ef-4ff3-4144-929b-598e98b11688" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_b0ae157a-0429-41d9-bdfa-c4eefa82fd29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsMember_8ecec568-7c45-44ca-8e80-7b4cd2278c5b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_b0ae157a-0429-41d9-bdfa-c4eefa82fd29" xlink:to="loc_us-gaap_OtherAssetsMember_8ecec568-7c45-44ca-8e80-7b4cd2278c5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_302ae657-a36f-4bef-bef5-04a0d91260da" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_b0ae157a-0429-41d9-bdfa-c4eefa82fd29" xlink:to="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_302ae657-a36f-4bef-bef5-04a0d91260da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesMember_ca1efbae-d821-43f3-9770-0350c115615e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_b0ae157a-0429-41d9-bdfa-c4eefa82fd29" xlink:to="loc_us-gaap_AccruedLiabilitiesMember_ca1efbae-d821-43f3-9770-0350c115615e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_DeferredIncomeTaxesandOtherLiabilitiesMember_ed619703-a3ba-4ac3-9a46-64980559c7a2" xlink:href="cah-20210630.xsd#cah_DeferredIncomeTaxesandOtherLiabilitiesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_b0ae157a-0429-41d9-bdfa-c4eefa82fd29" xlink:to="loc_cah_DeferredIncomeTaxesandOtherLiabilitiesMember_ed619703-a3ba-4ac3-9a46-64980559c7a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesFairValueLineItems_aea0826b-9e59-40eb-b1df-073e18551a74" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativesFairValueLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_9f1a6f67-0163-47a4-b92b-c2969ea8796c" xlink:to="loc_us-gaap_DerivativesFairValueLineItems_aea0826b-9e59-40eb-b1df-073e18551a74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_ae220fd7-af47-41ef-ad03-afb5390b3956" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeAsset"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_aea0826b-9e59-40eb-b1df-073e18551a74" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_ae220fd7-af47-41ef-ad03-afb5390b3956" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_4eee14fa-419a-4ae3-8d06-7ce6acdd2ec7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeLiability"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_aea0826b-9e59-40eb-b1df-073e18551a74" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_4eee14fa-419a-4ae3-8d06-7ce6acdd2ec7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/FinancialInstrumentsNarrativeDetails" xlink:type="simple" xlink:href="cah-20210630.xsd#FinancialInstrumentsNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/FinancialInstrumentsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_d9cf2895-e2a2-43a6-b461-8e1dd07aa77e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_d7a61cdb-2d25-42db-9fb3-ca3291405482" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_d9cf2895-e2a2-43a6-b461-8e1dd07aa77e" xlink:to="loc_us-gaap_DerivativeTable_d7a61cdb-2d25-42db-9fb3-ca3291405482" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_1d81af91-ad48-47cb-9570-6e01d76c0508" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_d7a61cdb-2d25-42db-9fb3-ca3291405482" xlink:to="loc_us-gaap_HedgingDesignationAxis_1d81af91-ad48-47cb-9570-6e01d76c0508" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_9ba0621b-a12a-47d8-8ffa-8189d5ab49ee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationAxis_1d81af91-ad48-47cb-9570-6e01d76c0508" xlink:to="loc_us-gaap_HedgingDesignationDomain_9ba0621b-a12a-47d8-8ffa-8189d5ab49ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_9e4b2528-5fda-4124-bbb3-55e2c278c3ca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_9ba0621b-a12a-47d8-8ffa-8189d5ab49ee" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_9e4b2528-5fda-4124-bbb3-55e2c278c3ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_a9306abc-60c1-4b1d-8bd8-5264c7fea278" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_d7a61cdb-2d25-42db-9fb3-ca3291405482" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_a9306abc-60c1-4b1d-8bd8-5264c7fea278" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_b52a140b-cdd1-4d41-bc6c-594e858db462" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_a9306abc-60c1-4b1d-8bd8-5264c7fea278" xlink:to="loc_us-gaap_HedgingRelationshipDomain_b52a140b-cdd1-4d41-bc6c-594e858db462" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueHedgingMember_c4048fbd-6eb7-46da-99c7-05af4eab7878" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueHedgingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_b52a140b-cdd1-4d41-bc6c-594e858db462" xlink:to="loc_us-gaap_FairValueHedgingMember_c4048fbd-6eb7-46da-99c7-05af4eab7878" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember_45d4fdb4-f0d3-443b-977c-6895a80a0db0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_b52a140b-cdd1-4d41-bc6c-594e858db462" xlink:to="loc_us-gaap_CashFlowHedgingMember_45d4fdb4-f0d3-443b-977c-6895a80a0db0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_9d94c1ce-bf42-41f0-8aa9-25e13be35668" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_d7a61cdb-2d25-42db-9fb3-ca3291405482" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_9d94c1ce-bf42-41f0-8aa9-25e13be35668" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_7ed05ee2-b825-4217-9285-ef7b4408924c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_9d94c1ce-bf42-41f0-8aa9-25e13be35668" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_7ed05ee2-b825-4217-9285-ef7b4408924c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_d11e9bc7-24bd-4257-b9e1-40f9735ae824" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_7ed05ee2-b825-4217-9285-ef7b4408924c" xlink:to="loc_us-gaap_InterestRateSwapMember_d11e9bc7-24bd-4257-b9e1-40f9735ae824" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrencySwapMember_bde95337-61a6-4a2e-acc4-f177193ae7e6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrencySwapMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_7ed05ee2-b825-4217-9285-ef7b4408924c" xlink:to="loc_us-gaap_CurrencySwapMember_bde95337-61a6-4a2e-acc4-f177193ae7e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_958d18fe-f10e-47a8-85dd-b8a0355260f8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_7ed05ee2-b825-4217-9285-ef7b4408924c" xlink:to="loc_us-gaap_ForeignExchangeContractMember_958d18fe-f10e-47a8-85dd-b8a0355260f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember_f3d011b1-6622-4827-bfd9-ad4a109e944e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_7ed05ee2-b825-4217-9285-ef7b4408924c" xlink:to="loc_us-gaap_CashFlowHedgingMember_f3d011b1-6622-4827-bfd9-ad4a109e944e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_258f136d-a4a4-42b7-a307-5d42b355867b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_d7a61cdb-2d25-42db-9fb3-ca3291405482" xlink:to="loc_us-gaap_DebtInstrumentAxis_258f136d-a4a4-42b7-a307-5d42b355867b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_95b059cb-54c6-482a-a375-63649ee05b56" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_258f136d-a4a4-42b7-a307-5d42b355867b" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_95b059cb-54c6-482a-a375-63649ee05b56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_bde7356e-3f7b-470a-957a-d2fffe49fbe9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_d7a61cdb-2d25-42db-9fb3-ca3291405482" xlink:to="loc_us-gaap_DerivativeLineItems_bde7356e-3f7b-470a-957a-d2fffe49fbe9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1_d1efebac-d240-46fb-81a9-70a6c0d3c1a9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_bde7356e-3f7b-470a-957a-d2fffe49fbe9" xlink:to="loc_us-gaap_ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1_d1efebac-d240-46fb-81a9-70a6c0d3c1a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilityNotionalAmount_e5f930fe-e630-4c9d-a485-a6081b2438ae" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLiabilityNotionalAmount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_bde7356e-3f7b-470a-957a-d2fffe49fbe9" xlink:to="loc_us-gaap_DerivativeLiabilityNotionalAmount_e5f930fe-e630-4c9d-a485-a6081b2438ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax_c9c77029-9b1b-4f1a-8c8b-f86b4c62559d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_bde7356e-3f7b-470a-957a-d2fffe49fbe9" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax_c9c77029-9b1b-4f1a-8c8b-f86b4c62559d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeExpenseNonoperatingNet_efb87c09-be11-49b2-a52f-b92908d0c77a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestIncomeExpenseNonoperatingNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_bde7356e-3f7b-470a-957a-d2fffe49fbe9" xlink:to="loc_us-gaap_InterestIncomeExpenseNonoperatingNet_efb87c09-be11-49b2-a52f-b92908d0c77a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetNotionalAmount_80ff20d4-393c-436f-9cf4-8aa3d7e22825" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeAssetNotionalAmount"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_bde7356e-3f7b-470a-957a-d2fffe49fbe9" xlink:to="loc_us-gaap_DerivativeAssetNotionalAmount_80ff20d4-393c-436f-9cf4-8aa3d7e22825" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_DerivativesHedgeDiscontinuancesHedgingInstrumentMaturedAmount_139775b2-7fa0-45d6-b0a7-54190fcf8d9b" xlink:href="cah-20210630.xsd#cah_DerivativesHedgeDiscontinuancesHedgingInstrumentMaturedAmount"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_bde7356e-3f7b-470a-957a-d2fffe49fbe9" xlink:to="loc_cah_DerivativesHedgeDiscontinuancesHedgingInstrumentMaturedAmount_139775b2-7fa0-45d6-b0a7-54190fcf8d9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_VestingPeriodinyearsforShares_72e2d4e1-2654-455c-8434-c67c76130aa3" xlink:href="cah-20210630.xsd#cah_VestingPeriodinyearsforShares"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_bde7356e-3f7b-470a-957a-d2fffe49fbe9" xlink:to="loc_cah_VestingPeriodinyearsforShares_72e2d4e1-2654-455c-8434-c67c76130aa3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_DerivatesHedgeDiscontinuancesHedgingInstrumentTerminatedAmount_af74e253-8419-4e5b-a2de-1f7c3017d0d5" xlink:href="cah-20210630.xsd#cah_DerivatesHedgeDiscontinuancesHedgingInstrumentTerminatedAmount"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_bde7356e-3f7b-470a-957a-d2fffe49fbe9" xlink:to="loc_cah_DerivatesHedgeDiscontinuancesHedgingInstrumentTerminatedAmount_af74e253-8419-4e5b-a2de-1f7c3017d0d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredGainLossOnDiscontinuationOfInterestRateFairValueHedge_05e36141-57ce-4284-8527-d1863b11c24a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredGainLossOnDiscontinuationOfInterestRateFairValueHedge"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_bde7356e-3f7b-470a-957a-d2fffe49fbe9" xlink:to="loc_us-gaap_DeferredGainLossOnDiscontinuationOfInterestRateFairValueHedge_05e36141-57ce-4284-8527-d1863b11c24a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_DerivativesHedgeDiscontinuancesTerminationofHedgingInstrumentAmount_0cc0a3e6-27b0-4c61-9f0c-c11ea77a2830" xlink:href="cah-20210630.xsd#cah_DerivativesHedgeDiscontinuancesTerminationofHedgingInstrumentAmount"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_bde7356e-3f7b-470a-957a-d2fffe49fbe9" xlink:to="loc_cah_DerivativesHedgeDiscontinuancesTerminationofHedgingInstrumentAmount_0cc0a3e6-27b0-4c61-9f0c-c11ea77a2830" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/FinancialInstrumentsScheduleofOutstandingInstrumentsFairValueHedgesDetails" xlink:type="simple" xlink:href="cah-20210630.xsd#FinancialInstrumentsScheduleofOutstandingInstrumentsFairValueHedgesDetails"/>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/FinancialInstrumentsScheduleofOutstandingInstrumentsFairValueHedgesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_98dbec92-d08e-49b4-b614-73abb0d9df7d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_b0ce9383-e73e-48bb-ad1b-6fc09e1ae82f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_98dbec92-d08e-49b4-b614-73abb0d9df7d" xlink:to="loc_us-gaap_DerivativeTable_b0ce9383-e73e-48bb-ad1b-6fc09e1ae82f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_b6523ce7-ce41-42c7-bfea-149ef37256ce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_b0ce9383-e73e-48bb-ad1b-6fc09e1ae82f" xlink:to="loc_us-gaap_HedgingDesignationAxis_b6523ce7-ce41-42c7-bfea-149ef37256ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_a70eeea1-aad7-477e-a5db-13207c90e04b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationAxis_b6523ce7-ce41-42c7-bfea-149ef37256ce" xlink:to="loc_us-gaap_HedgingDesignationDomain_a70eeea1-aad7-477e-a5db-13207c90e04b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_2a3d8c74-0fe3-4f5d-8fcc-d281e25c6508" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_a70eeea1-aad7-477e-a5db-13207c90e04b" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_2a3d8c74-0fe3-4f5d-8fcc-d281e25c6508" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_8cfb0954-21a3-4ddd-ad1a-8d954235b6a5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_b0ce9383-e73e-48bb-ad1b-6fc09e1ae82f" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_8cfb0954-21a3-4ddd-ad1a-8d954235b6a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_1ffa5b31-7558-4d1f-94b3-02d0c88182af" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_8cfb0954-21a3-4ddd-ad1a-8d954235b6a5" xlink:to="loc_us-gaap_HedgingRelationshipDomain_1ffa5b31-7558-4d1f-94b3-02d0c88182af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueHedgingMember_9c221c23-122d-4233-8b7a-9838e3a7b2db" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueHedgingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_1ffa5b31-7558-4d1f-94b3-02d0c88182af" xlink:to="loc_us-gaap_FairValueHedgingMember_9c221c23-122d-4233-8b7a-9838e3a7b2db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_705322ec-3cca-4771-9896-842716619084" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_b0ce9383-e73e-48bb-ad1b-6fc09e1ae82f" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_705322ec-3cca-4771-9896-842716619084" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_cedbec70-c702-47bf-b4f7-43df9c661910" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_705322ec-3cca-4771-9896-842716619084" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_cedbec70-c702-47bf-b4f7-43df9c661910" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_1a92514a-4eec-486f-ad46-65eccc142b24" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_cedbec70-c702-47bf-b4f7-43df9c661910" xlink:to="loc_us-gaap_InterestRateSwapMember_1a92514a-4eec-486f-ad46-65eccc142b24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_0b8d6a04-a1e9-4800-84a3-65763f9e6751" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_b0ce9383-e73e-48bb-ad1b-6fc09e1ae82f" xlink:to="loc_srt_RangeAxis_0b8d6a04-a1e9-4800-84a3-65763f9e6751" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_84a08491-27ed-481b-945f-5267dc252639" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_0b8d6a04-a1e9-4800-84a3-65763f9e6751" xlink:to="loc_srt_RangeMember_84a08491-27ed-481b-945f-5267dc252639" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_d217dca5-f909-445c-894d-0c00717a3bf6" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_84a08491-27ed-481b-945f-5267dc252639" xlink:to="loc_srt_MinimumMember_d217dca5-f909-445c-894d-0c00717a3bf6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_dd0c353e-9906-4e6d-bc12-2d2075eac4dd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_b0ce9383-e73e-48bb-ad1b-6fc09e1ae82f" xlink:to="loc_us-gaap_DerivativeLineItems_dd0c353e-9906-4e6d-bc12-2d2075eac4dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredGainLossOnDiscontinuationOfInterestRateFairValueHedge_0bf80ad9-5d63-4b4b-afe6-522f429c85b8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredGainLossOnDiscontinuationOfInterestRateFairValueHedge"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_dd0c353e-9906-4e6d-bc12-2d2075eac4dd" xlink:to="loc_us-gaap_DeferredGainLossOnDiscontinuationOfInterestRateFairValueHedge_0bf80ad9-5d63-4b4b-afe6-522f429c85b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_DerivativesHedgeDiscontinuancesHedgingInstrumentMaturedAmount_6f4ddfe3-5882-499b-81ad-aa63da4830a1" xlink:href="cah-20210630.xsd#cah_DerivativesHedgeDiscontinuancesHedgingInstrumentMaturedAmount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_dd0c353e-9906-4e6d-bc12-2d2075eac4dd" xlink:to="loc_cah_DerivativesHedgeDiscontinuancesHedgingInstrumentMaturedAmount_6f4ddfe3-5882-499b-81ad-aa63da4830a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetNotionalAmount_9013bb1c-5be3-4079-b7ef-214c31bfb1a6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeAssetNotionalAmount"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_dd0c353e-9906-4e6d-bc12-2d2075eac4dd" xlink:to="loc_us-gaap_DerivativeAssetNotionalAmount_9013bb1c-5be3-4079-b7ef-214c31bfb1a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/FinancialInstrumentsScheduleofGainLossRecognizedinEarningsforInterestRateContractsDesignatedasFairValueHedgesDetails" xlink:type="simple" xlink:href="cah-20210630.xsd#FinancialInstrumentsScheduleofGainLossRecognizedinEarningsforInterestRateContractsDesignatedasFairValueHedgesDetails"/>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/FinancialInstrumentsScheduleofGainLossRecognizedinEarningsforInterestRateContractsDesignatedasFairValueHedgesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_7ad33883-861e-4db5-8106-14eb821afd51" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_25dbc9d6-a711-4443-acff-3a935734c13e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_7ad33883-861e-4db5-8106-14eb821afd51" xlink:to="loc_us-gaap_DerivativeTable_25dbc9d6-a711-4443-acff-3a935734c13e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_61d45059-02b5-417e-b9bb-61ee048ecd20" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_25dbc9d6-a711-4443-acff-3a935734c13e" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_61d45059-02b5-417e-b9bb-61ee048ecd20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_b2dfee4e-839b-4470-831a-eb6c8f1d5322" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_61d45059-02b5-417e-b9bb-61ee048ecd20" xlink:to="loc_us-gaap_HedgingRelationshipDomain_b2dfee4e-839b-4470-831a-eb6c8f1d5322" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueHedgingMember_1e888a67-d5cf-4030-ae0e-fc7eae28c9ad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueHedgingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_b2dfee4e-839b-4470-831a-eb6c8f1d5322" xlink:to="loc_us-gaap_FairValueHedgingMember_1e888a67-d5cf-4030-ae0e-fc7eae28c9ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_8df11d74-7cb3-4af1-a873-41957b49490e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_25dbc9d6-a711-4443-acff-3a935734c13e" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_8df11d74-7cb3-4af1-a873-41957b49490e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_2cf2428b-2f8e-4e9f-b059-c08bf638d891" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_8df11d74-7cb3-4af1-a873-41957b49490e" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_2cf2428b-2f8e-4e9f-b059-c08bf638d891" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_44982702-fb13-4842-99ba-a5fdc7220115" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_2cf2428b-2f8e-4e9f-b059-c08bf638d891" xlink:to="loc_us-gaap_InterestRateSwapMember_44982702-fb13-4842-99ba-a5fdc7220115" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_FixedRateDebtMember_c4b83c6f-3d66-423f-9e77-b76031566028" xlink:href="cah-20210630.xsd#cah_FixedRateDebtMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_2cf2428b-2f8e-4e9f-b059-c08bf638d891" xlink:to="loc_cah_FixedRateDebtMember_c4b83c6f-3d66-423f-9e77-b76031566028" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_239d877d-0ef9-4141-99c3-e77732bda919" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_25dbc9d6-a711-4443-acff-3a935734c13e" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_239d877d-0ef9-4141-99c3-e77732bda919" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_882ede23-f715-48e4-8f93-9a37574d7bba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_239d877d-0ef9-4141-99c3-e77732bda919" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_882ede23-f715-48e4-8f93-9a37574d7bba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseMember_99fe1439-b29c-490f-9d8e-b12a92659bcf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpenseMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_882ede23-f715-48e4-8f93-9a37574d7bba" xlink:to="loc_us-gaap_InterestExpenseMember_99fe1439-b29c-490f-9d8e-b12a92659bcf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_042d22ad-99e3-43d2-9de6-53b8259389fd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_25dbc9d6-a711-4443-acff-3a935734c13e" xlink:to="loc_us-gaap_DerivativeLineItems_042d22ad-99e3-43d2-9de6-53b8259389fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeGainLossOnDerivativeNet_c151dcd7-d093-405d-b9f7-12010a1dc13b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeGainLossOnDerivativeNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_042d22ad-99e3-43d2-9de6-53b8259389fd" xlink:to="loc_us-gaap_DerivativeGainLossOnDerivativeNet_c151dcd7-d093-405d-b9f7-12010a1dc13b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/FinancialInstrumentsScheduleofOutstandingInstrumentsCashFlowHedgesDetails" xlink:type="simple" xlink:href="cah-20210630.xsd#FinancialInstrumentsScheduleofOutstandingInstrumentsCashFlowHedgesDetails"/>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/FinancialInstrumentsScheduleofOutstandingInstrumentsCashFlowHedgesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_2049432e-94f2-4dcc-a86a-2b9dd4f5253a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_ca390fde-4558-4a05-b781-c681e3cf3dc1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_2049432e-94f2-4dcc-a86a-2b9dd4f5253a" xlink:to="loc_us-gaap_DerivativeTable_ca390fde-4558-4a05-b781-c681e3cf3dc1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_279f1cbb-8f22-4d90-b53a-56d0a8ee165a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_ca390fde-4558-4a05-b781-c681e3cf3dc1" xlink:to="loc_us-gaap_HedgingDesignationAxis_279f1cbb-8f22-4d90-b53a-56d0a8ee165a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_586aa4a1-5c29-4bbf-9ea9-a1ed0005c1d9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationAxis_279f1cbb-8f22-4d90-b53a-56d0a8ee165a" xlink:to="loc_us-gaap_HedgingDesignationDomain_586aa4a1-5c29-4bbf-9ea9-a1ed0005c1d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_b4cc2e50-ed01-4786-85c3-c8f557b4adba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_586aa4a1-5c29-4bbf-9ea9-a1ed0005c1d9" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_b4cc2e50-ed01-4786-85c3-c8f557b4adba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_f410f18b-104a-460b-87c0-ab5288f190ab" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_ca390fde-4558-4a05-b781-c681e3cf3dc1" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_f410f18b-104a-460b-87c0-ab5288f190ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_9fe60bc1-11d7-47fe-92ac-5076af7e2264" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_f410f18b-104a-460b-87c0-ab5288f190ab" xlink:to="loc_us-gaap_HedgingRelationshipDomain_9fe60bc1-11d7-47fe-92ac-5076af7e2264" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueHedgingMember_bc11fc7c-2b39-41e4-b554-761820b58d6c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueHedgingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_9fe60bc1-11d7-47fe-92ac-5076af7e2264" xlink:to="loc_us-gaap_FairValueHedgingMember_bc11fc7c-2b39-41e4-b554-761820b58d6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember_7812b10c-5c7c-40e6-aff9-dcc7814982d9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_9fe60bc1-11d7-47fe-92ac-5076af7e2264" xlink:to="loc_us-gaap_CashFlowHedgingMember_7812b10c-5c7c-40e6-aff9-dcc7814982d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_96c3c6b4-781c-4d66-8771-d602bfaf35af" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_ca390fde-4558-4a05-b781-c681e3cf3dc1" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_96c3c6b4-781c-4d66-8771-d602bfaf35af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_57305aac-5985-479a-9c12-43f6cd16f4d2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_96c3c6b4-781c-4d66-8771-d602bfaf35af" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_57305aac-5985-479a-9c12-43f6cd16f4d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_c105d9ce-4ebc-43bd-aa25-107b66d19a34" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_57305aac-5985-479a-9c12-43f6cd16f4d2" xlink:to="loc_us-gaap_InterestRateSwapMember_c105d9ce-4ebc-43bd-aa25-107b66d19a34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_d7891921-9def-489e-9cea-d821176ef9d1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_57305aac-5985-479a-9c12-43f6cd16f4d2" xlink:to="loc_us-gaap_ForeignExchangeContractMember_d7891921-9def-489e-9cea-d821176ef9d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommodityContractMember_feeb98fb-595e-4807-819c-ca85797fab08" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommodityContractMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_57305aac-5985-479a-9c12-43f6cd16f4d2" xlink:to="loc_us-gaap_CommodityContractMember_feeb98fb-595e-4807-819c-ca85797fab08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember_a3fd77c8-8c3a-4d7b-8bc4-824d3f8506b5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_57305aac-5985-479a-9c12-43f6cd16f4d2" xlink:to="loc_us-gaap_CashFlowHedgingMember_a3fd77c8-8c3a-4d7b-8bc4-824d3f8506b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForwardContractsMember_b0696da0-0108-4bcc-ba4a-d5e439db0f8b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForwardContractsMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_57305aac-5985-479a-9c12-43f6cd16f4d2" xlink:to="loc_us-gaap_ForwardContractsMember_b0696da0-0108-4bcc-ba4a-d5e439db0f8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_55510999-5020-45a2-91de-f48a474c18a0" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_ca390fde-4558-4a05-b781-c681e3cf3dc1" xlink:to="loc_srt_RangeAxis_55510999-5020-45a2-91de-f48a474c18a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_b1489dc4-cf15-45f4-bc88-2c83aa0a6c57" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_55510999-5020-45a2-91de-f48a474c18a0" xlink:to="loc_srt_RangeMember_b1489dc4-cf15-45f4-bc88-2c83aa0a6c57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_c04fd123-5b7c-4067-b03f-8e5581067428" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_b1489dc4-cf15-45f4-bc88-2c83aa0a6c57" xlink:to="loc_srt_MinimumMember_c04fd123-5b7c-4067-b03f-8e5581067428" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_aabf9d26-a46e-4bfb-95ee-0eeafec13ce4" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_b1489dc4-cf15-45f4-bc88-2c83aa0a6c57" xlink:to="loc_srt_MaximumMember_aabf9d26-a46e-4bfb-95ee-0eeafec13ce4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_3221f6ca-adfa-4ce7-98bb-bb78481eb1dd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_ca390fde-4558-4a05-b781-c681e3cf3dc1" xlink:to="loc_us-gaap_DerivativeLineItems_3221f6ca-adfa-4ce7-98bb-bb78481eb1dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilityNotionalAmount_f006286e-d16f-4c47-bb2f-4119d17c5ab2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLiabilityNotionalAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_3221f6ca-adfa-4ce7-98bb-bb78481eb1dd" xlink:to="loc_us-gaap_DerivativeLiabilityNotionalAmount_f006286e-d16f-4c47-bb2f-4119d17c5ab2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetNotionalAmount_cf5ee2d2-50d2-4cce-859f-a087ecdc59dc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeAssetNotionalAmount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_3221f6ca-adfa-4ce7-98bb-bb78481eb1dd" xlink:to="loc_us-gaap_DerivativeAssetNotionalAmount_cf5ee2d2-50d2-4cce-859f-a087ecdc59dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/FinancialInstrumentsScheduleofGainLossIncludedinAOCIforDerivativeInstrumentsDesignatedasCashFlowHedgesDetails" xlink:type="simple" xlink:href="cah-20210630.xsd#FinancialInstrumentsScheduleofGainLossIncludedinAOCIforDerivativeInstrumentsDesignatedasCashFlowHedgesDetails"/>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/FinancialInstrumentsScheduleofGainLossIncludedinAOCIforDerivativeInstrumentsDesignatedasCashFlowHedgesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_60a87c1f-5b5e-4275-b64f-3f0914716647" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_e498a61c-de61-4087-aadf-7637aaa70fce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_60a87c1f-5b5e-4275-b64f-3f0914716647" xlink:to="loc_us-gaap_DerivativeTable_e498a61c-de61-4087-aadf-7637aaa70fce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_43755512-8da6-483d-8350-a6fb8130d117" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_e498a61c-de61-4087-aadf-7637aaa70fce" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_43755512-8da6-483d-8350-a6fb8130d117" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_7c9cde01-4b03-4629-b09f-9d86fc436918" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_43755512-8da6-483d-8350-a6fb8130d117" xlink:to="loc_us-gaap_HedgingRelationshipDomain_7c9cde01-4b03-4629-b09f-9d86fc436918" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember_46eca9b4-efd1-41b5-8ca6-c490e6dc1475" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_7c9cde01-4b03-4629-b09f-9d86fc436918" xlink:to="loc_us-gaap_CashFlowHedgingMember_46eca9b4-efd1-41b5-8ca6-c490e6dc1475" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_0c3379aa-336b-45e5-a464-14d5c1e84ae1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_e498a61c-de61-4087-aadf-7637aaa70fce" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_0c3379aa-336b-45e5-a464-14d5c1e84ae1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_6dd61e7c-e466-4909-8f36-44045da7fb51" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_0c3379aa-336b-45e5-a464-14d5c1e84ae1" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_6dd61e7c-e466-4909-8f36-44045da7fb51" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForwardContractsMember_14e88834-9e0b-4019-ae9a-c26ae8d827d8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForwardContractsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_6dd61e7c-e466-4909-8f36-44045da7fb51" xlink:to="loc_us-gaap_ForwardContractsMember_14e88834-9e0b-4019-ae9a-c26ae8d827d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_7b3d224e-27e6-4015-a596-5c317fa0ddee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_6dd61e7c-e466-4909-8f36-44045da7fb51" xlink:to="loc_us-gaap_InterestRateSwapMember_7b3d224e-27e6-4015-a596-5c317fa0ddee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommodityContractMember_30acb404-14d8-4045-96de-d3e865d8e36f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommodityContractMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_6dd61e7c-e466-4909-8f36-44045da7fb51" xlink:to="loc_us-gaap_CommodityContractMember_30acb404-14d8-4045-96de-d3e865d8e36f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_3d7d31e8-661c-4f93-998d-b3690d50b39a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_6dd61e7c-e466-4909-8f36-44045da7fb51" xlink:to="loc_us-gaap_ForeignExchangeContractMember_3d7d31e8-661c-4f93-998d-b3690d50b39a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_f772a243-8f68-4143-a524-beff56c70e1b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_e498a61c-de61-4087-aadf-7637aaa70fce" xlink:to="loc_us-gaap_DerivativeLineItems_f772a243-8f68-4143-a524-beff56c70e1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax_5d74f186-d7f0-426f-b990-34dba9661ee6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_f772a243-8f68-4143-a524-beff56c70e1b" xlink:to="loc_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax_5d74f186-d7f0-426f-b990-34dba9661ee6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/FinancialInstrumentsScheduleofGainLossReclassifiedfromAOCIintoEarningsforDerivativeInstrumentsDesignatedasCashFlowHedgesDetails" xlink:type="simple" xlink:href="cah-20210630.xsd#FinancialInstrumentsScheduleofGainLossReclassifiedfromAOCIintoEarningsforDerivativeInstrumentsDesignatedasCashFlowHedgesDetails"/>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/FinancialInstrumentsScheduleofGainLossReclassifiedfromAOCIintoEarningsforDerivativeInstrumentsDesignatedasCashFlowHedgesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_27023641-f062-4448-b729-08c16ac8e7d3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_ff8c01c6-ce92-4e74-8395-b2ec2298942d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_27023641-f062-4448-b729-08c16ac8e7d3" xlink:to="loc_us-gaap_DerivativeTable_ff8c01c6-ce92-4e74-8395-b2ec2298942d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_d190f847-ae3e-48f2-b4b4-a86d92693109" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_ff8c01c6-ce92-4e74-8395-b2ec2298942d" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_d190f847-ae3e-48f2-b4b4-a86d92693109" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_9adaee16-ae6e-4585-a3c1-06bccc9eadde" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_d190f847-ae3e-48f2-b4b4-a86d92693109" xlink:to="loc_us-gaap_HedgingRelationshipDomain_9adaee16-ae6e-4585-a3c1-06bccc9eadde" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember_fea43ce4-cf78-4054-a87f-8ad402233030" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_9adaee16-ae6e-4585-a3c1-06bccc9eadde" xlink:to="loc_us-gaap_CashFlowHedgingMember_fea43ce4-cf78-4054-a87f-8ad402233030" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_a08a391b-4d25-4a83-9df0-62e0852dafae" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_ff8c01c6-ce92-4e74-8395-b2ec2298942d" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_a08a391b-4d25-4a83-9df0-62e0852dafae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_23da4d3f-b2b7-43e0-9313-698b0a13392a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_a08a391b-4d25-4a83-9df0-62e0852dafae" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_23da4d3f-b2b7-43e0-9313-698b0a13392a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_eacfc8af-2fdb-4800-bd5e-ef6a832cca83" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_23da4d3f-b2b7-43e0-9313-698b0a13392a" xlink:to="loc_us-gaap_ForeignExchangeContractMember_eacfc8af-2fdb-4800-bd5e-ef6a832cca83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForwardContractsMember_7193419a-8d4a-4f74-8d5b-bd7bd3384181" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForwardContractsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_23da4d3f-b2b7-43e0-9313-698b0a13392a" xlink:to="loc_us-gaap_ForwardContractsMember_7193419a-8d4a-4f74-8d5b-bd7bd3384181" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommodityContractMember_7712a1c7-cba7-4854-802f-ad81656f176d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommodityContractMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_23da4d3f-b2b7-43e0-9313-698b0a13392a" xlink:to="loc_us-gaap_CommodityContractMember_7712a1c7-cba7-4854-802f-ad81656f176d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_100b7a02-500a-4b22-bb3a-5af9ad14c657" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_ff8c01c6-ce92-4e74-8395-b2ec2298942d" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_100b7a02-500a-4b22-bb3a-5af9ad14c657" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_89a014fc-4c9e-4eb3-ac25-c9959da2bdec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_100b7a02-500a-4b22-bb3a-5af9ad14c657" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_89a014fc-4c9e-4eb3-ac25-c9959da2bdec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesMember_396da7b2-4da9-4bca-92cb-0cd987a34588" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SalesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_89a014fc-4c9e-4eb3-ac25-c9959da2bdec" xlink:to="loc_us-gaap_SalesMember_396da7b2-4da9-4bca-92cb-0cd987a34588" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_f55d8790-3674-42cd-82e4-ffa1e551fbe9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfSalesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_89a014fc-4c9e-4eb3-ac25-c9959da2bdec" xlink:to="loc_us-gaap_CostOfSalesMember_f55d8790-3674-42cd-82e4-ffa1e551fbe9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_5e694b94-c642-448d-bd7a-fb1504002764" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_89a014fc-4c9e-4eb3-ac25-c9959da2bdec" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_5e694b94-c642-448d-bd7a-fb1504002764" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseMember_3aabdeee-a944-4c41-9882-21a507acc47a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpenseMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_89a014fc-4c9e-4eb3-ac25-c9959da2bdec" xlink:to="loc_us-gaap_InterestExpenseMember_3aabdeee-a944-4c41-9882-21a507acc47a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_b7cac97c-54dd-4d9b-b300-5b9ebf1a7b41" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_ff8c01c6-ce92-4e74-8395-b2ec2298942d" xlink:to="loc_us-gaap_DerivativeLineItems_b7cac97c-54dd-4d9b-b300-5b9ebf1a7b41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet_2828e0d9-354a-4cf5-8cf9-936fd39e04b3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_b7cac97c-54dd-4d9b-b300-5b9ebf1a7b41" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet_2828e0d9-354a-4cf5-8cf9-936fd39e04b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/FinancialInstrumentsScheduleofOutstandingInstrumentsEconomicHedgesDetails" xlink:type="simple" xlink:href="cah-20210630.xsd#FinancialInstrumentsScheduleofOutstandingInstrumentsEconomicHedgesDetails"/>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/FinancialInstrumentsScheduleofOutstandingInstrumentsEconomicHedgesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_1dc55eb2-04ec-43f6-9a7c-dae5be12c28f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_84223cb1-0faf-4ec3-95f3-ced1621f9f04" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_1dc55eb2-04ec-43f6-9a7c-dae5be12c28f" xlink:to="loc_us-gaap_DerivativeTable_84223cb1-0faf-4ec3-95f3-ced1621f9f04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_a4183c3c-93e2-490f-8741-787f13d9452f" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_84223cb1-0faf-4ec3-95f3-ced1621f9f04" xlink:to="loc_srt_RangeAxis_a4183c3c-93e2-490f-8741-787f13d9452f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_9fcec2f4-f589-4ddc-9a47-ae66008a41ab" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_a4183c3c-93e2-490f-8741-787f13d9452f" xlink:to="loc_srt_RangeMember_9fcec2f4-f589-4ddc-9a47-ae66008a41ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_661dd70f-d0d0-46d0-bc61-2813894f011b" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_9fcec2f4-f589-4ddc-9a47-ae66008a41ab" xlink:to="loc_srt_MinimumMember_661dd70f-d0d0-46d0-bc61-2813894f011b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_8d9b42a7-e095-4d69-89e0-16a889d45565" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_9fcec2f4-f589-4ddc-9a47-ae66008a41ab" xlink:to="loc_srt_MaximumMember_8d9b42a7-e095-4d69-89e0-16a889d45565" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_87c14b97-6085-42e5-b770-bd55fc9c174d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_84223cb1-0faf-4ec3-95f3-ced1621f9f04" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_87c14b97-6085-42e5-b770-bd55fc9c174d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_f31033a5-1905-4e9c-8a7c-e187fbca2794" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_87c14b97-6085-42e5-b770-bd55fc9c174d" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_f31033a5-1905-4e9c-8a7c-e187fbca2794" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_58364d47-c064-4c19-a3a1-cd7b2285c5eb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_f31033a5-1905-4e9c-8a7c-e187fbca2794" xlink:to="loc_us-gaap_ForeignExchangeContractMember_58364d47-c064-4c19-a3a1-cd7b2285c5eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_fe1d07ef-e4ca-4fd5-96f3-e3712c7955b9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_84223cb1-0faf-4ec3-95f3-ced1621f9f04" xlink:to="loc_us-gaap_HedgingDesignationAxis_fe1d07ef-e4ca-4fd5-96f3-e3712c7955b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_76484af1-7530-4c1e-987c-3556db5784ba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationAxis_fe1d07ef-e4ca-4fd5-96f3-e3712c7955b9" xlink:to="loc_us-gaap_HedgingDesignationDomain_76484af1-7530-4c1e-987c-3556db5784ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember_22b25165-21d0-4971-9441-d92ae3406b8d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NondesignatedMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_76484af1-7530-4c1e-987c-3556db5784ba" xlink:to="loc_us-gaap_NondesignatedMember_22b25165-21d0-4971-9441-d92ae3406b8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_a6d12fcb-ddef-40aa-b79c-921932ead084" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_84223cb1-0faf-4ec3-95f3-ced1621f9f04" xlink:to="loc_us-gaap_DerivativeLineItems_a6d12fcb-ddef-40aa-b79c-921932ead084" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetNotionalAmount_cf3aaf63-be8a-41b8-b587-780de0babfdf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeAssetNotionalAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_a6d12fcb-ddef-40aa-b79c-921932ead084" xlink:to="loc_us-gaap_DerivativeAssetNotionalAmount_cf3aaf63-be8a-41b8-b587-780de0babfdf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/FinancialInstrumentsScheduleofGainLossRecognizedinEarningsforDerivativesNotDesignatedasHedgingInstrumentDetails" xlink:type="simple" xlink:href="cah-20210630.xsd#FinancialInstrumentsScheduleofGainLossRecognizedinEarningsforDerivativesNotDesignatedasHedgingInstrumentDetails"/>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/FinancialInstrumentsScheduleofGainLossRecognizedinEarningsforDerivativesNotDesignatedasHedgingInstrumentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_a0476564-b304-4a1e-8128-c8ab206c8c60" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_cf168442-7160-48b7-9fe8-a188f7aac3be" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_a0476564-b304-4a1e-8128-c8ab206c8c60" xlink:to="loc_us-gaap_DerivativeTable_cf168442-7160-48b7-9fe8-a188f7aac3be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_7d218fdc-7e71-44b3-8e05-9b8a6edcfc45" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_cf168442-7160-48b7-9fe8-a188f7aac3be" xlink:to="loc_us-gaap_HedgingDesignationAxis_7d218fdc-7e71-44b3-8e05-9b8a6edcfc45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_25fe4fe7-3efc-494a-9e85-7f5c6d6b740f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationAxis_7d218fdc-7e71-44b3-8e05-9b8a6edcfc45" xlink:to="loc_us-gaap_HedgingDesignationDomain_25fe4fe7-3efc-494a-9e85-7f5c6d6b740f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember_6a01ab66-a772-4a50-bed5-0037287ebdcf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NondesignatedMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_25fe4fe7-3efc-494a-9e85-7f5c6d6b740f" xlink:to="loc_us-gaap_NondesignatedMember_6a01ab66-a772-4a50-bed5-0037287ebdcf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_3d96c644-817a-43ed-9c97-117b55901e06" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_cf168442-7160-48b7-9fe8-a188f7aac3be" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_3d96c644-817a-43ed-9c97-117b55901e06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_9cbdcb58-83d7-4545-94fb-f902ccc002c1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_3d96c644-817a-43ed-9c97-117b55901e06" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_9cbdcb58-83d7-4545-94fb-f902ccc002c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_edb0d6e9-79ec-4a0d-b70e-0190b7f1199e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_9cbdcb58-83d7-4545-94fb-f902ccc002c1" xlink:to="loc_us-gaap_ForeignExchangeContractMember_edb0d6e9-79ec-4a0d-b70e-0190b7f1199e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_f11c218b-87cb-4096-a98d-4dca3e60fd12" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_cf168442-7160-48b7-9fe8-a188f7aac3be" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_f11c218b-87cb-4096-a98d-4dca3e60fd12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_7849725f-f335-4804-b113-4ed86a205008" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_f11c218b-87cb-4096-a98d-4dca3e60fd12" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_7849725f-f335-4804-b113-4ed86a205008" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpenseMember_c224b704-c990-4944-bb66-151342481b9b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpenseMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_7849725f-f335-4804-b113-4ed86a205008" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpenseMember_c224b704-c990-4944-bb66-151342481b9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_9867514e-55b0-4235-8044-898fad0b8672" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_cf168442-7160-48b7-9fe8-a188f7aac3be" xlink:to="loc_us-gaap_DerivativeLineItems_9867514e-55b0-4235-8044-898fad0b8672" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet_95f5ec0e-3cd0-40d4-ace4-b9f737a60870" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_9867514e-55b0-4235-8044-898fad0b8672" xlink:to="loc_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet_95f5ec0e-3cd0-40d4-ace4-b9f737a60870" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/FinancialInstrumentsSummaryofEstimatedFairValueofLongtermObligationsandOtherShorttermBorrowingsDetails" xlink:type="simple" xlink:href="cah-20210630.xsd#FinancialInstrumentsSummaryofEstimatedFairValueofLongtermObligationsandOtherShorttermBorrowingsDetails"/>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/FinancialInstrumentsSummaryofEstimatedFairValueofLongtermObligationsandOtherShorttermBorrowingsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_e1a4aeca-689c-49b7-9a3d-96c3556921b5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_129e3742-a6b0-41f7-a34d-de264cc5a828" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_e1a4aeca-689c-49b7-9a3d-96c3556921b5" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_129e3742-a6b0-41f7-a34d-de264cc5a828" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_3ed49582-347b-4486-9f85-c927e6367ace" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_129e3742-a6b0-41f7-a34d-de264cc5a828" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_3ed49582-347b-4486-9f85-c927e6367ace" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_bf9e9eae-4e07-4164-8aa1-3152816dfd50" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_3ed49582-347b-4486-9f85-c927e6367ace" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_bf9e9eae-4e07-4164-8aa1-3152816dfd50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_6eb01775-9d9b-4d17-9351-065ce67e4248" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_bf9e9eae-4e07-4164-8aa1-3152816dfd50" xlink:to="loc_us-gaap_InterestRateSwapMember_6eb01775-9d9b-4d17-9351-065ce67e4248" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_d2138e81-0bba-4868-9b3d-dc5668533219" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_129e3742-a6b0-41f7-a34d-de264cc5a828" xlink:to="loc_us-gaap_HedgingDesignationAxis_d2138e81-0bba-4868-9b3d-dc5668533219" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_de690637-289c-48de-a55e-478d019f7c7a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationAxis_d2138e81-0bba-4868-9b3d-dc5668533219" xlink:to="loc_us-gaap_HedgingDesignationDomain_de690637-289c-48de-a55e-478d019f7c7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_c682b988-4046-49b0-a0b8-9c2f92f94e83" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_de690637-289c-48de-a55e-478d019f7c7a" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_c682b988-4046-49b0-a0b8-9c2f92f94e83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_e25778be-929a-4a91-bc19-a910165114e3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_129e3742-a6b0-41f7-a34d-de264cc5a828" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_e25778be-929a-4a91-bc19-a910165114e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_f1c5ebe9-9dae-4ffd-aff0-8deda0844321" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_e25778be-929a-4a91-bc19-a910165114e3" xlink:to="loc_us-gaap_HedgingRelationshipDomain_f1c5ebe9-9dae-4ffd-aff0-8deda0844321" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueHedgingMember_cae1a7a0-13f3-4258-982e-7f21743ac6d0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueHedgingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_f1c5ebe9-9dae-4ffd-aff0-8deda0844321" xlink:to="loc_us-gaap_FairValueHedgingMember_cae1a7a0-13f3-4258-982e-7f21743ac6d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_2c17d492-05d2-4abb-bea3-a6ddd84f8a5e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_129e3742-a6b0-41f7-a34d-de264cc5a828" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_2c17d492-05d2-4abb-bea3-a6ddd84f8a5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_c7866d84-8752-417e-bebd-bc63b99654e5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_2c17d492-05d2-4abb-bea3-a6ddd84f8a5e" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_c7866d84-8752-417e-bebd-bc63b99654e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_c154588b-5491-4bc4-95b6-ce6e5c0f2d31" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_c7866d84-8752-417e-bebd-bc63b99654e5" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_c154588b-5491-4bc4-95b6-ce6e5c0f2d31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_df9534ac-c8fa-427e-8d12-7c6bed17270d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_129e3742-a6b0-41f7-a34d-de264cc5a828" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_df9534ac-c8fa-427e-8d12-7c6bed17270d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFairValue_47f2d3ed-8427-46d1-9165-1c3afc3966a1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFairValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_df9534ac-c8fa-427e-8d12-7c6bed17270d" xlink:to="loc_us-gaap_DebtInstrumentFairValue_47f2d3ed-8427-46d1-9165-1c3afc3966a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_CarryingAmountofLongTermandotherShortTermBorrowings_ee3ab0a7-7b07-47b5-b80b-d98ed42c64d6" xlink:href="cah-20210630.xsd#cah_CarryingAmountofLongTermandotherShortTermBorrowings"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_df9534ac-c8fa-427e-8d12-7c6bed17270d" xlink:to="loc_cah_CarryingAmountofLongTermandotherShortTermBorrowings_ee3ab0a7-7b07-47b5-b80b-d98ed42c64d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtAndCapitalLeaseObligations_3bc88b48-52ea-442f-9e40-042b693351cb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtAndCapitalLeaseObligations"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_df9534ac-c8fa-427e-8d12-7c6bed17270d" xlink:to="loc_us-gaap_DebtAndCapitalLeaseObligations_3bc88b48-52ea-442f-9e40-042b693351cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/FinancialInstrumentsScheduleofFairValueGainLossDerivativeInstrumentDetails" xlink:type="simple" xlink:href="cah-20210630.xsd#FinancialInstrumentsScheduleofFairValueGainLossDerivativeInstrumentDetails"/>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/FinancialInstrumentsScheduleofFairValueGainLossDerivativeInstrumentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_3f1c547a-61a0-4f5f-b44e-a532e7cc5079" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_a3305b20-1469-437d-b49a-38f1bfab892d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_3f1c547a-61a0-4f5f-b44e-a532e7cc5079" xlink:to="loc_us-gaap_DerivativeTable_a3305b20-1469-437d-b49a-38f1bfab892d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_3c2e741b-da9c-4be4-bd55-aa963ee19397" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_a3305b20-1469-437d-b49a-38f1bfab892d" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_3c2e741b-da9c-4be4-bd55-aa963ee19397" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_3aa9e5bb-65f0-4e7c-8eae-7e2ccf609528" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_3c2e741b-da9c-4be4-bd55-aa963ee19397" xlink:to="loc_us-gaap_HedgingRelationshipDomain_3aa9e5bb-65f0-4e7c-8eae-7e2ccf609528" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueHedgingMember_fd41ed69-d52e-4662-b49c-e3b9d638cb69" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueHedgingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_3aa9e5bb-65f0-4e7c-8eae-7e2ccf609528" xlink:to="loc_us-gaap_FairValueHedgingMember_fd41ed69-d52e-4662-b49c-e3b9d638cb69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember_bac61974-8980-422e-bc4a-ed6d4967de05" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_3aa9e5bb-65f0-4e7c-8eae-7e2ccf609528" xlink:to="loc_us-gaap_CashFlowHedgingMember_bac61974-8980-422e-bc4a-ed6d4967de05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_c4c6fe5a-f913-4aa8-b6c8-517652e3e401" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_a3305b20-1469-437d-b49a-38f1bfab892d" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_c4c6fe5a-f913-4aa8-b6c8-517652e3e401" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_b15de776-cac9-4149-bde6-265c0f95dc93" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_c4c6fe5a-f913-4aa8-b6c8-517652e3e401" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_b15de776-cac9-4149-bde6-265c0f95dc93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_6de0ef35-d18f-4a48-8076-230b558c5452" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_b15de776-cac9-4149-bde6-265c0f95dc93" xlink:to="loc_us-gaap_InterestRateSwapMember_6de0ef35-d18f-4a48-8076-230b558c5452" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_4680b6c4-af10-4506-9317-712cce272773" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_b15de776-cac9-4149-bde6-265c0f95dc93" xlink:to="loc_us-gaap_ForeignExchangeContractMember_4680b6c4-af10-4506-9317-712cce272773" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForwardContractsMember_a8f29cf1-d304-4765-846a-036b05a0f0e6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForwardContractsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_b15de776-cac9-4149-bde6-265c0f95dc93" xlink:to="loc_us-gaap_ForwardContractsMember_a8f29cf1-d304-4765-846a-036b05a0f0e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrencySwapMember_00289724-7b24-47f0-a3e7-8e54966dbe53" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrencySwapMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_b15de776-cac9-4149-bde6-265c0f95dc93" xlink:to="loc_us-gaap_CurrencySwapMember_00289724-7b24-47f0-a3e7-8e54966dbe53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommodityContractMember_2824d220-0d82-47d9-99de-f254cb8aec03" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommodityContractMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_b15de776-cac9-4149-bde6-265c0f95dc93" xlink:to="loc_us-gaap_CommodityContractMember_2824d220-0d82-47d9-99de-f254cb8aec03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_7fdc73ec-5a73-47a8-ae71-ebf7999ea567" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_a3305b20-1469-437d-b49a-38f1bfab892d" xlink:to="loc_us-gaap_DerivativeLineItems_7fdc73ec-5a73-47a8-ae71-ebf7999ea567" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_8060f6ae-4c25-4b96-85c6-5e96c89c7c16" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_7fdc73ec-5a73-47a8-ae71-ebf7999ea567" xlink:to="loc_us-gaap_DerivativeNotionalAmount_8060f6ae-4c25-4b96-85c6-5e96c89c7c16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeNet_aea53dd9-dbcc-406c-892e-4d5249b0e515" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_7fdc73ec-5a73-47a8-ae71-ebf7999ea567" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeNet_aea53dd9-dbcc-406c-892e-4d5249b0e515" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/ShareholdersEquity" xlink:type="simple" xlink:href="cah-20210630.xsd#ShareholdersEquity"/>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/ShareholdersEquity" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_fbed2e97-7583-445d-ab37-1c5324ec0411" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_2bb8a2d0-2ed3-4b08-87bc-8227484f20c9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_fbed2e97-7583-445d-ab37-1c5324ec0411" xlink:to="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_2bb8a2d0-2ed3-4b08-87bc-8227484f20c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/ShareholdersEquityTables" xlink:type="simple" xlink:href="cah-20210630.xsd#ShareholdersEquityTables"/>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/ShareholdersEquityTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_9ecb82b2-8354-47d4-932c-e4735f829c91" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_70dd4d4d-89d1-468b-a52a-79ec369d109e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_9ecb82b2-8354-47d4-932c-e4735f829c91" xlink:to="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_70dd4d4d-89d1-468b-a52a-79ec369d109e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/ShareholdersEquityNarrativeDetails" xlink:type="simple" xlink:href="cah-20210630.xsd#ShareholdersEquityNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/ShareholdersEquityNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_6e24bae2-6dba-4ae4-b60f-69b24937ad6d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_ab5a9810-f745-488d-b6c0-4563e82e280f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_6e24bae2-6dba-4ae4-b60f-69b24937ad6d" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_ab5a9810-f745-488d-b6c0-4563e82e280f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_92b920df-a6f9-4bdc-b6d8-bea019609723" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_ab5a9810-f745-488d-b6c0-4563e82e280f" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_92b920df-a6f9-4bdc-b6d8-bea019609723" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_123efc04-d7cf-4727-957d-077417e22b65" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_92b920df-a6f9-4bdc-b6d8-bea019609723" xlink:to="loc_us-gaap_EquityComponentDomain_123efc04-d7cf-4727-957d-077417e22b65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockMember_547efc80-4403-4a80-82c5-a02ef5e647f7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_123efc04-d7cf-4727-957d-077417e22b65" xlink:to="loc_us-gaap_TreasuryStockMember_547efc80-4403-4a80-82c5-a02ef5e647f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_34a9a72b-eac2-436d-b2c8-72820e75b10b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_ab5a9810-f745-488d-b6c0-4563e82e280f" xlink:to="loc_us-gaap_StatementClassOfStockAxis_34a9a72b-eac2-436d-b2c8-72820e75b10b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_a69caa75-4ccf-498d-b892-6ddebe497a63" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_34a9a72b-eac2-436d-b2c8-72820e75b10b" xlink:to="loc_us-gaap_ClassOfStockDomain_a69caa75-4ccf-498d-b892-6ddebe497a63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassAMember_c3479769-8a56-4f19-b3af-6cfaad7ad6a1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonClassAMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_a69caa75-4ccf-498d-b892-6ddebe497a63" xlink:to="loc_us-gaap_CommonClassAMember_c3479769-8a56-4f19-b3af-6cfaad7ad6a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassBMember_17d1ea04-8492-4642-af7a-893bd16ad89e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonClassBMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_a69caa75-4ccf-498d-b892-6ddebe497a63" xlink:to="loc_us-gaap_CommonClassBMember_17d1ea04-8492-4642-af7a-893bd16ad89e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems_937b9b7c-ec25-40f8-bdf7-be56d4632635" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_ab5a9810-f745-488d-b6c0-4563e82e280f" xlink:to="loc_us-gaap_ClassOfStockLineItems_937b9b7c-ec25-40f8-bdf7-be56d4632635" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_5ecff69b-c4df-4984-89af-bb08ce2117e1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_937b9b7c-ec25-40f8-bdf7-be56d4632635" xlink:to="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_5ecff69b-c4df-4984-89af-bb08ce2117e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired_e2f206f7-ad6b-41df-8647-eeda759958cd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_937b9b7c-ec25-40f8-bdf7-be56d4632635" xlink:to="loc_us-gaap_TreasuryStockSharesAcquired_e2f206f7-ad6b-41df-8647-eeda759958cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_b637b24d-63bf-4e49-ab85-210ddcda7beb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_937b9b7c-ec25-40f8-bdf7-be56d4632635" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_b637b24d-63bf-4e49-ab85-210ddcda7beb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockAcquiredAverageCostPerShare_a24fccb2-593e-4ed2-b737-2000689d5ef8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockAcquiredAverageCostPerShare"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_937b9b7c-ec25-40f8-bdf7-be56d4632635" xlink:to="loc_us-gaap_TreasuryStockAcquiredAverageCostPerShare_a24fccb2-593e-4ed2-b737-2000689d5ef8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_TreasuryStockAcquiredShares_45ba53ce-e9cb-48a4-bc14-ab440cf3adcf" xlink:href="cah-20210630.xsd#cah_TreasuryStockAcquiredShares"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_937b9b7c-ec25-40f8-bdf7-be56d4632635" xlink:to="loc_cah_TreasuryStockAcquiredShares_45ba53ce-e9cb-48a4-bc14-ab440cf3adcf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_2ca1f940-f0c0-4e33-9496-1a51c0dc1242" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_937b9b7c-ec25-40f8-bdf7-be56d4632635" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_2ca1f940-f0c0-4e33-9496-1a51c0dc1242" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_d7f6a725-91e7-4ad4-9b7b-2807c89cded3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_937b9b7c-ec25-40f8-bdf7-be56d4632635" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_d7f6a725-91e7-4ad4-9b7b-2807c89cded3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_CommonStockVotingRightsVotes_a0128964-5711-4ff1-9759-6e4a9eeade7d" xlink:href="cah-20210630.xsd#cah_CommonStockVotingRightsVotes"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_937b9b7c-ec25-40f8-bdf7-be56d4632635" xlink:to="loc_cah_CommonStockVotingRightsVotes_a0128964-5711-4ff1-9759-6e4a9eeade7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/ShareholdersEquityChangesintheAccumulatedOtherComprehensiveIncomeLossDetails" xlink:type="simple" xlink:href="cah-20210630.xsd#ShareholdersEquityChangesintheAccumulatedOtherComprehensiveIncomeLossDetails"/>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/ShareholdersEquityChangesintheAccumulatedOtherComprehensiveIncomeLossDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_8510a254-03f3-43ba-a178-27a881c1d60d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_1bb8902b-ce6e-4616-805d-3af3f8178b93" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_8510a254-03f3-43ba-a178-27a881c1d60d" xlink:to="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_1bb8902b-ce6e-4616-805d-3af3f8178b93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_794e9d51-470b-400b-8872-81f0ca89f26e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_1bb8902b-ce6e-4616-805d-3af3f8178b93" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_794e9d51-470b-400b-8872-81f0ca89f26e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_808cabe5-d212-4f30-a3fd-e4346f3ca70f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_794e9d51-470b-400b-8872-81f0ca89f26e" xlink:to="loc_us-gaap_EquityComponentDomain_808cabe5-d212-4f30-a3fd-e4346f3ca70f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember_f074a85d-7bdb-40ef-9cc4-c91e4a61bc15" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_808cabe5-d212-4f30-a3fd-e4346f3ca70f" xlink:to="loc_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember_f074a85d-7bdb-40ef-9cc4-c91e4a61bc15" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember_ea8e9326-b2b1-49db-8be7-89b42ba092f7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_808cabe5-d212-4f30-a3fd-e4346f3ca70f" xlink:to="loc_us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember_ea8e9326-b2b1-49db-8be7-89b42ba092f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember_2f4e7fe8-8799-48bf-8f31-b75801514964" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_808cabe5-d212-4f30-a3fd-e4346f3ca70f" xlink:to="loc_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember_2f4e7fe8-8799-48bf-8f31-b75801514964" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_dbe54106-bedd-425b-a661-e9dacf412ae1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_808cabe5-d212-4f30-a3fd-e4346f3ca70f" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_dbe54106-bedd-425b-a661-e9dacf412ae1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_aa40c434-3b87-48af-bd3b-487ec38f0414" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_1bb8902b-ce6e-4616-805d-3af3f8178b93" xlink:to="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_aa40c434-3b87-48af-bd3b-487ec38f0414" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_543922aa-f5b8-46ae-adb1-1c70bb8e4487" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AOCIAttributableToParentNetOfTaxRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_aa40c434-3b87-48af-bd3b-487ec38f0414" xlink:to="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_543922aa-f5b8-46ae-adb1-1c70bb8e4487" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_b9487240-506c-4859-8fac-e0037cb718fa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_543922aa-f5b8-46ae-adb1-1c70bb8e4487" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_b9487240-506c-4859-8fac-e0037cb718fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_53d63553-37be-40e3-9464-fc2440fd42c6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_543922aa-f5b8-46ae-adb1-1c70bb8e4487" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_53d63553-37be-40e3-9464-fc2440fd42c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_2b54ce8e-d4e1-47ae-86c4-b35a3eeb9b8b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_543922aa-f5b8-46ae-adb1-1c70bb8e4487" xlink:to="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_2b54ce8e-d4e1-47ae-86c4-b35a3eeb9b8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_1f768487-0197-4cd4-b32d-a442e1f4f892" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_543922aa-f5b8-46ae-adb1-1c70bb8e4487" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_1f768487-0197-4cd4-b32d-a442e1f4f892" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_f156b4fb-6c04-45f0-8760-5357ace3dfeb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_543922aa-f5b8-46ae-adb1-1c70bb8e4487" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_f156b4fb-6c04-45f0-8760-5357ace3dfeb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/EarningsPerShareAttributabletoCardinalHealthInc" xlink:type="simple" xlink:href="cah-20210630.xsd#EarningsPerShareAttributabletoCardinalHealthInc"/>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/EarningsPerShareAttributabletoCardinalHealthInc" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_5f1455cd-8ebb-4279-9440-6888726c9ae0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock_e33ba533-36bf-4a37-9a88-15c4f1755f94" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_5f1455cd-8ebb-4279-9440-6888726c9ae0" xlink:to="loc_us-gaap_EarningsPerShareTextBlock_e33ba533-36bf-4a37-9a88-15c4f1755f94" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/EarningsPerShareAttributabletoCardinalHealthIncTables" xlink:type="simple" xlink:href="cah-20210630.xsd#EarningsPerShareAttributabletoCardinalHealthIncTables"/>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/EarningsPerShareAttributabletoCardinalHealthIncTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_c4892c13-4610-4aae-8061-d3331b5a880c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock_65e04e36-17b5-42e1-8f45-fbb78eb485a5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_c4892c13-4610-4aae-8061-d3331b5a880c" xlink:to="loc_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock_65e04e36-17b5-42e1-8f45-fbb78eb485a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/EarningsPerShareAttributabletoCardinalHealthIncReconciliationofCommonSharesUsedtoComputeBasicandDilutedEPSDetails" xlink:type="simple" xlink:href="cah-20210630.xsd#EarningsPerShareAttributabletoCardinalHealthIncReconciliationofCommonSharesUsedtoComputeBasicandDilutedEPSDetails"/>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/EarningsPerShareAttributabletoCardinalHealthIncReconciliationofCommonSharesUsedtoComputeBasicandDilutedEPSDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_3119c8bb-6531-405c-9fa1-eda4f2a3980d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_e8553958-f991-4b50-9bf2-504d0316a16c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_3119c8bb-6531-405c-9fa1-eda4f2a3980d" xlink:to="loc_us-gaap_ProfitLoss_e8553958-f991-4b50-9bf2-504d0316a16c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_4368b557-7f1b-4dbc-a684-cb8f40ba71fb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_3119c8bb-6531-405c-9fa1-eda4f2a3980d" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_4368b557-7f1b-4dbc-a684-cb8f40ba71fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_82c94db4-32c7-4384-9fce-ae223e179609" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_3119c8bb-6531-405c-9fa1-eda4f2a3980d" xlink:to="loc_us-gaap_NetIncomeLoss_82c94db4-32c7-4384-9fce-ae223e179609" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_d72674e2-64ae-432a-be63-799fefe0db40" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_3119c8bb-6531-405c-9fa1-eda4f2a3980d" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_d72674e2-64ae-432a-be63-799fefe0db40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract_48eb6d17-4b8f-4648-bc39-0829ca6d6c54" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_3119c8bb-6531-405c-9fa1-eda4f2a3980d" xlink:to="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract_48eb6d17-4b8f-4648-bc39-0829ca6d6c54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_f2346c62-48f6-4ef7-9e88-ae3975f2566f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract_48eb6d17-4b8f-4648-bc39-0829ca6d6c54" xlink:to="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_f2346c62-48f6-4ef7-9e88-ae3975f2566f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_39148551-7162-4959-9679-7d285d69f93f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_3119c8bb-6531-405c-9fa1-eda4f2a3980d" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_39148551-7162-4959-9679-7d285d69f93f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAbstract_d55d9d34-35cf-457b-b90b-6c3e2ab3d5b2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasicAbstract"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_3119c8bb-6531-405c-9fa1-eda4f2a3980d" xlink:to="loc_us-gaap_EarningsPerShareBasicAbstract_d55d9d34-35cf-457b-b90b-6c3e2ab3d5b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDilutedAbstract_a77b969f-ecd7-4233-b225-4395196697a7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDilutedAbstract"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_3119c8bb-6531-405c-9fa1-eda4f2a3980d" xlink:to="loc_us-gaap_EarningsPerShareDilutedAbstract_a77b969f-ecd7-4233-b225-4395196697a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_1d168947-7ebc-4c3c-8952-991d30da810f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_3119c8bb-6531-405c-9fa1-eda4f2a3980d" xlink:to="loc_us-gaap_EarningsPerShareBasic_1d168947-7ebc-4c3c-8952-991d30da810f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_0b6bfbd1-f12d-489e-8560-028a871670cd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_3119c8bb-6531-405c-9fa1-eda4f2a3980d" xlink:to="loc_us-gaap_EarningsPerShareDiluted_0b6bfbd1-f12d-489e-8560-028a871670cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/EarningsPerShareAttributabletoCardinalHealthIncNarrativeDetails" xlink:type="simple" xlink:href="cah-20210630.xsd#EarningsPerShareAttributabletoCardinalHealthIncNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/EarningsPerShareAttributabletoCardinalHealthIncNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_842b237e-004e-4413-b8a4-9a7462a25beb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_0c63f16a-43c2-419f-80f7-f056ed10dc43" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_842b237e-004e-4413-b8a4-9a7462a25beb" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_0c63f16a-43c2-419f-80f7-f056ed10dc43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_Sharesthatwouldbeantidilutiveasaresultofnetloss_71e540fa-353b-4675-bd56-d35727479cc2" xlink:href="cah-20210630.xsd#cah_Sharesthatwouldbeantidilutiveasaresultofnetloss"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_842b237e-004e-4413-b8a4-9a7462a25beb" xlink:to="loc_cah_Sharesthatwouldbeantidilutiveasaresultofnetloss_71e540fa-353b-4675-bd56-d35727479cc2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/SegmentInformation" xlink:type="simple" xlink:href="cah-20210630.xsd#SegmentInformation"/>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/SegmentInformation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_45d7c552-48dd-4c3f-8af5-b87c548059c5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock_d8dc4e33-1762-4fa3-9ce2-7b293f51e19b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_45d7c552-48dd-4c3f-8af5-b87c548059c5" xlink:to="loc_us-gaap_SegmentReportingDisclosureTextBlock_d8dc4e33-1762-4fa3-9ce2-7b293f51e19b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/SegmentInformationTables" xlink:type="simple" xlink:href="cah-20210630.xsd#SegmentInformationTables"/>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/SegmentInformationTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_a4390b94-b6c2-4919-9774-925b8a68b7a9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_bdb22c4a-a012-4cb7-aa07-f4861ce34058" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_a4390b94-b6c2-4919-9774-925b8a68b7a9" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_bdb22c4a-a012-4cb7-aa07-f4861ce34058" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock_c8f79050-0eba-41f9-815a-0ff8e642dc83" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_a4390b94-b6c2-4919-9774-925b8a68b7a9" xlink:to="loc_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock_c8f79050-0eba-41f9-815a-0ff8e642dc83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_20768cc8-a0c1-412b-8d47-ca3c2c8ba1c4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_a4390b94-b6c2-4919-9774-925b8a68b7a9" xlink:to="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_20768cc8-a0c1-412b-8d47-ca3c2c8ba1c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock_114cb6e5-deff-4513-a458-c01703cfae6b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_a4390b94-b6c2-4919-9774-925b8a68b7a9" xlink:to="loc_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock_114cb6e5-deff-4513-a458-c01703cfae6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock_36a669ee-5540-4944-86c5-b6749b99a375" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_a4390b94-b6c2-4919-9774-925b8a68b7a9" xlink:to="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock_36a669ee-5540-4944-86c5-b6749b99a375" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfOtherSignificantReconcilingItemsFromSegmentsToConsolidatedTextBlock_54ce533a-002a-4014-b50e-37a22ebb98dc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReconciliationOfOtherSignificantReconcilingItemsFromSegmentsToConsolidatedTextBlock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_a4390b94-b6c2-4919-9774-925b8a68b7a9" xlink:to="loc_us-gaap_ReconciliationOfOtherSignificantReconcilingItemsFromSegmentsToConsolidatedTextBlock_54ce533a-002a-4014-b50e-37a22ebb98dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock_32463757-0c97-4a8b-893e-854a6b16f3ef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_a4390b94-b6c2-4919-9774-925b8a68b7a9" xlink:to="loc_us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock_32463757-0c97-4a8b-893e-854a6b16f3ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock_b6d43a49-09ae-447d-98eb-dcdeb806609d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_a4390b94-b6c2-4919-9774-925b8a68b7a9" xlink:to="loc_us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock_b6d43a49-09ae-447d-98eb-dcdeb806609d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/SegmentInformationNarrativeDetails" xlink:type="simple" xlink:href="cah-20210630.xsd#SegmentInformationNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/SegmentInformationNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_d2ee6f9c-818e-423c-ba3c-4fbadfa3a68e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_143b970a-91ff-4567-99a9-c6980bf0128c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_d2ee6f9c-818e-423c-ba3c-4fbadfa3a68e" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_143b970a-91ff-4567-99a9-c6980bf0128c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_OpioidLitigationAxis_f74c9bd1-78c0-410a-aaa3-d21314147f5e" xlink:href="cah-20210630.xsd#cah_OpioidLitigationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_143b970a-91ff-4567-99a9-c6980bf0128c" xlink:to="loc_cah_OpioidLitigationAxis_f74c9bd1-78c0-410a-aaa3-d21314147f5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_OpioidLitigationDomain_515cca71-5f67-4e03-b71d-149e76f74278" xlink:href="cah-20210630.xsd#cah_OpioidLitigationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cah_OpioidLitigationAxis_f74c9bd1-78c0-410a-aaa3-d21314147f5e" xlink:to="loc_cah_OpioidLitigationDomain_515cca71-5f67-4e03-b71d-149e76f74278" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_TotalOpioidLitigationMember_fe808021-8166-4ee0-8e8c-a6a72e49104d" xlink:href="cah-20210630.xsd#cah_TotalOpioidLitigationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cah_OpioidLitigationDomain_515cca71-5f67-4e03-b71d-149e76f74278" xlink:to="loc_cah_TotalOpioidLitigationMember_fe808021-8166-4ee0-8e8c-a6a72e49104d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_9cc9bb14-3158-4e85-9aa5-4602276a2034" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_143b970a-91ff-4567-99a9-c6980bf0128c" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_9cc9bb14-3158-4e85-9aa5-4602276a2034" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_b0f2bef0-bc27-4cae-ad4c-7809e8b3f0a7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_9cc9bb14-3158-4e85-9aa5-4602276a2034" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_b0f2bef0-bc27-4cae-ad4c-7809e8b3f0a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_NaviHealthMember_b6d89605-0a9c-4d41-b643-8ac12c240b98" xlink:href="cah-20210630.xsd#cah_NaviHealthMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_b0f2bef0-bc27-4cae-ad4c-7809e8b3f0a7" xlink:to="loc_cah_NaviHealthMember_b6d89605-0a9c-4d41-b643-8ac12c240b98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_675d87b1-7bc2-48c5-b9d8-71f7dc82b144" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LitigationCaseAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_143b970a-91ff-4567-99a9-c6980bf0128c" xlink:to="loc_srt_LitigationCaseAxis_675d87b1-7bc2-48c5-b9d8-71f7dc82b144" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_8beba5fe-5fd9-42d2-9564-cd85143e1d78" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseAxis_675d87b1-7bc2-48c5-b9d8-71f7dc82b144" xlink:to="loc_srt_LitigationCaseTypeDomain_8beba5fe-5fd9-42d2-9564-cd85143e1d78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_NewYorkOpioidStewardshipActMember_5a56adfe-ff8b-418b-81e9-e5931a36adb8" xlink:href="cah-20210630.xsd#cah_NewYorkOpioidStewardshipActMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_8beba5fe-5fd9-42d2-9564-cd85143e1d78" xlink:to="loc_cah_NewYorkOpioidStewardshipActMember_5a56adfe-ff8b-418b-81e9-e5931a36adb8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_SterileSurgicalGownRecallAxis_ef16e9ff-803d-432d-828f-15b1d034248c" xlink:href="cah-20210630.xsd#cah_SterileSurgicalGownRecallAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_143b970a-91ff-4567-99a9-c6980bf0128c" xlink:to="loc_cah_SterileSurgicalGownRecallAxis_ef16e9ff-803d-432d-828f-15b1d034248c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_SterileSurgicalGownRecallDomain_cd0e017c-dfcc-4d76-8a94-b05cf338c561" xlink:href="cah-20210630.xsd#cah_SterileSurgicalGownRecallDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cah_SterileSurgicalGownRecallAxis_ef16e9ff-803d-432d-828f-15b1d034248c" xlink:to="loc_cah_SterileSurgicalGownRecallDomain_cd0e017c-dfcc-4d76-8a94-b05cf338c561" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_SterileSurgicalGownRecallMemberDomain_5259f8ba-157c-4632-9bc2-b3d0c90e6791" xlink:href="cah-20210630.xsd#cah_SterileSurgicalGownRecallMemberDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cah_SterileSurgicalGownRecallDomain_cd0e017c-dfcc-4d76-8a94-b05cf338c561" xlink:to="loc_cah_SterileSurgicalGownRecallMemberDomain_5259f8ba-157c-4632-9bc2-b3d0c90e6791" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_f024f3de-76bb-449c-b6ef-855c233741a1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_143b970a-91ff-4567-99a9-c6980bf0128c" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_f024f3de-76bb-449c-b6ef-855c233741a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_PreTaxGainonDivestiture_52e560b6-b6c9-48f1-97f0-2d14103f7e79" xlink:href="cah-20210630.xsd#cah_PreTaxGainonDivestiture"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_f024f3de-76bb-449c-b6ef-855c233741a1" xlink:to="loc_cah_PreTaxGainonDivestiture_52e560b6-b6c9-48f1-97f0-2d14103f7e79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossRelatedToLitigationSettlement_40c355a9-a3a9-4791-8168-e58c12c9472e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossRelatedToLitigationSettlement"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_f024f3de-76bb-449c-b6ef-855c233741a1" xlink:to="loc_us-gaap_GainLossRelatedToLitigationSettlement_40c355a9-a3a9-4791-8168-e58c12c9472e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_EstimatedLiabilityForNewYorkOpioidStewardshipAct_6b4313ab-0e56-4ba9-819e-e3f2cfbdbdcf" xlink:href="cah-20210630.xsd#cah_EstimatedLiabilityForNewYorkOpioidStewardshipAct"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_f024f3de-76bb-449c-b6ef-855c233741a1" xlink:to="loc_cah_EstimatedLiabilityForNewYorkOpioidStewardshipAct_6b4313ab-0e56-4ba9-819e-e3f2cfbdbdcf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRecallExpense_41203ade-5b6b-4a45-8aee-61afd56762b3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryRecallExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_f024f3de-76bb-449c-b6ef-855c233741a1" xlink:to="loc_us-gaap_InventoryRecallExpense_41203ade-5b6b-4a45-8aee-61afd56762b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_ProjectCostsOnInvestmentAndOtherSpending_2a94460d-9506-43f3-a6b4-d4566a85b909" xlink:href="cah-20210630.xsd#cah_ProjectCostsOnInvestmentAndOtherSpending"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_f024f3de-76bb-449c-b6ef-855c233741a1" xlink:to="loc_cah_ProjectCostsOnInvestmentAndOtherSpending_2a94460d-9506-43f3-a6b4-d4566a85b909" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments_10623d5c-ed15-4b21-bbb1-c6e48b296ba3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_f024f3de-76bb-449c-b6ef-855c233741a1" xlink:to="loc_us-gaap_NumberOfReportableSegments_10623d5c-ed15-4b21-bbb1-c6e48b296ba3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainOnSaleOfInvestments_402a5835-65ba-405d-a24a-b6745e0e1477" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainOnSaleOfInvestments"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_f024f3de-76bb-449c-b6ef-855c233741a1" xlink:to="loc_us-gaap_GainOnSaleOfInvestments_402a5835-65ba-405d-a24a-b6745e0e1477" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_GainonDivestitureAfterTax_0cf64e13-56bf-4149-ad8d-9bda65bf34fc" xlink:href="cah-20210630.xsd#cah_GainonDivestitureAfterTax"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_f024f3de-76bb-449c-b6ef-855c233741a1" xlink:to="loc_cah_GainonDivestitureAfterTax_0cf64e13-56bf-4149-ad8d-9bda65bf34fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/SegmentInformationRevenuebyReportableSegmentDetails" xlink:type="simple" xlink:href="cah-20210630.xsd#SegmentInformationRevenuebyReportableSegmentDetails"/>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/SegmentInformationRevenuebyReportableSegmentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_8f77314b-e340-49f6-9c95-36a5f175cff7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_05e6d26d-765c-460f-b483-bb283562c759" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_8f77314b-e340-49f6-9c95-36a5f175cff7" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_05e6d26d-765c-460f-b483-bb283562c759" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_6da44989-4ba3-4886-80b2-9d0e0bf3833e" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_05e6d26d-765c-460f-b483-bb283562c759" xlink:to="loc_srt_ConsolidationItemsAxis_6da44989-4ba3-4886-80b2-9d0e0bf3833e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_96a32952-0393-4bb2-857f-cb37afce9d1e" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsAxis_6da44989-4ba3-4886-80b2-9d0e0bf3833e" xlink:to="loc_srt_ConsolidationItemsDomain_96a32952-0393-4bb2-857f-cb37afce9d1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_2ebdefcc-de22-4524-8425-2d0f7b23e89b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_96a32952-0393-4bb2-857f-cb37afce9d1e" xlink:to="loc_us-gaap_OperatingSegmentsMember_2ebdefcc-de22-4524-8425-2d0f7b23e89b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember_f55edc37-d1d2-4eed-8636-5f0c81fa2ef8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_96a32952-0393-4bb2-857f-cb37afce9d1e" xlink:to="loc_us-gaap_CorporateNonSegmentMember_f55edc37-d1d2-4eed-8636-5f0c81fa2ef8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_b2f2d342-7531-4a79-a342-20c0a9e20f76" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_05e6d26d-765c-460f-b483-bb283562c759" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_b2f2d342-7531-4a79-a342-20c0a9e20f76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_a21221b1-7cf4-4cef-8891-810e545787b5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_b2f2d342-7531-4a79-a342-20c0a9e20f76" xlink:to="loc_us-gaap_SegmentDomain_a21221b1-7cf4-4cef-8891-810e545787b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_PharmaceuticalMember_ec049c31-c0de-4ef5-a2d4-ea0b408f6194" xlink:href="cah-20210630.xsd#cah_PharmaceuticalMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_a21221b1-7cf4-4cef-8891-810e545787b5" xlink:to="loc_cah_PharmaceuticalMember_ec049c31-c0de-4ef5-a2d4-ea0b408f6194" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_MedicalMemberMember_ac17134a-d040-4bce-a3bc-26c422b302e3" xlink:href="cah-20210630.xsd#cah_MedicalMemberMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_a21221b1-7cf4-4cef-8891-810e545787b5" xlink:to="loc_cah_MedicalMemberMember_ac17134a-d040-4bce-a3bc-26c422b302e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsegmentsAxis_bcb34ccd-7182-4cd0-88af-411893170dac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsegmentsAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_05e6d26d-765c-460f-b483-bb283562c759" xlink:to="loc_us-gaap_SubsegmentsAxis_bcb34ccd-7182-4cd0-88af-411893170dac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsegmentsDomain_d1b1057a-7cf6-42c5-b264-48070d28f2a6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsegmentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsegmentsAxis_bcb34ccd-7182-4cd0-88af-411893170dac" xlink:to="loc_us-gaap_SubsegmentsDomain_d1b1057a-7cf6-42c5-b264-48070d28f2a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_PharmaceuticalDistributionandSpecialtyMember_0f5ca610-73b6-4e8c-b533-adcbdd02f020" xlink:href="cah-20210630.xsd#cah_PharmaceuticalDistributionandSpecialtyMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsegmentsDomain_d1b1057a-7cf6-42c5-b264-48070d28f2a6" xlink:to="loc_cah_PharmaceuticalDistributionandSpecialtyMember_0f5ca610-73b6-4e8c-b533-adcbdd02f020" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_NuclearPrecisionHealthServicesMember_991afe78-5a70-408d-98b7-676eae6f6b3a" xlink:href="cah-20210630.xsd#cah_NuclearPrecisionHealthServicesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsegmentsDomain_d1b1057a-7cf6-42c5-b264-48070d28f2a6" xlink:to="loc_cah_NuclearPrecisionHealthServicesMember_991afe78-5a70-408d-98b7-676eae6f6b3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_MedicaldistributionandproductsMember_e8cf71a0-0823-40d4-b2f4-79dcff731548" xlink:href="cah-20210630.xsd#cah_MedicaldistributionandproductsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsegmentsDomain_d1b1057a-7cf6-42c5-b264-48070d28f2a6" xlink:to="loc_cah_MedicaldistributionandproductsMember_e8cf71a0-0823-40d4-b2f4-79dcff731548" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_CardinalHealthAtHomeSolutionsMember_13fd7c73-54c2-4d7f-a771-43c77c27cdf4" xlink:href="cah-20210630.xsd#cah_CardinalHealthAtHomeSolutionsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsegmentsDomain_d1b1057a-7cf6-42c5-b264-48070d28f2a6" xlink:to="loc_cah_CardinalHealthAtHomeSolutionsMember_13fd7c73-54c2-4d7f-a771-43c77c27cdf4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsegmentsConsolidationItemsAxis_bea894dd-cbe9-453b-a8d5-36d30925ee47" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsegmentsConsolidationItemsAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_05e6d26d-765c-460f-b483-bb283562c759" xlink:to="loc_us-gaap_SubsegmentsConsolidationItemsAxis_bea894dd-cbe9-453b-a8d5-36d30925ee47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsegmentsConsolidationItemsDomain_152c45b3-3d04-4ece-8efa-194fedfe39b2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsegmentsConsolidationItemsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsegmentsConsolidationItemsAxis_bea894dd-cbe9-453b-a8d5-36d30925ee47" xlink:to="loc_us-gaap_SubsegmentsConsolidationItemsDomain_152c45b3-3d04-4ece-8efa-194fedfe39b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_271a2601-263e-4a89-a817-db67118a3e07" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_05e6d26d-765c-460f-b483-bb283562c759" xlink:to="loc_srt_StatementGeographicalAxis_271a2601-263e-4a89-a817-db67118a3e07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_e5557c61-85d2-4e68-a2ec-a256b276e439" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_271a2601-263e-4a89-a817-db67118a3e07" xlink:to="loc_srt_SegmentGeographicalDomain_e5557c61-85d2-4e68-a2ec-a256b276e439" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonUsMember_db21b6b3-3e11-4b71-a367-011d88afdbcc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonUsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_e5557c61-85d2-4e68-a2ec-a256b276e439" xlink:to="loc_us-gaap_NonUsMember_db21b6b3-3e11-4b71-a367-011d88afdbcc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_0d9e65a2-3d52-4beb-ae3a-4ac99b643959" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_US"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_e5557c61-85d2-4e68-a2ec-a256b276e439" xlink:to="loc_country_US_0d9e65a2-3d52-4beb-ae3a-4ac99b643959" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_409e5cfa-cea6-47e4-a319-4fb1cc2b8f14" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_05e6d26d-765c-460f-b483-bb283562c759" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_409e5cfa-cea6-47e4-a319-4fb1cc2b8f14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_3397e51c-1723-42d0-b61e-a7f2d1145bda" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Revenues"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_409e5cfa-cea6-47e4-a319-4fb1cc2b8f14" xlink:to="loc_us-gaap_Revenues_3397e51c-1723-42d0-b61e-a7f2d1145bda" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/SegmentInformationSegmentProfitbyReportableSegmentDetails" xlink:type="simple" xlink:href="cah-20210630.xsd#SegmentInformationSegmentProfitbyReportableSegmentDetails"/>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/SegmentInformationSegmentProfitbyReportableSegmentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_371bd62e-75d3-4df3-9022-8291a91c3ff8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable_273fe0d7-39c9-4986-bed3-15726e94a80a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_371bd62e-75d3-4df3-9022-8291a91c3ff8" xlink:to="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable_273fe0d7-39c9-4986-bed3-15726e94a80a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_89879e77-45af-4266-a9cf-139e8c954299" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable_273fe0d7-39c9-4986-bed3-15726e94a80a" xlink:to="loc_srt_ConsolidationItemsAxis_89879e77-45af-4266-a9cf-139e8c954299" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_b73b4b8a-e110-4491-86eb-965f6cdc59f5" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsAxis_89879e77-45af-4266-a9cf-139e8c954299" xlink:to="loc_srt_ConsolidationItemsDomain_b73b4b8a-e110-4491-86eb-965f6cdc59f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_e0d253cd-6c14-4049-9642-9b4b4501a04f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_b73b4b8a-e110-4491-86eb-965f6cdc59f5" xlink:to="loc_us-gaap_OperatingSegmentsMember_e0d253cd-6c14-4049-9642-9b4b4501a04f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember_2a95deba-cad7-4ce7-8591-5e17f076c3bb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_b73b4b8a-e110-4491-86eb-965f6cdc59f5" xlink:to="loc_us-gaap_CorporateNonSegmentMember_2a95deba-cad7-4ce7-8591-5e17f076c3bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_a631f6e2-f66b-4901-b1a9-a7495d9a563d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable_273fe0d7-39c9-4986-bed3-15726e94a80a" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_a631f6e2-f66b-4901-b1a9-a7495d9a563d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_6750f3a8-8093-4553-9c4a-024ef4fde2fc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_a631f6e2-f66b-4901-b1a9-a7495d9a563d" xlink:to="loc_us-gaap_SegmentDomain_6750f3a8-8093-4553-9c4a-024ef4fde2fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_PharmaceuticalMember_bb623312-6253-4f1d-9151-2c1c5fe28014" xlink:href="cah-20210630.xsd#cah_PharmaceuticalMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_6750f3a8-8093-4553-9c4a-024ef4fde2fc" xlink:to="loc_cah_PharmaceuticalMember_bb623312-6253-4f1d-9151-2c1c5fe28014" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_MedicalMemberMember_ce9ed144-7a12-481a-b8da-c68dd091e92b" xlink:href="cah-20210630.xsd#cah_MedicalMemberMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_6750f3a8-8093-4553-9c4a-024ef4fde2fc" xlink:to="loc_cah_MedicalMemberMember_ce9ed144-7a12-481a-b8da-c68dd091e92b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems_33c8ba7e-f5cc-438c-a31d-35672bf27547" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable_273fe0d7-39c9-4986-bed3-15726e94a80a" xlink:to="loc_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems_33c8ba7e-f5cc-438c-a31d-35672bf27547" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_d76abbec-11f6-4a89-89da-12b9ba6338d4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems_33c8ba7e-f5cc-438c-a31d-35672bf27547" xlink:to="loc_us-gaap_OperatingIncomeLoss_d76abbec-11f6-4a89-89da-12b9ba6338d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/SegmentInformationDepreciationandAmortizationandAdditionstoPropertyandEquipmentbyReportableSegmentDetails" xlink:type="simple" xlink:href="cah-20210630.xsd#SegmentInformationDepreciationandAmortizationandAdditionstoPropertyandEquipmentbyReportableSegmentDetails"/>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/SegmentInformationDepreciationandAmortizationandAdditionstoPropertyandEquipmentbyReportableSegmentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_8c094b4e-9329-4b56-9d82-9b8cb0ca0f2e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_6d30362b-b55c-44c9-8ca0-1be56ac7cf76" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_8c094b4e-9329-4b56-9d82-9b8cb0ca0f2e" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_6d30362b-b55c-44c9-8ca0-1be56ac7cf76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_90ef2c95-e067-4749-acd2-0c38de8ae93c" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_6d30362b-b55c-44c9-8ca0-1be56ac7cf76" xlink:to="loc_srt_ConsolidationItemsAxis_90ef2c95-e067-4749-acd2-0c38de8ae93c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_337d091f-33b7-4838-9588-4eca6e8a1a4b" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsAxis_90ef2c95-e067-4749-acd2-0c38de8ae93c" xlink:to="loc_srt_ConsolidationItemsDomain_337d091f-33b7-4838-9588-4eca6e8a1a4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_91bae7af-0be5-44a0-8bee-725c19b195cd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_337d091f-33b7-4838-9588-4eca6e8a1a4b" xlink:to="loc_us-gaap_OperatingSegmentsMember_91bae7af-0be5-44a0-8bee-725c19b195cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember_d0b40f13-48cf-4dfd-92b3-14ac007891dd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_337d091f-33b7-4838-9588-4eca6e8a1a4b" xlink:to="loc_us-gaap_CorporateNonSegmentMember_d0b40f13-48cf-4dfd-92b3-14ac007891dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_1d2ab568-92b9-4587-8149-5c07d12f0187" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_6d30362b-b55c-44c9-8ca0-1be56ac7cf76" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_1d2ab568-92b9-4587-8149-5c07d12f0187" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_80e86aed-caf1-4c61-8bd7-0b5f3a0b7572" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_1d2ab568-92b9-4587-8149-5c07d12f0187" xlink:to="loc_us-gaap_SegmentDomain_80e86aed-caf1-4c61-8bd7-0b5f3a0b7572" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_PharmaceuticalMember_74595d19-36f2-4859-8c7e-565a57840ab5" xlink:href="cah-20210630.xsd#cah_PharmaceuticalMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_80e86aed-caf1-4c61-8bd7-0b5f3a0b7572" xlink:to="loc_cah_PharmaceuticalMember_74595d19-36f2-4859-8c7e-565a57840ab5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_MedicalMemberMember_dbc5010f-e2b7-471c-8db8-1ba29955c106" xlink:href="cah-20210630.xsd#cah_MedicalMemberMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_80e86aed-caf1-4c61-8bd7-0b5f3a0b7572" xlink:to="loc_cah_MedicalMemberMember_dbc5010f-e2b7-471c-8db8-1ba29955c106" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_975bb12f-2864-4ea7-9e48-73a69ba83c9e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_6d30362b-b55c-44c9-8ca0-1be56ac7cf76" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_975bb12f-2864-4ea7-9e48-73a69ba83c9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_d8472cd2-ca6c-427a-bfd1-ce944fed1db8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_975bb12f-2864-4ea7-9e48-73a69ba83c9e" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_d8472cd2-ca6c-427a-bfd1-ce944fed1db8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_5d426bbe-82da-47dd-9a70-f8c514bda931" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_975bb12f-2864-4ea7-9e48-73a69ba83c9e" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_5d426bbe-82da-47dd-9a70-f8c514bda931" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/SegmentInformationAssetsbyReportableSegmentDetails" xlink:type="simple" xlink:href="cah-20210630.xsd#SegmentInformationAssetsbyReportableSegmentDetails"/>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/SegmentInformationAssetsbyReportableSegmentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_aa4848ab-2c64-4683-b8f6-6a7af74ab96d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_dda079a9-5a7a-4649-9797-27d4c69085a8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_aa4848ab-2c64-4683-b8f6-6a7af74ab96d" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_dda079a9-5a7a-4649-9797-27d4c69085a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_c9199b0e-e6cd-4df8-9130-4ac9c15cd000" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_dda079a9-5a7a-4649-9797-27d4c69085a8" xlink:to="loc_srt_ConsolidationItemsAxis_c9199b0e-e6cd-4df8-9130-4ac9c15cd000" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_1021f903-fdab-46db-9ac2-859441762df2" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsAxis_c9199b0e-e6cd-4df8-9130-4ac9c15cd000" xlink:to="loc_srt_ConsolidationItemsDomain_1021f903-fdab-46db-9ac2-859441762df2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_92cad0bd-365f-43c6-a592-4bb2872cbe51" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_1021f903-fdab-46db-9ac2-859441762df2" xlink:to="loc_us-gaap_OperatingSegmentsMember_92cad0bd-365f-43c6-a592-4bb2872cbe51" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember_5cb3d753-5ea3-4111-8179-e5501693e3ea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_1021f903-fdab-46db-9ac2-859441762df2" xlink:to="loc_us-gaap_CorporateNonSegmentMember_5cb3d753-5ea3-4111-8179-e5501693e3ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_046d3b18-291e-41a7-8b75-8a3b132d1d8e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_dda079a9-5a7a-4649-9797-27d4c69085a8" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_046d3b18-291e-41a7-8b75-8a3b132d1d8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_1c9d5a60-e883-44b4-bf8a-8097c40a6669" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_046d3b18-291e-41a7-8b75-8a3b132d1d8e" xlink:to="loc_us-gaap_SegmentDomain_1c9d5a60-e883-44b4-bf8a-8097c40a6669" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_PharmaceuticalMember_3268d1f8-65e1-4e55-a72d-541139c01b1f" xlink:href="cah-20210630.xsd#cah_PharmaceuticalMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_1c9d5a60-e883-44b4-bf8a-8097c40a6669" xlink:to="loc_cah_PharmaceuticalMember_3268d1f8-65e1-4e55-a72d-541139c01b1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_MedicalMemberMember_f9e9003a-7983-45f4-a98b-d051e3921e55" xlink:href="cah-20210630.xsd#cah_MedicalMemberMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_1c9d5a60-e883-44b4-bf8a-8097c40a6669" xlink:to="loc_cah_MedicalMemberMember_f9e9003a-7983-45f4-a98b-d051e3921e55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_CordisDivestitureAxis_3ddd4ecd-0962-43f9-8983-3a2def3eba98" xlink:href="cah-20210630.xsd#cah_CordisDivestitureAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_dda079a9-5a7a-4649-9797-27d4c69085a8" xlink:to="loc_cah_CordisDivestitureAxis_3ddd4ecd-0962-43f9-8983-3a2def3eba98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_CordisDivestitureDomain_34fa786a-2a5a-43ca-86ad-17b718fd4380" xlink:href="cah-20210630.xsd#cah_CordisDivestitureDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cah_CordisDivestitureAxis_3ddd4ecd-0962-43f9-8983-3a2def3eba98" xlink:to="loc_cah_CordisDivestitureDomain_34fa786a-2a5a-43ca-86ad-17b718fd4380" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_CordisDivestitureMember_57142c71-4268-41b1-b023-9220bf258af6" xlink:href="cah-20210630.xsd#cah_CordisDivestitureMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cah_CordisDivestitureDomain_34fa786a-2a5a-43ca-86ad-17b718fd4380" xlink:to="loc_cah_CordisDivestitureMember_57142c71-4268-41b1-b023-9220bf258af6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_e9dc9a8f-fe35-40a4-9a78-f8ae3550e434" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_dda079a9-5a7a-4649-9797-27d4c69085a8" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_e9dc9a8f-fe35-40a4-9a78-f8ae3550e434" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_20ab0108-1829-40e3-8553-a47438efec15" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_e9dc9a8f-fe35-40a4-9a78-f8ae3550e434" xlink:to="loc_us-gaap_Assets_20ab0108-1829-40e3-8553-a47438efec15" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_fbb696fc-f744-4336-91ce-f27b1aa1045c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_e9dc9a8f-fe35-40a4-9a78-f8ae3550e434" xlink:to="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_fbb696fc-f744-4336-91ce-f27b1aa1045c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/SegmentInformationPropertyandEquipmentnetbyGeographicAreaDetails" xlink:type="simple" xlink:href="cah-20210630.xsd#SegmentInformationPropertyandEquipmentnetbyGeographicAreaDetails"/>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/SegmentInformationPropertyandEquipmentnetbyGeographicAreaDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_ec77bec9-beae-49c5-b451-ea21f7311cc3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_62aaf170-baaf-468b-85cf-e3d695813c43" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_ec77bec9-beae-49c5-b451-ea21f7311cc3" xlink:to="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_62aaf170-baaf-468b-85cf-e3d695813c43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_a686f119-016e-4d31-991c-399cfefd9c67" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_62aaf170-baaf-468b-85cf-e3d695813c43" xlink:to="loc_srt_StatementGeographicalAxis_a686f119-016e-4d31-991c-399cfefd9c67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_6145390c-748e-48bd-9b9b-6ae81200364f" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_a686f119-016e-4d31-991c-399cfefd9c67" xlink:to="loc_srt_SegmentGeographicalDomain_6145390c-748e-48bd-9b9b-6ae81200364f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_07f4b914-e5c8-48ef-9df3-bae84804f51c" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_US"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_6145390c-748e-48bd-9b9b-6ae81200364f" xlink:to="loc_country_US_07f4b914-e5c8-48ef-9df3-bae84804f51c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonUsMember_cfe17581-ca21-4a1b-bb19-671635a08bf5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonUsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_6145390c-748e-48bd-9b9b-6ae81200364f" xlink:to="loc_us-gaap_NonUsMember_cfe17581-ca21-4a1b-bb19-671635a08bf5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_1c615ba7-d8e4-4b0f-bd7f-72d7633790cd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_62aaf170-baaf-468b-85cf-e3d695813c43" xlink:to="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_1c615ba7-d8e4-4b0f-bd7f-72d7633790cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_45e7d1cc-bfd6-4e3d-9599-d6d0595bfcca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_1c615ba7-d8e4-4b0f-bd7f-72d7633790cd" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_45e7d1cc-bfd6-4e3d-9599-d6d0595bfcca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/ShareBasedCompensation" xlink:type="simple" xlink:href="cah-20210630.xsd#ShareBasedCompensation"/>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/ShareBasedCompensation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_49c78f50-9bf9-4154-9760-538375fc1c01" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_021f59b7-5692-4b7c-a5c3-c93424837756" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_49c78f50-9bf9-4154-9760-538375fc1c01" xlink:to="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_021f59b7-5692-4b7c-a5c3-c93424837756" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/ShareBasedCompensationTables" xlink:type="simple" xlink:href="cah-20210630.xsd#ShareBasedCompensationTables"/>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/ShareBasedCompensationTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_333cd2aa-31e5-4c32-ae5d-81de7b5ba4cf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock_f27de452-e66e-4ca9-8d23-042e870ce386" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_333cd2aa-31e5-4c32-ae5d-81de7b5ba4cf" xlink:to="loc_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock_f27de452-e66e-4ca9-8d23-042e870ce386" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_7b4c3afa-2be3-42da-8c15-fd700894630e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_333cd2aa-31e5-4c32-ae5d-81de7b5ba4cf" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_7b4c3afa-2be3-42da-8c15-fd700894630e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_AdditionalStockOptionPlanDataTableTextBlock_2b0232b8-fca5-4dc3-bac7-24349b6247d8" xlink:href="cah-20210630.xsd#cah_AdditionalStockOptionPlanDataTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_333cd2aa-31e5-4c32-ae5d-81de7b5ba4cf" xlink:to="loc_cah_AdditionalStockOptionPlanDataTableTextBlock_2b0232b8-fca5-4dc3-bac7-24349b6247d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_RemainingStockOptionPlanDataTableTextBlock_09ce9c2a-927f-4d4a-8630-d59738084f4e" xlink:href="cah-20210630.xsd#cah_RemainingStockOptionPlanDataTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_333cd2aa-31e5-4c32-ae5d-81de7b5ba4cf" xlink:to="loc_cah_RemainingStockOptionPlanDataTableTextBlock_09ce9c2a-927f-4d4a-8630-d59738084f4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_bacbb2d0-0f1f-41b3-a013-850ea2497cad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_333cd2aa-31e5-4c32-ae5d-81de7b5ba4cf" xlink:to="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_bacbb2d0-0f1f-41b3-a013-850ea2497cad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock_a26d4b96-3fce-416d-986d-b438a7763fc8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_333cd2aa-31e5-4c32-ae5d-81de7b5ba4cf" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock_a26d4b96-3fce-416d-986d-b438a7763fc8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_AdditionalRestrictedSharesAndRestrictedShareUnitsDataTableTextBlock_b503a1a9-1444-462a-a229-59e250157a97" xlink:href="cah-20210630.xsd#cah_AdditionalRestrictedSharesAndRestrictedShareUnitsDataTableTextBlock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_333cd2aa-31e5-4c32-ae5d-81de7b5ba4cf" xlink:to="loc_cah_AdditionalRestrictedSharesAndRestrictedShareUnitsDataTableTextBlock_b503a1a9-1444-462a-a229-59e250157a97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNonvestedPerformanceBasedUnitsActivityTableTextBlock_cdcc1221-d2f4-4e13-8f45-fe5c67865647" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfNonvestedPerformanceBasedUnitsActivityTableTextBlock"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_333cd2aa-31e5-4c32-ae5d-81de7b5ba4cf" xlink:to="loc_us-gaap_ScheduleOfNonvestedPerformanceBasedUnitsActivityTableTextBlock_cdcc1221-d2f4-4e13-8f45-fe5c67865647" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_AdditionalPerformanceShareUnitsDataTableTextBlock_3512bbc7-c3ac-444d-9ee4-a7778dce0363" xlink:href="cah-20210630.xsd#cah_AdditionalPerformanceShareUnitsDataTableTextBlock"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_333cd2aa-31e5-4c32-ae5d-81de7b5ba4cf" xlink:to="loc_cah_AdditionalPerformanceShareUnitsDataTableTextBlock_3512bbc7-c3ac-444d-9ee4-a7778dce0363" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/ShareBasedCompensationNarrativeDetails" xlink:type="simple" xlink:href="cah-20210630.xsd#ShareBasedCompensationNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/ShareBasedCompensationNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_04b9e887-9712-4610-b18d-3f500728e41a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_08585156-da8d-4aad-80f1-c52462dfe19d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_04b9e887-9712-4610-b18d-3f500728e41a" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_08585156-da8d-4aad-80f1-c52462dfe19d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_2dc61c9e-47c3-4b6f-8964-2ea681748a1e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_08585156-da8d-4aad-80f1-c52462dfe19d" xlink:to="loc_us-gaap_PlanNameAxis_2dc61c9e-47c3-4b6f-8964-2ea681748a1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_e72ab2b4-40ec-4b08-aa2f-c74df11de4c2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameAxis_2dc61c9e-47c3-4b6f-8964-2ea681748a1e" xlink:to="loc_us-gaap_PlanNameDomain_e72ab2b4-40ec-4b08-aa2f-c74df11de4c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_A2011LtipMember_a0982a55-68ae-4bd6-a2d4-2956ac429781" xlink:href="cah-20210630.xsd#cah_A2011LtipMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_e72ab2b4-40ec-4b08-aa2f-c74df11de4c2" xlink:to="loc_cah_A2011LtipMember_a0982a55-68ae-4bd6-a2d4-2956ac429781" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_45efa945-4569-47af-803f-dd3cf2e35b71" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_08585156-da8d-4aad-80f1-c52462dfe19d" xlink:to="loc_us-gaap_AwardTypeAxis_45efa945-4569-47af-803f-dd3cf2e35b71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_29fbf45d-fd5d-4c2c-9c1e-043672981984" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_45efa945-4569-47af-803f-dd3cf2e35b71" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_29fbf45d-fd5d-4c2c-9c1e-043672981984" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_AwardsOtherThanStockOptionsMember_d0acf7c4-19b1-411a-a62a-cc4ed7c87657" xlink:href="cah-20210630.xsd#cah_AwardsOtherThanStockOptionsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_29fbf45d-fd5d-4c2c-9c1e-043672981984" xlink:to="loc_cah_AwardsOtherThanStockOptionsMember_d0acf7c4-19b1-411a-a62a-cc4ed7c87657" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceSharesMember_af50ab9f-35c5-44d6-9eaa-6df164aceb7f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PerformanceSharesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_29fbf45d-fd5d-4c2c-9c1e-043672981984" xlink:to="loc_us-gaap_PerformanceSharesMember_af50ab9f-35c5-44d6-9eaa-6df164aceb7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_acabd121-b738-4f2a-98ce-682620c29f11" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_29fbf45d-fd5d-4c2c-9c1e-043672981984" xlink:to="loc_us-gaap_EmployeeStockOptionMember_acabd121-b738-4f2a-98ce-682620c29f11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_5076d7bb-e651-4407-91ed-676e8e012e5d" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_08585156-da8d-4aad-80f1-c52462dfe19d" xlink:to="loc_srt_RangeAxis_5076d7bb-e651-4407-91ed-676e8e012e5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_3f934713-ffb8-4415-85aa-25dfc76fbf10" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_5076d7bb-e651-4407-91ed-676e8e012e5d" xlink:to="loc_srt_RangeMember_3f934713-ffb8-4415-85aa-25dfc76fbf10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_9840d71f-0bf6-4c65-b344-df84e010ced0" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_3f934713-ffb8-4415-85aa-25dfc76fbf10" xlink:to="loc_srt_MaximumMember_9840d71f-0bf6-4c65-b344-df84e010ced0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_997cffec-8314-455e-a9d8-3de8194abd96" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_08585156-da8d-4aad-80f1-c52462dfe19d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_997cffec-8314-455e-a9d8-3de8194abd96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_e9125ae3-ad2b-4310-a255-624acfe96629" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_997cffec-8314-455e-a9d8-3de8194abd96" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_e9125ae3-ad2b-4310-a255-624acfe96629" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_e43b933b-17f0-4a60-917f-0eb3be5186c4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_997cffec-8314-455e-a9d8-3de8194abd96" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_e43b933b-17f0-4a60-917f-0eb3be5186c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_c980bdca-121f-419a-96bd-ea87e463f7c3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_997cffec-8314-455e-a9d8-3de8194abd96" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_c980bdca-121f-419a-96bd-ea87e463f7c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_ExercisablePeriodOfPlansInYears_3f94eda1-bbbc-4551-9e76-5ae93b505e6f" xlink:href="cah-20210630.xsd#cah_ExercisablePeriodOfPlansInYears"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_997cffec-8314-455e-a9d8-3de8194abd96" xlink:to="loc_cah_ExercisablePeriodOfPlansInYears_3f94eda1-bbbc-4551-9e76-5ae93b505e6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_30710197-aabb-4ed5-86f3-5382e2873f51" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_997cffec-8314-455e-a9d8-3de8194abd96" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_30710197-aabb-4ed5-86f3-5382e2873f51" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanCostRecognized_87fb1f8e-f633-4569-96a8-ff034f8cc0fc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedContributionPlanCostRecognized"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_997cffec-8314-455e-a9d8-3de8194abd96" xlink:to="loc_us-gaap_DefinedContributionPlanCostRecognized_87fb1f8e-f633-4569-96a8-ff034f8cc0fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_eb5f41e7-4b96-44e9-8a16-c9ba2321854b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_997cffec-8314-455e-a9d8-3de8194abd96" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_eb5f41e7-4b96-44e9-8a16-c9ba2321854b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/ShareBasedCompensationScheduleofTotalShareBasedCompensationExpensebyTypeofAwardDetails" xlink:type="simple" xlink:href="cah-20210630.xsd#ShareBasedCompensationScheduleofTotalShareBasedCompensationExpensebyTypeofAwardDetails"/>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/ShareBasedCompensationScheduleofTotalShareBasedCompensationExpensebyTypeofAwardDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_5ce55d51-f0fe-4bea-a625-fbb4a45b8c83" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_defeb823-6f4d-4d33-82fd-7e023994ad8e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_5ce55d51-f0fe-4bea-a625-fbb4a45b8c83" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_defeb823-6f4d-4d33-82fd-7e023994ad8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_48c5f632-686d-46c3-8ce3-f30daad6c091" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_defeb823-6f4d-4d33-82fd-7e023994ad8e" xlink:to="loc_us-gaap_AwardTypeAxis_48c5f632-686d-46c3-8ce3-f30daad6c091" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_43b35ba3-bae7-4186-8c97-2205ffd7a07b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_48c5f632-686d-46c3-8ce3-f30daad6c091" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_43b35ba3-bae7-4186-8c97-2205ffd7a07b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_4bec3763-f382-469b-bc0c-452360d3f4d0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_43b35ba3-bae7-4186-8c97-2205ffd7a07b" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_4bec3763-f382-469b-bc0c-452360d3f4d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_21ef6f47-efef-46e3-8530-844d2557a675" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_43b35ba3-bae7-4186-8c97-2205ffd7a07b" xlink:to="loc_us-gaap_EmployeeStockOptionMember_21ef6f47-efef-46e3-8530-844d2557a675" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceSharesMember_f60feace-1ea4-4658-9703-4cec5d25bd2d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PerformanceSharesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_43b35ba3-bae7-4186-8c97-2205ffd7a07b" xlink:to="loc_us-gaap_PerformanceSharesMember_f60feace-1ea4-4658-9703-4cec5d25bd2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_fa5edcf2-5934-4975-849d-d9d824d1fc34" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_defeb823-6f4d-4d33-82fd-7e023994ad8e" xlink:to="loc_us-gaap_PlanNameAxis_fa5edcf2-5934-4975-849d-d9d824d1fc34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_04a16cc9-9ed8-4320-981e-0df31cb37a69" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameAxis_fa5edcf2-5934-4975-849d-d9d824d1fc34" xlink:to="loc_us-gaap_PlanNameDomain_04a16cc9-9ed8-4320-981e-0df31cb37a69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_A2011LtipMember_2d3a5132-c0bb-46b7-ad62-91c435153c67" xlink:href="cah-20210630.xsd#cah_A2011LtipMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_04a16cc9-9ed8-4320-981e-0df31cb37a69" xlink:to="loc_cah_A2011LtipMember_2d3a5132-c0bb-46b7-ad62-91c435153c67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_cbcc20b4-f037-4109-8a9b-64d84c747875" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_defeb823-6f4d-4d33-82fd-7e023994ad8e" xlink:to="loc_srt_RangeAxis_cbcc20b4-f037-4109-8a9b-64d84c747875" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_b08d1397-f6f1-4c07-a3f0-9d18490f0d68" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_cbcc20b4-f037-4109-8a9b-64d84c747875" xlink:to="loc_srt_RangeMember_b08d1397-f6f1-4c07-a3f0-9d18490f0d68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_c4ab9384-0391-4cd1-b8a2-a34d030a5c46" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_b08d1397-f6f1-4c07-a3f0-9d18490f0d68" xlink:to="loc_srt_MinimumMember_c4ab9384-0391-4cd1-b8a2-a34d030a5c46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_6c100d63-341a-4239-a994-4ffb8d0022c4" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_b08d1397-f6f1-4c07-a3f0-9d18490f0d68" xlink:to="loc_srt_MaximumMember_6c100d63-341a-4239-a994-4ffb8d0022c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_32299059-f5e7-4116-b2d6-8ea13fee1722" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_defeb823-6f4d-4d33-82fd-7e023994ad8e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_32299059-f5e7-4116-b2d6-8ea13fee1722" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_56a35403-6d66-4b4d-9474-c66870762d2b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_32299059-f5e7-4116-b2d6-8ea13fee1722" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_56a35403-6d66-4b4d-9474-c66870762d2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/ShareBasedCompensationScheduleofAllStockOptionTransactionsUnderthePlansDetails" xlink:type="simple" xlink:href="cah-20210630.xsd#ShareBasedCompensationScheduleofAllStockOptionTransactionsUnderthePlansDetails"/>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/ShareBasedCompensationScheduleofAllStockOptionTransactionsUnderthePlansDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_12ef9c43-bdab-4413-ab73-4a312118fbb1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_acd2579b-b656-452f-ac18-eef6527cebe1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_12ef9c43-bdab-4413-ab73-4a312118fbb1" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_acd2579b-b656-452f-ac18-eef6527cebe1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_de67f812-066d-403f-b2a3-f1ad9da2b186" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_acd2579b-b656-452f-ac18-eef6527cebe1" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_de67f812-066d-403f-b2a3-f1ad9da2b186" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_80412fbb-dbfc-4d9a-80ba-f975a3f35670" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_acd2579b-b656-452f-ac18-eef6527cebe1" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_80412fbb-dbfc-4d9a-80ba-f975a3f35670" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_04b7d2b5-56ad-4434-8e76-c49c76bbc6d5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_acd2579b-b656-452f-ac18-eef6527cebe1" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_04b7d2b5-56ad-4434-8e76-c49c76bbc6d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_96064c8c-1b2f-41be-a198-a9dc6b8772eb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_acd2579b-b656-452f-ac18-eef6527cebe1" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_96064c8c-1b2f-41be-a198-a9dc6b8772eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_448cff68-3e4a-4df4-8390-0b0188ed1af5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_acd2579b-b656-452f-ac18-eef6527cebe1" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_448cff68-3e4a-4df4-8390-0b0188ed1af5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_40b013cc-f657-4f02-91d0-12317e470be6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_acd2579b-b656-452f-ac18-eef6527cebe1" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_40b013cc-f657-4f02-91d0-12317e470be6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_4cc6dc3a-ce03-4898-8a04-0931fb4f9180" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_12ef9c43-bdab-4413-ab73-4a312118fbb1" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_4cc6dc3a-ce03-4898-8a04-0931fb4f9180" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_654a7313-fb93-4b86-a23a-aced44d68918" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_4cc6dc3a-ce03-4898-8a04-0931fb4f9180" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_654a7313-fb93-4b86-a23a-aced44d68918" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_9c8e87d1-2685-43f3-96a7-64209b74e49e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_4cc6dc3a-ce03-4898-8a04-0931fb4f9180" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_9c8e87d1-2685-43f3-96a7-64209b74e49e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_8d300c46-b5a9-48fb-a2cb-b9decf61b3df" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_4cc6dc3a-ce03-4898-8a04-0931fb4f9180" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_8d300c46-b5a9-48fb-a2cb-b9decf61b3df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_59b39df4-a39b-4868-8b89-27417355a2f3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_4cc6dc3a-ce03-4898-8a04-0931fb4f9180" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_59b39df4-a39b-4868-8b89-27417355a2f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_c070563f-3c42-4bc0-b336-ca30638e23e6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_4cc6dc3a-ce03-4898-8a04-0931fb4f9180" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_c070563f-3c42-4bc0-b336-ca30638e23e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_4534989e-8441-4e33-a2a2-bc24fd3d1ef1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_4cc6dc3a-ce03-4898-8a04-0931fb4f9180" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_4534989e-8441-4e33-a2a2-bc24fd3d1ef1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/ShareBasedCompensationScheduleofAdditionalDataRelatedtoStockOptionsDetails" xlink:type="simple" xlink:href="cah-20210630.xsd#ShareBasedCompensationScheduleofAdditionalDataRelatedtoStockOptionsDetails"/>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/ShareBasedCompensationScheduleofAdditionalDataRelatedtoStockOptionsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_b3d29460-7366-4c2a-a0c7-7345de9b6130" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_10fc1908-d0ce-4cb1-8d97-b6d93c2fe026" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_b3d29460-7366-4c2a-a0c7-7345de9b6130" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_10fc1908-d0ce-4cb1-8d97-b6d93c2fe026" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_597c0368-07b6-4e5c-904b-d7e9d7afffba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_10fc1908-d0ce-4cb1-8d97-b6d93c2fe026" xlink:to="loc_us-gaap_AwardTypeAxis_597c0368-07b6-4e5c-904b-d7e9d7afffba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_a0ba6bca-b593-4192-ac6e-5b15bed55cd3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_597c0368-07b6-4e5c-904b-d7e9d7afffba" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_a0ba6bca-b593-4192-ac6e-5b15bed55cd3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_bbbadf36-1822-4467-8b38-e16f3872ec34" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_a0ba6bca-b593-4192-ac6e-5b15bed55cd3" xlink:to="loc_us-gaap_EmployeeStockOptionMember_bbbadf36-1822-4467-8b38-e16f3872ec34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_2a1bc396-b319-4d38-997b-698f8da73372" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_10fc1908-d0ce-4cb1-8d97-b6d93c2fe026" xlink:to="loc_srt_RangeAxis_2a1bc396-b319-4d38-997b-698f8da73372" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_d007e72a-306e-470d-ae98-8d28cbc67d97" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_2a1bc396-b319-4d38-997b-698f8da73372" xlink:to="loc_srt_RangeMember_d007e72a-306e-470d-ae98-8d28cbc67d97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_507cb449-e0f4-455e-af50-0801c9108b7a" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_d007e72a-306e-470d-ae98-8d28cbc67d97" xlink:to="loc_srt_MaximumMember_507cb449-e0f4-455e-af50-0801c9108b7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_04b5e3a4-a7ff-4cdc-8e16-ced9e41f779b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_10fc1908-d0ce-4cb1-8d97-b6d93c2fe026" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_04b5e3a4-a7ff-4cdc-8e16-ced9e41f779b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_9dc64f79-bed3-46be-99c1-f2b8e21a83e0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_04b5e3a4-a7ff-4cdc-8e16-ced9e41f779b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_9dc64f79-bed3-46be-99c1-f2b8e21a83e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_79a5c6de-b977-4f25-be00-c37850c7054e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_04b5e3a4-a7ff-4cdc-8e16-ced9e41f779b" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_79a5c6de-b977-4f25-be00-c37850c7054e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_917a78ce-dd3c-471a-99a1-2cb68dc27e6f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_04b5e3a4-a7ff-4cdc-8e16-ced9e41f779b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_917a78ce-dd3c-471a-99a1-2cb68dc27e6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_Netproceedstaxwithholdingsfromsharebasedcompensation_f604861d-c172-4cda-9828-29982412e3bb" xlink:href="cah-20210630.xsd#cah_Netproceedstaxwithholdingsfromsharebasedcompensation"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_04b5e3a4-a7ff-4cdc-8e16-ced9e41f779b" xlink:to="loc_cah_Netproceedstaxwithholdingsfromsharebasedcompensation_f604861d-c172-4cda-9828-29982412e3bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ExcessTaxBenefitFromShareBasedCompensationFinancingActivities_b601fb94-fe73-4a41-9086-776db23d1167" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ExcessTaxBenefitFromShareBasedCompensationFinancingActivities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_04b5e3a4-a7ff-4cdc-8e16-ced9e41f779b" xlink:to="loc_us-gaap_ExcessTaxBenefitFromShareBasedCompensationFinancingActivities_b601fb94-fe73-4a41-9086-776db23d1167" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_0dbcc9dd-5b60-45c1-9a96-59403e761527" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_04b5e3a4-a7ff-4cdc-8e16-ced9e41f779b" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_0dbcc9dd-5b60-45c1-9a96-59403e761527" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_45c494ba-e397-4f95-84e5-a387ad1fc387" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_04b5e3a4-a7ff-4cdc-8e16-ced9e41f779b" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_45c494ba-e397-4f95-84e5-a387ad1fc387" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_7e2a33f7-302a-4c86-90d6-f2089bbf2877" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_04b5e3a4-a7ff-4cdc-8e16-ced9e41f779b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_7e2a33f7-302a-4c86-90d6-f2089bbf2877" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_623580db-24c3-4b7c-881f-e0c8cd9ae7ad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_04b5e3a4-a7ff-4cdc-8e16-ced9e41f779b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_623580db-24c3-4b7c-881f-e0c8cd9ae7ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_ExercisablePeriodOfPlansInYears_9335a02b-ed85-4ce8-87fa-04f7c914c02e" xlink:href="cah-20210630.xsd#cah_ExercisablePeriodOfPlansInYears"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_04b5e3a4-a7ff-4cdc-8e16-ced9e41f779b" xlink:to="loc_cah_ExercisablePeriodOfPlansInYears_9335a02b-ed85-4ce8-87fa-04f7c914c02e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/ShareBasedCompensationScheduleofRemainingStockOptionPlanDataDetails" xlink:type="simple" xlink:href="cah-20210630.xsd#ShareBasedCompensationScheduleofRemainingStockOptionPlanDataDetails"/>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/ShareBasedCompensationScheduleofRemainingStockOptionPlanDataDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_85e0ab4e-b373-4d2d-af12-0e9931963219" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_2b64c298-0954-4c04-a4ca-9f68783d85a1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_85e0ab4e-b373-4d2d-af12-0e9931963219" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_2b64c298-0954-4c04-a4ca-9f68783d85a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_a9691cf7-4394-4eec-b1c5-417ea44b73ac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_2b64c298-0954-4c04-a4ca-9f68783d85a1" xlink:to="loc_us-gaap_AwardTypeAxis_a9691cf7-4394-4eec-b1c5-417ea44b73ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8faffaab-40da-46cd-b6f6-55e2326342c8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_a9691cf7-4394-4eec-b1c5-417ea44b73ac" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8faffaab-40da-46cd-b6f6-55e2326342c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_ef6653c9-2ee2-4c9a-8a3c-9088ca18c63f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8faffaab-40da-46cd-b6f6-55e2326342c8" xlink:to="loc_us-gaap_EmployeeStockOptionMember_ef6653c9-2ee2-4c9a-8a3c-9088ca18c63f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c7a528ab-6d13-4580-98a8-f713aa171137" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_2b64c298-0954-4c04-a4ca-9f68783d85a1" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c7a528ab-6d13-4580-98a8-f713aa171137" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_548987b8-8076-4bc2-a8b0-7fa29f37144b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c7a528ab-6d13-4580-98a8-f713aa171137" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_548987b8-8076-4bc2-a8b0-7fa29f37144b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_993c49eb-b754-4811-b6ca-4b7bc3c29115" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c7a528ab-6d13-4580-98a8-f713aa171137" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_993c49eb-b754-4811-b6ca-4b7bc3c29115" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_784ef5b9-94e2-4f58-bba4-c6eb5061278d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c7a528ab-6d13-4580-98a8-f713aa171137" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_784ef5b9-94e2-4f58-bba4-c6eb5061278d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/ShareBasedCompensationScheduleofAllTransactionsRelatedtoRestrictedShareUnitsUnderthePlansDetails" xlink:type="simple" xlink:href="cah-20210630.xsd#ShareBasedCompensationScheduleofAllTransactionsRelatedtoRestrictedShareUnitsUnderthePlansDetails"/>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/ShareBasedCompensationScheduleofAllTransactionsRelatedtoRestrictedShareUnitsUnderthePlansDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_abd76164-ab9f-4f03-b828-6817620c4572" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_48894ea4-425e-41be-a1f5-aa821618f46a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_abd76164-ab9f-4f03-b828-6817620c4572" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_48894ea4-425e-41be-a1f5-aa821618f46a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_16e27a1a-8181-4082-9344-8a5734b18aa2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_48894ea4-425e-41be-a1f5-aa821618f46a" xlink:to="loc_us-gaap_AwardTypeAxis_16e27a1a-8181-4082-9344-8a5734b18aa2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_384161b9-1544-4945-9ce5-c0ee320a9e1a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_16e27a1a-8181-4082-9344-8a5734b18aa2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_384161b9-1544-4945-9ce5-c0ee320a9e1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_e24c1778-67cb-4eb1-a38a-7aff904f7895" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_384161b9-1544-4945-9ce5-c0ee320a9e1a" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_e24c1778-67cb-4eb1-a38a-7aff904f7895" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_08ac4bf1-1a2e-4281-8e1b-4bd6c3566c47" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_48894ea4-425e-41be-a1f5-aa821618f46a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_08ac4bf1-1a2e-4281-8e1b-4bd6c3566c47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_d216b205-d629-4713-a0cc-39ac784d3118" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_08ac4bf1-1a2e-4281-8e1b-4bd6c3566c47" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_d216b205-d629-4713-a0cc-39ac784d3118" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_33e333c3-3c70-411c-b769-23c708e12413" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_d216b205-d629-4713-a0cc-39ac784d3118" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_33e333c3-3c70-411c-b769-23c708e12413" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_8f0843a9-38ea-4afa-b531-dcc823ed6236" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_d216b205-d629-4713-a0cc-39ac784d3118" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_8f0843a9-38ea-4afa-b531-dcc823ed6236" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_0d4ab964-e6ee-4b7b-a15a-3c9725405b2d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_d216b205-d629-4713-a0cc-39ac784d3118" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_0d4ab964-e6ee-4b7b-a15a-3c9725405b2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_ac7456b4-566e-4676-a914-e6a0796f8564" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_d216b205-d629-4713-a0cc-39ac784d3118" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_ac7456b4-566e-4676-a914-e6a0796f8564" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_057d7e0f-db2b-4a09-83dd-01f34bffcb4a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_d216b205-d629-4713-a0cc-39ac784d3118" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_057d7e0f-db2b-4a09-83dd-01f34bffcb4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_8a820b50-1552-4272-955e-d8311eb45009" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_08ac4bf1-1a2e-4281-8e1b-4bd6c3566c47" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_8a820b50-1552-4272-955e-d8311eb45009" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_e773fd86-c2eb-4e7e-9591-b0953add3bcf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_8a820b50-1552-4272-955e-d8311eb45009" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_e773fd86-c2eb-4e7e-9591-b0953add3bcf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_7cb3b257-f756-4c1a-8048-719318722391" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_8a820b50-1552-4272-955e-d8311eb45009" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_7cb3b257-f756-4c1a-8048-719318722391" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_81acd6db-341e-49ce-b473-453af2f4c3a0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_8a820b50-1552-4272-955e-d8311eb45009" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_81acd6db-341e-49ce-b473-453af2f4c3a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_99145d91-b07b-4a26-b3a3-0ccb42e23862" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_8a820b50-1552-4272-955e-d8311eb45009" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_99145d91-b07b-4a26-b3a3-0ccb42e23862" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_413cbf0e-e91a-42e4-a3af-4ed03b8d3e21" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_8a820b50-1552-4272-955e-d8311eb45009" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_413cbf0e-e91a-42e4-a3af-4ed03b8d3e21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/ShareBasedCompensationAdditionalDataRelatedtoRestrictedShareUnitActivityDetails" xlink:type="simple" xlink:href="cah-20210630.xsd#ShareBasedCompensationAdditionalDataRelatedtoRestrictedShareUnitActivityDetails"/>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/ShareBasedCompensationAdditionalDataRelatedtoRestrictedShareUnitActivityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_675c20ef-6880-460b-8aea-c5df4a075e96" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_6a60c4a2-d7c5-465a-bbb9-5d8ca5b8a076" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_675c20ef-6880-460b-8aea-c5df4a075e96" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_6a60c4a2-d7c5-465a-bbb9-5d8ca5b8a076" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_6d7ffdc0-04a6-495c-b2f8-b5af53c0951e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_6a60c4a2-d7c5-465a-bbb9-5d8ca5b8a076" xlink:to="loc_us-gaap_AwardTypeAxis_6d7ffdc0-04a6-495c-b2f8-b5af53c0951e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_70bb3494-423d-4b66-ba1b-64b7e80f6193" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_6d7ffdc0-04a6-495c-b2f8-b5af53c0951e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_70bb3494-423d-4b66-ba1b-64b7e80f6193" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_4055ac20-221a-4d7c-88d8-8926bc3fb1ac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_70bb3494-423d-4b66-ba1b-64b7e80f6193" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_4055ac20-221a-4d7c-88d8-8926bc3fb1ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceSharesMember_d610fb99-f21e-4276-9675-8f0ba6f17aaa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PerformanceSharesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_70bb3494-423d-4b66-ba1b-64b7e80f6193" xlink:to="loc_us-gaap_PerformanceSharesMember_d610fb99-f21e-4276-9675-8f0ba6f17aaa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_d5935ce6-49e6-4aa1-af37-e2c71b378d98" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_6a60c4a2-d7c5-465a-bbb9-5d8ca5b8a076" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_d5935ce6-49e6-4aa1-af37-e2c71b378d98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_a4eb8d2f-3ac6-487a-b637-44838bc9fd83" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_d5935ce6-49e6-4aa1-af37-e2c71b378d98" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_a4eb8d2f-3ac6-487a-b637-44838bc9fd83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_b9adecfa-ce3a-4da3-b129-c32eb4faae2b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_d5935ce6-49e6-4aa1-af37-e2c71b378d98" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_b9adecfa-ce3a-4da3-b129-c32eb4faae2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_503c7ef1-1da5-440f-9ed4-b135b3cf9c24" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_d5935ce6-49e6-4aa1-af37-e2c71b378d98" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_503c7ef1-1da5-440f-9ed4-b135b3cf9c24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_a47d42aa-1e2d-45fa-9d42-b84486ea77b8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_d5935ce6-49e6-4aa1-af37-e2c71b378d98" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_a47d42aa-1e2d-45fa-9d42-b84486ea77b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/ShareBasedCompensationScheduleofAllTransactionsRelatedtoPerformanceShareUnitsUnderthePlansDetails" xlink:type="simple" xlink:href="cah-20210630.xsd#ShareBasedCompensationScheduleofAllTransactionsRelatedtoPerformanceShareUnitsUnderthePlansDetails"/>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/ShareBasedCompensationScheduleofAllTransactionsRelatedtoPerformanceShareUnitsUnderthePlansDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_e5a095a8-3fc3-47b6-bd98-fe9baa352aad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_2d627ac7-8d3b-4157-a863-d8ca11332dab" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_e5a095a8-3fc3-47b6-bd98-fe9baa352aad" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_2d627ac7-8d3b-4157-a863-d8ca11332dab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_4177d5b1-0b08-42b3-99b4-39402a98c644" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_2d627ac7-8d3b-4157-a863-d8ca11332dab" xlink:to="loc_us-gaap_AwardTypeAxis_4177d5b1-0b08-42b3-99b4-39402a98c644" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_3ed0d0c7-a061-401f-9b9f-a51b838f8292" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_4177d5b1-0b08-42b3-99b4-39402a98c644" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_3ed0d0c7-a061-401f-9b9f-a51b838f8292" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceSharesMember_68d899a3-c390-4e99-b239-02f1f1e51195" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PerformanceSharesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_3ed0d0c7-a061-401f-9b9f-a51b838f8292" xlink:to="loc_us-gaap_PerformanceSharesMember_68d899a3-c390-4e99-b239-02f1f1e51195" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e9c939c7-9a18-4bd7-869b-9da7b53e272e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_2d627ac7-8d3b-4157-a863-d8ca11332dab" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e9c939c7-9a18-4bd7-869b-9da7b53e272e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_3dd8ab2a-0c49-4b5c-a6bb-ed79e5c2a7a7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e9c939c7-9a18-4bd7-869b-9da7b53e272e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_3dd8ab2a-0c49-4b5c-a6bb-ed79e5c2a7a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_30e2ddec-25dd-4a54-a9d3-31100af9986d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_3dd8ab2a-0c49-4b5c-a6bb-ed79e5c2a7a7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_30e2ddec-25dd-4a54-a9d3-31100af9986d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_bf1c5026-83ac-45b9-9d78-83e60f15f974" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_3dd8ab2a-0c49-4b5c-a6bb-ed79e5c2a7a7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_bf1c5026-83ac-45b9-9d78-83e60f15f974" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_315f722e-419e-498d-a396-23b2b3d4304b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_3dd8ab2a-0c49-4b5c-a6bb-ed79e5c2a7a7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_315f722e-419e-498d-a396-23b2b3d4304b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_fb52efb8-27c1-4af4-9e89-065d6f80309f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_3dd8ab2a-0c49-4b5c-a6bb-ed79e5c2a7a7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_fb52efb8-27c1-4af4-9e89-065d6f80309f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_dab22622-2e28-4a1d-be3c-730b971b91f9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_3dd8ab2a-0c49-4b5c-a6bb-ed79e5c2a7a7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_dab22622-2e28-4a1d-be3c-730b971b91f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_21a10e23-530d-411f-8d3d-3db51967584f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e9c939c7-9a18-4bd7-869b-9da7b53e272e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_21a10e23-530d-411f-8d3d-3db51967584f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_9e7dcb03-6909-41fe-b5b6-cffa11af8c33" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_21a10e23-530d-411f-8d3d-3db51967584f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_9e7dcb03-6909-41fe-b5b6-cffa11af8c33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_1a0ab315-1002-4a4f-bd6f-5e602ba740ec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_21a10e23-530d-411f-8d3d-3db51967584f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_1a0ab315-1002-4a4f-bd6f-5e602ba740ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_c0d4f2bf-6551-41bc-be8f-c71c017448e0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_21a10e23-530d-411f-8d3d-3db51967584f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_c0d4f2bf-6551-41bc-be8f-c71c017448e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_030d9583-ed97-4a7a-af06-28382641062d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_21a10e23-530d-411f-8d3d-3db51967584f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_030d9583-ed97-4a7a-af06-28382641062d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_b69c78f9-a7b0-4f4f-8225-43058a783ac8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_21a10e23-530d-411f-8d3d-3db51967584f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_b69c78f9-a7b0-4f4f-8225-43058a783ac8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_8739dc30-2387-4f13-9df8-4c897f8d5632" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_21a10e23-530d-411f-8d3d-3db51967584f" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_8739dc30-2387-4f13-9df8-4c897f8d5632" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/ShareBasedCompensationAdditionalDataRelatedtoPerformanceShareUnitActivityDetails" xlink:type="simple" xlink:href="cah-20210630.xsd#ShareBasedCompensationAdditionalDataRelatedtoPerformanceShareUnitActivityDetails"/>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/ShareBasedCompensationAdditionalDataRelatedtoPerformanceShareUnitActivityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_a5f75b9d-c788-4d22-95b6-cc46e8e321c2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_f86244c5-5a79-4389-b0b5-a2c4f972c41a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_a5f75b9d-c788-4d22-95b6-cc46e8e321c2" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_f86244c5-5a79-4389-b0b5-a2c4f972c41a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_7c0b041b-34a3-47db-9783-6e28b216fefa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_f86244c5-5a79-4389-b0b5-a2c4f972c41a" xlink:to="loc_us-gaap_AwardTypeAxis_7c0b041b-34a3-47db-9783-6e28b216fefa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_ad950051-d1e2-4a4a-bb2a-d10388dd2430" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_7c0b041b-34a3-47db-9783-6e28b216fefa" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_ad950051-d1e2-4a4a-bb2a-d10388dd2430" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceSharesMember_533125cd-267e-4dea-a9ba-06db150c87a4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PerformanceSharesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_ad950051-d1e2-4a4a-bb2a-d10388dd2430" xlink:to="loc_us-gaap_PerformanceSharesMember_533125cd-267e-4dea-a9ba-06db150c87a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_d144bfec-a58a-40bd-bed6-b27388832a87" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_f86244c5-5a79-4389-b0b5-a2c4f972c41a" xlink:to="loc_srt_RangeAxis_d144bfec-a58a-40bd-bed6-b27388832a87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_3bcba638-40d4-430e-8fa9-b5300cad6a71" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_d144bfec-a58a-40bd-bed6-b27388832a87" xlink:to="loc_srt_RangeMember_3bcba638-40d4-430e-8fa9-b5300cad6a71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_4c20c689-b71d-46ff-99f0-8feda610d528" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_3bcba638-40d4-430e-8fa9-b5300cad6a71" xlink:to="loc_srt_MinimumMember_4c20c689-b71d-46ff-99f0-8feda610d528" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_242d9bc8-22cc-463f-abbc-83d38746956b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_f86244c5-5a79-4389-b0b5-a2c4f972c41a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_242d9bc8-22cc-463f-abbc-83d38746956b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_86994b70-bf52-48c1-be82-c74dbef4f872" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_242d9bc8-22cc-463f-abbc-83d38746956b" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_86994b70-bf52-48c1-be82-c74dbef4f872" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_882e0e7d-cdbb-471e-9cc2-80aa8ba6e8f5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_242d9bc8-22cc-463f-abbc-83d38746956b" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_882e0e7d-cdbb-471e-9cc2-80aa8ba6e8f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_f915cd4e-3a21-4903-8bb2-5abf63f6fc68" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_242d9bc8-22cc-463f-abbc-83d38746956b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_f915cd4e-3a21-4903-8bb2-5abf63f6fc68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_VestingPeriodinyearsforShares_597ad2ac-a048-4abc-9869-3f85080f2c5f" xlink:href="cah-20210630.xsd#cah_VestingPeriodinyearsforShares"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_242d9bc8-22cc-463f-abbc-83d38746956b" xlink:to="loc_cah_VestingPeriodinyearsforShares_597ad2ac-a048-4abc-9869-3f85080f2c5f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_4ce874da-4cec-4cec-b6f0-87f221e49fdf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_242d9bc8-22cc-463f-abbc-83d38746956b" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_4ce874da-4cec-4cec-b6f0-87f221e49fdf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/ScheduleIIValuationsandQualifyingAccounts" xlink:type="simple" xlink:href="cah-20210630.xsd#ScheduleIIValuationsandQualifyingAccounts"/>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/ScheduleIIValuationsandQualifyingAccounts" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_srt_ValuationAndQualifyingAccountsAbstract_361e3e41-dfa9-47b2-a11a-dd0ecd24bbd2" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ValuationAndQualifyingAccountsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock_037751a8-d43e-450a-8b65-1afbc763e210" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ValuationAndQualifyingAccountsAbstract_361e3e41-dfa9-47b2-a11a-dd0ecd24bbd2" xlink:to="loc_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock_037751a8-d43e-450a-8b65-1afbc763e210" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/ScheduleIIValuationsandQualifyingAccountsDetails" xlink:type="simple" xlink:href="cah-20210630.xsd#ScheduleIIValuationsandQualifyingAccountsDetails"/>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/ScheduleIIValuationsandQualifyingAccountsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_srt_ValuationAndQualifyingAccountsAbstract_339195e5-4193-448d-9f6f-2e1ac37fca24" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ValuationAndQualifyingAccountsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ValuationAndQualifyingAccountsDisclosureTable_f2695750-7727-466c-a5dc-27f29e6eb7d8" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ValuationAndQualifyingAccountsDisclosureTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ValuationAndQualifyingAccountsAbstract_339195e5-4193-448d-9f6f-2e1ac37fca24" xlink:to="loc_srt_ValuationAndQualifyingAccountsDisclosureTable_f2695750-7727-466c-a5dc-27f29e6eb7d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_28fbce3a-20ba-4975-bd22-b0a6cf277a7c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureTable_f2695750-7727-466c-a5dc-27f29e6eb7d8" xlink:to="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_28fbce3a-20ba-4975-bd22-b0a6cf277a7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivableTypeDomain_04afd755-9586-4035-893e-111a88fa4fb0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReceivableTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_28fbce3a-20ba-4975-bd22-b0a6cf277a7c" xlink:to="loc_us-gaap_ReceivableTypeDomain_04afd755-9586-4035-893e-111a88fa4fb0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_c363f75d-1930-4b41-9c7c-fc2443f7fcc2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationAllowancesAndReservesTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureTable_f2695750-7727-466c-a5dc-27f29e6eb7d8" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_c363f75d-1930-4b41-9c7c-fc2443f7fcc2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesDomain_9dc9cf6d-97f6-422f-aa52-d97a561047a7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationAllowancesAndReservesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_c363f75d-1930-4b41-9c7c-fc2443f7fcc2" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesDomain_9dc9cf6d-97f6-422f-aa52-d97a561047a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_PricingDisputesMember_1302e1bb-181f-49c2-99cb-2bb301936623" xlink:href="cah-20210630.xsd#cah_PricingDisputesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesDomain_9dc9cf6d-97f6-422f-aa52-d97a561047a7" xlink:to="loc_cah_PricingDisputesMember_1302e1bb-181f-49c2-99cb-2bb301936623" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForCreditLossMember_1e1a4fa1-c9c8-4955-adb2-ea7e57a67ada" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllowanceForCreditLossMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesDomain_9dc9cf6d-97f6-422f-aa52-d97a561047a7" xlink:to="loc_us-gaap_AllowanceForCreditLossMember_1e1a4fa1-c9c8-4955-adb2-ea7e57a67ada" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_PriorYearRecoveriesMember_2408823c-fb2c-48cb-b8c2-b7727d923c70" xlink:href="cah-20210630.xsd#cah_PriorYearRecoveriesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesDomain_9dc9cf6d-97f6-422f-aa52-d97a561047a7" xlink:to="loc_cah_PriorYearRecoveriesMember_2408823c-fb2c-48cb-b8c2-b7727d923c70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForLossesOnFinanceReceivablesMember_8ad1c9d1-8ddd-465d-a5c9-7bb3c250d6c4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllowanceForLossesOnFinanceReceivablesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesDomain_9dc9cf6d-97f6-422f-aa52-d97a561047a7" xlink:to="loc_us-gaap_AllowanceForLossesOnFinanceReceivablesMember_8ad1c9d1-8ddd-465d-a5c9-7bb3c250d6c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesReturnsAndAllowancesMember_017d6b9b-0fb6-4a75-8184-baa74ea6cf4b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SalesReturnsAndAllowancesMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesDomain_9dc9cf6d-97f6-422f-aa52-d97a561047a7" xlink:to="loc_us-gaap_SalesReturnsAndAllowancesMember_017d6b9b-0fb6-4a75-8184-baa74ea6cf4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForLoanAndLeaseLossesMember_c5e64b03-c8b2-47a3-95f9-90f5f8befcf6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllowanceForLoanAndLeaseLossesMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesDomain_9dc9cf6d-97f6-422f-aa52-d97a561047a7" xlink:to="loc_us-gaap_AllowanceForLoanAndLeaseLossesMember_c5e64b03-c8b2-47a3-95f9-90f5f8befcf6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems_bdbc4f88-569d-4f43-9e0b-4c701e608c2c" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ValuationAndQualifyingAccountsDisclosureLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureTable_f2695750-7727-466c-a5dc-27f29e6eb7d8" xlink:to="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems_bdbc4f88-569d-4f43-9e0b-4c701e608c2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesBalance_6618911d-c225-40a6-9c70-2057797b3e2f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationAllowancesAndReservesBalance"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems_bdbc4f88-569d-4f43-9e0b-4c701e608c2c" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesBalance_6618911d-c225-40a6-9c70-2057797b3e2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesRecoveries_1f5384d4-5616-4408-8c29-7149ebc4d770" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationAllowancesAndReservesRecoveries"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems_bdbc4f88-569d-4f43-9e0b-4c701e608c2c" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesRecoveries_1f5384d4-5616-4408-8c29-7149ebc4d770" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_455e1081-13e2-4395-94df-8fef37e8b274" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MovementInValuationAllowancesAndReservesRollForward"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems_bdbc4f88-569d-4f43-9e0b-4c701e608c2c" xlink:to="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_455e1081-13e2-4395-94df-8fef37e8b274" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_881aee50-9791-42bc-b82a-51141eed5e5a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems_bdbc4f88-569d-4f43-9e0b-4c701e608c2c" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_881aee50-9791-42bc-b82a-51141eed5e5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesChargedToOtherAccounts_f6048b16-f643-4293-8165-871879a91080" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationAllowancesAndReservesChargedToOtherAccounts"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems_bdbc4f88-569d-4f43-9e0b-4c701e608c2c" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesChargedToOtherAccounts_f6048b16-f643-4293-8165-871879a91080" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesDeductions_5f192b78-45ff-4572-aa1f-7e60d4ad51af" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationAllowancesAndReservesDeductions"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems_bdbc4f88-569d-4f43-9e0b-4c701e608c2c" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesDeductions_5f192b78-45ff-4572-aa1f-7e60d4ad51af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>13
<FILENAME>cah-20210630_g1.jpg
<TEXT>
begin 644 cah-20210630_g1.jpg
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M;X5C\=?!CXG>'O%VB2RM%%K/AC6H+^T=UQN430.R$C(R,Y&:Y[XK_M<?LH_
M;7H/"OQR_:<^'O@S5+J(26VF^+/&ECIT\J$X#+'<2HS GN!BOQ6_X-FO!U]^
MR#_P6P_:X_X)_> /%NI77@+PW9ZH]A:ZA/O9WT[6H+6TFD  4S"WNW1W 7<>
MP& /+_VHO^"=O_!$_P#9T^,?QG\9_P#!7_\ X*PW_P 4OBWXGUVXNK*V^'-G
M,NI:3<N'+I<VD!O$BG5V54BGF2*..)%P 1@ _HPT'7]"\5:+:^)/#&M6FI:=
M?0+-97]A<K-#<1L,JZ.A*NI'(()!KA_&_P"UU^RA\,_'D7PK^)'[3OP\\/\
MB>X*"#PYK?C6QM+^0O\ <"V\LJR'=D8PO.>*_"+_ (-^OV[OBS^RM_P0#_:Q
M^)^D^(I;B;X7:E+<> H[U_-CTR^U"SBBCV*_'E"Z:.8QCAF:0XRY)R?^"6__
M  ;A?"O_ (*C_P#!+76/VY_C3\9?%MW\:/BE=:]>^#=:N];'V.VN[:[N+6.2
M^#122W/G7=O*TSEMWEN-@# LP!_1L"& 92""."*X'P)^U9^R[\4O'=U\+OAE
M^TEX!\1^)K'?]M\.Z%XQLKR_M]GW]]O%*TB;<'.5&,<U^,7_  57\1_MX?\
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M10 4444 %%%% !1110 4444 > ?\%8O^467[2W_9O_C+_P!,=Y7QA_P9Z?\
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M+[#XP^![K6K#P%<S)%##I=S>32S@7T,Y$BM!=3RR@(CK,K*OR??/]-%9.I>
M? NLZ_;^*]8\%:3=ZI:8^R:E<Z;%)<0X.1LD92RX/3!H _"?]MW]D#_@J_\
M\%)/^#<WP[\9_P!KZ#4_%7QG\,>/3XVTOPVGA:WL=5?PN;5[3[.UK:Q1AKDJ
MYO=NP2&,!-I?"U\_6?\ P6+_ &"/B%^S]\*?@-^QC_P0<^#OBO\ :1O;K3])
M\5:7XJ^ ^C7NF7\D<)CG:U-J4NIIII KCS%01 R;R^W+?TWUDZ=X"\"Z/X@N
M/%FD>"])M=5N\_:]3MM.B2XFR<G?(JAFS@=3VH _#K_@Z]_9>^+&@?\ !/7]
MF7XQ>$_@CH?AZ#X1WCVOB[0?A_IOE:/X9GO;6S;;!%$ (;-;FS:)7P "\0R"
MXS\S?\%\O^"U%A_P6)_88\'I^SY^R_XY\/\ @;P-XULM0^('BWQ3%;I:0:]-
M97,-MIEJ\,KBX_=R7<A=MC[44F-0:_IPO+.SU&TET_4+6.>">,QS031ADD0C
M!5@>""."#5;0/#GA[PII<>A^%M!LM-LHB3%9Z?:I#$A)R<(@ &22>E 'X3_\
M'6?@#Q?KO_!'[]EWX@:/H=Q<Z3X?N-,BUF[AB++:&YT1%A:0@?*K-$4W' W,
MJ]6 KC/^"^'_  4:^''_  5"_P"#?KX;_M(?"_P)K/AS3[3]IFQT&;3==DB:
M<3VWA[5B[YB8KL/FC'.<#D#H/Z#]7T?2/$&F3:+KVEVU]9W*;+BTO(%EBE7^
MZRL"&'L13=$T'0_#.EQ:)X<T:TT^R@!$%I8VZQ11C.<*B@ <GL* /PE_X. _
MV3OCKJ7[!_[''_!23]GGPI=:Q?\ P-\'Z)+XDM[.V:9[6U:UT^ZM;UT3YO)A
MGMF60C[HN%8X5688OQ5_X.8OVV?^"GGQ<^#G[,G_  1O^%'B?P#XYU/5UE\=
M7>N:5I^K6X1E6-TP\<JBPA#22R7+B%\(F A'/[_D!@58 @CD&LGPUX#\#>"Y
M+B7P=X,TG27NV#7;:9IT4!F(S@N44;CR>OJ: /YWO^"O_BOX<_LG_P#!RII'
M[17_  5-^".K?$;X&W/A/3D\*V]SHZ7EI-%%HZ0.R6TK+!.(M4-Q-);$X G#
M[6W(K9'[(7[3?@OX[_\ !U+\%/VG?#O[-^H?"3X<^--!O(?A;H^MZ*FFM>:5
M_P ([JFF6M['#%B)5N+J*55";DYP&8C<?Z/?$O@_PEXSLX]/\8>%M.U:WBE$
ML4&IV,<Z(X! 8*X(!Y//7FM!55%"(H  P !P!0!^&7_!+K_E;Q_:L_[$_7?_
M $MT2OW.HHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M6\+Z3)X[\8>(#XDT:SU.YG\->&5N(]$BN8UDC2]+S(5E5&#/%$)73[K -\M
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M<,!"@-U$=QXQN/:@#Z+I))(X8VEED545269C@ #J2:_.+2_^#JK_ () ZO\
MM+1?LWV?Q4\1^5/JPTV'X@R>'POAQYR_E@_:#+YPB+\>>81%CY]^SYJ^1_\
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M+E45Y(YHM[*K-'(^PN@?;O3=]8T %%%% !1110 4444 %%%% !1110 4444
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M\ 3_ /"^[+2=+T_QIX:O-)N#H5S]EU!UBCN8T=H6O8I\L!M)E=?45]U^%?\
M@FM^P_?_ /!J]]ONO@GX4&JR?LUS_$!_%S:3#_:*>(!I3:F+DW>WS<K.!#C=
M_JE\K[G%>MWG_!+OXD^)?^"$.O?L2?\ !4']MI]6\<>)8DU"_P#B1XZ\5-=6
MWAW5S<0/IUJMW=N&EACEBAB;+9E::<)_K%K\W$_8E_X.)O ?_!,#XE?LF?%[
MXL>%- _9E^'OP[\0:^/%&E>(M)U637]/L+:XO4TFQGM9&NOLT]Q$%Q,L6V-V
M0DJ/(8 S?@W_ ,J7'Q8_[+!;?^GS1J]:\<?L5_LT^!O^#-P_%33_ (,>&_\
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M[T"-S=^)4^WV^GFPA6)2TES+;V20IM5F#7)V@ER#W7_!'O\ X-R/VJ_V0O\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M,_LW^Q?+GOY=N_[9/]IS]NQG;'CRLX^;"\O_ ,$W?^" W_#OC]AKX]?L7_\
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M_P#HMJ]HKQ?X._\ (_VG_7.7_P!%M7M% !1110 4444 %%%% !1110 4444
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M?^1_M/\ KG+_ .BVKVBO%_@[_P C_:?]<Y?_ $6U>T4 %%%% !1110 4444
M%%%% !1110 RZ_X]I/\ KF?Y5\Y5]&W7_'M)_P!<S_*OFX7=J;HV(N8_/$8D
M,.\;PA) ;'7&01GVH DHHHH **** "BBB@ KTS]G[_CVU3_KI#_)Z\SKTS]G
M[_CVU3_KI#_)Z /1**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@#^7C_@HK<R?\$[O^"O_P 2+?\ ;1^
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MN<O_ *+:O:*\/^!%K<V/BO2[*\O6N9H;1DEN7&&E81$%SCN3S^->X4 %%%%
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M^#?[0_QPG\-Q6?C9M:T/PQ8>((K"[\4SV]K*LMK$2RS,%AFD+F#YU1V.5R&
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MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /$/BI_R/\ J/\
MUT3_ -%K7/5T/Q4_Y'_4?^NB?^BUKGJ "BBB@ HHHH **** .H^#O_(_VG_7
M.7_T6U>T5XO\'?\ D?[3_KG+_P"BVKVB@ HHHH **** "BBB@ HHHH ****
M&77_ ![2?]<S_*OG*OHVZ_X]I/\ KF?Y5\Y4 %%%% !1110 4444 %>F?L_?
M\>VJ?]=(?Y/7F=>F?L_?\>VJ?]=(?Y/0!Z)1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 >(?%3_D?]1_
MZZ)_Z+6N>KH?BI_R/^H_]=$_]%K7/4 %%%% !1110 4444 =1\'?^1_M/^N<
MO_HMJ]HKQ?X._P#(_P!I_P!<Y?\ T6U>T4 %%%% !1110 4444 %%%% !111
M0 RZ_P"/:3_KF?Y5\Y5]&W7_ ![2?]<S_*OG*@ HHHH **** "BBB@ KTS]G
M[_CVU3_KI#_)Z\SKTS]G[_CVU3_KI#_)Z /1**** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@#Q+5/VI?C+8:G<V%M^Q;XWNHX)
MWCCN8KFVVS*&(#C+="!D?6H/^&L/C9_T8_X[_P# JV_^*KW2B@#PO_AK#XV?
M]&/^._\ P*MO_BJ/^&L/C9_T8_X[_P# JV_^*KW2B@#PO_AK#XV?]&/^._\
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MWQW_ -^K;_X[7UY10!\A_P#"7?&S_HTWQW_WZMO_ ([1_P )=\;/^C3?'?\
MWZMO_CM?7E% 'R'_ ,)=\;/^C3?'?_?JV_\ CM'_  EWQL_Z--\=_P#?JV_^
M.U]>44 ?(?\ PEWQL_Z--\=_]^K;_P".UTOP_P#CE\;/ L5U'_PQKX[NOM+(
M<[[9-NW/^V<]:^EZ* /"_P#AK#XV?]&/^.__  *MO_BJ/^&L/C9_T8_X[_\
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M-MEECB*.")FCW?+NH ^[J*^2(/\ @K[^S]<?\$FT_P""JL*E]$?PB+Q/#:3
MW+:Z7^S#11CDS_;O]&SC_;^[S7FWBG]MC_@J/I'A3]G[]D[1/AI\+S^TU\8/
M#>H^)?&MYK=A?P>&/ NE6HC>19;>*=[BXN1]HAME59MK31R,<(1@ _0"BOA3
MX(_\%1/C5\&5_:'^%'_!3'PGX/L?&W[//@N'QI=ZY\,VN!I7BGP]/;SR0RVT
M%V[307*R6[0/&[$&1TV<<UROPT_X*%?\%0_A%XE^"OQC_;\^#?PETSX2?'SQ
M+I_A_3]/\#RZ@-=\!:CJB,^DQZC)<N8;Q)#L@F>-(Q'*^1P K 'Z*T444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 5^?G_!POH7Q)\3_  G_ &:O#GP;\=6WA?Q;??MA^"X/#7B2
M\TM;V'2[YXM06"Y>W8A9UCD*L8R0&"X[U^@=>(?MM_L:_P##8W_"HO\ BX__
M  CG_"J_CAH'Q#_Y _VS^U/[,\__ $'_ %T?D>9Y_P#KOGV;?]6V> #S_P#9
M"_9T_P""LWPT^,L'BC]L#_@H[X3^)O@Q-/GCG\+:/\(+319I+A@/*E%S%(S
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M1G %?>5>(?MM_L:_\-C?\*B_XN/_ ,(Y_P *K^.&@?$/_D#_ &S^U/[,\_\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
F**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH _]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>14
<FILENAME>cah-20210630_g2.jpg
<TEXT>
begin 644 cah-20210630_g2.jpg
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M"47QL^,?[3?_  =47?[37QO^$VH^!]4^(/A'4M:TOPQJX(NK+1WT2./31*"
M=S645NW09W9  (K^B77O"/A/Q4UJ_BCPQIVI&RG$]D;^RCF-O*.CIO!V-[C!
MK1H _"7_ ((@:%IOBC_@XY_;W\,ZS!YMGJ,GBZUNX\_?BD\2Q(P_$$U\\_\
M!.G_ (*-^*?^#7SX]?'+]A/]M/\ 9V\5>(-+U'74U+PGJF@B*%KTQ"2&&\3S
MV5);2ZA\EO,1BT31,I1FW*G],%97BCP)X'\;K GC3P;I6KK;,6MAJFG17 B8
M]2OF*=I.!T]* /PR^#GQR_X+6_\ !2__ ((C?M>_';XN7FL3Z7XNT]1\%?"]
MEX<M[6]FTL7WVC5H[9X8(YKRW^Q$VL1;>TQ65021S\6_ +]N+]B1?^")?B?]
MA;]FS_@GUJ^M?M+:MX5U8^/_ !Q9^$+:X-MI-O</>7>J2ZAN:Y6&.Q38(=J(
MC@CI@R?U9QQI$@BB0*J@!548 'I6;HO@OP=X;U"\U?P[X3TRPN]1DWZA=65A
M'%)<MDG=(R@%SDDY.>IH _G2\6^+=$\1_P#!DQX7T?2KU)9] ^(4EAJ:(V3#
M.WBR[N@C>A\JYB;'HP]:_:'_ ((I?\HC_P!G+_LC^A_^DB5]/T4 ?CG_ ,'7
M/[/'[9NE6_P@_P""B_['U]XDO/\ A4.K>;XLT;199Y4M5BN8;RRU*2VC.)(H
MIHI5E8@[5DC)PH9A\E?MU?\ !V//^WS^PWK_ .QC\+/V'=3L?'?Q-T5- U6X
M;6AJ%M#YQ59OL4$<(EGE?E8PVTHSAOG*@-_2#7/:'\)/A3X8\1S>,/#7PR\/
M:=J]R3]HU2QT6"&YESUW2H@9L^YH _!O]HO_ ((>_M5:=_P; > ?A2OP_OKK
MXK>!/&DWQ'UCP7:P&2^CL[I;F.:Q2->6N([::WF>,?-O@EC4,VT'Q2R_X+%_
ML$>/_P!GKX5? ;]C?_@@Y\'?%?[2=Y=:?I'BK2_%7P'T:]TN_DCB,<[VOV4I
M=333R!7'F*@B!DWF3:"W].%9.G> ? NC^(+CQ;I'@K2;75;O/VK4[;38DN)L
MD$[Y%4,V2!G)[4 ?B;_P<C_L#_M(^'_V;/V9?V[?V>O@5H.E>(_V?K.V7QEX
M*^'6C9TS0#FTNXY;.VB _P!!MKR"9#M'"3(YPJNP^-_^"W'_  6T^.?_  6!
M_8)\*W/A#]CO5_ 7PO\ "OCFQD\8^+-0U/[3;:AXDDLKQ;>PM'$<8:-(A>2-
M]YN8]XCPOF?L?_P7[^#/_!63QI\(_!/Q@_X)+?&#Q#I/BCP3J%__ ,)/X.T#
M4H8'\065RD&R41W'[FXDMWMSMC;YBMS+LR?E;\VOVO;#_@XC_P""\GA?P!^Q
M'\=/^"><?PH\+Z3XIM-7\2>,]2T2ZTZW,\4$ML;N1[N8[HT2XG?[/ KN[,N,
M[10!7_X.#O\ D@?_  2T_P"Q/7_TE\)U[!_P>O?\BK^S'_V.&N_^@:=7[8?"
MWX?:)\)/AEX<^%7AHN=.\,Z#9Z3IYDQN,%M"D,><<9VH*WJ /Q!_X/>?^36/
M@?\ ]E U'_TA%<7_ ,'(?[/&M?LU_M^? +_@KGXG_9ML_BI\)-,T'3-$^)WA
MG5-'BO[+=;RS?+=1S(\2K/;W6V)Y%*+-;#."R _OE4=Y9VFH6DMA?VL<\$T9
M2:&9 R2*1@JP/!!'!!H _!3]C7]O+]DS_@HA_P %1O 7P<_X)A_\$/\ X%VW
MPOTZ.TU#Q]XW\;_ S2K75_#[12M++>P3V#/#:E55(X Y=Y)\$; *Z'6?^5WK
M2?\ L3V_]0J:OV\\,>#O"/@FP;2_!OA;3=(M7D,CVVF6,=O&SD %BJ  G '/
MM6E0!^&/_!8/_E;._8X_[$_PS_Z?M=KSC_@LS^U /^"8?_!S[\.?V^_BM\,M
M:U?PG8?#R.6TATI$$FHQRZ7J.ERB%Y&6,O').&92P(&TG[RY_H5K,\2>"_!W
MC)((O%_A/3-56UE\VU74K".<0O\ WEW@[3[CF@#.^#GQ*TOXS_"+PK\8=#LY
M;>R\6>&['6;.WF8%XHKJW2=%8C@D*X!QZ5TE   P!10 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110!X_XK_P""A7[ O@3Q-J'@KQQ^W#\']&UG2;R2TU72
M-5^)>E6]U9W$;%9(98I+@/&ZL"K*P!!!!%;_ ,*/VM/V5OCSJC:)\#?VF/A]
MXSO4C:1K/PIXSL=1E"#JQ2WE<X'<XK^</]G'_@E_\ O^"LO_  <7_M<?LY_M
M%^+_ !AHNB:+X@\:>)+6Z\%:A:VUT]U#XEM;54=KJVN$,12\E) 0-N5#N !!
MI_\ !=#_ ((X_#3_ (()ZK\'?VKOV&/VF_'2:W>^*YTL8_%%_:2:C975K&D\
M=U;RVL$"M&,E)$:,C]X@)(8K0!_4317SQ^T9_P %*/V<?V)/V-O#_P"UY^V-
MXQ3PO8:SH]A)%I=M;//>7NH7%LLWV.U@'SR2#Y^N JH6=E4%AY%_P3K_ .#A
MG_@G#_P4P^*[? GX)>*_$GA_QG+!+-I7ASQUHT=E-JL<:EY3;/#--%(RH"YC
M+B3:K,%*JQ !]R45\U? S_@K!^R)^T#^W!XX_P"">/@O6->M/B?X AO)M;TK
M6M#>UAECMIH8G>WE8D3 ^?%(N.6C;>!@'#_CM_P5:_9'_9Z_;<\"?\$]O&^K
MZ]=?$[XAP6DVA:5HNAO=0QQ7$\T*/<2J0(0/(E=L\K&F\C!&0#Z2HKX:_P""
MB?\ P<._\$X?^":'Q:7X#?&OQ3XE\0^,XH(YM6\/>!=&CO9=(CD4/&;IYIH8
MHV9"'$8=I-K*Q4*ZD^^_L4_\% OV6/\ @H-\ A^TA^RW\15U[P]%+)!J<,EN
MT%YIEU&@=[:Y@?YHI K*P'*LK*RLRL&(![117YP:]_P=6?\ !(?1/@&/C[#\
M1_%=]#-XCGT:Q\+6?A@C6+N:&"":698))$1(%6YB'FR2(K,65=Q5@/I;]@G_
M (*D_LA?\%(O@#JO[1'[,WC"^NM-\/RR0^)=&U:P^S:EI$JQF4)/"&8?,@W*
MZ,Z-A@&)5@H!]$T5\\_\$[/^"GW[*O\ P5%^'VO_ !-_91U;6[S2O#6LKI>J
M/K>C-9.MPT2R@*K$[AM8<^M1?L3?\%2OV3_^"@'Q.^)GPB_9VU?7+G6?A+JD
M>G^,$U;17M8XYGGNH5$3,3YHWVDW([ 'O0!]%T5^<G[3G_!TW_P2?_9;_: U
M+]G?Q'XO\8^)M1T/47L-?UOP;X<2[TS3KE'V2Q-,\\;3%&!#&!)5R" 2017W
M;\!_CQ\(?VG?A#H/QZ^ OCRR\3>$?$UB+O1-:T]F\NXCR5/# ,CJRLC(X#HZ
MLK ,I  .NHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH _E@^'O[%'[6O[>'_!P7^UQ\(_V,OVL;[X.^+-,\3^--9N?$EAK-_8M
M>6<?B*WA:R:6Q990CRW$$A!W+^X!VDA:I_\ !.7]DOPI\<_^"SR_L2?\%T?C
M?\1M7\<>#M9-IX7T+Q)XBEU+3M?OXCYZV4UY=.\B6US&$EB6-5%RK!=Z,Z*_
MZ<_\$I/^"87[<G[-?_!P#^TY^VW\:_@A_8OPP^(=GXM3P?XF_P"$ETRY_M!K
MWQ'I][;#[-!<O<1;[>"5_P!Y&FW;M;:Q -7_ (.3/^")_P"TG^V1\2_AO^W3
M_P $YO!WVSXQ>%KZ"QURULM<L],GN+:!S<6.HQSW<T,0FMIE*<OO998L<0XH
M ^;O^#J_XEZIK7_!7S]E[X$^*?@WKWQ*\'Z#X?T_Q ?AEX?MWDG\2S7>M3PW
M-A#'&K,\DT.G0PX52V'XZUYK^W-XJ_:B_:=_;5_9Z_:N_8^_X(%?'CX&>(?A
M9XHMIM=OK'X2:A%!JUK%=VLMLCI;6$2 1*ERA+?>CGV'Y5 'VU_P5S_X)@_\
M%$OV_O@7^SS_ ,%#/@_\/[?P3^UA\'K"UG\0>!Y=;L'^T7,,R7 -K<I-):%H
MKN)YXD:38\5TRNP=0AYG]G+X>_\ !RU_P4-_;P^&OQ8_;.6]_9O^&'PZ:-O$
MVE^!O$,FGP^*$61)9;=[-+VX:ZDG*)&7EQ##'N*?/E9 #F?^"OFG2?\ !-C_
M (.1/V;/^"C^DP&R\+_%EK?0/&UT.(VF0+I-Y))VPMC=V,J@\EK8D<KQ+_P2
M1L)/^"E/_!R5^TA_P4:U*+[;X4^$(G\.^";EAF-9V5M*M)(CTVO9VE_*0.0U
MT"<;N?LS_@XV_P"";/Q)_P""EG_!/2;X?_ 'PA'K7Q*\(>*;'7O!>GMJ%O9M
M=L&-M=0>?<21QQ@V\\DGSNH+P1C.<4S_ (-Q/^":_P 3?^":?_!/E? O[0?A
M"/1?B7XQ\5WVN^,]/&H6]X]H<BVM8#/;2212 00)+\CL UPXSG- 'XN_\$IO
MVN]8TG]N?]I3]JOXC?\ !)SQ_P#M7^*?$_B60&?POX4DUF+PL+J\OI)UF3[)
M<+&9PD4<9(0B.UE1?E+ ?9/_  ;>_#']I_X1_M\_M0WFJ_L'?%3X'?!WXB>&
M+O7O#/A_QSX,O].L].N(;\?9;"*:X@CC=XX+VY557YO+BZ$*2&^/OV ?^"T?
M_!&3_@HC\5OVD_\ @DC\"M ^*WPQ^,MY+>WGAG4I(W3397FEN(X)K?[5;3!K
M>6>X6&6-V0Q28?#' ^OO^"'?[)?_  5>^&O@7XG_ !T_X*E_'OQ)JOBGXCW<
MT_ASX8W_ (K_ +0M/#22/+-*ZJLCP6S222*J6\#>7#%& <%RD8!\'_\ !F7^
MR!^S7\8_A5\;_B_\8O@MX:\6ZS%K6GZ#9R>)M%@ODM;)K>66:.-)E95\UG4.
M0,L(U'08JY_P:W>'[#X;?M$_M\_";PFK6VA:.R6EE8AB52.VN];AAZ]U0D9]
MZ^KO^#63_@G#^V=_P3B^ 7Q4\$_MF_!O_A#=3\2>,+.^T6V_X2+3M1^T01VI
MC=]UC<3*F&XPQ!/88K-_X(&_\$R?VR_V-_VS?VM/B7^U;\$1X=\+?%+7Q-X0
MO3XCTZ]&J6YU'4I6/EVES+)#^ZN(CB54/SXZ@@ 'F'_!D<Z']C'XR1AAN'Q/
MMR5SR =.AQ_(_E7@G_!%[XL^)?@_I/\ P5B^-OPYOI(M8\.>']4U?0KR#(:&
MXA;Q-+#,.XVLJO\ \!K2_89_8*_X./?^"0?QJ^)G[)G[#WP*\&^(?!7Q UF-
M=.^)OBJ>WETZPBC\R.'5DQ=1R0S"%_WD$L,WS1J%BD &_P"D?^" '_!%_P#:
MN_8U\4?M=_";]NCX?R2>#?BO;6V@Z+XF;7;"X;Q78!]7AN;KRK>XFEMC+#=1
M2;9PK#SL8)5@ #\\?^"+?QL\'?#;]@GQO\,=<_X(+_%+]H__ (6#KE];Z]\2
M_"W@B;4H1;FWBB2QAN%L9O)> EY1L<,LDV_@A2/TN_X-$OAY^UY\#/V*_B%\
M!_VJO@/X_P# D>C_ !!&H>%+/Q[X4O=*>2WN[2,3+;K=QH7C66 N=N0'F8GE
MJ^5/@U^R3_P<L_\ !&_PW\2OV$?V'O@1H7Q+^''C+5KNX\)>/4GMFETU[B);
M?[;;[[V V5P8DB+QW"21)+'N3>NYI/UB_P"",G[*_P"V5^R7^Q3IG@?]O;]H
MS7_B-\2M4U&74M6N-=\23:M_8D3I&D6FQ7,S%I1&L>]VR1YDL@4LBJQ /K"B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BOG+]OK_@
MI=\'?V -?^%?@'QGX1U[Q3XM^,?CF#PQX)\*>&5A-U<3.\:/<-YTB*L$;S6Z
MNV209TP",D8WQ(_X*[_LP?"W_@I/X4_X)8^(_#?C.3XC^,=.CO=*U"TTJV;2
M4C>"XG DF:Y$JMMMI.!$W)7GDD 'U-1110 445\L_LA?\%=_V8/VUOVPOBU^
MQ'\)/#?C.U\7_!K4;^R\5W>NZ5;0V$\EGJ#6$IMI([F1Y%,RDJ7C3*\D \4
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MVS[9)]HV?9]G^ICW;]W&-I^YZ* /A#_@E)_P1._X=B_%3X]?$S_AIC_A-_\
MA=VH077V+_A#/[-_L7RY[^7;O^V3_:<_;L9VQX\K./FPO+_\$W?^" W_  [X
M_8:^/7[%_P#PUC_PEW_"[M'OK'_A)/\ A!/L']B_:-,FL=_V?[=-]IV^;YF/
M,CSMVY&=P_1>B@#XH_X)K_\ !%WX;_L,_P#!.SQ9_P $Y?C!\2(?BSX7\::O
MJESKMU<>&CI*S6U[;P0/;B(74Y5E$.Y95D#!B" I4&O@'Q#_ ,&<OQ:TG5=8
M^$GP:_X*I^)M#^"NOZLMYJ/@N\T6XD>15(VB>&&\BM;R50J 3-&G0'8-H!_=
M6B@#X[\3_P#!&OX&Z3_P23UW_@DO^SWXKG\&>']9T'["WBR^TQ=2NY+IKF.X
MFOKB-9(!<2R.AR \:J"JJ%5%4:O['O\ P3!_X9/_ ."2X_X)<?\ "\/[?QX/
M\3:%_P )S_PC7V7_ )"]S?S^=]B^TR?ZK[=MV>?\_E9W)NPOU?10!^=7[)G_
M  ;M_!;X)_\ !*[QW_P2P^/GQHNOB)H'C?QA<>(1XIT_PXNC7>E730V:0/!&
MUQ=#S(9+-7#EMKAV1D*E@WRK;?\ !J)^VMJ/@6V_90\8_P#!:+Q==_ 6UOUD
M7P+#H]Z(S;K+YJQ+:/?M;1G?\P^\BO\ O!&3Q7[?T4 ?FK_P6\LO@[_P3"_X
M-Y_&7[.?P8M3IFC1^%;#P%X2L[B8-+=&\N$CN&=\#?*]O]LG=L#<P<X&>/HO
M_@B_^RUJG[&?_!+CX+?L_>(M,:RUG3?!T5_K]G*N'M]1OY'O[J%_]J.:Y>,_
M[GIBNJ_;9_X)X?L_?\% ;GX=Q?M%R:[>:5\-O&L'BG2_#MAJ"16&I7\(Q%]M
MC:-C-&JF1=@9,K-("3NX]UH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M.UKS)YFVQI]FD&3]2H%;M !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% 'SQK'_ "%KK_KY?_T(U6JSK'_(6NO^
MOE__ $(U6H **** "BBB@ HHHH W/AO_ ,CSIG_7R/Y&O=*\+^&__(\Z9_U\
MC^1KW2@ HHHH **** "BBB@ HHHH **** "BL3XD?\B-J?\ U['^8KPJ@#Z0
MHKYOHH ^D**^;Z* /I"BOF^B@#Z0HKYOKT#X _\ (6U#_KV3_P!"H ]0HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** /GC6/^0M=?]?+_ /H1JM5G6/\ D+77_7R__H1JM0 4444 %%%%
M !1110!N?#?_ )'G3/\ KY'\C7NE>%_#?_D>=,_Z^1_(U[I0 4444 %%%% !
M1110 4444 %%%% &)\2/^1&U/_KV/\Q7A5>Z_$C_ )$;4_\ KV/\Q7A5 !11
M10 4444 %%%% !7H'P!_Y"VH?]>R?^A5Y_7H'P!_Y"VH?]>R?^A4 >H4444
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M\,^,? VF:[X1\16&JV,EHBQWNFW:3Q,RJ%8!T)!(((//!%>N? '_ )"VH?\
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M5Y_7H'P!_P"0MJ'_ %[)_P"A4 >H4444 %%%% !1110 4444 %%%% !1110
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M*Y_QKW2B@#PO_AWO\$_^AM\=_P#A97/^-'_#O?X)_P#0V^.__"RN?\:]THH
M\+_X=[_!/_H;?'?_ (65S_C1_P .]_@G_P!#;X[_ /"RN?\ &O=** /"_P#A
MWO\ !/\ Z&WQW_X65S_C1_P[W^"?_0V^._\ PLKG_&O=** /"_\ AWO\$_\
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M_$7P$^-GAC^VO"?BS2Y-.\0:3]MGMOM5M(,/'YL#I*F?[R,K#L:W/"?A;0O
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M (*.^+-#\;_MG? )_&>I>&].DL=%G/B_5]/6U@>3S'41V-W"C$M@EF4MP!G
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
3"BBB@ HHHH **** "BBB@#__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>15
<FILENAME>cah-20210630_g3.jpg
<TEXT>
begin 644 cah-20210630_g3.jpg
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M ^ _^#A?_@KWJ?\ P2;_ &2+#5/A3;65U\4OB'?3:9X$COXA+#8+$BM=ZB\9
MXE$*R1*J'@RSQ%@R!E/YG>&/^"/?_!TC^T#\)H_VR-?_ ."AWB70O&&IZ?\
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M+P[8:79JY=;33K-((@QZD*@ R>YQ0!^+?_!8/_@IJ_[//_!1&Y_9G_X+%_\
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ML[N02)K=[J([ S*',@5_+*D ^3O^"L?_  34_8@^'W_!MS--X'^"OA33-2\
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M.&VA#%5,LTSQQ("0-TBY(&2/G#]H_P#X+M_LP?LA_L1?"7]NC]H7X1_$;2]
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MLG^!>FW,2Q^%[*;5+E$MHY?-C5;&3RXFVM\Z1M,41@I'W1C]K?V7OV<_AO\
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MM9%LV'\J.XMK&V1A_$K3:BT@'3=:J>PKTS_@Y4_:?^!_[!'[(WPH;QC^PO\
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MGI%\'/!_Q&NHHO#>LQP7MO=:7%-*(X[BX-R[1W<2.Z+-L$+Q!BY0D"-O6O\
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MBZ=/^TS^VEXCEMU-W:^)="MH)2HRL<M[KS.N>O)AC/\ P$>U 'UE_P $)/\
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M\)5HYL/^%=_\(=Y?V7.FVMCO^W_;#O\ ^/;S,?9U^_MSQN/W/10!\,?L'_\
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M_M!P^+;+XW:?J]G=^ +CP4+:/3HK_4+>[=6NC>2BY4" Q$&&/<),\8VGY/\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MFU_Z]D_]!% %BBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M !1110 5\\:Q_P A:Z_Z^7_]"-?0]?/&L?\ (6NO^OE__0C0!6HHHH ****
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M? G_ **SH/\ X,4_QH_X:*^!/_16=!_\&*?XU]3?\*N^&?\ T3O0O_!1#_\
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M &1_^B]:#_W^?_XFC_AN?]D?_HO6@_\ ?Y__ (FNZ_X5=\,_^B=Z%_X*(?\
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MB^$Y-8U-YK'PU;MXAT]9WL+8_)!-.'*RS<NRC:"JE@WZ@U\L?\%K?V</C/\
MM;_\$ROB7^SW^SWX-_X2#QAX@_L;^R-(_M&VM/M'D:U8W,O[VYDCB3;##(WS
M.,[<#)(!^IZ "BBB@ HHHH **** "BBB@ HHHH ^'/\ @Y'EF@_X(L?&F>WM
MS-(D?A]DB#8+D>(=,PN3TSTK4^ /_!0O_@H_\4?C+X>^'WQ7_P""*_C3X?\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
C%%%% !1110 4444 %%%% !1110 4444 %%%% !1110!__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>16
<FILENAME>cah-20210630_g4.jpg
<TEXT>
begin 644 cah-20210630_g4.jpg
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M ^ _^#A?_@KWJ?\ P2;_ &2+#5/A3;65U\4OB'?3:9X$COXA+#8+$BM=ZB\9
MXE$*R1*J'@RSQ%@R!E/YG>&/^"/?_!TC^T#\)H_VR-?_ ."AWB70O&&IZ?\
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M+P[8:79JY=;33K-((@QZD*@ R>YQ0!^+?_!8/_@IJ_[//_!1&Y_9G_X+%_\
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M?:M_8!N-1O;0:+'+:2W44>T1R/;0AGP  Y( %<%\5/\ @Z@_X)$_"7]I.?\
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M^#1WX%?L_?LJ_"YO%'B]_%$FJKI#:S96&;1-;UAFE\V\FBBZ2(<;MQW< \T
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MM\2O%O@G1]3\1^%]:O(O#6OZAID4U[I*3^.+J&=;:=U+P"2*-$<(5WJBAL@
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MOO&GA?XB^(-)U&VN;O3()T6.4S2YM[SS(?.E/V=0$\HJ&D."?EWQ+_P=8?\
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MT&EZK#$T)CN);<QEC<JMO"@D#CY8\8^9MWNE 'X8_ +_ (,S+?6_BG!\1O\
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MG_!8#QI\0O@]X-O(I=-\#06U[EXH@42.+[5>2Q6A$1**X24QHQ1, YK]KZ*
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M<GPYO[33/BG\7-</A35?%EMID>S3Y;634X;N]AB=3$D\QTP[5V[4\]V0#8N
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M)^U?_P %/M"^&=_X:^'OCK6KVR\(17MN(U8WFJO?M;(4^1FMX8K=9-F55IE
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M/VM/V_O$7Q6_:9\56=Q::!X1U[XBBXN=+U0ZAY(C-D2UVYC@'GO)*XA*%"%
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M&E""*0MM!P$)/ H [.BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *^8/^"UO_*(_
M]HW_ +(_KG_I(]?3]?,'_!:W_E$?^T;_ -D?US_TD>@#\3?^"#G_  ;@?L1?
M\%1_V"Q^U!\>_BK\5-&\1-XPU+21:^$-:TV"R$-NL)1MEQI\[EB9#G]Y@X&
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MT&F^*_%]_)K9B8@3I:7.J/'"_JIDD63!_B@4]J /U5_9M_X.I/\ @DQ^TO\
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M!/B'5?$__!&[]GK4M8=FFB^'T%HA?KY5O++!$/IY<: >U?7U !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 5X/\ \%0O@S\2OVBO^"=?QJ^!/P<\-_VQXJ\6_#?5=+\/
M:5]LAM_M=W-;ND<?FSND<>6(&YV51W(KWBB@#X$_X-N/V)_VF?V!_P#@FZGP
M"_:V^&0\*>+!X[U746TDZS97_P#HLRP"-_-LYIHN=C?+NR,<@9%?'_PL_P""
M/7_!0G_@F%_P7JD_:K_8#^ /_"3_ +/7C/4"OBJRL/%FDV/]FZ5J+YO++[-=
MW4,LGV.=5N80BL&2.&/<6W@?MW10!^(?[4?_  3P_P""O/\ P2X_X*I?$#_@
MHK_P2(^$.A_$[PG\8FNKCQ9X,U26-A:7=U,+BXCF@-S;R.OVH-/#- ^4$C1N
M N?,^F/^"%_[,O\ P5]T/XD?$O\ ;$_X*K_&OQ!9W'CR>4^%_@P_B=KS3="\
MZ=9I+E+=9I8;,*J)##"CEE1I3)\Q%?I)10!^&/\ P<C?\$#/VQOV[OV[O"7[
M2?[$GPLM]9LO%?AFVTCXE79\0Z?8C3Y[6<)%>2I=7$3W"M;/&NV(.1]AZ LN
M?U(_:1_X)U?";X\_\$T]8_X)I6$W]D>%Y_AW:^&- NA )/[.:SBB%A<%!C?Y
M4UO!(5R-VPC(SFOH:B@#^=_X=? C_@ZX_9:_90N_^"1_P;_9_P!-'A:/4);7
MP[\7- \16\%[I=A+=&>3['J(OHO(A9S(P,D(N8UD95VGRPOV=_P4V_X)>?M_
M_%W_ (()>&_V&M!\7ZM\=?C79:WI5_XFUS6/%$$<M_,MQ+/<;+K49H0T4(D$
M49=@[I&I*[B17ZI44 ?G9^T9^PI^U3X\_P"#;'3_ -@/PI\+/M?Q;@^"?A;0
M)?"?]N6,>W4;-M/-Q#]J><6QV""7Y_-V-M^5CD9\@E_X(U_M7?%__@V'\-?\
M$V_&/A2T\,?&3PTEQJMEH&H:S:S0&]BUZ[O([9KFVDD@S-:S%5<.55Y4WE=K
M8_7*B@#^=^#]C'_@YG_:]_X)CS_\$R?BG^SYX:\%_#WX>>'+>WTXW5W91:YX
MS^P2(^G:0)3?M;B*.2.%O/*P)MMUS)(P*O\ 57BW_@A?\>/VHO\ @W)^&/\
MP3_^)VB67@[XT_#=IM:T*RU+5(+BWAU);V_/V6:XM'EC,<UK=LNY&8*[1LWW
M"*_7:B@#\!;?P!_P=M?M5> _AI^P;XG\#_\ "E]'\"ZC:1:I\:-$\2)I]_<V
MUM$;='N[JSU!S>*(V),5M&//8*7S@L/K#_@Z<\;M\ ?^"%UY\%-2\8:AK6H^
M*]=\,>$XM6U27S+W5);:9+YYY6'+22+IKLY'4L?6OU*KXL_X*2?\$P_B#_P4
M3_:]_9V\8^,O'.A6WP<^#OB2X\2^*/"LWG/?>(-3!C:UCV>7Y7D(855BSABE
MQ.,'Y: /:?\ @G!\ ]0_9<_8#^#?[/FM6A@U+PG\-](L-9B*XVWRVD9NN.W[
M\R5[5110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 445\\:Q_P A:Z_Z
M^7_]"- 'T/17S+KFNZ)X8T:Z\1>)=9M-.T^R@::\OKZX6&&"-1EG=W(5% Y)
M) %-T#Q#H'BS1;;Q)X6URSU+3KV(2V=_I]RDT,Z'HZ.A*LI]02* /IRBOFRX
MN+>SMY+N[G2**)"\LLC!510,DDG@ #O67X?^(/@+Q;X63QSX5\;Z1J>B2!S'
MK&GZE%-:MM8HV)48H<,"IYX((ZT ?4]%?*G_  LSX;_]%!T/_P &T/\ \553
MQO\ &KX-_#.ZTFQ^)'Q:\,^'Y]>G$.APZYKUO:/J,AQA(!*ZF9OF7A,GD>M
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M"_\ "W/AY_T,'_DI-_\ $4?\+<^'G_0P?^2DW_Q%>)T4 >V?\+<^'G_0P?\
MDI-_\1710S1W$*3Q-E'4,IQU!Y%?.-?1&C_\@FU_Z]D_]!% %BBBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KYXUC_D+77_7R_P#Z
M$:^AZ^>-8_Y"UU_U\O\ ^A&@#\C_ /@Y7_:U\?>+_!-Q_P $[/V=9#<7Z^%+
MCQO\8;RWE(73- LP)(+:1ESM,\P1BIP>+=?NS&OM'_@C?_RBT^!/_9.K#_T$
MU^.GQ]\-_P#!8CX'>%OVJ?B;\4OV&[6\TKXR?;#XZ^)6OKOO--T6-F6&*T\N
M\"PP)'LPIC<X2,'(C4#] ?\ @B]^V?KWP1_X)3>&/'_[?L&@?#'P5H$MGHGP
M]\0W1D1-9TMK9'@N)#YDN9'D\Y>%08C^Z.I -C_@N=\3?^"A&N^!M2_9;_8T
M^&GV+PQJOPYU/7?B=\4[F1XXM+TN!)O.L(GV[5GFCB9<*7D99,!8P&E&#_P1
M:_9V\$_M:_\ !OOX:_9N^(^J:K9:'XP@\0V&IW>B3QQW<41UR\8F)I8Y$5LJ
M.61A[5]G_MJWUIJ?[#?Q:U*PG66"X^%&O2PRKT=&TR<@CV((KYN_X-N/^4//
MPO\ ^O[7_P#T]7M 'YP?MK?\$(/V1/AW^V]\&_\ @GY^R5\1?B1JOC?QY.^K
M>--0\4:OI]S:^'_#D6_S+@1V]E QF;RIBFY]N80I!,JE>\_X*]>&?V>/!7[8
MGQQ\"_M/M9"VT/\ 9#T^Q^ "^)9-Q%Y%<1HGV,M]ZZ\]9>5^8KYV?EW5]-_\
M$G7/[3?_  5U_;$_;/U]?/\ ^$;UZW^'WA.9AE8[2VEDBFV9^Z&&GVK\=3,Q
M/4Y^\_CS\//V;=9\/GXM?M%_#+PAK%GX$L[C6(=9\4>'[:\.C1PH99;B)YD8
MPE5CW%DP?E'I0!^?NB2>/OVUOBO^QO\ L)_$IKFZB^&?PLT#XK_'1+S<7EU&
M"QAATRRN=W65KIWEEB;.Y6W8^7-?I_7XGW7C?]H?4?@/X2_:ATWQUXA^'WBS
M]O+]JG1M)U3Q3H=QY&JZ!X)\R2TTVSMI^3#*(1YJ2J>8V [FOM7_ ((G_&/X
MR>+_  I\</V?OC#\5M;\=M\&/CIK?@_P]XP\377VC4K_ $VW<"(74Q&9IE(<
MESDX<+T44 ?;=%%% 'T1H_\ R";7_KV3_P!!%6*KZ/\ \@FU_P"O9/\ T$58
MH **** "BBB@#YXUC_D+77_7R_\ Z$:_(_\ X.5_VM?'WB_P3<?\$[/V=9#<
M7Z^%+CQO\8;RWE(73- LP)(+:1ESM,\P1BIP>+=?NS&OUPUC_D+77_7R_P#Z
M$:_G5^/OAO\ X+$? [PM^U3\3?BE^PW:WFE?&3[8?'7Q*U]=]YINBQLRPQ6G
MEW@6&!(]F%,;G"1@Y$:@ '[%_P#!&_\ Y1:? G_LG5A_Z":P/^"QO[:OBK]D
MK]F"+P9\$(I;WXN_%C5$\)?"S2K,C[0U_<E8WNT&>/(60$,?E$LD ;AB:\4_
MX(O?MGZ]\$?^"4WACQ_^W[!H'PQ\%:!+9Z)\/?$-T9$36=+:V1X+B0^9+F1Y
M/.7A4&(_NCJ?(/\ @H;X;_X*PP_\%>+;]LC]F3]C.V^*_A/P/X2M=/\ A9-K
M@#Z9:FZLXY+J\CCCNX':X\V:>/>W\(3@F-" #R'_ ()5_$_XI_LH_P#!#/\
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MZ9_;CV_VFW<89/,A=)$SZHRGWK[,_P"%7?#/_HG>A?\ @HA_^)H_X5=\,_\
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MM,LO#'AIK"3PG)X?U\6=YH,UE'Y5K-:3+DQ21QY0$@C:Q!!S7Z'?\*N^&?\
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MM?\ @@7<W.I^)==CU'XK_%K6/VJ_#=SJ?B'4YY!]LU>Z41-)(1N=T@#MM4;
MQ8L[>M>,_#_[?O\ P3F_;!^-OC_]E+]B6Y^.7@;X^:E9^)M$M]%\6V.F3>&/
M%*64=E<Q7PO'3=9W'DPS>?&3Y>UU(Y!H ZO_ (-^G.F?L+:]\.[' TGP=\<O
M'FB>'TC_ -6EC'K]W)&J>B RN !P,?A7W!7SY_P2V_9(\6_L2_L/^#O@7\2]
M:M=3\8AK[6O'&I61)AN-:U&\FOKS82!N1);AHD; RD2G )KZ#H **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
9HH **** "BBB@ HHHH **** "BBB@#__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>17
<FILENAME>cah-20210630_g5.jpg
<TEXT>
begin 644 cah-20210630_g5.jpg
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MJ_)'X:?\KB?Q"_[-O@_] TROUNH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KXX\3?\$EO^$B_P""
MS?A[_@KI_P +_P#)_L'P._AW_A7W_"*[O/W6MS!Y_P!O^U#;_P ?.[9Y!^YC
M=SD?8]% !7R1_P $U/\ @EG_ ,.\/C1^T-\7O^%Z_P#"8?\ "^OB1)XK_L[_
M (1C^S_[#WW-[/\ 9O,^TS?:L?;-OF;8O]7G;\V!];T4 ?E-X"_X-=_ _AG_
M ()(^,?^"7_C#]K*YUVZUSXK'Q_X;\>V_@H6(TC4186EDD3V9O)OM$?EP3!B
M)D)%R<!2@+0:'_P;I_M9>/OC)\$_VH?VLO\ @K3KOCWX@?!3QCI>I:"NH> 8
MY-+&EV,\,ZV"1+=Q.LTS0CS;QB[N-H*,4#M^L%% 'R!^RM_P2E_X9F_X*=?'
M+_@HY_POK^V_^%SZ?#:_\(;_ ,(M]F_L?RVMSN^U_:G^T9\CIY,>-W7CFQ^S
M_P#\$L_^%%_\%8/C/_P4_P#^%Z_VI_PM[PO9:/\ \(/_ ,(QY']D_9XM/C\W
M[9]I?S]WV'.WR8\>;U.WYOK>B@#X(_8V_P""('_#)/[-O[3_ .SW_P -._\
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M#=<^$^KG7? WQ2@MEFU"#6I':2YNID1X]Z32,&V)(AC\F#:^(@#+_P $[?\
M@B7\:/V?OVS9O^"A?[>O[=>L?'3XIV?A@^'O"US+I'V"TTFR*LA8CS&,KE'E
M 4*B*9YG(D=]Z_H?10!^3U[_ ,&T_P 4- _:E^*WB;X'_P#!2CQ?X"^"'QMU
MN?4OB1\,/#VDF.ZOTGEEDET];L3A4@;SYD$@C#B&0Q,'Y8]SX _X-W-#\&_\
M$7?&7_!(K6OVHY=8;Q)XD?7=/\?Q>#A9_8;L7-K<Q*UF;N7S$#6H1OWREED;
M&T@&OTHHH _+75_^#>G]H'XO_L%_"G]D']HW_@HY=>(=7^%GQ9M_%FE>)[GP
M5+>*NF6UDEI;Z+&DM^C)'&%+"7=QO*^6<%CZ#_P5+_X(>>+_ -LO]I_PO^WG
M^QS^U]J_P+^-'AS1_P"R;GQ'I=@\T6JV8WA!)Y4L3QR*DLD98^8LD>U&3"@U
M^A-% 'YB_"7_ (-G_A%X<_8#^-/[+'QF_:1\0>,_B-\>M4M=8\<_&"[L/])&
MHVER;NT=())G:2-)VD>3?*7G,TF73*"/S#6?^#8S]K3XS_#SX;Z+^TW_ ,%?
M]=\2:M\'=8T\_#"WD^'J3Z1I&F6HY@>V^V127$\ABM!]H>7<D=N8R) RM'^Q
M-% 'R1X:_P""6?\ PCO_  6*\0_\%9?^%Z^=_;WPW3PI_P (!_PC&WR-JVP^
MT_;OM)W?\>_^K\@??^]QS];T44 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5\=?\ !>3]O'XI?\$Y
M?^":7C7]HSX(6UO_ ,)A]JL='\.WUY;+-#IT]W.L9NVC8%7,<?F,BL"IDV;@
MRY4_8M?*O_!9GXI_\$]OAW^PKKWAG_@IOJE[:_"_QS?0^'IGT[2+N[N/M[K)
M=6S1?98I&AE0VC2I*X"!XE!)W!6 /RLU/X!?\''G[-/[.G@/_@IK^SK_ ,%*
M_$/[1UUXA;3=2UCX5Z!#>:[92VMTH=EAMP7BN(E)$<A@C@>,,60C9N'[/?$+
M]MKX$_L\_LR:#^T]^V!XTL/A1I6K:38W%[9^+[@P3V5Y<0+*;#RR/,EN$.]3
M$B%_W;G;A3C\+?VO_P#@C7^VI_P0B^"^J_\ !2#_ ()F?\%,M5N_A]X=GL=3
MO_#E^[6K7-I<W,$$)DCC=[+55+31%A)%%E3E5) !L_\ !4/]K3XD?MZ_M\_L
M$ZOXC_8_E^,.B^)/@19_$$? VUUN.QM-;UF]2^>[@\V=71HXO[/@?;(K>9%&
M8R/WK"@#]W?V6OVQ_P!EW]MGX?2?%/\ 92^.&@^.="@NC;7=YHEUN:UG #>5
M-$P62!]I#!9%4E2"!@@UY[J/_!7;_@F9I/QKUW]G;4_VV/ 4'C'PS;7D^N:1
M+K  M1:1O+<QF;'E-+$D<A>%7,B^6^5!4X_*7]C_ .%W[>G[+7[6_P"U=^V%
M\./^":FM?LS?#+Q/^S9K]W;^#+/7+.[T[3/$VGZ>EQ9S0):B,1LSI<,D:Q!4
M^TR!< @#A_V$O^"<_P"P;\3_ /@UA^)O[5/Q&^%7AR]^)<GAWQ?XA;Q_>VR/
MJ^GZIILUR+"VANC^]@1_L]N&A5@LAN6+!MPH _;BX_X*)_L-VOPZ\#_%VZ_:
MC\'Q^&/B7JS:7X"UQ]646VNWBS- T%NYX=Q*K)CU!KE_AS_P5\_X)B?%G6_&
M&@?#[]N'X>ZA<> M-FU#Q4XUU(H;.SA8++<K-)MCGA1F4&2)G4%U&?F&?P,_
M:9\(:7\0?^" ?_!.7P%KAD%EK?Q;UO3[PPOM<13:U>1OM(Z':QP:^E_V^?\
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MR*T8>-GC<Q0O\DD;J\$;*XVE6\8_X)Z?\$&/B'\"/VPK7_@H#_P4#_;AU_\
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MM8TGX2_ +PU%\._#.@IJLL>EW'B!GFDO]5FA0[)9H);::(.P.(I(\#/3J/\
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M\4?'CPI\&KF.;X9^!=1T^>&UADB9&A>X,]S-\BF*(M$H/F")%:0QKL;]9:*
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%>=WGQ[^R7<MK_PBF[RI&3=]NQG!QG[E 'HE%>;
M_P##0?\ U*/_ )/_ /VNC_AH/_J4?_)__P"UT >D45YO_P -!_\ 4H_^3_\
M]KH_X:#_ .I1_P#)_P#^UT >D45YO_PT'_U*/_D__P#:Z/\ AH/_ *E'_P G
M_P#[70!Z117F_P#PT'_U*/\ Y/\ _P!KH_X:#_ZE'_R?_P#M= 'I%%>;_P##
M0?\ U*/_ )/_ /VNC_AH/_J4?_)__P"UT >D45'9W'VNTBNMFWS8U?;G.,C.
M*DH **** "BBB@#SN\^/?V2[EM?^$4W>5(R;OMV,X.,_<J/_ (:#_P"I1_\
M)_\ ^UUP&L?\A:Z_Z^7_ /0C5:@#TC_AH/\ ZE'_ ,G_ /[71_PT'_U*/_D_
M_P#:Z\WHH ](_P"&@_\ J4?_ "?_ /M='_#0?_4H_P#D_P#_ &NO-Z* /2/^
M&@_^I1_\G_\ [71_PT'_ -2C_P"3_P#]KKS>B@#TC_AH/_J4?_)__P"UT?\
M#0?_ %*/_D__ /:Z\WHH ](_X:#_ .I1_P#)_P#^UUZ)9W'VNTBNMFWS8U?;
MG.,C.*^<Z^B-'_Y!-K_U[)_Z"* +%%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !7SQK'_ "%KK_KY?_T(U]#U\\:Q_P A:Z_Z^7_]
M"- %:BBB@ HHHH **** "BBB@ HHHH ^B-'_ .03:_\ 7LG_ *"*L57T?_D$
MVO\ U[)_Z"*L4 %%%% !1110!\\:Q_R%KK_KY?\ ]"-5JLZQ_P A:Z_Z^7_]
M"-5J "BBB@ HHHH **** "BBB@ KZ(T?_D$VO_7LG_H(KYWKZ(T?_D$VO_7L
MG_H(H L4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%?/&L?\ (6NO^OE__0C7T/7SQK'_ "%KK_KY?_T(T 5J*** "BBB@ HHHH *
M*** "BBB@#Z(T?\ Y!-K_P!>R?\ H(JQ5?1_^03:_P#7LG_H(JQ0 4444 %%
M%% 'SQK'_(6NO^OE_P#T(U6JSK'_ "%KK_KY?_T(U6H **** "BBB@ HHHH
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M:BBB@ HHHH **** "BBB@ HHHH ^B-'_ .03:_\ 7LG_ *"*L57T?_D$VO\
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M -!% %BBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M_P @FU_Z]D_]!%6*KZ/_ ,@FU_Z]D_\ 015B@ HHHH **** /GC6/^0M=?\
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M&OQLN[N6Z_X9*\=KYLC/M\NV.,G./];7UQ10!\A_\)=\;/\ HTWQW_WZMO\
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M%#Q7H^B:YX>\"-J:>(? QU=UCL)[B>YE:WO5C>2-+@1HI#-^[RHS0!^D5%?
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MPMI-W^SC^S5X<N=+;4[6SE;5?%_C&UC,U[;6=QYOE);P9CM2#$2TTJN)-@8
M ^[:*_-V/_@H#_P5L_9IT[X4?M/_ +=_PK^"2?"#XH>*]'T37/#W@1M33Q#X
M&.KNL=A/<3W,K6]ZL;R1I<"-%(9OW>5&:[GXW?MC_P#!2KXY?M6?$_\ 9_\
M^"8W@7X1G2O@?9V$/C/7OBO_ &A(/$&O75L+Q='L/L<L:P".W:/S9Y2P6295
MP I) /NFBO'?V OVO-#_ &[OV1/!?[4FB^&)]"D\26,J:OX?N9?,DTG4K:XD
MM+VT9L#=Y5S!,@8A2RJK;1G%>Q4 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %?#G_!R.EQ)_P18^-,=I.(I6C\/B
M*0KN"-_PD.F8..^#VK[CKQ#_ (*/?L:_\/ _V,?&7[(G_"Q_^$2_X2[^SO\
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M>_LW?#CXT3?#S5O&WA^72(_&-OI!OI-.@F(6X*PB:$LSP&6,$2(4,@8$E<$
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8H **** "BBB@ HHHH **** "BBB@#__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>18
<FILENAME>cah-20210630_g6.jpg
<TEXT>
begin 644 cah-20210630_g6.jpg
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MVJ?$?[$7[ OQ6_:J\':#!J6L^#/",]YHUG= F%KQBL4#2@$%HUDD1W4$$JK
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MV"+)+%"D3G($H[[XL?\ !M?_ ,+/_P"".OPR_P""37_#:'V'_A7/Q(N/%?\
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M_P#:'\/7O@+4_"MUJ4LFG:7XC@GCDLK^"%CLAFG>YM;8E<;D$A.2*_&^-?\
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MQM*,_GFS9@0'B\WYPK X;D8KLZ /B#_@I?\ \$:_^'B?[+/P;_9I_P"&CO\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **\[O/CW]DNY;7_ (13=Y4C)N^W
M8S@XS]RH_P#AH/\ ZE'_ ,G_ /[70!Z117F__#0?_4H_^3__ -KH_P"&@_\
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M_P#7LG_H(KYWKZ(T?_D$VO\ U[)_Z"* +%%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !7XR_$C_DHFO\ _8:NO_1S5^S5?C+\2/\
MDHFO_P#8:NO_ $<U &+1110 4444 %%%% !1110 4444 ?LU\-_^2=Z!_P!@
M6U_]$K6U6+\-_P#DG>@?]@6U_P#1*UM4 %%%% !1110!\\:Q_P A:Z_Z^7_]
M"-5JLZQ_R%KK_KY?_P!"-5J "BOFW_@H7_P4O^%/[ ?AZTTS4O!7B/QKXYUW
M1]1O_#/@CPEIAN;F:"SA,DUW<L"!;6<?!DF.2%#E5?8V-G]@W_@H+\(/V]_
MFJZWX(T/7O#?B3PM<06GC7P5XLTTV>I:+<2Q>9'OC)(:*10S1R X=5/ (*@
M]YHKY/\ !?\ P6J_8'\>?&O3_@QH/CS7!'K/B)M \/\ C:Y\+W47AS5M55BA
MLK;467RI)"P*J>$8XVL=RY^L* "BOF7]J/\ X*V_L=_LE_$R]^$/CW5?%&MZ
M[HFGQW_BVU\%^$[K5E\-6<B[DN-0>!2MLI7Y\$E]I#;<,I/IWB[]L;]F;P-^
MS+_PV-XE^,&E0_#5M&AU2'Q2C,\,]O+M$7EJJEWD=F5!$%,A<[-N[B@#TRBO
MGC]DS_@I]^RU^V+\0[_X/_#VY\3Z#XOL=*754\+^.?"USI%[>:<S!5O;=)U
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MP-\9WGQ'^"?@[XAZCC[1KWA;3]1GPN/GGMHY6X'3EC7Y;_%+_@HI\/?VD?\
M@E/H?_!-_P"'=KJ<G[2'BOP_I?PVU7X87.C7$5YI.H0F&VO[JYS'LAM4BBEF
M\S) 5ESC:Y3]$K;X^_!3X _%WX8_L(7=_J'_  DOB/PI.?"L:6):"2TTRW42
MF20'$;;%&!SF@#\W_P#@GQ^WM\8?"_PX^,'CO]GW_@G9XL^.&K:_\7/$NO\
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MFU_Z]D_]!% %BBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ K\9?B1_P E$U__ +#5U_Z.:OV:K\9?B1_R437_ /L-77_HYJ ,6BBB
M@ HHHH **** "BBB@ HHHH _9KX;_P#).] _[ MK_P"B5K:K%^&__).] _[
MMK_Z)6MJ@ HHHH **** /GC6/^0M=?\ 7R__ *$:K59UC_D+77_7R_\ Z$:K
M4 %%%% !1110 4444 %%%% !7T1H_P#R";7_ *]D_P#017SO7T1H_P#R";7_
M *]D_P#010!8HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH *_&7XD?\E$U_P#[#5U_Z.:OV:K\9?B1_P E$U__ +#5U_Z.:@#%HHHH
M **** "BBB@ HHHH **** /V:^&__).] _[ MK_Z)6MJL7X;_P#).] _[ MK
M_P"B5K:H **** "BBB@#YXUC_D+77_7R_P#Z$:K59UC_ )"UU_U\O_Z$:K4
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MT@\-Z?8?!&*">:Z&70)(^FHJ,-N0Q88QUH ^]OA?\</@W\;8M:F^#WQ3\/\
MBA?#>NSZ+XA_L'5H;K^S-2AQYUG<"-CY,Z;EW1OAER,CFG'XU?" ?%\?L_?\
M+/T'_A.CH/\ ;?\ PAXU6(ZF--\WR?MAMMWF"#S?D\S;MW<9SQ7YZ?M8>-O#
MO_!%7_@IG+^WCK[3Z?\ L_?M':<VE_%X6<#/%H/C&QMI)K#4Q&O ^V0)+ P4
M?-*'=R6*BMC]B+]B#XV?M4_LC?&_]K?XT>,;SX=_&;]L+1I_LVL+8FZNO ?A
M22!H-(TV&,R1$21VC^;)M>-C+,I;#Q T ?9'PW_;@_8Q^,?Q1N_@A\)/VLOA
MOXG\96'F_;/"V@>-K&\U"+RO];FWBE:3Y,'=Q\O?%7OC?^UY^RG^S-J6DZ/^
MT7^TKX#\!W>O.5T6U\8>+;/39+X@A28EN)$+@$@$C@$@$\BOSQ_X*/?L=_LF
M?LG>$OV1/V8OV/OA%X:T;XWVOQI\,1?#34?#6BQ6^KM86+J^M:A=RQ 2RVAM
M5D:Y,K,KM*I;<1D=Y^QK^SM^SW^WY^V;^VA\;OVH_A)X>\>2V/Q07X5:-:>)
M]-CO8]*T/3-*M6DM[82 _9_.N+N:9V0AB^#D%10!^BD$\%U ES;3))'(@:.1
M&!5E(R"".H(IU?%__! WQ9XBU#_@G5IGPI\4:U=:C<_"KQUXF\!P7U[(7EDL
M]*U>YM[16)Z^7:B"(8[1BOM"@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ KX@_X./0&_X(Q?&56 ((\/9!_[&+3*
M^WZ* ,73_AO\.])O8]2TKP%HMM<0MNBGM]+A1T/J&"Y!^E?$O_!RQ96=]_P2
M)\;PWUI%,G_"8>$/EEC##GQ)IRG@^JL1]"1WK[THH \J_;=_:N\#?L+?LD>/
M?VLOB#8R7.D^!?#TM^=/MW"/>SY$=O:JQ!"&6=XH@Q&%,@)X%?E%_P $K_\
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M*+:[TVU@OK6T:-&$EU!<VOEF#(=O-5E!!S7Z;U2U?PWX=\0/;2:]H-E?-97
MGLVO+5)3!*.DB;@=K#^\,&@#Y0_X(;_"'XA?"O\ X)X^']>^+?A2ZT'Q/\1/
M$VO>.M8T2^C*SV!U?4[B\@AE!^82"VD@WJP!5MRGI7UY110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
,% !1110 4444 ?_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>19
<FILENAME>cah-20210630_g7.jpg
<TEXT>
begin 644 cah-20210630_g7.jpg
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M!_WU0!I45F_\)CX8_P"@U!_WU1_PF/AC_H-0?]]4 :5%9O\ PF/AC_H-0?\
M?5'_  F/AC_H-0?]]4 :5%9O_"8^&/\ H-0?]]4?\)CX8_Z#4'_?5 &E16;_
M ,)CX8_Z#4'_ 'U1_P )CX8_Z#4'_?5 &E16;_PF/AC_ *#4'_?5'_"8^&/^
M@U!_WU0!I45F_P#"8^&/^@U!_P!]4?\ "8^&/^@U!_WU0!I45F_\)CX8_P"@
MU!_WU1_PF/AC_H-0?]]4 :5%9O\ PF/AC_H-0?\ ?5'_  F/AC_H-0?]]4 :
M5%9O_"8^&/\ H-0?]]4?\)CX8_Z#4'_?5 &E16;_ ,)CX8_Z#4'_ 'U1_P )
MCX8_Z#4'_?5 &E16;_PF/AC_ *#4'_?5'_"8^&/^@U!_WU0!I45F_P#"8^&/
M^@U!_P!]4?\ "8^&/^@U!_WU0!I45F_\)CX8_P"@U!_WU1_PF/AC_H-0?]]4
M :5%9O\ PF/AC_H-0?\ ?5'_  F/AC_H-0?]]4 :5%9O_"8^&/\ H-0?]]4?
M\)CX8_Z#4'_?5 &E16;_ ,)CX8_Z#4'_ 'U1_P )CX8_Z#4'_?5 &E16;_PF
M/AC_ *#4'_?5'_"8^&/^@U!_WU0!I45F_P#"8^&/^@U!_P!]4?\ "8^&/^@U
M!_WU0!I45F_\)CX8_P"@U!_WU1_PF/AC_H-0?]]4 :5%9O\ PF/AC_H-0?\
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M!_WU0!I45F_\)CX8_P"@U!_WU1_PF/AC_H-0?]]4 :5%9O\ PF/AC_H-0?\
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M!_WU0!I45F_\)CX8_P"@U!_WU1_PF/AC_H-0?]]4 :5%9O\ PF/AC_H-0?\
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MD/U?_L>]8_\ 1]>]4 0_V=I__/C#_P!^A1_9VG_\^,/_ 'Z%344 0_V=I_\
MSXP_]^A1_9VG_P#/C#_WZ%344 0_V=I__/C#_P!^A1_9VG_\^,/_ 'Z%344
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M_L[3_P#GQA_[]"C^SM/_ .?&'_OT*FHH A_L[3_^?&'_ +]"C^SM/_Y\8?\
MOT*FHH A_L[3_P#GQA_[]"C^SM/_ .?&'_OT*FHH A_L[3_^?&'_ +]"C^SM
M/_Y\8?\ OT*FHH A_L[3_P#GQA_[]"LGQ%:VL6JZ2D5M&H>[(<*@ 8;>A]:W
M*Q_$O_(7T?\ Z_3_ .@F@#2_L[3_ /GQA_[]"C^SM/\ ^?&'_OT*FHH A_L[
M3_\ GQA_[]"C^SM/_P"?&'_OT*FHH A_L[3_ /GQA_[]"C^SM/\ ^?&'_OT*
MFHH A_L[3_\ GQA_[]"C^SM/_P"?&'_OT*FHH A_L[3_ /GQA_[]"C^SM/\
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MU% $/]G:?_SXP_\ ?H4?V=I__/C#_P!^A4U% $/]G:?_ ,^,/_?H4?V=I_\
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M%']G:?\ \^,/_?H5-10!#_9VG_\ /C#_ -^A1_9VG_\ /C#_ -^A4U% $/\
M9VG_ //C#_WZ%']G:?\ \^,/_?H5-10!#_9VG_\ /C#_ -^A1_9VG_\ /C#_
M -^A4U% $/\ 9VG_ //C#_WZ%']G:?\ \^,/_?H5-10!#_9VG_\ /C#_ -^A
M1_9VG_\ /C#_ -^A4U% $/\ 9VG_ //C#_WZ%']G:?\ \^,/_?H5-10!#_9V
MG_\ /C#_ -^A1_9VG_\ /C#_ -^A4U% $/\ 9VG_ //C#_WZ%']G:?\ \^,/
M_?H5-10!#_9VG_\ /C#_ -^A1_9VG_\ /C#_ -^A4U% $/\ 9VG_ //C#_WZ
M%']G:?\ \^,/_?H5-10!#_9VG_\ /C#_ -^A1_9VG_\ /C#_ -^A4U% $/\
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MW_H5;%8_@?\ Y!$O_7[-_P"A5L4 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110!X+_P3J_Y(?J__ &/>L?\ H^O>J\%_X)U?
M\D/U?_L>]8_]'U[U0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %8_B7_D+Z/_ -?I_P#036Q6/XE_Y"^C_P#7Z?\ T$T ;%%%% !1110
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MV00^.?@A>:CJA\77G[/VEWEOKNLW$S?9]1?3&O%LX9+6V*P19CD*L&F5E=^
M!O[-/[)GQ_\ CO\ #O\ :!_;^_;:UVU^$OQ$_:!^&\_A7PGI.I@31_"WPF+:
M=+**Y#20B2Z,MQ]LN$+QC>%3,)WJOA'[3G["7Q%_X(J?L,>#_P!OC]FO]O\
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M &%>Z4(/M$\$E]=0RO+*C/-)/%"8XDW'<PEV*:W?^"+/Q6^.FJ^!?C'^RO\
MM _%?4/B!JWP#^,^I>"=(\>ZPV^_UO24M[>YLY+Q_P#EI=(EP8Y'Y)V*6);+
M-)^T5_P3=_:@C_:NUK]M;_@G]^V/IWPO\:>.O"]AH7Q1TWQ-X&CUO2O$/V)&
MCL]16+SHF@NX(W9%P61EPI &[?Z[_P $_/V(O#W[!OP)N/AA;_$'4O&?B7Q%
MXEO_ !/\0O'FM0+%=^)=>O7#W5])&A*Q9VHBQ@G8D2#+$%B >XT444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 >"_\ !.K_ )(?J_\
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MZ\HOYFMBL>R_Y'>]_P"O*+^9K8H **** "BBB@ HHHH **** "BBB@ HHHH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
MQ[+_ )'>]_Z\HOYFMBL>R_Y'>]_Z\HOYFMB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *Q_ __ "")?^OV
M;_T*MBL?P/\ \@B7_K]F_P#0J -BBBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@#\9_^"KO_)_?CW_N%_\ IJLZ
M^=Z^B/\ @J[_ ,G]^/?^X7_Z:K.OG>O[!X9_Y)O!?]>:?_I$3\@S/_D95O\
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M_D6+W_K@:N:=_P @^#_KBO\ (4 34444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %8_B7_D+Z/_ -?I_P#036Q6
M/XE_Y"^C_P#7Z?\ T$T ;%%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110!CV7_ ".][_UY1?S-;%8]E_R.
M][_UY1?S-;% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 5C^!_^01+_ -?LW_H5;%8_@?\ Y!$O_7[-_P"A
M4 ;%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %>3?M/_M2Z9\!K73_  ;X3T"3Q/\ $#Q,Q@\)>$+(YDN9.1YTQS^Z
MMT()9SCA3CHS+7_:@_:G'P;FL/A?\,/#G_"5_$OQ(-OAKPK;MG:.0;NY((\J
MW3!))(W;2 0 S*W]F#]EAOA#=ZA\5_BKXB'BKXF>)0'\1^)YTXA'&+2U!'[J
MW3@  #=M!( "JONX/!8?"8=8W'J\7\$-G4?=]533WEO)^['6[CPUJU2K4="@
M]5\4ND?\Y=ETW?1/S[P3_P $R?A9\08KOXF_MG6'_"<?$+Q#.MUK=]!JEU9V
MMH0BHEM EM)'F.-%5 S D[>,#BMS_AU%^P)_T07_ ,NG5?\ Y*KZ(HIU.*.(
MISO'%5(+I&,Y1BET48II)):))"CE>7)6=*+?=I-OS;>K9\R^%?\ @EE^P?J6
MG23WOP*WNMS(@/\ PD^J#@-@#BYKM/A1_P $^OV0O@?X_L/BC\+OA'_9>NZ7
MYOV&^_M_4)_*\R)X7^2:=D;*2..5.,Y&" :].\#_ /((E_Z_9O\ T*MBL:O$
M.?UZ4J=3%U91DFFG4FTT]&FF]4^J+CE^ A)2C1BFMGRK_(****\<[ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH \%_X)U?\ )#]7
M_P"Q[UC_ -'U[U7@O_!.K_DA^K_]CWK'_H^O>J "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#-\8_P#(L7O_
M %P-7-._Y!\'_7%?Y"J?C'_D6+W_ *X&KFG?\@^#_KBO\A0!-1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5C
M^)?^0OH__7Z?_036Q6/XE_Y"^C_]?I_]!- &Q1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 8]E_R.][_
M ->47\S6Q6/9?\CO>_\ 7E%_,UL4 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !6/X'_ .01+_U^S?\ H5;%
M8_@?_D$2_P#7[-_Z%0!L4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !7BW[3O[4U]\-=8L?@C\$_#Z>*/BAXC0C1M#1\Q:?$
M>M[>,/\ 50IUP2"^,# R17_:9_:B\0>%/$UM^SK^SIHL/B+XI:U!OM[1SFUT
M*V.,WUZW1%4$%4/+$KQRH;>_9B_9=\/_ +/>DWVLZEK4_B+QKXBE%SXN\8:@
M,W&H3GDJO_/.%3PD8X QG)KW\+@\/E^'CC,=&_-K3I_S_P!Z754_QGLK*\EP
M5:U3$5'1H.UOBEV\EWE^"Z]BO^R_^RS8_ N"^\<^-O$#^*?B)XDQ)XK\87@S
M).W!%O"#_JK=, *@ SM!( "JOK=%%>3C,9B,?B'6KRO)_P!));)):)+1+1'5
M1HTZ%-0@K)?U\WW84445S&IC^!_^01+_ -?LW_H5;%8_@?\ Y!$O_7[-_P"A
M5L4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10!X+_P3J_Y(?J__ &/>L?\ H^O>J\%_X)U?\D/U?_L>]8_]'U[U0 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 9OC'_ )%B]_ZX&KFG?\@^#_KBO\A5/QC_ ,BQ>_\ 7 U<T[_D'P?]<5_D
M* )J*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "L?Q+_R%]'_Z_3_Z":V*Q_$O_(7T?_K]/_H)H V**** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@#'LO^1WO?\ KRB_F:V*Q[+_ )'>]_Z\HOYFMB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *Q_ _\
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M .01+_U^S?\ H5;% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 >"_\$ZO^2'ZO_P!CWK'_ */KWJO!?^"=7_)#]7_['O6/
M_1]>]4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M.HNW6,/M;R]VREYTZD\9-TZ3M!?%)=?*/ZOILM=J_P"SQ^SM\/?V:O 2^"/
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M_P!!NR_\!C_C1]B\;_\ 0;LO_ 8_XT ;%%8_V+QO_P!!NR_\!C_C1]B\;_\
M0;LO_ 8_XT ;%%8_V+QO_P!!NR_\!C_C1]B\;_\ 0;LO_ 8_XT ;%%8_V+QO
M_P!!NR_\!C_C1]B\;_\ 0;LO_ 8_XT ;%%8_V+QO_P!!NR_\!C_C1]B\;_\
M0;LO_ 8_XT ;%%8_V+QO_P!!NR_\!C_C1]B\;_\ 0;LO_ 8_XT ;%%8_V+QO
M_P!!NR_\!C_C1]B\;_\ 0;LO_ 8_XT ;%%8_V+QO_P!!NR_\!C_C1]B\;_\
M0;LO_ 8_XT ;%%8_V+QO_P!!NR_\!C_C1]B\;_\ 0;LO_ 8_XT ;%%8_V+QO
M_P!!NR_\!C_C1]B\;_\ 0;LO_ 8_XT ;%%8_V+QO_P!!NR_\!C_C1]B\;_\
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M8HK'^Q>-_P#H-V7_ (#'_&C[%XW_ .@W9?\ @,?\: -BBL?[%XW_ .@W9?\
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MJN(JRJU9.4I.[;U;;ZL[X0A3@HQ5DMD;%%8_V+QO_P!!NR_\!C_C1]B\;_\
M0;LO_ 8_XUD4;%%8_P!B\;_]!NR_\!C_ (T?8O&__0;LO_ 8_P"- &Q16/\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %8_B7_D+Z/_ -?I_P#036Q6/XE_Y"^C_P#7Z?\ T$T ;%%%% !1110
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MK]#Z?">?TN)<AHXZ/Q-6DNTUI)??JO)H,%B5B\-&HM^OKU"BBBOHSK"BBB@
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M %%%% !1110 4444 %%%% !1110 5C^!_P#D$2_]?LW_ *%6Q6/X'_Y!$O\
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M[O2E_P"E^O\ =\OM>F[=+TK3-#TRWT71=/@M+.TA6&UM;:()'#&HPJ*JX"J
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M5X+_ ,$ZO^2'ZO\ ]CWK'_H^O>J "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@#-\8_\ (L7O_7 U<T[_ )!\
M'_7%?Y"J?C'_ )%B]_ZX&KFG?\@^#_KBO\A0!-1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5C^)?^0OH_P#U
M^G_T$UL5C^)?^0OH_P#U^G_T$T ;%%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110!CV7_([WO_ %Y1?S-;
M%8]E_P CO>_]>47\S6Q0 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %8_@?_ )!$O_7[-_Z%6Q6/X'_Y!$O_
M %^S?^A4 ;%%%% !1110 4444 %%%<_\4OBGX"^"_@6_^)'Q+\1P:7H^FQ;[
MFZG/4]%15'+NQP%4 DDX%73IU*U14Z:;DW9):MM[)(F4HPBY2=DB?XA?$+P9
M\*O!FH?$'X@^(+?2]'TNW,U[>W+85%'   Y9B2 %&2Q( !) KYO\'^ _''_!
M03Q59?&#XXZ'=Z-\)-.N%NO!/@*[&R777!^34-04=8R.4AR00>ZDM+-\/?A=
MX_\ VX?&>G_'[]I/P]/I'@'2[C[3X ^&MXO-V?X-1U%>C,1RD1X /]TDR_42
MJJ*$10 !@ #@"OH9U*?#\73HM2Q+TE):JGWC!]9])37P[1UNSSU&68/FFK4N
MB_F\W_=[+KN^PD,,5O$L$$2HB*%1$7 4#@  =!3J**^;/2"BBB@ HHHH ***
M* "BN2^,WQU^$_[/OA"3QQ\7?&EIH]@N1#Y[9EN7 SY<,:Y>5_\ 94$]S@9-
M>%C4?VM?VWOET5-3^#?PPN.M]*H7Q+KD)[QKR+&-A_%RW0C>K8'CX_.L/A*W
MU:E%U:[5U3CJ[=Y/:$?[TFD^EWH85<1&G+D2O+LOU[+U.U^.'[;'@_X>^*C\
M'?A'X9O/B'\19@5A\)^'G#"T/]^\GY2U09&=V6&02 #NKF?"W[&GCWXX:_:_
M$_\ ;P\90>)+FWD$^E?#O1RT>@Z4W;>F<W<@Z%GR.JG>N*]=^!_[/7PA_9T\
M*CPC\)/!UOID#D->77+W-[)_STFF;+R-R>IP,X  XKM:XX9-B,RDJN;24UNJ
M4;^RC_BO9U6N\DH]5!/4S5"=5\U=W_NK;Y]_GIY$5C8V6EV46FZ;9Q6]O;QK
M'!;P1A$C0# 55'  '  J6BBOHTDE9'6?EW_P6Z_82^ 7A7Q?X5_;RNK#5=;^
M(_B?]HWX9Z7:ZGK^J/<P^'=-BU*SA:RTR$X2SBE:$SR[07>6:4EMK;1W/_!5
MSXB>'_V._P#@HM^R]_P4/^.^EZDWPA\(:=XL\+>+/$UGIDEY%X0OM5M[5;2_
MFCB1I%BE,,D#2*#MX'5@K>R?\%;OV</C/^T[\#/A_P"#O@=X-_MS4M$^._@W
MQ%JEM_:-M;>3IMCJD<]U/NN)$5MD:EMBDNV,*K'BM#_@H7K_ .WC\.-9^'/Q
MD_9 ^'8^)/A;0=5U"W^+GP=@FT^VO/$VF75L$@N;6YO$PLMI*ID\A9(Q.LK*
MV["[6!\A_LT_M#_ ?_@H[_P7.^)LGP_\-S:]\&_&O['"Z'=WNJ:5+;6/CB.#
MQ T,]W%',J236P6_N+(2E0KF"8(2JYJ__P %8_%'Q*\ ?'/]G;X(?$_]FP_#
M[]DKX<?&OP??K\7M#U6VU%S>V4:?V5I\M@K)+I5@+MEMI+IO-.$7 0,-_HGP
M._9-_;4_:;\8_'S]M7XS:/<_ +Q[\1?A=!\//@AH-IK,%[J/@?2+87%Q'>W4
MUJ3%Y\U_<"<PQDF)(PA8L<CRSXO>#?\ @K3_ ,%(OV<_"'_!,;]I;]B*3P%:
M#6-!7XY?&_4?&]A>Z;JEAI5Y;W;3:3#"YN);B]EM8W =5$.YDDZEE /M3]N;
MQ7K?@3_@FY\?O''AF25-2T;X2^+K[3W@^^L\.EW4D97'?<HQ[U\9_MJ^!O#?
MAS_@TYT[2=#6"!-"_9X\%:II=U""#'>P+IEU'<(0,B0S+OW<99CG&37V-<V'
MQS^.GQ!^)7[*WQ*^ ]M:?!/Q!\.KBSM?B+!X@MWN=0O[TRVUW8?8]QEC$<#[
MQ*R!&)P">E?#$W[.O_!4OXV?L6^#?^"'GQ@_9"73/"VA76B>&_'/[0D'B^R?
M1]3\%Z5=021265J'^U?;;BWM8;<PNOR%G9BH;* '2:7^VE\#?^"9O_!6CX]?
M%C]OO4KOP-H'[1'@GP1KGPX\;76AW=U8SG2M):SOM(,EO%(8[A)R9A%C+"4$
MX+1A^W_X-\?BKK'Q;MOVK_%<G@75?#6D:K^U7KNM:%H>MV+VUU:07]CI]THE
MA?F"5T>.9XC@H\[@@'->B_M4_%;_ (*6?LV?M5ZKXK^&?[)MW^T1\'?$_AC3
MU\*^%-!U71]+OO!7B*U:59#(]TJ--:W2O$YG+R&!HB J+@/VO_!*[]E3XM?L
MO_L^:]JW[1MSIS_%#XJ_$/6/B!\2(='F\VSLM4U&1,64#_QQV]O#;0!N03$Q
M!*D4 ?2]%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "L?Q+_ ,A?1_\
MK]/_ *":V*Q_$O\ R%]'_P"OT_\ H)H V**** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#'LO^1WO?^O*+
M^9K8K'LO^1WO?^O*+^9K8H **** "BBB@ HHHH **** "BBB@ HHHH ****
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M .01+_U^S?\ H5;% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 >"_\$ZO^2'ZO_P!CWK'_ */KWJO!?^"=7_)#]7_['O6/
M_1]>]4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M;_T*MBL?P/\ \@B7_K]F_P#0JV* "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH \%_X)U?\ )#]7_P"Q[UC_ -'U[U7@O_!.
MK_DA^K_]CWK'_H^O>J "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@#-\8_P#(L7O_ %P-7-._Y!\'_7%?Y"J?
MC'_D6+W_ *X&KFG?\@^#_KBO\A0!-1110 4444 %%%% !1110 4444 %%%%
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M\/?AY#;R?Z/XGUUM75M<U?CB2&W>WAL(&&Y2R7C _-7K7_!6#XB?LV?LU?\
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MX'_Y!$O_ %^S?^A5L5C^!_\ D$2_]?LW_H5;% !1110 4444 %%%% !1110
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M7T?_ *_3_P"@FMBL?Q+_ ,A?1_\ K]/_ *": -BBBB@ HHHH **** "BBB@
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M^&_[!=QI\#_<U'QGXSM;79Z;K= 9/R/%+_PC/_!3[QN?^)O\3?A7X'@?[O\
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M%%8EA1110 4444 %%%% %;6-7TSP_I-UKVMWT=K965L]Q=W,S82*)%+.['L
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M5SS;P9\'O@Y\.PA\"?LSZ%I#ITET_0[6*0^Y=5W$^Y.:['_A)=7_ .A0O?\
MOI:V**\FM7K8B7-5DY/NVW^9UPA"FK15EY&/_P )+J__ $*%[_WTM'_"2ZO_
M -"A>_\ ?2UL45D48_\ PDNK_P#0H7O_ 'TM'_"2ZO\ ]"A>_P#?2UL44 8_
M_"2ZO_T*%[_WTM'_  DNK_\ 0H7O_?2UL44 8_\ PDNK_P#0H7O_ 'TM'_"2
MZO\ ]"A>_P#?2UL44 8__"2ZO_T*%[_WTM'_  DNK_\ 0H7O_?2UL44 8_\
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M/(YI/^&7/VQ_B)\_QE_;IU/3;:3_ %FD_#K0(=-\OUV7;9E/XCBN7^WJE?\
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M^$EU?_H4+W_OI:V** ,?_A)=7_Z%"]_[Z6C_ (275_\ H4+W_OI:V** ,?\
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M0JGXQ_Y%B]_ZX&KFG?\ (/@_ZXK_ "% $U%%% !1110 4444 %%%% !1110
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MAWJI ?RDW9VC'JE<_P#%CP+_ ,+0^%GB7X:?VI]A_P"$B\/WFF?;?(\W[/\
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M&\.WO@&/5;O3M3:UCM;K4-(N3/']GFN(8HPV]6V.HD4\*J[WQQ_X(^^#K_\
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MHH **** "BBB@ HHHH Q_ __ "")?^OV;_T*MBL?P/\ \@B7_K]F_P#0JV*
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M1-]W[S^]W8D<:1(L42!54 *JC  ]!2T45Y!UGXS_ /#J+]OO_H@O_ETZ5_\
M)50W/_!++]O"SFA@N?@5M>X?9"/^$GTL[CC..+GC\:_9ZL?Q+_R%]'_Z_3_Z
M":_4_P#B+G$G_/JC_P" S_\ EA\M_JEEO\\_O7_R)^/_ /PZB_;[_P"B"_\
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M110!X+_P3J_Y(?J__8]ZQ_Z/KWJO!?\ @G5_R0_5_P#L>]8_]'U[U0 4444
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M.P\0^)-2\2ZS"-0N+DW.J7TWG75P6N)'8%Y#G:"$7@*J@ 5)X8_98^ VA_M
MZI^USIG@,1_$+Q'X0M/#FM:^VI7+BYTR!_-BMS;M*8%PY)WK&'.<%B.* /R
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M@P^K8FI_%JOTBE%?J_Q/G/\ X8D^,7Q$_>_M%?MM>.=:C?F72?"*Q:%9L/\
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M?G)MW_\ "<9Q^'V&IK?_ (+T?9[>.#_AE3.Q N?^$YZX&/\ GQK\\J*_9_\
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M5/VB]"EV]?[-$U[^7V>-\_A6#_P\W^ FK?\ )._ OQ'\7Y_U?_"->!+J7?\
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M:N_HHKVL/A<+@Z?LZ$%"/:*27W(Z(0A35HJR\@HHHK<H**** "BBB@ HHHH
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MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#P7_ ()U?\D/U?\
M['O6/_1]>]5X+_P3J_Y(?J__ &/>L?\ H^O>J "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBH[N\M+"VDO;^ZC@AB4M+-,X54 ZDD\
M4)-NR DHKQKXC?\ !0/]D3X:7?\ 9.I?&;3M4U(MLBTOPTKZG/))_<Q;!PK>
MS%:Y<_M>?M+?$W]U^SU^Q'XE-O)_J];^(E[%HT"CM((&+22J>,;2"17L4L@S
M:I!5)4^2+^U-JG'Y.;BG\KG'/'X2,N52YGVC>3^Y7/HVL_Q+XL\+>#-+?7/&
M'B73])LH_P#67FI7B01+]7<@#\Z\"/P/_;]^*WS_ !9_:LT7P592<RZ-\--
M+.0>PO+H^8C#U4$9_"O(/VL_"_\ P3B_8";P-XE_:HD\0_$7Q?\ $+QUIGA7
MP?9>+?$+ZEJ.I7=Y=10O*(7>.(P0B42RR,F% 51EY$5M?[/RG#?[QBN9]J47
M+_R:7)'YIR^9/UC%U/X=*WG)I?@N9_?8]R\5?\%)/V6='U1O#G@;Q'JOCS6!
MG9I'@+19M2ED_P!UU B;\'K\OO\ @H%XZU;XE_M=>+?&^N?#_5O"US?_ & M
MH6NQA+NV5=/MD3S%!(4LJJ^.P< \U^S2VGPJ^!W@:^U>*QT'PEX;T>RDN]1G
MBAAL;.SMXD+O*Y 5$15!)8X  -?A+^TA^W#\%_VX_B]XU_:[^$L]Y:^"K[4)
M(;&_UB-86EM]/A2S>[*Y.R.3[,TJAL,$==P5L@?HWAAB,I_M^K##4I1_=2O*
M<[MKFAI91C%+KU>FY\[Q/3Q?U"+J23]Y:)66S[MM_AZ'-45XIX<_;E^'OB'5
MM'6\^'/C72-!\17R6>@^,-8T,0Z;>RN<18?S"Z"0_<9T /7@9KVE#D8KW:/B
M]D=?Q0I\(0U]I1<XU>DJJ;;I+O\ NUSW^75'QU7!5Z%+GJ*Q]%?\$HO^3^_
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M2?PPD_E;\['T517SK_PR/^U=XB_Y*%_P40\53!OOIX:\+66E8]@T>X_C0/\
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MA(HU)'F32.5CCB7YI)'1%!9@*\^^%/\ P4.^!'CS_@GKI?\ P4H\;W%QX,\
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M110 4444 %%%% !1110 4444 %%%% !1110 4444 ?!'[//_  6I\)_ME?\
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M6'BNULU\)^*K^ 1ZA'JD4P4FV,T<4JOOCC$<2)YN^1_*^U/^"=7_ "0_5_\
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MCQWI]GI,.G3_ +/>E>(9-(TBU11%807.H7C&.,R!II/*2(2R-N=6(4C]$**
M/CKQK_P30_:*^/\ ^Q2?V>_VN_\ @H#J'CKXGZ)X\M?%_P //C7I/PWT_0;G
MPQJ=FT;V$B:?:R&"81.)@Q9@9([EURN%8,_9>_8(_:%\ _M5#]M+]N?]J.P^
M*?Q)F\/+X3\+#P_X271=)\.Z/YHN)Q#;^;*9+BXF2-Y)F8$!!&OR@5]D5C^)
M?^0OH_\ U^G_ -!- '%_LM?!_P"-/P6\%ZWX>^.7[2-Y\3]2U'Q?J.J:;K-[
MH,>GMIVGSR!K?30B2R!U@7Y!*2"^<E16)\/_ -D/_A!?VZOB-^VI_P +"^U?
M\+ \#Z!X=_X1K^R=GV#^S);V3S_M'FGS?,^V8V>6FSR_O-NX]GHH _._QY_P
M1A_:>LK#Q_\ LT_LT_\ !0J;P%^SI\5=>O\ 4O%7P_\ ^$&AO-6T:+4)#)J=
MAI&HM*!;VUT7E&UXV\D2L5#%FW?>OPT^'?@_X0_#GP_\)OAYHT>G:!X7T2TT
MC0]/B)*VMG;0K##$,\X6-%4?2MNB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@#'LO^1WO?\ KRB_F:V*Q[+_ )'>
M]_Z\HOYFMB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M'_A,74[2R0:1:W:75I 7?)81Q7JQC).%15'  K[@H _._P#X+V_\TH_[CO\
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M;/)=-^!OC;XF7T>M:A^Q5\6OB7>!M\>J?&_XA)ID5NW/S"S4CY>WEY;%>S>
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M#T]^M \*?\%,+P9N?VUOAE9'KBS\!/(.>W[QN@[5[=/%^R@H4\--)=$HI?\
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M  NXF;585X]>6Z5\WVO_  2J_P""7UH2R_ RUD9L;FG\5:M(2?7YKHUJV?\
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M/;9SJD63P^HV4C,[*B_Q1MLC0<;F)S]@_"7]IKX"?'7PK'XT^$WQ1TO6]/D
MW26LI#PL1G9+&P#Q/_LN ?:OV7(*M6E@XX7$SO6CNGHTO+^9+^971_F_XL8/
M!8_B.OG>2851R^JURU*;YH2D]W)+^#*3U]E)1DM[:G=T5F_\)CX8_P"@U!_W
MU1_PF/AC_H-0?]]5[Y^3FE16;_PF/AC_ *#4'_?5'_"8^&/^@U!_WU0!I45F
M_P#"8^&/^@U!_P!]4?\ "8^&/^@U!_WU0!I45F_\)CX8_P"@U!_WU1_PF/AC
M_H-0?]]4 :5%9O\ PF/AC_H-0?\ ?5'_  F/AC_H-0?]]4 :5%9O_"8^&/\
MH-0?]]4?\)CX8_Z#4'_?5 &E16;_ ,)CX8_Z#4'_ 'U1_P )CX8_Z#4'_?5
M&E16;_PF/AC_ *#4'_?5'_"8^&/^@U!_WU0!I45F_P#"8^&/^@U!_P!]4?\
M"8^&/^@U!_WU0!I45F_\)CX8_P"@U!_WU1_PF/AC_H-0?]]4 :5%9O\ PF/A
MC_H-0?\ ?5'_  F/AC_H-0?]]4 :5%9O_"8^&/\ H-0?]]4?\)CX8_Z#4'_?
M5 &E6/XE_P"0OH__ %^G_P!!-3?\)CX8_P"@U!_WU67KWB70;G4],F@U2)EA
MNBTK _=&WJ: .FHK-_X3'PQ_T&H/^^J/^$Q\,?\ 0:@_[ZH TJ*S?^$Q\,?]
M!J#_ +ZH_P"$Q\,?]!J#_OJ@#2HK-_X3'PQ_T&H/^^J/^$Q\,?\ 0:@_[ZH
MTJ*S?^$Q\,?]!J#_ +ZH_P"$Q\,?]!J#_OJ@#2HK-_X3'PQ_T&H/^^J/^$Q\
M,?\ 0:@_[ZH TJ*S?^$Q\,?]!J#_ +ZH_P"$Q\,?]!J#_OJ@#2HK-_X3'PQ_
MT&H/^^J/^$Q\,?\ 0:@_[ZH TJ*S?^$Q\,?]!J#_ +ZH_P"$Q\,?]!J#_OJ@
M#2HK-_X3'PQ_T&H/^^J/^$Q\,?\ 0:@_[ZH TJ*S?^$Q\,?]!J#_ +ZH_P"$
MQ\,?]!J#_OJ@#2HK-_X3'PQ_T&H/^^J/^$Q\,?\ 0:@_[ZH TJ*S?^$Q\,?]
M!J#_ +ZH_P"$Q\,?]!J#_OJ@#2HK-_X3'PQ_T&H/^^J/^$Q\,?\ 0:@_[ZH
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M1_PF/AC_ *#4'_?5 &E16;_PF/AC_H-0?]]4?\)CX8_Z#4'_ 'U0!I45F_\
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M!_WU0!I45F_\)CX8_P"@U!_WU1_PF/AC_H-0?]]4 :5%9O\ PF/AC_H-0?\
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M#_WZ%']G:?\ \^,/_?H5-10!#_9VG_\ /C#_ -^A1_9VG_\ /C#_ -^A4U%
M$/\ 9VG_ //C#_WZ%']G:?\ \^,/_?H5-10!#_9VG_\ /C#_ -^A1_9VG_\
M/C#_ -^A4U% $/\ 9VG_ //C#_WZ%']G:?\ \^,/_?H5-10!#_9VG_\ /C#_
M -^A1_9VG_\ /C#_ -^A4U% $/\ 9VG_ //C#_WZ%']G:?\ \^,/_?H5-10!
M#_9VG_\ /C#_ -^A1_9VG_\ /C#_ -^A4U% $/\ 9VG_ //C#_WZ%']G:?\
M\^,/_?H5-10!#_9VG_\ /C#_ -^A1_9VG_\ /C#_ -^A4U% $/\ 9VG_ //C
M#_WZ%']G:?\ \^,/_?H5-10!#_9VG_\ /C#_ -^A1_9VG_\ /C#_ -^A4U%
M'D'[9_[)WPC_ &K?@EJ'@'XB:'&DL*&?1M8MH5%SIMSC EC;T/1D/#C@]B+'
M[(G[(GP@_9%^$%E\-_AOHL<CR1I/K.LW4*FYU.Y*\RR'L.H5!\J+P.Y/HOC'
M_D6+W_K@:N:=_P @^#_KBO\ (5S?4\+]:^L\B]I:U^MCVO\ 6+/?["_L;ZQ/
MZKS\_L[^[S=[?C;:^MKZA_9VG_\ /C#_ -^A7S_\:_\ @G/\*O&WBM_B_P#
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MKY?\/_M^^._@3K5M\/?^"AOPC?P/<S2B"Q^(>@"2\\,ZDYZ'S0"]HQ_N29P
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M%']G:?\ \^,/_?H5-10!#_9VG_\ /C#_ -^A1_9VG_\ /C#_ -^A4U% $/\
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M%']G:?\ \^,/_?H5-10!#_9VG_\ /C#_ -^A1_9VG_\ /C#_ -^A4U% $/\
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M"T_[:'PS/[6OQ'^%'@32[?P%?ZHWPGUM='UO6[B70WCLU^W['>.T@>/4&:)
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MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#F_C)\)?
MOQ[^$GB?X'_$_1QJ'ASQAH%YHVNV6\J9K2YA:&50PY4E';##D'!'(KX.T?\
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M.M]5<_3JBBBOTX_A\**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M^"LGCKGQ/^TY\+/ BOU'@SP9-J;1CV^WL 3^E?3]%']G.?\ $K3E_P!O<O\
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M?$=Q)YM]H$,9N/#FK-_=GLCE8B0-H>(?("=J9YJ+PM_P4(\0_"#7K7X:?\%
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M9UW71<10V6C^=&_VJ"!8C+<.\:>7( 8V8-LP ?7%%?"__!*?Q1\5OA=^UO\
MM,_\$\O%?[0'BOXI^%/@YJ/AB_\ !?BWQSJAU#6;*+6;":YFTF[O" ;DP-"K
M1LV7"3@,0 H'W10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %<I\9?CM\$_V=/!$OQ+^/\ \7?#7@GP]#,D,NN>*]<@T^T65\[(
M_-G=5WM@X7.3C@5U=?E)_P %%?VF/V?K3_@M=H7@G]I?X+>*/B_8_#'X*V]Y
M\,O@OX1\(#7[W6/%.K7US]IU!+%B(F%MI]BH,TY5(?,+!@[)D _3SX8_%;X8
M?&SP+8?$_P"#GQ%T/Q7X;U2,R:;K_AS58;VSNE#%28YH69'PP(.#P00>17*_
M"+]LK]D7X_\ C;5?AK\"OVH?A]XR\1:&K-K&A>%O&-E?W=DJOL9I(H)6= '(
M4DC ;@\\5^4/Q@^-7['7P_\ ^"0O[2/Q1_8-\=>,OA9I/Q8^,FE>'?'_ ( \
M5:9'HTWPJU"_NK&PUJ);*-<V7F6?FR, [H&;Y"-A0>D?LU>-/^"3/Q<_;-_9
M[\(?!?\ 96^*G[-_B;P4MY=? [Q9K/PQB\-V'Q/TD6+PW-@ES('EOHI('%P1
M<+',V0X8-*0P!^HUHRIXUOG=@ +*,DD]!DUQ_P 'OVR/V1_VAO&&K?#[X"?M
M/_#[QKKV@J6UK1O"GC"RU"ZLE#["TL4$K,BA_E)(P&XZ\5E_M4_ 2Y_:F^#O
MQ%_9QMOB3JOA#_A-O"$FCS>(]$16NK*&=2DIC#\9:,LG8X<X(.#7YV_$RV_8
M'\,_\%8?V4_V&O\ @GOX*\/>#_B3\&O$]Z_CG6K+15T8#PW#I,D=UI+7$J1'
M6;BY,L+[8?M!4K+(Y7]XP /U6^(?Q&\ ?"/P1J?Q+^*?C72O#GAW1;1KG5]<
MUR_CM;2RA7K)++(0J*/4D=:U;*\M-1LXM0L+F.:">)9(9HF#+(C#(8$=0000
M:_)C_@XM\>^+?VO/@Q\9/V3OA?XBN;/P-\"?AM)XU^-.J6,F!?:U)$7T+P_N
M]L'4IQ@X6*U7*F2OU+^$W_)*_#/_ &+]E_Z(2@#H**** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHKYN_P""F/[<UY^Q-\$1
MK_@_PY_:GB76IVLM(:10UMI[E<_:+@9S@#[J?QL,9 !KGQ>*HX+#RKU7:,5=
MGKY#D>9<2YQ1RS 0YJU67+%7LO5M[)+5OL8?_!2[_@I=X1_8K\(MX+\%R6NK
M?$;5K4MIFF,=\>F1MD"[N0.W]R/JY'9037Y__P#!/S_@K-\4OV<_BI>V_P =
MO$>I>)_!WBG5&NM>:YD,MSI]S(?FO(/;IOB& 0/E (P?DWQQXX\7?$KQ=J/C
MWQ[XANM6UG5KIKC4=1O)-\D\C=23^@ X      K*K\AQ_%.8XK,8XBE+E4?A
MCTMY][]?P/\ 0WA/P,X/R+@^ID^.I*O4KI>UJ-6ES+;V;W@H/6-M6]97O8_I
MB\'>,?"WQ"\+6'C?P1K]KJFD:I:I<:?J%E*'BGB89#*1_P#K!X/-:5?AQ_P3
M>_X*&_M)_LS:\OP3^&OA+_A-]-\27:Q:3X4NY9?]&OI& $L!C5F4'DN@!!QN
MX()/Z4_V;_P5W\=G_3/$OP3\!VK_ '?L%GJ&J7L8]_-(A;\*_0\KXCHYEAE.
M%.3FOB25TGZNRUZ:W/Y XY\',PX*SJ6'Q&-HPH2NZ<ZD^64H^=.*E.\=G:+3
M>S/IZD9E12[L  ,DD\ 5\P_\,4_M@>,QGXO?\%+_ !G*C_>M_!/AFRT/8/[J
MR1[V/^\1FE7_ ()+_LQZZRR?&#Q;\2/B&P.7;QK\0+R?>?4^2T5>C]:S"?P8
M>W^*27_I/.?&_P!A\)8;_><V4_\ KQ0J3^[VWU<]A\;_ +4_[,_PVWKX^_:!
M\&:0\?WH+_Q+:QRY] A?<3[ 9KRK7O\ @K5^PGIE\='\/_%NZ\2ZA_!8>%_#
ME]>N_P#NLD/EG_OJNP\$?\$^?V(_AYL;PS^R[X,#Q_ZN;4-%CO9%/J'N [ ^
M^<UZKH/AOP[X6L1IGAC0++3K8=+>PM4A0?\  4 %'+F\]Y0A\I2_6/Y![7P^
MPNU+$UWYSI4%\TH5W\E)>I\W?\/&/'/BT^7\&O\ @G_\:-<!_P!5=ZWH$>CV
MLOH5EGD.1[X%(/C'_P %5/'0_P"*2_8\^'W@A7_U<GC;QZ=1VCL66P4'\.M?
M3]%'U+%3_B8B7I%12_\ 26_Q#_67(L/_ +KE%'UJ3KU)?<JD*;^=,^8/^%*_
M\%3O'6/^$P_;/\"^"E?_ %L/@CX?B_P.ZJ]\P8?7J*/^'</BSQ;E_C-^WO\
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MV%[MO+)W$B5GW8'!ZUYQX_\ ^"(7_!-;XF_M 7G[1?B_X!23:IJOB"/7]?\
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M[)=N'F@EU:2ZENE.P1Q+(/N)$BHJJ H_4C]@SX=_';X6_LI^$?"'[1W[1?\
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M #@1R#@ *JDG->F_LZ_MV? ?]HK5)?!&FZE>>&O&EF2NI^ _%MJ;'5;:0#+
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M FNM5^&^J7.Z]L4)>7296/-U;@]N[Q=&ZC#?>^-R/C"O'%.&/E>,GH_Y7_\
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M/_#0O_!3'QN<>"/V"- \+PM_JKWQK\1H)LCU:&U7>GT)S2#X?_\ !6OQR/\
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M%%% !1110 4444 %%%% &/X'_P"01+_U^S?^A5L5C^!_^01+_P!?LW_H5;%
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M]DG_ )^?'?\ X7U__P#'*^G**7]CY7_SYC]R#_B(?'7_ $,JW_@R7^9\Q?\
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M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% &/X'_ .01+_U^S?\
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M#8HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M&/9?\CO>_P#7E%_,UL5CV7_([WO_ %Y1?S-;% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5C^!_P#D$2_]
M?LW_ *%6Q6/X'_Y!$O\ U^S?^A4 ;%%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!C^!_^01+_P!?LW_H
M5;%8_@?_ )!$O_7[-_Z%6Q0 4444 %%%% !1110 4444 %%%% !1110 4444
M %9_BSQ+I7@OPKJ?C'79O+L=)T^:\O)/[L42%W/X*IK0KA?VHM7^&'A_]F;X
MBZ]\;M+O[[P78^!=7N/%]EI8F-U<:6EE*UU'#Y#++YC0B0+Y;*^XC:0<&@#\
MC_\ @EQX.\ ?MC>&/ACXV^,'_!P7\<+3XU^,($\3ZG\%M ^/MJMO$LEP]U#8
M+8R1O+M^R^5O@W;MA8X5<8^G?B=\/?B?_P %0_\ @I%\:/V>=0_:U^*OPP^&
MW[/>@>'],L+'X0^+I-#N]8\2:O9/?RWUS<Q M*EM;M;QI V4WL6(^\&\7_X*
M??LX?\$VO!G_  0>T'X_?L+_  ?\,^%KW3H?"NM?L\^)?#VFQIKXUFXO[-K1
M$N<M<3W4BLXF61Y')61GRT6Y?HS_ ()XW#^!_P#@K#^VS\+/%<L5MK&LZIX(
M\7Z=!(0&O+&XT%+:6:+/+Q17-O)$2,A3M!/S#(!WG_!';]H'XP_&W]EK7? W
M[0_B_P#X2/Q]\'?BCXB^&WBWQ.8!$=:N-)O#%%>L@X#RVSV[,?XG+-_%BOJV
MOAG_ ((10VNO?#+]HOXV:!/]I\/?$K]L#Q]XC\*ZBC!HK_3_ +3!9)<1$<%&
M>RDP?8U]S4 %%9/CKP=I?Q!\(W_@O6[B[AM-1@,,\EC<M#,JD@Y1UY4\=17D
M/_#O?X)_]#;X[_\ "RN?\: (?^"=7_)#]7_['O6/_1]>]5\9?LA_L;_"_P"*
MOPPO_$/B7Q)XLBGMO%.I64:Z?XDEA0QQ3E5) ZMCJW4UZG_P[J^!_P#T-WCO
M_P *^>@#WJBO!?\ AW5\#_\ H;O'?_A7ST?\.ZO@?_T-WCO_ ,*^>@#WJBO!
M?^'=7P/_ .AN\=_^%?/1_P .ZO@?_P!#=X[_ /"OGH ]ZHKP7_AW5\#_ /H;
MO'?_ (5\]'_#NKX'_P#0W>.__"OGH ]ZHKP7_AW5\#_^AN\=_P#A7ST?\.ZO
M@?\ ]#=X[_\ "OGH ]ZHKP7_ (=U? __ *&[QW_X5\]'_#NKX'_]#=X[_P#"
MOGH ]ZHKP7_AW5\#_P#H;O'?_A7ST?\ #NKX'_\ 0W>._P#PKYZ />J*\%_X
M=U? _P#Z&[QW_P"%?/1_P[J^!_\ T-WCO_PKYZ />J*\%_X=U? __H;O'?\
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M#=X[_P#"OGH ]ZHKP7_AW5\#_P#H;O'?_A7ST?\ #NKX'_\ 0W>._P#PKYZ
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M17@O_#NKX'_]#=X[_P#"OGH_X=U? _\ Z&[QW_X5\] 'O5%>"_\ #NKX'_\
M0W>._P#PKYZ/^'=7P/\ ^AN\=_\ A7ST >]45X+_ ,.ZO@?_ -#=X[_\*^>C
M_AW5\#_^AN\=_P#A7ST >]45X+_P[J^!_P#T-WCO_P *^>C_ (=U? __ *&[
MQW_X5\] 'O5%>"_\.ZO@?_T-WCO_ ,*^>C_AW5\#_P#H;O'?_A7ST >]45X+
M_P .ZO@?_P!#=X[_ /"OGH_X=U? _P#Z&[QW_P"%?/0![U17@O\ P[J^!_\
MT-WCO_PKYZ/^'=7P/_Z&[QW_ .%?/0![U6/X'_Y!$O\ U^S?^A5X[_P[J^!_
M_0W>._\ PKYZ\L_9$_8X^&?Q8^&6H>)/%/BKQ>MQ!XJU*R067B::)/*AG*)D
M#JV.I[T ?9M%>"_\.ZO@?_T-WCO_ ,*^>C_AW5\#_P#H;O'?_A7ST >]45X+
M_P .ZO@?_P!#=X[_ /"OGH_X=U? _P#Z&[QW_P"%?/0![U17@O\ P[J^!_\
MT-WCO_PKYZ/^'=7P/_Z&[QW_ .%?/0![U17@O_#NKX'_ /0W>.__  KYZ/\
MAW5\#_\ H;O'?_A7ST >]45X+_P[J^!__0W>._\ PKYZ/^'=7P/_ .AN\=_^
M%?/0![U17@O_  [J^!__ $-WCO\ \*^>C_AW5\#_ /H;O'?_ (5\] 'O5%>"
M_P##NKX'_P#0W>.__"OGH_X=U? __H;O'?\ X5\] 'O5%>"_\.ZO@?\ ]#=X
M[_\ "OGH_P"'=7P/_P"AN\=_^%?/0![U17@O_#NKX'_]#=X[_P#"OGH_X=U?
M _\ Z&[QW_X5\] 'O5%>"_\ #NKX'_\ 0W>._P#PKYZ/^'=7P/\ ^AN\=_\
MA7ST >]45X+_ ,.ZO@?_ -#=X[_\*^>C_AW5\#_^AN\=_P#A7ST >]45X+_P
M[J^!_P#T-WCO_P *^>C_ (=U? __ *&[QW_X5\] 'O5%>"_\.ZO@?_T-WCO_
M ,*^>C_AW5\#_P#H;O'?_A7ST >]45X+_P .ZO@?_P!#=X[_ /"OGH_X=U?
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M^(+CPG\!/VH/AWXWU6TLS=W>F>$/&MAJ=Q#;AU0S/';2NRH&=%W$8RZC.2*
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MND]G>6DRR13Q.H9)$=20RL""&!((((JQ0 4444 %%%% !1110 4444 %%%%
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M*U/CC^T;^S]^S+X3C\=_M&?&_P )^ ]%FN1;P:KXO\0VVG02S$$B)'G=0SD
MG:,G )QQ0!V=%<_\-OBQ\+OC+X#LOBE\(OB/H7BGPSJ4+2Z?XA\/:M#>V5RB
MDJS)/"S(P!!!P>""#R*YKX*?M??LH?M)ZWJ_AO\ 9X_:7\!>.M1T!L:W8^$/
M%UGJ,UC\Q4&5+>1B@+ KD@ D$9R* /1:*** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHKCOC=^T/\!/V:/""_$#]HGXU>%/
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M1>)/%'>6L[V]S 60D;XYHWC8=F4@]*W: "BBB@ HHHH **** "BBB@ HHHH
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MB+X3:#\*TTJX;4-?NM1GN[;3;^S&S;-9R6MW#<>=N";489Y3< ?4G[8'@_\
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M&-Y)9$VH&" ?<%?AS^TK_P %?O\ @FQ^UM_P4F\3>"/^"BO[5D?A?X&_L_\
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M0"[>YR:NT44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M_P"3//\ ]8\F_P"?O_DLO\C]$**Y7X&_$W_A='P=\,_%G^Q/[-_X2+18+_\
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MO? C]J;]F;]J/2+O7OV:_P!H3P3\0+/3Y%CU"Y\&>*+34UM'8$JLIMY'\MB
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M8_\ !_;_ /Q=>8_\.R?V"/\ HUSPO_X#O_\ %T?\.R?V"/\ HUSPO_X#O_\
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M<_O%QXA\%/B=X'_9[_X(T_\ !-3]IOXNZR^E>"/ WQW-SXLUP6,TZ:;;R_\
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MP]X#L/%'B;1X+61[2VMKE_*'EW)4++B4,N.#@ D#- 'K%%%% !1110 4444
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MA;Q;\5KKXBFS0ZS;^(X;F^O;&6"\P)H%A^SP1*D;*H0.,8D;/IW[/&N>&?\
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MI=W=K;QCB&%;F"1EB3"+YAV@9(IO_!2/_E+E_P $_P#_ +'#Q_\ ^HRU3?\
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MIK7[-WA71_ ^KI926\?BJXM+C5I]]J90IDBDN%DM$EP$<Q$@E<&O+?#VB_\
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M_P#!W!_\77YX_P#!)#P+^RE^T+X4USX5?%_X-:#JGBK0I/MMG?74)\V\L)"
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M/Z<^"/ G@CX9>%++P'\-_!NE>']#TR'RM-T;0].BM+2TCR3LCAB54C7))PH
MYKY=_:^_X*<>'OV#OVT?!WP^_:OT+3_"OP4\:^![IM'^,%W'.T5GXHBN@6TF
M[9%:.VBDM )4D;&]U*]$) !\>?'S]J;]CF[_ ."*_P"T+!_P3M_9P7]G[QA)
MXATCP)\2? +^"K?P]K'A^_U34K/37>[@MN&W6EU,8IE)W $ JRL%]8_;N_92
M_9U_X)\_$_\ 8Q^.'[)?P>T+P3JFA_M >'_AE=W'A_38K:34_#VMV]Q8SV]X
MT84W9$JP3!I=["0.X^9B:^=/BU\+/&O_  4S^&G[?7[<'['GA#4]5\+>,U\!
MQ_".X_LZ2!O&]YX/E2]O+NWAD4/-&[1FT@;!\PA@/F&T>T?&S]O3]FW_ (+$
M_'+]D_X _L5>+;GQ/=Z%\8](^*_Q+6+39XSX.TW1(+B5;;42Z@07$E[)! L>
M22R'^%E8@&Q^P5^QW^S9_P %&]&_:X^-W[5/PCT3QAJWQ'^/7BKP=:ZUKNF1
MW-UIOA[23'INGP6<DBEK4Q^4\P:/:WFL&))12/<_^"#?QH\8?'S_ ()%_!#X
M@^/M:EU+5X?#-QHE[J$\I>2Y;2[^YTP2.S<N[+: ECR223DDU\S?L_\ _!07
M]GC_ (([Z]^U'^S+^U[KMSX=\20?&7Q'\0?A5H<FFSLWC31M:*7=E!IK(A6>
M87)EM712-C@%L .5^LO^"+7[-_CG]DS_ ();_!KX&_$_2'T[Q)8>%WU#7]-E
MCV265[J%U/J,UNZ]GCDNF1AV93UZT ?$/@W_ (*T_L'?\$T?^"Q/[;FA_ME?
M&*Y\+7/B[Q1X*GT".#PSJ&H?:([?PW"LI)M()0F#+'PV,YXS@UN?L??\%)/V
M./V^O^#@G4_V@_V7?BPVN^$/"_[$FH:?KNKWNBWFG+:3P^*[.YE!2[BC<JL,
MT;%@"O)&<@@>Z?\ !-S_ )2Y?\% /^QP\ ?^HRM<9^TM\-]2^,G_  7L\7_"
M#1K];2\\5_\ !-W7='M+IF*B&6Y\4I KDCD8+@Y]J *X_P""R'[=UQ\#G_X*
M5V7["/AT_LIQW1N?M$GC"8>-Y/#HN/)/B 6/D_9Q"%S/]F,GFF,9W;2)*]R_
M:6_;-_;9U_X]:9^SE_P3B_9I\+>+9G\#6_BS6_B5\3-9O=-\,P6MS*T=M96T
MEK;R27=U(JF4A2%C0H6R7^7\C?A1X>_X).^!_P!@/2O@C\>)_C[K/[26CV$7
M@GQ'^RS8_%7Q!97^L:^&%JUI!:)OMTLYE_?!T5X5B?: 6&P_3_[4OQ(^%'A7
M]NV;]CO_ (*'_MO_ !*_9R^"GP\^"/A=_A3X1\(>.KO2;?Q?)Y+Q:C]JU.VB
M\[4'MWCCMQ$K*7VAU4'?N -[]MW]MKQ]^VM_P2:\63_&GX0VW@7XA?#']JGP
MOX%\?^'=/U;[;9IJ5EXATF0SVLQ56>WDBN(G4L,YW#+8W'4T#Q9^V#=?\%K?
MVN])UCX;>#1X2_X4IIEOK>H)XIN7N[+1H[+6GTJ>WA-OL>>:<XGB+*L08LK2
M'BODCX:1?#W2O^"7'[3'A[X8>#=?\-Z#%^WQX6NO#N@^+OM8U:'29[_PZUE/
M=+>LUR))H0)3YQ+Y8YY%?:_CWXV?#/X*_P#!;']I'X2_%'Q&='U[XP?LX:(/
MAO:7-E,5UQM/L]9DNUCE5#&IC5'.'9<[2!D\4 >*?\$__P#@I7^WU^QW_P $
MG/@;^T9XD_8K\*R?LV^%M%T30/$6O7'C20>*9+26[2P?68;-8C"MLMQ* D3.
M99$4.=B/N3[=_:=_;S_:\U?]KW4OV&?^"</[/G@[QEXM\&^%K/Q!\3/%/Q&\
M2SZ=HN@1WAD^PZ>!;12337<Z122C "(B@DMEMGR1\1?^5/3P_P#]D?\ "_\
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MY&K[TH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MC,!A,?!1KQYDM=VOR:/SO_X<)?\ 5UO_ )8O_P!W4?\ #A+_ *NM_P#+%_\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
C %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>cah-20210630_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:cah="http://www.cardinal.com/20210630"
  xmlns:country="http://xbrl.sec.gov/country/2021"
  xmlns:dei="http://xbrl.sec.gov/dei/2021"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:srt="http://fasb.org/srt/2021-01-31"
  xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="cah-20210630.xsd" xlink:type="simple"/>
    <context id="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="if53145a5ccc7474d828f32716fb56f3f_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i8567a5e9e68d45bd946706441532802e_I20210731">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
        </entity>
        <period>
            <instant>2021-07-31</instant>
        </period>
    </context>
    <context id="ia31e9a409b874bb19d0ff6f2f39ecc09_D20190701-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i00a6d666bf604826b24e68ddbd63eac4_D20180701-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
        </entity>
        <period>
            <startDate>2018-07-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i2e87824102b34590a0208cc7da91b5f5_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i299cea70f47b4fbe96772aaa8cc00b79_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="iba537ecaa59e43b0a9b66571c8100267_I20180630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-06-30</instant>
        </period>
    </context>
    <context id="id3a1b5ab2e8f487b9c151040675e8c4e_I20180630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-06-30</instant>
        </period>
    </context>
    <context id="if1e3a4cc24f142cdafa5042dfc5dd64d_I20180630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-06-30</instant>
        </period>
    </context>
    <context id="ifb73250f67a2413d876abaab75f9b78e_I20180630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-06-30</instant>
        </period>
    </context>
    <context id="i9ffaf87e6d734e599ad2b8cf9d894639_I20180630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-06-30</instant>
        </period>
    </context>
    <context id="i39bbe70148ff4daea469e8420c1859d6_I20180630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
        </entity>
        <period>
            <instant>2018-06-30</instant>
        </period>
    </context>
    <context id="i368e27a25f8645faa683a133e4fd114e_D20180701-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-07-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i7a763b06539a46f2af8919fe47c2b61a_D20180701-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-07-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i192683d94cc4483f889528979a51af74_D20180701-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-07-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i8d9cc349c75d4429b567d5aa909a3433_D20180701-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-07-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="ifec5466baa034dc5b60b6acb6798f00e_D20180701-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-07-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i2c0babdbad624aa0b4937db55d311dfe_I20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="i04bec8a518fa429988f9b9473cfeb451_I20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="i0acb4be80aa74c89bc743cf58fc67d77_I20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="i08559a107c7a4c31965cd373a397c3af_I20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="i401ce4a0ca0546f58fbbd8672082718a_I20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="if6dc09eec4e74751b47cdf037a5b1860_I20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="ibeaaa4c81e084b86a689f640458f607a_D20190701-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i6b350fae2224486aa2a6ffc44c36559b_D20190701-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i4c5f25e0cc4f4d04a3afc3f86804554c_D20190701-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i0361658ee5604068a75c34f27c83ef6b_D20190701-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i61b655b20bf94b27a3ebf574f93a9915_D20190701-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i3eeed4226e40446da06738c489d87462_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i177d5a23d5d64051ad7ef088e9f5ebd4_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="idf14ef20aa2d4674855f6bc891acf9de_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="iab6212d6a7c945a59137402110f15a40_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i2f4057fc39254faf97951f0ee6826f17_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i400d2c56806648c1b6c3bdbab87c1d9d_D20200701-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="idaac2fb8e90844538a6c23b3c7452e2b_D20200701-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i97b5509a63f04bc7ab5194aaf760af37_D20200701-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i93e121bdfcb240d3a40552629748af1b_D20200701-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i2c9548aef74d4f1a8451e70e1ab67a37_D20200701-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i2356cc59616246e39e97302436e6c7df_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i8c7b0f49c7c44e0398779672048b5d26_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i4295fef126f64025b7be038ce6dfbe12_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="idec34558c686494fbf6ff02881153059_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i1335220d8ce44acc9542c3208bad8a10_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="iaf39bca192e042209819db3ca973f9f5_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="ida278becedcc42e688e90f303ce681a6_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="ia892a1655a98484e8d25b9944babb1df_D20200701-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="icc7d995e453e439bb115adae40076bfd_D20200701-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="id99ac5e3640e4d909d5ebe92cc1a2ccc_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForLossesOnFinanceReceivablesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i8572a6af84c14033a1b8f2ffeeaa45fa_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForLossesOnFinanceReceivablesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i9acbd6b22d7142e09e2d233e54af7d6b_D20200701-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">cah:CVSCaremarkCorporationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:PharmaceuticalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i40defd3d1e074fa6bc03365b87fbc0b2_D20190701-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">cah:CVSCaremarkCorporationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:PharmaceuticalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="if0d0d489f9374df68a492baec5bcd02d_D20180701-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">cah:CVSCaremarkCorporationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:PharmaceuticalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-07-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i8e11ba21ea4c434ca0730a61f91af07b_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">cah:CVSCaremarkCorporationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:PharmaceuticalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i26a1dbe593234221b3e2a9fe87790b80_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">cah:CVSCaremarkCorporationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:PharmaceuticalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i23c2808f4a0248299010d7304821d021_D20200701-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">cah:OptumRxMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:PharmaceuticalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i59cb1fe9f0d846b1911e81858e217d59_D20190701-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">cah:OptumRxMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:PharmaceuticalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="id8d95892717a49629b3d443c58d7bb6f_D20180701-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">cah:OptumRxMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:PharmaceuticalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-07-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="ife972a3c1957499f9517925bfb292b1e_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">cah:OptumRxMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:PharmaceuticalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i2603a56be62748bcadc6977aeeb99c1b_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">cah:OptumRxMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:PharmaceuticalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i9ff517d7ac9a411688a31be9bf4cb05e_D20200701-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">cah:GroupPurchasingOrganizationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i996d2cdb68d6466fbd2b2c5d332e8f86_D20190701-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">cah:GroupPurchasingOrganizationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i9ac168f728314508a0b6274f4b016f43_D20180701-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">cah:GroupPurchasingOrganizationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-07-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i614ddf8189e1435c9f69debafd0268da_D20200701-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingAndBuildingImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i74619ac5c2144773b658fb4dc96df2b7_D20200701-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingAndBuildingImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i4462638f30ef4b028287aa4982bcdc4f_D20200701-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i931fb7e29527410db9aa126b3ff884f1_D20200701-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i8ffd747abee84446822890ec937c3087_D20200701-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i761e5d4debc244e2b82864c57e70fa08_D20200701-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i863c52bff06f4314bb6767d10ced9400_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LandBuildingsAndImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="ia665b083fde8404d909e9610ecbf7ad2_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LandBuildingsAndImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="ic27322390092452ca30941dd0197b1c6_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="ia561b68251434cae953175730691825e_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i98ce0cd9b3ce4100a31e1cfb9d99189d_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i4e7acf9f1e1840958a192fad32010e75_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i2ae0fa0d058b4f21aac5c8701cbd2fb7_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cah:CordisDivestitureAxis">cah:CordisDivestitureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="id2a6b6641ae248c98d689f30c606f881_D20200701-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cah:OpioidLitigationAxis">cah:TotalOpioidLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i373ba6a0cdc044dea9602bdbad13174c_D20190701-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cah:OpioidLitigationAxis">cah:TotalOpioidLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="ic3592f06406544abac446d0e612f00d3_D20200701-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ShippingAndHandlingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ifee3aa6b50684ca4a55e508c43164afe_D20190701-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ShippingAndHandlingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i6e042ca2958c43e0a7786484c6024fa9_D20180701-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ShippingAndHandlingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-07-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="ia92b5f17e3cb4ca99a1789f7499fb2b2_D20210802-20210802">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cah:CordisDivestitureAxis">cah:CordisDivestitureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-08-02</startDate>
            <endDate>2021-08-02</endDate>
        </period>
    </context>
    <context id="i0c45da2d8021400f85c81b3a75b9c057_D20200701-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cah:CordisDivestitureAxis">cah:CordisDivestitureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i7f43dacd4cde4469bf87d551b8b075a1_D20180801-20180831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cah:NaviHealthAxis">cah:NaviHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-08-01</startDate>
            <endDate>2018-08-31</endDate>
        </period>
    </context>
    <context id="ibfc08d70138644988d1a3a9486dd3ada_D20180701-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cah:NaviHealthAxis">cah:NaviHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-07-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i463eed964bd04d08b29df93f74be293d_I20180801">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cah:NaviHealthAxis">cah:NaviHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-08-01</instant>
        </period>
    </context>
    <context id="i240ee16a678541f0949ac8f39755276a_D20190701-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cah:NaviHealthAxis">cah:NaviHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i054d56750a764f7e93ff85a2bf9a1b2b_I20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="i033d53d46d0d43139442c42e765cd554_I20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:FacilityClosingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="i979647fadf85426a8ed1ad60900d45dc_D20190701-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i690a654e053647b6a93151845b9d81e9_D20190701-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:FacilityClosingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i6b154a090610482d9bfc35edbf9bab55_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i74208c384ff247b5a96f11cafa8f324e_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:FacilityClosingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i66e672ad39ba4fbda69ce9255eb8afa1_D20200701-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i369bbd13125e4ca2a3de4a5c3da1ffc5_D20200701-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:FacilityClosingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="iec538c38949543a3a758a69a4da1d7f4_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i3af47ae162d94351b026bc1510125da6_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:FacilityClosingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i3b152a2afe4f4679a06346db852d336d_I20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:PharmaceuticalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="ie6cb132adb5f4ff7aba14ffe42cc56d3_I20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:MedicalMemberMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="ib1a6fd7bfc8b43f5b583eff60a34f03f_D20190701-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:PharmaceuticalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="icf7ee031a48e4d11b1c35c9709df0a86_D20190701-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:MedicalMemberMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i2e9e49271a494ffb9966fdbbe81322b3_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:PharmaceuticalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i3ca9000f2c0043198ff629f5aeec40d5_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:MedicalMemberMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="if8ec1f608f8f43c6bb4bb0cd8bd6fb89_D20200701-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:PharmaceuticalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i4f2593aaba1d4bcea5ad84327da58c41_D20200701-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:MedicalMemberMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i4bc96e0706314db5b186dfb752f90fbf_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cah:CordisDivestitureAxis">cah:CordisDivestitureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="if49fcb6df2f04a0aa6c1338190b0051b_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:MedicalMemberMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cah:CordisDivestitureAxis">cah:CordisDivestitureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i04a42200e8d447d5a05dcf88ecdb626a_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:PharmaceuticalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="ie33f818d5fa545a6bf5a055023560358_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:MedicalMemberMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="ie9082e4c164d4b1eb60733de4e88ad24_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">cah:IPRDTrademarksandOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i23d1c32c20a5440bb56a79d381e03b23_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i71898d44e3ea4dc6b493f7a21c418128_D20200701-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ia82a764d4393423da214b8d6611567aa_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">cah:TrademarksAndPatentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="idb9a0bc30ecf49c28ad8c5f1cd53fb7f_D20200701-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">cah:TrademarksAndPatentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i9d370528192046c8b78cd2c5462f6fed_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i3bd75edcbf314eb28cab79abc9a18d41_D20200701-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i19314c2cdba1474abcdc53474c121932_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">cah:IPRDTrademarksandOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="ic919be303957403e934baefe49c63756_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i5dae75b349b54d55a0e972014f606ac7_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">cah:TrademarksAndPatentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="idd95a519999348e3a6516e5fa7e6fcba_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="if156c7b3d30345a395262b86a56d2779_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="ib54859ab704046a7a3be64f76f566d69_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i473efc3a1c3141748a845b14896f4459_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="if8918e18bf5f4dea9e6f6e70f8d28bcf_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i7b139144658040af96c5e7fe53846762_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccruedLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i4dc82a9dc1f44fe7a3214de6a700a3e1_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccruedLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="iae9792a738c242f7bf603db4cdc6f6ea_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i143c1782b3aa4747968fda061bcedf08_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i1f2e316db9cd4fdfabceb7ed40f4de88_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PropertyPlantAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="ie4f28db5f64a4f11b597d0108259b1f2_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PropertyPlantAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="if00203a4c9a34b58a93c869a759f0035_D20200701-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">cah:ASC842Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i455f42e4f43447dc98cf9ec500532a90_D20190701-20190701">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">cah:ASC842Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-07-01</endDate>
        </period>
    </context>
    <context id="ie6662f5b1e3d4807b4fbf7aa426005bb_D20190701-20190701">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-07-01</endDate>
        </period>
    </context>
    <context id="i1a0dd756c14d48d7a436a9f95e4c95c3_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">cah:OperatingLeaseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i566381a05b1444c1a852e8768ae88ad3_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">cah:FinanceLeaseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i6040899ecc9f44f893d3f559f74eb30e_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:A2.616Notesdue2022Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i1079054a38c64aa1b73f425120be8b95_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:A2.616Notesdue2022Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i4681cfaabaed494eb4cdf968725268ad_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:A3.2Notesdue2022Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="idd88c476ee2d4612ba0be20c3b31959f_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:A3.2Notesdue2022Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="id7a8329ac0d44ba88b3081e963420a51_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:FloatingRateNotesdue2022Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i6108c3790b344ba09f455a14ad158d62_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:FloatingRateNotesdue2022Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i52aed3fcb7884bf0a519d03f6726bab7_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:A3.2Notesdue2023Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i39f995524bc54afd96d0837c392791d0_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:A3.2Notesdue2023Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i3079877c28ab4fc7acfe2cebacdaf0a2_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:A3.079Notesdue2024Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="iea859ed78b0341729f419cd2af57c361_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:A3.079Notesdue2024Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="id9068073bcf44ebfa32fbd94e54fa0bb_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:A3.5Notesdue2025Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i19386d9a9665443da76f29f541da851b_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:A3.5Notesdue2025Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="ia1f00593041245b2884a1d027a7a5789_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:A3.75Notesdue2026Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i1a8da22c2d104c07b8e124a12e07a40a_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:A3.75Notesdue2026Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i7f818bbd6041415ab92166ff89fb7e19_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:A3.41Notesdue2027Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i9f29332f948b439e93e2d67c75208f61_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:A3.41Notesdue2027Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i90cac66be512421fbc3704be2d9730c5_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:A4.6Notesdue2043Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="id14e22824b7b4593bfd07bc8ab4bb51a_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:A4.6Notesdue2043Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i9e575fac51a64f15bbc8ee5ae661cbbc_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:A4.5Notesdue2044Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i3a3d93f3182045b2979e580513d975cd_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:A4.5Notesdue2044Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="ife3234ddac5f446990273bd3ceb3091d_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:A4.9Notesdue2045Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i5c8388e50dd844709e91931b05259f87_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:A4.9Notesdue2045Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i6c1b2f1400e147e8a50fddbaf3a101ab_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:A4.368Notesdue2047Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i12b2bfab3db94c15be13cf683c78c053_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:A4.368Notesdue2047Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="ie0a9e0fdeffa40c9b581b00676cf4639_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:A7.0Debenturesduefiscal2027Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i89ff9fc63c07435d9b32595a42af3796_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:A7.0Debenturesduefiscal2027Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="ia5893ebe5da345e6a62bdc4932db4f7d_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:A7.0Debenturesduefiscal2027Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cah:AllegianceCorporationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i48e47b1be977446da19d44b2c23cb1f4_D20200701-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:A3.2Notesdue2022Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i464045c4aa5e46c28d8ccea38aea7f82_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:A2.616Notesdue2022Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ib3a5af086f334f83b59a840d35a3a24d_D20200701-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:A32Notes2616NotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i17d91fe6344242d2bf1252b509c16031_D20200701-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:FloatingRateNotesdue2022Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i7837defbe13947a6aa80a30d88599754_D20200701-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:A2.616Notesdue2022Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ie2038f77bf814473a8b5a3994d58411e_D20200701-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:FloatingRateNotes2616NotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="id79807de4e034b8ab663df3b706eba8a_D20190701-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:A4.625Notesdue2021Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i1f2e8fb9ffc746439d8749702977bc40_D20190701-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:A2.616Notesdue2022Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i97442363603544a4af2ceec2ab7ca6b2_D20190701-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:A3.2Notesdue2022Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i4638eb18574e4673aa4ca0d635ff8fed_D20190701-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:FloatingRateNotesdue2022Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i230f0206f083410f87c775c9c1709681_D20190701-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:A3.41Notesdue2027Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="id913564d8b3443a8af2a95fc5de03be7_D20190701-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:A4.6Notesdue2043Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="ibe4534f68d8a40109be5a39a86e86f4f_D20190701-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:A4.9Notesdue2045Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="iab9dfb1f8e404e5d8f9dbf5632e6590f_D20190701-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:A4.368Notesdue2047Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="ifd0a92fc87ae4632bce31919cea5ac88_D20190701-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:A2.616Notes3.2Notes3.41Notes4.6Notes4.9Notesand4.368NotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i569c9ebb1c9744c6a46c4bedf478f497_D20190701-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:A24NotesDue2019Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i9514a111b1dd465cb9bd660db2bf2bda_D20180701-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:A2.616Notesdue2022Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-07-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i211ab1e401334bc28102d404a589f244_D20180701-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:A3.2Notesdue2022Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-07-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i6c59631d68f748078379fec096820b35_D20180701-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:FloatingRateNotesdue2022Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-07-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i97bd654b86404619830471d41f60a11d_D20180701-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:A3.41Notesdue2027Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-07-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i09916dad25ba4c3c8af380f01d737407_D20180701-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:A1.948Notesdue2019Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-07-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i9820f36cdd3f46ff836bba721b3236ec_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i0c9f608d73754d42bf91b8f887a3643b_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i74a8ee2e9e1b481491947bdcd81fe93b_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">cah:ShortTermCreditFacilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:CommittedReceivablesSalesFacilityProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i2085dadd50db412cae65d5356e28138c_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LetterOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i6f57fbcd87fd4740ba92695d57c1ffe0_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LetterOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="ide18edefc53a43f1823ee90886c4b766_D20200701-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">cah:CommittedReceivablesSalesFacilityProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i947b0014f3864d1bbe6799521fc7f7ec_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">cah:CommittedReceivablesSalesFacilityProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="ic2fe7a908c6f4f61af7f7d8c6c00e82b_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">cah:CommittedReceivablesSalesFacilityProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i28f8f11500fa40cba044c5da762695f8_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LetterOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:CommittedReceivablesSalesFacilityProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i12ab314ad2e0406699d32582ff5dabfd_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LetterOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:CommittedReceivablesSalesFacilityProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i944f1f41fd954de4b4dc8f6b5c5c2db1_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="id267a8471edd4bc9bf4d5efa60da5922_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">cah:ShortTermCreditFacilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i47649611840740c9a47bac619a623132_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">cah:NewYorkOpioidStewardshipActMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i457f80b8744948758645272a98e06c10_D20200701-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">cah:NewYorkOpioidStewardshipActMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i5aad644cd5714c75b9ef8163bf7a97f7_I20210810">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">cah:OpioidLawsuitsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-08-10</instant>
        </period>
    </context>
    <context id="i69aa4c6826204c058cfb939b8d352e27_I20210810">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">cah:OpioidLawsuitsStateDomain</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-08-10</instant>
        </period>
    </context>
    <context id="iddd4821afbbd40c4a6c811e70974bf4a_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cah:OpioidLitigationAxis">cah:TotalOpioidLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i358dc7a7b0ec46769a803fbd85db0e3a_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccruedLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cah:OpioidLitigationAxis">cah:TotalOpioidLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i0e267f0781804e14b232b824ab81c9b0_I20210810">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">cah:OpioidLawsuitsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cah:PlaintiffTypeAxis">cah:PrivatePartiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-08-10</instant>
        </period>
    </context>
    <context id="ia0377f0db1e745b29e4b4fa403caefda_I20210810">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">cah:OpioidLawsuitsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cah:LawsuitTypeAxis">cah:ClassActionLawsuitsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cah:PlaintiffTypeAxis">cah:PrivatePartiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-08-10</instant>
        </period>
    </context>
    <context id="ieb82df38431448b4bf42dd698ac840f8_D20210810-20210810">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">cah:ProductLiabilityLawsuitsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-08-10</startDate>
            <endDate>2021-08-10</endDate>
        </period>
    </context>
    <context id="i31649c55524f4013acd74a3b9ce10a01_D20210810-20210810">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">cah:ProductLiabilityLawsuitsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">cah:AlamedaCountyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-08-10</startDate>
            <endDate>2021-08-10</endDate>
        </period>
    </context>
    <context id="i3caca7e07f5c4d03b8646b949d36c06e_D20210810-20210810">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">cah:ProductLiabilityLawsuitsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-08-10</startDate>
            <endDate>2021-08-10</endDate>
        </period>
    </context>
    <context id="i1687680dbb664c18933d117965cb34b0_D20210810-20210810">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">cah:ProductLiabilityLawsuitsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">cah:OtherJurisdictionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-08-10</startDate>
            <endDate>2021-08-10</endDate>
        </period>
    </context>
    <context id="i8068ea91c8ff4c3b8bd8310ae462197c_D20210701-20210731">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">cah:ProductLiabilityLawsuitsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-07-31</endDate>
        </period>
    </context>
    <context id="id300e006612f4c21bb7c72fd2b74da8f_D20200701-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">cah:DOJInvestigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i267869e21f794c639e2b4ecddb88f627_D20200701-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cah:NetOperatingLossCarrybackAxis">cah:NetOperatingLossCarrybackMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i58599d5030cc46db8dc1c2d03162cce3_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cah:NetOperatingLossCarrybackAxis">cah:NetOperatingLossCarrybackMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i44b4e02791f742199433f84d47a44563_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cah:OpioidLitigationAxis">cah:TotalOpioidLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="ia9314223dc824180abfdd254ebfb27a4_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:InternalRevenueServiceIRSMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i0e143b481d18458ab822c450cdd8c4b9_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i78a614f0d6654bc1bcffa521f2779f70_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i5861e52e19f84919b7cf3da21acd4a1c_D20190401-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i6ab12e7e0f7d4134995f67ad334fc7bb_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cah:TaxMatterAxis">cah:CareFusionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="ia26e78a845f44434a842d2f2d0afeb9c_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cah:TaxMatterAxis">cah:CareFusionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i5248507f2033461eab9f4d201b5cc2cd_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cah:TaxMatterAxis">cah:PatientRecoveryBusinessMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="ia1d9ae03c64d4c31b1115e366d980c83_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cah:TaxMatterAxis">cah:PatientRecoveryBusinessMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="if0e5c8d6266b4e399e3e86ab88d0ff94_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i2cb758f7ff794e2881dfc3872f11414b_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="iaf7e71fcba5f483ebe952262b8f49189_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i53e687ceccba4bac9c2829e01e82f358_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i7a7f821903974542847e3a426b2298e4_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i9b176a5bd18a4585bcea35c6994491bf_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="ib9e3c2a498984b619e5cd20d787935fc_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i66a08b6bbc4f404da5d4e4aeaf846429_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i19e92323b7e546339ee3ca1cd768d7dc_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="ieeeae5f04d634c51844ac9a96e9b09ed_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="ied457f9542c6444e96d2897053b037cd_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i4f2eecbc56bc4483ba6ecd0e80dc8c95_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="ie2fc3cb346df4a8790d437caebe5bfeb_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i3646dde5708840a9844baca98633b4d9_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="if1331393b0e34887b04264776d257b9d_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i027cf29054524efda48f2d0dea27a987_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="ia5a1a9623870472f8b2069242d333329_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i6a96679386eb4368a6920765ed1afdd6_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccruedLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i185e5c7efe754824b8a884fe900d3d71_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccruedLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i86f91bfc61ad471a9cb0bef75b551b70_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">cah:DeferredIncomeTaxesandOtherLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="ibe5ee12c49f146b8bc66d2c3290cbd7f_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">cah:DeferredIncomeTaxesandOtherLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="ibc2ebe6c60f8474283c818e4eb4db2ee_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccruedLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CommodityContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="ied8ca13a46124e0186f0557c51ad5050_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccruedLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CommodityContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i1f99a8613bb24104868a314b77c67aa4_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i69a44d9974c04cc3abf8c7aeb68f22c6_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i0168bf25346243ffba7498cecba4a9cc_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="icee22ead7e494923bbe522fa98e2c282_I20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="i85f45ef64e47468d81d7e9def6ee8bdd_D20200701-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i04848fa4190a4546999fce3b74a1093a_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="iffa4055c7e214900820c0a0df90cdebf_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i17248417fcbc4d118aebc5dfbe183bfc_D20200701-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i0845a3b72a6e4a848138beb4170c6fba_D20190701-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="ibe9e1edad1c3406abdda7b5fca98220a_D20180701-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-07-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="ia80ca9aee82849b1a44b4c376a866386_D20200701-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">cah:FixedRateDebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ic47a87ff22934f0a928e5fd2824d30f8_D20190701-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">cah:FixedRateDebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="ic94b1b2e248e48cdb5c5ff6dca1da5fb_D20180701-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">cah:FixedRateDebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-07-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i58c9aa5163a64897b2ad19c7f47190d0_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i54cc6ff9187745ac8eb02d90c7a86a72_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i88d0b5894f144c978ac101959057bde3_D20200701-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i8f3de44e96774f7296c0c1deb3f17775_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i82a8006ead354bb59b15285e08a487f9_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForwardContractsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="ie09b4e9c614244d1bd722525781f1905_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i4de6f0288abd431bbc839b56b68b328b_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CommodityContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i405b6b2ebdbb4b00959f5be8d40c1adb_D20200701-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForwardContractsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i3977a8adbc674a3db02afa95292219d7_D20190701-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForwardContractsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="ie29079d55386424da44448bd2dd0f7b9_D20180701-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForwardContractsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-07-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i8660a36c1b824eb4b6d2ad1d1026a6f3_D20200701-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CommodityContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i47b375ab68594453a768538fa7711d00_D20190701-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CommodityContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i3cf9aa045e7e4557acc082d5c2059d82_D20180701-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CommodityContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-07-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i88bb1d629e614ee2843091d49bcc870c_D20200701-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i45480cf9423f4da49ba73dd67b12ad65_D20190701-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="ib59a0c13c5ee4ae9aa9b88933c02ef8e_D20180701-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-07-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="ibb6fbf503d8d4b92b0852c5ea1309753_D20200701-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="iff868024f7f64db3bfeadcc44347a563_D20190701-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i310f8b1e6b5d4407acac6e3bf1a8f700_D20180701-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-07-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i3f26acb0755444a5b5ae1bcdc825ac67_D20200701-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i37fec931826541839b3ab83c0e5334f7_D20190701-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i987d48debeb4454198012308b3db9d71_D20180701-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-07-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="iccd66091b41c4c73b464f972ba9df372_D20200701-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i63ef41121d204393a0ebe9effaf8d432_D20190701-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i9f15f52c79704d46af60964d622dedab_D20180701-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-07-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i7a11a5ca49904135831f29f2e02611af_D20200701-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForwardContractsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i5459407c23c44c3aa651aec1bc97a889_D20190701-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForwardContractsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="ia2835dfb9ad14f699e13cc2bec62ea7e_D20180701-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForwardContractsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-07-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i4b9f0ce7440942e7bc207e8b7e6a8b82_D20200701-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CommodityContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i70ce64c92675430e973ad1616d164211_D20190701-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CommodityContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="ie940dc4896674168a3ab782e27d582e1_D20180701-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CommodityContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-07-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i254785c21f4b45739afff24cf0bc5323_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i2816c95fd6cb499095fe954700d7e965_I20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-30</instant>
        </period>
    </context>
    <context id="i935ecef2ff6941d394a6beccc5c10088_D20200701-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i193fb65a21864d5cb26c7c22aca8ad2b_D20190701-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="if722552b851a401795eb756ce826c809_D20200701-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i6ca29000e9a8453b9f0281faeb2f2ed2_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i7d5cf04c44ad4849821d4bb8a6945748_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="ifca9e60bdc7a4338aa4de50477f141d8_D20200701-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ia0fd144ab6c343f591a8767092fb681e_D20190701-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i3395922d014c40c59d772a4a5b2ebd31_D20180701-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-07-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i8b9a24f3941f46f085d16a60c26ec523_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i406116eedea746848300007f225725fd_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="ica8d8074683f4bda8b6a214c21c399ee_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForwardContractsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="ic67d0c6fd59147399881dd3fb666cc2a_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i83ca59dc22f646eaa9de5eecb3e81988_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i4cf22529a370428e82c5511fa7e35f8b_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CommodityContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i0a081dfdf3e846b387ac5e60a2f4e8a5_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i217241ce39cf47f0acdc17b79210218f_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i61106b444fde4f55a97a7eaed9e98693_D20200701-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i1eef4a3d4f414af4b5f60b07ff29ecc2_D20170701-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i25a5a0d717e04a1cb651e174b69d2257_I20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="ic2fe183f79d9435fa6fb7b20cb241684_I20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="i06a1421a7f5a434ab21bb6e7f6c4217d_D20190701-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="if2c1cb49d0374d86b2830517b2b187db_D20190701-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="ic4bf74d204c843148850dd8cf1a97c4c_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i6260475b94ac4643968f9f3d0742c126_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i87f033cb2d3241b690c413fa8321d9dd_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i10ebef79cb324951a3c60cf340e5e0c7_D20200701-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i6a93d5b1ddba4766830bc552988b0f64_D20200701-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ifb49b5f7c6944c1ba0d4367e9d8295ee_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="ic7926ed91fae47b7a3fcb884911ab862_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="ia3fefcfeaf9c46ce91e01b1989e54336_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i76b6a114dfd6424fb4c07d91075a91ff_D20200701-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:PharmaceuticalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i78632f0315fd45fb85ed1c2272933a36_D20190701-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:PharmaceuticalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i6d7435bb60af47f4a69d23c973a60d43_D20180701-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:PharmaceuticalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-07-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="id8c82c11050f452c9befaa43705026a6_D20200701-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:MedicalMemberMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i1faf47ea4d994e879fd1c1bf2cc15983_D20190701-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:MedicalMemberMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i4dcc4f5896f24eb98e3473b71e1d10b7_D20180701-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:MedicalMemberMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-07-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="ie5f1ec6cee11430ab0571ee6201cd0f7_D20200701-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i7a96c8334d2e46928c83a274df8be377_D20190701-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i3ab52d1ad77045aa97d1dbfb8cb6186e_D20180701-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-07-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i792ece330cb74d35afecabca6b7f49ea_D20200701-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i16818ee6ea724c8691b1f0065031735b_D20190701-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="ic5128c57d92d4336ae115d6ba4e979cb_D20180701-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-07-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i155c6a70937b40b68b1699cc88ad54f0_D20200701-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">cah:PharmaceuticalDistributionandSpecialtyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i76773aa4b180454e80d866fd2a2396b6_D20190701-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">cah:PharmaceuticalDistributionandSpecialtyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="ic18e242a8d2744198de6fca3c9aaccdd_D20180701-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">cah:PharmaceuticalDistributionandSpecialtyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-07-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i5aa6abf0d0ff4864be49a2c272e9ae17_D20200701-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">cah:NuclearPrecisionHealthServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i86db5a9e2c2b4d719e8263c1bfc96ca5_D20190701-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">cah:NuclearPrecisionHealthServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="iaa4c204e977543369238d8e99ef5f86e_D20180701-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">cah:NuclearPrecisionHealthServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-07-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i00d597531405494bb66494a39ed9a378_D20200701-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:MedicalMemberMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">cah:MedicaldistributionandproductsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="icf4b31c19dc549a1883307cdf7dbe88c_D20190701-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:MedicalMemberMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">cah:MedicaldistributionandproductsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i321e2ade5757483681291e8d89208466_D20180701-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:MedicalMemberMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">cah:MedicaldistributionandproductsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-07-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i2f0de7fef24f4d40bd4de0a2976f37d8_D20200701-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:MedicalMemberMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">cah:CardinalHealthAtHomeSolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ieaa341ac8f284f1582d38baefdc71c05_D20190701-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:MedicalMemberMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">cah:CardinalHealthAtHomeSolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i5c109faf3fc4429686c141f4abd59a0c_D20180701-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:MedicalMemberMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">cah:CardinalHealthAtHomeSolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-07-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="id0012edd1a484009af89832a87b38690_D20200701-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i634f4d42b1cb4e6cb3a43cc4bc98832d_D20190701-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i78774426f41940febec7d66ff52bb8d1_D20180701-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-07-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i3d4fc04fd3ba4fe9b28a1f419dbc6b15_D20200701-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i780324fcbcb345e29107285be707bc45_D20190701-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="if26a26c7dce04a669d805364e23fcbb7_D20180701-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-07-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="ic436b3ed22eb4cdcb413eaef19ec4ca5_D20190701-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cah:SterileSurgicalGownRecallAxis">cah:SterileSurgicalGownRecallMemberDomain</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="if5b3bab2d32340dea26c681d53110711_D20190701-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">cah:NaviHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i6e8acb06a2eb434ab88bfebe2a6d8a18_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:PharmaceuticalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="ia8a118e953bd4d1f9600cde58c7b110c_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:PharmaceuticalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i776ad5c7cad44d45a8cbf169d5b49ea5_I20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:PharmaceuticalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="i1395a9d318334a7bbf4965e8f0833f2b_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:MedicalMemberMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i2921a9a3e731468c9171a26f22574eba_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:MedicalMemberMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i2dbe5e7ed6284e6ba51e84d62ff6f50d_I20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:MedicalMemberMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="i8858cf546314492eb3e695791497ad0e_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="ia1e90564105346fb9b66345306cd8bed_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="ia3e5b233ccea481cbde3ab011c52f4b7_I20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="ieb5c5f04a3584568a0813006020736e0_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i1c873da0bc8f4cfea1d6280c5bb54279_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i6ab941d8314b4dffa0444dc05ecc3315_I20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="icd695cac6ddb4cbe8fd3520e0cdd88f2_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="ic6d6926b307941eea48b73ec840b45ba_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i5d8622203bb84c40af423bc2e4742dc2_I20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="i12a70580710847829f909cea8ceeacc3_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">cah:A2011LtipMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="ibaee55518fbe497ca65e202e76660b9e_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">cah:AwardsOtherThanStockOptionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">cah:A2011LtipMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="ib82e9bbd88e1416c896321662307b4fc_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">cah:A2011LtipMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i31f1c30559534af396751cc62e9e19a9_D20200701-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i956130d849c84807b9f6f7b055f5ebec_D20190701-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i579d152d52624fc381bd7cae2c7ddd4a_D20180701-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-07-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i9fac2b1e8f484ef081a25d163aa2c3a6_D20200701-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i5ec12fa139c6458fb260601a40c83a61_D20190701-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i4ff833c8f18c425d87db9b23fa00bd06_D20180701-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-07-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i217c2671c6f84df1ab8278415bc34c16_D20200701-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i4f0f3088df2a4e019bd09b2ef236fef0_D20190701-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="id7eb385b0eaf45a0aa833269191797b8_D20180701-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-07-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="icf32a92391924ff7b30fe54e99e0979b_I20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="ifb9b7ea1688a4fb4a266a5ac9179360e_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i401c6da5266c42ffb2f8a5466c3eba3c_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="ib473c6ce356d4388a73564ce9f41c306_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i6844f415cc38462c93502fde5a64b55f_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i0a3264d2aa5e4528bea7fa195a0d07b5_I20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="i6425a2ad601a4906adbbf99175836b8d_D20200701-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i2072923bec904f33a89202306af14057_D20200701-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i064bd318128c454cbd68ef31c37fed9d_D20200701-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i837fa9d3c1f04fb6aa54fd33592f52b3_I20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="ib996ace534574f9da807e45a4e349efc_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i09a66472ecae47489b82c3a6aade6b47_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i55e9481bb093412a97e842b3caeb64ec_D20200701-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i1206afb1bf5546759bbe9e6ed075350a_D20200701-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForLossesOnFinanceReceivablesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ie3de935dc1e7482faedb9bef40e18bc4_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:SalesReturnsAndAllowancesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i366d2f82d08341029a0c689efe436023_D20200701-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:SalesReturnsAndAllowancesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i35ade71063ad48868742425618cf24be_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:SalesReturnsAndAllowancesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i957454a121b24a28a13445f765e222b9_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForLoanAndLeaseLossesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i28620b092acd45fdaaad27b89277c8ad_D20200701-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForLoanAndLeaseLossesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ice14673b485d4f138bf5ec444359bc54_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForLoanAndLeaseLossesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="ide7e4b7157284fadb3309a188a76b7ca_I20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="i350af5c515834421987f12b1b2358e1f_D20190701-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i0d2f5152ae66452889546df6cb3b59aa_I20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForLossesOnFinanceReceivablesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="i6b4ffa7933dc41899a2489f876ca34b9_D20190701-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForLossesOnFinanceReceivablesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i5dd4173715e6498fb0d0dc27a3f02b9f_I20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:SalesReturnsAndAllowancesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="i400f4736cc2f44ec981957aa5112a379_D20190701-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:SalesReturnsAndAllowancesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i6e4105a2962247bab2434b9253c1a87a_I20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForLoanAndLeaseLossesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="if31c4c1d06774db4b770c1df3a18845b_D20190701-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForLoanAndLeaseLossesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="ic65be2ae369247318f0256c8cc4689d5_I20180630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-06-30</instant>
        </period>
    </context>
    <context id="i6f1dad679d0a49a586cbe4e15230d23d_D20180701-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-07-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="if5788af627104325bd77f50e1ab1ce2a_I20180630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForLossesOnFinanceReceivablesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-06-30</instant>
        </period>
    </context>
    <context id="ia954270fdd5c46e9a903107394449dd7_D20180701-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForLossesOnFinanceReceivablesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-07-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="ia84d7235822744479f9a7c898af562ac_I20180630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:SalesReturnsAndAllowancesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-06-30</instant>
        </period>
    </context>
    <context id="i4bfe813f83c04e8e9985198d3c0abce1_D20180701-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:SalesReturnsAndAllowancesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-07-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="ifbbe723cddd144c7bb4c9eab1d1f2f33_I20180630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForLoanAndLeaseLossesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-06-30</instant>
        </period>
    </context>
    <context id="i657bcf6c5a8f4e898448d61c3949243a_D20180701-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForLoanAndLeaseLossesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-07-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i1673490f38b2424cacdaabe5743e3504_D20200701-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">cah:PricingDisputesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i7ed96bb7a92d4005acebfec1c9075c82_D20190701-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">cah:PricingDisputesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="iecf663e1bbf54d3bbd24255d898605e0_D20180701-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">cah:PricingDisputesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-07-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i5dc92adfefad4108a6405a1cbdeeaf2f_D20200701-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">cah:PriorYearRecoveriesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ie90c978acfea4d6ea4dde9db8c7997ef_D20190701-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">cah:PriorYearRecoveriesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="iecd1cbc227d64a688441fd4ccc382b99_D20180701-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">cah:PriorYearRecoveriesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-07-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <unit id="usdPerShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="number">
        <measure>pure</measure>
    </unit>
    <unit id="organization">
        <measure>cah:organization</measure>
    </unit>
    <unit id="segment">
        <measure>cah:segment</measure>
    </unit>
    <unit id="stateag">
        <measure>cah:StateAG</measure>
    </unit>
    <unit id="lawsuit">
        <measure>cah:lawsuit</measure>
    </unit>
    <unit id="plaintiff">
        <measure>cah:plaintiff</measure>
    </unit>
    <unit id="jpy">
        <measure>iso4217:JPY</measure>
    </unit>
    <unit id="eur">
        <measure>iso4217:EUR</measure>
    </unit>
    <unit id="vestingperiods">
        <measure>cah:vestingPeriods</measure>
    </unit>
    <dei:AmendmentFlag
      contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF80L2ZyYWc6NDY5NTgyNjRiYWY1NDM3YmE4ZDAyMzIxYjBjODQ2YmEvdGFibGU6YTJhYzY4ZjFjY2M4NDI4ZjgxZWQ4MzQwYTQ1MjA1YTMvdGFibGVyYW5nZTphMmFjNjhmMWNjYzg0MjhmODFlZDgzNDBhNDUyMDVhM18xLTEtMS0xLTA_648f2c0a-818f-4371-8c48-e1fe776bf23e">false</dei:AmendmentFlag>
    <dei:DocumentPeriodEndDate
      contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF80L2ZyYWc6NDY5NTgyNjRiYWY1NDM3YmE4ZDAyMzIxYjBjODQ2YmEvdGFibGU6YTJhYzY4ZjFjY2M4NDI4ZjgxZWQ4MzQwYTQ1MjA1YTMvdGFibGVyYW5nZTphMmFjNjhmMWNjYzg0MjhmODFlZDgzNDBhNDUyMDVhM18yLTEtMS0xLTA_5764b1fe-c1b7-4e5e-a45c-a3ac22c8f484">2021-06-30</dei:DocumentPeriodEndDate>
    <dei:DocumentFiscalYearFocus
      contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF80L2ZyYWc6NDY5NTgyNjRiYWY1NDM3YmE4ZDAyMzIxYjBjODQ2YmEvdGFibGU6YTJhYzY4ZjFjY2M4NDI4ZjgxZWQ4MzQwYTQ1MjA1YTMvdGFibGVyYW5nZTphMmFjNjhmMWNjYzg0MjhmODFlZDgzNDBhNDUyMDVhM18zLTEtMS0xLTA_5ceb952b-3cd4-4a7f-ab46-ac32d2050d7e">2021</dei:DocumentFiscalYearFocus>
    <dei:DocumentFiscalPeriodFocus
      contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF80L2ZyYWc6NDY5NTgyNjRiYWY1NDM3YmE4ZDAyMzIxYjBjODQ2YmEvdGFibGU6YTJhYzY4ZjFjY2M4NDI4ZjgxZWQ4MzQwYTQ1MjA1YTMvdGFibGVyYW5nZTphMmFjNjhmMWNjYzg0MjhmODFlZDgzNDBhNDUyMDVhM180LTEtMS0xLTA_455ed8e3-8b92-44b8-b4dd-0fdb08dbea85">FY</dei:DocumentFiscalPeriodFocus>
    <dei:EntityCentralIndexKey
      contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF80L2ZyYWc6NDY5NTgyNjRiYWY1NDM3YmE4ZDAyMzIxYjBjODQ2YmEvdGFibGU6YTJhYzY4ZjFjY2M4NDI4ZjgxZWQ4MzQwYTQ1MjA1YTMvdGFibGVyYW5nZTphMmFjNjhmMWNjYzg0MjhmODFlZDgzNDBhNDUyMDVhM181LTEtMS0xLTA_9a12d34e-befa-4059-a3d4-8e9bb5103e38">0000721371</dei:EntityCentralIndexKey>
    <dei:CurrentFiscalYearEndDate
      contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF80L2ZyYWc6NDY5NTgyNjRiYWY1NDM3YmE4ZDAyMzIxYjBjODQ2YmEvdGFibGU6YTJhYzY4ZjFjY2M4NDI4ZjgxZWQ4MzQwYTQ1MjA1YTMvdGFibGVyYW5nZTphMmFjNjhmMWNjYzg0MjhmODFlZDgzNDBhNDUyMDVhM182LTEtMS0xLTA_8f2be3e5-1f87-4de2-a1cf-ac1ea8ecace7">--06-30</dei:CurrentFiscalYearEndDate>
    <dei:DocumentType
      contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xL2ZyYWc6ZDJkMWU5ZmExZTljNGMwODhiZThmZDIwY2YwNTQyOGYvdGV4dHJlZ2lvbjpkMmQxZTlmYTFlOWM0YzA4OGJlOGZkMjBjZjA1NDI4Zl8yMjI4_507822cc-e095-419a-b19b-bbeb214cb6a2">10-K</dei:DocumentType>
    <dei:DocumentAnnualReport
      contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xL2ZyYWc6ZDJkMWU5ZmExZTljNGMwODhiZThmZDIwY2YwNTQyOGYvdGFibGU6ZWM5Mzk0OWJlOTNjNGI5MmE4MDI5ODEzMWZmNzY1NDIvdGFibGVyYW5nZTplYzkzOTQ5YmU5M2M0YjkyYTgwMjk4MTMxZmY3NjU0Ml8wLTAtMS0xLTA_b3bc4778-a72d-48ad-8ece-91b6f80c1d5b">true</dei:DocumentAnnualReport>
    <dei:DocumentTransitionReport
      contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xL2ZyYWc6ZDJkMWU5ZmExZTljNGMwODhiZThmZDIwY2YwNTQyOGYvdGFibGU6NzY3ZDk1ZGMxMjI3NDc3Y2JmYjk3NzRjZTY0NDUxNDkvdGFibGVyYW5nZTo3NjdkOTVkYzEyMjc0NzdjYmZiOTc3NGNlNjQ0NTE0OV8wLTAtMS0xLTA_a95d245f-662f-4b06-ad00-502dfa2cd872">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber
      contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xL2ZyYWc6ZDJkMWU5ZmExZTljNGMwODhiZThmZDIwY2YwNTQyOGYvdGV4dHJlZ2lvbjpkMmQxZTlmYTFlOWM0YzA4OGJlOGZkMjBjZjA1NDI4Zl8yMjIz_c6394048-0120-41f6-a511-b2a91c9cde8b">1-11373</dei:EntityFileNumber>
    <dei:EntityRegistrantName
      contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xL2ZyYWc6ZDJkMWU5ZmExZTljNGMwODhiZThmZDIwY2YwNTQyOGYvdGV4dHJlZ2lvbjpkMmQxZTlmYTFlOWM0YzA4OGJlOGZkMjBjZjA1NDI4Zl8yMjI5_2943c814-3ba1-4d3f-b9ea-7ba462c5a6b5">Cardinal Health, Inc.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xL2ZyYWc6ZDJkMWU5ZmExZTljNGMwODhiZThmZDIwY2YwNTQyOGYvdGFibGU6NmFmNGVkNDBhODdmNDY4MTk2ZTlhNjEyYzI4NDMxZTUvdGFibGVyYW5nZTo2YWY0ZWQ0MGE4N2Y0NjgxOTZlOWE2MTJjMjg0MzFlNV8wLTAtMS0xLTA_a666273c-d223-4a36-b6e0-55863e68f2a2">OH</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber
      contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xL2ZyYWc6ZDJkMWU5ZmExZTljNGMwODhiZThmZDIwY2YwNTQyOGYvdGFibGU6NmFmNGVkNDBhODdmNDY4MTk2ZTlhNjEyYzI4NDMxZTUvdGFibGVyYW5nZTo2YWY0ZWQ0MGE4N2Y0NjgxOTZlOWE2MTJjMjg0MzFlNV8wLTYtMS0xLTA_1f9c2c85-bab0-428c-b810-81a7539d9eaf">31-0958666</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xL2ZyYWc6ZDJkMWU5ZmExZTljNGMwODhiZThmZDIwY2YwNTQyOGYvdGFibGU6NmFmNGVkNDBhODdmNDY4MTk2ZTlhNjEyYzI4NDMxZTUvdGFibGVyYW5nZTo2YWY0ZWQ0MGE4N2Y0NjgxOTZlOWE2MTJjMjg0MzFlNV8zLTAtMS0xLTA_56e74991-95fa-475a-a7e9-bc41b9a195a0">7000 Cardinal Place</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown
      contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xL2ZyYWc6ZDJkMWU5ZmExZTljNGMwODhiZThmZDIwY2YwNTQyOGYvdGFibGU6NmFmNGVkNDBhODdmNDY4MTk2ZTlhNjEyYzI4NDMxZTUvdGFibGVyYW5nZTo2YWY0ZWQ0MGE4N2Y0NjgxOTZlOWE2MTJjMjg0MzFlNV8zLTItMS0xLTA_659b8735-a927-471d-a4d4-1c87e60afc82">Dublin</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xL2ZyYWc6ZDJkMWU5ZmExZTljNGMwODhiZThmZDIwY2YwNTQyOGYvdGFibGU6NmFmNGVkNDBhODdmNDY4MTk2ZTlhNjEyYzI4NDMxZTUvdGFibGVyYW5nZTo2YWY0ZWQ0MGE4N2Y0NjgxOTZlOWE2MTJjMjg0MzFlNV8zLTQtMS0xLTA_20d999f1-f038-4c51-957e-b88bd6487213">OH</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xL2ZyYWc6ZDJkMWU5ZmExZTljNGMwODhiZThmZDIwY2YwNTQyOGYvdGFibGU6NmFmNGVkNDBhODdmNDY4MTk2ZTlhNjEyYzI4NDMxZTUvdGFibGVyYW5nZTo2YWY0ZWQ0MGE4N2Y0NjgxOTZlOWE2MTJjMjg0MzFlNV8zLTYtMS0xLTA_54fb931e-7600-4102-a02a-589163dc8509">43017</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xL2ZyYWc6ZDJkMWU5ZmExZTljNGMwODhiZThmZDIwY2YwNTQyOGYvdGFibGU6NmFmNGVkNDBhODdmNDY4MTk2ZTlhNjEyYzI4NDMxZTUvdGFibGVyYW5nZTo2YWY0ZWQ0MGE4N2Y0NjgxOTZlOWE2MTJjMjg0MzFlNV82LTQtMS0xLTA_6b25231d-d408-4394-8337-c1fb0fd1730d">(614)</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xL2ZyYWc6ZDJkMWU5ZmExZTljNGMwODhiZThmZDIwY2YwNTQyOGYvdGFibGU6NmFmNGVkNDBhODdmNDY4MTk2ZTlhNjEyYzI4NDMxZTUvdGFibGVyYW5nZTo2YWY0ZWQ0MGE4N2Y0NjgxOTZlOWE2MTJjMjg0MzFlNV82LTYtMS0xLTA_24565572-908f-4b33-8aa4-470594c68644">757-5000</dei:LocalPhoneNumber>
    <dei:Security12bTitle
      contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xL2ZyYWc6ZDJkMWU5ZmExZTljNGMwODhiZThmZDIwY2YwNTQyOGYvdGFibGU6YWMyMjI0YTEwZTNhNGY0NmI3YWVhOGYyMDdmOGJjZmEvdGFibGVyYW5nZTphYzIyMjRhMTBlM2E0ZjQ2YjdhZWE4ZjIwN2Y4YmNmYV8zLTAtMS0xLTA_a486d663-020c-4820-8ee6-b5f33132edbf">Common shares (without par value)</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xL2ZyYWc6ZDJkMWU5ZmExZTljNGMwODhiZThmZDIwY2YwNTQyOGYvdGFibGU6YWMyMjI0YTEwZTNhNGY0NmI3YWVhOGYyMDdmOGJjZmEvdGFibGVyYW5nZTphYzIyMjRhMTBlM2E0ZjQ2YjdhZWE4ZjIwN2Y4YmNmYV8zLTEtMS0xLTA_0fae4f93-2285-47e9-b2de-f4ea3b9dd43f">CAH</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xL2ZyYWc6ZDJkMWU5ZmExZTljNGMwODhiZThmZDIwY2YwNTQyOGYvdGFibGU6YWMyMjI0YTEwZTNhNGY0NmI3YWVhOGYyMDdmOGJjZmEvdGFibGVyYW5nZTphYzIyMjRhMTBlM2E0ZjQ2YjdhZWE4ZjIwN2Y4YmNmYV8zLTItMS0xLTA_ca96c4f4-f0d4-4584-8133-9d076b53130b">NYSE</dei:SecurityExchangeName>
    <dei:EntityWellKnownSeasonedIssuer
      contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xL2ZyYWc6ZDJkMWU5ZmExZTljNGMwODhiZThmZDIwY2YwNTQyOGYvdGV4dHJlZ2lvbjpkMmQxZTlmYTFlOWM0YzA4OGJlOGZkMjBjZjA1NDI4Zl8yMjI0_64516982-332b-4ed7-9528-99603bf9fd7d">Yes</dei:EntityWellKnownSeasonedIssuer>
    <dei:EntityVoluntaryFilers
      contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xL2ZyYWc6ZDJkMWU5ZmExZTljNGMwODhiZThmZDIwY2YwNTQyOGYvdGV4dHJlZ2lvbjpkMmQxZTlmYTFlOWM0YzA4OGJlOGZkMjBjZjA1NDI4Zl8yMjMw_8cc6c6ba-03f7-4ddc-8f8a-804104a57484">No</dei:EntityVoluntaryFilers>
    <dei:EntityCurrentReportingStatus
      contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xL2ZyYWc6ZDJkMWU5ZmExZTljNGMwODhiZThmZDIwY2YwNTQyOGYvdGV4dHJlZ2lvbjpkMmQxZTlmYTFlOWM0YzA4OGJlOGZkMjBjZjA1NDI4Zl8yMjI1_1dc35fe3-f5a5-45ef-97bc-8e7997bcce41">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent
      contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xL2ZyYWc6ZDJkMWU5ZmExZTljNGMwODhiZThmZDIwY2YwNTQyOGYvdGV4dHJlZ2lvbjpkMmQxZTlmYTFlOWM0YzA4OGJlOGZkMjBjZjA1NDI4Zl8yMjMx_872588f7-690c-4f8d-b7de-ac3f1285d1fe">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory
      contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xL2ZyYWc6ZDJkMWU5ZmExZTljNGMwODhiZThmZDIwY2YwNTQyOGYvdGFibGU6NWI0OWFhYzFhYWEyNGU3YWEzMDBiM2FlNWZmN2E4ODcvdGFibGVyYW5nZTo1YjQ5YWFjMWFhYTI0ZTdhYTMwMGIzYWU1ZmY3YTg4N18wLTAtMS0xLTA_3929b577-f167-41cd-be13-52cc19f35f66">Large Accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness
      contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xL2ZyYWc6ZDJkMWU5ZmExZTljNGMwODhiZThmZDIwY2YwNTQyOGYvdGFibGU6NWI0OWFhYzFhYWEyNGU3YWEzMDBiM2FlNWZmN2E4ODcvdGFibGVyYW5nZTo1YjQ5YWFjMWFhYTI0ZTdhYTMwMGIzYWU1ZmY3YTg4N18xLTQtMS0xLTA_123fe286-d8af-483c-b89c-39b8378bb0e0">false</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany
      contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xL2ZyYWc6ZDJkMWU5ZmExZTljNGMwODhiZThmZDIwY2YwNTQyOGYvdGFibGU6NWI0OWFhYzFhYWEyNGU3YWEzMDBiM2FlNWZmN2E4ODcvdGFibGVyYW5nZTo1YjQ5YWFjMWFhYTI0ZTdhYTMwMGIzYWU1ZmY3YTg4N18yLTQtMS0xLTA_1f24256f-0823-4aa5-8339-033277d55455">false</dei:EntityEmergingGrowthCompany>
    <dei:IcfrAuditorAttestationFlag
      contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xL2ZyYWc6ZDJkMWU5ZmExZTljNGMwODhiZThmZDIwY2YwNTQyOGYvdGFibGU6NWI0OWFhYzFhYWEyNGU3YWEzMDBiM2FlNWZmN2E4ODcvdGFibGVyYW5nZTo1YjQ5YWFjMWFhYTI0ZTdhYTMwMGIzYWU1ZmY3YTg4N181LTAtMS0xLTkwOTU_1d9b8c82-b72b-41e9-b808-ce759dcacf42">true</dei:IcfrAuditorAttestationFlag>
    <dei:EntityShellCompany
      contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xL2ZyYWc6ZDJkMWU5ZmExZTljNGMwODhiZThmZDIwY2YwNTQyOGYvdGV4dHJlZ2lvbjpkMmQxZTlmYTFlOWM0YzA4OGJlOGZkMjBjZjA1NDI4Zl8yMjI2_860fddf9-d085-436e-87d5-fa6f5f043f60">false</dei:EntityShellCompany>
    <dei:EntityPublicFloat
      contextRef="if53145a5ccc7474d828f32716fb56f3f_I20201231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xL2ZyYWc6ZDJkMWU5ZmExZTljNGMwODhiZThmZDIwY2YwNTQyOGYvdGV4dHJlZ2lvbjpkMmQxZTlmYTFlOWM0YzA4OGJlOGZkMjBjZjA1NDI4Zl8xODQy_fa72b43f-502f-40e2-b0b1-d15e03f0e0e3"
      unitRef="usd">15693865917</dei:EntityPublicFloat>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="i8567a5e9e68d45bd946706441532802e_I20210731"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xL2ZyYWc6ZDJkMWU5ZmExZTljNGMwODhiZThmZDIwY2YwNTQyOGYvdGV4dHJlZ2lvbjpkMmQxZTlmYTFlOWM0YzA4OGJlOGZkMjBjZjA1NDI4Zl8xOTUy_ea511691-f70e-4bd8-adbe-31c4e3b8669b"
      unitRef="shares">290441408</dei:EntityCommonStockSharesOutstanding>
    <dei:DocumentsIncorporatedByReferenceTextBlock
      contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xL2ZyYWc6ZDJkMWU5ZmExZTljNGMwODhiZThmZDIwY2YwNTQyOGYvdGV4dHJlZ2lvbjpkMmQxZTlmYTFlOWM0YzA4OGJlOGZkMjBjZjA1NDI4Zl8yMjMy_5eade316-ade8-4bd7-a84d-95d336ce503d">&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;Documents Incorporated by Reference: &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Portions of the registrant&#x2019;s Definitive Proxy Statement to be filed for its 2021 Annual Meeting of Shareholders are incorporated by reference into the sections of this Form 10-K addressing the requirements of Part&#160;III of Form&#160;10-K.&lt;/span&gt;&lt;/div&gt;</dei:DocumentsIncorporatedByReferenceTextBlock>
    <us-gaap:Revenues
      contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF83OS9mcmFnOmYxNjk1NzMwNTY2MzRiMzg5NDM4MDUzMzY5ODYzNDA3L3RhYmxlOjUyZjNlMzM5YjkzMjRkN2NhZTc5MmM2ZGM4N2E1YzY4L3RhYmxlcmFuZ2U6NTJmM2UzMzliOTMyNGQ3Y2FlNzkyYzZkYzg3YTVjNjhfMS0xLTEtMS0w_6c0ff04c-7f7a-4588-9c9f-fa025c4aa544"
      unitRef="usd">162467000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ia31e9a409b874bb19d0ff6f2f39ecc09_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF83OS9mcmFnOmYxNjk1NzMwNTY2MzRiMzg5NDM4MDUzMzY5ODYzNDA3L3RhYmxlOjUyZjNlMzM5YjkzMjRkN2NhZTc5MmM2ZGM4N2E1YzY4L3RhYmxlcmFuZ2U6NTJmM2UzMzliOTMyNGQ3Y2FlNzkyYzZkYzg3YTVjNjhfMS0zLTEtMS0w_ce401778-03c2-4212-9f68-a03f64f51448"
      unitRef="usd">152922000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i00a6d666bf604826b24e68ddbd63eac4_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF83OS9mcmFnOmYxNjk1NzMwNTY2MzRiMzg5NDM4MDUzMzY5ODYzNDA3L3RhYmxlOjUyZjNlMzM5YjkzMjRkN2NhZTc5MmM2ZGM4N2E1YzY4L3RhYmxlcmFuZ2U6NTJmM2UzMzliOTMyNGQ3Y2FlNzkyYzZkYzg3YTVjNjhfMS01LTEtMS0w_899eb95a-4e0b-436f-abbd-967524a0aa7a"
      unitRef="usd">145534000000</us-gaap:Revenues>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF83OS9mcmFnOmYxNjk1NzMwNTY2MzRiMzg5NDM4MDUzMzY5ODYzNDA3L3RhYmxlOjUyZjNlMzM5YjkzMjRkN2NhZTc5MmM2ZGM4N2E1YzY4L3RhYmxlcmFuZ2U6NTJmM2UzMzliOTMyNGQ3Y2FlNzkyYzZkYzg3YTVjNjhfMi0xLTEtMS0w_2ad22b0d-f207-4acf-9a4c-751857e88f2f"
      unitRef="usd">155689000000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="ia31e9a409b874bb19d0ff6f2f39ecc09_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF83OS9mcmFnOmYxNjk1NzMwNTY2MzRiMzg5NDM4MDUzMzY5ODYzNDA3L3RhYmxlOjUyZjNlMzM5YjkzMjRkN2NhZTc5MmM2ZGM4N2E1YzY4L3RhYmxlcmFuZ2U6NTJmM2UzMzliOTMyNGQ3Y2FlNzkyYzZkYzg3YTVjNjhfMi0zLTEtMS0w_72518c51-b544-405e-8a1c-5df2eae16160"
      unitRef="usd">146054000000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i00a6d666bf604826b24e68ddbd63eac4_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF83OS9mcmFnOmYxNjk1NzMwNTY2MzRiMzg5NDM4MDUzMzY5ODYzNDA3L3RhYmxlOjUyZjNlMzM5YjkzMjRkN2NhZTc5MmM2ZGM4N2E1YzY4L3RhYmxlcmFuZ2U6NTJmM2UzMzliOTMyNGQ3Y2FlNzkyYzZkYzg3YTVjNjhfMi01LTEtMS0w_8ca10d9d-6e74-4842-b0f0-68fea29f60bb"
      unitRef="usd">138700000000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:GrossProfit
      contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF83OS9mcmFnOmYxNjk1NzMwNTY2MzRiMzg5NDM4MDUzMzY5ODYzNDA3L3RhYmxlOjUyZjNlMzM5YjkzMjRkN2NhZTc5MmM2ZGM4N2E1YzY4L3RhYmxlcmFuZ2U6NTJmM2UzMzliOTMyNGQ3Y2FlNzkyYzZkYzg3YTVjNjhfMy0xLTEtMS0w_f3b623e1-eb17-47e3-88f9-eec33c486215"
      unitRef="usd">6778000000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="ia31e9a409b874bb19d0ff6f2f39ecc09_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF83OS9mcmFnOmYxNjk1NzMwNTY2MzRiMzg5NDM4MDUzMzY5ODYzNDA3L3RhYmxlOjUyZjNlMzM5YjkzMjRkN2NhZTc5MmM2ZGM4N2E1YzY4L3RhYmxlcmFuZ2U6NTJmM2UzMzliOTMyNGQ3Y2FlNzkyYzZkYzg3YTVjNjhfMy0zLTEtMS0w_22be9707-e53d-4bee-a780-c9703bdef95d"
      unitRef="usd">6868000000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="i00a6d666bf604826b24e68ddbd63eac4_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF83OS9mcmFnOmYxNjk1NzMwNTY2MzRiMzg5NDM4MDUzMzY5ODYzNDA3L3RhYmxlOjUyZjNlMzM5YjkzMjRkN2NhZTc5MmM2ZGM4N2E1YzY4L3RhYmxlcmFuZ2U6NTJmM2UzMzliOTMyNGQ3Y2FlNzkyYzZkYzg3YTVjNjhfMy01LTEtMS0w_5ce0ddb1-275a-4f4a-900c-c36fa9c80802"
      unitRef="usd">6834000000</us-gaap:GrossProfit>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF83OS9mcmFnOmYxNjk1NzMwNTY2MzRiMzg5NDM4MDUzMzY5ODYzNDA3L3RhYmxlOjUyZjNlMzM5YjkzMjRkN2NhZTc5MmM2ZGM4N2E1YzY4L3RhYmxlcmFuZ2U6NTJmM2UzMzliOTMyNGQ3Y2FlNzkyYzZkYzg3YTVjNjhfNi0xLTEtMS0w_ffc14c8e-4baf-4ffa-8ba7-e8188b0f617f"
      unitRef="usd">4533000000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="ia31e9a409b874bb19d0ff6f2f39ecc09_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF83OS9mcmFnOmYxNjk1NzMwNTY2MzRiMzg5NDM4MDUzMzY5ODYzNDA3L3RhYmxlOjUyZjNlMzM5YjkzMjRkN2NhZTc5MmM2ZGM4N2E1YzY4L3RhYmxlcmFuZ2U6NTJmM2UzMzliOTMyNGQ3Y2FlNzkyYzZkYzg3YTVjNjhfNi0zLTEtMS0w_99ed2833-d6cf-43a8-a209-537f932b3aff"
      unitRef="usd">4572000000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="i00a6d666bf604826b24e68ddbd63eac4_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF83OS9mcmFnOmYxNjk1NzMwNTY2MzRiMzg5NDM4MDUzMzY5ODYzNDA3L3RhYmxlOjUyZjNlMzM5YjkzMjRkN2NhZTc5MmM2ZGM4N2E1YzY4L3RhYmxlcmFuZ2U6NTJmM2UzMzliOTMyNGQ3Y2FlNzkyYzZkYzg3YTVjNjhfNi01LTEtMS0w_7ac6d5ca-1afc-45d3-b21a-cfc0b3b69412"
      unitRef="usd">4480000000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:RestructuringCharges
      contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF83OS9mcmFnOmYxNjk1NzMwNTY2MzRiMzg5NDM4MDUzMzY5ODYzNDA3L3RhYmxlOjUyZjNlMzM5YjkzMjRkN2NhZTc5MmM2ZGM4N2E1YzY4L3RhYmxlcmFuZ2U6NTJmM2UzMzliOTMyNGQ3Y2FlNzkyYzZkYzg3YTVjNjhfNy0xLTEtMS0w_6f0a251d-4c2d-4423-8c00-8ea0122d61fd"
      unitRef="usd">114000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="ia31e9a409b874bb19d0ff6f2f39ecc09_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF83OS9mcmFnOmYxNjk1NzMwNTY2MzRiMzg5NDM4MDUzMzY5ODYzNDA3L3RhYmxlOjUyZjNlMzM5YjkzMjRkN2NhZTc5MmM2ZGM4N2E1YzY4L3RhYmxlcmFuZ2U6NTJmM2UzMzliOTMyNGQ3Y2FlNzkyYzZkYzg3YTVjNjhfNy0zLTEtMS0w_2ff923e0-1296-4eea-b168-bcd9788ce67b"
      unitRef="usd">122000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i00a6d666bf604826b24e68ddbd63eac4_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF83OS9mcmFnOmYxNjk1NzMwNTY2MzRiMzg5NDM4MDUzMzY5ODYzNDA3L3RhYmxlOjUyZjNlMzM5YjkzMjRkN2NhZTc5MmM2ZGM4N2E1YzY4L3RhYmxlcmFuZ2U6NTJmM2UzMzliOTMyNGQ3Y2FlNzkyYzZkYzg3YTVjNjhfNy01LTEtMS0w_318d2461-a0e3-4ff3-af56-41a67baf7e51"
      unitRef="usd">125000000</us-gaap:RestructuringCharges>
    <cah:Amortizationandotheracquisitionrelatedcosts
      contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF83OS9mcmFnOmYxNjk1NzMwNTY2MzRiMzg5NDM4MDUzMzY5ODYzNDA3L3RhYmxlOjUyZjNlMzM5YjkzMjRkN2NhZTc5MmM2ZGM4N2E1YzY4L3RhYmxlcmFuZ2U6NTJmM2UzMzliOTMyNGQ3Y2FlNzkyYzZkYzg3YTVjNjhfOC0xLTEtMS0w_bc47ea25-a6e0-4ced-b238-ef7a2fbfb819"
      unitRef="usd">451000000</cah:Amortizationandotheracquisitionrelatedcosts>
    <cah:Amortizationandotheracquisitionrelatedcosts
      contextRef="ia31e9a409b874bb19d0ff6f2f39ecc09_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF83OS9mcmFnOmYxNjk1NzMwNTY2MzRiMzg5NDM4MDUzMzY5ODYzNDA3L3RhYmxlOjUyZjNlMzM5YjkzMjRkN2NhZTc5MmM2ZGM4N2E1YzY4L3RhYmxlcmFuZ2U6NTJmM2UzMzliOTMyNGQ3Y2FlNzkyYzZkYzg3YTVjNjhfOC0zLTEtMS0w_1b78a558-5d0f-494b-8ab5-274a9407c28a"
      unitRef="usd">524000000</cah:Amortizationandotheracquisitionrelatedcosts>
    <cah:Amortizationandotheracquisitionrelatedcosts
      contextRef="i00a6d666bf604826b24e68ddbd63eac4_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF83OS9mcmFnOmYxNjk1NzMwNTY2MzRiMzg5NDM4MDUzMzY5ODYzNDA3L3RhYmxlOjUyZjNlMzM5YjkzMjRkN2NhZTc5MmM2ZGM4N2E1YzY4L3RhYmxlcmFuZ2U6NTJmM2UzMzliOTMyNGQ3Y2FlNzkyYzZkYzg3YTVjNjhfOC01LTEtMS0w_ba74d5c0-11bd-4223-97c6-59eca4738121"
      unitRef="usd">621000000</cah:Amortizationandotheracquisitionrelatedcosts>
    <us-gaap:GainLossOnSalesOfAssetsAndAssetImpairmentCharges
      contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF83OS9mcmFnOmYxNjk1NzMwNTY2MzRiMzg5NDM4MDUzMzY5ODYzNDA3L3RhYmxlOjUyZjNlMzM5YjkzMjRkN2NhZTc5MmM2ZGM4N2E1YzY4L3RhYmxlcmFuZ2U6NTJmM2UzMzliOTMyNGQ3Y2FlNzkyYzZkYzg3YTVjNjhfOS0xLTEtMS0w_435adf2c-92ec-406d-ad32-d374aefb78a9"
      unitRef="usd">-79000000</us-gaap:GainLossOnSalesOfAssetsAndAssetImpairmentCharges>
    <us-gaap:GainLossOnSalesOfAssetsAndAssetImpairmentCharges
      contextRef="ia31e9a409b874bb19d0ff6f2f39ecc09_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF83OS9mcmFnOmYxNjk1NzMwNTY2MzRiMzg5NDM4MDUzMzY5ODYzNDA3L3RhYmxlOjUyZjNlMzM5YjkzMjRkN2NhZTc5MmM2ZGM4N2E1YzY4L3RhYmxlcmFuZ2U6NTJmM2UzMzliOTMyNGQ3Y2FlNzkyYzZkYzg3YTVjNjhfOS0zLTEtMS0w_61ecaf19-9f23-46f8-8ede-7c13533d263e"
      unitRef="usd">-7000000</us-gaap:GainLossOnSalesOfAssetsAndAssetImpairmentCharges>
    <us-gaap:GainLossOnSalesOfAssetsAndAssetImpairmentCharges
      contextRef="i00a6d666bf604826b24e68ddbd63eac4_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF83OS9mcmFnOmYxNjk1NzMwNTY2MzRiMzg5NDM4MDUzMzY5ODYzNDA3L3RhYmxlOjUyZjNlMzM5YjkzMjRkN2NhZTc5MmM2ZGM4N2E1YzY4L3RhYmxlcmFuZ2U6NTJmM2UzMzliOTMyNGQ3Y2FlNzkyYzZkYzg3YTVjNjhfOS01LTEtMS0w_a19432e3-9a6d-4332-a331-a7cd061b2832"
      unitRef="usd">488000000</us-gaap:GainLossOnSalesOfAssetsAndAssetImpairmentCharges>
    <us-gaap:GainLossRelatedToLitigationSettlement
      contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF83OS9mcmFnOmYxNjk1NzMwNTY2MzRiMzg5NDM4MDUzMzY5ODYzNDA3L3RhYmxlOjUyZjNlMzM5YjkzMjRkN2NhZTc5MmM2ZGM4N2E1YzY4L3RhYmxlcmFuZ2U6NTJmM2UzMzliOTMyNGQ3Y2FlNzkyYzZkYzg3YTVjNjhfMTAtMS0xLTEtMA_d162e042-9b27-4739-9c4a-79effa8be25e"
      unitRef="usd">-1129000000</us-gaap:GainLossRelatedToLitigationSettlement>
    <us-gaap:GainLossRelatedToLitigationSettlement
      contextRef="ia31e9a409b874bb19d0ff6f2f39ecc09_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF83OS9mcmFnOmYxNjk1NzMwNTY2MzRiMzg5NDM4MDUzMzY5ODYzNDA3L3RhYmxlOjUyZjNlMzM5YjkzMjRkN2NhZTc5MmM2ZGM4N2E1YzY4L3RhYmxlcmFuZ2U6NTJmM2UzMzliOTMyNGQ3Y2FlNzkyYzZkYzg3YTVjNjhfMTAtMy0xLTEtMA_b0996665-5a85-439a-b223-0afc6f855598"
      unitRef="usd">-5741000000</us-gaap:GainLossRelatedToLitigationSettlement>
    <us-gaap:GainLossRelatedToLitigationSettlement
      contextRef="i00a6d666bf604826b24e68ddbd63eac4_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF83OS9mcmFnOmYxNjk1NzMwNTY2MzRiMzg5NDM4MDUzMzY5ODYzNDA3L3RhYmxlOjUyZjNlMzM5YjkzMjRkN2NhZTc5MmM2ZGM4N2E1YzY4L3RhYmxlcmFuZ2U6NTJmM2UzMzliOTMyNGQ3Y2FlNzkyYzZkYzg3YTVjNjhfMTAtNS0xLTEtMA_19de35a3-966e-428d-9992-c4edc80024b6"
      unitRef="usd">-36000000</us-gaap:GainLossRelatedToLitigationSettlement>
    <us-gaap:OperatingIncomeLoss
      contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF83OS9mcmFnOmYxNjk1NzMwNTY2MzRiMzg5NDM4MDUzMzY5ODYzNDA3L3RhYmxlOjUyZjNlMzM5YjkzMjRkN2NhZTc5MmM2ZGM4N2E1YzY4L3RhYmxlcmFuZ2U6NTJmM2UzMzliOTMyNGQ3Y2FlNzkyYzZkYzg3YTVjNjhfMTEtMS0xLTEtMA_2386ef12-51c9-467b-937f-36ac223c7b63"
      unitRef="usd">472000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="ia31e9a409b874bb19d0ff6f2f39ecc09_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF83OS9mcmFnOmYxNjk1NzMwNTY2MzRiMzg5NDM4MDUzMzY5ODYzNDA3L3RhYmxlOjUyZjNlMzM5YjkzMjRkN2NhZTc5MmM2ZGM4N2E1YzY4L3RhYmxlcmFuZ2U6NTJmM2UzMzliOTMyNGQ3Y2FlNzkyYzZkYzg3YTVjNjhfMTEtMy0xLTEtMA_3de119ed-5e05-4ab7-ba28-84aff098bc2e"
      unitRef="usd">-4098000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i00a6d666bf604826b24e68ddbd63eac4_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF83OS9mcmFnOmYxNjk1NzMwNTY2MzRiMzg5NDM4MDUzMzY5ODYzNDA3L3RhYmxlOjUyZjNlMzM5YjkzMjRkN2NhZTc5MmM2ZGM4N2E1YzY4L3RhYmxlcmFuZ2U6NTJmM2UzMzliOTMyNGQ3Y2FlNzkyYzZkYzg3YTVjNjhfMTEtNS0xLTEtMA_d7aa8d99-9474-41c8-b42e-d1903357440f"
      unitRef="usd">2060000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF83OS9mcmFnOmYxNjk1NzMwNTY2MzRiMzg5NDM4MDUzMzY5ODYzNDA3L3RhYmxlOjUyZjNlMzM5YjkzMjRkN2NhZTc5MmM2ZGM4N2E1YzY4L3RhYmxlcmFuZ2U6NTJmM2UzMzliOTMyNGQ3Y2FlNzkyYzZkYzg3YTVjNjhfMTMtMS0xLTEtMA_cfad6aa9-5de7-4216-afd8-925089aace32"
      unitRef="usd">47000000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="ia31e9a409b874bb19d0ff6f2f39ecc09_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF83OS9mcmFnOmYxNjk1NzMwNTY2MzRiMzg5NDM4MDUzMzY5ODYzNDA3L3RhYmxlOjUyZjNlMzM5YjkzMjRkN2NhZTc5MmM2ZGM4N2E1YzY4L3RhYmxlcmFuZ2U6NTJmM2UzMzliOTMyNGQ3Y2FlNzkyYzZkYzg3YTVjNjhfMTMtMy0xLTEtMA_82b43a08-2a73-459e-b1a5-eaf440178f4c"
      unitRef="usd">1000000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i00a6d666bf604826b24e68ddbd63eac4_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF83OS9mcmFnOmYxNjk1NzMwNTY2MzRiMzg5NDM4MDUzMzY5ODYzNDA3L3RhYmxlOjUyZjNlMzM5YjkzMjRkN2NhZTc5MmM2ZGM4N2E1YzY4L3RhYmxlcmFuZ2U6NTJmM2UzMzliOTMyNGQ3Y2FlNzkyYzZkYzg3YTVjNjhfMTMtNS0xLTEtMA_e9cf0b33-aeeb-465c-bb57-1f672048e718"
      unitRef="usd">-15000000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:InterestExpense
      contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF83OS9mcmFnOmYxNjk1NzMwNTY2MzRiMzg5NDM4MDUzMzY5ODYzNDA3L3RhYmxlOjUyZjNlMzM5YjkzMjRkN2NhZTc5MmM2ZGM4N2E1YzY4L3RhYmxlcmFuZ2U6NTJmM2UzMzliOTMyNGQ3Y2FlNzkyYzZkYzg3YTVjNjhfMTQtMS0xLTEtMA_c0422a6d-4a22-48ce-a889-a743c3e31630"
      unitRef="usd">180000000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="ia31e9a409b874bb19d0ff6f2f39ecc09_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF83OS9mcmFnOmYxNjk1NzMwNTY2MzRiMzg5NDM4MDUzMzY5ODYzNDA3L3RhYmxlOjUyZjNlMzM5YjkzMjRkN2NhZTc5MmM2ZGM4N2E1YzY4L3RhYmxlcmFuZ2U6NTJmM2UzMzliOTMyNGQ3Y2FlNzkyYzZkYzg3YTVjNjhfMTQtMy0xLTEtMA_70845fc7-2929-461d-87d8-87bf3f381b78"
      unitRef="usd">238000000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="i00a6d666bf604826b24e68ddbd63eac4_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF83OS9mcmFnOmYxNjk1NzMwNTY2MzRiMzg5NDM4MDUzMzY5ODYzNDA3L3RhYmxlOjUyZjNlMzM5YjkzMjRkN2NhZTc5MmM2ZGM4N2E1YzY4L3RhYmxlcmFuZ2U6NTJmM2UzMzliOTMyNGQ3Y2FlNzkyYzZkYzg3YTVjNjhfMTQtNS0xLTEtMA_2982cb19-6ca4-4abd-828c-125892b1bb08"
      unitRef="usd">294000000</us-gaap:InterestExpense>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF83OS9mcmFnOmYxNjk1NzMwNTY2MzRiMzg5NDM4MDUzMzY5ODYzNDA3L3RhYmxlOjUyZjNlMzM5YjkzMjRkN2NhZTc5MmM2ZGM4N2E1YzY4L3RhYmxlcmFuZ2U6NTJmM2UzMzliOTMyNGQ3Y2FlNzkyYzZkYzg3YTVjNjhfMTUtMS0xLTEtMA_9606e17b-751d-4007-9a0d-dcd682af9754"
      unitRef="usd">-14000000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="ia31e9a409b874bb19d0ff6f2f39ecc09_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF83OS9mcmFnOmYxNjk1NzMwNTY2MzRiMzg5NDM4MDUzMzY5ODYzNDA3L3RhYmxlOjUyZjNlMzM5YjkzMjRkN2NhZTc5MmM2ZGM4N2E1YzY4L3RhYmxlcmFuZ2U6NTJmM2UzMzliOTMyNGQ3Y2FlNzkyYzZkYzg3YTVjNjhfMTUtMy0xLTEtMA_9c5a2459-b232-4758-a908-5aba0e69872f"
      unitRef="usd">-16000000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="i00a6d666bf604826b24e68ddbd63eac4_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF83OS9mcmFnOmYxNjk1NzMwNTY2MzRiMzg5NDM4MDUzMzY5ODYzNDA3L3RhYmxlOjUyZjNlMzM5YjkzMjRkN2NhZTc5MmM2ZGM4N2E1YzY4L3RhYmxlcmFuZ2U6NTJmM2UzMzliOTMyNGQ3Y2FlNzkyYzZkYzg3YTVjNjhfMTUtNS0xLTEtMA_96a0a786-0bd6-491e-a888-61c5bd0661b5"
      unitRef="usd">0</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GainLossOnSaleOfInvestments
      contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF83OS9mcmFnOmYxNjk1NzMwNTY2MzRiMzg5NDM4MDUzMzY5ODYzNDA3L3RhYmxlOjUyZjNlMzM5YjkzMjRkN2NhZTc5MmM2ZGM4N2E1YzY4L3RhYmxlcmFuZ2U6NTJmM2UzMzliOTMyNGQ3Y2FlNzkyYzZkYzg3YTVjNjhfMTYtMS0xLTEtMA_c9facd2a-2b20-4e59-a23b-f4bac88159da"
      unitRef="usd">-2000000</us-gaap:GainLossOnSaleOfInvestments>
    <us-gaap:GainLossOnSaleOfInvestments
      contextRef="ia31e9a409b874bb19d0ff6f2f39ecc09_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF83OS9mcmFnOmYxNjk1NzMwNTY2MzRiMzg5NDM4MDUzMzY5ODYzNDA3L3RhYmxlOjUyZjNlMzM5YjkzMjRkN2NhZTc5MmM2ZGM4N2E1YzY4L3RhYmxlcmFuZ2U6NTJmM2UzMzliOTMyNGQ3Y2FlNzkyYzZkYzg3YTVjNjhfMTYtMy0xLTEtMA_4c6487be-d69e-4229-81ec-a334be98c516"
      unitRef="usd">579000000</us-gaap:GainLossOnSaleOfInvestments>
    <us-gaap:GainLossOnSaleOfInvestments
      contextRef="i00a6d666bf604826b24e68ddbd63eac4_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF83OS9mcmFnOmYxNjk1NzMwNTY2MzRiMzg5NDM4MDUzMzY5ODYzNDA3L3RhYmxlOjUyZjNlMzM5YjkzMjRkN2NhZTc5MmM2ZGM4N2E1YzY4L3RhYmxlcmFuZ2U6NTJmM2UzMzliOTMyNGQ3Y2FlNzkyYzZkYzg3YTVjNjhfMTYtNS0xLTEtMA_c3afae0c-ae2a-4701-8337-cee06888e55a"
      unitRef="usd">0</us-gaap:GainLossOnSaleOfInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF83OS9mcmFnOmYxNjk1NzMwNTY2MzRiMzg5NDM4MDUzMzY5ODYzNDA3L3RhYmxlOjUyZjNlMzM5YjkzMjRkN2NhZTc5MmM2ZGM4N2E1YzY4L3RhYmxlcmFuZ2U6NTJmM2UzMzliOTMyNGQ3Y2FlNzkyYzZkYzg3YTVjNjhfMTctMS0xLTEtMA_9e78b5ea-9a6d-48aa-b25d-19416d149973"
      unitRef="usd">323000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="ia31e9a409b874bb19d0ff6f2f39ecc09_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF83OS9mcmFnOmYxNjk1NzMwNTY2MzRiMzg5NDM4MDUzMzY5ODYzNDA3L3RhYmxlOjUyZjNlMzM5YjkzMjRkN2NhZTc5MmM2ZGM4N2E1YzY4L3RhYmxlcmFuZ2U6NTJmM2UzMzliOTMyNGQ3Y2FlNzkyYzZkYzg3YTVjNjhfMTctMy0xLTEtMA_f423b403-af23-478b-b258-96b4c0a942e7"
      unitRef="usd">-3772000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="i00a6d666bf604826b24e68ddbd63eac4_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF83OS9mcmFnOmYxNjk1NzMwNTY2MzRiMzg5NDM4MDUzMzY5ODYzNDA3L3RhYmxlOjUyZjNlMzM5YjkzMjRkN2NhZTc5MmM2ZGM4N2E1YzY4L3RhYmxlcmFuZ2U6NTJmM2UzMzliOTMyNGQ3Y2FlNzkyYzZkYzg3YTVjNjhfMTctNS0xLTEtMA_4cd6d960-559f-41f1-bd52-b4d8eb4c7da9"
      unitRef="usd">1751000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF83OS9mcmFnOmYxNjk1NzMwNTY2MzRiMzg5NDM4MDUzMzY5ODYzNDA3L3RhYmxlOjUyZjNlMzM5YjkzMjRkN2NhZTc5MmM2ZGM4N2E1YzY4L3RhYmxlcmFuZ2U6NTJmM2UzMzliOTMyNGQ3Y2FlNzkyYzZkYzg3YTVjNjhfMTktMS0xLTEtMA_2236bc98-0715-4a56-833a-ebab6402cf98"
      unitRef="usd">-289000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="ia31e9a409b874bb19d0ff6f2f39ecc09_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF83OS9mcmFnOmYxNjk1NzMwNTY2MzRiMzg5NDM4MDUzMzY5ODYzNDA3L3RhYmxlOjUyZjNlMzM5YjkzMjRkN2NhZTc5MmM2ZGM4N2E1YzY4L3RhYmxlcmFuZ2U6NTJmM2UzMzliOTMyNGQ3Y2FlNzkyYzZkYzg3YTVjNjhfMTktMy0xLTEtMA_b6b41f4f-0aec-4a65-83c1-793cdeb01c72"
      unitRef="usd">-79000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i00a6d666bf604826b24e68ddbd63eac4_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF83OS9mcmFnOmYxNjk1NzMwNTY2MzRiMzg5NDM4MDUzMzY5ODYzNDA3L3RhYmxlOjUyZjNlMzM5YjkzMjRkN2NhZTc5MmM2ZGM4N2E1YzY4L3RhYmxlcmFuZ2U6NTJmM2UzMzliOTMyNGQ3Y2FlNzkyYzZkYzg3YTVjNjhfMTktNS0xLTEtMA_e79ae2a2-fc20-4afb-95a0-19aba67ce784"
      unitRef="usd">386000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:ProfitLoss
      contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF83OS9mcmFnOmYxNjk1NzMwNTY2MzRiMzg5NDM4MDUzMzY5ODYzNDA3L3RhYmxlOjUyZjNlMzM5YjkzMjRkN2NhZTc5MmM2ZGM4N2E1YzY4L3RhYmxlcmFuZ2U6NTJmM2UzMzliOTMyNGQ3Y2FlNzkyYzZkYzg3YTVjNjhfMjAtMS0xLTEtMA_93c32009-fe11-4248-a81f-a0cddb385adb"
      unitRef="usd">612000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="ia31e9a409b874bb19d0ff6f2f39ecc09_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF83OS9mcmFnOmYxNjk1NzMwNTY2MzRiMzg5NDM4MDUzMzY5ODYzNDA3L3RhYmxlOjUyZjNlMzM5YjkzMjRkN2NhZTc5MmM2ZGM4N2E1YzY4L3RhYmxlcmFuZ2U6NTJmM2UzMzliOTMyNGQ3Y2FlNzkyYzZkYzg3YTVjNjhfMjAtMy0xLTEtMA_ef4455fd-ac83-4947-8873-f04823175360"
      unitRef="usd">-3693000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i00a6d666bf604826b24e68ddbd63eac4_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF83OS9mcmFnOmYxNjk1NzMwNTY2MzRiMzg5NDM4MDUzMzY5ODYzNDA3L3RhYmxlOjUyZjNlMzM5YjkzMjRkN2NhZTc5MmM2ZGM4N2E1YzY4L3RhYmxlcmFuZ2U6NTJmM2UzMzliOTMyNGQ3Y2FlNzkyYzZkYzg3YTVjNjhfMjAtNS0xLTEtMA_7103a0a9-eeb5-4179-8300-4a1cf29e3ce1"
      unitRef="usd">1365000000</us-gaap:ProfitLoss>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF83OS9mcmFnOmYxNjk1NzMwNTY2MzRiMzg5NDM4MDUzMzY5ODYzNDA3L3RhYmxlOjUyZjNlMzM5YjkzMjRkN2NhZTc5MmM2ZGM4N2E1YzY4L3RhYmxlcmFuZ2U6NTJmM2UzMzliOTMyNGQ3Y2FlNzkyYzZkYzg3YTVjNjhfMjItMS0xLTEtMA_eed69b1a-4481-4f2c-9c2f-5042d7a37f34"
      unitRef="usd">1000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="ia31e9a409b874bb19d0ff6f2f39ecc09_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF83OS9mcmFnOmYxNjk1NzMwNTY2MzRiMzg5NDM4MDUzMzY5ODYzNDA3L3RhYmxlOjUyZjNlMzM5YjkzMjRkN2NhZTc5MmM2ZGM4N2E1YzY4L3RhYmxlcmFuZ2U6NTJmM2UzMzliOTMyNGQ3Y2FlNzkyYzZkYzg3YTVjNjhfMjItMy0xLTEtMA_7bb6209f-17c5-46ac-82fe-064374496a27"
      unitRef="usd">3000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i00a6d666bf604826b24e68ddbd63eac4_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF83OS9mcmFnOmYxNjk1NzMwNTY2MzRiMzg5NDM4MDUzMzY5ODYzNDA3L3RhYmxlOjUyZjNlMzM5YjkzMjRkN2NhZTc5MmM2ZGM4N2E1YzY4L3RhYmxlcmFuZ2U6NTJmM2UzMzliOTMyNGQ3Y2FlNzkyYzZkYzg3YTVjNjhfMjItNS0xLTEtMA_f5033487-a052-47e6-bf87-72437eb32df4"
      unitRef="usd">2000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLoss
      contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF83OS9mcmFnOmYxNjk1NzMwNTY2MzRiMzg5NDM4MDUzMzY5ODYzNDA3L3RhYmxlOjUyZjNlMzM5YjkzMjRkN2NhZTc5MmM2ZGM4N2E1YzY4L3RhYmxlcmFuZ2U6NTJmM2UzMzliOTMyNGQ3Y2FlNzkyYzZkYzg3YTVjNjhfMjMtMS0xLTEtMA_030f1bdb-7425-49bc-8a6e-f2d6ee903024"
      unitRef="usd">611000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ia31e9a409b874bb19d0ff6f2f39ecc09_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF83OS9mcmFnOmYxNjk1NzMwNTY2MzRiMzg5NDM4MDUzMzY5ODYzNDA3L3RhYmxlOjUyZjNlMzM5YjkzMjRkN2NhZTc5MmM2ZGM4N2E1YzY4L3RhYmxlcmFuZ2U6NTJmM2UzMzliOTMyNGQ3Y2FlNzkyYzZkYzg3YTVjNjhfMjMtMy0xLTEtMA_ed44b04b-b169-4c03-be1d-6eff6a89b284"
      unitRef="usd">-3696000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i00a6d666bf604826b24e68ddbd63eac4_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF83OS9mcmFnOmYxNjk1NzMwNTY2MzRiMzg5NDM4MDUzMzY5ODYzNDA3L3RhYmxlOjUyZjNlMzM5YjkzMjRkN2NhZTc5MmM2ZGM4N2E1YzY4L3RhYmxlcmFuZ2U6NTJmM2UzMzliOTMyNGQ3Y2FlNzkyYzZkYzg3YTVjNjhfMjMtNS0xLTEtMA_b201c961-3a07-4ff1-bff6-51c0a041797b"
      unitRef="usd">1363000000</us-gaap:NetIncomeLoss>
    <us-gaap:EarningsPerShareBasic
      contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF83OS9mcmFnOmYxNjk1NzMwNTY2MzRiMzg5NDM4MDUzMzY5ODYzNDA3L3RhYmxlOjUyZjNlMzM5YjkzMjRkN2NhZTc5MmM2ZGM4N2E1YzY4L3RhYmxlcmFuZ2U6NTJmM2UzMzliOTMyNGQ3Y2FlNzkyYzZkYzg3YTVjNjhfMjYtMS0xLTEtMA_8122f096-b95e-45f5-bebf-2adf7a1c601d"
      unitRef="usdPerShare">2.09</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="ia31e9a409b874bb19d0ff6f2f39ecc09_D20190701-20200630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF83OS9mcmFnOmYxNjk1NzMwNTY2MzRiMzg5NDM4MDUzMzY5ODYzNDA3L3RhYmxlOjUyZjNlMzM5YjkzMjRkN2NhZTc5MmM2ZGM4N2E1YzY4L3RhYmxlcmFuZ2U6NTJmM2UzMzliOTMyNGQ3Y2FlNzkyYzZkYzg3YTVjNjhfMjYtMy0xLTEtMA_bc43877f-4f77-4e5d-9d09-df4eae92a237"
      unitRef="usdPerShare">-12.61</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i00a6d666bf604826b24e68ddbd63eac4_D20180701-20190630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF83OS9mcmFnOmYxNjk1NzMwNTY2MzRiMzg5NDM4MDUzMzY5ODYzNDA3L3RhYmxlOjUyZjNlMzM5YjkzMjRkN2NhZTc5MmM2ZGM4N2E1YzY4L3RhYmxlcmFuZ2U6NTJmM2UzMzliOTMyNGQ3Y2FlNzkyYzZkYzg3YTVjNjhfMjYtNS0xLTEtMA_3cdd316a-c0d2-42a7-9d03-ac5ab0b7e4c9"
      unitRef="usdPerShare">4.55</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF83OS9mcmFnOmYxNjk1NzMwNTY2MzRiMzg5NDM4MDUzMzY5ODYzNDA3L3RhYmxlOjUyZjNlMzM5YjkzMjRkN2NhZTc5MmM2ZGM4N2E1YzY4L3RhYmxlcmFuZ2U6NTJmM2UzMzliOTMyNGQ3Y2FlNzkyYzZkYzg3YTVjNjhfMjctMS0xLTEtMA_db7c0727-84a9-41bc-afe3-85f540a4fc07"
      unitRef="usdPerShare">2.08</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="ia31e9a409b874bb19d0ff6f2f39ecc09_D20190701-20200630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF83OS9mcmFnOmYxNjk1NzMwNTY2MzRiMzg5NDM4MDUzMzY5ODYzNDA3L3RhYmxlOjUyZjNlMzM5YjkzMjRkN2NhZTc5MmM2ZGM4N2E1YzY4L3RhYmxlcmFuZ2U6NTJmM2UzMzliOTMyNGQ3Y2FlNzkyYzZkYzg3YTVjNjhfMjctMy0xLTEtMA_82523bf2-4938-4dd1-9419-e763b9798a79"
      unitRef="usdPerShare">-12.61</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i00a6d666bf604826b24e68ddbd63eac4_D20180701-20190630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF83OS9mcmFnOmYxNjk1NzMwNTY2MzRiMzg5NDM4MDUzMzY5ODYzNDA3L3RhYmxlOjUyZjNlMzM5YjkzMjRkN2NhZTc5MmM2ZGM4N2E1YzY4L3RhYmxlcmFuZ2U6NTJmM2UzMzliOTMyNGQ3Y2FlNzkyYzZkYzg3YTVjNjhfMjctNS0xLTEtMA_65aa49df-9479-4d44-9163-3fb24c0af710"
      unitRef="usdPerShare">4.53</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF83OS9mcmFnOmYxNjk1NzMwNTY2MzRiMzg5NDM4MDUzMzY5ODYzNDA3L3RhYmxlOjUyZjNlMzM5YjkzMjRkN2NhZTc5MmM2ZGM4N2E1YzY4L3RhYmxlcmFuZ2U6NTJmM2UzMzliOTMyNGQ3Y2FlNzkyYzZkYzg3YTVjNjhfMzAtMS0xLTEtMA_65ff9ac0-f24c-45ef-98c4-279c3914c1b4"
      unitRef="shares">292000000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="ia31e9a409b874bb19d0ff6f2f39ecc09_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF83OS9mcmFnOmYxNjk1NzMwNTY2MzRiMzg5NDM4MDUzMzY5ODYzNDA3L3RhYmxlOjUyZjNlMzM5YjkzMjRkN2NhZTc5MmM2ZGM4N2E1YzY4L3RhYmxlcmFuZ2U6NTJmM2UzMzliOTMyNGQ3Y2FlNzkyYzZkYzg3YTVjNjhfMzAtMy0xLTEtMA_1d368dc1-feda-434d-b506-95a9db8ddf20"
      unitRef="shares">293000000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i00a6d666bf604826b24e68ddbd63eac4_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF83OS9mcmFnOmYxNjk1NzMwNTY2MzRiMzg5NDM4MDUzMzY5ODYzNDA3L3RhYmxlOjUyZjNlMzM5YjkzMjRkN2NhZTc5MmM2ZGM4N2E1YzY4L3RhYmxlcmFuZ2U6NTJmM2UzMzliOTMyNGQ3Y2FlNzkyYzZkYzg3YTVjNjhfMzAtNS0xLTEtMA_2de8edae-3913-4ee0-ae53-0aa70ecd4dc7"
      unitRef="shares">300000000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF83OS9mcmFnOmYxNjk1NzMwNTY2MzRiMzg5NDM4MDUzMzY5ODYzNDA3L3RhYmxlOjUyZjNlMzM5YjkzMjRkN2NhZTc5MmM2ZGM4N2E1YzY4L3RhYmxlcmFuZ2U6NTJmM2UzMzliOTMyNGQ3Y2FlNzkyYzZkYzg3YTVjNjhfMzEtMS0xLTEtMA_019ad1b9-d948-4932-9b6f-28ce6f9533df"
      unitRef="shares">294000000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="ia31e9a409b874bb19d0ff6f2f39ecc09_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF83OS9mcmFnOmYxNjk1NzMwNTY2MzRiMzg5NDM4MDUzMzY5ODYzNDA3L3RhYmxlOjUyZjNlMzM5YjkzMjRkN2NhZTc5MmM2ZGM4N2E1YzY4L3RhYmxlcmFuZ2U6NTJmM2UzMzliOTMyNGQ3Y2FlNzkyYzZkYzg3YTVjNjhfMzEtMy0xLTEtMA_9dad21d8-d7f8-425d-bd0d-46c29602e89f"
      unitRef="shares">293000000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i00a6d666bf604826b24e68ddbd63eac4_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF83OS9mcmFnOmYxNjk1NzMwNTY2MzRiMzg5NDM4MDUzMzY5ODYzNDA3L3RhYmxlOjUyZjNlMzM5YjkzMjRkN2NhZTc5MmM2ZGM4N2E1YzY4L3RhYmxlcmFuZ2U6NTJmM2UzMzliOTMyNGQ3Y2FlNzkyYzZkYzg3YTVjNjhfMzEtNS0xLTEtMA_7f6b9a38-4683-46bc-9255-89fa8f21b4c6"
      unitRef="shares">301000000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:ProfitLoss
      contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF84Mi9mcmFnOjZmZGVjOTljZTU5MDQ3OTQ4ZTJiM2FmYmEzZDdjMDFlL3RhYmxlOjRjZjQ1YjgzM2I3YjQ3MTdhMGU2M2FkOWEzOGU4NTRiL3RhYmxlcmFuZ2U6NGNmNDViODMzYjdiNDcxN2EwZTYzYWQ5YTM4ZTg1NGJfMS0xLTEtMS0w_93c32009-fe11-4248-a81f-a0cddb385adb"
      unitRef="usd">612000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="ia31e9a409b874bb19d0ff6f2f39ecc09_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF84Mi9mcmFnOjZmZGVjOTljZTU5MDQ3OTQ4ZTJiM2FmYmEzZDdjMDFlL3RhYmxlOjRjZjQ1YjgzM2I3YjQ3MTdhMGU2M2FkOWEzOGU4NTRiL3RhYmxlcmFuZ2U6NGNmNDViODMzYjdiNDcxN2EwZTYzYWQ5YTM4ZTg1NGJfMS0zLTEtMS0w_ef4455fd-ac83-4947-8873-f04823175360"
      unitRef="usd">-3693000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i00a6d666bf604826b24e68ddbd63eac4_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF84Mi9mcmFnOjZmZGVjOTljZTU5MDQ3OTQ4ZTJiM2FmYmEzZDdjMDFlL3RhYmxlOjRjZjQ1YjgzM2I3YjQ3MTdhMGU2M2FkOWEzOGU4NTRiL3RhYmxlcmFuZ2U6NGNmNDViODMzYjdiNDcxN2EwZTYzYWQ5YTM4ZTg1NGJfMS01LTEtMS0w_7103a0a9-eeb5-4179-8300-4a1cf29e3ce1"
      unitRef="usd">1365000000</us-gaap:ProfitLoss>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF84Mi9mcmFnOjZmZGVjOTljZTU5MDQ3OTQ4ZTJiM2FmYmEzZDdjMDFlL3RhYmxlOjRjZjQ1YjgzM2I3YjQ3MTdhMGU2M2FkOWEzOGU4NTRiL3RhYmxlcmFuZ2U6NGNmNDViODMzYjdiNDcxN2EwZTYzYWQ5YTM4ZTg1NGJfNC0xLTEtMS0w_7f94b6e6-00ca-44bf-9258-0ab9f944fef6"
      unitRef="usd">46000000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="ia31e9a409b874bb19d0ff6f2f39ecc09_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF84Mi9mcmFnOjZmZGVjOTljZTU5MDQ3OTQ4ZTJiM2FmYmEzZDdjMDFlL3RhYmxlOjRjZjQ1YjgzM2I3YjQ3MTdhMGU2M2FkOWEzOGU4NTRiL3RhYmxlcmFuZ2U6NGNmNDViODMzYjdiNDcxN2EwZTYzYWQ5YTM4ZTg1NGJfNC0zLTEtMS0w_1587038d-a89c-4372-b637-242ad40ee951"
      unitRef="usd">3000000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="i00a6d666bf604826b24e68ddbd63eac4_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF84Mi9mcmFnOjZmZGVjOTljZTU5MDQ3OTQ4ZTJiM2FmYmEzZDdjMDFlL3RhYmxlOjRjZjQ1YjgzM2I3YjQ3MTdhMGU2M2FkOWEzOGU4NTRiL3RhYmxlcmFuZ2U6NGNmNDViODMzYjdiNDcxN2EwZTYzYWQ5YTM4ZTg1NGJfNC01LTEtMS0w_0e4bbeb3-c3cd-448b-aa8b-8f49882b6770"
      unitRef="usd">18000000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax
      contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF84Mi9mcmFnOjZmZGVjOTljZTU5MDQ3OTQ4ZTJiM2FmYmEzZDdjMDFlL3RhYmxlOjRjZjQ1YjgzM2I3YjQ3MTdhMGU2M2FkOWEzOGU4NTRiL3RhYmxlcmFuZ2U6NGNmNDViODMzYjdiNDcxN2EwZTYzYWQ5YTM4ZTg1NGJfNi0xLTEtMS0w_7fb93fa2-000b-4b81-b89f-c0b29fb2f162"
      unitRef="usd">24000000</us-gaap:OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax
      contextRef="ia31e9a409b874bb19d0ff6f2f39ecc09_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF84Mi9mcmFnOjZmZGVjOTljZTU5MDQ3OTQ4ZTJiM2FmYmEzZDdjMDFlL3RhYmxlOjRjZjQ1YjgzM2I3YjQ3MTdhMGU2M2FkOWEzOGU4NTRiL3RhYmxlcmFuZ2U6NGNmNDViODMzYjdiNDcxN2EwZTYzYWQ5YTM4ZTg1NGJfNi0zLTEtMS0w_14c32b84-91bd-4749-97ab-347b193173b1"
      unitRef="usd">-28000000</us-gaap:OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax
      contextRef="i00a6d666bf604826b24e68ddbd63eac4_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF84Mi9mcmFnOjZmZGVjOTljZTU5MDQ3OTQ4ZTJiM2FmYmEzZDdjMDFlL3RhYmxlOjRjZjQ1YjgzM2I3YjQ3MTdhMGU2M2FkOWEzOGU4NTRiL3RhYmxlcmFuZ2U6NGNmNDViODMzYjdiNDcxN2EwZTYzYWQ5YTM4ZTg1NGJfNi01LTEtMS0w_21330e3d-9cf8-4e4c-b419-4d816949a791"
      unitRef="usd">-5000000</us-gaap:OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF84Mi9mcmFnOjZmZGVjOTljZTU5MDQ3OTQ4ZTJiM2FmYmEzZDdjMDFlL3RhYmxlOjRjZjQ1YjgzM2I3YjQ3MTdhMGU2M2FkOWEzOGU4NTRiL3RhYmxlcmFuZ2U6NGNmNDViODMzYjdiNDcxN2EwZTYzYWQ5YTM4ZTg1NGJfNy0xLTEtMS0w_3c51796a-7653-4e1a-9765-fcb8d6343f45"
      unitRef="usd">70000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ia31e9a409b874bb19d0ff6f2f39ecc09_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF84Mi9mcmFnOjZmZGVjOTljZTU5MDQ3OTQ4ZTJiM2FmYmEzZDdjMDFlL3RhYmxlOjRjZjQ1YjgzM2I3YjQ3MTdhMGU2M2FkOWEzOGU4NTRiL3RhYmxlcmFuZ2U6NGNmNDViODMzYjdiNDcxN2EwZTYzYWQ5YTM4ZTg1NGJfNy0zLTEtMS0w_5c8b7052-c239-4545-aa19-4bd528cfb9bd"
      unitRef="usd">-25000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i00a6d666bf604826b24e68ddbd63eac4_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF84Mi9mcmFnOjZmZGVjOTljZTU5MDQ3OTQ4ZTJiM2FmYmEzZDdjMDFlL3RhYmxlOjRjZjQ1YjgzM2I3YjQ3MTdhMGU2M2FkOWEzOGU4NTRiL3RhYmxlcmFuZ2U6NGNmNDViODMzYjdiNDcxN2EwZTYzYWQ5YTM4ZTg1NGJfNy01LTEtMS0w_1c7af253-660a-4bc1-8493-224cd4eadaf8"
      unitRef="usd">13000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF84Mi9mcmFnOjZmZGVjOTljZTU5MDQ3OTQ4ZTJiM2FmYmEzZDdjMDFlL3RhYmxlOjRjZjQ1YjgzM2I3YjQ3MTdhMGU2M2FkOWEzOGU4NTRiL3RhYmxlcmFuZ2U6NGNmNDViODMzYjdiNDcxN2EwZTYzYWQ5YTM4ZTg1NGJfOS0xLTEtMS0w_6f06d793-9cc6-480a-91e1-cac0531cb3fc"
      unitRef="usd">682000000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ia31e9a409b874bb19d0ff6f2f39ecc09_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF84Mi9mcmFnOjZmZGVjOTljZTU5MDQ3OTQ4ZTJiM2FmYmEzZDdjMDFlL3RhYmxlOjRjZjQ1YjgzM2I3YjQ3MTdhMGU2M2FkOWEzOGU4NTRiL3RhYmxlcmFuZ2U6NGNmNDViODMzYjdiNDcxN2EwZTYzYWQ5YTM4ZTg1NGJfOS0zLTEtMS0w_9eb98061-1707-49c4-9416-8b8c5edebbc6"
      unitRef="usd">-3718000000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i00a6d666bf604826b24e68ddbd63eac4_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF84Mi9mcmFnOjZmZGVjOTljZTU5MDQ3OTQ4ZTJiM2FmYmEzZDdjMDFlL3RhYmxlOjRjZjQ1YjgzM2I3YjQ3MTdhMGU2M2FkOWEzOGU4NTRiL3RhYmxlcmFuZ2U6NGNmNDViODMzYjdiNDcxN2EwZTYzYWQ5YTM4ZTg1NGJfOS01LTEtMS0w_2681ed09-7388-4238-a322-68c7a4c068d0"
      unitRef="usd">1378000000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF84Mi9mcmFnOjZmZGVjOTljZTU5MDQ3OTQ4ZTJiM2FmYmEzZDdjMDFlL3RhYmxlOjRjZjQ1YjgzM2I3YjQ3MTdhMGU2M2FkOWEzOGU4NTRiL3RhYmxlcmFuZ2U6NGNmNDViODMzYjdiNDcxN2EwZTYzYWQ5YTM4ZTg1NGJfMTEtMS0xLTEtMA_eed69b1a-4481-4f2c-9c2f-5042d7a37f34"
      unitRef="usd">1000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="ia31e9a409b874bb19d0ff6f2f39ecc09_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF84Mi9mcmFnOjZmZGVjOTljZTU5MDQ3OTQ4ZTJiM2FmYmEzZDdjMDFlL3RhYmxlOjRjZjQ1YjgzM2I3YjQ3MTdhMGU2M2FkOWEzOGU4NTRiL3RhYmxlcmFuZ2U6NGNmNDViODMzYjdiNDcxN2EwZTYzYWQ5YTM4ZTg1NGJfMTEtMy0xLTEtMA_7bb6209f-17c5-46ac-82fe-064374496a27"
      unitRef="usd">3000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i00a6d666bf604826b24e68ddbd63eac4_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF84Mi9mcmFnOjZmZGVjOTljZTU5MDQ3OTQ4ZTJiM2FmYmEzZDdjMDFlL3RhYmxlOjRjZjQ1YjgzM2I3YjQ3MTdhMGU2M2FkOWEzOGU4NTRiL3RhYmxlcmFuZ2U6NGNmNDViODMzYjdiNDcxN2EwZTYzYWQ5YTM4ZTg1NGJfMTEtNS0xLTEtMA_f5033487-a052-47e6-bf87-72437eb32df4"
      unitRef="usd">2000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF84Mi9mcmFnOjZmZGVjOTljZTU5MDQ3OTQ4ZTJiM2FmYmEzZDdjMDFlL3RhYmxlOjRjZjQ1YjgzM2I3YjQ3MTdhMGU2M2FkOWEzOGU4NTRiL3RhYmxlcmFuZ2U6NGNmNDViODMzYjdiNDcxN2EwZTYzYWQ5YTM4ZTg1NGJfMTItMS0xLTEtMA_54d39793-1d4a-4b44-a427-0139101ae3a1"
      unitRef="usd">681000000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="ia31e9a409b874bb19d0ff6f2f39ecc09_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF84Mi9mcmFnOjZmZGVjOTljZTU5MDQ3OTQ4ZTJiM2FmYmEzZDdjMDFlL3RhYmxlOjRjZjQ1YjgzM2I3YjQ3MTdhMGU2M2FkOWEzOGU4NTRiL3RhYmxlcmFuZ2U6NGNmNDViODMzYjdiNDcxN2EwZTYzYWQ5YTM4ZTg1NGJfMTItMy0xLTEtMA_30a0ff79-2d77-43a0-b48d-19117cd88d33"
      unitRef="usd">-3721000000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i00a6d666bf604826b24e68ddbd63eac4_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF84Mi9mcmFnOjZmZGVjOTljZTU5MDQ3OTQ4ZTJiM2FmYmEzZDdjMDFlL3RhYmxlOjRjZjQ1YjgzM2I3YjQ3MTdhMGU2M2FkOWEzOGU4NTRiL3RhYmxlcmFuZ2U6NGNmNDViODMzYjdiNDcxN2EwZTYzYWQ5YTM4ZTg1NGJfMTItNS0xLTEtMA_d38b96d6-9fcc-4176-812f-06c2912de349"
      unitRef="usd">1376000000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i2e87824102b34590a0208cc7da91b5f5_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF84NS9mcmFnOjE0MGZhMGNkNWI5YTRiMzJiNGJiZjVlMTQ2OWJjMzU0L3RhYmxlOjI5YjhkZTNhZWM3ZTRjZjFhNTA0MzVjODBlYTg4ZDQyL3RhYmxlcmFuZ2U6MjliOGRlM2FlYzdlNGNmMWE1MDQzNWM4MGVhODhkNDJfNC0xLTEtMS0w_a37da982-62c8-4556-a68e-dcec22257c6d"
      unitRef="usd">3407000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i299cea70f47b4fbe96772aaa8cc00b79_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF84NS9mcmFnOjE0MGZhMGNkNWI5YTRiMzJiNGJiZjVlMTQ2OWJjMzU0L3RhYmxlOjI5YjhkZTNhZWM3ZTRjZjFhNTA0MzVjODBlYTg4ZDQyL3RhYmxlcmFuZ2U6MjliOGRlM2FlYzdlNGNmMWE1MDQzNWM4MGVhODhkNDJfNC0zLTEtMS0w_7bbca213-0d90-419a-b4d9-2820eb990c1e"
      unitRef="usd">2771000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:ReceivablesNetCurrent
      contextRef="i2e87824102b34590a0208cc7da91b5f5_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF84NS9mcmFnOjE0MGZhMGNkNWI5YTRiMzJiNGJiZjVlMTQ2OWJjMzU0L3RhYmxlOjI5YjhkZTNhZWM3ZTRjZjFhNTA0MzVjODBlYTg4ZDQyL3RhYmxlcmFuZ2U6MjliOGRlM2FlYzdlNGNmMWE1MDQzNWM4MGVhODhkNDJfNS0xLTEtMS0w_04ec09bd-b5f3-4b15-af64-deaa9ec964b5"
      unitRef="usd">9103000000</us-gaap:ReceivablesNetCurrent>
    <us-gaap:ReceivablesNetCurrent
      contextRef="i299cea70f47b4fbe96772aaa8cc00b79_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF84NS9mcmFnOjE0MGZhMGNkNWI5YTRiMzJiNGJiZjVlMTQ2OWJjMzU0L3RhYmxlOjI5YjhkZTNhZWM3ZTRjZjFhNTA0MzVjODBlYTg4ZDQyL3RhYmxlcmFuZ2U6MjliOGRlM2FlYzdlNGNmMWE1MDQzNWM4MGVhODhkNDJfNS0zLTEtMS0w_cf9e9319-17f0-4b48-9b2e-a30504750926"
      unitRef="usd">8264000000</us-gaap:ReceivablesNetCurrent>
    <us-gaap:InventoryNet
      contextRef="i2e87824102b34590a0208cc7da91b5f5_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF84NS9mcmFnOjE0MGZhMGNkNWI5YTRiMzJiNGJiZjVlMTQ2OWJjMzU0L3RhYmxlOjI5YjhkZTNhZWM3ZTRjZjFhNTA0MzVjODBlYTg4ZDQyL3RhYmxlcmFuZ2U6MjliOGRlM2FlYzdlNGNmMWE1MDQzNWM4MGVhODhkNDJfNi0xLTEtMS0w_ddef79f7-47d8-40ec-a531-451d3a0446b9"
      unitRef="usd">14594000000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="i299cea70f47b4fbe96772aaa8cc00b79_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF84NS9mcmFnOjE0MGZhMGNkNWI5YTRiMzJiNGJiZjVlMTQ2OWJjMzU0L3RhYmxlOjI5YjhkZTNhZWM3ZTRjZjFhNTA0MzVjODBlYTg4ZDQyL3RhYmxlcmFuZ2U6MjliOGRlM2FlYzdlNGNmMWE1MDQzNWM4MGVhODhkNDJfNi0zLTEtMS0w_ef196aaf-e9a1-4a65-94ff-ac7434f69dbc"
      unitRef="usd">13198000000</us-gaap:InventoryNet>
    <us-gaap:OtherAssetsCurrent
      contextRef="i2e87824102b34590a0208cc7da91b5f5_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF84NS9mcmFnOjE0MGZhMGNkNWI5YTRiMzJiNGJiZjVlMTQ2OWJjMzU0L3RhYmxlOjI5YjhkZTNhZWM3ZTRjZjFhNTA0MzVjODBlYTg4ZDQyL3RhYmxlcmFuZ2U6MjliOGRlM2FlYzdlNGNmMWE1MDQzNWM4MGVhODhkNDJfNy0xLTEtMS0w_edc931a7-aa68-4304-adf7-39b09f341a42"
      unitRef="usd">2843000000</us-gaap:OtherAssetsCurrent>
    <us-gaap:OtherAssetsCurrent
      contextRef="i299cea70f47b4fbe96772aaa8cc00b79_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF84NS9mcmFnOjE0MGZhMGNkNWI5YTRiMzJiNGJiZjVlMTQ2OWJjMzU0L3RhYmxlOjI5YjhkZTNhZWM3ZTRjZjFhNTA0MzVjODBlYTg4ZDQyL3RhYmxlcmFuZ2U6MjliOGRlM2FlYzdlNGNmMWE1MDQzNWM4MGVhODhkNDJfNy0zLTEtMS0w_20f605d0-41c5-4b25-bc08-580c6557d73a"
      unitRef="usd">1707000000</us-gaap:OtherAssetsCurrent>
    <us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperation
      contextRef="i2e87824102b34590a0208cc7da91b5f5_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF84NS9mcmFnOjE0MGZhMGNkNWI5YTRiMzJiNGJiZjVlMTQ2OWJjMzU0L3RhYmxlOjI5YjhkZTNhZWM3ZTRjZjFhNTA0MzVjODBlYTg4ZDQyL3RhYmxlcmFuZ2U6MjliOGRlM2FlYzdlNGNmMWE1MDQzNWM4MGVhODhkNDJfOC0xLTEtMS0w_c399854d-ed3e-4fbf-8f00-d0dd63ef3a50"
      unitRef="usd">1101000000</us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperation>
    <us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperation
      contextRef="i299cea70f47b4fbe96772aaa8cc00b79_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF84NS9mcmFnOjE0MGZhMGNkNWI5YTRiMzJiNGJiZjVlMTQ2OWJjMzU0L3RhYmxlOjI5YjhkZTNhZWM3ZTRjZjFhNTA0MzVjODBlYTg4ZDQyL3RhYmxlcmFuZ2U6MjliOGRlM2FlYzdlNGNmMWE1MDQzNWM4MGVhODhkNDJfOC0zLTEtMS0w_fd0ffbd4-2dcf-4655-9216-cb2d09b498df"
      unitRef="usd">0</us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperation>
    <us-gaap:AssetsCurrent
      contextRef="i2e87824102b34590a0208cc7da91b5f5_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF84NS9mcmFnOjE0MGZhMGNkNWI5YTRiMzJiNGJiZjVlMTQ2OWJjMzU0L3RhYmxlOjI5YjhkZTNhZWM3ZTRjZjFhNTA0MzVjODBlYTg4ZDQyL3RhYmxlcmFuZ2U6MjliOGRlM2FlYzdlNGNmMWE1MDQzNWM4MGVhODhkNDJfOS0xLTEtMS0w_287eb241-9a30-4f8b-bb9e-c3835426c497"
      unitRef="usd">31048000000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="i299cea70f47b4fbe96772aaa8cc00b79_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF84NS9mcmFnOjE0MGZhMGNkNWI5YTRiMzJiNGJiZjVlMTQ2OWJjMzU0L3RhYmxlOjI5YjhkZTNhZWM3ZTRjZjFhNTA0MzVjODBlYTg4ZDQyL3RhYmxlcmFuZ2U6MjliOGRlM2FlYzdlNGNmMWE1MDQzNWM4MGVhODhkNDJfOS0zLTEtMS0w_6f0a69e9-ffc7-40bb-8d36-637f89e655ad"
      unitRef="usd">25940000000</us-gaap:AssetsCurrent>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i2e87824102b34590a0208cc7da91b5f5_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF84NS9mcmFnOjE0MGZhMGNkNWI5YTRiMzJiNGJiZjVlMTQ2OWJjMzU0L3RhYmxlOjI5YjhkZTNhZWM3ZTRjZjFhNTA0MzVjODBlYTg4ZDQyL3RhYmxlcmFuZ2U6MjliOGRlM2FlYzdlNGNmMWE1MDQzNWM4MGVhODhkNDJfMTEtMS0xLTEtMA_da579983-2095-47b8-8542-c0ee4c2c23b5"
      unitRef="usd">2360000000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i299cea70f47b4fbe96772aaa8cc00b79_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF84NS9mcmFnOjE0MGZhMGNkNWI5YTRiMzJiNGJiZjVlMTQ2OWJjMzU0L3RhYmxlOjI5YjhkZTNhZWM3ZTRjZjFhNTA0MzVjODBlYTg4ZDQyL3RhYmxlcmFuZ2U6MjliOGRlM2FlYzdlNGNmMWE1MDQzNWM4MGVhODhkNDJfMTEtMy0xLTEtMA_f8a4a7a4-697d-4faa-81ca-005c0456b9fb"
      unitRef="usd">2366000000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:IntangibleAssetsNetIncludingGoodwill
      contextRef="i2e87824102b34590a0208cc7da91b5f5_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF84NS9mcmFnOjE0MGZhMGNkNWI5YTRiMzJiNGJiZjVlMTQ2OWJjMzU0L3RhYmxlOjI5YjhkZTNhZWM3ZTRjZjFhNTA0MzVjODBlYTg4ZDQyL3RhYmxlcmFuZ2U6MjliOGRlM2FlYzdlNGNmMWE1MDQzNWM4MGVhODhkNDJfMTItMS0xLTEtMA_8d3c12aa-0875-443b-9006-863890cd740a"
      unitRef="usd">10094000000</us-gaap:IntangibleAssetsNetIncludingGoodwill>
    <us-gaap:IntangibleAssetsNetIncludingGoodwill
      contextRef="i299cea70f47b4fbe96772aaa8cc00b79_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF84NS9mcmFnOjE0MGZhMGNkNWI5YTRiMzJiNGJiZjVlMTQ2OWJjMzU0L3RhYmxlOjI5YjhkZTNhZWM3ZTRjZjFhNTA0MzVjODBlYTg4ZDQyL3RhYmxlcmFuZ2U6MjliOGRlM2FlYzdlNGNmMWE1MDQzNWM4MGVhODhkNDJfMTItMy0xLTEtMA_353b03df-dbfd-49a0-bc35-2ed3d698e350"
      unitRef="usd">11275000000</us-gaap:IntangibleAssetsNetIncludingGoodwill>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="i2e87824102b34590a0208cc7da91b5f5_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF84NS9mcmFnOjE0MGZhMGNkNWI5YTRiMzJiNGJiZjVlMTQ2OWJjMzU0L3RhYmxlOjI5YjhkZTNhZWM3ZTRjZjFhNTA0MzVjODBlYTg4ZDQyL3RhYmxlcmFuZ2U6MjliOGRlM2FlYzdlNGNmMWE1MDQzNWM4MGVhODhkNDJfMTMtMS0xLTEtMA_9c84e538-adeb-4348-ac53-e6d1362e93c1"
      unitRef="usd">951000000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="i299cea70f47b4fbe96772aaa8cc00b79_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF84NS9mcmFnOjE0MGZhMGNkNWI5YTRiMzJiNGJiZjVlMTQ2OWJjMzU0L3RhYmxlOjI5YjhkZTNhZWM3ZTRjZjFhNTA0MzVjODBlYTg4ZDQyL3RhYmxlcmFuZ2U6MjliOGRlM2FlYzdlNGNmMWE1MDQzNWM4MGVhODhkNDJfMTMtMy0xLTEtMA_a4c9d7fc-0b5d-48f5-80fa-a715710af05e"
      unitRef="usd">1185000000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:Assets
      contextRef="i2e87824102b34590a0208cc7da91b5f5_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF84NS9mcmFnOjE0MGZhMGNkNWI5YTRiMzJiNGJiZjVlMTQ2OWJjMzU0L3RhYmxlOjI5YjhkZTNhZWM3ZTRjZjFhNTA0MzVjODBlYTg4ZDQyL3RhYmxlcmFuZ2U6MjliOGRlM2FlYzdlNGNmMWE1MDQzNWM4MGVhODhkNDJfMTQtMS0xLTEtMA_8b3c60e5-20ba-4060-9bd8-3df83091d5d7"
      unitRef="usd">44453000000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i299cea70f47b4fbe96772aaa8cc00b79_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF84NS9mcmFnOjE0MGZhMGNkNWI5YTRiMzJiNGJiZjVlMTQ2OWJjMzU0L3RhYmxlOjI5YjhkZTNhZWM3ZTRjZjFhNTA0MzVjODBlYTg4ZDQyL3RhYmxlcmFuZ2U6MjliOGRlM2FlYzdlNGNmMWE1MDQzNWM4MGVhODhkNDJfMTQtMy0xLTEtMA_9488952c-06f9-41a0-a17c-9bfcb2d43d8b"
      unitRef="usd">40766000000</us-gaap:Assets>
    <us-gaap:AccountsPayableCurrent
      contextRef="i2e87824102b34590a0208cc7da91b5f5_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF84NS9mcmFnOjE0MGZhMGNkNWI5YTRiMzJiNGJiZjVlMTQ2OWJjMzU0L3RhYmxlOjI5YjhkZTNhZWM3ZTRjZjFhNTA0MzVjODBlYTg4ZDQyL3RhYmxlcmFuZ2U6MjliOGRlM2FlYzdlNGNmMWE1MDQzNWM4MGVhODhkNDJfMTgtMS0xLTEtMA_f02d5a1c-bc5c-45e2-a6fc-0a5c403c134f"
      unitRef="usd">23700000000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent
      contextRef="i299cea70f47b4fbe96772aaa8cc00b79_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF84NS9mcmFnOjE0MGZhMGNkNWI5YTRiMzJiNGJiZjVlMTQ2OWJjMzU0L3RhYmxlOjI5YjhkZTNhZWM3ZTRjZjFhNTA0MzVjODBlYTg4ZDQyL3RhYmxlcmFuZ2U6MjliOGRlM2FlYzdlNGNmMWE1MDQzNWM4MGVhODhkNDJfMTgtMy0xLTEtMA_a9395471-0c31-4638-8eef-3838e758e37a"
      unitRef="usd">21374000000</us-gaap:AccountsPayableCurrent>
    <us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent
      contextRef="i2e87824102b34590a0208cc7da91b5f5_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF84NS9mcmFnOjE0MGZhMGNkNWI5YTRiMzJiNGJiZjVlMTQ2OWJjMzU0L3RhYmxlOjI5YjhkZTNhZWM3ZTRjZjFhNTA0MzVjODBlYTg4ZDQyL3RhYmxlcmFuZ2U6MjliOGRlM2FlYzdlNGNmMWE1MDQzNWM4MGVhODhkNDJfMTktMS0xLTEtMA_1e7f0d19-514b-482e-b932-470915a386dc"
      unitRef="usd">871000000</us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent>
    <us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent
      contextRef="i299cea70f47b4fbe96772aaa8cc00b79_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF84NS9mcmFnOjE0MGZhMGNkNWI5YTRiMzJiNGJiZjVlMTQ2OWJjMzU0L3RhYmxlOjI5YjhkZTNhZWM3ZTRjZjFhNTA0MzVjODBlYTg4ZDQyL3RhYmxlcmFuZ2U6MjliOGRlM2FlYzdlNGNmMWE1MDQzNWM4MGVhODhkNDJfMTktMy0xLTEtMA_f95fe53f-ce2d-43ef-90b0-56553ba4caff"
      unitRef="usd">10000000</us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent
      contextRef="i2e87824102b34590a0208cc7da91b5f5_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF84NS9mcmFnOjE0MGZhMGNkNWI5YTRiMzJiNGJiZjVlMTQ2OWJjMzU0L3RhYmxlOjI5YjhkZTNhZWM3ZTRjZjFhNTA0MzVjODBlYTg4ZDQyL3RhYmxlcmFuZ2U6MjliOGRlM2FlYzdlNGNmMWE1MDQzNWM4MGVhODhkNDJfMjAtMS0xLTEtMA_0b998b54-a287-4a0e-a017-d3e3d9910e74"
      unitRef="usd">2957000000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent
      contextRef="i299cea70f47b4fbe96772aaa8cc00b79_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF84NS9mcmFnOjE0MGZhMGNkNWI5YTRiMzJiNGJiZjVlMTQ2OWJjMzU0L3RhYmxlOjI5YjhkZTNhZWM3ZTRjZjFhNTA0MzVjODBlYTg4ZDQyL3RhYmxlcmFuZ2U6MjliOGRlM2FlYzdlNGNmMWE1MDQzNWM4MGVhODhkNDJfMjAtMy0xLTEtMA_aa116538-8228-4bb3-8b6c-dcc605a2247f"
      unitRef="usd">2231000000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation
      contextRef="i2e87824102b34590a0208cc7da91b5f5_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF84NS9mcmFnOjE0MGZhMGNkNWI5YTRiMzJiNGJiZjVlMTQ2OWJjMzU0L3RhYmxlOjI5YjhkZTNhZWM3ZTRjZjFhNTA0MzVjODBlYTg4ZDQyL3RhYmxlcmFuZ2U6MjliOGRlM2FlYzdlNGNmMWE1MDQzNWM4MGVhODhkNDJfMjEtMS0xLTEtMA_3606ac8b-8a07-44c4-aa4d-cc08f770067e"
      unitRef="usd">96000000</us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation>
    <us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation
      contextRef="i299cea70f47b4fbe96772aaa8cc00b79_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF84NS9mcmFnOjE0MGZhMGNkNWI5YTRiMzJiNGJiZjVlMTQ2OWJjMzU0L3RhYmxlOjI5YjhkZTNhZWM3ZTRjZjFhNTA0MzVjODBlYTg4ZDQyL3RhYmxlcmFuZ2U6MjliOGRlM2FlYzdlNGNmMWE1MDQzNWM4MGVhODhkNDJfMjEtMy0xLTEtMA_bb234d6e-2cec-4cc2-b0d0-bf2b6e83c18c"
      unitRef="usd">0</us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation>
    <us-gaap:LiabilitiesCurrent
      contextRef="i2e87824102b34590a0208cc7da91b5f5_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF84NS9mcmFnOjE0MGZhMGNkNWI5YTRiMzJiNGJiZjVlMTQ2OWJjMzU0L3RhYmxlOjI5YjhkZTNhZWM3ZTRjZjFhNTA0MzVjODBlYTg4ZDQyL3RhYmxlcmFuZ2U6MjliOGRlM2FlYzdlNGNmMWE1MDQzNWM4MGVhODhkNDJfMjItMS0xLTEtMA_64146158-72b5-49b2-b55c-334d6004655d"
      unitRef="usd">27624000000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="i299cea70f47b4fbe96772aaa8cc00b79_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF84NS9mcmFnOjE0MGZhMGNkNWI5YTRiMzJiNGJiZjVlMTQ2OWJjMzU0L3RhYmxlOjI5YjhkZTNhZWM3ZTRjZjFhNTA0MzVjODBlYTg4ZDQyL3RhYmxlcmFuZ2U6MjliOGRlM2FlYzdlNGNmMWE1MDQzNWM4MGVhODhkNDJfMjItMy0xLTEtMA_d8d84bb1-a5ef-4b79-a878-225bd3f50e16"
      unitRef="usd">23615000000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LongTermDebtAndCapitalLeaseObligations
      contextRef="i2e87824102b34590a0208cc7da91b5f5_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF84NS9mcmFnOjE0MGZhMGNkNWI5YTRiMzJiNGJiZjVlMTQ2OWJjMzU0L3RhYmxlOjI5YjhkZTNhZWM3ZTRjZjFhNTA0MzVjODBlYTg4ZDQyL3RhYmxlcmFuZ2U6MjliOGRlM2FlYzdlNGNmMWE1MDQzNWM4MGVhODhkNDJfMjQtMS0xLTEtMA_db73a7d4-45d2-4dc3-a6e6-6b40c7da2114"
      unitRef="usd">5365000000</us-gaap:LongTermDebtAndCapitalLeaseObligations>
    <us-gaap:LongTermDebtAndCapitalLeaseObligations
      contextRef="i299cea70f47b4fbe96772aaa8cc00b79_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF84NS9mcmFnOjE0MGZhMGNkNWI5YTRiMzJiNGJiZjVlMTQ2OWJjMzU0L3RhYmxlOjI5YjhkZTNhZWM3ZTRjZjFhNTA0MzVjODBlYTg4ZDQyL3RhYmxlcmFuZ2U6MjliOGRlM2FlYzdlNGNmMWE1MDQzNWM4MGVhODhkNDJfMjQtMy0xLTEtMjI0_11dfadfa-8117-417a-997c-07fff8d83db0"
      unitRef="usd">6765000000</us-gaap:LongTermDebtAndCapitalLeaseObligations>
    <us-gaap:DeferredTaxAndOtherLiabilitiesNoncurrent
      contextRef="i2e87824102b34590a0208cc7da91b5f5_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF84NS9mcmFnOjE0MGZhMGNkNWI5YTRiMzJiNGJiZjVlMTQ2OWJjMzU0L3RhYmxlOjI5YjhkZTNhZWM3ZTRjZjFhNTA0MzVjODBlYTg4ZDQyL3RhYmxlcmFuZ2U6MjliOGRlM2FlYzdlNGNmMWE1MDQzNWM4MGVhODhkNDJfMjUtMS0xLTEtMA_7e1a9ad3-5096-40f6-9ee6-3b5fbf5010c5"
      unitRef="usd">9670000000</us-gaap:DeferredTaxAndOtherLiabilitiesNoncurrent>
    <us-gaap:DeferredTaxAndOtherLiabilitiesNoncurrent
      contextRef="i299cea70f47b4fbe96772aaa8cc00b79_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF84NS9mcmFnOjE0MGZhMGNkNWI5YTRiMzJiNGJiZjVlMTQ2OWJjMzU0L3RhYmxlOjI5YjhkZTNhZWM3ZTRjZjFhNTA0MzVjODBlYTg4ZDQyL3RhYmxlcmFuZ2U6MjliOGRlM2FlYzdlNGNmMWE1MDQzNWM4MGVhODhkNDJfMjUtMy0xLTEtMjI0_60360d36-8ece-4040-a0a8-fc48c57a7d1d"
      unitRef="usd">8594000000</us-gaap:DeferredTaxAndOtherLiabilitiesNoncurrent>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="i2e87824102b34590a0208cc7da91b5f5_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF84NS9mcmFnOjE0MGZhMGNkNWI5YTRiMzJiNGJiZjVlMTQ2OWJjMzU0L3RhYmxlOjI5YjhkZTNhZWM3ZTRjZjFhNTA0MzVjODBlYTg4ZDQyL3RhYmxlcmFuZ2U6MjliOGRlM2FlYzdlNGNmMWE1MDQzNWM4MGVhODhkNDJfMzEtMC0xLTEtMC90ZXh0cmVnaW9uOmFjZWY5NWE4YTI2NzQwNjBhM2Y0MTNkZmQwYmUwMDYwXzI3NDg3NzkwNjk1MDA_45574df7-6af4-4591-bb04-be7bb0bc6668"
      unitRef="shares">500000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="i299cea70f47b4fbe96772aaa8cc00b79_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF84NS9mcmFnOjE0MGZhMGNkNWI5YTRiMzJiNGJiZjVlMTQ2OWJjMzU0L3RhYmxlOjI5YjhkZTNhZWM3ZTRjZjFhNTA0MzVjODBlYTg4ZDQyL3RhYmxlcmFuZ2U6MjliOGRlM2FlYzdlNGNmMWE1MDQzNWM4MGVhODhkNDJfMzEtMC0xLTEtMC90ZXh0cmVnaW9uOmFjZWY5NWE4YTI2NzQwNjBhM2Y0MTNkZmQwYmUwMDYwXzI3NDg3NzkwNjk1MDA_f4b44134-82c6-4576-9159-6cfc6e4b0238"
      unitRef="shares">500000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesIssued
      contextRef="i299cea70f47b4fbe96772aaa8cc00b79_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF84NS9mcmFnOjE0MGZhMGNkNWI5YTRiMzJiNGJiZjVlMTQ2OWJjMzU0L3RhYmxlOjI5YjhkZTNhZWM3ZTRjZjFhNTA0MzVjODBlYTg4ZDQyL3RhYmxlcmFuZ2U6MjliOGRlM2FlYzdlNGNmMWE1MDQzNWM4MGVhODhkNDJfMzEtMC0xLTEtMC90ZXh0cmVnaW9uOmFjZWY5NWE4YTI2NzQwNjBhM2Y0MTNkZmQwYmUwMDYwXzI3NDg3NzkwNjk1NDI_69f5dc45-5677-44a6-a544-c447013bdbaa"
      unitRef="shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesIssued
      contextRef="i2e87824102b34590a0208cc7da91b5f5_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF84NS9mcmFnOjE0MGZhMGNkNWI5YTRiMzJiNGJiZjVlMTQ2OWJjMzU0L3RhYmxlOjI5YjhkZTNhZWM3ZTRjZjFhNTA0MzVjODBlYTg4ZDQyL3RhYmxlcmFuZ2U6MjliOGRlM2FlYzdlNGNmMWE1MDQzNWM4MGVhODhkNDJfMzEtMC0xLTEtMC90ZXh0cmVnaW9uOmFjZWY5NWE4YTI2NzQwNjBhM2Y0MTNkZmQwYmUwMDYwXzI3NDg3NzkwNjk1NDI_99106033-c517-4523-82b8-34470e2673ed"
      unitRef="shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockValue
      contextRef="i2e87824102b34590a0208cc7da91b5f5_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF84NS9mcmFnOjE0MGZhMGNkNWI5YTRiMzJiNGJiZjVlMTQ2OWJjMzU0L3RhYmxlOjI5YjhkZTNhZWM3ZTRjZjFhNTA0MzVjODBlYTg4ZDQyL3RhYmxlcmFuZ2U6MjliOGRlM2FlYzdlNGNmMWE1MDQzNWM4MGVhODhkNDJfMzEtMS0xLTEtMA_f83ff81e-669a-44cf-8e15-e97818af20a4"
      unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:PreferredStockValue
      contextRef="i299cea70f47b4fbe96772aaa8cc00b79_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF84NS9mcmFnOjE0MGZhMGNkNWI5YTRiMzJiNGJiZjVlMTQ2OWJjMzU0L3RhYmxlOjI5YjhkZTNhZWM3ZTRjZjFhNTA0MzVjODBlYTg4ZDQyL3RhYmxlcmFuZ2U6MjliOGRlM2FlYzdlNGNmMWE1MDQzNWM4MGVhODhkNDJfMzEtMy0xLTEtMA_17ed1b6a-5c16-4468-a3cf-7e1bdc8002af"
      unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="i299cea70f47b4fbe96772aaa8cc00b79_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF84NS9mcmFnOjE0MGZhMGNkNWI5YTRiMzJiNGJiZjVlMTQ2OWJjMzU0L3RhYmxlOjI5YjhkZTNhZWM3ZTRjZjFhNTA0MzVjODBlYTg4ZDQyL3RhYmxlcmFuZ2U6MjliOGRlM2FlYzdlNGNmMWE1MDQzNWM4MGVhODhkNDJfMzMtMC0xLTEtMC90ZXh0cmVnaW9uOmQ5MGYxNThhNzhmNTQ2YTVhNjc0NjhkOGIxMjg5MWIyXzI3NDg3NzkwNjk2NDc_838a4009-d0c4-4765-a4a5-9177de9161ab"
      unitRef="shares">755000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="i2e87824102b34590a0208cc7da91b5f5_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF84NS9mcmFnOjE0MGZhMGNkNWI5YTRiMzJiNGJiZjVlMTQ2OWJjMzU0L3RhYmxlOjI5YjhkZTNhZWM3ZTRjZjFhNTA0MzVjODBlYTg4ZDQyL3RhYmxlcmFuZ2U6MjliOGRlM2FlYzdlNGNmMWE1MDQzNWM4MGVhODhkNDJfMzMtMC0xLTEtMC90ZXh0cmVnaW9uOmQ5MGYxNThhNzhmNTQ2YTVhNjc0NjhkOGIxMjg5MWIyXzI3NDg3NzkwNjk2NDc_e37b1568-c939-4728-89fd-c139e22a7cc3"
      unitRef="shares">755000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued
      contextRef="i299cea70f47b4fbe96772aaa8cc00b79_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF84NS9mcmFnOjE0MGZhMGNkNWI5YTRiMzJiNGJiZjVlMTQ2OWJjMzU0L3RhYmxlOjI5YjhkZTNhZWM3ZTRjZjFhNTA0MzVjODBlYTg4ZDQyL3RhYmxlcmFuZ2U6MjliOGRlM2FlYzdlNGNmMWE1MDQzNWM4MGVhODhkNDJfMzMtMC0xLTEtMC90ZXh0cmVnaW9uOmQ5MGYxNThhNzhmNTQ2YTVhNjc0NjhkOGIxMjg5MWIyXzI3NDg3NzkwNjk2Nzc_49133e1e-9911-45c5-ab67-66ab58aebd11"
      unitRef="shares">327000000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued
      contextRef="i2e87824102b34590a0208cc7da91b5f5_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF84NS9mcmFnOjE0MGZhMGNkNWI5YTRiMzJiNGJiZjVlMTQ2OWJjMzU0L3RhYmxlOjI5YjhkZTNhZWM3ZTRjZjFhNTA0MzVjODBlYTg4ZDQyL3RhYmxlcmFuZ2U6MjliOGRlM2FlYzdlNGNmMWE1MDQzNWM4MGVhODhkNDJfMzMtMC0xLTEtMC90ZXh0cmVnaW9uOmQ5MGYxNThhNzhmNTQ2YTVhNjc0NjhkOGIxMjg5MWIyXzI3NDg3NzkwNjk2Nzc_dc8c6cab-6141-4d08-8704-cdef77b1c352"
      unitRef="shares">327000000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockValue
      contextRef="i2e87824102b34590a0208cc7da91b5f5_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF84NS9mcmFnOjE0MGZhMGNkNWI5YTRiMzJiNGJiZjVlMTQ2OWJjMzU0L3RhYmxlOjI5YjhkZTNhZWM3ZTRjZjFhNTA0MzVjODBlYTg4ZDQyL3RhYmxlcmFuZ2U6MjliOGRlM2FlYzdlNGNmMWE1MDQzNWM4MGVhODhkNDJfMzMtMS0xLTEtMA_7f2224df-1af2-4a0a-9950-5fb9bf49ed45"
      unitRef="usd">2806000000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="i299cea70f47b4fbe96772aaa8cc00b79_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF84NS9mcmFnOjE0MGZhMGNkNWI5YTRiMzJiNGJiZjVlMTQ2OWJjMzU0L3RhYmxlOjI5YjhkZTNhZWM3ZTRjZjFhNTA0MzVjODBlYTg4ZDQyL3RhYmxlcmFuZ2U6MjliOGRlM2FlYzdlNGNmMWE1MDQzNWM4MGVhODhkNDJfMzMtMy0xLTEtMA_3499b2bc-4f96-4506-ba7d-b4f42bdcf1e7"
      unitRef="usd">2789000000</us-gaap:CommonStockValue>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="i2e87824102b34590a0208cc7da91b5f5_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF84NS9mcmFnOjE0MGZhMGNkNWI5YTRiMzJiNGJiZjVlMTQ2OWJjMzU0L3RhYmxlOjI5YjhkZTNhZWM3ZTRjZjFhNTA0MzVjODBlYTg4ZDQyL3RhYmxlcmFuZ2U6MjliOGRlM2FlYzdlNGNmMWE1MDQzNWM4MGVhODhkNDJfMzQtMS0xLTEtMA_25c0298e-c72b-4447-86b4-6ef9d967595b"
      unitRef="usd">1205000000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="i299cea70f47b4fbe96772aaa8cc00b79_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF84NS9mcmFnOjE0MGZhMGNkNWI5YTRiMzJiNGJiZjVlMTQ2OWJjMzU0L3RhYmxlOjI5YjhkZTNhZWM3ZTRjZjFhNTA0MzVjODBlYTg4ZDQyL3RhYmxlcmFuZ2U6MjliOGRlM2FlYzdlNGNmMWE1MDQzNWM4MGVhODhkNDJfMzQtMy0xLTEtMA_c2562bf2-7ffc-46cc-8b31-e84abd9809f1"
      unitRef="usd">1170000000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:TreasuryStockShares
      contextRef="i2e87824102b34590a0208cc7da91b5f5_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF84NS9mcmFnOjE0MGZhMGNkNWI5YTRiMzJiNGJiZjVlMTQ2OWJjMzU0L3RhYmxlOjI5YjhkZTNhZWM3ZTRjZjFhNTA0MzVjODBlYTg4ZDQyL3RhYmxlcmFuZ2U6MjliOGRlM2FlYzdlNGNmMWE1MDQzNWM4MGVhODhkNDJfMzUtMC0xLTEtMC90ZXh0cmVnaW9uOmMyZmZlMDJjYjdjNTQ3NWQ4MTZlZDBhZTdjNmQ2OTVkXzI3NDg3NzkwNjk3MTE_55e012da-ea0f-4ef5-abad-7cd14afb88ce"
      unitRef="shares">36000000</us-gaap:TreasuryStockShares>
    <us-gaap:TreasuryStockShares
      contextRef="i299cea70f47b4fbe96772aaa8cc00b79_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF84NS9mcmFnOjE0MGZhMGNkNWI5YTRiMzJiNGJiZjVlMTQ2OWJjMzU0L3RhYmxlOjI5YjhkZTNhZWM3ZTRjZjFhNTA0MzVjODBlYTg4ZDQyL3RhYmxlcmFuZ2U6MjliOGRlM2FlYzdlNGNmMWE1MDQzNWM4MGVhODhkNDJfMzUtMC0xLTEtMC90ZXh0cmVnaW9uOmMyZmZlMDJjYjdjNTQ3NWQ4MTZlZDBhZTdjNmQ2OTVkXzI3NDg3NzkwNjk2OTk_d6ba7812-b7da-4cc3-93f4-8374eabec5c2"
      unitRef="shares">34000000</us-gaap:TreasuryStockShares>
    <us-gaap:TreasuryStockValue
      contextRef="i2e87824102b34590a0208cc7da91b5f5_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF84NS9mcmFnOjE0MGZhMGNkNWI5YTRiMzJiNGJiZjVlMTQ2OWJjMzU0L3RhYmxlOjI5YjhkZTNhZWM3ZTRjZjFhNTA0MzVjODBlYTg4ZDQyL3RhYmxlcmFuZ2U6MjliOGRlM2FlYzdlNGNmMWE1MDQzNWM4MGVhODhkNDJfMzUtMS0xLTEtMA_e3a4bf8b-5a79-4973-bf65-35fda67c68e3"
      unitRef="usd">2186000000</us-gaap:TreasuryStockValue>
    <us-gaap:TreasuryStockValue
      contextRef="i299cea70f47b4fbe96772aaa8cc00b79_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF84NS9mcmFnOjE0MGZhMGNkNWI5YTRiMzJiNGJiZjVlMTQ2OWJjMzU0L3RhYmxlOjI5YjhkZTNhZWM3ZTRjZjFhNTA0MzVjODBlYTg4ZDQyL3RhYmxlcmFuZ2U6MjliOGRlM2FlYzdlNGNmMWE1MDQzNWM4MGVhODhkNDJfMzUtMy0xLTEtMA_b52172bb-9cb7-4bf8-acd7-bd86fd30adc5"
      unitRef="usd">2066000000</us-gaap:TreasuryStockValue>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i2e87824102b34590a0208cc7da91b5f5_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF84NS9mcmFnOjE0MGZhMGNkNWI5YTRiMzJiNGJiZjVlMTQ2OWJjMzU0L3RhYmxlOjI5YjhkZTNhZWM3ZTRjZjFhNTA0MzVjODBlYTg4ZDQyL3RhYmxlcmFuZ2U6MjliOGRlM2FlYzdlNGNmMWE1MDQzNWM4MGVhODhkNDJfMzYtMS0xLTEtMA_d0920879-99f6-4eca-ba4f-23a6d06f99f6"
      unitRef="usd">-34000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i299cea70f47b4fbe96772aaa8cc00b79_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF84NS9mcmFnOjE0MGZhMGNkNWI5YTRiMzJiNGJiZjVlMTQ2OWJjMzU0L3RhYmxlOjI5YjhkZTNhZWM3ZTRjZjFhNTA0MzVjODBlYTg4ZDQyL3RhYmxlcmFuZ2U6MjliOGRlM2FlYzdlNGNmMWE1MDQzNWM4MGVhODhkNDJfMzYtMy0xLTEtMA_1de5fa9d-2247-4796-8b19-e155d1dac811"
      unitRef="usd">-104000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:StockholdersEquity
      contextRef="i2e87824102b34590a0208cc7da91b5f5_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF84NS9mcmFnOjE0MGZhMGNkNWI5YTRiMzJiNGJiZjVlMTQ2OWJjMzU0L3RhYmxlOjI5YjhkZTNhZWM3ZTRjZjFhNTA0MzVjODBlYTg4ZDQyL3RhYmxlcmFuZ2U6MjliOGRlM2FlYzdlNGNmMWE1MDQzNWM4MGVhODhkNDJfMzctMS0xLTEtMA_282cc6b5-cb05-4d60-a63b-bacbe165d6be"
      unitRef="usd">1791000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i299cea70f47b4fbe96772aaa8cc00b79_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF84NS9mcmFnOjE0MGZhMGNkNWI5YTRiMzJiNGJiZjVlMTQ2OWJjMzU0L3RhYmxlOjI5YjhkZTNhZWM3ZTRjZjFhNTA0MzVjODBlYTg4ZDQyL3RhYmxlcmFuZ2U6MjliOGRlM2FlYzdlNGNmMWE1MDQzNWM4MGVhODhkNDJfMzctMy0xLTEtMA_b890f853-e9dd-478f-958b-aeb2379069cd"
      unitRef="usd">1789000000</us-gaap:StockholdersEquity>
    <us-gaap:MinorityInterest
      contextRef="i2e87824102b34590a0208cc7da91b5f5_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF84NS9mcmFnOjE0MGZhMGNkNWI5YTRiMzJiNGJiZjVlMTQ2OWJjMzU0L3RhYmxlOjI5YjhkZTNhZWM3ZTRjZjFhNTA0MzVjODBlYTg4ZDQyL3RhYmxlcmFuZ2U6MjliOGRlM2FlYzdlNGNmMWE1MDQzNWM4MGVhODhkNDJfMzgtMS0xLTEtMA_cf172500-58f1-47c4-9ef8-d575028b8e44"
      unitRef="usd">3000000</us-gaap:MinorityInterest>
    <us-gaap:MinorityInterest
      contextRef="i299cea70f47b4fbe96772aaa8cc00b79_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF84NS9mcmFnOjE0MGZhMGNkNWI5YTRiMzJiNGJiZjVlMTQ2OWJjMzU0L3RhYmxlOjI5YjhkZTNhZWM3ZTRjZjFhNTA0MzVjODBlYTg4ZDQyL3RhYmxlcmFuZ2U6MjliOGRlM2FlYzdlNGNmMWE1MDQzNWM4MGVhODhkNDJfMzgtMy0xLTEtMA_2b954c10-84bd-451f-9c78-dcd40959e91f"
      unitRef="usd">3000000</us-gaap:MinorityInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i2e87824102b34590a0208cc7da91b5f5_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF84NS9mcmFnOjE0MGZhMGNkNWI5YTRiMzJiNGJiZjVlMTQ2OWJjMzU0L3RhYmxlOjI5YjhkZTNhZWM3ZTRjZjFhNTA0MzVjODBlYTg4ZDQyL3RhYmxlcmFuZ2U6MjliOGRlM2FlYzdlNGNmMWE1MDQzNWM4MGVhODhkNDJfMzktMS0xLTEtMA_577c4808-ece3-43ee-973e-177bac99fbff"
      unitRef="usd">1794000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i299cea70f47b4fbe96772aaa8cc00b79_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF84NS9mcmFnOjE0MGZhMGNkNWI5YTRiMzJiNGJiZjVlMTQ2OWJjMzU0L3RhYmxlOjI5YjhkZTNhZWM3ZTRjZjFhNTA0MzVjODBlYTg4ZDQyL3RhYmxlcmFuZ2U6MjliOGRlM2FlYzdlNGNmMWE1MDQzNWM4MGVhODhkNDJfMzktMy0xLTEtMA_44a2c1f6-b88d-4b39-9cae-0a70a2477ab2"
      unitRef="usd">1792000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="i2e87824102b34590a0208cc7da91b5f5_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF84NS9mcmFnOjE0MGZhMGNkNWI5YTRiMzJiNGJiZjVlMTQ2OWJjMzU0L3RhYmxlOjI5YjhkZTNhZWM3ZTRjZjFhNTA0MzVjODBlYTg4ZDQyL3RhYmxlcmFuZ2U6MjliOGRlM2FlYzdlNGNmMWE1MDQzNWM4MGVhODhkNDJfNDAtMS0xLTEtMA_42b3c642-bd35-4840-b7a1-422410cde0ac"
      unitRef="usd">44453000000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="i299cea70f47b4fbe96772aaa8cc00b79_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF84NS9mcmFnOjE0MGZhMGNkNWI5YTRiMzJiNGJiZjVlMTQ2OWJjMzU0L3RhYmxlOjI5YjhkZTNhZWM3ZTRjZjFhNTA0MzVjODBlYTg4ZDQyL3RhYmxlcmFuZ2U6MjliOGRlM2FlYzdlNGNmMWE1MDQzNWM4MGVhODhkNDJfNDAtMy0xLTEtMA_e3b1e932-82d8-4ffe-b3f1-dcbf2f83db99"
      unitRef="usd">40766000000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:CommonStockSharesIssued
      contextRef="iba537ecaa59e43b0a9b66571c8100267_I20180630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85MS9mcmFnOmYzYjg0MmI1OWMxNzQ4OTU4NGJhNzkzYzQ5MWUxNzMwL3RhYmxlOjE2ZTc3ZjNhYjg4YzQ1ODY5NDkyZGU4ZWQzMTllMWJhL3RhYmxlcmFuZ2U6MTZlNzdmM2FiODhjNDU4Njk0OTJkZThlZDMxOWUxYmFfMi0xLTEtMS0w_59cc9fe5-bc8f-4468-871d-81c1185d5740"
      unitRef="shares">327000000</us-gaap:CommonStockSharesIssued>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="iba537ecaa59e43b0a9b66571c8100267_I20180630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85MS9mcmFnOmYzYjg0MmI1OWMxNzQ4OTU4NGJhNzkzYzQ5MWUxNzMwL3RhYmxlOjE2ZTc3ZjNhYjg4YzQ1ODY5NDkyZGU4ZWQzMTllMWJhL3RhYmxlcmFuZ2U6MTZlNzdmM2FiODhjNDU4Njk0OTJkZThlZDMxOWUxYmFfMi0zLTEtMS0w_7c2958f1-0270-4c2e-90ac-d29cf3622ea6"
      unitRef="usd">2730000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="id3a1b5ab2e8f487b9c151040675e8c4e_I20180630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85MS9mcmFnOmYzYjg0MmI1OWMxNzQ4OTU4NGJhNzkzYzQ5MWUxNzMwL3RhYmxlOjE2ZTc3ZjNhYjg4YzQ1ODY5NDkyZGU4ZWQzMTllMWJhL3RhYmxlcmFuZ2U6MTZlNzdmM2FiODhjNDU4Njk0OTJkZThlZDMxOWUxYmFfMi01LTEtMS0w_cefab5cd-ec29-4a6e-bf2c-2c07905d7ae4"
      unitRef="usd">4645000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:TreasuryStockShares
      contextRef="if1e3a4cc24f142cdafa5042dfc5dd64d_I20180630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85MS9mcmFnOmYzYjg0MmI1OWMxNzQ4OTU4NGJhNzkzYzQ5MWUxNzMwL3RhYmxlOjE2ZTc3ZjNhYjg4YzQ1ODY5NDkyZGU4ZWQzMTllMWJhL3RhYmxlcmFuZ2U6MTZlNzdmM2FiODhjNDU4Njk0OTJkZThlZDMxOWUxYmFfMi03LTEtMS0w_202cd800-f504-46a7-a6e3-1df7547a7708"
      unitRef="shares">18000000</us-gaap:TreasuryStockShares>
    <us-gaap:TreasuryStockValue
      contextRef="if1e3a4cc24f142cdafa5042dfc5dd64d_I20180630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85MS9mcmFnOmYzYjg0MmI1OWMxNzQ4OTU4NGJhNzkzYzQ5MWUxNzMwL3RhYmxlOjE2ZTc3ZjNhYjg4YzQ1ODY5NDkyZGU4ZWQzMTllMWJhL3RhYmxlcmFuZ2U6MTZlNzdmM2FiODhjNDU4Njk0OTJkZThlZDMxOWUxYmFfMi05LTEtMS0w_a362e27a-2c62-4870-b572-0c132ebb524e"
      unitRef="usd">1224000000</us-gaap:TreasuryStockValue>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ifb73250f67a2413d876abaab75f9b78e_I20180630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85MS9mcmFnOmYzYjg0MmI1OWMxNzQ4OTU4NGJhNzkzYzQ5MWUxNzMwL3RhYmxlOjE2ZTc3ZjNhYjg4YzQ1ODY5NDkyZGU4ZWQzMTllMWJhL3RhYmxlcmFuZ2U6MTZlNzdmM2FiODhjNDU4Njk0OTJkZThlZDMxOWUxYmFfMi0xMS0xLTEtMA_11d10067-0a45-4859-bab0-d77e1774d568"
      unitRef="usd">-92000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i9ffaf87e6d734e599ad2b8cf9d894639_I20180630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85MS9mcmFnOmYzYjg0MmI1OWMxNzQ4OTU4NGJhNzkzYzQ5MWUxNzMwL3RhYmxlOjE2ZTc3ZjNhYjg4YzQ1ODY5NDkyZGU4ZWQzMTllMWJhL3RhYmxlcmFuZ2U6MTZlNzdmM2FiODhjNDU4Njk0OTJkZThlZDMxOWUxYmFfMi0xMy0xLTEtMA_9f282fe3-94df-4f80-adca-4599df00dec7"
      unitRef="usd">0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i39bbe70148ff4daea469e8420c1859d6_I20180630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85MS9mcmFnOmYzYjg0MmI1OWMxNzQ4OTU4NGJhNzkzYzQ5MWUxNzMwL3RhYmxlOjE2ZTc3ZjNhYjg4YzQ1ODY5NDkyZGU4ZWQzMTllMWJhL3RhYmxlcmFuZ2U6MTZlNzdmM2FiODhjNDU4Njk0OTJkZThlZDMxOWUxYmFfMi0xNS0xLTEtMA_d418c83a-8392-4282-8298-0d387f090f2c"
      unitRef="usd">6059000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLoss
      contextRef="i368e27a25f8645faa683a133e4fd114e_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85MS9mcmFnOmYzYjg0MmI1OWMxNzQ4OTU4NGJhNzkzYzQ5MWUxNzMwL3RhYmxlOjE2ZTc3ZjNhYjg4YzQ1ODY5NDkyZGU4ZWQzMTllMWJhL3RhYmxlcmFuZ2U6MTZlNzdmM2FiODhjNDU4Njk0OTJkZThlZDMxOWUxYmFfMy01LTEtMS0w_6d66a8a6-4643-44c3-ac25-b778c79c4361"
      unitRef="usd">1363000000</us-gaap:NetIncomeLoss>
    <us-gaap:ProfitLoss
      contextRef="i7a763b06539a46f2af8919fe47c2b61a_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85MS9mcmFnOmYzYjg0MmI1OWMxNzQ4OTU4NGJhNzkzYzQ5MWUxNzMwL3RhYmxlOjE2ZTc3ZjNhYjg4YzQ1ODY5NDkyZGU4ZWQzMTllMWJhL3RhYmxlcmFuZ2U6MTZlNzdmM2FiODhjNDU4Njk0OTJkZThlZDMxOWUxYmFfMy0xMy0xLTEtMA_d447be2b-9fb4-4af9-a216-b833969671da"
      unitRef="usd">2000000</us-gaap:ProfitLoss>
    <cah:NetEarningsIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest
      contextRef="i00a6d666bf604826b24e68ddbd63eac4_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85MS9mcmFnOmYzYjg0MmI1OWMxNzQ4OTU4NGJhNzkzYzQ5MWUxNzMwL3RhYmxlOjE2ZTc3ZjNhYjg4YzQ1ODY5NDkyZGU4ZWQzMTllMWJhL3RhYmxlcmFuZ2U6MTZlNzdmM2FiODhjNDU4Njk0OTJkZThlZDMxOWUxYmFfMy0xNS0xLTEtMA_487855be-cbd8-4ef9-9fec-d86f82932b69"
      unitRef="usd">1365000000</cah:NetEarningsIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i192683d94cc4483f889528979a51af74_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85MS9mcmFnOmYzYjg0MmI1OWMxNzQ4OTU4NGJhNzkzYzQ5MWUxNzMwL3RhYmxlOjE2ZTc3ZjNhYjg4YzQ1ODY5NDkyZGU4ZWQzMTllMWJhL3RhYmxlcmFuZ2U6MTZlNzdmM2FiODhjNDU4Njk0OTJkZThlZDMxOWUxYmFfNC0xMS0xLTEtMA_2dc6b582-c7be-44f4-821a-effeb6337c40"
      unitRef="usd">13000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i00a6d666bf604826b24e68ddbd63eac4_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85MS9mcmFnOmYzYjg0MmI1OWMxNzQ4OTU4NGJhNzkzYzQ5MWUxNzMwL3RhYmxlOjE2ZTc3ZjNhYjg4YzQ1ODY5NDkyZGU4ZWQzMTllMWJhL3RhYmxlcmFuZ2U6MTZlNzdmM2FiODhjNDU4Njk0OTJkZThlZDMxOWUxYmFfNC0xNS0xLTEtMA_ce90e5f2-5af5-4d04-9e83-948b821e18db"
      unitRef="usd">13000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="i8d9cc349c75d4429b567d5aa909a3433_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85MS9mcmFnOmYzYjg0MmI1OWMxNzQ4OTU4NGJhNzkzYzQ5MWUxNzMwL3RhYmxlOjE2ZTc3ZjNhYjg4YzQ1ODY5NDkyZGU4ZWQzMTllMWJhL3RhYmxlcmFuZ2U6MTZlNzdmM2FiODhjNDU4Njk0OTJkZThlZDMxOWUxYmFfNi0xLTEtMS0w_461b8508-b2cf-48d9-8b8c-453d514902e7"
      unitRef="shares">0</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i8d9cc349c75d4429b567d5aa909a3433_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85MS9mcmFnOmYzYjg0MmI1OWMxNzQ4OTU4NGJhNzkzYzQ5MWUxNzMwL3RhYmxlOjE2ZTc3ZjNhYjg4YzQ1ODY5NDkyZGU4ZWQzMTllMWJhL3RhYmxlcmFuZ2U6MTZlNzdmM2FiODhjNDU4Njk0OTJkZThlZDMxOWUxYmFfNi0zLTEtMS0w_caa7d35d-6c4a-4ab9-a98e-2f0f5cd1862b"
      unitRef="usd">33000000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="ifec5466baa034dc5b60b6acb6798f00e_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85MS9mcmFnOmYzYjg0MmI1OWMxNzQ4OTU4NGJhNzkzYzQ5MWUxNzMwL3RhYmxlOjE2ZTc3ZjNhYjg4YzQ1ODY5NDkyZGU4ZWQzMTllMWJhL3RhYmxlcmFuZ2U6MTZlNzdmM2FiODhjNDU4Njk0OTJkZThlZDMxOWUxYmFfNi03LTEtMS0w_05e64804-e0e4-441a-8f91-d332399d19bf"
      unitRef="shares">1000000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="ifec5466baa034dc5b60b6acb6798f00e_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85MS9mcmFnOmYzYjg0MmI1OWMxNzQ4OTU4NGJhNzkzYzQ5MWUxNzMwL3RhYmxlOjE2ZTc3ZjNhYjg4YzQ1ODY5NDkyZGU4ZWQzMTllMWJhL3RhYmxlcmFuZ2U6MTZlNzdmM2FiODhjNDU4Njk0OTJkZThlZDMxOWUxYmFfNi05LTEtMS0w_8bdcb67b-ec58-4c9a-9b08-1b2067f2ef1c"
      unitRef="usd">34000000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i00a6d666bf604826b24e68ddbd63eac4_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85MS9mcmFnOmYzYjg0MmI1OWMxNzQ4OTU4NGJhNzkzYzQ5MWUxNzMwL3RhYmxlOjE2ZTc3ZjNhYjg4YzQ1ODY5NDkyZGU4ZWQzMTllMWJhL3RhYmxlcmFuZ2U6MTZlNzdmM2FiODhjNDU4Njk0OTJkZThlZDMxOWUxYmFfNi0xNS0xLTEtMA_f9c96be0-814d-4d61-bf8d-09cf03ce59ca"
      unitRef="usd">67000000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="ifec5466baa034dc5b60b6acb6798f00e_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85MS9mcmFnOmYzYjg0MmI1OWMxNzQ4OTU4NGJhNzkzYzQ5MWUxNzMwL3RhYmxlOjE2ZTc3ZjNhYjg4YzQ1ODY5NDkyZGU4ZWQzMTllMWJhL3RhYmxlcmFuZ2U6MTZlNzdmM2FiODhjNDU4Njk0OTJkZThlZDMxOWUxYmFfNy03LTEtMS0w_0bc4009d-cbbc-444b-b11b-8421bbb16c3c"
      unitRef="shares">11000000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="ifec5466baa034dc5b60b6acb6798f00e_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85MS9mcmFnOmYzYjg0MmI1OWMxNzQ4OTU4NGJhNzkzYzQ5MWUxNzMwL3RhYmxlOjE2ZTc3ZjNhYjg4YzQ1ODY5NDkyZGU4ZWQzMTllMWJhL3RhYmxlcmFuZ2U6MTZlNzdmM2FiODhjNDU4Njk0OTJkZThlZDMxOWUxYmFfNy05LTEtMS0w_9828b28b-f51b-4762-8c18-81ad48cdd0f9"
      unitRef="usd">600000000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="i00a6d666bf604826b24e68ddbd63eac4_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85MS9mcmFnOmYzYjg0MmI1OWMxNzQ4OTU4NGJhNzkzYzQ5MWUxNzMwL3RhYmxlOjE2ZTc3ZjNhYjg4YzQ1ODY5NDkyZGU4ZWQzMTllMWJhL3RhYmxlcmFuZ2U6MTZlNzdmM2FiODhjNDU4Njk0OTJkZThlZDMxOWUxYmFfNy0xNS0xLTEtMA_fdf40dd6-f9d3-4446-90b0-48e319572032"
      unitRef="usd">600000000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:Dividends
      contextRef="i368e27a25f8645faa683a133e4fd114e_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85MS9mcmFnOmYzYjg0MmI1OWMxNzQ4OTU4NGJhNzkzYzQ5MWUxNzMwL3RhYmxlOjE2ZTc3ZjNhYjg4YzQ1ODY5NDkyZGU4ZWQzMTllMWJhL3RhYmxlcmFuZ2U6MTZlNzdmM2FiODhjNDU4Njk0OTJkZThlZDMxOWUxYmFfOC01LTEtMS0w_efb4558c-da72-4f65-ba4c-5fe7a9e82324"
      unitRef="usd">575000000</us-gaap:Dividends>
    <us-gaap:Dividends
      contextRef="i00a6d666bf604826b24e68ddbd63eac4_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85MS9mcmFnOmYzYjg0MmI1OWMxNzQ4OTU4NGJhNzkzYzQ5MWUxNzMwL3RhYmxlOjE2ZTc3ZjNhYjg4YzQ1ODY5NDkyZGU4ZWQzMTllMWJhL3RhYmxlcmFuZ2U6MTZlNzdmM2FiODhjNDU4Njk0OTJkZThlZDMxOWUxYmFfOC0xNS0xLTEtMA_13b33974-586c-4799-b37c-1befa086ae23"
      unitRef="usd">575000000</us-gaap:Dividends>
    <us-gaap:StockholdersEquityOther
      contextRef="i8d9cc349c75d4429b567d5aa909a3433_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85MS9mcmFnOmYzYjg0MmI1OWMxNzQ4OTU4NGJhNzkzYzQ5MWUxNzMwL3RhYmxlOjE2ZTc3ZjNhYjg4YzQ1ODY5NDkyZGU4ZWQzMTllMWJhL3RhYmxlcmFuZ2U6MTZlNzdmM2FiODhjNDU4Njk0OTJkZThlZDMxOWUxYmFfOS0zLTEtMS0xMjYwNg_84bcf332-98c4-4ea6-bb78-8b66b98bd1dc"
      unitRef="usd">0</us-gaap:StockholdersEquityOther>
    <us-gaap:StockholdersEquityOther
      contextRef="i368e27a25f8645faa683a133e4fd114e_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85MS9mcmFnOmYzYjg0MmI1OWMxNzQ4OTU4NGJhNzkzYzQ5MWUxNzMwL3RhYmxlOjE2ZTc3ZjNhYjg4YzQ1ODY5NDkyZGU4ZWQzMTllMWJhL3RhYmxlcmFuZ2U6MTZlNzdmM2FiODhjNDU4Njk0OTJkZThlZDMxOWUxYmFfOS01LTEtMS0w_0c50fb86-cdbb-4e23-9756-ff91fa019e51"
      unitRef="usd">-1000000</us-gaap:StockholdersEquityOther>
    <us-gaap:StockholdersEquityOtherShares
      contextRef="ifec5466baa034dc5b60b6acb6798f00e_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85MS9mcmFnOmYzYjg0MmI1OWMxNzQ4OTU4NGJhNzkzYzQ5MWUxNzMwL3RhYmxlOjE2ZTc3ZjNhYjg4YzQ1ODY5NDkyZGU4ZWQzMTllMWJhL3RhYmxlcmFuZ2U6MTZlNzdmM2FiODhjNDU4Njk0OTJkZThlZDMxOWUxYmFfOS03LTEtMS0xMjYwOA_5e451b7b-fc70-400d-8c9e-a52687d10de4"
      unitRef="shares">0</us-gaap:StockholdersEquityOtherShares>
    <us-gaap:StockholdersEquityOther
      contextRef="i7a763b06539a46f2af8919fe47c2b61a_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85MS9mcmFnOmYzYjg0MmI1OWMxNzQ4OTU4NGJhNzkzYzQ5MWUxNzMwL3RhYmxlOjE2ZTc3ZjNhYjg4YzQ1ODY5NDkyZGU4ZWQzMTllMWJhL3RhYmxlcmFuZ2U6MTZlNzdmM2FiODhjNDU4Njk0OTJkZThlZDMxOWUxYmFfOS0xMy0xLTEtMA_65c47594-5b05-48b9-aeac-cdf44991441b"
      unitRef="usd">0</us-gaap:StockholdersEquityOther>
    <us-gaap:StockholdersEquityOther
      contextRef="i00a6d666bf604826b24e68ddbd63eac4_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85MS9mcmFnOmYzYjg0MmI1OWMxNzQ4OTU4NGJhNzkzYzQ5MWUxNzMwL3RhYmxlOjE2ZTc3ZjNhYjg4YzQ1ODY5NDkyZGU4ZWQzMTllMWJhL3RhYmxlcmFuZ2U6MTZlNzdmM2FiODhjNDU4Njk0OTJkZThlZDMxOWUxYmFfOS0xNS0xLTEtMA_3cec4cf1-764d-41fc-819a-fd7424e55618"
      unitRef="usd">-1000000</us-gaap:StockholdersEquityOther>
    <us-gaap:CommonStockSharesIssued
      contextRef="i2c0babdbad624aa0b4937db55d311dfe_I20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85MS9mcmFnOmYzYjg0MmI1OWMxNzQ4OTU4NGJhNzkzYzQ5MWUxNzMwL3RhYmxlOjE2ZTc3ZjNhYjg4YzQ1ODY5NDkyZGU4ZWQzMTllMWJhL3RhYmxlcmFuZ2U6MTZlNzdmM2FiODhjNDU4Njk0OTJkZThlZDMxOWUxYmFfMTEtMS0xLTEtMA_5df72bd4-da68-4bd5-9373-303873124716"
      unitRef="shares">327000000</us-gaap:CommonStockSharesIssued>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i2c0babdbad624aa0b4937db55d311dfe_I20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85MS9mcmFnOmYzYjg0MmI1OWMxNzQ4OTU4NGJhNzkzYzQ5MWUxNzMwL3RhYmxlOjE2ZTc3ZjNhYjg4YzQ1ODY5NDkyZGU4ZWQzMTllMWJhL3RhYmxlcmFuZ2U6MTZlNzdmM2FiODhjNDU4Njk0OTJkZThlZDMxOWUxYmFfMTEtMy0xLTEtMA_44c9c01d-ced2-4378-899d-3342e43a1de7"
      unitRef="usd">2763000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i04bec8a518fa429988f9b9473cfeb451_I20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85MS9mcmFnOmYzYjg0MmI1OWMxNzQ4OTU4NGJhNzkzYzQ5MWUxNzMwL3RhYmxlOjE2ZTc3ZjNhYjg4YzQ1ODY5NDkyZGU4ZWQzMTllMWJhL3RhYmxlcmFuZ2U6MTZlNzdmM2FiODhjNDU4Njk0OTJkZThlZDMxOWUxYmFfMTEtNS0xLTEtMA_b01c84a9-b639-4539-8068-990d101f2a04"
      unitRef="usd">5434000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:TreasuryStockShares
      contextRef="i0acb4be80aa74c89bc743cf58fc67d77_I20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85MS9mcmFnOmYzYjg0MmI1OWMxNzQ4OTU4NGJhNzkzYzQ5MWUxNzMwL3RhYmxlOjE2ZTc3ZjNhYjg4YzQ1ODY5NDkyZGU4ZWQzMTllMWJhL3RhYmxlcmFuZ2U6MTZlNzdmM2FiODhjNDU4Njk0OTJkZThlZDMxOWUxYmFfMTEtNy0xLTEtMA_cc24578d-cdae-47de-a9b9-764432c0bd9c"
      unitRef="shares">28000000</us-gaap:TreasuryStockShares>
    <us-gaap:TreasuryStockValue
      contextRef="i0acb4be80aa74c89bc743cf58fc67d77_I20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85MS9mcmFnOmYzYjg0MmI1OWMxNzQ4OTU4NGJhNzkzYzQ5MWUxNzMwL3RhYmxlOjE2ZTc3ZjNhYjg4YzQ1ODY5NDkyZGU4ZWQzMTllMWJhL3RhYmxlcmFuZ2U6MTZlNzdmM2FiODhjNDU4Njk0OTJkZThlZDMxOWUxYmFfMTEtOS0xLTEtMA_d27e13a9-1eca-4dc0-8b2b-2af2dcf7ed03"
      unitRef="usd">1790000000</us-gaap:TreasuryStockValue>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i08559a107c7a4c31965cd373a397c3af_I20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85MS9mcmFnOmYzYjg0MmI1OWMxNzQ4OTU4NGJhNzkzYzQ5MWUxNzMwL3RhYmxlOjE2ZTc3ZjNhYjg4YzQ1ODY5NDkyZGU4ZWQzMTllMWJhL3RhYmxlcmFuZ2U6MTZlNzdmM2FiODhjNDU4Njk0OTJkZThlZDMxOWUxYmFfMTEtMTEtMS0xLTA_ae431964-b2d2-4925-8926-bdbbc37c3eb4"
      unitRef="usd">-79000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i401ce4a0ca0546f58fbbd8672082718a_I20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85MS9mcmFnOmYzYjg0MmI1OWMxNzQ4OTU4NGJhNzkzYzQ5MWUxNzMwL3RhYmxlOjE2ZTc3ZjNhYjg4YzQ1ODY5NDkyZGU4ZWQzMTllMWJhL3RhYmxlcmFuZ2U6MTZlNzdmM2FiODhjNDU4Njk0OTJkZThlZDMxOWUxYmFfMTEtMTMtMS0xLTA_5ef7a439-cd30-4885-8499-e44c31b526e9"
      unitRef="usd">2000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="if6dc09eec4e74751b47cdf037a5b1860_I20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85MS9mcmFnOmYzYjg0MmI1OWMxNzQ4OTU4NGJhNzkzYzQ5MWUxNzMwL3RhYmxlOjE2ZTc3ZjNhYjg4YzQ1ODY5NDkyZGU4ZWQzMTllMWJhL3RhYmxlcmFuZ2U6MTZlNzdmM2FiODhjNDU4Njk0OTJkZThlZDMxOWUxYmFfMTEtMTUtMS0xLTA_bb5999db-8ed3-484a-a006-193c731176ca"
      unitRef="usd">6330000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLoss
      contextRef="ia31e9a409b874bb19d0ff6f2f39ecc09_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85MS9mcmFnOmYzYjg0MmI1OWMxNzQ4OTU4NGJhNzkzYzQ5MWUxNzMwL3RhYmxlOjE2ZTc3ZjNhYjg4YzQ1ODY5NDkyZGU4ZWQzMTllMWJhL3RhYmxlcmFuZ2U6MTZlNzdmM2FiODhjNDU4Njk0OTJkZThlZDMxOWUxYmFfMTItNS0xLTEtMA_dd3267f4-7714-46c1-80c2-b97144b82301"
      unitRef="usd">-3696000000</us-gaap:NetIncomeLoss>
    <us-gaap:ProfitLoss
      contextRef="ibeaaa4c81e084b86a689f640458f607a_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85MS9mcmFnOmYzYjg0MmI1OWMxNzQ4OTU4NGJhNzkzYzQ5MWUxNzMwL3RhYmxlOjE2ZTc3ZjNhYjg4YzQ1ODY5NDkyZGU4ZWQzMTllMWJhL3RhYmxlcmFuZ2U6MTZlNzdmM2FiODhjNDU4Njk0OTJkZThlZDMxOWUxYmFfMTItMTMtMS0xLTA_2c6e84c5-c271-43f4-b4c6-2d674b7002d2"
      unitRef="usd">3000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="ia31e9a409b874bb19d0ff6f2f39ecc09_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85MS9mcmFnOmYzYjg0MmI1OWMxNzQ4OTU4NGJhNzkzYzQ5MWUxNzMwL3RhYmxlOjE2ZTc3ZjNhYjg4YzQ1ODY5NDkyZGU4ZWQzMTllMWJhL3RhYmxlcmFuZ2U6MTZlNzdmM2FiODhjNDU4Njk0OTJkZThlZDMxOWUxYmFfMTItMTUtMS0xLTA_858a1a46-be8b-4dfc-9bee-99d679058637"
      unitRef="usd">-3693000000</us-gaap:ProfitLoss>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i6b350fae2224486aa2a6ffc44c36559b_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85MS9mcmFnOmYzYjg0MmI1OWMxNzQ4OTU4NGJhNzkzYzQ5MWUxNzMwL3RhYmxlOjE2ZTc3ZjNhYjg4YzQ1ODY5NDkyZGU4ZWQzMTllMWJhL3RhYmxlcmFuZ2U6MTZlNzdmM2FiODhjNDU4Njk0OTJkZThlZDMxOWUxYmFfMTMtMTEtMS0xLTA_edf1bf80-5977-46e8-acfc-4f2a14caad56"
      unitRef="usd">-25000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="ia31e9a409b874bb19d0ff6f2f39ecc09_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85MS9mcmFnOmYzYjg0MmI1OWMxNzQ4OTU4NGJhNzkzYzQ5MWUxNzMwL3RhYmxlOjE2ZTc3ZjNhYjg4YzQ1ODY5NDkyZGU4ZWQzMTllMWJhL3RhYmxlcmFuZ2U6MTZlNzdmM2FiODhjNDU4Njk0OTJkZThlZDMxOWUxYmFfMTMtMTUtMS0xLTA_da56eb6f-d90d-4fb0-aa5b-b826d0550597"
      unitRef="usd">-25000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="i4c5f25e0cc4f4d04a3afc3f86804554c_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85MS9mcmFnOmYzYjg0MmI1OWMxNzQ4OTU4NGJhNzkzYzQ5MWUxNzMwL3RhYmxlOjE2ZTc3ZjNhYjg4YzQ1ODY5NDkyZGU4ZWQzMTllMWJhL3RhYmxlcmFuZ2U6MTZlNzdmM2FiODhjNDU4Njk0OTJkZThlZDMxOWUxYmFfMTUtMS0xLTEtMA_a382272a-4d23-4b30-9324-0d5274f8c984"
      unitRef="shares">0</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i4c5f25e0cc4f4d04a3afc3f86804554c_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85MS9mcmFnOmYzYjg0MmI1OWMxNzQ4OTU4NGJhNzkzYzQ5MWUxNzMwL3RhYmxlOjE2ZTc3ZjNhYjg4YzQ1ODY5NDkyZGU4ZWQzMTllMWJhL3RhYmxlcmFuZ2U6MTZlNzdmM2FiODhjNDU4Njk0OTJkZThlZDMxOWUxYmFfMTUtMy0xLTEtMA_966dd227-8348-4db3-9dce-604a46cb5817"
      unitRef="usd">26000000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="i0361658ee5604068a75c34f27c83ef6b_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85MS9mcmFnOmYzYjg0MmI1OWMxNzQ4OTU4NGJhNzkzYzQ5MWUxNzMwL3RhYmxlOjE2ZTc3ZjNhYjg4YzQ1ODY5NDkyZGU4ZWQzMTllMWJhL3RhYmxlcmFuZ2U6MTZlNzdmM2FiODhjNDU4Njk0OTJkZThlZDMxOWUxYmFfMTUtNy0xLTEtMA_160af5b4-ee66-4ccb-b670-8062fce7c99e"
      unitRef="shares">0</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i0361658ee5604068a75c34f27c83ef6b_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85MS9mcmFnOmYzYjg0MmI1OWMxNzQ4OTU4NGJhNzkzYzQ5MWUxNzMwL3RhYmxlOjE2ZTc3ZjNhYjg4YzQ1ODY5NDkyZGU4ZWQzMTllMWJhL3RhYmxlcmFuZ2U6MTZlNzdmM2FiODhjNDU4Njk0OTJkZThlZDMxOWUxYmFfMTUtOS0xLTEtMA_c8e5bff4-1cc1-453e-bc94-2990c7a4ec0a"
      unitRef="usd">74000000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="ia31e9a409b874bb19d0ff6f2f39ecc09_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85MS9mcmFnOmYzYjg0MmI1OWMxNzQ4OTU4NGJhNzkzYzQ5MWUxNzMwL3RhYmxlOjE2ZTc3ZjNhYjg4YzQ1ODY5NDkyZGU4ZWQzMTllMWJhL3RhYmxlcmFuZ2U6MTZlNzdmM2FiODhjNDU4Njk0OTJkZThlZDMxOWUxYmFfMTUtMTUtMS0xLTA_8e6fd656-a9d8-431c-8150-59fe7150c3e4"
      unitRef="usd">100000000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="i0361658ee5604068a75c34f27c83ef6b_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85MS9mcmFnOmYzYjg0MmI1OWMxNzQ4OTU4NGJhNzkzYzQ5MWUxNzMwL3RhYmxlOjE2ZTc3ZjNhYjg4YzQ1ODY5NDkyZGU4ZWQzMTllMWJhL3RhYmxlcmFuZ2U6MTZlNzdmM2FiODhjNDU4Njk0OTJkZThlZDMxOWUxYmFfMTYtNy0xLTEtMA_8dca8de4-47dc-4a4d-81d5-e2b2d5d6de35"
      unitRef="shares">7000000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="i0361658ee5604068a75c34f27c83ef6b_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85MS9mcmFnOmYzYjg0MmI1OWMxNzQ4OTU4NGJhNzkzYzQ5MWUxNzMwL3RhYmxlOjE2ZTc3ZjNhYjg4YzQ1ODY5NDkyZGU4ZWQzMTllMWJhL3RhYmxlcmFuZ2U6MTZlNzdmM2FiODhjNDU4Njk0OTJkZThlZDMxOWUxYmFfMTYtOS0xLTEtMA_4c277ff8-e558-4431-a9ee-7ac3fbbbb819"
      unitRef="usd">350000000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="ia31e9a409b874bb19d0ff6f2f39ecc09_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85MS9mcmFnOmYzYjg0MmI1OWMxNzQ4OTU4NGJhNzkzYzQ5MWUxNzMwL3RhYmxlOjE2ZTc3ZjNhYjg4YzQ1ODY5NDkyZGU4ZWQzMTllMWJhL3RhYmxlcmFuZ2U6MTZlNzdmM2FiODhjNDU4Njk0OTJkZThlZDMxOWUxYmFfMTYtMTUtMS0xLTA_474cc08d-d12b-45ad-9958-432293be862a"
      unitRef="usd">350000000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:Dividends
      contextRef="i61b655b20bf94b27a3ebf574f93a9915_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85MS9mcmFnOmYzYjg0MmI1OWMxNzQ4OTU4NGJhNzkzYzQ5MWUxNzMwL3RhYmxlOjE2ZTc3ZjNhYjg4YzQ1ODY5NDkyZGU4ZWQzMTllMWJhL3RhYmxlcmFuZ2U6MTZlNzdmM2FiODhjNDU4Njk0OTJkZThlZDMxOWUxYmFfMTctNS0xLTEtMA_49a14b7a-998f-4d44-8a9d-217f11d7ec0c"
      unitRef="usd">570000000</us-gaap:Dividends>
    <us-gaap:Dividends
      contextRef="ia31e9a409b874bb19d0ff6f2f39ecc09_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85MS9mcmFnOmYzYjg0MmI1OWMxNzQ4OTU4NGJhNzkzYzQ5MWUxNzMwL3RhYmxlOjE2ZTc3ZjNhYjg4YzQ1ODY5NDkyZGU4ZWQzMTllMWJhL3RhYmxlcmFuZ2U6MTZlNzdmM2FiODhjNDU4Njk0OTJkZThlZDMxOWUxYmFfMTctMTUtMS0xLTA_b607939d-2f23-44b8-8d7b-46ec97c739b8"
      unitRef="usd">570000000</us-gaap:Dividends>
    <us-gaap:StockholdersEquityOther
      contextRef="i4c5f25e0cc4f4d04a3afc3f86804554c_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85MS9mcmFnOmYzYjg0MmI1OWMxNzQ4OTU4NGJhNzkzYzQ5MWUxNzMwL3RhYmxlOjE2ZTc3ZjNhYjg4YzQ1ODY5NDkyZGU4ZWQzMTllMWJhL3RhYmxlcmFuZ2U6MTZlNzdmM2FiODhjNDU4Njk0OTJkZThlZDMxOWUxYmFfMTgtMy0xLTEtMTI2MTE_1a8443a7-5797-4149-bc16-260bd0290b5e"
      unitRef="usd">0</us-gaap:StockholdersEquityOther>
    <us-gaap:StockholdersEquityOther
      contextRef="i61b655b20bf94b27a3ebf574f93a9915_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85MS9mcmFnOmYzYjg0MmI1OWMxNzQ4OTU4NGJhNzkzYzQ5MWUxNzMwL3RhYmxlOjE2ZTc3ZjNhYjg4YzQ1ODY5NDkyZGU4ZWQzMTllMWJhL3RhYmxlcmFuZ2U6MTZlNzdmM2FiODhjNDU4Njk0OTJkZThlZDMxOWUxYmFfMTgtNS0xLTEtMA_cf115b96-8971-48b7-b1b2-c53143c9c178"
      unitRef="usd">-2000000</us-gaap:StockholdersEquityOther>
    <us-gaap:StockholdersEquityOtherShares
      contextRef="i0361658ee5604068a75c34f27c83ef6b_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85MS9mcmFnOmYzYjg0MmI1OWMxNzQ4OTU4NGJhNzkzYzQ5MWUxNzMwL3RhYmxlOjE2ZTc3ZjNhYjg4YzQ1ODY5NDkyZGU4ZWQzMTllMWJhL3RhYmxlcmFuZ2U6MTZlNzdmM2FiODhjNDU4Njk0OTJkZThlZDMxOWUxYmFfMTgtNy0xLTEtMTI2MTY_2d6c914c-5d50-4e8b-a494-5a8fe6d1c2f9"
      unitRef="shares">0</us-gaap:StockholdersEquityOtherShares>
    <us-gaap:StockholdersEquityOther
      contextRef="ibeaaa4c81e084b86a689f640458f607a_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85MS9mcmFnOmYzYjg0MmI1OWMxNzQ4OTU4NGJhNzkzYzQ5MWUxNzMwL3RhYmxlOjE2ZTc3ZjNhYjg4YzQ1ODY5NDkyZGU4ZWQzMTllMWJhL3RhYmxlcmFuZ2U6MTZlNzdmM2FiODhjNDU4Njk0OTJkZThlZDMxOWUxYmFfMTgtMTMtMS0xLTYzNQ_d30b094d-d4dc-40eb-80a3-ffd06fe93f3d"
      unitRef="usd">-2000000</us-gaap:StockholdersEquityOther>
    <us-gaap:StockholdersEquityOther
      contextRef="ia31e9a409b874bb19d0ff6f2f39ecc09_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85MS9mcmFnOmYzYjg0MmI1OWMxNzQ4OTU4NGJhNzkzYzQ5MWUxNzMwL3RhYmxlOjE2ZTc3ZjNhYjg4YzQ1ODY5NDkyZGU4ZWQzMTllMWJhL3RhYmxlcmFuZ2U6MTZlNzdmM2FiODhjNDU4Njk0OTJkZThlZDMxOWUxYmFfMTgtMTUtMS0xLTA_0ba139b2-add2-4409-9446-f66aa14c13a2"
      unitRef="usd">0</us-gaap:StockholdersEquityOther>
    <us-gaap:CommonStockSharesIssued
      contextRef="i3eeed4226e40446da06738c489d87462_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85MS9mcmFnOmYzYjg0MmI1OWMxNzQ4OTU4NGJhNzkzYzQ5MWUxNzMwL3RhYmxlOjE2ZTc3ZjNhYjg4YzQ1ODY5NDkyZGU4ZWQzMTllMWJhL3RhYmxlcmFuZ2U6MTZlNzdmM2FiODhjNDU4Njk0OTJkZThlZDMxOWUxYmFfMjAtMS0xLTEtMA_077c5804-c5ad-49c5-9126-89cb281e0336"
      unitRef="shares">327000000</us-gaap:CommonStockSharesIssued>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i3eeed4226e40446da06738c489d87462_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85MS9mcmFnOmYzYjg0MmI1OWMxNzQ4OTU4NGJhNzkzYzQ5MWUxNzMwL3RhYmxlOjE2ZTc3ZjNhYjg4YzQ1ODY5NDkyZGU4ZWQzMTllMWJhL3RhYmxlcmFuZ2U6MTZlNzdmM2FiODhjNDU4Njk0OTJkZThlZDMxOWUxYmFfMjAtMy0xLTEtMA_a29e3c82-b080-469c-994f-163b0bf2b796"
      unitRef="usd">2789000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i177d5a23d5d64051ad7ef088e9f5ebd4_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85MS9mcmFnOmYzYjg0MmI1OWMxNzQ4OTU4NGJhNzkzYzQ5MWUxNzMwL3RhYmxlOjE2ZTc3ZjNhYjg4YzQ1ODY5NDkyZGU4ZWQzMTllMWJhL3RhYmxlcmFuZ2U6MTZlNzdmM2FiODhjNDU4Njk0OTJkZThlZDMxOWUxYmFfMjAtNS0xLTEtMA_cc21447d-19dc-492a-97a4-fa569381d415"
      unitRef="usd">1170000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:TreasuryStockShares
      contextRef="idf14ef20aa2d4674855f6bc891acf9de_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85MS9mcmFnOmYzYjg0MmI1OWMxNzQ4OTU4NGJhNzkzYzQ5MWUxNzMwL3RhYmxlOjE2ZTc3ZjNhYjg4YzQ1ODY5NDkyZGU4ZWQzMTllMWJhL3RhYmxlcmFuZ2U6MTZlNzdmM2FiODhjNDU4Njk0OTJkZThlZDMxOWUxYmFfMjAtNy0xLTEtMA_da4f5811-5890-4e2c-ad5b-9b0468e92e20"
      unitRef="shares">35000000</us-gaap:TreasuryStockShares>
    <us-gaap:TreasuryStockValue
      contextRef="idf14ef20aa2d4674855f6bc891acf9de_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85MS9mcmFnOmYzYjg0MmI1OWMxNzQ4OTU4NGJhNzkzYzQ5MWUxNzMwL3RhYmxlOjE2ZTc3ZjNhYjg4YzQ1ODY5NDkyZGU4ZWQzMTllMWJhL3RhYmxlcmFuZ2U6MTZlNzdmM2FiODhjNDU4Njk0OTJkZThlZDMxOWUxYmFfMjAtOS0xLTEtMA_2db55e15-3358-4d17-a449-a5a9d803a742"
      unitRef="usd">2066000000</us-gaap:TreasuryStockValue>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="iab6212d6a7c945a59137402110f15a40_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85MS9mcmFnOmYzYjg0MmI1OWMxNzQ4OTU4NGJhNzkzYzQ5MWUxNzMwL3RhYmxlOjE2ZTc3ZjNhYjg4YzQ1ODY5NDkyZGU4ZWQzMTllMWJhL3RhYmxlcmFuZ2U6MTZlNzdmM2FiODhjNDU4Njk0OTJkZThlZDMxOWUxYmFfMjAtMTEtMS0xLTA_566152c3-7da1-4429-9256-27a7990aedc0"
      unitRef="usd">-104000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i2f4057fc39254faf97951f0ee6826f17_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85MS9mcmFnOmYzYjg0MmI1OWMxNzQ4OTU4NGJhNzkzYzQ5MWUxNzMwL3RhYmxlOjE2ZTc3ZjNhYjg4YzQ1ODY5NDkyZGU4ZWQzMTllMWJhL3RhYmxlcmFuZ2U6MTZlNzdmM2FiODhjNDU4Njk0OTJkZThlZDMxOWUxYmFfMjAtMTMtMS0xLTA_8df1bf62-1ac5-47b2-b7c9-646a99441266"
      unitRef="usd">3000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i299cea70f47b4fbe96772aaa8cc00b79_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85MS9mcmFnOmYzYjg0MmI1OWMxNzQ4OTU4NGJhNzkzYzQ5MWUxNzMwL3RhYmxlOjE2ZTc3ZjNhYjg4YzQ1ODY5NDkyZGU4ZWQzMTllMWJhL3RhYmxlcmFuZ2U6MTZlNzdmM2FiODhjNDU4Njk0OTJkZThlZDMxOWUxYmFfMjAtMTUtMS0xLTA_16c74c5c-2fb7-43de-b69f-918600d3c38e"
      unitRef="usd">1792000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLoss
      contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85MS9mcmFnOmYzYjg0MmI1OWMxNzQ4OTU4NGJhNzkzYzQ5MWUxNzMwL3RhYmxlOjE2ZTc3ZjNhYjg4YzQ1ODY5NDkyZGU4ZWQzMTllMWJhL3RhYmxlcmFuZ2U6MTZlNzdmM2FiODhjNDU4Njk0OTJkZThlZDMxOWUxYmFfMjEtNS0xLTEtMA_81c6e5e0-508d-4942-b3b7-d9e47a567521"
      unitRef="usd">611000000</us-gaap:NetIncomeLoss>
    <us-gaap:ProfitLoss
      contextRef="i400d2c56806648c1b6c3bdbab87c1d9d_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85MS9mcmFnOmYzYjg0MmI1OWMxNzQ4OTU4NGJhNzkzYzQ5MWUxNzMwL3RhYmxlOjE2ZTc3ZjNhYjg4YzQ1ODY5NDkyZGU4ZWQzMTllMWJhL3RhYmxlcmFuZ2U6MTZlNzdmM2FiODhjNDU4Njk0OTJkZThlZDMxOWUxYmFfMjEtMTMtMS0xLTA_0629ab16-a309-46b0-b16e-fbb25aaa3c9d"
      unitRef="usd">1000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85MS9mcmFnOmYzYjg0MmI1OWMxNzQ4OTU4NGJhNzkzYzQ5MWUxNzMwL3RhYmxlOjE2ZTc3ZjNhYjg4YzQ1ODY5NDkyZGU4ZWQzMTllMWJhL3RhYmxlcmFuZ2U6MTZlNzdmM2FiODhjNDU4Njk0OTJkZThlZDMxOWUxYmFfMjEtMTUtMS0xLTA_934b16eb-2d24-4f5a-bd9b-715e04b612d3"
      unitRef="usd">612000000</us-gaap:ProfitLoss>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="idaac2fb8e90844538a6c23b3c7452e2b_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85MS9mcmFnOmYzYjg0MmI1OWMxNzQ4OTU4NGJhNzkzYzQ5MWUxNzMwL3RhYmxlOjE2ZTc3ZjNhYjg4YzQ1ODY5NDkyZGU4ZWQzMTllMWJhL3RhYmxlcmFuZ2U6MTZlNzdmM2FiODhjNDU4Njk0OTJkZThlZDMxOWUxYmFfMjItMTEtMS0xLTA_22766971-72f6-48de-aa49-df54a10e7369"
      unitRef="usd">70000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85MS9mcmFnOmYzYjg0MmI1OWMxNzQ4OTU4NGJhNzkzYzQ5MWUxNzMwL3RhYmxlOjE2ZTc3ZjNhYjg4YzQ1ODY5NDkyZGU4ZWQzMTllMWJhL3RhYmxlcmFuZ2U6MTZlNzdmM2FiODhjNDU4Njk0OTJkZThlZDMxOWUxYmFfMjItMTUtMS0xLTA_6ba54859-c26f-4992-92cf-4bf90941161c"
      unitRef="usd">70000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="i97b5509a63f04bc7ab5194aaf760af37_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85MS9mcmFnOmYzYjg0MmI1OWMxNzQ4OTU4NGJhNzkzYzQ5MWUxNzMwL3RhYmxlOjE2ZTc3ZjNhYjg4YzQ1ODY5NDkyZGU4ZWQzMTllMWJhL3RhYmxlcmFuZ2U6MTZlNzdmM2FiODhjNDU4Njk0OTJkZThlZDMxOWUxYmFfMjQtMS0xLTEtMA_3bca5951-6536-4c3d-a799-400f9887e1e9"
      unitRef="shares">0</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i97b5509a63f04bc7ab5194aaf760af37_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85MS9mcmFnOmYzYjg0MmI1OWMxNzQ4OTU4NGJhNzkzYzQ5MWUxNzMwL3RhYmxlOjE2ZTc3ZjNhYjg4YzQ1ODY5NDkyZGU4ZWQzMTllMWJhL3RhYmxlcmFuZ2U6MTZlNzdmM2FiODhjNDU4Njk0OTJkZThlZDMxOWUxYmFfMjQtMy0xLTEtMA_fb7900bc-b403-4e14-99d6-576a7fcb425b"
      unitRef="usd">17000000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="i93e121bdfcb240d3a40552629748af1b_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85MS9mcmFnOmYzYjg0MmI1OWMxNzQ4OTU4NGJhNzkzYzQ5MWUxNzMwL3RhYmxlOjE2ZTc3ZjNhYjg4YzQ1ODY5NDkyZGU4ZWQzMTllMWJhL3RhYmxlcmFuZ2U6MTZlNzdmM2FiODhjNDU4Njk0OTJkZThlZDMxOWUxYmFfMjQtNy0xLTEtMA_00a24100-38e5-41c9-b9ce-1c8b9a0ac6a9"
      unitRef="shares">3000000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i93e121bdfcb240d3a40552629748af1b_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85MS9mcmFnOmYzYjg0MmI1OWMxNzQ4OTU4NGJhNzkzYzQ5MWUxNzMwL3RhYmxlOjE2ZTc3ZjNhYjg4YzQ1ODY5NDkyZGU4ZWQzMTllMWJhL3RhYmxlcmFuZ2U6MTZlNzdmM2FiODhjNDU4Njk0OTJkZThlZDMxOWUxYmFfMjQtOS0xLTEtMA_e54193fb-a4f8-4423-bee2-4afc1726c2c6"
      unitRef="usd">80000000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85MS9mcmFnOmYzYjg0MmI1OWMxNzQ4OTU4NGJhNzkzYzQ5MWUxNzMwL3RhYmxlOjE2ZTc3ZjNhYjg4YzQ1ODY5NDkyZGU4ZWQzMTllMWJhL3RhYmxlcmFuZ2U6MTZlNzdmM2FiODhjNDU4Njk0OTJkZThlZDMxOWUxYmFfMjQtMTUtMS0xLTA_0f8cc29c-bc40-4c8f-96fc-70f2cb819363"
      unitRef="usd">97000000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="i93e121bdfcb240d3a40552629748af1b_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85MS9mcmFnOmYzYjg0MmI1OWMxNzQ4OTU4NGJhNzkzYzQ5MWUxNzMwL3RhYmxlOjE2ZTc3ZjNhYjg4YzQ1ODY5NDkyZGU4ZWQzMTllMWJhL3RhYmxlcmFuZ2U6MTZlNzdmM2FiODhjNDU4Njk0OTJkZThlZDMxOWUxYmFfMjUtNy0xLTEtMA_9b49c117-649f-48b0-9570-28f0f54ffbe1"
      unitRef="shares">4000000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="i93e121bdfcb240d3a40552629748af1b_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85MS9mcmFnOmYzYjg0MmI1OWMxNzQ4OTU4NGJhNzkzYzQ5MWUxNzMwL3RhYmxlOjE2ZTc3ZjNhYjg4YzQ1ODY5NDkyZGU4ZWQzMTllMWJhL3RhYmxlcmFuZ2U6MTZlNzdmM2FiODhjNDU4Njk0OTJkZThlZDMxOWUxYmFfMjUtOS0xLTEtMA_eca1a3cc-ab4b-41e2-a26e-5197a91d59ef"
      unitRef="usd">200000000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85MS9mcmFnOmYzYjg0MmI1OWMxNzQ4OTU4NGJhNzkzYzQ5MWUxNzMwL3RhYmxlOjE2ZTc3ZjNhYjg4YzQ1ODY5NDkyZGU4ZWQzMTllMWJhL3RhYmxlcmFuZ2U6MTZlNzdmM2FiODhjNDU4Njk0OTJkZThlZDMxOWUxYmFfMjUtMTUtMS0xLTA_c328f80c-7ae1-4afe-a7d2-1030dcfb9f79"
      unitRef="usd">200000000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:Dividends
      contextRef="i2c9548aef74d4f1a8451e70e1ab67a37_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85MS9mcmFnOmYzYjg0MmI1OWMxNzQ4OTU4NGJhNzkzYzQ5MWUxNzMwL3RhYmxlOjE2ZTc3ZjNhYjg4YzQ1ODY5NDkyZGU4ZWQzMTllMWJhL3RhYmxlcmFuZ2U6MTZlNzdmM2FiODhjNDU4Njk0OTJkZThlZDMxOWUxYmFfMjYtNS0xLTEtMA_68d079fe-95bc-42b3-b0c6-abd28c77440d"
      unitRef="usd">576000000</us-gaap:Dividends>
    <us-gaap:Dividends
      contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85MS9mcmFnOmYzYjg0MmI1OWMxNzQ4OTU4NGJhNzkzYzQ5MWUxNzMwL3RhYmxlOjE2ZTc3ZjNhYjg4YzQ1ODY5NDkyZGU4ZWQzMTllMWJhL3RhYmxlcmFuZ2U6MTZlNzdmM2FiODhjNDU4Njk0OTJkZThlZDMxOWUxYmFfMjYtMTUtMS0xLTA_0d05da4f-286e-48f2-9054-0f93869756d1"
      unitRef="usd">576000000</us-gaap:Dividends>
    <us-gaap:StockholdersEquityOther
      contextRef="i97b5509a63f04bc7ab5194aaf760af37_D20200701-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85MS9mcmFnOmYzYjg0MmI1OWMxNzQ4OTU4NGJhNzkzYzQ5MWUxNzMwL3RhYmxlOjE2ZTc3ZjNhYjg4YzQ1ODY5NDkyZGU4ZWQzMTllMWJhL3RhYmxlcmFuZ2U6MTZlNzdmM2FiODhjNDU4Njk0OTJkZThlZDMxOWUxYmFfMjctMy0xLTEtODQzOA_5fa3e5b4-8821-4631-acc2-0305d37867cc"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquityOther
      contextRef="i2c9548aef74d4f1a8451e70e1ab67a37_D20200701-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85MS9mcmFnOmYzYjg0MmI1OWMxNzQ4OTU4NGJhNzkzYzQ5MWUxNzMwL3RhYmxlOjE2ZTc3ZjNhYjg4YzQ1ODY5NDkyZGU4ZWQzMTllMWJhL3RhYmxlcmFuZ2U6MTZlNzdmM2FiODhjNDU4Njk0OTJkZThlZDMxOWUxYmFfMjctNS0xLTEtMA_6b01fbc6-5c8c-4719-95af-30641571bd17"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquityOtherShares
      contextRef="i93e121bdfcb240d3a40552629748af1b_D20200701-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85MS9mcmFnOmYzYjg0MmI1OWMxNzQ4OTU4NGJhNzkzYzQ5MWUxNzMwL3RhYmxlOjE2ZTc3ZjNhYjg4YzQ1ODY5NDkyZGU4ZWQzMTllMWJhL3RhYmxlcmFuZ2U6MTZlNzdmM2FiODhjNDU4Njk0OTJkZThlZDMxOWUxYmFfMjctNy0xLTEtODQzNA_08d723d0-5ed6-48e1-8b4e-6c1fbeca2b6e"
      unitRef="shares"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquityOther
      contextRef="i400d2c56806648c1b6c3bdbab87c1d9d_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85MS9mcmFnOmYzYjg0MmI1OWMxNzQ4OTU4NGJhNzkzYzQ5MWUxNzMwL3RhYmxlOjE2ZTc3ZjNhYjg4YzQ1ODY5NDkyZGU4ZWQzMTllMWJhL3RhYmxlcmFuZ2U6MTZlNzdmM2FiODhjNDU4Njk0OTJkZThlZDMxOWUxYmFfMjctMTMtMS0xLTA_c7343592-32ce-4301-83ab-d28b9f455fac"
      unitRef="usd">-1000000</us-gaap:StockholdersEquityOther>
    <us-gaap:StockholdersEquityOther
      contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85MS9mcmFnOmYzYjg0MmI1OWMxNzQ4OTU4NGJhNzkzYzQ5MWUxNzMwL3RhYmxlOjE2ZTc3ZjNhYjg4YzQ1ODY5NDkyZGU4ZWQzMTllMWJhL3RhYmxlcmFuZ2U6MTZlNzdmM2FiODhjNDU4Njk0OTJkZThlZDMxOWUxYmFfMjctMTUtMS0xLTA_f3f03204-edde-4367-b66f-b0cd73d27537"
      unitRef="usd">-1000000</us-gaap:StockholdersEquityOther>
    <us-gaap:CommonStockSharesIssued
      contextRef="i2356cc59616246e39e97302436e6c7df_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85MS9mcmFnOmYzYjg0MmI1OWMxNzQ4OTU4NGJhNzkzYzQ5MWUxNzMwL3RhYmxlOjE2ZTc3ZjNhYjg4YzQ1ODY5NDkyZGU4ZWQzMTllMWJhL3RhYmxlcmFuZ2U6MTZlNzdmM2FiODhjNDU4Njk0OTJkZThlZDMxOWUxYmFfMjktMS0xLTEtMA_74a51308-9e32-4037-8bed-8e669fd1ba30"
      unitRef="shares">327000000</us-gaap:CommonStockSharesIssued>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i2356cc59616246e39e97302436e6c7df_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85MS9mcmFnOmYzYjg0MmI1OWMxNzQ4OTU4NGJhNzkzYzQ5MWUxNzMwL3RhYmxlOjE2ZTc3ZjNhYjg4YzQ1ODY5NDkyZGU4ZWQzMTllMWJhL3RhYmxlcmFuZ2U6MTZlNzdmM2FiODhjNDU4Njk0OTJkZThlZDMxOWUxYmFfMjktMy0xLTEtMA_4a78e7d1-f9e0-4800-a985-776cc7667085"
      unitRef="usd">2806000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i8c7b0f49c7c44e0398779672048b5d26_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85MS9mcmFnOmYzYjg0MmI1OWMxNzQ4OTU4NGJhNzkzYzQ5MWUxNzMwL3RhYmxlOjE2ZTc3ZjNhYjg4YzQ1ODY5NDkyZGU4ZWQzMTllMWJhL3RhYmxlcmFuZ2U6MTZlNzdmM2FiODhjNDU4Njk0OTJkZThlZDMxOWUxYmFfMjktNS0xLTEtMA_1a249a1e-1848-42e7-9bc2-06254e2b3bc5"
      unitRef="usd">1205000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:TreasuryStockShares
      contextRef="i4295fef126f64025b7be038ce6dfbe12_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85MS9mcmFnOmYzYjg0MmI1OWMxNzQ4OTU4NGJhNzkzYzQ5MWUxNzMwL3RhYmxlOjE2ZTc3ZjNhYjg4YzQ1ODY5NDkyZGU4ZWQzMTllMWJhL3RhYmxlcmFuZ2U6MTZlNzdmM2FiODhjNDU4Njk0OTJkZThlZDMxOWUxYmFfMjktNy0xLTEtMA_ccfbebc6-f569-4f99-a325-4162474b6a11"
      unitRef="shares">36000000</us-gaap:TreasuryStockShares>
    <us-gaap:TreasuryStockValue
      contextRef="i4295fef126f64025b7be038ce6dfbe12_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85MS9mcmFnOmYzYjg0MmI1OWMxNzQ4OTU4NGJhNzkzYzQ5MWUxNzMwL3RhYmxlOjE2ZTc3ZjNhYjg4YzQ1ODY5NDkyZGU4ZWQzMTllMWJhL3RhYmxlcmFuZ2U6MTZlNzdmM2FiODhjNDU4Njk0OTJkZThlZDMxOWUxYmFfMjktOS0xLTEtMA_eaa58d73-91d1-4e0d-b588-eb41abae7d07"
      unitRef="usd">2186000000</us-gaap:TreasuryStockValue>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="idec34558c686494fbf6ff02881153059_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85MS9mcmFnOmYzYjg0MmI1OWMxNzQ4OTU4NGJhNzkzYzQ5MWUxNzMwL3RhYmxlOjE2ZTc3ZjNhYjg4YzQ1ODY5NDkyZGU4ZWQzMTllMWJhL3RhYmxlcmFuZ2U6MTZlNzdmM2FiODhjNDU4Njk0OTJkZThlZDMxOWUxYmFfMjktMTEtMS0xLTA_86c19dbe-0199-4a88-b542-b9fab80547ad"
      unitRef="usd">-34000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i1335220d8ce44acc9542c3208bad8a10_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85MS9mcmFnOmYzYjg0MmI1OWMxNzQ4OTU4NGJhNzkzYzQ5MWUxNzMwL3RhYmxlOjE2ZTc3ZjNhYjg4YzQ1ODY5NDkyZGU4ZWQzMTllMWJhL3RhYmxlcmFuZ2U6MTZlNzdmM2FiODhjNDU4Njk0OTJkZThlZDMxOWUxYmFfMjktMTMtMS0xLTA_5aa1edc9-62b1-47d2-aabb-fc0a1d08d3d6"
      unitRef="usd">3000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i2e87824102b34590a0208cc7da91b5f5_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85MS9mcmFnOmYzYjg0MmI1OWMxNzQ4OTU4NGJhNzkzYzQ5MWUxNzMwL3RhYmxlOjE2ZTc3ZjNhYjg4YzQ1ODY5NDkyZGU4ZWQzMTllMWJhL3RhYmxlcmFuZ2U6MTZlNzdmM2FiODhjNDU4Njk0OTJkZThlZDMxOWUxYmFfMjktMTUtMS0xLTA_11a389ea-c264-4f5e-9184-4bddb6cfb260"
      unitRef="usd">1794000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ProfitLoss
      contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85NC9mcmFnOmEwNGZkMjE3YTk3YjQ1Nzg5OWYyZTRlY2M2OGVmOTEwL3RhYmxlOmZhYTkxYWJmNjdkYzQ3ODdhY2NjZTgwNTcwMzUyZTU1L3RhYmxlcmFuZ2U6ZmFhOTFhYmY2N2RjNDc4N2FjY2NlODA1NzAzNTJlNTVfMi0xLTEtMS0w_93c32009-fe11-4248-a81f-a0cddb385adb"
      unitRef="usd">612000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="ia31e9a409b874bb19d0ff6f2f39ecc09_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85NC9mcmFnOmEwNGZkMjE3YTk3YjQ1Nzg5OWYyZTRlY2M2OGVmOTEwL3RhYmxlOmZhYTkxYWJmNjdkYzQ3ODdhY2NjZTgwNTcwMzUyZTU1L3RhYmxlcmFuZ2U6ZmFhOTFhYmY2N2RjNDc4N2FjY2NlODA1NzAzNTJlNTVfMi0zLTEtMS0w_ef4455fd-ac83-4947-8873-f04823175360"
      unitRef="usd">-3693000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i00a6d666bf604826b24e68ddbd63eac4_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85NC9mcmFnOmEwNGZkMjE3YTk3YjQ1Nzg5OWYyZTRlY2M2OGVmOTEwL3RhYmxlOmZhYTkxYWJmNjdkYzQ3ODdhY2NjZTgwNTcwMzUyZTU1L3RhYmxlcmFuZ2U6ZmFhOTFhYmY2N2RjNDc4N2FjY2NlODA1NzAzNTJlNTVfMi01LTEtMS0w_7103a0a9-eeb5-4179-8300-4a1cf29e3ce1"
      unitRef="usd">1365000000</us-gaap:ProfitLoss>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85NC9mcmFnOmEwNGZkMjE3YTk3YjQ1Nzg5OWYyZTRlY2M2OGVmOTEwL3RhYmxlOmZhYTkxYWJmNjdkYzQ3ODdhY2NjZTgwNTcwMzUyZTU1L3RhYmxlcmFuZ2U6ZmFhOTFhYmY2N2RjNDc4N2FjY2NlODA1NzAzNTJlNTVfNC0xLTEtMS0w_4daefabe-c566-448e-9b88-063784ee1c3a"
      unitRef="usd">783000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="ia31e9a409b874bb19d0ff6f2f39ecc09_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85NC9mcmFnOmEwNGZkMjE3YTk3YjQ1Nzg5OWYyZTRlY2M2OGVmOTEwL3RhYmxlOmZhYTkxYWJmNjdkYzQ3ODdhY2NjZTgwNTcwMzUyZTU1L3RhYmxlcmFuZ2U6ZmFhOTFhYmY2N2RjNDc4N2FjY2NlODA1NzAzNTJlNTVfNC0zLTEtMS0w_4d371759-0011-4a12-b10e-a158e500b5a0"
      unitRef="usd">913000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i00a6d666bf604826b24e68ddbd63eac4_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85NC9mcmFnOmEwNGZkMjE3YTk3YjQ1Nzg5OWYyZTRlY2M2OGVmOTEwL3RhYmxlOmZhYTkxYWJmNjdkYzQ3ODdhY2NjZTgwNTcwMzUyZTU1L3RhYmxlcmFuZ2U6ZmFhOTFhYmY2N2RjNDc4N2FjY2NlODA1NzAzNTJlNTVfNC01LTEtMS0w_379af5ad-a6f8-407d-b15a-327e4593b3f5"
      unitRef="usd">1000000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:GainLossOnSaleOfOtherInvestments
      contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85NC9mcmFnOmEwNGZkMjE3YTk3YjQ1Nzg5OWYyZTRlY2M2OGVmOTEwL3RhYmxlOmZhYTkxYWJmNjdkYzQ3ODdhY2NjZTgwNTcwMzUyZTU1L3RhYmxlcmFuZ2U6ZmFhOTFhYmY2N2RjNDc4N2FjY2NlODA1NzAzNTJlNTVfNS0xLTEtMS0w_7f705a6f-ec88-486d-ab02-11f72d641520"
      unitRef="usd">0</us-gaap:GainLossOnSaleOfOtherInvestments>
    <us-gaap:GainLossOnSaleOfOtherInvestments
      contextRef="ia31e9a409b874bb19d0ff6f2f39ecc09_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85NC9mcmFnOmEwNGZkMjE3YTk3YjQ1Nzg5OWYyZTRlY2M2OGVmOTEwL3RhYmxlOmZhYTkxYWJmNjdkYzQ3ODdhY2NjZTgwNTcwMzUyZTU1L3RhYmxlcmFuZ2U6ZmFhOTFhYmY2N2RjNDc4N2FjY2NlODA1NzAzNTJlNTVfNS0zLTEtMS0w_f9151eba-c19b-4270-8224-2446d0e1bd83"
      unitRef="usd">0</us-gaap:GainLossOnSaleOfOtherInvestments>
    <us-gaap:GainLossOnSaleOfOtherInvestments
      contextRef="i00a6d666bf604826b24e68ddbd63eac4_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85NC9mcmFnOmEwNGZkMjE3YTk3YjQ1Nzg5OWYyZTRlY2M2OGVmOTEwL3RhYmxlOmZhYTkxYWJmNjdkYzQ3ODdhY2NjZTgwNTcwMzUyZTU1L3RhYmxlcmFuZ2U6ZmFhOTFhYmY2N2RjNDc4N2FjY2NlODA1NzAzNTJlNTVfNS01LTEtMS0w_565bcac0-a07d-4845-93ee-03d1e8da039a"
      unitRef="usd">-3000000</us-gaap:GainLossOnSaleOfOtherInvestments>
    <us-gaap:GainLossOnSaleOfInvestments
      contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85NC9mcmFnOmEwNGZkMjE3YTk3YjQ1Nzg5OWYyZTRlY2M2OGVmOTEwL3RhYmxlOmZhYTkxYWJmNjdkYzQ3ODdhY2NjZTgwNTcwMzUyZTU1L3RhYmxlcmFuZ2U6ZmFhOTFhYmY2N2RjNDc4N2FjY2NlODA1NzAzNTJlNTVfNi0xLTEtMS0w_a3915a2f-51ca-4aea-91f5-1e0a6e12b0a1"
      unitRef="usd">-2000000</us-gaap:GainLossOnSaleOfInvestments>
    <us-gaap:GainLossOnSaleOfInvestments
      contextRef="ia31e9a409b874bb19d0ff6f2f39ecc09_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85NC9mcmFnOmEwNGZkMjE3YTk3YjQ1Nzg5OWYyZTRlY2M2OGVmOTEwL3RhYmxlOmZhYTkxYWJmNjdkYzQ3ODdhY2NjZTgwNTcwMzUyZTU1L3RhYmxlcmFuZ2U6ZmFhOTFhYmY2N2RjNDc4N2FjY2NlODA1NzAzNTJlNTVfNi0zLTEtMS0w_0176b869-45bb-4398-b77a-29ad39b5ca46"
      unitRef="usd">579000000</us-gaap:GainLossOnSaleOfInvestments>
    <us-gaap:GainLossOnSaleOfInvestments
      contextRef="i00a6d666bf604826b24e68ddbd63eac4_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85NC9mcmFnOmEwNGZkMjE3YTk3YjQ1Nzg5OWYyZTRlY2M2OGVmOTEwL3RhYmxlOmZhYTkxYWJmNjdkYzQ3ODdhY2NjZTgwNTcwMzUyZTU1L3RhYmxlcmFuZ2U6ZmFhOTFhYmY2N2RjNDc4N2FjY2NlODA1NzAzNTJlNTVfNi01LTEtMS0w_caff3d65-5c9b-428d-b097-1fc4274f43bf"
      unitRef="usd">0</us-gaap:GainLossOnSaleOfInvestments>
    <us-gaap:GainLossOnSalesOfAssetsAndAssetImpairmentCharges
      contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85NC9mcmFnOmEwNGZkMjE3YTk3YjQ1Nzg5OWYyZTRlY2M2OGVmOTEwL3RhYmxlOmZhYTkxYWJmNjdkYzQ3ODdhY2NjZTgwNTcwMzUyZTU1L3RhYmxlcmFuZ2U6ZmFhOTFhYmY2N2RjNDc4N2FjY2NlODA1NzAzNTJlNTVfNy0xLTEtMS0w_bb25287d-b639-43b5-9667-28cc9e17d17a"
      unitRef="usd">-79000000</us-gaap:GainLossOnSalesOfAssetsAndAssetImpairmentCharges>
    <us-gaap:GainLossOnSalesOfAssetsAndAssetImpairmentCharges
      contextRef="ia31e9a409b874bb19d0ff6f2f39ecc09_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85NC9mcmFnOmEwNGZkMjE3YTk3YjQ1Nzg5OWYyZTRlY2M2OGVmOTEwL3RhYmxlOmZhYTkxYWJmNjdkYzQ3ODdhY2NjZTgwNTcwMzUyZTU1L3RhYmxlcmFuZ2U6ZmFhOTFhYmY2N2RjNDc4N2FjY2NlODA1NzAzNTJlNTVfNy0zLTEtMS0w_fa8de549-def5-4193-a9aa-aa2342b81b91"
      unitRef="usd">-7000000</us-gaap:GainLossOnSalesOfAssetsAndAssetImpairmentCharges>
    <us-gaap:GainLossOnSalesOfAssetsAndAssetImpairmentCharges
      contextRef="i00a6d666bf604826b24e68ddbd63eac4_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85NC9mcmFnOmEwNGZkMjE3YTk3YjQ1Nzg5OWYyZTRlY2M2OGVmOTEwL3RhYmxlOmZhYTkxYWJmNjdkYzQ3ODdhY2NjZTgwNTcwMzUyZTU1L3RhYmxlcmFuZ2U6ZmFhOTFhYmY2N2RjNDc4N2FjY2NlODA1NzAzNTJlNTVfNy01LTEtMS0w_2795b340-af62-42d3-9f83-536eede14457"
      unitRef="usd">488000000</us-gaap:GainLossOnSalesOfAssetsAndAssetImpairmentCharges>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85NC9mcmFnOmEwNGZkMjE3YTk3YjQ1Nzg5OWYyZTRlY2M2OGVmOTEwL3RhYmxlOmZhYTkxYWJmNjdkYzQ3ODdhY2NjZTgwNTcwMzUyZTU1L3RhYmxlcmFuZ2U6ZmFhOTFhYmY2N2RjNDc4N2FjY2NlODA1NzAzNTJlNTVfOC0xLTEtMS0w_310eb12b-e65f-4a71-98f4-11f0721f5eba"
      unitRef="usd">-14000000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="ia31e9a409b874bb19d0ff6f2f39ecc09_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85NC9mcmFnOmEwNGZkMjE3YTk3YjQ1Nzg5OWYyZTRlY2M2OGVmOTEwL3RhYmxlOmZhYTkxYWJmNjdkYzQ3ODdhY2NjZTgwNTcwMzUyZTU1L3RhYmxlcmFuZ2U6ZmFhOTFhYmY2N2RjNDc4N2FjY2NlODA1NzAzNTJlNTVfOC0zLTEtMS0w_3c9055eb-0a46-46d4-a6f7-6000bca17d6c"
      unitRef="usd">-16000000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="i00a6d666bf604826b24e68ddbd63eac4_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85NC9mcmFnOmEwNGZkMjE3YTk3YjQ1Nzg5OWYyZTRlY2M2OGVmOTEwL3RhYmxlOmZhYTkxYWJmNjdkYzQ3ODdhY2NjZTgwNTcwMzUyZTU1L3RhYmxlcmFuZ2U6ZmFhOTFhYmY2N2RjNDc4N2FjY2NlODA1NzAzNTJlNTVfOC01LTEtMS0w_df615853-a87c-48f6-8d6d-d895229c820a"
      unitRef="usd">0</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:ShareBasedCompensation
      contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85NC9mcmFnOmEwNGZkMjE3YTk3YjQ1Nzg5OWYyZTRlY2M2OGVmOTEwL3RhYmxlOmZhYTkxYWJmNjdkYzQ3ODdhY2NjZTgwNTcwMzUyZTU1L3RhYmxlcmFuZ2U6ZmFhOTFhYmY2N2RjNDc4N2FjY2NlODA1NzAzNTJlNTVfOS0xLTEtMS0w_ef443f9a-aa62-4ccb-86fd-97a46e9d2e55"
      unitRef="usd">89000000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="ia31e9a409b874bb19d0ff6f2f39ecc09_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85NC9mcmFnOmEwNGZkMjE3YTk3YjQ1Nzg5OWYyZTRlY2M2OGVmOTEwL3RhYmxlOmZhYTkxYWJmNjdkYzQ3ODdhY2NjZTgwNTcwMzUyZTU1L3RhYmxlcmFuZ2U6ZmFhOTFhYmY2N2RjNDc4N2FjY2NlODA1NzAzNTJlNTVfOS0zLTEtMS0w_fefb9a4c-463d-40c2-8595-fa28946bb677"
      unitRef="usd">90000000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="i00a6d666bf604826b24e68ddbd63eac4_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85NC9mcmFnOmEwNGZkMjE3YTk3YjQ1Nzg5OWYyZTRlY2M2OGVmOTEwL3RhYmxlOmZhYTkxYWJmNjdkYzQ3ODdhY2NjZTgwNTcwMzUyZTU1L3RhYmxlcmFuZ2U6ZmFhOTFhYmY2N2RjNDc4N2FjY2NlODA1NzAzNTJlNTVfOS01LTEtMS0w_f4959ee9-a95a-45bc-b647-7caa98bd44da"
      unitRef="usd">82000000</us-gaap:ShareBasedCompensation>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85NC9mcmFnOmEwNGZkMjE3YTk3YjQ1Nzg5OWYyZTRlY2M2OGVmOTEwL3RhYmxlOmZhYTkxYWJmNjdkYzQ3ODdhY2NjZTgwNTcwMzUyZTU1L3RhYmxlcmFuZ2U6ZmFhOTFhYmY2N2RjNDc4N2FjY2NlODA1NzAzNTJlNTVfMTAtMS0xLTEtMA_d52c249f-3216-4df3-9eb0-16965098b179"
      unitRef="usd">496000000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="ia31e9a409b874bb19d0ff6f2f39ecc09_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85NC9mcmFnOmEwNGZkMjE3YTk3YjQ1Nzg5OWYyZTRlY2M2OGVmOTEwL3RhYmxlOmZhYTkxYWJmNjdkYzQ3ODdhY2NjZTgwNTcwMzUyZTU1L3RhYmxlcmFuZ2U6ZmFhOTFhYmY2N2RjNDc4N2FjY2NlODA1NzAzNTJlNTVfMTAtMy0xLTEtMA_b06df6f5-1921-4272-af43-a08a44541bf5"
      unitRef="usd">-961000000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="i00a6d666bf604826b24e68ddbd63eac4_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85NC9mcmFnOmEwNGZkMjE3YTk3YjQ1Nzg5OWYyZTRlY2M2OGVmOTEwL3RhYmxlOmZhYTkxYWJmNjdkYzQ3ODdhY2NjZTgwNTcwMzUyZTU1L3RhYmxlcmFuZ2U6ZmFhOTFhYmY2N2RjNDc4N2FjY2NlODA1NzAzNTJlNTVfMTAtNS0xLTEtMA_ce8ae665-4296-4ab7-9398-84dc0348cfca"
      unitRef="usd">-83000000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:ProvisionForDoubtfulAccounts
      contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85NC9mcmFnOmEwNGZkMjE3YTk3YjQ1Nzg5OWYyZTRlY2M2OGVmOTEwL3RhYmxlOmZhYTkxYWJmNjdkYzQ3ODdhY2NjZTgwNTcwMzUyZTU1L3RhYmxlcmFuZ2U6ZmFhOTFhYmY2N2RjNDc4N2FjY2NlODA1NzAzNTJlNTVfMTEtMS0xLTEtMA_9bd74add-85a6-4fab-8a0b-25fa6c9901fb"
      unitRef="usd">65000000</us-gaap:ProvisionForDoubtfulAccounts>
    <us-gaap:ProvisionForDoubtfulAccounts
      contextRef="ia31e9a409b874bb19d0ff6f2f39ecc09_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85NC9mcmFnOmEwNGZkMjE3YTk3YjQ1Nzg5OWYyZTRlY2M2OGVmOTEwL3RhYmxlOmZhYTkxYWJmNjdkYzQ3ODdhY2NjZTgwNTcwMzUyZTU1L3RhYmxlcmFuZ2U6ZmFhOTFhYmY2N2RjNDc4N2FjY2NlODA1NzAzNTJlNTVfMTEtMy0xLTEtMA_d4bd3fb1-9ff5-40f5-90bb-3c67d63f2a16"
      unitRef="usd">106000000</us-gaap:ProvisionForDoubtfulAccounts>
    <us-gaap:ProvisionForDoubtfulAccounts
      contextRef="i00a6d666bf604826b24e68ddbd63eac4_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85NC9mcmFnOmEwNGZkMjE3YTk3YjQ1Nzg5OWYyZTRlY2M2OGVmOTEwL3RhYmxlOmZhYTkxYWJmNjdkYzQ3ODdhY2NjZTgwNTcwMzUyZTU1L3RhYmxlcmFuZ2U6ZmFhOTFhYmY2N2RjNDc4N2FjY2NlODA1NzAzNTJlNTVfMTEtNS0xLTEtMA_2887b5f5-a7eb-43b6-8309-8b21c43fd064"
      unitRef="usd">88000000</us-gaap:ProvisionForDoubtfulAccounts>
    <us-gaap:IncreaseDecreaseInReceivables
      contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85NC9mcmFnOmEwNGZkMjE3YTk3YjQ1Nzg5OWYyZTRlY2M2OGVmOTEwL3RhYmxlOmZhYTkxYWJmNjdkYzQ3ODdhY2NjZTgwNTcwMzUyZTU1L3RhYmxlcmFuZ2U6ZmFhOTFhYmY2N2RjNDc4N2FjY2NlODA1NzAzNTJlNTVfMTQtMS0xLTEtMA_6ce1aa4c-e82e-45d4-91b7-efd3dea6ac4c"
      unitRef="usd">904000000</us-gaap:IncreaseDecreaseInReceivables>
    <us-gaap:IncreaseDecreaseInReceivables
      contextRef="ia31e9a409b874bb19d0ff6f2f39ecc09_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85NC9mcmFnOmEwNGZkMjE3YTk3YjQ1Nzg5OWYyZTRlY2M2OGVmOTEwL3RhYmxlOmZhYTkxYWJmNjdkYzQ3ODdhY2NjZTgwNTcwMzUyZTU1L3RhYmxlcmFuZ2U6ZmFhOTFhYmY2N2RjNDc4N2FjY2NlODA1NzAzNTJlNTVfMTQtMy0xLTEtMA_c13bfafd-5253-4608-9d90-c30882d89efe"
      unitRef="usd">-82000000</us-gaap:IncreaseDecreaseInReceivables>
    <us-gaap:IncreaseDecreaseInReceivables
      contextRef="i00a6d666bf604826b24e68ddbd63eac4_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85NC9mcmFnOmEwNGZkMjE3YTk3YjQ1Nzg5OWYyZTRlY2M2OGVmOTEwL3RhYmxlOmZhYTkxYWJmNjdkYzQ3ODdhY2NjZTgwNTcwMzUyZTU1L3RhYmxlcmFuZ2U6ZmFhOTFhYmY2N2RjNDc4N2FjY2NlODA1NzAzNTJlNTVfMTQtNS0xLTEtMA_846abce2-2498-4752-9ed6-2a0a74ba1e51"
      unitRef="usd">751000000</us-gaap:IncreaseDecreaseInReceivables>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85NC9mcmFnOmEwNGZkMjE3YTk3YjQ1Nzg5OWYyZTRlY2M2OGVmOTEwL3RhYmxlOmZhYTkxYWJmNjdkYzQ3ODdhY2NjZTgwNTcwMzUyZTU1L3RhYmxlcmFuZ2U6ZmFhOTFhYmY2N2RjNDc4N2FjY2NlODA1NzAzNTJlNTVfMTUtMS0xLTEtMA_0e42c056-cfd1-4d5c-802a-e4b59546e054"
      unitRef="usd">1584000000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="ia31e9a409b874bb19d0ff6f2f39ecc09_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85NC9mcmFnOmEwNGZkMjE3YTk3YjQ1Nzg5OWYyZTRlY2M2OGVmOTEwL3RhYmxlOmZhYTkxYWJmNjdkYzQ3ODdhY2NjZTgwNTcwMzUyZTU1L3RhYmxlcmFuZ2U6ZmFhOTFhYmY2N2RjNDc4N2FjY2NlODA1NzAzNTJlNTVfMTUtMy0xLTEtMA_d6de9587-8323-456e-b80a-27dc1d9f7a9f"
      unitRef="usd">409000000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="i00a6d666bf604826b24e68ddbd63eac4_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85NC9mcmFnOmEwNGZkMjE3YTk3YjQ1Nzg5OWYyZTRlY2M2OGVmOTEwL3RhYmxlOmZhYTkxYWJmNjdkYzQ3ODdhY2NjZTgwNTcwMzUyZTU1L3RhYmxlcmFuZ2U6ZmFhOTFhYmY2N2RjNDc4N2FjY2NlODA1NzAzNTJlNTVfMTUtNS0xLTEtMA_0e0b948f-a349-492d-9cc4-df6931eb0c6f"
      unitRef="usd">551000000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85NC9mcmFnOmEwNGZkMjE3YTk3YjQ1Nzg5OWYyZTRlY2M2OGVmOTEwL3RhYmxlOmZhYTkxYWJmNjdkYzQ3ODdhY2NjZTgwNTcwMzUyZTU1L3RhYmxlcmFuZ2U6ZmFhOTFhYmY2N2RjNDc4N2FjY2NlODA1NzAzNTJlNTVfMTYtMS0xLTEtMA_9f40155b-030a-40b2-809a-79f78c5572f3"
      unitRef="usd">2325000000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="ia31e9a409b874bb19d0ff6f2f39ecc09_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85NC9mcmFnOmEwNGZkMjE3YTk3YjQ1Nzg5OWYyZTRlY2M2OGVmOTEwL3RhYmxlOmZhYTkxYWJmNjdkYzQ3ODdhY2NjZTgwNTcwMzUyZTU1L3RhYmxlcmFuZ2U6ZmFhOTFhYmY2N2RjNDc4N2FjY2NlODA1NzAzNTJlNTVfMTYtMy0xLTEtMA_bc665474-09c8-4350-8780-798f1ac8f30f"
      unitRef="usd">-162000000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="i00a6d666bf604826b24e68ddbd63eac4_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85NC9mcmFnOmEwNGZkMjE3YTk3YjQ1Nzg5OWYyZTRlY2M2OGVmOTEwL3RhYmxlOmZhYTkxYWJmNjdkYzQ3ODdhY2NjZTgwNTcwMzUyZTU1L3RhYmxlcmFuZ2U6ZmFhOTFhYmY2N2RjNDc4N2FjY2NlODA1NzAzNTJlNTVfMTYtNS0xLTEtMA_d7301f7f-3e96-4600-ada4-6e8bda350ee4"
      unitRef="usd">1864000000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet
      contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85NC9mcmFnOmEwNGZkMjE3YTk3YjQ1Nzg5OWYyZTRlY2M2OGVmOTEwL3RhYmxlOmZhYTkxYWJmNjdkYzQ3ODdhY2NjZTgwNTcwMzUyZTU1L3RhYmxlcmFuZ2U6ZmFhOTFhYmY2N2RjNDc4N2FjY2NlODA1NzAzNTJlNTVfMTctMS0xLTEtMA_0c5365b9-9cdc-43ca-8316-443761d5a6b5"
      unitRef="usd">-452000000</us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet>
    <us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet
      contextRef="ia31e9a409b874bb19d0ff6f2f39ecc09_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85NC9mcmFnOmEwNGZkMjE3YTk3YjQ1Nzg5OWYyZTRlY2M2OGVmOTEwL3RhYmxlOmZhYTkxYWJmNjdkYzQ3ODdhY2NjZTgwNTcwMzUyZTU1L3RhYmxlcmFuZ2U6ZmFhOTFhYmY2N2RjNDc4N2FjY2NlODA1NzAzNTJlNTVfMTctMy0xLTEtMA_31619a24-02d5-4ffa-96d9-82cc4de9ac2f"
      unitRef="usd">-6550000000</us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet>
    <us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet
      contextRef="i00a6d666bf604826b24e68ddbd63eac4_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85NC9mcmFnOmEwNGZkMjE3YTk3YjQ1Nzg5OWYyZTRlY2M2OGVmOTEwL3RhYmxlOmZhYTkxYWJmNjdkYzQ3ODdhY2NjZTgwNTcwMzUyZTU1L3RhYmxlcmFuZ2U6ZmFhOTFhYmY2N2RjNDc4N2FjY2NlODA1NzAzNTJlNTVfMTctNS0xLTEtMA_d9a73033-6c2c-4e8c-bd49-f3f4c4ce2cdf"
      unitRef="usd">-193000000</us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85NC9mcmFnOmEwNGZkMjE3YTk3YjQ1Nzg5OWYyZTRlY2M2OGVmOTEwL3RhYmxlOmZhYTkxYWJmNjdkYzQ3ODdhY2NjZTgwNTcwMzUyZTU1L3RhYmxlcmFuZ2U6ZmFhOTFhYmY2N2RjNDc4N2FjY2NlODA1NzAzNTJlNTVfMTgtMS0xLTEtMA_172cb3ea-bd0d-421c-9b21-7f1104a56c4f"
      unitRef="usd">2429000000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="ia31e9a409b874bb19d0ff6f2f39ecc09_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85NC9mcmFnOmEwNGZkMjE3YTk3YjQ1Nzg5OWYyZTRlY2M2OGVmOTEwL3RhYmxlOmZhYTkxYWJmNjdkYzQ3ODdhY2NjZTgwNTcwMzUyZTU1L3RhYmxlcmFuZ2U6ZmFhOTFhYmY2N2RjNDc4N2FjY2NlODA1NzAzNTJlNTVfMTgtMy0xLTEtMA_781fce66-7311-40f9-af61-d7fd8129b569"
      unitRef="usd">1960000000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i00a6d666bf604826b24e68ddbd63eac4_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85NC9mcmFnOmEwNGZkMjE3YTk3YjQ1Nzg5OWYyZTRlY2M2OGVmOTEwL3RhYmxlOmZhYTkxYWJmNjdkYzQ3ODdhY2NjZTgwNTcwMzUyZTU1L3RhYmxlcmFuZ2U6ZmFhOTFhYmY2N2RjNDc4N2FjY2NlODA1NzAzNTJlNTVfMTgtNS0xLTEtMA_e8dd1cc0-6009-4678-aded-6c12c805f7d5"
      unitRef="usd">2722000000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85NC9mcmFnOmEwNGZkMjE3YTk3YjQ1Nzg5OWYyZTRlY2M2OGVmOTEwL3RhYmxlOmZhYTkxYWJmNjdkYzQ3ODdhY2NjZTgwNTcwMzUyZTU1L3RhYmxlcmFuZ2U6ZmFhOTFhYmY2N2RjNDc4N2FjY2NlODA1NzAzNTJlNTVfMjAtMS0xLTEtMA_1c95364d-877a-4822-8479-aadbdfab13cf"
      unitRef="usd">3000000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="ia31e9a409b874bb19d0ff6f2f39ecc09_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85NC9mcmFnOmEwNGZkMjE3YTk3YjQ1Nzg5OWYyZTRlY2M2OGVmOTEwL3RhYmxlOmZhYTkxYWJmNjdkYzQ3ODdhY2NjZTgwNTcwMzUyZTU1L3RhYmxlcmFuZ2U6ZmFhOTFhYmY2N2RjNDc4N2FjY2NlODA1NzAzNTJlNTVfMjAtMy0xLTEtMA_c433a62c-6ddb-420f-a5d8-254a3642a155"
      unitRef="usd">0</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="i00a6d666bf604826b24e68ddbd63eac4_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85NC9mcmFnOmEwNGZkMjE3YTk3YjQ1Nzg5OWYyZTRlY2M2OGVmOTEwL3RhYmxlOmZhYTkxYWJmNjdkYzQ3ODdhY2NjZTgwNTcwMzUyZTU1L3RhYmxlcmFuZ2U6ZmFhOTFhYmY2N2RjNDc4N2FjY2NlODA1NzAzNTJlNTVfMjAtNS0xLTEtMA_621fd1d6-9c91-42f0-a49d-c644c4c580af"
      unitRef="usd">82000000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85NC9mcmFnOmEwNGZkMjE3YTk3YjQ1Nzg5OWYyZTRlY2M2OGVmOTEwL3RhYmxlOmZhYTkxYWJmNjdkYzQ3ODdhY2NjZTgwNTcwMzUyZTU1L3RhYmxlcmFuZ2U6ZmFhOTFhYmY2N2RjNDc4N2FjY2NlODA1NzAzNTJlNTVfMjEtMS0xLTEtMA_e5a29e3f-402c-4e2d-a903-72eea3001e01"
      unitRef="usd">400000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="ia31e9a409b874bb19d0ff6f2f39ecc09_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85NC9mcmFnOmEwNGZkMjE3YTk3YjQ1Nzg5OWYyZTRlY2M2OGVmOTEwL3RhYmxlOmZhYTkxYWJmNjdkYzQ3ODdhY2NjZTgwNTcwMzUyZTU1L3RhYmxlcmFuZ2U6ZmFhOTFhYmY2N2RjNDc4N2FjY2NlODA1NzAzNTJlNTVfMjEtMy0xLTEtMA_76cfaecb-4761-42f5-9d8b-ee93abd96ed0"
      unitRef="usd">375000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i00a6d666bf604826b24e68ddbd63eac4_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85NC9mcmFnOmEwNGZkMjE3YTk3YjQ1Nzg5OWYyZTRlY2M2OGVmOTEwL3RhYmxlOmZhYTkxYWJmNjdkYzQ3ODdhY2NjZTgwNTcwMzUyZTU1L3RhYmxlcmFuZ2U6ZmFhOTFhYmY2N2RjNDc4N2FjY2NlODA1NzAzNTJlNTVfMjEtNS0xLTEtMA_7e28e0d6-0dab-447c-ac11-241a8795f0d4"
      unitRef="usd">328000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <cah:Purchaseofavailableforsalesecuritiesandotherinvestments
      contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85NC9mcmFnOmEwNGZkMjE3YTk3YjQ1Nzg5OWYyZTRlY2M2OGVmOTEwL3RhYmxlOmZhYTkxYWJmNjdkYzQ3ODdhY2NjZTgwNTcwMzUyZTU1L3RhYmxlcmFuZ2U6ZmFhOTFhYmY2N2RjNDc4N2FjY2NlODA1NzAzNTJlNTVfMjItMS0xLTEtMA_1b20973a-17b4-472f-8f9d-cf492a37545f"
      unitRef="usd">22000000</cah:Purchaseofavailableforsalesecuritiesandotherinvestments>
    <cah:Purchaseofavailableforsalesecuritiesandotherinvestments
      contextRef="ia31e9a409b874bb19d0ff6f2f39ecc09_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85NC9mcmFnOmEwNGZkMjE3YTk3YjQ1Nzg5OWYyZTRlY2M2OGVmOTEwL3RhYmxlOmZhYTkxYWJmNjdkYzQ3ODdhY2NjZTgwNTcwMzUyZTU1L3RhYmxlcmFuZ2U6ZmFhOTFhYmY2N2RjNDc4N2FjY2NlODA1NzAzNTJlNTVfMjItMy0xLTEtMA_5745eb35-ee50-4a98-86e1-f9dc45ab8cfd"
      unitRef="usd">20000000</cah:Purchaseofavailableforsalesecuritiesandotherinvestments>
    <cah:Purchaseofavailableforsalesecuritiesandotherinvestments
      contextRef="i00a6d666bf604826b24e68ddbd63eac4_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85NC9mcmFnOmEwNGZkMjE3YTk3YjQ1Nzg5OWYyZTRlY2M2OGVmOTEwL3RhYmxlOmZhYTkxYWJmNjdkYzQ3ODdhY2NjZTgwNTcwMzUyZTU1L3RhYmxlcmFuZ2U6ZmFhOTFhYmY2N2RjNDc4N2FjY2NlODA1NzAzNTJlNTVfMjItNS0xLTEtMA_a9812dbe-783f-40fa-be00-31ce00d06be3"
      unitRef="usd">18000000</cah:Purchaseofavailableforsalesecuritiesandotherinvestments>
    <cah:Proceedsfromsaleofavailableforsalesecuritiesandotherinvestments
      contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85NC9mcmFnOmEwNGZkMjE3YTk3YjQ1Nzg5OWYyZTRlY2M2OGVmOTEwL3RhYmxlOmZhYTkxYWJmNjdkYzQ3ODdhY2NjZTgwNTcwMzUyZTU1L3RhYmxlcmFuZ2U6ZmFhOTFhYmY2N2RjNDc4N2FjY2NlODA1NzAzNTJlNTVfMjMtMS0xLTEtMA_1875e5c8-5f70-4d5f-9f36-d048e8bdaa44"
      unitRef="usd">47000000</cah:Proceedsfromsaleofavailableforsalesecuritiesandotherinvestments>
    <cah:Proceedsfromsaleofavailableforsalesecuritiesandotherinvestments
      contextRef="ia31e9a409b874bb19d0ff6f2f39ecc09_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85NC9mcmFnOmEwNGZkMjE3YTk3YjQ1Nzg5OWYyZTRlY2M2OGVmOTEwL3RhYmxlOmZhYTkxYWJmNjdkYzQ3ODdhY2NjZTgwNTcwMzUyZTU1L3RhYmxlcmFuZ2U6ZmFhOTFhYmY2N2RjNDc4N2FjY2NlODA1NzAzNTJlNTVfMjMtMy0xLTEtMA_f80f7859-1cc1-41a5-be8d-9bfdce827fbc"
      unitRef="usd">886000000</cah:Proceedsfromsaleofavailableforsalesecuritiesandotherinvestments>
    <cah:Proceedsfromsaleofavailableforsalesecuritiesandotherinvestments
      contextRef="i00a6d666bf604826b24e68ddbd63eac4_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85NC9mcmFnOmEwNGZkMjE3YTk3YjQ1Nzg5OWYyZTRlY2M2OGVmOTEwL3RhYmxlOmZhYTkxYWJmNjdkYzQ3ODdhY2NjZTgwNTcwMzUyZTU1L3RhYmxlcmFuZ2U6ZmFhOTFhYmY2N2RjNDc4N2FjY2NlODA1NzAzNTJlNTVfMjMtNS0xLTEtMA_0f9efa2a-a1a4-47d5-863c-d61aec8411d8"
      unitRef="usd">3000000</cah:Proceedsfromsaleofavailableforsalesecuritiesandotherinvestments>
    <cah:Proceedsfromdivestituresanddisposalofpropertyandequipmentandheldforsaleassets
      contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85NC9mcmFnOmEwNGZkMjE3YTk3YjQ1Nzg5OWYyZTRlY2M2OGVmOTEwL3RhYmxlOmZhYTkxYWJmNjdkYzQ3ODdhY2NjZTgwNTcwMzUyZTU1L3RhYmxlcmFuZ2U6ZmFhOTFhYmY2N2RjNDc4N2FjY2NlODA1NzAzNTJlNTVfMjYtMS0xLTEtMA_7d2663e3-479c-42df-892e-df65ef7284ca"
      unitRef="usd">0</cah:Proceedsfromdivestituresanddisposalofpropertyandequipmentandheldforsaleassets>
    <cah:Proceedsfromdivestituresanddisposalofpropertyandequipmentandheldforsaleassets
      contextRef="ia31e9a409b874bb19d0ff6f2f39ecc09_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85NC9mcmFnOmEwNGZkMjE3YTk3YjQ1Nzg5OWYyZTRlY2M2OGVmOTEwL3RhYmxlOmZhYTkxYWJmNjdkYzQ3ODdhY2NjZTgwNTcwMzUyZTU1L3RhYmxlcmFuZ2U6ZmFhOTFhYmY2N2RjNDc4N2FjY2NlODA1NzAzNTJlNTVfMjYtMy0xLTEtMA_0fa5ecee-126a-42e7-8f1c-de5c19e8255d"
      unitRef="usd">2000000</cah:Proceedsfromdivestituresanddisposalofpropertyandequipmentandheldforsaleassets>
    <cah:Proceedsfromdivestituresanddisposalofpropertyandequipmentandheldforsaleassets
      contextRef="i00a6d666bf604826b24e68ddbd63eac4_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85NC9mcmFnOmEwNGZkMjE3YTk3YjQ1Nzg5OWYyZTRlY2M2OGVmOTEwL3RhYmxlOmZhYTkxYWJmNjdkYzQ3ODdhY2NjZTgwNTcwMzUyZTU1L3RhYmxlcmFuZ2U6ZmFhOTFhYmY2N2RjNDc4N2FjY2NlODA1NzAzNTJlNTVfMjYtNS0xLTEtMA_02a3ee8b-db5d-42d2-9218-1d8180dce903"
      unitRef="usd">763000000</cah:Proceedsfromdivestituresanddisposalofpropertyandequipmentandheldforsaleassets>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85NC9mcmFnOmEwNGZkMjE3YTk3YjQ1Nzg5OWYyZTRlY2M2OGVmOTEwL3RhYmxlOmZhYTkxYWJmNjdkYzQ3ODdhY2NjZTgwNTcwMzUyZTU1L3RhYmxlcmFuZ2U6ZmFhOTFhYmY2N2RjNDc4N2FjY2NlODA1NzAzNTJlNTVfMjctMS0xLTEtMA_2a5913f1-ecac-44c9-992c-b9e6f65bfaf0"
      unitRef="usd">-378000000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="ia31e9a409b874bb19d0ff6f2f39ecc09_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85NC9mcmFnOmEwNGZkMjE3YTk3YjQ1Nzg5OWYyZTRlY2M2OGVmOTEwL3RhYmxlOmZhYTkxYWJmNjdkYzQ3ODdhY2NjZTgwNTcwMzUyZTU1L3RhYmxlcmFuZ2U6ZmFhOTFhYmY2N2RjNDc4N2FjY2NlODA1NzAzNTJlNTVfMjctMy0xLTEtMA_c21a4e97-7011-4da0-8fae-ee98b6d829b5"
      unitRef="usd">493000000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="i00a6d666bf604826b24e68ddbd63eac4_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85NC9mcmFnOmEwNGZkMjE3YTk3YjQ1Nzg5OWYyZTRlY2M2OGVmOTEwL3RhYmxlOmZhYTkxYWJmNjdkYzQ3ODdhY2NjZTgwNTcwMzUyZTU1L3RhYmxlcmFuZ2U6ZmFhOTFhYmY2N2RjNDc4N2FjY2NlODA1NzAzNTJlNTVfMjctNS0xLTEtMA_ed38cda2-0c4b-4638-b140-3efff154f04e"
      unitRef="usd">338000000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:ProceedsFromRepaymentsOfShortTermDebt
      contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85NC9mcmFnOmEwNGZkMjE3YTk3YjQ1Nzg5OWYyZTRlY2M2OGVmOTEwL3RhYmxlOmZhYTkxYWJmNjdkYzQ3ODdhY2NjZTgwNTcwMzUyZTU1L3RhYmxlcmFuZ2U6ZmFhOTFhYmY2N2RjNDc4N2FjY2NlODA1NzAzNTJlNTVfMzAtMS0xLTEtMA_f6f13849-38cf-4937-a780-3118510cb7e1"
      unitRef="usd">0</us-gaap:ProceedsFromRepaymentsOfShortTermDebt>
    <us-gaap:ProceedsFromRepaymentsOfShortTermDebt
      contextRef="ia31e9a409b874bb19d0ff6f2f39ecc09_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85NC9mcmFnOmEwNGZkMjE3YTk3YjQ1Nzg5OWYyZTRlY2M2OGVmOTEwL3RhYmxlOmZhYTkxYWJmNjdkYzQ3ODdhY2NjZTgwNTcwMzUyZTU1L3RhYmxlcmFuZ2U6ZmFhOTFhYmY2N2RjNDc4N2FjY2NlODA1NzAzNTJlNTVfMzAtMy0xLTEtMA_4422145c-c986-4f39-921e-2fc1d6a5af3c"
      unitRef="usd">-2000000</us-gaap:ProceedsFromRepaymentsOfShortTermDebt>
    <us-gaap:ProceedsFromRepaymentsOfShortTermDebt
      contextRef="i00a6d666bf604826b24e68ddbd63eac4_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85NC9mcmFnOmEwNGZkMjE3YTk3YjQ1Nzg5OWYyZTRlY2M2OGVmOTEwL3RhYmxlOmZhYTkxYWJmNjdkYzQ3ODdhY2NjZTgwNTcwMzUyZTU1L3RhYmxlcmFuZ2U6ZmFhOTFhYmY2N2RjNDc4N2FjY2NlODA1NzAzNTJlNTVfMzAtNS0xLTEtMA_95ec271d-f890-4aa1-a350-cb128d578ae1"
      unitRef="usd">0</us-gaap:ProceedsFromRepaymentsOfShortTermDebt>
    <us-gaap:PaymentsForProceedsFromHedgeFinancingActivities
      contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85NC9mcmFnOmEwNGZkMjE3YTk3YjQ1Nzg5OWYyZTRlY2M2OGVmOTEwL3RhYmxlOmZhYTkxYWJmNjdkYzQ3ODdhY2NjZTgwNTcwMzUyZTU1L3RhYmxlcmFuZ2U6ZmFhOTFhYmY2N2RjNDc4N2FjY2NlODA1NzAzNTJlNTVfMzItMS0xLTEtMA_d7767386-aa2e-49a8-b5fb-7205be35bed0"
      unitRef="usd">-18000000</us-gaap:PaymentsForProceedsFromHedgeFinancingActivities>
    <us-gaap:PaymentsForProceedsFromHedgeFinancingActivities
      contextRef="ia31e9a409b874bb19d0ff6f2f39ecc09_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85NC9mcmFnOmEwNGZkMjE3YTk3YjQ1Nzg5OWYyZTRlY2M2OGVmOTEwL3RhYmxlOmZhYTkxYWJmNjdkYzQ3ODdhY2NjZTgwNTcwMzUyZTU1L3RhYmxlcmFuZ2U6ZmFhOTFhYmY2N2RjNDc4N2FjY2NlODA1NzAzNTJlNTVfMzItMy0xLTEtMA_c9d72c00-05cd-44ed-9ff2-3bb51f9be728"
      unitRef="usd">-112000000</us-gaap:PaymentsForProceedsFromHedgeFinancingActivities>
    <us-gaap:PaymentsForProceedsFromHedgeFinancingActivities
      contextRef="i00a6d666bf604826b24e68ddbd63eac4_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85NC9mcmFnOmEwNGZkMjE3YTk3YjQ1Nzg5OWYyZTRlY2M2OGVmOTEwL3RhYmxlOmZhYTkxYWJmNjdkYzQ3ODdhY2NjZTgwNTcwMzUyZTU1L3RhYmxlcmFuZ2U6ZmFhOTFhYmY2N2RjNDc4N2FjY2NlODA1NzAzNTJlNTVfMzItNS0xLTEtMA_b977c119-d193-46ed-bd67-c2941954992e"
      unitRef="usd">0</us-gaap:PaymentsForProceedsFromHedgeFinancingActivities>
    <us-gaap:RepaymentsOfLongTermDebt
      contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85NC9mcmFnOmEwNGZkMjE3YTk3YjQ1Nzg5OWYyZTRlY2M2OGVmOTEwL3RhYmxlOmZhYTkxYWJmNjdkYzQ3ODdhY2NjZTgwNTcwMzUyZTU1L3RhYmxlcmFuZ2U6ZmFhOTFhYmY2N2RjNDc4N2FjY2NlODA1NzAzNTJlNTVfMzQtMS0xLTEtMA_39ca85ef-2d67-4c63-b793-d635a8d8878c"
      unitRef="usd">570000000</us-gaap:RepaymentsOfLongTermDebt>
    <us-gaap:RepaymentsOfLongTermDebt
      contextRef="ia31e9a409b874bb19d0ff6f2f39ecc09_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85NC9mcmFnOmEwNGZkMjE3YTk3YjQ1Nzg5OWYyZTRlY2M2OGVmOTEwL3RhYmxlOmZhYTkxYWJmNjdkYzQ3ODdhY2NjZTgwNTcwMzUyZTU1L3RhYmxlcmFuZ2U6ZmFhOTFhYmY2N2RjNDc4N2FjY2NlODA1NzAzNTJlNTVfMzQtMy0xLTEtMA_c8514fc2-1e11-46e8-9a6c-e4c001bdf8ee"
      unitRef="usd">1399000000</us-gaap:RepaymentsOfLongTermDebt>
    <us-gaap:RepaymentsOfLongTermDebt
      contextRef="i00a6d666bf604826b24e68ddbd63eac4_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85NC9mcmFnOmEwNGZkMjE3YTk3YjQ1Nzg5OWYyZTRlY2M2OGVmOTEwL3RhYmxlOmZhYTkxYWJmNjdkYzQ3ODdhY2NjZTgwNTcwMzUyZTU1L3RhYmxlcmFuZ2U6ZmFhOTFhYmY2N2RjNDc4N2FjY2NlODA1NzAzNTJlNTVfMzQtNS0xLTEtMA_f39ea348-48ec-4b48-a7be-91ad00b148a7"
      unitRef="usd">1102000000</us-gaap:RepaymentsOfLongTermDebt>
    <cah:Netproceedstaxwithholdingsfromsharebasedcompensation
      contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85NC9mcmFnOmEwNGZkMjE3YTk3YjQ1Nzg5OWYyZTRlY2M2OGVmOTEwL3RhYmxlOmZhYTkxYWJmNjdkYzQ3ODdhY2NjZTgwNTcwMzUyZTU1L3RhYmxlcmFuZ2U6ZmFhOTFhYmY2N2RjNDc4N2FjY2NlODA1NzAzNTJlNTVfMzUtMS0xLTEtMA_93130f83-777e-4bee-a842-82093233a554"
      unitRef="usd">8000000</cah:Netproceedstaxwithholdingsfromsharebasedcompensation>
    <cah:Netproceedstaxwithholdingsfromsharebasedcompensation
      contextRef="ia31e9a409b874bb19d0ff6f2f39ecc09_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85NC9mcmFnOmEwNGZkMjE3YTk3YjQ1Nzg5OWYyZTRlY2M2OGVmOTEwL3RhYmxlOmZhYTkxYWJmNjdkYzQ3ODdhY2NjZTgwNTcwMzUyZTU1L3RhYmxlcmFuZ2U6ZmFhOTFhYmY2N2RjNDc4N2FjY2NlODA1NzAzNTJlNTVfMzUtMy0xLTEtMA_3ca7dd34-4445-45a7-a4cb-e314919b15ff"
      unitRef="usd">8000000</cah:Netproceedstaxwithholdingsfromsharebasedcompensation>
    <cah:Netproceedstaxwithholdingsfromsharebasedcompensation
      contextRef="i00a6d666bf604826b24e68ddbd63eac4_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85NC9mcmFnOmEwNGZkMjE3YTk3YjQ1Nzg5OWYyZTRlY2M2OGVmOTEwL3RhYmxlOmZhYTkxYWJmNjdkYzQ3ODdhY2NjZTgwNTcwMzUyZTU1L3RhYmxlcmFuZ2U6ZmFhOTFhYmY2N2RjNDc4N2FjY2NlODA1NzAzNTJlNTVfMzUtNS0xLTEtMA_5b395b95-6072-4c27-91d7-903cc13ad860"
      unitRef="usd">-14000000</cah:Netproceedstaxwithholdingsfromsharebasedcompensation>
    <us-gaap:PaymentsOfDividendsCommonStock
      contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85NC9mcmFnOmEwNGZkMjE3YTk3YjQ1Nzg5OWYyZTRlY2M2OGVmOTEwL3RhYmxlOmZhYTkxYWJmNjdkYzQ3ODdhY2NjZTgwNTcwMzUyZTU1L3RhYmxlcmFuZ2U6ZmFhOTFhYmY2N2RjNDc4N2FjY2NlODA1NzAzNTJlNTVfMzctMS0xLTEtMA_94474177-f50f-4147-94e2-e96163021a11"
      unitRef="usd">573000000</us-gaap:PaymentsOfDividendsCommonStock>
    <us-gaap:PaymentsOfDividendsCommonStock
      contextRef="ia31e9a409b874bb19d0ff6f2f39ecc09_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85NC9mcmFnOmEwNGZkMjE3YTk3YjQ1Nzg5OWYyZTRlY2M2OGVmOTEwL3RhYmxlOmZhYTkxYWJmNjdkYzQ3ODdhY2NjZTgwNTcwMzUyZTU1L3RhYmxlcmFuZ2U6ZmFhOTFhYmY2N2RjNDc4N2FjY2NlODA1NzAzNTJlNTVfMzctMy0xLTEtMA_145e66ad-5db6-4688-a021-fc12414a3b01"
      unitRef="usd">569000000</us-gaap:PaymentsOfDividendsCommonStock>
    <us-gaap:PaymentsOfDividendsCommonStock
      contextRef="i00a6d666bf604826b24e68ddbd63eac4_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85NC9mcmFnOmEwNGZkMjE3YTk3YjQ1Nzg5OWYyZTRlY2M2OGVmOTEwL3RhYmxlOmZhYTkxYWJmNjdkYzQ3ODdhY2NjZTgwNTcwMzUyZTU1L3RhYmxlcmFuZ2U6ZmFhOTFhYmY2N2RjNDc4N2FjY2NlODA1NzAzNTJlNTVfMzctNS0xLTEtMA_60004693-7b0b-4a36-bcbc-9ba674af0663"
      unitRef="usd">577000000</us-gaap:PaymentsOfDividendsCommonStock>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85NC9mcmFnOmEwNGZkMjE3YTk3YjQ1Nzg5OWYyZTRlY2M2OGVmOTEwL3RhYmxlOmZhYTkxYWJmNjdkYzQ3ODdhY2NjZTgwNTcwMzUyZTU1L3RhYmxlcmFuZ2U6ZmFhOTFhYmY2N2RjNDc4N2FjY2NlODA1NzAzNTJlNTVfMzgtMS0xLTEtMA_5023aba7-ffef-4cb1-a176-20b480df2fb1"
      unitRef="usd">200000000</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="ia31e9a409b874bb19d0ff6f2f39ecc09_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85NC9mcmFnOmEwNGZkMjE3YTk3YjQ1Nzg5OWYyZTRlY2M2OGVmOTEwL3RhYmxlOmZhYTkxYWJmNjdkYzQ3ODdhY2NjZTgwNTcwMzUyZTU1L3RhYmxlcmFuZ2U6ZmFhOTFhYmY2N2RjNDc4N2FjY2NlODA1NzAzNTJlNTVfMzgtMy0xLTEtMA_8a5bdf60-532d-4511-9f2d-da45e3943cbd"
      unitRef="usd">350000000</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="i00a6d666bf604826b24e68ddbd63eac4_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85NC9mcmFnOmEwNGZkMjE3YTk3YjQ1Nzg5OWYyZTRlY2M2OGVmOTEwL3RhYmxlOmZhYTkxYWJmNjdkYzQ3ODdhY2NjZTgwNTcwMzUyZTU1L3RhYmxlcmFuZ2U6ZmFhOTFhYmY2N2RjNDc4N2FjY2NlODA1NzAzNTJlNTVfMzgtNS0xLTEtMA_ee8ad828-08b0-4fe9-ad90-8a8f9eec8689"
      unitRef="usd">600000000</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85NC9mcmFnOmEwNGZkMjE3YTk3YjQ1Nzg5OWYyZTRlY2M2OGVmOTEwL3RhYmxlOmZhYTkxYWJmNjdkYzQ3ODdhY2NjZTgwNTcwMzUyZTU1L3RhYmxlcmFuZ2U6ZmFhOTFhYmY2N2RjNDc4N2FjY2NlODA1NzAzNTJlNTVfMzktMS0xLTEtMA_83e8f827-bbd4-4635-9576-de9edb389d12"
      unitRef="usd">-1317000000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="ia31e9a409b874bb19d0ff6f2f39ecc09_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85NC9mcmFnOmEwNGZkMjE3YTk3YjQ1Nzg5OWYyZTRlY2M2OGVmOTEwL3RhYmxlOmZhYTkxYWJmNjdkYzQ3ODdhY2NjZTgwNTcwMzUyZTU1L3RhYmxlcmFuZ2U6ZmFhOTFhYmY2N2RjNDc4N2FjY2NlODA1NzAzNTJlNTVfMzktMy0xLTEtMA_1363dfdb-723a-4aa5-853a-6367435fdab7"
      unitRef="usd">-2200000000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="i00a6d666bf604826b24e68ddbd63eac4_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85NC9mcmFnOmEwNGZkMjE3YTk3YjQ1Nzg5OWYyZTRlY2M2OGVmOTEwL3RhYmxlOmZhYTkxYWJmNjdkYzQ3ODdhY2NjZTgwNTcwMzUyZTU1L3RhYmxlcmFuZ2U6ZmFhOTFhYmY2N2RjNDc4N2FjY2NlODA1NzAzNTJlNTVfMzktNS0xLTEtMA_9cfd9a91-7193-4eb2-9035-b4313e9ceca3"
      unitRef="usd">-2293000000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:EffectOfExchangeRateOnCashAndCashEquivalents
      contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85NC9mcmFnOmEwNGZkMjE3YTk3YjQ1Nzg5OWYyZTRlY2M2OGVmOTEwL3RhYmxlOmZhYTkxYWJmNjdkYzQ3ODdhY2NjZTgwNTcwMzUyZTU1L3RhYmxlcmFuZ2U6ZmFhOTFhYmY2N2RjNDc4N2FjY2NlODA1NzAzNTJlNTVfNDAtMS0xLTEtMA_7bafcbbc-13f0-4852-a840-d6fe94d7c38b"
      unitRef="usd">11000000</us-gaap:EffectOfExchangeRateOnCashAndCashEquivalents>
    <us-gaap:EffectOfExchangeRateOnCashAndCashEquivalents
      contextRef="ia31e9a409b874bb19d0ff6f2f39ecc09_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85NC9mcmFnOmEwNGZkMjE3YTk3YjQ1Nzg5OWYyZTRlY2M2OGVmOTEwL3RhYmxlOmZhYTkxYWJmNjdkYzQ3ODdhY2NjZTgwNTcwMzUyZTU1L3RhYmxlcmFuZ2U6ZmFhOTFhYmY2N2RjNDc4N2FjY2NlODA1NzAzNTJlNTVfNDAtMy0xLTEtMA_5f2eee34-e3af-499d-a12f-6d8420c6a39a"
      unitRef="usd">-13000000</us-gaap:EffectOfExchangeRateOnCashAndCashEquivalents>
    <us-gaap:EffectOfExchangeRateOnCashAndCashEquivalents
      contextRef="i00a6d666bf604826b24e68ddbd63eac4_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85NC9mcmFnOmEwNGZkMjE3YTk3YjQ1Nzg5OWYyZTRlY2M2OGVmOTEwL3RhYmxlOmZhYTkxYWJmNjdkYzQ3ODdhY2NjZTgwNTcwMzUyZTU1L3RhYmxlcmFuZ2U6ZmFhOTFhYmY2N2RjNDc4N2FjY2NlODA1NzAzNTJlNTVfNDAtNS0xLTEtMA_8a71b5c0-6123-4aed-9bc9-a88236eeda0c"
      unitRef="usd">1000000</us-gaap:EffectOfExchangeRateOnCashAndCashEquivalents>
    <cah:CashReclassifiedtoAssetsHeldforSale
      contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85NC9mcmFnOmEwNGZkMjE3YTk3YjQ1Nzg5OWYyZTRlY2M2OGVmOTEwL3RhYmxlOmZhYTkxYWJmNjdkYzQ3ODdhY2NjZTgwNTcwMzUyZTU1L3RhYmxlcmFuZ2U6ZmFhOTFhYmY2N2RjNDc4N2FjY2NlODA1NzAzNTJlNTVfNDEtMS0xLTEtMA_c548da81-be9a-4a24-99c0-88e31aad02fc"
      unitRef="usd">-109000000</cah:CashReclassifiedtoAssetsHeldforSale>
    <cah:CashReclassifiedtoAssetsHeldforSale
      contextRef="ia31e9a409b874bb19d0ff6f2f39ecc09_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85NC9mcmFnOmEwNGZkMjE3YTk3YjQ1Nzg5OWYyZTRlY2M2OGVmOTEwL3RhYmxlOmZhYTkxYWJmNjdkYzQ3ODdhY2NjZTgwNTcwMzUyZTU1L3RhYmxlcmFuZ2U6ZmFhOTFhYmY2N2RjNDc4N2FjY2NlODA1NzAzNTJlNTVfNDEtMy0xLTEtMA_ee83ab31-c4a6-4609-9674-848adc509319"
      unitRef="usd">0</cah:CashReclassifiedtoAssetsHeldforSale>
    <cah:CashReclassifiedtoAssetsHeldforSale
      contextRef="i00a6d666bf604826b24e68ddbd63eac4_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85NC9mcmFnOmEwNGZkMjE3YTk3YjQ1Nzg5OWYyZTRlY2M2OGVmOTEwL3RhYmxlOmZhYTkxYWJmNjdkYzQ3ODdhY2NjZTgwNTcwMzUyZTU1L3RhYmxlcmFuZ2U6ZmFhOTFhYmY2N2RjNDc4N2FjY2NlODA1NzAzNTJlNTVfNDEtNS0xLTEtMA_01478922-a5ed-4d2f-8822-73cab9ac6d73"
      unitRef="usd">0</cah:CashReclassifiedtoAssetsHeldforSale>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85NC9mcmFnOmEwNGZkMjE3YTk3YjQ1Nzg5OWYyZTRlY2M2OGVmOTEwL3RhYmxlOmZhYTkxYWJmNjdkYzQ3ODdhY2NjZTgwNTcwMzUyZTU1L3RhYmxlcmFuZ2U6ZmFhOTFhYmY2N2RjNDc4N2FjY2NlODA1NzAzNTJlNTVfNDItMS0xLTEtMA_7a7f328a-2bac-48f5-9047-46dd87058587"
      unitRef="usd">636000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="ia31e9a409b874bb19d0ff6f2f39ecc09_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85NC9mcmFnOmEwNGZkMjE3YTk3YjQ1Nzg5OWYyZTRlY2M2OGVmOTEwL3RhYmxlOmZhYTkxYWJmNjdkYzQ3ODdhY2NjZTgwNTcwMzUyZTU1L3RhYmxlcmFuZ2U6ZmFhOTFhYmY2N2RjNDc4N2FjY2NlODA1NzAzNTJlNTVfNDItMy0xLTEtMA_655d3065-d71c-42db-bec7-506bd38da2f3"
      unitRef="usd">240000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="i00a6d666bf604826b24e68ddbd63eac4_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85NC9mcmFnOmEwNGZkMjE3YTk3YjQ1Nzg5OWYyZTRlY2M2OGVmOTEwL3RhYmxlOmZhYTkxYWJmNjdkYzQ3ODdhY2NjZTgwNTcwMzUyZTU1L3RhYmxlcmFuZ2U6ZmFhOTFhYmY2N2RjNDc4N2FjY2NlODA1NzAzNTJlNTVfNDItNS0xLTEtMA_c0961f3a-c5c2-426c-af25-061a6d6ad1b9"
      unitRef="usd">768000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i299cea70f47b4fbe96772aaa8cc00b79_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85NC9mcmFnOmEwNGZkMjE3YTk3YjQ1Nzg5OWYyZTRlY2M2OGVmOTEwL3RhYmxlOmZhYTkxYWJmNjdkYzQ3ODdhY2NjZTgwNTcwMzUyZTU1L3RhYmxlcmFuZ2U6ZmFhOTFhYmY2N2RjNDc4N2FjY2NlODA1NzAzNTJlNTVfNDMtMS0xLTEtMA_07e5b125-5f4c-4e41-bb4b-a55d9f0d28ea"
      unitRef="usd">2771000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="if6dc09eec4e74751b47cdf037a5b1860_I20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85NC9mcmFnOmEwNGZkMjE3YTk3YjQ1Nzg5OWYyZTRlY2M2OGVmOTEwL3RhYmxlOmZhYTkxYWJmNjdkYzQ3ODdhY2NjZTgwNTcwMzUyZTU1L3RhYmxlcmFuZ2U6ZmFhOTFhYmY2N2RjNDc4N2FjY2NlODA1NzAzNTJlNTVfNDMtMy0xLTEtMA_baa5e6bf-e62c-458a-9b4b-b2aaafd4712e"
      unitRef="usd">2531000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i39bbe70148ff4daea469e8420c1859d6_I20180630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85NC9mcmFnOmEwNGZkMjE3YTk3YjQ1Nzg5OWYyZTRlY2M2OGVmOTEwL3RhYmxlOmZhYTkxYWJmNjdkYzQ3ODdhY2NjZTgwNTcwMzUyZTU1L3RhYmxlcmFuZ2U6ZmFhOTFhYmY2N2RjNDc4N2FjY2NlODA1NzAzNTJlNTVfNDMtNS0xLTEtMA_9a0c7710-6125-4613-8be5-704f66bdf201"
      unitRef="usd">1763000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i2e87824102b34590a0208cc7da91b5f5_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85NC9mcmFnOmEwNGZkMjE3YTk3YjQ1Nzg5OWYyZTRlY2M2OGVmOTEwL3RhYmxlOmZhYTkxYWJmNjdkYzQ3ODdhY2NjZTgwNTcwMzUyZTU1L3RhYmxlcmFuZ2U6ZmFhOTFhYmY2N2RjNDc4N2FjY2NlODA1NzAzNTJlNTVfNDQtMS0xLTEtMA_a37da982-62c8-4556-a68e-dcec22257c6d"
      unitRef="usd">3407000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i299cea70f47b4fbe96772aaa8cc00b79_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85NC9mcmFnOmEwNGZkMjE3YTk3YjQ1Nzg5OWYyZTRlY2M2OGVmOTEwL3RhYmxlOmZhYTkxYWJmNjdkYzQ3ODdhY2NjZTgwNTcwMzUyZTU1L3RhYmxlcmFuZ2U6ZmFhOTFhYmY2N2RjNDc4N2FjY2NlODA1NzAzNTJlNTVfNDQtMy0xLTEtMA_cf23685f-4f44-4d65-914c-6c8b62a4b2a6"
      unitRef="usd">2771000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="if6dc09eec4e74751b47cdf037a5b1860_I20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85NC9mcmFnOmEwNGZkMjE3YTk3YjQ1Nzg5OWYyZTRlY2M2OGVmOTEwL3RhYmxlOmZhYTkxYWJmNjdkYzQ3ODdhY2NjZTgwNTcwMzUyZTU1L3RhYmxlcmFuZ2U6ZmFhOTFhYmY2N2RjNDc4N2FjY2NlODA1NzAzNTJlNTVfNDQtNS0xLTEtMA_e53311ae-23ba-40bc-be25-efb43664d687"
      unitRef="usd">2531000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:InterestPaidNet
      contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85NC9mcmFnOmEwNGZkMjE3YTk3YjQ1Nzg5OWYyZTRlY2M2OGVmOTEwL3RhYmxlOmZhYTkxYWJmNjdkYzQ3ODdhY2NjZTgwNTcwMzUyZTU1L3RhYmxlcmFuZ2U6ZmFhOTFhYmY2N2RjNDc4N2FjY2NlODA1NzAzNTJlNTVfNDYtMS0xLTEtMA_eddf4cf9-ea81-49a4-bfdf-bd8395a63c55"
      unitRef="usd">182000000</us-gaap:InterestPaidNet>
    <us-gaap:InterestPaidNet
      contextRef="ia31e9a409b874bb19d0ff6f2f39ecc09_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85NC9mcmFnOmEwNGZkMjE3YTk3YjQ1Nzg5OWYyZTRlY2M2OGVmOTEwL3RhYmxlOmZhYTkxYWJmNjdkYzQ3ODdhY2NjZTgwNTcwMzUyZTU1L3RhYmxlcmFuZ2U6ZmFhOTFhYmY2N2RjNDc4N2FjY2NlODA1NzAzNTJlNTVfNDYtMy0xLTEtMA_b239b213-d064-421d-8294-dfc9b351b44e"
      unitRef="usd">226000000</us-gaap:InterestPaidNet>
    <us-gaap:InterestPaidNet
      contextRef="i00a6d666bf604826b24e68ddbd63eac4_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85NC9mcmFnOmEwNGZkMjE3YTk3YjQ1Nzg5OWYyZTRlY2M2OGVmOTEwL3RhYmxlOmZhYTkxYWJmNjdkYzQ3ODdhY2NjZTgwNTcwMzUyZTU1L3RhYmxlcmFuZ2U6ZmFhOTFhYmY2N2RjNDc4N2FjY2NlODA1NzAzNTJlNTVfNDYtNS0xLTEtMA_33e10ca9-ebd6-4f95-aedd-23a59ca11ddb"
      unitRef="usd">285000000</us-gaap:InterestPaidNet>
    <us-gaap:IncomeTaxesPaidNet
      contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85NC9mcmFnOmEwNGZkMjE3YTk3YjQ1Nzg5OWYyZTRlY2M2OGVmOTEwL3RhYmxlOmZhYTkxYWJmNjdkYzQ3ODdhY2NjZTgwNTcwMzUyZTU1L3RhYmxlcmFuZ2U6ZmFhOTFhYmY2N2RjNDc4N2FjY2NlODA1NzAzNTJlNTVfNDctMS0xLTEtMA_2f97f638-9232-4c3c-93cf-4ea75c1afa5d"
      unitRef="usd">273000000</us-gaap:IncomeTaxesPaidNet>
    <us-gaap:IncomeTaxesPaidNet
      contextRef="ia31e9a409b874bb19d0ff6f2f39ecc09_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85NC9mcmFnOmEwNGZkMjE3YTk3YjQ1Nzg5OWYyZTRlY2M2OGVmOTEwL3RhYmxlOmZhYTkxYWJmNjdkYzQ3ODdhY2NjZTgwNTcwMzUyZTU1L3RhYmxlcmFuZ2U6ZmFhOTFhYmY2N2RjNDc4N2FjY2NlODA1NzAzNTJlNTVfNDctMy0xLTEtMA_9a239b99-9fff-4b62-8cb2-66eaf700ce0b"
      unitRef="usd">368000000</us-gaap:IncomeTaxesPaidNet>
    <us-gaap:IncomeTaxesPaidNet
      contextRef="i00a6d666bf604826b24e68ddbd63eac4_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF85NC9mcmFnOmEwNGZkMjE3YTk3YjQ1Nzg5OWYyZTRlY2M2OGVmOTEwL3RhYmxlOmZhYTkxYWJmNjdkYzQ3ODdhY2NjZTgwNTcwMzUyZTU1L3RhYmxlcmFuZ2U6ZmFhOTFhYmY2N2RjNDc4N2FjY2NlODA1NzAzNTJlNTVfNDctNS0xLTEtMA_eeb2695a-682c-4bdd-a13e-0676494896ed"
      unitRef="usd">311000000</us-gaap:IncomeTaxesPaidNet>
    <us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock
      contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDAvZnJhZzpiYzA3ODhjZjRkZDE0YTM3OGRlYzVjMDA1NTk3Zjc0OS90ZXh0cmVnaW9uOmJjMDc4OGNmNGRkMTRhMzc4ZGVjNWMwMDU1OTdmNzQ5XzM5NjE5_46bda56d-d127-48db-a644-320e64622644">&lt;div style="display:inline-block;vertical-align:top;width:48.214%"&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:13pt;font-weight:700;line-height:120%"&gt;1. Basis of Presentation and Summary of Significant Accounting Policies &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cardinal Health, Inc. is a globally integrated healthcare services and products company providing customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories and physician offices. We provide pharmaceuticals and medical products and cost-effective solutions that enhance supply chain efficiency. References to &#x201c;we&#x201d;, &#x201c;our&#x201d; and similar pronouns in these consolidated financial statements are to Cardinal Health, Inc. and its majority-owned or controlled subsidiaries unless the context otherwise requires.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our fiscal year ends on June&#160;30. References to fiscal 2021, 2020 and 2019 in these consolidated financial statements are to the fiscal years ended June&#160;30, 2021, 2020 and 2019, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%"&gt;Basis of Presentation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our consolidated financial statements include the accounts of all majority-owned or controlled subsidiaries, and all significant intercompany transactions and amounts have been eliminated. The results of businesses acquired or disposed of are included in the consolidated financial statements from the date of the acquisition or up to the date of disposal, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%"&gt;Use of Estimates&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our consolidated financial statements are prepared in accordance with accounting principles generally accepted in the United States (&#x201c;GAAP&#x201d;). The preparation of financial statements in accordance with GAAP requires us to make estimates, judgments and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes. Estimates, judgments and assumptions are used in the accounting and disclosure related to, among other items, allowance for doubtful accounts, inventory valuation and reserves, goodwill and other intangible asset impairment, loss contingencies (including product liability and self-insurance accruals), and income taxes. Actual amounts could ultimately differ from these estimated amounts.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The COVID-19 pandemic ("COVID-19") continues to affect the U.S. and global economies, and as previously disclosed, the pandemic began to materially affect our businesses during the third quarter of fiscal 2020. The length and severity of the pandemic and its impacts on our businesses and results of operations are uncertain.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%"&gt;Cash Equivalents&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We consider liquid investments purchased with an initial maturity of three months or less to be cash equivalents. The carrying value of cash equivalents approximates fair value.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%"&gt;Receivables and Allowance for Doubtful Accounts&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Trade receivables are presented net of an allowance for doubtful accounts of $242 million and $206 million at June&#160;30, 2021 and 2020, respectively. An account is considered past due on the first &lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="display:inline-block;max-width:3.571%;min-width:2.571%;vertical-align:top"/&gt;&lt;div style="display:inline-block;vertical-align:top;width:48.215%"&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;day after its due date. In accordance with contract terms, we generally have the ability to charge customers service fees or higher prices if an account is considered past due. We regularly monitor past due accounts and establish appropriate reserves to cover potential losses, and consider historical experience, the current economic environment, customer credit ratings or bankruptcies, and reasonable and supportable forecasts to develop our allowance for credit losses. We review these factors quarterly to determine if any adjustments are needed to the allowance. We write off any amounts deemed uncollectible against the established allowance for doubtful accounts.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We provide financing to various customers. Such financing arrangements range from 1 year&#160;to 5 years at interest rates that are generally subject to fluctuation. Interest income on these arrangements is recognized as it is earned. The financings may be collateralized, guaranteed by third parties or unsecured. Finance notes, net and related accrued interest were $63 million (current portion $7 million) and $104 million (current portion $12 million) at June&#160;30, 2021 and 2020, respectively, and are included in other assets (current portion is included in prepaid expenses and other) in the consolidated balance sheets. Finance notes receivable allowance for doubtful accounts were $12 million and $27 million at June&#160;30, 2021 and 2020, respectively. We estimate an allowance for these financing receivables based on historical collection rates and the credit worthiness of the customer. We write off any amounts deemed uncollectible against the established allowance for doubtful accounts.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%"&gt;Concentrations of Credit Risk&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We maintain cash depository accounts with major banks, and we invest in high quality, short-term liquid instruments, and in marketable securities. Our short-term liquid instruments mature within three months and we have not historically incurred any related losses.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our trade receivables and finance notes and related accrued interest are exposed to a concentration of credit risk with certain large customers and with customers in the retail and healthcare sectors. Credit risk can be affected by changes in reimbursement and other economic pressures impacting the healthcare industry. With respect to customers in the retail and healthcare sectors, such credit risk is limited due to supporting collateral and the diversity of the customer base, including its wide geographic dispersion. We perform regular credit evaluations of our customers&#x2019; financial conditions and maintain reserves for losses through the established allowance for doubtful accounts. Historically, such losses have been within our expectations. Refer to the "Receivables and Allowance for Doubtful Accounts" section within this Note for additional information on the accounting treatment of reserves for allowance for doubtful accounts. &lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="display:inline-block;vertical-align:top;width:48.214%"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%"&gt;Major Customers&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;CVS Health Corporation ("CVS") and OptumRx, are our only customers that individually account for at least 10 percent of revenue and gross trade receivables. These customers are primarily serviced through our Pharmaceutical segment.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In August 2021, we extended our pharmaceutical distribution agreements with CVS through June 2027. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes historical percent of revenue and gross trade receivables from CVS and OptumRx:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.382%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:35.235%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.148%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.352%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.769%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.352%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.769%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.352%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.632%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.352%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.639%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Percent of Revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Percent&#160;of&#160;Gross Trade&#160;Receivables at June 30&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;CVS&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;26&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;24&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;OptumRx&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;15&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;3&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We have entered into agreements with group purchasing organizations (&#x201c;GPOs&#x201d;) which act as purchasing agents that negotiate vendor contracts on behalf of their members. Vizient, Inc. and Premier, Inc. are our two largest GPO member relationships in terms of revenue. Sales to members of these two GPOs collectively accounted for 15 percent, 16 percent and 22 percent of revenue for fiscal 2021, 2020 and 2019, respectively. Our trade receivable balances are with individual members of the GPO, and therefore no significant concentration of credit risk exists with these types of arrangements.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%"&gt;Inventories&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A portion of our inventories (50 percent and 56 percent at June&#160;30, 2021 and 2020, respectively) are valued at the lower of cost, using the last-in, first-out ("LIFO") method, or market. These inventories are included within the core pharmaceutical distribution facilities of our Pharmaceutical segment (&#x201c;distribution facilities&#x201d;) and are primarily merchandise inventories. The LIFO method presumes that the most recent inventory purchases are the first items sold, so LIFO helps us better match current costs and revenue. We believe that the average cost method of inventory valuation provides a reasonable approximation of the current cost of replacing inventory within the distribution facilities. As such, the LIFO reserve is the difference between (a) inventory at the lower of LIFO cost or market and (b) inventory at replacement cost determined using the average cost method of inventory valuation.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At June&#160;30, 2021 and 2020, respectively, inventories valued at LIFO cost were $565 million and&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$411 million higher than the average cost value. We do not record inventories in excess of replacement cost. As such, we did not write-up the value of our inventory from average cost to LIFO cost at June&#160;30, 2021 or 2020. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our remaining inventory, including inventory in our Medical segment, that is not valued at the lower of LIFO cost or market is stated at the lower of cost, using the first-in, first-out method, or net realizable value. Net realizable value is defined as the estimated selling prices and estimated sales demand in the ordinary course of business, less reasonably predictable costs of completion, disposal and transportation. Due to the unprecedented demand for &lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="display:inline-block;max-width:3.571%;min-width:2.571%;vertical-align:top"/&gt;&lt;div style="display:inline-block;vertical-align:top;width:48.215%"&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;certain personal protective equipment as a result of COVID-19, our Medical segment manufactured and sourced inventory at higher costs than in periods prior to COVID-19. Personal protective equipment ("PPE") refers to protective clothing, medical and non-medical grade gloves, face shields, face masks and other equipment designed to protect the wearer from injury or the spread of infection or illness. As selling prices and customer demand have decreased compared to the peak of COVID-19, we recorded a reserve of $197&#160;million, primarily related to certain categories of gloves, to reduce the carrying value of certain PPE to its net realizable value.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We reserve for inventory obsolescence using estimates based on historical experience, historical and projected sales trends, specific&#160;categories of inventory, age and expiration dates of on-hand inventory and manufacturer return policies. Inventories presented in the consolidated balance sheets are net of reserves for excess and obsolete inventory which were $185 million and $155 million at June&#160;30, 2021 and 2020, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%"&gt;Cash Discounts&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Manufacturer cash discounts are recorded as a component of inventory cost and recognized as a reduction of cost of products sold as inventory is sold.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%"&gt;Property and Equipment&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Property and equipment are carried at cost less accumulated depreciation. Property and equipment held for sale are recorded at the lower of cost less accumulated depreciation before the decision to dispose of the asset was made or fair value less cost to sell. When certain events or changes in operating conditions occur, an impairment assessment may be performed on the recoverability of the carrying amounts.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Depreciation expense is computed using the straight-line method over the estimated useful lives of the assets, including finance lease assets which are depreciated over the terms of their respective leases. We generally use the following range of useful lives for our property and equipment categories: buildings and improvements&#x2014;3 to 39 years; machinery and equipment&#x2014;3 to 20 years; and furniture and fixtures&#x2014;3 to 7 years. We recorded depreciation and amortization expense of $377 million, $405 million and $455 million for fiscal 2021, 2020 and 2019, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the components of property and equipment, net at June&#160;30:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.183%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.343%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.186%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Land, building and improvements&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2,359&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,185&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Machinery and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;3,093&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3,008&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Furniture and fixtures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;136&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;138&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total property and equipment, at cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;5,588&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;5,331&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Accumulated depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(3,228)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(2,965)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Property and equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2,360&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,366&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Repairs and maintenance expenditures are expensed as incurred. Interest on long-term projects is capitalized using a rate that approximates the weighted-average interest rate on long-term &lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="display:inline-block;vertical-align:top;width:48.214%"&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;obligations, which was 3 percent at June&#160;30, 2021. The amount of capitalized interest was immaterial for all periods presented.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%"&gt;Goodwill and Other Intangible Assets&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Purchased goodwill and intangible assets with indefinite lives are not amortized, but instead are tested for impairment annually or when indicators of impairment exist.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Purchased goodwill is tested for impairment at least annually. Qualitative factors are first assessed to determine if it is more likely than not that the fair value of a reporting unit is less than its carrying amount. There is an option to bypass the qualitative assessment for any reporting unit in any period and proceed directly to performing the quantitative goodwill impairment test. We have elected to bypass the qualitative assessment for our annual goodwill impairment test in the current year. The quantitative goodwill impairment test involves a comparison of the estimated fair value of the reporting unit to the respective carrying amount. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Goodwill impairment testing involves judgment, including the identification of reporting units, qualitative evaluation of events and circumstances to determine if it is more likely than not that an impairment exists, and, if necessary, the estimation of the fair value of the applicable reporting unit. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We have two operating segments, which are the same as our reportable segments: Pharmaceutical and Medical. These operating segments are comprised of divisions (components), for which discrete financial information is available. Components are aggregated into reporting units for purposes of goodwill impairment testing to the extent that they share similar economic characteristics. Our reporting units are: Pharmaceutical operating segment (excluding our Nuclear and Precision Health Solutions division); Nuclear and Precision Health Solutions division; Medical operating segment (excluding our Cardinal Health at-Home Solutions division) (&#x201c;Medical Unit&#x201d;); and Cardinal Health at-Home Solutions division.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Fair value can be determined using market, income or cost-based approaches. Our determination of estimated fair value of the reporting units is based on a combination of the income-based and market-based approaches. Under the income-based approach, we use a discounted cash flow model in which cash flows anticipated over several future periods, plus a terminal value at the end of that time horizon, are discounted to their present value using an appropriate risk-adjusted rate of return.&#160;We use our internal forecasts to estimate future cash flows, which we believe are consistent with those of a market participant, and include an estimate of long-term growth rates based on our most recent views of the long-term outlook for each reporting unit. Actual results may differ materially from those used in our forecasts. We use discount rates that are commensurate with the risks and uncertainty inherent in the respective reporting units and in our internally-developed forecasts. Discount rates used in our reporting unit valuations ranged from 8.5 percent to 11.5 percent. Under the market-based guideline public company method, we determine fair value by comparing our reporting units to similar businesses or guideline companies whose securities are actively traded in public markets. We also use the guideline transaction method to &lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="display:inline-block;max-width:3.571%;min-width:2.571%;vertical-align:top"/&gt;&lt;div style="display:inline-block;vertical-align:top;width:48.215%"&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;determine fair value based on pricing multiples derived from the sale of companies that are similar to our reporting units. To further confirm fair value, we compare the aggregate fair value of our reporting units to our total market capitalization.&#160;Estimating the fair value of reporting units requires the use of estimates and significant judgments that are based on a number of factors including forecasted operating results. The use of alternate estimates and assumptions or changes in the industry or peer groups could materially affect the determination of fair value for each reporting unit and potentially result in goodwill impairment.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We performed annual impairment testing in fiscal 2021, 2020 and 2019 and concluded that there were no impairments of goodwill as the estimated fair value of each reporting unit exceeded its carrying value.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The impairment test for indefinite-lived intangibles other than goodwill involves first assessing qualitative factors to determine if it is more likely than not that the fair value of the indefinite-lived intangible asset is less than its carrying amount. If so, then a quantitative test is performed to compare the estimated fair value of the indefinite-lived intangible asset to the respective asset's carrying amount. Our qualitative evaluation requires the use of estimates and significant judgments and considers the weight of evidence and significance of all identified events and circumstances and most relevant drivers of fair value, both positive and negative, in determining whether it is more likely than not that the fair value of the indefinite-lived intangible asset is less than its carrying amount.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Intangible assets with finite lives, primarily customer relationships; trademarks, trade names and patents; and developed technology, are amortized using a combination of straight-line and accelerated methods based on the expected cash flows from the asset over their estimated useful lives. We review intangible assets with finite lives for impairment whenever events or changes in circumstances indicate that the related carrying amounts may not be recoverable. Determining whether an impairment loss occurred requires a comparison of the carrying amount to the sum of the future forecasted undiscounted cash flows expected to be generated by the asset group. Actual results may differ materially from those used in our forecasts.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%"&gt;Assets Held for Sale&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We classify assets and liabilities (the &#x201c;disposal group&#x201d;) as held for sale when management commits to a plan to sell the disposal group in its present condition and at a price that is reasonable in relation to its current fair value. We also consider whether an active program to locate a buyer has been initiated and if it is probable that the sale will occur within one year without significant changes to the plan to sell. Upon classification of the disposal group as held for sale, we test the assets for impairment and cease related depreciation and amortization.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On March 12, 2021, we announced that we signed a definitive agreement to sell our Cordis business to Hellman &amp;amp; Friedman for proceeds of $927 million in cash, subject to customary purchase price adjustments, and we retained certain working capital accounts and certain liabilities, including product liability for &lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="display:inline-block;vertical-align:top;width:48.214%"&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;lawsuits related to inferior vena cava filters in the U.S. and Canada as described in &lt;/span&gt;&lt;span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;&lt;a href="#i4f0ec56b9c604f1782a65ea4a19c284d_130" style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Note 7&lt;/a&gt;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; of the &#x201c;Notes to Consolidated Financial Statements.&#x201d; The transaction closed on August 2, 2021. See &lt;/span&gt;&lt;span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;&lt;a href="#i4f0ec56b9c604f1782a65ea4a19c284d_106" style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Note 2&lt;/a&gt;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; for additional information.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%"&gt;Investments&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Investments in non-marketable equity securities are accounted for under the fair value, equity or net asset value method of&#160;accounting and are included in other assets in the consolidated balance sheets. For equity securities without a readily determinable fair value, we use the fair value measurement alternative and measure the securities at cost less impairment, if any, including adjustments for observable price changes in orderly transactions for an identical or similar investment of the same issuer. For investments in which we can exercise significant influence but do not control, we use the equity method of accounting. Our share of the earnings and losses are recorded in other (income)/expense, net in the consolidated statements of earnings/(loss). We monitor our investments for impairment&#160;by considering factors such as the operating performance of the investment and current economic and market conditions.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%"&gt;Vendor Reserves&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In the ordinary course of business, our vendors may dispute deductions taken against payments otherwise due to them or assert other disputes. These disputes are researched and resolved based upon the findings of the research performed. At any given time, there are outstanding items in various stages of research and resolution. In determining appropriate reserves for areas of exposure with our vendors, we assess historical experience and current outstanding claims. We have established various levels of reserves based on the type of claim and status of review. Though the claim types are relatively consistent, we periodically refine our methodology by updating the reserve estimate percentages to reflect actual historical experience. The ultimate outcome of certain claims may be different than our original estimate and may require an adjustment. Adjustments to vendor reserves are included in cost of products sold. In addition, the reserve balance will fluctuate due to variations of outstanding claims from period-to-period, timing of settlements and specific vendor issues, such as bankruptcies. Vendor reserves were $77 million at both June&#160;30, 2021 and 2020, excluding third-party returns. See Third-Party Returns section within this Note for a description of third-party returns.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%"&gt;Distribution Services Agreement and Other Vendor Fees&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our Pharmaceutical segment recognizes fees received from distribution services agreements and other fees received from vendors related to the purchase or distribution of the vendors&#x2019; inventory when those fees have been earned and we are entitled to payment. Since the benefit provided to a vendor is related to the purchase and distribution of the vendor&#x2019;s inventory, we recognize the fees as a reduction in the carrying value of the inventory that generated the fees, and as such, a reduction of cost of products sold in our consolidated statements of earnings/(loss) when the inventory is sold.&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="display:inline-block;max-width:3.571%;min-width:2.571%;vertical-align:top"/&gt;&lt;div style="display:inline-block;vertical-align:top;width:48.215%"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%"&gt;Loss Contingencies and Self-Insurance&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Loss Contingencies&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We accrue for contingencies related to disputes, litigation and regulatory matters if it is probable that a liability has been incurred and the amount of the loss can be reasonably estimated. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In connection with the opioid litigation as described further in the &lt;/span&gt;&lt;span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;&lt;a href="#i4f0ec56b9c604f1782a65ea4a19c284d_130" style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Note 7&lt;/a&gt;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, we recorded pre-tax charges of&#160;$1.17 billion and $5.63 billion during fiscal 2021 and 2020 respectively which were retained at Corporate. In July 2021, we announced that we and two other national distributors have negotiated a proposed settlement agreement, subject to certain conditions and contingencies. There is no assurance that the contingencies to the proposed settlement agreement will be satisfied. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We develop and periodically update reserve estimates for the Cordis inferior vena cava ("Cordis IVC") claims, including those received to date and expected to be received in the future and related costs. To project future Cordis IVC claim costs, we use a methodology based largely on recent experience, including claim filing rates, estimated indemnity severity by claim type, sales data, implant and injury to report lag patterns and estimated defense costs.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Self-Insurance&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We also self-insure for employee healthcare, general liability, certain product liability matters, auto liability, property and workers' compensation. Self-insurance accruals include an estimate for expected settlements or pending claims, defense costs, administrative fees, claim adjustment costs and an estimate for claims incurred but not reported. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Because these matters are inherently unpredictable and unfavorable developments or resolutions can occur, assessing contingencies and other liabilities is highly subjective and requires judgments about future&#160;events. We regularly review contingencies and our self-insurance accruals to determine whether our accruals and related disclosures are adequate. Any adjustments for changes in reserves are recorded in the period in which the change in estimate occurs.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The amount of ultimate loss may differ materially from these estimates. We recognize these estimated loss contingencies, income from favorable resolution of litigation and certain defense costs in litigation (recoveries)/charges in our consolidated statements of earnings/(loss). See &lt;/span&gt;&lt;span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;&lt;a href="#i4f0ec56b9c604f1782a65ea4a19c284d_130" style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Note 7&lt;/a&gt;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; for additional information regarding loss contingencies and product liability lawsuits.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%"&gt;Guarantees&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In the ordinary course of business, we agree to indemnify certain other parties under acquisition and disposition agreements, customer agreements, intellectual property licensing agreements, and other agreements. Such indemnification obligations vary in scope and, when defined, in duration. In many cases, a maximum obligation is not explicitly stated, and therefore the overall maximum amount of the liability under such indemnification obligations cannot be reasonably estimated. Where appropriate, such indemnification obligations are recorded as a liability. Historically, we have not, individually or in the aggregate, made &lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="display:inline-block;vertical-align:top;width:48.214%"&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;payments under these indemnification obligations in any material amounts. In certain circumstances, we believe that existing insurance arrangements, subject to the general deduction and exclusion provisions, would cover portions of the liability that may arise from these indemnification obligations. In addition, we believe that the likelihood of a material liability being triggered under these indemnification obligations is not probable.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;From time to time we enter into agreements that obligate us to make fixed payments upon the occurrence of certain events. Such obligations primarily relate to obligations arising under acquisition transactions, where we have agreed to make payments based upon the achievement of certain financial performance measures by the acquired business. Generally, the obligation is capped at an explicit amount. There were no material obligations at June&#160;30, 2021. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%"&gt;Income Taxes&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We account for income taxes using the asset and liability method. Deferred tax assets and liabilities are measured using enacted tax rates in the respective jurisdictions in which we operate. We assess the realizability of deferred tax assets on a quarterly basis and provide a valuation allowance for deferred tax assets when it is more likely than not that at least a portion of the deferred tax assets will not be realized. The realizability of deferred tax assets depends on our ability to generate sufficient taxable income within the carryback or carryforward periods provided for in the tax law for each applicable tax jurisdiction and also considers all available positive and negative evidence.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Deferred taxes for non-U.S. liabilities are not provided on the unremitted earnings of subsidiaries outside of the United States&#160;when it is expected that these earnings are indefinitely reinvested.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We operate in a complex multinational tax environment and are subject to tax treaty arrangements and transfer pricing guidelines for intercompany transactions that are subject to interpretation. Uncertainty in a tax position may arise as tax laws are subject to interpretation. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Tax benefits from uncertain tax positions are recognized when it is more likely than not that the position will be sustained upon examination of the technical merits of the position, including resolutions of any related appeals or litigation processes. The amount recognized is measured as the largest amount of tax benefit that is greater than 50 percent likely of being realized upon settlement. For tax benefits that do not qualify for recognition, we recognize a liability for unrecognized tax benefits. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;See &lt;/span&gt;&lt;span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;&lt;a href="#i4f0ec56b9c604f1782a65ea4a19c284d_133" style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Note 8&lt;/a&gt;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; for additional information regarding income taxes.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%"&gt;Other Accrued Liabilities&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other accrued liabilities represent various current obligations, including certain accrued operating expenses and taxes payable.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%"&gt;Noncontrolling Interests&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Noncontrolling interests represent the portion of net earnings, comprehensive income and net assets that is not attributable to Cardinal Health, Inc. &lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="display:inline-block;max-width:3.571%;min-width:2.571%;vertical-align:top"/&gt;&lt;div style="display:inline-block;vertical-align:top;width:48.215%"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%"&gt;Share-Based Compensation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Share-based compensation provided to employees is recognized in the consolidated statements of earnings/(loss) based on the grant date fair value of the awards. The fair value of restricted share units and performance share units is determined by the grant date market price of our common shares. The fair value of stock options is determined on the grant date using a lattice valuation model. The compensation expense associated with nonvested performance share units is dependent on our periodic assessment of the probability of the targets being achieved and our estimate, which may vary over time, of the number of shares that ultimately will be issued. The compensation expense recognized for share-based awards is net of estimated forfeitures and is recognized ratably over the service period of the awards. All income tax effects of share-based awards are recognized in the consolidated statements of earnings/(loss) as awards vest or are settled. We classify share-based compensation expense in distribution, selling, general and administrative ("SG&amp;amp;A") expenses to correspond with the same line item as the majority of the cash compensation paid to employees. If awards are modified in connection with a restructuring activity, the incremental share-based compensation expense is classified in restructuring and employee severance. See &lt;/span&gt;&lt;span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;&lt;a href="#i4f0ec56b9c604f1782a65ea4a19c284d_160" style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Note 14&lt;/a&gt;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; for additional information regarding share-based compensation.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%"&gt;Dividends&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We paid cash dividends per common share of $1.94, $1.92 and $1.91 in fiscal 2021, 2020 and 2019, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%"&gt;Revenue Recognition&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We recognize revenue in an amount that reflects the consideration to which we expect to be entitled in exchange for the transfer of goods or services to customers.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenue in both segments is primarily related to the distribution of pharmaceutical and medical products, which include both manufactured and sourced products, and we recognize at a point in time when title transfers to customers and we have no further obligation to provide services related to such merchandise. Service revenues are recognized over the period that services are provided to the customer. Revenues derived from services are not material for either segment for all periods presented.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We are generally the principal in a transaction, therefore our revenue is primarily recorded on a gross basis. When we are a principal in a transaction, we have determined that we control the ability to direct the use of the product or service prior to transfer to a customer, are primarily responsible for fulfilling the promise to provide the product or service to our customer, have discretion in establishing prices, and ultimately control the transfer of the product or services provided to the customer. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%"&gt;Sales Returns and Allowances&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenue is recorded net of sales returns and allowances. Revenues are measured based on the amount of consideration that we expect to receive, reduced by estimates for return allowances, discounts, rebates and other variable consideration. Sales returns are recorded based on estimates using historical &lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="display:inline-block;vertical-align:top;width:48.214%"&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;data. Our customer return policies generally require that the product be physically returned, subject to restocking fees. We only allow customers to return products for credit in a condition suitable to be added back to inventory and resold at full value (&#x201c;merchantable product&#x201d;) or returned to vendors for credit. Product returns are generally consistent throughout the year and typically are not specific to any particular product or customer.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We accrue for estimated sales returns and allowances at the time of sale based upon historical customer return trends, margin rates and processing costs. Our accrual for sales returns is reflected as a reduction of revenue and cost of products sold for the sales price and cost, respectively. At June&#160;30, 2021 and 2020, the accrual for estimated sales returns and allowances was $689 million and $495 million, respectively, which is reflected in trade receivables, net and inventories, net in the consolidated balance sheets. Sales returns and allowances were $2.6 billion, $2.3 billion and $2.2 billion, for fiscal 2021, 2020 and 2019, respectively, and the net impact on net earnings/(loss) in the consolidated statements of earnings/(loss) was immaterial in fiscal 2021, 2020 and 2019. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%"&gt;Third-Party Returns&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We generally do not accept non-merchantable pharmaceutical product returns from our customers, so many of our customers return non-merchantable pharmaceutical products to the manufacturer through third parties. Since our customers generally do not have a direct relationship with manufacturers, our vendors pass the value of such returns to us (usually in the form of an accounts payable deduction). We, in turn, pass the value received to our customer. In certain instances, we pass the estimated value of the return to our customer prior to our receipt of the value from the vendor. Although we believe we have satisfactory protections, we could be subject to claims from customers or vendors if our administration of this overall process was deficient in some respect or our contractual terms with vendors are in conflict with our contractual terms with our customers. We have maintained reserves for some of these situations based on their nature and our historical experience with their resolution.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%"&gt;Shipping and Handling&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Shipping and handling costs are primarily included in SG&amp;amp;A expenses in our consolidated statements of earnings/(loss) and include all delivery expenses as well as all costs to prepare the product for shipment to the end customer. Shipping and handling costs were $634 million, $620 million and $622 million, for fiscal 2021, 2020 and 2019, respectively. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%"&gt;Restructuring and Employee Severance&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Restructuring activities are programs that are not part of the ongoing operations of our underlying business, such as divestitures, closing and consolidating facilities, changing the way we manufacture or distribute our products, moving manufacturing of a product to another location, changes in production or business process outsourcing or insourcing, employee severance (including rationalizing headcount or other significant changes in personnel) and realigning operations (including realignment of the management structure in response to changing market conditions). Also included within restructuring and employee severance are &lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="display:inline-block;max-width:3.571%;min-width:2.571%;vertical-align:top"/&gt;&lt;div style="display:inline-block;vertical-align:top;width:48.215%"&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;employee severance costs that are not incurred in connection with a restructuring activity. See &lt;/span&gt;&lt;span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;&lt;a href="#i4f0ec56b9c604f1782a65ea4a19c284d_109" style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Note 3&lt;/a&gt;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; for additional information regarding our restructuring activities.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%"&gt;Amortization and Other Acquisition-Related Costs&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We classify certain costs incurred in connection with acquisitions as amortization and other acquisition-related costs in our consolidated statements of earnings/(loss). These costs consist of amortization of acquisition-related intangible assets, transaction costs, integration costs and changes in the fair value of contingent consideration obligations. Transaction costs are incurred during the initial evaluation of a potential acquisition and primarily relate to costs to analyze, negotiate and consummate the transaction as well as due diligence activities. Integration costs relate to activities required to combine the operations of an acquired enterprise into our operations and, in the case of the Cordis and Patient Recovery businesses, to stand-up the systems and processes needed to support an expanded geographic footprint. We record changes in the fair value of contingent consideration obligations relating to acquisitions as income or expense in amortization and other acquisition-related costs. See &lt;/span&gt;&lt;span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;&lt;a href="#i4f0ec56b9c604f1782a65ea4a19c284d_112" style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Note 4&lt;/a&gt;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; for additional information regarding amortization of acquisition-related intangible assets. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%"&gt;Translation of Foreign Currencies&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Financial statements of our subsidiaries outside the United States&#160;are generally measured using the local currency as the functional currency. Adjustments to translate the assets and liabilities of these foreign subsidiaries into U.S.&#160;dollars are accumulated in shareholders&#x2019; equity through accumulated and other comprehensive loss ("AOCI") utilizing period-end exchange rates. Revenues and expenses of these foreign subsidiaries are translated using average exchange rates during the year.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The foreign currency translation gains/(losses) included in AOCI at June&#160;30, 2021 and 2020 are presented in &lt;/span&gt;&lt;span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;&lt;a href="#i4f0ec56b9c604f1782a65ea4a19c284d_145" style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Note 11&lt;/a&gt;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. Foreign currency transaction gains and losses for the period are included in the consolidated statements of earnings/(loss) in the respective financial statement line item.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%"&gt;Interest Rate, Currency and Commodity Risk&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;All derivative instruments are recognized at fair value on the consolidated balance sheets and all changes in fair value are recognized in net earnings or shareholders&#x2019; equity through AOCI, net of tax.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For contracts that qualify for hedge accounting treatment, the hedge contracts must be effective at reducing the risk associated with the exposure being hedged and must be designated as a hedge at the inception of the contract. Hedge effectiveness is assessed periodically. Any contract not designated as a hedge, or so designated but ineffective, is adjusted to fair value and recognized immediately in net earnings. If a fair value or cash flow hedge ceases to qualify for hedge accounting treatment, the contract continues to be carried on the balance sheet at fair value until settled and future adjustments to the contract&#x2019;s fair value are recognized immediately in net earnings. If a forecasted transaction is probable not to occur, amounts previously deferred in AOCI are recognized immediately in net earnings. Interest payments &lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;received from the cross currency swap are excluded from the net investment hedge effectiveness assessment and are recorded in interest expense, net in the consolidated statements of earnings/(loss).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;See &lt;/span&gt;&lt;span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;&lt;a href="#i4f0ec56b9c604f1782a65ea4a19c284d_139" style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Note 10&lt;/a&gt;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; for additional information regarding our derivative instruments, including the accounting treatment for instruments designated as fair value, cash flow, net investment and economic hedges.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%"&gt;Fair Value Measurements&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Fair value is defined as the price that would be received upon selling an asset or the price paid to transfer a liability on the measurement date. It focuses on the exit price in the principal or most advantageous market for the asset or liability in an orderly transaction between willing market participants. A three-tier fair value hierarchy is established as a basis for considering such assumptions and for inputs used in the valuation methodologies in measuring fair value. This hierarchy requires entities to maximize the use of observable inputs and minimize the use of unobservable inputs. The three levels of inputs used to measure fair values are:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-36pt"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Level 1 -&#160;&#160;&#160;&#160;Observable prices in active markets for identical assets and liabilities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-36pt"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Level 2 -&#160;&#160;&#160;&#160;Observable inputs other than quoted prices in active markets for identical assets and liabilities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-36pt"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Level 3 -&#160;&#160;&#160;&#160;Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets and liabilities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;See &lt;/span&gt;&lt;span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;&lt;a href="#i4f0ec56b9c604f1782a65ea4a19c284d_136" style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Note 9&lt;/a&gt;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; for additional information regarding fair value measurements.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%"&gt;Recently Adopted Financial Accounting Standards&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Financial Instruments - Credit Losses&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In June 2016, the Financial Accounting Standards Board ("FASB") issued amended accounting guidance that will require entities to measure credit losses on trade and other receivables, held-to-maturity debt securities, loans and other instruments using an "expected credit loss" model that considers historical experience, current conditions and reasonable supportable forecasts. This guidance also requires that credit losses on available-for-sale debt securities with unrealized losses be recognized as allowances rather than as deductions in the amortized cost of the securities. We consider historical experience, the current economic environment, customer credit ratings or bankruptcies, and reasonable and supportable forecasts to develop our allowance for credit losses. We review these factors quarterly to determine if any adjustments are needed to the allowance. This guidance was effective beginning the first quarter of fiscal 2021 and did not have a material impact on our consolidated financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%"&gt;Recently Issued Financial Accounting Standards Not Yet Adopted&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We address the adoption impacts of recently issued accounting standards by the FASB on the our consolidated financial statements as well as material updates to previous assessments, if any, from our fiscal 2020 Form 10-K. There were no accounting &lt;/span&gt;&lt;/div&gt;standards issued in fiscal 2021 that will have a material impact on our consolidated financial statements.</us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock>
    <us-gaap:BasisOfAccountingPolicyPolicyTextBlock
      contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDAvZnJhZzpiYzA3ODhjZjRkZDE0YTM3OGRlYzVjMDA1NTk3Zjc0OS90ZXh0cmVnaW9uOmJjMDc4OGNmNGRkMTRhMzc4ZGVjNWMwMDU1OTdmNzQ5XzM5NTU3_f838702f-5cc1-49de-8f28-e0756b3fee43">&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%"&gt;Basis of Presentation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our consolidated financial statements include the accounts of all majority-owned or controlled subsidiaries, and all significant intercompany transactions and amounts have been eliminated. The results of businesses acquired or disposed of are included in the consolidated financial statements from the date of the acquisition or up to the date of disposal, respectively.&lt;/span&gt;&lt;/div&gt;</us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
    <us-gaap:UseOfEstimates
      contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDAvZnJhZzpiYzA3ODhjZjRkZDE0YTM3OGRlYzVjMDA1NTk3Zjc0OS90ZXh0cmVnaW9uOmJjMDc4OGNmNGRkMTRhMzc4ZGVjNWMwMDU1OTdmNzQ5XzM5NjY4_5fa4363d-7b1a-4f96-9921-d68d242e34ea">&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%"&gt;Use of Estimates&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our consolidated financial statements are prepared in accordance with accounting principles generally accepted in the United States (&#x201c;GAAP&#x201d;). The preparation of financial statements in accordance with GAAP requires us to make estimates, judgments and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes. Estimates, judgments and assumptions are used in the accounting and disclosure related to, among other items, allowance for doubtful accounts, inventory valuation and reserves, goodwill and other intangible asset impairment, loss contingencies (including product liability and self-insurance accruals), and income taxes. Actual amounts could ultimately differ from these estimated amounts.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The COVID-19 pandemic ("COVID-19") continues to affect the U.S. and global economies, and as previously disclosed, the pandemic began to materially affect our businesses during the third quarter of fiscal 2020. The length and severity of the pandemic and its impacts on our businesses and results of operations are uncertain.&lt;/span&gt;&lt;/div&gt;</us-gaap:UseOfEstimates>
    <us-gaap:CashAndCashEquivalentsPolicyTextBlock
      contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDAvZnJhZzpiYzA3ODhjZjRkZDE0YTM3OGRlYzVjMDA1NTk3Zjc0OS90ZXh0cmVnaW9uOmJjMDc4OGNmNGRkMTRhMzc4ZGVjNWMwMDU1OTdmNzQ5XzM5NTQw_aaf13367-d143-411e-9a7b-7d042d162f60">&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%"&gt;Cash Equivalents&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We consider liquid investments purchased with an initial maturity of three months or less to be cash equivalents. The carrying value of cash equivalents approximates fair value.&lt;/span&gt;&lt;/div&gt;</us-gaap:CashAndCashEquivalentsPolicyTextBlock>
    <us-gaap:ReceivablesPolicyTextBlock
      contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDAvZnJhZzpiYzA3ODhjZjRkZDE0YTM3OGRlYzVjMDA1NTk3Zjc0OS90ZXh0cmVnaW9uOmJjMDc4OGNmNGRkMTRhMzc4ZGVjNWMwMDU1OTdmNzQ5XzM5NzAz_6f648e5d-5e65-4ef3-b482-f5a025e73ef1">&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%"&gt;Receivables and Allowance for Doubtful Accounts&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Trade receivables are presented net of an allowance for doubtful accounts of $242 million and $206 million at June&#160;30, 2021 and 2020, respectively. An account is considered past due on the first &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;day after its due date. In accordance with contract terms, we generally have the ability to charge customers service fees or higher prices if an account is considered past due. We regularly monitor past due accounts and establish appropriate reserves to cover potential losses, and consider historical experience, the current economic environment, customer credit ratings or bankruptcies, and reasonable and supportable forecasts to develop our allowance for credit losses. We review these factors quarterly to determine if any adjustments are needed to the allowance. We write off any amounts deemed uncollectible against the established allowance for doubtful accounts.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We provide financing to various customers. Such financing arrangements range from 1 year&#160;to 5 years at interest rates that are generally subject to fluctuation. Interest income on these arrangements is recognized as it is earned. The financings may be collateralized, guaranteed by third parties or unsecured. Finance notes, net and related accrued interest were $63 million (current portion $7 million) and $104 million (current portion $12 million) at June&#160;30, 2021 and 2020, respectively, and are included in other assets (current portion is included in prepaid expenses and other) in the consolidated balance sheets. Finance notes receivable allowance for doubtful accounts were $12 million and $27 million at June&#160;30, 2021 and 2020, respectively. We estimate an allowance for these financing receivables based on historical collection rates and the credit worthiness of the customer. We write off any amounts deemed uncollectible against the established allowance for doubtful accounts.&lt;/span&gt;&lt;/div&gt;</us-gaap:ReceivablesPolicyTextBlock>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="iaf39bca192e042209819db3ca973f9f5_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDAvZnJhZzpiYzA3ODhjZjRkZDE0YTM3OGRlYzVjMDA1NTk3Zjc0OS90ZXh0cmVnaW9uOmJjMDc4OGNmNGRkMTRhMzc4ZGVjNWMwMDU1OTdmNzQ5XzI5MjY_e2baecf5-20b7-4918-bf52-772c1465c16b"
      unitRef="usd">242000000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="ida278becedcc42e688e90f303ce681a6_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDAvZnJhZzpiYzA3ODhjZjRkZDE0YTM3OGRlYzVjMDA1NTk3Zjc0OS90ZXh0cmVnaW9uOmJjMDc4OGNmNGRkMTRhMzc4ZGVjNWMwMDU1OTdmNzQ5XzI5MzM_a388bfe1-927b-4cb6-b275-454d64e6101e"
      unitRef="usd">206000000</us-gaap:ValuationAllowancesAndReservesBalance>
    <cah:ReceivableFinancingAgreementTerm
      contextRef="ia892a1655a98484e8d25b9944babb1df_D20200701-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDAvZnJhZzpiYzA3ODhjZjRkZDE0YTM3OGRlYzVjMDA1NTk3Zjc0OS90ZXh0cmVnaW9uOmJjMDc4OGNmNGRkMTRhMzc4ZGVjNWMwMDU1OTdmNzQ5XzM1NzQ_3f3fdfa7-888d-4ab9-8370-f4bcfbe9c20a">P1Y</cah:ReceivableFinancingAgreementTerm>
    <cah:ReceivableFinancingAgreementTerm
      contextRef="icc7d995e453e439bb115adae40076bfd_D20200701-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDAvZnJhZzpiYzA3ODhjZjRkZDE0YTM3OGRlYzVjMDA1NTk3Zjc0OS90ZXh0cmVnaW9uOmJjMDc4OGNmNGRkMTRhMzc4ZGVjNWMwMDU1OTdmNzQ5XzM1ODA_329714df-a369-40f0-a89c-a276412c140e">P5Y</cah:ReceivableFinancingAgreementTerm>
    <us-gaap:NotesReceivableNet
      contextRef="i2e87824102b34590a0208cc7da91b5f5_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDAvZnJhZzpiYzA3ODhjZjRkZDE0YTM3OGRlYzVjMDA1NTk3Zjc0OS90ZXh0cmVnaW9uOmJjMDc4OGNmNGRkMTRhMzc4ZGVjNWMwMDU1OTdmNzQ5XzM4NDY_76695071-386f-433b-bc01-e8d1693b55b2"
      unitRef="usd">63000000</us-gaap:NotesReceivableNet>
    <us-gaap:NotesAndLoansReceivableNetCurrent
      contextRef="i2e87824102b34590a0208cc7da91b5f5_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDAvZnJhZzpiYzA3ODhjZjRkZDE0YTM3OGRlYzVjMDA1NTk3Zjc0OS90ZXh0cmVnaW9uOmJjMDc4OGNmNGRkMTRhMzc4ZGVjNWMwMDU1OTdmNzQ5XzM4NjY_41373b3e-87f8-4c87-abe6-2e7ca7751f24"
      unitRef="usd">7000000</us-gaap:NotesAndLoansReceivableNetCurrent>
    <us-gaap:NotesReceivableNet
      contextRef="i299cea70f47b4fbe96772aaa8cc00b79_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDAvZnJhZzpiYzA3ODhjZjRkZDE0YTM3OGRlYzVjMDA1NTk3Zjc0OS90ZXh0cmVnaW9uOmJjMDc4OGNmNGRkMTRhMzc4ZGVjNWMwMDU1OTdmNzQ5XzM4NzQ_bd9206d2-224d-4772-8764-aa436ca21fa6"
      unitRef="usd">104000000</us-gaap:NotesReceivableNet>
    <us-gaap:NotesAndLoansReceivableNetCurrent
      contextRef="i299cea70f47b4fbe96772aaa8cc00b79_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDAvZnJhZzpiYzA3ODhjZjRkZDE0YTM3OGRlYzVjMDA1NTk3Zjc0OS90ZXh0cmVnaW9uOmJjMDc4OGNmNGRkMTRhMzc4ZGVjNWMwMDU1OTdmNzQ5XzM4OTQ_3c8a4b67-7c90-4758-ba6e-42ab4085f951"
      unitRef="usd">12000000</us-gaap:NotesAndLoansReceivableNetCurrent>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="id99ac5e3640e4d909d5ebe92cc1a2ccc_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDAvZnJhZzpiYzA3ODhjZjRkZDE0YTM3OGRlYzVjMDA1NTk3Zjc0OS90ZXh0cmVnaW9uOmJjMDc4OGNmNGRkMTRhMzc4ZGVjNWMwMDU1OTdmNzQ5XzQ5NDc4MDIzODI1NjI_476f21f1-02dc-4429-bf2f-1ad952e3876b"
      unitRef="usd">12000000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="i8572a6af84c14033a1b8f2ffeeaa45fa_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDAvZnJhZzpiYzA3ODhjZjRkZDE0YTM3OGRlYzVjMDA1NTk3Zjc0OS90ZXh0cmVnaW9uOmJjMDc4OGNmNGRkMTRhMzc4ZGVjNWMwMDU1OTdmNzQ5XzQ5NDc4MDIzODI1NzI_6fd0ca3e-3f78-4744-b522-854a7e595f33"
      unitRef="usd">27000000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ConcentrationRiskCreditRisk
      contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDAvZnJhZzpiYzA3ODhjZjRkZDE0YTM3OGRlYzVjMDA1NTk3Zjc0OS90ZXh0cmVnaW9uOmJjMDc4OGNmNGRkMTRhMzc4ZGVjNWMwMDU1OTdmNzQ5XzM5Njg3_f9f26915-9563-4caa-b590-c694209c99e6">&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%"&gt;Concentrations of Credit Risk&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We maintain cash depository accounts with major banks, and we invest in high quality, short-term liquid instruments, and in marketable securities. Our short-term liquid instruments mature within three months and we have not historically incurred any related losses.&lt;/span&gt;&lt;/div&gt;Our trade receivables and finance notes and related accrued interest are exposed to a concentration of credit risk with certain large customers and with customers in the retail and healthcare sectors. Credit risk can be affected by changes in reimbursement and other economic pressures impacting the healthcare industry. With respect to customers in the retail and healthcare sectors, such credit risk is limited due to supporting collateral and the diversity of the customer base, including its wide geographic dispersion. We perform regular credit evaluations of our customers&#x2019; financial conditions and maintain reserves for losses through the established allowance for doubtful accounts. Historically, such losses have been within our expectations. Refer to the "Receivables and Allowance for Doubtful Accounts" section within this Note for additional information on the accounting treatment of reserves for allowance for doubtful accounts.</us-gaap:ConcentrationRiskCreditRisk>
    <us-gaap:MajorCustomersPolicyPolicyTextBlock
      contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDAvZnJhZzpiYzA3ODhjZjRkZDE0YTM3OGRlYzVjMDA1NTk3Zjc0OS90ZXh0cmVnaW9uOmJjMDc4OGNmNGRkMTRhMzc4ZGVjNWMwMDU1OTdmNzQ5XzM5NzEx_817e66e7-ee1c-4f98-84fc-1a9f7db95dd5">&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%"&gt;Major Customers&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;CVS Health Corporation ("CVS") and OptumRx, are our only customers that individually account for at least 10 percent of revenue and gross trade receivables. These customers are primarily serviced through our Pharmaceutical segment.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In August 2021, we extended our pharmaceutical distribution agreements with CVS through June 2027. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes historical percent of revenue and gross trade receivables from CVS and OptumRx:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.382%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:35.235%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.148%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.352%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.769%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.352%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.769%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.352%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.632%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.352%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.639%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Percent of Revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Percent&#160;of&#160;Gross Trade&#160;Receivables at June 30&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;CVS&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;26&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;24&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;OptumRx&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;15&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;3&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;We have entered into agreements with group purchasing organizations (&#x201c;GPOs&#x201d;) which act as purchasing agents that negotiate vendor contracts on behalf of their members. Vizient, Inc. and Premier, Inc. are our two largest GPO member relationships in terms of revenue. Sales to members of these two GPOs collectively accounted for 15 percent, 16 percent and 22 percent of revenue for fiscal 2021, 2020 and 2019, respectively. Our trade receivable balances are with individual members of the GPO, and therefore no significant concentration of credit risk exists with these types of arrangements</us-gaap:MajorCustomersPolicyPolicyTextBlock>
    <us-gaap:ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock
      contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDAvZnJhZzpiYzA3ODhjZjRkZDE0YTM3OGRlYzVjMDA1NTk3Zjc0OS90ZXh0cmVnaW9uOmJjMDc4OGNmNGRkMTRhMzc4ZGVjNWMwMDU1OTdmNzQ5XzM5NTky_d413f0d4-e4f3-411f-a90d-2eb0a96e8ebb">&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes historical percent of revenue and gross trade receivables from CVS and OptumRx:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.382%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:35.235%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.148%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.352%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.769%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.352%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.769%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.352%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.632%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.352%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.639%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Percent of Revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Percent&#160;of&#160;Gross Trade&#160;Receivables at June 30&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;CVS&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;26&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;24&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;OptumRx&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;15&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;3&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i9acbd6b22d7142e09e2d233e54af7d6b_D20200701-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDAvZnJhZzpiYzA3ODhjZjRkZDE0YTM3OGRlYzVjMDA1NTk3Zjc0OS90YWJsZToxMGI5YjljZjkzZTE0NDQ5OTRjYzYzZTViNzhiZThmYi90YWJsZXJhbmdlOjEwYjliOWNmOTNlMTQ0NDk5NGNjNjNlNWI3OGJlOGZiXzItMS0xLTEtMA_d1b7f021-1fda-414d-9ad5-c887e8a8b698"
      unitRef="number">0.26</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i40defd3d1e074fa6bc03365b87fbc0b2_D20190701-20200630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDAvZnJhZzpiYzA3ODhjZjRkZDE0YTM3OGRlYzVjMDA1NTk3Zjc0OS90YWJsZToxMGI5YjljZjkzZTE0NDQ5OTRjYzYzZTViNzhiZThmYi90YWJsZXJhbmdlOjEwYjliOWNmOTNlMTQ0NDk5NGNjNjNlNWI3OGJlOGZiXzItMy0xLTEtMA_8a030c56-e44a-4a89-9c8d-77ea87287b61"
      unitRef="number">0.26</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="if0d0d489f9374df68a492baec5bcd02d_D20180701-20190630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDAvZnJhZzpiYzA3ODhjZjRkZDE0YTM3OGRlYzVjMDA1NTk3Zjc0OS90YWJsZToxMGI5YjljZjkzZTE0NDQ5OTRjYzYzZTViNzhiZThmYi90YWJsZXJhbmdlOjEwYjliOWNmOTNlMTQ0NDk5NGNjNjNlNWI3OGJlOGZiXzItNS0xLTEtMA_dd61db83-5907-401d-8e9f-da638390382c"
      unitRef="number">0.26</us-gaap:ConcentrationRiskPercentage1>
    <cah:GrossTradeReceivablesMajorCustomerPercentage
      contextRef="i8e11ba21ea4c434ca0730a61f91af07b_I20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDAvZnJhZzpiYzA3ODhjZjRkZDE0YTM3OGRlYzVjMDA1NTk3Zjc0OS90YWJsZToxMGI5YjljZjkzZTE0NDQ5OTRjYzYzZTViNzhiZThmYi90YWJsZXJhbmdlOjEwYjliOWNmOTNlMTQ0NDk5NGNjNjNlNWI3OGJlOGZiXzItNy0xLTEtMA_f3cc50b8-d7d1-4307-9570-696709942133"
      unitRef="number">0.24</cah:GrossTradeReceivablesMajorCustomerPercentage>
    <cah:GrossTradeReceivablesMajorCustomerPercentage
      contextRef="i26a1dbe593234221b3e2a9fe87790b80_I20200630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDAvZnJhZzpiYzA3ODhjZjRkZDE0YTM3OGRlYzVjMDA1NTk3Zjc0OS90YWJsZToxMGI5YjljZjkzZTE0NDQ5OTRjYzYzZTViNzhiZThmYi90YWJsZXJhbmdlOjEwYjliOWNmOTNlMTQ0NDk5NGNjNjNlNWI3OGJlOGZiXzItOS0xLTEtMA_39876640-eeb0-4c81-8ff9-90e73c20695f"
      unitRef="number">0.26</cah:GrossTradeReceivablesMajorCustomerPercentage>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i23c2808f4a0248299010d7304821d021_D20200701-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDAvZnJhZzpiYzA3ODhjZjRkZDE0YTM3OGRlYzVjMDA1NTk3Zjc0OS90YWJsZToxMGI5YjljZjkzZTE0NDQ5OTRjYzYzZTViNzhiZThmYi90YWJsZXJhbmdlOjEwYjliOWNmOTNlMTQ0NDk5NGNjNjNlNWI3OGJlOGZiXzMtMS0xLTEtMA_5715e260-b661-47f5-b84c-86179cbbbd4b"
      unitRef="number">0.15</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i59cb1fe9f0d846b1911e81858e217d59_D20190701-20200630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDAvZnJhZzpiYzA3ODhjZjRkZDE0YTM3OGRlYzVjMDA1NTk3Zjc0OS90YWJsZToxMGI5YjljZjkzZTE0NDQ5OTRjYzYzZTViNzhiZThmYi90YWJsZXJhbmdlOjEwYjliOWNmOTNlMTQ0NDk5NGNjNjNlNWI3OGJlOGZiXzMtMy0xLTEtMA_a3f1b582-7111-40e9-8fa9-e4b9b32320b6"
      unitRef="number">0.14</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="id8d95892717a49629b3d443c58d7bb6f_D20180701-20190630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDAvZnJhZzpiYzA3ODhjZjRkZDE0YTM3OGRlYzVjMDA1NTk3Zjc0OS90YWJsZToxMGI5YjljZjkzZTE0NDQ5OTRjYzYzZTViNzhiZThmYi90YWJsZXJhbmdlOjEwYjliOWNmOTNlMTQ0NDk5NGNjNjNlNWI3OGJlOGZiXzMtNS0xLTEtMA_04fd11cb-287d-4fba-89ad-d1d0ac82cc4b"
      unitRef="number">0.13</us-gaap:ConcentrationRiskPercentage1>
    <cah:GrossTradeReceivablesMajorCustomerPercentage
      contextRef="ife972a3c1957499f9517925bfb292b1e_I20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDAvZnJhZzpiYzA3ODhjZjRkZDE0YTM3OGRlYzVjMDA1NTk3Zjc0OS90YWJsZToxMGI5YjljZjkzZTE0NDQ5OTRjYzYzZTViNzhiZThmYi90YWJsZXJhbmdlOjEwYjliOWNmOTNlMTQ0NDk5NGNjNjNlNWI3OGJlOGZiXzMtNy0xLTEtMA_d7d5c023-5046-4cbd-ab6a-e5ac92757cc9"
      unitRef="number">0.03</cah:GrossTradeReceivablesMajorCustomerPercentage>
    <cah:GrossTradeReceivablesMajorCustomerPercentage
      contextRef="i2603a56be62748bcadc6977aeeb99c1b_I20200630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDAvZnJhZzpiYzA3ODhjZjRkZDE0YTM3OGRlYzVjMDA1NTk3Zjc0OS90YWJsZToxMGI5YjljZjkzZTE0NDQ5OTRjYzYzZTViNzhiZThmYi90YWJsZXJhbmdlOjEwYjliOWNmOTNlMTQ0NDk5NGNjNjNlNWI3OGJlOGZiXzMtOS0xLTEtMA_18f87e1a-0296-4460-ab0b-b7c5530855ce"
      unitRef="number">0.06</cah:GrossTradeReceivablesMajorCustomerPercentage>
    <cah:ConcentrationRiskLargestGroupPurchasingOrganizations
      contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDAvZnJhZzpiYzA3ODhjZjRkZDE0YTM3OGRlYzVjMDA1NTk3Zjc0OS90ZXh0cmVnaW9uOmJjMDc4OGNmNGRkMTRhMzc4ZGVjNWMwMDU1OTdmNzQ5XzYyMDY_da0f3c10-60b7-4c6f-9e23-738466527940"
      unitRef="organization">2</cah:ConcentrationRiskLargestGroupPurchasingOrganizations>
    <cah:ConcentrationRiskLargestGroupPurchasingOrganizations
      contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDAvZnJhZzpiYzA3ODhjZjRkZDE0YTM3OGRlYzVjMDA1NTk3Zjc0OS90ZXh0cmVnaW9uOmJjMDc4OGNmNGRkMTRhMzc4ZGVjNWMwMDU1OTdmNzQ5XzYyODk_da0f3c10-60b7-4c6f-9e23-738466527940"
      unitRef="organization">2</cah:ConcentrationRiskLargestGroupPurchasingOrganizations>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i9ff517d7ac9a411688a31be9bf4cb05e_D20200701-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDAvZnJhZzpiYzA3ODhjZjRkZDE0YTM3OGRlYzVjMDA1NTk3Zjc0OS90ZXh0cmVnaW9uOmJjMDc4OGNmNGRkMTRhMzc4ZGVjNWMwMDU1OTdmNzQ5XzYzMjQ_48bd2286-84fc-414b-994d-4e663c68d41f"
      unitRef="number">0.15</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i996d2cdb68d6466fbd2b2c5d332e8f86_D20190701-20200630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDAvZnJhZzpiYzA3ODhjZjRkZDE0YTM3OGRlYzVjMDA1NTk3Zjc0OS90ZXh0cmVnaW9uOmJjMDc4OGNmNGRkMTRhMzc4ZGVjNWMwMDU1OTdmNzQ5XzYzMjg_4c4b7351-4ab7-4b3d-96df-e91d069fdd73"
      unitRef="number">0.16</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i9ac168f728314508a0b6274f4b016f43_D20180701-20190630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDAvZnJhZzpiYzA3ODhjZjRkZDE0YTM3OGRlYzVjMDA1NTk3Zjc0OS90ZXh0cmVnaW9uOmJjMDc4OGNmNGRkMTRhMzc4ZGVjNWMwMDU1OTdmNzQ5XzYzMzU_72785fee-01cd-4cd1-a7c1-cb8f753c8fd5"
      unitRef="number">0.22</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:InventoryPolicyTextBlock
      contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDAvZnJhZzpiYzA3ODhjZjRkZDE0YTM3OGRlYzVjMDA1NTk3Zjc0OS90ZXh0cmVnaW9uOmJjMDc4OGNmNGRkMTRhMzc4ZGVjNWMwMDU1OTdmNzQ5XzM5NjY5_0d8b263b-b48a-4e72-9d37-b543d6277ccc">&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%"&gt;Inventories&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A portion of our inventories (50 percent and 56 percent at June&#160;30, 2021 and 2020, respectively) are valued at the lower of cost, using the last-in, first-out ("LIFO") method, or market. These inventories are included within the core pharmaceutical distribution facilities of our Pharmaceutical segment (&#x201c;distribution facilities&#x201d;) and are primarily merchandise inventories. The LIFO method presumes that the most recent inventory purchases are the first items sold, so LIFO helps us better match current costs and revenue. We believe that the average cost method of inventory valuation provides a reasonable approximation of the current cost of replacing inventory within the distribution facilities. As such, the LIFO reserve is the difference between (a) inventory at the lower of LIFO cost or market and (b) inventory at replacement cost determined using the average cost method of inventory valuation.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At June&#160;30, 2021 and 2020, respectively, inventories valued at LIFO cost were $565 million and&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$411 million higher than the average cost value. We do not record inventories in excess of replacement cost. As such, we did not write-up the value of our inventory from average cost to LIFO cost at June&#160;30, 2021 or 2020. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our remaining inventory, including inventory in our Medical segment, that is not valued at the lower of LIFO cost or market is stated at the lower of cost, using the first-in, first-out method, or net realizable value. Net realizable value is defined as the estimated selling prices and estimated sales demand in the ordinary course of business, less reasonably predictable costs of completion, disposal and transportation. Due to the unprecedented demand for &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;certain personal protective equipment as a result of COVID-19, our Medical segment manufactured and sourced inventory at higher costs than in periods prior to COVID-19. Personal protective equipment ("PPE") refers to protective clothing, medical and non-medical grade gloves, face shields, face masks and other equipment designed to protect the wearer from injury or the spread of infection or illness. As selling prices and customer demand have decreased compared to the peak of COVID-19, we recorded a reserve of $197&#160;million, primarily related to certain categories of gloves, to reduce the carrying value of certain PPE to its net realizable value.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We reserve for inventory obsolescence using estimates based on historical experience, historical and projected sales trends, specific&#160;categories of inventory, age and expiration dates of on-hand inventory and manufacturer return policies. Inventories presented in the consolidated balance sheets are net of reserves for excess and obsolete inventory which were $185 million and $155 million at June&#160;30, 2021 and 2020, respectively.&lt;/span&gt;&lt;/div&gt;</us-gaap:InventoryPolicyTextBlock>
    <us-gaap:PercentageOfLIFOInventory
      contextRef="i2e87824102b34590a0208cc7da91b5f5_I20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDAvZnJhZzpiYzA3ODhjZjRkZDE0YTM3OGRlYzVjMDA1NTk3Zjc0OS90ZXh0cmVnaW9uOmJjMDc4OGNmNGRkMTRhMzc4ZGVjNWMwMDU1OTdmNzQ5XzY2MTI_19857964-ee03-4931-ba4c-53afb2fdb534"
      unitRef="number">0.50</us-gaap:PercentageOfLIFOInventory>
    <us-gaap:PercentageOfLIFOInventory
      contextRef="i299cea70f47b4fbe96772aaa8cc00b79_I20200630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDAvZnJhZzpiYzA3ODhjZjRkZDE0YTM3OGRlYzVjMDA1NTk3Zjc0OS90ZXh0cmVnaW9uOmJjMDc4OGNmNGRkMTRhMzc4ZGVjNWMwMDU1OTdmNzQ5XzQ5NDc4MDIzODIzNzc_bc5ff157-961a-4e30-92d8-baab64d29df3"
      unitRef="number">0.56</us-gaap:PercentageOfLIFOInventory>
    <us-gaap:InventoryLIFOReserve
      contextRef="i2e87824102b34590a0208cc7da91b5f5_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDAvZnJhZzpiYzA3ODhjZjRkZDE0YTM3OGRlYzVjMDA1NTk3Zjc0OS90ZXh0cmVnaW9uOmJjMDc4OGNmNGRkMTRhMzc4ZGVjNWMwMDU1OTdmNzQ5Xzc1MDg_1d921f53-8043-470e-a58d-9adcc4e36bcf"
      unitRef="usd">565000000</us-gaap:InventoryLIFOReserve>
    <us-gaap:InventoryLIFOReserve
      contextRef="i299cea70f47b4fbe96772aaa8cc00b79_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDAvZnJhZzpiYzA3ODhjZjRkZDE0YTM3OGRlYzVjMDA1NTk3Zjc0OS90ZXh0cmVnaW9uOmJjMDc4OGNmNGRkMTRhMzc4ZGVjNWMwMDU1OTdmNzQ5Xzc1MTU_caf07329-39ed-410f-a51e-f705d995ee77"
      unitRef="usd">411000000</us-gaap:InventoryLIFOReserve>
    <us-gaap:InventoryWriteDown
      contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDAvZnJhZzpiYzA3ODhjZjRkZDE0YTM3OGRlYzVjMDA1NTk3Zjc0OS90ZXh0cmVnaW9uOmJjMDc4OGNmNGRkMTRhMzc4ZGVjNWMwMDU1OTdmNzQ5XzIxOTkwMjMzMjIzNzA_0af402cc-5b40-4426-b043-8125e75c2161"
      unitRef="usd">197000000</us-gaap:InventoryWriteDown>
    <us-gaap:InventoryValuationReserves
      contextRef="i2e87824102b34590a0208cc7da91b5f5_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDAvZnJhZzpiYzA3ODhjZjRkZDE0YTM3OGRlYzVjMDA1NTk3Zjc0OS90ZXh0cmVnaW9uOmJjMDc4OGNmNGRkMTRhMzc4ZGVjNWMwMDU1OTdmNzQ5XzEyMDk0NjI3OTYzNjYx_e5975be3-df1c-4ebf-aed6-f7151b648478"
      unitRef="usd">185000000</us-gaap:InventoryValuationReserves>
    <us-gaap:InventoryValuationReserves
      contextRef="i299cea70f47b4fbe96772aaa8cc00b79_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDAvZnJhZzpiYzA3ODhjZjRkZDE0YTM3OGRlYzVjMDA1NTk3Zjc0OS90ZXh0cmVnaW9uOmJjMDc4OGNmNGRkMTRhMzc4ZGVjNWMwMDU1OTdmNzQ5XzEyMDk0NjI3OTYzNjcw_74f33589-015c-4e75-8957-d290d52cecbd"
      unitRef="usd">155000000</us-gaap:InventoryValuationReserves>
    <cah:CashDiscountsPolicyTextBlock
      contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDAvZnJhZzpiYzA3ODhjZjRkZDE0YTM3OGRlYzVjMDA1NTk3Zjc0OS90ZXh0cmVnaW9uOmJjMDc4OGNmNGRkMTRhMzc4ZGVjNWMwMDU1OTdmNzQ5XzM5NTQx_8ce7f488-4f68-40c1-a0c6-d6a952acbd6c">&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%"&gt;Cash Discounts&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Manufacturer cash discounts are recorded as a component of inventory cost and recognized as a reduction of cost of products sold as inventory is sold.&lt;/span&gt;&lt;/div&gt;</cah:CashDiscountsPolicyTextBlock>
    <us-gaap:PropertyPlantAndEquipmentPolicyTextBlock
      contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDAvZnJhZzpiYzA3ODhjZjRkZDE0YTM3OGRlYzVjMDA1NTk3Zjc0OS90ZXh0cmVnaW9uOmJjMDc4OGNmNGRkMTRhMzc4ZGVjNWMwMDU1OTdmNzQ5XzM5NjI3_830b3b01-48e5-4b12-b8e0-d4fdb8a0cecf">&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%"&gt;Property and Equipment&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Property and equipment are carried at cost less accumulated depreciation. Property and equipment held for sale are recorded at the lower of cost less accumulated depreciation before the decision to dispose of the asset was made or fair value less cost to sell. When certain events or changes in operating conditions occur, an impairment assessment may be performed on the recoverability of the carrying amounts.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Depreciation expense is computed using the straight-line method over the estimated useful lives of the assets, including finance lease assets which are depreciated over the terms of their respective leases. We generally use the following range of useful lives for our property and equipment categories: buildings and improvements&#x2014;3 to 39 years; machinery and equipment&#x2014;3 to 20 years; and furniture and fixtures&#x2014;3 to 7 years. We recorded depreciation and amortization expense of $377 million, $405 million and $455 million for fiscal 2021, 2020 and 2019, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the components of property and equipment, net at June&#160;30:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.183%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.343%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.186%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Land, building and improvements&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2,359&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,185&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Machinery and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;3,093&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3,008&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Furniture and fixtures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;136&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;138&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total property and equipment, at cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;5,588&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;5,331&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Accumulated depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(3,228)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(2,965)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Property and equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2,360&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,366&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Repairs and maintenance expenditures are expensed as incurred. Interest on long-term projects is capitalized using a rate that approximates the weighted-average interest rate on long-term &lt;/span&gt;&lt;/div&gt;obligations, which was 3 percent at June&#160;30, 2021. The amount of capitalized interest was immaterial for all periods presented.</us-gaap:PropertyPlantAndEquipmentPolicyTextBlock>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="i614ddf8189e1435c9f69debafd0268da_D20200701-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDAvZnJhZzpiYzA3ODhjZjRkZDE0YTM3OGRlYzVjMDA1NTk3Zjc0OS90ZXh0cmVnaW9uOmJjMDc4OGNmNGRkMTRhMzc4ZGVjNWMwMDU1OTdmNzQ5XzkzMTU_1e6e74b8-b823-4418-996d-22db8ec9b959">P3Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="i74619ac5c2144773b658fb4dc96df2b7_D20200701-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDAvZnJhZzpiYzA3ODhjZjRkZDE0YTM3OGRlYzVjMDA1NTk3Zjc0OS90ZXh0cmVnaW9uOmJjMDc4OGNmNGRkMTRhMzc4ZGVjNWMwMDU1OTdmNzQ5XzkzMjE_b7cbb8f6-be12-453d-8572-89ab1cf4718b">P39Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="i4462638f30ef4b028287aa4982bcdc4f_D20200701-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDAvZnJhZzpiYzA3ODhjZjRkZDE0YTM3OGRlYzVjMDA1NTk3Zjc0OS90ZXh0cmVnaW9uOmJjMDc4OGNmNGRkMTRhMzc4ZGVjNWMwMDU1OTdmNzQ5XzkzNDk_2e03d07f-c528-458a-a32b-4c1c91153dd7">P3Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="i931fb7e29527410db9aa126b3ff884f1_D20200701-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDAvZnJhZzpiYzA3ODhjZjRkZDE0YTM3OGRlYzVjMDA1NTk3Zjc0OS90ZXh0cmVnaW9uOmJjMDc4OGNmNGRkMTRhMzc4ZGVjNWMwMDU1OTdmNzQ5XzkzNTU_f06405b9-38e8-4470-9e96-73d4e9ea4bfd">P20Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="i8ffd747abee84446822890ec937c3087_D20200701-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDAvZnJhZzpiYzA3ODhjZjRkZDE0YTM3OGRlYzVjMDA1NTk3Zjc0OS90ZXh0cmVnaW9uOmJjMDc4OGNmNGRkMTRhMzc4ZGVjNWMwMDU1OTdmNzQ5XzkzODY_c2ba5d38-6093-490b-9076-5b6b8eecc3d8">P3Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="i761e5d4debc244e2b82864c57e70fa08_D20200701-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDAvZnJhZzpiYzA3ODhjZjRkZDE0YTM3OGRlYzVjMDA1NTk3Zjc0OS90ZXh0cmVnaW9uOmJjMDc4OGNmNGRkMTRhMzc4ZGVjNWMwMDU1OTdmNzQ5XzkzOTI_335d86d9-08af-4dcc-8e5c-8e25e13b59c5">P7Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:Depreciation
      contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDAvZnJhZzpiYzA3ODhjZjRkZDE0YTM3OGRlYzVjMDA1NTk3Zjc0OS90ZXh0cmVnaW9uOmJjMDc4OGNmNGRkMTRhMzc4ZGVjNWMwMDU1OTdmNzQ5Xzk0NDk_9754d1e3-7f50-4f8b-a4e8-857607417365"
      unitRef="usd">377000000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="ia31e9a409b874bb19d0ff6f2f39ecc09_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDAvZnJhZzpiYzA3ODhjZjRkZDE0YTM3OGRlYzVjMDA1NTk3Zjc0OS90ZXh0cmVnaW9uOmJjMDc4OGNmNGRkMTRhMzc4ZGVjNWMwMDU1OTdmNzQ5Xzk0NTM_64296993-0aab-4cf8-8931-6ca147ed5aa5"
      unitRef="usd">405000000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="i00a6d666bf604826b24e68ddbd63eac4_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDAvZnJhZzpiYzA3ODhjZjRkZDE0YTM3OGRlYzVjMDA1NTk3Zjc0OS90ZXh0cmVnaW9uOmJjMDc4OGNmNGRkMTRhMzc4ZGVjNWMwMDU1OTdmNzQ5Xzk0NjA_b0d4e260-2fde-43d0-8369-dac58629ddd3"
      unitRef="usd">455000000</us-gaap:Depreciation>
    <us-gaap:PropertyPlantAndEquipmentTextBlock
      contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDAvZnJhZzpiYzA3ODhjZjRkZDE0YTM3OGRlYzVjMDA1NTk3Zjc0OS90ZXh0cmVnaW9uOmJjMDc4OGNmNGRkMTRhMzc4ZGVjNWMwMDU1OTdmNzQ5XzM5NzE2_c858f00f-54c9-4b85-bf8a-53376cc763a7">&lt;div style="margin-top:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the components of property and equipment, net at June&#160;30:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.183%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.343%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.186%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Land, building and improvements&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2,359&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,185&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Machinery and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;3,093&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3,008&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Furniture and fixtures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;136&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;138&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total property and equipment, at cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;5,588&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;5,331&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Accumulated depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(3,228)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(2,965)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Property and equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2,360&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,366&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:PropertyPlantAndEquipmentTextBlock>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i863c52bff06f4314bb6767d10ced9400_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDAvZnJhZzpiYzA3ODhjZjRkZDE0YTM3OGRlYzVjMDA1NTk3Zjc0OS90YWJsZTphMzkwOGY5YWViNDI0MzA0OTY4ZjQ3OWE1ODIyYzFiMS90YWJsZXJhbmdlOmEzOTA4ZjlhZWI0MjQzMDQ5NjhmNDc5YTU4MjJjMWIxXzEtMS0xLTEtMA_42bd4456-63aa-4595-9163-222c2e610831"
      unitRef="usd">2359000000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="ia665b083fde8404d909e9610ecbf7ad2_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDAvZnJhZzpiYzA3ODhjZjRkZDE0YTM3OGRlYzVjMDA1NTk3Zjc0OS90YWJsZTphMzkwOGY5YWViNDI0MzA0OTY4ZjQ3OWE1ODIyYzFiMS90YWJsZXJhbmdlOmEzOTA4ZjlhZWI0MjQzMDQ5NjhmNDc5YTU4MjJjMWIxXzEtMy0xLTEtMA_f1db9bf1-cb29-4892-a500-528bcf463c66"
      unitRef="usd">2185000000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="ic27322390092452ca30941dd0197b1c6_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDAvZnJhZzpiYzA3ODhjZjRkZDE0YTM3OGRlYzVjMDA1NTk3Zjc0OS90YWJsZTphMzkwOGY5YWViNDI0MzA0OTY4ZjQ3OWE1ODIyYzFiMS90YWJsZXJhbmdlOmEzOTA4ZjlhZWI0MjQzMDQ5NjhmNDc5YTU4MjJjMWIxXzItMS0xLTEtMA_a67c33f9-6a57-46cc-9bb2-2e681b201843"
      unitRef="usd">3093000000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="ia561b68251434cae953175730691825e_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDAvZnJhZzpiYzA3ODhjZjRkZDE0YTM3OGRlYzVjMDA1NTk3Zjc0OS90YWJsZTphMzkwOGY5YWViNDI0MzA0OTY4ZjQ3OWE1ODIyYzFiMS90YWJsZXJhbmdlOmEzOTA4ZjlhZWI0MjQzMDQ5NjhmNDc5YTU4MjJjMWIxXzItMy0xLTEtMA_187ca5fd-685b-44fe-b9dd-e889562eb814"
      unitRef="usd">3008000000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i98ce0cd9b3ce4100a31e1cfb9d99189d_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDAvZnJhZzpiYzA3ODhjZjRkZDE0YTM3OGRlYzVjMDA1NTk3Zjc0OS90YWJsZTphMzkwOGY5YWViNDI0MzA0OTY4ZjQ3OWE1ODIyYzFiMS90YWJsZXJhbmdlOmEzOTA4ZjlhZWI0MjQzMDQ5NjhmNDc5YTU4MjJjMWIxXzMtMS0xLTEtMA_49e5ebf3-d7e0-4367-80f9-f03682cbd6df"
      unitRef="usd">136000000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i4e7acf9f1e1840958a192fad32010e75_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDAvZnJhZzpiYzA3ODhjZjRkZDE0YTM3OGRlYzVjMDA1NTk3Zjc0OS90YWJsZTphMzkwOGY5YWViNDI0MzA0OTY4ZjQ3OWE1ODIyYzFiMS90YWJsZXJhbmdlOmEzOTA4ZjlhZWI0MjQzMDQ5NjhmNDc5YTU4MjJjMWIxXzMtMy0xLTEtMA_d6da300e-7f50-4812-b6fe-2e35bb02003b"
      unitRef="usd">138000000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i2e87824102b34590a0208cc7da91b5f5_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDAvZnJhZzpiYzA3ODhjZjRkZDE0YTM3OGRlYzVjMDA1NTk3Zjc0OS90YWJsZTphMzkwOGY5YWViNDI0MzA0OTY4ZjQ3OWE1ODIyYzFiMS90YWJsZXJhbmdlOmEzOTA4ZjlhZWI0MjQzMDQ5NjhmNDc5YTU4MjJjMWIxXzQtMS0xLTEtMA_0ce89af2-6a8d-4396-acf2-42c86a875166"
      unitRef="usd">5588000000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i299cea70f47b4fbe96772aaa8cc00b79_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDAvZnJhZzpiYzA3ODhjZjRkZDE0YTM3OGRlYzVjMDA1NTk3Zjc0OS90YWJsZTphMzkwOGY5YWViNDI0MzA0OTY4ZjQ3OWE1ODIyYzFiMS90YWJsZXJhbmdlOmEzOTA4ZjlhZWI0MjQzMDQ5NjhmNDc5YTU4MjJjMWIxXzQtMy0xLTEtMA_741f3c31-b5de-4530-be82-b0bad73c3f09"
      unitRef="usd">5331000000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="i2e87824102b34590a0208cc7da91b5f5_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDAvZnJhZzpiYzA3ODhjZjRkZDE0YTM3OGRlYzVjMDA1NTk3Zjc0OS90YWJsZTphMzkwOGY5YWViNDI0MzA0OTY4ZjQ3OWE1ODIyYzFiMS90YWJsZXJhbmdlOmEzOTA4ZjlhZWI0MjQzMDQ5NjhmNDc5YTU4MjJjMWIxXzUtMS0xLTEtMA_18c9e19c-5657-424b-b55a-74e122c33897"
      unitRef="usd">3228000000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="i299cea70f47b4fbe96772aaa8cc00b79_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDAvZnJhZzpiYzA3ODhjZjRkZDE0YTM3OGRlYzVjMDA1NTk3Zjc0OS90YWJsZTphMzkwOGY5YWViNDI0MzA0OTY4ZjQ3OWE1ODIyYzFiMS90YWJsZXJhbmdlOmEzOTA4ZjlhZWI0MjQzMDQ5NjhmNDc5YTU4MjJjMWIxXzUtMy0xLTEtMA_f3e7418a-6c0c-48fd-8fe5-0378e22b54f1"
      unitRef="usd">2965000000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i2e87824102b34590a0208cc7da91b5f5_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDAvZnJhZzpiYzA3ODhjZjRkZDE0YTM3OGRlYzVjMDA1NTk3Zjc0OS90YWJsZTphMzkwOGY5YWViNDI0MzA0OTY4ZjQ3OWE1ODIyYzFiMS90YWJsZXJhbmdlOmEzOTA4ZjlhZWI0MjQzMDQ5NjhmNDc5YTU4MjJjMWIxXzYtMS0xLTEtMA_da579983-2095-47b8-8542-c0ee4c2c23b5"
      unitRef="usd">2360000000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i299cea70f47b4fbe96772aaa8cc00b79_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDAvZnJhZzpiYzA3ODhjZjRkZDE0YTM3OGRlYzVjMDA1NTk3Zjc0OS90YWJsZTphMzkwOGY5YWViNDI0MzA0OTY4ZjQ3OWE1ODIyYzFiMS90YWJsZXJhbmdlOmEzOTA4ZjlhZWI0MjQzMDQ5NjhmNDc5YTU4MjJjMWIxXzYtMy0xLTEtMA_f8a4a7a4-697d-4faa-81ca-005c0456b9fb"
      unitRef="usd">2366000000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:LongtermDebtWeightedAverageInterestRate
      contextRef="i2e87824102b34590a0208cc7da91b5f5_I20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDAvZnJhZzpiYzA3ODhjZjRkZDE0YTM3OGRlYzVjMDA1NTk3Zjc0OS90ZXh0cmVnaW9uOmJjMDc4OGNmNGRkMTRhMzc4ZGVjNWMwMDU1OTdmNzQ5Xzk4MDM_4d50ac7f-1867-4e90-9da5-2b5a4ac514ab"
      unitRef="number">0.03</us-gaap:LongtermDebtWeightedAverageInterestRate>
    <us-gaap:GoodwillAndIntangibleAssetsPolicyTextBlock
      contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDAvZnJhZzpiYzA3ODhjZjRkZDE0YTM3OGRlYzVjMDA1NTk3Zjc0OS90ZXh0cmVnaW9uOmJjMDc4OGNmNGRkMTRhMzc4ZGVjNWMwMDU1OTdmNzQ5XzM5NjY1_118a249c-5825-4ef7-9ca2-199bb57b1c7c">&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%"&gt;Goodwill and Other Intangible Assets&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Purchased goodwill and intangible assets with indefinite lives are not amortized, but instead are tested for impairment annually or when indicators of impairment exist.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Purchased goodwill is tested for impairment at least annually. Qualitative factors are first assessed to determine if it is more likely than not that the fair value of a reporting unit is less than its carrying amount. There is an option to bypass the qualitative assessment for any reporting unit in any period and proceed directly to performing the quantitative goodwill impairment test. We have elected to bypass the qualitative assessment for our annual goodwill impairment test in the current year. The quantitative goodwill impairment test involves a comparison of the estimated fair value of the reporting unit to the respective carrying amount. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Goodwill impairment testing involves judgment, including the identification of reporting units, qualitative evaluation of events and circumstances to determine if it is more likely than not that an impairment exists, and, if necessary, the estimation of the fair value of the applicable reporting unit. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We have two operating segments, which are the same as our reportable segments: Pharmaceutical and Medical. These operating segments are comprised of divisions (components), for which discrete financial information is available. Components are aggregated into reporting units for purposes of goodwill impairment testing to the extent that they share similar economic characteristics. Our reporting units are: Pharmaceutical operating segment (excluding our Nuclear and Precision Health Solutions division); Nuclear and Precision Health Solutions division; Medical operating segment (excluding our Cardinal Health at-Home Solutions division) (&#x201c;Medical Unit&#x201d;); and Cardinal Health at-Home Solutions division.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Fair value can be determined using market, income or cost-based approaches. Our determination of estimated fair value of the reporting units is based on a combination of the income-based and market-based approaches. Under the income-based approach, we use a discounted cash flow model in which cash flows anticipated over several future periods, plus a terminal value at the end of that time horizon, are discounted to their present value using an appropriate risk-adjusted rate of return.&#160;We use our internal forecasts to estimate future cash flows, which we believe are consistent with those of a market participant, and include an estimate of long-term growth rates based on our most recent views of the long-term outlook for each reporting unit. Actual results may differ materially from those used in our forecasts. We use discount rates that are commensurate with the risks and uncertainty inherent in the respective reporting units and in our internally-developed forecasts. Discount rates used in our reporting unit valuations ranged from 8.5 percent to 11.5 percent. Under the market-based guideline public company method, we determine fair value by comparing our reporting units to similar businesses or guideline companies whose securities are actively traded in public markets. We also use the guideline transaction method to &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;determine fair value based on pricing multiples derived from the sale of companies that are similar to our reporting units. To further confirm fair value, we compare the aggregate fair value of our reporting units to our total market capitalization.&#160;Estimating the fair value of reporting units requires the use of estimates and significant judgments that are based on a number of factors including forecasted operating results. The use of alternate estimates and assumptions or changes in the industry or peer groups could materially affect the determination of fair value for each reporting unit and potentially result in goodwill impairment.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We performed annual impairment testing in fiscal 2021, 2020 and 2019 and concluded that there were no impairments of goodwill as the estimated fair value of each reporting unit exceeded its carrying value.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The impairment test for indefinite-lived intangibles other than goodwill involves first assessing qualitative factors to determine if it is more likely than not that the fair value of the indefinite-lived intangible asset is less than its carrying amount. If so, then a quantitative test is performed to compare the estimated fair value of the indefinite-lived intangible asset to the respective asset's carrying amount. Our qualitative evaluation requires the use of estimates and significant judgments and considers the weight of evidence and significance of all identified events and circumstances and most relevant drivers of fair value, both positive and negative, in determining whether it is more likely than not that the fair value of the indefinite-lived intangible asset is less than its carrying amount.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Intangible assets with finite lives, primarily customer relationships; trademarks, trade names and patents; and developed technology, are amortized using a combination of straight-line and accelerated methods based on the expected cash flows from the asset over their estimated useful lives. We review intangible assets with finite lives for impairment whenever events or changes in circumstances indicate that the related carrying amounts may not be recoverable. Determining whether an impairment loss occurred requires a comparison of the carrying amount to the sum of the future forecasted undiscounted cash flows expected to be generated by the asset group. Actual results may differ materially from those used in our forecasts.&lt;/span&gt;&lt;/div&gt;</us-gaap:GoodwillAndIntangibleAssetsPolicyTextBlock>
    <us-gaap:NumberOfReportableSegments
      contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDAvZnJhZzpiYzA3ODhjZjRkZDE0YTM3OGRlYzVjMDA1NTk3Zjc0OS90ZXh0cmVnaW9uOmJjMDc4OGNmNGRkMTRhMzc4ZGVjNWMwMDU1OTdmNzQ5XzExMDYy_a0ed16e6-1f98-4436-b7af-838e7be5f525"
      unitRef="segment">2</us-gaap:NumberOfReportableSegments>
    <us-gaap:NumberOfOperatingSegments
      contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDAvZnJhZzpiYzA3ODhjZjRkZDE0YTM3OGRlYzVjMDA1NTk3Zjc0OS90ZXh0cmVnaW9uOmJjMDc4OGNmNGRkMTRhMzc4ZGVjNWMwMDU1OTdmNzQ5XzExMDYy_f090cdaf-7eab-4dd2-a990-822e2864749f"
      unitRef="segment">2</us-gaap:NumberOfOperatingSegments>
    <cah:DiscountRatefairvalueinputs
      contextRef="ia892a1655a98484e8d25b9944babb1df_D20200701-20210630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDAvZnJhZzpiYzA3ODhjZjRkZDE0YTM3OGRlYzVjMDA1NTk3Zjc0OS90ZXh0cmVnaW9uOmJjMDc4OGNmNGRkMTRhMzc4ZGVjNWMwMDU1OTdmNzQ5XzEzMDQy_ce6541d7-cf98-4904-bbf8-30cf5b6fc61e"
      unitRef="number">0.085</cah:DiscountRatefairvalueinputs>
    <cah:DiscountRatefairvalueinputs
      contextRef="icc7d995e453e439bb115adae40076bfd_D20200701-20210630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDAvZnJhZzpiYzA3ODhjZjRkZDE0YTM3OGRlYzVjMDA1NTk3Zjc0OS90ZXh0cmVnaW9uOmJjMDc4OGNmNGRkMTRhMzc4ZGVjNWMwMDU1OTdmNzQ5XzEzMDQ4_99bb9076-c935-444b-bd94-0b9275e9cb94"
      unitRef="number">0.115</cah:DiscountRatefairvalueinputs>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="i00a6d666bf604826b24e68ddbd63eac4_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDAvZnJhZzpiYzA3ODhjZjRkZDE0YTM3OGRlYzVjMDA1NTk3Zjc0OS90ZXh0cmVnaW9uOmJjMDc4OGNmNGRkMTRhMzc4ZGVjNWMwMDU1OTdmNzQ5XzQ5NDc4MDI0MDQyMjA_613f647d-88c8-49c1-8fe4-8e83670f68d2"
      unitRef="usd">0</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDAvZnJhZzpiYzA3ODhjZjRkZDE0YTM3OGRlYzVjMDA1NTk3Zjc0OS90ZXh0cmVnaW9uOmJjMDc4OGNmNGRkMTRhMzc4ZGVjNWMwMDU1OTdmNzQ5XzQ5NDc4MDI0MDQyMjA_7c4b8bba-c5ec-402b-bd38-7e13fa6ef60b"
      unitRef="usd">0</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="ia31e9a409b874bb19d0ff6f2f39ecc09_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDAvZnJhZzpiYzA3ODhjZjRkZDE0YTM3OGRlYzVjMDA1NTk3Zjc0OS90ZXh0cmVnaW9uOmJjMDc4OGNmNGRkMTRhMzc4ZGVjNWMwMDU1OTdmNzQ5XzQ5NDc4MDI0MDQyMjA_cfbc5b00-0a08-49fc-b9d6-859f07e62088"
      unitRef="usd">0</us-gaap:GoodwillImpairmentLoss>
    <cah:AssetsHeldforSalePolicyPolicyTextBlock
      contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDAvZnJhZzpiYzA3ODhjZjRkZDE0YTM3OGRlYzVjMDA1NTk3Zjc0OS90ZXh0cmVnaW9uOmJjMDc4OGNmNGRkMTRhMzc4ZGVjNWMwMDU1OTdmNzQ5XzM5Njc1_dac08363-793b-4b75-97dc-cae436055c9c">&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%"&gt;Assets Held for Sale&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We classify assets and liabilities (the &#x201c;disposal group&#x201d;) as held for sale when management commits to a plan to sell the disposal group in its present condition and at a price that is reasonable in relation to its current fair value. We also consider whether an active program to locate a buyer has been initiated and if it is probable that the sale will occur within one year without significant changes to the plan to sell. Upon classification of the disposal group as held for sale, we test the assets for impairment and cease related depreciation and amortization.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On March 12, 2021, we announced that we signed a definitive agreement to sell our Cordis business to Hellman &amp;amp; Friedman for proceeds of $927 million in cash, subject to customary purchase price adjustments, and we retained certain working capital accounts and certain liabilities, including product liability for &lt;/span&gt;&lt;/div&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;lawsuits related to inferior vena cava filters in the U.S. and Canada as described in &lt;/span&gt;&lt;span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;&lt;a href="#i4f0ec56b9c604f1782a65ea4a19c284d_130" style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Note 7&lt;/a&gt;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; of the &#x201c;Notes to Consolidated Financial Statements.&#x201d; The transaction closed on August 2, 2021. See &lt;/span&gt;&lt;span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;&lt;a href="#i4f0ec56b9c604f1782a65ea4a19c284d_106" style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Note 2&lt;/a&gt;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; for additional information.&lt;/span&gt;</cah:AssetsHeldforSalePolicyPolicyTextBlock>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationConsideration
      contextRef="i2ae0fa0d058b4f21aac5c8701cbd2fb7_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDAvZnJhZzpiYzA3ODhjZjRkZDE0YTM3OGRlYzVjMDA1NTk3Zjc0OS90ZXh0cmVnaW9uOmJjMDc4OGNmNGRkMTRhMzc4ZGVjNWMwMDU1OTdmNzQ5XzQ5NDc4MDIzNzk5MzY_282278f6-c8b0-4889-b9e9-f8451242aa43"
      unitRef="usd">927000000</us-gaap:DisposalGroupIncludingDiscontinuedOperationConsideration>
    <us-gaap:InvestmentPolicyTextBlock
      contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDAvZnJhZzpiYzA3ODhjZjRkZDE0YTM3OGRlYzVjMDA1NTk3Zjc0OS90ZXh0cmVnaW9uOmJjMDc4OGNmNGRkMTRhMzc4ZGVjNWMwMDU1OTdmNzQ5XzM5NjMx_ef4ea813-7f1d-49f3-a43c-2a527c061b82">&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%"&gt;Investments&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Investments in non-marketable equity securities are accounted for under the fair value, equity or net asset value method of&#160;accounting and are included in other assets in the consolidated balance sheets. For equity securities without a readily determinable fair value, we use the fair value measurement alternative and measure the securities at cost less impairment, if any, including adjustments for observable price changes in orderly transactions for an identical or similar investment of the same issuer. For investments in which we can exercise significant influence but do not control, we use the equity method of accounting. Our share of the earnings and losses are recorded in other (income)/expense, net in the consolidated statements of earnings/(loss). We monitor our investments for impairment&#160;by considering factors such as the operating performance of the investment and current economic and market conditions.&lt;/span&gt;&lt;/div&gt;</us-gaap:InvestmentPolicyTextBlock>
    <cah:CostofSalesVendorReservesPolicyPolicyTextBlock
      contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDAvZnJhZzpiYzA3ODhjZjRkZDE0YTM3OGRlYzVjMDA1NTk3Zjc0OS90ZXh0cmVnaW9uOmJjMDc4OGNmNGRkMTRhMzc4ZGVjNWMwMDU1OTdmNzQ5XzM5NTQ4_b53deae8-c382-4906-9911-dce0fdef5364">&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%"&gt;Vendor Reserves&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In the ordinary course of business, our vendors may dispute deductions taken against payments otherwise due to them or assert other disputes. These disputes are researched and resolved based upon the findings of the research performed. At any given time, there are outstanding items in various stages of research and resolution. In determining appropriate reserves for areas of exposure with our vendors, we assess historical experience and current outstanding claims. We have established various levels of reserves based on the type of claim and status of review. Though the claim types are relatively consistent, we periodically refine our methodology by updating the reserve estimate percentages to reflect actual historical experience. The ultimate outcome of certain claims may be different than our original estimate and may require an adjustment. Adjustments to vendor reserves are included in cost of products sold. In addition, the reserve balance will fluctuate due to variations of outstanding claims from period-to-period, timing of settlements and specific vendor issues, such as bankruptcies. Vendor reserves were $77 million at both June&#160;30, 2021 and 2020, excluding third-party returns. See Third-Party Returns section within this Note for a description of third-party returns.&lt;/span&gt;&lt;/div&gt;</cah:CostofSalesVendorReservesPolicyPolicyTextBlock>
    <cah:VendorReserves
      contextRef="i2e87824102b34590a0208cc7da91b5f5_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDAvZnJhZzpiYzA3ODhjZjRkZDE0YTM3OGRlYzVjMDA1NTk3Zjc0OS90ZXh0cmVnaW9uOmJjMDc4OGNmNGRkMTRhMzc4ZGVjNWMwMDU1OTdmNzQ5XzE5NDI1_1d7436ea-7c92-4174-80be-9d62900e6704"
      unitRef="usd">77000000</cah:VendorReserves>
    <cah:VendorReserves
      contextRef="i299cea70f47b4fbe96772aaa8cc00b79_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDAvZnJhZzpiYzA3ODhjZjRkZDE0YTM3OGRlYzVjMDA1NTk3Zjc0OS90ZXh0cmVnaW9uOmJjMDc4OGNmNGRkMTRhMzc4ZGVjNWMwMDU1OTdmNzQ5XzE5NDI1_95d1199e-f2b1-471d-a035-b0d10ca5b0d3"
      unitRef="usd">77000000</cah:VendorReserves>
    <cah:DistributionServiceAgreementAndOtherVendorFeesPolicyTextBlock
      contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDAvZnJhZzpiYzA3ODhjZjRkZDE0YTM3OGRlYzVjMDA1NTk3Zjc0OS90ZXh0cmVnaW9uOmJjMDc4OGNmNGRkMTRhMzc4ZGVjNWMwMDU1OTdmNzQ5XzM5NTU4_28d6d39d-b5b3-4333-bbf8-ffa9ac1a26a1">&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%"&gt;Distribution Services Agreement and Other Vendor Fees&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our Pharmaceutical segment recognizes fees received from distribution services agreements and other fees received from vendors related to the purchase or distribution of the vendors&#x2019; inventory when those fees have been earned and we are entitled to payment. Since the benefit provided to a vendor is related to the purchase and distribution of the vendor&#x2019;s inventory, we recognize the fees as a reduction in the carrying value of the inventory that generated the fees, and as such, a reduction of cost of products sold in our consolidated statements of earnings/(loss) when the inventory is sold.&lt;/span&gt;&lt;/div&gt;</cah:DistributionServiceAgreementAndOtherVendorFeesPolicyTextBlock>
    <us-gaap:CommitmentsAndContingenciesPolicyTextBlock
      contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDAvZnJhZzpiYzA3ODhjZjRkZDE0YTM3OGRlYzVjMDA1NTk3Zjc0OS90ZXh0cmVnaW9uOmJjMDc4OGNmNGRkMTRhMzc4ZGVjNWMwMDU1OTdmNzQ5XzM5NTc1_18438b33-675d-4dd4-9dad-d2232cb19082">&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%"&gt;Loss Contingencies and Self-Insurance&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Loss Contingencies&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We accrue for contingencies related to disputes, litigation and regulatory matters if it is probable that a liability has been incurred and the amount of the loss can be reasonably estimated. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In connection with the opioid litigation as described further in the &lt;/span&gt;&lt;span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;&lt;a href="#i4f0ec56b9c604f1782a65ea4a19c284d_130" style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Note 7&lt;/a&gt;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, we recorded pre-tax charges of&#160;$1.17 billion and $5.63 billion during fiscal 2021 and 2020 respectively which were retained at Corporate. In July 2021, we announced that we and two other national distributors have negotiated a proposed settlement agreement, subject to certain conditions and contingencies. There is no assurance that the contingencies to the proposed settlement agreement will be satisfied. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We develop and periodically update reserve estimates for the Cordis inferior vena cava ("Cordis IVC") claims, including those received to date and expected to be received in the future and related costs. To project future Cordis IVC claim costs, we use a methodology based largely on recent experience, including claim filing rates, estimated indemnity severity by claim type, sales data, implant and injury to report lag patterns and estimated defense costs.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Self-Insurance&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We also self-insure for employee healthcare, general liability, certain product liability matters, auto liability, property and workers' compensation. Self-insurance accruals include an estimate for expected settlements or pending claims, defense costs, administrative fees, claim adjustment costs and an estimate for claims incurred but not reported. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Because these matters are inherently unpredictable and unfavorable developments or resolutions can occur, assessing contingencies and other liabilities is highly subjective and requires judgments about future&#160;events. We regularly review contingencies and our self-insurance accruals to determine whether our accruals and related disclosures are adequate. Any adjustments for changes in reserves are recorded in the period in which the change in estimate occurs.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The amount of ultimate loss may differ materially from these estimates. We recognize these estimated loss contingencies, income from favorable resolution of litigation and certain defense costs in litigation (recoveries)/charges in our consolidated statements of earnings/(loss). See &lt;/span&gt;&lt;span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;&lt;a href="#i4f0ec56b9c604f1782a65ea4a19c284d_130" style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Note 7&lt;/a&gt;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; for additional information regarding loss contingencies and product liability lawsuits.&lt;/span&gt;&lt;/div&gt;</us-gaap:CommitmentsAndContingenciesPolicyTextBlock>
    <us-gaap:GainLossRelatedToLitigationSettlement
      contextRef="id2a6b6641ae248c98d689f30c606f881_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDAvZnJhZzpiYzA3ODhjZjRkZDE0YTM3OGRlYzVjMDA1NTk3Zjc0OS90ZXh0cmVnaW9uOmJjMDc4OGNmNGRkMTRhMzc4ZGVjNWMwMDU1OTdmNzQ5XzIwNTc2_fa04a4d2-d99c-4c13-92d5-b636406cf116"
      unitRef="usd">1170000000</us-gaap:GainLossRelatedToLitigationSettlement>
    <us-gaap:GainLossRelatedToLitigationSettlement
      contextRef="i373ba6a0cdc044dea9602bdbad13174c_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDAvZnJhZzpiYzA3ODhjZjRkZDE0YTM3OGRlYzVjMDA1NTk3Zjc0OS90ZXh0cmVnaW9uOmJjMDc4OGNmNGRkMTRhMzc4ZGVjNWMwMDU1OTdmNzQ5XzEwOTk1MTE2Njc2OTI_1a313f61-c937-4037-8038-233b7a976d14"
      unitRef="usd">5630000000</us-gaap:GainLossRelatedToLitigationSettlement>
    <us-gaap:GuaranteesIndemnificationsAndWarrantiesPolicies
      contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDAvZnJhZzpiYzA3ODhjZjRkZDE0YTM3OGRlYzVjMDA1NTk3Zjc0OS90ZXh0cmVnaW9uOmJjMDc4OGNmNGRkMTRhMzc4ZGVjNWMwMDU1OTdmNzQ5XzM5NjEy_472e1240-eca3-4135-9276-38acbac8729a">&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%"&gt;Guarantees&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In the ordinary course of business, we agree to indemnify certain other parties under acquisition and disposition agreements, customer agreements, intellectual property licensing agreements, and other agreements. Such indemnification obligations vary in scope and, when defined, in duration. In many cases, a maximum obligation is not explicitly stated, and therefore the overall maximum amount of the liability under such indemnification obligations cannot be reasonably estimated. Where appropriate, such indemnification obligations are recorded as a liability. Historically, we have not, individually or in the aggregate, made &lt;/span&gt;&lt;/div&gt;payments under these indemnification obligations in any material amounts. In certain circumstances, we believe that existing insurance arrangements, subject to the general deduction and exclusion provisions, would cover portions of the liability that may arise from these indemnification obligations. In addition, we believe that the likelihood of a material liability being triggered under these indemnification obligations is not probable.From time to time we enter into agreements that obligate us to make fixed payments upon the occurrence of certain events. Such obligations primarily relate to obligations arising under acquisition transactions, where we have agreed to make payments based upon the achievement of certain financial performance measures by the acquired business. Generally, the obligation is capped at an explicit amount. There were no material obligations at June&#160;30, 2021.</us-gaap:GuaranteesIndemnificationsAndWarrantiesPolicies>
    <us-gaap:IncomeTaxPolicyTextBlock
      contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDAvZnJhZzpiYzA3ODhjZjRkZDE0YTM3OGRlYzVjMDA1NTk3Zjc0OS90ZXh0cmVnaW9uOmJjMDc4OGNmNGRkMTRhMzc4ZGVjNWMwMDU1OTdmNzQ5XzM5NjIz_bb2b6d91-222b-45f1-b15b-cf14fab07b3c">&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%"&gt;Income Taxes&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We account for income taxes using the asset and liability method. Deferred tax assets and liabilities are measured using enacted tax rates in the respective jurisdictions in which we operate. We assess the realizability of deferred tax assets on a quarterly basis and provide a valuation allowance for deferred tax assets when it is more likely than not that at least a portion of the deferred tax assets will not be realized. The realizability of deferred tax assets depends on our ability to generate sufficient taxable income within the carryback or carryforward periods provided for in the tax law for each applicable tax jurisdiction and also considers all available positive and negative evidence.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Deferred taxes for non-U.S. liabilities are not provided on the unremitted earnings of subsidiaries outside of the United States&#160;when it is expected that these earnings are indefinitely reinvested.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We operate in a complex multinational tax environment and are subject to tax treaty arrangements and transfer pricing guidelines for intercompany transactions that are subject to interpretation. Uncertainty in a tax position may arise as tax laws are subject to interpretation. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Tax benefits from uncertain tax positions are recognized when it is more likely than not that the position will be sustained upon examination of the technical merits of the position, including resolutions of any related appeals or litigation processes. The amount recognized is measured as the largest amount of tax benefit that is greater than 50 percent likely of being realized upon settlement. For tax benefits that do not qualify for recognition, we recognize a liability for unrecognized tax benefits. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;See &lt;/span&gt;&lt;span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;&lt;a href="#i4f0ec56b9c604f1782a65ea4a19c284d_133" style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Note 8&lt;/a&gt;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; for additional information regarding income taxes.&lt;/span&gt;&lt;/div&gt;</us-gaap:IncomeTaxPolicyTextBlock>
    <cah:OtherAccruedLiabilitiesPolicyPolicyTextBlock
      contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDAvZnJhZzpiYzA3ODhjZjRkZDE0YTM3OGRlYzVjMDA1NTk3Zjc0OS90ZXh0cmVnaW9uOmJjMDc4OGNmNGRkMTRhMzc4ZGVjNWMwMDU1OTdmNzQ5XzM5NzEz_3f35b02e-036e-4b5c-a372-46d3725d288a">&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%"&gt;Other Accrued Liabilities&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other accrued liabilities represent various current obligations, including certain accrued operating expenses and taxes payable.&lt;/span&gt;&lt;/div&gt;</cah:OtherAccruedLiabilitiesPolicyPolicyTextBlock>
    <us-gaap:ConsolidationPolicyTextBlock
      contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDAvZnJhZzpiYzA3ODhjZjRkZDE0YTM3OGRlYzVjMDA1NTk3Zjc0OS90ZXh0cmVnaW9uOmJjMDc4OGNmNGRkMTRhMzc4ZGVjNWMwMDU1OTdmNzQ5XzM5NjUx_346c1afa-9145-489a-980c-60362f7c02d4">Noncontrolling InterestsNoncontrolling interests represent the portion of net earnings, comprehensive income and net assets that is not attributable to Cardinal Health, Inc.</us-gaap:ConsolidationPolicyTextBlock>
    <us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy
      contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDAvZnJhZzpiYzA3ODhjZjRkZDE0YTM3OGRlYzVjMDA1NTk3Zjc0OS90ZXh0cmVnaW9uOmJjMDc4OGNmNGRkMTRhMzc4ZGVjNWMwMDU1OTdmNzQ5XzM5NjI0_ed1ceb39-8f25-420b-b515-57c1c57c77d6">&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%"&gt;Share-Based Compensation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Share-based compensation provided to employees is recognized in the consolidated statements of earnings/(loss) based on the grant date fair value of the awards. The fair value of restricted share units and performance share units is determined by the grant date market price of our common shares. The fair value of stock options is determined on the grant date using a lattice valuation model. The compensation expense associated with nonvested performance share units is dependent on our periodic assessment of the probability of the targets being achieved and our estimate, which may vary over time, of the number of shares that ultimately will be issued. The compensation expense recognized for share-based awards is net of estimated forfeitures and is recognized ratably over the service period of the awards. All income tax effects of share-based awards are recognized in the consolidated statements of earnings/(loss) as awards vest or are settled. We classify share-based compensation expense in distribution, selling, general and administrative ("SG&amp;amp;A") expenses to correspond with the same line item as the majority of the cash compensation paid to employees. If awards are modified in connection with a restructuring activity, the incremental share-based compensation expense is classified in restructuring and employee severance. See &lt;/span&gt;&lt;span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;&lt;a href="#i4f0ec56b9c604f1782a65ea4a19c284d_160" style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Note 14&lt;/a&gt;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; for additional information regarding share-based compensation.&lt;/span&gt;&lt;/div&gt;</us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy>
    <cah:DividendsPolicyPolicyTextBlock
      contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDAvZnJhZzpiYzA3ODhjZjRkZDE0YTM3OGRlYzVjMDA1NTk3Zjc0OS90ZXh0cmVnaW9uOmJjMDc4OGNmNGRkMTRhMzc4ZGVjNWMwMDU1OTdmNzQ5XzM5Njc2_a97cee0b-4ebe-4a0c-b2b7-82baf464e444">&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%"&gt;Dividends&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We paid cash dividends per common share of $1.94, $1.92 and $1.91 in fiscal 2021, 2020 and 2019, respectively.&lt;/span&gt;&lt;/div&gt;</cah:DividendsPolicyPolicyTextBlock>
    <us-gaap:CommonStockDividendsPerShareCashPaid
      contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDAvZnJhZzpiYzA3ODhjZjRkZDE0YTM3OGRlYzVjMDA1NTk3Zjc0OS90ZXh0cmVnaW9uOmJjMDc4OGNmNGRkMTRhMzc4ZGVjNWMwMDU1OTdmNzQ5XzQ5NDc4MDIzNzI0ODU_dc354ede-2155-48e1-9c54-c995f32de3fa"
      unitRef="usdPerShare">1.94</us-gaap:CommonStockDividendsPerShareCashPaid>
    <us-gaap:CommonStockDividendsPerShareCashPaid
      contextRef="ia31e9a409b874bb19d0ff6f2f39ecc09_D20190701-20200630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDAvZnJhZzpiYzA3ODhjZjRkZDE0YTM3OGRlYzVjMDA1NTk3Zjc0OS90ZXh0cmVnaW9uOmJjMDc4OGNmNGRkMTRhMzc4ZGVjNWMwMDU1OTdmNzQ5XzI3NDg3NzkxMjkxMjM_5f933a44-2846-4b34-a33e-ac63a91a290e"
      unitRef="usdPerShare">1.92</us-gaap:CommonStockDividendsPerShareCashPaid>
    <us-gaap:CommonStockDividendsPerShareCashPaid
      contextRef="i00a6d666bf604826b24e68ddbd63eac4_D20180701-20190630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDAvZnJhZzpiYzA3ODhjZjRkZDE0YTM3OGRlYzVjMDA1NTk3Zjc0OS90ZXh0cmVnaW9uOmJjMDc4OGNmNGRkMTRhMzc4ZGVjNWMwMDU1OTdmNzQ5XzI3NjU3_846e0adb-44fb-4d52-90ae-2bb13a6880cb"
      unitRef="usdPerShare">1.91</us-gaap:CommonStockDividendsPerShareCashPaid>
    <us-gaap:RevenueRecognitionPolicyTextBlock
      contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDAvZnJhZzpiYzA3ODhjZjRkZDE0YTM3OGRlYzVjMDA1NTk3Zjc0OS90ZXh0cmVnaW9uOmJjMDc4OGNmNGRkMTRhMzc4ZGVjNWMwMDU1OTdmNzQ5XzM5NTY4_2a3daea5-40cc-4a7f-958d-e8e23074ec6d">&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%"&gt;Revenue Recognition&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We recognize revenue in an amount that reflects the consideration to which we expect to be entitled in exchange for the transfer of goods or services to customers.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenue in both segments is primarily related to the distribution of pharmaceutical and medical products, which include both manufactured and sourced products, and we recognize at a point in time when title transfers to customers and we have no further obligation to provide services related to such merchandise. Service revenues are recognized over the period that services are provided to the customer. Revenues derived from services are not material for either segment for all periods presented.&lt;/span&gt;&lt;/div&gt;We are generally the principal in a transaction, therefore our revenue is primarily recorded on a gross basis. When we are a principal in a transaction, we have determined that we control the ability to direct the use of the product or service prior to transfer to a customer, are primarily responsible for fulfilling the promise to provide the product or service to our customer, have discretion in establishing prices, and ultimately control the transfer of the product or services provided to the customer.</us-gaap:RevenueRecognitionPolicyTextBlock>
    <cah:SalesreturnsPolicyTextBlock
      contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDAvZnJhZzpiYzA3ODhjZjRkZDE0YTM3OGRlYzVjMDA1NTk3Zjc0OS90ZXh0cmVnaW9uOmJjMDc4OGNmNGRkMTRhMzc4ZGVjNWMwMDU1OTdmNzQ5XzM5NTcx_5d352f4f-c8c3-4fc9-b1e0-ee6de032a428">&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%"&gt;Sales Returns and Allowances&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenue is recorded net of sales returns and allowances. Revenues are measured based on the amount of consideration that we expect to receive, reduced by estimates for return allowances, discounts, rebates and other variable consideration. Sales returns are recorded based on estimates using historical &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;data. Our customer return policies generally require that the product be physically returned, subject to restocking fees. We only allow customers to return products for credit in a condition suitable to be added back to inventory and resold at full value (&#x201c;merchantable product&#x201d;) or returned to vendors for credit. Product returns are generally consistent throughout the year and typically are not specific to any particular product or customer.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We accrue for estimated sales returns and allowances at the time of sale based upon historical customer return trends, margin rates and processing costs. Our accrual for sales returns is reflected as a reduction of revenue and cost of products sold for the sales price and cost, respectively. At June&#160;30, 2021 and 2020, the accrual for estimated sales returns and allowances was $689 million and $495 million, respectively, which is reflected in trade receivables, net and inventories, net in the consolidated balance sheets. Sales returns and allowances were $2.6 billion, $2.3 billion and $2.2 billion, for fiscal 2021, 2020 and 2019, respectively, and the net impact on net earnings/(loss) in the consolidated statements of earnings/(loss) was immaterial in fiscal 2021, 2020 and 2019. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%"&gt;Third-Party Returns&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We generally do not accept non-merchantable pharmaceutical product returns from our customers, so many of our customers return non-merchantable pharmaceutical products to the manufacturer through third parties. Since our customers generally do not have a direct relationship with manufacturers, our vendors pass the value of such returns to us (usually in the form of an accounts payable deduction). We, in turn, pass the value received to our customer. In certain instances, we pass the estimated value of the return to our customer prior to our receipt of the value from the vendor. Although we believe we have satisfactory protections, we could be subject to claims from customers or vendors if our administration of this overall process was deficient in some respect or our contractual terms with vendors are in conflict with our contractual terms with our customers. We have maintained reserves for some of these situations based on their nature and our historical experience with their resolution.&lt;/span&gt;&lt;/div&gt;</cah:SalesreturnsPolicyTextBlock>
    <cah:RevenueRecognitionReserveforSalesReturnsandAllowances
      contextRef="i2e87824102b34590a0208cc7da91b5f5_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDAvZnJhZzpiYzA3ODhjZjRkZDE0YTM3OGRlYzVjMDA1NTk3Zjc0OS90ZXh0cmVnaW9uOmJjMDc4OGNmNGRkMTRhMzc4ZGVjNWMwMDU1OTdmNzQ5XzMwMDQy_fde85c30-5a20-4b6f-a665-1f4ecb7cca6e"
      unitRef="usd">689000000</cah:RevenueRecognitionReserveforSalesReturnsandAllowances>
    <cah:RevenueRecognitionReserveforSalesReturnsandAllowances
      contextRef="i299cea70f47b4fbe96772aaa8cc00b79_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDAvZnJhZzpiYzA3ODhjZjRkZDE0YTM3OGRlYzVjMDA1NTk3Zjc0OS90ZXh0cmVnaW9uOmJjMDc4OGNmNGRkMTRhMzc4ZGVjNWMwMDU1OTdmNzQ5XzMwMDQ5_099041ba-c097-4c8a-a0c6-efa33d762631"
      unitRef="usd">495000000</cah:RevenueRecognitionReserveforSalesReturnsandAllowances>
    <us-gaap:RevenueRecognitionSalesReturnsReserveForSalesReturns
      contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDAvZnJhZzpiYzA3ODhjZjRkZDE0YTM3OGRlYzVjMDA1NTk3Zjc0OS90ZXh0cmVnaW9uOmJjMDc4OGNmNGRkMTRhMzc4ZGVjNWMwMDU1OTdmNzQ5XzMwMjAz_6d741194-7b48-40c4-ae45-6d3ccd7d274d"
      unitRef="usd">2600000000</us-gaap:RevenueRecognitionSalesReturnsReserveForSalesReturns>
    <us-gaap:RevenueRecognitionSalesReturnsReserveForSalesReturns
      contextRef="ia31e9a409b874bb19d0ff6f2f39ecc09_D20190701-20200630"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDAvZnJhZzpiYzA3ODhjZjRkZDE0YTM3OGRlYzVjMDA1NTk3Zjc0OS90ZXh0cmVnaW9uOmJjMDc4OGNmNGRkMTRhMzc4ZGVjNWMwMDU1OTdmNzQ5XzMwMjA3_d28b33a2-4a1d-483e-82e1-adbd54dece6a"
      unitRef="usd">2300000000</us-gaap:RevenueRecognitionSalesReturnsReserveForSalesReturns>
    <us-gaap:RevenueRecognitionSalesReturnsReserveForSalesReturns
      contextRef="i00a6d666bf604826b24e68ddbd63eac4_D20180701-20190630"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDAvZnJhZzpiYzA3ODhjZjRkZDE0YTM3OGRlYzVjMDA1NTk3Zjc0OS90ZXh0cmVnaW9uOmJjMDc4OGNmNGRkMTRhMzc4ZGVjNWMwMDU1OTdmNzQ5XzMwMjE0_60627c1a-f9e5-44f1-9f97-8729bd0981e2"
      unitRef="usd">2200000000</us-gaap:RevenueRecognitionSalesReturnsReserveForSalesReturns>
    <cah:ShippingandHandlingCostsPolicyTextBlock
      contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDAvZnJhZzpiYzA3ODhjZjRkZDE0YTM3OGRlYzVjMDA1NTk3Zjc0OS90ZXh0cmVnaW9uOmJjMDc4OGNmNGRkMTRhMzc4ZGVjNWMwMDU1OTdmNzQ5XzM5Njg1_65229788-3197-46c4-a6a2-a048b3863f27">Shipping and HandlingShipping and handling costs are primarily included in SG&amp;amp;A expenses in our consolidated statements of earnings/(loss) and include all delivery expenses as well as all costs to prepare the product for shipment to the end customer. Shipping and handling costs were $634 million, $620 million and $622 million, for fiscal 2021, 2020 and 2019, respectively.</cah:ShippingandHandlingCostsPolicyTextBlock>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="ic3592f06406544abac446d0e612f00d3_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDAvZnJhZzpiYzA3ODhjZjRkZDE0YTM3OGRlYzVjMDA1NTk3Zjc0OS90ZXh0cmVnaW9uOmJjMDc4OGNmNGRkMTRhMzc4ZGVjNWMwMDU1OTdmNzQ5XzMxNzAw_6682425a-8580-449a-a4d2-3b7dcd23cd11"
      unitRef="usd">634000000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="ifee3aa6b50684ca4a55e508c43164afe_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDAvZnJhZzpiYzA3ODhjZjRkZDE0YTM3OGRlYzVjMDA1NTk3Zjc0OS90ZXh0cmVnaW9uOmJjMDc4OGNmNGRkMTRhMzc4ZGVjNWMwMDU1OTdmNzQ5XzMxNzA0_c1205275-8cfd-489c-a1d3-a3ffc984ac55"
      unitRef="usd">620000000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="i6e042ca2958c43e0a7786484c6024fa9_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDAvZnJhZzpiYzA3ODhjZjRkZDE0YTM3OGRlYzVjMDA1NTk3Zjc0OS90ZXh0cmVnaW9uOmJjMDc4OGNmNGRkMTRhMzc4ZGVjNWMwMDU1OTdmNzQ5XzMxNzEx_8c107584-1051-4912-a99d-cdcd6284cf45"
      unitRef="usd">622000000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock
      contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDAvZnJhZzpiYzA3ODhjZjRkZDE0YTM3OGRlYzVjMDA1NTk3Zjc0OS90ZXh0cmVnaW9uOmJjMDc4OGNmNGRkMTRhMzc4ZGVjNWMwMDU1OTdmNzQ5XzM5NTYx_f77e7a9d-e40f-4df4-b548-38539b6d0ae3">&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%"&gt;Restructuring and Employee Severance&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Restructuring activities are programs that are not part of the ongoing operations of our underlying business, such as divestitures, closing and consolidating facilities, changing the way we manufacture or distribute our products, moving manufacturing of a product to another location, changes in production or business process outsourcing or insourcing, employee severance (including rationalizing headcount or other significant changes in personnel) and realigning operations (including realignment of the management structure in response to changing market conditions). Also included within restructuring and employee severance are &lt;/span&gt;&lt;/div&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;employee severance costs that are not incurred in connection with a restructuring activity. See &lt;/span&gt;&lt;span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;&lt;a href="#i4f0ec56b9c604f1782a65ea4a19c284d_109" style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Note 3&lt;/a&gt;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; for additional information regarding our restructuring activities.&lt;/span&gt;</us-gaap:CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock>
    <cah:AmortizationandOtherAcquisitionRelatedCostsPolicyPolicyTextBlock
      contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDAvZnJhZzpiYzA3ODhjZjRkZDE0YTM3OGRlYzVjMDA1NTk3Zjc0OS90ZXh0cmVnaW9uOmJjMDc4OGNmNGRkMTRhMzc4ZGVjNWMwMDU1OTdmNzQ5XzM5NjQ3_aed6b30a-317a-4e55-b688-26473f6fef8d">Amortization and Other Acquisition-Related Costs&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We classify certain costs incurred in connection with acquisitions as amortization and other acquisition-related costs in our consolidated statements of earnings/(loss). These costs consist of amortization of acquisition-related intangible assets, transaction costs, integration costs and changes in the fair value of contingent consideration obligations. Transaction costs are incurred during the initial evaluation of a potential acquisition and primarily relate to costs to analyze, negotiate and consummate the transaction as well as due diligence activities. Integration costs relate to activities required to combine the operations of an acquired enterprise into our operations and, in the case of the Cordis and Patient Recovery businesses, to stand-up the systems and processes needed to support an expanded geographic footprint. We record changes in the fair value of contingent consideration obligations relating to acquisitions as income or expense in amortization and other acquisition-related costs. See &lt;/span&gt;&lt;span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;&lt;a href="#i4f0ec56b9c604f1782a65ea4a19c284d_112" style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Note 4&lt;/a&gt;&lt;/span&gt; for additional information regarding amortization of acquisition-related intangible assets.</cah:AmortizationandOtherAcquisitionRelatedCostsPolicyPolicyTextBlock>
    <us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock
      contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDAvZnJhZzpiYzA3ODhjZjRkZDE0YTM3OGRlYzVjMDA1NTk3Zjc0OS90ZXh0cmVnaW9uOmJjMDc4OGNmNGRkMTRhMzc4ZGVjNWMwMDU1OTdmNzQ5XzM5NTU1_6331b20f-ecbb-467c-91ca-d29d4d5a3f4b">&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%"&gt;Translation of Foreign Currencies&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Financial statements of our subsidiaries outside the United States&#160;are generally measured using the local currency as the functional currency. Adjustments to translate the assets and liabilities of these foreign subsidiaries into U.S.&#160;dollars are accumulated in shareholders&#x2019; equity through accumulated and other comprehensive loss ("AOCI") utilizing period-end exchange rates. Revenues and expenses of these foreign subsidiaries are translated using average exchange rates during the year.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The foreign currency translation gains/(losses) included in AOCI at June&#160;30, 2021 and 2020 are presented in &lt;/span&gt;&lt;span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;&lt;a href="#i4f0ec56b9c604f1782a65ea4a19c284d_145" style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Note 11&lt;/a&gt;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. Foreign currency transaction gains and losses for the period are included in the consolidated statements of earnings/(loss) in the respective financial statement line item.&lt;/span&gt;&lt;/div&gt;</us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock>
    <us-gaap:DerivativesMethodsOfAccountingHedgingDerivatives
      contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDAvZnJhZzpiYzA3ODhjZjRkZDE0YTM3OGRlYzVjMDA1NTk3Zjc0OS90ZXh0cmVnaW9uOmJjMDc4OGNmNGRkMTRhMzc4ZGVjNWMwMDU1OTdmNzQ5XzM5NjY3_cc38de73-5902-4978-9138-3d1f19b67ca2">&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%"&gt;Interest Rate, Currency and Commodity Risk&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;All derivative instruments are recognized at fair value on the consolidated balance sheets and all changes in fair value are recognized in net earnings or shareholders&#x2019; equity through AOCI, net of tax.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For contracts that qualify for hedge accounting treatment, the hedge contracts must be effective at reducing the risk associated with the exposure being hedged and must be designated as a hedge at the inception of the contract. Hedge effectiveness is assessed periodically. Any contract not designated as a hedge, or so designated but ineffective, is adjusted to fair value and recognized immediately in net earnings. If a fair value or cash flow hedge ceases to qualify for hedge accounting treatment, the contract continues to be carried on the balance sheet at fair value until settled and future adjustments to the contract&#x2019;s fair value are recognized immediately in net earnings. If a forecasted transaction is probable not to occur, amounts previously deferred in AOCI are recognized immediately in net earnings. Interest payments &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;received from the cross currency swap are excluded from the net investment hedge effectiveness assessment and are recorded in interest expense, net in the consolidated statements of earnings/(loss).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;See &lt;/span&gt;&lt;span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;&lt;a href="#i4f0ec56b9c604f1782a65ea4a19c284d_139" style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Note 10&lt;/a&gt;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; for additional information regarding our derivative instruments, including the accounting treatment for instruments designated as fair value, cash flow, net investment and economic hedges.&lt;/span&gt;&lt;/div&gt;</us-gaap:DerivativesMethodsOfAccountingHedgingDerivatives>
    <us-gaap:FairValueMeasurementPolicyPolicyTextBlock
      contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDAvZnJhZzpiYzA3ODhjZjRkZDE0YTM3OGRlYzVjMDA1NTk3Zjc0OS90ZXh0cmVnaW9uOmJjMDc4OGNmNGRkMTRhMzc4ZGVjNWMwMDU1OTdmNzQ5XzM5NjYw_95b61696-412f-41df-98c9-8de933f002d3">&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%"&gt;Fair Value Measurements&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Fair value is defined as the price that would be received upon selling an asset or the price paid to transfer a liability on the measurement date. It focuses on the exit price in the principal or most advantageous market for the asset or liability in an orderly transaction between willing market participants. A three-tier fair value hierarchy is established as a basis for considering such assumptions and for inputs used in the valuation methodologies in measuring fair value. This hierarchy requires entities to maximize the use of observable inputs and minimize the use of unobservable inputs. The three levels of inputs used to measure fair values are:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-36pt"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Level 1 -&#160;&#160;&#160;&#160;Observable prices in active markets for identical assets and liabilities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-36pt"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Level 2 -&#160;&#160;&#160;&#160;Observable inputs other than quoted prices in active markets for identical assets and liabilities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-36pt"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Level 3 -&#160;&#160;&#160;&#160;Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets and liabilities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;See &lt;/span&gt;&lt;span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;&lt;a href="#i4f0ec56b9c604f1782a65ea4a19c284d_136" style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Note 9&lt;/a&gt;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; for additional information regarding fair value measurements.&lt;/span&gt;&lt;/div&gt;</us-gaap:FairValueMeasurementPolicyPolicyTextBlock>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock
      contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDAvZnJhZzpiYzA3ODhjZjRkZDE0YTM3OGRlYzVjMDA1NTk3Zjc0OS90ZXh0cmVnaW9uOmJjMDc4OGNmNGRkMTRhMzc4ZGVjNWMwMDU1OTdmNzQ5XzM5NjI4_ece7ceaf-739e-4f03-ad82-005712414fd8">&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%"&gt;Recently Adopted Financial Accounting Standards&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Financial Instruments - Credit Losses&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In June 2016, the Financial Accounting Standards Board ("FASB") issued amended accounting guidance that will require entities to measure credit losses on trade and other receivables, held-to-maturity debt securities, loans and other instruments using an "expected credit loss" model that considers historical experience, current conditions and reasonable supportable forecasts. This guidance also requires that credit losses on available-for-sale debt securities with unrealized losses be recognized as allowances rather than as deductions in the amortized cost of the securities. We consider historical experience, the current economic environment, customer credit ratings or bankruptcies, and reasonable and supportable forecasts to develop our allowance for credit losses. We review these factors quarterly to determine if any adjustments are needed to the allowance. This guidance was effective beginning the first quarter of fiscal 2021 and did not have a material impact on our consolidated financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%"&gt;Recently Issued Financial Accounting Standards Not Yet Adopted&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We address the adoption impacts of recently issued accounting standards by the FASB on the our consolidated financial statements as well as material updates to previous assessments, if any, from our fiscal 2020 Form 10-K. There were no accounting &lt;/span&gt;&lt;/div&gt;standards issued in fiscal 2021 that will have a material impact on our consolidated financial statements.</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:BusinessCombinationDisclosureTextBlock
      contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDYvZnJhZzpjN2ZmYWQ5NzA5YjM0M2Q1OWVjZWY1OTQ0YzA1NDM0NS90ZXh0cmVnaW9uOmM3ZmZhZDk3MDliMzQzZDU5ZWNlZjU5NDRjMDU0MzQ1XzI3NDg3NzkwNzY3MTA_a96258a5-726b-4f24-96a5-85cb2556822c">&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:13pt;font-weight:700;line-height:120%"&gt;2. Divestitures and Acquisitions&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%"&gt;Divestitures&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Cordis Assets Held for Sale&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On March 12, 2021, we signed a definitive agreement with Hellman &amp;amp; Friedman to sell our Cordis business for gross proceeds of $927 million in cash, subject to customary purchase price adjustments, and we retained certain working capital accounts and certain liabilities. The transaction closed on August 2, 2021 and we received proceeds of $927 million, net of cash transferred. Cardinal Health will retain product liability associated with lawsuits and claims related to inferior vena cava ("IVC") filters in the U.S. and Canada, as well as authority for these matters discussed in &lt;/span&gt;&lt;span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;&lt;a href="#i4f0ec56b9c604f1782a65ea4a19c284d_130" style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Note 7&lt;/a&gt;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Upon signing the agreement, we met the criteria for the related assets and liabilities of the Cordis business to be classified as held for sale. In connection with the divestiture, we allocated $388&#160;million of goodwill from the Medical Unit (within our Medical Segment) to the Cordis disposal group based on the estimated relative fair values of the business to be disposed of and the portion of the reporting unit that will be retained. We determined that the sale of the Cordis business does not meet the criteria to be classified as discontinued operations. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At June&#160;30, 2021, the book value of the disposal group exceeded its fair value less costs to sell. Accordingly, we recognized a $60 million pre-tax write-down on the disposal group in impairments and (gain)/loss on disposal of assets in our consolidated statement of earnings/(loss). This write-down includes a $3 million loss related to currency translation adjustments in accumulated other comprehensive loss. We recorded a net tax expense of $9 million associated with the impact of the write-down and the required tax adjustments related to held for sale accounting.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents information related to the assets and liabilities that were classified as held for sale at June&#160;30, 2021 related to the Cordis divestiture in the consolidated balance sheets:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:61.554%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:36.246%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Cash and equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;109&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Inventories, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;164&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Property and equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;90&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Goodwill and other intangibles, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;778&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Other assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;10&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Write-down of assets held for sale&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(60)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total assets held for sale&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;1,091&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Other accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;61&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Deferred income taxes and other liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;34&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total liabilities related to assets held for sale&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;95&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;naviHealth&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In August 2018, we sold our majority ownership interest in naviHealth, which operated within our Medical segment in exchange for cash proceeds of $737 million (after adjusting for certain fees and expenses) and a noncontrolling equity interest in a partnership that owned naviHealth. We also had certain call rights to reacquire naviHealth. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As a result of this divestiture, during the fiscal year ended June&#160;30, 2019, we recognized a pre-tax gain of $508 million in impairments and (gain)/loss on disposal of assets in our consolidated statements of earnings/(loss). This gain included our initial recognition of an equity method investment for $358 million and the derecognition of redeemable noncontrolling interests of $12 million. The fiscal 2019 tax expense as a result of this transaction was $130 million. We determined that the sale of the naviHealth business did not meet the criteria to be classified as discontinued operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In May 2020 we sold the remainder of our noncontrolling equity interest in a partnership that owned naviHealth. We recognized a pre-tax gain of $579&#160;million from this disposal in gain on sale of equity interest in naviHealth in our consolidated statements of earnings/(loss) during fiscal year 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our proportionate share of naviHealth&#x2019;s results, which was recorded in other (income)/expense, net in the consolidated statements of earnings/(loss), was income of $2 million and a loss of $10 million during fiscal 2020 and 2019, respectively. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%"&gt;Acquisitions&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We did not complete any acquisitions during fiscal 2020. While we completed several small acquisitions during fiscal 2021 and 2019, the pro forma results of operations and the results of operations for acquired businesses since the acquisition dates have not been separately disclosed because the effects were not significant compared to the consolidated financial statements, individually or in the aggregate. The cash paid for these acquisitions, net of cash acquired was $3 million and $82 million for fiscal 2021 and 2019, respectively.&lt;/span&gt;&lt;/div&gt;</us-gaap:BusinessCombinationDisclosureTextBlock>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationConsideration
      contextRef="i2ae0fa0d058b4f21aac5c8701cbd2fb7_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDYvZnJhZzpjN2ZmYWQ5NzA5YjM0M2Q1OWVjZWY1OTQ0YzA1NDM0NS90ZXh0cmVnaW9uOmM3ZmZhZDk3MDliMzQzZDU5ZWNlZjU5NDRjMDU0MzQ1XzQ5NDc4MDIzMjk1ODg_282278f6-c8b0-4889-b9e9-f8451242aa43"
      unitRef="usd">927000000</us-gaap:DisposalGroupIncludingDiscontinuedOperationConsideration>
    <us-gaap:ProceedsFromDivestitureOfBusinesses
      contextRef="ia92b5f17e3cb4ca99a1789f7499fb2b2_D20210802-20210802"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDYvZnJhZzpjN2ZmYWQ5NzA5YjM0M2Q1OWVjZWY1OTQ0YzA1NDM0NS90ZXh0cmVnaW9uOmM3ZmZhZDk3MDliMzQzZDU5ZWNlZjU5NDRjMDU0MzQ1XzQ5NDc4MDIzMzIxNTM_4b4adbbf-dab8-4cd2-a148-7ca28dc9f968"
      unitRef="usd">927000000</us-gaap:ProceedsFromDivestitureOfBusinesses>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationGoodwill1
      contextRef="i2ae0fa0d058b4f21aac5c8701cbd2fb7_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDYvZnJhZzpjN2ZmYWQ5NzA5YjM0M2Q1OWVjZWY1OTQ0YzA1NDM0NS90ZXh0cmVnaW9uOmM3ZmZhZDk3MDliMzQzZDU5ZWNlZjU5NDRjMDU0MzQ1XzI3NDg3NzkwNzY3NDA_75317e52-aae2-445f-9221-ecff7ffc13b0"
      unitRef="usd">388000000</us-gaap:DisposalGroupIncludingDiscontinuedOperationGoodwill1>
    <cah:WriteDownOfAssetsHeldForSale
      contextRef="i2ae0fa0d058b4f21aac5c8701cbd2fb7_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDYvZnJhZzpjN2ZmYWQ5NzA5YjM0M2Q1OWVjZWY1OTQ0YzA1NDM0NS90ZXh0cmVnaW9uOmM3ZmZhZDk3MDliMzQzZDU5ZWNlZjU5NDRjMDU0MzQ1XzQ5NDc4MDIzMzA4MjM_a39c35cc-26f6-469f-be2c-86c121fa736b"
      unitRef="usd">-60000000</cah:WriteDownOfAssetsHeldForSale>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationForeignCurrencyTranslationGainsLosses
      contextRef="i0c45da2d8021400f85c81b3a75b9c057_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDYvZnJhZzpjN2ZmYWQ5NzA5YjM0M2Q1OWVjZWY1OTQ0YzA1NDM0NS90ZXh0cmVnaW9uOmM3ZmZhZDk3MDliMzQzZDU5ZWNlZjU5NDRjMDU0MzQ1XzQ5NDc4MDIzMzA4Mzk_f1a03d95-8357-4a1b-85f4-6a02dfe06620"
      unitRef="usd">-3000000</us-gaap:DisposalGroupIncludingDiscontinuedOperationForeignCurrencyTranslationGainsLosses>
    <us-gaap:DiscontinuedOperationTaxEffectOfIncomeLossFromDisposalOfDiscontinuedOperation
      contextRef="i0c45da2d8021400f85c81b3a75b9c057_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDYvZnJhZzpjN2ZmYWQ5NzA5YjM0M2Q1OWVjZWY1OTQ0YzA1NDM0NS90ZXh0cmVnaW9uOmM3ZmZhZDk3MDliMzQzZDU5ZWNlZjU5NDRjMDU0MzQ1XzQ5NDc4MDIzMzA4NDU_452c6975-b517-4f16-8e62-1d9cc77596dd"
      unitRef="usd">9000000</us-gaap:DiscontinuedOperationTaxEffectOfIncomeLossFromDisposalOfDiscontinuedOperation>
    <us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock
      contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDYvZnJhZzpjN2ZmYWQ5NzA5YjM0M2Q1OWVjZWY1OTQ0YzA1NDM0NS90ZXh0cmVnaW9uOmM3ZmZhZDk3MDliMzQzZDU5ZWNlZjU5NDRjMDU0MzQ1XzI3NDg3NzkwNzY3MTM_fcd3a24e-7c4b-43fd-a861-f67500d49715">&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents information related to the assets and liabilities that were classified as held for sale at June&#160;30, 2021 related to the Cordis divestiture in the consolidated balance sheets:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:61.554%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:36.246%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Cash and equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;109&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Inventories, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;164&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Property and equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;90&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Goodwill and other intangibles, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;778&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Other assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;10&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Write-down of assets held for sale&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(60)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total assets held for sale&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;1,091&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Other accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;61&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Deferred income taxes and other liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;34&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total liabilities related to assets held for sale&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;95&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents
      contextRef="i2ae0fa0d058b4f21aac5c8701cbd2fb7_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDYvZnJhZzpjN2ZmYWQ5NzA5YjM0M2Q1OWVjZWY1OTQ0YzA1NDM0NS90YWJsZTowNGIzZTNmMDM4NTg0MzFlOWU2ZDk0NmViYzAxOWU0OS90YWJsZXJhbmdlOjA0YjNlM2YwMzg1ODQzMWU5ZTZkOTQ2ZWJjMDE5ZTQ5XzEtMS0xLTEtMzYzOQ_7348cadb-6a11-4ba8-b9dd-1573c2ad3bf7"
      unitRef="usd">109000000</us-gaap:DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationInventory1
      contextRef="i2ae0fa0d058b4f21aac5c8701cbd2fb7_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDYvZnJhZzpjN2ZmYWQ5NzA5YjM0M2Q1OWVjZWY1OTQ0YzA1NDM0NS90YWJsZTowNGIzZTNmMDM4NTg0MzFlOWU2ZDk0NmViYzAxOWU0OS90YWJsZXJhbmdlOjA0YjNlM2YwMzg1ODQzMWU5ZTZkOTQ2ZWJjMDE5ZTQ5XzItMS0xLTEtMzYzOQ_2b608cee-d8fc-4344-a523-57e0fd381345"
      unitRef="usd">164000000</us-gaap:DisposalGroupIncludingDiscontinuedOperationInventory1>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment
      contextRef="i2ae0fa0d058b4f21aac5c8701cbd2fb7_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDYvZnJhZzpjN2ZmYWQ5NzA5YjM0M2Q1OWVjZWY1OTQ0YzA1NDM0NS90YWJsZTowNGIzZTNmMDM4NTg0MzFlOWU2ZDk0NmViYzAxOWU0OS90YWJsZXJhbmdlOjA0YjNlM2YwMzg1ODQzMWU5ZTZkOTQ2ZWJjMDE5ZTQ5XzMtMS0xLTEtMzY0Mg_8fe10c00-7c21-402a-9f26-7f1b90816a1d"
      unitRef="usd">90000000</us-gaap:DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment>
    <cah:DisposalGroupIncludingDiscontinuedOperationsGoodwillAndOtherIntangiblesNet
      contextRef="i2ae0fa0d058b4f21aac5c8701cbd2fb7_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDYvZnJhZzpjN2ZmYWQ5NzA5YjM0M2Q1OWVjZWY1OTQ0YzA1NDM0NS90YWJsZTowNGIzZTNmMDM4NTg0MzFlOWU2ZDk0NmViYzAxOWU0OS90YWJsZXJhbmdlOjA0YjNlM2YwMzg1ODQzMWU5ZTZkOTQ2ZWJjMDE5ZTQ5XzQtMS0xLTEtMzY0Mg_a49934ef-5186-41f0-93ee-62f398c0c80e"
      unitRef="usd">778000000</cah:DisposalGroupIncludingDiscontinuedOperationsGoodwillAndOtherIntangiblesNet>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationOtherAssets
      contextRef="i2ae0fa0d058b4f21aac5c8701cbd2fb7_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDYvZnJhZzpjN2ZmYWQ5NzA5YjM0M2Q1OWVjZWY1OTQ0YzA1NDM0NS90YWJsZTowNGIzZTNmMDM4NTg0MzFlOWU2ZDk0NmViYzAxOWU0OS90YWJsZXJhbmdlOjA0YjNlM2YwMzg1ODQzMWU5ZTZkOTQ2ZWJjMDE5ZTQ5XzUtMS0xLTEtMzY0Mg_d50fbe70-0c1d-42ee-92d1-c246c0bbab6e"
      unitRef="usd">10000000</us-gaap:DisposalGroupIncludingDiscontinuedOperationOtherAssets>
    <cah:WriteDownOfAssetsHeldForSale
      contextRef="i2ae0fa0d058b4f21aac5c8701cbd2fb7_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDYvZnJhZzpjN2ZmYWQ5NzA5YjM0M2Q1OWVjZWY1OTQ0YzA1NDM0NS90YWJsZTowNGIzZTNmMDM4NTg0MzFlOWU2ZDk0NmViYzAxOWU0OS90YWJsZXJhbmdlOjA0YjNlM2YwMzg1ODQzMWU5ZTZkOTQ2ZWJjMDE5ZTQ5XzYtMS0xLTEtMzY0Mg_94c39bbf-3268-44d0-b6e4-ac0e52d098a5"
      unitRef="usd">-60000000</cah:WriteDownOfAssetsHeldForSale>
    <us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperation
      contextRef="i2ae0fa0d058b4f21aac5c8701cbd2fb7_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDYvZnJhZzpjN2ZmYWQ5NzA5YjM0M2Q1OWVjZWY1OTQ0YzA1NDM0NS90YWJsZTowNGIzZTNmMDM4NTg0MzFlOWU2ZDk0NmViYzAxOWU0OS90YWJsZXJhbmdlOjA0YjNlM2YwMzg1ODQzMWU5ZTZkOTQ2ZWJjMDE5ZTQ5XzctMS0xLTEtMzY0NQ_b65f8d5e-1c1c-48ad-927c-b3d6fef597a7"
      unitRef="usd">1091000000</us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperation>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationAccruedLiabilities
      contextRef="i2ae0fa0d058b4f21aac5c8701cbd2fb7_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDYvZnJhZzpjN2ZmYWQ5NzA5YjM0M2Q1OWVjZWY1OTQ0YzA1NDM0NS90YWJsZTowNGIzZTNmMDM4NTg0MzFlOWU2ZDk0NmViYzAxOWU0OS90YWJsZXJhbmdlOjA0YjNlM2YwMzg1ODQzMWU5ZTZkOTQ2ZWJjMDE5ZTQ5XzktMS0xLTEtMzY0OA_08edabcb-5030-47ea-b0c6-a8f692411798"
      unitRef="usd">61000000</us-gaap:DisposalGroupIncludingDiscontinuedOperationAccruedLiabilities>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationOtherLiabilities
      contextRef="i2ae0fa0d058b4f21aac5c8701cbd2fb7_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDYvZnJhZzpjN2ZmYWQ5NzA5YjM0M2Q1OWVjZWY1OTQ0YzA1NDM0NS90YWJsZTowNGIzZTNmMDM4NTg0MzFlOWU2ZDk0NmViYzAxOWU0OS90YWJsZXJhbmdlOjA0YjNlM2YwMzg1ODQzMWU5ZTZkOTQ2ZWJjMDE5ZTQ5XzEwLTEtMS0xLTM2NDg_a9ac9c13-dccb-4f69-90ca-ec6abc602892"
      unitRef="usd">34000000</us-gaap:DisposalGroupIncludingDiscontinuedOperationOtherLiabilities>
    <us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation
      contextRef="i2ae0fa0d058b4f21aac5c8701cbd2fb7_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDYvZnJhZzpjN2ZmYWQ5NzA5YjM0M2Q1OWVjZWY1OTQ0YzA1NDM0NS90YWJsZTowNGIzZTNmMDM4NTg0MzFlOWU2ZDk0NmViYzAxOWU0OS90YWJsZXJhbmdlOjA0YjNlM2YwMzg1ODQzMWU5ZTZkOTQ2ZWJjMDE5ZTQ5XzExLTEtMS0xLTM2NTE_ef47dbec-19f2-490b-835b-7c5a261fa63f"
      unitRef="usd">95000000</us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation>
    <us-gaap:ProceedsFromDivestitureOfBusinesses
      contextRef="i7f43dacd4cde4469bf87d551b8b075a1_D20180801-20180831"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDYvZnJhZzpjN2ZmYWQ5NzA5YjM0M2Q1OWVjZWY1OTQ0YzA1NDM0NS90ZXh0cmVnaW9uOmM3ZmZhZDk3MDliMzQzZDU5ZWNlZjU5NDRjMDU0MzQ1XzQ5NDc4MDIzMjgyMDE_b6ef2970-175c-4e28-b2be-663e15602fc3"
      unitRef="usd">737000000</us-gaap:ProceedsFromDivestitureOfBusinesses>
    <cah:PreTaxGainonDivestiture
      contextRef="ibfc08d70138644988d1a3a9486dd3ada_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDYvZnJhZzpjN2ZmYWQ5NzA5YjM0M2Q1OWVjZWY1OTQ0YzA1NDM0NS90ZXh0cmVnaW9uOmM3ZmZhZDk3MDliMzQzZDU5ZWNlZjU5NDRjMDU0MzQ1XzQ5NDc4MDIzMjgyMDY_e9c9ab43-152a-4833-824c-920546c9a873"
      unitRef="usd">508000000</cah:PreTaxGainonDivestiture>
    <us-gaap:EquityMethodInvestments
      contextRef="i463eed964bd04d08b29df93f74be293d_I20180801"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDYvZnJhZzpjN2ZmYWQ5NzA5YjM0M2Q1OWVjZWY1OTQ0YzA1NDM0NS90ZXh0cmVnaW9uOmM3ZmZhZDk3MDliMzQzZDU5ZWNlZjU5NDRjMDU0MzQ1XzQ5NDc4MDIzMjgyMTA_6beb73f7-cf8b-46ec-b9db-82a1765789e9"
      unitRef="usd">358000000</us-gaap:EquityMethodInvestments>
    <us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount
      contextRef="i463eed964bd04d08b29df93f74be293d_I20180801"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDYvZnJhZzpjN2ZmYWQ5NzA5YjM0M2Q1OWVjZWY1OTQ0YzA1NDM0NS90ZXh0cmVnaW9uOmM3ZmZhZDk3MDliMzQzZDU5ZWNlZjU5NDRjMDU0MzQ1XzQ5NDc4MDIzMjgyMTQ_38e67e15-0773-4ade-9a3d-6205e503646c"
      unitRef="usd">12000000</us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount>
    <cah:Provisionaltaxbenefitrelatedtotransaction
      contextRef="i7f43dacd4cde4469bf87d551b8b075a1_D20180801-20180831"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDYvZnJhZzpjN2ZmYWQ5NzA5YjM0M2Q1OWVjZWY1OTQ0YzA1NDM0NS90ZXh0cmVnaW9uOmM3ZmZhZDk3MDliMzQzZDU5ZWNlZjU5NDRjMDU0MzQ1XzQ5NDc4MDIzMjgyMTg_f3690a52-05eb-49d9-8f2b-3601ffc8f113"
      unitRef="usd">130000000</cah:Provisionaltaxbenefitrelatedtotransaction>
    <us-gaap:GainOnSaleOfInvestments
      contextRef="i240ee16a678541f0949ac8f39755276a_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDYvZnJhZzpjN2ZmYWQ5NzA5YjM0M2Q1OWVjZWY1OTQ0YzA1NDM0NS90ZXh0cmVnaW9uOmM3ZmZhZDk3MDliMzQzZDU5ZWNlZjU5NDRjMDU0MzQ1XzQ5NDc4MDIzMjgyMjI_a40541cb-0d05-490c-8680-029c1ebae141"
      unitRef="usd">579000000</us-gaap:GainOnSaleOfInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="ia31e9a409b874bb19d0ff6f2f39ecc09_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDYvZnJhZzpjN2ZmYWQ5NzA5YjM0M2Q1OWVjZWY1OTQ0YzA1NDM0NS90ZXh0cmVnaW9uOmM3ZmZhZDk3MDliMzQzZDU5ZWNlZjU5NDRjMDU0MzQ1XzEzNzM_4a271d31-fc8f-4de0-88a4-9ecc75808fd5"
      unitRef="usd">2000000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i00a6d666bf604826b24e68ddbd63eac4_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDYvZnJhZzpjN2ZmYWQ5NzA5YjM0M2Q1OWVjZWY1OTQ0YzA1NDM0NS90ZXh0cmVnaW9uOmM3ZmZhZDk3MDliMzQzZDU5ZWNlZjU5NDRjMDU0MzQ1XzEzOTA_e0ad1485-c505-4dd7-9a20-fac9407b8dcc"
      unitRef="usd">10000000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDYvZnJhZzpjN2ZmYWQ5NzA5YjM0M2Q1OWVjZWY1OTQ0YzA1NDM0NS90ZXh0cmVnaW9uOmM3ZmZhZDk3MDliMzQzZDU5ZWNlZjU5NDRjMDU0MzQ1XzQ5NDc4MDIzMzE0OTU_1c95364d-877a-4822-8479-aadbdfab13cf"
      unitRef="usd">3000000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="i00a6d666bf604826b24e68ddbd63eac4_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDYvZnJhZzpjN2ZmYWQ5NzA5YjM0M2Q1OWVjZWY1OTQ0YzA1NDM0NS90ZXh0cmVnaW9uOmM3ZmZhZDk3MDliMzQzZDU5ZWNlZjU5NDRjMDU0MzQ1XzI1NDk_3ad0b7a1-d125-4af8-863b-1a9a8d6464f1"
      unitRef="usd">82000000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock
      contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDkvZnJhZzo1MTBkNDY1OTZlNDk0ZWRiOGViOGY1MWZmYTk4OTMxYS90ZXh0cmVnaW9uOjUxMGQ0NjU5NmU0OTRlZGI4ZWI4ZjUxZmZhOTg5MzFhXzE0ODE_4eabfc78-f098-4431-8b5a-f3e88f826329">&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:13pt;font-weight:700;line-height:120%"&gt;3. Restructuring and Employee Severance &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables summarize restructuring and employee severance costs:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.382%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:57.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.632%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.352%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.632%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.352%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Employee-related costs &lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;53&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;66&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;95&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Facility exit and other costs &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;61&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;56&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total restructuring and employee severance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;114&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;122&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;125&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Employee-related costs primarily consist of termination benefits provided to employees who have been involuntarily terminated, duplicate payroll costs and retention bonuses incurred during transition periods. Facility exit and other costs primarily consist of professional, project management and other service fees to support divestitures, vendor transition fees, accelerated depreciation, lease costs associated with vacant facilities, equipment relocation costs, project consulting fees, costs &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;associated with restructuring our delivery of information technology infrastructure services and certain other divestiture-related costs.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In fiscal 2021, restructuring costs were primarily related to the implementation of certain enterprise-wide cost-savings measures and the divestiture of our Cordis business. In fiscal 2020 and 2019, restructuring costs were primarily related to the implementation of certain enterprise-wide cost-savings measures.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes activity related to liabilities associated with restructuring and employee severance:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.691%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:42.553%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.714%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.347%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.191%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.347%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.048%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Employee-&lt;br/&gt;Related Costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Facility Exit&lt;br/&gt;and Other Costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Balance at June 30, 2019&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;64&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;72&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Additions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;85&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;109&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Payments and other adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(81)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(85)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Balance at June 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;68&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;96&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Additions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;49&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;75&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Payments and other adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(64)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(28)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(92)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Balance at June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;53&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;26&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;79&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock>
    <us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock
      contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDkvZnJhZzo1MTBkNDY1OTZlNDk0ZWRiOGViOGY1MWZmYTk4OTMxYS90ZXh0cmVnaW9uOjUxMGQ0NjU5NmU0OTRlZGI4ZWI4ZjUxZmZhOTg5MzFhXzE0ODg_527268cb-dbac-410b-ac37-c7efdc3be03b">&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables summarize restructuring and employee severance costs:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.382%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:57.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.632%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.352%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.632%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.352%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Employee-related costs &lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;53&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;66&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;95&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Facility exit and other costs &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;61&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;56&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total restructuring and employee severance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;114&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;122&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;125&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock>
    <us-gaap:SeveranceCosts1
      contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDkvZnJhZzo1MTBkNDY1OTZlNDk0ZWRiOGViOGY1MWZmYTk4OTMxYS90YWJsZTo2ZDU5ZWRiZDVmMDI0NzFjYWU5OWI5NjBlYjFiNzdlNy90YWJsZXJhbmdlOjZkNTllZGJkNWYwMjQ3MWNhZTk5Yjk2MGViMWI3N2U3XzEtMS0xLTEtMA_2a2f5585-d0f4-4f23-9a02-5dd8f030a595"
      unitRef="usd">53000000</us-gaap:SeveranceCosts1>
    <us-gaap:SeveranceCosts1
      contextRef="ia31e9a409b874bb19d0ff6f2f39ecc09_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDkvZnJhZzo1MTBkNDY1OTZlNDk0ZWRiOGViOGY1MWZmYTk4OTMxYS90YWJsZTo2ZDU5ZWRiZDVmMDI0NzFjYWU5OWI5NjBlYjFiNzdlNy90YWJsZXJhbmdlOjZkNTllZGJkNWYwMjQ3MWNhZTk5Yjk2MGViMWI3N2U3XzEtMy0xLTEtMA_131ca3d7-5171-4321-b38f-0269bbe648ff"
      unitRef="usd">66000000</us-gaap:SeveranceCosts1>
    <us-gaap:SeveranceCosts1
      contextRef="i00a6d666bf604826b24e68ddbd63eac4_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDkvZnJhZzo1MTBkNDY1OTZlNDk0ZWRiOGViOGY1MWZmYTk4OTMxYS90YWJsZTo2ZDU5ZWRiZDVmMDI0NzFjYWU5OWI5NjBlYjFiNzdlNy90YWJsZXJhbmdlOjZkNTllZGJkNWYwMjQ3MWNhZTk5Yjk2MGViMWI3N2U3XzEtNS0xLTEtMA_ee9d1648-db2e-4ed2-950a-66ae99986ec9"
      unitRef="usd">95000000</us-gaap:SeveranceCosts1>
    <cah:FacilityExitAndOtherCosts
      contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDkvZnJhZzo1MTBkNDY1OTZlNDk0ZWRiOGViOGY1MWZmYTk4OTMxYS90YWJsZTo2ZDU5ZWRiZDVmMDI0NzFjYWU5OWI5NjBlYjFiNzdlNy90YWJsZXJhbmdlOjZkNTllZGJkNWYwMjQ3MWNhZTk5Yjk2MGViMWI3N2U3XzItMS0xLTEtMA_7ab63a86-d9ed-48c6-bbc6-8a884a62544a"
      unitRef="usd">61000000</cah:FacilityExitAndOtherCosts>
    <cah:FacilityExitAndOtherCosts
      contextRef="ia31e9a409b874bb19d0ff6f2f39ecc09_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDkvZnJhZzo1MTBkNDY1OTZlNDk0ZWRiOGViOGY1MWZmYTk4OTMxYS90YWJsZTo2ZDU5ZWRiZDVmMDI0NzFjYWU5OWI5NjBlYjFiNzdlNy90YWJsZXJhbmdlOjZkNTllZGJkNWYwMjQ3MWNhZTk5Yjk2MGViMWI3N2U3XzItMy0xLTEtMA_cbfadd10-3a18-467d-9c41-2e51e1edf84a"
      unitRef="usd">56000000</cah:FacilityExitAndOtherCosts>
    <cah:FacilityExitAndOtherCosts
      contextRef="i00a6d666bf604826b24e68ddbd63eac4_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDkvZnJhZzo1MTBkNDY1OTZlNDk0ZWRiOGViOGY1MWZmYTk4OTMxYS90YWJsZTo2ZDU5ZWRiZDVmMDI0NzFjYWU5OWI5NjBlYjFiNzdlNy90YWJsZXJhbmdlOjZkNTllZGJkNWYwMjQ3MWNhZTk5Yjk2MGViMWI3N2U3XzItNS0xLTEtMA_c63816a1-f7dd-4531-8c73-0fd68b4ae54b"
      unitRef="usd">30000000</cah:FacilityExitAndOtherCosts>
    <us-gaap:RestructuringCharges
      contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDkvZnJhZzo1MTBkNDY1OTZlNDk0ZWRiOGViOGY1MWZmYTk4OTMxYS90YWJsZTo2ZDU5ZWRiZDVmMDI0NzFjYWU5OWI5NjBlYjFiNzdlNy90YWJsZXJhbmdlOjZkNTllZGJkNWYwMjQ3MWNhZTk5Yjk2MGViMWI3N2U3XzMtMS0xLTEtMA_407dde4d-008b-468b-8e7e-a5626933717c"
      unitRef="usd">114000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="ia31e9a409b874bb19d0ff6f2f39ecc09_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDkvZnJhZzo1MTBkNDY1OTZlNDk0ZWRiOGViOGY1MWZmYTk4OTMxYS90YWJsZTo2ZDU5ZWRiZDVmMDI0NzFjYWU5OWI5NjBlYjFiNzdlNy90YWJsZXJhbmdlOjZkNTllZGJkNWYwMjQ3MWNhZTk5Yjk2MGViMWI3N2U3XzMtMy0xLTEtMA_ea0e13b9-fcf1-4264-a06e-ed8909f3087a"
      unitRef="usd">122000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i00a6d666bf604826b24e68ddbd63eac4_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDkvZnJhZzo1MTBkNDY1OTZlNDk0ZWRiOGViOGY1MWZmYTk4OTMxYS90YWJsZTo2ZDU5ZWRiZDVmMDI0NzFjYWU5OWI5NjBlYjFiNzdlNy90YWJsZXJhbmdlOjZkNTllZGJkNWYwMjQ3MWNhZTk5Yjk2MGViMWI3N2U3XzMtNS0xLTEtMA_b44ecfcd-99e8-4eb6-9bb8-9ace640740e1"
      unitRef="usd">125000000</us-gaap:RestructuringCharges>
    <us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock
      contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDkvZnJhZzo1MTBkNDY1OTZlNDk0ZWRiOGViOGY1MWZmYTk4OTMxYS90ZXh0cmVnaW9uOjUxMGQ0NjU5NmU0OTRlZGI4ZWI4ZjUxZmZhOTg5MzFhXzE1MDk_c4f5d0bf-e395-47d4-a4d9-82ef89452e6a">&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes activity related to liabilities associated with restructuring and employee severance:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.691%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:42.553%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.714%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.347%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.191%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.347%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.048%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Employee-&lt;br/&gt;Related Costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Facility Exit&lt;br/&gt;and Other Costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Balance at June 30, 2019&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;64&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;72&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Additions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;85&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;109&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Payments and other adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(81)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(85)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Balance at June 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;68&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;96&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Additions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;49&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;75&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Payments and other adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(64)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(28)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(92)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Balance at June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;53&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;26&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;79&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock>
    <us-gaap:RestructuringReserve
      contextRef="i054d56750a764f7e93ff85a2bf9a1b2b_I20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDkvZnJhZzo1MTBkNDY1OTZlNDk0ZWRiOGViOGY1MWZmYTk4OTMxYS90YWJsZTo5MDFjZTJmMTc5M2M0ODIzYWQ5MjYwODY1YjVlMmY0Yi90YWJsZXJhbmdlOjkwMWNlMmYxNzkzYzQ4MjNhZDkyNjA4NjViNWUyZjRiXzEtMS0xLTEtMA_b8437c0c-694f-4628-b807-638d6ff8d3d3"
      unitRef="usd">64000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="i033d53d46d0d43139442c42e765cd554_I20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDkvZnJhZzo1MTBkNDY1OTZlNDk0ZWRiOGViOGY1MWZmYTk4OTMxYS90YWJsZTo5MDFjZTJmMTc5M2M0ODIzYWQ5MjYwODY1YjVlMmY0Yi90YWJsZXJhbmdlOjkwMWNlMmYxNzkzYzQ4MjNhZDkyNjA4NjViNWUyZjRiXzEtMy0xLTEtMA_cadb1195-874f-4f70-ae03-187995878a7c"
      unitRef="usd">8000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="if6dc09eec4e74751b47cdf037a5b1860_I20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDkvZnJhZzo1MTBkNDY1OTZlNDk0ZWRiOGViOGY1MWZmYTk4OTMxYS90YWJsZTo5MDFjZTJmMTc5M2M0ODIzYWQ5MjYwODY1YjVlMmY0Yi90YWJsZXJhbmdlOjkwMWNlMmYxNzkzYzQ4MjNhZDkyNjA4NjViNWUyZjRiXzEtNS0xLTEtMA_4d7cb679-5adb-4bde-9f7f-9b13c4c29fbd"
      unitRef="usd">72000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringCosts
      contextRef="i979647fadf85426a8ed1ad60900d45dc_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDkvZnJhZzo1MTBkNDY1OTZlNDk0ZWRiOGViOGY1MWZmYTk4OTMxYS90YWJsZTo5MDFjZTJmMTc5M2M0ODIzYWQ5MjYwODY1YjVlMmY0Yi90YWJsZXJhbmdlOjkwMWNlMmYxNzkzYzQ4MjNhZDkyNjA4NjViNWUyZjRiXzItMS0xLTEtMA_d2b13e6b-b75d-4b8b-8107-33e91cb79e0c"
      unitRef="usd">85000000</us-gaap:RestructuringCosts>
    <us-gaap:RestructuringCosts
      contextRef="i690a654e053647b6a93151845b9d81e9_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDkvZnJhZzo1MTBkNDY1OTZlNDk0ZWRiOGViOGY1MWZmYTk4OTMxYS90YWJsZTo5MDFjZTJmMTc5M2M0ODIzYWQ5MjYwODY1YjVlMmY0Yi90YWJsZXJhbmdlOjkwMWNlMmYxNzkzYzQ4MjNhZDkyNjA4NjViNWUyZjRiXzItMy0xLTEtMA_c75bde5f-f20d-4181-8574-5e86ead934b5"
      unitRef="usd">24000000</us-gaap:RestructuringCosts>
    <us-gaap:RestructuringCosts
      contextRef="ia31e9a409b874bb19d0ff6f2f39ecc09_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDkvZnJhZzo1MTBkNDY1OTZlNDk0ZWRiOGViOGY1MWZmYTk4OTMxYS90YWJsZTo5MDFjZTJmMTc5M2M0ODIzYWQ5MjYwODY1YjVlMmY0Yi90YWJsZXJhbmdlOjkwMWNlMmYxNzkzYzQ4MjNhZDkyNjA4NjViNWUyZjRiXzItNS0xLTEtMA_a4f49f1e-4d86-4bde-ad15-a51c7054e51c"
      unitRef="usd">109000000</us-gaap:RestructuringCosts>
    <us-gaap:PaymentsForRestructuring
      contextRef="i979647fadf85426a8ed1ad60900d45dc_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDkvZnJhZzo1MTBkNDY1OTZlNDk0ZWRiOGViOGY1MWZmYTk4OTMxYS90YWJsZTo5MDFjZTJmMTc5M2M0ODIzYWQ5MjYwODY1YjVlMmY0Yi90YWJsZXJhbmdlOjkwMWNlMmYxNzkzYzQ4MjNhZDkyNjA4NjViNWUyZjRiXzMtMS0xLTEtMA_3a6d355e-29c5-439a-9a6e-21e3f65e2e58"
      unitRef="usd">81000000</us-gaap:PaymentsForRestructuring>
    <us-gaap:PaymentsForRestructuring
      contextRef="i690a654e053647b6a93151845b9d81e9_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDkvZnJhZzo1MTBkNDY1OTZlNDk0ZWRiOGViOGY1MWZmYTk4OTMxYS90YWJsZTo5MDFjZTJmMTc5M2M0ODIzYWQ5MjYwODY1YjVlMmY0Yi90YWJsZXJhbmdlOjkwMWNlMmYxNzkzYzQ4MjNhZDkyNjA4NjViNWUyZjRiXzMtMy0xLTEtMA_f574ea45-b725-49ed-95a5-cb223f20377f"
      unitRef="usd">4000000</us-gaap:PaymentsForRestructuring>
    <us-gaap:PaymentsForRestructuring
      contextRef="ia31e9a409b874bb19d0ff6f2f39ecc09_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDkvZnJhZzo1MTBkNDY1OTZlNDk0ZWRiOGViOGY1MWZmYTk4OTMxYS90YWJsZTo5MDFjZTJmMTc5M2M0ODIzYWQ5MjYwODY1YjVlMmY0Yi90YWJsZXJhbmdlOjkwMWNlMmYxNzkzYzQ4MjNhZDkyNjA4NjViNWUyZjRiXzMtNS0xLTEtMA_eeb0cc9d-e634-4228-97a7-2163f4f869c9"
      unitRef="usd">85000000</us-gaap:PaymentsForRestructuring>
    <us-gaap:RestructuringReserve
      contextRef="i6b154a090610482d9bfc35edbf9bab55_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDkvZnJhZzo1MTBkNDY1OTZlNDk0ZWRiOGViOGY1MWZmYTk4OTMxYS90YWJsZTo5MDFjZTJmMTc5M2M0ODIzYWQ5MjYwODY1YjVlMmY0Yi90YWJsZXJhbmdlOjkwMWNlMmYxNzkzYzQ4MjNhZDkyNjA4NjViNWUyZjRiXzQtMS0xLTEtMA_71c886ee-32fe-4813-b0b0-8eb26be921e8"
      unitRef="usd">68000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="i74208c384ff247b5a96f11cafa8f324e_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDkvZnJhZzo1MTBkNDY1OTZlNDk0ZWRiOGViOGY1MWZmYTk4OTMxYS90YWJsZTo5MDFjZTJmMTc5M2M0ODIzYWQ5MjYwODY1YjVlMmY0Yi90YWJsZXJhbmdlOjkwMWNlMmYxNzkzYzQ4MjNhZDkyNjA4NjViNWUyZjRiXzQtMy0xLTEtMA_d09d9141-76bd-45ae-9036-f665f6d1f973"
      unitRef="usd">28000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="i299cea70f47b4fbe96772aaa8cc00b79_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDkvZnJhZzo1MTBkNDY1OTZlNDk0ZWRiOGViOGY1MWZmYTk4OTMxYS90YWJsZTo5MDFjZTJmMTc5M2M0ODIzYWQ5MjYwODY1YjVlMmY0Yi90YWJsZXJhbmdlOjkwMWNlMmYxNzkzYzQ4MjNhZDkyNjA4NjViNWUyZjRiXzQtNS0xLTEtMA_1ec68b6d-bee9-4243-8fc1-5933dcf87491"
      unitRef="usd">96000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringCosts
      contextRef="i66e672ad39ba4fbda69ce9255eb8afa1_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDkvZnJhZzo1MTBkNDY1OTZlNDk0ZWRiOGViOGY1MWZmYTk4OTMxYS90YWJsZTo5MDFjZTJmMTc5M2M0ODIzYWQ5MjYwODY1YjVlMmY0Yi90YWJsZXJhbmdlOjkwMWNlMmYxNzkzYzQ4MjNhZDkyNjA4NjViNWUyZjRiXzUtMS0xLTEtMA_159f063f-e2c0-463b-a7e7-3924a8586aab"
      unitRef="usd">49000000</us-gaap:RestructuringCosts>
    <us-gaap:RestructuringCosts
      contextRef="i369bbd13125e4ca2a3de4a5c3da1ffc5_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDkvZnJhZzo1MTBkNDY1OTZlNDk0ZWRiOGViOGY1MWZmYTk4OTMxYS90YWJsZTo5MDFjZTJmMTc5M2M0ODIzYWQ5MjYwODY1YjVlMmY0Yi90YWJsZXJhbmdlOjkwMWNlMmYxNzkzYzQ4MjNhZDkyNjA4NjViNWUyZjRiXzUtMy0xLTEtMA_a70a8761-b370-4e91-a2c4-9f9f0a8aedd1"
      unitRef="usd">26000000</us-gaap:RestructuringCosts>
    <us-gaap:RestructuringCosts
      contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDkvZnJhZzo1MTBkNDY1OTZlNDk0ZWRiOGViOGY1MWZmYTk4OTMxYS90YWJsZTo5MDFjZTJmMTc5M2M0ODIzYWQ5MjYwODY1YjVlMmY0Yi90YWJsZXJhbmdlOjkwMWNlMmYxNzkzYzQ4MjNhZDkyNjA4NjViNWUyZjRiXzUtNS0xLTEtMA_1a531aa1-f04b-4fbb-a4e6-e4b9ac94cbf0"
      unitRef="usd">75000000</us-gaap:RestructuringCosts>
    <us-gaap:PaymentsForRestructuring
      contextRef="i66e672ad39ba4fbda69ce9255eb8afa1_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDkvZnJhZzo1MTBkNDY1OTZlNDk0ZWRiOGViOGY1MWZmYTk4OTMxYS90YWJsZTo5MDFjZTJmMTc5M2M0ODIzYWQ5MjYwODY1YjVlMmY0Yi90YWJsZXJhbmdlOjkwMWNlMmYxNzkzYzQ4MjNhZDkyNjA4NjViNWUyZjRiXzYtMS0xLTEtMA_70e6df47-2e83-4f26-9967-f5eb361d3436"
      unitRef="usd">64000000</us-gaap:PaymentsForRestructuring>
    <us-gaap:PaymentsForRestructuring
      contextRef="i369bbd13125e4ca2a3de4a5c3da1ffc5_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDkvZnJhZzo1MTBkNDY1OTZlNDk0ZWRiOGViOGY1MWZmYTk4OTMxYS90YWJsZTo5MDFjZTJmMTc5M2M0ODIzYWQ5MjYwODY1YjVlMmY0Yi90YWJsZXJhbmdlOjkwMWNlMmYxNzkzYzQ4MjNhZDkyNjA4NjViNWUyZjRiXzYtMy0xLTEtMA_19de4726-aeb0-4640-8f28-c5ec9e38717c"
      unitRef="usd">28000000</us-gaap:PaymentsForRestructuring>
    <us-gaap:PaymentsForRestructuring
      contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDkvZnJhZzo1MTBkNDY1OTZlNDk0ZWRiOGViOGY1MWZmYTk4OTMxYS90YWJsZTo5MDFjZTJmMTc5M2M0ODIzYWQ5MjYwODY1YjVlMmY0Yi90YWJsZXJhbmdlOjkwMWNlMmYxNzkzYzQ4MjNhZDkyNjA4NjViNWUyZjRiXzYtNS0xLTEtMA_13ec2ee1-2adc-4fe3-9ad6-2d3f402378b0"
      unitRef="usd">92000000</us-gaap:PaymentsForRestructuring>
    <us-gaap:RestructuringReserve
      contextRef="iec538c38949543a3a758a69a4da1d7f4_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDkvZnJhZzo1MTBkNDY1OTZlNDk0ZWRiOGViOGY1MWZmYTk4OTMxYS90YWJsZTo5MDFjZTJmMTc5M2M0ODIzYWQ5MjYwODY1YjVlMmY0Yi90YWJsZXJhbmdlOjkwMWNlMmYxNzkzYzQ4MjNhZDkyNjA4NjViNWUyZjRiXzctMS0xLTEtMA_139dd230-487b-4e35-9403-cb9712340236"
      unitRef="usd">53000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="i3af47ae162d94351b026bc1510125da6_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDkvZnJhZzo1MTBkNDY1OTZlNDk0ZWRiOGViOGY1MWZmYTk4OTMxYS90YWJsZTo5MDFjZTJmMTc5M2M0ODIzYWQ5MjYwODY1YjVlMmY0Yi90YWJsZXJhbmdlOjkwMWNlMmYxNzkzYzQ4MjNhZDkyNjA4NjViNWUyZjRiXzctMy0xLTEtMA_96869d70-f1e6-467c-b2e6-1d3e3c6c3e6c"
      unitRef="usd">26000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="i2e87824102b34590a0208cc7da91b5f5_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMDkvZnJhZzo1MTBkNDY1OTZlNDk0ZWRiOGViOGY1MWZmYTk4OTMxYS90YWJsZTo5MDFjZTJmMTc5M2M0ODIzYWQ5MjYwODY1YjVlMmY0Yi90YWJsZXJhbmdlOjkwMWNlMmYxNzkzYzQ4MjNhZDkyNjA4NjViNWUyZjRiXzctNS0xLTEtMA_91cf4f3f-1e83-4436-bbf3-56ab307d4fba"
      unitRef="usd">79000000</us-gaap:RestructuringReserve>
    <us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock
      contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMTIvZnJhZzoxZjM3NDE4OGI0M2U0ZGQ4YjU1YzhiY2RlNzA0NjZmNi90ZXh0cmVnaW9uOjFmMzc0MTg4YjQzZTRkZDhiNTVjOGJjZGU3MDQ2NmY2XzYyOQ_f9644742-5b9b-4d3a-a915-6cbde4a955f8">&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:13pt;font-weight:700;line-height:120%"&gt;4. Goodwill and Other Intangible Assets &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%"&gt;Goodwill&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the changes in the carrying amount of goodwill by segment and in total:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:41.801%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:24.517%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.343%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.949%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.343%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.247%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Pharmaceutical (1)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Medical (2)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Balance at June 30, 2019&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,663&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;5,715&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;8,378&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Goodwill acquired, net of purchase price adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Foreign currency translation adjustments and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(15)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(16)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Balance at June 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,657&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;5,700&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;8,357&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Goodwill acquired, net of purchase price adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Foreign currency translation adjustments and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;18&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Cordis goodwill reclassified to assets held for sale&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(388)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(388)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2.5pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Balance at June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2.5pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2.5pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2,659&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2.5pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2.5pt solid #000000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2.5pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2.5pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;5,330&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2.5pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2.5pt solid #000000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2.5pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2.5pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;7,989&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2.5pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&#160;&#160;&#160;&#160;At June&#160;30, 2021 and 2020, the Pharmaceutical segment accumulated goodwill impairment loss was $829 million.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(2)&#160;&#160;&#160;&#160;At June&#160;30, 2021 and 2020, the Medical segment accumulated goodwill impairment loss was $1.4 billion. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In connection with the divestiture of our Cordis business, during fiscal 2021 we allocated and reclassified $388 million of goodwill from the Medical Unit (within our Medical Segment) to the Cordis disposal group based on the estimated relative fair values of the business to be disposed of and the portion of the reporting unit that will be retained, discussed further in &lt;/span&gt;&lt;span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;&lt;a href="#i4f0ec56b9c604f1782a65ea4a19c284d_106" style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Note 2&lt;/a&gt;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%"&gt;Other Intangible Assets&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables summarize other intangible assets by class at June&#160;30:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:22.356%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.023%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.343%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.653%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.343%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.023%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.343%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:20.816%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Intangible&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Accumulated&lt;br/&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net&lt;br/&gt;Intangible&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted- Average Remaining Amortization Period (Years)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Indefinite-life intangibles:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Trademarks and patents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;12&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;12&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total indefinite-life intangibles&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;12&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;12&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Definite-life intangibles:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;3,330&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;1,989&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;1,341&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;11&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Trademarks, trade names and patents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;551&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;328&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;223&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;9&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Developed technology and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;1,035&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;506&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;529&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;10&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total definite-life intangibles&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;4,916&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2,823&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2,093&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;10&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total other intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;4,928&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2,823&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2,105&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.691%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:42.243%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.308%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.347%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.643%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.347%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.312%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Gross&lt;br/&gt;Intangible&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Accumulated&lt;br/&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Net&lt;br/&gt;Intangible&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Indefinite-life intangibles:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;IPR&amp;amp;D, trademarks and other&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total indefinite-life intangibles&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Definite-life intangibles:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3,554&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,828&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,726&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Trademarks, trade names and patents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;673&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;341&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;332&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Developed technology and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,604&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;767&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;837&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total definite-life intangibles&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;5,831&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,936&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,895&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total other intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;5,854&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,936&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,918&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;Total amortization of intangible assets was $428 million, $512 million and $531 million for fiscal 2021, 2020 and 2019, respectively. The estimated annual amortization for intangible assets for fiscal 2022 through 2026 is as follows: $315 million, $287 million, $264 million, $238 million and $212 million.</us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock>
    <us-gaap:ScheduleOfGoodwillTextBlock
      contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMTIvZnJhZzoxZjM3NDE4OGI0M2U0ZGQ4YjU1YzhiY2RlNzA0NjZmNi90ZXh0cmVnaW9uOjFmMzc0MTg4YjQzZTRkZDhiNTVjOGJjZGU3MDQ2NmY2XzY0NA_394cfd4f-2a0a-4055-96a1-6389bb7574be">&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the changes in the carrying amount of goodwill by segment and in total:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:41.801%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:24.517%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.343%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.949%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.343%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.247%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Pharmaceutical (1)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Medical (2)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Balance at June 30, 2019&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,663&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;5,715&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;8,378&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Goodwill acquired, net of purchase price adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Foreign currency translation adjustments and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(15)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(16)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Balance at June 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,657&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;5,700&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;8,357&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Goodwill acquired, net of purchase price adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Foreign currency translation adjustments and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;18&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Cordis goodwill reclassified to assets held for sale&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(388)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(388)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2.5pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Balance at June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2.5pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2.5pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2,659&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2.5pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2.5pt solid #000000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2.5pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2.5pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;5,330&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2.5pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2.5pt solid #000000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2.5pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2.5pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;7,989&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2.5pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&#160;&#160;&#160;&#160;At June&#160;30, 2021 and 2020, the Pharmaceutical segment accumulated goodwill impairment loss was $829 million.&lt;/span&gt;&lt;/div&gt;(2)&#160;&#160;&#160;&#160;At June&#160;30, 2021 and 2020, the Medical segment accumulated goodwill impairment loss was $1.4 billion.</us-gaap:ScheduleOfGoodwillTextBlock>
    <us-gaap:Goodwill
      contextRef="i3b152a2afe4f4679a06346db852d336d_I20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMTIvZnJhZzoxZjM3NDE4OGI0M2U0ZGQ4YjU1YzhiY2RlNzA0NjZmNi90YWJsZTplZTgyNjg0YmNkNTI0YTI1ODY2MjFiM2Q5M2QxMzcwNC90YWJsZXJhbmdlOmVlODI2ODRiY2Q1MjRhMjU4NjYyMWIzZDkzZDEzNzA0XzEtMS0xLTEtMA_9b0178c8-6067-480e-9ecb-8236dcebb4d0"
      unitRef="usd">2663000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="ie6cb132adb5f4ff7aba14ffe42cc56d3_I20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMTIvZnJhZzoxZjM3NDE4OGI0M2U0ZGQ4YjU1YzhiY2RlNzA0NjZmNi90YWJsZTplZTgyNjg0YmNkNTI0YTI1ODY2MjFiM2Q5M2QxMzcwNC90YWJsZXJhbmdlOmVlODI2ODRiY2Q1MjRhMjU4NjYyMWIzZDkzZDEzNzA0XzEtMy0xLTEtMA_f0c9bb29-9eb1-47f0-900c-f6daa943fa85"
      unitRef="usd">5715000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="if6dc09eec4e74751b47cdf037a5b1860_I20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMTIvZnJhZzoxZjM3NDE4OGI0M2U0ZGQ4YjU1YzhiY2RlNzA0NjZmNi90YWJsZTplZTgyNjg0YmNkNTI0YTI1ODY2MjFiM2Q5M2QxMzcwNC90YWJsZXJhbmdlOmVlODI2ODRiY2Q1MjRhMjU4NjYyMWIzZDkzZDEzNzA0XzEtNS0xLTEtMA_ea53c095-5ab0-4786-9e05-728de7592ca4"
      unitRef="usd">8378000000</us-gaap:Goodwill>
    <us-gaap:GoodwillTransfers
      contextRef="ib1a6fd7bfc8b43f5b583eff60a34f03f_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMTIvZnJhZzoxZjM3NDE4OGI0M2U0ZGQ4YjU1YzhiY2RlNzA0NjZmNi90YWJsZTplZTgyNjg0YmNkNTI0YTI1ODY2MjFiM2Q5M2QxMzcwNC90YWJsZXJhbmdlOmVlODI2ODRiY2Q1MjRhMjU4NjYyMWIzZDkzZDEzNzA0XzItMS0xLTEtMA_da79163c-02b6-4912-a825-4a76b9bad282"
      unitRef="usd">-5000000</us-gaap:GoodwillTransfers>
    <us-gaap:GoodwillTransfers
      contextRef="icf7ee031a48e4d11b1c35c9709df0a86_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMTIvZnJhZzoxZjM3NDE4OGI0M2U0ZGQ4YjU1YzhiY2RlNzA0NjZmNi90YWJsZTplZTgyNjg0YmNkNTI0YTI1ODY2MjFiM2Q5M2QxMzcwNC90YWJsZXJhbmdlOmVlODI2ODRiY2Q1MjRhMjU4NjYyMWIzZDkzZDEzNzA0XzItMy0xLTEtMA_465f92f5-1553-4132-bc0b-21a7b7625ca9"
      unitRef="usd">0</us-gaap:GoodwillTransfers>
    <us-gaap:GoodwillTransfers
      contextRef="ia31e9a409b874bb19d0ff6f2f39ecc09_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMTIvZnJhZzoxZjM3NDE4OGI0M2U0ZGQ4YjU1YzhiY2RlNzA0NjZmNi90YWJsZTplZTgyNjg0YmNkNTI0YTI1ODY2MjFiM2Q5M2QxMzcwNC90YWJsZXJhbmdlOmVlODI2ODRiY2Q1MjRhMjU4NjYyMWIzZDkzZDEzNzA0XzItNS0xLTEtMA_5eb23618-3d0f-45ea-bc42-4ba6dbea38a8"
      unitRef="usd">-5000000</us-gaap:GoodwillTransfers>
    <us-gaap:GoodwillForeignCurrencyTranslationGainLoss
      contextRef="ib1a6fd7bfc8b43f5b583eff60a34f03f_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMTIvZnJhZzoxZjM3NDE4OGI0M2U0ZGQ4YjU1YzhiY2RlNzA0NjZmNi90YWJsZTplZTgyNjg0YmNkNTI0YTI1ODY2MjFiM2Q5M2QxMzcwNC90YWJsZXJhbmdlOmVlODI2ODRiY2Q1MjRhMjU4NjYyMWIzZDkzZDEzNzA0XzMtMS0xLTEtMA_c8562cf6-399c-45bd-bf48-1af2bb5120f7"
      unitRef="usd">-1000000</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
    <us-gaap:GoodwillForeignCurrencyTranslationGainLoss
      contextRef="icf7ee031a48e4d11b1c35c9709df0a86_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMTIvZnJhZzoxZjM3NDE4OGI0M2U0ZGQ4YjU1YzhiY2RlNzA0NjZmNi90YWJsZTplZTgyNjg0YmNkNTI0YTI1ODY2MjFiM2Q5M2QxMzcwNC90YWJsZXJhbmdlOmVlODI2ODRiY2Q1MjRhMjU4NjYyMWIzZDkzZDEzNzA0XzMtMy0xLTEtMA_3b069c6d-806f-422c-8440-9127fcc2fc3c"
      unitRef="usd">-15000000</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
    <us-gaap:GoodwillForeignCurrencyTranslationGainLoss
      contextRef="ia31e9a409b874bb19d0ff6f2f39ecc09_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMTIvZnJhZzoxZjM3NDE4OGI0M2U0ZGQ4YjU1YzhiY2RlNzA0NjZmNi90YWJsZTplZTgyNjg0YmNkNTI0YTI1ODY2MjFiM2Q5M2QxMzcwNC90YWJsZXJhbmdlOmVlODI2ODRiY2Q1MjRhMjU4NjYyMWIzZDkzZDEzNzA0XzMtNS0xLTEtMA_24ccc529-4694-4e58-9152-2ce222fab5a8"
      unitRef="usd">-16000000</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
    <us-gaap:Goodwill
      contextRef="i2e9e49271a494ffb9966fdbbe81322b3_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMTIvZnJhZzoxZjM3NDE4OGI0M2U0ZGQ4YjU1YzhiY2RlNzA0NjZmNi90YWJsZTplZTgyNjg0YmNkNTI0YTI1ODY2MjFiM2Q5M2QxMzcwNC90YWJsZXJhbmdlOmVlODI2ODRiY2Q1MjRhMjU4NjYyMWIzZDkzZDEzNzA0XzctMS0xLTEtMA_f7e2e2fc-f5a0-4723-9ddf-a1bc67668ab3"
      unitRef="usd">2657000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i3ca9000f2c0043198ff629f5aeec40d5_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMTIvZnJhZzoxZjM3NDE4OGI0M2U0ZGQ4YjU1YzhiY2RlNzA0NjZmNi90YWJsZTplZTgyNjg0YmNkNTI0YTI1ODY2MjFiM2Q5M2QxMzcwNC90YWJsZXJhbmdlOmVlODI2ODRiY2Q1MjRhMjU4NjYyMWIzZDkzZDEzNzA0XzctMy0xLTEtMA_663cf3d3-7eba-40bf-b6de-586992963f17"
      unitRef="usd">5700000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i299cea70f47b4fbe96772aaa8cc00b79_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMTIvZnJhZzoxZjM3NDE4OGI0M2U0ZGQ4YjU1YzhiY2RlNzA0NjZmNi90YWJsZTplZTgyNjg0YmNkNTI0YTI1ODY2MjFiM2Q5M2QxMzcwNC90YWJsZXJhbmdlOmVlODI2ODRiY2Q1MjRhMjU4NjYyMWIzZDkzZDEzNzA0XzctNS0xLTEtMA_51f1114b-8141-408f-86a4-a40b99c617a0"
      unitRef="usd">8357000000</us-gaap:Goodwill>
    <us-gaap:GoodwillTransfers
      contextRef="if8ec1f608f8f43c6bb4bb0cd8bd6fb89_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMTIvZnJhZzoxZjM3NDE4OGI0M2U0ZGQ4YjU1YzhiY2RlNzA0NjZmNi90YWJsZTplZTgyNjg0YmNkNTI0YTI1ODY2MjFiM2Q5M2QxMzcwNC90YWJsZXJhbmdlOmVlODI2ODRiY2Q1MjRhMjU4NjYyMWIzZDkzZDEzNzA0XzgtMS0xLTEtMA_a75045d7-7421-47cf-93cc-43234cf5743a"
      unitRef="usd">2000000</us-gaap:GoodwillTransfers>
    <us-gaap:GoodwillTransfers
      contextRef="i4f2593aaba1d4bcea5ad84327da58c41_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMTIvZnJhZzoxZjM3NDE4OGI0M2U0ZGQ4YjU1YzhiY2RlNzA0NjZmNi90YWJsZTplZTgyNjg0YmNkNTI0YTI1ODY2MjFiM2Q5M2QxMzcwNC90YWJsZXJhbmdlOmVlODI2ODRiY2Q1MjRhMjU4NjYyMWIzZDkzZDEzNzA0XzgtMy0xLTEtMA_067c89a5-30ca-411a-b403-5f2621548589"
      unitRef="usd">0</us-gaap:GoodwillTransfers>
    <us-gaap:GoodwillTransfers
      contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMTIvZnJhZzoxZjM3NDE4OGI0M2U0ZGQ4YjU1YzhiY2RlNzA0NjZmNi90YWJsZTplZTgyNjg0YmNkNTI0YTI1ODY2MjFiM2Q5M2QxMzcwNC90YWJsZXJhbmdlOmVlODI2ODRiY2Q1MjRhMjU4NjYyMWIzZDkzZDEzNzA0XzgtNS0xLTEtMA_591e2dfb-df13-4c92-865e-2bb6c5df9770"
      unitRef="usd">2000000</us-gaap:GoodwillTransfers>
    <us-gaap:GoodwillForeignCurrencyTranslationGainLoss
      contextRef="if8ec1f608f8f43c6bb4bb0cd8bd6fb89_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMTIvZnJhZzoxZjM3NDE4OGI0M2U0ZGQ4YjU1YzhiY2RlNzA0NjZmNi90YWJsZTplZTgyNjg0YmNkNTI0YTI1ODY2MjFiM2Q5M2QxMzcwNC90YWJsZXJhbmdlOmVlODI2ODRiY2Q1MjRhMjU4NjYyMWIzZDkzZDEzNzA0XzktMS0xLTEtMA_bdfcf130-f4be-4939-9a2e-18f13b494b64"
      unitRef="usd">0</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
    <us-gaap:GoodwillForeignCurrencyTranslationGainLoss
      contextRef="i4f2593aaba1d4bcea5ad84327da58c41_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMTIvZnJhZzoxZjM3NDE4OGI0M2U0ZGQ4YjU1YzhiY2RlNzA0NjZmNi90YWJsZTplZTgyNjg0YmNkNTI0YTI1ODY2MjFiM2Q5M2QxMzcwNC90YWJsZXJhbmdlOmVlODI2ODRiY2Q1MjRhMjU4NjYyMWIzZDkzZDEzNzA0XzktMy0xLTEtMA_c21d1edd-8b5d-41f9-8764-ad08d4f6bba2"
      unitRef="usd">18000000</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
    <us-gaap:GoodwillForeignCurrencyTranslationGainLoss
      contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMTIvZnJhZzoxZjM3NDE4OGI0M2U0ZGQ4YjU1YzhiY2RlNzA0NjZmNi90YWJsZTplZTgyNjg0YmNkNTI0YTI1ODY2MjFiM2Q5M2QxMzcwNC90YWJsZXJhbmdlOmVlODI2ODRiY2Q1MjRhMjU4NjYyMWIzZDkzZDEzNzA0XzktNS0xLTEtMA_d0878ea8-f050-4f52-b255-eb5c58a66992"
      unitRef="usd">18000000</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationGoodwill1
      contextRef="i4bc96e0706314db5b186dfb752f90fbf_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMTIvZnJhZzoxZjM3NDE4OGI0M2U0ZGQ4YjU1YzhiY2RlNzA0NjZmNi90YWJsZTplZTgyNjg0YmNkNTI0YTI1ODY2MjFiM2Q5M2QxMzcwNC90YWJsZXJhbmdlOmVlODI2ODRiY2Q1MjRhMjU4NjYyMWIzZDkzZDEzNzA0XzEwLTEtMS0xLTI1MDM_82903ac0-2248-4907-aae2-f6132c5fb120"
      unitRef="usd">0</us-gaap:DisposalGroupIncludingDiscontinuedOperationGoodwill1>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationGoodwill1
      contextRef="if49fcb6df2f04a0aa6c1338190b0051b_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMTIvZnJhZzoxZjM3NDE4OGI0M2U0ZGQ4YjU1YzhiY2RlNzA0NjZmNi90YWJsZTplZTgyNjg0YmNkNTI0YTI1ODY2MjFiM2Q5M2QxMzcwNC90YWJsZXJhbmdlOmVlODI2ODRiY2Q1MjRhMjU4NjYyMWIzZDkzZDEzNzA0XzEwLTMtMS0xLTI1MDY_03430da0-ac3c-4891-a9bb-3dfebd21dc32"
      unitRef="usd">388000000</us-gaap:DisposalGroupIncludingDiscontinuedOperationGoodwill1>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationGoodwill1
      contextRef="i2ae0fa0d058b4f21aac5c8701cbd2fb7_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMTIvZnJhZzoxZjM3NDE4OGI0M2U0ZGQ4YjU1YzhiY2RlNzA0NjZmNi90YWJsZTplZTgyNjg0YmNkNTI0YTI1ODY2MjFiM2Q5M2QxMzcwNC90YWJsZXJhbmdlOmVlODI2ODRiY2Q1MjRhMjU4NjYyMWIzZDkzZDEzNzA0XzEwLTUtMS0xLTI1MDk_d8d2d2b9-325a-4500-870f-1f691600218e"
      unitRef="usd">388000000</us-gaap:DisposalGroupIncludingDiscontinuedOperationGoodwill1>
    <us-gaap:Goodwill
      contextRef="i04a42200e8d447d5a05dcf88ecdb626a_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMTIvZnJhZzoxZjM3NDE4OGI0M2U0ZGQ4YjU1YzhiY2RlNzA0NjZmNi90YWJsZTplZTgyNjg0YmNkNTI0YTI1ODY2MjFiM2Q5M2QxMzcwNC90YWJsZXJhbmdlOmVlODI2ODRiY2Q1MjRhMjU4NjYyMWIzZDkzZDEzNzA0XzEwLTEtMS0xLTA_03446a75-f1da-4228-9b49-3e275c54dca7"
      unitRef="usd">2659000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="ie33f818d5fa545a6bf5a055023560358_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMTIvZnJhZzoxZjM3NDE4OGI0M2U0ZGQ4YjU1YzhiY2RlNzA0NjZmNi90YWJsZTplZTgyNjg0YmNkNTI0YTI1ODY2MjFiM2Q5M2QxMzcwNC90YWJsZXJhbmdlOmVlODI2ODRiY2Q1MjRhMjU4NjYyMWIzZDkzZDEzNzA0XzEwLTMtMS0xLTA_0feef2df-273a-4082-b92a-4a6172895743"
      unitRef="usd">5330000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i2e87824102b34590a0208cc7da91b5f5_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMTIvZnJhZzoxZjM3NDE4OGI0M2U0ZGQ4YjU1YzhiY2RlNzA0NjZmNi90YWJsZTplZTgyNjg0YmNkNTI0YTI1ODY2MjFiM2Q5M2QxMzcwNC90YWJsZXJhbmdlOmVlODI2ODRiY2Q1MjRhMjU4NjYyMWIzZDkzZDEzNzA0XzEwLTUtMS0xLTA_794cefa3-dece-4a3f-a813-00699b77a7db"
      unitRef="usd">7989000000</us-gaap:Goodwill>
    <us-gaap:GoodwillImpairedAccumulatedImpairmentLoss
      contextRef="i04a42200e8d447d5a05dcf88ecdb626a_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMTIvZnJhZzoxZjM3NDE4OGI0M2U0ZGQ4YjU1YzhiY2RlNzA0NjZmNi90ZXh0cmVnaW9uOjFmMzc0MTg4YjQzZTRkZDhiNTVjOGJjZGU3MDQ2NmY2XzIwOQ_d2b4ea74-998d-442d-b266-1318c6810817"
      unitRef="usd">829000000</us-gaap:GoodwillImpairedAccumulatedImpairmentLoss>
    <us-gaap:GoodwillImpairedAccumulatedImpairmentLoss
      contextRef="i2e9e49271a494ffb9966fdbbe81322b3_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMTIvZnJhZzoxZjM3NDE4OGI0M2U0ZGQ4YjU1YzhiY2RlNzA0NjZmNi90ZXh0cmVnaW9uOjFmMzc0MTg4YjQzZTRkZDhiNTVjOGJjZGU3MDQ2NmY2XzIwOQ_eece39d6-16c1-4b94-92fb-4246e3cb4ae2"
      unitRef="usd">829000000</us-gaap:GoodwillImpairedAccumulatedImpairmentLoss>
    <us-gaap:GoodwillImpairedAccumulatedImpairmentLoss
      contextRef="ie33f818d5fa545a6bf5a055023560358_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMTIvZnJhZzoxZjM3NDE4OGI0M2U0ZGQ4YjU1YzhiY2RlNzA0NjZmNi90ZXh0cmVnaW9uOjFmMzc0MTg4YjQzZTRkZDhiNTVjOGJjZGU3MDQ2NmY2XzI5Mg_67acf34c-c0f0-4036-933c-04f7ced27b19"
      unitRef="usd">1400000000</us-gaap:GoodwillImpairedAccumulatedImpairmentLoss>
    <us-gaap:GoodwillImpairedAccumulatedImpairmentLoss
      contextRef="i3ca9000f2c0043198ff629f5aeec40d5_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMTIvZnJhZzoxZjM3NDE4OGI0M2U0ZGQ4YjU1YzhiY2RlNzA0NjZmNi90ZXh0cmVnaW9uOjFmMzc0MTg4YjQzZTRkZDhiNTVjOGJjZGU3MDQ2NmY2XzI5Mg_9c383cbb-f422-49c6-8f43-355c8c217272"
      unitRef="usd">1400000000</us-gaap:GoodwillImpairedAccumulatedImpairmentLoss>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationGoodwill1
      contextRef="if49fcb6df2f04a0aa6c1338190b0051b_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMTIvZnJhZzoxZjM3NDE4OGI0M2U0ZGQ4YjU1YzhiY2RlNzA0NjZmNi90ZXh0cmVnaW9uOjFmMzc0MTg4YjQzZTRkZDhiNTVjOGJjZGU3MDQ2NmY2XzcxNDY4MjU1ODE3Mzg_03430da0-ac3c-4891-a9bb-3dfebd21dc32"
      unitRef="usd">388000000</us-gaap:DisposalGroupIncludingDiscontinuedOperationGoodwill1>
    <us-gaap:ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock
      contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMTIvZnJhZzoxZjM3NDE4OGI0M2U0ZGQ4YjU1YzhiY2RlNzA0NjZmNi90ZXh0cmVnaW9uOjFmMzc0MTg4YjQzZTRkZDhiNTVjOGJjZGU3MDQ2NmY2XzYyMQ_bfd393bd-b812-4511-8189-7a3d8d2922b3">&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables summarize other intangible assets by class at June&#160;30:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:22.356%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.023%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.343%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.653%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.343%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.023%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.343%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:20.816%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Intangible&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Accumulated&lt;br/&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net&lt;br/&gt;Intangible&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted- Average Remaining Amortization Period (Years)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Indefinite-life intangibles:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Trademarks and patents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;12&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;12&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total indefinite-life intangibles&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;12&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;12&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Definite-life intangibles:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;3,330&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;1,989&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;1,341&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;11&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Trademarks, trade names and patents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;551&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;328&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;223&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;9&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Developed technology and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;1,035&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;506&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;529&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;10&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total definite-life intangibles&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;4,916&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2,823&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2,093&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;10&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total other intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;4,928&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2,823&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2,105&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.691%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:42.243%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.308%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.347%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.643%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.347%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.312%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Gross&lt;br/&gt;Intangible&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Accumulated&lt;br/&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Net&lt;br/&gt;Intangible&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Indefinite-life intangibles:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;IPR&amp;amp;D, trademarks and other&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total indefinite-life intangibles&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Definite-life intangibles:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3,554&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,828&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,726&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Trademarks, trade names and patents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;673&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;341&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;332&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Developed technology and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,604&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;767&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;837&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total definite-life intangibles&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;5,831&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,936&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,895&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total other intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;5,854&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,936&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,918&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock>
    <us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock
      contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMTIvZnJhZzoxZjM3NDE4OGI0M2U0ZGQ4YjU1YzhiY2RlNzA0NjZmNi90ZXh0cmVnaW9uOjFmMzc0MTg4YjQzZTRkZDhiNTVjOGJjZGU3MDQ2NmY2XzY0OQ_49dfe660-da8e-46b4-82e5-4fc3b8972f9f">&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables summarize other intangible assets by class at June&#160;30:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:22.356%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.023%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.343%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.653%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.343%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.023%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.343%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:20.816%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Intangible&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Accumulated&lt;br/&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net&lt;br/&gt;Intangible&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted- Average Remaining Amortization Period (Years)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Indefinite-life intangibles:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Trademarks and patents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;12&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;12&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total indefinite-life intangibles&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;12&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;12&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Definite-life intangibles:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;3,330&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;1,989&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;1,341&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;11&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Trademarks, trade names and patents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;551&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;328&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;223&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;9&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Developed technology and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;1,035&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;506&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;529&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;10&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total definite-life intangibles&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;4,916&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2,823&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2,093&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;10&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total other intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;4,928&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2,823&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2,105&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.691%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:42.243%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.308%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.347%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.643%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.347%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.312%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Gross&lt;br/&gt;Intangible&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Accumulated&lt;br/&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Net&lt;br/&gt;Intangible&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Indefinite-life intangibles:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;IPR&amp;amp;D, trademarks and other&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total indefinite-life intangibles&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Definite-life intangibles:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3,554&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,828&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,726&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Trademarks, trade names and patents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;673&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;341&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;332&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Developed technology and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,604&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;767&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;837&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total definite-life intangibles&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;5,831&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,936&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,895&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total other intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;5,854&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,936&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,918&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="ie9082e4c164d4b1eb60733de4e88ad24_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMTIvZnJhZzoxZjM3NDE4OGI0M2U0ZGQ4YjU1YzhiY2RlNzA0NjZmNi90YWJsZTpiMWE4YjJiMjIzZjc0ZDU1OWJmNDExOTU0NmUzNmE5MC90YWJsZXJhbmdlOmIxYThiMmIyMjNmNzRkNTU5YmY0MTE5NTQ2ZTM2YTkwXzMtMS0xLTEtMA_6bed1a6b-3e76-4b1a-a9c6-6e554d99d86f"
      unitRef="usd">12000000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="ie9082e4c164d4b1eb60733de4e88ad24_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMTIvZnJhZzoxZjM3NDE4OGI0M2U0ZGQ4YjU1YzhiY2RlNzA0NjZmNi90YWJsZTpiMWE4YjJiMjIzZjc0ZDU1OWJmNDExOTU0NmUzNmE5MC90YWJsZXJhbmdlOmIxYThiMmIyMjNmNzRkNTU5YmY0MTE5NTQ2ZTM2YTkwXzMtNS0xLTEtMA_9e9c20c8-fb28-47a7-8183-e15014effd62"
      unitRef="usd">12000000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="i2e87824102b34590a0208cc7da91b5f5_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMTIvZnJhZzoxZjM3NDE4OGI0M2U0ZGQ4YjU1YzhiY2RlNzA0NjZmNi90YWJsZTpiMWE4YjJiMjIzZjc0ZDU1OWJmNDExOTU0NmUzNmE5MC90YWJsZXJhbmdlOmIxYThiMmIyMjNmNzRkNTU5YmY0MTE5NTQ2ZTM2YTkwXzQtMS0xLTEtMA_148b1861-4e1b-44e4-8ca3-f9ad77ff4d27"
      unitRef="usd">12000000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="i2e87824102b34590a0208cc7da91b5f5_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMTIvZnJhZzoxZjM3NDE4OGI0M2U0ZGQ4YjU1YzhiY2RlNzA0NjZmNi90YWJsZTpiMWE4YjJiMjIzZjc0ZDU1OWJmNDExOTU0NmUzNmE5MC90YWJsZXJhbmdlOmIxYThiMmIyMjNmNzRkNTU5YmY0MTE5NTQ2ZTM2YTkwXzQtNS0xLTEtMA_6ec4abe8-2fa3-416b-bc04-ce37b2089f6f"
      unitRef="usd">12000000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i23d1c32c20a5440bb56a79d381e03b23_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMTIvZnJhZzoxZjM3NDE4OGI0M2U0ZGQ4YjU1YzhiY2RlNzA0NjZmNi90YWJsZTpiMWE4YjJiMjIzZjc0ZDU1OWJmNDExOTU0NmUzNmE5MC90YWJsZXJhbmdlOmIxYThiMmIyMjNmNzRkNTU5YmY0MTE5NTQ2ZTM2YTkwXzYtMS0xLTEtMA_ba6473d2-8a1c-446a-a195-7e001d933445"
      unitRef="usd">3330000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i23d1c32c20a5440bb56a79d381e03b23_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMTIvZnJhZzoxZjM3NDE4OGI0M2U0ZGQ4YjU1YzhiY2RlNzA0NjZmNi90YWJsZTpiMWE4YjJiMjIzZjc0ZDU1OWJmNDExOTU0NmUzNmE5MC90YWJsZXJhbmdlOmIxYThiMmIyMjNmNzRkNTU5YmY0MTE5NTQ2ZTM2YTkwXzYtMy0xLTEtMA_ef69719d-d23c-4ce2-8a53-488db35f5b98"
      unitRef="usd">1989000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i23d1c32c20a5440bb56a79d381e03b23_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMTIvZnJhZzoxZjM3NDE4OGI0M2U0ZGQ4YjU1YzhiY2RlNzA0NjZmNi90YWJsZTpiMWE4YjJiMjIzZjc0ZDU1OWJmNDExOTU0NmUzNmE5MC90YWJsZXJhbmdlOmIxYThiMmIyMjNmNzRkNTU5YmY0MTE5NTQ2ZTM2YTkwXzYtNS0xLTEtMA_1ceb61ea-7c91-4d49-9261-a6b50294b4c1"
      unitRef="usd">1341000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1
      contextRef="i71898d44e3ea4dc6b493f7a21c418128_D20200701-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMTIvZnJhZzoxZjM3NDE4OGI0M2U0ZGQ4YjU1YzhiY2RlNzA0NjZmNi90YWJsZTpiMWE4YjJiMjIzZjc0ZDU1OWJmNDExOTU0NmUzNmE5MC90YWJsZXJhbmdlOmIxYThiMmIyMjNmNzRkNTU5YmY0MTE5NTQ2ZTM2YTkwXzYtNy0xLTEtMA_751a9d2d-6599-4340-b034-51d9535bf069">P11Y</us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="ia82a764d4393423da214b8d6611567aa_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMTIvZnJhZzoxZjM3NDE4OGI0M2U0ZGQ4YjU1YzhiY2RlNzA0NjZmNi90YWJsZTpiMWE4YjJiMjIzZjc0ZDU1OWJmNDExOTU0NmUzNmE5MC90YWJsZXJhbmdlOmIxYThiMmIyMjNmNzRkNTU5YmY0MTE5NTQ2ZTM2YTkwXzctMS0xLTEtMA_3616bb68-1e38-46b5-b561-4d9849874ff4"
      unitRef="usd">551000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="ia82a764d4393423da214b8d6611567aa_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMTIvZnJhZzoxZjM3NDE4OGI0M2U0ZGQ4YjU1YzhiY2RlNzA0NjZmNi90YWJsZTpiMWE4YjJiMjIzZjc0ZDU1OWJmNDExOTU0NmUzNmE5MC90YWJsZXJhbmdlOmIxYThiMmIyMjNmNzRkNTU5YmY0MTE5NTQ2ZTM2YTkwXzctMy0xLTEtMA_b3d21013-737d-4a21-b52e-8181bcffe2e7"
      unitRef="usd">328000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="ia82a764d4393423da214b8d6611567aa_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMTIvZnJhZzoxZjM3NDE4OGI0M2U0ZGQ4YjU1YzhiY2RlNzA0NjZmNi90YWJsZTpiMWE4YjJiMjIzZjc0ZDU1OWJmNDExOTU0NmUzNmE5MC90YWJsZXJhbmdlOmIxYThiMmIyMjNmNzRkNTU5YmY0MTE5NTQ2ZTM2YTkwXzctNS0xLTEtMA_6623f58d-788c-400c-8005-c92c11152135"
      unitRef="usd">223000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1
      contextRef="idb9a0bc30ecf49c28ad8c5f1cd53fb7f_D20200701-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMTIvZnJhZzoxZjM3NDE4OGI0M2U0ZGQ4YjU1YzhiY2RlNzA0NjZmNi90YWJsZTpiMWE4YjJiMjIzZjc0ZDU1OWJmNDExOTU0NmUzNmE5MC90YWJsZXJhbmdlOmIxYThiMmIyMjNmNzRkNTU5YmY0MTE5NTQ2ZTM2YTkwXzctNy0xLTEtMA_7878fea7-a39e-45a2-99ee-e692211bd724">P9Y</us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i9d370528192046c8b78cd2c5462f6fed_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMTIvZnJhZzoxZjM3NDE4OGI0M2U0ZGQ4YjU1YzhiY2RlNzA0NjZmNi90YWJsZTpiMWE4YjJiMjIzZjc0ZDU1OWJmNDExOTU0NmUzNmE5MC90YWJsZXJhbmdlOmIxYThiMmIyMjNmNzRkNTU5YmY0MTE5NTQ2ZTM2YTkwXzgtMS0xLTEtMA_a0e06f1d-39ba-4c53-9ee9-6a6980b0a33b"
      unitRef="usd">1035000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i9d370528192046c8b78cd2c5462f6fed_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMTIvZnJhZzoxZjM3NDE4OGI0M2U0ZGQ4YjU1YzhiY2RlNzA0NjZmNi90YWJsZTpiMWE4YjJiMjIzZjc0ZDU1OWJmNDExOTU0NmUzNmE5MC90YWJsZXJhbmdlOmIxYThiMmIyMjNmNzRkNTU5YmY0MTE5NTQ2ZTM2YTkwXzgtMy0xLTEtMA_1721963f-aea5-49c8-b992-26a1f4018b2e"
      unitRef="usd">506000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i9d370528192046c8b78cd2c5462f6fed_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMTIvZnJhZzoxZjM3NDE4OGI0M2U0ZGQ4YjU1YzhiY2RlNzA0NjZmNi90YWJsZTpiMWE4YjJiMjIzZjc0ZDU1OWJmNDExOTU0NmUzNmE5MC90YWJsZXJhbmdlOmIxYThiMmIyMjNmNzRkNTU5YmY0MTE5NTQ2ZTM2YTkwXzgtNS0xLTEtMA_e140ee4d-cde3-40a9-9f2c-4827d4395b18"
      unitRef="usd">529000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1
      contextRef="i3bd75edcbf314eb28cab79abc9a18d41_D20200701-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMTIvZnJhZzoxZjM3NDE4OGI0M2U0ZGQ4YjU1YzhiY2RlNzA0NjZmNi90YWJsZTpiMWE4YjJiMjIzZjc0ZDU1OWJmNDExOTU0NmUzNmE5MC90YWJsZXJhbmdlOmIxYThiMmIyMjNmNzRkNTU5YmY0MTE5NTQ2ZTM2YTkwXzgtNy0xLTEtMA_eec0a9d7-f256-45a4-a4e6-0f90507f6641">P10Y</us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i2e87824102b34590a0208cc7da91b5f5_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMTIvZnJhZzoxZjM3NDE4OGI0M2U0ZGQ4YjU1YzhiY2RlNzA0NjZmNi90YWJsZTpiMWE4YjJiMjIzZjc0ZDU1OWJmNDExOTU0NmUzNmE5MC90YWJsZXJhbmdlOmIxYThiMmIyMjNmNzRkNTU5YmY0MTE5NTQ2ZTM2YTkwXzktMS0xLTEtMA_20d2ad39-409f-444c-8c03-84f47e5f224b"
      unitRef="usd">4916000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i2e87824102b34590a0208cc7da91b5f5_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMTIvZnJhZzoxZjM3NDE4OGI0M2U0ZGQ4YjU1YzhiY2RlNzA0NjZmNi90YWJsZTpiMWE4YjJiMjIzZjc0ZDU1OWJmNDExOTU0NmUzNmE5MC90YWJsZXJhbmdlOmIxYThiMmIyMjNmNzRkNTU5YmY0MTE5NTQ2ZTM2YTkwXzktMy0xLTEtMA_63711e0f-aeea-4cc9-953c-7f01222ae840"
      unitRef="usd">2823000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i2e87824102b34590a0208cc7da91b5f5_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMTIvZnJhZzoxZjM3NDE4OGI0M2U0ZGQ4YjU1YzhiY2RlNzA0NjZmNi90YWJsZTpiMWE4YjJiMjIzZjc0ZDU1OWJmNDExOTU0NmUzNmE5MC90YWJsZXJhbmdlOmIxYThiMmIyMjNmNzRkNTU5YmY0MTE5NTQ2ZTM2YTkwXzktNS0xLTEtMA_083b94ea-13e5-4feb-b103-9ceb8b045fd6"
      unitRef="usd">2093000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1
      contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMTIvZnJhZzoxZjM3NDE4OGI0M2U0ZGQ4YjU1YzhiY2RlNzA0NjZmNi90YWJsZTpiMWE4YjJiMjIzZjc0ZDU1OWJmNDExOTU0NmUzNmE5MC90YWJsZXJhbmdlOmIxYThiMmIyMjNmNzRkNTU5YmY0MTE5NTQ2ZTM2YTkwXzktNy0xLTEtMA_81382b7d-b45f-4d23-8993-ddf2cc92338e">P10Y</us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1>
    <us-gaap:IntangibleAssetsGrossExcludingGoodwill
      contextRef="i2e87824102b34590a0208cc7da91b5f5_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMTIvZnJhZzoxZjM3NDE4OGI0M2U0ZGQ4YjU1YzhiY2RlNzA0NjZmNi90YWJsZTpiMWE4YjJiMjIzZjc0ZDU1OWJmNDExOTU0NmUzNmE5MC90YWJsZXJhbmdlOmIxYThiMmIyMjNmNzRkNTU5YmY0MTE5NTQ2ZTM2YTkwXzEwLTEtMS0xLTA_e454f8ce-05ea-4120-9542-54cb22f45393"
      unitRef="usd">4928000000</us-gaap:IntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i2e87824102b34590a0208cc7da91b5f5_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMTIvZnJhZzoxZjM3NDE4OGI0M2U0ZGQ4YjU1YzhiY2RlNzA0NjZmNi90YWJsZTpiMWE4YjJiMjIzZjc0ZDU1OWJmNDExOTU0NmUzNmE5MC90YWJsZXJhbmdlOmIxYThiMmIyMjNmNzRkNTU5YmY0MTE5NTQ2ZTM2YTkwXzEwLTMtMS0xLTA_b2d9ef88-89ac-44e5-9168-a74cc23be370"
      unitRef="usd">2823000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i2e87824102b34590a0208cc7da91b5f5_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMTIvZnJhZzoxZjM3NDE4OGI0M2U0ZGQ4YjU1YzhiY2RlNzA0NjZmNi90YWJsZTpiMWE4YjJiMjIzZjc0ZDU1OWJmNDExOTU0NmUzNmE5MC90YWJsZXJhbmdlOmIxYThiMmIyMjNmNzRkNTU5YmY0MTE5NTQ2ZTM2YTkwXzEwLTUtMS0xLTA_d010e1c5-e2bd-483e-86fa-ded19d64384f"
      unitRef="usd">2105000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="i19314c2cdba1474abcdc53474c121932_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMTIvZnJhZzoxZjM3NDE4OGI0M2U0ZGQ4YjU1YzhiY2RlNzA0NjZmNi90YWJsZTozN2EzMGQxMjFmZjY0NjBkOWM2MmM3MjllNjE4NjQ1MS90YWJsZXJhbmdlOjM3YTMwZDEyMWZmNjQ2MGQ5YzYyYzcyOWU2MTg2NDUxXzMtMS0xLTEtMA_9b0e65ae-e057-4faa-964f-578d26662b80"
      unitRef="usd">23000000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="i19314c2cdba1474abcdc53474c121932_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMTIvZnJhZzoxZjM3NDE4OGI0M2U0ZGQ4YjU1YzhiY2RlNzA0NjZmNi90YWJsZTozN2EzMGQxMjFmZjY0NjBkOWM2MmM3MjllNjE4NjQ1MS90YWJsZXJhbmdlOjM3YTMwZDEyMWZmNjQ2MGQ5YzYyYzcyOWU2MTg2NDUxXzMtNS0xLTEtMA_6a2acf70-47ab-4a6d-b085-3ebf34b5bf05"
      unitRef="usd">23000000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="i299cea70f47b4fbe96772aaa8cc00b79_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMTIvZnJhZzoxZjM3NDE4OGI0M2U0ZGQ4YjU1YzhiY2RlNzA0NjZmNi90YWJsZTozN2EzMGQxMjFmZjY0NjBkOWM2MmM3MjllNjE4NjQ1MS90YWJsZXJhbmdlOjM3YTMwZDEyMWZmNjQ2MGQ5YzYyYzcyOWU2MTg2NDUxXzQtMS0xLTEtMA_c6957d40-e357-44ee-947c-70509d2dd98e"
      unitRef="usd">23000000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="i299cea70f47b4fbe96772aaa8cc00b79_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMTIvZnJhZzoxZjM3NDE4OGI0M2U0ZGQ4YjU1YzhiY2RlNzA0NjZmNi90YWJsZTozN2EzMGQxMjFmZjY0NjBkOWM2MmM3MjllNjE4NjQ1MS90YWJsZXJhbmdlOjM3YTMwZDEyMWZmNjQ2MGQ5YzYyYzcyOWU2MTg2NDUxXzQtNS0xLTEtMA_acd51075-3a2b-4e30-ba89-43a78de764fc"
      unitRef="usd">23000000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="ic919be303957403e934baefe49c63756_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMTIvZnJhZzoxZjM3NDE4OGI0M2U0ZGQ4YjU1YzhiY2RlNzA0NjZmNi90YWJsZTozN2EzMGQxMjFmZjY0NjBkOWM2MmM3MjllNjE4NjQ1MS90YWJsZXJhbmdlOjM3YTMwZDEyMWZmNjQ2MGQ5YzYyYzcyOWU2MTg2NDUxXzYtMS0xLTEtMA_4bd01306-4a72-4db8-ad17-e68aca735bd9"
      unitRef="usd">3554000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="ic919be303957403e934baefe49c63756_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMTIvZnJhZzoxZjM3NDE4OGI0M2U0ZGQ4YjU1YzhiY2RlNzA0NjZmNi90YWJsZTozN2EzMGQxMjFmZjY0NjBkOWM2MmM3MjllNjE4NjQ1MS90YWJsZXJhbmdlOjM3YTMwZDEyMWZmNjQ2MGQ5YzYyYzcyOWU2MTg2NDUxXzYtMy0xLTEtMA_5f23a5bf-8570-4fd8-b313-07f02236c4e0"
      unitRef="usd">1828000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="ic919be303957403e934baefe49c63756_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMTIvZnJhZzoxZjM3NDE4OGI0M2U0ZGQ4YjU1YzhiY2RlNzA0NjZmNi90YWJsZTozN2EzMGQxMjFmZjY0NjBkOWM2MmM3MjllNjE4NjQ1MS90YWJsZXJhbmdlOjM3YTMwZDEyMWZmNjQ2MGQ5YzYyYzcyOWU2MTg2NDUxXzYtNS0xLTEtMA_6cf3ac64-a928-4261-b095-6a8902d63dcc"
      unitRef="usd">1726000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i5dae75b349b54d55a0e972014f606ac7_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMTIvZnJhZzoxZjM3NDE4OGI0M2U0ZGQ4YjU1YzhiY2RlNzA0NjZmNi90YWJsZTozN2EzMGQxMjFmZjY0NjBkOWM2MmM3MjllNjE4NjQ1MS90YWJsZXJhbmdlOjM3YTMwZDEyMWZmNjQ2MGQ5YzYyYzcyOWU2MTg2NDUxXzctMS0xLTEtMA_c7faddd5-bd96-48d3-9f82-109db65d1400"
      unitRef="usd">673000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i5dae75b349b54d55a0e972014f606ac7_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMTIvZnJhZzoxZjM3NDE4OGI0M2U0ZGQ4YjU1YzhiY2RlNzA0NjZmNi90YWJsZTozN2EzMGQxMjFmZjY0NjBkOWM2MmM3MjllNjE4NjQ1MS90YWJsZXJhbmdlOjM3YTMwZDEyMWZmNjQ2MGQ5YzYyYzcyOWU2MTg2NDUxXzctMy0xLTEtMA_c8ba11f6-45aa-485f-bc17-4a2cab297620"
      unitRef="usd">341000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i5dae75b349b54d55a0e972014f606ac7_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMTIvZnJhZzoxZjM3NDE4OGI0M2U0ZGQ4YjU1YzhiY2RlNzA0NjZmNi90YWJsZTozN2EzMGQxMjFmZjY0NjBkOWM2MmM3MjllNjE4NjQ1MS90YWJsZXJhbmdlOjM3YTMwZDEyMWZmNjQ2MGQ5YzYyYzcyOWU2MTg2NDUxXzctNS0xLTEtMA_85a9f5f6-3e87-44da-9f4b-b7fb3e620626"
      unitRef="usd">332000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="idd95a519999348e3a6516e5fa7e6fcba_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMTIvZnJhZzoxZjM3NDE4OGI0M2U0ZGQ4YjU1YzhiY2RlNzA0NjZmNi90YWJsZTozN2EzMGQxMjFmZjY0NjBkOWM2MmM3MjllNjE4NjQ1MS90YWJsZXJhbmdlOjM3YTMwZDEyMWZmNjQ2MGQ5YzYyYzcyOWU2MTg2NDUxXzgtMS0xLTEtMA_b35067ac-9929-48c2-acc6-6cb4ff02610b"
      unitRef="usd">1604000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="idd95a519999348e3a6516e5fa7e6fcba_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMTIvZnJhZzoxZjM3NDE4OGI0M2U0ZGQ4YjU1YzhiY2RlNzA0NjZmNi90YWJsZTozN2EzMGQxMjFmZjY0NjBkOWM2MmM3MjllNjE4NjQ1MS90YWJsZXJhbmdlOjM3YTMwZDEyMWZmNjQ2MGQ5YzYyYzcyOWU2MTg2NDUxXzgtMy0xLTEtMA_d29f9026-ba27-4fe8-8e4a-f6bb07ae467a"
      unitRef="usd">767000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="idd95a519999348e3a6516e5fa7e6fcba_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMTIvZnJhZzoxZjM3NDE4OGI0M2U0ZGQ4YjU1YzhiY2RlNzA0NjZmNi90YWJsZTozN2EzMGQxMjFmZjY0NjBkOWM2MmM3MjllNjE4NjQ1MS90YWJsZXJhbmdlOjM3YTMwZDEyMWZmNjQ2MGQ5YzYyYzcyOWU2MTg2NDUxXzgtNS0xLTEtMA_0c802f9b-e8d8-436e-b9e7-b6322d6468f5"
      unitRef="usd">837000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i299cea70f47b4fbe96772aaa8cc00b79_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMTIvZnJhZzoxZjM3NDE4OGI0M2U0ZGQ4YjU1YzhiY2RlNzA0NjZmNi90YWJsZTozN2EzMGQxMjFmZjY0NjBkOWM2MmM3MjllNjE4NjQ1MS90YWJsZXJhbmdlOjM3YTMwZDEyMWZmNjQ2MGQ5YzYyYzcyOWU2MTg2NDUxXzktMS0xLTEtMA_fd94cee6-a700-456a-ba9b-0ed4d5a804dd"
      unitRef="usd">5831000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i299cea70f47b4fbe96772aaa8cc00b79_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMTIvZnJhZzoxZjM3NDE4OGI0M2U0ZGQ4YjU1YzhiY2RlNzA0NjZmNi90YWJsZTozN2EzMGQxMjFmZjY0NjBkOWM2MmM3MjllNjE4NjQ1MS90YWJsZXJhbmdlOjM3YTMwZDEyMWZmNjQ2MGQ5YzYyYzcyOWU2MTg2NDUxXzktMy0xLTEtMA_f284be98-c4e5-4848-8b54-4c685af5ea6c"
      unitRef="usd">2936000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i299cea70f47b4fbe96772aaa8cc00b79_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMTIvZnJhZzoxZjM3NDE4OGI0M2U0ZGQ4YjU1YzhiY2RlNzA0NjZmNi90YWJsZTozN2EzMGQxMjFmZjY0NjBkOWM2MmM3MjllNjE4NjQ1MS90YWJsZXJhbmdlOjM3YTMwZDEyMWZmNjQ2MGQ5YzYyYzcyOWU2MTg2NDUxXzktNS0xLTEtMA_997cb3a9-df3c-4143-9295-e40decbc086d"
      unitRef="usd">2895000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:IntangibleAssetsGrossExcludingGoodwill
      contextRef="i299cea70f47b4fbe96772aaa8cc00b79_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMTIvZnJhZzoxZjM3NDE4OGI0M2U0ZGQ4YjU1YzhiY2RlNzA0NjZmNi90YWJsZTozN2EzMGQxMjFmZjY0NjBkOWM2MmM3MjllNjE4NjQ1MS90YWJsZXJhbmdlOjM3YTMwZDEyMWZmNjQ2MGQ5YzYyYzcyOWU2MTg2NDUxXzEwLTEtMS0xLTA_ecd5380c-2694-4a1f-833e-35d52d2684f4"
      unitRef="usd">5854000000</us-gaap:IntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i299cea70f47b4fbe96772aaa8cc00b79_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMTIvZnJhZzoxZjM3NDE4OGI0M2U0ZGQ4YjU1YzhiY2RlNzA0NjZmNi90YWJsZTozN2EzMGQxMjFmZjY0NjBkOWM2MmM3MjllNjE4NjQ1MS90YWJsZXJhbmdlOjM3YTMwZDEyMWZmNjQ2MGQ5YzYyYzcyOWU2MTg2NDUxXzEwLTMtMS0xLTA_b8619e6c-26ce-4630-95b1-6c2730d528ed"
      unitRef="usd">2936000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i299cea70f47b4fbe96772aaa8cc00b79_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMTIvZnJhZzoxZjM3NDE4OGI0M2U0ZGQ4YjU1YzhiY2RlNzA0NjZmNi90YWJsZTozN2EzMGQxMjFmZjY0NjBkOWM2MmM3MjllNjE4NjQ1MS90YWJsZXJhbmdlOjM3YTMwZDEyMWZmNjQ2MGQ5YzYyYzcyOWU2MTg2NDUxXzEwLTUtMS0xLTA_ac9ed1d5-281c-4de1-b40f-5fa85165370b"
      unitRef="usd">2918000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMTIvZnJhZzoxZjM3NDE4OGI0M2U0ZGQ4YjU1YzhiY2RlNzA0NjZmNi90ZXh0cmVnaW9uOjFmMzc0MTg4YjQzZTRkZDhiNTVjOGJjZGU3MDQ2NmY2XzQ0Nw_0c4205e9-0601-4dbd-91e2-df40677d0d7e"
      unitRef="usd">428000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="ia31e9a409b874bb19d0ff6f2f39ecc09_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMTIvZnJhZzoxZjM3NDE4OGI0M2U0ZGQ4YjU1YzhiY2RlNzA0NjZmNi90ZXh0cmVnaW9uOjFmMzc0MTg4YjQzZTRkZDhiNTVjOGJjZGU3MDQ2NmY2XzQ1MQ_21f34d7b-02fa-4297-8a1e-c4080b3a1faa"
      unitRef="usd">512000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i00a6d666bf604826b24e68ddbd63eac4_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMTIvZnJhZzoxZjM3NDE4OGI0M2U0ZGQ4YjU1YzhiY2RlNzA0NjZmNi90ZXh0cmVnaW9uOjFmMzc0MTg4YjQzZTRkZDhiNTVjOGJjZGU3MDQ2NmY2XzQ1OA_07d4fc7b-5cff-4cec-88a0-e251d12a450d"
      unitRef="usd">531000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
      contextRef="i2e87824102b34590a0208cc7da91b5f5_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMTIvZnJhZzoxZjM3NDE4OGI0M2U0ZGQ4YjU1YzhiY2RlNzA0NjZmNi90ZXh0cmVnaW9uOjFmMzc0MTg4YjQzZTRkZDhiNTVjOGJjZGU3MDQ2NmY2XzU5Nw_6d310470-31b2-414b-944a-98c068afd9fa"
      unitRef="usd">315000000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
      contextRef="i2e87824102b34590a0208cc7da91b5f5_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMTIvZnJhZzoxZjM3NDE4OGI0M2U0ZGQ4YjU1YzhiY2RlNzA0NjZmNi90ZXh0cmVnaW9uOjFmMzc0MTg4YjQzZTRkZDhiNTVjOGJjZGU3MDQ2NmY2XzYwMQ_96889e6b-0ee8-4a94-805c-3d08a78ae7a8"
      unitRef="usd">287000000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
      contextRef="i2e87824102b34590a0208cc7da91b5f5_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMTIvZnJhZzoxZjM3NDE4OGI0M2U0ZGQ4YjU1YzhiY2RlNzA0NjZmNi90ZXh0cmVnaW9uOjFmMzc0MTg4YjQzZTRkZDhiNTVjOGJjZGU3MDQ2NmY2XzYwNQ_5608e92e-7943-4db2-94d8-77a9654e9e2a"
      unitRef="usd">264000000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
      contextRef="i2e87824102b34590a0208cc7da91b5f5_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMTIvZnJhZzoxZjM3NDE4OGI0M2U0ZGQ4YjU1YzhiY2RlNzA0NjZmNi90ZXh0cmVnaW9uOjFmMzc0MTg4YjQzZTRkZDhiNTVjOGJjZGU3MDQ2NmY2XzYwOQ_d022a6ff-4be7-4f79-9f74-93c558538d3d"
      unitRef="usd">238000000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
      contextRef="i2e87824102b34590a0208cc7da91b5f5_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMTIvZnJhZzoxZjM3NDE4OGI0M2U0ZGQ4YjU1YzhiY2RlNzA0NjZmNi90ZXh0cmVnaW9uOjFmMzc0MTg4YjQzZTRkZDhiNTVjOGJjZGU3MDQ2NmY2XzYxNg_bdf4f26c-c5c5-4c09-b714-64114903ce4f"
      unitRef="usd">212000000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive>
    <cah:LeasesTextBlock
      contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMjEvZnJhZzpkNTEwOTAyZDMwZDc0NDk5YWUzNWE3NTg1ZDkwNDA4Ni90ZXh0cmVnaW9uOmQ1MTA5MDJkMzBkNzQ0OTlhZTM1YTc1ODVkOTA0MDg2XzQxNzQ_288e20eb-1bd6-48e7-9fa1-cc518189f899">&lt;div style="display:inline-block;vertical-align:top;width:48.214%"&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:13pt;font-weight:700;line-height:120%"&gt;5. Leases &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our operating leases are primarily for corporate offices, distribution facilities, vehicles, and equipment. We determine if an arrangement is a lease at its inception by evaluating whether the arrangement conveys the right to use an identified asset and whether we obtain substantially all of the economic benefits from and have the ability to direct the use of the asset. Our lease agreements generally do not contain any material residual value guarantees or material restrictive covenants. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Beginning July 1, 2019, operating lease right-of-use assets and corresponding operating lease liabilities are recognized in our consolidated balance sheets at lease commencement date based on the present value of lease payments over the lease term. Operating lease expense for operating lease assets is recognized on a straight-line basis over the lease term. As most of our leases do not provide an implicit rate, we use our collateralized incremental borrowing rate based on the information available at the lease commencement date in determining the present value of lease payments. We use the implicit rate if it is readily determinable. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our lease agreements contain lease components and non-lease components. For all asset classes, we have elected to account for both of these components as a single lease component. We also, from time to time, sublease portions of our real estate property, resulting in sublease income. Sublease income and the related assets and cash flows are not material to the consolidated financial statements at or for the fiscal years ended June&#160;30, 2021 and 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We also have elected to apply a practical expedient for short-term leases whereby we do not recognize a lease liability and right-of-use asset for leases with a term of less than 12 months. Short-term lease expense recognized in fiscal 2021 and 2020 was not material. In addition, upon adoption of the new lease standard, we elected the package of three practical expedients permitted under the transition guidance, which include the carry forward of our leases without reassessing 1) whether any contracts are leases or contain leases, 2) lease classification and 3) initial direct costs. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our leases have remaining lease terms from less than 1 year up to approximately 21 years. Our lease terms may include options to extend or terminate the lease when it is reasonably certain and there is a significant economic incentive to exercise that option. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the components of lease cost:  &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:85.185%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:32.233%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:32.233%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:32.234%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Operating lease cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;119&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;134&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Finance lease cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;16&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Variable lease cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;24&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total lease cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;159&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;164&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Variable lease cost primarily includes payments for property taxes, maintenance and insurance. Our rental expense relating to operating leases&#160;was $153 million in fiscal 2019. &lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="display:inline-block;max-width:3.571%;min-width:2.571%;vertical-align:top"/&gt;&lt;div style="display:inline-block;vertical-align:top;width:48.215%"&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes supplemental balance sheet and other information related to leases at June&#160;30:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:47.974%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:24.208%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:24.518%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Operating Leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Operating lease right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;460&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;426&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Current portion of operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;105&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;104&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Long-term operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;374&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;341&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;479&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;445&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Finance Leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Finance lease right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;63&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Current portion of finance lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;19&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Long-term finance lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;45&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total finance lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;64&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted-average remaining lease term (years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;6.5 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;6.4 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;4.2 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;4.3 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted-average discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2.9&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;1.5&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Operating leases are included in other assets, other accrued liabilities, and deferred income taxes and other liabilities in our consolidated balance sheet. Finance leases are included in property and equipment, net, current portion of long-term obligations and other short-term borrowings, and long-term obligations, less current portion in our consolidated balance sheet. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables summarizes supplemental cash flow information related to leases:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:40.258%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:28.220%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:28.222%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Cash paid for lease liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Operating cash flows paid for operating leases&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;115&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;125&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Financing cash flows paid for finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;15&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Non-cash right-of-use assets obtained in exchange for lease obligations:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;New operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;138&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;New finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;45&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Amended lease standard adoption impact as of July 1, 2019 &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;400&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:10pt"&gt;Includes the effect of $22&#160;million from reclassifying deferred rent as an offset to the lease right-of-use asset in accordance with the transition guidance. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Future lease payments under non-cancellable leases as of June&#160;30, 2021 were as follows: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.382%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.142%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.117%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.352%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.117%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.352%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.120%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Operating Leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Finance Leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;116&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;136&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;93&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;113&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;72&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;86&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;65&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;73&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;53&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;141&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;146&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total future lease payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;537&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;70&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;607&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Less: leases not yet commenced &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;3&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Less: imputed interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;55&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;61&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;479&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;64&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;543&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;(1)As of June&#160;30, 2021, we had certain leases that were executed but did not have control of the underlying assets; therefore, the lease liabilities and right-of-use assets are not recorded in the consolidated balance sheet.</cah:LeasesTextBlock>
    <us-gaap:LesseeOperatingLeaseTermOfContract
      contextRef="if156c7b3d30345a395262b86a56d2779_I20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMjEvZnJhZzpkNTEwOTAyZDMwZDc0NDk5YWUzNWE3NTg1ZDkwNDA4Ni90ZXh0cmVnaW9uOmQ1MTA5MDJkMzBkNzQ0OTlhZTM1YTc1ODVkOTA0MDg2XzIyMTQ_77a8f6ef-ccfe-47c2-9d28-d3f07563c1e0">P1Y</us-gaap:LesseeOperatingLeaseTermOfContract>
    <us-gaap:LesseeOperatingLeaseTermOfContract
      contextRef="ib54859ab704046a7a3be64f76f566d69_I20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMjEvZnJhZzpkNTEwOTAyZDMwZDc0NDk5YWUzNWE3NTg1ZDkwNDA4Ni90ZXh0cmVnaW9uOmQ1MTA5MDJkMzBkNzQ0OTlhZTM1YTc1ODVkOTA0MDg2XzIyMzc_2505e291-d198-469d-b5a4-8ba66244af76">P21Y</us-gaap:LesseeOperatingLeaseTermOfContract>
    <us-gaap:LeaseCostTableTextBlock
      contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMjEvZnJhZzpkNTEwOTAyZDMwZDc0NDk5YWUzNWE3NTg1ZDkwNDA4Ni90ZXh0cmVnaW9uOmQ1MTA5MDJkMzBkNzQ0OTlhZTM1YTc1ODVkOTA0MDg2XzQxNzU_95dacd65-6716-462e-8b8a-41b06870f715">&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the components of lease cost:  &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:85.185%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:32.233%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:32.233%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:32.234%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Operating lease cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;119&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;134&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Finance lease cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;16&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Variable lease cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;24&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total lease cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;159&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;164&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;Variable lease cost primarily includes payments for property taxes, maintenance and insurance.</us-gaap:LeaseCostTableTextBlock>
    <us-gaap:OperatingLeaseCost
      contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMjEvZnJhZzpkNTEwOTAyZDMwZDc0NDk5YWUzNWE3NTg1ZDkwNDA4Ni90YWJsZToyNzM1MGUyNDc5MWY0YWY1YmEzOWQ3ZTQ2OGNmM2I4Yy90YWJsZXJhbmdlOjI3MzUwZTI0NzkxZjRhZjViYTM5ZDdlNDY4Y2YzYjhjXzItMS0xLTEtOTk4_c67fb445-47af-4b84-8e00-72755a91f78a"
      unitRef="usd">119000000</us-gaap:OperatingLeaseCost>
    <us-gaap:OperatingLeaseCost
      contextRef="ia31e9a409b874bb19d0ff6f2f39ecc09_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMjEvZnJhZzpkNTEwOTAyZDMwZDc0NDk5YWUzNWE3NTg1ZDkwNDA4Ni90YWJsZToyNzM1MGUyNDc5MWY0YWY1YmEzOWQ3ZTQ2OGNmM2I4Yy90YWJsZXJhbmdlOjI3MzUwZTI0NzkxZjRhZjViYTM5ZDdlNDY4Y2YzYjhjXzItMi0xLTEtMA_72d8ec8a-2936-4972-99a1-ef776b3ecdb3"
      unitRef="usd">134000000</us-gaap:OperatingLeaseCost>
    <us-gaap:FinanceLeaseRightOfUseAssetAmortization
      contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMjEvZnJhZzpkNTEwOTAyZDMwZDc0NDk5YWUzNWE3NTg1ZDkwNDA4Ni90YWJsZToyNzM1MGUyNDc5MWY0YWY1YmEzOWQ3ZTQ2OGNmM2I4Yy90YWJsZXJhbmdlOjI3MzUwZTI0NzkxZjRhZjViYTM5ZDdlNDY4Y2YzYjhjXzQtMS0xLTEtMTAxMA_b440edea-b2b2-40c9-9a15-43982e1358bd"
      unitRef="usd">16000000</us-gaap:FinanceLeaseRightOfUseAssetAmortization>
    <us-gaap:FinanceLeaseRightOfUseAssetAmortization
      contextRef="ia31e9a409b874bb19d0ff6f2f39ecc09_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMjEvZnJhZzpkNTEwOTAyZDMwZDc0NDk5YWUzNWE3NTg1ZDkwNDA4Ni90YWJsZToyNzM1MGUyNDc5MWY0YWY1YmEzOWQ3ZTQ2OGNmM2I4Yy90YWJsZXJhbmdlOjI3MzUwZTI0NzkxZjRhZjViYTM5ZDdlNDY4Y2YzYjhjXzQtMi0xLTEtMA_567ee3a6-b5ef-4823-8142-c839fab5be4b"
      unitRef="usd">13000000</us-gaap:FinanceLeaseRightOfUseAssetAmortization>
    <us-gaap:VariableLeaseCost
      contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMjEvZnJhZzpkNTEwOTAyZDMwZDc0NDk5YWUzNWE3NTg1ZDkwNDA4Ni90YWJsZToyNzM1MGUyNDc5MWY0YWY1YmEzOWQ3ZTQ2OGNmM2I4Yy90YWJsZXJhbmdlOjI3MzUwZTI0NzkxZjRhZjViYTM5ZDdlNDY4Y2YzYjhjXzgtMS0xLTEtMTAxNA_7c6609c5-8562-4ad1-86e2-20fc696878d0"
      unitRef="usd">24000000</us-gaap:VariableLeaseCost>
    <us-gaap:VariableLeaseCost
      contextRef="ia31e9a409b874bb19d0ff6f2f39ecc09_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMjEvZnJhZzpkNTEwOTAyZDMwZDc0NDk5YWUzNWE3NTg1ZDkwNDA4Ni90YWJsZToyNzM1MGUyNDc5MWY0YWY1YmEzOWQ3ZTQ2OGNmM2I4Yy90YWJsZXJhbmdlOjI3MzUwZTI0NzkxZjRhZjViYTM5ZDdlNDY4Y2YzYjhjXzgtMi0xLTEtMA_88067a13-0c98-49b0-918a-a112899e8d99"
      unitRef="usd">17000000</us-gaap:VariableLeaseCost>
    <us-gaap:LeaseCost
      contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMjEvZnJhZzpkNTEwOTAyZDMwZDc0NDk5YWUzNWE3NTg1ZDkwNDA4Ni90YWJsZToyNzM1MGUyNDc5MWY0YWY1YmEzOWQ3ZTQ2OGNmM2I4Yy90YWJsZXJhbmdlOjI3MzUwZTI0NzkxZjRhZjViYTM5ZDdlNDY4Y2YzYjhjXzEwLTEtMS0xLTgwMzE_6a2141ad-dd9d-485d-b6bb-719bb317b2fb"
      unitRef="usd">159000000</us-gaap:LeaseCost>
    <us-gaap:LeaseCost
      contextRef="ia31e9a409b874bb19d0ff6f2f39ecc09_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMjEvZnJhZzpkNTEwOTAyZDMwZDc0NDk5YWUzNWE3NTg1ZDkwNDA4Ni90YWJsZToyNzM1MGUyNDc5MWY0YWY1YmEzOWQ3ZTQ2OGNmM2I4Yy90YWJsZXJhbmdlOjI3MzUwZTI0NzkxZjRhZjViYTM5ZDdlNDY4Y2YzYjhjXzEwLTItMS0xLTA_77647ac4-48da-4ee9-99e5-707cf51f1312"
      unitRef="usd">164000000</us-gaap:LeaseCost>
    <us-gaap:LeaseAndRentalExpense
      contextRef="i00a6d666bf604826b24e68ddbd63eac4_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMjEvZnJhZzpkNTEwOTAyZDMwZDc0NDk5YWUzNWE3NTg1ZDkwNDA4Ni90ZXh0cmVnaW9uOmQ1MTA5MDJkMzBkNzQ0OTlhZTM1YTc1ODVkOTA0MDg2XzI2MzY_e7c0b3af-fe49-4e4c-86dd-59f38dc85984"
      unitRef="usd">153000000</us-gaap:LeaseAndRentalExpense>
    <cah:LeasesSupplementalBalanceSheetInformationTableTextBlock
      contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMjEvZnJhZzpkNTEwOTAyZDMwZDc0NDk5YWUzNWE3NTg1ZDkwNDA4Ni90ZXh0cmVnaW9uOmQ1MTA5MDJkMzBkNzQ0OTlhZTM1YTc1ODVkOTA0MDg2XzQxNzY_3d6739e4-9c53-4982-b015-dd6b34a29cb7">The following table summarizes supplemental balance sheet and other information related to leases at June&#160;30:&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:47.974%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:24.208%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:24.518%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Operating Leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Operating lease right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;460&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;426&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Current portion of operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;105&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;104&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Long-term operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;374&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;341&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;479&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;445&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Finance Leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Finance lease right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;63&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Current portion of finance lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;19&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Long-term finance lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;45&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total finance lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;64&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted-average remaining lease term (years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;6.5 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;6.4 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;4.2 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;4.3 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted-average discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2.9&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;1.5&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</cah:LeasesSupplementalBalanceSheetInformationTableTextBlock>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="i473efc3a1c3141748a845b14896f4459_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMjEvZnJhZzpkNTEwOTAyZDMwZDc0NDk5YWUzNWE3NTg1ZDkwNDA4Ni90YWJsZTo0Yjk2NjQ4MWNlZjk0NDM1ODExOTBkZDc1N2M1ZmU1Ni90YWJsZXJhbmdlOjRiOTY2NDgxY2VmOTQ0MzU4MTE5MGRkNzU3YzVmZTU2XzItMS0xLTEtMA_ca8cf378-24ed-48ae-8e08-390c39d3eeaa"
      unitRef="usd">460000000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="if8918e18bf5f4dea9e6f6e70f8d28bcf_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMjEvZnJhZzpkNTEwOTAyZDMwZDc0NDk5YWUzNWE3NTg1ZDkwNDA4Ni90YWJsZTo0Yjk2NjQ4MWNlZjk0NDM1ODExOTBkZDc1N2M1ZmU1Ni90YWJsZXJhbmdlOjRiOTY2NDgxY2VmOTQ0MzU4MTE5MGRkNzU3YzVmZTU2XzItMi0xLTEtMTA4OQ_13f17a0b-500c-4f71-ac2d-cc7fada40dd9"
      unitRef="usd">426000000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="i7b139144658040af96c5e7fe53846762_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMjEvZnJhZzpkNTEwOTAyZDMwZDc0NDk5YWUzNWE3NTg1ZDkwNDA4Ni90YWJsZTo0Yjk2NjQ4MWNlZjk0NDM1ODExOTBkZDc1N2M1ZmU1Ni90YWJsZXJhbmdlOjRiOTY2NDgxY2VmOTQ0MzU4MTE5MGRkNzU3YzVmZTU2XzQtMS0xLTEtMA_eebf36e4-c392-4e2e-b2b9-552fe9b8cd7c"
      unitRef="usd">105000000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="i4dc82a9dc1f44fe7a3214de6a700a3e1_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMjEvZnJhZzpkNTEwOTAyZDMwZDc0NDk5YWUzNWE3NTg1ZDkwNDA4Ni90YWJsZTo0Yjk2NjQ4MWNlZjk0NDM1ODExOTBkZDc1N2M1ZmU1Ni90YWJsZXJhbmdlOjRiOTY2NDgxY2VmOTQ0MzU4MTE5MGRkNzU3YzVmZTU2XzQtMi0xLTEtMTA4OQ_78b45218-dbbd-464e-9123-5ec2d46eaa0e"
      unitRef="usd">104000000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="iae9792a738c242f7bf603db4cdc6f6ea_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMjEvZnJhZzpkNTEwOTAyZDMwZDc0NDk5YWUzNWE3NTg1ZDkwNDA4Ni90YWJsZTo0Yjk2NjQ4MWNlZjk0NDM1ODExOTBkZDc1N2M1ZmU1Ni90YWJsZXJhbmdlOjRiOTY2NDgxY2VmOTQ0MzU4MTE5MGRkNzU3YzVmZTU2XzUtMS0xLTEtMA_31cccf26-adb3-4971-88c3-b1f1c638288a"
      unitRef="usd">374000000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="i143c1782b3aa4747968fda061bcedf08_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMjEvZnJhZzpkNTEwOTAyZDMwZDc0NDk5YWUzNWE3NTg1ZDkwNDA4Ni90YWJsZTo0Yjk2NjQ4MWNlZjk0NDM1ODExOTBkZDc1N2M1ZmU1Ni90YWJsZXJhbmdlOjRiOTY2NDgxY2VmOTQ0MzU4MTE5MGRkNzU3YzVmZTU2XzUtMi0xLTEtMTA4OQ_d1ffdd25-5976-43fb-b2ee-ecdc3e9d4352"
      unitRef="usd">341000000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiability
      contextRef="i2e87824102b34590a0208cc7da91b5f5_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMjEvZnJhZzpkNTEwOTAyZDMwZDc0NDk5YWUzNWE3NTg1ZDkwNDA4Ni90YWJsZTo0Yjk2NjQ4MWNlZjk0NDM1ODExOTBkZDc1N2M1ZmU1Ni90YWJsZXJhbmdlOjRiOTY2NDgxY2VmOTQ0MzU4MTE5MGRkNzU3YzVmZTU2XzYtMS0xLTEtMA_5d072339-4cbc-4534-80c0-9c49717826b7"
      unitRef="usd">479000000</us-gaap:OperatingLeaseLiability>
    <us-gaap:OperatingLeaseLiability
      contextRef="i299cea70f47b4fbe96772aaa8cc00b79_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMjEvZnJhZzpkNTEwOTAyZDMwZDc0NDk5YWUzNWE3NTg1ZDkwNDA4Ni90YWJsZTo0Yjk2NjQ4MWNlZjk0NDM1ODExOTBkZDc1N2M1ZmU1Ni90YWJsZXJhbmdlOjRiOTY2NDgxY2VmOTQ0MzU4MTE5MGRkNzU3YzVmZTU2XzYtMi0xLTEtODAzNg_c4840675-7290-47e5-8298-d584baf66280"
      unitRef="usd">445000000</us-gaap:OperatingLeaseLiability>
    <us-gaap:FinanceLeaseRightOfUseAsset
      contextRef="i1f2e316db9cd4fdfabceb7ed40f4de88_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMjEvZnJhZzpkNTEwOTAyZDMwZDc0NDk5YWUzNWE3NTg1ZDkwNDA4Ni90YWJsZTo0Yjk2NjQ4MWNlZjk0NDM1ODExOTBkZDc1N2M1ZmU1Ni90YWJsZXJhbmdlOjRiOTY2NDgxY2VmOTQ0MzU4MTE5MGRkNzU3YzVmZTU2XzktMS0xLTEtMA_b5eb0733-695e-473d-b050-8a784b9b3fde"
      unitRef="usd">63000000</us-gaap:FinanceLeaseRightOfUseAsset>
    <us-gaap:FinanceLeaseRightOfUseAsset
      contextRef="ie4f28db5f64a4f11b597d0108259b1f2_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMjEvZnJhZzpkNTEwOTAyZDMwZDc0NDk5YWUzNWE3NTg1ZDkwNDA4Ni90YWJsZTo0Yjk2NjQ4MWNlZjk0NDM1ODExOTBkZDc1N2M1ZmU1Ni90YWJsZXJhbmdlOjRiOTY2NDgxY2VmOTQ0MzU4MTE5MGRkNzU3YzVmZTU2XzktMi0xLTEtMTA5Mg_a5a93d41-74ab-48cf-8407-063fbba6c54e"
      unitRef="usd">33000000</us-gaap:FinanceLeaseRightOfUseAsset>
    <us-gaap:FinanceLeaseLiabilityCurrent
      contextRef="i2e87824102b34590a0208cc7da91b5f5_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMjEvZnJhZzpkNTEwOTAyZDMwZDc0NDk5YWUzNWE3NTg1ZDkwNDA4Ni90YWJsZTo0Yjk2NjQ4MWNlZjk0NDM1ODExOTBkZDc1N2M1ZmU1Ni90YWJsZXJhbmdlOjRiOTY2NDgxY2VmOTQ0MzU4MTE5MGRkNzU3YzVmZTU2XzExLTEtMS0xLTA_185fac82-ff7a-45b2-a289-d20580767fc6"
      unitRef="usd">19000000</us-gaap:FinanceLeaseLiabilityCurrent>
    <us-gaap:FinanceLeaseLiabilityCurrent
      contextRef="i299cea70f47b4fbe96772aaa8cc00b79_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMjEvZnJhZzpkNTEwOTAyZDMwZDc0NDk5YWUzNWE3NTg1ZDkwNDA4Ni90YWJsZTo0Yjk2NjQ4MWNlZjk0NDM1ODExOTBkZDc1N2M1ZmU1Ni90YWJsZXJhbmdlOjRiOTY2NDgxY2VmOTQ0MzU4MTE5MGRkNzU3YzVmZTU2XzExLTItMS0xLTEwOTI_841de90f-2f51-492e-a368-0b94cdfb4503"
      unitRef="usd">9000000</us-gaap:FinanceLeaseLiabilityCurrent>
    <us-gaap:FinanceLeaseLiabilityNoncurrent
      contextRef="i2e87824102b34590a0208cc7da91b5f5_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMjEvZnJhZzpkNTEwOTAyZDMwZDc0NDk5YWUzNWE3NTg1ZDkwNDA4Ni90YWJsZTo0Yjk2NjQ4MWNlZjk0NDM1ODExOTBkZDc1N2M1ZmU1Ni90YWJsZXJhbmdlOjRiOTY2NDgxY2VmOTQ0MzU4MTE5MGRkNzU3YzVmZTU2XzEyLTEtMS0xLTA_898ae2de-a286-465e-8dde-9bcb73a7d6af"
      unitRef="usd">45000000</us-gaap:FinanceLeaseLiabilityNoncurrent>
    <us-gaap:FinanceLeaseLiabilityNoncurrent
      contextRef="i299cea70f47b4fbe96772aaa8cc00b79_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMjEvZnJhZzpkNTEwOTAyZDMwZDc0NDk5YWUzNWE3NTg1ZDkwNDA4Ni90YWJsZTo0Yjk2NjQ4MWNlZjk0NDM1ODExOTBkZDc1N2M1ZmU1Ni90YWJsZXJhbmdlOjRiOTY2NDgxY2VmOTQ0MzU4MTE5MGRkNzU3YzVmZTU2XzEyLTItMS0xLTEwOTI_3b403b25-ac9e-47b4-a9c1-44eb47dab210"
      unitRef="usd">25000000</us-gaap:FinanceLeaseLiabilityNoncurrent>
    <us-gaap:FinanceLeaseLiability
      contextRef="i2e87824102b34590a0208cc7da91b5f5_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMjEvZnJhZzpkNTEwOTAyZDMwZDc0NDk5YWUzNWE3NTg1ZDkwNDA4Ni90YWJsZTo0Yjk2NjQ4MWNlZjk0NDM1ODExOTBkZDc1N2M1ZmU1Ni90YWJsZXJhbmdlOjRiOTY2NDgxY2VmOTQ0MzU4MTE5MGRkNzU3YzVmZTU2XzEzLTEtMS0xLTA_c51488f6-fc1d-49ed-a1ae-c52feb8274f8"
      unitRef="usd">64000000</us-gaap:FinanceLeaseLiability>
    <us-gaap:FinanceLeaseLiability
      contextRef="i299cea70f47b4fbe96772aaa8cc00b79_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMjEvZnJhZzpkNTEwOTAyZDMwZDc0NDk5YWUzNWE3NTg1ZDkwNDA4Ni90YWJsZTo0Yjk2NjQ4MWNlZjk0NDM1ODExOTBkZDc1N2M1ZmU1Ni90YWJsZXJhbmdlOjRiOTY2NDgxY2VmOTQ0MzU4MTE5MGRkNzU3YzVmZTU2XzEzLTItMS0xLTgwMzg_b635a410-ccaa-4491-8934-540090b0a252"
      unitRef="usd">34000000</us-gaap:FinanceLeaseLiability>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="i2e87824102b34590a0208cc7da91b5f5_I20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMjEvZnJhZzpkNTEwOTAyZDMwZDc0NDk5YWUzNWE3NTg1ZDkwNDA4Ni90YWJsZTo0Yjk2NjQ4MWNlZjk0NDM1ODExOTBkZDc1N2M1ZmU1Ni90YWJsZXJhbmdlOjRiOTY2NDgxY2VmOTQ0MzU4MTE5MGRkNzU3YzVmZTU2XzE2LTEtMS0xLTg1NDA_b9ceafb6-6bc7-464d-850d-2fb6a86464cc">P6Y6M</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="i299cea70f47b4fbe96772aaa8cc00b79_I20200630"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMjEvZnJhZzpkNTEwOTAyZDMwZDc0NDk5YWUzNWE3NTg1ZDkwNDA4Ni90YWJsZTo0Yjk2NjQ4MWNlZjk0NDM1ODExOTBkZDc1N2M1ZmU1Ni90YWJsZXJhbmdlOjRiOTY2NDgxY2VmOTQ0MzU4MTE5MGRkNzU3YzVmZTU2XzE2LTItMS0xLTg1NDA_68c82446-d4c9-4af0-975a-016e899f6484">P6Y4M24D</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="i2e87824102b34590a0208cc7da91b5f5_I20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMjEvZnJhZzpkNTEwOTAyZDMwZDc0NDk5YWUzNWE3NTg1ZDkwNDA4Ni90YWJsZTo0Yjk2NjQ4MWNlZjk0NDM1ODExOTBkZDc1N2M1ZmU1Ni90YWJsZXJhbmdlOjRiOTY2NDgxY2VmOTQ0MzU4MTE5MGRkNzU3YzVmZTU2XzE3LTEtMS0xLTg1NDA_8847feef-55b0-49cc-aad6-33efa0fe7126">P4Y2M12D</us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="i299cea70f47b4fbe96772aaa8cc00b79_I20200630"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMjEvZnJhZzpkNTEwOTAyZDMwZDc0NDk5YWUzNWE3NTg1ZDkwNDA4Ni90YWJsZTo0Yjk2NjQ4MWNlZjk0NDM1ODExOTBkZDc1N2M1ZmU1Ni90YWJsZXJhbmdlOjRiOTY2NDgxY2VmOTQ0MzU4MTE5MGRkNzU3YzVmZTU2XzE3LTItMS0xLTg1NDA_ffc54b81-fee5-4d1e-9105-11c5821012f7">P4Y3M18D</us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent
      contextRef="i2e87824102b34590a0208cc7da91b5f5_I20210630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMjEvZnJhZzpkNTEwOTAyZDMwZDc0NDk5YWUzNWE3NTg1ZDkwNDA4Ni90YWJsZTo0Yjk2NjQ4MWNlZjk0NDM1ODExOTBkZDc1N2M1ZmU1Ni90YWJsZXJhbmdlOjRiOTY2NDgxY2VmOTQ0MzU4MTE5MGRkNzU3YzVmZTU2XzIwLTEtMS0xLTg1NDA_79bbea84-ecf4-4edd-94e5-3f4654f8aa4e"
      unitRef="number">0.029</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent
      contextRef="i299cea70f47b4fbe96772aaa8cc00b79_I20200630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMjEvZnJhZzpkNTEwOTAyZDMwZDc0NDk5YWUzNWE3NTg1ZDkwNDA4Ni90YWJsZTo0Yjk2NjQ4MWNlZjk0NDM1ODExOTBkZDc1N2M1ZmU1Ni90YWJsZXJhbmdlOjRiOTY2NDgxY2VmOTQ0MzU4MTE5MGRkNzU3YzVmZTU2XzIwLTItMS0xLTg1NDA_2bfd9455-b102-42db-8fcc-a390107f508d"
      unitRef="number">0.029</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent
      contextRef="i2e87824102b34590a0208cc7da91b5f5_I20210630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMjEvZnJhZzpkNTEwOTAyZDMwZDc0NDk5YWUzNWE3NTg1ZDkwNDA4Ni90YWJsZTo0Yjk2NjQ4MWNlZjk0NDM1ODExOTBkZDc1N2M1ZmU1Ni90YWJsZXJhbmdlOjRiOTY2NDgxY2VmOTQ0MzU4MTE5MGRkNzU3YzVmZTU2XzIxLTEtMS0xLTg1NDA_d54011de-f48d-4e27-addc-8666b47e6614"
      unitRef="number">0.015</us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent
      contextRef="i299cea70f47b4fbe96772aaa8cc00b79_I20200630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMjEvZnJhZzpkNTEwOTAyZDMwZDc0NDk5YWUzNWE3NTg1ZDkwNDA4Ni90YWJsZTo0Yjk2NjQ4MWNlZjk0NDM1ODExOTBkZDc1N2M1ZmU1Ni90YWJsZXJhbmdlOjRiOTY2NDgxY2VmOTQ0MzU4MTE5MGRkNzU3YzVmZTU2XzIxLTItMS0xLTg1NDA_01f1b91f-4572-43ae-8675-5648a751f009"
      unitRef="number">0.024</us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent>
    <cah:LeasePaymentsTableTextBlock
      contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMjEvZnJhZzpkNTEwOTAyZDMwZDc0NDk5YWUzNWE3NTg1ZDkwNDA4Ni90ZXh0cmVnaW9uOmQ1MTA5MDJkMzBkNzQ0OTlhZTM1YTc1ODVkOTA0MDg2XzQxNzc_a60f0918-7feb-4207-9f27-a3ed4c5568f9">&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables summarizes supplemental cash flow information related to leases:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:40.258%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:28.220%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:28.222%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Cash paid for lease liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Operating cash flows paid for operating leases&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;115&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;125&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Financing cash flows paid for finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;15&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Non-cash right-of-use assets obtained in exchange for lease obligations:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;New operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;138&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;New finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;45&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Amended lease standard adoption impact as of July 1, 2019 &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;400&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;(1)Includes the effect of $22&#160;million from reclassifying deferred rent as an offset to the lease right-of-use asset in accordance with the transition guidance.</cah:LeasePaymentsTableTextBlock>
    <us-gaap:OperatingLeasePayments
      contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMjEvZnJhZzpkNTEwOTAyZDMwZDc0NDk5YWUzNWE3NTg1ZDkwNDA4Ni90YWJsZToyYTRlM2FjMGQzZGQ0Y2Q2YTUwMjQ4ZjViOGM5YjEwYS90YWJsZXJhbmdlOjJhNGUzYWMwZDNkZDRjZDZhNTAyNDhmNWI4YzliMTBhXzMtMS0xLTEtMA_9e735386-b872-452e-8881-33318110b982"
      unitRef="usd">115000000</us-gaap:OperatingLeasePayments>
    <us-gaap:OperatingLeasePayments
      contextRef="ia31e9a409b874bb19d0ff6f2f39ecc09_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMjEvZnJhZzpkNTEwOTAyZDMwZDc0NDk5YWUzNWE3NTg1ZDkwNDA4Ni90YWJsZToyYTRlM2FjMGQzZGQ0Y2Q2YTUwMjQ4ZjViOGM5YjEwYS90YWJsZXJhbmdlOjJhNGUzYWMwZDNkZDRjZDZhNTAyNDhmNWI4YzliMTBhXzMtMi0xLTEtMTEwOQ_f2729ddc-cf66-41cd-a7ca-82dcf61d75f5"
      unitRef="usd">125000000</us-gaap:OperatingLeasePayments>
    <us-gaap:FinanceLeasePrincipalPayments
      contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMjEvZnJhZzpkNTEwOTAyZDMwZDc0NDk5YWUzNWE3NTg1ZDkwNDA4Ni90YWJsZToyYTRlM2FjMGQzZGQ0Y2Q2YTUwMjQ4ZjViOGM5YjEwYS90YWJsZXJhbmdlOjJhNGUzYWMwZDNkZDRjZDZhNTAyNDhmNWI4YzliMTBhXzUtMS0xLTEtMA_0422b3c6-220e-45c6-9171-d46f588e9adf"
      unitRef="usd">15000000</us-gaap:FinanceLeasePrincipalPayments>
    <us-gaap:FinanceLeasePrincipalPayments
      contextRef="ia31e9a409b874bb19d0ff6f2f39ecc09_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMjEvZnJhZzpkNTEwOTAyZDMwZDc0NDk5YWUzNWE3NTg1ZDkwNDA4Ni90YWJsZToyYTRlM2FjMGQzZGQ0Y2Q2YTUwMjQ4ZjViOGM5YjEwYS90YWJsZXJhbmdlOjJhNGUzYWMwZDNkZDRjZDZhNTAyNDhmNWI4YzliMTBhXzUtMi0xLTEtMTEwOQ_8e440466-05c6-4640-910f-63684e3881f8"
      unitRef="usd">7000000</us-gaap:FinanceLeasePrincipalPayments>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
      contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMjEvZnJhZzpkNTEwOTAyZDMwZDc0NDk5YWUzNWE3NTg1ZDkwNDA4Ni90YWJsZToyYTRlM2FjMGQzZGQ0Y2Q2YTUwMjQ4ZjViOGM5YjEwYS90YWJsZXJhbmdlOjJhNGUzYWMwZDNkZDRjZDZhNTAyNDhmNWI4YzliMTBhXzctMS0xLTEtMA_ef2df7a8-8b6e-4c63-b1b1-d3b21a135edd"
      unitRef="usd">138000000</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
      contextRef="ia31e9a409b874bb19d0ff6f2f39ecc09_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMjEvZnJhZzpkNTEwOTAyZDMwZDc0NDk5YWUzNWE3NTg1ZDkwNDA4Ni90YWJsZToyYTRlM2FjMGQzZGQ0Y2Q2YTUwMjQ4ZjViOGM5YjEwYS90YWJsZXJhbmdlOjJhNGUzYWMwZDNkZDRjZDZhNTAyNDhmNWI4YzliMTBhXzctMi0xLTEtMTEwOQ_88e33e9b-98d8-4c98-a486-28d40b70be0b"
      unitRef="usd">150000000</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability
      contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMjEvZnJhZzpkNTEwOTAyZDMwZDc0NDk5YWUzNWE3NTg1ZDkwNDA4Ni90YWJsZToyYTRlM2FjMGQzZGQ0Y2Q2YTUwMjQ4ZjViOGM5YjEwYS90YWJsZXJhbmdlOjJhNGUzYWMwZDNkZDRjZDZhNTAyNDhmNWI4YzliMTBhXzgtMS0xLTEtMA_00774946-9d63-495c-bfc7-dc9c723ad6b7"
      unitRef="usd">45000000</us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability>
    <us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability
      contextRef="ia31e9a409b874bb19d0ff6f2f39ecc09_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMjEvZnJhZzpkNTEwOTAyZDMwZDc0NDk5YWUzNWE3NTg1ZDkwNDA4Ni90YWJsZToyYTRlM2FjMGQzZGQ0Y2Q2YTUwMjQ4ZjViOGM5YjEwYS90YWJsZXJhbmdlOjJhNGUzYWMwZDNkZDRjZDZhNTAyNDhmNWI4YzliMTBhXzgtMi0xLTEtMTEwOQ_072e3a4e-43b0-4dfe-b146-f43acadacb9d"
      unitRef="usd">40000000</us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability>
    <cah:Impactofadoptionofnewaccountingstandard
      contextRef="if00203a4c9a34b58a93c869a759f0035_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMjEvZnJhZzpkNTEwOTAyZDMwZDc0NDk5YWUzNWE3NTg1ZDkwNDA4Ni90YWJsZToyYTRlM2FjMGQzZGQ0Y2Q2YTUwMjQ4ZjViOGM5YjEwYS90YWJsZXJhbmdlOjJhNGUzYWMwZDNkZDRjZDZhNTAyNDhmNWI4YzliMTBhXzktMS0xLTEtMA_8871bbee-9545-4d2d-adab-5977a04de223"
      unitRef="usd">0</cah:Impactofadoptionofnewaccountingstandard>
    <cah:Impactofadoptionofnewaccountingstandard
      contextRef="i455f42e4f43447dc98cf9ec500532a90_D20190701-20190701"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMjEvZnJhZzpkNTEwOTAyZDMwZDc0NDk5YWUzNWE3NTg1ZDkwNDA4Ni90YWJsZToyYTRlM2FjMGQzZGQ0Y2Q2YTUwMjQ4ZjViOGM5YjEwYS90YWJsZXJhbmdlOjJhNGUzYWMwZDNkZDRjZDZhNTAyNDhmNWI4YzliMTBhXzktMi0xLTEtMTEwOQ_153271ab-fe6d-4872-ad22-7bbc1fc350b7"
      unitRef="usd">400000000</cah:Impactofadoptionofnewaccountingstandard>
    <cah:ReclassificationofdeferredrentinaccordancewithASC842
      contextRef="ie6662f5b1e3d4807b4fbf7aa426005bb_D20190701-20190701"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMjEvZnJhZzpkNTEwOTAyZDMwZDc0NDk5YWUzNWE3NTg1ZDkwNDA4Ni90ZXh0cmVnaW9uOmQ1MTA5MDJkMzBkNzQ0OTlhZTM1YTc1ODVkOTA0MDg2XzI3NDg3NzkwNzQ4ODM_28165712-ff0a-4eec-b779-e49269d1857c"
      unitRef="usd">22000000</cah:ReclassificationofdeferredrentinaccordancewithASC842>
    <us-gaap:ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock
      contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMjEvZnJhZzpkNTEwOTAyZDMwZDc0NDk5YWUzNWE3NTg1ZDkwNDA4Ni90ZXh0cmVnaW9uOmQ1MTA5MDJkMzBkNzQ0OTlhZTM1YTc1ODVkOTA0MDg2XzQxNzM_7c19373c-3745-449d-b1e6-d555daf3bf37">&lt;div style="margin-bottom:3pt"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Future lease payments under non-cancellable leases as of June&#160;30, 2021 were as follows: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.382%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.142%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.117%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.352%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.117%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.352%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.120%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Operating Leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Finance Leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;116&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;136&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;93&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;113&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;72&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;86&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;65&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;73&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;53&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;141&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;146&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total future lease payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;537&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;70&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;607&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Less: leases not yet commenced &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;3&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Less: imputed interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;55&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;61&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;479&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;64&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;543&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;(1)As of June&#160;30, 2021, we had certain leases that were executed but did not have control of the underlying assets; therefore, the lease liabilities and right-of-use assets are not recorded in the consolidated balance sheet.</us-gaap:ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
      contextRef="i1a0dd756c14d48d7a436a9f95e4c95c3_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMjEvZnJhZzpkNTEwOTAyZDMwZDc0NDk5YWUzNWE3NTg1ZDkwNDA4Ni90YWJsZTpiZGJkNzVhODZlMzU0NDI3ODQyYjJmZDg3ZTM1NGM1YS90YWJsZXJhbmdlOmJkYmQ3NWE4NmUzNTQ0Mjc4NDJiMmZkODdlMzU0YzVhXzItMS0xLTEtMA_2409ee3d-9c23-4d53-b711-9bf1bb50941c"
      unitRef="usd">116000000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueNextTwelveMonths
      contextRef="i566381a05b1444c1a852e8768ae88ad3_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMjEvZnJhZzpkNTEwOTAyZDMwZDc0NDk5YWUzNWE3NTg1ZDkwNDA4Ni90YWJsZTpiZGJkNzVhODZlMzU0NDI3ODQyYjJmZDg3ZTM1NGM1YS90YWJsZXJhbmdlOmJkYmQ3NWE4NmUzNTQ0Mjc4NDJiMmZkODdlMzU0YzVhXzItMy0xLTEtMA_7e9020fd-324b-477b-b129-1d1750877df8"
      unitRef="usd">20000000</us-gaap:FinanceLeaseLiabilityPaymentsDueNextTwelveMonths>
    <cah:LesseeLeaseLiabilityPaymentsDueYearOne
      contextRef="i2e87824102b34590a0208cc7da91b5f5_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMjEvZnJhZzpkNTEwOTAyZDMwZDc0NDk5YWUzNWE3NTg1ZDkwNDA4Ni90YWJsZTpiZGJkNzVhODZlMzU0NDI3ODQyYjJmZDg3ZTM1NGM1YS90YWJsZXJhbmdlOmJkYmQ3NWE4NmUzNTQ0Mjc4NDJiMmZkODdlMzU0YzVhXzItNS0xLTEtMA_581003ec-dd16-42c6-9490-526d7cb86976"
      unitRef="usd">136000000</cah:LesseeLeaseLiabilityPaymentsDueYearOne>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
      contextRef="i1a0dd756c14d48d7a436a9f95e4c95c3_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMjEvZnJhZzpkNTEwOTAyZDMwZDc0NDk5YWUzNWE3NTg1ZDkwNDA4Ni90YWJsZTpiZGJkNzVhODZlMzU0NDI3ODQyYjJmZDg3ZTM1NGM1YS90YWJsZXJhbmdlOmJkYmQ3NWE4NmUzNTQ0Mjc4NDJiMmZkODdlMzU0YzVhXzMtMS0xLTEtMA_00d1b9a0-f086-4d4b-a413-ee9af27038ad"
      unitRef="usd">93000000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueYearTwo
      contextRef="i566381a05b1444c1a852e8768ae88ad3_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMjEvZnJhZzpkNTEwOTAyZDMwZDc0NDk5YWUzNWE3NTg1ZDkwNDA4Ni90YWJsZTpiZGJkNzVhODZlMzU0NDI3ODQyYjJmZDg3ZTM1NGM1YS90YWJsZXJhbmdlOmJkYmQ3NWE4NmUzNTQ0Mjc4NDJiMmZkODdlMzU0YzVhXzMtMy0xLTEtMA_44c1ae98-c9b7-466e-bd30-72f591c44115"
      unitRef="usd">20000000</us-gaap:FinanceLeaseLiabilityPaymentsDueYearTwo>
    <cah:LesseeLeaseLiabilityPaymentsDueYearTwo
      contextRef="i2e87824102b34590a0208cc7da91b5f5_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMjEvZnJhZzpkNTEwOTAyZDMwZDc0NDk5YWUzNWE3NTg1ZDkwNDA4Ni90YWJsZTpiZGJkNzVhODZlMzU0NDI3ODQyYjJmZDg3ZTM1NGM1YS90YWJsZXJhbmdlOmJkYmQ3NWE4NmUzNTQ0Mjc4NDJiMmZkODdlMzU0YzVhXzMtNS0xLTEtMA_9be7050b-27c6-4919-b9c7-b4503cc47c24"
      unitRef="usd">113000000</cah:LesseeLeaseLiabilityPaymentsDueYearTwo>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree
      contextRef="i1a0dd756c14d48d7a436a9f95e4c95c3_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMjEvZnJhZzpkNTEwOTAyZDMwZDc0NDk5YWUzNWE3NTg1ZDkwNDA4Ni90YWJsZTpiZGJkNzVhODZlMzU0NDI3ODQyYjJmZDg3ZTM1NGM1YS90YWJsZXJhbmdlOmJkYmQ3NWE4NmUzNTQ0Mjc4NDJiMmZkODdlMzU0YzVhXzQtMS0xLTEtMA_6dcb4016-019c-45b7-b037-882da2f22659"
      unitRef="usd">72000000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueYearThree
      contextRef="i566381a05b1444c1a852e8768ae88ad3_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMjEvZnJhZzpkNTEwOTAyZDMwZDc0NDk5YWUzNWE3NTg1ZDkwNDA4Ni90YWJsZTpiZGJkNzVhODZlMzU0NDI3ODQyYjJmZDg3ZTM1NGM1YS90YWJsZXJhbmdlOmJkYmQ3NWE4NmUzNTQ0Mjc4NDJiMmZkODdlMzU0YzVhXzQtMy0xLTEtMA_2fd13d0d-785c-4594-8576-779717dd33be"
      unitRef="usd">14000000</us-gaap:FinanceLeaseLiabilityPaymentsDueYearThree>
    <cah:LesseeLeaseLiabilityPaymentsDueYearThree
      contextRef="i2e87824102b34590a0208cc7da91b5f5_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMjEvZnJhZzpkNTEwOTAyZDMwZDc0NDk5YWUzNWE3NTg1ZDkwNDA4Ni90YWJsZTpiZGJkNzVhODZlMzU0NDI3ODQyYjJmZDg3ZTM1NGM1YS90YWJsZXJhbmdlOmJkYmQ3NWE4NmUzNTQ0Mjc4NDJiMmZkODdlMzU0YzVhXzQtNS0xLTEtMA_9f78629e-15cd-448f-918a-e7e430d80dbf"
      unitRef="usd">86000000</cah:LesseeLeaseLiabilityPaymentsDueYearThree>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour
      contextRef="i1a0dd756c14d48d7a436a9f95e4c95c3_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMjEvZnJhZzpkNTEwOTAyZDMwZDc0NDk5YWUzNWE3NTg1ZDkwNDA4Ni90YWJsZTpiZGJkNzVhODZlMzU0NDI3ODQyYjJmZDg3ZTM1NGM1YS90YWJsZXJhbmdlOmJkYmQ3NWE4NmUzNTQ0Mjc4NDJiMmZkODdlMzU0YzVhXzUtMS0xLTEtMA_c3277353-acc0-4411-8dd8-7f78ff57ecd0"
      unitRef="usd">65000000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueYearFour
      contextRef="i566381a05b1444c1a852e8768ae88ad3_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMjEvZnJhZzpkNTEwOTAyZDMwZDc0NDk5YWUzNWE3NTg1ZDkwNDA4Ni90YWJsZTpiZGJkNzVhODZlMzU0NDI3ODQyYjJmZDg3ZTM1NGM1YS90YWJsZXJhbmdlOmJkYmQ3NWE4NmUzNTQ0Mjc4NDJiMmZkODdlMzU0YzVhXzUtMy0xLTEtMA_9404d6fb-0a26-45a9-9928-3c20ea57bda6"
      unitRef="usd">8000000</us-gaap:FinanceLeaseLiabilityPaymentsDueYearFour>
    <cah:LesseeLeaseLiabilityPaymentsDueYearFour
      contextRef="i2e87824102b34590a0208cc7da91b5f5_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMjEvZnJhZzpkNTEwOTAyZDMwZDc0NDk5YWUzNWE3NTg1ZDkwNDA4Ni90YWJsZTpiZGJkNzVhODZlMzU0NDI3ODQyYjJmZDg3ZTM1NGM1YS90YWJsZXJhbmdlOmJkYmQ3NWE4NmUzNTQ0Mjc4NDJiMmZkODdlMzU0YzVhXzUtNS0xLTEtMA_16586532-b153-43e3-8c0b-5e1f5c0793f0"
      unitRef="usd">73000000</cah:LesseeLeaseLiabilityPaymentsDueYearFour>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive
      contextRef="i1a0dd756c14d48d7a436a9f95e4c95c3_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMjEvZnJhZzpkNTEwOTAyZDMwZDc0NDk5YWUzNWE3NTg1ZDkwNDA4Ni90YWJsZTpiZGJkNzVhODZlMzU0NDI3ODQyYjJmZDg3ZTM1NGM1YS90YWJsZXJhbmdlOmJkYmQ3NWE4NmUzNTQ0Mjc4NDJiMmZkODdlMzU0YzVhXzYtMS0xLTEtMA_24e28e74-404d-40ca-ada6-37e4dff9fca0"
      unitRef="usd">50000000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueYearFive
      contextRef="i566381a05b1444c1a852e8768ae88ad3_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMjEvZnJhZzpkNTEwOTAyZDMwZDc0NDk5YWUzNWE3NTg1ZDkwNDA4Ni90YWJsZTpiZGJkNzVhODZlMzU0NDI3ODQyYjJmZDg3ZTM1NGM1YS90YWJsZXJhbmdlOmJkYmQ3NWE4NmUzNTQ0Mjc4NDJiMmZkODdlMzU0YzVhXzYtMy0xLTEtMA_a0bccf50-7914-4eca-a454-2aff024cafb2"
      unitRef="usd">3000000</us-gaap:FinanceLeaseLiabilityPaymentsDueYearFive>
    <cah:LesseeLeaseLiabilityPaymentsDueYearFive
      contextRef="i2e87824102b34590a0208cc7da91b5f5_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMjEvZnJhZzpkNTEwOTAyZDMwZDc0NDk5YWUzNWE3NTg1ZDkwNDA4Ni90YWJsZTpiZGJkNzVhODZlMzU0NDI3ODQyYjJmZDg3ZTM1NGM1YS90YWJsZXJhbmdlOmJkYmQ3NWE4NmUzNTQ0Mjc4NDJiMmZkODdlMzU0YzVhXzYtNS0xLTEtMA_7704d536-b05f-4199-9794-f887e371ec54"
      unitRef="usd">53000000</cah:LesseeLeaseLiabilityPaymentsDueYearFive>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
      contextRef="i1a0dd756c14d48d7a436a9f95e4c95c3_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMjEvZnJhZzpkNTEwOTAyZDMwZDc0NDk5YWUzNWE3NTg1ZDkwNDA4Ni90YWJsZTpiZGJkNzVhODZlMzU0NDI3ODQyYjJmZDg3ZTM1NGM1YS90YWJsZXJhbmdlOmJkYmQ3NWE4NmUzNTQ0Mjc4NDJiMmZkODdlMzU0YzVhXzctMS0xLTEtMA_48b13e42-bfb6-43e7-83a9-04e1f794249d"
      unitRef="usd">141000000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueAfterYearFive
      contextRef="i566381a05b1444c1a852e8768ae88ad3_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMjEvZnJhZzpkNTEwOTAyZDMwZDc0NDk5YWUzNWE3NTg1ZDkwNDA4Ni90YWJsZTpiZGJkNzVhODZlMzU0NDI3ODQyYjJmZDg3ZTM1NGM1YS90YWJsZXJhbmdlOmJkYmQ3NWE4NmUzNTQ0Mjc4NDJiMmZkODdlMzU0YzVhXzctMy0xLTEtMA_c6da1cf7-18d3-4dc9-acf0-123dcde3ae0b"
      unitRef="usd">5000000</us-gaap:FinanceLeaseLiabilityPaymentsDueAfterYearFive>
    <cah:LesseeLeaseLiabilityPaymentsDueAfterYearFive
      contextRef="i2e87824102b34590a0208cc7da91b5f5_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMjEvZnJhZzpkNTEwOTAyZDMwZDc0NDk5YWUzNWE3NTg1ZDkwNDA4Ni90YWJsZTpiZGJkNzVhODZlMzU0NDI3ODQyYjJmZDg3ZTM1NGM1YS90YWJsZXJhbmdlOmJkYmQ3NWE4NmUzNTQ0Mjc4NDJiMmZkODdlMzU0YzVhXzctNS0xLTEtMA_b34343ff-ce56-4df0-a805-108924997c18"
      unitRef="usd">146000000</cah:LesseeLeaseLiabilityPaymentsDueAfterYearFive>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue
      contextRef="i1a0dd756c14d48d7a436a9f95e4c95c3_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMjEvZnJhZzpkNTEwOTAyZDMwZDc0NDk5YWUzNWE3NTg1ZDkwNDA4Ni90YWJsZTpiZGJkNzVhODZlMzU0NDI3ODQyYjJmZDg3ZTM1NGM1YS90YWJsZXJhbmdlOmJkYmQ3NWE4NmUzNTQ0Mjc4NDJiMmZkODdlMzU0YzVhXzgtMS0xLTEtMA_3cabb972-be48-427a-8bbe-73aa7f6eabdb"
      unitRef="usd">537000000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue>
    <us-gaap:FinanceLeaseLiabilityPaymentsDue
      contextRef="i566381a05b1444c1a852e8768ae88ad3_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMjEvZnJhZzpkNTEwOTAyZDMwZDc0NDk5YWUzNWE3NTg1ZDkwNDA4Ni90YWJsZTpiZGJkNzVhODZlMzU0NDI3ODQyYjJmZDg3ZTM1NGM1YS90YWJsZXJhbmdlOmJkYmQ3NWE4NmUzNTQ0Mjc4NDJiMmZkODdlMzU0YzVhXzgtMy0xLTEtMA_f4e560f6-66fe-43e6-bf1a-879b149c9cc3"
      unitRef="usd">70000000</us-gaap:FinanceLeaseLiabilityPaymentsDue>
    <cah:TotalLeaseLiabilityPaymentsDue
      contextRef="i2e87824102b34590a0208cc7da91b5f5_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMjEvZnJhZzpkNTEwOTAyZDMwZDc0NDk5YWUzNWE3NTg1ZDkwNDA4Ni90YWJsZTpiZGJkNzVhODZlMzU0NDI3ODQyYjJmZDg3ZTM1NGM1YS90YWJsZXJhbmdlOmJkYmQ3NWE4NmUzNTQ0Mjc4NDJiMmZkODdlMzU0YzVhXzgtNS0xLTEtMA_cae6caeb-5515-4bba-a0e3-302704e8081b"
      unitRef="usd">607000000</cah:TotalLeaseLiabilityPaymentsDue>
    <cah:LesseeOperatingLeaseLiabilityNotYetCommencedAmount
      contextRef="i1a0dd756c14d48d7a436a9f95e4c95c3_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMjEvZnJhZzpkNTEwOTAyZDMwZDc0NDk5YWUzNWE3NTg1ZDkwNDA4Ni90YWJsZTpiZGJkNzVhODZlMzU0NDI3ODQyYjJmZDg3ZTM1NGM1YS90YWJsZXJhbmdlOmJkYmQ3NWE4NmUzNTQ0Mjc4NDJiMmZkODdlMzU0YzVhXzktMS0xLTEtMA_bee2c146-484d-4fc4-b961-bbf9e51d8197"
      unitRef="usd">3000000</cah:LesseeOperatingLeaseLiabilityNotYetCommencedAmount>
    <cah:LesseeFinanceLeaseLiabilityNotYetCommencedAmount
      contextRef="i566381a05b1444c1a852e8768ae88ad3_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMjEvZnJhZzpkNTEwOTAyZDMwZDc0NDk5YWUzNWE3NTg1ZDkwNDA4Ni90YWJsZTpiZGJkNzVhODZlMzU0NDI3ODQyYjJmZDg3ZTM1NGM1YS90YWJsZXJhbmdlOmJkYmQ3NWE4NmUzNTQ0Mjc4NDJiMmZkODdlMzU0YzVhXzktMy0xLTEtMA_655e951a-d12f-4e9d-8073-bc84c86482ba"
      unitRef="usd">0</cah:LesseeFinanceLeaseLiabilityNotYetCommencedAmount>
    <cah:TotalLeaseLiabilityNotYetCommencedAmount
      contextRef="i2e87824102b34590a0208cc7da91b5f5_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMjEvZnJhZzpkNTEwOTAyZDMwZDc0NDk5YWUzNWE3NTg1ZDkwNDA4Ni90YWJsZTpiZGJkNzVhODZlMzU0NDI3ODQyYjJmZDg3ZTM1NGM1YS90YWJsZXJhbmdlOmJkYmQ3NWE4NmUzNTQ0Mjc4NDJiMmZkODdlMzU0YzVhXzktNS0xLTEtMA_88ae3380-81a2-44a5-b2c1-6613f5a37a2b"
      unitRef="usd">3000000</cah:TotalLeaseLiabilityNotYetCommencedAmount>
    <cah:OperatingLeaseImputedInterest
      contextRef="i1a0dd756c14d48d7a436a9f95e4c95c3_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMjEvZnJhZzpkNTEwOTAyZDMwZDc0NDk5YWUzNWE3NTg1ZDkwNDA4Ni90YWJsZTpiZGJkNzVhODZlMzU0NDI3ODQyYjJmZDg3ZTM1NGM1YS90YWJsZXJhbmdlOmJkYmQ3NWE4NmUzNTQ0Mjc4NDJiMmZkODdlMzU0YzVhXzEwLTEtMS0xLTA_b22466e7-188c-41d6-962e-86ed48b3e25b"
      unitRef="usd">55000000</cah:OperatingLeaseImputedInterest>
    <cah:FinanceLeaseImputedInterest
      contextRef="i566381a05b1444c1a852e8768ae88ad3_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMjEvZnJhZzpkNTEwOTAyZDMwZDc0NDk5YWUzNWE3NTg1ZDkwNDA4Ni90YWJsZTpiZGJkNzVhODZlMzU0NDI3ODQyYjJmZDg3ZTM1NGM1YS90YWJsZXJhbmdlOmJkYmQ3NWE4NmUzNTQ0Mjc4NDJiMmZkODdlMzU0YzVhXzEwLTMtMS0xLTA_b237694e-78fe-4b05-8a8b-db748b2cc6dc"
      unitRef="usd">6000000</cah:FinanceLeaseImputedInterest>
    <cah:TotalLeaseLiabilityUndiscountedExcessAmount
      contextRef="i2e87824102b34590a0208cc7da91b5f5_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMjEvZnJhZzpkNTEwOTAyZDMwZDc0NDk5YWUzNWE3NTg1ZDkwNDA4Ni90YWJsZTpiZGJkNzVhODZlMzU0NDI3ODQyYjJmZDg3ZTM1NGM1YS90YWJsZXJhbmdlOmJkYmQ3NWE4NmUzNTQ0Mjc4NDJiMmZkODdlMzU0YzVhXzEwLTUtMS0xLTA_5617a0cf-be74-45b2-b1e2-8a4d1d55cec7"
      unitRef="usd">61000000</cah:TotalLeaseLiabilityUndiscountedExcessAmount>
    <us-gaap:OperatingLeaseLiability
      contextRef="i1a0dd756c14d48d7a436a9f95e4c95c3_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMjEvZnJhZzpkNTEwOTAyZDMwZDc0NDk5YWUzNWE3NTg1ZDkwNDA4Ni90YWJsZTpiZGJkNzVhODZlMzU0NDI3ODQyYjJmZDg3ZTM1NGM1YS90YWJsZXJhbmdlOmJkYmQ3NWE4NmUzNTQ0Mjc4NDJiMmZkODdlMzU0YzVhXzExLTEtMS0xLTA_5078eaba-cc38-418a-adc0-01a98b878a53"
      unitRef="usd">479000000</us-gaap:OperatingLeaseLiability>
    <us-gaap:FinanceLeaseLiability
      contextRef="i566381a05b1444c1a852e8768ae88ad3_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMjEvZnJhZzpkNTEwOTAyZDMwZDc0NDk5YWUzNWE3NTg1ZDkwNDA4Ni90YWJsZTpiZGJkNzVhODZlMzU0NDI3ODQyYjJmZDg3ZTM1NGM1YS90YWJsZXJhbmdlOmJkYmQ3NWE4NmUzNTQ0Mjc4NDJiMmZkODdlMzU0YzVhXzExLTMtMS0xLTA_47655e6a-0f11-4178-9678-7d24cb798e68"
      unitRef="usd">64000000</us-gaap:FinanceLeaseLiability>
    <cah:TotalLeaseLiability
      contextRef="i2e87824102b34590a0208cc7da91b5f5_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMjEvZnJhZzpkNTEwOTAyZDMwZDc0NDk5YWUzNWE3NTg1ZDkwNDA4Ni90YWJsZTpiZGJkNzVhODZlMzU0NDI3ODQyYjJmZDg3ZTM1NGM1YS90YWJsZXJhbmdlOmJkYmQ3NWE4NmUzNTQ0Mjc4NDJiMmZkODdlMzU0YzVhXzExLTUtMS0xLTA_450138f1-7688-4fd9-a349-661bcb598251"
      unitRef="usd">543000000</cah:TotalLeaseLiability>
    <us-gaap:DebtDisclosureTextBlock
      contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMjQvZnJhZzpkMGRmMDA1NjdlMmI0ZWVjOTNmYTVlYWRiNjUyY2YzZS90ZXh0cmVnaW9uOmQwZGYwMDU2N2UyYjRlZWM5M2ZhNWVhZGI2NTJjZjNlXzUxNzI_56d1df23-ef64-418d-a9f2-cbddf2a6f846">&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:13pt;font-weight:700;line-height:120%"&gt;6. Long-Term Obligations and Other Short-Term Borrowings &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes long-term obligations and other short-term borrowings at June 30:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.691%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:57.104%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.023%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.347%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.026%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;(in millions) (1)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2.616% Notes due 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;572&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;834&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3.2% Notes due 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;236&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Floating Rate Notes due 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;281&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;321&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3.2% Notes due 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;564&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;576&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3.079% Notes due 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;794&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;809&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3.5% Notes due 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;410&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;413&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3.75% Notes due 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;524&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;529&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3.41% Notes due 2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;1,216&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,215&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;4.6% Notes due 2043&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;341&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;340&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;4.5% Notes due 2044&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;342&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;342&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;4.9% Notes due 2045&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;441&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;441&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;4.368% Notes due 2047&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;560&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;560&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;7.0%&#160;Debentures due 2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;124&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;124&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Other Obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;67&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;6,236&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;6,775&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Less: current portion of long-term obligations and other short-term borrowings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;871&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;&#160;&#160;Long-term obligations, less current portion&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;5,365&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;6,765&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)      Maturities are presented on a calendar year basis. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Maturities of existing long-term obligations and other short-term borrowings for fiscal 2022 through 2026 and thereafter are as follows: $872 million, $584 million, $808 million, $418 million, $525 million and $3.0 billion.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%"&gt;Long-Term Debt&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;All the notes represent unsecured obligations of Cardinal Health, Inc. and rank equally in right of payment with all of our existing and future unsecured and unsubordinated indebtedness. The 7.0% Debentures represent unsecured obligations of Allegiance Corporation (a wholly-owned subsidiary), which Cardinal Health, Inc. has guaranteed. None of these obligations are subject to a sinking fund and the Allegiance obligations are not redeemable prior to maturity. Interest is paid pursuant to the terms of the obligations. These notes are effectively subordinated to the liabilities of our subsidiaries, including trade payables of $23.7 billion and $21.4 billion at June&#160;30, 2021 and 2020, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In June 2021, we redeemed all outstanding 3.2% Notes due June 2022 for $238&#160;million and $262&#160;million aggregate principle amount of 2.616% Notes due June 2022 at a redemption price equal to 100% of the principal amount and accrued but unpaid interest, plus the make-whole premium applicable to the notes. In connection with these redemptions, we recorded a $13&#160;million loss on early extinguishment of debt. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During fiscal 2021, we also early repurchased $40 million of the Floating Rate Notes due 2022&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;and $2 million of the 2.616% Notes due 2022 with available cash. In connection with the early debt repurchases, we recorded a $1&#160;million&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;loss on early extinguishment of debt.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During fiscal 2020, we redeemed $500 million aggregate principle amount of 4.625% Notes due December 2020 at a redemption price equal to 100% of the principal amount and accrued but unpaid interest, plus the make-whole premium applicable to the notes. In connection with the redemption, we recorded a $7 million loss on early extinguishment of debt. We also early repurchased&#160;$247&#160;million&#160;of the&#160;2.616%&#160;Notes due 2022,&#160;$11&#160;million&#160;of the&#160;3.2% Notes due 2022,&#160;$20&#160;million&#160;of the&#160;Floating Rate Notes due 2022, $104&#160;million&#160;of the&#160;3.41% Notes due 2027,&#160;$6&#160;million&#160;of the&#160;4.6% Notes due 2043,&#160;$5&#160;million&#160;of the&#160;4.9% Notes due 2045, and&#160;$35&#160;million&#160;of the&#160;4.368% Notes due 2047. In connection with the early debt repurchases, we recognized a&#160;$9 million&#160;loss on early extinguishment of debt. We also repaid the full principal of the $450&#160;million 2.4% Notes due 2019 as they became due. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During fiscal 2019, we repurchased $67 million of the 2.616% Notes due 2022, $1 million of the 3.2% Notes due 2022, 8 million of the Floating Rate Notes due 2022, and $24 million of the 3.41% Notes due 2027 for a total of $100 million. The loss on early extinguishment of debt in connection with these early repurchases was immaterial. We also repaid the full principal of the $1.0 billion 1.948% Notes due 2019 as they became due.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The redemptions and repurchases were paid for with available cash and other short-term borrowings.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On August 13, 2021, we announced our intention to early redeem all remaining outstanding 2.616% Notes due June 2022 on September 15, 2021 at an expected redemption price equal to 100% of the principal amount and accrued but unpaid interest, plus the make-whole premium applicable to the notes.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;If we undergo a change of control, as defined in the notes, and if the notes receive specified ratings below investment grade by each of Standard &amp;amp; Poors Ratings Services, Moody&#x2019;s Investors Services and Fitch Ratings, any holder of the notes, excluding the debentures, can require with respect to the notes owned by such holder, or we can offer, to repurchase the notes at 101% of the principal amount plus accrued and unpaid interest.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%"&gt;Other Financing Arrangements&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In addition to cash and equivalents and operating cash flow, other sources of liquidity include a&#160;$2.0 billion&#160;commercial paper program backed by a $2.0 billion&#160;revolving credit facility. We also have a&#160;$1.0 billion&#160;committed receivables sales facility.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In September 2019, we renewed our committed receivables sales facility program through Cardinal Health Funding, LLC (&#x201c;CHF&#x201d;) through September 30, 2022. CHF was organized for&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;the sole purpose of buying receivables and selling undivided interests in those receivables to third-party purchasers. Although consolidated with Cardinal Health, Inc. in accordance with GAAP, CHF is a separate legal entity from Cardinal Health, Inc. and from our subsidiary that sells receivables to CHF. CHF is designed to be a special purpose, bankruptcy-remote entity whose assets are available solely to satisfy the claims of its creditors. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our revolving credit and committed receivables sales facilities require us to maintain a consolidated net leverage ratio of no more than 3.75-to-1. As of June&#160;30, 2021, we were in compliance with this financial covenant.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At June&#160;30, 2021 and 2020, we had no amounts outstanding under the revolving credit facility; however, availability was reduced by outstanding letters of credit of $1 million at both June&#160;30, 2021 and 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Under our committed receivables sales facility program, we had a maximum amount outstanding of $200 million and an immaterial daily amount outstanding during fiscal 2021. We had no amounts outstanding as of June&#160;30, 2021 under the committed receivables sales facility program; however, availability was reduced by outstanding standby letters of credit of $31 million and $29 million at June&#160;30, 2021 and 2020, respectively. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We had no amounts outstanding under the commercial paper program as of June&#160;30, 2021 and 2020. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We also maintain other short-term credit facilities and an unsecured line of credit that allowed for borrowings up to $6 million at both June&#160;30, 2021 and 2020. The $67 million and $35 million balance of other obligations at June&#160;30, 2021 and 2020, respectively, consisted of finance leases and short-term borrowings.&lt;/span&gt;&lt;/div&gt;</us-gaap:DebtDisclosureTextBlock>
    <us-gaap:ScheduleOfDebtTableTextBlock
      contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMjQvZnJhZzpkMGRmMDA1NjdlMmI0ZWVjOTNmYTVlYWRiNjUyY2YzZS90ZXh0cmVnaW9uOmQwZGYwMDU2N2UyYjRlZWM5M2ZhNWVhZGI2NTJjZjNlXzUxNzE_64aded48-285f-45c9-91d9-64741044852a">&lt;div style="margin-bottom:3pt"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes long-term obligations and other short-term borrowings at June 30:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.691%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:57.104%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.023%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.347%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.026%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;(in millions) (1)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2.616% Notes due 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;572&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;834&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3.2% Notes due 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;236&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Floating Rate Notes due 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;281&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;321&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3.2% Notes due 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;564&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;576&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3.079% Notes due 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;794&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;809&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3.5% Notes due 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;410&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;413&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3.75% Notes due 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;524&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;529&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3.41% Notes due 2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;1,216&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,215&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;4.6% Notes due 2043&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;341&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;340&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;4.5% Notes due 2044&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;342&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;342&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;4.9% Notes due 2045&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;441&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;441&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;4.368% Notes due 2047&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;560&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;560&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;7.0%&#160;Debentures due 2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;124&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;124&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Other Obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;67&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;6,236&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;6,775&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Less: current portion of long-term obligations and other short-term borrowings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;871&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;&#160;&#160;Long-term obligations, less current portion&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;5,365&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;6,765&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;(1)      Maturities are presented on a calendar year basis.</us-gaap:ScheduleOfDebtTableTextBlock>
    <us-gaap:NotesPayable
      contextRef="i6040899ecc9f44f893d3f559f74eb30e_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMjQvZnJhZzpkMGRmMDA1NjdlMmI0ZWVjOTNmYTVlYWRiNjUyY2YzZS90YWJsZTo5NTk5NjRhNjdkMDI0YzM0ODMxMmU5ZTE2ODc4ZjcxMC90YWJsZXJhbmdlOjk1OTk2NGE2N2QwMjRjMzQ4MzEyZTllMTY4NzhmNzEwXzMtMS0xLTEtMA_98d730d1-33a6-4820-badf-812eef84e36f"
      unitRef="usd">572000000</us-gaap:NotesPayable>
    <us-gaap:NotesPayable
      contextRef="i1079054a38c64aa1b73f425120be8b95_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMjQvZnJhZzpkMGRmMDA1NjdlMmI0ZWVjOTNmYTVlYWRiNjUyY2YzZS90YWJsZTo5NTk5NjRhNjdkMDI0YzM0ODMxMmU5ZTE2ODc4ZjcxMC90YWJsZXJhbmdlOjk1OTk2NGE2N2QwMjRjMzQ4MzEyZTllMTY4NzhmNzEwXzMtMy0xLTEtMA_1f3dd93d-c800-46a6-b34d-500be298621b"
      unitRef="usd">834000000</us-gaap:NotesPayable>
    <us-gaap:NotesPayable
      contextRef="i4681cfaabaed494eb4cdf968725268ad_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMjQvZnJhZzpkMGRmMDA1NjdlMmI0ZWVjOTNmYTVlYWRiNjUyY2YzZS90YWJsZTo5NTk5NjRhNjdkMDI0YzM0ODMxMmU5ZTE2ODc4ZjcxMC90YWJsZXJhbmdlOjk1OTk2NGE2N2QwMjRjMzQ4MzEyZTllMTY4NzhmNzEwXzQtMS0xLTEtMA_12e21ee5-ec0f-411e-a348-4f90138aeb35"
      unitRef="usd">0</us-gaap:NotesPayable>
    <us-gaap:NotesPayable
      contextRef="idd88c476ee2d4612ba0be20c3b31959f_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMjQvZnJhZzpkMGRmMDA1NjdlMmI0ZWVjOTNmYTVlYWRiNjUyY2YzZS90YWJsZTo5NTk5NjRhNjdkMDI0YzM0ODMxMmU5ZTE2ODc4ZjcxMC90YWJsZXJhbmdlOjk1OTk2NGE2N2QwMjRjMzQ4MzEyZTllMTY4NzhmNzEwXzQtMy0xLTEtMA_8e178a2a-3450-442f-903c-e532046b7598"
      unitRef="usd">236000000</us-gaap:NotesPayable>
    <us-gaap:NotesPayable
      contextRef="id7a8329ac0d44ba88b3081e963420a51_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMjQvZnJhZzpkMGRmMDA1NjdlMmI0ZWVjOTNmYTVlYWRiNjUyY2YzZS90YWJsZTo5NTk5NjRhNjdkMDI0YzM0ODMxMmU5ZTE2ODc4ZjcxMC90YWJsZXJhbmdlOjk1OTk2NGE2N2QwMjRjMzQ4MzEyZTllMTY4NzhmNzEwXzUtMS0xLTEtMA_4fe6d7ff-805e-4e24-a445-1032d14487e3"
      unitRef="usd">281000000</us-gaap:NotesPayable>
    <us-gaap:NotesPayable
      contextRef="i6108c3790b344ba09f455a14ad158d62_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMjQvZnJhZzpkMGRmMDA1NjdlMmI0ZWVjOTNmYTVlYWRiNjUyY2YzZS90YWJsZTo5NTk5NjRhNjdkMDI0YzM0ODMxMmU5ZTE2ODc4ZjcxMC90YWJsZXJhbmdlOjk1OTk2NGE2N2QwMjRjMzQ4MzEyZTllMTY4NzhmNzEwXzUtMy0xLTEtMA_05c60622-240c-4b5c-bb7f-dbbe8ff440a9"
      unitRef="usd">321000000</us-gaap:NotesPayable>
    <us-gaap:NotesPayable
      contextRef="i52aed3fcb7884bf0a519d03f6726bab7_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMjQvZnJhZzpkMGRmMDA1NjdlMmI0ZWVjOTNmYTVlYWRiNjUyY2YzZS90YWJsZTo5NTk5NjRhNjdkMDI0YzM0ODMxMmU5ZTE2ODc4ZjcxMC90YWJsZXJhbmdlOjk1OTk2NGE2N2QwMjRjMzQ4MzEyZTllMTY4NzhmNzEwXzYtMS0xLTEtMA_39b36d39-7e49-4717-8fe3-fc660a2a8eea"
      unitRef="usd">564000000</us-gaap:NotesPayable>
    <us-gaap:NotesPayable
      contextRef="i39f995524bc54afd96d0837c392791d0_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMjQvZnJhZzpkMGRmMDA1NjdlMmI0ZWVjOTNmYTVlYWRiNjUyY2YzZS90YWJsZTo5NTk5NjRhNjdkMDI0YzM0ODMxMmU5ZTE2ODc4ZjcxMC90YWJsZXJhbmdlOjk1OTk2NGE2N2QwMjRjMzQ4MzEyZTllMTY4NzhmNzEwXzYtMy0xLTEtMA_77f3bd6a-81aa-40c2-8eeb-6f07ed1eaca2"
      unitRef="usd">576000000</us-gaap:NotesPayable>
    <us-gaap:NotesPayable
      contextRef="i3079877c28ab4fc7acfe2cebacdaf0a2_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMjQvZnJhZzpkMGRmMDA1NjdlMmI0ZWVjOTNmYTVlYWRiNjUyY2YzZS90YWJsZTo5NTk5NjRhNjdkMDI0YzM0ODMxMmU5ZTE2ODc4ZjcxMC90YWJsZXJhbmdlOjk1OTk2NGE2N2QwMjRjMzQ4MzEyZTllMTY4NzhmNzEwXzctMS0xLTEtMA_40d1cf6f-4e41-4756-98b3-7b964121425b"
      unitRef="usd">794000000</us-gaap:NotesPayable>
    <us-gaap:NotesPayable
      contextRef="iea859ed78b0341729f419cd2af57c361_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMjQvZnJhZzpkMGRmMDA1NjdlMmI0ZWVjOTNmYTVlYWRiNjUyY2YzZS90YWJsZTo5NTk5NjRhNjdkMDI0YzM0ODMxMmU5ZTE2ODc4ZjcxMC90YWJsZXJhbmdlOjk1OTk2NGE2N2QwMjRjMzQ4MzEyZTllMTY4NzhmNzEwXzctMy0xLTEtMA_f4658982-81b7-42d4-a7fd-e404cc13fb5f"
      unitRef="usd">809000000</us-gaap:NotesPayable>
    <us-gaap:NotesPayable
      contextRef="id9068073bcf44ebfa32fbd94e54fa0bb_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMjQvZnJhZzpkMGRmMDA1NjdlMmI0ZWVjOTNmYTVlYWRiNjUyY2YzZS90YWJsZTo5NTk5NjRhNjdkMDI0YzM0ODMxMmU5ZTE2ODc4ZjcxMC90YWJsZXJhbmdlOjk1OTk2NGE2N2QwMjRjMzQ4MzEyZTllMTY4NzhmNzEwXzgtMS0xLTEtMA_f3506010-02fa-4b8a-9fa0-f6ab4950693e"
      unitRef="usd">410000000</us-gaap:NotesPayable>
    <us-gaap:NotesPayable
      contextRef="i19386d9a9665443da76f29f541da851b_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMjQvZnJhZzpkMGRmMDA1NjdlMmI0ZWVjOTNmYTVlYWRiNjUyY2YzZS90YWJsZTo5NTk5NjRhNjdkMDI0YzM0ODMxMmU5ZTE2ODc4ZjcxMC90YWJsZXJhbmdlOjk1OTk2NGE2N2QwMjRjMzQ4MzEyZTllMTY4NzhmNzEwXzgtMy0xLTEtMA_a1f8e906-dc9a-4cd7-982a-08160c3102f3"
      unitRef="usd">413000000</us-gaap:NotesPayable>
    <us-gaap:NotesPayable
      contextRef="ia1f00593041245b2884a1d027a7a5789_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMjQvZnJhZzpkMGRmMDA1NjdlMmI0ZWVjOTNmYTVlYWRiNjUyY2YzZS90YWJsZTo5NTk5NjRhNjdkMDI0YzM0ODMxMmU5ZTE2ODc4ZjcxMC90YWJsZXJhbmdlOjk1OTk2NGE2N2QwMjRjMzQ4MzEyZTllMTY4NzhmNzEwXzktMS0xLTEtMA_4d813aa9-9611-4980-8ea4-236cc3b29f75"
      unitRef="usd">524000000</us-gaap:NotesPayable>
    <us-gaap:NotesPayable
      contextRef="i1a8da22c2d104c07b8e124a12e07a40a_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMjQvZnJhZzpkMGRmMDA1NjdlMmI0ZWVjOTNmYTVlYWRiNjUyY2YzZS90YWJsZTo5NTk5NjRhNjdkMDI0YzM0ODMxMmU5ZTE2ODc4ZjcxMC90YWJsZXJhbmdlOjk1OTk2NGE2N2QwMjRjMzQ4MzEyZTllMTY4NzhmNzEwXzktMy0xLTEtMA_26709b17-1d80-453a-9734-c433762bb70d"
      unitRef="usd">529000000</us-gaap:NotesPayable>
    <us-gaap:NotesPayable
      contextRef="i7f818bbd6041415ab92166ff89fb7e19_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMjQvZnJhZzpkMGRmMDA1NjdlMmI0ZWVjOTNmYTVlYWRiNjUyY2YzZS90YWJsZTo5NTk5NjRhNjdkMDI0YzM0ODMxMmU5ZTE2ODc4ZjcxMC90YWJsZXJhbmdlOjk1OTk2NGE2N2QwMjRjMzQ4MzEyZTllMTY4NzhmNzEwXzEwLTEtMS0xLTA_8b1b6a7c-dd16-4eb7-89ef-d55d2a8140f1"
      unitRef="usd">1216000000</us-gaap:NotesPayable>
    <us-gaap:NotesPayable
      contextRef="i9f29332f948b439e93e2d67c75208f61_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMjQvZnJhZzpkMGRmMDA1NjdlMmI0ZWVjOTNmYTVlYWRiNjUyY2YzZS90YWJsZTo5NTk5NjRhNjdkMDI0YzM0ODMxMmU5ZTE2ODc4ZjcxMC90YWJsZXJhbmdlOjk1OTk2NGE2N2QwMjRjMzQ4MzEyZTllMTY4NzhmNzEwXzEwLTMtMS0xLTA_601f820f-c136-4368-bf16-776a782d2eee"
      unitRef="usd">1215000000</us-gaap:NotesPayable>
    <us-gaap:NotesPayable
      contextRef="i90cac66be512421fbc3704be2d9730c5_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMjQvZnJhZzpkMGRmMDA1NjdlMmI0ZWVjOTNmYTVlYWRiNjUyY2YzZS90YWJsZTo5NTk5NjRhNjdkMDI0YzM0ODMxMmU5ZTE2ODc4ZjcxMC90YWJsZXJhbmdlOjk1OTk2NGE2N2QwMjRjMzQ4MzEyZTllMTY4NzhmNzEwXzExLTEtMS0xLTA_5966de21-6801-4a1f-b0b6-36610426bb29"
      unitRef="usd">341000000</us-gaap:NotesPayable>
    <us-gaap:NotesPayable
      contextRef="id14e22824b7b4593bfd07bc8ab4bb51a_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMjQvZnJhZzpkMGRmMDA1NjdlMmI0ZWVjOTNmYTVlYWRiNjUyY2YzZS90YWJsZTo5NTk5NjRhNjdkMDI0YzM0ODMxMmU5ZTE2ODc4ZjcxMC90YWJsZXJhbmdlOjk1OTk2NGE2N2QwMjRjMzQ4MzEyZTllMTY4NzhmNzEwXzExLTMtMS0xLTA_a39d82db-b3a1-42fa-8772-a8eafdee4c5d"
      unitRef="usd">340000000</us-gaap:NotesPayable>
    <us-gaap:NotesPayable
      contextRef="i9e575fac51a64f15bbc8ee5ae661cbbc_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMjQvZnJhZzpkMGRmMDA1NjdlMmI0ZWVjOTNmYTVlYWRiNjUyY2YzZS90YWJsZTo5NTk5NjRhNjdkMDI0YzM0ODMxMmU5ZTE2ODc4ZjcxMC90YWJsZXJhbmdlOjk1OTk2NGE2N2QwMjRjMzQ4MzEyZTllMTY4NzhmNzEwXzEyLTEtMS0xLTA_7b6589f3-8d8e-45de-9f6a-cc984a1ba0d2"
      unitRef="usd">342000000</us-gaap:NotesPayable>
    <us-gaap:NotesPayable
      contextRef="i3a3d93f3182045b2979e580513d975cd_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMjQvZnJhZzpkMGRmMDA1NjdlMmI0ZWVjOTNmYTVlYWRiNjUyY2YzZS90YWJsZTo5NTk5NjRhNjdkMDI0YzM0ODMxMmU5ZTE2ODc4ZjcxMC90YWJsZXJhbmdlOjk1OTk2NGE2N2QwMjRjMzQ4MzEyZTllMTY4NzhmNzEwXzEyLTMtMS0xLTA_e47137c7-a3c8-459d-a036-90f377159b4c"
      unitRef="usd">342000000</us-gaap:NotesPayable>
    <us-gaap:NotesPayable
      contextRef="ife3234ddac5f446990273bd3ceb3091d_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMjQvZnJhZzpkMGRmMDA1NjdlMmI0ZWVjOTNmYTVlYWRiNjUyY2YzZS90YWJsZTo5NTk5NjRhNjdkMDI0YzM0ODMxMmU5ZTE2ODc4ZjcxMC90YWJsZXJhbmdlOjk1OTk2NGE2N2QwMjRjMzQ4MzEyZTllMTY4NzhmNzEwXzEzLTEtMS0xLTA_5ce43d0e-ee2c-4d39-a725-81c6a20307c8"
      unitRef="usd">441000000</us-gaap:NotesPayable>
    <us-gaap:NotesPayable
      contextRef="i5c8388e50dd844709e91931b05259f87_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMjQvZnJhZzpkMGRmMDA1NjdlMmI0ZWVjOTNmYTVlYWRiNjUyY2YzZS90YWJsZTo5NTk5NjRhNjdkMDI0YzM0ODMxMmU5ZTE2ODc4ZjcxMC90YWJsZXJhbmdlOjk1OTk2NGE2N2QwMjRjMzQ4MzEyZTllMTY4NzhmNzEwXzEzLTMtMS0xLTA_76977563-4d9b-4791-a4ee-cb9eb0e0d272"
      unitRef="usd">441000000</us-gaap:NotesPayable>
    <us-gaap:NotesPayable
      contextRef="i6c1b2f1400e147e8a50fddbaf3a101ab_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMjQvZnJhZzpkMGRmMDA1NjdlMmI0ZWVjOTNmYTVlYWRiNjUyY2YzZS90YWJsZTo5NTk5NjRhNjdkMDI0YzM0ODMxMmU5ZTE2ODc4ZjcxMC90YWJsZXJhbmdlOjk1OTk2NGE2N2QwMjRjMzQ4MzEyZTllMTY4NzhmNzEwXzE0LTEtMS0xLTA_39ec0abb-104d-407d-911e-4430d425e2d4"
      unitRef="usd">560000000</us-gaap:NotesPayable>
    <us-gaap:NotesPayable
      contextRef="i12b2bfab3db94c15be13cf683c78c053_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMjQvZnJhZzpkMGRmMDA1NjdlMmI0ZWVjOTNmYTVlYWRiNjUyY2YzZS90YWJsZTo5NTk5NjRhNjdkMDI0YzM0ODMxMmU5ZTE2ODc4ZjcxMC90YWJsZXJhbmdlOjk1OTk2NGE2N2QwMjRjMzQ4MzEyZTllMTY4NzhmNzEwXzE0LTMtMS0xLTA_65cc6f69-68b7-4682-8cc1-4851d15ca3d6"
      unitRef="usd">560000000</us-gaap:NotesPayable>
    <us-gaap:NotesPayable
      contextRef="ie0a9e0fdeffa40c9b581b00676cf4639_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMjQvZnJhZzpkMGRmMDA1NjdlMmI0ZWVjOTNmYTVlYWRiNjUyY2YzZS90YWJsZTo5NTk5NjRhNjdkMDI0YzM0ODMxMmU5ZTE2ODc4ZjcxMC90YWJsZXJhbmdlOjk1OTk2NGE2N2QwMjRjMzQ4MzEyZTllMTY4NzhmNzEwXzE1LTEtMS0xLTA_b6d5e9f0-8b39-42dc-8d25-6fce19727c1e"
      unitRef="usd">124000000</us-gaap:NotesPayable>
    <us-gaap:NotesPayable
      contextRef="i89ff9fc63c07435d9b32595a42af3796_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMjQvZnJhZzpkMGRmMDA1NjdlMmI0ZWVjOTNmYTVlYWRiNjUyY2YzZS90YWJsZTo5NTk5NjRhNjdkMDI0YzM0ODMxMmU5ZTE2ODc4ZjcxMC90YWJsZXJhbmdlOjk1OTk2NGE2N2QwMjRjMzQ4MzEyZTllMTY4NzhmNzEwXzE1LTMtMS0xLTA_31d616ac-5d98-43d8-a2a1-2f9065555100"
      unitRef="usd">124000000</us-gaap:NotesPayable>
    <us-gaap:OtherBorrowings
      contextRef="i2e87824102b34590a0208cc7da91b5f5_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMjQvZnJhZzpkMGRmMDA1NjdlMmI0ZWVjOTNmYTVlYWRiNjUyY2YzZS90YWJsZTo5NTk5NjRhNjdkMDI0YzM0ODMxMmU5ZTE2ODc4ZjcxMC90YWJsZXJhbmdlOjk1OTk2NGE2N2QwMjRjMzQ4MzEyZTllMTY4NzhmNzEwXzE2LTEtMS0xLTA_8f6fc2f8-e7ac-4e7b-8702-d84d9088c767"
      unitRef="usd">67000000</us-gaap:OtherBorrowings>
    <us-gaap:OtherBorrowings
      contextRef="i299cea70f47b4fbe96772aaa8cc00b79_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMjQvZnJhZzpkMGRmMDA1NjdlMmI0ZWVjOTNmYTVlYWRiNjUyY2YzZS90YWJsZTo5NTk5NjRhNjdkMDI0YzM0ODMxMmU5ZTE2ODc4ZjcxMC90YWJsZXJhbmdlOjk1OTk2NGE2N2QwMjRjMzQ4MzEyZTllMTY4NzhmNzEwXzE2LTMtMS0xLTA_1521b0bb-ce0f-4af0-a5ab-8db70dd52412"
      unitRef="usd">35000000</us-gaap:OtherBorrowings>
    <us-gaap:DebtAndCapitalLeaseObligations
      contextRef="i2e87824102b34590a0208cc7da91b5f5_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMjQvZnJhZzpkMGRmMDA1NjdlMmI0ZWVjOTNmYTVlYWRiNjUyY2YzZS90YWJsZTo5NTk5NjRhNjdkMDI0YzM0ODMxMmU5ZTE2ODc4ZjcxMC90YWJsZXJhbmdlOjk1OTk2NGE2N2QwMjRjMzQ4MzEyZTllMTY4NzhmNzEwXzE3LTEtMS0xLTA_1e151989-4337-40de-b477-8794bc06d432"
      unitRef="usd">6236000000</us-gaap:DebtAndCapitalLeaseObligations>
    <us-gaap:DebtAndCapitalLeaseObligations
      contextRef="i299cea70f47b4fbe96772aaa8cc00b79_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMjQvZnJhZzpkMGRmMDA1NjdlMmI0ZWVjOTNmYTVlYWRiNjUyY2YzZS90YWJsZTo5NTk5NjRhNjdkMDI0YzM0ODMxMmU5ZTE2ODc4ZjcxMC90YWJsZXJhbmdlOjk1OTk2NGE2N2QwMjRjMzQ4MzEyZTllMTY4NzhmNzEwXzE3LTMtMS0xLTA_a7e9f413-a325-4084-a5e3-a4424c47f56a"
      unitRef="usd">6775000000</us-gaap:DebtAndCapitalLeaseObligations>
    <us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent
      contextRef="i2e87824102b34590a0208cc7da91b5f5_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMjQvZnJhZzpkMGRmMDA1NjdlMmI0ZWVjOTNmYTVlYWRiNjUyY2YzZS90YWJsZTo5NTk5NjRhNjdkMDI0YzM0ODMxMmU5ZTE2ODc4ZjcxMC90YWJsZXJhbmdlOjk1OTk2NGE2N2QwMjRjMzQ4MzEyZTllMTY4NzhmNzEwXzE4LTEtMS0xLTA_1e7f0d19-514b-482e-b932-470915a386dc"
      unitRef="usd">871000000</us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent>
    <us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent
      contextRef="i299cea70f47b4fbe96772aaa8cc00b79_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMjQvZnJhZzpkMGRmMDA1NjdlMmI0ZWVjOTNmYTVlYWRiNjUyY2YzZS90YWJsZTo5NTk5NjRhNjdkMDI0YzM0ODMxMmU5ZTE2ODc4ZjcxMC90YWJsZXJhbmdlOjk1OTk2NGE2N2QwMjRjMzQ4MzEyZTllMTY4NzhmNzEwXzE4LTMtMS0xLTA_f95fe53f-ce2d-43ef-90b0-56553ba4caff"
      unitRef="usd">10000000</us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent>
    <us-gaap:LongTermDebtAndCapitalLeaseObligations
      contextRef="i2e87824102b34590a0208cc7da91b5f5_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMjQvZnJhZzpkMGRmMDA1NjdlMmI0ZWVjOTNmYTVlYWRiNjUyY2YzZS90YWJsZTo5NTk5NjRhNjdkMDI0YzM0ODMxMmU5ZTE2ODc4ZjcxMC90YWJsZXJhbmdlOjk1OTk2NGE2N2QwMjRjMzQ4MzEyZTllMTY4NzhmNzEwXzE5LTEtMS0xLTA_db73a7d4-45d2-4dc3-a6e6-6b40c7da2114"
      unitRef="usd">5365000000</us-gaap:LongTermDebtAndCapitalLeaseObligations>
    <us-gaap:LongTermDebtAndCapitalLeaseObligations
      contextRef="i299cea70f47b4fbe96772aaa8cc00b79_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMjQvZnJhZzpkMGRmMDA1NjdlMmI0ZWVjOTNmYTVlYWRiNjUyY2YzZS90YWJsZTo5NTk5NjRhNjdkMDI0YzM0ODMxMmU5ZTE2ODc4ZjcxMC90YWJsZXJhbmdlOjk1OTk2NGE2N2QwMjRjMzQ4MzEyZTllMTY4NzhmNzEwXzE5LTMtMS0xLTgxNjA_25ce7731-652f-4d93-be10-c7ae8bd461de"
      unitRef="usd">6765000000</us-gaap:LongTermDebtAndCapitalLeaseObligations>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
      contextRef="i2e87824102b34590a0208cc7da91b5f5_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMjQvZnJhZzpkMGRmMDA1NjdlMmI0ZWVjOTNmYTVlYWRiNjUyY2YzZS90ZXh0cmVnaW9uOmQwZGYwMDU2N2UyYjRlZWM5M2ZhNWVhZGI2NTJjZjNlXzMwMg_618abbc8-42b8-4a38-9724-45875464bc3e"
      unitRef="usd">872000000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
      contextRef="i2e87824102b34590a0208cc7da91b5f5_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMjQvZnJhZzpkMGRmMDA1NjdlMmI0ZWVjOTNmYTVlYWRiNjUyY2YzZS90ZXh0cmVnaW9uOmQwZGYwMDU2N2UyYjRlZWM5M2ZhNWVhZGI2NTJjZjNlXzMwNg_e0aee49a-2a57-4cfc-b9e0-98093f29d0c9"
      unitRef="usd">584000000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
      contextRef="i2e87824102b34590a0208cc7da91b5f5_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMjQvZnJhZzpkMGRmMDA1NjdlMmI0ZWVjOTNmYTVlYWRiNjUyY2YzZS90ZXh0cmVnaW9uOmQwZGYwMDU2N2UyYjRlZWM5M2ZhNWVhZGI2NTJjZjNlXzMxMA_ef3344cc-dcf1-45da-980c-6b0c863728a7"
      unitRef="usd">808000000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
      contextRef="i2e87824102b34590a0208cc7da91b5f5_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMjQvZnJhZzpkMGRmMDA1NjdlMmI0ZWVjOTNmYTVlYWRiNjUyY2YzZS90ZXh0cmVnaW9uOmQwZGYwMDU2N2UyYjRlZWM5M2ZhNWVhZGI2NTJjZjNlXzMxNA_b2b9bbf8-7ef7-448a-b73e-ce718143bf00"
      unitRef="usd">418000000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive
      contextRef="i2e87824102b34590a0208cc7da91b5f5_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMjQvZnJhZzpkMGRmMDA1NjdlMmI0ZWVjOTNmYTVlYWRiNjUyY2YzZS90ZXh0cmVnaW9uOmQwZGYwMDU2N2UyYjRlZWM5M2ZhNWVhZGI2NTJjZjNlXzMxOA_14cf237b-8580-4119-90b3-6f5eddf27bb5"
      unitRef="usd">525000000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive
      contextRef="i2e87824102b34590a0208cc7da91b5f5_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMjQvZnJhZzpkMGRmMDA1NjdlMmI0ZWVjOTNmYTVlYWRiNjUyY2YzZS90ZXh0cmVnaW9uOmQwZGYwMDU2N2UyYjRlZWM5M2ZhNWVhZGI2NTJjZjNlXzMyNQ_8748d49e-3801-4e38-b5d5-15c9cb1848dd"
      unitRef="usd">3000000000.0</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ia5893ebe5da345e6a62bdc4932db4f7d_I20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMjQvZnJhZzpkMGRmMDA1NjdlMmI0ZWVjOTNmYTVlYWRiNjUyY2YzZS90ZXh0cmVnaW9uOmQwZGYwMDU2N2UyYjRlZWM5M2ZhNWVhZGI2NTJjZjNlXzUzNQ_3a2beb69-dfeb-43f4-932d-4ed1029f493a"
      unitRef="number">0.070</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:AccountsPayableCurrentAndNoncurrent
      contextRef="i2e87824102b34590a0208cc7da91b5f5_I20210630"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMjQvZnJhZzpkMGRmMDA1NjdlMmI0ZWVjOTNmYTVlYWRiNjUyY2YzZS90ZXh0cmVnaW9uOmQwZGYwMDU2N2UyYjRlZWM5M2ZhNWVhZGI2NTJjZjNlXzI3NDg3NzkwNzcwNTg_7f6c3077-a117-4a1e-8026-c30f88767951"
      unitRef="usd">23700000000</us-gaap:AccountsPayableCurrentAndNoncurrent>
    <us-gaap:AccountsPayableCurrentAndNoncurrent
      contextRef="i299cea70f47b4fbe96772aaa8cc00b79_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMjQvZnJhZzpkMGRmMDA1NjdlMmI0ZWVjOTNmYTVlYWRiNjUyY2YzZS90ZXh0cmVnaW9uOmQwZGYwMDU2N2UyYjRlZWM5M2ZhNWVhZGI2NTJjZjNlXzI3NDg3NzkwNzcwNjg_f1ae863e-b41c-45e7-a77f-bc00f865cd6d"
      unitRef="usd">21400000000</us-gaap:AccountsPayableCurrentAndNoncurrent>
    <cah:NotesPayableRepurchased
      contextRef="i48e47b1be977446da19d44b2c23cb1f4_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMjQvZnJhZzpkMGRmMDA1NjdlMmI0ZWVjOTNmYTVlYWRiNjUyY2YzZS90ZXh0cmVnaW9uOmQwZGYwMDU2N2UyYjRlZWM5M2ZhNWVhZGI2NTJjZjNlXzEyMDk0NjI3OTEzMDY2_4a704007-8006-4f6e-b401-7b81e8ae79a5"
      unitRef="usd">238000000</cah:NotesPayableRepurchased>
    <cah:NotesPayableRepurchased
      contextRef="i464045c4aa5e46c28d8ccea38aea7f82_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMjQvZnJhZzpkMGRmMDA1NjdlMmI0ZWVjOTNmYTVlYWRiNjUyY2YzZS90ZXh0cmVnaW9uOmQwZGYwMDU2N2UyYjRlZWM5M2ZhNWVhZGI2NTJjZjNlXzQ5NDc4MDIzMzA3NjA_7d4a13de-81bb-4e91-8179-a6d8a052c642"
      unitRef="usd">262000000</cah:NotesPayableRepurchased>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="ib3a5af086f334f83b59a840d35a3a24d_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMjQvZnJhZzpkMGRmMDA1NjdlMmI0ZWVjOTNmYTVlYWRiNjUyY2YzZS90ZXh0cmVnaW9uOmQwZGYwMDU2N2UyYjRlZWM5M2ZhNWVhZGI2NTJjZjNlXzQ5NDc4MDIzMzE5NzA_8f13fc13-ebb7-4bcf-8c86-071b2626463a"
      unitRef="usd">13000000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <cah:NotesPayableRepurchased
      contextRef="i17d91fe6344242d2bf1252b509c16031_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMjQvZnJhZzpkMGRmMDA1NjdlMmI0ZWVjOTNmYTVlYWRiNjUyY2YzZS90ZXh0cmVnaW9uOmQwZGYwMDU2N2UyYjRlZWM5M2ZhNWVhZGI2NTJjZjNlXzQ5NDc4MDIzMzExMjk_bf801710-2bda-4f47-a75e-eb706840ee2f"
      unitRef="usd">40000000</cah:NotesPayableRepurchased>
    <cah:NotesPayableRepurchased
      contextRef="i7837defbe13947a6aa80a30d88599754_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMjQvZnJhZzpkMGRmMDA1NjdlMmI0ZWVjOTNmYTVlYWRiNjUyY2YzZS90ZXh0cmVnaW9uOmQwZGYwMDU2N2UyYjRlZWM5M2ZhNWVhZGI2NTJjZjNlXzQ5NDc4MDIzMzI0Njg_9d8ab84a-dd9e-4ba8-a6ad-65894eb5c1d7"
      unitRef="usd">2000000</cah:NotesPayableRepurchased>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="ie2038f77bf814473a8b5a3994d58411e_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMjQvZnJhZzpkMGRmMDA1NjdlMmI0ZWVjOTNmYTVlYWRiNjUyY2YzZS90ZXh0cmVnaW9uOmQwZGYwMDU2N2UyYjRlZWM5M2ZhNWVhZGI2NTJjZjNlXzQ5NDc4MDIzMzE3NDk_91e1777d-58eb-42a2-a2a5-26166e8c08ac"
      unitRef="usd">1000000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <cah:NotesPayableRepurchased
      contextRef="id79807de4e034b8ab663df3b706eba8a_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMjQvZnJhZzpkMGRmMDA1NjdlMmI0ZWVjOTNmYTVlYWRiNjUyY2YzZS90ZXh0cmVnaW9uOmQwZGYwMDU2N2UyYjRlZWM5M2ZhNWVhZGI2NTJjZjNlXzEwMDM_59b8c578-c89f-4b36-8e46-574a41000818"
      unitRef="usd">500000000</cah:NotesPayableRepurchased>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="id79807de4e034b8ab663df3b706eba8a_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMjQvZnJhZzpkMGRmMDA1NjdlMmI0ZWVjOTNmYTVlYWRiNjUyY2YzZS90ZXh0cmVnaW9uOmQwZGYwMDU2N2UyYjRlZWM5M2ZhNWVhZGI2NTJjZjNlXzEyNjI_0e31c00e-a4b2-4822-aecd-e21c00797d36"
      unitRef="usd">7000000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <cah:NotesPayableRepurchased
      contextRef="i1f2e8fb9ffc746439d8749702977bc40_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMjQvZnJhZzpkMGRmMDA1NjdlMmI0ZWVjOTNmYTVlYWRiNjUyY2YzZS90ZXh0cmVnaW9uOmQwZGYwMDU2N2UyYjRlZWM5M2ZhNWVhZGI2NTJjZjNlXzQ5NDc4MDIzMzEyOTI_502488df-2eb5-45d4-a677-daebf4f3567a"
      unitRef="usd">247000000</cah:NotesPayableRepurchased>
    <cah:NotesPayableRepurchased
      contextRef="i97442363603544a4af2ceec2ab7ca6b2_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMjQvZnJhZzpkMGRmMDA1NjdlMmI0ZWVjOTNmYTVlYWRiNjUyY2YzZS90ZXh0cmVnaW9uOmQwZGYwMDU2N2UyYjRlZWM5M2ZhNWVhZGI2NTJjZjNlXzQ5NDc4MDIzMzEzMDA_08ab1beb-c5c0-45c8-814b-7fe08b628bfa"
      unitRef="usd">11000000</cah:NotesPayableRepurchased>
    <cah:NotesPayableRepurchased
      contextRef="i4638eb18574e4673aa4ca0d635ff8fed_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMjQvZnJhZzpkMGRmMDA1NjdlMmI0ZWVjOTNmYTVlYWRiNjUyY2YzZS90ZXh0cmVnaW9uOmQwZGYwMDU2N2UyYjRlZWM5M2ZhNWVhZGI2NTJjZjNlXzQ5NDc4MDIzMzEzMDc_4e786a81-9e3c-4f69-9a6b-53f3619df879"
      unitRef="usd">20000000</cah:NotesPayableRepurchased>
    <cah:NotesPayableRepurchased
      contextRef="i230f0206f083410f87c775c9c1709681_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMjQvZnJhZzpkMGRmMDA1NjdlMmI0ZWVjOTNmYTVlYWRiNjUyY2YzZS90ZXh0cmVnaW9uOmQwZGYwMDU2N2UyYjRlZWM5M2ZhNWVhZGI2NTJjZjNlXzQ5NDc4MDIzMzEzMTY_e954c12b-8750-45b0-8401-1456d84ffb0f"
      unitRef="usd">104000000</cah:NotesPayableRepurchased>
    <cah:NotesPayableRepurchased
      contextRef="id913564d8b3443a8af2a95fc5de03be7_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMjQvZnJhZzpkMGRmMDA1NjdlMmI0ZWVjOTNmYTVlYWRiNjUyY2YzZS90ZXh0cmVnaW9uOmQwZGYwMDU2N2UyYjRlZWM5M2ZhNWVhZGI2NTJjZjNlXzQ5NDc4MDIzMzEzMjA_692d2266-9485-473e-82e0-9e9bcebff386"
      unitRef="usd">6000000</cah:NotesPayableRepurchased>
    <cah:NotesPayableRepurchased
      contextRef="ibe4534f68d8a40109be5a39a86e86f4f_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMjQvZnJhZzpkMGRmMDA1NjdlMmI0ZWVjOTNmYTVlYWRiNjUyY2YzZS90ZXh0cmVnaW9uOmQwZGYwMDU2N2UyYjRlZWM5M2ZhNWVhZGI2NTJjZjNlXzQ5NDc4MDIzMzEzMjQ_326a82ee-2280-4cac-87cd-ee6bea49217f"
      unitRef="usd">5000000</cah:NotesPayableRepurchased>
    <cah:NotesPayableRepurchased
      contextRef="iab9dfb1f8e404e5d8f9dbf5632e6590f_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMjQvZnJhZzpkMGRmMDA1NjdlMmI0ZWVjOTNmYTVlYWRiNjUyY2YzZS90ZXh0cmVnaW9uOmQwZGYwMDU2N2UyYjRlZWM5M2ZhNWVhZGI2NTJjZjNlXzQ5NDc4MDIzMzEzMzc_557ece6b-57b2-440b-8b98-24dc3ed55844"
      unitRef="usd">35000000</cah:NotesPayableRepurchased>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="ifd0a92fc87ae4632bce31919cea5ac88_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMjQvZnJhZzpkMGRmMDA1NjdlMmI0ZWVjOTNmYTVlYWRiNjUyY2YzZS90ZXh0cmVnaW9uOmQwZGYwMDU2N2UyYjRlZWM5M2ZhNWVhZGI2NTJjZjNlXzE2NDk_b3891642-b132-472a-9e45-fd9ac5c0ff96"
      unitRef="usd">9000000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <cah:NotesPayableRepurchased
      contextRef="i569c9ebb1c9744c6a46c4bedf478f497_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMjQvZnJhZzpkMGRmMDA1NjdlMmI0ZWVjOTNmYTVlYWRiNjUyY2YzZS90ZXh0cmVnaW9uOmQwZGYwMDU2N2UyYjRlZWM5M2ZhNWVhZGI2NTJjZjNlXzQ5NDc4MDIzMzE0ODE_d97e2bc2-ae70-4e50-89fe-8c72907b30e0"
      unitRef="usd">450000000</cah:NotesPayableRepurchased>
    <cah:NotesPayableRepurchased
      contextRef="i9514a111b1dd465cb9bd660db2bf2bda_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMjQvZnJhZzpkMGRmMDA1NjdlMmI0ZWVjOTNmYTVlYWRiNjUyY2YzZS90ZXh0cmVnaW9uOmQwZGYwMDU2N2UyYjRlZWM5M2ZhNWVhZGI2NTJjZjNlXzE5MTU_32820777-866f-478b-b61a-721bb41a3fc0"
      unitRef="usd">67000000</cah:NotesPayableRepurchased>
    <cah:NotesPayableRepurchased
      contextRef="i211ab1e401334bc28102d404a589f244_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMjQvZnJhZzpkMGRmMDA1NjdlMmI0ZWVjOTNmYTVlYWRiNjUyY2YzZS90ZXh0cmVnaW9uOmQwZGYwMDU2N2UyYjRlZWM5M2ZhNWVhZGI2NTJjZjNlXzE5NDg_053017cf-46b1-4491-9e8d-0a6b584e203b"
      unitRef="usd">1000000</cah:NotesPayableRepurchased>
    <cah:NotesPayableRepurchased
      contextRef="i6c59631d68f748078379fec096820b35_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMjQvZnJhZzpkMGRmMDA1NjdlMmI0ZWVjOTNmYTVlYWRiNjUyY2YzZS90ZXh0cmVnaW9uOmQwZGYwMDU2N2UyYjRlZWM5M2ZhNWVhZGI2NTJjZjNlXzE5Nzk_c23c3e56-8ba6-49e8-8c3e-84de906c2221"
      unitRef="usd">8000000</cah:NotesPayableRepurchased>
    <cah:NotesPayableRepurchased
      contextRef="i97bd654b86404619830471d41f60a11d_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMjQvZnJhZzpkMGRmMDA1NjdlMmI0ZWVjOTNmYTVlYWRiNjUyY2YzZS90ZXh0cmVnaW9uOmQwZGYwMDU2N2UyYjRlZWM5M2ZhNWVhZGI2NTJjZjNlXzIwMjM_c0142512-e270-4ea3-9aac-7f6453d69323"
      unitRef="usd">24000000</cah:NotesPayableRepurchased>
    <cah:NotesPayableRepurchased
      contextRef="i00a6d666bf604826b24e68ddbd63eac4_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMjQvZnJhZzpkMGRmMDA1NjdlMmI0ZWVjOTNmYTVlYWRiNjUyY2YzZS90ZXh0cmVnaW9uOmQwZGYwMDU2N2UyYjRlZWM5M2ZhNWVhZGI2NTJjZjNlXzIwNjk_3c98473a-a6f9-4c1f-94bd-bc5b7d0c87fe"
      unitRef="usd">100000000</cah:NotesPayableRepurchased>
    <cah:NotesPayableRepurchased
      contextRef="i09916dad25ba4c3c8af380f01d737407_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMjQvZnJhZzpkMGRmMDA1NjdlMmI0ZWVjOTNmYTVlYWRiNjUyY2YzZS90ZXh0cmVnaW9uOmQwZGYwMDU2N2UyYjRlZWM5M2ZhNWVhZGI2NTJjZjNlXzIyNDU_354dc62f-27c9-46e4-8796-8bfaaf876408"
      unitRef="usd">1000000000.0</cah:NotesPayableRepurchased>
    <cah:OfferAsPercentageOfPrincipalAmount
      contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMjQvZnJhZzpkMGRmMDA1NjdlMmI0ZWVjOTNmYTVlYWRiNjUyY2YzZS90ZXh0cmVnaW9uOmQwZGYwMDU2N2UyYjRlZWM5M2ZhNWVhZGI2NTJjZjNlXzI3NzU_c18472bb-6c80-4144-ac80-ff6fea11c1a1"
      unitRef="number">1.01</cah:OfferAsPercentageOfPrincipalAmount>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="i9820f36cdd3f46ff836bba721b3236ec_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMjQvZnJhZzpkMGRmMDA1NjdlMmI0ZWVjOTNmYTVlYWRiNjUyY2YzZS90ZXh0cmVnaW9uOmQwZGYwMDU2N2UyYjRlZWM5M2ZhNWVhZGI2NTJjZjNlXzI5NjM_387182db-3b3b-4590-906f-151d66e2e24f"
      unitRef="usd">2000000000.0</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="i0c9f608d73754d42bf91b8f887a3643b_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMjQvZnJhZzpkMGRmMDA1NjdlMmI0ZWVjOTNmYTVlYWRiNjUyY2YzZS90ZXh0cmVnaW9uOmQwZGYwMDU2N2UyYjRlZWM5M2ZhNWVhZGI2NTJjZjNlXzMwMDM_2473d512-ea23-4f64-ae12-b603b99ff969"
      unitRef="usd">2000000000.0</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="i74a8ee2e9e1b481491947bdcd81fe93b_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMjQvZnJhZzpkMGRmMDA1NjdlMmI0ZWVjOTNmYTVlYWRiNjUyY2YzZS90ZXh0cmVnaW9uOmQwZGYwMDU2N2UyYjRlZWM5M2ZhNWVhZGI2NTJjZjNlXzMwNDg_390ed2fa-5f67-45ce-9350-cc9952e9e964"
      unitRef="usd">1000000000.0</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:OtherShortTermBorrowings
      contextRef="i2085dadd50db412cae65d5356e28138c_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMjQvZnJhZzpkMGRmMDA1NjdlMmI0ZWVjOTNmYTVlYWRiNjUyY2YzZS90ZXh0cmVnaW9uOmQwZGYwMDU2N2UyYjRlZWM5M2ZhNWVhZGI2NTJjZjNlXzQ5NDc4MDIzMzI3MzA_866672f8-6c76-4207-bdaf-c096c398ad72"
      unitRef="usd">0</us-gaap:OtherShortTermBorrowings>
    <us-gaap:OtherShortTermBorrowings
      contextRef="i6f57fbcd87fd4740ba92695d57c1ffe0_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMjQvZnJhZzpkMGRmMDA1NjdlMmI0ZWVjOTNmYTVlYWRiNjUyY2YzZS90ZXh0cmVnaW9uOmQwZGYwMDU2N2UyYjRlZWM5M2ZhNWVhZGI2NTJjZjNlXzQ5NDc4MDIzMzI3MzA_cddb899b-692e-4a96-95d0-92c8018c77d3"
      unitRef="usd">0</us-gaap:OtherShortTermBorrowings>
    <us-gaap:LineOfCredit
      contextRef="i2085dadd50db412cae65d5356e28138c_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMjQvZnJhZzpkMGRmMDA1NjdlMmI0ZWVjOTNmYTVlYWRiNjUyY2YzZS90ZXh0cmVnaW9uOmQwZGYwMDU2N2UyYjRlZWM5M2ZhNWVhZGI2NTJjZjNlXzQyNDg_80f97bfd-2823-4af7-ba77-5e03fcb1009a"
      unitRef="usd">1000000</us-gaap:LineOfCredit>
    <us-gaap:LineOfCreditFacilityMaximumAmountOutstandingDuringPeriod
      contextRef="ide18edefc53a43f1823ee90886c4b766_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMjQvZnJhZzpkMGRmMDA1NjdlMmI0ZWVjOTNmYTVlYWRiNjUyY2YzZS90ZXh0cmVnaW9uOmQwZGYwMDU2N2UyYjRlZWM5M2ZhNWVhZGI2NTJjZjNlXzQzODM_f391ceb3-b531-4408-80f7-596e0666d38e"
      unitRef="usd">200000000</us-gaap:LineOfCreditFacilityMaximumAmountOutstandingDuringPeriod>
    <us-gaap:OtherShortTermBorrowings
      contextRef="i947b0014f3864d1bbe6799521fc7f7ec_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMjQvZnJhZzpkMGRmMDA1NjdlMmI0ZWVjOTNmYTVlYWRiNjUyY2YzZS90ZXh0cmVnaW9uOmQwZGYwMDU2N2UyYjRlZWM5M2ZhNWVhZGI2NTJjZjNlXzQ5NDc4MDIzMzI3MjE_1ae7319c-6f8f-4a04-ac5b-3295833aa66d"
      unitRef="usd">0</us-gaap:OtherShortTermBorrowings>
    <us-gaap:OtherShortTermBorrowings
      contextRef="ic2fe7a908c6f4f61af7f7d8c6c00e82b_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMjQvZnJhZzpkMGRmMDA1NjdlMmI0ZWVjOTNmYTVlYWRiNjUyY2YzZS90ZXh0cmVnaW9uOmQwZGYwMDU2N2UyYjRlZWM5M2ZhNWVhZGI2NTJjZjNlXzQ5NDc4MDIzMzI3MjE_f36bc104-de08-4c39-8571-c802d6bf3698"
      unitRef="usd">0</us-gaap:OtherShortTermBorrowings>
    <us-gaap:LineOfCredit
      contextRef="i28f8f11500fa40cba044c5da762695f8_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMjQvZnJhZzpkMGRmMDA1NjdlMmI0ZWVjOTNmYTVlYWRiNjUyY2YzZS90ZXh0cmVnaW9uOmQwZGYwMDU2N2UyYjRlZWM5M2ZhNWVhZGI2NTJjZjNlXzQ2MTk_b6b794c2-366d-4345-a5c5-844224fa58dd"
      unitRef="usd">31000000</us-gaap:LineOfCredit>
    <us-gaap:LineOfCredit
      contextRef="i12ab314ad2e0406699d32582ff5dabfd_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMjQvZnJhZzpkMGRmMDA1NjdlMmI0ZWVjOTNmYTVlYWRiNjUyY2YzZS90ZXh0cmVnaW9uOmQwZGYwMDU2N2UyYjRlZWM5M2ZhNWVhZGI2NTJjZjNlXzQ2MjY_256ab8c2-26e7-490a-bbd8-46aad3fa6e77"
      unitRef="usd">29000000</us-gaap:LineOfCredit>
    <us-gaap:OtherShortTermBorrowings
      contextRef="i944f1f41fd954de4b4dc8f6b5c5c2db1_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMjQvZnJhZzpkMGRmMDA1NjdlMmI0ZWVjOTNmYTVlYWRiNjUyY2YzZS90ZXh0cmVnaW9uOmQwZGYwMDU2N2UyYjRlZWM5M2ZhNWVhZGI2NTJjZjNlXzQ5NDc4MDIzMzI3MTI_328cca0a-e0d0-48c2-9b21-f06d8dc3df10"
      unitRef="usd">0</us-gaap:OtherShortTermBorrowings>
    <us-gaap:OtherShortTermBorrowings
      contextRef="i9820f36cdd3f46ff836bba721b3236ec_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMjQvZnJhZzpkMGRmMDA1NjdlMmI0ZWVjOTNmYTVlYWRiNjUyY2YzZS90ZXh0cmVnaW9uOmQwZGYwMDU2N2UyYjRlZWM5M2ZhNWVhZGI2NTJjZjNlXzQ5NDc4MDIzMzI3MTI_e967a81f-0548-48c7-a533-9592843d326b"
      unitRef="usd">0</us-gaap:OtherShortTermBorrowings>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="id267a8471edd4bc9bf4d5efa60da5922_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMjQvZnJhZzpkMGRmMDA1NjdlMmI0ZWVjOTNmYTVlYWRiNjUyY2YzZS90ZXh0cmVnaW9uOmQwZGYwMDU2N2UyYjRlZWM5M2ZhNWVhZGI2NTJjZjNlXzUwMDc_6d256de8-af92-4df2-8edd-e3d92653887f"
      unitRef="usd">6000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:OtherBorrowings
      contextRef="i2e87824102b34590a0208cc7da91b5f5_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMjQvZnJhZzpkMGRmMDA1NjdlMmI0ZWVjOTNmYTVlYWRiNjUyY2YzZS90ZXh0cmVnaW9uOmQwZGYwMDU2N2UyYjRlZWM5M2ZhNWVhZGI2NTJjZjNlXzUwNDI_8f6fc2f8-e7ac-4e7b-8702-d84d9088c767"
      unitRef="usd">67000000</us-gaap:OtherBorrowings>
    <us-gaap:OtherBorrowings
      contextRef="i299cea70f47b4fbe96772aaa8cc00b79_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMjQvZnJhZzpkMGRmMDA1NjdlMmI0ZWVjOTNmYTVlYWRiNjUyY2YzZS90ZXh0cmVnaW9uOmQwZGYwMDU2N2UyYjRlZWM5M2ZhNWVhZGI2NTJjZjNlXzUwNDk_1521b0bb-ce0f-4af0-a5ab-8db70dd52412"
      unitRef="usd">35000000</us-gaap:OtherBorrowings>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock
      contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzAvZnJhZzoxYzE1YWJmYzUxMTY0ZGUwODljYmRhNDgyYjQwNWYzYi90ZXh0cmVnaW9uOjFjMTVhYmZjNTExNjRkZTA4OWNiZGE0ODJiNDA1ZjNiXzE2MzY2_1ec74220-222b-412f-8f4f-c1e8cc6f7766">&lt;div style="display:inline-block;vertical-align:top;width:48.214%"&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:13pt;font-weight:700;line-height:120%"&gt;7. Commitments, Contingent Liabilities and Litigation &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%"&gt;Commitments&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Generic Sourcing Venture with CVS Health Corporation ("CVS Health")&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In July 2014, we established Red Oak Sourcing, LLC ("Red Oak Sourcing"), a U.S.-based generic pharmaceutical sourcing venture with CVS Health for an initial term of 10 years. Red Oak Sourcing negotiates generic pharmaceutical supply contracts on behalf of its participants. In August 2021, we amended our agreement to extend the term through June 2029. We are required to make quarterly payments to CVS Health for the term of the arrangement. These payments are included as purchase obligations and other payments in the Contractual Obligations section of MD&amp;amp;A. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%"&gt;Contingencies&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;New York Opioid Stewardship Act&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In April 2018, the State of New York passed a budget which included the Opioid Stewardship Act (the "OSA"). The OSA created an aggregate $100&#160;million annual assessment on all manufacturers and distributors licensed to sell or distribute opioids in New York. Under the OSA, each licensed manufacturer and distributor would be required to pay a portion of the assessment based on its share of the total morphine milligram equivalents sold or distributed in New York during the applicable calendar year, beginning in 2017.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The constitutionality of portions of the OSA has been challenged in court. In December 2018, the OSA was ruled unconstitutional by the U.S. District Court for the Southern District of New York. Subsequently, New York passed a new statute that modified the assessment going forward and limited the OSA to two years (2017 and 2018). The U.S. Court of Appeals for the Second Circuit reversed the district court's decision on procedural grounds. In February 2021, the Second Circuit stayed the effect of the ruling pending a petition to the U.S. Supreme Court to review the Second Circuit's opinion. If the U.S. Supreme Court declines to take the case, or if it ultimately upholds the Second Circuit's ruling, New York State would likely seek to collect amounts allegedly owed under the OSA. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We accrue contingencies if it is probable that a liability has been incurred and the amount can be estimated. Because of the Second Circuit ruling, we recorded an aggregate accrual of $41&#160;million for calendar years 2017 and 2018 in the fiscal year ended June&#160;30, 2021 based on the probable estimated payment amount, which is our best estimate of the OSA payments probable at June 30, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%"&gt;Legal Proceedings&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We become involved from time to time in disputes, litigation and regulatory matters.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;From time to time, we determine that products we source, manufacture or market do not meet our specifications, regulatory requirements, or published standards. When we or a regulatory agency identify a potential quality or regulatory issue, we investigate and take appropriate corrective action. Such actions &lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="display:inline-block;max-width:3.571%;min-width:2.571%;vertical-align:top"/&gt;&lt;div style="display:inline-block;vertical-align:top;width:48.215%"&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;have led to product recalls, costs to repair or replace affected products, temporary interruptions in product sales, product liability claims and lawsuits and can lead to action by regulators. Even absent an identified regulatory or quality issue or product recall, we can become subject to product liability claims and lawsuits.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;From time to time, we become aware through employees, internal audits or other parties of possible product quality, regulatory or compliance matters, such as complaints or concerns relating to accounting, internal accounting controls, financial reporting, auditing, or other ethical matters or relating to compliance with laws such as healthcare fraud and abuse, anti-corruption or anti-bribery laws. When we become aware of such possible compliance matters, we investigate internally and take appropriate corrective action. In addition, from time to time, we receive subpoenas or requests for information from various federal or state agencies relating to our business or to the business of a customer, supplier or other industry participants. Internal investigations, subpoenas or requests for information could directly or indirectly lead to the assertion of claims or the commencement of legal proceedings against us or result in sanctions.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We have been named from time to time in qui tam actions initiated by private third parties. In such actions, the private parties purport to act on behalf of federal or state governments, allege that false claims have been submitted for payment by the government and may receive an award if their claims are successful. After a private party has filed a qui tam action, the government must investigate the private party's claim and determine whether to intervene in and take control over the litigation. These actions may remain under seal while the government makes this determination. If the government declines to intervene, the private party may nonetheless continue to pursue the litigation on his or her own purporting to act on behalf of the government.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We accrue for contingencies related to disputes, litigation and regulatory matters if it is probable that a liability has been incurred and the amount of the loss can be reasonably estimated. Because these matters are inherently unpredictable and unfavorable developments or resolutions can occur, assessing contingencies is highly subjective and requires judgments about future events. We regularly review contingencies to determine whether our accruals and related disclosures are adequate. The amount of ultimate loss may differ from these estimates.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We recognize income from the favorable outcome of litigation when we receive the associated cash or assets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We recognize estimated loss contingencies for certain litigation and regulatory matters and income from favorable resolution of litigation in litigation (recoveries)/charges in our consolidated statements of earnings/(loss).&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Opioid Lawsuits and Investigations&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Pharmaceutical wholesale distributors, including us, have been named as defendants in approximately 3,300 lawsuits relating to the distribution of prescription opioid pain medications. The lawsuits seek equitable relief and monetary damages based on a variety of legal theories including various common law claims, such as public nuisance, negligence and unjust enrichment as well &lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="display:inline-block;vertical-align:top;width:48.214%"&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;as violations of controlled substance laws, the Racketeer Influenced and Corrupt Organizations Act and various other statutes. These lawsuits also name pharmaceutical manufacturers, retail pharmacy chains and other entities as defendants.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;States &amp;amp; Political Subdivisions&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Approximately 2,900 of these lawsuits have been filed by counties, municipalities, cities and political subdivisions in various federal, state, and other courts. The vast majority of these lawsuits were filed in U.S. federal court and have been transferred for consolidated pre-trial proceedings in a Multi-District Litigation proceeding in the U.S. District Court for the Northern District of Ohio (the &#x201c;MDL&#x201d;).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In addition, 25 state attorneys general have filed lawsuits against distributors, including us, in various state courts. We have also received requests, civil investigative demands, subpoenas or requests for information from additional state attorneys general offices and governmental authorities. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In October 2019, we agreed in principle to a global settlement framework with a leadership group of state attorneys general; the framework is designed to resolve pending and future opioid lawsuits and claims by states and political subdivisions, but not private plaintiffs (the "Settlement Framework"). We continued to build out the Settlement Framework and to negotiate the terms of the settlement with the leadership group and other representatives of states and political subdivisions. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In July, 2021, we announced that we and two other national distributors have negotiated a proposed settlement agreement (the &#x201c;Proposed Settlement Agreement&#x201d;) and settlement process that, if all conditions are satisfied, would result in the settlement of the vast majority of opioid lawsuits filed by state and local governmental entities. West Virginia subdivisions and Native American tribes are not a part of this settlement process and we have been involved in separate negotiations with these groups. The settlement process does not contemplate participation by any non-governmental or non-political entities or individuals. In connection with the negotiations of the Proposed Settlement Agreement, we and the two other national distributors entered into a settlement with the State of New York and its participating subdivisions. If the Proposed Settlement Agreement becomes effective, New York and its participating subdivisions will become a part of it. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Proposed Settlement Agreement is subject to contingencies and will not become effective unless and until the three distributors each make separate independent determinations that (1) following a sign-on period, a sufficient number of states have agreed to the Proposed Settlement Agreement (the &#x201c;Settling States&#x201d;); and, subsequently, (2) following a notice period, that a sufficient number of states and political subdivisions, including those that have not sued, have agreed to the Agreement (or otherwise had their claims foreclosed) to proceed to effectiveness. Prior to the second determination, the Settling States will also have an opportunity to make a determination as to whether a sufficient number of political subdivisions have agreed to the Proposed Settlement Agreement (or otherwise had their claims foreclosed) to proceed with the &lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="display:inline-block;max-width:3.571%;min-width:2.571%;vertical-align:top"/&gt;&lt;div style="display:inline-block;vertical-align:top;width:48.215%"&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Proposed Settlement Agreement. This process is currently contemplated to end in February 2022, although it may be extended by agreement. It is possible that a sufficient number of states and subdivisions will not agree to the Proposed Settlement Agreement or that other required contingencies will not be satisfied.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;If these conditions are satisfied, the Proposed Settlement Agreement would become effective sixty (60) days after the distributors determine that there is sufficient participation among political subdivisions. During this 60-day period, the Settling States and the distributors would cooperate to obtain consent judgments in each participating state embodying the terms of the Settlement. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The Proposed Settlement Agreement includes a cash component, pursuant to which the Company would pay up to approximately $6.37&#160;billion, the majority of which would be paid over 18 years. The exact payment amount will depend on several factors, including the participation rate of states and political subdivisions, the extent to which states take action to foreclose opioid lawsuits by political subdivisions (&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;e.g.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;, laws barring or limiting opioid lawsuits by political subdivisions), and the extent to which political subdivisions in Settling States file additional opioid lawsuits against the Company after the Proposed Settlement Agreement becomes effective. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Proposed Settlement Agreement also includes injunctive relief terms related to settling distributors&#x2019; controlled substance anti-diversion programs, including with respect to: (1) governance; (2) independence and training of the personnel operating our controlled substances monitoring program; (3) due diligence for new and existing customers; (4) ordering limits for certain products; and (5) suspicious order monitoring. A monitor will be selected to oversee compliance with these provisions for a period of five years. In addition, we and the two other settling distributors will engage a third-party vendor to act as a clearinghouse for data aggregation and reporting; distributors will fund the clearinghouse for ten years.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In total, we have recorded total pre-tax charges of $1.17&#160;billion and $5.63&#160;billion in litigation charges/(recoveries), net in the years ended June&#160;30, 2021 and 2020, respectively. In total, we have $6.73&#160;billion accrued at June&#160;30, 2021, of which $405&#160;million is included in other accrued liabilities and the remainder is included in deferred income taxes and other liabilities in the consolidated balance sheets. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Because loss contingencies are inherently unpredictable and unfavorable developments or resolutions can occur, the assessment is highly subjective and requires judgments about future events. We regularly review these opioid litigation matters to determine whether our accrual is adequate. The amount of ultimate loss may differ materially from this accrual, whether as a result of settlement discussions, a judicial decision or verdict or otherwise, but we are not able to estimate a range of reasonably possible additional losses for these matters. We continue to strongly dispute the allegations made in these lawsuits and reaching an agreement in principle on a global settlement framework is not an admission of liability or wrongdoing.&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="display:inline-block;vertical-align:top;width:48.214%"&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Additionally, a trial before a judge in West Virginia in the Cabell County and City of Huntington cases concluded in July 2021 and the judge has not yet issued a decision. In addition, a trial in the case brought by the Ohio Attorney General is scheduled to begin in September 2021 and a trial in the case brought by the Washington Attorney General is scheduled to begin in November 2021. The Ohio Attorney General has issued a press release indicating support for the Proposed Settlement Agreement; however, the Washington Attorney General has issued a press release stating that Washington will not agree to the Proposed Settlement Agreement. These public announcements are not binding and there is no assurance that any state that has made a public announcement of support for the Proposed Settlement Agreement will ultimately execute the Proposed Settlement Agreement.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Private Plaintiffs&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Proposed Settlement Agreement does not address claims by private parties, which includes unions and other health and welfare funds, hospital systems and other healthcare providers, businesses and individuals alleging personal injury. Private parties had brought approximately 442 lawsuits as of August 10, 2021. Of these, 128 are purported class actions. The causes of action asserted by these plaintiffs are similar to those asserted by public plaintiffs. A trial in one case is currently scheduled to begin in October 2021. We are vigorously defending ourselves in these matters.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Insurance Litigation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We are involved in legal proceedings with two insurers related to the availability of insurance coverage for the lawsuits described above. In October 2020, we filed a complaint for declaratory judgment against National Union Fire Insurance Company of Pittsburgh, PA (&#x201c;National Union&#x201d;) seeking a declaration that National Union is obligated to reimburse us for defense costs incurred in connection with the lawsuits described above. In January, 2021, Swiss Re International SE commenced an arbitration in London seeking a determination that it does not have an obligation to reimburse us for defense and indemnity expenses incurred in connection with the lawsuits described above. We have not recorded a receivable for any recoveries related to these insurance litigation matters as of June&#160;30, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Department of Justice Investigations&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We have received federal grand jury subpoenas issued in connection with investigations being conducted by the U.S. Attorney's Office for the Eastern District of New York and the Fraud Section of the U.S. Department of Justice ("DOJ"). We have also received civil requests for information from other DOJ offices. We believe that these investigations concern operation of our anti-diversion program, our anti-diversion policies and procedures, and distribution of certain controlled substances. We are cooperating with these requests. We are unable to predict the outcome of any of these investigations. &lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="display:inline-block;max-width:3.571%;min-width:2.571%;vertical-align:top"/&gt;&lt;div style="display:inline-block;vertical-align:top;width:48.215%"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Cordis Product Liability Lawsuits&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of August 10, 2021, we are named as a defendant in 419 product liability lawsuits coordinated in Alameda County Superior Court in California involving claims by approximately 5,427 plaintiffs that allege personal injuries associated with the use of Cordis OptEase and TrapEase inferior vena cava ("IVC") filter products. Another 32 lawsuits involving similar claims by approximately 37 plaintiffs are pending in other jurisdictions. These lawsuits seek a variety of remedies, including unspecified monetary damages. In July 2021, we entered into an agreement to settle approximately 1,300 claims. This agreement is subject to certain contingencies. We continue to vigorously defend ourselves in these lawsuits and are engaged in ongoing resolution discussions with certain plaintiffs. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At June&#160;30, 2021, we had a total of $524&#160;million net of estimated insurance recoveries, accrued for losses and legal defense costs, net of expected insurance recoveries, related to the Cordis IVC filter lawsuits in the consolidated balance sheets. We believe there is a range of estimated losses with respect to these matters. Because no amount within the range is a better estimate than any other amount within the range, we have accrued the minimum amount in the range. We estimate the high end of the range to be approximately $1.03&#160;billion, net of estimated insurance recoveries. The sale of the Cordis disposal group does not include product liability related to the IVC filters in the U.S. and Canada, which we retained. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;SEC Investigation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In February 2021, we received a subpoena from the U.S. Securities and Exchange Commission requesting the production of documents from 2015 through 2019 relating to inventory in the Cordis business, analysis of goodwill of the Medical segment and other matters. We are cooperating with this inquiry and cannot predict its outcome or duration. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Shareholder Securities Litigation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In August 2019, the Louisiana Sheriffs' Pension &amp;amp; Relief Fund filed a purported class action complaint against Cardinal Health and certain current and former officers and employees in the United States District Court for the Southern District of Ohio purportedly on behalf of all purchasers of our common shares between March 2015 and May 2018. In June 2020, the court appointed 1199 SEIU Health Care Employees Pension Fund as lead plaintiff and a consolidated amended complaint was filed in September 2020. The amended complaint alleges that the defendants violated Sections 10(b) and 20(a) of the Securities and Exchange Act of 1934 by making misrepresentations and omissions related to the acquisition integration of the Cordis business and inventory and supply chain problems within the Cordis business, and seeks to recover unspecified damages and equitable relief for the alleged misstatements and omissions. The complaint also alleges that one of the individual defendants violated Section 20A of the Exchange Act because he sold shares of Cardinal Health stock during the time period. In November 2020, we filed a motion to dismiss the amended complaint. We believe that the claims asserted in this &lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;complaint are without merit and intend to vigorously defend against them.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Specialty Solutions DOJ Investigation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In November 2018, the United States Attorney&#x2019;s Office for the District of Massachusetts (the "USAO") commenced an investigation pertaining to the U.S. federal healthcare fraud and abuse laws. These requests sought, among other things, documents and information relating to discounts and rebates offered or provided to certain Specialty Solutions customers. We are cooperating with these requests and are engaged in resolution discussions with the USAO and Department of Health and Human Services, Office of Inspector General. In connection with these discussions, we recorded $13 million of expense within litigation charges/(recoveries) on our consolidated statements of earnings/(loss) during the fiscal year ended June&#160;30, 2021. We cannot predict the outcome of the discussions and it is possible that we may incur additional losses or agree to other remedial measures; however, we are not currently able to estimate a range of reasonably possible additional losses.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Other Civil Litigation &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Generic Pharmaceutical Pricing Antitrust Litigation &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In December 2019, pharmaceutical distributors including us were added as defendants in a civil class action lawsuit filed by indirect purchasers of generic drugs, such as hospitals and retail pharmacies. The indirect purchaser case is part of a multidistrict litigation consisting of multiple individual class action matters consolidated in the Eastern District of Pennsylvania. The indirect purchaser plaintiffs allege that pharmaceutical distributors encouraged manufacturers to increase prices, provided anti-competitive pricing information to manufacturers and improperly engaged in customer allocation. We have filed a motion to dismiss the complaints and we intend to vigorously defend ourselves. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Active Pharmaceutical Ingredient Impurity Litigation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Many participants in the pharmaceutical supply chain, including active pharmaceutical ingredient ("API") manufacturers, finished dose manufacturers, repackagers, distributors, and retailers have been named as defendants in lawsuits arising out of recalls of certain medications due to alleged impurities in the active pharmaceutical ingredients or finished product. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In February 2019, a Multidistrict Litigation was created in the U.S. District Court for the District of New Jersey (the &#x201c;Sartan MDL&#x201d;) alleging API impurities in certain generic blood pressure medications. We have been named as a defendant in the Sartan MDL. We are vigorously defending ourselves in this matter. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Antitrust Litigation Proceeds&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We received and recognized income resulting from settlements of lawsuits in which we were a class member or plaintiff of $112 million&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$16 million and $94 million during fiscal 2021, 2020, and 2019, respectively.&lt;/span&gt;&lt;/div&gt;</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <cah:AggregateAnnualAssessment
      contextRef="i47649611840740c9a47bac619a623132_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzAvZnJhZzoxYzE1YWJmYzUxMTY0ZGUwODljYmRhNDgyYjQwNWYzYi90ZXh0cmVnaW9uOjFjMTVhYmZjNTExNjRkZTA4OWNiZGE0ODJiNDA1ZjNiXzI3NDg3NzkxMjE2MDk_26c31dc6-91cd-4f36-82f3-3a7ba0c69ac1"
      unitRef="usd">100000000</cah:AggregateAnnualAssessment>
    <cah:EstimatedLiabilityForNewYorkOpioidStewardshipAct
      contextRef="i457f80b8744948758645272a98e06c10_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzAvZnJhZzoxYzE1YWJmYzUxMTY0ZGUwODljYmRhNDgyYjQwNWYzYi90ZXh0cmVnaW9uOjFjMTVhYmZjNTExNjRkZTA4OWNiZGE0ODJiNDA1ZjNiXzI3NDg3NzkxMjE2MTY_bdd45fc0-f43f-4ecc-ab36-9831321fbbc8"
      unitRef="usd">41000000</cah:EstimatedLiabilityForNewYorkOpioidStewardshipAct>
    <cah:LossContingencyLawsuitsNumber
      contextRef="i5aad644cd5714c75b9ef8163bf7a97f7_I20210810"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzAvZnJhZzoxYzE1YWJmYzUxMTY0ZGUwODljYmRhNDgyYjQwNWYzYi90ZXh0cmVnaW9uOjFjMTVhYmZjNTExNjRkZTA4OWNiZGE0ODJiNDA1ZjNiXzI3NDg3NzkxMjE2MjY_8e1ecbe7-f25e-4327-bb1b-e368f6a4cfca"
      unitRef="number">3300</cah:LossContingencyLawsuitsNumber>
    <cah:LossContingencyLawsuitsNumber
      contextRef="i69aa4c6826204c058cfb939b8d352e27_I20210810"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzAvZnJhZzoxYzE1YWJmYzUxMTY0ZGUwODljYmRhNDgyYjQwNWYzYi90ZXh0cmVnaW9uOjFjMTVhYmZjNTExNjRkZTA4OWNiZGE0ODJiNDA1ZjNiXzI3NDg3NzkxMjE2MzA_f0cbe59b-3fc7-4b9a-ac15-a1f5206fabe4"
      unitRef="number">2900</cah:LossContingencyLawsuitsNumber>
    <cah:NumberofStateAttorneysGeneralfilinglawsuits
      contextRef="i5aad644cd5714c75b9ef8163bf7a97f7_I20210810"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzAvZnJhZzoxYzE1YWJmYzUxMTY0ZGUwODljYmRhNDgyYjQwNWYzYi90ZXh0cmVnaW9uOjFjMTVhYmZjNTExNjRkZTA4OWNiZGE0ODJiNDA1ZjNiXzI3NDg3NzkxMjE2MzQ_b0c99c44-ee7c-40c0-8e77-b697484558e9"
      unitRef="stateag">25</cah:NumberofStateAttorneysGeneralfilinglawsuits>
    <us-gaap:LossContingencyEstimateOfPossibleLoss
      contextRef="iddd4821afbbd40c4a6c811e70974bf4a_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzAvZnJhZzoxYzE1YWJmYzUxMTY0ZGUwODljYmRhNDgyYjQwNWYzYi90ZXh0cmVnaW9uOjFjMTVhYmZjNTExNjRkZTA4OWNiZGE0ODJiNDA1ZjNiXzYwNDczMTQwMzU1NDg_6cb1edc8-f047-4176-8f70-2f2a18ebe53e"
      unitRef="usd">6370000000</us-gaap:LossContingencyEstimateOfPossibleLoss>
    <us-gaap:GainLossRelatedToLitigationSettlement
      contextRef="id2a6b6641ae248c98d689f30c606f881_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzAvZnJhZzoxYzE1YWJmYzUxMTY0ZGUwODljYmRhNDgyYjQwNWYzYi90ZXh0cmVnaW9uOjFjMTVhYmZjNTExNjRkZTA4OWNiZGE0ODJiNDA1ZjNiXzI3NDg3NzkxMjE2Mzg_fa04a4d2-d99c-4c13-92d5-b636406cf116"
      unitRef="usd">1170000000</us-gaap:GainLossRelatedToLitigationSettlement>
    <us-gaap:GainLossRelatedToLitigationSettlement
      contextRef="i373ba6a0cdc044dea9602bdbad13174c_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzAvZnJhZzoxYzE1YWJmYzUxMTY0ZGUwODljYmRhNDgyYjQwNWYzYi90ZXh0cmVnaW9uOjFjMTVhYmZjNTExNjRkZTA4OWNiZGE0ODJiNDA1ZjNiXzI3NDg3NzkxMjE2NDY_1a313f61-c937-4037-8038-233b7a976d14"
      unitRef="usd">5630000000</us-gaap:GainLossRelatedToLitigationSettlement>
    <us-gaap:LitigationReserve
      contextRef="iddd4821afbbd40c4a6c811e70974bf4a_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzAvZnJhZzoxYzE1YWJmYzUxMTY0ZGUwODljYmRhNDgyYjQwNWYzYi90ZXh0cmVnaW9uOjFjMTVhYmZjNTExNjRkZTA4OWNiZGE0ODJiNDA1ZjNiXzI3NDg3NzkxMjE2NzA_28b38008-945f-454f-9a53-178811986b71"
      unitRef="usd">6730000000</us-gaap:LitigationReserve>
    <us-gaap:LitigationReserve
      contextRef="i358dc7a7b0ec46769a803fbd85db0e3a_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzAvZnJhZzoxYzE1YWJmYzUxMTY0ZGUwODljYmRhNDgyYjQwNWYzYi90ZXh0cmVnaW9uOjFjMTVhYmZjNTExNjRkZTA4OWNiZGE0ODJiNDA1ZjNiXzI3NDg3NzkxNTIxNzY_ed4f0b1f-aee9-4015-94af-0fe1bc302ff6"
      unitRef="usd">405000000</us-gaap:LitigationReserve>
    <cah:LossContingencyLawsuitsNumber
      contextRef="i0e267f0781804e14b232b824ab81c9b0_I20210810"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzAvZnJhZzoxYzE1YWJmYzUxMTY0ZGUwODljYmRhNDgyYjQwNWYzYi90ZXh0cmVnaW9uOjFjMTVhYmZjNTExNjRkZTA4OWNiZGE0ODJiNDA1ZjNiXzI3NDg3NzkxMjE2Nzg_72ee3a45-216f-468e-8c32-668bef0d2697"
      unitRef="lawsuit">442</cah:LossContingencyLawsuitsNumber>
    <cah:LossContingencyLawsuitsNumber
      contextRef="ia0377f0db1e745b29e4b4fa403caefda_I20210810"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzAvZnJhZzoxYzE1YWJmYzUxMTY0ZGUwODljYmRhNDgyYjQwNWYzYi90ZXh0cmVnaW9uOjFjMTVhYmZjNTExNjRkZTA4OWNiZGE0ODJiNDA1ZjNiXzI3NDg3NzkxMjE2ODI_9651e1d8-65c3-412e-be61-671cda9af5ce"
      unitRef="lawsuit">128</cah:LossContingencyLawsuitsNumber>
    <us-gaap:LossContingencyNewClaimsFiledNumber
      contextRef="ieb82df38431448b4bf42dd698ac840f8_D20210810-20210810"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzAvZnJhZzoxYzE1YWJmYzUxMTY0ZGUwODljYmRhNDgyYjQwNWYzYi90ZXh0cmVnaW9uOjFjMTVhYmZjNTExNjRkZTA4OWNiZGE0ODJiNDA1ZjNiXzI3NDg3NzkxMjE3MDM_0e069a5f-0bff-4a1b-ac30-550d2e25933c"
      unitRef="lawsuit">419</us-gaap:LossContingencyNewClaimsFiledNumber>
    <us-gaap:LossContingencyNumberOfPlaintiffs
      contextRef="i31649c55524f4013acd74a3b9ce10a01_D20210810-20210810"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzAvZnJhZzoxYzE1YWJmYzUxMTY0ZGUwODljYmRhNDgyYjQwNWYzYi90ZXh0cmVnaW9uOjFjMTVhYmZjNTExNjRkZTA4OWNiZGE0ODJiNDA1ZjNiXzI3NDg3NzkxMjE3MDc_0ada15b2-57ae-4282-93b6-d1f1a15661ff"
      unitRef="plaintiff">5427</us-gaap:LossContingencyNumberOfPlaintiffs>
    <us-gaap:LossContingencyNewClaimsFiledNumber
      contextRef="i3caca7e07f5c4d03b8646b949d36c06e_D20210810-20210810"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzAvZnJhZzoxYzE1YWJmYzUxMTY0ZGUwODljYmRhNDgyYjQwNWYzYi90ZXh0cmVnaW9uOjFjMTVhYmZjNTExNjRkZTA4OWNiZGE0ODJiNDA1ZjNiXzI3NDg3NzkxMjE3MTE_2d065ee3-d4a4-4dc3-b956-41e3294e6300"
      unitRef="lawsuit">32</us-gaap:LossContingencyNewClaimsFiledNumber>
    <us-gaap:LossContingencyNumberOfPlaintiffs
      contextRef="i1687680dbb664c18933d117965cb34b0_D20210810-20210810"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzAvZnJhZzoxYzE1YWJmYzUxMTY0ZGUwODljYmRhNDgyYjQwNWYzYi90ZXh0cmVnaW9uOjFjMTVhYmZjNTExNjRkZTA4OWNiZGE0ODJiNDA1ZjNiXzI3NDg3NzkxMjE3MTU_c9ff876a-2697-44c7-b079-09140c9e67d7"
      unitRef="plaintiff">37</us-gaap:LossContingencyNumberOfPlaintiffs>
    <us-gaap:LossContingencyClaimsSettledNumber
      contextRef="i8068ea91c8ff4c3b8bd8310ae462197c_D20210701-20210731"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzAvZnJhZzoxYzE1YWJmYzUxMTY0ZGUwODljYmRhNDgyYjQwNWYzYi90ZXh0cmVnaW9uOjFjMTVhYmZjNTExNjRkZTA4OWNiZGE0ODJiNDA1ZjNiXzQ5NDc4MDI0MDc3NDI_e689c141-af08-4c6a-9c8d-5d8cdd3d961f"
      unitRef="lawsuit">1300</us-gaap:LossContingencyClaimsSettledNumber>
    <us-gaap:LossContingencyAccrualAtCarryingValue
      contextRef="if156c7b3d30345a395262b86a56d2779_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzAvZnJhZzoxYzE1YWJmYzUxMTY0ZGUwODljYmRhNDgyYjQwNWYzYi90ZXh0cmVnaW9uOjFjMTVhYmZjNTExNjRkZTA4OWNiZGE0ODJiNDA1ZjNiXzI3NDg3NzkxMjE3MTk_a05abe99-d345-43eb-bfc9-17ea0c0f5ebd"
      unitRef="usd">524000000</us-gaap:LossContingencyAccrualAtCarryingValue>
    <us-gaap:LossContingencyEstimateOfPossibleLoss
      contextRef="ib54859ab704046a7a3be64f76f566d69_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzAvZnJhZzoxYzE1YWJmYzUxMTY0ZGUwODljYmRhNDgyYjQwNWYzYi90ZXh0cmVnaW9uOjFjMTVhYmZjNTExNjRkZTA4OWNiZGE0ODJiNDA1ZjNiXzI3NDg3NzkxMjE3Mjc_d403f7da-72bd-4542-937e-c1bfe2872a9a"
      unitRef="usd">1030000000.00</us-gaap:LossContingencyEstimateOfPossibleLoss>
    <us-gaap:GainLossRelatedToLitigationSettlement
      contextRef="id300e006612f4c21bb7c72fd2b74da8f_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzAvZnJhZzoxYzE1YWJmYzUxMTY0ZGUwODljYmRhNDgyYjQwNWYzYi90ZXh0cmVnaW9uOjFjMTVhYmZjNTExNjRkZTA4OWNiZGE0ODJiNDA1ZjNiXzI3NDg3NzkxMjE3Mzc_aec459f5-de19-4cc4-bddb-dbbedcf9009a"
      unitRef="usd">13000000</us-gaap:GainLossRelatedToLitigationSettlement>
    <cah:IncomefromSettlementsofClassActionLawsuits
      contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzAvZnJhZzoxYzE1YWJmYzUxMTY0ZGUwODljYmRhNDgyYjQwNWYzYi90ZXh0cmVnaW9uOjFjMTVhYmZjNTExNjRkZTA4OWNiZGE0ODJiNDA1ZjNiXzI3NDg3NzkwODkxMzc_3585a0a8-5c5b-4132-8e0b-dec54a9c3293"
      unitRef="usd">112000000</cah:IncomefromSettlementsofClassActionLawsuits>
    <cah:IncomefromSettlementsofClassActionLawsuits
      contextRef="ia31e9a409b874bb19d0ff6f2f39ecc09_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzAvZnJhZzoxYzE1YWJmYzUxMTY0ZGUwODljYmRhNDgyYjQwNWYzYi90ZXh0cmVnaW9uOjFjMTVhYmZjNTExNjRkZTA4OWNiZGE0ODJiNDA1ZjNiXzE2MzAx_a478533d-25e1-4bb7-b1a6-bc9a7853a2d4"
      unitRef="usd">16000000</cah:IncomefromSettlementsofClassActionLawsuits>
    <cah:IncomefromSettlementsofClassActionLawsuits
      contextRef="i00a6d666bf604826b24e68ddbd63eac4_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzAvZnJhZzoxYzE1YWJmYzUxMTY0ZGUwODljYmRhNDgyYjQwNWYzYi90ZXh0cmVnaW9uOjFjMTVhYmZjNTExNjRkZTA4OWNiZGE0ODJiNDA1ZjNiXzE2MzA4_e900e6a5-5ac2-4914-8549-a5c84fa7196a"
      unitRef="usd">94000000</cah:IncomefromSettlementsofClassActionLawsuits>
    <us-gaap:IncomeTaxDisclosureTextBlock
      contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90ZXh0cmVnaW9uOmViYTAwMWFhMmQ5YjRmODZiMGIyMTI2YzNmMjlhODhmXzI3NDg3NzkwOTk3OTc_64a3f317-f854-4ecf-ba84-014b50704a78">&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:13pt;font-weight:700;line-height:120%"&gt;8. Income Taxes &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Earnings/(Loss) before Income Taxes and Provision for/(Benefit From) Income Taxes&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes earnings/(loss) before income taxes:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.691%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:53.389%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.999%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.347%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.522%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.347%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.596%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;U.S. operations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(47)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(4,056)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,478&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Non-U.S. operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;370&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;284&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;273&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Earnings/(loss) before income taxes&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;323&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(3,772)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,751&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the components of provision for/(benefit from) income taxes:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:8pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:53.220%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.949%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.343%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.171%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.343%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.174%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Current:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Federal&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(989)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;659&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;295&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;State and local&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;92&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;154&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;89&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Non-U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;112&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;69&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;85&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total current&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(785)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;882&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;469&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Deferred:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Federal&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;539&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(822)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(28)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;State and local&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(28)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(127)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(37)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Non-U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(15)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(18)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total deferred&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;496&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(961)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(83)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Provision for/(benefit from) income taxes&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(289)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(79)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;386&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Tax Effects of Self-Insurance Pre-Tax Loss&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During fiscal 2021, our wholly-owned insurance subsidiary recorded a self-insurance pre-tax loss in its fiscal 2020 statutory financial statements primarily related to opioid litigation. This self-insurance pre-tax loss, which did not impact our pre-tax consolidated results, was deducted on our fiscal 2020 consolidated federal income tax return and contributed to a significant net operating loss for tax purposes. The net operating loss was carried back and applied to adjust our taxable income for fiscal 2015, 2016, 2017, and 2018 as permitted under the Coronavirus Aid, Relief and Economic Security ("CARES") Act enacted by the United States Congress in March 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accordingly, our provision for income taxes during fiscal 2021 included a $424 million benefit from the net operating loss carryback primarily to reflect the difference between the federal statutory income tax rate during the fiscal years from 2015 to 2018 (35 percent for fiscal 2015, 2016, and 2017 and 28 percent for fiscal 2018) and the current federal statutory income tax rate of 21 percent.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We have filed for a U.S. federal income tax refund of $974&#160;million as a result of the net operating loss carryback under the CARES Act, which we expect to receive within 12 months, and accordingly have recorded a current asset on our consolidated balance sheet at June&#160;30, 2021. We also increased our non-current deferred tax &lt;/span&gt;&lt;/div&gt;&lt;div style="display:inline-block;vertical-align:top;width:48.214%"&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;liability by approximately $700&#160;million during fiscal 2021 related to this matter.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We have recorded these amounts based on management's judgment and our current understanding of tax law; however, it is possible that the tax authorities could challenge these tax benefits or that the tax law could change. The actual amount of the tax benefit may differ materially from these estimates.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Tax Effects of Opioid Litigation Charges&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In connection with the $1.17&#160;billion and $5.63&#160;billion pre-tax charges for the opioid litigation, during fiscal 2021 and 2020, we recorded a tax benefit of $228 million and $488&#160;million, respectively. Our tax benefits are estimates, which reflect our current assessment of the estimated future deductibility of the amount that may be paid under the accrual taken in connection with the opioid litigation and are net of unrecognized tax benefits of $219&#160;million and $469&#160;million, respectively. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We have made reasonable estimates and recorded amounts based on management's judgment and our current understanding of the Tax Act; however, these estimates require significant judgment since the U.S. tax law governing deductibility was changed by the U.S. Tax Cuts and Jobs Act ("Tax Act"). Further, it is possible Congress or the tax authorities could challenge our interpretation of the Tax Act or the estimates and assumptions used to assess the future deductibility of these benefits. The actual amount of the tax benefit may differ materially from these estimates.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Effective Tax Rate&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents a reconciliation of the provision based on the federal statutory income tax rate to our effective income tax rate:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:53.220%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.343%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.343%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.482%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021 &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt; (1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2019 &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Provision at Federal statutory rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;21.0&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;21.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;21.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;State and local income taxes, net of federal benefit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;3.2&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;0.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Tax effect of foreign operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;0.7&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(0.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Nondeductible/nontaxable items &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;1.6&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;0.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Cordis Disposition&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;7.0&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Withholding Taxes &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;9.0&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(0.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Change in Valuation Allowances&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(1.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;4.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;US Taxes on International Income&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt; (2)(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(6.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Impact of Resolutions with IRS and other related matters &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(13.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(0.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Legal Entity Reorganization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(3.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Opioid litigation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;17.7&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(23.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Loss Carryback Claims&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(129.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Other &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;1.7&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;0.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(2.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Effective income tax rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(89.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;22.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&#160;&#160;&#160;&#160;The table represents the following: fiscal 2021 is pretax income with tax benefit, fiscal 2020 is pretax loss with tax benefit, and fiscal 2019 is pretax income with tax expense.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(2)&#160;&#160;&#160;&#160;Certain prior year amounts have been reclassified to conform to current year presentation.&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="display:inline-block;max-width:3.571%;min-width:2.571%;vertical-align:top"/&gt;&lt;div style="display:inline-block;vertical-align:top;width:48.215%"&gt;&lt;div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(3)&#160;&#160;&#160;&#160;Includes the tax impact of Global Intangible Low-Taxed Income ("GILTI") tax, the Foreign-Derived Intangible Income deduction and other foreign income that is taxable under the U.S. tax code. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The income tax benefit rate was 89.7% and 2.1% in fiscal 2021 and fiscal 2020 compared to an income tax expense rate of 22.1% in fiscal 2019. Fluctuations in the effective tax rates are primarily due to the impact of opioid litigation in fiscal 2021 and 2020, as well as the impact of the carryback claim filed in accordance with the CARES Act provision in fiscal year 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our effective tax rate has benefits from negotiated lower than statutory tax rates in select foreign jurisdictions which individually are not material to our effective tax rate but in aggregate have a favorable tax impact of approximately $20 million during fiscal 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of June&#160;30, 2021, foreign earnings of approximately $825 million are considered indefinitely reinvested for working capital and other offshore investment needs. The computation of tax required if those earnings are repatriated is not practicable. For amounts not considered indefinitely reinvested, we have recorded an immaterial amount of income tax expense in our financial statements in fiscal 2021. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Deferred Income Taxes&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Deferred income taxes arise from temporary differences between financial reporting and tax reporting bases of assets and liabilities and operating loss and tax credit carryforwards for tax purposes. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the components of the deferred income tax assets and liabilities at June 30:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:60.937%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.109%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.343%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.111%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Deferred income tax assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Receivable basis difference&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;40&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;874&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;607&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Share-based compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;38&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Loss and tax credit carryforwards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;805&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;589&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Deferred tax assets related to uncertain tax positions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;35&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;52&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;16&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;87&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total deferred income tax assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;1,808&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,412&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Valuation allowance for deferred income tax assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(515)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(470)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net deferred income tax assets&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;1,293&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;942&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Deferred income tax liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Inventory basis differences&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(1,119)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(1,083)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Property-related&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(375)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(327)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Goodwill and other intangibles&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(733)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(751)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Self-Insurance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(975)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(23)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total deferred income tax liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(3,225)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(2,161)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:6pt;padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net deferred income tax liability&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(1,932)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(1,219)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Deferred income tax assets and liabilities in the preceding table, after netting by taxing jurisdiction and for uncertain tax positions, are in the following captions in the consolidated balance sheets at June 30:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:60.937%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.109%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.343%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.111%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Noncurrent deferred income tax asset (1)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;52&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Noncurrent deferred income tax liability (2)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(1,981)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(1,258)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Noncurrent deferred income tax liability transferred to held for sale&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net deferred income tax liability&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(1,932)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(1,219)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:10pt"&gt;Included in other assets in the consolidated balance sheets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:10pt"&gt;Included in deferred income taxes and other liabilities in the consolidated balance sheets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At June&#160;30, 2021 we had gross federal, state and international loss and credit carryforwards of $272 million, $3.9 billion and $2.3 billion, respectively, the tax effect of which is an aggregate deferred tax asset of $805 million. Substantially all of these carryforwards are available for at least three years. Approximately $477 million of the valuation allowance at June&#160;30, 2021 applies to certain federal, state and international loss carryforwards that, in our opinion, are more likely than not to expire unutilized. However, to the extent that tax benefits related&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;to these carryforwards are realized in the future, the reduction in the valuation allowance would reduce income tax expense.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Unrecognized Tax Benefits&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We had $932 million, $998 million and $456 million of unrecognized tax benefits at June&#160;30, 2021, 2020 and 2019, respectively. The June&#160;30, 2021, 2020 and 2019 balances include $849 million, $753 million and $303 million, respectively, of unrecognized tax benefits that, if recognized, would have an impact on the effective tax rate. The remaining unrecognized tax benefits relate to tax positions for which ultimate deductibility is highly certain but for which there is uncertainty as to the timing of such deductibility. Recognition of these tax benefits would not affect our effective tax rate. We include the full amount of unrecognized tax benefits in deferred income taxes and other liabilities in the consolidated balance sheets. The following table presents a reconciliation of the beginning and ending amounts of unrecognized tax benefits:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.691%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:53.389%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.999%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.347%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.831%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.347%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.287%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Balance at beginning of fiscal year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;998&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;456&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;423&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Additions for tax positions of the current year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;121&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Additions for tax positions of prior years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;223&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;78&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Reductions for tax positions of prior years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(138)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(27)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Settlements with tax authorities &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(271)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(25)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Expiration of the statute of limitations &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Balance at end of fiscal year&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;932&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;998&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;456&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;It is reasonably possible that there could be a change in the amount of unrecognized tax benefits within the next 12 months due to activities of the U.S. Internal Revenue Service ("IRS") or other taxing authorities, possible settlement of audit issues, &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;reassessment of existing unrecognized tax benefits or the expiration of statutes of limitations. We estimate that the range of the possible change in unrecognized tax benefits within the next 12 months is a net decrease of $0 million to $20 million, exclusive of penalties and interest.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We recognize accrued interest and penalties related to unrecognized tax benefits in the provision for income taxes. At June&#160;30, 2021, 2020 and 2019, we had $49 million, $146 million and $122 million, respectively, accrued for the payment of interest and penalties. These balances are gross amounts before any tax benefits and are included in deferred income taxes and other liabilities in the consolidated balance sheets. As a result of our IRS audit settlements and carryback claim, an immaterial amount of interest was recorded in fiscal 2021. During fiscal 2020 and 2019, we recognized $16 million and $8 million of expense for interest and penalties in income tax expense, respectively. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Other Tax Matters&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We file income tax returns in the U.S. federal jurisdiction, various U.S. state and local jurisdictions, and various foreign jurisdictions. With few exceptions, we are subject to audit by taxing authorities for fiscal years 2015 through the current fiscal year. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We are a party to a tax matters agreement with CareFusion Corporation ("CareFusion"), which has been acquired by Becton, Dickinson and Company. Under the tax matters agreement, CareFusion is obligated to indemnify us for certain tax exposures and transaction taxes prior to our fiscal 2010 spin-off of CareFusion. The indemnification receivable was $72 million and $176 million at June&#160;30, 2021 and 2020, respectively, and is included in other assets in the consolidated balance sheets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As a result of the acquisition of the Patient Recovery Business, Medtronic plc is obligated to indemnify us for certain tax exposures and transaction taxes related to periods prior to the acquisition under the purchase agreement. The indemnification receivable was $12 million and $19 million at June&#160;30, 2021 and 2020, respectively, and is included in other assets in the consolidated balance sheets.&lt;/span&gt;&lt;/div&gt;</us-gaap:IncomeTaxDisclosureTextBlock>
    <us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock
      contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90ZXh0cmVnaW9uOmViYTAwMWFhMmQ5YjRmODZiMGIyMTI2YzNmMjlhODhmXzg3ODg_4fd4f502-7019-4ca5-85e2-cf9cf6aff503">&lt;div style="margin-bottom:3pt"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes earnings/(loss) before income taxes:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.691%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:53.389%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.999%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.347%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.522%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.347%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.596%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;U.S. operations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(47)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(4,056)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,478&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Non-U.S. operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;370&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;284&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;273&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Earnings/(loss) before income taxes&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;323&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(3,772)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,751&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
      contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90YWJsZTo3MGQ0NWU0YjdmZmY0N2JmYjJmMTlmZmNkYzkwMThiMC90YWJsZXJhbmdlOjcwZDQ1ZTRiN2ZmZjQ3YmZiMmYxOWZmY2RjOTAxOGIwXzEtMS0xLTEtMA_449f771b-1846-4e2c-9961-4bc7b6b23e51"
      unitRef="usd">-47000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
      contextRef="ia31e9a409b874bb19d0ff6f2f39ecc09_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90YWJsZTo3MGQ0NWU0YjdmZmY0N2JmYjJmMTlmZmNkYzkwMThiMC90YWJsZXJhbmdlOjcwZDQ1ZTRiN2ZmZjQ3YmZiMmYxOWZmY2RjOTAxOGIwXzEtMy0xLTEtMA_f039d5bc-afc6-42dc-9c7c-1e184a19bf11"
      unitRef="usd">-4056000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
      contextRef="i00a6d666bf604826b24e68ddbd63eac4_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90YWJsZTo3MGQ0NWU0YjdmZmY0N2JmYjJmMTlmZmNkYzkwMThiMC90YWJsZXJhbmdlOjcwZDQ1ZTRiN2ZmZjQ3YmZiMmYxOWZmY2RjOTAxOGIwXzEtNS0xLTEtMA_90238659-1cfc-4d2b-8440-6037e4fa5612"
      unitRef="usd">1478000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
      contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90YWJsZTo3MGQ0NWU0YjdmZmY0N2JmYjJmMTlmZmNkYzkwMThiMC90YWJsZXJhbmdlOjcwZDQ1ZTRiN2ZmZjQ3YmZiMmYxOWZmY2RjOTAxOGIwXzItMS0xLTEtMA_abbe52bd-9fe6-4cd5-ba2a-e7a24c2ec419"
      unitRef="usd">370000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
      contextRef="ia31e9a409b874bb19d0ff6f2f39ecc09_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90YWJsZTo3MGQ0NWU0YjdmZmY0N2JmYjJmMTlmZmNkYzkwMThiMC90YWJsZXJhbmdlOjcwZDQ1ZTRiN2ZmZjQ3YmZiMmYxOWZmY2RjOTAxOGIwXzItMy0xLTEtMA_419eea01-1547-4c5b-9691-03596d7e22dc"
      unitRef="usd">284000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
      contextRef="i00a6d666bf604826b24e68ddbd63eac4_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90YWJsZTo3MGQ0NWU0YjdmZmY0N2JmYjJmMTlmZmNkYzkwMThiMC90YWJsZXJhbmdlOjcwZDQ1ZTRiN2ZmZjQ3YmZiMmYxOWZmY2RjOTAxOGIwXzItNS0xLTEtMA_a6dffc8d-f803-4a65-8eb3-9b5f8ef3c77b"
      unitRef="usd">273000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90YWJsZTo3MGQ0NWU0YjdmZmY0N2JmYjJmMTlmZmNkYzkwMThiMC90YWJsZXJhbmdlOjcwZDQ1ZTRiN2ZmZjQ3YmZiMmYxOWZmY2RjOTAxOGIwXzMtMS0xLTEtMA_b86e0a6d-d87d-420c-b0cb-5cc3a2430e2f"
      unitRef="usd">323000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="ia31e9a409b874bb19d0ff6f2f39ecc09_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90YWJsZTo3MGQ0NWU0YjdmZmY0N2JmYjJmMTlmZmNkYzkwMThiMC90YWJsZXJhbmdlOjcwZDQ1ZTRiN2ZmZjQ3YmZiMmYxOWZmY2RjOTAxOGIwXzMtMy0xLTEtMA_2f9cc3e2-1e0d-44b8-8265-c656e9e3e9a0"
      unitRef="usd">-3772000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="i00a6d666bf604826b24e68ddbd63eac4_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90YWJsZTo3MGQ0NWU0YjdmZmY0N2JmYjJmMTlmZmNkYzkwMThiMC90YWJsZXJhbmdlOjcwZDQ1ZTRiN2ZmZjQ3YmZiMmYxOWZmY2RjOTAxOGIwXzMtNS0xLTEtMA_39b9ecc4-9e23-414b-ace2-7c845e5f6ce0"
      unitRef="usd">1751000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock
      contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90ZXh0cmVnaW9uOmViYTAwMWFhMmQ5YjRmODZiMGIyMTI2YzNmMjlhODhmXzg3NzI_69258910-c9a7-454f-93a9-1a4a84aa3151">&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the components of provision for/(benefit from) income taxes:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:8pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:53.220%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.949%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.343%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.171%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.343%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.174%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Current:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Federal&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(989)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;659&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;295&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;State and local&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;92&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;154&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;89&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Non-U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;112&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;69&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;85&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total current&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(785)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;882&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;469&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Deferred:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Federal&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;539&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(822)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(28)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;State and local&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(28)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(127)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(37)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Non-U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(15)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(18)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total deferred&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;496&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(961)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(83)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Provision for/(benefit from) income taxes&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(289)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(79)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;386&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock>
    <us-gaap:CurrentFederalTaxExpenseBenefit
      contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90YWJsZTo3ZjVkNzE0NjNhZmE0M2FlOWU4YWYxY2YxODFjODI3YS90YWJsZXJhbmdlOjdmNWQ3MTQ2M2FmYTQzYWU5ZThhZjFjZjE4MWM4MjdhXzItMS0xLTEtMA_dd9f13f1-4eb0-43b5-884b-8f2b28594742"
      unitRef="usd">-989000000</us-gaap:CurrentFederalTaxExpenseBenefit>
    <us-gaap:CurrentFederalTaxExpenseBenefit
      contextRef="ia31e9a409b874bb19d0ff6f2f39ecc09_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90YWJsZTo3ZjVkNzE0NjNhZmE0M2FlOWU4YWYxY2YxODFjODI3YS90YWJsZXJhbmdlOjdmNWQ3MTQ2M2FmYTQzYWU5ZThhZjFjZjE4MWM4MjdhXzItMy0xLTEtMA_fed5e635-c47f-4e20-a2a9-bcdeccf5f090"
      unitRef="usd">659000000</us-gaap:CurrentFederalTaxExpenseBenefit>
    <us-gaap:CurrentFederalTaxExpenseBenefit
      contextRef="i00a6d666bf604826b24e68ddbd63eac4_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90YWJsZTo3ZjVkNzE0NjNhZmE0M2FlOWU4YWYxY2YxODFjODI3YS90YWJsZXJhbmdlOjdmNWQ3MTQ2M2FmYTQzYWU5ZThhZjFjZjE4MWM4MjdhXzItNS0xLTEtMA_68abb596-7d5e-487e-8ddf-db556d49d999"
      unitRef="usd">295000000</us-gaap:CurrentFederalTaxExpenseBenefit>
    <us-gaap:CurrentStateAndLocalTaxExpenseBenefit
      contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90YWJsZTo3ZjVkNzE0NjNhZmE0M2FlOWU4YWYxY2YxODFjODI3YS90YWJsZXJhbmdlOjdmNWQ3MTQ2M2FmYTQzYWU5ZThhZjFjZjE4MWM4MjdhXzMtMS0xLTEtMA_5e225082-702a-4b99-9cf6-c847a60833bf"
      unitRef="usd">92000000</us-gaap:CurrentStateAndLocalTaxExpenseBenefit>
    <us-gaap:CurrentStateAndLocalTaxExpenseBenefit
      contextRef="ia31e9a409b874bb19d0ff6f2f39ecc09_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90YWJsZTo3ZjVkNzE0NjNhZmE0M2FlOWU4YWYxY2YxODFjODI3YS90YWJsZXJhbmdlOjdmNWQ3MTQ2M2FmYTQzYWU5ZThhZjFjZjE4MWM4MjdhXzMtMy0xLTEtMA_324fdc52-e7ff-465b-9ed9-86e3bf009406"
      unitRef="usd">154000000</us-gaap:CurrentStateAndLocalTaxExpenseBenefit>
    <us-gaap:CurrentStateAndLocalTaxExpenseBenefit
      contextRef="i00a6d666bf604826b24e68ddbd63eac4_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90YWJsZTo3ZjVkNzE0NjNhZmE0M2FlOWU4YWYxY2YxODFjODI3YS90YWJsZXJhbmdlOjdmNWQ3MTQ2M2FmYTQzYWU5ZThhZjFjZjE4MWM4MjdhXzMtNS0xLTEtMA_b007ca43-7d09-47f6-bd5e-007eeb872f20"
      unitRef="usd">89000000</us-gaap:CurrentStateAndLocalTaxExpenseBenefit>
    <us-gaap:CurrentForeignTaxExpenseBenefit
      contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90YWJsZTo3ZjVkNzE0NjNhZmE0M2FlOWU4YWYxY2YxODFjODI3YS90YWJsZXJhbmdlOjdmNWQ3MTQ2M2FmYTQzYWU5ZThhZjFjZjE4MWM4MjdhXzQtMS0xLTEtMA_4967330d-3e83-4bcb-9136-c8b914215e81"
      unitRef="usd">112000000</us-gaap:CurrentForeignTaxExpenseBenefit>
    <us-gaap:CurrentForeignTaxExpenseBenefit
      contextRef="ia31e9a409b874bb19d0ff6f2f39ecc09_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90YWJsZTo3ZjVkNzE0NjNhZmE0M2FlOWU4YWYxY2YxODFjODI3YS90YWJsZXJhbmdlOjdmNWQ3MTQ2M2FmYTQzYWU5ZThhZjFjZjE4MWM4MjdhXzQtMy0xLTEtMA_6742f58c-9371-4a0e-9cb5-5d739bed9618"
      unitRef="usd">69000000</us-gaap:CurrentForeignTaxExpenseBenefit>
    <us-gaap:CurrentForeignTaxExpenseBenefit
      contextRef="i00a6d666bf604826b24e68ddbd63eac4_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90YWJsZTo3ZjVkNzE0NjNhZmE0M2FlOWU4YWYxY2YxODFjODI3YS90YWJsZXJhbmdlOjdmNWQ3MTQ2M2FmYTQzYWU5ZThhZjFjZjE4MWM4MjdhXzQtNS0xLTEtMA_af09f46d-5125-4a8e-bd77-cec2289c367e"
      unitRef="usd">85000000</us-gaap:CurrentForeignTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit
      contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90YWJsZTo3ZjVkNzE0NjNhZmE0M2FlOWU4YWYxY2YxODFjODI3YS90YWJsZXJhbmdlOjdmNWQ3MTQ2M2FmYTQzYWU5ZThhZjFjZjE4MWM4MjdhXzUtMS0xLTEtMA_feb69bb8-bc2f-42d9-91ce-53a7e198eb60"
      unitRef="usd">-785000000</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit
      contextRef="ia31e9a409b874bb19d0ff6f2f39ecc09_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90YWJsZTo3ZjVkNzE0NjNhZmE0M2FlOWU4YWYxY2YxODFjODI3YS90YWJsZXJhbmdlOjdmNWQ3MTQ2M2FmYTQzYWU5ZThhZjFjZjE4MWM4MjdhXzUtMy0xLTEtMA_58815527-a3b4-4a40-960a-63b5b884f7ac"
      unitRef="usd">882000000</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit
      contextRef="i00a6d666bf604826b24e68ddbd63eac4_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90YWJsZTo3ZjVkNzE0NjNhZmE0M2FlOWU4YWYxY2YxODFjODI3YS90YWJsZXJhbmdlOjdmNWQ3MTQ2M2FmYTQzYWU5ZThhZjFjZjE4MWM4MjdhXzUtNS0xLTEtMA_8be84b1a-720e-4b7e-a005-4f491dfb220a"
      unitRef="usd">469000000</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:DeferredFederalIncomeTaxExpenseBenefit
      contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90YWJsZTo3ZjVkNzE0NjNhZmE0M2FlOWU4YWYxY2YxODFjODI3YS90YWJsZXJhbmdlOjdmNWQ3MTQ2M2FmYTQzYWU5ZThhZjFjZjE4MWM4MjdhXzgtMS0xLTEtMA_da9a6c00-0e88-41a8-b524-1f16696db96e"
      unitRef="usd">539000000</us-gaap:DeferredFederalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredFederalIncomeTaxExpenseBenefit
      contextRef="ia31e9a409b874bb19d0ff6f2f39ecc09_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90YWJsZTo3ZjVkNzE0NjNhZmE0M2FlOWU4YWYxY2YxODFjODI3YS90YWJsZXJhbmdlOjdmNWQ3MTQ2M2FmYTQzYWU5ZThhZjFjZjE4MWM4MjdhXzgtMy0xLTEtMA_363325ac-686a-484e-87f8-d0ecaff8c87c"
      unitRef="usd">-822000000</us-gaap:DeferredFederalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredFederalIncomeTaxExpenseBenefit
      contextRef="i00a6d666bf604826b24e68ddbd63eac4_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90YWJsZTo3ZjVkNzE0NjNhZmE0M2FlOWU4YWYxY2YxODFjODI3YS90YWJsZXJhbmdlOjdmNWQ3MTQ2M2FmYTQzYWU5ZThhZjFjZjE4MWM4MjdhXzgtNS0xLTEtMA_3389a107-9823-4e68-b840-3398a0fdb911"
      unitRef="usd">-28000000</us-gaap:DeferredFederalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit
      contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90YWJsZTo3ZjVkNzE0NjNhZmE0M2FlOWU4YWYxY2YxODFjODI3YS90YWJsZXJhbmdlOjdmNWQ3MTQ2M2FmYTQzYWU5ZThhZjFjZjE4MWM4MjdhXzktMS0xLTEtMA_9240fac8-b382-4f21-8564-e69f31f59b76"
      unitRef="usd">-28000000</us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit
      contextRef="ia31e9a409b874bb19d0ff6f2f39ecc09_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90YWJsZTo3ZjVkNzE0NjNhZmE0M2FlOWU4YWYxY2YxODFjODI3YS90YWJsZXJhbmdlOjdmNWQ3MTQ2M2FmYTQzYWU5ZThhZjFjZjE4MWM4MjdhXzktMy0xLTEtMA_933e5ac8-9de3-4b22-abbe-4c1b8fabb880"
      unitRef="usd">-127000000</us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit
      contextRef="i00a6d666bf604826b24e68ddbd63eac4_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90YWJsZTo3ZjVkNzE0NjNhZmE0M2FlOWU4YWYxY2YxODFjODI3YS90YWJsZXJhbmdlOjdmNWQ3MTQ2M2FmYTQzYWU5ZThhZjFjZjE4MWM4MjdhXzktNS0xLTEtMA_0248a9f4-4b22-4876-be12-024981a05754"
      unitRef="usd">-37000000</us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredForeignIncomeTaxExpenseBenefit
      contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90YWJsZTo3ZjVkNzE0NjNhZmE0M2FlOWU4YWYxY2YxODFjODI3YS90YWJsZXJhbmdlOjdmNWQ3MTQ2M2FmYTQzYWU5ZThhZjFjZjE4MWM4MjdhXzEwLTEtMS0xLTA_23a61afd-8e2f-4941-9262-9eabdf762008"
      unitRef="usd">-15000000</us-gaap:DeferredForeignIncomeTaxExpenseBenefit>
    <us-gaap:DeferredForeignIncomeTaxExpenseBenefit
      contextRef="ia31e9a409b874bb19d0ff6f2f39ecc09_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90YWJsZTo3ZjVkNzE0NjNhZmE0M2FlOWU4YWYxY2YxODFjODI3YS90YWJsZXJhbmdlOjdmNWQ3MTQ2M2FmYTQzYWU5ZThhZjFjZjE4MWM4MjdhXzEwLTMtMS0xLTA_25b68730-a177-4101-834e-f934c9b3b834"
      unitRef="usd">-12000000</us-gaap:DeferredForeignIncomeTaxExpenseBenefit>
    <us-gaap:DeferredForeignIncomeTaxExpenseBenefit
      contextRef="i00a6d666bf604826b24e68ddbd63eac4_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90YWJsZTo3ZjVkNzE0NjNhZmE0M2FlOWU4YWYxY2YxODFjODI3YS90YWJsZXJhbmdlOjdmNWQ3MTQ2M2FmYTQzYWU5ZThhZjFjZjE4MWM4MjdhXzEwLTUtMS0xLTA_2420d338-f135-49bb-9868-e68eb118a797"
      unitRef="usd">-18000000</us-gaap:DeferredForeignIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90YWJsZTo3ZjVkNzE0NjNhZmE0M2FlOWU4YWYxY2YxODFjODI3YS90YWJsZXJhbmdlOjdmNWQ3MTQ2M2FmYTQzYWU5ZThhZjFjZjE4MWM4MjdhXzExLTEtMS0xLTA_d86f5b19-febb-418a-aa32-6115ef6dabdc"
      unitRef="usd">496000000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="ia31e9a409b874bb19d0ff6f2f39ecc09_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90YWJsZTo3ZjVkNzE0NjNhZmE0M2FlOWU4YWYxY2YxODFjODI3YS90YWJsZXJhbmdlOjdmNWQ3MTQ2M2FmYTQzYWU5ZThhZjFjZjE4MWM4MjdhXzExLTMtMS0xLTA_132a7027-04d6-457c-a21a-8cfd035f3b82"
      unitRef="usd">-961000000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="i00a6d666bf604826b24e68ddbd63eac4_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90YWJsZTo3ZjVkNzE0NjNhZmE0M2FlOWU4YWYxY2YxODFjODI3YS90YWJsZXJhbmdlOjdmNWQ3MTQ2M2FmYTQzYWU5ZThhZjFjZjE4MWM4MjdhXzExLTUtMS0xLTA_9bdbcb51-d987-46e5-9811-f540876147b0"
      unitRef="usd">-83000000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90YWJsZTo3ZjVkNzE0NjNhZmE0M2FlOWU4YWYxY2YxODFjODI3YS90YWJsZXJhbmdlOjdmNWQ3MTQ2M2FmYTQzYWU5ZThhZjFjZjE4MWM4MjdhXzEyLTEtMS0xLTA_d9145237-32c1-4c7a-ab10-b8a7459eb17a"
      unitRef="usd">-289000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="ia31e9a409b874bb19d0ff6f2f39ecc09_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90YWJsZTo3ZjVkNzE0NjNhZmE0M2FlOWU4YWYxY2YxODFjODI3YS90YWJsZXJhbmdlOjdmNWQ3MTQ2M2FmYTQzYWU5ZThhZjFjZjE4MWM4MjdhXzEyLTMtMS0xLTA_41d4030c-16d3-433d-a1e4-d23b90309c88"
      unitRef="usd">-79000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i00a6d666bf604826b24e68ddbd63eac4_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90YWJsZTo3ZjVkNzE0NjNhZmE0M2FlOWU4YWYxY2YxODFjODI3YS90YWJsZXJhbmdlOjdmNWQ3MTQ2M2FmYTQzYWU5ZThhZjFjZjE4MWM4MjdhXzEyLTUtMS0xLTA_0d2befc9-89d3-4176-846a-bc622100fabd"
      unitRef="usd">386000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i267869e21f794c639e2b4ecddb88f627_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90ZXh0cmVnaW9uOmViYTAwMWFhMmQ5YjRmODZiMGIyMTI2YzNmMjlhODhmXzIxOTkwMjMyNzE1NTE_8bd3bafd-59c4-4d19-9336-3df80c877450"
      unitRef="usd">-424000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxReceivable
      contextRef="i58599d5030cc46db8dc1c2d03162cce3_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90ZXh0cmVnaW9uOmViYTAwMWFhMmQ5YjRmODZiMGIyMTI2YzNmMjlhODhmXzI3NDg3NzkwOTI0ODE_79cc2e63-3df2-4331-98a6-141d86db8867"
      unitRef="usd">974000000</us-gaap:IncomeTaxReceivable>
    <us-gaap:DeferredTaxAndOtherLiabilitiesNoncurrent
      contextRef="i58599d5030cc46db8dc1c2d03162cce3_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90ZXh0cmVnaW9uOmViYTAwMWFhMmQ5YjRmODZiMGIyMTI2YzNmMjlhODhmXzI3NDg3NzkwOTI0OTU_50589e8c-8718-4a7e-a459-b0520d82ac73"
      unitRef="usd">700000000</us-gaap:DeferredTaxAndOtherLiabilitiesNoncurrent>
    <us-gaap:LitigationSettlementExpense
      contextRef="id2a6b6641ae248c98d689f30c606f881_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90ZXh0cmVnaW9uOmViYTAwMWFhMmQ5YjRmODZiMGIyMTI2YzNmMjlhODhmXzIwODkwNzIwOTU3NjE3_f7b0a9d5-fb4b-4824-99dc-1e65da0fc4ee"
      unitRef="usd">1170000000</us-gaap:LitigationSettlementExpense>
    <us-gaap:LitigationSettlementExpense
      contextRef="i373ba6a0cdc044dea9602bdbad13174c_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90ZXh0cmVnaW9uOmViYTAwMWFhMmQ5YjRmODZiMGIyMTI2YzNmMjlhODhmXzI3NDg3NzkwOTk3ODM_1e2c07c1-e98e-4edc-9c1a-bef2d1c59d0d"
      unitRef="usd">5630000000</us-gaap:LitigationSettlementExpense>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="id2a6b6641ae248c98d689f30c606f881_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90ZXh0cmVnaW9uOmViYTAwMWFhMmQ5YjRmODZiMGIyMTI2YzNmMjlhODhmXzQ5NDc4MDIzMzg0ODc_69fd5dc6-9099-4960-8508-46f05d1a2013"
      unitRef="usd">228000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i373ba6a0cdc044dea9602bdbad13174c_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90ZXh0cmVnaW9uOmViYTAwMWFhMmQ5YjRmODZiMGIyMTI2YzNmMjlhODhmXzQ5NDc4MDIzMzg0OTY_7c52794a-9098-47f3-9f16-43f389a65451"
      unitRef="usd">488000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
      contextRef="iddd4821afbbd40c4a6c811e70974bf4a_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90ZXh0cmVnaW9uOmViYTAwMWFhMmQ5YjRmODZiMGIyMTI2YzNmMjlhODhmXzQ5NDc4MDIzMzg3NjM_f262da9f-cf3c-4182-a632-baeca19bab0c"
      unitRef="usd">219000000</us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate>
    <us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
      contextRef="i44b4e02791f742199433f84d47a44563_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90ZXh0cmVnaW9uOmViYTAwMWFhMmQ5YjRmODZiMGIyMTI2YzNmMjlhODhmXzQ5NDc4MDIzMzg3NzI_e8e9df7e-f92a-4e8a-b918-df5359b9ba11"
      unitRef="usd">469000000</us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate>
    <us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock
      contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90ZXh0cmVnaW9uOmViYTAwMWFhMmQ5YjRmODZiMGIyMTI2YzNmMjlhODhmXzg3OTA_8329e244-fdea-4902-9d31-a773bd3392ae">&lt;div style="margin-top:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents a reconciliation of the provision based on the federal statutory income tax rate to our effective income tax rate:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:53.220%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.343%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.343%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.482%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021 &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt; (1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2019 &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Provision at Federal statutory rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;21.0&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;21.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;21.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;State and local income taxes, net of federal benefit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;3.2&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;0.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Tax effect of foreign operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;0.7&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(0.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Nondeductible/nontaxable items &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;1.6&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;0.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Cordis Disposition&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;7.0&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Withholding Taxes &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;9.0&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(0.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Change in Valuation Allowances&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(1.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;4.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;US Taxes on International Income&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt; (2)(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(6.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Impact of Resolutions with IRS and other related matters &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(13.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(0.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Legal Entity Reorganization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(3.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Opioid litigation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;17.7&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(23.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Loss Carryback Claims&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(129.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Other &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;1.7&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;0.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(2.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Effective income tax rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(89.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;22.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&#160;&#160;&#160;&#160;The table represents the following: fiscal 2021 is pretax income with tax benefit, fiscal 2020 is pretax loss with tax benefit, and fiscal 2019 is pretax income with tax expense.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(2)&#160;&#160;&#160;&#160;Certain prior year amounts have been reclassified to conform to current year presentation.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90YWJsZTowODVmMDBiY2Q2YWQ0NDRhYmY3ODM4MGEwZWFhNWRkNy90YWJsZXJhbmdlOjA4NWYwMGJjZDZhZDQ0NGFiZjc4MzgwYTBlYWE1ZGQ3XzEtMS0xLTEtMA_ec877842-7ea6-48f9-bf85-8b869511bb9a"
      unitRef="number">0.210</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="ia31e9a409b874bb19d0ff6f2f39ecc09_D20190701-20200630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90YWJsZTowODVmMDBiY2Q2YWQ0NDRhYmY3ODM4MGEwZWFhNWRkNy90YWJsZXJhbmdlOjA4NWYwMGJjZDZhZDQ0NGFiZjc4MzgwYTBlYWE1ZGQ3XzEtMy0xLTEtMA_61d8e46b-3c4d-467f-a159-133e2ca775b3"
      unitRef="number">0.210</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="i00a6d666bf604826b24e68ddbd63eac4_D20180701-20190630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90YWJsZTowODVmMDBiY2Q2YWQ0NDRhYmY3ODM4MGEwZWFhNWRkNy90YWJsZXJhbmdlOjA4NWYwMGJjZDZhZDQ0NGFiZjc4MzgwYTBlYWE1ZGQ3XzEtNS0xLTEtMA_31bdb3ab-2fd9-435f-8d12-3fdd8c890a58"
      unitRef="number">0.210</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
      contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90YWJsZTowODVmMDBiY2Q2YWQ0NDRhYmY3ODM4MGEwZWFhNWRkNy90YWJsZXJhbmdlOjA4NWYwMGJjZDZhZDQ0NGFiZjc4MzgwYTBlYWE1ZGQ3XzItMS0xLTEtMA_d8f9196e-f4e7-4e1a-948f-c81c5261b87d"
      unitRef="number">0.032</us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
      contextRef="ia31e9a409b874bb19d0ff6f2f39ecc09_D20190701-20200630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90YWJsZTowODVmMDBiY2Q2YWQ0NDRhYmY3ODM4MGEwZWFhNWRkNy90YWJsZXJhbmdlOjA4NWYwMGJjZDZhZDQ0NGFiZjc4MzgwYTBlYWE1ZGQ3XzItMy0xLTEtMA_7983bd23-291d-4af3-8760-aed4ce4cc281"
      unitRef="number">0.025</us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
      contextRef="i00a6d666bf604826b24e68ddbd63eac4_D20180701-20190630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90YWJsZTowODVmMDBiY2Q2YWQ0NDRhYmY3ODM4MGEwZWFhNWRkNy90YWJsZXJhbmdlOjA4NWYwMGJjZDZhZDQ0NGFiZjc4MzgwYTBlYWE1ZGQ3XzItNS0xLTEtMA_0cb316e2-47db-46c2-b8b9-05b3189be875"
      unitRef="number">0.009</us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes>
    <cah:EffectiveIncomeTaxRateReconciliationTaxEffectOfForeignOperations
      contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90YWJsZTowODVmMDBiY2Q2YWQ0NDRhYmY3ODM4MGEwZWFhNWRkNy90YWJsZXJhbmdlOjA4NWYwMGJjZDZhZDQ0NGFiZjc4MzgwYTBlYWE1ZGQ3XzMtMS0xLTEtMA_18298b90-0f2e-4246-9f5a-43784f9485dd"
      unitRef="number">0.007</cah:EffectiveIncomeTaxRateReconciliationTaxEffectOfForeignOperations>
    <cah:EffectiveIncomeTaxRateReconciliationTaxEffectOfForeignOperations
      contextRef="ia31e9a409b874bb19d0ff6f2f39ecc09_D20190701-20200630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90YWJsZTowODVmMDBiY2Q2YWQ0NDRhYmY3ODM4MGEwZWFhNWRkNy90YWJsZXJhbmdlOjA4NWYwMGJjZDZhZDQ0NGFiZjc4MzgwYTBlYWE1ZGQ3XzMtMy0xLTEtMA_5eaf91fc-e357-424b-a852-e35ff6d5874d"
      unitRef="number">0</cah:EffectiveIncomeTaxRateReconciliationTaxEffectOfForeignOperations>
    <cah:EffectiveIncomeTaxRateReconciliationTaxEffectOfForeignOperations
      contextRef="i00a6d666bf604826b24e68ddbd63eac4_D20180701-20190630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90YWJsZTowODVmMDBiY2Q2YWQ0NDRhYmY3ODM4MGEwZWFhNWRkNy90YWJsZXJhbmdlOjA4NWYwMGJjZDZhZDQ0NGFiZjc4MzgwYTBlYWE1ZGQ3XzMtNS0xLTEtMA_6b250053-2d30-496d-98ec-d6e59f8edc64"
      unitRef="number">-0.007</cah:EffectiveIncomeTaxRateReconciliationTaxEffectOfForeignOperations>
    <us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpense
      contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90YWJsZTowODVmMDBiY2Q2YWQ0NDRhYmY3ODM4MGEwZWFhNWRkNy90YWJsZXJhbmdlOjA4NWYwMGJjZDZhZDQ0NGFiZjc4MzgwYTBlYWE1ZGQ3XzQtMS0xLTEtMA_8b0cd247-63c0-4ff1-9037-ce3a9270fe39"
      unitRef="number">0.016</us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpense>
    <us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpense
      contextRef="ia31e9a409b874bb19d0ff6f2f39ecc09_D20190701-20200630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90YWJsZTowODVmMDBiY2Q2YWQ0NDRhYmY3ODM4MGEwZWFhNWRkNy90YWJsZXJhbmdlOjA4NWYwMGJjZDZhZDQ0NGFiZjc4MzgwYTBlYWE1ZGQ3XzQtMy0xLTEtMA_cebec030-da8f-4056-9e8a-cc4aec599aa4"
      unitRef="number">0.002</us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpense>
    <us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpense
      contextRef="i00a6d666bf604826b24e68ddbd63eac4_D20180701-20190630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90YWJsZTowODVmMDBiY2Q2YWQ0NDRhYmY3ODM4MGEwZWFhNWRkNy90YWJsZXJhbmdlOjA4NWYwMGJjZDZhZDQ0NGFiZjc4MzgwYTBlYWE1ZGQ3XzQtNS0xLTEtMA_d49bb07f-a7f0-4ec1-a01c-3dec36a54f5d"
      unitRef="number">0.008</us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpense>
    <us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses
      contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90YWJsZTowODVmMDBiY2Q2YWQ0NDRhYmY3ODM4MGEwZWFhNWRkNy90YWJsZXJhbmdlOjA4NWYwMGJjZDZhZDQ0NGFiZjc4MzgwYTBlYWE1ZGQ3XzUtMS0xLTEtOTg1NA_25f15fbb-7883-438e-a15f-27984d64de38"
      unitRef="number">0.070</us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses>
    <us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses
      contextRef="ia31e9a409b874bb19d0ff6f2f39ecc09_D20190701-20200630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90YWJsZTowODVmMDBiY2Q2YWQ0NDRhYmY3ODM4MGEwZWFhNWRkNy90YWJsZXJhbmdlOjA4NWYwMGJjZDZhZDQ0NGFiZjc4MzgwYTBlYWE1ZGQ3XzUtMy0xLTEtOTg1Nw_f06dc55d-02b4-463f-8518-a3d3b3c0af1d"
      unitRef="number">0</us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses>
    <us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses
      contextRef="i00a6d666bf604826b24e68ddbd63eac4_D20180701-20190630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90YWJsZTowODVmMDBiY2Q2YWQ0NDRhYmY3ODM4MGEwZWFhNWRkNy90YWJsZXJhbmdlOjA4NWYwMGJjZDZhZDQ0NGFiZjc4MzgwYTBlYWE1ZGQ3XzUtNS0xLTEtOTg2Mg_1f165bc1-6903-4f40-9de6-b3617e371a5f"
      unitRef="number">0</us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses>
    <cah:EffectiveIncomeTaxRateReconciliationWithholdingTaxes
      contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90YWJsZTowODVmMDBiY2Q2YWQ0NDRhYmY3ODM4MGEwZWFhNWRkNy90YWJsZXJhbmdlOjA4NWYwMGJjZDZhZDQ0NGFiZjc4MzgwYTBlYWE1ZGQ3XzYtMS0xLTEtOTg2Ng_eb24cf64-35ab-4054-97e6-31e33c7f9238"
      unitRef="number">0.090</cah:EffectiveIncomeTaxRateReconciliationWithholdingTaxes>
    <cah:EffectiveIncomeTaxRateReconciliationWithholdingTaxes
      contextRef="ia31e9a409b874bb19d0ff6f2f39ecc09_D20190701-20200630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90YWJsZTowODVmMDBiY2Q2YWQ0NDRhYmY3ODM4MGEwZWFhNWRkNy90YWJsZXJhbmdlOjA4NWYwMGJjZDZhZDQ0NGFiZjc4MzgwYTBlYWE1ZGQ3XzYtMy0xLTEtOTg2OQ_f9c48c79-aed0-42cd-a9dc-e204d249bdc5"
      unitRef="number">-0.003</cah:EffectiveIncomeTaxRateReconciliationWithholdingTaxes>
    <cah:EffectiveIncomeTaxRateReconciliationWithholdingTaxes
      contextRef="i00a6d666bf604826b24e68ddbd63eac4_D20180701-20190630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90YWJsZTowODVmMDBiY2Q2YWQ0NDRhYmY3ODM4MGEwZWFhNWRkNy90YWJsZXJhbmdlOjA4NWYwMGJjZDZhZDQ0NGFiZjc4MzgwYTBlYWE1ZGQ3XzYtNS0xLTEtOTg3Mg_5bcffea5-34a4-473b-a86b-4dbd9b805840"
      unitRef="number">0.007</cah:EffectiveIncomeTaxRateReconciliationWithholdingTaxes>
    <us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
      contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90YWJsZTowODVmMDBiY2Q2YWQ0NDRhYmY3ODM4MGEwZWFhNWRkNy90YWJsZXJhbmdlOjA4NWYwMGJjZDZhZDQ0NGFiZjc4MzgwYTBlYWE1ZGQ3XzUtMS0xLTEtMA_e3c64ad2-0dcb-4d4b-9c7a-2059fc46ad59"
      unitRef="number">-0.014</us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
      contextRef="ia31e9a409b874bb19d0ff6f2f39ecc09_D20190701-20200630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90YWJsZTowODVmMDBiY2Q2YWQ0NDRhYmY3ODM4MGEwZWFhNWRkNy90YWJsZXJhbmdlOjA4NWYwMGJjZDZhZDQ0NGFiZjc4MzgwYTBlYWE1ZGQ3XzUtMy0xLTEtMA_348a2440-2b53-4207-a36c-55ce999431a5"
      unitRef="number">0.015</us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
      contextRef="i00a6d666bf604826b24e68ddbd63eac4_D20180701-20190630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90YWJsZTowODVmMDBiY2Q2YWQ0NDRhYmY3ODM4MGEwZWFhNWRkNy90YWJsZXJhbmdlOjA4NWYwMGJjZDZhZDQ0NGFiZjc4MzgwYTBlYWE1ZGQ3XzUtNS0xLTEtMA_30a85656-0237-43ac-ac17-bae75c1d66a0"
      unitRef="number">0.045</us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <cah:EffectiveTaxRateReconciliationUSTaxesOnInternationalIncome
      contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90YWJsZTowODVmMDBiY2Q2YWQ0NDRhYmY3ODM4MGEwZWFhNWRkNy90YWJsZXJhbmdlOjA4NWYwMGJjZDZhZDQ0NGFiZjc4MzgwYTBlYWE1ZGQ3XzYtMS0xLTEtMA_a99ea6bc-ef26-40f9-893f-ba9b30428b66"
      unitRef="number">-0.067</cah:EffectiveTaxRateReconciliationUSTaxesOnInternationalIncome>
    <cah:EffectiveTaxRateReconciliationUSTaxesOnInternationalIncome
      contextRef="ia31e9a409b874bb19d0ff6f2f39ecc09_D20190701-20200630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90YWJsZTowODVmMDBiY2Q2YWQ0NDRhYmY3ODM4MGEwZWFhNWRkNy90YWJsZXJhbmdlOjA4NWYwMGJjZDZhZDQ0NGFiZjc4MzgwYTBlYWE1ZGQ3XzYtMy0xLTEtMA_69777a28-2929-47e8-b700-76b8487583a4"
      unitRef="number">0.002</cah:EffectiveTaxRateReconciliationUSTaxesOnInternationalIncome>
    <cah:EffectiveTaxRateReconciliationUSTaxesOnInternationalIncome
      contextRef="i00a6d666bf604826b24e68ddbd63eac4_D20180701-20190630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90YWJsZTowODVmMDBiY2Q2YWQ0NDRhYmY3ODM4MGEwZWFhNWRkNy90YWJsZXJhbmdlOjA4NWYwMGJjZDZhZDQ0NGFiZjc4MzgwYTBlYWE1ZGQ3XzYtNS0xLTEtMA_36f6c2ec-3417-464a-84b7-37bbdb24459d"
      unitRef="number">0.007</cah:EffectiveTaxRateReconciliationUSTaxesOnInternationalIncome>
    <cah:EffectiveTaxRateReconciliationImpactOfResolutionsWithIRSAndOtherRelatedMatters
      contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90YWJsZTowODVmMDBiY2Q2YWQ0NDRhYmY3ODM4MGEwZWFhNWRkNy90YWJsZXJhbmdlOjA4NWYwMGJjZDZhZDQ0NGFiZjc4MzgwYTBlYWE1ZGQ3XzgtMS0xLTEtMA_6434d1f2-1fa0-4879-865b-3cbbbf8f32d8"
      unitRef="number">-0.136</cah:EffectiveTaxRateReconciliationImpactOfResolutionsWithIRSAndOtherRelatedMatters>
    <cah:EffectiveTaxRateReconciliationImpactOfResolutionsWithIRSAndOtherRelatedMatters
      contextRef="ia31e9a409b874bb19d0ff6f2f39ecc09_D20190701-20200630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90YWJsZTowODVmMDBiY2Q2YWQ0NDRhYmY3ODM4MGEwZWFhNWRkNy90YWJsZXJhbmdlOjA4NWYwMGJjZDZhZDQ0NGFiZjc4MzgwYTBlYWE1ZGQ3XzgtMy0xLTEtMA_90ab4014-2059-48dd-96e2-a1f2959ab9ef"
      unitRef="number">-0.004</cah:EffectiveTaxRateReconciliationImpactOfResolutionsWithIRSAndOtherRelatedMatters>
    <cah:EffectiveTaxRateReconciliationImpactOfResolutionsWithIRSAndOtherRelatedMatters
      contextRef="i00a6d666bf604826b24e68ddbd63eac4_D20180701-20190630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90YWJsZTowODVmMDBiY2Q2YWQ0NDRhYmY3ODM4MGEwZWFhNWRkNy90YWJsZXJhbmdlOjA4NWYwMGJjZDZhZDQ0NGFiZjc4MzgwYTBlYWE1ZGQ3XzgtNS0xLTEtMA_d8671394-b864-4fc2-90e4-e73a76ade3a2"
      unitRef="number">-0.001</cah:EffectiveTaxRateReconciliationImpactOfResolutionsWithIRSAndOtherRelatedMatters>
    <cah:EffectiveIncomeTaxRateReconciliationLegalEntityReorganizationReconcilingItemsPercent
      contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90YWJsZTowODVmMDBiY2Q2YWQ0NDRhYmY3ODM4MGEwZWFhNWRkNy90YWJsZXJhbmdlOjA4NWYwMGJjZDZhZDQ0NGFiZjc4MzgwYTBlYWE1ZGQ3XzktMS0xLTEtMA_fed1df49-b079-411b-ba32-c4dfa55e7e70"
      unitRef="number">0</cah:EffectiveIncomeTaxRateReconciliationLegalEntityReorganizationReconcilingItemsPercent>
    <cah:EffectiveIncomeTaxRateReconciliationLegalEntityReorganizationReconcilingItemsPercent
      contextRef="ia31e9a409b874bb19d0ff6f2f39ecc09_D20190701-20200630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90YWJsZTowODVmMDBiY2Q2YWQ0NDRhYmY3ODM4MGEwZWFhNWRkNy90YWJsZXJhbmdlOjA4NWYwMGJjZDZhZDQ0NGFiZjc4MzgwYTBlYWE1ZGQ3XzktMy0xLTEtMA_8a29416b-6355-4d16-b953-bc64256de459"
      unitRef="number">0</cah:EffectiveIncomeTaxRateReconciliationLegalEntityReorganizationReconcilingItemsPercent>
    <cah:EffectiveIncomeTaxRateReconciliationLegalEntityReorganizationReconcilingItemsPercent
      contextRef="i00a6d666bf604826b24e68ddbd63eac4_D20180701-20190630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90YWJsZTowODVmMDBiY2Q2YWQ0NDRhYmY3ODM4MGEwZWFhNWRkNy90YWJsZXJhbmdlOjA4NWYwMGJjZDZhZDQ0NGFiZjc4MzgwYTBlYWE1ZGQ3XzktNS0xLTEtMA_c88d6e86-3aa8-46fd-b713-cbb9c77d6675"
      unitRef="number">-0.036</cah:EffectiveIncomeTaxRateReconciliationLegalEntityReorganizationReconcilingItemsPercent>
    <cah:EffectiveIncomeTaxReconciliationOpioidLitigation
      contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90YWJsZTowODVmMDBiY2Q2YWQ0NDRhYmY3ODM4MGEwZWFhNWRkNy90YWJsZXJhbmdlOjA4NWYwMGJjZDZhZDQ0NGFiZjc4MzgwYTBlYWE1ZGQ3XzExLTEtMS0xLTA_a3386edb-c17c-4ad7-90b7-167e4fcc393d"
      unitRef="number">0.177</cah:EffectiveIncomeTaxReconciliationOpioidLitigation>
    <cah:EffectiveIncomeTaxReconciliationOpioidLitigation
      contextRef="ia31e9a409b874bb19d0ff6f2f39ecc09_D20190701-20200630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90YWJsZTowODVmMDBiY2Q2YWQ0NDRhYmY3ODM4MGEwZWFhNWRkNy90YWJsZXJhbmdlOjA4NWYwMGJjZDZhZDQ0NGFiZjc4MzgwYTBlYWE1ZGQ3XzExLTMtMS0xLTA_b1074647-09a6-46f3-9e51-b4a874694452"
      unitRef="number">-0.232</cah:EffectiveIncomeTaxReconciliationOpioidLitigation>
    <cah:EffectiveIncomeTaxReconciliationOpioidLitigation
      contextRef="i00a6d666bf604826b24e68ddbd63eac4_D20180701-20190630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90YWJsZTowODVmMDBiY2Q2YWQ0NDRhYmY3ODM4MGEwZWFhNWRkNy90YWJsZXJhbmdlOjA4NWYwMGJjZDZhZDQ0NGFiZjc4MzgwYTBlYWE1ZGQ3XzExLTUtMS0xLTA_22ca0f68-0588-4cce-9f9c-e24e4b90c92c"
      unitRef="number">0</cah:EffectiveIncomeTaxReconciliationOpioidLitigation>
    <cah:EffectiveIncomeTaxRateReconciliationLossCarrybackClaims
      contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90YWJsZTowODVmMDBiY2Q2YWQ0NDRhYmY3ODM4MGEwZWFhNWRkNy90YWJsZXJhbmdlOjA4NWYwMGJjZDZhZDQ0NGFiZjc4MzgwYTBlYWE1ZGQ3XzEyLTEtMS0xLTA_9e8a618b-bd4c-4b27-8c96-ee695d45eb5e"
      unitRef="number">-1.299</cah:EffectiveIncomeTaxRateReconciliationLossCarrybackClaims>
    <cah:EffectiveIncomeTaxRateReconciliationLossCarrybackClaims
      contextRef="ia31e9a409b874bb19d0ff6f2f39ecc09_D20190701-20200630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90YWJsZTowODVmMDBiY2Q2YWQ0NDRhYmY3ODM4MGEwZWFhNWRkNy90YWJsZXJhbmdlOjA4NWYwMGJjZDZhZDQ0NGFiZjc4MzgwYTBlYWE1ZGQ3XzEyLTMtMS0xLTA_fe4752fc-b967-4e69-bf99-2d23e82c5d45"
      unitRef="number">0</cah:EffectiveIncomeTaxRateReconciliationLossCarrybackClaims>
    <cah:EffectiveIncomeTaxRateReconciliationLossCarrybackClaims
      contextRef="i00a6d666bf604826b24e68ddbd63eac4_D20180701-20190630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90YWJsZTowODVmMDBiY2Q2YWQ0NDRhYmY3ODM4MGEwZWFhNWRkNy90YWJsZXJhbmdlOjA4NWYwMGJjZDZhZDQ0NGFiZjc4MzgwYTBlYWE1ZGQ3XzEyLTUtMS0xLTA_19afa086-bb91-4d0d-87e9-7358fe949a84"
      unitRef="number">0</cah:EffectiveIncomeTaxRateReconciliationLossCarrybackClaims>
    <us-gaap:EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent
      contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90YWJsZTowODVmMDBiY2Q2YWQ0NDRhYmY3ODM4MGEwZWFhNWRkNy90YWJsZXJhbmdlOjA4NWYwMGJjZDZhZDQ0NGFiZjc4MzgwYTBlYWE1ZGQ3XzEzLTEtMS0xLTA_02955519-4228-4180-bc33-ca81d08bf20d"
      unitRef="number">0.017</us-gaap:EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent>
    <us-gaap:EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent
      contextRef="ia31e9a409b874bb19d0ff6f2f39ecc09_D20190701-20200630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90YWJsZTowODVmMDBiY2Q2YWQ0NDRhYmY3ODM4MGEwZWFhNWRkNy90YWJsZXJhbmdlOjA4NWYwMGJjZDZhZDQ0NGFiZjc4MzgwYTBlYWE1ZGQ3XzEzLTMtMS0xLTA_fcb7c909-5ed5-4c7a-80d7-5523237cdb9f"
      unitRef="number">0.006</us-gaap:EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent>
    <us-gaap:EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent
      contextRef="i00a6d666bf604826b24e68ddbd63eac4_D20180701-20190630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90YWJsZTowODVmMDBiY2Q2YWQ0NDRhYmY3ODM4MGEwZWFhNWRkNy90YWJsZXJhbmdlOjA4NWYwMGJjZDZhZDQ0NGFiZjc4MzgwYTBlYWE1ZGQ3XzEzLTUtMS0xLTA_38d10ca9-edb5-454f-9dc4-fa35793795c1"
      unitRef="number">-0.021</us-gaap:EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90YWJsZTowODVmMDBiY2Q2YWQ0NDRhYmY3ODM4MGEwZWFhNWRkNy90YWJsZXJhbmdlOjA4NWYwMGJjZDZhZDQ0NGFiZjc4MzgwYTBlYWE1ZGQ3XzE0LTEtMS0xLTA_5ce68634-cfb8-4f8e-8057-77cb1f40b47a"
      unitRef="number">-0.897</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="ia31e9a409b874bb19d0ff6f2f39ecc09_D20190701-20200630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90YWJsZTowODVmMDBiY2Q2YWQ0NDRhYmY3ODM4MGEwZWFhNWRkNy90YWJsZXJhbmdlOjA4NWYwMGJjZDZhZDQ0NGFiZjc4MzgwYTBlYWE1ZGQ3XzE0LTMtMS0xLTA_f4ed847a-7aef-4e4b-b39c-436e9c8b3f0a"
      unitRef="number">0.021</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="i00a6d666bf604826b24e68ddbd63eac4_D20180701-20190630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90YWJsZTowODVmMDBiY2Q2YWQ0NDRhYmY3ODM4MGEwZWFhNWRkNy90YWJsZXJhbmdlOjA4NWYwMGJjZDZhZDQ0NGFiZjc4MzgwYTBlYWE1ZGQ3XzE0LTUtMS0xLTA_9913af26-15c8-47e5-bfbe-93b48e90f933"
      unitRef="number">0.221</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90ZXh0cmVnaW9uOmViYTAwMWFhMmQ5YjRmODZiMGIyMTI2YzNmMjlhODhmXzI3NDg3NzkwOTk3NzY_c6c80c77-b6e0-48c1-a8a4-69693359c479"
      unitRef="number">-0.897</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="ia31e9a409b874bb19d0ff6f2f39ecc09_D20190701-20200630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90ZXh0cmVnaW9uOmViYTAwMWFhMmQ5YjRmODZiMGIyMTI2YzNmMjlhODhmXzcxNDY4MjU1ODk2NTA_f4ed847a-7aef-4e4b-b39c-436e9c8b3f0a"
      unitRef="number">0.021</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="i00a6d666bf604826b24e68ddbd63eac4_D20180701-20190630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90ZXh0cmVnaW9uOmViYTAwMWFhMmQ5YjRmODZiMGIyMTI2YzNmMjlhODhmXzcxNDY4MjU1ODk2NjI_9913af26-15c8-47e5-bfbe-93b48e90f933"
      unitRef="number">0.221</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <cah:EffectiveTaxRateImpactFromCertainForeignJurisdictions
      contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90ZXh0cmVnaW9uOmViYTAwMWFhMmQ5YjRmODZiMGIyMTI2YzNmMjlhODhmXzI1NjE_b7559e2f-edaf-4719-825f-02cccca87c5e"
      unitRef="usd">20000000</cah:EffectiveTaxRateImpactFromCertainForeignJurisdictions>
    <us-gaap:TaxCutsAndJobsActOf2017TransitionTaxForAccumulatedForeignEarningsIncomeTaxExpense
      contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90ZXh0cmVnaW9uOmViYTAwMWFhMmQ5YjRmODZiMGIyMTI2YzNmMjlhODhmXzM4NTA_126bb505-6352-4c07-a3ee-cf1f83d42a63"
      unitRef="usd">825000000</us-gaap:TaxCutsAndJobsActOf2017TransitionTaxForAccumulatedForeignEarningsIncomeTaxExpense>
    <us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock
      contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90ZXh0cmVnaW9uOmViYTAwMWFhMmQ5YjRmODZiMGIyMTI2YzNmMjlhODhmXzg3OTc_b5561716-7a92-447f-a242-d26d3b0c3e08">&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the components of the deferred income tax assets and liabilities at June 30:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:60.937%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.109%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.343%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.111%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Deferred income tax assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Receivable basis difference&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;40&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;874&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;607&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Share-based compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;38&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Loss and tax credit carryforwards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;805&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;589&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Deferred tax assets related to uncertain tax positions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;35&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;52&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;16&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;87&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total deferred income tax assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;1,808&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,412&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Valuation allowance for deferred income tax assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(515)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(470)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net deferred income tax assets&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;1,293&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;942&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Deferred income tax liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Inventory basis differences&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(1,119)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(1,083)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Property-related&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(375)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(327)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Goodwill and other intangibles&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(733)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(751)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Self-Insurance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(975)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(23)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total deferred income tax liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(3,225)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(2,161)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:6pt;padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net deferred income tax liability&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(1,932)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(1,219)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts
      contextRef="i2e87824102b34590a0208cc7da91b5f5_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90YWJsZTo2NWM3MmU1ZDI1N2M0MzZlYjQ0NGJjMjViMzU4ODIzZS90YWJsZXJhbmdlOjY1YzcyZTVkMjU3YzQzNmViNDQ0YmMyNWIzNTg4MjNlXzItMS0xLTEtMA_73a9945d-8b96-411b-ad60-fb622f20218c"
      unitRef="usd">40000000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts
      contextRef="i299cea70f47b4fbe96772aaa8cc00b79_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90YWJsZTo2NWM3MmU1ZDI1N2M0MzZlYjQ0NGJjMjViMzU4ODIzZS90YWJsZXJhbmdlOjY1YzcyZTVkMjU3YzQzNmViNDQ0YmMyNWIzNTg4MjNlXzItMy0xLTEtMA_1b26551a-fb37-4725-8816-7580d499dcaa"
      unitRef="usd">39000000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
      contextRef="i2e87824102b34590a0208cc7da91b5f5_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90YWJsZTo2NWM3MmU1ZDI1N2M0MzZlYjQ0NGJjMjViMzU4ODIzZS90YWJsZXJhbmdlOjY1YzcyZTVkMjU3YzQzNmViNDQ0YmMyNWIzNTg4MjNlXzMtMS0xLTEtMA_adb28125-abf4-4ee3-9176-44f9bef10e0b"
      unitRef="usd">874000000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
      contextRef="i299cea70f47b4fbe96772aaa8cc00b79_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90YWJsZTo2NWM3MmU1ZDI1N2M0MzZlYjQ0NGJjMjViMzU4ODIzZS90YWJsZXJhbmdlOjY1YzcyZTVkMjU3YzQzNmViNDQ0YmMyNWIzNTg4MjNlXzMtMy0xLTEtMA_75160e8d-a4ee-421a-952c-6df1f6601a31"
      unitRef="usd">607000000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
      contextRef="i2e87824102b34590a0208cc7da91b5f5_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90YWJsZTo2NWM3MmU1ZDI1N2M0MzZlYjQ0NGJjMjViMzU4ODIzZS90YWJsZXJhbmdlOjY1YzcyZTVkMjU3YzQzNmViNDQ0YmMyNWIzNTg4MjNlXzQtMS0xLTEtMA_fee6d89a-abda-44c3-935e-3d8404301c35"
      unitRef="usd">38000000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
      contextRef="i299cea70f47b4fbe96772aaa8cc00b79_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90YWJsZTo2NWM3MmU1ZDI1N2M0MzZlYjQ0NGJjMjViMzU4ODIzZS90YWJsZXJhbmdlOjY1YzcyZTVkMjU3YzQzNmViNDQ0YmMyNWIzNTg4MjNlXzQtMy0xLTEtMA_eff753c0-e5fb-455f-a0b9-c893add81e3f"
      unitRef="usd">38000000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost>
    <us-gaap:DeferredTaxAssetsTaxCreditCarryforwards
      contextRef="i2e87824102b34590a0208cc7da91b5f5_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90YWJsZTo2NWM3MmU1ZDI1N2M0MzZlYjQ0NGJjMjViMzU4ODIzZS90YWJsZXJhbmdlOjY1YzcyZTVkMjU3YzQzNmViNDQ0YmMyNWIzNTg4MjNlXzUtMS0xLTEtMA_f2633284-07fa-4a76-b288-a6c406c6b93d"
      unitRef="usd">805000000</us-gaap:DeferredTaxAssetsTaxCreditCarryforwards>
    <us-gaap:DeferredTaxAssetsTaxCreditCarryforwards
      contextRef="i299cea70f47b4fbe96772aaa8cc00b79_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90YWJsZTo2NWM3MmU1ZDI1N2M0MzZlYjQ0NGJjMjViMzU4ODIzZS90YWJsZXJhbmdlOjY1YzcyZTVkMjU3YzQzNmViNDQ0YmMyNWIzNTg4MjNlXzUtMy0xLTEtMA_743fe2f7-5bd5-49e4-b07b-0d0e76a56b32"
      unitRef="usd">589000000</us-gaap:DeferredTaxAssetsTaxCreditCarryforwards>
    <cah:DeferredTaxAssetsRelatedtouncertaintaxpositions
      contextRef="i2e87824102b34590a0208cc7da91b5f5_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90YWJsZTo2NWM3MmU1ZDI1N2M0MzZlYjQ0NGJjMjViMzU4ODIzZS90YWJsZXJhbmdlOjY1YzcyZTVkMjU3YzQzNmViNDQ0YmMyNWIzNTg4MjNlXzYtMS0xLTEtMA_afd56c84-29e1-47bb-8293-910c24c9e23c"
      unitRef="usd">35000000</cah:DeferredTaxAssetsRelatedtouncertaintaxpositions>
    <cah:DeferredTaxAssetsRelatedtouncertaintaxpositions
      contextRef="i299cea70f47b4fbe96772aaa8cc00b79_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90YWJsZTo2NWM3MmU1ZDI1N2M0MzZlYjQ0NGJjMjViMzU4ODIzZS90YWJsZXJhbmdlOjY1YzcyZTVkMjU3YzQzNmViNDQ0YmMyNWIzNTg4MjNlXzYtMy0xLTEtMA_adb8468d-fe7a-4ad2-99d2-4158bab5bc04"
      unitRef="usd">52000000</cah:DeferredTaxAssetsRelatedtouncertaintaxpositions>
    <us-gaap:DeferredTaxAssetsOther
      contextRef="i2e87824102b34590a0208cc7da91b5f5_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90YWJsZTo2NWM3MmU1ZDI1N2M0MzZlYjQ0NGJjMjViMzU4ODIzZS90YWJsZXJhbmdlOjY1YzcyZTVkMjU3YzQzNmViNDQ0YmMyNWIzNTg4MjNlXzctMS0xLTEtMA_6b416c17-830b-4283-bf60-6bd4d82184eb"
      unitRef="usd">16000000</us-gaap:DeferredTaxAssetsOther>
    <us-gaap:DeferredTaxAssetsOther
      contextRef="i299cea70f47b4fbe96772aaa8cc00b79_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90YWJsZTo2NWM3MmU1ZDI1N2M0MzZlYjQ0NGJjMjViMzU4ODIzZS90YWJsZXJhbmdlOjY1YzcyZTVkMjU3YzQzNmViNDQ0YmMyNWIzNTg4MjNlXzctMy0xLTEtMA_55e50b39-278d-4102-961d-dbcbc7474c2f"
      unitRef="usd">87000000</us-gaap:DeferredTaxAssetsOther>
    <us-gaap:DeferredTaxAssetsGross
      contextRef="i2e87824102b34590a0208cc7da91b5f5_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90YWJsZTo2NWM3MmU1ZDI1N2M0MzZlYjQ0NGJjMjViMzU4ODIzZS90YWJsZXJhbmdlOjY1YzcyZTVkMjU3YzQzNmViNDQ0YmMyNWIzNTg4MjNlXzgtMS0xLTEtMA_a398ae8c-c1a0-4c82-99c1-aec25034b823"
      unitRef="usd">1808000000</us-gaap:DeferredTaxAssetsGross>
    <us-gaap:DeferredTaxAssetsGross
      contextRef="i299cea70f47b4fbe96772aaa8cc00b79_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90YWJsZTo2NWM3MmU1ZDI1N2M0MzZlYjQ0NGJjMjViMzU4ODIzZS90YWJsZXJhbmdlOjY1YzcyZTVkMjU3YzQzNmViNDQ0YmMyNWIzNTg4MjNlXzgtMy0xLTEtMA_056b79e8-4f4b-4fca-97ae-a3f4856e5291"
      unitRef="usd">1412000000</us-gaap:DeferredTaxAssetsGross>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="i2e87824102b34590a0208cc7da91b5f5_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90YWJsZTo2NWM3MmU1ZDI1N2M0MzZlYjQ0NGJjMjViMzU4ODIzZS90YWJsZXJhbmdlOjY1YzcyZTVkMjU3YzQzNmViNDQ0YmMyNWIzNTg4MjNlXzktMS0xLTEtMA_1577cede-a3d4-48ea-bd56-b903fbec328b"
      unitRef="usd">515000000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="i299cea70f47b4fbe96772aaa8cc00b79_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90YWJsZTo2NWM3MmU1ZDI1N2M0MzZlYjQ0NGJjMjViMzU4ODIzZS90YWJsZXJhbmdlOjY1YzcyZTVkMjU3YzQzNmViNDQ0YmMyNWIzNTg4MjNlXzktMy0xLTEtMA_86c79d97-6b0f-4c51-bdaa-2fde2786ff78"
      unitRef="usd">470000000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsLiabilitiesNet
      contextRef="i2e87824102b34590a0208cc7da91b5f5_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90YWJsZTo2NWM3MmU1ZDI1N2M0MzZlYjQ0NGJjMjViMzU4ODIzZS90YWJsZXJhbmdlOjY1YzcyZTVkMjU3YzQzNmViNDQ0YmMyNWIzNTg4MjNlXzEwLTEtMS0xLTA_41a1a88b-91df-4092-9430-f6855609b855"
      unitRef="usd">1293000000</us-gaap:DeferredTaxAssetsLiabilitiesNet>
    <us-gaap:DeferredTaxAssetsLiabilitiesNet
      contextRef="i299cea70f47b4fbe96772aaa8cc00b79_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90YWJsZTo2NWM3MmU1ZDI1N2M0MzZlYjQ0NGJjMjViMzU4ODIzZS90YWJsZXJhbmdlOjY1YzcyZTVkMjU3YzQzNmViNDQ0YmMyNWIzNTg4MjNlXzEwLTMtMS0xLTA_80747fae-1201-4f62-afbf-8d37f553338a"
      unitRef="usd">942000000</us-gaap:DeferredTaxAssetsLiabilitiesNet>
    <us-gaap:DeferredTaxLiabilitiesDeferredExpenseCapitalizedInventoryCosts
      contextRef="i2e87824102b34590a0208cc7da91b5f5_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90YWJsZTo2NWM3MmU1ZDI1N2M0MzZlYjQ0NGJjMjViMzU4ODIzZS90YWJsZXJhbmdlOjY1YzcyZTVkMjU3YzQzNmViNDQ0YmMyNWIzNTg4MjNlXzEzLTEtMS0xLTA_9c5a6b38-d388-4607-bf80-2fd6c66e0b97"
      unitRef="usd">1119000000</us-gaap:DeferredTaxLiabilitiesDeferredExpenseCapitalizedInventoryCosts>
    <us-gaap:DeferredTaxLiabilitiesDeferredExpenseCapitalizedInventoryCosts
      contextRef="i299cea70f47b4fbe96772aaa8cc00b79_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90YWJsZTo2NWM3MmU1ZDI1N2M0MzZlYjQ0NGJjMjViMzU4ODIzZS90YWJsZXJhbmdlOjY1YzcyZTVkMjU3YzQzNmViNDQ0YmMyNWIzNTg4MjNlXzEzLTMtMS0xLTA_9a99ccd5-7db2-47d0-acf4-956f40ae20e8"
      unitRef="usd">1083000000</us-gaap:DeferredTaxLiabilitiesDeferredExpenseCapitalizedInventoryCosts>
    <us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment
      contextRef="i2e87824102b34590a0208cc7da91b5f5_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90YWJsZTo2NWM3MmU1ZDI1N2M0MzZlYjQ0NGJjMjViMzU4ODIzZS90YWJsZXJhbmdlOjY1YzcyZTVkMjU3YzQzNmViNDQ0YmMyNWIzNTg4MjNlXzE0LTEtMS0xLTA_479e39a1-623a-4bed-9f48-07f68a182427"
      unitRef="usd">375000000</us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment>
    <us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment
      contextRef="i299cea70f47b4fbe96772aaa8cc00b79_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90YWJsZTo2NWM3MmU1ZDI1N2M0MzZlYjQ0NGJjMjViMzU4ODIzZS90YWJsZXJhbmdlOjY1YzcyZTVkMjU3YzQzNmViNDQ0YmMyNWIzNTg4MjNlXzE0LTMtMS0xLTA_2763d7aa-ec33-41ae-bfbc-332087633316"
      unitRef="usd">327000000</us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment>
    <us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssets
      contextRef="i2e87824102b34590a0208cc7da91b5f5_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90YWJsZTo2NWM3MmU1ZDI1N2M0MzZlYjQ0NGJjMjViMzU4ODIzZS90YWJsZXJhbmdlOjY1YzcyZTVkMjU3YzQzNmViNDQ0YmMyNWIzNTg4MjNlXzE1LTEtMS0xLTEwMDQ4_3d260399-ca28-4f8f-a262-4352abd2f3c1"
      unitRef="usd">733000000</us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssets>
    <us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssets
      contextRef="i299cea70f47b4fbe96772aaa8cc00b79_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90YWJsZTo2NWM3MmU1ZDI1N2M0MzZlYjQ0NGJjMjViMzU4ODIzZS90YWJsZXJhbmdlOjY1YzcyZTVkMjU3YzQzNmViNDQ0YmMyNWIzNTg4MjNlXzE1LTMtMS0xLTEwMDU0_6aab67f4-367c-442c-b797-3d5d388b5c20"
      unitRef="usd">751000000</us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssets>
    <us-gaap:DeferredTaxLiabilitiesDeferredExpenseReservesAndAccruals
      contextRef="i2e87824102b34590a0208cc7da91b5f5_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90YWJsZTo2NWM3MmU1ZDI1N2M0MzZlYjQ0NGJjMjViMzU4ODIzZS90YWJsZXJhbmdlOjY1YzcyZTVkMjU3YzQzNmViNDQ0YmMyNWIzNTg4MjNlXzE2LTEtMS0xLTEwMDQ4_4d4c5242-febd-4ffa-9d15-af731dd5f961"
      unitRef="usd">975000000</us-gaap:DeferredTaxLiabilitiesDeferredExpenseReservesAndAccruals>
    <us-gaap:DeferredTaxLiabilitiesDeferredExpenseReservesAndAccruals
      contextRef="i299cea70f47b4fbe96772aaa8cc00b79_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90YWJsZTo2NWM3MmU1ZDI1N2M0MzZlYjQ0NGJjMjViMzU4ODIzZS90YWJsZXJhbmdlOjY1YzcyZTVkMjU3YzQzNmViNDQ0YmMyNWIzNTg4MjNlXzE2LTMtMS0xLTEwMDU0_ee4d33c0-540c-4cc1-afae-ff0f18a72b3c"
      unitRef="usd">0</us-gaap:DeferredTaxLiabilitiesDeferredExpenseReservesAndAccruals>
    <us-gaap:DeferredTaxLiabilitiesOther
      contextRef="i2e87824102b34590a0208cc7da91b5f5_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90YWJsZTo2NWM3MmU1ZDI1N2M0MzZlYjQ0NGJjMjViMzU4ODIzZS90YWJsZXJhbmdlOjY1YzcyZTVkMjU3YzQzNmViNDQ0YmMyNWIzNTg4MjNlXzE1LTEtMS0xLTA_307a2789-05a2-4634-a615-49a9e2b4b1e7"
      unitRef="usd">23000000</us-gaap:DeferredTaxLiabilitiesOther>
    <us-gaap:DeferredTaxLiabilitiesOther
      contextRef="i299cea70f47b4fbe96772aaa8cc00b79_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90YWJsZTo2NWM3MmU1ZDI1N2M0MzZlYjQ0NGJjMjViMzU4ODIzZS90YWJsZXJhbmdlOjY1YzcyZTVkMjU3YzQzNmViNDQ0YmMyNWIzNTg4MjNlXzE1LTMtMS0xLTA_078b59d7-5787-4099-a683-f93f8cd5d7c4"
      unitRef="usd">0</us-gaap:DeferredTaxLiabilitiesOther>
    <us-gaap:DeferredIncomeTaxLiabilities
      contextRef="i2e87824102b34590a0208cc7da91b5f5_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90YWJsZTo2NWM3MmU1ZDI1N2M0MzZlYjQ0NGJjMjViMzU4ODIzZS90YWJsZXJhbmdlOjY1YzcyZTVkMjU3YzQzNmViNDQ0YmMyNWIzNTg4MjNlXzE2LTEtMS0xLTA_6cf606a2-df7e-4367-a7c6-0a4cce7d2ed2"
      unitRef="usd">3225000000</us-gaap:DeferredIncomeTaxLiabilities>
    <us-gaap:DeferredIncomeTaxLiabilities
      contextRef="i299cea70f47b4fbe96772aaa8cc00b79_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90YWJsZTo2NWM3MmU1ZDI1N2M0MzZlYjQ0NGJjMjViMzU4ODIzZS90YWJsZXJhbmdlOjY1YzcyZTVkMjU3YzQzNmViNDQ0YmMyNWIzNTg4MjNlXzE2LTMtMS0xLTA_2dd9d3c7-74a1-4e3a-bd01-431720255492"
      unitRef="usd">2161000000</us-gaap:DeferredIncomeTaxLiabilities>
    <us-gaap:DeferredTaxLiabilities
      contextRef="i2e87824102b34590a0208cc7da91b5f5_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90YWJsZTo2NWM3MmU1ZDI1N2M0MzZlYjQ0NGJjMjViMzU4ODIzZS90YWJsZXJhbmdlOjY1YzcyZTVkMjU3YzQzNmViNDQ0YmMyNWIzNTg4MjNlXzE3LTEtMS0xLTA_9b50dad6-2324-447d-8e75-008c28f9690a"
      unitRef="usd">1932000000</us-gaap:DeferredTaxLiabilities>
    <us-gaap:DeferredTaxLiabilities
      contextRef="i299cea70f47b4fbe96772aaa8cc00b79_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90YWJsZTo2NWM3MmU1ZDI1N2M0MzZlYjQ0NGJjMjViMzU4ODIzZS90YWJsZXJhbmdlOjY1YzcyZTVkMjU3YzQzNmViNDQ0YmMyNWIzNTg4MjNlXzE3LTMtMS0xLTA_18e66764-740d-4270-9d82-4c8ee70c6cfb"
      unitRef="usd">1219000000</us-gaap:DeferredTaxLiabilities>
    <cah:ScheduleOfDeferredTaxAssetsAndLiabilitiesAfterNettingByTaxJurisdictionTableTextBlock
      contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90ZXh0cmVnaW9uOmViYTAwMWFhMmQ5YjRmODZiMGIyMTI2YzNmMjlhODhmXzg4MjM_99975c15-83de-47a7-8d6f-75a5bfb7190d">&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Deferred income tax assets and liabilities in the preceding table, after netting by taxing jurisdiction and for uncertain tax positions, are in the following captions in the consolidated balance sheets at June 30:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:60.937%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.109%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.343%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.111%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Noncurrent deferred income tax asset (1)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;52&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Noncurrent deferred income tax liability (2)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(1,981)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(1,258)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Noncurrent deferred income tax liability transferred to held for sale&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net deferred income tax liability&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(1,932)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(1,219)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:10pt"&gt;Included in other assets in the consolidated balance sheets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:10pt"&gt;Included in deferred income taxes and other liabilities in the consolidated balance sheets.&lt;/span&gt;&lt;/div&gt;</cah:ScheduleOfDeferredTaxAssetsAndLiabilitiesAfterNettingByTaxJurisdictionTableTextBlock>
    <us-gaap:DeferredIncomeTaxesAndOtherAssetsNoncurrent
      contextRef="i2e87824102b34590a0208cc7da91b5f5_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90YWJsZToxYTY5NmEzZGNjZDI0MmZlOWM5MzI4NGE2NzRlZWUzMS90YWJsZXJhbmdlOjFhNjk2YTNkY2NkMjQyZmU5YzkzMjg0YTY3NGVlZTMxXzItMS0xLTEtMA_b6fa07e9-c08b-43c3-91da-8c98d5c78685"
      unitRef="usd">52000000</us-gaap:DeferredIncomeTaxesAndOtherAssetsNoncurrent>
    <us-gaap:DeferredIncomeTaxesAndOtherAssetsNoncurrent
      contextRef="i299cea70f47b4fbe96772aaa8cc00b79_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90YWJsZToxYTY5NmEzZGNjZDI0MmZlOWM5MzI4NGE2NzRlZWUzMS90YWJsZXJhbmdlOjFhNjk2YTNkY2NkMjQyZmU5YzkzMjg0YTY3NGVlZTMxXzItMy0xLTEtMA_3ad403d6-40f3-49f4-9ffa-8be6f3ca613b"
      unitRef="usd">39000000</us-gaap:DeferredIncomeTaxesAndOtherAssetsNoncurrent>
    <us-gaap:DeferredIncomeTaxesAndOtherTaxLiabilitiesNoncurrent
      contextRef="i2e87824102b34590a0208cc7da91b5f5_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90YWJsZToxYTY5NmEzZGNjZDI0MmZlOWM5MzI4NGE2NzRlZWUzMS90YWJsZXJhbmdlOjFhNjk2YTNkY2NkMjQyZmU5YzkzMjg0YTY3NGVlZTMxXzQtMS0xLTEtMTEyNDA_a8cd68d3-548e-41ff-918a-ff4775ccf485"
      unitRef="usd">1981000000</us-gaap:DeferredIncomeTaxesAndOtherTaxLiabilitiesNoncurrent>
    <us-gaap:DeferredIncomeTaxesAndOtherTaxLiabilitiesNoncurrent
      contextRef="i299cea70f47b4fbe96772aaa8cc00b79_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90YWJsZToxYTY5NmEzZGNjZDI0MmZlOWM5MzI4NGE2NzRlZWUzMS90YWJsZXJhbmdlOjFhNjk2YTNkY2NkMjQyZmU5YzkzMjg0YTY3NGVlZTMxXzQtMy0xLTEtMTEyNTQ_64fdba6c-d4d4-492b-85c7-d05abb0c669a"
      unitRef="usd">1258000000</us-gaap:DeferredIncomeTaxesAndOtherTaxLiabilitiesNoncurrent>
    <cah:DeferredIncomeTaxesAndOtherTaxLiabilitiesTransferredToHeldForSaleNoncurrent
      contextRef="i2e87824102b34590a0208cc7da91b5f5_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90YWJsZToxYTY5NmEzZGNjZDI0MmZlOWM5MzI4NGE2NzRlZWUzMS90YWJsZXJhbmdlOjFhNjk2YTNkY2NkMjQyZmU5YzkzMjg0YTY3NGVlZTMxXzMtMS0xLTEtMTAwNjY_dfb9c86e-6b5e-4c47-a2b0-62962188af23"
      unitRef="usd">3000000</cah:DeferredIncomeTaxesAndOtherTaxLiabilitiesTransferredToHeldForSaleNoncurrent>
    <cah:DeferredIncomeTaxesAndOtherTaxLiabilitiesTransferredToHeldForSaleNoncurrent
      contextRef="i299cea70f47b4fbe96772aaa8cc00b79_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90YWJsZToxYTY5NmEzZGNjZDI0MmZlOWM5MzI4NGE2NzRlZWUzMS90YWJsZXJhbmdlOjFhNjk2YTNkY2NkMjQyZmU5YzkzMjg0YTY3NGVlZTMxXzMtMy0xLTEtMTAwNjk_7aff8341-0d3e-402c-a1a7-7f8113754760"
      unitRef="usd">0</cah:DeferredIncomeTaxesAndOtherTaxLiabilitiesTransferredToHeldForSaleNoncurrent>
    <us-gaap:DeferredTaxLiabilities
      contextRef="i2e87824102b34590a0208cc7da91b5f5_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90YWJsZToxYTY5NmEzZGNjZDI0MmZlOWM5MzI4NGE2NzRlZWUzMS90YWJsZXJhbmdlOjFhNjk2YTNkY2NkMjQyZmU5YzkzMjg0YTY3NGVlZTMxXzMtMS0xLTEtMA_2fd02357-beba-403b-a575-b28924d47634"
      unitRef="usd">1932000000</us-gaap:DeferredTaxLiabilities>
    <us-gaap:DeferredTaxLiabilities
      contextRef="i299cea70f47b4fbe96772aaa8cc00b79_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90YWJsZToxYTY5NmEzZGNjZDI0MmZlOWM5MzI4NGE2NzRlZWUzMS90YWJsZXJhbmdlOjFhNjk2YTNkY2NkMjQyZmU5YzkzMjg0YTY3NGVlZTMxXzMtMy0xLTEtMA_46480403-4990-49f5-98c0-f4d796221560"
      unitRef="usd">1219000000</us-gaap:DeferredTaxLiabilities>
    <us-gaap:TaxCreditCarryforwardAmount
      contextRef="ia9314223dc824180abfdd254ebfb27a4_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90ZXh0cmVnaW9uOmViYTAwMWFhMmQ5YjRmODZiMGIyMTI2YzNmMjlhODhmXzQ5Nzc_691d29cb-4558-4a46-9587-53213b47f283"
      unitRef="usd">272000000</us-gaap:TaxCreditCarryforwardAmount>
    <us-gaap:TaxCreditCarryforwardAmount
      contextRef="i0e143b481d18458ab822c450cdd8c4b9_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90ZXh0cmVnaW9uOmViYTAwMWFhMmQ5YjRmODZiMGIyMTI2YzNmMjlhODhmXzQ5ODE_2d4fe3c0-fd20-446d-99c9-842507802c6d"
      unitRef="usd">3900000000</us-gaap:TaxCreditCarryforwardAmount>
    <us-gaap:TaxCreditCarryforwardAmount
      contextRef="i78a614f0d6654bc1bcffa521f2779f70_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90ZXh0cmVnaW9uOmViYTAwMWFhMmQ5YjRmODZiMGIyMTI2YzNmMjlhODhmXzQ5ODg_b8a9d8d2-b515-44d5-b339-3b5a117f84b1"
      unitRef="usd">2300000000</us-gaap:TaxCreditCarryforwardAmount>
    <us-gaap:DeferredTaxAssetsTaxCreditCarryforwards
      contextRef="i2e87824102b34590a0208cc7da91b5f5_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90ZXh0cmVnaW9uOmViYTAwMWFhMmQ5YjRmODZiMGIyMTI2YzNmMjlhODhmXzUwNjg_e1c39e85-c752-496b-ae12-0a8935cbe269"
      unitRef="usd">805000000</us-gaap:DeferredTaxAssetsTaxCreditCarryforwards>
    <us-gaap:OperatingLossCarryforwardsValuationAllowance
      contextRef="i2e87824102b34590a0208cc7da91b5f5_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90ZXh0cmVnaW9uOmViYTAwMWFhMmQ5YjRmODZiMGIyMTI2YzNmMjlhODhmXzUxNjc_93006099-4acd-4688-91f5-11e55042c8f5"
      unitRef="usd">477000000</us-gaap:OperatingLossCarryforwardsValuationAllowance>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="i2e87824102b34590a0208cc7da91b5f5_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90ZXh0cmVnaW9uOmViYTAwMWFhMmQ5YjRmODZiMGIyMTI2YzNmMjlhODhmXzU1NTA_d0b01471-ebba-42aa-a402-98cd329aa595"
      unitRef="usd">932000000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="i299cea70f47b4fbe96772aaa8cc00b79_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90ZXh0cmVnaW9uOmViYTAwMWFhMmQ5YjRmODZiMGIyMTI2YzNmMjlhODhmXzU1NTQ_c2f75399-5d5f-420f-aa75-fe6f97452881"
      unitRef="usd">998000000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="if6dc09eec4e74751b47cdf037a5b1860_I20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90ZXh0cmVnaW9uOmViYTAwMWFhMmQ5YjRmODZiMGIyMTI2YzNmMjlhODhmXzU1NjE_fb581d71-49e5-47d4-895f-0104f12f4aa1"
      unitRef="usd">456000000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
      contextRef="i2e87824102b34590a0208cc7da91b5f5_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90ZXh0cmVnaW9uOmViYTAwMWFhMmQ5YjRmODZiMGIyMTI2YzNmMjlhODhmXzU2NjA_44978611-ad60-4dc9-b98a-3df65514b98b"
      unitRef="usd">849000000</us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate>
    <us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
      contextRef="i299cea70f47b4fbe96772aaa8cc00b79_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90ZXh0cmVnaW9uOmViYTAwMWFhMmQ5YjRmODZiMGIyMTI2YzNmMjlhODhmXzU2NjQ_d6dcce72-3fc3-483f-b110-ecfe220e25f0"
      unitRef="usd">753000000</us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate>
    <us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
      contextRef="if6dc09eec4e74751b47cdf037a5b1860_I20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90ZXh0cmVnaW9uOmViYTAwMWFhMmQ5YjRmODZiMGIyMTI2YzNmMjlhODhmXzU2NzE_6ce308ca-5fb5-4857-be8c-d9dba5ea5394"
      unitRef="usd">303000000</us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate>
    <us-gaap:ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock
      contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90ZXh0cmVnaW9uOmViYTAwMWFhMmQ5YjRmODZiMGIyMTI2YzNmMjlhODhmXzg3NTQ_272b8cd8-5384-4634-96ca-7d0c06edba31">The following table presents a reconciliation of the beginning and ending amounts of unrecognized tax benefits:&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.691%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:53.389%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.999%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.347%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.831%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.347%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.287%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Balance at beginning of fiscal year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;998&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;456&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;423&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Additions for tax positions of the current year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;121&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Additions for tax positions of prior years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;223&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;78&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Reductions for tax positions of prior years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(138)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(27)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Settlements with tax authorities &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(271)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(25)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Expiration of the statute of limitations &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Balance at end of fiscal year&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;932&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;998&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;456&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="i299cea70f47b4fbe96772aaa8cc00b79_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90YWJsZToyNzU1NGI1NDNhOGQ0OWRjOWQ2OWU1YzU2YzhiNDE0OC90YWJsZXJhbmdlOjI3NTU0YjU0M2E4ZDQ5ZGM5ZDY5ZTVjNTZjOGI0MTQ4XzEtMS0xLTEtMA_1a47146d-d9c6-4a68-80b1-22d5e880b4d8"
      unitRef="usd">998000000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="if6dc09eec4e74751b47cdf037a5b1860_I20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90YWJsZToyNzU1NGI1NDNhOGQ0OWRjOWQ2OWU1YzU2YzhiNDE0OC90YWJsZXJhbmdlOjI3NTU0YjU0M2E4ZDQ5ZGM5ZDY5ZTVjNTZjOGI0MTQ4XzEtMy0xLTEtMA_5a447305-3846-4e2b-8647-09b12a6eb476"
      unitRef="usd">456000000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="i39bbe70148ff4daea469e8420c1859d6_I20180630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90YWJsZToyNzU1NGI1NDNhOGQ0OWRjOWQ2OWU1YzU2YzhiNDE0OC90YWJsZXJhbmdlOjI3NTU0YjU0M2E4ZDQ5ZGM5ZDY5ZTVjNTZjOGI0MTQ4XzEtNS0xLTEtMA_5203d616-e9ac-4ffd-9132-a26bfaae32fe"
      unitRef="usd">423000000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
      contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90YWJsZToyNzU1NGI1NDNhOGQ0OWRjOWQ2OWU1YzU2YzhiNDE0OC90YWJsZXJhbmdlOjI3NTU0YjU0M2E4ZDQ5ZGM5ZDY5ZTVjNTZjOGI0MTQ4XzItMS0xLTEtMA_27bcf558-4259-4876-be91-0684b51c63b5"
      unitRef="usd">121000000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
      contextRef="ia31e9a409b874bb19d0ff6f2f39ecc09_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90YWJsZToyNzU1NGI1NDNhOGQ0OWRjOWQ2OWU1YzU2YzhiNDE0OC90YWJsZXJhbmdlOjI3NTU0YjU0M2E4ZDQ5ZGM5ZDY5ZTVjNTZjOGI0MTQ4XzItMy0xLTEtMA_33e9d705-c678-45d6-9528-ca6a42735197"
      unitRef="usd">500000000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
      contextRef="i00a6d666bf604826b24e68ddbd63eac4_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90YWJsZToyNzU1NGI1NDNhOGQ0OWRjOWQ2OWU1YzU2YzhiNDE0OC90YWJsZXJhbmdlOjI3NTU0YjU0M2E4ZDQ5ZGM5ZDY5ZTVjNTZjOGI0MTQ4XzItNS0xLTEtMA_c3bcde63-f07d-4d56-8ef3-34b29990bbd5"
      unitRef="usd">24000000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
      contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90YWJsZToyNzU1NGI1NDNhOGQ0OWRjOWQ2OWU1YzU2YzhiNDE0OC90YWJsZXJhbmdlOjI3NTU0YjU0M2E4ZDQ5ZGM5ZDY5ZTVjNTZjOGI0MTQ4XzMtMS0xLTEtMA_c96ad109-f5cb-44ed-9c94-f9e8192b3b71"
      unitRef="usd">223000000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
      contextRef="ia31e9a409b874bb19d0ff6f2f39ecc09_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90YWJsZToyNzU1NGI1NDNhOGQ0OWRjOWQ2OWU1YzU2YzhiNDE0OC90YWJsZXJhbmdlOjI3NTU0YjU0M2E4ZDQ5ZGM5ZDY5ZTVjNTZjOGI0MTQ4XzMtMy0xLTEtMA_ee082112-a033-4cc2-abe5-08a70a89606d"
      unitRef="usd">78000000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
      contextRef="i00a6d666bf604826b24e68ddbd63eac4_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90YWJsZToyNzU1NGI1NDNhOGQ0OWRjOWQ2OWU1YzU2YzhiNDE0OC90YWJsZXJhbmdlOjI3NTU0YjU0M2E4ZDQ5ZGM5ZDY5ZTVjNTZjOGI0MTQ4XzMtNS0xLTEtMA_67ecd746-d5f4-4c66-bcf8-9419213e5a2f"
      unitRef="usd">39000000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions
      contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90YWJsZToyNzU1NGI1NDNhOGQ0OWRjOWQ2OWU1YzU2YzhiNDE0OC90YWJsZXJhbmdlOjI3NTU0YjU0M2E4ZDQ5ZGM5ZDY5ZTVjNTZjOGI0MTQ4XzQtMS0xLTEtMA_a9f99bd7-8458-4764-9ac0-fae788f0947d"
      unitRef="usd">138000000</us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions
      contextRef="ia31e9a409b874bb19d0ff6f2f39ecc09_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90YWJsZToyNzU1NGI1NDNhOGQ0OWRjOWQ2OWU1YzU2YzhiNDE0OC90YWJsZXJhbmdlOjI3NTU0YjU0M2E4ZDQ5ZGM5ZDY5ZTVjNTZjOGI0MTQ4XzQtMy0xLTEtMA_c6f3fd0a-6257-410c-bd60-0832e77086d0"
      unitRef="usd">27000000</us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions
      contextRef="i00a6d666bf604826b24e68ddbd63eac4_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90YWJsZToyNzU1NGI1NDNhOGQ0OWRjOWQ2OWU1YzU2YzhiNDE0OC90YWJsZXJhbmdlOjI3NTU0YjU0M2E4ZDQ5ZGM5ZDY5ZTVjNTZjOGI0MTQ4XzQtNS0xLTEtMA_72d7ddc1-341f-4f42-a04a-452068114b7f"
      unitRef="usd">5000000</us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities
      contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90YWJsZToyNzU1NGI1NDNhOGQ0OWRjOWQ2OWU1YzU2YzhiNDE0OC90YWJsZXJhbmdlOjI3NTU0YjU0M2E4ZDQ5ZGM5ZDY5ZTVjNTZjOGI0MTQ4XzUtMS0xLTEtMA_06498216-0cd2-456b-9fe3-3b308e638d92"
      unitRef="usd">271000000</us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities>
    <us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities
      contextRef="ia31e9a409b874bb19d0ff6f2f39ecc09_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90YWJsZToyNzU1NGI1NDNhOGQ0OWRjOWQ2OWU1YzU2YzhiNDE0OC90YWJsZXJhbmdlOjI3NTU0YjU0M2E4ZDQ5ZGM5ZDY5ZTVjNTZjOGI0MTQ4XzUtMy0xLTEtMA_afa456a6-903d-47fd-9bd1-caa0e91db746"
      unitRef="usd">6000000</us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities>
    <us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities
      contextRef="i00a6d666bf604826b24e68ddbd63eac4_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90YWJsZToyNzU1NGI1NDNhOGQ0OWRjOWQ2OWU1YzU2YzhiNDE0OC90YWJsZXJhbmdlOjI3NTU0YjU0M2E4ZDQ5ZGM5ZDY5ZTVjNTZjOGI0MTQ4XzUtNS0xLTEtMA_3a91971b-f42c-411b-840a-6f91ee934dbc"
      unitRef="usd">25000000</us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities>
    <us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
      contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90YWJsZToyNzU1NGI1NDNhOGQ0OWRjOWQ2OWU1YzU2YzhiNDE0OC90YWJsZXJhbmdlOjI3NTU0YjU0M2E4ZDQ5ZGM5ZDY5ZTVjNTZjOGI0MTQ4XzYtMS0xLTEtMA_d5680bc5-297c-47b6-ba78-d0cc5d547d47"
      unitRef="usd">1000000</us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations>
    <us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
      contextRef="ia31e9a409b874bb19d0ff6f2f39ecc09_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90YWJsZToyNzU1NGI1NDNhOGQ0OWRjOWQ2OWU1YzU2YzhiNDE0OC90YWJsZXJhbmdlOjI3NTU0YjU0M2E4ZDQ5ZGM5ZDY5ZTVjNTZjOGI0MTQ4XzYtMy0xLTEtMA_809dc6bc-3739-4b1a-ba96-e9354eff1528"
      unitRef="usd">3000000</us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations>
    <us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
      contextRef="i00a6d666bf604826b24e68ddbd63eac4_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90YWJsZToyNzU1NGI1NDNhOGQ0OWRjOWQ2OWU1YzU2YzhiNDE0OC90YWJsZXJhbmdlOjI3NTU0YjU0M2E4ZDQ5ZGM5ZDY5ZTVjNTZjOGI0MTQ4XzYtNS0xLTEtMA_0e930bc5-af7c-4372-bd0a-5bdd23cdee2f"
      unitRef="usd">0</us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="i2e87824102b34590a0208cc7da91b5f5_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90YWJsZToyNzU1NGI1NDNhOGQ0OWRjOWQ2OWU1YzU2YzhiNDE0OC90YWJsZXJhbmdlOjI3NTU0YjU0M2E4ZDQ5ZGM5ZDY5ZTVjNTZjOGI0MTQ4XzctMS0xLTEtMA_d0b01471-ebba-42aa-a402-98cd329aa595"
      unitRef="usd">932000000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="i299cea70f47b4fbe96772aaa8cc00b79_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90YWJsZToyNzU1NGI1NDNhOGQ0OWRjOWQ2OWU1YzU2YzhiNDE0OC90YWJsZXJhbmdlOjI3NTU0YjU0M2E4ZDQ5ZGM5ZDY5ZTVjNTZjOGI0MTQ4XzctMy0xLTEtMA_c2f75399-5d5f-420f-aa75-fe6f97452881"
      unitRef="usd">998000000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="if6dc09eec4e74751b47cdf037a5b1860_I20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90YWJsZToyNzU1NGI1NDNhOGQ0OWRjOWQ2OWU1YzU2YzhiNDE0OC90YWJsZXJhbmdlOjI3NTU0YjU0M2E4ZDQ5ZGM5ZDY5ZTVjNTZjOGI0MTQ4XzctNS0xLTEtMA_fb581d71-49e5-47d4-895f-0104f12f4aa1"
      unitRef="usd">456000000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible
      contextRef="if156c7b3d30345a395262b86a56d2779_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90ZXh0cmVnaW9uOmViYTAwMWFhMmQ5YjRmODZiMGIyMTI2YzNmMjlhODhmXzcwODU_c1a62763-682a-4e6a-bd9b-c9bee4895e17"
      unitRef="usd">0</us-gaap:DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible>
    <us-gaap:DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible
      contextRef="ib54859ab704046a7a3be64f76f566d69_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90ZXh0cmVnaW9uOmViYTAwMWFhMmQ5YjRmODZiMGIyMTI2YzNmMjlhODhmXzcwOTE_55ed0d5f-9c7d-472a-ad17-c4ab264d19a5"
      unitRef="usd">20000000</us-gaap:DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible>
    <us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
      contextRef="i2e87824102b34590a0208cc7da91b5f5_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90ZXh0cmVnaW9uOmViYTAwMWFhMmQ5YjRmODZiMGIyMTI2YzNmMjlhODhmXzcyNzM_aa0098f4-051d-4220-96fd-ed3fc17ab9a4"
      unitRef="usd">49000000</us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued>
    <us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
      contextRef="i299cea70f47b4fbe96772aaa8cc00b79_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90ZXh0cmVnaW9uOmViYTAwMWFhMmQ5YjRmODZiMGIyMTI2YzNmMjlhODhmXzcyNzc_8b9303e2-405e-46bc-a1f1-16fe7699e6ba"
      unitRef="usd">146000000</us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued>
    <us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
      contextRef="if6dc09eec4e74751b47cdf037a5b1860_I20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90ZXh0cmVnaW9uOmViYTAwMWFhMmQ5YjRmODZiMGIyMTI2YzNmMjlhODhmXzcyODQ_797887dc-eb9c-459b-9149-5802373171b9"
      unitRef="usd">122000000</us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued>
    <us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
      contextRef="i5861e52e19f84919b7cf3da21acd4a1c_D20190401-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90ZXh0cmVnaW9uOmViYTAwMWFhMmQ5YjRmODZiMGIyMTI2YzNmMjlhODhmXzc1NTc_7514e426-849d-472f-9c88-d44814dc37ae"
      unitRef="usd">16000000</us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense>
    <us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
      contextRef="i00a6d666bf604826b24e68ddbd63eac4_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90ZXh0cmVnaW9uOmViYTAwMWFhMmQ5YjRmODZiMGIyMTI2YzNmMjlhODhmXzc1NjU_146f30ce-e09e-4f7a-9908-572b10982531"
      unitRef="usd">8000000</us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense>
    <cah:IndemnificationReceivable
      contextRef="i6ab12e7e0f7d4134995f67ad334fc7bb_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90ZXh0cmVnaW9uOmViYTAwMWFhMmQ5YjRmODZiMGIyMTI2YzNmMjlhODhmXzgyNzQ_82e16ee4-10c9-43d1-8b22-59943e5757cc"
      unitRef="usd">72000000</cah:IndemnificationReceivable>
    <cah:IndemnificationReceivable
      contextRef="ia26e78a845f44434a842d2f2d0afeb9c_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90ZXh0cmVnaW9uOmViYTAwMWFhMmQ5YjRmODZiMGIyMTI2YzNmMjlhODhmXzgyODE_5e4266fd-b223-4227-ac5f-f9f90a6efe80"
      unitRef="usd">176000000</cah:IndemnificationReceivable>
    <cah:IndemnificationReceivable
      contextRef="i5248507f2033461eab9f4d201b5cc2cd_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90ZXh0cmVnaW9uOmViYTAwMWFhMmQ5YjRmODZiMGIyMTI2YzNmMjlhODhmXzg2NDU_ac678ca9-3089-432b-917e-a193cd6832e2"
      unitRef="usd">12000000</cah:IndemnificationReceivable>
    <cah:IndemnificationReceivable
      contextRef="ia1d9ae03c64d4c31b1115e366d980c83_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzMvZnJhZzplYmEwMDFhYTJkOWI0Zjg2YjBiMjEyNmMzZjI5YTg4Zi90ZXh0cmVnaW9uOmViYTAwMWFhMmQ5YjRmODZiMGIyMTI2YzNmMjlhODhmXzg2NTI_a3954d50-e723-4718-8a73-1ad826d838c5"
      unitRef="usd">19000000</cah:IndemnificationReceivable>
    <us-gaap:FairValueMeasurementInputsDisclosureTextBlock
      contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzYvZnJhZzozOWViYWM3NDQzM2U0NzdhYjRmM2Y4MTM2OTJmMjA3Ny90ZXh0cmVnaW9uOjM5ZWJhYzc0NDMzZTQ3N2FiNGYzZjgxMzY5MmYyMDc3XzEyNzI_440570af-d3d9-4411-bffe-126f9c132dfd">&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:13pt;font-weight:700;line-height:120%"&gt;9. Fair Value Measurements &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables present the fair values for assets and (liabilities) measured on a recurring basis at June 30:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:46.122%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.937%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.343%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.937%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.343%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.937%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.343%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.938%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level&#160;1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level&#160;2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level&#160;3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;1,883&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;1,883&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Other investments (1)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;126&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;126&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Forward contracts (2)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;42&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;42&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:46.122%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.937%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.343%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.937%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.343%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.937%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.343%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.938%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Level&#160;1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Level&#160;2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Level&#160;3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;721&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;721&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Other investments (1)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;114&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;114&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Forward contracts (2)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;53&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;53&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:10pt"&gt;The other investments balance includes investments in mutual funds, which offset fluctuations in deferred compensation liabilities. These mutual funds invest in the equity securities of companies with both large and small market capitalization and high-quality fixed income debt securities. The fair value of these investments is determined using quoted market prices.&lt;/span&gt;(2)The fair value of interest rate swaps, foreign currency contracts, net investment hedges and commodity contracts is determined based on the present value of expected future cash flows considering the risks involved, including non-performance risk, and using discount rates appropriate for the respective maturities. Observable Level 2 inputs are used to determine the present value of expected future cash flows. The fair value of these derivative contracts, which are subject to master netting arrangements under certain circumstances, is presented on a gross basis in prepaid expenses and other, other assets, other accrued liabilities, and deferred income taxes and other liabilities within the consolidated balance sheets.</us-gaap:FairValueMeasurementInputsDisclosureTextBlock>
    <us-gaap:FairValueDisclosuresTextBlock
      contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzYvZnJhZzozOWViYWM3NDQzM2U0NzdhYjRmM2Y4MTM2OTJmMjA3Ny90ZXh0cmVnaW9uOjM5ZWJhYzc0NDMzZTQ3N2FiNGYzZjgxMzY5MmYyMDc3XzI3NDg3NzkwNzEzMjg_653b2fbc-97eb-4836-b6a2-ffd1cdf94648">&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:13pt;font-weight:700;line-height:120%"&gt;9. Fair Value Measurements &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables present the fair values for assets and (liabilities) measured on a recurring basis at June 30:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:46.122%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.937%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.343%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.937%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.343%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.937%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.343%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.938%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level&#160;1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level&#160;2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level&#160;3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;1,883&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;1,883&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Other investments (1)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;126&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;126&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Forward contracts (2)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;42&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;42&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:46.122%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.937%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.343%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.937%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.343%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.937%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.343%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.938%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Level&#160;1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Level&#160;2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Level&#160;3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;721&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;721&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Other investments (1)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;114&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;114&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Forward contracts (2)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;53&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;53&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:10pt"&gt;The other investments balance includes investments in mutual funds, which offset fluctuations in deferred compensation liabilities. These mutual funds invest in the equity securities of companies with both large and small market capitalization and high-quality fixed income debt securities. The fair value of these investments is determined using quoted market prices.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:10pt"&gt;The fair value of interest rate swaps, foreign currency contracts, net investment hedges and commodity contracts is determined based on the present value of expected future cash flows considering the risks involved, including non-performance risk, and using discount rates appropriate for the respective maturities. Observable Level 2 inputs are used to determine the present value of expected future cash flows. The fair value of these derivative contracts, which are subject to master netting arrangements under certain circumstances, is presented on a gross basis in prepaid expenses and other, other assets, other accrued liabilities, and deferred income taxes and other liabilities within the consolidated balance sheets. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%"&gt;Assets and (Liabilities) Measured on a Nonrecurring Basis&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Assets and liabilities held for sale of $1.1&#160;billion and $96 million, respectively, at June&#160;30, 2021 are primarily related to the divestiture of our Cordis business. These estimated fair values utilized Level 3 unobservable inputs based on expected sales proceeds following a competitive bidding process. See &lt;/span&gt;&lt;span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;&lt;a href="#i4f0ec56b9c604f1782a65ea4a19c284d_106" style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Note 2&lt;/a&gt;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; for additional information regarding assets and liabilities held for sale.&lt;/span&gt;&lt;/div&gt;</us-gaap:FairValueDisclosuresTextBlock>
    <us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock
      contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzYvZnJhZzozOWViYWM3NDQzM2U0NzdhYjRmM2Y4MTM2OTJmMjA3Ny90ZXh0cmVnaW9uOjM5ZWJhYzc0NDMzZTQ3N2FiNGYzZjgxMzY5MmYyMDc3XzEyNTI_f64dff48-5250-4666-94f1-b368a2708c1a">&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables present the fair values for assets and (liabilities) measured on a recurring basis at June 30:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:46.122%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.937%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.343%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.937%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.343%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.937%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.343%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.938%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level&#160;1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level&#160;2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level&#160;3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;1,883&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;1,883&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Other investments (1)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;126&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;126&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Forward contracts (2)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;42&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;42&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:46.122%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.937%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.343%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.937%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.343%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.937%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.343%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.938%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Level&#160;1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Level&#160;2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Level&#160;3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;721&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;721&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Other investments (1)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;114&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;114&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Forward contracts (2)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;53&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;53&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:10pt"&gt;The other investments balance includes investments in mutual funds, which offset fluctuations in deferred compensation liabilities. These mutual funds invest in the equity securities of companies with both large and small market capitalization and high-quality fixed income debt securities. The fair value of these investments is determined using quoted market prices.&lt;/span&gt;(2)The fair value of interest rate swaps, foreign currency contracts, net investment hedges and commodity contracts is determined based on the present value of expected future cash flows considering the risks involved, including non-performance risk, and using discount rates appropriate for the respective maturities. Observable Level 2 inputs are used to determine the present value of expected future cash flows. The fair value of these derivative contracts, which are subject to master netting arrangements under certain circumstances, is presented on a gross basis in prepaid expenses and other, other assets, other accrued liabilities, and deferred income taxes and other liabilities within the consolidated balance sheets.</us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="if0e5c8d6266b4e399e3e86ab88d0ff94_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzYvZnJhZzozOWViYWM3NDQzM2U0NzdhYjRmM2Y4MTM2OTJmMjA3Ny90YWJsZTowNDY5YjFjNjE3NmQ0MzZhOGRkODUxMDZiMjAxM2FmYi90YWJsZXJhbmdlOjA0NjliMWM2MTc2ZDQzNmE4ZGQ4NTEwNmIyMDEzYWZiXzMtMS0xLTEtMA_03f78dca-cfa2-4f56-9383-ad06eb7e5783"
      unitRef="usd">1883000000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="i2cb758f7ff794e2881dfc3872f11414b_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzYvZnJhZzozOWViYWM3NDQzM2U0NzdhYjRmM2Y4MTM2OTJmMjA3Ny90YWJsZTowNDY5YjFjNjE3NmQ0MzZhOGRkODUxMDZiMjAxM2FmYi90YWJsZXJhbmdlOjA0NjliMWM2MTc2ZDQzNmE4ZGQ4NTEwNmIyMDEzYWZiXzMtMy0xLTEtMA_0f41f671-6c85-48cf-a907-00e44a890cab"
      unitRef="usd">0</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="iaf7e71fcba5f483ebe952262b8f49189_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzYvZnJhZzozOWViYWM3NDQzM2U0NzdhYjRmM2Y4MTM2OTJmMjA3Ny90YWJsZTowNDY5YjFjNjE3NmQ0MzZhOGRkODUxMDZiMjAxM2FmYi90YWJsZXJhbmdlOjA0NjliMWM2MTc2ZDQzNmE4ZGQ4NTEwNmIyMDEzYWZiXzMtNS0xLTEtMA_564b651d-2793-42c3-858a-16ac023dc0c4"
      unitRef="usd">0</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="i53e687ceccba4bac9c2829e01e82f358_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzYvZnJhZzozOWViYWM3NDQzM2U0NzdhYjRmM2Y4MTM2OTJmMjA3Ny90YWJsZTowNDY5YjFjNjE3NmQ0MzZhOGRkODUxMDZiMjAxM2FmYi90YWJsZXJhbmdlOjA0NjliMWM2MTc2ZDQzNmE4ZGQ4NTEwNmIyMDEzYWZiXzMtNy0xLTEtMA_46cbfc7a-c3ba-4bc5-85c1-496545df1a00"
      unitRef="usd">1883000000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="if0e5c8d6266b4e399e3e86ab88d0ff94_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzYvZnJhZzozOWViYWM3NDQzM2U0NzdhYjRmM2Y4MTM2OTJmMjA3Ny90YWJsZTowNDY5YjFjNjE3NmQ0MzZhOGRkODUxMDZiMjAxM2FmYi90YWJsZXJhbmdlOjA0NjliMWM2MTc2ZDQzNmE4ZGQ4NTEwNmIyMDEzYWZiXzUtMS0xLTEtMA_dc2ca87d-02de-40a3-8338-f9ba62787ab5"
      unitRef="usd">126000000</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="i2cb758f7ff794e2881dfc3872f11414b_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzYvZnJhZzozOWViYWM3NDQzM2U0NzdhYjRmM2Y4MTM2OTJmMjA3Ny90YWJsZTowNDY5YjFjNjE3NmQ0MzZhOGRkODUxMDZiMjAxM2FmYi90YWJsZXJhbmdlOjA0NjliMWM2MTc2ZDQzNmE4ZGQ4NTEwNmIyMDEzYWZiXzUtMy0xLTEtMA_5c9b0b7a-6ef9-4686-a035-c189d939a016"
      unitRef="usd">0</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="iaf7e71fcba5f483ebe952262b8f49189_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzYvZnJhZzozOWViYWM3NDQzM2U0NzdhYjRmM2Y4MTM2OTJmMjA3Ny90YWJsZTowNDY5YjFjNjE3NmQ0MzZhOGRkODUxMDZiMjAxM2FmYi90YWJsZXJhbmdlOjA0NjliMWM2MTc2ZDQzNmE4ZGQ4NTEwNmIyMDEzYWZiXzUtNS0xLTEtMA_66199c49-2de9-4c51-9024-6ec04b2bf298"
      unitRef="usd">0</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="i53e687ceccba4bac9c2829e01e82f358_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzYvZnJhZzozOWViYWM3NDQzM2U0NzdhYjRmM2Y4MTM2OTJmMjA3Ny90YWJsZTowNDY5YjFjNjE3NmQ0MzZhOGRkODUxMDZiMjAxM2FmYi90YWJsZXJhbmdlOjA0NjliMWM2MTc2ZDQzNmE4ZGQ4NTEwNmIyMDEzYWZiXzUtNy0xLTEtMA_c96be184-444b-4820-aa30-9e79e948ded4"
      unitRef="usd">126000000</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:DerivativeAssetsLiabilitiesAtFairValueNet
      contextRef="if0e5c8d6266b4e399e3e86ab88d0ff94_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzYvZnJhZzozOWViYWM3NDQzM2U0NzdhYjRmM2Y4MTM2OTJmMjA3Ny90YWJsZTowNDY5YjFjNjE3NmQ0MzZhOGRkODUxMDZiMjAxM2FmYi90YWJsZXJhbmdlOjA0NjliMWM2MTc2ZDQzNmE4ZGQ4NTEwNmIyMDEzYWZiXzYtMS0xLTEtMA_f78d9cd9-9d93-494b-9087-228eee5b4a73"
      unitRef="usd">0</us-gaap:DerivativeAssetsLiabilitiesAtFairValueNet>
    <us-gaap:DerivativeAssetsLiabilitiesAtFairValueNet
      contextRef="i2cb758f7ff794e2881dfc3872f11414b_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzYvZnJhZzozOWViYWM3NDQzM2U0NzdhYjRmM2Y4MTM2OTJmMjA3Ny90YWJsZTowNDY5YjFjNjE3NmQ0MzZhOGRkODUxMDZiMjAxM2FmYi90YWJsZXJhbmdlOjA0NjliMWM2MTc2ZDQzNmE4ZGQ4NTEwNmIyMDEzYWZiXzYtMy0xLTEtMA_428306fc-9b83-4df9-a5d0-1248639b8bfb"
      unitRef="usd">42000000</us-gaap:DerivativeAssetsLiabilitiesAtFairValueNet>
    <us-gaap:DerivativeAssetsLiabilitiesAtFairValueNet
      contextRef="iaf7e71fcba5f483ebe952262b8f49189_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzYvZnJhZzozOWViYWM3NDQzM2U0NzdhYjRmM2Y4MTM2OTJmMjA3Ny90YWJsZTowNDY5YjFjNjE3NmQ0MzZhOGRkODUxMDZiMjAxM2FmYi90YWJsZXJhbmdlOjA0NjliMWM2MTc2ZDQzNmE4ZGQ4NTEwNmIyMDEzYWZiXzYtNS0xLTEtMA_f04dcf3f-b77d-4fb4-8e13-92ac345c9890"
      unitRef="usd">0</us-gaap:DerivativeAssetsLiabilitiesAtFairValueNet>
    <us-gaap:DerivativeAssetsLiabilitiesAtFairValueNet
      contextRef="i53e687ceccba4bac9c2829e01e82f358_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzYvZnJhZzozOWViYWM3NDQzM2U0NzdhYjRmM2Y4MTM2OTJmMjA3Ny90YWJsZTowNDY5YjFjNjE3NmQ0MzZhOGRkODUxMDZiMjAxM2FmYi90YWJsZXJhbmdlOjA0NjliMWM2MTc2ZDQzNmE4ZGQ4NTEwNmIyMDEzYWZiXzYtNy0xLTEtMA_e7bfcbdd-688e-4866-aa67-1dda5ffedf92"
      unitRef="usd">42000000</us-gaap:DerivativeAssetsLiabilitiesAtFairValueNet>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="i7a7f821903974542847e3a426b2298e4_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzYvZnJhZzozOWViYWM3NDQzM2U0NzdhYjRmM2Y4MTM2OTJmMjA3Ny90YWJsZToyNmQ3MmE4ZWVhZWU0MDY5OTg1MTc1ZTlmMGYzODNiMC90YWJsZXJhbmdlOjI2ZDcyYThlZWFlZTQwNjk5ODUxNzVlOWYwZjM4M2IwXzMtMS0xLTEtMA_87c4e340-3b8e-4239-b399-fba983b938b9"
      unitRef="usd">721000000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="i9b176a5bd18a4585bcea35c6994491bf_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzYvZnJhZzozOWViYWM3NDQzM2U0NzdhYjRmM2Y4MTM2OTJmMjA3Ny90YWJsZToyNmQ3MmE4ZWVhZWU0MDY5OTg1MTc1ZTlmMGYzODNiMC90YWJsZXJhbmdlOjI2ZDcyYThlZWFlZTQwNjk5ODUxNzVlOWYwZjM4M2IwXzMtMy0xLTEtMA_8055a975-19e0-426c-94bc-1c6e2790acb5"
      unitRef="usd">0</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="ib9e3c2a498984b619e5cd20d787935fc_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzYvZnJhZzozOWViYWM3NDQzM2U0NzdhYjRmM2Y4MTM2OTJmMjA3Ny90YWJsZToyNmQ3MmE4ZWVhZWU0MDY5OTg1MTc1ZTlmMGYzODNiMC90YWJsZXJhbmdlOjI2ZDcyYThlZWFlZTQwNjk5ODUxNzVlOWYwZjM4M2IwXzMtNS0xLTEtMA_bccad5d3-96a4-47d7-a355-9447831aec68"
      unitRef="usd">0</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="i66a08b6bbc4f404da5d4e4aeaf846429_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzYvZnJhZzozOWViYWM3NDQzM2U0NzdhYjRmM2Y4MTM2OTJmMjA3Ny90YWJsZToyNmQ3MmE4ZWVhZWU0MDY5OTg1MTc1ZTlmMGYzODNiMC90YWJsZXJhbmdlOjI2ZDcyYThlZWFlZTQwNjk5ODUxNzVlOWYwZjM4M2IwXzMtNy0xLTEtMA_dc44b61c-bd45-49a1-8075-6b9b15322daf"
      unitRef="usd">721000000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="i7a7f821903974542847e3a426b2298e4_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzYvZnJhZzozOWViYWM3NDQzM2U0NzdhYjRmM2Y4MTM2OTJmMjA3Ny90YWJsZToyNmQ3MmE4ZWVhZWU0MDY5OTg1MTc1ZTlmMGYzODNiMC90YWJsZXJhbmdlOjI2ZDcyYThlZWFlZTQwNjk5ODUxNzVlOWYwZjM4M2IwXzUtMS0xLTEtMA_c490daef-cde9-41cf-a5ed-5903614a1482"
      unitRef="usd">114000000</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="i9b176a5bd18a4585bcea35c6994491bf_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzYvZnJhZzozOWViYWM3NDQzM2U0NzdhYjRmM2Y4MTM2OTJmMjA3Ny90YWJsZToyNmQ3MmE4ZWVhZWU0MDY5OTg1MTc1ZTlmMGYzODNiMC90YWJsZXJhbmdlOjI2ZDcyYThlZWFlZTQwNjk5ODUxNzVlOWYwZjM4M2IwXzUtMy0xLTEtMA_45c59a4d-0506-4818-8969-fc806831f300"
      unitRef="usd">0</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="ib9e3c2a498984b619e5cd20d787935fc_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzYvZnJhZzozOWViYWM3NDQzM2U0NzdhYjRmM2Y4MTM2OTJmMjA3Ny90YWJsZToyNmQ3MmE4ZWVhZWU0MDY5OTg1MTc1ZTlmMGYzODNiMC90YWJsZXJhbmdlOjI2ZDcyYThlZWFlZTQwNjk5ODUxNzVlOWYwZjM4M2IwXzUtNS0xLTEtMA_c915708b-9b86-4b18-969d-0f5d93a0203c"
      unitRef="usd">0</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="i66a08b6bbc4f404da5d4e4aeaf846429_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzYvZnJhZzozOWViYWM3NDQzM2U0NzdhYjRmM2Y4MTM2OTJmMjA3Ny90YWJsZToyNmQ3MmE4ZWVhZWU0MDY5OTg1MTc1ZTlmMGYzODNiMC90YWJsZXJhbmdlOjI2ZDcyYThlZWFlZTQwNjk5ODUxNzVlOWYwZjM4M2IwXzUtNy0xLTEtMA_f5598531-c85c-4f42-b5e3-eefdb3d6232e"
      unitRef="usd">114000000</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:DerivativeAssetsLiabilitiesAtFairValueNet
      contextRef="i7a7f821903974542847e3a426b2298e4_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzYvZnJhZzozOWViYWM3NDQzM2U0NzdhYjRmM2Y4MTM2OTJmMjA3Ny90YWJsZToyNmQ3MmE4ZWVhZWU0MDY5OTg1MTc1ZTlmMGYzODNiMC90YWJsZXJhbmdlOjI2ZDcyYThlZWFlZTQwNjk5ODUxNzVlOWYwZjM4M2IwXzYtMS0xLTEtMA_5d3a885c-d2b9-459a-86f3-f19ea6884c4a"
      unitRef="usd">0</us-gaap:DerivativeAssetsLiabilitiesAtFairValueNet>
    <us-gaap:DerivativeAssetsLiabilitiesAtFairValueNet
      contextRef="i9b176a5bd18a4585bcea35c6994491bf_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzYvZnJhZzozOWViYWM3NDQzM2U0NzdhYjRmM2Y4MTM2OTJmMjA3Ny90YWJsZToyNmQ3MmE4ZWVhZWU0MDY5OTg1MTc1ZTlmMGYzODNiMC90YWJsZXJhbmdlOjI2ZDcyYThlZWFlZTQwNjk5ODUxNzVlOWYwZjM4M2IwXzYtMy0xLTEtMA_4f469210-aad9-4bb7-97ec-7d6fca37b89f"
      unitRef="usd">53000000</us-gaap:DerivativeAssetsLiabilitiesAtFairValueNet>
    <us-gaap:DerivativeAssetsLiabilitiesAtFairValueNet
      contextRef="ib9e3c2a498984b619e5cd20d787935fc_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzYvZnJhZzozOWViYWM3NDQzM2U0NzdhYjRmM2Y4MTM2OTJmMjA3Ny90YWJsZToyNmQ3MmE4ZWVhZWU0MDY5OTg1MTc1ZTlmMGYzODNiMC90YWJsZXJhbmdlOjI2ZDcyYThlZWFlZTQwNjk5ODUxNzVlOWYwZjM4M2IwXzYtNS0xLTEtMA_711e0b00-7cb8-4ac2-8969-fcf2259564eb"
      unitRef="usd">0</us-gaap:DerivativeAssetsLiabilitiesAtFairValueNet>
    <us-gaap:DerivativeAssetsLiabilitiesAtFairValueNet
      contextRef="i66a08b6bbc4f404da5d4e4aeaf846429_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzYvZnJhZzozOWViYWM3NDQzM2U0NzdhYjRmM2Y4MTM2OTJmMjA3Ny90YWJsZToyNmQ3MmE4ZWVhZWU0MDY5OTg1MTc1ZTlmMGYzODNiMC90YWJsZXJhbmdlOjI2ZDcyYThlZWFlZTQwNjk5ODUxNzVlOWYwZjM4M2IwXzYtNy0xLTEtMA_d9d8880f-3003-422f-9489-0d9ca47840e9"
      unitRef="usd">53000000</us-gaap:DerivativeAssetsLiabilitiesAtFairValueNet>
    <us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperation
      contextRef="i19e92323b7e546339ee3ca1cd768d7dc_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzYvZnJhZzozOWViYWM3NDQzM2U0NzdhYjRmM2Y4MTM2OTJmMjA3Ny90ZXh0cmVnaW9uOjM5ZWJhYzc0NDMzZTQ3N2FiNGYzZjgxMzY5MmYyMDc3XzI3NDg3NzkwNzEzMzU_fdbb4285-e2fc-449c-b843-dbd406181a0f"
      unitRef="usd">1100000000</us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperation>
    <us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation
      contextRef="i2e87824102b34590a0208cc7da91b5f5_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzYvZnJhZzozOWViYWM3NDQzM2U0NzdhYjRmM2Y4MTM2OTJmMjA3Ny90ZXh0cmVnaW9uOjM5ZWJhYzc0NDMzZTQ3N2FiNGYzZjgxMzY5MmYyMDc3XzI3NDg3NzkwNzEyNjA_3606ac8b-8a07-44c4-aa4d-cc08f770067e"
      unitRef="usd">96000000</us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation>
    <us-gaap:FinancialInstrumentsDisclosureTextBlock
      contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzkvZnJhZzo4OGQ2MDhlMWNlMjY0N2E5OGJjZWNlYjAxZDg1NjFiMC90ZXh0cmVnaW9uOjg4ZDYwOGUxY2UyNjQ3YTk4YmNlY2ViMDFkODU2MWIwXzExMTMz_1a789c6f-21c1-4352-86f6-03682ea102a8">&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:13pt;font-weight:700;line-height:120%"&gt;10. Financial Instruments &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We utilize derivative financial instruments to manage exposure to certain risks related to our ongoing operations. The primary risks managed through the use of derivative instruments include interest rate risk, currency exchange risk, and commodity price risk. We do not use derivative instruments for trading or speculative purposes. While the majority of our derivative instruments are designated as hedging instruments, we also enter into derivative instruments that are designed to hedge a risk, but are not designated as hedging instruments. These derivative instruments are adjusted to current fair value through earnings at the end of each period. We are exposed to counterparty credit risk on all of our derivative instruments. Accordingly, we have established and maintain strict counterparty credit guidelines and only enter into derivative instruments with major financial institutions that are rated investment grade or better. We do not have significant exposure to any one counterparty and we believe the risk of loss is remote. Additionally, we do not require collateral under these agreements.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%"&gt;Interest Rate Risk Management&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We are exposed to the impact of interest rate changes. Our objective is to manage the impact of interest rate changes on cash flows and the market value of our borrowings. We utilize a mix of debt maturities along with both fixed-rate and variable-rate debt to manage changes in interest rates. In addition, we enter into interest rate swaps to further manage our exposure to interest rate variations related to our borrowings and to lower our overall borrowing costs.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%"&gt;Currency Exchange Risk Management&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We conduct business in several major international currencies and are subject to risks associated with changing foreign exchange &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;rates. Our objective is to reduce earnings and cash flow volatility associated with foreign exchange rate changes to allow management to focus its attention on business operations. Accordingly, we enter into various contracts that change in value as foreign exchange rates change to protect the value of existing foreign currency assets and liabilities, commitments and anticipated foreign currency revenue and expenses.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%"&gt;Commodity Price Risk Management&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We are exposed to changes in the price of certain commodities. Our objective is to reduce earnings and cash flow volatility associated with forecasted purchases of these commodities to allow management to focus its attention on business operations. Accordingly, we enter into derivative contracts when possible to manage the price risk associated with certain forecasted purchases.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the fair value of our assets and liabilities related to derivatives designated as hedging instruments and the respective line items in which they were recorded in the consolidated balance sheets at June 30:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.691%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:69.488%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.831%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.347%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.834%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Pay-floating interest rate swaps (1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;1&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Cross-currency swap (1) &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;6&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Cross-currency swap (2)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;34&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Foreign currency contracts (2)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;5&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;46&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;74&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:6pt"&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Foreign currency contracts (4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;4&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"/&gt;&lt;td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Forward interest rate swaps (3)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Commodity contracts (4)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;4&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&#160;&#160;&#160;&#160;Included in other assets in the consolidated balance sheets.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(2)&#160;&#160;&#160;&#160;Included in prepaid expenses and other in the consolidated balance sheets.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(3)&#160;&#160;&#160;&#160;Included in deferred income taxes and other liabilities in the consolidated balance sheets.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(4)&#160;&#160;&#160;&#160;Included in other accrued liabilities in the consolidated balance sheets.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%"&gt;Fair Value Hedges&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We enter into pay-floating interest rate swaps to hedge the changes in the fair value of fixed-rate debt resulting from fluctuations in interest rates. These contracts are designated and qualify as fair value hedges. Accordingly, the gain or loss recorded on the pay-floating interest rate swaps is directly offset by the change in fair value of the underlying debt. Both the derivative instrument and the underlying debt are adjusted to market value at the end of each period with any resulting gain or loss recorded in interest expense, net in the consolidated statements of earnings/(loss). During fiscal 2021, 2020 and 2019 there was no gain or loss recorded to interest expense as changes in the market value of our derivative instruments offset changes in the market value of the underlying debt.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;During fiscal 2021, we unwound certain interest rate swap contracts with the notional amount of $550&#160;million. In connection with the unwind of these contracts, we received cash proceeds of &lt;/span&gt;&lt;/div&gt;&lt;div style="display:inline-block;vertical-align:top;width:48.214%"&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$18&#160;million. The related gain will be recognized in interest expense, net in our statements of earnings/(loss) over the remaining term of the debt agreement, which matures in March 2023.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During fiscal 2021, we entered into a pay-floating interest rate swap with total notional amounts of $200&#160;million. This swap has been designated as fair value hedges of our fixed rate debt and is included in deferred income taxes and other liabilities in the consolidated balance sheets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In May 2020, we unwound certain interest rate swap contracts. In connection with the unwind of these contracts, we received cash proceeds of $112 million. The related gain will be recognized in interest expense, net in our statements of earnings/(loss) over the remaining term of the related debt agreements, which ranged from 48 months to 63 months at June&#160;30, 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In connection with the debt repayment as described in &lt;/span&gt;&lt;span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;&lt;a href="#i4f0ec56b9c604f1782a65ea4a19c284d_124" style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Note 6&lt;/a&gt;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, two pay-floating interest rate swaps with notional amounts of $200 million matured in the second quarter of fiscal 2020. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During fiscal&#160;2019, we terminated notional amounts of&#160;$163&#160;million&#160;of pay-floating interest rate swaps in connection with the debt repurchases in&#160;fiscal 2019&#160;described in &lt;/span&gt;&lt;span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;&lt;a href="#i4f0ec56b9c604f1782a65ea4a19c284d_124" style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Note 6&lt;/a&gt;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. These swaps were previously designated as fair value hedges.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables summarize the outstanding interest rate swaps designated as fair value hedges at June 30:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.691%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:43.482%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:26.454%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.347%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.045%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:2.615%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.357%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Notional Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Maturity&#160;Date&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Pay-floating interest rate swaps&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;200&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="9" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Mar 2028&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.691%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:43.791%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:26.144%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.347%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.045%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:2.615%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.358%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Notional Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Maturity&#160;Date&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Pay-floating interest rate swaps&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;550&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="9" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Mar 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the gain/(loss) recognized in earnings for interest rate swaps designated as fair value hedges:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:52.912%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.343%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.343%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.408%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Pay-floating interest rate swaps (1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;106&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Fixed-rate debt (1)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;8&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(106)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1) Included in interest expense, net in the consolidated statements of earnings/(loss).&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%"&gt;Cash Flow Hedges&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We enter into derivative instruments to hedge our exposure to changes in cash flows attributable to interest rate, foreign currency and commodity price fluctuations associated with certain forecasted transactions. These derivative instruments are designated and qualify as cash flow hedges. Accordingly, the gain or loss on the derivative instrument is reported as a component of accumulated other comprehensive loss and reclassified into earnings in the same line item associated with the forecasted transaction and in the same period during which the hedged transaction affects earnings. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During fiscal 2020, we entered into forward interest rate swaps with a total notional amount of $200&#160;million to hedge probable, but &lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="display:inline-block;max-width:3.571%;min-width:2.571%;vertical-align:top"/&gt;&lt;div style="display:inline-block;vertical-align:top;width:48.215%"&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;not firmly committed, future transactions associated with our debt. During fiscal 2021, we terminated these swaps and reclassified an immaterial deferred gain from accumulated other comprehensive loss into interest expense, net in our consolidated statements of earnings/(loss) because the forecasted transactions were probable of not occurring. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;All gains and losses currently included within accumulated other comprehensive loss associated with our cash flow hedges that are expected to be reclassified into net earnings within the next 12 months are immaterial.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We enter into foreign currency contracts to protect the value of anticipated foreign currency revenues and expenses. At June&#160;30, 2021 and 2020, we held contracts to hedge probable, but not firmly committed, revenue and expenses. The principal currencies hedged are the Chinese renminbi, Canadian dollar, euro, Thai baht and Mexican peso.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We enter into commodity contracts to manage the price risk associated with forecasted purchases of certain commodities used in our Medical segment.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables summarize the outstanding cash flow hedges at June 30:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:38.714%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:24.517%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.343%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:2.912%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.408%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Notional Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Maturity&#160;Date&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Foreign currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;436&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-bottom:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Jul 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Jun 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:38.714%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:24.517%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.343%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:2.912%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.408%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Notional Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Maturity&#160;Date&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Forward interest rate swaps&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="9" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Jun 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Foreign currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;328&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Jul 2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Jun 2021&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Commodity contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Jul 2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Jun 2021&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the pre-tax gain/(loss) included in OCI for derivative instruments designated as cash flow hedges:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:46.739%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.492%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.343%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.023%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.960%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.643%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Forward interest rate swaps&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;16&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(16)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Commodity contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;1&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Foreign currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;5&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the pre-tax gain/(loss) reclassified from AOCI into earnings for derivative instruments designated as cash flow hedges:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.382%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:46.415%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.359%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.352%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.359%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.352%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.363%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Foreign currency contracts (1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Foreign currency contracts (2)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Foreign currency contracts (3)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;4&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Forward interest rate swaps (4)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Commodity contracts (3)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;6&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&#160;&#160;&#160;&#160;Included in revenue in the consolidated statements of earnings/(loss).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(2)&#160;&#160;&#160;&#160;Included in cost of products sold in the consolidated statements of earnings/(loss).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(3)&#160;&#160;&#160;&#160;Included in SG&amp;amp;A expenses in the consolidated statements of earnings/(loss).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(4) &#160;&#160;&#160;&#160;Included in interest expense, net in the consolidated statements of earnings/(loss).&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%"&gt;Net Investment Hedges&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We hedge the foreign currency risk associated with certain net investment positions in foreign subsidiaries. To accomplish this, we enter into cross-currency swaps that are designated as hedges of net investments.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In August 2019, we entered into a &#xa5;64 billion ($600 million) cross-currency swap maturing in 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In September 2018, we entered into a &#x20ac;200&#160;million ($233&#160;million) cross-currency swap maturing in 2023.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cross-currency swaps designated as net investment hedges are marked-to-market using the current spot exchange rate as of the end of the period, with gains and losses included in the foreign currency translation component of accumulated other comprehensive loss until the sale or substantial liquidation of the underlying net investments. To the extent the cross-currency swaps designated as net investment hedges are not highly effective, changes in carrying value attributable to the change in spot rates are recorded in earnings. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Pre-tax gain and loss from net investment hedges recorded in the foreign currency translation component of accumulated other comprehensive loss was a $7 million loss and a $35 million gain during fiscal 2021 and 2020, respectively. Gains recognized in interest expense, net in the consolidated statements of earnings/(loss) for the portion of the net investment hedges excluded from the assessment of hedge effectiveness were $19 million and&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$17 million during fiscal 2021 and 2020, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%"&gt;Economic (Non-Designated) Hedges&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We enter into foreign currency contracts to manage our foreign exchange exposure related to sales transactions, intercompany financing transactions and other balance sheet items subject to revaluation that do not meet the requirements for hedge accounting treatment. Accordingly, these derivative instruments are adjusted to current market value at the end of each period through earnings. The gain or loss recorded on these instruments is substantially offset by the remeasurement adjustment on the foreign currency denominated asset or liability. The settlement of the derivative instrument and the remeasurement adjustment on the foreign currency denominated asset or liability are both recorded in other (income)/expense, net. The principal currency managed through foreign currency contracts is the Chinese renminbi, Canadian dollar, euro, Mexican Peso, and Brazilian Real. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables summarize the outstanding economic (non-designated) derivative instruments at June 30:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:38.714%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:24.517%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.343%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:2.912%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.408%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Notional Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Maturity Date&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Foreign currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;254&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="9" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;July 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:38.714%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:24.517%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.343%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:2.912%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.408%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Notional Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Maturity Date&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Foreign currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;325&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="9" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Jul 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the gain/(loss) recognized in earnings for economic (non-designated) derivative instruments:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.382%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:46.415%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.359%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.352%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.359%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.352%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.363%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Foreign currency contracts (1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(11)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(13)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&#160;&#160;&#160;&#160;Included in other income, net in the consolidated statements of earnings/(loss).&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%"&gt;Fair Value of Financial Instruments&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The carrying amounts of cash and equivalents, trade receivables, net, accounts payable, and other accrued liabilities at June&#160;30, 2021 and 2020 approximate fair value due to their short-term maturities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the estimated fair value of our long-term obligations and other short-term borrowings compared to the respective carrying amounts at June 30:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:47.974%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:23.591%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.343%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:23.592%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Estimated fair value&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;6,751&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;7,273&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Carrying amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;6,236&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;6,775&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair value of our long-term obligations and other short-term borrowings is estimated based on either the quoted market prices for the same or similar issues or other inputs derived from available market information, which represents a Level 2 measurement.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table is a summary of the fair value gain/(loss) of our derivative instruments based upon the estimated amount that we would receive (or pay), considering counter-party credit risk, to terminate the contracts at June 30:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.691%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:31.098%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.451%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.347%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.547%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.347%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.451%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.347%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.312%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Notional&lt;br/&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair&#160;Value&lt;br/&gt;Gain/(Loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Notional&lt;br/&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Fair&#160;Value&lt;br/&gt;Gain/(Loss)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Pay-floating interest rate swaps&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;200&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;1&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;550&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Foreign currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;690&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;1&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;653&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Forward interest rate swaps&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(16)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Cross-currency swap&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;833&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;40&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;833&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Commodity contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:FinancialInstrumentsDisclosureTextBlock>
    <us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock
      contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzkvZnJhZzo4OGQ2MDhlMWNlMjY0N2E5OGJjZWNlYjAxZDg1NjFiMC90ZXh0cmVnaW9uOjg4ZDYwOGUxY2UyNjQ3YTk4YmNlY2ViMDFkODU2MWIwXzExMTM1_69ad9c78-5b66-43a6-9008-4f1a8d030fd2">&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the fair value of our assets and liabilities related to derivatives designated as hedging instruments and the respective line items in which they were recorded in the consolidated balance sheets at June 30:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.691%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:69.488%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.831%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.347%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.834%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Pay-floating interest rate swaps (1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;1&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Cross-currency swap (1) &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;6&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Cross-currency swap (2)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;34&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Foreign currency contracts (2)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;5&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;46&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;74&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:6pt"&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Foreign currency contracts (4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;4&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"/&gt;&lt;td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Forward interest rate swaps (3)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Commodity contracts (4)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;4&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&#160;&#160;&#160;&#160;Included in other assets in the consolidated balance sheets.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(2)&#160;&#160;&#160;&#160;Included in prepaid expenses and other in the consolidated balance sheets.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(3)&#160;&#160;&#160;&#160;Included in deferred income taxes and other liabilities in the consolidated balance sheets.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(4)&#160;&#160;&#160;&#160;Included in other accrued liabilities in the consolidated balance sheets.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="ieeeae5f04d634c51844ac9a96e9b09ed_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzkvZnJhZzo4OGQ2MDhlMWNlMjY0N2E5OGJjZWNlYjAxZDg1NjFiMC90YWJsZTpiNDU0MDkwYzljMDc0NGZmODg0NjcwNTY0NWJiNjU3OS90YWJsZXJhbmdlOmI0NTQwOTBjOWMwNzQ0ZmY4ODQ2NzA1NjQ1YmI2NTc5XzItMS0xLTEtMA_63a8c5ab-b50b-464c-934b-0e538d9f13b1"
      unitRef="usd">1000000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="ied457f9542c6444e96d2897053b037cd_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzkvZnJhZzo4OGQ2MDhlMWNlMjY0N2E5OGJjZWNlYjAxZDg1NjFiMC90YWJsZTpiNDU0MDkwYzljMDc0NGZmODg0NjcwNTY0NWJiNjU3OS90YWJsZXJhbmdlOmI0NTQwOTBjOWMwNzQ0ZmY4ODQ2NzA1NjQ1YmI2NTc5XzItMy0xLTEtMA_774ec016-9343-43b1-b88f-5761f3bf974e"
      unitRef="usd">27000000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="i4f2eecbc56bc4483ba6ecd0e80dc8c95_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzkvZnJhZzo4OGQ2MDhlMWNlMjY0N2E5OGJjZWNlYjAxZDg1NjFiMC90YWJsZTpiNDU0MDkwYzljMDc0NGZmODg0NjcwNTY0NWJiNjU3OS90YWJsZXJhbmdlOmI0NTQwOTBjOWMwNzQ0ZmY4ODQ2NzA1NjQ1YmI2NTc5XzMtMS0xLTEtMA_ac234445-3787-4c17-a648-169ce99adbc7"
      unitRef="usd">6000000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="ie2fc3cb346df4a8790d437caebe5bfeb_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzkvZnJhZzo4OGQ2MDhlMWNlMjY0N2E5OGJjZWNlYjAxZDg1NjFiMC90YWJsZTpiNDU0MDkwYzljMDc0NGZmODg0NjcwNTY0NWJiNjU3OS90YWJsZXJhbmdlOmI0NTQwOTBjOWMwNzQ0ZmY4ODQ2NzA1NjQ1YmI2NTc5XzMtMy0xLTEtMA_5cc6fe0e-3d77-4f99-bce6-dcb7dbc8557a"
      unitRef="usd">47000000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="i3646dde5708840a9844baca98633b4d9_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzkvZnJhZzo4OGQ2MDhlMWNlMjY0N2E5OGJjZWNlYjAxZDg1NjFiMC90YWJsZTpiNDU0MDkwYzljMDc0NGZmODg0NjcwNTY0NWJiNjU3OS90YWJsZXJhbmdlOmI0NTQwOTBjOWMwNzQ0ZmY4ODQ2NzA1NjQ1YmI2NTc5XzQtMS0xLTEtNTY4NQ_49991901-0665-49b5-8187-2402774aaee5"
      unitRef="usd">34000000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="if1331393b0e34887b04264776d257b9d_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzkvZnJhZzo4OGQ2MDhlMWNlMjY0N2E5OGJjZWNlYjAxZDg1NjFiMC90YWJsZTpiNDU0MDkwYzljMDc0NGZmODg0NjcwNTY0NWJiNjU3OS90YWJsZXJhbmdlOmI0NTQwOTBjOWMwNzQ0ZmY4ODQ2NzA1NjQ1YmI2NTc5XzQtMy0xLTEtNTY5Mw_ad8fef73-cd7f-403d-b28c-8d2190ae5a28"
      unitRef="usd">0</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="i027cf29054524efda48f2d0dea27a987_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzkvZnJhZzo4OGQ2MDhlMWNlMjY0N2E5OGJjZWNlYjAxZDg1NjFiMC90YWJsZTpiNDU0MDkwYzljMDc0NGZmODg0NjcwNTY0NWJiNjU3OS90YWJsZXJhbmdlOmI0NTQwOTBjOWMwNzQ0ZmY4ODQ2NzA1NjQ1YmI2NTc5XzQtMS0xLTEtMA_79f0fe7b-4ef0-4d14-891c-5c363252854c"
      unitRef="usd">5000000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="ia5a1a9623870472f8b2069242d333329_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzkvZnJhZzo4OGQ2MDhlMWNlMjY0N2E5OGJjZWNlYjAxZDg1NjFiMC90YWJsZTpiNDU0MDkwYzljMDc0NGZmODg0NjcwNTY0NWJiNjU3OS90YWJsZXJhbmdlOmI0NTQwOTBjOWMwNzQ0ZmY4ODQ2NzA1NjQ1YmI2NTc5XzQtMy0xLTEtMA_7144558e-1ee6-407a-836f-deaf8b715893"
      unitRef="usd">0</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="i2e87824102b34590a0208cc7da91b5f5_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzkvZnJhZzo4OGQ2MDhlMWNlMjY0N2E5OGJjZWNlYjAxZDg1NjFiMC90YWJsZTpiNDU0MDkwYzljMDc0NGZmODg0NjcwNTY0NWJiNjU3OS90YWJsZXJhbmdlOmI0NTQwOTBjOWMwNzQ0ZmY4ODQ2NzA1NjQ1YmI2NTc5XzgtMS0xLTEtMA_91181d35-970a-4673-bf54-80edaedc93e3"
      unitRef="usd">46000000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="i299cea70f47b4fbe96772aaa8cc00b79_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzkvZnJhZzo4OGQ2MDhlMWNlMjY0N2E5OGJjZWNlYjAxZDg1NjFiMC90YWJsZTpiNDU0MDkwYzljMDc0NGZmODg0NjcwNTY0NWJiNjU3OS90YWJsZXJhbmdlOmI0NTQwOTBjOWMwNzQ0ZmY4ODQ2NzA1NjQ1YmI2NTc5XzgtMy0xLTEtMA_ceda5445-a907-44b0-9f50-5e50b861f5b5"
      unitRef="usd">74000000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="i6a96679386eb4368a6920765ed1afdd6_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzkvZnJhZzo4OGQ2MDhlMWNlMjY0N2E5OGJjZWNlYjAxZDg1NjFiMC90YWJsZTpiNDU0MDkwYzljMDc0NGZmODg0NjcwNTY0NWJiNjU3OS90YWJsZXJhbmdlOmI0NTQwOTBjOWMwNzQ0ZmY4ODQ2NzA1NjQ1YmI2NTc5XzEyLTEtMS0xLTA_6773c97c-73e4-4296-b0db-121edafaa9f5"
      unitRef="usd">4000000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="i185e5c7efe754824b8a884fe900d3d71_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzkvZnJhZzo4OGQ2MDhlMWNlMjY0N2E5OGJjZWNlYjAxZDg1NjFiMC90YWJsZTpiNDU0MDkwYzljMDc0NGZmODg0NjcwNTY0NWJiNjU3OS90YWJsZXJhbmdlOmI0NTQwOTBjOWMwNzQ0ZmY4ODQ2NzA1NjQ1YmI2NTc5XzEyLTMtMS0xLTA_5c51e4cd-5f45-4aa8-b756-525cdec2485e"
      unitRef="usd">4000000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="i86f91bfc61ad471a9cb0bef75b551b70_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzkvZnJhZzo4OGQ2MDhlMWNlMjY0N2E5OGJjZWNlYjAxZDg1NjFiMC90YWJsZTpiNDU0MDkwYzljMDc0NGZmODg0NjcwNTY0NWJiNjU3OS90YWJsZXJhbmdlOmI0NTQwOTBjOWMwNzQ0ZmY4ODQ2NzA1NjQ1YmI2NTc5XzEzLTEtMS0xLTA_45a1c7b8-1ec9-4b16-8cf6-6411b14a55e6"
      unitRef="usd">0</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="ibe5ee12c49f146b8bc66d2c3290cbd7f_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzkvZnJhZzo4OGQ2MDhlMWNlMjY0N2E5OGJjZWNlYjAxZDg1NjFiMC90YWJsZTpiNDU0MDkwYzljMDc0NGZmODg0NjcwNTY0NWJiNjU3OS90YWJsZXJhbmdlOmI0NTQwOTBjOWMwNzQ0ZmY4ODQ2NzA1NjQ1YmI2NTc5XzEzLTMtMS0xLTA_a1e10bb8-ccb5-427a-83d4-af7031035e7b"
      unitRef="usd">16000000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="ibc2ebe6c60f8474283c818e4eb4db2ee_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzkvZnJhZzo4OGQ2MDhlMWNlMjY0N2E5OGJjZWNlYjAxZDg1NjFiMC90YWJsZTpiNDU0MDkwYzljMDc0NGZmODg0NjcwNTY0NWJiNjU3OS90YWJsZXJhbmdlOmI0NTQwOTBjOWMwNzQ0ZmY4ODQ2NzA1NjQ1YmI2NTc5XzE1LTEtMS0xLTA_4e97882f-0cb4-4a76-8272-b1fdd7e0f9a4"
      unitRef="usd">0</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="ied8ca13a46124e0186f0557c51ad5050_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzkvZnJhZzo4OGQ2MDhlMWNlMjY0N2E5OGJjZWNlYjAxZDg1NjFiMC90YWJsZTpiNDU0MDkwYzljMDc0NGZmODg0NjcwNTY0NWJiNjU3OS90YWJsZXJhbmdlOmI0NTQwOTBjOWMwNzQ0ZmY4ODQ2NzA1NjQ1YmI2NTc5XzE1LTMtMS0xLTA_c2523650-30e3-468d-b6ca-8424e070fdbf"
      unitRef="usd">1000000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="i2e87824102b34590a0208cc7da91b5f5_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzkvZnJhZzo4OGQ2MDhlMWNlMjY0N2E5OGJjZWNlYjAxZDg1NjFiMC90YWJsZTpiNDU0MDkwYzljMDc0NGZmODg0NjcwNTY0NWJiNjU3OS90YWJsZXJhbmdlOmI0NTQwOTBjOWMwNzQ0ZmY4ODQ2NzA1NjQ1YmI2NTc5XzE2LTEtMS0xLTA_5949fd1d-acb9-4f32-9b99-cadd047ce88b"
      unitRef="usd">4000000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="i299cea70f47b4fbe96772aaa8cc00b79_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzkvZnJhZzo4OGQ2MDhlMWNlMjY0N2E5OGJjZWNlYjAxZDg1NjFiMC90YWJsZTpiNDU0MDkwYzljMDc0NGZmODg0NjcwNTY0NWJiNjU3OS90YWJsZXJhbmdlOmI0NTQwOTBjOWMwNzQ0ZmY4ODQ2NzA1NjQ1YmI2NTc5XzE2LTMtMS0xLTA_7d0b90ac-b5e6-4a3f-bfb8-34232fd5891a"
      unitRef="usd">21000000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1
      contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzkvZnJhZzo4OGQ2MDhlMWNlMjY0N2E5OGJjZWNlYjAxZDg1NjFiMC90ZXh0cmVnaW9uOjg4ZDYwOGUxY2UyNjQ3YTk4YmNlY2ViMDFkODU2MWIwXzM4MjE_3bc369c3-dab5-459c-97bc-213d34363847"
      unitRef="usd">0</us-gaap:ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1>
    <us-gaap:ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1
      contextRef="ia31e9a409b874bb19d0ff6f2f39ecc09_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzkvZnJhZzo4OGQ2MDhlMWNlMjY0N2E5OGJjZWNlYjAxZDg1NjFiMC90ZXh0cmVnaW9uOjg4ZDYwOGUxY2UyNjQ3YTk4YmNlY2ViMDFkODU2MWIwXzM4MjE_62f665ff-f473-486e-9078-7680684edee8"
      unitRef="usd">0</us-gaap:ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1>
    <cah:DerivatesHedgeDiscontinuancesHedgingInstrumentTerminatedAmount
      contextRef="i1f99a8613bb24104868a314b77c67aa4_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzkvZnJhZzo4OGQ2MDhlMWNlMjY0N2E5OGJjZWNlYjAxZDg1NjFiMC90ZXh0cmVnaW9uOjg4ZDYwOGUxY2UyNjQ3YTk4YmNlY2ViMDFkODU2MWIwXzI3NDg3NzkwODIxMTM_99a6ec36-206c-4956-9883-5d186cd14770"
      unitRef="usd">550000000</cah:DerivatesHedgeDiscontinuancesHedgingInstrumentTerminatedAmount>
    <us-gaap:DeferredGainLossOnDiscontinuationOfInterestRateFairValueHedge
      contextRef="i69a44d9974c04cc3abf8c7aeb68f22c6_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzkvZnJhZzo4OGQ2MDhlMWNlMjY0N2E5OGJjZWNlYjAxZDg1NjFiMC90ZXh0cmVnaW9uOjg4ZDYwOGUxY2UyNjQ3YTk4YmNlY2ViMDFkODU2MWIwXzI3NDg3NzkwODIxOTc_c92e8b5d-c0a3-4b32-8c29-64eba46d0f95"
      unitRef="usd">18000000</us-gaap:DeferredGainLossOnDiscontinuationOfInterestRateFairValueHedge>
    <us-gaap:DerivativeLiabilityNotionalAmount
      contextRef="i1f99a8613bb24104868a314b77c67aa4_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzkvZnJhZzo4OGQ2MDhlMWNlMjY0N2E5OGJjZWNlYjAxZDg1NjFiMC90ZXh0cmVnaW9uOjg4ZDYwOGUxY2UyNjQ3YTk4YmNlY2ViMDFkODU2MWIwXzI3NDg3NzkwODI0ODc_162ce315-d320-4010-839f-88469a94bd85"
      unitRef="usd">200000000</us-gaap:DerivativeLiabilityNotionalAmount>
    <us-gaap:DeferredGainLossOnDiscontinuationOfInterestRateFairValueHedge
      contextRef="i0168bf25346243ffba7498cecba4a9cc_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzkvZnJhZzo4OGQ2MDhlMWNlMjY0N2E5OGJjZWNlYjAxZDg1NjFiMC90ZXh0cmVnaW9uOjg4ZDYwOGUxY2UyNjQ3YTk4YmNlY2ViMDFkODU2MWIwXzQxMjU_8f1877e9-fc75-4149-a8df-3c9b794e4c8a"
      unitRef="usd">112000000</us-gaap:DeferredGainLossOnDiscontinuationOfInterestRateFairValueHedge>
    <cah:DerivativesHedgeDiscontinuancesHedgingInstrumentMaturedAmount
      contextRef="i0168bf25346243ffba7498cecba4a9cc_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzkvZnJhZzo4OGQ2MDhlMWNlMjY0N2E5OGJjZWNlYjAxZDg1NjFiMC90ZXh0cmVnaW9uOjg4ZDYwOGUxY2UyNjQ3YTk4YmNlY2ViMDFkODU2MWIwXzQ0NTQ_e4a4715e-2a78-4222-82a9-9e480440bb70"
      unitRef="usd">200000000</cah:DerivativesHedgeDiscontinuancesHedgingInstrumentMaturedAmount>
    <cah:DerivativesHedgeDiscontinuancesTerminationofHedgingInstrumentAmount
      contextRef="icee22ead7e494923bbe522fa98e2c282_I20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzkvZnJhZzo4OGQ2MDhlMWNlMjY0N2E5OGJjZWNlYjAxZDg1NjFiMC90ZXh0cmVnaW9uOjg4ZDYwOGUxY2UyNjQ3YTk4YmNlY2ViMDFkODU2MWIwXzI3NDg3NzkwODE1MDM_750cca7d-e6ec-46ce-9868-a02278b1013e"
      unitRef="usd">163000000</cah:DerivativesHedgeDiscontinuancesTerminationofHedgingInstrumentAmount>
    <us-gaap:ScheduleOfDerivativeInstrumentsTextBlock
      contextRef="i85f45ef64e47468d81d7e9def6ee8bdd_D20200701-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzkvZnJhZzo4OGQ2MDhlMWNlMjY0N2E5OGJjZWNlYjAxZDg1NjFiMC90ZXh0cmVnaW9uOjg4ZDYwOGUxY2UyNjQ3YTk4YmNlY2ViMDFkODU2MWIwXzExMTIw_a60c18e4-fabf-4bb7-b077-5217e7faa2a9">&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables summarize the outstanding interest rate swaps designated as fair value hedges at June 30:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.691%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:43.482%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:26.454%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.347%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.045%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:2.615%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.357%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Notional Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Maturity&#160;Date&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Pay-floating interest rate swaps&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;200&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="9" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Mar 2028&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.691%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:43.791%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:26.144%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.347%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.045%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:2.615%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.358%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Notional Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Maturity&#160;Date&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Pay-floating interest rate swaps&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;550&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="9" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Mar 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfDerivativeInstrumentsTextBlock>
    <us-gaap:DerivativeAssetNotionalAmount
      contextRef="i04848fa4190a4546999fce3b74a1093a_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzkvZnJhZzo4OGQ2MDhlMWNlMjY0N2E5OGJjZWNlYjAxZDg1NjFiMC90YWJsZTo4YzM1Y2Q5YmRiNjI0NzcyYTU5NDA4MGM2MTNkYTIwOC90YWJsZXJhbmdlOjhjMzVjZDliZGI2MjQ3NzJhNTk0MDgwYzYxM2RhMjA4XzItMS0xLTEtMA_38a6cb71-d95d-4a31-af79-a2947d4ab843"
      unitRef="usd">200000000</us-gaap:DerivativeAssetNotionalAmount>
    <us-gaap:DerivativeAssetNotionalAmount
      contextRef="iffa4055c7e214900820c0a0df90cdebf_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzkvZnJhZzo4OGQ2MDhlMWNlMjY0N2E5OGJjZWNlYjAxZDg1NjFiMC90YWJsZTo2NWRkOTYyYzdiNDg0NWNmYWU1OGVhNmFkMzlmODY5NC90YWJsZXJhbmdlOjY1ZGQ5NjJjN2I0ODQ1Y2ZhZTU4ZWE2YWQzOWY4Njk0XzItMS0xLTEtMA_f7da8e31-5953-4540-aabc-49e9a6f51fa5"
      unitRef="usd">550000000</us-gaap:DerivativeAssetNotionalAmount>
    <us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock
      contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzkvZnJhZzo4OGQ2MDhlMWNlMjY0N2E5OGJjZWNlYjAxZDg1NjFiMC90ZXh0cmVnaW9uOjg4ZDYwOGUxY2UyNjQ3YTk4YmNlY2ViMDFkODU2MWIwXzExMTQ4_1ee43e0a-e643-4a7d-9c39-b3acebfc6b72">&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the gain/(loss) recognized in earnings for interest rate swaps designated as fair value hedges:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:52.912%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.343%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.343%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.408%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Pay-floating interest rate swaps (1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;106&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Fixed-rate debt (1)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;8&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(106)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1) Included in interest expense, net in the consolidated statements of earnings/(loss).&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="i17248417fcbc4d118aebc5dfbe183bfc_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzkvZnJhZzo4OGQ2MDhlMWNlMjY0N2E5OGJjZWNlYjAxZDg1NjFiMC90YWJsZTplNDI3OWExYjM5M2U0Y2U4OTY5NzdiNmYzYjc1Njg3NS90YWJsZXJhbmdlOmU0Mjc5YTFiMzkzZTRjZTg5Njk3N2I2ZjNiNzU2ODc1XzEtMS0xLTEtMA_476cee54-6cfd-4f9c-9117-9c7fb8389348"
      unitRef="usd">-8000000</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="i0845a3b72a6e4a848138beb4170c6fba_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzkvZnJhZzo4OGQ2MDhlMWNlMjY0N2E5OGJjZWNlYjAxZDg1NjFiMC90YWJsZTplNDI3OWExYjM5M2U0Y2U4OTY5NzdiNmYzYjc1Njg3NS90YWJsZXJhbmdlOmU0Mjc5YTFiMzkzZTRjZTg5Njk3N2I2ZjNiNzU2ODc1XzEtMy0xLTEtMA_c733c423-142f-484b-b123-7131115c8b9b"
      unitRef="usd">106000000</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="ibe9e1edad1c3406abdda7b5fca98220a_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzkvZnJhZzo4OGQ2MDhlMWNlMjY0N2E5OGJjZWNlYjAxZDg1NjFiMC90YWJsZTplNDI3OWExYjM5M2U0Y2U4OTY5NzdiNmYzYjc1Njg3NS90YWJsZXJhbmdlOmU0Mjc5YTFiMzkzZTRjZTg5Njk3N2I2ZjNiNzU2ODc1XzEtNS0xLTEtMA_fb390cb8-81c9-4d68-94c0-d82c92d6899b"
      unitRef="usd">9000000</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="ia80ca9aee82849b1a44b4c376a866386_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzkvZnJhZzo4OGQ2MDhlMWNlMjY0N2E5OGJjZWNlYjAxZDg1NjFiMC90YWJsZTplNDI3OWExYjM5M2U0Y2U4OTY5NzdiNmYzYjc1Njg3NS90YWJsZXJhbmdlOmU0Mjc5YTFiMzkzZTRjZTg5Njk3N2I2ZjNiNzU2ODc1XzItMS0xLTEtMA_f8b9d81d-de0f-47de-82f3-792948650b2a"
      unitRef="usd">8000000</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="ic47a87ff22934f0a928e5fd2824d30f8_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzkvZnJhZzo4OGQ2MDhlMWNlMjY0N2E5OGJjZWNlYjAxZDg1NjFiMC90YWJsZTplNDI3OWExYjM5M2U0Y2U4OTY5NzdiNmYzYjc1Njg3NS90YWJsZXJhbmdlOmU0Mjc5YTFiMzkzZTRjZTg5Njk3N2I2ZjNiNzU2ODc1XzItMy0xLTEtMA_b94cb63c-197c-47de-88bc-a0b26f9e9549"
      unitRef="usd">-106000000</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="ic94b1b2e248e48cdb5c5ff6dca1da5fb_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzkvZnJhZzo4OGQ2MDhlMWNlMjY0N2E5OGJjZWNlYjAxZDg1NjFiMC90YWJsZTplNDI3OWExYjM5M2U0Y2U4OTY5NzdiNmYzYjc1Njg3NS90YWJsZXJhbmdlOmU0Mjc5YTFiMzkzZTRjZTg5Njk3N2I2ZjNiNzU2ODc1XzItNS0xLTEtMA_a8fbcb22-8874-471c-9d7f-87705df57bec"
      unitRef="usd">-9000000</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:DerivativeLiabilityNotionalAmount
      contextRef="i58c9aa5163a64897b2ad19c7f47190d0_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzkvZnJhZzo4OGQ2MDhlMWNlMjY0N2E5OGJjZWNlYjAxZDg1NjFiMC90ZXh0cmVnaW9uOjg4ZDYwOGUxY2UyNjQ3YTk4YmNlY2ViMDFkODU2MWIwXzQ5NDc4MDIzMzg0Mzk_85f6c044-ef61-4532-85e3-d8cef475aa6b"
      unitRef="usd">200000000</us-gaap:DerivativeLiabilityNotionalAmount>
    <cah:DerivatesHedgeDiscontinuancesHedgingInstrumentTerminatedAmount
      contextRef="i54cc6ff9187745ac8eb02d90c7a86a72_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzkvZnJhZzo4OGQ2MDhlMWNlMjY0N2E5OGJjZWNlYjAxZDg1NjFiMC90ZXh0cmVnaW9uOjg4ZDYwOGUxY2UyNjQ3YTk4YmNlY2ViMDFkODU2MWIwXzQ5NDc4MDIzMzg0Mzk_e576cea9-d070-4097-a14a-3fabc3ae6a2a"
      unitRef="usd">200000000</cah:DerivatesHedgeDiscontinuancesHedgingInstrumentTerminatedAmount>
    <us-gaap:ScheduleOfDerivativeInstrumentsTextBlock
      contextRef="i88d0b5894f144c978ac101959057bde3_D20200701-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzkvZnJhZzo4OGQ2MDhlMWNlMjY0N2E5OGJjZWNlYjAxZDg1NjFiMC90ZXh0cmVnaW9uOjg4ZDYwOGUxY2UyNjQ3YTk4YmNlY2ViMDFkODU2MWIwXzExMTE0_7e395f89-d438-4030-adb6-835c3918d2b0">&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables summarize the outstanding cash flow hedges at June 30:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:38.714%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:24.517%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.343%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:2.912%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.408%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Notional Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Maturity&#160;Date&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Foreign currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;436&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-bottom:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Jul 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Jun 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:38.714%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:24.517%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.343%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:2.912%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.408%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Notional Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Maturity&#160;Date&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Forward interest rate swaps&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="9" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Jun 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Foreign currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;328&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Jul 2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Jun 2021&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Commodity contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Jul 2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Jun 2021&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfDerivativeInstrumentsTextBlock>
    <us-gaap:DerivativeAssetNotionalAmount
      contextRef="i8f3de44e96774f7296c0c1deb3f17775_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzkvZnJhZzo4OGQ2MDhlMWNlMjY0N2E5OGJjZWNlYjAxZDg1NjFiMC90YWJsZTo4MmM4NzM3ZGYwYWY0ZWZhOGE3N2IxNjIyNDBkNGMzNC90YWJsZXJhbmdlOjgyYzg3MzdkZjBhZjRlZmE4YTc3YjE2MjI0MGQ0YzM0XzMtMS0xLTEtMA_605ead05-2e68-40de-93ce-29ebc19d8363"
      unitRef="usd">436000000</us-gaap:DerivativeAssetNotionalAmount>
    <us-gaap:DerivativeAssetNotionalAmount
      contextRef="i82a8006ead354bb59b15285e08a487f9_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzkvZnJhZzo4OGQ2MDhlMWNlMjY0N2E5OGJjZWNlYjAxZDg1NjFiMC90YWJsZTo0ZWEwNWEzMTJjNTc0ODIxOGE2ZjQ0MTY3ZThkNzI2Ni90YWJsZXJhbmdlOjRlYTA1YTMxMmM1NzQ4MjE4YTZmNDQxNjdlOGQ3MjY2XzItMS0xLTEtMA_42a7e674-a773-4204-8321-bfe727d010e2"
      unitRef="usd">200000000</us-gaap:DerivativeAssetNotionalAmount>
    <us-gaap:DerivativeAssetNotionalAmount
      contextRef="ie09b4e9c614244d1bd722525781f1905_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzkvZnJhZzo4OGQ2MDhlMWNlMjY0N2E5OGJjZWNlYjAxZDg1NjFiMC90YWJsZTo0ZWEwNWEzMTJjNTc0ODIxOGE2ZjQ0MTY3ZThkNzI2Ni90YWJsZXJhbmdlOjRlYTA1YTMxMmM1NzQ4MjE4YTZmNDQxNjdlOGQ3MjY2XzMtMS0xLTEtMA_470de256-6e15-49a9-b8ad-d72281eb2192"
      unitRef="usd">328000000</us-gaap:DerivativeAssetNotionalAmount>
    <us-gaap:DerivativeAssetNotionalAmount
      contextRef="i4de6f0288abd431bbc839b56b68b328b_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzkvZnJhZzo4OGQ2MDhlMWNlMjY0N2E5OGJjZWNlYjAxZDg1NjFiMC90YWJsZTo0ZWEwNWEzMTJjNTc0ODIxOGE2ZjQ0MTY3ZThkNzI2Ni90YWJsZXJhbmdlOjRlYTA1YTMxMmM1NzQ4MjE4YTZmNDQxNjdlOGQ3MjY2XzQtMS0xLTEtMA_5581695f-6d53-408b-93ae-69ad9c75a527"
      unitRef="usd">16000000</us-gaap:DerivativeAssetNotionalAmount>
    <us-gaap:ScheduleOfDerivativeInstrumentsEffectOnOtherComprehensiveIncomeLossTableTextBlock
      contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzkvZnJhZzo4OGQ2MDhlMWNlMjY0N2E5OGJjZWNlYjAxZDg1NjFiMC90ZXh0cmVnaW9uOjg4ZDYwOGUxY2UyNjQ3YTk4YmNlY2ViMDFkODU2MWIwXzExMTM5_209e50cc-15eb-4b07-ba0b-0c0b9844299e">&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the pre-tax gain/(loss) included in OCI for derivative instruments designated as cash flow hedges:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:46.739%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.492%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.343%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.023%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.960%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.643%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Forward interest rate swaps&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;16&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(16)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Commodity contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;1&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Foreign currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;5&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfDerivativeInstrumentsEffectOnOtherComprehensiveIncomeLossTableTextBlock>
    <us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax
      contextRef="i405b6b2ebdbb4b00959f5be8d40c1adb_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzkvZnJhZzo4OGQ2MDhlMWNlMjY0N2E5OGJjZWNlYjAxZDg1NjFiMC90YWJsZTo0NWU1NGM2OTA5MDM0YjlhYTE1YjZhMGFmNjhhZTVmMy90YWJsZXJhbmdlOjQ1ZTU0YzY5MDkwMzRiOWFhMTViNmEwYWY2OGFlNWYzXzEtMS0xLTEtMA_430acc03-f66a-464d-be5b-e0e76168d123"
      unitRef="usd">16000000</us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax
      contextRef="i3977a8adbc674a3db02afa95292219d7_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzkvZnJhZzo4OGQ2MDhlMWNlMjY0N2E5OGJjZWNlYjAxZDg1NjFiMC90YWJsZTo0NWU1NGM2OTA5MDM0YjlhYTE1YjZhMGFmNjhhZTVmMy90YWJsZXJhbmdlOjQ1ZTU0YzY5MDkwMzRiOWFhMTViNmEwYWY2OGFlNWYzXzEtMy0xLTEtMA_62b65816-733c-42f9-aa92-ab83753ce84a"
      unitRef="usd">-16000000</us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax
      contextRef="ie29079d55386424da44448bd2dd0f7b9_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzkvZnJhZzo4OGQ2MDhlMWNlMjY0N2E5OGJjZWNlYjAxZDg1NjFiMC90YWJsZTo0NWU1NGM2OTA5MDM0YjlhYTE1YjZhMGFmNjhhZTVmMy90YWJsZXJhbmdlOjQ1ZTU0YzY5MDkwMzRiOWFhMTViNmEwYWY2OGFlNWYzXzEtNS0xLTEtMA_8f4bd03d-2034-464c-b89f-2b655a77b79b"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax
      contextRef="i8660a36c1b824eb4b6d2ad1d1026a6f3_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzkvZnJhZzo4OGQ2MDhlMWNlMjY0N2E5OGJjZWNlYjAxZDg1NjFiMC90YWJsZTo0NWU1NGM2OTA5MDM0YjlhYTE1YjZhMGFmNjhhZTVmMy90YWJsZXJhbmdlOjQ1ZTU0YzY5MDkwMzRiOWFhMTViNmEwYWY2OGFlNWYzXzItMS0xLTEtMA_ab14baf3-ce39-4656-b042-a7f3d3ad9698"
      unitRef="usd">1000000</us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax
      contextRef="i47b375ab68594453a768538fa7711d00_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzkvZnJhZzo4OGQ2MDhlMWNlMjY0N2E5OGJjZWNlYjAxZDg1NjFiMC90YWJsZTo0NWU1NGM2OTA5MDM0YjlhYTE1YjZhMGFmNjhhZTVmMy90YWJsZXJhbmdlOjQ1ZTU0YzY5MDkwMzRiOWFhMTViNmEwYWY2OGFlNWYzXzItMy0xLTEtMA_da61b2c7-2e25-41bc-942c-732ec0f42462"
      unitRef="usd">1000000</us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax
      contextRef="i3cf9aa045e7e4557acc082d5c2059d82_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzkvZnJhZzo4OGQ2MDhlMWNlMjY0N2E5OGJjZWNlYjAxZDg1NjFiMC90YWJsZTo0NWU1NGM2OTA5MDM0YjlhYTE1YjZhMGFmNjhhZTVmMy90YWJsZXJhbmdlOjQ1ZTU0YzY5MDkwMzRiOWFhMTViNmEwYWY2OGFlNWYzXzItNS0xLTEtMA_c24cff24-67da-43ed-876f-f469d3489d70"
      unitRef="usd">-5000000</us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax
      contextRef="i88bb1d629e614ee2843091d49bcc870c_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzkvZnJhZzo4OGQ2MDhlMWNlMjY0N2E5OGJjZWNlYjAxZDg1NjFiMC90YWJsZTo0NWU1NGM2OTA5MDM0YjlhYTE1YjZhMGFmNjhhZTVmMy90YWJsZXJhbmdlOjQ1ZTU0YzY5MDkwMzRiOWFhMTViNmEwYWY2OGFlNWYzXzMtMS0xLTEtMA_04fac6eb-41f5-4d9b-84a5-6c2016e37f50"
      unitRef="usd">5000000</us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax
      contextRef="i45480cf9423f4da49ba73dd67b12ad65_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzkvZnJhZzo4OGQ2MDhlMWNlMjY0N2E5OGJjZWNlYjAxZDg1NjFiMC90YWJsZTo0NWU1NGM2OTA5MDM0YjlhYTE1YjZhMGFmNjhhZTVmMy90YWJsZXJhbmdlOjQ1ZTU0YzY5MDkwMzRiOWFhMTViNmEwYWY2OGFlNWYzXzMtMy0xLTEtMA_162a99f3-11bf-43e1-9cf9-a1bf54f8ef18"
      unitRef="usd">-8000000</us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax
      contextRef="ib59a0c13c5ee4ae9aa9b88933c02ef8e_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzkvZnJhZzo4OGQ2MDhlMWNlMjY0N2E5OGJjZWNlYjAxZDg1NjFiMC90YWJsZTo0NWU1NGM2OTA5MDM0YjlhYTE1YjZhMGFmNjhhZTVmMy90YWJsZXJhbmdlOjQ1ZTU0YzY5MDkwMzRiOWFhMTViNmEwYWY2OGFlNWYzXzMtNS0xLTEtMA_b455693d-d849-49b2-a253-33f8d54a9b7c"
      unitRef="usd">5000000</us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax>
    <us-gaap:ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock
      contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzkvZnJhZzo4OGQ2MDhlMWNlMjY0N2E5OGJjZWNlYjAxZDg1NjFiMC90ZXh0cmVnaW9uOjg4ZDYwOGUxY2UyNjQ3YTk4YmNlY2ViMDFkODU2MWIwXzExMDgy_e92eebf9-d117-4e2e-8ccf-05fb0e546611">&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the pre-tax gain/(loss) reclassified from AOCI into earnings for derivative instruments designated as cash flow hedges:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.382%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:46.415%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.359%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.352%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.359%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.352%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.363%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Foreign currency contracts (1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Foreign currency contracts (2)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Foreign currency contracts (3)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;4&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Forward interest rate swaps (4)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Commodity contracts (3)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;6&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&#160;&#160;&#160;&#160;Included in revenue in the consolidated statements of earnings/(loss).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(2)&#160;&#160;&#160;&#160;Included in cost of products sold in the consolidated statements of earnings/(loss).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(3)&#160;&#160;&#160;&#160;Included in SG&amp;amp;A expenses in the consolidated statements of earnings/(loss).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(4) &#160;&#160;&#160;&#160;Included in interest expense, net in the consolidated statements of earnings/(loss).&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock>
    <us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet
      contextRef="ibb6fbf503d8d4b92b0852c5ea1309753_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzkvZnJhZzo4OGQ2MDhlMWNlMjY0N2E5OGJjZWNlYjAxZDg1NjFiMC90YWJsZTo1OTBhYTg2MjMwNjA0OTEyOTgxZTI2Mjc4NDQxN2U4ZS90YWJsZXJhbmdlOjU5MGFhODYyMzA2MDQ5MTI5ODFlMjYyNzg0NDE3ZThlXzEtMS0xLTEtMA_a9b41294-0816-4c2f-b5b5-64ac6a062e1c"
      unitRef="usd">-12000000</us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet>
    <us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet
      contextRef="iff868024f7f64db3bfeadcc44347a563_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzkvZnJhZzo4OGQ2MDhlMWNlMjY0N2E5OGJjZWNlYjAxZDg1NjFiMC90YWJsZTo1OTBhYTg2MjMwNjA0OTEyOTgxZTI2Mjc4NDQxN2U4ZS90YWJsZXJhbmdlOjU5MGFhODYyMzA2MDQ5MTI5ODFlMjYyNzg0NDE3ZThlXzEtMy0xLTEtMA_480a708c-9f1e-4515-8dbe-c5ec931d3582"
      unitRef="usd">7000000</us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet>
    <us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet
      contextRef="i310f8b1e6b5d4407acac6e3bf1a8f700_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzkvZnJhZzo4OGQ2MDhlMWNlMjY0N2E5OGJjZWNlYjAxZDg1NjFiMC90YWJsZTo1OTBhYTg2MjMwNjA0OTEyOTgxZTI2Mjc4NDQxN2U4ZS90YWJsZXJhbmdlOjU5MGFhODYyMzA2MDQ5MTI5ODFlMjYyNzg0NDE3ZThlXzEtNS0xLTEtMA_dcdb2438-eadf-46b6-8908-745953379e2d"
      unitRef="usd">2000000</us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet>
    <us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet
      contextRef="i3f26acb0755444a5b5ae1bcdc825ac67_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzkvZnJhZzo4OGQ2MDhlMWNlMjY0N2E5OGJjZWNlYjAxZDg1NjFiMC90YWJsZTo1OTBhYTg2MjMwNjA0OTEyOTgxZTI2Mjc4NDQxN2U4ZS90YWJsZXJhbmdlOjU5MGFhODYyMzA2MDQ5MTI5ODFlMjYyNzg0NDE3ZThlXzItMS0xLTEtMA_9324c84e-d4a0-4269-be8d-2df6f9ca55f0"
      unitRef="usd">-2000000</us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet>
    <us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet
      contextRef="i37fec931826541839b3ab83c0e5334f7_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzkvZnJhZzo4OGQ2MDhlMWNlMjY0N2E5OGJjZWNlYjAxZDg1NjFiMC90YWJsZTo1OTBhYTg2MjMwNjA0OTEyOTgxZTI2Mjc4NDQxN2U4ZS90YWJsZXJhbmdlOjU5MGFhODYyMzA2MDQ5MTI5ODFlMjYyNzg0NDE3ZThlXzItMy0xLTEtMA_512a1863-d900-421f-bf82-8265a8dd43da"
      unitRef="usd">1000000</us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet>
    <us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet
      contextRef="i987d48debeb4454198012308b3db9d71_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzkvZnJhZzo4OGQ2MDhlMWNlMjY0N2E5OGJjZWNlYjAxZDg1NjFiMC90YWJsZTo1OTBhYTg2MjMwNjA0OTEyOTgxZTI2Mjc4NDQxN2U4ZS90YWJsZXJhbmdlOjU5MGFhODYyMzA2MDQ5MTI5ODFlMjYyNzg0NDE3ZThlXzItNS0xLTEtMA_d6679ef1-e6b1-481f-a929-926cca574e8d"
      unitRef="usd">0</us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet>
    <us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet
      contextRef="iccd66091b41c4c73b464f972ba9df372_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzkvZnJhZzo4OGQ2MDhlMWNlMjY0N2E5OGJjZWNlYjAxZDg1NjFiMC90YWJsZTo1OTBhYTg2MjMwNjA0OTEyOTgxZTI2Mjc4NDQxN2U4ZS90YWJsZXJhbmdlOjU5MGFhODYyMzA2MDQ5MTI5ODFlMjYyNzg0NDE3ZThlXzMtMS0xLTEtMA_161bffb2-29be-410e-b8c7-4d2d00c36f1f"
      unitRef="usd">4000000</us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet>
    <us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet
      contextRef="i63ef41121d204393a0ebe9effaf8d432_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzkvZnJhZzo4OGQ2MDhlMWNlMjY0N2E5OGJjZWNlYjAxZDg1NjFiMC90YWJsZTo1OTBhYTg2MjMwNjA0OTEyOTgxZTI2Mjc4NDQxN2U4ZS90YWJsZXJhbmdlOjU5MGFhODYyMzA2MDQ5MTI5ODFlMjYyNzg0NDE3ZThlXzMtMy0xLTEtMA_510d944d-4242-4ebd-8304-7ad3c3d34261"
      unitRef="usd">0</us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet>
    <us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet
      contextRef="i9f15f52c79704d46af60964d622dedab_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzkvZnJhZzo4OGQ2MDhlMWNlMjY0N2E5OGJjZWNlYjAxZDg1NjFiMC90YWJsZTo1OTBhYTg2MjMwNjA0OTEyOTgxZTI2Mjc4NDQxN2U4ZS90YWJsZXJhbmdlOjU5MGFhODYyMzA2MDQ5MTI5ODFlMjYyNzg0NDE3ZThlXzMtNS0xLTEtMA_49c8a0ce-f352-49b7-a516-8943bec12094"
      unitRef="usd">1000000</us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet>
    <us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet
      contextRef="i7a11a5ca49904135831f29f2e02611af_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzkvZnJhZzo4OGQ2MDhlMWNlMjY0N2E5OGJjZWNlYjAxZDg1NjFiMC90YWJsZTo1OTBhYTg2MjMwNjA0OTEyOTgxZTI2Mjc4NDQxN2U4ZS90YWJsZXJhbmdlOjU5MGFhODYyMzA2MDQ5MTI5ODFlMjYyNzg0NDE3ZThlXzQtMS0xLTEtMA_3a91f68e-91c5-4194-96bc-bfb9fda5c65f"
      unitRef="usd">2000000</us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet>
    <us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet
      contextRef="i5459407c23c44c3aa651aec1bc97a889_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzkvZnJhZzo4OGQ2MDhlMWNlMjY0N2E5OGJjZWNlYjAxZDg1NjFiMC90YWJsZTo1OTBhYTg2MjMwNjA0OTEyOTgxZTI2Mjc4NDQxN2U4ZS90YWJsZXJhbmdlOjU5MGFhODYyMzA2MDQ5MTI5ODFlMjYyNzg0NDE3ZThlXzQtMy0xLTEtMA_1d97bfd0-d8e0-4de4-a003-b6c198350fe4"
      unitRef="usd">2000000</us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet>
    <us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet
      contextRef="ia2835dfb9ad14f699e13cc2bec62ea7e_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzkvZnJhZzo4OGQ2MDhlMWNlMjY0N2E5OGJjZWNlYjAxZDg1NjFiMC90YWJsZTo1OTBhYTg2MjMwNjA0OTEyOTgxZTI2Mjc4NDQxN2U4ZS90YWJsZXJhbmdlOjU5MGFhODYyMzA2MDQ5MTI5ODFlMjYyNzg0NDE3ZThlXzQtNS0xLTEtMA_9f3c7029-3a63-48c5-bbcd-39eb1956de16"
      unitRef="usd">2000000</us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet>
    <us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet
      contextRef="i4b9f0ce7440942e7bc207e8b7e6a8b82_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzkvZnJhZzo4OGQ2MDhlMWNlMjY0N2E5OGJjZWNlYjAxZDg1NjFiMC90YWJsZTo1OTBhYTg2MjMwNjA0OTEyOTgxZTI2Mjc4NDQxN2U4ZS90YWJsZXJhbmdlOjU5MGFhODYyMzA2MDQ5MTI5ODFlMjYyNzg0NDE3ZThlXzUtMS0xLTEtMA_ca16be7c-8907-422d-948b-2847609f97ae"
      unitRef="usd">6000000</us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet>
    <us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet
      contextRef="i70ce64c92675430e973ad1616d164211_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzkvZnJhZzo4OGQ2MDhlMWNlMjY0N2E5OGJjZWNlYjAxZDg1NjFiMC90YWJsZTo1OTBhYTg2MjMwNjA0OTEyOTgxZTI2Mjc4NDQxN2U4ZS90YWJsZXJhbmdlOjU5MGFhODYyMzA2MDQ5MTI5ODFlMjYyNzg0NDE3ZThlXzUtMy0xLTEtMA_beef23a3-a668-47a8-9927-8cfb1f26b5a9"
      unitRef="usd">-5000000</us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet>
    <us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet
      contextRef="ie940dc4896674168a3ab782e27d582e1_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzkvZnJhZzo4OGQ2MDhlMWNlMjY0N2E5OGJjZWNlYjAxZDg1NjFiMC90YWJsZTo1OTBhYTg2MjMwNjA0OTEyOTgxZTI2Mjc4NDQxN2U4ZS90YWJsZXJhbmdlOjU5MGFhODYyMzA2MDQ5MTI5ODFlMjYyNzg0NDE3ZThlXzUtNS0xLTEtMA_bede33eb-c6e8-48e6-9f92-a685b8b03f30"
      unitRef="usd">0</us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet>
    <us-gaap:DerivativeLiabilityNotionalAmount
      contextRef="i254785c21f4b45739afff24cf0bc5323_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzkvZnJhZzo4OGQ2MDhlMWNlMjY0N2E5OGJjZWNlYjAxZDg1NjFiMC90ZXh0cmVnaW9uOjg4ZDYwOGUxY2UyNjQ3YTk4YmNlY2ViMDFkODU2MWIwXzc5MTM_e3acfb1e-8793-4f0f-a652-ad66ad80b9ce"
      unitRef="jpy">64000000000</us-gaap:DerivativeLiabilityNotionalAmount>
    <us-gaap:DerivativeLiabilityNotionalAmount
      contextRef="i254785c21f4b45739afff24cf0bc5323_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzkvZnJhZzo4OGQ2MDhlMWNlMjY0N2E5OGJjZWNlYjAxZDg1NjFiMC90ZXh0cmVnaW9uOjg4ZDYwOGUxY2UyNjQ3YTk4YmNlY2ViMDFkODU2MWIwXzc5MTc_aa8b92ea-6d23-4e72-ab13-7dfb16a1b68f"
      unitRef="usd">600000000</us-gaap:DerivativeLiabilityNotionalAmount>
    <us-gaap:DerivativeLiabilityNotionalAmount
      contextRef="i2816c95fd6cb499095fe954700d7e965_I20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzkvZnJhZzo4OGQ2MDhlMWNlMjY0N2E5OGJjZWNlYjAxZDg1NjFiMC90ZXh0cmVnaW9uOjg4ZDYwOGUxY2UyNjQ3YTk4YmNlY2ViMDFkODU2MWIwXzI3NDg3NzkwODE5NjY_b80f6599-f749-4b85-a3bf-c620422a6136"
      unitRef="eur">200000000</us-gaap:DerivativeLiabilityNotionalAmount>
    <us-gaap:DerivativeLiabilityNotionalAmount
      contextRef="i2816c95fd6cb499095fe954700d7e965_I20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzkvZnJhZzo4OGQ2MDhlMWNlMjY0N2E5OGJjZWNlYjAxZDg1NjFiMC90ZXh0cmVnaW9uOjg4ZDYwOGUxY2UyNjQ3YTk4YmNlY2ViMDFkODU2MWIwXzI3NDg3NzkwODE5OTg_710467b6-4bbf-4cc7-bfec-a9c01eb53855"
      unitRef="usd">233000000</us-gaap:DerivativeLiabilityNotionalAmount>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax
      contextRef="i935ecef2ff6941d394a6beccc5c10088_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzkvZnJhZzo4OGQ2MDhlMWNlMjY0N2E5OGJjZWNlYjAxZDg1NjFiMC90ZXh0cmVnaW9uOjg4ZDYwOGUxY2UyNjQ3YTk4YmNlY2ViMDFkODU2MWIwXzg2NTE_a2788a3e-5e4a-4c7d-9cae-5f2237c495e7"
      unitRef="usd">7000000</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax
      contextRef="i193fb65a21864d5cb26c7c22aca8ad2b_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzkvZnJhZzo4OGQ2MDhlMWNlMjY0N2E5OGJjZWNlYjAxZDg1NjFiMC90ZXh0cmVnaW9uOjg4ZDYwOGUxY2UyNjQ3YTk4YmNlY2ViMDFkODU2MWIwXzg2NTg_f28b7ebe-f19d-44cf-9e4d-30bf74cac752"
      unitRef="usd">35000000</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:InterestIncomeExpenseNonoperatingNet
      contextRef="i935ecef2ff6941d394a6beccc5c10088_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzkvZnJhZzo4OGQ2MDhlMWNlMjY0N2E5OGJjZWNlYjAxZDg1NjFiMC90ZXh0cmVnaW9uOjg4ZDYwOGUxY2UyNjQ3YTk4YmNlY2ViMDFkODU2MWIwXzg4OTI_46986dee-864c-47a0-901f-c9849b1c8b53"
      unitRef="usd">19000000</us-gaap:InterestIncomeExpenseNonoperatingNet>
    <us-gaap:InterestIncomeExpenseNonoperatingNet
      contextRef="i193fb65a21864d5cb26c7c22aca8ad2b_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzkvZnJhZzo4OGQ2MDhlMWNlMjY0N2E5OGJjZWNlYjAxZDg1NjFiMC90ZXh0cmVnaW9uOjg4ZDYwOGUxY2UyNjQ3YTk4YmNlY2ViMDFkODU2MWIwXzg4OTk_d3b62c82-cf25-42a0-afdd-bb080bb1ad24"
      unitRef="usd">17000000</us-gaap:InterestIncomeExpenseNonoperatingNet>
    <us-gaap:ScheduleOfDerivativeInstrumentsTextBlock
      contextRef="if722552b851a401795eb756ce826c809_D20200701-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzkvZnJhZzo4OGQ2MDhlMWNlMjY0N2E5OGJjZWNlYjAxZDg1NjFiMC90ZXh0cmVnaW9uOjg4ZDYwOGUxY2UyNjQ3YTk4YmNlY2ViMDFkODU2MWIwXzExMTUy_449ba516-af94-40f6-8299-af86690281cd">&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables summarize the outstanding economic (non-designated) derivative instruments at June 30:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:38.714%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:24.517%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.343%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:2.912%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.408%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Notional Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Maturity Date&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Foreign currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;254&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="9" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;July 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:38.714%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:24.517%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.343%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:2.912%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.408%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Notional Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Maturity Date&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Foreign currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;325&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="9" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Jul 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfDerivativeInstrumentsTextBlock>
    <us-gaap:DerivativeAssetNotionalAmount
      contextRef="i6ca29000e9a8453b9f0281faeb2f2ed2_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzkvZnJhZzo4OGQ2MDhlMWNlMjY0N2E5OGJjZWNlYjAxZDg1NjFiMC90YWJsZTpjZDBhNDY3M2RkNWU0MTQ5Yjc4ODhlMjkwYmU5ZTFiOC90YWJsZXJhbmdlOmNkMGE0NjczZGQ1ZTQxNDliNzg4OGUyOTBiZTllMWI4XzItMS0xLTEtMA_090b6868-ef2f-4207-95e9-867dceb4188d"
      unitRef="usd">254000000</us-gaap:DerivativeAssetNotionalAmount>
    <us-gaap:DerivativeAssetNotionalAmount
      contextRef="i7d5cf04c44ad4849821d4bb8a6945748_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzkvZnJhZzo4OGQ2MDhlMWNlMjY0N2E5OGJjZWNlYjAxZDg1NjFiMC90YWJsZTpmMzYwZDU3NjA1ZjI0ZGY2ODE5ZjA4NDg1ZTVkY2YxNy90YWJsZXJhbmdlOmYzNjBkNTc2MDVmMjRkZjY4MTlmMDg0ODVlNWRjZjE3XzItMS0xLTEtMA_76446e05-02b0-49e2-a1b9-7ed102cf57b1"
      unitRef="usd">325000000</us-gaap:DerivativeAssetNotionalAmount>
    <us-gaap:ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock
      contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzkvZnJhZzo4OGQ2MDhlMWNlMjY0N2E5OGJjZWNlYjAxZDg1NjFiMC90ZXh0cmVnaW9uOjg4ZDYwOGUxY2UyNjQ3YTk4YmNlY2ViMDFkODU2MWIwXzExMTIy_4ce7c8eb-b914-4609-bf37-cfd2b092ded6">&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the gain/(loss) recognized in earnings for economic (non-designated) derivative instruments:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.382%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:46.415%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.359%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.352%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.359%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.352%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.363%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Foreign currency contracts (1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(11)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(13)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&#160;&#160;&#160;&#160;Included in other income, net in the consolidated statements of earnings/(loss).&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock>
    <us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet
      contextRef="ifca9e60bdc7a4338aa4de50477f141d8_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzkvZnJhZzo4OGQ2MDhlMWNlMjY0N2E5OGJjZWNlYjAxZDg1NjFiMC90YWJsZTo0NTZhNjk0NDJlNDI0YzI5YTE2MjliZmM3ZmRiMDI2OC90YWJsZXJhbmdlOjQ1NmE2OTQ0MmU0MjRjMjlhMTYyOWJmYzdmZGIwMjY4XzEtMS0xLTEtMA_a514122c-0045-4c22-99df-41ff1198fc2f"
      unitRef="usd">-8000000</us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet>
    <us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet
      contextRef="ia0fd144ab6c343f591a8767092fb681e_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzkvZnJhZzo4OGQ2MDhlMWNlMjY0N2E5OGJjZWNlYjAxZDg1NjFiMC90YWJsZTo0NTZhNjk0NDJlNDI0YzI5YTE2MjliZmM3ZmRiMDI2OC90YWJsZXJhbmdlOjQ1NmE2OTQ0MmU0MjRjMjlhMTYyOWJmYzdmZGIwMjY4XzEtMy0xLTEtMA_9c54bc00-e2a5-4358-bd21-accedaf49b30"
      unitRef="usd">-11000000</us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet>
    <us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet
      contextRef="i3395922d014c40c59d772a4a5b2ebd31_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzkvZnJhZzo4OGQ2MDhlMWNlMjY0N2E5OGJjZWNlYjAxZDg1NjFiMC90YWJsZTo0NTZhNjk0NDJlNDI0YzI5YTE2MjliZmM3ZmRiMDI2OC90YWJsZXJhbmdlOjQ1NmE2OTQ0MmU0MjRjMjlhMTYyOWJmYzdmZGIwMjY4XzEtNS0xLTEtMA_6e37b820-7340-4b7e-9070-e2d9a12dc1bc"
      unitRef="usd">-13000000</us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet>
    <us-gaap:ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock
      contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzkvZnJhZzo4OGQ2MDhlMWNlMjY0N2E5OGJjZWNlYjAxZDg1NjFiMC90ZXh0cmVnaW9uOjg4ZDYwOGUxY2UyNjQ3YTk4YmNlY2ViMDFkODU2MWIwXzExMDgz_818558a5-d07c-4df8-b454-2d72ca74e837">&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the estimated fair value of our long-term obligations and other short-term borrowings compared to the respective carrying amounts at June 30:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:47.974%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:23.591%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.343%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:23.592%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Estimated fair value&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;6,751&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;7,273&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Carrying amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;6,236&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;6,775&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock>
    <us-gaap:DebtInstrumentFairValue
      contextRef="i8b9a24f3941f46f085d16a60c26ec523_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzkvZnJhZzo4OGQ2MDhlMWNlMjY0N2E5OGJjZWNlYjAxZDg1NjFiMC90YWJsZTo5ZTAyMDhhNTU5ZjI0OTI3OWUxNTFhNDc3YTIwN2UxZC90YWJsZXJhbmdlOjllMDIwOGE1NTlmMjQ5Mjc5ZTE1MWE0NzdhMjA3ZTFkXzEtMS0xLTEtMA_4e1edc98-9f7b-4bc9-bdd3-eb17b485a10c"
      unitRef="usd">6751000000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="i406116eedea746848300007f225725fd_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzkvZnJhZzo4OGQ2MDhlMWNlMjY0N2E5OGJjZWNlYjAxZDg1NjFiMC90YWJsZTo5ZTAyMDhhNTU5ZjI0OTI3OWUxNTFhNDc3YTIwN2UxZC90YWJsZXJhbmdlOjllMDIwOGE1NTlmMjQ5Mjc5ZTE1MWE0NzdhMjA3ZTFkXzEtMy0xLTEtMA_522378da-92bc-447b-940d-ff943f989d76"
      unitRef="usd">7273000000</us-gaap:DebtInstrumentFairValue>
    <cah:CarryingAmountofLongTermandotherShortTermBorrowings
      contextRef="i2e87824102b34590a0208cc7da91b5f5_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzkvZnJhZzo4OGQ2MDhlMWNlMjY0N2E5OGJjZWNlYjAxZDg1NjFiMC90YWJsZTo5ZTAyMDhhNTU5ZjI0OTI3OWUxNTFhNDc3YTIwN2UxZC90YWJsZXJhbmdlOjllMDIwOGE1NTlmMjQ5Mjc5ZTE1MWE0NzdhMjA3ZTFkXzItMS0xLTEtMA_cc3abe0a-d2ba-4f01-a0c5-aec3bfed2657"
      unitRef="usd">6236000000</cah:CarryingAmountofLongTermandotherShortTermBorrowings>
    <cah:CarryingAmountofLongTermandotherShortTermBorrowings
      contextRef="i299cea70f47b4fbe96772aaa8cc00b79_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzkvZnJhZzo4OGQ2MDhlMWNlMjY0N2E5OGJjZWNlYjAxZDg1NjFiMC90YWJsZTo5ZTAyMDhhNTU5ZjI0OTI3OWUxNTFhNDc3YTIwN2UxZC90YWJsZXJhbmdlOjllMDIwOGE1NTlmMjQ5Mjc5ZTE1MWE0NzdhMjA3ZTFkXzItMy0xLTEtMA_9e7125bf-8eed-43df-84e9-16215dc8d541"
      unitRef="usd">6775000000</cah:CarryingAmountofLongTermandotherShortTermBorrowings>
    <cah:ScheduleOfFairValueGainLossDerivativeInstrumentTableTextBlock
      contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzkvZnJhZzo4OGQ2MDhlMWNlMjY0N2E5OGJjZWNlYjAxZDg1NjFiMC90ZXh0cmVnaW9uOjg4ZDYwOGUxY2UyNjQ3YTk4YmNlY2ViMDFkODU2MWIwXzExMDgw_ae488212-95a3-4bc8-946b-87ef3e40033c">&lt;div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table is a summary of the fair value gain/(loss) of our derivative instruments based upon the estimated amount that we would receive (or pay), considering counter-party credit risk, to terminate the contracts at June 30:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.691%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:31.098%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.451%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.347%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.547%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.347%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.451%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.347%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.312%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Notional&lt;br/&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair&#160;Value&lt;br/&gt;Gain/(Loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Notional&lt;br/&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Fair&#160;Value&lt;br/&gt;Gain/(Loss)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Pay-floating interest rate swaps&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;200&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;1&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;550&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Foreign currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;690&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;1&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;653&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Forward interest rate swaps&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(16)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Cross-currency swap&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;833&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;40&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;833&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Commodity contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</cah:ScheduleOfFairValueGainLossDerivativeInstrumentTableTextBlock>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i04848fa4190a4546999fce3b74a1093a_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzkvZnJhZzo4OGQ2MDhlMWNlMjY0N2E5OGJjZWNlYjAxZDg1NjFiMC90YWJsZToyOGYzZTI3OTI4OTQ0ZjE1ODg0NTE1NTEwMjk2YTllMC90YWJsZXJhbmdlOjI4ZjNlMjc5Mjg5NDRmMTU4ODQ1MTU1MTAyOTZhOWUwXzItMS0xLTEtMA_ce415d5b-a2f7-46cd-863e-09e5b889bd57"
      unitRef="usd">200000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeFairValueOfDerivativeNet
      contextRef="i04848fa4190a4546999fce3b74a1093a_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzkvZnJhZzo4OGQ2MDhlMWNlMjY0N2E5OGJjZWNlYjAxZDg1NjFiMC90YWJsZToyOGYzZTI3OTI4OTQ0ZjE1ODg0NTE1NTEwMjk2YTllMC90YWJsZXJhbmdlOjI4ZjNlMjc5Mjg5NDRmMTU4ODQ1MTU1MTAyOTZhOWUwXzItMy0xLTEtMA_2f69e2ac-769e-4b27-b4e0-89d89a697571"
      unitRef="usd">1000000</us-gaap:DerivativeFairValueOfDerivativeNet>
    <us-gaap:DerivativeNotionalAmount
      contextRef="iffa4055c7e214900820c0a0df90cdebf_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzkvZnJhZzo4OGQ2MDhlMWNlMjY0N2E5OGJjZWNlYjAxZDg1NjFiMC90YWJsZToyOGYzZTI3OTI4OTQ0ZjE1ODg0NTE1NTEwMjk2YTllMC90YWJsZXJhbmdlOjI4ZjNlMjc5Mjg5NDRmMTU4ODQ1MTU1MTAyOTZhOWUwXzItNS0xLTEtMA_d7917433-816a-4f22-a8ed-e389301ca601"
      unitRef="usd">550000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeFairValueOfDerivativeNet
      contextRef="iffa4055c7e214900820c0a0df90cdebf_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzkvZnJhZzo4OGQ2MDhlMWNlMjY0N2E5OGJjZWNlYjAxZDg1NjFiMC90YWJsZToyOGYzZTI3OTI4OTQ0ZjE1ODg0NTE1NTEwMjk2YTllMC90YWJsZXJhbmdlOjI4ZjNlMjc5Mjg5NDRmMTU4ODQ1MTU1MTAyOTZhOWUwXzItNy0xLTEtMA_855c2e3b-ec70-4597-ae51-977231e23e33"
      unitRef="usd">27000000</us-gaap:DerivativeFairValueOfDerivativeNet>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i8f3de44e96774f7296c0c1deb3f17775_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzkvZnJhZzo4OGQ2MDhlMWNlMjY0N2E5OGJjZWNlYjAxZDg1NjFiMC90YWJsZToyOGYzZTI3OTI4OTQ0ZjE1ODg0NTE1NTEwMjk2YTllMC90YWJsZXJhbmdlOjI4ZjNlMjc5Mjg5NDRmMTU4ODQ1MTU1MTAyOTZhOWUwXzMtMS0xLTEtMA_ed1cbd02-de58-4e0d-9d98-48436c5b7099"
      unitRef="usd">690000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeFairValueOfDerivativeNet
      contextRef="i8f3de44e96774f7296c0c1deb3f17775_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzkvZnJhZzo4OGQ2MDhlMWNlMjY0N2E5OGJjZWNlYjAxZDg1NjFiMC90YWJsZToyOGYzZTI3OTI4OTQ0ZjE1ODg0NTE1NTEwMjk2YTllMC90YWJsZXJhbmdlOjI4ZjNlMjc5Mjg5NDRmMTU4ODQ1MTU1MTAyOTZhOWUwXzMtMy0xLTEtMA_e527da88-7c14-4e39-b255-01f80816117e"
      unitRef="usd">1000000</us-gaap:DerivativeFairValueOfDerivativeNet>
    <us-gaap:DerivativeNotionalAmount
      contextRef="ie09b4e9c614244d1bd722525781f1905_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzkvZnJhZzo4OGQ2MDhlMWNlMjY0N2E5OGJjZWNlYjAxZDg1NjFiMC90YWJsZToyOGYzZTI3OTI4OTQ0ZjE1ODg0NTE1NTEwMjk2YTllMC90YWJsZXJhbmdlOjI4ZjNlMjc5Mjg5NDRmMTU4ODQ1MTU1MTAyOTZhOWUwXzMtNS0xLTEtMA_1b2812f5-2060-4626-93dc-e7833bc92ffe"
      unitRef="usd">653000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeFairValueOfDerivativeNet
      contextRef="ie09b4e9c614244d1bd722525781f1905_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzkvZnJhZzo4OGQ2MDhlMWNlMjY0N2E5OGJjZWNlYjAxZDg1NjFiMC90YWJsZToyOGYzZTI3OTI4OTQ0ZjE1ODg0NTE1NTEwMjk2YTllMC90YWJsZXJhbmdlOjI4ZjNlMjc5Mjg5NDRmMTU4ODQ1MTU1MTAyOTZhOWUwXzMtNy0xLTEtMA_1524c810-068b-4229-9221-20b4b79a42b5"
      unitRef="usd">-4000000</us-gaap:DerivativeFairValueOfDerivativeNet>
    <us-gaap:DerivativeNotionalAmount
      contextRef="ica8d8074683f4bda8b6a214c21c399ee_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzkvZnJhZzo4OGQ2MDhlMWNlMjY0N2E5OGJjZWNlYjAxZDg1NjFiMC90YWJsZToyOGYzZTI3OTI4OTQ0ZjE1ODg0NTE1NTEwMjk2YTllMC90YWJsZXJhbmdlOjI4ZjNlMjc5Mjg5NDRmMTU4ODQ1MTU1MTAyOTZhOWUwXzQtMS0xLTEtMA_1513afb5-815d-4ce5-9516-5d4c050aea72"
      unitRef="usd">0</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeFairValueOfDerivativeNet
      contextRef="ica8d8074683f4bda8b6a214c21c399ee_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzkvZnJhZzo4OGQ2MDhlMWNlMjY0N2E5OGJjZWNlYjAxZDg1NjFiMC90YWJsZToyOGYzZTI3OTI4OTQ0ZjE1ODg0NTE1NTEwMjk2YTllMC90YWJsZXJhbmdlOjI4ZjNlMjc5Mjg5NDRmMTU4ODQ1MTU1MTAyOTZhOWUwXzQtMy0xLTEtMA_527dc698-33a6-4725-9dfb-84d58e2ab694"
      unitRef="usd">0</us-gaap:DerivativeFairValueOfDerivativeNet>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i82a8006ead354bb59b15285e08a487f9_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzkvZnJhZzo4OGQ2MDhlMWNlMjY0N2E5OGJjZWNlYjAxZDg1NjFiMC90YWJsZToyOGYzZTI3OTI4OTQ0ZjE1ODg0NTE1NTEwMjk2YTllMC90YWJsZXJhbmdlOjI4ZjNlMjc5Mjg5NDRmMTU4ODQ1MTU1MTAyOTZhOWUwXzQtNS0xLTEtMA_d85765ee-48e7-4c8e-b53e-6f69d533657d"
      unitRef="usd">200000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeFairValueOfDerivativeNet
      contextRef="i82a8006ead354bb59b15285e08a487f9_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzkvZnJhZzo4OGQ2MDhlMWNlMjY0N2E5OGJjZWNlYjAxZDg1NjFiMC90YWJsZToyOGYzZTI3OTI4OTQ0ZjE1ODg0NTE1NTEwMjk2YTllMC90YWJsZXJhbmdlOjI4ZjNlMjc5Mjg5NDRmMTU4ODQ1MTU1MTAyOTZhOWUwXzQtNy0xLTEtMA_c7122063-0922-4951-a21b-b43f19ff9dbc"
      unitRef="usd">-16000000</us-gaap:DerivativeFairValueOfDerivativeNet>
    <us-gaap:DerivativeNotionalAmount
      contextRef="ic67d0c6fd59147399881dd3fb666cc2a_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzkvZnJhZzo4OGQ2MDhlMWNlMjY0N2E5OGJjZWNlYjAxZDg1NjFiMC90YWJsZToyOGYzZTI3OTI4OTQ0ZjE1ODg0NTE1NTEwMjk2YTllMC90YWJsZXJhbmdlOjI4ZjNlMjc5Mjg5NDRmMTU4ODQ1MTU1MTAyOTZhOWUwXzUtMS0xLTEtMA_8933ddc2-87fd-46ed-8cc7-f2f488d864f9"
      unitRef="usd">833000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeFairValueOfDerivativeNet
      contextRef="ic67d0c6fd59147399881dd3fb666cc2a_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzkvZnJhZzo4OGQ2MDhlMWNlMjY0N2E5OGJjZWNlYjAxZDg1NjFiMC90YWJsZToyOGYzZTI3OTI4OTQ0ZjE1ODg0NTE1NTEwMjk2YTllMC90YWJsZXJhbmdlOjI4ZjNlMjc5Mjg5NDRmMTU4ODQ1MTU1MTAyOTZhOWUwXzUtMy0xLTEtMA_97385e84-05eb-4f31-8981-e477c2858e22"
      unitRef="usd">40000000</us-gaap:DerivativeFairValueOfDerivativeNet>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i83ca59dc22f646eaa9de5eecb3e81988_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzkvZnJhZzo4OGQ2MDhlMWNlMjY0N2E5OGJjZWNlYjAxZDg1NjFiMC90YWJsZToyOGYzZTI3OTI4OTQ0ZjE1ODg0NTE1NTEwMjk2YTllMC90YWJsZXJhbmdlOjI4ZjNlMjc5Mjg5NDRmMTU4ODQ1MTU1MTAyOTZhOWUwXzUtNS0xLTEtMA_0de310e2-8cd3-4c0a-897c-75ef7c99b775"
      unitRef="usd">833000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeFairValueOfDerivativeNet
      contextRef="i83ca59dc22f646eaa9de5eecb3e81988_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzkvZnJhZzo4OGQ2MDhlMWNlMjY0N2E5OGJjZWNlYjAxZDg1NjFiMC90YWJsZToyOGYzZTI3OTI4OTQ0ZjE1ODg0NTE1NTEwMjk2YTllMC90YWJsZXJhbmdlOjI4ZjNlMjc5Mjg5NDRmMTU4ODQ1MTU1MTAyOTZhOWUwXzUtNy0xLTEtMA_b5c5211a-6c33-458c-9982-d1b689315157"
      unitRef="usd">47000000</us-gaap:DerivativeFairValueOfDerivativeNet>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i4cf22529a370428e82c5511fa7e35f8b_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzkvZnJhZzo4OGQ2MDhlMWNlMjY0N2E5OGJjZWNlYjAxZDg1NjFiMC90YWJsZToyOGYzZTI3OTI4OTQ0ZjE1ODg0NTE1NTEwMjk2YTllMC90YWJsZXJhbmdlOjI4ZjNlMjc5Mjg5NDRmMTU4ODQ1MTU1MTAyOTZhOWUwXzYtMS0xLTEtMA_20a3e2bb-ac93-4a0a-b4e1-9c18ed303d35"
      unitRef="usd">0</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeFairValueOfDerivativeNet
      contextRef="i4cf22529a370428e82c5511fa7e35f8b_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzkvZnJhZzo4OGQ2MDhlMWNlMjY0N2E5OGJjZWNlYjAxZDg1NjFiMC90YWJsZToyOGYzZTI3OTI4OTQ0ZjE1ODg0NTE1NTEwMjk2YTllMC90YWJsZXJhbmdlOjI4ZjNlMjc5Mjg5NDRmMTU4ODQ1MTU1MTAyOTZhOWUwXzYtMy0xLTEtMA_414dc60e-4114-4aeb-81a5-c80787460da7"
      unitRef="usd">0</us-gaap:DerivativeFairValueOfDerivativeNet>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i4de6f0288abd431bbc839b56b68b328b_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzkvZnJhZzo4OGQ2MDhlMWNlMjY0N2E5OGJjZWNlYjAxZDg1NjFiMC90YWJsZToyOGYzZTI3OTI4OTQ0ZjE1ODg0NTE1NTEwMjk2YTllMC90YWJsZXJhbmdlOjI4ZjNlMjc5Mjg5NDRmMTU4ODQ1MTU1MTAyOTZhOWUwXzYtNS0xLTEtMA_4e0f3dc3-8fca-4a06-b77f-ac021e892f07"
      unitRef="usd">16000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeFairValueOfDerivativeNet
      contextRef="i4de6f0288abd431bbc839b56b68b328b_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xMzkvZnJhZzo4OGQ2MDhlMWNlMjY0N2E5OGJjZWNlYjAxZDg1NjFiMC90YWJsZToyOGYzZTI3OTI4OTQ0ZjE1ODg0NTE1NTEwMjk2YTllMC90YWJsZXJhbmdlOjI4ZjNlMjc5Mjg5NDRmMTU4ODQ1MTU1MTAyOTZhOWUwXzYtNy0xLTEtMA_3829187a-71ce-426d-a12f-7b15cc12fad0"
      unitRef="usd">-1000000</us-gaap:DerivativeFairValueOfDerivativeNet>
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock
      contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNDUvZnJhZzoyODYyODkzYjc2Yjk0ZjdhOGU1ZjAyYmY4YzhlNzZiYS90ZXh0cmVnaW9uOjI4NjI4OTNiNzZiOTRmN2E4ZTVmMDJiZjhjOGU3NmJhXzIxNDQ_9572ad25-b44e-4c2e-bebb-5698725092d1">&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:13pt;font-weight:700;line-height:120%"&gt;11. Shareholders' Equity &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At June&#160;30, 2021 and 2020, authorized capital shares consisted of the following: 750 million Class A common shares, without par value; 5 million Class B common shares, without par value; and 500 thousand non-voting preferred shares, without par value. The Class A common shares and Class B common shares are collectively referred to below as &#x201c;common shares&#x201d;. Holders of common shares are entitled to share equally in any dividends declared by the Board of Directors and to participate equally in all distributions of assets upon liquidation. Generally, the holders of Class A common shares are entitled to one vote per share, and the holders of Class B common shares are entitled to one-fifth of one vote per share on proposals presented to shareholders for vote. Under certain circumstances, the holders of Class B common &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;shares are entitled to vote as a separate class. Only Class A common shares were outstanding at June&#160;30, 2021 and 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We repurchased $1.15 billion of our common shares, in the aggregate, through share repurchase programs during fiscal 2021&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2020 and 2019, as described below. We funded the repurchases with available cash and short term borrowings. The common shares repurchased are held in treasury to be used for general corporate purposes.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During fiscal 2021, we repurchased 3.7 million common shares having an aggregate cost of $200 million. The average price paid per common share was $54.40. These repurchases were made under an accelerated share repurchase ("ASR") program, which began on February&#160;9, 2021 and was completed on March&#160;31, 2021. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During fiscal 2020, we repurchased 7.3 million common shares having an aggregate cost of $350 million. The average price paid per common share was $48.00. These repurchases were made under an ASR program, which began on August&#160;20, 2019 and was completed on December&#160;4, 2019. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During fiscal 2019, we repurchased 11.5 million common shares having an aggregate cost of $600 million. The average price paid per common share was $52.32. These repurchases were made under an ASR program, which began on August&#160;16, 2018 and was completed on October&#160;25, 2018.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%"&gt;Accumulated Other Comprehensive Loss&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the changes in the balance of accumulated other comprehensive loss by component and in total:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:38.097%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.492%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.343%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.875%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.343%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:22.050%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Foreign&lt;br/&gt;Currency&lt;br/&gt;Translation&lt;br/&gt;Adjustments and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Unrealized&lt;br/&gt;Gain/(Loss) on&lt;br/&gt;Derivatives,&lt;br/&gt;net of tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Accumulated Other&lt;br/&gt;Comprehensive&lt;br/&gt;Loss&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Balance at June 30, 2019&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(95)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(79)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Other comprehensive income/(loss), net before reclassifications&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(23)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(20)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Amounts reclassified to earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total other comprehensive income/(loss) attributable to Cardinal Health, Inc., net of tax of $4 million&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(28)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(25)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Balance at June 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(92)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(104)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Other comprehensive income, before reclassifications&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;68&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Amounts reclassified to earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total other comprehensive income/(loss) attributable to Cardinal Health, Inc., net of tax of $4 million&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;70&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Balance at June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(46)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;12&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(34)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="i0a081dfdf3e846b387ac5e60a2f4e8a5_I20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNDUvZnJhZzoyODYyODkzYjc2Yjk0ZjdhOGU1ZjAyYmY4YzhlNzZiYS90ZXh0cmVnaW9uOjI4NjI4OTNiNzZiOTRmN2E4ZTVmMDJiZjhjOGU3NmJhXzcxNDY4MjU1ODI4NTY_bad53ddf-2851-4e83-8fb3-6cb001006545"
      unitRef="shares">750000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="i217241ce39cf47f0acdc17b79210218f_I20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNDUvZnJhZzoyODYyODkzYjc2Yjk0ZjdhOGU1ZjAyYmY4YzhlNzZiYS90ZXh0cmVnaW9uOjI4NjI4OTNiNzZiOTRmN2E4ZTVmMDJiZjhjOGU3NmJhXzEyMg_27c2cb4d-3fa1-4374-bb3c-888d49a8c30f"
      unitRef="shares">5000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="i2e87824102b34590a0208cc7da91b5f5_I20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNDUvZnJhZzoyODYyODkzYjc2Yjk0ZjdhOGU1ZjAyYmY4YzhlNzZiYS90ZXh0cmVnaW9uOjI4NjI4OTNiNzZiOTRmN2E4ZTVmMDJiZjhjOGU3NmJhXzE3MQ_3945bb0a-32e7-4e42-8f08-d90280c81fa7"
      unitRef="shares">500000</us-gaap:PreferredStockSharesAuthorized>
    <cah:CommonStockVotingRightsVotes
      contextRef="i61106b444fde4f55a97a7eaed9e98693_D20200701-20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNDUvZnJhZzoyODYyODkzYjc2Yjk0ZjdhOGU1ZjAyYmY4YzhlNzZiYS90ZXh0cmVnaW9uOjI4NjI4OTNiNzZiOTRmN2E4ZTVmMDJiZjhjOGU3NmJhXzI3NDg3NzkwNzE2MjY_37dd7902-453d-48cf-948d-729986e415da"
      unitRef="number">1</cah:CommonStockVotingRightsVotes>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="i1eef4a3d4f414af4b5f60b07ff29ecc2_D20170701-20200630"
      decimals="-7"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNDUvZnJhZzoyODYyODkzYjc2Yjk0ZjdhOGU1ZjAyYmY4YzhlNzZiYS90ZXh0cmVnaW9uOjI4NjI4OTNiNzZiOTRmN2E4ZTVmMDJiZjhjOGU3NmJhXzg5MA_34987894-8383-4c9b-8bf0-c6d9b8c76987"
      unitRef="usd">1150000000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="i93e121bdfcb240d3a40552629748af1b_D20200701-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNDUvZnJhZzoyODYyODkzYjc2Yjk0ZjdhOGU1ZjAyYmY4YzhlNzZiYS90ZXh0cmVnaW9uOjI4NjI4OTNiNzZiOTRmN2E4ZTVmMDJiZjhjOGU3NmJhXzEyMTY_a7f03be5-113b-4ce3-b2c7-3cda9c69cb1e"
      unitRef="shares">3700000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="i93e121bdfcb240d3a40552629748af1b_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNDUvZnJhZzoyODYyODkzYjc2Yjk0ZjdhOGU1ZjAyYmY4YzhlNzZiYS90ZXh0cmVnaW9uOjI4NjI4OTNiNzZiOTRmN2E4ZTVmMDJiZjhjOGU3NmJhXzEyNjE_5b7a22cd-4d8a-477d-b469-18f0c23baf79"
      unitRef="usd">200000000</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:TreasuryStockAcquiredAverageCostPerShare
      contextRef="i93e121bdfcb240d3a40552629748af1b_D20200701-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNDUvZnJhZzoyODYyODkzYjc2Yjk0ZjdhOGU1ZjAyYmY4YzhlNzZiYS90ZXh0cmVnaW9uOjI4NjI4OTNiNzZiOTRmN2E4ZTVmMDJiZjhjOGU3NmJhXzEzMDk_b1fc5650-09d0-4ca5-b4f3-c1fa9a5f07f0"
      unitRef="usdPerShare">54.40</us-gaap:TreasuryStockAcquiredAverageCostPerShare>
    <cah:TreasuryStockAcquiredShares
      contextRef="i0361658ee5604068a75c34f27c83ef6b_D20190701-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNDUvZnJhZzoyODYyODkzYjc2Yjk0ZjdhOGU1ZjAyYmY4YzhlNzZiYS90ZXh0cmVnaW9uOjI4NjI4OTNiNzZiOTRmN2E4ZTVmMDJiZjhjOGU3NmJhXzE0NzM_6d626264-335a-4cec-92aa-cdb91b0be66b"
      unitRef="shares">7300000</cah:TreasuryStockAcquiredShares>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="i0361658ee5604068a75c34f27c83ef6b_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNDUvZnJhZzoyODYyODkzYjc2Yjk0ZjdhOGU1ZjAyYmY4YzhlNzZiYS90ZXh0cmVnaW9uOjI4NjI4OTNiNzZiOTRmN2E4ZTVmMDJiZjhjOGU3NmJhXzE1MTg_eea97f63-3d89-47a6-802a-70d7b2789ceb"
      unitRef="usd">350000000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockAcquiredAverageCostPerShare
      contextRef="i0361658ee5604068a75c34f27c83ef6b_D20190701-20200630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNDUvZnJhZzoyODYyODkzYjc2Yjk0ZjdhOGU1ZjAyYmY4YzhlNzZiYS90ZXh0cmVnaW9uOjI4NjI4OTNiNzZiOTRmN2E4ZTVmMDJiZjhjOGU3NmJhXzE1NjY_485e6cb6-3913-486c-9a26-a280a3f8a22f"
      unitRef="usdPerShare">48.00</us-gaap:TreasuryStockAcquiredAverageCostPerShare>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="ifec5466baa034dc5b60b6acb6798f00e_D20180701-20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNDUvZnJhZzoyODYyODkzYjc2Yjk0ZjdhOGU1ZjAyYmY4YzhlNzZiYS90ZXh0cmVnaW9uOjI4NjI4OTNiNzZiOTRmN2E4ZTVmMDJiZjhjOGU3NmJhXzE2OTQ_130d290e-e2ab-453e-9ee7-6da70ba220a1"
      unitRef="shares">11500000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="ifec5466baa034dc5b60b6acb6798f00e_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNDUvZnJhZzoyODYyODkzYjc2Yjk0ZjdhOGU1ZjAyYmY4YzhlNzZiYS90ZXh0cmVnaW9uOjI4NjI4OTNiNzZiOTRmN2E4ZTVmMDJiZjhjOGU3NmJhXzE3Mzk_75595602-d4c0-4de2-915c-7f5afd514480"
      unitRef="usd">600000000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockAcquiredAverageCostPerShare
      contextRef="ifec5466baa034dc5b60b6acb6798f00e_D20180701-20190630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNDUvZnJhZzoyODYyODkzYjc2Yjk0ZjdhOGU1ZjAyYmY4YzhlNzZiYS90ZXh0cmVnaW9uOjI4NjI4OTNiNzZiOTRmN2E4ZTVmMDJiZjhjOGU3NmJhXzE3ODc_0bd28cd1-d4b0-49ad-8995-f0843827b412"
      unitRef="usdPerShare">52.32</us-gaap:TreasuryStockAcquiredAverageCostPerShare>
    <us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock
      contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNDUvZnJhZzoyODYyODkzYjc2Yjk0ZjdhOGU1ZjAyYmY4YzhlNzZiYS90ZXh0cmVnaW9uOjI4NjI4OTNiNzZiOTRmN2E4ZTVmMDJiZjhjOGU3NmJhXzIxNDI_17ff58cf-cab6-4561-b47c-672e5b8f9109">&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the changes in the balance of accumulated other comprehensive loss by component and in total:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:38.097%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.492%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.343%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.875%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.343%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:22.050%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Foreign&lt;br/&gt;Currency&lt;br/&gt;Translation&lt;br/&gt;Adjustments and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Unrealized&lt;br/&gt;Gain/(Loss) on&lt;br/&gt;Derivatives,&lt;br/&gt;net of tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Accumulated Other&lt;br/&gt;Comprehensive&lt;br/&gt;Loss&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Balance at June 30, 2019&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(95)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(79)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Other comprehensive income/(loss), net before reclassifications&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(23)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(20)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Amounts reclassified to earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total other comprehensive income/(loss) attributable to Cardinal Health, Inc., net of tax of $4 million&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(28)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(25)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Balance at June 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(92)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(104)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Other comprehensive income, before reclassifications&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;68&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Amounts reclassified to earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total other comprehensive income/(loss) attributable to Cardinal Health, Inc., net of tax of $4 million&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;70&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Balance at June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(46)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;12&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(34)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i25a5a0d717e04a1cb651e174b69d2257_I20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNDUvZnJhZzoyODYyODkzYjc2Yjk0ZjdhOGU1ZjAyYmY4YzhlNzZiYS90YWJsZTo0NTU4ZDdiYWFmZmI0MTZjODg4ZjFhZDVjN2NlM2U0Mi90YWJsZXJhbmdlOjQ1NThkN2JhYWZmYjQxNmM4ODhmMWFkNWM3Y2UzZTQyXzEtMS0xLTEtMA_f22441f0-79a2-40ae-9c27-c35b6b9351fe"
      unitRef="usd">-95000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ic2fe183f79d9435fa6fb7b20cb241684_I20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNDUvZnJhZzoyODYyODkzYjc2Yjk0ZjdhOGU1ZjAyYmY4YzhlNzZiYS90YWJsZTo0NTU4ZDdiYWFmZmI0MTZjODg4ZjFhZDVjN2NlM2U0Mi90YWJsZXJhbmdlOjQ1NThkN2JhYWZmYjQxNmM4ODhmMWFkNWM3Y2UzZTQyXzEtMy0xLTEtMA_62acb658-078f-4551-953d-85a85632ae3e"
      unitRef="usd">16000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i08559a107c7a4c31965cd373a397c3af_I20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNDUvZnJhZzoyODYyODkzYjc2Yjk0ZjdhOGU1ZjAyYmY4YzhlNzZiYS90YWJsZTo0NTU4ZDdiYWFmZmI0MTZjODg4ZjFhZDVjN2NlM2U0Mi90YWJsZXJhbmdlOjQ1NThkN2JhYWZmYjQxNmM4ODhmMWFkNWM3Y2UzZTQyXzEtNS0xLTEtMA_eac7e8e9-aca3-4b30-a616-3473eb042c6c"
      unitRef="usd">-79000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i06a1421a7f5a434ab21bb6e7f6c4217d_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNDUvZnJhZzoyODYyODkzYjc2Yjk0ZjdhOGU1ZjAyYmY4YzhlNzZiYS90YWJsZTo0NTU4ZDdiYWFmZmI0MTZjODg4ZjFhZDVjN2NlM2U0Mi90YWJsZXJhbmdlOjQ1NThkN2JhYWZmYjQxNmM4ODhmMWFkNWM3Y2UzZTQyXzItMS0xLTEtMA_7ba968bc-e55e-4f75-b399-4ec77136ee13"
      unitRef="usd">3000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="if2c1cb49d0374d86b2830517b2b187db_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNDUvZnJhZzoyODYyODkzYjc2Yjk0ZjdhOGU1ZjAyYmY4YzhlNzZiYS90YWJsZTo0NTU4ZDdiYWFmZmI0MTZjODg4ZjFhZDVjN2NlM2U0Mi90YWJsZXJhbmdlOjQ1NThkN2JhYWZmYjQxNmM4ODhmMWFkNWM3Y2UzZTQyXzItMy0xLTEtMA_0fbcd6af-9356-4712-b9e6-4872539ba4c6"
      unitRef="usd">-23000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i6b350fae2224486aa2a6ffc44c36559b_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNDUvZnJhZzoyODYyODkzYjc2Yjk0ZjdhOGU1ZjAyYmY4YzhlNzZiYS90YWJsZTo0NTU4ZDdiYWFmZmI0MTZjODg4ZjFhZDVjN2NlM2U0Mi90YWJsZXJhbmdlOjQ1NThkN2JhYWZmYjQxNmM4ODhmMWFkNWM3Y2UzZTQyXzItNS0xLTEtMA_0f11f774-db37-4428-bfe9-3a2344c11ce9"
      unitRef="usd">-20000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i06a1421a7f5a434ab21bb6e7f6c4217d_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNDUvZnJhZzoyODYyODkzYjc2Yjk0ZjdhOGU1ZjAyYmY4YzhlNzZiYS90YWJsZTo0NTU4ZDdiYWFmZmI0MTZjODg4ZjFhZDVjN2NlM2U0Mi90YWJsZXJhbmdlOjQ1NThkN2JhYWZmYjQxNmM4ODhmMWFkNWM3Y2UzZTQyXzMtMS0xLTEtMA_41062cab-b7fd-46b8-8ae7-91689de66078"
      unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="if2c1cb49d0374d86b2830517b2b187db_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNDUvZnJhZzoyODYyODkzYjc2Yjk0ZjdhOGU1ZjAyYmY4YzhlNzZiYS90YWJsZTo0NTU4ZDdiYWFmZmI0MTZjODg4ZjFhZDVjN2NlM2U0Mi90YWJsZXJhbmdlOjQ1NThkN2JhYWZmYjQxNmM4ODhmMWFkNWM3Y2UzZTQyXzMtMy0xLTEtMA_3c506e86-282c-4186-8518-b27dff308bc7"
      unitRef="usd">5000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i6b350fae2224486aa2a6ffc44c36559b_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNDUvZnJhZzoyODYyODkzYjc2Yjk0ZjdhOGU1ZjAyYmY4YzhlNzZiYS90YWJsZTo0NTU4ZDdiYWFmZmI0MTZjODg4ZjFhZDVjN2NlM2U0Mi90YWJsZXJhbmdlOjQ1NThkN2JhYWZmYjQxNmM4ODhmMWFkNWM3Y2UzZTQyXzMtNS0xLTEtMA_23841b08-3fa5-48e4-afc1-c772f3bc7602"
      unitRef="usd">5000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i06a1421a7f5a434ab21bb6e7f6c4217d_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNDUvZnJhZzoyODYyODkzYjc2Yjk0ZjdhOGU1ZjAyYmY4YzhlNzZiYS90YWJsZTo0NTU4ZDdiYWFmZmI0MTZjODg4ZjFhZDVjN2NlM2U0Mi90YWJsZXJhbmdlOjQ1NThkN2JhYWZmYjQxNmM4ODhmMWFkNWM3Y2UzZTQyXzQtMS0xLTEtMA_fb64379b-05c5-468c-bfe6-e6c5c027820b"
      unitRef="usd">3000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="if2c1cb49d0374d86b2830517b2b187db_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNDUvZnJhZzoyODYyODkzYjc2Yjk0ZjdhOGU1ZjAyYmY4YzhlNzZiYS90YWJsZTo0NTU4ZDdiYWFmZmI0MTZjODg4ZjFhZDVjN2NlM2U0Mi90YWJsZXJhbmdlOjQ1NThkN2JhYWZmYjQxNmM4ODhmMWFkNWM3Y2UzZTQyXzQtMy0xLTEtMA_6f75d8e7-d57f-4be5-b475-c21a44993974"
      unitRef="usd">-28000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i6b350fae2224486aa2a6ffc44c36559b_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNDUvZnJhZzoyODYyODkzYjc2Yjk0ZjdhOGU1ZjAyYmY4YzhlNzZiYS90YWJsZTo0NTU4ZDdiYWFmZmI0MTZjODg4ZjFhZDVjN2NlM2U0Mi90YWJsZXJhbmdlOjQ1NThkN2JhYWZmYjQxNmM4ODhmMWFkNWM3Y2UzZTQyXzQtNS0xLTEtMA_96a63079-a889-4685-9186-9f2a9e8bd409"
      unitRef="usd">-25000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ic4bf74d204c843148850dd8cf1a97c4c_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNDUvZnJhZzoyODYyODkzYjc2Yjk0ZjdhOGU1ZjAyYmY4YzhlNzZiYS90YWJsZTo0NTU4ZDdiYWFmZmI0MTZjODg4ZjFhZDVjN2NlM2U0Mi90YWJsZXJhbmdlOjQ1NThkN2JhYWZmYjQxNmM4ODhmMWFkNWM3Y2UzZTQyXzUtMS0xLTEtMA_4d14fd37-94f6-4871-8614-87cbed7eeaad"
      unitRef="usd">-92000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i6260475b94ac4643968f9f3d0742c126_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNDUvZnJhZzoyODYyODkzYjc2Yjk0ZjdhOGU1ZjAyYmY4YzhlNzZiYS90YWJsZTo0NTU4ZDdiYWFmZmI0MTZjODg4ZjFhZDVjN2NlM2U0Mi90YWJsZXJhbmdlOjQ1NThkN2JhYWZmYjQxNmM4ODhmMWFkNWM3Y2UzZTQyXzUtMy0xLTEtMA_244195dc-02cf-4ef1-a240-4a997f563677"
      unitRef="usd">-12000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i87f033cb2d3241b690c413fa8321d9dd_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNDUvZnJhZzoyODYyODkzYjc2Yjk0ZjdhOGU1ZjAyYmY4YzhlNzZiYS90YWJsZTo0NTU4ZDdiYWFmZmI0MTZjODg4ZjFhZDVjN2NlM2U0Mi90YWJsZXJhbmdlOjQ1NThkN2JhYWZmYjQxNmM4ODhmMWFkNWM3Y2UzZTQyXzUtNS0xLTEtMA_86e2ff0f-b5bb-4993-bd63-25b5e9573550"
      unitRef="usd">-104000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i10ebef79cb324951a3c60cf340e5e0c7_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNDUvZnJhZzoyODYyODkzYjc2Yjk0ZjdhOGU1ZjAyYmY4YzhlNzZiYS90YWJsZTo0NTU4ZDdiYWFmZmI0MTZjODg4ZjFhZDVjN2NlM2U0Mi90YWJsZXJhbmdlOjQ1NThkN2JhYWZmYjQxNmM4ODhmMWFkNWM3Y2UzZTQyXzYtMS0xLTEtMA_e098a86c-d449-436c-90d7-2d49c5d28e03"
      unitRef="usd">46000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i6a93d5b1ddba4766830bc552988b0f64_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNDUvZnJhZzoyODYyODkzYjc2Yjk0ZjdhOGU1ZjAyYmY4YzhlNzZiYS90YWJsZTo0NTU4ZDdiYWFmZmI0MTZjODg4ZjFhZDVjN2NlM2U0Mi90YWJsZXJhbmdlOjQ1NThkN2JhYWZmYjQxNmM4ODhmMWFkNWM3Y2UzZTQyXzYtMy0xLTEtMA_42eedf14-7598-44d0-b604-a47c154ca461"
      unitRef="usd">22000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="idaac2fb8e90844538a6c23b3c7452e2b_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNDUvZnJhZzoyODYyODkzYjc2Yjk0ZjdhOGU1ZjAyYmY4YzhlNzZiYS90YWJsZTo0NTU4ZDdiYWFmZmI0MTZjODg4ZjFhZDVjN2NlM2U0Mi90YWJsZXJhbmdlOjQ1NThkN2JhYWZmYjQxNmM4ODhmMWFkNWM3Y2UzZTQyXzYtNS0xLTEtMA_eb446aef-2f81-4b15-9755-27f4928335b8"
      unitRef="usd">68000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i10ebef79cb324951a3c60cf340e5e0c7_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNDUvZnJhZzoyODYyODkzYjc2Yjk0ZjdhOGU1ZjAyYmY4YzhlNzZiYS90YWJsZTo0NTU4ZDdiYWFmZmI0MTZjODg4ZjFhZDVjN2NlM2U0Mi90YWJsZXJhbmdlOjQ1NThkN2JhYWZmYjQxNmM4ODhmMWFkNWM3Y2UzZTQyXzctMS0xLTEtMA_ba6280ea-633a-4cee-8be4-757a5bb1276b"
      unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i6a93d5b1ddba4766830bc552988b0f64_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNDUvZnJhZzoyODYyODkzYjc2Yjk0ZjdhOGU1ZjAyYmY4YzhlNzZiYS90YWJsZTo0NTU4ZDdiYWFmZmI0MTZjODg4ZjFhZDVjN2NlM2U0Mi90YWJsZXJhbmdlOjQ1NThkN2JhYWZmYjQxNmM4ODhmMWFkNWM3Y2UzZTQyXzctMy0xLTEtMA_7b7368b7-6850-4432-a596-db00ea7d5c8a"
      unitRef="usd">-2000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="idaac2fb8e90844538a6c23b3c7452e2b_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNDUvZnJhZzoyODYyODkzYjc2Yjk0ZjdhOGU1ZjAyYmY4YzhlNzZiYS90YWJsZTo0NTU4ZDdiYWFmZmI0MTZjODg4ZjFhZDVjN2NlM2U0Mi90YWJsZXJhbmdlOjQ1NThkN2JhYWZmYjQxNmM4ODhmMWFkNWM3Y2UzZTQyXzctNS0xLTEtMA_f896d043-0153-438b-8e0a-fbb87bd7b4d8"
      unitRef="usd">-2000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i10ebef79cb324951a3c60cf340e5e0c7_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNDUvZnJhZzoyODYyODkzYjc2Yjk0ZjdhOGU1ZjAyYmY4YzhlNzZiYS90YWJsZTo0NTU4ZDdiYWFmZmI0MTZjODg4ZjFhZDVjN2NlM2U0Mi90YWJsZXJhbmdlOjQ1NThkN2JhYWZmYjQxNmM4ODhmMWFkNWM3Y2UzZTQyXzgtMS0xLTEtMA_4f3766c6-7e23-4b50-b26f-c7da38a75e7e"
      unitRef="usd">46000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i6a93d5b1ddba4766830bc552988b0f64_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNDUvZnJhZzoyODYyODkzYjc2Yjk0ZjdhOGU1ZjAyYmY4YzhlNzZiYS90YWJsZTo0NTU4ZDdiYWFmZmI0MTZjODg4ZjFhZDVjN2NlM2U0Mi90YWJsZXJhbmdlOjQ1NThkN2JhYWZmYjQxNmM4ODhmMWFkNWM3Y2UzZTQyXzgtMy0xLTEtMA_11929f45-5d99-423a-8328-bf4a79917487"
      unitRef="usd">24000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="idaac2fb8e90844538a6c23b3c7452e2b_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNDUvZnJhZzoyODYyODkzYjc2Yjk0ZjdhOGU1ZjAyYmY4YzhlNzZiYS90YWJsZTo0NTU4ZDdiYWFmZmI0MTZjODg4ZjFhZDVjN2NlM2U0Mi90YWJsZXJhbmdlOjQ1NThkN2JhYWZmYjQxNmM4ODhmMWFkNWM3Y2UzZTQyXzgtNS0xLTEtMA_52f34a41-53c4-4064-a1ca-ece9db158a96"
      unitRef="usd">70000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ifb49b5f7c6944c1ba0d4367e9d8295ee_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNDUvZnJhZzoyODYyODkzYjc2Yjk0ZjdhOGU1ZjAyYmY4YzhlNzZiYS90YWJsZTo0NTU4ZDdiYWFmZmI0MTZjODg4ZjFhZDVjN2NlM2U0Mi90YWJsZXJhbmdlOjQ1NThkN2JhYWZmYjQxNmM4ODhmMWFkNWM3Y2UzZTQyXzktMS0xLTEtMA_0f0d4869-ab88-4e9d-bd3d-5c498d3ecd07"
      unitRef="usd">-46000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ic7926ed91fae47b7a3fcb884911ab862_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNDUvZnJhZzoyODYyODkzYjc2Yjk0ZjdhOGU1ZjAyYmY4YzhlNzZiYS90YWJsZTo0NTU4ZDdiYWFmZmI0MTZjODg4ZjFhZDVjN2NlM2U0Mi90YWJsZXJhbmdlOjQ1NThkN2JhYWZmYjQxNmM4ODhmMWFkNWM3Y2UzZTQyXzktMy0xLTEtMA_f7924d8c-4ab7-47a2-9bff-f76488608566"
      unitRef="usd">12000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ia3fefcfeaf9c46ce91e01b1989e54336_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNDUvZnJhZzoyODYyODkzYjc2Yjk0ZjdhOGU1ZjAyYmY4YzhlNzZiYS90YWJsZTo0NTU4ZDdiYWFmZmI0MTZjODg4ZjFhZDVjN2NlM2U0Mi90YWJsZXJhbmdlOjQ1NThkN2JhYWZmYjQxNmM4ODhmMWFkNWM3Y2UzZTQyXzktNS0xLTEtMA_78145cf9-ba3f-4b02-922a-44ed30ddd097"
      unitRef="usd">-34000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:EarningsPerShareTextBlock
      contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTEvZnJhZzo0M2E4ZTJiZTY1ZTM0MDIxOTkxZWVhYTgxNjNlODAxYS90ZXh0cmVnaW9uOjQzYThlMmJlNjVlMzQwMjE5OTFlZWFhODE2M2U4MDFhXzY1Ng_54c10310-deff-431a-b43e-1bd4149c3645">&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:13pt;font-weight:700;line-height:120%"&gt;12. Earnings/(Loss) Per Share Attributable to Cardinal Health, Inc. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table reconciles the computation of basic and diluted earnings per share attributable to Cardinal Health, Inc.:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.691%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:61.748%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.045%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.347%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.347%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.358%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;(in millions, except per share amounts)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Net earnings/(loss)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;612&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(3,693)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,365&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Net earnings attributable to noncontrolling interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net earnings/(loss) attributable to Cardinal Health, Inc.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;611&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(3,696)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,363&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Weighted-average common shares&#x2013;basic&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;292&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;293&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Effect of dilutive securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Employee stock options, restricted share units, and performance share units&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted-average common shares&#x2013;diluted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;294&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;293&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;301&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Basic earnings/(loss) per common share attributable to Cardinal Health, Inc.:&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2.09&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(12.61)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;4.55&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Diluted earnings/(loss) per common share attributable to Cardinal Health, Inc.:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2.08&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(12.61)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;4.53&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The potentially dilutive employee stock options, restricted share units and performance share units that were anti-dilutive for fiscal 2021&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2020 and 2019 were 3 million, 6 million and 7 million, respectively. During fiscal 2020, there were 2 million potentially dilutive employee stock options, restricted share units and performance share units not included in the computation of diluted loss per common share attributable to Cardinal Health, Inc. because their effect would be anti-dilutive as a result of the net loss for the fiscal year.&lt;/span&gt;&lt;/div&gt;</us-gaap:EarningsPerShareTextBlock>
    <us-gaap:ScheduleOfWeightedAverageNumberOfSharesTableTextBlock
      contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTEvZnJhZzo0M2E4ZTJiZTY1ZTM0MDIxOTkxZWVhYTgxNjNlODAxYS90ZXh0cmVnaW9uOjQzYThlMmJlNjVlMzQwMjE5OTFlZWFhODE2M2U4MDFhXzY1MA_13136c61-103b-4683-834d-7661ed64d5b7">&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table reconciles the computation of basic and diluted earnings per share attributable to Cardinal Health, Inc.:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.691%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:61.748%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.045%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.347%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.347%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.358%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;(in millions, except per share amounts)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Net earnings/(loss)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;612&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(3,693)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,365&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Net earnings attributable to noncontrolling interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net earnings/(loss) attributable to Cardinal Health, Inc.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;611&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(3,696)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,363&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Weighted-average common shares&#x2013;basic&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;292&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;293&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Effect of dilutive securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Employee stock options, restricted share units, and performance share units&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted-average common shares&#x2013;diluted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;294&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;293&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;301&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Basic earnings/(loss) per common share attributable to Cardinal Health, Inc.:&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2.09&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(12.61)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;4.55&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Diluted earnings/(loss) per common share attributable to Cardinal Health, Inc.:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2.08&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(12.61)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;4.53&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfWeightedAverageNumberOfSharesTableTextBlock>
    <us-gaap:ProfitLoss
      contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTEvZnJhZzo0M2E4ZTJiZTY1ZTM0MDIxOTkxZWVhYTgxNjNlODAxYS90YWJsZToyY2UwMTVkMzFhNDc0Zjk3ODYxNTE3MjA0ZmQ0MGI3Mi90YWJsZXJhbmdlOjJjZTAxNWQzMWE0NzRmOTc4NjE1MTcyMDRmZDQwYjcyXzEtMS0xLTEtMA_5dc9de89-fc9f-45d1-b378-262f02dc4a49"
      unitRef="usd">612000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="ia31e9a409b874bb19d0ff6f2f39ecc09_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTEvZnJhZzo0M2E4ZTJiZTY1ZTM0MDIxOTkxZWVhYTgxNjNlODAxYS90YWJsZToyY2UwMTVkMzFhNDc0Zjk3ODYxNTE3MjA0ZmQ0MGI3Mi90YWJsZXJhbmdlOjJjZTAxNWQzMWE0NzRmOTc4NjE1MTcyMDRmZDQwYjcyXzEtMy0xLTEtMA_23bb9c60-4a85-4383-afb4-1036b99af086"
      unitRef="usd">-3693000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i00a6d666bf604826b24e68ddbd63eac4_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTEvZnJhZzo0M2E4ZTJiZTY1ZTM0MDIxOTkxZWVhYTgxNjNlODAxYS90YWJsZToyY2UwMTVkMzFhNDc0Zjk3ODYxNTE3MjA0ZmQ0MGI3Mi90YWJsZXJhbmdlOjJjZTAxNWQzMWE0NzRmOTc4NjE1MTcyMDRmZDQwYjcyXzEtNS0xLTEtMA_2da7c4d7-b4c4-4349-a185-fa319bcef210"
      unitRef="usd">1365000000</us-gaap:ProfitLoss>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTEvZnJhZzo0M2E4ZTJiZTY1ZTM0MDIxOTkxZWVhYTgxNjNlODAxYS90YWJsZToyY2UwMTVkMzFhNDc0Zjk3ODYxNTE3MjA0ZmQ0MGI3Mi90YWJsZXJhbmdlOjJjZTAxNWQzMWE0NzRmOTc4NjE1MTcyMDRmZDQwYjcyXzItMS0xLTEtMA_affb2e3a-30c5-4bcf-961a-a9a87ba46869"
      unitRef="usd">1000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="ia31e9a409b874bb19d0ff6f2f39ecc09_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTEvZnJhZzo0M2E4ZTJiZTY1ZTM0MDIxOTkxZWVhYTgxNjNlODAxYS90YWJsZToyY2UwMTVkMzFhNDc0Zjk3ODYxNTE3MjA0ZmQ0MGI3Mi90YWJsZXJhbmdlOjJjZTAxNWQzMWE0NzRmOTc4NjE1MTcyMDRmZDQwYjcyXzItMy0xLTEtMA_7bb6209f-17c5-46ac-82fe-064374496a27"
      unitRef="usd">3000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i00a6d666bf604826b24e68ddbd63eac4_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTEvZnJhZzo0M2E4ZTJiZTY1ZTM0MDIxOTkxZWVhYTgxNjNlODAxYS90YWJsZToyY2UwMTVkMzFhNDc0Zjk3ODYxNTE3MjA0ZmQ0MGI3Mi90YWJsZXJhbmdlOjJjZTAxNWQzMWE0NzRmOTc4NjE1MTcyMDRmZDQwYjcyXzItNS0xLTEtMA_f5033487-a052-47e6-bf87-72437eb32df4"
      unitRef="usd">2000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLoss
      contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTEvZnJhZzo0M2E4ZTJiZTY1ZTM0MDIxOTkxZWVhYTgxNjNlODAxYS90YWJsZToyY2UwMTVkMzFhNDc0Zjk3ODYxNTE3MjA0ZmQ0MGI3Mi90YWJsZXJhbmdlOjJjZTAxNWQzMWE0NzRmOTc4NjE1MTcyMDRmZDQwYjcyXzUtMS0xLTEtMA_797a6a5d-77bd-449f-aee9-0da69aaba5f5"
      unitRef="usd">611000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ia31e9a409b874bb19d0ff6f2f39ecc09_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTEvZnJhZzo0M2E4ZTJiZTY1ZTM0MDIxOTkxZWVhYTgxNjNlODAxYS90YWJsZToyY2UwMTVkMzFhNDc0Zjk3ODYxNTE3MjA0ZmQ0MGI3Mi90YWJsZXJhbmdlOjJjZTAxNWQzMWE0NzRmOTc4NjE1MTcyMDRmZDQwYjcyXzUtMy0xLTEtMA_ed44b04b-b169-4c03-be1d-6eff6a89b284"
      unitRef="usd">-3696000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i00a6d666bf604826b24e68ddbd63eac4_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTEvZnJhZzo0M2E4ZTJiZTY1ZTM0MDIxOTkxZWVhYTgxNjNlODAxYS90YWJsZToyY2UwMTVkMzFhNDc0Zjk3ODYxNTE3MjA0ZmQ0MGI3Mi90YWJsZXJhbmdlOjJjZTAxNWQzMWE0NzRmOTc4NjE1MTcyMDRmZDQwYjcyXzUtNS0xLTEtMA_b201c961-3a07-4ff1-bff6-51c0a041797b"
      unitRef="usd">1363000000</us-gaap:NetIncomeLoss>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTEvZnJhZzo0M2E4ZTJiZTY1ZTM0MDIxOTkxZWVhYTgxNjNlODAxYS90YWJsZToyY2UwMTVkMzFhNDc0Zjk3ODYxNTE3MjA0ZmQ0MGI3Mi90YWJsZXJhbmdlOjJjZTAxNWQzMWE0NzRmOTc4NjE1MTcyMDRmZDQwYjcyXzYtMS0xLTEtMA_84acd046-361e-4c51-b844-75cb49ee4498"
      unitRef="shares">292000000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="ia31e9a409b874bb19d0ff6f2f39ecc09_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTEvZnJhZzo0M2E4ZTJiZTY1ZTM0MDIxOTkxZWVhYTgxNjNlODAxYS90YWJsZToyY2UwMTVkMzFhNDc0Zjk3ODYxNTE3MjA0ZmQ0MGI3Mi90YWJsZXJhbmdlOjJjZTAxNWQzMWE0NzRmOTc4NjE1MTcyMDRmZDQwYjcyXzYtMy0xLTEtMA_1d368dc1-feda-434d-b506-95a9db8ddf20"
      unitRef="shares">293000000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i00a6d666bf604826b24e68ddbd63eac4_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTEvZnJhZzo0M2E4ZTJiZTY1ZTM0MDIxOTkxZWVhYTgxNjNlODAxYS90YWJsZToyY2UwMTVkMzFhNDc0Zjk3ODYxNTE3MjA0ZmQ0MGI3Mi90YWJsZXJhbmdlOjJjZTAxNWQzMWE0NzRmOTc4NjE1MTcyMDRmZDQwYjcyXzYtNS0xLTEtMA_2de8edae-3913-4ee0-ae53-0aa70ecd4dc7"
      unitRef="shares">300000000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment
      contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTEvZnJhZzo0M2E4ZTJiZTY1ZTM0MDIxOTkxZWVhYTgxNjNlODAxYS90YWJsZToyY2UwMTVkMzFhNDc0Zjk3ODYxNTE3MjA0ZmQ0MGI3Mi90YWJsZXJhbmdlOjJjZTAxNWQzMWE0NzRmOTc4NjE1MTcyMDRmZDQwYjcyXzgtMS0xLTEtMA_2ede7023-5dca-4b16-9c7e-d59191a7c5cd"
      unitRef="shares">2000000</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
    <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment
      contextRef="ia31e9a409b874bb19d0ff6f2f39ecc09_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTEvZnJhZzo0M2E4ZTJiZTY1ZTM0MDIxOTkxZWVhYTgxNjNlODAxYS90YWJsZToyY2UwMTVkMzFhNDc0Zjk3ODYxNTE3MjA0ZmQ0MGI3Mi90YWJsZXJhbmdlOjJjZTAxNWQzMWE0NzRmOTc4NjE1MTcyMDRmZDQwYjcyXzgtMy0xLTEtMA_54c5947a-398f-4bd7-b283-eeee289358d2"
      unitRef="shares">0</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
    <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment
      contextRef="i00a6d666bf604826b24e68ddbd63eac4_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTEvZnJhZzo0M2E4ZTJiZTY1ZTM0MDIxOTkxZWVhYTgxNjNlODAxYS90YWJsZToyY2UwMTVkMzFhNDc0Zjk3ODYxNTE3MjA0ZmQ0MGI3Mi90YWJsZXJhbmdlOjJjZTAxNWQzMWE0NzRmOTc4NjE1MTcyMDRmZDQwYjcyXzgtNS0xLTEtMA_49ae8a39-24ba-4658-b0f9-4c70c830cbcd"
      unitRef="shares">1000000</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTEvZnJhZzo0M2E4ZTJiZTY1ZTM0MDIxOTkxZWVhYTgxNjNlODAxYS90YWJsZToyY2UwMTVkMzFhNDc0Zjk3ODYxNTE3MjA0ZmQ0MGI3Mi90YWJsZXJhbmdlOjJjZTAxNWQzMWE0NzRmOTc4NjE1MTcyMDRmZDQwYjcyXzktMS0xLTEtMA_ff1e24bb-9de9-439b-97fd-62c334eb42e4"
      unitRef="shares">294000000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="ia31e9a409b874bb19d0ff6f2f39ecc09_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTEvZnJhZzo0M2E4ZTJiZTY1ZTM0MDIxOTkxZWVhYTgxNjNlODAxYS90YWJsZToyY2UwMTVkMzFhNDc0Zjk3ODYxNTE3MjA0ZmQ0MGI3Mi90YWJsZXJhbmdlOjJjZTAxNWQzMWE0NzRmOTc4NjE1MTcyMDRmZDQwYjcyXzktMy0xLTEtMA_9dad21d8-d7f8-425d-bd0d-46c29602e89f"
      unitRef="shares">293000000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i00a6d666bf604826b24e68ddbd63eac4_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTEvZnJhZzo0M2E4ZTJiZTY1ZTM0MDIxOTkxZWVhYTgxNjNlODAxYS90YWJsZToyY2UwMTVkMzFhNDc0Zjk3ODYxNTE3MjA0ZmQ0MGI3Mi90YWJsZXJhbmdlOjJjZTAxNWQzMWE0NzRmOTc4NjE1MTcyMDRmZDQwYjcyXzktNS0xLTEtMA_7f6b9a38-4683-46bc-9255-89fa8f21b4c6"
      unitRef="shares">301000000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:EarningsPerShareBasic
      contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTEvZnJhZzo0M2E4ZTJiZTY1ZTM0MDIxOTkxZWVhYTgxNjNlODAxYS90YWJsZToyY2UwMTVkMzFhNDc0Zjk3ODYxNTE3MjA0ZmQ0MGI3Mi90YWJsZXJhbmdlOjJjZTAxNWQzMWE0NzRmOTc4NjE1MTcyMDRmZDQwYjcyXzEwLTEtMS0xLTA_557eea4e-fe51-4fd8-81a4-50b3273746e3"
      unitRef="usdPerShare">2.09</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="ia31e9a409b874bb19d0ff6f2f39ecc09_D20190701-20200630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTEvZnJhZzo0M2E4ZTJiZTY1ZTM0MDIxOTkxZWVhYTgxNjNlODAxYS90YWJsZToyY2UwMTVkMzFhNDc0Zjk3ODYxNTE3MjA0ZmQ0MGI3Mi90YWJsZXJhbmdlOjJjZTAxNWQzMWE0NzRmOTc4NjE1MTcyMDRmZDQwYjcyXzEwLTMtMS0xLTA_127ebfca-cc47-4b29-a8b3-9940c4b745f9"
      unitRef="usdPerShare">-12.61</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i00a6d666bf604826b24e68ddbd63eac4_D20180701-20190630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTEvZnJhZzo0M2E4ZTJiZTY1ZTM0MDIxOTkxZWVhYTgxNjNlODAxYS90YWJsZToyY2UwMTVkMzFhNDc0Zjk3ODYxNTE3MjA0ZmQ0MGI3Mi90YWJsZXJhbmdlOjJjZTAxNWQzMWE0NzRmOTc4NjE1MTcyMDRmZDQwYjcyXzEwLTUtMS0xLTA_54e6b0fb-8e36-4143-aa05-d4734014d06f"
      unitRef="usdPerShare">4.55</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTEvZnJhZzo0M2E4ZTJiZTY1ZTM0MDIxOTkxZWVhYTgxNjNlODAxYS90YWJsZToyY2UwMTVkMzFhNDc0Zjk3ODYxNTE3MjA0ZmQ0MGI3Mi90YWJsZXJhbmdlOjJjZTAxNWQzMWE0NzRmOTc4NjE1MTcyMDRmZDQwYjcyXzE1LTEtMS0xLTA_97204efd-cd2f-4469-875d-8c01ef045482"
      unitRef="usdPerShare">2.08</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="ia31e9a409b874bb19d0ff6f2f39ecc09_D20190701-20200630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTEvZnJhZzo0M2E4ZTJiZTY1ZTM0MDIxOTkxZWVhYTgxNjNlODAxYS90YWJsZToyY2UwMTVkMzFhNDc0Zjk3ODYxNTE3MjA0ZmQ0MGI3Mi90YWJsZXJhbmdlOjJjZTAxNWQzMWE0NzRmOTc4NjE1MTcyMDRmZDQwYjcyXzE1LTMtMS0xLTA_82523bf2-4938-4dd1-9419-e763b9798a79"
      unitRef="usdPerShare">-12.61</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i00a6d666bf604826b24e68ddbd63eac4_D20180701-20190630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTEvZnJhZzo0M2E4ZTJiZTY1ZTM0MDIxOTkxZWVhYTgxNjNlODAxYS90YWJsZToyY2UwMTVkMzFhNDc0Zjk3ODYxNTE3MjA0ZmQ0MGI3Mi90YWJsZXJhbmdlOjJjZTAxNWQzMWE0NzRmOTc4NjE1MTcyMDRmZDQwYjcyXzE1LTUtMS0xLTA_935ac921-102b-4b00-8061-753ed9ed8171"
      unitRef="usdPerShare">4.53</us-gaap:EarningsPerShareDiluted>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTEvZnJhZzo0M2E4ZTJiZTY1ZTM0MDIxOTkxZWVhYTgxNjNlODAxYS90ZXh0cmVnaW9uOjQzYThlMmJlNjVlMzQwMjE5OTFlZWFhODE2M2U4MDFhXzI5MQ_8ce82a7b-84a0-43ad-8f1a-2a4b2124e8e6"
      unitRef="shares">3000000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="ia31e9a409b874bb19d0ff6f2f39ecc09_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTEvZnJhZzo0M2E4ZTJiZTY1ZTM0MDIxOTkxZWVhYTgxNjNlODAxYS90ZXh0cmVnaW9uOjQzYThlMmJlNjVlMzQwMjE5OTFlZWFhODE2M2U4MDFhXzI5NQ_91416819-3865-468c-ad02-0a753fe6362d"
      unitRef="shares">6000000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i00a6d666bf604826b24e68ddbd63eac4_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTEvZnJhZzo0M2E4ZTJiZTY1ZTM0MDIxOTkxZWVhYTgxNjNlODAxYS90ZXh0cmVnaW9uOjQzYThlMmJlNjVlMzQwMjE5OTFlZWFhODE2M2U4MDFhXzMwMg_f396e177-2037-4606-b7b2-8cc69191f356"
      unitRef="shares">7000000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <cah:Sharesthatwouldbeantidilutiveasaresultofnetloss
      contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTEvZnJhZzo0M2E4ZTJiZTY1ZTM0MDIxOTkxZWVhYTgxNjNlODAxYS90ZXh0cmVnaW9uOjQzYThlMmJlNjVlMzQwMjE5OTFlZWFhODE2M2U4MDFhXzcxNDY4MjU1ODE2OTQ_1df0979a-b3b1-4dbc-a887-fddf9b15e432"
      unitRef="shares">2000000</cah:Sharesthatwouldbeantidilutiveasaresultofnetloss>
    <us-gaap:SegmentReportingDisclosureTextBlock
      contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTQvZnJhZzo3OWNmN2IxZmM4OTI0ODhkYjBjZTZhNDYxZmMyNjIzNC90ZXh0cmVnaW9uOjc5Y2Y3YjFmYzg5MjQ4OGRiMGNlNmE0NjFmYzI2MjM0XzYwMzE_eadbb003-b030-4991-96ab-5f0ab61f4265">&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:13pt;font-weight:700;line-height:120%"&gt;13. Segment Information &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our operations are principally managed on a products and services basis and are comprised of two operating segments, which are the same as our reportable segments: Pharmaceutical and Medical. The factors for determining the reportable segments include the manner in which management evaluates performance for purposes of allocating resources and assessing performance combined with the nature of the individual business activities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Revenue&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical and over-the-counter healthcare and consumer products in the United States. This segment also provides services to pharmaceutical manufacturers and healthcare providers for specialty pharmaceutical products; operates pharmacies, including pharmacies in community health centers, nuclear pharmacies and radiopharmaceutical manufacturing facilities; provides pharmacy management services to hospitals as well as medication therapy management and patient outcomes services to hospitals, other healthcare providers and payers; and repackages generic pharmaceuticals and over-the-counter healthcare products. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our Medical segment manufactures, sources and distributes Cardinal Health branded medical, surgical and laboratory products, which are sold in the United States, Canada, Europe, Asia and other markets. In addition to distributing Cardinal Health branded &lt;/span&gt;&lt;/div&gt;&lt;div style="display:inline-block;vertical-align:top;width:48.214%"&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;products, this segment also distributes a broad range of medical, surgical and laboratory products known as national brand products and provides supply chain services and solutions to hospitals, ambulatory surgery centers, clinical laboratories and other healthcare providers in the United States and Canada. This segment also distributes medical products to patients' homes in the United States through our Cardinal Health at-Home Solutions division.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents revenue for each reportable segment and Corporate:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:55.690%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.480%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.343%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.171%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.343%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.173%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Pharmaceutical&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;145,796&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;137,495&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;129,917&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Medical&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;16,687&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;15,444&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;15,633&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total segment revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;162,483&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;152,939&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;145,550&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Corporate (1)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(16)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(17)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(16)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;162,467&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;152,922&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;145,534&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:10pt"&gt;Corporate revenue consists of the elimination of inter-segment revenue and other revenue not allocated to the segments.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables present revenue for each reportable segment and disaggregated revenue within our two reportable segments and Corporate:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:46.791%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.004%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.004%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.469%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Pharmaceutical Distribution and Specialty Solutions (1) (2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;144,988&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;136,693&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;129,067&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Nuclear and Precision Health Solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;808&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;802&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;850&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Pharmaceutical segment revenue&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;145,796&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;137,495&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;129,917&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Medical distribution and products (3)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;14,485&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;13,429&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;13,833&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Cardinal Health at-Home Solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2,202&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,015&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,800&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Medical segment revenue&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;16,687&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;15,444&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;15,633&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&#160;Total segment revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;162,483&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;152,939&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;145,550&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Corporate (4)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(16)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(17)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(16)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;162,467&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;152,922&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;145,534&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:10pt"&gt;Products and services offered by our Specialty Solutions division are referred to as &#x201c;specialty pharmaceutical products and services"&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:10pt"&gt;Comprised of all Pharmaceutical segment businesses except for Nuclear and Precision Health Solutions division.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:10pt"&gt;Comprised of all Medical segment businesses except for Cardinal Health at-Home Solutions division&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(4)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:10pt"&gt;Corporate revenue consists of the elimination of inter-segment revenue and other revenue not allocated to the segments.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents revenue by geographic area:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:42.109%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.183%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.269%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.183%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.269%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.187%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;157,756&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;148,707&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;141,479&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;4,727&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;4,232&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;4,071&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total segment revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;162,483&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;152,939&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;145,550&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Corporate (1)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(16)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(17)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(16)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;162,467&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;152,922&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;145,534&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:10pt"&gt;Corporate revenue consists of the elimination of inter-segment revenue and other revenue not allocated to the segments.&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="display:inline-block;max-width:3.571%;min-width:2.571%;vertical-align:top"/&gt;&lt;div style="display:inline-block;vertical-align:top;width:48.215%"&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Segment Profit&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We evaluate segment performance based on segment profit, among other measures. Segment profit is segment revenue, less segment cost of products sold, less segment distribution, selling, general, and administrative ("SG&amp;amp;A") expenses. Segment SG&amp;amp;A expenses include share-based compensation expense as well as allocated corporate expenses for shared functions, including corporate management, corporate finance, financial and customer care shared services, human resources, information technology, legal and compliance, including certain litigation defense costs. Corporate expenses are allocated to the segments based on headcount, level of benefit provided and other ratable allocation methodologies. The results attributable to noncontrolling interests are recorded within segment profit.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We do not allocate the following items to our segments: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.13pt"&gt;last-in first-out, or ("LIFO"), inventory charges/(credits);&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.13pt"&gt;surgical gown recall costs/(income); in connection with a voluntary recall for certain surgical gowns and a voluntary recall and field actions for surgical procedure packs containing affected gowns, we recognized a pre-tax charge of $85&#160;million during fiscal 2020;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.13pt"&gt;restructuring and employee severance;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.13pt"&gt;amortization and other acquisition-related costs;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.13pt"&gt;impairments and (gain)/loss on disposal of assets; in connection with the divestiture of the Cordis business, we recognized a $60 million pre-tax write-down of the net assets held for sale&lt;/span&gt;&lt;span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:13pt;font-weight:700;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;during fiscal 2021; in connection with the naviHealth divestiture discussed in &lt;/span&gt;&lt;span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;&lt;a href="#i4f0ec56b9c604f1782a65ea4a19c284d_106" style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Note 2&lt;/a&gt;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, we recognized a pre-tax gain of $508 million during fiscal 2019;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.13pt"&gt;litigation (recoveries)/charges, net; in connection with the opioid litigation as discussed further in &lt;/span&gt;&lt;span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;&lt;a href="#i4f0ec56b9c604f1782a65ea4a19c284d_130" style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Note 7&lt;/a&gt;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, we recognized pre-tax charges of $1.17&#160;billion and $5.63&#160;billion&lt;/span&gt;&lt;span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:13pt;font-weight:700;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;during fiscal 2021 and 2020, respectively;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.13pt"&gt;state opioid assessment related to prior fiscal years; in connection with the New York Opioid Stewardship Act as discussed further in &lt;/span&gt;&lt;span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;&lt;a href="#i4f0ec56b9c604f1782a65ea4a19c284d_130" style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Note 7&lt;/a&gt;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, we recognized a pre-tax charge of $41&#160;million during fiscal 2021, related to calendar years 2017 and 2018 assessments;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.13pt"&gt;other (income)/expense, net;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.13pt"&gt;interest expense, net;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.13pt"&gt;loss on early extinguishment of debt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.13pt"&gt;(gain)/loss on sale of equity interest in naviHealth; in connection with the sale of our remaining equity interest in a partnership that owned naviHealth as discussed in &lt;/span&gt;&lt;span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;&lt;a href="#i4f0ec56b9c604f1782a65ea4a19c284d_106" style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Note 2&lt;/a&gt;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, we recognized a $579&#160;million pre-tax gain ($493 million after tax) during fiscal 2020;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.13pt"&gt;provision for/(benefit from) income taxes &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In addition, certain investment spending, certain portions of enterprise-wide incentive compensation and other spending are not allocated to the segments. Investment spending generally &lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;includes the first-year spend for certain projects that require incremental investments in the form of additional operating expenses. Because approval for these projects is dependent on executive management, we retain these expenses at Corporate. Investment spending within Corporate was $27 million, $69 million and $55 million for fiscal 2021, 2020 and 2019, respectively. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables present segment profit by reportable segment and Corporate:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.691%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:51.221%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.451%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.347%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.760%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.347%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.074%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Pharmaceutical&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;1,684&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,753&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,834&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Medical&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;577&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;663&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;576&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total segment profit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2,261&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,416&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,410&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Corporate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(1,789)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(6,514)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(350)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total operating earnings&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;472&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(4,098)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,060&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables present depreciation and amortization and additions to property and equipment by reportable segment and Corporate:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.691%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:47.506%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.999%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.347%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.999%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.347%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.002%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Pharmaceutical&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;151&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;135&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;147&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Medical&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;226&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;243&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;288&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Corporate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;406&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;535&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;565&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;783&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;913&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.691%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:47.506%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.999%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.347%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.999%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.347%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.002%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Pharmaceutical&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;55&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Medical&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;97&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;86&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;74&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Corporate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;248&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;242&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;219&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total additions to property and equipment&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;400&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;375&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;328&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents total assets for each reportable segment and Corporate at June 30:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.691%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:46.887%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.547%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.347%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.547%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.347%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.525%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Pharmaceutical&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;23,624&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;22,398&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;22,446&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Medical (1)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;15,408&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;14,691&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;15,284&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Corporate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;5,421&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3,677&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3,233&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;44,453&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;40,766&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;40,963&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;Assets of $1.1 billion classified as held for sale related to the Cordis divestiture were included within Medical at June&#160;30, 2021&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables present property and equipment, net by geographic area:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.691%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:46.887%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.547%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.347%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.547%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.347%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.525%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;1,958&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,880&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,846&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;402&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;486&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;510&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Property and equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2,360&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,366&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,356&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:SegmentReportingDisclosureTextBlock>
    <us-gaap:NumberOfReportableSegments
      contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTQvZnJhZzo3OWNmN2IxZmM4OTI0ODhkYjBjZTZhNDYxZmMyNjIzNC90ZXh0cmVnaW9uOjc5Y2Y3YjFmYzg5MjQ4OGRiMGNlNmE0NjFmYzI2MjM0XzEwMg_a0ed16e6-1f98-4436-b7af-838e7be5f525"
      unitRef="segment">2</us-gaap:NumberOfReportableSegments>
    <us-gaap:NumberOfOperatingSegments
      contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTQvZnJhZzo3OWNmN2IxZmM4OTI0ODhkYjBjZTZhNDYxZmMyNjIzNC90ZXh0cmVnaW9uOjc5Y2Y3YjFmYzg5MjQ4OGRiMGNlNmE0NjFmYzI2MjM0XzEwMg_f090cdaf-7eab-4dd2-a990-822e2864749f"
      unitRef="segment">2</us-gaap:NumberOfOperatingSegments>
    <us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock
      contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTQvZnJhZzo3OWNmN2IxZmM4OTI0ODhkYjBjZTZhNDYxZmMyNjIzNC90ZXh0cmVnaW9uOjc5Y2Y3YjFmYzg5MjQ4OGRiMGNlNmE0NjFmYzI2MjM0XzU5ODU_eeec1433-d04a-4b69-bdee-f01b4dec1a74">&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents revenue for each reportable segment and Corporate:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:55.690%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.480%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.343%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.171%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.343%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.173%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Pharmaceutical&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;145,796&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;137,495&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;129,917&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Medical&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;16,687&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;15,444&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;15,633&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total segment revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;162,483&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;152,939&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;145,550&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Corporate (1)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(16)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(17)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(16)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;162,467&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;152,922&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;145,534&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:10pt"&gt;Corporate revenue consists of the elimination of inter-segment revenue and other revenue not allocated to the segments.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock>
    <us-gaap:Revenues
      contextRef="i76b6a114dfd6424fb4c07d91075a91ff_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTQvZnJhZzo3OWNmN2IxZmM4OTI0ODhkYjBjZTZhNDYxZmMyNjIzNC90YWJsZToxMDUyNWQyNDhlZWY0NTdjOTdhNTE3MDc4ZjA3MDNkOS90YWJsZXJhbmdlOjEwNTI1ZDI0OGVlZjQ1N2M5N2E1MTcwNzhmMDcwM2Q5XzEtMS0xLTEtMA_da101699-fd8b-426a-bff7-82e5597e6faa"
      unitRef="usd">145796000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i78632f0315fd45fb85ed1c2272933a36_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTQvZnJhZzo3OWNmN2IxZmM4OTI0ODhkYjBjZTZhNDYxZmMyNjIzNC90YWJsZToxMDUyNWQyNDhlZWY0NTdjOTdhNTE3MDc4ZjA3MDNkOS90YWJsZXJhbmdlOjEwNTI1ZDI0OGVlZjQ1N2M5N2E1MTcwNzhmMDcwM2Q5XzEtMy0xLTEtMA_df95e01a-ab1e-42a8-92bf-653585f20247"
      unitRef="usd">137495000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i6d7435bb60af47f4a69d23c973a60d43_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTQvZnJhZzo3OWNmN2IxZmM4OTI0ODhkYjBjZTZhNDYxZmMyNjIzNC90YWJsZToxMDUyNWQyNDhlZWY0NTdjOTdhNTE3MDc4ZjA3MDNkOS90YWJsZXJhbmdlOjEwNTI1ZDI0OGVlZjQ1N2M5N2E1MTcwNzhmMDcwM2Q5XzEtNS0xLTEtMA_4ed76c01-d25e-4bef-ba40-e7140e526880"
      unitRef="usd">129917000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="id8c82c11050f452c9befaa43705026a6_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTQvZnJhZzo3OWNmN2IxZmM4OTI0ODhkYjBjZTZhNDYxZmMyNjIzNC90YWJsZToxMDUyNWQyNDhlZWY0NTdjOTdhNTE3MDc4ZjA3MDNkOS90YWJsZXJhbmdlOjEwNTI1ZDI0OGVlZjQ1N2M5N2E1MTcwNzhmMDcwM2Q5XzItMS0xLTEtMA_801f9b18-3be1-4c0f-aac3-e8e91cd89a36"
      unitRef="usd">16687000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i1faf47ea4d994e879fd1c1bf2cc15983_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTQvZnJhZzo3OWNmN2IxZmM4OTI0ODhkYjBjZTZhNDYxZmMyNjIzNC90YWJsZToxMDUyNWQyNDhlZWY0NTdjOTdhNTE3MDc4ZjA3MDNkOS90YWJsZXJhbmdlOjEwNTI1ZDI0OGVlZjQ1N2M5N2E1MTcwNzhmMDcwM2Q5XzItMy0xLTEtMA_37a08ebe-7653-480e-b7dc-4663eeaf9074"
      unitRef="usd">15444000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i4dcc4f5896f24eb98e3473b71e1d10b7_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTQvZnJhZzo3OWNmN2IxZmM4OTI0ODhkYjBjZTZhNDYxZmMyNjIzNC90YWJsZToxMDUyNWQyNDhlZWY0NTdjOTdhNTE3MDc4ZjA3MDNkOS90YWJsZXJhbmdlOjEwNTI1ZDI0OGVlZjQ1N2M5N2E1MTcwNzhmMDcwM2Q5XzItNS0xLTEtMA_ce1af9fd-d5f3-4b1f-8f93-15d3905879f1"
      unitRef="usd">15633000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ie5f1ec6cee11430ab0571ee6201cd0f7_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTQvZnJhZzo3OWNmN2IxZmM4OTI0ODhkYjBjZTZhNDYxZmMyNjIzNC90YWJsZToxMDUyNWQyNDhlZWY0NTdjOTdhNTE3MDc4ZjA3MDNkOS90YWJsZXJhbmdlOjEwNTI1ZDI0OGVlZjQ1N2M5N2E1MTcwNzhmMDcwM2Q5XzMtMS0xLTEtMA_90ed073f-559b-49f4-9223-6278957c6088"
      unitRef="usd">162483000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i7a96c8334d2e46928c83a274df8be377_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTQvZnJhZzo3OWNmN2IxZmM4OTI0ODhkYjBjZTZhNDYxZmMyNjIzNC90YWJsZToxMDUyNWQyNDhlZWY0NTdjOTdhNTE3MDc4ZjA3MDNkOS90YWJsZXJhbmdlOjEwNTI1ZDI0OGVlZjQ1N2M5N2E1MTcwNzhmMDcwM2Q5XzMtMy0xLTEtMA_06bce748-9e45-4e78-bf2e-119935ac02a7"
      unitRef="usd">152939000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i3ab52d1ad77045aa97d1dbfb8cb6186e_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTQvZnJhZzo3OWNmN2IxZmM4OTI0ODhkYjBjZTZhNDYxZmMyNjIzNC90YWJsZToxMDUyNWQyNDhlZWY0NTdjOTdhNTE3MDc4ZjA3MDNkOS90YWJsZXJhbmdlOjEwNTI1ZDI0OGVlZjQ1N2M5N2E1MTcwNzhmMDcwM2Q5XzMtNS0xLTEtMA_3c6993ad-dbd3-4758-be7e-22ec9b83d585"
      unitRef="usd">145550000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i792ece330cb74d35afecabca6b7f49ea_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTQvZnJhZzo3OWNmN2IxZmM4OTI0ODhkYjBjZTZhNDYxZmMyNjIzNC90YWJsZToxMDUyNWQyNDhlZWY0NTdjOTdhNTE3MDc4ZjA3MDNkOS90YWJsZXJhbmdlOjEwNTI1ZDI0OGVlZjQ1N2M5N2E1MTcwNzhmMDcwM2Q5XzQtMS0xLTEtMA_9e76f224-ff2d-4a8c-b583-7e2d68faf978"
      unitRef="usd">-16000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i16818ee6ea724c8691b1f0065031735b_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTQvZnJhZzo3OWNmN2IxZmM4OTI0ODhkYjBjZTZhNDYxZmMyNjIzNC90YWJsZToxMDUyNWQyNDhlZWY0NTdjOTdhNTE3MDc4ZjA3MDNkOS90YWJsZXJhbmdlOjEwNTI1ZDI0OGVlZjQ1N2M5N2E1MTcwNzhmMDcwM2Q5XzQtMy0xLTEtMA_b8abbb9c-7906-4872-ac85-d5b62459b468"
      unitRef="usd">-17000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ic5128c57d92d4336ae115d6ba4e979cb_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTQvZnJhZzo3OWNmN2IxZmM4OTI0ODhkYjBjZTZhNDYxZmMyNjIzNC90YWJsZToxMDUyNWQyNDhlZWY0NTdjOTdhNTE3MDc4ZjA3MDNkOS90YWJsZXJhbmdlOjEwNTI1ZDI0OGVlZjQ1N2M5N2E1MTcwNzhmMDcwM2Q5XzQtNS0xLTEtMA_d2aaa116-bd3e-4eb8-a9f5-ea17607e2712"
      unitRef="usd">-16000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTQvZnJhZzo3OWNmN2IxZmM4OTI0ODhkYjBjZTZhNDYxZmMyNjIzNC90YWJsZToxMDUyNWQyNDhlZWY0NTdjOTdhNTE3MDc4ZjA3MDNkOS90YWJsZXJhbmdlOjEwNTI1ZDI0OGVlZjQ1N2M5N2E1MTcwNzhmMDcwM2Q5XzUtMS0xLTEtMA_4a77e242-386e-4d53-961f-128155e243f5"
      unitRef="usd">162467000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ia31e9a409b874bb19d0ff6f2f39ecc09_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTQvZnJhZzo3OWNmN2IxZmM4OTI0ODhkYjBjZTZhNDYxZmMyNjIzNC90YWJsZToxMDUyNWQyNDhlZWY0NTdjOTdhNTE3MDc4ZjA3MDNkOS90YWJsZXJhbmdlOjEwNTI1ZDI0OGVlZjQ1N2M5N2E1MTcwNzhmMDcwM2Q5XzUtMy0xLTEtMA_96ceb081-e684-426a-ad23-e690088f8ad1"
      unitRef="usd">152922000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i00a6d666bf604826b24e68ddbd63eac4_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTQvZnJhZzo3OWNmN2IxZmM4OTI0ODhkYjBjZTZhNDYxZmMyNjIzNC90YWJsZToxMDUyNWQyNDhlZWY0NTdjOTdhNTE3MDc4ZjA3MDNkOS90YWJsZXJhbmdlOjEwNTI1ZDI0OGVlZjQ1N2M5N2E1MTcwNzhmMDcwM2Q5XzUtNS0xLTEtMA_2bc53c50-202b-4f00-9beb-ccf18b4af9d5"
      unitRef="usd">145534000000</us-gaap:Revenues>
    <us-gaap:ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock
      contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTQvZnJhZzo3OWNmN2IxZmM4OTI0ODhkYjBjZTZhNDYxZmMyNjIzNC90ZXh0cmVnaW9uOjc5Y2Y3YjFmYzg5MjQ4OGRiMGNlNmE0NjFmYzI2MjM0XzYwMjE_3a868714-2f70-4023-bf5e-d8acf0321095">&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables present revenue for each reportable segment and disaggregated revenue within our two reportable segments and Corporate:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:46.791%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.004%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.004%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.469%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Pharmaceutical Distribution and Specialty Solutions (1) (2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;144,988&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;136,693&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;129,067&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Nuclear and Precision Health Solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;808&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;802&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;850&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Pharmaceutical segment revenue&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;145,796&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;137,495&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;129,917&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Medical distribution and products (3)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;14,485&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;13,429&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;13,833&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Cardinal Health at-Home Solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2,202&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,015&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,800&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Medical segment revenue&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;16,687&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;15,444&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;15,633&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&#160;Total segment revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;162,483&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;152,939&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;145,550&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Corporate (4)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(16)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(17)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(16)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;162,467&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;152,922&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;145,534&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:10pt"&gt;Products and services offered by our Specialty Solutions division are referred to as &#x201c;specialty pharmaceutical products and services"&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:10pt"&gt;Comprised of all Pharmaceutical segment businesses except for Nuclear and Precision Health Solutions division.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:10pt"&gt;Comprised of all Medical segment businesses except for Cardinal Health at-Home Solutions division&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(4)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:10pt"&gt;Corporate revenue consists of the elimination of inter-segment revenue and other revenue not allocated to the segments.&lt;/span&gt;&lt;/div&gt;</us-gaap:ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock>
    <us-gaap:DisaggregationOfRevenueTableTextBlock
      contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTQvZnJhZzo3OWNmN2IxZmM4OTI0ODhkYjBjZTZhNDYxZmMyNjIzNC90ZXh0cmVnaW9uOjc5Y2Y3YjFmYzg5MjQ4OGRiMGNlNmE0NjFmYzI2MjM0XzU5OTk_f90cfdfd-95f5-496f-8412-4f61ebe4b50d">&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:46.791%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.004%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.004%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.469%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Pharmaceutical Distribution and Specialty Solutions (1) (2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;144,988&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;136,693&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;129,067&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Nuclear and Precision Health Solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;808&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;802&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;850&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Pharmaceutical segment revenue&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;145,796&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;137,495&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;129,917&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Medical distribution and products (3)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;14,485&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;13,429&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;13,833&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Cardinal Health at-Home Solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2,202&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,015&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,800&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Medical segment revenue&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;16,687&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;15,444&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;15,633&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&#160;Total segment revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;162,483&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;152,939&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;145,550&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Corporate (4)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(16)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(17)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(16)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;162,467&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;152,922&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;145,534&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:10pt"&gt;Products and services offered by our Specialty Solutions division are referred to as &#x201c;specialty pharmaceutical products and services"&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:10pt"&gt;Comprised of all Pharmaceutical segment businesses except for Nuclear and Precision Health Solutions division.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:10pt"&gt;Comprised of all Medical segment businesses except for Cardinal Health at-Home Solutions division&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(4)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:10pt"&gt;Corporate revenue consists of the elimination of inter-segment revenue and other revenue not allocated to the segments.&lt;/span&gt;&lt;/div&gt;</us-gaap:DisaggregationOfRevenueTableTextBlock>
    <us-gaap:Revenues
      contextRef="i155c6a70937b40b68b1699cc88ad54f0_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTQvZnJhZzo3OWNmN2IxZmM4OTI0ODhkYjBjZTZhNDYxZmMyNjIzNC90YWJsZTpmZGYzNWU3MjZhMjk0YzllOGFiNGU3YTY2ZWI0ZDkxZC90YWJsZXJhbmdlOmZkZjM1ZTcyNmEyOTRjOWU4YWI0ZTdhNjZlYjRkOTFkXzEtMS0xLTEtMA_0101509f-cdc1-4f5e-bf51-47ef86a9a08c"
      unitRef="usd">144988000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i76773aa4b180454e80d866fd2a2396b6_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTQvZnJhZzo3OWNmN2IxZmM4OTI0ODhkYjBjZTZhNDYxZmMyNjIzNC90YWJsZTpmZGYzNWU3MjZhMjk0YzllOGFiNGU3YTY2ZWI0ZDkxZC90YWJsZXJhbmdlOmZkZjM1ZTcyNmEyOTRjOWU4YWI0ZTdhNjZlYjRkOTFkXzEtMi0xLTEtMA_fe59fc25-20b2-423b-a1c5-d7695583dbf4"
      unitRef="usd">136693000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ic18e242a8d2744198de6fca3c9aaccdd_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTQvZnJhZzo3OWNmN2IxZmM4OTI0ODhkYjBjZTZhNDYxZmMyNjIzNC90YWJsZTpmZGYzNWU3MjZhMjk0YzllOGFiNGU3YTY2ZWI0ZDkxZC90YWJsZXJhbmdlOmZkZjM1ZTcyNmEyOTRjOWU4YWI0ZTdhNjZlYjRkOTFkXzEtMy0xLTEtNTIxMQ_331e8959-c5dd-4960-a4dc-7230f2a88023"
      unitRef="usd">129067000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i5aa6abf0d0ff4864be49a2c272e9ae17_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTQvZnJhZzo3OWNmN2IxZmM4OTI0ODhkYjBjZTZhNDYxZmMyNjIzNC90YWJsZTpmZGYzNWU3MjZhMjk0YzllOGFiNGU3YTY2ZWI0ZDkxZC90YWJsZXJhbmdlOmZkZjM1ZTcyNmEyOTRjOWU4YWI0ZTdhNjZlYjRkOTFkXzItMS0xLTEtMA_0dc0ffce-ce58-4e60-8e73-90b4834110b9"
      unitRef="usd">808000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i86db5a9e2c2b4d719e8263c1bfc96ca5_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTQvZnJhZzo3OWNmN2IxZmM4OTI0ODhkYjBjZTZhNDYxZmMyNjIzNC90YWJsZTpmZGYzNWU3MjZhMjk0YzllOGFiNGU3YTY2ZWI0ZDkxZC90YWJsZXJhbmdlOmZkZjM1ZTcyNmEyOTRjOWU4YWI0ZTdhNjZlYjRkOTFkXzItMi0xLTEtMA_f297f67e-4726-4f7b-a19c-aa49b7781c76"
      unitRef="usd">802000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="iaa4c204e977543369238d8e99ef5f86e_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTQvZnJhZzo3OWNmN2IxZmM4OTI0ODhkYjBjZTZhNDYxZmMyNjIzNC90YWJsZTpmZGYzNWU3MjZhMjk0YzllOGFiNGU3YTY2ZWI0ZDkxZC90YWJsZXJhbmdlOmZkZjM1ZTcyNmEyOTRjOWU4YWI0ZTdhNjZlYjRkOTFkXzItMy0xLTEtNTIxNQ_96f58353-74e5-44f8-867b-b766089d4720"
      unitRef="usd">850000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i76b6a114dfd6424fb4c07d91075a91ff_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTQvZnJhZzo3OWNmN2IxZmM4OTI0ODhkYjBjZTZhNDYxZmMyNjIzNC90YWJsZTpmZGYzNWU3MjZhMjk0YzllOGFiNGU3YTY2ZWI0ZDkxZC90YWJsZXJhbmdlOmZkZjM1ZTcyNmEyOTRjOWU4YWI0ZTdhNjZlYjRkOTFkXzMtMS0xLTEtMA_da101699-fd8b-426a-bff7-82e5597e6faa"
      unitRef="usd">145796000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i78632f0315fd45fb85ed1c2272933a36_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTQvZnJhZzo3OWNmN2IxZmM4OTI0ODhkYjBjZTZhNDYxZmMyNjIzNC90YWJsZTpmZGYzNWU3MjZhMjk0YzllOGFiNGU3YTY2ZWI0ZDkxZC90YWJsZXJhbmdlOmZkZjM1ZTcyNmEyOTRjOWU4YWI0ZTdhNjZlYjRkOTFkXzMtMi0xLTEtMA_df95e01a-ab1e-42a8-92bf-653585f20247"
      unitRef="usd">137495000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i6d7435bb60af47f4a69d23c973a60d43_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTQvZnJhZzo3OWNmN2IxZmM4OTI0ODhkYjBjZTZhNDYxZmMyNjIzNC90YWJsZTpmZGYzNWU3MjZhMjk0YzllOGFiNGU3YTY2ZWI0ZDkxZC90YWJsZXJhbmdlOmZkZjM1ZTcyNmEyOTRjOWU4YWI0ZTdhNjZlYjRkOTFkXzMtMy0xLTEtNTIxOQ_4ed76c01-d25e-4bef-ba40-e7140e526880"
      unitRef="usd">129917000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i00d597531405494bb66494a39ed9a378_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTQvZnJhZzo3OWNmN2IxZmM4OTI0ODhkYjBjZTZhNDYxZmMyNjIzNC90YWJsZTpmZGYzNWU3MjZhMjk0YzllOGFiNGU3YTY2ZWI0ZDkxZC90YWJsZXJhbmdlOmZkZjM1ZTcyNmEyOTRjOWU4YWI0ZTdhNjZlYjRkOTFkXzQtMS0xLTEtMA_b9d70dab-961a-4b19-a0c9-6957772ef01e"
      unitRef="usd">14485000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="icf4b31c19dc549a1883307cdf7dbe88c_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTQvZnJhZzo3OWNmN2IxZmM4OTI0ODhkYjBjZTZhNDYxZmMyNjIzNC90YWJsZTpmZGYzNWU3MjZhMjk0YzllOGFiNGU3YTY2ZWI0ZDkxZC90YWJsZXJhbmdlOmZkZjM1ZTcyNmEyOTRjOWU4YWI0ZTdhNjZlYjRkOTFkXzQtMi0xLTEtMA_9deb09ca-ef89-4394-a62e-c40423ccebd5"
      unitRef="usd">13429000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i321e2ade5757483681291e8d89208466_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTQvZnJhZzo3OWNmN2IxZmM4OTI0ODhkYjBjZTZhNDYxZmMyNjIzNC90YWJsZTpmZGYzNWU3MjZhMjk0YzllOGFiNGU3YTY2ZWI0ZDkxZC90YWJsZXJhbmdlOmZkZjM1ZTcyNmEyOTRjOWU4YWI0ZTdhNjZlYjRkOTFkXzQtMy0xLTEtNTIyMg_f58beaba-6927-4a32-bbf0-96b580409e6e"
      unitRef="usd">13833000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i2f0de7fef24f4d40bd4de0a2976f37d8_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTQvZnJhZzo3OWNmN2IxZmM4OTI0ODhkYjBjZTZhNDYxZmMyNjIzNC90YWJsZTpmZGYzNWU3MjZhMjk0YzllOGFiNGU3YTY2ZWI0ZDkxZC90YWJsZXJhbmdlOmZkZjM1ZTcyNmEyOTRjOWU4YWI0ZTdhNjZlYjRkOTFkXzUtMS0xLTEtMA_bdc9be64-1380-4d16-ad52-4c2f1cde9de1"
      unitRef="usd">2202000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ieaa341ac8f284f1582d38baefdc71c05_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTQvZnJhZzo3OWNmN2IxZmM4OTI0ODhkYjBjZTZhNDYxZmMyNjIzNC90YWJsZTpmZGYzNWU3MjZhMjk0YzllOGFiNGU3YTY2ZWI0ZDkxZC90YWJsZXJhbmdlOmZkZjM1ZTcyNmEyOTRjOWU4YWI0ZTdhNjZlYjRkOTFkXzUtMi0xLTEtMA_3229137f-3f40-40c7-91af-3dee9420ae75"
      unitRef="usd">2015000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i5c109faf3fc4429686c141f4abd59a0c_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTQvZnJhZzo3OWNmN2IxZmM4OTI0ODhkYjBjZTZhNDYxZmMyNjIzNC90YWJsZTpmZGYzNWU3MjZhMjk0YzllOGFiNGU3YTY2ZWI0ZDkxZC90YWJsZXJhbmdlOmZkZjM1ZTcyNmEyOTRjOWU4YWI0ZTdhNjZlYjRkOTFkXzUtMy0xLTEtNTIyNg_c6a275b2-882b-4b0e-af1e-4fa18b3e1bbe"
      unitRef="usd">1800000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="id8c82c11050f452c9befaa43705026a6_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTQvZnJhZzo3OWNmN2IxZmM4OTI0ODhkYjBjZTZhNDYxZmMyNjIzNC90YWJsZTpmZGYzNWU3MjZhMjk0YzllOGFiNGU3YTY2ZWI0ZDkxZC90YWJsZXJhbmdlOmZkZjM1ZTcyNmEyOTRjOWU4YWI0ZTdhNjZlYjRkOTFkXzYtMS0xLTEtMA_801f9b18-3be1-4c0f-aac3-e8e91cd89a36"
      unitRef="usd">16687000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i1faf47ea4d994e879fd1c1bf2cc15983_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTQvZnJhZzo3OWNmN2IxZmM4OTI0ODhkYjBjZTZhNDYxZmMyNjIzNC90YWJsZTpmZGYzNWU3MjZhMjk0YzllOGFiNGU3YTY2ZWI0ZDkxZC90YWJsZXJhbmdlOmZkZjM1ZTcyNmEyOTRjOWU4YWI0ZTdhNjZlYjRkOTFkXzYtMi0xLTEtMA_37a08ebe-7653-480e-b7dc-4663eeaf9074"
      unitRef="usd">15444000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i4dcc4f5896f24eb98e3473b71e1d10b7_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTQvZnJhZzo3OWNmN2IxZmM4OTI0ODhkYjBjZTZhNDYxZmMyNjIzNC90YWJsZTpmZGYzNWU3MjZhMjk0YzllOGFiNGU3YTY2ZWI0ZDkxZC90YWJsZXJhbmdlOmZkZjM1ZTcyNmEyOTRjOWU4YWI0ZTdhNjZlYjRkOTFkXzYtMy0xLTEtNTIzMA_ce1af9fd-d5f3-4b1f-8f93-15d3905879f1"
      unitRef="usd">15633000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ie5f1ec6cee11430ab0571ee6201cd0f7_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTQvZnJhZzo3OWNmN2IxZmM4OTI0ODhkYjBjZTZhNDYxZmMyNjIzNC90YWJsZTpmZGYzNWU3MjZhMjk0YzllOGFiNGU3YTY2ZWI0ZDkxZC90YWJsZXJhbmdlOmZkZjM1ZTcyNmEyOTRjOWU4YWI0ZTdhNjZlYjRkOTFkXzctMS0xLTEtMA_90ed073f-559b-49f4-9223-6278957c6088"
      unitRef="usd">162483000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i7a96c8334d2e46928c83a274df8be377_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTQvZnJhZzo3OWNmN2IxZmM4OTI0ODhkYjBjZTZhNDYxZmMyNjIzNC90YWJsZTpmZGYzNWU3MjZhMjk0YzllOGFiNGU3YTY2ZWI0ZDkxZC90YWJsZXJhbmdlOmZkZjM1ZTcyNmEyOTRjOWU4YWI0ZTdhNjZlYjRkOTFkXzctMi0xLTEtMA_06bce748-9e45-4e78-bf2e-119935ac02a7"
      unitRef="usd">152939000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i3ab52d1ad77045aa97d1dbfb8cb6186e_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTQvZnJhZzo3OWNmN2IxZmM4OTI0ODhkYjBjZTZhNDYxZmMyNjIzNC90YWJsZTpmZGYzNWU3MjZhMjk0YzllOGFiNGU3YTY2ZWI0ZDkxZC90YWJsZXJhbmdlOmZkZjM1ZTcyNmEyOTRjOWU4YWI0ZTdhNjZlYjRkOTFkXzctMy0xLTEtNTIzMw_3c6993ad-dbd3-4758-be7e-22ec9b83d585"
      unitRef="usd">145550000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i792ece330cb74d35afecabca6b7f49ea_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTQvZnJhZzo3OWNmN2IxZmM4OTI0ODhkYjBjZTZhNDYxZmMyNjIzNC90YWJsZTpmZGYzNWU3MjZhMjk0YzllOGFiNGU3YTY2ZWI0ZDkxZC90YWJsZXJhbmdlOmZkZjM1ZTcyNmEyOTRjOWU4YWI0ZTdhNjZlYjRkOTFkXzgtMS0xLTEtMA_9e76f224-ff2d-4a8c-b583-7e2d68faf978"
      unitRef="usd">-16000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i16818ee6ea724c8691b1f0065031735b_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTQvZnJhZzo3OWNmN2IxZmM4OTI0ODhkYjBjZTZhNDYxZmMyNjIzNC90YWJsZTpmZGYzNWU3MjZhMjk0YzllOGFiNGU3YTY2ZWI0ZDkxZC90YWJsZXJhbmdlOmZkZjM1ZTcyNmEyOTRjOWU4YWI0ZTdhNjZlYjRkOTFkXzgtMi0xLTEtMA_b8abbb9c-7906-4872-ac85-d5b62459b468"
      unitRef="usd">-17000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ic5128c57d92d4336ae115d6ba4e979cb_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTQvZnJhZzo3OWNmN2IxZmM4OTI0ODhkYjBjZTZhNDYxZmMyNjIzNC90YWJsZTpmZGYzNWU3MjZhMjk0YzllOGFiNGU3YTY2ZWI0ZDkxZC90YWJsZXJhbmdlOmZkZjM1ZTcyNmEyOTRjOWU4YWI0ZTdhNjZlYjRkOTFkXzgtMy0xLTEtNTIzNg_d2aaa116-bd3e-4eb8-a9f5-ea17607e2712"
      unitRef="usd">-16000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTQvZnJhZzo3OWNmN2IxZmM4OTI0ODhkYjBjZTZhNDYxZmMyNjIzNC90YWJsZTpmZGYzNWU3MjZhMjk0YzllOGFiNGU3YTY2ZWI0ZDkxZC90YWJsZXJhbmdlOmZkZjM1ZTcyNmEyOTRjOWU4YWI0ZTdhNjZlYjRkOTFkXzktMS0xLTEtMA_4a77e242-386e-4d53-961f-128155e243f5"
      unitRef="usd">162467000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ia31e9a409b874bb19d0ff6f2f39ecc09_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTQvZnJhZzo3OWNmN2IxZmM4OTI0ODhkYjBjZTZhNDYxZmMyNjIzNC90YWJsZTpmZGYzNWU3MjZhMjk0YzllOGFiNGU3YTY2ZWI0ZDkxZC90YWJsZXJhbmdlOmZkZjM1ZTcyNmEyOTRjOWU4YWI0ZTdhNjZlYjRkOTFkXzktMi0xLTEtMA_96ceb081-e684-426a-ad23-e690088f8ad1"
      unitRef="usd">152922000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i00a6d666bf604826b24e68ddbd63eac4_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTQvZnJhZzo3OWNmN2IxZmM4OTI0ODhkYjBjZTZhNDYxZmMyNjIzNC90YWJsZTpmZGYzNWU3MjZhMjk0YzllOGFiNGU3YTY2ZWI0ZDkxZC90YWJsZXJhbmdlOmZkZjM1ZTcyNmEyOTRjOWU4YWI0ZTdhNjZlYjRkOTFkXzktMy0xLTEtNTIzOQ_2bc53c50-202b-4f00-9beb-ccf18b4af9d5"
      unitRef="usd">145534000000</us-gaap:Revenues>
    <us-gaap:RevenueFromExternalCustomersByGeographicAreasTableTextBlock
      contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTQvZnJhZzo3OWNmN2IxZmM4OTI0ODhkYjBjZTZhNDYxZmMyNjIzNC90ZXh0cmVnaW9uOjc5Y2Y3YjFmYzg5MjQ4OGRiMGNlNmE0NjFmYzI2MjM0XzYwMjU_de3d1881-f4fb-44a5-8220-d4d51cc85849">&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents revenue by geographic area:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:42.109%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.183%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.269%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.183%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.269%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.187%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;157,756&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;148,707&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;141,479&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;4,727&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;4,232&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;4,071&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total segment revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;162,483&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;152,939&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;145,550&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Corporate (1)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(16)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(17)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(16)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;162,467&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;152,922&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;145,534&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:10pt"&gt;Corporate revenue consists of the elimination of inter-segment revenue and other revenue not allocated to the segments.&lt;/span&gt;&lt;/div&gt;</us-gaap:RevenueFromExternalCustomersByGeographicAreasTableTextBlock>
    <us-gaap:Revenues
      contextRef="id0012edd1a484009af89832a87b38690_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTQvZnJhZzo3OWNmN2IxZmM4OTI0ODhkYjBjZTZhNDYxZmMyNjIzNC90YWJsZTo1MjJhMmQ1OWRmZjU0ODI3OTU5NzNkNTdlYzE3ZjM3My90YWJsZXJhbmdlOjUyMmEyZDU5ZGZmNTQ4Mjc5NTk3M2Q1N2VjMTdmMzczXzEtMS0xLTEtMA_dd1fb910-4b73-42c0-8889-2c16023477fe"
      unitRef="usd">157756000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i634f4d42b1cb4e6cb3a43cc4bc98832d_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTQvZnJhZzo3OWNmN2IxZmM4OTI0ODhkYjBjZTZhNDYxZmMyNjIzNC90YWJsZTo1MjJhMmQ1OWRmZjU0ODI3OTU5NzNkNTdlYzE3ZjM3My90YWJsZXJhbmdlOjUyMmEyZDU5ZGZmNTQ4Mjc5NTk3M2Q1N2VjMTdmMzczXzEtMy0xLTEtMA_b1e7e725-ef05-408c-abda-235d27501265"
      unitRef="usd">148707000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i78774426f41940febec7d66ff52bb8d1_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTQvZnJhZzo3OWNmN2IxZmM4OTI0ODhkYjBjZTZhNDYxZmMyNjIzNC90YWJsZTo1MjJhMmQ1OWRmZjU0ODI3OTU5NzNkNTdlYzE3ZjM3My90YWJsZXJhbmdlOjUyMmEyZDU5ZGZmNTQ4Mjc5NTk3M2Q1N2VjMTdmMzczXzEtNS0xLTEtMA_e4a9e942-1a4a-4014-8058-8d563a5ed13f"
      unitRef="usd">141479000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i3d4fc04fd3ba4fe9b28a1f419dbc6b15_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTQvZnJhZzo3OWNmN2IxZmM4OTI0ODhkYjBjZTZhNDYxZmMyNjIzNC90YWJsZTo1MjJhMmQ1OWRmZjU0ODI3OTU5NzNkNTdlYzE3ZjM3My90YWJsZXJhbmdlOjUyMmEyZDU5ZGZmNTQ4Mjc5NTk3M2Q1N2VjMTdmMzczXzItMS0xLTEtMA_101ed0ec-a4f6-444c-aab5-b12d93024a01"
      unitRef="usd">4727000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i780324fcbcb345e29107285be707bc45_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTQvZnJhZzo3OWNmN2IxZmM4OTI0ODhkYjBjZTZhNDYxZmMyNjIzNC90YWJsZTo1MjJhMmQ1OWRmZjU0ODI3OTU5NzNkNTdlYzE3ZjM3My90YWJsZXJhbmdlOjUyMmEyZDU5ZGZmNTQ4Mjc5NTk3M2Q1N2VjMTdmMzczXzItMy0xLTEtMA_63bc4dc0-711f-430c-a806-381686dbb873"
      unitRef="usd">4232000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="if26a26c7dce04a669d805364e23fcbb7_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTQvZnJhZzo3OWNmN2IxZmM4OTI0ODhkYjBjZTZhNDYxZmMyNjIzNC90YWJsZTo1MjJhMmQ1OWRmZjU0ODI3OTU5NzNkNTdlYzE3ZjM3My90YWJsZXJhbmdlOjUyMmEyZDU5ZGZmNTQ4Mjc5NTk3M2Q1N2VjMTdmMzczXzItNS0xLTEtMA_8f96bb09-8ff4-492e-92a9-13a8bdedcaeb"
      unitRef="usd">4071000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ie5f1ec6cee11430ab0571ee6201cd0f7_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTQvZnJhZzo3OWNmN2IxZmM4OTI0ODhkYjBjZTZhNDYxZmMyNjIzNC90YWJsZTo1MjJhMmQ1OWRmZjU0ODI3OTU5NzNkNTdlYzE3ZjM3My90YWJsZXJhbmdlOjUyMmEyZDU5ZGZmNTQ4Mjc5NTk3M2Q1N2VjMTdmMzczXzMtMS0xLTEtMA_9c5609cb-7d09-46b9-899a-c2d69e3dcbc0"
      unitRef="usd">162483000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i7a96c8334d2e46928c83a274df8be377_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTQvZnJhZzo3OWNmN2IxZmM4OTI0ODhkYjBjZTZhNDYxZmMyNjIzNC90YWJsZTo1MjJhMmQ1OWRmZjU0ODI3OTU5NzNkNTdlYzE3ZjM3My90YWJsZXJhbmdlOjUyMmEyZDU5ZGZmNTQ4Mjc5NTk3M2Q1N2VjMTdmMzczXzMtMy0xLTEtMA_66fd9ba1-546c-4b6a-9604-136229092fd2"
      unitRef="usd">152939000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i3ab52d1ad77045aa97d1dbfb8cb6186e_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTQvZnJhZzo3OWNmN2IxZmM4OTI0ODhkYjBjZTZhNDYxZmMyNjIzNC90YWJsZTo1MjJhMmQ1OWRmZjU0ODI3OTU5NzNkNTdlYzE3ZjM3My90YWJsZXJhbmdlOjUyMmEyZDU5ZGZmNTQ4Mjc5NTk3M2Q1N2VjMTdmMzczXzMtNS0xLTEtMA_b501e6d9-105b-4ef4-9c87-7a6f142157b5"
      unitRef="usd">145550000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i792ece330cb74d35afecabca6b7f49ea_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTQvZnJhZzo3OWNmN2IxZmM4OTI0ODhkYjBjZTZhNDYxZmMyNjIzNC90YWJsZTo1MjJhMmQ1OWRmZjU0ODI3OTU5NzNkNTdlYzE3ZjM3My90YWJsZXJhbmdlOjUyMmEyZDU5ZGZmNTQ4Mjc5NTk3M2Q1N2VjMTdmMzczXzQtMS0xLTEtMA_30162340-322b-4d3f-b28c-2c785eb46a1e"
      unitRef="usd">-16000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i16818ee6ea724c8691b1f0065031735b_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTQvZnJhZzo3OWNmN2IxZmM4OTI0ODhkYjBjZTZhNDYxZmMyNjIzNC90YWJsZTo1MjJhMmQ1OWRmZjU0ODI3OTU5NzNkNTdlYzE3ZjM3My90YWJsZXJhbmdlOjUyMmEyZDU5ZGZmNTQ4Mjc5NTk3M2Q1N2VjMTdmMzczXzQtMy0xLTEtMA_1bfb6f86-e959-42a7-9aab-5c5ea3c53fbb"
      unitRef="usd">-17000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ic5128c57d92d4336ae115d6ba4e979cb_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTQvZnJhZzo3OWNmN2IxZmM4OTI0ODhkYjBjZTZhNDYxZmMyNjIzNC90YWJsZTo1MjJhMmQ1OWRmZjU0ODI3OTU5NzNkNTdlYzE3ZjM3My90YWJsZXJhbmdlOjUyMmEyZDU5ZGZmNTQ4Mjc5NTk3M2Q1N2VjMTdmMzczXzQtNS0xLTEtMA_98159bb7-3c8c-4f40-afbb-cc5e1efe9423"
      unitRef="usd">-16000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTQvZnJhZzo3OWNmN2IxZmM4OTI0ODhkYjBjZTZhNDYxZmMyNjIzNC90YWJsZTo1MjJhMmQ1OWRmZjU0ODI3OTU5NzNkNTdlYzE3ZjM3My90YWJsZXJhbmdlOjUyMmEyZDU5ZGZmNTQ4Mjc5NTk3M2Q1N2VjMTdmMzczXzUtMS0xLTEtMA_58987dee-0750-4b3b-8a00-c6657c19d0bf"
      unitRef="usd">162467000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ia31e9a409b874bb19d0ff6f2f39ecc09_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTQvZnJhZzo3OWNmN2IxZmM4OTI0ODhkYjBjZTZhNDYxZmMyNjIzNC90YWJsZTo1MjJhMmQ1OWRmZjU0ODI3OTU5NzNkNTdlYzE3ZjM3My90YWJsZXJhbmdlOjUyMmEyZDU5ZGZmNTQ4Mjc5NTk3M2Q1N2VjMTdmMzczXzUtMy0xLTEtMA_96b48f98-c46c-4e22-a61e-02f4a4538c90"
      unitRef="usd">152922000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i00a6d666bf604826b24e68ddbd63eac4_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTQvZnJhZzo3OWNmN2IxZmM4OTI0ODhkYjBjZTZhNDYxZmMyNjIzNC90YWJsZTo1MjJhMmQ1OWRmZjU0ODI3OTU5NzNkNTdlYzE3ZjM3My90YWJsZXJhbmdlOjUyMmEyZDU5ZGZmNTQ4Mjc5NTk3M2Q1N2VjMTdmMzczXzUtNS0xLTEtMA_e05b2622-d468-45f0-a074-0527aa14c08b"
      unitRef="usd">145534000000</us-gaap:Revenues>
    <us-gaap:InventoryRecallExpense
      contextRef="ic436b3ed22eb4cdcb413eaef19ec4ca5_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTQvZnJhZzo3OWNmN2IxZmM4OTI0ODhkYjBjZTZhNDYxZmMyNjIzNC90ZXh0cmVnaW9uOjc5Y2Y3YjFmYzg5MjQ4OGRiMGNlNmE0NjFmYzI2MjM0XzEyMDk0NjI3OTE2MDcz_8b2538f0-11bf-42ad-a1f0-ed657bc12965"
      unitRef="usd">85000000</us-gaap:InventoryRecallExpense>
    <cah:WriteDownOfAssetsHeldForSale
      contextRef="i2ae0fa0d058b4f21aac5c8701cbd2fb7_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTQvZnJhZzo3OWNmN2IxZmM4OTI0ODhkYjBjZTZhNDYxZmMyNjIzNC90ZXh0cmVnaW9uOjc5Y2Y3YjFmYzg5MjQ4OGRiMGNlNmE0NjFmYzI2MjM0XzEyMDk0NjI3OTE0NzM1_a39c35cc-26f6-469f-be2c-86c121fa736b"
      unitRef="usd">-60000000</cah:WriteDownOfAssetsHeldForSale>
    <cah:PreTaxGainonDivestiture
      contextRef="i00a6d666bf604826b24e68ddbd63eac4_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTQvZnJhZzo3OWNmN2IxZmM4OTI0ODhkYjBjZTZhNDYxZmMyNjIzNC90ZXh0cmVnaW9uOjc5Y2Y3YjFmYzg5MjQ4OGRiMGNlNmE0NjFmYzI2MjM0XzEyMDk0NjI3OTE2NDc5_e1ed3fce-d0e9-4227-ae77-b20abda7b42f"
      unitRef="usd">508000000</cah:PreTaxGainonDivestiture>
    <us-gaap:GainLossRelatedToLitigationSettlement
      contextRef="id2a6b6641ae248c98d689f30c606f881_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTQvZnJhZzo3OWNmN2IxZmM4OTI0ODhkYjBjZTZhNDYxZmMyNjIzNC90ZXh0cmVnaW9uOjc5Y2Y3YjFmYzg5MjQ4OGRiMGNlNmE0NjFmYzI2MjM0XzEyMDk0NjI3OTE1MTM2_fa04a4d2-d99c-4c13-92d5-b636406cf116"
      unitRef="usd">1170000000</us-gaap:GainLossRelatedToLitigationSettlement>
    <us-gaap:GainLossRelatedToLitigationSettlement
      contextRef="i373ba6a0cdc044dea9602bdbad13174c_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTQvZnJhZzo3OWNmN2IxZmM4OTI0ODhkYjBjZTZhNDYxZmMyNjIzNC90ZXh0cmVnaW9uOjc5Y2Y3YjFmYzg5MjQ4OGRiMGNlNmE0NjFmYzI2MjM0XzEyMDk0NjI3OTE1MTQ1_1a313f61-c937-4037-8038-233b7a976d14"
      unitRef="usd">5630000000</us-gaap:GainLossRelatedToLitigationSettlement>
    <cah:EstimatedLiabilityForNewYorkOpioidStewardshipAct
      contextRef="i457f80b8744948758645272a98e06c10_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTQvZnJhZzo3OWNmN2IxZmM4OTI0ODhkYjBjZTZhNDYxZmMyNjIzNC90ZXh0cmVnaW9uOjc5Y2Y3YjFmYzg5MjQ4OGRiMGNlNmE0NjFmYzI2MjM0XzEyMDk0NjI3OTE1NTQx_bdd45fc0-f43f-4ecc-ab36-9831321fbbc8"
      unitRef="usd">41000000</cah:EstimatedLiabilityForNewYorkOpioidStewardshipAct>
    <us-gaap:GainOnSaleOfInvestments
      contextRef="if5b3bab2d32340dea26c681d53110711_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTQvZnJhZzo3OWNmN2IxZmM4OTI0ODhkYjBjZTZhNDYxZmMyNjIzNC90ZXh0cmVnaW9uOjc5Y2Y3YjFmYzg5MjQ4OGRiMGNlNmE0NjFmYzI2MjM0XzEyMDk0NjI3OTE2ODI4_13e3d38e-6296-40e2-81da-9180e950e86f"
      unitRef="usd">579000000</us-gaap:GainOnSaleOfInvestments>
    <cah:GainonDivestitureAfterTax
      contextRef="if5b3bab2d32340dea26c681d53110711_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTQvZnJhZzo3OWNmN2IxZmM4OTI0ODhkYjBjZTZhNDYxZmMyNjIzNC90ZXh0cmVnaW9uOjc5Y2Y3YjFmYzg5MjQ4OGRiMGNlNmE0NjFmYzI2MjM0XzEyMDk0NjI3OTE2ODQ2_c27bde83-c24a-4937-b09f-458ad707e5e8"
      unitRef="usd">493000000</cah:GainonDivestitureAfterTax>
    <cah:ProjectCostsOnInvestmentAndOtherSpending
      contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTQvZnJhZzo3OWNmN2IxZmM4OTI0ODhkYjBjZTZhNDYxZmMyNjIzNC90ZXh0cmVnaW9uOjc5Y2Y3YjFmYzg5MjQ4OGRiMGNlNmE0NjFmYzI2MjM0XzQ2ODg_b5419a98-6728-41a5-9da8-17197d5e41b4"
      unitRef="usd">27000000</cah:ProjectCostsOnInvestmentAndOtherSpending>
    <cah:ProjectCostsOnInvestmentAndOtherSpending
      contextRef="ia31e9a409b874bb19d0ff6f2f39ecc09_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTQvZnJhZzo3OWNmN2IxZmM4OTI0ODhkYjBjZTZhNDYxZmMyNjIzNC90ZXh0cmVnaW9uOjc5Y2Y3YjFmYzg5MjQ4OGRiMGNlNmE0NjFmYzI2MjM0XzQ2OTI_a615bd56-d3d9-4a8b-b24d-ea6aed1bd3b8"
      unitRef="usd">69000000</cah:ProjectCostsOnInvestmentAndOtherSpending>
    <cah:ProjectCostsOnInvestmentAndOtherSpending
      contextRef="i00a6d666bf604826b24e68ddbd63eac4_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTQvZnJhZzo3OWNmN2IxZmM4OTI0ODhkYjBjZTZhNDYxZmMyNjIzNC90ZXh0cmVnaW9uOjc5Y2Y3YjFmYzg5MjQ4OGRiMGNlNmE0NjFmYzI2MjM0XzQ2OTk_d9e0e203-72d0-4df2-b082-b90f5c976daa"
      unitRef="usd">55000000</cah:ProjectCostsOnInvestmentAndOtherSpending>
    <us-gaap:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock
      contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTQvZnJhZzo3OWNmN2IxZmM4OTI0ODhkYjBjZTZhNDYxZmMyNjIzNC90ZXh0cmVnaW9uOjc5Y2Y3YjFmYzg5MjQ4OGRiMGNlNmE0NjFmYzI2MjM0XzYwMjY_2a2ffd9c-baaa-4f1d-bee9-833f14281fa4">&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables present segment profit by reportable segment and Corporate:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.691%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:51.221%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.451%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.347%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.760%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.347%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.074%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Pharmaceutical&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;1,684&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,753&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,834&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Medical&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;577&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;663&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;576&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total segment profit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2,261&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,416&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,410&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Corporate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(1,789)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(6,514)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(350)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total operating earnings&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;472&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(4,098)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,060&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock>
    <us-gaap:OperatingIncomeLoss
      contextRef="i76b6a114dfd6424fb4c07d91075a91ff_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTQvZnJhZzo3OWNmN2IxZmM4OTI0ODhkYjBjZTZhNDYxZmMyNjIzNC90YWJsZTo4Yzg1NWU1ZThkNzM0NjAyODY3NmYyMDQ5MDhmMmE2MS90YWJsZXJhbmdlOjhjODU1ZTVlOGQ3MzQ2MDI4Njc2ZjIwNDkwOGYyYTYxXzEtMS0xLTEtMA_3fdfaea3-0ed7-4a59-b23c-6f7c5c06f7cd"
      unitRef="usd">1684000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i78632f0315fd45fb85ed1c2272933a36_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTQvZnJhZzo3OWNmN2IxZmM4OTI0ODhkYjBjZTZhNDYxZmMyNjIzNC90YWJsZTo4Yzg1NWU1ZThkNzM0NjAyODY3NmYyMDQ5MDhmMmE2MS90YWJsZXJhbmdlOjhjODU1ZTVlOGQ3MzQ2MDI4Njc2ZjIwNDkwOGYyYTYxXzEtMy0xLTEtMA_485b958b-6552-4cc6-8bc4-4307bb692c54"
      unitRef="usd">1753000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i6d7435bb60af47f4a69d23c973a60d43_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTQvZnJhZzo3OWNmN2IxZmM4OTI0ODhkYjBjZTZhNDYxZmMyNjIzNC90YWJsZTo4Yzg1NWU1ZThkNzM0NjAyODY3NmYyMDQ5MDhmMmE2MS90YWJsZXJhbmdlOjhjODU1ZTVlOGQ3MzQ2MDI4Njc2ZjIwNDkwOGYyYTYxXzEtNS0xLTEtMA_86ee69cc-9d24-4b53-92b7-42ca0ba6d15f"
      unitRef="usd">1834000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="id8c82c11050f452c9befaa43705026a6_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTQvZnJhZzo3OWNmN2IxZmM4OTI0ODhkYjBjZTZhNDYxZmMyNjIzNC90YWJsZTo4Yzg1NWU1ZThkNzM0NjAyODY3NmYyMDQ5MDhmMmE2MS90YWJsZXJhbmdlOjhjODU1ZTVlOGQ3MzQ2MDI4Njc2ZjIwNDkwOGYyYTYxXzItMS0xLTEtMA_17c8fe16-a6d9-4b69-a5ae-e76ea38d5c55"
      unitRef="usd">577000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i1faf47ea4d994e879fd1c1bf2cc15983_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTQvZnJhZzo3OWNmN2IxZmM4OTI0ODhkYjBjZTZhNDYxZmMyNjIzNC90YWJsZTo4Yzg1NWU1ZThkNzM0NjAyODY3NmYyMDQ5MDhmMmE2MS90YWJsZXJhbmdlOjhjODU1ZTVlOGQ3MzQ2MDI4Njc2ZjIwNDkwOGYyYTYxXzItMy0xLTEtMA_5d592b6a-36eb-47b8-8690-fc806ce1c452"
      unitRef="usd">663000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i4dcc4f5896f24eb98e3473b71e1d10b7_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTQvZnJhZzo3OWNmN2IxZmM4OTI0ODhkYjBjZTZhNDYxZmMyNjIzNC90YWJsZTo4Yzg1NWU1ZThkNzM0NjAyODY3NmYyMDQ5MDhmMmE2MS90YWJsZXJhbmdlOjhjODU1ZTVlOGQ3MzQ2MDI4Njc2ZjIwNDkwOGYyYTYxXzItNS0xLTEtMA_afe49f3c-4b63-47ae-bff2-9edff9101a85"
      unitRef="usd">576000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="ie5f1ec6cee11430ab0571ee6201cd0f7_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTQvZnJhZzo3OWNmN2IxZmM4OTI0ODhkYjBjZTZhNDYxZmMyNjIzNC90YWJsZTo4Yzg1NWU1ZThkNzM0NjAyODY3NmYyMDQ5MDhmMmE2MS90YWJsZXJhbmdlOjhjODU1ZTVlOGQ3MzQ2MDI4Njc2ZjIwNDkwOGYyYTYxXzMtMS0xLTEtMA_d15fd05d-1fde-4a58-82ac-3827b5c6012a"
      unitRef="usd">2261000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i7a96c8334d2e46928c83a274df8be377_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTQvZnJhZzo3OWNmN2IxZmM4OTI0ODhkYjBjZTZhNDYxZmMyNjIzNC90YWJsZTo4Yzg1NWU1ZThkNzM0NjAyODY3NmYyMDQ5MDhmMmE2MS90YWJsZXJhbmdlOjhjODU1ZTVlOGQ3MzQ2MDI4Njc2ZjIwNDkwOGYyYTYxXzMtMy0xLTEtMA_bcd27fe4-d28d-4b7c-b965-53b127949fde"
      unitRef="usd">2416000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i3ab52d1ad77045aa97d1dbfb8cb6186e_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTQvZnJhZzo3OWNmN2IxZmM4OTI0ODhkYjBjZTZhNDYxZmMyNjIzNC90YWJsZTo4Yzg1NWU1ZThkNzM0NjAyODY3NmYyMDQ5MDhmMmE2MS90YWJsZXJhbmdlOjhjODU1ZTVlOGQ3MzQ2MDI4Njc2ZjIwNDkwOGYyYTYxXzMtNS0xLTEtMA_fce0ba17-945d-4685-90dc-898ffdfbdd74"
      unitRef="usd">2410000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i792ece330cb74d35afecabca6b7f49ea_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTQvZnJhZzo3OWNmN2IxZmM4OTI0ODhkYjBjZTZhNDYxZmMyNjIzNC90YWJsZTo4Yzg1NWU1ZThkNzM0NjAyODY3NmYyMDQ5MDhmMmE2MS90YWJsZXJhbmdlOjhjODU1ZTVlOGQ3MzQ2MDI4Njc2ZjIwNDkwOGYyYTYxXzQtMS0xLTEtMA_2e3bc6af-f979-4056-b9b4-df9e29de841c"
      unitRef="usd">-1789000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i16818ee6ea724c8691b1f0065031735b_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTQvZnJhZzo3OWNmN2IxZmM4OTI0ODhkYjBjZTZhNDYxZmMyNjIzNC90YWJsZTo4Yzg1NWU1ZThkNzM0NjAyODY3NmYyMDQ5MDhmMmE2MS90YWJsZXJhbmdlOjhjODU1ZTVlOGQ3MzQ2MDI4Njc2ZjIwNDkwOGYyYTYxXzQtMy0xLTEtMA_9d02ca00-19e3-445a-95ae-1bdb025c9d56"
      unitRef="usd">-6514000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="ic5128c57d92d4336ae115d6ba4e979cb_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTQvZnJhZzo3OWNmN2IxZmM4OTI0ODhkYjBjZTZhNDYxZmMyNjIzNC90YWJsZTo4Yzg1NWU1ZThkNzM0NjAyODY3NmYyMDQ5MDhmMmE2MS90YWJsZXJhbmdlOjhjODU1ZTVlOGQ3MzQ2MDI4Njc2ZjIwNDkwOGYyYTYxXzQtNS0xLTEtMA_7cb1a13e-7acc-42d7-8552-3fa0a924a8de"
      unitRef="usd">-350000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTQvZnJhZzo3OWNmN2IxZmM4OTI0ODhkYjBjZTZhNDYxZmMyNjIzNC90YWJsZTo4Yzg1NWU1ZThkNzM0NjAyODY3NmYyMDQ5MDhmMmE2MS90YWJsZXJhbmdlOjhjODU1ZTVlOGQ3MzQ2MDI4Njc2ZjIwNDkwOGYyYTYxXzUtMS0xLTEtMA_b88216f7-fc16-4820-af72-ff2ae667a4ec"
      unitRef="usd">472000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="ia31e9a409b874bb19d0ff6f2f39ecc09_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTQvZnJhZzo3OWNmN2IxZmM4OTI0ODhkYjBjZTZhNDYxZmMyNjIzNC90YWJsZTo4Yzg1NWU1ZThkNzM0NjAyODY3NmYyMDQ5MDhmMmE2MS90YWJsZXJhbmdlOjhjODU1ZTVlOGQ3MzQ2MDI4Njc2ZjIwNDkwOGYyYTYxXzUtMy0xLTEtMA_dc479f95-16da-4cf6-b359-c0093ecd890b"
      unitRef="usd">-4098000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i00a6d666bf604826b24e68ddbd63eac4_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTQvZnJhZzo3OWNmN2IxZmM4OTI0ODhkYjBjZTZhNDYxZmMyNjIzNC90YWJsZTo4Yzg1NWU1ZThkNzM0NjAyODY3NmYyMDQ5MDhmMmE2MS90YWJsZXJhbmdlOjhjODU1ZTVlOGQ3MzQ2MDI4Njc2ZjIwNDkwOGYyYTYxXzUtNS0xLTEtMA_eef02984-c29e-4200-8c56-1ceaf77e8c40"
      unitRef="usd">2060000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:ReconciliationOfOtherSignificantReconcilingItemsFromSegmentsToConsolidatedTextBlock
      contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTQvZnJhZzo3OWNmN2IxZmM4OTI0ODhkYjBjZTZhNDYxZmMyNjIzNC90ZXh0cmVnaW9uOjc5Y2Y3YjFmYzg5MjQ4OGRiMGNlNmE0NjFmYzI2MjM0XzYwMjM_3a385a29-7244-46b7-84f2-3dcc7d38c6d0">&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables present depreciation and amortization and additions to property and equipment by reportable segment and Corporate:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.691%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:47.506%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.999%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.347%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.999%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.347%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.002%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Pharmaceutical&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;151&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;135&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;147&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Medical&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;226&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;243&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;288&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Corporate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;406&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;535&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;565&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;783&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;913&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.691%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:47.506%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.999%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.347%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.999%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.347%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.002%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Pharmaceutical&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;55&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Medical&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;97&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;86&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;74&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Corporate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;248&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;242&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;219&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total additions to property and equipment&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;400&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;375&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;328&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ReconciliationOfOtherSignificantReconcilingItemsFromSegmentsToConsolidatedTextBlock>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i76b6a114dfd6424fb4c07d91075a91ff_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTQvZnJhZzo3OWNmN2IxZmM4OTI0ODhkYjBjZTZhNDYxZmMyNjIzNC90YWJsZTpkN2JhMmI3YjA2ZjA0OGU4YjY2ZDE5NzUwZDRiNWYzMC90YWJsZXJhbmdlOmQ3YmEyYjdiMDZmMDQ4ZThiNjZkMTk3NTBkNGI1ZjMwXzEtMS0xLTEtMA_3b796f63-e7f8-4de4-b6ef-c8386519e521"
      unitRef="usd">151000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i78632f0315fd45fb85ed1c2272933a36_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTQvZnJhZzo3OWNmN2IxZmM4OTI0ODhkYjBjZTZhNDYxZmMyNjIzNC90YWJsZTpkN2JhMmI3YjA2ZjA0OGU4YjY2ZDE5NzUwZDRiNWYzMC90YWJsZXJhbmdlOmQ3YmEyYjdiMDZmMDQ4ZThiNjZkMTk3NTBkNGI1ZjMwXzEtMy0xLTEtMA_ebd2ae2d-49d8-4266-9dd7-b7f57bb19fd0"
      unitRef="usd">135000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i6d7435bb60af47f4a69d23c973a60d43_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTQvZnJhZzo3OWNmN2IxZmM4OTI0ODhkYjBjZTZhNDYxZmMyNjIzNC90YWJsZTpkN2JhMmI3YjA2ZjA0OGU4YjY2ZDE5NzUwZDRiNWYzMC90YWJsZXJhbmdlOmQ3YmEyYjdiMDZmMDQ4ZThiNjZkMTk3NTBkNGI1ZjMwXzEtNS0xLTEtMA_ffc1ed07-7a68-41bc-bcab-1d3f8b343436"
      unitRef="usd">147000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="id8c82c11050f452c9befaa43705026a6_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTQvZnJhZzo3OWNmN2IxZmM4OTI0ODhkYjBjZTZhNDYxZmMyNjIzNC90YWJsZTpkN2JhMmI3YjA2ZjA0OGU4YjY2ZDE5NzUwZDRiNWYzMC90YWJsZXJhbmdlOmQ3YmEyYjdiMDZmMDQ4ZThiNjZkMTk3NTBkNGI1ZjMwXzItMS0xLTEtMA_1e3fc59b-3187-43a3-947f-58f102a05145"
      unitRef="usd">226000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i1faf47ea4d994e879fd1c1bf2cc15983_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTQvZnJhZzo3OWNmN2IxZmM4OTI0ODhkYjBjZTZhNDYxZmMyNjIzNC90YWJsZTpkN2JhMmI3YjA2ZjA0OGU4YjY2ZDE5NzUwZDRiNWYzMC90YWJsZXJhbmdlOmQ3YmEyYjdiMDZmMDQ4ZThiNjZkMTk3NTBkNGI1ZjMwXzItMy0xLTEtMA_7e885987-d090-4f00-9c14-d17269c2291a"
      unitRef="usd">243000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i4dcc4f5896f24eb98e3473b71e1d10b7_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTQvZnJhZzo3OWNmN2IxZmM4OTI0ODhkYjBjZTZhNDYxZmMyNjIzNC90YWJsZTpkN2JhMmI3YjA2ZjA0OGU4YjY2ZDE5NzUwZDRiNWYzMC90YWJsZXJhbmdlOmQ3YmEyYjdiMDZmMDQ4ZThiNjZkMTk3NTBkNGI1ZjMwXzItNS0xLTEtMA_b3642999-0d28-41c1-a275-2ae333b07f71"
      unitRef="usd">288000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i792ece330cb74d35afecabca6b7f49ea_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTQvZnJhZzo3OWNmN2IxZmM4OTI0ODhkYjBjZTZhNDYxZmMyNjIzNC90YWJsZTpkN2JhMmI3YjA2ZjA0OGU4YjY2ZDE5NzUwZDRiNWYzMC90YWJsZXJhbmdlOmQ3YmEyYjdiMDZmMDQ4ZThiNjZkMTk3NTBkNGI1ZjMwXzMtMS0xLTEtMA_1c7f4ea7-6b42-45b4-93b5-9a53aa9083e6"
      unitRef="usd">406000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i16818ee6ea724c8691b1f0065031735b_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTQvZnJhZzo3OWNmN2IxZmM4OTI0ODhkYjBjZTZhNDYxZmMyNjIzNC90YWJsZTpkN2JhMmI3YjA2ZjA0OGU4YjY2ZDE5NzUwZDRiNWYzMC90YWJsZXJhbmdlOmQ3YmEyYjdiMDZmMDQ4ZThiNjZkMTk3NTBkNGI1ZjMwXzMtMy0xLTEtMA_dce572cc-9e10-4d7e-b3dd-5fd20204fd5b"
      unitRef="usd">535000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="ic5128c57d92d4336ae115d6ba4e979cb_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTQvZnJhZzo3OWNmN2IxZmM4OTI0ODhkYjBjZTZhNDYxZmMyNjIzNC90YWJsZTpkN2JhMmI3YjA2ZjA0OGU4YjY2ZDE5NzUwZDRiNWYzMC90YWJsZXJhbmdlOmQ3YmEyYjdiMDZmMDQ4ZThiNjZkMTk3NTBkNGI1ZjMwXzMtNS0xLTEtMA_bc2a522e-343a-48ee-a219-d550b1b4e0e2"
      unitRef="usd">565000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTQvZnJhZzo3OWNmN2IxZmM4OTI0ODhkYjBjZTZhNDYxZmMyNjIzNC90YWJsZTpkN2JhMmI3YjA2ZjA0OGU4YjY2ZDE5NzUwZDRiNWYzMC90YWJsZXJhbmdlOmQ3YmEyYjdiMDZmMDQ4ZThiNjZkMTk3NTBkNGI1ZjMwXzQtMS0xLTEtMA_1927365d-82e8-42c5-b21a-9ef917dcbb66"
      unitRef="usd">783000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="ia31e9a409b874bb19d0ff6f2f39ecc09_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTQvZnJhZzo3OWNmN2IxZmM4OTI0ODhkYjBjZTZhNDYxZmMyNjIzNC90YWJsZTpkN2JhMmI3YjA2ZjA0OGU4YjY2ZDE5NzUwZDRiNWYzMC90YWJsZXJhbmdlOmQ3YmEyYjdiMDZmMDQ4ZThiNjZkMTk3NTBkNGI1ZjMwXzQtMy0xLTEtMA_342a3b0e-e5f4-4b40-99b3-2029c1332838"
      unitRef="usd">913000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i00a6d666bf604826b24e68ddbd63eac4_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTQvZnJhZzo3OWNmN2IxZmM4OTI0ODhkYjBjZTZhNDYxZmMyNjIzNC90YWJsZTpkN2JhMmI3YjA2ZjA0OGU4YjY2ZDE5NzUwZDRiNWYzMC90YWJsZXJhbmdlOmQ3YmEyYjdiMDZmMDQ4ZThiNjZkMTk3NTBkNGI1ZjMwXzQtNS0xLTEtMA_228ae087-f1f1-48f6-a155-6a73c98e3cb8"
      unitRef="usd">1000000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i76b6a114dfd6424fb4c07d91075a91ff_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTQvZnJhZzo3OWNmN2IxZmM4OTI0ODhkYjBjZTZhNDYxZmMyNjIzNC90YWJsZTpjNjg2ZDI0YzJiZmE0ZmM4OTkxM2RlMmZjODFhNDY2YS90YWJsZXJhbmdlOmM2ODZkMjRjMmJmYTRmYzg5OTEzZGUyZmM4MWE0NjZhXzEtMS0xLTEtMA_07ceaf45-a245-4b2e-9237-7651386613cc"
      unitRef="usd">55000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i78632f0315fd45fb85ed1c2272933a36_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTQvZnJhZzo3OWNmN2IxZmM4OTI0ODhkYjBjZTZhNDYxZmMyNjIzNC90YWJsZTpjNjg2ZDI0YzJiZmE0ZmM4OTkxM2RlMmZjODFhNDY2YS90YWJsZXJhbmdlOmM2ODZkMjRjMmJmYTRmYzg5OTEzZGUyZmM4MWE0NjZhXzEtMy0xLTEtMA_19118a8a-b657-4d70-9b83-9bbb74daa555"
      unitRef="usd">47000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i6d7435bb60af47f4a69d23c973a60d43_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTQvZnJhZzo3OWNmN2IxZmM4OTI0ODhkYjBjZTZhNDYxZmMyNjIzNC90YWJsZTpjNjg2ZDI0YzJiZmE0ZmM4OTkxM2RlMmZjODFhNDY2YS90YWJsZXJhbmdlOmM2ODZkMjRjMmJmYTRmYzg5OTEzZGUyZmM4MWE0NjZhXzEtNS0xLTEtMA_bff80207-2c3d-402e-87d2-d6c523f9a98c"
      unitRef="usd">35000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="id8c82c11050f452c9befaa43705026a6_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTQvZnJhZzo3OWNmN2IxZmM4OTI0ODhkYjBjZTZhNDYxZmMyNjIzNC90YWJsZTpjNjg2ZDI0YzJiZmE0ZmM4OTkxM2RlMmZjODFhNDY2YS90YWJsZXJhbmdlOmM2ODZkMjRjMmJmYTRmYzg5OTEzZGUyZmM4MWE0NjZhXzItMS0xLTEtMA_8b4a8235-51c8-4051-8ec2-464a6991d7d3"
      unitRef="usd">97000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i1faf47ea4d994e879fd1c1bf2cc15983_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTQvZnJhZzo3OWNmN2IxZmM4OTI0ODhkYjBjZTZhNDYxZmMyNjIzNC90YWJsZTpjNjg2ZDI0YzJiZmE0ZmM4OTkxM2RlMmZjODFhNDY2YS90YWJsZXJhbmdlOmM2ODZkMjRjMmJmYTRmYzg5OTEzZGUyZmM4MWE0NjZhXzItMy0xLTEtMA_ae8c5bac-1e5a-4a7f-a7df-004ed47b4509"
      unitRef="usd">86000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i4dcc4f5896f24eb98e3473b71e1d10b7_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTQvZnJhZzo3OWNmN2IxZmM4OTI0ODhkYjBjZTZhNDYxZmMyNjIzNC90YWJsZTpjNjg2ZDI0YzJiZmE0ZmM4OTkxM2RlMmZjODFhNDY2YS90YWJsZXJhbmdlOmM2ODZkMjRjMmJmYTRmYzg5OTEzZGUyZmM4MWE0NjZhXzItNS0xLTEtMA_15ae8a9a-faf5-408c-b675-3f7df150c7e2"
      unitRef="usd">74000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i792ece330cb74d35afecabca6b7f49ea_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTQvZnJhZzo3OWNmN2IxZmM4OTI0ODhkYjBjZTZhNDYxZmMyNjIzNC90YWJsZTpjNjg2ZDI0YzJiZmE0ZmM4OTkxM2RlMmZjODFhNDY2YS90YWJsZXJhbmdlOmM2ODZkMjRjMmJmYTRmYzg5OTEzZGUyZmM4MWE0NjZhXzMtMS0xLTEtMA_dc12ffec-4ada-44bc-bc6c-a1f997fd84af"
      unitRef="usd">248000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i16818ee6ea724c8691b1f0065031735b_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTQvZnJhZzo3OWNmN2IxZmM4OTI0ODhkYjBjZTZhNDYxZmMyNjIzNC90YWJsZTpjNjg2ZDI0YzJiZmE0ZmM4OTkxM2RlMmZjODFhNDY2YS90YWJsZXJhbmdlOmM2ODZkMjRjMmJmYTRmYzg5OTEzZGUyZmM4MWE0NjZhXzMtMy0xLTEtMA_4710ebbf-5db8-4a7e-83fa-dba760078a41"
      unitRef="usd">242000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="ic5128c57d92d4336ae115d6ba4e979cb_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTQvZnJhZzo3OWNmN2IxZmM4OTI0ODhkYjBjZTZhNDYxZmMyNjIzNC90YWJsZTpjNjg2ZDI0YzJiZmE0ZmM4OTkxM2RlMmZjODFhNDY2YS90YWJsZXJhbmdlOmM2ODZkMjRjMmJmYTRmYzg5OTEzZGUyZmM4MWE0NjZhXzMtNS0xLTEtMA_49e45eb9-a328-44d5-9e44-e902e62bc956"
      unitRef="usd">219000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTQvZnJhZzo3OWNmN2IxZmM4OTI0ODhkYjBjZTZhNDYxZmMyNjIzNC90YWJsZTpjNjg2ZDI0YzJiZmE0ZmM4OTkxM2RlMmZjODFhNDY2YS90YWJsZXJhbmdlOmM2ODZkMjRjMmJmYTRmYzg5OTEzZGUyZmM4MWE0NjZhXzQtMS0xLTEtMA_4e0358f3-0203-4ca2-9a0c-bb9635fec031"
      unitRef="usd">400000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="ia31e9a409b874bb19d0ff6f2f39ecc09_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTQvZnJhZzo3OWNmN2IxZmM4OTI0ODhkYjBjZTZhNDYxZmMyNjIzNC90YWJsZTpjNjg2ZDI0YzJiZmE0ZmM4OTkxM2RlMmZjODFhNDY2YS90YWJsZXJhbmdlOmM2ODZkMjRjMmJmYTRmYzg5OTEzZGUyZmM4MWE0NjZhXzQtMy0xLTEtMA_daa0d9a7-f20d-47a2-af89-7399724fd79d"
      unitRef="usd">375000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i00a6d666bf604826b24e68ddbd63eac4_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTQvZnJhZzo3OWNmN2IxZmM4OTI0ODhkYjBjZTZhNDYxZmMyNjIzNC90YWJsZTpjNjg2ZDI0YzJiZmE0ZmM4OTkxM2RlMmZjODFhNDY2YS90YWJsZXJhbmdlOmM2ODZkMjRjMmJmYTRmYzg5OTEzZGUyZmM4MWE0NjZhXzQtNS0xLTEtMA_4d43379a-df37-4a03-b0db-db51be43574a"
      unitRef="usd">328000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock
      contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTQvZnJhZzo3OWNmN2IxZmM4OTI0ODhkYjBjZTZhNDYxZmMyNjIzNC90ZXh0cmVnaW9uOjc5Y2Y3YjFmYzg5MjQ4OGRiMGNlNmE0NjFmYzI2MjM0XzU5ODM_bc1a741d-3394-4ae7-bc29-693185c2b386">&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents total assets for each reportable segment and Corporate at June 30:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.691%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:46.887%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.547%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.347%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.547%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.347%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.525%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Pharmaceutical&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;23,624&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;22,398&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;22,446&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Medical (1)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;15,408&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;14,691&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;15,284&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Corporate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;5,421&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3,677&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3,233&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;44,453&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;40,766&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;40,963&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;Assets of $1.1 billion classified as held for sale related to the Cordis divestiture were included within Medical at June&#160;30, 2021&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;.&lt;/span&gt;&lt;/div&gt;</us-gaap:ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock>
    <us-gaap:Assets
      contextRef="i6e8acb06a2eb434ab88bfebe2a6d8a18_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTQvZnJhZzo3OWNmN2IxZmM4OTI0ODhkYjBjZTZhNDYxZmMyNjIzNC90YWJsZTpkOGY5NzBiNDBlODU0MTM3OTgwZTMzZWI3MjA4ZTg2ZC90YWJsZXJhbmdlOmQ4Zjk3MGI0MGU4NTQxMzc5ODBlMzNlYjcyMDhlODZkXzEtMS0xLTEtMA_60d91d1f-f723-4d16-9354-431262fa61b2"
      unitRef="usd">23624000000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="ia8a118e953bd4d1f9600cde58c7b110c_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTQvZnJhZzo3OWNmN2IxZmM4OTI0ODhkYjBjZTZhNDYxZmMyNjIzNC90YWJsZTpkOGY5NzBiNDBlODU0MTM3OTgwZTMzZWI3MjA4ZTg2ZC90YWJsZXJhbmdlOmQ4Zjk3MGI0MGU4NTQxMzc5ODBlMzNlYjcyMDhlODZkXzEtMy0xLTEtMA_83b724ea-e197-42ee-abb4-3b7b52824029"
      unitRef="usd">22398000000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i776ad5c7cad44d45a8cbf169d5b49ea5_I20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTQvZnJhZzo3OWNmN2IxZmM4OTI0ODhkYjBjZTZhNDYxZmMyNjIzNC90YWJsZTpkOGY5NzBiNDBlODU0MTM3OTgwZTMzZWI3MjA4ZTg2ZC90YWJsZXJhbmdlOmQ4Zjk3MGI0MGU4NTQxMzc5ODBlMzNlYjcyMDhlODZkXzEtNS0xLTEtMA_897e6854-0ca5-4af7-9c48-3d4ccf14b61b"
      unitRef="usd">22446000000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i1395a9d318334a7bbf4965e8f0833f2b_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTQvZnJhZzo3OWNmN2IxZmM4OTI0ODhkYjBjZTZhNDYxZmMyNjIzNC90YWJsZTpkOGY5NzBiNDBlODU0MTM3OTgwZTMzZWI3MjA4ZTg2ZC90YWJsZXJhbmdlOmQ4Zjk3MGI0MGU4NTQxMzc5ODBlMzNlYjcyMDhlODZkXzItMS0xLTEtMA_51836d29-1dd5-45f9-8738-db09e5f864c1"
      unitRef="usd">15408000000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i2921a9a3e731468c9171a26f22574eba_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTQvZnJhZzo3OWNmN2IxZmM4OTI0ODhkYjBjZTZhNDYxZmMyNjIzNC90YWJsZTpkOGY5NzBiNDBlODU0MTM3OTgwZTMzZWI3MjA4ZTg2ZC90YWJsZXJhbmdlOmQ4Zjk3MGI0MGU4NTQxMzc5ODBlMzNlYjcyMDhlODZkXzItMy0xLTEtMA_eddbbb16-59d9-4f92-a271-13be42716081"
      unitRef="usd">14691000000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i2dbe5e7ed6284e6ba51e84d62ff6f50d_I20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTQvZnJhZzo3OWNmN2IxZmM4OTI0ODhkYjBjZTZhNDYxZmMyNjIzNC90YWJsZTpkOGY5NzBiNDBlODU0MTM3OTgwZTMzZWI3MjA4ZTg2ZC90YWJsZXJhbmdlOmQ4Zjk3MGI0MGU4NTQxMzc5ODBlMzNlYjcyMDhlODZkXzItNS0xLTEtMA_fb0316a4-d2dd-4b34-8cea-bcf207e241b2"
      unitRef="usd">15284000000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i8858cf546314492eb3e695791497ad0e_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTQvZnJhZzo3OWNmN2IxZmM4OTI0ODhkYjBjZTZhNDYxZmMyNjIzNC90YWJsZTpkOGY5NzBiNDBlODU0MTM3OTgwZTMzZWI3MjA4ZTg2ZC90YWJsZXJhbmdlOmQ4Zjk3MGI0MGU4NTQxMzc5ODBlMzNlYjcyMDhlODZkXzMtMS0xLTEtMA_31c7882f-a02c-4164-9771-14c1f6623fc2"
      unitRef="usd">5421000000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="ia1e90564105346fb9b66345306cd8bed_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTQvZnJhZzo3OWNmN2IxZmM4OTI0ODhkYjBjZTZhNDYxZmMyNjIzNC90YWJsZTpkOGY5NzBiNDBlODU0MTM3OTgwZTMzZWI3MjA4ZTg2ZC90YWJsZXJhbmdlOmQ4Zjk3MGI0MGU4NTQxMzc5ODBlMzNlYjcyMDhlODZkXzMtMy0xLTEtMA_a655ec89-e4f3-45d8-bfb0-4dcc551cb9fd"
      unitRef="usd">3677000000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="ia3e5b233ccea481cbde3ab011c52f4b7_I20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTQvZnJhZzo3OWNmN2IxZmM4OTI0ODhkYjBjZTZhNDYxZmMyNjIzNC90YWJsZTpkOGY5NzBiNDBlODU0MTM3OTgwZTMzZWI3MjA4ZTg2ZC90YWJsZXJhbmdlOmQ4Zjk3MGI0MGU4NTQxMzc5ODBlMzNlYjcyMDhlODZkXzMtNS0xLTEtMA_b198f1c1-97c4-4b80-9c8e-2de2dec3c862"
      unitRef="usd">3233000000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i2e87824102b34590a0208cc7da91b5f5_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTQvZnJhZzo3OWNmN2IxZmM4OTI0ODhkYjBjZTZhNDYxZmMyNjIzNC90YWJsZTpkOGY5NzBiNDBlODU0MTM3OTgwZTMzZWI3MjA4ZTg2ZC90YWJsZXJhbmdlOmQ4Zjk3MGI0MGU4NTQxMzc5ODBlMzNlYjcyMDhlODZkXzQtMS0xLTEtMA_56cba758-09bf-4b50-b298-d48783493a36"
      unitRef="usd">44453000000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i299cea70f47b4fbe96772aaa8cc00b79_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTQvZnJhZzo3OWNmN2IxZmM4OTI0ODhkYjBjZTZhNDYxZmMyNjIzNC90YWJsZTpkOGY5NzBiNDBlODU0MTM3OTgwZTMzZWI3MjA4ZTg2ZC90YWJsZXJhbmdlOmQ4Zjk3MGI0MGU4NTQxMzc5ODBlMzNlYjcyMDhlODZkXzQtMy0xLTEtMA_545c73f6-01b7-4514-85bf-6d26f58d2bc1"
      unitRef="usd">40766000000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="if6dc09eec4e74751b47cdf037a5b1860_I20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTQvZnJhZzo3OWNmN2IxZmM4OTI0ODhkYjBjZTZhNDYxZmMyNjIzNC90YWJsZTpkOGY5NzBiNDBlODU0MTM3OTgwZTMzZWI3MjA4ZTg2ZC90YWJsZXJhbmdlOmQ4Zjk3MGI0MGU4NTQxMzc5ODBlMzNlYjcyMDhlODZkXzQtNS0xLTEtMA_5f46aee3-a00b-40c3-bd18-e47d3950b9c3"
      unitRef="usd">40963000000</us-gaap:Assets>
    <us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperation
      contextRef="if49fcb6df2f04a0aa6c1338190b0051b_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTQvZnJhZzo3OWNmN2IxZmM4OTI0ODhkYjBjZTZhNDYxZmMyNjIzNC90ZXh0cmVnaW9uOjc5Y2Y3YjFmYzg5MjQ4OGRiMGNlNmE0NjFmYzI2MjM0XzI3NDg3NzkwNzg0Nzc_7da6973f-87dd-4fae-bf91-ca83d9577014"
      unitRef="usd">1100000000</us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperation>
    <us-gaap:LongLivedAssetsByGeographicAreasTableTextBlock
      contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTQvZnJhZzo3OWNmN2IxZmM4OTI0ODhkYjBjZTZhNDYxZmMyNjIzNC90ZXh0cmVnaW9uOjc5Y2Y3YjFmYzg5MjQ4OGRiMGNlNmE0NjFmYzI2MjM0XzU5OTg_9ad13db1-7a4c-489f-bb60-fff6bbdb26a1">&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables present property and equipment, net by geographic area:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.691%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:46.887%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.547%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.347%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.547%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.347%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.525%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;1,958&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,880&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,846&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;402&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;486&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;510&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Property and equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2,360&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,366&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,356&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:LongLivedAssetsByGeographicAreasTableTextBlock>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="ieb5c5f04a3584568a0813006020736e0_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTQvZnJhZzo3OWNmN2IxZmM4OTI0ODhkYjBjZTZhNDYxZmMyNjIzNC90YWJsZTo1ZmM2YTUzMGE1OWE0ZDJkOTNkOTJmMDIyNmQ3YWViYS90YWJsZXJhbmdlOjVmYzZhNTMwYTU5YTRkMmQ5M2Q5MmYwMjI2ZDdhZWJhXzEtMS0xLTEtMA_02e63521-5b88-49f8-912a-da364c3f512c"
      unitRef="usd">1958000000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i1c873da0bc8f4cfea1d6280c5bb54279_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTQvZnJhZzo3OWNmN2IxZmM4OTI0ODhkYjBjZTZhNDYxZmMyNjIzNC90YWJsZTo1ZmM2YTUzMGE1OWE0ZDJkOTNkOTJmMDIyNmQ3YWViYS90YWJsZXJhbmdlOjVmYzZhNTMwYTU5YTRkMmQ5M2Q5MmYwMjI2ZDdhZWJhXzEtMy0xLTEtMA_03afae22-2337-4a00-899c-3357c27347de"
      unitRef="usd">1880000000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i6ab941d8314b4dffa0444dc05ecc3315_I20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTQvZnJhZzo3OWNmN2IxZmM4OTI0ODhkYjBjZTZhNDYxZmMyNjIzNC90YWJsZTo1ZmM2YTUzMGE1OWE0ZDJkOTNkOTJmMDIyNmQ3YWViYS90YWJsZXJhbmdlOjVmYzZhNTMwYTU5YTRkMmQ5M2Q5MmYwMjI2ZDdhZWJhXzEtNS0xLTEtMA_5efecb7c-b16c-4969-9f35-cfab914f9009"
      unitRef="usd">1846000000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="icd695cac6ddb4cbe8fd3520e0cdd88f2_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTQvZnJhZzo3OWNmN2IxZmM4OTI0ODhkYjBjZTZhNDYxZmMyNjIzNC90YWJsZTo1ZmM2YTUzMGE1OWE0ZDJkOTNkOTJmMDIyNmQ3YWViYS90YWJsZXJhbmdlOjVmYzZhNTMwYTU5YTRkMmQ5M2Q5MmYwMjI2ZDdhZWJhXzItMS0xLTEtMA_1f2e4c9a-93be-4b36-9461-9e0b0135950a"
      unitRef="usd">402000000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="ic6d6926b307941eea48b73ec840b45ba_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTQvZnJhZzo3OWNmN2IxZmM4OTI0ODhkYjBjZTZhNDYxZmMyNjIzNC90YWJsZTo1ZmM2YTUzMGE1OWE0ZDJkOTNkOTJmMDIyNmQ3YWViYS90YWJsZXJhbmdlOjVmYzZhNTMwYTU5YTRkMmQ5M2Q5MmYwMjI2ZDdhZWJhXzItMy0xLTEtMA_7fd5b03c-6d76-4956-951c-e467a0957656"
      unitRef="usd">486000000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i5d8622203bb84c40af423bc2e4742dc2_I20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTQvZnJhZzo3OWNmN2IxZmM4OTI0ODhkYjBjZTZhNDYxZmMyNjIzNC90YWJsZTo1ZmM2YTUzMGE1OWE0ZDJkOTNkOTJmMDIyNmQ3YWViYS90YWJsZXJhbmdlOjVmYzZhNTMwYTU5YTRkMmQ5M2Q5MmYwMjI2ZDdhZWJhXzItNS0xLTEtMA_57d1dc6d-a3ee-4557-adad-0613e366d9a7"
      unitRef="usd">510000000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i2e87824102b34590a0208cc7da91b5f5_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTQvZnJhZzo3OWNmN2IxZmM4OTI0ODhkYjBjZTZhNDYxZmMyNjIzNC90YWJsZTo1ZmM2YTUzMGE1OWE0ZDJkOTNkOTJmMDIyNmQ3YWViYS90YWJsZXJhbmdlOjVmYzZhNTMwYTU5YTRkMmQ5M2Q5MmYwMjI2ZDdhZWJhXzMtMS0xLTEtMA_f6e61643-c03d-4981-b0c7-0fe84d8d27be"
      unitRef="usd">2360000000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i299cea70f47b4fbe96772aaa8cc00b79_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTQvZnJhZzo3OWNmN2IxZmM4OTI0ODhkYjBjZTZhNDYxZmMyNjIzNC90YWJsZTo1ZmM2YTUzMGE1OWE0ZDJkOTNkOTJmMDIyNmQ3YWViYS90YWJsZXJhbmdlOjVmYzZhNTMwYTU5YTRkMmQ5M2Q5MmYwMjI2ZDdhZWJhXzMtMy0xLTEtMA_c0637a65-8247-4cac-9996-77b9631350ca"
      unitRef="usd">2366000000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="if6dc09eec4e74751b47cdf037a5b1860_I20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNTQvZnJhZzo3OWNmN2IxZmM4OTI0ODhkYjBjZTZhNDYxZmMyNjIzNC90YWJsZTo1ZmM2YTUzMGE1OWE0ZDJkOTNkOTJmMDIyNmQ3YWViYS90YWJsZXJhbmdlOjVmYzZhNTMwYTU5YTRkMmQ5M2Q5MmYwMjI2ZDdhZWJhXzMtNS0xLTEtMA_08013765-2c95-4375-bfbb-a4a4ed160b21"
      unitRef="usd">2356000000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock
      contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNjAvZnJhZzozYmFjYzZmYWNhNmU0ZTMyYTU0NmNjZjhmNzBmY2Y4Yy90ZXh0cmVnaW9uOjNiYWNjNmZhY2E2ZTRlMzJhNTQ2Y2NmOGY3MGZjZjhjXzQxODc_1f4254a9-d1be-4e75-8ccc-7fa34d3d0fe9">&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:13pt;font-weight:700;line-height:120%"&gt;14. Share-Based Compensation &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We maintain stock incentive plans (collectively, the &#x201c;Plans&#x201d;) for the benefit of certain of our officers, directors and employees. At June&#160;30, 2021, 9 million shares remain available for future grants under the Amended Cardinal Health, Inc. 2011 Long-Term Incentive Plan ("2011 LTIP"). Under the 2011 LTIP's fungible share counting provisions, stock options are counted against the plan as one share for every share issued; awards other than stock options are counted against the plan as two and one-half shares for every share issued. This means that only 3 million shares could be issued under awards other than stock options while 9 million shares could be issued under stock options. Shares are issued out of treasury shares when stock options are exercised and when restricted share units and performance share units vest. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table provides total share-based compensation expense by type of award:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.691%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:58.652%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.283%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.347%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.283%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.347%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.288%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Restricted share unit expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;73&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;70&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;63&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Employee stock option expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Performance share unit expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;16&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total share-based compensation expense&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;89&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;90&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;82&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The total tax benefit related to share-based compensation was $12 million, $16 million and $16 million for fiscal 2021, 2020 and 2019, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%"&gt;Restricted Share Units&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Restricted share units granted under the Plans generally vest in equal annual installments over three years. Restricted share units accrue cash dividend equivalents that are payable upon vesting of the awards.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes all transactions related to restricted share units under the Plans:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.691%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:51.221%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.714%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.347%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:25.218%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;(in millions, except per share amounts)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Restricted Share Units&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted-Average&lt;br/&gt;Grant Date Fair&lt;br/&gt;Value per Share&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Nonvested at June 30, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;51.65&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;42.71&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;60.21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Canceled and forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Nonvested at June 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;45.92&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;53.76&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;49.37&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Canceled and forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;48.74&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nonvested at June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;3&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;49.05&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="display:inline-block;vertical-align:top;width:48.214%"&gt;&lt;div style="margin-bottom:4pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table provides additional data related to restricted share unit activity:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.691%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:53.698%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.451%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.347%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.522%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.347%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.835%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total compensation cost, net of estimated forfeitures, related to nonvested restricted share and share unit awards not yet recognized, pre-tax&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;73&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;77&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Weighted-average period in years over which restricted share and share unit cost is expected to be recognized (in years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total fair value of shares vested during the year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;70&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;57&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;68&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%"&gt;Stock Options&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Until the end of fiscal 2018, stock options were granted to our officers and certain employees. There were no stock options granted to employees during fiscal year 2021, 2020 or 2019. Employee stock options granted under the Plans generally vest in equal annual installments over three years and are exercisable for a period up to ten years from the grant date. All stock options are exercisable at a price equal to the market value of the common shares underlying the option on the grant date.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes all stock option transactions under the Plans:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:56.616%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.480%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.343%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:26.061%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;(in millions, except per share amounts)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Stock&lt;br/&gt;Options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted-Average&lt;br/&gt;Exercise Price per&lt;br/&gt;Common Share&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Outstanding at June 30, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;63.78&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;42.36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Canceled and forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Outstanding at June 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;65.15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;43.08&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Canceled and forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Outstanding at June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;4&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;68.46&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Exercisable at June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;4&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;68.62&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="display:inline-block;max-width:3.571%;min-width:2.571%;vertical-align:top"/&gt;&lt;div style="display:inline-block;vertical-align:top;width:48.215%"&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table provides additional detail related to stock options:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.691%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:53.698%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.451%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.347%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.522%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.347%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.835%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;(in millions, except per share amounts)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Aggregate intrinsic value of outstanding options at period end&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;11&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Aggregate intrinsic value of exercisable options at period end&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;11&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Aggregate intrinsic value of exercised options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;10&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Net proceeds/(withholding) from share-based compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;32&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Excess tax benefits from share based compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total compensation cost, net of estimated forfeitures, related to unvested stock options not yet recognized, pre-tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total fair value of shares vested during the year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;3&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Weighted-average grant date fair value per stock option&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;12.94&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;8.26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;8.34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.382%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:65.049%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.148%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.352%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.148%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.352%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;(in years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Weighted-average remaining contractual life of outstanding options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;4&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;5&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;5&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Weighted-average remaining contractual life of exercisable options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;4&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;5&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;5&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Weighted-average period over which stock option compensation cost is expected to be recognized&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair values were estimated on the grant date using a lattice valuation model. We believe the lattice model provides reasonable estimates because it has the ability to take into account individual exercise patterns based on changes in our stock price and other variables, and it provides for a range of input assumptions, which are disclosed in the table below. The risk-free rate is based on the U.S. Treasury yield curve at the time of the grant. We analyzed historical data to estimate option exercise behaviors and employee terminations to be used within the lattice model. The expected life of the options granted was calculated from the option valuation model and represents the length of time in years that the options granted are expected to be outstanding. Expected volatilities are based on implied volatility from traded options on our common shares and historical volatility over a period of time commensurate with the contractual term of the option grant (up to ten years). &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%"&gt;Performance Share Units&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Performance share units generally vest over a 3-year performance period based on achievement of specific performance goals. Based on the extent to which the targets are achieved, vested shares may range from zero to 240 percent of the target award amount. Performance share units accrue cash dividend equivalents that are payable upon vesting of the awards.&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes all transactions related to performance share units under the Plans (based on target award amounts):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.691%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:49.983%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.023%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.347%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:26.147%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;(in millions, except per share amounts)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Performance&lt;br/&gt;Share Units&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted-Average&lt;br/&gt;Grant Date Fair&lt;br/&gt;Value per Share&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Nonvested at June 30, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;0.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;51.45&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;44.03&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;48.40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Canceled and forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(0.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;50.92&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Nonvested at June 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;54.24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;55.45&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;42.72&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Canceled and forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(0.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;53.71&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nonvested at June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;1.2&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;54.89&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table provides additional data related to performance share unit activity:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.691%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:58.652%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.283%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.347%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.283%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.347%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.288%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total compensation cost, net of estimated forfeitures, related to nonvested performance share units not yet recognized, pre-tax&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;26&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Weighted-average period over which performance share unit cost is expected to be recognized (in years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total fair value of shares vested during the year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;1&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%"&gt;Employee Retirement Savings Plans&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Substantially all of our domestic non-union employees are eligible to be enrolled in our company-sponsored contributory retirement savings plans, which include features under Section 401(k) of the Internal Revenue Code of 1986, and provide for matching and discretionary contributions by us. The total expense for our employee retirement savings plans was $55 million, $66 million and $99 million for fiscal 2021, 2020 and 2019, respectively.&lt;/span&gt;&lt;/div&gt;</us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="i12a70580710847829f909cea8ceeacc3_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNjAvZnJhZzozYmFjYzZmYWNhNmU0ZTMyYTU0NmNjZjhmNzBmY2Y4Yy90ZXh0cmVnaW9uOjNiYWNjNmZhY2E2ZTRlMzJhNTQ2Y2NmOGY3MGZjZjhjXzE0Nw_73e1ccce-7b6f-45be-ba9d-1b40073ce0dc"
      unitRef="shares">9000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="ibaee55518fbe497ca65e202e76660b9e_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNjAvZnJhZzozYmFjYzZmYWNhNmU0ZTMyYTU0NmNjZjhmNzBmY2Y4Yy90ZXh0cmVnaW9uOjNiYWNjNmZhY2E2ZTRlMzJhNTQ2Y2NmOGY3MGZjZjhjXzQ3NA_1ff238f1-0e4a-45f9-b20e-65faca69a155"
      unitRef="shares">3000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="ib82e9bbd88e1416c896321662307b4fc_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNjAvZnJhZzozYmFjYzZmYWNhNmU0ZTMyYTU0NmNjZjhmNzBmY2Y4Yy90ZXh0cmVnaW9uOjNiYWNjNmZhY2E2ZTRlMzJhNTQ2Y2NmOGY3MGZjZjhjXzU0NA_db859877-5c29-4524-a414-c4285a527e06"
      unitRef="shares">9000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock
      contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNjAvZnJhZzozYmFjYzZmYWNhNmU0ZTMyYTU0NmNjZjhmNzBmY2Y4Yy90ZXh0cmVnaW9uOjNiYWNjNmZhY2E2ZTRlMzJhNTQ2Y2NmOGY3MGZjZjhjXzQxNzk_436f07f0-589e-44a6-948c-07438e312f9c">&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table provides total share-based compensation expense by type of award:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.691%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:58.652%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.283%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.347%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.283%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.347%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.288%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Restricted share unit expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;73&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;70&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;63&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Employee stock option expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Performance share unit expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;16&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total share-based compensation expense&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;89&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;90&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;82&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i31f1c30559534af396751cc62e9e19a9_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNjAvZnJhZzozYmFjYzZmYWNhNmU0ZTMyYTU0NmNjZjhmNzBmY2Y4Yy90YWJsZTo3MjgxMDU3MGRlMDg0MmE5YmJlMTUxOTIyZjljMmFjOC90YWJsZXJhbmdlOjcyODEwNTcwZGUwODQyYTliYmUxNTE5MjJmOWMyYWM4XzEtMS0xLTEtMA_d9b1e4d4-997e-483f-8606-01407ec2adb1"
      unitRef="usd">73000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i956130d849c84807b9f6f7b055f5ebec_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNjAvZnJhZzozYmFjYzZmYWNhNmU0ZTMyYTU0NmNjZjhmNzBmY2Y4Yy90YWJsZTo3MjgxMDU3MGRlMDg0MmE5YmJlMTUxOTIyZjljMmFjOC90YWJsZXJhbmdlOjcyODEwNTcwZGUwODQyYTliYmUxNTE5MjJmOWMyYWM4XzEtMy0xLTEtMA_dfb12c07-12a8-4504-805c-a3995756247f"
      unitRef="usd">70000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i579d152d52624fc381bd7cae2c7ddd4a_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNjAvZnJhZzozYmFjYzZmYWNhNmU0ZTMyYTU0NmNjZjhmNzBmY2Y4Yy90YWJsZTo3MjgxMDU3MGRlMDg0MmE5YmJlMTUxOTIyZjljMmFjOC90YWJsZXJhbmdlOjcyODEwNTcwZGUwODQyYTliYmUxNTE5MjJmOWMyYWM4XzEtNS0xLTEtMA_35c85eaa-644b-47fc-97e6-df4a40bea24f"
      unitRef="usd">63000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i9fac2b1e8f484ef081a25d163aa2c3a6_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNjAvZnJhZzozYmFjYzZmYWNhNmU0ZTMyYTU0NmNjZjhmNzBmY2Y4Yy90YWJsZTo3MjgxMDU3MGRlMDg0MmE5YmJlMTUxOTIyZjljMmFjOC90YWJsZXJhbmdlOjcyODEwNTcwZGUwODQyYTliYmUxNTE5MjJmOWMyYWM4XzItMS0xLTEtMA_0d4551b1-4356-4fb0-858a-6d01ac887216"
      unitRef="usd">0</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i5ec12fa139c6458fb260601a40c83a61_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNjAvZnJhZzozYmFjYzZmYWNhNmU0ZTMyYTU0NmNjZjhmNzBmY2Y4Yy90YWJsZTo3MjgxMDU3MGRlMDg0MmE5YmJlMTUxOTIyZjljMmFjOC90YWJsZXJhbmdlOjcyODEwNTcwZGUwODQyYTliYmUxNTE5MjJmOWMyYWM4XzItMy0xLTEtMA_f814cfcb-49c4-4af8-b3a5-ffa19c085875"
      unitRef="usd">3000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i4ff833c8f18c425d87db9b23fa00bd06_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNjAvZnJhZzozYmFjYzZmYWNhNmU0ZTMyYTU0NmNjZjhmNzBmY2Y4Yy90YWJsZTo3MjgxMDU3MGRlMDg0MmE5YmJlMTUxOTIyZjljMmFjOC90YWJsZXJhbmdlOjcyODEwNTcwZGUwODQyYTliYmUxNTE5MjJmOWMyYWM4XzItNS0xLTEtMA_f3649d14-4a51-4a43-9060-27bcc3877eb3"
      unitRef="usd">10000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i217c2671c6f84df1ab8278415bc34c16_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNjAvZnJhZzozYmFjYzZmYWNhNmU0ZTMyYTU0NmNjZjhmNzBmY2Y4Yy90YWJsZTo3MjgxMDU3MGRlMDg0MmE5YmJlMTUxOTIyZjljMmFjOC90YWJsZXJhbmdlOjcyODEwNTcwZGUwODQyYTliYmUxNTE5MjJmOWMyYWM4XzMtMS0xLTEtMA_f248da08-835e-4263-bbb5-7687e541cf1b"
      unitRef="usd">16000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i4f0f3088df2a4e019bd09b2ef236fef0_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNjAvZnJhZzozYmFjYzZmYWNhNmU0ZTMyYTU0NmNjZjhmNzBmY2Y4Yy90YWJsZTo3MjgxMDU3MGRlMDg0MmE5YmJlMTUxOTIyZjljMmFjOC90YWJsZXJhbmdlOjcyODEwNTcwZGUwODQyYTliYmUxNTE5MjJmOWMyYWM4XzMtMy0xLTEtMA_70937af3-a785-4df9-89d2-575dcd930f88"
      unitRef="usd">17000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="id7eb385b0eaf45a0aa833269191797b8_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNjAvZnJhZzozYmFjYzZmYWNhNmU0ZTMyYTU0NmNjZjhmNzBmY2Y4Yy90YWJsZTo3MjgxMDU3MGRlMDg0MmE5YmJlMTUxOTIyZjljMmFjOC90YWJsZXJhbmdlOjcyODEwNTcwZGUwODQyYTliYmUxNTE5MjJmOWMyYWM4XzMtNS0xLTEtMA_885379b0-d62d-4533-be24-64d73443dd6e"
      unitRef="usd">9000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNjAvZnJhZzozYmFjYzZmYWNhNmU0ZTMyYTU0NmNjZjhmNzBmY2Y4Yy90YWJsZTo3MjgxMDU3MGRlMDg0MmE5YmJlMTUxOTIyZjljMmFjOC90YWJsZXJhbmdlOjcyODEwNTcwZGUwODQyYTliYmUxNTE5MjJmOWMyYWM4XzQtMS0xLTEtMA_54221fbf-b378-4a40-92b8-741822882729"
      unitRef="usd">89000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ia31e9a409b874bb19d0ff6f2f39ecc09_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNjAvZnJhZzozYmFjYzZmYWNhNmU0ZTMyYTU0NmNjZjhmNzBmY2Y4Yy90YWJsZTo3MjgxMDU3MGRlMDg0MmE5YmJlMTUxOTIyZjljMmFjOC90YWJsZXJhbmdlOjcyODEwNTcwZGUwODQyYTliYmUxNTE5MjJmOWMyYWM4XzQtMy0xLTEtMA_704a92ae-9bf3-4d10-9f52-1154c6f4fc8f"
      unitRef="usd">90000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i00a6d666bf604826b24e68ddbd63eac4_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNjAvZnJhZzozYmFjYzZmYWNhNmU0ZTMyYTU0NmNjZjhmNzBmY2Y4Yy90YWJsZTo3MjgxMDU3MGRlMDg0MmE5YmJlMTUxOTIyZjljMmFjOC90YWJsZXJhbmdlOjcyODEwNTcwZGUwODQyYTliYmUxNTE5MjJmOWMyYWM4XzQtNS0xLTEtMA_ed99a2fd-f459-4aa0-88d8-823618c27245"
      unitRef="usd">82000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
      contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNjAvZnJhZzozYmFjYzZmYWNhNmU0ZTMyYTU0NmNjZjhmNzBmY2Y4Yy90ZXh0cmVnaW9uOjNiYWNjNmZhY2E2ZTRlMzJhNTQ2Y2NmOGY3MGZjZjhjXzg4Mg_4d767512-1fb5-4463-9fbe-3919219fc3d4"
      unitRef="usd">12000000</us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense>
    <us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
      contextRef="ia31e9a409b874bb19d0ff6f2f39ecc09_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNjAvZnJhZzozYmFjYzZmYWNhNmU0ZTMyYTU0NmNjZjhmNzBmY2Y4Yy90ZXh0cmVnaW9uOjNiYWNjNmZhY2E2ZTRlMzJhNTQ2Y2NmOGY3MGZjZjhjXzg4Ng_17d6c02a-9b27-4212-b8b0-aa517f3852f0"
      unitRef="usd">16000000</us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense>
    <us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
      contextRef="i00a6d666bf604826b24e68ddbd63eac4_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNjAvZnJhZzozYmFjYzZmYWNhNmU0ZTMyYTU0NmNjZjhmNzBmY2Y4Yy90ZXh0cmVnaW9uOjNiYWNjNmZhY2E2ZTRlMzJhNTQ2Y2NmOGY3MGZjZjhjXzg5Mw_6f93e28c-71fc-4acb-b95a-557d573bbbb0"
      unitRef="usd">16000000</us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="i31f1c30559534af396751cc62e9e19a9_D20200701-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNjAvZnJhZzozYmFjYzZmYWNhNmU0ZTMyYTU0NmNjZjhmNzBmY2Y4Yy90ZXh0cmVnaW9uOjNiYWNjNmZhY2E2ZTRlMzJhNTQ2Y2NmOGY3MGZjZjhjXzEwNTU_e94a06a2-4c26-461f-86f8-a3a82a7734fc">P3Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock
      contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNjAvZnJhZzozYmFjYzZmYWNhNmU0ZTMyYTU0NmNjZjhmNzBmY2Y4Yy90ZXh0cmVnaW9uOjNiYWNjNmZhY2E2ZTRlMzJhNTQ2Y2NmOGY3MGZjZjhjXzQxNzM_b1574c28-3c2e-486e-b9ee-ca1242e31609">&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes all transactions related to restricted share units under the Plans:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.691%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:51.221%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.714%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.347%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:25.218%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;(in millions, except per share amounts)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Restricted Share Units&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted-Average&lt;br/&gt;Grant Date Fair&lt;br/&gt;Value per Share&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Nonvested at June 30, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;51.65&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;42.71&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;60.21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Canceled and forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Nonvested at June 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;45.92&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;53.76&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;49.37&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Canceled and forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;48.74&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nonvested at June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;3&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;49.05&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="icf32a92391924ff7b30fe54e99e0979b_I20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNjAvZnJhZzozYmFjYzZmYWNhNmU0ZTMyYTU0NmNjZjhmNzBmY2Y4Yy90YWJsZTphMzY4Y2FiZTJiNTQ0ZGU2YmM3OTJjMzU0ZmVkNTdhYi90YWJsZXJhbmdlOmEzNjhjYWJlMmI1NDRkZTZiYzc5MmMzNTRmZWQ1N2FiXzEtMS0xLTEtMA_a860d793-0071-4ef3-939a-311bf27ba330"
      unitRef="shares">2000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="icf32a92391924ff7b30fe54e99e0979b_I20190630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNjAvZnJhZzozYmFjYzZmYWNhNmU0ZTMyYTU0NmNjZjhmNzBmY2Y4Yy90YWJsZTphMzY4Y2FiZTJiNTQ0ZGU2YmM3OTJjMzU0ZmVkNTdhYi90YWJsZXJhbmdlOmEzNjhjYWJlMmI1NDRkZTZiYzc5MmMzNTRmZWQ1N2FiXzEtMy0xLTEtMA_8f348326-a7de-4ae8-90cf-a62d558168ca"
      unitRef="usdPerShare">51.65</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="i956130d849c84807b9f6f7b055f5ebec_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNjAvZnJhZzozYmFjYzZmYWNhNmU0ZTMyYTU0NmNjZjhmNzBmY2Y4Yy90YWJsZTphMzY4Y2FiZTJiNTQ0ZGU2YmM3OTJjMzU0ZmVkNTdhYi90YWJsZXJhbmdlOmEzNjhjYWJlMmI1NDRkZTZiYzc5MmMzNTRmZWQ1N2FiXzItMS0xLTEtMA_5dea4628-5f49-4b32-8fef-e96117e93938"
      unitRef="shares">2000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i956130d849c84807b9f6f7b055f5ebec_D20190701-20200630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNjAvZnJhZzozYmFjYzZmYWNhNmU0ZTMyYTU0NmNjZjhmNzBmY2Y4Yy90YWJsZTphMzY4Y2FiZTJiNTQ0ZGU2YmM3OTJjMzU0ZmVkNTdhYi90YWJsZXJhbmdlOmEzNjhjYWJlMmI1NDRkZTZiYzc5MmMzNTRmZWQ1N2FiXzItMy0xLTEtMA_478747c7-822e-47b2-a5bd-5fdef424bc33"
      unitRef="usdPerShare">42.71</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="i956130d849c84807b9f6f7b055f5ebec_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNjAvZnJhZzozYmFjYzZmYWNhNmU0ZTMyYTU0NmNjZjhmNzBmY2Y4Yy90YWJsZTphMzY4Y2FiZTJiNTQ0ZGU2YmM3OTJjMzU0ZmVkNTdhYi90YWJsZXJhbmdlOmEzNjhjYWJlMmI1NDRkZTZiYzc5MmMzNTRmZWQ1N2FiXzMtMS0xLTEtMA_6c7b63ea-5316-4f01-b7e3-ee0332daadaa"
      unitRef="shares">1000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
      contextRef="i956130d849c84807b9f6f7b055f5ebec_D20190701-20200630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNjAvZnJhZzozYmFjYzZmYWNhNmU0ZTMyYTU0NmNjZjhmNzBmY2Y4Yy90YWJsZTphMzY4Y2FiZTJiNTQ0ZGU2YmM3OTJjMzU0ZmVkNTdhYi90YWJsZXJhbmdlOmEzNjhjYWJlMmI1NDRkZTZiYzc5MmMzNTRmZWQ1N2FiXzMtMy0xLTEtMA_293fd15e-28cb-4cee-b33f-af0095789ebf"
      unitRef="usdPerShare">60.21</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
      contextRef="i956130d849c84807b9f6f7b055f5ebec_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNjAvZnJhZzozYmFjYzZmYWNhNmU0ZTMyYTU0NmNjZjhmNzBmY2Y4Yy90YWJsZTphMzY4Y2FiZTJiNTQ0ZGU2YmM3OTJjMzU0ZmVkNTdhYi90YWJsZXJhbmdlOmEzNjhjYWJlMmI1NDRkZTZiYzc5MmMzNTRmZWQ1N2FiXzQtMS0xLTEtMA_b1a6f0ef-879c-4e76-a2c7-6594d868c945"
      unitRef="shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
      contextRef="i956130d849c84807b9f6f7b055f5ebec_D20190701-20200630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNjAvZnJhZzozYmFjYzZmYWNhNmU0ZTMyYTU0NmNjZjhmNzBmY2Y4Yy90YWJsZTphMzY4Y2FiZTJiNTQ0ZGU2YmM3OTJjMzU0ZmVkNTdhYi90YWJsZXJhbmdlOmEzNjhjYWJlMmI1NDRkZTZiYzc5MmMzNTRmZWQ1N2FiXzQtMy0xLTEtMA_cfba553d-894b-4032-8fb8-0f8430a8cc86"
      unitRef="usdPerShare">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="ifb9b7ea1688a4fb4a266a5ac9179360e_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNjAvZnJhZzozYmFjYzZmYWNhNmU0ZTMyYTU0NmNjZjhmNzBmY2Y4Yy90YWJsZTphMzY4Y2FiZTJiNTQ0ZGU2YmM3OTJjMzU0ZmVkNTdhYi90YWJsZXJhbmdlOmEzNjhjYWJlMmI1NDRkZTZiYzc5MmMzNTRmZWQ1N2FiXzUtMS0xLTEtMA_99630eed-08a7-478d-a3a9-31550941af52"
      unitRef="shares">3000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="ifb9b7ea1688a4fb4a266a5ac9179360e_I20200630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNjAvZnJhZzozYmFjYzZmYWNhNmU0ZTMyYTU0NmNjZjhmNzBmY2Y4Yy90YWJsZTphMzY4Y2FiZTJiNTQ0ZGU2YmM3OTJjMzU0ZmVkNTdhYi90YWJsZXJhbmdlOmEzNjhjYWJlMmI1NDRkZTZiYzc5MmMzNTRmZWQ1N2FiXzUtMy0xLTEtMA_8615b08b-5ade-4bac-80cf-2762831dc8aa"
      unitRef="usdPerShare">45.92</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="i31f1c30559534af396751cc62e9e19a9_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNjAvZnJhZzozYmFjYzZmYWNhNmU0ZTMyYTU0NmNjZjhmNzBmY2Y4Yy90YWJsZTphMzY4Y2FiZTJiNTQ0ZGU2YmM3OTJjMzU0ZmVkNTdhYi90YWJsZXJhbmdlOmEzNjhjYWJlMmI1NDRkZTZiYzc5MmMzNTRmZWQ1N2FiXzYtMS0xLTEtMA_ea588246-1ea3-4c3e-9801-2e5c943e0be2"
      unitRef="shares">2000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i31f1c30559534af396751cc62e9e19a9_D20200701-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNjAvZnJhZzozYmFjYzZmYWNhNmU0ZTMyYTU0NmNjZjhmNzBmY2Y4Yy90YWJsZTphMzY4Y2FiZTJiNTQ0ZGU2YmM3OTJjMzU0ZmVkNTdhYi90YWJsZXJhbmdlOmEzNjhjYWJlMmI1NDRkZTZiYzc5MmMzNTRmZWQ1N2FiXzYtMy0xLTEtMA_812707cd-bed8-4b84-9aae-ca41b0e57e6a"
      unitRef="usdPerShare">53.76</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="i31f1c30559534af396751cc62e9e19a9_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNjAvZnJhZzozYmFjYzZmYWNhNmU0ZTMyYTU0NmNjZjhmNzBmY2Y4Yy90YWJsZTphMzY4Y2FiZTJiNTQ0ZGU2YmM3OTJjMzU0ZmVkNTdhYi90YWJsZXJhbmdlOmEzNjhjYWJlMmI1NDRkZTZiYzc5MmMzNTRmZWQ1N2FiXzctMS0xLTEtMA_4dbffece-20b8-484b-8501-62f72919f0ce"
      unitRef="shares">1000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
      contextRef="i31f1c30559534af396751cc62e9e19a9_D20200701-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNjAvZnJhZzozYmFjYzZmYWNhNmU0ZTMyYTU0NmNjZjhmNzBmY2Y4Yy90YWJsZTphMzY4Y2FiZTJiNTQ0ZGU2YmM3OTJjMzU0ZmVkNTdhYi90YWJsZXJhbmdlOmEzNjhjYWJlMmI1NDRkZTZiYzc5MmMzNTRmZWQ1N2FiXzctMy0xLTEtMA_374e2284-189d-49e2-9cf5-5d6a241d0d66"
      unitRef="usdPerShare">49.37</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
      contextRef="i31f1c30559534af396751cc62e9e19a9_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNjAvZnJhZzozYmFjYzZmYWNhNmU0ZTMyYTU0NmNjZjhmNzBmY2Y4Yy90YWJsZTphMzY4Y2FiZTJiNTQ0ZGU2YmM3OTJjMzU0ZmVkNTdhYi90YWJsZXJhbmdlOmEzNjhjYWJlMmI1NDRkZTZiYzc5MmMzNTRmZWQ1N2FiXzgtMS0xLTEtMA_0a12cc93-75ee-4f34-8f80-271f42ec8185"
      unitRef="shares">1000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
      contextRef="i31f1c30559534af396751cc62e9e19a9_D20200701-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNjAvZnJhZzozYmFjYzZmYWNhNmU0ZTMyYTU0NmNjZjhmNzBmY2Y4Yy90YWJsZTphMzY4Y2FiZTJiNTQ0ZGU2YmM3OTJjMzU0ZmVkNTdhYi90YWJsZXJhbmdlOmEzNjhjYWJlMmI1NDRkZTZiYzc5MmMzNTRmZWQ1N2FiXzgtMy0xLTEtMA_710d9670-f6a8-4ad9-8831-18258792fd18"
      unitRef="usdPerShare">48.74</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="i401c6da5266c42ffb2f8a5466c3eba3c_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNjAvZnJhZzozYmFjYzZmYWNhNmU0ZTMyYTU0NmNjZjhmNzBmY2Y4Yy90YWJsZTphMzY4Y2FiZTJiNTQ0ZGU2YmM3OTJjMzU0ZmVkNTdhYi90YWJsZXJhbmdlOmEzNjhjYWJlMmI1NDRkZTZiYzc5MmMzNTRmZWQ1N2FiXzktMS0xLTEtMA_f609b914-78df-43c1-a143-d00ab43ff8ef"
      unitRef="shares">3000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="i401c6da5266c42ffb2f8a5466c3eba3c_I20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNjAvZnJhZzozYmFjYzZmYWNhNmU0ZTMyYTU0NmNjZjhmNzBmY2Y4Yy90YWJsZTphMzY4Y2FiZTJiNTQ0ZGU2YmM3OTJjMzU0ZmVkNTdhYi90YWJsZXJhbmdlOmEzNjhjYWJlMmI1NDRkZTZiYzc5MmMzNTRmZWQ1N2FiXzktMy0xLTEtMA_654b879e-2dc1-4d16-bd15-6444aa394063"
      unitRef="usdPerShare">49.05</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <cah:AdditionalRestrictedSharesAndRestrictedShareUnitsDataTableTextBlock
      contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNjAvZnJhZzozYmFjYzZmYWNhNmU0ZTMyYTU0NmNjZjhmNzBmY2Y4Yy90ZXh0cmVnaW9uOjNiYWNjNmZhY2E2ZTRlMzJhNTQ2Y2NmOGY3MGZjZjhjXzQxMjg_bef7e7bf-f2bf-4adf-a704-b1302ccd613b">&lt;div style="margin-bottom:4pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table provides additional data related to restricted share unit activity:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.691%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:53.698%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.451%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.347%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.522%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.347%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.835%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total compensation cost, net of estimated forfeitures, related to nonvested restricted share and share unit awards not yet recognized, pre-tax&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;73&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;77&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Weighted-average period in years over which restricted share and share unit cost is expected to be recognized (in years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total fair value of shares vested during the year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;70&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;57&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;68&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</cah:AdditionalRestrictedSharesAndRestrictedShareUnitsDataTableTextBlock>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
      contextRef="i401c6da5266c42ffb2f8a5466c3eba3c_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNjAvZnJhZzozYmFjYzZmYWNhNmU0ZTMyYTU0NmNjZjhmNzBmY2Y4Yy90YWJsZTowZjE3NDM5OGVhNWM0OWY4YWI2YjJjZWMzMjQ5MTBkMy90YWJsZXJhbmdlOjBmMTc0Mzk4ZWE1YzQ5ZjhhYjZiMmNlYzMyNDkxMGQzXzEtMS0xLTEtMA_20cb6d89-fd9c-4132-b957-aa5530250fd1"
      unitRef="usd">73000000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
      contextRef="ifb9b7ea1688a4fb4a266a5ac9179360e_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNjAvZnJhZzozYmFjYzZmYWNhNmU0ZTMyYTU0NmNjZjhmNzBmY2Y4Yy90YWJsZTowZjE3NDM5OGVhNWM0OWY4YWI2YjJjZWMzMjQ5MTBkMy90YWJsZXJhbmdlOjBmMTc0Mzk4ZWE1YzQ5ZjhhYjZiMmNlYzMyNDkxMGQzXzEtMy0xLTEtMA_d7088a84-4146-496d-ba0d-44a9d0ebab06"
      unitRef="usd">77000000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
      contextRef="icf32a92391924ff7b30fe54e99e0979b_I20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNjAvZnJhZzozYmFjYzZmYWNhNmU0ZTMyYTU0NmNjZjhmNzBmY2Y4Yy90YWJsZTowZjE3NDM5OGVhNWM0OWY4YWI2YjJjZWMzMjQ5MTBkMy90YWJsZXJhbmdlOjBmMTc0Mzk4ZWE1YzQ5ZjhhYjZiMmNlYzMyNDkxMGQzXzEtNS0xLTEtMA_d821f126-4072-4dcb-9013-754e768948c8"
      unitRef="usd">75000000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
      contextRef="i31f1c30559534af396751cc62e9e19a9_D20200701-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNjAvZnJhZzozYmFjYzZmYWNhNmU0ZTMyYTU0NmNjZjhmNzBmY2Y4Yy90YWJsZTowZjE3NDM5OGVhNWM0OWY4YWI2YjJjZWMzMjQ5MTBkMy90YWJsZXJhbmdlOjBmMTc0Mzk4ZWE1YzQ5ZjhhYjZiMmNlYzMyNDkxMGQzXzItMS0xLTEtMA_d73e9db3-d856-4a4a-9769-87dc53c3707b">P2Y</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
      contextRef="i956130d849c84807b9f6f7b055f5ebec_D20190701-20200630"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNjAvZnJhZzozYmFjYzZmYWNhNmU0ZTMyYTU0NmNjZjhmNzBmY2Y4Yy90YWJsZTowZjE3NDM5OGVhNWM0OWY4YWI2YjJjZWMzMjQ5MTBkMy90YWJsZXJhbmdlOjBmMTc0Mzk4ZWE1YzQ5ZjhhYjZiMmNlYzMyNDkxMGQzXzItMy0xLTEtMA_029b886d-ffcf-4607-9ae4-1ff5366bf36b">P2Y</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
      contextRef="i579d152d52624fc381bd7cae2c7ddd4a_D20180701-20190630"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNjAvZnJhZzozYmFjYzZmYWNhNmU0ZTMyYTU0NmNjZjhmNzBmY2Y4Yy90YWJsZTowZjE3NDM5OGVhNWM0OWY4YWI2YjJjZWMzMjQ5MTBkMy90YWJsZXJhbmdlOjBmMTc0Mzk4ZWE1YzQ5ZjhhYjZiMmNlYzMyNDkxMGQzXzItNS0xLTEtMA_189a3d21-98c0-47cd-9f47-0310873e0c1f">P2Y</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
      contextRef="i31f1c30559534af396751cc62e9e19a9_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNjAvZnJhZzozYmFjYzZmYWNhNmU0ZTMyYTU0NmNjZjhmNzBmY2Y4Yy90YWJsZTowZjE3NDM5OGVhNWM0OWY4YWI2YjJjZWMzMjQ5MTBkMy90YWJsZXJhbmdlOjBmMTc0Mzk4ZWE1YzQ5ZjhhYjZiMmNlYzMyNDkxMGQzXzMtMS0xLTEtMA_127a2565-a6c9-46e0-821f-8bf6e2730c0a"
      unitRef="usd">70000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
      contextRef="i956130d849c84807b9f6f7b055f5ebec_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNjAvZnJhZzozYmFjYzZmYWNhNmU0ZTMyYTU0NmNjZjhmNzBmY2Y4Yy90YWJsZTowZjE3NDM5OGVhNWM0OWY4YWI2YjJjZWMzMjQ5MTBkMy90YWJsZXJhbmdlOjBmMTc0Mzk4ZWE1YzQ5ZjhhYjZiMmNlYzMyNDkxMGQzXzMtMy0xLTEtMA_1f9f2f7c-3e0a-4398-82e8-2b9d63d5e27d"
      unitRef="usd">57000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
      contextRef="i579d152d52624fc381bd7cae2c7ddd4a_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNjAvZnJhZzozYmFjYzZmYWNhNmU0ZTMyYTU0NmNjZjhmNzBmY2Y4Yy90YWJsZTowZjE3NDM5OGVhNWM0OWY4YWI2YjJjZWMzMjQ5MTBkMy90YWJsZXJhbmdlOjBmMTc0Mzk4ZWE1YzQ5ZjhhYjZiMmNlYzMyNDkxMGQzXzMtNS0xLTEtMA_87338921-cc86-4e45-828b-4b2faeb8ace4"
      unitRef="usd">68000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="i00a6d666bf604826b24e68ddbd63eac4_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNjAvZnJhZzozYmFjYzZmYWNhNmU0ZTMyYTU0NmNjZjhmNzBmY2Y4Yy90ZXh0cmVnaW9uOjNiYWNjNmZhY2E2ZTRlMzJhNTQ2Y2NmOGY3MGZjZjhjXzU0OTc1NTgxNDM3MDA_0dabb7b7-3e66-469c-bd5a-1d49516a3bac"
      unitRef="shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNjAvZnJhZzozYmFjYzZmYWNhNmU0ZTMyYTU0NmNjZjhmNzBmY2Y4Yy90ZXh0cmVnaW9uOjNiYWNjNmZhY2E2ZTRlMzJhNTQ2Y2NmOGY3MGZjZjhjXzU0OTc1NTgxNDM3MDA_4fe32eb5-9a03-496e-9a71-db761555b0ff"
      unitRef="shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="ia31e9a409b874bb19d0ff6f2f39ecc09_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNjAvZnJhZzozYmFjYzZmYWNhNmU0ZTMyYTU0NmNjZjhmNzBmY2Y4Yy90ZXh0cmVnaW9uOjNiYWNjNmZhY2E2ZTRlMzJhNTQ2Y2NmOGY3MGZjZjhjXzU0OTc1NTgxNDM3MDA_e3a383ce-dbfd-4a13-86a9-9ba79c176f4b"
      unitRef="shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="i9fac2b1e8f484ef081a25d163aa2c3a6_D20200701-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNjAvZnJhZzozYmFjYzZmYWNhNmU0ZTMyYTU0NmNjZjhmNzBmY2Y4Yy90ZXh0cmVnaW9uOjNiYWNjNmZhY2E2ZTRlMzJhNTQ2Y2NmOGY3MGZjZjhjXzE0NjE_b85ed10e-aa5d-4b9c-84d3-0de56e2de8a4">P3Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <cah:ExercisablePeriodOfPlansInYears
      contextRef="i9fac2b1e8f484ef081a25d163aa2c3a6_D20200701-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNjAvZnJhZzozYmFjYzZmYWNhNmU0ZTMyYTU0NmNjZjhmNzBmY2Y4Yy90ZXh0cmVnaW9uOjNiYWNjNmZhY2E2ZTRlMzJhNTQ2Y2NmOGY3MGZjZjhjXzE1MDM_83ec77e0-d695-46d3-8929-898b47143678">P10Y</cah:ExercisablePeriodOfPlansInYears>
    <us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
      contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNjAvZnJhZzozYmFjYzZmYWNhNmU0ZTMyYTU0NmNjZjhmNzBmY2Y4Yy90ZXh0cmVnaW9uOjNiYWNjNmZhY2E2ZTRlMzJhNTQ2Y2NmOGY3MGZjZjhjXzQyMjY_e3216f75-6536-4838-b1c0-071b118608aa">&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes all stock option transactions under the Plans:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:56.616%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.480%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.343%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:26.061%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;(in millions, except per share amounts)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Stock&lt;br/&gt;Options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted-Average&lt;br/&gt;Exercise Price per&lt;br/&gt;Common Share&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Outstanding at June 30, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;63.78&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;42.36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Canceled and forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Outstanding at June 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;65.15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;43.08&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Canceled and forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Outstanding at June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;4&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;68.46&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Exercisable at June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;4&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;68.62&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="if6dc09eec4e74751b47cdf037a5b1860_I20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNjAvZnJhZzozYmFjYzZmYWNhNmU0ZTMyYTU0NmNjZjhmNzBmY2Y4Yy90YWJsZToxZjdmNmZkY2U2NTI0Zjc4OWU4NjY4NTFlNjUwZmI0Mi90YWJsZXJhbmdlOjFmN2Y2ZmRjZTY1MjRmNzg5ZTg2Njg1MWU2NTBmYjQyXzEtMS0xLTEtMA_6e64bd0c-6d7a-41cb-80ce-955c25e30620"
      unitRef="shares">6000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="if6dc09eec4e74751b47cdf037a5b1860_I20190630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNjAvZnJhZzozYmFjYzZmYWNhNmU0ZTMyYTU0NmNjZjhmNzBmY2Y4Yy90YWJsZToxZjdmNmZkY2U2NTI0Zjc4OWU4NjY4NTFlNjUwZmI0Mi90YWJsZXJhbmdlOjFmN2Y2ZmRjZTY1MjRmNzg5ZTg2Njg1MWU2NTBmYjQyXzEtMy0xLTEtMA_60053b25-93de-4500-adea-b6296d0a9488"
      unitRef="usdPerShare">63.78</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="ia31e9a409b874bb19d0ff6f2f39ecc09_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNjAvZnJhZzozYmFjYzZmYWNhNmU0ZTMyYTU0NmNjZjhmNzBmY2Y4Yy90YWJsZToxZjdmNmZkY2U2NTI0Zjc4OWU4NjY4NTFlNjUwZmI0Mi90YWJsZXJhbmdlOjFmN2Y2ZmRjZTY1MjRmNzg5ZTg2Njg1MWU2NTBmYjQyXzItMS0xLTEtMA_8301f52b-0b25-43e5-ab09-de8d341fdaf7"
      unitRef="shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="ia31e9a409b874bb19d0ff6f2f39ecc09_D20190701-20200630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNjAvZnJhZzozYmFjYzZmYWNhNmU0ZTMyYTU0NmNjZjhmNzBmY2Y4Yy90YWJsZToxZjdmNmZkY2U2NTI0Zjc4OWU4NjY4NTFlNjUwZmI0Mi90YWJsZXJhbmdlOjFmN2Y2ZmRjZTY1MjRmNzg5ZTg2Njg1MWU2NTBmYjQyXzItMy0xLTEtMA_ddc486d6-7258-4782-ab71-b3c3deff5e31"
      unitRef="usdPerShare">0</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="ia31e9a409b874bb19d0ff6f2f39ecc09_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNjAvZnJhZzozYmFjYzZmYWNhNmU0ZTMyYTU0NmNjZjhmNzBmY2Y4Yy90YWJsZToxZjdmNmZkY2U2NTI0Zjc4OWU4NjY4NTFlNjUwZmI0Mi90YWJsZXJhbmdlOjFmN2Y2ZmRjZTY1MjRmNzg5ZTg2Njg1MWU2NTBmYjQyXzMtMS0xLTEtMA_32552193-39a4-4a23-aef1-6029c8f482ff"
      unitRef="shares">1000000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="ia31e9a409b874bb19d0ff6f2f39ecc09_D20190701-20200630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNjAvZnJhZzozYmFjYzZmYWNhNmU0ZTMyYTU0NmNjZjhmNzBmY2Y4Yy90YWJsZToxZjdmNmZkY2U2NTI0Zjc4OWU4NjY4NTFlNjUwZmI0Mi90YWJsZXJhbmdlOjFmN2Y2ZmRjZTY1MjRmNzg5ZTg2Njg1MWU2NTBmYjQyXzMtMy0xLTEtMA_02888f8b-85cb-4f1a-880e-6756d254c82a"
      unitRef="usdPerShare">42.36</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
      contextRef="ia31e9a409b874bb19d0ff6f2f39ecc09_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNjAvZnJhZzozYmFjYzZmYWNhNmU0ZTMyYTU0NmNjZjhmNzBmY2Y4Yy90YWJsZToxZjdmNmZkY2U2NTI0Zjc4OWU4NjY4NTFlNjUwZmI0Mi90YWJsZXJhbmdlOjFmN2Y2ZmRjZTY1MjRmNzg5ZTg2Njg1MWU2NTBmYjQyXzQtMS0xLTEtMA_e6a301ae-d075-4400-92dd-04198b5d28a6"
      unitRef="shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
      contextRef="ia31e9a409b874bb19d0ff6f2f39ecc09_D20190701-20200630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNjAvZnJhZzozYmFjYzZmYWNhNmU0ZTMyYTU0NmNjZjhmNzBmY2Y4Yy90YWJsZToxZjdmNmZkY2U2NTI0Zjc4OWU4NjY4NTFlNjUwZmI0Mi90YWJsZXJhbmdlOjFmN2Y2ZmRjZTY1MjRmNzg5ZTg2Njg1MWU2NTBmYjQyXzQtMy0xLTEtMA_60ef644c-c230-4e66-8cbf-b5c11794db62"
      unitRef="usdPerShare">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="i299cea70f47b4fbe96772aaa8cc00b79_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNjAvZnJhZzozYmFjYzZmYWNhNmU0ZTMyYTU0NmNjZjhmNzBmY2Y4Yy90YWJsZToxZjdmNmZkY2U2NTI0Zjc4OWU4NjY4NTFlNjUwZmI0Mi90YWJsZXJhbmdlOjFmN2Y2ZmRjZTY1MjRmNzg5ZTg2Njg1MWU2NTBmYjQyXzUtMS0xLTEtMA_25af2f04-8990-4140-815e-857ea62417ef"
      unitRef="shares">5000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="i299cea70f47b4fbe96772aaa8cc00b79_I20200630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNjAvZnJhZzozYmFjYzZmYWNhNmU0ZTMyYTU0NmNjZjhmNzBmY2Y4Yy90YWJsZToxZjdmNmZkY2U2NTI0Zjc4OWU4NjY4NTFlNjUwZmI0Mi90YWJsZXJhbmdlOjFmN2Y2ZmRjZTY1MjRmNzg5ZTg2Njg1MWU2NTBmYjQyXzUtMy0xLTEtMA_9cd9f14b-2a35-402e-85a9-a52c910c6e00"
      unitRef="usdPerShare">65.15</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNjAvZnJhZzozYmFjYzZmYWNhNmU0ZTMyYTU0NmNjZjhmNzBmY2Y4Yy90YWJsZToxZjdmNmZkY2U2NTI0Zjc4OWU4NjY4NTFlNjUwZmI0Mi90YWJsZXJhbmdlOjFmN2Y2ZmRjZTY1MjRmNzg5ZTg2Njg1MWU2NTBmYjQyXzYtMS0xLTEtMA_8f67d16b-818d-4035-81c3-6ea0474f8eaa"
      unitRef="shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNjAvZnJhZzozYmFjYzZmYWNhNmU0ZTMyYTU0NmNjZjhmNzBmY2Y4Yy90YWJsZToxZjdmNmZkY2U2NTI0Zjc4OWU4NjY4NTFlNjUwZmI0Mi90YWJsZXJhbmdlOjFmN2Y2ZmRjZTY1MjRmNzg5ZTg2Njg1MWU2NTBmYjQyXzYtMy0xLTEtMA_2f788c50-a8b9-4d32-9ebf-b7eedcf134c8"
      unitRef="usdPerShare">0</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNjAvZnJhZzozYmFjYzZmYWNhNmU0ZTMyYTU0NmNjZjhmNzBmY2Y4Yy90YWJsZToxZjdmNmZkY2U2NTI0Zjc4OWU4NjY4NTFlNjUwZmI0Mi90YWJsZXJhbmdlOjFmN2Y2ZmRjZTY1MjRmNzg5ZTg2Njg1MWU2NTBmYjQyXzctMS0xLTEtMA_f0ccd87f-91ee-4084-9acd-f4cec7911f8e"
      unitRef="shares">1000000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNjAvZnJhZzozYmFjYzZmYWNhNmU0ZTMyYTU0NmNjZjhmNzBmY2Y4Yy90YWJsZToxZjdmNmZkY2U2NTI0Zjc4OWU4NjY4NTFlNjUwZmI0Mi90YWJsZXJhbmdlOjFmN2Y2ZmRjZTY1MjRmNzg5ZTg2Njg1MWU2NTBmYjQyXzctMy0xLTEtMA_3bf54816-8c2c-4f70-a745-5bb660058961"
      unitRef="usdPerShare">43.08</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
      contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNjAvZnJhZzozYmFjYzZmYWNhNmU0ZTMyYTU0NmNjZjhmNzBmY2Y4Yy90YWJsZToxZjdmNmZkY2U2NTI0Zjc4OWU4NjY4NTFlNjUwZmI0Mi90YWJsZXJhbmdlOjFmN2Y2ZmRjZTY1MjRmNzg5ZTg2Njg1MWU2NTBmYjQyXzgtMS0xLTEtMA_8a8f44a9-c582-4ad4-9384-ed9efd15491c"
      unitRef="shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
      contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNjAvZnJhZzozYmFjYzZmYWNhNmU0ZTMyYTU0NmNjZjhmNzBmY2Y4Yy90YWJsZToxZjdmNmZkY2U2NTI0Zjc4OWU4NjY4NTFlNjUwZmI0Mi90YWJsZXJhbmdlOjFmN2Y2ZmRjZTY1MjRmNzg5ZTg2Njg1MWU2NTBmYjQyXzgtMy0xLTEtMA_065c8a88-deb5-4e53-809f-e030d25d7c7c"
      unitRef="usdPerShare">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="i2e87824102b34590a0208cc7da91b5f5_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNjAvZnJhZzozYmFjYzZmYWNhNmU0ZTMyYTU0NmNjZjhmNzBmY2Y4Yy90YWJsZToxZjdmNmZkY2U2NTI0Zjc4OWU4NjY4NTFlNjUwZmI0Mi90YWJsZXJhbmdlOjFmN2Y2ZmRjZTY1MjRmNzg5ZTg2Njg1MWU2NTBmYjQyXzktMS0xLTEtMA_b4b1ec9a-3964-4f58-a4a0-fd4082a0e42b"
      unitRef="shares">4000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="i2e87824102b34590a0208cc7da91b5f5_I20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNjAvZnJhZzozYmFjYzZmYWNhNmU0ZTMyYTU0NmNjZjhmNzBmY2Y4Yy90YWJsZToxZjdmNmZkY2U2NTI0Zjc4OWU4NjY4NTFlNjUwZmI0Mi90YWJsZXJhbmdlOjFmN2Y2ZmRjZTY1MjRmNzg5ZTg2Njg1MWU2NTBmYjQyXzktMy0xLTEtMA_b3c22d2c-95d4-4961-b7c6-e93f35a12821"
      unitRef="usdPerShare">68.46</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
      contextRef="i2e87824102b34590a0208cc7da91b5f5_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNjAvZnJhZzozYmFjYzZmYWNhNmU0ZTMyYTU0NmNjZjhmNzBmY2Y4Yy90YWJsZToxZjdmNmZkY2U2NTI0Zjc4OWU4NjY4NTFlNjUwZmI0Mi90YWJsZXJhbmdlOjFmN2Y2ZmRjZTY1MjRmNzg5ZTg2Njg1MWU2NTBmYjQyXzEwLTEtMS0xLTA_1d0bb6cd-772c-41c2-b297-b7aadd1aaba9"
      unitRef="shares">4000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
      contextRef="i2e87824102b34590a0208cc7da91b5f5_I20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNjAvZnJhZzozYmFjYzZmYWNhNmU0ZTMyYTU0NmNjZjhmNzBmY2Y4Yy90YWJsZToxZjdmNmZkY2U2NTI0Zjc4OWU4NjY4NTFlNjUwZmI0Mi90YWJsZXJhbmdlOjFmN2Y2ZmRjZTY1MjRmNzg5ZTg2Njg1MWU2NTBmYjQyXzEwLTMtMS0xLTA_b896cbda-30d6-4697-95c3-33d4f6a18786"
      unitRef="usdPerShare">68.62</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice>
    <cah:AdditionalStockOptionPlanDataTableTextBlock
      contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNjAvZnJhZzozYmFjYzZmYWNhNmU0ZTMyYTU0NmNjZjhmNzBmY2Y4Yy90ZXh0cmVnaW9uOjNiYWNjNmZhY2E2ZTRlMzJhNTQ2Y2NmOGY3MGZjZjhjXzQyMDE_c01d9ca8-37eb-4392-bde0-bc820f1f01a2">&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table provides additional detail related to stock options:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.691%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:53.698%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.451%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.347%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.522%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.347%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.835%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;(in millions, except per share amounts)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Aggregate intrinsic value of outstanding options at period end&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;11&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Aggregate intrinsic value of exercisable options at period end&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;11&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Aggregate intrinsic value of exercised options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;10&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Net proceeds/(withholding) from share-based compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;32&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Excess tax benefits from share based compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total compensation cost, net of estimated forfeitures, related to unvested stock options not yet recognized, pre-tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total fair value of shares vested during the year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;3&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Weighted-average grant date fair value per stock option&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;12.94&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;8.26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;8.34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</cah:AdditionalStockOptionPlanDataTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="ib473c6ce356d4388a73564ce9f41c306_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNjAvZnJhZzozYmFjYzZmYWNhNmU0ZTMyYTU0NmNjZjhmNzBmY2Y4Yy90YWJsZTpkY2QzNzk2ZGQwZDM0NmZiYjNhMDllMDg2Y2IyZTVjMi90YWJsZXJhbmdlOmRjZDM3OTZkZDBkMzQ2ZmJiM2EwOWUwODZjYjJlNWMyXzEtMS0xLTEtMA_5cb6d88d-0c05-4a65-9b53-51136dd1e676"
      unitRef="usd">11000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="i6844f415cc38462c93502fde5a64b55f_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNjAvZnJhZzozYmFjYzZmYWNhNmU0ZTMyYTU0NmNjZjhmNzBmY2Y4Yy90YWJsZTpkY2QzNzk2ZGQwZDM0NmZiYjNhMDllMDg2Y2IyZTVjMi90YWJsZXJhbmdlOmRjZDM3OTZkZDBkMzQ2ZmJiM2EwOWUwODZjYjJlNWMyXzEtMy0xLTEtMA_dd9c78ee-a555-4bdc-b6b6-fb3526b6cd27"
      unitRef="usd">12000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="i0a3264d2aa5e4528bea7fa195a0d07b5_I20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNjAvZnJhZzozYmFjYzZmYWNhNmU0ZTMyYTU0NmNjZjhmNzBmY2Y4Yy90YWJsZTpkY2QzNzk2ZGQwZDM0NmZiYjNhMDllMDg2Y2IyZTVjMi90YWJsZXJhbmdlOmRjZDM3OTZkZDBkMzQ2ZmJiM2EwOWUwODZjYjJlNWMyXzEtNS0xLTEtMA_b5e6bf44-15d6-41e7-905e-08fef2cd5116"
      unitRef="usd">10000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
      contextRef="ib473c6ce356d4388a73564ce9f41c306_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNjAvZnJhZzozYmFjYzZmYWNhNmU0ZTMyYTU0NmNjZjhmNzBmY2Y4Yy90YWJsZTpkY2QzNzk2ZGQwZDM0NmZiYjNhMDllMDg2Y2IyZTVjMi90YWJsZXJhbmdlOmRjZDM3OTZkZDBkMzQ2ZmJiM2EwOWUwODZjYjJlNWMyXzItMS0xLTEtMA_7e30d46d-31e0-420e-a08b-20ee6a57c3b1"
      unitRef="usd">11000000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
      contextRef="i6844f415cc38462c93502fde5a64b55f_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNjAvZnJhZzozYmFjYzZmYWNhNmU0ZTMyYTU0NmNjZjhmNzBmY2Y4Yy90YWJsZTpkY2QzNzk2ZGQwZDM0NmZiYjNhMDllMDg2Y2IyZTVjMi90YWJsZXJhbmdlOmRjZDM3OTZkZDBkMzQ2ZmJiM2EwOWUwODZjYjJlNWMyXzItMy0xLTEtMA_adbf785a-48f7-4b12-8a10-8c6035b3c8e4"
      unitRef="usd">12000000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
      contextRef="i0a3264d2aa5e4528bea7fa195a0d07b5_I20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNjAvZnJhZzozYmFjYzZmYWNhNmU0ZTMyYTU0NmNjZjhmNzBmY2Y4Yy90YWJsZTpkY2QzNzk2ZGQwZDM0NmZiYjNhMDllMDg2Y2IyZTVjMi90YWJsZXJhbmdlOmRjZDM3OTZkZDBkMzQ2ZmJiM2EwOWUwODZjYjJlNWMyXzItNS0xLTEtMA_df41fb26-dab7-405f-aff3-defec4a8dbc5"
      unitRef="usd">10000000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
      contextRef="i9fac2b1e8f484ef081a25d163aa2c3a6_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNjAvZnJhZzozYmFjYzZmYWNhNmU0ZTMyYTU0NmNjZjhmNzBmY2Y4Yy90YWJsZTpkY2QzNzk2ZGQwZDM0NmZiYjNhMDllMDg2Y2IyZTVjMi90YWJsZXJhbmdlOmRjZDM3OTZkZDBkMzQ2ZmJiM2EwOWUwODZjYjJlNWMyXzMtMS0xLTEtMA_cb0ac67a-66ce-400b-bcf2-7148c421019b"
      unitRef="usd">10000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
      contextRef="i5ec12fa139c6458fb260601a40c83a61_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNjAvZnJhZzozYmFjYzZmYWNhNmU0ZTMyYTU0NmNjZjhmNzBmY2Y4Yy90YWJsZTpkY2QzNzk2ZGQwZDM0NmZiYjNhMDllMDg2Y2IyZTVjMi90YWJsZXJhbmdlOmRjZDM3OTZkZDBkMzQ2ZmJiM2EwOWUwODZjYjJlNWMyXzMtMy0xLTEtMA_f28de040-1ddf-44f8-8f7d-403f85c524e1"
      unitRef="usd">8000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
      contextRef="i4ff833c8f18c425d87db9b23fa00bd06_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNjAvZnJhZzozYmFjYzZmYWNhNmU0ZTMyYTU0NmNjZjhmNzBmY2Y4Yy90YWJsZTpkY2QzNzk2ZGQwZDM0NmZiYjNhMDllMDg2Y2IyZTVjMi90YWJsZXJhbmdlOmRjZDM3OTZkZDBkMzQ2ZmJiM2EwOWUwODZjYjJlNWMyXzMtNS0xLTEtMA_19b7d70c-c711-40c3-836d-b3b40ea55a05"
      unitRef="usd">1000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
    <cah:Netproceedstaxwithholdingsfromsharebasedcompensation
      contextRef="i9fac2b1e8f484ef081a25d163aa2c3a6_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNjAvZnJhZzozYmFjYzZmYWNhNmU0ZTMyYTU0NmNjZjhmNzBmY2Y4Yy90YWJsZTpkY2QzNzk2ZGQwZDM0NmZiYjNhMDllMDg2Y2IyZTVjMi90YWJsZXJhbmdlOmRjZDM3OTZkZDBkMzQ2ZmJiM2EwOWUwODZjYjJlNWMyXzQtMS0xLTEtMA_6d489a65-3370-4bd3-99fd-fad45be1868e"
      unitRef="usd">32000000</cah:Netproceedstaxwithholdingsfromsharebasedcompensation>
    <cah:Netproceedstaxwithholdingsfromsharebasedcompensation
      contextRef="i5ec12fa139c6458fb260601a40c83a61_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNjAvZnJhZzozYmFjYzZmYWNhNmU0ZTMyYTU0NmNjZjhmNzBmY2Y4Yy90YWJsZTpkY2QzNzk2ZGQwZDM0NmZiYjNhMDllMDg2Y2IyZTVjMi90YWJsZXJhbmdlOmRjZDM3OTZkZDBkMzQ2ZmJiM2EwOWUwODZjYjJlNWMyXzQtMy0xLTEtMA_53476298-20ab-4c69-871d-658be91cfe5e"
      unitRef="usd">26000000</cah:Netproceedstaxwithholdingsfromsharebasedcompensation>
    <cah:Netproceedstaxwithholdingsfromsharebasedcompensation
      contextRef="i4ff833c8f18c425d87db9b23fa00bd06_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNjAvZnJhZzozYmFjYzZmYWNhNmU0ZTMyYTU0NmNjZjhmNzBmY2Y4Yy90YWJsZTpkY2QzNzk2ZGQwZDM0NmZiYjNhMDllMDg2Y2IyZTVjMi90YWJsZXJhbmdlOmRjZDM3OTZkZDBkMzQ2ZmJiM2EwOWUwODZjYjJlNWMyXzQtNS0xLTEtMA_059ed624-6281-4eb8-a918-85393620c063"
      unitRef="usd">3000000</cah:Netproceedstaxwithholdingsfromsharebasedcompensation>
    <us-gaap:ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
      contextRef="i9fac2b1e8f484ef081a25d163aa2c3a6_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNjAvZnJhZzozYmFjYzZmYWNhNmU0ZTMyYTU0NmNjZjhmNzBmY2Y4Yy90YWJsZTpkY2QzNzk2ZGQwZDM0NmZiYjNhMDllMDg2Y2IyZTVjMi90YWJsZXJhbmdlOmRjZDM3OTZkZDBkMzQ2ZmJiM2EwOWUwODZjYjJlNWMyXzUtMS0xLTEtMA_6fdb590b-2a56-49fb-8943-e5f99c627970"
      unitRef="usd">-5000000</us-gaap:ExcessTaxBenefitFromShareBasedCompensationFinancingActivities>
    <us-gaap:ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
      contextRef="i5ec12fa139c6458fb260601a40c83a61_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNjAvZnJhZzozYmFjYzZmYWNhNmU0ZTMyYTU0NmNjZjhmNzBmY2Y4Yy90YWJsZTpkY2QzNzk2ZGQwZDM0NmZiYjNhMDllMDg2Y2IyZTVjMi90YWJsZXJhbmdlOmRjZDM3OTZkZDBkMzQ2ZmJiM2EwOWUwODZjYjJlNWMyXzUtMy0xLTEtMA_445f52a8-8ae6-4941-8ad7-944f03be7971"
      unitRef="usd">6000000</us-gaap:ExcessTaxBenefitFromShareBasedCompensationFinancingActivities>
    <us-gaap:ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
      contextRef="i4ff833c8f18c425d87db9b23fa00bd06_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNjAvZnJhZzozYmFjYzZmYWNhNmU0ZTMyYTU0NmNjZjhmNzBmY2Y4Yy90YWJsZTpkY2QzNzk2ZGQwZDM0NmZiYjNhMDllMDg2Y2IyZTVjMi90YWJsZXJhbmdlOmRjZDM3OTZkZDBkMzQ2ZmJiM2EwOWUwODZjYjJlNWMyXzUtNS0xLTEtMA_d77a2c7e-12a3-4983-a05d-f38a027f40ef"
      unitRef="usd">7000000</us-gaap:ExcessTaxBenefitFromShareBasedCompensationFinancingActivities>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
      contextRef="ib473c6ce356d4388a73564ce9f41c306_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNjAvZnJhZzozYmFjYzZmYWNhNmU0ZTMyYTU0NmNjZjhmNzBmY2Y4Yy90YWJsZTpkY2QzNzk2ZGQwZDM0NmZiYjNhMDllMDg2Y2IyZTVjMi90YWJsZXJhbmdlOmRjZDM3OTZkZDBkMzQ2ZmJiM2EwOWUwODZjYjJlNWMyXzYtMS0xLTEtMA_97dc39bf-6a5a-430b-ab4b-6f80e1b68512"
      unitRef="usd">0</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
      contextRef="i6844f415cc38462c93502fde5a64b55f_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNjAvZnJhZzozYmFjYzZmYWNhNmU0ZTMyYTU0NmNjZjhmNzBmY2Y4Yy90YWJsZTpkY2QzNzk2ZGQwZDM0NmZiYjNhMDllMDg2Y2IyZTVjMi90YWJsZXJhbmdlOmRjZDM3OTZkZDBkMzQ2ZmJiM2EwOWUwODZjYjJlNWMyXzYtMy0xLTEtMA_ec0f6a70-1bd7-4b2e-a1ee-cfb59292555a"
      unitRef="usd">1000000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
      contextRef="i0a3264d2aa5e4528bea7fa195a0d07b5_I20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNjAvZnJhZzozYmFjYzZmYWNhNmU0ZTMyYTU0NmNjZjhmNzBmY2Y4Yy90YWJsZTpkY2QzNzk2ZGQwZDM0NmZiYjNhMDllMDg2Y2IyZTVjMi90YWJsZXJhbmdlOmRjZDM3OTZkZDBkMzQ2ZmJiM2EwOWUwODZjYjJlNWMyXzYtNS0xLTEtMA_014218b3-d34a-4e8c-a1f4-a9419f9f16f6"
      unitRef="usd">5000000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
      contextRef="i9fac2b1e8f484ef081a25d163aa2c3a6_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNjAvZnJhZzozYmFjYzZmYWNhNmU0ZTMyYTU0NmNjZjhmNzBmY2Y4Yy90YWJsZTpkY2QzNzk2ZGQwZDM0NmZiYjNhMDllMDg2Y2IyZTVjMi90YWJsZXJhbmdlOmRjZDM3OTZkZDBkMzQ2ZmJiM2EwOWUwODZjYjJlNWMyXzctMS0xLTEtMA_429f0361-3779-46a3-92e5-3a1b767b7b3f"
      unitRef="usd">3000000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
      contextRef="i5ec12fa139c6458fb260601a40c83a61_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNjAvZnJhZzozYmFjYzZmYWNhNmU0ZTMyYTU0NmNjZjhmNzBmY2Y4Yy90YWJsZTpkY2QzNzk2ZGQwZDM0NmZiYjNhMDllMDg2Y2IyZTVjMi90YWJsZXJhbmdlOmRjZDM3OTZkZDBkMzQ2ZmJiM2EwOWUwODZjYjJlNWMyXzctMy0xLTEtMA_0a3a5500-f8ea-4926-9fe3-3a7ae9982c8f"
      unitRef="usd">8000000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
      contextRef="i4ff833c8f18c425d87db9b23fa00bd06_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNjAvZnJhZzozYmFjYzZmYWNhNmU0ZTMyYTU0NmNjZjhmNzBmY2Y4Yy90YWJsZTpkY2QzNzk2ZGQwZDM0NmZiYjNhMDllMDg2Y2IyZTVjMi90YWJsZXJhbmdlOmRjZDM3OTZkZDBkMzQ2ZmJiM2EwOWUwODZjYjJlNWMyXzctNS0xLTEtMA_b9341ff2-032d-4086-8e6c-a39882d8ff6f"
      unitRef="usd">20000000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i9fac2b1e8f484ef081a25d163aa2c3a6_D20200701-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNjAvZnJhZzozYmFjYzZmYWNhNmU0ZTMyYTU0NmNjZjhmNzBmY2Y4Yy90YWJsZTpkY2QzNzk2ZGQwZDM0NmZiYjNhMDllMDg2Y2IyZTVjMi90YWJsZXJhbmdlOmRjZDM3OTZkZDBkMzQ2ZmJiM2EwOWUwODZjYjJlNWMyXzgtMS0xLTEtMA_a170c38d-0e88-4c35-8a47-34acf0aad10b"
      unitRef="usdPerShare">12.94</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i5ec12fa139c6458fb260601a40c83a61_D20190701-20200630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNjAvZnJhZzozYmFjYzZmYWNhNmU0ZTMyYTU0NmNjZjhmNzBmY2Y4Yy90YWJsZTpkY2QzNzk2ZGQwZDM0NmZiYjNhMDllMDg2Y2IyZTVjMi90YWJsZXJhbmdlOmRjZDM3OTZkZDBkMzQ2ZmJiM2EwOWUwODZjYjJlNWMyXzgtMy0xLTEtMA_b5d1ae85-ed67-4161-85d6-8de99ac130fc"
      unitRef="usdPerShare">8.26</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i4ff833c8f18c425d87db9b23fa00bd06_D20180701-20190630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNjAvZnJhZzozYmFjYzZmYWNhNmU0ZTMyYTU0NmNjZjhmNzBmY2Y4Yy90YWJsZTpkY2QzNzk2ZGQwZDM0NmZiYjNhMDllMDg2Y2IyZTVjMi90YWJsZXJhbmdlOmRjZDM3OTZkZDBkMzQ2ZmJiM2EwOWUwODZjYjJlNWMyXzgtNS0xLTEtMA_57b525df-7890-4e22-9ee6-c70af15f4633"
      unitRef="usdPerShare">8.34</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <cah:RemainingStockOptionPlanDataTableTextBlock
      contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNjAvZnJhZzozYmFjYzZmYWNhNmU0ZTMyYTU0NmNjZjhmNzBmY2Y4Yy90ZXh0cmVnaW9uOjNiYWNjNmZhY2E2ZTRlMzJhNTQ2Y2NmOGY3MGZjZjhjXzQxNDE_6d8c801d-7974-4e83-a652-f62fdd10c23d">&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.382%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:65.049%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.148%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.352%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.148%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.352%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;(in years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Weighted-average remaining contractual life of outstanding options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;4&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;5&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;5&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Weighted-average remaining contractual life of exercisable options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;4&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;5&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;5&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Weighted-average period over which stock option compensation cost is expected to be recognized&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</cah:RemainingStockOptionPlanDataTableTextBlock>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
      contextRef="i9fac2b1e8f484ef081a25d163aa2c3a6_D20200701-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNjAvZnJhZzozYmFjYzZmYWNhNmU0ZTMyYTU0NmNjZjhmNzBmY2Y4Yy90YWJsZTplZGVlNGJjY2U4YTk0MDQzOGM5MTkwMDk2MDFkZTM4Ny90YWJsZXJhbmdlOmVkZWU0YmNjZThhOTQwNDM4YzkxOTAwOTYwMWRlMzg3XzEtMS0xLTEtMA_17769ada-f201-494d-87c6-0d0e06f7ef5c">P4Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
      contextRef="i5ec12fa139c6458fb260601a40c83a61_D20190701-20200630"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNjAvZnJhZzozYmFjYzZmYWNhNmU0ZTMyYTU0NmNjZjhmNzBmY2Y4Yy90YWJsZTplZGVlNGJjY2U4YTk0MDQzOGM5MTkwMDk2MDFkZTM4Ny90YWJsZXJhbmdlOmVkZWU0YmNjZThhOTQwNDM4YzkxOTAwOTYwMWRlMzg3XzEtMy0xLTEtMA_22ef05aa-aab0-4315-90a6-5186d67d8f94">P5Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
      contextRef="i4ff833c8f18c425d87db9b23fa00bd06_D20180701-20190630"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNjAvZnJhZzozYmFjYzZmYWNhNmU0ZTMyYTU0NmNjZjhmNzBmY2Y4Yy90YWJsZTplZGVlNGJjY2U4YTk0MDQzOGM5MTkwMDk2MDFkZTM4Ny90YWJsZXJhbmdlOmVkZWU0YmNjZThhOTQwNDM4YzkxOTAwOTYwMWRlMzg3XzEtNS0xLTEtMA_5cb93c72-a3a1-41a8-a8d7-ae719b048730">P5Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
      contextRef="i9fac2b1e8f484ef081a25d163aa2c3a6_D20200701-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNjAvZnJhZzozYmFjYzZmYWNhNmU0ZTMyYTU0NmNjZjhmNzBmY2Y4Yy90YWJsZTplZGVlNGJjY2U4YTk0MDQzOGM5MTkwMDk2MDFkZTM4Ny90YWJsZXJhbmdlOmVkZWU0YmNjZThhOTQwNDM4YzkxOTAwOTYwMWRlMzg3XzItMS0xLTEtMA_52bb573c-3d83-4058-95e7-60a6bc287e29">P4Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
      contextRef="i5ec12fa139c6458fb260601a40c83a61_D20190701-20200630"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNjAvZnJhZzozYmFjYzZmYWNhNmU0ZTMyYTU0NmNjZjhmNzBmY2Y4Yy90YWJsZTplZGVlNGJjY2U4YTk0MDQzOGM5MTkwMDk2MDFkZTM4Ny90YWJsZXJhbmdlOmVkZWU0YmNjZThhOTQwNDM4YzkxOTAwOTYwMWRlMzg3XzItMy0xLTEtMA_4ae622c5-9bcb-4359-9635-1b802d9d9c00">P5Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
      contextRef="i4ff833c8f18c425d87db9b23fa00bd06_D20180701-20190630"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNjAvZnJhZzozYmFjYzZmYWNhNmU0ZTMyYTU0NmNjZjhmNzBmY2Y4Yy90YWJsZTplZGVlNGJjY2U4YTk0MDQzOGM5MTkwMDk2MDFkZTM4Ny90YWJsZXJhbmdlOmVkZWU0YmNjZThhOTQwNDM4YzkxOTAwOTYwMWRlMzg3XzItNS0xLTEtMA_2d3f2a1c-732b-442a-ba04-2c5adb8198d3">P5Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
      contextRef="i9fac2b1e8f484ef081a25d163aa2c3a6_D20200701-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNjAvZnJhZzozYmFjYzZmYWNhNmU0ZTMyYTU0NmNjZjhmNzBmY2Y4Yy90YWJsZTplZGVlNGJjY2U4YTk0MDQzOGM5MTkwMDk2MDFkZTM4Ny90YWJsZXJhbmdlOmVkZWU0YmNjZThhOTQwNDM4YzkxOTAwOTYwMWRlMzg3XzMtMS0xLTEtMA_411875a7-6675-4b0f-9a4b-279d9797034d">P2Y</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
      contextRef="i5ec12fa139c6458fb260601a40c83a61_D20190701-20200630"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNjAvZnJhZzozYmFjYzZmYWNhNmU0ZTMyYTU0NmNjZjhmNzBmY2Y4Yy90YWJsZTplZGVlNGJjY2U4YTk0MDQzOGM5MTkwMDk2MDFkZTM4Ny90YWJsZXJhbmdlOmVkZWU0YmNjZThhOTQwNDM4YzkxOTAwOTYwMWRlMzg3XzMtMy0xLTEtMA_02b9181a-dfd6-414c-928f-6fb684c107cf">P1Y</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
      contextRef="i4ff833c8f18c425d87db9b23fa00bd06_D20180701-20190630"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNjAvZnJhZzozYmFjYzZmYWNhNmU0ZTMyYTU0NmNjZjhmNzBmY2Y4Yy90YWJsZTplZGVlNGJjY2U4YTk0MDQzOGM5MTkwMDk2MDFkZTM4Ny90YWJsZXJhbmdlOmVkZWU0YmNjZThhOTQwNDM4YzkxOTAwOTYwMWRlMzg3XzMtNS0xLTEtMA_a3339ed2-137a-4a32-865b-2ad4cfcdacc7">P1Y</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <cah:ExercisablePeriodOfPlansInYears
      contextRef="i6425a2ad601a4906adbbf99175836b8d_D20200701-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNjAvZnJhZzozYmFjYzZmYWNhNmU0ZTMyYTU0NmNjZjhmNzBmY2Y4Yy90ZXh0cmVnaW9uOjNiYWNjNmZhY2E2ZTRlMzJhNTQ2Y2NmOGY3MGZjZjhjXzI4OTI_377872dd-ebc5-4db9-83ba-35f9e48d8ceb">P10Y</cah:ExercisablePeriodOfPlansInYears>
    <us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock
      contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNjAvZnJhZzozYmFjYzZmYWNhNmU0ZTMyYTU0NmNjZjhmNzBmY2Y4Yy90ZXh0cmVnaW9uOjNiYWNjNmZhY2E2ZTRlMzJhNTQ2Y2NmOGY3MGZjZjhjXzQxNjY_9497ff4a-3726-4562-824f-d9d526bd930e"
      xsi:nil="true"/>
    <cah:VestingPeriodinyearsforShares
      contextRef="i217c2671c6f84df1ab8278415bc34c16_D20200701-20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNjAvZnJhZzozYmFjYzZmYWNhNmU0ZTMyYTU0NmNjZjhmNzBmY2Y4Yy90ZXh0cmVnaW9uOjNiYWNjNmZhY2E2ZTRlMzJhNTQ2Y2NmOGY3MGZjZjhjXzMxNTY_b6f193a6-aebe-4bca-814a-316bd24bda47"
      unitRef="vestingperiods">3</cah:VestingPeriodinyearsforShares>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage
      contextRef="i2072923bec904f33a89202306af14057_D20200701-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNjAvZnJhZzozYmFjYzZmYWNhNmU0ZTMyYTU0NmNjZjhmNzBmY2Y4Yy90ZXh0cmVnaW9uOjNiYWNjNmZhY2E2ZTRlMzJhNTQ2Y2NmOGY3MGZjZjhjXzMzMTk_81cf0376-bb93-4dbb-a29e-1db46692db76"
      unitRef="number">0</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage
      contextRef="i064bd318128c454cbd68ef31c37fed9d_D20200701-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNjAvZnJhZzozYmFjYzZmYWNhNmU0ZTMyYTU0NmNjZjhmNzBmY2Y4Yy90ZXh0cmVnaW9uOjNiYWNjNmZhY2E2ZTRlMzJhNTQ2Y2NmOGY3MGZjZjhjXzMzMjU_22e62abc-a373-47fb-b454-c76878be24f0"
      unitRef="number">2.40</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage>
    <us-gaap:ScheduleOfNonvestedPerformanceBasedUnitsActivityTableTextBlock
      contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNjAvZnJhZzozYmFjYzZmYWNhNmU0ZTMyYTU0NmNjZjhmNzBmY2Y4Yy90ZXh0cmVnaW9uOjNiYWNjNmZhY2E2ZTRlMzJhNTQ2Y2NmOGY3MGZjZjhjXzQxMzU_c6039185-4dcf-4fe0-bdad-3da5a3ec979b">&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes all transactions related to performance share units under the Plans (based on target award amounts):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.691%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:49.983%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.023%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.347%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:26.147%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;(in millions, except per share amounts)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Performance&lt;br/&gt;Share Units&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted-Average&lt;br/&gt;Grant Date Fair&lt;br/&gt;Value per Share&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Nonvested at June 30, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;0.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;51.45&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;44.03&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;48.40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Canceled and forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(0.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;50.92&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Nonvested at June 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;54.24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;55.45&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;42.72&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Canceled and forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(0.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;53.71&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nonvested at June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;1.2&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;54.89&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfNonvestedPerformanceBasedUnitsActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="i837fa9d3c1f04fb6aa54fd33592f52b3_I20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNjAvZnJhZzozYmFjYzZmYWNhNmU0ZTMyYTU0NmNjZjhmNzBmY2Y4Yy90YWJsZTo3ODZkYTk4M2E2MTU0NGFlODE4NWM3ZmM0NGE0YjA1MS90YWJsZXJhbmdlOjc4NmRhOTgzYTYxNTQ0YWU4MTg1YzdmYzQ0YTRiMDUxXzEtMS0xLTEtMA_2a545e5c-c4e3-44be-8cd7-514b848fc781"
      unitRef="shares">900000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="i837fa9d3c1f04fb6aa54fd33592f52b3_I20190630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNjAvZnJhZzozYmFjYzZmYWNhNmU0ZTMyYTU0NmNjZjhmNzBmY2Y4Yy90YWJsZTo3ODZkYTk4M2E2MTU0NGFlODE4NWM3ZmM0NGE0YjA1MS90YWJsZXJhbmdlOjc4NmRhOTgzYTYxNTQ0YWU4MTg1YzdmYzQ0YTRiMDUxXzEtMy0xLTEtMA_c300ed3c-63c1-4c14-a159-a4e6ac191aa4"
      unitRef="usdPerShare">51.45</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="i4f0f3088df2a4e019bd09b2ef236fef0_D20190701-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNjAvZnJhZzozYmFjYzZmYWNhNmU0ZTMyYTU0NmNjZjhmNzBmY2Y4Yy90YWJsZTo3ODZkYTk4M2E2MTU0NGFlODE4NWM3ZmM0NGE0YjA1MS90YWJsZXJhbmdlOjc4NmRhOTgzYTYxNTQ0YWU4MTg1YzdmYzQ0YTRiMDUxXzItMS0xLTEtMA_887c1c86-c892-4fbd-ba5a-5989c6d493bd"
      unitRef="shares">700000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i4f0f3088df2a4e019bd09b2ef236fef0_D20190701-20200630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNjAvZnJhZzozYmFjYzZmYWNhNmU0ZTMyYTU0NmNjZjhmNzBmY2Y4Yy90YWJsZTo3ODZkYTk4M2E2MTU0NGFlODE4NWM3ZmM0NGE0YjA1MS90YWJsZXJhbmdlOjc4NmRhOTgzYTYxNTQ0YWU4MTg1YzdmYzQ0YTRiMDUxXzItMy0xLTEtMA_770b97f2-e660-4f15-8cdf-4a70639b628c"
      unitRef="usdPerShare">44.03</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="i4f0f3088df2a4e019bd09b2ef236fef0_D20190701-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNjAvZnJhZzozYmFjYzZmYWNhNmU0ZTMyYTU0NmNjZjhmNzBmY2Y4Yy90YWJsZTo3ODZkYTk4M2E2MTU0NGFlODE4NWM3ZmM0NGE0YjA1MS90YWJsZXJhbmdlOjc4NmRhOTgzYTYxNTQ0YWU4MTg1YzdmYzQ0YTRiMDUxXzMtMS0xLTEtMA_efb5c137-aea9-4c4c-aecd-f7e6551323e7"
      unitRef="shares">100000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
      contextRef="i4f0f3088df2a4e019bd09b2ef236fef0_D20190701-20200630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNjAvZnJhZzozYmFjYzZmYWNhNmU0ZTMyYTU0NmNjZjhmNzBmY2Y4Yy90YWJsZTo3ODZkYTk4M2E2MTU0NGFlODE4NWM3ZmM0NGE0YjA1MS90YWJsZXJhbmdlOjc4NmRhOTgzYTYxNTQ0YWU4MTg1YzdmYzQ0YTRiMDUxXzMtMy0xLTEtMA_0ca071f1-2fc3-4fde-8e42-3cc8c9f5d47e"
      unitRef="usdPerShare">48.40</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
      contextRef="i4f0f3088df2a4e019bd09b2ef236fef0_D20190701-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNjAvZnJhZzozYmFjYzZmYWNhNmU0ZTMyYTU0NmNjZjhmNzBmY2Y4Yy90YWJsZTo3ODZkYTk4M2E2MTU0NGFlODE4NWM3ZmM0NGE0YjA1MS90YWJsZXJhbmdlOjc4NmRhOTgzYTYxNTQ0YWU4MTg1YzdmYzQ0YTRiMDUxXzQtMS0xLTEtMA_e8eda6b2-2cf6-461e-a56e-3bf662102555"
      unitRef="shares">200000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
      contextRef="i4f0f3088df2a4e019bd09b2ef236fef0_D20190701-20200630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNjAvZnJhZzozYmFjYzZmYWNhNmU0ZTMyYTU0NmNjZjhmNzBmY2Y4Yy90YWJsZTo3ODZkYTk4M2E2MTU0NGFlODE4NWM3ZmM0NGE0YjA1MS90YWJsZXJhbmdlOjc4NmRhOTgzYTYxNTQ0YWU4MTg1YzdmYzQ0YTRiMDUxXzQtMy0xLTEtMA_26742176-5560-4562-9667-8fe77d43f8c6"
      unitRef="usdPerShare">50.92</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="ib996ace534574f9da807e45a4e349efc_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNjAvZnJhZzozYmFjYzZmYWNhNmU0ZTMyYTU0NmNjZjhmNzBmY2Y4Yy90YWJsZTo3ODZkYTk4M2E2MTU0NGFlODE4NWM3ZmM0NGE0YjA1MS90YWJsZXJhbmdlOjc4NmRhOTgzYTYxNTQ0YWU4MTg1YzdmYzQ0YTRiMDUxXzUtMS0xLTEtMA_0a8e5a6b-61ca-442f-8760-1f56157b0655"
      unitRef="shares">1300000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="ib996ace534574f9da807e45a4e349efc_I20200630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNjAvZnJhZzozYmFjYzZmYWNhNmU0ZTMyYTU0NmNjZjhmNzBmY2Y4Yy90YWJsZTo3ODZkYTk4M2E2MTU0NGFlODE4NWM3ZmM0NGE0YjA1MS90YWJsZXJhbmdlOjc4NmRhOTgzYTYxNTQ0YWU4MTg1YzdmYzQ0YTRiMDUxXzUtMy0xLTEtMA_5c98fb8e-4f48-42fd-a832-722b55237192"
      unitRef="usdPerShare">54.24</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="i217c2671c6f84df1ab8278415bc34c16_D20200701-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNjAvZnJhZzozYmFjYzZmYWNhNmU0ZTMyYTU0NmNjZjhmNzBmY2Y4Yy90YWJsZTo3ODZkYTk4M2E2MTU0NGFlODE4NWM3ZmM0NGE0YjA1MS90YWJsZXJhbmdlOjc4NmRhOTgzYTYxNTQ0YWU4MTg1YzdmYzQ0YTRiMDUxXzYtMS0xLTEtMA_1bda76d9-1498-455e-af3f-e7ff1af32383"
      unitRef="shares">400000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i217c2671c6f84df1ab8278415bc34c16_D20200701-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNjAvZnJhZzozYmFjYzZmYWNhNmU0ZTMyYTU0NmNjZjhmNzBmY2Y4Yy90YWJsZTo3ODZkYTk4M2E2MTU0NGFlODE4NWM3ZmM0NGE0YjA1MS90YWJsZXJhbmdlOjc4NmRhOTgzYTYxNTQ0YWU4MTg1YzdmYzQ0YTRiMDUxXzYtMy0xLTEtMA_93eac170-0b7b-4c92-8a3c-6ea867e69434"
      unitRef="usdPerShare">55.45</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="i217c2671c6f84df1ab8278415bc34c16_D20200701-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNjAvZnJhZzozYmFjYzZmYWNhNmU0ZTMyYTU0NmNjZjhmNzBmY2Y4Yy90YWJsZTo3ODZkYTk4M2E2MTU0NGFlODE4NWM3ZmM0NGE0YjA1MS90YWJsZXJhbmdlOjc4NmRhOTgzYTYxNTQ0YWU4MTg1YzdmYzQ0YTRiMDUxXzctMS0xLTEtMA_6ea23060-ef3f-48a8-acd7-77f1be56afb4"
      unitRef="shares">100000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
      contextRef="i217c2671c6f84df1ab8278415bc34c16_D20200701-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNjAvZnJhZzozYmFjYzZmYWNhNmU0ZTMyYTU0NmNjZjhmNzBmY2Y4Yy90YWJsZTo3ODZkYTk4M2E2MTU0NGFlODE4NWM3ZmM0NGE0YjA1MS90YWJsZXJhbmdlOjc4NmRhOTgzYTYxNTQ0YWU4MTg1YzdmYzQ0YTRiMDUxXzctMy0xLTEtMA_ccb4455a-a308-4381-bff0-ac9852346d5b"
      unitRef="usdPerShare">42.72</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
      contextRef="i217c2671c6f84df1ab8278415bc34c16_D20200701-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNjAvZnJhZzozYmFjYzZmYWNhNmU0ZTMyYTU0NmNjZjhmNzBmY2Y4Yy90YWJsZTo3ODZkYTk4M2E2MTU0NGFlODE4NWM3ZmM0NGE0YjA1MS90YWJsZXJhbmdlOjc4NmRhOTgzYTYxNTQ0YWU4MTg1YzdmYzQ0YTRiMDUxXzgtMS0xLTEtMA_bf099aa7-31c9-4e3b-b7c9-666e58a92b9f"
      unitRef="shares">400000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
      contextRef="i217c2671c6f84df1ab8278415bc34c16_D20200701-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNjAvZnJhZzozYmFjYzZmYWNhNmU0ZTMyYTU0NmNjZjhmNzBmY2Y4Yy90YWJsZTo3ODZkYTk4M2E2MTU0NGFlODE4NWM3ZmM0NGE0YjA1MS90YWJsZXJhbmdlOjc4NmRhOTgzYTYxNTQ0YWU4MTg1YzdmYzQ0YTRiMDUxXzgtMy0xLTEtMA_94046633-564e-4fdf-ad62-27d40d58f59b"
      unitRef="usdPerShare">53.71</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="i09a66472ecae47489b82c3a6aade6b47_I20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNjAvZnJhZzozYmFjYzZmYWNhNmU0ZTMyYTU0NmNjZjhmNzBmY2Y4Yy90YWJsZTo3ODZkYTk4M2E2MTU0NGFlODE4NWM3ZmM0NGE0YjA1MS90YWJsZXJhbmdlOjc4NmRhOTgzYTYxNTQ0YWU4MTg1YzdmYzQ0YTRiMDUxXzktMS0xLTEtMA_411b79a5-65c0-4e75-9879-b761d69fa558"
      unitRef="shares">1200000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="i09a66472ecae47489b82c3a6aade6b47_I20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNjAvZnJhZzozYmFjYzZmYWNhNmU0ZTMyYTU0NmNjZjhmNzBmY2Y4Yy90YWJsZTo3ODZkYTk4M2E2MTU0NGFlODE4NWM3ZmM0NGE0YjA1MS90YWJsZXJhbmdlOjc4NmRhOTgzYTYxNTQ0YWU4MTg1YzdmYzQ0YTRiMDUxXzktMy0xLTEtMA_961fb6db-1ab4-40f9-a907-7dea02a19cb2"
      unitRef="usdPerShare">54.89</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <cah:AdditionalPerformanceShareUnitsDataTableTextBlock
      contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNjAvZnJhZzozYmFjYzZmYWNhNmU0ZTMyYTU0NmNjZjhmNzBmY2Y4Yy90ZXh0cmVnaW9uOjNiYWNjNmZhY2E2ZTRlMzJhNTQ2Y2NmOGY3MGZjZjhjXzQxNDI_7a2f04b2-cfc9-4231-8803-66f0b06c233c">&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table provides additional data related to performance share unit activity:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.691%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:58.652%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.283%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.347%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.283%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.347%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.288%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total compensation cost, net of estimated forfeitures, related to nonvested performance share units not yet recognized, pre-tax&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;26&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Weighted-average period over which performance share unit cost is expected to be recognized (in years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total fair value of shares vested during the year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;1&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</cah:AdditionalPerformanceShareUnitsDataTableTextBlock>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
      contextRef="i09a66472ecae47489b82c3a6aade6b47_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNjAvZnJhZzozYmFjYzZmYWNhNmU0ZTMyYTU0NmNjZjhmNzBmY2Y4Yy90YWJsZTpkY2ExNzc1NGI3NzI0OWI3YThjYWNjZDM2OTE3MmNkZi90YWJsZXJhbmdlOmRjYTE3NzU0Yjc3MjQ5YjdhOGNhY2NkMzY5MTcyY2RmXzEtMS0xLTEtMA_f9bda7bb-de2a-4df9-936d-cc39441fb59c"
      unitRef="usd">26000000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
      contextRef="ib996ace534574f9da807e45a4e349efc_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNjAvZnJhZzozYmFjYzZmYWNhNmU0ZTMyYTU0NmNjZjhmNzBmY2Y4Yy90YWJsZTpkY2ExNzc1NGI3NzI0OWI3YThjYWNjZDM2OTE3MmNkZi90YWJsZXJhbmdlOmRjYTE3NzU0Yjc3MjQ5YjdhOGNhY2NkMzY5MTcyY2RmXzEtMy0xLTEtMA_35558724-f425-42d1-9a52-1a4bf1d7ff95"
      unitRef="usd">29000000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
      contextRef="i837fa9d3c1f04fb6aa54fd33592f52b3_I20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNjAvZnJhZzozYmFjYzZmYWNhNmU0ZTMyYTU0NmNjZjhmNzBmY2Y4Yy90YWJsZTpkY2ExNzc1NGI3NzI0OWI3YThjYWNjZDM2OTE3MmNkZi90YWJsZXJhbmdlOmRjYTE3NzU0Yjc3MjQ5YjdhOGNhY2NkMzY5MTcyY2RmXzEtNS0xLTEtMA_a66003be-ac61-4bf1-81f9-9ccf483ea8d7"
      unitRef="usd">12000000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
      contextRef="i217c2671c6f84df1ab8278415bc34c16_D20200701-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNjAvZnJhZzozYmFjYzZmYWNhNmU0ZTMyYTU0NmNjZjhmNzBmY2Y4Yy90YWJsZTpkY2ExNzc1NGI3NzI0OWI3YThjYWNjZDM2OTE3MmNkZi90YWJsZXJhbmdlOmRjYTE3NzU0Yjc3MjQ5YjdhOGNhY2NkMzY5MTcyY2RmXzItMS0xLTEtMA_47bb9bb6-8122-4912-a963-6a6b375d387a">P2Y</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
      contextRef="i4f0f3088df2a4e019bd09b2ef236fef0_D20190701-20200630"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNjAvZnJhZzozYmFjYzZmYWNhNmU0ZTMyYTU0NmNjZjhmNzBmY2Y4Yy90YWJsZTpkY2ExNzc1NGI3NzI0OWI3YThjYWNjZDM2OTE3MmNkZi90YWJsZXJhbmdlOmRjYTE3NzU0Yjc3MjQ5YjdhOGNhY2NkMzY5MTcyY2RmXzItMy0xLTEtMA_689bedfe-c7cb-4ae8-9ef9-369cd2bcf416">P2Y</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
      contextRef="id7eb385b0eaf45a0aa833269191797b8_D20180701-20190630"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNjAvZnJhZzozYmFjYzZmYWNhNmU0ZTMyYTU0NmNjZjhmNzBmY2Y4Yy90YWJsZTpkY2ExNzc1NGI3NzI0OWI3YThjYWNjZDM2OTE3MmNkZi90YWJsZXJhbmdlOmRjYTE3NzU0Yjc3MjQ5YjdhOGNhY2NkMzY5MTcyY2RmXzItNS0xLTEtMA_3a1ac462-d31d-47b6-aa67-6e56df960b47">P2Y</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
      contextRef="i217c2671c6f84df1ab8278415bc34c16_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNjAvZnJhZzozYmFjYzZmYWNhNmU0ZTMyYTU0NmNjZjhmNzBmY2Y4Yy90YWJsZTpkY2ExNzc1NGI3NzI0OWI3YThjYWNjZDM2OTE3MmNkZi90YWJsZXJhbmdlOmRjYTE3NzU0Yjc3MjQ5YjdhOGNhY2NkMzY5MTcyY2RmXzMtMS0xLTEtMA_7be0b0e0-3fa2-466b-a65f-10c69f2c352f"
      unitRef="usd">1000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
      contextRef="i4f0f3088df2a4e019bd09b2ef236fef0_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNjAvZnJhZzozYmFjYzZmYWNhNmU0ZTMyYTU0NmNjZjhmNzBmY2Y4Yy90YWJsZTpkY2ExNzc1NGI3NzI0OWI3YThjYWNjZDM2OTE3MmNkZi90YWJsZXJhbmdlOmRjYTE3NzU0Yjc3MjQ5YjdhOGNhY2NkMzY5MTcyY2RmXzMtMy0xLTEtMA_50163f7d-0098-444e-a8ff-d13afa300e30"
      unitRef="usd">5000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
      contextRef="id7eb385b0eaf45a0aa833269191797b8_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNjAvZnJhZzozYmFjYzZmYWNhNmU0ZTMyYTU0NmNjZjhmNzBmY2Y4Yy90YWJsZTpkY2ExNzc1NGI3NzI0OWI3YThjYWNjZDM2OTE3MmNkZi90YWJsZXJhbmdlOmRjYTE3NzU0Yjc3MjQ5YjdhOGNhY2NkMzY5MTcyY2RmXzMtNS0xLTEtMA_4795a370-1431-4a75-bc71-2b16af2d7a5f"
      unitRef="usd">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue>
    <us-gaap:DefinedContributionPlanCostRecognized
      contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNjAvZnJhZzozYmFjYzZmYWNhNmU0ZTMyYTU0NmNjZjhmNzBmY2Y4Yy90ZXh0cmVnaW9uOjNiYWNjNmZhY2E2ZTRlMzJhNTQ2Y2NmOGY3MGZjZjhjXzQwNzU_de01263d-64d5-46c6-83e7-f826fe3ca09f"
      unitRef="usd">55000000</us-gaap:DefinedContributionPlanCostRecognized>
    <us-gaap:DefinedContributionPlanCostRecognized
      contextRef="ia31e9a409b874bb19d0ff6f2f39ecc09_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNjAvZnJhZzozYmFjYzZmYWNhNmU0ZTMyYTU0NmNjZjhmNzBmY2Y4Yy90ZXh0cmVnaW9uOjNiYWNjNmZhY2E2ZTRlMzJhNTQ2Y2NmOGY3MGZjZjhjXzQwNzk_c4c85960-c00d-4cee-8af1-cbb4c0f575fb"
      unitRef="usd">66000000</us-gaap:DefinedContributionPlanCostRecognized>
    <us-gaap:DefinedContributionPlanCostRecognized
      contextRef="i00a6d666bf604826b24e68ddbd63eac4_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNjAvZnJhZzozYmFjYzZmYWNhNmU0ZTMyYTU0NmNjZjhmNzBmY2Y4Yy90ZXh0cmVnaW9uOjNiYWNjNmZhY2E2ZTRlMzJhNTQ2Y2NmOGY3MGZjZjhjXzQwODY_0927a0f4-fc09-4adb-9582-cdf699670e54"
      unitRef="usd">99000000</us-gaap:DefinedContributionPlanCostRecognized>
    <srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock
      contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNzIvZnJhZzo2YzUyMDU0YWU0ZTk0NTlmOTdjN2ExNDljMmZhNGU3Mi90ZXh0cmVnaW9uOjZjNTIwNTRhZTRlOTQ1OWY5N2M3YTE0OWMyZmE0ZTcyXzY0Mg_7be7b2e0-00ba-44b5-8697-7111f6c7ee79">&lt;div style="margin-bottom:3pt;text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:14pt;font-weight:700;line-height:120%"&gt;Cardinal Health, Inc. and Subsidiaries&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:center"&gt;&lt;span style="color:#ff0000;font-family:'Arial Narrow',sans-serif;font-size:13pt;font-weight:700;line-height:120%"&gt;Schedule&#160;II - Valuation and Qualifying Accounts&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:27.471%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.036%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.544%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.544%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.544%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.544%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.594%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Balance&#160;at&lt;br/&gt;Beginning of Period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Charged&#160;to Costs&lt;br/&gt;and Expenses (1)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Charged&#160;to&lt;br/&gt;Other Accounts&#160;(2)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Deductions&#160;(3)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Balance&#160;at&lt;br/&gt;End of Period&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fiscal 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Accounts receivable&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;206&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;129&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;1&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(94)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;242&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Finance notes receivable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;27&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;5&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(20)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;12&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Sales returns and allowances&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;495&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2,568&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(2,374)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;689&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;1&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;1&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;729&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2,702&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;1&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(2,488)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;944&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1.5pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1.5pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1.5pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1.5pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1.5pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1.5pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1.5pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1.5pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1.5pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Fiscal 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Accounts receivable&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;193&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;139&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(127)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;206&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Finance notes receivable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Sales returns and allowances&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;479&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,253&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(2,237)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;495&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;687&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,407&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(2,366)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;729&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Fiscal 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Accounts receivable&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;139&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;140&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(87)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;193&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Finance notes receivable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Sales returns and allowances&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;479&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,205&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(2,205)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;479&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;626&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,353&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(2,293)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;687&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:10pt"&gt;Fiscal 2021, 2020 and 2019 include $70 million, $49 million and $60 million, respectively, for reserves related to service charges and customer pricing disputes, excluded from provision for bad debts on the consolidated statements of cash flows and classified as a reduction in revenue in the consolidated statements of earnings/(loss).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:10pt"&gt;Recoveries of amounts provided for or written off in prior years was $1 million in each fiscal year 2021, 2020 and 2019.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:10pt"&gt;Write-off of uncollectible accounts or actual sales returns.&lt;/span&gt;&lt;/div&gt;The sum of the components may not equal the total due to rounding.</srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="ida278becedcc42e688e90f303ce681a6_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNzIvZnJhZzo2YzUyMDU0YWU0ZTk0NTlmOTdjN2ExNDljMmZhNGU3Mi90YWJsZTpjMjBmNmY4ZGNmNTk0ZmUyOWY2OTNiN2MxZjliNzU3Mi90YWJsZXJhbmdlOmMyMGY2ZjhkY2Y1OTRmZTI5ZjY5M2I3YzFmOWI3NTcyXzItMS0xLTEtMA_a388bfe1-927b-4cb6-b275-454d64e6101e"
      unitRef="usd">206000000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense
      contextRef="i55e9481bb093412a97e842b3caeb64ec_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNzIvZnJhZzo2YzUyMDU0YWU0ZTk0NTlmOTdjN2ExNDljMmZhNGU3Mi90YWJsZTpjMjBmNmY4ZGNmNTk0ZmUyOWY2OTNiN2MxZjliNzU3Mi90YWJsZXJhbmdlOmMyMGY2ZjhkY2Y1OTRmZTI5ZjY5M2I3YzFmOWI3NTcyXzItMy0xLTEtMA_ee758d27-d959-486b-ba8a-f60744b717a3"
      unitRef="usd">129000000</us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense>
    <us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts
      contextRef="i55e9481bb093412a97e842b3caeb64ec_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNzIvZnJhZzo2YzUyMDU0YWU0ZTk0NTlmOTdjN2ExNDljMmZhNGU3Mi90YWJsZTpjMjBmNmY4ZGNmNTk0ZmUyOWY2OTNiN2MxZjliNzU3Mi90YWJsZXJhbmdlOmMyMGY2ZjhkY2Y1OTRmZTI5ZjY5M2I3YzFmOWI3NTcyXzItNS0xLTEtMA_4a9a8d07-d3dd-4af3-896c-c197e6f3f090"
      unitRef="usd">1000000</us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts>
    <us-gaap:ValuationAllowancesAndReservesDeductions
      contextRef="i55e9481bb093412a97e842b3caeb64ec_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNzIvZnJhZzo2YzUyMDU0YWU0ZTk0NTlmOTdjN2ExNDljMmZhNGU3Mi90YWJsZTpjMjBmNmY4ZGNmNTk0ZmUyOWY2OTNiN2MxZjliNzU3Mi90YWJsZXJhbmdlOmMyMGY2ZjhkY2Y1OTRmZTI5ZjY5M2I3YzFmOWI3NTcyXzItNy0xLTEtMA_ecbea82e-75d4-40c7-962a-a5ece71f5ec6"
      unitRef="usd">94000000</us-gaap:ValuationAllowancesAndReservesDeductions>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="iaf39bca192e042209819db3ca973f9f5_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNzIvZnJhZzo2YzUyMDU0YWU0ZTk0NTlmOTdjN2ExNDljMmZhNGU3Mi90YWJsZTpjMjBmNmY4ZGNmNTk0ZmUyOWY2OTNiN2MxZjliNzU3Mi90YWJsZXJhbmdlOmMyMGY2ZjhkY2Y1OTRmZTI5ZjY5M2I3YzFmOWI3NTcyXzItOS0xLTEtMA_e2baecf5-20b7-4918-bf52-772c1465c16b"
      unitRef="usd">242000000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="i8572a6af84c14033a1b8f2ffeeaa45fa_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNzIvZnJhZzo2YzUyMDU0YWU0ZTk0NTlmOTdjN2ExNDljMmZhNGU3Mi90YWJsZTpjMjBmNmY4ZGNmNTk0ZmUyOWY2OTNiN2MxZjliNzU3Mi90YWJsZXJhbmdlOmMyMGY2ZjhkY2Y1OTRmZTI5ZjY5M2I3YzFmOWI3NTcyXzMtMS0xLTEtMA_081b4523-6b04-4c65-9b29-fb0ffce5f778"
      unitRef="usd">27000000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense
      contextRef="i1206afb1bf5546759bbe9e6ed075350a_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNzIvZnJhZzo2YzUyMDU0YWU0ZTk0NTlmOTdjN2ExNDljMmZhNGU3Mi90YWJsZTpjMjBmNmY4ZGNmNTk0ZmUyOWY2OTNiN2MxZjliNzU3Mi90YWJsZXJhbmdlOmMyMGY2ZjhkY2Y1OTRmZTI5ZjY5M2I3YzFmOWI3NTcyXzMtMy0xLTEtMA_2e00b519-0e57-4ee6-a2e1-ff3d2e900c8a"
      unitRef="usd">5000000</us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense>
    <us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts
      contextRef="i1206afb1bf5546759bbe9e6ed075350a_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNzIvZnJhZzo2YzUyMDU0YWU0ZTk0NTlmOTdjN2ExNDljMmZhNGU3Mi90YWJsZTpjMjBmNmY4ZGNmNTk0ZmUyOWY2OTNiN2MxZjliNzU3Mi90YWJsZXJhbmdlOmMyMGY2ZjhkY2Y1OTRmZTI5ZjY5M2I3YzFmOWI3NTcyXzMtNS0xLTEtMA_d355f08c-384e-4e96-bebd-584b530ba40b"
      unitRef="usd">0</us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts>
    <us-gaap:ValuationAllowancesAndReservesDeductions
      contextRef="i1206afb1bf5546759bbe9e6ed075350a_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNzIvZnJhZzo2YzUyMDU0YWU0ZTk0NTlmOTdjN2ExNDljMmZhNGU3Mi90YWJsZTpjMjBmNmY4ZGNmNTk0ZmUyOWY2OTNiN2MxZjliNzU3Mi90YWJsZXJhbmdlOmMyMGY2ZjhkY2Y1OTRmZTI5ZjY5M2I3YzFmOWI3NTcyXzMtNy0xLTEtMA_e57003de-cc5f-40d6-a1cf-4c9a236ab9e9"
      unitRef="usd">20000000</us-gaap:ValuationAllowancesAndReservesDeductions>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="id99ac5e3640e4d909d5ebe92cc1a2ccc_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNzIvZnJhZzo2YzUyMDU0YWU0ZTk0NTlmOTdjN2ExNDljMmZhNGU3Mi90YWJsZTpjMjBmNmY4ZGNmNTk0ZmUyOWY2OTNiN2MxZjliNzU3Mi90YWJsZXJhbmdlOmMyMGY2ZjhkY2Y1OTRmZTI5ZjY5M2I3YzFmOWI3NTcyXzMtOS0xLTEtMA_b6a896a2-c6f9-4710-ad0e-f5c09fe6acac"
      unitRef="usd">12000000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="ie3de935dc1e7482faedb9bef40e18bc4_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNzIvZnJhZzo2YzUyMDU0YWU0ZTk0NTlmOTdjN2ExNDljMmZhNGU3Mi90YWJsZTpjMjBmNmY4ZGNmNTk0ZmUyOWY2OTNiN2MxZjliNzU3Mi90YWJsZXJhbmdlOmMyMGY2ZjhkY2Y1OTRmZTI5ZjY5M2I3YzFmOWI3NTcyXzQtMS0xLTEtMA_66841199-2891-469a-9d8c-4925a45d7599"
      unitRef="usd">495000000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense
      contextRef="i366d2f82d08341029a0c689efe436023_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNzIvZnJhZzo2YzUyMDU0YWU0ZTk0NTlmOTdjN2ExNDljMmZhNGU3Mi90YWJsZTpjMjBmNmY4ZGNmNTk0ZmUyOWY2OTNiN2MxZjliNzU3Mi90YWJsZXJhbmdlOmMyMGY2ZjhkY2Y1OTRmZTI5ZjY5M2I3YzFmOWI3NTcyXzQtMy0xLTEtMA_899965b7-2195-4a6f-8612-a47fb3ffe822"
      unitRef="usd">2568000000</us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense>
    <us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts
      contextRef="i366d2f82d08341029a0c689efe436023_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNzIvZnJhZzo2YzUyMDU0YWU0ZTk0NTlmOTdjN2ExNDljMmZhNGU3Mi90YWJsZTpjMjBmNmY4ZGNmNTk0ZmUyOWY2OTNiN2MxZjliNzU3Mi90YWJsZXJhbmdlOmMyMGY2ZjhkY2Y1OTRmZTI5ZjY5M2I3YzFmOWI3NTcyXzQtNS0xLTEtMA_7caa6251-3af0-44d2-a899-db7c7ba4c8d3"
      unitRef="usd">0</us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts>
    <us-gaap:ValuationAllowancesAndReservesDeductions
      contextRef="i366d2f82d08341029a0c689efe436023_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNzIvZnJhZzo2YzUyMDU0YWU0ZTk0NTlmOTdjN2ExNDljMmZhNGU3Mi90YWJsZTpjMjBmNmY4ZGNmNTk0ZmUyOWY2OTNiN2MxZjliNzU3Mi90YWJsZXJhbmdlOmMyMGY2ZjhkY2Y1OTRmZTI5ZjY5M2I3YzFmOWI3NTcyXzQtNy0xLTEtMA_ec8fb846-aed7-4ca7-bedc-c63b4a312426"
      unitRef="usd">2374000000</us-gaap:ValuationAllowancesAndReservesDeductions>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="i35ade71063ad48868742425618cf24be_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNzIvZnJhZzo2YzUyMDU0YWU0ZTk0NTlmOTdjN2ExNDljMmZhNGU3Mi90YWJsZTpjMjBmNmY4ZGNmNTk0ZmUyOWY2OTNiN2MxZjliNzU3Mi90YWJsZXJhbmdlOmMyMGY2ZjhkY2Y1OTRmZTI5ZjY5M2I3YzFmOWI3NTcyXzQtOS0xLTEtMA_a5fe1c6a-2c32-43bc-a1e8-3fb1333b5054"
      unitRef="usd">689000000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="i957454a121b24a28a13445f765e222b9_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNzIvZnJhZzo2YzUyMDU0YWU0ZTk0NTlmOTdjN2ExNDljMmZhNGU3Mi90YWJsZTpjMjBmNmY4ZGNmNTk0ZmUyOWY2OTNiN2MxZjliNzU3Mi90YWJsZXJhbmdlOmMyMGY2ZjhkY2Y1OTRmZTI5ZjY5M2I3YzFmOWI3NTcyXzUtMS0xLTEtMA_71ce7cc9-1e50-4197-a955-4e7697bab30d"
      unitRef="usd">1000000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense
      contextRef="i28620b092acd45fdaaad27b89277c8ad_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNzIvZnJhZzo2YzUyMDU0YWU0ZTk0NTlmOTdjN2ExNDljMmZhNGU3Mi90YWJsZTpjMjBmNmY4ZGNmNTk0ZmUyOWY2OTNiN2MxZjliNzU3Mi90YWJsZXJhbmdlOmMyMGY2ZjhkY2Y1OTRmZTI5ZjY5M2I3YzFmOWI3NTcyXzUtMy0xLTEtMA_b80faae0-78d8-45a2-bf46-e53e38219bca"
      unitRef="usd">0</us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense>
    <us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts
      contextRef="i28620b092acd45fdaaad27b89277c8ad_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNzIvZnJhZzo2YzUyMDU0YWU0ZTk0NTlmOTdjN2ExNDljMmZhNGU3Mi90YWJsZTpjMjBmNmY4ZGNmNTk0ZmUyOWY2OTNiN2MxZjliNzU3Mi90YWJsZXJhbmdlOmMyMGY2ZjhkY2Y1OTRmZTI5ZjY5M2I3YzFmOWI3NTcyXzUtNS0xLTEtMA_96b4aec4-115c-411c-8318-e88c0a5a98bf"
      unitRef="usd">0</us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts>
    <us-gaap:ValuationAllowancesAndReservesDeductions
      contextRef="i28620b092acd45fdaaad27b89277c8ad_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNzIvZnJhZzo2YzUyMDU0YWU0ZTk0NTlmOTdjN2ExNDljMmZhNGU3Mi90YWJsZTpjMjBmNmY4ZGNmNTk0ZmUyOWY2OTNiN2MxZjliNzU3Mi90YWJsZXJhbmdlOmMyMGY2ZjhkY2Y1OTRmZTI5ZjY5M2I3YzFmOWI3NTcyXzUtNy0xLTEtMA_6e4cf0e5-1711-4644-870a-2454232e0904"
      unitRef="usd">0</us-gaap:ValuationAllowancesAndReservesDeductions>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="ice14673b485d4f138bf5ec444359bc54_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNzIvZnJhZzo2YzUyMDU0YWU0ZTk0NTlmOTdjN2ExNDljMmZhNGU3Mi90YWJsZTpjMjBmNmY4ZGNmNTk0ZmUyOWY2OTNiN2MxZjliNzU3Mi90YWJsZXJhbmdlOmMyMGY2ZjhkY2Y1OTRmZTI5ZjY5M2I3YzFmOWI3NTcyXzUtOS0xLTEtMA_55cd4d87-25d3-4287-95b7-d89310eba023"
      unitRef="usd">1000000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="i299cea70f47b4fbe96772aaa8cc00b79_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNzIvZnJhZzo2YzUyMDU0YWU0ZTk0NTlmOTdjN2ExNDljMmZhNGU3Mi90YWJsZTpjMjBmNmY4ZGNmNTk0ZmUyOWY2OTNiN2MxZjliNzU3Mi90YWJsZXJhbmdlOmMyMGY2ZjhkY2Y1OTRmZTI5ZjY5M2I3YzFmOWI3NTcyXzYtMS0xLTEtMA_7a7e2374-d115-40af-894b-7c3c20a410ad"
      unitRef="usd">729000000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense
      contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNzIvZnJhZzo2YzUyMDU0YWU0ZTk0NTlmOTdjN2ExNDljMmZhNGU3Mi90YWJsZTpjMjBmNmY4ZGNmNTk0ZmUyOWY2OTNiN2MxZjliNzU3Mi90YWJsZXJhbmdlOmMyMGY2ZjhkY2Y1OTRmZTI5ZjY5M2I3YzFmOWI3NTcyXzYtMy0xLTEtMA_f1d3ff19-3cee-48b4-96cc-70ddc90d32bd"
      unitRef="usd">2702000000</us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense>
    <us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts
      contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNzIvZnJhZzo2YzUyMDU0YWU0ZTk0NTlmOTdjN2ExNDljMmZhNGU3Mi90YWJsZTpjMjBmNmY4ZGNmNTk0ZmUyOWY2OTNiN2MxZjliNzU3Mi90YWJsZXJhbmdlOmMyMGY2ZjhkY2Y1OTRmZTI5ZjY5M2I3YzFmOWI3NTcyXzYtNS0xLTEtMA_67f63c27-ac08-489b-bde5-b529d0b14629"
      unitRef="usd">1000000</us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts>
    <us-gaap:ValuationAllowancesAndReservesDeductions
      contextRef="i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNzIvZnJhZzo2YzUyMDU0YWU0ZTk0NTlmOTdjN2ExNDljMmZhNGU3Mi90YWJsZTpjMjBmNmY4ZGNmNTk0ZmUyOWY2OTNiN2MxZjliNzU3Mi90YWJsZXJhbmdlOmMyMGY2ZjhkY2Y1OTRmZTI5ZjY5M2I3YzFmOWI3NTcyXzYtNy0xLTEtMA_e7c87bfe-464e-41bc-8264-2321a5345c42"
      unitRef="usd">2488000000</us-gaap:ValuationAllowancesAndReservesDeductions>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="i2e87824102b34590a0208cc7da91b5f5_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNzIvZnJhZzo2YzUyMDU0YWU0ZTk0NTlmOTdjN2ExNDljMmZhNGU3Mi90YWJsZTpjMjBmNmY4ZGNmNTk0ZmUyOWY2OTNiN2MxZjliNzU3Mi90YWJsZXJhbmdlOmMyMGY2ZjhkY2Y1OTRmZTI5ZjY5M2I3YzFmOWI3NTcyXzYtOS0xLTEtMA_6c52d0e9-33c8-48d6-aa4a-063023fd3050"
      unitRef="usd">944000000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="ide7e4b7157284fadb3309a188a76b7ca_I20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNzIvZnJhZzo2YzUyMDU0YWU0ZTk0NTlmOTdjN2ExNDljMmZhNGU3Mi90YWJsZTpjMjBmNmY4ZGNmNTk0ZmUyOWY2OTNiN2MxZjliNzU3Mi90YWJsZXJhbmdlOmMyMGY2ZjhkY2Y1OTRmZTI5ZjY5M2I3YzFmOWI3NTcyXzktMS0xLTEtMA_f86cfbee-2fcc-46f9-b022-dac671674ddb"
      unitRef="usd">193000000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense
      contextRef="i350af5c515834421987f12b1b2358e1f_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNzIvZnJhZzo2YzUyMDU0YWU0ZTk0NTlmOTdjN2ExNDljMmZhNGU3Mi90YWJsZTpjMjBmNmY4ZGNmNTk0ZmUyOWY2OTNiN2MxZjliNzU3Mi90YWJsZXJhbmdlOmMyMGY2ZjhkY2Y1OTRmZTI5ZjY5M2I3YzFmOWI3NTcyXzktMy0xLTEtMA_52483b20-99c6-4b9a-bb6e-0fff3226ec08"
      unitRef="usd">139000000</us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense>
    <us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts
      contextRef="i350af5c515834421987f12b1b2358e1f_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNzIvZnJhZzo2YzUyMDU0YWU0ZTk0NTlmOTdjN2ExNDljMmZhNGU3Mi90YWJsZTpjMjBmNmY4ZGNmNTk0ZmUyOWY2OTNiN2MxZjliNzU3Mi90YWJsZXJhbmdlOmMyMGY2ZjhkY2Y1OTRmZTI5ZjY5M2I3YzFmOWI3NTcyXzktNS0xLTEtMA_b7c2d111-e82f-4e6d-ab7c-aa0449952944"
      unitRef="usd">1000000</us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts>
    <us-gaap:ValuationAllowancesAndReservesDeductions
      contextRef="i350af5c515834421987f12b1b2358e1f_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNzIvZnJhZzo2YzUyMDU0YWU0ZTk0NTlmOTdjN2ExNDljMmZhNGU3Mi90YWJsZTpjMjBmNmY4ZGNmNTk0ZmUyOWY2OTNiN2MxZjliNzU3Mi90YWJsZXJhbmdlOmMyMGY2ZjhkY2Y1OTRmZTI5ZjY5M2I3YzFmOWI3NTcyXzktNy0xLTEtMA_c0d80852-93b5-405e-a6a0-638185270cf9"
      unitRef="usd">127000000</us-gaap:ValuationAllowancesAndReservesDeductions>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="ida278becedcc42e688e90f303ce681a6_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNzIvZnJhZzo2YzUyMDU0YWU0ZTk0NTlmOTdjN2ExNDljMmZhNGU3Mi90YWJsZTpjMjBmNmY4ZGNmNTk0ZmUyOWY2OTNiN2MxZjliNzU3Mi90YWJsZXJhbmdlOmMyMGY2ZjhkY2Y1OTRmZTI5ZjY5M2I3YzFmOWI3NTcyXzktOS0xLTEtMA_a388bfe1-927b-4cb6-b275-454d64e6101e"
      unitRef="usd">206000000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="i0d2f5152ae66452889546df6cb3b59aa_I20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNzIvZnJhZzo2YzUyMDU0YWU0ZTk0NTlmOTdjN2ExNDljMmZhNGU3Mi90YWJsZTpjMjBmNmY4ZGNmNTk0ZmUyOWY2OTNiN2MxZjliNzU3Mi90YWJsZXJhbmdlOmMyMGY2ZjhkY2Y1OTRmZTI5ZjY5M2I3YzFmOWI3NTcyXzEwLTEtMS0xLTA_532f7592-e7c0-40f8-9e99-6ae295743c44"
      unitRef="usd">14000000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense
      contextRef="i6b4ffa7933dc41899a2489f876ca34b9_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNzIvZnJhZzo2YzUyMDU0YWU0ZTk0NTlmOTdjN2ExNDljMmZhNGU3Mi90YWJsZTpjMjBmNmY4ZGNmNTk0ZmUyOWY2OTNiN2MxZjliNzU3Mi90YWJsZXJhbmdlOmMyMGY2ZjhkY2Y1OTRmZTI5ZjY5M2I3YzFmOWI3NTcyXzEwLTMtMS0xLTA_865cca69-a512-4097-86a7-a173b45daece"
      unitRef="usd">15000000</us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense>
    <us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts
      contextRef="i6b4ffa7933dc41899a2489f876ca34b9_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNzIvZnJhZzo2YzUyMDU0YWU0ZTk0NTlmOTdjN2ExNDljMmZhNGU3Mi90YWJsZTpjMjBmNmY4ZGNmNTk0ZmUyOWY2OTNiN2MxZjliNzU3Mi90YWJsZXJhbmdlOmMyMGY2ZjhkY2Y1OTRmZTI5ZjY5M2I3YzFmOWI3NTcyXzEwLTUtMS0xLTA_0c1029ba-974d-44b8-b93d-f1e603eb0411"
      unitRef="usd">0</us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts>
    <us-gaap:ValuationAllowancesAndReservesDeductions
      contextRef="i6b4ffa7933dc41899a2489f876ca34b9_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNzIvZnJhZzo2YzUyMDU0YWU0ZTk0NTlmOTdjN2ExNDljMmZhNGU3Mi90YWJsZTpjMjBmNmY4ZGNmNTk0ZmUyOWY2OTNiN2MxZjliNzU3Mi90YWJsZXJhbmdlOmMyMGY2ZjhkY2Y1OTRmZTI5ZjY5M2I3YzFmOWI3NTcyXzEwLTctMS0xLTA_0e12de9a-581f-4a74-87d0-94103f5cc079"
      unitRef="usd">2000000</us-gaap:ValuationAllowancesAndReservesDeductions>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="i8572a6af84c14033a1b8f2ffeeaa45fa_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNzIvZnJhZzo2YzUyMDU0YWU0ZTk0NTlmOTdjN2ExNDljMmZhNGU3Mi90YWJsZTpjMjBmNmY4ZGNmNTk0ZmUyOWY2OTNiN2MxZjliNzU3Mi90YWJsZXJhbmdlOmMyMGY2ZjhkY2Y1OTRmZTI5ZjY5M2I3YzFmOWI3NTcyXzEwLTktMS0xLTA_081b4523-6b04-4c65-9b29-fb0ffce5f778"
      unitRef="usd">27000000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="i5dd4173715e6498fb0d0dc27a3f02b9f_I20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNzIvZnJhZzo2YzUyMDU0YWU0ZTk0NTlmOTdjN2ExNDljMmZhNGU3Mi90YWJsZTpjMjBmNmY4ZGNmNTk0ZmUyOWY2OTNiN2MxZjliNzU3Mi90YWJsZXJhbmdlOmMyMGY2ZjhkY2Y1OTRmZTI5ZjY5M2I3YzFmOWI3NTcyXzExLTEtMS0xLTA_072fffd6-1760-4fc9-a13c-6898219d1515"
      unitRef="usd">479000000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense
      contextRef="i400f4736cc2f44ec981957aa5112a379_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNzIvZnJhZzo2YzUyMDU0YWU0ZTk0NTlmOTdjN2ExNDljMmZhNGU3Mi90YWJsZTpjMjBmNmY4ZGNmNTk0ZmUyOWY2OTNiN2MxZjliNzU3Mi90YWJsZXJhbmdlOmMyMGY2ZjhkY2Y1OTRmZTI5ZjY5M2I3YzFmOWI3NTcyXzExLTMtMS0xLTA_02f0f641-4b38-48e2-985b-571ed5cc1dfc"
      unitRef="usd">2253000000</us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense>
    <us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts
      contextRef="i400f4736cc2f44ec981957aa5112a379_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNzIvZnJhZzo2YzUyMDU0YWU0ZTk0NTlmOTdjN2ExNDljMmZhNGU3Mi90YWJsZTpjMjBmNmY4ZGNmNTk0ZmUyOWY2OTNiN2MxZjliNzU3Mi90YWJsZXJhbmdlOmMyMGY2ZjhkY2Y1OTRmZTI5ZjY5M2I3YzFmOWI3NTcyXzExLTUtMS0xLTA_c96e29a9-107c-4b17-9dd7-efd6d31c738f"
      unitRef="usd">0</us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts>
    <us-gaap:ValuationAllowancesAndReservesDeductions
      contextRef="i400f4736cc2f44ec981957aa5112a379_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNzIvZnJhZzo2YzUyMDU0YWU0ZTk0NTlmOTdjN2ExNDljMmZhNGU3Mi90YWJsZTpjMjBmNmY4ZGNmNTk0ZmUyOWY2OTNiN2MxZjliNzU3Mi90YWJsZXJhbmdlOmMyMGY2ZjhkY2Y1OTRmZTI5ZjY5M2I3YzFmOWI3NTcyXzExLTctMS0xLTA_a3764552-8f79-4f57-b0a0-850d416ab256"
      unitRef="usd">2237000000</us-gaap:ValuationAllowancesAndReservesDeductions>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="ie3de935dc1e7482faedb9bef40e18bc4_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNzIvZnJhZzo2YzUyMDU0YWU0ZTk0NTlmOTdjN2ExNDljMmZhNGU3Mi90YWJsZTpjMjBmNmY4ZGNmNTk0ZmUyOWY2OTNiN2MxZjliNzU3Mi90YWJsZXJhbmdlOmMyMGY2ZjhkY2Y1OTRmZTI5ZjY5M2I3YzFmOWI3NTcyXzExLTktMS0xLTA_66841199-2891-469a-9d8c-4925a45d7599"
      unitRef="usd">495000000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="i6e4105a2962247bab2434b9253c1a87a_I20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNzIvZnJhZzo2YzUyMDU0YWU0ZTk0NTlmOTdjN2ExNDljMmZhNGU3Mi90YWJsZTpjMjBmNmY4ZGNmNTk0ZmUyOWY2OTNiN2MxZjliNzU3Mi90YWJsZXJhbmdlOmMyMGY2ZjhkY2Y1OTRmZTI5ZjY5M2I3YzFmOWI3NTcyXzEyLTEtMS0xLTA_58924c35-e598-481a-a8c4-92d8b6ab1898"
      unitRef="usd">1000000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense
      contextRef="if31c4c1d06774db4b770c1df3a18845b_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNzIvZnJhZzo2YzUyMDU0YWU0ZTk0NTlmOTdjN2ExNDljMmZhNGU3Mi90YWJsZTpjMjBmNmY4ZGNmNTk0ZmUyOWY2OTNiN2MxZjliNzU3Mi90YWJsZXJhbmdlOmMyMGY2ZjhkY2Y1OTRmZTI5ZjY5M2I3YzFmOWI3NTcyXzEyLTMtMS0xLTA_31efb779-6948-42e8-999b-ccc940316a00"
      unitRef="usd">0</us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense>
    <us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts
      contextRef="if31c4c1d06774db4b770c1df3a18845b_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNzIvZnJhZzo2YzUyMDU0YWU0ZTk0NTlmOTdjN2ExNDljMmZhNGU3Mi90YWJsZTpjMjBmNmY4ZGNmNTk0ZmUyOWY2OTNiN2MxZjliNzU3Mi90YWJsZXJhbmdlOmMyMGY2ZjhkY2Y1OTRmZTI5ZjY5M2I3YzFmOWI3NTcyXzEyLTUtMS0xLTA_945bc5c0-e071-4a1b-8d71-9c2f72381b7f"
      unitRef="usd">0</us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts>
    <us-gaap:ValuationAllowancesAndReservesDeductions
      contextRef="if31c4c1d06774db4b770c1df3a18845b_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNzIvZnJhZzo2YzUyMDU0YWU0ZTk0NTlmOTdjN2ExNDljMmZhNGU3Mi90YWJsZTpjMjBmNmY4ZGNmNTk0ZmUyOWY2OTNiN2MxZjliNzU3Mi90YWJsZXJhbmdlOmMyMGY2ZjhkY2Y1OTRmZTI5ZjY5M2I3YzFmOWI3NTcyXzEyLTctMS0xLTA_8048cfe0-cc72-4287-bda0-cadd568a1445"
      unitRef="usd">0</us-gaap:ValuationAllowancesAndReservesDeductions>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="i957454a121b24a28a13445f765e222b9_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNzIvZnJhZzo2YzUyMDU0YWU0ZTk0NTlmOTdjN2ExNDljMmZhNGU3Mi90YWJsZTpjMjBmNmY4ZGNmNTk0ZmUyOWY2OTNiN2MxZjliNzU3Mi90YWJsZXJhbmdlOmMyMGY2ZjhkY2Y1OTRmZTI5ZjY5M2I3YzFmOWI3NTcyXzEyLTktMS0xLTA_71ce7cc9-1e50-4197-a955-4e7697bab30d"
      unitRef="usd">1000000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="if6dc09eec4e74751b47cdf037a5b1860_I20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNzIvZnJhZzo2YzUyMDU0YWU0ZTk0NTlmOTdjN2ExNDljMmZhNGU3Mi90YWJsZTpjMjBmNmY4ZGNmNTk0ZmUyOWY2OTNiN2MxZjliNzU3Mi90YWJsZXJhbmdlOmMyMGY2ZjhkY2Y1OTRmZTI5ZjY5M2I3YzFmOWI3NTcyXzEzLTEtMS0xLTA_3bea77eb-4a7f-4cfc-b79c-3ded6ead1869"
      unitRef="usd">687000000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense
      contextRef="ia31e9a409b874bb19d0ff6f2f39ecc09_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNzIvZnJhZzo2YzUyMDU0YWU0ZTk0NTlmOTdjN2ExNDljMmZhNGU3Mi90YWJsZTpjMjBmNmY4ZGNmNTk0ZmUyOWY2OTNiN2MxZjliNzU3Mi90YWJsZXJhbmdlOmMyMGY2ZjhkY2Y1OTRmZTI5ZjY5M2I3YzFmOWI3NTcyXzEzLTMtMS0xLTA_d3dd79b3-b4f9-4506-880f-8436c169079b"
      unitRef="usd">2407000000</us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense>
    <us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts
      contextRef="ia31e9a409b874bb19d0ff6f2f39ecc09_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNzIvZnJhZzo2YzUyMDU0YWU0ZTk0NTlmOTdjN2ExNDljMmZhNGU3Mi90YWJsZTpjMjBmNmY4ZGNmNTk0ZmUyOWY2OTNiN2MxZjliNzU3Mi90YWJsZXJhbmdlOmMyMGY2ZjhkY2Y1OTRmZTI5ZjY5M2I3YzFmOWI3NTcyXzEzLTUtMS0xLTA_fb7f0c5f-9865-4fcb-9e8e-d4bba7a48ee6"
      unitRef="usd">1000000</us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts>
    <us-gaap:ValuationAllowancesAndReservesDeductions
      contextRef="ia31e9a409b874bb19d0ff6f2f39ecc09_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNzIvZnJhZzo2YzUyMDU0YWU0ZTk0NTlmOTdjN2ExNDljMmZhNGU3Mi90YWJsZTpjMjBmNmY4ZGNmNTk0ZmUyOWY2OTNiN2MxZjliNzU3Mi90YWJsZXJhbmdlOmMyMGY2ZjhkY2Y1OTRmZTI5ZjY5M2I3YzFmOWI3NTcyXzEzLTctMS0xLTA_4f47ef44-7089-4077-9685-aae64b3767f4"
      unitRef="usd">2366000000</us-gaap:ValuationAllowancesAndReservesDeductions>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="i299cea70f47b4fbe96772aaa8cc00b79_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNzIvZnJhZzo2YzUyMDU0YWU0ZTk0NTlmOTdjN2ExNDljMmZhNGU3Mi90YWJsZTpjMjBmNmY4ZGNmNTk0ZmUyOWY2OTNiN2MxZjliNzU3Mi90YWJsZXJhbmdlOmMyMGY2ZjhkY2Y1OTRmZTI5ZjY5M2I3YzFmOWI3NTcyXzEzLTktMS0xLTA_de0d5a5e-d408-43bf-9f15-ac0dc25fcdd9"
      unitRef="usd">729000000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="ic65be2ae369247318f0256c8cc4689d5_I20180630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNzIvZnJhZzo2YzUyMDU0YWU0ZTk0NTlmOTdjN2ExNDljMmZhNGU3Mi90YWJsZTpjMjBmNmY4ZGNmNTk0ZmUyOWY2OTNiN2MxZjliNzU3Mi90YWJsZXJhbmdlOmMyMGY2ZjhkY2Y1OTRmZTI5ZjY5M2I3YzFmOWI3NTcyXzE2LTEtMS0xLTA_06ad0fda-d2d5-4651-b8dc-4d3076290f48"
      unitRef="usd">139000000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense
      contextRef="i6f1dad679d0a49a586cbe4e15230d23d_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNzIvZnJhZzo2YzUyMDU0YWU0ZTk0NTlmOTdjN2ExNDljMmZhNGU3Mi90YWJsZTpjMjBmNmY4ZGNmNTk0ZmUyOWY2OTNiN2MxZjliNzU3Mi90YWJsZXJhbmdlOmMyMGY2ZjhkY2Y1OTRmZTI5ZjY5M2I3YzFmOWI3NTcyXzE2LTMtMS0xLTA_62b73573-6ab0-4154-9094-bd1fbe11b151"
      unitRef="usd">140000000</us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense>
    <us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts
      contextRef="i6f1dad679d0a49a586cbe4e15230d23d_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNzIvZnJhZzo2YzUyMDU0YWU0ZTk0NTlmOTdjN2ExNDljMmZhNGU3Mi90YWJsZTpjMjBmNmY4ZGNmNTk0ZmUyOWY2OTNiN2MxZjliNzU3Mi90YWJsZXJhbmdlOmMyMGY2ZjhkY2Y1OTRmZTI5ZjY5M2I3YzFmOWI3NTcyXzE2LTUtMS0xLTA_f4e09b33-66a6-4974-a8a9-a9a34c499cc8"
      unitRef="usd">1000000</us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts>
    <us-gaap:ValuationAllowancesAndReservesDeductions
      contextRef="i6f1dad679d0a49a586cbe4e15230d23d_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNzIvZnJhZzo2YzUyMDU0YWU0ZTk0NTlmOTdjN2ExNDljMmZhNGU3Mi90YWJsZTpjMjBmNmY4ZGNmNTk0ZmUyOWY2OTNiN2MxZjliNzU3Mi90YWJsZXJhbmdlOmMyMGY2ZjhkY2Y1OTRmZTI5ZjY5M2I3YzFmOWI3NTcyXzE2LTctMS0xLTA_d50fb1a4-abb0-4e18-b710-cf998552ff01"
      unitRef="usd">87000000</us-gaap:ValuationAllowancesAndReservesDeductions>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="ide7e4b7157284fadb3309a188a76b7ca_I20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNzIvZnJhZzo2YzUyMDU0YWU0ZTk0NTlmOTdjN2ExNDljMmZhNGU3Mi90YWJsZTpjMjBmNmY4ZGNmNTk0ZmUyOWY2OTNiN2MxZjliNzU3Mi90YWJsZXJhbmdlOmMyMGY2ZjhkY2Y1OTRmZTI5ZjY5M2I3YzFmOWI3NTcyXzE2LTktMS0xLTA_7ccd9a21-a7d8-4f97-91fb-797b727b2537"
      unitRef="usd">193000000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="if5788af627104325bd77f50e1ab1ce2a_I20180630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNzIvZnJhZzo2YzUyMDU0YWU0ZTk0NTlmOTdjN2ExNDljMmZhNGU3Mi90YWJsZTpjMjBmNmY4ZGNmNTk0ZmUyOWY2OTNiN2MxZjliNzU3Mi90YWJsZXJhbmdlOmMyMGY2ZjhkY2Y1OTRmZTI5ZjY5M2I3YzFmOWI3NTcyXzE3LTEtMS0xLTA_bb18cf1c-7fa4-4e93-a71b-cf69683e1ba7"
      unitRef="usd">7000000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense
      contextRef="ia954270fdd5c46e9a903107394449dd7_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNzIvZnJhZzo2YzUyMDU0YWU0ZTk0NTlmOTdjN2ExNDljMmZhNGU3Mi90YWJsZTpjMjBmNmY4ZGNmNTk0ZmUyOWY2OTNiN2MxZjliNzU3Mi90YWJsZXJhbmdlOmMyMGY2ZjhkY2Y1OTRmZTI5ZjY5M2I3YzFmOWI3NTcyXzE3LTMtMS0xLTA_53e7348e-c1e3-4bdc-a3a9-1cf722ff4c68"
      unitRef="usd">8000000</us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense>
    <us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts
      contextRef="ia954270fdd5c46e9a903107394449dd7_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNzIvZnJhZzo2YzUyMDU0YWU0ZTk0NTlmOTdjN2ExNDljMmZhNGU3Mi90YWJsZTpjMjBmNmY4ZGNmNTk0ZmUyOWY2OTNiN2MxZjliNzU3Mi90YWJsZXJhbmdlOmMyMGY2ZjhkY2Y1OTRmZTI5ZjY5M2I3YzFmOWI3NTcyXzE3LTUtMS0xLTA_0bb3e24e-b97c-40af-9cf5-1fbc07eb3c10"
      unitRef="usd">0</us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts>
    <us-gaap:ValuationAllowancesAndReservesDeductions
      contextRef="ia954270fdd5c46e9a903107394449dd7_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNzIvZnJhZzo2YzUyMDU0YWU0ZTk0NTlmOTdjN2ExNDljMmZhNGU3Mi90YWJsZTpjMjBmNmY4ZGNmNTk0ZmUyOWY2OTNiN2MxZjliNzU3Mi90YWJsZXJhbmdlOmMyMGY2ZjhkY2Y1OTRmZTI5ZjY5M2I3YzFmOWI3NTcyXzE3LTctMS0xLTA_c042f002-7391-4062-be36-b1f716f1a5a7"
      unitRef="usd">1000000</us-gaap:ValuationAllowancesAndReservesDeductions>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="i0d2f5152ae66452889546df6cb3b59aa_I20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNzIvZnJhZzo2YzUyMDU0YWU0ZTk0NTlmOTdjN2ExNDljMmZhNGU3Mi90YWJsZTpjMjBmNmY4ZGNmNTk0ZmUyOWY2OTNiN2MxZjliNzU3Mi90YWJsZXJhbmdlOmMyMGY2ZjhkY2Y1OTRmZTI5ZjY5M2I3YzFmOWI3NTcyXzE3LTktMS0xLTA_fd6bc68f-ea83-4c48-9085-6d102a6d0455"
      unitRef="usd">14000000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="ia84d7235822744479f9a7c898af562ac_I20180630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNzIvZnJhZzo2YzUyMDU0YWU0ZTk0NTlmOTdjN2ExNDljMmZhNGU3Mi90YWJsZTpjMjBmNmY4ZGNmNTk0ZmUyOWY2OTNiN2MxZjliNzU3Mi90YWJsZXJhbmdlOmMyMGY2ZjhkY2Y1OTRmZTI5ZjY5M2I3YzFmOWI3NTcyXzE4LTEtMS0xLTA_262feede-e658-44e5-83d7-d1eb88cf1caf"
      unitRef="usd">479000000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense
      contextRef="i4bfe813f83c04e8e9985198d3c0abce1_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNzIvZnJhZzo2YzUyMDU0YWU0ZTk0NTlmOTdjN2ExNDljMmZhNGU3Mi90YWJsZTpjMjBmNmY4ZGNmNTk0ZmUyOWY2OTNiN2MxZjliNzU3Mi90YWJsZXJhbmdlOmMyMGY2ZjhkY2Y1OTRmZTI5ZjY5M2I3YzFmOWI3NTcyXzE4LTMtMS0xLTA_e69e5353-307f-4b6b-b446-ea690c8af976"
      unitRef="usd">2205000000</us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense>
    <us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts
      contextRef="i4bfe813f83c04e8e9985198d3c0abce1_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNzIvZnJhZzo2YzUyMDU0YWU0ZTk0NTlmOTdjN2ExNDljMmZhNGU3Mi90YWJsZTpjMjBmNmY4ZGNmNTk0ZmUyOWY2OTNiN2MxZjliNzU3Mi90YWJsZXJhbmdlOmMyMGY2ZjhkY2Y1OTRmZTI5ZjY5M2I3YzFmOWI3NTcyXzE4LTUtMS0xLTA_c4fc71e6-3b94-4d54-871c-c3ef85709c68"
      unitRef="usd">0</us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts>
    <us-gaap:ValuationAllowancesAndReservesDeductions
      contextRef="i4bfe813f83c04e8e9985198d3c0abce1_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNzIvZnJhZzo2YzUyMDU0YWU0ZTk0NTlmOTdjN2ExNDljMmZhNGU3Mi90YWJsZTpjMjBmNmY4ZGNmNTk0ZmUyOWY2OTNiN2MxZjliNzU3Mi90YWJsZXJhbmdlOmMyMGY2ZjhkY2Y1OTRmZTI5ZjY5M2I3YzFmOWI3NTcyXzE4LTctMS0xLTA_0f153b28-759d-47ea-833f-bb84945a1039"
      unitRef="usd">2205000000</us-gaap:ValuationAllowancesAndReservesDeductions>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="i5dd4173715e6498fb0d0dc27a3f02b9f_I20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNzIvZnJhZzo2YzUyMDU0YWU0ZTk0NTlmOTdjN2ExNDljMmZhNGU3Mi90YWJsZTpjMjBmNmY4ZGNmNTk0ZmUyOWY2OTNiN2MxZjliNzU3Mi90YWJsZXJhbmdlOmMyMGY2ZjhkY2Y1OTRmZTI5ZjY5M2I3YzFmOWI3NTcyXzE4LTktMS0xLTA_c4c11fa1-b085-49a8-bafa-c8c875d04795"
      unitRef="usd">479000000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="ifbbe723cddd144c7bb4c9eab1d1f2f33_I20180630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNzIvZnJhZzo2YzUyMDU0YWU0ZTk0NTlmOTdjN2ExNDljMmZhNGU3Mi90YWJsZTpjMjBmNmY4ZGNmNTk0ZmUyOWY2OTNiN2MxZjliNzU3Mi90YWJsZXJhbmdlOmMyMGY2ZjhkY2Y1OTRmZTI5ZjY5M2I3YzFmOWI3NTcyXzE5LTEtMS0xLTA_64d41589-deaf-44a5-923d-bdbaa84d58f9"
      unitRef="usd">1000000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense
      contextRef="i657bcf6c5a8f4e898448d61c3949243a_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNzIvZnJhZzo2YzUyMDU0YWU0ZTk0NTlmOTdjN2ExNDljMmZhNGU3Mi90YWJsZTpjMjBmNmY4ZGNmNTk0ZmUyOWY2OTNiN2MxZjliNzU3Mi90YWJsZXJhbmdlOmMyMGY2ZjhkY2Y1OTRmZTI5ZjY5M2I3YzFmOWI3NTcyXzE5LTMtMS0xLTA_cad69b23-9d4c-45d6-92d0-7ec0eea046d2"
      unitRef="usd">0</us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense>
    <us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts
      contextRef="i657bcf6c5a8f4e898448d61c3949243a_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNzIvZnJhZzo2YzUyMDU0YWU0ZTk0NTlmOTdjN2ExNDljMmZhNGU3Mi90YWJsZTpjMjBmNmY4ZGNmNTk0ZmUyOWY2OTNiN2MxZjliNzU3Mi90YWJsZXJhbmdlOmMyMGY2ZjhkY2Y1OTRmZTI5ZjY5M2I3YzFmOWI3NTcyXzE5LTUtMS0xLTA_40d689e4-b957-4921-8b84-8c5263513763"
      unitRef="usd">0</us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts>
    <us-gaap:ValuationAllowancesAndReservesDeductions
      contextRef="i657bcf6c5a8f4e898448d61c3949243a_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNzIvZnJhZzo2YzUyMDU0YWU0ZTk0NTlmOTdjN2ExNDljMmZhNGU3Mi90YWJsZTpjMjBmNmY4ZGNmNTk0ZmUyOWY2OTNiN2MxZjliNzU3Mi90YWJsZXJhbmdlOmMyMGY2ZjhkY2Y1OTRmZTI5ZjY5M2I3YzFmOWI3NTcyXzE5LTctMS0xLTA_642de194-3549-434d-a189-6e134bd7a068"
      unitRef="usd">0</us-gaap:ValuationAllowancesAndReservesDeductions>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="i6e4105a2962247bab2434b9253c1a87a_I20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNzIvZnJhZzo2YzUyMDU0YWU0ZTk0NTlmOTdjN2ExNDljMmZhNGU3Mi90YWJsZTpjMjBmNmY4ZGNmNTk0ZmUyOWY2OTNiN2MxZjliNzU3Mi90YWJsZXJhbmdlOmMyMGY2ZjhkY2Y1OTRmZTI5ZjY5M2I3YzFmOWI3NTcyXzE5LTktMS0xLTA_fded0164-dc07-4f86-a424-5856b274c646"
      unitRef="usd">1000000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="i39bbe70148ff4daea469e8420c1859d6_I20180630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNzIvZnJhZzo2YzUyMDU0YWU0ZTk0NTlmOTdjN2ExNDljMmZhNGU3Mi90YWJsZTpjMjBmNmY4ZGNmNTk0ZmUyOWY2OTNiN2MxZjliNzU3Mi90YWJsZXJhbmdlOmMyMGY2ZjhkY2Y1OTRmZTI5ZjY5M2I3YzFmOWI3NTcyXzIwLTEtMS0xLTA_32d50882-707c-4aad-bb74-bd9c812a0af4"
      unitRef="usd">626000000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense
      contextRef="i00a6d666bf604826b24e68ddbd63eac4_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNzIvZnJhZzo2YzUyMDU0YWU0ZTk0NTlmOTdjN2ExNDljMmZhNGU3Mi90YWJsZTpjMjBmNmY4ZGNmNTk0ZmUyOWY2OTNiN2MxZjliNzU3Mi90YWJsZXJhbmdlOmMyMGY2ZjhkY2Y1OTRmZTI5ZjY5M2I3YzFmOWI3NTcyXzIwLTMtMS0xLTA_4c8acc20-7d69-461e-9072-1f80cc1cbe88"
      unitRef="usd">2353000000</us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense>
    <us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts
      contextRef="i00a6d666bf604826b24e68ddbd63eac4_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNzIvZnJhZzo2YzUyMDU0YWU0ZTk0NTlmOTdjN2ExNDljMmZhNGU3Mi90YWJsZTpjMjBmNmY4ZGNmNTk0ZmUyOWY2OTNiN2MxZjliNzU3Mi90YWJsZXJhbmdlOmMyMGY2ZjhkY2Y1OTRmZTI5ZjY5M2I3YzFmOWI3NTcyXzIwLTUtMS0xLTA_dc819f75-393d-471b-9eb7-9578d36732a0"
      unitRef="usd">1000000</us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts>
    <us-gaap:ValuationAllowancesAndReservesDeductions
      contextRef="i00a6d666bf604826b24e68ddbd63eac4_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNzIvZnJhZzo2YzUyMDU0YWU0ZTk0NTlmOTdjN2ExNDljMmZhNGU3Mi90YWJsZTpjMjBmNmY4ZGNmNTk0ZmUyOWY2OTNiN2MxZjliNzU3Mi90YWJsZXJhbmdlOmMyMGY2ZjhkY2Y1OTRmZTI5ZjY5M2I3YzFmOWI3NTcyXzIwLTctMS0xLTA_46fb777a-c4fc-4f01-92cf-7c9b227bd989"
      unitRef="usd">2293000000</us-gaap:ValuationAllowancesAndReservesDeductions>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="if6dc09eec4e74751b47cdf037a5b1860_I20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNzIvZnJhZzo2YzUyMDU0YWU0ZTk0NTlmOTdjN2ExNDljMmZhNGU3Mi90YWJsZTpjMjBmNmY4ZGNmNTk0ZmUyOWY2OTNiN2MxZjliNzU3Mi90YWJsZXJhbmdlOmMyMGY2ZjhkY2Y1OTRmZTI5ZjY5M2I3YzFmOWI3NTcyXzIwLTktMS0xLTA_87cb846c-41d7-4453-906b-1091b4357fd2"
      unitRef="usd">687000000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense
      contextRef="i1673490f38b2424cacdaabe5743e3504_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNzIvZnJhZzo2YzUyMDU0YWU0ZTk0NTlmOTdjN2ExNDljMmZhNGU3Mi90ZXh0cmVnaW9uOjZjNTIwNTRhZTRlOTQ1OWY5N2M3YTE0OWMyZmE0ZTcyXzEyNQ_3088e5c2-e70c-4102-8c17-8692344430c2"
      unitRef="usd">70000000</us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense>
    <us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense
      contextRef="i7ed96bb7a92d4005acebfec1c9075c82_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNzIvZnJhZzo2YzUyMDU0YWU0ZTk0NTlmOTdjN2ExNDljMmZhNGU3Mi90ZXh0cmVnaW9uOjZjNTIwNTRhZTRlOTQ1OWY5N2M3YTE0OWMyZmE0ZTcyXzEyOQ_e0003f06-4d7d-4d93-b5e5-faaf26dd110b"
      unitRef="usd">49000000</us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense>
    <us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense
      contextRef="iecf663e1bbf54d3bbd24255d898605e0_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNzIvZnJhZzo2YzUyMDU0YWU0ZTk0NTlmOTdjN2ExNDljMmZhNGU3Mi90ZXh0cmVnaW9uOjZjNTIwNTRhZTRlOTQ1OWY5N2M3YTE0OWMyZmE0ZTcyXzEzNg_bc0da923-8ee3-4a7d-b730-b79b4bbadcc7"
      unitRef="usd">60000000</us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense>
    <us-gaap:ValuationAllowancesAndReservesRecoveries
      contextRef="i5dc92adfefad4108a6405a1cbdeeaf2f_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNzIvZnJhZzo2YzUyMDU0YWU0ZTk0NTlmOTdjN2ExNDljMmZhNGU3Mi90ZXh0cmVnaW9uOjZjNTIwNTRhZTRlOTQ1OWY5N2M3YTE0OWMyZmE0ZTcyXzQ2OQ_08271ad3-bc4e-4918-98ab-0a0c888961ef"
      unitRef="usd">1000000</us-gaap:ValuationAllowancesAndReservesRecoveries>
    <us-gaap:ValuationAllowancesAndReservesRecoveries
      contextRef="ie90c978acfea4d6ea4dde9db8c7997ef_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNzIvZnJhZzo2YzUyMDU0YWU0ZTk0NTlmOTdjN2ExNDljMmZhNGU3Mi90ZXh0cmVnaW9uOjZjNTIwNTRhZTRlOTQ1OWY5N2M3YTE0OWMyZmE0ZTcyXzQ2OQ_b66e09b8-208f-4059-a324-93dbfbf1fe1d"
      unitRef="usd">1000000</us-gaap:ValuationAllowancesAndReservesRecoveries>
    <us-gaap:ValuationAllowancesAndReservesRecoveries
      contextRef="iecd1cbc227d64a688441fd4ccc382b99_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRmMGVjNTZiOWM2MDRmMTc4MmE2NWVhNGExOWMyODRkL3NlYzo0ZjBlYzU2YjljNjA0ZjE3ODJhNjVlYTRhMTljMjg0ZF8xNzIvZnJhZzo2YzUyMDU0YWU0ZTk0NTlmOTdjN2ExNDljMmZhNGU3Mi90ZXh0cmVnaW9uOjZjNTIwNTRhZTRlOTQ1OWY5N2M3YTE0OWMyZmE0ZTcyXzQ2OQ_d6b02bc4-2bce-4a89-9bdc-bac3c3507016"
      unitRef="usd">1000000</us-gaap:ValuationAllowancesAndReservesRecoveries>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140421286044536">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover Page - USD ($)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jul. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-K<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentAnnualReport', window );">Document Annual Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">1-11373<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Cardinal Health, Inc.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">OH<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">31-0958666<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">7000 Cardinal Place<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Dublin<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">OH<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">43017<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(614)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">757-5000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common shares (without par value)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">CAH<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityWellKnownSeasonedIssuer', window );">Entity Well-Known Seasoned Issuer</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityVoluntaryFilers', window );">Entity Voluntary Filers</a></td>
<td class="text">No<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Large Accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_IcfrAuditorAttestationFlag', window );">ICFR Auditor Attestation Flag</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityPublicFloat', window );">Entity Public Float</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 15,693,865,917<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">290,441,408<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Jun. 30,  2021<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2021<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">FY<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000721371<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--06-30<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentsIncorporatedByReferenceTextBlock', window );">Documents Incorporated by Reference</a></td>
<td class="text"><div style="text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Documents Incorporated by Reference: </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Portions of the registrant&#8217;s Definitive Proxy Statement to be filed for its 2021 Annual Meeting of Shareholders are incorporated by reference into the sections of this Form 10-K addressing the requirements of Part&#160;III of Form&#160;10-K.</span></div><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentAnnualReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an annual report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentAnnualReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentsIncorporatedByReferenceTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Documents incorporated by reference.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-23<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentsIncorporatedByReferenceTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityPublicFloat">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityPublicFloat</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityVoluntaryFilers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityVoluntaryFilers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityWellKnownSeasonedIssuer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityWellKnownSeasonedIssuer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_IcfrAuditorAttestationFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_IcfrAuditorAttestationFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140421173241160">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Earnings - USD ($)<br> shares in Millions, $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementAbstract', window );"><strong>Income Statement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenue</a></td>
<td class="nump">$ 162,467<span></span>
</td>
<td class="nump">$ 152,922<span></span>
</td>
<td class="nump">$ 145,534<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Cost of products sold</a></td>
<td class="nump">155,689<span></span>
</td>
<td class="nump">146,054<span></span>
</td>
<td class="nump">138,700<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">Gross margin</a></td>
<td class="nump">6,778<span></span>
</td>
<td class="nump">6,868<span></span>
</td>
<td class="nump">6,834<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>Operating expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpense', window );">Distribution, selling, general and administrative expenses</a></td>
<td class="nump">4,533<span></span>
</td>
<td class="nump">4,572<span></span>
</td>
<td class="nump">4,480<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring and employee severance</a></td>
<td class="nump">114<span></span>
</td>
<td class="nump">122<span></span>
</td>
<td class="nump">125<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_Amortizationandotheracquisitionrelatedcosts', window );">Amortization and other acquisition-related costs</a></td>
<td class="nump">451<span></span>
</td>
<td class="nump">524<span></span>
</td>
<td class="nump">621<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges', window );">Impairments and (gain)/loss on disposal of assets, net</a></td>
<td class="nump">79<span></span>
</td>
<td class="nump">7<span></span>
</td>
<td class="num">(488)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossRelatedToLitigationSettlement', window );">Litigation (recoveries)/charges, net</a></td>
<td class="nump">1,129<span></span>
</td>
<td class="nump">5,741<span></span>
</td>
<td class="nump">36<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating earnings/(loss)</a></td>
<td class="nump">472<span></span>
</td>
<td class="num">(4,098)<span></span>
</td>
<td class="nump">2,060<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other (income)/expense, net</a></td>
<td class="num">(47)<span></span>
</td>
<td class="num">(1)<span></span>
</td>
<td class="nump">15<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense, net</a></td>
<td class="nump">180<span></span>
</td>
<td class="nump">238<span></span>
</td>
<td class="nump">294<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Loss on early extinguishment of debt</a></td>
<td class="nump">14<span></span>
</td>
<td class="nump">16<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfInvestments', window );">Gain (Loss) on Sale of Investments</a></td>
<td class="num">(2)<span></span>
</td>
<td class="nump">579<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments', window );">Earnings/(loss) before income taxes</a></td>
<td class="nump">323<span></span>
</td>
<td class="num">(3,772)<span></span>
</td>
<td class="nump">1,751<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Provision for/(benefit from) income taxes</a></td>
<td class="num">(289)<span></span>
</td>
<td class="num">(79)<span></span>
</td>
<td class="nump">386<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net earnings</a></td>
<td class="nump">612<span></span>
</td>
<td class="num">(3,693)<span></span>
</td>
<td class="nump">1,365<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest', window );">Less: Net earnings attributable to noncontrolling interests</a></td>
<td class="num">(1)<span></span>
</td>
<td class="num">(3)<span></span>
</td>
<td class="num">(2)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net earnings/(loss) attributable to Cardinal Health, Inc.</a></td>
<td class="nump">$ 611<span></span>
</td>
<td class="num">$ (3,696)<span></span>
</td>
<td class="nump">$ 1,363<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAbstract', window );"><strong>Earnings/(loss) per common share attributable to Cardinal Health, Inc.</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Earnings Per Share, Basic</a></td>
<td class="nump">$ 2.09<span></span>
</td>
<td class="num">$ (12.61)<span></span>
</td>
<td class="nump">$ 4.55<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Earnings Per Share, Diluted</a></td>
<td class="nump">$ 2.08<span></span>
</td>
<td class="num">$ (12.61)<span></span>
</td>
<td class="nump">$ 4.53<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract', window );"><strong>Weighted-average number of common shares outstanding:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Basic (in shares)</a></td>
<td class="nump">292<span></span>
</td>
<td class="nump">293<span></span>
</td>
<td class="nump">300<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Diluted (in shares)</a></td>
<td class="nump">294<span></span>
</td>
<td class="nump">293<span></span>
</td>
<td class="nump">301<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_Amortizationandotheracquisitionrelatedcosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of acquired intangible assets and changes in the fair value of contingent consideration obligations. This also represents acquisition-related costs incurred to effect a business combination which costs have been expensed during the period. Such costs include finder's fees; advisory, legal, accounting, valuation, and other professional or consulting fees; general administrative costs, including the costs of maintaining an internal acquisitions department; and may include costs of registering and issuing debt and equity securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_Amortizationandotheracquisitionrelatedcosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsAndServicesSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2(a),(d))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsAndServicesSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasicAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnSaleOfInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net realized gain (loss) on investments sold during the period, not including gains (losses) on securities separately or otherwise categorized as trading, available-for-sale, or held-to-maturity, which, for cash flow reporting, is a component of proceeds from investing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnSaleOfInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) from the difference between the sale price or salvage price and the book value of an asset that was sold or retired, and gain (loss) from the write down of assets from their carrying value to fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossRelatedToLitigationSettlement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) recognized in settlement of litigation and insurance claims. Excludes claims within an insurance entity's normal claims settlement process.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossRelatedToLitigationSettlement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainsLossesOnExtinguishmentOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123467658&amp;loc=d3e12355-112629<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467658&amp;loc=d3e12317-112629<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainsLossesOnExtinguishmentOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GrossProfit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 18: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1,2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GrossProfit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of income (loss) from equity method investments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (210.5-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of Net Income (Loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109237686&amp;loc=d3e17752-110868<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.P.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140864-122747<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingGeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingGeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140421167986232">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Comprehensive Income - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract', window );"><strong>Statement of Comprehensive Income [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net earnings</a></td>
<td class="nump">$ 612<span></span>
</td>
<td class="num">$ (3,693)<span></span>
</td>
<td class="nump">$ 1,365<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract', window );"><strong>Other comprehensive income/(loss):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax', window );">Foreign currency translation adjustments and other</a></td>
<td class="nump">46<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="nump">18<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax', window );">Net unrealized gain/(loss) on derivative instruments, net of tax</a></td>
<td class="nump">24<span></span>
</td>
<td class="num">(28)<span></span>
</td>
<td class="num">(5)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Total other comprehensive income/(loss), net of tax</a></td>
<td class="nump">70<span></span>
</td>
<td class="num">(25)<span></span>
</td>
<td class="nump">13<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest', window );">Total comprehensive income/(loss)</a></td>
<td class="nump">682<span></span>
</td>
<td class="num">(3,718)<span></span>
</td>
<td class="nump">1,378<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest', window );">Net Income (Loss) Attributable to Noncontrolling Interest</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Total comprehensive income attributable to Cardinal Health, Inc.</a></td>
<td class="nump">$ 681<span></span>
</td>
<td class="num">$ (3,721)<span></span>
</td>
<td class="nump">$ 1,376<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e557-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(26))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of Net Income (Loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments, of increase (decrease) in accumulated gain (loss) from derivative instruments designated and qualifying as the effective portion of cash flow hedges and an entity's share of an equity investee's increase (decrease) in deferred hedging gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=124507222&amp;loc=d3e1436-108581<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140421173426056">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Balance Sheets - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and equivalents</a></td>
<td class="nump">$ 3,407<span></span>
</td>
<td class="nump">$ 2,771<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReceivablesNetCurrent', window );">Trade receivables, net</a></td>
<td class="nump">9,103<span></span>
</td>
<td class="nump">8,264<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventories, net</a></td>
<td class="nump">14,594<span></span>
</td>
<td class="nump">13,198<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsCurrent', window );">Prepaid expenses and other</a></td>
<td class="nump">2,843<span></span>
</td>
<td class="nump">1,707<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation', window );">Disposal Group, Including Discontinued Operation, Assets</a></td>
<td class="nump">1,101<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">31,048<span></span>
</td>
<td class="nump">25,940<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
<td class="nump">2,360<span></span>
</td>
<td class="nump">2,366<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetIncludingGoodwill', window );">Goodwill and other intangibles, net</a></td>
<td class="nump">10,094<span></span>
</td>
<td class="nump">11,275<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other assets</a></td>
<td class="nump">951<span></span>
</td>
<td class="nump">1,185<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">44,453<span></span>
</td>
<td class="nump">40,766<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="nump">23,700<span></span>
</td>
<td class="nump">21,374<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent', window );">Current portion of long-term obligations and other short-term borrowings</a></td>
<td class="nump">871<span></span>
</td>
<td class="nump">10<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAccruedLiabilitiesCurrent', window );">Other accrued liabilities</a></td>
<td class="nump">2,957<span></span>
</td>
<td class="nump">2,231<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation', window );">Disposal Group, Including Discontinued Operation, Liabilities</a></td>
<td class="nump">96<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">27,624<span></span>
</td>
<td class="nump">23,615<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtAndCapitalLeaseObligations', window );">Long-term obligations, less current portion</a></td>
<td class="nump">5,365<span></span>
</td>
<td class="nump">6,765<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAndOtherLiabilitiesNoncurrent', window );">Deferred income taxes and other liabilities</a></td>
<td class="nump">9,670<span></span>
</td>
<td class="nump">8,594<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockNumberOfSharesParValueAndOtherDisclosuresAbstract', window );"><strong>Preferred shares, without par value:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Authorized&#8212;500 thousand shares, Issued&#8212;none</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract', window );"><strong>Common shares, without par value:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Authorized&#8212;755 million shares, Issued&#8212; 327 million shares at June 30, 2021 and 2020</a></td>
<td class="nump">2,806<span></span>
</td>
<td class="nump">2,789<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Retained earnings</a></td>
<td class="nump">$ 1,205<span></span>
</td>
<td class="nump">$ 1,170<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockShares', window );">Common shares in treasury</a></td>
<td class="nump">36,000,000<span></span>
</td>
<td class="nump">34,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockValue', window );">Common shares in treasury, at cost: 36 million shares and 34 million shares at June 30, 2021 and 2020, respectively</a></td>
<td class="num">$ (2,186)<span></span>
</td>
<td class="num">$ (2,066)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive loss</a></td>
<td class="num">(34)<span></span>
</td>
<td class="num">(104)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total Cardinal Health, Inc. shareholders' equity</a></td>
<td class="nump">1,791<span></span>
</td>
<td class="nump">1,789<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterest', window );">Noncontrolling interests</a></td>
<td class="nump">3<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Total shareholders&#8217; equity</a></td>
<td class="nump">1,794<span></span>
</td>
<td class="nump">1,792<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities and shareholders&#8217; equity</a></td>
<td class="nump">$ 44,453<span></span>
</td>
<td class="nump">$ 40,766<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred shares, authorized</a></td>
<td class="nump">500,000<span></span>
</td>
<td class="nump">500,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred shares, issued</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common shares, authorized</a></td>
<td class="nump">755,000,000<span></span>
</td>
<td class="nump">755,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common shares, issued</a></td>
<td class="nump">327,000,000<span></span>
</td>
<td class="nump">327,000,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669686-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e681-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6801-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 15: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount classified as assets attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3044-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAndOtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences, with jurisdictional netting, and liabilities classified as noncurrent and other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAndOtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetIncludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount of finite-lived intangible assets, indefinite-lived intangible assets and goodwill. Goodwill is an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized. Intangible assets are assets, not including financial assets, lacking physical substance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetIncludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 20: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount classified as liabilities attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtAndCapitalLeaseObligations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt and lease obligation, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtAndCapitalLeaseObligations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt and lease obligation, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.31)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6911-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e7018-107765<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6935-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.8)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockNumberOfSharesParValueAndOtherDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockNumberOfSharesParValueAndOtherDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124429447&amp;loc=SL124453093-239630<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReceivablesNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The total amount due to the entity within one year of the balance sheet date (or one operating cycle, if longer) from outside sources, including trade accounts receivable, notes and loans receivable, as well as any other types of receivables, net of allowances established for the purpose of reducing such receivables to an amount that approximates their net realizable value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 210<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-06(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120401414&amp;loc=d3e604059-122996<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReceivablesNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21930-107793<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21914-107793<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4568740-111683<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21711-107793<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123459177&amp;loc=SL121830611-158277<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123459177&amp;loc=SL121830611-158277<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4590271-111686<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 24: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4568447-111683<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Publisher FASB<br> -Subparagraph (a)(3)(iii)(03)<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of common and preferred shares that were previously issued and that were repurchased by the issuing entity and held in treasury on the financial statement date. This stock has no voting rights and receives no dividends.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29,30)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=6405834&amp;loc=d3e23315-112656<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29,30)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140421171094312">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Statements of Shareholders' Equity - USD ($)<br> shares in Thousands, $ in Millions</strong></div></th>
<th class="th"><div>Total</div></th>
<th class="th"><div>Common Shares</div></th>
<th class="th"><div>Retained Earnings</div></th>
<th class="th"><div>Treasury Shares</div></th>
<th class="th"><div>Accumulated Other Comprehensive Loss</div></th>
<th class="th"><div>Noncontrolling Interests</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net Income (Loss) Attributable to Parent</a></td>
<td class="nump">$ 1,363<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,363<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Balance at beginning of period (in shares) at Jun. 30, 2018</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">327,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance at beginning of period at Jun. 30, 2018</a></td>
<td class="nump">6,059<span></span>
</td>
<td class="nump">$ 2,730<span></span>
</td>
<td class="nump">4,645<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (92)<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockShares', window );">Treasury, balance at beginning of period (in shares) at Jun. 30, 2018</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(18,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockValue', window );">Treasury, balance at beginning of period at Jun. 30, 2018</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (1,224)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Shareholders' Equity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net earnings</a></td>
<td class="nump">1,365<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_NetEarningsIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest', window );">Net Earnings Including Portion Attributable to Noncontrolling Interest Excluding Redeemable Noncontrolling Interest</a></td>
<td class="nump">1,365<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive loss, net of tax</a></td>
<td class="nump">13<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture</a></td>
<td class="nump">67<span></span>
</td>
<td class="nump">$ 33<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 34<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Treasury shares acquired (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(11,500)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredCostMethod', window );">Share repurchase program activity</a></td>
<td class="num">(600)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (600)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Dividends', window );">Dividends declared</a></td>
<td class="num">(575)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(575)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityOtherShares', window );">Stockholders' Equity, Other Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityOther', window );">Other</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Balance at end of period (in shares) at Jun. 30, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">327,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance at end of period at Jun. 30, 2019</a></td>
<td class="nump">6,330<span></span>
</td>
<td class="nump">$ 2,763<span></span>
</td>
<td class="nump">5,434<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(79)<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockShares', window );">Treasury, balance at end of period (in shares) at Jun. 30, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(28,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockValue', window );">Treasury, balance at end of period at Jun. 30, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (1,790)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net Income (Loss) Attributable to Parent</a></td>
<td class="num">(3,696)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Shareholders' Equity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net earnings</a></td>
<td class="num">(3,693)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive loss, net of tax</a></td>
<td class="num">(25)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(25)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture</a></td>
<td class="nump">100<span></span>
</td>
<td class="nump">$ 26<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 74<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Treasury shares acquired (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(7,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredCostMethod', window );">Share repurchase program activity</a></td>
<td class="num">(350)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (350)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Dividends', window );">Dividends declared</a></td>
<td class="num">(570)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(570)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityOtherShares', window );">Stockholders' Equity, Other Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityOther', window );">Other</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Balance at end of period (in shares) at Jun. 30, 2020</a></td>
<td class="nump">327,000<span></span>
</td>
<td class="nump">327,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance at end of period at Jun. 30, 2020</a></td>
<td class="nump">$ 1,792<span></span>
</td>
<td class="nump">$ 2,789<span></span>
</td>
<td class="nump">1,170<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(104)<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockShares', window );">Treasury, balance at end of period (in shares) at Jun. 30, 2020</a></td>
<td class="num">(34,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(35,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockValue', window );">Treasury, balance at end of period at Jun. 30, 2020</a></td>
<td class="num">$ (2,066)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (2,066)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net Income (Loss) Attributable to Parent</a></td>
<td class="nump">611<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Shareholders' Equity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net earnings</a></td>
<td class="nump">612<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive loss, net of tax</a></td>
<td class="nump">70<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">70<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture</a></td>
<td class="nump">97<span></span>
</td>
<td class="nump">$ 17<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 80<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Treasury shares acquired (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3,700)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredCostMethod', window );">Share repurchase program activity</a></td>
<td class="num">(200)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (200)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Dividends', window );">Dividends declared</a></td>
<td class="num">(576)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(576)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityOtherShares', window );">Stockholders' Equity, Other Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityOther', window );">Other</a></td>
<td class="nump">$ 1<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Balance at end of period (in shares) at Jun. 30, 2021</a></td>
<td class="nump">327,000<span></span>
</td>
<td class="nump">327,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance at end of period at Jun. 30, 2021</a></td>
<td class="nump">$ 1,794<span></span>
</td>
<td class="nump">$ 2,806<span></span>
</td>
<td class="nump">$ 1,205<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (34)<span></span>
</td>
<td class="nump">$ 3<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockShares', window );">Treasury, balance at end of period (in shares) at Jun. 30, 2021</a></td>
<td class="num">(36,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(36,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockValue', window );">Treasury, balance at end of period at Jun. 30, 2021</a></td>
<td class="num">$ (2,186)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (2,186)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_NetEarningsIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Net Earnings Including Portion Attributable to Noncontrolling Interest Excluding Redeemable Noncontrolling Interest</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_NetEarningsIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Dividends">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of paid and unpaid cash, stock, and paid-in-kind (PIK) dividends declared, for example, but not limited to, common and preferred stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 405<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6957935&amp;loc=d3e64057-112817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Dividends</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInStockholdersEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of other comprehensive income (loss) attributable to parent entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569643-111683<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21930-107793<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21914-107793<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4568740-111683<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21711-107793<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123459177&amp;loc=SL121830611-158277<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123459177&amp;loc=SL121830611-158277<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4590271-111686<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 24: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4568447-111683<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Publisher FASB<br> -Subparagraph (a)(3)(iii)(03)<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This element represents movements included in the statement of changes in stockholders' equity which are not separately disclosed or provided for elsewhere in the taxonomy.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityOtherShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of increase (decrease) in shares of stock classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityOtherShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of common and preferred shares that were previously issued and that were repurchased by the issuing entity and held in treasury on the financial statement date. This stock has no voting rights and receives no dividends.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29,30)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockSharesAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased during the period and are being held in treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockSharesAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=6405834&amp;loc=d3e23315-112656<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29,30)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockValueAcquiredCostMethod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the cost of common and preferred stock that were repurchased during the period. Recorded using the cost method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockValueAcquiredCostMethod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140421173565320">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Cash Flows - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Cash flows from operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net earnings</a></td>
<td class="nump">$ 612<span></span>
</td>
<td class="num">$ (3,693)<span></span>
</td>
<td class="nump">$ 1,365<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net earnings/(loss) to net cash provided by operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">783<span></span>
</td>
<td class="nump">913<span></span>
</td>
<td class="nump">1,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfOtherInvestments', window );">Loss on Sale of Investments</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfInvestments', window );">Gain (Loss) on Sale of Investments</a></td>
<td class="num">(2)<span></span>
</td>
<td class="nump">579<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges', window );">Impairments and (gain)/loss on disposal of assets, net</a></td>
<td class="nump">79<span></span>
</td>
<td class="nump">7<span></span>
</td>
<td class="num">(488)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Loss on early extinguishment of debt</a></td>
<td class="nump">14<span></span>
</td>
<td class="nump">16<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Share-based compensation</a></td>
<td class="nump">89<span></span>
</td>
<td class="nump">90<span></span>
</td>
<td class="nump">82<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefit', window );">Provision for/(benefit from) deferred income taxes</a></td>
<td class="nump">496<span></span>
</td>
<td class="num">(961)<span></span>
</td>
<td class="num">(83)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProvisionForDoubtfulAccounts', window );">Provision for bad debts</a></td>
<td class="nump">65<span></span>
</td>
<td class="nump">106<span></span>
</td>
<td class="nump">88<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Change in operating assets and liabilities, net of effects from acquisitions and divestitures:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInReceivables', window );">(Increase)/decrease in trade receivables</a></td>
<td class="num">(904)<span></span>
</td>
<td class="nump">82<span></span>
</td>
<td class="num">(751)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInInventories', window );">Increase in inventories</a></td>
<td class="num">(1,584)<span></span>
</td>
<td class="num">(409)<span></span>
</td>
<td class="num">(551)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayable', window );">Increase/(decrease) in accounts payable</a></td>
<td class="nump">2,325<span></span>
</td>
<td class="num">(162)<span></span>
</td>
<td class="nump">1,864<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet', window );">Other accrued liabilities and operating items, net</a></td>
<td class="nump">452<span></span>
</td>
<td class="nump">6,550<span></span>
</td>
<td class="nump">193<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash provided by operating activities</a></td>
<td class="nump">2,429<span></span>
</td>
<td class="nump">1,960<span></span>
</td>
<td class="nump">2,722<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Cash flows from investing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired', window );">Acquisition of subsidiaries, net of cash acquired</a></td>
<td class="num">(3)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(82)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Additions to property and equipment</a></td>
<td class="num">(400)<span></span>
</td>
<td class="num">(375)<span></span>
</td>
<td class="num">(328)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_Purchaseofavailableforsalesecuritiesandotherinvestments', window );">Purchase of other investments</a></td>
<td class="num">(22)<span></span>
</td>
<td class="num">(20)<span></span>
</td>
<td class="num">(18)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_Proceedsfromsaleofavailableforsalesecuritiesandotherinvestments', window );">Proceeds from sale of investments</a></td>
<td class="nump">47<span></span>
</td>
<td class="nump">886<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_Proceedsfromdivestituresanddisposalofpropertyandequipmentandheldforsaleassets', window );">Proceeds from divestitures, net of cash sold, and disposal of property and equipment</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="nump">763<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash provided by/(used in) investing activities</a></td>
<td class="num">(378)<span></span>
</td>
<td class="nump">493<span></span>
</td>
<td class="nump">338<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Cash flows from financing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromRepaymentsOfShortTermDebt', window );">Net change in short-term borrowings</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(2)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForProceedsFromHedgeFinancingActivities', window );">Proceeds from interest rate swap terminations</a></td>
<td class="nump">18<span></span>
</td>
<td class="nump">112<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfLongTermDebt', window );">Reduction of long-term obligations</a></td>
<td class="num">(570)<span></span>
</td>
<td class="num">(1,399)<span></span>
</td>
<td class="num">(1,102)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_Netproceedstaxwithholdingsfromsharebasedcompensation', window );">Net tax proceeds/(withholding) from share-based compensation</a></td>
<td class="nump">8<span></span>
</td>
<td class="nump">8<span></span>
</td>
<td class="num">(14)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfDividendsCommonStock', window );">Dividends on common shares</a></td>
<td class="num">(573)<span></span>
</td>
<td class="num">(569)<span></span>
</td>
<td class="num">(577)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRepurchaseOfCommonStock', window );">Purchase of treasury shares</a></td>
<td class="num">(200)<span></span>
</td>
<td class="num">(350)<span></span>
</td>
<td class="num">(600)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash used in financing activities</a></td>
<td class="num">(1,317)<span></span>
</td>
<td class="num">(2,200)<span></span>
</td>
<td class="num">(2,293)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents', window );">Effect of exchange rates changes on cash and equivalents</a></td>
<td class="nump">11<span></span>
</td>
<td class="num">(13)<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_CashReclassifiedtoAssetsHeldforSale', window );">Cash reclassified to assets held for sale</a></td>
<td class="num">(109)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</a></td>
<td class="nump">636<span></span>
</td>
<td class="nump">240<span></span>
</td>
<td class="nump">768<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and equivalents at beginning of period</a></td>
<td class="nump">2,771<span></span>
</td>
<td class="nump">2,531<span></span>
</td>
<td class="nump">1,763<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and equivalents at end of period</a></td>
<td class="nump">3,407<span></span>
</td>
<td class="nump">2,771<span></span>
</td>
<td class="nump">2,531<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowInformationAbstract', window );"><strong>Supplemental Information:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestPaidNet', window );">Cash payments for interest</a></td>
<td class="nump">182<span></span>
</td>
<td class="nump">226<span></span>
</td>
<td class="nump">285<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxesPaidNet', window );">Cash payments for income taxes</a></td>
<td class="nump">$ 273<span></span>
</td>
<td class="nump">$ 368<span></span>
</td>
<td class="nump">$ 311<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_CashReclassifiedtoAssetsHeldforSale">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>CashReclassifiedtoAssetsHeldforSale</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_CashReclassifiedtoAssetsHeldforSale</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_Netproceedstaxwithholdingsfromsharebasedcompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net cash inflow/(outflow) associated with the amount received from holders exercising their stock options and paid by the company to satisfy an employee's income tax withholding obligation when shares are withheld from settlement of a share-based award to cover taxes. This item inherently excludes any excess tax benefit, which the entity may have realized and reported separately.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_Netproceedstaxwithholdingsfromsharebasedcompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_Proceedsfromdivestituresanddisposalofpropertyandequipmentandheldforsaleassets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Proceeds from divestitures and disposal of property and equipment and held for sale assets</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_Proceedsfromdivestituresanddisposalofpropertyandequipmentandheldforsaleassets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_Proceedsfromsaleofavailableforsalesecuritiesandotherinvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from sales of available-for-sale securities and other investments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_Proceedsfromsaleofavailableforsalesecuritiesandotherinvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_Purchaseofavailableforsalesecuritiesandotherinvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow from purchases of available-for-sale securities and other investments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_Purchaseofavailableforsalesecuritiesandotherinvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3044-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) from the effect of exchange rate changes on cash and cash equivalent balances held in foreign currencies.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnSaleOfInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net realized gain (loss) on investments sold during the period, not including gains (losses) on securities separately or otherwise categorized as trading, available-for-sale, or held-to-maturity, which, for cash flow reporting, is a component of proceeds from investing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnSaleOfInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnSaleOfOtherInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) included in earnings for investments classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnSaleOfOtherInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) from the difference between the sale price or salvage price and the book value of an asset that was sold or retired, and gain (loss) from the write down of assets from their carrying value to fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainsLossesOnExtinguishmentOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123467658&amp;loc=d3e12355-112629<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467658&amp;loc=d3e12317-112629<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainsLossesOnExtinguishmentOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxesPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4297-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxesPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInInventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInInventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in operating assets after deduction of operating liabilities classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the total amount due within one year (or one operating cycle) from all parties, associated with underlying transactions that are classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4297-108586<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3367-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForProceedsFromHedgeFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net cash outflow or inflow for a financial contract that meets the hedge criteria as either cash flow hedge, fair value hedge or hedge of net investment in foreign operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForProceedsFromHedgeFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRepurchaseOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to reacquire common stock during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRepurchaseOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDividendsCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow in the form of ordinary dividends to common shareholders of the parent entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDividendsCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromRepaymentsOfShortTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net cash inflow or outflow for borrowing having initial term of repayment within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromRepaymentsOfShortTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProvisionForDoubtfulAccounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense (reversal of expense) for expected credit loss on accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919249-210447<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProvisionForDoubtfulAccounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140421166247512">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basis of Presentation and Summary of Significant Accounting Policies<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock', window );">Basis of Presentation and Summary of Significant Accounting Policies</a></td>
<td class="text"><div style="display:inline-block;vertical-align:top;width:48.214%"><div style="margin-bottom:6pt;text-align:justify"><span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:13pt;font-weight:700;line-height:120%">1. Basis of Presentation and Summary of Significant Accounting Policies </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cardinal Health, Inc. is a globally integrated healthcare services and products company providing customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories and physician offices. We provide pharmaceuticals and medical products and cost-effective solutions that enhance supply chain efficiency. References to &#8220;we&#8221;, &#8220;our&#8221; and similar pronouns in these consolidated financial statements are to Cardinal Health, Inc. and its majority-owned or controlled subsidiaries unless the context otherwise requires.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our fiscal year ends on June&#160;30. References to fiscal 2021, 2020 and 2019 in these consolidated financial statements are to the fiscal years ended June&#160;30, 2021, 2020 and 2019, respectively.</span></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Basis of Presentation</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our consolidated financial statements include the accounts of all majority-owned or controlled subsidiaries, and all significant intercompany transactions and amounts have been eliminated. The results of businesses acquired or disposed of are included in the consolidated financial statements from the date of the acquisition or up to the date of disposal, respectively.</span></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our consolidated financial statements are prepared in accordance with accounting principles generally accepted in the United States (&#8220;GAAP&#8221;). The preparation of financial statements in accordance with GAAP requires us to make estimates, judgments and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes. Estimates, judgments and assumptions are used in the accounting and disclosure related to, among other items, allowance for doubtful accounts, inventory valuation and reserves, goodwill and other intangible asset impairment, loss contingencies (including product liability and self-insurance accruals), and income taxes. Actual amounts could ultimately differ from these estimated amounts.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The COVID-19 pandemic ("COVID-19") continues to affect the U.S. and global economies, and as previously disclosed, the pandemic began to materially affect our businesses during the third quarter of fiscal 2020. The length and severity of the pandemic and its impacts on our businesses and results of operations are uncertain.</span></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Cash Equivalents</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We consider liquid investments purchased with an initial maturity of three months or less to be cash equivalents. The carrying value of cash equivalents approximates fair value.</span></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Receivables and Allowance for Doubtful Accounts</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Trade receivables are presented net of an allowance for doubtful accounts of $242 million and $206 million at June&#160;30, 2021 and 2020, respectively. An account is considered past due on the first </span></div></div><div style="display:inline-block;max-width:3.571%;min-width:2.571%;vertical-align:top"/><div style="display:inline-block;vertical-align:top;width:48.215%"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">day after its due date. In accordance with contract terms, we generally have the ability to charge customers service fees or higher prices if an account is considered past due. We regularly monitor past due accounts and establish appropriate reserves to cover potential losses, and consider historical experience, the current economic environment, customer credit ratings or bankruptcies, and reasonable and supportable forecasts to develop our allowance for credit losses. We review these factors quarterly to determine if any adjustments are needed to the allowance. We write off any amounts deemed uncollectible against the established allowance for doubtful accounts.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We provide financing to various customers. Such financing arrangements range from 1 year&#160;to 5 years at interest rates that are generally subject to fluctuation. Interest income on these arrangements is recognized as it is earned. The financings may be collateralized, guaranteed by third parties or unsecured. Finance notes, net and related accrued interest were $63 million (current portion $7 million) and $104 million (current portion $12 million) at June&#160;30, 2021 and 2020, respectively, and are included in other assets (current portion is included in prepaid expenses and other) in the consolidated balance sheets. Finance notes receivable allowance for doubtful accounts were $12 million and $27 million at June&#160;30, 2021 and 2020, respectively. We estimate an allowance for these financing receivables based on historical collection rates and the credit worthiness of the customer. We write off any amounts deemed uncollectible against the established allowance for doubtful accounts.</span></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Concentrations of Credit Risk</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We maintain cash depository accounts with major banks, and we invest in high quality, short-term liquid instruments, and in marketable securities. Our short-term liquid instruments mature within three months and we have not historically incurred any related losses.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our trade receivables and finance notes and related accrued interest are exposed to a concentration of credit risk with certain large customers and with customers in the retail and healthcare sectors. Credit risk can be affected by changes in reimbursement and other economic pressures impacting the healthcare industry. With respect to customers in the retail and healthcare sectors, such credit risk is limited due to supporting collateral and the diversity of the customer base, including its wide geographic dispersion. We perform regular credit evaluations of our customers&#8217; financial conditions and maintain reserves for losses through the established allowance for doubtful accounts. Historically, such losses have been within our expectations. Refer to the "Receivables and Allowance for Doubtful Accounts" section within this Note for additional information on the accounting treatment of reserves for allowance for doubtful accounts. </span></div></div><div style="display:inline-block;vertical-align:top;width:48.214%"><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Major Customers</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CVS Health Corporation ("CVS") and OptumRx, are our only customers that individually account for at least 10 percent of revenue and gross trade receivables. These customers are primarily serviced through our Pharmaceutical segment.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2021, we extended our pharmaceutical distribution agreements with CVS through June 2027. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes historical percent of revenue and gross trade receivables from CVS and OptumRx:</span></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.382%"><tr><td style="width:1.0%"/><td style="width:35.235%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.148%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.352%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.769%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.352%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.769%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.352%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.632%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.352%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.639%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Percent of Revenue</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Percent&#160;of&#160;Gross Trade&#160;Receivables at June 30</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CVS</span></td><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">26</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">24</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">OptumRx</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">15</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">3</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have entered into agreements with group purchasing organizations (&#8220;GPOs&#8221;) which act as purchasing agents that negotiate vendor contracts on behalf of their members. Vizient, Inc. and Premier, Inc. are our two largest GPO member relationships in terms of revenue. Sales to members of these two GPOs collectively accounted for 15 percent, 16 percent and 22 percent of revenue for fiscal 2021, 2020 and 2019, respectively. Our trade receivable balances are with individual members of the GPO, and therefore no significant concentration of credit risk exists with these types of arrangements.</span></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Inventories</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A portion of our inventories (50 percent and 56 percent at June&#160;30, 2021 and 2020, respectively) are valued at the lower of cost, using the last-in, first-out ("LIFO") method, or market. These inventories are included within the core pharmaceutical distribution facilities of our Pharmaceutical segment (&#8220;distribution facilities&#8221;) and are primarily merchandise inventories. The LIFO method presumes that the most recent inventory purchases are the first items sold, so LIFO helps us better match current costs and revenue. We believe that the average cost method of inventory valuation provides a reasonable approximation of the current cost of replacing inventory within the distribution facilities. As such, the LIFO reserve is the difference between (a) inventory at the lower of LIFO cost or market and (b) inventory at replacement cost determined using the average cost method of inventory valuation.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At June&#160;30, 2021 and 2020, respectively, inventories valued at LIFO cost were $565 million and</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$411 million higher than the average cost value. We do not record inventories in excess of replacement cost. As such, we did not write-up the value of our inventory from average cost to LIFO cost at June&#160;30, 2021 or 2020. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our remaining inventory, including inventory in our Medical segment, that is not valued at the lower of LIFO cost or market is stated at the lower of cost, using the first-in, first-out method, or net realizable value. Net realizable value is defined as the estimated selling prices and estimated sales demand in the ordinary course of business, less reasonably predictable costs of completion, disposal and transportation. Due to the unprecedented demand for </span></div></div><div style="display:inline-block;max-width:3.571%;min-width:2.571%;vertical-align:top"/><div style="display:inline-block;vertical-align:top;width:48.215%"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">certain personal protective equipment as a result of COVID-19, our Medical segment manufactured and sourced inventory at higher costs than in periods prior to COVID-19. Personal protective equipment ("PPE") refers to protective clothing, medical and non-medical grade gloves, face shields, face masks and other equipment designed to protect the wearer from injury or the spread of infection or illness. As selling prices and customer demand have decreased compared to the peak of COVID-19, we recorded a reserve of $197&#160;million, primarily related to certain categories of gloves, to reduce the carrying value of certain PPE to its net realizable value.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We reserve for inventory obsolescence using estimates based on historical experience, historical and projected sales trends, specific&#160;categories of inventory, age and expiration dates of on-hand inventory and manufacturer return policies. Inventories presented in the consolidated balance sheets are net of reserves for excess and obsolete inventory which were $185 million and $155 million at June&#160;30, 2021 and 2020, respectively.</span></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Cash Discounts</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Manufacturer cash discounts are recorded as a component of inventory cost and recognized as a reduction of cost of products sold as inventory is sold.</span></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Property and Equipment</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Property and equipment are carried at cost less accumulated depreciation. Property and equipment held for sale are recorded at the lower of cost less accumulated depreciation before the decision to dispose of the asset was made or fair value less cost to sell. When certain events or changes in operating conditions occur, an impairment assessment may be performed on the recoverability of the carrying amounts.</span></div><div style="margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Depreciation expense is computed using the straight-line method over the estimated useful lives of the assets, including finance lease assets which are depreciated over the terms of their respective leases. We generally use the following range of useful lives for our property and equipment categories: buildings and improvements&#8212;3 to 39 years; machinery and equipment&#8212;3 to 20 years; and furniture and fixtures&#8212;3 to 7 years. We recorded depreciation and amortization expense of $377 million, $405 million and $455 million for fiscal 2021, 2020 and 2019, respectively.</span></div><div style="margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the components of property and equipment, net at June&#160;30:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:62.788%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.183%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.343%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.186%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Land, building and improvements</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2,359</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,185&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Machinery and equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">3,093</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,008&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Furniture and fixtures</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">136</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">138&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total property and equipment, at cost</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">5,588</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5,331&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accumulated depreciation and amortization</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(3,228)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(2,965)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Property and equipment, net</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2,360</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,366&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Repairs and maintenance expenditures are expensed as incurred. Interest on long-term projects is capitalized using a rate that approximates the weighted-average interest rate on long-term </span></div></div><div style="display:inline-block;vertical-align:top;width:48.214%"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">obligations, which was 3 percent at June&#160;30, 2021. The amount of capitalized interest was immaterial for all periods presented.</span></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Goodwill and Other Intangible Assets</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Purchased goodwill and intangible assets with indefinite lives are not amortized, but instead are tested for impairment annually or when indicators of impairment exist.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Purchased goodwill is tested for impairment at least annually. Qualitative factors are first assessed to determine if it is more likely than not that the fair value of a reporting unit is less than its carrying amount. There is an option to bypass the qualitative assessment for any reporting unit in any period and proceed directly to performing the quantitative goodwill impairment test. We have elected to bypass the qualitative assessment for our annual goodwill impairment test in the current year. The quantitative goodwill impairment test involves a comparison of the estimated fair value of the reporting unit to the respective carrying amount. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Goodwill impairment testing involves judgment, including the identification of reporting units, qualitative evaluation of events and circumstances to determine if it is more likely than not that an impairment exists, and, if necessary, the estimation of the fair value of the applicable reporting unit. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have two operating segments, which are the same as our reportable segments: Pharmaceutical and Medical. These operating segments are comprised of divisions (components), for which discrete financial information is available. Components are aggregated into reporting units for purposes of goodwill impairment testing to the extent that they share similar economic characteristics. Our reporting units are: Pharmaceutical operating segment (excluding our Nuclear and Precision Health Solutions division); Nuclear and Precision Health Solutions division; Medical operating segment (excluding our Cardinal Health at-Home Solutions division) (&#8220;Medical Unit&#8221;); and Cardinal Health at-Home Solutions division.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fair value can be determined using market, income or cost-based approaches. Our determination of estimated fair value of the reporting units is based on a combination of the income-based and market-based approaches. Under the income-based approach, we use a discounted cash flow model in which cash flows anticipated over several future periods, plus a terminal value at the end of that time horizon, are discounted to their present value using an appropriate risk-adjusted rate of return.&#160;We use our internal forecasts to estimate future cash flows, which we believe are consistent with those of a market participant, and include an estimate of long-term growth rates based on our most recent views of the long-term outlook for each reporting unit. Actual results may differ materially from those used in our forecasts. We use discount rates that are commensurate with the risks and uncertainty inherent in the respective reporting units and in our internally-developed forecasts. Discount rates used in our reporting unit valuations ranged from 8.5 percent to 11.5 percent. Under the market-based guideline public company method, we determine fair value by comparing our reporting units to similar businesses or guideline companies whose securities are actively traded in public markets. We also use the guideline transaction method to </span></div></div><div style="display:inline-block;max-width:3.571%;min-width:2.571%;vertical-align:top"/><div style="display:inline-block;vertical-align:top;width:48.215%"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">determine fair value based on pricing multiples derived from the sale of companies that are similar to our reporting units. To further confirm fair value, we compare the aggregate fair value of our reporting units to our total market capitalization.&#160;Estimating the fair value of reporting units requires the use of estimates and significant judgments that are based on a number of factors including forecasted operating results. The use of alternate estimates and assumptions or changes in the industry or peer groups could materially affect the determination of fair value for each reporting unit and potentially result in goodwill impairment.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We performed annual impairment testing in fiscal 2021, 2020 and 2019 and concluded that there were no impairments of goodwill as the estimated fair value of each reporting unit exceeded its carrying value.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The impairment test for indefinite-lived intangibles other than goodwill involves first assessing qualitative factors to determine if it is more likely than not that the fair value of the indefinite-lived intangible asset is less than its carrying amount. If so, then a quantitative test is performed to compare the estimated fair value of the indefinite-lived intangible asset to the respective asset's carrying amount. Our qualitative evaluation requires the use of estimates and significant judgments and considers the weight of evidence and significance of all identified events and circumstances and most relevant drivers of fair value, both positive and negative, in determining whether it is more likely than not that the fair value of the indefinite-lived intangible asset is less than its carrying amount.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intangible assets with finite lives, primarily customer relationships; trademarks, trade names and patents; and developed technology, are amortized using a combination of straight-line and accelerated methods based on the expected cash flows from the asset over their estimated useful lives. We review intangible assets with finite lives for impairment whenever events or changes in circumstances indicate that the related carrying amounts may not be recoverable. Determining whether an impairment loss occurred requires a comparison of the carrying amount to the sum of the future forecasted undiscounted cash flows expected to be generated by the asset group. Actual results may differ materially from those used in our forecasts.</span></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Assets Held for Sale</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We classify assets and liabilities (the &#8220;disposal group&#8221;) as held for sale when management commits to a plan to sell the disposal group in its present condition and at a price that is reasonable in relation to its current fair value. We also consider whether an active program to locate a buyer has been initiated and if it is probable that the sale will occur within one year without significant changes to the plan to sell. Upon classification of the disposal group as held for sale, we test the assets for impairment and cease related depreciation and amortization.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 12, 2021, we announced that we signed a definitive agreement to sell our Cordis business to Hellman &amp; Friedman for proceeds of $927 million in cash, subject to customary purchase price adjustments, and we retained certain working capital accounts and certain liabilities, including product liability for </span></div></div><div style="display:inline-block;vertical-align:top;width:48.214%"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">lawsuits related to inferior vena cava filters in the U.S. and Canada as described in </span><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i4f0ec56b9c604f1782a65ea4a19c284d_130" style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Note 7</a></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of the &#8220;Notes to Consolidated Financial Statements.&#8221; The transaction closed on August 2, 2021. See </span><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i4f0ec56b9c604f1782a65ea4a19c284d_106" style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Note 2</a></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for additional information.</span></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Investments</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Investments in non-marketable equity securities are accounted for under the fair value, equity or net asset value method of&#160;accounting and are included in other assets in the consolidated balance sheets. For equity securities without a readily determinable fair value, we use the fair value measurement alternative and measure the securities at cost less impairment, if any, including adjustments for observable price changes in orderly transactions for an identical or similar investment of the same issuer. For investments in which we can exercise significant influence but do not control, we use the equity method of accounting. Our share of the earnings and losses are recorded in other (income)/expense, net in the consolidated statements of earnings/(loss). We monitor our investments for impairment&#160;by considering factors such as the operating performance of the investment and current economic and market conditions.</span></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Vendor Reserves</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the ordinary course of business, our vendors may dispute deductions taken against payments otherwise due to them or assert other disputes. These disputes are researched and resolved based upon the findings of the research performed. At any given time, there are outstanding items in various stages of research and resolution. In determining appropriate reserves for areas of exposure with our vendors, we assess historical experience and current outstanding claims. We have established various levels of reserves based on the type of claim and status of review. Though the claim types are relatively consistent, we periodically refine our methodology by updating the reserve estimate percentages to reflect actual historical experience. The ultimate outcome of certain claims may be different than our original estimate and may require an adjustment. Adjustments to vendor reserves are included in cost of products sold. In addition, the reserve balance will fluctuate due to variations of outstanding claims from period-to-period, timing of settlements and specific vendor issues, such as bankruptcies. Vendor reserves were $77 million at both June&#160;30, 2021 and 2020, excluding third-party returns. See Third-Party Returns section within this Note for a description of third-party returns.</span></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Distribution Services Agreement and Other Vendor Fees</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Pharmaceutical segment recognizes fees received from distribution services agreements and other fees received from vendors related to the purchase or distribution of the vendors&#8217; inventory when those fees have been earned and we are entitled to payment. Since the benefit provided to a vendor is related to the purchase and distribution of the vendor&#8217;s inventory, we recognize the fees as a reduction in the carrying value of the inventory that generated the fees, and as such, a reduction of cost of products sold in our consolidated statements of earnings/(loss) when the inventory is sold.</span></div></div><div style="display:inline-block;max-width:3.571%;min-width:2.571%;vertical-align:top"/><div style="display:inline-block;vertical-align:top;width:48.215%"><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Loss Contingencies and Self-Insurance</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Loss Contingencies</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We accrue for contingencies related to disputes, litigation and regulatory matters if it is probable that a liability has been incurred and the amount of the loss can be reasonably estimated. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the opioid litigation as described further in the </span><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i4f0ec56b9c604f1782a65ea4a19c284d_130" style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Note 7</a></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, we recorded pre-tax charges of&#160;$1.17 billion and $5.63 billion during fiscal 2021 and 2020 respectively which were retained at Corporate. In July 2021, we announced that we and two other national distributors have negotiated a proposed settlement agreement, subject to certain conditions and contingencies. There is no assurance that the contingencies to the proposed settlement agreement will be satisfied. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We develop and periodically update reserve estimates for the Cordis inferior vena cava ("Cordis IVC") claims, including those received to date and expected to be received in the future and related costs. To project future Cordis IVC claim costs, we use a methodology based largely on recent experience, including claim filing rates, estimated indemnity severity by claim type, sales data, implant and injury to report lag patterns and estimated defense costs.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Self-Insurance</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also self-insure for employee healthcare, general liability, certain product liability matters, auto liability, property and workers' compensation. Self-insurance accruals include an estimate for expected settlements or pending claims, defense costs, administrative fees, claim adjustment costs and an estimate for claims incurred but not reported. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Because these matters are inherently unpredictable and unfavorable developments or resolutions can occur, assessing contingencies and other liabilities is highly subjective and requires judgments about future&#160;events. We regularly review contingencies and our self-insurance accruals to determine whether our accruals and related disclosures are adequate. Any adjustments for changes in reserves are recorded in the period in which the change in estimate occurs.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The amount of ultimate loss may differ materially from these estimates. We recognize these estimated loss contingencies, income from favorable resolution of litigation and certain defense costs in litigation (recoveries)/charges in our consolidated statements of earnings/(loss). See </span><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i4f0ec56b9c604f1782a65ea4a19c284d_130" style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Note 7</a></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for additional information regarding loss contingencies and product liability lawsuits.</span></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Guarantees</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the ordinary course of business, we agree to indemnify certain other parties under acquisition and disposition agreements, customer agreements, intellectual property licensing agreements, and other agreements. Such indemnification obligations vary in scope and, when defined, in duration. In many cases, a maximum obligation is not explicitly stated, and therefore the overall maximum amount of the liability under such indemnification obligations cannot be reasonably estimated. Where appropriate, such indemnification obligations are recorded as a liability. Historically, we have not, individually or in the aggregate, made </span></div></div><div style="display:inline-block;vertical-align:top;width:48.214%"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">payments under these indemnification obligations in any material amounts. In certain circumstances, we believe that existing insurance arrangements, subject to the general deduction and exclusion provisions, would cover portions of the liability that may arise from these indemnification obligations. In addition, we believe that the likelihood of a material liability being triggered under these indemnification obligations is not probable.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time we enter into agreements that obligate us to make fixed payments upon the occurrence of certain events. Such obligations primarily relate to obligations arising under acquisition transactions, where we have agreed to make payments based upon the achievement of certain financial performance measures by the acquired business. Generally, the obligation is capped at an explicit amount. There were no material obligations at June&#160;30, 2021. </span></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Income Taxes</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We account for income taxes using the asset and liability method. Deferred tax assets and liabilities are measured using enacted tax rates in the respective jurisdictions in which we operate. We assess the realizability of deferred tax assets on a quarterly basis and provide a valuation allowance for deferred tax assets when it is more likely than not that at least a portion of the deferred tax assets will not be realized. The realizability of deferred tax assets depends on our ability to generate sufficient taxable income within the carryback or carryforward periods provided for in the tax law for each applicable tax jurisdiction and also considers all available positive and negative evidence.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deferred taxes for non-U.S. liabilities are not provided on the unremitted earnings of subsidiaries outside of the United States&#160;when it is expected that these earnings are indefinitely reinvested.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We operate in a complex multinational tax environment and are subject to tax treaty arrangements and transfer pricing guidelines for intercompany transactions that are subject to interpretation. Uncertainty in a tax position may arise as tax laws are subject to interpretation. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Tax benefits from uncertain tax positions are recognized when it is more likely than not that the position will be sustained upon examination of the technical merits of the position, including resolutions of any related appeals or litigation processes. The amount recognized is measured as the largest amount of tax benefit that is greater than 50 percent likely of being realized upon settlement. For tax benefits that do not qualify for recognition, we recognize a liability for unrecognized tax benefits. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See </span><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i4f0ec56b9c604f1782a65ea4a19c284d_133" style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Note 8</a></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for additional information regarding income taxes.</span></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Other Accrued Liabilities</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other accrued liabilities represent various current obligations, including certain accrued operating expenses and taxes payable.</span></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Noncontrolling Interests</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Noncontrolling interests represent the portion of net earnings, comprehensive income and net assets that is not attributable to Cardinal Health, Inc. </span></div></div><div style="display:inline-block;max-width:3.571%;min-width:2.571%;vertical-align:top"/><div style="display:inline-block;vertical-align:top;width:48.215%"><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Share-Based Compensation</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Share-based compensation provided to employees is recognized in the consolidated statements of earnings/(loss) based on the grant date fair value of the awards. The fair value of restricted share units and performance share units is determined by the grant date market price of our common shares. The fair value of stock options is determined on the grant date using a lattice valuation model. The compensation expense associated with nonvested performance share units is dependent on our periodic assessment of the probability of the targets being achieved and our estimate, which may vary over time, of the number of shares that ultimately will be issued. The compensation expense recognized for share-based awards is net of estimated forfeitures and is recognized ratably over the service period of the awards. All income tax effects of share-based awards are recognized in the consolidated statements of earnings/(loss) as awards vest or are settled. We classify share-based compensation expense in distribution, selling, general and administrative ("SG&amp;A") expenses to correspond with the same line item as the majority of the cash compensation paid to employees. If awards are modified in connection with a restructuring activity, the incremental share-based compensation expense is classified in restructuring and employee severance. See </span><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i4f0ec56b9c604f1782a65ea4a19c284d_160" style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Note 14</a></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for additional information regarding share-based compensation.</span></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Dividends</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We paid cash dividends per common share of $1.94, $1.92 and $1.91 in fiscal 2021, 2020 and 2019, respectively.</span></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Revenue Recognition</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recognize revenue in an amount that reflects the consideration to which we expect to be entitled in exchange for the transfer of goods or services to customers.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue in both segments is primarily related to the distribution of pharmaceutical and medical products, which include both manufactured and sourced products, and we recognize at a point in time when title transfers to customers and we have no further obligation to provide services related to such merchandise. Service revenues are recognized over the period that services are provided to the customer. Revenues derived from services are not material for either segment for all periods presented.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are generally the principal in a transaction, therefore our revenue is primarily recorded on a gross basis. When we are a principal in a transaction, we have determined that we control the ability to direct the use of the product or service prior to transfer to a customer, are primarily responsible for fulfilling the promise to provide the product or service to our customer, have discretion in establishing prices, and ultimately control the transfer of the product or services provided to the customer. </span></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Sales Returns and Allowances</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue is recorded net of sales returns and allowances. Revenues are measured based on the amount of consideration that we expect to receive, reduced by estimates for return allowances, discounts, rebates and other variable consideration. Sales returns are recorded based on estimates using historical </span></div></div><div style="display:inline-block;vertical-align:top;width:48.214%"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">data. Our customer return policies generally require that the product be physically returned, subject to restocking fees. We only allow customers to return products for credit in a condition suitable to be added back to inventory and resold at full value (&#8220;merchantable product&#8221;) or returned to vendors for credit. Product returns are generally consistent throughout the year and typically are not specific to any particular product or customer.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We accrue for estimated sales returns and allowances at the time of sale based upon historical customer return trends, margin rates and processing costs. Our accrual for sales returns is reflected as a reduction of revenue and cost of products sold for the sales price and cost, respectively. At June&#160;30, 2021 and 2020, the accrual for estimated sales returns and allowances was $689 million and $495 million, respectively, which is reflected in trade receivables, net and inventories, net in the consolidated balance sheets. Sales returns and allowances were $2.6 billion, $2.3 billion and $2.2 billion, for fiscal 2021, 2020 and 2019, respectively, and the net impact on net earnings/(loss) in the consolidated statements of earnings/(loss) was immaterial in fiscal 2021, 2020 and 2019. </span></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Third-Party Returns</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We generally do not accept non-merchantable pharmaceutical product returns from our customers, so many of our customers return non-merchantable pharmaceutical products to the manufacturer through third parties. Since our customers generally do not have a direct relationship with manufacturers, our vendors pass the value of such returns to us (usually in the form of an accounts payable deduction). We, in turn, pass the value received to our customer. In certain instances, we pass the estimated value of the return to our customer prior to our receipt of the value from the vendor. Although we believe we have satisfactory protections, we could be subject to claims from customers or vendors if our administration of this overall process was deficient in some respect or our contractual terms with vendors are in conflict with our contractual terms with our customers. We have maintained reserves for some of these situations based on their nature and our historical experience with their resolution.</span></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Shipping and Handling</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Shipping and handling costs are primarily included in SG&amp;A expenses in our consolidated statements of earnings/(loss) and include all delivery expenses as well as all costs to prepare the product for shipment to the end customer. Shipping and handling costs were $634 million, $620 million and $622 million, for fiscal 2021, 2020 and 2019, respectively. </span></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Restructuring and Employee Severance</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Restructuring activities are programs that are not part of the ongoing operations of our underlying business, such as divestitures, closing and consolidating facilities, changing the way we manufacture or distribute our products, moving manufacturing of a product to another location, changes in production or business process outsourcing or insourcing, employee severance (including rationalizing headcount or other significant changes in personnel) and realigning operations (including realignment of the management structure in response to changing market conditions). Also included within restructuring and employee severance are </span></div></div><div style="display:inline-block;max-width:3.571%;min-width:2.571%;vertical-align:top"/><div style="display:inline-block;vertical-align:top;width:48.215%"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">employee severance costs that are not incurred in connection with a restructuring activity. See </span><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i4f0ec56b9c604f1782a65ea4a19c284d_109" style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Note 3</a></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for additional information regarding our restructuring activities.</span></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Amortization and Other Acquisition-Related Costs</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We classify certain costs incurred in connection with acquisitions as amortization and other acquisition-related costs in our consolidated statements of earnings/(loss). These costs consist of amortization of acquisition-related intangible assets, transaction costs, integration costs and changes in the fair value of contingent consideration obligations. Transaction costs are incurred during the initial evaluation of a potential acquisition and primarily relate to costs to analyze, negotiate and consummate the transaction as well as due diligence activities. Integration costs relate to activities required to combine the operations of an acquired enterprise into our operations and, in the case of the Cordis and Patient Recovery businesses, to stand-up the systems and processes needed to support an expanded geographic footprint. We record changes in the fair value of contingent consideration obligations relating to acquisitions as income or expense in amortization and other acquisition-related costs. See </span><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i4f0ec56b9c604f1782a65ea4a19c284d_112" style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Note 4</a></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for additional information regarding amortization of acquisition-related intangible assets. </span></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Translation of Foreign Currencies</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial statements of our subsidiaries outside the United States&#160;are generally measured using the local currency as the functional currency. Adjustments to translate the assets and liabilities of these foreign subsidiaries into U.S.&#160;dollars are accumulated in shareholders&#8217; equity through accumulated and other comprehensive loss ("AOCI") utilizing period-end exchange rates. Revenues and expenses of these foreign subsidiaries are translated using average exchange rates during the year.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The foreign currency translation gains/(losses) included in AOCI at June&#160;30, 2021 and 2020 are presented in </span><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i4f0ec56b9c604f1782a65ea4a19c284d_145" style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Note 11</a></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Foreign currency transaction gains and losses for the period are included in the consolidated statements of earnings/(loss) in the respective financial statement line item.</span></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Interest Rate, Currency and Commodity Risk</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All derivative instruments are recognized at fair value on the consolidated balance sheets and all changes in fair value are recognized in net earnings or shareholders&#8217; equity through AOCI, net of tax.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For contracts that qualify for hedge accounting treatment, the hedge contracts must be effective at reducing the risk associated with the exposure being hedged and must be designated as a hedge at the inception of the contract. Hedge effectiveness is assessed periodically. Any contract not designated as a hedge, or so designated but ineffective, is adjusted to fair value and recognized immediately in net earnings. If a fair value or cash flow hedge ceases to qualify for hedge accounting treatment, the contract continues to be carried on the balance sheet at fair value until settled and future adjustments to the contract&#8217;s fair value are recognized immediately in net earnings. If a forecasted transaction is probable not to occur, amounts previously deferred in AOCI are recognized immediately in net earnings. Interest payments </span></div></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">received from the cross currency swap are excluded from the net investment hedge effectiveness assessment and are recorded in interest expense, net in the consolidated statements of earnings/(loss).</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See </span><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i4f0ec56b9c604f1782a65ea4a19c284d_139" style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Note 10</a></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for additional information regarding our derivative instruments, including the accounting treatment for instruments designated as fair value, cash flow, net investment and economic hedges.</span></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Fair Value Measurements</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fair value is defined as the price that would be received upon selling an asset or the price paid to transfer a liability on the measurement date. It focuses on the exit price in the principal or most advantageous market for the asset or liability in an orderly transaction between willing market participants. A three-tier fair value hierarchy is established as a basis for considering such assumptions and for inputs used in the valuation methodologies in measuring fair value. This hierarchy requires entities to maximize the use of observable inputs and minimize the use of unobservable inputs. The three levels of inputs used to measure fair values are:</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 1 -&#160;&#160;&#160;&#160;Observable prices in active markets for identical assets and liabilities.</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 2 -&#160;&#160;&#160;&#160;Observable inputs other than quoted prices in active markets for identical assets and liabilities.</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 3 -&#160;&#160;&#160;&#160;Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets and liabilities.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See </span><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i4f0ec56b9c604f1782a65ea4a19c284d_136" style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Note 9</a></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for additional information regarding fair value measurements.</span></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Recently Adopted Financial Accounting Standards</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financial Instruments - Credit Losses</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2016, the Financial Accounting Standards Board ("FASB") issued amended accounting guidance that will require entities to measure credit losses on trade and other receivables, held-to-maturity debt securities, loans and other instruments using an "expected credit loss" model that considers historical experience, current conditions and reasonable supportable forecasts. This guidance also requires that credit losses on available-for-sale debt securities with unrealized losses be recognized as allowances rather than as deductions in the amortized cost of the securities. We consider historical experience, the current economic environment, customer credit ratings or bankruptcies, and reasonable and supportable forecasts to develop our allowance for credit losses. We review these factors quarterly to determine if any adjustments are needed to the allowance. This guidance was effective beginning the first quarter of fiscal 2021 and did not have a material impact on our consolidated financial statements.</span></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Recently Issued Financial Accounting Standards Not Yet Adopted</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We address the adoption impacts of recently issued accounting standards by the FASB on the our consolidated financial statements as well as material updates to previous assessments, if any, from our fiscal 2020 Form 10-K. There were no accounting </span></div>standards issued in fiscal 2021 that will have a material impact on our consolidated financial statements.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the basis of presentation and significant accounting policies concepts. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).  Accounting policies describe all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI http://asc.fasb.org/topic&amp;trid=2122369<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140421166253784">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Divestitures and Acquisitions<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract', window );"><strong>Business Combination and Asset Acquisition [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationDisclosureTextBlock', window );">Business Combination Disclosure</a></td>
<td class="text"><div style="margin-bottom:6pt;text-align:justify"><span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:13pt;font-weight:700;line-height:120%">2. Divestitures and Acquisitions</span></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Divestitures</span></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cordis Assets Held for Sale</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 12, 2021, we signed a definitive agreement with Hellman &amp; Friedman to sell our Cordis business for gross proceeds of $927 million in cash, subject to customary purchase price adjustments, and we retained certain working capital accounts and certain liabilities. The transaction closed on August 2, 2021 and we received proceeds of $927 million, net of cash transferred. Cardinal Health will retain product liability associated with lawsuits and claims related to inferior vena cava ("IVC") filters in the U.S. and Canada, as well as authority for these matters discussed in </span><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i4f0ec56b9c604f1782a65ea4a19c284d_130" style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Note 7</a></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Upon signing the agreement, we met the criteria for the related assets and liabilities of the Cordis business to be classified as held for sale. In connection with the divestiture, we allocated $388&#160;million of goodwill from the Medical Unit (within our Medical Segment) to the Cordis disposal group based on the estimated relative fair values of the business to be disposed of and the portion of the reporting unit that will be retained. We determined that the sale of the Cordis business does not meet the criteria to be classified as discontinued operations. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At June&#160;30, 2021, the book value of the disposal group exceeded its fair value less costs to sell. Accordingly, we recognized a $60 million pre-tax write-down on the disposal group in impairments and (gain)/loss on disposal of assets in our consolidated statement of earnings/(loss). This write-down includes a $3 million loss related to currency translation adjustments in accumulated other comprehensive loss. We recorded a net tax expense of $9 million associated with the impact of the write-down and the required tax adjustments related to held for sale accounting.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents information related to the assets and liabilities that were classified as held for sale at June&#160;30, 2021 related to the Cordis divestiture in the consolidated balance sheets:</span></div><div style="margin-bottom:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:61.554%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:36.246%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cash and equivalents</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">109</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Inventories, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">164</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Property and equipment, net</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">90</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Goodwill and other intangibles, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">778</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">10</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Write-down of assets held for sale</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(60)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total assets held for sale</span></td><td style="background-color:#cccccc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1,091</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other accrued liabilities</span></td><td style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">61</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Deferred income taxes and other liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">34</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total liabilities related to assets held for sale</span></td><td style="background-color:#cccccc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">95</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:120%">naviHealth</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2018, we sold our majority ownership interest in naviHealth, which operated within our Medical segment in exchange for cash proceeds of $737 million (after adjusting for certain fees and expenses) and a noncontrolling equity interest in a partnership that owned naviHealth. We also had certain call rights to reacquire naviHealth. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a result of this divestiture, during the fiscal year ended June&#160;30, 2019, we recognized a pre-tax gain of $508 million in impairments and (gain)/loss on disposal of assets in our consolidated statements of earnings/(loss). This gain included our initial recognition of an equity method investment for $358 million and the derecognition of redeemable noncontrolling interests of $12 million. The fiscal 2019 tax expense as a result of this transaction was $130 million. We determined that the sale of the naviHealth business did not meet the criteria to be classified as discontinued operations.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2020 we sold the remainder of our noncontrolling equity interest in a partnership that owned naviHealth. We recognized a pre-tax gain of $579&#160;million from this disposal in gain on sale of equity interest in naviHealth in our consolidated statements of earnings/(loss) during fiscal year 2020.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our proportionate share of naviHealth&#8217;s results, which was recorded in other (income)/expense, net in the consolidated statements of earnings/(loss), was income of $2 million and a loss of $10 million during fiscal 2020 and 2019, respectively. </span></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Acquisitions</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We did not complete any acquisitions during fiscal 2020. While we completed several small acquisitions during fiscal 2021 and 2019, the pro forma results of operations and the results of operations for acquired businesses since the acquisition dates have not been separately disclosed because the effects were not significant compared to the consolidated financial statements, individually or in the aggregate. The cash paid for these acquisitions, net of cash acquired was $3 million and $82 million for fiscal 2021 and 2019, respectively.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationAndAssetAcquisitionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -URI http://asc.fasb.org/topic&amp;trid=2303972<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140421166253224">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Restructuring and Employee Severance<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringChargesAbstract', window );"><strong>Restructuring Charges [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock', window );">Restructuring and Employee Severance</a></td>
<td class="text"><div style="margin-bottom:6pt;text-align:justify"><span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:13pt;font-weight:700;line-height:120%">3. Restructuring and Employee Severance </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables summarize restructuring and employee severance costs:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.382%"><tr><td style="width:1.0%"/><td style="width:57.595%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.632%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.352%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.632%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.352%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Employee-related costs </span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">53</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">66&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">95&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Facility exit and other costs </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">61</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">56&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total restructuring and employee severance</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">114</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">122&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">125&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Employee-related costs primarily consist of termination benefits provided to employees who have been involuntarily terminated, duplicate payroll costs and retention bonuses incurred during transition periods. Facility exit and other costs primarily consist of professional, project management and other service fees to support divestitures, vendor transition fees, accelerated depreciation, lease costs associated with vacant facilities, equipment relocation costs, project consulting fees, costs </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">associated with restructuring our delivery of information technology infrastructure services and certain other divestiture-related costs.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In fiscal 2021, restructuring costs were primarily related to the implementation of certain enterprise-wide cost-savings measures and the divestiture of our Cordis business. In fiscal 2020 and 2019, restructuring costs were primarily related to the implementation of certain enterprise-wide cost-savings measures.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes activity related to liabilities associated with restructuring and employee severance:</span></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.691%"><tr><td style="width:1.0%"/><td style="width:42.553%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.714%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.347%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.191%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.347%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.048%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Employee-<br/>Related Costs</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Facility Exit<br/>and Other Costs</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance at June 30, 2019</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">64&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">72</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Additions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">85&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">109</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Payments and other adjustments</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(81)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(85)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance at June 30, 2020</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">68&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">96</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Additions</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">49&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">75</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Payments and other adjustments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(64)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(28)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(92)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance at June 30, 2021</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">53</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">26</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">79</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for restructuring and related activities. Description of restructuring activities such as exit and disposal activities, include facts and circumstances leading to the plan, the expected plan completion date, the major types of costs associated with the plan activities, total expected costs, the accrual balance at the end of the period, and the periods over which the remaining accrual will be settled.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(e))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -URI http://asc.fasb.org/topic&amp;trid=2175745<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringChargesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringChargesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140421166240936">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and Other Intangible Assets<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock', window );">Goodwill and Other Intangible Assets</a></td>
<td class="text"><div style="margin-bottom:6pt;text-align:justify"><span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:13pt;font-weight:700;line-height:120%">4. Goodwill and Other Intangible Assets </span></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Goodwill</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the changes in the carrying amount of goodwill by segment and in total:</span></div><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:41.801%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:24.517%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.343%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.949%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.343%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.247%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Pharmaceutical (1)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Medical (2)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total </span></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance at June 30, 2019</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,663&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5,715&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">8,378</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Goodwill acquired, net of purchase price adjustments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Foreign currency translation adjustments and other</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(15)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(16)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance at June 30, 2020</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,657&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5,700&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">8,357</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Goodwill acquired, net of purchase price adjustments</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Foreign currency translation adjustments and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">18</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cordis goodwill reclassified to assets held for sale</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(388)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(388)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2.5pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance at June 30, 2021</span></td><td style="background-color:#ffffff;border-bottom:2.5pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2.5pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2,659</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:2.5pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2.5pt solid #000000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2.5pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2.5pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">5,330</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:2.5pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2.5pt solid #000000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2.5pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2.5pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">7,989</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:2.5pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;At June&#160;30, 2021 and 2020, the Pharmaceutical segment accumulated goodwill impairment loss was $829 million.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)&#160;&#160;&#160;&#160;At June&#160;30, 2021 and 2020, the Medical segment accumulated goodwill impairment loss was $1.4 billion. </span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the divestiture of our Cordis business, during fiscal 2021 we allocated and reclassified $388 million of goodwill from the Medical Unit (within our Medical Segment) to the Cordis disposal group based on the estimated relative fair values of the business to be disposed of and the portion of the reporting unit that will be retained, discussed further in </span><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i4f0ec56b9c604f1782a65ea4a19c284d_106" style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Note 2</a></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Other Intangible Assets</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables summarize other intangible assets by class at June&#160;30:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:22.356%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.023%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.343%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.653%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.343%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.023%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.343%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:20.816%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Intangible</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net<br/>Intangible</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted- Average Remaining Amortization Period (Years)</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Indefinite-life intangibles:</span></td><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Trademarks and patents</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">12</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">12</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total indefinite-life intangibles</span></td><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">12</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">12</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Definite-life intangibles:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">3,330</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1,989</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1,341</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">11</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Trademarks, trade names and patents</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">551</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">328</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">223</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">9</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Developed technology and other</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1,035</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">506</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">529</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">10</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total definite-life intangibles</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">4,916</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2,823</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2,093</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">10</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total other intangible assets</span></td><td style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">4,928</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2,823</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2,105</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">N/A</span></td></tr></table></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.691%"><tr><td style="width:1.0%"/><td style="width:42.243%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.308%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.347%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.643%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.347%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.312%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Gross<br/>Intangible</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net<br/>Intangible</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Indefinite-life intangibles:</span></td><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">IPR&amp;D, trademarks and other</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total indefinite-life intangibles</span></td><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Definite-life intangibles:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,554&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,828&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,726&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Trademarks, trade names and patents</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">673&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">341&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">332&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Developed technology and other</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,604&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">767&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">837&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total definite-life intangibles</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5,831&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,936&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,895&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total other intangible assets</span></td><td style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5,854&#160;</span></td><td style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,936&#160;</span></td><td style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,918&#160;</span></td><td style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div>Total amortization of intangible assets was $428 million, $512 million and $531 million for fiscal 2021, 2020 and 2019, respectively. The estimated annual amortization for intangible assets for fiscal 2022 through 2026 is as follows: $315 million, $287 million, $264 million, $238 million and $212 million.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for goodwill and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -URI http://asc.fasb.org/topic&amp;trid=2144416<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140421166227944">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_LeasesTextBlock', window );">Leases</a></td>
<td class="text"><div style="display:inline-block;vertical-align:top;width:48.214%"><div style="margin-bottom:6pt;text-align:justify"><span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:13pt;font-weight:700;line-height:120%">5. Leases </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our operating leases are primarily for corporate offices, distribution facilities, vehicles, and equipment. We determine if an arrangement is a lease at its inception by evaluating whether the arrangement conveys the right to use an identified asset and whether we obtain substantially all of the economic benefits from and have the ability to direct the use of the asset. Our lease agreements generally do not contain any material residual value guarantees or material restrictive covenants. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Beginning July 1, 2019, operating lease right-of-use assets and corresponding operating lease liabilities are recognized in our consolidated balance sheets at lease commencement date based on the present value of lease payments over the lease term. Operating lease expense for operating lease assets is recognized on a straight-line basis over the lease term. As most of our leases do not provide an implicit rate, we use our collateralized incremental borrowing rate based on the information available at the lease commencement date in determining the present value of lease payments. We use the implicit rate if it is readily determinable. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our lease agreements contain lease components and non-lease components. For all asset classes, we have elected to account for both of these components as a single lease component. We also, from time to time, sublease portions of our real estate property, resulting in sublease income. Sublease income and the related assets and cash flows are not material to the consolidated financial statements at or for the fiscal years ended June&#160;30, 2021 and 2020.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also have elected to apply a practical expedient for short-term leases whereby we do not recognize a lease liability and right-of-use asset for leases with a term of less than 12 months. Short-term lease expense recognized in fiscal 2021 and 2020 was not material. In addition, upon adoption of the new lease standard, we elected the package of three practical expedients permitted under the transition guidance, which include the carry forward of our leases without reassessing 1) whether any contracts are leases or contain leases, 2) lease classification and 3) initial direct costs. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our leases have remaining lease terms from less than 1 year up to approximately 21 years. Our lease terms may include options to extend or terminate the lease when it is reasonably certain and there is a significant economic incentive to exercise that option. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the components of lease cost:  </span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:85.185%"><tr><td style="width:1.0%"/><td style="width:32.233%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.233%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.234%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Operating lease cost</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">119</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">134&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Finance lease cost</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">16</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Variable lease cost</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">24</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total lease cost</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">159</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">164&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Variable lease cost primarily includes payments for property taxes, maintenance and insurance. Our rental expense relating to operating leases&#160;was $153 million in fiscal 2019. </span></div></div><div style="display:inline-block;max-width:3.571%;min-width:2.571%;vertical-align:top"/><div style="display:inline-block;vertical-align:top;width:48.215%"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes supplemental balance sheet and other information related to leases at June&#160;30:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:47.974%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:24.208%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:24.518%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Operating Leases</span></td><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">460</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">426&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Current portion of operating lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">105</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">104&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Long-term operating lease liabilities</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">374</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">341&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total operating lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">479</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">445&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Finance Leases</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Finance lease right-of-use assets</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">63</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Current portion of finance lease liabilities</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">19</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Long-term finance lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">45</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total finance lease liabilities</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">64</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-average remaining lease term (years)</span></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">6.5 years</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6.4 years</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Finance leases</span></td><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">4.2 years</span></td><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4.3 years</span></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-average discount rate</span></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2.9</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Finance leases</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1.5</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2.4&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr></table><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating leases are included in other assets, other accrued liabilities, and deferred income taxes and other liabilities in our consolidated balance sheet. Finance leases are included in property and equipment, net, current portion of long-term obligations and other short-term borrowings, and long-term obligations, less current portion in our consolidated balance sheet. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables summarizes supplemental cash flow information related to leases:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:40.258%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:28.220%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:28.222%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cash paid for lease liabilities:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Operating cash flows paid for operating leases</span></td><td style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">115</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">125&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Financing cash flows paid for finance leases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">15</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Non-cash right-of-use assets obtained in exchange for lease obligations:</span></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">New operating leases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">138</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">150&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">New finance leases</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">45</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">40&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Amended lease standard adoption impact as of July 1, 2019 </span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">400&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:10pt">Includes the effect of $22&#160;million from reclassifying deferred rent as an offset to the lease right-of-use asset in accordance with the transition guidance. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:3pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:3pt;text-align:justify"><span><br/></span></div></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Future lease payments under non-cancellable leases as of June&#160;30, 2021 were as follows: </span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.382%"><tr><td style="width:1.0%"/><td style="width:50.142%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.117%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.352%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.117%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.352%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.120%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Operating Leases</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Finance Leases</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2022</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">116&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">136</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">93&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">113</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">72&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">86</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">65&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">73</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">50&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">53</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">141&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">146</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total future lease payments</span></td><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">537&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">70&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">607</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Less: leases not yet commenced </span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">3</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Less: imputed interest</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">55&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">61</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total lease liabilities</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">479&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">64&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">543</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div>(1)As of June&#160;30, 2021, we had certain leases that were executed but did not have control of the underlying assets; therefore, the lease liabilities and right-of-use assets are not recorded in the consolidated balance sheet.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_LeasesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Leases [Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_LeasesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140421166236280">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Long-Term Obligations and Other Short-Term Borrowings<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureTextBlock', window );">Long-Term Obligations and Other Short-Term Borrowings</a></td>
<td class="text"><div style="margin-bottom:6pt;text-align:justify"><span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:13pt;font-weight:700;line-height:120%">6. Long-Term Obligations and Other Short-Term Borrowings </span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes long-term obligations and other short-term borrowings at June 30:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.691%"><tr><td style="width:1.0%"/><td style="width:57.104%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.023%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.347%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.026%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in millions) (1)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2.616% Notes due 2022</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">572</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">834&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3.2% Notes due 2022</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">236&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Floating Rate Notes due 2022</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">281</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">321&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3.2% Notes due 2023</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">564</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">576&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3.079% Notes due 2024</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">794</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">809&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3.5% Notes due 2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">410</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">413&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3.75% Notes due 2025</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">524</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">529&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3.41% Notes due 2027</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1,216</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,215&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4.6% Notes due 2043</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">341</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">340&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4.5% Notes due 2044</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">342</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">342&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4.9% Notes due 2045</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">441</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">441&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4.368% Notes due 2047</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">560</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">560&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7.0%&#160;Debentures due 2026</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">124</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">124&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other Obligations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">67</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">6,236</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6,775&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Less: current portion of long-term obligations and other short-term borrowings</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">871</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;&#160;&#160;Long-term obligations, less current portion</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">5,365</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6,765&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)      Maturities are presented on a calendar year basis. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Maturities of existing long-term obligations and other short-term borrowings for fiscal 2022 through 2026 and thereafter are as follows: $872 million, $584 million, $808 million, $418 million, $525 million and $3.0 billion.</span></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Long-Term Debt</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All the notes represent unsecured obligations of Cardinal Health, Inc. and rank equally in right of payment with all of our existing and future unsecured and unsubordinated indebtedness. The 7.0% Debentures represent unsecured obligations of Allegiance Corporation (a wholly-owned subsidiary), which Cardinal Health, Inc. has guaranteed. None of these obligations are subject to a sinking fund and the Allegiance obligations are not redeemable prior to maturity. Interest is paid pursuant to the terms of the obligations. These notes are effectively subordinated to the liabilities of our subsidiaries, including trade payables of $23.7 billion and $21.4 billion at June&#160;30, 2021 and 2020, respectively.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2021, we redeemed all outstanding 3.2% Notes due June 2022 for $238&#160;million and $262&#160;million aggregate principle amount of 2.616% Notes due June 2022 at a redemption price equal to 100% of the principal amount and accrued but unpaid interest, plus the make-whole premium applicable to the notes. In connection with these redemptions, we recorded a $13&#160;million loss on early extinguishment of debt. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During fiscal 2021, we also early repurchased $40 million of the Floating Rate Notes due 2022</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and $2 million of the 2.616% Notes due 2022 with available cash. In connection with the early debt repurchases, we recorded a $1&#160;million</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">loss on early extinguishment of debt.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During fiscal 2020, we redeemed $500 million aggregate principle amount of 4.625% Notes due December 2020 at a redemption price equal to 100% of the principal amount and accrued but unpaid interest, plus the make-whole premium applicable to the notes. In connection with the redemption, we recorded a $7 million loss on early extinguishment of debt. We also early repurchased&#160;$247&#160;million&#160;of the&#160;2.616%&#160;Notes due 2022,&#160;$11&#160;million&#160;of the&#160;3.2% Notes due 2022,&#160;$20&#160;million&#160;of the&#160;Floating Rate Notes due 2022, $104&#160;million&#160;of the&#160;3.41% Notes due 2027,&#160;$6&#160;million&#160;of the&#160;4.6% Notes due 2043,&#160;$5&#160;million&#160;of the&#160;4.9% Notes due 2045, and&#160;$35&#160;million&#160;of the&#160;4.368% Notes due 2047. In connection with the early debt repurchases, we recognized a&#160;$9 million&#160;loss on early extinguishment of debt. We also repaid the full principal of the $450&#160;million 2.4% Notes due 2019 as they became due. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During fiscal 2019, we repurchased $67 million of the 2.616% Notes due 2022, $1 million of the 3.2% Notes due 2022, 8 million of the Floating Rate Notes due 2022, and $24 million of the 3.41% Notes due 2027 for a total of $100 million. The loss on early extinguishment of debt in connection with these early repurchases was immaterial. We also repaid the full principal of the $1.0 billion 1.948% Notes due 2019 as they became due.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The redemptions and repurchases were paid for with available cash and other short-term borrowings.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 13, 2021, we announced our intention to early redeem all remaining outstanding 2.616% Notes due June 2022 on September 15, 2021 at an expected redemption price equal to 100% of the principal amount and accrued but unpaid interest, plus the make-whole premium applicable to the notes.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If we undergo a change of control, as defined in the notes, and if the notes receive specified ratings below investment grade by each of Standard &amp; Poors Ratings Services, Moody&#8217;s Investors Services and Fitch Ratings, any holder of the notes, excluding the debentures, can require with respect to the notes owned by such holder, or we can offer, to repurchase the notes at 101% of the principal amount plus accrued and unpaid interest.</span></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Other Financing Arrangements</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to cash and equivalents and operating cash flow, other sources of liquidity include a&#160;$2.0 billion&#160;commercial paper program backed by a $2.0 billion&#160;revolving credit facility. We also have a&#160;$1.0 billion&#160;committed receivables sales facility.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In September 2019, we renewed our committed receivables sales facility program through Cardinal Health Funding, LLC (&#8220;CHF&#8221;) through September 30, 2022. CHF was organized for</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the sole purpose of buying receivables and selling undivided interests in those receivables to third-party purchasers. Although consolidated with Cardinal Health, Inc. in accordance with GAAP, CHF is a separate legal entity from Cardinal Health, Inc. and from our subsidiary that sells receivables to CHF. CHF is designed to be a special purpose, bankruptcy-remote entity whose assets are available solely to satisfy the claims of its creditors. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our revolving credit and committed receivables sales facilities require us to maintain a consolidated net leverage ratio of no more than 3.75-to-1. As of June&#160;30, 2021, we were in compliance with this financial covenant.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At June&#160;30, 2021 and 2020, we had no amounts outstanding under the revolving credit facility; however, availability was reduced by outstanding letters of credit of $1 million at both June&#160;30, 2021 and 2020.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under our committed receivables sales facility program, we had a maximum amount outstanding of $200 million and an immaterial daily amount outstanding during fiscal 2021. We had no amounts outstanding as of June&#160;30, 2021 under the committed receivables sales facility program; however, availability was reduced by outstanding standby letters of credit of $31 million and $29 million at June&#160;30, 2021 and 2020, respectively. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We had no amounts outstanding under the commercial paper program as of June&#160;30, 2021 and 2020. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also maintain other short-term credit facilities and an unsecured line of credit that allowed for borrowings up to $6 million at both June&#160;30, 2021 and 2020. The $67 million and $35 million balance of other obligations at June&#160;30, 2021 and 2020, respectively, consisted of finance leases and short-term borrowings.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -URI http://asc.fasb.org/topic&amp;trid=2208564<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140421167539560">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments, Contingent Liabilities and Litigation<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">Commitments, Contingent Liabilities and Litigation</a></td>
<td class="text"><div style="display:inline-block;vertical-align:top;width:48.214%"><div style="margin-bottom:6pt;text-align:justify"><span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:13pt;font-weight:700;line-height:120%">7. Commitments, Contingent Liabilities and Litigation </span></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Commitments</span></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Generic Sourcing Venture with CVS Health Corporation ("CVS Health")</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In July 2014, we established Red Oak Sourcing, LLC ("Red Oak Sourcing"), a U.S.-based generic pharmaceutical sourcing venture with CVS Health for an initial term of 10 years. Red Oak Sourcing negotiates generic pharmaceutical supply contracts on behalf of its participants. In August 2021, we amended our agreement to extend the term through June 2029. We are required to make quarterly payments to CVS Health for the term of the arrangement. These payments are included as purchase obligations and other payments in the Contractual Obligations section of MD&amp;A. </span></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Contingencies</span></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:120%">New York Opioid Stewardship Act</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In April 2018, the State of New York passed a budget which included the Opioid Stewardship Act (the "OSA"). The OSA created an aggregate $100&#160;million annual assessment on all manufacturers and distributors licensed to sell or distribute opioids in New York. Under the OSA, each licensed manufacturer and distributor would be required to pay a portion of the assessment based on its share of the total morphine milligram equivalents sold or distributed in New York during the applicable calendar year, beginning in 2017.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The constitutionality of portions of the OSA has been challenged in court. In December 2018, the OSA was ruled unconstitutional by the U.S. District Court for the Southern District of New York. Subsequently, New York passed a new statute that modified the assessment going forward and limited the OSA to two years (2017 and 2018). The U.S. Court of Appeals for the Second Circuit reversed the district court's decision on procedural grounds. In February 2021, the Second Circuit stayed the effect of the ruling pending a petition to the U.S. Supreme Court to review the Second Circuit's opinion. If the U.S. Supreme Court declines to take the case, or if it ultimately upholds the Second Circuit's ruling, New York State would likely seek to collect amounts allegedly owed under the OSA. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We accrue contingencies if it is probable that a liability has been incurred and the amount can be estimated. Because of the Second Circuit ruling, we recorded an aggregate accrual of $41&#160;million for calendar years 2017 and 2018 in the fiscal year ended June&#160;30, 2021 based on the probable estimated payment amount, which is our best estimate of the OSA payments probable at June 30, 2021.</span></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Legal Proceedings</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We become involved from time to time in disputes, litigation and regulatory matters.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, we determine that products we source, manufacture or market do not meet our specifications, regulatory requirements, or published standards. When we or a regulatory agency identify a potential quality or regulatory issue, we investigate and take appropriate corrective action. Such actions </span></div></div><div style="display:inline-block;max-width:3.571%;min-width:2.571%;vertical-align:top"/><div style="display:inline-block;vertical-align:top;width:48.215%"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">have led to product recalls, costs to repair or replace affected products, temporary interruptions in product sales, product liability claims and lawsuits and can lead to action by regulators. Even absent an identified regulatory or quality issue or product recall, we can become subject to product liability claims and lawsuits.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, we become aware through employees, internal audits or other parties of possible product quality, regulatory or compliance matters, such as complaints or concerns relating to accounting, internal accounting controls, financial reporting, auditing, or other ethical matters or relating to compliance with laws such as healthcare fraud and abuse, anti-corruption or anti-bribery laws. When we become aware of such possible compliance matters, we investigate internally and take appropriate corrective action. In addition, from time to time, we receive subpoenas or requests for information from various federal or state agencies relating to our business or to the business of a customer, supplier or other industry participants. Internal investigations, subpoenas or requests for information could directly or indirectly lead to the assertion of claims or the commencement of legal proceedings against us or result in sanctions.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have been named from time to time in qui tam actions initiated by private third parties. In such actions, the private parties purport to act on behalf of federal or state governments, allege that false claims have been submitted for payment by the government and may receive an award if their claims are successful. After a private party has filed a qui tam action, the government must investigate the private party's claim and determine whether to intervene in and take control over the litigation. These actions may remain under seal while the government makes this determination. If the government declines to intervene, the private party may nonetheless continue to pursue the litigation on his or her own purporting to act on behalf of the government.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We accrue for contingencies related to disputes, litigation and regulatory matters if it is probable that a liability has been incurred and the amount of the loss can be reasonably estimated. Because these matters are inherently unpredictable and unfavorable developments or resolutions can occur, assessing contingencies is highly subjective and requires judgments about future events. We regularly review contingencies to determine whether our accruals and related disclosures are adequate. The amount of ultimate loss may differ from these estimates.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recognize income from the favorable outcome of litigation when we receive the associated cash or assets.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recognize estimated loss contingencies for certain litigation and regulatory matters and income from favorable resolution of litigation in litigation (recoveries)/charges in our consolidated statements of earnings/(loss).</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Opioid Lawsuits and Investigations</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pharmaceutical wholesale distributors, including us, have been named as defendants in approximately 3,300 lawsuits relating to the distribution of prescription opioid pain medications. The lawsuits seek equitable relief and monetary damages based on a variety of legal theories including various common law claims, such as public nuisance, negligence and unjust enrichment as well </span></div></div><div style="display:inline-block;vertical-align:top;width:48.214%"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">as violations of controlled substance laws, the Racketeer Influenced and Corrupt Organizations Act and various other statutes. These lawsuits also name pharmaceutical manufacturers, retail pharmacy chains and other entities as defendants.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">States &amp; Political Subdivisions</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Approximately 2,900 of these lawsuits have been filed by counties, municipalities, cities and political subdivisions in various federal, state, and other courts. The vast majority of these lawsuits were filed in U.S. federal court and have been transferred for consolidated pre-trial proceedings in a Multi-District Litigation proceeding in the U.S. District Court for the Northern District of Ohio (the &#8220;MDL&#8221;).</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, 25 state attorneys general have filed lawsuits against distributors, including us, in various state courts. We have also received requests, civil investigative demands, subpoenas or requests for information from additional state attorneys general offices and governmental authorities. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In October 2019, we agreed in principle to a global settlement framework with a leadership group of state attorneys general; the framework is designed to resolve pending and future opioid lawsuits and claims by states and political subdivisions, but not private plaintiffs (the "Settlement Framework"). We continued to build out the Settlement Framework and to negotiate the terms of the settlement with the leadership group and other representatives of states and political subdivisions. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In July, 2021, we announced that we and two other national distributors have negotiated a proposed settlement agreement (the &#8220;Proposed Settlement Agreement&#8221;) and settlement process that, if all conditions are satisfied, would result in the settlement of the vast majority of opioid lawsuits filed by state and local governmental entities. West Virginia subdivisions and Native American tribes are not a part of this settlement process and we have been involved in separate negotiations with these groups. The settlement process does not contemplate participation by any non-governmental or non-political entities or individuals. In connection with the negotiations of the Proposed Settlement Agreement, we and the two other national distributors entered into a settlement with the State of New York and its participating subdivisions. If the Proposed Settlement Agreement becomes effective, New York and its participating subdivisions will become a part of it. </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Proposed Settlement Agreement is subject to contingencies and will not become effective unless and until the three distributors each make separate independent determinations that (1) following a sign-on period, a sufficient number of states have agreed to the Proposed Settlement Agreement (the &#8220;Settling States&#8221;); and, subsequently, (2) following a notice period, that a sufficient number of states and political subdivisions, including those that have not sued, have agreed to the Agreement (or otherwise had their claims foreclosed) to proceed to effectiveness. Prior to the second determination, the Settling States will also have an opportunity to make a determination as to whether a sufficient number of political subdivisions have agreed to the Proposed Settlement Agreement (or otherwise had their claims foreclosed) to proceed with the </span></div></div><div style="display:inline-block;max-width:3.571%;min-width:2.571%;vertical-align:top"/><div style="display:inline-block;vertical-align:top;width:48.215%"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Proposed Settlement Agreement. This process is currently contemplated to end in February 2022, although it may be extended by agreement. It is possible that a sufficient number of states and subdivisions will not agree to the Proposed Settlement Agreement or that other required contingencies will not be satisfied.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If these conditions are satisfied, the Proposed Settlement Agreement would become effective sixty (60) days after the distributors determine that there is sufficient participation among political subdivisions. During this 60-day period, the Settling States and the distributors would cooperate to obtain consent judgments in each participating state embodying the terms of the Settlement. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Proposed Settlement Agreement includes a cash component, pursuant to which the Company would pay up to approximately $6.37&#160;billion, the majority of which would be paid over 18 years. The exact payment amount will depend on several factors, including the participation rate of states and political subdivisions, the extent to which states take action to foreclose opioid lawsuits by political subdivisions (</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">e.g.</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, laws barring or limiting opioid lawsuits by political subdivisions), and the extent to which political subdivisions in Settling States file additional opioid lawsuits against the Company after the Proposed Settlement Agreement becomes effective. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Proposed Settlement Agreement also includes injunctive relief terms related to settling distributors&#8217; controlled substance anti-diversion programs, including with respect to: (1) governance; (2) independence and training of the personnel operating our controlled substances monitoring program; (3) due diligence for new and existing customers; (4) ordering limits for certain products; and (5) suspicious order monitoring. A monitor will be selected to oversee compliance with these provisions for a period of five years. In addition, we and the two other settling distributors will engage a third-party vendor to act as a clearinghouse for data aggregation and reporting; distributors will fund the clearinghouse for ten years.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In total, we have recorded total pre-tax charges of $1.17&#160;billion and $5.63&#160;billion in litigation charges/(recoveries), net in the years ended June&#160;30, 2021 and 2020, respectively. In total, we have $6.73&#160;billion accrued at June&#160;30, 2021, of which $405&#160;million is included in other accrued liabilities and the remainder is included in deferred income taxes and other liabilities in the consolidated balance sheets. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Because loss contingencies are inherently unpredictable and unfavorable developments or resolutions can occur, the assessment is highly subjective and requires judgments about future events. We regularly review these opioid litigation matters to determine whether our accrual is adequate. The amount of ultimate loss may differ materially from this accrual, whether as a result of settlement discussions, a judicial decision or verdict or otherwise, but we are not able to estimate a range of reasonably possible additional losses for these matters. We continue to strongly dispute the allegations made in these lawsuits and reaching an agreement in principle on a global settlement framework is not an admission of liability or wrongdoing.</span></div></div><div style="display:inline-block;vertical-align:top;width:48.214%"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, a trial before a judge in West Virginia in the Cabell County and City of Huntington cases concluded in July 2021 and the judge has not yet issued a decision. In addition, a trial in the case brought by the Ohio Attorney General is scheduled to begin in September 2021 and a trial in the case brought by the Washington Attorney General is scheduled to begin in November 2021. The Ohio Attorney General has issued a press release indicating support for the Proposed Settlement Agreement; however, the Washington Attorney General has issued a press release stating that Washington will not agree to the Proposed Settlement Agreement. These public announcements are not binding and there is no assurance that any state that has made a public announcement of support for the Proposed Settlement Agreement will ultimately execute the Proposed Settlement Agreement.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Private Plaintiffs</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Proposed Settlement Agreement does not address claims by private parties, which includes unions and other health and welfare funds, hospital systems and other healthcare providers, businesses and individuals alleging personal injury. Private parties had brought approximately 442 lawsuits as of August 10, 2021. Of these, 128 are purported class actions. The causes of action asserted by these plaintiffs are similar to those asserted by public plaintiffs. A trial in one case is currently scheduled to begin in October 2021. We are vigorously defending ourselves in these matters.</span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Insurance Litigation</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are involved in legal proceedings with two insurers related to the availability of insurance coverage for the lawsuits described above. In October 2020, we filed a complaint for declaratory judgment against National Union Fire Insurance Company of Pittsburgh, PA (&#8220;National Union&#8221;) seeking a declaration that National Union is obligated to reimburse us for defense costs incurred in connection with the lawsuits described above. In January, 2021, Swiss Re International SE commenced an arbitration in London seeking a determination that it does not have an obligation to reimburse us for defense and indemnity expenses incurred in connection with the lawsuits described above. We have not recorded a receivable for any recoveries related to these insurance litigation matters as of June&#160;30, 2021.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Department of Justice Investigations</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have received federal grand jury subpoenas issued in connection with investigations being conducted by the U.S. Attorney's Office for the Eastern District of New York and the Fraud Section of the U.S. Department of Justice ("DOJ"). We have also received civil requests for information from other DOJ offices. We believe that these investigations concern operation of our anti-diversion program, our anti-diversion policies and procedures, and distribution of certain controlled substances. We are cooperating with these requests. We are unable to predict the outcome of any of these investigations. </span></div></div><div style="display:inline-block;max-width:3.571%;min-width:2.571%;vertical-align:top"/><div style="display:inline-block;vertical-align:top;width:48.215%"><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cordis Product Liability Lawsuits</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of August 10, 2021, we are named as a defendant in 419 product liability lawsuits coordinated in Alameda County Superior Court in California involving claims by approximately 5,427 plaintiffs that allege personal injuries associated with the use of Cordis OptEase and TrapEase inferior vena cava ("IVC") filter products. Another 32 lawsuits involving similar claims by approximately 37 plaintiffs are pending in other jurisdictions. These lawsuits seek a variety of remedies, including unspecified monetary damages. In July 2021, we entered into an agreement to settle approximately 1,300 claims. This agreement is subject to certain contingencies. We continue to vigorously defend ourselves in these lawsuits and are engaged in ongoing resolution discussions with certain plaintiffs. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At June&#160;30, 2021, we had a total of $524&#160;million net of estimated insurance recoveries, accrued for losses and legal defense costs, net of expected insurance recoveries, related to the Cordis IVC filter lawsuits in the consolidated balance sheets. We believe there is a range of estimated losses with respect to these matters. Because no amount within the range is a better estimate than any other amount within the range, we have accrued the minimum amount in the range. We estimate the high end of the range to be approximately $1.03&#160;billion, net of estimated insurance recoveries. The sale of the Cordis disposal group does not include product liability related to the IVC filters in the U.S. and Canada, which we retained. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SEC Investigation</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In February 2021, we received a subpoena from the U.S. Securities and Exchange Commission requesting the production of documents from 2015 through 2019 relating to inventory in the Cordis business, analysis of goodwill of the Medical segment and other matters. We are cooperating with this inquiry and cannot predict its outcome or duration. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Shareholder Securities Litigation</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2019, the Louisiana Sheriffs' Pension &amp; Relief Fund filed a purported class action complaint against Cardinal Health and certain current and former officers and employees in the United States District Court for the Southern District of Ohio purportedly on behalf of all purchasers of our common shares between March 2015 and May 2018. In June 2020, the court appointed 1199 SEIU Health Care Employees Pension Fund as lead plaintiff and a consolidated amended complaint was filed in September 2020. The amended complaint alleges that the defendants violated Sections 10(b) and 20(a) of the Securities and Exchange Act of 1934 by making misrepresentations and omissions related to the acquisition integration of the Cordis business and inventory and supply chain problems within the Cordis business, and seeks to recover unspecified damages and equitable relief for the alleged misstatements and omissions. The complaint also alleges that one of the individual defendants violated Section 20A of the Exchange Act because he sold shares of Cardinal Health stock during the time period. In November 2020, we filed a motion to dismiss the amended complaint. We believe that the claims asserted in this </span></div></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">complaint are without merit and intend to vigorously defend against them.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Specialty Solutions DOJ Investigation</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2018, the United States Attorney&#8217;s Office for the District of Massachusetts (the "USAO") commenced an investigation pertaining to the U.S. federal healthcare fraud and abuse laws. These requests sought, among other things, documents and information relating to discounts and rebates offered or provided to certain Specialty Solutions customers. We are cooperating with these requests and are engaged in resolution discussions with the USAO and Department of Health and Human Services, Office of Inspector General. In connection with these discussions, we recorded $13 million of expense within litigation charges/(recoveries) on our consolidated statements of earnings/(loss) during the fiscal year ended June&#160;30, 2021. We cannot predict the outcome of the discussions and it is possible that we may incur additional losses or agree to other remedial measures; however, we are not currently able to estimate a range of reasonably possible additional losses.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Other Civil Litigation </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Generic Pharmaceutical Pricing Antitrust Litigation </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2019, pharmaceutical distributors including us were added as defendants in a civil class action lawsuit filed by indirect purchasers of generic drugs, such as hospitals and retail pharmacies. The indirect purchaser case is part of a multidistrict litigation consisting of multiple individual class action matters consolidated in the Eastern District of Pennsylvania. The indirect purchaser plaintiffs allege that pharmaceutical distributors encouraged manufacturers to increase prices, provided anti-competitive pricing information to manufacturers and improperly engaged in customer allocation. We have filed a motion to dismiss the complaints and we intend to vigorously defend ourselves. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Active Pharmaceutical Ingredient Impurity Litigation</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Many participants in the pharmaceutical supply chain, including active pharmaceutical ingredient ("API") manufacturers, finished dose manufacturers, repackagers, distributors, and retailers have been named as defendants in lawsuits arising out of recalls of certain medications due to alleged impurities in the active pharmaceutical ingredients or finished product. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In February 2019, a Multidistrict Litigation was created in the U.S. District Court for the District of New Jersey (the &#8220;Sartan MDL&#8221;) alleging API impurities in certain generic blood pressure medications. We have been named as a defendant in the Sartan MDL. We are vigorously defending ourselves in this matter. </span></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Antitrust Litigation Proceeds</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We received and recognized income resulting from settlements of lawsuits in which we were a class member or plaintiff of $112 million</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$16 million and $94 million during fiscal 2021, 2020, and 2019, respectively.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -URI http://asc.fasb.org/topic&amp;trid=2127136<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -URI http://asc.fasb.org/topic&amp;trid=2144648<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 440<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6491277&amp;loc=d3e6429-115629<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140421166249608">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">Income Taxes</a></td>
<td class="text"><div style="margin-bottom:6pt;text-align:justify"><span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:13pt;font-weight:700;line-height:120%">8. Income Taxes </span></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Earnings/(Loss) before Income Taxes and Provision for/(Benefit From) Income Taxes</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes earnings/(loss) before income taxes:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.691%"><tr><td style="width:1.0%"/><td style="width:53.389%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.999%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.347%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.522%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.347%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.596%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">U.S. operations</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(47)</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4,056)</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,478&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Non-U.S. operations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">370</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">284&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">273&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Earnings/(loss) before income taxes</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">323</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(3,772)</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,751&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the components of provision for/(benefit from) income taxes:</span></div><div style="margin-top:8pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:53.220%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.949%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.343%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.171%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.343%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.174%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Current:</span></td><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Federal</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(989)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">659&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">295&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">State and local</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">92</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">154&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">89&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Non-U.S.</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">112</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">69&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">85&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total current</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(785)</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">882&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">469&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:3pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Deferred:</span></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Federal</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">539</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(822)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(28)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">State and local</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(28)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(127)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(37)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Non-U.S.</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(15)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(18)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total deferred</span></td><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">496</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(961)</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(83)</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Provision for/(benefit from) income taxes</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(289)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(79)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">386&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Tax Effects of Self-Insurance Pre-Tax Loss</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During fiscal 2021, our wholly-owned insurance subsidiary recorded a self-insurance pre-tax loss in its fiscal 2020 statutory financial statements primarily related to opioid litigation. This self-insurance pre-tax loss, which did not impact our pre-tax consolidated results, was deducted on our fiscal 2020 consolidated federal income tax return and contributed to a significant net operating loss for tax purposes. The net operating loss was carried back and applied to adjust our taxable income for fiscal 2015, 2016, 2017, and 2018 as permitted under the Coronavirus Aid, Relief and Economic Security ("CARES") Act enacted by the United States Congress in March 2020.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accordingly, our provision for income taxes during fiscal 2021 included a $424 million benefit from the net operating loss carryback primarily to reflect the difference between the federal statutory income tax rate during the fiscal years from 2015 to 2018 (35 percent for fiscal 2015, 2016, and 2017 and 28 percent for fiscal 2018) and the current federal statutory income tax rate of 21 percent.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have filed for a U.S. federal income tax refund of $974&#160;million as a result of the net operating loss carryback under the CARES Act, which we expect to receive within 12 months, and accordingly have recorded a current asset on our consolidated balance sheet at June&#160;30, 2021. We also increased our non-current deferred tax </span></div><div style="display:inline-block;vertical-align:top;width:48.214%"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">liability by approximately $700&#160;million during fiscal 2021 related to this matter.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have recorded these amounts based on management's judgment and our current understanding of tax law; however, it is possible that the tax authorities could challenge these tax benefits or that the tax law could change. The actual amount of the tax benefit may differ materially from these estimates.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Tax Effects of Opioid Litigation Charges</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the $1.17&#160;billion and $5.63&#160;billion pre-tax charges for the opioid litigation, during fiscal 2021 and 2020, we recorded a tax benefit of $228 million and $488&#160;million, respectively. Our tax benefits are estimates, which reflect our current assessment of the estimated future deductibility of the amount that may be paid under the accrual taken in connection with the opioid litigation and are net of unrecognized tax benefits of $219&#160;million and $469&#160;million, respectively. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have made reasonable estimates and recorded amounts based on management's judgment and our current understanding of the Tax Act; however, these estimates require significant judgment since the U.S. tax law governing deductibility was changed by the U.S. Tax Cuts and Jobs Act ("Tax Act"). Further, it is possible Congress or the tax authorities could challenge our interpretation of the Tax Act or the estimates and assumptions used to assess the future deductibility of these benefits. The actual amount of the tax benefit may differ materially from these estimates.</span></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Effective Tax Rate</span></div><div style="margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents a reconciliation of the provision based on the federal statutory income tax rate to our effective income tax rate:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:53.220%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.406%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.343%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.406%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.343%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.482%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021 </span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2020</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"> (1)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2019 </span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Provision at Federal statutory rate</span></td><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">21.0</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">21.0&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">21.0&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">State and local income taxes, net of federal benefit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">3.2</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Tax effect of foreign operations</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">0.7</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(0.7)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Nondeductible/nontaxable items </span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1.6</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cordis Disposition</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">7.0</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Withholding Taxes </span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">9.0</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(0.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Change in Valuation Allowances</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(1.4)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1.5&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4.5&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">US Taxes on International Income</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"> (2)(3)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(6.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Impact of Resolutions with IRS and other related matters </span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(13.6)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(0.4)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Legal Entity Reorganization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(3.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Opioid litigation</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">17.7</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(23.2)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Loss Carryback Claims</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(129.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other </span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1.7</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(2.1)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Effective income tax rate</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(89.7)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2.1&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">22.1&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;The table represents the following: fiscal 2021 is pretax income with tax benefit, fiscal 2020 is pretax loss with tax benefit, and fiscal 2019 is pretax income with tax expense.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)&#160;&#160;&#160;&#160;Certain prior year amounts have been reclassified to conform to current year presentation.</span></div></div><div style="display:inline-block;max-width:3.571%;min-width:2.571%;vertical-align:top"/><div style="display:inline-block;vertical-align:top;width:48.215%"><div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(3)&#160;&#160;&#160;&#160;Includes the tax impact of Global Intangible Low-Taxed Income ("GILTI") tax, the Foreign-Derived Intangible Income deduction and other foreign income that is taxable under the U.S. tax code. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The income tax benefit rate was 89.7% and 2.1% in fiscal 2021 and fiscal 2020 compared to an income tax expense rate of 22.1% in fiscal 2019. Fluctuations in the effective tax rates are primarily due to the impact of opioid litigation in fiscal 2021 and 2020, as well as the impact of the carryback claim filed in accordance with the CARES Act provision in fiscal year 2021.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our effective tax rate has benefits from negotiated lower than statutory tax rates in select foreign jurisdictions which individually are not material to our effective tax rate but in aggregate have a favorable tax impact of approximately $20 million during fiscal 2021.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of June&#160;30, 2021, foreign earnings of approximately $825 million are considered indefinitely reinvested for working capital and other offshore investment needs. The computation of tax required if those earnings are repatriated is not practicable. For amounts not considered indefinitely reinvested, we have recorded an immaterial amount of income tax expense in our financial statements in fiscal 2021. </span></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Deferred Income Taxes</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deferred income taxes arise from temporary differences between financial reporting and tax reporting bases of assets and liabilities and operating loss and tax credit carryforwards for tax purposes. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the components of the deferred income tax assets and liabilities at June 30:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:60.937%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.109%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.343%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.111%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Deferred income tax assets:</span></td><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Receivable basis difference</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">40</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accrued liabilities</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">874</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">607&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Share-based compensation</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">38</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">38&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Loss and tax credit carryforwards</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">805</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">589&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Deferred tax assets related to uncertain tax positions</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">35</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">52&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">16</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">87&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total deferred income tax assets</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1,808</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,412&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Valuation allowance for deferred income tax assets</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(515)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(470)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net deferred income tax assets</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1,293</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">942</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cccccc;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cccccc;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cccccc;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cccccc;border-top:2pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Deferred income tax liabilities:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Inventory basis differences</span></td><td style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(1,119)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1,083)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Property-related</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(375)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(327)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Goodwill and other intangibles</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(733)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(751)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Self-Insurance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(975)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(23)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total deferred income tax liabilities</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(3,225)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(2,161)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:6pt;padding-left:6.75pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net deferred income tax liability</span></div></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(1,932)</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1,219)</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deferred income tax assets and liabilities in the preceding table, after netting by taxing jurisdiction and for uncertain tax positions, are in the following captions in the consolidated balance sheets at June 30:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:60.937%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.109%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.343%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.111%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Noncurrent deferred income tax asset (1)</span></td><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">52</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Noncurrent deferred income tax liability (2)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(1,981)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1,258)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Noncurrent deferred income tax liability transferred to held for sale</span></td><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(3)</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net deferred income tax liability</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(1,932)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1,219)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:10pt">Included in other assets in the consolidated balance sheets.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:10pt">Included in deferred income taxes and other liabilities in the consolidated balance sheets.</span></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At June&#160;30, 2021 we had gross federal, state and international loss and credit carryforwards of $272 million, $3.9 billion and $2.3 billion, respectively, the tax effect of which is an aggregate deferred tax asset of $805 million. Substantially all of these carryforwards are available for at least three years. Approximately $477 million of the valuation allowance at June&#160;30, 2021 applies to certain federal, state and international loss carryforwards that, in our opinion, are more likely than not to expire unutilized. However, to the extent that tax benefits related</span><span style="color:#ffffff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">to these carryforwards are realized in the future, the reduction in the valuation allowance would reduce income tax expense.</span></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Unrecognized Tax Benefits</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We had $932 million, $998 million and $456 million of unrecognized tax benefits at June&#160;30, 2021, 2020 and 2019, respectively. The June&#160;30, 2021, 2020 and 2019 balances include $849 million, $753 million and $303 million, respectively, of unrecognized tax benefits that, if recognized, would have an impact on the effective tax rate. The remaining unrecognized tax benefits relate to tax positions for which ultimate deductibility is highly certain but for which there is uncertainty as to the timing of such deductibility. Recognition of these tax benefits would not affect our effective tax rate. We include the full amount of unrecognized tax benefits in deferred income taxes and other liabilities in the consolidated balance sheets. The following table presents a reconciliation of the beginning and ending amounts of unrecognized tax benefits:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.691%"><tr><td style="width:1.0%"/><td style="width:53.389%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.999%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.347%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.831%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.347%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.287%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance at beginning of fiscal year</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">998</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">456&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">423&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Additions for tax positions of the current year</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">121</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">500&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Additions for tax positions of prior years</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">223</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">78&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Reductions for tax positions of prior years</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(138)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(27)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Settlements with tax authorities </span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(271)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(25)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Expiration of the statute of limitations </span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(1)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(3)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance at end of fiscal year</span></div></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">932</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">998&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">456&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">It is reasonably possible that there could be a change in the amount of unrecognized tax benefits within the next 12 months due to activities of the U.S. Internal Revenue Service ("IRS") or other taxing authorities, possible settlement of audit issues, </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">reassessment of existing unrecognized tax benefits or the expiration of statutes of limitations. We estimate that the range of the possible change in unrecognized tax benefits within the next 12 months is a net decrease of $0 million to $20 million, exclusive of penalties and interest.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recognize accrued interest and penalties related to unrecognized tax benefits in the provision for income taxes. At June&#160;30, 2021, 2020 and 2019, we had $49 million, $146 million and $122 million, respectively, accrued for the payment of interest and penalties. These balances are gross amounts before any tax benefits and are included in deferred income taxes and other liabilities in the consolidated balance sheets. As a result of our IRS audit settlements and carryback claim, an immaterial amount of interest was recorded in fiscal 2021. During fiscal 2020 and 2019, we recognized $16 million and $8 million of expense for interest and penalties in income tax expense, respectively. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Other Tax Matters</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We file income tax returns in the U.S. federal jurisdiction, various U.S. state and local jurisdictions, and various foreign jurisdictions. With few exceptions, we are subject to audit by taxing authorities for fiscal years 2015 through the current fiscal year. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are a party to a tax matters agreement with CareFusion Corporation ("CareFusion"), which has been acquired by Becton, Dickinson and Company. Under the tax matters agreement, CareFusion is obligated to indemnify us for certain tax exposures and transaction taxes prior to our fiscal 2010 spin-off of CareFusion. The indemnification receivable was $72 million and $176 million at June&#160;30, 2021 and 2020, respectively, and is included in other assets in the consolidated balance sheets.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a result of the acquisition of the Patient Recovery Business, Medtronic plc is obligated to indemnify us for certain tax exposures and transaction taxes related to periods prior to the acquisition under the purchase agreement. The indemnification receivable was $12 million and $19 million at June&#160;30, 2021 and 2020, respectively, and is included in other assets in the consolidated balance sheets.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32857-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330215-122817<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32809-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.5.Q1)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32705-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 270<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6424409&amp;loc=d3e44925-109338<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -URI http://asc.fasb.org/topic&amp;trid=2144680<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6424122&amp;loc=d3e41874-109331<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140421172981416">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementInputsDisclosureTextBlock', window );">Fair Value Measurements</a></td>
<td class="text"><div style="margin-bottom:6pt;text-align:justify"><span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:13pt;font-weight:700;line-height:120%">9. Fair Value Measurements </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables present the fair values for assets and (liabilities) measured on a recurring basis at June 30:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:46.122%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.937%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.343%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.937%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.343%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.937%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.343%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.938%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cash equivalents</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1,883</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1,883</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other investments (1)</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">126</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">126</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Forward contracts (2)</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">42</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">42</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:46.122%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.937%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.343%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.937%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.343%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.937%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.343%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.938%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Level&#160;1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Level&#160;2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Level&#160;3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cash equivalents</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">721&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">721&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other investments (1)</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">114&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">114&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Forward contracts (2)</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">53&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">53&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:10pt">The other investments balance includes investments in mutual funds, which offset fluctuations in deferred compensation liabilities. These mutual funds invest in the equity securities of companies with both large and small market capitalization and high-quality fixed income debt securities. The fair value of these investments is determined using quoted market prices.</span>(2)The fair value of interest rate swaps, foreign currency contracts, net investment hedges and commodity contracts is determined based on the present value of expected future cash flows considering the risks involved, including non-performance risk, and using discount rates appropriate for the respective maturities. Observable Level 2 inputs are used to determine the present value of expected future cash flows. The fair value of these derivative contracts, which are subject to master netting arrangements under certain circumstances, is presented on a gross basis in prepaid expenses and other, other assets, other accrued liabilities, and deferred income taxes and other liabilities within the consolidated balance sheets.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresTextBlock', window );">Fair Value Disclosures</a></td>
<td class="text"><div style="margin-bottom:6pt;text-align:justify"><span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:13pt;font-weight:700;line-height:120%">9. Fair Value Measurements </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables present the fair values for assets and (liabilities) measured on a recurring basis at June 30:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:46.122%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.937%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.343%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.937%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.343%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.937%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.343%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.938%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cash equivalents</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1,883</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1,883</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other investments (1)</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">126</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">126</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Forward contracts (2)</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">42</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">42</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:46.122%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.937%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.343%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.937%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.343%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.937%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.343%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.938%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Level&#160;1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Level&#160;2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Level&#160;3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cash equivalents</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">721&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">721&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other investments (1)</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">114&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">114&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Forward contracts (2)</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">53&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">53&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:10pt">The other investments balance includes investments in mutual funds, which offset fluctuations in deferred compensation liabilities. These mutual funds invest in the equity securities of companies with both large and small market capitalization and high-quality fixed income debt securities. The fair value of these investments is determined using quoted market prices.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:10pt">The fair value of interest rate swaps, foreign currency contracts, net investment hedges and commodity contracts is determined based on the present value of expected future cash flows considering the risks involved, including non-performance risk, and using discount rates appropriate for the respective maturities. Observable Level 2 inputs are used to determine the present value of expected future cash flows. The fair value of these derivative contracts, which are subject to master netting arrangements under certain circumstances, is presented on a gross basis in prepaid expenses and other, other assets, other accrued liabilities, and deferred income taxes and other liabilities within the consolidated balance sheets. </span></div><div style="margin-bottom:3pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Assets and (Liabilities) Measured on a Nonrecurring Basis</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Assets and liabilities held for sale of $1.1&#160;billion and $96 million, respectively, at June&#160;30, 2021 are primarily related to the divestiture of our Cordis business. These estimated fair values utilized Level 3 unobservable inputs based on expected sales proceeds following a competitive bidding process. See </span><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i4f0ec56b9c604f1782a65ea4a19c284d_106" style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Note 2</a></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for additional information regarding assets and liabilities held for sale.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementInputsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure of the fair value measurement of assets and liabilities, which includes financial instruments measured at fair value that are classified in shareholders' equity, which may be measured on a recurring or nonrecurring basis.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -URI http://asc.fasb.org/topic&amp;trid=2155941<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementInputsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140421167421320">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financial Instruments<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract', window );"><strong>Derivative Instruments and Hedging Activities Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentsDisclosureTextBlock', window );">Financial Instruments</a></td>
<td class="text"><div style="margin-bottom:6pt;text-align:justify"><span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:13pt;font-weight:700;line-height:120%">10. Financial Instruments </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We utilize derivative financial instruments to manage exposure to certain risks related to our ongoing operations. The primary risks managed through the use of derivative instruments include interest rate risk, currency exchange risk, and commodity price risk. We do not use derivative instruments for trading or speculative purposes. While the majority of our derivative instruments are designated as hedging instruments, we also enter into derivative instruments that are designed to hedge a risk, but are not designated as hedging instruments. These derivative instruments are adjusted to current fair value through earnings at the end of each period. We are exposed to counterparty credit risk on all of our derivative instruments. Accordingly, we have established and maintain strict counterparty credit guidelines and only enter into derivative instruments with major financial institutions that are rated investment grade or better. We do not have significant exposure to any one counterparty and we believe the risk of loss is remote. Additionally, we do not require collateral under these agreements.</span></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Interest Rate Risk Management</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are exposed to the impact of interest rate changes. Our objective is to manage the impact of interest rate changes on cash flows and the market value of our borrowings. We utilize a mix of debt maturities along with both fixed-rate and variable-rate debt to manage changes in interest rates. In addition, we enter into interest rate swaps to further manage our exposure to interest rate variations related to our borrowings and to lower our overall borrowing costs.</span></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Currency Exchange Risk Management</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We conduct business in several major international currencies and are subject to risks associated with changing foreign exchange </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">rates. Our objective is to reduce earnings and cash flow volatility associated with foreign exchange rate changes to allow management to focus its attention on business operations. Accordingly, we enter into various contracts that change in value as foreign exchange rates change to protect the value of existing foreign currency assets and liabilities, commitments and anticipated foreign currency revenue and expenses.</span></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Commodity Price Risk Management</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are exposed to changes in the price of certain commodities. Our objective is to reduce earnings and cash flow volatility associated with forecasted purchases of these commodities to allow management to focus its attention on business operations. Accordingly, we enter into derivative contracts when possible to manage the price risk associated with certain forecasted purchases.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the fair value of our assets and liabilities related to derivatives designated as hedging instruments and the respective line items in which they were recorded in the consolidated balance sheets at June 30:</span></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.691%"><tr><td style="width:1.0%"/><td style="width:69.488%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.831%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.347%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.834%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"/><td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Pay-floating interest rate swaps (1)</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cross-currency swap (1) </span></td><td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">6</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"/><td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">47&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cross-currency swap (2)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">34</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Foreign currency contracts (2)</span></td><td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">5</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"/><td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total assets</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">46</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">74&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:6pt"><td colspan="3" style="background-color:#dbdbdb;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#dbdbdb;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#dbdbdb;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#dbdbdb;border-top:2pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Foreign currency contracts (4)</span></td><td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">4</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"/><td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Forward interest rate swaps (3)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Commodity contracts (4)</span></td><td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"/><td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total liabilities</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">4</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;Included in other assets in the consolidated balance sheets.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)&#160;&#160;&#160;&#160;Included in prepaid expenses and other in the consolidated balance sheets.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(3)&#160;&#160;&#160;&#160;Included in deferred income taxes and other liabilities in the consolidated balance sheets.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(4)&#160;&#160;&#160;&#160;Included in other accrued liabilities in the consolidated balance sheets.</span></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Fair Value Hedges</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We enter into pay-floating interest rate swaps to hedge the changes in the fair value of fixed-rate debt resulting from fluctuations in interest rates. These contracts are designated and qualify as fair value hedges. Accordingly, the gain or loss recorded on the pay-floating interest rate swaps is directly offset by the change in fair value of the underlying debt. Both the derivative instrument and the underlying debt are adjusted to market value at the end of each period with any resulting gain or loss recorded in interest expense, net in the consolidated statements of earnings/(loss). During fiscal 2021, 2020 and 2019 there was no gain or loss recorded to interest expense as changes in the market value of our derivative instruments offset changes in the market value of the underlying debt.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:115%">During fiscal 2021, we unwound certain interest rate swap contracts with the notional amount of $550&#160;million. In connection with the unwind of these contracts, we received cash proceeds of </span></div><div style="display:inline-block;vertical-align:top;width:48.214%"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$18&#160;million. The related gain will be recognized in interest expense, net in our statements of earnings/(loss) over the remaining term of the debt agreement, which matures in March 2023.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During fiscal 2021, we entered into a pay-floating interest rate swap with total notional amounts of $200&#160;million. This swap has been designated as fair value hedges of our fixed rate debt and is included in deferred income taxes and other liabilities in the consolidated balance sheets.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2020, we unwound certain interest rate swap contracts. In connection with the unwind of these contracts, we received cash proceeds of $112 million. The related gain will be recognized in interest expense, net in our statements of earnings/(loss) over the remaining term of the related debt agreements, which ranged from 48 months to 63 months at June&#160;30, 2020.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the debt repayment as described in </span><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i4f0ec56b9c604f1782a65ea4a19c284d_124" style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Note 6</a></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, two pay-floating interest rate swaps with notional amounts of $200 million matured in the second quarter of fiscal 2020. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During fiscal&#160;2019, we terminated notional amounts of&#160;$163&#160;million&#160;of pay-floating interest rate swaps in connection with the debt repurchases in&#160;fiscal 2019&#160;described in </span><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i4f0ec56b9c604f1782a65ea4a19c284d_124" style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Note 6</a></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. These swaps were previously designated as fair value hedges.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables summarize the outstanding interest rate swaps designated as fair value hedges at June 30:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.691%"><tr><td style="width:1.0%"/><td style="width:43.482%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:26.454%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.347%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.045%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:2.615%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.357%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Notional Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Maturity&#160;Date</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Pay-floating interest rate swaps</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">200</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="9" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Mar 2028</span></td></tr></table></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.691%"><tr><td style="width:1.0%"/><td style="width:43.791%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:26.144%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.347%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.045%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:2.615%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.358%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Notional Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Maturity&#160;Date</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Pay-floating interest rate swaps</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">550&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="9" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Mar 2023</span></td></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the gain/(loss) recognized in earnings for interest rate swaps designated as fair value hedges:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:52.912%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.343%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.406%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.343%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.408%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Pay-floating interest rate swaps (1)</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(8)</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">106&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Fixed-rate debt (1)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">8</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(106)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:3pt;padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1) Included in interest expense, net in the consolidated statements of earnings/(loss).</span></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Cash Flow Hedges</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We enter into derivative instruments to hedge our exposure to changes in cash flows attributable to interest rate, foreign currency and commodity price fluctuations associated with certain forecasted transactions. These derivative instruments are designated and qualify as cash flow hedges. Accordingly, the gain or loss on the derivative instrument is reported as a component of accumulated other comprehensive loss and reclassified into earnings in the same line item associated with the forecasted transaction and in the same period during which the hedged transaction affects earnings. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During fiscal 2020, we entered into forward interest rate swaps with a total notional amount of $200&#160;million to hedge probable, but </span></div></div><div style="display:inline-block;max-width:3.571%;min-width:2.571%;vertical-align:top"/><div style="display:inline-block;vertical-align:top;width:48.215%"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">not firmly committed, future transactions associated with our debt. During fiscal 2021, we terminated these swaps and reclassified an immaterial deferred gain from accumulated other comprehensive loss into interest expense, net in our consolidated statements of earnings/(loss) because the forecasted transactions were probable of not occurring. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All gains and losses currently included within accumulated other comprehensive loss associated with our cash flow hedges that are expected to be reclassified into net earnings within the next 12 months are immaterial.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We enter into foreign currency contracts to protect the value of anticipated foreign currency revenues and expenses. At June&#160;30, 2021 and 2020, we held contracts to hedge probable, but not firmly committed, revenue and expenses. The principal currencies hedged are the Chinese renminbi, Canadian dollar, euro, Thai baht and Mexican peso.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We enter into commodity contracts to manage the price risk associated with forecasted purchases of certain commodities used in our Medical segment.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables summarize the outstanding cash flow hedges at June 30:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:38.714%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:24.517%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.343%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:2.912%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.408%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Notional Amount</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Maturity&#160;Date</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#dbdbdb;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td style="background-color:#dbdbdb;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#dbdbdb;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">436</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dbdbdb;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dbdbdb;border-bottom:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#dbdbdb;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Jul 2021</span></td><td colspan="3" style="background-color:#dbdbdb;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">-</span></td><td colspan="3" style="background-color:#dbdbdb;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Jun 2022</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:38.714%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:24.517%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.343%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:2.912%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.408%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Notional Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Maturity&#160;Date</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Forward interest rate swaps</span></td><td style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">200&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="9" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Jun 2022</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">328&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Jul 2020</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Jun 2021</span></div></td></tr><tr><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Commodity contracts</span></td><td colspan="2" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Jul 2020</span></div></td><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Jun 2021</span></div></td></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the pre-tax gain/(loss) included in OCI for derivative instruments designated as cash flow hedges:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:46.739%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.492%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.343%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.023%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.960%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.643%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Forward interest rate swaps</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">16</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(16)</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Commodity contracts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td colspan="2" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">5</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the pre-tax gain/(loss) reclassified from AOCI into earnings for derivative instruments designated as cash flow hedges:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.382%"><tr><td style="width:1.0%"/><td style="width:46.415%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.359%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.352%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.359%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.352%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.363%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Foreign currency contracts (1)</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(12)</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Foreign currency contracts (2)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Foreign currency contracts (3)</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">4</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Forward interest rate swaps (4)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Commodity contracts (3)</span></td><td colspan="2" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">6</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;Included in revenue in the consolidated statements of earnings/(loss).</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)&#160;&#160;&#160;&#160;Included in cost of products sold in the consolidated statements of earnings/(loss).</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(3)&#160;&#160;&#160;&#160;Included in SG&amp;A expenses in the consolidated statements of earnings/(loss).</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(4) &#160;&#160;&#160;&#160;Included in interest expense, net in the consolidated statements of earnings/(loss).</span></div></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Net Investment Hedges</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We hedge the foreign currency risk associated with certain net investment positions in foreign subsidiaries. To accomplish this, we enter into cross-currency swaps that are designated as hedges of net investments.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2019, we entered into a &#165;64 billion ($600 million) cross-currency swap maturing in 2022.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In September 2018, we entered into a &#8364;200&#160;million ($233&#160;million) cross-currency swap maturing in 2023.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cross-currency swaps designated as net investment hedges are marked-to-market using the current spot exchange rate as of the end of the period, with gains and losses included in the foreign currency translation component of accumulated other comprehensive loss until the sale or substantial liquidation of the underlying net investments. To the extent the cross-currency swaps designated as net investment hedges are not highly effective, changes in carrying value attributable to the change in spot rates are recorded in earnings. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pre-tax gain and loss from net investment hedges recorded in the foreign currency translation component of accumulated other comprehensive loss was a $7 million loss and a $35 million gain during fiscal 2021 and 2020, respectively. Gains recognized in interest expense, net in the consolidated statements of earnings/(loss) for the portion of the net investment hedges excluded from the assessment of hedge effectiveness were $19 million and</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$17 million during fiscal 2021 and 2020, respectively.</span></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Economic (Non-Designated) Hedges</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We enter into foreign currency contracts to manage our foreign exchange exposure related to sales transactions, intercompany financing transactions and other balance sheet items subject to revaluation that do not meet the requirements for hedge accounting treatment. Accordingly, these derivative instruments are adjusted to current market value at the end of each period through earnings. The gain or loss recorded on these instruments is substantially offset by the remeasurement adjustment on the foreign currency denominated asset or liability. The settlement of the derivative instrument and the remeasurement adjustment on the foreign currency denominated asset or liability are both recorded in other (income)/expense, net. The principal currency managed through foreign currency contracts is the Chinese renminbi, Canadian dollar, euro, Mexican Peso, and Brazilian Real. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables summarize the outstanding economic (non-designated) derivative instruments at June 30:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:38.714%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:24.517%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.343%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:2.912%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.408%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Notional Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Maturity Date</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">254</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="9" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">July 2021</span></td></tr></table></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:38.714%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:24.517%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.343%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:2.912%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.408%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Notional Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Maturity Date</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">325&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="9" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Jul 2020</span></td></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the gain/(loss) recognized in earnings for economic (non-designated) derivative instruments:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.382%"><tr><td style="width:1.0%"/><td style="width:46.415%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.359%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.352%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.359%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.352%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.363%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Foreign currency contracts (1)</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(8)</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(13)</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;Included in other income, net in the consolidated statements of earnings/(loss).</span></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Fair Value of Financial Instruments</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The carrying amounts of cash and equivalents, trade receivables, net, accounts payable, and other accrued liabilities at June&#160;30, 2021 and 2020 approximate fair value due to their short-term maturities.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the estimated fair value of our long-term obligations and other short-term borrowings compared to the respective carrying amounts at June 30:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:47.974%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:23.591%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.343%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:23.592%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Estimated fair value</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">6,751</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7,273&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Carrying amount</span></td><td colspan="2" style="border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">6,236</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="2" style="border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6,775&#160;</span></td><td style="border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of our long-term obligations and other short-term borrowings is estimated based on either the quoted market prices for the same or similar issues or other inputs derived from available market information, which represents a Level 2 measurement.</span></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table is a summary of the fair value gain/(loss) of our derivative instruments based upon the estimated amount that we would receive (or pay), considering counter-party credit risk, to terminate the contracts at June 30:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.691%"><tr><td style="width:1.0%"/><td style="width:31.098%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.451%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.347%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.547%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.347%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.451%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.347%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.312%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Notional<br/>Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair&#160;Value<br/>Gain/(Loss)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Notional<br/>Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Fair&#160;Value<br/>Gain/(Loss)</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Pay-floating interest rate swaps</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">200</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">550&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">690</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">653&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Forward interest rate swaps</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">200&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(16)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cross-currency swap</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">833</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">40</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">833&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">47&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Commodity contracts</span></td><td colspan="2" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for financial instruments. This disclosure includes, but is not limited to, fair value measurements of short and long term marketable securities, international currencies forward contracts, and auction rate securities. Financial instruments may include hedging and non-hedging currency exchange instruments, derivatives, securitizations and securities available for sale at fair value. Also included are investment results, realized and unrealized gains and losses as well as impairments and risk management disclosures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140421168167160">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Shareholders' Equity<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock', window );">Shareholders' Equity</a></td>
<td class="text"><div style="margin-bottom:6pt;text-align:justify"><span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:13pt;font-weight:700;line-height:120%">11. Shareholders' Equity </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At June&#160;30, 2021 and 2020, authorized capital shares consisted of the following: 750 million Class A common shares, without par value; 5 million Class B common shares, without par value; and 500 thousand non-voting preferred shares, without par value. The Class A common shares and Class B common shares are collectively referred to below as &#8220;common shares&#8221;. Holders of common shares are entitled to share equally in any dividends declared by the Board of Directors and to participate equally in all distributions of assets upon liquidation. Generally, the holders of Class A common shares are entitled to one vote per share, and the holders of Class B common shares are entitled to one-fifth of one vote per share on proposals presented to shareholders for vote. Under certain circumstances, the holders of Class B common </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">shares are entitled to vote as a separate class. Only Class A common shares were outstanding at June&#160;30, 2021 and 2020.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We repurchased $1.15 billion of our common shares, in the aggregate, through share repurchase programs during fiscal 2021</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2020 and 2019, as described below. We funded the repurchases with available cash and short term borrowings. The common shares repurchased are held in treasury to be used for general corporate purposes.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During fiscal 2021, we repurchased 3.7 million common shares having an aggregate cost of $200 million. The average price paid per common share was $54.40. These repurchases were made under an accelerated share repurchase ("ASR") program, which began on February&#160;9, 2021 and was completed on March&#160;31, 2021. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During fiscal 2020, we repurchased 7.3 million common shares having an aggregate cost of $350 million. The average price paid per common share was $48.00. These repurchases were made under an ASR program, which began on August&#160;20, 2019 and was completed on December&#160;4, 2019. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During fiscal 2019, we repurchased 11.5 million common shares having an aggregate cost of $600 million. The average price paid per common share was $52.32. These repurchases were made under an ASR program, which began on August&#160;16, 2018 and was completed on October&#160;25, 2018.</span></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Accumulated Other Comprehensive Loss</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the changes in the balance of accumulated other comprehensive loss by component and in total:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:38.097%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.492%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.343%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.875%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.343%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:22.050%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Foreign<br/>Currency<br/>Translation<br/>Adjustments and other</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Unrealized<br/>Gain/(Loss) on<br/>Derivatives,<br/>net of tax</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated Other<br/>Comprehensive<br/>Loss</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance at June 30, 2019</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(95)</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(79)</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other comprehensive income/(loss), net before reclassifications</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(23)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(20)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Amounts reclassified to earnings</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(5)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total other comprehensive income/(loss) attributable to Cardinal Health, Inc., net of tax of $4 million</span></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(28)</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(25)</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance at June 30, 2020</span></td><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(92)</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(104)</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other comprehensive income, before reclassifications</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">46&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">68</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Amounts reclassified to earnings</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total other comprehensive income/(loss) attributable to Cardinal Health, Inc., net of tax of $4 million</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">46&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">70</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance at June 30, 2021</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(46)</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">12</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(34)</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496171-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496171-112644<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496189-112644<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -URI http://asc.fasb.org/topic&amp;trid=2208762<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496189-112644<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496171-112644<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496189-112644<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 16<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496180-112644<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(e)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140421166315208">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Earnings Per Share Attributable to Cardinal Health, Inc.<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareTextBlock', window );">Earnings Per Share Attributable to Cardinal Health, Inc.</a></td>
<td class="text"><div style="margin-bottom:6pt;text-align:justify"><span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:13pt;font-weight:700;line-height:120%">12. Earnings/(Loss) Per Share Attributable to Cardinal Health, Inc. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table reconciles the computation of basic and diluted earnings per share attributable to Cardinal Health, Inc.:</span></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.691%"><tr><td style="width:1.0%"/><td style="width:61.748%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.045%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.347%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.355%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.347%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.358%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in millions, except per share amounts)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net earnings/(loss)</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">612</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(3,693)</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,365&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net earnings attributable to noncontrolling interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net earnings/(loss) attributable to Cardinal Health, Inc.</span></div></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">611</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(3,696)</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,363&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Weighted-average common shares&#8211;basic</span></td><td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">292</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">293&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">300&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Effect of dilutive securities:</span></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Employee stock options, restricted share units, and performance share units</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-average common shares&#8211;diluted</span></td><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">294</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">293&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">301&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Basic earnings/(loss) per common share attributable to Cardinal Health, Inc.:</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2.09</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(12.61)</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4.55&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Diluted earnings/(loss) per common share attributable to Cardinal Health, Inc.:</span></td><td colspan="2" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2.08</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(12.61)</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4.53&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The potentially dilutive employee stock options, restricted share units and performance share units that were anti-dilutive for fiscal 2021</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2020 and 2019 were 3 million, 6 million and 7 million, respectively. During fiscal 2020, there were 2 million potentially dilutive employee stock options, restricted share units and performance share units not included in the computation of diluted loss per common share attributable to Cardinal Health, Inc. because their effect would be anti-dilutive as a result of the net loss for the fiscal year.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109243012&amp;loc=SL65017193-207537<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -URI http://asc.fasb.org/topic&amp;trid=2144383<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140421167396648">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Information<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingDisclosureTextBlock', window );">Segment Information</a></td>
<td class="text"><div style="margin-bottom:6pt;text-align:justify"><span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:13pt;font-weight:700;line-height:120%">13. Segment Information </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our operations are principally managed on a products and services basis and are comprised of two operating segments, which are the same as our reportable segments: Pharmaceutical and Medical. The factors for determining the reportable segments include the manner in which management evaluates performance for purposes of allocating resources and assessing performance combined with the nature of the individual business activities.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Revenue</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical and over-the-counter healthcare and consumer products in the United States. This segment also provides services to pharmaceutical manufacturers and healthcare providers for specialty pharmaceutical products; operates pharmacies, including pharmacies in community health centers, nuclear pharmacies and radiopharmaceutical manufacturing facilities; provides pharmacy management services to hospitals as well as medication therapy management and patient outcomes services to hospitals, other healthcare providers and payers; and repackages generic pharmaceuticals and over-the-counter healthcare products. </span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Medical segment manufactures, sources and distributes Cardinal Health branded medical, surgical and laboratory products, which are sold in the United States, Canada, Europe, Asia and other markets. In addition to distributing Cardinal Health branded </span></div><div style="display:inline-block;vertical-align:top;width:48.214%"><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">products, this segment also distributes a broad range of medical, surgical and laboratory products known as national brand products and provides supply chain services and solutions to hospitals, ambulatory surgery centers, clinical laboratories and other healthcare providers in the United States and Canada. This segment also distributes medical products to patients' homes in the United States through our Cardinal Health at-Home Solutions division.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents revenue for each reportable segment and Corporate:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:55.690%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.480%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.343%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.171%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.343%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.173%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Pharmaceutical</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">145,796</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">137,495&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">129,917&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Medical</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">16,687</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">15,444&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">15,633&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total segment revenue</span></td><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">162,483</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">152,939&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">145,550&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Corporate (1)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(16)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(17)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(16)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total revenue</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">162,467</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">152,922&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">145,534&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:10pt">Corporate revenue consists of the elimination of inter-segment revenue and other revenue not allocated to the segments.</span></div><div style="margin-bottom:3pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables present revenue for each reportable segment and disaggregated revenue within our two reportable segments and Corporate:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:46.791%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.466%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.004%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.466%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.004%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.469%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Pharmaceutical Distribution and Specialty Solutions (1) (2)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">144,988</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">136,693&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">129,067&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Nuclear and Precision Health Solutions</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">808</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">802&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">850&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Pharmaceutical segment revenue</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">145,796</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">137,495&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">129,917&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Medical distribution and products (3)</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">14,485</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">13,429&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">13,833&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cardinal Health at-Home Solutions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2,202</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,015&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,800&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Medical segment revenue</span></div></td><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">16,687</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">15,444&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">15,633&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;Total segment revenue</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">162,483</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">152,939&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">145,550&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Corporate (4)</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(16)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(17)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(16)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total revenue</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">162,467</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">152,922&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">145,534&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:10pt">Products and services offered by our Specialty Solutions division are referred to as &#8220;specialty pharmaceutical products and services"</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:10pt">Comprised of all Pharmaceutical segment businesses except for Nuclear and Precision Health Solutions division.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:10pt">Comprised of all Medical segment businesses except for Cardinal Health at-Home Solutions division</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:10pt">Corporate revenue consists of the elimination of inter-segment revenue and other revenue not allocated to the segments.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents revenue by geographic area:</span></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:42.109%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.183%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.269%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.183%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.269%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.187%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">United States</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">157,756</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">148,707&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">141,479&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">International</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">4,727</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,232&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,071&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total segment revenue</span></td><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">162,483</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">152,939&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">145,550&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Corporate (1)</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(16)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(17)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(16)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total revenue</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">162,467</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">152,922&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">145,534&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:10pt">Corporate revenue consists of the elimination of inter-segment revenue and other revenue not allocated to the segments.</span></div></div><div style="display:inline-block;max-width:3.571%;min-width:2.571%;vertical-align:top"/><div style="display:inline-block;vertical-align:top;width:48.215%"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Segment Profit</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We evaluate segment performance based on segment profit, among other measures. Segment profit is segment revenue, less segment cost of products sold, less segment distribution, selling, general, and administrative ("SG&amp;A") expenses. Segment SG&amp;A expenses include share-based compensation expense as well as allocated corporate expenses for shared functions, including corporate management, corporate finance, financial and customer care shared services, human resources, information technology, legal and compliance, including certain litigation defense costs. Corporate expenses are allocated to the segments based on headcount, level of benefit provided and other ratable allocation methodologies. The results attributable to noncontrolling interests are recorded within segment profit.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We do not allocate the following items to our segments: </span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.13pt">last-in first-out, or ("LIFO"), inventory charges/(credits);</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.13pt">surgical gown recall costs/(income); in connection with a voluntary recall for certain surgical gowns and a voluntary recall and field actions for surgical procedure packs containing affected gowns, we recognized a pre-tax charge of $85&#160;million during fiscal 2020;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.13pt">restructuring and employee severance;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.13pt">amortization and other acquisition-related costs;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.13pt">impairments and (gain)/loss on disposal of assets; in connection with the divestiture of the Cordis business, we recognized a $60 million pre-tax write-down of the net assets held for sale</span><span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:13pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">during fiscal 2021; in connection with the naviHealth divestiture discussed in </span><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i4f0ec56b9c604f1782a65ea4a19c284d_106" style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Note 2</a></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, we recognized a pre-tax gain of $508 million during fiscal 2019;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.13pt">litigation (recoveries)/charges, net; in connection with the opioid litigation as discussed further in </span><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i4f0ec56b9c604f1782a65ea4a19c284d_130" style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Note 7</a></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, we recognized pre-tax charges of $1.17&#160;billion and $5.63&#160;billion</span><span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:13pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">during fiscal 2021 and 2020, respectively;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.13pt">state opioid assessment related to prior fiscal years; in connection with the New York Opioid Stewardship Act as discussed further in </span><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i4f0ec56b9c604f1782a65ea4a19c284d_130" style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Note 7</a></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, we recognized a pre-tax charge of $41&#160;million during fiscal 2021, related to calendar years 2017 and 2018 assessments;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.13pt">other (income)/expense, net;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.13pt">interest expense, net;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.13pt">loss on early extinguishment of debt;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.13pt">(gain)/loss on sale of equity interest in naviHealth; in connection with the sale of our remaining equity interest in a partnership that owned naviHealth as discussed in </span><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i4f0ec56b9c604f1782a65ea4a19c284d_106" style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Note 2</a></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, we recognized a $579&#160;million pre-tax gain ($493 million after tax) during fiscal 2020;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.13pt">provision for/(benefit from) income taxes </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, certain investment spending, certain portions of enterprise-wide incentive compensation and other spending are not allocated to the segments. Investment spending generally </span></div></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">includes the first-year spend for certain projects that require incremental investments in the form of additional operating expenses. Because approval for these projects is dependent on executive management, we retain these expenses at Corporate. Investment spending within Corporate was $27 million, $69 million and $55 million for fiscal 2021, 2020 and 2019, respectively. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables present segment profit by reportable segment and Corporate:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.691%"><tr><td style="width:1.0%"/><td style="width:51.221%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.451%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.347%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.760%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.347%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.074%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Pharmaceutical</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1,684</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,753&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,834&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Medical</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">577</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">663&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">576&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total segment profit</span></td><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2,261</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,416&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,410&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Corporate</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(1,789)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(6,514)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(350)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total operating earnings</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">472</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4,098)</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,060&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables present depreciation and amortization and additions to property and equipment by reportable segment and Corporate:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.691%"><tr><td style="width:1.0%"/><td style="width:47.506%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.999%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.347%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.999%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.347%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.002%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Pharmaceutical</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">151</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">135&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">147&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Medical</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">226</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">243&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">288&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Corporate</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">406</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">535&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">565&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total depreciation and amortization</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">783</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">913&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,000&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.691%"><tr><td style="width:1.0%"/><td style="width:47.506%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.999%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.347%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.999%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.347%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.002%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Pharmaceutical</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">55</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">47&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Medical</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">97</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">86&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">74&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Corporate</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">248</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">242&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">219&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total additions to property and equipment</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">400</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">375&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">328&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents total assets for each reportable segment and Corporate at June 30:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.691%"><tr><td style="width:1.0%"/><td style="width:46.887%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.547%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.347%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.547%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.347%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.525%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Pharmaceutical</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">23,624</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">22,398&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">22,446&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Medical (1)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">15,408</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">14,691&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">15,284&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Corporate</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">5,421</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,677&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,233&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total assets</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">44,453</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">40,766&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">40,963&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:5pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Assets of $1.1 billion classified as held for sale related to the Cordis divestiture were included within Medical at June&#160;30, 2021</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="margin-bottom:3pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables present property and equipment, net by geographic area:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.691%"><tr><td style="width:1.0%"/><td style="width:46.887%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.547%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.347%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.547%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.347%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.525%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">United States</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1,958</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,880&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,846&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">International</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">402</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">486&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">510&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Property and equipment, net</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2,360</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,366&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,356&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 34<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8981-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8721-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 26<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8844-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8657-108599<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8721-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -URI http://asc.fasb.org/topic&amp;trid=2134510<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140421166253784">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-Based Compensation<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock', window );">Share-Based Compensation</a></td>
<td class="text"><div style="margin-bottom:6pt;text-align:justify"><span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:13pt;font-weight:700;line-height:120%">14. Share-Based Compensation </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We maintain stock incentive plans (collectively, the &#8220;Plans&#8221;) for the benefit of certain of our officers, directors and employees. At June&#160;30, 2021, 9 million shares remain available for future grants under the Amended Cardinal Health, Inc. 2011 Long-Term Incentive Plan ("2011 LTIP"). Under the 2011 LTIP's fungible share counting provisions, stock options are counted against the plan as one share for every share issued; awards other than stock options are counted against the plan as two and one-half shares for every share issued. This means that only 3 million shares could be issued under awards other than stock options while 9 million shares could be issued under stock options. Shares are issued out of treasury shares when stock options are exercised and when restricted share units and performance share units vest. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides total share-based compensation expense by type of award:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.691%"><tr><td style="width:1.0%"/><td style="width:58.652%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.283%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.347%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.283%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.347%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.288%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Restricted share unit expense</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">73</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">70&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">63&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Employee stock option expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Performance share unit expense</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">16</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total share-based compensation expense</span></div></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">89</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">90&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">82&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total tax benefit related to share-based compensation was $12 million, $16 million and $16 million for fiscal 2021, 2020 and 2019, respectively.</span></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Restricted Share Units</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Restricted share units granted under the Plans generally vest in equal annual installments over three years. Restricted share units accrue cash dividend equivalents that are payable upon vesting of the awards.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes all transactions related to restricted share units under the Plans:</span></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.691%"><tr><td style="width:1.0%"/><td style="width:51.221%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.714%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.347%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:25.218%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in millions, except per share amounts)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Restricted Share Units</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-Average<br/>Grant Date Fair<br/>Value per Share</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Nonvested at June 30, 2019</span></td><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">51.65&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">42.71&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">60.21&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Canceled and forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Nonvested at June 30, 2020</span></td><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">45.92&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">53.76&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">49.37&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Canceled and forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">48.74&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nonvested at June 30, 2021</span></td><td colspan="2" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">3</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">49.05</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="display:inline-block;vertical-align:top;width:48.214%"><div style="margin-bottom:4pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides additional data related to restricted share unit activity:</span></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.691%"><tr><td style="width:1.0%"/><td style="width:53.698%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.451%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.347%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.522%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.347%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.835%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total compensation cost, net of estimated forfeitures, related to nonvested restricted share and share unit awards not yet recognized, pre-tax</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">73</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">77&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">75&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Weighted-average period in years over which restricted share and share unit cost is expected to be recognized (in years)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total fair value of shares vested during the year</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">70</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">57&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">68&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Stock Options</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Until the end of fiscal 2018, stock options were granted to our officers and certain employees. There were no stock options granted to employees during fiscal year 2021, 2020 or 2019. Employee stock options granted under the Plans generally vest in equal annual installments over three years and are exercisable for a period up to ten years from the grant date. All stock options are exercisable at a price equal to the market value of the common shares underlying the option on the grant date.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes all stock option transactions under the Plans:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:56.616%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.480%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.343%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:26.061%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in millions, except per share amounts)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Stock<br/>Options</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-Average<br/>Exercise Price per<br/>Common Share</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Outstanding at June 30, 2019</span></td><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">63.78&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">42.36&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Canceled and forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Outstanding at June 30, 2020</span></td><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">65.15&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">43.08&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Canceled and forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Outstanding at June 30, 2021</span></td><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">4</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">68.46</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Exercisable at June 30, 2021</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">4</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">68.62</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></div><div style="display:inline-block;max-width:3.571%;min-width:2.571%;vertical-align:top"/><div style="display:inline-block;vertical-align:top;width:48.215%"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides additional detail related to stock options:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.691%"><tr><td style="width:1.0%"/><td style="width:53.698%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.451%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.347%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.522%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.347%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.835%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in millions, except per share amounts)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Aggregate intrinsic value of outstanding options at period end</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">11</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Aggregate intrinsic value of exercisable options at period end</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">11</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Aggregate intrinsic value of exercised options</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">10</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net proceeds/(withholding) from share-based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">32</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Excess tax benefits from share based compensation</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(5)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total compensation cost, net of estimated forfeitures, related to unvested stock options not yet recognized, pre-tax</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total fair value of shares vested during the year</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">3</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Weighted-average grant date fair value per stock option</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">12.94</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8.26&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8.34&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.382%"><tr><td style="width:1.0%"/><td style="width:65.049%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.148%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.352%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.148%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.352%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.151%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in years)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Weighted-average remaining contractual life of outstanding options</span></td><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">4</span></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5</span></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Weighted-average remaining contractual life of exercisable options</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">4</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Weighted-average period over which stock option compensation cost is expected to be recognized</span></td><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2</span></td><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1</span></td><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1</span></td></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair values were estimated on the grant date using a lattice valuation model. We believe the lattice model provides reasonable estimates because it has the ability to take into account individual exercise patterns based on changes in our stock price and other variables, and it provides for a range of input assumptions, which are disclosed in the table below. The risk-free rate is based on the U.S. Treasury yield curve at the time of the grant. We analyzed historical data to estimate option exercise behaviors and employee terminations to be used within the lattice model. The expected life of the options granted was calculated from the option valuation model and represents the length of time in years that the options granted are expected to be outstanding. Expected volatilities are based on implied volatility from traded options on our common shares and historical volatility over a period of time commensurate with the contractual term of the option grant (up to ten years). </span></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Performance Share Units</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Performance share units generally vest over a 3-year performance period based on achievement of specific performance goals. Based on the extent to which the targets are achieved, vested shares may range from zero to 240 percent of the target award amount. Performance share units accrue cash dividend equivalents that are payable upon vesting of the awards.</span></div></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes all transactions related to performance share units under the Plans (based on target award amounts):</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.691%"><tr><td style="width:1.0%"/><td style="width:49.983%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.023%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.347%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:26.147%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in millions, except per share amounts)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Performance<br/>Share Units</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-Average<br/>Grant Date Fair<br/>Value per Share</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Nonvested at June 30, 2019</span></td><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.9&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">51.45&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">44.03&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">48.40&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Canceled and forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">50.92&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Nonvested at June 30, 2020</span></td><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1.3&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">54.24&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">55.45&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">42.72&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Canceled and forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(0.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">53.71&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nonvested at June 30, 2021</span></td><td colspan="2" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1.2</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">54.89</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides additional data related to performance share unit activity:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.691%"><tr><td style="width:1.0%"/><td style="width:58.652%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.283%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.347%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.283%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.347%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.288%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total compensation cost, net of estimated forfeitures, related to nonvested performance share units not yet recognized, pre-tax</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">26</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Weighted-average period over which performance share unit cost is expected to be recognized (in years)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total fair value of shares vested during the year</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Employee Retirement Savings Plans</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Substantially all of our domestic non-union employees are eligible to be enrolled in our company-sponsored contributory retirement savings plans, which include features under Section 401(k) of the Internal Revenue Code of 1986, and provide for matching and discretionary contributions by us. The total expense for our employee retirement savings plans was $55 million, $66 million and $99 million for fiscal 2021, 2020 and 2019, respectively.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -URI http://asc.fasb.org/topic&amp;trid=2228938<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140421168167160">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Schedule II - Valuations and Qualifying Accounts<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ValuationAndQualifyingAccountsAbstract', window );"><strong>SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock', window );">SEC Schedule, 12-09, Schedule of Valuation and Qualifying Accounts Disclosure [Text Block]</a></td>
<td class="text"><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:14pt;font-weight:700;line-height:120%">Cardinal Health, Inc. and Subsidiaries</span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#ff0000;font-family:'Arial Narrow',sans-serif;font-size:13pt;font-weight:700;line-height:120%">Schedule&#160;II - Valuation and Qualifying Accounts</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:27.471%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.036%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.441%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.441%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.441%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.594%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance&#160;at<br/>Beginning of Period</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Charged&#160;to Costs<br/>and Expenses (1)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Charged&#160;to<br/>Other Accounts&#160;(2)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Deductions&#160;(3)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance&#160;at<br/>End of Period</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fiscal 2021</span></td><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">206</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">129</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(94)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">242</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Finance notes receivable</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">27</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">5</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(20)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">12</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Sales returns and allowances</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">495</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2,568</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(2,374)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">689</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">729</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2,702</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(2,488)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">944</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:3pt"><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="3" style="background-color:#cccccc;border-top:1.5pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cccccc;border-top:1.5pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cccccc;border-top:1.5pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cccccc;border-top:1.5pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cccccc;border-top:1.5pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cccccc;border-top:1.5pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cccccc;border-top:1.5pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cccccc;border-top:1.5pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cccccc;border-top:1.5pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Fiscal 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">193&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">139&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(127)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">206&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Finance notes receivable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Sales returns and allowances</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">479&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,253&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(2,237)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">495&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">687&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,407&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(2,366)</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">729&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:3pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Fiscal 2019</span></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">139&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">140&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(87)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">193&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Finance notes receivable</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Sales returns and allowances</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">479&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,205&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(2,205)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">479&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">626&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,353&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(2,293)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">687&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:10pt">Fiscal 2021, 2020 and 2019 include $70 million, $49 million and $60 million, respectively, for reserves related to service charges and customer pricing disputes, excluded from provision for bad debts on the consolidated statements of cash flows and classified as a reduction in revenue in the consolidated statements of earnings/(loss).</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:10pt">Recoveries of amounts provided for or written off in prior years was $1 million in each fiscal year 2021, 2020 and 2019.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:10pt">Write-off of uncollectible accounts or actual sales returns.</span></div>The sum of the components may not equal the total due to rounding.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for valuation and qualifying accounts and reserves.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 12<br> -Subsection 09<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.12-09)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24092-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>srt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ValuationAndQualifyingAccountsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ValuationAndQualifyingAccountsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>srt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140421173408392">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basis of Presentation and Summary of Significant Accounting Policies (Policies)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock', window );">Basis of Presentation</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Basis of Presentation</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our consolidated financial statements include the accounts of all majority-owned or controlled subsidiaries, and all significant intercompany transactions and amounts have been eliminated. The results of businesses acquired or disposed of are included in the consolidated financial statements from the date of the acquisition or up to the date of disposal, respectively.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use of Estimates</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our consolidated financial statements are prepared in accordance with accounting principles generally accepted in the United States (&#8220;GAAP&#8221;). The preparation of financial statements in accordance with GAAP requires us to make estimates, judgments and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes. Estimates, judgments and assumptions are used in the accounting and disclosure related to, among other items, allowance for doubtful accounts, inventory valuation and reserves, goodwill and other intangible asset impairment, loss contingencies (including product liability and self-insurance accruals), and income taxes. Actual amounts could ultimately differ from these estimated amounts.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The COVID-19 pandemic ("COVID-19") continues to affect the U.S. and global economies, and as previously disclosed, the pandemic began to materially affect our businesses during the third quarter of fiscal 2020. The length and severity of the pandemic and its impacts on our businesses and results of operations are uncertain.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock', window );">Cash Equivalents</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Cash Equivalents</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We consider liquid investments purchased with an initial maturity of three months or less to be cash equivalents. The carrying value of cash equivalents approximates fair value.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReceivablesPolicyTextBlock', window );">Receivables</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Receivables and Allowance for Doubtful Accounts</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Trade receivables are presented net of an allowance for doubtful accounts of $242 million and $206 million at June&#160;30, 2021 and 2020, respectively. An account is considered past due on the first </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">day after its due date. In accordance with contract terms, we generally have the ability to charge customers service fees or higher prices if an account is considered past due. We regularly monitor past due accounts and establish appropriate reserves to cover potential losses, and consider historical experience, the current economic environment, customer credit ratings or bankruptcies, and reasonable and supportable forecasts to develop our allowance for credit losses. We review these factors quarterly to determine if any adjustments are needed to the allowance. We write off any amounts deemed uncollectible against the established allowance for doubtful accounts.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We provide financing to various customers. Such financing arrangements range from 1 year&#160;to 5 years at interest rates that are generally subject to fluctuation. Interest income on these arrangements is recognized as it is earned. The financings may be collateralized, guaranteed by third parties or unsecured. Finance notes, net and related accrued interest were $63 million (current portion $7 million) and $104 million (current portion $12 million) at June&#160;30, 2021 and 2020, respectively, and are included in other assets (current portion is included in prepaid expenses and other) in the consolidated balance sheets. Finance notes receivable allowance for doubtful accounts were $12 million and $27 million at June&#160;30, 2021 and 2020, respectively. We estimate an allowance for these financing receivables based on historical collection rates and the credit worthiness of the customer. We write off any amounts deemed uncollectible against the established allowance for doubtful accounts.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskCreditRisk', window );">Concentrations of Credit Risk</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Concentrations of Credit Risk</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We maintain cash depository accounts with major banks, and we invest in high quality, short-term liquid instruments, and in marketable securities. Our short-term liquid instruments mature within three months and we have not historically incurred any related losses.</span></div>Our trade receivables and finance notes and related accrued interest are exposed to a concentration of credit risk with certain large customers and with customers in the retail and healthcare sectors. Credit risk can be affected by changes in reimbursement and other economic pressures impacting the healthcare industry. With respect to customers in the retail and healthcare sectors, such credit risk is limited due to supporting collateral and the diversity of the customer base, including its wide geographic dispersion. We perform regular credit evaluations of our customers&#8217; financial conditions and maintain reserves for losses through the established allowance for doubtful accounts. Historically, such losses have been within our expectations. Refer to the "Receivables and Allowance for Doubtful Accounts" section within this Note for additional information on the accounting treatment of reserves for allowance for doubtful accounts.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MajorCustomersPolicyPolicyTextBlock', window );">Major Customers</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Major Customers</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CVS Health Corporation ("CVS") and OptumRx, are our only customers that individually account for at least 10 percent of revenue and gross trade receivables. These customers are primarily serviced through our Pharmaceutical segment.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2021, we extended our pharmaceutical distribution agreements with CVS through June 2027. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes historical percent of revenue and gross trade receivables from CVS and OptumRx:</span></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.382%"><tr><td style="width:1.0%"/><td style="width:35.235%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.148%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.352%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.769%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.352%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.769%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.352%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.632%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.352%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.639%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Percent of Revenue</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Percent&#160;of&#160;Gross Trade&#160;Receivables at June 30</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CVS</span></td><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">26</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">24</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">OptumRx</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">15</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">3</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr></table></div>We have entered into agreements with group purchasing organizations (&#8220;GPOs&#8221;) which act as purchasing agents that negotiate vendor contracts on behalf of their members. Vizient, Inc. and Premier, Inc. are our two largest GPO member relationships in terms of revenue. Sales to members of these two GPOs collectively accounted for 15 percent, 16 percent and 22 percent of revenue for fiscal 2021, 2020 and 2019, respectively. Our trade receivable balances are with individual members of the GPO, and therefore no significant concentration of credit risk exists with these types of arrangements<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryPolicyTextBlock', window );">Inventories</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Inventories</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A portion of our inventories (50 percent and 56 percent at June&#160;30, 2021 and 2020, respectively) are valued at the lower of cost, using the last-in, first-out ("LIFO") method, or market. These inventories are included within the core pharmaceutical distribution facilities of our Pharmaceutical segment (&#8220;distribution facilities&#8221;) and are primarily merchandise inventories. The LIFO method presumes that the most recent inventory purchases are the first items sold, so LIFO helps us better match current costs and revenue. We believe that the average cost method of inventory valuation provides a reasonable approximation of the current cost of replacing inventory within the distribution facilities. As such, the LIFO reserve is the difference between (a) inventory at the lower of LIFO cost or market and (b) inventory at replacement cost determined using the average cost method of inventory valuation.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At June&#160;30, 2021 and 2020, respectively, inventories valued at LIFO cost were $565 million and</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$411 million higher than the average cost value. We do not record inventories in excess of replacement cost. As such, we did not write-up the value of our inventory from average cost to LIFO cost at June&#160;30, 2021 or 2020. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our remaining inventory, including inventory in our Medical segment, that is not valued at the lower of LIFO cost or market is stated at the lower of cost, using the first-in, first-out method, or net realizable value. Net realizable value is defined as the estimated selling prices and estimated sales demand in the ordinary course of business, less reasonably predictable costs of completion, disposal and transportation. Due to the unprecedented demand for </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">certain personal protective equipment as a result of COVID-19, our Medical segment manufactured and sourced inventory at higher costs than in periods prior to COVID-19. Personal protective equipment ("PPE") refers to protective clothing, medical and non-medical grade gloves, face shields, face masks and other equipment designed to protect the wearer from injury or the spread of infection or illness. As selling prices and customer demand have decreased compared to the peak of COVID-19, we recorded a reserve of $197&#160;million, primarily related to certain categories of gloves, to reduce the carrying value of certain PPE to its net realizable value.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We reserve for inventory obsolescence using estimates based on historical experience, historical and projected sales trends, specific&#160;categories of inventory, age and expiration dates of on-hand inventory and manufacturer return policies. Inventories presented in the consolidated balance sheets are net of reserves for excess and obsolete inventory which were $185 million and $155 million at June&#160;30, 2021 and 2020, respectively.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_CashDiscountsPolicyTextBlock', window );">Cash Discounts</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Cash Discounts</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Manufacturer cash discounts are recorded as a component of inventory cost and recognized as a reduction of cost of products sold as inventory is sold.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock', window );">Property and Equipment</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Property and Equipment</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Property and equipment are carried at cost less accumulated depreciation. Property and equipment held for sale are recorded at the lower of cost less accumulated depreciation before the decision to dispose of the asset was made or fair value less cost to sell. When certain events or changes in operating conditions occur, an impairment assessment may be performed on the recoverability of the carrying amounts.</span></div><div style="margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Depreciation expense is computed using the straight-line method over the estimated useful lives of the assets, including finance lease assets which are depreciated over the terms of their respective leases. We generally use the following range of useful lives for our property and equipment categories: buildings and improvements&#8212;3 to 39 years; machinery and equipment&#8212;3 to 20 years; and furniture and fixtures&#8212;3 to 7 years. We recorded depreciation and amortization expense of $377 million, $405 million and $455 million for fiscal 2021, 2020 and 2019, respectively.</span></div><div style="margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the components of property and equipment, net at June&#160;30:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:62.788%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.183%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.343%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.186%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Land, building and improvements</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2,359</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,185&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Machinery and equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">3,093</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,008&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Furniture and fixtures</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">136</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">138&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total property and equipment, at cost</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">5,588</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5,331&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accumulated depreciation and amortization</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(3,228)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(2,965)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Property and equipment, net</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2,360</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,366&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Repairs and maintenance expenditures are expensed as incurred. Interest on long-term projects is capitalized using a rate that approximates the weighted-average interest rate on long-term </span></div>obligations, which was 3 percent at June&#160;30, 2021. The amount of capitalized interest was immaterial for all periods presented.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock', window );">Goodwill and Other Intangible Assets</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Goodwill and Other Intangible Assets</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Purchased goodwill and intangible assets with indefinite lives are not amortized, but instead are tested for impairment annually or when indicators of impairment exist.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Purchased goodwill is tested for impairment at least annually. Qualitative factors are first assessed to determine if it is more likely than not that the fair value of a reporting unit is less than its carrying amount. There is an option to bypass the qualitative assessment for any reporting unit in any period and proceed directly to performing the quantitative goodwill impairment test. We have elected to bypass the qualitative assessment for our annual goodwill impairment test in the current year. The quantitative goodwill impairment test involves a comparison of the estimated fair value of the reporting unit to the respective carrying amount. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Goodwill impairment testing involves judgment, including the identification of reporting units, qualitative evaluation of events and circumstances to determine if it is more likely than not that an impairment exists, and, if necessary, the estimation of the fair value of the applicable reporting unit. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have two operating segments, which are the same as our reportable segments: Pharmaceutical and Medical. These operating segments are comprised of divisions (components), for which discrete financial information is available. Components are aggregated into reporting units for purposes of goodwill impairment testing to the extent that they share similar economic characteristics. Our reporting units are: Pharmaceutical operating segment (excluding our Nuclear and Precision Health Solutions division); Nuclear and Precision Health Solutions division; Medical operating segment (excluding our Cardinal Health at-Home Solutions division) (&#8220;Medical Unit&#8221;); and Cardinal Health at-Home Solutions division.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fair value can be determined using market, income or cost-based approaches. Our determination of estimated fair value of the reporting units is based on a combination of the income-based and market-based approaches. Under the income-based approach, we use a discounted cash flow model in which cash flows anticipated over several future periods, plus a terminal value at the end of that time horizon, are discounted to their present value using an appropriate risk-adjusted rate of return.&#160;We use our internal forecasts to estimate future cash flows, which we believe are consistent with those of a market participant, and include an estimate of long-term growth rates based on our most recent views of the long-term outlook for each reporting unit. Actual results may differ materially from those used in our forecasts. We use discount rates that are commensurate with the risks and uncertainty inherent in the respective reporting units and in our internally-developed forecasts. Discount rates used in our reporting unit valuations ranged from 8.5 percent to 11.5 percent. Under the market-based guideline public company method, we determine fair value by comparing our reporting units to similar businesses or guideline companies whose securities are actively traded in public markets. We also use the guideline transaction method to </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">determine fair value based on pricing multiples derived from the sale of companies that are similar to our reporting units. To further confirm fair value, we compare the aggregate fair value of our reporting units to our total market capitalization.&#160;Estimating the fair value of reporting units requires the use of estimates and significant judgments that are based on a number of factors including forecasted operating results. The use of alternate estimates and assumptions or changes in the industry or peer groups could materially affect the determination of fair value for each reporting unit and potentially result in goodwill impairment.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We performed annual impairment testing in fiscal 2021, 2020 and 2019 and concluded that there were no impairments of goodwill as the estimated fair value of each reporting unit exceeded its carrying value.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The impairment test for indefinite-lived intangibles other than goodwill involves first assessing qualitative factors to determine if it is more likely than not that the fair value of the indefinite-lived intangible asset is less than its carrying amount. If so, then a quantitative test is performed to compare the estimated fair value of the indefinite-lived intangible asset to the respective asset's carrying amount. Our qualitative evaluation requires the use of estimates and significant judgments and considers the weight of evidence and significance of all identified events and circumstances and most relevant drivers of fair value, both positive and negative, in determining whether it is more likely than not that the fair value of the indefinite-lived intangible asset is less than its carrying amount.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intangible assets with finite lives, primarily customer relationships; trademarks, trade names and patents; and developed technology, are amortized using a combination of straight-line and accelerated methods based on the expected cash flows from the asset over their estimated useful lives. We review intangible assets with finite lives for impairment whenever events or changes in circumstances indicate that the related carrying amounts may not be recoverable. Determining whether an impairment loss occurred requires a comparison of the carrying amount to the sum of the future forecasted undiscounted cash flows expected to be generated by the asset group. Actual results may differ materially from those used in our forecasts.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_AssetsHeldforSalePolicyPolicyTextBlock', window );">Assets Held for Sale, Policy [Policy Text Block]</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Assets Held for Sale</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We classify assets and liabilities (the &#8220;disposal group&#8221;) as held for sale when management commits to a plan to sell the disposal group in its present condition and at a price that is reasonable in relation to its current fair value. We also consider whether an active program to locate a buyer has been initiated and if it is probable that the sale will occur within one year without significant changes to the plan to sell. Upon classification of the disposal group as held for sale, we test the assets for impairment and cease related depreciation and amortization.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 12, 2021, we announced that we signed a definitive agreement to sell our Cordis business to Hellman &amp; Friedman for proceeds of $927 million in cash, subject to customary purchase price adjustments, and we retained certain working capital accounts and certain liabilities, including product liability for </span></div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">lawsuits related to inferior vena cava filters in the U.S. and Canada as described in </span><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i4f0ec56b9c604f1782a65ea4a19c284d_130" style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Note 7</a></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of the &#8220;Notes to Consolidated Financial Statements.&#8221; The transaction closed on August 2, 2021. See </span><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i4f0ec56b9c604f1782a65ea4a19c284d_106" style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Note 2</a></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for additional information.</span><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentPolicyTextBlock', window );">Investments</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Investments</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Investments in non-marketable equity securities are accounted for under the fair value, equity or net asset value method of&#160;accounting and are included in other assets in the consolidated balance sheets. For equity securities without a readily determinable fair value, we use the fair value measurement alternative and measure the securities at cost less impairment, if any, including adjustments for observable price changes in orderly transactions for an identical or similar investment of the same issuer. For investments in which we can exercise significant influence but do not control, we use the equity method of accounting. Our share of the earnings and losses are recorded in other (income)/expense, net in the consolidated statements of earnings/(loss). We monitor our investments for impairment&#160;by considering factors such as the operating performance of the investment and current economic and market conditions.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_CostofSalesVendorReservesPolicyPolicyTextBlock', window );">Vendor Reserves</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Vendor Reserves</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the ordinary course of business, our vendors may dispute deductions taken against payments otherwise due to them or assert other disputes. These disputes are researched and resolved based upon the findings of the research performed. At any given time, there are outstanding items in various stages of research and resolution. In determining appropriate reserves for areas of exposure with our vendors, we assess historical experience and current outstanding claims. We have established various levels of reserves based on the type of claim and status of review. Though the claim types are relatively consistent, we periodically refine our methodology by updating the reserve estimate percentages to reflect actual historical experience. The ultimate outcome of certain claims may be different than our original estimate and may require an adjustment. Adjustments to vendor reserves are included in cost of products sold. In addition, the reserve balance will fluctuate due to variations of outstanding claims from period-to-period, timing of settlements and specific vendor issues, such as bankruptcies. Vendor reserves were $77 million at both June&#160;30, 2021 and 2020, excluding third-party returns. See Third-Party Returns section within this Note for a description of third-party returns.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_DistributionServiceAgreementAndOtherVendorFeesPolicyTextBlock', window );">Distribution Service Agreement and Other Vendor Fees</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Distribution Services Agreement and Other Vendor Fees</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Pharmaceutical segment recognizes fees received from distribution services agreements and other fees received from vendors related to the purchase or distribution of the vendors&#8217; inventory when those fees have been earned and we are entitled to payment. Since the benefit provided to a vendor is related to the purchase and distribution of the vendor&#8217;s inventory, we recognize the fees as a reduction in the carrying value of the inventory that generated the fees, and as such, a reduction of cost of products sold in our consolidated statements of earnings/(loss) when the inventory is sold.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesPolicyTextBlock', window );">Loss Contingencies</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Loss Contingencies and Self-Insurance</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Loss Contingencies</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We accrue for contingencies related to disputes, litigation and regulatory matters if it is probable that a liability has been incurred and the amount of the loss can be reasonably estimated. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the opioid litigation as described further in the </span><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i4f0ec56b9c604f1782a65ea4a19c284d_130" style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Note 7</a></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, we recorded pre-tax charges of&#160;$1.17 billion and $5.63 billion during fiscal 2021 and 2020 respectively which were retained at Corporate. In July 2021, we announced that we and two other national distributors have negotiated a proposed settlement agreement, subject to certain conditions and contingencies. There is no assurance that the contingencies to the proposed settlement agreement will be satisfied. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We develop and periodically update reserve estimates for the Cordis inferior vena cava ("Cordis IVC") claims, including those received to date and expected to be received in the future and related costs. To project future Cordis IVC claim costs, we use a methodology based largely on recent experience, including claim filing rates, estimated indemnity severity by claim type, sales data, implant and injury to report lag patterns and estimated defense costs.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Self-Insurance</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also self-insure for employee healthcare, general liability, certain product liability matters, auto liability, property and workers' compensation. Self-insurance accruals include an estimate for expected settlements or pending claims, defense costs, administrative fees, claim adjustment costs and an estimate for claims incurred but not reported. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Because these matters are inherently unpredictable and unfavorable developments or resolutions can occur, assessing contingencies and other liabilities is highly subjective and requires judgments about future&#160;events. We regularly review contingencies and our self-insurance accruals to determine whether our accruals and related disclosures are adequate. Any adjustments for changes in reserves are recorded in the period in which the change in estimate occurs.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The amount of ultimate loss may differ materially from these estimates. We recognize these estimated loss contingencies, income from favorable resolution of litigation and certain defense costs in litigation (recoveries)/charges in our consolidated statements of earnings/(loss). See </span><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i4f0ec56b9c604f1782a65ea4a19c284d_130" style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Note 7</a></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for additional information regarding loss contingencies and product liability lawsuits.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxPolicyTextBlock', window );">Income Taxes</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Income Taxes</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We account for income taxes using the asset and liability method. Deferred tax assets and liabilities are measured using enacted tax rates in the respective jurisdictions in which we operate. We assess the realizability of deferred tax assets on a quarterly basis and provide a valuation allowance for deferred tax assets when it is more likely than not that at least a portion of the deferred tax assets will not be realized. The realizability of deferred tax assets depends on our ability to generate sufficient taxable income within the carryback or carryforward periods provided for in the tax law for each applicable tax jurisdiction and also considers all available positive and negative evidence.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deferred taxes for non-U.S. liabilities are not provided on the unremitted earnings of subsidiaries outside of the United States&#160;when it is expected that these earnings are indefinitely reinvested.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We operate in a complex multinational tax environment and are subject to tax treaty arrangements and transfer pricing guidelines for intercompany transactions that are subject to interpretation. Uncertainty in a tax position may arise as tax laws are subject to interpretation. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Tax benefits from uncertain tax positions are recognized when it is more likely than not that the position will be sustained upon examination of the technical merits of the position, including resolutions of any related appeals or litigation processes. The amount recognized is measured as the largest amount of tax benefit that is greater than 50 percent likely of being realized upon settlement. For tax benefits that do not qualify for recognition, we recognize a liability for unrecognized tax benefits. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See </span><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i4f0ec56b9c604f1782a65ea4a19c284d_133" style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Note 8</a></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for additional information regarding income taxes.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_OtherAccruedLiabilitiesPolicyPolicyTextBlock', window );">Other Accrued Liabilities, Policy [Policy Text Block]</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Other Accrued Liabilities</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other accrued liabilities represent various current obligations, including certain accrued operating expenses and taxes payable.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConsolidationPolicyTextBlock', window );">Noncontrolling Interests and Redeemable Noncontrolling Interests</a></td>
<td class="text">Noncontrolling InterestsNoncontrolling interests represent the portion of net earnings, comprehensive income and net assets that is not attributable to Cardinal Health, Inc.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy', window );">Share-Based Compensation</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Share-Based Compensation</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Share-based compensation provided to employees is recognized in the consolidated statements of earnings/(loss) based on the grant date fair value of the awards. The fair value of restricted share units and performance share units is determined by the grant date market price of our common shares. The fair value of stock options is determined on the grant date using a lattice valuation model. The compensation expense associated with nonvested performance share units is dependent on our periodic assessment of the probability of the targets being achieved and our estimate, which may vary over time, of the number of shares that ultimately will be issued. The compensation expense recognized for share-based awards is net of estimated forfeitures and is recognized ratably over the service period of the awards. All income tax effects of share-based awards are recognized in the consolidated statements of earnings/(loss) as awards vest or are settled. We classify share-based compensation expense in distribution, selling, general and administrative ("SG&amp;A") expenses to correspond with the same line item as the majority of the cash compensation paid to employees. If awards are modified in connection with a restructuring activity, the incremental share-based compensation expense is classified in restructuring and employee severance. See </span><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i4f0ec56b9c604f1782a65ea4a19c284d_160" style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Note 14</a></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for additional information regarding share-based compensation.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_DividendsPolicyPolicyTextBlock', window );">Dividends, Policy [Policy Text Block]</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Dividends</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We paid cash dividends per common share of $1.94, $1.92 and $1.91 in fiscal 2021, 2020 and 2019, respectively.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRecognitionPolicyTextBlock', window );">Revenue Recognition</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Revenue Recognition</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recognize revenue in an amount that reflects the consideration to which we expect to be entitled in exchange for the transfer of goods or services to customers.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue in both segments is primarily related to the distribution of pharmaceutical and medical products, which include both manufactured and sourced products, and we recognize at a point in time when title transfers to customers and we have no further obligation to provide services related to such merchandise. Service revenues are recognized over the period that services are provided to the customer. Revenues derived from services are not material for either segment for all periods presented.</span></div>We are generally the principal in a transaction, therefore our revenue is primarily recorded on a gross basis. When we are a principal in a transaction, we have determined that we control the ability to direct the use of the product or service prior to transfer to a customer, are primarily responsible for fulfilling the promise to provide the product or service to our customer, have discretion in establishing prices, and ultimately control the transfer of the product or services provided to the customer.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_SalesreturnsPolicyTextBlock', window );">Sales Returns and Allowances</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Sales Returns and Allowances</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue is recorded net of sales returns and allowances. Revenues are measured based on the amount of consideration that we expect to receive, reduced by estimates for return allowances, discounts, rebates and other variable consideration. Sales returns are recorded based on estimates using historical </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">data. Our customer return policies generally require that the product be physically returned, subject to restocking fees. We only allow customers to return products for credit in a condition suitable to be added back to inventory and resold at full value (&#8220;merchantable product&#8221;) or returned to vendors for credit. Product returns are generally consistent throughout the year and typically are not specific to any particular product or customer.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We accrue for estimated sales returns and allowances at the time of sale based upon historical customer return trends, margin rates and processing costs. Our accrual for sales returns is reflected as a reduction of revenue and cost of products sold for the sales price and cost, respectively. At June&#160;30, 2021 and 2020, the accrual for estimated sales returns and allowances was $689 million and $495 million, respectively, which is reflected in trade receivables, net and inventories, net in the consolidated balance sheets. Sales returns and allowances were $2.6 billion, $2.3 billion and $2.2 billion, for fiscal 2021, 2020 and 2019, respectively, and the net impact on net earnings/(loss) in the consolidated statements of earnings/(loss) was immaterial in fiscal 2021, 2020 and 2019. </span></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Third-Party Returns</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We generally do not accept non-merchantable pharmaceutical product returns from our customers, so many of our customers return non-merchantable pharmaceutical products to the manufacturer through third parties. Since our customers generally do not have a direct relationship with manufacturers, our vendors pass the value of such returns to us (usually in the form of an accounts payable deduction). We, in turn, pass the value received to our customer. In certain instances, we pass the estimated value of the return to our customer prior to our receipt of the value from the vendor. Although we believe we have satisfactory protections, we could be subject to claims from customers or vendors if our administration of this overall process was deficient in some respect or our contractual terms with vendors are in conflict with our contractual terms with our customers. We have maintained reserves for some of these situations based on their nature and our historical experience with their resolution.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_ShippingandHandlingCostsPolicyTextBlock', window );">Shipping and Handling</a></td>
<td class="text">Shipping and HandlingShipping and handling costs are primarily included in SG&amp;A expenses in our consolidated statements of earnings/(loss) and include all delivery expenses as well as all costs to prepare the product for shipment to the end customer. Shipping and handling costs were $634 million, $620 million and $622 million, for fiscal 2021, 2020 and 2019, respectively.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock', window );">Restructuring and Employee Severance</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Restructuring and Employee Severance</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Restructuring activities are programs that are not part of the ongoing operations of our underlying business, such as divestitures, closing and consolidating facilities, changing the way we manufacture or distribute our products, moving manufacturing of a product to another location, changes in production or business process outsourcing or insourcing, employee severance (including rationalizing headcount or other significant changes in personnel) and realigning operations (including realignment of the management structure in response to changing market conditions). Also included within restructuring and employee severance are </span></div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">employee severance costs that are not incurred in connection with a restructuring activity. See </span><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i4f0ec56b9c604f1782a65ea4a19c284d_109" style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Note 3</a></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for additional information regarding our restructuring activities.</span><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_AmortizationandOtherAcquisitionRelatedCostsPolicyPolicyTextBlock', window );">Amortization and Other Acquisition-Related Costs</a></td>
<td class="text">Amortization and Other Acquisition-Related Costs<span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We classify certain costs incurred in connection with acquisitions as amortization and other acquisition-related costs in our consolidated statements of earnings/(loss). These costs consist of amortization of acquisition-related intangible assets, transaction costs, integration costs and changes in the fair value of contingent consideration obligations. Transaction costs are incurred during the initial evaluation of a potential acquisition and primarily relate to costs to analyze, negotiate and consummate the transaction as well as due diligence activities. Integration costs relate to activities required to combine the operations of an acquired enterprise into our operations and, in the case of the Cordis and Patient Recovery businesses, to stand-up the systems and processes needed to support an expanded geographic footprint. We record changes in the fair value of contingent consideration obligations relating to acquisitions as income or expense in amortization and other acquisition-related costs. See </span><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i4f0ec56b9c604f1782a65ea4a19c284d_112" style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Note 4</a></span> for additional information regarding amortization of acquisition-related intangible assets.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock', window );">Translation of Foreign Currencies</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Translation of Foreign Currencies</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial statements of our subsidiaries outside the United States&#160;are generally measured using the local currency as the functional currency. Adjustments to translate the assets and liabilities of these foreign subsidiaries into U.S.&#160;dollars are accumulated in shareholders&#8217; equity through accumulated and other comprehensive loss ("AOCI") utilizing period-end exchange rates. Revenues and expenses of these foreign subsidiaries are translated using average exchange rates during the year.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The foreign currency translation gains/(losses) included in AOCI at June&#160;30, 2021 and 2020 are presented in </span><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i4f0ec56b9c604f1782a65ea4a19c284d_145" style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Note 11</a></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Foreign currency transaction gains and losses for the period are included in the consolidated statements of earnings/(loss) in the respective financial statement line item.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesMethodsOfAccountingHedgingDerivatives', window );">Interest Rate, Currency and Commodity Risk</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Interest Rate, Currency and Commodity Risk</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All derivative instruments are recognized at fair value on the consolidated balance sheets and all changes in fair value are recognized in net earnings or shareholders&#8217; equity through AOCI, net of tax.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For contracts that qualify for hedge accounting treatment, the hedge contracts must be effective at reducing the risk associated with the exposure being hedged and must be designated as a hedge at the inception of the contract. Hedge effectiveness is assessed periodically. Any contract not designated as a hedge, or so designated but ineffective, is adjusted to fair value and recognized immediately in net earnings. If a fair value or cash flow hedge ceases to qualify for hedge accounting treatment, the contract continues to be carried on the balance sheet at fair value until settled and future adjustments to the contract&#8217;s fair value are recognized immediately in net earnings. If a forecasted transaction is probable not to occur, amounts previously deferred in AOCI are recognized immediately in net earnings. Interest payments </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">received from the cross currency swap are excluded from the net investment hedge effectiveness assessment and are recorded in interest expense, net in the consolidated statements of earnings/(loss).</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See </span><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i4f0ec56b9c604f1782a65ea4a19c284d_139" style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Note 10</a></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for additional information regarding our derivative instruments, including the accounting treatment for instruments designated as fair value, cash flow, net investment and economic hedges.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementPolicyPolicyTextBlock', window );">Fair Value Measurements</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Fair Value Measurements</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fair value is defined as the price that would be received upon selling an asset or the price paid to transfer a liability on the measurement date. It focuses on the exit price in the principal or most advantageous market for the asset or liability in an orderly transaction between willing market participants. A three-tier fair value hierarchy is established as a basis for considering such assumptions and for inputs used in the valuation methodologies in measuring fair value. This hierarchy requires entities to maximize the use of observable inputs and minimize the use of unobservable inputs. The three levels of inputs used to measure fair values are:</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 1 -&#160;&#160;&#160;&#160;Observable prices in active markets for identical assets and liabilities.</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 2 -&#160;&#160;&#160;&#160;Observable inputs other than quoted prices in active markets for identical assets and liabilities.</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 3 -&#160;&#160;&#160;&#160;Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets and liabilities.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See </span><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i4f0ec56b9c604f1782a65ea4a19c284d_136" style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Note 9</a></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for additional information regarding fair value measurements.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">Recent Financial Accounting Standards</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Recently Adopted Financial Accounting Standards</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financial Instruments - Credit Losses</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2016, the Financial Accounting Standards Board ("FASB") issued amended accounting guidance that will require entities to measure credit losses on trade and other receivables, held-to-maturity debt securities, loans and other instruments using an "expected credit loss" model that considers historical experience, current conditions and reasonable supportable forecasts. This guidance also requires that credit losses on available-for-sale debt securities with unrealized losses be recognized as allowances rather than as deductions in the amortized cost of the securities. We consider historical experience, the current economic environment, customer credit ratings or bankruptcies, and reasonable and supportable forecasts to develop our allowance for credit losses. We review these factors quarterly to determine if any adjustments are needed to the allowance. This guidance was effective beginning the first quarter of fiscal 2021 and did not have a material impact on our consolidated financial statements.</span></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Recently Issued Financial Accounting Standards Not Yet Adopted</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We address the adoption impacts of recently issued accounting standards by the FASB on the our consolidated financial statements as well as material updates to previous assessments, if any, from our fiscal 2020 Form 10-K. There were no accounting </span></div>standards issued in fiscal 2021 that will have a material impact on our consolidated financial statements.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GuaranteesIndemnificationsAndWarrantiesPolicies', window );">Guarantees, Indemnifications and Warranties Policies [Policy Text Block]</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Guarantees</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the ordinary course of business, we agree to indemnify certain other parties under acquisition and disposition agreements, customer agreements, intellectual property licensing agreements, and other agreements. Such indemnification obligations vary in scope and, when defined, in duration. In many cases, a maximum obligation is not explicitly stated, and therefore the overall maximum amount of the liability under such indemnification obligations cannot be reasonably estimated. Where appropriate, such indemnification obligations are recorded as a liability. Historically, we have not, individually or in the aggregate, made </span></div>payments under these indemnification obligations in any material amounts. In certain circumstances, we believe that existing insurance arrangements, subject to the general deduction and exclusion provisions, would cover portions of the liability that may arise from these indemnification obligations. In addition, we believe that the likelihood of a material liability being triggered under these indemnification obligations is not probable.From time to time we enter into agreements that obligate us to make fixed payments upon the occurrence of certain events. Such obligations primarily relate to obligations arising under acquisition transactions, where we have agreed to make payments based upon the achievement of certain financial performance measures by the acquired business. Generally, the obligation is capped at an explicit amount. There were no material obligations at June&#160;30, 2021.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_AmortizationandOtherAcquisitionRelatedCostsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the costs incurred during and relating to an acquisition. These costs specifically include transaction and integration costs; changes in fair value of contingent consideration obligations and amortization of acquisition-related intangible assets, and are recorded within amortization and other acquisition-related costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_AmortizationandOtherAcquisitionRelatedCostsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_AssetsHeldforSalePolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Assets Held for Sale, Policy [Policy Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_AssetsHeldforSalePolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_CashDiscountsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cash Discounts [Policy Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_CashDiscountsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_CostofSalesVendorReservesPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for allowances received from a vendor. The disclosure differentiates between those allowances that are recorded as a reduction in the price of the vendors' products or services (that is, the entity's inventory) and which ultimately will be recorded as a reduction in the entity's cost of sales and those that are not.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_CostofSalesVendorReservesPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_DistributionServiceAgreementAndOtherVendorFeesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Describes an entity's accounting policy for fees received from distribution service agreements and other fees received from vendors related to the purchase or distribution of the vendor's inventory. Such fees are recognized as a reduction of inventory when those fees have been earned and the entity is entitled to payment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_DistributionServiceAgreementAndOtherVendorFeesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_DividendsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Dividends, Policy [Policy Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_DividendsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_OtherAccruedLiabilitiesPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Other Accrued Liabilities, Policy [Policy Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_OtherAccruedLiabilitiesPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_SalesreturnsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>sales returns [Policy Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_SalesreturnsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_ShippingandHandlingCostsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>ShippingandHandlingCosts [Policy Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_ShippingandHandlingCostsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfAccountingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4273-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for commitments and contingencies, which may include policies for recognizing and measuring loss and gain contingencies.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123368208&amp;loc=d3e12565-110249<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 450<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6491354&amp;loc=d3e6049-115624<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskCreditRisk">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for credit risk.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 825<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123345438&amp;loc=d3e61044-112788<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskCreditRisk</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConsolidationPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting.  The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123372394&amp;loc=d3e18823-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=d3e5614-111684<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConsolidationPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for recognizing and reporting costs associated with exiting, disposing of, and restructuring certain operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140864-122747<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.P.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140864-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativesMethodsOfAccountingHedgingDerivatives">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for derivatives used in hedging relationships, which may include how gains or losses are recognized and presented in the financial statements, and amortization policies for deferred amounts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4EEEE<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL109999725-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativesMethodsOfAccountingHedgingDerivatives</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for fair value measurements of financial and non-financial assets, liabilities and instruments classified in shareholders' equity. Disclosures include, but are not limited to, how an entity that manages a group of financial assets and liabilities on the basis of its net exposure measures the fair value of those assets and liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -URI http://asc.fasb.org/topic&amp;trid=2175825<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for goodwill and intangible assets. This accounting policy also may address how an entity assesses and measures impairment of goodwill and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GuaranteesIndemnificationsAndWarrantiesPolicies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for guarantees, indemnifications and product warranties, and methodologies used in determining the amount of such liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123368208&amp;loc=d3e12565-110249<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GuaranteesIndemnificationsAndWarrantiesPolicies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e32247-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32847-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32840-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL116659661-227067<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e32280-109318<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32809-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of inventory accounting policy for inventory classes, including, but not limited to, basis for determining inventory amounts, methods by which amounts are added and removed from inventory classes, loss recognition on impairment of inventories, and situations in which inventories are stated above cost.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=116847112&amp;loc=d3e4556-108314<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6361739&amp;loc=d3e7789-107766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 912<br> -SubTopic 330<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6471895&amp;loc=d3e55923-109411<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=116847112&amp;loc=d3e4492-108314<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 270<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124437754&amp;loc=d3e543-108305<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -URI http://asc.fasb.org/topic&amp;trid=2126998<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123372394&amp;loc=d3e18823-107790<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for investment in financial asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(3)(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MajorCustomersPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for major customers. Major customers are those that the loss of such customers would have a material adverse effect on the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6404-108592<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6327-108592<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6351-108592<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MajorCustomersPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120429125&amp;loc=d3e99779-112916<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.13(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=120429125&amp;loc=d3e99893-112916<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReceivablesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for receivable. Includes, but is not limited to, accounts receivable and financing receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=d3e5033-111524<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=84159169&amp;loc=d3e10178-111534<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=84159169&amp;loc=d3e10149-111534<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=84159169&amp;loc=d3e10133-111534<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReceivablesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRecognitionPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for revenue. Includes revenue from contract with customer and from other sources.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123372394&amp;loc=d3e18823-107790<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123372394&amp;loc=d3e18823-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRecognitionPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b),(f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6191-108592<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6161-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6143-108592<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6061-108592<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6132-108592<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140421171364728">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basis of Presentation and Summary of Significant Accounting Policies (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock', window );">Schedule of Revenue and Gross Trade Receivables Percentage by Major Customers</a></td>
<td class="text"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes historical percent of revenue and gross trade receivables from CVS and OptumRx:</span></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.382%"><tr><td style="width:1.0%"/><td style="width:35.235%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.148%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.352%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.769%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.352%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.769%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.352%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.632%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.352%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.639%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Percent of Revenue</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Percent&#160;of&#160;Gross Trade&#160;Receivables at June 30</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CVS</span></td><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">26</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">24</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">OptumRx</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">15</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">3</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentTextBlock', window );">Components of Property and Equipment</a></td>
<td class="text"><div style="margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the components of property and equipment, net at June&#160;30:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:62.788%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.183%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.343%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.186%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Land, building and improvements</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2,359</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,185&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Machinery and equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">3,093</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,008&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Furniture and fixtures</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">136</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">138&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total property and equipment, at cost</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">5,588</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5,331&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accumulated depreciation and amortization</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(3,228)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(2,965)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Property and equipment, net</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2,360</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,366&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the extent of the entity's reliance on its major customers, if revenues from transactions with a single external customer amount to 10 percent or more of entity revenues, including the disclosure of that fact, the total amount of revenues from each such customer, and the identity of the reportable segment or segments reporting the revenues. The entity need not disclose the identity of a major customer or the amount of revenues that each segment reports from that customer. For these purposes, a group of companies known to the entity to be under common control is considered a single customer, and the federal government, a state government, a local government such as a county or municipality, or a foreign government is each considered a single customer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140421168031464">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Divestitures and Acquisitions (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract', window );"><strong>Business Combination and Asset Acquisition [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock', window );">Disposal Groups, Including Discontinued Operations</a></td>
<td class="text"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents information related to the assets and liabilities that were classified as held for sale at June&#160;30, 2021 related to the Cordis divestiture in the consolidated balance sheets:</span></div><div style="margin-bottom:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:61.554%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:36.246%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cash and equivalents</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">109</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Inventories, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">164</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Property and equipment, net</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">90</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Goodwill and other intangibles, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">778</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">10</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Write-down of assets held for sale</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(60)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total assets held for sale</span></td><td style="background-color:#cccccc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1,091</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other accrued liabilities</span></td><td style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">61</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Deferred income taxes and other liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">34</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total liabilities related to assets held for sale</span></td><td style="background-color:#cccccc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">95</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationAndAssetAcquisitionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of information related to a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3A<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=SL51724579-110230<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=d3e1474-107760<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5D<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721677-107760<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3A<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721659-107760<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4B<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721665-107760<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=d3e1361-107760<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5A<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721671-107760<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4A<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721663-107760<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140421171349192">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Restructuring and Employee Severance (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringChargesAbstract', window );"><strong>Restructuring Charges [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock', window );">Summary of Restructuring and Employee Severance</a></td>
<td class="text"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables summarize restructuring and employee severance costs:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.382%"><tr><td style="width:1.0%"/><td style="width:57.595%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.632%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.352%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.632%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.352%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Employee-related costs </span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">53</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">66&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">95&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Facility exit and other costs </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">61</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">56&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total restructuring and employee severance</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">114</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">122&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">125&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock', window );">Schedule of Activity Related to Liabilities Associated with Restructuring and Employee Severance</a></td>
<td class="text"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes activity related to liabilities associated with restructuring and employee severance:</span></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.691%"><tr><td style="width:1.0%"/><td style="width:42.553%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.714%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.347%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.191%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.347%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.048%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Employee-<br/>Related Costs</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Facility Exit<br/>and Other Costs</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance at June 30, 2019</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">64&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">72</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Additions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">85&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">109</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Payments and other adjustments</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(81)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(85)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance at June 30, 2020</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">68&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">96</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Additions</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">49&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">75</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Payments and other adjustments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(64)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(28)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(92)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance at June 30, 2021</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">53</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">26</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">79</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringChargesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringChargesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of costs incurred for restructuring including, but not limited to, exit and disposal activities, remediation, implementation, integration, asset impairment, and charges against earnings from the write-down of assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 5.P.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140864-122747<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB TOPIC 5.P.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's restructuring reserve that occurred during the period associated with the exit from or disposal of business activities or restructurings for each major type of cost. This element may also include a description of any reversal and other adjustment made during the period to the amount of an accrued liability for restructuring activities. This element may be used to encapsulate the roll forward presentations of an entity's restructuring reserve by type of cost and in total, and explanation of changes that occurred in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140421172684408">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and Other Intangible Assets (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfGoodwillTextBlock', window );">Schedule of Goodwill by Reportable Segment</a></td>
<td class="text"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the changes in the carrying amount of goodwill by segment and in total:</span></div><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:41.801%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:24.517%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.343%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.949%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.343%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.247%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Pharmaceutical (1)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Medical (2)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total </span></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance at June 30, 2019</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,663&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5,715&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">8,378</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Goodwill acquired, net of purchase price adjustments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Foreign currency translation adjustments and other</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(15)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(16)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance at June 30, 2020</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,657&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5,700&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">8,357</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Goodwill acquired, net of purchase price adjustments</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Foreign currency translation adjustments and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">18</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cordis goodwill reclassified to assets held for sale</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(388)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(388)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2.5pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance at June 30, 2021</span></td><td style="background-color:#ffffff;border-bottom:2.5pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2.5pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2,659</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:2.5pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2.5pt solid #000000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2.5pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2.5pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">5,330</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:2.5pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2.5pt solid #000000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2.5pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2.5pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">7,989</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:2.5pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;At June&#160;30, 2021 and 2020, the Pharmaceutical segment accumulated goodwill impairment loss was $829 million.</span></div>(2)&#160;&#160;&#160;&#160;At June&#160;30, 2021 and 2020, the Medical segment accumulated goodwill impairment loss was $1.4 billion.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock', window );">Schedule of Finite-Lived Intangible Assets</a></td>
<td class="text"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables summarize other intangible assets by class at June&#160;30:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:22.356%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.023%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.343%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.653%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.343%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.023%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.343%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:20.816%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Intangible</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net<br/>Intangible</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted- Average Remaining Amortization Period (Years)</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Indefinite-life intangibles:</span></td><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Trademarks and patents</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">12</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">12</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total indefinite-life intangibles</span></td><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">12</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">12</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Definite-life intangibles:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">3,330</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1,989</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1,341</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">11</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Trademarks, trade names and patents</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">551</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">328</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">223</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">9</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Developed technology and other</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1,035</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">506</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">529</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">10</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total definite-life intangibles</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">4,916</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2,823</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2,093</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">10</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total other intangible assets</span></td><td style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">4,928</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2,823</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2,105</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">N/A</span></td></tr></table></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.691%"><tr><td style="width:1.0%"/><td style="width:42.243%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.308%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.347%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.643%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.347%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.312%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Gross<br/>Intangible</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net<br/>Intangible</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Indefinite-life intangibles:</span></td><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">IPR&amp;D, trademarks and other</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total indefinite-life intangibles</span></td><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Definite-life intangibles:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,554&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,828&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,726&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Trademarks, trade names and patents</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">673&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">341&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">332&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Developed technology and other</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,604&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">767&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">837&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total definite-life intangibles</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5,831&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,936&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,895&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total other intangible assets</span></td><td style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5,854&#160;</span></td><td style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,936&#160;</span></td><td style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,918&#160;</span></td><td style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock', window );">Schedule of Indefinite-Lived Intangible Assets</a></td>
<td class="text"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables summarize other intangible assets by class at June&#160;30:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:22.356%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.023%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.343%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.653%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.343%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.023%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.343%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:20.816%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Intangible</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net<br/>Intangible</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted- Average Remaining Amortization Period (Years)</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Indefinite-life intangibles:</span></td><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Trademarks and patents</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">12</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">12</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total indefinite-life intangibles</span></td><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">12</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">12</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Definite-life intangibles:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">3,330</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1,989</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1,341</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">11</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Trademarks, trade names and patents</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">551</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">328</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">223</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">9</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Developed technology and other</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1,035</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">506</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">529</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">10</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total definite-life intangibles</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">4,916</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2,823</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2,093</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">10</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total other intangible assets</span></td><td style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">4,928</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2,823</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2,105</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">N/A</span></td></tr></table></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.691%"><tr><td style="width:1.0%"/><td style="width:42.243%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.308%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.347%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.643%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.347%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.312%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Gross<br/>Intangible</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net<br/>Intangible</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Indefinite-life intangibles:</span></td><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">IPR&amp;D, trademarks and other</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total indefinite-life intangibles</span></td><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Definite-life intangibles:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,554&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,828&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,726&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Trademarks, trade names and patents</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">673&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">341&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">332&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Developed technology and other</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,604&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">767&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">837&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total definite-life intangibles</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5,831&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,936&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,895&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total other intangible assets</span></td><td style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5,854&#160;</span></td><td style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,936&#160;</span></td><td style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,918&#160;</span></td><td style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfGoodwillTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13854-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfGoodwillTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance and exist in perpetuity, by either major class or business segment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b),(d)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16373-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140421172387352">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeaseCostTableTextBlock', window );">Schedule of Lease Costs</a></td>
<td class="text"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the components of lease cost:  </span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:85.185%"><tr><td style="width:1.0%"/><td style="width:32.233%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.233%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.234%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Operating lease cost</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">119</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">134&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Finance lease cost</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">16</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Variable lease cost</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">24</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total lease cost</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">159</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">164&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div>Variable lease cost primarily includes payments for property taxes, maintenance and insurance.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_LeasesSupplementalBalanceSheetInformationTableTextBlock', window );">Leases Supplemental Balance Sheet Information</a></td>
<td class="text">The following table summarizes supplemental balance sheet and other information related to leases at June&#160;30:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:47.974%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:24.208%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:24.518%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Operating Leases</span></td><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">460</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">426&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Current portion of operating lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">105</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">104&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Long-term operating lease liabilities</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">374</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">341&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total operating lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">479</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">445&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Finance Leases</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Finance lease right-of-use assets</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">63</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Current portion of finance lease liabilities</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">19</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Long-term finance lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">45</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total finance lease liabilities</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">64</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-average remaining lease term (years)</span></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">6.5 years</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6.4 years</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Finance leases</span></td><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">4.2 years</span></td><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4.3 years</span></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-average discount rate</span></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2.9</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Finance leases</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1.5</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2.4&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_LeasePaymentsTableTextBlock', window );">Leases Supplemental Cash Flow Information</a></td>
<td class="text"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables summarizes supplemental cash flow information related to leases:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:40.258%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:28.220%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:28.222%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cash paid for lease liabilities:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Operating cash flows paid for operating leases</span></td><td style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">115</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">125&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Financing cash flows paid for finance leases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">15</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Non-cash right-of-use assets obtained in exchange for lease obligations:</span></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">New operating leases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">138</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">150&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">New finance leases</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">45</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">40&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Amended lease standard adoption impact as of July 1, 2019 </span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">400&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div>(1)Includes the effect of $22&#160;million from reclassifying deferred rent as an offset to the lease right-of-use asset in accordance with the transition guidance.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock', window );">Schedule of Future Lease Payments</a></td>
<td class="text"><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Future lease payments under non-cancellable leases as of June&#160;30, 2021 were as follows: </span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.382%"><tr><td style="width:1.0%"/><td style="width:50.142%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.117%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.352%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.117%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.352%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.120%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Operating Leases</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Finance Leases</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2022</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">116&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">136</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">93&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">113</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">72&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">86</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">65&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">73</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">50&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">53</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">141&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">146</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total future lease payments</span></td><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">537&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">70&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">607</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Less: leases not yet commenced </span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">3</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Less: imputed interest</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">55&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">61</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total lease liabilities</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">479&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">64&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">543</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div>(1)As of June&#160;30, 2021, we had certain leases that were executed but did not have control of the underlying assets; therefore, the lease liabilities and right-of-use assets are not recorded in the consolidated balance sheet.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_LeasePaymentsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>[Table Text Block] for Lease Payments [Table]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_LeasePaymentsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_LeasesSupplementalBalanceSheetInformationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>[Table Text Block] for LeasesSupplementalBalanceSheetInformation [Table]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_LeasesSupplementalBalanceSheetInformationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCostTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCostTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of future minimum payments required in the aggregate and for each of the five succeeding fiscal years for operating leases having initial or remaining noncancelable lease terms in excess of one year and the total minimum rentals to be received in the future under noncancelable subleases as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123406913&amp;loc=d3e41502-112717<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140421166325128">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Long-Term Obligations and Other Short-Term Borrowings (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDebtTableTextBlock', window );">Schedule of Debt</a></td>
<td class="text"><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes long-term obligations and other short-term borrowings at June 30:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.691%"><tr><td style="width:1.0%"/><td style="width:57.104%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.023%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.347%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.026%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in millions) (1)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2.616% Notes due 2022</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">572</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">834&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3.2% Notes due 2022</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">236&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Floating Rate Notes due 2022</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">281</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">321&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3.2% Notes due 2023</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">564</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">576&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3.079% Notes due 2024</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">794</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">809&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3.5% Notes due 2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">410</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">413&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3.75% Notes due 2025</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">524</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">529&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3.41% Notes due 2027</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1,216</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,215&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4.6% Notes due 2043</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">341</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">340&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4.5% Notes due 2044</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">342</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">342&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4.9% Notes due 2045</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">441</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">441&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4.368% Notes due 2047</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">560</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">560&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7.0%&#160;Debentures due 2026</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">124</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">124&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other Obligations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">67</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">6,236</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6,775&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Less: current portion of long-term obligations and other short-term borrowings</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">871</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;&#160;&#160;Long-term obligations, less current portion</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">5,365</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6,765&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr></table></div>(1)      Maturities are presented on a calendar year basis.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDebtTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of information pertaining to short-term and long-debt instruments or arrangements, including but not limited to identification of terms, features, collateral requirements and other information necessary to a fair presentation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDebtTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140421172465624">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock', window );">Schedule of Income Before Income Tax, Domestic and Foreign</a></td>
<td class="text"><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes earnings/(loss) before income taxes:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.691%"><tr><td style="width:1.0%"/><td style="width:53.389%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.999%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.347%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.522%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.347%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.596%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">U.S. operations</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(47)</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4,056)</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,478&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Non-U.S. operations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">370</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">284&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">273&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Earnings/(loss) before income taxes</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">323</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(3,772)</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,751&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock', window );">Schedule of Components of Income Tax Expense (Benefit), Current and Deferred</a></td>
<td class="text"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the components of provision for/(benefit from) income taxes:</span></div><div style="margin-top:8pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:53.220%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.949%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.343%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.171%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.343%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.174%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Current:</span></td><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Federal</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(989)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">659&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">295&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">State and local</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">92</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">154&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">89&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Non-U.S.</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">112</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">69&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">85&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total current</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(785)</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">882&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">469&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:3pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Deferred:</span></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Federal</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">539</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(822)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(28)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">State and local</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(28)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(127)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(37)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Non-U.S.</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(15)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(18)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total deferred</span></td><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">496</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(961)</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(83)</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Provision for/(benefit from) income taxes</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(289)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(79)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">386&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock', window );">Schedule of Effective Income Tax Rate Reconciliation</a></td>
<td class="text"><div style="margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents a reconciliation of the provision based on the federal statutory income tax rate to our effective income tax rate:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:53.220%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.406%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.343%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.406%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.343%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.482%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021 </span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2020</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"> (1)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2019 </span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Provision at Federal statutory rate</span></td><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">21.0</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">21.0&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">21.0&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">State and local income taxes, net of federal benefit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">3.2</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Tax effect of foreign operations</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">0.7</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(0.7)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Nondeductible/nontaxable items </span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1.6</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cordis Disposition</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">7.0</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Withholding Taxes </span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">9.0</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(0.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Change in Valuation Allowances</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(1.4)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1.5&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4.5&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">US Taxes on International Income</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"> (2)(3)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(6.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Impact of Resolutions with IRS and other related matters </span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(13.6)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(0.4)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Legal Entity Reorganization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(3.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Opioid litigation</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">17.7</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(23.2)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Loss Carryback Claims</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(129.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other </span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1.7</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(2.1)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Effective income tax rate</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(89.7)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2.1&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">22.1&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;The table represents the following: fiscal 2021 is pretax income with tax benefit, fiscal 2020 is pretax loss with tax benefit, and fiscal 2019 is pretax income with tax expense.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)&#160;&#160;&#160;&#160;Certain prior year amounts have been reclassified to conform to current year presentation.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock', window );">Schedule of Deferred Tax Assets and Liabilities</a></td>
<td class="text"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the components of the deferred income tax assets and liabilities at June 30:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:60.937%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.109%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.343%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.111%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Deferred income tax assets:</span></td><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Receivable basis difference</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">40</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accrued liabilities</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">874</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">607&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Share-based compensation</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">38</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">38&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Loss and tax credit carryforwards</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">805</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">589&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Deferred tax assets related to uncertain tax positions</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">35</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">52&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">16</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">87&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total deferred income tax assets</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1,808</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,412&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Valuation allowance for deferred income tax assets</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(515)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(470)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net deferred income tax assets</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1,293</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">942</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cccccc;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cccccc;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cccccc;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cccccc;border-top:2pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Deferred income tax liabilities:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Inventory basis differences</span></td><td style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(1,119)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1,083)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Property-related</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(375)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(327)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Goodwill and other intangibles</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(733)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(751)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Self-Insurance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(975)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(23)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total deferred income tax liabilities</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(3,225)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(2,161)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:6pt;padding-left:6.75pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net deferred income tax liability</span></div></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(1,932)</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1,219)</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_ScheduleOfDeferredTaxAssetsAndLiabilitiesAfterNettingByTaxJurisdictionTableTextBlock', window );">Schedule of Deferred Tax Assets and Liabilities after Netting by Tax Jurisdiction</a></td>
<td class="text"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deferred income tax assets and liabilities in the preceding table, after netting by taxing jurisdiction and for uncertain tax positions, are in the following captions in the consolidated balance sheets at June 30:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:60.937%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.109%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.343%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.111%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Noncurrent deferred income tax asset (1)</span></td><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">52</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Noncurrent deferred income tax liability (2)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(1,981)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1,258)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Noncurrent deferred income tax liability transferred to held for sale</span></td><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(3)</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net deferred income tax liability</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(1,932)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1,219)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:10pt">Included in other assets in the consolidated balance sheets.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:10pt">Included in deferred income taxes and other liabilities in the consolidated balance sheets.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock', window );">Schedule of Unrecognized Tax Benefits Roll Forward</a></td>
<td class="text">The following table presents a reconciliation of the beginning and ending amounts of unrecognized tax benefits:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.691%"><tr><td style="width:1.0%"/><td style="width:53.389%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.999%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.347%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.831%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.347%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.287%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance at beginning of fiscal year</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">998</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">456&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">423&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Additions for tax positions of the current year</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">121</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">500&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Additions for tax positions of prior years</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">223</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">78&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Reductions for tax positions of prior years</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(138)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(27)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Settlements with tax authorities </span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(271)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(25)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Expiration of the statute of limitations </span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(1)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(3)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance at end of fiscal year</span></div></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">932</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">998&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">456&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_ScheduleOfDeferredTaxAssetsAndLiabilitiesAfterNettingByTaxJurisdictionTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Schedule Of Deferred Tax Assets And Liabilities After Netting By Tax Jurisdiction [Table Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_ScheduleOfDeferredTaxAssetsAndLiabilitiesAfterNettingByTaxJurisdictionTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of income before income tax between domestic and foreign jurisdictions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the change in unrecognized tax benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 55<br> -Paragraph 217<br> -URI http://asc.fasb.org/extlink&amp;oid=124434304&amp;loc=d3e36027-109320<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140421167398616">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock', window );">Fair Value, Assets and Liabilities Measured on Recurring Basis</a></td>
<td class="text"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables present the fair values for assets and (liabilities) measured on a recurring basis at June 30:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:46.122%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.937%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.343%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.937%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.343%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.937%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.343%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.938%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cash equivalents</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1,883</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1,883</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other investments (1)</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">126</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">126</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Forward contracts (2)</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">42</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">42</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:46.122%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.937%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.343%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.937%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.343%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.937%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.343%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.938%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Level&#160;1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Level&#160;2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Level&#160;3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cash equivalents</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">721&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">721&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other investments (1)</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">114&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">114&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Forward contracts (2)</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">53&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">53&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:10pt">The other investments balance includes investments in mutual funds, which offset fluctuations in deferred compensation liabilities. These mutual funds invest in the equity securities of companies with both large and small market capitalization and high-quality fixed income debt securities. The fair value of these investments is determined using quoted market prices.</span>(2)The fair value of interest rate swaps, foreign currency contracts, net investment hedges and commodity contracts is determined based on the present value of expected future cash flows considering the risks involved, including non-performance risk, and using discount rates appropriate for the respective maturities. Observable Level 2 inputs are used to determine the present value of expected future cash flows. The fair value of these derivative contracts, which are subject to master netting arrangements under certain circumstances, is presented on a gross basis in prepaid expenses and other, other assets, other accrued liabilities, and deferred income taxes and other liabilities within the consolidated balance sheets.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140421262083816">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financial Instruments (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract', window );"><strong>Derivative Instruments and Hedging Activities Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock', window );">Schedule of Fair Value of Assets and Liabilities Related to Derivatives Designated as Hedging Instruments</a></td>
<td class="text"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the fair value of our assets and liabilities related to derivatives designated as hedging instruments and the respective line items in which they were recorded in the consolidated balance sheets at June 30:</span></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.691%"><tr><td style="width:1.0%"/><td style="width:69.488%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.831%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.347%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.834%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"/><td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Pay-floating interest rate swaps (1)</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cross-currency swap (1) </span></td><td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">6</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"/><td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">47&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cross-currency swap (2)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">34</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Foreign currency contracts (2)</span></td><td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">5</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"/><td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total assets</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">46</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">74&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:6pt"><td colspan="3" style="background-color:#dbdbdb;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#dbdbdb;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#dbdbdb;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#dbdbdb;border-top:2pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Foreign currency contracts (4)</span></td><td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">4</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"/><td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Forward interest rate swaps (3)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Commodity contracts (4)</span></td><td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"/><td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total liabilities</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">4</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;Included in other assets in the consolidated balance sheets.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)&#160;&#160;&#160;&#160;Included in prepaid expenses and other in the consolidated balance sheets.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(3)&#160;&#160;&#160;&#160;Included in deferred income taxes and other liabilities in the consolidated balance sheets.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(4)&#160;&#160;&#160;&#160;Included in other accrued liabilities in the consolidated balance sheets.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDerivativeInstrumentsEffectOnOtherComprehensiveIncomeLossTableTextBlock', window );">Schedule of Gain/(Loss) Included in AOCI for Derivative Instruments</a></td>
<td class="text"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the pre-tax gain/(loss) included in OCI for derivative instruments designated as cash flow hedges:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:46.739%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.492%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.343%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.023%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.960%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.643%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Forward interest rate swaps</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">16</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(16)</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Commodity contracts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td colspan="2" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">5</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock', window );">Schedule of Gain/(Loss) Recognized in Earnings for Interest Rate Contracts Designated as Fair Value Hedges</a></td>
<td class="text"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the gain/(loss) recognized in earnings for interest rate swaps designated as fair value hedges:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:52.912%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.343%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.406%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.343%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.408%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Pay-floating interest rate swaps (1)</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(8)</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">106&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Fixed-rate debt (1)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">8</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(106)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:3pt;padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1) Included in interest expense, net in the consolidated statements of earnings/(loss).</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock', window );">Schedule of Gain/(Loss) Reclassified from AOCI into Earnings for Derivative Instruments Designated as Cash Flow Hedges</a></td>
<td class="text"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the pre-tax gain/(loss) reclassified from AOCI into earnings for derivative instruments designated as cash flow hedges:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.382%"><tr><td style="width:1.0%"/><td style="width:46.415%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.359%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.352%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.359%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.352%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.363%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Foreign currency contracts (1)</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(12)</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Foreign currency contracts (2)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Foreign currency contracts (3)</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">4</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Forward interest rate swaps (4)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Commodity contracts (3)</span></td><td colspan="2" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">6</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;Included in revenue in the consolidated statements of earnings/(loss).</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)&#160;&#160;&#160;&#160;Included in cost of products sold in the consolidated statements of earnings/(loss).</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(3)&#160;&#160;&#160;&#160;Included in SG&amp;A expenses in the consolidated statements of earnings/(loss).</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(4) &#160;&#160;&#160;&#160;Included in interest expense, net in the consolidated statements of earnings/(loss).</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock', window );">Schedule of Gain/(Loss) Recognized in Earnings for Economic (Non-designated) Derivative Instruments</a></td>
<td class="text"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the gain/(loss) recognized in earnings for economic (non-designated) derivative instruments:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.382%"><tr><td style="width:1.0%"/><td style="width:46.415%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.359%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.352%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.359%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.352%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.363%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Foreign currency contracts (1)</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(8)</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(13)</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;Included in other income, net in the consolidated statements of earnings/(loss).</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock', window );">Schedule of Estimated Fair Value of Long-term Obligations and Other Short-term Borrowings Compared to the Respective Carrying Amount</a></td>
<td class="text"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the estimated fair value of our long-term obligations and other short-term borrowings compared to the respective carrying amounts at June 30:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:47.974%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:23.591%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.343%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:23.592%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Estimated fair value</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">6,751</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7,273&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Carrying amount</span></td><td colspan="2" style="border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">6,236</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="2" style="border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6,775&#160;</span></td><td style="border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_ScheduleOfFairValueGainLossDerivativeInstrumentTableTextBlock', window );">Schedule of Fair Value Gain/(Loss) Derivative Instrument</a></td>
<td class="text"><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table is a summary of the fair value gain/(loss) of our derivative instruments based upon the estimated amount that we would receive (or pay), considering counter-party credit risk, to terminate the contracts at June 30:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.691%"><tr><td style="width:1.0%"/><td style="width:31.098%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.451%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.347%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.547%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.347%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.451%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.347%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.312%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Notional<br/>Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair&#160;Value<br/>Gain/(Loss)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Notional<br/>Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Fair&#160;Value<br/>Gain/(Loss)</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Pay-floating interest rate swaps</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">200</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">550&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">690</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">653&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Forward interest rate swaps</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">200&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(16)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cross-currency swap</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">833</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">40</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">833&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">47&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Commodity contracts</span></td><td colspan="2" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember', window );">Not Designated as Hedging Instrument</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock', window );">Schedule of Outstanding Instruments</a></td>
<td class="text"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables summarize the outstanding economic (non-designated) derivative instruments at June 30:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:38.714%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:24.517%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.343%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:2.912%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.408%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Notional Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Maturity Date</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">254</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="9" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">July 2021</span></td></tr></table></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:38.714%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:24.517%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.343%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:2.912%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.408%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Notional Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Maturity Date</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">325&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="9" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Jul 2020</span></td></tr></table></div><span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_FairValueHedgingMember', window );">Fair Value Hedging</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock', window );">Schedule of Outstanding Instruments</a></td>
<td class="text"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables summarize the outstanding interest rate swaps designated as fair value hedges at June 30:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.691%"><tr><td style="width:1.0%"/><td style="width:43.482%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:26.454%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.347%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.045%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:2.615%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.357%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Notional Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Maturity&#160;Date</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Pay-floating interest rate swaps</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">200</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="9" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Mar 2028</span></td></tr></table></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.691%"><tr><td style="width:1.0%"/><td style="width:43.791%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:26.144%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.347%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.045%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:2.615%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.358%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Notional Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Maturity&#160;Date</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Pay-floating interest rate swaps</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">550&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="9" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Mar 2023</span></td></tr></table></div><span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember', window );">Cash Flow Hedging</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock', window );">Schedule of Outstanding Instruments</a></td>
<td class="text"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables summarize the outstanding cash flow hedges at June 30:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:38.714%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:24.517%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.343%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:2.912%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.408%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Notional Amount</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Maturity&#160;Date</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#dbdbdb;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td style="background-color:#dbdbdb;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#dbdbdb;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">436</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dbdbdb;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dbdbdb;border-bottom:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#dbdbdb;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Jul 2021</span></td><td colspan="3" style="background-color:#dbdbdb;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">-</span></td><td colspan="3" style="background-color:#dbdbdb;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Jun 2022</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:38.714%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:24.517%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.343%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:2.912%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.408%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Notional Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Maturity&#160;Date</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Forward interest rate swaps</span></td><td style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">200&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="9" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Jun 2022</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">328&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Jul 2020</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Jun 2021</span></div></td></tr><tr><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Commodity contracts</span></td><td colspan="2" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Jul 2020</span></div></td><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Jun 2021</span></div></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_ScheduleOfFairValueGainLossDerivativeInstrumentTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Summarizes the fair value and notional amounts of derivative instruments held as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_ScheduleOfFairValueGainLossDerivativeInstrumentTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of information pertaining to carrying amount and estimated fair value of short-term and long-term debt instruments or arrangements, including but not limited to, identification of terms, features, and collateral requirements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of gain (loss) on derivative and nonderivative instruments designated and qualifying as cash flow hedge recorded in accumulated other comprehensive income (AOCI) and reclassified into earnings.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDerivativeInstrumentsEffectOnOtherComprehensiveIncomeLossTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the effective portion of the gains and losses on derivative instruments designated (and non-derivative instruments) designated and qualifying in cash flow hedges and net investment hedges that was recognized in other comprehensive income (loss) during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDerivativeInstrumentsEffectOnOtherComprehensiveIncomeLossTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the location and amount of derivative instruments and nonderivative instruments designated as hedging instruments reported before netting adjustments, and the amount of gain (loss) on derivative instruments and nonderivative instruments designated and qualified as hedging instruments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4E<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624181-113959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5618551-113959<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the location and fair value amounts of derivative instruments (and nonderivative instruments that are designated and qualify as hedging instruments) reported in the statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624163-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of pertinent information about a derivative or group of derivatives on a disaggregated basis, such as for individual instruments, or small groups of similar instruments. May include a combination of the type of instrument, risks being hedged, notional amount, hedge designation, related hedged item, inception date, maturity date, or other relevant item.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624163-113959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5580258-113959<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=d3e41620-113959<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579245-113959<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=d3e41638-113959<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=d3e41678-113959<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=d3e41641-113959<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624171-113959<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579240-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDerivativeInstrumentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of derivative instrument not designated or qualifying as hedging instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624171-113959<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4CC<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL109998890-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_FairValueHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_FairValueHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140421166301416">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Shareholders' Equity (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock', window );">Schedule of Changes in the Balance of Accumulated Other Comprehensive Loss by Component and in Total</a></td>
<td class="text"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the changes in the balance of accumulated other comprehensive loss by component and in total:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:38.097%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.492%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.343%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.875%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.343%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:22.050%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Foreign<br/>Currency<br/>Translation<br/>Adjustments and other</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Unrealized<br/>Gain/(Loss) on<br/>Derivatives,<br/>net of tax</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated Other<br/>Comprehensive<br/>Loss</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance at June 30, 2019</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(95)</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(79)</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other comprehensive income/(loss), net before reclassifications</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(23)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(20)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Amounts reclassified to earnings</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(5)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total other comprehensive income/(loss) attributable to Cardinal Health, Inc., net of tax of $4 million</span></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(28)</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(25)</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance at June 30, 2020</span></td><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(92)</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(104)</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other comprehensive income, before reclassifications</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">46&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">68</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Amounts reclassified to earnings</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total other comprehensive income/(loss) attributable to Cardinal Health, Inc., net of tax of $4 million</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">46&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">70</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance at June 30, 2021</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(46)</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">12</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(34)</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of accumulated other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669686-108580<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140421166305592">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Earnings Per Share Attributable to Cardinal Health, Inc. (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock', window );">Reconciliation of Common Shares Used to Compute Basic and Diluted Earnings Per Share</a></td>
<td class="text"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table reconciles the computation of basic and diluted earnings per share attributable to Cardinal Health, Inc.:</span></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.691%"><tr><td style="width:1.0%"/><td style="width:61.748%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.045%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.347%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.355%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.347%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.358%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in millions, except per share amounts)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net earnings/(loss)</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">612</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(3,693)</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,365&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net earnings attributable to noncontrolling interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net earnings/(loss) attributable to Cardinal Health, Inc.</span></div></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">611</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(3,696)</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,363&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Weighted-average common shares&#8211;basic</span></td><td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">292</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">293&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">300&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Effect of dilutive securities:</span></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Employee stock options, restricted share units, and performance share units</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-average common shares&#8211;diluted</span></td><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">294</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">293&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">301&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Basic earnings/(loss) per common share attributable to Cardinal Health, Inc.:</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2.09</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(12.61)</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4.55&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Diluted earnings/(loss) per common share attributable to Cardinal Health, Inc.:</span></td><td colspan="2" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2.08</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(12.61)</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4.53&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the weighted average number of shares used in calculating basic net earnings per share (or unit) and diluted earnings per share (or unit).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140421168395336">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Information (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock', window );">Schedule of Segment Reporting Information, by Segment [Table Text Block]</a></td>
<td class="text"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents revenue for each reportable segment and Corporate:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:55.690%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.480%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.343%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.171%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.343%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.173%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Pharmaceutical</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">145,796</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">137,495&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">129,917&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Medical</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">16,687</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">15,444&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">15,633&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total segment revenue</span></td><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">162,483</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">152,939&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">145,550&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Corporate (1)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(16)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(17)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(16)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total revenue</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">162,467</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">152,922&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">145,534&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:10pt">Corporate revenue consists of the elimination of inter-segment revenue and other revenue not allocated to the segments.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock', window );">Revenue by Reportable Segment</a></td>
<td class="text"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables present revenue for each reportable segment and disaggregated revenue within our two reportable segments and Corporate:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:46.791%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.466%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.004%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.466%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.004%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.469%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Pharmaceutical Distribution and Specialty Solutions (1) (2)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">144,988</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">136,693&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">129,067&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Nuclear and Precision Health Solutions</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">808</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">802&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">850&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Pharmaceutical segment revenue</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">145,796</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">137,495&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">129,917&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Medical distribution and products (3)</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">14,485</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">13,429&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">13,833&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cardinal Health at-Home Solutions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2,202</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,015&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,800&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Medical segment revenue</span></div></td><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">16,687</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">15,444&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">15,633&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;Total segment revenue</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">162,483</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">152,939&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">145,550&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Corporate (4)</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(16)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(17)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(16)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total revenue</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">162,467</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">152,922&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">145,534&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:10pt">Products and services offered by our Specialty Solutions division are referred to as &#8220;specialty pharmaceutical products and services"</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:10pt">Comprised of all Pharmaceutical segment businesses except for Nuclear and Precision Health Solutions division.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:10pt">Comprised of all Medical segment businesses except for Cardinal Health at-Home Solutions division</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:10pt">Corporate revenue consists of the elimination of inter-segment revenue and other revenue not allocated to the segments.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueTableTextBlock', window );">Disaggregation of Revenue [Table Text Block]</a></td>
<td class="text"><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:46.791%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.466%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.004%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.466%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.004%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.469%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Pharmaceutical Distribution and Specialty Solutions (1) (2)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">144,988</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">136,693&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">129,067&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Nuclear and Precision Health Solutions</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">808</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">802&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">850&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Pharmaceutical segment revenue</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">145,796</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">137,495&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">129,917&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Medical distribution and products (3)</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">14,485</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">13,429&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">13,833&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cardinal Health at-Home Solutions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2,202</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,015&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,800&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Medical segment revenue</span></div></td><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">16,687</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">15,444&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">15,633&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;Total segment revenue</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">162,483</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">152,939&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">145,550&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Corporate (4)</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(16)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(17)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(16)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total revenue</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">162,467</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">152,922&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">145,534&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:10pt">Products and services offered by our Specialty Solutions division are referred to as &#8220;specialty pharmaceutical products and services"</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:10pt">Comprised of all Pharmaceutical segment businesses except for Nuclear and Precision Health Solutions division.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:10pt">Comprised of all Medical segment businesses except for Cardinal Health at-Home Solutions division</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:10pt">Corporate revenue consists of the elimination of inter-segment revenue and other revenue not allocated to the segments.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock', window );">Revenue from External Customers by Geographic Areas [Table Text Block]</a></td>
<td class="text"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents revenue by geographic area:</span></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:42.109%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.183%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.269%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.183%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.269%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.187%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">United States</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">157,756</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">148,707&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">141,479&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">International</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">4,727</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,232&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,071&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total segment revenue</span></td><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">162,483</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">152,939&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">145,550&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Corporate (1)</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(16)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(17)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(16)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total revenue</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">162,467</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">152,922&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">145,534&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:10pt">Corporate revenue consists of the elimination of inter-segment revenue and other revenue not allocated to the segments.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock', window );">Segment Profit by Reportable Segment</a></td>
<td class="text"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables present segment profit by reportable segment and Corporate:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.691%"><tr><td style="width:1.0%"/><td style="width:51.221%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.451%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.347%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.760%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.347%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.074%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Pharmaceutical</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1,684</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,753&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,834&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Medical</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">577</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">663&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">576&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total segment profit</span></td><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2,261</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,416&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,410&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Corporate</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(1,789)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(6,514)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(350)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total operating earnings</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">472</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4,098)</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,060&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReconciliationOfOtherSignificantReconcilingItemsFromSegmentsToConsolidatedTextBlock', window );">Depreciation and Amortization and Additions to Property and Equipment by Reportable Segment</a></td>
<td class="text"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables present depreciation and amortization and additions to property and equipment by reportable segment and Corporate:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.691%"><tr><td style="width:1.0%"/><td style="width:47.506%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.999%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.347%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.999%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.347%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.002%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Pharmaceutical</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">151</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">135&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">147&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Medical</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">226</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">243&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">288&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Corporate</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">406</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">535&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">565&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total depreciation and amortization</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">783</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">913&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,000&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.691%"><tr><td style="width:1.0%"/><td style="width:47.506%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.999%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.347%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.999%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.347%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.002%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Pharmaceutical</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">55</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">47&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Medical</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">97</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">86&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">74&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Corporate</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">248</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">242&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">219&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total additions to property and equipment</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">400</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">375&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">328&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock', window );">Assets by Reportable Segment</a></td>
<td class="text"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents total assets for each reportable segment and Corporate at June 30:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.691%"><tr><td style="width:1.0%"/><td style="width:46.887%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.547%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.347%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.547%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.347%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.525%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Pharmaceutical</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">23,624</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">22,398&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">22,446&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Medical (1)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">15,408</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">14,691&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">15,284&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Corporate</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">5,421</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,677&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,233&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total assets</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">44,453</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">40,766&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">40,963&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:5pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Assets of $1.1 billion classified as held for sale related to the Cordis divestiture were included within Medical at June&#160;30, 2021</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock', window );">Property and Equipment, Net by Geographic Area</a></td>
<td class="text"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables present property and equipment, net by geographic area:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.691%"><tr><td style="width:1.0%"/><td style="width:46.887%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.547%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.347%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.547%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.347%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.525%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">United States</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1,958</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,880&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,846&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">International</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">402</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">486&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">510&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Property and equipment, net</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2,360</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,366&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,356&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130545-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of long-lived assets, excluding financial instruments, long-term customer relationships of a financial institution, mortgage rights, deferred policy acquisition costs, and deferred tax assets, by geographic areas located in the entity's country of domicile and foreign countries in which the entity holds assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph b<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of all significant reconciling items in the reconciliation of total assets from reportable segments to the entity's consolidated assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the reconciliation of profit (loss) from reportable segments to the consolidated income (loss) before income tax expense (benefit) and discontinued operations. Includes, but is not limited to, reconciliation after income tax if income tax is allocated to the reportable segment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReconciliationOfOtherSignificantReconcilingItemsFromSegmentsToConsolidatedTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of each significant reconciling item, other than profit (loss), revenues, or assets, in the reconciliation of totals of such items in reportable segments to the entity's corresponding consolidated amount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReconciliationOfOtherSignificantReconcilingItemsFromSegmentsToConsolidatedTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of all significant reconciling items in the reconciliation of total revenues from reportable segments to the entity's consolidated revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of revenue from external customers by geographic areas attributed to the entity's country of domicile and to foreign countries from which the entity derives revenue.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph a<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8813-108599<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140421349808968">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-Based Compensation (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock', window );">Schedule of Total Share-based Compensation Expense by Type of Award</a></td>
<td class="text"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides total share-based compensation expense by type of award:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.691%"><tr><td style="width:1.0%"/><td style="width:58.652%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.283%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.347%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.283%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.347%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.288%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Restricted share unit expense</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">73</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">70&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">63&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Employee stock option expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Performance share unit expense</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">16</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total share-based compensation expense</span></div></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">89</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">90&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">82&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock', window );">Schedule of Stock Option Transactions Under the Plans</a></td>
<td class="text"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes all stock option transactions under the Plans:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:56.616%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.480%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.343%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:26.061%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in millions, except per share amounts)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Stock<br/>Options</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-Average<br/>Exercise Price per<br/>Common Share</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Outstanding at June 30, 2019</span></td><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">63.78&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">42.36&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Canceled and forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Outstanding at June 30, 2020</span></td><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">65.15&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">43.08&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Canceled and forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Outstanding at June 30, 2021</span></td><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">4</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">68.46</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Exercisable at June 30, 2021</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">4</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">68.62</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_AdditionalStockOptionPlanDataTableTextBlock', window );">Schedule of Additional Data Related to Stock Option Activity</a></td>
<td class="text"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides additional detail related to stock options:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.691%"><tr><td style="width:1.0%"/><td style="width:53.698%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.451%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.347%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.522%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.347%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.835%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in millions, except per share amounts)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Aggregate intrinsic value of outstanding options at period end</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">11</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Aggregate intrinsic value of exercisable options at period end</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">11</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Aggregate intrinsic value of exercised options</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">10</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net proceeds/(withholding) from share-based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">32</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Excess tax benefits from share based compensation</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(5)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total compensation cost, net of estimated forfeitures, related to unvested stock options not yet recognized, pre-tax</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total fair value of shares vested during the year</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">3</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Weighted-average grant date fair value per stock option</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">12.94</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8.26&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8.34&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_RemainingStockOptionPlanDataTableTextBlock', window );">Schedule of Remaining Stock Option Plan Data</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.382%"><tr><td style="width:1.0%"/><td style="width:65.049%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.148%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.352%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.148%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.352%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.151%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in years)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Weighted-average remaining contractual life of outstanding options</span></td><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">4</span></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5</span></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Weighted-average remaining contractual life of exercisable options</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">4</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Weighted-average period over which stock option compensation cost is expected to be recognized</span></td><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2</span></td><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1</span></td><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1</span></td></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock', window );">Schedule of Range of Assumptions Used to Estimate Fair Value of Stock Options</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock', window );">Schedule of Transactions Related to Restricted Share Units Under the Plans</a></td>
<td class="text"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes all transactions related to restricted share units under the Plans:</span></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.691%"><tr><td style="width:1.0%"/><td style="width:51.221%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.714%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.347%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:25.218%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in millions, except per share amounts)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Restricted Share Units</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-Average<br/>Grant Date Fair<br/>Value per Share</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Nonvested at June 30, 2019</span></td><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">51.65&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">42.71&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">60.21&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Canceled and forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Nonvested at June 30, 2020</span></td><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">45.92&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">53.76&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">49.37&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Canceled and forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">48.74&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nonvested at June 30, 2021</span></td><td colspan="2" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">3</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">49.05</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_AdditionalRestrictedSharesAndRestrictedShareUnitsDataTableTextBlock', window );">Additional Restricted Shares and Restricted Share Units Activity</a></td>
<td class="text"><div style="margin-bottom:4pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides additional data related to restricted share unit activity:</span></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.691%"><tr><td style="width:1.0%"/><td style="width:53.698%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.451%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.347%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.522%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.347%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.835%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total compensation cost, net of estimated forfeitures, related to nonvested restricted share and share unit awards not yet recognized, pre-tax</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">73</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">77&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">75&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Weighted-average period in years over which restricted share and share unit cost is expected to be recognized (in years)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total fair value of shares vested during the year</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">70</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">57&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">68&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfNonvestedPerformanceBasedUnitsActivityTableTextBlock', window );">Schedule of Transactions Related to Performance Share Units Under the Plans</a></td>
<td class="text"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes all transactions related to performance share units under the Plans (based on target award amounts):</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.691%"><tr><td style="width:1.0%"/><td style="width:49.983%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.023%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.347%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:26.147%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in millions, except per share amounts)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Performance<br/>Share Units</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-Average<br/>Grant Date Fair<br/>Value per Share</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Nonvested at June 30, 2019</span></td><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.9&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">51.45&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">44.03&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">48.40&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Canceled and forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">50.92&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Nonvested at June 30, 2020</span></td><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1.3&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">54.24&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">55.45&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">42.72&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Canceled and forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(0.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">53.71&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nonvested at June 30, 2021</span></td><td colspan="2" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1.2</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">54.89</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_AdditionalPerformanceShareUnitsDataTableTextBlock', window );">Additional Data Related to Performance Share Units Activity</a></td>
<td class="text"><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides additional data related to performance share unit activity:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.691%"><tr><td style="width:1.0%"/><td style="width:58.652%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.283%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.347%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.283%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.347%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.288%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total compensation cost, net of estimated forfeitures, related to nonvested performance share units not yet recognized, pre-tax</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">26</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Weighted-average period over which performance share unit cost is expected to be recognized (in years)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total fair value of shares vested during the year</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_AdditionalPerformanceShareUnitsDataTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Additional Performance Share Units Data [Table Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_AdditionalPerformanceShareUnitsDataTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_AdditionalRestrictedSharesAndRestrictedShareUnitsDataTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Additional Restricted Shares And Restricted Share Units Data [Table Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_AdditionalRestrictedSharesAndRestrictedShareUnitsDataTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_AdditionalStockOptionPlanDataTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A disclosure of additional data related to all stock option activity</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_AdditionalStockOptionPlanDataTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_RemainingStockOptionPlanDataTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>[Table Text Block] for Remaining Stock Option Plan Data [Table]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_RemainingStockOptionPlanDataTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of cost recognized for award under share-based payment arrangement by plan. Includes, but is not limited to, related tax benefit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfNonvestedPerformanceBasedUnitsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the changes in outstanding nonvested performance-based units.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfNonvestedPerformanceBasedUnitsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the number and weighted-average grant date fair value for restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock units that were granted, vested, or forfeited during the year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140421173336440">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basis of Presentation and Summary of Significant Accounting Policies (Narrative, Receivables) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
<th class="th"><div>Jun. 30, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsNotesAndLoansReceivableLineItems', window );"><strong>Accounts, Notes, Loans and Financing Receivable [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesBalance', window );">SEC Schedule, 12-09, Valuation Allowances and Reserves, Amount</a></td>
<td class="nump">$ 944<span></span>
</td>
<td class="nump">$ 729<span></span>
</td>
<td class="nump">$ 687<span></span>
</td>
<td class="nump">$ 626<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NotesReceivableNet', window );">Finance notes and related accrued interest, net, total</a></td>
<td class="nump">63<span></span>
</td>
<td class="nump">104<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NotesAndLoansReceivableNetCurrent', window );">Finance notes and related accrued interest, net, current</a></td>
<td class="nump">$ 7<span></span>
</td>
<td class="nump">12<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsNotesAndLoansReceivableLineItems', window );"><strong>Accounts, Notes, Loans and Financing Receivable [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_ReceivableFinancingAgreementTerm', window );">Receivable financing agreement term</a></td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsNotesAndLoansReceivableLineItems', window );"><strong>Accounts, Notes, Loans and Financing Receivable [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_ReceivableFinancingAgreementTerm', window );">Receivable financing agreement term</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesTypeAxis=us-gaap_AllowanceForCreditLossMember', window );">SEC Schedule, 12-09, Allowance, Credit Loss [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsNotesAndLoansReceivableLineItems', window );"><strong>Accounts, Notes, Loans and Financing Receivable [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesBalance', window );">SEC Schedule, 12-09, Valuation Allowances and Reserves, Amount</a></td>
<td class="nump">$ 242<span></span>
</td>
<td class="nump">206<span></span>
</td>
<td class="nump">193<span></span>
</td>
<td class="nump">139<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesTypeAxis=us-gaap_AllowanceForLossesOnFinanceReceivablesMember', window );">SEC Schedule, 12-09, Allowance, Loss on Finance Receivable [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsNotesAndLoansReceivableLineItems', window );"><strong>Accounts, Notes, Loans and Financing Receivable [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesBalance', window );">SEC Schedule, 12-09, Valuation Allowances and Reserves, Amount</a></td>
<td class="nump">$ 12<span></span>
</td>
<td class="nump">$ 27<span></span>
</td>
<td class="nump">$ 14<span></span>
</td>
<td class="nump">$ 7<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_ReceivableFinancingAgreementTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Receivable Financing Agreement Term</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_ReceivableFinancingAgreementTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsNotesAndLoansReceivableLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsNotesAndLoansReceivableLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NotesAndLoansReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of financing receivable, classified as current. Includes, but is not limited to, notes and loan receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4428-111522<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4531-111522<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(7))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NotesAndLoansReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NotesReceivableNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of financing receivable. Excludes financing receivable covered under loss sharing agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919230-210447<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4428-111522<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NotesReceivableNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowancesAndReservesBalance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of valuation and qualifying accounts and reserves.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.12-09(Column B))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24092-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.12-09(Column E))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24092-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowancesAndReservesBalance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowancesAndReservesTypeAxis=us-gaap_AllowanceForCreditLossMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowancesAndReservesTypeAxis=us-gaap_AllowanceForCreditLossMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowancesAndReservesTypeAxis=us-gaap_AllowanceForLossesOnFinanceReceivablesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowancesAndReservesTypeAxis=us-gaap_AllowanceForLossesOnFinanceReceivablesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140421173303112">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basis of Presentation and Summary of Significant Accounting Policies (Revenue and Gross Trade Receivables Percentage by Major Customers) (Details) - Pharmaceutical<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=cah_PharmaceuticalMember', window );">CVS Health</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EntityWideRevenueMajorCustomerLineItems', window );"><strong>Revenue, Major Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_GrossTradeReceivablesMajorCustomerPercentage', window );">Percent&#160;of&#160;Gross Trade&#160;Receivables</a></td>
<td class="nump">24.00%<span></span>
</td>
<td class="nump">26.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=cah_PharmaceuticalMember', window );">CVS Health | Revenue Benchmark | Customer Concentration Risk</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EntityWideRevenueMajorCustomerLineItems', window );"><strong>Revenue, Major Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Percent of Revenue</a></td>
<td class="nump">26.00%<span></span>
</td>
<td class="nump">26.00%<span></span>
</td>
<td class="nump">26.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=cah_PharmaceuticalMember', window );">OptumRx [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EntityWideRevenueMajorCustomerLineItems', window );"><strong>Revenue, Major Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_GrossTradeReceivablesMajorCustomerPercentage', window );">Percent&#160;of&#160;Gross Trade&#160;Receivables</a></td>
<td class="nump">3.00%<span></span>
</td>
<td class="nump">6.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=cah_PharmaceuticalMember', window );">OptumRx [Member] | Revenue Benchmark | Customer Concentration Risk</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EntityWideRevenueMajorCustomerLineItems', window );"><strong>Revenue, Major Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Percent of Revenue</a></td>
<td class="nump">15.00%<span></span>
</td>
<td class="nump">14.00%<span></span>
</td>
<td class="nump">13.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_GrossTradeReceivablesMajorCustomerPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gross Trade Receivables, Major Customer Percentage</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_GrossTradeReceivablesMajorCustomerPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskPercentage1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6351-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13531-108611<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13537-108611<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6404-108592<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskPercentage1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EntityWideRevenueMajorCustomerLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EntityWideRevenueMajorCustomerLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=cah_PharmaceuticalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=cah_PharmaceuticalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=cah_CVSCaremarkCorporationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=cah_CVSCaremarkCorporationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=cah_OptumRxMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=cah_OptumRxMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140421267250328">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basis of Presentation and Summary of Significant Accounting Policies (Narrative, Major Customers) (Details) - organization<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_ConcentrationRiskLargestGroupPurchasingOrganizations', window );">Largest group purchasing organizations</a></td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MajorCustomersAxis=cah_GroupPurchasingOrganizationsMember', window );">Group Purchasing Organizations | Revenue Benchmark | Customer Concentration Risk</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Revenue, major customer, percentage</a></td>
<td class="nump">15.00%<span></span>
</td>
<td class="nump">16.00%<span></span>
</td>
<td class="nump">22.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_ConcentrationRiskLargestGroupPurchasingOrganizations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Concentration Risk, Largest Group Purchasing Organizations</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_ConcentrationRiskLargestGroupPurchasingOrganizations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskPercentage1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6351-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13531-108611<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13537-108611<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6404-108592<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskPercentage1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=cah_GroupPurchasingOrganizationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=cah_GroupPurchasingOrganizationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140421166005480">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basis of Presentation and Summary of Significant Accounting Policies (Narrative, Inventories) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PercentageOfLIFOInventory', window );">Portion of inventories held at LIFO, percentage</a></td>
<td class="nump">50.00%<span></span>
</td>
<td class="nump">56.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryLIFOReserve', window );">Inventories valued at LIFO amount higher than average cost value</a></td>
<td class="nump">$ 565<span></span>
</td>
<td class="nump">$ 411<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryValuationReserves', window );">Reserves for excess and obsolete inventory</a></td>
<td class="nump">185<span></span>
</td>
<td class="nump">$ 155<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryWriteDown', window );">Inventory Write-down</a></td>
<td class="nump">$ 197<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryLIFOReserve">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount by which inventory stated at last-in first-out (LIFO) is less than (in excess of) inventory stated at other inventory cost methods.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryLIFOReserve</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryValuationReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of valuation reserve for inventory.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB TOPIC 5.BB)<br> -URI http://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e100047-122729<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryValuationReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryWriteDown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of loss from reductions in inventory due to subsequent measurement adjustments, including, but not limited to, physical deterioration, obsolescence, or changes in price levels.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=116847112&amp;loc=d3e4542-108314<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryWriteDown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PercentageOfLIFOInventory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The percentage of LIFO (last in first out) inventory to total inventory as of the balance sheet date if other than 100 percent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PercentageOfLIFOInventory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140421173515256">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basis of Presentation and Summary of Significant Accounting Policies (Narrative, Property and Equipment) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation</a></td>
<td class="nump">$ 377<span></span>
</td>
<td class="nump">$ 405<span></span>
</td>
<td class="nump">$ 455<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtWeightedAverageInterestRate', window );">Interest rate on long-term projects (approximates weighted-average on long-term obligations)</a></td>
<td class="nump">3.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingAndBuildingImprovementsMember', window );">Building and Improvements | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Useful life of property and equipment</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingAndBuildingImprovementsMember', window );">Building and Improvements | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Useful life of property and equipment</a></td>
<td class="text">39 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember', window );">Machinery and equipment | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Useful life of property and equipment</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember', window );">Machinery and equipment | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Useful life of property and equipment</a></td>
<td class="text">20 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember', window );">Furniture and fixtures | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Useful life of property and equipment</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember', window );">Furniture and fixtures | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Useful life of property and equipment</a></td>
<td class="text">7 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Depreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Depreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtWeightedAverageInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average interest rate of long-term debt outstanding calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtWeightedAverageInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingAndBuildingImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingAndBuildingImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140421171738776">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basis of Presentation and Summary of Significant Accounting Policies (Components of Property and Equipment) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Total property and equipment, at cost</a></td>
<td class="nump">$ 5,588<span></span>
</td>
<td class="nump">$ 5,331<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment', window );">Accumulated depreciation and amortization</a></td>
<td class="num">(3,228)<span></span>
</td>
<td class="num">(2,965)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
<td class="nump">2,360<span></span>
</td>
<td class="nump">2,366<span></span>
</td>
<td class="nump">$ 2,356<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LandBuildingsAndImprovementsMember', window );">Land, building and improvements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Total property and equipment, at cost</a></td>
<td class="nump">2,359<span></span>
</td>
<td class="nump">2,185<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember', window );">Machinery and equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Total property and equipment, at cost</a></td>
<td class="nump">3,093<span></span>
</td>
<td class="nump">3,008<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember', window );">Furniture and fixtures</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Total property and equipment, at cost</a></td>
<td class="nump">$ 136<span></span>
</td>
<td class="nump">$ 138<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum | Building and Improvements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property, Plant and Equipment, Useful Life</a></td>
<td class="text">39 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum | Machinery and equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property, Plant and Equipment, Useful Life</a></td>
<td class="text">20 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum | Furniture and fixtures</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property, Plant and Equipment, Useful Life</a></td>
<td class="text">7 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum | Building and Improvements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property, Plant and Equipment, Useful Life</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum | Machinery and equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property, Plant and Equipment, Useful Life</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum | Furniture and fixtures</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property, Plant and Equipment, Useful Life</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.14)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.13)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124429447&amp;loc=SL124453093-239630<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LandBuildingsAndImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LandBuildingsAndImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingAndBuildingImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingAndBuildingImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140421173112680">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basis of Presentation and Summary of Significant Accounting Policies (Narrative, Goodwill and Other Intangible Assets) (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Jun. 30, 2021 </div>
<div>USD ($) </div>
<div>segment</div>
</th>
<th class="th">
<div>Jun. 30, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2019 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_GoodwillAndIntangibleAssetsLineItems', window );"><strong>Goodwill and Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfOperatingSegments', window );">Number of Operating Segments | segment</a></td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Goodwill, Impairment Loss | $</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_GoodwillAndIntangibleAssetsLineItems', window );"><strong>Goodwill and Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_DiscountRatefairvalueinputs', window );">Discount Rate, fair value inputs</a></td>
<td class="nump">8.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_GoodwillAndIntangibleAssetsLineItems', window );"><strong>Goodwill and Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_DiscountRatefairvalueinputs', window );">Discount Rate, fair value inputs</a></td>
<td class="nump">11.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_DiscountRatefairvalueinputs">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Discount Rate, fair value inputs</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_DiscountRatefairvalueinputs</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_GoodwillAndIntangibleAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Goodwill and Intangible Assets [Line Items]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_GoodwillAndIntangibleAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillImpairmentLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13854-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13777-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillImpairmentLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfOperatingSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8672-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfOperatingSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140421166260024">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Basis of Presentation and Summary of Significant Accounting Policies (Narrative, Vendor Reserves) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_VendorReserves', window );">Vendor reserves</a></td>
<td class="nump">$ 77<span></span>
</td>
<td class="nump">$ 77<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_VendorReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of reserves, relating to vendor disputes or deductions, that are netted against vendor liabilities in the ordinary course of business.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_VendorReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140421171510728">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basis of Presentation and Summary of Significant Accounting Policies (Narrative, Dividends) (Details) - $ / shares<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockDividendsPerShareCashPaid', window );">Cash dividends per common share (in usd per share)</a></td>
<td class="nump">$ 1.94<span></span>
</td>
<td class="nump">$ 1.92<span></span>
</td>
<td class="nump">$ 1.91<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockDividendsPerShareCashPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate dividends paid during the period for each share of common stock outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockDividendsPerShareCashPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140421165996072">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basis of Presentation and Summary of Significant Accounting Policies (Narrative, Sales Returns and Allowances) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_RevenueRecognitionReserveforSalesReturnsandAllowances', window );">Accrual for estimated sales returns and allowances</a></td>
<td class="nump">$ 689<span></span>
</td>
<td class="nump">$ 495<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRecognitionSalesReturnsReserveForSalesReturns', window );">Revenue Recognition, Sales Returns, Reserve for Sales Returns</a></td>
<td class="nump">$ 2,600<span></span>
</td>
<td class="nump">$ 2,300<span></span>
</td>
<td class="nump">$ 2,200<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_RevenueRecognitionReserveforSalesReturnsandAllowances">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Revenue Recognition, Reserve for Sales Returns and Allowances</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_RevenueRecognitionReserveforSalesReturnsandAllowances</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRecognitionSalesReturnsReserveForSalesReturns">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of estimated sales returns.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRecognitionSalesReturnsReserveForSalesReturns</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140421173113816">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basis of Presentation and Summary of Significant Accounting Policies (Narrative, Shipping and Handling) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_GoodsandservicessoldLineItems', window );"><strong>Distribution, selling, general and administrative expenses [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpense', window );">Distribution, selling, general and administrative expenses</a></td>
<td class="nump">$ 4,533<span></span>
</td>
<td class="nump">$ 4,572<span></span>
</td>
<td class="nump">$ 4,480<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ShippingAndHandlingMember', window );">Shipping and Handling [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_GoodsandservicessoldLineItems', window );"><strong>Distribution, selling, general and administrative expenses [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpense', window );">Distribution, selling, general and administrative expenses</a></td>
<td class="nump">$ 634<span></span>
</td>
<td class="nump">$ 620<span></span>
</td>
<td class="nump">$ 622<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_GoodsandservicessoldLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>[Line Items] for goods and services sold [Table]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_GoodsandservicessoldLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingGeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingGeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_ShippingAndHandlingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_ShippingAndHandlingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140421172633592">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basis of Presentation and Summary of Significant Accounting Policies Loss Contingencies (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossRelatedToLitigationSettlement', window );">Gain (Loss) Related to Litigation Settlement</a></td>
<td class="num">$ (1,129)<span></span>
</td>
<td class="num">$ (5,741)<span></span>
</td>
<td class="num">$ (36)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_OpioidLitigationAxis=cah_TotalOpioidLitigationMember', window );">Total Opioid Litigation [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossRelatedToLitigationSettlement', window );">Gain (Loss) Related to Litigation Settlement</a></td>
<td class="nump">$ 1,170<span></span>
</td>
<td class="nump">$ 5,630<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossRelatedToLitigationSettlement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) recognized in settlement of litigation and insurance claims. Excludes claims within an insurance entity's normal claims settlement process.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossRelatedToLitigationSettlement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_OpioidLitigationAxis=cah_TotalOpioidLitigationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_OpioidLitigationAxis=cah_TotalOpioidLitigationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140421172508328">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Divestitures and Acquisitions (Narrative) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Aug. 02, 2021</div></th>
<th class="th"><div>Aug. 31, 2018</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
<th class="th"><div>Aug. 01, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired', window );">Payments to Acquire Businesses, Net of Cash Acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 82<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_PreTaxGainonDivestiture', window );">Pre-Tax Gain on Divestiture</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">508<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestments', window );">Income (Loss) from Equity Method Investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="nump">10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation', window );">Disposal Group, Including Discontinued Operation, Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,101<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation', window );">Disposal Group, Including Discontinued Operation, Liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">96<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_NaviHealthAxis=cah_NaviHealthMember', window );">naviHealth [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromDivestitureOfBusinesses', window );">Proceeds from Divestiture of Businesses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 737<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_PreTaxGainonDivestiture', window );">Pre-Tax Gain on Divestiture</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 508<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestments', window );">Equity Method Investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 358<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount', window );">Redeemable Noncontrolling Interest, Equity, Carrying Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 12<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_Provisionaltaxbenefitrelatedtotransaction', window );">Provisional tax benefit related to transaction</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 130<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainOnSaleOfInvestments', window );">Gain on Sale of Investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">579<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_CordisDivestitureAxis=cah_CordisDivestitureMember', window );">Cordis Divestiture</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration', window );">Disposal Group, Including Discontinued Operation, Consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">927<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1', window );">Disposal Group, Including Discontinued Operation, Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(388)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_WriteDownOfAssetsHeldForSale', window );">Write-down of assets held for sale</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(60)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation', window );">Disposal Group, Including Discontinued Operation, Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,091<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccruedLiabilities', window );">Disposal Group, Including Discontinued Operation, Accrued Liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">61<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherLiabilities', window );">Disposal Group, Including Discontinued Operation, Other Liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">34<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation', window );">Disposal Group, Including Discontinued Operation, Liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">95<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationForeignCurrencyTranslationGainsLosses', window );">Disposal Group, Including Discontinued Operation, Foreign Currency Translation Gains (Losses)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DiscontinuedOperationTaxEffectOfIncomeLossFromDisposalOfDiscontinuedOperation', window );">Discontinued Operation, Tax Effect of Gain (Loss) from Disposal of Discontinued Operation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents', window );">Disposal Group, Including Discontinued Operation, Cash and Cash Equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">109<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1', window );">Disposal Group, Including Discontinued Operation, Inventory</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">164<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment', window );">Disposal Group, Including Discontinued Operation, Property, Plant and Equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">90<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_DisposalGroupIncludingDiscontinuedOperationsGoodwillAndOtherIntangiblesNet', window );">Disposal Group Including Discontinued Operations Goodwill and Other Intangibles, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">778<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets', window );">Disposal Group, Including Discontinued Operation, Other Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_CordisDivestitureAxis=cah_CordisDivestitureMember', window );">Cordis Divestiture | Subsequent Event</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromDivestitureOfBusinesses', window );">Proceeds from Divestiture of Businesses</a></td>
<td class="nump">$ 927<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=cah_NaviHealthMember', window );">naviHealth [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainOnSaleOfInvestments', window );">Gain on Sale of Investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 579<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_DisposalGroupIncludingDiscontinuedOperationsGoodwillAndOtherIntangiblesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disposal Group Including Discontinued Operations Goodwill and Other Intangibles, net</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_DisposalGroupIncludingDiscontinuedOperationsGoodwillAndOtherIntangiblesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_PreTaxGainonDivestiture">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Pre-Tax Gain on Divestiture</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_PreTaxGainonDivestiture</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_Provisionaltaxbenefitrelatedtotransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Provisional tax benefit related to transaction</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_Provisionaltaxbenefitrelatedtotransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_WriteDownOfAssetsHeldForSale">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Write-down of assets held for sale</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_WriteDownOfAssetsHeldForSale</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount classified as assets attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DiscontinuedOperationTaxEffectOfIncomeLossFromDisposalOfDiscontinuedOperation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of tax expense (benefit) on gain (loss) not previously recognized resulting from the disposal of a discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3B<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721525-107759<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=d3e1361-107760<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DiscontinuedOperationTaxEffectOfIncomeLossFromDisposalOfDiscontinuedOperation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount classified as accrued liabilities attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount classified as cash and cash equivalents attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of consideration received or receivable for the disposal of assets and liabilities, including discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationForeignCurrencyTranslationGainsLosses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of foreign currency translation gain (loss) in the disposal group, including discontinued operation, recognized in the statement of income as a result of the sale or complete or substantially complete liquidation of an investment in a foreign entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationForeignCurrencyTranslationGainsLosses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount classified as goodwill attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount classified as inventory attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount classified as other assets attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount classified as other liabilities attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount classified as property, plant and equipment attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109237563&amp;loc=d3e33749-111570<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8813-108599<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.12)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainOnSaleOfInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The difference between the carrying value and the sale price of an investment.  A gain would be recognized when the sale price of the investment is greater than the carrying value of the investment.  This element refers to the Gain included in earnings and not to the cash proceeds of the sale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(3)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(b)(9)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(b)(7)(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainOnSaleOfInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) for proportionate share of equity method investee's income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(13)(f))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109237563&amp;loc=d3e33749-111570<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount classified as liabilities attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromDivestitureOfBusinesses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from the sale of a portion of the company's business, for example a segment, division, branch or other business, during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromDivestitureOfBusinesses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>As of the reporting date, the aggregate carrying amount of all noncontrolling interests which are redeemable by the (parent) entity (1) at a fixed or determinable price on a fixed or determinable date, (2) at the option of the holder of the noncontrolling interest, or (3) upon occurrence of an event that is not solely within the control of the (parent) entity. This item includes noncontrolling interest holder's ownership (or holders' ownership) regardless of the type of equity interest (common, preferred, other) including all potential organizational (legal) forms of the investee entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (16)(c)<br> -URI http://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=SL6540498-122764<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=SL6540498-122764<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (12)(c)<br> -URI http://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=SL6540498-122764<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=SL6540498-122764<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_NaviHealthAxis=cah_NaviHealthMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_NaviHealthAxis=cah_NaviHealthMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_CordisDivestitureAxis=cah_CordisDivestitureMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_CordisDivestitureAxis=cah_CordisDivestitureMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=cah_NaviHealthMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=cah_NaviHealthMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140421172713048">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Restructuring and Employee Severance (Activity Related to Restructuring and Employee Severance Costs) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringChargesAbstract', window );"><strong>Restructuring Charges [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SeveranceCosts1', window );">Employee-related costs</a></td>
<td class="nump">$ 53<span></span>
</td>
<td class="nump">$ 66<span></span>
</td>
<td class="nump">$ 95<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_FacilityExitAndOtherCosts', window );">Facility Exit and Other Costs</a></td>
<td class="nump">61<span></span>
</td>
<td class="nump">56<span></span>
</td>
<td class="nump">30<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Total restructuring and employee severance</a></td>
<td class="nump">$ 114<span></span>
</td>
<td class="nump">$ 122<span></span>
</td>
<td class="nump">$ 125<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_FacilityExitAndOtherCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Facility exit and other costs primarily consist of lease termination costs, accelerated depreciation, equipment relocation costs, project consulting fees and costs associated with restructuring our delivery of information technology infrastructure services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_FacilityExitAndOtherCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109237686&amp;loc=d3e17752-110868<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.P.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140864-122747<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringChargesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringChargesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SeveranceCosts1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses for special or contractual termination benefits provided to current employees involuntarily terminated under a benefit arrangement associated exit or disposal activities pursuant to an authorized plan. Excludes expenses related to one-time termination benefits, a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SeveranceCosts1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140421173288648">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Restructuring and Employee Severance (Liabilities Associated with Restructuring and Employee Severance Activities) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Restructuring Reserve [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Beginning Balance</a></td>
<td class="nump">$ 96<span></span>
</td>
<td class="nump">$ 72<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCosts', window );">Additions</a></td>
<td class="nump">75<span></span>
</td>
<td class="nump">109<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRestructuring', window );">Payments and other adjustments</a></td>
<td class="num">(92)<span></span>
</td>
<td class="num">(85)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Ending Balance</a></td>
<td class="nump">79<span></span>
</td>
<td class="nump">96<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveAxis=us-gaap_EmployeeSeveranceMember', window );">Employee- Related Costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Restructuring Reserve [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Beginning Balance</a></td>
<td class="nump">68<span></span>
</td>
<td class="nump">64<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCosts', window );">Additions</a></td>
<td class="nump">49<span></span>
</td>
<td class="nump">85<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRestructuring', window );">Payments and other adjustments</a></td>
<td class="num">(64)<span></span>
</td>
<td class="num">(81)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Ending Balance</a></td>
<td class="nump">53<span></span>
</td>
<td class="nump">68<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveAxis=us-gaap_FacilityClosingMember', window );">Facility Exit and Other Costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Restructuring Reserve [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Beginning Balance</a></td>
<td class="nump">28<span></span>
</td>
<td class="nump">8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCosts', window );">Additions</a></td>
<td class="nump">26<span></span>
</td>
<td class="nump">24<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRestructuring', window );">Payments and other adjustments</a></td>
<td class="num">(28)<span></span>
</td>
<td class="num">(4)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Ending Balance</a></td>
<td class="nump">$ 26<span></span>
</td>
<td class="nump">$ 28<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRestructuring">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash payments made as the result of exit or disposal activities. Excludes payments associated with a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3367-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRestructuring</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after cash payment, of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringReserve">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount (including both current and noncurrent portions of the accrual) as of the balance sheet date pertaining to a specified type of cost associated with exit from or disposal of business activities or restructuring pursuant to a duly authorized plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB TOPIC 5.P.4(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringReserve</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringReserveRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringReserveRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveAxis=us-gaap_EmployeeSeveranceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveAxis=us-gaap_EmployeeSeveranceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveAxis=us-gaap_FacilityClosingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveAxis=us-gaap_FacilityClosingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140421171873384">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and Other Intangible Assets (Schedule of Goodwill by Reportable Segment) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillLineItems', window );"><strong>Goodwill [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillTransfers', window );">Goodwill, Transfers</a></td>
<td class="nump">$ 2<span></span>
</td>
<td class="num">$ (5)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Beginning balance</a></td>
<td class="nump">8,357<span></span>
</td>
<td class="nump">8,378<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillForeignCurrencyTranslationGainLoss', window );">Foreign currency translation adjustments and other</a></td>
<td class="num">(18)<span></span>
</td>
<td class="nump">16<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Ending balance</a></td>
<td class="nump">7,989<span></span>
</td>
<td class="nump">8,357<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_CordisDivestitureAxis=cah_CordisDivestitureMember', window );">Cordis Divestiture</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1', window );">Disposal Group, Including Discontinued Operation, Goodwill</a></td>
<td class="num">(388)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=cah_MedicalMemberMember', window );">Medical</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillLineItems', window );"><strong>Goodwill [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillTransfers', window );">Goodwill, Transfers</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Beginning balance</a></td>
<td class="nump">5,700<span></span>
</td>
<td class="nump">5,715<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillForeignCurrencyTranslationGainLoss', window );">Foreign currency translation adjustments and other</a></td>
<td class="num">(18)<span></span>
</td>
<td class="nump">15<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Ending balance</a></td>
<td class="nump">5,330<span></span>
</td>
<td class="nump">5,700<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss', window );">Accumulated goodwill impairment loss</a></td>
<td class="nump">1,400<span></span>
</td>
<td class="nump">1,400<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=cah_MedicalMemberMember', window );">Medical | Cordis Divestiture</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1', window );">Disposal Group, Including Discontinued Operation, Goodwill</a></td>
<td class="num">(388)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=cah_PharmaceuticalMember', window );">Pharmaceutical</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillLineItems', window );"><strong>Goodwill [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillTransfers', window );">Goodwill, Transfers</a></td>
<td class="nump">2<span></span>
</td>
<td class="num">(5)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Beginning balance</a></td>
<td class="nump">2,657<span></span>
</td>
<td class="nump">2,663<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillForeignCurrencyTranslationGainLoss', window );">Foreign currency translation adjustments and other</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Ending balance</a></td>
<td class="nump">2,659<span></span>
</td>
<td class="nump">2,657<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss', window );">Accumulated goodwill impairment loss</a></td>
<td class="nump">829<span></span>
</td>
<td class="nump">$ 829<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=cah_PharmaceuticalMember', window );">Pharmaceutical | Cordis Divestiture</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1', window );">Disposal Group, Including Discontinued Operation, Goodwill</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount classified as goodwill attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120320667&amp;loc=SL49117168-202975<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillForeignCurrencyTranslationGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of foreign currency translation gain (loss) which increases (decreases) an asset representing future economic benefits from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillForeignCurrencyTranslationGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated impairment loss for an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillImpairedAccumulatedImpairmentLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillTransfers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of transfers into (out of) an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillTransfers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_CordisDivestitureAxis=cah_CordisDivestitureMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_CordisDivestitureAxis=cah_CordisDivestitureMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=cah_MedicalMemberMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=cah_MedicalMemberMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=cah_PharmaceuticalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=cah_PharmaceuticalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140421171889160">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and Other Intangible Assets (Schedule of Intangible Assets) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems', window );"><strong>Indefinite-lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill', window );">Net Intangible</a></td>
<td class="nump">$ 12<span></span>
</td>
<td class="nump">$ 23<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization of Intangible Assets</a></td>
<td class="nump">428<span></span>
</td>
<td class="nump">512<span></span>
</td>
<td class="nump">$ 531<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Intangible</a></td>
<td class="nump">4,916<span></span>
</td>
<td class="nump">5,831<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="nump">2,823<span></span>
</td>
<td class="nump">2,936<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net Intangible</a></td>
<td class="nump">$ 2,093<span></span>
</td>
<td class="nump">2,895<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1', window );">Weighted- Average Remaining Amortization Period (Years)</a></td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsGrossExcludingGoodwill', window );">Gross Intangible, Total other intangible assets</a></td>
<td class="nump">$ 4,928<span></span>
</td>
<td class="nump">5,854<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Net Intangible, Total other intangible assets</a></td>
<td class="nump">2,105<span></span>
</td>
<td class="nump">2,918<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=cah_IPRDTrademarksandOtherMember', window );">Trademarks and patents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems', window );"><strong>Indefinite-lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill', window );">Net Intangible</a></td>
<td class="nump">12<span></span>
</td>
<td class="nump">23<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember', window );">Customer relationships</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Intangible</a></td>
<td class="nump">3,330<span></span>
</td>
<td class="nump">3,554<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="nump">1,989<span></span>
</td>
<td class="nump">1,828<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net Intangible</a></td>
<td class="nump">$ 1,341<span></span>
</td>
<td class="nump">1,726<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1', window );">Weighted- Average Remaining Amortization Period (Years)</a></td>
<td class="text">11 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=cah_TrademarksAndPatentsMember', window );">Trademarks, trade names and patents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Intangible</a></td>
<td class="nump">$ 551<span></span>
</td>
<td class="nump">673<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="nump">328<span></span>
</td>
<td class="nump">341<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net Intangible</a></td>
<td class="nump">$ 223<span></span>
</td>
<td class="nump">332<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1', window );">Weighted- Average Remaining Amortization Period (Years)</a></td>
<td class="text">9 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DevelopedTechnologyRightsMember', window );">Developed technology and other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Intangible</a></td>
<td class="nump">$ 1,035<span></span>
</td>
<td class="nump">1,604<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="nump">506<span></span>
</td>
<td class="nump">767<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net Intangible</a></td>
<td class="nump">$ 529<span></span>
</td>
<td class="nump">$ 837<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1', window );">Weighted- Average Remaining Amortization Period (Years)</a></td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16225-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 928<br> -SubTopic 340<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6473545&amp;loc=d3e61844-108004<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120154696&amp;loc=d3e54445-107959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Remaining amortization period of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120154696&amp;loc=d3e54445-107959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsGrossExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated amortization of intangible assets, excluding goodwill.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsGrossExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph ((a)(1),(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16212-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=cah_IPRDTrademarksandOtherMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=cah_IPRDTrademarksandOtherMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=cah_TrademarksAndPatentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=cah_TrademarksAndPatentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DevelopedTechnologyRightsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DevelopedTechnologyRightsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>73
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140421172722744">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and Other Intangible Assets (Narrative) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillLineItems', window );"><strong>Goodwill [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">$ 7,989<span></span>
</td>
<td class="nump">$ 8,357<span></span>
</td>
<td class="nump">$ 8,378<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization of Intangible Assets</a></td>
<td class="nump">428<span></span>
</td>
<td class="nump">512<span></span>
</td>
<td class="nump">531<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths', window );">Estimated annual amortization of intangible assets - 2022</a></td>
<td class="nump">315<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo', window );">Estimated annual amortization of intangible assets - 2023</a></td>
<td class="nump">287<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree', window );">Estimated annual amortization of intangible assets - 2024</a></td>
<td class="nump">264<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour', window );">Estimated annual amortization of intangible assets - 2025</a></td>
<td class="nump">238<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive', window );">Estimated annual amortization of intangible assets - 2026</a></td>
<td class="nump">212<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=cah_MedicalMemberMember', window );">Medical</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillLineItems', window );"><strong>Goodwill [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">5,330<span></span>
</td>
<td class="nump">5,700<span></span>
</td>
<td class="nump">5,715<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss', window );">Accumulated goodwill impairment loss</a></td>
<td class="nump">1,400<span></span>
</td>
<td class="nump">1,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=cah_PharmaceuticalMember', window );">Pharmaceutical</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillLineItems', window );"><strong>Goodwill [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">2,659<span></span>
</td>
<td class="nump">2,657<span></span>
</td>
<td class="nump">$ 2,663<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss', window );">Accumulated goodwill impairment loss</a></td>
<td class="nump">$ 829<span></span>
</td>
<td class="nump">$ 829<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16225-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120320667&amp;loc=SL49117168-202975<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated impairment loss for an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillImpairedAccumulatedImpairmentLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=cah_MedicalMemberMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=cah_MedicalMemberMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=cah_PharmaceuticalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=cah_PharmaceuticalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>74
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140421173324120">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jul. 01, 2019</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeaseAndRentalExpense', window );">Operating Leases, Rent Expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 153<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_ReclassificationofdeferredrentinaccordancewithASC842', window );">Reclassification of deferred rent in accordance with ASC 842</a></td>
<td class="nump">$ 22<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1', window );">Operating Lease, Weighted Average Remaining Lease Term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">6 years 6 months<span></span>
</td>
<td class="text">6 years 4 months 24 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent', window );">Operating Lease, Weighted Average Discount Rate, Percent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.90%<span></span>
</td>
<td class="nump">2.90%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1', window );">Finance Lease, Weighted Average Remaining Lease Term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">4 years 2 months 12 days<span></span>
</td>
<td class="text">4 years 3 months 18 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent', window );">Finance Lease, Weighted Average Discount Rate, Percent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.50%<span></span>
</td>
<td class="nump">2.40%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseTermOfContract', window );">Lessee, Operating Lease, Term of Contract</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseTermOfContract', window );">Lessee, Operating Lease, Term of Contract</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">21 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_ReclassificationofdeferredrentinaccordancewithASC842">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Reclassification of deferred rent in accordance with ASC 842</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_ReclassificationofdeferredrentinaccordancewithASC842</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average discount rate for finance lease calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining lease term for finance lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseAndRentalExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of rent expense incurred for leased assets, including but not limited to, furniture and equipment, that is not directly or indirectly associated with the manufacture, sale or creation of a product or product line.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseAndRentalExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseTermOfContract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Term of lessee's operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918673-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseTermOfContract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average discount rate for operating lease calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>75
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140421165972264">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases Schedule of Lease Costs (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseCost', window );">Operating Lease, Cost</a></td>
<td class="nump">$ 119<span></span>
</td>
<td class="nump">$ 134<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseRightOfUseAssetAmortization', window );">Amortization of right-of-use assets</a></td>
<td class="nump">16<span></span>
</td>
<td class="nump">13<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_VariableLeaseCost', window );">Variable lease cost</a></td>
<td class="nump">24<span></span>
</td>
<td class="nump">17<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeaseCost', window );">Total lease cost</a></td>
<td class="nump">$ 159<span></span>
</td>
<td class="nump">$ 164<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseRightOfUseAssetAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense attributable to right-of-use asset from finance lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918638-209977<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseRightOfUseAssetAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lease cost recognized by lessee for lease contract.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of variable lease cost, excluded from lease liability, recognized when obligation for payment is incurred for finance and operating leases.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>76
<FILENAME>R56.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140421169462616">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Leases Supplemental Balance Sheet Information (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Total operating lease liabilities</a></td>
<td class="nump">$ 479<span></span>
</td>
<td class="nump">$ 445<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiability', window );">Total finance lease liabilities</a></td>
<td class="nump">64<span></span>
</td>
<td class="nump">34<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityCurrent', window );">Finance Lease, Liability, Current</a></td>
<td class="nump">19<span></span>
</td>
<td class="nump">9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityNoncurrent', window );">Finance Lease, Liability, Noncurrent</a></td>
<td class="nump">$ 45<span></span>
</td>
<td class="nump">$ 25<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1', window );">Operating Lease, Weighted Average Remaining Lease Term</a></td>
<td class="text">6 years 6 months<span></span>
</td>
<td class="text">6 years 4 months 24 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1', window );">Finance Lease, Weighted Average Remaining Lease Term</a></td>
<td class="text">4 years 2 months 12 days<span></span>
</td>
<td class="text">4 years 3 months 18 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent', window );">Operating Lease, Weighted Average Discount Rate, Percent</a></td>
<td class="nump">2.90%<span></span>
</td>
<td class="nump">2.90%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent', window );">Finance Lease, Weighted Average Discount Rate, Percent</a></td>
<td class="nump">1.50%<span></span>
</td>
<td class="nump">2.40%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Total lease liabilities</a></td>
<td class="nump">$ 479<span></span>
</td>
<td class="nump">$ 445<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityCurrent', window );">Finance Lease, Liability, Current</a></td>
<td class="nump">19<span></span>
</td>
<td class="nump">9<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherAssetsMember', window );">Other Assets [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating Lease, Right-of-Use Asset</a></td>
<td class="nump">460<span></span>
</td>
<td class="nump">426<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating Lease, Right-of-Use Asset</a></td>
<td class="nump">460<span></span>
</td>
<td class="nump">426<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherLiabilitiesMember', window );">Other Liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Operating Lease, Liability, Noncurrent</a></td>
<td class="nump">374<span></span>
</td>
<td class="nump">341<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Operating Lease, Liability, Noncurrent</a></td>
<td class="nump">374<span></span>
</td>
<td class="nump">341<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_AccruedLiabilitiesMember', window );">Other Accrued Liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Operating Lease, Liability, Current</a></td>
<td class="nump">105<span></span>
</td>
<td class="nump">104<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Operating Lease, Liability, Current</a></td>
<td class="nump">105<span></span>
</td>
<td class="nump">104<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_PropertyPlantAndEquipmentMember', window );">Property, Plant and Equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseRightOfUseAsset', window );">Finance Lease, Right-of-Use Asset, after Accumulated Amortization</a></td>
<td class="nump">63<span></span>
</td>
<td class="nump">33<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseRightOfUseAsset', window );">Finance Lease, Right-of-Use Asset, after Accumulated Amortization</a></td>
<td class="nump">$ 63<span></span>
</td>
<td class="nump">$ 33<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of right-of-use asset from finance lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average discount rate for finance lease calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining lease term for finance lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average discount rate for operating lease calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_AccruedLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_AccruedLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_PropertyPlantAndEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_PropertyPlantAndEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>77
<FILENAME>R57.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140421173200952">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases Supplemental Cash Flow Information (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jul. 01, 2019</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasePayments', window );">Operating Lease, Payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 115<span></span>
</td>
<td class="nump">$ 125<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeasePrincipalPayments', window );">Finance Lease, Principal Payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15<span></span>
</td>
<td class="nump">7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability', window );">Right-of-Use Asset Obtained in Exchange for Operating Lease Liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">138<span></span>
</td>
<td class="nump">150<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability', window );">Right-of-Use Asset Obtained in Exchange for Finance Lease Liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">45<span></span>
</td>
<td class="nump">$ 40<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_ReclassificationofdeferredrentinaccordancewithASC842', window );">Reclassification of deferred rent in accordance with ASC 842</a></td>
<td class="nump">$ 22<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=cah_ASC842Member', window );">ASC 842</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_Impactofadoptionofnewaccountingstandard', window );">New Accounting Pronouncement or Change in Accounting Principle, Effect of Adoption, Quantification (Deprecated 2020-01-31)</a></td>
<td class="nump">$ 400<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_Impactofadoptionofnewaccountingstandard">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>impact of adoption of new accounting standard</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_Impactofadoptionofnewaccountingstandard</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_ReclassificationofdeferredrentinaccordancewithASC842">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Reclassification of deferred rent in accordance with ASC 842</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_ReclassificationofdeferredrentinaccordancewithASC842</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeasePrincipalPayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for principal payment on finance lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918643-209977<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeasePrincipalPayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasePayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918643-209977<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasePayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in right-of-use asset obtained in exchange for finance lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in right-of-use asset obtained in exchange for operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=cah_ASC842Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=cah_ASC842Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>78
<FILENAME>R58.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140421173159016">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Leases Schedule of Future Lease Payments (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_LesseeLeaseLiabilityPaymentsDueYearTwo', window );">2023</a></td>
<td class="nump">$ 113<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_LesseeLeaseLiabilityPaymentsDueYearThree', window );">2024</a></td>
<td class="nump">86<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_LesseeLeaseLiabilityPaymentsDueYearFour', window );">2025</a></td>
<td class="nump">73<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_LesseeLeaseLiabilityPaymentsDueYearFive', window );">2026</a></td>
<td class="nump">53<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_LesseeLeaseLiabilityPaymentsDueAfterYearFive', window );">Thereafter</a></td>
<td class="nump">146<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_TotalLeaseLiabilityPaymentsDue', window );">Total future lease payments</a></td>
<td class="nump">607<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_TotalLeaseLiabilityNotYetCommencedAmount', window );">Less: leases not yet commenced (1)</a></td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_TotalLeaseLiabilityUndiscountedExcessAmount', window );">Less: imputed interest</a></td>
<td class="nump">61<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Total lease liabilities</a></td>
<td class="nump">479<span></span>
</td>
<td class="nump">$ 445<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiability', window );">Total lease liabilities</a></td>
<td class="nump">64<span></span>
</td>
<td class="nump">$ 34<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_TotalLeaseLiability', window );">Total Lease Liability</a></td>
<td class="nump">543<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_LesseeLeaseLiabilityPaymentsDueYearOne', window );">2022</a></td>
<td class="nump">136<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=cah_OperatingLeaseMember', window );">Operating Leases</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo', window );">2023</a></td>
<td class="nump">93<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree', window );">2024</a></td>
<td class="nump">72<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour', window );">2025</a></td>
<td class="nump">65<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive', window );">2026</a></td>
<td class="nump">50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive', window );">Thereafter</a></td>
<td class="nump">141<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue', window );">Total future lease payments</a></td>
<td class="nump">537<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_LesseeOperatingLeaseLiabilityNotYetCommencedAmount', window );">Less: leases not yet commenced (1)</a></td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_OperatingLeaseImputedInterest', window );">Less: imputed interest</a></td>
<td class="nump">55<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Total lease liabilities</a></td>
<td class="nump">479<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths', window );">2022</a></td>
<td class="nump">116<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=cah_FinanceLeaseMember', window );">Finance Leases</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo', window );">2023</a></td>
<td class="nump">20<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree', window );">2024</a></td>
<td class="nump">14<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour', window );">2025</a></td>
<td class="nump">8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive', window );">2026</a></td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive', window );">Thereafter</a></td>
<td class="nump">5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDue', window );">Total future lease payments</a></td>
<td class="nump">70<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_LesseeFinanceLeaseLiabilityNotYetCommencedAmount', window );">Less: leases not yet commenced (1)</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_FinanceLeaseImputedInterest', window );">Less: imputed interest</a></td>
<td class="nump">6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiability', window );">Total lease liabilities</a></td>
<td class="nump">64<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths', window );">2022</a></td>
<td class="nump">$ 20<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_FinanceLeaseImputedInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Finance Lease Imputed Interest</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_FinanceLeaseImputedInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_LesseeFinanceLeaseLiabilityNotYetCommencedAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Lessee Finance Lease Liability Not Yet Commenced, Amount</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_LesseeFinanceLeaseLiabilityNotYetCommencedAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_LesseeLeaseLiabilityPaymentsDueAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Lessee Lease Liability Payments Due After Year Five</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_LesseeLeaseLiabilityPaymentsDueAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_LesseeLeaseLiabilityPaymentsDueYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Lessee Lease Liability Payments Due Year Five</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_LesseeLeaseLiabilityPaymentsDueYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_LesseeLeaseLiabilityPaymentsDueYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Lessee Lease Liability Payments Due Year Four</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_LesseeLeaseLiabilityPaymentsDueYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_LesseeLeaseLiabilityPaymentsDueYearOne">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Lessee Lease Liability Payments Due Year One</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_LesseeLeaseLiabilityPaymentsDueYearOne</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_LesseeLeaseLiabilityPaymentsDueYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Lessee Lease Liability Payments Due Year Three</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_LesseeLeaseLiabilityPaymentsDueYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_LesseeLeaseLiabilityPaymentsDueYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Lessee Lease Liability Payments Due Year Two</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_LesseeLeaseLiabilityPaymentsDueYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_LesseeOperatingLeaseLiabilityNotYetCommencedAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Lessee Operating Lease Liability Not Yet Commenced, Amount</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_LesseeOperatingLeaseLiabilityNotYetCommencedAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_OperatingLeaseImputedInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Operating Lease Imputed Interest</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_OperatingLeaseImputedInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_TotalLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total Lease Liability</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_TotalLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_TotalLeaseLiabilityNotYetCommencedAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total Lease Liability Not Yet Commenced, Amount</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_TotalLeaseLiabilityNotYetCommencedAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_TotalLeaseLiabilityPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total undiscounted Lease Liability Payments Due for both operating and financing leases</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_TotalLeaseLiabilityPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_TotalLeaseLiabilityUndiscountedExcessAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total Lease Liability Undiscounted Excess Amount</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_TotalLeaseLiabilityUndiscountedExcessAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments for finance lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease due after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=cah_OperatingLeaseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=cah_OperatingLeaseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=cah_FinanceLeaseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=cah_FinanceLeaseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>79
<FILENAME>R59.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140421269877400">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Long-Term Obligations and Other Short-Term Borrowings Summary of Debt (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="nump">$ 23,700<span></span>
</td>
<td class="nump">$ 21,374<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherBorrowings', window );">Other obligations</a></td>
<td class="nump">67<span></span>
</td>
<td class="nump">35<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtAndCapitalLeaseObligations', window );">Total</a></td>
<td class="nump">6,236<span></span>
</td>
<td class="nump">6,775<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent', window );">Less: current portion of long-term obligations and other short-term borrowings</a></td>
<td class="nump">871<span></span>
</td>
<td class="nump">10<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtAndCapitalLeaseObligations', window );">Long-term obligations, less current portion</a></td>
<td class="nump">5,365<span></span>
</td>
<td class="nump">6,765<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=cah_A2.616Notesdue2022Member', window );">2.616% Notes due fiscal 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NotesPayable', window );">Notes Payable</a></td>
<td class="nump">572<span></span>
</td>
<td class="nump">834<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=cah_A3.2Notesdue2022Member', window );">3.2% Notes due 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NotesPayable', window );">Notes Payable</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">236<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=cah_FloatingRateNotesdue2022Member', window );">Floating Rate Notes due fiscal 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NotesPayable', window );">Notes Payable</a></td>
<td class="nump">281<span></span>
</td>
<td class="nump">321<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=cah_A3.2Notesdue2023Member', window );">3.2% Notes due 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NotesPayable', window );">Notes Payable</a></td>
<td class="nump">564<span></span>
</td>
<td class="nump">576<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=cah_A3.079Notesdue2024Member', window );">3.079% Notes due fiscal 2024</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NotesPayable', window );">Notes Payable</a></td>
<td class="nump">794<span></span>
</td>
<td class="nump">809<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=cah_A3.5Notesdue2025Member', window );">3.5% Notes due fiscal 2025</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NotesPayable', window );">Notes Payable</a></td>
<td class="nump">410<span></span>
</td>
<td class="nump">413<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=cah_A3.75Notesdue2026Member', window );">3.75% Notes due 2025</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NotesPayable', window );">Notes Payable</a></td>
<td class="nump">524<span></span>
</td>
<td class="nump">529<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=cah_A3.41Notesdue2027Member', window );">3.41% Notes due fiscal 2027</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NotesPayable', window );">Notes Payable</a></td>
<td class="nump">1,216<span></span>
</td>
<td class="nump">1,215<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=cah_A4.6Notesdue2043Member', window );">4.6% Notes due 2043</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NotesPayable', window );">Notes Payable</a></td>
<td class="nump">341<span></span>
</td>
<td class="nump">340<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=cah_A4.5Notesdue2044Member', window );">4.5% Notes due 2044</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NotesPayable', window );">Notes Payable</a></td>
<td class="nump">342<span></span>
</td>
<td class="nump">342<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=cah_A4.9Notesdue2045Member', window );">4.9% Notes due 2045</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NotesPayable', window );">Notes Payable</a></td>
<td class="nump">441<span></span>
</td>
<td class="nump">441<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=cah_A4.368Notesdue2047Member', window );">4.368% Notes due fiscal 2047</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NotesPayable', window );">Notes Payable</a></td>
<td class="nump">560<span></span>
</td>
<td class="nump">560<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=cah_A7.0Debenturesduefiscal2027Member', window );">7.0%&#160;Debentures due 2026</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NotesPayable', window );">Notes Payable</a></td>
<td class="nump">$ 124<span></span>
</td>
<td class="nump">$ 124<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtAndCapitalLeaseObligations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of short-term and long-term debt and lease obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.13,16)<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.16)<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtAndCapitalLeaseObligations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtAndCapitalLeaseObligations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt and lease obligation, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtAndCapitalLeaseObligations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt and lease obligation, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Including the current and noncurrent portions, aggregate carrying amount of all types of notes payable, as of the balance sheet date, with initial maturities beyond one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherBorrowings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The carrying amount as of the balance sheet date for the aggregate of other miscellaneous borrowings owed by the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.13,16)<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherBorrowings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cah_A2.616Notesdue2022Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cah_A2.616Notesdue2022Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cah_A3.2Notesdue2022Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cah_A3.2Notesdue2022Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cah_FloatingRateNotesdue2022Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cah_FloatingRateNotesdue2022Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cah_A3.2Notesdue2023Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cah_A3.2Notesdue2023Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cah_A3.079Notesdue2024Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cah_A3.079Notesdue2024Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cah_A3.5Notesdue2025Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cah_A3.5Notesdue2025Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cah_A3.75Notesdue2026Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cah_A3.75Notesdue2026Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cah_A3.41Notesdue2027Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cah_A3.41Notesdue2027Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cah_A4.6Notesdue2043Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cah_A4.6Notesdue2043Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cah_A4.5Notesdue2044Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cah_A4.5Notesdue2044Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cah_A4.9Notesdue2045Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cah_A4.9Notesdue2045Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cah_A4.368Notesdue2047Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cah_A4.368Notesdue2047Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cah_A7.0Debenturesduefiscal2027Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cah_A7.0Debenturesduefiscal2027Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>80
<FILENAME>R60.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140421171132744">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Long-Term Obligations and Other Short-Term Borrowings Narrative (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2021<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts Payable, Current</a></td>
<td class="nump">$ 23,700<span></span>
</td>
<td class="nump">$ 23,700<span></span>
</td>
<td class="nump">$ 21,374<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_NotesPayableRepurchased', window );">Notes Payable Repurchased</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherBorrowings', window );">Other Borrowings</a></td>
<td class="nump">67<span></span>
</td>
<td class="nump">67<span></span>
</td>
<td class="nump">35<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Gain (Loss) on Extinguishment of Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(14)<span></span>
</td>
<td class="num">(16)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrentAndNoncurrent', window );">Accounts Payable</a></td>
<td class="nump">23,700<span></span>
</td>
<td class="nump">23,700<span></span>
</td>
<td class="nump">21,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths', window );">Maturities of existing long-term obligations and other short-term borrowings - 2020</a></td>
<td class="nump">872<span></span>
</td>
<td class="nump">872<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo', window );">Maturities of existing long-term obligations and other short-term borrowings-2021</a></td>
<td class="nump">584<span></span>
</td>
<td class="nump">584<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree', window );">Maturities of existing long-term obligations and other short-term borrowings-2022</a></td>
<td class="nump">808<span></span>
</td>
<td class="nump">808<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour', window );">Maturities of existing long-term obligations and other short-term borrowings-2023</a></td>
<td class="nump">418<span></span>
</td>
<td class="nump">418<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive', window );">Maturities of existing long-term obligations and other short-term borrowings-2024</a></td>
<td class="nump">525<span></span>
</td>
<td class="nump">525<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive', window );">Maturities of existing long-term obligations and other short-term borrowings-Thereafter</a></td>
<td class="nump">3,000<span></span>
</td>
<td class="nump">3,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_LetterOfCreditMember', window );">Letter of Credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCredit', window );">Long-term Line of Credit</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=cah_CommittedReceivablesSalesFacilityProgramMember', window );">Committed Receivables Sales Facility Program</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumAmountOutstandingDuringPeriod', window );">Line of Credit Facility, Maximum Amount Outstanding During Period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Line of Credit Facility, Maximum Borrowing Capacity</a></td>
<td class="nump">2,000<span></span>
</td>
<td class="nump">2,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_CommercialPaperMember', window );">Commercial paper</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Line of Credit Facility, Maximum Borrowing Capacity</a></td>
<td class="nump">2,000<span></span>
</td>
<td class="nump">2,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=cah_ShortTermCreditFacilitiesMember', window );">Short Term Credit Facilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Line of Credit Facility, Maximum Borrowing Capacity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=cah_A2.616Notesdue2022Member', window );">2.616% Notes due fiscal 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_NotesPayableRepurchased', window );">Notes Payable Repurchased</a></td>
<td class="nump">$ 262<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="nump">247<span></span>
</td>
<td class="nump">67<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=cah_FloatingRateNotesdue2022Member', window );">Floating Rate Notes due fiscal 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_NotesPayableRepurchased', window );">Notes Payable Repurchased</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">40<span></span>
</td>
<td class="nump">20<span></span>
</td>
<td class="nump">8<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=cah_A3.41Notesdue2027Member', window );">3.41% Notes due fiscal 2027</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_NotesPayableRepurchased', window );">Notes Payable Repurchased</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">104<span></span>
</td>
<td class="nump">24<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=cah_A4.6Notesdue2043Member', window );">4.6% Notes due 2043</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_NotesPayableRepurchased', window );">Notes Payable Repurchased</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=cah_A4.9Notesdue2045Member', window );">4.9% Notes due 2045</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_NotesPayableRepurchased', window );">Notes Payable Repurchased</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=cah_A4.368Notesdue2047Member', window );">4.368% Notes due fiscal 2047</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_NotesPayableRepurchased', window );">Notes Payable Repurchased</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">35<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=cah_A2.616Notes3.2Notes3.41Notes4.6Notes4.9Notesand4.368NotesMember', window );">2.616% Notes, 3.2% Notes, 3.41% Notes, 4.6% Notes, 4.9% Notes and 4.368% Notes [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Gain (Loss) on Extinguishment of Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=cah_A4.625Notesdue2021Member', window );">4.625% Notes due 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_NotesPayableRepurchased', window );">Notes Payable Repurchased</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Gain (Loss) on Extinguishment of Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=cah_A3.2Notesdue2022Member', window );">3.2% Notes due 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_NotesPayableRepurchased', window );">Notes Payable Repurchased</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">238<span></span>
</td>
<td class="nump">11<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=cah_FloatingRateNotes2616NotesMember', window );">Floating rate notes, 2.616% Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Gain (Loss) on Extinguishment of Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=cah_A32Notes2616NotesMember', window );">3.2% notes, 2.616% Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Gain (Loss) on Extinguishment of Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 13<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=cah_A24NotesDue2019Member', window );">2.4% Notes due 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_NotesPayableRepurchased', window );">Notes Payable Repurchased</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 450<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_NotesPayableRepurchased">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Principal Amount of Notes Payable Repurchased during the year</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_NotesPayableRepurchased</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrentAndNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.15(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.15(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrentAndNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainsLossesOnExtinguishmentOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123467658&amp;loc=d3e12355-112629<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467658&amp;loc=d3e12317-112629<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainsLossesOnExtinguishmentOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityMaximumAmountOutstandingDuringPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Maximum amount borrowed under the credit facility at any time during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityMaximumAmountOutstandingDuringPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherBorrowings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The carrying amount as of the balance sheet date for the aggregate of other miscellaneous borrowings owed by the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.13,16)<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherBorrowings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_LetterOfCreditMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_LetterOfCreditMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=cah_CommittedReceivablesSalesFacilityProgramMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=cah_CommittedReceivablesSalesFacilityProgramMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_CommercialPaperMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_CommercialPaperMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=cah_ShortTermCreditFacilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=cah_ShortTermCreditFacilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cah_A2.616Notesdue2022Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cah_A2.616Notesdue2022Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cah_FloatingRateNotesdue2022Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cah_FloatingRateNotesdue2022Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cah_A3.41Notesdue2027Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cah_A3.41Notesdue2027Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cah_A4.6Notesdue2043Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cah_A4.6Notesdue2043Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cah_A4.9Notesdue2045Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cah_A4.9Notesdue2045Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cah_A4.368Notesdue2047Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cah_A4.368Notesdue2047Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cah_A2.616Notes3.2Notes3.41Notes4.6Notes4.9Notesand4.368NotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cah_A2.616Notes3.2Notes3.41Notes4.6Notes4.9Notesand4.368NotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cah_A4.625Notesdue2021Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cah_A4.625Notesdue2021Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cah_A3.2Notesdue2022Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cah_A3.2Notesdue2022Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cah_FloatingRateNotes2616NotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cah_FloatingRateNotes2616NotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cah_A32Notes2616NotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cah_A32Notes2616NotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cah_A24NotesDue2019Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cah_A24NotesDue2019Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>81
<FILENAME>R61.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140421173484776">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Long-Term Obligations and Other Short-Term Borrowings Long-Term Debt (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="nump">$ 23,700<span></span>
</td>
<td class="nump">$ 23,700<span></span>
</td>
<td class="nump">$ 21,374<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_OfferAsPercentageOfPrincipalAmount', window );">Offer as percentage of principal amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">101.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Gain (Loss) on Extinguishment of Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (14)<span></span>
</td>
<td class="num">(16)<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_NotesPayableRepurchased', window );">Notes Payable Repurchased</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=cah_A1.948Notesdue2019Member', window );">1.948% Notes due 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_NotesPayableRepurchased', window );">Notes Payable Repurchased</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=cah_A2.616Notesdue2022Member', window );">2.616% Notes due fiscal 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_NotesPayableRepurchased', window );">Notes Payable Repurchased</a></td>
<td class="nump">$ 262<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="nump">247<span></span>
</td>
<td class="nump">67<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=cah_A3.41Notesdue2027Member', window );">3.41% Notes due fiscal 2027</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_NotesPayableRepurchased', window );">Notes Payable Repurchased</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">104<span></span>
</td>
<td class="nump">24<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=cah_A4.368Notesdue2047Member', window );">4.368% Notes due fiscal 2047</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_NotesPayableRepurchased', window );">Notes Payable Repurchased</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">35<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=cah_A2.616Notes3.2Notes3.41Notes4.6Notes4.9Notesand4.368NotesMember', window );">2.616% Notes, 3.2% Notes, 3.41% Notes, 4.6% Notes, 4.9% Notes and 4.368% Notes [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Gain (Loss) on Extinguishment of Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=cah_FloatingRateNotesdue2022Member', window );">Floating Rate Notes due fiscal 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_NotesPayableRepurchased', window );">Notes Payable Repurchased</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">40<span></span>
</td>
<td class="nump">20<span></span>
</td>
<td class="nump">8<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=cah_A24NotesDue2019Member', window );">2.4% Notes due 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_NotesPayableRepurchased', window );">Notes Payable Repurchased</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">450<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=cah_A3.2Notesdue2022Member', window );">3.2% Notes due 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_NotesPayableRepurchased', window );">Notes Payable Repurchased</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 238<span></span>
</td>
<td class="nump">11<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=cah_A4.6Notesdue2043Member', window );">4.6% Notes due 2043</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_NotesPayableRepurchased', window );">Notes Payable Repurchased</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=cah_A4.625Notesdue2021Member', window );">4.625% Notes due 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Gain (Loss) on Extinguishment of Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_NotesPayableRepurchased', window );">Notes Payable Repurchased</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=cah_A4.9Notesdue2045Member', window );">4.9% Notes due 2045</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_NotesPayableRepurchased', window );">Notes Payable Repurchased</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=cah_A7.0Debenturesduefiscal2027Member', window );">7.0%&#160;Debentures due 2026 | Allegiance Corporation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate</a></td>
<td class="nump">7.00%<span></span>
</td>
<td class="nump">7.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_NotesPayableRepurchased">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Principal Amount of Notes Payable Repurchased during the year</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_NotesPayableRepurchased</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_OfferAsPercentageOfPrincipalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of principal amount that the company is required to offer to purchase certain notes, under certain circumstances.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_OfferAsPercentageOfPrincipalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainsLossesOnExtinguishmentOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123467658&amp;loc=d3e12355-112629<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467658&amp;loc=d3e12317-112629<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainsLossesOnExtinguishmentOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cah_A1.948Notesdue2019Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cah_A1.948Notesdue2019Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cah_A2.616Notesdue2022Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cah_A2.616Notesdue2022Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cah_A3.41Notesdue2027Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cah_A3.41Notesdue2027Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cah_A4.368Notesdue2047Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cah_A4.368Notesdue2047Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cah_A2.616Notes3.2Notes3.41Notes4.6Notes4.9Notesand4.368NotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cah_A2.616Notes3.2Notes3.41Notes4.6Notes4.9Notesand4.368NotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cah_FloatingRateNotesdue2022Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cah_FloatingRateNotesdue2022Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cah_A24NotesDue2019Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cah_A24NotesDue2019Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cah_A3.2Notesdue2022Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cah_A3.2Notesdue2022Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cah_A4.6Notesdue2043Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cah_A4.6Notesdue2043Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cah_A4.625Notesdue2021Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cah_A4.625Notesdue2021Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cah_A4.9Notesdue2045Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cah_A4.9Notesdue2045Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cah_A7.0Debenturesduefiscal2027Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cah_A7.0Debenturesduefiscal2027Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=cah_AllegianceCorporationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=cah_AllegianceCorporationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>82
<FILENAME>R62.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140421173549768">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Long-Term Obligations and Other Short-Term Borrowings Other Financing Arrangements (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherBorrowings', window );">Other obligations</a></td>
<td class="nump">$ 67<span></span>
</td>
<td class="nump">$ 35<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Maximum borrowing capacity</a></td>
<td class="nump">2,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_LetterOfCreditMember', window );">Letter of Credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCredit', window );">Line of credit</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherShortTermBorrowings', window );">Other Short-term Borrowings</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_LetterOfCreditMember', window );">Letter of Credit | Committed Receivables Sales Facility Program</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCredit', window );">Line of credit</a></td>
<td class="nump">31<span></span>
</td>
<td class="nump">29<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=cah_ShortTermCreditFacilitiesMember', window );">Short Term Credit Facilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Maximum borrowing capacity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=cah_ShortTermCreditFacilitiesMember', window );">Short Term Credit Facilities | Committed Receivables Sales Facility Program</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Maximum borrowing capacity</a></td>
<td class="nump">1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_CommercialPaperMember', window );">Commercial Paper</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Maximum borrowing capacity</a></td>
<td class="nump">2,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherShortTermBorrowings', window );">Other Short-term Borrowings</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=cah_CommittedReceivablesSalesFacilityProgramMember', window );">Committed Receivables Sales Facility Program</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherShortTermBorrowings', window );">Other Short-term Borrowings</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherBorrowings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The carrying amount as of the balance sheet date for the aggregate of other miscellaneous borrowings owed by the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.13,16)<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherBorrowings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherShortTermBorrowings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of borrowings classified as other, maturing within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a)(7))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherShortTermBorrowings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_LetterOfCreditMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_LetterOfCreditMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cah_CommittedReceivablesSalesFacilityProgramMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cah_CommittedReceivablesSalesFacilityProgramMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=cah_ShortTermCreditFacilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=cah_ShortTermCreditFacilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_CommercialPaperMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_CommercialPaperMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=cah_CommittedReceivablesSalesFacilityProgramMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=cah_CommittedReceivablesSalesFacilityProgramMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>83
<FILENAME>R63.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140421169654520">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments, Contingent Liabilities and Litigation (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Aug. 10, 2021 </div>
<div>lawsuit </div>
<div>plaintiff </div>
<div>StateAG</div>
</th>
<th class="th">
<div>Jul. 31, 2021 </div>
<div>lawsuit</div>
</th>
<th class="th">
<div>Jun. 30, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2019 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_IncomefromSettlementsofClassActionLawsuits', window );">Income from Settlements of Class Action Lawsuits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 112<span></span>
</td>
<td class="nump">$ 16<span></span>
</td>
<td class="nump">$ 94<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Cost of Goods and Services Sold</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">155,689<span></span>
</td>
<td class="nump">146,054<span></span>
</td>
<td class="nump">138,700<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpense', window );">Distribution, selling, general and administrative expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,533<span></span>
</td>
<td class="nump">4,572<span></span>
</td>
<td class="nump">4,480<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossRelatedToLitigationSettlement', window );">Gain (Loss) Related to Litigation Settlement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,129)<span></span>
</td>
<td class="num">(5,741)<span></span>
</td>
<td class="num">$ (36)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=cah_OpioidLawsuitsMember', window );">Opioid Lawsuits | Subsequent Event</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_LossContingencyLawsuitsNumber', window );">Loss Contingency, Lawsuits, Number</a></td>
<td class="nump">3,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_NumberofStateAttorneysGeneralfilinglawsuits', window );">Number of State Attorneys General filing lawsuits | StateAG</a></td>
<td class="nump">25<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=cah_OpioidLawsuitsStateDomain', window );">Opioid Lawsuits State [Domain] | Subsequent Event</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_LossContingencyLawsuitsNumber', window );">Loss Contingency, Lawsuits, Number</a></td>
<td class="nump">2,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=cah_ProductLiabilityLawsuitsMember', window );">Product Liability Lawsuits | Subsequent Event</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyNewClaimsFiledNumber', window );">Number of lawsuits filed | lawsuit</a></td>
<td class="nump">32<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyClaimsSettledNumber', window );">Loss Contingency, Claims Settled, Number | lawsuit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=cah_NewYorkOpioidStewardshipActMember', window );">New York Opioid Stewardship Act</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_AggregateAnnualAssessment', window );">Aggregate Annual Assessment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=cah_DOJInvestigationMember', window );">DOJ Investigation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossRelatedToLitigationSettlement', window );">Gain (Loss) Related to Litigation Settlement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=cah_AlamedaCountyMember', window );">Alameda County [Member] | Product Liability Lawsuits | Subsequent Event</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyNumberOfPlaintiffs', window );">Number of plaintiffs | plaintiff</a></td>
<td class="nump">5,427<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=cah_OtherJurisdictionsMember', window );">Other Jurisdictions [Member] | Product Liability Lawsuits | Subsequent Event</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyNumberOfPlaintiffs', window );">Number of plaintiffs | plaintiff</a></td>
<td class="nump">37<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesByNatureOfContingencyAxis=cah_ProductLiabilityLawsuitsMember', window );">Product Liability Lawsuits | Subsequent Event</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyNewClaimsFiledNumber', window );">Number of lawsuits filed | lawsuit</a></td>
<td class="nump">419<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyAccrualAtCarryingValue', window );">Loss Contingency Accrual</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">524<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyEstimateOfPossibleLoss', window );">Loss Contingency, Estimate of Possible Loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,030<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_OpioidLitigationAxis=cah_TotalOpioidLitigationMember', window );">Total Opioid Litigation [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LitigationReserve', window );">Estimated Litigation Liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,730<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyEstimateOfPossibleLoss', window );">Loss Contingency, Estimate of Possible Loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,370<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossRelatedToLitigationSettlement', window );">Gain (Loss) Related to Litigation Settlement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,170<span></span>
</td>
<td class="nump">5,630<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LitigationSettlementExpense', window );">Litigation Settlement, Expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,170<span></span>
</td>
<td class="nump">$ 5,630<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_OpioidLitigationAxis=cah_TotalOpioidLitigationMember', window );">Total Opioid Litigation [Member] | Other Accrued Liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LitigationReserve', window );">Estimated Litigation Liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 405<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_PlaintiffTypeAxis=cah_PrivatePartiesMember', window );">Private Parties [Member] | Opioid Lawsuits | Subsequent Event</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_LossContingencyLawsuitsNumber', window );">Loss Contingency, Lawsuits, Number | lawsuit</a></td>
<td class="nump">442<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_LawsuitTypeAxis=cah_ClassActionLawsuitsMember', window );">Class Action Lawsuits [Member] | Private Parties [Member] | Opioid Lawsuits | Subsequent Event</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_LossContingencyLawsuitsNumber', window );">Loss Contingency, Lawsuits, Number | lawsuit</a></td>
<td class="nump">128<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_AggregateAnnualAssessment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate Annual Assessment</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_AggregateAnnualAssessment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_IncomefromSettlementsofClassActionLawsuits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Income from Settlements of Class Action Lawsuits</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_IncomefromSettlementsofClassActionLawsuits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_LossContingencyLawsuitsNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Lawsuits, Number</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_LossContingencyLawsuitsNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_NumberofStateAttorneysGeneralfilinglawsuits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of State Attorneys General filing lawsuits</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_NumberofStateAttorneysGeneralfilinglawsuits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsAndServicesSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2(a),(d))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsAndServicesSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossRelatedToLitigationSettlement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) recognized in settlement of litigation and insurance claims. Excludes claims within an insurance entity's normal claims settlement process.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossRelatedToLitigationSettlement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationReserve">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate carrying amount of the estimated litigation liability for known or estimated probable loss from litigation, which may include attorneys' fees and other litigation costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationReserve</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationSettlementExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of litigation expense, including but not limited to legal, forensic, accounting, and investigative fees.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationSettlementExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyAccrualAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of loss contingency liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyAccrualAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyClaimsSettledNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of claims settled.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyClaimsSettledNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyEstimateOfPossibleLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Reflects the estimated amount of loss from the specified contingency as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14435-108349<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14557-108349<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124440162&amp;loc=d3e12021-110248<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyEstimateOfPossibleLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyNewClaimsFiledNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The total number of new claims filed pertaining to a loss contingency during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14435-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyNewClaimsFiledNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyNumberOfPlaintiffs">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of plaintiffs that have filed claims pertaining to a loss contingency.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyNumberOfPlaintiffs</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingGeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingGeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=cah_OpioidLawsuitsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=cah_OpioidLawsuitsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=cah_OpioidLawsuitsStateDomain">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=cah_OpioidLawsuitsStateDomain</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=cah_ProductLiabilityLawsuitsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=cah_ProductLiabilityLawsuitsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=cah_NewYorkOpioidStewardshipActMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=cah_NewYorkOpioidStewardshipActMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=cah_DOJInvestigationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=cah_DOJInvestigationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=cah_AlamedaCountyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=cah_AlamedaCountyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=cah_OtherJurisdictionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=cah_OtherJurisdictionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesByNatureOfContingencyAxis=cah_ProductLiabilityLawsuitsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesByNatureOfContingencyAxis=cah_ProductLiabilityLawsuitsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_OpioidLitigationAxis=cah_TotalOpioidLitigationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_OpioidLitigationAxis=cah_TotalOpioidLitigationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_AccruedLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_AccruedLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_PlaintiffTypeAxis=cah_PrivatePartiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_PlaintiffTypeAxis=cah_PrivatePartiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_LawsuitTypeAxis=cah_ClassActionLawsuitsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_LawsuitTypeAxis=cah_ClassActionLawsuitsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>84
<FILENAME>R64.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140421172687080">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes (Schedule of Income before Income Tax, Domestic and Foreign) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2021<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic', window );">U.S. operations</a></td>
<td class="num">$ (47)<span></span>
</td>
<td class="num">$ (4,056)<span></span>
</td>
<td class="nump">$ 1,478<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign', window );">Non-U.S. operations</a></td>
<td class="nump">370<span></span>
</td>
<td class="nump">284<span></span>
</td>
<td class="nump">273<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments', window );">Earnings/(loss) before income taxes</a></td>
<td class="nump">$ 323<span></span>
</td>
<td class="num">$ (3,772)<span></span>
</td>
<td class="nump">$ 1,751<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of earnings or loss from continuing operations before income taxes that is attributable to domestic operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of earnings or loss from continuing operations before income taxes that is attributable to foreign operations, which is defined as Income or Loss generated from operations located outside the entity's country of domicile.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of income (loss) from equity method investments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>85
<FILENAME>R65.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140421173698104">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes (Schedule of Components of Income Tax Expense (Benefit), Current and Deferred) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract', window );"><strong>Current:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CurrentFederalTaxExpenseBenefit', window );">Federal</a></td>
<td class="num">$ (989)<span></span>
</td>
<td class="nump">$ 659<span></span>
</td>
<td class="nump">$ 295<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CurrentStateAndLocalTaxExpenseBenefit', window );">State and local</a></td>
<td class="nump">92<span></span>
</td>
<td class="nump">154<span></span>
</td>
<td class="nump">89<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CurrentForeignTaxExpenseBenefit', window );">Non-U.S.</a></td>
<td class="nump">112<span></span>
</td>
<td class="nump">69<span></span>
</td>
<td class="nump">85<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CurrentIncomeTaxExpenseBenefit', window );">Total current</a></td>
<td class="num">(785)<span></span>
</td>
<td class="nump">882<span></span>
</td>
<td class="nump">469<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract', window );"><strong>Deferred:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredFederalIncomeTaxExpenseBenefit', window );">Federal</a></td>
<td class="nump">539<span></span>
</td>
<td class="num">(822)<span></span>
</td>
<td class="num">(28)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit', window );">State and local</a></td>
<td class="num">(28)<span></span>
</td>
<td class="num">(127)<span></span>
</td>
<td class="num">(37)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredForeignIncomeTaxExpenseBenefit', window );">Non-U.S.</a></td>
<td class="num">(15)<span></span>
</td>
<td class="num">(12)<span></span>
</td>
<td class="num">(18)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefit', window );">Total deferred</a></td>
<td class="nump">496<span></span>
</td>
<td class="num">(961)<span></span>
</td>
<td class="num">(83)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Provision for/(benefit from) income taxes</a></td>
<td class="num">$ (289)<span></span>
</td>
<td class="num">$ (79)<span></span>
</td>
<td class="nump">$ 386<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentFederalTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current federal tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentFederalTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentForeignTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentForeignTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentStateAndLocalTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current state and local tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentStateAndLocalTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredFederalIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred federal income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredFederalIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredForeignIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredForeignIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred state and local tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>86
<FILENAME>R66.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140421174908024">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes (Schedule of Effective Income Tax Rate Reconciliation) (Details)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate', window );">Provision at Federal statutory rate</a></td>
<td class="nump">21.00%<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes', window );">State and local income taxes, net of federal benefit</a></td>
<td class="nump">3.20%<span></span>
</td>
<td class="nump">2.50%<span></span>
</td>
<td class="nump">0.90%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_EffectiveIncomeTaxRateReconciliationTaxEffectOfForeignOperations', window );">Effective Income Tax Rate Reconciliation, Tax Effect of Foreign Operations</a></td>
<td class="nump">0.70%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="num">(0.70%)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense', window );">Nondeductible/nontaxable items (2)</a></td>
<td class="nump">1.60%<span></span>
</td>
<td class="nump">0.20%<span></span>
</td>
<td class="nump">0.80%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses', window );">Goodwill impairment</a></td>
<td class="nump">7.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_EffectiveIncomeTaxRateReconciliationWithholdingTaxes', window );">Effective Income Tax Rate Reconciliation, Withholding Taxes</a></td>
<td class="nump">9.00%<span></span>
</td>
<td class="num">(0.30%)<span></span>
</td>
<td class="nump">0.70%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance', window );">Change in valuation allowances</a></td>
<td class="num">(1.40%)<span></span>
</td>
<td class="nump">1.50%<span></span>
</td>
<td class="nump">4.50%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_EffectiveTaxRateReconciliationImpactOfResolutionsWithIRSAndOtherRelatedMatters', window );">China tax related to divestiture</a></td>
<td class="num">(13.60%)<span></span>
</td>
<td class="num">(0.40%)<span></span>
</td>
<td class="num">(0.10%)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_EffectiveIncomeTaxRateReconciliationLegalEntityReorganizationReconcilingItemsPercent', window );">Effective Income Tax Rate Reconciliation Legal Entity Reorganization Reconciling Items Percent</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="num">(3.60%)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_EffectiveIncomeTaxReconciliationOpioidLitigation', window );">Effective Income Tax Reconciliation, Opioid Litigation</a></td>
<td class="nump">17.70%<span></span>
</td>
<td class="num">(23.20%)<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_EffectiveIncomeTaxRateReconciliationLossCarrybackClaims', window );">Effective Income Tax Rate Reconciliation, Loss Carryback Claims</a></td>
<td class="num">(129.90%)<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent', window );">Other (2)</a></td>
<td class="nump">1.70%<span></span>
</td>
<td class="nump">0.60%<span></span>
</td>
<td class="num">(2.10%)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_EffectiveTaxRateReconciliationUSTaxesOnInternationalIncome', window );">US Taxes on International Income</a></td>
<td class="num">(6.70%)<span></span>
</td>
<td class="nump">0.20%<span></span>
</td>
<td class="nump">0.70%<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations', window );">Effective income tax rate</a></td>
<td class="num">(89.70%)<span></span>
</td>
<td class="nump">2.10%<span></span>
</td>
<td class="nump">22.10%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_EffectiveIncomeTaxRateReconciliationLegalEntityReorganizationReconcilingItemsPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Effective Income Tax Rate Reconciliation Legal Entity Reorganization Reconciling Items Percent</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_EffectiveIncomeTaxRateReconciliationLegalEntityReorganizationReconcilingItemsPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_EffectiveIncomeTaxRateReconciliationLossCarrybackClaims">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Effective Income Tax Rate Reconciliation, Loss Carryback Claims</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_EffectiveIncomeTaxRateReconciliationLossCarrybackClaims</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_EffectiveIncomeTaxRateReconciliationTaxEffectOfForeignOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Effective Income Tax Rate Reconciliation, Tax Effect of Foreign Operations</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_EffectiveIncomeTaxRateReconciliationTaxEffectOfForeignOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_EffectiveIncomeTaxRateReconciliationWithholdingTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Effective Income Tax Rate Reconciliation, Withholding Taxes</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_EffectiveIncomeTaxRateReconciliationWithholdingTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_EffectiveIncomeTaxReconciliationOpioidLitigation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Effective Income Tax Reconciliation, Opioid Litigation</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_EffectiveIncomeTaxReconciliationOpioidLitigation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_EffectiveTaxRateReconciliationImpactOfResolutionsWithIRSAndOtherRelatedMatters">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Effective Tax Rate Reconciliation, Impact of Resolutions with IRS and other related matters</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_EffectiveTaxRateReconciliationImpactOfResolutionsWithIRSAndOtherRelatedMatters</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_EffectiveTaxRateReconciliationUSTaxesOnInternationalIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Effective Tax Rate Reconciliation, US Taxes on International Income</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_EffectiveTaxRateReconciliationUSTaxesOnInternationalIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of domestic federal statutory tax rate applicable to pretax income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to changes in the valuation allowance for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to nondeductible expenses.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to impairment loss.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference, between reported income tax expense (benefit) and the expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations, that is attributable to tax exempt income, equity in earnings (loss) of an unconsolidated subsidiary, minority interest income (expense), tax holiday, disposition of a business, disposition of an asset, repatriation of foreign earnings, repatriation of foreign earnings jobs creation act of 2004, change in enacted tax rate, prior year income taxes, change in deferred tax asset valuation allowance, and other adjustments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to state and local income tax expense (benefit), net of federal tax expense (benefit).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>87
<FILENAME>R67.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140421164255448">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes (Narrative) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2019</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
<th class="th"><div>Jun. 30, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TaxCreditCarryforwardLineItems', window );"><strong>Income Taxes</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations', window );">Effective Income Tax Rate Reconciliation, Percent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(89.70%)<span></span>
</td>
<td class="nump">2.10%<span></span>
</td>
<td class="nump">22.10%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income Tax Expense (Benefit)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (289)<span></span>
</td>
<td class="num">$ (79)<span></span>
</td>
<td class="nump">$ 386<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_EffectiveTaxRateImpactFromCertainForeignJurisdictions', window );">Effective Tax Rate Impact From Certain Foreign Jurisdictions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 20<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate', window );">Provision at Federal statutory rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredFederalIncomeTaxExpenseBenefit', window );">Federal</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (539)<span></span>
</td>
<td class="nump">$ 822<span></span>
</td>
<td class="nump">$ 28<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards', window );">Deferred tax assets on tax credit carryforwards</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(805)<span></span>
</td>
<td class="num">(589)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsValuationAllowance', window );">Valuation allowance on operating loss carryforwards</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">477<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate', window );">Unrecognized tax benefits that would impact effective tax rate</a></td>
<td class="nump">$ 303<span></span>
</td>
<td class="nump">849<span></span>
</td>
<td class="nump">753<span></span>
</td>
<td class="nump">303<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions', window );">Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">223<span></span>
</td>
<td class="nump">78<span></span>
</td>
<td class="nump">39<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefits', window );">Unrecognized tax benefits</a></td>
<td class="nump">456<span></span>
</td>
<td class="nump">932<span></span>
</td>
<td class="nump">998<span></span>
</td>
<td class="nump">456<span></span>
</td>
<td class="nump">$ 423<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities', window );">Unrecognized Tax Benefits, Decrease Resulting from Settlements with Taxing Authorities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">271<span></span>
</td>
<td class="nump">6<span></span>
</td>
<td class="nump">25<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations', window );">Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued', window );">Unrecognized tax benefits, interest and penalties accrued</a></td>
<td class="nump">122<span></span>
</td>
<td class="nump">49<span></span>
</td>
<td class="nump">146<span></span>
</td>
<td class="nump">122<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense', window );">Unrecognized tax benefits, interest and penalties</a></td>
<td class="nump">$ 16<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TaxCutsAndJobsActOf2017TransitionTaxForAccumulatedForeignEarningsIncomeTaxExpense', window );">Tax Cuts and Jobs Act, Transition Tax for Accumulated Foreign Earnings, Income Tax Expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">825<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAndOtherLiabilitiesNoncurrent', window );">Deferred income taxes and other liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,670<span></span>
</td>
<td class="nump">8,594<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_NetOperatingLossCarrybackAxis=cah_NetOperatingLossCarrybackMember', window );">Net Operating Loss Carryback</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TaxCreditCarryforwardLineItems', window );"><strong>Income Taxes</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income Tax Expense (Benefit)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(424)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxReceivable', window );">Income Taxes Receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">974<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAndOtherLiabilitiesNoncurrent', window );">Deferred income taxes and other liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TaxCreditCarryforwardLineItems', window );"><strong>Income Taxes</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible', window );">Estimated range of decrease in unrecognized tax benefits within the next 12 months</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TaxCreditCarryforwardLineItems', window );"><strong>Income Taxes</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible', window );">Estimated range of decrease in unrecognized tax benefits within the next 12 months</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_InternalRevenueServiceIRSMember', window );">Federal</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TaxCreditCarryforwardLineItems', window );"><strong>Income Taxes</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TaxCreditCarryforwardAmount', window );">Tax credit carryforwards</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">272<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember', window );">State and Local</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TaxCreditCarryforwardLineItems', window );"><strong>Income Taxes</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TaxCreditCarryforwardAmount', window );">Tax credit carryforwards</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_ForeignCountryMember', window );">Foreign</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TaxCreditCarryforwardLineItems', window );"><strong>Income Taxes</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TaxCreditCarryforwardAmount', window );">Tax credit carryforwards</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_TaxMatterAxis=cah_PatientRecoveryBusinessMember', window );">Patient Recovery Business [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TaxCreditCarryforwardLineItems', window );"><strong>Income Taxes</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_IndemnificationReceivable', window );">Amount CareFusion is liable under tax matters agreement in the event amount must be paid to the taxing authority</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12<span></span>
</td>
<td class="nump">19<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_TaxMatterAxis=cah_CareFusionMember', window );">CareFusion [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TaxCreditCarryforwardLineItems', window );"><strong>Income Taxes</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_IndemnificationReceivable', window );">Amount CareFusion is liable under tax matters agreement in the event amount must be paid to the taxing authority</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">72<span></span>
</td>
<td class="nump">176<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_OpioidLitigationAxis=cah_TotalOpioidLitigationMember', window );">Total Opioid Litigation [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TaxCreditCarryforwardLineItems', window );"><strong>Income Taxes</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LitigationReserve', window );">Estimated Litigation Liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,730<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income Tax Expense (Benefit)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">228<span></span>
</td>
<td class="nump">488<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate', window );">Unrecognized tax benefits that would impact effective tax rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">219<span></span>
</td>
<td class="nump">469<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LitigationSettlementExpense', window );">Litigation Settlement, Expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,170<span></span>
</td>
<td class="nump">$ 5,630<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_EffectiveTaxRateImpactFromCertainForeignJurisdictions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Effective Tax Rate Impact From Certain Foreign Jurisdictions</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_EffectiveTaxRateImpactFromCertainForeignJurisdictions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_IndemnificationReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indemnification receivable from Patient recovery related to certain pre-acquisition tax exposures and transaction taxes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_IndemnificationReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease reasonably possible in the next twelve months for the unrecognized tax benefit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (d)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32718-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredFederalIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred federal income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredFederalIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAndOtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences, with jurisdictional netting, and liabilities classified as noncurrent and other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAndOtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before allocation of a valuation allowances, of deferred tax assets attributable to deductible tax credit carryforwards including, but not limited to, research, foreign, general business, alternative minimum tax, and other deductible tax credit carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32559-109319<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxCreditCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of domestic federal statutory tax rate applicable to pretax income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of income taxes previously overpaid to tax authorities (such as U.S. Federal, state and local tax authorities) representing refunds of overpayments or recoveries based on agreed-upon resolutions of disputes. Also called income tax refund receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationReserve">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate carrying amount of the estimated litigation liability for known or estimated probable loss from litigation, which may include attorneys' fees and other litigation costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationReserve</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationSettlementExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of litigation expense, including but not limited to legal, forensic, accounting, and investigative fees.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationSettlementExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLossCarryforwardsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of the valuation allowance pertaining to the deferred tax asset representing potential future taxable deductions from net operating loss carryforwards for which it is more likely than not that a tax benefit will not be realized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLossCarryforwardsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxCreditCarryforwardAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of the tax credit carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32559-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxCreditCarryforwardAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxCreditCarryforwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxCreditCarryforwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxCutsAndJobsActOf2017TransitionTaxForAccumulatedForeignEarningsIncomeTaxExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income tax expense from transition tax on accumulated earnings of controlled foreign corporation deemed repatriated pursuant to Tax Cuts and Jobs Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxCutsAndJobsActOf2017TransitionTaxForAccumulatedForeignEarningsIncomeTaxExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of unrecognized tax benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10B<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=SL37586934-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in unrecognized tax benefits resulting from settlements with taxing authorities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount accrued for interest on an underpayment of income taxes and penalties related to a tax position claimed or expected to be claimed in the tax return.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32718-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for interest on an underpayment of income taxes and penalties related to a tax position claimed or expected to be claimed in the tax return.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32718-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in unrecognized tax benefits resulting from tax positions taken in prior period tax returns.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in unrecognized tax benefits resulting from lapses of applicable statutes of limitations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The total amount of unrecognized tax benefits that, if recognized, would affect the effective tax rate.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_NetOperatingLossCarrybackAxis=cah_NetOperatingLossCarrybackMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_NetOperatingLossCarrybackAxis=cah_NetOperatingLossCarrybackMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_InternalRevenueServiceIRSMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_InternalRevenueServiceIRSMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_ForeignCountryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_ForeignCountryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_TaxMatterAxis=cah_PatientRecoveryBusinessMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_TaxMatterAxis=cah_PatientRecoveryBusinessMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_TaxMatterAxis=cah_CareFusionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_TaxMatterAxis=cah_CareFusionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_OpioidLitigationAxis=cah_TotalOpioidLitigationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_OpioidLitigationAxis=cah_TotalOpioidLitigationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>88
<FILENAME>R68.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140421262084104">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Income Taxes (Schedule of Deferred Tax Assets and Liabilities) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComponentsOfDeferredTaxAssetsAbstract', window );"><strong>Deferred income tax assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts', window );">Receivable basis difference</a></td>
<td class="nump">$ 40<span></span>
</td>
<td class="nump">$ 39<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities', window );">Accrued liabilities</a></td>
<td class="nump">874<span></span>
</td>
<td class="nump">607<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost', window );">Share-based compensation</a></td>
<td class="nump">38<span></span>
</td>
<td class="nump">38<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards', window );">Loss and tax credit carryforwards</a></td>
<td class="nump">805<span></span>
</td>
<td class="nump">589<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_DeferredTaxAssetsRelatedtouncertaintaxpositions', window );">Deferred tax assets related to uncertain tax positions</a></td>
<td class="nump">35<span></span>
</td>
<td class="nump">52<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOther', window );">Other</a></td>
<td class="nump">16<span></span>
</td>
<td class="nump">87<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsGross', window );">Total deferred income tax assets</a></td>
<td class="nump">1,808<span></span>
</td>
<td class="nump">1,412<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsValuationAllowance', window );">Deferred Tax Assets, Valuation Allowance</a></td>
<td class="num">(515)<span></span>
</td>
<td class="num">(470)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsLiabilitiesNet', window );">Deferred Tax Assets, Net</a></td>
<td class="nump">1,293<span></span>
</td>
<td class="nump">942<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract', window );"><strong>Deferred income tax liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesDeferredExpenseCapitalizedInventoryCosts', window );">Inventory basis differences</a></td>
<td class="num">(1,119)<span></span>
</td>
<td class="num">(1,083)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment', window );">Property-related</a></td>
<td class="num">(375)<span></span>
</td>
<td class="num">(327)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets', window );">Other</a></td>
<td class="num">(733)<span></span>
</td>
<td class="num">(751)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesDeferredExpenseReservesAndAccruals', window );">Deferred Tax Liabilities, Deferred Expense, Reserves and Accruals</a></td>
<td class="num">(975)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesOther', window );">Deferred Tax Liabilities, Other</a></td>
<td class="num">(23)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxLiabilities', window );">Total deferred income tax liabilities</a></td>
<td class="num">(3,225)<span></span>
</td>
<td class="num">(2,161)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilities', window );">Net deferred income tax liability</a></td>
<td class="num">$ (1,932)<span></span>
</td>
<td class="num">$ (1,219)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_DeferredTaxAssetsRelatedtouncertaintaxpositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Deferred tax assets related to uncertain tax positions</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_DeferredTaxAssetsRelatedtouncertaintaxpositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComponentsOfDeferredTaxAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComponentsOfDeferredTaxAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26)(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(15)(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, without jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before allocation of a valuation allowances, of deferred tax assets attributable to deductible tax credit carryforwards including, but not limited to, research, foreign, general business, alternative minimum tax, and other deductible tax credit carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32559-109319<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxCreditCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from share-based compensation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from accrued liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary difference from allowance for credit loss on accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences without jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesDeferredExpenseCapitalizedInventoryCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax consequences attributable to taxable temporary differences derived from inventory.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesDeferredExpenseCapitalizedInventoryCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesDeferredExpenseReservesAndAccruals">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences from reserves and accruals.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesDeferredExpenseReservesAndAccruals</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences from intangible assets including goodwill.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences from property, plant, and equipment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>89
<FILENAME>R69.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140421167406248">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Income Taxes (Schedule of Deferred Tax Assets and Liabilities After Netting by Tax Jurisdiction) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxesAndOtherAssetsNoncurrent', window );">Deferred Income Taxes and Other Assets, Noncurrent</a></td>
<td class="nump">$ 52<span></span>
</td>
<td class="nump">$ 39<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxesAndOtherTaxLiabilitiesNoncurrent', window );">Deferred Income Taxes and Other Tax Liabilities, Noncurrent</a></td>
<td class="nump">1,981<span></span>
</td>
<td class="nump">1,258<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_DeferredIncomeTaxesAndOtherTaxLiabilitiesTransferredToHeldForSaleNoncurrent', window );">Deferred Income Taxes and Other Tax Liabilities, Transferred to Held for Sale, Noncurrent</a></td>
<td class="num">(3)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilities', window );">Net deferred income tax liability</a></td>
<td class="num">$ (1,932)<span></span>
</td>
<td class="num">$ (1,219)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_DeferredIncomeTaxesAndOtherTaxLiabilitiesTransferredToHeldForSaleNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Deferred Income Taxes and Other Tax Liabilities, Transferred to Held for Sale, Noncurrent</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_DeferredIncomeTaxesAndOtherTaxLiabilitiesTransferredToHeldForSaleNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxesAndOtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and other assets expected to be realized or consumed after one year or normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxesAndOtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxesAndOtherTaxLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences, after deferred tax asset, and other tax liabilities expected to be paid after one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxesAndOtherTaxLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences without jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>90
<FILENAME>R70.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140421171093960">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes (Schedule of Unrecognized Tax Benefits Roll Forward) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxContingencyLineItems', window );"><strong>Income Tax Contingency [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CurrentFederalTaxExpenseBenefit', window );">Current Federal Tax Expense (Benefit)</a></td>
<td class="num">$ (989)<span></span>
</td>
<td class="nump">$ 659<span></span>
</td>
<td class="nump">$ 295<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CurrentStateAndLocalTaxExpenseBenefit', window );">Current State and Local Tax Expense (Benefit)</a></td>
<td class="nump">92<span></span>
</td>
<td class="nump">154<span></span>
</td>
<td class="nump">89<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CurrentForeignTaxExpenseBenefit', window );">Current Foreign Tax Expense (Benefit)</a></td>
<td class="nump">112<span></span>
</td>
<td class="nump">69<span></span>
</td>
<td class="nump">85<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CurrentIncomeTaxExpenseBenefit', window );">Current Income Tax Expense (Benefit)</a></td>
<td class="num">(785)<span></span>
</td>
<td class="nump">882<span></span>
</td>
<td class="nump">469<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredFederalIncomeTaxExpenseBenefit', window );">Deferred Federal Income Tax Expense (Benefit)</a></td>
<td class="nump">539<span></span>
</td>
<td class="num">(822)<span></span>
</td>
<td class="num">(28)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit', window );">Deferred State and Local Income Tax Expense (Benefit)</a></td>
<td class="num">(28)<span></span>
</td>
<td class="num">(127)<span></span>
</td>
<td class="num">(37)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredForeignIncomeTaxExpenseBenefit', window );">Deferred Foreign Income Tax Expense (Benefit)</a></td>
<td class="num">(15)<span></span>
</td>
<td class="num">(12)<span></span>
</td>
<td class="num">(18)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefit', window );">Deferred Income Tax Expense (Benefit)</a></td>
<td class="nump">496<span></span>
</td>
<td class="num">(961)<span></span>
</td>
<td class="num">(83)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income Tax Expense (Benefit)</a></td>
<td class="num">(289)<span></span>
</td>
<td class="num">(79)<span></span>
</td>
<td class="nump">386<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward', window );"><strong>Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefits', window );">Balance at beginning of fiscal year</a></td>
<td class="nump">998<span></span>
</td>
<td class="nump">456<span></span>
</td>
<td class="nump">423<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions', window );">Additions for tax positions of the current year</a></td>
<td class="nump">121<span></span>
</td>
<td class="nump">500<span></span>
</td>
<td class="nump">24<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions', window );">Additions for tax positions of prior years</a></td>
<td class="nump">223<span></span>
</td>
<td class="nump">78<span></span>
</td>
<td class="nump">39<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions', window );">Reductions for tax positions of prior years</a></td>
<td class="num">(138)<span></span>
</td>
<td class="num">(27)<span></span>
</td>
<td class="num">(5)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities', window );">Settlements with tax authorities</a></td>
<td class="num">(271)<span></span>
</td>
<td class="num">(6)<span></span>
</td>
<td class="num">(25)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations', window );">Expiration of the statute of limitations</a></td>
<td class="num">(1)<span></span>
</td>
<td class="num">(3)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefits', window );">Balance at end of fiscal year</a></td>
<td class="nump">$ 932<span></span>
</td>
<td class="nump">$ 998<span></span>
</td>
<td class="nump">$ 456<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentFederalTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current federal tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentFederalTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentForeignTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentForeignTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentStateAndLocalTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current state and local tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentStateAndLocalTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredFederalIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred federal income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredFederalIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredForeignIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredForeignIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred state and local tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxContingencyLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxContingencyLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of unrecognized tax benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10B<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=SL37586934-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in unrecognized tax benefits resulting from tax positions taken in prior period tax returns.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in unrecognized tax benefits resulting from settlements with taxing authorities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in unrecognized tax benefits resulting from tax positions that have been or will be taken in current period tax return.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in unrecognized tax benefits resulting from tax positions taken in prior period tax returns.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in unrecognized tax benefits resulting from lapses of applicable statutes of limitations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>91
<FILENAME>R71.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140421174895848">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fair Value Measurements (Fair Value of Assets and Liabilities Measured on a Recurring Basis) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation', window );">Disposal Group, Including Discontinued Operation, Assets</a></td>
<td class="nump">$ 1,101<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation', window );">Disposal Group, Including Discontinued Operation, Liabilities</a></td>
<td class="nump">96<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Measurements, Recurring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash equivalents</a></td>
<td class="nump">1,883<span></span>
</td>
<td class="nump">721<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Other investments</a></td>
<td class="nump">126<span></span>
</td>
<td class="nump">114<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet', window );">Forward contracts</a></td>
<td class="nump">42<span></span>
</td>
<td class="nump">53<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Measurements, Recurring | Level&#160;1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash equivalents</a></td>
<td class="nump">1,883<span></span>
</td>
<td class="nump">721<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Other investments</a></td>
<td class="nump">126<span></span>
</td>
<td class="nump">114<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet', window );">Forward contracts</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Measurements, Recurring | Level&#160;2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash equivalents</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Other investments</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet', window );">Forward contracts</a></td>
<td class="nump">42<span></span>
</td>
<td class="nump">53<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Measurements, Recurring | Level&#160;3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash equivalents</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Other investments</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet', window );">Forward contracts</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsNonrecurringMember', window );">Fair Value, Nonrecurring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation', window );">Disposal Group, Including Discontinued Operation, Assets</a></td>
<td class="nump">$ 1,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsFairValueDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsFairValueDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount classified as assets attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair values as of the balance sheet date of the net amount of all assets and liabilities resulting from contracts that meet the criteria of being accounted for as derivative instruments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=117331979&amp;loc=d3e41228-113958<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of investment securities, including, but not limited to, marketable securities, derivative financial instruments, and investments accounted for under the equity method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesFairValueDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesFairValueDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount classified as liabilities attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsNonrecurringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsNonrecurringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>92
<FILENAME>R72.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140421171180056">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fair Value Measurements (Reconciliation of Liabilities Measured at Fair Value on a Recurring Basis Using Unobservable Inputs (Level 3)) (Details) - Fair Value, Measurements, Recurring - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems', window );"><strong>Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet', window );">Forward contracts</a></td>
<td class="nump">$ 42<span></span>
</td>
<td class="nump">$ 53<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level&#160;1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems', window );"><strong>Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet', window );">Forward contracts</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level&#160;2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems', window );"><strong>Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet', window );">Forward contracts</a></td>
<td class="nump">42<span></span>
</td>
<td class="nump">53<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level&#160;3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems', window );"><strong>Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet', window );">Forward contracts</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair values as of the balance sheet date of the net amount of all assets and liabilities resulting from contracts that meet the criteria of being accounted for as derivative instruments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=117331979&amp;loc=d3e41228-113958<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>93
<FILENAME>R73.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140421168014056">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fair Value Measurements (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation', window );">Disposal Group, Including Discontinued Operation, Liabilities</a></td>
<td class="nump">$ 96<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount classified as liabilities attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>94
<FILENAME>R74.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140421178912280">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Financial Instruments (Schedule of the Fair Value of Assets and Liabilities Related to Derivatives Designated as Hedging Instruments) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Total assets</a></td>
<td class="nump">$ 46<span></span>
</td>
<td class="nump">$ 74<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Total liabilities</a></td>
<td class="nump">4<span></span>
</td>
<td class="nump">21<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Designated as Hedging Instrument | Cash Flow Hedging | Foreign Currency Contracts | Prepaid Expenses and Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Total assets</a></td>
<td class="nump">5<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Designated as Hedging Instrument | Cash Flow Hedging | Foreign Currency Contracts | Other Accrued Liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Total liabilities</a></td>
<td class="nump">4<span></span>
</td>
<td class="nump">4<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Designated as Hedging Instrument | Cash Flow Hedging | Interest Rate Swaps | Deferred Income Taxes and Other Liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Total liabilities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">16<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Designated as Hedging Instrument | Cash Flow Hedging | Commodity Contracts | Other Accrued Liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Total liabilities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Designated as Hedging Instrument | Fair Value Hedging | Interest Rate Swaps | Other Assets [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Total assets</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">27<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Designated as Hedging Instrument | Fair Value Hedging | Cross Currency Interest Rate Contract [Member] | Other Assets [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Total assets</a></td>
<td class="nump">6<span></span>
</td>
<td class="nump">47<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Designated as Hedging Instrument | Fair Value Hedging | Cross Currency Interest Rate Contract [Member] | Prepaid Expenses and Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Total assets</a></td>
<td class="nump">$ 34<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeFairValueOfDerivativeAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value, before effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets elected not to be offset. Excludes assets not subject to a master netting arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226052-175313<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226000-175313<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 860<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4D<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121570589&amp;loc=SL51823488-111719<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -Subparagraph (a),(c)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624163-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeFairValueOfDerivativeAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeFairValueOfDerivativeLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value, before effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities elected not to be offset. Excludes liabilities not subject to a master netting arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 860<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4D<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121570589&amp;loc=SL51823488-111719<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -Subparagraph (a),(c)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624163-113959<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226000-175313<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226052-175313<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeFairValueOfDerivativeLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativesFairValueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativesFairValueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_AccruedLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_AccruedLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=cah_DeferredIncomeTaxesandOtherLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=cah_DeferredIncomeTaxesandOtherLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CommodityContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CommodityContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_FairValueHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_FairValueHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CrossCurrencyInterestRateContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CrossCurrencyInterestRateContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>95
<FILENAME>R75.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140421171686040">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financial Instruments (Narrative) (Details)<br> &#8364; in Millions, &#165; in Millions, $ in Millions</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Jun. 30, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2020 </div>
<div>JPY (&#165;)</div>
</th>
<th class="th">
<div>Sep. 30, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2019 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th">
<div>Jun. 30, 2019 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1', window );">Change in Unrealized Gain (Loss) on Fair Value Hedging Instruments</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember', window );">Interest Rate Swaps</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredGainLossOnDiscontinuationOfInterestRateFairValueHedge', window );">Deferred Gain (Loss) on Discontinuation of Interest Rate Fair Value Hedge</a></td>
<td class="nump">18<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CurrencySwapMember', window );">Currency Swap [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilityNotionalAmount', window );">Derivative Liability, Notional Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">600<span></span>
</td>
<td class="nump">&#165; 64,000<span></span>
</td>
<td class="nump">$ 233<span></span>
</td>
<td class="nump">&#8364; 200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember', window );">Foreign Currency Contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax', window );">Other Comprehensive Income (Loss), Net Investment Hedge, Gain (Loss), before Reclassification and Tax</a></td>
<td class="nump">7<span></span>
</td>
<td class="nump">35<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestIncomeExpenseNonoperatingNet', window );">Interest Income (Expense), Nonoperating, Net</a></td>
<td class="nump">19<span></span>
</td>
<td class="nump">17<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CashFlowHedgingMember', window );">Cash Flow Hedging</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilityNotionalAmount', window );">Derivative Liability, Notional Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_DerivatesHedgeDiscontinuancesHedgingInstrumentTerminatedAmount', window );">Derivates, Hedge Discontinuances, Hedging Instrument Terminated, Amount</a></td>
<td class="nump">200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_FairValueHedgingMember', window );">Fair Value Hedging | Interest Rate Swaps</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssetNotionalAmount', window );">Derivative, notional amount</a></td>
<td class="nump">200<span></span>
</td>
<td class="nump">550<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember', window );">Cash Flow Hedging | Foreign Currency Contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssetNotionalAmount', window );">Derivative, notional amount</a></td>
<td class="nump">436<span></span>
</td>
<td class="nump">328<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Designated as Hedging Instrument | Fair Value Hedging | Interest Rate Swaps</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilityNotionalAmount', window );">Derivative Liability, Notional Amount</a></td>
<td class="nump">200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_DerivativesHedgeDiscontinuancesHedgingInstrumentMaturedAmount', window );">Derivatives, matured notional amounts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_DerivatesHedgeDiscontinuancesHedgingInstrumentTerminatedAmount', window );">Derivates, Hedge Discontinuances, Hedging Instrument Terminated, Amount</a></td>
<td class="nump">$ 550<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredGainLossOnDiscontinuationOfInterestRateFairValueHedge', window );">Deferred Gain (Loss) on Discontinuation of Interest Rate Fair Value Hedge</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 112<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_DerivativesHedgeDiscontinuancesTerminationofHedgingInstrumentAmount', window );">Derivatives, terminated notional amounts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 163<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_DerivatesHedgeDiscontinuancesHedgingInstrumentTerminatedAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Derivates, Hedge Discontinuances, Hedging Instrument Terminated, Amount</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_DerivatesHedgeDiscontinuancesHedgingInstrumentTerminatedAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_DerivativesHedgeDiscontinuancesHedgingInstrumentMaturedAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Derivatives, Hedge Discontinuances, Hedging Instrument Matured, Amount</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_DerivativesHedgeDiscontinuancesHedgingInstrumentMaturedAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_DerivativesHedgeDiscontinuancesTerminationofHedgingInstrumentAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Derivatives, Hedge Discontinuances, Termination of Hedging Instrument, Amount</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_DerivativesHedgeDiscontinuancesTerminationofHedgingInstrumentAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) from the increase (decrease) in fair value of derivative and nonderivative instruments designated as fair value hedging instruments recognized in the income statement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 25<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121577467&amp;loc=d3e76258-113986<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredGainLossOnDiscontinuationOfInterestRateFairValueHedge">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount as of the balance sheet date of the unamortized adjustment to the carrying value of an interest-bearing hedged item made under an effective interest rate fair value hedge that is amortized upon discontinuation of the interest rate fair value hedge.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 25<br> -Section 35<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124267147&amp;loc=d3e75592-113984<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredGainLossOnDiscontinuationOfInterestRateFairValueHedge</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeAssetNotionalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Nominal or face amount used to calculate payments on the derivative asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579245-113959<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5580258-113959<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579245-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeAssetNotionalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLiabilityNotionalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Nominal or face amount used to calculate payments on the derivative liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579245-113959<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5580258-113959<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579245-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLiabilityNotionalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestIncomeExpenseNonoperatingNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net amount of nonoperating interest income (expense).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestIncomeExpenseNonoperatingNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax and reclassification, of gain (loss) from derivative designated and qualifying as net investment hedge.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4CCC<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL109998896-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CurrencySwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CurrencySwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CashFlowHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CashFlowHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_FairValueHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_FairValueHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>96
<FILENAME>R76.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140421171360184">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Financial Instruments (Schedule of Outstanding Instruments, Fair Value Hedges) (Details) - Interest Rate Swaps - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredGainLossOnDiscontinuationOfInterestRateFairValueHedge', window );">Deferred Gain (Loss) on Discontinuation of Interest Rate Fair Value Hedge</a></td>
<td class="nump">$ 18<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_FairValueHedgingMember', window );">Fair Value Hedging</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssetNotionalAmount', window );">Notional Amount</a></td>
<td class="nump">$ 200<span></span>
</td>
<td class="nump">$ 550<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Designated as Hedging Instrument | Fair Value Hedging</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredGainLossOnDiscontinuationOfInterestRateFairValueHedge', window );">Deferred Gain (Loss) on Discontinuation of Interest Rate Fair Value Hedge</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">112<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_DerivativesHedgeDiscontinuancesHedgingInstrumentMaturedAmount', window );">Derivatives, matured notional amounts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 200<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_DerivativesHedgeDiscontinuancesHedgingInstrumentMaturedAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Derivatives, Hedge Discontinuances, Hedging Instrument Matured, Amount</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_DerivativesHedgeDiscontinuancesHedgingInstrumentMaturedAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredGainLossOnDiscontinuationOfInterestRateFairValueHedge">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount as of the balance sheet date of the unamortized adjustment to the carrying value of an interest-bearing hedged item made under an effective interest rate fair value hedge that is amortized upon discontinuation of the interest rate fair value hedge.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 25<br> -Section 35<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124267147&amp;loc=d3e75592-113984<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredGainLossOnDiscontinuationOfInterestRateFairValueHedge</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeAssetNotionalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Nominal or face amount used to calculate payments on the derivative asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579245-113959<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5580258-113959<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579245-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeAssetNotionalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_FairValueHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_FairValueHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>97
<FILENAME>R77.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140421165982776">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financial Instruments (Schedule of Gain/(Loss) Recognized in Earnings for Interest Rate Contracts Designated as Fair Value Hedges) (Details) - Fair Value Hedging - Interest Expense, Net - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_FairValueHedgingMember', window );">Interest Rate Swaps</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeGainLossOnDerivativeNet', window );">Gain/(loss) on derivative</a></td>
<td class="num">$ (8)<span></span>
</td>
<td class="nump">$ 106<span></span>
</td>
<td class="nump">$ 9<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_FairValueHedgingMember', window );">Fixed-Rate Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeGainLossOnDerivativeNet', window );">Gain/(loss) on derivative</a></td>
<td class="nump">$ 8<span></span>
</td>
<td class="num">$ (106)<span></span>
</td>
<td class="num">$ (9)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeGainLossOnDerivativeNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the fair value of derivatives recognized in the income statement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5618551-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeGainLossOnDerivativeNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_FairValueHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_FairValueHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_InterestExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_InterestExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=cah_FixedRateDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=cah_FixedRateDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>98
<FILENAME>R78.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140421173720904">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Financial Instruments (Schedule of Outstanding Instruments, Cash Flow Hedges) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CashFlowHedgingMember', window );">Cash Flow Hedging</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilityNotionalAmount', window );">Derivative Liability, Notional Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 200<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_FairValueHedgingMember', window );">Fair Value Hedging | Interest Rate Swaps</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssetNotionalAmount', window );">Notional Amount</a></td>
<td class="nump">$ 200<span></span>
</td>
<td class="nump">550<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember', window );">Cash Flow Hedging | Foreign Currency Contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssetNotionalAmount', window );">Notional Amount</a></td>
<td class="nump">436<span></span>
</td>
<td class="nump">328<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember', window );">Cash Flow Hedging | Commodity Contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssetNotionalAmount', window );">Notional Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember', window );">Cash Flow Hedging | Forward Contracts [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssetNotionalAmount', window );">Notional Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 200<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Designated as Hedging Instrument | Fair Value Hedging | Interest Rate Swaps</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilityNotionalAmount', window );">Derivative Liability, Notional Amount</a></td>
<td class="nump">$ 200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeAssetNotionalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Nominal or face amount used to calculate payments on the derivative asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579245-113959<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5580258-113959<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579245-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeAssetNotionalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLiabilityNotionalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Nominal or face amount used to calculate payments on the derivative liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579245-113959<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5580258-113959<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579245-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLiabilityNotionalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CashFlowHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CashFlowHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_FairValueHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_FairValueHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CommodityContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CommodityContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForwardContractsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForwardContractsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>99
<FILENAME>R79.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140421171347000">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financial Instruments (Schedule of Gain/(Loss) Included in AOCI for Derivative Instruments Designated as Cash Flow Hedges) (Details) - Cash Flow Hedging - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember', window );">Forward Contracts [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax', window );">Gain/(loss) included in AOCI for derivative instruments designated as cash flow hedges</a></td>
<td class="nump">$ 16<span></span>
</td>
<td class="num">$ (16)<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember', window );">Commodity Contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax', window );">Gain/(loss) included in AOCI for derivative instruments designated as cash flow hedges</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="num">(5)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember', window );">Foreign Currency Contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax', window );">Gain/(loss) included in AOCI for derivative instruments designated as cash flow hedges</a></td>
<td class="nump">$ 5<span></span>
</td>
<td class="num">$ (8)<span></span>
</td>
<td class="nump">$ 5<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before tax of increase (decrease) in accumulated gain (loss) from derivative instruments designated and qualifying as the effective portion of cash flow hedges and an entity's share of an equity investee's increase (decrease) in deferred hedging gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121558989&amp;loc=d3e80720-113993<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForwardContractsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForwardContractsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CommodityContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CommodityContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>100
<FILENAME>R80.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140421173097672">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financial Instruments (Schedule of Gain/(Loss) Reclassified from AOCI into Earnings for Derivative Instruments Designated as Cash Flow Hedges) (Details) - Cash Flow Hedging - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember', window );">Foreign Currency Contracts | Revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet', window );">Gain/(loss) reclassified from AOCI into earnings for derivative instruments designated as cash flow hedges</a></td>
<td class="num">$ (12)<span></span>
</td>
<td class="nump">$ 7<span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember', window );">Foreign Currency Contracts | Cost of Products Sold</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet', window );">Gain/(loss) reclassified from AOCI into earnings for derivative instruments designated as cash flow hedges</a></td>
<td class="num">(2)<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember', window );">Foreign Currency Contracts | SG&amp;A Expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet', window );">Gain/(loss) reclassified from AOCI into earnings for derivative instruments designated as cash flow hedges</a></td>
<td class="nump">4<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember', window );">Forward Contracts [Member] | Interest Expense, Net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet', window );">Gain/(loss) reclassified from AOCI into earnings for derivative instruments designated as cash flow hedges</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember', window );">Commodity Contracts | SG&amp;A Expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet', window );">Gain/(loss) reclassified from AOCI into earnings for derivative instruments designated as cash flow hedges</a></td>
<td class="nump">$ 6<span></span>
</td>
<td class="num">$ (5)<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The effective portion of net gain (loss) reclassified from accumulated other comprehensive income into income on derivative instruments designated and qualifying as hedging instruments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4D<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624177-113959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SalesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_SalesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForwardContractsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForwardContractsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_InterestExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_InterestExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CommodityContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CommodityContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>101
<FILENAME>R81.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140421170975656">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Financial Instruments (Schedule of Outstanding Instruments, Economic Hedges) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember', window );">Foreign Currency Contracts | Not Designated as Hedging Instrument</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssetNotionalAmount', window );">Notional Amount</a></td>
<td class="nump">$ 254<span></span>
</td>
<td class="nump">$ 325<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeAssetNotionalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Nominal or face amount used to calculate payments on the derivative asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579245-113959<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5580258-113959<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579245-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeAssetNotionalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>102
<FILENAME>R82.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140421163972024">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financial Instruments (Schedule of Gain/(Loss) Recognized in Earnings for Derivatives Not Designated as Hedging Instrument) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember', window );">Not Designated as Hedging Instrument | Foreign Currency Contracts | Other Income, Net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet', window );">Gain/(loss) recognized in earnings for economic (non-designated) derivative instruments</a></td>
<td class="num">$ (8)<span></span>
</td>
<td class="num">$ (11)<span></span>
</td>
<td class="num">$ (13)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of realized and unrealized gain (loss) of derivative instruments not designated or qualifying as hedging instruments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4CC<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL109998890-113959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_OtherNonoperatingIncomeExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_OtherNonoperatingIncomeExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>103
<FILENAME>R83.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140421171364200">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Financial Instruments (Summary of Estimated Fair Value of Long-term Obligations and Other Short-term Borrowings) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_CarryingAmountofLongTermandotherShortTermBorrowings', window );">Carrying Amount of Long-Term and other Short-Term Borrowings</a></td>
<td class="nump">$ 6,236<span></span>
</td>
<td class="nump">$ 6,775<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtAndCapitalLeaseObligations', window );">Carrying amount</a></td>
<td class="nump">6,236<span></span>
</td>
<td class="nump">6,775<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level&#160;2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValue', window );">Estimated fair value</a></td>
<td class="nump">$ 6,751<span></span>
</td>
<td class="nump">$ 7,273<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_CarryingAmountofLongTermandotherShortTermBorrowings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying Amount of Long-Term and other Short-Term Borrowings</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_CarryingAmountofLongTermandotherShortTermBorrowings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtAndCapitalLeaseObligations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of short-term and long-term debt and lease obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.13,16)<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.16)<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtAndCapitalLeaseObligations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of debt instrument payable, including, but not limited to, notes payable and loans payable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13433-108611<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>104
<FILENAME>R84.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140421168888872">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Financial Instruments (Schedule of Fair Value Gain Loss Derivative Instrument) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_FairValueHedgingMember', window );">Fair Value Hedging | Interest Rate Swaps</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Notional Amount</a></td>
<td class="nump">$ 200<span></span>
</td>
<td class="nump">$ 550<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeNet', window );">Fair&#160;Value Gain/(Loss)</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">27<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember', window );">Cash Flow Hedging | Foreign Currency Contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Notional Amount</a></td>
<td class="nump">690<span></span>
</td>
<td class="nump">653<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeNet', window );">Fair&#160;Value Gain/(Loss)</a></td>
<td class="nump">1<span></span>
</td>
<td class="num">(4)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember', window );">Cash Flow Hedging | Forward Contracts [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Notional Amount</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">200<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeNet', window );">Fair&#160;Value Gain/(Loss)</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(16)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember', window );">Cash Flow Hedging | Currency Swap [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Notional Amount</a></td>
<td class="nump">833<span></span>
</td>
<td class="nump">833<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeNet', window );">Fair&#160;Value Gain/(Loss)</a></td>
<td class="nump">40<span></span>
</td>
<td class="nump">47<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember', window );">Cash Flow Hedging | Commodity Contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Notional Amount</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">16<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeNet', window );">Fair&#160;Value Gain/(Loss)</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="num">$ (1)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeFairValueOfDerivativeNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of the assets less the liabilities of a derivative or group of derivatives.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13433-108611<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeFairValueOfDerivativeNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeNotionalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Nominal or face amount used to calculate payment on derivative.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5580258-113959<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579245-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeNotionalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_FairValueHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_FairValueHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForwardContractsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForwardContractsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CurrencySwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CurrencySwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CommodityContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CommodityContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>105
<FILENAME>R85.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140421164365208">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Shareholders' Equity (Narrative) (Details)<br> $ / shares in Units, $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1">36 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Jun. 30, 2021 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Jun. 30, 2020 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Jun. 30, 2019 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Jun. 30, 2020 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredCostMethod', window );">Treasury shares acquired | $</a></td>
<td class="nump">$ 200<span></span>
</td>
<td class="nump">$ 350<span></span>
</td>
<td class="nump">$ 600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRepurchaseOfCommonStock', window );">Payments for Repurchase of Common Stock | $</a></td>
<td class="nump">200<span></span>
</td>
<td class="nump">350<span></span>
</td>
<td class="nump">600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Retained earnings decrease | $</a></td>
<td class="num">$ (1,205)<span></span>
</td>
<td class="num">$ (1,170)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (1,170)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common shares, authorized | shares</a></td>
<td class="nump">755,000,000<span></span>
</td>
<td class="nump">755,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">755,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember', window );">Common Class A</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common shares, authorized | shares</a></td>
<td class="nump">750,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_CommonStockVotingRightsVotes', window );">Common Stock, Voting Rights, Votes</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember', window );">Common Class B</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common shares, authorized | shares</a></td>
<td class="nump">5,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_TreasuryStockMember', window );">Treasury Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredCostMethod', window );">Treasury shares acquired | $</a></td>
<td class="nump">$ 200<span></span>
</td>
<td class="nump">$ 350<span></span>
</td>
<td class="nump">$ 600<span></span>
</td>
<td class="nump">$ 1,150<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Treasury Stock, Shares, Acquired | shares</a></td>
<td class="nump">3,700,000<span></span>
</td>
<td class="nump">7,000,000<span></span>
</td>
<td class="nump">11,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRepurchaseOfCommonStock', window );">Payments for Repurchase of Common Stock | $</a></td>
<td class="nump">$ 200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockAcquiredAverageCostPerShare', window );">Treasury shares acquired, average price per share (in usd per share) | $ / shares</a></td>
<td class="nump">$ 54.40<span></span>
</td>
<td class="nump">$ 48.00<span></span>
</td>
<td class="nump">$ 52.32<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_TreasuryStockAcquiredShares', window );">Treasury Stock Acquired Shares | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_CommonStockVotingRightsVotes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Common Stock, Voting Rights, Votes</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_CommonStockVotingRightsVotes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_TreasuryStockAcquiredShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Treasury Stock Acquired Shares</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_TreasuryStockAcquiredShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRepurchaseOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to reacquire common stock during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRepurchaseOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockAcquiredAverageCostPerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total cost of shares repurchased divided by the total number of shares repurchased.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockAcquiredAverageCostPerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockSharesAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased during the period and are being held in treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockSharesAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockValueAcquiredCostMethod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the cost of common and preferred stock that were repurchased during the period. Recorded using the cost method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockValueAcquiredCostMethod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_TreasuryStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_TreasuryStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>106
<FILENAME>R86.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140421264812600">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Shareholders' Equity (Changes in the Accumulated Other Comprehensive Income (Loss)) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward', window );"><strong>AOCI Attributable to Parent, Net of Tax [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance at beginning of period</a></td>
<td class="nump">$ 1,792<span></span>
</td>
<td class="nump">$ 6,330<span></span>
</td>
<td class="nump">$ 6,059<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent</a></td>
<td class="nump">70<span></span>
</td>
<td class="num">(25)<span></span>
</td>
<td class="nump">13<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance at end of period</a></td>
<td class="nump">1,794<span></span>
</td>
<td class="nump">1,792<span></span>
</td>
<td class="nump">6,330<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember', window );">Foreign Currency Translation Adjustments and other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward', window );"><strong>AOCI Attributable to Parent, Net of Tax [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance at beginning of period</a></td>
<td class="num">(92)<span></span>
</td>
<td class="num">(95)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax', window );">Other comprehensive income/(loss), net before reclassifications</a></td>
<td class="nump">46<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax', window );">Amounts reclassified to earnings</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent</a></td>
<td class="nump">46<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance at end of period</a></td>
<td class="num">(46)<span></span>
</td>
<td class="num">(92)<span></span>
</td>
<td class="num">(95)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember', window );">Unrealized Gain/(Loss) on Derivatives, net of tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward', window );"><strong>AOCI Attributable to Parent, Net of Tax [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance at beginning of period</a></td>
<td class="num">(12)<span></span>
</td>
<td class="nump">16<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax', window );">Other comprehensive income/(loss), net before reclassifications</a></td>
<td class="nump">22<span></span>
</td>
<td class="num">(23)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax', window );">Amounts reclassified to earnings</a></td>
<td class="nump">2<span></span>
</td>
<td class="num">(5)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent</a></td>
<td class="nump">24<span></span>
</td>
<td class="num">(28)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance at end of period</a></td>
<td class="nump">12<span></span>
</td>
<td class="num">(12)<span></span>
</td>
<td class="nump">16<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember', window );">AOCI Including Portion Attributable to Noncontrolling Interest [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward', window );"><strong>AOCI Attributable to Parent, Net of Tax [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance at beginning of period</a></td>
<td class="num">(104)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance at end of period</a></td>
<td class="num">(34)<span></span>
</td>
<td class="num">(104)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember', window );">Accumulated Other Comprehensive Loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward', window );"><strong>AOCI Attributable to Parent, Net of Tax [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance at beginning of period</a></td>
<td class="num">(104)<span></span>
</td>
<td class="num">(79)<span></span>
</td>
<td class="num">(92)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax', window );">Other comprehensive income/(loss), net before reclassifications</a></td>
<td class="nump">68<span></span>
</td>
<td class="num">(20)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax', window );">Amounts reclassified to earnings</a></td>
<td class="nump">2<span></span>
</td>
<td class="num">(5)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent</a></td>
<td class="nump">70<span></span>
</td>
<td class="num">(25)<span></span>
</td>
<td class="nump">13<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance at end of period</a></td>
<td class="num">$ (34)<span></span>
</td>
<td class="num">$ (104)<span></span>
</td>
<td class="num">$ (79)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AOCIAttributableToParentNetOfTaxRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax, before reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669686-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=124507222&amp;loc=d3e1436-108581<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of other comprehensive income (loss) attributable to parent entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569643-111683<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669686-108580<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=124507222&amp;loc=d3e1436-108581<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21930-107793<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21914-107793<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4568740-111683<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21711-107793<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123459177&amp;loc=SL121830611-158277<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123459177&amp;loc=SL121830611-158277<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4590271-111686<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 24: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4568447-111683<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Publisher FASB<br> -Subparagraph (a)(3)(iii)(03)<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>107
<FILENAME>R87.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140421173126136">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Earnings Per Share Attributable to Cardinal Health, Inc. (Reconciliation of Common Shares Used to Compute Basic and Diluted EPS) (Details) - USD ($)<br> $ / shares in Units, shares in Millions, $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net Income (Loss), Including Portion Attributable to Noncontrolling Interest</a></td>
<td class="nump">$ 612<span></span>
</td>
<td class="num">$ (3,693)<span></span>
</td>
<td class="nump">$ 1,365<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest', window );">Net earnings attributable to noncontrolling interest</a></td>
<td class="num">(1)<span></span>
</td>
<td class="num">(3)<span></span>
</td>
<td class="num">(2)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net Income (Loss) Attributable to Parent</a></td>
<td class="nump">$ 611<span></span>
</td>
<td class="num">$ (3,696)<span></span>
</td>
<td class="nump">$ 1,363<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted-average common shares&#8211;basic (in shares)</a></td>
<td class="nump">292<span></span>
</td>
<td class="nump">293<span></span>
</td>
<td class="nump">300<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract', window );"><strong>Effect of dilutive securities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment', window );">Employee stock options, restricted share units, and performance share units (in shares)</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted-average common shares&#8211;diluted (in shares)</a></td>
<td class="nump">294<span></span>
</td>
<td class="nump">293<span></span>
</td>
<td class="nump">301<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDilutedAbstract', window );"><strong>Diluted earnings per common share attributable to Cardinal Health, Inc.:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Earnings Per Share, Basic</a></td>
<td class="nump">$ 2.09<span></span>
</td>
<td class="num">$ (12.61)<span></span>
</td>
<td class="nump">$ 4.55<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Earnings Per Share, Diluted</a></td>
<td class="nump">$ 2.08<span></span>
</td>
<td class="num">$ (12.61)<span></span>
</td>
<td class="nump">$ 4.53<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDilutedAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDilutedAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of Net Income (Loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The sum of dilutive potential common shares or units used in the calculation of the diluted per-share or per-unit computation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>108
<FILENAME>R88.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140421171214264">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Earnings Per Share Attributable to Cardinal Health, Inc. (Narrative) (Details) - shares<br> shares in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Potentially dilutive employee stock options, restricted share units and performance share units that were antidilutive (in shares)</a></td>
<td class="nump">3,000<span></span>
</td>
<td class="nump">6,000<span></span>
</td>
<td class="nump">7,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_Sharesthatwouldbeantidilutiveasaresultofnetloss', window );">shares that would be antidilutive as a result of net loss</a></td>
<td class="nump">2,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_Sharesthatwouldbeantidilutiveasaresultofnetloss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>shares that would be antidilutive as a result of net loss</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_Sharesthatwouldbeantidilutiveasaresultofnetloss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>109
<FILENAME>R89.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140421164368712">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Information (Narrative) (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Jun. 30, 2021 </div>
<div>USD ($) </div>
<div>segment</div>
</th>
<th class="th">
<div>Jun. 30, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2019 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_PreTaxGainonDivestiture', window );">Pre-Tax Gain on Divestiture</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 508<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossRelatedToLitigationSettlement', window );">Gain (Loss) Related to Litigation Settlement</a></td>
<td class="num">$ (1,129)<span></span>
</td>
<td class="num">$ (5,741)<span></span>
</td>
<td class="num">(36)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_ProjectCostsOnInvestmentAndOtherSpending', window );">Project costs on investment and other spending</a></td>
<td class="nump">$ 27<span></span>
</td>
<td class="nump">69<span></span>
</td>
<td class="nump">$ 55<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfReportableSegments', window );">Number of Reportable Segments | segment</a></td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_SterileSurgicalGownRecallAxis=cah_SterileSurgicalGownRecallMemberDomain', window );">Sterile Surgical Gown Recall [Member] [Domain]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryRecallExpense', window );">Inventory Recall Expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">85<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=cah_NewYorkOpioidStewardshipActMember', window );">New York Opioid Stewardship Act</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_EstimatedLiabilityForNewYorkOpioidStewardshipAct', window );">Estimated Liability for New York Opioid Stewardship Act</a></td>
<td class="nump">$ 41<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=cah_NaviHealthMember', window );">naviHealth [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainOnSaleOfInvestments', window );">Gain on Sale of Investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">579<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_GainonDivestitureAfterTax', window );">Gain on Divestiture After Tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">493<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_OpioidLitigationAxis=cah_TotalOpioidLitigationMember', window );">Total Opioid Litigation [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossRelatedToLitigationSettlement', window );">Gain (Loss) Related to Litigation Settlement</a></td>
<td class="nump">$ 1,170<span></span>
</td>
<td class="nump">$ 5,630<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_EstimatedLiabilityForNewYorkOpioidStewardshipAct">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Estimated Liability for New York Opioid Stewardship Act</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_EstimatedLiabilityForNewYorkOpioidStewardshipAct</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_GainonDivestitureAfterTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gain on Divestiture After Tax</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_GainonDivestitureAfterTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_PreTaxGainonDivestiture">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Pre-Tax Gain on Divestiture</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_PreTaxGainonDivestiture</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_ProjectCostsOnInvestmentAndOtherSpending">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Investment spending at the Corporate level. Investment spending generally includes the first year spend for certain projects that require incremental investments in the form of additional operating expenses.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_ProjectCostsOnInvestmentAndOtherSpending</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossRelatedToLitigationSettlement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) recognized in settlement of litigation and insurance claims. Excludes claims within an insurance entity's normal claims settlement process.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossRelatedToLitigationSettlement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainOnSaleOfInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The difference between the carrying value and the sale price of an investment.  A gain would be recognized when the sale price of the investment is greater than the carrying value of the investment.  This element refers to the Gain included in earnings and not to the cash proceeds of the sale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(3)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(b)(9)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(b)(7)(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainOnSaleOfInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryRecallExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Reflects the amount charged against earnings comprised of the costs to announce and effect a recall of defective merchandise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryRecallExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfReportableSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8672-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfReportableSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_SterileSurgicalGownRecallAxis=cah_SterileSurgicalGownRecallMemberDomain">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_SterileSurgicalGownRecallAxis=cah_SterileSurgicalGownRecallMemberDomain</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=cah_NewYorkOpioidStewardshipActMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=cah_NewYorkOpioidStewardshipActMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=cah_NaviHealthMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=cah_NaviHealthMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_OpioidLitigationAxis=cah_TotalOpioidLitigationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_OpioidLitigationAxis=cah_TotalOpioidLitigationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>110
<FILENAME>R90.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140421169333640">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Information (Revenue by Reportable Segment) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenue</a></td>
<td class="nump">$ 162,467<span></span>
</td>
<td class="nump">$ 152,922<span></span>
</td>
<td class="nump">$ 145,534<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=us-gaap_NonUsMember', window );">Non-US [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenue</a></td>
<td class="nump">4,727<span></span>
</td>
<td class="nump">4,232<span></span>
</td>
<td class="nump">4,071<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_US', window );">United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenue</a></td>
<td class="nump">157,756<span></span>
</td>
<td class="nump">148,707<span></span>
</td>
<td class="nump">141,479<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenue</a></td>
<td class="nump">162,483<span></span>
</td>
<td class="nump">152,939<span></span>
</td>
<td class="nump">145,550<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Pharmaceutical</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenue</a></td>
<td class="nump">145,796<span></span>
</td>
<td class="nump">137,495<span></span>
</td>
<td class="nump">129,917<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Pharmaceutical | Pharmaceutical Distribution and Specialty [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenue</a></td>
<td class="nump">144,988<span></span>
</td>
<td class="nump">136,693<span></span>
</td>
<td class="nump">129,067<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Pharmaceutical | Nuclear Precision Health Services [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenue</a></td>
<td class="nump">808<span></span>
</td>
<td class="nump">802<span></span>
</td>
<td class="nump">850<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Medical</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenue</a></td>
<td class="nump">16,687<span></span>
</td>
<td class="nump">15,444<span></span>
</td>
<td class="nump">15,633<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Medical | Medical distribution and products [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenue</a></td>
<td class="nump">14,485<span></span>
</td>
<td class="nump">13,429<span></span>
</td>
<td class="nump">13,833<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Medical | Cardinal Health At Home Solutions [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenue</a></td>
<td class="nump">2,202<span></span>
</td>
<td class="nump">2,015<span></span>
</td>
<td class="nump">1,800<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember', window );">Corporate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenue</a></td>
<td class="num">$ (16)<span></span>
</td>
<td class="num">$ (17)<span></span>
</td>
<td class="num">$ (16)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=us-gaap_NonUsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=us-gaap_NonUsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=cah_PharmaceuticalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=cah_PharmaceuticalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsegmentsAxis=cah_PharmaceuticalDistributionandSpecialtyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsegmentsAxis=cah_PharmaceuticalDistributionandSpecialtyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsegmentsAxis=cah_NuclearPrecisionHealthServicesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsegmentsAxis=cah_NuclearPrecisionHealthServicesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=cah_MedicalMemberMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=cah_MedicalMemberMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsegmentsAxis=cah_MedicaldistributionandproductsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsegmentsAxis=cah_MedicaldistributionandproductsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsegmentsAxis=cah_CardinalHealthAtHomeSolutionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsegmentsAxis=cah_CardinalHealthAtHomeSolutionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>111
<FILENAME>R91.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140421269853432">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Information (Segment Profit by Reportable Segment) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems', window );"><strong>Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Total operating earnings</a></td>
<td class="nump">$ 472<span></span>
</td>
<td class="num">$ (4,098)<span></span>
</td>
<td class="nump">$ 2,060<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems', window );"><strong>Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Total operating earnings</a></td>
<td class="nump">2,261<span></span>
</td>
<td class="nump">2,416<span></span>
</td>
<td class="nump">2,410<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Pharmaceutical</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems', window );"><strong>Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Total operating earnings</a></td>
<td class="nump">1,684<span></span>
</td>
<td class="nump">1,753<span></span>
</td>
<td class="nump">1,834<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Medical</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems', window );"><strong>Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Total operating earnings</a></td>
<td class="nump">577<span></span>
</td>
<td class="nump">663<span></span>
</td>
<td class="nump">576<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember', window );">Corporate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems', window );"><strong>Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Total operating earnings</a></td>
<td class="num">$ (1,789)<span></span>
</td>
<td class="num">$ (6,514)<span></span>
</td>
<td class="num">$ (350)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=cah_PharmaceuticalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=cah_PharmaceuticalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=cah_MedicalMemberMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=cah_MedicalMemberMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>112
<FILENAME>R92.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140421172493352">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Information (Depreciation and Amortization and Additions to Property and Equipment by Reportable Segment) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Total depreciation and amortization</a></td>
<td class="nump">$ 783<span></span>
</td>
<td class="nump">$ 913<span></span>
</td>
<td class="nump">$ 1,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Total additions to property and equipment</a></td>
<td class="nump">400<span></span>
</td>
<td class="nump">375<span></span>
</td>
<td class="nump">328<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Pharmaceutical</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Total depreciation and amortization</a></td>
<td class="nump">151<span></span>
</td>
<td class="nump">135<span></span>
</td>
<td class="nump">147<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Total additions to property and equipment</a></td>
<td class="nump">55<span></span>
</td>
<td class="nump">47<span></span>
</td>
<td class="nump">35<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Medical</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Total depreciation and amortization</a></td>
<td class="nump">226<span></span>
</td>
<td class="nump">243<span></span>
</td>
<td class="nump">288<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Total additions to property and equipment</a></td>
<td class="nump">97<span></span>
</td>
<td class="nump">86<span></span>
</td>
<td class="nump">74<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember', window );">Corporate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Total depreciation and amortization</a></td>
<td class="nump">406<span></span>
</td>
<td class="nump">535<span></span>
</td>
<td class="nump">565<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Total additions to property and equipment</a></td>
<td class="nump">$ 248<span></span>
</td>
<td class="nump">$ 242<span></span>
</td>
<td class="nump">$ 219<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=cah_PharmaceuticalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=cah_PharmaceuticalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=cah_MedicalMemberMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=cah_MedicalMemberMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>113
<FILENAME>R93.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140421164180264">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Segment Information (Assets by Reportable Segment) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">$ 44,453<span></span>
</td>
<td class="nump">$ 40,766<span></span>
</td>
<td class="nump">$ 40,963<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation', window );">Disposal Group, Including Discontinued Operation, Assets</a></td>
<td class="nump">1,101<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_CordisDivestitureAxis=cah_CordisDivestitureMember', window );">Cordis Divestiture</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation', window );">Disposal Group, Including Discontinued Operation, Assets</a></td>
<td class="nump">1,091<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=cah_MedicalMemberMember', window );">Medical | Cordis Divestiture</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation', window );">Disposal Group, Including Discontinued Operation, Assets</a></td>
<td class="nump">1,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Pharmaceutical</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">23,624<span></span>
</td>
<td class="nump">22,398<span></span>
</td>
<td class="nump">22,446<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Medical</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">15,408<span></span>
</td>
<td class="nump">14,691<span></span>
</td>
<td class="nump">15,284<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember', window );">Corporate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">$ 5,421<span></span>
</td>
<td class="nump">$ 3,677<span></span>
</td>
<td class="nump">$ 3,233<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount classified as assets attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_CordisDivestitureAxis=cah_CordisDivestitureMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_CordisDivestitureAxis=cah_CordisDivestitureMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=cah_MedicalMemberMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=cah_MedicalMemberMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=cah_PharmaceuticalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=cah_PharmaceuticalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>114
<FILENAME>R94.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140421172909528">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Segment Information Property and Equipment, net by Geographic Area) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Long-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
<td class="nump">$ 2,360<span></span>
</td>
<td class="nump">$ 2,366<span></span>
</td>
<td class="nump">$ 2,356<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_US', window );">United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Long-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
<td class="nump">1,958<span></span>
</td>
<td class="nump">1,880<span></span>
</td>
<td class="nump">1,846<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=us-gaap_NonUsMember', window );">International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Long-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
<td class="nump">$ 402<span></span>
</td>
<td class="nump">$ 486<span></span>
</td>
<td class="nump">$ 510<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124429447&amp;loc=SL124453093-239630<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=us-gaap_NonUsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=us-gaap_NonUsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>115
<FILENAME>R95.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140421169296424">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-Based Compensation (Narrative) (Details) - USD ($)<br> shares in Millions, $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense', window );">Tax benefit related to share-based compensation</a></td>
<td class="nump">$ 12<span></span>
</td>
<td class="nump">$ 16<span></span>
</td>
<td class="nump">$ 16<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedContributionPlanCostRecognized', window );">Total expense on employee retirement savings plans</a></td>
<td class="nump">$ 55<span></span>
</td>
<td class="nump">$ 66<span></span>
</td>
<td class="nump">$ 99<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Granted (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember', window );">Performance Share Units | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage', window );">Target performance goal (as a percent)</a></td>
<td class="nump">240.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Stock Options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Award vesting period (in years)</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_ExercisablePeriodOfPlansInYears', window );">Exercisable period of plans (in years)</a></td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Stock Options | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_ExercisablePeriodOfPlansInYears', window );">Exercisable period of plans (in years)</a></td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=cah_A2011LtipMember', window );">2011 LTIP</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Number of shares available for grant</a></td>
<td class="nump">9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=cah_A2011LtipMember', window );">2011 LTIP | Awards Other than Stock Options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Number of shares available for grant</a></td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=cah_A2011LtipMember', window );">2011 LTIP | Stock Options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Number of shares available for grant</a></td>
<td class="nump">9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_ExercisablePeriodOfPlansInYears">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The instrument's contractual term.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_ExercisablePeriodOfPlansInYears</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedContributionPlanCostRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cost for defined contribution plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 70<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=49170846&amp;loc=d3e28014-114942<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedContributionPlanCostRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of tax benefit for recognition of expense of award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of vesting of award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=cah_A2011LtipMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=cah_A2011LtipMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=cah_AwardsOtherThanStockOptionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=cah_AwardsOtherThanStockOptionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>116
<FILENAME>R96.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140421173452424">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-Based Compensation (Schedule of Total Share-Based Compensation Expense by Type of Award) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total share-based compensation expense</a></td>
<td class="nump">$ 89<span></span>
</td>
<td class="nump">$ 90<span></span>
</td>
<td class="nump">$ 82<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted Share Unit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total share-based compensation expense</a></td>
<td class="nump">73<span></span>
</td>
<td class="nump">70<span></span>
</td>
<td class="nump">63<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Stock Options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total share-based compensation expense</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="nump">10<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember', window );">Performance Share Units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total share-based compensation expense</a></td>
<td class="nump">$ 16<span></span>
</td>
<td class="nump">$ 17<span></span>
</td>
<td class="nump">$ 9<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -URI http://asc.fasb.org/extlink&amp;oid=122041274&amp;loc=d3e301413-122809<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>117
<FILENAME>R97.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140421164088344">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-Based Compensation (Schedule of All Stock Option Transactions Under the Plans) (Details) - $ / shares<br> shares in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward', window );"><strong>Stock Options</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Outstanding at beginning of period (in shares)</a></td>
<td class="nump">5<span></span>
</td>
<td class="nump">6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Granted (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercised (in shares)</a></td>
<td class="num">(1)<span></span>
</td>
<td class="num">(1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod', window );">Canceled and forfeited (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Outstanding at end of period (in shares)</a></td>
<td class="nump">4<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="nump">6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber', window );">Exercisable at end of period (in shares)</a></td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward', window );"><strong>Weighted-Average Exercise Price per Common Share</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Outstanding at beginning of period (in usd per share)</a></td>
<td class="nump">$ 65.15<span></span>
</td>
<td class="nump">$ 63.78<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Granted (in usd per share)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice', window );">Exercised (in usd per share)</a></td>
<td class="nump">43.08<span></span>
</td>
<td class="nump">42.36<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice', window );">Canceled and forfeited (in usd per share)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Outstanding at end of period (in usd per share)</a></td>
<td class="nump">68.46<span></span>
</td>
<td class="nump">$ 65.15<span></span>
</td>
<td class="nump">$ 63.78<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice', window );">Exercisable at end of period (in usd per share)</a></td>
<td class="nump">$ 68.62<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For presentations that combine terminations, the number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan or that expired.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(3)-(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price of options that were either forfeited or expired.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(3)-(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which option holders acquired shares when converting their stock options into shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>118
<FILENAME>R98.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140421164208088">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-Based Compensation (Schedule of Additional Data Related to Stock Options) (Details) - USD ($)<br> $ / shares in Units, $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_Netproceedstaxwithholdingsfromsharebasedcompensation', window );">Net proceeds/(withholding) from share-based compensation</a></td>
<td class="nump">$ 8<span></span>
</td>
<td class="nump">$ 8<span></span>
</td>
<td class="num">$ (14)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Stock Options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue', window );">Aggregate intrinsic value of outstanding options at period end</a></td>
<td class="nump">11<span></span>
</td>
<td class="nump">12<span></span>
</td>
<td class="nump">10<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1', window );">Aggregate intrinsic value of exercisable options at period end</a></td>
<td class="nump">11<span></span>
</td>
<td class="nump">12<span></span>
</td>
<td class="nump">10<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue', window );">Aggregate intrinsic value of exercised options</a></td>
<td class="nump">10<span></span>
</td>
<td class="nump">8<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_Netproceedstaxwithholdingsfromsharebasedcompensation', window );">Net proceeds/(withholding) from share-based compensation</a></td>
<td class="nump">32<span></span>
</td>
<td class="nump">26<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ExcessTaxBenefitFromShareBasedCompensationFinancingActivities', window );">Excess tax benefits from share based compensation</a></td>
<td class="num">(5)<span></span>
</td>
<td class="nump">6<span></span>
</td>
<td class="nump">7<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized', window );">Total compensation cost, net of estimated forfeitures, related to unvested stock options not yet recognized, pre-tax</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="nump">5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1', window );">Total fair value of shares vested during the year</a></td>
<td class="nump">$ 3<span></span>
</td>
<td class="nump">$ 8<span></span>
</td>
<td class="nump">$ 20<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Weighted-average grant date fair value per stock option (in usd per share)</a></td>
<td class="nump">$ 12.94<span></span>
</td>
<td class="nump">$ 8.26<span></span>
</td>
<td class="nump">$ 8.34<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Award vesting period (in years)</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_ExercisablePeriodOfPlansInYears', window );">Exercisable period of plans (in years)</a></td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Stock Options | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_ExercisablePeriodOfPlansInYears', window );">Exercisable period of plans (in years)</a></td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_ExercisablePeriodOfPlansInYears">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The instrument's contractual term.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_ExercisablePeriodOfPlansInYears</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_Netproceedstaxwithholdingsfromsharebasedcompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net cash inflow/(outflow) associated with the amount received from holders exercising their stock options and paid by the company to satisfy an employee's income tax withholding obligation when shares are withheld from settlement of a share-based award to cover taxes. This item inherently excludes any excess tax benefit, which the entity may have realized and reported separately.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_Netproceedstaxwithholdingsfromsharebasedcompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cost not yet recognized for nonvested award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ExcessTaxBenefitFromShareBasedCompensationFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from realized tax benefit related to deductible compensation cost reported on the entity's tax return for equity instruments in excess of the compensation cost for those instruments recognized for financial reporting purposes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=122142933&amp;loc=d3e11374-113907<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ExcessTaxBenefitFromShareBasedCompensationFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of options vested. Excludes equity instruments other than options, for example, but not limited to, share units, stock appreciation rights, restricted stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>119
<FILENAME>R99.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140421167406248">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-Based Compensation Schedule of Remaining Stock Option Plan Data (Details) - Stock Options<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Weighted-average remaining contractual life of outstanding options</a></td>
<td class="text">4 years<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">5 years<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1', window );">Weighted-average remaining contractual life of exercisable options</a></td>
<td class="text">4 years<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">5 years<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Weighted-average period over which stock option compensation cost is expected to be recognized</a></td>
<td class="text">2 years<span></span>
</td>
<td class="text">1 year<span></span>
</td>
<td class="text">1 year<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>120
<FILENAME>R100.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140421172916296">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-Based Compensation (Schedule of All Transactions Related to Restricted Share Units Under the Plans) (Details) - Restricted Share Units - $ / shares<br> shares in Millions</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward', window );"><strong>Restricted Share Units</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Nonvested at beginning of period (in shares)</a></td>
<td class="nump">3<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted (in shares)</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Vested (in shares)</a></td>
<td class="num">(1)<span></span>
</td>
<td class="num">(1)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod', window );">Canceled and forfeited (in shares)</a></td>
<td class="num">(1)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Nonvested at end of period (in shares)</a></td>
<td class="nump">3<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward', window );"><strong>Weighted-Average Grant Date Fair Value per Share</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Nonvested at beginning of period (in usd per share)</a></td>
<td class="nump">$ 45.92<span></span>
</td>
<td class="nump">$ 51.65<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Granted (in usd per share)</a></td>
<td class="nump">53.76<span></span>
</td>
<td class="nump">42.71<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue', window );">Vested (in usd per share)</a></td>
<td class="nump">49.37<span></span>
</td>
<td class="nump">60.21<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue', window );">Canceled and forfeited (in usd per share)</a></td>
<td class="nump">48.74<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Nonvested at end of period (in usd per share)</a></td>
<td class="nump">$ 49.05<span></span>
</td>
<td class="nump">$ 45.92<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>121
<FILENAME>R101.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140421172946440">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-Based Compensation (Additional Data Related to Restricted Share Unit Activity) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted Share Units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized', window );">Total compensation cost, net of estimated forfeitures, related to nonvested restricted share and share unit awards not yet recognized, pre-tax</a></td>
<td class="nump">$ 73<span></span>
</td>
<td class="nump">$ 77<span></span>
</td>
<td class="nump">$ 75<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Weighted-average period in years over which restricted share and share unit cost is expected to be recognized (in years)</a></td>
<td class="text">2 years<span></span>
</td>
<td class="text">2 years<span></span>
</td>
<td class="text">2 years<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue', window );">Total fair value of shares vested during the year</a></td>
<td class="nump">$ 70<span></span>
</td>
<td class="nump">$ 57<span></span>
</td>
<td class="nump">$ 68<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Award vesting period (in years)</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember', window );">Performance Share Units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized', window );">Total compensation cost, net of estimated forfeitures, related to nonvested restricted share and share unit awards not yet recognized, pre-tax</a></td>
<td class="nump">$ 26<span></span>
</td>
<td class="nump">$ 29<span></span>
</td>
<td class="nump">$ 12<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Weighted-average period in years over which restricted share and share unit cost is expected to be recognized (in years)</a></td>
<td class="text">2 years<span></span>
</td>
<td class="text">2 years<span></span>
</td>
<td class="text">2 years<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue', window );">Total fair value of shares vested during the year</a></td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">$ 5<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cost not yet recognized for nonvested award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of share-based awards for which the grantee gained the right by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>122
<FILENAME>R102.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140421173274504">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-Based Compensation (Schedule of All Transactions Related to Performance Share Units Under the Plans) (Details) - Performance Share Units - $ / shares<br> shares in Millions</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward', window );"><strong>Performance Share Units</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Nonvested at beginning of period (in shares)</a></td>
<td class="nump">1.3<span></span>
</td>
<td class="nump">0.9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted (in shares)</a></td>
<td class="nump">0.4<span></span>
</td>
<td class="nump">0.7<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Vested (in shares)</a></td>
<td class="num">(0.1)<span></span>
</td>
<td class="num">(0.1)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod', window );">Canceled and forfeited (in shares)</a></td>
<td class="num">(0.4)<span></span>
</td>
<td class="num">(0.2)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Nonvested at end of period (in shares)</a></td>
<td class="nump">1.2<span></span>
</td>
<td class="nump">1.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward', window );"><strong>Weighted-Average Grant Date Fair Value per Share</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Nonvested at beginning of period (in usd per share)</a></td>
<td class="nump">$ 54.24<span></span>
</td>
<td class="nump">$ 51.45<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Granted (in usd per share)</a></td>
<td class="nump">55.45<span></span>
</td>
<td class="nump">44.03<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue', window );">Vested (in usd per share)</a></td>
<td class="nump">42.72<span></span>
</td>
<td class="nump">48.40<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue', window );">Canceled and forfeited (in usd per share)</a></td>
<td class="nump">53.71<span></span>
</td>
<td class="nump">50.92<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Nonvested at end of period (in usd per share)</a></td>
<td class="nump">$ 54.89<span></span>
</td>
<td class="nump">$ 54.24<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>123
<FILENAME>R103.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140421171091416">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-Based Compensation (Additional Data Related to Performance Share Unit Activity) (Details) - Performance Share Units<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Jun. 30, 2021 </div>
<div>USD ($) </div>
<div>vestingPeriods</div>
</th>
<th class="th">
<div>Jun. 30, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2019 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized', window );">Total compensation cost, net of estimated forfeitures, related to nonvested performance share units not yet recognized, pre-tax</a></td>
<td class="nump">$ 26<span></span>
</td>
<td class="nump">$ 29<span></span>
</td>
<td class="nump">$ 12<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Weighted-average period over which performance share unit cost is expected to be recognized (in years)</a></td>
<td class="text">2 years<span></span>
</td>
<td class="text">2 years<span></span>
</td>
<td class="text">2 years<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue', window );">Total fair value of shares vested during the year</a></td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">$ 5<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_VestingPeriodinyearsforShares', window );">Vesting Period in years for Shares | vestingPeriods</a></td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember', window );">Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage', window );">Target performance goal (as a percent)</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_VestingPeriodinyearsforShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Vesting Period in years for Shares</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_VestingPeriodinyearsforShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cost not yet recognized for nonvested award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of share-based awards for which the grantee gained the right by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of vesting of award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>124
<FILENAME>R104.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140421170947688">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Schedule II - Valuations and Qualifying Accounts (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
<th class="th"><div>Jun. 30, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ValuationAndQualifyingAccountsDisclosureLineItems', window );"><strong>SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesBalance', window );">SEC Schedule, 12-09, Valuation Allowances and Reserves, Amount</a></td>
<td class="nump">$ 944<span></span>
</td>
<td class="nump">$ 729<span></span>
</td>
<td class="nump">$ 687<span></span>
</td>
<td class="nump">$ 626<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MovementInValuationAllowancesAndReservesRollForward', window );"><strong>SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense', window );">SEC Schedule, 12-09, Valuation Allowances and Reserves, Additions, Charge to Cost and Expense</a></td>
<td class="nump">2,702<span></span>
</td>
<td class="nump">2,407<span></span>
</td>
<td class="nump">2,353<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesChargedToOtherAccounts', window );">SEC Schedule, 12-09, Valuation Allowances and Reserves, Additions, Charge to Other Account</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesDeductions', window );">SEC Schedule, 12-09, Valuation Allowances and Reserves, Deduction</a></td>
<td class="nump">2,488<span></span>
</td>
<td class="nump">2,366<span></span>
</td>
<td class="nump">2,293<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesTypeAxis=cah_PricingDisputesMember', window );">Pricing Disputes [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MovementInValuationAllowancesAndReservesRollForward', window );"><strong>SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense', window );">SEC Schedule, 12-09, Valuation Allowances and Reserves, Additions, Charge to Cost and Expense</a></td>
<td class="nump">70<span></span>
</td>
<td class="nump">49<span></span>
</td>
<td class="nump">60<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesTypeAxis=us-gaap_AllowanceForCreditLossMember', window );">SEC Schedule, 12-09, Allowance, Credit Loss [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ValuationAndQualifyingAccountsDisclosureLineItems', window );"><strong>SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesBalance', window );">SEC Schedule, 12-09, Valuation Allowances and Reserves, Amount</a></td>
<td class="nump">242<span></span>
</td>
<td class="nump">206<span></span>
</td>
<td class="nump">193<span></span>
</td>
<td class="nump">139<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MovementInValuationAllowancesAndReservesRollForward', window );"><strong>SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense', window );">SEC Schedule, 12-09, Valuation Allowances and Reserves, Additions, Charge to Cost and Expense</a></td>
<td class="nump">129<span></span>
</td>
<td class="nump">139<span></span>
</td>
<td class="nump">140<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesChargedToOtherAccounts', window );">SEC Schedule, 12-09, Valuation Allowances and Reserves, Additions, Charge to Other Account</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesDeductions', window );">SEC Schedule, 12-09, Valuation Allowances and Reserves, Deduction</a></td>
<td class="nump">94<span></span>
</td>
<td class="nump">127<span></span>
</td>
<td class="nump">87<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesTypeAxis=cah_PriorYearRecoveriesMember', window );">Prior Year Recoveries</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ValuationAndQualifyingAccountsDisclosureLineItems', window );"><strong>SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesRecoveries', window );">SEC Schedule, 12-09, Valuation Allowances and Reserves, Addition, Recovery</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesTypeAxis=us-gaap_AllowanceForLossesOnFinanceReceivablesMember', window );">SEC Schedule, 12-09, Allowance, Loss on Finance Receivable [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ValuationAndQualifyingAccountsDisclosureLineItems', window );"><strong>SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesBalance', window );">SEC Schedule, 12-09, Valuation Allowances and Reserves, Amount</a></td>
<td class="nump">12<span></span>
</td>
<td class="nump">27<span></span>
</td>
<td class="nump">14<span></span>
</td>
<td class="nump">7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MovementInValuationAllowancesAndReservesRollForward', window );"><strong>SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense', window );">SEC Schedule, 12-09, Valuation Allowances and Reserves, Additions, Charge to Cost and Expense</a></td>
<td class="nump">5<span></span>
</td>
<td class="nump">15<span></span>
</td>
<td class="nump">8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesChargedToOtherAccounts', window );">SEC Schedule, 12-09, Valuation Allowances and Reserves, Additions, Charge to Other Account</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesDeductions', window );">SEC Schedule, 12-09, Valuation Allowances and Reserves, Deduction</a></td>
<td class="nump">20<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesTypeAxis=us-gaap_SalesReturnsAndAllowancesMember', window );">Sales Returns and Allowances [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ValuationAndQualifyingAccountsDisclosureLineItems', window );"><strong>SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesBalance', window );">SEC Schedule, 12-09, Valuation Allowances and Reserves, Amount</a></td>
<td class="nump">689<span></span>
</td>
<td class="nump">495<span></span>
</td>
<td class="nump">479<span></span>
</td>
<td class="nump">479<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MovementInValuationAllowancesAndReservesRollForward', window );"><strong>SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense', window );">SEC Schedule, 12-09, Valuation Allowances and Reserves, Additions, Charge to Cost and Expense</a></td>
<td class="nump">2,568<span></span>
</td>
<td class="nump">2,253<span></span>
</td>
<td class="nump">2,205<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesChargedToOtherAccounts', window );">SEC Schedule, 12-09, Valuation Allowances and Reserves, Additions, Charge to Other Account</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesDeductions', window );">SEC Schedule, 12-09, Valuation Allowances and Reserves, Deduction</a></td>
<td class="nump">2,374<span></span>
</td>
<td class="nump">2,237<span></span>
</td>
<td class="nump">2,205<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesTypeAxis=us-gaap_AllowanceForLoanAndLeaseLossesMember', window );">SEC Schedule, 12-09, Allowance, Loan and Lease Loss [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ValuationAndQualifyingAccountsDisclosureLineItems', window );"><strong>SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesBalance', window );">SEC Schedule, 12-09, Valuation Allowances and Reserves, Amount</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MovementInValuationAllowancesAndReservesRollForward', window );"><strong>SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense', window );">SEC Schedule, 12-09, Valuation Allowances and Reserves, Additions, Charge to Cost and Expense</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesChargedToOtherAccounts', window );">SEC Schedule, 12-09, Valuation Allowances and Reserves, Additions, Charge to Other Account</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesDeductions', window );">SEC Schedule, 12-09, Valuation Allowances and Reserves, Deduction</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ValuationAndQualifyingAccountsDisclosureLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ValuationAndQualifyingAccountsDisclosureLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>srt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MovementInValuationAllowancesAndReservesRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MovementInValuationAllowancesAndReservesRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowancesAndReservesBalance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of valuation and qualifying accounts and reserves.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.12-09(Column B))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24092-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.12-09(Column E))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24092-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowancesAndReservesBalance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in valuation and qualifying accounts and reserves from charge to cost and expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.12-09(Column C)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24092-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowancesAndReservesChargedToOtherAccounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in valuation and qualifying accounts and reserves from charge to accounts other than cost and expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.12-09(Column C)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24092-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowancesAndReservesChargedToOtherAccounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowancesAndReservesDeductions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in valuation and qualifying accounts and reserves.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.12-09(Column D))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24092-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowancesAndReservesDeductions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowancesAndReservesRecoveries">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in valuation and qualifying accounts and reserves from recovery of amount previously written off or reestablishment of reserve previously utilized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.12-09(Column C)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24092-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowancesAndReservesRecoveries</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowancesAndReservesTypeAxis=cah_PricingDisputesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowancesAndReservesTypeAxis=cah_PricingDisputesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowancesAndReservesTypeAxis=us-gaap_AllowanceForCreditLossMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowancesAndReservesTypeAxis=us-gaap_AllowanceForCreditLossMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowancesAndReservesTypeAxis=cah_PriorYearRecoveriesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowancesAndReservesTypeAxis=cah_PriorYearRecoveriesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowancesAndReservesTypeAxis=us-gaap_AllowanceForLossesOnFinanceReceivablesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowancesAndReservesTypeAxis=us-gaap_AllowanceForLossesOnFinanceReceivablesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowancesAndReservesTypeAxis=us-gaap_SalesReturnsAndAllowancesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowancesAndReservesTypeAxis=us-gaap_SalesReturnsAndAllowancesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowancesAndReservesTypeAxis=us-gaap_AllowanceForLoanAndLeaseLossesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowancesAndReservesTypeAxis=us-gaap_AllowanceForLoanAndLeaseLossesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>125
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
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M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
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MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
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M+]GFS_;['1)D2HND, 8&"4_S__2I<,2>P=@Y8. 5!MX+ _?0+_B%@?_28'C
MH%\8]*UG\J58/\RHIA=G4FR)-$\#FCFPSK36L'R>FGU?:@EW.=CIBZEX9)(L
M8(M)EWQ:SLC1;Z_/>AJ0S?U>4*!<YBC> 137(Q]$JB-%KM*0A=\#](!2R<O;
M\;KT4,2_LO2$^,XQ\1S/K2$T;3*/P=P]:#[#S6<L*,T=9#5^Z67?XOFHE_^9
MK)26$.G_(I#]$K)O(?N'*(H@@_=/D[OG#:O;,=S<=;KO$!:#DL6@'8M)FF8T
M)K=L(Z2NHX/C:)DQA,ZPI#-LZ11)09JLLARFA&.M::PP3J.2TPC%N4HUU\_D
MFL>,W&3)BLDZ+CB&VW5=?^0C;,8EFW$;-K?L@9M8!%?=T*0V?G"<*94A3V''
MWS(:Z^B8S-/@!.%W6O([;<,/T(2$?:-F"X_)4E/-B)!D*K)4RV?X']:2QL$_
MOD48NDXEF4X;CG?TB<Q#B#:^YH$EBNQO Z3O=IW3P7@X'&(,]T3=;<-P$H:2
M*76\.R#OX3GR,:UU70/DR'$<4N[Z(J8!]G*X7D75^R&J4W,&.WTGMFDM31QN
MEJW@$L:LTFS7_R%F91 NI'CDZ<OU%_1P3#P"*^UW<?5^26TAE(9=^9MO#KX9
M#8A]WW%'&+<J([BXE-L-G$ ->I@*#G T=/NO,2I5-G!Q"7\O A.KD4@QZ6T
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M 791[C/#SIAI"\#_6Z7@:6 =U+WVXG]02P,$%     @ .4804WK9?PU2!@
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MM?]X*CF7]&:O11OB9&&^A06+QYN@:D7ABLF@(55,5Q(7'32^&*(1#M1Z(DM
MI1% M;M+\TUS0B%VBQ5O2;CGLAN"/$Q'+T0]<]5W.^36Y'XL )V&I)")&FS6
M1$D=AZ;K/HKGATYYCW=KAK^EH,,HUZ3^)%M>\_NQ%JN4P/QAK\)6VC%-\SP)
MWU Z._()6&R43T=D7<AS'Q ,@+[4!GTA$=1[7*X-L-@!-C>GFL(K>J,!^"J'
M+%W&1#](<GS8Z*YD^4_/0N :J'%Q$7^GM)61WVHD98!]#MN1K(5%*"RT&,,N
M82XI-T"FEN@XR@ZG*X=S1@5#4DQ AQRGE+G@-]SQR<4L.Y%@%I[G:+GD=PJ0
ML@0YU++Q7?!&Q+&3&BYSIV0*2KH4PUCXJ9EYHGYD*T&/GD"H8ND5.\$T>B&@
M!PRRU=(T!_:#%(,.#HA!P@4MJ?V;! C>:/5^BS)CXGO"@H]L->=+L FM5!Q,
M-_7N::%1""ME@TX'# 53''01_A ]U5(W&;,-8N%2V(M$(K0C9VV@/D6MGL1/
MI=B/9X.X54(7Q5LG)Y$(VAG<!(RT2BIW^(D4D=P_W-HZ H(38:Q(:+_61KR2
M$UF8[-01%B46CI40<,B!0TP$Q0&E*LW>8X'()LE!-?ZVXDTM4- D!E/)D#SB
M)!\DCIBK=WNQOQP5#JT/#GDN LB,1XUVX)2FAI"$/<Q2/VV8AJ)%[S7\Q/9
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MK)$6+AWQ F8>P(GK#;X\:/>'XT YBJG++TE>LFCQ-)C#:B?08YZ$?V!UOSJ
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MS_0_5H"SJVN[JBEMF1:=%CR8%R3Z0+X^83IKD]0@*0&UZ80BT<L,]BSM-_"
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MBI8-Z/O:&-^\<(#V6KO\%U!+ P04    "  Y1A!3!P6#)6@%  "E#0  &0
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M">C]2E'GZ@ZLH/\RF_\#4$L#!!0    ( #E&$%.\9PS&_0@  (,7   9
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MB^'G9];4TUEP,A$3K9(YZ%A!Z9K,@R^/QX!\DR8=<3P8)ZVK<6_<NDJB]M4
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M"KVEI05XGAN4^>:"!*S?=E_^&U!+ P04    "  Y1A!3XK1QCA0>  " 60
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M"U?B=;=2W]/Q;S -.$;->)N_X;SO=75@'W=%Y8?R256$VV@;0 )^"4%KK42
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MB#4B($AE*X9W!RXJ6V&\]61L@&(P&TKN!R%M;H#>8D5FN>D)86.C]:_7E^^
MZT?YCE$D17YWH;">W]\1X_2[CT6'4\__& 5WO.-@O>EFH>E'_1$U8 UY'YRC
MLG,(@W.O2!P;[MJ0 L]"&-&P+F;+<)">6=4RA]O'.)[J]I\;F1X#VO<!;&$6
M&"SOC;,#F2OZ>[\UM)/M#4/[6=Q!//1:5)WE_U ]N*N+U]MQ12^_TN.K\\<)
MK =43:P=[,XG"MOT45]VKBS7UT_< *)1SQA93"+\T,F5V*I=NX==>7LKU5%)
MDAVI,3;M4#N)774,$WE\R1HYIIB5<++RYI!J_I<+G?/BG<Q\)0F?#!'%>]TF
MA^W>XSLR\I(-W2T!TQA%Y1<B 4=-3F6-^B?RPS-Z^@C4'3V9%])1(T 5XJBA
M)3\>CY_@E7@A6]GVZ^P 7*R$1'7-CX>E4.%PR)3MCWW7,.JL$J7+C'+)A6B$
M7AP\*(^QL)LYJM&"8M9R)-3!!Q]+ 0(3U?ZVNC&U,W>2F^<QLL/P]VT+#"YT
M2PS)^!(R@?Z\TDS:>-0J)*,6[IK8ZJU*-_J$IDP&>REMP--[S=R61T7D$KK,
M@$4K2+*;9<#Q,5=YOS_-[O (YR/N<X$I@S$G#B#E$XE_7:]I!6@A7V]WO70M
M9C+_EG%Q?O-#W+,[;@ DSLJS0'KOZ/1I-TQZ>G+Y_C6<X>1$XPK.3Z[.*1L)
M\2?''7=F^0&\Y(?QD;5!W&WK/WTJ=LCFM,YK<:I3XR*7W^3IU>RHJ_2G=4T"
M>4X9E_7C?&K98AW3&D.T.KT#C!8FG"@LCQPH).*/5_!]QHG":7[])_:QW8[/
M"V"?X16S4X5#&12[-%EG9$PT08L*L;!6U]F^,SH:?.26C<,DKX03B80O*B(Z
M'PS,_+CI#M=.^7# /.0;1%;":?/4;:6M.W)U'),%0W.*2$.>WTHI#[7NP=YM
MU4$TF772?K?SBP0)9OCX=79+(@##\R&[%YQY<.2:)U&P'6[[>C[I93MV&^NC
M[%9<&)JUW/WK]4RN7I";ODW7"U_JK;K#XWHW,2+?-8\35W:%5\_FSYZ>%*W>
M]ZL?NF8G=^PN&@#CK?RYD:-\? "_KYJFBQ\X0;IT^?O_ U!+ P04    "  Y
M1A!3X^=OV)D1  "W,P  &0   'AL+W=O<FMS:&5E=',O<VAE970Q-"YX;6S%
M6VUSVSB2_BLHG>=.KI)ED9(L*9NDRG&266\EFY2=;#Y<W0=(A"1,*%)#D%:\
MOWZ?;H @J!<[-[=35Y50,@DT&MU/OX)ZN<N+[V:M5"E^;-+,O.JLRW+[XO+2
M+-9J(TT_WZH,3Y9YL9$E_BQ6EV9;*)GPI$UZ&0\&5Y<;J;/.ZY=\[W/Q^F5>
ME:G.U.="F&JSD<7C&Y7FNU>=J%/?N-.K=4DW+E^_W,J5NE?EU^WG G]=>BJ)
MWJC,Z#P3A5J^ZEQ'+]Z,:#P/^(=6.Q-\%[23>9Y_IS]NDU>= 3&D4K4HB8+$
MQX.Z46E*A,#&[XYFQR])$\/O-?7WO'?L92Z-NLG3;SHIUZ\ZTXY(U%)6:7F7
M[_ZJW'[&1&^1IX:O8F?'#H<=L:A,F6_<9'"PT9G]E#^<'(()T\&)";&;$#/?
M=B'F\JTLY>N71;X3!8T&-?K"6^798$YGI)3[LL!3C7GEZ]MLD6^4^")_*//R
ML@1%NG^Y<+/?V-GQB=E1+#[F6;DVXEV6J*1-X!*L>'[BFI\W\9,4_U9E?3$<
M]$0\B*,GZ W]_H9,;_CL_L1;;19I;JI"B?^^GINR "+^YXDE1GZ)$2\Q^H,B
M?'KVM"]" N*=+#*=K<QE]T-NS+F8*UB>:H^162(^%_F#9M/ \\ON&Y6II2[%
M^R+?G+='?UDKC$EA?J K2CE/E;-!_4\\5G[!-%Q06Q(ED7@ANCH#^M(4ZV$(
MZ88N URBF?C:O^\+N(E"DJ$9<2:ZH\DY?_0&XROZ%O5&DZGX>YY=[ \>3D!E
M.A+Q9!CL_20KH#6,AT1[V)M,8DM[,HZ>VV6)QZ"RS3.5E4;D2[%M"W#N!+AD
M ?XO=G]3%05HOA#O58)=I<3;;#HCSJ[&,USCV5C<E[)4K+<T7V#,+!;1>"2F
MLT8F$8SI:B:F8_$E+S%D8>D2N<ET3.2FTQC7$0:]54N%ITFXZ'A(BW6G,0NE
M&T_/#U;EF]THAG*Z0US\VMUHS _H@B&6@<0M(D:S*VSI*L+3Z?!\'WFG!6?9
M8$ET)_PQG%ZQ*;Y;+N&560WW*EU>W&8P2YDM%(BK"QI!X!=OJX*4N83A@A^2
M>T_D52%V:RCZ\2+?9>!.^[FFFAN=:,06A(M%7L C"2D,+= ,0NBZ '>"$(:Y
M0H.-9H&!,)!95>:@L=099F@\H'MJP\#9%IH@E=(2*>XFHLP!9YUK"%F7>L6P
M[@..VCRU= ^;T(NU2# ORTNA-UNX(]Y=/6P!M.6I3GB50AG$&9HF#3235 NZ
M"QW0C)#_UJRE0T>C%1 JJR)C4&!H6>AYY78!4>E5II=Z(0&[# F!,U.H@*4%
M=3.);55L<Z-,GXWNR$#B<2&+0H/P7"Z^\VIRNTVU6RGY#9&-60<]-E7'(2WA
M=Q.-*0Q$5WR=])@*ODT%R&/!C2Z)\PJ1IV#[OLF+/),/NJB,N-9)3]PIK+CD
M>>^PV7RC%\ ;#$N7CZ+;N;F^>W??.1?7$+S*)$MT_LBDOF::_F(#,B"<K:
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MW7'W=UL=(%@BJ-L436VVP$3Q&#1IC._2-"M#-'G!C0?NCK LZSN4@UF%4VO
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M$7_&X^GYST\N 0U3&V@NUBJUHC(2KJ,;8../:9BV<UMW\BEV,.B<CI^7J\W
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M,8K<0%%46A6ICJLK/P@E92;1,6\RE0GJ,L2@GHC!"5H)A5;BJ3C#^J5.$C+
M.3<6]*,O[EB@I^*#W%S 1V3N.-S.R6>#<W$J!O@WO!&O+(QQ4;D_K> %$S'>
M\>'P7(S&XOOO;H>#X0_B33N :EO3RNMJX2>3(W=ZK9^*\00_;L;BEUKW3_<2
M&Q/38_Z'96MIXV[A1N?5EH-)$+A-4M42SU?H FX;J)7T\-9A>K:2X3KF13AL
MM4O60$A@9=5*ZCJQ.-#&5(\B-VJ20]^NH"CZ&V&-()(/#9JA4$?1'W?*&T6V
M4/&CJ;VAD/N=0XYZ4\5M79 ?5H?\M&H1>*MF/FW&<X!M&,F 4I&X(F'-$AD3
MY;WPL*(#TWSRF;%TD';[ X5^+F2B9QLN6_76S%X["Q)[<TI6  Z,8JM -[X6
M'!(<!2 &IHWRA!JU&=Q-3#>!%DB&I@*X-R78FVR(*"GA4KPDV$>?=+8!5<)J
M/;?5/#7 Z,XNR>5I0OFU\KNU$!K !T)/I-BARZG0$^4.O[O]7#&\.B.2YY?B
M-= N65EG$8*8<F'/)4,2;M@?/"&*D&<-NZ5F!T,A"/4,D9U;'M>%R7?T5]YF
M!PATVJQ+H#6M6Z-OBJLZN.TU88W5WN[HCQQBE4OJNFC3T^OK?ED]&,SCL=3/
M%JOGL)MV!LZ;D<&\0&\*$GLT HP6*16S>4X'MS7M3UP+73%EO:\U(717]] C
M_GW %4B_>ZW/J-^77.J5N?8KNRQUZYRY[/]ZOOYRA^2,\DX"09".1SOUSNF*
M&26L="ARO0:YH+1T[_0S[/=#!2'.^3' &"A&I2V4L95H2K?C="?J=$?.KJOQ
MTS<I#6])71N.K4<[Y#?PL\'P_\C1RLV;#I>5'F<I"\2N$HT1(&["#'^:C,H7
M-;QSZ6NGQGQU@Q^Z%,[ -+)ZZF1\CWX)R TU:'U$?66JA_S4!TR%4C-%[3+5
M0TN5G(MO&3/][3@:/&%;DKJT<^S.#0>D"[\A7A^ND/O54[4]5"AK5CJ5599_
MKQ.J%H!I]]3#HOP>B,C.WB.KFP_FRA0Y_"N-=PES*.I#\,]PO]D!O"\5>N>R
M_#LW ]J(U[3%P6X 2!?61BXDVK>N>G[E#:CF^ U&QS1K%,5E[#6#N.J&9^54
MYG&ZW-T]L7\<V3J=W7(#U:<6YHEXTP*?M.86/_N3<W'VY'RKB_AJX.<5Y<4W
MU+]WXNM=H_@25;<'<0%<"4>2>8Z(*9R=VN.Z7L<0IN,\HX&_CVCM40323$;U
MR<S^2?]NJ%[/2XY#ZAZ@=^-E'D:OC/6^)4G,E4F5 U;HDHIEX0J!*['TL54+
M.OJE60#1)_8@90(=Z)DN<47EU&6*E<M@=K"E,&Y_.I7E@$! Q$/SV"7E:@#A
MM-%Z=#93!!Y+9CH@47\;$LWV=.*N(>B&0UM5IO)*U/DI^9H[$*()_TS;9;+Q
M4SQ(#*<K<O;9P$VVM.3@^1Y('92D/"@ 6R:2B%AD)RRG4Y(*5['?<$T_RO+-
M 7D7!#D^\H%M(DEG@KL]H2ID3IE$A%1I(HI3D$(@ ".1#'X"!KHT>G7G9-!V
MA25)F3H]TKT[;- .P?IHB900^1[3H;567)!RJMCP?'!;HQYR00C0@R>K @M=
MMK+@5H(*YM([)LS'S(>SUH#XKHG@!KX!]3&S4$G<W/AX9^\>2/OCZI3X;)Q(
M^- FI9!0KQ8TLR7MIO#VJ>ZA:J0RUO#JF$[,;$^HPIH>"$H-U+]PW<0[]4!'
M>$@@F6EK-.H8J1T]R-TUG.X8B].Q=UQ&QSL5:PK?3,TI+!Z-N[;<\!^!JCUS
MRE,Q'DU VF4:<4&[T)_#QR.K?6-.A]HJVGL8&@'4>7;Z-3N#SLGH8-*Y] C(
MAE1P@1ZS =W"?O375V\9L^THXTW8UC;6 =2V7T\#0FEG@PE!MG+JVRD[_CN[
M/M^GRFM&?M=?JH]&AN/2<4=J:6* ;ZBDG:-U!VH'0_IU0ZYU:*I/_P9''0&,
MSL4X&+;OG=R/P33_USFT']&9!!FHI-;&U66B_ (DW9[3T^DQ]Z'6T,DP$HM)
MNL]I#A%N3>Q_^^E[N5S]<%>? 'P)T?$W:BC>X[&W]56/NJNHQ_#;]7#?<9WC
MHR*(7D-70_B24E9,,XV"9/DD]),AJ %H01=AL*/.VL>*T?:9U-;]HO"<SM67
M)B=N)'57S MHK1I2M(9]WW\WF%S_,!F+J<>H9Z>3&K&>=S'B[U]P\\B)F??Y
M3:V@]:FB!GAPV[W5[6@R_B$$Q&>GP]'H49N-+KO.Z]IIHV62LAI:/Y^.+W)S
MX2?5=-X[=T[D[T]E*Y.W+A7(\FRY/!/@[,=]1\\YPQ;*#.M"IT\QD$VX7_R"
M)@N%5">^!TKXJA*Y6$ZHC@_Z/A<4#7[2U!K";[G))W<-"(B3#\=)%_]$QWQ-
M2L\7=$V+&RYPW6MVWM8R)^5Q2[/[;IX!L3G<I0G9.E"NV[@/026JK.#*3S>?
M[7/IKVR>-??.IS>5IU>=,=X=75=O,[_Q5N\6 .OZI#W97(J?V,V.G/D^+C.Z
M6Y;DU^C^ \?IUA_BP[DWZYC6T8EQEBV]EEPRK<S/5RJX6SM%F2ZE)RE/![62
M'J&('R&86>I(G+TWZ<7KRC//N\=$^QNDX-+6UG6=:G@4W)F@D,L:G6C/68$\
M@4X'_85#2BR-]KTZF6B<//C;$^'U*D61X9R/L[Z_![BDU6X:SQ<"Z^NQ_III
MQ#</W<9*YJZ+:(^#'G^E],C3T?9U4]? [#LFSEIWB[,PC6T=#)/ DHSAS@68
M4>=P.X(X5N0D9<HB2J8^%=HX]O!NGJC2;P^?)']E)ECG?'<Q3$G.2\[<N=;Y
M51C9.]KBS=95[CT^K[/']<UEI_P!G;*[S?W2RK_!/][[J&@>\<A.557AFR)\
MXR!\=WGF-^MDA]=CZ@<W02_QU6B/AM=UK_GUS@0>J[U_W#7=NM[)MU"C[7%_
M>;V'W/6+D7EPEP8?=W]I@I18P8?@<(T;19X>(3$B3[FSR9SO<;LS5G9)YJU7
MYLF,SN#<:*I.S5TW@>2NP9>0*[1/#YH&<^%!3%R42 9O90M4U L^3*VO+A]U
MH0]%ETG''5?[Z.:S(VJFB9[+=HD)=@UN%7.%LO75[^ BWY9:C[F/]V,7AZ=B
MTKNYIKMW-[WAS0A9I4$9GPY'$UISX\<,7TDXI+5:8_0%,"XS2O,C).WGPM!'
MOISQ!"^K< \?)A"0UA!4PINSC$:@>*?T[E7! PK+!_9N+'XOL98LYVGJU'W[
MSMT<=T?C"N@P<UE,_(+^'?E !#6DVQ,TK?;?ORL+4Z"G,%/LOZ?C]%"L?'FJ
M%>2-P?@"W=K:%$E<WD<09Q ;P7'>XPC61)LOG//W&BZVOA+28W\J#QO*R"]O
MFK5S][XD&R2!KO>./.EU-S_I2);O?^[)<),G?:R=7(]XXK!O=%..9,K?M ^/
MW+HND-ZBKQWWW:^;SEE/F]Q@0EFUZXMK5\%W!I?*SOF;D9DSAOOZ8/5N]>7+
M._>=PWJY^^;F.VGGU$$D:H9'^Y<WUR>P'W\;TKW(S8J_@0A$DILE_[E02**6
M%N#SF4$$^1>T0?65U!?_ U!+ P04    "  Y1A!3EFH!SN<%  #1#P  &0
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M4J@NYI9*-5>E-*5'62BT8,_CVS@)EU:X."/7RH&>=6T< $+,015J)L(FG-:
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M;#%?V7%1X/3!096/)W&_,[KYV.G>328BJU1109LI+.'SM1R[!L<D.EG++J8
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MAOT( BMH7^F:02HXDA$:^*8#B?@)@@SB%4WN#H> I="XY9ER ELUB4=>--Q
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M6DG*/-#6VU4MR>#0N%D&L?@"JACKJ)*U&3=,50TQ4DRLA%Z':VE,+;)7C#]
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M*XM#MG&PR1PY6#COO] ?4Y1W&2Q5Z3WAL+E@",#"@'Y2<T!#/9<3]M+Y _V
MK J6C>4X,Q&:Z&9;.*3CB0_7L(F @2AR/S"1OX.QBP>@*[?(WS)V<,F(R/O
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ME6K?6WC.+Z1=?PCPG$OB+8,R[N\WFWST6(H()-2'!XG3-2_)#,3H"O,>TL/
M?A5B<$33+3GQ4<,GMQ&LG&/Y9F5 6;*;&KZ^0]F"OFM@51CH144D/.GN<[3Q
M!P:*7I?AQM7=K;V<)/])(8N4N*T&E'%T[-!BB<2:?A19YFCG!@5JD7]";!(9
M:CAE[[0R@A,Q$P(T0S+K2GZ?H2=DX2'<*99BQ'IJDEHI2M%6!/;\89LV3)%_
MF<$;X4F>?8IPQ!V6]"U;DJKP+S#XFN5PA%L.H(O(5>D(792M]A%6.*PIKC0Q
M;3*["'_-Z_6T<5+4GW9C;^M>[Q=W'<H)YLM/&ASJG%5!1"FV8-X$'V"0[_%V
ML;(1K9_8CT8\[^S8]WO&((X?'H9B ZW:@ WGZ(,@'*VJT?$ 0,^P"^F"SQ,>
M%=6+[.&\!O;<M,@LFV=3;JR2T2'CB-T$WRX=VE$IVGQF]8Q/=7<5@8^"64=R
M,YY/H)KVKC)JHGA+$)#C]292U-(-D@^1#+<DH4-^_,N^XQS70CPPZK'?[835
M=2 +H K&%&.HK"$E]3"(]J,)42L/",VF&BW(@ [-2TZ9D!A^>IOF!8[N)+D*
MZ@%VE:Y6M5NE;,Z2>R#:8NIEV]6HDK,G882BA" I5!;XS@/8PMA3DX-^D=8!
MRH/H)>!P</SA]46CWLJX?WAS9R%W5BTY!'M:*!=WX^=N42 $!5?\8ZW&A40N
M;ZJB8Z5?5_;HJ^>^\95WI3TZEJN4W(B%-I:VQS\@C&5@&#ZDHHTC?EGC**RW
M/KVUD^1](/U%BO;6KC.>7;43#ZUA+]\Q^VE(X0!U3F/@^G8XXT_F5:3>>.\/
M\;VY:8BX#0U!NR85"\<V,);?RDP,E?@=>83\9VB3I-Z?@%XW]"\L06L&5I,Y
M/"!R>/P/R*R OO)M,(8(V J+O>Q(6Q6?YR39%AUR;UF.0F8N8M:5&<\)/^>P
MJFLP:OZ!9@ 97&%(?%SR6M5W:48TOS+&U.7-IV.&CL&;M:0 L)^*^!9.F(,&
M,"H<4X1I\X@7F4F8],0[FWR4BSE0V<"QQ%&10@5&:"-J@[CW"1>%JT5*.4.G
M*8D#1NZ[@Q>"#KH"A1.:JF-7( [:1O404.?MV? RIG15U2=VGL$N[_!NP6HK
MF!@-=H%G&]RS(+5Q+HIYQ_[]6OFEU&WJP]6 WC IK*,=D)7AW6%9YQ'++<93
M4%\JO;Y@!/4.ERO]6'0#BX=C02*RWJ@#?!>/S$ZCIQ]X>2SHO(RG__KDW(>N
M@32FT_#9GJWH^*TZ4 ;('['MY@7R;LFHT3#-G6$NEAO,'U3'$7;8GSDZ;D0P
M&%@X;'+HDOM"U^L=[5S YK $$].8L1 ,4^-!\A1X4].BJ;RG(K1M,H+4U1(I
M*'8J2K'HZB?FB9D 6XX;U3"$+"3RD(-, D \=$]!.EOH9F ]0#&HT#G1<L2E
M!+5_8P9!"RT!!%9F5'SW6/">I<:O6S*OY11[DU,\?Y(RXB-S4:/]!GWJ"\6M
MF#\$9S_%DTPF5DA!\6MA)$+9;>:2:2!6C_%A"?7CLU[<RD%GQ5LZ!Y&(9Z=U
MO6'8?)?8&<A2) .VRE&?K8-! */JMIKNL9LUP1[+GBPT*[6'1;&%HTAHBMI0
ME Y&,:!4,3#7NQO%)!E4XT><1XJS%AR(JF2(57-D$9L68_5N)WP:D\+0_#"F
M05CFR'B4@!'N4M\0XLB16NK'!9VA8-$W$L$C>R LD9HMUB+&COX:L)S_OIDL
M!+)OC)J4]*CM_&&9-!49*4CMD:'(1F%C=IN \^&0C^E9CX]MUTRD[_]]8)"H
MY>TQZ3[WK%N@OW5;L8V()N;"]5Y?.,W]5 L4IK77GB15D?6' L:+<5YDQNR>
ML9QS#M24$):4U@#CRL@YX0/JOYY.<#WNUDXRV_[/R&78KV5]6C8 [$/.% E&
M/K?.M\U7+!*1U6/LER+G9;J114,]%Y:4[8J@:K1NL2ZKHEH]L,+J/6;>)=E3
MWN-XA>0BPE[41+$L5(V^QQ;BEMTR1OGVLI.72(,1L+C#(0^;?[''"QAY 'NN
M-_3EH78_'".*24Q<?@;_I0'W?J"'U$XDC[D)#:'5_6Z NF+/!N4R4A@*L0'^
MN WYB'J]Z@D'&>>]'JSF&\'9E4/&4!.V@C/..*K3:@*$[@9)Q'^6CCWFBPY)
MZ]/Q='-Q"_^@(<D;T+@FG"'_D/RW_/NKNV^3MT6U^/0_@W[IYW=!*7\%+$J^
M?%!:0Y+7'%."BN*Z!7 DHWYH!0,FLND%4\FUO$G+=*5XL<U&=+84S$U.X,0(
MIR+_3*NXPOBLFI$^K,F'L<46$)WB@5P&AYB7GF4HX$/=FB9MT"O0/F7+T##K
MW^B[7=7I!EN!!:?L"M#H'S"]*VTXMYZS'UNQ[[TXAC?G-!A_O'A)4-K3@5#0
M8P7\A5*+\#."Q*S(T=.KJ!JS9F#6;&%^LF_&GSFPEOV=(8V;)'2(K^[&".!(
M47Q5^<)H$ KD;)G\E-:@04UGDP Q!QVO0OM1]+0[EPA>*4U$H)#@4GRYIPCR
M,B%8K?$F%/X&=%L 127_EFZV7R7O,?Z/'\FAQWYVSHI\8[)H).EB8I.Q6+:D
M!F8KY&0RV7P"1NW0^$46(R%XK(I"L78V-.+\07W(G![KA-Y-X,;!%^E=T['Y
MX5%/",\B(!HP<^"8Z6T*S!^- :_D^U3J*SAD68K[G+EF4>=S9E$_@V*>O%*B
MD-/[,Z4I(;C-0GS>>R_KC<_!/Y&C37JN-2HY)1L%GV84\(Z?)#?.<:\S#I!D
M?&ACY^THLPSU'*;CY1@^A*3D03[XY+<3^W=>,C(O9,V@T&H?=@UTE3M+2J)3
M#X-5SN1-07NRT&&E*L"#>Y4)1A/9GI2,5M4#(U;>0G#M#)4K;^M1JFALBWOL
M0] "-\ )0/@R9Q"#5#5.^8V9G%DE"\NQ!0XX9]2>"9L^2O&J.8*"! 6 I](B
M7>J,TU!MV1,.QHEJ31[LVOLD0O*Z'@2*<>1@/F/&VOO*/M($'^H=>YC=O:L7
M".J/"[ L854(:@ZK*M!I*>$2+:%LQ=!^:PX6Y11)G"RM2P\0X92I&)'D*>*0
MO<1'+R0LS\'](0(Q)37(Q.4>7AQB\T<D!#4=6N'9=B>,0""O%TM*\E^(-8K8
M;S6L@R-#S#ZU>]B"\/O @-)>$G1PCQL,TRBK"$42IN,U#GYW90:3N1:PXB"[
M>%8+F$SU*)H:U_.6WE.MLD%8%!P] ?'!HJ6?T'26-,AM^B ;A7M\AT27>0SU
M!FD:&4'="@U(>SY+3#\+R30.I;'H)? 1'0R9F"S=UJ?SEPQ)\A$.?BW8[92L
M@%[1%9SWDIS_$W&W<#9<BQ8%H^XI,P6(4-.LX9>5:Q0G2NWZP72:"!T9J8,I
M]W2Z4;\C"K[?<N46LH;,&K.Z09Z382AN1'9VW*!#Y9O&Q-=-*JI.I4!;TD^%
MAA59?^W#EIVCV!;;_G#P.GD##3K<)DJ8HR-*C^%+NEU%*A[?$*6@&7%\1G(K
M:\H#X/ "L12R:?%H=MLL>#@5Q>Q#%N(*3T67A&800H!:+IH^@ZLE/LA"@QY=
MR]&T@*?F95,4H:;?M.P H"S).E]1*,GD)F?TO%B"I&E[W@^49N0 9NOSH?,+
MWA>.@P!8+D(A>L<D6@Z5E:2$:SJ^/V.XTR%]=Y<^V ;D[3ANJV/^:X(G@N(
M2Q!^;5N8\D4>TBT3(9&#4&]AF;:<PTGR>V^VC)1^%66#D[MG'S@ZA&@IR?\8
M@UD/$DYK6#7[E7[X2#]<\P\HLDFI\TE8H'*3"D?'3A3*;; N=IL>X]&A LMT
MO(K*.YOX=2,E/RZ]71!@5+).[]T>1O[\;IK'^B%)O2=CT$.T&RY0PFFK&C>)
MTMD:[<ZDTX:<CH&W57H8HX#,0#59N%!;Z$"8N+Q&P,]77T40?.3@Y,6@WDR%
M."HIH08/X?W0EUM(8@D+)J"AO)0TB[DK@1>UF@F8L5'O"7WOD%,NO[5GS#)D
M V'WB2.TQBRS<.@].+QJ/CO)'ZIY\ *0#1K<0=J:KSS%B6Q/PMF+!^CINI:N
MOAW/4_#YH:+!=+P&P8_H;+NRA<,&S\=S&Z&UN<$"8Q]\@;&!I_Z0LF-252;Z
MS1"#*BF3!$WCE2V8AN5Y:%5 5+"5.^Q,28WM;-PPONH [ZNX$7W,'4'U#!@Q
M"6[>"TM2 P9=&F8H*FU>Y5DT6&MD:U13Z$\,[CC;:5N[XS:]E\)&[)^8GDQ?
M)7,+GCX_N3CSWTC1,A,#\WP^0D[;I!KOI8 ETD(&7)+I/SIX<L0C0TN&Z#":
M"CO!;08ULB"N]>!6E3J[",M,;H @]@)CBYTMJC"$U 2)H 0:,4#,LJ+8)E.:
M=Y_%%*5L96P,+.?G:.^U>8,!%TYTE5)(%"ZPRA6I4+O*4Z-%5-0?->"7.3R0
MWS[\?H6E[TAAB*&'5>,"=\>#H/I0SUGMGQ&2$J^W+<1#28L45!>@M3X4!B$*
M)CUIL$.1TDCJ:X$TB4C@4K$J-G<M3(#;6^8%IT+0"0XQ#(P.;4IV.DC9/#07
MO9([T5S4M$TG:%06J<A:R4WT(#T8T JC..ABZ.>S9FY)J0@R_QY/4G=NJ(4H
M46OHK7H Y6=-Z#(0$3 <2?0(G&024E%W''3"CT P=.@(#J]$<'YT"L)3_TZQ
M#1BGN$5OADLS#B*+.(E.R,%JDQ3$M\KH)%X,&%J&%E1#%6AN5:J),>*U:E,)
MH-^MZ+B>C:)?@_/!N7#G2?+6+5)Q:S3.\VC6R1D3A&>HM#G##!Y:IK<518ST
MZ/DY!4.0F;,F+/GP]V)'$#&/LI&)O*%DWE!L2_U2/MQD K=S](+):>$@6:\V
MG 3?!CI&9\V>O8PB\AI%(-"U/F&/;Z@^*J[$# 9*O/JR5TIM&0?P(D/(^H2(
M%3+BW+NOB&?2NY3 [\%KN,0", DBTIMY)"='0V"V(&A()/+:650N=+>4J4=E
M4FN!,@(E$+PN5@WT9$8DGY"+W3]W*)%)K)C]0B7MLW4TX\!^->+ 1GHAS.IJ
MJ%JK@/Y[3$0]_*.Z7BB"-!TO8O2!5_%7+.DZJ.4]_771W'RY(ELMUI:W(/>U
M#0NJ6Q,#P4 KE/T-:LZ> "+2K'B*->H.XI,%'[S%P+]=4"%(A[Q!AD),PCIG
MV=DH<3QV^_"[G-;M<Q>S@<%5@E>1DH9S*O,M^T95 U-;SC>N1C;0'.?0/(;Y
M]WDQMB0/XZX&FD3=Q0?=.7]*BW<_88*90WGAB].:\IIJ_0"W7"XQ$QP]-NF]
M!$YIZVUE'32HYNGB$V$)\ .LP5U:9Z96@AB 3#OL#(.! +T'T)A)3\#?[*:R
M-+)QV(9@,A[=/PQO\3B;F/I$6\,0#@7'^A2(*^I'+*Z[KJS=)F^1$KT#'KTY
MI@P[N8.0+F3'XAK<9ON#,B=Z:V.]^K7%T9"P8:>X:*9"T91#)&4V[AF0Z75R
M7#U3+=3'C(RVC8^T0"2HEMABDKY$QU**I^(1]*!1<??O+2P?H)ZA)WIZBW8'
MJSJ_13AAQ)+#4'CW$(F*-6,Q 82B!4PAS6-- H=25X,XX#P8.6H]R$1)EW_2
MD22YJ>/SU@*(7S:DR$ON[M--#]5/:")R FU0U_7.<VW*ZLU6Q:F6B:V)!X?"
MH6Z X=\@R"B,S;58C8PV,\,9*1^5N LI\4UK;=ZP;AXAL4*B4.BAJ?PE2X.Q
M"\=#UG3-+3FM5 WE6%EK=X2:EO 78>R6',Z6X?)B1 Z<M!?XQL/GIV;;-J+X
M]=-$<53F?.S2BU"&;39>2(T=@9=2]_1'&]!_'BCG<_L15Z167K7<K'8APT*+
MVDIH8UX(,44FJ!X;;2P$ZZ+"I\Q$M^D#8;S&EC'4V)B-E\CXN2KU>@OL3G.&
MN;]KAZ5!B='O>VYP13^OR][WN1]*6$X^R5Y 8UQ5.?B$D]C<&J_0N?7RDN52
MJ[+7EI8"*XE<*"SZJGZJTP1&MAA=Y%"=8S9>G>,& \G';\FHOS(6Z.#B?5Y3
M"?\P]Q5__ _6"ZSV=K]\\;.#TW& ;543#'8W*X"44U1)A&/VX?WHQ&*#>LWE
M]S4WQ<:H[6]4;\OGE EDT'2ON4*$3)"T!(2V(;/$9@;'T;05*E&"UX^[V)VA
MHE)!4+382U!&*=%+2N;;'= R#4"#E92^(!\F:$*L88Q/%[5%XAVL+ZI?S"82
MJY C7VQ4&:1%\=,V(CZP5H*[%4\L-J;VH&9EH2)P2]<@$1R6 LK24DB8X)7D
MLV0NIU A3:&T;&0=#.$1ZLU0+A,+G5 N8F2@Z%6]=%KTH,QZ% SLDKS&OJ:(
M5J87V[M'C)<$[%>9E#A*M&C\Y.+1]-27YQ\6#(AP4U0MF$/F(KU9O?00SV;?
M,?8U7,HH1C/1@F#!;T9Z9^QR.CRX^9Y@>9<'1T&D$.J_1H.N*K/@5B<(#F&K
M$32@>HQ>BQ0PP<VZQVBP4+=E,I2$8-80S@=CZ_-=?W[*W #COC53*@R<''D<
ME5DPP F#>X^N4..1E]Q7KV7T6ZK?D1,NR53Q*LWTY=-TFGT#&949H?;%;+Q(
MQ;N<C*CL^?K,$]NE?!_<,JF$I5]O7<PR)2;RYN6$_IEQ2 3^FHZG CV](M@L
M@+!GXPAI+25\'738P25X=BNQKTS+'E/!" ]Z7U.Y44)G-)X#H%'LT<S>_\&F
MID0-?+26BW6RWT_C%M[JDUPH,CE\,-JC8>DZA.LP+ (;^!1^"L,-U.83N'$4
MT-WNU@C04H<:1%5AH&YPZFQOZ<;PEH?D>H."'2JYI*1B;C('6G$]_-3C:6HK
M4L#<1_&"YBSE%,D7Y%?*S)H@'*;D[XF'+,B^[G!T+S1$6-!6!T1 [2(EBK;>
M5]6_UC:CG,SH950VU5G+?I><IJ0P!>(V16'<-E+P;_30!##N;!Q.>T/A'864
MX/+Z6W"&U??/;RZ0:!.<X"+).<I4F_>\\ZXQRQCY(B,M,UC0O8,GH=)PZ"1.
M-V&L "N*<<A0"BZ&$4Q"+4!\;>ZSS#BH00 D+K5JNCY);N))6=^_'WOHF55'
M ^G"F!MC34U"550*TI0]4V!6<(^((QOKQ*T?&H]#PP:PX)#QW: (!(%!@6LG
ML0$JE$\K8,OE5WX$"JDP-]&(]TO3/=!IKM;3'(,E/&]0ILE=9,M=DJ^%XM_+
MKM "!EI^0@ZKUA:C?GWJBM\M/GV*NPFCHO*!M!!V'\*ZF=("4A<? TVX@ ]:
M@:-]V,KJZ7GU^##$SF#1(*H^@($HO^Q5'5^N82 6_3J_PU2O!1R(,<H)L2!0
M>^]'CSRT,BGP_%5N[P(1%Q4'Z"@4^TN(=?DDDS B.JA+*5JT6\?27@ PC+51
M0<;-2J*&/+USD]7^ZJ%TP,THG[B"6*?QBXO7;WK%[MZ<AUIX<=%ND6QVUBB:
M^K<:A!MV3+7M_4#N/M+_9G3,!!Z<G5PHI&2"G\YBR,GL9!9^?D[!OHE'V91R
M>>&"3$?K*U&[Y/F6#*YWOO'";%0!/!F$-$:5',4]R==H2MEERPIB767;.^8D
M:2O#/!NJNK_!\ZJVOV=L<G">V(='L41E>O5:C>BB)D7>Q=WMS)'TF50JC45I
MLWJ[3.BH!U#W9<2"QZ*C;'A>AA;K3"2'7=/)'2^,3:GJ#7NU0PJ4> X#RIV2
M#"@;&9N:]'NRF!@[/49DB<\2X?$B0A$2K2V$ ]PKT\/\*VXP5/7F.A+0[=9[
M-:3(@:;K\JJ@"=\R9MM4DE&]D5%%E 7QX,M]D\^5REE@F85Y%-NP,.*PB578
M@YSIR=K5'G3;D ))&AQS7SHF&$OB$!XL4H.>!CFFB>1SZ.U[R/*X BH1@O;(
M$2FJR0&J0!LP]7O>B^@O .;U<B,7[CUE,2"(<8Z#-7FKI5NLSI43Y$PQ3MC#
M,'I??0>YQ8V,:J\A/V0VGMUQ R=DJW;[#_ _='8,JJV?T4[TY5J^5"1.=(6(
MQ;:++X7\*<&;\GS0:53$"*@'HWVW6,DT./U16G!Q#'Q *N)7>F=QI 6R*TVJ
MGVIEM#(SAW9LMGI?W$M31/8"F'DD5R]FL_#SLZK(CI%"@*'/'KO,L^_'^4[]
M.#?JQQFDC+_?;'(]Y)W*@W6(J<@F$DNQ[+3V/*PJ5Q5E(H3[9D5"47IB0<#H
MD)ZD60@95A)HV>DYH=1.'6(@,TGX\M$O<C H,N0N?4"69X1+!$QW6A]9+/@-
M6+E4I4T?E^R)U%,9J<,"]*HXL7EB<5#R7,X7%_CT8&6,&*M'OP&UBS%M_309
M\,G9NY5KB;+G_R 3RJ49HV*0E[(Q/9":[2^O*%UQ)&8(-+$J>UMA^^$'K%?=
M9,DK#4@>.SI.&R<7H_*B[V3)':&D:JK 0 3!\12G)(/]=[_V-V,$8O/@P&?X
M5HW/\^QI+D^6SL,G8?2,!Z#\;!SC?FF+)X>$C\MP.?WQM;AZKJI]\<=_;A>1
M?S[@I1GG-K+JH3U.B>AW*_G#IML(1/PY"#E.-N37Q>REXVN[ID37W3YW2II,
MXK1RAK)B4'8ERD\ K/;J6\71-0_ :WM^&Q,+/\&[X.*^-*.,U]?<%*Y76L?E
M7U-SYZ^9GMC$L6^4 Q\B2N%P%P__H"1= =![_MJ1H1/<M#(\(Y3I=F7@O"O.
M80QG@:+:\4*%OHWT$)^.5F":4XFXD*WKD2D\)WS0,0J'KS(3A=G>8DYU:A4@
M%JXU$/@Y3NTC/(J[<<VHS =3!X\N;*'<.KT@JGEH*'/4^!9<8^X0EEN-";-\
M3_>P9V#[H#C<@J4-7*5J8;!27DPNL/K;Y"+F$U> [9^S4%K4A,R>>_@,:WPY
MQM<"*'0VCNHD^BX\N;ZO:@=B)KDB7,B^?*"_VZ:I'!$S#@),#V'H=@%TL2^M
MAQ+E]!UV4%&G#QHN7';E0D2)_K230]K*^%T L>YB4[V)LI3I1>.F(T!HP@RO
M5JY] 0A?GC^7,-:Z*A"_J(EWDORO%KU](Y!'C"@A./'AP>4O5Q\.CA(P<409
MD;131_DB$MZI&8$=O-JEN<-X?$JDU^O*^")84G$_[L"RQ5 47%OU6](:.J%T
M=I87CCQ P:S!B>V_X$<477,5$0=+I\F)I[RX1V&7U*.MFJ >0ZW#WLL<?J9'
M:A>6O-PE^A#.'M-2S@+X[.RQ6SSEXH-KPDY<>>(O"96#@6YT>>VYKOB?UCC!
M&"CNQ&%^>T5P+\25MA&??<)%4NRTM,S:-+ +B;#^Q411'>.'#@ENHN&A-KUG
M$*.Z-T3!M=#%M<M6SI9E(2RM7AKHY/?0P ;KWV $EN =!%-NV;_ML_%Q%?NX
M'+*<M90! V>H92D3+8WR[6ZI]YO+X%H%+#B3EQT&=9+\0,_Y(9%YA))9;UJP
M>6^<=J+ODJ(_V"U=6]A4]D>^;<)W,Z$^M)XS7GEO-K.,;K/*-Q@09DQ/;V,9
MT1%14FTJ7<OZTYT]V,=S]LY/DA6 CEN8AZNDA&8C,NV1-;9<**Z&IJ49>CW!
M8_KS:<TCU/WX@H2Z=Y;UV?18 C97/HU*RO=M,:>IZAJJ^B-0><^*GS,*Y1F^
M3DF<K4XSIDN7/8]N[M*MW!XCS-<_R6$.7Q)F/4"Q!GRF.'>;]>1OAOF[-7 "
M*N?TZ2;J,$OL7S<Q1(N"M ]L-#YNMAB3)_M)?[U(V&OI'%J\4>/X+(!US\:1
MLU1@_W<BT9]"T:=!U?'S6K(E_'>O-C5%_>[4A^[)3 #IC-U%@X6K:M;F306(
M><R+!9S+\;;%K#).DL9-672D.&DUSUPAGII@!VH0EH:GXE)4G#7-L#0KJ$R(
MOA:GC"H>?FBA=T;Z#-2O\O<5([K1.'A,-7J$$Z),<^X8--;HOK@U?,;2.E1-
MP):N(=;-J4V2DN^+-XGO+Q20)CY&9+D%+=W7N-30B&!/??:P7 O,"\G.P5!7
M\=<UI63JJ'P:)F&4)'E[D][G&RWH()5W3=4O&0:)0K#%^T]VY<ZSK);2"IE:
M/78ZV*M4*@NCE;LX?L0WDFERG/S2*SU&\Y1JD%)ZG1?*EQH;MBE.I,U9W*8,
MR-2 _JNK")W[S^CL##K[;7=M;/+.EM-Y$:T"[R)$BM*E_/W7XK:3 *\O[Q[\
MGB+:!C#8>X;FN>N;IS'7X:ISX]PMH.3/QJ'MUYSC'FS6R\"@;] G@4#205[W
M&5=:<F=PUB^S:AL761SJUOS\P4B'X^2*@3$_LFE#!1W TIB=3B]8K7FDV;<5
MYNL='KR_O'D+1B5#IT$[<.1(,1(*D\%"T06"6BL>*#J[<HH$KR,65Z4(AV#:
M1E@'+$"*99,V&.M#"LO<O#7U B?04%I:/)05D?[^D(-09CET?R#WG]"X0QKA
MG@MYPXWT43D*4T!6C@G71@RW5!!C\XM$.8NF@CAVW5\1G\1X#,T<$_:F-VVV
M!C +2I*NY.5Y;%DU%MP!=KEG'Q0$]O7D<H]BD_+6BJ=AM+IVRG!P+7N[9YD8
M@M@KTF=R#R<ALB[SYG0BLLQL::M)?WD)V3FTQ)Q(S^4Y*!(>9=Y&JVLK98NC
M0PH2AK3>?J'\M)=>S_<8.P.Y]!WV-QN#[<'"F[M57I:JXW'-?NF6"K3WRK9D
M>6;A&0'9XH$S.S[X ?\"N7J$H7S@,_S(P0>NF_P7,'5E/W\0?*[63.DTD_ON
M>!Q2JDYZ4"X1VFU\NY(2@_Q$U:4G3<!ZM?TB<-45C3B3H6(4_R:4"_5(G+"\
MIVC,;T!M/_Y_6C]&KX P Q\3' $J?_;(?8ZPO2#^J*S&!ZYVHD67F7W\0<FV
M=*0_*J[RB6CZ\:Z'94L8SY-J4=Y)C64&3?+P0Z")^:U@C:28;3_ P26EY;.O
M7V:8@/T23;,"H6^=O?04U@+=G,C(S;/&4^Z_!:VA6ZS]2'UU:^.>IPPB=+PN
MH'4.21#N6^P)OOZ@4PSMAY(A6QBNP#Y9 <7:\@'R+2E[P -Q^_ 0$.EF'NU6
MA\N=%8RCS?2J37F=G]>R>6PR"RS*U.XO3O4'U]L,Q3$GC[>Y>]NX']9)\H/G
M^0676!,H/%V;1GD:_H)0E2EZ*<^$+ZT>.E4OR&'R+FW3;[\&DEBY*Z "NG.F
M!,I&$]1_B]A(+'/QY>7LX 6\&1[_]NLMF%0_$>@4ZVXNX=73DU?G!TF--S+H
MA[;:8I.8. #T1W]BQ-[5^ #\CE$A_8 =8'D>&MZW_Q]02P,$%     @ .480
M4_?7-5YS P  Y@<  !D   !X;"]W;W)K<VAE971S+W-H965T,C,N>&UL?55M
M;]LX#/XKA+$#6B"HWYHL#9( 36Z[;5AQ0=/;?3C<!\6F8]UDR9/DI-VO/TIV
M4G=(\L&R7D@^#TF1FNZ5_FY*1 O/E9!F%I36UI,P-%F)%3,WJD9))X72%;.T
MU-O0U!I9[I4J$291- HKQF4PG_J]E9Y/56,%E[C28)JJ8OIE@4+M9T$<'#8>
M^;:T;B.<3VNVQ37:O^J5IE5XM)+S"J7A2H+&8A;<QY/%T,E[@6\<]Z8W!^?)
M1JGO;O$YGP61(X0",^LL,/KM<(E".$-$XT=G,SA".L7^_&#]H_>=?-DP@TLE
M_N:Y+6?!.( <"]8(^ZCVG[#SQQ/,E#!^A'TK^YZ$L\98577*Q*#BLOVSYRX.
M/85Q=$8AZ102S[L%\BQ_9Y;-IUKM03MILN8FWE6O3>2X=$E96TVGG/3L?,$,
M-Z *6&DT*"UK8R5S6+=I<F=KOI6\X!F3%NZS3#72<KF%E1(\XVC@ZHEM!)KK
M:6B)DC,<9AW\HH5/SL#'"3PH:4L#'V2.^5L#(?ER="@Y.+1(+EK\TL@;2*,!
M)%$27["7'@.4>GOI&7NG_/WG?F.LI@OU[P6 VR/ K0>X/0.PICK+&X$NT(^X
M0]F@C_\?6AD#3YKE2/L9\IT/,JQ09RY16X3-"SRP_Y2&I;\HJ,VI#%R&?RH1
M"B6H.)V+UF%T%<I_$EK)R;*FU NH6V#'4_=X;CU/ZWGJ'L]"JPJ6W]9>Z,_:
M-M7C\^3 ON]L;^N<S\P"Y14IKSZM;G"S^*ZW=%#)"'[K#[>'68</\9 6L=N.
M4QK<1\<7LC@\9G%X,8Q+5=5*DAM=,5'7U/;%^_[A1\-KZF/V5'(N6G4=>6)J
MEN$LJ%U]ZAT&)S-6M]5+>:##[ V7NL\%#UP&(*GCO\9U E=<4H,1@NK?7/?B
M^I7T!K!IN,@=GK/"*S*ZP\I#O(-DD [O_#\>#^E&9B6YH7\!A'00W:5NC,;P
ML=&2VT:W-ZC@SVYN*"<C^L;PI*R[;V>($^E,&0O#P7 \IC%-8]>5FJH1S&).
M/9FBD?'73L8JI2W_V6Y<I8,D&5_#53*X&PVOWZ;JE_!XUT91]Q_!J7L2]GHO
M5>#6OS &?--HV_!Q]_B(W;>]^U6\?0$?F-YR:4!@0:K1S7NZ'+I]5=J%5;7O
MY!MEJ=S]M*2'&+43H/-"*7M8.(#CTS[_'U!+ P04    "  Y1A!3;^/@XS #
M  #C!@  &0   'AL+W=O<FMS:&5E=',O<VAE970R-"YX;6Q]5<ENVS 0_96!
MT$,"I-%B9X5M(':Z D6#-FT/10^T-+*(4J3*H:+T[SND9%4MXEQL<I8WC[-I
MT1G[DRI$!X^UTK2,*N>:ZSBFO,):T*EI4+.F-+86CJ]V%U-C413!J59QEB3G
M<2VDCE:+(+NSJX5IG9(:[RQ06]?"_EZC,MTR2J.]X)/<5<X+XM6B$3O\C.Y+
M<V?Y%H\HA:Q1DS0:+);+Z":]7L^]?3#X*K&CR1G\2[;&_/27=\4R2CPA5)@[
MCR#X[P$WJ)0'8AJ_!LQH#.D=I^<]^NOP=G[+5A!NC/HF"U<MH\L("BQ%J]PG
MT[W%X3UG'B\WBL(O=+WMV3R"O"5GZL&9&=12]__B<<C#Q.$R.>"0#0Y9X-T'
M"BQOA1.KA34=6&_-:/X0GAJ\F9S4OBB?G66M9#^WNN6<D).NM4@@= $W^:]6
MDO0I(SBZ%UN%=+R('<?R'G$^X*Y[W.P ;IK!!Z-=1?!*%UC\"Q SR9%IMF>Z
MSIY%?-_J4Y@E)Y E6?H,WFQ\^2S@S0[@K5MB"1%L3+V56O1-XC- Q,,PR0-\
MO]F2L]Q /YZ).Q_CSD/<^<&,4V-(*'AC3=O0";S3N6H+J7? JIR3)G6+!7QL
MT 92]%3VGXWA)_F:&I'C,N)1);0/&*WN*X32*!Y#'\OYRD+0:D<@=3_@_:PI
MX9B!,^#81_A\],VAI-A*Q4GA9G&5<-"A1<@5F\A2LHL@J% 5'(<'7W  MN'"
MX5BX_\$WQA:2H/C;ADPE:#@39)0L@O56**%SA-#H= U';%1+I7QZCO^+L!%4
M!;;(%7Q@$OY]+R!-KCC5#WPSEOF?@.8JI^=SN+.\XJS[/?HTO'1<K[]*X(TQ
M1<>A@MHP,\L,G= [Z4>C-[NXN(2/034D*TW@FY4.7Q:FTV#*O?S?Y!R=)\=P
M;QPWPY-Z)GV27*5[Z#RWOC&F17@!YRG<8HG6LD;JW-3(I7T<AKFG.W68S8>
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MRBT_CN== ^#;-=J-?2:W,F?;K9^ZHY%BI;"M#5WP6D/D$C)PZ1AXT22 (-A
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M,C5WK6J2TXF'1:6H?*;>]&E)82X8%DS)%Z!-:%S5E/^B)1J7<U'5@E.NE:'
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M9!06*32 ZW,A=/$%!RB??%_]"U!+ P04    "  Y1A!3SLV-."L#  "1!P
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M.MXIDS6:97@,+%&GD-N*N9W=OC?3MLP^F[>/U6=NEH*$D[@@U^3\\B("TSX
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MKLGDUUD$IKM;NHG33>CG.^WH=@C#BJYC--Z ]DNMW7'B PP7_.8?4$L#!!0
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MD!\L50;/\NA%#Z._O*3]VEY=75[@?OT%#N06$O]XHV];@)MNW=XVX)J=DF?
M7:F'=,:FMJZ48 N7_)]?CI:UZX6MV)Z,=TQ-:^NL)4U>$/>)F%(F(<&)IO2.
M3O0O0N0U9MY1?&:KKC%7VC;;C'5=CL),T-\GG*M%QP0H*_WV7U!+ P04
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MNW#!=&ARGPN;]J51=,L)9\83IKD&N8*Y0HW"L"H;(H9E50CV;LD3P5<\8L+
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M1SU^6_$6M(-SB((H;" T^3@\.$*G75>D[?RU#_AK2O#OT5QI:8[\GR,!.G6
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M4"DK=->AK1FMQG&_/PQ7N^K^_TPGZNZ?F1XXTVW/[*7>;5+O>E-_Y)J8[M?
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MF4A[P+S/A-#;!QN@&<C'_P%02P,$%     @ .4804Y$E\5E,!   U!0  !D
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M$$".<[82=*O67['6TW9\F1+&/V%=^T8!9"M#JJS!-H.2R^K-GNHZ; 'BS@%
M4@.274#K ""M >EK :T:T/*5J:3X.HP8L4%/JS5HYVW9W,(7TZ.M?"Y=VZ>D
M[2FW.!H,F>$&U!PF&@U*8E4W9 [3ZD-P9U->2#[G&9,$EUFF5I*X+&"B!,\X
M&KA1QL"5\E:4WG0R0F)<F%,X@[OI"$[>G<([X!+&7 @;PO1"LNF[),*L3G58
MI9H<2#5.8&QC+ Q\DCGFSPE"J[L1GVS$#Y.CC-]6\AS2Z#TD41+O2>CJ]?!H
M#WST:GC\\8B:M&EEZOG2 WQ[NG!_8WW@FK TOX]$:#416CY"ZT"$+W:,P(F+
M<PJW*!AA#J3@AA,OJ@_'C@D2:,<"[>MOQ=[V[&X>/0[.XCBQVA^WB[['J]UM
MQ<^]1GN\TD[C\TQ>NY'7/BKOAR(FX/N2*YYOB[H?8SE#?:R"G29$YXUZU&TB
M=-^T1]T7=8WC;K33HI=.[4X:[50_W)I*)>K"3W<#?GQ4_VAC;2Z02S\W=^Q#
M>[%4]\!_FNI6&C-=<&E X-Q21N==FY*N)GVU(;7TLV^FR$Y2OUS8RQ&U<[#G
M<Z5HLW$!FNMV\ ]02P,$%     @ .4804U2;#L[&!0  YQD  !D   !X;"]W
M;W)K<VAE971S+W-H965T-#@N>&ULK5G;;MLX$/T5PNA# CBU2/I:. 82.TFS
M:-J@:;</BWV@)=HF*I$N2=D)L!^_I*Q(<BG*3N&71!?.\ PY<\Y0'F^%_*E6
ME&KPG,1<7;966J\_=#HJ7-&$J/=B3;EYLQ R(=K<RF5'K24E46:4Q!T4!/U.
M0AAO3<;9LT<Y&8M4QXS31PE4FB1$OES36&PO6[#U^N K6ZZT?="9C-=D29^H
M_KY^E.:N4WB)6$*Y8H(#21>7K2OXX0X/K$$VXF]&MZIR#6PH<R%^VIO[Z+(5
M6$0TIJ&V+HCYMZ%3&L?6D\'Q*W?:*N:TAM7K5^^W6? FF#E1="KB'RS2J\O6
ML 4BNB!IK+^*[4>:!]2S_D(1J^POV.9C@Q8(4Z5%DAL;! GCN__D.5^(B@'L
M>@Q0;H".-<"Y 3[6H)L;=(\UZ.4&O6,-^KE!_UB#06Z0[7YGM[K9ULR()I.Q
M%%L@[6CCS5YD^YM9FQUAW*;BDY;F+3-V>C(SB: TTZFD"A >@:OP5\H4LWFB
MP-EG(B6QR7(.SF94$Q:K<W !OC_-P-F[<_ ., X>6!S;T>..-H"LVTZ83WZ]
MFQQY)K]*E^]!@-H !0C6F$^/,,?0FL-AC?FLV?ROE!OSP#O[S?'F08WY[='F
M<%1C?G?,TM7&WC$I4.0!*O( 9?ZPQ]]UJLP3I:K[W^ 6%VYQYK;K<?M(7@QO
M:06TV'F6%+Q.154;?#9D*Q9@2M3J]7U4MY.[67K9+)9=-Q,\[FRJF^6."/9'
MW+HCAJ@8LA==MXBNVQR=I!??R#.X,Y0/#*]6BJDN(7;.^A4 O6!8CZ!7(.@U
M(KCGH4@H./LDE"G,A10)N#&KJ%_  ]4K$8%[;B%E>U"7XCT'$OIMU=P1,*C'
MW"\P]QLQSYA:"T5B<"=%NFX;B&&<1HPOS?JI4'#->$HC\&5-+?4(W@97)EEJ
M\<_Z+CH8P-]2PQWDB6!01# X<02?&)FSV%05K0UCX" <]7\+PAWB"6)8!#%L
M#(*3#?M(2:Q7X)\'FLRI_+>AX$>%U]$I>00&I4X%!VI-A)1&:I?DE4JS_%%2
M2JV*!$[E#_"@?O5@13CA*8L_]]8[IOIAR=H0-8)X2['?Y;[V6+3G@U R/&RF
M^*\THJ8]GL<4?!;<9K\4IB$PQ7#/-35MA6[GG-0V/"_EBWUUE8B4ZUJ0+DU#
M#TW#DJ?A(:(6&V:[9U.SVNS9G'*Z8-KTTC'1IE*-.FE)N"*AFZ]Y#G5=6-A3
M@;!D;]A,WZ^Y\T3B+(\/L#5TR;@W&'E E'0,F_EX*F3$E#]_]]V6' D')V6"
MDK=@,W&]G7VGICME47Y;VR@.70)&/H8HJ1".3@ST3HAH:]KI6HPC!^,%'GK*
M%Y6\BIIY]8=DFEY$8LMM I),:<&*QA$PYUQ@T->QV2QWN@>F[RD'5%(J:J;4
M4W8&^53[C<L(>B!6VN1FPOT#B&$H[:,#+4 ^;Q5OWX>VY&;4S,UO1_M%KZ@\
MB!4[6''7@[7D:-3,T2=OJI#;;X]Z'I0E8Z-FQGX[RELA*5MR,$VEI#Q\ =^L
MTL39VZQY4+OVG:KSVBA<SK_ GBA*RD<'6_!:K+:?N5DL:)B=RC)UJAXMBN#-
MRWH7M1&X_;='LU I+NC4'7AVQ+0?.+(+VY!L#+?5"^T,N=VV(0\/Z%*XT*F%
MR_8#7 OY4@O2%2W8]Y5A*5KHU*)EFBMS8]N[QYAPG2VR7=^U[6-J@;M*-O)H
M!RYU##?KV#[N@[!5H;49WAWMF8:5\"4SK:QJ TYKP6-7^08#CPKC4OGPJ95O
MA]BO?]@];_@.[KA4/]RL?FZK"/X#3^E<T5^IV6QPLW&V?'^FRG<C?-+O4:7,
MX(-'@3\\1UYC]PS@[1)QJ2BX65'>=@[')<?C_DE7L.1>W,R];SRTY-[V#K[.
MH:53^8)M?P)Y(')IE3&F"V,5O!\8<[G[56%WH\4Z^Z@]%UJ+)+M<46)Z?#O
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M*T!H)@51L!QZX_!VFEA[9_"3P5;OC8E5LI#RQ4Z^9D,OL X!AQ0M S6_#4R
M<TMDW/A;<WK-D1:X/]ZQ/SCM1LN":IA(_HMEF ^]SQ[)8$E+CC.Y_0*UGK[E
M2R77[DNVM6W@D;34*(L:;#PHF*C^]+6.PQX@3(X HAH0M0&](X"X!L3G GHU
MH.<B4TEQ<9A2I*.!DENBK+5ALP,73(<V\IFP:9^C,KO,X' T XVJ3+%43*P(
M%1FY+]9<O@&0.6Q 49$"N1C;[#!\(S/@%"$C*,E9R(G4J"_)Q120,FY&5^1Y
M/B47'R[)!\($>62<F_3K@8]&C'7)3VO'[RK'HR..AQ%YE )S3>Y%!ME[ M]$
MH0E%M O%7722\5LIKDD<?"11$(4=#DW.AP<=\.G9\/#FA)JX26SL^.*S$CO)
MJ5J!)K_'"[-L+MN?$T?TFB-Z[HC>D2-V^;Y2=56D-MM=J:QX^H['-J+-J!\/
M_,U^< ]-DN2]R?30Y*;?F+Q3T&\4]$\J>* IX[:N[U\9NAK^CCFHJFR[A%1T
MR;Z784O(H4F_+>30) ZZA22-D.2DD!\2*3=MN'TE87<E]>Y*=JE*#@(;AKV6
MK Z;*&KIZK)I9\C?ZU4%F**T/5^;TBD%5G>U66V>E;'KIJWU._/<5*_#?YKJ
MK7HTM<Z$)AR6AC*X_F0\4E7_KR8HUZXC+B2:_NJ&N7DR05D#L[^4$G<3>T#S
M"(_^ 5!+ P04    "  Y1A!3UE9-"9L#  "]#0  &0   'AL+W=O<FMS:&5E
M=',O<VAE970U,"YX;6RU5]MNVS@0_15"Z$,*;")1OJJP#=A.BMW%!ALDZ.Y#
MT0=&&MML*=)+TG;R]TM2BB3KUJ!I7VR1FCD\,\,Y(F<G(;^I'8!&3RGC:N[M
MM-Y_\'T5[R EZDKL@9LW&R%3HLU0;GVUET 2YY0R/PR"L9\2RKW%S,W=R<5,
M'#2C'.XD4H<T)?)Y!4R<YA[V7B;NZ7:G[82_F.W)%AY ?]K?23/R"Y2$IL 5
M%1Q)V,R])?ZPQI%U<!;_4#BIRC.RH3P*\<T._DCF7F 9 8-86PAB_HZP!L8L
MDN'Q7P[J%6M:Q^KS"_I'%[P)YI$H6 OV+TWT;NY-/93 AAR8OA>GWR$/:&3Q
M8L&4^T6GW#;P4'Q06J2YLV&04I[]DZ<\$14'/.YP"'.'L.XP[' 8Y X#%VC&
MS(5U3319S*0X(6FM#9I]<+EQWB8:RFT9'[0T;ZGQTXM[4%H>8GV0E&\1X0FZ
M2?=,/ .@!SB")#P&=/$7)8^444U!H:52(J9$0V*HZAUZ%<+25LOYOT<7UZ )
M9>;I$GUZN$87[]ZC=XAR=$L9,Z55,U^;R"P_/\ZC6&51A!U1X!#="JYW"MWP
M!))S -^DI,A+^)*75=B+^.>!7Z%!\!L*@Q"W$%J_WCWHH3,HRC1P>(-7E<F,
M0!X!?;X7C"&SG4]$)E]ZEAD6RPS=,L..95:PI9S;)5:$V<*UE2*#&#D(JQ+'
M132>^<=J<IHFD[ P.6,V*IB->IDMDX3JKLV1N8ZKRXUJC)HF.(C:*8T+2N->
M2G?DV>B95F[/"[T#B4CRU;2LFVWC.6Z0N(S"&M$6F^FHG>BD(#KI)6IZXCLE
MG303&-5X-4TJ53^C-2UH3?MIY3)Q:?8S<WJR%JJ>N#/DJ$".?F6WX* 4S^#M
M_9)C5%,WGM:RVV8S;$\OKD@[_O&>R7VK*P[K-6^QZ=J+."Q9A3^Y;7+ LYZH
M9"?GVF(TQ1UD2]G%@S>V3@Y077<TJ'-KVE1VP#FU4JIQOU9_)+'])#^CFR>J
M73+_=LG\7A/A4G+QZ)>V42FDN%])7]=&364,&VW4M.G*<RF>N%\]^[NH*8MA
M_6/89M/5VZ5VXG[Q_($NFC8;I)G %J,NKJ4:X^BM310U#@S--+;8U(OK5P["
M*<BMNQ\H%(L#U]G9KY@M[B!+=_*NS:_LW<0=L$N8[&)S2Z39K HQV!C(X&IB
M",GLKI -M-B[X_:CT.;P[AYWYGX%TAJ8]QLA],O +E#<V!;_ U!+ P04
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M],CR#*N\T2(MCH%>A-8B*2XW!,=$Y@;F_4H(_7Z3#U"?)"[^ 5!+ P04
M"  Y1A!3"^29:.H$  "W%@  &0   'AL+W=O<FMS:&5E=',O<VAE970U,BYX
M;6R]6&U/XS@0_BM6M1]  A+;29J@4@GH[1ZKY0[![JU.I_L0&K>--HE[MDN7
M^_7G."%N$\=M#\072)QY>6;L>6;JT9JR'WQ!B  _\ZS@%X.%$,MSQ^'3!<EC
M?D:7I)!?9I3EL9"O;.[P)2-QHI3RS$&N&SAYG!:#\4BMW;'QB*Y$EA;DC@&^
MRO.8/5^1C*XO!G#PLG"?SA>B7'#&HV4\)P]$?%O>,?GF-%:2-"<%3VD!&)E=
M#"[A^03C4D%)_)&2-=]X!F4HCY3^*%]NDHN!6R(B&9F*TD0L_SV1:Y)EI26)
MXY_:Z*#Q62IN/K]8_ZB"E\$\QIQ<T^Q[FHC%Q2 <@(3,XE4F[NGZ5U('Y)?V
MIC3CZB]8U[+N $Q77-"\5I8(\K2H_L<_ZT1L*,"@1P'5"JBMX/4HX%H![ZO@
MU0J>RDP5BLK#)!;Q>,3H&K!26EHK'U0RE;8,/RW*?7\03'Y-I9X8?Z(T6:=9
M!N(B ;^+!6'@IA!Q,4\?,P(N.2>"@Z,'>=R2E5R@L^[G8W T(2).,_ET"KX]
M3,#1AV/P :0%N)66Y>[RD2,DUM*C,ZUQ756X4 \NB, M+<2"@U^*A"3;!AP9
M9!,I>HGT"EDM?EX59P"[)P"Y"!H 7>^O[AK4)WNKP\@2#6[V#2M[N,?>C<S*
M+"U204XS63B)8=?^^B)UP(T@.?_;XM%K/'K*H]?C\3=)0MJ):4<K?5_IEWSS
M)'=QY#QMYK@K@G CL@7+;V#YUD1\K)+PY75)"!IO@34)ESEE(OTW5IQE*@93
M7BJ3P4;0'@I;B>G*^.WD38).\GP,S=D;-O$,K?%\8I3S'=LZ[,*/8-#"WQ7R
MPSYP80,NM"=[.EWEJRP6<F<W$V\"&7;\HW#C:%4@#4(1#LP@HP9D],JRB+IG
MWHW:T"(#_L@W0X.N)G?7"NZ[:GLD.0673X3)/@[N23D,I,5\*Z/@CK"4)N#H
M3Q(S?FRD:[LGZ(+G4M=28W"C)\&#3N4)^$I%G &J^E.J:R[NK;G:@[]U:CM5
M5TMM'UO?ZTD[TOC1 6?B_Z!'W>, 7;^-WB 5P; 'O>XL$%O1?V5Q(D^)'#S5
M4+"4]5>T86Z;UBT$>N_4M:#N#]!_98'6!@);XS+(]'4NJ)L)M'>3:S7?R4/!
M2*;JD"_2I373FM?A\!W:(M14#>U<O4\C@5W^Q1B[[4P;I/S>FM0T#>T\?4@S
M@5TVAE$8M8$:I$+44WY(<S:R,^GN\UH;V!JTL =;\&JI+7A#U-/MD.9F9.?F
M-VPI.SQ!N+.E($W)R$[)FM1.@"B?01'G9%^&0YH\D7TN?YNZ0YI1D7TJWZ?N
M4'?J]OW.<?$ZQR48]C <TN2+[.1[2-6A+L7B3L<V"7D]<R;21(SL1+Q'S76'
M;]29+U%WBL<8]8#35([L,_I;5IS=4[2[X'1#0/:&,"%/)*-+N>^"3!<%S>C\
M656;&H-L+C2EH^@=:@UK9L9V9MZGUK"!FUW<GMRP@9L#MZ?'8<W-V,Z8AU0;
M-HR^;OM7G4%H& Q[8&HNQH>,QT9PJ,M8J-U_#4(A[@.W<:]BGW[?L-IV>++]
M9'(V;O3D@#A7-Z,<3.FJ$-655[/:W+Y>JCO'UOH5/)]4=ZC:3'6E>QNS>5IP
MD)&9-.F>#64B675+6KT(NE3WAH]4R"E5/2Z([)RL%)#?9Y2*EY?207-7/?X/
M4$L#!!0    ( #E&$%,5E1JVCP,  -,-   9    >&PO=V]R:W-H965T<R]S
M:&5E=#4S+GAM;+5776_;-A3]*X30AP1H(U'?+FP#3MQM*98M:-#M8>@#(]$6
M44KT2"IN]^M'4K)D2[02%,V++5+W')W#C\O+^9[QKZ+ 6()O):W$PBFDW+UW
M79$5N$3BBNUPI=YL&"^15$V^=<6.8Y0;4$E=W_-BMT2D<I9STW?/EW-62THJ
M?,^!J,L2\>_7F++]PH'.H>,3V192=[C+^0YM\0.6GW?W7+7<CB4G):X$817@
M>+-P5O#]&J8:8"+^(G@OCIZ!MO+(V%?=N,T7CJ<588HSJ2F0^GO"-YA2S:1T
M_-N2.MTW-?#X^<#^BS&OS#PB@6\8_9ODLE@XJ0-RO$$UE9_8_C?<&HHT7\:H
M,+]@W\9Z#LAJ(5G9@I6"DE3-/_K6#L01 ,9G 'X+\(> \ P@: '!2P%A"PC-
MR#16S#BLD43+.6=[P'6T8M,/9C -6MDGE9[W!\G56Z)P<ODK8_F>4 I0E8,_
M98$YN*TDJK;DD6*P$@)+ 2[^0)PC/4&7X&*-)2)47()WX//#&ER\N01O *G
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MEO.K4HJK#TEQ>L;K[?B-9G7&ZV&T$=9FO%V&V:[EN<=TIJNTAJE3,G5JF>Y
M*4 EWC2+*1+S8AM@BB2.(54:U5/[-LTU/OK>WX^K5Q\OVQZ)U]_[4/O_+^(C
MW#2/N;*2W;WAPLR.]TPN>*9( G/D\AI7^+*0^3B6;[18VGGC26B<7NPRQA$6
MI+F YW,A]&YC1IAR*.[_ 5!+ P04    "  Y1A!36#<Z3YH"  #I!@  &0
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M+0)E%?!\):79;:R#]G7+_@!02P,$%     @ .4804T@10J!K!   2!0  !D
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MT-"/[#"'7PPB30"\SX30'Q/3E)J?ELD?4$L#!!0    ( #E&$%//0US((P0
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M32/R[P;YC>2;[&!\SJ7D47:Y9G3!1&J@?E]RU9G%33I ^?5F_ ]02P,$%
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M508  '\?   9    >&PO=V]R:W-H965T<R]S:&5E=#8S+GAM;+69;4_;.A2
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MSR8\29A42T6*(S#AJ63I2CV :Q;.6<PDHP*$::2>)5N%Q6)X,Z4R9+%X"_X
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M*MN^[=T^2+XNWD[.N90\*3[>T3"BF1Z@?E]R+G</^H5G]<[][']02P,$%
M  @ .4804TE%<:'? @  ^P<  !D   !X;"]W;W)K<VAE971S+W-H965T-C0N
M>&ULC55M3]LP$/XKIX@/($'SVH:AMA(EH#&)"=&Q:9KVP4W<UL*Q.]NA[-_O
M[*2A]&W]TOKEGN?NN7/N^DNI7O2<4@-O)1=ZX,V-65SYOL[GM"2Z(Q=4X,U4
MJI(8W*J9KQ>*DL*!2NY'0=#S2\*$-^R[LT<U[,O*<";HHP)=E251?T>4R^7
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MTX/0([=42=(,F$PY0P+V"^>3?[?Q T.PB/]2N,C*-3)1GCG_:09?DX7C&4=
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MVD ^GM4BM*&"64>&RC'F__'6*:AO?=478"NH7OY64%?]\<T[?L<.2HJEV)H
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M:Z1Z0@IVW+>O8:,9[J7I+S[Z/XB;OQ]WP,9QP\9QT-"=L1E.1(&XS($(5FV
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MW:WQ;U8=-OM4-!D 9ZP;%78WJGN6LZS,7!NM@1Y/CU(Y&BBQ&R@7A619A1^
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M=1B-L8<Z'+5"$+UO[]MZ?XF^$[:OCA.Z95KQB:<NU:&[D$83W-]PE]5X%GF
M=Q0,_S[P?T Y@6*;NSA-^D!MJW3L([@5$OS[2M*IJ4-R@EL]P<."\E >H%1<
MG"P]<4MQ8F\)QCCM$^(RB^:)AY)66?"PM#P*?1\5ZC2JBXP3HBT:HV1FY9;+
M*O:<8-R*"QY6%V]%P;90C&:)E4@NJPGVH&H5!0]+RIN,[]S'+MM+VQ\O1@GA
M$CV!!'& LP154DZ8.Q5L/1FE-L^VE>\ MZ*#WZDZUG+\]-OB,8HM]FTC']96
M8?"PQ/B+^B^N1]@6&)V@L<6OPRS&4U_*M%J$A\5(U\-!U"<GYM2Z3(YPFL1]
MS"ZS&/?O(F'GE6*>B%^(>*:E1 PVVB^ZFND XOSJ.G<4WU4/ES57^AE4-;?Z
MI0K"&.CQ#>?JM6/>0LW;=_D_4$L#!!0    ( #E&$%-,O5<6JP(  "8'   9
M    >&PO=V]R:W-H965T<R]S:&5E=#8Y+GAM;*U5VT[C,!#]E5'$ TA ;K0+
MJ*U46JT +2RBL/NPV@<WF;06CMVU)Q3^?FTG1*4M%VGWI;7C<V;.F7$FO:72
M#V:.2/!4"FGZP9QH<1J&)IMCR<RA6J"T)X72)2.[U;/0+#2RW)-*$291U U+
MQF4PZ/EG-WK04Q4)+O%&@ZG*DNGG,Q1JV0_BX.7!+9_-R3T(![T%F^$$Z7YQ
MH^TN;*/DO$1IN)*@L>@'P_ATU'5X#_C!<6E6UN"<3)5Z<)N+O!]$3A *S,A%
M8/;O$4<HA MD9?QI8@9M2D=<7;]$_^J]6R]39G"DQ$^>T[P?' >08\$J0;=J
M>8Z-GXZ+EREA_"\L&VP40%894F5#M@I*+NM_]M348840'[U!2!I"\EE"VA!2
M;[16YFV-&;%!3ZLE:(>VT=S"U\:SK1LN71<GI.TIMSP:7,A,E0AW[ D-[$[L
M)<DK@: *&&.!6F/NSF!H#)(!)G/XQMF4"T[<$H8%H89K).)R!M-GC[VL-#<Y
M]VW:@]TQ$N/"[,$!W$_&L+NS!SO )5QQ(2S"]$*R/IR:,&LTG]6:DS<T7U;R
M$-)H'Y(HB;?01Y^G1Z_IH:U>6\*D+6'BXZ4?EA#&W&1"F4HC_!I.#6E[2W^_
MDR)M4Z0^Q=$;*=I>O&J7Z\9WFML.U.W9AVLEL\H")6VK:IVCXW.XM_MQT$EZ
MX>-JY38AZ4D+>27]J)5^]$_27=E6KM1''NIDW16!\<EQO.9B"RCI'&_WT6E]
M=/ZOCSO-I&DXI. <10YVZL*$"?S(96?#P$&ZYG$3$FTWV&T-=M\U:-]B-_]J
MP;PV2=:4:$P];Q/:W;@O!_%)NGZKMJ&2>/UBA2M3S'U!KIB><6E 8&%YT>$7
M&T#74[G>D%KXP3959,>D7\[MAPRU ]CS0BEZV;A9V7X:!W\!4$L#!!0    (
M #E&$%/-[\-@U 0  %43   9    >&PO=V]R:W-H965T<R]S:&5E=#<P+GAM
M;*6874_C.!2&_XI5S05( XV3-DU1J43IC);5(*&R[%Z,]L(D;FM-8G=MA\+^
M^CWY( VV$UKM#33.>X[/8\?.&\_V0OY26THU>LU2KJX'6ZUW5\.ABK<T(^I2
M["B'.VLA,Z+A4FZ&:B<I2<J@+!WZGA<.,\+X8#XKVQ[D?"9RG3).'R12>981
M^;:@J=A?#_#@O6'%-EM=- SGLQW9T$>JGW8/$JZ&39:$990K)CB2='T]N,%7
M2]\K DK%GXSN5>LW*E">A?A57-PEUP.OJ(BF--9%"@+_7N@M3=,B$]3Q3YUT
MT/19!+9_OV?_7L(#S#-1]%:D?[%$;Z\'T0 E=$WR5*_$_C=: XV+?+%(5?D7
M[6NM-T!QKK3(ZF"H(&.\^D]>ZX%H!>"P(\"O WPS8-01$-0!P;$!HSI@5(Y,
MA5*.PY)H,I])L4>R4$.VXD<YF&4TX#->S/NCEG"709R>W_%89!3]05ZI0F>/
M\%@E>4J16*,G+FDL-IS]2Y/B/EI03M=,*[02:8I@U/=$)N?H;$DU8:DZ1Q?H
MZ7&)SKZ<HR^(<73/TA2F5LV&&@HMNAO&=5&+JBB_HRCLHWO!]5:A;SRAR<<$
M0R!L,/UWS(7?F_'WG%^BP/N*?,_'CH)NCP_W'.'+H\/QM(<F:"8M*/,%GTX:
MNH5Q8GQ#>?R&?OX ';K3-%-_]_0R:GH9E;V,.GJYS:6D7*/O-*&2I&5WWUYA
MPU$4G=4/P[EK<JNTXS)ML>^\S"^F$7"_M ?<%H5C0[.T-?YTW&@^0(T;J/%1
M4(^::(H(3] /$9\"5Z4/6S5-?0/-EN#QR$"S-:T1^D 6-F3A<=,E)&QV_'BB
MT"X7FTBV)C0GRY9$'7,U:8@F1Q&U'O>C@"96)1>35BT5D2V*(H-Z:6M&8<<L
M10U3U,NTI&L*5$FSJDZ%BZR:QH&YMFS-1>2;< Z1'[GAI@W<]#@X<W6="CGM
MK:V"=&BP/S$@':)@XH;$WN&5Z1TYA_52.Q6OSO^Q=O,!=8K,272*.F81MSP!
M/@[P9#!LKYAI:(+9HHMIB$TRARH*.LC\ YG?2W8RD.]Z$LWUYE)-S/W1(0JB
ML /HX 1POQ58@4?C,4L9*6UTGV_["LAQFB=@%]!-)G(.5NZ!2C!OO&C2 NX3
ML)AUV(KJ7'*%?K;M7I^OP =C@?N=Q8*DA,>P06CT3#>,E_U#Z6NFBMWBC1+I
MG(R1_>Z=FMN"0S0:A^9<.$1^U\-UL!:XWUO<) DK9D$A^!Y#&L9P)U3= G1Z
M2\'15Z^T3D2'=_"QB6B+QIYG(MHB?]1!>+ 8N-]C?$*XDPR:"S:WZ;<M@M\:
M]1K.%DTBD\W6!!WO97PP&[C?;:S@RR?^'W .UX$#Z^ETJ*R7EDO48:7PP7?@
M?N,!7_ ZI?#%#JM^S_2V!"2YW@H)C-3-Y/(($^MQ=*BL!>?*U,5TL!NXWV_
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MNG4O!AJ?X/;76M,^\$W9OT'9;U!+ P04    "  Y1A!3 NREK=X#  !Q$0
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MI2[EASG]>%"[ -J?*F57$_>!YE<V_ ]02P,$%     @ .4804S37O]*] @
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M.&>%H%NU_HJ5GI;+-U7"^"^LJ]@H@&EA2.45V#+(N2S_[*FJPP:@T=P!B"M
M_%Y 4@$2+[1DYF5=,&*]CE9KT"[:9G,#7QN/MFJX="Z.2=M=;G'4N^22R2EG
M H;2D"ZL063@<%R:"FH.7PQQ6RZ<P27C&AZ8*-"MCY1<G!#J'*XG@B^8<\4
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M8*\OI33/ _=J7W[*37\"4$L#!!0    ( #E&$%.THUJJ,P0  !\1   9
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M2)XOE8&\OZ%RHRL'Z@'5?R*S_P%02P,$%     @ .4804S@<'68O!0  9A@
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M') ZYC8(Q\$Y:EE'>4$X*$!G[ <%^\&'[.&D,*ZP9.<L20O+[)2PS,"KD&R
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MS_TXQSV8\8:+.[D"4.@^8:F<6"NELA/;EM$*$B*/>0:I?K+@(B%*+\72EID
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M0XT7Y:&^7"B>%<?<.5?ZT%Q<KO2'$ @3H)\O.%>/"W-RKC^MIG\!4$L#!!0
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M5':_SQI&3MV-MR\-WI_=XP3X$)0=@.]'4IIUPTY0?&7I_ 102P,$%     @
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M0&4-:'\KI=E/[ '-!\WT#U!+ P04    "  Y1A!3V:X!XX #   F#   &@
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M6"6Z9HZ%/"AK@.]74II#QTY0_S68_0-02P,$%     @ .4804XOG/&+* P
M,0X  !H   !X;"]W;W)K<VAE971S+W-H965T,3 Q+GAM;-5776_B.!3]*U?1
M/+12VWSQT8X "<JL=E9;";73F8?5/ICD0JQ);,9VH.RO7]L)(4":HFH>9E[
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MMV21R/Z"78%U!V"Y%9+%A;"R( Z3_)=\+P)Q( "'#0*H$$"F@-<@@ L!?*R
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MR8KR%*#N/S F]R?I \KM4;/_ 5!+ P04    "  Y1A!3R%8_\#\#   &$P
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MMR2*DL2/ .97$$48 F\CCF *0 .&1%&]#^[L1^%ZGPK;7[Y&OP%02P,$%
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M[;+LS.V[+JZT6![^ \?AOX=\_ ]02P,$%     @ .4804_$(LOGR @  &ST
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M^>QP_?[/Y=?%]B[^A+J_S1@?_P)02P,$%     @ .4804V51Z6]F @  ZSH
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M-3]9_N-Z\Q-02P$"% ,4    "  Y1A!3!T%-8H$   "Q    $
M    @ $     9&]C4')O<',O87!P+GAM;%!+ 0(4 Q0    ( #E&$%-!FUTE
M[P   "L"   1              "  :\   !D;V-0<F]P<R]C;W)E+GAM;%!+
M 0(4 Q0    ( #E&$%.97)PC$ 8  )PG   3              "  <T!  !X
M;"]T:&5M92]T:&5M93$N>&UL4$L! A0#%     @ .4804W;]U^Y0!@  P1D
M !@              ("!#@@  'AL+W=O<FMS:&5E=',O<VAE970Q+GAM;%!+
M 0(4 Q0    ( #E&$%,WBL:J208  (\8   8              " @90.  !X
M;"]W;W)K<VAE971S+W-H965T,BYX;6Q02P$"% ,4    "  Y1A!36G/)3I<#
M  !W"P  &               @($3%0  >&PO=V]R:W-H965T<R]S:&5E=#,N
M>&UL4$L! A0#%     @ .4804WK9?PU2!@  PQH  !@              ("!
MX!@  'AL+W=O<FMS:&5E=',O<VAE970T+GAM;%!+ 0(4 Q0    ( #E&$%-R
M80-!A0<  $(J   8              " @6@?  !X;"]W;W)K<VAE971S+W-H
M965T-2YX;6Q02P$"% ,4    "  Y1A!3M3;&GW\(  "4)   &
M    @($C)P  >&PO=V]R:W-H965T<R]S:&5E=#8N>&UL4$L! A0#%     @
M.4804R09SU2E*@  0X4  !@              ("!V"\  'AL+W=O<FMS:&5E
M=',O<VAE970W+GAM;%!+ 0(4 Q0    ( #E&$%-L=7$*< @  ,$5   8
M          " @;-:  !X;"]W;W)K<VAE971S+W-H965T."YX;6Q02P$"% ,4
M    "  Y1A!3)\Y8#&0$  #B"@  &               @(%98P  >&PO=V]R
M:W-H965T<R]S:&5E=#DN>&UL4$L! A0#%     @ .4804P<%@R5H!0  I0T
M !D              ("!\V<  'AL+W=O<FMS:&5E=',O<VAE970Q,"YX;6Q0
M2P$"% ,4    "  Y1A!3O&<,QOT(  "#%P  &0              @(&2;0
M>&PO=V]R:W-H965T<R]S:&5E=#$Q+GAM;%!+ 0(4 Q0    ( #E&$%,,3WN#
M=@H  /D>   9              " @<9V  !X;"]W;W)K<VAE971S+W-H965T
M,3(N>&UL4$L! A0#%     @ .4804^*T<8X4'@  @%D  !D
M ("!<X$  'AL+W=O<FMS:&5E=',O<VAE970Q,RYX;6Q02P$"% ,4    "  Y
M1A!3X^=OV)D1  "W,P  &0              @(&^GP  >&PO=V]R:W-H965T
M<R]S:&5E=#$T+GAM;%!+ 0(4 Q0    ( #E&$%.<>R:A5@4  )80   9
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M970Q.2YX;6Q02P$"% ,4    "  Y1A!3IMFB19P*  !((   &0
M    @(%>W@  >&PO=V]R:W-H965T<R]S:&5E=#(P+GAM;%!+ 0(4 Q0    (
M #E&$%.[^IL;0@0  $(*   9              " @3'I  !X;"]W;W)K<VAE
M971S+W-H965T,C$N>&UL4$L! A0#%     @ .4804QYL*JL1,   H*$  !D
M             ("!JNT  'AL+W=O<FMS:&5E=',O<VAE970R,BYX;6Q02P$"
M% ,4    "  Y1A!3]]<U7G,#  #F!P  &0              @('R'0$ >&PO
M=V]R:W-H965T<R]S:&5E=#(S+GAM;%!+ 0(4 Q0    ( #E&$%-OX^#C, ,
M .,&   9              " @9PA 0!X;"]W;W)K<VAE971S+W-H965T,C0N
M>&UL4$L! A0#%     @ .4804V NFWLK P   P@  !D              ("!
M R4! 'AL+W=O<FMS:&5E=',O<VAE970R-2YX;6Q02P$"% ,4    "  Y1A!3
MD+L$Y^<$  #1$   &0              @(%E* $ >&PO=V]R:W-H965T<R]S
M:&5E=#(V+GAM;%!+ 0(4 Q0    ( #E&$%-^@?X@V@0  $0-   9
M      " @8,M 0!X;"]W;W)K<VAE971S+W-H965T,C<N>&UL4$L! A0#%
M  @ .4804P.9L,E  P  1@<  !D              ("!E#(! 'AL+W=O<FMS
M:&5E=',O<VAE970R."YX;6Q02P$"% ,4    "  Y1A!3L#"[^3((  #N%@
M&0              @($+-@$ >&PO=V]R:W-H965T<R]S:&5E=#(Y+GAM;%!+
M 0(4 Q0    ( #E&$%._3Q;$<P,  /4'   9              " @70^ 0!X
M;"]W;W)K<VAE971S+W-H965T,S N>&UL4$L! A0#%     @ .4804SLZ5!V"
M!P  !1\  !D              ("!'D(! 'AL+W=O<FMS:&5E=',O<VAE970S
M,2YX;6Q02P$"% ,4    "  Y1A!3SLV-."L#  "1!P  &0
M@('720$ >&PO=V]R:W-H965T<R]S:&5E=#,R+GAM;%!+ 0(4 Q0    ( #E&
M$%/P#C"#5@,  .P'   9              " @3E- 0!X;"]W;W)K<VAE971S
M+W-H965T,S,N>&UL4$L! A0#%     @ .4804QG=F66T!@  )AH  !D
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M=#,X+GAM;%!+ 0(4 Q0    ( #E&$%.Q\C!4YP(  '<'   9
M  " @0YI 0!X;"]W;W)K<VAE971S+W-H965T,SDN>&UL4$L! A0#%     @
M.4804]]N&7G$ P  G \  !D              ("!+&P! 'AL+W=O<FMS:&5E
M=',O<VAE970T,"YX;6Q02P$"% ,4    "  Y1A!3D27Q64P$  #4%   &0
M            @($G< $ >&PO=V]R:W-H965T<R]S:&5E=#0Q+GAM;%!+ 0(4
M Q0    ( #E&$%.ET>]J#0,  %8)   9              " @:IT 0!X;"]W
M;W)K<VAE971S+W-H965T-#(N>&UL4$L! A0#%     @ .4804QX$+XH> @
MJ00  !D              ("![G<! 'AL+W=O<FMS:&5E=',O<VAE970T,RYX
M;6Q02P$"% ,4    "  Y1A!3-.K<4G("  #Y!0  &0              @(%#
M>@$ >&PO=V]R:W-H965T<R]S:&5E=#0T+GAM;%!+ 0(4 Q0    ( #E&$%.+
M)&ZVM (  -\&   9              " @>Q\ 0!X;"]W;W)K<VAE971S+W-H
M965T-#4N>&UL4$L! A0#%     @ .4804Q!9^2S% @  %0@  !D
M     ("!UW\! 'AL+W=O<FMS:&5E=',O<VAE970T-BYX;6Q02P$"% ,4
M"  Y1A!303REQ+8"  !Z!P  &0              @('3@@$ >&PO=V]R:W-H
M965T<R]S:&5E=#0W+GAM;%!+ 0(4 Q0    ( #E&$%-4FP[.Q@4  .<9   9
M              " @<"% 0!X;"]W;W)K<VAE971S+W-H965T-#@N>&UL4$L!
M A0#%     @ .4804\271AB\ @  D <  !D              ("!O8L! 'AL
M+W=O<FMS:&5E=',O<VAE970T.2YX;6Q02P$"% ,4    "  Y1A!3UE9-"9L#
M  "]#0  &0              @(&PC@$ >&PO=V]R:W-H965T<R]S:&5E=#4P
M+GAM;%!+ 0(4 Q0    ( #E&$%.'T^BWB 0  %44   9              "
M@8*2 0!X;"]W;W)K<VAE971S+W-H965T-3$N>&UL4$L! A0#%     @ .480
M4PODF6CJ!   MQ8  !D              ("!09<! 'AL+W=O<FMS:&5E=',O
M<VAE970U,BYX;6Q02P$"% ,4    "  Y1A!3%94:MH\#  #3#0  &0
M        @(%BG $ >&PO=V]R:W-H965T<R]S:&5E=#4S+GAM;%!+ 0(4 Q0
M   ( #E&$%,GX5J7&P,  " +   9              " @2B@ 0!X;"]W;W)K
M<VAE971S+W-H965T-30N>&UL4$L! A0#%     @ .4804U@W.D^: @  Z08
M !D              ("!>J,! 'AL+W=O<FMS:&5E=',O<VAE970U-2YX;6Q0
M2P$"% ,4    "  Y1A!32!%"H&L$  !(%   &0              @(%+I@$
M>&PO=V]R:W-H965T<R]S:&5E=#4V+GAM;%!+ 0(4 Q0    ( #E&$%-RQ]5:
M%P,  , (   9              " @>VJ 0!X;"]W;W)K<VAE971S+W-H965T
M-3<N>&UL4$L! A0#%     @ .4804\]#7,@C!   .!,  !D
M ("!.ZX! 'AL+W=O<FMS:&5E=',O<VAE970U."YX;6Q02P$"% ,4    "  Y
M1A!3"N3>G^L$  #A&   &0              @(&5L@$ >&PO=V]R:W-H965T
M<R]S:&5E=#4Y+GAM;%!+ 0(4 Q0    ( #E&$%,9P>-4(P<   @H   9
M          " @;>W 0!X;"]W;W)K<VAE971S+W-H965T-C N>&UL4$L! A0#
M%     @ .4804[V/U:U4!0  R1D  !D              ("!$;\! 'AL+W=O
M<FMS:&5E=',O<VAE970V,2YX;6Q02P$"% ,4    "  Y1A!3;S+,HIP#   V
M#P  &0              @(&<Q $ >&PO=V]R:W-H965T<R]S:&5E=#8R+GAM
M;%!+ 0(4 Q0    ( #E&$%-87)0(508  '\?   9              " @6_(
M 0!X;"]W;W)K<VAE971S+W-H965T-C,N>&UL4$L! A0#%     @ .4804TE%
M<:'? @  ^P<  !D              ("!^\X! 'AL+W=O<FMS:&5E=',O<VAE
M970V-"YX;6Q02P$"% ,4    "  Y1A!3TK,[5GT#   4#   &0
M    @($1T@$ >&PO=V]R:W-H965T<R]S:&5E=#8U+GAM;%!+ 0(4 Q0    (
M #E&$%.:JNKZI00  %$4   9              " @<75 0!X;"]W;W)K<VAE
M971S+W-H965T-C8N>&UL4$L! A0#%     @ .4804T@<*[BT!P  22,  !D
M             ("!H=H! 'AL+W=O<FMS:&5E=',O<VAE970V-RYX;6Q02P$"
M% ,4    "  Y1A!3_1?"<PP$   '#P  &0              @(&,X@$ >&PO
M=V]R:W-H965T<R]S:&5E=#8X+GAM;%!+ 0(4 Q0    ( #E&$%-,O5<6JP(
M "8'   9              " @<_F 0!X;"]W;W)K<VAE971S+W-H965T-CDN
M>&UL4$L! A0#%     @ .4804\WOPV#4!   51,  !D              ("!
ML>D! 'AL+W=O<FMS:&5E=',O<VAE970W,"YX;6Q02P$"% ,4    "  Y1A!3
M>&GB ^\#  !H$@  &0              @(&\[@$ >&PO=V]R:W-H965T<R]S
M:&5E=#<Q+GAM;%!+ 0(4 Q0    ( #E&$%.+4B_LRP(  -H)   9
M      " @>+R 0!X;"]W;W)K<VAE971S+W-H965T-S(N>&UL4$L! A0#%
M  @ .4804T.LVDL< @  CP0  !D              ("!Y/4! 'AL+W=O<FMS
M:&5E=',O<VAE970W,RYX;6Q02P$"% ,4    "  Y1A!3 NREK=X#  !Q$0
M&0              @($W^ $ >&PO=V]R:W-H965T<R]S:&5E=#<T+GAM;%!+
M 0(4 Q0    ( #E&$%-P7;:.' 4  +H5   9              " @4S\ 0!X
M;"]W;W)K<VAE971S+W-H965T-S4N>&UL4$L! A0#%     @ .4804RMQ&(W,
M @  %P@  !D              ("!GP$" 'AL+W=O<FMS:&5E=',O<VAE970W
M-BYX;6Q02P$"% ,4    "  Y1A!3T>ZU1>,"  #Z!P  &0
M@(&B! ( >&PO=V]R:W-H965T<R]S:&5E=#<W+GAM;%!+ 0(4 Q0    ( #E&
M$%, O;.J+P,  *(+   9              " @;P' @!X;"]W;W)K<VAE971S
M+W-H965T-S@N>&UL4$L! A0#%     @ .4804\-"FR\9 P  &@H  !D
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M=#@S+GAM;%!+ 0(4 Q0    ( #E&$%-G\J_/>P,  -8-   9
M  " @=,: @!X;"]W;W)K<VAE971S+W-H965T.#0N>&UL4$L! A0#%     @
M.4804[2C6JHS!   'Q$  !D              ("!A1X" 'AL+W=O<FMS:&5E
M=',O<VAE970X-2YX;6Q02P$"% ,4    "  Y1A!3.!P=9B\%  !F&   &0
M            @('O(@( >&PO=V]R:W-H965T<R]S:&5E=#@V+GAM;%!+ 0(4
M Q0    ( #E&$%/G,NK$&@0  (L-   9              " @54H @!X;"]W
M;W)K<VAE971S+W-H965T.#<N>&UL4$L! A0#%     @ .4804QI:WD?" @
MX@8  !D              ("!IBP" 'AL+W=O<FMS:&5E=',O<VAE970X."YX
M;6Q02P$"% ,4    "  Y1A!3% M2]1 $    #@  &0              @(&?
M+P( >&PO=V]R:W-H965T<R]S:&5E=#@Y+GAM;%!+ 0(4 Q0    ( #E&$%.'
M0JH#HP0  /,5   9              " @>8S @!X;"]W;W)K<VAE971S+W-H
M965T.3 N>&UL4$L! A0#%     @ .4804VLM ?5= P  :0T  !D
M     ("!P#@" 'AL+W=O<FMS:&5E=',O<VAE970Y,2YX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( #E&$%/#4*U^&@,  %P+   9              "
M@>5* @!X;"]W;W)K<VAE971S+W-H965T.38N>&UL4$L! A0#%     @ .480
M4\V=E2:V P  %PX  !D              ("!-DX" 'AL+W=O<FMS:&5E=',O
M<VAE970Y-RYX;6Q02P$"% ,4    "  Y1A!3RID%Q*D$  !O$0  &0
M        @($C4@( >&PO=V]R:W-H965T<R]S:&5E=#DX+GAM;%!+ 0(4 Q0
M   ( #E&$%.78QTCXP(  -P(   9              " @0-7 @!X;"]W;W)K
M<VAE971S+W-H965T.3DN>&UL4$L! A0#%     @ .4804]FN >.  P  )@P
M !H              ("!'5H" 'AL+W=O<FMS:&5E=',O<VAE970Q,# N>&UL
M4$L! A0#%     @ .4804XOG/&+* P  ,0X  !H              ("!U5T"
M 'AL+W=O<FMS:&5E=',O<VAE970Q,#$N>&UL4$L! A0#%     @ .4804_$V
M5\F+ P  3 P  !H              ("!UV$" 'AL+W=O<FMS:&5E=',O<VAE
M970Q,#(N>&UL4$L! A0#%     @ .4804TL".J&H P  [0H  !H
M     ("!FF4" 'AL+W=O<FMS:&5E=',O<VAE970Q,#,N>&UL4$L! A0#%
M  @ .4804RF Q?"S!0  *B4  !H              ("!>FD" 'AL+W=O<FMS
M:&5E=',O<VAE970Q,#0N>&UL4$L! A0#%     @ .4804\A6/_ _ P  !A,
M  T              ( !96\" 'AL+W-T>6QE<RYX;6Q02P$"% ,4    "  Y
M1A!3EXJ[',     3 @  "P              @ '/<@( 7W)E;',O+G)E;'-0
M2P$"% ,4    "  Y1A!3"5_T:NX&  #!1   #P              @ &X<P(
M>&PO=V]R:V)O;VLN>&UL4$L! A0#%     @ .4804_$(LOGR @  &ST  !H
M             ( !TWH" 'AL+U]R96QS+W=O<FMB;V]K+GAM;"YR96QS4$L!
M A0#%     @ .4804V51Z6]F @  ZSH  !,              ( !_7T" %M#
G;VYT96YT7U1Y<&5S72YX;6Q02P4&     '  < #,'@  E( "

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>126
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>127
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>128
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.21.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>420</ContextCount>
  <ElementCount>562</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>128</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>12</UnitCount>
  <MyReports>
    <Report instance="cah-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>000010001 - Document - Cover Page</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/CoverPage</Role>
      <ShortName>Cover Page</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="cah-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>100010002 - Statement - Consolidated Statements of Earnings</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/ConsolidatedStatementsofEarnings</Role>
      <ShortName>Consolidated Statements of Earnings</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="cah-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>100020003 - Statement - Consolidated Statements of Comprehensive Income</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/ConsolidatedStatementsofComprehensiveIncome</Role>
      <ShortName>Consolidated Statements of Comprehensive Income</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="cah-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>100030004 - Statement - Consolidated Balance Sheets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/ConsolidatedBalanceSheets</Role>
      <ShortName>Consolidated Balance Sheets</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="cah-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>100050006 - Statement - Consolidated Statements of Shareholders' Equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/ConsolidatedStatementsofShareholdersEquity</Role>
      <ShortName>Consolidated Statements of Shareholders' Equity</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="cah-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>100060007 - Statement - Consolidated Statements of Cash Flows</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/ConsolidatedStatementsofCashFlows</Role>
      <ShortName>Consolidated Statements of Cash Flows</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="cah-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>210011001 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPolicies</Role>
      <ShortName>Basis of Presentation and Summary of Significant Accounting Policies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="cah-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>210171002 - Disclosure - Divestitures and Acquisitions</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/DivestituresandAcquisitions</Role>
      <ShortName>Divestitures and Acquisitions</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="cah-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>210201003 - Disclosure - Restructuring and Employee Severance</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/RestructuringandEmployeeSeverance</Role>
      <ShortName>Restructuring and Employee Severance</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="cah-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>210241004 - Disclosure - Goodwill and Other Intangible Assets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/GoodwillandOtherIntangibleAssets</Role>
      <ShortName>Goodwill and Other Intangible Assets</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="cah-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>210291005 - Disclosure - Leases</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/Leases</Role>
      <ShortName>Leases</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="cah-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>210361006 - Disclosure - Long-Term Obligations and Other Short-Term Borrowings</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/LongTermObligationsandOtherShortTermBorrowings</Role>
      <ShortName>Long-Term Obligations and Other Short-Term Borrowings</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="cah-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>210421007 - Disclosure - Commitments, Contingent Liabilities and Litigation</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/CommitmentsContingentLiabilitiesandLitigation</Role>
      <ShortName>Commitments, Contingent Liabilities and Litigation</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="cah-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>210441008 - Disclosure - Income Taxes</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/IncomeTaxes</Role>
      <ShortName>Income Taxes</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="cah-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>210541010 - Disclosure - Fair Value Measurements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/FairValueMeasurements</Role>
      <ShortName>Fair Value Measurements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="cah-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>210591011 - Disclosure - Financial Instruments</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/FinancialInstruments</Role>
      <ShortName>Financial Instruments</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="cah-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>210721012 - Disclosure - Shareholders' Equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/ShareholdersEquity</Role>
      <ShortName>Shareholders' Equity</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="cah-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>210761013 - Disclosure - Earnings Per Share Attributable to Cardinal Health, Inc.</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/EarningsPerShareAttributabletoCardinalHealthInc</Role>
      <ShortName>Earnings Per Share Attributable to Cardinal Health, Inc.</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="cah-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>210801014 - Disclosure - Segment Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/SegmentInformation</Role>
      <ShortName>Segment Information</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="cah-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>210881015 - Disclosure - Share-Based Compensation</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/ShareBasedCompensation</Role>
      <ShortName>Share-Based Compensation</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="cah-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>210991016 - Disclosure - Schedule II - Valuations and Qualifying Accounts</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/ScheduleIIValuationsandQualifyingAccounts</Role>
      <ShortName>Schedule II - Valuations and Qualifying Accounts</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="cah-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>220022001 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies</Role>
      <ShortName>Basis of Presentation and Summary of Significant Accounting Policies (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPolicies</ParentRole>
      <Position>22</Position>
    </Report>
    <Report instance="cah-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>230033001 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesTables</Role>
      <ShortName>Basis of Presentation and Summary of Significant Accounting Policies (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPolicies</ParentRole>
      <Position>23</Position>
    </Report>
    <Report instance="cah-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>230183002 - Disclosure - Divestitures and Acquisitions (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/DivestituresandAcquisitionsTables</Role>
      <ShortName>Divestitures and Acquisitions (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.cardinal.com/role/DivestituresandAcquisitions</ParentRole>
      <Position>24</Position>
    </Report>
    <Report instance="cah-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>230213003 - Disclosure - Restructuring and Employee Severance (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/RestructuringandEmployeeSeveranceTables</Role>
      <ShortName>Restructuring and Employee Severance (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.cardinal.com/role/RestructuringandEmployeeSeverance</ParentRole>
      <Position>25</Position>
    </Report>
    <Report instance="cah-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>230253004 - Disclosure - Goodwill and Other Intangible Assets (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/GoodwillandOtherIntangibleAssetsTables</Role>
      <ShortName>Goodwill and Other Intangible Assets (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.cardinal.com/role/GoodwillandOtherIntangibleAssets</ParentRole>
      <Position>26</Position>
    </Report>
    <Report instance="cah-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>230303005 - Disclosure - Leases (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/LeasesTables</Role>
      <ShortName>Leases (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.cardinal.com/role/Leases</ParentRole>
      <Position>27</Position>
    </Report>
    <Report instance="cah-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>230373006 - Disclosure - Long-Term Obligations and Other Short-Term Borrowings (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/LongTermObligationsandOtherShortTermBorrowingsTables</Role>
      <ShortName>Long-Term Obligations and Other Short-Term Borrowings (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.cardinal.com/role/LongTermObligationsandOtherShortTermBorrowings</ParentRole>
      <Position>28</Position>
    </Report>
    <Report instance="cah-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>230453007 - Disclosure - Income Taxes (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/IncomeTaxesTables</Role>
      <ShortName>Income Taxes (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.cardinal.com/role/IncomeTaxes</ParentRole>
      <Position>29</Position>
    </Report>
    <Report instance="cah-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>230553008 - Disclosure - Fair Value Measurements (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/FairValueMeasurementsTables</Role>
      <ShortName>Fair Value Measurements (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.cardinal.com/role/FairValueMeasurements</ParentRole>
      <Position>30</Position>
    </Report>
    <Report instance="cah-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>230603009 - Disclosure - Financial Instruments (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/FinancialInstrumentsTables</Role>
      <ShortName>Financial Instruments (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.cardinal.com/role/FinancialInstruments</ParentRole>
      <Position>31</Position>
    </Report>
    <Report instance="cah-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>230733010 - Disclosure - Shareholders' Equity (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/ShareholdersEquityTables</Role>
      <ShortName>Shareholders' Equity (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.cardinal.com/role/ShareholdersEquity</ParentRole>
      <Position>32</Position>
    </Report>
    <Report instance="cah-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>230773011 - Disclosure - Earnings Per Share Attributable to Cardinal Health, Inc. (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/EarningsPerShareAttributabletoCardinalHealthIncTables</Role>
      <ShortName>Earnings Per Share Attributable to Cardinal Health, Inc. (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.cardinal.com/role/EarningsPerShareAttributabletoCardinalHealthInc</ParentRole>
      <Position>33</Position>
    </Report>
    <Report instance="cah-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>230813012 - Disclosure - Segment Information (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/SegmentInformationTables</Role>
      <ShortName>Segment Information (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.cardinal.com/role/SegmentInformation</ParentRole>
      <Position>34</Position>
    </Report>
    <Report instance="cah-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>230893013 - Disclosure - Share-Based Compensation (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/ShareBasedCompensationTables</Role>
      <ShortName>Share-Based Compensation (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.cardinal.com/role/ShareBasedCompensation</ParentRole>
      <Position>35</Position>
    </Report>
    <Report instance="cah-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>240044001 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Narrative, Receivables) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeReceivablesDetails</Role>
      <ShortName>Basis of Presentation and Summary of Significant Accounting Policies (Narrative, Receivables) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesTables</ParentRole>
      <Position>36</Position>
    </Report>
    <Report instance="cah-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>240054002 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Revenue and Gross Trade Receivables Percentage by Major Customers) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesRevenueandGrossTradeReceivablesPercentagebyMajorCustomersDetails</Role>
      <ShortName>Basis of Presentation and Summary of Significant Accounting Policies (Revenue and Gross Trade Receivables Percentage by Major Customers) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesTables</ParentRole>
      <Position>37</Position>
    </Report>
    <Report instance="cah-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>240064003 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Narrative, Major Customers) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeMajorCustomersDetails</Role>
      <ShortName>Basis of Presentation and Summary of Significant Accounting Policies (Narrative, Major Customers) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesTables</ParentRole>
      <Position>38</Position>
    </Report>
    <Report instance="cah-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>240074004 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Narrative, Inventories) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeInventoriesDetails</Role>
      <ShortName>Basis of Presentation and Summary of Significant Accounting Policies (Narrative, Inventories) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesTables</ParentRole>
      <Position>39</Position>
    </Report>
    <Report instance="cah-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>240084005 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Narrative, Property and Equipment) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativePropertyandEquipmentDetails</Role>
      <ShortName>Basis of Presentation and Summary of Significant Accounting Policies (Narrative, Property and Equipment) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesTables</ParentRole>
      <Position>40</Position>
    </Report>
    <Report instance="cah-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>240094006 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Components of Property and Equipment) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesComponentsofPropertyandEquipmentDetails</Role>
      <ShortName>Basis of Presentation and Summary of Significant Accounting Policies (Components of Property and Equipment) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesTables</ParentRole>
      <Position>41</Position>
    </Report>
    <Report instance="cah-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>240104007 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Narrative, Goodwill and Other Intangible Assets) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeGoodwillandOtherIntangibleAssetsDetails</Role>
      <ShortName>Basis of Presentation and Summary of Significant Accounting Policies (Narrative, Goodwill and Other Intangible Assets) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesTables</ParentRole>
      <Position>42</Position>
    </Report>
    <Report instance="cah-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>240124009 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Narrative, Vendor Reserves) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeVendorReservesDetails</Role>
      <ShortName>Basis of Presentation and Summary of Significant Accounting Policies (Narrative, Vendor Reserves) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesTables</ParentRole>
      <Position>43</Position>
    </Report>
    <Report instance="cah-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>240134010 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Narrative, Dividends) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDividendsDetails</Role>
      <ShortName>Basis of Presentation and Summary of Significant Accounting Policies (Narrative, Dividends) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesTables</ParentRole>
      <Position>44</Position>
    </Report>
    <Report instance="cah-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>240144011 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Narrative, Sales Returns and Allowances) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeSalesReturnsandAllowancesDetails</Role>
      <ShortName>Basis of Presentation and Summary of Significant Accounting Policies (Narrative, Sales Returns and Allowances) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesTables</ParentRole>
      <Position>45</Position>
    </Report>
    <Report instance="cah-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>240154012 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Narrative, Shipping and Handling) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeShippingandHandlingDetails</Role>
      <ShortName>Basis of Presentation and Summary of Significant Accounting Policies (Narrative, Shipping and Handling) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesTables</ParentRole>
      <Position>46</Position>
    </Report>
    <Report instance="cah-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>240164013 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies Loss Contingencies (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesLossContingenciesDetails</Role>
      <ShortName>Basis of Presentation and Summary of Significant Accounting Policies Loss Contingencies (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>47</Position>
    </Report>
    <Report instance="cah-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>240194014 - Disclosure - Divestitures and Acquisitions (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/DivestituresandAcquisitionsNarrativeDetails</Role>
      <ShortName>Divestitures and Acquisitions (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cardinal.com/role/DivestituresandAcquisitionsTables</ParentRole>
      <Position>48</Position>
    </Report>
    <Report instance="cah-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>240224015 - Disclosure - Restructuring and Employee Severance (Activity Related to Restructuring and Employee Severance Costs) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/RestructuringandEmployeeSeveranceActivityRelatedtoRestructuringandEmployeeSeveranceCostsDetails</Role>
      <ShortName>Restructuring and Employee Severance (Activity Related to Restructuring and Employee Severance Costs) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cardinal.com/role/RestructuringandEmployeeSeveranceTables</ParentRole>
      <Position>49</Position>
    </Report>
    <Report instance="cah-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>240234016 - Disclosure - Restructuring and Employee Severance (Liabilities Associated with Restructuring and Employee Severance Activities) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/RestructuringandEmployeeSeveranceLiabilitiesAssociatedwithRestructuringandEmployeeSeveranceActivitiesDetails</Role>
      <ShortName>Restructuring and Employee Severance (Liabilities Associated with Restructuring and Employee Severance Activities) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cardinal.com/role/RestructuringandEmployeeSeveranceTables</ParentRole>
      <Position>50</Position>
    </Report>
    <Report instance="cah-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>240264017 - Disclosure - Goodwill and Other Intangible Assets (Schedule of Goodwill by Reportable Segment) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/GoodwillandOtherIntangibleAssetsScheduleofGoodwillbyReportableSegmentDetails</Role>
      <ShortName>Goodwill and Other Intangible Assets (Schedule of Goodwill by Reportable Segment) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cardinal.com/role/GoodwillandOtherIntangibleAssetsTables</ParentRole>
      <Position>51</Position>
    </Report>
    <Report instance="cah-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>240274018 - Disclosure - Goodwill and Other Intangible Assets (Schedule of Intangible Assets) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/GoodwillandOtherIntangibleAssetsScheduleofIntangibleAssetsDetails</Role>
      <ShortName>Goodwill and Other Intangible Assets (Schedule of Intangible Assets) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cardinal.com/role/GoodwillandOtherIntangibleAssetsTables</ParentRole>
      <Position>52</Position>
    </Report>
    <Report instance="cah-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>240284019 - Disclosure - Goodwill and Other Intangible Assets (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/GoodwillandOtherIntangibleAssetsNarrativeDetails</Role>
      <ShortName>Goodwill and Other Intangible Assets (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cardinal.com/role/GoodwillandOtherIntangibleAssetsTables</ParentRole>
      <Position>53</Position>
    </Report>
    <Report instance="cah-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>240314020 - Disclosure - Leases (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/LeasesDetails</Role>
      <ShortName>Leases (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cardinal.com/role/LeasesTables</ParentRole>
      <Position>54</Position>
    </Report>
    <Report instance="cah-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>240324021 - Disclosure - Leases Schedule of Lease Costs (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/LeasesScheduleofLeaseCostsDetails</Role>
      <ShortName>Leases Schedule of Lease Costs (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>55</Position>
    </Report>
    <Report instance="cah-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R56.htm</HtmlFileName>
      <LongName>240334022 - Disclosure - Leases Supplemental Balance Sheet Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/LeasesSupplementalBalanceSheetInformationDetails</Role>
      <ShortName>Leases Supplemental Balance Sheet Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>56</Position>
    </Report>
    <Report instance="cah-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R57.htm</HtmlFileName>
      <LongName>240344023 - Disclosure - Leases Supplemental Cash Flow Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/LeasesSupplementalCashFlowInformationDetails</Role>
      <ShortName>Leases Supplemental Cash Flow Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>57</Position>
    </Report>
    <Report instance="cah-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R58.htm</HtmlFileName>
      <LongName>240354024 - Disclosure - Leases Schedule of Future Lease Payments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/LeasesScheduleofFutureLeasePaymentsDetails</Role>
      <ShortName>Leases Schedule of Future Lease Payments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>58</Position>
    </Report>
    <Report instance="cah-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R59.htm</HtmlFileName>
      <LongName>240384025 - Disclosure - Long-Term Obligations and Other Short-Term Borrowings Summary of Debt (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/LongTermObligationsandOtherShortTermBorrowingsSummaryofDebtDetails</Role>
      <ShortName>Long-Term Obligations and Other Short-Term Borrowings Summary of Debt (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>59</Position>
    </Report>
    <Report instance="cah-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R60.htm</HtmlFileName>
      <LongName>240394026 - Disclosure - Long-Term Obligations and Other Short-Term Borrowings Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/LongTermObligationsandOtherShortTermBorrowingsNarrativeDetails</Role>
      <ShortName>Long-Term Obligations and Other Short-Term Borrowings Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cardinal.com/role/LongTermObligationsandOtherShortTermBorrowingsTables</ParentRole>
      <Position>60</Position>
    </Report>
    <Report instance="cah-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R61.htm</HtmlFileName>
      <LongName>240404027 - Disclosure - Long-Term Obligations and Other Short-Term Borrowings Long-Term Debt (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/LongTermObligationsandOtherShortTermBorrowingsLongTermDebtDetails</Role>
      <ShortName>Long-Term Obligations and Other Short-Term Borrowings Long-Term Debt (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>61</Position>
    </Report>
    <Report instance="cah-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R62.htm</HtmlFileName>
      <LongName>240414028 - Disclosure - Long-Term Obligations and Other Short-Term Borrowings Other Financing Arrangements (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/LongTermObligationsandOtherShortTermBorrowingsOtherFinancingArrangementsDetails</Role>
      <ShortName>Long-Term Obligations and Other Short-Term Borrowings Other Financing Arrangements (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>62</Position>
    </Report>
    <Report instance="cah-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R63.htm</HtmlFileName>
      <LongName>240434029 - Disclosure - Commitments, Contingent Liabilities and Litigation (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/CommitmentsContingentLiabilitiesandLitigationDetails</Role>
      <ShortName>Commitments, Contingent Liabilities and Litigation (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cardinal.com/role/CommitmentsContingentLiabilitiesandLitigation</ParentRole>
      <Position>63</Position>
    </Report>
    <Report instance="cah-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R64.htm</HtmlFileName>
      <LongName>240464030 - Disclosure - Income Taxes (Schedule of Income before Income Tax, Domestic and Foreign) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/IncomeTaxesScheduleofIncomebeforeIncomeTaxDomesticandForeignDetails</Role>
      <ShortName>Income Taxes (Schedule of Income before Income Tax, Domestic and Foreign) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cardinal.com/role/IncomeTaxesTables</ParentRole>
      <Position>64</Position>
    </Report>
    <Report instance="cah-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R65.htm</HtmlFileName>
      <LongName>240474031 - Disclosure - Income Taxes (Schedule of Components of Income Tax Expense (Benefit), Current and Deferred) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/IncomeTaxesScheduleofComponentsofIncomeTaxExpenseBenefitCurrentandDeferredDetails</Role>
      <ShortName>Income Taxes (Schedule of Components of Income Tax Expense (Benefit), Current and Deferred) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cardinal.com/role/IncomeTaxesTables</ParentRole>
      <Position>65</Position>
    </Report>
    <Report instance="cah-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R66.htm</HtmlFileName>
      <LongName>240484032 - Disclosure - Income Taxes (Schedule of Effective Income Tax Rate Reconciliation) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/IncomeTaxesScheduleofEffectiveIncomeTaxRateReconciliationDetails</Role>
      <ShortName>Income Taxes (Schedule of Effective Income Tax Rate Reconciliation) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cardinal.com/role/IncomeTaxesTables</ParentRole>
      <Position>66</Position>
    </Report>
    <Report instance="cah-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R67.htm</HtmlFileName>
      <LongName>240494033 - Disclosure - Income Taxes (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/IncomeTaxesNarrativeDetails</Role>
      <ShortName>Income Taxes (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cardinal.com/role/IncomeTaxesTables</ParentRole>
      <Position>67</Position>
    </Report>
    <Report instance="cah-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R68.htm</HtmlFileName>
      <LongName>240504034 - Disclosure - Income Taxes (Schedule of Deferred Tax Assets and Liabilities) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails</Role>
      <ShortName>Income Taxes (Schedule of Deferred Tax Assets and Liabilities) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cardinal.com/role/IncomeTaxesTables</ParentRole>
      <Position>68</Position>
    </Report>
    <Report instance="cah-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R69.htm</HtmlFileName>
      <LongName>240514035 - Disclosure - Income Taxes (Schedule of Deferred Tax Assets and Liabilities After Netting by Tax Jurisdiction) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesAfterNettingbyTaxJurisdictionDetails</Role>
      <ShortName>Income Taxes (Schedule of Deferred Tax Assets and Liabilities After Netting by Tax Jurisdiction) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cardinal.com/role/IncomeTaxesTables</ParentRole>
      <Position>69</Position>
    </Report>
    <Report instance="cah-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R70.htm</HtmlFileName>
      <LongName>240524036 - Disclosure - Income Taxes (Schedule of Unrecognized Tax Benefits Roll Forward) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/IncomeTaxesScheduleofUnrecognizedTaxBenefitsRollForwardDetails</Role>
      <ShortName>Income Taxes (Schedule of Unrecognized Tax Benefits Roll Forward) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cardinal.com/role/IncomeTaxesTables</ParentRole>
      <Position>70</Position>
    </Report>
    <Report instance="cah-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R71.htm</HtmlFileName>
      <LongName>240564037 - Disclosure - Fair Value Measurements (Fair Value of Assets and Liabilities Measured on a Recurring Basis) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/FairValueMeasurementsFairValueofAssetsandLiabilitiesMeasuredonaRecurringBasisDetails</Role>
      <ShortName>Fair Value Measurements (Fair Value of Assets and Liabilities Measured on a Recurring Basis) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cardinal.com/role/FairValueMeasurementsTables</ParentRole>
      <Position>71</Position>
    </Report>
    <Report instance="cah-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R72.htm</HtmlFileName>
      <LongName>240574038 - Disclosure - Fair Value Measurements (Reconciliation of Liabilities Measured at Fair Value on a Recurring Basis Using Unobservable Inputs (Level 3)) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/FairValueMeasurementsReconciliationofLiabilitiesMeasuredatFairValueonaRecurringBasisUsingUnobservableInputsLevel3Details</Role>
      <ShortName>Fair Value Measurements (Reconciliation of Liabilities Measured at Fair Value on a Recurring Basis Using Unobservable Inputs (Level 3)) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cardinal.com/role/FairValueMeasurementsTables</ParentRole>
      <Position>72</Position>
    </Report>
    <Report instance="cah-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R73.htm</HtmlFileName>
      <LongName>240584039 - Disclosure - Fair Value Measurements (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/FairValueMeasurementsDetails</Role>
      <ShortName>Fair Value Measurements (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cardinal.com/role/FairValueMeasurementsTables</ParentRole>
      <Position>73</Position>
    </Report>
    <Report instance="cah-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R74.htm</HtmlFileName>
      <LongName>240614040 - Disclosure - Financial Instruments (Schedule of the Fair Value of Assets and Liabilities Related to Derivatives Designated as Hedging Instruments) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/FinancialInstrumentsScheduleoftheFairValueofAssetsandLiabilitiesRelatedtoDerivativesDesignatedasHedgingInstrumentsDetails</Role>
      <ShortName>Financial Instruments (Schedule of the Fair Value of Assets and Liabilities Related to Derivatives Designated as Hedging Instruments) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cardinal.com/role/FinancialInstrumentsTables</ParentRole>
      <Position>74</Position>
    </Report>
    <Report instance="cah-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R75.htm</HtmlFileName>
      <LongName>240624041 - Disclosure - Financial Instruments (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/FinancialInstrumentsNarrativeDetails</Role>
      <ShortName>Financial Instruments (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cardinal.com/role/FinancialInstrumentsTables</ParentRole>
      <Position>75</Position>
    </Report>
    <Report instance="cah-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R76.htm</HtmlFileName>
      <LongName>240634042 - Disclosure - Financial Instruments (Schedule of Outstanding Instruments, Fair Value Hedges) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/FinancialInstrumentsScheduleofOutstandingInstrumentsFairValueHedgesDetails</Role>
      <ShortName>Financial Instruments (Schedule of Outstanding Instruments, Fair Value Hedges) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cardinal.com/role/FinancialInstrumentsTables</ParentRole>
      <Position>76</Position>
    </Report>
    <Report instance="cah-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R77.htm</HtmlFileName>
      <LongName>240644043 - Disclosure - Financial Instruments (Schedule of Gain/(Loss) Recognized in Earnings for Interest Rate Contracts Designated as Fair Value Hedges) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/FinancialInstrumentsScheduleofGainLossRecognizedinEarningsforInterestRateContractsDesignatedasFairValueHedgesDetails</Role>
      <ShortName>Financial Instruments (Schedule of Gain/(Loss) Recognized in Earnings for Interest Rate Contracts Designated as Fair Value Hedges) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cardinal.com/role/FinancialInstrumentsTables</ParentRole>
      <Position>77</Position>
    </Report>
    <Report instance="cah-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R78.htm</HtmlFileName>
      <LongName>240654044 - Disclosure - Financial Instruments (Schedule of Outstanding Instruments, Cash Flow Hedges) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/FinancialInstrumentsScheduleofOutstandingInstrumentsCashFlowHedgesDetails</Role>
      <ShortName>Financial Instruments (Schedule of Outstanding Instruments, Cash Flow Hedges) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cardinal.com/role/FinancialInstrumentsTables</ParentRole>
      <Position>78</Position>
    </Report>
    <Report instance="cah-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R79.htm</HtmlFileName>
      <LongName>240664045 - Disclosure - Financial Instruments (Schedule of Gain/(Loss) Included in AOCI for Derivative Instruments Designated as Cash Flow Hedges) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/FinancialInstrumentsScheduleofGainLossIncludedinAOCIforDerivativeInstrumentsDesignatedasCashFlowHedgesDetails</Role>
      <ShortName>Financial Instruments (Schedule of Gain/(Loss) Included in AOCI for Derivative Instruments Designated as Cash Flow Hedges) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cardinal.com/role/FinancialInstrumentsTables</ParentRole>
      <Position>79</Position>
    </Report>
    <Report instance="cah-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R80.htm</HtmlFileName>
      <LongName>240674046 - Disclosure - Financial Instruments (Schedule of Gain/(Loss) Reclassified from AOCI into Earnings for Derivative Instruments Designated as Cash Flow Hedges) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/FinancialInstrumentsScheduleofGainLossReclassifiedfromAOCIintoEarningsforDerivativeInstrumentsDesignatedasCashFlowHedgesDetails</Role>
      <ShortName>Financial Instruments (Schedule of Gain/(Loss) Reclassified from AOCI into Earnings for Derivative Instruments Designated as Cash Flow Hedges) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cardinal.com/role/FinancialInstrumentsTables</ParentRole>
      <Position>80</Position>
    </Report>
    <Report instance="cah-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R81.htm</HtmlFileName>
      <LongName>240684047 - Disclosure - Financial Instruments (Schedule of Outstanding Instruments, Economic Hedges) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/FinancialInstrumentsScheduleofOutstandingInstrumentsEconomicHedgesDetails</Role>
      <ShortName>Financial Instruments (Schedule of Outstanding Instruments, Economic Hedges) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cardinal.com/role/FinancialInstrumentsTables</ParentRole>
      <Position>81</Position>
    </Report>
    <Report instance="cah-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R82.htm</HtmlFileName>
      <LongName>240694048 - Disclosure - Financial Instruments (Schedule of Gain/(Loss) Recognized in Earnings for Derivatives Not Designated as Hedging Instrument) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/FinancialInstrumentsScheduleofGainLossRecognizedinEarningsforDerivativesNotDesignatedasHedgingInstrumentDetails</Role>
      <ShortName>Financial Instruments (Schedule of Gain/(Loss) Recognized in Earnings for Derivatives Not Designated as Hedging Instrument) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cardinal.com/role/FinancialInstrumentsTables</ParentRole>
      <Position>82</Position>
    </Report>
    <Report instance="cah-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R83.htm</HtmlFileName>
      <LongName>240704049 - Disclosure - Financial Instruments (Summary of Estimated Fair Value of Long-term Obligations and Other Short-term Borrowings) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/FinancialInstrumentsSummaryofEstimatedFairValueofLongtermObligationsandOtherShorttermBorrowingsDetails</Role>
      <ShortName>Financial Instruments (Summary of Estimated Fair Value of Long-term Obligations and Other Short-term Borrowings) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cardinal.com/role/FinancialInstrumentsTables</ParentRole>
      <Position>83</Position>
    </Report>
    <Report instance="cah-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R84.htm</HtmlFileName>
      <LongName>240714050 - Disclosure - Financial Instruments (Schedule of Fair Value Gain Loss Derivative Instrument) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/FinancialInstrumentsScheduleofFairValueGainLossDerivativeInstrumentDetails</Role>
      <ShortName>Financial Instruments (Schedule of Fair Value Gain Loss Derivative Instrument) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cardinal.com/role/FinancialInstrumentsTables</ParentRole>
      <Position>84</Position>
    </Report>
    <Report instance="cah-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R85.htm</HtmlFileName>
      <LongName>240744051 - Disclosure - Shareholders' Equity (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/ShareholdersEquityNarrativeDetails</Role>
      <ShortName>Shareholders' Equity (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cardinal.com/role/ShareholdersEquityTables</ParentRole>
      <Position>85</Position>
    </Report>
    <Report instance="cah-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R86.htm</HtmlFileName>
      <LongName>240754052 - Disclosure - Shareholders' Equity (Changes in the Accumulated Other Comprehensive Income (Loss)) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/ShareholdersEquityChangesintheAccumulatedOtherComprehensiveIncomeLossDetails</Role>
      <ShortName>Shareholders' Equity (Changes in the Accumulated Other Comprehensive Income (Loss)) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cardinal.com/role/ShareholdersEquityTables</ParentRole>
      <Position>86</Position>
    </Report>
    <Report instance="cah-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R87.htm</HtmlFileName>
      <LongName>240784053 - Disclosure - Earnings Per Share Attributable to Cardinal Health, Inc. (Reconciliation of Common Shares Used to Compute Basic and Diluted EPS) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/EarningsPerShareAttributabletoCardinalHealthIncReconciliationofCommonSharesUsedtoComputeBasicandDilutedEPSDetails</Role>
      <ShortName>Earnings Per Share Attributable to Cardinal Health, Inc. (Reconciliation of Common Shares Used to Compute Basic and Diluted EPS) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cardinal.com/role/EarningsPerShareAttributabletoCardinalHealthIncTables</ParentRole>
      <Position>87</Position>
    </Report>
    <Report instance="cah-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R88.htm</HtmlFileName>
      <LongName>240794054 - Disclosure - Earnings Per Share Attributable to Cardinal Health, Inc. (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/EarningsPerShareAttributabletoCardinalHealthIncNarrativeDetails</Role>
      <ShortName>Earnings Per Share Attributable to Cardinal Health, Inc. (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cardinal.com/role/EarningsPerShareAttributabletoCardinalHealthIncTables</ParentRole>
      <Position>88</Position>
    </Report>
    <Report instance="cah-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R89.htm</HtmlFileName>
      <LongName>240824055 - Disclosure - Segment Information (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/SegmentInformationNarrativeDetails</Role>
      <ShortName>Segment Information (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cardinal.com/role/SegmentInformationTables</ParentRole>
      <Position>89</Position>
    </Report>
    <Report instance="cah-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R90.htm</HtmlFileName>
      <LongName>240834056 - Disclosure - Segment Information (Revenue by Reportable Segment) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/SegmentInformationRevenuebyReportableSegmentDetails</Role>
      <ShortName>Segment Information (Revenue by Reportable Segment) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cardinal.com/role/SegmentInformationTables</ParentRole>
      <Position>90</Position>
    </Report>
    <Report instance="cah-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R91.htm</HtmlFileName>
      <LongName>240844057 - Disclosure - Segment Information (Segment Profit by Reportable Segment) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/SegmentInformationSegmentProfitbyReportableSegmentDetails</Role>
      <ShortName>Segment Information (Segment Profit by Reportable Segment) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cardinal.com/role/SegmentInformationTables</ParentRole>
      <Position>91</Position>
    </Report>
    <Report instance="cah-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R92.htm</HtmlFileName>
      <LongName>240854058 - Disclosure - Segment Information (Depreciation and Amortization and Additions to Property and Equipment by Reportable Segment) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/SegmentInformationDepreciationandAmortizationandAdditionstoPropertyandEquipmentbyReportableSegmentDetails</Role>
      <ShortName>Segment Information (Depreciation and Amortization and Additions to Property and Equipment by Reportable Segment) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cardinal.com/role/SegmentInformationTables</ParentRole>
      <Position>92</Position>
    </Report>
    <Report instance="cah-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R93.htm</HtmlFileName>
      <LongName>240864059 - Disclosure - Segment Information (Assets by Reportable Segment) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/SegmentInformationAssetsbyReportableSegmentDetails</Role>
      <ShortName>Segment Information (Assets by Reportable Segment) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cardinal.com/role/SegmentInformationTables</ParentRole>
      <Position>93</Position>
    </Report>
    <Report instance="cah-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R94.htm</HtmlFileName>
      <LongName>240874060 - Disclosure - Segment Information Property and Equipment, net by Geographic Area) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/SegmentInformationPropertyandEquipmentnetbyGeographicAreaDetails</Role>
      <ShortName>Segment Information Property and Equipment, net by Geographic Area) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>94</Position>
    </Report>
    <Report instance="cah-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R95.htm</HtmlFileName>
      <LongName>240904061 - Disclosure - Share-Based Compensation (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/ShareBasedCompensationNarrativeDetails</Role>
      <ShortName>Share-Based Compensation (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cardinal.com/role/ShareBasedCompensationTables</ParentRole>
      <Position>95</Position>
    </Report>
    <Report instance="cah-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R96.htm</HtmlFileName>
      <LongName>240914062 - Disclosure - Share-Based Compensation (Schedule of Total Share-Based Compensation Expense by Type of Award) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/ShareBasedCompensationScheduleofTotalShareBasedCompensationExpensebyTypeofAwardDetails</Role>
      <ShortName>Share-Based Compensation (Schedule of Total Share-Based Compensation Expense by Type of Award) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cardinal.com/role/ShareBasedCompensationTables</ParentRole>
      <Position>96</Position>
    </Report>
    <Report instance="cah-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R97.htm</HtmlFileName>
      <LongName>240924063 - Disclosure - Share-Based Compensation (Schedule of All Stock Option Transactions Under the Plans) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/ShareBasedCompensationScheduleofAllStockOptionTransactionsUnderthePlansDetails</Role>
      <ShortName>Share-Based Compensation (Schedule of All Stock Option Transactions Under the Plans) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cardinal.com/role/ShareBasedCompensationTables</ParentRole>
      <Position>97</Position>
    </Report>
    <Report instance="cah-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R98.htm</HtmlFileName>
      <LongName>240934064 - Disclosure - Share-Based Compensation (Schedule of Additional Data Related to Stock Options) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/ShareBasedCompensationScheduleofAdditionalDataRelatedtoStockOptionsDetails</Role>
      <ShortName>Share-Based Compensation (Schedule of Additional Data Related to Stock Options) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cardinal.com/role/ShareBasedCompensationTables</ParentRole>
      <Position>98</Position>
    </Report>
    <Report instance="cah-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R99.htm</HtmlFileName>
      <LongName>240944065 - Disclosure - Share-Based Compensation Schedule of Remaining Stock Option Plan Data (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/ShareBasedCompensationScheduleofRemainingStockOptionPlanDataDetails</Role>
      <ShortName>Share-Based Compensation Schedule of Remaining Stock Option Plan Data (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>99</Position>
    </Report>
    <Report instance="cah-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R100.htm</HtmlFileName>
      <LongName>240954066 - Disclosure - Share-Based Compensation (Schedule of All Transactions Related to Restricted Share Units Under the Plans) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/ShareBasedCompensationScheduleofAllTransactionsRelatedtoRestrictedShareUnitsUnderthePlansDetails</Role>
      <ShortName>Share-Based Compensation (Schedule of All Transactions Related to Restricted Share Units Under the Plans) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cardinal.com/role/ShareBasedCompensationTables</ParentRole>
      <Position>100</Position>
    </Report>
    <Report instance="cah-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R101.htm</HtmlFileName>
      <LongName>240964067 - Disclosure - Share-Based Compensation (Additional Data Related to Restricted Share Unit Activity) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/ShareBasedCompensationAdditionalDataRelatedtoRestrictedShareUnitActivityDetails</Role>
      <ShortName>Share-Based Compensation (Additional Data Related to Restricted Share Unit Activity) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cardinal.com/role/ShareBasedCompensationTables</ParentRole>
      <Position>101</Position>
    </Report>
    <Report instance="cah-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R102.htm</HtmlFileName>
      <LongName>240974068 - Disclosure - Share-Based Compensation (Schedule of All Transactions Related to Performance Share Units Under the Plans) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/ShareBasedCompensationScheduleofAllTransactionsRelatedtoPerformanceShareUnitsUnderthePlansDetails</Role>
      <ShortName>Share-Based Compensation (Schedule of All Transactions Related to Performance Share Units Under the Plans) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cardinal.com/role/ShareBasedCompensationTables</ParentRole>
      <Position>102</Position>
    </Report>
    <Report instance="cah-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R103.htm</HtmlFileName>
      <LongName>240984069 - Disclosure - Share-Based Compensation (Additional Data Related to Performance Share Unit Activity) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/ShareBasedCompensationAdditionalDataRelatedtoPerformanceShareUnitActivityDetails</Role>
      <ShortName>Share-Based Compensation (Additional Data Related to Performance Share Unit Activity) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cardinal.com/role/ShareBasedCompensationTables</ParentRole>
      <Position>103</Position>
    </Report>
    <Report instance="cah-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R104.htm</HtmlFileName>
      <LongName>241004070 - Disclosure - Schedule II - Valuations and Qualifying Accounts (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/ScheduleIIValuationsandQualifyingAccountsDetails</Role>
      <ShortName>Schedule II - Valuations and Qualifying Accounts (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cardinal.com/role/ScheduleIIValuationsandQualifyingAccounts</ParentRole>
      <Position>104</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="10-K" original="cah-20210630.htm">cah-20210630.htm</File>
    <File>a21q4_10kx063021xexhibit311.htm</File>
    <File>a21q4_10kx063021xexhibit312.htm</File>
    <File>a21q4_10kx063021xexhibit321.htm</File>
    <File>a21q4_10kx063021xexhibit991.htm</File>
    <File>a21q4_10kx63021xexhibit211.htm</File>
    <File>a21q4_10kx63021xexhibit231.htm</File>
    <File>cah-20210630.xsd</File>
    <File>cah-20210630_cal.xml</File>
    <File>cah-20210630_def.xml</File>
    <File>cah-20210630_lab.xml</File>
    <File>cah-20210630_pre.xml</File>
  </InputFiles>
  <SupplementalFiles>
    <File>cah-20210630_g1.jpg</File>
    <File>cah-20210630_g2.jpg</File>
    <File>cah-20210630_g3.jpg</File>
    <File>cah-20210630_g4.jpg</File>
    <File>cah-20210630_g5.jpg</File>
    <File>cah-20210630_g6.jpg</File>
    <File>cah-20210630_g7.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy>http://fasb.org/us-gaap/2021-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://xbrl.sec.gov/dei/2021</BaseTaxonomy>
    <BaseTaxonomy>http://xbrl.sec.gov/country/2021</BaseTaxonomy>
    <BaseTaxonomy>http://fasb.org/srt/2021-01-31</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>131
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "cah-20210630.htm": {
   "axisCustom": 8,
   "axisStandard": 34,
   "contextCount": 420,
   "dts": {
    "calculationLink": {
     "local": [
      "cah-20210630_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "cah-20210630_def.xml"
     ]
    },
    "inline": {
     "local": [
      "cah-20210630.htm"
     ]
    },
    "labelLink": {
     "local": [
      "cah-20210630_lab.xml"
     ],
     "remote": [
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-doc-2021-01-31.xml",
      "https://xbrl.fasb.org/srt/2021/elts/srt-doc-2021-01-31.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "cah-20210630_pre.xml"
     ]
    },
    "referenceLink": {
     "remote": [
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-ref-2021-01-31.xml",
      "https://xbrl.fasb.org/srt/2021/elts/srt-ref-2021-01-31.xml"
     ]
    },
    "schema": {
     "local": [
      "cah-20210630.xsd"
     ],
     "remote": [
      "https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd",
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd",
      "https://xbrl.sec.gov/country/2021/country-2021.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-roles-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-roles-2021-01-31.xsd",
      "https://xbrl.sec.gov/dei/2021/dei-2021.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://xbrl.sec.gov/dei/2021/dei-2021_ref.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-parts-codification-2021-01-31.xsd",
      "https://xbrl.sec.gov/dei/2021/dei-2021_doc.xsd"
     ]
    }
   },
   "elementCount": 840,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2021": 6,
    "total": 6
   },
   "keyCustom": 81,
   "keyStandard": 481,
   "memberCustom": 58,
   "memberStandard": 66,
   "nsprefix": "cah",
   "nsuri": "http://www.cardinal.com/20210630",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20210630.htm",
      "contextRef": "i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "000010001 - Document - Cover Page",
     "role": "http://www.cardinal.com/role/CoverPage",
     "shortName": "Cover Page",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20210630.htm",
      "contextRef": "i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R10": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20210630.htm",
      "contextRef": "i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210241004 - Disclosure - Goodwill and Other Intangible Assets",
     "role": "http://www.cardinal.com/role/GoodwillandOtherIntangibleAssets",
     "shortName": "Goodwill and Other Intangible Assets",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20210630.htm",
      "contextRef": "i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R100": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock",
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20210630.htm",
      "contextRef": "ifb9b7ea1688a4fb4a266a5ac9179360e_I20200630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240954066 - Disclosure - Share-Based Compensation (Schedule of All Transactions Related to Restricted Share Units Under the Plans) (Details)",
     "role": "http://www.cardinal.com/role/ShareBasedCompensationScheduleofAllTransactionsRelatedtoRestrictedShareUnitsUnderthePlansDetails",
     "shortName": "Share-Based Compensation (Schedule of All Transactions Related to Restricted Share Units Under the Plans) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock",
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20210630.htm",
      "contextRef": "icf32a92391924ff7b30fe54e99e0979b_I20190630",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R101": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "cah:AdditionalRestrictedSharesAndRestrictedShareUnitsDataTableTextBlock",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20210630.htm",
      "contextRef": "i401c6da5266c42ffb2f8a5466c3eba3c_I20210630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240964067 - Disclosure - Share-Based Compensation (Additional Data Related to Restricted Share Unit Activity) (Details)",
     "role": "http://www.cardinal.com/role/ShareBasedCompensationAdditionalDataRelatedtoRestrictedShareUnitActivityDetails",
     "shortName": "Share-Based Compensation (Additional Data Related to Restricted Share Unit Activity) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "cah:AdditionalRestrictedSharesAndRestrictedShareUnitsDataTableTextBlock",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20210630.htm",
      "contextRef": "i401c6da5266c42ffb2f8a5466c3eba3c_I20210630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R102": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfNonvestedPerformanceBasedUnitsActivityTableTextBlock",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20210630.htm",
      "contextRef": "ib996ace534574f9da807e45a4e349efc_I20200630",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240974068 - Disclosure - Share-Based Compensation (Schedule of All Transactions Related to Performance Share Units Under the Plans) (Details)",
     "role": "http://www.cardinal.com/role/ShareBasedCompensationScheduleofAllTransactionsRelatedtoPerformanceShareUnitsUnderthePlansDetails",
     "shortName": "Share-Based Compensation (Schedule of All Transactions Related to Performance Share Units Under the Plans) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfNonvestedPerformanceBasedUnitsActivityTableTextBlock",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20210630.htm",
      "contextRef": "i837fa9d3c1f04fb6aa54fd33592f52b3_I20190630",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R103": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "cah:AdditionalPerformanceShareUnitsDataTableTextBlock",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20210630.htm",
      "contextRef": "i09a66472ecae47489b82c3a6aade6b47_I20210630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240984069 - Disclosure - Share-Based Compensation (Additional Data Related to Performance Share Unit Activity) (Details)",
     "role": "http://www.cardinal.com/role/ShareBasedCompensationAdditionalDataRelatedtoPerformanceShareUnitActivityDetails",
     "shortName": "Share-Based Compensation (Additional Data Related to Performance Share Unit Activity) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20210630.htm",
      "contextRef": "i217c2671c6f84df1ab8278415bc34c16_D20200701-20210630",
      "decimals": "INF",
      "lang": "en-US",
      "name": "cah:VestingPeriodinyearsforShares",
      "reportCount": 1,
      "unique": true,
      "unitRef": "vestingperiods",
      "xsiNil": "false"
     }
    },
    "R104": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "cah-20210630.htm",
      "contextRef": "i2e87824102b34590a0208cc7da91b5f5_I20210630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ValuationAllowancesAndReservesBalance",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "241004070 - Disclosure - Schedule II - Valuations and Qualifying Accounts (Details)",
     "role": "http://www.cardinal.com/role/ScheduleIIValuationsandQualifyingAccountsDetails",
     "shortName": "Schedule II - Valuations and Qualifying Accounts (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "cah-20210630.htm",
      "contextRef": "i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R11": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20210630.htm",
      "contextRef": "i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "cah:LeasesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210291005 - Disclosure - Leases",
     "role": "http://www.cardinal.com/role/Leases",
     "shortName": "Leases",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20210630.htm",
      "contextRef": "i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "cah:LeasesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R12": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20210630.htm",
      "contextRef": "i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210361006 - Disclosure - Long-Term Obligations and Other Short-Term Borrowings",
     "role": "http://www.cardinal.com/role/LongTermObligationsandOtherShortTermBorrowings",
     "shortName": "Long-Term Obligations and Other Short-Term Borrowings",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20210630.htm",
      "contextRef": "i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R13": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20210630.htm",
      "contextRef": "i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210421007 - Disclosure - Commitments, Contingent Liabilities and Litigation",
     "role": "http://www.cardinal.com/role/CommitmentsContingentLiabilitiesandLitigation",
     "shortName": "Commitments, Contingent Liabilities and Litigation",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20210630.htm",
      "contextRef": "i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R14": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20210630.htm",
      "contextRef": "i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210441008 - Disclosure - Income Taxes",
     "role": "http://www.cardinal.com/role/IncomeTaxes",
     "shortName": "Income Taxes",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20210630.htm",
      "contextRef": "i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R15": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20210630.htm",
      "contextRef": "i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueMeasurementInputsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210541010 - Disclosure - Fair Value Measurements",
     "role": "http://www.cardinal.com/role/FairValueMeasurements",
     "shortName": "Fair Value Measurements",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20210630.htm",
      "contextRef": "i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueMeasurementInputsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R16": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20210630.htm",
      "contextRef": "i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FinancialInstrumentsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210591011 - Disclosure - Financial Instruments",
     "role": "http://www.cardinal.com/role/FinancialInstruments",
     "shortName": "Financial Instruments",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20210630.htm",
      "contextRef": "i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FinancialInstrumentsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R17": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20210630.htm",
      "contextRef": "i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210721012 - Disclosure - Shareholders' Equity",
     "role": "http://www.cardinal.com/role/ShareholdersEquity",
     "shortName": "Shareholders' Equity",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20210630.htm",
      "contextRef": "i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R18": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20210630.htm",
      "contextRef": "i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210761013 - Disclosure - Earnings Per Share Attributable to Cardinal Health, Inc.",
     "role": "http://www.cardinal.com/role/EarningsPerShareAttributabletoCardinalHealthInc",
     "shortName": "Earnings Per Share Attributable to Cardinal Health, Inc.",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20210630.htm",
      "contextRef": "i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R19": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20210630.htm",
      "contextRef": "i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210801014 - Disclosure - Segment Information",
     "role": "http://www.cardinal.com/role/SegmentInformation",
     "shortName": "Segment Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20210630.htm",
      "contextRef": "i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R2": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:RevenueFromExternalCustomersByGeographicAreasTableTextBlock",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20210630.htm",
      "contextRef": "i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Revenues",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "100010002 - Statement - Consolidated Statements of Earnings",
     "role": "http://www.cardinal.com/role/ConsolidatedStatementsofEarnings",
     "shortName": "Consolidated Statements of Earnings",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20210630.htm",
      "contextRef": "i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:GrossProfit",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R20": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20210630.htm",
      "contextRef": "i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210881015 - Disclosure - Share-Based Compensation",
     "role": "http://www.cardinal.com/role/ShareBasedCompensation",
     "shortName": "Share-Based Compensation",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20210630.htm",
      "contextRef": "i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R21": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "cah-20210630.htm",
      "contextRef": "i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210991016 - Disclosure - Schedule II - Valuations and Qualifying Accounts",
     "role": "http://www.cardinal.com/role/ScheduleIIValuationsandQualifyingAccounts",
     "shortName": "Schedule II - Valuations and Qualifying Accounts",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "cah-20210630.htm",
      "contextRef": "i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R22": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20210630.htm",
      "contextRef": "i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "220022001 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Policies)",
     "role": "http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies",
     "shortName": "Basis of Presentation and Summary of Significant Accounting Policies (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20210630.htm",
      "contextRef": "i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R23": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:MajorCustomersPolicyPolicyTextBlock",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20210630.htm",
      "contextRef": "i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "230033001 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Tables)",
     "role": "http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesTables",
     "shortName": "Basis of Presentation and Summary of Significant Accounting Policies (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:MajorCustomersPolicyPolicyTextBlock",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20210630.htm",
      "contextRef": "i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R24": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:BusinessCombinationDisclosureTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20210630.htm",
      "contextRef": "i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "230183002 - Disclosure - Divestitures and Acquisitions (Tables)",
     "role": "http://www.cardinal.com/role/DivestituresandAcquisitionsTables",
     "shortName": "Divestitures and Acquisitions (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:BusinessCombinationDisclosureTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20210630.htm",
      "contextRef": "i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R25": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20210630.htm",
      "contextRef": "i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "230213003 - Disclosure - Restructuring and Employee Severance (Tables)",
     "role": "http://www.cardinal.com/role/RestructuringandEmployeeSeveranceTables",
     "shortName": "Restructuring and Employee Severance (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20210630.htm",
      "contextRef": "i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R26": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20210630.htm",
      "contextRef": "i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfGoodwillTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "230253004 - Disclosure - Goodwill and Other Intangible Assets (Tables)",
     "role": "http://www.cardinal.com/role/GoodwillandOtherIntangibleAssetsTables",
     "shortName": "Goodwill and Other Intangible Assets (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20210630.htm",
      "contextRef": "i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfGoodwillTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R27": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "cah:LeasesTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20210630.htm",
      "contextRef": "i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LeaseCostTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "230303005 - Disclosure - Leases (Tables)",
     "role": "http://www.cardinal.com/role/LeasesTables",
     "shortName": "Leases (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "cah:LeasesTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20210630.htm",
      "contextRef": "i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LeaseCostTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R28": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:DebtDisclosureTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20210630.htm",
      "contextRef": "i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDebtTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "230373006 - Disclosure - Long-Term Obligations and Other Short-Term Borrowings (Tables)",
     "role": "http://www.cardinal.com/role/LongTermObligationsandOtherShortTermBorrowingsTables",
     "shortName": "Long-Term Obligations and Other Short-Term Borrowings (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:DebtDisclosureTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20210630.htm",
      "contextRef": "i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDebtTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R29": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20210630.htm",
      "contextRef": "i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "230453007 - Disclosure - Income Taxes (Tables)",
     "role": "http://www.cardinal.com/role/IncomeTaxesTables",
     "shortName": "Income Taxes (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20210630.htm",
      "contextRef": "i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R3": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20210630.htm",
      "contextRef": "i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProfitLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "100020003 - Statement - Consolidated Statements of Comprehensive Income",
     "role": "http://www.cardinal.com/role/ConsolidatedStatementsofComprehensiveIncome",
     "shortName": "Consolidated Statements of Comprehensive Income",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20210630.htm",
      "contextRef": "i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R30": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:FairValueDisclosuresTextBlock",
       "us-gaap:FairValueMeasurementInputsDisclosureTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20210630.htm",
      "contextRef": "i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "230553008 - Disclosure - Fair Value Measurements (Tables)",
     "role": "http://www.cardinal.com/role/FairValueMeasurementsTables",
     "shortName": "Fair Value Measurements (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:FairValueDisclosuresTextBlock",
       "us-gaap:FairValueMeasurementInputsDisclosureTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20210630.htm",
      "contextRef": "i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R31": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20210630.htm",
      "contextRef": "i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "230603009 - Disclosure - Financial Instruments (Tables)",
     "role": "http://www.cardinal.com/role/FinancialInstrumentsTables",
     "shortName": "Financial Instruments (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20210630.htm",
      "contextRef": "i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R32": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20210630.htm",
      "contextRef": "i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "230733010 - Disclosure - Shareholders' Equity (Tables)",
     "role": "http://www.cardinal.com/role/ShareholdersEquityTables",
     "shortName": "Shareholders' Equity (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20210630.htm",
      "contextRef": "i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R33": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:EarningsPerShareTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20210630.htm",
      "contextRef": "i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfWeightedAverageNumberOfSharesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "230773011 - Disclosure - Earnings Per Share Attributable to Cardinal Health, Inc. (Tables)",
     "role": "http://www.cardinal.com/role/EarningsPerShareAttributabletoCardinalHealthIncTables",
     "shortName": "Earnings Per Share Attributable to Cardinal Health, Inc. (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:EarningsPerShareTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20210630.htm",
      "contextRef": "i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfWeightedAverageNumberOfSharesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R34": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20210630.htm",
      "contextRef": "i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "230813012 - Disclosure - Segment Information (Tables)",
     "role": "http://www.cardinal.com/role/SegmentInformationTables",
     "shortName": "Segment Information (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20210630.htm",
      "contextRef": "i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R35": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20210630.htm",
      "contextRef": "i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "230893013 - Disclosure - Share-Based Compensation (Tables)",
     "role": "http://www.cardinal.com/role/ShareBasedCompensationTables",
     "shortName": "Share-Based Compensation (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20210630.htm",
      "contextRef": "i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R36": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "cah-20210630.htm",
      "contextRef": "i2e87824102b34590a0208cc7da91b5f5_I20210630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ValuationAllowancesAndReservesBalance",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240044001 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Narrative, Receivables) (Details)",
     "role": "http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeReceivablesDetails",
     "shortName": "Basis of Presentation and Summary of Significant Accounting Policies (Narrative, Receivables) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "div",
       "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20210630.htm",
      "contextRef": "i2e87824102b34590a0208cc7da91b5f5_I20210630",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:NotesReceivableNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R37": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock",
       "us-gaap:MajorCustomersPolicyPolicyTextBlock",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20210630.htm",
      "contextRef": "i8e11ba21ea4c434ca0730a61f91af07b_I20210630",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "cah:GrossTradeReceivablesMajorCustomerPercentage",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240054002 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Revenue and Gross Trade Receivables Percentage by Major Customers) (Details)",
     "role": "http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesRevenueandGrossTradeReceivablesPercentagebyMajorCustomersDetails",
     "shortName": "Basis of Presentation and Summary of Significant Accounting Policies (Revenue and Gross Trade Receivables Percentage by Major Customers) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock",
       "us-gaap:MajorCustomersPolicyPolicyTextBlock",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20210630.htm",
      "contextRef": "i8e11ba21ea4c434ca0730a61f91af07b_I20210630",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "cah:GrossTradeReceivablesMajorCustomerPercentage",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R38": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20210630.htm",
      "contextRef": "i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "cah:ConcentrationRiskLargestGroupPurchasingOrganizations",
      "reportCount": 1,
      "unique": true,
      "unitRef": "organization",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240064003 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Narrative, Major Customers) (Details)",
     "role": "http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeMajorCustomersDetails",
     "shortName": "Basis of Presentation and Summary of Significant Accounting Policies (Narrative, Major Customers) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20210630.htm",
      "contextRef": "i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "cah:ConcentrationRiskLargestGroupPurchasingOrganizations",
      "reportCount": 1,
      "unique": true,
      "unitRef": "organization",
      "xsiNil": "false"
     }
    },
    "R39": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:InventoryPolicyTextBlock",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20210630.htm",
      "contextRef": "i2e87824102b34590a0208cc7da91b5f5_I20210630",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PercentageOfLIFOInventory",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240074004 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Narrative, Inventories) (Details)",
     "role": "http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeInventoriesDetails",
     "shortName": "Basis of Presentation and Summary of Significant Accounting Policies (Narrative, Inventories) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:InventoryPolicyTextBlock",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20210630.htm",
      "contextRef": "i2e87824102b34590a0208cc7da91b5f5_I20210630",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PercentageOfLIFOInventory",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R4": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20210630.htm",
      "contextRef": "i2e87824102b34590a0208cc7da91b5f5_I20210630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "100030004 - Statement - Consolidated Balance Sheets",
     "role": "http://www.cardinal.com/role/ConsolidatedBalanceSheets",
     "shortName": "Consolidated Balance Sheets",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20210630.htm",
      "contextRef": "i2e87824102b34590a0208cc7da91b5f5_I20210630",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:ReceivablesNetCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R40": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20210630.htm",
      "contextRef": "i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Depreciation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240084005 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Narrative, Property and Equipment) (Details)",
     "role": "http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativePropertyandEquipmentDetails",
     "shortName": "Basis of Presentation and Summary of Significant Accounting Policies (Narrative, Property and Equipment) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20210630.htm",
      "contextRef": "i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Depreciation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R41": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20210630.htm",
      "contextRef": "i2e87824102b34590a0208cc7da91b5f5_I20210630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240094006 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Components of Property and Equipment) (Details)",
     "role": "http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesComponentsofPropertyandEquipmentDetails",
     "shortName": "Basis of Presentation and Summary of Significant Accounting Policies (Components of Property and Equipment) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20210630.htm",
      "contextRef": "i2e87824102b34590a0208cc7da91b5f5_I20210630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R42": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:NumberOfReportableSegments",
       "span",
       "div",
       "us-gaap:SegmentReportingDisclosureTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20210630.htm",
      "contextRef": "i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NumberOfOperatingSegments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "segment",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240104007 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Narrative, Goodwill and Other Intangible Assets) (Details)",
     "role": "http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeGoodwillandOtherIntangibleAssetsDetails",
     "shortName": "Basis of Presentation and Summary of Significant Accounting Policies (Narrative, Goodwill and Other Intangible Assets) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:NumberOfReportableSegments",
       "span",
       "div",
       "us-gaap:SegmentReportingDisclosureTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20210630.htm",
      "contextRef": "i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NumberOfOperatingSegments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "segment",
      "xsiNil": "false"
     }
    },
    "R43": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "cah:CostofSalesVendorReservesPolicyPolicyTextBlock",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20210630.htm",
      "contextRef": "i2e87824102b34590a0208cc7da91b5f5_I20210630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "cah:VendorReserves",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240124009 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Narrative, Vendor Reserves) (Details)",
     "role": "http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeVendorReservesDetails",
     "shortName": "Basis of Presentation and Summary of Significant Accounting Policies (Narrative, Vendor Reserves) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "cah:CostofSalesVendorReservesPolicyPolicyTextBlock",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20210630.htm",
      "contextRef": "i2e87824102b34590a0208cc7da91b5f5_I20210630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "cah:VendorReserves",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R44": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "cah:DividendsPolicyPolicyTextBlock",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20210630.htm",
      "contextRef": "i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockDividendsPerShareCashPaid",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240134010 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Narrative, Dividends) (Details)",
     "role": "http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDividendsDetails",
     "shortName": "Basis of Presentation and Summary of Significant Accounting Policies (Narrative, Dividends) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "cah:DividendsPolicyPolicyTextBlock",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20210630.htm",
      "contextRef": "i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockDividendsPerShareCashPaid",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     }
    },
    "R45": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20210630.htm",
      "contextRef": "i2e87824102b34590a0208cc7da91b5f5_I20210630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "cah:RevenueRecognitionReserveforSalesReturnsandAllowances",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240144011 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Narrative, Sales Returns and Allowances) (Details)",
     "role": "http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeSalesReturnsandAllowancesDetails",
     "shortName": "Basis of Presentation and Summary of Significant Accounting Policies (Narrative, Sales Returns and Allowances) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20210630.htm",
      "contextRef": "i2e87824102b34590a0208cc7da91b5f5_I20210630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "cah:RevenueRecognitionReserveforSalesReturnsandAllowances",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R46": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20210630.htm",
      "contextRef": "i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SellingGeneralAndAdministrativeExpense",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240154012 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Narrative, Shipping and Handling) (Details)",
     "role": "http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeShippingandHandlingDetails",
     "shortName": "Basis of Presentation and Summary of Significant Accounting Policies (Narrative, Shipping and Handling) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20210630.htm",
      "contextRef": "ic3592f06406544abac446d0e612f00d3_D20200701-20210630",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:SellingGeneralAndAdministrativeExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R47": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20210630.htm",
      "contextRef": "i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GainLossRelatedToLitigationSettlement",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240164013 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies Loss Contingencies (Details)",
     "role": "http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesLossContingenciesDetails",
     "shortName": "Basis of Presentation and Summary of Significant Accounting Policies Loss Contingencies (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R48": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20210630.htm",
      "contextRef": "i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240194014 - Disclosure - Divestitures and Acquisitions (Narrative) (Details)",
     "role": "http://www.cardinal.com/role/DivestituresandAcquisitionsNarrativeDetails",
     "shortName": "Divestitures and Acquisitions (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20210630.htm",
      "contextRef": "ia31e9a409b874bb19d0ff6f2f39ecc09_D20190701-20200630",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:IncomeLossFromEquityMethodInvestments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R49": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock",
       "us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20210630.htm",
      "contextRef": "i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SeveranceCosts1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240224015 - Disclosure - Restructuring and Employee Severance (Activity Related to Restructuring and Employee Severance Costs) (Details)",
     "role": "http://www.cardinal.com/role/RestructuringandEmployeeSeveranceActivityRelatedtoRestructuringandEmployeeSeveranceCostsDetails",
     "shortName": "Restructuring and Employee Severance (Activity Related to Restructuring and Employee Severance Costs) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock",
       "us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20210630.htm",
      "contextRef": "i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SeveranceCosts1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R5": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20210630.htm",
      "contextRef": "i00a6d666bf604826b24e68ddbd63eac4_D20180701-20190630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "100050006 - Statement - Consolidated Statements of Shareholders' Equity",
     "role": "http://www.cardinal.com/role/ConsolidatedStatementsofShareholdersEquity",
     "shortName": "Consolidated Statements of Shareholders' Equity",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20210630.htm",
      "contextRef": "i368e27a25f8645faa683a133e4fd114e_D20180701-20190630",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R50": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20210630.htm",
      "contextRef": "i299cea70f47b4fbe96772aaa8cc00b79_I20200630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestructuringReserve",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240234016 - Disclosure - Restructuring and Employee Severance (Liabilities Associated with Restructuring and Employee Severance Activities) (Details)",
     "role": "http://www.cardinal.com/role/RestructuringandEmployeeSeveranceLiabilitiesAssociatedwithRestructuringandEmployeeSeveranceActivitiesDetails",
     "shortName": "Restructuring and Employee Severance (Liabilities Associated with Restructuring and Employee Severance Activities) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20210630.htm",
      "contextRef": "if6dc09eec4e74751b47cdf037a5b1860_I20190630",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:RestructuringReserve",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R51": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfGoodwillTextBlock",
       "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20210630.htm",
      "contextRef": "i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillTransfers",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240264017 - Disclosure - Goodwill and Other Intangible Assets (Schedule of Goodwill by Reportable Segment) (Details)",
     "role": "http://www.cardinal.com/role/GoodwillandOtherIntangibleAssetsScheduleofGoodwillbyReportableSegmentDetails",
     "shortName": "Goodwill and Other Intangible Assets (Schedule of Goodwill by Reportable Segment) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfGoodwillTextBlock",
       "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20210630.htm",
      "contextRef": "i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillTransfers",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R52": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
       "us-gaap:ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20210630.htm",
      "contextRef": "i2e87824102b34590a0208cc7da91b5f5_I20210630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240274018 - Disclosure - Goodwill and Other Intangible Assets (Schedule of Intangible Assets) (Details)",
     "role": "http://www.cardinal.com/role/GoodwillandOtherIntangibleAssetsScheduleofIntangibleAssetsDetails",
     "shortName": "Goodwill and Other Intangible Assets (Schedule of Intangible Assets) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
       "us-gaap:ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20210630.htm",
      "contextRef": "i2e87824102b34590a0208cc7da91b5f5_I20210630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R53": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfGoodwillTextBlock",
       "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20210630.htm",
      "contextRef": "i2e87824102b34590a0208cc7da91b5f5_I20210630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Goodwill",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240284019 - Disclosure - Goodwill and Other Intangible Assets (Narrative) (Details)",
     "role": "http://www.cardinal.com/role/GoodwillandOtherIntangibleAssetsNarrativeDetails",
     "shortName": "Goodwill and Other Intangible Assets (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20210630.htm",
      "contextRef": "i2e87824102b34590a0208cc7da91b5f5_I20210630",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R54": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "div",
       "cah:LeasesTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20210630.htm",
      "contextRef": "i00a6d666bf604826b24e68ddbd63eac4_D20180701-20190630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LeaseAndRentalExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240314020 - Disclosure - Leases (Details)",
     "role": "http://www.cardinal.com/role/LeasesDetails",
     "shortName": "Leases (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "div",
       "cah:LeasesTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20210630.htm",
      "contextRef": "i00a6d666bf604826b24e68ddbd63eac4_D20180701-20190630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LeaseAndRentalExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R55": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LeaseCostTableTextBlock",
       "div",
       "cah:LeasesTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20210630.htm",
      "contextRef": "i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseCost",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240324021 - Disclosure - Leases Schedule of Lease Costs (Details)",
     "role": "http://www.cardinal.com/role/LeasesScheduleofLeaseCostsDetails",
     "shortName": "Leases Schedule of Lease Costs (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LeaseCostTableTextBlock",
       "div",
       "cah:LeasesTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20210630.htm",
      "contextRef": "i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseCost",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R56": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "div",
       "cah:LeasesTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20210630.htm",
      "contextRef": "i2e87824102b34590a0208cc7da91b5f5_I20210630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseLiability",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240334022 - Disclosure - Leases Supplemental Balance Sheet Information (Details)",
     "role": "http://www.cardinal.com/role/LeasesSupplementalBalanceSheetInformationDetails",
     "shortName": "Leases Supplemental Balance Sheet Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "div",
       "cah:LeasesTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20210630.htm",
      "contextRef": "i2e87824102b34590a0208cc7da91b5f5_I20210630",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:FinanceLeaseLiabilityNoncurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R57": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "cah:LeasePaymentsTableTextBlock",
       "div",
       "cah:LeasesTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20210630.htm",
      "contextRef": "i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeasePayments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240344023 - Disclosure - Leases Supplemental Cash Flow Information (Details)",
     "role": "http://www.cardinal.com/role/LeasesSupplementalCashFlowInformationDetails",
     "shortName": "Leases Supplemental Cash Flow Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "cah:LeasePaymentsTableTextBlock",
       "div",
       "cah:LeasesTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20210630.htm",
      "contextRef": "i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeasePayments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R58": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20210630.htm",
      "contextRef": "i2e87824102b34590a0208cc7da91b5f5_I20210630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "cah:LesseeLeaseLiabilityPaymentsDueYearTwo",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240354024 - Disclosure - Leases Schedule of Future Lease Payments (Details)",
     "role": "http://www.cardinal.com/role/LeasesScheduleofFutureLeasePaymentsDetails",
     "shortName": "Leases Schedule of Future Lease Payments (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20210630.htm",
      "contextRef": "i2e87824102b34590a0208cc7da91b5f5_I20210630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "cah:LesseeLeaseLiabilityPaymentsDueYearTwo",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R59": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20210630.htm",
      "contextRef": "i2e87824102b34590a0208cc7da91b5f5_I20210630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccountsPayableCurrent",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240384025 - Disclosure - Long-Term Obligations and Other Short-Term Borrowings Summary of Debt (Details)",
     "role": "http://www.cardinal.com/role/LongTermObligationsandOtherShortTermBorrowingsSummaryofDebtDetails",
     "shortName": "Long-Term Obligations and Other Short-Term Borrowings Summary of Debt (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDebtTableTextBlock",
       "us-gaap:DebtDisclosureTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20210630.htm",
      "contextRef": "i6040899ecc9f44f893d3f559f74eb30e_I20210630",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:NotesPayable",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R6": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20210630.htm",
      "contextRef": "i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProfitLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "100060007 - Statement - Consolidated Statements of Cash Flows",
     "role": "http://www.cardinal.com/role/ConsolidatedStatementsofCashFlows",
     "shortName": "Consolidated Statements of Cash Flows",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20210630.htm",
      "contextRef": "i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:GainLossOnSaleOfOtherInvestments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R60": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20210630.htm",
      "contextRef": "i2e87824102b34590a0208cc7da91b5f5_I20210630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccountsPayableCurrent",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240394026 - Disclosure - Long-Term Obligations and Other Short-Term Borrowings Narrative (Details)",
     "role": "http://www.cardinal.com/role/LongTermObligationsandOtherShortTermBorrowingsNarrativeDetails",
     "shortName": "Long-Term Obligations and Other Short-Term Borrowings Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20210630.htm",
      "contextRef": "i299cea70f47b4fbe96772aaa8cc00b79_I20200630",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:AccountsPayableCurrentAndNoncurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R61": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20210630.htm",
      "contextRef": "i2e87824102b34590a0208cc7da91b5f5_I20210630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccountsPayableCurrent",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240404027 - Disclosure - Long-Term Obligations and Other Short-Term Borrowings Long-Term Debt (Details)",
     "role": "http://www.cardinal.com/role/LongTermObligationsandOtherShortTermBorrowingsLongTermDebtDetails",
     "shortName": "Long-Term Obligations and Other Short-Term Borrowings Long-Term Debt (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20210630.htm",
      "contextRef": "i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630",
      "decimals": "INF",
      "lang": "en-US",
      "name": "cah:OfferAsPercentageOfPrincipalAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R62": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20210630.htm",
      "contextRef": "i2e87824102b34590a0208cc7da91b5f5_I20210630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherBorrowings",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240414028 - Disclosure - Long-Term Obligations and Other Short-Term Borrowings Other Financing Arrangements (Details)",
     "role": "http://www.cardinal.com/role/LongTermObligationsandOtherShortTermBorrowingsOtherFinancingArrangementsDetails",
     "shortName": "Long-Term Obligations and Other Short-Term Borrowings Other Financing Arrangements (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20210630.htm",
      "contextRef": "i2085dadd50db412cae65d5356e28138c_I20210630",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:OtherShortTermBorrowings",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R63": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20210630.htm",
      "contextRef": "i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "cah:IncomefromSettlementsofClassActionLawsuits",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240434029 - Disclosure - Commitments, Contingent Liabilities and Litigation (Details)",
     "role": "http://www.cardinal.com/role/CommitmentsContingentLiabilitiesandLitigationDetails",
     "shortName": "Commitments, Contingent Liabilities and Litigation (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20210630.htm",
      "contextRef": "i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "cah:IncomefromSettlementsofClassActionLawsuits",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R64": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20210630.htm",
      "contextRef": "i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240464030 - Disclosure - Income Taxes (Schedule of Income before Income Tax, Domestic and Foreign) (Details)",
     "role": "http://www.cardinal.com/role/IncomeTaxesScheduleofIncomebeforeIncomeTaxDomesticandForeignDetails",
     "shortName": "Income Taxes (Schedule of Income before Income Tax, Domestic and Foreign) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20210630.htm",
      "contextRef": "i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R65": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20210630.htm",
      "contextRef": "i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CurrentFederalTaxExpenseBenefit",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240474031 - Disclosure - Income Taxes (Schedule of Components of Income Tax Expense (Benefit), Current and Deferred) (Details)",
     "role": "http://www.cardinal.com/role/IncomeTaxesScheduleofComponentsofIncomeTaxExpenseBenefitCurrentandDeferredDetails",
     "shortName": "Income Taxes (Schedule of Components of Income Tax Expense (Benefit), Current and Deferred) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R66": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20210630.htm",
      "contextRef": "i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630",
      "decimals": "3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate",
      "reportCount": 1,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240484032 - Disclosure - Income Taxes (Schedule of Effective Income Tax Rate Reconciliation) (Details)",
     "role": "http://www.cardinal.com/role/IncomeTaxesScheduleofEffectiveIncomeTaxRateReconciliationDetails",
     "shortName": "Income Taxes (Schedule of Effective Income Tax Rate Reconciliation) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20210630.htm",
      "contextRef": "i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630",
      "decimals": "3",
      "lang": "en-US",
      "name": "us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R67": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20210630.htm",
      "contextRef": "i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630",
      "decimals": "3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EffectiveIncomeTaxRateContinuingOperations",
      "reportCount": 1,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240494033 - Disclosure - Income Taxes (Narrative) (Details)",
     "role": "http://www.cardinal.com/role/IncomeTaxesNarrativeDetails",
     "shortName": "Income Taxes (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20210630.htm",
      "contextRef": "i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630",
      "decimals": "-6",
      "lang": "en-US",
      "name": "cah:EffectiveTaxRateImpactFromCertainForeignJurisdictions",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R68": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20210630.htm",
      "contextRef": "i2e87824102b34590a0208cc7da91b5f5_I20210630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240504034 - Disclosure - Income Taxes (Schedule of Deferred Tax Assets and Liabilities) (Details)",
     "role": "http://www.cardinal.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails",
     "shortName": "Income Taxes (Schedule of Deferred Tax Assets and Liabilities) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20210630.htm",
      "contextRef": "i2e87824102b34590a0208cc7da91b5f5_I20210630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R69": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "cah:ScheduleOfDeferredTaxAssetsAndLiabilitiesAfterNettingByTaxJurisdictionTableTextBlock",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20210630.htm",
      "contextRef": "i2e87824102b34590a0208cc7da91b5f5_I20210630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DeferredIncomeTaxesAndOtherAssetsNoncurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240514035 - Disclosure - Income Taxes (Schedule of Deferred Tax Assets and Liabilities After Netting by Tax Jurisdiction) (Details)",
     "role": "http://www.cardinal.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesAfterNettingbyTaxJurisdictionDetails",
     "shortName": "Income Taxes (Schedule of Deferred Tax Assets and Liabilities After Netting by Tax Jurisdiction) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "cah:ScheduleOfDeferredTaxAssetsAndLiabilitiesAfterNettingByTaxJurisdictionTableTextBlock",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20210630.htm",
      "contextRef": "i2e87824102b34590a0208cc7da91b5f5_I20210630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DeferredIncomeTaxesAndOtherAssetsNoncurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R7": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20210630.htm",
      "contextRef": "i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210011001 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies",
     "role": "http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPolicies",
     "shortName": "Basis of Presentation and Summary of Significant Accounting Policies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20210630.htm",
      "contextRef": "i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R70": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20210630.htm",
      "contextRef": "i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CurrentFederalTaxExpenseBenefit",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240524036 - Disclosure - Income Taxes (Schedule of Unrecognized Tax Benefits Roll Forward) (Details)",
     "role": "http://www.cardinal.com/role/IncomeTaxesScheduleofUnrecognizedTaxBenefitsRollForwardDetails",
     "shortName": "Income Taxes (Schedule of Unrecognized Tax Benefits Roll Forward) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20210630.htm",
      "contextRef": "i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R71": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20210630.htm",
      "contextRef": "i2e87824102b34590a0208cc7da91b5f5_I20210630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperation",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240564037 - Disclosure - Fair Value Measurements (Fair Value of Assets and Liabilities Measured on a Recurring Basis) (Details)",
     "role": "http://www.cardinal.com/role/FairValueMeasurementsFairValueofAssetsandLiabilitiesMeasuredonaRecurringBasisDetails",
     "shortName": "Fair Value Measurements (Fair Value of Assets and Liabilities Measured on a Recurring Basis) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
       "us-gaap:FairValueDisclosuresTextBlock",
       "us-gaap:FairValueMeasurementInputsDisclosureTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20210630.htm",
      "contextRef": "i53e687ceccba4bac9c2829e01e82f358_I20210630",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsFairValueDisclosure",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R72": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
       "us-gaap:FairValueDisclosuresTextBlock",
       "us-gaap:FairValueMeasurementInputsDisclosureTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20210630.htm",
      "contextRef": "i53e687ceccba4bac9c2829e01e82f358_I20210630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeAssetsLiabilitiesAtFairValueNet",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240574038 - Disclosure - Fair Value Measurements (Reconciliation of Liabilities Measured at Fair Value on a Recurring Basis Using Unobservable Inputs (Level 3)) (Details)",
     "role": "http://www.cardinal.com/role/FairValueMeasurementsReconciliationofLiabilitiesMeasuredatFairValueonaRecurringBasisUsingUnobservableInputsLevel3Details",
     "shortName": "Fair Value Measurements (Reconciliation of Liabilities Measured at Fair Value on a Recurring Basis Using Unobservable Inputs (Level 3)) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R73": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20210630.htm",
      "contextRef": "i2e87824102b34590a0208cc7da91b5f5_I20210630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240584039 - Disclosure - Fair Value Measurements (Details)",
     "role": "http://www.cardinal.com/role/FairValueMeasurementsDetails",
     "shortName": "Fair Value Measurements (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R74": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20210630.htm",
      "contextRef": "i2e87824102b34590a0208cc7da91b5f5_I20210630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeFairValueOfDerivativeAsset",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240614040 - Disclosure - Financial Instruments (Schedule of the Fair Value of Assets and Liabilities Related to Derivatives Designated as Hedging Instruments) (Details)",
     "role": "http://www.cardinal.com/role/FinancialInstrumentsScheduleoftheFairValueofAssetsandLiabilitiesRelatedtoDerivativesDesignatedasHedgingInstrumentsDetails",
     "shortName": "Financial Instruments (Schedule of the Fair Value of Assets and Liabilities Related to Derivatives Designated as Hedging Instruments) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20210630.htm",
      "contextRef": "i2e87824102b34590a0208cc7da91b5f5_I20210630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeFairValueOfDerivativeAsset",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R75": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20210630.htm",
      "contextRef": "i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240624041 - Disclosure - Financial Instruments (Narrative) (Details)",
     "role": "http://www.cardinal.com/role/FinancialInstrumentsNarrativeDetails",
     "shortName": "Financial Instruments (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20210630.htm",
      "contextRef": "i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R76": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20210630.htm",
      "contextRef": "i69a44d9974c04cc3abf8c7aeb68f22c6_I20210630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DeferredGainLossOnDiscontinuationOfInterestRateFairValueHedge",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240634042 - Disclosure - Financial Instruments (Schedule of Outstanding Instruments, Fair Value Hedges) (Details)",
     "role": "http://www.cardinal.com/role/FinancialInstrumentsScheduleofOutstandingInstrumentsFairValueHedgesDetails",
     "shortName": "Financial Instruments (Schedule of Outstanding Instruments, Fair Value Hedges) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R77": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20210630.htm",
      "contextRef": "i17248417fcbc4d118aebc5dfbe183bfc_D20200701-20210630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeGainLossOnDerivativeNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240644043 - Disclosure - Financial Instruments (Schedule of Gain/(Loss) Recognized in Earnings for Interest Rate Contracts Designated as Fair Value Hedges) (Details)",
     "role": "http://www.cardinal.com/role/FinancialInstrumentsScheduleofGainLossRecognizedinEarningsforInterestRateContractsDesignatedasFairValueHedgesDetails",
     "shortName": "Financial Instruments (Schedule of Gain/(Loss) Recognized in Earnings for Interest Rate Contracts Designated as Fair Value Hedges) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20210630.htm",
      "contextRef": "i17248417fcbc4d118aebc5dfbe183bfc_D20200701-20210630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeGainLossOnDerivativeNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R78": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20210630.htm",
      "contextRef": "i58c9aa5163a64897b2ad19c7f47190d0_I20200630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeLiabilityNotionalAmount",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240654044 - Disclosure - Financial Instruments (Schedule of Outstanding Instruments, Cash Flow Hedges) (Details)",
     "role": "http://www.cardinal.com/role/FinancialInstrumentsScheduleofOutstandingInstrumentsCashFlowHedgesDetails",
     "shortName": "Financial Instruments (Schedule of Outstanding Instruments, Cash Flow Hedges) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDerivativeInstrumentsTextBlock",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20210630.htm",
      "contextRef": "i4de6f0288abd431bbc839b56b68b328b_I20200630",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:DerivativeAssetNotionalAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R79": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDerivativeInstrumentsEffectOnOtherComprehensiveIncomeLossTableTextBlock",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20210630.htm",
      "contextRef": "i405b6b2ebdbb4b00959f5be8d40c1adb_D20200701-20210630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240664045 - Disclosure - Financial Instruments (Schedule of Gain/(Loss) Included in AOCI for Derivative Instruments Designated as Cash Flow Hedges) (Details)",
     "role": "http://www.cardinal.com/role/FinancialInstrumentsScheduleofGainLossIncludedinAOCIforDerivativeInstrumentsDesignatedasCashFlowHedgesDetails",
     "shortName": "Financial Instruments (Schedule of Gain/(Loss) Included in AOCI for Derivative Instruments Designated as Cash Flow Hedges) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDerivativeInstrumentsEffectOnOtherComprehensiveIncomeLossTableTextBlock",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20210630.htm",
      "contextRef": "i405b6b2ebdbb4b00959f5be8d40c1adb_D20200701-20210630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R8": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20210630.htm",
      "contextRef": "i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210171002 - Disclosure - Divestitures and Acquisitions",
     "role": "http://www.cardinal.com/role/DivestituresandAcquisitions",
     "shortName": "Divestitures and Acquisitions",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20210630.htm",
      "contextRef": "i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R80": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20210630.htm",
      "contextRef": "ibb6fbf503d8d4b92b0852c5ea1309753_D20200701-20210630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240674046 - Disclosure - Financial Instruments (Schedule of Gain/(Loss) Reclassified from AOCI into Earnings for Derivative Instruments Designated as Cash Flow Hedges) (Details)",
     "role": "http://www.cardinal.com/role/FinancialInstrumentsScheduleofGainLossReclassifiedfromAOCIintoEarningsforDerivativeInstrumentsDesignatedasCashFlowHedgesDetails",
     "shortName": "Financial Instruments (Schedule of Gain/(Loss) Reclassified from AOCI into Earnings for Derivative Instruments Designated as Cash Flow Hedges) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20210630.htm",
      "contextRef": "ibb6fbf503d8d4b92b0852c5ea1309753_D20200701-20210630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R81": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDerivativeInstrumentsTextBlock",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20210630.htm",
      "contextRef": "i6ca29000e9a8453b9f0281faeb2f2ed2_I20210630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeAssetNotionalAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240684047 - Disclosure - Financial Instruments (Schedule of Outstanding Instruments, Economic Hedges) (Details)",
     "role": "http://www.cardinal.com/role/FinancialInstrumentsScheduleofOutstandingInstrumentsEconomicHedgesDetails",
     "shortName": "Financial Instruments (Schedule of Outstanding Instruments, Economic Hedges) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDerivativeInstrumentsTextBlock",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20210630.htm",
      "contextRef": "i6ca29000e9a8453b9f0281faeb2f2ed2_I20210630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeAssetNotionalAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R82": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20210630.htm",
      "contextRef": "ifca9e60bdc7a4338aa4de50477f141d8_D20200701-20210630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240694048 - Disclosure - Financial Instruments (Schedule of Gain/(Loss) Recognized in Earnings for Derivatives Not Designated as Hedging Instrument) (Details)",
     "role": "http://www.cardinal.com/role/FinancialInstrumentsScheduleofGainLossRecognizedinEarningsforDerivativesNotDesignatedasHedgingInstrumentDetails",
     "shortName": "Financial Instruments (Schedule of Gain/(Loss) Recognized in Earnings for Derivatives Not Designated as Hedging Instrument) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20210630.htm",
      "contextRef": "ifca9e60bdc7a4338aa4de50477f141d8_D20200701-20210630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R83": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20210630.htm",
      "contextRef": "i2e87824102b34590a0208cc7da91b5f5_I20210630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "cah:CarryingAmountofLongTermandotherShortTermBorrowings",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240704049 - Disclosure - Financial Instruments (Summary of Estimated Fair Value of Long-term Obligations and Other Short-term Borrowings) (Details)",
     "role": "http://www.cardinal.com/role/FinancialInstrumentsSummaryofEstimatedFairValueofLongtermObligationsandOtherShorttermBorrowingsDetails",
     "shortName": "Financial Instruments (Summary of Estimated Fair Value of Long-term Obligations and Other Short-term Borrowings) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20210630.htm",
      "contextRef": "i2e87824102b34590a0208cc7da91b5f5_I20210630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "cah:CarryingAmountofLongTermandotherShortTermBorrowings",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R84": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "cah:ScheduleOfFairValueGainLossDerivativeInstrumentTableTextBlock",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20210630.htm",
      "contextRef": "i04848fa4190a4546999fce3b74a1093a_I20210630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeNotionalAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240714050 - Disclosure - Financial Instruments (Schedule of Fair Value Gain Loss Derivative Instrument) (Details)",
     "role": "http://www.cardinal.com/role/FinancialInstrumentsScheduleofFairValueGainLossDerivativeInstrumentDetails",
     "shortName": "Financial Instruments (Schedule of Fair Value Gain Loss Derivative Instrument) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "cah:ScheduleOfFairValueGainLossDerivativeInstrumentTableTextBlock",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20210630.htm",
      "contextRef": "i04848fa4190a4546999fce3b74a1093a_I20210630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeNotionalAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R85": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20210630.htm",
      "contextRef": "i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:TreasuryStockValueAcquiredCostMethod",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240744051 - Disclosure - Shareholders' Equity (Narrative) (Details)",
     "role": "http://www.cardinal.com/role/ShareholdersEquityNarrativeDetails",
     "shortName": "Shareholders' Equity (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20210630.htm",
      "contextRef": "i0a081dfdf3e846b387ac5e60a2f4e8a5_I20210630",
      "decimals": "INF",
      "lang": "en-US",
      "name": "us-gaap:CommonStockSharesAuthorized",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R86": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20210630.htm",
      "contextRef": "i299cea70f47b4fbe96772aaa8cc00b79_I20200630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240754052 - Disclosure - Shareholders' Equity (Changes in the Accumulated Other Comprehensive Income (Loss)) (Details)",
     "role": "http://www.cardinal.com/role/ShareholdersEquityChangesintheAccumulatedOtherComprehensiveIncomeLossDetails",
     "shortName": "Shareholders' Equity (Changes in the Accumulated Other Comprehensive Income (Loss)) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20210630.htm",
      "contextRef": "i10ebef79cb324951a3c60cf340e5e0c7_D20200701-20210630",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R87": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20210630.htm",
      "contextRef": "i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProfitLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240784053 - Disclosure - Earnings Per Share Attributable to Cardinal Health, Inc. (Reconciliation of Common Shares Used to Compute Basic and Diluted EPS) (Details)",
     "role": "http://www.cardinal.com/role/EarningsPerShareAttributabletoCardinalHealthIncReconciliationofCommonSharesUsedtoComputeBasicandDilutedEPSDetails",
     "shortName": "Earnings Per Share Attributable to Cardinal Health, Inc. (Reconciliation of Common Shares Used to Compute Basic and Diluted EPS) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfWeightedAverageNumberOfSharesTableTextBlock",
       "us-gaap:EarningsPerShareTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20210630.htm",
      "contextRef": "i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R88": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:EarningsPerShareTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20210630.htm",
      "contextRef": "i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240794054 - Disclosure - Earnings Per Share Attributable to Cardinal Health, Inc. (Narrative) (Details)",
     "role": "http://www.cardinal.com/role/EarningsPerShareAttributabletoCardinalHealthIncNarrativeDetails",
     "shortName": "Earnings Per Share Attributable to Cardinal Health, Inc. (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:EarningsPerShareTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20210630.htm",
      "contextRef": "i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R89": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20210630.htm",
      "contextRef": "i00a6d666bf604826b24e68ddbd63eac4_D20180701-20190630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "cah:PreTaxGainonDivestiture",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240824055 - Disclosure - Segment Information (Narrative) (Details)",
     "role": "http://www.cardinal.com/role/SegmentInformationNarrativeDetails",
     "shortName": "Segment Information (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20210630.htm",
      "contextRef": "i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630",
      "decimals": "-6",
      "lang": "en-US",
      "name": "cah:ProjectCostsOnInvestmentAndOtherSpending",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R9": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20210630.htm",
      "contextRef": "i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210201003 - Disclosure - Restructuring and Employee Severance",
     "role": "http://www.cardinal.com/role/RestructuringandEmployeeSeverance",
     "shortName": "Restructuring and Employee Severance",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20210630.htm",
      "contextRef": "i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R90": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:RevenueFromExternalCustomersByGeographicAreasTableTextBlock",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20210630.htm",
      "contextRef": "i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Revenues",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240834056 - Disclosure - Segment Information (Revenue by Reportable Segment) (Details)",
     "role": "http://www.cardinal.com/role/SegmentInformationRevenuebyReportableSegmentDetails",
     "shortName": "Segment Information (Revenue by Reportable Segment) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:RevenueFromExternalCustomersByGeographicAreasTableTextBlock",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20210630.htm",
      "contextRef": "i3d4fc04fd3ba4fe9b28a1f419dbc6b15_D20200701-20210630",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:Revenues",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R91": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20210630.htm",
      "contextRef": "i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240844057 - Disclosure - Segment Information (Segment Profit by Reportable Segment) (Details)",
     "role": "http://www.cardinal.com/role/SegmentInformationSegmentProfitbyReportableSegmentDetails",
     "shortName": "Segment Information (Segment Profit by Reportable Segment) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20210630.htm",
      "contextRef": "ie5f1ec6cee11430ab0571ee6201cd0f7_D20200701-20210630",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:OperatingIncomeLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R92": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20210630.htm",
      "contextRef": "i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DepreciationDepletionAndAmortization",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240854058 - Disclosure - Segment Information (Depreciation and Amortization and Additions to Property and Equipment by Reportable Segment) (Details)",
     "role": "http://www.cardinal.com/role/SegmentInformationDepreciationandAmortizationandAdditionstoPropertyandEquipmentbyReportableSegmentDetails",
     "shortName": "Segment Information (Depreciation and Amortization and Additions to Property and Equipment by Reportable Segment) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ReconciliationOfOtherSignificantReconcilingItemsFromSegmentsToConsolidatedTextBlock",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20210630.htm",
      "contextRef": "i76b6a114dfd6424fb4c07d91075a91ff_D20200701-20210630",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:DepreciationDepletionAndAmortization",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R93": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20210630.htm",
      "contextRef": "i2e87824102b34590a0208cc7da91b5f5_I20210630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Assets",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240864059 - Disclosure - Segment Information (Assets by Reportable Segment) (Details)",
     "role": "http://www.cardinal.com/role/SegmentInformationAssetsbyReportableSegmentDetails",
     "shortName": "Segment Information (Assets by Reportable Segment) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20210630.htm",
      "contextRef": "if6dc09eec4e74751b47cdf037a5b1860_I20190630",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:Assets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R94": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20210630.htm",
      "contextRef": "i2e87824102b34590a0208cc7da91b5f5_I20210630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentNet",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240874060 - Disclosure - Segment Information Property and Equipment, net by Geographic Area) (Details)",
     "role": "http://www.cardinal.com/role/SegmentInformationPropertyandEquipmentnetbyGeographicAreaDetails",
     "shortName": "Segment Information Property and Equipment, net by Geographic Area) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LongLivedAssetsByGeographicAreasTableTextBlock",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20210630.htm",
      "contextRef": "ieb5c5f04a3584568a0813006020736e0_I20210630",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R95": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20210630.htm",
      "contextRef": "i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240904061 - Disclosure - Share-Based Compensation (Narrative) (Details)",
     "role": "http://www.cardinal.com/role/ShareBasedCompensationNarrativeDetails",
     "shortName": "Share-Based Compensation (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20210630.htm",
      "contextRef": "i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R96": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock",
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20210630.htm",
      "contextRef": "i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240914062 - Disclosure - Share-Based Compensation (Schedule of Total Share-Based Compensation Expense by Type of Award) (Details)",
     "role": "http://www.cardinal.com/role/ShareBasedCompensationScheduleofTotalShareBasedCompensationExpensebyTypeofAwardDetails",
     "shortName": "Share-Based Compensation (Schedule of Total Share-Based Compensation Expense by Type of Award) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock",
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20210630.htm",
      "contextRef": "i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R97": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20210630.htm",
      "contextRef": "i299cea70f47b4fbe96772aaa8cc00b79_I20200630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240924063 - Disclosure - Share-Based Compensation (Schedule of All Stock Option Transactions Under the Plans) (Details)",
     "role": "http://www.cardinal.com/role/ShareBasedCompensationScheduleofAllStockOptionTransactionsUnderthePlansDetails",
     "shortName": "Share-Based Compensation (Schedule of All Stock Option Transactions Under the Plans) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20210630.htm",
      "contextRef": "i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R98": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20210630.htm",
      "contextRef": "i8d202c3bdf6c4f3c8a5885a63cf6bb9c_D20200701-20210630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "cah:Netproceedstaxwithholdingsfromsharebasedcompensation",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240934064 - Disclosure - Share-Based Compensation (Schedule of Additional Data Related to Stock Options) (Details)",
     "role": "http://www.cardinal.com/role/ShareBasedCompensationScheduleofAdditionalDataRelatedtoStockOptionsDetails",
     "shortName": "Share-Based Compensation (Schedule of Additional Data Related to Stock Options) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "cah:AdditionalStockOptionPlanDataTableTextBlock",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20210630.htm",
      "contextRef": "ib473c6ce356d4388a73564ce9f41c306_I20210630",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R99": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "cah:RemainingStockOptionPlanDataTableTextBlock",
       "div",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20210630.htm",
      "contextRef": "i9fac2b1e8f484ef081a25d163aa2c3a6_D20200701-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240944065 - Disclosure - Share-Based Compensation Schedule of Remaining Stock Option Plan Data (Details)",
     "role": "http://www.cardinal.com/role/ShareBasedCompensationScheduleofRemainingStockOptionPlanDataDetails",
     "shortName": "Share-Based Compensation Schedule of Remaining Stock Option Plan Data (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "cah:RemainingStockOptionPlanDataTableTextBlock",
       "div",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20210630.htm",
      "contextRef": "i9fac2b1e8f484ef081a25d163aa2c3a6_D20200701-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 128,
   "tag": {
    "cah_A1.948Notesdue2019Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "1.948% Notes due 2019",
        "label": "1.948% Notes due 2019 [Member]",
        "terseLabel": "1.948% Notes due 2019"
       }
      }
     },
     "localname": "A1.948Notesdue2019Member",
     "nsuri": "http://www.cardinal.com/20210630",
     "presentation": [
      "http://www.cardinal.com/role/LongTermObligationsandOtherShortTermBorrowingsLongTermDebtDetails",
      "http://www.cardinal.com/role/LongTermObligationsandOtherShortTermBorrowingsSummaryofDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cah_A2.616Notes3.2Notes3.41Notes4.6Notes4.9Notesand4.368NotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2.616% Notes, 3.2% Notes, 3.41% Notes, 4.6% Notes, 4.9% Notes and 4.368% Notes [Member]",
        "label": "2.616% Notes, 3.2% Notes, 3.41% Notes, 4.6% Notes, 4.9% Notes and 4.368% Notes [Member]",
        "terseLabel": "2.616% Notes, 3.2% Notes, 3.41% Notes, 4.6% Notes, 4.9% Notes and 4.368% Notes [Member]"
       }
      }
     },
     "localname": "A2.616Notes3.2Notes3.41Notes4.6Notes4.9Notesand4.368NotesMember",
     "nsuri": "http://www.cardinal.com/20210630",
     "presentation": [
      "http://www.cardinal.com/role/LongTermObligationsandOtherShortTermBorrowingsLongTermDebtDetails",
      "http://www.cardinal.com/role/LongTermObligationsandOtherShortTermBorrowingsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cah_A2.616Notesdue2022Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2.616% Notes due 2022",
        "label": "2.616% Notes due 2022 [Member]",
        "terseLabel": "2.616% Notes due fiscal 2022"
       }
      }
     },
     "localname": "A2.616Notesdue2022Member",
     "nsuri": "http://www.cardinal.com/20210630",
     "presentation": [
      "http://www.cardinal.com/role/LongTermObligationsandOtherShortTermBorrowingsLongTermDebtDetails",
      "http://www.cardinal.com/role/LongTermObligationsandOtherShortTermBorrowingsNarrativeDetails",
      "http://www.cardinal.com/role/LongTermObligationsandOtherShortTermBorrowingsSummaryofDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cah_A2011LtipMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2011 LTIP [Member]",
        "label": "2011 LTIP [Member]",
        "terseLabel": "2011 LTIP"
       }
      }
     },
     "localname": "A2011LtipMember",
     "nsuri": "http://www.cardinal.com/20210630",
     "presentation": [
      "http://www.cardinal.com/role/ShareBasedCompensationNarrativeDetails",
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleofTotalShareBasedCompensationExpensebyTypeofAwardDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cah_A24NotesDue2019Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2.4% Notes due 2019",
        "label": "2.4% Notes due 2019 [Member]",
        "terseLabel": "2.4% Notes due 2019"
       }
      }
     },
     "localname": "A24NotesDue2019Member",
     "nsuri": "http://www.cardinal.com/20210630",
     "presentation": [
      "http://www.cardinal.com/role/LongTermObligationsandOtherShortTermBorrowingsLongTermDebtDetails",
      "http://www.cardinal.com/role/LongTermObligationsandOtherShortTermBorrowingsNarrativeDetails",
      "http://www.cardinal.com/role/LongTermObligationsandOtherShortTermBorrowingsSummaryofDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cah_A3.079Notesdue2024Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "3.079% Notes due 2024",
        "label": "3.079% Notes due 2024 [Member]",
        "terseLabel": "3.079% Notes due fiscal 2024"
       }
      }
     },
     "localname": "A3.079Notesdue2024Member",
     "nsuri": "http://www.cardinal.com/20210630",
     "presentation": [
      "http://www.cardinal.com/role/LongTermObligationsandOtherShortTermBorrowingsLongTermDebtDetails",
      "http://www.cardinal.com/role/LongTermObligationsandOtherShortTermBorrowingsSummaryofDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cah_A3.2Notesdue2022Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "3.2% Notes due 2022",
        "label": "3.2% Notes due 2022 [Member]",
        "terseLabel": "3.2% Notes due 2022"
       }
      }
     },
     "localname": "A3.2Notesdue2022Member",
     "nsuri": "http://www.cardinal.com/20210630",
     "presentation": [
      "http://www.cardinal.com/role/LongTermObligationsandOtherShortTermBorrowingsLongTermDebtDetails",
      "http://www.cardinal.com/role/LongTermObligationsandOtherShortTermBorrowingsNarrativeDetails",
      "http://www.cardinal.com/role/LongTermObligationsandOtherShortTermBorrowingsSummaryofDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cah_A3.2Notesdue2023Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "3.2% Notes due 2023",
        "label": "3.2% Notes due 2023 [Member]",
        "terseLabel": "3.2% Notes due 2023"
       }
      }
     },
     "localname": "A3.2Notesdue2023Member",
     "nsuri": "http://www.cardinal.com/20210630",
     "presentation": [
      "http://www.cardinal.com/role/LongTermObligationsandOtherShortTermBorrowingsLongTermDebtDetails",
      "http://www.cardinal.com/role/LongTermObligationsandOtherShortTermBorrowingsNarrativeDetails",
      "http://www.cardinal.com/role/LongTermObligationsandOtherShortTermBorrowingsSummaryofDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cah_A3.41Notesdue2027Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "3.41% Notes due 2027",
        "label": "3.41% Notes due 2027 [Member]",
        "terseLabel": "3.41% Notes due fiscal 2027"
       }
      }
     },
     "localname": "A3.41Notesdue2027Member",
     "nsuri": "http://www.cardinal.com/20210630",
     "presentation": [
      "http://www.cardinal.com/role/LongTermObligationsandOtherShortTermBorrowingsLongTermDebtDetails",
      "http://www.cardinal.com/role/LongTermObligationsandOtherShortTermBorrowingsNarrativeDetails",
      "http://www.cardinal.com/role/LongTermObligationsandOtherShortTermBorrowingsSummaryofDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cah_A3.5Notesdue2025Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "3.5% Notes due 2025",
        "label": "3.5% Notes due 2025 [Member]",
        "terseLabel": "3.5% Notes due fiscal 2025"
       }
      }
     },
     "localname": "A3.5Notesdue2025Member",
     "nsuri": "http://www.cardinal.com/20210630",
     "presentation": [
      "http://www.cardinal.com/role/LongTermObligationsandOtherShortTermBorrowingsLongTermDebtDetails",
      "http://www.cardinal.com/role/LongTermObligationsandOtherShortTermBorrowingsSummaryofDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cah_A3.75Notesdue2026Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "3.75% Notes due 2026",
        "label": "3.75% Notes due 2026 [Member]",
        "terseLabel": "3.75% Notes due 2025"
       }
      }
     },
     "localname": "A3.75Notesdue2026Member",
     "nsuri": "http://www.cardinal.com/20210630",
     "presentation": [
      "http://www.cardinal.com/role/LongTermObligationsandOtherShortTermBorrowingsLongTermDebtDetails",
      "http://www.cardinal.com/role/LongTermObligationsandOtherShortTermBorrowingsSummaryofDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cah_A32Notes2616NotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "3.2% notes, 2.616% Notes",
        "label": "3.2% notes, 2.616% Notes [Member]",
        "terseLabel": "3.2% notes, 2.616% Notes"
       }
      }
     },
     "localname": "A32Notes2616NotesMember",
     "nsuri": "http://www.cardinal.com/20210630",
     "presentation": [
      "http://www.cardinal.com/role/LongTermObligationsandOtherShortTermBorrowingsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cah_A4.368Notesdue2047Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "4.368% Notes due 2047",
        "label": "4.368% Notes due 2047 [Member]",
        "terseLabel": "4.368% Notes due fiscal 2047"
       }
      }
     },
     "localname": "A4.368Notesdue2047Member",
     "nsuri": "http://www.cardinal.com/20210630",
     "presentation": [
      "http://www.cardinal.com/role/LongTermObligationsandOtherShortTermBorrowingsLongTermDebtDetails",
      "http://www.cardinal.com/role/LongTermObligationsandOtherShortTermBorrowingsNarrativeDetails",
      "http://www.cardinal.com/role/LongTermObligationsandOtherShortTermBorrowingsSummaryofDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cah_A4.5Notesdue2044Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "4.5% Notes due 2044",
        "label": "4.5% Notes due 2044 [Member]",
        "terseLabel": "4.5% Notes due 2044"
       }
      }
     },
     "localname": "A4.5Notesdue2044Member",
     "nsuri": "http://www.cardinal.com/20210630",
     "presentation": [
      "http://www.cardinal.com/role/LongTermObligationsandOtherShortTermBorrowingsLongTermDebtDetails",
      "http://www.cardinal.com/role/LongTermObligationsandOtherShortTermBorrowingsSummaryofDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cah_A4.625Notesdue2021Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "4.625% Notes due 2021",
        "label": "4.625% Notes due 2021 [Member]",
        "terseLabel": "4.625% Notes due 2020"
       }
      }
     },
     "localname": "A4.625Notesdue2021Member",
     "nsuri": "http://www.cardinal.com/20210630",
     "presentation": [
      "http://www.cardinal.com/role/LongTermObligationsandOtherShortTermBorrowingsLongTermDebtDetails",
      "http://www.cardinal.com/role/LongTermObligationsandOtherShortTermBorrowingsNarrativeDetails",
      "http://www.cardinal.com/role/LongTermObligationsandOtherShortTermBorrowingsSummaryofDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cah_A4.6Notesdue2043Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "4.6% Notes due 2043",
        "label": "4.6% Notes due 2043 [Member]",
        "terseLabel": "4.6% Notes due 2043"
       }
      }
     },
     "localname": "A4.6Notesdue2043Member",
     "nsuri": "http://www.cardinal.com/20210630",
     "presentation": [
      "http://www.cardinal.com/role/LongTermObligationsandOtherShortTermBorrowingsLongTermDebtDetails",
      "http://www.cardinal.com/role/LongTermObligationsandOtherShortTermBorrowingsNarrativeDetails",
      "http://www.cardinal.com/role/LongTermObligationsandOtherShortTermBorrowingsSummaryofDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cah_A4.9Notesdue2045Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "4.9% Notes due 2045",
        "label": "4.9% Notes due 2045 [Member]",
        "terseLabel": "4.9% Notes due 2045"
       }
      }
     },
     "localname": "A4.9Notesdue2045Member",
     "nsuri": "http://www.cardinal.com/20210630",
     "presentation": [
      "http://www.cardinal.com/role/LongTermObligationsandOtherShortTermBorrowingsLongTermDebtDetails",
      "http://www.cardinal.com/role/LongTermObligationsandOtherShortTermBorrowingsNarrativeDetails",
      "http://www.cardinal.com/role/LongTermObligationsandOtherShortTermBorrowingsSummaryofDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cah_A7.0Debenturesduefiscal2027Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "7.0% Debentures due fiscal 2027",
        "label": "7.0% Debentures due fiscal 2027 [Member]",
        "terseLabel": "7.0%\u00a0Debentures due 2026"
       }
      }
     },
     "localname": "A7.0Debenturesduefiscal2027Member",
     "nsuri": "http://www.cardinal.com/20210630",
     "presentation": [
      "http://www.cardinal.com/role/LongTermObligationsandOtherShortTermBorrowingsLongTermDebtDetails",
      "http://www.cardinal.com/role/LongTermObligationsandOtherShortTermBorrowingsSummaryofDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cah_ASC842Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ASC 842",
        "label": "ASC 842 [Member]",
        "terseLabel": "ASC 842"
       }
      }
     },
     "localname": "ASC842Member",
     "nsuri": "http://www.cardinal.com/20210630",
     "presentation": [
      "http://www.cardinal.com/role/LeasesSupplementalCashFlowInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cah_AdditionalPerformanceShareUnitsDataTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additional Performance Share Units Data [Table Text Block]",
        "label": "Additional Performance Share Units Data [Table Text Block]",
        "terseLabel": "Additional Data Related to Performance Share Units Activity"
       }
      }
     },
     "localname": "AdditionalPerformanceShareUnitsDataTableTextBlock",
     "nsuri": "http://www.cardinal.com/20210630",
     "presentation": [
      "http://www.cardinal.com/role/ShareBasedCompensationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cah_AdditionalRestrictedSharesAndRestrictedShareUnitsDataTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additional Restricted Shares And Restricted Share Units Data [Table Text Block]",
        "label": "Additional Restricted Shares And Restricted Share Units Data [Table Text Block]",
        "terseLabel": "Additional Restricted Shares and Restricted Share Units Activity"
       }
      }
     },
     "localname": "AdditionalRestrictedSharesAndRestrictedShareUnitsDataTableTextBlock",
     "nsuri": "http://www.cardinal.com/20210630",
     "presentation": [
      "http://www.cardinal.com/role/ShareBasedCompensationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cah_AdditionalStockOptionPlanDataTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A disclosure of additional data related to all stock option activity",
        "label": "Additional Stock Option Plan Data [Table Text Block]",
        "terseLabel": "Schedule of Additional Data Related to Stock Option Activity"
       }
      }
     },
     "localname": "AdditionalStockOptionPlanDataTableTextBlock",
     "nsuri": "http://www.cardinal.com/20210630",
     "presentation": [
      "http://www.cardinal.com/role/ShareBasedCompensationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cah_AggregateAnnualAssessment": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate Annual Assessment",
        "label": "Aggregate Annual Assessment",
        "terseLabel": "Aggregate Annual Assessment"
       }
      }
     },
     "localname": "AggregateAnnualAssessment",
     "nsuri": "http://www.cardinal.com/20210630",
     "presentation": [
      "http://www.cardinal.com/role/CommitmentsContingentLiabilitiesandLitigationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cah_AlamedaCountyMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Alameda County [Member]",
        "label": "Alameda County [Member]",
        "terseLabel": "Alameda County [Member]"
       }
      }
     },
     "localname": "AlamedaCountyMember",
     "nsuri": "http://www.cardinal.com/20210630",
     "presentation": [
      "http://www.cardinal.com/role/CommitmentsContingentLiabilitiesandLitigationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cah_AllegianceCorporationMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Allegiance Corporation [Member]",
        "label": "Allegiance Corporation [Member]",
        "terseLabel": "Allegiance Corporation"
       }
      }
     },
     "localname": "AllegianceCorporationMember",
     "nsuri": "http://www.cardinal.com/20210630",
     "presentation": [
      "http://www.cardinal.com/role/LongTermObligationsandOtherShortTermBorrowingsLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cah_AmortizationandOtherAcquisitionRelatedCostsPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for the costs incurred during and relating to an acquisition. These costs specifically include transaction and integration costs; changes in fair value of contingent consideration obligations and amortization of acquisition-related intangible assets, and are recorded within amortization and other acquisition-related costs.",
        "label": "Amortization and Other Acquisition Related Costs Policy [Policy Text Block]",
        "terseLabel": "Amortization and Other Acquisition-Related Costs"
       }
      }
     },
     "localname": "AmortizationandOtherAcquisitionRelatedCostsPolicyPolicyTextBlock",
     "nsuri": "http://www.cardinal.com/20210630",
     "presentation": [
      "http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cah_Amortizationandotheracquisitionrelatedcosts": {
     "auth_ref": [],
     "calculation": {
      "http://www.cardinal.com/role/ConsolidatedStatementsofEarnings": {
       "order": 4.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense charged against earnings to allocate the cost of acquired intangible assets and changes in the fair value of contingent consideration obligations. This also represents acquisition-related costs incurred to effect a business combination which costs have been expensed during the period. Such costs include finder's fees; advisory, legal, accounting, valuation, and other professional or consulting fees; general administrative costs, including the costs of maintaining an internal acquisitions department; and may include costs of registering and issuing debt and equity securities.",
        "label": "Amortization and other acquisition-related costs",
        "terseLabel": "Amortization and other acquisition-related costs"
       }
      }
     },
     "localname": "Amortizationandotheracquisitionrelatedcosts",
     "nsuri": "http://www.cardinal.com/20210630",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedStatementsofEarnings"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cah_AssetsHeldforSalePolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Assets Held for Sale, Policy [Policy Text Block]",
        "label": "Assets Held for Sale, Policy [Policy Text Block]",
        "terseLabel": "Assets Held for Sale, Policy [Policy Text Block]"
       }
      }
     },
     "localname": "AssetsHeldforSalePolicyPolicyTextBlock",
     "nsuri": "http://www.cardinal.com/20210630",
     "presentation": [
      "http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cah_AwardsOtherThanStockOptionsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Awards Other than Stock Options [Member]",
        "label": "Awards Other than Stock Options [Member]",
        "terseLabel": "Awards Other than Stock Options"
       }
      }
     },
     "localname": "AwardsOtherThanStockOptionsMember",
     "nsuri": "http://www.cardinal.com/20210630",
     "presentation": [
      "http://www.cardinal.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cah_CVSCaremarkCorporationMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "CVS Caremark Corporation [Member]",
        "label": "CVS Caremark Corporation [Member]",
        "terseLabel": "CVS Health"
       }
      }
     },
     "localname": "CVSCaremarkCorporationMember",
     "nsuri": "http://www.cardinal.com/20210630",
     "presentation": [
      "http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesRevenueandGrossTradeReceivablesPercentagebyMajorCustomersDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cah_CardinalHealthAtHomeSolutionsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cardinal Health At Home Solutions [Member]",
        "label": "Cardinal Health At Home Solutions [Member]",
        "terseLabel": "Cardinal Health At Home Solutions [Member]"
       }
      }
     },
     "localname": "CardinalHealthAtHomeSolutionsMember",
     "nsuri": "http://www.cardinal.com/20210630",
     "presentation": [
      "http://www.cardinal.com/role/SegmentInformationRevenuebyReportableSegmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cah_CareFusionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "CareFusion [Member]",
        "label": "CareFusion [Member]",
        "terseLabel": "CareFusion [Member]"
       }
      }
     },
     "localname": "CareFusionMember",
     "nsuri": "http://www.cardinal.com/20210630",
     "presentation": [
      "http://www.cardinal.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cah_CarryingAmountofLongTermandotherShortTermBorrowings": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying Amount of Long-Term and other Short-Term Borrowings",
        "label": "Carrying Amount of Long-Term and other Short-Term Borrowings",
        "terseLabel": "Carrying Amount of Long-Term and other Short-Term Borrowings"
       }
      }
     },
     "localname": "CarryingAmountofLongTermandotherShortTermBorrowings",
     "nsuri": "http://www.cardinal.com/20210630",
     "presentation": [
      "http://www.cardinal.com/role/FinancialInstrumentsSummaryofEstimatedFairValueofLongtermObligationsandOtherShorttermBorrowingsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cah_CashDiscountsPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash Discounts [Policy Text Block]",
        "label": "Cash Discounts [Policy Text Block]",
        "terseLabel": "Cash Discounts"
       }
      }
     },
     "localname": "CashDiscountsPolicyTextBlock",
     "nsuri": "http://www.cardinal.com/20210630",
     "presentation": [
      "http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cah_CashReclassifiedtoAssetsHeldforSale": {
     "auth_ref": [],
     "calculation": {
      "http://www.cardinal.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 5.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "CashReclassifiedtoAssetsHeldforSale",
        "label": "CashReclassifiedtoAssetsHeldforSale",
        "terseLabel": "Cash reclassified to assets held for sale"
       }
      }
     },
     "localname": "CashReclassifiedtoAssetsHeldforSale",
     "nsuri": "http://www.cardinal.com/20210630",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cah_ClassActionLawsuitsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Class Action Lawsuits [Member]",
        "label": "Class Action Lawsuits [Member]",
        "terseLabel": "Class Action Lawsuits [Member]"
       }
      }
     },
     "localname": "ClassActionLawsuitsMember",
     "nsuri": "http://www.cardinal.com/20210630",
     "presentation": [
      "http://www.cardinal.com/role/CommitmentsContingentLiabilitiesandLitigationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cah_CommittedReceivablesSalesFacilityProgramMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Committed receivables sales facility program that exists largely to provide liquidity by selling interests in trade receivables.",
        "label": "Committed Receivables Sales Facility Program [Member]",
        "terseLabel": "Committed Receivables Sales Facility Program"
       }
      }
     },
     "localname": "CommittedReceivablesSalesFacilityProgramMember",
     "nsuri": "http://www.cardinal.com/20210630",
     "presentation": [
      "http://www.cardinal.com/role/LongTermObligationsandOtherShortTermBorrowingsNarrativeDetails",
      "http://www.cardinal.com/role/LongTermObligationsandOtherShortTermBorrowingsOtherFinancingArrangementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cah_CommonStockVotingRightsVotes": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Common Stock, Voting Rights, Votes",
        "label": "Common Stock, Voting Rights, Votes",
        "terseLabel": "Common Stock, Voting Rights, Votes"
       }
      }
     },
     "localname": "CommonStockVotingRightsVotes",
     "nsuri": "http://www.cardinal.com/20210630",
     "presentation": [
      "http://www.cardinal.com/role/ShareholdersEquityNarrativeDetails"
     ],
     "xbrltype": "pureItemType"
    },
    "cah_ConcentrationRiskLargestGroupPurchasingOrganizations": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Concentration Risk, Largest Group Purchasing Organizations",
        "label": "Concentration Risk, Largest Group Purchasing Organizations",
        "terseLabel": "Largest group purchasing organizations"
       }
      }
     },
     "localname": "ConcentrationRiskLargestGroupPurchasingOrganizations",
     "nsuri": "http://www.cardinal.com/20210630",
     "presentation": [
      "http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeMajorCustomersDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "cah_CordisDivestitureAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cordis Divestiture",
        "label": "Cordis Divestiture [Axis]",
        "terseLabel": "Cordis Divestiture [Axis]"
       }
      }
     },
     "localname": "CordisDivestitureAxis",
     "nsuri": "http://www.cardinal.com/20210630",
     "presentation": [
      "http://www.cardinal.com/role/DivestituresandAcquisitionsNarrativeDetails",
      "http://www.cardinal.com/role/GoodwillandOtherIntangibleAssetsScheduleofGoodwillbyReportableSegmentDetails",
      "http://www.cardinal.com/role/SegmentInformationAssetsbyReportableSegmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cah_CordisDivestitureDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cordis Divestiture [Domain]",
        "label": "Cordis Divestiture [Domain]",
        "terseLabel": "Cordis Divestiture [Domain]"
       }
      }
     },
     "localname": "CordisDivestitureDomain",
     "nsuri": "http://www.cardinal.com/20210630",
     "presentation": [
      "http://www.cardinal.com/role/DivestituresandAcquisitionsNarrativeDetails",
      "http://www.cardinal.com/role/GoodwillandOtherIntangibleAssetsScheduleofGoodwillbyReportableSegmentDetails",
      "http://www.cardinal.com/role/SegmentInformationAssetsbyReportableSegmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cah_CordisDivestitureMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cordis Divestiture",
        "label": "Cordis Divestiture [Member]",
        "terseLabel": "Cordis Divestiture"
       }
      }
     },
     "localname": "CordisDivestitureMember",
     "nsuri": "http://www.cardinal.com/20210630",
     "presentation": [
      "http://www.cardinal.com/role/DivestituresandAcquisitionsNarrativeDetails",
      "http://www.cardinal.com/role/GoodwillandOtherIntangibleAssetsScheduleofGoodwillbyReportableSegmentDetails",
      "http://www.cardinal.com/role/SegmentInformationAssetsbyReportableSegmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cah_CostofSalesVendorReservesPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for allowances received from a vendor. The disclosure differentiates between those allowances that are recorded as a reduction in the price of the vendors' products or services (that is, the entity's inventory) and which ultimately will be recorded as a reduction in the entity's cost of sales and those that are not.",
        "label": "Cost of Sales, Vendor Reserves, Policy [Policy Text Block]",
        "terseLabel": "Vendor Reserves"
       }
      }
     },
     "localname": "CostofSalesVendorReservesPolicyPolicyTextBlock",
     "nsuri": "http://www.cardinal.com/20210630",
     "presentation": [
      "http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cah_DOJInvestigationMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "DOJ Investigation",
        "label": "DOJ Investigation [Member]",
        "terseLabel": "DOJ Investigation"
       }
      }
     },
     "localname": "DOJInvestigationMember",
     "nsuri": "http://www.cardinal.com/20210630",
     "presentation": [
      "http://www.cardinal.com/role/CommitmentsContingentLiabilitiesandLitigationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cah_DeferredIncomeTaxesAndOtherTaxLiabilitiesTransferredToHeldForSaleNoncurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.cardinal.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesAfterNettingbyTaxJurisdictionDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredTaxLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred Income Taxes and Other Tax Liabilities, Transferred to Held for Sale, Noncurrent",
        "label": "Deferred Income Taxes and Other Tax Liabilities, Transferred to Held for Sale, Noncurrent",
        "negatedTerseLabel": "Deferred Income Taxes and Other Tax Liabilities, Transferred to Held for Sale, Noncurrent"
       }
      }
     },
     "localname": "DeferredIncomeTaxesAndOtherTaxLiabilitiesTransferredToHeldForSaleNoncurrent",
     "nsuri": "http://www.cardinal.com/20210630",
     "presentation": [
      "http://www.cardinal.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesAfterNettingbyTaxJurisdictionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cah_DeferredIncomeTaxesandOtherLiabilitiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred Income Taxes and Other Liabilities [Member]",
        "label": "Deferred Income Taxes and Other Liabilities [Member]",
        "terseLabel": "Deferred Income Taxes and Other Liabilities"
       }
      }
     },
     "localname": "DeferredIncomeTaxesandOtherLiabilitiesMember",
     "nsuri": "http://www.cardinal.com/20210630",
     "presentation": [
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleoftheFairValueofAssetsandLiabilitiesRelatedtoDerivativesDesignatedasHedgingInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cah_DeferredTaxAssetsRelatedtouncertaintaxpositions": {
     "auth_ref": [],
     "calculation": {
      "http://www.cardinal.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred tax assets related to uncertain tax positions",
        "label": "Deferred Tax Assets, Related to uncertain tax positions",
        "terseLabel": "Deferred tax assets related to uncertain tax positions"
       }
      }
     },
     "localname": "DeferredTaxAssetsRelatedtouncertaintaxpositions",
     "nsuri": "http://www.cardinal.com/20210630",
     "presentation": [
      "http://www.cardinal.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cah_DerivatesHedgeDiscontinuancesHedgingInstrumentTerminatedAmount": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Derivates, Hedge Discontinuances, Hedging Instrument Terminated, Amount",
        "label": "Derivates, Hedge Discontinuances, Hedging Instrument Terminated, Amount",
        "terseLabel": "Derivates, Hedge Discontinuances, Hedging Instrument Terminated, Amount"
       }
      }
     },
     "localname": "DerivatesHedgeDiscontinuancesHedgingInstrumentTerminatedAmount",
     "nsuri": "http://www.cardinal.com/20210630",
     "presentation": [
      "http://www.cardinal.com/role/FinancialInstrumentsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cah_DerivativesHedgeDiscontinuancesHedgingInstrumentMaturedAmount": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Derivatives, Hedge Discontinuances, Hedging Instrument Matured, Amount",
        "label": "Derivatives, Hedge Discontinuances, Hedging Instrument Matured, Amount",
        "terseLabel": "Derivatives, matured notional amounts"
       }
      }
     },
     "localname": "DerivativesHedgeDiscontinuancesHedgingInstrumentMaturedAmount",
     "nsuri": "http://www.cardinal.com/20210630",
     "presentation": [
      "http://www.cardinal.com/role/FinancialInstrumentsNarrativeDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleofOutstandingInstrumentsFairValueHedgesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cah_DerivativesHedgeDiscontinuancesTerminationofHedgingInstrumentAmount": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Derivatives, Hedge Discontinuances, Termination of Hedging Instrument, Amount",
        "label": "Derivatives, Hedge Discontinuances, Termination of Hedging Instrument, Amount",
        "terseLabel": "Derivatives, terminated notional amounts"
       }
      }
     },
     "localname": "DerivativesHedgeDiscontinuancesTerminationofHedgingInstrumentAmount",
     "nsuri": "http://www.cardinal.com/20210630",
     "presentation": [
      "http://www.cardinal.com/role/FinancialInstrumentsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cah_DiscountRatefairvalueinputs": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Discount Rate, fair value inputs",
        "label": "Discount Rate, fair value inputs",
        "terseLabel": "Discount Rate, fair value inputs"
       }
      }
     },
     "localname": "DiscountRatefairvalueinputs",
     "nsuri": "http://www.cardinal.com/20210630",
     "presentation": [
      "http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeGoodwillandOtherIntangibleAssetsDetails",
      "http://www.cardinal.com/role/GoodwillandOtherIntangibleAssetsNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "cah_DisposalGroupIncludingDiscontinuedOperationsGoodwillAndOtherIntangiblesNet": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal Group Including Discontinued Operations Goodwill and Other Intangibles, net",
        "label": "Disposal Group Including Discontinued Operations Goodwill and Other Intangibles, net",
        "terseLabel": "Disposal Group Including Discontinued Operations Goodwill and Other Intangibles, net"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationsGoodwillAndOtherIntangiblesNet",
     "nsuri": "http://www.cardinal.com/20210630",
     "presentation": [
      "http://www.cardinal.com/role/DivestituresandAcquisitionsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cah_DistributionServiceAgreementAndOtherVendorFeesPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Describes an entity's accounting policy for fees received from distribution service agreements and other fees received from vendors related to the purchase or distribution of the vendor's inventory. Such fees are recognized as a reduction of inventory when those fees have been earned and the entity is entitled to payment.",
        "label": "Distribution Service Agreement And Other Vendor Fees [Policy Text Block]",
        "terseLabel": "Distribution Service Agreement and Other Vendor Fees"
       }
      }
     },
     "localname": "DistributionServiceAgreementAndOtherVendorFeesPolicyTextBlock",
     "nsuri": "http://www.cardinal.com/20210630",
     "presentation": [
      "http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cah_DividendsPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Dividends, Policy [Policy Text Block]",
        "label": "Dividends, Policy [Policy Text Block]",
        "terseLabel": "Dividends, Policy [Policy Text Block]"
       }
      }
     },
     "localname": "DividendsPolicyPolicyTextBlock",
     "nsuri": "http://www.cardinal.com/20210630",
     "presentation": [
      "http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cah_EffectiveIncomeTaxRateReconciliationLegalEntityReorganizationReconcilingItemsPercent": {
     "auth_ref": [],
     "calculation": {
      "http://www.cardinal.com/role/IncomeTaxesScheduleofEffectiveIncomeTaxRateReconciliationDetails": {
       "order": 7.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Effective Income Tax Rate Reconciliation Legal Entity Reorganization Reconciling Items Percent",
        "label": "Effective Income Tax Rate Reconciliation Legal Entity Reorganization Reconciling Items Percent",
        "terseLabel": "Effective Income Tax Rate Reconciliation Legal Entity Reorganization Reconciling Items Percent"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationLegalEntityReorganizationReconcilingItemsPercent",
     "nsuri": "http://www.cardinal.com/20210630",
     "presentation": [
      "http://www.cardinal.com/role/IncomeTaxesScheduleofEffectiveIncomeTaxRateReconciliationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "cah_EffectiveIncomeTaxRateReconciliationLossCarrybackClaims": {
     "auth_ref": [],
     "calculation": {
      "http://www.cardinal.com/role/IncomeTaxesScheduleofEffectiveIncomeTaxRateReconciliationDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Effective Income Tax Rate Reconciliation, Loss Carryback Claims",
        "label": "Effective Income Tax Rate Reconciliation, Loss Carryback Claims",
        "terseLabel": "Effective Income Tax Rate Reconciliation, Loss Carryback Claims"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationLossCarrybackClaims",
     "nsuri": "http://www.cardinal.com/20210630",
     "presentation": [
      "http://www.cardinal.com/role/IncomeTaxesScheduleofEffectiveIncomeTaxRateReconciliationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "cah_EffectiveIncomeTaxRateReconciliationTaxEffectOfForeignOperations": {
     "auth_ref": [],
     "calculation": {
      "http://www.cardinal.com/role/IncomeTaxesScheduleofEffectiveIncomeTaxRateReconciliationDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Effective Income Tax Rate Reconciliation, Tax Effect of Foreign Operations",
        "label": "Effective Income Tax Rate Reconciliation, Tax Effect of Foreign Operations",
        "terseLabel": "Effective Income Tax Rate Reconciliation, Tax Effect of Foreign Operations"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationTaxEffectOfForeignOperations",
     "nsuri": "http://www.cardinal.com/20210630",
     "presentation": [
      "http://www.cardinal.com/role/IncomeTaxesScheduleofEffectiveIncomeTaxRateReconciliationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "cah_EffectiveIncomeTaxRateReconciliationWithholdingTaxes": {
     "auth_ref": [],
     "calculation": {
      "http://www.cardinal.com/role/IncomeTaxesScheduleofEffectiveIncomeTaxRateReconciliationDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Effective Income Tax Rate Reconciliation, Withholding Taxes",
        "label": "Effective Income Tax Rate Reconciliation, Withholding Taxes",
        "terseLabel": "Effective Income Tax Rate Reconciliation, Withholding Taxes"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationWithholdingTaxes",
     "nsuri": "http://www.cardinal.com/20210630",
     "presentation": [
      "http://www.cardinal.com/role/IncomeTaxesScheduleofEffectiveIncomeTaxRateReconciliationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "cah_EffectiveIncomeTaxReconciliationOpioidLitigation": {
     "auth_ref": [],
     "calculation": {
      "http://www.cardinal.com/role/IncomeTaxesScheduleofEffectiveIncomeTaxRateReconciliationDetails": {
       "order": 13.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Effective Income Tax Reconciliation, Opioid Litigation",
        "label": "Effective Income Tax Reconciliation, Opioid Litigation",
        "terseLabel": "Effective Income Tax Reconciliation, Opioid Litigation"
       }
      }
     },
     "localname": "EffectiveIncomeTaxReconciliationOpioidLitigation",
     "nsuri": "http://www.cardinal.com/20210630",
     "presentation": [
      "http://www.cardinal.com/role/IncomeTaxesScheduleofEffectiveIncomeTaxRateReconciliationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "cah_EffectiveTaxRateImpactFromCertainForeignJurisdictions": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Effective Tax Rate Impact From Certain Foreign Jurisdictions",
        "label": "Effective Tax Rate Impact From Certain Foreign Jurisdictions",
        "terseLabel": "Effective Tax Rate Impact From Certain Foreign Jurisdictions"
       }
      }
     },
     "localname": "EffectiveTaxRateImpactFromCertainForeignJurisdictions",
     "nsuri": "http://www.cardinal.com/20210630",
     "presentation": [
      "http://www.cardinal.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cah_EffectiveTaxRateReconciliationImpactOfResolutionsWithIRSAndOtherRelatedMatters": {
     "auth_ref": [],
     "calculation": {
      "http://www.cardinal.com/role/IncomeTaxesScheduleofEffectiveIncomeTaxRateReconciliationDetails": {
       "order": 10.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Effective Tax Rate Reconciliation, Impact of Resolutions with IRS and other related matters",
        "label": "Effective Tax Rate Reconciliation, Impact of Resolutions with IRS and other related matters",
        "terseLabel": "China tax related to divestiture"
       }
      }
     },
     "localname": "EffectiveTaxRateReconciliationImpactOfResolutionsWithIRSAndOtherRelatedMatters",
     "nsuri": "http://www.cardinal.com/20210630",
     "presentation": [
      "http://www.cardinal.com/role/IncomeTaxesScheduleofEffectiveIncomeTaxRateReconciliationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "cah_EffectiveTaxRateReconciliationUSTaxesOnInternationalIncome": {
     "auth_ref": [],
     "calculation": {
      "http://www.cardinal.com/role/IncomeTaxesScheduleofEffectiveIncomeTaxRateReconciliationDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Effective Tax Rate Reconciliation, US Taxes on International Income",
        "label": "Effective Tax Rate Reconciliation, US Taxes on International Income",
        "terseLabel": "US Taxes on International Income"
       }
      }
     },
     "localname": "EffectiveTaxRateReconciliationUSTaxesOnInternationalIncome",
     "nsuri": "http://www.cardinal.com/20210630",
     "presentation": [
      "http://www.cardinal.com/role/IncomeTaxesScheduleofEffectiveIncomeTaxRateReconciliationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "cah_EstimatedLiabilityForNewYorkOpioidStewardshipAct": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Estimated Liability for New York Opioid Stewardship Act",
        "label": "Estimated Liability for New York Opioid Stewardship Act",
        "terseLabel": "Estimated Liability for New York Opioid Stewardship Act"
       }
      }
     },
     "localname": "EstimatedLiabilityForNewYorkOpioidStewardshipAct",
     "nsuri": "http://www.cardinal.com/20210630",
     "presentation": [
      "http://www.cardinal.com/role/SegmentInformationNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cah_ExercisablePeriodOfPlansInYears": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The instrument's contractual term.",
        "label": "Exercisable period of plans, in years",
        "terseLabel": "Exercisable period of plans (in years)"
       }
      }
     },
     "localname": "ExercisablePeriodOfPlansInYears",
     "nsuri": "http://www.cardinal.com/20210630",
     "presentation": [
      "http://www.cardinal.com/role/ShareBasedCompensationNarrativeDetails",
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleofAdditionalDataRelatedtoStockOptionsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "cah_FacilityExitAndOtherCosts": {
     "auth_ref": [],
     "calculation": {
      "http://www.cardinal.com/role/RestructuringandEmployeeSeveranceActivityRelatedtoRestructuringandEmployeeSeveranceCostsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_RestructuringCharges",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Facility exit and other costs primarily consist of lease termination costs, accelerated depreciation, equipment relocation costs, project consulting fees and costs associated with restructuring our delivery of information technology infrastructure services.",
        "label": "Facility Exit and Other Costs",
        "terseLabel": "Facility Exit and Other Costs"
       }
      }
     },
     "localname": "FacilityExitAndOtherCosts",
     "nsuri": "http://www.cardinal.com/20210630",
     "presentation": [
      "http://www.cardinal.com/role/RestructuringandEmployeeSeveranceActivityRelatedtoRestructuringandEmployeeSeveranceCostsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cah_FinanceLeaseImputedInterest": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Finance Lease Imputed Interest",
        "label": "Finance Lease Imputed Interest",
        "terseLabel": "Less: imputed interest"
       }
      }
     },
     "localname": "FinanceLeaseImputedInterest",
     "nsuri": "http://www.cardinal.com/20210630",
     "presentation": [
      "http://www.cardinal.com/role/LeasesScheduleofFutureLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cah_FinanceLeaseMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Finance Lease",
        "label": "Finance Lease [Member]",
        "terseLabel": "Finance Leases"
       }
      }
     },
     "localname": "FinanceLeaseMember",
     "nsuri": "http://www.cardinal.com/20210630",
     "presentation": [
      "http://www.cardinal.com/role/LeasesScheduleofFutureLeasePaymentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cah_FixedRateDebtMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fixed Rate Debt [Member]",
        "label": "Fixed Rate Debt [Member]",
        "terseLabel": "Fixed-Rate Debt"
       }
      }
     },
     "localname": "FixedRateDebtMember",
     "nsuri": "http://www.cardinal.com/20210630",
     "presentation": [
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleofGainLossRecognizedinEarningsforInterestRateContractsDesignatedasFairValueHedgesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cah_FloatingRateNotes2616NotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Floating rate notes, 2.616% Notes",
        "label": "Floating rate notes, 2.616% Notes [Member]",
        "terseLabel": "Floating rate notes, 2.616% Notes"
       }
      }
     },
     "localname": "FloatingRateNotes2616NotesMember",
     "nsuri": "http://www.cardinal.com/20210630",
     "presentation": [
      "http://www.cardinal.com/role/LongTermObligationsandOtherShortTermBorrowingsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cah_FloatingRateNotesdue2022Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Floating Rate Notes due 2022",
        "label": "Floating Rate Notes due 2022 [Member]",
        "terseLabel": "Floating Rate Notes due fiscal 2022"
       }
      }
     },
     "localname": "FloatingRateNotesdue2022Member",
     "nsuri": "http://www.cardinal.com/20210630",
     "presentation": [
      "http://www.cardinal.com/role/LongTermObligationsandOtherShortTermBorrowingsLongTermDebtDetails",
      "http://www.cardinal.com/role/LongTermObligationsandOtherShortTermBorrowingsNarrativeDetails",
      "http://www.cardinal.com/role/LongTermObligationsandOtherShortTermBorrowingsSummaryofDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cah_GainonDivestitureAfterTax": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gain on Divestiture After Tax",
        "label": "Gain on Divestiture After Tax",
        "terseLabel": "Gain on Divestiture After Tax"
       }
      }
     },
     "localname": "GainonDivestitureAfterTax",
     "nsuri": "http://www.cardinal.com/20210630",
     "presentation": [
      "http://www.cardinal.com/role/SegmentInformationNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cah_GoodsandservicessoldLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "[Line Items] for goods and services sold [Table]",
        "label": "goods and services sold [Line Items]",
        "terseLabel": "Distribution, selling, general and administrative expenses [Line Items]"
       }
      }
     },
     "localname": "GoodsandservicessoldLineItems",
     "nsuri": "http://www.cardinal.com/20210630",
     "presentation": [
      "http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeShippingandHandlingDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cah_GoodsandservicessoldTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "goods and services sold [Table]",
        "label": "goods and services sold [Table]",
        "terseLabel": "Distribution, selling, general and administrative expenses [Table]"
       }
      }
     },
     "localname": "GoodsandservicessoldTable",
     "nsuri": "http://www.cardinal.com/20210630",
     "presentation": [
      "http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeShippingandHandlingDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cah_GoodwillAndIntangibleAssetsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Goodwill and Intangible Assets [Line Items]",
        "label": "Goodwill and Intangible Assets [Line Items]",
        "terseLabel": "Goodwill and Intangible Assets [Line Items]"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsLineItems",
     "nsuri": "http://www.cardinal.com/20210630",
     "presentation": [
      "http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeGoodwillandOtherIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cah_GoodwillAndIntangibleAssetsTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Goodwill and Intangible Assets [Table]",
        "label": "Goodwill and Intangible Assets [Table]",
        "terseLabel": "Goodwill and Intangible Assets [Table]"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsTable",
     "nsuri": "http://www.cardinal.com/20210630",
     "presentation": [
      "http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeGoodwillandOtherIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cah_GownRecallAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gown Recall [Axis]",
        "label": "Gown Recall [Axis]",
        "terseLabel": "Gown Recall [Axis]"
       }
      }
     },
     "localname": "GownRecallAxis",
     "nsuri": "http://www.cardinal.com/20210630",
     "presentation": [
      "http://www.cardinal.com/role/CommitmentsContingentLiabilitiesandLitigationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cah_GownRecallDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "[Domain] for Gown Recall [Axis]",
        "label": "Gown Recall [Domain]",
        "terseLabel": "Gown Recall [Domain]"
       }
      }
     },
     "localname": "GownRecallDomain",
     "nsuri": "http://www.cardinal.com/20210630",
     "presentation": [
      "http://www.cardinal.com/role/CommitmentsContingentLiabilitiesandLitigationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cah_GrossTradeReceivablesMajorCustomerPercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gross Trade Receivables, Major Customer Percentage",
        "label": "Gross Trade Receivables, Major Customer Percentage",
        "terseLabel": "Percent\u00a0of\u00a0Gross Trade\u00a0Receivables"
       }
      }
     },
     "localname": "GrossTradeReceivablesMajorCustomerPercentage",
     "nsuri": "http://www.cardinal.com/20210630",
     "presentation": [
      "http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesRevenueandGrossTradeReceivablesPercentagebyMajorCustomersDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "cah_GroupPurchasingOrganizationsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Group Purchasing Organizations [Member]",
        "label": "Group Purchasing Organizations [Member]",
        "terseLabel": "Group Purchasing Organizations"
       }
      }
     },
     "localname": "GroupPurchasingOrganizationsMember",
     "nsuri": "http://www.cardinal.com/20210630",
     "presentation": [
      "http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeMajorCustomersDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cah_IPRDTrademarksandOtherMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Includes in process investigation of new knowledge useful in developing new product or service or new process or techniques or improvement to existing product or process, and translation of knowledge into plan or design for new product or process or for the improvements to existing product or process and rights acquired through registration of a trademark to gain or protect exclusive use of a business name, symbol or other device or style.",
        "label": "IPR&amp;D,TrademarksandOther [Member]",
        "terseLabel": "Trademarks and patents"
       }
      }
     },
     "localname": "IPRDTrademarksandOtherMember",
     "nsuri": "http://www.cardinal.com/20210630",
     "presentation": [
      "http://www.cardinal.com/role/GoodwillandOtherIntangibleAssetsScheduleofIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cah_Impactofadoptionofnewaccountingstandard": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "impact of adoption of new accounting standard",
        "label": "impact of adoption of new accounting standard",
        "terseLabel": "New Accounting Pronouncement or Change in Accounting Principle, Effect of Adoption, Quantification (Deprecated 2020-01-31)"
       }
      }
     },
     "localname": "Impactofadoptionofnewaccountingstandard",
     "nsuri": "http://www.cardinal.com/20210630",
     "presentation": [
      "http://www.cardinal.com/role/LeasesSupplementalCashFlowInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cah_IncomefromSettlementsofClassActionLawsuits": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Income from Settlements of Class Action Lawsuits",
        "label": "Income from Settlements of Class Action Lawsuits",
        "terseLabel": "Income from Settlements of Class Action Lawsuits"
       }
      }
     },
     "localname": "IncomefromSettlementsofClassActionLawsuits",
     "nsuri": "http://www.cardinal.com/20210630",
     "presentation": [
      "http://www.cardinal.com/role/CommitmentsContingentLiabilitiesandLitigationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cah_IndemnificationReceivable": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indemnification receivable from Patient recovery related to certain pre-acquisition tax exposures and transaction taxes.",
        "label": "Indemnification Receivable",
        "terseLabel": "Amount CareFusion is liable under tax matters agreement in the event amount must be paid to the taxing authority"
       }
      }
     },
     "localname": "IndemnificationReceivable",
     "nsuri": "http://www.cardinal.com/20210630",
     "presentation": [
      "http://www.cardinal.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cah_LawsuitTypeAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lawsuit Type [Axis]",
        "label": "Lawsuit Type [Axis]",
        "terseLabel": "Lawsuit Type [Axis]"
       }
      }
     },
     "localname": "LawsuitTypeAxis",
     "nsuri": "http://www.cardinal.com/20210630",
     "presentation": [
      "http://www.cardinal.com/role/CommitmentsContingentLiabilitiesandLitigationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cah_LawsuitTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "[Domain] for Lawsuit Type [Axis]",
        "label": "Lawsuit Type [Domain]",
        "terseLabel": "Lawsuit Type [Domain]"
       }
      }
     },
     "localname": "LawsuitTypeDomain",
     "nsuri": "http://www.cardinal.com/20210630",
     "presentation": [
      "http://www.cardinal.com/role/CommitmentsContingentLiabilitiesandLitigationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cah_LeasePaymentsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "[Table Text Block] for Lease Payments [Table]",
        "label": "Lease Payments [Table Text Block]",
        "terseLabel": "Leases Supplemental Cash Flow Information"
       }
      }
     },
     "localname": "LeasePaymentsTableTextBlock",
     "nsuri": "http://www.cardinal.com/20210630",
     "presentation": [
      "http://www.cardinal.com/role/LeasesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cah_LeasesSupplementalBalanceSheetInformationTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "[Table Text Block] for LeasesSupplementalBalanceSheetInformation [Table]",
        "label": "LeasesSupplementalBalanceSheetInformation [Table Text Block]",
        "terseLabel": "Leases Supplemental Balance Sheet Information"
       }
      }
     },
     "localname": "LeasesSupplementalBalanceSheetInformationTableTextBlock",
     "nsuri": "http://www.cardinal.com/20210630",
     "presentation": [
      "http://www.cardinal.com/role/LeasesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cah_LeasesTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Leases [Text Block]",
        "label": "Leases [Text Block]",
        "terseLabel": "Leases"
       }
      }
     },
     "localname": "LeasesTextBlock",
     "nsuri": "http://www.cardinal.com/20210630",
     "presentation": [
      "http://www.cardinal.com/role/Leases"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cah_LesseeFinanceLeaseLiabilityNotYetCommencedAmount": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lessee Finance Lease Liability Not Yet Commenced, Amount",
        "label": "Lessee Finance Lease Liability Not Yet Commenced, Amount",
        "terseLabel": "Less: leases not yet commenced (1)"
       }
      }
     },
     "localname": "LesseeFinanceLeaseLiabilityNotYetCommencedAmount",
     "nsuri": "http://www.cardinal.com/20210630",
     "presentation": [
      "http://www.cardinal.com/role/LeasesScheduleofFutureLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cah_LesseeLeaseLiabilityPaymentsDueAfterYearFive": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lessee Lease Liability Payments Due After Year Five",
        "label": "Lessee Lease Liability Payments Due After Year Five",
        "terseLabel": "Thereafter"
       }
      }
     },
     "localname": "LesseeLeaseLiabilityPaymentsDueAfterYearFive",
     "nsuri": "http://www.cardinal.com/20210630",
     "presentation": [
      "http://www.cardinal.com/role/LeasesScheduleofFutureLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cah_LesseeLeaseLiabilityPaymentsDueYearFive": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lessee Lease Liability Payments Due Year Five",
        "label": "Lessee Lease Liability Payments Due Year Five",
        "terseLabel": "2026"
       }
      }
     },
     "localname": "LesseeLeaseLiabilityPaymentsDueYearFive",
     "nsuri": "http://www.cardinal.com/20210630",
     "presentation": [
      "http://www.cardinal.com/role/LeasesScheduleofFutureLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cah_LesseeLeaseLiabilityPaymentsDueYearFour": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lessee Lease Liability Payments Due Year Four",
        "label": "Lessee Lease Liability Payments Due Year Four",
        "terseLabel": "2025"
       }
      }
     },
     "localname": "LesseeLeaseLiabilityPaymentsDueYearFour",
     "nsuri": "http://www.cardinal.com/20210630",
     "presentation": [
      "http://www.cardinal.com/role/LeasesScheduleofFutureLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cah_LesseeLeaseLiabilityPaymentsDueYearOne": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lessee Lease Liability Payments Due Year One",
        "label": "Lessee Lease Liability Payments Due Year One",
        "terseLabel": "2022"
       }
      }
     },
     "localname": "LesseeLeaseLiabilityPaymentsDueYearOne",
     "nsuri": "http://www.cardinal.com/20210630",
     "presentation": [
      "http://www.cardinal.com/role/LeasesScheduleofFutureLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cah_LesseeLeaseLiabilityPaymentsDueYearThree": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lessee Lease Liability Payments Due Year Three",
        "label": "Lessee Lease Liability Payments Due Year Three",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "LesseeLeaseLiabilityPaymentsDueYearThree",
     "nsuri": "http://www.cardinal.com/20210630",
     "presentation": [
      "http://www.cardinal.com/role/LeasesScheduleofFutureLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cah_LesseeLeaseLiabilityPaymentsDueYearTwo": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lessee Lease Liability Payments Due Year Two",
        "label": "Lessee Lease Liability Payments Due Year Two",
        "terseLabel": "2023"
       }
      }
     },
     "localname": "LesseeLeaseLiabilityPaymentsDueYearTwo",
     "nsuri": "http://www.cardinal.com/20210630",
     "presentation": [
      "http://www.cardinal.com/role/LeasesScheduleofFutureLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cah_LesseeOperatingLeaseLiabilityNotYetCommencedAmount": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lessee Operating Lease Liability Not Yet Commenced, Amount",
        "label": "Lessee Operating Lease Liability Not Yet Commenced, Amount",
        "terseLabel": "Less: leases not yet commenced (1)"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityNotYetCommencedAmount",
     "nsuri": "http://www.cardinal.com/20210630",
     "presentation": [
      "http://www.cardinal.com/role/LeasesScheduleofFutureLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cah_LitigationTypeAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Litigation Type [Axis]",
        "label": "Litigation Type [Axis]",
        "terseLabel": "Litigation Type [Axis]"
       }
      }
     },
     "localname": "LitigationTypeAxis",
     "nsuri": "http://www.cardinal.com/20210630",
     "presentation": [
      "http://www.cardinal.com/role/CommitmentsContingentLiabilitiesandLitigationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cah_LitigationTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "[Domain] for Litigation Type [Axis]",
        "label": "Litigation Type [Domain]",
        "terseLabel": "Litigation Type [Domain]"
       }
      }
     },
     "localname": "LitigationTypeDomain",
     "nsuri": "http://www.cardinal.com/20210630",
     "presentation": [
      "http://www.cardinal.com/role/CommitmentsContingentLiabilitiesandLitigationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cah_LossContingencyLawsuitsNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loss Contingency, Lawsuits, Number",
        "label": "Loss Contingency, Lawsuits, Number",
        "terseLabel": "Loss Contingency, Lawsuits, Number"
       }
      }
     },
     "localname": "LossContingencyLawsuitsNumber",
     "nsuri": "http://www.cardinal.com/20210630",
     "presentation": [
      "http://www.cardinal.com/role/CommitmentsContingentLiabilitiesandLitigationDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "cah_MedicalMemberMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Medical [Member]",
        "label": "Medical Member [Member]",
        "terseLabel": "Medical"
       }
      }
     },
     "localname": "MedicalMemberMember",
     "nsuri": "http://www.cardinal.com/20210630",
     "presentation": [
      "http://www.cardinal.com/role/GoodwillandOtherIntangibleAssetsNarrativeDetails",
      "http://www.cardinal.com/role/GoodwillandOtherIntangibleAssetsScheduleofGoodwillbyReportableSegmentDetails",
      "http://www.cardinal.com/role/SegmentInformationAssetsbyReportableSegmentDetails",
      "http://www.cardinal.com/role/SegmentInformationDepreciationandAmortizationandAdditionstoPropertyandEquipmentbyReportableSegmentDetails",
      "http://www.cardinal.com/role/SegmentInformationRevenuebyReportableSegmentDetails",
      "http://www.cardinal.com/role/SegmentInformationSegmentProfitbyReportableSegmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cah_MedicaldistributionandproductsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Medical distribution and products [Member]",
        "label": "Medical distribution and products [Member]",
        "terseLabel": "Medical distribution and products [Member]"
       }
      }
     },
     "localname": "MedicaldistributionandproductsMember",
     "nsuri": "http://www.cardinal.com/20210630",
     "presentation": [
      "http://www.cardinal.com/role/SegmentInformationRevenuebyReportableSegmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cah_NaviHealthAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "naviHealth",
        "label": "naviHealth [Axis]",
        "terseLabel": "naviHealth [Axis]"
       }
      }
     },
     "localname": "NaviHealthAxis",
     "nsuri": "http://www.cardinal.com/20210630",
     "presentation": [
      "http://www.cardinal.com/role/DivestituresandAcquisitionsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cah_NaviHealthDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "naviHealth [Domain]",
        "label": "naviHealth [Domain]",
        "terseLabel": "naviHealth [Domain]"
       }
      }
     },
     "localname": "NaviHealthDomain",
     "nsuri": "http://www.cardinal.com/20210630",
     "presentation": [
      "http://www.cardinal.com/role/DivestituresandAcquisitionsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cah_NaviHealthMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "naviHealth [Member]",
        "label": "naviHealth [Member]",
        "terseLabel": "naviHealth [Member]"
       }
      }
     },
     "localname": "NaviHealthMember",
     "nsuri": "http://www.cardinal.com/20210630",
     "presentation": [
      "http://www.cardinal.com/role/DivestituresandAcquisitionsNarrativeDetails",
      "http://www.cardinal.com/role/GoodwillandOtherIntangibleAssetsNarrativeDetails",
      "http://www.cardinal.com/role/SegmentInformationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cah_NetEarningsIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Net Earnings Including Portion Attributable to Noncontrolling Interest Excluding Redeemable Noncontrolling Interest",
        "label": "Net Earnings Including Portion Attributable to Noncontrolling Interest Excluding Redeemable Noncontrolling Interest",
        "terseLabel": "Net Earnings Including Portion Attributable to Noncontrolling Interest Excluding Redeemable Noncontrolling Interest"
       }
      }
     },
     "localname": "NetEarningsIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest",
     "nsuri": "http://www.cardinal.com/20210630",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedStatementsofShareholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cah_NetOperatingLossCarrybackAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Net Operating Loss Carryback",
        "label": "Net Operating Loss Carryback [Axis]",
        "terseLabel": "Net Operating Loss Carryback [Axis]"
       }
      }
     },
     "localname": "NetOperatingLossCarrybackAxis",
     "nsuri": "http://www.cardinal.com/20210630",
     "presentation": [
      "http://www.cardinal.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cah_NetOperatingLossCarrybackDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Net Operating Loss Carryback [Domain]",
        "label": "Net Operating Loss Carryback [Domain]",
        "terseLabel": "Net Operating Loss Carryback [Domain]"
       }
      }
     },
     "localname": "NetOperatingLossCarrybackDomain",
     "nsuri": "http://www.cardinal.com/20210630",
     "presentation": [
      "http://www.cardinal.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cah_NetOperatingLossCarrybackMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Net Operating Loss Carryback",
        "label": "Net Operating Loss Carryback [Member]",
        "terseLabel": "Net Operating Loss Carryback"
       }
      }
     },
     "localname": "NetOperatingLossCarrybackMember",
     "nsuri": "http://www.cardinal.com/20210630",
     "presentation": [
      "http://www.cardinal.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cah_Netproceedstaxwithholdingsfromsharebasedcompensation": {
     "auth_ref": [],
     "calculation": {
      "http://www.cardinal.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net cash inflow/(outflow) associated with the amount received from holders exercising their stock options and paid by the company to satisfy an employee's income tax withholding obligation when shares are withheld from settlement of a share-based award to cover taxes. This item inherently excludes any excess tax benefit, which the entity may have realized and reported separately.",
        "label": "Net proceeds/(tax withholdings) from share-based compensation",
        "terseLabel": "Net tax proceeds/(withholding) from share-based compensation",
        "verboseLabel": "Net proceeds/(withholding) from share-based compensation"
       }
      }
     },
     "localname": "Netproceedstaxwithholdingsfromsharebasedcompensation",
     "nsuri": "http://www.cardinal.com/20210630",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleofAdditionalDataRelatedtoStockOptionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cah_NewYorkOpioidStewardshipActMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "New York Opioid Stewardship Act",
        "label": "New York Opioid Stewardship Act [Member]",
        "terseLabel": "New York Opioid Stewardship Act"
       }
      }
     },
     "localname": "NewYorkOpioidStewardshipActMember",
     "nsuri": "http://www.cardinal.com/20210630",
     "presentation": [
      "http://www.cardinal.com/role/CommitmentsContingentLiabilitiesandLitigationDetails",
      "http://www.cardinal.com/role/SegmentInformationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cah_NotesPayableRepurchased": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Principal Amount of Notes Payable Repurchased during the year",
        "label": "Notes Payable Repurchased",
        "terseLabel": "Notes Payable Repurchased"
       }
      }
     },
     "localname": "NotesPayableRepurchased",
     "nsuri": "http://www.cardinal.com/20210630",
     "presentation": [
      "http://www.cardinal.com/role/LongTermObligationsandOtherShortTermBorrowingsLongTermDebtDetails",
      "http://www.cardinal.com/role/LongTermObligationsandOtherShortTermBorrowingsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cah_NuclearPrecisionHealthServicesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Nuclear Precision Health Services [Member]",
        "label": "Nuclear Precision Health Services [Member]",
        "terseLabel": "Nuclear Precision Health Services [Member]"
       }
      }
     },
     "localname": "NuclearPrecisionHealthServicesMember",
     "nsuri": "http://www.cardinal.com/20210630",
     "presentation": [
      "http://www.cardinal.com/role/SegmentInformationRevenuebyReportableSegmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cah_NumberofStateAttorneysGeneralfilinglawsuits": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of State Attorneys General filing lawsuits",
        "label": "Number of State Attorneys General filing lawsuits",
        "terseLabel": "Number of State Attorneys General filing lawsuits"
       }
      }
     },
     "localname": "NumberofStateAttorneysGeneralfilinglawsuits",
     "nsuri": "http://www.cardinal.com/20210630",
     "presentation": [
      "http://www.cardinal.com/role/CommitmentsContingentLiabilitiesandLitigationDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "cah_OfferAsPercentageOfPrincipalAmount": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of principal amount that the company is required to offer to purchase certain notes, under certain circumstances.",
        "label": "Offer As Percentage Of Principal Amount",
        "terseLabel": "Offer as percentage of principal amount"
       }
      }
     },
     "localname": "OfferAsPercentageOfPrincipalAmount",
     "nsuri": "http://www.cardinal.com/20210630",
     "presentation": [
      "http://www.cardinal.com/role/LongTermObligationsandOtherShortTermBorrowingsLongTermDebtDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "cah_OperatingLeaseImputedInterest": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operating Lease Imputed Interest",
        "label": "Operating Lease Imputed Interest",
        "terseLabel": "Less: imputed interest"
       }
      }
     },
     "localname": "OperatingLeaseImputedInterest",
     "nsuri": "http://www.cardinal.com/20210630",
     "presentation": [
      "http://www.cardinal.com/role/LeasesScheduleofFutureLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cah_OperatingLeaseMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operating Lease",
        "label": "Operating Lease [Member]",
        "terseLabel": "Operating Leases"
       }
      }
     },
     "localname": "OperatingLeaseMember",
     "nsuri": "http://www.cardinal.com/20210630",
     "presentation": [
      "http://www.cardinal.com/role/LeasesScheduleofFutureLeasePaymentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cah_OpioidLawsuitsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Opioid Lawsuits [Member]",
        "label": "Opioid Lawsuits [Member]",
        "terseLabel": "Opioid Lawsuits"
       }
      }
     },
     "localname": "OpioidLawsuitsMember",
     "nsuri": "http://www.cardinal.com/20210630",
     "presentation": [
      "http://www.cardinal.com/role/CommitmentsContingentLiabilitiesandLitigationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cah_OpioidLawsuitsStateDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Opioid Lawsuits State and Political Subdivisions [Domain]",
        "label": "Opioid Lawsuits State [Domain]",
        "terseLabel": "Opioid Lawsuits State [Domain]"
       }
      }
     },
     "localname": "OpioidLawsuitsStateDomain",
     "nsuri": "http://www.cardinal.com/20210630",
     "presentation": [
      "http://www.cardinal.com/role/CommitmentsContingentLiabilitiesandLitigationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cah_OpioidLitigationAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Opioid Litigation",
        "label": "Opioid Litigation [Axis]",
        "terseLabel": "Opioid Litigation [Axis]"
       }
      }
     },
     "localname": "OpioidLitigationAxis",
     "nsuri": "http://www.cardinal.com/20210630",
     "presentation": [
      "http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesLossContingenciesDetails",
      "http://www.cardinal.com/role/CommitmentsContingentLiabilitiesandLitigationDetails",
      "http://www.cardinal.com/role/IncomeTaxesNarrativeDetails",
      "http://www.cardinal.com/role/SegmentInformationNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cah_OpioidLitigationDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Opioid Litigation [Domain]",
        "label": "Opioid Litigation [Domain]",
        "terseLabel": "Opioid Litigation [Domain]"
       }
      }
     },
     "localname": "OpioidLitigationDomain",
     "nsuri": "http://www.cardinal.com/20210630",
     "presentation": [
      "http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesLossContingenciesDetails",
      "http://www.cardinal.com/role/CommitmentsContingentLiabilitiesandLitigationDetails",
      "http://www.cardinal.com/role/IncomeTaxesNarrativeDetails",
      "http://www.cardinal.com/role/SegmentInformationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cah_OptumRxMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "OptumRx [Member]",
        "label": "OptumRx [Member]",
        "terseLabel": "OptumRx [Member]"
       }
      }
     },
     "localname": "OptumRxMember",
     "nsuri": "http://www.cardinal.com/20210630",
     "presentation": [
      "http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesRevenueandGrossTradeReceivablesPercentagebyMajorCustomersDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cah_OtherAccruedLiabilitiesPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other Accrued Liabilities, Policy [Policy Text Block]",
        "label": "Other Accrued Liabilities, Policy [Policy Text Block]",
        "terseLabel": "Other Accrued Liabilities, Policy [Policy Text Block]"
       }
      }
     },
     "localname": "OtherAccruedLiabilitiesPolicyPolicyTextBlock",
     "nsuri": "http://www.cardinal.com/20210630",
     "presentation": [
      "http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cah_OtherJurisdictionsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other Jurisdictions [Member]",
        "label": "Other Jurisdictions [Member]",
        "terseLabel": "Other Jurisdictions [Member]"
       }
      }
     },
     "localname": "OtherJurisdictionsMember",
     "nsuri": "http://www.cardinal.com/20210630",
     "presentation": [
      "http://www.cardinal.com/role/CommitmentsContingentLiabilitiesandLitigationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cah_PatientRecoveryBusinessMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Patient Recovery Business [Member]",
        "label": "Patient Recovery Business [Member]",
        "terseLabel": "Patient Recovery Business [Member]"
       }
      }
     },
     "localname": "PatientRecoveryBusinessMember",
     "nsuri": "http://www.cardinal.com/20210630",
     "presentation": [
      "http://www.cardinal.com/role/DivestituresandAcquisitionsNarrativeDetails",
      "http://www.cardinal.com/role/IncomeTaxesNarrativeDetails",
      "http://www.cardinal.com/role/IncomeTaxesScheduleofUnrecognizedTaxBenefitsRollForwardDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cah_PharmaceuticalDistributionandSpecialtyMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Pharmaceutical Distribution and Specialty [Member]",
        "label": "Pharmaceutical Distribution and Specialty [Member]",
        "terseLabel": "Pharmaceutical Distribution and Specialty [Member]"
       }
      }
     },
     "localname": "PharmaceuticalDistributionandSpecialtyMember",
     "nsuri": "http://www.cardinal.com/20210630",
     "presentation": [
      "http://www.cardinal.com/role/SegmentInformationRevenuebyReportableSegmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cah_PharmaceuticalMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Pharmaceutical [Member]",
        "label": "Pharmaceutical Member",
        "terseLabel": "Pharmaceutical"
       }
      }
     },
     "localname": "PharmaceuticalMember",
     "nsuri": "http://www.cardinal.com/20210630",
     "presentation": [
      "http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesRevenueandGrossTradeReceivablesPercentagebyMajorCustomersDetails",
      "http://www.cardinal.com/role/GoodwillandOtherIntangibleAssetsNarrativeDetails",
      "http://www.cardinal.com/role/GoodwillandOtherIntangibleAssetsScheduleofGoodwillbyReportableSegmentDetails",
      "http://www.cardinal.com/role/SegmentInformationAssetsbyReportableSegmentDetails",
      "http://www.cardinal.com/role/SegmentInformationDepreciationandAmortizationandAdditionstoPropertyandEquipmentbyReportableSegmentDetails",
      "http://www.cardinal.com/role/SegmentInformationRevenuebyReportableSegmentDetails",
      "http://www.cardinal.com/role/SegmentInformationSegmentProfitbyReportableSegmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cah_PlaintiffTypeAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Plaintiff Type [Axis]",
        "label": "Plaintiff Type [Axis]",
        "terseLabel": "Plaintiff Type [Axis]"
       }
      }
     },
     "localname": "PlaintiffTypeAxis",
     "nsuri": "http://www.cardinal.com/20210630",
     "presentation": [
      "http://www.cardinal.com/role/CommitmentsContingentLiabilitiesandLitigationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cah_PlaintiffTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "[Domain] for Plaintiff Type [Axis]",
        "label": "Plaintiff Type [Domain]",
        "terseLabel": "Plaintiff Type [Domain]"
       }
      }
     },
     "localname": "PlaintiffTypeDomain",
     "nsuri": "http://www.cardinal.com/20210630",
     "presentation": [
      "http://www.cardinal.com/role/CommitmentsContingentLiabilitiesandLitigationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cah_PreTaxGainonDivestiture": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Pre-Tax Gain on Divestiture",
        "label": "Pre-Tax Gain on Divestiture",
        "terseLabel": "Pre-Tax Gain on Divestiture"
       }
      }
     },
     "localname": "PreTaxGainonDivestiture",
     "nsuri": "http://www.cardinal.com/20210630",
     "presentation": [
      "http://www.cardinal.com/role/DivestituresandAcquisitionsNarrativeDetails",
      "http://www.cardinal.com/role/SegmentInformationNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cah_PricingDisputesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Expense related to pricing disputes, excluded from provision for bad debts in the consolidated statements of cash flows and recorded as a reduction in gross margin in the consolidated statements of earnings.",
        "label": "Pricing Disputes [Member]",
        "terseLabel": "Pricing Disputes [Member]"
       }
      }
     },
     "localname": "PricingDisputesMember",
     "nsuri": "http://www.cardinal.com/20210630",
     "presentation": [
      "http://www.cardinal.com/role/ScheduleIIValuationsandQualifyingAccountsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cah_PriorYearRecoveriesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Prior Year Recoveries [Member]",
        "label": "Prior Year Recoveries [Member]",
        "terseLabel": "Prior Year Recoveries"
       }
      }
     },
     "localname": "PriorYearRecoveriesMember",
     "nsuri": "http://www.cardinal.com/20210630",
     "presentation": [
      "http://www.cardinal.com/role/ScheduleIIValuationsandQualifyingAccountsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cah_PrivatePartiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Private Parties [Member]",
        "label": "Private Parties [Member]",
        "terseLabel": "Private Parties [Member]"
       }
      }
     },
     "localname": "PrivatePartiesMember",
     "nsuri": "http://www.cardinal.com/20210630",
     "presentation": [
      "http://www.cardinal.com/role/CommitmentsContingentLiabilitiesandLitigationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cah_Proceedsfromdivestituresanddisposalofpropertyandequipmentandheldforsaleassets": {
     "auth_ref": [],
     "calculation": {
      "http://www.cardinal.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Proceeds from divestitures and disposal of property and equipment and held for sale assets",
        "label": "Proceeds from divestitures and disposal of property and equipment and held for sale assets",
        "terseLabel": "Proceeds from divestitures, net of cash sold, and disposal of property and equipment"
       }
      }
     },
     "localname": "Proceedsfromdivestituresanddisposalofpropertyandequipmentandheldforsaleassets",
     "nsuri": "http://www.cardinal.com/20210630",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cah_Proceedsfromsaleofavailableforsalesecuritiesandotherinvestments": {
     "auth_ref": [],
     "calculation": {
      "http://www.cardinal.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from sales of available-for-sale securities and other investments.",
        "label": "Proceeds from sale of available-for-sale securities and other investments",
        "terseLabel": "Proceeds from sale of investments"
       }
      }
     },
     "localname": "Proceedsfromsaleofavailableforsalesecuritiesandotherinvestments",
     "nsuri": "http://www.cardinal.com/20210630",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cah_ProductLiabilityLawsuitsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Product Liability Lawsuits [Member]",
        "label": "Product Liability Lawsuits [Member]",
        "terseLabel": "Product Liability Lawsuits"
       }
      }
     },
     "localname": "ProductLiabilityLawsuitsMember",
     "nsuri": "http://www.cardinal.com/20210630",
     "presentation": [
      "http://www.cardinal.com/role/CommitmentsContingentLiabilitiesandLitigationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cah_ProjectCostsOnInvestmentAndOtherSpending": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Investment spending at the Corporate level. Investment spending generally includes the first year spend for certain projects that require incremental investments in the form of additional operating expenses.",
        "label": "Project Costs On Investment And Other Spending",
        "terseLabel": "Project costs on investment and other spending"
       }
      }
     },
     "localname": "ProjectCostsOnInvestmentAndOtherSpending",
     "nsuri": "http://www.cardinal.com/20210630",
     "presentation": [
      "http://www.cardinal.com/role/SegmentInformationNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cah_Provisionaltaxbenefitrelatedtotransaction": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Provisional tax benefit related to transaction",
        "label": "Provisional tax benefit related to transaction",
        "terseLabel": "Provisional tax benefit related to transaction"
       }
      }
     },
     "localname": "Provisionaltaxbenefitrelatedtotransaction",
     "nsuri": "http://www.cardinal.com/20210630",
     "presentation": [
      "http://www.cardinal.com/role/DivestituresandAcquisitionsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cah_Purchaseofavailableforsalesecuritiesandotherinvestments": {
     "auth_ref": [],
     "calculation": {
      "http://www.cardinal.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow from purchases of available-for-sale securities and other investments.",
        "label": "Purchase of available-for-sale securities and other investments",
        "negatedLabel": "Purchase of other investments"
       }
      }
     },
     "localname": "Purchaseofavailableforsalesecuritiesandotherinvestments",
     "nsuri": "http://www.cardinal.com/20210630",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cah_ReceivableFinancingAgreementTerm": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Receivable Financing Agreement Term",
        "label": "Receivable Financing Agreement Term",
        "terseLabel": "Receivable financing agreement term"
       }
      }
     },
     "localname": "ReceivableFinancingAgreementTerm",
     "nsuri": "http://www.cardinal.com/20210630",
     "presentation": [
      "http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeReceivablesDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "cah_ReclassificationofdeferredrentinaccordancewithASC842": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reclassification of deferred rent in accordance with ASC 842",
        "label": "Reclassification of deferred rent in accordance with ASC 842",
        "terseLabel": "Reclassification of deferred rent in accordance with ASC 842"
       }
      }
     },
     "localname": "ReclassificationofdeferredrentinaccordancewithASC842",
     "nsuri": "http://www.cardinal.com/20210630",
     "presentation": [
      "http://www.cardinal.com/role/LeasesDetails",
      "http://www.cardinal.com/role/LeasesSupplementalCashFlowInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cah_RemainingStockOptionPlanDataTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "[Table Text Block] for Remaining Stock Option Plan Data [Table]",
        "label": "Remaining Stock Option Plan Data [Table Text Block]",
        "terseLabel": "Schedule of Remaining Stock Option Plan Data"
       }
      }
     },
     "localname": "RemainingStockOptionPlanDataTableTextBlock",
     "nsuri": "http://www.cardinal.com/20210630",
     "presentation": [
      "http://www.cardinal.com/role/ShareBasedCompensationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cah_RevenueRecognitionReserveforSalesReturnsandAllowances": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Revenue Recognition, Reserve for Sales Returns and Allowances",
        "label": "Revenue Recognition, Reserve for Sales Returns and Allowances",
        "terseLabel": "Accrual for estimated sales returns and allowances"
       }
      }
     },
     "localname": "RevenueRecognitionReserveforSalesReturnsandAllowances",
     "nsuri": "http://www.cardinal.com/20210630",
     "presentation": [
      "http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeSalesReturnsandAllowancesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cah_SalesreturnsPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "sales returns [Policy Text Block]",
        "label": "sales returns [Policy Text Block]",
        "terseLabel": "Sales Returns and Allowances"
       }
      }
     },
     "localname": "SalesreturnsPolicyTextBlock",
     "nsuri": "http://www.cardinal.com/20210630",
     "presentation": [
      "http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cah_ScheduleOfDeferredTaxAssetsAndLiabilitiesAfterNettingByTaxJurisdictionTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule Of Deferred Tax Assets And Liabilities After Netting By Tax Jurisdiction [Table Text Block]",
        "label": "Schedule Of Deferred Tax Assets And Liabilities After Netting By Tax Jurisdiction [Table Text Block]",
        "terseLabel": "Schedule of Deferred Tax Assets and Liabilities after Netting by Tax Jurisdiction"
       }
      }
     },
     "localname": "ScheduleOfDeferredTaxAssetsAndLiabilitiesAfterNettingByTaxJurisdictionTableTextBlock",
     "nsuri": "http://www.cardinal.com/20210630",
     "presentation": [
      "http://www.cardinal.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cah_ScheduleOfFairValueGainLossDerivativeInstrumentTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Summarizes the fair value and notional amounts of derivative instruments held as of the balance sheet date.",
        "label": "Schedule Of Fair Value Gain Loss Derivative Instrument [Table Text Block]",
        "terseLabel": "Schedule of Fair Value Gain/(Loss) Derivative Instrument"
       }
      }
     },
     "localname": "ScheduleOfFairValueGainLossDerivativeInstrumentTableTextBlock",
     "nsuri": "http://www.cardinal.com/20210630",
     "presentation": [
      "http://www.cardinal.com/role/FinancialInstrumentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cah_Sharesthatwouldbeantidilutiveasaresultofnetloss": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "shares that would be antidilutive as a result of net loss",
        "label": "shares that would be antidilutive as a result of net loss",
        "terseLabel": "shares that would be antidilutive as a result of net loss"
       }
      }
     },
     "localname": "Sharesthatwouldbeantidilutiveasaresultofnetloss",
     "nsuri": "http://www.cardinal.com/20210630",
     "presentation": [
      "http://www.cardinal.com/role/EarningsPerShareAttributabletoCardinalHealthIncNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "cah_ShippingandHandlingCostsPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ShippingandHandlingCosts [Policy Text Block]",
        "label": "ShippingandHandlingCosts [Policy Text Block]",
        "terseLabel": "Shipping and Handling"
       }
      }
     },
     "localname": "ShippingandHandlingCostsPolicyTextBlock",
     "nsuri": "http://www.cardinal.com/20210630",
     "presentation": [
      "http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cah_ShortTermCreditFacilitiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other short-term credit facilities and an unsecured line of credit",
        "label": "Short Term Credit Facilities Member",
        "terseLabel": "Short Term Credit Facilities"
       }
      }
     },
     "localname": "ShortTermCreditFacilitiesMember",
     "nsuri": "http://www.cardinal.com/20210630",
     "presentation": [
      "http://www.cardinal.com/role/LongTermObligationsandOtherShortTermBorrowingsNarrativeDetails",
      "http://www.cardinal.com/role/LongTermObligationsandOtherShortTermBorrowingsOtherFinancingArrangementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cah_SterileSurgicalGownRecallAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sterile Surgical Gown Recall",
        "label": "Sterile Surgical Gown Recall [Axis]",
        "terseLabel": "Sterile Surgical Gown Recall [Axis]"
       }
      }
     },
     "localname": "SterileSurgicalGownRecallAxis",
     "nsuri": "http://www.cardinal.com/20210630",
     "presentation": [
      "http://www.cardinal.com/role/SegmentInformationNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cah_SterileSurgicalGownRecallDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sterile Surgical Gown Recall [Domain]",
        "label": "Sterile Surgical Gown Recall [Domain]",
        "terseLabel": "Sterile Surgical Gown Recall [Domain]"
       }
      }
     },
     "localname": "SterileSurgicalGownRecallDomain",
     "nsuri": "http://www.cardinal.com/20210630",
     "presentation": [
      "http://www.cardinal.com/role/SegmentInformationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cah_SterileSurgicalGownRecallMemberDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sterile Surgical Gown Recall [Member] [Domain]",
        "label": "Sterile Surgical Gown Recall [Member] [Domain]",
        "terseLabel": "Sterile Surgical Gown Recall [Member] [Domain]"
       }
      }
     },
     "localname": "SterileSurgicalGownRecallMemberDomain",
     "nsuri": "http://www.cardinal.com/20210630",
     "presentation": [
      "http://www.cardinal.com/role/CommitmentsContingentLiabilitiesandLitigationDetails",
      "http://www.cardinal.com/role/SegmentInformationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cah_TaxMatterAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tax Matter [Axis]",
        "label": "Tax Matter [Axis]",
        "terseLabel": "Tax Matter [Axis]"
       }
      }
     },
     "localname": "TaxMatterAxis",
     "nsuri": "http://www.cardinal.com/20210630",
     "presentation": [
      "http://www.cardinal.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cah_TaxMatterDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "[Domain] for Tax Matter [Axis]",
        "label": "Tax Matter [Domain]",
        "terseLabel": "Tax Matter [Domain]"
       }
      }
     },
     "localname": "TaxMatterDomain",
     "nsuri": "http://www.cardinal.com/20210630",
     "presentation": [
      "http://www.cardinal.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cah_TotalLeaseLiability": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total Lease Liability",
        "label": "Total Lease Liability",
        "terseLabel": "Total Lease Liability"
       }
      }
     },
     "localname": "TotalLeaseLiability",
     "nsuri": "http://www.cardinal.com/20210630",
     "presentation": [
      "http://www.cardinal.com/role/LeasesScheduleofFutureLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cah_TotalLeaseLiabilityNotYetCommencedAmount": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total Lease Liability Not Yet Commenced, Amount",
        "label": "Total Lease Liability Not Yet Commenced, Amount",
        "terseLabel": "Less: leases not yet commenced (1)"
       }
      }
     },
     "localname": "TotalLeaseLiabilityNotYetCommencedAmount",
     "nsuri": "http://www.cardinal.com/20210630",
     "presentation": [
      "http://www.cardinal.com/role/LeasesScheduleofFutureLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cah_TotalLeaseLiabilityPaymentsDue": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total undiscounted Lease Liability Payments Due for both operating and financing leases",
        "label": "Total Lease Liability Payments Due",
        "terseLabel": "Total future lease payments"
       }
      }
     },
     "localname": "TotalLeaseLiabilityPaymentsDue",
     "nsuri": "http://www.cardinal.com/20210630",
     "presentation": [
      "http://www.cardinal.com/role/LeasesScheduleofFutureLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cah_TotalLeaseLiabilityUndiscountedExcessAmount": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total Lease Liability Undiscounted Excess Amount",
        "label": "Total Lease Liability Undiscounted Excess Amount",
        "terseLabel": "Less: imputed interest"
       }
      }
     },
     "localname": "TotalLeaseLiabilityUndiscountedExcessAmount",
     "nsuri": "http://www.cardinal.com/20210630",
     "presentation": [
      "http://www.cardinal.com/role/LeasesScheduleofFutureLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cah_TotalOpioidLitigationMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total Opioid Litigation",
        "label": "Total Opioid Litigation [Member]",
        "terseLabel": "Total Opioid Litigation [Member]"
       }
      }
     },
     "localname": "TotalOpioidLitigationMember",
     "nsuri": "http://www.cardinal.com/20210630",
     "presentation": [
      "http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesLossContingenciesDetails",
      "http://www.cardinal.com/role/CommitmentsContingentLiabilitiesandLitigationDetails",
      "http://www.cardinal.com/role/IncomeTaxesNarrativeDetails",
      "http://www.cardinal.com/role/SegmentInformationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cah_TrademarksAndPatentsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The rights acquired through registration of a trademark to gain or protect exclusive use of a business name, symbol or other device or style, and the exclusive legal right granted by the government to the owner of the patent to exploit an invention or a process for a period of time specified by law.",
        "label": "Trademarks And Patents Member",
        "terseLabel": "Trademarks, trade names and patents"
       }
      }
     },
     "localname": "TrademarksAndPatentsMember",
     "nsuri": "http://www.cardinal.com/20210630",
     "presentation": [
      "http://www.cardinal.com/role/GoodwillandOtherIntangibleAssetsScheduleofIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cah_TreasuryStockAcquiredShares": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Treasury Stock Acquired Shares",
        "label": "Treasury Stock Acquired Shares",
        "terseLabel": "Treasury Stock Acquired Shares"
       }
      }
     },
     "localname": "TreasuryStockAcquiredShares",
     "nsuri": "http://www.cardinal.com/20210630",
     "presentation": [
      "http://www.cardinal.com/role/ShareholdersEquityNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "cah_VendorReserves": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of reserves, relating to vendor disputes or deductions, that are netted against vendor liabilities in the ordinary course of business.",
        "label": "Vendor Reserves",
        "terseLabel": "Vendor reserves"
       }
      }
     },
     "localname": "VendorReserves",
     "nsuri": "http://www.cardinal.com/20210630",
     "presentation": [
      "http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeVendorReservesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cah_VestingPeriodinyearsforShares": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Vesting Period in years for Shares",
        "label": "Vesting Period in years for Shares",
        "terseLabel": "Vesting Period in years for Shares"
       }
      }
     },
     "localname": "VestingPeriodinyearsforShares",
     "nsuri": "http://www.cardinal.com/20210630",
     "presentation": [
      "http://www.cardinal.com/role/FinancialInstrumentsNarrativeDetails",
      "http://www.cardinal.com/role/ShareBasedCompensationAdditionalDataRelatedtoPerformanceShareUnitActivityDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "cah_WriteDownOfAssetsHeldForSale": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Write-down of assets held for sale",
        "label": "Write-down of assets held for sale",
        "terseLabel": "Write-down of assets held for sale"
       }
      }
     },
     "localname": "WriteDownOfAssetsHeldForSale",
     "nsuri": "http://www.cardinal.com/20210630",
     "presentation": [
      "http://www.cardinal.com/role/DivestituresandAcquisitionsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "country_US": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "UNITED STATES",
        "terseLabel": "United States"
       }
      }
     },
     "localname": "US",
     "nsuri": "http://xbrl.sec.gov/country/2021",
     "presentation": [
      "http://www.cardinal.com/role/SegmentInformationPropertyandEquipmentnetbyGeographicAreaDetails",
      "http://www.cardinal.com/role/SegmentInformationRevenuebyReportableSegmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.cardinal.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.cardinal.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]",
        "terseLabel": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date",
        "terseLabel": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.cardinal.com/role/CoverPage"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentAnnualReport": {
     "auth_ref": [
      "r776",
      "r777",
      "r778"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an annual report.",
        "label": "Document Annual Report",
        "terseLabel": "Document Annual Report"
       }
      }
     },
     "localname": "DocumentAnnualReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.cardinal.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus",
        "terseLabel": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.cardinal.com/role/CoverPage"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus",
        "terseLabel": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.cardinal.com/role/CoverPage",
      "http://www.cardinal.com/role/IncomeTaxesScheduleofIncomebeforeIncomeTaxDomesticandForeignDetails",
      "http://www.cardinal.com/role/LongTermObligationsandOtherShortTermBorrowingsNarrativeDetails"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.cardinal.com/role/CoverPage"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r779"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report",
        "terseLabel": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.cardinal.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.cardinal.com/role/CoverPage"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "auth_ref": [
      "r774"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Documents incorporated by reference.",
        "label": "Documents Incorporated by Reference [Text Block]",
        "terseLabel": "Documents Incorporated by Reference"
       }
      }
     },
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.cardinal.com/role/CoverPage"
     ],
     "xbrltype": "textBlockItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.cardinal.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.cardinal.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.cardinal.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.cardinal.com/role/CoverPage"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r780"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.cardinal.com/role/CoverPage"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding",
        "terseLabel": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.cardinal.com/role/CoverPage"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status",
        "terseLabel": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.cardinal.com/role/CoverPage"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains.",
        "label": "Entity [Domain]",
        "terseLabel": "Entity [Domain]"
       }
      }
     },
     "localname": "EntityDomain",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.cardinal.com/role/LongTermObligationsandOtherShortTermBorrowingsLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r780"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.cardinal.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.cardinal.com/role/CoverPage"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r780"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category",
        "terseLabel": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.cardinal.com/role/CoverPage"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.cardinal.com/role/CoverPage"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r782"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current",
        "terseLabel": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.cardinal.com/role/CoverPage"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityPublicFloat": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.",
        "label": "Entity Public Float",
        "terseLabel": "Entity Public Float"
       }
      }
     },
     "localname": "EntityPublicFloat",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.cardinal.com/role/CoverPage"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r780"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.cardinal.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r780"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company",
        "terseLabel": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.cardinal.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r780"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business",
        "terseLabel": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.cardinal.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r780"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.cardinal.com/role/CoverPage"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_EntityVoluntaryFilers": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.",
        "label": "Entity Voluntary Filers",
        "terseLabel": "Entity Voluntary Filers"
       }
      }
     },
     "localname": "EntityVoluntaryFilers",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.cardinal.com/role/CoverPage"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.",
        "label": "Entity Well-known Seasoned Issuer",
        "terseLabel": "Entity Well-Known Seasoned Issuer"
       }
      }
     },
     "localname": "EntityWellKnownSeasonedIssuer",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.cardinal.com/role/CoverPage"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_IcfrAuditorAttestationFlag": {
     "auth_ref": [
      "r776",
      "r777",
      "r778"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "ICFR Auditor Attestation Flag",
        "terseLabel": "ICFR Auditor Attestation Flag"
       }
      }
     },
     "localname": "IcfrAuditorAttestationFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.cardinal.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_LegalEntityAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The set of legal entities associated with a report.",
        "label": "Legal Entity [Axis]",
        "terseLabel": "Legal Entity [Axis]"
       }
      }
     },
     "localname": "LegalEntityAxis",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.cardinal.com/role/LongTermObligationsandOtherShortTermBorrowingsLongTermDebtDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.cardinal.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r773"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.cardinal.com/role/CoverPage"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r775"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.cardinal.com/role/CoverPage"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.cardinal.com/role/CoverPage"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "srt_ConsolidationItemsAxis": {
     "auth_ref": [
      "r144",
      "r209",
      "r222",
      "r223",
      "r224",
      "r225",
      "r227",
      "r229",
      "r233",
      "r343",
      "r344",
      "r345",
      "r346",
      "r347",
      "r348",
      "r350",
      "r351",
      "r353",
      "r355",
      "r356",
      "r794",
      "r795",
      "r796",
      "r797",
      "r798",
      "r799",
      "r800",
      "r801",
      "r802",
      "r803",
      "r804"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by components, eliminations, non-segment corporate-level activity and reconciling items used in consolidating a parent entity and its subsidiaries or its operating segments.",
        "label": "Consolidation Items [Axis]",
        "terseLabel": "Consolidation Items [Axis]"
       }
      }
     },
     "localname": "ConsolidationItemsAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/SegmentInformationAssetsbyReportableSegmentDetails",
      "http://www.cardinal.com/role/SegmentInformationDepreciationandAmortizationandAdditionstoPropertyandEquipmentbyReportableSegmentDetails",
      "http://www.cardinal.com/role/SegmentInformationRevenuebyReportableSegmentDetails",
      "http://www.cardinal.com/role/SegmentInformationSegmentProfitbyReportableSegmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ConsolidationItemsDomain": {
     "auth_ref": [
      "r144",
      "r209",
      "r222",
      "r223",
      "r224",
      "r225",
      "r227",
      "r229",
      "r233",
      "r343",
      "r344",
      "r345",
      "r346",
      "r347",
      "r348",
      "r350",
      "r351",
      "r353",
      "r355",
      "r356",
      "r794",
      "r795",
      "r796",
      "r797",
      "r798",
      "r799",
      "r800",
      "r801",
      "r802",
      "r803",
      "r804"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components, elimination, non-segment corporate-level activity and reconciling items used in consolidating a parent entity and its subsidiaries or its operating segments.",
        "label": "Consolidation Items [Domain]",
        "terseLabel": "Consolidation Items [Domain]"
       }
      }
     },
     "localname": "ConsolidationItemsDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/SegmentInformationAssetsbyReportableSegmentDetails",
      "http://www.cardinal.com/role/SegmentInformationDepreciationandAmortizationandAdditionstoPropertyandEquipmentbyReportableSegmentDetails",
      "http://www.cardinal.com/role/SegmentInformationRevenuebyReportableSegmentDetails",
      "http://www.cardinal.com/role/SegmentInformationSegmentProfitbyReportableSegmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_LitigationCaseAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of judicial proceeding, alternative dispute resolution or claim.",
        "label": "Litigation Case [Axis]",
        "terseLabel": "Litigation Case"
       }
      }
     },
     "localname": "LitigationCaseAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CommitmentsContingentLiabilitiesandLitigationDetails",
      "http://www.cardinal.com/role/SegmentInformationNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_LitigationCaseTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Judicial proceeding, alternative dispute resolution or claim. For example, but not limited to, name of case, category of litigation, or other differentiating information.",
        "label": "Litigation Case [Domain]",
        "terseLabel": "Litigation Case Type"
       }
      }
     },
     "localname": "LitigationCaseTypeDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CommitmentsContingentLiabilitiesandLitigationDetails",
      "http://www.cardinal.com/role/SegmentInformationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MajorCustomersAxis": {
     "auth_ref": [
      "r242",
      "r427",
      "r430",
      "r740"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by name or description of a single external customer or a group of external customers.",
        "label": "Customer [Axis]",
        "terseLabel": "Customer [Axis]"
       }
      }
     },
     "localname": "MajorCustomersAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeMajorCustomersDetails",
      "http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesRevenueandGrossTradeReceivablesPercentagebyMajorCustomersDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_MaximumMember": {
     "auth_ref": [
      "r361",
      "r402",
      "r442",
      "r444",
      "r676",
      "r677",
      "r678",
      "r679",
      "r680",
      "r681",
      "r683",
      "r737",
      "r741",
      "r771",
      "r772"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Upper limit of the provided range.",
        "label": "Maximum [Member]",
        "terseLabel": "Maximum"
       }
      }
     },
     "localname": "MaximumMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesComponentsofPropertyandEquipmentDetails",
      "http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeGoodwillandOtherIntangibleAssetsDetails",
      "http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativePropertyandEquipmentDetails",
      "http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeReceivablesDetails",
      "http://www.cardinal.com/role/CommitmentsContingentLiabilitiesandLitigationDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleofOutstandingInstrumentsCashFlowHedgesDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleofOutstandingInstrumentsEconomicHedgesDetails",
      "http://www.cardinal.com/role/IncomeTaxesNarrativeDetails",
      "http://www.cardinal.com/role/LeasesDetails",
      "http://www.cardinal.com/role/ShareBasedCompensationNarrativeDetails",
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleofAdditionalDataRelatedtoStockOptionsDetails",
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleofTotalShareBasedCompensationExpensebyTypeofAwardDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MinimumMember": {
     "auth_ref": [
      "r361",
      "r402",
      "r442",
      "r444",
      "r676",
      "r677",
      "r678",
      "r679",
      "r680",
      "r681",
      "r683",
      "r737",
      "r741",
      "r771",
      "r772"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lower limit of the provided range.",
        "label": "Minimum [Member]",
        "terseLabel": "Minimum"
       }
      }
     },
     "localname": "MinimumMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesComponentsofPropertyandEquipmentDetails",
      "http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeGoodwillandOtherIntangibleAssetsDetails",
      "http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativePropertyandEquipmentDetails",
      "http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeReceivablesDetails",
      "http://www.cardinal.com/role/CommitmentsContingentLiabilitiesandLitigationDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleofOutstandingInstrumentsCashFlowHedgesDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleofOutstandingInstrumentsEconomicHedgesDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleofOutstandingInstrumentsFairValueHedgesDetails",
      "http://www.cardinal.com/role/IncomeTaxesNarrativeDetails",
      "http://www.cardinal.com/role/LeasesDetails",
      "http://www.cardinal.com/role/ShareBasedCompensationAdditionalDataRelatedtoPerformanceShareUnitActivityDetails",
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleofTotalShareBasedCompensationExpensebyTypeofAwardDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_NameOfMajorCustomerDomain": {
     "auth_ref": [
      "r242",
      "r427",
      "r430",
      "r740"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Single external customer or group of external customers.",
        "label": "Customer [Domain]",
        "terseLabel": "Customer [Domain]"
       }
      }
     },
     "localname": "NameOfMajorCustomerDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeMajorCustomersDetails",
      "http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesRevenueandGrossTradeReceivablesPercentagebyMajorCustomersDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ProductOrServiceAxis": {
     "auth_ref": [
      "r236",
      "r427",
      "r428",
      "r685",
      "r736",
      "r738"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by product and service, or group of similar products and similar services.",
        "label": "Product and Service [Axis]",
        "terseLabel": "Product and Service [Axis]"
       }
      }
     },
     "localname": "ProductOrServiceAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeShippingandHandlingDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ProductsAndServicesDomain": {
     "auth_ref": [
      "r236",
      "r427",
      "r428",
      "r685",
      "r736",
      "r738"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Product or service, or a group of similar products or similar services.",
        "label": "Product and Service [Domain]",
        "terseLabel": "Product and Service [Domain]"
       }
      }
     },
     "localname": "ProductsAndServicesDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeShippingandHandlingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RangeAxis": {
     "auth_ref": [
      "r361",
      "r402",
      "r431",
      "r442",
      "r444",
      "r676",
      "r677",
      "r678",
      "r679",
      "r680",
      "r681",
      "r683",
      "r737",
      "r741",
      "r771",
      "r772"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by statistical measurement. Includes, but is not limited to, minimum, maximum, weighted average, arithmetic average, and median.",
        "label": "Statistical Measurement [Axis]",
        "terseLabel": "Statistical Measurement [Axis]"
       }
      }
     },
     "localname": "RangeAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesComponentsofPropertyandEquipmentDetails",
      "http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeGoodwillandOtherIntangibleAssetsDetails",
      "http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativePropertyandEquipmentDetails",
      "http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeReceivablesDetails",
      "http://www.cardinal.com/role/CommitmentsContingentLiabilitiesandLitigationDetails",
      "http://www.cardinal.com/role/DivestituresandAcquisitionsNarrativeDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleofOutstandingInstrumentsCashFlowHedgesDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleofOutstandingInstrumentsEconomicHedgesDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleofOutstandingInstrumentsFairValueHedgesDetails",
      "http://www.cardinal.com/role/IncomeTaxesNarrativeDetails",
      "http://www.cardinal.com/role/LeasesDetails",
      "http://www.cardinal.com/role/LongTermObligationsandOtherShortTermBorrowingsOtherFinancingArrangementsDetails",
      "http://www.cardinal.com/role/ShareBasedCompensationAdditionalDataRelatedtoPerformanceShareUnitActivityDetails",
      "http://www.cardinal.com/role/ShareBasedCompensationNarrativeDetails",
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleofAdditionalDataRelatedtoStockOptionsDetails",
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleofTotalShareBasedCompensationExpensebyTypeofAwardDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_RangeMember": {
     "auth_ref": [
      "r361",
      "r402",
      "r431",
      "r442",
      "r444",
      "r676",
      "r677",
      "r678",
      "r679",
      "r680",
      "r681",
      "r683",
      "r737",
      "r741",
      "r771",
      "r772"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Statistical measurement. Includes, but is not limited to, minimum, maximum, weighted average, arithmetic average, and median.",
        "label": "Statistical Measurement [Domain]",
        "terseLabel": "Statistical Measurement [Domain]"
       }
      }
     },
     "localname": "RangeMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesComponentsofPropertyandEquipmentDetails",
      "http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeGoodwillandOtherIntangibleAssetsDetails",
      "http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativePropertyandEquipmentDetails",
      "http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeReceivablesDetails",
      "http://www.cardinal.com/role/CommitmentsContingentLiabilitiesandLitigationDetails",
      "http://www.cardinal.com/role/DivestituresandAcquisitionsNarrativeDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleofOutstandingInstrumentsCashFlowHedgesDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleofOutstandingInstrumentsEconomicHedgesDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleofOutstandingInstrumentsFairValueHedgesDetails",
      "http://www.cardinal.com/role/IncomeTaxesNarrativeDetails",
      "http://www.cardinal.com/role/LeasesDetails",
      "http://www.cardinal.com/role/LongTermObligationsandOtherShortTermBorrowingsOtherFinancingArrangementsDetails",
      "http://www.cardinal.com/role/ShareBasedCompensationAdditionalDataRelatedtoPerformanceShareUnitActivityDetails",
      "http://www.cardinal.com/role/ShareBasedCompensationNarrativeDetails",
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleofAdditionalDataRelatedtoStockOptionsDetails",
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleofTotalShareBasedCompensationExpensebyTypeofAwardDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock": {
     "auth_ref": [
      "r152",
      "r793"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for valuation and qualifying accounts and reserves.",
        "label": "SEC Schedule, 12-09, Schedule of Valuation and Qualifying Accounts Disclosure [Text Block]",
        "terseLabel": "SEC Schedule, 12-09, Schedule of Valuation and Qualifying Accounts Disclosure [Text Block]"
       }
      }
     },
     "localname": "ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ScheduleIIValuationsandQualifyingAccounts"
     ],
     "xbrltype": "textBlockItemType"
    },
    "srt_SegmentGeographicalDomain": {
     "auth_ref": [
      "r237",
      "r238",
      "r427",
      "r429",
      "r739",
      "r762",
      "r763",
      "r764",
      "r765",
      "r766",
      "r767",
      "r768",
      "r769",
      "r770",
      "r783",
      "r785",
      "r786",
      "r787",
      "r788",
      "r789",
      "r790",
      "r791",
      "r792"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Geographical area.",
        "label": "Geographical [Domain]",
        "terseLabel": "Geographical [Domain]"
       }
      }
     },
     "localname": "SegmentGeographicalDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CommitmentsContingentLiabilitiesandLitigationDetails",
      "http://www.cardinal.com/role/SegmentInformationPropertyandEquipmentnetbyGeographicAreaDetails",
      "http://www.cardinal.com/role/SegmentInformationRevenuebyReportableSegmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_StatementGeographicalAxis": {
     "auth_ref": [
      "r237",
      "r238",
      "r427",
      "r429",
      "r739",
      "r756",
      "r762",
      "r763",
      "r764",
      "r765",
      "r766",
      "r767",
      "r768",
      "r769",
      "r770",
      "r783",
      "r784"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by geographical components.",
        "label": "Geographical [Axis]",
        "terseLabel": "Geographical [Axis]"
       }
      }
     },
     "localname": "StatementGeographicalAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CommitmentsContingentLiabilitiesandLitigationDetails",
      "http://www.cardinal.com/role/SegmentInformationPropertyandEquipmentnetbyGeographicAreaDetails",
      "http://www.cardinal.com/role/SegmentInformationRevenuebyReportableSegmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ValuationAndQualifyingAccountsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract]",
        "terseLabel": "SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract]"
       }
      }
     },
     "localname": "ValuationAndQualifyingAccountsAbstract",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "srt_ValuationAndQualifyingAccountsDisclosureLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Line Items]",
        "terseLabel": "SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Line Items]"
       }
      }
     },
     "localname": "ValuationAndQualifyingAccountsDisclosureLineItems",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ScheduleIIValuationsandQualifyingAccountsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ValuationAndQualifyingAccountsDisclosureTable": {
     "auth_ref": [
      "r145",
      "r146",
      "r147",
      "r150",
      "r151",
      "r793"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of valuation and qualifying accounts and reserves.",
        "label": "SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Table]",
        "terseLabel": "SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Table]"
       }
      }
     },
     "localname": "ValuationAndQualifyingAccountsDisclosureTable",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ScheduleIIValuationsandQualifyingAccountsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AOCIAttributableToParentNetOfTaxRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "AOCI Attributable to Parent, Net of Tax [Roll Forward]",
        "terseLabel": "AOCI Attributable to Parent, Net of Tax [Roll Forward]"
       }
      }
     },
     "localname": "AOCIAttributableToParentNetOfTaxRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ShareholdersEquityChangesintheAccumulatedOtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountingPoliciesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Policies [Abstract]",
        "terseLabel": "Accounting Policies [Abstract]"
       }
      }
     },
     "localname": "AccountingPoliciesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountsNotesAndLoansReceivableLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Accounts, Notes, Loans and Financing Receivable [Line Items]",
        "terseLabel": "Accounts, Notes, Loans and Financing Receivable [Line Items]"
       }
      }
     },
     "localname": "AccountsNotesAndLoansReceivableLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeReceivablesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis": {
     "auth_ref": [
      "r70"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of receivable.",
        "label": "Receivable Type [Axis]",
        "terseLabel": "Receivable Type [Axis]"
       }
      }
     },
     "localname": "AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeReceivablesDetails",
      "http://www.cardinal.com/role/ScheduleIIValuationsandQualifyingAccountsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountsPayableCurrent": {
     "auth_ref": [
      "r60",
      "r671"
     ],
     "calculation": {
      "http://www.cardinal.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accounts Payable, Current",
        "terseLabel": "Accounts payable",
        "verboseLabel": "Accounts Payable, Current"
       }
      }
     },
     "localname": "AccountsPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedBalanceSheets",
      "http://www.cardinal.com/role/LongTermObligationsandOtherShortTermBorrowingsLongTermDebtDetails",
      "http://www.cardinal.com/role/LongTermObligationsandOtherShortTermBorrowingsNarrativeDetails",
      "http://www.cardinal.com/role/LongTermObligationsandOtherShortTermBorrowingsSummaryofDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsPayableCurrentAndNoncurrent": {
     "auth_ref": [
      "r700",
      "r725"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.",
        "label": "Accounts Payable",
        "terseLabel": "Accounts Payable"
       }
      }
     },
     "localname": "AccountsPayableCurrentAndNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/LongTermObligationsandOtherShortTermBorrowingsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedLiabilitiesMember": {
     "auth_ref": [
      "r62"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This item represents obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered.",
        "label": "Accrued Liabilities [Member]",
        "terseLabel": "Other Accrued Liabilities"
       }
      }
     },
     "localname": "AccruedLiabilitiesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CommitmentsContingentLiabilitiesandLitigationDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleoftheFairValueofAssetsandLiabilitiesRelatedtoDerivativesDesignatedasHedgingInstrumentsDetails",
      "http://www.cardinal.com/role/LeasesSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": {
     "auth_ref": [
      "r57",
      "r297"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.",
        "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment",
        "negatedTerseLabel": "Accumulated depreciation and amortization"
       }
      }
     },
     "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesComponentsofPropertyandEquipmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember": {
     "auth_ref": [
      "r81",
      "r86",
      "r94",
      "r95",
      "r96",
      "r554"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated other comprehensive income (loss) resulting from foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, including the portion attributable to the noncontrolling interest.",
        "label": "Accumulated Foreign Currency Adjustment Including Portion Attributable to Noncontrolling Interest [Member]",
        "terseLabel": "Foreign Currency Translation Adjustments and other"
       }
      }
     },
     "localname": "AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ShareholdersEquityChangesintheAccumulatedOtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember": {
     "auth_ref": [
      "r82",
      "r86",
      "r554"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated other comprehensive income (loss) resulting from gain (loss) from derivative instruments designated and qualifying as the effective portion of cash flow hedges, including the portion attributable to the noncontrolling interest.",
        "label": "Accumulated Net Gain (Loss) from Cash Flow Hedges Including Portion Attributable to Noncontrolling Interest [Member]",
        "terseLabel": "Unrealized Gain/(Loss) on Derivatives, net of tax"
       }
      }
     },
     "localname": "AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ShareholdersEquityChangesintheAccumulatedOtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r47",
      "r84",
      "r85",
      "r86",
      "r719",
      "r749",
      "r753"
     ],
     "calculation": {
      "http://www.cardinal.com/role/ConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.",
        "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax",
        "terseLabel": "Accumulated other comprehensive loss"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeMember": {
     "auth_ref": [
      "r83",
      "r86",
      "r94",
      "r95",
      "r96",
      "r154",
      "r155",
      "r156",
      "r554",
      "r744",
      "r745",
      "r809"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.",
        "label": "AOCI Attributable to Parent [Member]",
        "terseLabel": "Accumulated Other Comprehensive Loss"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedStatementsofShareholdersEquity",
      "http://www.cardinal.com/role/ShareholdersEquityChangesintheAccumulatedOtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdjustmentsForNewAccountingPronouncementsAxis": {
     "auth_ref": [
      "r0",
      "r1",
      "r2",
      "r3",
      "r4",
      "r157",
      "r158",
      "r159",
      "r160",
      "r169",
      "r251",
      "r252",
      "r256",
      "r257",
      "r258",
      "r259",
      "r260",
      "r261",
      "r342",
      "r476",
      "r477",
      "r478",
      "r479",
      "r480",
      "r481",
      "r482",
      "r483",
      "r521",
      "r522",
      "r523",
      "r524",
      "r600",
      "r601",
      "r602",
      "r603",
      "r604",
      "r605",
      "r606",
      "r607",
      "r608",
      "r609",
      "r610",
      "r627",
      "r628",
      "r629",
      "r630",
      "r631",
      "r632",
      "r633",
      "r634",
      "r668",
      "r687",
      "r688",
      "r689",
      "r742",
      "r743",
      "r744",
      "r745",
      "r746",
      "r747",
      "r748",
      "r749",
      "r750",
      "r751",
      "r752",
      "r753",
      "r805",
      "r806",
      "r807",
      "r808",
      "r809"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by amendment to accounting standards.",
        "label": "Accounting Standards Update [Axis]",
        "terseLabel": "Accounting Standards Update [Axis]"
       }
      }
     },
     "localname": "AdjustmentsForNewAccountingPronouncementsAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/LeasesSupplementalCashFlowInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Adjustments to reconcile net earnings/(loss) to net cash provided by operating activities:"
       }
      }
     },
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AllocatedShareBasedCompensationExpense": {
     "auth_ref": [
      "r446",
      "r473",
      "r484"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.",
        "label": "Share-based Payment Arrangement, Expense",
        "terseLabel": "Total share-based compensation expense"
       }
      }
     },
     "localname": "AllocatedShareBasedCompensationExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleofTotalShareBasedCompensationExpensebyTypeofAwardDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AllowanceForCreditLossMember": {
     "auth_ref": [
      "r145",
      "r146",
      "r147",
      "r150",
      "r151"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Allowance for credit loss from right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time.",
        "label": "SEC Schedule, 12-09, Allowance, Credit Loss [Member]",
        "terseLabel": "SEC Schedule, 12-09, Allowance, Credit Loss [Member]"
       }
      }
     },
     "localname": "AllowanceForCreditLossMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeReceivablesDetails",
      "http://www.cardinal.com/role/ScheduleIIValuationsandQualifyingAccountsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AllowanceForLoanAndLeaseLossesMember": {
     "auth_ref": [
      "r145",
      "r146",
      "r147",
      "r150",
      "r151"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Allowance for portion expected to be uncollectible of receivable from loan and lease portfolio.",
        "label": "SEC Schedule, 12-09, Allowance, Loan and Lease Loss [Member]",
        "terseLabel": "SEC Schedule, 12-09, Allowance, Loan and Lease Loss [Member]"
       }
      }
     },
     "localname": "AllowanceForLoanAndLeaseLossesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ScheduleIIValuationsandQualifyingAccountsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AllowanceForLossesOnFinanceReceivablesMember": {
     "auth_ref": [
      "r145",
      "r146",
      "r147",
      "r150",
      "r151"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Allowance for portion expected to be uncollectible of investment in contractual right to receive money on demand or on fixed or determinable date recognized as asset in creditor's statement of financial position.",
        "label": "SEC Schedule, 12-09, Allowance, Loss on Finance Receivable [Member]",
        "terseLabel": "SEC Schedule, 12-09, Allowance, Loss on Finance Receivable [Member]",
        "verboseLabel": "SEC Schedule, 12-09, Allowance, Loss on Finance Receivable [Member]"
       }
      }
     },
     "localname": "AllowanceForLossesOnFinanceReceivablesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeReceivablesDetails",
      "http://www.cardinal.com/role/ScheduleIIValuationsandQualifyingAccountsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AmortizationOfIntangibleAssets": {
     "auth_ref": [
      "r126",
      "r281",
      "r289"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.",
        "label": "Amortization of Intangible Assets",
        "terseLabel": "Amortization of Intangible Assets"
       }
      }
     },
     "localname": "AmortizationOfIntangibleAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/GoodwillandOtherIntangibleAssetsNarrativeDetails",
      "http://www.cardinal.com/role/GoodwillandOtherIntangibleAssetsScheduleofIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "auth_ref": [
      "r179"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount",
        "terseLabel": "Potentially dilutive employee stock options, restricted share units and performance share units that were antidilutive (in shares)"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/EarningsPerShareAttributabletoCardinalHealthIncNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember": {
     "auth_ref": [
      "r83",
      "r86",
      "r94",
      "r95",
      "r96",
      "r554"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, including the portion attributable to the noncontrolling interest. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.",
        "label": "AOCI Including Portion Attributable to Noncontrolling Interest [Member]",
        "terseLabel": "AOCI Including Portion Attributable to Noncontrolling Interest [Member]"
       }
      }
     },
     "localname": "AociIncludingPortionAttributableToNoncontrollingInterestMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ShareholdersEquityChangesintheAccumulatedOtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_Assets": {
     "auth_ref": [
      "r139",
      "r217",
      "r224",
      "r231",
      "r255",
      "r343",
      "r344",
      "r345",
      "r347",
      "r348",
      "r349",
      "r350",
      "r352",
      "r354",
      "r356",
      "r357",
      "r547",
      "r555",
      "r626",
      "r669",
      "r671",
      "r692",
      "r717"
     ],
     "calculation": {
      "http://www.cardinal.com/role/ConsolidatedBalanceSheets": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets",
        "terseLabel": "Total assets",
        "totalLabel": "Total assets"
       }
      }
     },
     "localname": "Assets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedBalanceSheets",
      "http://www.cardinal.com/role/SegmentInformationAssetsbyReportableSegmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets [Abstract]",
        "terseLabel": "Assets"
       }
      }
     },
     "localname": "AssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsCurrent": {
     "auth_ref": [
      "r27",
      "r28",
      "r76",
      "r139",
      "r255",
      "r343",
      "r344",
      "r345",
      "r347",
      "r348",
      "r349",
      "r350",
      "r352",
      "r354",
      "r356",
      "r357",
      "r547",
      "r555",
      "r626",
      "r669",
      "r671"
     ],
     "calculation": {
      "http://www.cardinal.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Current",
        "totalLabel": "Total current assets"
       }
      }
     },
     "localname": "AssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets, Current [Abstract]",
        "terseLabel": "Current assets:"
       }
      }
     },
     "localname": "AssetsCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsFairValueDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets, Fair Value Disclosure [Abstract]",
        "terseLabel": "Assets:"
       }
      }
     },
     "localname": "AssetsFairValueDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/FairValueMeasurementsFairValueofAssetsandLiabilitiesMeasuredonaRecurringBasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation": {
     "auth_ref": [
      "r5",
      "r6",
      "r16",
      "r18",
      "r22",
      "r300"
     ],
     "calculation": {
      "http://www.cardinal.com/role/ConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as assets attributable to disposal group held for sale or disposed of.",
        "label": "Disposal Group, Including Discontinued Operation, Assets",
        "terseLabel": "Disposal Group, Including Discontinued Operation, Assets"
       }
      }
     },
     "localname": "AssetsOfDisposalGroupIncludingDiscontinuedOperation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedBalanceSheets",
      "http://www.cardinal.com/role/DivestituresandAcquisitionsNarrativeDetails",
      "http://www.cardinal.com/role/FairValueMeasurementsFairValueofAssetsandLiabilitiesMeasuredonaRecurringBasisDetails",
      "http://www.cardinal.com/role/SegmentInformationAssetsbyReportableSegmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AwardTypeAxis": {
     "auth_ref": [
      "r448",
      "r475"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of award under share-based payment arrangement.",
        "label": "Award Type [Axis]",
        "terseLabel": "Award Type [Axis]"
       }
      }
     },
     "localname": "AwardTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ShareBasedCompensationAdditionalDataRelatedtoPerformanceShareUnitActivityDetails",
      "http://www.cardinal.com/role/ShareBasedCompensationAdditionalDataRelatedtoRestrictedShareUnitActivityDetails",
      "http://www.cardinal.com/role/ShareBasedCompensationNarrativeDetails",
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleofAdditionalDataRelatedtoStockOptionsDetails",
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleofAllTransactionsRelatedtoPerformanceShareUnitsUnderthePlansDetails",
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleofAllTransactionsRelatedtoRestrictedShareUnitsUnderthePlansDetails",
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleofRemainingStockOptionPlanDataDetails",
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleofTotalShareBasedCompensationExpensebyTypeofAwardDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BalanceSheetLocationAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location on balance sheet (statement of financial position).",
        "label": "Balance Sheet Location [Axis]",
        "terseLabel": "Balance Sheet Location [Axis]"
       }
      }
     },
     "localname": "BalanceSheetLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CommitmentsContingentLiabilitiesandLitigationDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleoftheFairValueofAssetsandLiabilitiesRelatedtoDerivativesDesignatedasHedgingInstrumentsDetails",
      "http://www.cardinal.com/role/LeasesSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BalanceSheetLocationDomain": {
     "auth_ref": [
      "r570",
      "r575"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in the balance sheet (statement of financial position).",
        "label": "Balance Sheet Location [Domain]",
        "terseLabel": "Balance Sheet Location [Domain]"
       }
      }
     },
     "localname": "BalanceSheetLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CommitmentsContingentLiabilitiesandLitigationDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleoftheFairValueofAssetsandLiabilitiesRelatedtoDerivativesDesignatedasHedgingInstrumentsDetails",
      "http://www.cardinal.com/role/LeasesSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).",
        "label": "Basis of Accounting, Policy [Policy Text Block]",
        "terseLabel": "Basis of Presentation"
       }
      }
     },
     "localname": "BasisOfAccountingPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock": {
     "auth_ref": [
      "r153"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the basis of presentation and significant accounting policies concepts. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).  Accounting policies describe all significant accounting policies of the reporting entity.",
        "label": "Basis of Presentation and Significant Accounting Policies [Text Block]",
        "verboseLabel": "Basis of Presentation and Summary of Significant Accounting Policies"
       }
      }
     },
     "localname": "BasisOfPresentationAndSignificantAccountingPoliciesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BuildingAndBuildingImprovementsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Facility held for productive use including, but not limited to, office, production, storage and distribution facilities and any addition, improvement, or renovation to the structure, for example, but not limited to, interior masonry, interior flooring, electrical, and plumbing.",
        "label": "Building and Building Improvements [Member]",
        "terseLabel": "Building and Improvements"
       }
      }
     },
     "localname": "BuildingAndBuildingImprovementsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesComponentsofPropertyandEquipmentDetails",
      "http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativePropertyandEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BusinessAcquisitionAcquireeDomain": {
     "auth_ref": [
      "r441",
      "r443"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree.",
        "label": "Business Acquisition, Acquiree [Domain]",
        "terseLabel": "Business Acquisition, Acquiree [Domain]",
        "verboseLabel": "Business Acquisition, Acquiree"
       }
      }
     },
     "localname": "BusinessAcquisitionAcquireeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CommitmentsContingentLiabilitiesandLitigationDetails",
      "http://www.cardinal.com/role/DivestituresandAcquisitionsNarrativeDetails",
      "http://www.cardinal.com/role/IncomeTaxesNarrativeDetails",
      "http://www.cardinal.com/role/IncomeTaxesScheduleofUnrecognizedTaxBenefitsRollForwardDetails",
      "http://www.cardinal.com/role/LongTermObligationsandOtherShortTermBorrowingsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BusinessAcquisitionAxis": {
     "auth_ref": [
      "r441",
      "r443",
      "r538",
      "r539"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by business combination or series of individually immaterial business combinations.",
        "label": "Business Acquisition [Axis]",
        "terseLabel": "Business Acquisition [Axis]"
       }
      }
     },
     "localname": "BusinessAcquisitionAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CommitmentsContingentLiabilitiesandLitigationDetails",
      "http://www.cardinal.com/role/DivestituresandAcquisitionsNarrativeDetails",
      "http://www.cardinal.com/role/IncomeTaxesNarrativeDetails",
      "http://www.cardinal.com/role/IncomeTaxesScheduleofUnrecognizedTaxBenefitsRollForwardDetails",
      "http://www.cardinal.com/role/LongTermObligationsandOtherShortTermBorrowingsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessAcquisitionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Business Acquisition [Line Items]",
        "verboseLabel": "Business Acquisition"
       }
      }
     },
     "localname": "BusinessAcquisitionLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/DivestituresandAcquisitionsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessCombinationAndAssetAcquisitionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Combination and Asset Acquisition [Abstract]"
       }
      }
     },
     "localname": "BusinessCombinationAndAssetAcquisitionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessCombinationDisclosureTextBlock": {
     "auth_ref": [
      "r542"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).",
        "label": "Business Combination Disclosure [Text Block]",
        "terseLabel": "Business Combination Disclosure"
       }
      }
     },
     "localname": "BusinessCombinationDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/DivestituresandAcquisitions"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BusinessCombinationsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Combinations [Abstract]",
        "terseLabel": "Business Combinations [Abstract]"
       }
      }
     },
     "localname": "BusinessCombinationsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r23",
      "r53",
      "r128"
     ],
     "calculation": {
      "http://www.cardinal.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash and Cash Equivalents, at Carrying Value",
        "periodEndLabel": "Cash and equivalents at end of period",
        "periodStartLabel": "Cash and equivalents at beginning of period",
        "terseLabel": "Cash and equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedBalanceSheets",
      "http://www.cardinal.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsFairValueDisclosure": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash and Cash Equivalents, Fair Value Disclosure",
        "terseLabel": "Cash equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/FairValueMeasurementsFairValueofAssetsandLiabilitiesMeasuredonaRecurringBasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsPolicyTextBlock": {
     "auth_ref": [
      "r33",
      "r129"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.",
        "label": "Cash and Cash Equivalents, Policy [Policy Text Block]",
        "terseLabel": "Cash Equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "auth_ref": [
      "r122",
      "r635"
     ],
     "calculation": {
      "http://www.cardinal.com/role/ConsolidatedStatementsofCashFlows": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
        "totalLabel": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashFlowHedgingMember": {
     "auth_ref": [
      "r567"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Hedge of the exposure to variability in the cash flows of a recognized asset or liability, or of a forecasted transaction, that is attributable to a particular risk.",
        "label": "Cash Flow Hedging [Member]",
        "terseLabel": "Cash Flow Hedging"
       }
      }
     },
     "localname": "CashFlowHedgingMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/FinancialInstrumentsNarrativeDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleofFairValueGainLossDerivativeInstrumentDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleofGainLossIncludedinAOCIforDerivativeInstrumentsDesignatedasCashFlowHedgesDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleofGainLossReclassifiedfromAOCIintoEarningsforDerivativeInstrumentsDesignatedasCashFlowHedgesDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleofOutstandingInstrumentsCashFlowHedgesDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleoftheFairValueofAssetsandLiabilitiesRelatedtoDerivativesDesignatedasHedgingInstrumentsDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsTables"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1": {
     "auth_ref": [
      "r596"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) from the increase (decrease) in fair value of derivative and nonderivative instruments designated as fair value hedging instruments recognized in the income statement.",
        "label": "Change in Unrealized Gain (Loss) on Fair Value Hedging Instruments",
        "terseLabel": "Change in Unrealized Gain (Loss) on Fair Value Hedging Instruments"
       }
      }
     },
     "localname": "ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/FinancialInstrumentsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ClassOfStockDomain": {
     "auth_ref": [
      "r136",
      "r139",
      "r172",
      "r173",
      "r174",
      "r176",
      "r178",
      "r188",
      "r189",
      "r190",
      "r255",
      "r343",
      "r348",
      "r349",
      "r350",
      "r356",
      "r357",
      "r400",
      "r401",
      "r405",
      "r409",
      "r626",
      "r781"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock.",
        "label": "Class of Stock [Domain]",
        "terseLabel": "Class of Stock [Domain]"
       }
      }
     },
     "localname": "ClassOfStockDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ShareholdersEquityNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ClassOfStockLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Class of Stock [Line Items]",
        "terseLabel": "Class of Stock [Line Items]"
       }
      }
     },
     "localname": "ClassOfStockLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ShareholdersEquityNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommercialPaperMember": {
     "auth_ref": [
      "r340"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unsecured promissory note (generally negotiable) that provides institutions with short-term funds.",
        "label": "Commercial Paper [Member]",
        "terseLabel": "Commercial paper",
        "verboseLabel": "Commercial Paper"
       }
      }
     },
     "localname": "CommercialPaperMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/LongTermObligationsandOtherShortTermBorrowingsNarrativeDetails",
      "http://www.cardinal.com/role/LongTermObligationsandOtherShortTermBorrowingsOtherFinancingArrangementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies Disclosure [Abstract]",
        "terseLabel": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
     "auth_ref": [
      "r323",
      "r324",
      "r325",
      "r336",
      "r758"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for commitments and contingencies.",
        "label": "Commitments and Contingencies Disclosure [Text Block]",
        "terseLabel": "Commitments, Contingent Liabilities and Litigation"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CommitmentsContingentLiabilitiesandLitigation"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CommitmentsAndContingenciesPolicyTextBlock": {
     "auth_ref": [
      "r339",
      "r759"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for commitments and contingencies, which may include policies for recognizing and measuring loss and gain contingencies.",
        "label": "Commitments and Contingencies, Policy [Policy Text Block]",
        "terseLabel": "Loss Contingencies"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CommodityContractMember": {
     "auth_ref": [
      "r432",
      "r586"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Derivative instrument whose primary underlying risk is tied to commodity prices.",
        "label": "Commodity Contract [Member]",
        "terseLabel": "Commodity Contracts"
       }
      }
     },
     "localname": "CommodityContractMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleofFairValueGainLossDerivativeInstrumentDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleofGainLossIncludedinAOCIforDerivativeInstrumentsDesignatedasCashFlowHedgesDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleofGainLossReclassifiedfromAOCIintoEarningsforDerivativeInstrumentsDesignatedasCashFlowHedgesDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleofOutstandingInstrumentsCashFlowHedgesDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleoftheFairValueofAssetsandLiabilitiesRelatedtoDerivativesDesignatedasHedgingInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonClassAMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Classification of common stock representing ownership interest in a corporation.",
        "label": "Common Class A [Member]",
        "terseLabel": "Common Class A"
       }
      }
     },
     "localname": "CommonClassAMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ShareholdersEquityNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonClassBMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Classification of common stock that has different rights than Common Class A, representing ownership interest in a corporation.",
        "label": "Common Class B [Member]",
        "terseLabel": "Common Class B"
       }
      }
     },
     "localname": "CommonClassBMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ShareholdersEquityNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockDividendsPerShareCashPaid": {
     "auth_ref": [
      "r423"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate dividends paid during the period for each share of common stock outstanding.",
        "label": "Common Stock, Dividends, Per Share, Cash Paid",
        "terseLabel": "Cash dividends per common share (in usd per share)"
       }
      }
     },
     "localname": "CommonStockDividendsPerShareCashPaid",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDividendsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockMember": {
     "auth_ref": [
      "r154",
      "r155",
      "r608"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock that is subordinate to all other stock of the issuer.",
        "label": "Common Stock [Member]",
        "terseLabel": "Common Shares"
       }
      }
     },
     "localname": "CommonStockMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedStatementsofShareholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common Stock, Number of Shares, Par Value and Other Disclosures [Abstract]",
        "terseLabel": "Common shares, without par value:"
       }
      }
     },
     "localname": "CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "auth_ref": [
      "r43"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.",
        "label": "Common Stock, Shares Authorized",
        "terseLabel": "Common shares, authorized"
       }
      }
     },
     "localname": "CommonStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedBalanceSheets",
      "http://www.cardinal.com/role/ShareholdersEquityNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesIssued": {
     "auth_ref": [
      "r43"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.",
        "label": "Common Stock, Shares, Issued",
        "periodEndLabel": "Balance at end of period (in shares)",
        "periodStartLabel": "Balance at beginning of period (in shares)",
        "terseLabel": "Common shares, issued"
       }
      }
     },
     "localname": "CommonStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedBalanceSheets",
      "http://www.cardinal.com/role/ConsolidatedStatementsofShareholdersEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockValue": {
     "auth_ref": [
      "r43",
      "r671"
     ],
     "calculation": {
      "http://www.cardinal.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Common Stock, Value, Issued",
        "terseLabel": "Authorized\u2014755 million shares, Issued\u2014 327 million shares at June 30, 2021 and 2020"
       }
      }
     },
     "localname": "CommonStockValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComponentsOfDeferredTaxAssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Components of Deferred Tax Assets [Abstract]",
        "terseLabel": "Deferred income tax assets:"
       }
      }
     },
     "localname": "ComponentsOfDeferredTaxAssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Components of Deferred Tax Liabilities [Abstract]",
        "terseLabel": "Deferred income tax liabilities:"
       }
      }
     },
     "localname": "ComponentsOfDeferredTaxLiabilitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTax": {
     "auth_ref": [
      "r89",
      "r91",
      "r92",
      "r104",
      "r706",
      "r731"
     ],
     "calculation": {
      "http://www.cardinal.com/role/ConsolidatedStatementsofComprehensiveIncome": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent",
        "totalLabel": "Total comprehensive income attributable to Cardinal Health, Inc."
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedStatementsofComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r89",
      "r91",
      "r103",
      "r545",
      "r559",
      "r705",
      "r730"
     ],
     "calculation": {
      "http://www.cardinal.com/role/ConsolidatedStatementsofComprehensiveIncome": {
       "order": 1.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest",
        "totalLabel": "Total comprehensive income/(loss)"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedStatementsofComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ConcentrationRiskBenchmarkDomain": {
     "auth_ref": [
      "r198",
      "r199",
      "r242",
      "r623",
      "r624",
      "r757"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The denominator in a calculation of a disclosed concentration risk percentage.",
        "label": "Concentration Risk Benchmark [Domain]",
        "terseLabel": "Concentration Risk Benchmark [Domain]"
       }
      }
     },
     "localname": "ConcentrationRiskBenchmarkDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeMajorCustomersDetails",
      "http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesRevenueandGrossTradeReceivablesPercentagebyMajorCustomersDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ConcentrationRiskByBenchmarkAxis": {
     "auth_ref": [
      "r198",
      "r199",
      "r242",
      "r623",
      "r624",
      "r754",
      "r757"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by benchmark of concentration risk.",
        "label": "Concentration Risk Benchmark [Axis]",
        "terseLabel": "Concentration Risk Benchmark [Axis]"
       }
      }
     },
     "localname": "ConcentrationRiskByBenchmarkAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeMajorCustomersDetails",
      "http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesRevenueandGrossTradeReceivablesPercentagebyMajorCustomersDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConcentrationRiskByTypeAxis": {
     "auth_ref": [
      "r198",
      "r199",
      "r242",
      "r623",
      "r624",
      "r754",
      "r757"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of concentration risk, for example, but not limited to, asset, liability, net assets, geographic, customer, employees, supplier, lender.",
        "label": "Concentration Risk Type [Axis]",
        "terseLabel": "Concentration Risk Type [Axis]"
       }
      }
     },
     "localname": "ConcentrationRiskByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeMajorCustomersDetails",
      "http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesRevenueandGrossTradeReceivablesPercentagebyMajorCustomersDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConcentrationRiskCreditRisk": {
     "auth_ref": [
      "r193",
      "r713"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for credit risk.",
        "label": "Concentration Risk, Credit Risk, Policy [Policy Text Block]",
        "terseLabel": "Concentrations of Credit Risk"
       }
      }
     },
     "localname": "ConcentrationRiskCreditRisk",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ConcentrationRiskLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Concentration Risk [Line Items]",
        "terseLabel": "Concentration Risk [Line Items]"
       }
      }
     },
     "localname": "ConcentrationRiskLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeMajorCustomersDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConcentrationRiskPercentage1": {
     "auth_ref": [
      "r198",
      "r199",
      "r242",
      "r623",
      "r624"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the \"benchmark\" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.",
        "label": "Concentration Risk, Percentage",
        "terseLabel": "Revenue, major customer, percentage",
        "verboseLabel": "Percent of Revenue"
       }
      }
     },
     "localname": "ConcentrationRiskPercentage1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeMajorCustomersDetails",
      "http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesRevenueandGrossTradeReceivablesPercentagebyMajorCustomersDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ConcentrationRiskTable": {
     "auth_ref": [
      "r196",
      "r198",
      "r199",
      "r200",
      "r623",
      "r625",
      "r757"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Describes the nature of a concentration, a benchmark to which it is compared, and the percentage that the risk is to the benchmark.",
        "label": "Concentration Risk [Table]",
        "terseLabel": "Concentration Risk [Table]"
       }
      }
     },
     "localname": "ConcentrationRiskTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeMajorCustomersDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConcentrationRiskTypeDomain": {
     "auth_ref": [
      "r198",
      "r199",
      "r242",
      "r623",
      "r624",
      "r757"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For an entity that discloses a concentration risk as a percentage of some financial balance or benchmark, identifies the type (for example, asset, liability, net assets, geographic, customer, employees, supplier, lender) of the concentration.",
        "label": "Concentration Risk Type [Domain]",
        "terseLabel": "Concentration Risk Type [Domain]"
       }
      }
     },
     "localname": "ConcentrationRiskTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeMajorCustomersDetails",
      "http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesRevenueandGrossTradeReceivablesPercentagebyMajorCustomersDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ConsolidationPolicyTextBlock": {
     "auth_ref": [
      "r131",
      "r549"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting.  The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.",
        "label": "Consolidation, Policy [Policy Text Block]",
        "terseLabel": "Noncontrolling Interests and Redeemable Noncontrolling Interests"
       }
      }
     },
     "localname": "ConsolidationPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CorporateNonSegmentMember": {
     "auth_ref": [
      "r222",
      "r223",
      "r224",
      "r225",
      "r227",
      "r233",
      "r235"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Corporate headquarters or functional department that may not earn revenues or may earn revenues that are only incidental to the activities of the entity and is not considered an operating segment.",
        "label": "Corporate, Non-Segment [Member]",
        "terseLabel": "Corporate"
       }
      }
     },
     "localname": "CorporateNonSegmentMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/SegmentInformationAssetsbyReportableSegmentDetails",
      "http://www.cardinal.com/role/SegmentInformationDepreciationandAmortizationandAdditionstoPropertyandEquipmentbyReportableSegmentDetails",
      "http://www.cardinal.com/role/SegmentInformationRevenuebyReportableSegmentDetails",
      "http://www.cardinal.com/role/SegmentInformationSegmentProfitbyReportableSegmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CostOfGoodsAndServicesSold": {
     "auth_ref": [
      "r110",
      "r685"
     ],
     "calculation": {
      "http://www.cardinal.com/role/ConsolidatedStatementsofEarnings": {
       "order": 2.0,
       "parentTag": "us-gaap_GrossProfit",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.",
        "label": "Cost of Goods and Services Sold",
        "terseLabel": "Cost of Goods and Services Sold",
        "verboseLabel": "Cost of products sold"
       }
      }
     },
     "localname": "CostOfGoodsAndServicesSold",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CommitmentsContingentLiabilitiesandLitigationDetails",
      "http://www.cardinal.com/role/ConsolidatedStatementsofEarnings"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CostOfSalesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing cost of sales.",
        "label": "Cost of Sales [Member]",
        "terseLabel": "Cost of Products Sold"
       }
      }
     },
     "localname": "CostOfSalesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleofGainLossReclassifiedfromAOCIintoEarningsforDerivativeInstrumentsDesignatedasCashFlowHedgesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock": {
     "auth_ref": [
      "r313",
      "r314",
      "r321"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for recognizing and reporting costs associated with exiting, disposing of, and restructuring certain operations.",
        "label": "Costs Associated with Exit or Disposal Activities or Restructurings, Policy [Policy Text Block]",
        "terseLabel": "Restructuring and Employee Severance"
       }
      }
     },
     "localname": "CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CreditFacilityAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.",
        "label": "Credit Facility [Axis]",
        "terseLabel": "Credit Facility [Axis]"
       }
      }
     },
     "localname": "CreditFacilityAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/LongTermObligationsandOtherShortTermBorrowingsLongTermDebtDetails",
      "http://www.cardinal.com/role/LongTermObligationsandOtherShortTermBorrowingsNarrativeDetails",
      "http://www.cardinal.com/role/LongTermObligationsandOtherShortTermBorrowingsOtherFinancingArrangementsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CreditFacilityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.",
        "label": "Credit Facility [Domain]",
        "terseLabel": "Credit Facility [Domain]"
       }
      }
     },
     "localname": "CreditFacilityDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/LongTermObligationsandOtherShortTermBorrowingsLongTermDebtDetails",
      "http://www.cardinal.com/role/LongTermObligationsandOtherShortTermBorrowingsNarrativeDetails",
      "http://www.cardinal.com/role/LongTermObligationsandOtherShortTermBorrowingsOtherFinancingArrangementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CrossCurrencyInterestRateContractMember": {
     "auth_ref": [
      "r432",
      "r587"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Derivative instrument whose primary underlying risk is tied to interest rates and foreign exchange rates.",
        "label": "Cross Currency Interest Rate Contract [Member]",
        "terseLabel": "Cross Currency Interest Rate Contract [Member]"
       }
      }
     },
     "localname": "CrossCurrencyInterestRateContractMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleoftheFairValueofAssetsandLiabilitiesRelatedtoDerivativesDesignatedasHedgingInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CurrencySwapMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Swap involving the exchange of principal and interest in one currency for another currency.",
        "label": "Currency Swap [Member]",
        "terseLabel": "Currency Swap [Member]"
       }
      }
     },
     "localname": "CurrencySwapMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/FinancialInstrumentsNarrativeDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleofFairValueGainLossDerivativeInstrumentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CurrentFederalTaxExpenseBenefit": {
     "auth_ref": [
      "r140",
      "r517",
      "r527"
     ],
     "calculation": {
      "http://www.cardinal.com/role/IncomeTaxesScheduleofComponentsofIncomeTaxExpenseBenefitCurrentandDeferredDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_CurrentIncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current federal tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Current Federal Tax Expense (Benefit)",
        "terseLabel": "Federal",
        "verboseLabel": "Current Federal Tax Expense (Benefit)"
       }
      }
     },
     "localname": "CurrentFederalTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/IncomeTaxesScheduleofComponentsofIncomeTaxExpenseBenefitCurrentandDeferredDetails",
      "http://www.cardinal.com/role/IncomeTaxesScheduleofUnrecognizedTaxBenefitsRollForwardDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CurrentForeignTaxExpenseBenefit": {
     "auth_ref": [
      "r140",
      "r517"
     ],
     "calculation": {
      "http://www.cardinal.com/role/IncomeTaxesScheduleofComponentsofIncomeTaxExpenseBenefitCurrentandDeferredDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_CurrentIncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Current Foreign Tax Expense (Benefit)",
        "terseLabel": "Non-U.S.",
        "verboseLabel": "Current Foreign Tax Expense (Benefit)"
       }
      }
     },
     "localname": "CurrentForeignTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/IncomeTaxesScheduleofComponentsofIncomeTaxExpenseBenefitCurrentandDeferredDetails",
      "http://www.cardinal.com/role/IncomeTaxesScheduleofUnrecognizedTaxBenefitsRollForwardDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CurrentIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r140",
      "r517",
      "r527",
      "r529"
     ],
     "calculation": {
      "http://www.cardinal.com/role/IncomeTaxesScheduleofComponentsofIncomeTaxExpenseBenefitCurrentandDeferredDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations.",
        "label": "Current Income Tax Expense (Benefit)",
        "terseLabel": "Current Income Tax Expense (Benefit)",
        "totalLabel": "Total current"
       }
      }
     },
     "localname": "CurrentIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/IncomeTaxesScheduleofComponentsofIncomeTaxExpenseBenefitCurrentandDeferredDetails",
      "http://www.cardinal.com/role/IncomeTaxesScheduleofUnrecognizedTaxBenefitsRollForwardDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Income Tax Expense (Benefit), Continuing Operations [Abstract]",
        "terseLabel": "Current:"
       }
      }
     },
     "localname": "CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/IncomeTaxesScheduleofComponentsofIncomeTaxExpenseBenefitCurrentandDeferredDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CurrentStateAndLocalTaxExpenseBenefit": {
     "auth_ref": [
      "r140",
      "r517",
      "r527"
     ],
     "calculation": {
      "http://www.cardinal.com/role/IncomeTaxesScheduleofComponentsofIncomeTaxExpenseBenefitCurrentandDeferredDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_CurrentIncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current state and local tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Current State and Local Tax Expense (Benefit)",
        "terseLabel": "State and local",
        "verboseLabel": "Current State and Local Tax Expense (Benefit)"
       }
      }
     },
     "localname": "CurrentStateAndLocalTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/IncomeTaxesScheduleofComponentsofIncomeTaxExpenseBenefitCurrentandDeferredDetails",
      "http://www.cardinal.com/role/IncomeTaxesScheduleofUnrecognizedTaxBenefitsRollForwardDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CustomerConcentrationRiskMember": {
     "auth_ref": [
      "r197",
      "r242"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reflects the percentage that revenues in the period from one or more significant customers is to net revenues, as defined by the entity, such as total net revenues, product line revenues, segment revenues. The risk is the materially adverse effects of loss of a significant customer.",
        "label": "Customer Concentration Risk [Member]",
        "terseLabel": "Customer Concentration Risk"
       }
      }
     },
     "localname": "CustomerConcentrationRiskMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeMajorCustomersDetails",
      "http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesRevenueandGrossTradeReceivablesPercentagebyMajorCustomersDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CustomerRelationshipsMember": {
     "auth_ref": [
      "r540"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Customer relationship that exists between an entity and its customer, for example, but not limited to, tenant relationships.",
        "label": "Customer Relationships [Member]",
        "terseLabel": "Customer relationships"
       }
      }
     },
     "localname": "CustomerRelationshipsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/GoodwillandOtherIntangibleAssetsScheduleofIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtAndCapitalLeaseObligations": {
     "auth_ref": [
      "r699",
      "r726"
     ],
     "calculation": {
      "http://www.cardinal.com/role/LongTermObligationsandOtherShortTermBorrowingsSummaryofDebtDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of short-term and long-term debt and lease obligation.",
        "label": "Debt and Lease Obligation",
        "totalLabel": "Total",
        "verboseLabel": "Carrying amount"
       }
      }
     },
     "localname": "DebtAndCapitalLeaseObligations",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/FinancialInstrumentsSummaryofEstimatedFairValueofLongtermObligationsandOtherShorttermBorrowingsDetails",
      "http://www.cardinal.com/role/LongTermObligationsandOtherShortTermBorrowingsSummaryofDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Disclosure [Abstract]",
        "terseLabel": "Debt Disclosure [Abstract]"
       }
      }
     },
     "localname": "DebtDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtDisclosureTextBlock": {
     "auth_ref": [
      "r135",
      "r364",
      "r365",
      "r366",
      "r367",
      "r368",
      "r369",
      "r370",
      "r375",
      "r382",
      "r383",
      "r385",
      "r392"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.",
        "label": "Debt Disclosure [Text Block]",
        "terseLabel": "Long-Term Obligations and Other Short-Term Borrowings"
       }
      }
     },
     "localname": "DebtDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/LongTermObligationsandOtherShortTermBorrowings"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DebtInstrumentAxis": {
     "auth_ref": [
      "r36",
      "r37",
      "r38",
      "r138",
      "r144",
      "r358",
      "r359",
      "r360",
      "r361",
      "r362",
      "r363",
      "r365",
      "r371",
      "r372",
      "r373",
      "r374",
      "r376",
      "r377",
      "r378",
      "r379",
      "r380",
      "r381",
      "r386",
      "r387",
      "r388",
      "r389",
      "r649",
      "r693",
      "r695",
      "r716"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities.",
        "label": "Debt Instrument [Axis]",
        "terseLabel": "Debt Instrument [Axis]"
       }
      }
     },
     "localname": "DebtInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/FinancialInstrumentsNarrativeDetails",
      "http://www.cardinal.com/role/LongTermObligationsandOtherShortTermBorrowingsLongTermDebtDetails",
      "http://www.cardinal.com/role/LongTermObligationsandOtherShortTermBorrowingsNarrativeDetails",
      "http://www.cardinal.com/role/LongTermObligationsandOtherShortTermBorrowingsOtherFinancingArrangementsDetails",
      "http://www.cardinal.com/role/LongTermObligationsandOtherShortTermBorrowingsSummaryofDebtDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentFairValue": {
     "auth_ref": [
      "r373",
      "r386",
      "r387",
      "r622"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of debt instrument payable, including, but not limited to, notes payable and loans payable.",
        "label": "Debt Instrument, Fair Value Disclosure",
        "terseLabel": "Estimated fair value"
       }
      }
     },
     "localname": "DebtInstrumentFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/FinancialInstrumentsSummaryofEstimatedFairValueofLongtermObligationsandOtherShorttermBorrowingsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentInterestRateStatedPercentage": {
     "auth_ref": [
      "r64",
      "r359"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contractual interest rate for funds borrowed, under the debt agreement.",
        "label": "Debt Instrument, Interest Rate, Stated Percentage",
        "terseLabel": "Stated interest rate"
       }
      }
     },
     "localname": "DebtInstrumentInterestRateStatedPercentage",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/LongTermObligationsandOtherShortTermBorrowingsLongTermDebtDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Debt Instrument [Line Items]",
        "terseLabel": "Debt Instrument [Line Items]"
       }
      }
     },
     "localname": "DebtInstrumentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/LongTermObligationsandOtherShortTermBorrowingsLongTermDebtDetails",
      "http://www.cardinal.com/role/LongTermObligationsandOtherShortTermBorrowingsOtherFinancingArrangementsDetails",
      "http://www.cardinal.com/role/LongTermObligationsandOtherShortTermBorrowingsSummaryofDebtDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentNameDomain": {
     "auth_ref": [
      "r65",
      "r138",
      "r144",
      "r358",
      "r359",
      "r360",
      "r361",
      "r362",
      "r363",
      "r365",
      "r371",
      "r372",
      "r373",
      "r374",
      "r376",
      "r377",
      "r378",
      "r379",
      "r380",
      "r381",
      "r386",
      "r387",
      "r388",
      "r389",
      "r649"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities.",
        "label": "Debt Instrument, Name [Domain]",
        "terseLabel": "Debt Instrument, Name [Domain]"
       }
      }
     },
     "localname": "DebtInstrumentNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/FinancialInstrumentsNarrativeDetails",
      "http://www.cardinal.com/role/LongTermObligationsandOtherShortTermBorrowingsLongTermDebtDetails",
      "http://www.cardinal.com/role/LongTermObligationsandOtherShortTermBorrowingsNarrativeDetails",
      "http://www.cardinal.com/role/LongTermObligationsandOtherShortTermBorrowingsOtherFinancingArrangementsDetails",
      "http://www.cardinal.com/role/LongTermObligationsandOtherShortTermBorrowingsSummaryofDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentTable": {
     "auth_ref": [
      "r65",
      "r138",
      "r144",
      "r358",
      "r359",
      "r360",
      "r361",
      "r362",
      "r363",
      "r365",
      "r371",
      "r372",
      "r373",
      "r374",
      "r376",
      "r377",
      "r378",
      "r379",
      "r380",
      "r381",
      "r384",
      "r386",
      "r387",
      "r388",
      "r389",
      "r417",
      "r420",
      "r421",
      "r422",
      "r646",
      "r647",
      "r649",
      "r650",
      "r712"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Schedule of Long-term Debt Instruments [Table]",
        "terseLabel": "Schedule of Long-term Debt Instruments [Table]"
       }
      }
     },
     "localname": "DebtInstrumentTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/LongTermObligationsandOtherShortTermBorrowingsLongTermDebtDetails",
      "http://www.cardinal.com/role/LongTermObligationsandOtherShortTermBorrowingsOtherFinancingArrangementsDetails",
      "http://www.cardinal.com/role/LongTermObligationsandOtherShortTermBorrowingsSummaryofDebtDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible": {
     "auth_ref": [
      "r495"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease reasonably possible in the next twelve months for the unrecognized tax benefit.",
        "label": "Decrease in Unrecognized Tax Benefits is Reasonably Possible",
        "terseLabel": "Estimated range of decrease in unrecognized tax benefits within the next 12 months"
       }
      }
     },
     "localname": "DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredFederalIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r140",
      "r518",
      "r527"
     ],
     "calculation": {
      "http://www.cardinal.com/role/IncomeTaxesScheduleofComponentsofIncomeTaxExpenseBenefitCurrentandDeferredDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredIncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred federal income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Deferred Federal Income Tax Expense (Benefit)",
        "negatedTerseLabel": "Federal",
        "terseLabel": "Federal",
        "verboseLabel": "Deferred Federal Income Tax Expense (Benefit)"
       }
      }
     },
     "localname": "DeferredFederalIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/IncomeTaxesNarrativeDetails",
      "http://www.cardinal.com/role/IncomeTaxesScheduleofComponentsofIncomeTaxExpenseBenefitCurrentandDeferredDetails",
      "http://www.cardinal.com/role/IncomeTaxesScheduleofUnrecognizedTaxBenefitsRollForwardDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredForeignIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r140",
      "r518",
      "r527"
     ],
     "calculation": {
      "http://www.cardinal.com/role/IncomeTaxesScheduleofComponentsofIncomeTaxExpenseBenefitCurrentandDeferredDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_DeferredIncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Deferred Foreign Income Tax Expense (Benefit)",
        "terseLabel": "Non-U.S.",
        "verboseLabel": "Deferred Foreign Income Tax Expense (Benefit)"
       }
      }
     },
     "localname": "DeferredForeignIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/IncomeTaxesScheduleofComponentsofIncomeTaxExpenseBenefitCurrentandDeferredDetails",
      "http://www.cardinal.com/role/IncomeTaxesScheduleofUnrecognizedTaxBenefitsRollForwardDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredGainLossOnDiscontinuationOfInterestRateFairValueHedge": {
     "auth_ref": [
      "r595"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount as of the balance sheet date of the unamortized adjustment to the carrying value of an interest-bearing hedged item made under an effective interest rate fair value hedge that is amortized upon discontinuation of the interest rate fair value hedge.",
        "label": "Deferred Gain (Loss) on Discontinuation of Interest Rate Fair Value Hedge",
        "terseLabel": "Deferred Gain (Loss) on Discontinuation of Interest Rate Fair Value Hedge"
       }
      }
     },
     "localname": "DeferredGainLossOnDiscontinuationOfInterestRateFairValueHedge",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/FinancialInstrumentsNarrativeDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleofOutstandingInstrumentsFairValueHedgesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r126",
      "r140",
      "r518",
      "r527",
      "r528",
      "r529"
     ],
     "calculation": {
      "http://www.cardinal.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://www.cardinal.com/role/IncomeTaxesScheduleofComponentsofIncomeTaxExpenseBenefitCurrentandDeferredDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Deferred Income Tax Expense (Benefit)",
        "terseLabel": "Provision for/(benefit from) deferred income taxes",
        "totalLabel": "Total deferred",
        "verboseLabel": "Deferred Income Tax Expense (Benefit)"
       }
      }
     },
     "localname": "DeferredIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.cardinal.com/role/IncomeTaxesScheduleofComponentsofIncomeTaxExpenseBenefitCurrentandDeferredDetails",
      "http://www.cardinal.com/role/IncomeTaxesScheduleofUnrecognizedTaxBenefitsRollForwardDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Income Tax Expense (Benefit), Continuing Operations [Abstract]",
        "terseLabel": "Deferred:"
       }
      }
     },
     "localname": "DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/IncomeTaxesScheduleofComponentsofIncomeTaxExpenseBenefitCurrentandDeferredDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DeferredIncomeTaxLiabilities": {
     "auth_ref": [
      "r39",
      "r40",
      "r507",
      "r694",
      "r715"
     ],
     "calculation": {
      "http://www.cardinal.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredTaxLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences.",
        "label": "Deferred Tax Liabilities, Gross",
        "negatedTotalLabel": "Total deferred income tax liabilities"
       }
      }
     },
     "localname": "DeferredIncomeTaxLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxesAndOtherAssetsNoncurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.cardinal.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesAfterNettingbyTaxJurisdictionDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredTaxLiabilities",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and other assets expected to be realized or consumed after one year or normal operating cycle, if longer.",
        "label": "Deferred Income Taxes and Other Assets, Noncurrent",
        "terseLabel": "Deferred Income Taxes and Other Assets, Noncurrent"
       }
      }
     },
     "localname": "DeferredIncomeTaxesAndOtherAssetsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesAfterNettingbyTaxJurisdictionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxesAndOtherTaxLiabilitiesNoncurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.cardinal.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesAfterNettingbyTaxJurisdictionDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_DeferredTaxLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences, after deferred tax asset, and other tax liabilities expected to be paid after one year or operating cycle, if longer.",
        "label": "Deferred Income Taxes and Other Tax Liabilities, Noncurrent",
        "terseLabel": "Deferred Income Taxes and Other Tax Liabilities, Noncurrent"
       }
      }
     },
     "localname": "DeferredIncomeTaxesAndOtherTaxLiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesAfterNettingbyTaxJurisdictionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r140",
      "r518",
      "r527"
     ],
     "calculation": {
      "http://www.cardinal.com/role/IncomeTaxesScheduleofComponentsofIncomeTaxExpenseBenefitCurrentandDeferredDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredIncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred state and local tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Deferred State and Local Income Tax Expense (Benefit)",
        "terseLabel": "State and local",
        "verboseLabel": "Deferred State and Local Income Tax Expense (Benefit)"
       }
      }
     },
     "localname": "DeferredStateAndLocalIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/IncomeTaxesScheduleofComponentsofIncomeTaxExpenseBenefitCurrentandDeferredDetails",
      "http://www.cardinal.com/role/IncomeTaxesScheduleofUnrecognizedTaxBenefitsRollForwardDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAndOtherLiabilitiesNoncurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.cardinal.com/role/ConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences, with jurisdictional netting, and liabilities classified as noncurrent and other.",
        "label": "Deferred Tax and Other Liabilities, Noncurrent",
        "terseLabel": "Deferred income taxes and other liabilities"
       }
      }
     },
     "localname": "DeferredTaxAndOtherLiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedBalanceSheets",
      "http://www.cardinal.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsGross": {
     "auth_ref": [
      "r508"
     ],
     "calculation": {
      "http://www.cardinal.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredTaxAssetsLiabilitiesNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.",
        "label": "Deferred Tax Assets, Gross",
        "totalLabel": "Total deferred income tax assets"
       }
      }
     },
     "localname": "DeferredTaxAssetsGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsLiabilitiesNet": {
     "auth_ref": [
      "r510"
     ],
     "calculation": {
      "http://www.cardinal.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredTaxLiabilities",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, without jurisdictional netting.",
        "label": "Deferred Tax Assets, Net",
        "totalLabel": "Deferred Tax Assets, Net"
       }
      }
     },
     "localname": "DeferredTaxAssetsLiabilitiesNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsOther": {
     "auth_ref": [
      "r515",
      "r516"
     ],
     "calculation": {
      "http://www.cardinal.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences, classified as other.",
        "label": "Deferred Tax Assets, Other",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "DeferredTaxAssetsOther",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsTaxCreditCarryforwards": {
     "auth_ref": [
      "r513",
      "r515",
      "r516"
     ],
     "calculation": {
      "http://www.cardinal.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before allocation of a valuation allowances, of deferred tax assets attributable to deductible tax credit carryforwards including, but not limited to, research, foreign, general business, alternative minimum tax, and other deductible tax credit carryforwards.",
        "label": "Deferred Tax Assets, Tax Credit Carryforwards",
        "negatedLabel": "Deferred tax assets on tax credit carryforwards",
        "terseLabel": "Loss and tax credit carryforwards"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxCreditCarryforwards",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/IncomeTaxesNarrativeDetails",
      "http://www.cardinal.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost": {
     "auth_ref": [
      "r515",
      "r516"
     ],
     "calculation": {
      "http://www.cardinal.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from share-based compensation.",
        "label": "Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost",
        "terseLabel": "Share-based compensation"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities": {
     "auth_ref": [
      "r515",
      "r516"
     ],
     "calculation": {
      "http://www.cardinal.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from accrued liabilities.",
        "label": "Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Accrued Liabilities",
        "terseLabel": "Accrued liabilities"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts": {
     "auth_ref": [
      "r515",
      "r516"
     ],
     "calculation": {
      "http://www.cardinal.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary difference from allowance for credit loss on accounts receivable.",
        "label": "Deferred Tax Asset, Tax Deferred Expense, Reserve and Accrual, Accounts Receivable, Allowance for Credit Loss",
        "terseLabel": "Receivable basis difference"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsValuationAllowance": {
     "auth_ref": [
      "r509"
     ],
     "calculation": {
      "http://www.cardinal.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredTaxAssetsLiabilitiesNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.",
        "label": "Deferred Tax Assets, Valuation Allowance",
        "negatedTerseLabel": "Deferred Tax Assets, Valuation Allowance"
       }
      }
     },
     "localname": "DeferredTaxAssetsValuationAllowance",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxLiabilities": {
     "auth_ref": [
      "r490",
      "r510"
     ],
     "calculation": {
      "http://www.cardinal.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesAfterNettingbyTaxJurisdictionDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.cardinal.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences without jurisdictional netting.",
        "label": "Deferred Tax Liabilities, Net",
        "negatedTotalLabel": "Net deferred income tax liability"
       }
      }
     },
     "localname": "DeferredTaxLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesAfterNettingbyTaxJurisdictionDetails",
      "http://www.cardinal.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxLiabilitiesDeferredExpenseCapitalizedInventoryCosts": {
     "auth_ref": [
      "r515",
      "r516"
     ],
     "calculation": {
      "http://www.cardinal.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax consequences attributable to taxable temporary differences derived from inventory.",
        "label": "Deferred Tax Liabilities, Inventory",
        "negatedLabel": "Inventory basis differences"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesDeferredExpenseCapitalizedInventoryCosts",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxLiabilitiesDeferredExpenseReservesAndAccruals": {
     "auth_ref": [],
     "calculation": {
      "http://www.cardinal.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from reserves and accruals.",
        "label": "Deferred Tax Liabilities, Deferred Expense, Reserves and Accruals",
        "negatedTerseLabel": "Deferred Tax Liabilities, Deferred Expense, Reserves and Accruals"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesDeferredExpenseReservesAndAccruals",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets": {
     "auth_ref": [
      "r515",
      "r516"
     ],
     "calculation": {
      "http://www.cardinal.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from intangible assets including goodwill.",
        "label": "Deferred Tax Liabilities, Goodwill and Intangible Assets",
        "negatedLabel": "Other"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesGoodwillAndIntangibleAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxLiabilitiesOther": {
     "auth_ref": [
      "r515",
      "r516"
     ],
     "calculation": {
      "http://www.cardinal.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences classified as other.",
        "label": "Deferred Tax Liabilities, Other",
        "negatedTerseLabel": "Deferred Tax Liabilities, Other"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesOther",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment": {
     "auth_ref": [
      "r515",
      "r516"
     ],
     "calculation": {
      "http://www.cardinal.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from property, plant, and equipment.",
        "label": "Deferred Tax Liabilities, Property, Plant and Equipment",
        "negatedLabel": "Property-related"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedContributionPlanCostRecognized": {
     "auth_ref": [
      "r440"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost for defined contribution plan.",
        "label": "Defined Contribution Plan, Cost",
        "terseLabel": "Total expense on employee retirement savings plans"
       }
      }
     },
     "localname": "DefinedContributionPlanCostRecognized",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Depreciation": {
     "auth_ref": [
      "r126",
      "r295"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.",
        "label": "Depreciation",
        "terseLabel": "Depreciation"
       }
      }
     },
     "localname": "Depreciation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativePropertyandEquipmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DepreciationDepletionAndAmortization": {
     "auth_ref": [
      "r126",
      "r212"
     ],
     "calculation": {
      "http://www.cardinal.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.",
        "label": "Depreciation, Depletion and Amortization",
        "terseLabel": "Depreciation and amortization",
        "verboseLabel": "Total depreciation and amortization"
       }
      }
     },
     "localname": "DepreciationDepletionAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.cardinal.com/role/SegmentInformationDepreciationandAmortizationandAdditionstoPropertyandEquipmentbyReportableSegmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeAssetNotionalAmount": {
     "auth_ref": [
      "r562",
      "r563",
      "r565"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Nominal or face amount used to calculate payments on the derivative asset.",
        "label": "Derivative Asset, Notional Amount",
        "terseLabel": "Notional Amount",
        "verboseLabel": "Derivative, notional amount"
       }
      }
     },
     "localname": "DerivativeAssetNotionalAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/FinancialInstrumentsNarrativeDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleofOutstandingInstrumentsCashFlowHedgesDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleofOutstandingInstrumentsEconomicHedgesDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleofOutstandingInstrumentsFairValueHedgesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet": {
     "auth_ref": [
      "r560"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair values as of the balance sheet date of the net amount of all assets and liabilities resulting from contracts that meet the criteria of being accounted for as derivative instruments.",
        "label": "Derivative Assets (Liabilities), at Fair Value, Net",
        "terseLabel": "Forward contracts"
       }
      }
     },
     "localname": "DerivativeAssetsLiabilitiesAtFairValueNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/FairValueMeasurementsFairValueofAssetsandLiabilitiesMeasuredonaRecurringBasisDetails",
      "http://www.cardinal.com/role/FairValueMeasurementsReconciliationofLiabilitiesMeasuredatFairValueonaRecurringBasisUsingUnobservableInputsLevel3Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeContractTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Financial instrument or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset.",
        "label": "Derivative Contract [Domain]",
        "terseLabel": "Derivative, Name [Domain]",
        "verboseLabel": "Derivative Contract [Domain]"
       }
      }
     },
     "localname": "DerivativeContractTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/FinancialInstrumentsNarrativeDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleofFairValueGainLossDerivativeInstrumentDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleofGainLossIncludedinAOCIforDerivativeInstrumentsDesignatedasCashFlowHedgesDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleofGainLossReclassifiedfromAOCIintoEarningsforDerivativeInstrumentsDesignatedasCashFlowHedgesDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleofGainLossRecognizedinEarningsforDerivativesNotDesignatedasHedgingInstrumentDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleofGainLossRecognizedinEarningsforInterestRateContractsDesignatedasFairValueHedgesDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleofOutstandingInstrumentsCashFlowHedgesDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleofOutstandingInstrumentsEconomicHedgesDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleofOutstandingInstrumentsFairValueHedgesDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleoftheFairValueofAssetsandLiabilitiesRelatedtoDerivativesDesignatedasHedgingInstrumentsDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsSummaryofEstimatedFairValueofLongtermObligationsandOtherShorttermBorrowingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DerivativeFairValueOfDerivativeAsset": {
     "auth_ref": [
      "r77",
      "r78",
      "r79",
      "r573",
      "r682"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value, before effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets elected not to be offset. Excludes assets not subject to a master netting arrangement.",
        "label": "Derivative Asset, Fair Value, Gross Asset",
        "terseLabel": "Total assets"
       }
      }
     },
     "localname": "DerivativeFairValueOfDerivativeAsset",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleoftheFairValueofAssetsandLiabilitiesRelatedtoDerivativesDesignatedasHedgingInstrumentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeFairValueOfDerivativeLiability": {
     "auth_ref": [
      "r77",
      "r78",
      "r79",
      "r573",
      "r682"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value, before effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities elected not to be offset. Excludes liabilities not subject to a master netting arrangement.",
        "label": "Derivative Liability, Fair Value, Gross Liability",
        "terseLabel": "Total liabilities"
       }
      }
     },
     "localname": "DerivativeFairValueOfDerivativeLiability",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleoftheFairValueofAssetsandLiabilitiesRelatedtoDerivativesDesignatedasHedgingInstrumentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeFairValueOfDerivativeNet": {
     "auth_ref": [
      "r622"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of the assets less the liabilities of a derivative or group of derivatives.",
        "label": "Derivative, Fair Value, Net",
        "terseLabel": "Fair\u00a0Value Gain/(Loss)"
       }
      }
     },
     "localname": "DerivativeFairValueOfDerivativeNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleofFairValueGainLossDerivativeInstrumentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeGainLossOnDerivativeNet": {
     "auth_ref": [
      "r572"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in the fair value of derivatives recognized in the income statement.",
        "label": "Derivative, Gain (Loss) on Derivative, Net",
        "terseLabel": "Gain/(loss) on derivative"
       }
      }
     },
     "localname": "DerivativeGainLossOnDerivativeNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleofGainLossRecognizedinEarningsforInterestRateContractsDesignatedasFairValueHedgesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeInstrumentRiskAxis": {
     "auth_ref": [
      "r78",
      "r571",
      "r574",
      "r580",
      "r589"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of derivative contract.",
        "label": "Derivative Instrument [Axis]",
        "terseLabel": "Derivative Instrument [Axis]"
       }
      }
     },
     "localname": "DerivativeInstrumentRiskAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/FinancialInstrumentsNarrativeDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleofFairValueGainLossDerivativeInstrumentDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleofGainLossIncludedinAOCIforDerivativeInstrumentsDesignatedasCashFlowHedgesDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleofGainLossReclassifiedfromAOCIintoEarningsforDerivativeInstrumentsDesignatedasCashFlowHedgesDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleofGainLossRecognizedinEarningsforDerivativesNotDesignatedasHedgingInstrumentDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleofGainLossRecognizedinEarningsforInterestRateContractsDesignatedasFairValueHedgesDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleofOutstandingInstrumentsCashFlowHedgesDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleofOutstandingInstrumentsEconomicHedgesDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleofOutstandingInstrumentsFairValueHedgesDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleoftheFairValueofAssetsandLiabilitiesRelatedtoDerivativesDesignatedasHedgingInstrumentsDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsSummaryofEstimatedFairValueofLongtermObligationsandOtherShorttermBorrowingsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Derivative Instruments and Hedging Activities Disclosure [Abstract]",
        "terseLabel": "Derivative Instruments and Hedging Activities Disclosure [Abstract]"
       }
      }
     },
     "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis": {
     "auth_ref": [
      "r568",
      "r571",
      "r580"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of hedging relationship.",
        "label": "Hedging Relationship [Axis]",
        "terseLabel": "Hedging Relationship [Axis]"
       }
      }
     },
     "localname": "DerivativeInstrumentsGainLossByHedgingRelationshipAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/FinancialInstrumentsNarrativeDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleofFairValueGainLossDerivativeInstrumentDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleofGainLossIncludedinAOCIforDerivativeInstrumentsDesignatedasCashFlowHedgesDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleofGainLossReclassifiedfromAOCIintoEarningsforDerivativeInstrumentsDesignatedasCashFlowHedgesDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleofGainLossRecognizedinEarningsforInterestRateContractsDesignatedasFairValueHedgesDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleofOutstandingInstrumentsCashFlowHedgesDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleofOutstandingInstrumentsFairValueHedgesDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleoftheFairValueofAssetsandLiabilitiesRelatedtoDerivativesDesignatedasHedgingInstrumentsDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsSummaryofEstimatedFairValueofLongtermObligationsandOtherShorttermBorrowingsDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsTables"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet": {
     "auth_ref": [
      "r578",
      "r588"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The effective portion of net gain (loss) reclassified from accumulated other comprehensive income into income on derivative instruments designated and qualifying as hedging instruments.",
        "label": "Derivative Instruments, Gain (Loss) Reclassified from Accumulated OCI into Income, Effective Portion, Net",
        "terseLabel": "Gain/(loss) reclassified from AOCI into earnings for derivative instruments designated as cash flow hedges"
       }
      }
     },
     "localname": "DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleofGainLossReclassifiedfromAOCIintoEarningsforDerivativeInstrumentsDesignatedasCashFlowHedgesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet": {
     "auth_ref": [
      "r579",
      "r581"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of realized and unrealized gain (loss) of derivative instruments not designated or qualifying as hedging instruments.",
        "label": "Derivative Instruments Not Designated as Hedging Instruments, Gain (Loss), Net",
        "terseLabel": "Gain/(loss) recognized in earnings for economic (non-designated) derivative instruments"
       }
      }
     },
     "localname": "DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleofGainLossRecognizedinEarningsforDerivativesNotDesignatedasHedgingInstrumentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeLiabilityNotionalAmount": {
     "auth_ref": [
      "r562",
      "r563",
      "r565"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Nominal or face amount used to calculate payments on the derivative liability.",
        "label": "Derivative Liability, Notional Amount",
        "terseLabel": "Derivative Liability, Notional Amount"
       }
      }
     },
     "localname": "DerivativeLiabilityNotionalAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/FinancialInstrumentsNarrativeDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleofOutstandingInstrumentsCashFlowHedgesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Derivative [Line Items]",
        "terseLabel": "Derivative [Line Items]"
       }
      }
     },
     "localname": "DerivativeLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/FinancialInstrumentsNarrativeDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleofFairValueGainLossDerivativeInstrumentDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleofGainLossIncludedinAOCIforDerivativeInstrumentsDesignatedasCashFlowHedgesDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleofGainLossReclassifiedfromAOCIintoEarningsforDerivativeInstrumentsDesignatedasCashFlowHedgesDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleofGainLossRecognizedinEarningsforDerivativesNotDesignatedasHedgingInstrumentDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleofGainLossRecognizedinEarningsforInterestRateContractsDesignatedasFairValueHedgesDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleofOutstandingInstrumentsCashFlowHedgesDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleofOutstandingInstrumentsEconomicHedgesDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleofOutstandingInstrumentsFairValueHedgesDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsTables"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeNotionalAmount": {
     "auth_ref": [
      "r563",
      "r565"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Nominal or face amount used to calculate payment on derivative.",
        "label": "Derivative, Notional Amount",
        "terseLabel": "Notional Amount"
       }
      }
     },
     "localname": "DerivativeNotionalAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleofFairValueGainLossDerivativeInstrumentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeTable": {
     "auth_ref": [
      "r561",
      "r564",
      "r565",
      "r568",
      "r569",
      "r576",
      "r580",
      "r592",
      "r593",
      "r597",
      "r599"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule that describes and identifies a derivative or group of derivatives on a disaggregated basis, such as for individual instruments, or small groups of similar instruments. May include a combination of the type of instrument, risks being hedged, notional amount, hedge designation, related hedged item, inception date, maturity date, or other relevant item.",
        "label": "Derivative [Table]",
        "terseLabel": "Derivative [Table]"
       }
      }
     },
     "localname": "DerivativeTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/FinancialInstrumentsNarrativeDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleofFairValueGainLossDerivativeInstrumentDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleofGainLossIncludedinAOCIforDerivativeInstrumentsDesignatedasCashFlowHedgesDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleofGainLossReclassifiedfromAOCIintoEarningsforDerivativeInstrumentsDesignatedasCashFlowHedgesDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleofGainLossRecognizedinEarningsforDerivativesNotDesignatedasHedgingInstrumentDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleofGainLossRecognizedinEarningsforInterestRateContractsDesignatedasFairValueHedgesDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleofOutstandingInstrumentsCashFlowHedgesDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleofOutstandingInstrumentsEconomicHedgesDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleofOutstandingInstrumentsFairValueHedgesDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsTables"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativesFairValueLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Derivatives, Fair Value [Line Items]",
        "terseLabel": "Derivatives, Fair Value [Line Items]"
       }
      }
     },
     "localname": "DerivativesFairValueLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleoftheFairValueofAssetsandLiabilitiesRelatedtoDerivativesDesignatedasHedgingInstrumentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativesMethodsOfAccountingHedgingDerivatives": {
     "auth_ref": [
      "r591"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for derivatives used in hedging relationships, which may include how gains or losses are recognized and presented in the financial statements, and amortization policies for deferred amounts.",
        "label": "Derivatives, Methods of Accounting, Hedging Derivatives [Policy Text Block]",
        "terseLabel": "Interest Rate, Currency and Commodity Risk"
       }
      }
     },
     "localname": "DerivativesMethodsOfAccountingHedgingDerivatives",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DesignatedAsHedgingInstrumentMember": {
     "auth_ref": [
      "r568"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Derivative instrument designated as hedging instrument under Generally Accepted Accounting Principles (GAAP).",
        "label": "Designated as Hedging Instrument [Member]",
        "terseLabel": "Designated as Hedging Instrument"
       }
      }
     },
     "localname": "DesignatedAsHedgingInstrumentMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/FinancialInstrumentsNarrativeDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleofOutstandingInstrumentsCashFlowHedgesDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleofOutstandingInstrumentsFairValueHedgesDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleoftheFairValueofAssetsandLiabilitiesRelatedtoDerivativesDesignatedasHedgingInstrumentsDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsSummaryofEstimatedFairValueofLongtermObligationsandOtherShorttermBorrowingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DevelopedTechnologyRightsMember": {
     "auth_ref": [
      "r541"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rights to developed technology, which can include the right to develop, use, market, sell, or offer for sale products, compounds, or intellectual property.",
        "label": "Developed Technology Rights [Member]",
        "verboseLabel": "Developed technology and other"
       }
      }
     },
     "localname": "DevelopedTechnologyRightsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/GoodwillandOtherIntangibleAssetsScheduleofIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DisaggregationOfRevenueTableTextBlock": {
     "auth_ref": [
      "r427"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.",
        "label": "Disaggregation of Revenue [Table Text Block]",
        "terseLabel": "Disaggregation of Revenue [Table Text Block]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/SegmentInformationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": {
     "auth_ref": [
      "r486"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for share-based payment arrangement.",
        "label": "Share-based Payment Arrangement [Text Block]",
        "verboseLabel": "Share-Based Compensation"
       }
      }
     },
     "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ShareBasedCompensation"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-based Payment Arrangement [Abstract]",
        "terseLabel": "Share-based Payment Arrangement [Abstract]"
       }
      }
     },
     "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DiscontinuedOperationTaxEffectOfIncomeLossFromDisposalOfDiscontinuedOperation": {
     "auth_ref": [
      "r7",
      "r8",
      "r19",
      "r534"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of tax expense (benefit) on gain (loss) not previously recognized resulting from the disposal of a discontinued operation.",
        "label": "Discontinued Operation, Tax Effect of Gain (Loss) from Disposal of Discontinued Operation",
        "terseLabel": "Discontinued Operation, Tax Effect of Gain (Loss) from Disposal of Discontinued Operation"
       }
      }
     },
     "localname": "DiscontinuedOperationTaxEffectOfIncomeLossFromDisposalOfDiscontinuedOperation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/DivestituresandAcquisitionsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationAccruedLiabilities": {
     "auth_ref": [
      "r5",
      "r6",
      "r16",
      "r300"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as accrued liabilities attributable to disposal group held for sale or disposed of.",
        "label": "Disposal Group, Including Discontinued Operation, Accrued Liabilities",
        "terseLabel": "Disposal Group, Including Discontinued Operation, Accrued Liabilities"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationAccruedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/DivestituresandAcquisitionsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents": {
     "auth_ref": [
      "r5",
      "r6",
      "r16",
      "r300"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as cash and cash equivalents attributable to disposal group held for sale or disposed of.",
        "label": "Disposal Group, Including Discontinued Operation, Cash and Cash Equivalents",
        "terseLabel": "Disposal Group, Including Discontinued Operation, Cash and Cash Equivalents"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/DivestituresandAcquisitionsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of consideration received or receivable for the disposal of assets and liabilities, including discontinued operation.",
        "label": "Disposal Group, Including Discontinued Operation, Consideration",
        "terseLabel": "Disposal Group, Including Discontinued Operation, Consideration"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationConsideration",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/DivestituresandAcquisitionsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationForeignCurrencyTranslationGainsLosses": {
     "auth_ref": [
      "r640"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of foreign currency translation gain (loss) in the disposal group, including discontinued operation, recognized in the statement of income as a result of the sale or complete or substantially complete liquidation of an investment in a foreign entity.",
        "label": "Disposal Group, Including Discontinued Operation, Foreign Currency Translation Gains (Losses)",
        "terseLabel": "Disposal Group, Including Discontinued Operation, Foreign Currency Translation Gains (Losses)"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationForeignCurrencyTranslationGainsLosses",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/DivestituresandAcquisitionsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1": {
     "auth_ref": [
      "r5",
      "r6",
      "r16",
      "r300"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as goodwill attributable to disposal group held for sale or disposed of.",
        "label": "Disposal Group, Including Discontinued Operation, Goodwill",
        "negatedTerseLabel": "Disposal Group, Including Discontinued Operation, Goodwill"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationGoodwill1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/DivestituresandAcquisitionsNarrativeDetails",
      "http://www.cardinal.com/role/GoodwillandOtherIntangibleAssetsScheduleofGoodwillbyReportableSegmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1": {
     "auth_ref": [
      "r5",
      "r6",
      "r16",
      "r300"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as inventory attributable to disposal group held for sale or disposed of.",
        "label": "Disposal Group, Including Discontinued Operation, Inventory",
        "terseLabel": "Disposal Group, Including Discontinued Operation, Inventory"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationInventory1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/DivestituresandAcquisitionsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets": {
     "auth_ref": [
      "r5",
      "r6",
      "r16",
      "r300"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as other assets attributable to disposal group held for sale or disposed of.",
        "label": "Disposal Group, Including Discontinued Operation, Other Assets",
        "terseLabel": "Disposal Group, Including Discontinued Operation, Other Assets"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationOtherAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/DivestituresandAcquisitionsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherLiabilities": {
     "auth_ref": [
      "r5",
      "r6",
      "r16",
      "r300"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as other liabilities attributable to disposal group held for sale or disposed of.",
        "label": "Disposal Group, Including Discontinued Operation, Other Liabilities",
        "terseLabel": "Disposal Group, Including Discontinued Operation, Other Liabilities"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationOtherLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/DivestituresandAcquisitionsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment": {
     "auth_ref": [
      "r5",
      "r6",
      "r16",
      "r300"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as property, plant and equipment attributable to disposal group held for sale or disposed of.",
        "label": "Disposal Group, Including Discontinued Operation, Property, Plant and Equipment",
        "terseLabel": "Disposal Group, Including Discontinued Operation, Property, Plant and Equipment"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/DivestituresandAcquisitionsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain": {
     "auth_ref": [
      "r441",
      "r443"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of disposal group.",
        "label": "Disposal Group Name [Domain]",
        "terseLabel": "Disposal Group Name [Domain]"
       }
      }
     },
     "localname": "DisposalGroupsIncludingDiscontinuedOperationsNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/DivestituresandAcquisitionsNarrativeDetails",
      "http://www.cardinal.com/role/GoodwillandOtherIntangibleAssetsNarrativeDetails",
      "http://www.cardinal.com/role/SegmentInformationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_Dividends": {
     "auth_ref": [
      "r423",
      "r711"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of paid and unpaid cash, stock, and paid-in-kind (PIK) dividends declared, for example, but not limited to, common and preferred stock.",
        "label": "Dividends",
        "negatedLabel": "Dividends declared"
       }
      }
     },
     "localname": "Dividends",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedStatementsofShareholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EarningsPerShareAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share [Abstract]",
        "terseLabel": "Earnings Per Share [Abstract]"
       }
      }
     },
     "localname": "EarningsPerShareAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareBasic": {
     "auth_ref": [
      "r105",
      "r161",
      "r162",
      "r163",
      "r164",
      "r165",
      "r170",
      "r172",
      "r176",
      "r177",
      "r178",
      "r183",
      "r184",
      "r609",
      "r610",
      "r707",
      "r732"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.",
        "label": "Earnings Per Share, Basic",
        "terseLabel": "Earnings Per Share, Basic"
       }
      }
     },
     "localname": "EarningsPerShareBasic",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedStatementsofEarnings",
      "http://www.cardinal.com/role/EarningsPerShareAttributabletoCardinalHealthIncReconciliationofCommonSharesUsedtoComputeBasicandDilutedEPSDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareBasicAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share, Basic [Abstract]",
        "terseLabel": "Earnings/(loss) per common share attributable to Cardinal Health, Inc."
       }
      }
     },
     "localname": "EarningsPerShareBasicAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedStatementsofEarnings",
      "http://www.cardinal.com/role/EarningsPerShareAttributabletoCardinalHealthIncReconciliationofCommonSharesUsedtoComputeBasicandDilutedEPSDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareDiluted": {
     "auth_ref": [
      "r105",
      "r161",
      "r162",
      "r163",
      "r164",
      "r165",
      "r172",
      "r176",
      "r177",
      "r178",
      "r183",
      "r184",
      "r609",
      "r610",
      "r707",
      "r732"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
        "label": "Earnings Per Share, Diluted",
        "terseLabel": "Earnings Per Share, Diluted"
       }
      }
     },
     "localname": "EarningsPerShareDiluted",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedStatementsofEarnings",
      "http://www.cardinal.com/role/EarningsPerShareAttributabletoCardinalHealthIncReconciliationofCommonSharesUsedtoComputeBasicandDilutedEPSDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareDilutedAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share, Diluted [Abstract]",
        "terseLabel": "Diluted earnings per common share attributable to Cardinal Health, Inc.:"
       }
      }
     },
     "localname": "EarningsPerShareDilutedAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/EarningsPerShareAttributabletoCardinalHealthIncReconciliationofCommonSharesUsedtoComputeBasicandDilutedEPSDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareTextBlock": {
     "auth_ref": [
      "r179",
      "r181",
      "r182",
      "r185"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for earnings per share.",
        "label": "Earnings Per Share [Text Block]",
        "verboseLabel": "Earnings Per Share Attributable to Cardinal Health, Inc."
       }
      }
     },
     "localname": "EarningsPerShareTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/EarningsPerShareAttributabletoCardinalHealthInc"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents": {
     "auth_ref": [
      "r635"
     ],
     "calculation": {
      "http://www.cardinal.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) from the effect of exchange rate changes on cash and cash equivalent balances held in foreign currencies.",
        "label": "Effect of Exchange Rate on Cash and Cash Equivalents",
        "terseLabel": "Effect of exchange rates changes on cash and equivalents"
       }
      }
     },
     "localname": "EffectOfExchangeRateOnCashAndCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateContinuingOperations": {
     "auth_ref": [
      "r492"
     ],
     "calculation": {
      "http://www.cardinal.com/role/IncomeTaxesScheduleofEffectiveIncomeTaxRateReconciliationDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Effective Income Tax Rate Reconciliation, Percent",
        "terseLabel": "Effective Income Tax Rate Reconciliation, Percent",
        "totalLabel": "Effective income tax rate"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateContinuingOperations",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/IncomeTaxesNarrativeDetails",
      "http://www.cardinal.com/role/IncomeTaxesScheduleofEffectiveIncomeTaxRateReconciliationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate": {
     "auth_ref": [
      "r142",
      "r492",
      "r531"
     ],
     "calculation": {
      "http://www.cardinal.com/role/IncomeTaxesScheduleofEffectiveIncomeTaxRateReconciliationDetails": {
       "order": 11.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of domestic federal statutory tax rate applicable to pretax income (loss).",
        "label": "Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent",
        "terseLabel": "Provision at Federal statutory rate"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/IncomeTaxesNarrativeDetails",
      "http://www.cardinal.com/role/IncomeTaxesScheduleofEffectiveIncomeTaxRateReconciliationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance": {
     "auth_ref": [
      "r492",
      "r531"
     ],
     "calculation": {
      "http://www.cardinal.com/role/IncomeTaxesScheduleofEffectiveIncomeTaxRateReconciliationDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to changes in the valuation allowance for deferred tax assets.",
        "label": "Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent",
        "terseLabel": "Change in valuation allowances"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/IncomeTaxesScheduleofEffectiveIncomeTaxRateReconciliationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense": {
     "auth_ref": [
      "r492",
      "r531"
     ],
     "calculation": {
      "http://www.cardinal.com/role/IncomeTaxesScheduleofEffectiveIncomeTaxRateReconciliationDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to nondeductible expenses.",
        "label": "Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent",
        "terseLabel": "Nondeductible/nontaxable items (2)"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationNondeductibleExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/IncomeTaxesScheduleofEffectiveIncomeTaxRateReconciliationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses": {
     "auth_ref": [
      "r492",
      "r531"
     ],
     "calculation": {
      "http://www.cardinal.com/role/IncomeTaxesScheduleofEffectiveIncomeTaxRateReconciliationDetails": {
       "order": 12.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to impairment loss.",
        "label": "Effective Income Tax Rate Reconciliation, Nondeductible Expense, Impairment Losses, Percent",
        "verboseLabel": "Goodwill impairment"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/IncomeTaxesScheduleofEffectiveIncomeTaxRateReconciliationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent": {
     "auth_ref": [],
     "calculation": {
      "http://www.cardinal.com/role/IncomeTaxesScheduleofEffectiveIncomeTaxRateReconciliationDetails": {
       "order": 9.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference, between reported income tax expense (benefit) and the expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations, that is attributable to tax exempt income, equity in earnings (loss) of an unconsolidated subsidiary, minority interest income (expense), tax holiday, disposition of a business, disposition of an asset, repatriation of foreign earnings, repatriation of foreign earnings jobs creation act of 2004, change in enacted tax rate, prior year income taxes, change in deferred tax asset valuation allowance, and other adjustments.",
        "label": "Effective Income Tax Rate Reconciliation,Other Reconciling Items, Percent",
        "terseLabel": "Other (2)"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/IncomeTaxesScheduleofEffectiveIncomeTaxRateReconciliationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes": {
     "auth_ref": [
      "r492",
      "r531"
     ],
     "calculation": {
      "http://www.cardinal.com/role/IncomeTaxesScheduleofEffectiveIncomeTaxRateReconciliationDetails": {
       "order": 8.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to state and local income tax expense (benefit), net of federal tax expense (benefit).",
        "label": "Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent",
        "terseLabel": "State and local income taxes, net of federal benefit"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/IncomeTaxesScheduleofEffectiveIncomeTaxRateReconciliationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized": {
     "auth_ref": [
      "r474"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost not yet recognized for nonvested award under share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount",
        "netLabel": "Total compensation cost, net of estimated forfeitures, related to nonvested performance share units not yet recognized, pre-tax",
        "terseLabel": "Total compensation cost, net of estimated forfeitures, related to unvested stock options not yet recognized, pre-tax",
        "verboseLabel": "Total compensation cost, net of estimated forfeitures, related to nonvested restricted share and share unit awards not yet recognized, pre-tax"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ShareBasedCompensationAdditionalDataRelatedtoPerformanceShareUnitActivityDetails",
      "http://www.cardinal.com/role/ShareBasedCompensationAdditionalDataRelatedtoRestrictedShareUnitActivityDetails",
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleofAdditionalDataRelatedtoStockOptionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1": {
     "auth_ref": [
      "r474"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition",
        "netLabel": "Weighted-average period over which performance share unit cost is expected to be recognized (in years)",
        "terseLabel": "Weighted-average period over which stock option compensation cost is expected to be recognized",
        "verboseLabel": "Weighted-average period in years over which restricted share and share unit cost is expected to be recognized (in years)"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ShareBasedCompensationAdditionalDataRelatedtoPerformanceShareUnitActivityDetails",
      "http://www.cardinal.com/role/ShareBasedCompensationAdditionalDataRelatedtoRestrictedShareUnitActivityDetails",
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleofRemainingStockOptionPlanDataDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense": {
     "auth_ref": [
      "r473"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of tax benefit for recognition of expense of award under share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Expense, Tax Benefit",
        "terseLabel": "Tax benefit related to share-based compensation"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeSeveranceMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Termination of an employee associated with exit from or disposal of business activities or restructurings pursuant to a plan.",
        "label": "Employee Severance [Member]",
        "terseLabel": "Employee- Related Costs"
       }
      }
     },
     "localname": "EmployeeSeveranceMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/RestructuringandEmployeeSeveranceLiabilitiesAssociatedwithRestructuringandEmployeeSeveranceActivitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EmployeeStockOptionMember": {
     "auth_ref": [
      "r471"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time.",
        "label": "Share-based Payment Arrangement, Option [Member]",
        "terseLabel": "Stock Options",
        "verboseLabel": "Stock Options"
       }
      }
     },
     "localname": "EmployeeStockOptionMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ShareBasedCompensationNarrativeDetails",
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleofAdditionalDataRelatedtoStockOptionsDetails",
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleofRemainingStockOptionPlanDataDetails",
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleofTotalShareBasedCompensationExpensebyTypeofAwardDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EntityWideRevenueMajorCustomerLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Revenue, Major Customer [Line Items]",
        "terseLabel": "Revenue, Major Customer [Line Items]"
       }
      }
     },
     "localname": "EntityWideRevenueMajorCustomerLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesRevenueandGrossTradeReceivablesPercentagebyMajorCustomersDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity [Abstract]",
        "terseLabel": "Equity [Abstract]"
       }
      }
     },
     "localname": "EquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EquityComponentDomain": {
     "auth_ref": [
      "r2",
      "r94",
      "r95",
      "r96",
      "r154",
      "r155",
      "r156",
      "r158",
      "r166",
      "r168",
      "r187",
      "r259",
      "r416",
      "r423",
      "r480",
      "r481",
      "r482",
      "r523",
      "r524",
      "r608",
      "r636",
      "r637",
      "r638",
      "r639",
      "r640",
      "r642",
      "r744",
      "r745",
      "r746",
      "r809"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.",
        "label": "Equity Component [Domain]",
        "terseLabel": "Equity Component [Domain]"
       }
      }
     },
     "localname": "EquityComponentDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedStatementsofShareholdersEquity",
      "http://www.cardinal.com/role/ShareholdersEquityChangesintheAccumulatedOtherComprehensiveIncomeLossDetails",
      "http://www.cardinal.com/role/ShareholdersEquityNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityMethodInvestments": {
     "auth_ref": [
      "r54",
      "r218",
      "r253"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized.",
        "label": "Equity Method Investments",
        "terseLabel": "Equity Method Investments"
       }
      }
     },
     "localname": "EquityMethodInvestments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/DivestituresandAcquisitionsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ExcessTaxBenefitFromShareBasedCompensationFinancingActivities": {
     "auth_ref": [
      "r485"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from realized tax benefit related to deductible compensation cost reported on the entity's tax return for equity instruments in excess of the compensation cost for those instruments recognized for financial reporting purposes.",
        "label": "Excess Tax Benefit from Share-based Compensation, Financing Activities",
        "verboseLabel": "Excess tax benefits from share based compensation"
       }
      }
     },
     "localname": "ExcessTaxBenefitFromShareBasedCompensationFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleofAdditionalDataRelatedtoStockOptionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FacilityClosingMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Closing of a facility associated with exit from or disposal of business activities or restructurings pursuant to a plan.",
        "label": "Facility Closing [Member]",
        "terseLabel": "Facility Exit and Other Costs"
       }
      }
     },
     "localname": "FacilityClosingMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/RestructuringandEmployeeSeveranceLiabilitiesAssociatedwithRestructuringandEmployeeSeveranceActivitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]",
        "terseLabel": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/FairValueMeasurementsFairValueofAssetsandLiabilitiesMeasuredonaRecurringBasisDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsSummaryofEstimatedFairValueofLongtermObligationsandOtherShorttermBorrowingsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": {
     "auth_ref": [
      "r611",
      "r612",
      "r613",
      "r619"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis.",
        "label": "Fair Value, Recurring and Nonrecurring [Table]",
        "terseLabel": "Fair Value Measurements, Recurring and Nonrecurring"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/FairValueMeasurementsFairValueofAssetsandLiabilitiesMeasuredonaRecurringBasisDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsSummaryofEstimatedFairValueofLongtermObligationsandOtherShorttermBorrowingsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]",
        "terseLabel": "Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]"
       }
      }
     },
     "localname": "FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/FairValueMeasurementsReconciliationofLiabilitiesMeasuredatFairValueonaRecurringBasisUsingUnobservableInputsLevel3Details"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable": {
     "auth_ref": [
      "r616",
      "r619"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of information required and determined to be provided for purposes of reconciling beginning and ending balances of fair value measurements of assets using significant unobservable inputs (level 3). Such reconciliation, separately presenting changes during the period, at a minimum, may include, but is not limited to: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets) and gains or losses recognized in other comprehensive income, and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of level 3 (for example, transfers due to changes in the observability of significant inputs), by class of asset.",
        "label": "Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Table]",
        "terseLabel": "Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Table]"
       }
      }
     },
     "localname": "FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/FairValueMeasurementsReconciliationofLiabilitiesMeasuredatFairValueonaRecurringBasisUsingUnobservableInputsLevel3Details"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByFairValueHierarchyLevelAxis": {
     "auth_ref": [
      "r373",
      "r386",
      "r387",
      "r432",
      "r433",
      "r434",
      "r435",
      "r436",
      "r437",
      "r438",
      "r439",
      "r612",
      "r673",
      "r674",
      "r675"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.",
        "label": "Fair Value Hierarchy and NAV [Axis]",
        "terseLabel": "Fair Value Hierarchy and NAV [Axis]"
       }
      }
     },
     "localname": "FairValueByFairValueHierarchyLevelAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/FairValueMeasurementsFairValueofAssetsandLiabilitiesMeasuredonaRecurringBasisDetails",
      "http://www.cardinal.com/role/FairValueMeasurementsReconciliationofLiabilitiesMeasuredatFairValueonaRecurringBasisUsingUnobservableInputsLevel3Details",
      "http://www.cardinal.com/role/FinancialInstrumentsSummaryofEstimatedFairValueofLongtermObligationsandOtherShorttermBorrowingsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByLiabilityClassAxis": {
     "auth_ref": [
      "r618",
      "r619"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by class of liability.",
        "label": "Liability Class [Axis]",
        "terseLabel": "Liability Class [Axis]"
       }
      }
     },
     "localname": "FairValueByLiabilityClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/FairValueMeasurementsReconciliationofLiabilitiesMeasuredatFairValueonaRecurringBasisUsingUnobservableInputsLevel3Details"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByMeasurementFrequencyAxis": {
     "auth_ref": [
      "r611",
      "r612",
      "r614",
      "r615",
      "r620"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by measurement frequency.",
        "label": "Measurement Frequency [Axis]",
        "terseLabel": "Measurement Frequency [Axis]"
       }
      }
     },
     "localname": "FairValueByMeasurementFrequencyAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/FairValueMeasurementsFairValueofAssetsandLiabilitiesMeasuredonaRecurringBasisDetails",
      "http://www.cardinal.com/role/FairValueMeasurementsReconciliationofLiabilitiesMeasuredatFairValueonaRecurringBasisUsingUnobservableInputsLevel3Details"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Disclosures [Abstract]",
        "terseLabel": "Fair Value Disclosures [Abstract]"
       }
      }
     },
     "localname": "FairValueDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresTextBlock": {
     "auth_ref": [
      "r618"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.",
        "label": "Fair Value Disclosures [Text Block]",
        "terseLabel": "Fair Value Disclosures"
       }
      }
     },
     "localname": "FairValueDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/FairValueMeasurements"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueHedgingMember": {
     "auth_ref": [
      "r566"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A hedge of the exposure to changes in the fair value of a recognized asset or liability, or of an unrecognized firm commitment, that are attributable to a particular risk.",
        "label": "Fair Value Hedging [Member]",
        "terseLabel": "Fair Value Hedging"
       }
      }
     },
     "localname": "FairValueHedgingMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/FinancialInstrumentsNarrativeDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleofFairValueGainLossDerivativeInstrumentDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleofGainLossRecognizedinEarningsforInterestRateContractsDesignatedasFairValueHedgesDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleofOutstandingInstrumentsCashFlowHedgesDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleofOutstandingInstrumentsFairValueHedgesDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleoftheFairValueofAssetsandLiabilitiesRelatedtoDerivativesDesignatedasHedgingInstrumentsDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsSummaryofEstimatedFairValueofLongtermObligationsandOtherShorttermBorrowingsDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsTables"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel1Member": {
     "auth_ref": [
      "r373",
      "r432",
      "r433",
      "r438",
      "r439",
      "r612",
      "r673"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.",
        "label": "Fair Value, Inputs, Level 1 [Member]",
        "terseLabel": "Level\u00a01"
       }
      }
     },
     "localname": "FairValueInputsLevel1Member",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/FairValueMeasurementsFairValueofAssetsandLiabilitiesMeasuredonaRecurringBasisDetails",
      "http://www.cardinal.com/role/FairValueMeasurementsReconciliationofLiabilitiesMeasuredatFairValueonaRecurringBasisUsingUnobservableInputsLevel3Details"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel2Member": {
     "auth_ref": [
      "r373",
      "r386",
      "r387",
      "r432",
      "r433",
      "r438",
      "r439",
      "r612",
      "r674"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.",
        "label": "Fair Value, Inputs, Level 2 [Member]",
        "terseLabel": "Level\u00a02"
       }
      }
     },
     "localname": "FairValueInputsLevel2Member",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/FairValueMeasurementsFairValueofAssetsandLiabilitiesMeasuredonaRecurringBasisDetails",
      "http://www.cardinal.com/role/FairValueMeasurementsReconciliationofLiabilitiesMeasuredatFairValueonaRecurringBasisUsingUnobservableInputsLevel3Details",
      "http://www.cardinal.com/role/FinancialInstrumentsSummaryofEstimatedFairValueofLongtermObligationsandOtherShorttermBorrowingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel3Member": {
     "auth_ref": [
      "r373",
      "r386",
      "r387",
      "r432",
      "r433",
      "r434",
      "r435",
      "r436",
      "r437",
      "r438",
      "r439",
      "r612",
      "r675"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Inputs, Level 3 [Member]",
        "terseLabel": "Level\u00a03"
       }
      }
     },
     "localname": "FairValueInputsLevel3Member",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/FairValueMeasurementsFairValueofAssetsandLiabilitiesMeasuredonaRecurringBasisDetails",
      "http://www.cardinal.com/role/FairValueMeasurementsReconciliationofLiabilitiesMeasuredatFairValueonaRecurringBasisUsingUnobservableInputsLevel3Details"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain": {
     "auth_ref": [
      "r616"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents classes of liabilities measured and disclosed at fair value.",
        "label": "Fair Value by Liability Class [Domain]",
        "terseLabel": "Fair Value by Liability Class [Domain]"
       }
      }
     },
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/FairValueMeasurementsReconciliationofLiabilitiesMeasuredatFairValueonaRecurringBasisUsingUnobservableInputsLevel3Details"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]",
        "terseLabel": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]"
       }
      }
     },
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/FairValueMeasurementsReconciliationofLiabilitiesMeasuredatFairValueonaRecurringBasisUsingUnobservableInputsLevel3Details"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueMeasurementFrequencyDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement frequency.",
        "label": "Measurement Frequency [Domain]",
        "terseLabel": "Measurement Frequency [Domain]"
       }
      }
     },
     "localname": "FairValueMeasurementFrequencyDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/FairValueMeasurementsFairValueofAssetsandLiabilitiesMeasuredonaRecurringBasisDetails",
      "http://www.cardinal.com/role/FairValueMeasurementsReconciliationofLiabilitiesMeasuredatFairValueonaRecurringBasisUsingUnobservableInputsLevel3Details"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementInputsDisclosureTextBlock": {
     "auth_ref": [
      "r621"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure of the fair value measurement of assets and liabilities, which includes financial instruments measured at fair value that are classified in shareholders' equity, which may be measured on a recurring or nonrecurring basis.",
        "label": "Fair Value Measurement and Measurement Inputs, Recurring and Nonrecurring [Text Block]",
        "terseLabel": "Fair Value Measurements"
       }
      }
     },
     "localname": "FairValueMeasurementInputsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/FairValueMeasurements"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueMeasurementPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for fair value measurements of financial and non-financial assets, liabilities and instruments classified in shareholders' equity. Disclosures include, but are not limited to, how an entity that manages a group of financial assets and liabilities on the basis of its net exposure measures the fair value of those assets and liabilities.",
        "label": "Fair Value Measurement, Policy [Policy Text Block]",
        "terseLabel": "Fair Value Measurements"
       }
      }
     },
     "localname": "FairValueMeasurementPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": {
     "auth_ref": [
      "r373",
      "r386",
      "r387",
      "r432",
      "r433",
      "r434",
      "r435",
      "r436",
      "r437",
      "r438",
      "r439",
      "r673",
      "r674",
      "r675"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.",
        "label": "Fair Value Hierarchy and NAV [Domain]",
        "terseLabel": "Fair Value Hierarchy and NAV [Domain]"
       }
      }
     },
     "localname": "FairValueMeasurementsFairValueHierarchyDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/FairValueMeasurementsFairValueofAssetsandLiabilitiesMeasuredonaRecurringBasisDetails",
      "http://www.cardinal.com/role/FairValueMeasurementsReconciliationofLiabilitiesMeasuredatFairValueonaRecurringBasisUsingUnobservableInputsLevel3Details",
      "http://www.cardinal.com/role/FinancialInstrumentsSummaryofEstimatedFairValueofLongtermObligationsandOtherShorttermBorrowingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementsNonrecurringMember": {
     "auth_ref": [
      "r611",
      "r612",
      "r614",
      "r615",
      "r617",
      "r620"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Infrequent fair value measurement. Includes, but is not limited to, fair value adjustment for impairment of asset, liability or equity, not frequently measured at fair value.",
        "label": "Fair Value, Nonrecurring [Member]",
        "terseLabel": "Fair Value, Nonrecurring"
       }
      }
     },
     "localname": "FairValueMeasurementsNonrecurringMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/FairValueMeasurementsFairValueofAssetsandLiabilitiesMeasuredonaRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementsRecurringMember": {
     "auth_ref": [
      "r618",
      "r620"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Frequent fair value measurement. Includes, but is not limited to, fair value adjustment for impairment of asset, liability or equity, frequently measured at fair value.",
        "label": "Fair Value, Recurring [Member]",
        "terseLabel": "Fair Value, Measurements, Recurring"
       }
      }
     },
     "localname": "FairValueMeasurementsRecurringMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/FairValueMeasurementsFairValueofAssetsandLiabilitiesMeasuredonaRecurringBasisDetails",
      "http://www.cardinal.com/role/FairValueMeasurementsReconciliationofLiabilitiesMeasuredatFairValueonaRecurringBasisUsingUnobservableInputsLevel3Details"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable": {
     "auth_ref": [
      "r570",
      "r576",
      "r594"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule that discloses the location and fair value amounts of derivative instruments (and nonderivative instruments that are designated and qualify as hedging instruments) reported in the statement of financial position.",
        "label": "Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table]",
        "terseLabel": "Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table]"
       }
      }
     },
     "localname": "FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleoftheFairValueofAssetsandLiabilitiesRelatedtoDerivativesDesignatedasHedgingInstrumentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FinanceLeaseLiability": {
     "auth_ref": [
      "r653",
      "r666"
     ],
     "calculation": {
      "http://www.cardinal.com/role/LeasesSupplementalBalanceSheetInformationDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease.",
        "label": "Finance Lease, Liability",
        "terseLabel": "Total lease liabilities",
        "totalLabel": "Total finance lease liabilities"
       }
      }
     },
     "localname": "FinanceLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/LeasesScheduleofFutureLeasePaymentsDetails",
      "http://www.cardinal.com/role/LeasesSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityCurrent": {
     "auth_ref": [
      "r653"
     ],
     "calculation": {
      "http://www.cardinal.com/role/LeasesSupplementalBalanceSheetInformationDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_FinanceLeaseLiability",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease, classified as current.",
        "label": "Finance Lease, Liability, Current",
        "terseLabel": "Finance Lease, Liability, Current"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/LeasesSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityNoncurrent": {
     "auth_ref": [
      "r653"
     ],
     "calculation": {
      "http://www.cardinal.com/role/LeasesSupplementalBalanceSheetInformationDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_FinanceLeaseLiability",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease, classified as noncurrent.",
        "label": "Finance Lease, Liability, Noncurrent",
        "terseLabel": "Finance Lease, Liability, Noncurrent"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/LeasesSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDue": {
     "auth_ref": [
      "r666"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments for finance lease.",
        "label": "Finance Lease, Liability, Payment, Due",
        "terseLabel": "Total future lease payments"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/LeasesScheduleofFutureLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive": {
     "auth_ref": [
      "r666"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finance Lease, Liability, to be Paid, after Year Five",
        "terseLabel": "Thereafter"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDueAfterYearFive",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/LeasesScheduleofFutureLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths": {
     "auth_ref": [
      "r666"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finance Lease, Liability, to be Paid, Year One",
        "terseLabel": "2022"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDueNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/LeasesScheduleofFutureLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive": {
     "auth_ref": [
      "r666"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finance Lease, Liability, to be Paid, Year Five",
        "terseLabel": "2026"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDueYearFive",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/LeasesScheduleofFutureLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour": {
     "auth_ref": [
      "r666"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finance Lease, Liability, to be Paid, Year Four",
        "terseLabel": "2025"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDueYearFour",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/LeasesScheduleofFutureLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree": {
     "auth_ref": [
      "r666"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finance Lease, Liability, to be Paid, Year Three",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDueYearThree",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/LeasesScheduleofFutureLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo": {
     "auth_ref": [
      "r666"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finance Lease, Liability, to be Paid, Year Two",
        "terseLabel": "2023"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDueYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/LeasesScheduleofFutureLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeasePrincipalPayments": {
     "auth_ref": [
      "r655",
      "r661"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow for principal payment on finance lease.",
        "label": "Finance Lease, Principal Payments",
        "terseLabel": "Finance Lease, Principal Payments"
       }
      }
     },
     "localname": "FinanceLeasePrincipalPayments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/LeasesSupplementalCashFlowInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseRightOfUseAsset": {
     "auth_ref": [
      "r652"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after accumulated amortization, of right-of-use asset from finance lease.",
        "label": "Finance Lease, Right-of-Use Asset, after Accumulated Amortization",
        "terseLabel": "Finance Lease, Right-of-Use Asset, after Accumulated Amortization"
       }
      }
     },
     "localname": "FinanceLeaseRightOfUseAsset",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/LeasesSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseRightOfUseAssetAmortization": {
     "auth_ref": [
      "r654",
      "r658",
      "r667"
     ],
     "calculation": {
      "http://www.cardinal.com/role/LeasesScheduleofLeaseCostsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LeaseCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization expense attributable to right-of-use asset from finance lease.",
        "label": "Finance Lease, Right-of-Use Asset, Amortization",
        "terseLabel": "Amortization of right-of-use assets"
       }
      }
     },
     "localname": "FinanceLeaseRightOfUseAssetAmortization",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/LeasesScheduleofLeaseCostsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent": {
     "auth_ref": [
      "r664",
      "r667"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average discount rate for finance lease calculated at point in time.",
        "label": "Finance Lease, Weighted Average Discount Rate, Percent",
        "terseLabel": "Finance Lease, Weighted Average Discount Rate, Percent"
       }
      }
     },
     "localname": "FinanceLeaseWeightedAverageDiscountRatePercent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/LeasesDetails",
      "http://www.cardinal.com/role/LeasesSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1": {
     "auth_ref": [
      "r663",
      "r667"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining lease term for finance lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Finance Lease, Weighted Average Remaining Lease Term",
        "terseLabel": "Finance Lease, Weighted Average Remaining Lease Term"
       }
      }
     },
     "localname": "FinanceLeaseWeightedAverageRemainingLeaseTerm1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/LeasesDetails",
      "http://www.cardinal.com/role/LeasesSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_FinancialInstrumentsDisclosureTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for financial instruments. This disclosure includes, but is not limited to, fair value measurements of short and long term marketable securities, international currencies forward contracts, and auction rate securities. Financial instruments may include hedging and non-hedging currency exchange instruments, derivatives, securitizations and securities available for sale at fair value. Also included are investment results, realized and unrealized gains and losses as well as impairments and risk management disclosures.",
        "label": "Financial Instruments Disclosure [Text Block]",
        "terseLabel": "Financial Instruments"
       }
      }
     },
     "localname": "FinancialInstrumentsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/FinancialInstruments"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": {
     "auth_ref": [
      "r288"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Accumulated Amortization",
        "terseLabel": "Accumulated Amortization"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/GoodwillandOtherIntangibleAssetsScheduleofIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths": {
     "auth_ref": [
      "r290"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year One",
        "terseLabel": "Estimated annual amortization of intangible assets - 2022"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/GoodwillandOtherIntangibleAssetsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive": {
     "auth_ref": [
      "r290"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Five",
        "terseLabel": "Estimated annual amortization of intangible assets - 2026"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFive",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/GoodwillandOtherIntangibleAssetsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour": {
     "auth_ref": [
      "r290"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Four",
        "terseLabel": "Estimated annual amortization of intangible assets - 2025"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFour",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/GoodwillandOtherIntangibleAssetsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree": {
     "auth_ref": [
      "r290"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Three",
        "terseLabel": "Estimated annual amortization of intangible assets - 2024"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearThree",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/GoodwillandOtherIntangibleAssetsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo": {
     "auth_ref": [
      "r290"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Two",
        "terseLabel": "Estimated annual amortization of intangible assets - 2023"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/GoodwillandOtherIntangibleAssetsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": {
     "auth_ref": [
      "r282",
      "r284",
      "r288",
      "r292",
      "r686",
      "r690"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by major type or class of finite-lived intangible assets.",
        "label": "Finite-Lived Intangible Assets by Major Class [Axis]",
        "terseLabel": "Finite-Lived Intangible Assets by Major Class"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/GoodwillandOtherIntangibleAssetsScheduleofIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsGross": {
     "auth_ref": [
      "r288",
      "r690"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Gross",
        "terseLabel": "Gross Intangible"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/GoodwillandOtherIntangibleAssetsScheduleofIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Finite-Lived Intangible Assets [Line Items]",
        "terseLabel": "Finite-Lived Intangible Assets [Line Items]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/GoodwillandOtherIntangibleAssetsScheduleofIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": {
     "auth_ref": [
      "r282",
      "r287"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company.",
        "label": "Finite-Lived Intangible Assets, Major Class Name [Domain]",
        "verboseLabel": "Finite-Lived Intangible Assets, Major Class Name"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/GoodwillandOtherIntangibleAssetsScheduleofIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsNet": {
     "auth_ref": [
      "r288",
      "r686"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Net",
        "terseLabel": "Net Intangible"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/GoodwillandOtherIntangibleAssetsScheduleofIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1": {
     "auth_ref": [
      "r686"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Remaining amortization period of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Finite-Lived Intangible Assets, Remaining Amortization Period",
        "terseLabel": "Weighted- Average Remaining Amortization Period (Years)"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/GoodwillandOtherIntangibleAssetsScheduleofIntangibleAssetsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_ForeignCountryMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Designated tax departments of governments entitled to levy and collect income taxes from the entity outside the entity's country of domicile.",
        "label": "Foreign Tax Authority [Member]",
        "terseLabel": "Foreign"
       }
      }
     },
     "localname": "ForeignCountryMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock": {
     "auth_ref": [
      "r644"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy.",
        "label": "Foreign Currency Transactions and Translations Policy [Policy Text Block]",
        "terseLabel": "Translation of Foreign Currencies"
       }
      }
     },
     "localname": "ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ForeignExchangeContractMember": {
     "auth_ref": [
      "r78",
      "r432",
      "r585"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Derivative instrument whose primary underlying risk is tied to foreign exchange rates.",
        "label": "Foreign Exchange Contract [Member]",
        "terseLabel": "Foreign Currency Contracts"
       }
      }
     },
     "localname": "ForeignExchangeContractMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/FinancialInstrumentsNarrativeDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleofFairValueGainLossDerivativeInstrumentDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleofGainLossIncludedinAOCIforDerivativeInstrumentsDesignatedasCashFlowHedgesDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleofGainLossReclassifiedfromAOCIintoEarningsforDerivativeInstrumentsDesignatedasCashFlowHedgesDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleofGainLossRecognizedinEarningsforDerivativesNotDesignatedasHedgingInstrumentDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleofOutstandingInstrumentsCashFlowHedgesDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleofOutstandingInstrumentsEconomicHedgesDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleoftheFairValueofAssetsandLiabilitiesRelatedtoDerivativesDesignatedasHedgingInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ForwardContractsMember": {
     "auth_ref": [
      "r583"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contracts negotiated between two parties to purchase and sell a specific quantity of a financial instrument, foreign currency, or commodity at a price specified at origination of the contract, with delivery and settlement at a specified future date.",
        "label": "Forward Contracts [Member]",
        "terseLabel": "Forward Contracts [Member]"
       }
      }
     },
     "localname": "ForwardContractsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleofFairValueGainLossDerivativeInstrumentDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleofGainLossIncludedinAOCIforDerivativeInstrumentsDesignatedasCashFlowHedgesDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleofGainLossReclassifiedfromAOCIintoEarningsforDerivativeInstrumentsDesignatedasCashFlowHedgesDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleofOutstandingInstrumentsCashFlowHedgesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FurnitureAndFixturesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equipment commonly used in offices and stores that have no permanent connection to the structure of a building or utilities. Examples include, but are not limited to, desks, chairs, tables, and bookcases.",
        "label": "Furniture and Fixtures [Member]",
        "verboseLabel": "Furniture and fixtures"
       }
      }
     },
     "localname": "FurnitureAndFixturesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesComponentsofPropertyandEquipmentDetails",
      "http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativePropertyandEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_GainLossOnSaleOfInvestments": {
     "auth_ref": [
      "r126"
     ],
     "calculation": {
      "http://www.cardinal.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      },
      "http://www.cardinal.com/role/ConsolidatedStatementsofEarnings": {
       "order": 5.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net realized gain (loss) on investments sold during the period, not including gains (losses) on securities separately or otherwise categorized as trading, available-for-sale, or held-to-maturity, which, for cash flow reporting, is a component of proceeds from investing activities.",
        "label": "Gain (Loss) on Sale of Investments",
        "terseLabel": "Gain (Loss) on Sale of Investments"
       }
      }
     },
     "localname": "GainLossOnSaleOfInvestments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.cardinal.com/role/ConsolidatedStatementsofEarnings"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GainLossOnSaleOfOtherInvestments": {
     "auth_ref": [
      "r126"
     ],
     "calculation": {
      "http://www.cardinal.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) included in earnings for investments classified as other.",
        "label": "Gain (Loss) on Sale of Other Investments",
        "negatedTerseLabel": "Loss on Sale of Investments"
       }
      }
     },
     "localname": "GainLossOnSaleOfOtherInvestments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges": {
     "auth_ref": [
      "r126"
     ],
     "calculation": {
      "http://www.cardinal.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      },
      "http://www.cardinal.com/role/ConsolidatedStatementsofEarnings": {
       "order": 5.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) from the difference between the sale price or salvage price and the book value of an asset that was sold or retired, and gain (loss) from the write down of assets from their carrying value to fair value.",
        "label": "Gain (Loss) on Sale of Assets and Asset Impairment Charges",
        "negatedTerseLabel": "Impairments and (gain)/loss on disposal of assets, net"
       }
      }
     },
     "localname": "GainLossOnSalesOfAssetsAndAssetImpairmentCharges",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.cardinal.com/role/ConsolidatedStatementsofEarnings"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GainLossRelatedToLitigationSettlement": {
     "auth_ref": [
      "r326"
     ],
     "calculation": {
      "http://www.cardinal.com/role/ConsolidatedStatementsofEarnings": {
       "order": 6.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) recognized in settlement of litigation and insurance claims. Excludes claims within an insurance entity's normal claims settlement process.",
        "label": "Gain (Loss) Related to Litigation Settlement",
        "negatedTerseLabel": "Litigation (recoveries)/charges, net",
        "terseLabel": "Gain (Loss) Related to Litigation Settlement"
       }
      }
     },
     "localname": "GainLossRelatedToLitigationSettlement",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesLossContingenciesDetails",
      "http://www.cardinal.com/role/CommitmentsContingentLiabilitiesandLitigationDetails",
      "http://www.cardinal.com/role/ConsolidatedStatementsofEarnings",
      "http://www.cardinal.com/role/SegmentInformationNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GainOnSaleOfInvestments": {
     "auth_ref": [
      "r107",
      "r108",
      "r126",
      "r702",
      "r733"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The difference between the carrying value and the sale price of an investment.  A gain would be recognized when the sale price of the investment is greater than the carrying value of the investment.  This element refers to the Gain included in earnings and not to the cash proceeds of the sale.",
        "label": "Gain on Sale of Investments",
        "terseLabel": "Gain on Sale of Investments"
       }
      }
     },
     "localname": "GainOnSaleOfInvestments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/DivestituresandAcquisitionsNarrativeDetails",
      "http://www.cardinal.com/role/SegmentInformationNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GainsLossesOnExtinguishmentOfDebt": {
     "auth_ref": [
      "r126",
      "r390",
      "r391"
     ],
     "calculation": {
      "http://www.cardinal.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      },
      "http://www.cardinal.com/role/ConsolidatedStatementsofEarnings": {
       "order": 4.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.",
        "label": "Gain (Loss) on Extinguishment of Debt",
        "negatedTerseLabel": "Loss on early extinguishment of debt",
        "terseLabel": "Gain (Loss) on Extinguishment of Debt"
       }
      }
     },
     "localname": "GainsLossesOnExtinguishmentOfDebt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.cardinal.com/role/ConsolidatedStatementsofEarnings",
      "http://www.cardinal.com/role/LongTermObligationsandOtherShortTermBorrowingsLongTermDebtDetails",
      "http://www.cardinal.com/role/LongTermObligationsandOtherShortTermBorrowingsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Goodwill": {
     "auth_ref": [
      "r269",
      "r271",
      "r671",
      "r691"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance",
        "terseLabel": "Goodwill"
       }
      }
     },
     "localname": "Goodwill",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/GoodwillandOtherIntangibleAssetsNarrativeDetails",
      "http://www.cardinal.com/role/GoodwillandOtherIntangibleAssetsScheduleofGoodwillbyReportableSegmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Goodwill and Intangible Assets Disclosure [Abstract]",
        "terseLabel": "Goodwill and Intangible Assets Disclosure [Abstract]"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock": {
     "auth_ref": [
      "r294"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for goodwill and intangible assets.",
        "label": "Goodwill and Intangible Assets Disclosure [Text Block]",
        "terseLabel": "Goodwill and Other Intangible Assets"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/GoodwillandOtherIntangibleAssets"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock": {
     "auth_ref": [
      "r277",
      "r285"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for goodwill and intangible assets. This accounting policy also may address how an entity assesses and measures impairment of goodwill and intangible assets.",
        "label": "Goodwill and Intangible Assets, Policy [Policy Text Block]",
        "terseLabel": "Goodwill and Other Intangible Assets"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_GoodwillForeignCurrencyTranslationGainLoss": {
     "auth_ref": [
      "r274"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of foreign currency translation gain (loss) which increases (decreases) an asset representing future economic benefits from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Foreign Currency Translation Gain (Loss)",
        "negatedTerseLabel": "Foreign currency translation adjustments and other"
       }
      }
     },
     "localname": "GoodwillForeignCurrencyTranslationGainLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/GoodwillandOtherIntangibleAssetsScheduleofGoodwillbyReportableSegmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillImpairedAccumulatedImpairmentLoss": {
     "auth_ref": [
      "r272",
      "r276"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated impairment loss for an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Impaired, Accumulated Impairment Loss",
        "terseLabel": "Accumulated goodwill impairment loss"
       }
      }
     },
     "localname": "GoodwillImpairedAccumulatedImpairmentLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/GoodwillandOtherIntangibleAssetsNarrativeDetails",
      "http://www.cardinal.com/role/GoodwillandOtherIntangibleAssetsScheduleofGoodwillbyReportableSegmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillImpairmentLoss": {
     "auth_ref": [
      "r126",
      "r270",
      "r273",
      "r278"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Impairment Loss",
        "terseLabel": "Goodwill, Impairment Loss"
       }
      }
     },
     "localname": "GoodwillImpairmentLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeGoodwillandOtherIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Goodwill [Line Items]",
        "terseLabel": "Goodwill [Line Items]"
       }
      }
     },
     "localname": "GoodwillLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/GoodwillandOtherIntangibleAssetsNarrativeDetails",
      "http://www.cardinal.com/role/GoodwillandOtherIntangibleAssetsScheduleofGoodwillbyReportableSegmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_GoodwillRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Goodwill [Roll Forward]",
        "terseLabel": "Goodwill [Roll Forward]"
       }
      }
     },
     "localname": "GoodwillRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/GoodwillandOtherIntangibleAssetsScheduleofGoodwillbyReportableSegmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_GoodwillTransfers": {
     "auth_ref": [
      "r275"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of transfers into (out of) an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Transfers",
        "terseLabel": "Goodwill, Transfers"
       }
      }
     },
     "localname": "GoodwillTransfers",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/GoodwillandOtherIntangibleAssetsScheduleofGoodwillbyReportableSegmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GrossProfit": {
     "auth_ref": [
      "r109",
      "r139",
      "r217",
      "r223",
      "r227",
      "r230",
      "r233",
      "r255",
      "r343",
      "r344",
      "r345",
      "r348",
      "r349",
      "r350",
      "r352",
      "r354",
      "r356",
      "r357",
      "r626"
     ],
     "calculation": {
      "http://www.cardinal.com/role/ConsolidatedStatementsofEarnings": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.",
        "label": "Gross Profit",
        "totalLabel": "Gross margin"
       }
      }
     },
     "localname": "GrossProfit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedStatementsofEarnings"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GuaranteesIndemnificationsAndWarrantiesPolicies": {
     "auth_ref": [
      "r339"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for guarantees, indemnifications and product warranties, and methodologies used in determining the amount of such liabilities.",
        "label": "Guarantees, Indemnifications and Warranties Policies [Policy Text Block]",
        "terseLabel": "Guarantees, Indemnifications and Warranties Policies [Policy Text Block]"
       }
      }
     },
     "localname": "GuaranteesIndemnificationsAndWarrantiesPolicies",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_HedgingDesignationAxis": {
     "auth_ref": [
      "r568",
      "r590"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by designation of purpose of derivative instrument.",
        "label": "Hedging Designation [Axis]",
        "terseLabel": "Hedging Designation [Axis]"
       }
      }
     },
     "localname": "HedgingDesignationAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/FinancialInstrumentsNarrativeDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleofGainLossRecognizedinEarningsforDerivativesNotDesignatedasHedgingInstrumentDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleofOutstandingInstrumentsCashFlowHedgesDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleofOutstandingInstrumentsEconomicHedgesDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleofOutstandingInstrumentsFairValueHedgesDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleoftheFairValueofAssetsandLiabilitiesRelatedtoDerivativesDesignatedasHedgingInstrumentsDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsSummaryofEstimatedFairValueofLongtermObligationsandOtherShorttermBorrowingsDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsTables"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_HedgingDesignationDomain": {
     "auth_ref": [
      "r568"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Designation of purpose of derivative instrument.",
        "label": "Hedging Designation [Domain]",
        "terseLabel": "Hedging Designation [Domain]"
       }
      }
     },
     "localname": "HedgingDesignationDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/FinancialInstrumentsNarrativeDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleofGainLossRecognizedinEarningsforDerivativesNotDesignatedasHedgingInstrumentDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleofOutstandingInstrumentsCashFlowHedgesDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleofOutstandingInstrumentsEconomicHedgesDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleofOutstandingInstrumentsFairValueHedgesDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleoftheFairValueofAssetsandLiabilitiesRelatedtoDerivativesDesignatedasHedgingInstrumentsDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsSummaryofEstimatedFairValueofLongtermObligationsandOtherShorttermBorrowingsDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsTables"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_HedgingRelationshipDomain": {
     "auth_ref": [
      "r568"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Nature or intent of a hedge.",
        "label": "Hedging Relationship [Domain]",
        "terseLabel": "Hedging Relationship [Domain]"
       }
      }
     },
     "localname": "HedgingRelationshipDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/FinancialInstrumentsNarrativeDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleofFairValueGainLossDerivativeInstrumentDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleofGainLossIncludedinAOCIforDerivativeInstrumentsDesignatedasCashFlowHedgesDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleofGainLossReclassifiedfromAOCIintoEarningsforDerivativeInstrumentsDesignatedasCashFlowHedgesDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleofGainLossRecognizedinEarningsforInterestRateContractsDesignatedasFairValueHedgesDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleofOutstandingInstrumentsCashFlowHedgesDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleofOutstandingInstrumentsFairValueHedgesDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleoftheFairValueofAssetsandLiabilitiesRelatedtoDerivativesDesignatedasHedgingInstrumentsDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsSummaryofEstimatedFairValueofLongtermObligationsandOtherShorttermBorrowingsDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsTables"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic": {
     "auth_ref": [
      "r141",
      "r530"
     ],
     "calculation": {
      "http://www.cardinal.com/role/IncomeTaxesScheduleofIncomebeforeIncomeTaxDomesticandForeignDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of earnings or loss from continuing operations before income taxes that is attributable to domestic operations.",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Domestic",
        "terseLabel": "U.S. operations"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/IncomeTaxesScheduleofIncomebeforeIncomeTaxDomesticandForeignDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign": {
     "auth_ref": [
      "r141",
      "r530"
     ],
     "calculation": {
      "http://www.cardinal.com/role/IncomeTaxesScheduleofIncomebeforeIncomeTaxDomesticandForeignDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of earnings or loss from continuing operations before income taxes that is attributable to foreign operations, which is defined as Income or Loss generated from operations located outside the entity's country of domicile.",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Foreign",
        "terseLabel": "Non-U.S. operations"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/IncomeTaxesScheduleofIncomebeforeIncomeTaxDomesticandForeignDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments": {
     "auth_ref": [
      "r217",
      "r223",
      "r227",
      "r230",
      "r233"
     ],
     "calculation": {
      "http://www.cardinal.com/role/ConsolidatedStatementsofEarnings": {
       "order": 1.0,
       "parentTag": "us-gaap_ProfitLoss",
       "weight": 1.0
      },
      "http://www.cardinal.com/role/IncomeTaxesScheduleofIncomebeforeIncomeTaxDomesticandForeignDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (loss) from continuing operations before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of income (loss) from equity method investments.",
        "label": "Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest",
        "totalLabel": "Earnings/(loss) before income taxes"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedStatementsofEarnings",
      "http://www.cardinal.com/role/IncomeTaxesScheduleofIncomebeforeIncomeTaxDomesticandForeignDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromEquityMethodInvestments": {
     "auth_ref": [
      "r100",
      "r126",
      "r214",
      "r253",
      "r701",
      "r727"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (loss) for proportionate share of equity method investee's income (loss).",
        "label": "Income (Loss) from Equity Method Investments",
        "terseLabel": "Income (Loss) from Equity Method Investments"
       }
      }
     },
     "localname": "IncomeLossFromEquityMethodInvestments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/DivestituresandAcquisitionsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeStatementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Statement [Abstract]",
        "terseLabel": "Income Statement [Abstract]"
       }
      }
     },
     "localname": "IncomeStatementAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis": {
     "auth_ref": [
      "r441",
      "r443"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by name of disposal group.",
        "label": "Disposal Group Name [Axis]",
        "terseLabel": "Disposal Group Name [Axis]"
       }
      }
     },
     "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/DivestituresandAcquisitionsNarrativeDetails",
      "http://www.cardinal.com/role/GoodwillandOtherIntangibleAssetsNarrativeDetails",
      "http://www.cardinal.com/role/SegmentInformationNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationAxis": {
     "auth_ref": [
      "r299",
      "r308"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location in the income statement.",
        "label": "Income Statement Location [Axis]",
        "terseLabel": "Income Statement Location [Axis]"
       }
      }
     },
     "localname": "IncomeStatementLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleofGainLossReclassifiedfromAOCIintoEarningsforDerivativeInstrumentsDesignatedasCashFlowHedgesDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleofGainLossRecognizedinEarningsforDerivativesNotDesignatedasHedgingInstrumentDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleofGainLossRecognizedinEarningsforInterestRateContractsDesignatedasFairValueHedgesDetails",
      "http://www.cardinal.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationDomain": {
     "auth_ref": [
      "r308"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in the income statement.",
        "label": "Income Statement Location [Domain]",
        "terseLabel": "Income Statement Location [Domain]"
       }
      }
     },
     "localname": "IncomeStatementLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleofGainLossReclassifiedfromAOCIintoEarningsforDerivativeInstrumentsDesignatedasCashFlowHedgesDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleofGainLossRecognizedinEarningsforDerivativesNotDesignatedasHedgingInstrumentDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleofGainLossRecognizedinEarningsforInterestRateContractsDesignatedasFairValueHedgesDetails",
      "http://www.cardinal.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxAuthorityAxis": {
     "auth_ref": [
      "r496"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by tax jurisdiction.",
        "label": "Income Tax Authority [Axis]",
        "terseLabel": "Income Tax Authority"
       }
      }
     },
     "localname": "IncomeTaxAuthorityAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxAuthorityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Agency, division or body classification that levies income taxes, examines tax returns for compliance, or grants exemptions from or makes other decisions pertaining to income taxes.",
        "label": "Income Tax Authority [Domain]",
        "terseLabel": "Income Tax Authority"
       }
      }
     },
     "localname": "IncomeTaxAuthorityDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxAuthorityNameAxis": {
     "auth_ref": [
      "r496"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by name of taxing authority.",
        "label": "Income Tax Authority, Name [Axis]",
        "terseLabel": "Income Tax Authority, Name [Axis]"
       }
      }
     },
     "localname": "IncomeTaxAuthorityNameAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/IncomeTaxesScheduleofUnrecognizedTaxBenefitsRollForwardDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxAuthorityNameDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Named agency, division or body that levies income taxes, examines tax returns for compliance, or grants exemptions from or makes other decisions pertaining to income taxes.",
        "label": "Income Tax Authority, Name [Domain]",
        "terseLabel": "Income Tax Authority, Name [Domain]"
       }
      }
     },
     "localname": "IncomeTaxAuthorityNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/IncomeTaxesScheduleofUnrecognizedTaxBenefitsRollForwardDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxContingencyLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Income Tax Contingency [Line Items]",
        "terseLabel": "Income Tax Contingency [Line Items]"
       }
      }
     },
     "localname": "IncomeTaxContingencyLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/IncomeTaxesScheduleofUnrecognizedTaxBenefitsRollForwardDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxContingencyTable": {
     "auth_ref": [
      "r497",
      "r504",
      "r506",
      "r520"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about tax positions taken in the tax returns filed or to be filed for which it is more likely than not that the tax position will not be sustained upon examination by taxing authorities and other income tax contingencies. Includes, but is not limited to, interest and penalties, reconciliation of unrecognized tax benefits, unrecognized tax benefits that would affect the effective tax rate, tax years that remain subject to examination by tax jurisdictions, and information about positions for which it is reasonably possible that amounts unrecognized will significantly change within 12 months.",
        "label": "Income Tax Contingency [Table]",
        "terseLabel": "Income Tax Contingency [Table]"
       }
      }
     },
     "localname": "IncomeTaxContingencyTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/IncomeTaxesScheduleofUnrecognizedTaxBenefitsRollForwardDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Disclosure [Abstract]",
        "terseLabel": "Income Tax Disclosure [Abstract]"
       }
      }
     },
     "localname": "IncomeTaxDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxDisclosureTextBlock": {
     "auth_ref": [
      "r142",
      "r493",
      "r505",
      "r512",
      "r525",
      "r532",
      "r535",
      "r536",
      "r537"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.",
        "label": "Income Tax Disclosure [Text Block]",
        "terseLabel": "Income Taxes"
       }
      }
     },
     "localname": "IncomeTaxDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/IncomeTaxes"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r143",
      "r167",
      "r168",
      "r215",
      "r491",
      "r526",
      "r533",
      "r735"
     ],
     "calculation": {
      "http://www.cardinal.com/role/ConsolidatedStatementsofEarnings": {
       "order": 2.0,
       "parentTag": "us-gaap_ProfitLoss",
       "weight": -1.0
      },
      "http://www.cardinal.com/role/IncomeTaxesScheduleofComponentsofIncomeTaxExpenseBenefitCurrentandDeferredDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Income Tax Expense (Benefit)",
        "terseLabel": "Income Tax Expense (Benefit)",
        "totalLabel": "Provision for/(benefit from) income taxes",
        "verboseLabel": "Provision for/(benefit from) income taxes"
       }
      }
     },
     "localname": "IncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedStatementsofEarnings",
      "http://www.cardinal.com/role/IncomeTaxesNarrativeDetails",
      "http://www.cardinal.com/role/IncomeTaxesScheduleofComponentsofIncomeTaxExpenseBenefitCurrentandDeferredDetails",
      "http://www.cardinal.com/role/IncomeTaxesScheduleofUnrecognizedTaxBenefitsRollForwardDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxPolicyTextBlock": {
     "auth_ref": [
      "r93",
      "r488",
      "r489",
      "r505",
      "r506",
      "r511",
      "r519"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.",
        "label": "Income Tax, Policy [Policy Text Block]",
        "terseLabel": "Income Taxes"
       }
      }
     },
     "localname": "IncomeTaxPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxReceivable": {
     "auth_ref": [
      "r52",
      "r714"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount as of the balance sheet date of income taxes previously overpaid to tax authorities (such as U.S. Federal, state and local tax authorities) representing refunds of overpayments or recoveries based on agreed-upon resolutions of disputes. Also called income tax refund receivable.",
        "label": "Income Taxes Receivable",
        "terseLabel": "Income Taxes Receivable"
       }
      }
     },
     "localname": "IncomeTaxReceivable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxesPaidNet": {
     "auth_ref": [
      "r130"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes.",
        "label": "Income Taxes Paid, Net",
        "terseLabel": "Cash payments for income taxes"
       }
      }
     },
     "localname": "IncomeTaxesPaidNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsPayable": {
     "auth_ref": [
      "r125"
     ],
     "calculation": {
      "http://www.cardinal.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 12.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.",
        "label": "Increase (Decrease) in Accounts Payable",
        "terseLabel": "Increase/(decrease) in accounts payable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsPayable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInInventories": {
     "auth_ref": [
      "r125"
     ],
     "calculation": {
      "http://www.cardinal.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 11.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.",
        "label": "Increase (Decrease) in Inventories",
        "negatedTerseLabel": "Increase in inventories"
       }
      }
     },
     "localname": "IncreaseDecreaseInInventories",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (Decrease) in Operating Capital [Abstract]",
        "terseLabel": "Change in operating assets and liabilities, net of effects from acquisitions and divestitures:"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet": {
     "auth_ref": [
      "r125"
     ],
     "calculation": {
      "http://www.cardinal.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 13.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in operating assets after deduction of operating liabilities classified as other.",
        "label": "Increase (Decrease) in Other Operating Assets and Liabilities, Net",
        "negatedTerseLabel": "Other accrued liabilities and operating items, net"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherOperatingCapitalNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInReceivables": {
     "auth_ref": [
      "r125"
     ],
     "calculation": {
      "http://www.cardinal.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the total amount due within one year (or one operating cycle) from all parties, associated with underlying transactions that are classified as operating activities.",
        "label": "Increase (Decrease) in Receivables",
        "negatedTerseLabel": "(Increase)/decrease in trade receivables"
       }
      }
     },
     "localname": "IncreaseDecreaseInReceivables",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]",
        "terseLabel": "Increase (Decrease) in Shareholders' Equity"
       }
      }
     },
     "localname": "IncreaseDecreaseInStockholdersEquityRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedStatementsofShareholdersEquity"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis": {
     "auth_ref": [
      "r283",
      "r291"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type or class of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.",
        "label": "Indefinite-lived Intangible Assets [Axis]",
        "terseLabel": "Indefinite-lived Intangible Assets [Axis]"
       }
      }
     },
     "localname": "IndefiniteLivedIntangibleAssetsByMajorClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/DivestituresandAcquisitionsNarrativeDetails",
      "http://www.cardinal.com/role/GoodwillandOtherIntangibleAssetsScheduleofIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Indefinite-lived Intangible Assets [Line Items]",
        "terseLabel": "Indefinite-lived Intangible Assets [Line Items]"
       }
      }
     },
     "localname": "IndefiniteLivedIntangibleAssetsByMajorClassLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/GoodwillandOtherIntangibleAssetsScheduleofIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill": {
     "auth_ref": [
      "r291"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.",
        "label": "Indefinite-lived Intangible Assets (Excluding Goodwill)",
        "terseLabel": "Net Intangible"
       }
      }
     },
     "localname": "IndefiniteLivedIntangibleAssetsExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/GoodwillandOtherIntangibleAssetsScheduleofIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain": {
     "auth_ref": [
      "r283",
      "r291"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The major class of indefinite-lived intangible asset (for example, trade names, etc. but not all-inclusive), excluding goodwill. A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of the company.",
        "label": "Indefinite-lived Intangible Assets, Major Class Name [Domain]",
        "terseLabel": "Indefinite-lived Intangible Assets, Major Class Name [Domain]"
       }
      }
     },
     "localname": "IndefiniteLivedIntangibleAssetsMajorClassNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/DivestituresandAcquisitionsNarrativeDetails",
      "http://www.cardinal.com/role/GoodwillandOtherIntangibleAssetsScheduleofIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IntangibleAssetsGrossExcludingGoodwill": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated amortization of intangible assets, excluding goodwill.",
        "label": "Intangible Assets, Gross (Excluding Goodwill)",
        "terseLabel": "Gross Intangible, Total other intangible assets"
       }
      }
     },
     "localname": "IntangibleAssetsGrossExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/GoodwillandOtherIntangibleAssetsScheduleofIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IntangibleAssetsNetExcludingGoodwill": {
     "auth_ref": [
      "r280",
      "r286"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.",
        "label": "Intangible Assets, Net (Excluding Goodwill)",
        "terseLabel": "Net Intangible, Total other intangible assets"
       }
      }
     },
     "localname": "IntangibleAssetsNetExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/GoodwillandOtherIntangibleAssetsScheduleofIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IntangibleAssetsNetIncludingGoodwill": {
     "auth_ref": [],
     "calculation": {
      "http://www.cardinal.com/role/ConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount of finite-lived intangible assets, indefinite-lived intangible assets and goodwill. Goodwill is an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized. Intangible assets are assets, not including financial assets, lacking physical substance.",
        "label": "Intangible Assets, Net (Including Goodwill)",
        "terseLabel": "Goodwill and other intangibles, net"
       }
      }
     },
     "localname": "IntangibleAssetsNetIncludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestExpense": {
     "auth_ref": [
      "r98",
      "r211",
      "r645",
      "r648",
      "r708"
     ],
     "calculation": {
      "http://www.cardinal.com/role/ConsolidatedStatementsofEarnings": {
       "order": 3.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the cost of borrowed funds accounted for as interest expense.",
        "label": "Interest Expense",
        "terseLabel": "Interest expense, net"
       }
      }
     },
     "localname": "InterestExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedStatementsofEarnings"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestExpenseMember": {
     "auth_ref": [
      "r588"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing interest expense.",
        "label": "Interest Expense [Member]",
        "terseLabel": "Interest Expense, Net"
       }
      }
     },
     "localname": "InterestExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleofGainLossReclassifiedfromAOCIintoEarningsforDerivativeInstrumentsDesignatedasCashFlowHedgesDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleofGainLossRecognizedinEarningsforInterestRateContractsDesignatedasFairValueHedgesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InterestIncomeExpenseNonoperatingNet": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net amount of nonoperating interest income (expense).",
        "label": "Interest Income (Expense), Nonoperating, Net",
        "terseLabel": "Interest Income (Expense), Nonoperating, Net"
       }
      }
     },
     "localname": "InterestIncomeExpenseNonoperatingNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/FinancialInstrumentsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestPaidNet": {
     "auth_ref": [
      "r119",
      "r123",
      "r130"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.",
        "label": "Interest Paid, Excluding Capitalized Interest, Operating Activities",
        "terseLabel": "Cash payments for interest"
       }
      }
     },
     "localname": "InterestPaidNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestRateSwapMember": {
     "auth_ref": [
      "r584"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Forward based contracts in which two parties agree to swap periodic payments that are fixed at the outset of the swap contract with variable payments based on a market interest rate (index rate) over a specified period.",
        "label": "Interest Rate Swap [Member]",
        "terseLabel": "Interest Rate Swaps",
        "verboseLabel": "Interest Rate Swaps"
       }
      }
     },
     "localname": "InterestRateSwapMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/FinancialInstrumentsNarrativeDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleofFairValueGainLossDerivativeInstrumentDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleofGainLossIncludedinAOCIforDerivativeInstrumentsDesignatedasCashFlowHedgesDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleofGainLossRecognizedinEarningsforInterestRateContractsDesignatedasFairValueHedgesDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleofOutstandingInstrumentsCashFlowHedgesDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleofOutstandingInstrumentsFairValueHedgesDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleoftheFairValueofAssetsandLiabilitiesRelatedtoDerivativesDesignatedasHedgingInstrumentsDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsSummaryofEstimatedFairValueofLongtermObligationsandOtherShorttermBorrowingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InternalRevenueServiceIRSMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Designated tax department of the United States of America government entitled to levy and collect income taxes from the entity.",
        "label": "Internal Revenue Service (IRS) [Member]",
        "terseLabel": "Federal"
       }
      }
     },
     "localname": "InternalRevenueServiceIRSMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InventoryLIFOReserve": {
     "auth_ref": [
      "r74"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount by which inventory stated at last-in first-out (LIFO) is less than (in excess of) inventory stated at other inventory cost methods.",
        "label": "Inventory, LIFO Reserve",
        "terseLabel": "Inventories valued at LIFO amount higher than average cost value"
       }
      }
     },
     "localname": "InventoryLIFOReserve",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeInventoriesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryNet": {
     "auth_ref": [
      "r24",
      "r72",
      "r671"
     ],
     "calculation": {
      "http://www.cardinal.com/role/ConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.",
        "label": "Inventory, Net",
        "terseLabel": "Inventories, net"
       }
      }
     },
     "localname": "InventoryNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryPolicyTextBlock": {
     "auth_ref": [
      "r32",
      "r73",
      "r132",
      "r186",
      "r264",
      "r266",
      "r268",
      "r684"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of inventory accounting policy for inventory classes, including, but not limited to, basis for determining inventory amounts, methods by which amounts are added and removed from inventory classes, loss recognition on impairment of inventories, and situations in which inventories are stated above cost.",
        "label": "Inventory, Policy [Policy Text Block]",
        "terseLabel": "Inventories"
       }
      }
     },
     "localname": "InventoryPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InventoryRecallExpense": {
     "auth_ref": [
      "r111"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reflects the amount charged against earnings comprised of the costs to announce and effect a recall of defective merchandise.",
        "label": "Inventory Recall Expense",
        "terseLabel": "Inventory Recall Expense"
       }
      }
     },
     "localname": "InventoryRecallExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CommitmentsContingentLiabilitiesandLitigationDetails",
      "http://www.cardinal.com/role/SegmentInformationNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryValuationReserves": {
     "auth_ref": [
      "r72",
      "r267"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of valuation reserve for inventory.",
        "label": "Inventory Valuation Reserves",
        "terseLabel": "Reserves for excess and obsolete inventory"
       }
      }
     },
     "localname": "InventoryValuationReserves",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeInventoriesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryWriteDown": {
     "auth_ref": [
      "r265"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of loss from reductions in inventory due to subsequent measurement adjustments, including, but not limited to, physical deterioration, obsolescence, or changes in price levels.",
        "label": "Inventory Write-down",
        "terseLabel": "Inventory Write-down"
       }
      }
     },
     "localname": "InventoryWriteDown",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeInventoriesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentPolicyTextBlock": {
     "auth_ref": [
      "r254",
      "r734"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for investment in financial asset.",
        "label": "Investment, Policy [Policy Text Block]",
        "terseLabel": "Investments"
       }
      }
     },
     "localname": "InvestmentPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InvestmentsFairValueDisclosure": {
     "auth_ref": [
      "r611"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of investment securities, including, but not limited to, marketable securities, derivative financial instruments, and investments accounted for under the equity method.",
        "label": "Investments, Fair Value Disclosure",
        "terseLabel": "Other investments"
       }
      }
     },
     "localname": "InvestmentsFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/FairValueMeasurementsFairValueofAssetsandLiabilitiesMeasuredonaRecurringBasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LandBuildingsAndImprovementsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Real estate held and additions or improvements to real estate held and structures used in the conduct of business.",
        "label": "Land, Buildings and Improvements [Member]",
        "terseLabel": "Land, building and improvements"
       }
      }
     },
     "localname": "LandBuildingsAndImprovementsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesComponentsofPropertyandEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LeaseAndRentalExpense": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of rent expense incurred for leased assets, including but not limited to, furniture and equipment, that is not directly or indirectly associated with the manufacture, sale or creation of a product or product line.",
        "label": "Operating Leases, Rent Expense",
        "terseLabel": "Operating Leases, Rent Expense"
       }
      }
     },
     "localname": "LeaseAndRentalExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/LeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LeaseCost": {
     "auth_ref": [
      "r665",
      "r667"
     ],
     "calculation": {
      "http://www.cardinal.com/role/LeasesScheduleofLeaseCostsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lease cost recognized by lessee for lease contract.",
        "label": "Lease, Cost",
        "totalLabel": "Total lease cost"
       }
      }
     },
     "localname": "LeaseCost",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/LeasesScheduleofLeaseCostsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LeaseCostTableTextBlock": {
     "auth_ref": [
      "r665"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.",
        "label": "Lease, Cost [Table Text Block]",
        "terseLabel": "Schedule of Lease Costs"
       }
      }
     },
     "localname": "LeaseCostTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/LeasesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LeasesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Leases [Abstract]",
        "terseLabel": "Leases [Abstract]"
       }
      }
     },
     "localname": "LeasesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": {
     "auth_ref": [
      "r666"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease.",
        "label": "Lessee, Operating Lease, Liability, to be Paid",
        "terseLabel": "Total future lease payments"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/LeasesScheduleofFutureLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive": {
     "auth_ref": [
      "r666"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease due after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, after Year Five",
        "terseLabel": "Thereafter"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/LeasesScheduleofFutureLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": {
     "auth_ref": [
      "r666"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year One",
        "terseLabel": "2022"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/LeasesScheduleofFutureLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive": {
     "auth_ref": [
      "r666"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Five",
        "terseLabel": "2026"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFive",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/LeasesScheduleofFutureLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour": {
     "auth_ref": [
      "r666"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Four",
        "terseLabel": "2025"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFour",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/LeasesScheduleofFutureLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree": {
     "auth_ref": [
      "r666"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Three",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearThree",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/LeasesScheduleofFutureLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": {
     "auth_ref": [
      "r666"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Two",
        "terseLabel": "2023"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/LeasesScheduleofFutureLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseTermOfContract": {
     "auth_ref": [
      "r657"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Term of lessee's operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Lessee, Operating Lease, Term of Contract",
        "terseLabel": "Lessee, Operating Lease, Term of Contract"
       }
      }
     },
     "localname": "LesseeOperatingLeaseTermOfContract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/LeasesDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_LetterOfCreditMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A document typically issued by a financial institution which acts as a guarantee of payment to a beneficiary, or as the source of payment for a specific transaction (for example, wiring funds to a foreign exporter if and when specified merchandise is accepted pursuant to the terms of the letter of credit).",
        "label": "Letter of Credit [Member]",
        "terseLabel": "Letter of Credit"
       }
      }
     },
     "localname": "LetterOfCreditMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/LongTermObligationsandOtherShortTermBorrowingsNarrativeDetails",
      "http://www.cardinal.com/role/LongTermObligationsandOtherShortTermBorrowingsOtherFinancingArrangementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "auth_ref": [
      "r50",
      "r139",
      "r255",
      "r626",
      "r671",
      "r697",
      "r722"
     ],
     "calculation": {
      "http://www.cardinal.com/role/ConsolidatedBalanceSheets": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.",
        "label": "Liabilities and Equity",
        "totalLabel": "Total liabilities and shareholders\u2019 equity"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities and Equity [Abstract]",
        "terseLabel": "Liabilities and Shareholders\u2019 Equity"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesCurrent": {
     "auth_ref": [
      "r63",
      "r139",
      "r255",
      "r343",
      "r344",
      "r345",
      "r348",
      "r349",
      "r350",
      "r352",
      "r354",
      "r356",
      "r357",
      "r548",
      "r555",
      "r556",
      "r626",
      "r669",
      "r670",
      "r671"
     ],
     "calculation": {
      "http://www.cardinal.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.",
        "label": "Liabilities, Current",
        "totalLabel": "Total current liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities, Current [Abstract]",
        "terseLabel": "Current liabilities:"
       }
      }
     },
     "localname": "LiabilitiesCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesFairValueDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities, Fair Value Disclosure [Abstract]",
        "terseLabel": "Liabilities:"
       }
      }
     },
     "localname": "LiabilitiesFairValueDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/FairValueMeasurementsFairValueofAssetsandLiabilitiesMeasuredonaRecurringBasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation": {
     "auth_ref": [
      "r5",
      "r6",
      "r16",
      "r18",
      "r22",
      "r300"
     ],
     "calculation": {
      "http://www.cardinal.com/role/ConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as liabilities attributable to disposal group held for sale or disposed of.",
        "label": "Disposal Group, Including Discontinued Operation, Liabilities",
        "terseLabel": "Disposal Group, Including Discontinued Operation, Liabilities"
       }
      }
     },
     "localname": "LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedBalanceSheets",
      "http://www.cardinal.com/role/DivestituresandAcquisitionsNarrativeDetails",
      "http://www.cardinal.com/role/FairValueMeasurementsDetails",
      "http://www.cardinal.com/role/FairValueMeasurementsFairValueofAssetsandLiabilitiesMeasuredonaRecurringBasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCredit": {
     "auth_ref": [
      "r38",
      "r695",
      "r716"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.",
        "label": "Long-term Line of Credit",
        "terseLabel": "Long-term Line of Credit",
        "verboseLabel": "Line of credit"
       }
      }
     },
     "localname": "LineOfCredit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/LongTermObligationsandOtherShortTermBorrowingsLongTermDebtDetails",
      "http://www.cardinal.com/role/LongTermObligationsandOtherShortTermBorrowingsNarrativeDetails",
      "http://www.cardinal.com/role/LongTermObligationsandOtherShortTermBorrowingsOtherFinancingArrangementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditFacilityAxis": {
     "auth_ref": [
      "r61",
      "r138"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by name of lender, which may be a single entity (for example, but not limited to, a bank, pension fund, venture capital firm) or a group of entities that participate in the line of credit.",
        "label": "Lender Name [Axis]",
        "terseLabel": "Lender Name [Axis]"
       }
      }
     },
     "localname": "LineOfCreditFacilityAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/LongTermObligationsandOtherShortTermBorrowingsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LineOfCreditFacilityLenderDomain": {
     "auth_ref": [
      "r61",
      "r138"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification of the lender, which may be a single entity (for example, a bank, pension fund, venture capital firm) or a group of entities that participate in the line of credit, including a letter of credit facility.",
        "label": "Line of Credit Facility, Lender [Domain]",
        "terseLabel": "Line of Credit Facility, Lender [Domain]"
       }
      }
     },
     "localname": "LineOfCreditFacilityLenderDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/LongTermObligationsandOtherShortTermBorrowingsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LineOfCreditFacilityLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Line of Credit Facility [Line Items]",
        "terseLabel": "Line of Credit Facility [Line Items]"
       }
      }
     },
     "localname": "LineOfCreditFacilityLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/LongTermObligationsandOtherShortTermBorrowingsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LineOfCreditFacilityMaximumAmountOutstandingDuringPeriod": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Maximum amount borrowed under the credit facility at any time during the period.",
        "label": "Line of Credit Facility, Maximum Amount Outstanding During Period",
        "terseLabel": "Line of Credit Facility, Maximum Amount Outstanding During Period"
       }
      }
     },
     "localname": "LineOfCreditFacilityMaximumAmountOutstandingDuringPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/LongTermObligationsandOtherShortTermBorrowingsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity": {
     "auth_ref": [
      "r61"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.",
        "label": "Line of Credit Facility, Maximum Borrowing Capacity",
        "terseLabel": "Maximum borrowing capacity",
        "verboseLabel": "Line of Credit Facility, Maximum Borrowing Capacity"
       }
      }
     },
     "localname": "LineOfCreditFacilityMaximumBorrowingCapacity",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/LongTermObligationsandOtherShortTermBorrowingsLongTermDebtDetails",
      "http://www.cardinal.com/role/LongTermObligationsandOtherShortTermBorrowingsNarrativeDetails",
      "http://www.cardinal.com/role/LongTermObligationsandOtherShortTermBorrowingsOtherFinancingArrangementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditFacilityTable": {
     "auth_ref": [
      "r61",
      "r138"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table or schedule providing information pertaining to short-term or long-term contractual arrangements with lenders, including letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line.",
        "label": "Line of Credit Facility [Table]",
        "terseLabel": "Line of Credit Facility [Table]"
       }
      }
     },
     "localname": "LineOfCreditFacilityTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/LongTermObligationsandOtherShortTermBorrowingsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LitigationReserve": {
     "auth_ref": [
      "r66",
      "r326"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate carrying amount of the estimated litigation liability for known or estimated probable loss from litigation, which may include attorneys' fees and other litigation costs.",
        "label": "Estimated Litigation Liability",
        "terseLabel": "Estimated Litigation Liability"
       }
      }
     },
     "localname": "LitigationReserve",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CommitmentsContingentLiabilitiesandLitigationDetails",
      "http://www.cardinal.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LitigationSettlementExpense": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of litigation expense, including but not limited to legal, forensic, accounting, and investigative fees.",
        "label": "Litigation Settlement, Expense",
        "terseLabel": "Litigation Settlement, Expense"
       }
      }
     },
     "localname": "LitigationSettlementExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CommitmentsContingentLiabilitiesandLitigationDetails",
      "http://www.cardinal.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock": {
     "auth_ref": [
      "r240"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of long-lived assets, excluding financial instruments, long-term customer relationships of a financial institution, mortgage rights, deferred policy acquisition costs, and deferred tax assets, by geographic areas located in the entity's country of domicile and foreign countries in which the entity holds assets.",
        "label": "Long-lived Assets by Geographic Areas [Table Text Block]",
        "terseLabel": "Property and Equipment, Net by Geographic Area"
       }
      }
     },
     "localname": "LongLivedAssetsByGeographicAreasTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/SegmentInformationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LongTermDebtAndCapitalLeaseObligations": {
     "auth_ref": [
      "r38"
     ],
     "calculation": {
      "http://www.cardinal.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      },
      "http://www.cardinal.com/role/LongTermObligationsandOtherShortTermBorrowingsSummaryofDebtDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DebtAndCapitalLeaseObligations",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt and lease obligation, classified as noncurrent.",
        "label": "Long-term Debt and Lease Obligation",
        "terseLabel": "Long-term obligations, less current portion"
       }
      }
     },
     "localname": "LongTermDebtAndCapitalLeaseObligations",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedBalanceSheets",
      "http://www.cardinal.com/role/LongTermObligationsandOtherShortTermBorrowingsSummaryofDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent": {
     "auth_ref": [
      "r62"
     ],
     "calculation": {
      "http://www.cardinal.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      },
      "http://www.cardinal.com/role/LongTermObligationsandOtherShortTermBorrowingsSummaryofDebtDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DebtAndCapitalLeaseObligations",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt and lease obligation, classified as current.",
        "label": "Long-term Debt and Lease Obligation, Current",
        "terseLabel": "Current portion of long-term obligations and other short-term borrowings",
        "verboseLabel": "Less: current portion of long-term obligations and other short-term borrowings"
       }
      }
     },
     "localname": "LongTermDebtAndCapitalLeaseObligationsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedBalanceSheets",
      "http://www.cardinal.com/role/LongTermObligationsandOtherShortTermBorrowingsSummaryofDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive": {
     "auth_ref": [
      "r144",
      "r341",
      "r377"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, after Year Five",
        "terseLabel": "Maturities of existing long-term obligations and other short-term borrowings-Thereafter"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/LongTermObligationsandOtherShortTermBorrowingsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths": {
     "auth_ref": [
      "r144",
      "r341",
      "r377"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, Year One",
        "terseLabel": "Maturities of existing long-term obligations and other short-term borrowings - 2020"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/LongTermObligationsandOtherShortTermBorrowingsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive": {
     "auth_ref": [
      "r144",
      "r341",
      "r377"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, Year Five",
        "terseLabel": "Maturities of existing long-term obligations and other short-term borrowings-2024"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/LongTermObligationsandOtherShortTermBorrowingsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour": {
     "auth_ref": [
      "r144",
      "r341",
      "r377"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, Year Four",
        "terseLabel": "Maturities of existing long-term obligations and other short-term borrowings-2023"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/LongTermObligationsandOtherShortTermBorrowingsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree": {
     "auth_ref": [
      "r144",
      "r341",
      "r377"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, Year Three",
        "terseLabel": "Maturities of existing long-term obligations and other short-term borrowings-2022"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/LongTermObligationsandOtherShortTermBorrowingsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo": {
     "auth_ref": [
      "r144",
      "r341",
      "r377"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, Year Two",
        "terseLabel": "Maturities of existing long-term obligations and other short-term borrowings-2021"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/LongTermObligationsandOtherShortTermBorrowingsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongtermDebtWeightedAverageInterestRate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average interest rate of long-term debt outstanding calculated at point in time.",
        "label": "Long-term Debt, Weighted Average Interest Rate, at Point in Time",
        "verboseLabel": "Interest rate on long-term projects (approximates weighted-average on long-term obligations)"
       }
      }
     },
     "localname": "LongtermDebtWeightedAverageInterestRate",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativePropertyandEquipmentDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_LossContingenciesByNatureOfContingencyAxis": {
     "auth_ref": [
      "r326",
      "r327",
      "r328",
      "r331",
      "r332",
      "r333",
      "r335",
      "r337",
      "r338"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of existing condition, situation, or set of circumstances involving uncertainty as to possible loss to an enterprise that will ultimately be resolved when one or more future events occur or fail to occur.",
        "label": "Loss Contingency Nature [Axis]",
        "terseLabel": "Loss Contingency Nature [Axis]"
       }
      }
     },
     "localname": "LossContingenciesByNatureOfContingencyAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CommitmentsContingentLiabilitiesandLitigationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LossContingenciesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Loss Contingencies [Line Items]",
        "terseLabel": "Loss Contingencies [Line Items]"
       }
      }
     },
     "localname": "LossContingenciesLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesLossContingenciesDetails",
      "http://www.cardinal.com/role/CommitmentsContingentLiabilitiesandLitigationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LossContingenciesTable": {
     "auth_ref": [
      "r326",
      "r327",
      "r328",
      "r331",
      "r332",
      "r333",
      "r335",
      "r337",
      "r338"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Discloses the specific components (such as the nature, name, and date) of the loss contingency and gives an estimate of the possible loss or range of loss, or states that a reasonable estimate cannot be made. Excludes environmental contingencies, warranties and unconditional purchase obligations.",
        "label": "Loss Contingencies [Table]",
        "terseLabel": "Loss Contingencies"
       }
      }
     },
     "localname": "LossContingenciesTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesLossContingenciesDetails",
      "http://www.cardinal.com/role/CommitmentsContingentLiabilitiesandLitigationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LossContingencyAccrualAtCarryingValue": {
     "auth_ref": [
      "r326"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of loss contingency liability.",
        "label": "Loss Contingency Accrual",
        "terseLabel": "Loss Contingency Accrual"
       }
      }
     },
     "localname": "LossContingencyAccrualAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CommitmentsContingentLiabilitiesandLitigationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LossContingencyClaimsSettledNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of claims settled.",
        "label": "Loss Contingency, Claims Settled, Number",
        "terseLabel": "Loss Contingency, Claims Settled, Number"
       }
      }
     },
     "localname": "LossContingencyClaimsSettledNumber",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CommitmentsContingentLiabilitiesandLitigationDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_LossContingencyEstimateOfPossibleLoss": {
     "auth_ref": [
      "r330",
      "r334",
      "r337"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reflects the estimated amount of loss from the specified contingency as of the balance sheet date.",
        "label": "Loss Contingency, Estimate of Possible Loss",
        "terseLabel": "Loss Contingency, Estimate of Possible Loss"
       }
      }
     },
     "localname": "LossContingencyEstimateOfPossibleLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CommitmentsContingentLiabilitiesandLitigationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LossContingencyNatureDomain": {
     "auth_ref": [
      "r326",
      "r327",
      "r328",
      "r331",
      "r332",
      "r333",
      "r335",
      "r337",
      "r338"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "An existing condition, situation, or set of circumstances involving uncertainty as to possible loss to an enterprise that will ultimately be resolved when one or more future events occur or fail to occur. Resolution of the uncertainty may confirm the incurrence of a loss or impairment of an asset or the incurrence of a liability.",
        "label": "Loss Contingency, Nature [Domain]",
        "terseLabel": "Loss Contingency, Nature [Domain]"
       }
      }
     },
     "localname": "LossContingencyNatureDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CommitmentsContingentLiabilitiesandLitigationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LossContingencyNewClaimsFiledNumber": {
     "auth_ref": [
      "r329"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The total number of new claims filed pertaining to a loss contingency during the period.",
        "label": "Loss Contingency, New Claims Filed, Number",
        "terseLabel": "Number of lawsuits filed"
       }
      }
     },
     "localname": "LossContingencyNewClaimsFiledNumber",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CommitmentsContingentLiabilitiesandLitigationDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_LossContingencyNumberOfPlaintiffs": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of plaintiffs that have filed claims pertaining to a loss contingency.",
        "label": "Loss Contingency, Number of Plaintiffs",
        "terseLabel": "Number of plaintiffs"
       }
      }
     },
     "localname": "LossContingencyNumberOfPlaintiffs",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CommitmentsContingentLiabilitiesandLitigationDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_MachineryAndEquipmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tangible personal property used to produce goods and services, including, but is not limited to, tools, dies and molds, computer and office equipment.",
        "label": "Machinery and Equipment [Member]",
        "verboseLabel": "Machinery and equipment"
       }
      }
     },
     "localname": "MachineryAndEquipmentMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesComponentsofPropertyandEquipmentDetails",
      "http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativePropertyandEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MajorCustomersPolicyPolicyTextBlock": {
     "auth_ref": [
      "r196",
      "r198",
      "r199",
      "r242"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for major customers. Major customers are those that the loss of such customers would have a material adverse effect on the entity.",
        "label": "Major Customers, Policy [Policy Text Block]",
        "terseLabel": "Major Customers"
       }
      }
     },
     "localname": "MajorCustomersPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_MinorityInterest": {
     "auth_ref": [
      "r71",
      "r139",
      "r255",
      "r343",
      "r348",
      "r349",
      "r350",
      "r356",
      "r357",
      "r626",
      "r696",
      "r721"
     ],
     "calculation": {
      "http://www.cardinal.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).",
        "label": "Stockholders' Equity Attributable to Noncontrolling Interest",
        "terseLabel": "Noncontrolling interests"
       }
      }
     },
     "localname": "MinorityInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MovementInValuationAllowancesAndReservesRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]",
        "terseLabel": "SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]"
       }
      }
     },
     "localname": "MovementInValuationAllowancesAndReservesRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ScheduleIIValuationsandQualifyingAccountsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "auth_ref": [
      "r122"
     ],
     "calculation": {
      "http://www.cardinal.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "totalLabel": "Net cash used in financing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]",
        "terseLabel": "Cash flows from financing activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "auth_ref": [
      "r122"
     ],
     "calculation": {
      "http://www.cardinal.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "totalLabel": "Net cash provided by/(used in) investing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]",
        "terseLabel": "Cash flows from investing activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "auth_ref": [
      "r122",
      "r124",
      "r127"
     ],
     "calculation": {
      "http://www.cardinal.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "totalLabel": "Net cash provided by operating activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Cash flows from operating activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetIncomeLoss": {
     "auth_ref": [
      "r22",
      "r87",
      "r90",
      "r96",
      "r101",
      "r127",
      "r139",
      "r157",
      "r161",
      "r162",
      "r163",
      "r164",
      "r167",
      "r168",
      "r175",
      "r217",
      "r223",
      "r227",
      "r230",
      "r233",
      "r255",
      "r343",
      "r344",
      "r345",
      "r348",
      "r349",
      "r350",
      "r352",
      "r354",
      "r356",
      "r357",
      "r610",
      "r626",
      "r703",
      "r728"
     ],
     "calculation": {
      "http://www.cardinal.com/role/ConsolidatedStatementsofEarnings": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.",
        "label": "Net Income (Loss) Attributable to Parent",
        "totalLabel": "Net earnings/(loss) attributable to Cardinal Health, Inc.",
        "verboseLabel": "Net Income (Loss) Attributable to Parent"
       }
      }
     },
     "localname": "NetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedStatementsofEarnings",
      "http://www.cardinal.com/role/ConsolidatedStatementsofShareholdersEquity",
      "http://www.cardinal.com/role/EarningsPerShareAttributabletoCardinalHealthIncReconciliationofCommonSharesUsedtoComputeBasicandDilutedEPSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetIncomeLossAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r87",
      "r90",
      "r96",
      "r167",
      "r168",
      "r551",
      "r558"
     ],
     "calculation": {
      "http://www.cardinal.com/role/ConsolidatedStatementsofComprehensiveIncome": {
       "order": 2.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": -1.0
      },
      "http://www.cardinal.com/role/ConsolidatedStatementsofEarnings": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of Net Income (Loss) attributable to noncontrolling interest.",
        "label": "Net Income (Loss) Attributable to Noncontrolling Interest",
        "negatedLabel": "Net earnings attributable to noncontrolling interest",
        "negatedTerseLabel": "Less: Net earnings attributable to noncontrolling interests",
        "terseLabel": "Net Income (Loss) Attributable to Noncontrolling Interest"
       }
      }
     },
     "localname": "NetIncomeLossAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedStatementsofComprehensiveIncome",
      "http://www.cardinal.com/role/ConsolidatedStatementsofEarnings",
      "http://www.cardinal.com/role/EarningsPerShareAttributabletoCardinalHealthIncReconciliationofCommonSharesUsedtoComputeBasicandDilutedEPSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.",
        "label": "New Accounting Pronouncements, Policy [Policy Text Block]",
        "terseLabel": "Recent Financial Accounting Standards"
       }
      }
     },
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NonUsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Countries excluding the United States of America (US).",
        "label": "Non-US [Member]",
        "terseLabel": "International",
        "verboseLabel": "Non-US [Member]"
       }
      }
     },
     "localname": "NonUsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/SegmentInformationPropertyandEquipmentnetbyGeographicAreaDetails",
      "http://www.cardinal.com/role/SegmentInformationRevenuebyReportableSegmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NoncontrollingInterestMember": {
     "auth_ref": [
      "r154",
      "r155",
      "r156",
      "r423",
      "r543"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents that portion of equity (net assets) in a subsidiary not attributable, directly or indirectly, to the parent. A noncontrolling interest is sometimes called a minority interest.",
        "label": "Noncontrolling Interest [Member]",
        "terseLabel": "Noncontrolling Interests"
       }
      }
     },
     "localname": "NoncontrollingInterestMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedStatementsofShareholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NondesignatedMember": {
     "auth_ref": [
      "r568"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Derivative instrument not designated as hedging instrument under Generally Accepted Accounting Principles (GAAP).",
        "label": "Not Designated as Hedging Instrument [Member]",
        "terseLabel": "Not Designated as Hedging Instrument"
       }
      }
     },
     "localname": "NondesignatedMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleofGainLossRecognizedinEarningsforDerivativesNotDesignatedasHedgingInstrumentDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleofOutstandingInstrumentsEconomicHedgesDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsTables"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NotesAndLoansReceivableNetCurrent": {
     "auth_ref": [
      "r25",
      "r26",
      "r44",
      "r244",
      "r245",
      "r698"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance for credit loss, of financing receivable, classified as current. Includes, but is not limited to, notes and loan receivable.",
        "label": "Financing Receivable, after Allowance for Credit Loss, Current",
        "terseLabel": "Finance notes and related accrued interest, net, current"
       }
      }
     },
     "localname": "NotesAndLoansReceivableNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeReceivablesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NotesPayable": {
     "auth_ref": [
      "r38",
      "r695",
      "r718"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Including the current and noncurrent portions, aggregate carrying amount of all types of notes payable, as of the balance sheet date, with initial maturities beyond one year or beyond the normal operating cycle, if longer.",
        "label": "Notes Payable",
        "terseLabel": "Notes Payable"
       }
      }
     },
     "localname": "NotesPayable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/LongTermObligationsandOtherShortTermBorrowingsSummaryofDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NotesReceivableNet": {
     "auth_ref": [
      "r45",
      "r244",
      "r263"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance for credit loss, of financing receivable. Excludes financing receivable covered under loss sharing agreement.",
        "label": "Financing Receivable, after Allowance for Credit Loss",
        "terseLabel": "Finance notes and related accrued interest, net, total"
       }
      }
     },
     "localname": "NotesReceivableNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeReceivablesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NumberOfOperatingSegments": {
     "auth_ref": [
      "r205"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues.",
        "label": "Number of Operating Segments",
        "terseLabel": "Number of Operating Segments"
       }
      }
     },
     "localname": "NumberOfOperatingSegments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeGoodwillandOtherIntangibleAssetsDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_NumberOfReportableSegments": {
     "auth_ref": [
      "r205"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.",
        "label": "Number of Reportable Segments",
        "terseLabel": "Number of Reportable Segments"
       }
      }
     },
     "localname": "NumberOfReportableSegments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/SegmentInformationNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_OperatingExpensesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Expenses [Abstract]",
        "terseLabel": "Operating expenses:"
       }
      }
     },
     "localname": "OperatingExpensesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedStatementsofEarnings"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingIncomeLoss": {
     "auth_ref": [
      "r217",
      "r223",
      "r227",
      "r230",
      "r233"
     ],
     "calculation": {
      "http://www.cardinal.com/role/ConsolidatedStatementsofEarnings": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net result for the period of deducting operating expenses from operating revenues.",
        "label": "Operating Income (Loss)",
        "terseLabel": "Total operating earnings",
        "totalLabel": "Operating earnings/(loss)"
       }
      }
     },
     "localname": "OperatingIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedStatementsofEarnings",
      "http://www.cardinal.com/role/SegmentInformationSegmentProfitbyReportableSegmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseCost": {
     "auth_ref": [
      "r659",
      "r667"
     ],
     "calculation": {
      "http://www.cardinal.com/role/LeasesScheduleofLeaseCostsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LeaseCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.",
        "label": "Operating Lease, Cost",
        "terseLabel": "Operating Lease, Cost"
       }
      }
     },
     "localname": "OperatingLeaseCost",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/LeasesScheduleofLeaseCostsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiability": {
     "auth_ref": [
      "r653"
     ],
     "calculation": {
      "http://www.cardinal.com/role/LeasesSupplementalBalanceSheetInformationDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease.",
        "label": "Operating Lease, Liability",
        "terseLabel": "Total lease liabilities",
        "totalLabel": "Total operating lease liabilities"
       }
      }
     },
     "localname": "OperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/LeasesScheduleofFutureLeasePaymentsDetails",
      "http://www.cardinal.com/role/LeasesSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityCurrent": {
     "auth_ref": [
      "r653"
     ],
     "calculation": {
      "http://www.cardinal.com/role/LeasesSupplementalBalanceSheetInformationDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingLeaseLiability",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.",
        "label": "Operating Lease, Liability, Current",
        "terseLabel": "Operating Lease, Liability, Current"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/LeasesSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrent": {
     "auth_ref": [
      "r653"
     ],
     "calculation": {
      "http://www.cardinal.com/role/LeasesSupplementalBalanceSheetInformationDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingLeaseLiability",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.",
        "label": "Operating Lease, Liability, Noncurrent",
        "terseLabel": "Operating Lease, Liability, Noncurrent"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/LeasesSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeasePayments": {
     "auth_ref": [
      "r656",
      "r661"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.",
        "label": "Operating Lease, Payments",
        "terseLabel": "Operating Lease, Payments"
       }
      }
     },
     "localname": "OperatingLeasePayments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/LeasesSupplementalCashFlowInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseRightOfUseAsset": {
     "auth_ref": [
      "r652"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's right to use underlying asset under operating lease.",
        "label": "Operating Lease, Right-of-Use Asset",
        "terseLabel": "Operating Lease, Right-of-Use Asset"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAsset",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/LeasesSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent": {
     "auth_ref": [
      "r664",
      "r667"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average discount rate for operating lease calculated at point in time.",
        "label": "Operating Lease, Weighted Average Discount Rate, Percent",
        "terseLabel": "Operating Lease, Weighted Average Discount Rate, Percent"
       }
      }
     },
     "localname": "OperatingLeaseWeightedAverageDiscountRatePercent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/LeasesDetails",
      "http://www.cardinal.com/role/LeasesSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": {
     "auth_ref": [
      "r663",
      "r667"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Operating Lease, Weighted Average Remaining Lease Term",
        "terseLabel": "Operating Lease, Weighted Average Remaining Lease Term"
       }
      }
     },
     "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/LeasesDetails",
      "http://www.cardinal.com/role/LeasesSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_OperatingLossCarryforwardsValuationAllowance": {
     "auth_ref": [
      "r509"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of the valuation allowance pertaining to the deferred tax asset representing potential future taxable deductions from net operating loss carryforwards for which it is more likely than not that a tax benefit will not be realized.",
        "label": "Operating Loss Carryforwards, Valuation Allowance",
        "terseLabel": "Valuation allowance on operating loss carryforwards"
       }
      }
     },
     "localname": "OperatingLossCarryforwardsValuationAllowance",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingSegmentsMember": {
     "auth_ref": [
      "r222",
      "r223",
      "r224",
      "r225",
      "r227",
      "r233"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identifies components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.",
        "label": "Operating Segments [Member]",
        "terseLabel": "Operating Segments"
       }
      }
     },
     "localname": "OperatingSegmentsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/SegmentInformationAssetsbyReportableSegmentDetails",
      "http://www.cardinal.com/role/SegmentInformationDepreciationandAmortizationandAdditionstoPropertyandEquipmentbyReportableSegmentDetails",
      "http://www.cardinal.com/role/SegmentInformationRevenuebyReportableSegmentDetails",
      "http://www.cardinal.com/role/SegmentInformationSegmentProfitbyReportableSegmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherAccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r29",
      "r30",
      "r31",
      "r62"
     ],
     "calculation": {
      "http://www.cardinal.com/role/ConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.",
        "label": "Other Accrued Liabilities, Current",
        "terseLabel": "Other accrued liabilities"
       }
      }
     },
     "localname": "OtherAccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAssetsCurrent": {
     "auth_ref": [
      "r75",
      "r671"
     ],
     "calculation": {
      "http://www.cardinal.com/role/ConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current assets classified as other.",
        "label": "Other Assets, Current",
        "terseLabel": "Prepaid expenses and other"
       }
      }
     },
     "localname": "OtherAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAssetsMember": {
     "auth_ref": [
      "r570",
      "r594"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other assets.",
        "label": "Other Assets [Member]",
        "terseLabel": "Other Assets [Member]"
       }
      }
     },
     "localname": "OtherAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleoftheFairValueofAssetsandLiabilitiesRelatedtoDerivativesDesignatedasHedgingInstrumentsDetails",
      "http://www.cardinal.com/role/LeasesSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherAssetsNoncurrent": {
     "auth_ref": [
      "r58"
     ],
     "calculation": {
      "http://www.cardinal.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncurrent assets classified as other.",
        "label": "Other Assets, Noncurrent",
        "terseLabel": "Other assets"
       }
      }
     },
     "localname": "OtherAssetsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherBorrowings": {
     "auth_ref": [
      "r699"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The carrying amount as of the balance sheet date for the aggregate of other miscellaneous borrowings owed by the reporting entity.",
        "label": "Other Borrowings",
        "terseLabel": "Other obligations",
        "verboseLabel": "Other Borrowings"
       }
      }
     },
     "localname": "OtherBorrowings",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/LongTermObligationsandOtherShortTermBorrowingsNarrativeDetails",
      "http://www.cardinal.com/role/LongTermObligationsandOtherShortTermBorrowingsOtherFinancingArrangementsDetails",
      "http://www.cardinal.com/role/LongTermObligationsandOtherShortTermBorrowingsSummaryofDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax": {
     "auth_ref": [
      "r86",
      "r94",
      "r95",
      "r97",
      "r636",
      "r638",
      "r642"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax, before reclassification adjustments of other comprehensive income (loss).",
        "label": "Other Comprehensive Income (Loss), before Reclassifications, Net of Tax",
        "verboseLabel": "Other comprehensive income/(loss), net before reclassifications"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ShareholdersEquityChangesintheAccumulatedOtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax": {
     "auth_ref": [
      "r82"
     ],
     "calculation": {
      "http://www.cardinal.com/role/ConsolidatedStatementsofComprehensiveIncome": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments, of increase (decrease) in accumulated gain (loss) from derivative instruments designated and qualifying as the effective portion of cash flow hedges and an entity's share of an equity investee's increase (decrease) in deferred hedging gain (loss).",
        "label": "Other Comprehensive Income (Loss), Derivatives Qualifying as Hedges, Net of Tax",
        "terseLabel": "Net unrealized gain/(loss) on derivative instruments, net of tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedStatementsofComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax": {
     "auth_ref": [
      "r80"
     ],
     "calculation": {
      "http://www.cardinal.com/role/ConsolidatedStatementsofComprehensiveIncome": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.",
        "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax",
        "terseLabel": "Foreign currency translation adjustments and other"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedStatementsofComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax": {
     "auth_ref": [
      "r582"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax and reclassification, of gain (loss) from derivative designated and qualifying as net investment hedge.",
        "label": "Other Comprehensive Income (Loss), Net Investment Hedge, Gain (Loss), before Reclassification and Tax",
        "terseLabel": "Other Comprehensive Income (Loss), Net Investment Hedge, Gain (Loss), before Reclassification and Tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/FinancialInstrumentsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r88",
      "r91",
      "r94",
      "r95",
      "r97",
      "r102",
      "r416",
      "r636",
      "r641",
      "r642",
      "r704",
      "r729"
     ],
     "calculation": {
      "http://www.cardinal.com/role/ConsolidatedStatementsofComprehensiveIncome": {
       "order": 2.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments of other comprehensive income (loss).",
        "label": "Other Comprehensive Income (Loss), Net of Tax",
        "totalLabel": "Total other comprehensive income/(loss), net of tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedStatementsofComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Comprehensive Income (Loss), Net of Tax [Abstract]",
        "terseLabel": "Other comprehensive income/(loss):"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedStatementsofComprehensiveIncome"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent": {
     "auth_ref": [
      "r88",
      "r91",
      "r545",
      "r546",
      "r553"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of other comprehensive income (loss) attributable to parent entity.",
        "label": "Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent",
        "terseLabel": "Other comprehensive loss, net of tax",
        "verboseLabel": "Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedStatementsofShareholdersEquity",
      "http://www.cardinal.com/role/ShareholdersEquityChangesintheAccumulatedOtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax": {
     "auth_ref": [
      "r82",
      "r84",
      "r598"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before tax of increase (decrease) in accumulated gain (loss) from derivative instruments designated and qualifying as the effective portion of cash flow hedges and an entity's share of an equity investee's increase (decrease) in deferred hedging gain (loss).",
        "label": "Other Comprehensive Income (Loss), Unrealized Gain (Loss) on Derivatives Arising During Period, before Tax",
        "terseLabel": "Gain/(loss) included in AOCI for derivative instruments designated as cash flow hedges"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleofGainLossIncludedinAOCIforDerivativeInstrumentsDesignatedasCashFlowHedgesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherLiabilitiesMember": {
     "auth_ref": [
      "r570",
      "r594"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other liabilities.",
        "label": "Other Liabilities [Member]",
        "terseLabel": "Other Liabilities"
       }
      }
     },
     "localname": "OtherLiabilitiesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/LeasesSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherNonoperatingIncomeExpense": {
     "auth_ref": [
      "r113"
     ],
     "calculation": {
      "http://www.cardinal.com/role/ConsolidatedStatementsofEarnings": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (expense) related to nonoperating activities, classified as other.",
        "label": "Other Nonoperating Income (Expense)",
        "negatedLabel": "Other (income)/expense, net"
       }
      }
     },
     "localname": "OtherNonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedStatementsofEarnings"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNonoperatingIncomeExpenseMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other nonoperating income (expense).",
        "label": "Other Nonoperating Income (Expense) [Member]",
        "terseLabel": "Other Income, Net"
       }
      }
     },
     "localname": "OtherNonoperatingIncomeExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleofGainLossRecognizedinEarningsforDerivativesNotDesignatedasHedgingInstrumentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherShortTermBorrowings": {
     "auth_ref": [
      "r59"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of borrowings classified as other, maturing within one year or the normal operating cycle, if longer.",
        "label": "Other Short-term Borrowings",
        "terseLabel": "Other Short-term Borrowings"
       }
      }
     },
     "localname": "OtherShortTermBorrowings",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/LongTermObligationsandOtherShortTermBorrowingsOtherFinancingArrangementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForProceedsFromHedgeFinancingActivities": {
     "auth_ref": [],
     "calculation": {
      "http://www.cardinal.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net cash outflow or inflow for a financial contract that meets the hedge criteria as either cash flow hedge, fair value hedge or hedge of net investment in foreign operations.",
        "label": "Payments for (Proceeds from) Hedge, Financing Activities",
        "negatedTerseLabel": "Proceeds from interest rate swap terminations"
       }
      }
     },
     "localname": "PaymentsForProceedsFromHedgeFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForRepurchaseOfCommonStock": {
     "auth_ref": [
      "r117"
     ],
     "calculation": {
      "http://www.cardinal.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow to reacquire common stock during the period.",
        "label": "Payments for Repurchase of Common Stock",
        "negatedLabel": "Purchase of treasury shares",
        "terseLabel": "Payments for Repurchase of Common Stock"
       }
      }
     },
     "localname": "PaymentsForRepurchaseOfCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.cardinal.com/role/ShareholdersEquityNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForRestructuring": {
     "auth_ref": [
      "r120",
      "r307"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash payments made as the result of exit or disposal activities. Excludes payments associated with a discontinued operation or an asset retirement obligation.",
        "label": "Payments for Restructuring",
        "negatedLabel": "Payments and other adjustments"
       }
      }
     },
     "localname": "PaymentsForRestructuring",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/RestructuringandEmployeeSeveranceLiabilitiesAssociatedwithRestructuringandEmployeeSeveranceActivitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsOfDividendsCommonStock": {
     "auth_ref": [
      "r117"
     ],
     "calculation": {
      "http://www.cardinal.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow in the form of ordinary dividends to common shareholders of the parent entity.",
        "label": "Payments of Ordinary Dividends, Common Stock",
        "negatedLabel": "Dividends on common shares"
       }
      }
     },
     "localname": "PaymentsOfDividendsCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired": {
     "auth_ref": [
      "r115"
     ],
     "calculation": {
      "http://www.cardinal.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.",
        "label": "Payments to Acquire Businesses, Net of Cash Acquired",
        "negatedLabel": "Acquisition of subsidiaries, net of cash acquired",
        "terseLabel": "Payments to Acquire Businesses, Net of Cash Acquired"
       }
      }
     },
     "localname": "PaymentsToAcquireBusinessesNetOfCashAcquired",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.cardinal.com/role/DivestituresandAcquisitionsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
     "auth_ref": [
      "r116"
     ],
     "calculation": {
      "http://www.cardinal.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.",
        "label": "Payments to Acquire Property, Plant, and Equipment",
        "negatedLabel": "Additions to property and equipment",
        "terseLabel": "Total additions to property and equipment"
       }
      }
     },
     "localname": "PaymentsToAcquirePropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.cardinal.com/role/SegmentInformationDepreciationandAmortizationandAdditionstoPropertyandEquipmentbyReportableSegmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PercentageOfLIFOInventory": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The percentage of LIFO (last in first out) inventory to total inventory as of the balance sheet date if other than 100 percent.",
        "label": "Percentage of LIFO Inventory",
        "terseLabel": "Portion of inventories held at LIFO, percentage"
       }
      }
     },
     "localname": "PercentageOfLIFOInventory",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeInventoriesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_PerformanceSharesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based payment arrangement awarded for meeting performance target.",
        "label": "Performance Shares [Member]",
        "terseLabel": "Performance Share Units"
       }
      }
     },
     "localname": "PerformanceSharesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ShareBasedCompensationAdditionalDataRelatedtoPerformanceShareUnitActivityDetails",
      "http://www.cardinal.com/role/ShareBasedCompensationAdditionalDataRelatedtoRestrictedShareUnitActivityDetails",
      "http://www.cardinal.com/role/ShareBasedCompensationNarrativeDetails",
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleofAllTransactionsRelatedtoPerformanceShareUnitsUnderthePlansDetails",
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleofTotalShareBasedCompensationExpensebyTypeofAwardDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PlanNameAxis": {
     "auth_ref": [
      "r448",
      "r475"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by plan name for share-based payment arrangement.",
        "label": "Plan Name [Axis]",
        "terseLabel": "Plan Name [Axis]"
       }
      }
     },
     "localname": "PlanNameAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ShareBasedCompensationNarrativeDetails",
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleofTotalShareBasedCompensationExpensebyTypeofAwardDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PlanNameDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Plan name for share-based payment arrangement.",
        "label": "Plan Name [Domain]",
        "terseLabel": "Plan Name [Domain]"
       }
      }
     },
     "localname": "PlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ShareBasedCompensationNarrativeDetails",
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleofTotalShareBasedCompensationExpensebyTypeofAwardDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PreferredStockNumberOfSharesParValueAndOtherDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Preferred Stock, Number of Shares, Par Value and Other Disclosures [Abstract]",
        "terseLabel": "Preferred shares, without par value:"
       }
      }
     },
     "localname": "PreferredStockNumberOfSharesParValueAndOtherDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PreferredStockSharesAuthorized": {
     "auth_ref": [
      "r42"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.",
        "label": "Preferred Stock, Shares Authorized",
        "terseLabel": "Preferred shares, authorized"
       }
      }
     },
     "localname": "PreferredStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesIssued": {
     "auth_ref": [
      "r42",
      "r400"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.",
        "label": "Preferred Stock, Shares Issued",
        "terseLabel": "Preferred shares, issued"
       }
      }
     },
     "localname": "PreferredStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockValue": {
     "auth_ref": [
      "r42",
      "r671"
     ],
     "calculation": {
      "http://www.cardinal.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Preferred Stock, Value, Issued",
        "terseLabel": "Authorized\u2014500 thousand shares, Issued\u2014none"
       }
      }
     },
     "localname": "PreferredStockValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing prepaid expenses and other current assets.",
        "label": "Prepaid Expenses and Other Current Assets [Member]",
        "terseLabel": "Prepaid Expenses and Other"
       }
      }
     },
     "localname": "PrepaidExpensesAndOtherCurrentAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleoftheFairValueofAssetsandLiabilitiesRelatedtoDerivativesDesignatedasHedgingInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ProceedsFromDivestitureOfBusinesses": {
     "auth_ref": [
      "r114"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow associated with the amount received from the sale of a portion of the company's business, for example a segment, division, branch or other business, during the period.",
        "label": "Proceeds from Divestiture of Businesses",
        "terseLabel": "Proceeds from Divestiture of Businesses"
       }
      }
     },
     "localname": "ProceedsFromDivestitureOfBusinesses",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/DivestituresandAcquisitionsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromRepaymentsOfShortTermDebt": {
     "auth_ref": [],
     "calculation": {
      "http://www.cardinal.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net cash inflow or outflow for borrowing having initial term of repayment within one year or the normal operating cycle, if longer.",
        "label": "Proceeds from (Repayments of) Short-term Debt",
        "terseLabel": "Net change in short-term borrowings"
       }
      }
     },
     "localname": "ProceedsFromRepaymentsOfShortTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProfitLoss": {
     "auth_ref": [
      "r22",
      "r87",
      "r90",
      "r96",
      "r121",
      "r139",
      "r157",
      "r167",
      "r168",
      "r217",
      "r223",
      "r227",
      "r230",
      "r233",
      "r255",
      "r343",
      "r344",
      "r345",
      "r348",
      "r349",
      "r350",
      "r352",
      "r354",
      "r356",
      "r357",
      "r545",
      "r550",
      "r552",
      "r558",
      "r559",
      "r610",
      "r626",
      "r709"
     ],
     "calculation": {
      "http://www.cardinal.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://www.cardinal.com/role/ConsolidatedStatementsofComprehensiveIncome": {
       "order": 1.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      },
      "http://www.cardinal.com/role/ConsolidatedStatementsofEarnings": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.",
        "label": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest",
        "terseLabel": "Net earnings",
        "totalLabel": "Net earnings",
        "verboseLabel": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest"
       }
      }
     },
     "localname": "ProfitLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.cardinal.com/role/ConsolidatedStatementsofComprehensiveIncome",
      "http://www.cardinal.com/role/ConsolidatedStatementsofEarnings",
      "http://www.cardinal.com/role/ConsolidatedStatementsofShareholdersEquity",
      "http://www.cardinal.com/role/EarningsPerShareAttributabletoCardinalHealthIncReconciliationofCommonSharesUsedtoComputeBasicandDilutedEPSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentByTypeAxis": {
     "auth_ref": [
      "r57",
      "r298"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale.",
        "label": "Long-Lived Tangible Asset [Axis]",
        "terseLabel": "Long-Lived Tangible Asset [Axis]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesComponentsofPropertyandEquipmentDetails",
      "http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativePropertyandEquipmentDetails",
      "http://www.cardinal.com/role/LeasesScheduleofFutureLeasePaymentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentGross": {
     "auth_ref": [
      "r56",
      "r296"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Gross",
        "terseLabel": "Total property and equipment, at cost"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesComponentsofPropertyandEquipmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Property, Plant and Equipment [Line Items]",
        "terseLabel": "Property, Plant and Equipment [Line Items]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesComponentsofPropertyandEquipmentDetails",
      "http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativePropertyandEquipmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment [Member]",
        "terseLabel": "Property, Plant and Equipment"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/LeasesSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "auth_ref": [
      "r34",
      "r35",
      "r298",
      "r671",
      "r710",
      "r724"
     ],
     "calculation": {
      "http://www.cardinal.com/role/ConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Net",
        "terseLabel": "Property and equipment, net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesComponentsofPropertyandEquipmentDetails",
      "http://www.cardinal.com/role/ConsolidatedBalanceSheets",
      "http://www.cardinal.com/role/SegmentInformationPropertyandEquipmentnetbyGeographicAreaDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentPolicyTextBlock": {
     "auth_ref": [
      "r55",
      "r298",
      "r760",
      "r761"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.",
        "label": "Property, Plant and Equipment, Policy [Policy Text Block]",
        "terseLabel": "Property and Equipment"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentTextBlock": {
     "auth_ref": [
      "r34",
      "r298"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.",
        "label": "Property, Plant and Equipment [Table Text Block]",
        "terseLabel": "Components of Property and Equipment"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentTypeDomain": {
     "auth_ref": [
      "r34",
      "r296"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software.",
        "label": "Long-Lived Tangible Asset [Domain]",
        "terseLabel": "Long-Lived Tangible Asset [Domain]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesComponentsofPropertyandEquipmentDetails",
      "http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativePropertyandEquipmentDetails",
      "http://www.cardinal.com/role/LeasesScheduleofFutureLeasePaymentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentUsefulLife": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.",
        "label": "Property, Plant and Equipment, Useful Life",
        "terseLabel": "Property, Plant and Equipment, Useful Life",
        "verboseLabel": "Useful life of property and equipment"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentUsefulLife",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesComponentsofPropertyandEquipmentDetails",
      "http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativePropertyandEquipmentDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_ProvisionForDoubtfulAccounts": {
     "auth_ref": [
      "r106",
      "r262"
     ],
     "calculation": {
      "http://www.cardinal.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense (reversal of expense) for expected credit loss on accounts receivable.",
        "label": "Accounts Receivable, Credit Loss Expense (Reversal)",
        "terseLabel": "Provision for bad debts"
       }
      }
     },
     "localname": "ProvisionForDoubtfulAccounts",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ReceivableTypeDomain": {
     "auth_ref": [
      "r70"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Financing arrangement representing a contractual right to receive money either on demand or on fixed and determinable dates.",
        "label": "Receivable [Domain]",
        "terseLabel": "Receivable [Domain]"
       }
      }
     },
     "localname": "ReceivableTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeReceivablesDetails",
      "http://www.cardinal.com/role/ScheduleIIValuationsandQualifyingAccountsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ReceivablesNetCurrent": {
     "auth_ref": [
      "r45",
      "r51",
      "r671",
      "r723",
      "r755"
     ],
     "calculation": {
      "http://www.cardinal.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The total amount due to the entity within one year of the balance sheet date (or one operating cycle, if longer) from outside sources, including trade accounts receivable, notes and loans receivable, as well as any other types of receivables, net of allowances established for the purpose of reducing such receivables to an amount that approximates their net realizable value.",
        "label": "Receivables, Net, Current",
        "terseLabel": "Trade receivables, net"
       }
      }
     },
     "localname": "ReceivablesNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ReceivablesPolicyTextBlock": {
     "auth_ref": [
      "r246",
      "r248",
      "r249",
      "r250"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for receivable. Includes, but is not limited to, accounts receivable and financing receivable.",
        "label": "Receivable [Policy Text Block]",
        "terseLabel": "Receivables"
       }
      }
     },
     "localname": "ReceivablesPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]",
        "terseLabel": "Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]"
       }
      }
     },
     "localname": "ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ShareholdersEquityChangesintheAccumulatedOtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax": {
     "auth_ref": [
      "r86",
      "r94",
      "r95",
      "r97",
      "r636",
      "r640",
      "r642"
     ],
     "calculation": {
      "http://www.cardinal.com/role/ConsolidatedStatementsofComprehensiveIncome": {
       "order": 3.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of reclassification adjustments of other comprehensive income (loss).",
        "label": "Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax",
        "negatedTerseLabel": "Amounts reclassified to earnings"
       }
      }
     },
     "localname": "ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedStatementsofComprehensiveIncome",
      "http://www.cardinal.com/role/ShareholdersEquityChangesintheAccumulatedOtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable": {
     "auth_ref": [
      "r96"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about items reclassified out of accumulated other comprehensive income (loss).",
        "label": "Reclassification out of Accumulated Other Comprehensive Income [Table]",
        "terseLabel": "Reclassification out of Accumulated Other Comprehensive Loss [Table]"
       }
      }
     },
     "localname": "ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ShareholdersEquityChangesintheAccumulatedOtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock": {
     "auth_ref": [
      "r224",
      "r227"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of all significant reconciling items in the reconciliation of total assets from reportable segments to the entity's consolidated assets.",
        "label": "Reconciliation of Assets from Segment to Consolidated [Table Text Block]",
        "terseLabel": "Assets by Reportable Segment"
       }
      }
     },
     "localname": "ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/SegmentInformationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable": {
     "auth_ref": [
      "r223",
      "r227"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about the reconciliation of profit (loss) from reportable segments to the consolidated income (loss) before income tax expense (benefit) and discontinued operations. Includes, but is not limited to, reconciliation after income tax if income tax is allocated to the reportable segment.",
        "label": "Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Table]",
        "terseLabel": "Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Table]"
       }
      }
     },
     "localname": "ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/SegmentInformationSegmentProfitbyReportableSegmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock": {
     "auth_ref": [
      "r223",
      "r227"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the reconciliation of profit (loss) from reportable segments to the consolidated income (loss) before income tax expense (benefit) and discontinued operations. Includes, but is not limited to, reconciliation after income tax if income tax is allocated to the reportable segment.",
        "label": "Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Table Text Block]",
        "terseLabel": "Segment Profit by Reportable Segment"
       }
      }
     },
     "localname": "ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/SegmentInformationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ReconciliationOfOtherSignificantReconcilingItemsFromSegmentsToConsolidatedTextBlock": {
     "auth_ref": [
      "r225",
      "r227"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of each significant reconciling item, other than profit (loss), revenues, or assets, in the reconciliation of totals of such items in reportable segments to the entity's corresponding consolidated amount.",
        "label": "Reconciliation of Other Significant Reconciling Items from Segments to Consolidated [Table Text Block]",
        "terseLabel": "Depreciation and Amortization and Additions to Property and Equipment by Reportable Segment"
       }
      }
     },
     "localname": "ReconciliationOfOtherSignificantReconcilingItemsFromSegmentsToConsolidatedTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/SegmentInformationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock": {
     "auth_ref": [
      "r222",
      "r227"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of all significant reconciling items in the reconciliation of total revenues from reportable segments to the entity's consolidated revenues.",
        "label": "Reconciliation of Revenue from Segments to Consolidated [Table Text Block]",
        "terseLabel": "Revenue by Reportable Segment"
       }
      }
     },
     "localname": "ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/SegmentInformationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]",
        "terseLabel": "Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]"
       }
      }
     },
     "localname": "ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/IncomeTaxesScheduleofUnrecognizedTaxBenefitsRollForwardDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount": {
     "auth_ref": [
      "r394",
      "r395",
      "r396",
      "r397"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "As of the reporting date, the aggregate carrying amount of all noncontrolling interests which are redeemable by the (parent) entity (1) at a fixed or determinable price on a fixed or determinable date, (2) at the option of the holder of the noncontrolling interest, or (3) upon occurrence of an event that is not solely within the control of the (parent) entity. This item includes noncontrolling interest holder's ownership (or holders' ownership) regardless of the type of equity interest (common, preferred, other) including all potential organizational (legal) forms of the investee entity.",
        "label": "Redeemable Noncontrolling Interest, Equity, Carrying Amount",
        "terseLabel": "Redeemable Noncontrolling Interest, Equity, Carrying Amount"
       }
      }
     },
     "localname": "RedeemableNoncontrollingInterestEquityCarryingAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/DivestituresandAcquisitionsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RepaymentsOfLongTermDebt": {
     "auth_ref": [
      "r118"
     ],
     "calculation": {
      "http://www.cardinal.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer.",
        "label": "Repayments of Long-term Debt",
        "negatedTerseLabel": "Reduction of long-term obligations"
       }
      }
     },
     "localname": "RepaymentsOfLongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestrictedStockUnitsRSUMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share instrument which is convertible to stock or an equivalent amount of cash, after a specified period of time or when specified performance conditions are met.",
        "label": "Restricted Stock Units (RSUs) [Member]",
        "terseLabel": "Restricted Share Units",
        "verboseLabel": "Restricted Share Unit"
       }
      }
     },
     "localname": "RestrictedStockUnitsRSUMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ShareBasedCompensationAdditionalDataRelatedtoRestrictedShareUnitActivityDetails",
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleofAllTransactionsRelatedtoRestrictedShareUnitsUnderthePlansDetails",
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleofTotalShareBasedCompensationExpensebyTypeofAwardDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock": {
     "auth_ref": [
      "r305",
      "r307",
      "r310",
      "r320",
      "r322"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for restructuring and related activities. Description of restructuring activities such as exit and disposal activities, include facts and circumstances leading to the plan, the expected plan completion date, the major types of costs associated with the plan activities, total expected costs, the accrual balance at the end of the period, and the periods over which the remaining accrual will be settled.",
        "label": "Restructuring and Related Activities Disclosure [Text Block]",
        "terseLabel": "Restructuring and Employee Severance"
       }
      }
     },
     "localname": "RestructuringAndRelatedActivitiesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/RestructuringandEmployeeSeverance"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RestructuringCharges": {
     "auth_ref": [
      "r126",
      "r304",
      "r313",
      "r317"
     ],
     "calculation": {
      "http://www.cardinal.com/role/ConsolidatedStatementsofEarnings": {
       "order": 3.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      },
      "http://www.cardinal.com/role/RestructuringandEmployeeSeveranceActivityRelatedtoRestructuringandEmployeeSeveranceCostsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.",
        "label": "Restructuring Charges",
        "totalLabel": "Total restructuring and employee severance",
        "verboseLabel": "Restructuring and employee severance"
       }
      }
     },
     "localname": "RestructuringCharges",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedStatementsofEarnings",
      "http://www.cardinal.com/role/RestructuringandEmployeeSeveranceActivityRelatedtoRestructuringandEmployeeSeveranceCostsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringChargesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restructuring Charges [Abstract]",
        "terseLabel": "Restructuring Charges [Abstract]"
       }
      }
     },
     "localname": "RestructuringChargesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_RestructuringCostAndReserveAxis": {
     "auth_ref": [
      "r306",
      "r307",
      "r317",
      "r318"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of restructuring cost.",
        "label": "Restructuring Type [Axis]",
        "terseLabel": "Restructuring Type [Axis]"
       }
      }
     },
     "localname": "RestructuringCostAndReserveAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/RestructuringandEmployeeSeveranceLiabilitiesAssociatedwithRestructuringandEmployeeSeveranceActivitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RestructuringCostAndReserveLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Restructuring Cost and Reserve [Line Items]",
        "terseLabel": "Restructuring Cost and Reserve [Line Items]"
       }
      }
     },
     "localname": "RestructuringCostAndReserveLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/RestructuringandEmployeeSeveranceLiabilitiesAssociatedwithRestructuringandEmployeeSeveranceActivitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RestructuringCosts": {
     "auth_ref": [
      "r126"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after cash payment, of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.",
        "label": "Restructuring Costs",
        "terseLabel": "Additions"
       }
      }
     },
     "localname": "RestructuringCosts",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/RestructuringandEmployeeSeveranceLiabilitiesAssociatedwithRestructuringandEmployeeSeveranceActivitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringReserve": {
     "auth_ref": [
      "r307",
      "r315"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount (including both current and noncurrent portions of the accrual) as of the balance sheet date pertaining to a specified type of cost associated with exit from or disposal of business activities or restructuring pursuant to a duly authorized plan.",
        "label": "Restructuring Reserve",
        "periodEndLabel": "Ending Balance",
        "periodStartLabel": "Beginning Balance"
       }
      }
     },
     "localname": "RestructuringReserve",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/RestructuringandEmployeeSeveranceLiabilitiesAssociatedwithRestructuringandEmployeeSeveranceActivitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringReserveRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Restructuring Reserve [Roll Forward]",
        "terseLabel": "Restructuring Reserve [Roll Forward]"
       }
      }
     },
     "localname": "RestructuringReserveRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/RestructuringandEmployeeSeveranceLiabilitiesAssociatedwithRestructuringandEmployeeSeveranceActivitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "auth_ref": [
      "r46",
      "r423",
      "r483",
      "r671",
      "r720",
      "r748",
      "r753"
     ],
     "calculation": {
      "http://www.cardinal.com/role/ConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings (Accumulated Deficit)",
        "negatedLabel": "Retained earnings decrease",
        "terseLabel": "Retained earnings"
       }
      }
     },
     "localname": "RetainedEarningsAccumulatedDeficit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedBalanceSheets",
      "http://www.cardinal.com/role/ShareholdersEquityNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsMember": {
     "auth_ref": [
      "r2",
      "r154",
      "r155",
      "r156",
      "r158",
      "r166",
      "r168",
      "r259",
      "r480",
      "r481",
      "r482",
      "r523",
      "r524",
      "r608",
      "r744",
      "r746"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings [Member]",
        "terseLabel": "Retained Earnings"
       }
      }
     },
     "localname": "RetainedEarningsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedStatementsofShareholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock": {
     "auth_ref": [
      "r239"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of revenue from external customers by geographic areas attributed to the entity's country of domicile and to foreign countries from which the entity derives revenue.",
        "label": "Revenue from External Customers by Geographic Areas [Table Text Block]",
        "terseLabel": "Revenue from External Customers by Geographic Areas [Table Text Block]"
       }
      }
     },
     "localname": "RevenueFromExternalCustomersByGeographicAreasTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/SegmentInformationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RevenueRecognitionPolicyTextBlock": {
     "auth_ref": [
      "r133",
      "r134"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for revenue. Includes revenue from contract with customer and from other sources.",
        "label": "Revenue [Policy Text Block]",
        "terseLabel": "Revenue Recognition"
       }
      }
     },
     "localname": "RevenueRecognitionPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RevenueRecognitionSalesReturnsReserveForSalesReturns": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of estimated sales returns.",
        "label": "Revenue Recognition, Sales Returns, Reserve for Sales Returns",
        "terseLabel": "Revenue Recognition, Sales Returns, Reserve for Sales Returns"
       }
      }
     },
     "localname": "RevenueRecognitionSalesReturnsReserveForSalesReturns",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeSalesReturnsandAllowancesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Revenues": {
     "auth_ref": [
      "r99",
      "r139",
      "r208",
      "r209",
      "r222",
      "r228",
      "r229",
      "r236",
      "r237",
      "r242",
      "r255",
      "r343",
      "r344",
      "r345",
      "r348",
      "r349",
      "r350",
      "r352",
      "r354",
      "r356",
      "r357",
      "r626",
      "r709"
     ],
     "calculation": {
      "http://www.cardinal.com/role/ConsolidatedStatementsofEarnings": {
       "order": 1.0,
       "parentTag": "us-gaap_GrossProfit",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).",
        "label": "Revenues",
        "terseLabel": "Revenue"
       }
      }
     },
     "localname": "Revenues",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedStatementsofEarnings",
      "http://www.cardinal.com/role/SegmentInformationRevenuebyReportableSegmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Revenues from External Customers and Long-Lived Assets [Line Items]",
        "terseLabel": "Long-Lived Assets [Line Items]"
       }
      }
     },
     "localname": "RevenuesFromExternalCustomersAndLongLivedAssetsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/SegmentInformationPropertyandEquipmentnetbyGeographicAreaDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RevolvingCreditFacilityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Arrangement in which loan proceeds can continuously be obtained following repayments, but the total amount borrowed cannot exceed a specified maximum amount.",
        "label": "Revolving Credit Facility [Member]",
        "terseLabel": "Revolving Credit Facility"
       }
      }
     },
     "localname": "RevolvingCreditFacilityMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/LongTermObligationsandOtherShortTermBorrowingsNarrativeDetails",
      "http://www.cardinal.com/role/LongTermObligationsandOtherShortTermBorrowingsOtherFinancingArrangementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability": {
     "auth_ref": [
      "r662",
      "r667"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in right-of-use asset obtained in exchange for finance lease liability.",
        "label": "Right-of-Use Asset Obtained in Exchange for Finance Lease Liability",
        "terseLabel": "Right-of-Use Asset Obtained in Exchange for Finance Lease Liability"
       }
      }
     },
     "localname": "RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/LeasesSupplementalCashFlowInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability": {
     "auth_ref": [
      "r662",
      "r667"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in right-of-use asset obtained in exchange for operating lease liability.",
        "label": "Right-of-Use Asset Obtained in Exchange for Operating Lease Liability",
        "terseLabel": "Right-of-Use Asset Obtained in Exchange for Operating Lease Liability"
       }
      }
     },
     "localname": "RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/LeasesSupplementalCashFlowInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SalesMember": {
     "auth_ref": [
      "r588"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing revenue from sale of goods and services rendered in the normal course of business.",
        "label": "Sales [Member]",
        "terseLabel": "Revenue"
       }
      }
     },
     "localname": "SalesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleofGainLossReclassifiedfromAOCIintoEarningsforDerivativeInstrumentsDesignatedasCashFlowHedgesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SalesReturnsAndAllowancesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A revision in the estimated reserve needed for product returns and price or other concessions granted to customers.",
        "label": "Sales Returns and Allowances [Member]",
        "terseLabel": "Sales Returns and Allowances [Member]"
       }
      }
     },
     "localname": "SalesReturnsAndAllowancesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ScheduleIIValuationsandQualifyingAccountsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SalesRevenueNetMember": {
     "auth_ref": [
      "r198",
      "r242"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Revenue from sale of product and rendering of service and other sources of income, when it serves as benchmark in concentration of risk calculation.",
        "label": "Revenue Benchmark [Member]",
        "terseLabel": "Revenue Benchmark"
       }
      }
     },
     "localname": "SalesRevenueNetMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeMajorCustomersDetails",
      "http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesRevenueandGrossTradeReceivablesPercentagebyMajorCustomersDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable": {
     "auth_ref": [
      "r70"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule itemizing specific types of trade accounts and notes receivable, and for each the gross carrying value, allowance, and net carrying value as of the balance sheet date. Presentation is categorized by current, noncurrent and unclassified receivables.",
        "label": "Schedule of Accounts, Notes, Loans and Financing Receivable [Table]",
        "terseLabel": "Schedule of Accounts, Notes, Loans and Financing Receivable [Table]"
       }
      }
     },
     "localname": "ScheduleOfAccountsNotesLoansAndFinancingReceivableTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeReceivablesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock": {
     "auth_ref": [
      "r86",
      "r641",
      "r642"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of accumulated other comprehensive income (loss).",
        "label": "Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]",
        "terseLabel": "Schedule of Changes in the Balance of Accumulated Other Comprehensive Loss by Component and in Total"
       }
      }
     },
     "localname": "ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ShareholdersEquityTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable": {
     "auth_ref": [
      "r538",
      "r539"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting each material business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities.",
        "label": "Schedule of Business Acquisitions, by Acquisition [Table]",
        "terseLabel": "Schedule of Business Acquisitions, by Acquisition [Table]"
       }
      }
     },
     "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/DivestituresandAcquisitionsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of information pertaining to carrying amount and estimated fair value of short-term and long-term debt instruments or arrangements, including but not limited to, identification of terms, features, and collateral requirements.",
        "label": "Schedule of Carrying Values and Estimated Fair Values of Debt Instruments [Table Text Block]",
        "terseLabel": "Schedule of Estimated Fair Value of Long-term Obligations and Other Short-term Borrowings Compared to the Respective Carrying Amount"
       }
      }
     },
     "localname": "ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/FinancialInstrumentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock": {
     "auth_ref": [
      "r578"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of gain (loss) on derivative and nonderivative instruments designated and qualifying as cash flow hedge recorded in accumulated other comprehensive income (AOCI) and reclassified into earnings.",
        "label": "Schedule of Cash Flow Hedges Included in Accumulated Other Comprehensive Income (Loss) [Table Text Block]",
        "terseLabel": "Schedule of Gain/(Loss) Reclassified from AOCI into Earnings for Derivative Instruments Designated as Cash Flow Hedges"
       }
      }
     },
     "localname": "ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/FinancialInstrumentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock": {
     "auth_ref": [
      "r472"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of cost recognized for award under share-based payment arrangement by plan. Includes, but is not limited to, related tax benefit.",
        "label": "Share-based Payment Arrangement, Cost by Plan [Table Text Block]",
        "terseLabel": "Schedule of Total Share-based Compensation Expense by Type of Award"
       }
      }
     },
     "localname": "ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ShareBasedCompensationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock": {
     "auth_ref": [
      "r519"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.",
        "label": "Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]",
        "terseLabel": "Schedule of Components of Income Tax Expense (Benefit), Current and Deferred"
       }
      }
     },
     "localname": "ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDebtTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of information pertaining to short-term and long-debt instruments or arrangements, including but not limited to identification of terms, features, collateral requirements and other information necessary to a fair presentation.",
        "label": "Schedule of Debt [Table Text Block]",
        "terseLabel": "Schedule of Debt"
       }
      }
     },
     "localname": "ScheduleOfDebtTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/LongTermObligationsandOtherShortTermBorrowingsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock": {
     "auth_ref": [
      "r510"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.",
        "label": "Schedule of Deferred Tax Assets and Liabilities [Table Text Block]",
        "terseLabel": "Schedule of Deferred Tax Assets and Liabilities"
       }
      }
     },
     "localname": "ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDerivativeInstrumentsEffectOnOtherComprehensiveIncomeLossTableTextBlock": {
     "auth_ref": [
      "r577"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the effective portion of the gains and losses on derivative instruments designated (and non-derivative instruments) designated and qualifying in cash flow hedges and net investment hedges that was recognized in other comprehensive income (loss) during the current period.",
        "label": "Schedule of Derivative Instruments, Effect on Other Comprehensive Income (Loss) [Table Text Block]",
        "terseLabel": "Schedule of Gain/(Loss) Included in AOCI for Derivative Instruments"
       }
      }
     },
     "localname": "ScheduleOfDerivativeInstrumentsEffectOnOtherComprehensiveIncomeLossTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/FinancialInstrumentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock": {
     "auth_ref": [
      "r571",
      "r580",
      "r590"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the location and amount of derivative instruments and nonderivative instruments designated as hedging instruments reported before netting adjustments, and the amount of gain (loss) on derivative instruments and nonderivative instruments designated and qualified as hedging instruments.",
        "label": "Derivative Instruments, Gain (Loss) [Table Text Block]",
        "terseLabel": "Schedule of Gain/(Loss) Recognized in Earnings for Interest Rate Contracts Designated as Fair Value Hedges"
       }
      }
     },
     "localname": "ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/FinancialInstrumentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock": {
     "auth_ref": [
      "r576"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the location and fair value amounts of derivative instruments (and nonderivative instruments that are designated and qualify as hedging instruments) reported in the statement of financial position.",
        "label": "Schedule of Derivative Instruments in Statement of Financial Position, Fair Value [Table Text Block]",
        "terseLabel": "Schedule of Fair Value of Assets and Liabilities Related to Derivatives Designated as Hedging Instruments"
       }
      }
     },
     "localname": "ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/FinancialInstrumentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDerivativeInstrumentsTextBlock": {
     "auth_ref": [
      "r561",
      "r564",
      "r565",
      "r568",
      "r569",
      "r576",
      "r580",
      "r592",
      "r593"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of pertinent information about a derivative or group of derivatives on a disaggregated basis, such as for individual instruments, or small groups of similar instruments. May include a combination of the type of instrument, risks being hedged, notional amount, hedge designation, related hedged item, inception date, maturity date, or other relevant item.",
        "label": "Schedule of Derivative Instruments [Table Text Block]",
        "terseLabel": "Schedule of Outstanding Instruments"
       }
      }
     },
     "localname": "ScheduleOfDerivativeInstrumentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/FinancialInstrumentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock": {
     "auth_ref": [
      "r6",
      "r10",
      "r11",
      "r12",
      "r13",
      "r14",
      "r15",
      "r17",
      "r20",
      "r21",
      "r22",
      "r302",
      "r303"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of information related to a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.",
        "label": "Disposal Groups, Including Discontinued Operations [Table Text Block]",
        "terseLabel": "Disposal Groups, Including Discontinued Operations"
       }
      }
     },
     "localname": "ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/DivestituresandAcquisitionsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock": {
     "auth_ref": [
      "r492"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.",
        "label": "Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]",
        "terseLabel": "Schedule of Effective Income Tax Rate Reconciliation"
       }
      }
     },
     "localname": "ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable": {
     "auth_ref": [
      "r242"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure about the extent of the entity's reliance on its major customers.",
        "label": "Schedule of Revenue by Major Customers, by Reporting Segments [Table]",
        "terseLabel": "Schedule of Revenue by Major Customers, by Reporting Segments [Table]"
       }
      }
     },
     "localname": "ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesRevenueandGrossTradeReceivablesPercentagebyMajorCustomersDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock": {
     "auth_ref": [
      "r611",
      "r612"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).",
        "label": "Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]",
        "terseLabel": "Fair Value, Assets and Liabilities Measured on Recurring Basis"
       }
      }
     },
     "localname": "ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/FairValueMeasurementsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable": {
     "auth_ref": [
      "r282",
      "r287",
      "r686"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Schedule of Finite-Lived Intangible Assets [Table]",
        "terseLabel": "Schedule of Finite-Lived Intangible Assets [Table]"
       }
      }
     },
     "localname": "ScheduleOfFiniteLivedIntangibleAssetsTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/GoodwillandOtherIntangibleAssetsScheduleofIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock": {
     "auth_ref": [
      "r282",
      "r287"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment.",
        "label": "Schedule of Finite-Lived Intangible Assets [Table Text Block]",
        "terseLabel": "Schedule of Finite-Lived Intangible Assets"
       }
      }
     },
     "localname": "ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/GoodwillandOtherIntangibleAssetsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock": {
     "auth_ref": [
      "r651"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of future minimum payments required in the aggregate and for each of the five succeeding fiscal years for operating leases having initial or remaining noncancelable lease terms in excess of one year and the total minimum rentals to be received in the future under noncancelable subleases as of the balance sheet date.",
        "label": "Schedule of Future Minimum Rental Payments for Operating Leases [Table Text Block]",
        "terseLabel": "Schedule of Future Lease Payments"
       }
      }
     },
     "localname": "ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/LeasesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfGoodwillTable": {
     "auth_ref": [
      "r277",
      "r279"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of goodwill and the changes during the year due to acquisition, sale, impairment or for other reasons.",
        "label": "Schedule of Goodwill [Table]",
        "terseLabel": "Schedule of Goodwill [Table]",
        "verboseLabel": "Goodwill [Table]"
       }
      }
     },
     "localname": "ScheduleOfGoodwillTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/GoodwillandOtherIntangibleAssetsNarrativeDetails",
      "http://www.cardinal.com/role/GoodwillandOtherIntangibleAssetsScheduleofGoodwillbyReportableSegmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfGoodwillTextBlock": {
     "auth_ref": [
      "r277",
      "r279"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.",
        "label": "Schedule of Goodwill [Table Text Block]",
        "terseLabel": "Schedule of Goodwill by Reportable Segment"
       }
      }
     },
     "localname": "ScheduleOfGoodwillTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/GoodwillandOtherIntangibleAssetsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock": {
     "auth_ref": [
      "r140"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of income before income tax between domestic and foreign jurisdictions.",
        "label": "Schedule of Income before Income Tax, Domestic and Foreign [Table Text Block]",
        "terseLabel": "Schedule of Income Before Income Tax, Domestic and Foreign"
       }
      }
     },
     "localname": "ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable": {
     "auth_ref": [
      "r291",
      "r293"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of assets, excluding financial assets and goodwill, lacking physical substance and exist in perpetuity.",
        "label": "Schedule of Indefinite-Lived Intangible Assets [Table]",
        "terseLabel": "Schedule of Indefinite-Lived Intangible Assets [Table]"
       }
      }
     },
     "localname": "ScheduleOfIndefiniteLivedIntangibleAssetsTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/GoodwillandOtherIntangibleAssetsScheduleofIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock": {
     "auth_ref": [
      "r291",
      "r293"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance and exist in perpetuity, by either major class or business segment.",
        "label": "Schedule of Indefinite-Lived Intangible Assets [Table Text Block]",
        "terseLabel": "Schedule of Indefinite-Lived Intangible Assets"
       }
      }
     },
     "localname": "ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/GoodwillandOtherIntangibleAssetsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfNonvestedPerformanceBasedUnitsActivityTableTextBlock": {
     "auth_ref": [
      "r460"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the changes in outstanding nonvested performance-based units.",
        "label": "Schedule of Nonvested Performance-based Units Activity [Table Text Block]",
        "terseLabel": "Schedule of Transactions Related to Performance Share Units Under the Plans"
       }
      }
     },
     "localname": "ScheduleOfNonvestedPerformanceBasedUnitsActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ShareBasedCompensationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock": {
     "auth_ref": [
      "r579",
      "r581"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of derivative instrument not designated or qualifying as hedging instrument.",
        "label": "Derivatives Not Designated as Hedging Instruments [Table Text Block]",
        "terseLabel": "Schedule of Gain/(Loss) Recognized in Earnings for Economic (Non-designated) Derivative Instruments"
       }
      }
     },
     "localname": "ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/FinancialInstrumentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": {
     "auth_ref": [
      "r57",
      "r298"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.",
        "label": "Property, Plant and Equipment [Table]",
        "terseLabel": "Property, Plant and Equipment [Table]"
       }
      }
     },
     "localname": "ScheduleOfPropertyPlantAndEquipmentTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesComponentsofPropertyandEquipmentDetails",
      "http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativePropertyandEquipmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfRestructuringAndRelatedCostsTable": {
     "auth_ref": [
      "r306",
      "r307",
      "r308",
      "r309",
      "r317",
      "r318",
      "r319"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Table presenting the description of the restructuring costs, such as the expected cost; the costs incurred during the period; the cumulative costs incurred as of the balance sheet date; the income statement caption within which the restructuring charges recognized for the period are included; and the amount of and periodic changes to an entity's restructuring reserve that occurred during the period associated with the exit from or disposal of business activities or restructurings for each major type of cost by type of restructuring.",
        "label": "Schedule of Restructuring and Related Costs [Table]",
        "terseLabel": "Schedule of Restructuring and Related Costs [Table]"
       }
      }
     },
     "localname": "ScheduleOfRestructuringAndRelatedCostsTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/RestructuringandEmployeeSeveranceLiabilitiesAssociatedwithRestructuringandEmployeeSeveranceActivitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock": {
     "auth_ref": [
      "r311",
      "r312",
      "r316"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of costs incurred for restructuring including, but not limited to, exit and disposal activities, remediation, implementation, integration, asset impairment, and charges against earnings from the write-down of assets.",
        "label": "Restructuring and Related Costs [Table Text Block]",
        "terseLabel": "Summary of Restructuring and Employee Severance"
       }
      }
     },
     "localname": "ScheduleOfRestructuringAndRelatedCostsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/RestructuringandEmployeeSeveranceTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock": {
     "auth_ref": [
      "r307",
      "r318"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of an entity's restructuring reserve that occurred during the period associated with the exit from or disposal of business activities or restructurings for each major type of cost. This element may also include a description of any reversal and other adjustment made during the period to the amount of an accrued liability for restructuring activities. This element may be used to encapsulate the roll forward presentations of an entity's restructuring reserve by type of cost and in total, and explanation of changes that occurred in the period.",
        "label": "Schedule of Restructuring Reserve by Type of Cost [Table Text Block]",
        "terseLabel": "Schedule of Activity Related to Liabilities Associated with Restructuring and Employee Severance"
       }
      }
     },
     "localname": "ScheduleOfRestructuringReserveByTypeOfCostTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/RestructuringandEmployeeSeveranceTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the extent of the entity's reliance on its major customers, if revenues from transactions with a single external customer amount to 10 percent or more of entity revenues, including the disclosure of that fact, the total amount of revenues from each such customer, and the identity of the reportable segment or segments reporting the revenues. The entity need not disclose the identity of a major customer or the amount of revenues that each segment reports from that customer. For these purposes, a group of companies known to the entity to be under common control is considered a single customer, and the federal government, a state government, a local government such as a county or municipality, or a foreign government is each considered a single customer.",
        "label": "Schedule of Revenue by Major Customers by Reporting Segments [Table Text Block]",
        "terseLabel": "Schedule of Revenue and Gross Trade Receivables Percentage by Major Customers"
       }
      }
     },
     "localname": "ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable": {
     "auth_ref": [
      "r99",
      "r241"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of material long-lived assets (excluding financial instruments, customer relationships with financial institutions, mortgage and other servicing rights, deferred policy acquisition costs, and deferred taxes assets) located in identified geographic areas and/or the amount of revenue from external customers attributed to that country from which revenue is material.  An entity may also provide subtotals of geographic information about groups of countries.",
        "label": "Schedule of Revenues from External Customers and Long-Lived Assets [Table]",
        "terseLabel": "Schedule of Long-Lived Assets [Table]"
       }
      }
     },
     "localname": "ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/SegmentInformationPropertyandEquipmentnetbyGeographicAreaDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable": {
     "auth_ref": [
      "r217",
      "r220",
      "r226",
      "r277"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table disclosing the profit or loss and total assets for each reportable segment of the entity. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.",
        "label": "Schedule of Segment Reporting Information, by Segment [Table]",
        "terseLabel": "Schedule of Segment Reporting Information, by Segment [Table]"
       }
      }
     },
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/SegmentInformationAssetsbyReportableSegmentDetails",
      "http://www.cardinal.com/role/SegmentInformationDepreciationandAmortizationandAdditionstoPropertyandEquipmentbyReportableSegmentDetails",
      "http://www.cardinal.com/role/SegmentInformationNarrativeDetails",
      "http://www.cardinal.com/role/SegmentInformationRevenuebyReportableSegmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock": {
     "auth_ref": [
      "r217",
      "r220",
      "r226",
      "r277"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.",
        "label": "Schedule of Segment Reporting Information, by Segment [Table Text Block]",
        "terseLabel": "Schedule of Segment Reporting Information, by Segment [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/SegmentInformationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": {
     "auth_ref": [
      "r448",
      "r475"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about share-based payment arrangement.",
        "label": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]",
        "terseLabel": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ShareBasedCompensationAdditionalDataRelatedtoPerformanceShareUnitActivityDetails",
      "http://www.cardinal.com/role/ShareBasedCompensationAdditionalDataRelatedtoRestrictedShareUnitActivityDetails",
      "http://www.cardinal.com/role/ShareBasedCompensationNarrativeDetails",
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleofAdditionalDataRelatedtoStockOptionsDetails",
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleofAllTransactionsRelatedtoPerformanceShareUnitsUnderthePlansDetails",
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleofAllTransactionsRelatedtoRestrictedShareUnitsUnderthePlansDetails",
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleofRemainingStockOptionPlanDataDetails",
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleofTotalShareBasedCompensationExpensebyTypeofAwardDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock": {
     "auth_ref": [
      "r453"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the number and weighted-average grant date fair value for restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock units that were granted, vested, or forfeited during the year.",
        "label": "Share-based Payment Arrangement, Restricted Stock Unit, Activity [Table Text Block]",
        "terseLabel": "Schedule of Transactions Related to Restricted Share Units Under the Plans"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ShareBasedCompensationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": {
     "auth_ref": [
      "r453",
      "r465",
      "r468"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.",
        "label": "Share-based Payment Arrangement, Option, Activity [Table Text Block]",
        "terseLabel": "Schedule of Stock Option Transactions Under the Plans"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ShareBasedCompensationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock": {
     "auth_ref": [
      "r470"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.",
        "label": "Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]",
        "terseLabel": "Schedule of Range of Assumptions Used to Estimate Fair Value of Stock Options"
       }
      }
     },
     "localname": "ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ShareBasedCompensationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfStockByClassTable": {
     "auth_ref": [
      "r67",
      "r136",
      "r188",
      "r189",
      "r393",
      "r398",
      "r399",
      "r400",
      "r401",
      "r402",
      "r403",
      "r405",
      "r409",
      "r414",
      "r417",
      "r418",
      "r419",
      "r420",
      "r421",
      "r422",
      "r423"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule detailing information related to equity by class of stock. Class of stock includes common, convertible, and preferred stocks which are not redeemable or redeemable solely at the option of the issuer. It also includes preferred stock with redemption features that are solely within the control of the issuer and mandatorily redeemable stock if redemption is required to occur only upon liquidation or termination of the reporting entity.",
        "label": "Schedule of Stock by Class [Table]",
        "terseLabel": "Schedule of Stock by Class [Table]"
       }
      }
     },
     "localname": "ScheduleOfStockByClassTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ShareholdersEquityNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock": {
     "auth_ref": [
      "r504",
      "r520"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the change in unrecognized tax benefits.",
        "label": "Schedule of Unrecognized Tax Benefits Roll Forward [Table Text Block]",
        "terseLabel": "Schedule of Unrecognized Tax Benefits Roll Forward"
       }
      }
     },
     "localname": "ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock": {
     "auth_ref": [
      "r180"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the weighted average number of shares used in calculating basic net earnings per share (or unit) and diluted earnings per share (or unit).",
        "label": "Schedule of Weighted Average Number of Shares [Table Text Block]",
        "terseLabel": "Reconciliation of Common Shares Used to Compute Basic and Diluted Earnings Per Share"
       }
      }
     },
     "localname": "ScheduleOfWeightedAverageNumberOfSharesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/EarningsPerShareAttributabletoCardinalHealthIncTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SegmentDomain": {
     "auth_ref": [
      "r204",
      "r208",
      "r209",
      "r210",
      "r211",
      "r212",
      "r213",
      "r214",
      "r215",
      "r216",
      "r217",
      "r218",
      "r219",
      "r222",
      "r223",
      "r224",
      "r225",
      "r227",
      "r228",
      "r229",
      "r230",
      "r231",
      "r233",
      "r242",
      "r309",
      "r319",
      "r736"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.",
        "label": "Segments [Domain]",
        "terseLabel": "Segments [Domain]"
       }
      }
     },
     "localname": "SegmentDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesRevenueandGrossTradeReceivablesPercentagebyMajorCustomersDetails",
      "http://www.cardinal.com/role/GoodwillandOtherIntangibleAssetsNarrativeDetails",
      "http://www.cardinal.com/role/GoodwillandOtherIntangibleAssetsScheduleofGoodwillbyReportableSegmentDetails",
      "http://www.cardinal.com/role/SegmentInformationAssetsbyReportableSegmentDetails",
      "http://www.cardinal.com/role/SegmentInformationDepreciationandAmortizationandAdditionstoPropertyandEquipmentbyReportableSegmentDetails",
      "http://www.cardinal.com/role/SegmentInformationRevenuebyReportableSegmentDetails",
      "http://www.cardinal.com/role/SegmentInformationSegmentProfitbyReportableSegmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SegmentReportingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment Reporting [Abstract]",
        "terseLabel": "Segment Reporting [Abstract]"
       }
      }
     },
     "localname": "SegmentReportingAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_SegmentReportingDisclosureTextBlock": {
     "auth_ref": [
      "r204",
      "r206",
      "r207",
      "r217",
      "r221",
      "r227",
      "r231",
      "r232",
      "r233",
      "r234",
      "r236",
      "r241",
      "r242",
      "r243"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.",
        "label": "Segment Reporting Disclosure [Text Block]",
        "terseLabel": "Segment Information"
       }
      }
     },
     "localname": "SegmentReportingDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/SegmentInformation"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SegmentReportingInformationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Segment Reporting Information [Line Items]",
        "terseLabel": "Segment Reporting Information [Line Items]"
       }
      }
     },
     "localname": "SegmentReportingInformationLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/SegmentInformationAssetsbyReportableSegmentDetails",
      "http://www.cardinal.com/role/SegmentInformationDepreciationandAmortizationandAdditionstoPropertyandEquipmentbyReportableSegmentDetails",
      "http://www.cardinal.com/role/SegmentInformationNarrativeDetails",
      "http://www.cardinal.com/role/SegmentInformationRevenuebyReportableSegmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]",
        "terseLabel": "Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]"
       }
      }
     },
     "localname": "SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/SegmentInformationSegmentProfitbyReportableSegmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SellingGeneralAndAdministrativeExpense": {
     "auth_ref": [
      "r112"
     ],
     "calculation": {
      "http://www.cardinal.com/role/ConsolidatedStatementsofEarnings": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.",
        "label": "Selling, General and Administrative Expense",
        "terseLabel": "Distribution, selling, general and administrative expenses"
       }
      }
     },
     "localname": "SellingGeneralAndAdministrativeExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeShippingandHandlingDetails",
      "http://www.cardinal.com/role/CommitmentsContingentLiabilitiesandLitigationDetails",
      "http://www.cardinal.com/role/ConsolidatedStatementsofEarnings"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SellingGeneralAndAdministrativeExpensesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing selling, general and administrative expense.",
        "label": "Selling, General and Administrative Expenses [Member]",
        "terseLabel": "SG&amp;A Expenses"
       }
      }
     },
     "localname": "SellingGeneralAndAdministrativeExpensesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleofGainLossReclassifiedfromAOCIintoEarningsforDerivativeInstrumentsDesignatedasCashFlowHedgesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SeveranceCosts1": {
     "auth_ref": [
      "r126"
     ],
     "calculation": {
      "http://www.cardinal.com/role/RestructuringandEmployeeSeveranceActivityRelatedtoRestructuringandEmployeeSeveranceCostsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_RestructuringCharges",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expenses for special or contractual termination benefits provided to current employees involuntarily terminated under a benefit arrangement associated exit or disposal activities pursuant to an authorized plan. Excludes expenses related to one-time termination benefits, a discontinued operation or an asset retirement obligation.",
        "label": "Severance Costs",
        "verboseLabel": "Employee-related costs"
       }
      }
     },
     "localname": "SeveranceCosts1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/RestructuringandEmployeeSeveranceActivityRelatedtoRestructuringandEmployeeSeveranceCostsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensation": {
     "auth_ref": [
      "r125"
     ],
     "calculation": {
      "http://www.cardinal.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncash expense for share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Noncash Expense",
        "verboseLabel": "Share-based compensation"
       }
      }
     },
     "localname": "ShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1": {
     "auth_ref": [
      "r449"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period",
        "terseLabel": "Award vesting period (in years)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ShareBasedCompensationAdditionalDataRelatedtoRestrictedShareUnitActivityDetails",
      "http://www.cardinal.com/role/ShareBasedCompensationNarrativeDetails",
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleofAdditionalDataRelatedtoStockOptionsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod": {
     "auth_ref": [
      "r458"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period",
        "negatedTerseLabel": "Canceled and forfeited (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleofAllTransactionsRelatedtoPerformanceShareUnitsUnderthePlansDetails",
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleofAllTransactionsRelatedtoRestrictedShareUnitsUnderthePlansDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r464"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value",
        "terseLabel": "Canceled and forfeited (in usd per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleofAllTransactionsRelatedtoPerformanceShareUnitsUnderthePlansDetails",
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleofAllTransactionsRelatedtoRestrictedShareUnitsUnderthePlansDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": {
     "auth_ref": [
      "r462"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period",
        "terseLabel": "Granted (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleofAllTransactionsRelatedtoPerformanceShareUnitsUnderthePlansDetails",
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleofAllTransactionsRelatedtoRestrictedShareUnitsUnderthePlansDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r462"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Granted (in usd per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleofAllTransactionsRelatedtoPerformanceShareUnitsUnderthePlansDetails",
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleofAllTransactionsRelatedtoRestrictedShareUnitsUnderthePlansDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber": {
     "auth_ref": [
      "r461"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number",
        "periodEndLabel": "Nonvested at end of period (in shares)",
        "periodStartLabel": "Nonvested at beginning of period (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleofAllTransactionsRelatedtoPerformanceShareUnitsUnderthePlansDetails",
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleofAllTransactionsRelatedtoRestrictedShareUnitsUnderthePlansDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]",
        "terseLabel": "Restricted Share Units",
        "verboseLabel": "Performance Share Units"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleofAllTransactionsRelatedtoPerformanceShareUnitsUnderthePlansDetails",
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleofAllTransactionsRelatedtoRestrictedShareUnitsUnderthePlansDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r461"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value",
        "periodEndLabel": "Nonvested at end of period (in usd per share)",
        "periodStartLabel": "Nonvested at beginning of period (in usd per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleofAllTransactionsRelatedtoPerformanceShareUnitsUnderthePlansDetails",
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleofAllTransactionsRelatedtoRestrictedShareUnitsUnderthePlansDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]",
        "terseLabel": "Weighted-Average Grant Date Fair Value per Share",
        "verboseLabel": "Weighted-Average Grant Date Fair Value per Share"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleofAllTransactionsRelatedtoPerformanceShareUnitsUnderthePlansDetails",
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleofAllTransactionsRelatedtoRestrictedShareUnitsUnderthePlansDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod": {
     "auth_ref": [
      "r463"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period",
        "negatedTerseLabel": "Vested (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleofAllTransactionsRelatedtoPerformanceShareUnitsUnderthePlansDetails",
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleofAllTransactionsRelatedtoRestrictedShareUnitsUnderthePlansDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue": {
     "auth_ref": [
      "r467"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of share-based awards for which the grantee gained the right by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value",
        "terseLabel": "Total fair value of shares vested during the year"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ShareBasedCompensationAdditionalDataRelatedtoPerformanceShareUnitActivityDetails",
      "http://www.cardinal.com/role/ShareBasedCompensationAdditionalDataRelatedtoRestrictedShareUnitActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r463"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Vested (in usd per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleofAllTransactionsRelatedtoPerformanceShareUnitsUnderthePlansDetails",
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleofAllTransactionsRelatedtoRestrictedShareUnitsUnderthePlansDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ShareBasedCompensationAdditionalDataRelatedtoPerformanceShareUnitActivityDetails",
      "http://www.cardinal.com/role/ShareBasedCompensationAdditionalDataRelatedtoRestrictedShareUnitActivityDetails",
      "http://www.cardinal.com/role/ShareBasedCompensationNarrativeDetails",
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleofAdditionalDataRelatedtoStockOptionsDetails",
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleofAllTransactionsRelatedtoPerformanceShareUnitsUnderthePlansDetails",
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleofAllTransactionsRelatedtoRestrictedShareUnitsUnderthePlansDetails",
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleofRemainingStockOptionPlanDataDetails",
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleofTotalShareBasedCompensationExpensebyTypeofAwardDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant": {
     "auth_ref": [
      "r475"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant",
        "terseLabel": "Number of shares available for grant"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber": {
     "auth_ref": [
      "r456"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number",
        "terseLabel": "Exercisable at end of period (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleofAllStockOptionTransactionsUnderthePlansDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice": {
     "auth_ref": [
      "r456"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price",
        "terseLabel": "Exercisable at end of period (in usd per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleofAllStockOptionTransactionsUnderthePlansDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue": {
     "auth_ref": [
      "r467"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value",
        "terseLabel": "Aggregate intrinsic value of exercised options"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleofAdditionalDataRelatedtoStockOptionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod": {
     "auth_ref": [
      "r459"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For presentations that combine terminations, the number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan or that expired.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period",
        "negatedTerseLabel": "Canceled and forfeited (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleofAllStockOptionTransactionsUnderthePlansDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [
      "r459"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price of options that were either forfeited or expired.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price",
        "terseLabel": "Canceled and forfeited (in usd per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleofAllStockOptionTransactionsUnderthePlansDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gross number of share options (or share units) granted during the period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross",
        "terseLabel": "Granted (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ShareBasedCompensationNarrativeDetails",
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleofAllStockOptionTransactionsUnderthePlansDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r466"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Weighted-average grant date fair value per stock option (in usd per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleofAdditionalDataRelatedtoStockOptionsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue": {
     "auth_ref": [
      "r475"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value",
        "terseLabel": "Aggregate intrinsic value of outstanding options at period end"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleofAdditionalDataRelatedtoStockOptionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": {
     "auth_ref": [
      "r455",
      "r475"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of options outstanding, including both vested and non-vested options.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number",
        "periodEndLabel": "Outstanding at end of period (in shares)",
        "periodStartLabel": "Outstanding at beginning of period (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleofAllStockOptionTransactionsUnderthePlansDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]",
        "terseLabel": "Stock Options"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleofAllStockOptionTransactionsUnderthePlansDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": {
     "auth_ref": [
      "r454"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price",
        "periodEndLabel": "Outstanding at end of period (in usd per share)",
        "periodStartLabel": "Outstanding at beginning of period (in usd per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleofAllStockOptionTransactionsUnderthePlansDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]",
        "terseLabel": "Weighted-Average Exercise Price per Common Share"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleofAllStockOptionTransactionsUnderthePlansDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "auth_ref": [
      "r445",
      "r450"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Award under share-based payment arrangement.",
        "label": "Award Type [Domain]",
        "terseLabel": "Award Type [Domain]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ShareBasedCompensationAdditionalDataRelatedtoPerformanceShareUnitActivityDetails",
      "http://www.cardinal.com/role/ShareBasedCompensationAdditionalDataRelatedtoRestrictedShareUnitActivityDetails",
      "http://www.cardinal.com/role/ShareBasedCompensationNarrativeDetails",
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleofAdditionalDataRelatedtoStockOptionsDetails",
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleofAllTransactionsRelatedtoPerformanceShareUnitsUnderthePlansDetails",
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleofAllTransactionsRelatedtoRestrictedShareUnitsUnderthePlansDetails",
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleofRemainingStockOptionPlanDataDetails",
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleofTotalShareBasedCompensationExpensebyTypeofAwardDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares.",
        "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price",
        "terseLabel": "Exercised (in usd per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleofAllStockOptionTransactionsUnderthePlansDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.",
        "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price",
        "terseLabel": "Granted (in usd per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleofAllStockOptionTransactionsUnderthePlansDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy": {
     "auth_ref": [
      "r448",
      "r451"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.",
        "label": "Share-based Payment Arrangement [Policy Text Block]",
        "terseLabel": "Share-Based Compensation"
       }
      }
     },
     "localname": "ShareBasedCompensationOptionAndIncentivePlansPolicy",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage": {
     "auth_ref": [
      "r449"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of vesting of award under share-based payment arrangement.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage",
        "terseLabel": "Target performance goal (as a percent)"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ShareBasedCompensationAdditionalDataRelatedtoPerformanceShareUnitActivityDetails",
      "http://www.cardinal.com/role/ShareBasedCompensationNarrativeDetails",
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleofAllTransactionsRelatedtoPerformanceShareUnitsUnderthePlansDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1": {
     "auth_ref": [
      "r475"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value",
        "terseLabel": "Aggregate intrinsic value of exercisable options at period end"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleofAdditionalDataRelatedtoStockOptionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1": {
     "auth_ref": [
      "r475"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term",
        "terseLabel": "Weighted-average remaining contractual life of exercisable options"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleofRemainingStockOptionPlanDataDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2": {
     "auth_ref": [
      "r469"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term",
        "verboseLabel": "Weighted-average remaining contractual life of outstanding options"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleofRemainingStockOptionPlanDataDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1": {
     "auth_ref": [
      "r452"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of options vested. Excludes equity instruments other than options, for example, but not limited to, share units, stock appreciation rights, restricted stock.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value",
        "terseLabel": "Total fair value of shares vested during the year"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleofAdditionalDataRelatedtoStockOptionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShippingAndHandlingMember": {
     "auth_ref": [
      "r428"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Packing and transport of product.",
        "label": "Shipping and Handling [Member]",
        "terseLabel": "Shipping and Handling [Member]"
       }
      }
     },
     "localname": "ShippingAndHandlingMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeShippingandHandlingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_StateAndLocalJurisdictionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Designated tax department of a state or local government entitled to levy and collect income taxes from the entity.",
        "label": "State and Local Jurisdiction [Member]",
        "terseLabel": "State and Local"
       }
      }
     },
     "localname": "StateAndLocalJurisdictionMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_StatementBusinessSegmentsAxis": {
     "auth_ref": [
      "r9",
      "r204",
      "r208",
      "r209",
      "r210",
      "r211",
      "r212",
      "r213",
      "r214",
      "r215",
      "r216",
      "r217",
      "r218",
      "r219",
      "r222",
      "r223",
      "r224",
      "r225",
      "r227",
      "r228",
      "r229",
      "r230",
      "r231",
      "r233",
      "r242",
      "r277",
      "r301",
      "r309",
      "r319",
      "r736"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by business segments.",
        "label": "Segments [Axis]",
        "terseLabel": "Segments [Axis]",
        "verboseLabel": "Operating and Reportable Segment"
       }
      }
     },
     "localname": "StatementBusinessSegmentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesRevenueandGrossTradeReceivablesPercentagebyMajorCustomersDetails",
      "http://www.cardinal.com/role/GoodwillandOtherIntangibleAssetsNarrativeDetails",
      "http://www.cardinal.com/role/GoodwillandOtherIntangibleAssetsScheduleofGoodwillbyReportableSegmentDetails",
      "http://www.cardinal.com/role/SegmentInformationAssetsbyReportableSegmentDetails",
      "http://www.cardinal.com/role/SegmentInformationDepreciationandAmortizationandAdditionstoPropertyandEquipmentbyReportableSegmentDetails",
      "http://www.cardinal.com/role/SegmentInformationRevenuebyReportableSegmentDetails",
      "http://www.cardinal.com/role/SegmentInformationSegmentProfitbyReportableSegmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementClassOfStockAxis": {
     "auth_ref": [
      "r41",
      "r42",
      "r43",
      "r136",
      "r139",
      "r172",
      "r173",
      "r174",
      "r176",
      "r178",
      "r188",
      "r189",
      "r190",
      "r255",
      "r343",
      "r348",
      "r349",
      "r350",
      "r356",
      "r357",
      "r400",
      "r401",
      "r405",
      "r409",
      "r416",
      "r626",
      "r781"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by the different classes of stock of the entity.",
        "label": "Class of Stock [Axis]",
        "terseLabel": "Class of Stock [Axis]"
       }
      }
     },
     "localname": "StatementClassOfStockAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ShareholdersEquityNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "auth_ref": [
      "r2",
      "r69",
      "r94",
      "r95",
      "r96",
      "r154",
      "r155",
      "r156",
      "r158",
      "r166",
      "r168",
      "r187",
      "r259",
      "r416",
      "r423",
      "r480",
      "r481",
      "r482",
      "r523",
      "r524",
      "r608",
      "r636",
      "r637",
      "r638",
      "r639",
      "r640",
      "r642",
      "r744",
      "r745",
      "r746",
      "r809"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by component of equity.",
        "label": "Equity Components [Axis]",
        "terseLabel": "Equity Components [Axis]"
       }
      }
     },
     "localname": "StatementEquityComponentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedStatementsofShareholdersEquity",
      "http://www.cardinal.com/role/ShareholdersEquityChangesintheAccumulatedOtherComprehensiveIncomeLossDetails",
      "http://www.cardinal.com/role/ShareholdersEquityNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Statement [Line Items]",
        "terseLabel": "Statement [Line Items]"
       }
      }
     },
     "localname": "StatementLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedStatementsofShareholdersEquity",
      "http://www.cardinal.com/role/LeasesDetails",
      "http://www.cardinal.com/role/LeasesScheduleofFutureLeasePaymentsDetails",
      "http://www.cardinal.com/role/LeasesSupplementalBalanceSheetInformationDetails",
      "http://www.cardinal.com/role/LeasesSupplementalCashFlowInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]",
        "terseLabel": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "localname": "StatementOfCashFlowsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Financial Position [Abstract]",
        "terseLabel": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "localname": "StatementOfFinancialPositionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Comprehensive Income [Abstract]",
        "terseLabel": "Statement of Comprehensive Income [Abstract]"
       }
      }
     },
     "localname": "StatementOfIncomeAndComprehensiveIncomeAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Stockholders' Equity [Abstract]",
        "terseLabel": "Statement of Stockholders' Equity [Abstract]"
       }
      }
     },
     "localname": "StatementOfStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementTable": {
     "auth_ref": [
      "r154",
      "r155",
      "r156",
      "r187",
      "r685"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.",
        "label": "Statement [Table]",
        "terseLabel": "Statement [Table]"
       }
      }
     },
     "localname": "StatementTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedStatementsofShareholdersEquity",
      "http://www.cardinal.com/role/LeasesDetails",
      "http://www.cardinal.com/role/LeasesScheduleofFutureLeasePaymentsDetails",
      "http://www.cardinal.com/role/LeasesSupplementalBalanceSheetInformationDetails",
      "http://www.cardinal.com/role/LeasesSupplementalCashFlowInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation": {
     "auth_ref": [
      "r42",
      "r43",
      "r416",
      "r423"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP).",
        "label": "Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture",
        "terseLabel": "Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedStatementsofShareholdersEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": {
     "auth_ref": [
      "r42",
      "r43",
      "r416",
      "r423",
      "r457"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of share options (or share units) exercised during the current period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period",
        "negatedTerseLabel": "Exercised (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleofAllStockOptionTransactionsUnderthePlansDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation": {
     "auth_ref": [
      "r42",
      "r43",
      "r423",
      "r447",
      "r466"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).",
        "label": "Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture",
        "terseLabel": "Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedStatementsofShareholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquity": {
     "auth_ref": [
      "r43",
      "r48",
      "r49",
      "r139",
      "r247",
      "r255",
      "r626",
      "r671"
     ],
     "calculation": {
      "http://www.cardinal.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.",
        "label": "Stockholders' Equity Attributable to Parent",
        "totalLabel": "Total Cardinal Health, Inc. shareholders' equity"
       }
      }
     },
     "localname": "StockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders' Equity Attributable to Parent [Abstract]",
        "terseLabel": "Shareholders\u2019 equity:"
       }
      }
     },
     "localname": "StockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r2",
      "r3",
      "r95",
      "r139",
      "r154",
      "r155",
      "r156",
      "r158",
      "r166",
      "r255",
      "r259",
      "r423",
      "r480",
      "r481",
      "r482",
      "r523",
      "r524",
      "r543",
      "r544",
      "r557",
      "r608",
      "r626",
      "r636",
      "r637",
      "r642",
      "r745",
      "r746",
      "r809"
     ],
     "calculation": {
      "http://www.cardinal.com/role/ConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.",
        "label": "Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest",
        "periodEndLabel": "Balance at end of period",
        "periodStartLabel": "Balance at beginning of period",
        "totalLabel": "Total shareholders\u2019 equity"
       }
      }
     },
     "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedBalanceSheets",
      "http://www.cardinal.com/role/ConsolidatedStatementsofShareholdersEquity",
      "http://www.cardinal.com/role/ShareholdersEquityChangesintheAccumulatedOtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityNoteDisclosureTextBlock": {
     "auth_ref": [
      "r137",
      "r401",
      "r404",
      "r405",
      "r406",
      "r407",
      "r408",
      "r409",
      "r410",
      "r411",
      "r412",
      "r413",
      "r415",
      "r423",
      "r426"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.",
        "label": "Stockholders' Equity Note Disclosure [Text Block]",
        "terseLabel": "Shareholders' Equity"
       }
      }
     },
     "localname": "StockholdersEquityNoteDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ShareholdersEquity"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_StockholdersEquityOther": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents movements included in the statement of changes in stockholders' equity which are not separately disclosed or provided for elsewhere in the taxonomy.",
        "label": "Stockholders' Equity, Other",
        "negatedTerseLabel": "Other"
       }
      }
     },
     "localname": "StockholdersEquityOther",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedStatementsofShareholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityOtherShares": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of increase (decrease) in shares of stock classified as other.",
        "label": "Stockholders' Equity, Other Shares",
        "terseLabel": "Stockholders' Equity, Other Shares"
       }
      }
     },
     "localname": "StockholdersEquityOtherShares",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedStatementsofShareholdersEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_SubsegmentsAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by business subsegments.",
        "label": "Subsegments [Axis]",
        "terseLabel": "Subsegments [Axis]"
       }
      }
     },
     "localname": "SubsegmentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/SegmentInformationRevenuebyReportableSegmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsegmentsConsolidationItemsAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by subsegments, eliminations and reconciling items used in consolidating a reportable segment and its subsegments.",
        "label": "Subsegments Consolidation Items [Axis]",
        "terseLabel": "Subsegments Consolidation Items [Axis]"
       }
      }
     },
     "localname": "SubsegmentsConsolidationItemsAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/SegmentInformationRevenuebyReportableSegmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsegmentsConsolidationItemsDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Subsegments, eliminations and reconciling items used in consolidating a reportable segment and its subsegments.",
        "label": "Subsegments Consolidation Items [Domain]",
        "terseLabel": "Subsegments Consolidation Items [Domain]"
       }
      }
     },
     "localname": "SubsegmentsConsolidationItemsDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/SegmentInformationRevenuebyReportableSegmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SubsegmentsDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Divisions of a component of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.",
        "label": "Subsegments [Domain]",
        "terseLabel": "Subsegments [Domain]"
       }
      }
     },
     "localname": "SubsegmentsDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/SegmentInformationRevenuebyReportableSegmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SubsequentEventMember": {
     "auth_ref": [
      "r643",
      "r672"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event [Member]",
        "terseLabel": "Subsequent Event"
       }
      }
     },
     "localname": "SubsequentEventMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CommitmentsContingentLiabilitiesandLitigationDetails",
      "http://www.cardinal.com/role/DivestituresandAcquisitionsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SubsequentEventTypeAxis": {
     "auth_ref": [
      "r643",
      "r672"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Axis]",
        "terseLabel": "Subsequent Event Type [Axis]"
       }
      }
     },
     "localname": "SubsequentEventTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CommitmentsContingentLiabilitiesandLitigationDetails",
      "http://www.cardinal.com/role/DivestituresandAcquisitionsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventTypeDomain": {
     "auth_ref": [
      "r643",
      "r672"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Domain]",
        "terseLabel": "Subsequent Event Type [Domain]"
       }
      }
     },
     "localname": "SubsequentEventTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CommitmentsContingentLiabilitiesandLitigationDetails",
      "http://www.cardinal.com/role/DivestituresandAcquisitionsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SupplementalCashFlowInformationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Supplemental Cash Flow Information [Abstract]",
        "terseLabel": "Supplemental Information:"
       }
      }
     },
     "localname": "SupplementalCashFlowInformationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TaxCreditCarryforwardAmount": {
     "auth_ref": [
      "r513"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of the tax credit carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.",
        "label": "Tax Credit Carryforward, Amount",
        "terseLabel": "Tax credit carryforwards"
       }
      }
     },
     "localname": "TaxCreditCarryforwardAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TaxCreditCarryforwardLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Tax Credit Carryforward [Line Items]",
        "terseLabel": "Income Taxes"
       }
      }
     },
     "localname": "TaxCreditCarryforwardLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TaxCreditCarryforwardTable": {
     "auth_ref": [
      "r514"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A listing of tax credit carryforwards available to reduce future taxable income including descriptions, amounts, expiration dates, limitations on use and the related deferred tax assets and valuation allowances.",
        "label": "Tax Credit Carryforward [Table]",
        "terseLabel": "Income Taxes"
       }
      }
     },
     "localname": "TaxCreditCarryforwardTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TaxCutsAndJobsActOf2017TransitionTaxForAccumulatedForeignEarningsIncomeTaxExpense": {
     "auth_ref": [
      "r519"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income tax expense from transition tax on accumulated earnings of controlled foreign corporation deemed repatriated pursuant to Tax Cuts and Jobs Act.",
        "label": "Tax Cuts and Jobs Act, Transition Tax for Accumulated Foreign Earnings, Income Tax Expense",
        "terseLabel": "Tax Cuts and Jobs Act, Transition Tax for Accumulated Foreign Earnings, Income Tax Expense"
       }
      }
     },
     "localname": "TaxCutsAndJobsActOf2017TransitionTaxForAccumulatedForeignEarningsIncomeTaxExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TaxPeriodAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information about the period subject to enacted tax laws.",
        "label": "Tax Period [Axis]",
        "terseLabel": "Tax Period [Axis]"
       }
      }
     },
     "localname": "TaxPeriodAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/IncomeTaxesScheduleofUnrecognizedTaxBenefitsRollForwardDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TaxPeriodDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identified tax period.",
        "label": "Tax Period [Domain]",
        "terseLabel": "Tax Period [Domain]"
       }
      }
     },
     "localname": "TaxPeriodDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/IncomeTaxesScheduleofUnrecognizedTaxBenefitsRollForwardDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TreasuryStockAcquiredAverageCostPerShare": {
     "auth_ref": [
      "r424"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total cost of shares repurchased divided by the total number of shares repurchased.",
        "label": "Treasury Stock Acquired, Average Cost Per Share",
        "terseLabel": "Treasury shares acquired, average price per share (in usd per share)"
       }
      }
     },
     "localname": "TreasuryStockAcquiredAverageCostPerShare",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ShareholdersEquityNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_TreasuryStockMember": {
     "auth_ref": [
      "r68",
      "r424"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Shares of an entity that have been repurchased by the entity. This stock has no voting rights and receives no dividends. Note that treasury stock may be recorded at its total cost or separately as par (or stated) value and additional paid in capital. Classified within stockholders' equity if nonredeemable or redeemable solely at the option of the issuer. Classified within temporary equity if redemption is outside the control of the issuer.",
        "label": "Treasury Stock [Member]",
        "terseLabel": "Treasury Shares"
       }
      }
     },
     "localname": "TreasuryStockMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedStatementsofShareholdersEquity",
      "http://www.cardinal.com/role/ShareholdersEquityNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TreasuryStockShares": {
     "auth_ref": [
      "r68",
      "r424"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of common and preferred shares that were previously issued and that were repurchased by the issuing entity and held in treasury on the financial statement date. This stock has no voting rights and receives no dividends.",
        "label": "Treasury Stock, Shares",
        "negatedPeriodEndLabel": "Treasury, balance at end of period (in shares)",
        "negatedPeriodStartLabel": "Treasury, balance at beginning of period (in shares)",
        "terseLabel": "Common shares in treasury"
       }
      }
     },
     "localname": "TreasuryStockShares",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedBalanceSheets",
      "http://www.cardinal.com/role/ConsolidatedStatementsofShareholdersEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_TreasuryStockSharesAcquired": {
     "auth_ref": [
      "r43",
      "r416",
      "r423"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares that have been repurchased during the period and are being held in treasury.",
        "label": "Treasury Stock, Shares, Acquired",
        "negatedLabel": "Treasury shares acquired (in shares)",
        "terseLabel": "Treasury Stock, Shares, Acquired"
       }
      }
     },
     "localname": "TreasuryStockSharesAcquired",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedStatementsofShareholdersEquity",
      "http://www.cardinal.com/role/ShareholdersEquityNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_TreasuryStockValue": {
     "auth_ref": [
      "r68",
      "r424",
      "r425"
     ],
     "calculation": {
      "http://www.cardinal.com/role/ConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury.",
        "label": "Treasury Stock, Value",
        "negatedLabel": "Common shares in treasury, at cost: 36 million shares and 34 million shares at June 30, 2021 and 2020, respectively",
        "negatedPeriodEndLabel": "Treasury, balance at end of period",
        "negatedPeriodStartLabel": "Treasury, balance at beginning of period"
       }
      }
     },
     "localname": "TreasuryStockValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedBalanceSheets",
      "http://www.cardinal.com/role/ConsolidatedStatementsofShareholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TreasuryStockValueAcquiredCostMethod": {
     "auth_ref": [
      "r416",
      "r423",
      "r424"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity impact of the cost of common and preferred stock that were repurchased during the period. Recorded using the cost method.",
        "label": "Treasury Stock, Value, Acquired, Cost Method",
        "negatedTerseLabel": "Share repurchase program activity",
        "terseLabel": "Treasury shares acquired"
       }
      }
     },
     "localname": "TreasuryStockValueAcquiredCostMethod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedStatementsofShareholdersEquity",
      "http://www.cardinal.com/role/ShareholdersEquityNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TypeOfAdoptionMember": {
     "auth_ref": [
      "r0",
      "r1",
      "r2",
      "r3",
      "r4",
      "r157",
      "r158",
      "r159",
      "r160",
      "r169",
      "r251",
      "r252",
      "r256",
      "r257",
      "r258",
      "r259",
      "r260",
      "r261",
      "r342",
      "r476",
      "r477",
      "r478",
      "r479",
      "r480",
      "r481",
      "r482",
      "r483",
      "r521",
      "r522",
      "r523",
      "r524",
      "r600",
      "r601",
      "r602",
      "r603",
      "r604",
      "r605",
      "r606",
      "r607",
      "r608",
      "r609",
      "r610",
      "r627",
      "r628",
      "r629",
      "r630",
      "r631",
      "r632",
      "r633",
      "r634",
      "r668",
      "r687",
      "r688",
      "r689",
      "r742",
      "r743",
      "r744",
      "r745",
      "r746",
      "r747",
      "r748",
      "r749",
      "r750",
      "r751",
      "r752",
      "r753",
      "r805",
      "r806",
      "r807",
      "r808",
      "r809"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amendment to accounting standards.",
        "label": "Accounting Standards Update [Domain]",
        "terseLabel": "Accounting Standards Update [Domain]"
       }
      }
     },
     "localname": "TypeOfAdoptionMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/LeasesSupplementalCashFlowInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TypeOfRestructuringDomain": {
     "auth_ref": [
      "r306",
      "r307",
      "r317",
      "r318"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification of the types of restructuring costs.",
        "label": "Type of Restructuring [Domain]",
        "terseLabel": "Type of Restructuring [Domain]"
       }
      }
     },
     "localname": "TypeOfRestructuringDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/RestructuringandEmployeeSeveranceLiabilitiesAssociatedwithRestructuringandEmployeeSeveranceActivitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_UnrecognizedTaxBenefits": {
     "auth_ref": [
      "r487",
      "r498"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of unrecognized tax benefits.",
        "label": "Unrecognized Tax Benefits",
        "periodEndLabel": "Balance at end of fiscal year",
        "periodStartLabel": "Balance at beginning of fiscal year",
        "terseLabel": "Unrecognized tax benefits"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefits",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/IncomeTaxesNarrativeDetails",
      "http://www.cardinal.com/role/IncomeTaxesScheduleofUnrecognizedTaxBenefitsRollForwardDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions": {
     "auth_ref": [
      "r499"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease in unrecognized tax benefits resulting from tax positions taken in prior period tax returns.",
        "label": "Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions",
        "negatedLabel": "Reductions for tax positions of prior years"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/IncomeTaxesScheduleofUnrecognizedTaxBenefitsRollForwardDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities": {
     "auth_ref": [
      "r501"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease in unrecognized tax benefits resulting from settlements with taxing authorities.",
        "label": "Unrecognized Tax Benefits, Decrease Resulting from Settlements with Taxing Authorities",
        "negatedLabel": "Settlements with tax authorities",
        "terseLabel": "Unrecognized Tax Benefits, Decrease Resulting from Settlements with Taxing Authorities"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/IncomeTaxesNarrativeDetails",
      "http://www.cardinal.com/role/IncomeTaxesScheduleofUnrecognizedTaxBenefitsRollForwardDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued": {
     "auth_ref": [
      "r494"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount accrued for interest on an underpayment of income taxes and penalties related to a tax position claimed or expected to be claimed in the tax return.",
        "label": "Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued",
        "terseLabel": "Unrecognized tax benefits, interest and penalties accrued"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense": {
     "auth_ref": [
      "r494"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense for interest on an underpayment of income taxes and penalties related to a tax position claimed or expected to be claimed in the tax return.",
        "label": "Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense",
        "terseLabel": "Unrecognized tax benefits, interest and penalties"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions": {
     "auth_ref": [
      "r500"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in unrecognized tax benefits resulting from tax positions that have been or will be taken in current period tax return.",
        "label": "Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions",
        "terseLabel": "Additions for tax positions of the current year"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/IncomeTaxesScheduleofUnrecognizedTaxBenefitsRollForwardDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions": {
     "auth_ref": [
      "r499"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in unrecognized tax benefits resulting from tax positions taken in prior period tax returns.",
        "label": "Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions",
        "terseLabel": "Additions for tax positions of prior years",
        "verboseLabel": "Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/IncomeTaxesNarrativeDetails",
      "http://www.cardinal.com/role/IncomeTaxesScheduleofUnrecognizedTaxBenefitsRollForwardDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations": {
     "auth_ref": [
      "r502"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease in unrecognized tax benefits resulting from lapses of applicable statutes of limitations.",
        "label": "Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations",
        "negatedTerseLabel": "Expiration of the statute of limitations",
        "terseLabel": "Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/IncomeTaxesNarrativeDetails",
      "http://www.cardinal.com/role/IncomeTaxesScheduleofUnrecognizedTaxBenefitsRollForwardDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate": {
     "auth_ref": [
      "r503"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The total amount of unrecognized tax benefits that, if recognized, would affect the effective tax rate.",
        "label": "Unrecognized Tax Benefits that Would Impact Effective Tax Rate",
        "terseLabel": "Unrecognized tax benefits that would impact effective tax rate"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UseOfEstimates": {
     "auth_ref": [
      "r191",
      "r192",
      "r194",
      "r195",
      "r201",
      "r202",
      "r203"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.",
        "label": "Use of Estimates, Policy [Policy Text Block]",
        "terseLabel": "Use of Estimates"
       }
      }
     },
     "localname": "UseOfEstimates",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ValuationAllowancesAndReservesBalance": {
     "auth_ref": [
      "r145",
      "r151"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of valuation and qualifying accounts and reserves.",
        "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves, Amount",
        "terseLabel": "SEC Schedule, 12-09, Valuation Allowances and Reserves, Amount"
       }
      }
     },
     "localname": "ValuationAllowancesAndReservesBalance",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeReceivablesDetails",
      "http://www.cardinal.com/role/ScheduleIIValuationsandQualifyingAccountsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense": {
     "auth_ref": [
      "r148"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in valuation and qualifying accounts and reserves from charge to cost and expense.",
        "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves, Additions, Charge to Cost and Expense",
        "terseLabel": "SEC Schedule, 12-09, Valuation Allowances and Reserves, Additions, Charge to Cost and Expense"
       }
      }
     },
     "localname": "ValuationAllowancesAndReservesChargedToCostAndExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ScheduleIIValuationsandQualifyingAccountsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ValuationAllowancesAndReservesChargedToOtherAccounts": {
     "auth_ref": [
      "r149"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in valuation and qualifying accounts and reserves from charge to accounts other than cost and expense.",
        "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves, Additions, Charge to Other Account",
        "terseLabel": "SEC Schedule, 12-09, Valuation Allowances and Reserves, Additions, Charge to Other Account"
       }
      }
     },
     "localname": "ValuationAllowancesAndReservesChargedToOtherAccounts",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ScheduleIIValuationsandQualifyingAccountsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ValuationAllowancesAndReservesDeductions": {
     "auth_ref": [
      "r150"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease in valuation and qualifying accounts and reserves.",
        "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves, Deduction",
        "terseLabel": "SEC Schedule, 12-09, Valuation Allowances and Reserves, Deduction"
       }
      }
     },
     "localname": "ValuationAllowancesAndReservesDeductions",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ScheduleIIValuationsandQualifyingAccountsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ValuationAllowancesAndReservesDomain": {
     "auth_ref": [
      "r145",
      "r146",
      "r147",
      "r150",
      "r151"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Valuation and qualifying accounts and reserves.",
        "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves [Domain]",
        "terseLabel": "SEC Schedule, 12-09, Valuation Allowances and Reserves [Domain]"
       }
      }
     },
     "localname": "ValuationAllowancesAndReservesDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeReceivablesDetails",
      "http://www.cardinal.com/role/ScheduleIIValuationsandQualifyingAccountsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ValuationAllowancesAndReservesRecoveries": {
     "auth_ref": [
      "r149"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in valuation and qualifying accounts and reserves from recovery of amount previously written off or reestablishment of reserve previously utilized.",
        "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves, Addition, Recovery",
        "terseLabel": "SEC Schedule, 12-09, Valuation Allowances and Reserves, Addition, Recovery"
       }
      }
     },
     "localname": "ValuationAllowancesAndReservesRecoveries",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ScheduleIIValuationsandQualifyingAccountsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ValuationAllowancesAndReservesTypeAxis": {
     "auth_ref": [
      "r145",
      "r146",
      "r147",
      "r150",
      "r151"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by valuation and qualifying accounts and reserves.",
        "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves Type [Axis]",
        "terseLabel": "SEC Schedule, 12-09, Valuation Allowances and Reserves Type [Axis]"
       }
      }
     },
     "localname": "ValuationAllowancesAndReservesTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeReceivablesDetails",
      "http://www.cardinal.com/role/ScheduleIIValuationsandQualifyingAccountsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_VariableLeaseCost": {
     "auth_ref": [
      "r660",
      "r667"
     ],
     "calculation": {
      "http://www.cardinal.com/role/LeasesScheduleofLeaseCostsDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_LeaseCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of variable lease cost, excluded from lease liability, recognized when obligation for payment is incurred for finance and operating leases.",
        "label": "Variable Lease, Cost",
        "terseLabel": "Variable lease cost"
       }
      }
     },
     "localname": "VariableLeaseCost",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/LeasesScheduleofLeaseCostsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment": {
     "auth_ref": [
      "r178"
     ],
     "calculation": {
      "http://www.cardinal.com/role/EarningsPerShareAttributabletoCardinalHealthIncReconciliationofCommonSharesUsedtoComputeBasicandDilutedEPSDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The sum of dilutive potential common shares or units used in the calculation of the diluted per-share or per-unit computation.",
        "label": "Weighted Average Number Diluted Shares Outstanding Adjustment",
        "terseLabel": "Employee stock options, restricted share units, and performance share units (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberDilutedSharesOutstandingAdjustment",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/EarningsPerShareAttributabletoCardinalHealthIncReconciliationofCommonSharesUsedtoComputeBasicandDilutedEPSDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Incremental Weighted Average Shares Attributable to Dilutive Effect [Abstract]",
        "terseLabel": "Effect of dilutive securities:"
       }
      }
     },
     "localname": "WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/EarningsPerShareAttributabletoCardinalHealthIncReconciliationofCommonSharesUsedtoComputeBasicandDilutedEPSDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "auth_ref": [
      "r171",
      "r178"
     ],
     "calculation": {
      "http://www.cardinal.com/role/EarningsPerShareAttributabletoCardinalHealthIncReconciliationofCommonSharesUsedtoComputeBasicandDilutedEPSDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.",
        "label": "Weighted Average Number of Shares Outstanding, Diluted",
        "terseLabel": "Diluted (in shares)",
        "totalLabel": "Weighted-average common shares\u2013diluted (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedStatementsofEarnings",
      "http://www.cardinal.com/role/EarningsPerShareAttributabletoCardinalHealthIncReconciliationofCommonSharesUsedtoComputeBasicandDilutedEPSDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "auth_ref": [
      "r170",
      "r178"
     ],
     "calculation": {
      "http://www.cardinal.com/role/EarningsPerShareAttributabletoCardinalHealthIncReconciliationofCommonSharesUsedtoComputeBasicandDilutedEPSDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.",
        "label": "Weighted Average Number of Shares Outstanding, Basic",
        "terseLabel": "Basic (in shares)",
        "verboseLabel": "Weighted-average common shares\u2013basic (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedStatementsofEarnings",
      "http://www.cardinal.com/role/EarningsPerShareAttributabletoCardinalHealthIncReconciliationofCommonSharesUsedtoComputeBasicandDilutedEPSDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average Number of Shares Outstanding Reconciliation [Abstract]",
        "terseLabel": "Weighted-average number of common shares outstanding:"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedStatementsofEarnings"
     ],
     "xbrltype": "stringItemType"
    }
   },
   "unitCount": 12
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "105",
   "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695"
  },
  "r1": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "105",
   "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695"
  },
  "r10": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760"
  },
  "r100": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(12))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r101": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(20))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r102": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(21))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r103": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(22))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r104": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(24))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r105": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(25))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r106": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(5))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r107": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(b)(7)(c))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r108": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(b)(9)(a))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r109": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.1,2)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r11": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=d3e1474-107760"
  },
  "r110": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.2(a),(d))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r111": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.3)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r112": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.4)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r113": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.9)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r114": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3179-108585"
  },
  "r115": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3213-108585"
  },
  "r116": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3213-108585"
  },
  "r117": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3291-108585"
  },
  "r118": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3291-108585"
  },
  "r119": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3367-108585"
  },
  "r12": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721659-107760"
  },
  "r120": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3367-108585"
  },
  "r121": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3000-108585"
  },
  "r122": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3521-108585"
  },
  "r123": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585"
  },
  "r124": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585"
  },
  "r125": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585"
  },
  "r126": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585"
  },
  "r127": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585"
  },
  "r128": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3044-108585"
  },
  "r129": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4273-108586"
  },
  "r13": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721663-107760"
  },
  "r130": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4297-108586"
  },
  "r131": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=123372394&loc=d3e18823-107790"
  },
  "r132": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=123372394&loc=d3e18823-107790"
  },
  "r133": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=123372394&loc=d3e18823-107790"
  },
  "r134": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=123372394&loc=d3e18823-107790"
  },
  "r135": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(c))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r136": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(d))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r137": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(e)(1))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r138": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(f))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r139": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r14": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721665-107760"
  },
  "r140": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(1)(Note 1))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r141": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(1))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r142": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(2))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r143": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r144": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-04(a))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690"
  },
  "r145": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09(Column B))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690"
  },
  "r146": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09(Column C(1)))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690"
  },
  "r147": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09(Column C(2)))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690"
  },
  "r148": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09(Column C)(1))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690"
  },
  "r149": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09(Column C)(2))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690"
  },
  "r15": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721671-107760"
  },
  "r150": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09(Column D))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690"
  },
  "r151": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09(Column E))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690"
  },
  "r152": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09)",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690"
  },
  "r153": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "235",
   "URI": "http://asc.fasb.org/topic&trid=2122369"
  },
  "r154": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793"
  },
  "r155": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793"
  },
  "r156": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793"
  },
  "r157": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r158": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r159": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(4)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r16": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721673-107760"
  },
  "r160": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r161": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794"
  },
  "r162": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794"
  },
  "r163": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794"
  },
  "r164": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794"
  },
  "r165": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794"
  },
  "r166": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794"
  },
  "r167": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794"
  },
  "r168": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794"
  },
  "r169": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.M.Q2)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=122038215&loc=d3e31137-122693"
  },
  "r17": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721673-107760"
  },
  "r170": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1448-109256"
  },
  "r171": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1505-109256"
  },
  "r172": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1252-109256"
  },
  "r173": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1278-109256"
  },
  "r174": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "55",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e2626-109256"
  },
  "r175": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256"
  },
  "r176": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256"
  },
  "r177": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1337-109256"
  },
  "r178": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257"
  },
  "r179": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257"
  },
  "r18": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(2)",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721675-107760"
  },
  "r180": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257"
  },
  "r181": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257"
  },
  "r182": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=109243012&loc=SL65017193-207537"
  },
  "r183": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125512782&loc=d3e3842-109258"
  },
  "r184": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "52",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125512782&loc=d3e4984-109258"
  },
  "r185": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "260",
   "URI": "http://asc.fasb.org/topic&trid=2144383"
  },
  "r186": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "270",
   "URI": "http://asc.fasb.org/extlink&oid=124437754&loc=d3e543-108305"
  },
  "r187": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054"
  },
  "r188": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=125520817&loc=d3e70229-108054"
  },
  "r189": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=6373374&loc=d3e70434-108055"
  },
  "r19": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721675-107760"
  },
  "r190": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=6373374&loc=d3e70478-108055"
  },
  "r191": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r192": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r193": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r194": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592"
  },
  "r195": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592"
  },
  "r196": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6327-108592"
  },
  "r197": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592"
  },
  "r198": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592"
  },
  "r199": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6404-108592"
  },
  "r2": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "105",
   "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695"
  },
  "r20": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721675-107760"
  },
  "r200": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6442-108592"
  },
  "r201": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592"
  },
  "r202": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592"
  },
  "r203": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592"
  },
  "r204": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8657-108599"
  },
  "r205": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8672-108599"
  },
  "r206": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8721-108599"
  },
  "r207": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8721-108599"
  },
  "r208": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r209": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r21": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721677-107760"
  },
  "r210": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r211": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r212": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r213": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r214": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r215": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r216": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(j)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r217": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r218": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8813-108599"
  },
  "r219": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8813-108599"
  },
  "r22": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760"
  },
  "r220": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8813-108599"
  },
  "r221": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "26",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8844-108599"
  },
  "r222": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r223": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r224": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r225": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r226": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r227": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8924-108599"
  },
  "r228": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r229": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r23": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r230": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r231": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r232": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r233": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r234": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "34",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8981-108599"
  },
  "r235": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8475-108599"
  },
  "r236": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9031-108599"
  },
  "r237": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599"
  },
  "r238": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599"
  },
  "r239": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "a",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599"
  },
  "r24": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r240": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "b",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599"
  },
  "r241": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599"
  },
  "r242": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "42",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9054-108599"
  },
  "r243": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "280",
   "URI": "http://asc.fasb.org/topic&trid=2134510"
  },
  "r244": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=124259787&loc=d3e4428-111522"
  },
  "r245": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=124259787&loc=d3e4531-111522"
  },
  "r246": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=123577603&loc=d3e5033-111524"
  },
  "r247": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 4.E)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707"
  },
  "r248": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=84159169&loc=d3e10133-111534"
  },
  "r249": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=84159169&loc=d3e10149-111534"
  },
  "r25": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r250": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=84159169&loc=d3e10178-111534"
  },
  "r251": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=124402435&loc=SL124402458-218513"
  },
  "r252": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=124402435&loc=SL124402458-218513"
  },
  "r253": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=109237563&loc=d3e33749-111570"
  },
  "r254": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r255": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r256": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r257": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r258": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r259": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r26": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r260": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(3)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r261": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(4)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r262": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447"
  },
  "r263": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919230-210447"
  },
  "r264": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "330",
   "URI": "http://asc.fasb.org/extlink&oid=116847112&loc=d3e4492-108314"
  },
  "r265": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "330",
   "URI": "http://asc.fasb.org/extlink&oid=116847112&loc=d3e4542-108314"
  },
  "r266": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "330",
   "URI": "http://asc.fasb.org/extlink&oid=116847112&loc=d3e4556-108314"
  },
  "r267": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 5.BB)",
   "Topic": "330",
   "URI": "http://asc.fasb.org/extlink&oid=27011343&loc=d3e100047-122729"
  },
  "r268": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "330",
   "URI": "http://asc.fasb.org/topic&trid=2126998"
  },
  "r269": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=99380562&loc=d3e13770-109266"
  },
  "r27": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r270": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=99380562&loc=d3e13777-109266"
  },
  "r271": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=120320667&loc=SL49117168-202975"
  },
  "r272": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r273": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r274": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r275": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r276": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r277": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r278": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13854-109267"
  },
  "r279": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13854-109267"
  },
  "r28": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6801-107765"
  },
  "r280": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=6388964&loc=d3e16212-109274"
  },
  "r281": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=6388964&loc=d3e16225-109274"
  },
  "r282": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r283": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r284": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r285": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r286": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "((a)(1),(b))",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r287": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r288": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r289": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(2)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r29": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6911-107765"
  },
  "r290": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(3)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r291": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r292": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r293": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b),(d)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16373-109275"
  },
  "r294": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "350",
   "URI": "http://asc.fasb.org/topic&trid=2144416"
  },
  "r295": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r296": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r297": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r298": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r299": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r3": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "105",
   "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695"
  },
  "r30": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6935-107765"
  },
  "r300": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r301": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r302": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r303": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=SL51724579-110230"
  },
  "r304": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=109237686&loc=d3e17752-110868"
  },
  "r305": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r306": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(1)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r307": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r308": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r309": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r31": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e7018-107765"
  },
  "r310": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r311": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r312": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 5.P.3)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140864-122747"
  },
  "r313": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.3)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140864-122747"
  },
  "r314": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140864-122747"
  },
  "r315": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 5.P.4(b)(2))",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r316": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 5.P.4)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r317": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(b)(1))",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r318": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(b)(2))",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r319": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(d))",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r32": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6361739&loc=d3e7789-107766"
  },
  "r320": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(e))",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r321": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r322": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "420",
   "URI": "http://asc.fasb.org/topic&trid=2175745"
  },
  "r323": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "440",
   "URI": "http://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308"
  },
  "r324": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "440",
   "URI": "http://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308"
  },
  "r325": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "440",
   "URI": "http://asc.fasb.org/topic&trid=2144648"
  },
  "r326": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349"
  },
  "r327": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14615-108349"
  },
  "r328": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14394-108349"
  },
  "r329": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349"
  },
  "r33": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r330": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349"
  },
  "r331": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349"
  },
  "r332": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14453-108349"
  },
  "r333": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14472-108349"
  },
  "r334": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349"
  },
  "r335": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349"
  },
  "r336": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "450",
   "URI": "http://asc.fasb.org/topic&trid=2127136"
  },
  "r337": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "460",
   "URI": "http://asc.fasb.org/extlink&oid=124440162&loc=d3e12021-110248"
  },
  "r338": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "460",
   "URI": "http://asc.fasb.org/extlink&oid=124440162&loc=d3e12053-110248"
  },
  "r339": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "460",
   "URI": "http://asc.fasb.org/extlink&oid=123368208&loc=d3e12565-110249"
  },
  "r34": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(13))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r340": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=99376301&loc=SL5988623-112600"
  },
  "r341": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123465755&loc=d3e1835-112601"
  },
  "r342": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S65",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359872&loc=SL124427846-239511"
  },
  "r343": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r344": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r345": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r346": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r347": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r348": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r349": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r35": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(14))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r350": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r351": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r352": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r353": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r354": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r355": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(C))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r356": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r357": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r358": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r359": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r36": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(19))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r360": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r361": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r362": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r363": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r364": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r365": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r366": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(i)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r367": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r368": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611"
  },
  "r369": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611"
  },
  "r37": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(20))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r370": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611"
  },
  "r371": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r372": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r373": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r374": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r375": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r376": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r377": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r378": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r379": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r38": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(22))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r380": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r381": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r382": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
  },
  "r383": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
  },
  "r384": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
  },
  "r385": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
  },
  "r386": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69B",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612"
  },
  "r387": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69C",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495737-112612"
  },
  "r388": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69E",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495743-112612"
  },
  "r389": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495745-112612"
  },
  "r39": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(26)(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r390": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "40",
   "SubTopic": "50",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123467658&loc=d3e12317-112629"
  },
  "r391": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "40",
   "SubTopic": "50",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123467658&loc=d3e12355-112629"
  },
  "r392": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "470",
   "URI": "http://asc.fasb.org/topic&trid=2208564"
  },
  "r393": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(CFRR 211.02)",
   "Topic": "480",
   "URI": "http://asc.fasb.org/extlink&oid=122040564&loc=d3e177068-122764"
  },
  "r394": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(12)(c)",
   "Topic": "480",
   "URI": "http://asc.fasb.org/extlink&oid=122040564&loc=SL6540498-122764"
  },
  "r395": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(16)(c)",
   "Topic": "480",
   "URI": "http://asc.fasb.org/extlink&oid=122040564&loc=SL6540498-122764"
  },
  "r396": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "14",
   "Topic": "480",
   "URI": "http://asc.fasb.org/extlink&oid=122040564&loc=SL6540498-122764"
  },
  "r397": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "15",
   "Topic": "480",
   "URI": "http://asc.fasb.org/extlink&oid=122040564&loc=SL6540498-122764"
  },
  "r398": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=65888546&loc=d3e21300-112643"
  },
  "r399": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21553-112644"
  },
  "r4": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "105",
   "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695"
  },
  "r40": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(26)(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r400": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r401": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r402": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r403": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r404": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r405": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r406": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r407": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r408": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644"
  },
  "r409": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644"
  },
  "r41": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(27))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r410": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644"
  },
  "r411": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496180-112644"
  },
  "r412": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644"
  },
  "r413": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644"
  },
  "r414": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644"
  },
  "r415": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644"
  },
  "r416": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21463-112644"
  },
  "r417": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21475-112644"
  },
  "r418": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21484-112644"
  },
  "r419": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21488-112644"
  },
  "r42": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r420": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21506-112644"
  },
  "r421": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21521-112644"
  },
  "r422": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21538-112644"
  },
  "r423": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770"
  },
  "r424": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=6405813&loc=d3e23239-112655"
  },
  "r425": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=6405834&loc=d3e23315-112656"
  },
  "r426": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "505",
   "URI": "http://asc.fasb.org/topic&trid=2208762"
  },
  "r427": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130545-203045"
  },
  "r428": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r429": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r43": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r430": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r431": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(i)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r432": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(ii)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r433": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r434": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r435": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r436": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(B)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r437": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r438": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(03)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r439": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123450688&loc=d3e4179-114921"
  },
  "r44": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(3)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r440": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "70",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=49170846&loc=d3e28014-114942"
  },
  "r441": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947"
  },
  "r442": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(d)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947"
  },
  "r443": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947"
  },
  "r444": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948"
  },
  "r445": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r446": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r447": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r448": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r449": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r45": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r450": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a),(g)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r451": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b),(f)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r452": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r453": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r454": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r455": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)-(ii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r456": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r457": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r458": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(3)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r459": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(3)-(4)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r46": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r460": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r461": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(i)-(ii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r462": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r463": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r464": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(3)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r465": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r466": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r467": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r468": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r469": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r47": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(4))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r470": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r471": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r472": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r473": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(1)(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r474": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r475": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r476": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r477": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r478": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r479": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r48": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r480": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r481": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r482": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r483": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(g)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r484": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 14.F)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=122041274&loc=d3e301413-122809"
  },
  "r485": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=122142933&loc=d3e11374-113907"
  },
  "r486": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "718",
   "URI": "http://asc.fasb.org/topic&trid=2228938"
  },
  "r487": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=SL37586934-109318"
  },
  "r488": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=d3e32247-109318"
  },
  "r489": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=d3e32280-109318"
  },
  "r49": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(31))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r490": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=d3e31931-109318"
  },
  "r491": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32672-109319"
  },
  "r492": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319"
  },
  "r493": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32705-109319"
  },
  "r494": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319"
  },
  "r495": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(3)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319"
  },
  "r496": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319"
  },
  "r497": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319"
  },
  "r498": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319"
  },
  "r499": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319"
  },
  "r5": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222160&loc=d3e1107-107759"
  },
  "r50": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(32))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r500": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319"
  },
  "r501": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319"
  },
  "r502": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(4)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319"
  },
  "r503": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319"
  },
  "r504": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319"
  },
  "r505": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319"
  },
  "r506": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32840-109319"
  },
  "r507": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319"
  },
  "r508": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319"
  },
  "r509": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319"
  },
  "r51": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(4))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r510": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319"
  },
  "r511": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32847-109319"
  },
  "r512": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32857-109319"
  },
  "r513": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32559-109319"
  },
  "r514": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32559-109319"
  },
  "r515": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32621-109319"
  },
  "r516": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32632-109319"
  },
  "r517": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319"
  },
  "r518": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319"
  },
  "r519": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319"
  },
  "r52": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(8))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r520": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "217",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=124434304&loc=d3e36027-109320"
  },
  "r521": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277"
  },
  "r522": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277"
  },
  "r523": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277"
  },
  "r524": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(3)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277"
  },
  "r525": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.5.Q1)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r526": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.7)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r527": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.7)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r528": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.1)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r529": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.2)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r53": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.1)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r530": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.3)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r531": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.4)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r532": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.C)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330215-122817"
  },
  "r533": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324"
  },
  "r534": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324"
  },
  "r535": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "270",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338"
  },
  "r536": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331"
  },
  "r537": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "740",
   "URI": "http://asc.fasb.org/topic&trid=2144680"
  },
  "r538": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463"
  },
  "r539": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1486-128463"
  },
  "r54": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.12)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r540": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123410050&loc=d3e5333-128473"
  },
  "r541": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "38",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123410050&loc=d3e5504-128473"
  },
  "r542": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "805",
   "URI": "http://asc.fasb.org/topic&trid=2303972"
  },
  "r543": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4568447-111683"
  },
  "r544": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4568740-111683"
  },
  "r545": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4569616-111683"
  },
  "r546": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4569643-111683"
  },
  "r547": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r548": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r549": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=d3e5614-111684"
  },
  "r55": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.13(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r550": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r551": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r552": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r553": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(3)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r554": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c),(3)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r555": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685"
  },
  "r556": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685"
  },
  "r557": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4I",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4590271-111686"
  },
  "r558": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4J",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4591551-111686"
  },
  "r559": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4K",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4591552-111686"
  },
  "r56": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.13)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r560": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=117331979&loc=d3e41228-113958"
  },
  "r561": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5579240-113959"
  },
  "r562": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5579245-113959"
  },
  "r563": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5579245-113959"
  },
  "r564": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5579245-113959"
  },
  "r565": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5580258-113959"
  },
  "r566": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)(i)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=d3e41620-113959"
  },
  "r567": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)(ii)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=d3e41620-113959"
  },
  "r568": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=d3e41620-113959"
  },
  "r569": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=d3e41638-113959"
  },
  "r57": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.14)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r570": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959"
  },
  "r571": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959"
  },
  "r572": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(1)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959"
  },
  "r573": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a),(c)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959"
  },
  "r574": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959"
  },
  "r575": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959"
  },
  "r576": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959"
  },
  "r577": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959"
  },
  "r578": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959"
  },
  "r579": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959"
  },
  "r58": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.17)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r580": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959"
  },
  "r581": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4CC",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL109998890-113959"
  },
  "r582": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4CCC",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL109998896-113959"
  },
  "r583": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959"
  },
  "r584": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959"
  },
  "r585": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959"
  },
  "r586": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(4)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959"
  },
  "r587": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(6)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959"
  },
  "r588": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959"
  },
  "r589": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959"
  },
  "r59": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a)(7))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r590": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624181-113959"
  },
  "r591": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4EEEE",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL109999725-113959"
  },
  "r592": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=d3e41641-113959"
  },
  "r593": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=d3e41678-113959"
  },
  "r594": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "182",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123421605&loc=SL5629052-113961"
  },
  "r595": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "25",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=124267147&loc=d3e75592-113984"
  },
  "r596": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "25",
   "Subparagraph": "(a)(1)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121577467&loc=d3e76258-113986"
  },
  "r597": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "25",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121577467&loc=d3e76258-113986"
  },
  "r598": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121558989&loc=d3e80720-113993"
  },
  "r599": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123477628&loc=d3e90205-114008"
  },
  "r6": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222160&loc=SL51721533-107759"
  },
  "r60": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r600": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)(1)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r601": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)(2)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r602": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)(3)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r603": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(b)(1)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r604": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(b)(2)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r605": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(c)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r606": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r607": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(2)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r608": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(3)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r609": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(4)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r61": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(b),22(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r610": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r611": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r612": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r613": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r614": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(1)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r615": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(2)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r616": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r617": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r618": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r619": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19279-110258"
  },
  "r62": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.20)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r620": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=SL6742756-110258"
  },
  "r621": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "820",
   "URI": "http://asc.fasb.org/topic&trid=2155941"
  },
  "r622": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13433-108611"
  },
  "r623": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13531-108611"
  },
  "r624": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13537-108611"
  },
  "r625": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13537-108611"
  },
  "r626": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612"
  },
  "r627": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL120254526-165497"
  },
  "r628": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL120254526-165497"
  },
  "r629": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL121967933-165497"
  },
  "r63": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.21)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r630": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL121967933-165497"
  },
  "r631": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL121967933-165497"
  },
  "r632": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL121967933-165497"
  },
  "r633": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL122642865-165497"
  },
  "r634": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL122642865-165497"
  },
  "r635": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906"
  },
  "r636": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900"
  },
  "r637": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r638": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r639": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r64": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r640": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r641": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r642": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901"
  },
  "r643": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32618-110901"
  },
  "r644": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "830",
   "URI": "http://asc.fasb.org/topic&trid=2175825"
  },
  "r645": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391"
  },
  "r646": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28541-108399"
  },
  "r647": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28551-108399"
  },
  "r648": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28555-108399"
  },
  "r649": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=124429444&loc=SL124452920-239629"
  },
  "r65": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r650": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400"
  },
  "r651": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "840",
   "URI": "http://asc.fasb.org/extlink&oid=123406913&loc=d3e41502-112717"
  },
  "r652": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977"
  },
  "r653": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977"
  },
  "r654": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918638-209977"
  },
  "r655": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918643-209977"
  },
  "r656": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918643-209977"
  },
  "r657": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(3)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918673-209980"
  },
  "r658": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r659": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r66": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.25)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r660": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r661": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(1)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r662": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(2)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r663": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(3)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r664": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(4)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r665": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r666": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918701-209980"
  },
  "r667": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "53",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123414884&loc=SL77918982-209971"
  },
  "r668": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "848",
   "URI": "http://asc.fasb.org/extlink&oid=122150657&loc=SL122150809-237846"
  },
  "r669": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765"
  },
  "r67": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.28,29)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r670": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765"
  },
  "r671": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766"
  },
  "r672": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "855",
   "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662"
  },
  "r673": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r674": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r675": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r676": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r677": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r678": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r679": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r68": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29,30)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r680": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r681": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r682": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=SL51823488-111719"
  },
  "r683": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "910",
   "URI": "http://asc.fasb.org/extlink&oid=123353855&loc=SL119991595-234733"
  },
  "r684": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "330",
   "Topic": "912",
   "URI": "http://asc.fasb.org/extlink&oid=6471895&loc=d3e55923-109411"
  },
  "r685": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.L)",
   "Topic": "924",
   "URI": "http://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856"
  },
  "r686": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154696&loc=d3e54445-107959"
  },
  "r687": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079"
  },
  "r688": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079"
  },
  "r689": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079"
  },
  "r69": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r690": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "340",
   "Topic": "928",
   "URI": "http://asc.fasb.org/extlink&oid=6473545&loc=d3e61844-108004"
  },
  "r691": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(10)(1))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r692": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(11))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r693": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(13))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r694": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(15)(2))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r695": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(16))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r696": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(22))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r697": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(23))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r698": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(7))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r699": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.13,16)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r7": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222160&loc=SL51721525-107759"
  },
  "r70": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.3,4)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r700": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.15(5))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r701": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(13)(f))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r702": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(13))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r703": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(22))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r704": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(23))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r705": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(24))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r706": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(26))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r707": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(27))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r708": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04.9)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r709": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884"
  },
  "r71": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.31)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r710": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=124429447&loc=SL124453093-239630"
  },
  "r711": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "405",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=6957935&loc=d3e64057-112817"
  },
  "r712": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "470",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823"
  },
  "r713": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "825",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=123345438&loc=d3e61044-112788"
  },
  "r714": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(10))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r715": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(15)(b)(2))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r716": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(16))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r717": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r718": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(16))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r719": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r72": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.6(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r720": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r721": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(24))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r722": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r723": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(5))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r724": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r725": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.15(a))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r726": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.16)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r727": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(10))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r728": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(18))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r729": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(19))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r73": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.6(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r730": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(20))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r731": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(22))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r732": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(23))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r733": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(3)(a))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r734": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(3)(b))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r735": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(9))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r736": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4H",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438"
  },
  "r737": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124506351&loc=SL117782755-158439"
  },
  "r738": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117783719-158441"
  },
  "r739": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117783719-158441"
  },
  "r74": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.6(c))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r740": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(c)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117783719-158441"
  },
  "r741": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117819544-158441"
  },
  "r742": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r743": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r744": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r745": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r746": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r747": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r748": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(i)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r749": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(ii)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r75": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.8)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r750": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(iii)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r751": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(iv)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r752": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r753": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r754": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "825",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=123600520&loc=SL75241803-196195"
  },
  "r755": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-06(3))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=120401414&loc=d3e604059-122996"
  },
  "r756": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "310",
   "Subparagraph": "(SX 210.12-29(Footnote 4))",
   "Topic": "948",
   "URI": "http://asc.fasb.org/extlink&oid=120402547&loc=d3e617274-123014"
  },
  "r757": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Topic": "954",
   "URI": "http://asc.fasb.org/extlink&oid=123364037&loc=d3e3115-115594"
  },
  "r758": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "440",
   "Subparagraph": "(a)",
   "Topic": "954",
   "URI": "http://asc.fasb.org/extlink&oid=6491277&loc=d3e6429-115629"
  },
  "r759": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "450",
   "Topic": "954",
   "URI": "http://asc.fasb.org/extlink&oid=6491354&loc=d3e6049-115624"
  },
  "r76": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.9)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r760": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Subparagraph": "(d)",
   "Topic": "958",
   "URI": "http://asc.fasb.org/extlink&oid=120429125&loc=d3e99779-112916"
  },
  "r761": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "958",
   "URI": "http://asc.fasb.org/extlink&oid=120429125&loc=d3e99893-112916"
  },
  "r762": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column B))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r763": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column C))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r764": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column D))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r765": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column E))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r766": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column F))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r767": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column G))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r768": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column H))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r769": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column I))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r77": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312"
  },
  "r770": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Footnote 2))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r771": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(c)",
   "Topic": "976",
   "URI": "http://asc.fasb.org/extlink&oid=6497875&loc=d3e22274-108663"
  },
  "r772": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(b)",
   "Topic": "978",
   "URI": "http://asc.fasb.org/extlink&oid=123360121&loc=d3e27327-108691"
  },
  "r773": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r774": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r775": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r776": {
   "Name": "Form 10-K",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "310"
  },
  "r777": {
   "Name": "Form 20-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "220",
   "Subsection": "f"
  },
  "r778": {
   "Name": "Form 40-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "240",
   "Subsection": "f"
  },
  "r779": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r78": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226052-175313"
  },
  "r780": {
   "Name": "Regulation 12B",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r781": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "1402"
  },
  "r782": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r783": {
   "Footnote": "2",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "28"
  },
  "r784": {
   "Footnote": "4",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "29"
  },
  "r785": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "Column B",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "28"
  },
  "r786": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "Column C",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "28"
  },
  "r787": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "Column D",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "28"
  },
  "r788": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "Column E",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "28"
  },
  "r789": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "Column F",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "28"
  },
  "r79": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226000-175313"
  },
  "r790": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "Column G",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "28"
  },
  "r791": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "Column H",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "28"
  },
  "r792": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "Column I",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "28"
  },
  "r793": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "09"
  },
  "r794": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "13",
   "Subparagraph": "(4)(i)",
   "Subsection": "01"
  },
  "r795": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "13",
   "Subparagraph": "(4)(i)",
   "Subsection": "02"
  },
  "r796": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "13",
   "Subparagraph": "(4)(ii)",
   "Subsection": "01"
  },
  "r797": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "13",
   "Subparagraph": "(4)(iii)",
   "Subsection": "01"
  },
  "r798": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "13",
   "Subparagraph": "(4)(iii)(A)",
   "Subsection": "01"
  },
  "r799": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "13",
   "Subparagraph": "(4)(iii)(A)",
   "Subsection": "02"
  },
  "r8": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760"
  },
  "r80": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r800": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "13",
   "Subparagraph": "(4)(iii)(B)",
   "Subsection": "01"
  },
  "r801": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "13",
   "Subparagraph": "(4)(iii)(B)",
   "Subsection": "02"
  },
  "r802": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "13",
   "Subparagraph": "(4)(iii)(C)",
   "Subsection": "02"
  },
  "r803": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "13",
   "Subparagraph": "(4)(iv)",
   "Subsection": "01"
  },
  "r804": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "13",
   "Subparagraph": "(4)(iv)",
   "Subsection": "02"
  },
  "r805": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "848"
  },
  "r806": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "848"
  },
  "r807": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "848"
  },
  "r808": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(01)",
   "Topic": "848"
  },
  "r809": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Topic": "848"
  },
  "r81": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a),(b),(c)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r82": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r83": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r84": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e637-108580"
  },
  "r85": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e681-108580"
  },
  "r86": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669686-108580"
  },
  "r87": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580"
  },
  "r88": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580"
  },
  "r89": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580"
  },
  "r9": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760"
  },
  "r90": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669625-108580"
  },
  "r91": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669625-108580"
  },
  "r92": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e557-108580"
  },
  "r93": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL116659661-227067"
  },
  "r94": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067"
  },
  "r95": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067"
  },
  "r96": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067"
  },
  "r97": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124507222&loc=d3e1436-108581"
  },
  "r98": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(210.5-03(11))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r99": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(1))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>132
<FILENAME>0000721371-21-000080-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0000721371-21-000080-xbrl.zip
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MB$7F1XV@(Y;E#_X:"#($,Z.^2)[%Q)N-Z<'&8GIM(KL%[?4I<&V$8U6,94+
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MQLZU@7\!EZ.1=$Z(!Q+&0$-]4'DB$9]WL@-\@Y\M\3_^)2$^6Y3BCU(B?+\
MRSSVYQ=O_]ZTO0@CGRA(.PR1!/!HSTR[[U@*P*1*ZO/-TT3P*\K20>KY/.U%
MJC]AG9T[/0E\U3XGG%C<07L\044KYJQW+U K:8LJ0!L4:"U(!0N=8,L1L((1
M\IVILLV=)W2O7 9LTJ[J!-D^-:"3&B @/ D"1/YPO$);+21+F8^U&@O*F#D?
M5F?\IN)-,2J4G@J43C(=F)*O8!G8^RIRHO$8(IPN^@?_GWD]PX!YJF0GY1"
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M.N\<2"]X% =_?9LO5#W7(&262^,]@&4"'YQ7'4&/OOME77>PL'>ZL:[- &X
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M"Y$8A: *C3:")_2 'TOB@B[SP*MPZL:9'#'FZ3-:!:X^3H]LI+8M\*&,=''
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MU!QX'&ADW8BA1RH96W4;3#Q&,T0/KZL2-A(@C5$B\@:+M/AM0JK2&%&*#FT
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M<].[L##AX;B:[SJ@@.Q]0/TO=LS^K;6L&M RMJ>^IH1:5I%_)))%ISH\S3]
M PB#LW'ZIBS1^PVK^+ZF'#5X[[\PEH3[((:G/(-#7IN5J;)WN.N8)Q@7]5.7
M5YCV^*[?XS27LE^\+FCH#PXMWYV/7).H8^!\0YGRV5O)N,'G5LH9,#Y$'YI9
MY0J";F A$[E#40W+'+";P37*.4HAR\\M>/.+")%XI[>T=MR,VYG<(U8/K$^Q
M0G\7W^Q^1"/WMG6 SS5E%:U *PBIBHB$&;GL<N7U1/Q<!7 I^-K*@+E%25 =
MP*_NN18P:EU9RDZ:#-GY9* <3E I!>;'C! '"GE'?3[26KF:+"BR(-DL9";J
MM?D5LT(FT5THK#GZ"H&D\U'?/#PCK#>$G" "C8\:Q!YY3!YXRX\IM,M=,44T
MWP2IS,8ST.; 7U +0O^*QDM.[FZT=%Q&S@*R27(PPD63(5*I-X,,MV0]A*6N
M:X(!(P-2[C)PU:HB1_1.9\=6X)S]=V!R5T'!8/\VZ5W#[$:\3MZW=*M<LI+[
MD7BK0@@L-[+ZKS@.L=)[:X8$[<_[5]2,O/)W7_E$/03_=^'Z&I2YGLZ<5C=3
M50+Q7JEJK3;^Y.^M;OKM91@C)?_A64-]?/]'4=.])@?0 []=4Y%]XU0O)08*
MSIU\$R(55)U)<7<*A$;'A@BI!AA((CV'X2M9W\ 8-)5K)!GM(^L_3C<SL 7<
MPZ"([D8@WS4-<,Y\02IM5)E#D$O?AT.@M!C00V@RS/TFOU;,72*6*Z4G<2%C
M\L41<1?"%%#O&MU[+9$A3+U:44D5&!^M8=\_TO_W'^YP"I2\.VVI?P!-DMDF
M^X+<, DYQ^,X@+B._!]W(\[BI>_CXM'AQDZ&6E<C.AX4';'ZR.3H-I/"![1Z
M8FK0P,9I8BK0'7LGID$B"G#BN[BU:KW&8?4M6$2<YIYDT/EH*O>8NV=!=U30
M&:*2Y"V%S$T*SVE.BQO8AY0=0=9E< (BH=EUS;$@4+\Y2*?] W+C45+@BC+G
M[G!UZU.B&R7O(;%WZ$7MK8@$T 57UR3(H/([>4?;-_D-K.C)7K<+^,A:9V]N
MP1[+M#A4?$H/T=6,SMO@'/6JU-'[3.:^6O=9,WZ!+H&Y3GW#A'HS+86"S";%
MV6!\ZJ<&"ZV%!]"LJO26*QG^8K9/Z$K>"WR^@GEK=*S(_1%U#XRZ^Z+:+&1G
M@RK3$-W<3MQ4M^0%)PM_@6DP=%?4"+P;K-T[NL&=F;G,FX-</+)C'UWO.(PK
M"Z5VQ8A!1V!VI.X5!BOPA)6Q59\SQSY8<E6#[MBQ>UO-D,T@_HQ@_/< 8Q*B
M8$?VM74H\+*W6%Y  8V06,,F9&@$@:7CTYP?#J$SBB724Q]!<'@P2OOT%II$
M*MO88WY+71G$YP^F 847]'(&F& YJU:B"B,^'2$^L55983L&4M=!C!15KZ[W
MRG,#R 8[.C6XKZ8T%&>1"$[JRDY03%.;JI7NZ[<)<6+FS<#CS#GE6ST42HY9
MA<A/BG>$J-)-@E0T-F%)/\+TL8&_6RS8.-V(AD>&AB%LNY7%K4/94XBG3O%!
MP#X*+3;8YH)3*&(>)5F2D7\)_K!%F<0<2=Y)J27JXX@>*@0V8WPQ/!"]%V&X
MAX_.O\D*C 'W)=KT:$#C9/U;&*UR4) *T_;$$@P$C),6%%+M2<AUE<3*!<FW
M%3:%>Y!+S!,9,1$Q:&\5_=&H3:R"<!K8?#&]T;J)QK#38ZKBOQ<Y#"VZK1H\
MXMGB1$YS@Y(\H#OU?UQS@N30.; 4/+>0 1Z[G'4.?[4+*H=AYP>RT]#@20+J
MZ"[<3")M8!1[/Z5]BCSN$FS/Y[7'7FC&+S(-F!5,E#)=+2%[:'@S(%])VNS)
M94AN"7F-Q' D!8B)_9J:MEC7Y!KT%X>L"8%JB%:']P8L,VFK%55H]#U36PXJ
MG5IBI(4;=O58LG.LA/T.6^7$D9=(R^DR.2_#^&2I(Z(=V#\H[C;7%S=@JR'A
M@N3$8]DN^#>A.CRG:[U&C50K;! '8RQ-+2HLNZ1-3;5VT4==*DHO'Q9\2WAG
MD%\\XL-A@V]]/4C@.*$;" #9<X7KW0R7I=;MH([?@HR:]Y9Y"F+.%6.U50ID
MX:F%:=B_FS"Z^,;2C)GD1Z>=]7 B=TB2/QC]KMQ5;X!2]SEAN>"$M77N"DG%
MS-*LK'\Y:%!4]LNN7^!"2NIK.]<G7/6.6BMSR>@C.AU/C%\B4%%OZ%-44_79
M4?'>L#,8EB:A^I[D(,6<8[),G9Z1RR3I*C+I)P*+0+.R#G]52I*IL=9 ?11S
M.OH5W[+G)TD%)FQ]B7G[!2'W-<[Z,N= \-V%#4K]!V9SBZW,8;+88JD/0& ;
MD\+&%,3H /C6NNG+JAJQ^*!,L=>9J"Q_::*:6P_SK$NIBY8X$MMTMO?,5)A&
M0&D 7 :"UEN"^GTB.*>L&N:?G'D=^65IW>[L@1%+CL26&[0R>A#H?Q+:AT[Z
M/J23K?))%Y+@&HLUNEIJK"2J,0+X2 !<Z;GQ533)$WM9^(&11I8[!<$DI?E8
M?4;I.W6ATHRT$>!' O"%]8U!#C_KJ Y^[FS7$,RV[XS$>FRPN\-A0X[>TA:Z
M$GFZW[5,$C;4O>[*9E=U3 3AZ;!S/)=N2M)1NH(1+8X!+6(;VVT6/72NHR4"
MG'U0K!LC3X.@TGV];\4;%B)M(P8<ME:>.HUSK7;M0<TJI.LC.]P'ZCCWK0EN
M",[[FAO)'^^K[#5[OPV&>.9TMI3+,",D)!/8-49C*,5@T_.*T.@:K0AJ#2G]
M9KH]ZOVP4I+Z[&"?&2QP&YVJQX!:?=KM)#0,0'L16P#U986M)>^G1&/@!K<A
M$L#?5P$)EL2.*DI^/<?B7A10?5;K=K%,[!U6V3GFH.<^XT.1)F'R@:"L=;NV
M[F9$J2/PQXH/-022I=/:, M)4M)\K*X5'D%'PW!(.;X?6D1*$9VXR[;J:5 [
M D/FUSZBEY;@P)(P^>A>?"5VAA&!L*2D/:4$P[';5%HUBX>YT'H^E5,[%L".
MU/>'I*9+PZP)=W:9Q!Z-&&>0?L%E)C7O(((IU2\<FC))7=PA:L;!=T-N/CEZ
M"5.76CKC"4C0B ,[=MS[/?>$AKM"^]7DOP%*H.]FK5H>"$HG+Z0J9;BQPYZ3
MD\R#]JT7MD*=.S:GC%V$L$5FQ5Q((\A' 7?@SG42_I CA])&RG?;(NWJ7^SB
MX8=1:T:Y$[LVYZI&*<-U<CO&[)WN'-F4-R6)-MQ+3W4JP.ZC#%Q,I%E)#=WN
MOI#W?,):DP24$^&J#7>EEC*L?A.HJ2OVB I9Q=2<BIH*[:BSEF:9UQ9V!%6
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MIL@=LW3W;#^G-1_V]O\"4$L#!!0    ( #E&$%,G4-'4XGH$ $ZB,@ 0
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MF=4[M4[64]H]KX^G\^7)0I;?GNJ;X_E2L5[,3X[?%5_JY^@P368G4L]C2XU
M+ZWPT^O)69"]BT8["A(7HY9;-;X7YD8LG?HZBE5)% ZW4-.7GAMQ-76[%'.+
MDH/O:Q6VY6@,5PG(J:B5&'"=Y;TX7$%IUY0BU<")J0)4"(1<FE5F%TK?_AB&
MVZ)A+PY7T,7!^APH5V_[5G5*I33(,0@VHQ\T-X(.=5_HA/;5-#C+SE(F+\E;
MB,C9)JN<<MWW&*30<'W%7AHV[RI<+1(D28T.06*A8 5!W[466S!UN*YB+PV;
M]Q2(2AE;@*BF ;+&%EYB#BE;R(FJ&7!-Y\'LR;X:?F\EFQ#!FN AMI)+C!Z"
M-Y$K%AEPSX4AXK(YZZE>-!3G/;,0H.52Q5,QUG)P#<J >]X-$)<-VC$I@4,S
M0#X@A(B]UZY7_5#LDX]BAFW'KGTI\$ILEF5,OI(IC UZ37';.8;A4$H E_*P
M;=8V,=A@7R8J&6Q%=><%:FMD *"R"<+LO1WX1, 6,=ADO\RJ%(J)8ZT%N&C8
M77UP1@S7BM@&W#]AN\MJ5]/,(BH:+A9ODBJ&=*]=DA=&, 7"D(/?P8"Q.>L4
M*D;GG/&E(##T"N'.%W8""5QE-UKK=&U@;'*2T%$R 4VR!B&ARRV;K+066;5$
MO<5PS=3%:'\_I=D3.I)W<?\='2'[:#4Y'HEU*B020K#8>KV+Q!2#Z TDQ1A-
MR0,.O]_V5?F)%O7%Z?%E$/I'RZ>K0UF\.*39NO_YT^.-YCOO /+H))>BA$ L
MV,B8HW<V1J>.JD#CX2/_^S'XO<)U\?']H^/I_%3DDF2-!'5OFV5O0LC! S6?
M8PJ6.:HLB,V41Y  ^1%LGDG?JL@KJ6MT?IA-5LMGSW_8Q53('*+UIB)D99/J
M1TMNL:6BZ+;0DY)'E*<S)#"WM TIY6J#J\'%GM[JT9:J_E@<IUHKT B2(@<)
MYE;2(W,C=L5JY T(T@Q:<J':Z(D<^U&UC]FF"]R^B0W"UC6R/G.$H"S911.-
M)3"]\'X<4RKD4(#<4B.5UM![QF:107414RVY.-_(F%+-F I$# ;([91*L(E=
M3)9C0ZBM=X1U"<&&PA[8[H!I_5X6;;XX.DM4IL5'BX.-TK!",\T;Q-H<@:B
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MCG=ZX_K3M77]X[?Z]=U%_>:/I"1CO9:A-5N#:KNM#:K-?KU=94:]7FW5-6/
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M;^D 6>=L_A:>3:UN]'J]@5H=U!O=:E-OH:CL<## NGVCW>QB&=9+.D!*IT)
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M0+;W*HK-IZ](/U0KJE845IAC%:3(A+%$0ZQTFNKQ;-!+ZXC)@AQM(0-@V_2
M7"6'A;GKBYESFXK0G:U7GC*#GIM2M_.UR0.[69)K7-%:K8+(H3T<\9=0&7<R
MWK4S^H[Y7#\WX^\HS_62//I*H[NIJZD\7]L9V_L]:_F2%Z>MC7.R#DE/+[T\
M_UQ,VER*CR&G5D5F^K.:@@N7U:7B(Y.ZCOY<Q8M>EI?(%JV(H3P.6B4BNK1C
MA]Y-V?V1/O9E;U5J0BI[92I$$Q0K-W!6HCWJ.E76^4$K_<J5$3.4)3HW+LR;
M9D<+RM%$C[_TU<+]BU?6U* \5S$D+F>J&S160540Z'DBD*VM>8"O%C:\G;A8
M,/HH.P.*)ZLUM1,^&I_SIE5K-Z):X.0#T0LSM D3/.BI'+3!-13+9'V$"L4>
MF9ZCF_0A-;"WV,SSS6#S+6:.$:85T;ZF"D-/MS?%%GC]N>)%<&,3!V%'"9?.
M[P=P7YY()L,%D TV$P7%,"-LR*J[YD3\+7+1)DAL$?JH5U-N.<?^@11[-.(W
M#()[PC%+L+);,VII^B'6M1>__YC:BSN7V]@[5S9_#YJ)QIOVKM4X:Q> '5G4
MN:I&\E\L'P-11L ,_GWRCW5:+M71OIURI?.OG]B[W5LF:YYXL:62XYW@@ C\
M+H&($;6XB/IOUTZ4IUA;-CQJ?IC=8HE\!LO+8%PS:E-M@"CV.#8L&$^8+CMV
MO[_YX_)#5>TM<#&&!PH;:"/D(1QV[CYP8DRN(7),76[X.A=R!^8VQY<^,,L7
M75&EZ$EC7L)P/4)GG+BP<:(W /;LI4,>!SH(91=LWU  *L)CAY;S@!YI>+W-
M,>,5MN1O*NBG-]>4SZN>KYR>?/Y\<7(FVI0+R,3H,MUR@'W8PTJ(K8@K;<-*
M!W\/76;P< P#A@T,1B:WC."O,0M:+XMTB^C-L*) .T%R+KV35FX&VP87$H2#
M:?_P8:TEP_> PX)@@TF;]D!R.&QG8%G8@T"PUETR2VK$*H$]X;Y8 ]6:\H=C
M^6/L'HU(EP)8TEF.$B[QGU$0.K!DXP72PND)&L3I111(()<HS9D=4*N\+NC%
M/1!MJ@5!3QAHEM2!PQD,/" '(&=\=!_>CYTD<!;A6ZB>&,C+XP@*S45_"H\]
MT)$9<^8)%-:HS;UH[Y%"Z0Y;5)@1O&:*Q$47VA&<6MA7['4>2DW:Y! 2-;5V
M!.@Q-A_7[4*[R*->&)QI"4/Z8"+<IJ%<?+[=DMUV2YB. D)?%&FL)4R'@.EX
M@^(81!B(H&?"=.0#.'5]#(\]-%5MU9Y$[,?]6 0S1IY7U6K=13[59Z"NB:W2
M4IA'>P?@R.>.+D<F>9$=S3QA6^^H<MIXZ5TM8572;L@=8YUM@*UB1)I2P;B1
M<JHN(=RG=JF0L:T2!B;BM+5ZP8HK<Q,2>R(MYRA/3HD#$T7G5*W65DL<F!('
M)C>8+24.3(D#\\R4@WJMWBF18'(I<.JULL[W^&LW2BR8U1RJ7E/KQ3)8\JC4
M%9DNEG''>EG*<?3:6@D(DU8)BE+8EF-5I,ATL8P9-C9EACG>GU)5+"%A-F2,
M:DUM%(0QYE@+*3)=+('*JC5*4)BCUQ)+4)B5*F-1T+)RK)(4F2Z6VL^E=_'8
MDE6VAX<I7/95\ZG,JR(K,\N4W$[!<C?RJ$05F2Z6*+F=VL;UZ#G>H%++7<+&
MI3K+F6O-%1@D#!H,_Q&%BT"U-7A_.Y2OO"LPRQ3;>HF.72JVF71Q//N3<\7V
M8+U,3S\E3'RLOJ,BP;]\K*LW,4F>>]B56['9@_E?SJSIZ!7Y0S$Z6A#FF&--
MI,ATL2R)M=;>O)=A'O<FYUKBP1CCG0OW!C7@"&(BBJFGVX/ YET-R.: _^\?
M74W5G@(.R0L3S+$&4F326,($43H>1=+K2VN'+XD &Z]5/2 ,K)$!A[!/'^DN
M:XZ?6>1W7 "7NRT"/!* R^Q%:=5:G8((SCTPII=0;U\6M_:8C_5N*Q2/Y%@O
M@;^O-3=M+EP>K^W< J\)ME8K145>MZ:$S-T19*ZDEL8BKF1AEBUF#;SLJU-+
M5,?9!R!S >;E3Z?HR3^+X*P4-A6X>X0BA^B@S(6'P'B$+[^B7-IZ33D]B=EG
M)PBO&'Y H8'P>2=G&VQQ<?94R]&>XKG$]");-RT\7^:4C^%,(LXCHH_: <IQ
M %PIMA9SC_ DL\>*PA]U#DR5$)-7N3$%=N9?/K.G!)X9(!+C=7R 6)L4"V+Z
M:&%  ?(EV?9 5J&=_R6X4+(,B0T9H&U.S:D%XS^Y>)Q8S(Y2\).WX6O#)T80
MME<2G7(5@*U<W%83Z6_!W ]!#O^9!.^21%N/;F%]D%AP );>LDCN60A@+XO>
MV.O4-$W#@6X*WMC0:FJCL?3K;4$&X;'-_3Q6;:P'B;@G\,(=.].>ACW.T-3V
M^/HE#8,W!FG++9[>F@N>DI:K/)><:QVMN:^E_[\].$W77(,X?O)'QQTK:KWZ
MO\^#Z\O0H./_CMSH[B&O]EW.[JML #3P,[-F;.Z=_)1DQ< FY9 [Z =^'LL6
M$^N[\(ZU59T7Y_3/P.G5FK6.MAU*[:K'MNJU7K>W\\=J\-C>3G!J%RU9WE0'
MC5;*DHT9J_+['8:L93!I3TPB@#!? \+V!>>\7YGTA7N^-25,_!O1 @"TSATN
MP'I\ZTC,H$:.S*"/$5:+:#63"",FK=(UK5PT-- 8P1BD!,0G*'K\+#!D[,#L
MB!Z>;8S!P'1?5 G['OE!%#%#^( AI,*0,NFT7B/LN:,[XS$FV>%3O: 9 !AK
MLEN.,X7-%SC^-$WLQ0!VD^^"10+?AT,%&G% Y+$IK)#A<]F8QG05M..JX:W"
M@L,&-GA"J!,&/B&TVM!BI&4,.NO C$W'J,4:)M2CY8C';\'H7'OVK=6SCWH%
M9<Z>KMW$JU2<L];,T5E;I[*I$NN($O<D1*U0,OJMQ-"7F'!1)'M-4;\4%,PU
MY0;H<C8"/6E>=6;8(,2TP=A'8!+LQ^29ALFH_XI\&8.C80VJT45!LREZKFDK
MV$HIQC\4[/3D4P^70>A0\,*>.+&&*[$Q!ZV9PN7!]ANFM^K5 6$;)K9,F8:-
M-V!V83NL>(,><3KQ-N;!R39\ZD?C".]*?/R)NP8<A!<U)T&D/=H.ET]]5SA3
MPF8;P<ICRY6@/4K&+A #@$=,?'?B>'#@L,E(UH4X1MPR$UOFP*Z)+F+D_\5!
M^_08XL%R8(,X$U=;%?RW3?]V9!,QM:LPXN1C<TK<!&'YB1V]=UP'DXY=WU/.
M3:.B?.&6R0=TWP5,$7B@KMP*_CA73C%13:N_?7_^Y>*6?E??GBGGLF,*+,,4
MQA"0;,A*5Y$DS?9-4VL&'.RM,G)FB)93H7D%JY5P5D6T%;52F8%\LBQ'IYU[
MT^CV0I8H7>_!L&"OK+5.HN2=7B \##&CD%E'[\8L%B*G*7D5A1M,86-0@Z?!
MZU<=I%6'(>BLAOUI?#P4$^8B"!O>' \*B V(<8QH-61/M66W4L>X1B1"3"]@
M0@:EI*?GNXFDR$<C*UR:H#W>C,?[W<'\LEKN%;H/GNAII+PY;=0T]4RT_SM5
M.[56,Q&R0$N?2#!@GK:2UD&2C0)KZW;8R<_&?U@0EE+##7IM+6A=HM43^:<?
MTLW+WJBU9E.L)UC$6K28Z8:*4E],2O#UV&&FA%PIABO(VI-=#_N"LG?<W/ I
MYUC9U[!(?0V5;5H:%HX!+)SO!?6Y3AK(@#W IO93!Y[AD6]W8UP3V7ETDH-"
M+B'VQ\PDM0J[C?KNZNJNV$$-CBY\7QZP71RP>EL>,.UH&H?N=/CMIUQ^F@C*
M>"-A!0 =/P"AVS$DHA6]FEO+SGYA7/>];JU77\]U+YWAJ;"X#%6L\HBF$K9D
M6&M==V@!&"\Z&O2 A'A$0F K6:3"D-W7J#6C-M53Y1??YN+8-.H5H9M@9A0P
M7E*#WFBU[LK+Z\(* NO%!5L%?Q%CR.I1BXX H::A/D:735SGP30$ZX\4-(9J
MG7 .HJ&D14.NQ#J!BO=P@GNE-JIO6IW()XGF!"KY!BI9%?RN+@:>N(#WT<\S
M87/B W 9+&WB$3J;F&AA\\<)/,B<"NN3%%(M=6G@5 7[&2P?;Y75EH]DCD,Q
MBEZOUFTUML[F:.TEFT/K[B>;H[/+;(YCZ/A7N R%@R4H*+O)4-@-)5#B\B$"
MH:V,">],0&?E0Y09&V7&1IFQ469L'%_&1O:J;"D^M?4:R&_N$<V%*7[SQ^6'
MJMI[KO>M,*RXM,!W%/0**$>!EQL<0[FG)\%G)V<4PC9M7SBFF*A%0&_5[[5;
MD<<SM)P^VILB$!P8FQA*=OF#Z?@>Y9%XNN5XW*B(_);@37T^A!G#@S%^YHJ<
M$_D.=(_V,:.%8PNIP#S'NZ<CTS6P6,*="D]JS%$KC'N+V\.I<"M04Q7TL4HG
M6_AJ_!(#<L*7ZP6!_M@K\0HW8I%.R"(IZ\BW96%6\4*=X8Z+(*#-AR(8'07Y
M<"42:0Z1JR-=X)01'4WLQ]<H0 H;P 3Q1&^*W[OX$G+!L,G$=1[I"4 >Z,5(
M^D6&H.-.*54!UC'QR'K&(P5YSM8=5=8C@JEG#$Z-7"S%HXO/(^:.F<Y]&73F
M0T+BA EB;'($L^US;H?TD@J$A%1E81 =#[UPG3TXEC_&7#D=W^@%]4I#;L,H
M=603SM!E8]J6:U^W8)7I]\\NURGB'1C4M^@YPO,'1#4R04K%:4>\Q0OJL3+?
M0'%;RYD%M&*A=/=D-SITN\L95%+4L'I=X#K7>1"Y'8RZV54Q6:2*OV'6AYE@
M7@,'0SG9W$NM*;<F;"K"H5846?+)7--S[*AK'CXV.<!!M/1PX7I+2+0;A+#)
M&;AZDFO/H'!$CT[H*TJ,B":-OE/7Y,#A#<4 RF&T)DCOTFL,'_,QL3KTN,H"
M7;C'H^H^6+.I"/235YO4Q^ T!%M54SZOO/STY//G"Q"_+A_ =6+[P\M EB*5
M#RLRI<,*<Q6"OX'>#8ZB^0$%\H!A[M[(Y)81_#5FWKT7Z[D3&RC')+6@42.]
MD_9]!E0%%U)@T[1_^.Y<D0DP'DAZ1@YMTQ[(Y #X"M@@2E(ADB><W0L9#.=!
M; "WHW44KO:0QCS4)@R9)AR3]M["@:$LP(5M$6);9#B,X%T8FV46L ?)C!+;
MYCJ8Z^=58H^A;D-"+[%]6"_TH@MU HA?1Y'!/1[>2=_(UYCV RPB)C=*[H(/
MX1@] !)WQMRE[%LS2,@ZQQQ.,5I*3_-$2I#C3Q74,F6YJ'AKF!^<?C6^0N2"
M\11C$!?C;,+)B32X$0,R<IGIR6Q!CUN450T\)O8BJ8O!-<'[:LJ'-3E!)?U,
MRGP*%B'C^ "]HY"0.X#YC;&PSE224"2]'R>",)&]"M&"UP7:*H;4G=AP-$DI
M<<*(MHH6B/7AL%"@!X9@F7^3(?3 +)]2=^!XR(Y]L?NP"MA]H/#^&[772:@E
ME>PTG;":'SX8.JZ,& 4'5:03,@,3^1+R-<VA!%L6N;J!(B.V+;W$0@E.[H2+
MZP/4"D^"EX2:K-")!PN/<!;H(UAQ65,\\.F ]/D<3RTIC[Z+3\<\.'],F6BH
M>$44O;"& M*@S^52XV*A6C9S?,M86)"ERX%5U.]=F31WKNN87(G#_@R*K&Y*
M(KSEMI1[L2LNPD5<FMZ$JYN8 GPP%LG(A9-Z64EOH18AL]&6DATNC8=)Q>A/
MQI,Z ^JH*?\5'##0Q*069L&Y<AEM=6!;R=1H.',>>R U/RN9;MD>GX=;0&ET
MW)O 4"5%XIS6. #!^).'$!D0I7X'63?$$2K+%F%&^G"P4J  X\.#8+ HN <1
M9_!5_#G)F4GEDT=12&4<4C3(FG)IAQ1(S,(*]-D8/_6"?O"AC$C5G;B8VXY0
M%994)^!"^!L#Q<(BM(,#%].!ERQ"7"\T79B,C6QA#/0W2LOJ2C#(4&%>5ZE4
M @V!12IKF%DO5/>4VIVBF<(=3S":)0=%APAP*-V<)$S5!9M=>#<6?3F4 KQH
M5H.,0F9K<5&B$1.4PC22])TT[A=*A8B8UY*&Z5.5TGQ6VCIQ:1^;8E WEJA.
MT\*I!90"?"FH%9CAB;>Q%B1F^X?>(I)R26=1QG*Z42Z?D.GD!X./DVXPG=PG
M(,K0B-C(N114]^!^S49<-,1$^A]QU&6!MP&;B5Y#\CG<8-2:36G@X3K@&\;
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MHG8IMBD]I_P1(VBRICN !*.C*R0U]8/&T"0L$":C 1$D)53:J>I*S^,:@HX
MK)"QQ68L;YN2B)#= IR((2\XX3'W(5LHG/+:L%:A*Y4^PM7!<->^^ZP2TG]Z
MA$M>AWA&J1.$ 8)XUD[Z[0'X5GR7(U:PH1NV>)SUZ;-"2D1X8##QTQ:,TQ4@
M@()OQ#')O& +XER+NM=VWHJ\#5#;.(E H#3$>9!PJ9AS@L0F\[63H7"4^Q)!
M"U[R,ZFI(F* CWA+^F"DVNK2E>\RD1045']0SJW-K5C,7-8Z+(S*PS06$\/M
ME#A$0X+7-,XHE=<P8>OH/9B 8/.9 +%XA"G'DY \N*-YII!51$A>YIC"5AGY
MIZ3E*J>M,QB"-X'#[/B>N#$VD)IR'OP59CIXE,@CH0$I;T?T$+), :(1A6L(
MO$(<%4IFD[)'I-O EDJ>E,PR6C\H0@/B]A A9YE(W*TB8YHKH,T:0HU%3D>9
M/)2E#C,"+<L3BVBP*8/S")0WC-J1N!S55KCN;<:[!KX<V>+#@%_(Z13N3"83
MW!C&] @Q$QDP_(G"G3(ODZ%!&4-]S_H<5N8]RI YK>![*8S^*S(=IPX!GG#,
MKXTA.(;1Z7"WQ7NPZ@,5R#E'-1<-'[(:1%E!BE2"H<JAX%M"D$/@\OC9S<AT
ME'-8<-?F<^435FC@#:!/Z2-N^):@XCX?4GXN<*0)Z.JH/8=#6^,E7T&FRYFN
M_ZIK.#KAFX1<SAXLKDBX$HBU2-Q/8LD(@$4*N)&]%692KV2R,3S3I\:_XNTH
MMH4^ (IJ[!E;6!<%U/J6A($7Y'TROR$>)8XEQ@?8Q@*L-H0+EO"@E.!64V6&
M6P@VA! [K5J[D?P82"L.U"H>\5,<4I:@9 -Z)IZE"#LS ^HH !]-HVY>VF*L
MT1Q ->VDAL)TW27"R4)1JD0*ZYMF?2G2J^#_P9,"P%-1]NG%4_6DBT& )V-F
M*+-MGQ)(HS0!J?%2$!WS YV9(DI')+.+CG\TRH ]15AZJ1$:6#$C8O,!)#./
M5[K$QAPRD7BI8P ^Y8TXQX*'_W"=H501()Q)]UTZD1XH!3B B%D(MUT &H@9
MRK%:<@=-=B^LQL+4#4?7?<D &*8(>H'W$"M+X.G2B4BHP208R>+W8L8>ZV/=
MB$S&YP^BPN0K+M70IZ(R!2MR0541VL BC/"83:>RVBBR>P-W$.XD[;O@HLR
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M%/,RQ;Q,,3^2%'-$*4+A/L1T &&>R#0.4M838:Z,+B9A;(PE>FANW7,.K(?
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M@WMDW#H9-X![S'$L7W!)%"$>.B!J9A*7MHP>E-&#5Q0]>(\,VE,^ !.' 6*
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M68%>:S5Z_WR+!::R/D1\L#C"DW4?OGIR(I<_.=:=5FYI:U5NQ0NGWQ.VL<"
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M-N<ZCW HIJ#9*6] 9H?KE7$($[H12 R1IYPSO4+T'B$1]VND?+U/*E^%(?Q
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M)5>2GYZY@NF]T6K=E9?71?97D(=)R6@XAHQ,2LJ+%\E=F"!&EY'_VQ!YX)%
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M!)-NU#HM8.)5%6AYJ8(*^TS>0:KS'4\L4SASA7?)]&)*ENZ '<@P3%906_P
M\N)7QQY6[]!'>A,%4PM'T:LYH> (%LZ4O,&QL'$\S3R>QC]QW!1 7\R;#-J'
M2Z"6PC_?KFD!XUY1L9S7I<NPD V,-LL"@QCC;-2T?RK7SI2+.$9PET;&WANM
MT17+GZB:U]I:ZM/AT.5#3"V8@'#0S8G%8Z:45FNK[>R7@*1F-#91QHZW QO
M- 4+N1!FT 0^"_GDR$B3J!RN3^D%4Q!"A"@0.'TKRL3RA2=QS.YY%=&;" QI
M;()@(5@@LB,##X#M4''Z92;P@,=CH_3DBH;X'V_41G(]"('$L5>F'Q20JI84
MKY#"(Z8:N;D17*$>=\40BJ;E"#WN"])*1!!("QLFEMZ98[@9JT.^.&-F/V]B
M!\EJI3>+\Y1>IX430X>%B#&>.N2-EM&KW(X@>!&YR-.$FZ#;U[D%:QW6PIW5
MF 2H)R7 FU8LTKN:<S=K;:T5I\,/H$&.^R X"?0MS;W7\N;DHS2F!/DH03[*
M<H\2Y"/G(!^=C!D?'\A'6<I2EK*4I2QE*<LS2EE>:7IL7OTE,:M@P>:,$C1>
MBYNDOL)-(@SP-UJSDXQ=B%T4OPMW@/@]Z1.HR-O5I"&_^(B4FR]^KU9_XMY5
M7IMP /7FDR-HJJDA=(*[VT_<"U(T>6NS$=S:>O+67NK6%F6GRML;3]_?:'=3
M3^C4@BXS2WR%3WA?)& HDV/H)7?^2$_%78(K$#>*K8T$3$6&1%E&BZZNI[SV
MQ7/1W-C*N3]$2'JU$0MN,-MV$*=5Q$N1/=M!A#S@'NC)(4\^<&=FVA0 C?GT
M5SC<EWAI"A!&R_MNWO+)5/C&! X\PB^CT)4(XQ1^S4^<8[]0W^M%*;^8WKUR
MQ6PF,JG6/+_MW.SX5PR6\ZC*@+"EO!F8GE$"I@@]ZO.PPM4+8_(.:=+1YQ1U
MQ\40)0R/$\=#?*L@,0:S7@@43:*^1[DF2P:!=TY<V&W9&N&!67Y8(4&RB1"A
M/;XX6/A@QEPC.;BES^*/IB?J2VSBWAS&*]-%DX\E?'RQ  %XO8DZY"WG]-23
MWWPL]YB2*Y@N^XW*?L3?'T"?LFA-/.6\#_P.VVC<\ZF"= 06AA3#&<G[2RAC
M%\9A%F4(\C10Y:5X],^4'B,:A_^+Y6,@RLCE@W^?_.-I;!/@32?O4)0HZK]^
M8N\.%J8A>BAW=!<[VN@%.UH_[)9*D8=(AEI@V@"G>1_/.(I2:V_#=&NZ07TK
M\06Q^^7_9^]=F]S&D37AO\+P^NQ41:C4NI3JTMZ=B&K;/>,YW6VOW6?FW4]O
M0!0DL4V1:EZJK(GSXS<O  A2U+6D$BGS[$:/2Z) ()%(Y/5)H: ))^0ZY[2/
ME.MZLE0B+\O-)6X:83-'$BZQ+3:*<JM5D*YY :X%=?%.+>TSN-*A^>(IS0\6
M.,-*3TZ3EURCO.25"O)A=:/M=+OS; ]'QDB)U2]RO3".U0C1H1YLL1MY0^JV
M$I$Q[ 7.%ZMMQSOY*/UP;JI2?BZT@_D]HE)5K2U1-:07.]J=?;);%DA;C5MV
M_41VN67[ZI:].]4E2^RJ+]E7VU^OK5>F3FK_/ET[]=AJ.[FV<LM56H4>6]03
M$/E6YZJ<3\^M36*\UF XE;JCWB+#Q6!78G$@06'4Z2[2+D3N)=GME7H0J=_6
M$S=VHF.DRB+)OM8 5,B2L:2\X,A11#%X7?#=W^&[&2R,;@CG9^ROB7_B&31(
M#G3XK=I;!?C1LD'1N9!;6#7[R@^608@KY @NZ154H:$;5BT5GFK\$%+'U4,Y
MM\+OU/;7H%\YZ#U@_#7E=NVULGN17?.2FKNO6E5+=QDCAPP-S;)AO>I_N#K+
MDV!!,;G?$4C&-GZZIJRQ,1^>*YI5WT<++N_G2,PDRH#:R>A_<;W*ZYOVK2H3
M,-A3RJM?7J]H*0Q:O"TA$!8K7=8"#1*PB38;,D-"Z6+X\W,P),[07:<=L+>5
M\-;M8$BT7Z&"K=5_BE#]@=U73%M0A<IC2CIAT"$VQ 1='"[J1PRFW>E.(#E@
MU<RDP*"7PF6(8HQI!!A46T;FM%J-KCTE&B HRX)_?=T96(H-QF'A[(1/9'5$
M,&%T&#I9_"^S+CYLT<K3&862\2N&DDPJT["DQ2=*S_\)9H#4,6 G"89^VC:%
M%340X$3^F3)2*I'#H!\-)<C(@%O3@- !2F)8N!+A0*UIO+>@Z6HG[-^6X>N5
M6(.Z,R_G/>1@^AA%[':PHC%MS2V_DV]3M\=WLCHSI8"(.327GI)*NI_\\F9=
M#_(?\/.9@Z\8IDBD.PU@F1-.I(2O(H&1"9<:&BE@XZ5&N96NIVE:S32M9LZP
MU<Q=TVJF:37S JUFFE*;IM2F*;5I2FV^XU*;$UB<[S1R<^W,S!5(')08_&<J
M(I#K6(!@D*D)+ =_\;K;OK]VYE+A4K<('TOCW(=CIXO?N=3S%K,8K!J6C9%*
MA<]8$0I19&SA#&R0^I]"3&J%5;[S(LF TQ3#I<:[)70CYT^G?7W?N;-)AL X
M0,:;[#/JZ1,H9PO5=@Q%[!F4=40KIZT)E<_%9(ACY T'F(8^'%8*.'',.WNT
MM3.B:%7W0T7=KH^P)7.Q(#4%J/811LEEX:^EL7EZ%9E/():^$$M]SHICSD \
M&8>7*H*R8()Z2[ZOS)V2]WVU=,8Y95\&O*WL <4,%(IWRWQ5T8HZHO(*(DI$
M;V(6AXA97 ]TBO&)L\9W#UJ\*K:_LEQWF^ Y7]]>9PCMJM?\OU4"U5(C"+MZ
M"X$6-50F)6W(;W,/79'PC0'=Z9=+J7KX@"OMOFS@@!HXH,8EM]$EU\ !G18.
MZ/Z4<$"C[=MAWQEY?RS'9@5"3W?M^]N;/3V5UX/#QX@&8!8-MDMBV]%3>7M_
M$-'=>"K/T5-)O3%>T!]Y:.&V>^KC<?MA@WUB6B%O@][]G2(?K>M%&98VD[9S
M)3'A?T86H,F,0IR,X0*=2EY(C8*PY3(6@_I^^!3_N"W@RDW> 3>H1IK$?;M_
MMU^:1+]]?W_XN^J^?7MSO]>HZ]_8'_0./M=NI]V_W^]>;29[1I/MM7LW.]4(
M'-H:.9R,O=O"Z%KGD+SP NWEBB^WN/O7K)@E8D76_.JO-A+]KCD>9[#V/GI(
MX7^OOV,:#!0-;KY7&OP."KUD(_W\25!NU/R.\?+<XG>V;5WZOPK8<=MM^B^F
MD8Z!ABIOCG/179+XFVA07@&GEF,3J.-4G4ROC[?V-T478V46?3?HYQ-Q#[YX
M_'9'(JQS-6PZC$59U3#P>3-PM]4?W#<LW+!P?5GXOG_=,'##P/5EX'X+3*J&
MA6O'PN4&TIFS</FB;UK=VUW[%![L_%3TZ.QL%ZL(;%WLX@\:^I/Z5=@V\DK?
M2*_4X5%ZIJLEHGO]WEHN>TE16V"3E=ZEVA*[?WO7$/O%./MNO>K1$/N@UO;@
MNE-C<F]U9U5J'\K5E5[KNG]3$W6E7"MX&8VD9IYZKEF0CL\U>UF"BW/16QV,
M7<?>)02H%'NO"M7MIQ)7R& \X]W9UUW5[,Z+7-'=9G>JNSN#9G.JL#GE6M5M
MIR8JU0&Y8H-*I=-4@Y"J5=<P4O/D\9\\=X_<QZRCQK(&W-]/ ZZZ@;?J%M\U
MH') ,ZNQOS=NS\VN%WFS/2]Z>IKMJ?+V7.]JHS3;\X)J\*!_6Q,]N'$M;DW9
M3[HOBZU397VW3:W<Q?7WY&B\W?FB: SR%]R>Z[OU@=1F>TY[C]_MF7G;;,^+
M1%%N]\SM;[;G)=2L;NOF9E 31>OE'(XKE;P\R$1O*>-MYW2XV_;MX"0*VVU[
ML'VEVBK( ^=B<.E<W&Q?L'5H,IY3(NO!:5-EJ7-?M\R1@Y_\([L,#C+?K1/0
MFW/=G&O.",M*^YMSW9SKYER?Q;GNM@;]NE@)S;ENSG5SKK<CRG7K_JXYU\VY
M;L[U>9WK;J=U=U>7/,*J'.Q=L6#5.Z_P./S8O2M%+N6/O& D@^3'*WSH95WP
M!&5J(2J][*L+).K@ZC_+>21CBO+.1))&7N+)6/==R1? KH@2E\-&R6\:>W6\
MLGXEZTD_E'[X=*Q^+%N1Y@7:L3QS'CMT8^E=JVXL-\=IQK(=G^M>+/_S?]SU
M>ITWVW=DH1]TWU 7E7$:$9?935EVZ(]4'Z'0JZA0\ )OEL[6G&)&68:MQ.9+
M7N"X:11A0[DYB 5LBP-<D,F1740(?E_ZRQ;,(HZ77@3O5G#0&7L-A4_3CJ=2
M)CRDYJA,^L /&ZES *G355)G4$NITU9BYRRE2[_:TB5<D^-?E"\L,H3K1BE\
MZ'MBZ/FLM>#I'LFQ!+& A]H-9]))Q#=IBQK[^49@- *C$1CE N.Z0@+CP9DO
M)ZHZ'AH0H)9@Y]"8VK%.(DD[@[MG?C$)PU&,/5QA-H^>BWN+_?;@U[Z<"-]?
M.!)52U=2AP;"P9U+UQN30/%])X:M@;]<@>."(I+K*S'VOL'K87 MR/Y,X3F6
M+C")H33S&+WAAUN9S(L*/2;JT=?OV?Q] FY^%# 2;N\\ @[ QHN/7HR7RQO:
M<.I ^XT:A#B)-\.-53(AB>"EPN56D+]/92DCBEF84D<1+W;]$'N<BF'X2*T?
M^9XS[4=B/:[1JH$)5,]@X+W(#(MC!-S>%'XI59<2O'?X:6IL&J;)&'N5P,4(
M?!JZH ^WG2RE.Z+NM[0^U9A27:CVZ>"S$#R&/DPX"(%'0=7&=JM>,C-=H:6G
MTL$C[$\.LV3C'OM<XM<X2UXQ.6O:SH? M--LF50E=>[@'.&Q2 //AV5&= !=
MO'%]=</C+/"<@< EZHXEKH6_@FW")L!!F. V+L\$;W-J?5VV3^23D/.$B$YS
MIGTS6[W\3GNGLH=9H-!B9MC?V#[DSH@[X7)?VC]3X+)$ZOGR)MI;M#[K7OAQ
MJ+6?V.J-;![ 2^J?7W2;P+=A-%?7,3(*T#V0Q+E,N\\PNX_BJ_,%.\K#''6S
M:GH+7-F^Y#V2NF\SM_&%-XVT3(6C+#57HDF63*,PG4RI,0\^?M]X< ZE&O4[
M2C4BS:B6T[^MI5)G^YY6] 0^2WUO4"%]+^M-8%EK+2=.45S%<'=@/W?0RK#3
M,MAW(($#4 03>,18?T6S#Q_+#385<%\-I0S67V;4)@SX!C_V FR4 :(PA>LJ
M2H07P'6H^(Q/R8)D/[Q*MRDFQ7,H79&BN!^K87@:"QPW G,7&&R(:JA2$O2M
MK]00$2SRUWTC9 \FI?I*R-Y5053MW++<^"5 [TSC6/E:;;_'>8JJFPJ)JO7I
M^*,0=3^MPUF*&RF/8H&ZXTR,9)F^ABP1SKW00Q]7HH9L48O",G_4%\M,?2<?
MI1_.^5WPG=U,&47B[R#%0(6-U>O@B60*]K#N9HK/J)AQV9$^%G6+1YHP3O91
MF4CQX 7L?K3:K]!\^4<* ID[3*)A%@0AROP1;]P3NPF2IU!=+FPUP#!P$A/8
MD30)P?*B&R:0$U#^Z6TXD4]@P)"%^$4FB<_.B@?CMB#G0_8%6#LNQCGPI2W'
M&Y,[ MADI*X6M']B>'4\]M"O\!2F_@@NE#CU$]Y3:8^F2/$H8F2]/\ >Y-M+
M\YAXBE.X0\$"1$MLN("=Q\N(@S#(/A.X%*, QX(_I/)RL%6\?EG 6G$Z_ .X
M#7= 79UT9N P2=@ =5,;4T?PA0=R; X\$,#BP<"*4\%6")LMN):W\ !>C[QR
M.%U..L<G+'L>MO'U3;M_R^PPY!YV+;;L+"(H&YS&07M. $5PN4[WSEE($<$Z
M_R5UP GOZF]SM9R9^"K)[@3+.<8M#% (V+O(AQ[?\OJZ,]!]]&"U:%'!"0Z?
M$&N:] 20ZA)H. =>',++=9M3L*C'Q>W,G%VC$$B&8@;T#)3\<CS&@_TH6WRL
M]03(2S!$NS1)(_2:P?M37IA:#NQ2#$8KLR*MPS8UM:P:2K@Y M1.O.R@] Y]
MU;Q:W<=W^\;D_>ZKOZ[H;+YR<E8SUQ-U!/XX'E_]I,(07S ,X3Q$D8"C0ENQ
M YVKT;D7^&LJ1NC6L5VIKT)892[8 O(L6^4K1R1\9LNZ_@IUA9*-8/F!E=3[
M\OZM$Z5^J?ZS)>-<E[E,J\@LGR6VTK.NL@?714\5GD^XU8*1B$;UXYGC6#A;
MO?PE3)SG3F0'K:BCM:+N<6R<+3?T,/Z8@JD3,>^/S<]$QONQYOW5%Y.:X. :
MKR1EL/\825_@Y?G&]%DO!#W46>ED/Q%#6$*:K/[)VE-VJA;AM^U>;[\6X;TV
M6,X'[[<,PUX?9]AN__J4;9R)[5[RP)4D_1[Q]2LJ#SN%V.9>76(WT54/47:<
M7ISB;T':>&@%JGC,&MKOJ1)L2?O_WG1U'H\&MJ?AYQ"4LV[GZC]WYH1<>45)
M&GA1E]]2I[LU.MTTREXYD5?#2(JOW #Y1^$_B47\ZH>\  ?AJM9YVP-";"WH
M-U@Q:W[VPK?!7?N.[NF=;X/>=?NVM_KK?<7VH-.^O[L_^+ ]&/9^]4]WN V6
MZR;D=7?<'Q3J)JS2"/7] ;'A5*7&D<2(=@=NT1/\!==\W&OK+=8_N'DKZA,L
MQ?BHOL@ M;Y':3_Q7J=W')!4V\G +63/BUJCAZ)?7>Q4LU[+\IB;]488RPMC
M6?HM.3 NO$M6U# MAAS&(N<E\69SX5(O.G8Q:D/'>(&)J.SSY:H=3J35&247
MGGX!9:-$'%Q4P4CTK_KR&[N=V4&+&Y,E*PTII26=PVOFZ#9&-V'D2?38X&]F
M(A#LKD$CK7O[)G;^2$<3_*#M?.1<%AG.,:MN/N?8J EW2O.HCJ[&8B:=,24*
MX>"N%[GI#*TX3-ESR3,[XK@&6('C,4=BS5S;SD\JRII-'^FO8[;^(HO:MAP5
MJM%TPT@,CTFY2^0U5<$1\O_K0 O/T]J>;*MA@1X[H.:1G M* EK*+<[V+S;V
MK8X%:5)B*90'Z]3L(YU9"*0?R;FDL!OR@K5$S.Z*XW0VISUOH]*U(BY8QH-H
M5'LPD5CG5MM+Y^CYV,Z"*!FC!8\WOIK&5[-G0G0UQ#C&L-Y^_.>'=U?=>Q!U
ML'<SSU41JI07+RBJ0G3YK_:7-AV.B1\.,18&#X8S.@M\'E$&/'IA&ON++"F4
M@TYF\*&<P"(I@ 1FAT=YD.H=*#>&:0RSC&-XN952",<S&NE,0-RFL;&W.AR)
M\V4P =N3(XF@5GE9BHIY-<7:,#),ETNL;Q?KE6LNE4AF@G39M7;0O;O92N5X
M\/WPB:((*,W>A>DP&:=& =E6I1BLXL67M<- !+0[G;T,,3#A[CO;&6+*M"GX
M097=N4YK+11[*UUR6Y75(O[2:I^7F'Z]B\/UQ')&Y/AUI/E57:UQ%@6?R #S
MH^V2!!=/I8P>)8=M1Y*3ECD O6G@X<)!L22QN#+[%'WHWB/7/DPH+1A4@"2,
M2*M] ODAK\(Q"!!*&6F98#(_M,!:B!'0,UJ8)T#E *++**?M1"26K"_=2()6
MX7#1%V?)B>!KE,X3UU.KB^0D]04F/,M'X:>8C# -GQQWBD%"RFM1@M>UDB+L
MX@P4>N81K4FS+%P2]BU2 I4 UI/SXJ]'R[9K])OZZ3<;ZM+U14JJ\8*>^FQ.
M%U^J&RZK79(HJB'1'ISI8HY94&P&PRV#90X4EH.#&'$Q)Z:JJ7^K"+T28U2X
MI7\ !A#M3(1))I%-N,0I2P(HYCN)8.4KAV+$"!9HP09L_;Z^UZDX)&V4V96;
MW0Q3? 57F,'FJ1^3S,3[D,R]L9U;%TG./9I'F/*U>C<KLG<)VWM88=32!4B8
M2"2>J!2)<X_!,O47O+L@T4=:7!M)[H'YJ=T9^#/?^XI95W">?"DHR2COTABG
M24J&>9XC-MU>)9P"MYD$];Q0;X2#K<^&<'X*X7^,SZ+F17C5X"6J$\)SDM%[
MDH(HQ0TEUE#^I]AD#I+M QR S* N7+"3\'B!&&4AD*7OV^( S90)GO97G+8&
M;[5^_\J9A2/IJV(SD.@>E<%92DWFQ6H9" D[JY)L'^.F8N?8'#$FZ&],T7-%
M#!SY!"QI<NV(:]-8<S,G Y8::ETTU.#4&?*,O!&=.N7^T_9@P?>WV9$41MK8
M!)*JQ,QQB,>*JQ*X_E$5WMO7%BA:%+J<;*5&4EHDVY,Q"I!(2KTZRI3\<<L[
M[":?/E5_ ^RFW^[<WQX\9-6%"76W"UGM]LK^]>&S+>[;MYU>C>:Z76+(";IV
MGCYBM@VVW#K[Y )$H5*PP"I3I;?9!1ZO[BBU%14XSZ,R"'\HV'=8T,J.)M5>
M^XJ6,ATKV^>[6WOW?HNUOW"'WYJUH7LH53G8WLL,@,2J/ "-BJOI=VU6\UTB
MK>Z\]NHBJ?8Z=>E3LBO13]Q3ZRP/3OE&GOG!6=&6[W[/OF\- S<,7(5%=_M[
M]I4\$0._L,I7WO6XLBS\=BJB"=>@NF&L<KZT@WVO7L/U;*O=[=<,%K[IMOXB
MPNZZTVQ/E;>G6[7M:3P,ZS;LLQREE-3*VX9!2>USX$_&8:02L75<<Z1_$BM'
M!%Q0)A_&BAJ>?T_BB_OK[3O*-MVB7Y"M+[J]VV9KJKDU=U7:F=,8([M87I6]
M.LJ=TX[MEY9<*+&C1WI7(E7)+W'8WE\U\4NL\$A?]^IEP57&H;?+?/;LN%>O
M4_5<;U\M3]6JN.I-P]T-=Y\I=^\>C#DM=S?.A:TT1.4H )V0_Y5/5S:>!2N9
M]3OR(O3:MS71DPYCC;TT??]C&_")QD"W^'%P9GQ1OLZ&+W;EBST3)<Z0+T[J
M-EK9>7J-7J!QZJM"Y"U5 U7)])RX]RY$J]0I++_-.NWNH";JPGY<6QWQ<$AU
M8D=:/"=D7%N&+V<Z8/CGV83U8[Q#ZBL-XS6,5P^%:"4FRHN7^&_7;@?+2&-L
M5\J@":8I!\.F8>&J_!/!U B?B+KAJ)99Q#*P_X4R^/7PA6N1]/=<YY9 0A\"
M4,*P2'@S#F%)P>J)8+P;P* S 0PJY\E?/OS\T=&,N:@A.@C6S2L 0BPN][(S
MYEP,.@8K!).K!C?9GV6('_00UAJV$*!CSG7W_N*24"<0(0CA!QBA#8PN+KO'
MW.*60@R@+T2,_<M:7*!_%::)<_$*B?SJTIG)9!J.6M3-641?94(E]#'#8LPC
M#SX$\L!CV+T5)!MA5V3+4:]VL87/?"JBF7!ERK@9IBT4]985KNX_KQO: V$^
MY7\12\;&O% 8-2M&4( TEUSL3\R2H0;P;"S4 !LK8.Q($6$I7?S#!<(F7"J$
M24)?*$Q_)H(4@3G3"!$]J8,RHIQ(UU.P-Y@L-_9%!AI)6*4&$N!*4G,GQ<2.
MCRB><<MT,J9^P#,I<#;C%''PO& ,NTD-MX:+S&\^3 E#="BGXM%#Y,K93(X\
M;O*$TY$&PZ#P\K;S=P/_X"]:O 9&OQQ&@G K\DM6S;L4 A>BF3"Z!=YJL.\M
MA3JC>B#9P#/4V"HFG*EY%&(&88S"#]MS(1 I80.:E]/XGKOT\OQ[\:TCZ>+I
M*KXX!W)3^MX&OJJ!K]H?OLI2B4JUN!K!Y%3UBOPONIM0=%.+/]P4B2VM\F>[
M*#T9WH:$5 9G4Y1B);*ZI?&M$#,K$S.Z-5S^I0JIJ52N(!X3,@O\4T;6]&#F
M4^G312S4-8R_;R-WPH;%$N7OL]<IRE=JI.3Z1>;%];-7.87=-,O<RM:I1N.A
M4T'LW-^W[P;]?2P6ZN4S.#@0#'8>ZMT=8]AN?SL\H"W!8)Z'G-$TT]FKF<[)
M>NDXAVFF<QA.(%?="UO '([MEJSX8(ZTLL8\]G^;1D%-HZ!G"N^F45#3**A2
MC8+.WI6ZL@UQAO&KG'5@5T28@D'*/_O_T ;(%'T&'D?C&.R"1X^;D]OHH*;3
MN')RDM/-@(JR21%)H*G+/AL]L.FW@@[&%=Z]MO. G=/=*1LTY-[3T,0(VSN5
MIA..BXM+GJ0,G MQ:;VGZ!"E07ABVLW)C8*&A5_QI+DEC<L=:!38_,CRIVY/
M0%C,#D[=5LZUFCEWL^D_H?WX>G"3-52'D7;4U7[W9C#Z;_+)^1S.1/!,M\S)
M'$*OK[M=0P5EC0*+!\L[1(3DU@$AA>X8R3I';,35_^;*.,Y8-^,"BR6?,N1:
M+HM.Y_1">D?1W[]PQE$XRT\F":WM+/?X X]2:Y,*!S[*XS8_USMN\S'%+'6$
M/\])+;NY@N4,8;?AKW)DARY:+&5!3B&'K C/E$DC;$"5D ]S4S"'8SC%:,[/
M2]&<0"*C U'_33([.P1:F**K<^E-JWYI34#WX<)>.W#ZL"L6._<)S";[4B!L
M]0CH&9@6]2&9MT ]T TB!J37_7=:CH^GS]PR%-P VK*BSV@YIGL;._7PV@YC
MU2LDB6#G":^:Y>X[#L=3X[> XR1HUH_TC'#UJJ&/\^G3>T9:5]XS>(]NE=$J
MVV4[-L0@^3$\Y<I1_C*Q7&0QBR9LE$;ELA000?J'=0=BK^IAUAO(LGN942W$
M"^('\K9JI^R(^$Q$'/PBV&\P@?-\\22SC@C"'"ILL="]OV6)KFZGEA5')7^G
M0H!2W.?"!Q.^A>#7$S]\Q)Y:&'1#+ [NS> "12@,:.X9FW?A6>QL57[B4:IE
MK?.0[4NHH8BPJG<@-\_BR\UJO*==SP;_G9S*+;MW7G8@= \?2J 92@V-/^+N
M??*;P(/=0L^RW5IC8*+CA7>ME$+<(*.PG?E?E JXI;M[N+ 478RVONYW,K6+
M-@LO;T??VT4W>*4.2?F%_9Y5'MS=C^A5!V6WQO=WX6[+=C*DM<4N60Q\D17;
M?9(.6=HLP?H8Z00,\0>W7^ +3C> TKVJ=&-3^TQ;J@3J@0KTS>.HK#.B:2#[
M!5=3D4L:4/U&LSR$2,+_!J8-9=N.5>HV!])<M[D\B*'P"<\AGDJ9<$L[/ >D
M[JJ3.::#:%@BU"QA&7"4O<!62/<N9X7 !P/K@QW,'EC%6#<GM5M28%L5G,M8
M/(81G52Z1 M":%=QLT.CAKT=J)7*\/M;&(XH"DC'G.+?'X*1'(.:"_;++[ %
M(_@@$<'$0QH_Q+'<W$ 0UW/7Y (VN8#'%NJ?4DP\0Q$]L?G8RQA6$,.2;PG[
M\BG&=GS/M!,&82]9X\<\,2^:<?)=D%*$'#Y^FDI4SE')!^'!,CM[4G[ST =@
MSI'U%0ZM[,+0I_<IS=&+,\]8IGB,X7>9NA%)RA.$GZ<!ZF]*U<Q$8Z;VB1DZ
M4W7VF!)I<$=A&@NZIA(/E!FZUSPZX *[\/A>0K%U7"'\B1V(^&^D6!QSQ^K_
M8SV'UPPN'XG&O7SX2:FRL73?1= $/3)99Z'5^@IE,UJ]QL^87ZTHK!=_3^*=
M+2-8?V&UE-ZGTB6 EB3M<1[#Q5S$[ BT%YDMBG8:FW@57QC0IVR!Z<O<E6@3
MPLW@)MR_2U%56[LYPDU6L #9U9ROX;-RL/4\R5M%K+AR='.=*P\K)OAQ[N-6
MD]N/.9D3<_3;R)]@:Y5L,IU(25DEM(^2VU\:8QJ($ :24U_061T^E3]W(?PX
M=+X&X5/ UKI)RK^LM.J]4EDEADF>PN6UFCQ1W0V=VL2KM!RF,-^QZO$?BYFT
MR-S*::'S>9=?0J,C$3&[DSS80#<O)N7K(GM_5OMPV2*6Y:^PZU:$VF'6ELM.
MJ\-3^R@\'^>)>5"F?H+:!4XFV'Z+556R=/.2$-\R3Z-Y&"NC>(WH55P)FTJ?
M*N&S #T7WQ1[L'$BLIJFPL<@YF#3X.=NS/9Q\?WPRR62EC DZ,K*+XC[\EOJ
M^G RB?:?,/>,>M"K3(XOF++$-K.B\>6;77_QQOBA-LYE52))XV0Z;/^_Y.KO
M(9S,DMTU2>QZS_X+.$MGKK^A+2]NTNK1:BC?MM*6_DA'RFV>[U_LH:^66F?J
M"&/AA+9R5ZK, I:8XO_(<@:=?%[DIK,X0<,WWEF'0;6DH 72L)3*&4BTDP7:
M]-8U:L5#EZ]3,9^#V4Z".[^<&FXO2DU-S(SR*W2)L$3$>I;GA:[RH340\4
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M#>I#-1OL*E'*'?:,T+T;+*0BHZ*WG9^D*U1">RS-%)9P56QL(ZXAR$ .5 F
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MYT?87>_F"HN31B0="/2F8GM\[MB%GV6<1*F;I!',EIJGR=G<#Q=2.K&$28K
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M@@T.,7)!/EK0'_3P0 F*USUYY&)%P)?6%O3)$, 5BSN&NXE>.9KPL!2VR]*
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M8KRV5]Y#IY_ANMT*QYRL4PZGN;1W-^>V=Y8-5.$=?/57ZAU6X1FNX[$+;,G
M6FM\N0H^>Y=\")?^;]=\!W9H'X\LY5E)G=L?NK?;)#K4>I4KC1DT$(PATT)+
MYNQI\2O\=.Q)?]1R?GTX^]5NMHS7&\8K"73S+ *1!5H-"J'5GEOE!GFGC<L@
MI/K[-9Q3O2?/>&D-$<Y[:0T1&B+L1805?8CKDHU1D6#4+@'1RH4@/NH@TWQU
M (*C5>6.^I&U^!IF%'S,2H1;695PMDPJ$\R6J"O1WX81\*^)C&"XX._2]V<P
M^_\I9O,WSL^1]$;XY\6KO],G/V-L)(R<@'H AZZ4([(P7M_W;DW_0!48P42K
MX1\Z&D;(OB*R6@RK OL1THU*\2F20KM$L,%87*^['C^%T5?"M18*1MBUP#*R
MU#PQ1'2O!4W1%T]QBMD4&J @0>01A"^%+Q]E(&"P1P%LXB=VKD_[2]M*\<&.
MCLY(QF[D#;E',>$:W69A%P4IA']LA!7B4)$=UBKN /?.#:<PD-X#_1?%G[KM
M>SO^]-%-0HRX]CK=008@9K8YC[;RX!*4\UMN%L_!&XP)Y5!8<E6C(<5R@<,C
MH%3LIKZ('-5K7J>+MCB@:X?K<**%YL#]7L?FCE\%A?FN:WC2[&+\[EW),2/0
M"G6^)%"$^F #AR%L":+%B4<OUW.$N!*W#*B&_4@1FXZ1 3!EE6I=W\(%0QV\
MWZ7(W[!+S!F?80,TFL';=_399W4^<V?SMI^=S0NJCE*GCA#QK-[B8ZF2UC"*
M'<0RYKIK@2EK>DKXFY)U"2K!#> D3;TY\T3XA"<X6S"%>'GK5=MGRHY%HD42
MP<I'G#NPD7+UBY#_BUM<FR.R<8DF'4Q@!H)'<  .',,@%BY'D8<25AHH#-PL
M0GR#("4RR!U(/.)_A!$US,V_M)X'\&<YC%*\2K8X@B5=%I8R#7-)(D84 UG?
M3D&(XPG]@FUXI\(K8%'$SM^!@W$/WH8@2G])1NWETW=WTUU_^B@5W.%4<#P$
M0U@'S8#O-HGH-0$NU]I_^]J\/,AYV+60\5"52Q4MS&^:X3;-<)MB\XW%YDTS
MW-,VP^V?LAEN4WW?5-\WU?=-]?VSJ^]/4 _R5G>::FH_OK/:CZH:MEA1[&/S
MJSC)^J"U",\1#<&/\R2=??[6TJY/Y6CKW6CT5'JJ.S!_*@/8 B+/,,O!]I]S
M#U=_06X9RBJ?3"(Y$8ELJ1\^RK()9<UW-DQMT-EB+O7T0!3Q.!EF4SEVUI:@
M%#![D81%_,W;K6ER4QF:F&*@POJ6$!'#:"("[]_<@="Y4*B5?_OT46/N7[+S
M$)M>B)@+$<C!;E!5=1_#''KJ615D5V=;,U!:$!!>Y,PD%G@I^(/D*33R 3:P
MT%@2XRDRFI$/3)UU@B,@MOBG]V^/*DS(!:YZO<P\&:E/O@A? 4GS"]4,8DDO
M16[1X,X!8LR':6RQ@W ).1^/8E;STS(0$"CS"I)J66KJ&=N^55!QMRAY?5$M
MY@O6R'N-%E-!+::JMQ<!#R,628"!/P0?(9QAA6A+S-3.,);#H0K$FJX&.;7
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M#*>.4A@UI>"NFJ%F(QG5!E.02=>5X1S.@J2"U)%88#(K<,(C*5:4LO>M8!;
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M\<_];GR3W3!FJG/]4\J[J!0CZ<#@I-+H%'LM(*5Y]9PH+S]1WK6TVMLLB-
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M-UV_'*H,=G!A/DN1"$A(N./T!47P\0SKOY)=^*F^=P1OR0!(6=:6@)E4KXO
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M=Q)0'7(2<G;3Y 6-J'E-2UWQ?G6X]R,'2F /8X<M0NL79UXM;17%<0G/=RJ
M32FS%]>5NI(F4PO)9C<(Z\2L#0= & S33&JAY7CR$V)0/+O8VGT!5"!)K"7;
MH2OVW,J-5D0/"SG:O$^$#&$^I/;W'8VF%5_"WT^GPZ:L; %?J+-H-NS&<D]G
M*%P\%9V*X-VM'&L*SD,J>6EW:<+6OKA!KKAHLL35(Z0[4(DL<+^U,VE9455:
MS!VX34N(.]2ZE8VU9+LCU^H7(IV#6H#%M*V('09G"B.G7"B/@_TEJBJ0AP9Y
M+2J*_ V50G[YG&*P=$\XY3(HX X]# (*,!JKUW%([Z>+E3>?N$H2_K+.(%]A
M(A=F-0^N,(3&RZY+6Y@B0]8?QM?2P#QWJI!U4KJ<-4PK?Z A08J>@@P):1@W
M@@QI]4"VB@R)P5>2)+B5 VD+T1Z85O7L7JL$G,X,VDI9N(0, P+63C:LZ5H7
MPNT:D^\F6S7'9E;)WW,;J!I+U"O<\TVP*9C&!(E-HBE<%Y5/H;EHE[EF&5<:
MFCZPJ%([%P''@58%4616DLU)0 ^5]$6R^3M^2"W7-R*A^=:V?4>23:=/P!6Q
MJP0_@VV[=;+<Q?S@T9L;&HQ%\%N+5#*4,\!=:=$84>Z2&<27OHG)%]#BZY=@
MBG@(0F@2_1LL ")*-&1AGFL@3[)\A<2&@)+#K!TY)\]X8EDT1 6+0,_-RIB?
M(X2V1 S 5DK2)PU$7'1#0\Y#TJ>5%3%" BWTR6$4EW5"C4>LK9)Z/E.:E9,@
M!@FR-2;2(96X[2@<4*=,@['4#\5:?ZL$#1EGE]5HE"%I1E\;#A@HA[YDAE"_
M=#2J-!P03=0A96+Y1_C>AO QXPC;'2/A1V>).O'%99G"=K61$0SX>7!MIN,-
MD!U=A@8HO"%$EV]M$<$3G$ \=XS[$CWR3H23:>IQ[S\8J/S6'5 Z?@0UE5F)
MVG1YIPU:R_I=[:[FS*$E](OTG\3$ES,) .*2D#  !%7W*A8:7 X76'>>(++"
M%>E#7M42.)0^H?):(9&TK>4#-05S8ES(36-I +J :GR_>11'^O@8P(EQQ*E.
MQVHH;6?9/ZNRNQOY%HC%%<<%'5!K.[R[(#/4EKK,]:6M];"8?_JK;D_LSM9)
M_+6+HBR;60U*5)>DG", B;_W?P;!CX@Z*1DWY?C?\FM2]T/Y"@>9SPEFJ@GC
ML%U]Z&K]CL S4>WGCG"F):-T,*H2T9:3?6KCT,A8QTP01*)!=H:$>^@<%>C'
MD^SCX5@@]:LLB1V&'=G,X6H?>6:I]#],:^\%*HEW:ECZ7!(4E:;JH"\I'C^8
MY'>G@\-@BB$I+@,B!F/&HND)O_T2PV$<>WTX-*.L0I!3.=91<-Q?84[)] %$
M.PRD!@E$JH;F+61:C"5#A4%P)[M TXB5C(*I%'.E*D=T$'C.97,>3LVNPA:!
MAWK:BY[VXAG27ISVM!<][45/>]'CBGI<48\KV@9<T1,T/^>4KEL%MV;S\VU2
M(7VK\\UW[\_!7J%*($IVZ\XV'-GP2<4IG($\DNV@D"E@QJ1M3I%S:F=DPR.V
MX!?]R(H+X#K]-\%D6"<<W49#J0L^(;4',3EF]^V<GF\0P[0P$(<>/JJ(:)P#
MPL1H*4 N_FXKTW8A065#]F@S5DL6P?%Q[3#TJ^"Q)9<B)@H6%T-AL #HF@O%
M)I;>P#"DGU\K)\?Q,N2=I3+KA6EV%LYL02BW^XP<;\P9^>#('$9>FA*DC?"'
MRB<S9X&@2(A+&#I$A,V\PH6@K^$#W)HVY!M1\/B8XD0CI;AU0)'C5F=9<>-+
MO!Z!/)V8B0BV)'T>F*(8-"">&"PB))RC%A7&=U38E@R^3#5MUU&&=*H4<K(/
MT..D5!XU/ZF<=VU?(!-7E'J1"4N.AE]QJR1AP+',K%L41^J+T/HBM#XVTA>A
M;7@1VME3%J'A4]/DKSNW0^2.CHQYTT>8'M,]W(=?'JX7G[_38\\&1T</GTTX
M/AGL[ZWWV#]]A,EA_NNC3.N<V8>[# ]NW:&#]@XM#SW]26,B"%4K88'<YK[@
MF*,?1H@MUQ/77>PJ9?URHO<AX!AGKAV@@Z5Q,[!#)/<$QS&1-A=Q5$V"$;S,
MU,-%DCU'EY)\0A[;C4*&(#4(7!I+Y4/+E R)8R?F=Q)LB)NRY!Y2F@7-3$W[
M0W;L!(H9668D/2KD)^&'1#?PMT>&2JX77;WX\,_W;W;WSXB"=!&)Y8]H41V+
M<GQLJTA[I01HI&(- 4VU6N0(<C&GGJ+75LXL0U:1CPL,'9AYS[![US2-M\]+
MOU)*]Z@TK#?"HR2(=6DJ5:54&40KH9&;BPN@PQUP%J77*X*)=&-)C_/69[JE
MBIBFJC2A#0)JI#7;+U$.UB#&#DQ=SAO^LJX:.P=_9UZE-"Q;U'"A3[SPQQD%
M84&# ^GYYG+Z:%2.9B1.IS,N&T!>HEQ0K[4!(74O@V':(?Q2R<US7 %#5>(2
M^YH5;KW6QVIAD+*E([>P8.,-$Z1UKES8V1X/#VF98K_I)$C*"%,X'-RS/)0<
MX&6@+O632F""Y3RH)LB[.A:(LF84OWQK"QVG$2BMT.GD,\Y  .DZH,JHUAM8
MNKDMF_T0.Y1)8-K6!1+0DIG+30=J(9@F:8)#PK"P,)C ^JC%2/H@.+=E721$
MI+TJ3"'4KOSP:PR0S:V=CI@C;)I*WR;&"%:U&7UE'UQ&*54?4L$IMVC"JDZ-
M@-9ZT+9<=?9R!+^J)UC"66('-(*ADA^.[97)&0_;#R7XMH[T.COH[!/\.481
M2D)[%W;H;#B21?M]![*%6)SG[YI>9+Q+2]IKO-2Q FYJX-XR'$T0[HZ:BN@F
M2BYSHQ18\$;ZE\7"&AJ<J^[S-<_A<,65GJ/&G@O#^%#-"^GR)J8#B&O53&=B
MW'B\X.TI:=(WG<PQRT>6BK6A6,]T=;X=I?46*I=SLRAXK'1)L@80DY#KDY!H
M '7$:%EFT5OW1),.:15=\DW:4A@+$F0:PTES05!$V+1OU&1!5&N1%HBW=VJ]
MH5:+@_7$9POW3MB54> O_9)J$<O07!B[NI@6&TA,E3Y!LL..[<9K)CJM^ZF<
M4\)S*)7"G"7$8\Z:1I*714+LB+C,BYKF_<A58"T5G!0P,DZM4BZ)J(G5KKG]
M6-F'@C2&;U1<JEO!!8^4#Y1(S74U=*)YHGF26BR,#T(_A7=G8*=R-;'+;$P/
M0VO$>",\R2V4EW?+*MV<RD63.&2K@"@G4M2/W)6=MQ;T8\.7--<;:-@UG#2S
M1^3GN=<(W:-8_99EIBERHD:JI!+\$==3$=,D;I+#", M3*0. VL6!&YMLXY(
M-B_(\PI$HT1!AOV"2T9W34Q+KTW$[Q-DQ@5I\>]1TZ;02**US<EZY8DG=IC.
M\+!/"LJ=9Y"B&=]]5P2)8PH0X6>.5]H4=G%2.=8 &P(R2 *C8X>59 T[@KOF
MPD%[5GGWS3E.]M200R+GYJ[G1%0<4:YW*$0M748EZDN,CX]8I'"'E6@IB=^$
MBHWK$-%SK*),&1=TP2:5^]:2!2W1=KZA4,&R1VAF!EQ\82Y3F$%.AKG83]*=
MHD+R$AR,PS/A5W%3BR%ZC";;1YU/Y/:&Q<@Q D;1=4$4M-1Z:!OK\'\G=8C3
MT8:T+D>2SL.9RL?(_BU*C0)PR^((4H^C;WE<0C!D>>D*VX!!^VM#+&^FIA=S
MTQEY2:3!]:AO)HKKSN ;-]@D-T=\H'Z4A#/DIW[I,A$+XV9/E1XK;()4VK"D
MB @[01!N@BMZU!FA&Z?4&(6P.Z3IA2R9#WAQ\=#A84)BVA^%8BVL RGYNG8%
M.$8);D41,Q>3,!:8@ET*.%*/E-!P#$D1(@QGDLZJT&_>["WULC8^H3EF$FVA
MS73.DE.K#M^=#ZE3!U-VL_,LQP]]P&B&38C$J7KLXO'U(J(_@VT&=LE'._W_
MBJ:SUUC2I=M*=,=*.S+(W4?Z:<.HGZA6;IA9RO\8)(F)9*1%$"GGH7 &>*S:
MQ2PMD%$*768VBTR4#D^%]-L0F!8\S5$#PA]F+P3'!T:&@MP8[":R;LQD$[OT
M Y%=,(5OM;C=BG3[HL@?EOM6!G:*I&ZW2P&W;D!>0?@MNE?2]OY.DL1L3#&:
MUE&GF&[?"I][/ES>3(=L&C-_0\AEST0,,FUR\A,S6U'*NE\6PK(BA'R$1N Z
M)(M4"$M[92C<D]:G-Y,";+((>0[T?F.FT^E4TE0O0RZCS9BHWQG:8E6[UTI#
M-^L3C\@#,J\G$2Q5_VBRN;@?U#X@+QJ***,IUAG*P:X+6.(./Y,.8$BT1W6X
MPI(3317RFIA^!-C2DE?;7(?>@NCH1"',A]21:-9^KL&%BRUK/B#[N:IDQ.D(
MX:H>H0K&#.#%%64>7OAEWKI-H9[=C]C1!?_Q)H7SAL.#';IIT;CA%YT!R$^O
M(^QC$/U1:"-.EMT($<L4$Q<L\<R)D*:6CC;X4$GW7.H%N;*O/=<+(OF:EQ+9
M7?G=5HM!MD,1#>Y4EF,D%]T0"JQRGS8FXW-QY>W3)@0*0U ;:66M0=HU+<"K
MMU5#?]G$%;2]/T!ZY-#93A!AFI+)%-$3))(XPF-%%R9R%$9D3V;.NU?1ORT9
MK-$;O+<FX):EAM .GE*3-NCYXGJ^N"VZ2NN2&_M)" \Y2DO.J$F"_\,D+0P;
MI&GRAOHDGBCD_15ZHS%EDT#[S& Y4$<0Y)3<D]M?\CNX<7#>:SA(Z[_J5]"?
MYDWL_W4/UNE%$[$/AY<L9PO2G"]&;&H#+AVRMV@"C)4:]74P*6[0=0]OG8#S
M^BU"]O<,$3U#Q/-CB#C<ZQDB>H:(GB&BQ^_W^/T>O[]M^/T_*2B^9;13Z($C
M.>#U.Y8WQ0DPZ>:%'U::\8- D.X2$=21,-M?@G*2*;?8O2U2DNL@#_US$@F?
M7-3U=(JAW,7CX.E9H&2@OJBXD<SB+9/D< FW<7%C)F& O50Q>G;[ZSF*7-E&
MZ^V$=,V4FC@9$_QR_#RG.0LWL7&C1D*9C,7G51W\,T5!3*/6=V#U?^7\Q?D4
M04H1TI^F0V4W*B(J!@[-H=^X&"ZD]*82W"+F9QC 4F%O9MPY'9 T')N2KD>M
M.]M&%[\#SJV;TR0)'BN+Y5^Y_WYC^:%BC[G5L<:)IVM(<9-S^I.W?V*YR6&_
M1]3DIR$RBDE1<>Z2>\NV?J&;5V CB%(#F% TDH9H7)&/F$"%NLM[FO_1E'-S
MLJIH2BA^^(5)!1B06!XA23,%O1&TE"<1,6BX"34MT%LH +K,@QM4P40-"W:)
MJT#+!.=L5JC<!BH8JI$K)CRG<^#UQ:A$ H1@U<H0):]U".3[A;8A;R-L79Y[
M[4-^53?!OXKRL^'??4=MGZZ4Z=]L'OS&:Z'^#UQ4>/B+G3<?_K'SDI@K.!/*
M^#29+_-;8VQ95<)OZ@9^F3^59 T>P_RH0H-A*5$X0$TX4V\5A&_6)OI-\Q9D
M?TVPL32A@@R:LNLS%Y9G84&<VV]G>#2^6AA.,VIWI*GGMU Z/Q%,>(3DQY8?
MQ,Y68[T1.L5(<)N<(QW@[4:+(MB6J,R= \\28I/B&M2GI((NOW,1G:V;<PKJ
M0MU7PFOC@]DSU&&@\J0/DN[O1G4&DX@V7M#NE*F:2F^<."X;RGRT6F[/?0@
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MB\T[R(<PHR&@#J%7B8B^PJA^6DTTUZAIL<##$[^XMG:4@_76)9&$I\?WPWU
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M32LV9'LL,TR*U!5B N2/6'L,;N95S075UC5_VV"[P# XKU)F7/H9?=S@?(I
ML6@0_,3K[1&!8 2QJ]F2CG*B-<%IK<7=HL2C R\%K0!?T/( ?O!U6A:+Z9 T
M'V42F<98!-&H&Y(>BLTAHL-6U6,LDRA2QL*OU^2T.VGD$;RZ3;"X6YW&E\=N
M73NNH"2><V3I +V<N^XRQSE-0M+F'K=.X'#3D&6$F+OMKM'9U0P;"P0Z7@"6
M59TEP\VB&TRA<=XJQ*+WM')HP/F2PV)_ILS'$FC!@FNV<1O#E66E7^<Z+6>"
MX535[_QS9*/3K:Y^& 7Z*A7NI.(6":$6A)Y:,=XP&5D+X$89+!T HZ2YQ(TE
M T9K6A$.@%"DTR)73%N\)#5.(JP#VAH3D"LAA/4!!/K'K<R9T%RLX%F^O2W$
M]DF^EY^\\?6NJ^%(/!)T/63[M!K6#5<)14W76"H)'N=,5<T0U#)H(<HO7%AL
MO?Z"N0'AH#!8C!E25X3O%NXY4]51*J%(X)H;=^A&UEKIT8E*."$H1YB0.\@X
M7]62/=#W>*53EW/^464>YS7UF\*2CFTO _/K10E9RTN\D[VZA;_[2@O]>3]I
M.]!]&QTJ[[DY>FZ.9\C-<=QS<_3<'-^ FP.E($W^NI,>CO94?'0\/(N/]PY'
M^R>G!]'QD8H.H_VS^.#T,/F?HU-S%?2A]\<,O1\<#_8.CA]<DQ_!@$X>_H(X
MV!L<[RW_:1]Z=X[W)8:FN$T61::(C_72\K%N9SA^K=/W<%K\8+T(K5WKI5KB
MV0?[EP8&.B*HG?U!&"J^I/)52"P2 O:8N%)6C)'Q.@8/GQ3V:R^\QAC'>1<U
M!9:2PA3KN0\2==J\.4&GO(DS!%H:]!37)B1IL;1,T*=,)D2_8;)<F)+P9.R"
M9S^F;[AC"HG\>3K$F*S_?(N>M8%49P)IQ\IO(?+]O%M47&I0O: $)[.KNF0S
MJ$5"E$=)% 87155'P4=X"@O?&VPQA7#>X*.:-<,,<RP_*2P#A]5_C^YFGH3!
M/R)8A##X)4+"[32B_ZKQ?]27-"YH7SY-L-(EWVCXYO(8MI U8VKABXH;@NX6
M6)XBB.B)BA(!(W-L#(OS;ZBJM$DS2CE@9H(*:.H 5.9>8 SN2^I<"K]Y@^L+
MR_AADA;;MTR<6\(D4>DFE[CV1M^[#.I%=@-JDT=I\+G35XB+$J0'*8:7=9,8
M9'M!B<;0L]NE]::[;TW7NW4) I4;ZE9V.D;+'Z?8F?!:ZD2(-\;@0'G_^)M4
MGEPI]1E>A.%09(N5V=E.!"J?$%<"GB(EE4SQ7 =P'[32H8]M]3#0'@;:PT![
M&.B?$09Z\I0PT/4#6,?[?0"K#V#U :P^@+45 :SEB[LM#IF#0-&EK&[S*4N?
M.E19<</N_F*/*H]E]9:K_B$DOVLNO* )=O(@%^P'XH#";\&Z1ILQD&!2JM%?
M=_[C]HMP_]7>SM]^+<"EA)L[^MM3F$\,WQ4LYPZ.A9S7"[?L\9V! 5&DC'SB
MG8#K,V'^LX*#2A142ZM@9^' &,Y=Q&7"XB@$(FUGYW:,MX&9B20<OZ@LK:H(
MUFJB,!2)K#0"B:HFL#J3(DLP,#%*,V)+$<8.!!@.U23*1KCL+>-=.HZZE<%O
M4B;J@/<T96W(K:Z*!L,6N?T<GH;Q(@.J,NA&W=@I3[A\M0RF"N/ !D/V8P&C
MP'^\(4ZF@MC.,JRT'S/2CSD81RI/(J)'X=[SB5 UC=*D ?$HYT'2T)4TY.Z
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MGQVHLH^6;D6T=$-C-_<.JOV]N,&,X'F2E+:1#H?5T&7#3"?YD/>*L6UQ#.T
MS.^#Y%'\\F.&)3 H0$.0'#:8T/9(;/.S2*R#$K_+J5I,#39!O;H"<5VN/[C
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M_I/O6!R*]%8IO4<3=2"!<*#<)+8B1 !&E >M-0''@G<*(<*LV-FGHD:B6PH
MSI1&N.WSF9TM]_<%W-KZ.W7@.G>!ZW9Q7G==[R)D#"LPM11,O9AF+80J$2(F
MP+'3P(2TH*F,0(5Q2=EPT@JZL\_F9),VA+.LBE&EWE=] 'D9 ^^C<*$"2A6
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M:4$* BV%0']-<P8MD A86I"C&L=I@4 ;Y,$[+Q0Q44O.$F<HU8V+Y;)NE*'
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M\;90?7HU3ZC=O0S^^&,8!S,7/%H"CXZG0VP<U5IQYB%X&B =(!%41 @\\KF
M0:2&CTK28]3T$E3%IK*5FLM5Z/>\&9P5%'EP%)EH-3%7G[*> ?$N DN*#&B"
M!3A+/-*6:>5CEEM%,/EY"\PNJZ9RU$KIN2YC>B?$O?0QK*]&5+C7"B@U'=)"
ME PVK11H0Q,!B\J"M3J HXIR1H1C.E=1Q[N(S=J&&Z+LE#9B30*?FNA0!7PV
M!3Y7TTU1C=!!0XQ. D/6@O)4@* R*AV2RF3\SC[ANYJATOSK\9(@2].ME5U\
MO42DAE]N\^P^YOH=)2;Z,17'FS7YO6.ZPV==_^)F64J,P7)0_E4C+6^XU%I1
M($AS2&>O I4T2' H!.:((S0'1Y-=*F:QO%F*9/'W/3V-KZ!&E:@QJ?,=E6%&
M&@9"2Y_XIS&@L#. $'>(Y=IRT8Y18^TZL\7WM[#LO>KU_*=VIS,)2<JE9$WW
M?7N]G*ZZV^^;H+^\OEV(,0L=]RX;F_!OUJT@TE*(=*?]3&*@#J?3 Y"228]A
MU().9P<H095&SDN&<C0"VD4EI+JX_QJGR!3XV 1\3#4NX=0BZB-X&Y-"HW/C
M$D<YD."I%UH%.@H>P+M$\BWP^C5%HQG%ZU7@T*LM]CRBZG)O9&3NG5ILY"L@
MRN&T0J*=8H%3!<8'"XRR])OC%(+PF H2=-)7=O8U;VPP4C&K/%EMI(!%)6 Q
M43\,<]K+Z !9GM0/%3DH% T8B;G$R$3$PRAV4:VM?=3 GK*=793G:RF5/8LZ
M%2BKMM-Q%?W5MEM56S+"H2#Q4DC\YHX=R5(G4$C,#UD## D$VGH%B1LJBC3V
MW,N=?<9V&6]L MRJ,+QA(],F^U\V"U^K[6_9$'QM@N);\'4U?)UHNIHII3E)
MFJZ(&A@V" R6+H%LS"'VC'IE$[ZB7;F^Z_"A<*Z2X+'92+?99II55$U_BA?8
M_KX.O[6-;7?:P_9U08H_STP_G/4ZZ4$-1LDJ\N=6#GX8?EFG]T.)2JQ!!X?.
M9*E+&X>FAFH\<R[-?CAH?31?<NW&TL*AWJ7+&T'^K_?4[^,M5?(<5E%6WT\;
M R(BGAOLP#KN@/% P(ALI37<,40=IBSN[!.ZF[9'PXT!-0HJ:2KVE;8-CTC,
M"_95@GU3+BE--6<2 W*Y,JF@"E0($:BB*DBN I4F81_>I7+M2L@E(F;Q_E_7
M+.!CKS\2NUYL=7K=]Y#(Z$6K9]/D1@4@ILH2M@9GZ;/C#R3JG":0[K-$TVPT
MFN:WM"0GZ8$?!#L<=9/YV!Z:SF_!#,+Q9(T*2JV"4A^F-30<9$0>:^"866"*
M!+":$F 2:<P-5<*[G7TUIYM,0]2S$F6S;3I-08H'1(JIE"7-8^ T@@O$ Z-)
ME='((N""<VH-<R;&G""P!?$U3=%EKJ-[G>M?!C]MURQ92H]:27F\(%,NA0(_
M*\#/^;-I1059K97E# Q1$IA! 0S"$CP-U&N-49 L9TQJ7AJ EO2DFJ@J!3<>
M"3>FS# &8Y'3"!0A"IBU%)05#KQS G%#")/9!+U+:&F8^7#2-^UN[X>.&2;]
M9=B[#@&NH/ARW>E3?0PMDX4H!5(W!TEW2L90@81QRH(R**DRS"6EQK"T=QU2
M4::M(63:?7HV?*LA>DPQN6RS'G-?E>6") ^%)!/EQEI"F1<!B L.F',$+/((
M;"16!$4=5JZR8LLU,,PT-_%ID;K+%1EPFEG_M G6G<+,U@2O.Q5G!,-,8*Y
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MX]J<!'TT9!W1D.\.DP72!D6PH, 8S!"T0DQ5A6FUB\F"?4CD,6V.:C\^3;+
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M?)99RI61J+XTVY"(\]<>G\'$N:GYA(?RDKW_PW>GY?3H:#S$T7_?5.(\,I-
MK,&C>FY\?!)&5;("^G#-O9?C!/&TD@$I=413U^5"P22Y=,72X].-\.F/KFV@
M<YIG4>5$2AD GT(@1G%&%,MTSO+<",%WGO11FMZ_NVE1FAXS'A8S%B9)[HST
M/N>$<RX(%T82PYTE(:=<4VVIB'$59O2ZN[FZ^\ VR;D0:Z_%#Z3%'<M$V%P+
MJP4I,LD(=TR"4>+A1Y8[1W/C58$)&GPK6@%L7LBD#\/<'(2>E7B<=N2K 0 0
MZ/GQ>%3;8GWXY8$;'>_'N2Q^3G)X,QV[#SW<W@ANEZJ<:,XEIU*2*+)(..6
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MNK_1NM\QG@#9"QIS0YQP#'2_<,1$)DA64%P3QE.K=Y[(8I,*\7T3H91SAM+
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M,&%5U+,/:\'C8EQX"$<A^.2&JH7;WC!=_A3,!N3\S3<;QXT/X1B^ >8YAB,
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M!WY_(Y]0$W ^E^95IQ2D/(+JXIHJJZ4/IZ20TB<#>]3&?M,5OE^9FF%K[]\
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MRV<O#[@7F7$R$JH*27C0&='>",*L 'O?"<J-[=1-7I1>/ D3E_J9K.J#MC?
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M$"M-)"I70=H AAL35X2#-TF\^VV_QEZZK71CIC/G09PR8,L%[QDQ&LQ!Q5C
MIC>2Z[CS9'HZ7I'3<]XX7+3#;(0^=Q:8ICMG!6+!0"/NN9.YKLT__N/@]9$!
MH;HP2\Z6A,TO ]+%8=IOL6G+A9O4;4EA7X5M%=LY1F 3'U,3T&KPW:+T^O>[
M:;NO!X0-B2> \4V?2 2[<E0OJ.06@8M^-.401[<W^'E1OAUO90X/)^$P[=A
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M"GB7[G<;0*?EA<Z*\_DXIGHCQ&V<CA(FHT2J,#7Q0^*\>=/0)^2BTJD1I2A
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MB>><4K[IRH(7!4*32JG";CX+1TR8K'^&_V-AVN\Q<M655>V?'*%#SC"6A1"
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M$(O'P1LLEHDW> =,I0Y";]D0>L^&H-=;#H3><B1A' ?VN()P#7QD,>>)YX"
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MS0/U[75*@[_QNPE\-@ICCC-D\7[CYWZOD]926O=?O3^D#!LN"P8T0T%:/>)
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MVHO",H:TT+!@"D7()R2@2)!/\1>".FCS1X?K/[H,SOBAYLYC64" "F8 =5@
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M.E@M%=2&0&<\C;#FR@K#/#*6$:\+WP4=5E91M((.HA#>J0(H(AV@3&$@I7/
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M-[;9IB#+"BJN3%'\4GA3.L6PFHJA<TV6I"H:U\1C0<,R"F B'#,5-+@FFE%
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M<]#O/LRUFE_+.#2 NZ<6U@D.YK)U"G/,I566N2AY4C()*8.L%G99"WOG3ZG
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M8VS#!V7_:M5@=:YMO4+%9Z'B2-=/S"EUS$M$*8Y W.!OABB" I<)U@PVM9
M$=>6MU7E[M: [%3:O53M'N4\.G*..= =G)6;2XYSZDQ"DDG-(P,K+1=<4JL1
M1/@N8OD.F@U4,HLI?8R*INM8N*(\-8Y?_;EMG,4A!^?0F>[S')QKDN&R#CSQ
M(-Y\TQGY)G:,U>.#8QUK#OM*L]?XN:\ROS1;;[Q)XROM)WZ8+<9$0U)6(^TD
ML$4O<WMX!VR1.4HL82*& &R1Z8HNOAGE7SVZ6"G_*RK_&)G4D;%H'#(Z:
MHY'E&JQ''3AV"KN(7387\=NCD^O"2);@GUKU".[UY"-ONK;F*P'2V8CO"BO%
M#9?(!" BW B/7/(*!6^\HLR&7MOXM?5=+??,\4UH_GJ2D4KSEZ+YHU0$*QJ9
MY6"&L%P**:0(M@B 0>+,>ANL=P9L$;XP$WF]H[QO!8OU@X8?+S([K^-K*.RY
M?PN4?_]!EBSG.RCRSE5LY(R)GJ^KW;&-8%NAL*%YW<M7N+J&12QL.^=(_-:M
MWQ9DL\@*6RP?TL46G25X]KK9KI51LV6,>>U+_#'']"&ZI2=CNQV\53^NEOSP
MO3:AL8R.Y]BJ\\CC2FT?"Q/'A&%3 -3QQC+NA+8&R*,T5@D#7S$Q W$<*BOV
MX2ZVFL&VSX<38?9*&6^F@= W4R/>6%\F ^8LG[Y25-O'7-O'2-]UK15Q+D9D
M!,_5Q&A L&$X)(Q2%O,0*669K6E*Z(_KRAZ?MW>\AJMK;>%C8?;)A4B<1@X<
MA7,%=HKV"7BGP%@P:@T>89^]OTQGGQ50O"!0C/), DNC"*!#BC(@GN-;;: 4
M*><\29X)7%J9>%DNK]=0V-'4WAX/&*V;^'1BX A;)'IJGESOHQKPN4;G \H_
M>EW=I /='$Y;[FG M[,D1[,J+;6"Z22U)8R38$T*TD2AHE,XJEQYLN1S$RG2
MK[]1T,Q(1Q8'E_,^=1J^_5I[O13F=M$YCT5,*0+Y!N;]7W- 7I12TB0<B2QP
MC<MR"0EFGU,)J.?<#) WS)@:W:O0[/2_'T;#3]'7;;M=2R#T/30<9'CGC&<P
MP $86R&;X3>USOG.'S]I3M<>&I^?8KS'#G;/V,$=W.ON(S_<W3^EFDBA2.ZE
MCBWB,7KDE#(H<D.E"40+Y3>V*7T$YOI9@D5J-:^*UF Q;O/)^'VJ?9E[;G,>
M.TA1:L=.3LC-HM6S]R;#(7(0Q,/"%7GERM]W6J =I=E5G'5KY9=;D_I7?"O)
MMX]H$K1J*.U7/I7YO/W?KO6/[1EO_&0.]<O>:3JH3SRECQN"9U"?L&3O\X__
M-NHLZ \*/UQB'6Q2W<[CE\SX.J^;66W,EA;L.8G5C&X1)I:> 0VWY73Y^=KE
M:-4R$JOG"!M:@E-J(MGVE<L/]--,6_ ><+/_B;8.^//$KAXC590O/I#I;HK_
M6SZ?F'$*BE]J>:,LLDNC^ 5VXX)@]+_?\".]E"24N\3+"L+T^5=DRAM/8=)+
M!_'RS_/6PW2>1>1:T5XBFT I/MCZC;UM;_QC]-'PW/[P97[PS,#\S.WI>X"W
MPO0YX$WYEGJ!\A4";QEMEE\5 VYK'K]T#O">-#DC)XF),9-S*!^]__T2 VO[
M1NX+J>A!LY.-E6:_'%.^[1\=VRF+P\S4_&+&B9@E:O8YMWH%-!FZWT1YF:'O
MQK34Y3I,$SK9O.[K(M=;E/!'[6WBC0Q8@"7A&%?):$RYMX$S$[4PWHW;VRJ:
M0)4AT3K)M2/62*:X]2F"I>Y"W'BI0E2#0]T__'D,W7H\3+]T.]U6W*\U:E?=
MJT]EC:%!8L)$E%E5MNK@;O]4>6*88A[!DHG<[#0@,/XE"D*(8!-SB:GQ!7=4
M)LQL/E-A/%AIN&'1)AN, $&)?*ZR5=^C1E5/3/IV['5?0(JRD$[1*,/]P42%
M#3!OD(,2<?U#S$;L&= ,;_8(UDUL9?.W7_.J_>&;9FR_5M7WV(&9?M8.#%LE
MX;-5>IKGMH1O$3*;G3/?(YFH!DMFITQ5]:RW7CWKH4+/[[,VU%N.ZV#%YF%0
M]O-]S\)1$VC1#"__#!!XK?(&Z_++MYX;"0R(OEB_^S=82F?V=W\3 13$XA"4
MD)[PP'50EC-I33)@6WHC/)O>WV$R:O?WV&['^$B2T,# V^W& WCRT4VL?XG[
M,(SSMY*,?ET[^?4WL.;^/#_</:GOWWV&:_;@61]OCR]^NSK9/6/9PCOX%:R\
M\6"*J]\NCZ\^,K@W/[B"9^0*[!>>'^S^5MN_.KD\W WE_8[AWO^^VQN.NJ(<
MFQA90,93AG@0##E%"#(N$><$-ISX7"-,+BEB=V;56$;8TP(IUQ6\5?#6AS<A
M)=. <<(1SKDG5HO<T49J&[6V869XFYIP4,':$F'M]A[65#28XA00H]PAKI1#
MCE"#2"!*8*U4R/4UZ++R$"I46_\2K>N%:@L'S3^O*==HL&N/L#T*:,?1M@[!
M2JIP;#X<.WB@9T+#PK+H40A$(DYS)3!N,!)4!N6=ED;)7-MADIZM24#\]P70
M%ZRIN + ^*@QS]YD09RULV,S/A[=-"M\G L?]T>SS0-QQF*4L 9\#$#V+"<,
MQ6ALH@HS(.@;VX:M4.6+9\+*H[[I=ZVRKV6;5:KZ3%5],,G*Y8E&(V^<0ES*
MB%Q@&"F:A"&><T+$,DRR2E7?M<%1:>G\6CID<!@7%1;8(:IR85)##'+&*^2X
MP,Q[KCS-37_)Y(ZZ)@;'B\/#.ST@Y&^RJ-5ZVA3GK5AY7>8#P8_#5H4,WG%,
M),+$>,0%\!6'F4):TV!IHE0*L[&M'LNZ^]ZUI)91:?A=*^VK6A65LCY'61_L
M"IH"80$'I+3(RFHXTD))I)111(7 F(-]F*Q(]_!*6=?5KJCT]!EZ.FQ9)*4E
M-1$1X0/B7"=DB+8HJL@9#AH'ES:V];J?9*RX8;%^AQ6B.JQ8%</BEV:W54'@
M7! XTM?),ZIR2TYDO<<H>SR1#D$C!="8DE#1![RQ+1=N=%>Y0%=39U_3KJAT
M]3FZ^F!6&(YYD,DA;*D$L\(:9 S5B'F*HQ7*!2N!KE2JNI*JNBY61:6ES]#2
M(:."2*&E8!0Y MLJ9Y$A[;%#(I(D/%:&)=A1575:49U6C!@5LCJM6!FCHO:E
M\JO,!X''HQD\D>JH.,J$!?[P-M=-EHBIR$-*)GD+$+AX\Y_*_[F:.ONJ1D6E
MJ\_0U0>CPF+G?1(8*4- 86/652XXHC:ELOQ.<G1C>^%HQ4I5W[=146GI_%HZ
M9%0HA7,BK$0.BX0X,6#Z*\-1TEI%IDCT@L..NK9&1752\0)K<'0>6[$L_5B=
M5ZR":;&3EZ)"PV>AX4A[X5SKCT5.D4M.9A>+0II9@S"/) $L4IY;>A%.*E?H
MV]3<US(P*HU=2&,?K PO@R4^*41TR#4]O$'6)XP(9<&'R&S9#[@Z95Q-?5T'
M*Z-2U454=<C4@!6"_Z:$?!0Y?Q&TU&HL$,':P,9JE"<Z;ZYK&Q6U5@<8\V2A
MKZXADNO^%6E:[=M%#CT6*PVRMN3GM<V6"DSG M.1UN/,6^>, DLE<HTX519I
MYR)2S%J59+0N9-[#U!NM^C/3>!;QS+Y3#'@M ZC2_7EU_\'F21P(%$X229ER
M]_$HD4L$ $ 96#7CC?=L8UN]U8)?E>JOKBU5$K)*Z9>E]$/6D[=1PO\<$H((
MQ)VSR.+($,-481XUU@0V?(DG-_PUL9Z^+]HL\QAGZ!6^V3UWGEYDK[^$F<E_
M&/0+:30[Q6WLP%1<@4+[&)[J1/?,88DM.DO+@\E.D7FR$=W2DVU#' R^WPV!
M_/"]=&&LA<ISG'@S2]5*[4K?W2A]\/ ]8I >-#O'L?/30*AWKG+[\FJGFFNG
MNAPV35V,%%9+(JYSD%[R'#DC"7(NF2A(T,2H)03^/ -L7\-?/]-X%G'FOU,<
M>+YA.MR]^RZVFL&VSR?18:K!6F'#4K#AP7250D0CP%8-A";$HPE(8\60\YI[
M+;FFSF;FJ"FA/U8(\9X08E7MUPH#EH$!0Y8LP'5D3&,$<$X1YU8@!X0!24E8
M$I8I2]TT?K F=NSW19WWF./4LU)K5]?=#ABEM=R9++8[5=;32YE3HX;47F_>
M]_K37B'C7,CX\TV)BB4Z@NE$:2X6FZ.9M$><!(F,I!%I&6&U'(M4Y%.]A<.9
MJJ2)U=3.14_?LG8.&S*5;BZJF_M#NLF4-#PBI?.IF\,"::L="DZ!:E+O9? ;
MV\OJ'5:IYONP+CXW@+'Y;%+$\/-7#TRF,C">J:J?[U552*(L]@FY,E=8N%PS
M(5+05QY($,)'KT!5)Z/XU\3$6*NDIKXAU._K/FD+O:% Q%X$8KVOV[7)?LRO
M-E>KU+-LT4Z,2Y^;5=B/OKLA-PC4>N14K-I_YMM_O@Z;<0(K':VSR'NFP8S3
MN4R%QP@3:[0#'F$%V]CFRBS7P[T4B'U%#_ABXYVYWV.%K16VKE 0;(6L<R/K
M@Q'.53Y!E!;A1 @@J]+(2/A#!<J]4T9'J8'9+UP O0+6=PZLBS;:?9/ NJI.
ME I2YX;4!V<)%Y@PG0B"_0W(:@H&6<9-/HYUW@FCJ2 ;VX*_D0/95</R9[A:
MIEWRGG]935<U7=5TK<@OJ^FJIJN:KA7Y93E=_^A85X_WJ2<]$G?0O0+NY7O_
MSAR]UNC:'JN#GPWN>65;9[7&@#,Q8&=](H2R6?:!Z%%;[:+;[M32;>^C6B/$
M1N<#RC]Z77</'5@EP^_5,PQ4-($J0Z)U,A?[LD8RQ:U/T;GD0NS9*W!-##LY
M9)R:9"DV(3F:N%+,2,>$)<0Z0[7+I86F/\=1F3"S0*3!T E6&FY8M,D&([BW
MD8\_)QJ7! ]$,L\Y\PJ>$XS$*0J>&.6JG[PTL593/GEU3DYS0M:(6.!RQ:=.
MS',G]-L3M-,NFJGXK=N(/?N X<TB6Y.;Q4TLSBWH#)!S6VL,TMDZY[8#7[5B
M$;]&7X8.NFZG",#Z<Z;;N?T2RT5J->OYQIWS")8M6 CU6WC1PK;;L=/^,7_<
MBJG9BIOE+R9.  O;"$5I'*!F0EWXLG=E8>'!^3FMZ+/AD>,6RSO (TO3PY8#
MLO7L0"S:YS%VMF99_[%$LR=U>5)S^WJZ_=^N]8_MR3N5*\$3CEY(9[S$/!&P
MYZT4T7)+C*>:AU.2NR;WKQH!FU%?@ ZP.IZYD*2'-?3:"JV%A05.TL'=3W?A
M>XP5)NC!*3#J7]V-KK-;:_MZL]UMQ2.X]3_K37_YW9T '^^= /N_PKUW=\C!
M!1C@5WOXY*\_+PZ/#JZ.C^"ZOS[5#BX^WQ[3X[L3,.A/_GV._=6?#?N7Z1Y>
M?;PY^?7X9G_W,SV@\)N+3_63O_;%/CTYSV,\^76/'AS]=G%R<5#_]]WGKP=W
M>Z="!A(292@FR?.I4T#6)(J\"_"QE4ES.8X[V($J6L F[S#7/CGAF:?,)9TX
M,P1VE]CV]AKFO-/JQHTG!$H^)5!C2!0C593/C42$?<L?52*_W"I^;P(6'<76
M57'H8#BE:O14\3 K;/''>;/5Z?W@G\W\1%#I]ICJO*SH_N'/8^C6XV'*0GR4
M=^CW+;\_GTIN0PYS153G4L3"&V1(,$ARQ0GF7 MJQ^67$^FH=SX0*WD4V@$
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M\EWY*RI_Q7)YA?"::1T%#D%SKK")AAA&'!94F*15Q2M>!0D>>(621BDA&8"
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M<EXX%3!8R2DW\WXB9J27<SZ+!9;SWZ<G0HR?IK>+&^#;M2M8UYC)[PO9;MB
M[1ELH"(7AV=>V\0T3I@$Q13'ZK6$[QUF5]X>[ )_%3QX21.BRH/PR<ASN[2\
M=25KDU:P66@0OB=J@11DRW ]B[&V=K;:T4B@4J\<XXB&Q%RW,BM#AM\I ;_?
M*N"X?E-RV"AVNF?P_(*PS:&$D4:CV6WX7/R@VRI#QAJEYG<>PG1R-&.9A-J*
M5[;6R+QF.!WUB70RN,\?\;K3"W,C8I"QFR/6 .9RLFX,*Q7T-ED=9Z1HZ>#S
M\37O3[3@L!+7S78M__A#*]9M3D;NEZ_I%TH>NJHO(OCA$NO:S7JW\_@E3PI7
M+A 26W!!69_VX2EE35R0L;J];L</@[_\.%9]I[SHQ]$'Y$ZIX_5X\O-Z7_='
M:=06\.(\T'XKCOZ#^^^P5;[#6(7??O4@N@4&[Z-?XRWRZ'??N"U_F=L2QF>Z
M[3<:D\S90J0WVR]0C^B;P#&E;/X+/GYZ:PE%QY3R\9KX"\SKX!;3U.G59WRL
M>LQ38?L1;!+*7VKN_^^[9 R4C_[E(;&Q^ 5X(FP&Z'_GEH21/@;3BG</_7G>
M>KCZ+"+7BO82E168/]CZC;UM;_QC%(L!)_M#EAF)9\;LODAM_[=K_6-[=A[Q
MZL .K[*%>Z\S+[)3OJ7HXU\_%X(%WC+:+/VV%&YK'K]T#F2?K%P?.4E,C%6N
M'RI.W__^N= U12_[#;9>"!)Z- ](TR^ 4,#(X+9EA;*R;N.C;3.'9FC&B7BT
MK=Z"MYH" L\C[]/4=^)^$XJT6/5#_FCUP]FJ&:ZZC;*7LDD"VA-;9[GJ&5AK
MC;.R1%I^XU:SOIFMTQ!3K5$6[WM@[CVO:BV-E![T$>AWD8L"U5(M6QJE4[8-
MEFV]>0.7?P$[H?2QG)55Q]PMF#S^/#_NCVS<P"Y<_#][=?UC\:]FL]7.SMSR
M\C]BZPO8*?#,_68SW/Z__T]3HGYL%WOE#?,O![\H!_5+K0,W[5^<QWE;@"T"
MKS@P;?HO$+_>%T&##\-]I;I-,$@;\#;_Z=; :"UMU7ZEHQ';I>@5HW.Y!!L\
MK_>(S2*;M[&\0S.E_$&G.60)#UT.5ME\M0]U@,W9,Q>2]#QE!Y#06EC)?)+.
M&?^-1-6A(HC9S7.81[?3?JAS.%P#MK3XWG/APSUV</?YU!/-%74.25\6 ^8<
MV?RWE&2*EA!/+,G^QLF#JL?-Z-)*'MC1O0J9(W;TI*/C.Y1$/2P=,?T=!Q1D
MI]7*P#"ZYZR+(V:O4>2-:>!EN?<V907_DGNG=/KM0ZYC#[!Z/TF 69L#EU03
M]+=7'K%>@\O@;K?](HKQ.6%=1E.<F/0AL,1E2IJ!!MM\$LXHD]$OH^0SS,-A
M^JD58:R_6)_+0=[NVZ^UJ^[5/P=>M9_L-7S3N7W/OEUQ<+%_RK0BF@:'F&,.
MY4J6R&"9$!$D2!EII#QM;-,G?+L]&?#-JRL U"RYUQ;$"=2_"7O=59%Y:F^S
MF"]M$WN3)-;9Q2]XX-0E0YS.A1PMDYRY2E!>L7O,[OXIY8J%\FC24I;38V!'
MB/!/)S%SQN0 0#.+H+3BEV;]2XDUY<07J3_S#X='Y_;+L[!%<:LCB*R)Q'%-
MN"&&*Q=\T"1%4XG,JW::V3T[90;'0)-%(DF5<^\B,DQ@Y+TQ(B^3D?SI<Z,'
M;*EU>@[\3+1[!7O;-O]Y+SWKN#D_G%@,Q?@UXDW_B&26][['V4%;KW&/WB_=
M\NQDL_C]]Y^*OV<+@N(??_J?7\J_D1]_N+_P83#]@J=TJX#?E4>\S=:9[45R
M@Z:\S[HBF=*VRX.=;NNZV2Y-1=>]S4 VO#J93K4C""]\GF?^2RW$!XK;[EF2
MS;*HX,-%I7%5:P5T;5MY2?LF4ZN]5>S &I;+ TA7^AS*:M>E:3:]\C<\ #AV
MLQ7*8MWE#W_=V?G79KF6M78N\!WA,3E:J![/X.I\"@</3:WFU1,%\LNO1\II
MW\*8P9+++]L>?QMXUM;@@2&V0=-Z);I=S,_/5G+F";V)W 2*T+AL=:\[_A:U
MXA68B(,QW90S9=OMV.F5_WXX.<U+4;_-]VP#<VVGV]+F\'5;ZU42K\$5O0VF
MF:=Q[=#A$*9Z8JO,"S$#*-1*ET3/B.^V>[7800)MK>R9."Q'C=@!*?@"[/\L
MECZ+9IZ[!ES0;&6+'5Z:;2F!.DU$0!;+F9TLC%P"5WG.74:.7%W7:P_"!X(-
M [OWX/GFEPA_7\,2/#O?J D-<W!NPSPQF!1K$<! $S@X3JBW48H@F #:K0G3
ML]E"\#H^<Y8;4/EV;(P3EM*>_2/'%>0^'_<<Y3UW0QPI\L;V<_U/*:6B22/I
ME42<8H5<L GE<%C/C+9!T;DZ#\LD5') /%4*7''LK*'2P.(J3U**>*:R\-7*
M+KZR/@2GC7%(&AH1MT8B6 :P<:G7F&BO5& ;VXWFE,[QXY2TY\5JCP2DE/[C
M?JVB1\R:'XOSYDV&V,W![M7C;9E6P2^[OF<<#]^U'@'?6R78]F\V;W.*90#+
M[(;0>Y:XVVSH:)R,<BD@JK-M;!/@AU4*B8A9\HY@;.R30?W HV"_.W]J@UF_
M#?-SJ1SS&C+W&ZD%UE(:UO>5S8949$Z%")'H&&+R@EG.$H%EBM%@K7,2H))R
MF94NGW 1]$X7#A_>HY?H]2^8W^9[CG'^>'>XNW^:F"$^.H:<8#DU!FL$B@5:
M9&3$L$,'IF,NP/)47;RR9=%01'(1 ')OITE0F*AJ73J@YJ1PV<&$,>&YA ,/
MQ+DH579ND.154GUW=K71O_!&?_'S*;%1,6(\DDDG@&"<#ZR$0XP:H1FS5N:N
M+W.LK*<I*@L8X7,5#$D U),*\*]<O4[3V9R)U<HNOK*)2><)K&>(@ @<^#C2
M0A$$!(X&Z>!KHQ>@</81HW:(V\VS?3V#[I5_@<\6IWT:9)\0@7&R''L'2L ]
M$$$EL_&1=$7[EB:E=/_H\M1)IPSW%#$ %\09%\@*+Y#FG%*>K.CU2'V*]\V9
MGT>H=8QP&VC$'/9$8P*C0M.48)F!@"ZAW5BUPH,5OC@^I4):IV&%J8P*<8,M
M<BX "DEK TL6/LW5WQ^O>S%?)['U<U,^AS'Q1!(G*1C!0^2.!Z^3=* XG@9'
M*L;T&OOJT5ZN2N"]!8F..&#$LY0;1PE*6 8=/ N)X+D8TU)".ZJ577QE<Q=*
MJTE"6'"=5U;!OL08,L)0S1EL&=(MQ>GU:-#'HZ3JWINQEE!71B?<GZ5,Y.R-
M>OYJ_=- VQAJ^YMO.T3PRA,T6Z\W;WI'JT-I?T7W.I_<S.7EH'G=N2(Q!.Z\
M<8D'$6&7PL'"TM,ELX.9XQ_>GTY^OLD5964 _A"B1C89BGA(%&E8&A19,%0*
MIG4NYS=9]W$NMV"9UOT*G8OGD9(2I2MP+@7A8'?O%/A-\OE\*2KK$8\JEXW%
M% 7-0_9">B75TP6 5K O<;7(PXM\>4H$,!WL'/(19P]4PK#K6ECIX!0.08#*
MT:GU&.\7V=EZK\-ZZN\M(ZW6YS D-LM3_EH[NRS@9KW3]QSO46:DER$J,V2:
M3^8DOV#ZRM04E2O[%?4S8K>$(G_[,2?"]1.I>A],)K%LS'KSI_-?Q-\V'AWK
M:N1@/TSR*R=AFRTMV+.3L,6+)&%3_3))V&J92=@S))I5><7+SBO^;FG%Q7+R
MBI<C":T\L)<5A$=RZMF4-WZ%S,B'NY9DA"<<O9#.>(EY(D" K131<DN,!YLX
MG!*&[P%_@?1L1:OT[/'T;*GIBZ1GD]GRJ.<:+=DB>"F87Z5GKV%Z]K>3JGO4
M_:![!7/FEY"D.FI2_50>-)83N-,(/Y7<^RS"W,;V+FPF]6:[VXI'\,1_9@;[
MO>VLNYV^G=7\>GSW,SG^Z[<KN/;K_M$Q/OGU\\WA;OWB^.K3^<'N&=A/'V\.
M_CJ^.ZZ-V5D7OUSL'_UY?GP%EM31SU\/+CY=GASM\,._#FHGO^9JT;_5#L!^
M@V]KN13Y_MTQ/271*TXI1I12A\"J2D@GGI G$<Q;F922LF<.@^42PTXV9GFN
M]^VE,#(D[ID%\UAZK$V.TN2$F(TBPF9]G3?-5C<N)WO^40B7<_@TG\N.V$S9
MKFJK&)*YS>)>Y#K%[[7>T?7 C?D[_+5GBTZZ;K]#GN[0L%]V.-\$PW(XO\9&
MB0A_Y'39["3_LY=2W\_4^/./ 1'^J=FZ;K9Z\_CWC8<O-GY8.X?X7J/XK5N_
MS;E+O(S:B^V,IK7V>0S%)_C?H;V\GY!^_M'&^.<;/VP6MOB\]<<6<F5A\[/^
M3%Z?V]:5];%;JEDO#SE/[)=')K8L;MHH:@V0TUS3+;LVF@DX=W$;;4X!&7]R
MT8AG3?AMWL4>>VCW^AI>L*P(87VGK)SIXKFMIT&*24[8J>4L=Y##LD=&O_#=
M0]$[$-'0S^>R9ZU8;H]ER;NO'?BF/$8IQSI(PQJ4M#.]?,A6'*1RA%XBQV4L
M_M.%I\9<,>_:WI8J4.;<C,[%_8W[Z?CV(9&]]!FWX\/5MDS=*'.Z0SZ[N:_9
M,.* NB]3>']=ORS&3_WYR;7T#H>N:/<KB,((]G?+\A8[4\Y]O@MX#.VLJP ?
M.3ONN-FZ+ ZO:TT@+G]TX@U8T.WSVG6QXSOK" T[UZU:V;M ;Y9"4G+#+ KW
M[WJ=$[MRG*_KAK/8*6[.:_[\00[S1=.GH_A[_F[C\(^=C1]ZYQ_PUWRD5N8T
MV>'VR',U8U22&TF(YEAQ[(WE"EB\),9*R@BC"QR,Y+(C.X-![30:H"D[N=M,
M.^O1ZGC.7YW1[3&X%SNXN_RZ?P'L;O?RE$K/2/#_/WM?^M1&LNS[KRB(>^)Z
M(BBFNZMZ*<\+(CA>YC)O@/$8CP_^0M0*;6OAJB5C'.^/?YE5W:W6PB(C0,)]
M/LPQ4JNZELQ?Y9X)X:'2!.3HA&21I80*.(Q )5RH<'&AX^G>(,)MLLL=]+N,
MV(V517NB/[8(5D.,M4-0 _EN-,SEV-73Z>;*] L/MIC:B%5MZ@> ?AU!.N2K
MZ'BG\Z%VB ,=;OO*/O4XS??-OJYS.1AW-69%-C$>X!68 J2$"CP=?$\6XN])
M+,<$$%R<(WB7#_G2WCT0,<[1S^SVPOGCFP4_0#72TZO2S>54@='NI9/:I4BA
M6*?(W:;;,&7 '5>?%7X*3)YN7GK"L0M@Z,/[1V/<:>'B-&$GRYTOJEU%<(';
M$-9L^E@GJ@L[<>8W3<&U/G+W?J/%>H5X^#L7]CGN&BQV,_TRC +%IU#TZ;QV
M9P'(]@H'K.]O$%7PPNU/OF_@YT[G_5@6<+)PJNCRF<?5/GP"(MD("==%&O0&
MVI>GFJ&HLX$+A1\,$64=D79SD*XK$(9U8(;RY<"+4IT7>."EZRG,2@AVZ_#3
MATGN75R *%),5F)@];KS*A^J<8ZMPD!_*LKQ=;4XMYO_73AP+1SM8YW>@3)
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M'A3>\4X^G4RK_K J>@R#3DKU /FB)HP_<0MP_ZK78$;GSD9>SL;3^^2%LV6
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MQF]7Z'7'VH>EH6?&[!Z8*$EMD&9A%C 3PH5+(YE%3,@L5%P&=\C=;;/\[^:
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M12]!U'X24;N!)KVAW4&^-VH\G"2TOOFFSATLO1KTJNRWTK-05[GR-%/Z+/1
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M;IQ>6ME3>D*CK"B*0=]Y2FK$=_0_$2)796<!P$9=?T^-&K:6&?,%O/9_QSD
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M*4*+)"*+(_P3CEG'<.@:V3F+PNBW%9F16S9_VM9##Z3"S#0?:EG[*5B[H<O
M$<9!$%,2:1I@QKHF/#.*Z,3$W&9&JX0MEAJ6;AGZE%U![Q$G^OA,>3CH5VEC
M7?,K['G=@F!D>L7&Q8E&MT7^;K)A:)U4L&4,0U,T-ELTI@72.P'INZ;ZE<E
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M+D$Y0POT?+^3NP?UM)S\C+6NEG\?EW\;>A0%/0IT*-AV$1/*!",LI1AOFX!
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MAZFO&KVSLM)KOW?6[I3'\G^@#8_-(0P3J_89%@VNAR_>CE>M@J='P=.G2>:
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M=.CI,3RS?O&.'W_XR.N'[Z[J%WO7^[OO;HX^'S>F^K=CEI0.WB*?+$4\"8F
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MD15@K!8PQDZF\,9A!TZFC,D@+K5$%C.!/-$F&&8L)G+C27<%&NL)&L\;M*M
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M&>(Z\;38L3D=.''W&]#MJ8C[C//U4%N.^URI,I[TX*2R'",J?W5KU_8V/NL
M>NF9"TEZGIC75F@MK&0^20=W/]DM\I$4)F@,U+?Q=Q04W6MU>YU^X4J/#V(=
MPJ-^S0'#[PZR7X8@RP\^?(3[GS7W/]>;^^='N$[?B8,/_S@_AG\?G;_]=KQ[
M2NKG[XM4HML@>\J/=X^N#CY\^G9$/P%P?F1'AU_XT07\COZKL;_[/G<CH_N?
M<RK1NV\ V#<G0"TUK%)"E'B".!,TGT60"#.98X)@&:V>YO%1F.2)EBIGB0D@
MJX'@8&!]-$T2*.L6(*"WEUEZ@$+<%S%]C..Y[$8C6\C%)GA[(GX^(2LKX1TO
M"A2?X]#63#+/-'JYQL3+%92S94]C-CB%1N2/AARS9.D3=C ;O7;KM)V1ICWT
M5 ;,MS2<UX,?E7>%'YV!JW-Z5EA0H-C9<DX,:G(H@ZCH5$"CI/^C.$;\YL\R
M(YX("XRC%D4PL/AFNP:3$-JU5KM7//6.1Q8!@XXM@#-C(YC<?ID&4KOL=V ^
M<MC@\UFC608#+NQYNY,?-##_=]PU>Q$A=D$*BFFSW2+&DI\Q<17P_U@#;[)=
M*S;Y\UNW[[IA[PS<E?%=RZ4HXC;@!)03X?KE%?F%'WSVT$^Y9_PV9 $NGU1.
M?F\RM#%<U6@[+;AY-_M314@Y1P$2?.S/:B >C78H5B+?L9"OP0US_"9V+FTG
MAYJ OC9ZQ6L4++;9O']ZMVMOO6\7QBX[<C"+9_9KX7.!']7HGN6W;N7X,,QH
MEF'X8</WYC[SM-\(,>O/('S1 J?OX=4HXN*%*$SI%+B&97Q^M%Z=8A$F@FVG
M(&PQBYJ+/7C.I)@6;Y$7KI$:WL*UDPII6R!TK7C[+?*8X?4=O )XE*.P6IZ^
M9@[]-++J7H#C E,V<AL&<S9X:"?O >0H5MZHAAO#FY11IC)P94\[L0P^;<^@
MX'<(@^P-D>&/C Q_Y'?=+V F#W$387I*+_(*-BXN@;K,!G9+V,M1S S!1;RP
M$,Q)"%_@]UG%)L*R681*9"MV4T9QRZQ^KIW?,6MW(:9#DV*!4GTK8=SU)N*K
MH+E@&29VC8KM'U0\/#_F*Y"JS'3*3XH?CT<^'!WHZZUAPZ/W6B.GMY#<"06=
M$_K.]TS]3A&('-P[O\ND+MW^53&L4FVG[-SX_<MI:H-67<%M"QOX->M*<WP-
M:%!W3;3DMZ&M?#>TE:] 4\ !#7V0ZR'5SI+2C<4J#+"X6-:6'9"C@</0&$#[
M5)2]=%& *K5]HUCR0FJ+V<IK.=P]&3D;LWQI-LWTH82$"_L-#3(3MX4B__/7
MG*PT2'8I/YA-6=A:].;W9SN(.W<*'_;D;WO^T@4!?$Z$9 C7P.N\PAJN2U%C
M3@A=*O_UQ>5I@"SSD!0<@S[XD&._)CN80[RL?6UG[[#8W)X6GAF9N86ZV83G
MN,T DPI?("-5V_=!E+//!>Y JU@7^/^1D$^ZV-->SP0.9@QK][L3NW:%!S(8
M"&A*B>NV.W^4W>&5<*O+#O@+OG3F)O:\&MW>I&*,W/'YT88WA4_>&&SB%_H'
M[^8;EV5,;/HF'=#C5K^T$L/=J?5 TA&S^+U@%J\ 1Z<]\;'=+7<[\VOF+)#A
M)N-@!AK/HB_>%A0#J!:,HUOFGY2.Y\1SGUEWYNW-UJ[.8JL&D]1MY-#L;0=K
M3#)G#<A@UN:]VY1 /V_,ZT\/-*C?C =I?!!O(J2QUQKE!QZD4=#C]\&YAM'Q
MO!\\-D9.I+'!>*61<%(BSJQ$!F.-P ):'3##*=#%8UWK@P-%GL)H'V&0P=R_
MR-L>-UGA9M(8LLM[1V!YPFD>JU+WX1C$B'I,)&ODD8)&QXL"D,K\"+CD&E0V
MD^D<Q@\%GWXHH6"XO5-C^)=';($//LG]U\2\9HK?XZR.++.@'YOM+<TVUZL_
M5$/HMF;+=49^J&OR<KV8'QPL7^4)H/4NL[7*?L'KV%AT?O9[MH&/>*&G'>):
MLZ:JC^U[/7L6(KC\?VM81V[U/54'K_I\G4"GYO(I]Z@Z@4ZO_._V&@&GL+W2
MCY@-_,TI]_^8=U^G]C/S97_SV\_,?Z]'I&O%&&T4"?,@&?>":,ZM-];(:!PV
M,=R=KG57>9(1V9FD2@7*K%'^U7+TIZQ,<MFH[^9J)%^NCF[@GKL>US\<7QSL
MGN+ZN;^J'\(]/O^C43__Q [^G*I,<K&'ZX<?KPX.?SV'\5_5;S[BXXLC?K#[
MD=9OWL)S/I*CBSU:/_3BWS=[DP4.);/:"^N0$]@A+KE'AG&'<!1,!Y,(<V1K
M9S:9[SOD]1<B6#7:6BNLWWRD>W(AIABX4,D(3KWDG$<C ]5&8<$<9LJ'QQ=B
MJI!N=4@WKL&D%(\>$YGQC2$.N(:<U@D))4EB+AGX'OQTM3DMMC:((]Q1NR*?
M>T&CW87L'6;GL'8G:;BO(MR<=U^KBF]/=JEXHC%ZEY,U/>>:.2NC#SAJ'+SV
MYIX,^ IHGAEH;O5:MYXR, 0",:45XIXH9"77B$CCHS$V.*^V=F83X#?$I9J/
M,<_J4BU*US<9'I[NA]#DF7>,RY"XU<KDB@3*V^BB<"FZR@_YGO P]D.$]S)%
M'!$+"N A&8.<CQ(%[Q1 @Q9"V:T=_F0_9(5Z^MHC5G/]D*=UO5A;G'FR&\(D
M($R(N?^2SI4*-.<P"_!?R9CCP51NR'?#F8\C-P3NR>L?3[@QAAA,$)8R]Q5V
M FD"3@GEF (?LC9&L;7#9OOO;(@OLG[AG0HC,D8DPAAAACD<&==:.<RIY$K)
M0(5RYIZ8R..*V%?(L3KDN!XAA]B_.K%!IY@40SZHA#AF 3FJ/=(A-S2R45BJ
M[ZYA_^/!QVL/U;R_LTS-TI[2NC.R)Z,@V%B?J,&""\IC"I;K1 ,.T5(%_I*J
M/*4U\)1R9-@DG*)R"!8)(QX(1]H0CX1GDE&12V;YK1VQJ2A7!6S6,V!CA276
M2,JTPES1I!W%TE!. X/_W=?!HW*2OK.35#3YX5P('1&)48*#I"S23"84<@<6
MIXC0AJVLR<_+Q7+6M+M ->#O-^"'VLS,IK[-%52UK<1:.+CS_;K#=@]N5*;.
M+]EOYX&)6*=LCA7EK2WXXNM@KI_LS2]?@*PRS,]LF$\GO7E#B":!"604MHA+
MQ9!+ EQZ'(.-P1L6P3#SC=U_70I\7Z;5WSV#>6P:W.9!ZHH2Y#8(4I_,@*@Q
M/EJ%$U>.)Q>-5(I::P%6,79JB1Z&%:2N#E+'7,<#<HJ<T6)-4=/18622P$A$
M@9V6) DGMG;4[#;2.D+;P-L=CF(@N[)L$;/TV8\EVIM6#WCEQV/FNYP356:7
M.QVUZ [D][S'Z^? KVC_AB]^'&O1H.Q::=SB/MB\UUL'3^O)Y%5:(Z4R3,OH
M.)/:2D.QDB(&8E,(<D7D=8AMUY6W]2AOZ]UUX6D5)/;M"7C!S!OED6*1(TZ-
M1 X'AP@EX(@E:\'Y @:[J01V_?:C-A7NGDHYUQ7NGDPLB09JXE5,40FN*7?:
M:LU3-!@'%A19$;&LX&YYN-L?P9WP@D3N Q()*"8'^H^<$A()*CPL#N6PF//@
M;FWWT#:(HMSI+%[93IA_>)]5>=%S,4?+9(A+7A(;N"+6>(==3$HX(8A3>+$&
M)4MNYU=(M"02W4PZ7EQ8XI73B$1O$'=$(NV31)(3X@BW0D19)3U6.=//XK.X
M*&(DU'.3")=..R]EH)Y1@[T+*E4^RW='BK'/8DDDV %2>._ 9Z%%]D_@R":%
M&<%,1.6V=LCL)N/:9BA7(;D7/W4VIX?GG%C<JTB6?+)WY3R-+DHO<=)<<:J9
MUT1''AT/CL98>5?KB)GDEG<5C=*:)@3VC //4^!=4461(RD$%7$REF^\=[5^
MP:U7@1\KJ-*CO27,<DDHCY@ 6\-"*"^ K0DL<.5=?7>D&'M7G@K*I,"(X<@0
MESH@)SVX6#ROG<(IN#2O*-GF180&V^.#2L.S.^0+59?<N"S;B:K42^:&/'W"
MUBF.O]ILW!7,S3I _J8D[%:0OR3DTTGG4!AN4B !6>\,XHE19)PQR(-88JY\
MU-IM\)[G<\']R^3U/FV\2Z;^OBZ(7VUV\"N!^$U)(*X@?GF('WOU*F '5M@C
M)_*)2<L2<LEIQ#AE- 6A#;%;._3);OVZ8&W!"7XN.HKLS/8T&3P!93SZA>@A
M2#5:(;9ZOZ#\R<OJ7M%OYB?REW*V9__<*YO^%DU=VD77QD&?F8>;O,RV"%OS
M6: +S<)E)U[:QK@36MF:MIB:9YB36[V(UF.:V$+3%&**G4[Q=]^^B+6>_79K
MKB9[%/T8\\8?HV3>=_HQ/&V6IOM@?I\F?=FVU@KC6OM[;HG=O7,IU[4=U^=;
M#>DN'VIT,>K]7:S6[09^M]MV373@+?KMPIWZS;*18Z=]44O-ON_U!\UOYW3>
M/1RTXAMN(TWW-0==^T\?9B]=%ZTEQX\NAC?==B\/[S1WQVMWRO;4HWY>[4'S
MP8=>O-&MA0;\JM?,'=@3F(F:NYZ8A?P.MR>@:#I?-$&ZSC?-D[!=^S4W)\[?
MS.WO/>I+-O6[F:[HMUHFW]G^O&P,F-MWCR=__BQ,+L  ^]_46O"$>7K9'?;O
MZY;/*[LO_OQ3ON5?MFN[_4ZQRHWL6-9R0.)-_A,7+T<Q,?F.\#Y7L&Z/249:
MIC/AG?MFH"[^EU;_X@K>OQM;T][S;\6:[K4^M3K1YL[3X0/,VS_A!0_&+0K_
M7C:6F^AM2$;>--Y0;WKYMH7[?/_\W0ESGDGC&0HV9Q$(XY%1SB-*6&"<2::Y
M>EQ)&4:BL1P;IQ5WCIB 4Y*))F8B4"*3EYV8X;(_5%NF6O;G679)DY0B)02T
ME2&N942P)AHIJ;'4/(88]=9.JSTGV#7UP1T -=DZ?0!0&?>G+-"\3O)S@;8[
MQ/ ';C /PS?)Q!?=M^<!\E5^KZO,,4>-8V>MWF13VL; ;K7:@R;G]@)^W<N3
M]-^/26-/QE@M"7,NQ[%!4C1H.'=*>:FLY8LE/8 &AW9O\/U0B;T]&T8]8K?P
MQG;AC=MEUW'P([LSBGL8.Q>-PI]X6[S,QL="EE?C/5;?/67UFR]7![M[N0'M
M":R3C #F *O2(VZ$1$9KAD0@6OI N%)X:T<(?$=P8]#P<;NVESLYMUJQE(V1
M(('X-4J/I7?;U2N$$Q0_@LH.^CE?=MH^QE#X&[,T8+*S_.CS:>4<:(3@H#*7
M@V;#OQ3]8^$Q@XZG@V#=Q*\&NHS'/[$.'*%^[^Z?W(L"WZN5J]JFE"[3RI71
M;<+8RKNCPFWY\]R6?-^FJZNFH0\B_)RMFV=\_/P=3(VGE'*I]J8/S>OP%O/4
MZ<5G_#>;N27<[._@* *BW3/W,5)%^7/-_?_=]^CGG8/W8X>B]AZL<XU@]+^/
MEH390_:W \R3?YYUQK\^C<B!E_X%V00R\(MM7MGK[M;/M[$8<'(P9)4#.@MC
M]D"D=O[F.C_O+.[PO3BPPZMLX_)U'HOLE&]+35<.P0)O&[)L(^Y[1DNV"5ZL
M2_>C$Y<B)XF)J=V5B0V4P?<K3,(>[.<\$R34V^  9\;T'A"JY?-M_QR%;!:I
MS['@1"Q28F.96]T) A.J-R/^4WY@Z;]+%P1/1(1D"-=$::^P)M&FJ#$GA);D
M!'X##"!3"^42,Q*;W.Z0.^JMU(Q))2ECWL'/;Z/&E!*[9MM_F5'9]N5 5;G>
MIH0_QEG\CI3Q,91.&LMY,$9QC[GWS+H$\VRCDSI1ZN\IQ/ @I1MO9I?[+>-H
MS 2UR^,[2'L#]OH'"/JM4$VL6-V U1T<^A-O:-1. /9ARQ!WC"+MJ4&21V>Y
M##@9L;5#]$.D[O L<[1F$0\N(C97\$W-%<2M?=K*H;-[@\HY,G-O'+G6!DTJ
MB&(G7L #<@0#[G4QC,J48?'33BSN )SQK.'/:B!._4X9SMFW'?@ 1(]M5,2F
MV)2Y(V)3>+O%Q *XVX?V+ 94NTA/G8K:=-<H;#.;L#+*3:D/1EU%9R;U&!_L
M^A,BJ8^,"!08Q8AC<+TU,PEIS0&/P7@%#7I,\8/1F<.S1K<4ES/;!06.K5O;
M;'.VUH:!U6*#KS;>X,O;.XVL>B^_3[ZN>KR78>BZV/UZ=,AUY8&SQ^@[)E*[
M1 7CDG*6DK.*&^VC!R-AC?>+%?*O;/HS8,'';_OGGTYT(EJI:%#R2B!.N$%6
MAX28-TX9'KG7%NPXH;,;+.MCPX</OVW+NT-CWLE;,Z%,%^"Z=@&R<5;P&LF&
M_["]VC_ZK5AB&L/E1O-&XL0\31_D38"=+Y,#NAF:?:?ARH5Y(/"S"H(Y;[CE
MG(6\,U?HZ2_E!EFC..9LUV,@M;-.QK'_:O"$8VXO;;S$P 25IE:*""!&C*>:
MAQ-"><F8:_)O/]MG2+Y?4 3>U'I7"^3?%++Q5&_N&=%]8A,.K-!BVW#[A=->
M[<%]S'G()Y%;KHB(B%JE$:<4&!JU!IG(->8<.Y?WW>9Y=D-D'["@,'2INJ A
M9;I4)R=Z%;E90V*!MVL;AY:WV%$)_3D'I'!_>J,MW7E:4E[\&%4![XG2:(.*
MW'!#@?]$06FR1D<* $*SJA#S7*HRW*"&0;;3C-[\\ HS28O>D?W=_1,EL/=6
M!11E](A+'Y$!KHHLIE1I1S!A,1<Q8??3HO(?H"@/IP7>;[G['0^TJF WY3U'
MFD=,^4%ET5^K11_FL X,=TYYO.S$KXUVO]N\?HAD3_FPMY*=I_(B<XW!F"3X
M_"J?*]<$P,H \Y8Q:A?"W+S(VU3L3P\/[3=O'1":2&\[A&?]FH/;/QS O/NV
M?[AW=6(E]KDR"PB)2XB#!48.*X4$)2JJ9"W8YZT:*+*]S/O3G7Y<^RA_(:&9
M *9VL]F^*IA9WG#IUKK]"Q@OW*4 LG:_!Q2O%>["OX=B10."5F/XEX?\C'QL
M2:Q'NHS9EH8LLZG*V39_ADU5*K>Y6"ROY7&/9'RQ/=7'#);@;<S%ZN=@6Y+5
MWQ4&R\1*]I4WI4;7_*.'HQ<BXN'-V_DG"F<5=VU*+&3#=^N-7\5:WN>V_03>
MY,"9[=Y=?VUFHWZAHZ-KO-##':-:R8U6]>)W9CJ8A97EE4QP$:MI]*Y+%-D%
MP_\8O9K-O?'%_QX\V;P9"KFU\_L#?''A$]\+SLM&%HYX:FV@E<_-.A2.>')M
M(,PUU\ER8K %9U$:8Y*/S"E@QM@P^_C:0$63N5>V!U]6BVCSHYM]<D0_BJ.+
M/QKU\SU<O_'71X>?1'WW+=__ .,]K'\Y NYW\-M4M8CSL_/]FW^='^\V&\<?
M]N@^\,?Z#8SQ\ O>WSV].KHY^K9/8:SG;_F_;_8FNW@R;:5WBJ!@1,C%(DBN
MK6N0I8:KP*W3G,T/[&Y(1:!5Z^5S5P1ZI.U9Q EXB3E9:^^@DS<5]*Q/<&?1
MD UG^\H\0ZZSW":\8OO/Q?;U*MG^G:"PX3QZOD'(D>2*1[\J'CU_H;\[C][T
M":QX<L63OW>!Q5?)DY]<8#$!1\8BM]*CA!N,-<4>6QR2P3Y$MT13FE?,DV$,
M?WPY.#RZ/KH)C7JNIOBY?G'T^1,Y^ !CNWC_9?^F>7&P>R3J,SSYB!Q_^"CJ
MY_\XK].<L_X1^/;QV?'A)W[\^1T]^OSQYN#S$:^??\%3/#FI8'4$=BR,8(@+
MCI&U+I<@B,;*)$BRXK[" Q5??7Z^NHZ&^%Y*RAZBI-/UY.[+N%BF$M6C,BZ&
M.?%[K='!S8,T.LWY>^P4R64M'W_LU(R/_(3$R%G$%D7)6>[ $I#QS"#'K(^Y
M=:%3])6D9HPS,[JC>G;#1/O;&?O#-/R<@[A,UL8&I6H\X0"\H-N&K#Y7@]!M
MI1>+,3PV>K/Z@BF$;7,L-VFP*XW>K+>OO\JXQ.88[)E<C24#<.O][@O&UWZH
M=R=F)3&2S5#NAV,@M9_(C&8OZ+=O5IQCM?D &Q+'F/_2/SWF3+ZB7'.BDG>>
M!T*TC<Z+D%PDFH'KNT!!W.P%PM_N#FU,',X=?5:/KR6\<=FL[^ZQ@\_OOAV=
M[XM]^@D#[^ 'AT>BGL,=%T<W1^<>?G/*ZC--(S[A_7,OC@[A?C=?;HX/_S@_
M/CP5]?,OK$[WZ/%YO5&'=SC8]02XRF1X@ROI8Q0<29\"XBE7R"5$ 6U1R6FF
M#>-Z:V>V ,?S8<$+Q2T>W3QGDS%MM;';#<&T)\=FL>;",J#L5D9N-=>$:1<=
M@!SV,CF[0+'G"LF>&<FN1TCF%6.>4X8(IPF!+7+($?BG(HP0(KQV)G<,QT]N
M&5X!6@5HFPEH+II(8K"!>,:QM"X$JYQ(WAI-*2X!30\ ;?XYX@K0GA?0ZA,[
M3XX9[)U&FGB#>) :&>XQ"IIZ0^&?)@.:V10X6[:#[Z80Z/=3'6;F\.71:]_7
M*7S.:Z]5I_ GIX9;C0%P;(R::FX<L9P[[IF25DO)M%R *58H])PH='O_&_RF
M?(H;A8C!K5(A(DT3N%6&&JZEP([:>01Q0[+$YX/,2[1^?3!LNLD@,7]M'A-/
M\EQ9K5*BU#">L#541Y$"U90'AI->@'Q5\:27@HLQ"W/@HCC)/")&^0%<:.>1
M!9R0R40CN)G/PA:/*%4ZNZXZ:[@CCD;*=>3:!R>\2$D&;TFP(KD%^$6ELR^D
MLQ-$P^KDO,N5O;3BH+/$(Q-40EHI+$(2RD4_CVA\%XU]@$8,,SE@G/%^)=_D
M*^\_Q#2;172K<ZN9;@)LOE<GY-ID-]95=7Q<Q\:LO^7JM^^;[:O7T9?UCB9V
MHVZLN10KK&*[V^_$_.E$6[NB#G""F<C%>'J=ANN7&5J3'?4RAWZ3L\5@!/"+
M?J<36_ZZ*-3LVQ<7[=#H7=<N83GC[;ZMMMMM^T8A(D7ILV%=XWPG>&[1K+0#
MDU#"UZBKZQUO<W^+U]%[+-CA==#8=7Z?U49N+7C9[@PRX&Q^S4M0][*AG?6^
M?]$O:].6A:KSUYUX!EJ2;U3</P\/WK()<]!(C6%5]E'JW;#V(AC56E[=6@,T
M:&;"BK:Y<R>K+*<]<9-!2]=0%C\L*^3F+XO9F/II2C$W[1L.9M-K/(X+:-^J
M@ \3=V4[X>XZJ79^]?O'EDL5VAMK!9',2JZ- OX=2-ZN!<-M<, K*89=%;^_
MLRRJJ._"^'?W;O9O3C$\_T2+)#WF',4D">(B-[$0D:&@?81%$=9*]Z@ F>#>
MRY1,KJG-A?4Z.DR#P1X8L;2*5ETIUV7IH\CI$]:@ *0&<6P4LH1;Q))UGMDH
M;0Z.S2^B<%_%S[$IO>RT73:0;VI@*:>[34[#Y]P60!?V&QKT(]P6BOS/7W,;
MLN&QYN*#V29!6XO>_/[^0F+]^PL5\ Z(#-C>N6A>%PY&HP?2#@Y(OU?X+Q,N
MPXS%+%OZYE;J=S1)F:@ W)NHOSECKN&-&Q>@N[%XJ5&GBL*'*$K.+^0%%(;H
MW@KYBSO2-6!]MM^-]W@%HSJBI8SFF^2I;/OLL\&M-M#2OVTVBTDOERA/!/BM
MI0O: _$8M1/)JP]3NIAO-D=HIOU'F&7;*WS.O&J^5S:9+KL?3#EU>35'CMU@
M'$4O9)C &J&C9@1PK[%(;5X7@MN48X8-C)M!P[<@@3V8M&(:1MVR+5@UW[@L
MYGWFYYWX-;;Z@_8O T7)3OR<#@ZDN&;D])W%9KC]]'E(/1]2!D^=>F@^70-T
MII4'VQP.,3>A&3C3>27SF_T&*YTA!+X&3'&--[7?;,N&!BQ,R"=9.F]JL=]I
MOX$;VD;-V;.R"\Y^_ 80W0*7O=O>=#$8\[];*W !\W!:3E+)"SN-[I<9O9L
ML7$I;!"4(4\<WCQ//0!?&&+F?@S9QM6Z\32#Y2.*(>N G="&)\*Y-TI;3S Q
MPF"A7(BL*H;\M!-W[_")BLR(I,$#XTR#!\8PLL%)I)GP##SH0!U^)2?N[BN&
M/&-.-K+2\1..SS&]K<AR58H>:$LKR')EBC;J^-S]Q8^>Y6#B#W9\;E6ECC?H
ML'M5YWCI,D4;M,HK+,ZTDLI,&S1U3RO+M*;;DH])\0PN_]_=O<X?6,YYJ%!&
MKUX\^?-.>KKP'ODB<[&1N?I//5"YVHE9ATR;)Z?0ZL1"Y#P:J11/BAKIL2<A
M.I:(4DI4U94GJROO7^SS^LT^._YP='7T^0@??SX^._CP+J?%?*N?[UW7=W_]
M4O^P?S-;->KT^NCFE.W?A"\PWK/C\S^:QQ?O^-&A9T?G[^C^^1[>__ 1']WL
MXW_?[$]FS4HLH@U8(!IEIJ4A(L-\1-1$YXD)FDFVM</9;!K<AN3-KE0IGSM[
M[S%F9H$J!L\_&VOLL_RC7^YN+.+G_<CSA*H)>DB06EF0Z&:[O"^?W5>%Z:HP
M716F6_<PW;IB<55)O:JD7G4D>[X)?J9*ZYNA<$4<[*XDV,<>2%_7<-:*2D^L
M75#JR=4E-+4:8QEM8(([)XPC@FH1L;9<JV2J4N8302E\_/G=5?WSNYO]PW_
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M:W!DZ#5P$K8<)YDS VL%8T\^]N,]2#,VQ''BN5?,<<F34=19$Q)3]-''?BK
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MM,B1W!2(%TH?)$UL9&51RBO^!J"N>UE:C>;U=NU#85DS_)VV<M_3%6[;%PT
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M5#5T7RX&31@[,@7C+$&"2X^XDQ89B7/O5TFIP8:F0)=60[?"@A>%!54-W37
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MW7P9@+DGEB%@=&2@!I$0 &!$,D@KIE%PV$21M.2>;&T3\8;CM2UP*Y7WJ\E
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MI'A>6P7N[P]G[CS1R=NL0H+%;BIN2"'!.A3DEL5@88O!/?VD)*,DDC/D,0O
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ME7%V,F+8LW3S9*>?KU[;/V[V:JV8$0/.!N;?/KMZI-TZ&Z,0@NCD(C?*9X(
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M9 7UAF O(\ZIA*).%H4();Q34F/F)2:+E2(HJ3$KBU4']U)CDE2!2 =\10?
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MC4U"$3,<J C*JY7$BE>2&C-=?.@[J3'D]:7&/+()VO34F*B5IIQ@ZA@7!EO
M1.V]"M80)Y*H=LB7V?ZLI,8L!-M.1WF0XXY$;RQB1G)PZ(1&EEN,4N!84XLC
MIPX<NLUH;+;R*3ESAY96"H(?+=FS<JH\C^\=^5!VT9.PLV07K0N@WI%%QSRE
M@7ID!/B4W$B"G/(21<,2$Y908(FY+4Z=3Q:/K1>HOF1D[D?=@$8!OR[6EL2^
MNR^V/3^)7?SC*S1W231W9.P+S7V*5MIEA<@5U7W[E03LG/0!*94W+HBGR%&C
M )LM3&9BK;-FC7GN4F#Q.0*4"^](^<CC;AJ3?LKMKR%RKSS3'D'OPK07BNF-
M6TQWVDCO@D4,AZKCFP+2[1EB+/ D+8&)("NJ+>F&X_HS-;^<Z%TQUG'"Y28H
M_VK9;VC0ZH#5A2+_]U^M9GOX AV\,-Z!HG.^->O!)[\Z;%K!=9T2<8<9B^X2
MDYL/O86GG&>//1M)*LOM/79LWY96,#OOOGI,@O%6(Z:BRRVV@6:%B)'SFN)$
M$B:6;DHKF/-NY^]FR(U@;J<%K"A]VSRK=>.9'?9WN]=!:9VZP!A3EX8\J0D,
M@V_JQ3>!874NGM;HY4=-8-0R.M8(2M?G8C43I6/-:^U8\]UPTL8TJ9E.R+XK
ME;#Q]S[68V8)Q1G#Y6ME[OGMT5$W'L'J7&NV^]UFNP<<\;9186<D:>"VZ6'_
MIO%E;$_D5"XW6V!-8Q"/OO?U#$",!1X<5\Q+'YF0@3.MK8+?N(\F<>(9EB^0
M'O'Q9H;_E2?XAL2/ST\/Z*?KW>M3>OCAT^7A3@,^>]@\.-D];NR<G35VCL Y
M^7AUN/_7R42L(<<8=AIL;__P]'#GE]/&]2=ZV/JMV:#O+O>^?+[<VSD\.3CY
M[6P7[FVL_9#P3@:M \(>"\2M%,@XP9 @A,D02)1*;FV3R:*7-8DS;%B>Q%K"
M;NE[]!38E9IS0%CA/=-<4F^8P#2%**SD3HCT H)-!7;G@]U1_7_CE8X162$
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M5 43X!'<F579&%JJLY2+NV!H;D:F;[^-#$TOCTSO-L@S.BP%GQZ%3_>:T\K
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MV&ZU(-I8C:XMUL]][-;KG8/5U,]M5@>R_AGWDQOXYV)PV7W^_P!02P,$%
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MHYLS].L!_-?!/V<WMZ-W'5G7P<J_[+^N\HI8'%+O-OA5?GX-\[1R6D11\15
MC.LM#FUEM?1A-I;*$0Y"[C,/]Q /T EI:X9\>$E$ 'N/T'S@-704\NBD\C@$
M(<SK2H'D-/,?0H</G8SL5E+#<SZ!CHUI$+(G>@U[QDF#V6).4B,_F/D'77/Y
M+;3@)$ULJ"P_$1]M\X<QI5&KZ;9(0".G+OSU5')*J3D)N:U,HO".".C5F$8,
M^%Q:0(O4--+JP=^1N;2<'Q>H_[2ATBNJLH<QC,B8^QX5X>7WF$6S995C!46-
M%(_@[]A<-Q8;^)N3-+&5Y/"<A.,KGS\O;9+DA#1R.X:_DP9K&M!U).$-DM8G
M$C(8T[M")TC@/<23"1$SF"QL%+ A**,@ZKO2!P%6VQT,H M;#U-!+M6&0L:P
MNSGH=-)]  M=GX>QH/!%-H@B+3;I0)M.VJB<IGFS3MZNDS6\Q8"1?-X2"T:8
M $,6_]:""5B?TT^;M#0O([)',O#?!AQI2RIH@.W<[:X-&@D#6V"8B>L+$0)J
M/-%[ZE+V),?N@D:$^6^"%E7S*@B!0=_KK0U"<ZY^=@I\_>3\F+*V!9>9=._I
M$PUB"N4_"QZ&CX)X14'?4>$BS1$=S'XG_^;B/ XC/@%S_0T1N#2/&I@>]1*'
MW!I@FK(NZTGF'<E]$;-.SK\SF#FR!\Z\"UM$M]97[X97#0<:-![W$O?B>I7F
M%F:K@MEU %,\XH*]SZI<T;P&8">]Q"^Z7H 5^-J"J[5T[Y+#RQG41._8%#TP
M[X$R%1\:N)WV$L?N>N&6,2AIS%G<(J^IQ/&TB@>)]_"=P6?*B@9_9[W$);T&
M_.4<)J2V$%RI\OO,N??,?!]JWD9C*JZ!4C!B8#3WPY!&[[+<FO*D!F4'C[M.
MUJX4,V8E#<FND_/K) QO\;F4Z15&\E#DO2R_5\UK4-?!Y?A-++^4KRVX6DOW
M#QIX7-P#"?'T/CN+:@XT$),K[MHAEK#F9+QM8=9:R!?LB7DPFN^"L%+C&G!U
M<>5<.[CF7&UAU5JR#\1'OVT4BR"$VGW?Y\\8O?,N,-,RHX%=#Y?.M<-.<NFD
M;$I".:-;)+87_ICA;8L1U/P-_J"5T;M@L)X-#?J.<%5=/_I2_B2-C,,M[)K*
M^X:'X3F7CVC@OJU+N+9M#<".<65="\"0(V>!I8T$%!@4L"%BH-BI7'_<[S$+
M)7%C7*A(J,.^.B>=BM/-(KUDK2E0W(H&1Z%9/(Z>D#K<IG/:;2JF38RC40QS
MOJMHIG*;D-1HTC,T%AO*<-[&9BZVL(6/1.S"Z"3&T>5DZO,9I0_TB8KD KB9
M&/6$U'KR$.]EE9;!!:J)8S^EZ\P);Z65#W(SI6E*3JTZ#SO=EI+;1 VJ'?.^
M"]J(1;-[ZF/D?\2U-<YYV-@#OFXVU)KZ4&ZLVD$F8\Q).7,B;E93\K?5\I6R
MNV%DP'R&M[3[8<A=AB.+>7Y,<=)\J_6F/&G@B([-TAFU&1P+7#HYFTF.)",*
M.;.;B4W=B:XIGK1T-/9'KU,1EF5R@KN5U7R,FYD?AM0TUL=1MZ7<-M'ZT TY
M9D?S8I_R859R !8 9NW!H7J@HQ8Q2"MM4Z/(T9=6BNLP T/&!CK6YC4&:&9D
MK#@I+UL]K1;CDG%"RS>D <D)@*04AM$<)-M0'B-<M/4+-::KD?HI.HC:27W#
M?40WE(3FJWI:6F-MG74JHI*3JALWLLVLIH4Z:ML(_Z\;Y4VT?I*>-]1#BY74
M2J;; 453BI#)!GQC54>^8LOO;?Q5>D(:R> 24 HB22537-7EH\17M,D2BZ?3
M)!DP\8LYA:Z#(1<3R6([ 9K3U<BSBU[$.GD66EG,6^04&MJ*5PY0EJ-FE:)5
MT-2(M8?>.!.QSE/@;$7Z2C5>Q7C6*9_>D5F;\/@&%#7B/ )QEIPS%5HW:2%5
MOED;FRE-'HP>J9C<#GPVDKR$V0[H8<Q%A+]]XD+PYR8Y,QM251OOW>-.Q94N
M;&(7Z3B%1@K[*ME.4B!O:2O8&A$TW!.TH:W9.YQT5R7DC=QJ-)+(/,#P@@Z:
MNE=7T))&B9^"$B_O(ELAH1"\B QL-;Q68&W=9TNVHH'$&?K:5P.)>=-;,&C%
ME)5>NYJH:D@-"?S_L'3TT@X2>:VMDC 2EWQ^!0(/7/C:APD5C&@KRW_%S6HP
M@^ZRTDE,.\PDO\V9<8K<;"2"SOEDPI)KP/,K %$A6@4&] 8^).-KGNBV"5'U
M-J*'25%+&J/0PL_YW87(*<;9(!;R9K8RK1[^AE._%6W-_$8G7>G,K;F$-W+^
M)F\J>"0OYMO 8A7-W,-HIY+F3>H[DL!FCG2S;7>YHGI/W<-8I9+&*X[Z)FZ5
M"Z-8#.W AP,ZY(+."US /R&^;R#PKN Y&S75<:MH2J/RCF%W5#H!7!3Q8A")
M_"5IO5#N9R?C0.K"E(?-C#^HE%HQ.]6\P.7+E 8A_40#:#\ZCP6^H@+&[X(.
M*7SV5@&7I1K6@.<$CY#-P;.8_RHOYZ3L.#^F#/T$"VW"DT13QM463G.I7@Z'
MU(WF[R""7^])A%EN.6PG?-;&H%JZ'0U83O%4VQPL\Y:+0,'&G<76-QX4;3UN
M*A(:49[A@;9:E!L>@U8YF3(]!H^34#VY1YGO(E8Q7PV;4,OWZ !/MLVG:M:H
MG*)I$&*R(YHWO$6!J8CZPXB*+S3";>9@!H7^$0L6>LQ=E4I?1?L:_'3P*'VE
M^'$D6T[*%\:Y8]DB:UN$S27\-1"P1(X"]A\IY=2H"N^Y[X-A_@PP606.S%O1
MH 4/:$J',_5H*;8K49"U[&#33MKV9L+A<TP$"2+:X%)37D/M@CGJ=BI2]>75
M-VB4KP@3?Q _IK]3@N,@?8.F UY=63/VO4Y%)CNDY$A23I'6I@NBF4],14+M
M'3M"[UC))UDCE$UTE%4.[?PA'U99'VE1CP<$MGFQP)O(,K=4PQ5K+6UKUC%T
MI96\I;5X*/P BUJ-U9.QY& R+6?.59)N:S.7N$K)+KH$^+!"JB3*Q?]:P%]#
M^/0UX /,#XOS]#J8QE%X0Y^HWUT%\MZ"/PTZT5=GKJT6&987#:I@2:(BB2J0
M.I)WI\B\DW#O_"CY=[H_;8$\'_E5@,T0$.B/*]ESM8#81 $EP1G$OPXP+T8S
M*Z^JKL;(.^M4Y(V=$W(*E#9<" TMO'H*:@/O&*\CEF=(E4 VTKRK&-?<.Q"-
MJ<;<FF=JNJ""/4E?,:BND(T"?$S"WZ@W@J6C0+VI<GPW!M6:][B#P8>&N"IZ
M/H!EQ\AL+*2:*O#NY,P[)'12]HO-;>A"7(&3MH<J1K0T\)"1AH;PV/!C%O44
MOP4K$T^U%R?I?-;C!&A\ZK+"%C4PZ (,2N>E!EJBP$.QT,]%U9$PLL5,68*?
M"0LP#_7]W,?,@DLB @S:'7+,ZD&A]Q$>1&,LH"!NM+ HK!-=:^)-@\,>!D:V
MP"%RN_\C\ON3DW/LL,#)>': :2?C.CG;G_/]:K':8K>UOLLN-[^9NJMN4(.R
M(T!9Z<AY&6V77[C> D:G4*X#UX\]5"?]V_-KF)6YU;A@W>:J9(V@6C53&N =
M _!*9]4-U5O&*BHW9%8JMIS=!2*+>FV+TD9+LD_"D T9]8:"3W"D61#QPA)H
M V[7QZ8&R2<8SKO\0CUGWD'N$SPC_XO+]A;=:UVT+UT>\ ESWVS1KFY0@[A3
MC %>Y:*=<;'%2]M-0,'?\X5'2G?56^Y-6K"EP=X9AA2O;UM2])L!QUK?V1:J
M<TQD*1LNPXA-<,0*?E:\+!LI+NQ&"Q=V5X'0U7.C!N8)7BTW/34HY)>8\_?*
MQ2NO%T>ZZ\71XO7B+1K+&FHN]TQ555EA*]6)C5K4H*J#8=DMU%T!3,A%\HZU
M2N-M,S'S,":"CKGO41%>?H]9-#.5?45-]0'O";Y>K>31+9+YFY,0VNCQ;W:Z
M6UM??;9[TNU61%16R6(3CW;+@]KV/,R DD;Q]? ^@9F@-OPPK#S6YV/,*1+"
M[GU,^ZX;3V)Y+BP-![R,"<5I$,YO]R5+U)+R7:)-#1*.\*Z &1)2)M"JQT/S
M A^IU;3 27;9(-D5;"9XLLW/'9J^,*3]*!)L$,L7243\/!7\;Y3XT1B&RQ0?
M3<EJ5M#C3L6[9^?[MCMI#D,K3K$9C(+(&G*2EGY&B>]MI5LGAF9+<#OBFO7Y
MI%L1#-=6TINXAC>4RNL(9<QZPP-9,_P:8A04JLPXHAC5BVDF+I@/W[S+NX>&
M2\;;,Z995TYA75F94JD*G4Y83JA@0'02F96R+<.DDZP9*><.L+Y=A R@T=8H
M7;89#9[. $^EH^SV>-ITJS9YB54A:[JQ;5JNJ38O3F%+6'XA<TJFF+=]HX>_
MX?Z\KKYZ_3_M=*M\)651;.+27A[3UMMS/26ULCO%FR2E\(E*.6WUV*NAOJ=/
M-(CI\F\L;$-:(]8NWF<T$FO:U/;5@RI1IT_N!!^R:!T"-VU (W9TMI4.]"O%
MGCU,6MQ*7R7]"PH]<I/] -CY_0F,$_O/_*OGR:;#B,-@3JF(9OB2Z.\QFR*=
M=:!E70QIT(4.O-*1?26ZB@S*K5&1Q>1!QB1:SAF;R3NK,T:WH%2!,KDZM YT
M:2EK8'(,,"D=H%?")+W^M)6S0LY54SB@,(L_4SX29#IF;E]0LK34&[:CP<!)
M[^"X?#Q7@8'JJ?^S TTC+O+&'6Q]0T&![H9/!&JCSXD&8;-M='5MS5;Z%+;2
MY7T!DMJ5M)PBL8V718LS[SH:FGWU6;?B!*5.+ANYN:X<W*7.O_74U-KP[  O
M#9L+;=-WVI5CGH=E/?*(^-6%TD3$@QD2X\-^BUQY:VI=@Y .WALV1T@Q0DPR
M5%\VR\V,*1=QA/'6^>8FV--)M^_[#Q%WO]U.I4H6!$K(])3AU\ #.V5,[WQX
MMF),-6Q5@R5Y^;@=EH 11W+B)*PX15X<R8P,R)#L;!%4*<MT8TO\"Q*1>0Z*
M@GQ7CA[S%C7(Z>)UX9;(F3/A(!?%%!9%0&U!4RG">SHA#,\7"T+#.89#N6*T
MF#2E@4D/[_L:PZ2(DGGCBUH&VT]@LP5'Y>I05,/S"7Y/PT@P%SY+"E^!H76O
M4LOQH8'5$=[F;;]N+2Q5!?63LY>>VTL&MXM9/?1J%I0*.??Q#0\LFJT$:>V;
MU0#K&"_7F@-+L9158LG)V-EBJ(G:N*-"N@$#E[ZO_C)G1(,S='J6ST>65F %
M_K8:;"D-5B7IMU!A)NUJL'6*5V97HL.JX;3I2BR=B]?7>-=.,H-72?\W)CX;
MSO!MLZ[+XP8)1,T)JAWQ9YA5M&P59:KC^AJ^Y2W(4Y2\#2=K9"O)\L WG?!-
MZ2HG=.?@ *\:+RO7__:Y^LO^2_B!3*<L&')\DGP/ I[P+A_!$^K+-,=2_BX9
M_VO^[K'T?6?7DRFLJU>"3\YA48<=:/I^P^+[9P (9!#*Y&4?=X;$#^F.$Y )
M_;C3DEK ?!]/7S[N1"(&8B\#X;,/4RH8]["''W>\6*0G><EO ^*C5H8^" KJ
M>\<)8^"(13$6^BQX//VXDY1D$9WL.)&DDCR9\ "0(&;7\ M2W]FO&YP,8[=F
M]YOE"=(C?8D^^;!CKQVD):DV&2RC4?$BL8N?P@]1UHI^:*0K_8;">IIE8YW=
MD5F2W0>YJNF[KIJ^<RS ?"K1VP(!-$\2P(Y6,A5/S*7]D:"R4#]-H_ '#3PN
MKB@-[[C/W)D>"$M2M0,(J)11P>)T'P*>GQ#/3*:]5W6\OLX:NP5$7 SET$_\
M")KSZ4,L1@P4^6?^'-Q3^.#W7]A"MQ(6TWFMKK2"?GG1!X]-\"8G#ZY+<$8P
M!2-]YZY\3O#58CCZ7WA$P\/CSK'\\#N=#*BHZY^^WAI%YW%TA^H[E\1)_49]
M#RSW!^+39-J83DG3ZG;,/9-7EN*R<DZ$F V(^^W<)VQBL'PWI6?#G,WGVX7$
M2AV,R^4L@.V7&&<0'SZ M8:7M+@(Z"S\3 ,JB#^$L0]&/GD.8Z;0JHUH-%AH
M&ZRH+(CHB J#:?IP?MH[5.N;Q3(6".E/ ?4O #ZWPUQ/7"5ZHE8JZDJ6VCLW
M%%BE2<X=NFBN@<+_BT9XSY/";QA0'2-W-;UO3LCJ$:FU7/^B1#P^<\TXZ*M;
MVOOKN_N+1T$\.B'BVSQQF'KZJNM8,)T-9'(;U$]LT^J6BM2 _2NP!);I?E+?
MTO[?0?L"N43SY@FXT9F_B@H6@/F*N%($ER]LOG<\YZ'"7%#46,(?X]'!VD36
M[^X=ROV&%]/#@\.NQGRH*6V!L$SF#H_%4G-/UK=T[GVAT2TP(7>3"_L)U?9:
M4\F:[76^YL&LN@-3'(2B1JJJA@5H39V25.:OI=)W$X 08@1*.:?M(Q43)K/'
M:DS#9<FVQ_8Z=91T<-Y.&6?>#8O2)*8:\:NJ6"#_VHFG[I:VF@5=R\<;RZG]
M!M5E+>C$%7NA'CIJ+N@@TKCPJHI:T(5SS,3?E\=!-ZF+0MT1104+NI,F"DAS
M;B/Q>XJOA*6I4S&\IU$LY*%HW_?YLU1YM8JR)35+U_[7BDX]Z>I*6R#D+^2)
M)>F+E%;+JU+6F"DY8QHU7BIGP=CG1Z@7=$@%X/61O"3NM?["BRW[PX@*6(EP
M$?HT@T+%D^?&Y[6K;,R.$X3/G'O/P ETY#H 93!BP%+2-\EPO1-=5V\U0!_/
MT/\?#^@2]CAY^9U@?GNUIBD5LP#F)N<Q?[)HC$EA82S@=\4RTHZ8#2<[_>YA
MDW/*VN(62#1=SU*319[4&"V 514LZ ZJ ;0[PB1Z(0P!.S<LD+.U=DG45%IY
MMYJIBU<98J1;K.]^CUF8FEXR.E0ZRAH>+2]-V(XEH_"Z&*.=.VC56)AZ ]I2
MM=,9<"?X$PME;'%$7@8TH$,6B2S4.<J#V&N'I0$%2YVV0"@,I8<+EAH*,L8L
M"[^3?W-Q'H<1+$3B+ED'R*C^L*$9D56?;;=8LG+/!SIIKV7Z6R][_VMM-S6U
M[ 3Y[[!9= G8#'DP&ZBWJ>!>[.JV\69U+5CH:F.[U*NWMIH%75/=<C7<(34A
M8<<B!MPQ6%V&0[W?K[*H!7)[=;ZE"Z:I*6U!1XRBSNB(^)<@AFAV3[D8D2"U
MI.;%$MLN3->!Y4+<&C=FQ2X)4Y6$TJQ\').@F--  PU]10M0 @ ^.2H@^%B+
M]^KB-G3EL"<YNT#..F>:CE07MJ ;"XI1Y0.M*&B-&[3?VSO+8=([T@BCIK0%
MTK@./#H)V!#LC%15I79RK2I4U+#3TGP48!;'8B8UE-PZB_2F>[W72UEG7:X&
M2=XT#&31Z%\JSK(9*3N%7(P5-=TW*>O8V<V^[],1PW;.N9AR81 GH*QB@0:2
M9Y$B.8LT=8HIZUBR51#<I=0+\17Q(<'L".2),,G8D M\$E(W%O($"#:O'.TH
M%CP!]F0\ELJULQQ=2QT^J:]:9Q24BEEC$J2>61>X*)[N-?/V-B-B!]+S3 BO
M$LG@.6=5ZJ(&+H*5T+9CF)(KF6D,1OW\?EW,TG6HMW=\6-PH=;06<$UY"U8@
M-'%8!# J>(GE"I/%.H/.'0DRT<06-:1B0<=K8^W4KBUM-0NZIH@T,#IIU-=]
MYP-':;5FT=N&VE19QPXM*;&$N3[D;H,/;W@PPB#>S)1Y&',AHWH_<2'X,[XP
MKK:[K6A9&O]F=I?<VLOC$GFA(4)#ZU#9/]D[N* #>!0+N8(-60BC#.O8B6;=
MTU>T0%DNQB@KS>^*DM: [)P'Z/-.VKIGX;<;(D9@(\J&[F+ACDD(A&X+KGF%
M\FA%;$V+@O$%Z7,2CK,T&<:[:74E.V;@[32*)_<OZMGVJI -,\O@ N]8T'IO
MJSD!2Q>NB]M_7$OW@]&EEKK2%HBRW]TK;F!T+O^:TA9T9/'UO?WH-SZA#]R/
M#<[\C*I:T,7<;5"9>K25 \*8DAT*\X(],8\&7D,'E*Z:'9W3:$494;_L5?17
M1"Q5KVDH5#+WC**F%HM:,%F+QS"Z>VCEDA9TX$Y@0 @FX^/!!9.K%YK["A=^
M37E+7?/S??*Y1'+JS])F/M!6LT!T7V@T30]4(O+RG-]C2,Y74,\/,/FON_!:
MN+I,2JV(62KT>^KB9<GY.3\?>NDU)D$QP)JX+A<>\H$=39(N*2+]VA"S=&1
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MH*Y,G9*X]=(7+&D6?[.Z%NC3TJ&C/.5^)"_U.53J:]@*SS0Z;W57KMK2LW:
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M7_.<7P$-#9(0?YHL2CK_FW)H@A-GF_02PQ47CD<BHO9$)HZK8P*.]!-.R<Q
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MRI2(L,I%+7*TJ<UBLB/0(:5,5J9.2Y75X]7RUO@H. O&)DH22V499(R$" C
M"DJU]C3X-C?(5L^O<OR\^J@2$:U.;4;.196L3D1K5DQUQCB7JDQH%,YR;7EL
MF<1T&<Z0?.H]M'[M0?!!0UZ9P^NSNA$+#D0HNQN@-#KS3A.G<?)FG%^<"N5R
M:.,Y78 Q)!^Z@K;W'^)J6G[3E3M7\\]O)GY:4M.+A3Y;9[Z,<F*!,\@D4NN(
MM C+^\ 0E@8%@,;:^E;YKC>B&I*C7($#U110\^*;G[X?APFL#='RQ&:U759N
M@G\<3R8C\)X'"(IHOXSP/!#O9"3 #?KK,4CJVUR^W ;=D"XK5:!(=854H\JK
ML0_CR7@^AF5Y@&LVQ87+(EI/' N("ET[]/2BPC /7U<IZF#;9%+>A:RBY.?V
M&WBTPMB(&O"X2EM()&3'"41!N<Z(4[5QC*YB&9)75)4CEZ?&@6JH-Q%FT_>_
M07=:;O6AE$_]V7CN)Z\PRH778;*N_=./O O<0G;$</3F9!:>V ""^&B*-9=.
M0!LO:CM\0W*OVM*FOKJJ4>G9>B<=@U>$M@P(-L9B(RK0*DG/62 JEEOQD3KB
MC2R]/W@2&5< Q=O4V=@6X9 \M:9T:J*RAH=^>YU^>BJS0F^"^.0\3@:&WSGT
M97A(.0OA:.1M;%>+](S[]0F;DO$>U-UHSR')TM4I<Z)YN7.1P1!+>4D+YDD:
M*X)RT(1QM^PY['$BZ?N3Y1K3GQ1U?/"3<B_X\?RI[[J2RK\^,5-"J93*82D'
MU#AZ[M8K].$C9124BXRWD74K>$/R)_?GR)5CR^J:J7FS A 03M 2[9T+:RC&
M^]X 82 DD4)*1,$T"65WT'M&@V@335T+9TC>8CU2'#[R%3=B/N"S9]WGLA64
M> )K-"?!02:2)70=E%:E)9)ATFE@JLWUF$T40_+HZJE\[W&N>]'OHD ^!)"6
M!P+!112H[/EKE]$CH!Y05I5:WMO=>=?]N-MI-;1^X)A7]GE>YV?C_FS6^\G/
MW6QQ]L5EPU?CJLH,I"]%9D:! ACG@"1=2.J-0C?-HY/(J4@&7$Z\39VH/< .
MZ2RZ'GM::ZW%%NVYW(%S:W441 DK2[,,C0PO1:ZU1'_&1.\;W8BY:Z-RKP2.
MV0*=MC?^<UFROVB6>JU XOK,090+*HX$JS)1W%)I*%6Z4>+\]7B&Y#X?R(=K
MTC$.5<"1-V'/(:K(9/"ED*F+I5D7DR3X[(EV8 !#;L$:U3?:">:0G.S*U&FG
MKLI^68P=VO%KI.>9"D%Y(IK)98:S+>VK#.%).>DMZC^V"=IOQS4D+[TR9RHJ
MI,4*NYL_H"5G,J&"HRDICRP'8C,3Q'M56J0Z;5WS \/JKMP][*%6,4;'4.+]
M5%/T_<F+R>QCS:;M7S^S:>7$ZY%7NK5:=G?P 6^ZV8<Q?MJ3S[_WD%Y.OU0_
M?QSGXP]+0HP,X^" 8C1HO2N]ATNG317QQY1T89<3;?*@ML=8L<HAHTXZX2C)
M5)>DHW+XD 4&Q39@Q!0\VM V;6&&6>6P$4]N*6"XBP(J'CN?=1#'RQ'![R>P
M+HNUV6AME)P0*N&"FCF-B"PC,F8-40Q$MC9SK]OL.VR#;DBN\I%(4UUIS8I,
M+QVWS2K$2DK(/G%TU4I"7+DI[3R. @,JHC2A%!!I0J6[D VJA-.1>%156T<I
M5,Z"*_E<Z.0[78ICNU NC#&2O=1!4I=,/$:WQ)T+E1_MQM8],6=?'=U?WTV%
MQI!:![C&*H4H0RFXGBR)23">RXW5V.9.5^.^F]\AO2IK\XB-/:S7)LODB8ZE
M/[7TC(1@$K&2RE)U/QG5YC2O2F,/_1VRJIZ^ZB7J(8?AB4>1RZ5&F/8K_XT;
M%;1@@3 'DLBL'+'.21)<RC1E;:AHL]1=CV<;PICOR\VNH)CJZ<%?.HRL6QH]
M@2F4;H\YFBB\-$3+PES0DCB1T?F/B66F5-:LS5[%'<"VH8W]OFA34U4U+_Q]
M&/>E6.NL>S9;A'E>3,X/\4:BU*NGZ.:+4! )&4G(0J*JK=+9).\;M?^Y#=4V
MS''?%W.J*:EFX]52LP&>P>K_E].-1+E1*<\+0HC2FRB5%K.9E%X;!'BF3&4K
MN6N3F'@KK*UV$>EWYMO44U1#[IQGW!5AM6,L4"Z(M\JB%:0E 0<$22FQ4B4"
M!_M8W-F M15WV'?/G7T5U9 [ES).1L):$YF)Q%DJRRJ*KCHNGT1HJZ*,R4G7
MQCV^$]I6'/K.=J3KZJLAC99;G%^D7R>?E 1@[QWCBD:B-2TTMP(=>BE)4LYY
MGB(Z;6T<Z.TQ;D6L[VV/NI$*ZU4>Q#&X=)7D+?3S;ASGD-9732Z^L/'.52^$
MJR*N4P^>?XHG?OH>WOHY/,\9XGP4 WI^RXTN+W$H(P )(CN2G ,5M=6Q47[X
M<>6L4"]^6W)FF2%KCX31HE10X(8XG21!SF)\YAF3C?H]['O*?\]M"H;+]VMJ
MSK<@0<VF!M?A6YVE7,3G@:$5"X"N%^-H0;/'89"9Y"B=U33:W"C2VA[CD,[A
MOWV2'DJ"UB1],9[Z:;PTB:P/(>E$@K2>2(Z+\+($1^8"ATEI+^A1\Z6NP3BD
M'-EOGZ2'DJ :25<BOLZ;8K^>7G_1=Z2T\\XQ()E&1M"P"YQ07A*A)$!V+(C4
M)M%M%Y1#RKG]AHC:C @'4S7ZD^5 ?FV>!FD^6YUK_QTF*<^Z<M8]X@%<J1I&
M-#.VE$1&<T\I3B>KP7(I&667*M=?2=_=\E%#NJ'W#5"LA0+O8Y4&9:A,%-#5
M-2B[H)EX)X"DX+GC#E+0;1)?]EVE]SKL0I6FOC0F? MG_O,R,>EU?G<RZ^;G
M=X]&/D0)/ ?B2A_$DNA&7$#84N@0HM9<YC:A]%;PAA3S-6+7-<=?E=56[_AT
M#>;%K-M$N>S&>MTP)"^4+14\=93E)@I7)#C!B(DJ1A# 16ASQV='H(/J/7<L
MFC749<5*,%_YOWEC<E0:X>6 _DK"]:3<)G?$,Y'*F0Q&A< "YVV*B]^$Z%M(
MG*Y-H2K:J>)2HL!G:Q+/_:>/X_E)J0%6VFV4P>E+!E,H&4QQ,X,I(6LU8Y[8
M&,K5 ".(%;24M9&@LS7@:-K"Q]SGV4.*:QJ3Y2CJJ;["E6N093BFJ=_H[S.*
M)F-8)%!L 11CI7(*+!-:0B:8<<[$:!K5!+\5U[>0'-UJ_:J@J1;^$=K&18<1
M5P^O\R8NFZ05TB.K!?=$IESZN4I/M,J&!F]84&TND=V-[5M(AF[H!=70V'T<
MBH *2&DE"+6.EAXOG*#TDDBGM/1<2=WHR'[?0Y']Y]5OL\?Q?Q?C#IXL^O$4
M2@K[LM7-<FMD]9LTDL('4_9:0UDM9&:4.,<IT32ZJ),)K%$GW5U0[AC7WLM<
M.Y1L-\VUZEJL;K^_(+RQ/\4H)@]90,E7+ED6ME3'+N=1F08*^!(&Y&WM^-T8
MOX6HMCG'ZFBP2I#R9KV\S++_X,>3D@^69UU?KG9!7'1+X?TTS4IBSWCC)F'*
MSM.L(HD:%)'4:X(#PS$0-]D8!SKX;>*4/1__+02VM5AT+"W5H=,ZHEJ&4 AO
M5\!!(3PG#8'E $F<"5XKA_:& 3H\:'^%WH96A\'X!B+AJNPZHM*JLRR-EP,Q
M7W1+<&E=*&B6S]9&%E^$<_N*WY^LSH.*5'[5"$AE1R4")E$R=-5+6J)+^(4+
MJI3P,O'++4#NY-S!H(9T 'AD!AY7H4T+0"V/11<11<%A0JC/3\\FL\\ [^ #
M=!@RPGKH/K^%9?O,^>S.OW@ZZ^?]L]*^=[)/^:C6B&H4GSKJJ%4J774!P?G-
M=Y%,Y%)2PDT)TDW6&#@H3HQFJC0Z95FUZ<AV'9J#KT)?&$LVTAJ-OD^FS"_
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M7=P*RGWE->X^3I63'B]MW(>DG!0A$>%8*0F2-+&X-A%(64?-HH.D6L_\"L>
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MKWN$!T\-\_>X6/Y]/KO\^/OE/'T@'5V\?S-_'RZF_W?UMQ:3XNNP66U!ICI
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M(QPKFZ4Q.9HHY-!Y+D_*[H[')(4TS'D')5LRBC%Y"(@>K+7T=129G6L3E>H
M[O!55D.2HNOAM*=R&NQ6VU=_ZU1U@=@T?M4!Y&'B6(,KN"N!>FKG0$2*1H82
M,GU&4=14!9G HRJ@<RE:.>XEMAG\<C "/1'G.@;^[**4!KSY\7)Z1O[Y>T)W
M\]-?SS_.9Y]6Y^1-)@H/:(S7"%((!<K& -X*!]DR<J%]P*#;5$-T@G=$]O2^
MBIVUUDH#Q^JWD#Z0A3C_<E< -\$ZPXW49"&ZDC5!2[7?=U'TZ3CA@G&*8QL_
MZQ%0IT>3H3308%_YY7).TKV<XVIDS>?ZLQO:HE6I*!1@=:K]%=!"U)F#X=QF
MR05&TV; [W9,IT>-@>0_< ?+VU&8OCA4M#XPR190B4N@!04(2;H8#4J-;+ ,
MX2.:W=O W=E?L"VT>]/MI .,4QW6NY,*MHQYW4=^ Z?WWX4C8HE%Q@C6!8*C
M1*2#Q%A 3YQ,M@: !AZU??!AO4-H<1>Q#:R]^R-G'18K9;&04LZ@N.?@LR8@
M.OB8@U$\#S=L^4B&]>XD_*W#>G>1W. ]P.^.G-79224X(R"A3A1U#F*.!43D
M*0<M%1^T_?=1#.O=6X5[2V[K5W@TF0,O9^<?9Q?5#9R5SK?@S9,'NJ(Z</[
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M4G7(M/&UW"(@L[DPZP>NSS]XEL\06MQ%;$T+?E6(1CMCP296:QZSH2U%)[(
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MR$=>,>[%QA#2GPTONG$<VY^FGW"Q7-79U,#NB_3?E]/%ZJFWEXC[^ZN[/'T
M-W3OQ:QYEPF3RLYXJS6J%$UPLFC/1?;*E)+B9)<7]:V'7I#=MUC<><6M(2B$
MDLYD!&V] Y5LAAA8@IC(#*2])D;19M#-8ZAZ=PX(7U;IYN]FJZ?/\>9EN'B-
MRS?E95A\N/Z3/+'&,1-#K%UZ20*6OL^HR6]AWG).'@M'UB8RMPO*\=W(P5CS
MH(- *^6TZ:B<$//B%Q+/G0_V3;G%/ DL>[%JI*!3O=Q,&F+Q=6OF#E.0);)F
MHU.? G=*M!E8%0-;.[_/\5WX7(,D=/K?PIL(VOJM30I<7:WRT8.S='JK8.N
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M*JHTZ!BV$^#7X?QF+%X7V$TG:.\)_#!3M8^12X_9EHV)<$0\1B\-2S(!DUF
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MU-AI9N806MQ%; WLNPV;SFII5M89@LJ!2+&>+[*V<2X&<I*HM#%.NS;1LRV
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M0V8#GZ6W%^(K@L88% ^1:!F0:!E+A.CID&<Z<:5824+8#MJ[_]23/SU["''
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MZ5[DO-)'.*NQ3H)U.<?%CU_N]8E>/-XH^BIQH$@CB?H<G$02=Z#],WJ!D*-
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MQWF;J:6!4_6._MZ;\N+:[;\..';!U#1C8!.JP^0*-%3FK)$FQF()I\] %V'
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M1BJ-!414U<?/%CQW K0- 4764G4BM.C$^O+#&': $*5R7"8PIHZY,R(!?<L
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M]L*9/XG12%V+7K)N?$F^'URT+,@0.&@*^$!YQ0')0X<4+85YDLZM;?ZTTS&
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M;M:;+.H826M%5]*CF!PX8P4H5KMVT,:$?4HS=^,YR\-EDM [< 4]175_23,
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M^\.R<74GVD>?/H%1Y=6P=LHAO8*@MU)4Y/.2A(WC)6@5578:R2"=(E<U)_*
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M V\2>60R.Z.3R]+T:7\ZC2K4*8;00N0=',SGBZ5ELDG2J0>F^M9JPS/J78)
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M2S1*YHG97""K6,LU4^7SH3,U2\LK/X;6H4]">S>><W U&DBZ0_W;4U3W%C\
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MZ'2(,"^[Z'047(\7'VZAZ^Y%I\Y;434&"*)5Y%NK(6:#()2A:FHA=7>NZ_$
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M24A":8A*B525#5B'9",]\./GNT0G4_MC,&ZALP=MH,ZY2?>U.CBG=?KR=:;
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MY_#B"]$?M/Q\FNG^9?Z)?_] YPSRNCFEM__FY[_;?]()&9VBU@G:6!2^E9R
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MTOF>5UG2+E[GUGATY,85^X=(\[+*DD;A\WBQRC;*[5^6) Q*EW.$2"6 T4I
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MY/W^Z7%(7>F_71G=M)G<I/3?W=S2HV_UF*VA 1C/1F2,*$'EY$+)RG_7#_Q
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M??<"^6&&*5WQM98L0!ALRK09DJH!DL5J=1;12NI"VF<6IAS%A$?#E&,0.98
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M9\B9R4%Y,&CY0/KVU1^W7UJ_B?_W?_U?4$L#!!0    ( #E&$%,(Y74["4P
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M+;-PJ6Z/+L'-U?%;2[Y?D^7=C9N41"_*=%21:6-44'^%\0'@!&)]8&LT051
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M&96+K2+5O/&_\OI@W.3A&.U=K]B/9(OG=7/V^ ;Y99]5<O+WC4,L.!$_&IE
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M;0+U74?0D5O>QK\Z[[8I7H#81<PB, /M4UF6'>IHAA=LW3L\TG3;)^M#S[S
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M16R1<K.$'&]F973DXU=G@R9RP*LB6NM$>;;U<K'0J3,UAPEV0'L F99/99[
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MMK#>S=E?%'RKCJG;WQ61.URE<_%)3G7UW+,XFS+8W=;WWG&0 6X<15))A6U
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MSIC2&_)<]-!6@KI'C?5N?G:.>?9A:]%/1X"L/W;[Z=K/R*E7^UW8 [7K&T=
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MQ?2Y'HF1N'2LHLZJ=\N]^S.)]RU^7,CX&CH[&2A(QR>CUV>V1=%(13 5BN\
M.IUX1$B^0A-FS<U\Q&VK/H[QM7$O+3XBG'.!"K/!*7^;CV0@##/A\A\1>FV_
M(L)MAMIM IK]L@[B.'#]>576,.$4EF29)-KH8-:FE1_#M2ZY:261:VY<B+IM
M'+82MNQ?'SL])#G9\_;:EMV;&JY<E-ECI(#K.&F+?+">3@#0LK^3S#RVDJ&M
MSRN']D&?+ DJ.!.P0+PB.95X^6G:?ANUA_L[7Q1X^!5]]S]+O;(D,_%(,+)V
M#55MR96+A%1A5'N750M)N/$1TG#6%T=RC0UOGC(!83I.E^$@V0[CYH8A$[Q:
M1L[-)P%C;. %/IHWX1O$*4I#@(<@\?5 .@[+?)%[!OS%,H74?2$% /2FW%9!
M7X0M:<JQY*CT%4'>S= 8BA+)7@JXC/E1BW\@"6?_=DN %D=EKN"_A,R,+J'A
M^7WA^6.XQ@SM/[V0O MXP*:=E\[.W!T"+T0 YQHU:/S[[WL_=3Y.-JI-H.SF
M'LFFH6@P?6+:49/XB*I^KD)M-X%Y')V!E-\,UM(!]> _)1^;HR+H3YZ6CXS6
M,VW9TYNC]KJ>E/EV]Y*4:OR&NR)M BQ9KEH?*\1I. I_FR!"IKW$;?T$22S^
MJ9D*MI%L&0C3C55RI.@G:;RI"-<[\5SH@_HUT?,4 =YP<9R-%0O%E2/2PF#4
M))0["M!R8#^@ILTR Y)_%8HN&4WW,79%&38:%WRW2B56ZGAL4I%_,W=5L.>E
MQ,O$,V?5R=4K7 512 T%B1NC:/E(9@NJ@47C(Q0"T<R',%4V9Z-_2TY0^V=O
MIC-V R\YT9-%0/^W@*MA'3PT'&Y1N+<$9ABU/1P&(T=68/NT[["QP08V@:F/
M,-0>%>W-VML&N7N:S*?N7OLT]E16*#3BFO6;2[5N,EXAR9<N;7>W?%=/90;K
M,RJ>@\KC[!,L/%<YO7L4$ @-'[%C[MBW?RYCO+PMN*L>CQL9*.0C=G+>$#GM
M:M9N#)ZBP&\8SPBWU(!6L.(=<'6*Y?IQ]G)52?O\,Y&)EZV%Z896J0E'KX4;
MRULEQ;RF&H[S:F(N2[_7I 7@B^%"ELY'U(R\X*P_,F]L(XGKG]HRJ-[G,8C5
M4H+( =OIC%\:O[6A!3@L@O=6^IA"L\\,7_+J 5H1LG:-JR@R2Y] UYTK8'R_
MRQSOJ<*4'F4RDAYENP>[,3/LV%\H%J;V+R]YW\HU-(O+;<9'_:<C]O^3FPRR
M&ZT&T-5&EZ^A0'LN[,XU>$O&@QB_ _-5,\2* #B;PU5E" 8BL,OS*AOQ:80?
MJ 74KP'4JN?H?EOM;#B"8?)P"@_!\(#=A*(_XB,63O(1;_D(:-0GW YQW8%K
MAN0=0?U&\1&4.3XB*8&/>.' 1\!IA^,=VZHH,(]D?@)^&? 17]=18,@32%T6
M*D%R"7P$(^K[Z@G12HP5G!^Y>@7<?4BN#C7@YUG\ W8K2'FZ^F7__I ZHLJZ
M3^KP2GF1^7R$'>G&_Z1>G;+:OBUZ#^)2P2R*'H:UYB,>PX+H;>4CI@T$GQ8W
MDD$O@BQJ[CPLN1,93/O_\YI!)A^1;HV:OGMW58./L#YH^]?OX\V1#V_23#]]
M$LE4/&DK_$\T[<VLTY #SP%JTH?2/6?+'H,O8"M!\#IZPUC4KB)R"''23O&_
M-8$A+)Q.LJ%!J!'.T<64UN(6-&V%BV<3?GU$\Y2'&8I_?_5_;WU$D)T+-1*^
MH?>Z#32@60Q]7B3J7=O5?_2R5E,V#N:!H:>AID/<HI:/_W@>MU_^GR72&_^U
M3L.?N&=@-6!"PD=4PH2K>*1QX1\>W5NPD>$CWO 1,&L\]XV/& CU&? Q8<9
M#AR7/[,F4'HP^]]_Y,]OE'L#+GKG^G\0'Y;-C?\/M?]NJP%N/O<Y**"W'I;*
M>S/DXA/PC^>VVJE_?_'_1A--P?X;O>9PVP%8D^=\Q.AA6).0<[_^P=^CD*+
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MSHKI:/P8]U9OXJI%JZ[;J/:EZ(6'>'.S^3LZ5Z>N$SVY/\!OG #N?EX;F?:
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M__W?-*!D VN_D<:-'2^G\;? -6 H2 ]U1U>^V9+ ,^CF[8<[OC/CRI.TZU]
MZS@&K3\J+&+M75[^DN\',R5S[7.T2;SLGQ%X79!F 9YR$0=IG4( <L/00[F9
M@GIB#,MI7#)6X6A&O\W'R+"CWHUG?7Q\VY_0'R=Y=]4ET#L.NZW(N=U:=9[)
M%@*TS;@ 'QON!O3>Y28](X?G.ANHUTJ)*LPO=EW[/OV>)INRJ[,_KL\YF.S^
M6JP]8&,U;K-;F_76YTQKB:D4OD(1HXC]FP'"6\?9LAQU;H*@UIBB0=P^.!N5
MR)!-,:4H!GX*A.C-99G6E<$?3(\M13,?:I.8%A+BS?WP*]Y!4C>E:H8;/:Y%
M#7(1A3<X[U<HZF0) 67/J=)($=I\>]LUZOU=W:1MJ)[RC?9%L 6R!BMHYOL4
MA_.VWQ8"DG'?/M"ROK6SCN57S"69L/"0O2R\";Q,94S(7@.UA "A'-Y,;9M3
M&?/I8D7V1SI;M#8T6)\IS-7+$WF<\9=-F,)>14-@+3":>$(*0&Y$[HG9S[$B
MA[&P,J&F#1F42U+=@7%^9ZML+,\8E65<*=ZBD2 IWCB'%]3B_%RD8 &B&%O
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M:)@0H/&V\F%[KA8L]Y#H!)^;,/":G6CQW>/(SO4QF=W@#=:.SC7%CQQ7S=S
M^:Q[4[=BUGGZY6/!*=2[C4COA$"MQTP.3W'JOH2@B1K4#;+,VDJ/N.8<_E1F
M,B[O7 R>VC^E9OND/6*G\BV[BKGHMUK^E2NWI9986[WX3]FW;CXO:*8R"L<E
MP!,R(!,?3PQD:EYJMS* .R?NH%R!(A4;<-+,0\&B@WQV+/)JL1C!I.&5_XW
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MX)^!J.QIWO%8D)O)V1?JBZL>,![F^Z&T;;*PX]'V.?Y\:<W>0TNB4HK BGA
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MUR]<07PW<Q0/?6S__R8 4$L#!!0    ( #E&$%.#N1-!=S0  "I$   3
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MMHR%&*U8Z-HN\U6)L>XWG<T;\XSZ32/E*WE1-E[('[T;!>U9A$6&6%Y?BO9
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M2^).#Z'EH<7CSSQ]C9SR I=#'DA\$.+=9;KAZ^K>F?[$0T?0=&L,I/:1O2\
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M^/W!#D=#]X<%4\'APET:TVI/>V[;;1%<CI%CD-FR\[!(E?82,B,(*72"<:#
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M=VR[I[V/V*Y0?67L:*P2LK9Z/+"%=99PN5@K^X")Z4.>Z7,9U]/EKWXG;()
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MTUFDI+: P&?OPY64GV_HU;\XY\"S:Y*'<1;GSR'!%(4\M=7M#DF 6ZQS.#/
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M.P^<=*%./7;+<6%4I>LV\*7;?ML\&>;PVUR!(.+Q 0V$F/;ZR3//<:I@-F\
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MU<6F017:RZB<@S]JG($[F%L(#HQG2=%DZFMBO3-;CIM"E+6P8UGAC@+HU">
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M4*"N<R=9#'<\+C/+B&IZ)YIS H8OYR+G-(<;NR0GL^S<-XTF;O)?1 \'=Q%
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M:4KD.O JKI45KM4J]/99B-J;V!2JAZ'HV[L9:^0 (JA)7G5C<85#I@R[U3P
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M\P1A_:5E%MP93J6"0E0DD26 A87Q^;003BGA6W1.)IFIU015W')#X![ 5[7
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M6MMZ@^J<V$%7NH_U47R4!YF3"X:[S!Y-3$S\7D8^<K#H[C(NF5=EHT7L:9
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MN795H>W*>NDR[91]\#=*^#-@O$P#FN'?P*QP>^/AD3HX/M[1[-[=LO%:?VO
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M\RGG^HC!R$%CYN&J6$SJAE6A\:ZDG&%% -7D%?<KG+]$XPTOW9"*UI;(B"4
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MZL5TP%;#+1?[;.D/$<7OD3##L410WZV9-C@CB.*%0'I:._@R @N!0YJH("A
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M?BK\ERI?_[_]WVHHR> _ %!+ P04    "  Y1A!3#_"VKQ4[   (3   $P
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MRNMLG@.7XQPS7&VV>Y]9W^=3F?K\EEM.HGNSLM_Y5B4_OU-+M>MK^ &HL*_
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M/=Y+F,OOW1*:I+U:>->\01M PV@Q%]7F>F&@B$([.TQC/01KJ-S!8N)%N#"
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MXCQ(+COV$_R]F"$&!LO!K]K%_UXIN_^BR&?O_F;F_N#_N*7A;Q%0<_X%Z%^
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MD$'_Z02,V@8XNH@PTC+S30%N9SI8] ;U'-CS4?GZ01E_PK*R6-T]\;L:;[W
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M71P!OG5\P!'T!^!]!R1W!\<>"P%" /3@XTT"]L ZOM_'[W'=[T. __<H*"#
M+R D*"3TEPB+BJ B+"0D(BXB*O;[0'];+RZV_O?)[YO\[U/7"?+S"XH)"PF+
M_;</7BL@(\)'X[O$SZ<!K)/AXY?AXW4"&'2-@G\MCP_X'P??.GX!02%A=!GB
MZ 7UTNCR^?G110NB*T8_/8M^#@C(",JJ&^\6DCMP5%@C3M[D7.$=$<T]-6T*
M!P>96J;'3J:)BBDJ*6]0T=;1U=NRU<S<PG+'3BO[O0Z.3LXN^SS_]/+V\?7S
M#PH."0T+CX@\=3H^(3$I^4SZ^8S,K O9.9>+KEPMOG;]1LG=>_<?/"Q_]/C)
ML]JZ^H;&YR]>MG=T=G7WO.Y],S3\861T;'R"0I^>^?QE=N[K_#?6CY_+O]@K
MT.K:;[WX 'Z^_^/XAWK)H'JM^^T#X=]Z\:U+_'V!C("@NK&0[.X#PD?CY#1,
MSHG([RF\4],FJFEZD*EP[.2@F**6&5V;]5NUOS3[YQ1+^U_2[#\4^Y]Z48#U
M_'RH\_AE "S A>_FZ '_EO]/"/_J/ ](6P#; K"TVYB:1%BQ8:Z=*@*&@_*^
M>&-F8'E&/%4:LNIZ/^$:VA_%OE*X3]8[]))CA\WJ<U((#TBO &F/B/4%C%<S
ML>F@,'BT('^MY_Q2O9%X)*+/\EK)"BNP]$_X&E27$'I0(*BW68T'R&P5WH6W
M1,35F6J$03+3CTSAT#N]=::GJ6R3Z(1N[4--[@_R= _F>;;,1MG=EFRJF6KQ
M^6!KL@ R#QJE@QAL) ^0[S#O)[=2QQO;-O/7OWSA^?Q;V(&A>R4Q9V(+S8.6
M9H-/Q-EAWB\QKG%.P#N@ SQ H C2Y1Q&/H)UDC?N.E3@MS 7ERXT!TZ7?LDC
M_1(OL]V" =;WFUT,;'[^H?;HA<,29^88#SC'D5X>T(A)VT;00'J)F\VD-LY;
M6&I0/4H=7^@$;''^^-AFFZ+OAE0M8:^/?)KF,$+XN-F01<Z/!FG%U-JR'L9B
M"BNKG4WE.XV5[F$62X08:+ "5VNS53Y].='[HR?RIM6E@R[28$7D"G6\G*Z[
M.,C9Q0/:7)#M! I&G$R[NE;.Z&,.=&+YS!_%%PC[+218GO%J: P+CJG<II$Y
M<LS7M6^=8)XZWQ]#E^+4Y?G6-#GA8-LA'G"4+) 4,#W'F* 93;JW*V(W+!ME
M43CS5INJ*FR'HY^TE;]CM5\N_,RMU/+J5'W;="WF[46?MA9![A,><)P'%/
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M^354;/]DDIM<5BIV1^M89^H+K; N'H#2_5,S4@P4:PLV<<MBXTG99[[TM/$
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M<678^@SE7K=*.XD:L-M,L^IB7^]*(,N-)MN$I]@2/L*L^PO#UR;+VCWO;X.
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M\I[Q?1:*B6/'-@#O2YGW8)>BP"-!3U .8 EY)QD7FZO$Q3 G!_?'F,M456]
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M')<W#I\5P,M4CVCMWCK)AD&2C6Q>S88)V<_JP5#0@^Z>H6F4D';ZGA5O&/Q
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M>Y7A5\.'KVSPY79*C-V,'%'+Q6LJXI?LV^56X]>Y*'(])QF_0(-0-JS)BQE
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MS<_C7R*I1MA1#F-@D&;4@B@A,05WJH;I<@&S>2HY-/&F:L(.K'E=;Z5&9>S
M_/4>E6LT5IK[B[LO-=8]8M/UM!6+-]K@@/1R""2?G2&&SL.&.>*CJXF<VNX,
MC2LRP"6*3Y9>WN91(Z_RB89@S]_J-5&T4\X-%^V6))Q$=W5!+IUW'],4&H1
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M(3;,5":=#:-R.V]<G@9_-'4 ECC@IOLR@!&@%4?)XQ=VK1S$;V^ QHNU+1I
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MQKG'WPE^]>U7P*,V*5J,=E>>>&E+A3L/";]1B(]X<0QJ!]@F=#ZBH[,/R\R
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M_1'G1\JQ"*!&E[]V@CV\E#302]ET2S-:+Q$_$!\Q%F>>8 VM<(Q.A"U;2K
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M=;U*9LA8J-;PLWED?-SOQ,(5#<CE%S--232_3-71F&RDL/(A.$@/G\O9"M3
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M'6/<["SZ_-X?Q3B1Z8*9,<Q+JKZ'*A%D:(T2,%L(7^2.Q!['C%-C?(,\1?=
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M!(UH3>&0 .AB XC]>6;GX'&BE[B[>R#Z6_+"[-A""&+^FZ/9)L2AVPB$=7F
M-YU4!VQBP SZ+!V*2+_%H?277SSL-)FOY]F!,S!:]S#5M.V=<J/QKV+Q1.]<
M1EEOEGE4>20EV51/HO<_4[1N'=-@9H&/V)C%)#%@ [GQ2A$/=MXW!H5\*:%V
M0%VNMWDW9G_Q4\I-UJ9\-_\;FZ,NOGT69V\?\<[YQ:;MAGL&SNRK+.<C9"@>
M)%!%L D8U!E1FH&?LV&(65IK+--$&XY/UXKA>K!BJ.9E4:8]OK)._IX9/VNN
M[7?>=[HX_=V;3^U%AZQ_?V<)/N1*,OL@D2[FV2_8+97R'UQE=L9Q5 -2!B]T
M%'D(,3P/TAV<+HGL,M5?KQ]2D(FPS@)JSL.V]+TDJ<#Q^7NN*(]4N04/<$YQ
MC8_:XE5 GUL^O\]OVM\]]WH;.QCS\Z;A_NOO2R1$*3J-ZT:M*$Q;[\A5$G?'
M5,M(>O@,'Y%NP#GCCI(AT7)08A,]NR8-1S/G' <N]PE,<+;KB<??.CVT331H
M7G=@"GMS;J"/36=F,"@94 T,S$RI2+QF?/W]B<?.+/\ZLBS^0-@J]6*/)V/<
M*(B'<46GQ9XK?S@>>>K;H)Q2F\1#P2_<((ZD"6># 6<35X5%B3:)6*J D<''
M!0?PY4B_I+N'X\$>C7=F@5ZGOGQ15S>0.Z4C?S&ZGWR'5_H5UO,C*E1_;-7+
M+@@GBC=)-+=932^T<3.4!BR//A+D6*Q;-L:OG9F&+?VCK&E<:2ECFC5!RPC!
MHZ])UE+#5AUC\8(C%J7/K@1$#T]!G>P5YT-.L3^&^HUV*8A[V1C-ZGRY0@'1
M?8QQNO=/*MOL!R0[397XP!3 N[+.$;96@:$[W_G<PZNEEDMV+PF-E,08.G^V
MO\PZE9D6D1$]O^&6QSB,G!617/%P:'-@#E!CIWN-&<1&@TU>PRB6=0U6, !-
M8Y,D'Q=[.%>4=XSV."?]Y*5TB#I>49-]H_2S8*>VRZU(!)N\%:C1P]*R2;LK
M)5A(=@<O!+.>>Z 7$L+K]"T9[1:I<U1P,/,6YQJ4='X(\)6M.F%D->\9TBS*
M&FCL:-E/W#Q$.?J>)PBZC+I""EPM&%_7N^)/9DUN'A';WF7FH&I7Z!'4LE=7
M1?E1P-M-D1:_BG\\L'P1\I5<CP05R3,W.+@ V$T*N;PG#,EMA=48@[=E"D;A
M!>DF6Z< $>X.NMH--;RZF]S+(+QSB.6G(Z7L%Z76AZ]4%EQLNOI&7%%>F9J/
M^K3<Q#!B9_.B"1*$SM5>HAPI>)0:7JY?!3@)?XH9'IEJ4TD_]ZOYU&R-X52R
MW.*Z*8M_(#1Y[<^I'_@Z%\1'.)H"ZC I_2N3_J<.(?[+'FT43(1^0NM9+@VX
M_ATC&;5\Q#HWK'<?WI!)O=*Y:(_":%=W^-^YIGNXJ5K?PKAM2DM]HW3S'N>^
M!FN :82,H<K"]F%H+7]!C9:N]S47.BHR 5?'T+!I" [<^-W.KRQCV"!(U/AD
M1;.4K<PV$2-9;8LWKS<U=JWJZ"$(]J#!:;C_$V!A"S["@_) $B@ASDCZ,M%?
ML(5-D?M9Q.@\;R[.,R#I .M&,>5E1E[B+OO7]@WJS5JO[<ZY#I];\#_PYOA)
M#WH?5\(?VER6#750\Y=G CF"ABRC6IQ<93 Y@$Q'U4?+-OB5!U-"9I<RMQWR
M+!:ZZ33><'.*O$U1,_Z:;'/<+5S>B\N"OYNX.R1K@!+TC!Y'BKN!]YJ/N(E^
M<!]=K[:E?<2X-YH57Q^/V1?VU54&2)0N[\Y-3;))HKUQ?M>K:1V<N6GHD^;W
M .(9^&O2@9H#@!MI0.0T[RGVFBUT(D"6'<:JATZ 03DV 7F]K7BED6QPP_W'
M]]/,-RK^;-UEECT7<V37^22O%=0WCOF_<Y9TW8H6;(@5 0_J3Q^V$B\&4B!\
M2Y+]!$:SXMBFO9J>YO6.(C(Y5G? I/;Z??JLC2]SO[>4MIU%QXO&;'+2OQV]
MY[Q]/Y;V#B5,N44:L(:$4:,44!7%B.+H7,%+/QJEWR#5X4(I8KXGK51;33A[
MO2E%7G/DA#T;+BU?V.!JB?,X6C"B$>O]0_B_,\#D[B5C=;W\./->32DUM?<.
MG4-7ON>G(,V^GQ*8=CPRV@XJQ\]$T3S/<C911W(P\CVVD35IX)E>8S.WU[Z6
MAS<]15VOK3C\AH!%';JBJ6+,1_AJ>=M[+AS)??(^W#I+ 67M-)A)?AO.,.9<
MX9KRJ%^\?Y(LNCR=^0CK//RE'OG.WB,_BU-VOH''_8ULU0:L*.#^R[V+8\Y.
MYE7=,T&XQ:Z_V<D5=-N2E.S?#_C56C;]Z+LW'T#?-Q%3;Y[R:CE>G9.U8,M'
M1+WX'0 V$Z:VQ[_+J5ZQ9Y8MND1Q VE ^(!M+S=H5$WU7(%TZS YT\ 3A6*<
M_V(="89 PN8<S::/AG1**'D$^Z2\_/:]]G4!?D&_FVD$9NA3XNW&RBM\1!VI
M6F(ZU9(57B\$*01$)[I6]:*]N(8GN[;4ZY.]FH8R5_LR P!V1V7<16-!MAML
M>>5Q_4H[/W@CZ]Z[M4)CL;N3[_ Z'!4N*3,Y&[6$^EXI>J0=I,S;$7J]^0@%
M%YV&OL127:?)0$IM+^>--R2)XHK+C^3W,RGLZ\RY!S/.(R?M1XY5N[S.@M %
M V*L3S-YY]L=E?F(,&W>>XPBM,R.Y)5PK7TWO&U."1#N5=O^$[GRNW./RQOL
M,.+Y)1@!U4'"_J-\Q,HZ/ J\01/:SVFJ+^>NYGYWXI$*UDE[D\6!NH.$GTG:
M*]4'H>'5AASD<M'<>O#ZH/$\[\P0OA.5)8&:[E6_159[@>>]O<X+S-_.CH)^
M&:Z(_.3@HBU(V>,X_PKPP[WA];S'%"=*R& Q!QDRH+%L2CH:[%*?X_V;.GQ6
MH4O[[&R%AT'CFC4(998@"P*(<),>,PAM%82&:UE-/ONOWI.SK&:C+EI+N\&^
MN('W9DGD!07,\!]%H1ST_45(,@&-L^-1]Y_+ZF?\T5?MPF_F'(;: -$2[(-J
MP0!KHU>ZGN4E/V@[6-,J9A,LS=_7"S&:K1GMN%ATY=2E' I3/#D^)?&$FUGN
MA6/IEP[C %HLM_T0EFE&"<4H8G UV,?8[=">G2.J1%'P$%!(\HL%T.Z<$2*(
MPY7R$40,+AS(]XNC9Z)XEU)'*=+U_<L>'M=^H[LT%VT0HNOT[L)#=T*"CQ@^
MTNEH01="<]]8Q/_:SVT-C@[$6Z*:%59^04IM(71!KKA_4R5(97]BAH?L Y9*
MDC8Q_0>UH:F6^V?1G+H$+'T(DF%9SV&.09TH"5U/"L_S5?I(7VD!IN+J@T,_
M@A/6,OLN.1W(@I@9UE"UQ=L^:/UX\[*>8/<?2N3\DB<D64H+1#[$7@5^4NEM
M3<R^F3EZ::RN>*)EH=:\RI+8/><]G-]5UH8=1=&;&C1:12Z4%)00>0Y5:2(R
MZ X+Q(%6B2GZT1G*.KDK:E)=N%^1Q+'G12IF'W*%TO_DP![43^:_Y79"-N)^
MZK M>,F5GDKUN*<HT?V]OA%JJ:5:WB.[SVS-WU.;TB11F[(N]O;'HX9*^^,<
MJ_3N.MV6VO6-6-#0&7W>D?W6XB6G_T.>W@6+J:97=XP#LTD: ?'09EO.1K=5
MB1Y&QI?HV*9MRE3F"_=PP3]>'WOBN=OCV!M?M:DX@R*O7%_DPP,GPW+L.>QI
M+>?)7 DR)%PC?F<**"B=J1O9T^9O!U(:2LR8[Y+:>IH(*88&ERP#FV%O]N@B
M4&.[\6L7]@9I@%C_^L6M8F9X%#F=PY,X./MV^4_^M_O,')]'!/G^VY+LC&XH
MW:!4JR"CI760SO6K#I\FL1 !9)X!'V$#Y<KB'9OBEZN_];%?E;;'CXPO5Q)+
M,**$6BS<@J512S"<Z4]_FG#H4TF!?7"6[MG,BS)*C6/."?[Z@HCYC(VGI?;(
M+ THDTMKKAX^[HNZ\3A=YG850R@S>[G \ HWYMV!>ZDM0FF5+Q]%*N<5U/YG
MPQ*VLG S'GS$9BQ7'%V+*HWG'@3DH6TFH:OD$#Z"+@$U_6*32X;MK_"R&9C;
M_84S'#Q%I=2[;:D1V4*5QM*(V-(V"H> /\NKQMZD@JHPH-<D[IYDW[]XXAX?
M43C\<D1:(WI?C[C>M8UM[P,:M;\__!#W[?SC@F,35GO/\[:F/,"<8)&Y.\ZR
M(T$^@B-.ZI]CP_C\T8,IN1,@*25@OJ^!CT!B-">Q8HN\31-U,N\2]=G;%4D>
M>Q]=VQ$1LO.J<\QXGVKHU?;^(+80[SU>@&.)'#1B3_ R9S J7,/$NA8Z5@2)
M! WO.2C5E6,3#BEM'5PI>'/HD.+Y8<,W#]=M\)A_B'.VPD8 8^A4&"M-\A$_
MC!%W@((^F&Q$8S=62N:"0:/Q#/E %M:L&X_+G$KP*@Q*;LHH>9?1OL<C6&.?
MT1[?AX33*GNJ[UI8*=7Q$?U(:"MN,'M$BY'%1XB(,'#,3[K(Y !_:!MYYAWI
M*O3]%=L$RY!S6\"WESBYO$K4I50.?F;?5Q98H#21F/JH@?O?ZII@S9G,=,'T
M4#CQ"ZXPH\'A/A]AQK*&'P^>?E_94^1:O%DTX5W8\\RB9/M!!\D7G@&#S=OS
M+S<D^@]3Q#"[02P=64="<A7!P%2##%<YR0XUC6BDR9/8DA*_'SF'Z]7;=FI8
MHBX,_F/9FOZ6L6F&,N9?Q4>0E2EO<B.;"OB(Y\/+4&4*=/,?JW+QET+=_T&$
MS3]7I'MM>_!_2"7UC]3CR,&NXQJ!P2R#2U4]T*Z KHM]:O=^79\SI)1UDK??
M*ZTN?OF^K,3OS*E8%<OG?1\+G@5*3&!+E6HI QFC_C4"S RV(3B7@5?O+6ZU
MDL5M#1B>, [*;D7K.S^[4DV2VJLWB;%KG+6\K/YY;X\87A+V6#4LKRR.)%!#
M 797.C&7[:K+*" NBVM!JEN-23T<^]L^2B0;'@\MJK1-=UGRZE>=8^\,/,">
MK41SG C-&"VP"^!H!VBQDT @&W^Z<\"R&[\M(Z#VFZ==?XKT2\>._4>S3K>L
M+W,$L[%R6/?V_G"V?4&7+WK GOV$:5#'";Y.3^Z\R2)%>FHT5#X_=3!?-F+'
M]P-"2EZWA=K4<?'88O2,)W,'&PW/R8UX-"\?LY6KWE$T%TG:M#BW 7^VF+64
M_D@Q.W.JT/$G)G-9Z]3F//DRH^QDUOGO.:+NIX62@Y:_$!\!FRB>,,XL97B,
M4@9,Z%XAH]FHL/M *$8.1)FP'.,D>'EO7# O?'=?U!/]]I6LV?!#E.;U\Z%/
MV)X'P7Q$VM2 %27=WJ-\9X9WD%.05US_L-W% CW=2^]CS_GN/UKP[.SZTQNV
M6:G2X=FQIW4%=EX3+!?VU:ZES;,:V(>XHHQH# J\Z'"ILWG3<P^_>*MGDOA7
MVQKNYS^-"]4S_;*^FI:,;(-%T=[<3B(GAH^8Q5!TFK^T$IX -4' [Q? D#\?
M<6=I96"BF- 0/9J##7<4UIWR8S\WCU:F%%M9*B97=A(6*172Z@L'V8G92=U$
M$%A\(=2OK3'U=->NKOFF9ZH+)JD9T?FMVG:!F#N,[%%EP\^<$Y8>E^Y]F O4
MUK^@&^NEUMIX[+;AT,(=#36,ZTS[GX=O+(V.(-;%FKC/MT>B2N9F4IF!2=0F
MU*XBY=E4;4^L29E6Z=X*E; AG2REF%/D[[MQ%KR/A),WULY&\!%N:F<$=3YT
MP?8WK/-DJ@"O/G9>JC$83[ZDFL\4K"&')$E;!5%^1K%C^M)>GAFJ"?9Q^6#_
M+4BL9":ZM/N5-OEI1L-Q>^N,T%Q3/B(H]@4N+;[T795KQAAAY9#0Z&K"64%A
M@J^J*2Z\"/=F28D(T'*&98I<BD$GIK79YSV$.5-66[$;?= :124RMCB_]A_X
M*+5(5NVF>!-C*))HY\X9BJN'V.$=81T8,?SQJC[TMX5YS8:1IJT^// U\=*2
M]Y>!B4>Z&_.K43 5E$0GG>,CS#%5.9,+YW-T5N)O6N&6"QW?9T #0,G)Z 0W
M:&W1P+%Y8[GHV0TDB<4H#5/J^#R3<FFI=+4K$;ML)^X:R!$&W_"6Q%6X/.)7
M(A@V=,V:-[KM# 9G7UL3# TCYV[-.VC1O*.K%7$&N>ZH?.L&<H3_P]*FCWAO
M\'&"LQ6C_?O!;F)\:?RKAB"M!] F:/B^0S@;]Y .*C##+SV[JD?C(T0- _U2
MH83 A]?]EN>&4V"]PR;R4;CC@N=:'>(?!Q].2)*D;CGO ?R7[RPM3QIP-?RY
MXM6+?$0JH04G.D.97AC98=@'E65X0579<9(QK3XV\Z,LL#P?LI0V>[1H,5E#
MY@H-$,->?]LRWW M;KZ!#FA;>+-<#.%7HUDZC3AL(W4P=<2KM(+G2PX_M/<'
M(YWMFFRU$EQH5PV#RT?NA$8YZ4JHIQS4V5F&KY?VKC3.'')'JBS=2- _RT?@
M^T0)Z#7B[1U0#/HRY5IT;R[4GWCQ&3O,&UAD3S<H<16Q3"O8+:\\A;[W"E$9
M'IU?*1R5]OD\H1NZ6.FLEHT'8AW<]2U15--F2.D"3<;4/RNZECO=",0?62P-
M@63Q,.'U9&,1H*#>#_H@4?5\)[WDROWKFA+%..5 $M-2==BK6H>[*;]=:<9N
M2\8A9/("TH10A!0&:BZB-WD!GMYA5@9Y![D;YK<$$5CE6WH870T<967S.F.%
M#N5T/B)=_OWMF"W"G:VW8817^I'"4XS"D%.J3?B(4"/8AR(K5[P V@=(KF"W
MEBUW;_ZSA[RY8</N^_=@T;! 7LD<=NP(?-O-"CR3>ATT2K=G#<I>H7%Z>$';
MV74F<QE\1(L@E..<#Q;F:'W3+EVYY@F2K#MPRD"="M3A_W8:R[1$RF("@?R
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M[[0/3PYF8$=-9DP8Q)RS4Y5OH4YH[M R9;)JL7@1"[,S6B2)>1D;"4@O0RV
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MG=&J)*/Q:;=<&FQ=2A<W>S\O+8@=0>9!"C79#R$8(1Y$I!(T$@'$KU;<\GX
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M9E9%Q^]:OLQ\ZC%M<4WLU?KMI)]<)AV'*)E6K4G7)^RRZ;PT>VO5+S\[+VM
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M5*6MEPZZS=<4!XGM\QR]WS#K=AO\-K!7FBWN0O6;WQ+,,@5(9(D4[S1BM,K
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M3>I3#B+$'IE;]^K56\F[F1W[2G ?;P1L_E4U];\]^VW4160\PM2LS^$1^48
M383Y-'%_78RZSJ"5ZK&*N&E[:-!Z%UCG7)-3%JUU>2MI("'D'^/AG_/]XN>&
M'-O<:0C !P/N>$($G.D?7W5LQ]WBN31R2&F6('(WHV#PO'1@W=BE'QL=L]U:
M,E2RG#8W)NS;MCUI::FF;*PC!DFD07*"(DA]+2,E!!=AUYHFJHD4U2;Q-DH.
M?,'C)F(D0G9Y>I7%62C*JWW@F+SW-X]^86Y\Y>7&#5W6.YIT#0$LUPPTY!T4
M-=!,0 I>0MOY^T9?$';COG="QF#33<[6I0E>*+U[UW!4A<>P_ _DUS.JL7-;
M/2;WI^VE#4W^HH/Z"':3$";A5=^1RMTK*$2'&]%3,9M0NWSF%HF*R',O0'7?
MAG%\^#-:D-W@^,KPS0N9]G*7'=#98G?U]-B^0TN8'@@!S5 4B $D4(^>3F1D
M%*&SCV.G(JE_#9,ZE(/1,F-'FL/M,:WC06V-8]BEWL$ZS_ZP2'E:8?.V\7-%
M)R]+C9,;I>*$L# LN%T(XV\<8S:EX:5YAZ;Y=@ \'27>E(JR<"GYF/WB^X!5
M:LC-\#+/(XYY8>'F=A];[L9^E@A^]F9%AD-*6:LH819'!D)=NZJ7AG7[F1C0
M&=+&Z7=%SFW+\-<<_24XLC#TX6\T-:>G8"9]MJ[H_>H3BM1G01&%D2</K(]*
M6B"*X]>A$#?/:3A:>1E.IIK5K*P8,3%)B#IBNLB/T4%+9R;V#DH;IT=4_MXJ
MU;6\'BRB4:U&;F:%<KZ-3OGZ>#V&'<W@C@Q5Q&P<.KW?X)TD:;*REPPXD5/)
MC=BE529<1&=JFWI<)RG=<S+> ]6WYXP_$#1ZF&WPY+^':W"7+FY<V+]"=S!0
M,-W0[+%P,5%.RTW[-X%B@@Y&3].XGD)8;"/T#E%KUBF$?;3N6<%1NU%:X'0I
MWIF3QLT_!5#BKNOL&?WJ:U]A_DBMSL6 ,[W!Z0\YXT!:TZ+OOX0P\=\X9$AZ
M$!C@I@A:VXUX9_FW7HVU8QZ!".;G#_%,UX0./6 I\H86H>H:KLZUJO+(4L*-
MV+WL+HV.XVW4+S "!N_ *7O ($[:0C(ZU1#5%F\)8%E2O7!IG#;S89'VB?7Y
M$6$?:D;QKA'EQL3-*8<>QG ([!3\?7'Q&0JC P.<HM^AR'78X:PAZ=OS]*G'
M\PQ*/#+@4>&U><?N*C/'CH[QL^_RG?1(A\9&>Z6?I"P /=MO3A[LV2"U\-/*
MG+ ;[RNX36$\I@.'JE,0M4U\)7OWQ)YPP,@%^%#S!.?H"!15G@4LB\I:[RD>
M,F,_CGKPXZ3+*^V[_?IONEM,-L^(S4!SB-K5I;7]*[_!$9X:_KH@!Z7X%24Y
M7K],:C7L&B@'?A3H/!W_)7]IZ,<'Y[#&] -M1L:7CU:9L@SF_LQT%\$AV6K>
M/FC<;R?8 \QS[X)U/(>#%%F^$>\0'UD+G@::J+GA&YWL>G[G^RW>:A^&.AA'
M+IV/M?BC'Y]3J_/I9 NGB;LHR"<R:A#UZDL% ()KQ+E89%Q Q6A<'TY%*\V9
M[+D@A-U!NXY4F7K91MN_W;^Y)7<%]\ACQ?NJ\NJ1&JXK:.;*+[#N(O/VB>@P
M^6]40@PJ25!.N3#\L8X;/U;,:6)'\VSY*$YITYTET\#&\?8(9H'S[U%VTL9C
M?1,;YMR4M.K\84L2OZHST(P82FUB9U0J/ D-G*J6X(L!RVNY4OQLVKE"F'S[
M;N;L.GDK>7BG5?;-,TZ?NE(>1]'BV-G[AOB=:9+K7F$@V3\<VVZ*')J12=<@
MQ;XX>FLBI;X O>';;>^0&Q_,V/7],#M*1,2.X4>6O^&=V'B"!J@.1':1)=I5
M+VT9:4<PVW24CR296DU[33]12E,@&Y^/L0G]5X(G2*1A %?*1T>N-X!@F_'.
MKQWP"^?OX.A.T/YRRUD8%9#<6Z06,Q.B)34YGS!PH%'DXI)NZRMUCVC,.5UP
MJ=#8C+CLSAQF&PEADH2U$CB$#W3 #:N,TX=DC'AG')G$VY0Z(2Q-BR::F-(E
M0&Y=1<_\L-+4X7ZKNJ>OTI^,V!6VO^G'AK[])QY/._[\S'Z% NXI,&B>DE8$
M^[<:1UU"6*-ZXJ6(</GV'2PZ E?>I;O5=9\I^U<?#/BD?F5O=[*<-9"M$J>9
M?/K>BM$B=I+2B1(39!,9[4*8,CI0"+L]I_$2^'*G8R=AR ;3'7Z2ZF7W;'K2
MOFHR[%J(VPQUG=@F%V/E@Q>V2]W_UE)[*"Q)\%P(NTB<G.\F:Q O($ 32A=)
MW3>,7@>E1\^+)ND838V@VY$4<B,_7U;#[$M3ODISRI2.XS'<A<@TL85*N1^^
ML\0E!P[Z-;F)SE>38@6Q!3QT*&::*,N7!QQ=0.]BW*BVNS=:,31KL79Q8F'(
M\7A !LSD\0WQD$!)9X5@\3Y* 'URF/L8M!:)] _@V$V:/LE-261)=5,0A"$_
M_5<?YM\]GYH^ "PI+N;?.E 6<IRR+-D>]?"! ?7-CZ'7YKLOTJ?=YQ.7=O,V
M$3LO=!CA'41R+,-)'>64)_*C /M_,'<2B'+ER1B'FEJ>5R@7?C;9N)$8DO]/
M3A#N@_HZAY^'#,2_F:705UXV=<%Y5G!5XK<OQZKU "+['&^/R#PLB8SGB(8S
MKT2]D^/D4&Z_Z-B)@'\GRB-OLDQ0@7432+N0TM+VUHCZKQEJSF$YES_,F#]0
MC6U:'V-7!\G_ <J3VPU%ON,I>#U_\*W]D?>F#>GNG;<NWAKW2AZMEZTZMA"-
MZO^A%^D87#6K4N'_60BKW+O]5'0Q9NU8^CJD2>4W8JUC!K3Y(PYQ'*#=1FW!
MXSC85)0B[II;;9CC2Z"4/=5PUSL0-NVXQ;/L,+!^,B=13CZZY_^<'%W#:+:K
MLS#):"F^NXB3%B')7:V]%&8EV]:)8U=%*30E7;-KZU%E.;ZRKC\VL-EW("OF
MDF;?M[ 4P1,4$H?@^@K(_!">(_Y([NEW>'EFZBSVM"(L($L[V.ODIK._;TPW
M.-XX:_M.:@'-5_G)E15DH\\M@]N:.NF3KMQ(,(C9*WCTA$._4T^.G3,>N:X1
MCK=_ALN7Y3EA&Q)RK(\^>U?ZMJ[.MK?H8F@W88D4""H!KHR)-8@B>4-0A8_D
M.?%-WN$C_(%A5Z"<2A?_!AF-GJ<TC!E_&<TH>9I4_,!3=:&Y5>RA_+2BZ>5N
MA B/D(F %QDT&*KD9!\7V4D.L=,)?4DVC)(QMZ4Q?Z"K ]X$2"7]J*?'MRK7
MA8\^][.S>YS[>6P]B[WG@G%?><B-[,5E,)1T&P$<P8 [*>PME= 4P<IU'4Y_
MOB./2='@VW(NE028AZPVV=QX("A\%@)=/$QEAX[8[^E9G=VF(9$S Z.#VXX5
M\([.$#N1$!*B(6J(W0)U:M%VT)+G!%8S*53L1G#H@^\A^C\C9]^'OQ"WP->O
M3'_T>_ORT"?:@J.,E;Z4(K%3&@7'E7,#7PIJ"1M#=-$?\)$LN#P_N@,!9(&/
MSZZV_GARW5FZB'45G>(Y>S_CL'Q:XY[H:]"& $:U*I5G"BYS[W(B[YBUHX0P
M1(<-KIIU*>_Q8FZ9=J6OM5OKJ9J?=U<TV>&/[@45UIJ-5A [#="?%HCAP[Q]
M/))@3\@],8Y4YW ,Y257I(?U';AJ;C.GMX YV6'H@W/UXQ#J.,<XYS%*]AP9
MH[9D$P_Z61_[ZTU=<Y+[WQQIUM [Z/U[FFL%EE?CKPGN=JCB+W+.T-FN&GSK
M=[\'G<_'H$8BRSN1]\5CK ^'<;#SPTD41A99$]+@.W,,18CI_ B3.$VBM18U
M,#7006V^_J=>9;MPXJ>'S[9V3:FD]#3:FTWW/CK[SW'9V-I/$VS*T@20B8(1
MAHI@H)+.XDQU+%ZU--CHZH/NQT-#1M'S2,:?FU\^Q-C^*P0,:0C)2/(40S"B
MT7=1Y/!P3A[IR6C[5G^.]B&.5'H]>FGL&CS5HDW3*VBD?)T'OSGPWL&W0A@*
M>==JTR=\X;Q(9H1AHJP0MN:QI7X1/TXS<^.8A?:OR>OQ[M$\^^I8B_O&52</
MY&]8GQJ&RUVL>= QH9F[]Z.TQ#GM>].DLR*K98E\@XN^Z(<?U,/FV%,GIL)%
M*/E<=2>3)#$7INAL6500>3D+F9_S]O*3+"?)^MW]N_]Q# I(MRK\S4  A]#3
M6&A#0TBT^M(5G@UARIVBUK$7?[;EU3BT&4?U!4S;PBK Z=,90U$%3S\7K?3K
M)6@P4HC;Q#?_XS#55OBQ6>H!7EN0"DE#[RC )00)?1&=@E:X7DE.\[,!B*DH
MDSF\4Y0E--7$D3.?6U0SIT:1;%3CSS8EG[$ZKJ^P^V<CH1W4X6W&R7(A3N1K
M,K@3S38GEH)#0]C)IL.N<+PM!Y[PN&6L_I7WR0SY@\O>]D:U-U<.]6.;WFB[
M[;(/NLUQ%"&.Z3SF\%*-R*]Z<ZKY2F.TE5!YWC&0^ ]'O2M<BND5XBY?$;;J
ME;9Z8RI<<'^R,6R?R25F\\\FB:DT\S>7UESY?D$K!"?TM3J^'@:W-/6@IX:P
M<45R8P3%8 [_"IA7'#RQVGHGWZ'AF:=#<4AE -:<:ODE<TO6C>,UKQU-VKL9
MF[ 9>/\GH#/72M#^0V27T_$BMDA/02#X)@Q,@C(N^A^M6S-S'>0R7-F78Z?_
MH ;-D6_2%5>&%(84;_]N8O?P=A.&14B$/F7+-07_\';P=43>,U*JEXUF'JOH
MT!S;.![JM;ZNW,_AD^^?L]K%F[C D2K3!4]I_*=L'W4:-HW^DL17L84V?!/9
MD\@;.0R [1C$$H3?7?4-)3^"W_K,0Z,GH5SW46Y-U>]ZUVL6P,>YL^7WEW<,
M;!R5GR:+*.8EL\D22%:)=P+J%XF1>)ZD[3POBUW//]D -G'TN-,N199 :6[.
MN1NYC1/0^=NJW1-Y3ANI69TEQI?;/&((12/_PEXR]R&RYEH-2KH<);AZNK*+
MT@BG5<[:]OR%WX9T?8/]5, PEID"+?)<^>*$=:K%WZGZ%WU!P?H9,UM2/\NV
MHRY+C43\<18I;64MLO.W@@&<[YT4X"A<%WJOCI#D[Y@WD?A.UD)M#;EE]YM;
MLO[.J)/*+:NBW%TN!N[6"3OLA]ZH;=^/MGY0$X.T9IFE6PR+0_UTX#B;R-6<
M9E;'$151NW#.K^ERGX"I)(NQ2K^&C&Q65-4^_S\2;A:?I%)7+Y[\]%H#<>K_
M+1'0GE?OH7_4AF1,1$V$@L4\(V*GBB4.?X:^KIXN'Z;E>.<Z47JQ$2[NN1CV
M](#$>6C*L*7HL\7T2(M<%O*Y<Y9(<6AMXJ7JR?(UO1T@]%/$1(9'4>MG];=;
M<A*/@G4<'=;8-E?0_I= :_1S2=,XLGN=[ .L88HD:6O3%O3U2D6X.Y@I>CE/
M$(N^,!Q'J:>Q0T1BE6H FKJCB$DV4 V+I(ZK[H'48WR_3=EV9WI\M<HZO-*L
M]C59OB4]<\[=Y9EV^#5$3?G2LN@Q-;!0U):YH$@("Z++\*.%L'CO>1=W*M=J
MSHYSXVFYT[7GW_Q4<"^F]AHK9>B-XQ/&BMWOD;8B%S0R%=W[$3H4QDLZX *?
M^@G)V+.,X.!V"OMLD0:X Y#JQ?H#JTP5@N*'" U\>/64N4$K5,$]<\UA:_V>
M!.>P,]B"2ZNGSP3D<6VY 8(RP@;H(T6\'C'ER+W":>(;$&0Y%M<Z$JN(@3.3
M@M)SS5ES]I]F'3<]33Z72;CNP^[KVWP7GH5F3),V?)M;P]Q^(47B(S], ^M'
M4-MP0UT?O/OMWW*H+-F/[PMCM._'2SR4>\C!W)SH1@!8$K_D#89GK+N6L"(+
MZJ#_GWW_?^K,I"@,O^AA/?BE;3C.N%T<=R+JE#E-:=_V6O_+;K=BKK@'_]N-
M,E[N">W[BGWG,%^+$+5UY.,%0Y3\#R/Z40]LL'<K)*=G/KV?^M>WR*ZURK<M
M]IF="\Z7SWDX=0>*X#<V/M7V&1C#Q^\WG?NR[<7(?Z_LCN/-H) *+^=SQ+!-
M@(NF4_$#<8.40S(O_VW5,O7PR"\2_-O=KZT*>>'^01<+3-@FFST>)Q-;GSV2
MU'U].G\[[)F6R&+:S5EMN"KD">:T_)'MAI[%*=#@-H]/F-;%38H:-_0SW;_^
MZ]N"GX85:0/+R>R2.HYI7$ %5>Z[Q0F,UY,W6=4[&7LW[UIRU'LQ\F_85R6/
M2M#QQ8%/K\MN>69)N3MUM\&U7J..;/:VE]WRY9)(+?_ZMND=_WM=BVXL?0)B
MJ:T2$^Y::G$! 5M_+41-FIBX637?^QVY<SUW=9_EC7^]H,;.W!S1J[^Z6T?F
M;XL+"+(J1A<23:J>'9K8\XN^Y;AL4TM_9?U_ZT3 _W_]?W$%@K2U8]Q1S# A
M3!ND8QI&?Z6;OO]A*7^0>SSSP,:TW/-$P05@7[6<((/"*"76#;-+6(51G0CX
MCQ?ULYC#K7<_?OO;[/'YO?$]AF^7^1AOA%PH)I&F]>5I*O5$M8QYOEON0&7-
MTEF0:/OVZIL_&=KP?>^*L2$6U1KT,,IP[?M)Q,$1!]5W..:_=RCM38KO1]AZ
M)\.8[6+!U;* *U_E.R0]R=&?UX.&BV""1D@C#&61]75J&HP\QLEYTJ2N#F-T
M*KKK>1[HVUUL<O?0WKVK1_[=-%_<X+&^=,U:LXZBI2P12?G&NL;-[TH_/ +&
M6^\Y1V\K4*E4R4L5"U]0S7PO=W]*,\9P6RD8Q$$S:;VD=2$4%8(2;ODP!YWP
M^[[<U+%7CQ:59KW\#FD\Q96FY43,/-\C_4D+-OMO!RM>MJ/7GDI%AK#@B;H:
MG+G,"EQ<5WAHA^'(Q=\;/K6.NKSUBVAN3G8*/EJ#_]8L/]#75]%^DG.-B;W-
M#V%2$G7W@,F/O_EMYJ2M[@)='<8MMQ>W?C!H2ATJ-'D<*&_KJ#[4*3;5_E &
M]K7B123+L6<XGB)E,2 ?QJ)UNZA3S]QZ41?^Y%N>UT*IZO-(]U5XK:S'U"&Q
MSYD=IP[\W,T0]U7]C_5Z2^#+O%F7:ZH0!J^GI")DH&W!*#V@H_E*"2[1X?WY
MEMH.5$C2AK)#.[;\5"E_X_IVP_>3. RKB6JFC6OK]H,!Q&YYQ*D)Y)9K6"RK
M2H]Z(L.[4"^$J4S5>1OJ?'!8V3AET[HW!S8=7R_XMY7/(;X9V (TS4?>F:"1
MI0AZP1T[1G1_1)U^7R]_Q*C-'[FQ_N0_!NDIRTY*F7G[SKC!]5IW_J_RXFJ!
MGT6!_Y'(;YMQ4KOITA1F ;&>PM3Y4/X2>B>$W:'U\QSO?8Y<XFE?'#)/I^F6
MO<*3MPQ>6QPMC2D?WE[9@*NRXKELNO^6H"PFN7/ELZM+ 3\;]?DQ111/F0+*
M[U#,GVCBJCP"@.A_&\SX'11>0D<<M(4F H_OS"!75R$L&RF$_29M$\+(E#_&
ME#Z!XN,6S&V*,I%Y':\##/>0EUR7Z.#A>@\S(:P.&OL231[</VW-]@6'S.N#
MWKF?QFAZY1RU"W&KJ-K>F/_3RWSRSKR;S(G)19%J H^?<,"5TY;!'5)+\CPC
M\ >=261K\\[RD0 FZ8>>D_L_'*D4$_:/DG3H4]:AP5:#2\4S.^]*2\'>236,
MG,+;L;#R8!NUD6 *E"<91[@8GJAWKD*?&GLQ&A55H6-O4--WI[)DA\0N \6K
M\C>'7Q.G4[G[!!7MYU[PT8*'E!"Z.$CW!H:.M96"_MVYJ]E3VZ,3#GE\S-85
MPO+>:OIVRWUZ)_7LA)\S9Y[[6Y",#J"H3^/1@B=KZR2)J'436(OQ<1,+HCK8
M.^S:DC_R*<NRT+_((3"MW:WB["XO*\T^RU> /K=,\( 2:J>W["?(%\*"727X
M^^O&/GG\EB6OQST>.^GM>/;(\[(YQY6/,8?E8R\'B[<_KFV_,D\1Y^\&<E9)
M'0;@P!& &U_:^27TUH>6BIZ0D!#=_73CT=HG85GK/6[WO4 PL>Q*GC;_*N<\
M3I9!9H<  [TV2W>1(U\[U#@+A16^]8?W_-@2&W3UV8;^7JE;L%]31D.6U=.R
MW*, G2:+F2SH1M?38XP)>O2;YX=?YQ',ZDCN]_O:2D[7AT@\?TO9$]-RKD_B
M#*5W> K.<%R:8-!!#W(]NA<KB],^P#LR_:*&Q;Y%/]884F![?N.QQ=(A!95-
M#W7W/E+H2J$!4MUF8GAW(+"0H\V,3*\G;\01W1O5M<ZT%(?N]IV<^\=IW>&R
MY <&/K%[GF3(G^:XBF9WAQ2G/ ':A!M@;4LMQ<7UFL]0F7;JQ\<?)WSWR)HS
ML[G>F'S?@KT)8RLA%;IR>;OXXW_W0O7T9"%,P9*4Y%6^EJ+KEL-PBH4+:HKG
M ?S2NA,>%1!V^8+'MES%2-JFA!WK:F"[TVL>:LW^K_:.#.-U>$?QYAP:30A3
M@8:\=$LI?D!187@D7E:^]D_+W-.,,I-WB;_,Q<:UOE2E4,^5;SB=GUKP.?UO
MFW7 EPOTO@?'%$.L.Y)^[=S^N%7F_X8J1IW\M<*!:T6[K^+JYO= PWZ:@F:4
M.ATW*F):+ZG,[QC-*>1/WQ_3W M4=E8XW>S>DP[&H3T;JMW!2DX0,_'U<.)?
M<@\QC:YH093%!3DT_?P='H49]V^H;S@:+_GI;KQ/S6GQ?<:OY;(D8=<MW-4!
M.#<#E.6=Y",36<-+\QPB=<X*F)G8Z%U6QWSE9ELAT9_.,=]BJW-5^A 5]GI>
MPKT 1X5D*D4,8Q",FI=W9RZ3ULH)QK5:M14OGOPV-41ZAG<8>]12TY9P*"5X
M6_J"_*:DQ3=O7JON/-"[79P>_!R32%&"=/$^0 2I&Q./0H[@79D"-_UM#UZ
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M64F](+VMS^=+BB@>K@6'Y_!DC&J')EX+Z..4]U0G::$3KL=%8P,M[2)/9'R
MU_L<>=FI]F>#[\KAKRDM ^:P/2XAH7[Z )36)%\9EIM+OU ;-E"-8IZB7FJ9
M-;_ K]AUE98A#_-]7-.AR[<'$#UDB6_DC1WJX,!1#CRQH=*A=>3W*ZW?IN%F
M9[%MQFZ]1_H2Z]8=J,K_?Z+5<XH(1G72Y9$ZS_CV8"*K$&W_[KH=*HP=Y/G^
MTJBLM[;'W?9L9_V[-8\KC-]VP\2VE0,3R7B[>;1""+0+R&@*>_K-J^&>>WY@
MZ3F; <G9]@K=??X1!C9[]KP\>WAS[/9U;)4S4B3("+\'/*E&0G?312-.'.O6
M$I3%%Z/J*F@7+>6/?4OQ]K1?4%IP-5KW5.OS_318L#CAOW'(\;][R;E$LMRI
M9%EZH5'W''K$XONCXO0&;J7<'DD[A8FSET/)?-/A./0O=^1NT;SB$2'3%DR*
M$%;COE3)&>@9GJ>GDL5_N41Y9$G$_Y8%[_?Y'XCW2=@D-V$M\F_]@ECTUPFD
M*,S&+ MA/1.23H&AV*Q=3<YOW(6P4<_?'D>0BL [7#X8[S;PX%".H<K?R=;^
MALEZ<N8W.M"&DA/"1GP &@1G"V%@Z]-J: 0#:S=[/(M+Q8#OF=YA1MNUPI[2
M_9JZ]-*R8_Z@#V3=4@@;1C,GT2\=!5I?XH4P0&?MP0 :7QG.E6RYS7XBR,-;
MJ/VSLW?OYT.PM,MO&$]7)92.?W[H??BD$/:Z5 CK*SQ>S)S*_U*=TN1]HB3J
M)D$ .7ZF\54F()DP%GG:ML<,$&$0_JH7AAIM^MW*RN1>GGN.J[J[^%CK/[@3
M_7\ZE@<@J;5\85I@VS'.<DR[?<23[S8NHS,A4^D/"PQB';X>$&Q *HHLPR%:
M)$Y)T_\XQ&[$N8:;Z#PQ&TI7B A[W!I81L7G7TC/,C$]O"SHM]FK<U\)LP=G
MVSFW$XQG5:X=)=_?^MXRVNV;R2\!ZHW>RK#1)LGC:,'^J[CJWI]!^<10Y^^1
M:Y_=$SZOL+%OA3#'YO5(A6;=E+Z;J)*^Y:@;JX(J:([/I^>0ILB@821?U9&9
MR/9D;'V',L&E.@$TDL5]E=#<IKP0+/;IYGFV54_?)E%4N?E&>?:PY:^\_VP/
M'4Z"9 HC#2U&4.:;I2QS'P+'"N<1&HO!M71:A/ZKLMS=F=@-9\3ZH!W'KN)\
MMO]Y50+I9/,DB",O<!@A3(PNA*56OU^9O"(U7OP[J?/-K+?KE^ &PA< K3D"
M9/FX)$-OJI+2%8("9*Y_/B:(+LCQ<,X2PN0_3%L]OQ7YG_M" GW)ZXE?7^#\
MA3 IKA#&][U)XML:<C<(824^  42IPAAZH[_Y3^^,Y.4%7LA;%V>$*:'I[P$
M>%#L;@RX3?2GF5WY08YZ(O_$64N,W/?&6^E/SS]>Z/VV+>WEHO46?;V.G2(5
M<D$R:WTQSPR_3Y"+%&-%L>4((IRKVVX.4+MMYAZ8#A28((Z')5?G6RWYS8T>
M)CT[,O\J^B90PEBEFMWN4'(5PQL  45Q)33;M_G1L9D:F4.>+YT^Y?^)A&2)
M@/J\64_UI"T5K2Z$!6$WN+(PF_A28 -3"$OQTP:J&O&#5WX]O?!SZ1W,V7;:
M]?)IV-;)TZ<V=K4]Y3E*#H?];J2]87U0/1_X<NA8(=THZXC+]5:7)[PG4S]-
MH1'1#/F'_A$^CUFZ0N09B* B&:_#@->%H#"Q2 QS6?9U:U["[^WCVN&']HU=
M6'E3N]/BSANM*Z]\H:OCY'IU-IQW$Z_.05#-/N9QCX*[R_@>8$XD0_P9CL+*
MZ_9.+52GWG@Y^4>M^HKMM(.YW>Q[JII:S>[@SIE(P[=(^WDB?Q.)IXE;YEYJ
M$W7D'%PMK,,2%+#85BY&S.6N5%<I/YWSPY@'<E>J/KE1/_4VCA:N_+B:IG>V
MM'/P)H7=PRFG31FR(X!$KH]( R($T+F?'P X,B<%A281@V$]:/F(!TC+D'F,
MCBS%T*TN^T1CVKW8[;%]C<].ZCE<Y+\I&[HV*3*2V'[^3? *3PL:I6PD!B]/
MENP?(9@0WMJ\RB&E(BV+P2SG*NTS&6R3LL:VQN;=R4H&"8RFW#>>-TP/&Y]V
M%WFQV&?$SOT="+[V*-^1X\V5>G=]&8&_P)DK+"8,SL$:.5W]5B782*SEV,QW
MMYTOZ]1R.<^S[PTY7Q3;Y4.(I)EU:B- 0SI?59DJHB)#\:PJV\XJ1%P$0D8(
MZPJ_$FU:^C1DS+LW<_'25)QV>0:;F;]@G:V9<>'U\76D43AHM+[T&@_-/R#(
M1C,>H_1'++67Q? ;.8,K?*<"E]JLS_711IXC 6,9E08G$@(3ILZDM1SW_.>!
M>!7LIOMKLLB)-TRD$AD=^<1$2OAR3)$F4)[*M^3I?>\T!/PHIB7%8.P;WTC7
M3%.3)T7;%](2-E(-W$P9(Y<DGJ>Z=R@2.SV1X< RUUI LB!-RG(E@.E01#VJ
MH'H2=&4VWGXACS[VSO3B[:Q=!KO/A1_Z%O2 ^\-C/OK9V_TE3#)[D(>"9C"
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M][N?!JE'").I'U18[=;2(_W*JVVI#U+H*]G3V:X*$S!(==\PX(Y(-I$#YVJ
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MAY$V[\L:>-8X=T< ]2+7S9O&JDQU3O>*YI8=+SO\I-G39*./Q#6ES3F=U28
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MQ@E"SAD5S)YH*B!^NF7(-UF^0_]U"FDKA,4UH\'6_XJV"D6QO9UXGOC7&J%
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M]L?2_/!=SDAE,#\K%SAYA?X7;"^#^D?0#V#H__"MY'_X]W\"H(:CR-?BDY!
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M>!Z!F@O5=8;GO#CT#,OUW#@+Q9T7O.4WBRN'';/>B4K1QP?YJA \JUIZ2]*
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MK(C$RTAQ87)UFR"1B:%I>:_(FFUK7\NG?+U6>P>]LUA1Q+F7>@+ZOA]#1+&
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MS>Z&2PND&S?"ENE,Z<U-XX?_Z5%O;3Y([87?6YJ)CT0<)@%D(L40(0]!0HB
M'@T\QGU!?$J&E4*WEF%I=-(MEMVZL\&GIM5#E3\I4*,H/6>9^<W7K+H%3Y2N
MPUSN[M?YHQ#J ],MD:P=!I=,JN51:=JIFOH0U9FEIZ@W"FB_@CE8J0M,T-$4
MKM,1L)RH5+F]'"]4E-P9J-/EQ]T?-8Q@_[(I!,MO-ME_"?Z%?/M);(3,C(O$
ME+73=?&V:UT6YF>E]\<BRXLF48U\^YB7=2S<"K' DPPE$)%0;=-X$D%*N(#(
M4YP;AUBF+%@IJJ"Y+>>.(9;+E]T5;KH/O*N53CH#K5Y7^Z*9.\V ?M. T:VM
MK*EOV:GGQKFCS#/Q4Q0B2J$OM>LI0!RFU&-05U9",69)PE.7E77N69XSRJPT
M!<(K-6/WK:B:MN_-?#X*4KS$!-JMHG-/R\3+ZCQ?G?/Z.B;*HRZXHP@VZPH\
M)I2'2_*HSQZV1K_6$0J%&;ZVMW2VZ^]%M<)I%."8JN4W#;DZ\' ?IJ' 4%).
M1*BHFH?$I9KZF?&<&'>&\N>MN.9#K06^ DI.-WX]![(==8X(W<2LZ(R:,\%9
M8C$J=YT;<U9:L@3@D'%L;QOHP]E4&<_6VRI[$)]U+4_SW#??M.]9<$UBNI3%
MMFI,O6](H7L=ZZK7)GSS^B[?;JI5&D5AZBN.X6$HU3Y?30;%/( 1HC*-$QZ3
M.'%R]8PAU=*V@A_S2BB]R'K]"%KE@&B-)V6E3F]MQ:(K4.PCI$V'(; U$=+:
MWG(O"K67O#,=([N_JVY)!;X*]6_2@0]\EVV:)D7?.[J<1GDU+#U3<T_XU ZL
M[@SL%0*M1O6^LJ.3/@RT6NF=9AT7?P5JS49T=XT)]+A>L5$DF]=Y-B:8SWQL
MHSY\V.KP07$-J=KF]@>=[U]G)=-CZ-8&:E2FR&WE^]B344HA"Z3:@"KZAYB1
M (8D8C).@S2B3@N!JP!+X_R=_, H< 5:%4"C VB5,/U/3-,4K8<;4SM/DQTI
M3PG^Q/P[.N[.1#L4O%$YU5F(6>ES*$2'3#GX.>YYN7]5+"Q>YU\5X=:;\3^+
MM0[A_$S68I5(G"1"2B@PU9[&D$ B6 )3F82*!,.8)%9%Y<\-M#22,[)"KGWL
M:A=#C+C@5LEK;)ZEDM@^_;(7X'[:&A.VB>EI-L3L,U''0FZF%-,+$'3*&K6!
MI2<=M/?VV?(\;93H)G!:73]L1_G3MLPVHBS5WI5FF[JDPH:;4:[9W[=9;2*]
MINKT2ZQ[];D]=$$\T H..I*;,[Z1'72$![^UXH_HTQ^&VZ@[%$<19MV?#(/G
M<'<R\"F7?5[=)W_+RA47$4*()S )$P11$C%(_!BKG0IG$4I2*E+N<BX[,<[2
M=B:[[^OIEZ0D=4S:.(6K&S]=@-9<1.0 U&"Z.0'#)+QR.-:+$,@)A4\QQ:G+
MA_=R_GF=?WU:7I1Z2.(P0-!GB$%$? %)%(<P#7F,?<9EZ#NE#1\=96ET8'K4
M:BF'56H]CJ0=!5R,S\0$\ R:"5)=>S$8O6?N\Y%F;VU[4MEC'6A/7SSLNZ^+
MF6NOX;:ZS76_L/=J_LVJY1-$9!1'NLMZK#Y^+U:[@4A CU-%!PDEGN>4F75Z
MJ*4QP+[".]C)>@6TM(.V!3T8V]'".,A-S W#07.FB/-XC,H3/</-2A;GU3YD
M#(L[+DVQ>+OA0F:;K!+OL@?!#[.\#FJ>I=R+,-+63A\1B%#@08K4KB(DS$,>
MEXAY3N5?!\JQ-,+I!O'O%8%&DTMS0H=.E1TUS3 !$_.6&_8S94\, G.B# HW
M65XHBV(08*<S*88];J)^<N6IAD#F#YW><;WA']5+K<F]J1+AQ2010G$L]JD'
M42Q]2 76_>,$#6B8X!B[$>T$0BZ-A8VD%Q7MF&(F+7GXA>=G8I)VF9KQ^[)=
M@-V\?=B&"+JLOFL70.W<9^V2L891_=-&]Q_D+B;A8Y'+K'J7EZ4.V?HL;HQ\
MNE3XILS7&=>9M6;16:6A( %73.XG@>Y)+R2D1%"8)"A)/$]MKZ53HO+E(BV-
MQI]JI+=U^SB?6BGPG5;K^SJ\LM6L+LJ_UZW9Z3DN 2/,L!WASSMO$]/[7%/F
MO#2,A_*H"\$(8LU*^^/!>$CR(SYY&*7_HE8%/<J'C8Y[T">'!]&4 UT1[F/N
M800Q)JEN=N-#'!.F9C.,?#\1,25.F_">L99&PEK4]IM57[26MSY@[R1VX]4^
MF.T(<R3P)F;""W!S)C<+1$9EK;[Q9J4C"\4/><;F%O= T3=2"EU91>P,M0=\
M=I_E&7^75=E-'9LG94H1ICY,O3C2P:,4$I8BB"(>!3JL7FT";8-'70=?&L7L
MY <=U\-3%72K;ZT$V&MA'S+I/#G]/#0UY!,3T^+0M@]:G1+UF0)91T;?*;AU
M*'P] :_.CYPM"':HLMW V,'/N+#/\J^"E-NB-FV\SW4)@FU1[$-0N&Y60FD(
M8P]1B+"O2YRQ"*;43Z,D("&._$&-E_O'7=JRL>\U? 6ZT@[LQWP&=+N]Z010
M3KP<G$)QRK[-=N!,T\CYS-@OT]G9#I"3K9XM;Y_(JW7*^/JA3FY_\TT4+"OU
M"?W]UGQ*7BI]E/@>1$RHTW3J^Y#0(((L$IRF"?(P=XI'&EW"I3%=1T! *B!T
M<Q*I"P/H D6#$_['G]B1/%Q33M?4,0A:<$BUY*"K'>BHI^LX=J]K5 1&1[WY
M:VI"=/14U&PTG=%5-G02YO63.4NY+"?94)"=/62#!QIH2\US_C5;KZ\WSR(N
M/N;KC#WNHY.2*%++@4 PHCHX%1,,L8@E]&7(1$*CF(1.;C#[H9?&\JWD)B/L
M@VX^=6G$F,,T6)I>)P%W:DML%]=GB%Z!6G+P6_/_20+"W($;UV!K/_R\]EMG
M6)Z9<]V?,+0,7UWR[^WF5$W \I.I?:Y(]/%C7I9:D%6@2 R1((0>%B%$04Q@
MFK 4<H&P((0C1JR:<E\DQ=*([DU997?&S6O6)[V7Y8U>0&UFM]V*G;J$*FUT
M,Q7)U06*&L%&?Z5^ .[R377K2(O#IM*.(2>?H(G)\G5G(DZ63@59"?9:@%:-
M,8L'7H#BR"4%AT@R<Z'!"\!Z7G[PDH<-H]:/15/S\+,NBF<L&BN.(XH\CT <
MI0PBWY<0<Y_!)/8I$UQB7SAYW(^,L31:;%([%-S_\L]IX =_BCQ/<5V^+?7&
MI3[B7]7=3-HK-OG&L?O",:SMF.U"!"?FK9UTP(AWU9HT:[C&8Z8>%$;EG6/C
MS,HJ/8H><D;?I4,W6T7V0+3GY5D-U.MJ9_;4A7E#G(K(2U)(%9 0<13JC"0)
MI90L25D21LRI1Z7UR$MCCY_SPH16FS:AA+D>%>T1M]T'38#CY'N?5N8V1^B[
MCMC?7VG;ZQ-WR;CUDAT!&WF;8SOZS%L;1U">;V=<'S T'KPBV4;PMBQG6W8!
MA=2/10"C2.U=4!1)2#D)=.V%*$;"$XF;<>OX,$NCHE;*785;U\CKHUC:\<[E
M"$U,,L_ F<#1V@_"R ',1X>:.2BY3]WG@<:]5[O'_GTL\O\4K-)]F<H/FWT\
MX?6&&RONYWNQT8V]5U'B^4G$0RAQP"%B#$,<T!3ZV/=P["=^+*V,02Z#+HT;
M&KG5-D4)K@-CLYWHQCZ;&[MWV4AO'W5F/0G]-#(5M).??FI4C<S@PZ839@RN
M=]Z$S].A:A_#-P6Z,\7N=4!M7U"])=3FR%=Y<9\7I!)@+1[$^@=P[-H;L1&%
MZ0>0;4Q9[]+<*[.BK$Q3J/I24]*2B4+3%+BOX6K*_1?B[]NLT,8Y5H=[D'7G
M RI!8QS5_0),G<RF&Y6Z*M^EX8AOVD$HRA_&"2ITG<^>8$+K1\T61.BJ7#=X
MT/G>H4=E6KW=Z':!^N&[+>T*A0%.I5IB/)SHZL11!-.8(1A++F.?)]R+G$H
MGAAG:>O+WK<@]4GM0<OH>A(^#JCMN?=BF"8_Y=(*[$6\ZAQI397T=:YCR<8\
MV/8B,O(Q]OA8,Q]:>Q5^?D3MO]Q]0_HJO[O+-[4Q+M><_TF72"_5WT6Y(C@-
M14 5=$1!B&3"(!&80A'2($[3T$M]:KL)[1MH:<10R[JS#AMQ02VO^:>P/*6>
M!?C\!G,LV"8FBMD0L]\\CH7<3!O&"Q!TVH/9P-*S[^J]?;:]EHT2W?V5U?7N
MY*D+!MUM,IDQ\W)\$DQD#R:=7V*)D,<%) H]B$(J(&8BA)&/4!PQCJAGG;)W
M<I2ET6;=5PB\(H7X>5OJ2-:L!.O,A")OE1)UDUNUX]+" ')3B#K&M3F)J,.0
M/MC7#[G;JG,.%>">9*;OO+Y W6V.46U9.WM*.3U1YQEX%/@GIM\#&<%>R#$P
MLN?<4;":[83^%+-B)VS3V5?]6+^0.K+A012/ZB]K<UA0;^/^Q*V^\$Y9;/U^
MJS.SV177'?FJ@FQ*PMK?CG:4/HMT#X>?OG<V C\K?I>]SU_L3MW7 7JOV?_U
M5@2>CQN_@41^Z@5!!*.0Q1!Q3T(2APE4VU\2>3+!7AK9TO;1$99&V<$/Z'\
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MM5_\S=^WV;T>_EVV$6\K<5>N2.(3ZB$,"0NQ-KI&D+(@A1CC,.1IDA(BW/)
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MIUQ$5[QZ\A&M'S5;3J*K<MV\1.=[Q_'TO<[66W4NWM<,2B-!/$7B44JH8O(
M:9]?!#W. NF%)$'8J@ZEY7A+(_%&/"!:%]>]VO*RND"V,9D"<I"#]HH4/-.]
M2_XLR+JZ-=D*/_SQ,F?AX:0,<QM> /4+.!!;Y*>HXV.)S*1^Q<,Q7]3#> *
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M0):EK2LG4\VOZB8FNNVS]M/>MRII;[=69)3D7:O9LSO!S#0G$R\]/277.BE
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ME1]!GW 1,()YD%KU"K(8:VE$:,0U/@]0"PSV$MM'F9X#N)_01H9M<O_4:<1
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M1V+ M,2804EROS#X#EESHTBK:M32]2:JM?5,KW-!V8WV F$W,J?UA\V;RAP
M"<I37?(F)2$'PX\9QN46/_J0JEB\5W=L^=8\=?M4MYI%E&4(YP!RXWEAG K
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M)H^PD9UWRG[WE?'1WOJ^;8IZCZ\;WTX[:F.?2IT9L-.1L+\Z-*;<&>53.'1
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M=,7TGKMMNK#>#J6?1?9V7=>["<3ZN_K*?MP^;+^M-X8R/YAA;%Y#C25'E"&
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MT001D&6$ TQD#LQ?$Y!*J3.)[)3C59GB[Z0C[L0H(]E45H*I,DNF#&: 0"E
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M&? _1Y7^-]'>@NA@0CB>ZHE=4 ;SU6%2;NL)T#'K]7U,7U?(1HY8@763MD,
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MV90UV!J8#L'U>Z3.A-:??T7'*(X^TS=A'D'Y(]GX]Q&\/^X !POR'UE-_V2
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M?#;4OGSSP]1/EPN417&6B CB+"40!=PDF6%FDGQYFD0!4FY)4R='F?E'7MV
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MG$@MI >5G%[34CL$VB#YJZ3+]7WM&_[)C:J>(QPDB5(L17HEB&*(E(8Y(T+
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MGZ]DN" 1E0D7&50AR2 2@FKC(XJAGELE*15A0ASCX$Z,,K</MHWL:D6\V?X
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M+JNJ6.KAV%(N&*>(4:ZI*M0$A52801IGF2E_@Q27A"29E1G8.\KL>"FOFBY
M==!F)9=ZG+L;<"=7=8=,\SE1\9"OS&5-:H3\\2A7E;$P:H4<_,OST%_VR+T
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MKU@ZVWTV('DU\7H'G-2:LU']T'"SNF> C::4+&\["0P?U:<R7_'\D2[;&)H
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MLQIM;K2DY?WW__BW$ ?_N1<;:+F!%AG;GV->1OGR^;!7[$:F'P,;.$"L$=<
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MM$A2.(9,90J&+$V0R!22<3I@R]Y>@IENW)\MH-&T/]]9YKF)&+L!*VE98W?
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MM2*K:^-3X[R=_3M1O:=$CTSZT_LC,3XDG1/)@1=Z7N*PIN7<.]>7%V-B'ID
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M;!T; &XNI'6Q@=%*:5US\;"8UM5K?4\3Z#&]$_\[S3'>;98P0I0L*U.$%98
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MJ3175*42E!"GIMZ* HS2"A0E+BNF8]^B=,J^LVQW:KRF7TT85A%G"[ =B46
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M5[("BJI27#! <Z5#2<P1H!+E0&4$86RR$ZK43>?K7#-38TACY4%11>]BE!=
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MPFZI%]&P'R<;8VL^H)W]SQ9*FW__-YQGV7^R,;O(;OR*!GOD06MK=](;WN_
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MJ@QG#<SE0G'VC_"CN%?+[X\K^4TNFIU:@IF_JJ_TYXQDN:@HRD"1Y@5 *82
M,:6G3-"<)L5(X4Q3FHE#["AMH"TG"MNU&._+ZJ(K?FCP=D$^@FSH4"?8\5<@
M:"/SU3,KMWHM78)"%WAI'M,6WYV<X/I$5T&SC2W@"LI50^V-RDT6CA]SD<TM
MGB?7^_,!7Z1).M;V]\L-:2G2BC$$)*I*8((G@'E::%S+,LU3RD3A)EM\OIVI
MA4U;,\'SD=OQU/H%3.UH) !2D2ED=Z9D9V*$I9TK,(0]M7ZAK7%/K0\[?')J
M_<KE?G30JFF>81LS/FP9YY-<U4O1'@*FC7PMN__N3D,CF7&8$@4$P02@@E)
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M5AON=JQCU82[P;*7J@5W.Y@#-> "/-Q#0A7^&64?EFO9B(W4?5;UJ3 0,EI
MF /)BLI4>9. %0P!R*N,(4*K'"MK^=3S;4R-6XV5_T_2VIEH0Q-5-UQ_Q<9@
M!TG0"W@.<V0@E"(SWC% QD@?U=0+$#DHIMX.U4@'[LY!%D@B=1B#(7G4"W>.
M)XTZ;/HS6=0KEWH&K-OR0VWME&Q&%8;,5&B'6$%3*8X!BLH2E$I 4:J4E!5Q
MT^T_:L'ES1Q'K'];B@EL!0#,X177Z/$(1LLXT!^:V!'=UK*N?%+ <.R\RV$#
MJZ,VQ@V1SCMX$NQ<N"Q<'D(;%\T0+%A&*@QRKG* F&QS$(0.7I"B."NR COE
M+UUL:6HAS/OSAS'[N4: M(2O#MIT05"+_,G[ A8D2^%K-+VZRZV]>)["UR'M
MNNLWN,]PGL^<^EB3%[ @W,A$<8X RB@$+$L+0#.9$JY# 26M)4G.-3 U8CA>
M?;"/UL_"=WTV<RLHD;_[(SP\9C%G<;&?PMR*STCSER.<PDQ=AGP?F+><O6VT
M2<N0T8<SEL'K_ *=SY(;T?A:U;SM[H^;]4=E46.[&ZQIQ@LF2@9RB"A "IMS
MO.8P+X%Y*3F1)7'*RKS)FJGQXK$SR7+3%HXZ\"<YIP'>'I/PBJINZTR[R&NT
M+HK,TKZ]T^L.!P_B@N :--"[S:)1@\$@X!T'C&$>ZI]4=;\0K^AC;71&#-U_
M9//ZH3O9-ZNDRC-1$0 KS@ R,U&F6 52@C%$E4)I4;A(H PWYT2L8^FBN.=2
M#> IJ<2,50(HHN-V<](9,%0A0%F.:28(+AEU6Z0+A^A(!3;I:O745OK^OMPL
M'*5FKJ!K-["$0RSRR-'FK1FMT2Z\WQL9-FGM.A;!<]<&FAP]A>VZ^^<RV2SN
M\ET0W*6UO*7UZK_I?"-?UPV?+YO-2MZS9KVB_W]UU];CMHZDW_=7\&6Q&:!Y
M1J0HB9H%!NC<S@:;28).9@>+/!B\=K3CV#V6.TG/KU]2%UO=MF52IM2:AUPZ
MD515'Z6/562Q2FP7]MQS;)->XPQ+2' B(=,9@DPJ)-(HBC"1?JN#+F+GYOEV
MM/Z3[[J@$\RNBX2AP1M]Q;"3SF95!I7.8*\T^-JJ'73]T >GP(N)3J(G7EGT
M@>-PF='K[DNSXFS7VY_%<EF'<'&B29YC#%%$$VC+:$$JJ(!)(E*$<B6Q2#TW
M&X]+FI\#TZHW+'(^!2AA/,TR8E-5C'=($,,PCVU-4V2[7,8"">&UVQ, SJE3
M <<!UG$_]W*XQM[7'8+4!3EW1W$8*8ONL:QGRHL[:O#I3+?CEP]CV>ME-3)*
M5N>E7AI_4MIPW\3ZE4O9M#E8J$RQ*#?,@&*40I+&*62Q"<NC6/-<2)Q&VLOG
M<Q,[-\JHBY56QT\AMSH#T5$:J%IK/_)P'  W+@D/Z]C4TL&RR=8$UYN-N:1J
M4G$%WIS!U)MF_" *RCJ.HB<E(3\XGG*2Y]T#'4'[;/[TV9VWY.7#_I+F);K^
MR3;RXUT5%;_YI3:B*"U9_DT5M]^,NM<VC^96W2A;M+E8W=KZ0-9EO6?++VKS
M'2V4%)*A*(9)G@E(-(\@C>,8R@PG+.<JBH77B?!GL&%NY-GJ#5FM.-BTFML.
M-:WJ8%GHRM%0>XO!^JZ_DNAL7AM'CV_>+\.$E-^UO\O[@#^ HU.#1>$*-#C8
MV6&'Q!5HL0 -&&"'!NC  2P> ;W6YQO+L![Q,]@QK;?]? -UX,D_HRI#FQ5O
MC6Z%$7A=EFI;?E#;=U6G=B.JC486FF.BDBB!:40B,V<R!"F),ZAT@B3&B#+E
M52?31>C<)KE=>&SW3M;5UGJQ,\,0UDIY;CLY(>\V[83&<^1Y8J\NJ/6] D9C
M\&*G\VXMXG0EH $-D=TQ"MPAV4'PQ"V3W:$X[*'L<>^ 0W=+\]Y(]LKNXCZT
M!^XPHUE,)201X9 HG,&<40UQDB91EO \B5/G W>'SY\;T30J@EK'(:?(CF#8
MSR,!D!F9,D8!Q>-8W67@3)22Z@N2WZFZTQ#TG:@[<M=TI^E.J_SH)%W/99=N
M<+U6F^*'&7:;7=56J2G?:*W$]N/J5 J63:%\4DA \Y@0D>0P14ELZPYS2!-$
M8)KJ5.1"1$GDM4H;7,.YL>BCG0WC.?_QA=7Y#Z">K$PH69BP]..K=U4%@CT&
MG8I.@PM&A!ISWTVF9QC)";>GCH_1%:@-!.M57[YK,_C3%)8(/ XC;8^%TO*9
M-M8"@WQZ2RZT('^?N!;62=#]=<.VZD99S(IE43D5YA\;G?3;]485MZOFM(7-
M8$02(4R%ME5/$22$*ICC3$$1Q2F.4T42PET=Z$N5F=L\L;.GI0I;F,N:!![;
M=%7]1TLV&C2&@;UE[K[HQ0-ZWIN?<IA&G@3^)4?(/;28<J0FBD,F&#&OT"44
MQ#UQSL4B)@N*0H'1C:""/7-@NY;-6A=;.^<N<IO,HK6&E-K^+"8P@HPG&&:9
MXHIS1'.,?(Z6[!_M-7%-<(S$KI@JMK%; IZ12@<N+C0E""D8VX+TA$@**28(
M)A(QK;,XC;7P:F<S#*X)YOD@<&&J(T'R&&+,L8G"-8&4\ A&/$YR(E641IX)
MJL, FR8GU4+V*'ZZ OL5^K8?T/5VNRGX_;8*K+9K\,%\\G:':KU<VLO>K<S@
M*M_FSQW(W8+@83".[+A,@I]_AZ #J,*V!-H_?MH>0 =F'33].;S"/Q;;1X/E
M?REY6^7&5QW([FWQGM+NR!:K:E);:WN!&<-]V'A='4Y;B%1%,F4,BL10K>$/
M&XYQ 6E*L3!QF8ZD4P92('WFQM0=DZ[ MC% 2;!:6S/8LCGCY^'-AQBT\R'7
MQ$,Q,GD]&H7*'O#$H"O0,<FZ[XU1G>6Y*W#M<1XSU%"YQUX3#]E$X=<T0^<5
M@04$NB<("R%ELC@L("3=4"SD8X=F%#7-].SAL4K2C2K5QBBTP$C@B.@,(I4*
M2*24D)/<1!]44?,N<ZZ99Q[1*5%SF]1:O:KM)O7+C$19)Q+QTJBP5;NFFJ=[
M0?J"[>8YAX%PY,EHIR38:0E:-4-F")V#(G!>T$EQ$V<#G3/[, ?H[!V7[IO7
M<=-+93Z7_:+2:_-'N2W$]4HV2TA/=\D5384A&4AR$D.B1 RYTBEDF$649I'2
ML5?3I@OUF1L)=;=3F\"TMJBS3GL%6JLJ?FKL&KH5/FP8?3>^1Q^<";>YFY'@
M;N,RT8[V10"/M'\]3*=GVJV^",#3>].7/7881[]:?_^^7KVRM:6NFSPZ%&>*
MI#&'.$D,]U+CX'&NS&_&S2.QPE%J%]W=:?=0Q-R8M-805"J":S]V/ *@&^%=
M!LO('/88D8"YA^>M#THP1\1,RAFGS7Q* SU7CI*UN)^?12XII0F!2BKSO0N"
M(4."PB07FB"EA8H&NEG]@N?& MUY^^/]MMR:F?GQ*DK8',+ J8%S=X6.9_P]
M9Q+?L^;F/;L3XP:)9R;=5 ER=M^GJA+(F?B[(<WB>[G0:1X)+E,8LP39TR4$
MYD2DD)(,92PAG'*GI.H+=)@;I;FG[E1U?G?6@-J<L!E6Q\;L_#[,!",Q,@G.
M?A#"9K==.!BS2VKS&Y3@F6P]<%Z8P';LR;/*6^LQW3==K>]1P]QK>PKEX^HS
MJP/W'R9&KR; 1:+SB$O.(.-(0Y*E"K*<"DBC3"!;'#GVZ^YZ0L[<9AJKICVU
M816M%[YVJOHYS:=P=?.1 Z U\FPP!"AOQ_<,#$']W%.R)G5KSQC\U(L]=_G
M$FW5$>I7]YN-W7S=5>&--4ET1J'D>09)(F+(,.8PQE*E49)+%6.OBFS'I,R-
M#AKU *N4]:R[>QQ'-P*X&)V1/_^V0D(+T!@E='LQ"%LH[:BD:>NB]1E[4 :M
M]^*!ZVS&5:V*P;0+^+;L]^$9LMU[G*0X3E0F35P:Q9!(SF&.4 YC+A-$I,8\
M\ZOBZB=_;DRQ4[_J3G>TN\GY3R3(P#BNPHT']]B+<2&0]E^#&X97V*4X3QVF
M79$;!M#!PMS QPPCO;?%JMBJ]^:Q\FD)F=\W-M%?:LVI%!@*S%/#<CJ%.97<
M# Y%)D320C"G*B^N N=&:Y528*^J'W6=A=>-JT*"-C(YU:K"2E=PI*)4I6\X
M5G)%)B@-G14Z*>^X0O"4:)SO\V,6J8K%F]6VV#Z\4K8DWO+=2JI?_ZT>%ED2
ML4QG#&84&8<IBC/(I4@@(JE.N8ARGCF=:CLI86[<42L)&BU!I28P>KIQR&D@
M^TDC"#QC+Z7[(N-,#&>M/\($I1*_W:Y__-'<6Y. ^4OU[5=?_>DG3O*9GS6H
M_:[/7WAI_D$/8SQ)%4RQ%&E&&$1Q@B%)H@SF$;5G,],<I5$D*1[8X<)9A[F1
M07<+O7^2')J<X#X\CA'2N*"/'24YXSU1ZH(WB"-E,;CK\4P)#=Y G<YM\'_4
MD';MQ;J0[XMMTQ3N^E=1+E06:ZI,Q,2971P260RI3BC,.8E0G$64$H]V[8<"
MYL9NM8Y@KR3X:M7T:D]^!,9^H@H!SL@L-!(N/FW;+\-GLK;M3W *U;C]M/6]
MC=N/W#9AX_;32C]NW-YSG7_0]EF)^XWQ'M_\$M]L7?0/9K@66!M/CM$,)DHE
M)F:C#+(H(I +)G@LXAQK[1JS'1,P-QYK=02MDL!JZ1ZP'07Q?+QV*31C^U)^
MJ'@%:WVF#XK5CCYPLE"MSYQNI-9[W8 "W5(6=1V&SUOCSM1]"SZ907S-MNR)
M]Y_HE&2":.,B*EN]F]N3>"*#@J.$1H1PH3+GPMWN<F?WJ7<"A+T9P"H.;E35
MC-U6?JGL:AJ@@&N;GV1&S:/ M<? G/=V1H)[9/KHH/L(3:MXC;='!'81PAZE
MQ<=!>JJ2XT#NN_N:]YOM1T!:O#?[]YLMEZ"L1J5N^@38N7?<KSZY/XY]=<L]
MGC9=/7-_$Q_5.1]P^^"F,FICY-RH'VIUKSZKS8]"J'<WG]N.#AQ'N4XP-&X=
MAR2E".8TCF&N2*28IB+!3A.#H[RY30AOE8&2+;W;Q?1BZK;4%A"ID;F\U10T
MJH)&5_#":/N'$0X8.D(3NC=,K\RIV\*X '"D(XS3;0./&[/RFTU,,'^\^<=]
M\8,M;=[ED=[D"QEQ+'0:0:DE@80*6UQ&Y##.TLQP>ZI4Y!1!>DN>&[U8C8':
MJ^QY/-D9<#?&&07&D;FG0M"66:C^TE'["EC%JRHT=5&M6O6 IYQ]T0I[^-E9
M^K1GHGU!.3@J[?V H9F=QG=Z5Y;W2KXV0??J]I/:%.NZA6[9<;K:/G]*+A*4
M2YHBN^Z%3(QL?H(<F;\EB2:8Z532F"Y6ZM9ZT5]\<CQ]-7'Z_/+Z\SO09\0-
M_%8_\*)8U0VZR]-=X4*-BN.^Y3@@_\LV:U6E[:I3@Q R'W0HRH%30KW5F#@K
M="A,AXFA@Y\TC#;[NJA\4-N/^@O[M4@PETF4F2 Q9PR2/,\ARU)JV3+CE"<T
M0=2GLKN+4"_/;H*:[U^LC*;YJ'B4CUU4NO_QQ;*N,[U25<[VEOWRHTJGD7 C
MQ]#XCKU_>JYY5-VCU(#ZI0=4;W+S02DHG3D)GI3 ?*!X2EE>]PY,8&^]Q;\H
M9EW%ZOS?C=U<L139+,+H2..,8 %5+#@D3&'(14RAP AK%FD:^2ULN0B=6_BY
MCY"N0%?M*[!3W#.WW05Y-U(*C>?(I-2%<J?E"$M?/K"$37!W$3QMDKL'% >)
M[C[W#F.A?1)&4W)U(1,6,\X2F"5I HF(,&2I9% BS#-)L4B%5_F  PESXY<W
MY;;X7FTJ=9*=WA>,%TOG#=/3<+KQR$4@C4P: _'Q)HV3& 1EB$,ID]+!22.?
M?ONG+_1/D&J.&[\M2L&6_ZO8YLU*OC8CNA"<<Y+EW(3C662^=<X@5_5B-U,\
M40+'3M]ZGY"Y?>[MN?=:46 U!495NYWOD2YU$M+^[ST44&.O5P_!R"MYZAP(
M@Q*H3CYTLB2J<V9U$ZG.7NN?3/47)0OSL-HS:$.(1 @B"(.YS'-(\@Q!GJ0<
M,A+%B$9)EG'GA.XCSY_;Y]VHZ)Z%<PRS_H\X !(C?[^-=J!6[+R#[P2*>PK2
MA>!,E&K4@A0N_#EC>T]ZT+&[)DL#ZE&YF^[3=]D%VUO?UDMS1VGWT;8/'];;
MSN[9/OT-)PF3B*20(R*-HV)[,%"%(,UCA3,SU+'V.LSO+'EN]%8MFC>*_P>H
M51^P>^4$NL>F56@HQ]ZKZNC<H@BLVIT]>/!UG&-UOG"%WW1RDC[]7I,/*$>W
MF+P><'%)\Z*\6Y=L^?MF?7]7[OIP[MMC*;GO1UPO'N\*I+QD2]L\Z_,WI;;7
M*[G/H]PKW*G-;8*Q+%<F/D,XM@LR,84T8CG,A*(HUIF,_?*0GL&&N;%H:SBH
M+>_V4>T:[]WJ_3E?$T>VGO?@C\S[_N,^577XJ0=CK$+SD]GQ7#7KIQZHGO+W
MDZLR;,[\ZVJCQ/IV5?Q3R2_LUTNU4KJP^QCR7E2ZW:CR?FD4OGUK@'_/[DIC
MW/7=W=)$&^;3LSK?;\T_O2^^%W5,6"XH)6FL!(6:9-C,B:F"W%8X34G&!$(Z
MP=JK\>,(.LYMSNN:6-4:;XVT6X&-F6!G)K ? :@,K8Z9[4P%C:WV7SO6^LV/
M8[P2.%$X3Q2!$F<:$IDCF"M!($*"(XY0*O-H0.+C<[T9SY$9>5=L=AU\M]\4
M*/=#O9S34+NY.L_\38_LRCS3Y^SMXXPX"D%]F#'TG-1'&1'HIS[(F**"5P.]
M_K[>;(M_5F(,Q:E5J>QFRUMS[4(P@05A'.9);N:,G$M(<1I!H35&*95:8:]<
MAV%JS,U3V&_XL]7JWD1+K*.[)8IB7XBJ+J\.(#"?51JLQ&C?F+F1__@C,3*_
M]U;^LAGR=TK8(>I:<U7OU%I+)BE4ZH#D5.5+^U292U%3![@\2IVZ/,U_![DY
M='E3\WLG_42O-[9;A:'V[?UF53(3-"Z7ZY\VBBP7F69IEI$82AYS2"A*(,WR
M%.9YGD01QBIAQ'6/>9 &<Z/0:R$VECF-SD#MZ+2TZH--K7]U'I#M+'#?FQTV
M1.>WM$<'?F3&;,]U=PRPOG!E0C40E1'@I@/_]63PNV^>CSX,$VVOCS,<7GOQ
M%T'9LUL_[+F3[>=?9'9WQ_^R!PT\GU]E18F'SS_97=L.'"49$4Q!$9/<YB8J
MF,>$0)KF,L(ZQ@HYM=4\+6)NTT>K(; J>J;O] #IYCI?!L_().^)C/]Y^9/&
MAST8?RAFVA/P)\T\..I^^DI_[[)J@EAM3MS:9[YG/\O[8EM^N*]>SSQAE&>8
M0H6I;0,>:<@IT="6\,D3PI14SEYDKZ2Y?>YU@\^]ME>@U?<*U!J[NR?]$)_W
M H,!-S(13(>9N^L6#+N)7+0+,/3RPYQPZ?&W^N^?S*]R,J/K/[G=,*!F9OQ;
MEM@$IU+>*[OPULSO.4-,)1&#E".;*60"<L.;"90Z3PG/=*244Y^2'AESHTZK
MY;]7J7LE,(K:9<C$HP+C"2#/TV0 >$8FR"/(I ,RP4]!Y%&0\G*H)N+#8Y %
M*B;9CT%?X<@3=TY7)+)?]4<%(<]<.BPB_*"VMM#2I\WZ1R&5?/GPU]*NAM9=
M<PVU-J5M"U4N<B(0)E3#7) ($IQCR+"44$<4Y3AB&5*Y3TT/=]%>O#A!90];
M6T+88F-WC>Z /_SQQ;TMNE.L_F!^-1:T15,+UR6P :/B%G:.@_7()&MAKFJZ
M?=K##%[\M85YISRX/@^S=ZSJCUC0&-9#_*2QK3\L3V/> 4\81FUV96TEBF51
M36P?=9.OM[HUHG6QM?ZCW4'_K&ZKH_]?UL:;+-?+0M8Y06WJ+XU9I+-<09XR
M#4EJC_A)Q6&48(EXFBE"O4['A%%K;JYBHRZHC; ?ZHVZ6V^V=1I,_9]^'!AH
M^-SX<?I!&7V_IFN0S2O8F=2.45TIJ4Y>:@VSI;^[IHV:H1T6]*#T&TBU2:DY
M+)Q/:3OPTX=1^LO[8FG3L*]7LOWKN^_6":NKM[21NC;.J#(\31E6D-!,0$8I
M@2AE3"0JQ2)Q6NKTDCHW0FXUK?;^NNKZL; ;XFXD&QS'D3GT$82['[HJC[!'
MX@524,YSDSPII7F!\92Q_&X>VCM!;!0KU6M5__ENM>/%5^RN,*%HVY%]H2CE
M(A4)E(C&D"1Q!+E*B3UI&%.,J<B5UZD*=]%SHZ97=;.HPK@E.Y^D276T7]JR
MJ7YD(H!=;4REM1+F_RMGA8E_W!=E41\ALW?(HHH=MO9@S9]\&S4X#Z ;R8TS
M+",S7:LT>-&J;5<Q.BYCHSKXVBH?M)6#+V*!NSHXBY^XP8,O+(>]'KR?,(P%
M7ZM-\<,\]T>=/?EA71]WN_Z^OE]M%Y+$.M<Z@RQ2AO@HRZ$A0@QSB8U#%M,\
M1VSQ0VWXVI7Z>N7Y?%9=J>-]77MU#9\UNMJT[WO?D+@?9T2,=YLK,ZTDPM8B
M$AARZ_L2'&6() P1MWICP5&>8DYIM0/7P7%UX_U@:(U,]7L]VVQW5^B\B=T)
MDJ!<WB]Q4OIV,OXI8[O=-+"ZABUN\])V!N@V$.CT#WCYL+^DZ1U0M0ZH2WZ\
M6YFIHMHG+*OZS5^,$]=4EO\?XWS9)=RZ\OS?5''[S?Q\;<B5W:K?S?.WMO+:
MKM[J D><I\8!AAG/37R>YASFL<8P0VDN8L40QDX[Z;.S;&ZD6*M?]>*X+R4P
MDW_=D\.W)<=<\'4MPS$7?6=$^P$:B#25G#KP@+H._]8 M&\OTKQTN]XB5Z#%
M"31 @0JIJMYEIT-3P,H?<QO_L/5 9F/=M%5"9F/VB;E[?@H./".P9&7Y45=%
MOUZOO[-BM>":8YHA$[PQ:7[34IG@#1&(,5.QBG622K]F?0<BYC9S5AK:A:>Z
M,_'76DO?0P*'2+I-8)?A,_),X@N-_RF!D]:'/25P*&;:4P(GS3PX)7#ZRJ'K
M-5IM-E5Y@??[Q=;?UVOYLU@NKU<'QV$76*DD%YF VC8O("33D&>XKFH>Y2S+
M<:[:^B^NJPN>.CA] H\+NXQ,$A5/^ZXT^"+ONOHP!II3K4C4NE>%5MYW%_];
M_>L]S"?'] /F>@U&+_#BA:\6$R]H# 3I<)%CZ(.&=F%9J8_ZE9%8;-\R4376
M^ O[57R___YRO=FL?];KX>9_M@\+Q;,XLPY.@G0."4<2\BB64#"<)C)E29P2
MO\5J'_'S6[NVVMO)OM8?M 9<@<8$L+,!M$;X-G7Q&!T4\R1!,H-9')G)APL"
M&6<41FG*B!(T$XE7QZZQQF:26OS- /#= (CQ!\!M-AH+UI$GHI#O^H &/?Z8
M!>[=XZ' Q&U]_*$Y[/@SX!G^A\<^F0A]8RO%V'0YP]!F8FM2I+(HX90F K(J
MC9AA"JF.!<Q8'A&>QYI*Y^-C)Z7,C:,J1>NZ27M5W8]'G4:SGX>"830RX1R%
M9\ QLM,XN1\D"X+71$?)!N+F=:CL+!X]Q\I.WSO9P;*SZG>/EIV_>)CGW?KT
M;]<;5=RNVFH'7S9L52ZK=^1W5JQLZO BCB2G6:PABVS.+LZ0\>R,WRT9EG$6
MH313:D"!67<-!BPO3%$WME$<B+8TQW:O.F#R_^[+;;T58T/DM?^"A,<0N?E^
M@1&?AHA;I:] B_>N%$I'<6 U;XY-A'/\_ $+ZO9YB)_4Z?.'Y:G+-^ ) S,K
MZC,/]8$GFV6\TNO-]TJ"=3O?;=7W<J'RG.6$2)AH,PXD1S&D2:9@EN(D9HFB
MR*\:JHO0N;F#[2&QG=*@HS7X6L5?E>*>&RU. ^"8.Q 8UK&W]2]'U'][W0.B
ML#O?+H*GW93V@.)@O]CGWF'$="V$31PK/[$'>XJOZ8EYO9(?C'GU#PL48QQ1
MGD&D=6P<+YU II6"FO(TQBQ+,YW[\)*#S+G14JLR:'3V(Q\7D-VX)S!T(U./
M,VK>!..!0U!^<9$[*;UX /&477QN#;>MLI]M6:89(1&%&14$D@Q%D.74[J/$
M*D<L(\GE*_6S]7-.+"1?X.'T@SU\57Z./LU%Z 59=Q_7C>F7^.PKZV<=%[>;
MAF:F\.T^$^Z#>4N:Q*DLUY&2-(&"(P$->RA(,>%02B12&J<QRIC?X9;C@N9&
M)5;/3LKM%;"J#LQ'.PFN&W^$@&QDZAB(UH"$D7XH N>%G! V<?I'O\F'61YG
MKA]&$%7.59T6TO@TBR@C,A>Y@$I*0PU1ED.:&Y(0B&8\$@DFPBL[]5#$W$CA
MTT;=L4("57>F&+SX>P1,-RJX#**12: ^E%!K=]4LY 8\U7;:]J!?_1$QDW[O
MI\U\^J7W7#GL&V]>[Z;O2FF"EDI$&\-4DMK]31UG5+,4)HGFD$B40QX;/+FB
M:<IRA")"?;Y]=]%SY80W74X8D*'J ;X;5XP#Z<@<<AK-EE :@AFA HP_8$&)
MQT/\I(3D#\M3HAKPA 'EHSN=HU@CX7I?L.1&+>W6\:MUN2T_K9>%>*A_[]0;
M3%$L%<8P5JEMFY=1F&><P"2*F)09BE+MU) CA#)S([FN/9U/LF,2;&P"E5$>
ME9@O';9^,IQZ,,9>^ST[#N#1.(#:%/"U^=.EG&#X(?*HJCWA4$V4,[7O/6[7
MUEB]/&PW#._J(;%-HVQ;8E&-5U$O$DL@[S=M!;2-M=K^L%V;G[M5F'X#7[ZI
MLKVWO%.BT(5@R^6#?=#R7JHZ;86)W0M3K+;JMFF(7-WVGT!49:&L;*#MJ> ?
M]C"C55:T5?ZW]J]E(57;29DOBUNVKP/UM)5F1T6X:=['@_::5_6M!A?;=W5C
MRPS_++;?C!;LZ5M>A5A'GUJ9\%N@<N:!7KZ^NN>7BIBN0'H@,!Y54@_US$NK
M)>V.['[4^W]LS\0\+#+.L393/B3,%D[BN81,:01Q*EG,5$Z1BH<5].D7/+=9
M_XLMZ=XM"S>TNL\9O%V70<.C./JRZ*[FSTZ]JT[IA2OP^\9VJ]G]YQ@U@-S0
M&JD<T!GASU09R V2TT6"'.\?1E/VP74)@UWW01,Q-3T*RY=L:?]I@5,<H221
MD"MIHA62*Y@+\R-%& DM**?<:U_&2>K<".KSFU?@L_BFY/W2?$L(PRB_ CM+
M.ITW*R^B->9J4*TRMV%QH[+@8(_,8R/A[$UJ7K@%930WR9/2F1<83[G,[^:!
M!4V,(_=15RU5V[-83$1)%"4PRF+C72F*(9.1A@@KA#5+<AUYY;P=2)@;05D%
M;4#T:;.6][:.[N?U4GH6,SE T8UC+L)F9#YI8:F;)8_0[_24[6$+F1Q(F;:.
MR2DC#\J8G+QP8'9K2QEOUYOW:[8RQ/'>EKFU&?V[ES2*)2)Y',-<8^.?9#2"
MC!$#H^8))HGYQ?W26QV$SNWK/SIM[@RY M:.:L:L+ %5X\IA;9&=AL2--T(#
M_1RNR:48^V?.>H 6-G761?"TN;,>4!PDS_K<.[1QP ^U,H-YL$AMG(^8I3&#
M<6:[[#$408YP"ID@4C*59#CR*HYZ2M#<2*K5TWMYYR22;CP3 I^1N66GXM60
M?90!]?C[$0E<??^$L(EK[?>;?%A9_\SU R.5>B>Z.;#XA?UJMJI?JI72Q7:A
MA,1$)AGDG%!(8IY!*F(!44RC-*6"FE]><4N_O+E1Q(>U^?.WSZ>W68:!&J<1
MTS*%B.6&<".&((]3 257*"(IXHA0OXI/ 6&=ILA3F]+2'GZVA=@:G<&+1FO/
MFM'G4'<,'L,A.78H>1&$_I&E&S!AX\PS,J>-.MT .(A!'6\;NK/W0RW7=[8R
MA/BV6B_7MP\WMEAO&_F(C*J$(0D1L8>B<I5"RF,$B<29X%&B>)[X=D+IE3@_
MJMDI#+8[C8>F+Y^#VW4_+QB$HV_CM=CM506UKB/$DHZX!-ZPZY<Y\3Z=$P"'
MVW-NMPU=S#:ZK[9U LQ-4?[]Y8/A+O'M.]O\_?I742[R6"9,&5(Q'F$&28)R
M2.-(F" RBY2*!(TSKX.7YP3.S4E\I"^P"H.=ON"KU=BWBO<YQ%W7P</A./JR
M^' (!ZR1N^$2>,G\C-")5]#=(#A<4'>\;V!9FV8Y\Z-^6ZR*K7I?_% 'M7FK
M]M +FF.%C/,"4ZXQ)$A7Q6V0\7-B)G(691'Q*V[C+'IN]--J;K>5:MUAI?QA
M^>JFM;9OJ1OW07'CI7&@'GNU/1S*_N5OO $+6P3'7?RTI7"\83DHB./_A%/$
MUAWM]^9O?_ZW]E_,;[:YT9__[?\!4$L#!!0    ( #E&$%,LQR!,FRP! (<]
M#@ 4    8V%H+3(P,C$P-C,P7W!R92YX;6SLO5F36SF2+OC>OR(G[^N@$OM2
MUMW7M&;)KC*ED515=^:%AL41P4X&&<5%*?6O'P?)V+=#\H '(;N=75(H%")\
M^>!P=SC<__U_?CN;_/05YHOQ;/H?/[._T)]_@FF<I?'TY#]^_ON7M\3^_#__
M\]_^[=__+T+^]\M/[W]Z/8NK,Y@N?WHU![^$]-.?X^7I3_],L/CCISR?G?WT
MS]G\C_%73\A_KO_1J]GY]_GXY'3Y$Z><W?[;^5^#%D"U,\1H08F$'(G3G!-E
MM(R2<6NR^+]/_LILBE1Q2IQ4ADBI!0F:6<)=E#Y2S;3BZP^=C*=__+7\$OP"
M?D+FIHOU'__CY]/E\OROO_SRYY]__N5;F$_^,IN?_,(I%;]<_/3/VQ__=N?G
M_Q3KGV;.N5_6?WOYHXOQ?3^('\M^^=^_O?\<3^',D_%TL?336!98C/^Z6'_S
M_2SZY5KF3]+UTX,_4?Y$+GZ,E&\1QHE@?_FV2#__Y[_]]--&'//9!#Y!_JG\
M_O=/[VXL&?T<=>TG?XFSLU_*#_SR:H9P^.A/"KGK?[[\?@[_\?-B?'8^N?S>
MZ1SR?_P<_2DI:J6HN[+F_[CZM[]<+7\^AP4B9LWN>_S&]B/*8ON1 M^6,$VP
M8?%BE<DLWOBA21'P;'[Q+R<^P&3]W5&"\6C]R2_"8CGW<3F*7B:P*I-0?I'.
M*>(EUR0XX4V2.0JN;G)>R%X@W6M]+"#^Y63V]1?\X%^*.,H7:[FL97)GN8UL
M]J/[8OM]P9\=,9^#E5X1$VD@,AE/+"0@E +7EDL;63Z([.NKW:3ZNDY?S.-/
MLWF".=J/B^7\/-[1[TWL;G_BEW,_QP\B\70\21?_NAB2/G2UG/4@N8U:D-R?
M?T*N,\SGD-YOM/(@<VO.EFA58?V3?6C\Q72Z\I-/<#Z;+T=".T>=C\1(Y!\-
M92+6!T<2#9(+EKFSOA?-7U^U$P)X^PC86Y*-(.'+W$\7XR+W+0\:DJ'<24(Y
M:"(-\N!]PK. @?0I)P[6]&,';JW<"1&B?40<)-&!4?%FNAPOO[\=3^#WU5F
M^<@P &#!$F;1'Y!*R"(,I)V:*")Z53K(@]!P>\5.*)#MHN @"3:A_4]P,BY"
MF"Y_]V=XNCETJ14X= 9U1/1&]*E99D0G'QEW*G#->T# S54[H4"UCH(#)-D$
M$MYA[#9'$[86_&>4/[R:K:;+^?=7LP2CD*(+"0,H9 )E(X!C%&6 0++2H'A
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M$FX '>NL\0V1(+YMYH9G/,D-E"8Y$=T_Z8D%D%HD%92L6-5P@Y9A4T3](^5
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M@M>9'=T?ZJHUK!@8=;NHII%I,9]7Y^>3M<C\Y$)D[Z;H 9UME'8A/!F,T$$
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MQA%>G,QA73^'A_=ZJL>&Y;=P-Y&;<P"KM2:>2=PXM#398TD0R($''J6T0G6
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MO!MP*F1MJ+%=!H_<]]D# V!_-<UZE-G@5_G7#>D:^]$E$3FU)-*2&>(8R3G
M,,LF&4!2Q7CHU JBXWW^[?5;J?HZ[JG3@RX&1M+O_@RE=H.'[=XRW&B($4@P
M2I:.9YF$H 41/M#H0#IO.C5SZ 2H!\D8KE;H4+W.^A;RT)/5_O'Y%0H- _ _
M7LWFN(766MC:3F5M]L%YDH3$S1.D)<&AH$(&Q5@07O/0X;QY;(WAD-"3^F85
M9#GT:)?SY>KLT[>+,NDRAD8HW!36 1*N$_$F.Y*R!!JR-Y1U<3IN?.APQ6+]
M:WU_:340B[R:K><I;)#Z:;SXX^7WES"-IP7#:^/(-&@+A1^JH;Q&9P2QRLN
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M/ XE/FO)HHI4WRY&O'\LXQ/K-%M2N(N^;TQF[%.P+92,K>\:%3?9".[0OKM
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M61*R02IU-E0 >H^YTQW#SGQWH:Y9 [D+6NZ.4^Y9+3^TZ?SL)[#X!,O5?+K
M?_UB,IG]Z:=Q<)_P2;K:,:V[B;"^J?6)T6"Y)"K'LGG0/ 0I 8-BL(C[A$%R
MI\88#9C:XO1\@J\P7>&^B#/4QK6AFWDV?U#T(YJTL$Y'$G-T1(:8B44[0A(#
MK@7N[@A=',J]%F_6K.Z"C.M^9WT5-)"!N\OD==:V#+^]R? H&*:"5X$@GZ5_
MABUUU]02SEB.R*%VJE,7DIWWVC[4-MME<A]<'DUM/_;Q?SH^/\>_P'_Y-_P?
MDG$R],'_,$4-'?D=Q7:$N,HI(YA*!(VJ(9))0RS3G%#+C&-*95GIO6&]6LYR
MC)1=.\9#9#&;I,W%M+7!,DB:9,_11@CDUJEB,H :G6)TXG8CZ >OY^]=H-E#
M>Q<-W[Z1/UR4 Q?N?)S/TBHN/\P_;[A8UZY)FZ((BA.NHB;2)$:<**/7LQ,)
M<A)9]U>_<Q\%PU[/]Z#468\2;@,AI2?&EH/%]M4Z5R[HK%EI7@ZEE[DCGIM(
M;%!&*P,">'^%O@^2,5S%W^&:O0N3 \7<@)M_<72_N#JZ+\OBI.)1 .%>!R+!
M)N(L;J/(RB,SXZEBG<S*[CV+'R)I<.P<JN[;_8E[D7T#Q82W3?#[RQ($X3#&
MY=820\M8HL L<2%A#*R34=G;R"S=TTUYWT;Y8'_'3[_2;,&VP*1@^E>8PMR7
M4I47Z6P\'1='KD0-;[Z=PW0!(R9 AA1PX^B(8$_,E:)91VRBUHH<L@UUBGJZ
MT=>6=[,G&&Y;GOXU\R/F!4K)TZO9^ELP+=\8)AGP(!F#9P"Z">@(U2!14I,%
M(UJZ4I9&$[$ZX%Z0H"!9X"G4\57J7:?>$>WF8-&2.NFS(&D]@PV<)\')3% "
MVOF<$M-U'LO?3T^S:8)=$'%W4L_!HA_8*?MP/IZ-\:Q8CD\VRBBQ#F,QTZ0B
M\<X8I)]EXD,T)%D99(0$-OL.OMA]GSTL#/K0UZQ'X36F_&VD@DQCK"(B,:7Q
MJLR +JEVDJ0D(5CJ%'"YA_J'#.O[T=8CJM]#= ,K_\MLZ2>WV=A&E<&APZ:\
M)L'R,K\S!&)+[Q@OI38^&,]N)PKO1< C2[0#@WTT-^M?C U$87>LXU4($9(,
MP+TGC%I9>@O&TN7%DB05>OW&: 5U2B,>IFG82]D>3Y*>Q=\ D'[%#56X^03K
M/E9?9E<[XS,LEY-U]^51C#PXYQ71ZY?T05@2F*,DF:A!,.N U7%0.Y'7F*.R
M)Q9NO]7I73&M!O.OQ^4YR;I_[KJZ)OYK-5ZLJQSVB<D?^[1>0NO.Y/84(;]<
M+1!0!6-G 2FY:"Q7GH5=6_LR1E)298' (\*ETOXF.V*S,$0'R;U*@F96YPW%
M;G0>/C[BSFKEY>UDMD"]?$'1O\2?_F-D>!8)N" A6(6N0H[$*NT(^,Q#]!;=
MQCJ]_+O1-ZSEJHBLN[,D>E?7,S1G:\>C9Z.V_<S:INT^TH<Q<$)*CS $HK)Q
M1%I#B2NM##4-V2(R=4QURA&/:^"N>HGC1CF?+?SDU_EL=;YX-XV359F0L6XT
M4-R.%:3MTW#4$_[U[ P^H_;7#L)+/RF%JI]/ 9;K&X&T)M)/KG;?XFK[T0"9
M SHHH$N-(C/HKUBA<8=S0;4.UL8Z;MX S#XKT[L+YA\>F-LFD)ZA';]Z<;;W
MU=$NGU[;MC_.3CTK?Y78-YXE9DPB1C%*9!F*X!,H L)"5(Y%KNMTZWR,JOXL
M^,4JUX7^\ONU/VTR$B*A(P71$45#PF"N2($K(-H;K;,4&-[5>3^X*Z7-V<[]
MD/2PI:R@L 9R/7N8])??=SHTUGEZ;96*@04BM&>EU[0AW@6)&LF:)A07TW42
MD,?AKY5AZ34P.FL>, ULHYT8_-V?74R8 B<TC2(2*E(9^N,\\8(!,1 <:!5\
M4G6&]NY)\+! ;Q%[L^,#8>";Q]_]U_'?P$^6IQ>SU%VR2K.2<(XH+Y8DL=Y8
M8GRRAF6?HN]2^WG[<X?%VE$4.>M)J@U8P'<8#^3Q=+R$]Q@UW&E6]O+[;_Z_
M9O-7$[_8;K)HE7 Y$^.$0*<L,Q*4QYU&8QF#%Y@4==S['0EM973Y48[V>BIL
M'Z%7S%W;S9H%1PTKN]E@Z*!P_WD3.!$Y*=SH+(&I4V^X![%#G\T5P;,;4 _6
MY, '[$=4&DJ\/.W^"O/O%SM_>RXHD4O'6$.DL?A+5+'4*'#"F77<9Z&B[-+A
MX=%%FH;2X>J=U9!U"P,>UCO+"<ZY THL0\,O(5#B1+(D.Q7P/\:C[W094F'0
MQQ&FK%8\)_<7<PO8V$*:!D2P,0$=THAVMVP9"V7$<4X^!&ULNET<_.,,_]A)
M90\,_]A%?@TX/?=LA[4HC"A##*0E/(9B+T4I0\J:I"A *HTAL*V3>'B H&''
M\!W5S>Y#)8TBJWPYAXLS60BPAH(ECI:9"C9!>5_&"6B?(T!.5-69S_PD:6U<
M5AP$@ Z@VE\;@TZ=?]HMR\%:804EP6BTP<(G$CQ;>VF*@P MLGO>+G#/ZNSL
M\.XBV8&CI%>H@_'BVA7V>@]E19V77I!(E2*2"H:'O8#" (8(:)9SMAV@<>^'
M=X*$>M9G5#^";0T9VRWCM0&-:Y5B&81TRHRX8#EA65O/7*F>>:I$XY&/'^Y)
M3 \*>TS]>TBO-0!<^.Z6R<1C)K@Q\(#EUA'/(!,7A4XL@\MF+P ,_2:J%Y4]
M!H$]Y-?,)=5Z,X3@)?,!MX O4W%"#B0X/.:HBDQ*FB/GIH/F;WYJ)X7K9W\>
M'"#*9D"PW1 L<!NXHL0+AQM"&G1T$F ((;0'D8QE9C<8#&WZ#]'-O2K>0U#-
M*'EKI8075$F)0A ":2_]OCRZK20#A^1M8#ET29"W<1U]N'8>NV/>150-I!P^
MK\("_K5"<;WYBK]\P7^VAGU$7\=8B.C;%#8R!6(UGE#&)!:8%RSS.LFL!PCJ
M!!7SK ^&/E72)K*V>RUG$,QE]* 3E^A&1X'NC@7"DT-3ZY,"6Z=.X4&2!BXV
M[$/A3X-H#^FW!Z.ME8V&<<X2)VA043[1!.*RUT0QZI7-$+FMDP>]EYSFX+./
MJA\'T!YR;P \]UCK]Y?/QCF7PNKRVL<X6W@IB3D:28C!&9M]"+SN:XC[J.H$
M)?M#G'.]*6?0U/H%-Q_]]_6HQB^S;5;Y@CU8_ [+#[G,"]K^31H9;:D./A!+
M W)GG"1!"4NH,XPQZQC0.C50NU#97+I^3W3,CJ2H!NS=Q_DL J3%6Q3GM5S3
MU7:&Q<C3Y#C7KL0FI?=E5"1D5YKQ,/0U,%8)5-?!WM/$#5L96@]R/:MEZ&*Z
M.7SQWTKGE-)>X)*=$0]H]DV4Q!;I2!<<L0:= ^E-B FX]J[+1=$#'S]L-53O
MV.A+D U8G3<HDN7WWV!Y.DO7AA:/;)0I\N2)L1Z=1<4L\1ZY8E*"!F:C%75R
M" \0-&Q!3#7KTH?X&T#1)T@ 9\6K_'TV+0]"\//Q9T_>37$-9&K#YBL_GW\O
M?=_/2O?2D;>)*\7R_T_>NRVW=21KPJ\R,??I7>=#Q'\CRW:/)]260]:>B;Y"
MU"%+PC1%: .@;,W3_UD@(5(D2"Y@K<(J>J*C;8F25^7AJZS,JCP G<:"0F02
MGDLI0PZ%Y9*Y8JQ-''@*M?,^=C?#7W/%S7[<K;Z0P&H5W#;\%?$2RW*[ONX7
MMEUMU^%R$U(5YT(8C2HQ"\Z[",K4*<HV1HC9<YF81,N'=(D=O."\KV6-CL06
MPN[ O%T76M96<]4+?,QFLQ(\+Y[V@8O5"XP6HLH.<LHERN2XN9^&-6E1]S/D
MS7L)W\R 3:^:#O#V7;'ET[66KU>7FV6^^<U"ZR*%40FX-+NQ/AI"S73Q&"7Q
M*BWC;=ICG$KQO%=FS5!Y%@6^+*#6H1Y_+B\N^(*G++BJ7645NEU<!#Z+.M@N
MQIP#R3:WN<0XA=I! /5_9X">IKCCP>FOP7F)'W;-7"=Q__[W>KG%GU9_7KXM
MU\5R_P,O\LT4V$6*@L>2)!11#P4G8FW6J$$Z)Y%'IST.N?)X:HUAU[#LQ<!G
M4IEV8+^N&;C7]NWI[;!(CGR(; *@K#=^*A1P,7*P2C$EO(W$;Q/S=0*QP_#W
M\MX!6NNM V@>P=JKE-;T^S?+$)<7)&7<+'1F$2F2@I2UA,H@1$'Q5O*":2RR
ME',TTCF6[&%P?7EO".?3Y<L"[MOM1US?955&&1U:!KE(<G\E)O"B&!#&2H-2
M.V[;-*X=0?0PT+Z<QXUSZ[$#R-XA_;@SQ=2=66=C)%>;N-:DTZAY!)$<#\ZQ
M&# UP>NI% \#Z\M[1SF+!CM ZA&LD4N.RP^7KZ^(S,OT]7V]?KVXCNC"\G(W
MPI!V:E)6IWJ#GPKGH+STX!(OH&OFA,K2\C#[C=$@3H8A^^6]T,RJ\3X0_Y#3
M]^&OGTO!M'U;OK\ WDMK9P0.;7?AA%:,@H"B+:A(V]UK9H .I6*+3%PB:P7W
MZ=@8AO67\W@TOZ[[ /K@.^.:YG:9Z[_JB\>7<+%[Y3#%RJ!0@72Z7$\Z"BH7
M2"(E&3C/VC<#]SC2AP'ZY;U.G5>G+PO$]7WNDK[VE2^L+\B0(\ALZMA* ED,
M.@$G$E4Q"O/\3L@MN</ ^K=^M#I1=R\+H+^O5_3+[=??+^H,\,M<M^7GW4BY
MJ(15M40PNX@D95,[(LL(Q42C="Y%V-GQ^BCUP^#[MW[2FD:S,Z<V'<'O9O^&
M1[SN[FIN>TC6O/F%R3(D3_&OP=KFACD&'ND?)B$SS@I?[E?3''P)FXZB8;GD
M+^O=;"9]O2R;N^/V^G5GD1+:Y$FR65ER?8I2$)QUQ*J2.::4S;#6C,TO@Z_I
M'8;9E_?6=@;M=8#1>D/R]K*^8=<P\S9SK 2ALHH9"LN>V+#FNHZWR%"4-<SE
M:)N \!&"AJ'LY3V132'_7L>DO2-NUE=I>[6FC1/(W?CT^6+U%?$/_$(;YS+=
M:Q(T:#C:\]^<9"3:D:1/- CMNU5??PSK#W@[ODKFHFTJ&KC3&91S"AP3M9^3
M\Z5XQ8IN4_K[%%7C"RCN?)M._9N1UJ_2=OEE]ZIQ:!0L[8U2QZ^ E8;V6]X-
M9E$1K$A>.12^5;;G*=3.6Y$Z&:(>%E T5MR+-6HG3_(=^N7S&+B&4WV?!*7+
M(8BD'.1ZN:(R\^!B<2"#$"Y*C=*W*3-O:>9N>Q0\LF]>KS;;.T-2==)HBB47
M@AE&@8Z/$%W-WK).!!83BXW>UX\DM&/C=@R.'I_V.+VZ.O#Y'V&/?H/K+_CC
MU]J-Y6VI/-ZR*!R%+T:6>D+4\MZ<:Z%O 2&D$T5[H7GK^<^#B9VW(O_<J)Q,
M;2_VQ+UQ.KZ^VY?</?M?[/;OZ1.:6U-TGA-^2K&=Q3/0";USU5VL_8N#"Q02
M9P.<AZQ9TIGG-B:HJ6?PG6SY@A<O2L  (M0#Q)=$&Y8<\YR"%DC;.:4V;]GW
M".GY9#\"!P]LZ AQSSX-X9>0:J[?UY__6F[W-^0[/A;1H_.(%M#(1)&<5! R
M0S Q,VVD#!1J#7C(>'2!GD_4$] PG3 [\.8.26?A(Q%)KB=$$3DHPPN$E"0$
M(8UPFB2DVES?'J)FWBXXS6S):,&?#I[5-ES,Z'#=R3I^M=FLTK+Z#W\NMQ^'
M^ASU?JB=]S4E>>=QQ9H)]!Q^F0V9:\,T9,8<G:'>0E R4#"<>&;<9]:H_T,'
M-S:[AI(HC'61]CSCDM^,A[0JT*EAG>=6BF#/&AL?(K)C?^X8_)QX4W.TFKH[
MUXF-'5.[6'_7:1EMO4PW"($B>: PGY'K2E(LA6DZU5+1$<^P[1X0-G-CX5:
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MY.L?U:O%'>8#"2*[A)!T(<PK3YA'S2$+I(@A$X&Y3<K-8!+[0-6T'M"T>NG
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M]?9!ZLC"Q&"\U!R<MW6;H@*7B3F7G2G1&</NU^5/!+JGZ>K6 3L1!ZMF2ND
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M(OI%UCXSAV<14VV"QF+@=4Z\@:B#!Q:B<E[+Z,Z;QWM,6M0Y6XDUP-0I*N@
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MH@2A(IVI+@5PFG'RLWA@G#N.]QMY3]]8Z_Q%\6,<D]%BG!L*AUL!,95C0F[
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M8\=S8EKF?']TZ_G!^1W%\_?KF0^?IZON[S'YXZZHSC7\X]":,\S_>);UMB-
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M>=\K)@/%U +MP*"\7GWZA.NT#!>_A\^XW@/<1)4UDF,G32$_+]&OF$' $)7
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MOS\8[=OQA*@#E@S%AEH51E()A>2#1&1@,:+V;5JD'B2G._B<HNJG 72"W#L
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M3K_[:[:ZR-JP(KTGJNN>K&P+^%!WEPO'A4]9JO26B=GULZ?%PE@Z6XPHP,X
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M"+S4K:R\,'".Y$#^#Q-1,6,%GA+PQS S\4#UT\/^9)KO /QW1_R7^2Z'B82
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MO%J]B_^\F=WV&+S[:[:Z4"F9Z# !YZK4]76U5;9N9E3":::,2KI-EG@'09W
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M%0UDYB3CQ81@VMQ=9U7@-$C;^Q8X#1%]!Q!Z]:UH4WVCF?6YCG$7LE;?D'#
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M.=H#5*]^2"\[CX\'S7BRG'RNR%HH>V+_C[R\FMV6^-_"'XM566A)_'$/*NL
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M6#%$)5V@[*".=Q=+8%XK$!R)RY12M?"X7JFJA-3!8.O\U?E.K#CF>CR!OCI
MY>Y.9UX*ZB Y6*T=,<(+>!4D,)%8=(X[@6U\^>]K8L4@/.P]L6*(<CI V8ZY
M"3X*P:.0P(6HK8%2@@L6P3OILD0;1&JT.?*L)E8,4O9^$RN&2+X#_+S:_&R9
MED+D"#+&.AG+<F+#&W!*6&X,KRNE3W9#]CET8.Q[\"#9=X6C+;UB,=>G%\N
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MMK-CS[227@A$*#HX(C%FP$0&$8_DG >7%=VQC>;=_9!]1<V.!J3[&KL15SL
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MG*%3+3N$Z]_,Z]B/P%V$<_[(ZYN U4[>O)+&!:TMV,+)^DXA AJG( 9Z)%A
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MK7L%S5:R8F*9<1LAE5A-,&O(^JII4Z9CD9)4L.&'P&;J .F(C-P%'GM0M5>
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M^2IXY#W'DJT#C9;>7E93O"Y8,-9DS*:8('$'W.SR71.;+Z/A972Z]F'$IKO
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MRZ??VKM/[4U20,KH MH,1=?5%+)NY)4$?JF-%:$(JUN51[:YT+05W5/;/QV
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M$NO(;D5O3<X*Z)VQ+L7,I)&#E.^.7[P3&/T+ F-[]IQ6-<0?N*R]4%_R =U
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M2?V<DD'J@)L5/F1V<6>(!G5EL6"ZE&21V8G,\5/O&Q@"KF/T#0SA= =H?VB
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M\A:"25Y&43(3C8R^'R.3!^*WW<CD(2#HP"&Z.SU5>QN9)!^.V4 DS#J"9RI
MLMDGBZ64@&WZ65_BR.1!4'AR9/(0OG0 JOT)]\080&0!38@(0=>T&_<",)H,
M.G =<M(ZIHE"82<^,GD0N(XQ,GD(ISM ^^-33D,(F IYX-P)<LB5L>""=)"Y
M*=)9D5M-:CQL0.UIC4H>A):=!]0.85T/@[DVDBR0ARB]@2"YKS,^''AO QCO
MBDMHI;0[C5EI,,WM!$:![O-<[T__'D"SQ7IBS&9+YK)D)#?*L@28:T E"1=#
M-):H,"YLNACI-9QECTQS&T*_KL9Y:69C4,I#9N5J#UG1#)AC/'K.7+ [F?N-
MQGDUG^8VB'&/CO,:0L4.S)6]HY^OK\?RD'6HLT0%:$NI\^LBN%SWQ>7DL^+%
M6M]9Z]KK0>.\3F#TZ"&^Y9$1<,J8_S9!\7O=-#I?S>(_\?PBG]7^.E6L!S(U
M99WZF^G]B!R*""X+CD[F[NO][UZI<Q=A9&RV2]4> )1>)"8\3XCP""%NY<CN
M$H*?68\ZFI0A>%N;B(0FFC &45JG6;1,JX;EP4WN=*+5P"/*S/10Z45H#D\L
MWQ12;O:QWE<DW*)U].BG)",9K1Q)D2 '$8-Q*0J;S40EO"/<[D0+=_MX?$:'
MS\3+*/[(Z\_+1<PYT9OZ][]GZX\?%^?U:5U5UJVN=4J\1:VZV4<YPQ-$;D5E
M -W/"0?"T_\H+K(,]WR3!S=6[//=)UJV>AAXC\*H+E: _?IWS*O5>_S[ISS/
M9;;^C>[V,-%_F\UQ'NG^K^)Z]F6VGN7563",E^ 5E+QI,U4<R'TS8*U)0<C$
M^?U-*F/E @XY]HG6>8ZCCX_'\#[P?94,R<LOL^V^M&]N^L=B_B6O:L5;I?-J
M\\+<_O=:I/''8OVOO'Z;X^+#?/8_=014"C'ZE$ 344!I<GL\>@/:*R:S-5R+
M1MAO=:43K;<<22ZZ $HO]OX!GL\_-P2ZLM9^P]ERZ_?0S957 2'791.J^+I\
M+&M Z2QN=H^Y-@+3ZD8[R8M]H?+2!4QZ$9<#_)LGNX W__@+KO,U?<YL%BAE
ML2"90.(9/;Z>)0-%,.=#*,+9AE)TO(ON)%SN)0M7IZ Z99G;_*B:YWK()S\S
M0FI';S0(%>OD"TM\<KQ 9M'%Y#&3UNE+H!ZXQ4[2XG](R[APF#B4="O&?'GZ
M-V6SW>/W^;\R+E=G7DJ-3 3(J4Z-B-F!LP6!J6*CYRHR\5RSR@Y?LUMJC;TP
M[(U-_U-ME7J;:[TBR<^M:L-*A-HKU*Y':I=O/4ISU.#K]]$5Y71F&%2&(&L8
M)XD$6.IB@^R]Y-Y(P=MLQGXI75$B&!6%=\"\5G5G(BD/%1%\,<XZ2?*.C5IO
M?W1%#<1ONZZH(2#HP&J^VR"!WG@>R>17LF[IS#E"X)&>*6XS*K)[),8?75%-
MH/!D5]00OG0 JB;=#ZY@*5A'F+)$[JB)"8(I!K3.0@HCE8@33< \\:ZH0> Z
M1E?4$$YW@/;'6VMR,4;+Z$'D7!._=<,-RMITYEQ$[J*1;0I8OJ>NJ$%HV;DK
M:@CK.L#@" YOM*B%(SJ:Q,E\THZ!=^B@6"X1N>5<=A9#?CVHU/T$^K(.,1B.
MC(!>,'] LNGQ63S7#OS/B_G&M[C \_=Y^4F<Z3I_QP8'CMFZ0SD*0!<8V(+"
M%VDYO9==IBOWN&SG;\7(>!XYD]D:7%W4T8Q8#[TCD?@9^?)1^1P@V*HC'>?T
MW)..)#LU1$G:D_.&>X^.>]F3+[:?4@);@ZN#%[!9>=*V_F*QW/ZJ_G?\S#J5
MBPX>O*HV<=$.0D %T>2@F>'"NC9)T>/>\^0K\P^1NHXA=:K9L%?GY^^)>RM2
M-%4O70_+>TLD7,XB_7GS"7\1359_S0E=ZX]YDS)L.$[PT",=9\C@J(3K(\F&
M(5G##3EVP9>Z5TQ"J+T QG%K!(M*[S:XY+M-LBGG2%>0BE!"YZO]GT4#HA/<
M<%>4:3.X[4>2;2A^VR79AH"@ SOM;KR=FRPL<@3''0?%G  OE0*'VDH5N$-L
MHP)>9))M$!2>3+(-X4L'H&H23)=.$='('N.:;JZ\TN!CUA!9SE(P])DWTJXO
M/,DV"%S'2+(-X70':+]E\]5<S<;F>_ONKZMLC5"16TO/D(T!5 Z\=@8@U)F.
MOE;6.=\F*/3DL3H/H#9'S:(5"SO XQ@5I@ZC"H4#1T$OER"]X#*GNX=DHM3&
M1/4CX=:O\7!D!)PRYG_][XO9^NOO<Y+_BPU7WI"GOGS_$>?;6.UU0.GMK87@
MB5@0!-.0C/!U?H.L4\XC2(_1.I4D[VWE[5[W[/R5&!G%8PE1>TA]'P*W77<O
M99921@DR6D:*D$<(UG@0]>_$3:%X9]OWAE[Q1,7L"#@_ODCN ;K362^]-WGN
M]F>>N<*<DNA!NHR@L-2YWY)#BM$)F8FSLK/%>@-O>*+9[9<DD0= [D4_CW?G
M$)RQI#!XHR";G#?% .0F:"2]Y:W0BND@.NL&'GC#$TUYOR11/ !RPT717XKB
M/'^H.9_W)R"1V]V]MRA$S%+:! 7D81"%C#6 GE>"(;/>%*=-FY4C1[SDB<[9
M>TER>1CPO@?1O&_6,VV3S:Q "B*0%<$\.)D225*1*I02@YHHAW147[*_68$O
M22P/ =VI;X3>G3C/#OFYS6B'3K"@&7"M!2AA!?BZXB,Y8G$.2I-R.E6Y'4*(
M$_5+3R8@VPR4+]HEW9U\9]E:69(S$$6NJ52;B6:>0V!>2TQ)AMC9W/01;__B
MX[SMQ*=#53 (R]]=C'B'&7XQR""TA6)UW11="Y"8<F"YE]Q9(:1O-)*F%Q*<
MZ&O^7>F#EJA^T4;!W:#A\X1S'&,R*8!4G"Q#'S,$96N/D,0BBHH2.]OA-38)
M7GRD^P6H@Y:H?M'J8!NKO"!4/T\U[[G2:6-*V1HQ$74S+$I@,08ELI#.M&E#
MZ./^+SZT_@(403,\OV@M,,"[4ES&4%B&[,F&(BHI0-*9Y&<E)H-+,HM3<P]&
MCA2<<A3_!6B 1E@>-0-PE';R5REM6N;QO$X1?JH5>KN8Z>O8W>/[GZ!AL_A(
M9.FC-]Q8'07+!8QS#)1A 1QFA*A34<BLSKY-Q=]+Z0TW:%BDEQ^2K?,KC48(
M(7C0R474P1$-&Y5,_N@-'XC?=KWA0T#0@1UXMTW4)%M*B@R80D.NK(X01'$0
M-!8M(_.:M]D8_2)[PP=!X<G>\"%\Z0!437H_+0M!JCHB6,@$*AARL) ',"K8
M[%@QW$_4(W+BO>&#P'6,WO AG.X [4\W%BNF-=*[!$)4OR!M=O<D!\X+$Z(L
M@3>::?^]]88/0LV@WO A+.P CW_F95DL/^%\.S]MM;U&,IR5X#T44>/4PAKP
M9#.!*RR@*=PBMBF,?.1 G:=&CXW!,=C6 ?I&*"!+VDL=<WV+Z@]$#EBDA2RB
MY4%:EWQGG=>O7]ID@D-,UR,CH /,M]O3C"H'ET0!B9$(X2SQP1 AE'+2A>A+
M<FV,WFD7>O=7(+<G-H^VT'L(4+H8WGWD2:_!8\JQ(,0LJPV'$@(7'J(4.:B"
MF$6;R?D=#@_NK]RL<^DZ'%)=B-RQ2F8V-+W)C&DFH\VU'R AV1**%? Y*2*6
MU$'&XJ,XM4[)I^Y[HB5>XXC@"4"L WMQ;RIM?MQ;#HW*)B40@6=!/J<FA>3I
M%Q <O?TFH[6A,V_I@5N<:#G4Q$)S*!Q>VDC[^R&4'F;:[WZF28?:[TFZ/BH7
MLD;F-3J0)4I0-A@()&]0L@^(4I,XM!F0\E(J%T0RPF*TX)(,H+BV@,Y(J-$>
MSJ44"1OM%?M1N3 0OPU71P\ 00=&U-TDIN+6)AT(8X$Y4")(\#XHD%XQ@=Y%
MH]HX&2^R<F$0%)ZL7!C"EPY U20K)'-BB1$UD9DZ?)V3=U+75Z#FP4E7G/ 3
MM3J<>.7"(' =9:K] $YW@/;'4H[&)><]2HC2,U#9>PA">F"B\,*SYKS1//M#
M,L6G5:TP""D[9HJ'L*T#](W@=6<?O?1$18_<U0$C]&(9'\CC11NTS,**-O6*
M/S+%8Y@*1T; *6-^O^%9,B6'02"PJ#Q11T= $P+D9'W64:#%SG8\?)\S[ >A
M>-H9]D,@]<*S7M\,%&=9I)0C")T2*-0*T"=)LL$9P^*],Z<VI_=[GF(_".G3
M3;$? +KO;D+162@\:B8,.(D1U&;5;[*._IH-*UP7;T\M]_P=3['O4R(/@-R+
MMDCOC127='4KZD1([NN8%)< I3<@9!!!)B69:I1C.-(-3[3PXR6)X@&0^QY&
M97\[3+P$+7()#H2-O*[<4."S\\",3J8X)ID_M5F=W_<4^S[E\C#@?0^B>=^L
M3\1$880 D84C^O $(<L(5K+@+0^>EY.=AOT=3K'O4RP/ =V/*?8/SC$2'#EY
MY!*T9*DNE2LU,)Y IJ!Y[=MSZM0>U.]SBGWG(=EFH/Q>8K8[3/3+-L7 )!C/
M2&?SDB'H8""6@IQC<5&>[%+2'W/LVPE0A\I@$):_NRCQ\^3CR#!(KH$S)L@P
M4@4"N2F@LV$BH%4LMQGBT0T)3O0]_Z[T04M4?T>1ZN<)%UE2180"1FM.[ ^1
M_"17(%H>&;=*N?QCCOUIQ[I?@#IHB>H7K0X&S?UFQ'*OG82<O"4E:A&P, /"
M22>,XLR<W'+F'W/L7Y8B:(;G%ZT%!GA7P?AH7?& -C!0A0PI)X0&)9EV:&LA
M0&<MV#_FV']7&J 1EGO* 83GZ1;NT^UV__S;2I@5V4JQPO=#/G-6^A0E R$=
M*<+")?A4'*CHO"TN:2,;=FV-?9V=I-3\D-(=I712M)W6V(9'=B0\-'#@R+LC
M=CG"\9='#"9,'S,84!>K@T_D+CJ";1)U@4N-,$=ELLM2\-A&7;Z4&0S%&:%4
MU*#1>GING8? @@84415OZ2=O,Y[WQPR&H?AM-X-A" @Z\+[NMF/;R )3O"Y"
MQ#K&(@7P9#""R<(%P4W)I0V"7^0,AD%0>'(&PQ"^= "J_0GW1+\U)J\9TQP2
MSYM<1QUH+)#^RJ1S*0GR;W[,8-@)X@> ZQ@S&(9PN@.T/];,KZ7D0L<$PMA,
M[U%&0!\0F$F!:Q:=Q3:=2]_/#(9!2-EQ!L,0MDV(OM5R??:VTFXCPXDK%4J.
M@-HA*!9JW6<R$(0E0C@IT.W4)DZ?>@MG]+?[&+OSM2]E L(^#_7^].\!-%NL
MRQ #&DG6,DNJ!@@SN()T>RT9BY@,VIW6M^X.FRE5T0$LN\_T/>@W,=O_8S:?
M?;KX=+40)PH63<6YY0F4*06\+XQ.GQ,:SI(6.^4[=F+\G:^>F/7[,&XQ!A4[
M,%1&J*D62B0?H@,A8J0;RP(80@0GDW16&:]-9RV@KP>-ZVE7\-*%5WED!'2
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M,#(Q>&5X:&EB:70S,3$N:'1M4$L! A0#%     @ .4804VV[OID#"   M"<
M !\              ( !.@@  &$R,7$T7S$P:W@P-C,P,C%X97AH:6)I=#,Q
M,BYH=&U02P$"% ,4    "  Y1A!3U#G<KNX$  !M%P  'P
M@ %Z$   83(Q<31?,3!K># V,S R,7AE>&AI8FET,S(Q+FAT;5!+ 0(4 Q0
M   ( #E&$%,#UDNW+QH  '*=   ?              "  :45  !A,C%Q-%\Q
M,&MX,#8S,#(Q>&5X:&EB:70Y.3$N:'1M4$L! A0#%     @ .4804TH3C,9S
M#@  E$4! !X              ( !$3   &$R,7$T7S$P:W@V,S R,7AE>&AI
M8FET,C$Q+FAT;5!+ 0(4 Q0    ( #E&$%-I%XT[P 0  #,4   >
M      "  < ^  !A,C%Q-%\Q,&MX-C,P,C%X97AH:6)I=#(S,2YH=&U02P$"
M% ,4    "  Y1A!3)U#1U.)Z! !.HC( $               @ &\0P  8V%H
M+3(P,C$P-C,P+FAT;5!+ 0(4 Q0    ( #E&$%/[PW+$!R   -AX 0 0
M          "  <R^! !C86@M,C R,3 V,S N>'-D4$L! A0#%     @ .480
M4Y&DN)H\)   D6D! !0              ( ! =\$ &-A:"TR,#(Q,#8S,%]C
M86PN>&UL4$L! A0#%     @ .4804^\(5_(XVP  O#(* !0
M ( !;P,% &-A:"TR,#(Q,#8S,%]D968N>&UL4$L! A0#%     @ .4804PCE
M=3L)3   4%T  !,              ( !V=X% &-A:"TR,#(Q,#8S,%]G,2YJ
M<&=02P$"% ,4    "  Y1A!3\%C8N2E#  !&5   $P              @ $3
M*P8 8V%H+3(P,C$P-C,P7V<R+FIP9U!+ 0(4 Q0    ( #E&$%.#N1-!=S0
M "I$   3              "  6UN!@!C86@M,C R,3 V,S!?9S,N:G!G4$L!
M A0#%     @ .4804]B=8J&86@  *6@  !,              ( !%:,& &-A
M:"TR,#(Q,#8S,%]G-"YJ<&=02P$"% ,4    "  Y1A!3#_"VKQ4[   (3
M$P              @ '>_08 8V%H+3(P,C$P-C,P7V<U+FIP9U!+ 0(4 Q0
M   ( #E&$%.G-6SL2#0  +E#   3              "  20Y!P!C86@M,C R
M,3 V,S!?9S8N:G!G4$L! A0#%     @ .4804_'#6(*@50$ BM,! !,
M         ( !G6T' &-A:"TR,#(Q,#8S,%]G-RYJ<&=02P$"% ,4    "  Y
M1A!3%_RZC;:6 0#BP!  %               @ %NPP@ 8V%H+3(P,C$P-C,P
M7VQA8BYX;6Q02P$"% ,4    "  Y1A!3+,<@3)LL 0"'/0X %
M    @ %66@H 8V%H+3(P,C$P-C,P7W!R92YX;6Q02P4&     !, $P 7!0
&(X<+

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
